| UniProt ID | Protein Name | Mutation Position | Original | From | Mutation | To | Score Change | Disorder Change | Disease |
| P04217 | A1BG_HUMAN Alpha-1B-glycoprotein OS=Homo sapiens GN=A1BG PE=1 SV=4 | 52 | H | 0.237722 | R | 0.237 | 7.22E-04 | No Change: Both O | - |
| P04217 | A1BG_HUMAN Alpha-1B-glycoprotein OS=Homo sapiens GN=A1BG PE=1 SV=4 | 395 | H | 0.638279 | R | 0.699633 | -0.061354 | No Change: Both D | - |
| Q9NQ94 | A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens GN=A1CF PE=1 SV=1 | 555 | V | 0.438181 | M | 0.492859 | -0.054678 | No Change: Both O | - |
| Q9NQ94 | A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens GN=A1CF PE=1 SV=1 | 558 | A | 0.421698 | S | 0.488868 | -0.06717 | No Change: Both O | - |
| P01023 | A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 | 704 | R | 0.411148 | H | 0.405604 | 0.005544 | No Change: Both O | - |
| P01023 | A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 | 972 | C | 0.235061 | Y | 0.285407 | -0.050346 | No Change: Both O | - |
| P01023 | A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 | 1000 | I | 0.495642 | V | 0.511447 | -0.015805 | O to D | - |
| P01023 | A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 | 639 | N | 0.511368 | D | 0.522565 | -0.011197 | No Change: Both D | - |
| P01023 | A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 | 815 | L | 0.082767 | Q | 0.134303 | -0.051536 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 207 | G | 0.306967 | R | 0.282309 | 0.024658 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 970 | C | 0.400512 | Y | 0.46009 | -0.059578 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 1131 | T | 0.470985 | M | 0.394069 | 0.076916 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 1412 | T | 0.23761 | A | 0.192253 | 0.045357 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 850 | D | 0.368522 | E | 0.376057 | -0.007535 | No Change: Both O | - |
| A8K2U0 | A2ML1_HUMAN Alpha-2-macroglobulin-like protein 1 OS=Homo sapiens GN=A2ML1 PE=1 SV=3 | 1229 | H | 0.236278 | R | 0.235917 | 3.61E-04 | No Change: Both O | - |
| Q9NPC4 | A4GAT_HUMAN Lactosylceramide 4-alpha-galactosyltransferase OS=Homo sapiens GN=A4GALT PE=2 SV=1 | 37 | M | 0.016624 | V | 0.013765 | 0.002859 | No Change: Both O | - |
| Q9NPC4 | A4GAT_HUMAN Lactosylceramide 4-alpha-galactosyltransferase OS=Homo sapiens GN=A4GALT PE=2 SV=1 | 183 | M | 0.068237 | K | 0.12558 | -0.057343 | No Change: Both O | - |
| Q9NPC4 | A4GAT_HUMAN Lactosylceramide 4-alpha-galactosyltransferase OS=Homo sapiens GN=A4GALT PE=2 SV=1 | 187 | G | 0.048751 | D | 0.056398 | -0.007647 | No Change: Both O | - |
| Q9NPC4 | A4GAT_HUMAN Lactosylceramide 4-alpha-galactosyltransferase OS=Homo sapiens GN=A4GALT PE=2 SV=1 | 251 | P | 0.172344 | L | 0.096521 | 0.075823 | No Change: Both O | - |
| Q9NPC4 | A4GAT_HUMAN Lactosylceramide 4-alpha-galactosyltransferase OS=Homo sapiens GN=A4GALT PE=2 SV=1 | 163 | Q | 0.092387 | R | 0.091019 | 0.001368 | No Change: Both O | - |
| Q9UNA3 | A4GCT_HUMAN Alpha-1 4-N-acetylglucosaminyltransferase OS=Homo sapiens GN=A4GNT PE=2 SV=1 | 218 | A | 0.220401 | D | 0.292543 | -0.072142 | No Change: Both O | - |
| Q9NRG9 | AAAS_HUMAN Aladin OS=Homo sapiens GN=AAAS PE=1 SV=1 | 15 | Q | 0.625506 | K | 0.64396 | -0.018454 | No Change: Both D | Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550] |
| Q9NRG9 | AAAS_HUMAN Aladin OS=Homo sapiens GN=AAAS PE=1 SV=1 | 160 | H | 0.102137 | R | 0.102067 | 7.00E-05 | No Change: Both O | Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550] |
| Q9NRG9 | AAAS_HUMAN Aladin OS=Homo sapiens GN=AAAS PE=1 SV=1 | 263 | S | 0.384677 | P | 0.362622 | 0.022055 | No Change: Both O | Achalasia-addisonianism-alacrima syndrome (AAAS) [MIM:231550] |
| Q9NRG9 | AAAS_HUMAN Aladin OS=Homo sapiens GN=AAAS PE=1 SV=1 | 108 | K | 0.146658 | M | 0.086478 | 0.06018 | No Change: Both O | - |
| Q86V21 | AACS_HUMAN Acetoacetyl-CoA synthetase OS=Homo sapiens GN=AACS PE=1 SV=1 | 118 | I | 0.198832 | V | 0.233491 | -0.034659 | No Change: Both O | - |
| Q86V21 | AACS_HUMAN Acetoacetyl-CoA synthetase OS=Homo sapiens GN=AACS PE=1 SV=1 | 470 | A | 0.30744 | V | 0.232886 | 0.074554 | No Change: Both O | - |
| P22760 | AAAD_HUMAN Arylacetamide deacetylase OS=Homo sapiens GN=AADAC PE=1 SV=5 | 281 | V | 0.197801 | I | 0.171544 | 0.026257 | No Change: Both O | - |
| Q6P093 | ADCL2_HUMAN Arylacetamide deacetylase-like 2 OS=Homo sapiens GN=AADACL2 PE=2 SV=3 | 186 | A | 0.303939 | S | 0.432146 | -0.128207 | No Change: Both O | - |
| Q6P093 | ADCL2_HUMAN Arylacetamide deacetylase-like 2 OS=Homo sapiens GN=AADACL2 PE=2 SV=3 | 343 | L | 0.214426 | I | 0.178238 | 0.036188 | No Change: Both O | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 195 | C | 0.014518 | F | 0.01619 | -0.001672 | No Change: Both O | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 47 | S | 0.355444 | P | 0.327017 | 0.028427 | No Change: Both O | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 71 | L | 0.480565 | M | 0.540774 | -0.060209 | O to D | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 129 | R | 0.146458 | W | 0.059855 | 0.086603 | No Change: Both O | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 250 | M | 0.547969 | I | 0.45578 | 0.092189 | D to O | - |
| Q5VUY0 | ADCL3_HUMAN Arylacetamide deacetylase-like 3 OS=Homo sapiens GN=AADACL3 PE=2 SV=4 | 280 | P | 0.199644 | L | 0.110924 | 0.08872 | No Change: Both O | - |
| Q8N5Z0 | AADAT_HUMAN Kynurenine/alpha-aminoadipate aminotransferase mitochondrial OS=Homo sapiens GN=AADAT PE=1 SV=2 | 243 | V | 0.125856 | I | 0.10939 | 0.016466 | No Change: Both O | - |
| Q6PD74 | AAGAB_HUMAN Alpha- and gamma-adaptin-binding protein p34 OS=Homo sapiens GN=AAGAB PE=1 SV=1 | 132 | I | 0.208014 | L | 0.240895 | -0.032881 | No Change: Both O | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 509 | K | 0.963121 | Q | 0.976406 | -0.013285 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 59 | I | 0.050197 | V | 0.064878 | -0.014681 | No Change: Both O | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 533 | Q | 0.991748 | H | 0.986104 | 0.005644 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 603 | V | 0.993266 | A | 0.994645 | -0.001379 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 694 | T | 0.789249 | M | 0.757225 | 0.032024 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 725 | P | 0.79936 | T | 0.772157 | 0.027203 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 771 | P | 0.671456 | R | 0.609626 | 0.06183 | No Change: Both D | - |
| Q2M2I8 | AAK1_HUMAN AP2-associated protein kinase 1 OS=Homo sapiens GN=AAK1 PE=1 SV=3 | 835 | G | 0.76329 | D | 0.808451 | -0.045161 | No Change: Both D | - |
| Q13685 | AAMP_HUMAN Angio-associated migratory cell protein OS=Homo sapiens GN=AAMP PE=1 SV=2 | 250 | I | 0.321692 | V | 0.363787 | -0.042095 | No Change: Both O | - |
| Q16613 | SNAT_HUMAN Serotonin N-acetyltransferase OS=Homo sapiens GN=AANAT PE=1 SV=1 | 15 | R | 0.978013 | C | 0.969655 | 0.008358 | No Change: Both D | - |
| Q16613 | SNAT_HUMAN Serotonin N-acetyltransferase OS=Homo sapiens GN=AANAT PE=1 SV=1 | 129 | A | 0.272049 | T | 0.283284 | -0.011235 | No Change: Both O | Delayed sleep phase syndrome (DSPS) [MIM:614163] |
| Q4LEZ3 | AARD_HUMAN Alanine and arginine-rich domain-containing protein OS=Homo sapiens GN=AARD PE=2 SV=1 | 96 | G | 0.46704 | R | 0.55037 | -0.08333 | O to D | - |
| P49588 | SYAC_HUMAN Alanine--tRNA ligase cytoplasmic OS=Homo sapiens GN=AARS PE=1 SV=2 | 275 | G | 0.443692 | D | 0.446929 | -0.003237 | No Change: Both O | - |
| P49588 | SYAC_HUMAN Alanine--tRNA ligase cytoplasmic OS=Homo sapiens GN=AARS PE=1 SV=2 | 329 | R | 0.163734 | H | 0.147551 | 0.016183 | No Change: Both O | Charcot-Marie-Tooth disease type 2N (CMT2N) [MIM:613287] |
| Q5JTZ9 | SYAM_HUMAN Alanine--tRNA ligase mitochondrial OS=Homo sapiens GN=AARS2 PE=1 SV=1 | 339 | I | 0.261009 | V | 0.28431 | -0.023301 | No Change: Both O | - |
| Q5JTZ9 | SYAM_HUMAN Alanine--tRNA ligase mitochondrial OS=Homo sapiens GN=AARS2 PE=1 SV=1 | 484 | A | 0.769279 | D | 0.797618 | -0.028339 | No Change: Both D | - |
| Q5JTZ9 | SYAM_HUMAN Alanine--tRNA ligase mitochondrial OS=Homo sapiens GN=AARS2 PE=1 SV=1 | 850 | M | 0.462481 | V | 0.376899 | 0.085582 | No Change: Both O | - |
| Q5JTZ9 | SYAM_HUMAN Alanine--tRNA ligase mitochondrial OS=Homo sapiens GN=AARS2 PE=1 SV=1 | 155 | L | 0.060903 | R | 0.099126 | -0.038223 | No Change: Both O | Combined oxidative phosphorylation deficiency type 8 (COXPD8) [MIM:614096] |
| Q5JTZ9 | SYAM_HUMAN Alanine--tRNA ligase mitochondrial OS=Homo sapiens GN=AARS2 PE=1 SV=1 | 592 | R | 0.091888 | W | 0.03348 | 0.058408 | No Change: Both O | Combined oxidative phosphorylation deficiency type 8 (COXPD8) [MIM:614096] |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 368 | K | 0.278499 | R | 0.21347 | 0.065029 | No Change: Both O | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 747 | A | 0.59127 | V | 0.546645 | 0.044625 | No Change: Both D | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 774 | V | 0.181895 | I | 0.159937 | 0.021958 | No Change: Both O | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 865 | T | 0.361552 | A | 0.324625 | 0.036927 | No Change: Both O | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 1030 | Y | 0.35179 | D | 0.522415 | -0.170625 | O to D | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 61 | I | 0.105872 | V | 0.11234 | -0.006468 | No Change: Both O | - |
| Q4L235 | ACSF4_HUMAN Acyl-CoA synthetase family member 4 OS=Homo sapiens GN=AASDH PE=2 SV=3 | 93 | P | 0.715278 | R | 0.68623 | 0.029048 | No Change: Both D | - |
| Q7Z4T9 | AAT1_HUMAN AMY-1-associating protein expressed in testis 1 OS=Homo sapiens GN=AAT1 PE=1 SV=2 | 207 | A | 0.305344 | P | 0.403194 | -0.09785 | No Change: Both O | - |
| Q7Z4T9 | AAT1_HUMAN AMY-1-associating protein expressed in testis 1 OS=Homo sapiens GN=AAT1 PE=1 SV=2 | 253 | S | 0.756109 | T | 0.714183 | 0.041926 | No Change: Both D | - |
| Q7Z4T9 | AAT1_HUMAN AMY-1-associating protein expressed in testis 1 OS=Homo sapiens GN=AAT1 PE=1 SV=2 | 320 | S | 0.548862 | C | 0.406662 | 0.1422 | D to O | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 118 | T | 0.516674 | M | 0.464325 | 0.052349 | D to O | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 81 | S | 0.559946 | F | 0.379307 | 0.180639 | D to O | An ovarian mucinous carcinoma sample |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 97 | L | 0.344296 | V | 0.337902 | 0.006394 | No Change: Both O | A lung adenocarcinoma sample |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 104 | M | 0.506937 | V | 0.470361 | 0.036576 | D to O | An ovarian mucinous carcinoma sample |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 703 | G | 0.941947 | C | 0.923543 | 0.018404 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 815 | S | 0.989642 | R | 0.984941 | 0.004701 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 923 | S | 0.862183 | L | 0.749714 | 0.112469 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 1160 | E | 0.994378 | K | 0.992089 | 0.002289 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 1192 | P | 0.944501 | S | 0.947987 | -0.003486 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 1266 | F | 0.953205 | S | 0.972033 | -0.018828 | No Change: Both D | - |
| Q6ZMQ8 | LMTK1_HUMAN Serine/threonine-protein kinase LMTK1 OS=Homo sapiens GN=AATK PE=1 SV=2 | 1332 | A | 0.962587 | T | 0.965098 | -0.002511 | No Change: Both D | - |
| P80404 | GABT_HUMAN 4-aminobutyrate aminotransferase mitochondrial OS=Homo sapiens GN=ABAT PE=1 SV=3 | 220 | R | 0.233592 | K | 0.284982 | -0.05139 | No Change: Both O | GABA transaminase deficiency (GABATD) [MIM:613163] |
| P80404 | GABT_HUMAN 4-aminobutyrate aminotransferase mitochondrial OS=Homo sapiens GN=ABAT PE=1 SV=3 | 56 | Q | 0.555822 | R | 0.536708 | 0.019114 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 399 | V | 0.351223 | A | 0.442533 | -0.09131 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 587 | R | 0.136976 | W | 0.061025 | 0.075951 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 590 | W | 0.058269 | S | 0.178907 | -0.120638 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 597 | Q | 0.075062 | R | 0.065882 | 0.00918 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 935 | N | 0.517133 | S | 0.576181 | -0.059048 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 937 | A | 0.570547 | V | 0.487625 | 0.082922 | D to O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1289 | D | 0.900879 | N | 0.87871 | 0.022169 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1477 | C | 0.775445 | R | 0.822527 | -0.047082 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1517 | I | 0.12773 | R | 0.214235 | -0.086505 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1800 | N | 0.261819 | H | 0.222414 | 0.039405 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 219 | R | 0.507697 | K | 0.554136 | -0.046439 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 230 | R | 0.526637 | C | 0.413914 | 0.112723 | D to O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 255 | A | 0.653646 | T | 0.695986 | -0.04234 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 771 | V | 0.030968 | M | 0.039479 | -0.008511 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 774 | T | 0.051096 | P | 0.065033 | -0.013937 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 776 | K | 0.064977 | N | 0.053263 | 0.011714 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 825 | V | 0.212714 | I | 0.18874 | 0.023974 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 883 | I | 0.616603 | M | 0.709327 | -0.092724 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 929 | T | 0.231228 | I | 0.139156 | 0.092072 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1046 | A | 0.210752 | D | 0.268169 | -0.057417 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1091 | M | 0.395154 | T | 0.462922 | -0.067768 | No Change: Both O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1172 | E | 0.75861 | D | 0.764576 | -0.005966 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1506 | S | 0.223816 | L | 0.11766 | 0.106156 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1587 | K | 0.311114 | R | 0.252192 | 0.058922 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1611 | N | 0.120599 | D | 0.11471 | 0.005889 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1731 | S | 0.379873 | C | 0.150684 | 0.229189 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2081 | R | 0.165319 | W | 0.068784 | 0.096535 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2150 | P | 0.405485 | L | 0.250886 | 0.154599 | No Change: Both O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2168 | L | 0.459856 | P | 0.597968 | -0.138112 | O to D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1555 | I | 0.573661 | T | 0.704667 | -0.131006 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1648 | L | 0.258401 | P | 0.405418 | -0.147017 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1181 | S | 0.349362 | F | 0.153461 | 0.195901 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 85 | P | 0.378211 | L | 0.202369 | 0.175842 | No Change: Both O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1099 | D | 0.206025 | Y | 0.097309 | 0.108716 | No Change: Both O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 210 | E | 0.451138 | D | 0.411399 | 0.039739 | No Change: Both O | A colorectal cancer sample |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 917 | D | 0.146014 | Y | 0.075604 | 0.07041 | No Change: Both O | A colorectal cancer sample |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1407 | A | 0.425287 | T | 0.495254 | -0.069967 | No Change: Both O | A colorectal cancer sample |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2109 | A | 0.314476 | T | 0.346474 | -0.031998 | No Change: Both O | A colorectal cancer sample |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 935 | N | 0.517133 | H | 0.513299 | 0.003834 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1054 | V | 0.207865 | I | 0.182232 | 0.025633 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1680 | R | 0.26404 | W | 0.117253 | 0.146787 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2009 | F | 0.137645 | S | 0.296254 | -0.158609 | No Change: Both O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 248 | P | 0.672302 | A | 0.593549 | 0.078753 | No Change: Both D | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 284 | E | 0.343131 | K | 0.330815 | 0.012316 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 364 | S | 0.450649 | C | 0.250472 | 0.200177 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 401 | K | 0.291915 | Q | 0.268288 | 0.023627 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 482 | Y | 0.277218 | C | 0.237265 | 0.039953 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 496 | R | 0.218706 | W | 0.089403 | 0.129303 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 590 | W | 0.058269 | L | 0.087983 | -0.029714 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 638 | R | 0.217962 | Q | 0.221385 | -0.003423 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 774 | T | 0.051096 | S | 0.079158 | -0.028062 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 815 | E | 0.546032 | G | 0.477272 | 0.06876 | D to O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 840 | W | 0.024867 | R | 0.064006 | -0.039139 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1065 | P | 0.369956 | S | 0.400958 | -0.031002 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1068 | R | 0.197751 | C | 0.094927 | 0.102824 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1216 | G | 0.285396 | V | 0.192361 | 0.093035 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1341 | R | 0.215083 | T | 0.186101 | 0.028982 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1376 | S | 0.303109 | G | 0.266767 | 0.036342 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1379 | L | 0.254393 | F | 0.22116 | 0.033233 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1615 | R | 0.206601 | Q | 0.233006 | -0.026405 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1670 | A | 0.059751 | T | 0.064605 | -0.004854 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1680 | R | 0.26404 | Q | 0.300448 | -0.036408 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1704 | V | 0.018443 | D | 0.039437 | -0.020994 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1851 | R | 0.093951 | Q | 0.102237 | -0.008286 | No Change: Both O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1897 | R | 0.675569 | W | 0.426195 | 0.249374 | D to O | High density lipoprotein deficiency type 2 (HDLD2) [MIM:604091] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1901 | R | 0.682653 | S | 0.665305 | 0.017348 | No Change: Both D | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 1925 | R | 0.433211 | Q | 0.417435 | 0.015776 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2163 | F | 0.170141 | S | 0.346447 | -0.176306 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2196 | Q | 0.529817 | H | 0.494874 | 0.034943 | D to O | High density lipoprotein deficiency type 1 (HDLD1) [MIM:205400] |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2243 | D | 0.296462 | E | 0.298293 | -0.001831 | No Change: Both O | - |
| O95477 | ABCA1_HUMAN ATP-binding cassette sub-family A member 1 OS=Homo sapiens GN=ABCA1 PE=1 SV=3 | 2244 | V | 0.285853 | I | 0.197843 | 0.08801 | No Change: Both O | - |
| Q8WWZ4 | ABCAA_HUMAN ATP-binding cassette sub-family A member 10 OS=Homo sapiens GN=ABCA10 PE=1 SV=3 | 203 | P | 0.05798 | S | 0.070801 | -0.012821 | No Change: Both O | - |
| Q8WWZ4 | ABCAA_HUMAN ATP-binding cassette sub-family A member 10 OS=Homo sapiens GN=ABCA10 PE=1 SV=3 | 287 | I | 0.187606 | V | 0.211705 | -0.024099 | No Change: Both O | - |
| Q8WWZ4 | ABCAA_HUMAN ATP-binding cassette sub-family A member 10 OS=Homo sapiens GN=ABCA10 PE=1 SV=3 | 916 | M | 0.42608 | T | 0.497994 | -0.071914 | No Change: Both O | - |
| Q8WWZ4 | ABCAA_HUMAN ATP-binding cassette sub-family A member 10 OS=Homo sapiens GN=ABCA10 PE=1 SV=3 | 1322 | R | 0.266098 | W | 0.117596 | 0.148502 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 459 | S | 0.687627 | T | 0.592246 | 0.095381 | No Change: Both D | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1380 | N | 0.563537 | S | 0.628161 | -0.064624 | No Change: Both D | Ichthyosis lamellar type 2 (LI2) [MIM:601277] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1381 | G | 0.568657 | E | 0.606239 | -0.037582 | No Change: Both D | Ichthyosis lamellar type 2 (LI2) [MIM:601277] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1514 | R | 0.30661 | H | 0.27726 | 0.02935 | No Change: Both O | Ichthyosis lamellar type 2 (LI2) [MIM:601277] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1539 | E | 0.502198 | K | 0.485223 | 0.016975 | D to O | Ichthyosis lamellar type 2 (LI2) [MIM:601277] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1651 | G | 0.154676 | S | 0.190826 | -0.03615 | No Change: Both O | Ichthyosis lamellar type 2 (LI2) [MIM:601277] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 550 | E | 0.638771 | G | 0.613405 | 0.025366 | No Change: Both D | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 777 | S | 0.175653 | T | 0.127908 | 0.047745 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1251 | G | 0.042034 | D | 0.052388 | -0.010354 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 1546 | R | 0.199083 | C | 0.099198 | 0.099885 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 2064 | E | 0.309362 | K | 0.318038 | -0.008676 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 2365 | D | 0.563041 | N | 0.563492 | -4.51E-04 | No Change: Both D | Ichthyosis harlequin (HI) [MIM:242500] |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 199 | W | 0.067876 | C | 0.104311 | -0.036435 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 237 | N | 0.682325 | H | 0.623556 | 0.058769 | No Change: Both D | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 274 | Q | 0.424311 | R | 0.403161 | 0.02115 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 287 | R | 0.207501 | G | 0.206033 | 0.001468 | No Change: Both O | - |
| Q86UK0 | ABCAC_HUMAN ATP-binding cassette sub-family A member 12 OS=Homo sapiens GN=ABCA12 PE=1 SV=3 | 476 | A | 0.329152 | V | 0.240577 | 0.088575 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 1508 | T | 0.288612 | I | 0.187811 | 0.100801 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 506 | P | 0.305891 | L | 0.175848 | 0.130043 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 555 | R | 0.223655 | H | 0.226187 | -0.002532 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 767 | I | 0.400832 | S | 0.635318 | -0.234486 | O to D | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 799 | E | 0.121699 | K | 0.125349 | -0.00365 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 1434 | I | 0.149903 | V | 0.166042 | -0.016139 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 1540 | F | 0.177068 | L | 0.211433 | -0.034365 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 1889 | I | 0.064813 | K | 0.14344 | -0.078627 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2033 | N | 0.421849 | D | 0.411187 | 0.010662 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2154 | S | 0.521952 | L | 0.315124 | 0.206828 | D to O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2178 | A | 0.252931 | E | 0.340126 | -0.087195 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2212 | L | 0.111189 | S | 0.213675 | -0.102486 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2436 | K | 0.317021 | R | 0.252909 | 0.064112 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2537 | S | 0.501026 | A | 0.360228 | 0.140798 | D to O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 2674 | R | 0.258574 | W | 0.118214 | 0.14036 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 3142 | A | 0.267075 | V | 0.187127 | 0.079948 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 3851 | Y | 0.472499 | F | 0.445143 | 0.027356 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 4277 | N | 0.39515 | D | 0.448811 | -0.053661 | No Change: Both O | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 4302 | Q | 0.777068 | R | 0.792521 | -0.015453 | No Change: Both D | - |
| Q86UQ4 | ABCAD_HUMAN ATP-binding cassette sub-family A member 13 OS=Homo sapiens GN=ABCA13 PE=2 SV=3 | 4335 | P | 0.513188 | A | 0.430929 | 0.082259 | D to O | - |
| Q9BZC7 | ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens GN=ABCA2 PE=1 SV=3 | 583 | H | 0.322995 | P | 0.363796 | -0.040801 | No Change: Both O | - |
| Q9BZC7 | ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens GN=ABCA2 PE=1 SV=3 | 674 | F | 0.121931 | V | 0.153546 | -0.031615 | No Change: Both O | - |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 101 | L | 0.141762 | P | 0.26888 | -0.127118 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 3 (SMDP3) [MIM:610921] |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 568 | N | 0.399786 | D | 0.416517 | -0.016731 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 3 (SMDP3) [MIM:610921] |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 1553 | L | 0.157968 | P | 0.283137 | -0.125169 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 3 (SMDP3) [MIM:610921] |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 1591 | Q | 0.33146 | P | 0.330711 | 7.49E-04 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 3 (SMDP3) [MIM:610921] |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 140 | N | 0.500626 | H | 0.505544 | -0.004918 | No Change: Both D | - |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 766 | P | 0.407636 | S | 0.421976 | -0.01434 | No Change: Both O | - |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 290 | L | 0.621429 | M | 0.709302 | -0.087873 | No Change: Both D | A breast cancer sample |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 801 | E | 0.48963 | D | 0.419087 | 0.070543 | No Change: Both O | A breast cancer sample |
| Q99758 | ABCA3_HUMAN ATP-binding cassette sub-family A member 3 OS=Homo sapiens GN=ABCA3 PE=1 SV=2 | 1069 | H | 0.129623 | Q | 0.156426 | -0.026803 | No Change: Both O | A breast cancer sample |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 18 | R | 0.169507 | W | 0.069337 | 0.10017 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 24 | R | 0.099508 | H | 0.092235 | 0.007273 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 54 | C | 0.423875 | Y | 0.504328 | -0.080453 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 65 | G | 0.269061 | E | 0.311692 | -0.042631 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 65 | G | 0.269061 | E | 0.311692 | -0.042631 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 75 | C | 0.166113 | G | 0.224766 | -0.058653 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 96 | N | 0.393081 | D | 0.38554 | 0.007541 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 96 | N | 0.393081 | H | 0.345702 | 0.047379 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 192 | A | 0.353194 | T | 0.374447 | -0.021253 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 212 | R | 0.09858 | C | 0.047147 | 0.051433 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 212 | R | 0.09858 | C | 0.047147 | 0.051433 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 249 | D | 0.058763 | G | 0.049194 | 0.009569 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 300 | T | 0.181995 | N | 0.208979 | -0.026984 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 336 | S | 0.191825 | C | 0.071999 | 0.119826 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 340 | Y | 0.179793 | D | 0.305876 | -0.126083 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 407 | A | 0.389864 | V | 0.29701 | 0.092854 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 407 | A | 0.389864 | V | 0.29701 | 0.092854 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 445 | S | 0.201234 | R | 0.16678 | 0.034454 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 471 | E | 0.347067 | K | 0.328157 | 0.01891 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 471 | E | 0.347067 | K | 0.328157 | 0.01891 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 523 | D | 0.177871 | E | 0.204558 | -0.026687 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 541 | L | 0.237038 | P | 0.371638 | -0.1346 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 541 | L | 0.237038 | P | 0.371638 | -0.1346 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 541 | L | 0.237038 | P | 0.371638 | -0.1346 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 572 | R | 0.23034 | P | 0.275244 | -0.044904 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 572 | R | 0.23034 | Q | 0.240354 | -0.010014 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 602 | R | 0.095278 | W | 0.039958 | 0.05532 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 608 | F | 0.048093 | I | 0.049518 | -0.001425 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 643 | V | 0.095036 | G | 0.169295 | -0.074259 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 645 | D | 0.070717 | N | 0.063473 | 0.007244 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 818 | G | 0.246149 | E | 0.294781 | -0.048632 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 818 | G | 0.246149 | E | 0.294781 | -0.048632 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 821 | W | 0.321105 | R | 0.536068 | -0.214963 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 851 | G | 0.032936 | D | 0.041101 | -0.008165 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 863 | G | 0.204232 | A | 0.15461 | 0.049622 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 863 | G | 0.204232 | A | 0.15461 | 0.049622 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 863 | G | 0.204232 | A | 0.15461 | 0.049622 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 901 | T | 0.869744 | A | 0.841837 | 0.027907 | No Change: Both D | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 931 | V | 0.125207 | M | 0.143294 | -0.018087 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 943 | R | 0.173608 | Q | 0.176384 | -0.002776 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 957 | Q | 0.131939 | R | 0.127224 | 0.004715 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 965 | N | 0.414408 | S | 0.45662 | -0.042212 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 978 | G | 0.320651 | C | 0.163995 | 0.156656 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1036 | E | 0.693588 | K | 0.686012 | 0.007576 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1038 | A | 0.704619 | V | 0.642237 | 0.062382 | No Change: Both D | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1038 | A | 0.704619 | V | 0.642237 | 0.062382 | No Change: Both D | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1038 | A | 0.704619 | V | 0.642237 | 0.062382 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1071 | S | 0.223488 | L | 0.118311 | 0.105177 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1072 | V | 0.184295 | A | 0.247532 | -0.063237 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1087 | E | 0.340837 | K | 0.357369 | -0.016532 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1112 | T | 0.361028 | N | 0.385266 | -0.024238 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1122 | E | 0.538297 | K | 0.534456 | 0.003841 | No Change: Both D | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1122 | E | 0.538297 | K | 0.534456 | 0.003841 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1129 | R | 0.146449 | L | 0.091245 | 0.055204 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1129 | R | 0.146449 | L | 0.091245 | 0.055204 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1129 | R | 0.146449 | L | 0.091245 | 0.055204 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1201 | L | 0.430679 | R | 0.518961 | -0.088282 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1204 | D | 0.378324 | N | 0.351308 | 0.027016 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1314 | P | 0.957914 | T | 0.939477 | 0.018437 | No Change: Both D | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1380 | P | 0.033449 | L | 0.017048 | 0.016401 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1406 | H | 0.083529 | Y | 0.05313 | 0.030399 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1408 | W | 0.072892 | L | 0.113283 | -0.040391 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1408 | W | 0.072892 | R | 0.177157 | -0.104265 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1428 | T | 0.205204 | M | 0.178517 | 0.026687 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1429 | V | 0.154634 | A | 0.208729 | -0.054095 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1433 | V | 0.125538 | I | 0.102907 | 0.022631 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1439 | G | 0.257989 | D | 0.272249 | -0.01426 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1440 | F | 0.259278 | S | 0.447995 | -0.188717 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1486 | P | 0.889874 | L | 0.811403 | 0.078471 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1488 | C | 0.896597 | R | 0.91763 | -0.021033 | No Change: Both D | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1488 | C | 0.896597 | R | 0.91763 | -0.021033 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1490 | C | 0.899751 | Y | 0.844388 | 0.055363 | No Change: Both D | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1490 | C | 0.899751 | Y | 0.844388 | 0.055363 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1517 | R | 0.729078 | S | 0.749318 | -0.02024 | No Change: Both D | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1526 | T | 0.432443 | M | 0.383445 | 0.048998 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1532 | D | 0.257382 | N | 0.240004 | 0.017378 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1562 | I | 0.288335 | T | 0.417083 | -0.128748 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1562 | I | 0.288335 | T | 0.417083 | -0.128748 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1562 | I | 0.288335 | T | 0.417083 | -0.128748 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1562 | I | 0.288335 | T | 0.417083 | -0.128748 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1578 | G | 0.123188 | R | 0.113916 | 0.009272 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1631 | L | 0.105333 | P | 0.190472 | -0.085139 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1640 | R | 0.323861 | W | 0.160125 | 0.163736 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1640 | R | 0.323861 | W | 0.160125 | 0.163736 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1652 | Y | 0.44432 | D | 0.611151 | -0.166831 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1696 | S | 0.068576 | N | 0.051718 | 0.016858 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1703 | Q | 0.173441 | K | 0.222816 | -0.049375 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1729 | L | 0.028047 | P | 0.062438 | -0.034391 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1794 | A | 0.089057 | D | 0.121598 | -0.032541 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1820 | R | 0.188111 | P | 0.20647 | -0.018359 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1838 | H | 0.027965 | Y | 0.015592 | 0.012373 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1843 | R | 0.077064 | W | 0.029729 | 0.047335 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1868 | N | 0.381766 | I | 0.218952 | 0.162814 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1886 | G | 0.03349 | E | 0.046459 | -0.012969 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1898 | R | 0.046666 | H | 0.050584 | -0.003918 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1898 | R | 0.046666 | H | 0.050584 | -0.003918 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1948 | P | 0.425471 | L | 0.277439 | 0.148032 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1961 | G | 0.152625 | E | 0.177896 | -0.025271 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1961 | G | 0.152625 | E | 0.177896 | -0.025271 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1970 | L | 0.19669 | F | 0.177979 | 0.018711 | No Change: Both O | Age-related macular degeneration type 2 (ARMD2) [MIM:153800] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1970 | L | 0.19669 | F | 0.177979 | 0.018711 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1977 | G | 0.416344 | S | 0.443311 | -0.026967 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2027 | L | 0.248434 | F | 0.21522 | 0.033214 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2027 | L | 0.248434 | F | 0.21522 | 0.033214 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2030 | R | 0.214427 | Q | 0.225303 | -0.010876 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2030 | R | 0.214427 | Q | 0.225303 | -0.010876 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2050 | V | 0.316839 | L | 0.311809 | 0.00503 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2077 | R | 0.566848 | W | 0.388227 | 0.178621 | D to O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2096 | E | 0.413549 | K | 0.410813 | 0.002736 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2106 | R | 0.226265 | C | 0.12509 | 0.101175 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2106 | R | 0.226265 | C | 0.12509 | 0.101175 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2107 | R | 0.156989 | H | 0.145556 | 0.011433 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2128 | H | 0.371895 | R | 0.38162 | -0.009725 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2131 | E | 0.43957 | K | 0.413962 | 0.025608 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2139 | R | 0.060336 | W | 0.022194 | 0.038142 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2150 | C | 0.124136 | Y | 0.1388 | -0.014664 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2150 | C | 0.124136 | Y | 0.1388 | -0.014664 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2160 | K | 0.358829 | R | 0.285099 | 0.07373 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2177 | D | 0.557031 | N | 0.534074 | 0.022957 | No Change: Both D | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 60 | A | 0.533438 | V | 0.439871 | 0.093567 | D to O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 846 | D | 0.103458 | H | 0.086537 | 0.016921 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1846 | I | 0.109399 | T | 0.198485 | -0.089086 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2038 | R | 0.15131 | W | 0.055777 | 0.095533 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2255 | S | 0.634857 | I | 0.4305 | 0.204357 | D to O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 11 | L | 0.042972 | P | 0.081251 | -0.038279 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 58 | N | 0.600792 | K | 0.653339 | -0.052547 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 60 | A | 0.533438 | E | 0.620644 | -0.087206 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 60 | A | 0.533438 | T | 0.547672 | -0.014234 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 68 | P | 0.146056 | L | 0.070676 | 0.07538 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 68 | P | 0.146056 | R | 0.106627 | 0.039429 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 72 | G | 0.175342 | R | 0.172929 | 0.002413 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 77 | V | 0.192344 | E | 0.352206 | -0.159862 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 100 | S | 0.232729 | P | 0.208738 | 0.023991 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 152 | R | 0.20772 | Q | 0.203459 | 0.004261 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 156 | I | 0.318457 | V | 0.327301 | -0.008844 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 190 | Q | 0.411913 | H | 0.396339 | 0.015574 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 206 | S | 0.145678 | R | 0.117333 | 0.028345 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 212 | R | 0.09858 | H | 0.091318 | 0.007262 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 220 | R | 0.272968 | C | 0.129418 | 0.14355 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 230 | C | 0.142678 | S | 0.363177 | -0.220499 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 244 | L | 0.067429 | P | 0.128582 | -0.061153 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 247 | N | 0.060155 | S | 0.073161 | -0.013006 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 309 | P | 0.485448 | R | 0.451002 | 0.034446 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 328 | E | 0.413668 | V | 0.249028 | 0.16464 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 333 | R | 0.304387 | W | 0.157003 | 0.147384 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 339 | W | 0.170737 | G | 0.354569 | -0.183832 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 380 | N | 0.318005 | K | 0.359089 | -0.041084 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 423 | H | 0.320966 | R | 0.331175 | -0.010209 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 525 | F | 0.285634 | C | 0.284242 | 0.001392 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 537 | R | 0.35507 | C | 0.200398 | 0.154672 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 549 | A | 0.056779 | P | 0.089563 | -0.032784 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 550 | G | 0.05138 | R | 0.05192 | -5.40E-04 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 552 | V | 0.056365 | I | 0.045344 | 0.011021 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 602 | R | 0.095278 | Q | 0.098531 | -0.003253 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 607 | G | 0.041438 | R | 0.041244 | 1.94E-04 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 607 | G | 0.041438 | W | 0.014665 | 0.026773 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 635 | Q | 0.10813 | K | 0.122076 | -0.013946 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 636 | Q | 0.098979 | H | 0.085717 | 0.013262 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 643 | V | 0.095036 | M | 0.136369 | -0.041333 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 653 | R | 0.023522 | C | 0.011296 | 0.012226 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 686 | L | 0.571822 | S | 0.750688 | -0.178866 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 716 | T | 0.035825 | M | 0.031824 | 0.004001 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 764 | C | 0.10489 | Y | 0.14039 | -0.0355 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 765 | S | 0.08008 | R | 0.055164 | 0.024916 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 765 | S | 0.08008 | N | 0.06179 | 0.01829 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 767 | V | 0.045149 | D | 0.09401 | -0.048861 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 797 | L | 0.20441 | P | 0.360334 | -0.155924 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 824 | I | 0.449083 | T | 0.604917 | -0.155834 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 849 | V | 0.052532 | A | 0.084036 | -0.031504 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 854 | A | 0.026702 | T | 0.028597 | -0.001895 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 873 | F | 0.058114 | L | 0.07543 | -0.017316 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 897 | T | 0.847116 | I | 0.749723 | 0.097393 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 914 | H | 0.722583 | R | 0.739294 | -0.016711 | No Change: Both D | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 935 | V | 0.108145 | A | 0.133356 | -0.025211 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 943 | R | 0.173608 | W | 0.066758 | 0.10685 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 943 | R | 0.173608 | W | 0.066758 | 0.10685 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 959 | T | 0.150607 | I | 0.087143 | 0.063464 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 971 | T | 0.433081 | N | 0.458162 | -0.025081 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 972 | T | 0.37268 | N | 0.395956 | -0.023276 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 974 | S | 0.27203 | P | 0.261462 | 0.010568 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 989 | V | 0.329269 | A | 0.39426 | -0.064991 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 991 | G | 0.366852 | R | 0.351495 | 0.015357 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1014 | L | 0.138771 | R | 0.204573 | -0.065802 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1019 | T | 0.153852 | A | 0.150964 | 0.002888 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1019 | T | 0.153852 | M | 0.152845 | 0.001007 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1022 | E | 0.182112 | K | 0.178021 | 0.004091 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1031 | K | 0.514837 | E | 0.533761 | -0.018924 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1055 | R | 0.727522 | W | 0.560727 | 0.166795 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1063 | S | 0.555225 | P | 0.533509 | 0.021716 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1087 | E | 0.340837 | D | 0.342806 | -0.001969 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1091 | G | 0.538182 | E | 0.594625 | -0.056443 | No Change: Both D | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1097 | R | 0.298332 | C | 0.159374 | 0.138958 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1108 | R | 0.18518 | C | 0.090322 | 0.094858 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1108 | R | 0.18518 | C | 0.090322 | 0.094858 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1108 | R | 0.18518 | H | 0.173437 | 0.011743 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1108 | R | 0.18518 | L | 0.117561 | 0.067619 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1129 | R | 0.146449 | C | 0.06849 | 0.077959 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1148 | K | 0.128786 | T | 0.100959 | 0.027827 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1250 | L | 0.36156 | P | 0.496425 | -0.134865 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1253 | T | 0.381166 | M | 0.338822 | 0.042344 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1300 | R | 0.817936 | Q | 0.827129 | -0.009193 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1388 | L | 0.021317 | P | 0.046371 | -0.025054 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1399 | E | 0.190972 | K | 0.189214 | 0.001758 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1430 | L | 0.128374 | P | 0.235 | -0.106626 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1440 | F | 0.259278 | V | 0.291279 | -0.032001 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1443 | R | 0.258397 | H | 0.250485 | 0.007912 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1488 | C | 0.896597 | F | 0.864453 | 0.032144 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1488 | C | 0.896597 | Y | 0.839608 | 0.056989 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1508 | G | 0.831238 | C | 0.785504 | 0.045734 | No Change: Both D | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1513 | Q | 0.792159 | R | 0.795901 | -0.003742 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1525 | L | 0.461126 | P | 0.601899 | -0.140773 | O to D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1537 | T | 0.18791 | M | 0.156649 | 0.031261 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1598 | A | 0.601567 | D | 0.686996 | -0.085429 | No Change: Both D | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1637 | A | 0.173992 | T | 0.179441 | -0.005449 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1640 | R | 0.323861 | Q | 0.330923 | -0.007062 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1640 | R | 0.323861 | Q | 0.330923 | -0.007062 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1640 | R | 0.323861 | Q | 0.330923 | -0.007062 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1689 | S | 0.048839 | P | 0.042178 | 0.006661 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1693 | V | 0.073767 | I | 0.063368 | 0.010399 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1705 | R | 0.319482 | L | 0.224068 | 0.095414 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1733 | M | 0.065991 | T | 0.085389 | -0.019398 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1736 | S | 0.099607 | P | 0.082104 | 0.017503 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1748 | G | 0.095937 | R | 0.08283 | 0.013107 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1763 | L | 0.110914 | P | 0.204613 | -0.093699 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1776 | P | 0.046509 | L | 0.021288 | 0.025221 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1780 | P | 0.088692 | A | 0.061407 | 0.027285 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1799 | N | 0.061278 | D | 0.061939 | -6.61E-04 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1805 | N | 0.11404 | D | 0.115785 | -0.001745 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1817 | E | 0.164422 | D | 0.138549 | 0.025873 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1884 | V | 0.042609 | E | 0.0991 | -0.056491 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1885 | E | 0.039056 | K | 0.040457 | -0.001401 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1896 | V | 0.041752 | D | 0.087783 | -0.046031 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1921 | V | 0.61502 | M | 0.657807 | -0.042787 | No Change: Both D | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1940 | L | 0.244766 | P | 0.385409 | -0.140643 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1940 | L | 0.244766 | P | 0.385409 | -0.140643 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1971 | L | 0.21069 | R | 0.313938 | -0.103248 | No Change: Both O | Fundus flavimaculatus (FFM) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 1975 | G | 0.351272 | R | 0.323645 | 0.027627 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2035 | L | 0.134395 | P | 0.24137 | -0.106975 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2059 | G | 0.102454 | A | 0.087436 | 0.015018 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2060 | L | 0.087779 | R | 0.13705 | -0.049271 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2071 | Y | 0.350248 | F | 0.311831 | 0.038417 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2077 | R | 0.566848 | G | 0.601543 | -0.034695 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2107 | R | 0.156989 | C | 0.081241 | 0.075748 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2146 | G | 0.10933 | D | 0.11358 | -0.00425 | No Change: Both O | Cone-rod dystrophy type 3 (CORD3) [MIM:604116] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2149 | R | 0.105681 | L | 0.064219 | 0.041462 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2150 | C | 0.124136 | R | 0.233616 | -0.10948 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2216 | A | 0.307446 | V | 0.262425 | 0.045021 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2229 | L | 0.376225 | P | 0.481637 | -0.105412 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2241 | L | 0.279239 | V | 0.281895 | -0.002656 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 2263 | R | 0.670822 | L | 0.554615 | 0.116207 | No Change: Both D | Stargardt disease type 1 (STGD1) [MIM:248200] |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 752 | S | 0.06502 | I | 0.021479 | 0.043541 | No Change: Both O | - |
| P78363 | ABCA4_HUMAN Retinal-specific ATP-binding cassette transporter OS=Homo sapiens GN=ABCA4 PE=1 SV=3 | 224 | T | 0.270515 | M | 0.228902 | 0.041613 | No Change: Both O | A breast cancer sample |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 93 | Q | 0.459625 | K | 0.50391 | -0.044285 | O to D | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 484 | Q | 0.422028 | R | 0.431727 | -0.009699 | No Change: Both O | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 753 | M | 0.417227 | V | 0.362299 | 0.054928 | No Change: Both O | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 832 | A | 0.446538 | S | 0.555108 | -0.10857 | O to D | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 960 | M | 0.40662 | V | 0.363483 | 0.043137 | No Change: Both O | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 178 | A | 0.144935 | T | 0.158188 | -0.013253 | No Change: Both O | - |
| Q8WWZ7 | ABCA5_HUMAN ATP-binding cassette sub-family A member 5 OS=Homo sapiens GN=ABCA5 PE=2 SV=2 | 1260 | D | 0.96529 | G | 0.955596 | 0.009694 | No Change: Both D | - |
| Q8N139 | ABCA6_HUMAN ATP-binding cassette sub-family A member 6 OS=Homo sapiens GN=ABCA6 PE=1 SV=2 | 282 | V | 0.011725 | I | 0.011854 | -1.29E-04 | No Change: Both O | - |
| Q8N139 | ABCA6_HUMAN ATP-binding cassette sub-family A member 6 OS=Homo sapiens GN=ABCA6 PE=1 SV=2 | 610 | N | 0.467837 | Y | 0.301556 | 0.166281 | No Change: Both O | - |
| Q8N139 | ABCA6_HUMAN ATP-binding cassette sub-family A member 6 OS=Homo sapiens GN=ABCA6 PE=1 SV=2 | 698 | M | 0.232179 | I | 0.165058 | 0.067121 | No Change: Both O | - |
| Q8N139 | ABCA6_HUMAN ATP-binding cassette sub-family A member 6 OS=Homo sapiens GN=ABCA6 PE=1 SV=2 | 875 | M | 0.065294 | I | 0.043628 | 0.021666 | No Change: Both O | - |
| Q8N139 | ABCA6_HUMAN ATP-binding cassette sub-family A member 6 OS=Homo sapiens GN=ABCA6 PE=1 SV=2 | 1322 | N | 0.5665 | S | 0.647193 | -0.080693 | No Change: Both D | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 188 | E | 0.788686 | G | 0.72975 | 0.058936 | No Change: Both D | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 319 | T | 0.222601 | A | 0.187292 | 0.035309 | No Change: Both O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 395 | H | 0.271898 | R | 0.282351 | -0.010453 | No Change: Both O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 463 | R | 0.388795 | H | 0.352344 | 0.036451 | No Change: Both O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 718 | N | 0.358343 | T | 0.340606 | 0.017737 | No Change: Both O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 1349 | R | 0.916778 | Q | 0.914935 | 0.001843 | No Change: Both D | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 1527 | G | 0.523196 | A | 0.490531 | 0.032665 | D to O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 1686 | Q | 0.065029 | R | 0.061492 | 0.003537 | No Change: Both O | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 2045 | A | 0.670091 | S | 0.69435 | -0.024259 | No Change: Both D | - |
| Q8IZY2 | ABCA7_HUMAN ATP-binding cassette sub-family A member 7 OS=Homo sapiens GN=ABCA7 PE=1 SV=3 | 676 | A | 0.042955 | T | 0.044328 | -0.001373 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 256 | T | 0.315748 | A | 0.303056 | 0.012692 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 331 | G | 0.048967 | S | 0.067411 | -0.018444 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 489 | Y | 0.562771 | F | 0.54945 | 0.013321 | No Change: Both D | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 680 | C | 0.182586 | G | 0.328982 | -0.146396 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 416 | A | 0.02101 | V | 0.013235 | 0.007775 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 619 | L | 0.290672 | R | 0.405605 | -0.114933 | No Change: Both O | - |
| O94911 | ABCA8_HUMAN ATP-binding cassette sub-family A member 8 OS=Homo sapiens GN=ABCA8 PE=1 SV=3 | 1430 | G | 0.383073 | S | 0.430055 | -0.046982 | No Change: Both O | - |
| Q8IUA7 | ABCA9_HUMAN ATP-binding cassette sub-family A member 9 OS=Homo sapiens GN=ABCA9 PE=1 SV=1 | 353 | R | 0.073833 | H | 0.074773 | -9.40E-04 | No Change: Both O | - |
| Q8IUA7 | ABCA9_HUMAN ATP-binding cassette sub-family A member 9 OS=Homo sapiens GN=ABCA9 PE=1 SV=1 | 785 | N | 0.165203 | S | 0.210867 | -0.045664 | No Change: Both O | - |
| Q8IUA7 | ABCA9_HUMAN ATP-binding cassette sub-family A member 9 OS=Homo sapiens GN=ABCA9 PE=1 SV=1 | 1306 | K | 0.587668 | T | 0.493878 | 0.09379 | D to O | - |
| Q8IUA7 | ABCA9_HUMAN ATP-binding cassette sub-family A member 9 OS=Homo sapiens GN=ABCA9 PE=1 SV=1 | 1356 | G | 0.517483 | S | 0.552961 | -0.035478 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 893 | S | 0.629171 | A | 0.555411 | 0.07376 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 893 | S | 0.629171 | T | 0.57936 | 0.049811 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 21 | N | 0.866301 | D | 0.868952 | -0.002651 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 103 | F | 0.238139 | L | 0.263363 | -0.025224 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 185 | G | 0.435912 | V | 0.286551 | 0.149361 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 400 | S | 0.434933 | N | 0.398001 | 0.036932 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 999 | A | 0.488244 | T | 0.488969 | -7.25E-04 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 1107 | Q | 0.097513 | P | 0.105715 | -0.008202 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 108 | E | 0.351862 | K | 0.334676 | 0.017186 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 986 | M | 0.169532 | V | 0.146901 | 0.022631 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 1251 | V | 0.482043 | I | 0.445714 | 0.036329 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 17 | F | 0.900152 | L | 0.90483 | -0.004678 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 566 | E | 0.422305 | K | 0.413941 | 0.008364 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 593 | R | 0.234702 | C | 0.114657 | 0.120045 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 836 | I | 0.133091 | V | 0.149304 | -0.016213 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 1051 | P | 0.254981 | A | 0.172075 | 0.082906 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 1141 | S | 0.446773 | T | 0.34856 | 0.098213 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 887 | K | 0.730353 | N | 0.703523 | 0.02683 | No Change: Both D | A colorectal cancer sample |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 44 | N | 0.120374 | S | 0.153869 | -0.033495 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 80 | A | 0.215356 | E | 0.316719 | -0.101363 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 261 | I | 0.101312 | V | 0.116583 | -0.015271 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 599 | A | 0.167335 | T | 0.182191 | -0.014856 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 669 | R | 0.950277 | C | 0.912684 | 0.037593 | No Change: Both D | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 801 | V | 0.258084 | M | 0.332338 | -0.074254 | No Change: Both O | - |
| P08183 | MDR1_HUMAN Multidrug resistance protein 1 OS=Homo sapiens GN=ABCB1 PE=1 SV=3 | 829 | I | 0.276526 | V | 0.318381 | -0.041855 | No Change: Both O | - |
| Q9NRK6 | ABCBA_HUMAN ATP-binding cassette sub-family B member 10 mitochondrial OS=Homo sapiens GN=ABCB10 PE=1 SV=2 | 150 | A | 0.845803 | S | 0.854653 | -0.00885 | No Change: Both D | - |
| Q9NRK6 | ABCBA_HUMAN ATP-binding cassette sub-family B member 10 mitochondrial OS=Homo sapiens GN=ABCB10 PE=1 SV=2 | 545 | D | 0.317063 | N | 0.288521 | 0.028542 | No Change: Both O | - |
| Q9NRK6 | ABCBA_HUMAN ATP-binding cassette sub-family B member 10 mitochondrial OS=Homo sapiens GN=ABCB10 PE=1 SV=2 | 471 | R | 0.406245 | T | 0.377844 | 0.028401 | No Change: Both O | A breast cancer sample |
| Q9NRK6 | ABCBA_HUMAN ATP-binding cassette sub-family B member 10 mitochondrial OS=Homo sapiens GN=ABCB10 PE=1 SV=2 | 242 | R | 0.33631 | G | 0.345104 | -0.008794 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 297 | E | 0.575681 | G | 0.52372 | 0.051961 | No Change: Both D | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 297 | E | 0.575681 | G | 0.52372 | 0.051961 | No Change: Both D | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 284 | V | 0.326601 | L | 0.300396 | 0.026205 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 444 | V | 0.213099 | A | 0.281438 | -0.068339 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 461 | K | 0.520183 | E | 0.519171 | 0.001012 | No Change: Both D | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 482 | D | 0.297441 | G | 0.275972 | 0.021469 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 982 | G | 0.036504 | R | 0.036487 | 1.70E-05 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1004 | G | 0.292507 | D | 0.301694 | -0.009187 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1153 | R | 0.163211 | C | 0.085507 | 0.077704 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1268 | R | 0.200285 | Q | 0.201025 | -7.40E-04 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 186 | E | 0.077372 | G | 0.065078 | 0.012294 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 206 | I | 0.428559 | V | 0.44344 | -0.014881 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 238 | G | 0.032472 | V | 0.016442 | 0.01603 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 299 | R | 0.624976 | K | 0.681867 | -0.056891 | No Change: Both D | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 336 | C | 0.002784 | S | 0.008291 | -0.005507 | No Change: Both O | Progressive familial intrahepatic cholestasis type 2 (PFIC2) [MIM:601847] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 432 | R | 0.346262 | T | 0.34651 | -2.48E-04 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 570 | A | 0.219427 | T | 0.224825 | -0.005398 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 677 | M | 0.579019 | V | 0.508708 | 0.070311 | No Change: Both D | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 923 | T | 0.374493 | P | 0.409531 | -0.035038 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 926 | A | 0.413114 | P | 0.489133 | -0.076019 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1050 | R | 0.136595 | C | 0.063103 | 0.073492 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1128 | R | 0.275938 | H | 0.269322 | 0.006616 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 2 (BRIC2) [MIM:605479] |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 1186 | E | 0.301765 | K | 0.304893 | -0.003128 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 284 | V | 0.326601 | A | 0.409624 | -0.083023 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 616 | R | 0.261227 | G | 0.255653 | 0.005574 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 619 | T | 0.268082 | A | 0.252555 | 0.015527 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 698 | R | 0.72736 | H | 0.684118 | 0.043242 | No Change: Both D | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 865 | A | 0.500866 | V | 0.409846 | 0.09102 | D to O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 958 | R | 0.295693 | Q | 0.299044 | -0.003351 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 415 | R | 0.393286 | Q | 0.414489 | -0.021203 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 591 | N | 0.61271 | S | 0.639371 | -0.026661 | No Change: Both D | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 676 | D | 0.613737 | Y | 0.433573 | 0.180164 | D to O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 855 | G | 0.428524 | R | 0.441862 | -0.013338 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 56 | S | 0.153434 | L | 0.065925 | 0.087509 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 444 | V | 0.213099 | D | 0.365434 | -0.152335 | No Change: Both O | - |
| O95342 | ABCBB_HUMAN Bile salt export pump OS=Homo sapiens GN=ABCB11 PE=1 SV=2 | 444 | V | 0.213099 | G | 0.341421 | -0.128322 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 238 | L | 0.148818 | V | 0.154242 | -0.005424 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 652 | R | 0.589518 | G | 0.579788 | 0.00973 | No Change: Both D | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 175 | T | 0.449504 | A | 0.389795 | 0.059709 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 320 | S | 0.064755 | F | 0.022706 | 0.042049 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 320 | S | 0.064755 | F | 0.022706 | 0.042049 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 546 | A | 0.266229 | D | 0.312161 | -0.045932 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 1168 | P | 0.332565 | S | 0.345185 | -0.01262 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 788 | R | 0.246586 | Q | 0.244302 | 0.002284 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 263 | I | 0.141484 | V | 0.158368 | -0.016884 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 651 | T | 0.599282 | N | 0.646098 | -0.046816 | No Change: Both D | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 87 | D | 0.29046 | E | 0.306662 | -0.016202 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 95 | P | 0.226387 | S | 0.272536 | -0.046149 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 138 | W | 0.047223 | R | 0.128624 | -0.081401 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 150 | R | 0.28579 | K | 0.35406 | -0.06827 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 165 | F | 0.113003 | I | 0.123823 | -0.01082 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 301 | M | 0.104652 | T | 0.12642 | -0.021768 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 346 | S | 0.108397 | I | 0.041406 | 0.066991 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 367 | I | 0.072706 | V | 0.076618 | -0.003912 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 395 | E | 0.380273 | G | 0.344535 | 0.035738 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 424 | T | 0.369739 | A | 0.353609 | 0.01613 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 425 | V | 0.38041 | M | 0.427171 | -0.046761 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 450 | E | 0.382557 | G | 0.357634 | 0.024923 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 528 | E | 0.382358 | D | 0.374356 | 0.008002 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 535 | G | 0.574159 | D | 0.571875 | 0.002284 | No Change: Both D | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 541 | I | 0.311633 | F | 0.296686 | 0.014947 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 556 | L | 0.391894 | R | 0.510644 | -0.11875 | O to D | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 564 | D | 0.644712 | G | 0.608181 | 0.036531 | No Change: Both D | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 590 | R | 0.224354 | Q | 0.220438 | 0.003916 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 591 | L | 0.223965 | Q | 0.334376 | -0.110411 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 711 | F | 0.041537 | S | 0.110445 | -0.068908 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 742 | G | 0.321269 | S | 0.362648 | -0.041379 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 762 | G | 0.014427 | E | 0.018621 | -0.004194 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 764 | I | 0.017363 | L | 0.020565 | -0.003202 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 775 | T | 0.126835 | M | 0.100438 | 0.026397 | No Change: Both O | - |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 934 | A | 0.235192 | T | 0.271266 | -0.036074 | No Change: Both O | Gallbladder disease type 1 (GBD1) [MIM:600803] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 983 | G | 0.098869 | S | 0.125568 | -0.026699 | No Change: Both O | Progressive familial intrahepatic cholestasis type 3 (PFIC3) [MIM:602347] |
| P21439 | MDR3_HUMAN Multidrug resistance protein 3 OS=Homo sapiens GN=ABCB4 PE=1 SV=2 | 1082 | L | 0.131434 | Q | 0.221527 | -0.090093 | No Change: Both O | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 115 | K | 0.674706 | E | 0.682595 | -0.007889 | No Change: Both D | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 224 | K | 0.73896 | R | 0.691922 | 0.047038 | No Change: Both D | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 470 | A | 0.487099 | T | 0.523587 | -0.036488 | O to D | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 525 | E | 0.156502 | K | 0.150716 | 0.005786 | No Change: Both O | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 460 | Q | 0.568111 | H | 0.548463 | 0.019648 | No Change: Both D | - |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 230 | E | 0.453905 | V | 0.281495 | 0.17241 | No Change: Both O | A colorectal cancer sample |
| Q2M3G0 | ABCB5_HUMAN ATP-binding cassette sub-family B member 5 OS=Homo sapiens GN=ABCB5 PE=1 SV=3 | 435 | A | 0.395884 | T | 0.431524 | -0.03564 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| Q9NP58 | ABCB6_HUMAN ATP-binding cassette sub-family B member 6 mitochondrial OS=Homo sapiens GN=ABCB6 PE=1 SV=1 | 648 | R | 0.259659 | Q | 0.293089 | -0.03343 | No Change: Both O | - |
| Q9NP58 | ABCB6_HUMAN ATP-binding cassette sub-family B member 6 mitochondrial OS=Homo sapiens GN=ABCB6 PE=1 SV=1 | 69 | R | 0.310382 | G | 0.312857 | -0.002475 | No Change: Both O | A breast cancer sample |
| Q9NP58 | ABCB6_HUMAN ATP-binding cassette sub-family B member 6 mitochondrial OS=Homo sapiens GN=ABCB6 PE=1 SV=1 | 293 | L | 0.150324 | V | 0.152867 | -0.002543 | No Change: Both O | - |
| Q9NP58 | ABCB6_HUMAN ATP-binding cassette sub-family B member 6 mitochondrial OS=Homo sapiens GN=ABCB6 PE=1 SV=1 | 343 | R | 0.18664 | Q | 0.201133 | -0.014493 | No Change: Both O | - |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 400 | I | 0.151824 | M | 0.220196 | -0.068372 | No Change: Both O | X-linked sideroblastic anemia with ataxia (ASAT) [MIM:301310] |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 433 | E | 0.191607 | K | 0.190555 | 0.001052 | No Change: Both O | X-linked sideroblastic anemia with ataxia (ASAT) [MIM:301310] |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 315 | R | 0.116243 | G | 0.109408 | 0.006835 | No Change: Both O | - |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 346 | F | 0.296231 | I | 0.292608 | 0.003623 | No Change: Both O | - |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 411 | V | 0.095276 | L | 0.096844 | -0.001568 | No Change: Both O | X-linked sideroblastic anemia with ataxia (ASAT) [MIM:301310] |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 581 | V | 0.260679 | A | 0.352245 | -0.091566 | No Change: Both O | - |
| O75027 | ABCB7_HUMAN ATP-binding cassette sub-family B member 7 mitochondrial OS=Homo sapiens GN=ABCB7 PE=1 SV=2 | 580 | A | 0.274106 | V | 0.202455 | 0.071651 | No Change: Both O | - |
| Q9NUT2 | ABCB8_HUMAN ATP-binding cassette sub-family B member 8 mitochondrial OS=Homo sapiens GN=ABCB8 PE=1 SV=3 | 152 | V | 0.047476 | I | 0.036251 | 0.011225 | No Change: Both O | - |
| Q9NUT2 | ABCB8_HUMAN ATP-binding cassette sub-family B member 8 mitochondrial OS=Homo sapiens GN=ABCB8 PE=1 SV=3 | 165 | I | 0.073801 | T | 0.137551 | -0.06375 | No Change: Both O | A breast cancer sample |
| Q9NUT2 | ABCB8_HUMAN ATP-binding cassette sub-family B member 8 mitochondrial OS=Homo sapiens GN=ABCB8 PE=1 SV=3 | 690 | A | 0.339507 | G | 0.409605 | -0.070098 | No Change: Both O | A breast cancer sample |
| Q9NP78 | ABCB9_HUMAN ATP-binding cassette sub-family B member 9 OS=Homo sapiens GN=ABCB9 PE=1 SV=1 | 121 | V | 0.007207 | M | 0.009815 | -0.002608 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 633 | R | 0.622883 | Q | 0.602762 | 0.020121 | No Change: Both D | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 671 | G | 0.157543 | V | 0.093886 | 0.063657 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 43 | C | 0.004654 | S | 0.013719 | -0.009065 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 73 | T | 0.391162 | I | 0.231649 | 0.159513 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 117 | M | 0.048438 | T | 0.067394 | -0.018956 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 433 | R | 0.194009 | S | 0.263506 | -0.069497 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 723 | R | 0.182378 | Q | 0.211362 | -0.028984 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 1058 | R | 0.306496 | Q | 0.314765 | -0.008269 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 1512 | S | 0.447537 | L | 0.265061 | 0.182476 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 861 | A | 0.254417 | T | 0.271279 | -0.016862 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 1047 | C | 0.10398 | S | 0.27514 | -0.17116 | No Change: Both O | - |
| P33527 | MRP1_HUMAN Multidrug resistance-associated protein 1 OS=Homo sapiens GN=ABCC1 PE=1 SV=3 | 1146 | V | 0.641444 | I | 0.592923 | 0.048521 | No Change: Both D | - |
| Q5T3U5 | MRP7_HUMAN Multidrug resistance-associated protein 7 OS=Homo sapiens GN=ABCC10 PE=1 SV=1 | 948 | I | 0.22418 | T | 0.33014 | -0.10596 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 19 | R | 0.349863 | H | 0.353816 | -0.003953 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 180 | G | 0.031072 | R | 0.029098 | 0.001974 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 317 | A | 0.031462 | E | 0.050332 | -0.01887 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 546 | T | 0.596987 | M | 0.63431 | -0.037323 | No Change: Both D | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 648 | V | 0.212977 | I | 0.206065 | 0.006912 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 687 | V | 0.174945 | I | 0.143056 | 0.031889 | No Change: Both O | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 735 | K | 0.781247 | R | 0.702642 | 0.078605 | No Change: Both D | - |
| Q96J66 | ABCCB_HUMAN ATP-binding cassette sub-family C member 11 OS=Homo sapiens GN=ABCC11 PE=1 SV=1 | 1344 | H | 0.079568 | R | 0.081104 | -0.001536 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 9 | I | 0.487135 | L | 0.572906 | -0.085771 | O to D | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 102 | A | 0.300563 | E | 0.430577 | -0.130014 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 587 | N | 0.346979 | Y | 0.230045 | 0.116934 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 894 | K | 0.513787 | M | 0.444568 | 0.069219 | D to O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 989 | T | 0.319996 | S | 0.424011 | -0.104015 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 1013 | Y | 0.05027 | H | 0.086188 | -0.035918 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 1117 | R | 0.366474 | C | 0.221933 | 0.144541 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 1191 | E | 0.139079 | A | 0.085204 | 0.053875 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 1349 | F | 0.263115 | L | 0.317409 | -0.054294 | No Change: Both O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 690 | E | 0.591649 | V | 0.401974 | 0.189675 | D to O | - |
| Q96J65 | MRP9_HUMAN Multidrug resistance-associated protein 9 OS=Homo sapiens GN=ABCC12 PE=1 SV=2 | 1187 | I | 0.070522 | T | 0.12331 | -0.052788 | No Change: Both O | - |
| Q9NSE7 | ABCCD_HUMAN Putative ATP-binding cassette sub-family C member 13 OS=Homo sapiens GN=ABCC13 PE=2 SV=2 | 228 | S | 0.631085 | N | 0.590364 | 0.040721 | No Change: Both D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 768 | R | 0.475322 | W | 0.264588 | 0.210734 | No Change: Both O | Dubin-Johnson syndrome (DJS) [MIM:237500] |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1382 | Q | 0.19398 | R | 0.185995 | 0.007985 | No Change: Both O | Dubin-Johnson syndrome (DJS) [MIM:237500] |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 281 | S | 0.961582 | N | 0.954228 | 0.007354 | No Change: Both D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 417 | V | 0.331841 | I | 0.286327 | 0.045514 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 789 | S | 0.323466 | F | 0.14958 | 0.173886 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1150 | R | 0.566166 | H | 0.547252 | 0.018914 | No Change: Both D | Dubin-Johnson syndrome (DJS) [MIM:237500] |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1173 | I | 0.226951 | F | 0.245958 | -0.019007 | No Change: Both O | Dubin-Johnson syndrome (DJS) [MIM:237500] |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1450 | A | 0.161982 | T | 0.18219 | -0.020208 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 333 | D | 0.065436 | G | 0.057485 | 0.007951 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 353 | R | 0.146246 | H | 0.148056 | -0.00181 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 670 | I | 0.224422 | T | 0.334648 | -0.110226 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 849 | L | 0.411067 | R | 0.503336 | -0.092269 | O to D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1036 | I | 0.038295 | T | 0.068348 | -0.030053 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1181 | R | 0.353198 | L | 0.231347 | 0.121851 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1188 | V | 0.334029 | E | 0.55398 | -0.219951 | O to D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1291 | P | 0.64188 | L | 0.469263 | 0.172617 | D to O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1515 | C | 0.317909 | Y | 0.376217 | -0.058308 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1273 | T | 0.298968 | A | 0.267149 | 0.031819 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 246 | M | 0.815189 | L | 0.782796 | 0.032393 | No Change: Both D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 495 | K | 0.702362 | E | 0.681856 | 0.020506 | No Change: Both D | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 562 | F | 0.065232 | L | 0.081219 | -0.015987 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 982 | I | 0.008786 | V | 0.009941 | -0.001155 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 1063 | N | 0.17613 | S | 0.194032 | -0.017902 | No Change: Both O | - |
| Q92887 | MRP2_HUMAN Canalicular multispecific organic anion transporter 1 OS=Homo sapiens GN=ABCC2 PE=1 SV=3 | 39 | Y | 0.010539 | F | 0.009126 | 0.001413 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 346 | S | 0.094364 | F | 0.034686 | 0.059678 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 1297 | R | 0.326169 | H | 0.275234 | 0.050935 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 1365 | Q | 0.25555 | R | 0.241338 | 0.014212 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 1381 | R | 0.219316 | S | 0.292982 | -0.073666 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 11 | G | 0.432477 | D | 0.457457 | -0.02498 | No Change: Both O | - |
| O15438 | MRP3_HUMAN Canalicular multispecific organic anion transporter 2 OS=Homo sapiens GN=ABCC3 PE=1 SV=3 | 1286 | R | 0.657248 | G | 0.645969 | 0.011279 | No Change: Both D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 184 | M | 0.451279 | T | 0.514553 | -0.063274 | O to D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 187 | G | 0.501364 | W | 0.245911 | 0.255453 | D to O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 498 | K | 0.506023 | E | 0.507818 | -0.001795 | No Change: Both D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 744 | M | 0.292493 | V | 0.251958 | 0.040535 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 860 | V | 0.028728 | M | 0.034144 | -0.005416 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 900 | V | 0.645937 | L | 0.663069 | -0.017132 | No Change: Both D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 304 | K | 0.456787 | N | 0.411417 | 0.04537 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 757 | E | 0.362096 | K | 0.37878 | -0.016684 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 78 | P | 0.508524 | A | 0.453207 | 0.055317 | D to O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 403 | P | 0.631971 | L | 0.523536 | 0.108435 | No Change: Both D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 487 | G | 0.1631 | E | 0.19825 | -0.03515 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 625 | I | 0.460914 | M | 0.574124 | -0.11321 | O to D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 667 | P | 0.943169 | L | 0.91075 | 0.032419 | No Change: Both D | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 1142 | T | 0.481516 | M | 0.467682 | 0.013834 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 556 | Y | 0.159167 | C | 0.126055 | 0.033112 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 776 | V | 0.059005 | I | 0.051241 | 0.007764 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 820 | R | 0.190349 | I | 0.100902 | 0.089447 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 854 | V | 0.067074 | F | 0.050237 | 0.016837 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 866 | I | 0.02257 | V | 0.025924 | -0.003354 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 18 | L | 0.11607 | I | 0.09602 | 0.02005 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 171 | C | 0.070859 | G | 0.160661 | -0.089802 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 293 | K | 0.214712 | E | 0.213595 | 0.001117 | No Change: Both O | - |
| O15439 | MRP4_HUMAN Multidrug resistance-associated protein 4 OS=Homo sapiens GN=ABCC4 PE=1 SV=3 | 356 | T | 0.055635 | M | 0.042867 | 0.012768 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 614 | V | 0.581616 | A | 0.613428 | -0.031812 | No Change: Both D | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1114 | R | 0.491756 | P | 0.508768 | -0.017012 | O to D | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1138 | R | 0.424457 | Q | 0.437076 | -0.012619 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1138 | R | 0.424457 | W | 0.188205 | 0.236252 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1268 | R | 0.260302 | Q | 0.278297 | -0.017995 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1314 | R | 0.378001 | W | 0.189858 | 0.188143 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 61 | G | 0.367983 | D | 0.382047 | -0.014064 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 64 | R | 0.365056 | W | 0.1623 | 0.202756 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 207 | G | 0.549164 | R | 0.545692 | 0.003472 | No Change: Both D | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 265 | R | 0.829105 | G | 0.793976 | 0.035129 | No Change: Both D | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 281 | K | 0.697379 | E | 0.700987 | -0.003608 | No Change: Both D | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 319 | I | 0.065934 | V | 0.076252 | -0.010318 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 364 | T | 0.132582 | R | 0.145167 | -0.012585 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 411 | N | 0.183915 | K | 0.220174 | -0.036259 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 455 | A | 0.088343 | P | 0.124548 | -0.036205 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 497 | N | 0.484354 | K | 0.550412 | -0.066058 | O to D | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 518 | R | 0.232027 | Q | 0.245152 | -0.013125 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 568 | F | 0.166217 | S | 0.336623 | -0.170406 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 632 | H | 0.15398 | Q | 0.181474 | -0.027494 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 673 | L | 0.45186 | P | 0.593756 | -0.141896 | O to D | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 765 | R | 0.245348 | Q | 0.258208 | -0.01286 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 953 | L | 0.012317 | H | 0.020059 | -0.007742 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1121 | S | 0.598453 | W | 0.274571 | 0.323882 | D to O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1138 | R | 0.424457 | P | 0.435911 | -0.011454 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1203 | G | 0.259577 | D | 0.270335 | -0.010758 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1241 | W | 0.272394 | C | 0.307739 | -0.035345 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1298 | V | 0.397153 | F | 0.349252 | 0.047901 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1301 | T | 0.489232 | I | 0.363914 | 0.125318 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1302 | G | 0.539906 | R | 0.516129 | 0.023777 | No Change: Both D | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1303 | A | 0.579205 | P | 0.629533 | -0.050328 | No Change: Both D | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1314 | R | 0.378001 | Q | 0.416566 | -0.038565 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1321 | G | 0.184956 | S | 0.211079 | -0.026123 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1339 | R | 0.238966 | C | 0.120488 | 0.118478 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1347 | Q | 0.244037 | H | 0.228896 | 0.015141 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1354 | G | 0.215526 | R | 0.219407 | -0.003881 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1361 | D | 0.397443 | N | 0.387373 | 0.01007 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1424 | I | 0.154172 | T | 0.265222 | -0.11105 | No Change: Both O | Pseudoxanthoma elasticum (PXE) [MIM:264800] |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 665 | V | 0.343876 | A | 0.422036 | -0.07816 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 848 | M | 0.400066 | V | 0.314044 | 0.086022 | No Change: Both O | - |
| O95255 | MRP6_HUMAN Multidrug resistance-associated protein 6 OS=Homo sapiens GN=ABCC6 PE=1 SV=2 | 1097 | L | 0.029733 | I | 0.023467 | 0.006266 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 716 | G | 0.220194 | V | 0.12982 | 0.090374 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1352 | R | 0.335152 | P | 0.39402 | -0.058868 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1420 | R | 0.23779 | C | 0.116574 | 0.121216 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1493 | R | 0.069951 | W | 0.022762 | 0.047189 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 74 | R | 0.051428 | Q | 0.056447 | -0.005019 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 125 | H | 0.21152 | Q | 0.224987 | -0.013467 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 187 | V | 0.060447 | D | 0.115305 | -0.054858 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 188 | N | 0.061267 | S | 0.074045 | -0.012778 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 275 | R | 0.352415 | Q | 0.400434 | -0.048019 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 406 | N | 0.649214 | D | 0.663214 | -0.014 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 560 | V | 0.044938 | M | 0.054988 | -0.01005 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 591 | F | 0.131147 | L | 0.155354 | -0.024207 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 810 | D | 0.28765 | N | 0.260184 | 0.027466 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 834 | R | 0.468685 | C | 0.288337 | 0.180348 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1138 | T | 0.38331 | M | 0.319191 | 0.064119 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1214 | R | 0.160005 | Q | 0.163432 | -0.003427 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1360 | V | 0.340248 | G | 0.434829 | -0.094581 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1369 | A | 0.184021 | S | 0.266432 | -0.082411 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1378 | G | 0.425784 | R | 0.399088 | 0.026696 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1381 | G | 0.598865 | S | 0.644826 | -0.045961 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1393 | R | 0.106484 | H | 0.109382 | -0.002898 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1478 | G | 0.51455 | R | 0.481396 | 0.033154 | D to O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1572 | V | 0.410581 | I | 0.366012 | 0.044569 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 673 | D | 0.400632 | N | 0.377382 | 0.02325 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1360 | V | 0.340248 | M | 0.381101 | -0.040853 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1436 | R | 0.171845 | Q | 0.176195 | -0.00435 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1506 | E | 0.279466 | K | 0.284799 | -0.005333 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1543 | L | 0.118376 | P | 0.211052 | -0.092676 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 104 | L | 0.353308 | V | 0.35032 | 0.002988 | No Change: Both O | - |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 132 | F | 0.222774 | L | 0.269397 | -0.046623 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 213 | L | 0.255464 | R | 0.372981 | -0.117517 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 435 | C | 0.012361 | R | 0.028188 | -0.015827 | No Change: Both O | Transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 582 | L | 0.085738 | V | 0.085351 | 3.87E-04 | No Change: Both O | Transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1023 | H | 0.063553 | Y | 0.036926 | 0.026627 | No Change: Both O | Transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1182 | R | 0.105371 | Q | 0.117187 | -0.011816 | No Change: Both O | Transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1352 | R | 0.335152 | H | 0.336858 | -0.001706 | No Change: Both O | Leucine-induced hypoglycemia (LIH) [MIM:240800] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1379 | R | 0.492828 | C | 0.329808 | 0.16302 | No Change: Both O | Transient neonatal diabetes mellitus type 2 (TNDM2) [MIM:610374] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1424 | I | 0.168185 | V | 0.188094 | -0.019909 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 7 | G | 0.53625 | R | 0.520412 | 0.015838 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 21 | V | 0.171614 | D | 0.314556 | -0.142942 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 27 | F | 0.08995 | S | 0.222811 | -0.132861 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 70 | G | 0.136576 | E | 0.169042 | -0.032466 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 74 | R | 0.051428 | W | 0.020746 | 0.030682 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 86 | V | 0.018376 | A | 0.026838 | -0.008462 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 111 | G | 0.221199 | R | 0.210657 | 0.010542 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 116 | A | 0.131763 | P | 0.174937 | -0.043174 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 233 | M | 0.04912 | R | 0.06493 | -0.01581 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 310 | D | 0.085509 | N | 0.079318 | 0.006191 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 418 | C | 0.086041 | R | 0.177165 | -0.091124 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 495 | R | 0.659521 | Q | 0.68529 | -0.025769 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 501 | E | 0.392703 | K | 0.400145 | -0.007442 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 503 | L | 0.313412 | P | 0.418968 | -0.105556 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 508 | L | 0.224069 | P | 0.29272 | -0.068651 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 551 | P | 0.052784 | R | 0.045886 | 0.006898 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 620 | R | 0.730482 | C | 0.639138 | 0.091344 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 686 | F | 0.095709 | S | 0.2287 | -0.132991 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 719 | K | 0.277409 | T | 0.217518 | 0.059891 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 841 | R | 0.235098 | G | 0.230726 | 0.004372 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 889 | K | 0.170975 | T | 0.132467 | 0.038508 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 956 | S | 0.960326 | F | 0.92428 | 0.036046 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1130 | T | 0.419052 | P | 0.485025 | -0.065973 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1147 | L | 0.122712 | R | 0.196184 | -0.073472 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1214 | R | 0.160005 | W | 0.05889 | 0.101115 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1295 | N | 0.07726 | K | 0.085684 | -0.008424 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1336 | K | 0.352042 | N | 0.316789 | 0.035253 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1342 | G | 0.371666 | E | 0.421387 | -0.049721 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1349 | L | 0.294981 | Q | 0.452309 | -0.157328 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1384 | K | 0.623173 | Q | 0.588717 | 0.034456 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1386 | S | 0.541259 | F | 0.320209 | 0.22105 | D to O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1400 | G | 0.118291 | R | 0.113669 | 0.004622 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1418 | R | 0.231631 | H | 0.234184 | -0.002553 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1450 | L | 0.224129 | P | 0.353288 | -0.129159 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1457 | A | 0.10662 | T | 0.116145 | -0.009525 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1471 | D | 0.215967 | H | 0.18902 | 0.026947 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1471 | D | 0.215967 | N | 0.207965 | 0.008002 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1486 | R | 0.246795 | K | 0.293482 | -0.046687 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1493 | R | 0.069951 | Q | 0.075916 | -0.005965 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1550 | V | 0.073084 | D | 0.14417 | -0.071086 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| Q09428 | ABCC8_HUMAN ATP-binding cassette sub-family C member 8 OS=Homo sapiens GN=ABCC8 PE=1 SV=6 | 1551 | L | 0.080458 | V | 0.080666 | -2.08E-04 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 1 (HHF1) [MIM:256450] |
| O60706 | ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens GN=ABCC9 PE=1 SV=2 | 1513 | A | 0.167167 | T | 0.184727 | -0.01756 | No Change: Both O | Cardiomyopathy dilated type 1O (CMD1O) [MIM:608569] |
| O60706 | ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens GN=ABCC9 PE=1 SV=2 | 1108 | P | 0.370438 | S | 0.402176 | -0.031738 | No Change: Both O | - |
| O60706 | ABCC9_HUMAN ATP-binding cassette sub-family C member 9 OS=Homo sapiens GN=ABCC9 PE=1 SV=2 | 1547 | T | 0.782508 | I | 0.639411 | 0.143097 | No Change: Both D | Familial atrial fibrillation type 12 (ATFB12) [MIM:614050] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 98 | S | 0.210348 | L | 0.101662 | 0.108686 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 104 | R | 0.180457 | C | 0.088297 | 0.09216 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 104 | R | 0.180457 | H | 0.188752 | -0.008295 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 105 | T | 0.150255 | I | 0.081944 | 0.068311 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 107 | L | 0.1062 | P | 0.193694 | -0.087494 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 108 | S | 0.098999 | W | 0.02645 | 0.072549 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 116 | G | 0.125582 | R | 0.133354 | -0.007772 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 141 | A | 0.029521 | T | 0.033539 | -0.004018 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 148 | N | 0.108246 | S | 0.137748 | -0.029502 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 149 | S | 0.114954 | N | 0.102785 | 0.012169 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 152 | R | 0.130077 | C | 0.061991 | 0.068086 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 152 | R | 0.130077 | P | 0.154539 | -0.024462 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 163 | R | 0.246628 | H | 0.246235 | 3.93E-04 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 174 | Y | 0.154783 | D | 0.255125 | -0.100342 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 174 | Y | 0.154783 | S | 0.293758 | -0.138975 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 178 | Q | 0.224415 | E | 0.24658 | -0.022165 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 181 | Y | 0.274119 | C | 0.217445 | 0.056674 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 182 | R | 0.300377 | P | 0.325078 | -0.024701 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 194 | D | 0.594117 | H | 0.546571 | 0.047546 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 200 | D | 0.31212 | V | 0.181424 | 0.130696 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 211 | L | 0.203798 | P | 0.323257 | -0.119459 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 220 | L | 0.208154 | P | 0.342394 | -0.13424 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 221 | D | 0.192046 | G | 0.173599 | 0.018447 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 254 | T | 0.063115 | M | 0.054055 | 0.00906 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 254 | T | 0.063115 | P | 0.085753 | -0.022638 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 263 | P | 0.2542 | L | 0.159927 | 0.094273 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 266 | G | 0.355366 | R | 0.363079 | -0.007713 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 276 | K | 0.6412 | E | 0.664537 | -0.023337 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 277 | G | 0.617284 | R | 0.631952 | -0.014668 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 277 | G | 0.617284 | W | 0.395895 | 0.221389 | D to O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 291 | E | 0.388909 | D | 0.342493 | 0.046416 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 291 | E | 0.388909 | K | 0.371092 | 0.017817 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 294 | A | 0.296819 | T | 0.308157 | -0.011338 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 342 | S | 0.09772 | P | 0.082871 | 0.014849 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 389 | R | 0.433072 | G | 0.376842 | 0.05623 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 389 | R | 0.433072 | H | 0.354765 | 0.078307 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 401 | R | 0.316994 | Q | 0.316707 | 2.87E-04 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 418 | R | 0.181053 | W | 0.07428 | 0.106773 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 484 | P | 0.247394 | R | 0.20846 | 0.038934 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 507 | G | 0.344447 | V | 0.207414 | 0.137033 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 512 | G | 0.378608 | S | 0.42969 | -0.051082 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 515 | S | 0.28235 | F | 0.127189 | 0.155161 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 518 | R | 0.120622 | Q | 0.12965 | -0.009028 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 518 | R | 0.120622 | W | 0.050664 | 0.069958 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 522 | G | 0.099133 | W | 0.035785 | 0.063348 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 534 | P | 0.37055 | L | 0.21358 | 0.15697 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 560 | P | 0.435748 | L | 0.274876 | 0.160872 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 560 | P | 0.435748 | R | 0.41299 | 0.022758 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 566 | M | 0.60132 | K | 0.683554 | -0.082234 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 591 | R | 0.299669 | Q | 0.331526 | -0.031857 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 606 | S | 0.361138 | L | 0.201666 | 0.159472 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 606 | S | 0.361138 | P | 0.333229 | 0.027909 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 609 | E | 0.553483 | G | 0.524879 | 0.028604 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 609 | E | 0.553483 | K | 0.574104 | -0.020621 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 617 | R | 0.21447 | C | 0.100663 | 0.113807 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 617 | R | 0.21447 | G | 0.221074 | -0.006604 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 617 | R | 0.21447 | H | 0.211862 | 0.002608 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 626 | A | 0.198768 | T | 0.226473 | -0.027705 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 629 | D | 0.225027 | H | 0.198582 | 0.026445 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 660 | R | 0.247767 | W | 0.123767 | 0.124 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 679 | W | 0.393767 | R | 0.584942 | -0.191175 | O to D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 90 | E | 0.148375 | K | 0.147934 | 4.41E-04 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 103 | S | 0.206139 | R | 0.156052 | 0.050087 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 105 | T | 0.150255 | P | 0.185601 | -0.035346 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 108 | S | 0.098999 | L | 0.043346 | 0.055653 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 113 | R | 0.118835 | C | 0.052727 | 0.066108 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 143 | P | 0.045857 | S | 0.055595 | -0.009738 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 152 | R | 0.130077 | L | 0.082845 | 0.047232 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 152 | R | 0.130077 | S | 0.18289 | -0.052813 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 161 | S | 0.236548 | P | 0.198721 | 0.037827 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 163 | R | 0.246628 | P | 0.266232 | -0.019604 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 174 | Y | 0.154783 | C | 0.118444 | 0.036339 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 189 | R | 0.552368 | W | 0.33604 | 0.216328 | D to O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 190 | L | 0.590293 | P | 0.698899 | -0.108606 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 198 | T | 0.395696 | K | 0.477191 | -0.081495 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 200 | D | 0.31212 | N | 0.291051 | 0.021069 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 213 | S | 0.239774 | C | 0.096161 | 0.143613 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 214 | N | 0.245486 | D | 0.271203 | -0.025717 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 218 | P | 0.247548 | T | 0.224084 | 0.023464 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 229 | L | 0.232304 | P | 0.375652 | -0.143348 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 271 | E | 0.532744 | K | 0.528008 | 0.004736 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 285 | R | 0.337682 | P | 0.350843 | -0.013161 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 296 | Y | 0.257549 | C | 0.220153 | 0.037396 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 298 | G | 0.21739 | D | 0.226797 | -0.009407 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 302 | E | 0.237158 | K | 0.223147 | 0.014011 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 322 | L | 0.029005 | P | 0.056271 | -0.027266 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 336 | K | 0.075259 | M | 0.045263 | 0.029996 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 401 | R | 0.316994 | W | 0.156153 | 0.160841 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 529 | G | 0.19575 | S | 0.222476 | -0.026726 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 540 | F | 0.350146 | S | 0.571498 | -0.221352 | O to D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 543 | P | 0.366643 | L | 0.202174 | 0.164469 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 544 | Q | 0.367745 | R | 0.365024 | 0.002721 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 552 | S | 0.392218 | P | 0.389497 | 0.002721 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 554 | R | 0.379013 | H | 0.353141 | 0.025872 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 591 | R | 0.299669 | W | 0.159587 | 0.140082 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 616 | A | 0.251125 | V | 0.187455 | 0.06367 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 630 | E | 0.206745 | G | 0.168953 | 0.037792 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 631 | C | 0.205575 | Y | 0.258693 | -0.053118 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 633 | S | 0.191297 | R | 0.140763 | 0.050534 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 636 | S | 0.210425 | I | 0.086451 | 0.123974 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 638 | D | 0.251378 | Y | 0.137847 | 0.113531 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 646 | A | 0.260828 | P | 0.316565 | -0.055737 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 654 | L | 0.200659 | P | 0.346292 | -0.145633 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 667 | H | 0.191075 | D | 0.208963 | -0.017888 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 668 | T | 0.150235 | I | 0.084508 | 0.065727 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 693 | T | 0.672297 | M | 0.650623 | 0.021674 | No Change: Both D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 13 | N | 0.406992 | T | 0.404549 | 0.002443 | No Change: Both O | - |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 99 | A | 0.212717 | D | 0.26373 | -0.051013 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 113 | R | 0.118835 | P | 0.12809 | -0.009255 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 217 | K | 0.245601 | E | 0.24773 | -0.002129 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 224 | V | 0.129854 | E | 0.254054 | -0.1242 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 274 | R | 0.566756 | W | 0.340796 | 0.22596 | D to O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 280 | R | 0.449781 | C | 0.270693 | 0.179088 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 339 | W | 0.083235 | R | 0.198355 | -0.11512 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 343 | G | 0.090813 | D | 0.102818 | -0.012005 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 556 | Q | 0.371095 | R | 0.366539 | 0.004556 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 560 | P | 0.435748 | S | 0.473844 | -0.038096 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 591 | R | 0.299669 | P | 0.336282 | -0.036613 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 608 | G | 0.499781 | D | 0.523843 | -0.024062 | O to D | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 626 | A | 0.198768 | D | 0.273604 | -0.074836 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 632 | T | 0.183382 | I | 0.115335 | 0.068047 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 633 | S | 0.191297 | I | 0.078238 | 0.113059 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 635 | V | 0.211429 | M | 0.248765 | -0.037336 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 660 | R | 0.247767 | P | 0.293962 | -0.046195 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 88 | C | 0.089666 | W | 0.075291 | 0.014375 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 343 | G | 0.090813 | S | 0.125331 | -0.034518 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 503 | L | 0.188183 | P | 0.337388 | -0.149205 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| P33897 | ABCD1_HUMAN ATP-binding cassette sub-family D member 1 OS=Homo sapiens GN=ABCD1 PE=1 SV=2 | 514 | S | 0.3317 | R | 0.270941 | 0.060759 | No Change: Both O | Adrenoleukodystrophy X-linked (X-ALD) [MIM:300100] |
| Q9UBJ2 | ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens GN=ABCD2 PE=1 SV=1 | 244 | Q | 0.350504 | K | 0.397225 | -0.046721 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| P28288 | ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens GN=ABCD3 PE=1 SV=1 | 17 | G | 0.336628 | D | 0.33492 | 0.001708 | No Change: Both O | - |
| O14678 | ABCD4_HUMAN ATP-binding cassette sub-family D member 4 OS=Homo sapiens GN=ABCD4 PE=2 SV=1 | 368 | E | 0.431214 | K | 0.398375 | 0.032839 | No Change: Both O | - |
| O14678 | ABCD4_HUMAN ATP-binding cassette sub-family D member 4 OS=Homo sapiens GN=ABCD4 PE=2 SV=1 | 304 | A | 0.482462 | T | 0.538549 | -0.056087 | O to D | - |
| O14678 | ABCD4_HUMAN ATP-binding cassette sub-family D member 4 OS=Homo sapiens GN=ABCD4 PE=2 SV=1 | 172 | V | 0.037387 | I | 0.034653 | 0.002734 | No Change: Both O | - |
| O14678 | ABCD4_HUMAN ATP-binding cassette sub-family D member 4 OS=Homo sapiens GN=ABCD4 PE=2 SV=1 | 350 | T | 0.343621 | R | 0.376645 | -0.033024 | No Change: Both O | - |
| Q8NE71 | ABCF1_HUMAN ATP-binding cassette sub-family F member 1 OS=Homo sapiens GN=ABCF1 PE=1 SV=2 | 198 | N | 0.997065 | D | 0.997416 | -3.51E-04 | No Change: Both D | - |
| Q9NUQ8 | ABCF3_HUMAN ATP-binding cassette sub-family F member 3 OS=Homo sapiens GN=ABCF3 PE=1 SV=2 | 503 | P | 0.196512 | L | 0.106444 | 0.090068 | No Change: Both O | - |
| Q9NUQ8 | ABCF3_HUMAN ATP-binding cassette sub-family F member 3 OS=Homo sapiens GN=ABCF3 PE=1 SV=2 | 510 | R | 0.255331 | H | 0.270415 | -0.015084 | No Change: Both O | - |
| P45844 | ABCG1_HUMAN ATP-binding cassette sub-family G member 1 OS=Homo sapiens GN=ABCG1 PE=2 SV=3 | 668 | F | 0.023509 | L | 0.029919 | -0.00641 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 431 | F | 0.050926 | L | 0.059144 | -0.008218 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 489 | F | 0.019599 | L | 0.023199 | -0.0036 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 12 | V | 0.352864 | M | 0.423688 | -0.070824 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 141 | Q | 0.236403 | K | 0.269575 | -0.033172 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 316 | T | 0.483454 | P | 0.557965 | -0.074511 | O to D | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 166 | Q | 0.272117 | E | 0.322018 | -0.049901 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 206 | I | 0.340933 | L | 0.388088 | -0.047155 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 208 | F | 0.3258 | S | 0.569252 | -0.243452 | O to D | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 248 | S | 0.171558 | P | 0.153377 | 0.018181 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 571 | F | 0.06058 | I | 0.062984 | -0.002404 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 620 | D | 0.149217 | N | 0.141408 | 0.007809 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 296 | D | 0.139713 | H | 0.106248 | 0.033465 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 528 | A | 0.301118 | T | 0.303746 | -0.002628 | No Change: Both O | - |
| Q9UNQ0 | ABCG2_HUMAN ATP-binding cassette sub-family G member 2 OS=Homo sapiens GN=ABCG2 PE=1 SV=3 | 590 | N | 0.212131 | Y | 0.109678 | 0.102453 | No Change: Both O | - |
| Q9H172 | ABCG4_HUMAN ATP-binding cassette sub-family G member 4 OS=Homo sapiens GN=ABCG4 PE=2 SV=2 | 352 | P | 0.795314 | L | 0.628214 | 0.1671 | No Change: Both D | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 146 | E | 0.280604 | Q | 0.246358 | 0.034246 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 389 | R | 0.066676 | H | 0.062324 | 0.004352 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 419 | R | 0.122103 | H | 0.124281 | -0.002178 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 419 | R | 0.122103 | P | 0.143582 | -0.021479 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 550 | R | 0.183255 | S | 0.249281 | -0.066026 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 604 | Q | 0.105603 | E | 0.127438 | -0.021835 | No Change: Both O | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 437 | N | 0.125737 | K | 0.140201 | -0.014464 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 523 | I | 0.076944 | V | 0.092342 | -0.015398 | No Change: Both O | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 600 | C | 0.153113 | Y | 0.181952 | -0.028839 | No Change: Both O | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 622 | M | 0.083435 | V | 0.062324 | 0.021111 | No Change: Both O | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 517 | T | 0.040692 | S | 0.059004 | -0.018312 | No Change: Both O | - |
| Q9H222 | ABCG5_HUMAN ATP-binding cassette sub-family G member 5 OS=Homo sapiens GN=ABCG5 PE=1 SV=1 | 50 | R | 0.243061 | C | 0.138705 | 0.104356 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 19 | D | 0.816013 | H | 0.752183 | 0.06383 | No Change: Both D | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 54 | Y | 0.251929 | C | 0.265055 | -0.013126 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 184 | R | 0.552043 | H | 0.522293 | 0.02975 | No Change: Both D | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 231 | P | 0.065094 | T | 0.050682 | 0.014412 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 238 | E | 0.347411 | K | 0.346432 | 9.79E-04 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 259 | A | 0.307988 | V | 0.25078 | 0.057208 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 263 | R | 0.228615 | Q | 0.236918 | -0.008303 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 400 | T | 0.295911 | K | 0.324569 | -0.028658 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 405 | R | 0.255591 | H | 0.230236 | 0.025355 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 501 | L | 0.144988 | P | 0.274545 | -0.129557 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 543 | R | 0.011222 | S | 0.015448 | -0.004226 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 572 | L | 0.087038 | P | 0.162957 | -0.075919 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 574 | G | 0.104055 | E | 0.122461 | -0.018406 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 574 | G | 0.104055 | R | 0.091644 | 0.012411 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 575 | G | 0.099375 | R | 0.087135 | 0.01224 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 596 | L | 0.034321 | R | 0.063411 | -0.02909 | No Change: Both O | Sitosterolemia (STSL) [MIM:210250] |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 632 | V | 0.280527 | A | 0.362065 | -0.081538 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 641 | Y | 0.036769 | F | 0.027943 | 0.008826 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 210 | V | 0.319234 | M | 0.38443 | -0.065196 | No Change: Both O | - |
| Q9H221 | ABCG8_HUMAN ATP-binding cassette sub-family G member 8 OS=Homo sapiens GN=ABCG8 PE=1 SV=1 | 655 | M | 0.05448 | V | 0.045037 | 0.009443 | No Change: Both O | - |
| Q96SE0 | ABHD1_HUMAN Abhydrolase domain-containing protein 1 OS=Homo sapiens GN=ABHD1 PE=2 SV=2 | 137 | D | 0.387721 | E | 0.401929 | -0.014208 | No Change: Both O | - |
| Q96SE0 | ABHD1_HUMAN Abhydrolase domain-containing protein 1 OS=Homo sapiens GN=ABHD1 PE=2 SV=2 | 371 | W | 0.080001 | C | 0.087494 | -0.007493 | No Change: Both O | - |
| Q96SE0 | ABHD1_HUMAN Abhydrolase domain-containing protein 1 OS=Homo sapiens GN=ABHD1 PE=2 SV=2 | 54 | P | 0.154526 | Q | 0.14478 | 0.009746 | No Change: Both O | - |
| Q9NUJ1 | ABHDA_HUMAN Abhydrolase domain-containing protein 10 mitochondrial OS=Homo sapiens GN=ABHD10 PE=1 SV=1 | 251 | I | 0.307701 | V | 0.353158 | -0.045457 | No Change: Both O | - |
| Q8N2K0 | ABD12_HUMAN Monoacylglycerol lipase ABHD12 OS=Homo sapiens GN=ABHD12 PE=2 SV=2 | 349 | A | 0.259242 | T | 0.263741 | -0.004499 | No Change: Both O | - |
| Q7Z5M8 | AB12B_HUMAN Abhydrolase domain-containing protein 12B OS=Homo sapiens GN=ABHD12B PE=2 SV=1 | 334 | F | 0.150299 | L | 0.163574 | -0.013275 | No Change: Both O | - |
| Q7Z5M8 | AB12B_HUMAN Abhydrolase domain-containing protein 12B OS=Homo sapiens GN=ABHD12B PE=2 SV=1 | 282 | I | 0.271447 | V | 0.293537 | -0.02209 | No Change: Both O | A breast cancer sample |
| Q9BUJ0 | ABHEA_HUMAN Abhydrolase domain-containing protein 14A OS=Homo sapiens GN=ABHD14A PE=2 SV=2 | 32 | R | 0.467176 | Q | 0.510159 | -0.042983 | O to D | - |
| Q9BUJ0 | ABHEA_HUMAN Abhydrolase domain-containing protein 14A OS=Homo sapiens GN=ABHD14A PE=2 SV=2 | 61 | C | 0.287037 | W | 0.265046 | 0.021991 | No Change: Both O | - |
| Q6UXT9 | ABH15_HUMAN Abhydrolase domain-containing protein 15 OS=Homo sapiens GN=ABHD15 PE=2 SV=2 | 334 | T | 0.193334 | A | 0.174962 | 0.018372 | No Change: Both O | - |
| Q9H3Z7 | ABHGB_HUMAN Abhydrolase domain-containing protein 16B OS=Homo sapiens GN=ABHD16B PE=2 SV=1 | 10 | L | 0.018132 | Q | 0.03546 | -0.017328 | No Change: Both O | - |
| P08910 | ABHD2_HUMAN Abhydrolase domain-containing protein 2 OS=Homo sapiens GN=ABHD2 PE=2 SV=1 | 253 | R | 0.071538 | Q | 0.080348 | -0.00881 | No Change: Both O | - |
| Q8WU67 | ABHD3_HUMAN Abhydrolase domain-containing protein 3 OS=Homo sapiens GN=ABHD3 PE=2 SV=2 | 3 | R | 0.754365 | C | 0.616356 | 0.138009 | No Change: Both D | - |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 7 | E | 0.752559 | K | 0.719253 | 0.033306 | No Change: Both D | Chanarin-Dorfman syndrome (CDS) [MIM:275630] |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 130 | Q | 0.471948 | P | 0.491812 | -0.019864 | No Change: Both O | Chanarin-Dorfman syndrome (CDS) [MIM:275630] |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 260 | E | 0.444126 | K | 0.453521 | -0.009395 | No Change: Both O | Chanarin-Dorfman syndrome (CDS) [MIM:275630] |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 72 | I | 0.378133 | T | 0.541442 | -0.163309 | O to D | - |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 82 | H | 0.151494 | R | 0.14994 | 0.001554 | No Change: Both O | - |
| Q8WTS1 | ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens GN=ABHD5 PE=1 SV=1 | 115 | S | 0.528169 | G | 0.478367 | 0.049802 | D to O | Chanarin-Dorfman syndrome (CDS) [MIM:275630] |
| Q8IZP0 | ABI1_HUMAN Abl interactor 1 OS=Homo sapiens GN=ABI1 PE=1 SV=4 | 331 | G | 0.939309 | A | 0.931364 | 0.007945 | No Change: Both D | - |
| Q9P2A4 | ABI3_HUMAN ABI gene family member 3 OS=Homo sapiens GN=ABI3 PE=1 SV=2 | 44 | R | 0.512694 | Q | 0.544771 | -0.032077 | No Change: Both D | - |
| Q9P2A4 | ABI3_HUMAN ABI gene family member 3 OS=Homo sapiens GN=ABI3 PE=1 SV=2 | 203 | S | 0.879589 | F | 0.783225 | 0.096364 | No Change: Both D | - |
| Q9P2A4 | ABI3_HUMAN ABI gene family member 3 OS=Homo sapiens GN=ABI3 PE=1 SV=2 | 209 | F | 0.901976 | S | 0.957015 | -0.055039 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 706 | G | 0.930248 | V | 0.896909 | 0.033339 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 852 | T | 0.978754 | P | 0.984224 | -0.00547 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 900 | P | 0.997113 | S | 0.99689 | 2.23E-04 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 972 | S | 0.991994 | L | 0.985641 | 0.006353 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 47 | R | 0.596451 | G | 0.604357 | -0.007906 | No Change: Both D | A lung large cell carcinoma sample |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 166 | R | 0.463851 | K | 0.475901 | -0.01205 | No Change: Both O | A melanoma sample |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 810 | P | 0.916625 | L | 0.856499 | 0.060126 | No Change: Both D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 140 | L | 0.402785 | P | 0.549643 | -0.146858 | O to D | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 247 | K | 0.446174 | R | 0.386218 | 0.059956 | No Change: Both O | - |
| P00519 | ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | 968 | S | 0.990744 | P | 0.99181 | -0.001066 | No Change: Both D | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 930 | K | 0.557015 | R | 0.47533 | 0.081685 | D to O | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 946 | V | 0.548525 | M | 0.591737 | -0.043212 | No Change: Both D | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 996 | P | 0.93928 | R | 0.925297 | 0.013983 | No Change: Both D | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 1085 | S | 0.674931 | N | 0.610696 | 0.064235 | No Change: Both D | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 1101 | T | 0.492738 | A | 0.485078 | 0.00766 | No Change: Both O | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 78 | R | 0.450156 | H | 0.457649 | -0.007493 | No Change: Both O | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 99 | E | 0.444982 | Q | 0.389954 | 0.055028 | No Change: Both O | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 519 | R | 0.168775 | I | 0.080834 | 0.087941 | No Change: Both O | - |
| P42684 | ABL2_HUMAN Abelson tyrosine-protein kinase 2 OS=Homo sapiens GN=ABL2 PE=1 SV=1 | 769 | T | 0.889543 | S | 0.906472 | -0.016929 | No Change: Both D | - |
| O14639 | ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens GN=ABLIM1 PE=1 SV=3 | 434 | P | 0.880887 | T | 0.853656 | 0.027231 | No Change: Both D | - |
| O14639 | ABLM1_HUMAN Actin-binding LIM protein 1 OS=Homo sapiens GN=ABLIM1 PE=1 SV=3 | 637 | R | 0.8937 | G | 0.878663 | 0.015037 | No Change: Both D | - |
| Q6H8Q1 | ABLM2_HUMAN Actin-binding LIM protein 2 OS=Homo sapiens GN=ABLIM2 PE=1 SV=2 | 227 | G | 0.480965 | R | 0.473454 | 0.007511 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| Q6H8Q1 | ABLM2_HUMAN Actin-binding LIM protein 2 OS=Homo sapiens GN=ABLIM2 PE=1 SV=2 | 274 | K | 0.842347 | M | 0.836863 | 0.005484 | No Change: Both D | A pancreatic ductal adenocarcinoma sample |
| O94929 | ABLM3_HUMAN Actin-binding LIM protein 3 OS=Homo sapiens GN=ABLIM3 PE=1 SV=3 | 125 | G | 0.584197 | D | 0.602975 | -0.018778 | No Change: Both D | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 156 | P | 0.260394 | L | 0.13106 | 0.129334 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 176 | R | 0.183578 | G | 0.173133 | 0.010445 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 235 | G | 0.360574 | S | 0.418533 | -0.057959 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 266 | L | 0.157268 | M | 0.209781 | -0.052513 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 268 | G | 0.157168 | A | 0.118737 | 0.038431 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 352 | R | 0.89865 | W | 0.842878 | 0.055772 | No Change: Both D | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 35 | G | 0.1258 | R | 0.126221 | -4.21E-04 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 36 | V | 0.173177 | F | 0.158621 | 0.014556 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 63 | R | 0.477306 | H | 0.443695 | 0.033611 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 74 | P | 0.356926 | S | 0.3636 | -0.006674 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 161 | R | 0.297842 | H | 0.292869 | 0.004973 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 199 | R | 0.195223 | C | 0.103401 | 0.091822 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 216 | F | 0.226634 | I | 0.231114 | -0.00448 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 277 | V | 0.336028 | M | 0.377982 | -0.041954 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 257 | P | 0.446482 | L | 0.290594 | 0.155888 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 268 | G | 0.157168 | R | 0.147741 | 0.009427 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 163 | T | 0.307055 | M | 0.251204 | 0.055851 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 198 | R | 0.224955 | W | 0.087021 | 0.137934 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 214 | M | 0.200834 | R | 0.257196 | -0.056362 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 223 | E | 0.135027 | D | 0.126481 | 0.008546 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 288 | M | 0.233485 | R | 0.286239 | -0.052754 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 291 | D | 0.282589 | N | 0.282136 | 4.53E-04 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 346 | K | 0.455021 | M | 0.321906 | 0.133115 | No Change: Both O | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 352 | R | 0.89865 | G | 0.914765 | -0.016115 | No Change: Both D | - |
| P16442 | BGAT_HUMAN Histo-blood group ABO system transferase OS=Homo sapiens GN=ABO PE=1 SV=2 | 230 | G | 0.154336 | R | 0.140606 | 0.01373 | No Change: Both O | - |
| P19801 | ABP1_HUMAN Amiloride-sensitive amine oxidase [copper-containing] OS=Homo sapiens GN=ABP1 PE=1 SV=4 | 645 | H | 0.284513 | D | 0.326114 | -0.041601 | No Change: Both O | - |
| P19801 | ABP1_HUMAN Amiloride-sensitive amine oxidase [copper-containing] OS=Homo sapiens GN=ABP1 PE=1 SV=4 | 16 | T | 0.285416 | M | 0.288305 | -0.002889 | No Change: Both O | - |
| P19801 | ABP1_HUMAN Amiloride-sensitive amine oxidase [copper-containing] OS=Homo sapiens GN=ABP1 PE=1 SV=4 | 332 | S | 0.405294 | F | 0.194149 | 0.211145 | No Change: Both O | - |
| P19801 | ABP1_HUMAN Amiloride-sensitive amine oxidase [copper-containing] OS=Homo sapiens GN=ABP1 PE=1 SV=4 | 479 | M | 0.445499 | I | 0.316947 | 0.128552 | No Change: Both O | - |
| P19801 | ABP1_HUMAN Amiloride-sensitive amine oxidase [copper-containing] OS=Homo sapiens GN=ABP1 PE=1 SV=4 | 659 | N | 0.457397 | H | 0.4405 | 0.016897 | No Change: Both O | - |
| Q12979 | ABR_HUMAN Active breakpoint cluster region-related protein OS=Homo sapiens GN=ABR PE=2 SV=2 | 517 | K | 0.409634 | R | 0.328415 | 0.081219 | No Change: Both O | - |
| Q8N961 | ABTB2_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 2 OS=Homo sapiens GN=ABTB2 PE=2 SV=1 | 64 | H | 0.646822 | Q | 0.662102 | -0.01528 | No Change: Both D | - |
| Q8N961 | ABTB2_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein 2 OS=Homo sapiens GN=ABTB2 PE=2 SV=1 | 732 | T | 0.325259 | A | 0.285786 | 0.039473 | No Change: Both O | - |
| P09110 | THIK_HUMAN 3-ketoacyl-CoA thiolase peroxisomal OS=Homo sapiens GN=ACAA1 PE=1 SV=2 | 172 | E | 0.59545 | D | 0.569167 | 0.026283 | No Change: Both D | - |
| P42765 | THIM_HUMAN 3-ketoacyl-CoA thiolase mitochondrial OS=Homo sapiens GN=ACAA2 PE=1 SV=2 | 217 | M | 0.738655 | V | 0.686912 | 0.051743 | No Change: Both D | - |
| Q13085 | ACACA_HUMAN Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 | 2271 | A | 0.279579 | V | 0.214618 | 0.064961 | No Change: Both O | - |
| Q13085 | ACACA_HUMAN Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 | 1687 | R | 0.185115 | Q | 0.206581 | -0.021466 | No Change: Both O | A colorectal cancer sample |
| Q13085 | ACACA_HUMAN Acetyl-CoA carboxylase 1 OS=Homo sapiens GN=ACACA PE=1 SV=2 | 838 | R | 0.483702 | W | 0.257614 | 0.226088 | No Change: Both O | - |
| O00763 | ACACB_HUMAN Acetyl-CoA carboxylase 2 OS=Homo sapiens GN=ACACB PE=1 SV=3 | 552 | I | 0.074479 | V | 0.089914 | -0.015435 | No Change: Both O | - |
| O00763 | ACACB_HUMAN Acetyl-CoA carboxylase 2 OS=Homo sapiens GN=ACACB PE=1 SV=3 | 651 | A | 0.397504 | T | 0.439433 | -0.041929 | No Change: Both O | - |
| O00763 | ACACB_HUMAN Acetyl-CoA carboxylase 2 OS=Homo sapiens GN=ACACB PE=1 SV=3 | 2141 | V | 0.372916 | I | 0.343722 | 0.029194 | No Change: Both O | - |
| O00763 | ACACB_HUMAN Acetyl-CoA carboxylase 2 OS=Homo sapiens GN=ACACB PE=1 SV=3 | 193 | R | 0.891475 | L | 0.841581 | 0.049894 | No Change: Both D | A pancreatic ductal adenocarcinoma sample |
| Q6JQN1 | ACD10_HUMAN Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens GN=ACAD10 PE=2 SV=1 | 200 | Q | 0.242721 | R | 0.222905 | 0.019816 | No Change: Both O | - |
| Q6JQN1 | ACD10_HUMAN Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens GN=ACAD10 PE=2 SV=1 | 216 | T | 0.30152 | P | 0.354897 | -0.053377 | No Change: Both O | - |
| Q6JQN1 | ACD10_HUMAN Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens GN=ACAD10 PE=2 SV=1 | 463 | D | 0.22574 | N | 0.21095 | 0.01479 | No Change: Both O | - |
| Q6JQN1 | ACD10_HUMAN Acyl-CoA dehydrogenase family member 10 OS=Homo sapiens GN=ACAD10 PE=2 SV=1 | 880 | A | 0.490675 | V | 0.44881 | 0.041865 | No Change: Both O | - |
| Q709F0 | ACD11_HUMAN Acyl-CoA dehydrogenase family member 11 OS=Homo sapiens GN=ACAD11 PE=1 SV=2 | 157 | R | 0.263778 | H | 0.267272 | -0.003494 | No Change: Both O | - |
| Q709F0 | ACD11_HUMAN Acyl-CoA dehydrogenase family member 11 OS=Homo sapiens GN=ACAD11 PE=1 SV=2 | 362 | V | 0.310713 | L | 0.333084 | -0.022371 | No Change: Both O | - |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 128 | M | 0.061213 | I | 0.040115 | 0.021098 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 134 | D | 0.172319 | Y | 0.093317 | 0.079002 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 137 | G | 0.36612 | R | 0.372931 | -0.006811 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 152 | M | 0.260146 | T | 0.297841 | -0.037695 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 203 | V | 0.15623 | I | 0.146708 | 0.009522 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 302 | R | 0.357626 | Q | 0.381645 | -0.024019 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 320 | A | 0.157408 | T | 0.17331 | -0.015902 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 334 | R | 0.21849 | C | 0.121823 | 0.096667 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9UKU7 | ACAD8_HUMAN Isobutyryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACAD8 PE=1 SV=1 | 385 | Q | 0.237979 | R | 0.224974 | 0.013005 | No Change: Both O | Isobutyryl-CoA dehydrogenase deficiency (IBDD) [MIM:611283] |
| Q9H845 | ACAD9_HUMAN Acyl-CoA dehydrogenase family member 9 mitochondrial OS=Homo sapiens GN=ACAD9 PE=1 SV=1 | 477 | R | 0.422969 | Q | 0.415842 | 0.007127 | No Change: Both O | - |
| P28330 | ACADL_HUMAN Long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADL PE=2 SV=2 | 303 | S | 0.282003 | T | 0.210663 | 0.07134 | No Change: Both O | - |
| P28330 | ACADL_HUMAN Long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADL PE=2 SV=2 | 333 | K | 0.377897 | Q | 0.344937 | 0.03296 | No Change: Both O | - |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 53 | R | 0.508446 | C | 0.348608 | 0.159838 | D to O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 149 | M | 0.4043 | I | 0.302813 | 0.101487 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 193 | T | 0.198946 | A | 0.192794 | 0.006152 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 195 | G | 0.177545 | R | 0.160091 | 0.017454 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 244 | C | 0.34405 | R | 0.514135 | -0.170085 | O to D | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 267 | G | 0.231587 | R | 0.213067 | 0.01852 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 326 | M | 0.223077 | T | 0.237098 | -0.014021 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 329 | K | 0.321998 | E | 0.346161 | -0.024163 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 336 | S | 0.234247 | R | 0.201649 | 0.032598 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 375 | I | 0.186612 | T | 0.314651 | -0.128039 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 67 | Y | 0.389949 | H | 0.483289 | -0.09334 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 245 | S | 0.309192 | L | 0.174415 | 0.134777 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 281 | R | 0.311648 | T | 0.310098 | 0.00155 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 78 | I | 0.105594 | T | 0.193807 | -0.088213 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 116 | C | 0.153315 | Y | 0.188262 | -0.034947 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 121 | T | 0.251725 | I | 0.155541 | 0.096184 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 206 | R | 0.274376 | L | 0.208231 | 0.066145 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 310 | G | 0.262554 | R | 0.2837 | -0.021146 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 352 | Y | 0.28687 | C | 0.230717 | 0.056153 | No Change: Both O | Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) [MIM:201450] |
| P11310 | ACADM_HUMAN Medium-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADM PE=1 SV=1 | 132 | P | 0.214049 | R | 0.185511 | 0.028538 | No Change: Both O | A breast cancer sample |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 46 | R | 0.211203 | W | 0.090508 | 0.120695 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 92 | G | 0.251746 | C | 0.12154 | 0.130206 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 107 | R | 0.325343 | C | 0.196008 | 0.129335 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 177 | W | 0.284061 | R | 0.474 | -0.189939 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 209 | G | 0.269134 | S | 0.328366 | -0.059232 | No Change: Both O | - |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 383 | R | 0.391545 | C | 0.22596 | 0.165585 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 90 | G | 0.353264 | S | 0.382862 | -0.029598 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 171 | R | 0.514466 | W | 0.353012 | 0.161454 | D to O | - |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 192 | A | 0.155779 | V | 0.110357 | 0.045422 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 325 | R | 0.260339 | W | 0.129939 | 0.1304 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 353 | S | 0.527184 | L | 0.349242 | 0.177942 | D to O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 380 | R | 0.474659 | W | 0.254884 | 0.219775 | No Change: Both O | Acyl-CoA dehydrogenase short-chain deficiency (ACADSD) [MIM:201470] |
| P16219 | ACADS_HUMAN Short-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADS PE=1 SV=1 | 383 | R | 0.391545 | H | 0.38848 | 0.003065 | No Change: Both O | - |
| P45954 | ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADSB PE=1 SV=1 | 255 | L | 0.457371 | F | 0.408276 | 0.049095 | No Change: Both O | Short/branched-chain acyl-CoA dehydrogenase deficiency (SBCADD) [MIM:610006] |
| P45954 | ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADSB PE=1 SV=1 | 209 | S | 0.351155 | G | 0.296235 | 0.05492 | No Change: Both O | - |
| P45954 | ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADSB PE=1 SV=1 | 13 | R | 0.341063 | K | 0.343511 | -0.002448 | No Change: Both O | - |
| P45954 | ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADSB PE=1 SV=1 | 316 | I | 0.141437 | V | 0.146726 | -0.005289 | No Change: Both O | - |
| P45954 | ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADSB PE=1 SV=1 | 376 | E | 0.432495 | G | 0.392195 | 0.0403 | No Change: Both O | - |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 43 | G | 0.917258 | D | 0.923848 | -0.00659 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 158 | T | 0.101293 | N | 0.128014 | -0.026721 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 159 | Q | 0.093967 | R | 0.092289 | 0.001678 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 174 | V | 0.222795 | M | 0.284097 | -0.061302 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 185 | G | 0.190088 | S | 0.2269 | -0.036812 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 218 | E | 0.536162 | K | 0.545943 | -0.009781 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 243 | L | 0.226323 | R | 0.307965 | -0.081642 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 247 | K | 0.231695 | T | 0.19563 | 0.036065 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 260 | T | 0.088209 | M | 0.065844 | 0.022365 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 281 | A | 0.250348 | D | 0.308416 | -0.058068 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 283 | V | 0.225714 | A | 0.292289 | -0.066575 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 290 | G | 0.444069 | D | 0.43916 | 0.004909 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 294 | G | 0.557588 | E | 0.58771 | -0.030122 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 299 | K | 0.590134 | N | 0.563734 | 0.0264 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 317 | V | 0.279721 | A | 0.326214 | -0.046493 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 352 | M | 0.197818 | V | 0.151561 | 0.046257 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 366 | R | 0.448161 | C | 0.283377 | 0.164784 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 366 | R | 0.448161 | H | 0.476664 | -0.028503 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 382 | K | 0.178122 | Q | 0.16342 | 0.014702 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 405 | D | 0.428162 | H | 0.37536 | 0.052802 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 441 | G | 0.310208 | D | 0.312722 | -0.002514 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 450 | R | 0.262256 | H | 0.247047 | 0.015209 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 453 | R | 0.134195 | Q | 0.130028 | 0.004167 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 454 | D | 0.11843 | N | 0.109369 | 0.009061 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 456 | R | 0.081648 | H | 0.067912 | 0.013736 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 459 | R | 0.089322 | W | 0.029235 | 0.060087 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 463 | G | 0.123202 | E | 0.160356 | -0.037154 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 469 | R | 0.074745 | Q | 0.078868 | -0.004123 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 469 | R | 0.074745 | W | 0.024651 | 0.050094 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 502 | L | 0.655433 | P | 0.749377 | -0.093944 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 602 | L | 0.186825 | I | 0.171849 | 0.014976 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 613 | R | 0.25302 | W | 0.117888 | 0.135132 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 213 | A | 0.322899 | P | 0.415339 | -0.09244 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 247 | K | 0.231695 | E | 0.222842 | 0.008853 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 458 | F | 0.091476 | L | 0.104544 | -0.013068 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 490 | A | 0.539081 | P | 0.615549 | -0.076468 | No Change: Both D | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 534 | E | 0.509673 | K | 0.492188 | 0.017485 | D to O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 615 | R | 0.320053 | Q | 0.33312 | -0.013067 | No Change: Both O | Acyl-CoA dehydrogenase very long chain deficiency (ACADVLD) [MIM:201475] |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 359 | A | 0.289328 | S | 0.376567 | -0.087239 | No Change: Both O | - |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 623 | S | 0.381519 | F | 0.188877 | 0.192642 | No Change: Both O | - |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 17 | L | 0.940568 | F | 0.908053 | 0.032515 | No Change: Both D | - |
| P49748 | ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=ACADVL PE=1 SV=1 | 65 | P | 0.807438 | L | 0.72851 | 0.078928 | No Change: Both D | - |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 102 | D | 0.438394 | E | 0.467671 | -0.029277 | No Change: Both O | - |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 275 | R | 0.300665 | Q | 0.304451 | -0.003786 | No Change: Both O | - |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 1943 | P | 0.787135 | L | 0.646518 | 0.140617 | No Change: Both D | - |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 2005 | S | 0.978576 | R | 0.972749 | 0.005827 | No Change: Both D | - |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 2266 | D | 0.221017 | N | 0.213764 | 0.007253 | No Change: Both O | Spondyloepimetaphyseal dysplasia aggrecan type (SEMD-ACAN) [MIM:612813] |
| P16112 | PGCA_HUMAN Aggrecan core protein OS=Homo sapiens GN=ACAN PE=1 SV=2 | 2303 | V | 0.065662 | M | 0.092636 | -0.026974 | No Change: Both O | Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800] |
| Q15027 | ACAP1_HUMAN Arf-GAP with coiled-coil ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ACAP1 PE=1 SV=1 | 114 | K | 0.369395 | R | 0.366405 | 0.00299 | No Change: Both O | A breast cancer sample |
| Q15027 | ACAP1_HUMAN Arf-GAP with coiled-coil ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ACAP1 PE=1 SV=1 | 129 | R | 0.56184 | Q | 0.552834 | 0.009006 | No Change: Both D | A colorectal cancer sample |
| Q15027 | ACAP1_HUMAN Arf-GAP with coiled-coil ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ACAP1 PE=1 SV=1 | 68 | R | 0.214503 | C | 0.128784 | 0.085719 | No Change: Both O | - |
| Q15027 | ACAP1_HUMAN Arf-GAP with coiled-coil ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ACAP1 PE=1 SV=1 | 533 | R | 0.923172 | W | 0.855027 | 0.068145 | No Change: Both D | - |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 5 | A | 0.602575 | P | 0.690659 | -0.088084 | No Change: Both D | - |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 93 | N | 0.43659 | S | 0.490464 | -0.053874 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 152 | G | 0.562774 | A | 0.506943 | 0.055831 | No Change: Both D | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 158 | N | 0.514547 | D | 0.523681 | -0.009134 | No Change: Both D | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 183 | G | 0.198993 | R | 0.195098 | 0.003895 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 297 | T | 0.224931 | M | 0.202529 | 0.022402 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 301 | A | 0.309534 | P | 0.372722 | -0.063188 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 312 | I | 0.095083 | T | 0.179496 | -0.084413 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 333 | A | 0.121094 | P | 0.168536 | -0.047442 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 379 | G | 0.363727 | V | 0.228447 | 0.13528 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| P24752 | THIL_HUMAN Acetyl-CoA acetyltransferase mitochondrial OS=Homo sapiens GN=ACAT1 PE=1 SV=1 | 380 | A | 0.354121 | T | 0.386888 | -0.032767 | No Change: Both O | 3-ketothiolase deficiency (3KTD) [MIM:203750] |
| Q9BWD1 | THIC_HUMAN Acetyl-CoA acetyltransferase cytosolic OS=Homo sapiens GN=ACAT2 PE=1 SV=2 | 211 | K | 0.281677 | R | 0.23323 | 0.048447 | No Change: Both O | - |
| Q9H3P7 | GCP60_HUMAN Golgi resident protein GCP60 OS=Homo sapiens GN=ACBD3 PE=1 SV=4 | 187 | E | 0.92345 | D | 0.903026 | 0.020424 | No Change: Both D | - |
| Q8NC06 | ACBD4_HUMAN Acyl-CoA-binding domain-containing protein 4 OS=Homo sapiens GN=ACBD4 PE=1 SV=2 | 118 | P | 0.119183 | L | 0.055426 | 0.063757 | No Change: Both O | - |
| Q8NC06 | ACBD4_HUMAN Acyl-CoA-binding domain-containing protein 4 OS=Homo sapiens GN=ACBD4 PE=1 SV=2 | 242 | R | 0.746377 | G | 0.699788 | 0.046589 | No Change: Both D | - |
| Q5T8D3 | ACBD5_HUMAN Acyl-CoA-binding domain-containing protein 5 OS=Homo sapiens GN=ACBD5 PE=1 SV=1 | 472 | T | 0.748058 | M | 0.730274 | 0.017784 | No Change: Both D | - |
| Q16515 | ACCN1_HUMAN Amiloride-sensitive cation channel 1 neuronal OS=Homo sapiens GN=ACCN1 PE=1 SV=1 | 354 | D | 0.482025 | G | 0.47119 | 0.010835 | No Change: Both O | - |
| Q9UHC3 | ACCN3_HUMAN Amiloride-sensitive cation channel 3 OS=Homo sapiens GN=ACCN3 PE=1 SV=2 | 228 | N | 0.392611 | S | 0.437736 | -0.045125 | No Change: Both O | - |
| Q96FT7 | ACCN4_HUMAN Amiloride-sensitive cation channel 4 OS=Homo sapiens GN=ACCN4 PE=1 SV=2 | 614 | P | 0.905503 | Q | 0.888995 | 0.016508 | No Change: Both D | - |
| Q96FT7 | ACCN4_HUMAN Amiloride-sensitive cation channel 4 OS=Homo sapiens GN=ACCN4 PE=1 SV=2 | 616 | R | 0.908939 | L | 0.866382 | 0.042557 | No Change: Both D | - |
| Q96FT7 | ACCN4_HUMAN Amiloride-sensitive cation channel 4 OS=Homo sapiens GN=ACCN4 PE=1 SV=2 | 619 | V | 0.894786 | A | 0.910123 | -0.015337 | No Change: Both D | - |
| Q96QU6 | 1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens GN=ACCS PE=2 SV=1 | 221 | G | 0.334838 | E | 0.408397 | -0.073559 | No Change: Both O | A breast cancer sample |
| Q96QU6 | 1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens GN=ACCS PE=2 SV=1 | 393 | S | 0.362201 | L | 0.197016 | 0.165185 | No Change: Both O | A breast cancer sample |
| Q96QU6 | 1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens GN=ACCS PE=2 SV=1 | 421 | P | 0.305809 | L | 0.188925 | 0.116884 | No Change: Both O | - |
| Q96QU6 | 1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens GN=ACCS PE=2 SV=1 | 59 | D | 0.597546 | N | 0.566332 | 0.031214 | No Change: Both D | - |
| Q96QU6 | 1A1L1_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Homo sapiens GN=ACCS PE=2 SV=1 | 134 | D | 0.137796 | E | 0.161693 | -0.023897 | No Change: Both O | - |
| Q4AC99 | 1A1L2_HUMAN 1-aminocyclopropane-1-carboxylate synthase-like protein 2 OS=Homo sapiens GN=ACCSL PE=2 SV=3 | 529 | C | 0.03263 | R | 0.061621 | -0.028991 | No Change: Both O | - |
| Q96AP0 | ACD_HUMAN Adrenocortical dysplasia protein homolog OS=Homo sapiens GN=ACD PE=1 SV=3 | 301 | T | 0.353437 | M | 0.308097 | 0.04534 | No Change: Both O | - |
| Q96AP0 | ACD_HUMAN Adrenocortical dysplasia protein homolog OS=Homo sapiens GN=ACD PE=1 SV=3 | 518 | V | 0.325067 | A | 0.423137 | -0.09807 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 261 | A | 0.236097 | S | 0.323255 | -0.087158 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 561 | R | 0.294773 | W | 0.133446 | 0.161327 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1286 | R | 0.650526 | S | 0.704373 | -0.053847 | No Change: Both D | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1018 | I | 0.239254 | T | 0.362073 | -0.122819 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1051 | F | 0.232702 | V | 0.260689 | -0.027987 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1279 | R | 0.2927 | Q | 0.304233 | -0.011533 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1296 | Q | 0.771807 | P | 0.789831 | -0.018024 | No Change: Both D | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 592 | D | 0.282471 | G | 0.25367 | 0.028801 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 244 | Y | 0.290443 | C | 0.234628 | 0.055815 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 351 | P | 0.530829 | L | 0.39345 | 0.137379 | D to O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 916 | T | 0.327166 | M | 0.314537 | 0.012629 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1187 | T | 0.399195 | M | 0.3965 | 0.002695 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 1228 | P | 0.472656 | L | 0.305377 | 0.167279 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 154 | A | 0.253812 | T | 0.291161 | -0.037349 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 183 | A | 0.125728 | T | 0.129307 | -0.003579 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 379 | R | 0.188877 | Q | 0.209891 | -0.021014 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 524 | V | 0.15031 | A | 0.20051 | -0.0502 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 828 | M | 0.486957 | T | 0.556603 | -0.069646 | O to D | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 354 | G | 0.4383 | R | 0.448597 | -0.010297 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 260 | R | 0.223795 | C | 0.101474 | 0.122321 | No Change: Both O | - |
| P12821 | ACE_HUMAN Angiotensin-converting enzyme OS=Homo sapiens GN=ACE PE=1 SV=1 | 260 | R | 0.223795 | L | 0.133056 | 0.090739 | No Change: Both O | - |
| Q9BYF1 | ACE2_HUMAN Angiotensin-converting enzyme 2 OS=Homo sapiens GN=ACE2 PE=1 SV=2 | 26 | K | 0.404802 | R | 0.327973 | 0.076829 | No Change: Both O | - |
| Q9BYF1 | ACE2_HUMAN Angiotensin-converting enzyme 2 OS=Homo sapiens GN=ACE2 PE=1 SV=2 | 638 | N | 0.270498 | S | 0.305393 | -0.034895 | No Change: Both O | - |
| Q5QJU3 | ACER2_HUMAN Alkaline ceramidase 2 OS=Homo sapiens GN=ACER2 PE=1 SV=2 | 134 | A | 0.081299 | V | 0.061068 | 0.020231 | No Change: Both O | - |
| P22303 | ACES_HUMAN Acetylcholinesterase OS=Homo sapiens GN=ACHE PE=1 SV=1 | 353 | H | 0.120716 | N | 0.140365 | -0.019649 | No Change: Both O | - |
| P22303 | ACES_HUMAN Acetylcholinesterase OS=Homo sapiens GN=ACHE PE=1 SV=1 | 333 | V | 0.149302 | E | 0.275012 | -0.12571 | No Change: Both O | - |
| P22303 | ACES_HUMAN Acetylcholinesterase OS=Homo sapiens GN=ACHE PE=1 SV=1 | 34 | R | 0.556737 | Q | 0.558856 | -0.002119 | No Change: Both D | - |
| P22303 | ACES_HUMAN Acetylcholinesterase OS=Homo sapiens GN=ACHE PE=1 SV=1 | 135 | P | 0.25407 | A | 0.176868 | 0.077202 | No Change: Both O | - |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 311 | I | 0.992081 | M | 0.995467 | -0.003386 | No Change: Both D | - |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 467 | S | 0.733333 | P | 0.749715 | -0.016382 | No Change: Both D | - |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 478 | S | 0.85016 | F | 0.68414 | 0.16602 | No Change: Both D | - |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 1160 | R | 0.999179 | Q | 0.999001 | 1.78E-04 | No Change: Both D | A colorectal cancer sample |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 257 | R | 0.995041 | K | 0.994457 | 5.84E-04 | No Change: Both D | - |
| Q9UKV3 | ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens GN=ACIN1 PE=1 SV=2 | 447 | A | 0.788535 | P | 0.857007 | -0.068472 | No Change: Both D | - |
| P53396 | ACLY_HUMAN ATP-citrate synthase OS=Homo sapiens GN=ACLY PE=1 SV=3 | 175 | E | 0.57311 | D | 0.54875 | 0.02436 | No Change: Both D | - |
| P21399 | ACOC_HUMAN Cytoplasmic aconitate hydratase OS=Homo sapiens GN=ACO1 PE=1 SV=3 | 395 | A | 0.445409 | D | 0.540845 | -0.095436 | O to D | - |
| P21399 | ACOC_HUMAN Cytoplasmic aconitate hydratase OS=Homo sapiens GN=ACO1 PE=1 SV=3 | 486 | G | 0.272844 | R | 0.258737 | 0.014107 | No Change: Both O | - |
| Q99798 | ACON_HUMAN Aconitate hydratase mitochondrial OS=Homo sapiens GN=ACO2 PE=1 SV=2 | 768 | A | 0.21016 | S | 0.312153 | -0.101993 | No Change: Both O | - |
| Q99798 | ACON_HUMAN Aconitate hydratase mitochondrial OS=Homo sapiens GN=ACO2 PE=1 SV=2 | 697 | T | 0.384935 | N | 0.42381 | -0.038875 | No Change: Both O | A breast cancer sample |
| Q86TX2 | ACOT1_HUMAN Acyl-coenzyme A thioesterase 1 OS=Homo sapiens GN=ACOT1 PE=1 SV=1 | 266 | R | 0.36296 | H | 0.368051 | -0.005091 | No Change: Both O | - |
| Q8WXI4 | ACO11_HUMAN Acyl-coenzyme A thioesterase 11 OS=Homo sapiens GN=ACOT11 PE=1 SV=1 | 165 | P | 0.64588 | L | 0.523211 | 0.122669 | No Change: Both D | - |
| Q8WXI4 | ACO11_HUMAN Acyl-coenzyme A thioesterase 11 OS=Homo sapiens GN=ACOT11 PE=1 SV=1 | 202 | G | 0.36882 | D | 0.46266 | -0.09384 | No Change: Both O | - |
| Q8WXI4 | ACO11_HUMAN Acyl-coenzyme A thioesterase 11 OS=Homo sapiens GN=ACOT11 PE=1 SV=1 | 212 | M | 0.470786 | I | 0.367523 | 0.103263 | No Change: Both O | - |
| Q8WXI4 | ACO11_HUMAN Acyl-coenzyme A thioesterase 11 OS=Homo sapiens GN=ACOT11 PE=1 SV=1 | 11 | R | 0.510372 | W | 0.197406 | 0.312966 | D to O | - |
| Q8WXI4 | ACO11_HUMAN Acyl-coenzyme A thioesterase 11 OS=Homo sapiens GN=ACOT11 PE=1 SV=1 | 536 | R | 0.13038 | H | 0.119169 | 0.011211 | No Change: Both O | - |
| Q8WYK0 | ACO12_HUMAN Acyl-coenzyme A thioesterase 12 OS=Homo sapiens GN=ACOT12 PE=1 SV=1 | 230 | V | 0.233031 | I | 0.20828 | 0.024751 | No Change: Both O | - |
| Q8WYK0 | ACO12_HUMAN Acyl-coenzyme A thioesterase 12 OS=Homo sapiens GN=ACOT12 PE=1 SV=1 | 403 | A | 0.230737 | T | 0.248635 | -0.017898 | No Change: Both O | - |
| Q8WYK0 | ACO12_HUMAN Acyl-coenzyme A thioesterase 12 OS=Homo sapiens GN=ACOT12 PE=1 SV=1 | 190 | L | 0.377822 | H | 0.504947 | -0.127125 | O to D | - |
| P49753 | ACOT2_HUMAN Acyl-coenzyme A thioesterase 2 mitochondrial OS=Homo sapiens GN=ACOT2 PE=1 SV=6 | 475 | H | 0.622136 | R | 0.59056 | 0.031576 | No Change: Both D | - |
| P49753 | ACOT2_HUMAN Acyl-coenzyme A thioesterase 2 mitochondrial OS=Homo sapiens GN=ACOT2 PE=1 SV=6 | 16 | R | 0.727382 | S | 0.792774 | -0.065392 | No Change: Both D | - |
| Q8N9L9 | ACOT4_HUMAN Acyl-coenzyme A thioesterase 4 OS=Homo sapiens GN=ACOT4 PE=1 SV=2 | 57 | R | 0.518875 | C | 0.385815 | 0.13306 | D to O | - |
| Q8N9L9 | ACOT4_HUMAN Acyl-coenzyme A thioesterase 4 OS=Homo sapiens GN=ACOT4 PE=1 SV=2 | 187 | A | 0.08808 | D | 0.118457 | -0.030377 | No Change: Both O | - |
| Q3I5F7 | ACOT6_HUMAN Putative acyl-coenzyme A thioesterase 6 OS=Homo sapiens GN=ACOT6 PE=1 SV=1 | 166 | E | 0.174777 | K | 0.171589 | 0.003188 | No Change: Both O | - |
| Q9Y305 | ACOT9_HUMAN Acyl-coenzyme A thioesterase 9 mitochondrial OS=Homo sapiens GN=ACOT9 PE=1 SV=2 | 305 | N | 0.213323 | H | 0.198879 | 0.014444 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| Q15067 | ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens GN=ACOX1 PE=1 SV=3 | 312 | I | 0.680261 | M | 0.712715 | -0.032454 | No Change: Both D | - |
| Q15067 | ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens GN=ACOX1 PE=1 SV=3 | 178 | G | 0.282569 | C | 0.129201 | 0.153368 | No Change: Both O | Adrenoleukodystrophy pseudoneonatal (Pseudo-NALD) [MIM:264470] |
| Q15067 | ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens GN=ACOX1 PE=1 SV=3 | 278 | M | 0.095197 | V | 0.07933 | 0.015867 | No Change: Both O | Adrenoleukodystrophy pseudoneonatal (Pseudo-NALD) [MIM:264470] |
| Q15067 | ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens GN=ACOX1 PE=1 SV=3 | 153 | T | 0.496424 | I | 0.322623 | 0.173801 | No Change: Both O | - |
| Q15067 | ACOX1_HUMAN Peroxisomal acyl-coenzyme A oxidase 1 OS=Homo sapiens GN=ACOX1 PE=1 SV=3 | 101 | G | 0.136069 | S | 0.177579 | -0.04151 | No Change: Both O | - |
| O15254 | ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 | 34 | E | 0.284107 | A | 0.209132 | 0.074975 | No Change: Both O | - |
| O15254 | ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 | 497 | D | 0.251114 | N | 0.23036 | 0.020754 | No Change: Both O | - |
| Q9NUZ1 | ACOXL_HUMAN Acyl-coenzyme A oxidase-like protein OS=Homo sapiens GN=ACOXL PE=2 SV=3 | 255 | T | 0.183135 | M | 0.1769 | 0.006235 | No Change: Both O | - |
| Q9NUZ1 | ACOXL_HUMAN Acyl-coenzyme A oxidase-like protein OS=Homo sapiens GN=ACOXL PE=2 SV=3 | 535 | P | 0.319012 | L | 0.190653 | 0.128359 | No Change: Both O | - |
| P24666 | PPAC_HUMAN Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens GN=ACP1 PE=1 SV=3 | 106 | Q | 0.504488 | R | 0.506707 | -0.002219 | No Change: Both D | - |
| P24666 | PPAC_HUMAN Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens GN=ACP1 PE=1 SV=3 | 7 | K | 0.338014 | N | 0.30985 | 0.028164 | No Change: Both O | - |
| P24666 | PPAC_HUMAN Low molecular weight phosphotyrosine protein phosphatase OS=Homo sapiens GN=ACP1 PE=1 SV=3 | 137 | S | 0.433452 | F | 0.238361 | 0.195091 | No Change: Both O | - |
| P11117 | PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens GN=ACP2 PE=1 SV=3 | 29 | R | 0.30958 | Q | 0.302799 | 0.006781 | No Change: Both O | - |
| P11117 | PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens GN=ACP2 PE=1 SV=3 | 320 | S | 0.421794 | F | 0.229564 | 0.19223 | No Change: Both O | - |
| P11117 | PPAL_HUMAN Lysosomal acid phosphatase OS=Homo sapiens GN=ACP2 PE=1 SV=3 | 402 | V | 0.030905 | I | 0.025829 | 0.005076 | No Change: Both O | - |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 148 | V | 0.12326 | M | 0.157103 | -0.033843 | No Change: Both O | - |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 200 | V | 0.150374 | M | 0.17841 | -0.028036 | No Change: Both O | - |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 221 | V | 0.223463 | I | 0.198693 | 0.02477 | No Change: Both O | - |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 52 | K | 0.478396 | M | 0.358623 | 0.119773 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 89 | T | 0.414348 | I | 0.272147 | 0.142201 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 109 | G | 0.182894 | R | 0.166559 | 0.016335 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 201 | L | 0.122198 | P | 0.22767 | -0.105472 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 215 | G | 0.23134 | R | 0.219705 | 0.011635 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 241 | D | 0.21001 | N | 0.204151 | 0.005859 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 262 | N | 0.423254 | H | 0.409858 | 0.013396 | No Change: Both O | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| P13686 | PPA5_HUMAN Tartrate-resistant acid phosphatase type 5 OS=Homo sapiens GN=ACP5 PE=1 SV=3 | 264 | M | 0.573203 | K | 0.67732 | -0.104117 | No Change: Both D | Spondyloenchondrodysplasia with immune dysregulation (SPENCDI) [MIM:607944] |
| Q9NPH0 | PPA6_HUMAN Lysophosphatidic acid phosphatase type 6 OS=Homo sapiens GN=ACP6 PE=1 SV=2 | 316 | V | 0.415629 | M | 0.481325 | -0.065696 | No Change: Both O | - |
| P15309 | PPAP_HUMAN Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 | 15 | S | 0.118493 | N | 0.091061 | 0.027432 | No Change: Both O | - |
| P15309 | PPAP_HUMAN Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 | 124 | F | 0.18138 | V | 0.214855 | -0.033475 | No Change: Both O | - |
| P15309 | PPAP_HUMAN Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 | 226 | W | 0.315007 | R | 0.523701 | -0.208694 | O to D | - |
| P15309 | PPAP_HUMAN Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 | 330 | Y | 0.279727 | H | 0.380416 | -0.100689 | No Change: Both O | - |
| P15309 | PPAP_HUMAN Prostatic acid phosphatase OS=Homo sapiens GN=ACPP PE=1 SV=3 | 360 | V | 0.412488 | A | 0.481851 | -0.069363 | No Change: Both O | - |
| P10323 | ACRO_HUMAN Acrosin OS=Homo sapiens GN=ACR PE=2 SV=4 | 120 | L | 0.403845 | V | 0.42888 | -0.025035 | No Change: Both O | - |
| P10323 | ACRO_HUMAN Acrosin OS=Homo sapiens GN=ACR PE=2 SV=4 | 166 | F | 0.296603 | L | 0.335169 | -0.038566 | No Change: Both O | - |
| Q8NEB7 | ACRBP_HUMAN Acrosin-binding protein OS=Homo sapiens GN=ACRBP PE=2 SV=1 | 336 | T | 0.086557 | A | 0.073094 | 0.013463 | No Change: Both O | - |
| Q96QF7 | ACRC_HUMAN Acidic repeat-containing protein OS=Homo sapiens GN=ACRC PE=2 SV=1 | 662 | T | 0.209039 | I | 0.119976 | 0.089063 | No Change: Both O | - |
| Q96QF7 | ACRC_HUMAN Acidic repeat-containing protein OS=Homo sapiens GN=ACRC PE=2 SV=1 | 471 | R | 0.984829 | H | 0.981263 | 0.003566 | No Change: Both D | - |
| P26436 | ASPX_HUMAN Acrosomal protein SP-10 OS=Homo sapiens GN=ACRV1 PE=1 SV=2 | 126 | G | 0.998173 | R | 0.997789 | 3.84E-04 | No Change: Both D | - |
| Q96GR2 | ACBG1_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG1 OS=Homo sapiens GN=ACSBG1 PE=1 SV=2 | 194 | E | 0.353211 | V | 0.179851 | 0.17336 | No Change: Both O | - |
| Q96GR2 | ACBG1_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG1 OS=Homo sapiens GN=ACSBG1 PE=1 SV=2 | 633 | M | 0.468165 | V | 0.396218 | 0.071947 | No Change: Both O | - |
| Q96GR2 | ACBG1_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG1 OS=Homo sapiens GN=ACSBG1 PE=1 SV=2 | 673 | A | 0.298583 | V | 0.226665 | 0.071918 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 143 | V | 0.148509 | A | 0.2112 | -0.062691 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 152 | K | 0.079764 | R | 0.058681 | 0.021083 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 584 | G | 0.210395 | D | 0.223727 | -0.013332 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 586 | G | 0.285758 | D | 0.297821 | -0.012063 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 601 | P | 0.247181 | R | 0.217504 | 0.029677 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 624 | R | 0.227069 | K | 0.29718 | -0.070111 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 626 | E | 0.155672 | Q | 0.133269 | 0.022403 | No Change: Both O | - |
| Q5FVE4 | ACBG2_HUMAN Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Homo sapiens GN=ACSBG2 PE=1 SV=2 | 650 | R | 0.303918 | S | 0.372187 | -0.068269 | No Change: Both O | - |
| Q96CM8 | ACSF2_HUMAN Acyl-CoA synthetase family member 2 mitochondrial OS=Homo sapiens GN=ACSF2 PE=1 SV=2 | 75 | G | 0.393146 | V | 0.285409 | 0.107737 | No Change: Both O | - |
| Q96CM8 | ACSF2_HUMAN Acyl-CoA synthetase family member 2 mitochondrial OS=Homo sapiens GN=ACSF2 PE=1 SV=2 | 316 | V | 0.150308 | M | 0.221636 | -0.071328 | No Change: Both O | - |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 2 | L | 0.559393 | P | 0.664483 | -0.10509 | No Change: Both D | - |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 17 | A | 0.387072 | P | 0.495741 | -0.108669 | No Change: Both O | - |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 372 | V | 0.384732 | M | 0.451773 | -0.067041 | No Change: Both O | - |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 198 | M | 0.203786 | R | 0.270728 | -0.066942 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 243 | P | 0.163137 | L | 0.089375 | 0.073762 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 358 | T | 0.288043 | I | 0.186099 | 0.101944 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 359 | E | 0.287558 | K | 0.274046 | 0.013512 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 462 | K | 0.154134 | T | 0.116226 | 0.037908 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 471 | R | 0.148627 | Q | 0.158901 | -0.010274 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 471 | R | 0.148627 | W | 0.060511 | 0.088116 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 480 | G | 0.301451 | S | 0.362214 | -0.060763 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| Q4G176 | ACSF3_HUMAN Acyl-CoA synthetase family member 3 mitochondrial OS=Homo sapiens GN=ACSF3 PE=1 SV=3 | 558 | R | 0.346334 | W | 0.174465 | 0.171869 | No Change: Both O | Combined malonic and methylmalonic aciduria (CMAMMA) [MIM:614265] |
| O95573 | ACSL3_HUMAN Long-chain-fatty-acid--CoA ligase 3 OS=Homo sapiens GN=ACSL3 PE=1 SV=3 | 551 | F | 0.42302 | S | 0.549803 | -0.126783 | O to D | - |
| O60488 | ACSL4_HUMAN Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens GN=ACSL4 PE=1 SV=2 | 570 | R | 0.254553 | S | 0.313365 | -0.058812 | No Change: Both O | Mental retardation X-linked type 63 (MRX63) [MIM:300387] |
| O60488 | ACSL4_HUMAN Long-chain-fatty-acid--CoA ligase 4 OS=Homo sapiens GN=ACSL4 PE=1 SV=2 | 133 | R | 0.246751 | C | 0.124778 | 0.121973 | No Change: Both O | A colorectal cancer sample |
| Q9ULC5 | ACSL5_HUMAN Long-chain-fatty-acid--CoA ligase 5 OS=Homo sapiens GN=ACSL5 PE=1 SV=1 | 182 | M | 0.086331 | V | 0.070649 | 0.015682 | No Change: Both O | - |
| Q9ULC5 | ACSL5_HUMAN Long-chain-fatty-acid--CoA ligase 5 OS=Homo sapiens GN=ACSL5 PE=1 SV=1 | 388 | K | 0.403765 | R | 0.335253 | 0.068512 | No Change: Both O | A colorectal cancer sample |
| Q9ULC5 | ACSL5_HUMAN Long-chain-fatty-acid--CoA ligase 5 OS=Homo sapiens GN=ACSL5 PE=1 SV=1 | 466 | G | 0.151417 | D | 0.161222 | -0.009805 | No Change: Both O | A colorectal cancer sample |
| Q9ULC5 | ACSL5_HUMAN Long-chain-fatty-acid--CoA ligase 5 OS=Homo sapiens GN=ACSL5 PE=1 SV=1 | 486 | T | 0.200343 | A | 0.187488 | 0.012855 | No Change: Both O | - |
| Q08AH1 | ACSM1_HUMAN Acyl-coenzyme A synthetase ACSM1 mitochondrial OS=Homo sapiens GN=ACSM1 PE=2 SV=1 | 479 | I | 0.341029 | V | 0.3682 | -0.027171 | No Change: Both O | - |
| Q08AH1 | ACSM1_HUMAN Acyl-coenzyme A synthetase ACSM1 mitochondrial OS=Homo sapiens GN=ACSM1 PE=2 SV=1 | 515 | I | 0.146564 | T | 0.251329 | -0.104765 | No Change: Both O | - |
| Q08AH1 | ACSM1_HUMAN Acyl-coenzyme A synthetase ACSM1 mitochondrial OS=Homo sapiens GN=ACSM1 PE=2 SV=1 | 272 | I | 0.038204 | M | 0.055062 | -0.016858 | No Change: Both O | - |
| Q08AH3 | ACS2A_HUMAN Acyl-coenzyme A synthetase ACSM2A mitochondrial OS=Homo sapiens GN=ACSM2A PE=1 SV=2 | 513 | S | 0.267681 | L | 0.149682 | 0.117999 | No Change: Both O | - |
| Q08AH3 | ACS2A_HUMAN Acyl-coenzyme A synthetase ACSM2A mitochondrial OS=Homo sapiens GN=ACSM2A PE=1 SV=2 | 561 | A | 0.473539 | T | 0.519424 | -0.045885 | O to D | - |
| Q08AH3 | ACS2A_HUMAN Acyl-coenzyme A synthetase ACSM2A mitochondrial OS=Homo sapiens GN=ACSM2A PE=1 SV=2 | 335 | V | 0.177749 | L | 0.185457 | -0.007708 | No Change: Both O | - |
| Q08AH3 | ACS2A_HUMAN Acyl-coenzyme A synthetase ACSM2A mitochondrial OS=Homo sapiens GN=ACSM2A PE=1 SV=2 | 336 | T | 0.192212 | A | 0.168299 | 0.023913 | No Change: Both O | - |
| Q08AH3 | ACS2A_HUMAN Acyl-coenzyme A synthetase ACSM2A mitochondrial OS=Homo sapiens GN=ACSM2A PE=1 SV=2 | 337 | V | 0.218803 | G | 0.332876 | -0.114073 | No Change: Both O | - |
| Q53FZ2 | ACSM3_HUMAN Acyl-coenzyme A synthetase ACSM3 mitochondrial OS=Homo sapiens GN=ACSM3 PE=1 SV=2 | 100 | L | 0.450987 | P | 0.574262 | -0.123275 | O to D | - |
| Q53FZ2 | ACSM3_HUMAN Acyl-coenzyme A synthetase ACSM3 mitochondrial OS=Homo sapiens GN=ACSM3 PE=1 SV=2 | 308 | P | 0.453053 | T | 0.40185 | 0.051203 | No Change: Both O | - |
| Q53FZ2 | ACSM3_HUMAN Acyl-coenzyme A synthetase ACSM3 mitochondrial OS=Homo sapiens GN=ACSM3 PE=1 SV=2 | 367 | K | 0.296001 | N | 0.262662 | 0.033339 | No Change: Both O | - |
| Q53FZ2 | ACSM3_HUMAN Acyl-coenzyme A synthetase ACSM3 mitochondrial OS=Homo sapiens GN=ACSM3 PE=1 SV=2 | 270 | D | 0.264807 | H | 0.215655 | 0.049152 | No Change: Both O | - |
| P0C7M7 | ACSM4_HUMAN Acyl-coenzyme A synthetase ACSM4 mitochondrial OS=Homo sapiens GN=ACSM4 PE=1 SV=1 | 481 | R | 0.233254 | H | 0.234856 | -0.001602 | No Change: Both O | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 159 | Q | 0.424731 | H | 0.389094 | 0.035637 | No Change: Both O | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 352 | P | 0.423129 | R | 0.400248 | 0.022881 | No Change: Both O | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 360 | H | 0.38396 | R | 0.39747 | -0.01351 | No Change: Both O | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 533 | T | 0.529756 | M | 0.50001 | 0.029746 | No Change: Both D | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 65 | R | 0.339164 | Q | 0.349557 | -0.010393 | No Change: Both O | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 182 | E | 0.524611 | K | 0.543613 | -0.019002 | No Change: Both D | - |
| Q6NUN0 | ACSM5_HUMAN Acyl-coenzyme A synthetase ACSM5 mitochondrial OS=Homo sapiens GN=ACSM5 PE=2 SV=2 | 217 | M | 0.555846 | V | 0.489871 | 0.065975 | D to O | - |
| Q6P461 | ACSM6_HUMAN Acyl-coenzyme A synthetase ACSM6 mitochondrial OS=Homo sapiens GN=ACSM6 PE=2 SV=3 | 227 | K | 0.387116 | R | 0.327567 | 0.059549 | No Change: Both O | - |
| Q6P461 | ACSM6_HUMAN Acyl-coenzyme A synthetase ACSM6 mitochondrial OS=Homo sapiens GN=ACSM6 PE=2 SV=3 | 19 | E | 0.17572 | G | 0.171064 | 0.004656 | No Change: Both O | - |
| Q6P461 | ACSM6_HUMAN Acyl-coenzyme A synthetase ACSM6 mitochondrial OS=Homo sapiens GN=ACSM6 PE=2 SV=3 | 40 | C | 0.298632 | S | 0.510657 | -0.212025 | O to D | - |
| Q9NUB1 | ACS2L_HUMAN Acetyl-coenzyme A synthetase 2-like mitochondrial OS=Homo sapiens GN=ACSS1 PE=1 SV=2 | 488 | V | 0.598835 | M | 0.626096 | -0.027261 | No Change: Both D | - |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 17 | G | 0.3117 | R | 0.296962 | 0.014738 | No Change: Both O | Myopathy congenital with excess of thin myofilaments (MPCETM) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 96 | L | 0.354031 | P | 0.519944 | -0.165913 | O to D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 117 | N | 0.656854 | S | 0.673853 | -0.016999 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 138 | I | 0.070176 | M | 0.11494 | -0.044764 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 165 | V | 0.254613 | L | 0.243161 | 0.011452 | No Change: Both O | Myopathy congenital with excess of thin myofilaments (MPCETM) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 261 | E | 0.270906 | V | 0.126797 | 0.144109 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 270 | G | 0.328477 | C | 0.175812 | 0.152665 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 372 | V | 0.435586 | F | 0.413084 | 0.022502 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 134 | M | 0.075232 | V | 0.059247 | 0.015985 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 271 | M | 0.369667 | R | 0.431828 | -0.062161 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 42 | H | 0.4533 | Y | 0.342561 | 0.110739 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 184 | G | 0.263966 | D | 0.313626 | -0.04966 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 185 | R | 0.238295 | G | 0.252535 | -0.01424 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 185 | R | 0.238295 | C | 0.115003 | 0.123292 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 258 | R | 0.28029 | H | 0.246465 | 0.033825 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 265 | Q | 0.237887 | L | 0.15437 | 0.083517 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 282 | N | 0.251618 | K | 0.301154 | -0.049536 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 288 | D | 0.196679 | G | 0.16786 | 0.028819 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 359 | I | 0.202948 | L | 0.230279 | -0.027331 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 223 | L | 0.138054 | P | 0.238187 | -0.100133 | No Change: Both O | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 294 | D | 0.213121 | V | 0.109145 | 0.103976 | No Change: Both O | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 334 | P | 0.305173 | S | 0.328179 | -0.023006 | No Change: Both O | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 3 | D | 0.773824 | Y | 0.755002 | 0.018822 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 27 | D | 0.430914 | N | 0.391765 | 0.039149 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 37 | V | 0.390793 | L | 0.364752 | 0.026041 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 40 | P | 0.427368 | L | 0.25091 | 0.176458 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 43 | Q | 0.468143 | R | 0.470693 | -0.00255 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 44 | G | 0.459815 | V | 0.32387 | 0.135945 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 45 | V | 0.465114 | F | 0.415905 | 0.049209 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 66 | I | 0.275154 | N | 0.445737 | -0.170583 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 68 | T | 0.212031 | I | 0.133214 | 0.078817 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 74 | E | 0.130241 | K | 0.138705 | -0.008464 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 75 | H | 0.120452 | L | 0.074089 | 0.046363 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 75 | H | 0.120452 | R | 0.119003 | 0.001449 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 77 | I | 0.134919 | L | 0.142112 | -0.007193 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 79 | T | 0.147989 | A | 0.131183 | 0.016806 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 85 | E | 0.230731 | K | 0.242659 | -0.011928 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 116 | A | 0.682248 | T | 0.710733 | -0.028485 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 117 | N | 0.656854 | T | 0.62537 | 0.031484 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 118 | R | 0.62096 | H | 0.624239 | -0.003279 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 136 | V | 0.061269 | A | 0.089262 | -0.027993 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 140 | A | 0.08225 | P | 0.109706 | -0.027456 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 142 | L | 0.11526 | P | 0.208651 | -0.093391 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 148 | G | 0.272043 | D | 0.289434 | -0.017391 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 150 | T | 0.298008 | N | 0.322481 | -0.024473 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 156 | D | 0.45375 | N | 0.425022 | 0.028728 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 165 | V | 0.254613 | M | 0.299228 | -0.044615 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 172 | A | 0.148153 | G | 0.185451 | -0.037298 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 181 | D | 0.230519 | G | 0.205937 | 0.024582 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 181 | D | 0.230519 | H | 0.195589 | 0.03493 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 181 | D | 0.230519 | N | 0.202706 | 0.027813 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 185 | R | 0.238295 | D | 0.283216 | -0.044921 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 185 | R | 0.238295 | S | 0.286054 | -0.047759 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 198 | R | 0.188351 | L | 0.121252 | 0.067099 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 199 | G | 0.197499 | S | 0.254426 | -0.056927 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 226 | E | 0.306579 | G | 0.241987 | 0.064592 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 226 | E | 0.306579 | Q | 0.252053 | 0.054526 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 227 | N | 0.380315 | V | 0.275232 | 0.105083 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 229 | M | 0.538453 | I | 0.448195 | 0.090258 | D to O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 229 | M | 0.538453 | T | 0.588497 | -0.050044 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 229 | M | 0.538453 | V | 0.483916 | 0.054537 | D to O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 243 | E | 0.511188 | K | 0.502747 | 0.008441 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 248 | Q | 0.294733 | K | 0.339069 | -0.044336 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 248 | Q | 0.294733 | R | 0.29097 | 0.003763 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 253 | G | 0.286816 | D | 0.311233 | -0.024417 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 258 | R | 0.28029 | L | 0.191076 | 0.089214 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 270 | G | 0.328477 | D | 0.339176 | -0.010699 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 270 | G | 0.328477 | R | 0.305503 | 0.022974 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 274 | A | 0.433454 | E | 0.558531 | -0.125077 | O to D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 281 | Y | 0.292418 | H | 0.418611 | -0.126193 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 285 | M | 0.214011 | K | 0.320415 | -0.106404 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 336 | E | 0.274761 | A | 0.207731 | 0.06703 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 338 | K | 0.243749 | E | 0.249795 | -0.006046 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 338 | K | 0.243749 | I | 0.116724 | 0.127025 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 350 | S | 0.172168 | L | 0.076476 | 0.095692 | No Change: Both O | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 374 | R | 0.613351 | S | 0.695307 | -0.081956 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 375 | K | 0.686453 | E | 0.70723 | -0.020777 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P68133 | ACTS_HUMAN Actin alpha skeletal muscle OS=Homo sapiens GN=ACTA1 PE=1 SV=1 | 375 | K | 0.686453 | Q | 0.641914 | 0.044539 | No Change: Both D | Nemaline myopathy type 3 (NEM3) [MIM:161800] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 196 | T | 0.172576 | S | 0.235313 | -0.062737 | No Change: Both O | - |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 320 | T | 0.386047 | A | 0.366423 | 0.019624 | No Change: Both O | - |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 373 | H | 0.518743 | P | 0.552016 | -0.033273 | No Change: Both D | - |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 117 | N | 0.652894 | T | 0.622109 | 0.030785 | No Change: Both D | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 118 | R | 0.617164 | Q | 0.648746 | -0.031582 | No Change: Both D | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 135 | Y | 0.066455 | H | 0.111647 | -0.045192 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 149 | R | 0.278864 | C | 0.14641 | 0.132454 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 154 | V | 0.397302 | A | 0.487097 | -0.089795 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 258 | R | 0.28029 | C | 0.200799 | 0.079491 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 258 | R | 0.28029 | H | 0.246465 | 0.033825 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 292 | R | 0.180702 | G | 0.188795 | -0.008093 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 353 | T | 0.177861 | N | 0.204285 | -0.026424 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 39 | R | 0.4216 | H | 0.406615 | 0.014985 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 145 | Y | 0.196327 | C | 0.160122 | 0.036205 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 185 | R | 0.238295 | Q | 0.243007 | -0.004712 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 212 | R | 0.274732 | Q | 0.27221 | 0.002522 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 326 | T | 0.304299 | N | 0.322127 | -0.017828 | No Change: Both O | Familial aortic aneurysm thoracic type 6 (AAT6) [MIM:611788] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 179 | R | 0.179163 | H | 0.184072 | -0.004909 | No Change: Both O | Moyamoya disease type 5 (MYMY5) [MIM:614042] |
| P62736 | ACTA_HUMAN Actin aortic smooth muscle OS=Homo sapiens GN=ACTA2 PE=1 SV=1 | 179 | R | 0.179163 | H | 0.184072 | -0.004909 | No Change: Both O | Multisystemic smooth muscle dysfunction syndrome (MSMDYS) [MIM:613834] |
| P60709 | ACTB_HUMAN Actin cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 | 183 | R | 0.218946 | W | 0.090874 | 0.128072 | No Change: Both O | Dystonia juvenile-onset (DYTJ) [MIM:607371] |
| P60709 | ACTB_HUMAN Actin cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 | 243 | P | 0.40739 | L | 0.286065 | 0.121325 | No Change: Both O | - |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 101 | E | 0.516676 | K | 0.494172 | 0.022504 | D to O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 166 | P | 0.224697 | A | 0.16745 | 0.057247 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 297 | A | 0.219737 | S | 0.321385 | -0.101648 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 314 | R | 0.341749 | H | 0.341126 | 6.23E-04 | No Change: Both O | Cardiomyopathy dilated type 1R (CMD1R) [MIM:613424] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 333 | A | 0.325587 | P | 0.422107 | -0.09652 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 363 | E | 0.463496 | G | 0.41205 | 0.051446 | No Change: Both O | Cardiomyopathy dilated type 1R (CMD1R) [MIM:613424] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 90 | H | 0.120281 | Y | 0.071728 | 0.048553 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 97 | R | 0.38948 | C | 0.241403 | 0.148077 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 125 | M | 0.225502 | V | 0.171075 | 0.054427 | No Change: Both O | Atrial septal defect type 5 (ASD5) [MIM:612794] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 168 | Y | 0.221378 | C | 0.170787 | 0.050591 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P68032 | ACTC_HUMAN Actin alpha cardiac muscle 1 OS=Homo sapiens GN=ACTC1 PE=1 SV=1 | 307 | M | 0.299836 | L | 0.245742 | 0.054094 | No Change: Both O | Familial hypertrophic cardiomyopathy type 11 (CMH11) [MIM:612098] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 89 | T | 0.109602 | I | 0.064271 | 0.045331 | No Change: Both O | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 118 | K | 0.490806 | M | 0.391154 | 0.099652 | No Change: Both O | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 264 | P | 0.237994 | L | 0.133169 | 0.104825 | No Change: Both O | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 278 | T | 0.257203 | I | 0.159499 | 0.097704 | No Change: Both O | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 332 | P | 0.305558 | A | 0.233543 | 0.072015 | No Change: Both O | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 370 | V | 0.540205 | A | 0.618365 | -0.07816 | No Change: Both D | Deafness autosomal dominant type 20 (DFNA20) [MIM:604717] |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 160 | T | 0.331201 | I | 0.203932 | 0.127269 | No Change: Both O | - |
| P63261 | ACTG_HUMAN Actin cytoplasmic 2 OS=Homo sapiens GN=ACTG1 PE=1 SV=1 | 243 | P | 0.40739 | L | 0.286065 | 0.121325 | No Change: Both O | - |
| Q9Y615 | ACL7A_HUMAN Actin-like protein 7A OS=Homo sapiens GN=ACTL7A PE=1 SV=1 | 340 | V | 0.209582 | M | 0.318277 | -0.108695 | No Change: Both O | - |
| Q9Y615 | ACL7A_HUMAN Actin-like protein 7A OS=Homo sapiens GN=ACTL7A PE=1 SV=1 | 45 | R | 0.850062 | C | 0.770885 | 0.079177 | No Change: Both D | - |
| Q9Y615 | ACL7A_HUMAN Actin-like protein 7A OS=Homo sapiens GN=ACTL7A PE=1 SV=1 | 161 | A | 0.453031 | P | 0.540926 | -0.087895 | O to D | - |
| Q9Y615 | ACL7A_HUMAN Actin-like protein 7A OS=Homo sapiens GN=ACTL7A PE=1 SV=1 | 343 | L | 0.188785 | V | 0.171303 | 0.017482 | No Change: Both O | - |
| Q9H568 | ACTL8_HUMAN Actin-like protein 8 OS=Homo sapiens GN=ACTL8 PE=2 SV=1 | 3 | A | 0.70851 | S | 0.805152 | -0.096642 | No Change: Both D | - |
| Q9H568 | ACTL8_HUMAN Actin-like protein 8 OS=Homo sapiens GN=ACTL8 PE=2 SV=1 | 245 | R | 0.755227 | C | 0.654434 | 0.100793 | No Change: Both D | - |
| Q8TC94 | ACTL9_HUMAN Actin-like protein 9 OS=Homo sapiens GN=ACTL9 PE=2 SV=3 | 37 | F | 0.705143 | S | 0.804618 | -0.099475 | No Change: Both D | - |
| Q8TC94 | ACTL9_HUMAN Actin-like protein 9 OS=Homo sapiens GN=ACTL9 PE=2 SV=3 | 42 | A | 0.602063 | D | 0.674109 | -0.072046 | No Change: Both D | A colorectal cancer sample |
| Q8TC94 | ACTL9_HUMAN Actin-like protein 9 OS=Homo sapiens GN=ACTL9 PE=2 SV=3 | 51 | V | 0.327639 | A | 0.377789 | -0.05015 | No Change: Both O | - |
| Q8TC94 | ACTL9_HUMAN Actin-like protein 9 OS=Homo sapiens GN=ACTL9 PE=2 SV=3 | 227 | H | 0.185326 | N | 0.213301 | -0.027975 | No Change: Both O | - |
| Q8TC94 | ACTL9_HUMAN Actin-like protein 9 OS=Homo sapiens GN=ACTL9 PE=2 SV=3 | 332 | A | 0.403813 | T | 0.421482 | -0.017669 | No Change: Both O | A colorectal cancer sample |
| P12814 | ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 | 707 | N | 0.357134 | T | 0.323463 | 0.033671 | No Change: Both O | - |
| P12814 | ACTN1_HUMAN Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 | 868 | T | 0.425318 | S | 0.509827 | -0.084509 | O to D | - |
| P35609 | ACTN2_HUMAN Alpha-actinin-2 OS=Homo sapiens GN=ACTN2 PE=1 SV=1 | 604 | M | 0.445528 | V | 0.395863 | 0.049665 | No Change: Both O | - |
| P35609 | ACTN2_HUMAN Alpha-actinin-2 OS=Homo sapiens GN=ACTN2 PE=1 SV=1 | 9 | Q | 0.285874 | R | 0.252438 | 0.033436 | No Change: Both O | Cardiomyopathy dilated type 1AA (CMD1AA) [MIM:612158] |
| Q08043 | ACTN3_HUMAN Alpha-actinin-3 OS=Homo sapiens GN=ACTN3 PE=1 SV=2 | 523 | R | 0.224415 | Q | 0.239363 | -0.014948 | No Change: Both O | - |
| Q08043 | ACTN3_HUMAN Alpha-actinin-3 OS=Homo sapiens GN=ACTN3 PE=1 SV=2 | 635 | E | 0.548744 | A | 0.436053 | 0.112691 | D to O | - |
| Q08043 | ACTN3_HUMAN Alpha-actinin-3 OS=Homo sapiens GN=ACTN3 PE=1 SV=2 | 628 | C | 0.418762 | R | 0.578759 | -0.159997 | O to D | - |
| Q08043 | ACTN3_HUMAN Alpha-actinin-3 OS=Homo sapiens GN=ACTN3 PE=1 SV=2 | 776 | Q | 0.598245 | R | 0.604881 | -0.006636 | No Change: Both D | - |
| O43707 | ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 | 255 | K | 0.404028 | E | 0.420712 | -0.016684 | No Change: Both O | Focal segmental glomerulosclerosis type 1 (FSGS1) [MIM:603278] |
| O43707 | ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 | 259 | T | 0.18908 | I | 0.115392 | 0.073688 | No Change: Both O | Focal segmental glomerulosclerosis type 1 (FSGS1) [MIM:603278] |
| O43707 | ACTN4_HUMAN Alpha-actinin-4 OS=Homo sapiens GN=ACTN4 PE=1 SV=2 | 262 | S | 0.162091 | P | 0.138112 | 0.023979 | No Change: Both O | Focal segmental glomerulosclerosis type 1 (FSGS1) [MIM:603278] |
| P42025 | ACTY_HUMAN Beta-centractin OS=Homo sapiens GN=ACTR1B PE=1 SV=1 | 93 | V | 0.135495 | A | 0.177527 | -0.042032 | No Change: Both O | - |
| P42025 | ACTY_HUMAN Beta-centractin OS=Homo sapiens GN=ACTR1B PE=1 SV=1 | 143 | A | 0.089692 | V | 0.062505 | 0.027187 | No Change: Both O | - |
| Q9P1U1 | ARP3B_HUMAN Actin-related protein 3B OS=Homo sapiens GN=ACTR3B PE=1 SV=1 | 250 | R | 0.243688 | Q | 0.276091 | -0.032403 | No Change: Both O | - |
| Q9H9F9 | ARP5_HUMAN Actin-related protein 5 OS=Homo sapiens GN=ACTR5 PE=1 SV=2 | 298 | R | 0.946565 | L | 0.923365 | 0.0232 | No Change: Both D | - |
| Q9H9F9 | ARP5_HUMAN Actin-related protein 5 OS=Homo sapiens GN=ACTR5 PE=1 SV=2 | 483 | I | 0.262059 | V | 0.299048 | -0.036989 | No Change: Both O | - |
| Q9H9F9 | ARP5_HUMAN Actin-related protein 5 OS=Homo sapiens GN=ACTR5 PE=1 SV=2 | 580 | P | 0.62837 | L | 0.482008 | 0.146362 | D to O | - |
| Q9H9F9 | ARP5_HUMAN Actin-related protein 5 OS=Homo sapiens GN=ACTR5 PE=1 SV=2 | 461 | I | 0.318172 | L | 0.343107 | -0.024935 | No Change: Both O | - |
| Q9H981 | ARP8_HUMAN Actin-related protein 8 OS=Homo sapiens GN=ACTR8 PE=1 SV=2 | 56 | T | 0.303582 | I | 0.210663 | 0.092919 | No Change: Both O | - |
| Q8TDY3 | ACTT2_HUMAN Actin-related protein T2 OS=Homo sapiens GN=ACTRT2 PE=2 SV=2 | 247 | G | 0.533622 | R | 0.57179 | -0.038168 | No Change: Both D | - |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 206 | R | 0.113164 | H | 0.103077 | 0.010087 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 15 | A | 0.378698 | G | 0.486719 | -0.108021 | No Change: Both O | - |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 41 | S | 0.423311 | F | 0.234907 | 0.188404 | No Change: Both O | - |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 47 | H | 0.564882 | Q | 0.630863 | -0.065981 | No Change: Both D | - |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 115 | P | 0.579792 | S | 0.617429 | -0.037637 | No Change: Both D | A melanoma sample |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 202 | R | 0.14313 | I | 0.071041 | 0.072089 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 207 | Q | 0.108873 | E | 0.133121 | -0.024248 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 328 | G | 0.372091 | E | 0.422967 | -0.050876 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 328 | G | 0.372091 | R | 0.351718 | 0.020373 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 328 | G | 0.372091 | W | 0.168927 | 0.203164 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 356 | G | 0.170685 | D | 0.197979 | -0.027294 | No Change: Both O | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| Q04771 | ACVR1_HUMAN Activin receptor type-1 OS=Homo sapiens GN=ACVR1 PE=1 SV=1 | 375 | R | 0.468465 | P | 0.508667 | -0.040202 | O to D | Fibrodysplasia ossificans progressiva (FOP) [MIM:135100] |
| P36896 | ACV1B_HUMAN Activin receptor type-1B OS=Homo sapiens GN=ACVR1B PE=1 SV=1 | 408 | L | 0.019736 | V | 0.019909 | -1.73E-04 | No Change: Both O | - |
| P36896 | ACV1B_HUMAN Activin receptor type-1B OS=Homo sapiens GN=ACVR1B PE=1 SV=1 | 146 | F | 0.006695 | L | 0.008304 | -0.001609 | No Change: Both O | - |
| Q8NER5 | ACV1C_HUMAN Activin receptor type-1C OS=Homo sapiens GN=ACVR1C PE=1 SV=1 | 195 | I | 0.084228 | T | 0.154954 | -0.070726 | No Change: Both O | - |
| Q8NER5 | ACV1C_HUMAN Activin receptor type-1C OS=Homo sapiens GN=ACVR1C PE=1 SV=1 | 216 | G | 0.112007 | R | 0.106833 | 0.005174 | No Change: Both O | - |
| Q8NER5 | ACV1C_HUMAN Activin receptor type-1C OS=Homo sapiens GN=ACVR1C PE=1 SV=1 | 267 | W | 0.091736 | R | 0.2046 | -0.112864 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q8NER5 | ACV1C_HUMAN Activin receptor type-1C OS=Homo sapiens GN=ACVR1C PE=1 SV=1 | 355 | I | 0.287722 | V | 0.302732 | -0.01501 | No Change: Both O | - |
| Q8NER5 | ACV1C_HUMAN Activin receptor type-1C OS=Homo sapiens GN=ACVR1C PE=1 SV=1 | 482 | I | 0.206232 | V | 0.226878 | -0.020646 | No Change: Both O | - |
| P27037 | AVR2A_HUMAN Activin receptor type-2A OS=Homo sapiens GN=ACVR2A PE=1 SV=1 | 258 | S | 0.250763 | R | 0.212131 | 0.038632 | No Change: Both O | - |
| P27037 | AVR2A_HUMAN Activin receptor type-2A OS=Homo sapiens GN=ACVR2A PE=1 SV=1 | 306 | D | 0.354177 | N | 0.325795 | 0.028382 | No Change: Both O | A gastric adenocarcinoma sample |
| P27037 | AVR2A_HUMAN Activin receptor type-2A OS=Homo sapiens GN=ACVR2A PE=1 SV=1 | 367 | A | 0.287927 | T | 0.32494 | -0.037013 | No Change: Both O | - |
| Q13705 | AVR2B_HUMAN Activin receptor type-2B OS=Homo sapiens GN=ACVR2B PE=1 SV=3 | 40 | R | 0.517659 | H | 0.479902 | 0.037757 | D to O | Visceral heterotaxy autosomal type 4 (HTX4) [MIM:613751] |
| Q13705 | AVR2B_HUMAN Activin receptor type-2B OS=Homo sapiens GN=ACVR2B PE=1 SV=3 | 494 | V | 0.482238 | I | 0.420747 | 0.061491 | No Change: Both O | Visceral heterotaxy autosomal type 4 (HTX4) [MIM:613751] |
| Q13705 | AVR2B_HUMAN Activin receptor type-2B OS=Homo sapiens GN=ACVR2B PE=1 SV=3 | 176 | P | 0.804887 | R | 0.773378 | 0.031509 | No Change: Both D | - |
| Q13705 | AVR2B_HUMAN Activin receptor type-2B OS=Homo sapiens GN=ACVR2B PE=1 SV=3 | 459 | E | 0.139038 | D | 0.125006 | 0.014032 | No Change: Both O | - |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 50 | W | 0.677751 | C | 0.824097 | -0.146346 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 51 | C | 0.69585 | Y | 0.541126 | 0.154724 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 67 | R | 0.730353 | Q | 0.71436 | 0.015993 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 77 | C | 0.456017 | W | 0.343877 | 0.11214 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 96 | N | 0.317775 | D | 0.328246 | -0.010471 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 333 | S | 0.405803 | I | 0.197611 | 0.208192 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 374 | R | 0.395168 | W | 0.187353 | 0.207815 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 376 | M | 0.306475 | R | 0.395221 | -0.088746 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 411 | R | 0.061193 | Q | 0.062114 | -9.21E-04 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 424 | P | 0.242439 | T | 0.183368 | 0.059071 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 245 | I | 0.146039 | N | 0.297695 | -0.151656 | No Change: Both O | - |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 48 | G | 0.648155 | R | 0.68287 | -0.034715 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 67 | R | 0.730353 | W | 0.517406 | 0.212947 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 179 | D | 0.611431 | A | 0.514394 | 0.097037 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 211 | G | 0.208483 | D | 0.210383 | -0.0019 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 215 | E | 0.176543 | K | 0.18251 | -0.005967 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 223 | G | 0.145134 | R | 0.13642 | 0.008714 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 229 | K | 0.351281 | R | 0.29892 | 0.052361 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 285 | L | 0.371924 | F | 0.340432 | 0.031492 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 306 | A | 0.156251 | P | 0.194395 | -0.038144 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 314 | H | 0.115321 | Y | 0.063109 | 0.052212 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 337 | L | 0.277211 | P | 0.421219 | -0.144008 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 344 | C | 0.063357 | Y | 0.066863 | -0.003506 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 347 | A | 0.066416 | P | 0.092213 | -0.025797 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 374 | R | 0.395168 | Q | 0.39974 | -0.004572 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 376 | M | 0.306475 | V | 0.263521 | 0.042954 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 378 | P | 0.305462 | L | 0.175236 | 0.130226 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 379 | E | 0.316659 | K | 0.312952 | 0.003707 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 397 | D | 0.033004 | G | 0.030425 | 0.002579 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 398 | I | 0.0232 | N | 0.054529 | -0.031329 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 399 | W | 0.018363 | S | 0.063936 | -0.045573 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 407 | E | 0.034141 | D | 0.030381 | 0.00376 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 411 | R | 0.061193 | P | 0.067704 | -0.006511 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 411 | R | 0.061193 | W | 0.023443 | 0.03775 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 425 | F | 0.276682 | L | 0.303575 | -0.026893 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 425 | F | 0.276682 | V | 0.330836 | -0.054154 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 479 | R | 0.406646 | L | 0.296536 | 0.11011 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 482 | A | 0.447189 | V | 0.3545 | 0.092689 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 484 | R | 0.451528 | W | 0.222955 | 0.228573 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| P37023 | ACVL1_HUMAN Serine/threonine-protein kinase receptor R3 OS=Homo sapiens GN=ACVRL1 PE=1 SV=2 | 487 | K | 0.548308 | T | 0.457029 | 0.091279 | D to O | Hereditary hemorrhagic telangiectasia type 2 (HHT2) [MIM:600376] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 386 | R | 0.10755 | C | 0.049428 | 0.058122 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 233 | E | 0.380974 | D | 0.336255 | 0.044719 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 353 | R | 0.158069 | C | 0.07621 | 0.081859 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 381 | E | 0.310814 | D | 0.295128 | 0.015686 | No Change: Both O | A breast cancer sample |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 197 | R | 0.256019 | W | 0.116478 | 0.139541 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 393 | R | 0.143672 | H | 0.119497 | 0.024175 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 179 | N | 0.256078 | S | 0.292711 | -0.036633 | No Change: Both O | - |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 378 | R | 0.437307 | Q | 0.446545 | -0.009238 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q03154 | ACY1_HUMAN Aminoacylase-1 OS=Homo sapiens GN=ACY1 PE=1 SV=1 | 378 | R | 0.437307 | W | 0.243911 | 0.193396 | No Change: Both O | Aminoacylase-1 deficiency (ACY1D) [MIM:609924] |
| Q96HD9 | ACY3_HUMAN Aspartoacylase-2 OS=Homo sapiens GN=ACY3 PE=1 SV=1 | 8 | R | 0.53765 | Q | 0.515732 | 0.021918 | No Change: Both D | - |
| Q96HD9 | ACY3_HUMAN Aspartoacylase-2 OS=Homo sapiens GN=ACY3 PE=1 SV=1 | 281 | V | 0.122447 | M | 0.151269 | -0.028822 | No Change: Both O | - |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 8 | D | 0.598895 | N | 0.586384 | 0.012511 | No Change: Both D | - |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 15 | H | 0.30803 | D | 0.347074 | -0.039044 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 20 | G | 0.396805 | R | 0.382345 | 0.01446 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 74 | G | 0.131154 | C | 0.065168 | 0.065986 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 76 | R | 0.173217 | W | 0.06623 | 0.106987 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 80 | K | 0.142531 | R | 0.118944 | 0.023587 | No Change: Both O | - |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 83 | A | 0.137835 | D | 0.178313 | -0.040478 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 101 | R | 0.192826 | L | 0.127599 | 0.065227 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 101 | R | 0.192826 | W | 0.082771 | 0.110055 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 101 | R | 0.192826 | Q | 0.207485 | -0.014659 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 107 | L | 0.345349 | P | 0.519611 | -0.174262 | O to D | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 129 | V | 0.269374 | M | 0.306892 | -0.037518 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 140 | G | 0.476299 | E | 0.504279 | -0.02798 | O to D | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 142 | R | 0.500464 | Q | 0.525885 | -0.025421 | No Change: Both D | A pancreatic ductal adenocarcinoma sample |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 149 | R | 0.151311 | Q | 0.160343 | -0.009032 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 149 | R | 0.151311 | W | 0.058112 | 0.093199 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 152 | L | 0.098332 | M | 0.139508 | -0.041176 | No Change: Both O | - |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 156 | R | 0.144697 | C | 0.083265 | 0.061432 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 156 | R | 0.144697 | H | 0.143766 | 9.31E-04 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 177 | V | 0.150131 | M | 0.182068 | -0.031937 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 179 | A | 0.16327 | D | 0.226958 | -0.063688 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 199 | Q | 0.324993 | P | 0.344552 | -0.019559 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 211 | R | 0.384161 | C | 0.23908 | 0.145081 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 211 | R | 0.384161 | H | 0.414011 | -0.02985 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 215 | A | 0.458713 | T | 0.485049 | -0.026336 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 216 | G | 0.46413 | R | 0.454252 | 0.009878 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 233 | T | 0.35056 | I | 0.234008 | 0.116552 | No Change: Both O | - |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 274 | P | 0.363762 | L | 0.232736 | 0.131026 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 291 | S | 0.431072 | L | 0.271124 | 0.159948 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 297 | P | 0.363917 | Q | 0.351589 | 0.012328 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 304 | L | 0.401295 | R | 0.518573 | -0.117278 | O to D | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| P00813 | ADA_HUMAN Adenosine deaminase OS=Homo sapiens GN=ADA PE=1 SV=3 | 329 | A | 0.544686 | V | 0.416765 | 0.127921 | D to O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-negative due to adenosine deaminase deficiency (ADASCID) [MIM:102700] |
| Q8NCV1 | ADAD2_HUMAN Adenosine deaminase domain-containing protein 2 OS=Homo sapiens GN=ADAD2 PE=2 SV=1 | 44 | G | 0.879722 | E | 0.888675 | -0.008953 | No Change: Both D | - |
| Q8NCV1 | ADAD2_HUMAN Adenosine deaminase domain-containing protein 2 OS=Homo sapiens GN=ADAD2 PE=2 SV=1 | 235 | G | 0.093474 | R | 0.087112 | 0.006362 | No Change: Both O | - |
| O14672 | ADA10_HUMAN Disintegrin and metalloproteinase domain-containing protein 10 OS=Homo sapiens GN=ADAM10 PE=1 SV=1 | 176 | H | 0.343673 | Y | 0.243995 | 0.099678 | No Change: Both O | A cutaneous metastatic melanoma sample |
| O75078 | ADA11_HUMAN Disintegrin and metalloproteinase domain-containing protein 11 OS=Homo sapiens GN=ADAM11 PE=2 SV=3 | 693 | S | 0.644364 | R | 0.606721 | 0.037643 | No Change: Both D | A pancreatic ductal adenocarcinoma sample |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 301 | D | 0.449289 | H | 0.448441 | 8.48E-04 | No Change: Both O | A breast cancer sample |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 479 | G | 0.695543 | E | 0.747336 | -0.051793 | No Change: Both D | A breast cancer sample |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 792 | L | 0.877114 | F | 0.836576 | 0.040538 | No Change: Both D | A breast cancer sample |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 48 | G | 0.300151 | R | 0.29074 | 0.009411 | No Change: Both O | - |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 712 | G | 0.050053 | E | 0.058743 | -0.00869 | No Change: Both O | A cutaneous metastatic melanoma sample |
| O43184 | ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens GN=ADAM12 PE=1 SV=3 | 893 | P | 0.70317 | S | 0.661852 | 0.041318 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q13444 | ADA15_HUMAN Disintegrin and metalloproteinase domain-containing protein 15 OS=Homo sapiens GN=ADAM15 PE=1 SV=4 | 502 | P | 0.915788 | Q | 0.906993 | 0.008795 | No Change: Both D | - |
| Q13444 | ADA15_HUMAN Disintegrin and metalloproteinase domain-containing protein 15 OS=Homo sapiens GN=ADAM15 PE=1 SV=4 | 191 | K | 0.745595 | T | 0.737248 | 0.008347 | No Change: Both D | - |
| Q13444 | ADA15_HUMAN Disintegrin and metalloproteinase domain-containing protein 15 OS=Homo sapiens GN=ADAM15 PE=1 SV=4 | 294 | P | 0.408056 | H | 0.381961 | 0.026095 | No Change: Both O | - |
| P78536 | ADA17_HUMAN Disintegrin and metalloproteinase domain-containing protein 17 OS=Homo sapiens GN=ADAM17 PE=1 SV=1 | 162 | K | 0.403157 | E | 0.390806 | 0.012351 | No Change: Both O | - |
| P78536 | ADA17_HUMAN Disintegrin and metalloproteinase domain-containing protein 17 OS=Homo sapiens GN=ADAM17 PE=1 SV=1 | 202 | R | 0.768446 | G | 0.745848 | 0.022598 | No Change: Both D | - |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 212 | V | 0.097146 | F | 0.076212 | 0.020934 | No Change: Both O | - |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 170 | P | 0.416334 | S | 0.448488 | -0.032154 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 284 | V | 0.32104 | G | 0.486341 | -0.165301 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 344 | M | 0.165455 | I | 0.122424 | 0.043031 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 362 | M | 0.205494 | K | 0.316794 | -0.1113 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9Y3Q7 | ADA18_HUMAN Disintegrin and metalloproteinase domain-containing protein 18 OS=Homo sapiens GN=ADAM18 PE=2 SV=1 | 536 | S | 0.702142 | L | 0.575478 | 0.126664 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9H013 | ADA19_HUMAN Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 | 133 | R | 0.237622 | Q | 0.230703 | 0.006919 | No Change: Both O | A colorectal cancer sample |
| Q9H013 | ADA19_HUMAN Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 | 298 | A | 0.303347 | T | 0.341819 | -0.038472 | No Change: Both O | A colorectal cancer sample |
| Q9H013 | ADA19_HUMAN Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 | 4 | G | 0.821098 | S | 0.821385 | -2.87E-04 | No Change: Both D | - |
| Q9H013 | ADA19_HUMAN Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 | 609 | H | 0.34825 | Q | 0.411132 | -0.062882 | No Change: Both O | A pancreatic ductal adenocarcinoma sample |
| Q99965 | ADAM2_HUMAN Disintegrin and metalloproteinase domain-containing protein 2 OS=Homo sapiens GN=ADAM2 PE=1 SV=2 | 10 | G | 0.169338 | W | 0.062381 | 0.106957 | No Change: Both O | - |
| O43506 | ADA20_HUMAN Disintegrin and metalloproteinase domain-containing protein 20 OS=Homo sapiens GN=ADAM20 PE=2 SV=2 | 19 | F | 0.021657 | L | 0.026675 | -0.005018 | No Change: Both O | - |
| Q9P0K1 | ADA22_HUMAN Disintegrin and metalloproteinase domain-containing protein 22 OS=Homo sapiens GN=ADAM22 PE=1 SV=1 | 81 | P | 0.509052 | R | 0.492667 | 0.016385 | D to O | - |
| Q9P0K1 | ADA22_HUMAN Disintegrin and metalloproteinase domain-containing protein 22 OS=Homo sapiens GN=ADAM22 PE=1 SV=1 | 119 | H | 0.526459 | Y | 0.389282 | 0.137177 | D to O | - |
| Q9P0K1 | ADA22_HUMAN Disintegrin and metalloproteinase domain-containing protein 22 OS=Homo sapiens GN=ADAM22 PE=1 SV=1 | 207 | V | 0.670922 | I | 0.671595 | -6.73E-04 | No Change: Both D | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 765 | V | 0.94995 | M | 0.959566 | -0.009616 | No Change: Both D | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 219 | R | 0.472545 | M | 0.414315 | 0.05823 | No Change: Both O | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 226 | E | 0.502065 | D | 0.475707 | 0.026358 | D to O | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 493 | N | 0.655244 | S | 0.676886 | -0.021642 | No Change: Both D | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 593 | T | 0.521346 | K | 0.561498 | -0.040152 | No Change: Both D | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 604 | T | 0.402563 | P | 0.446137 | -0.043574 | No Change: Both O | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 684 | M | 0.182443 | I | 0.135319 | 0.047124 | No Change: Both O | - |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 65 | G | 0.31454 | E | 0.408596 | -0.094056 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 134 | G | 0.330874 | E | 0.372887 | -0.042013 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 450 | G | 0.75635 | E | 0.809428 | -0.053078 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 482 | S | 0.826627 | F | 0.763107 | 0.06352 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKQ2 | ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens GN=ADAM28 PE=2 SV=3 | 502 | G | 0.54593 | D | 0.555174 | -0.009244 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 31 | P | 0.483403 | L | 0.299439 | 0.183964 | No Change: Both O | A colorectal cancer sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 205 | V | 0.022963 | I | 0.019868 | 0.003095 | No Change: Both O | A colorectal cancer sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 72 | L | 0.264638 | F | 0.236045 | 0.028593 | No Change: Both O | A melanoma cell line |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 89 | I | 0.251613 | M | 0.342649 | -0.091036 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 111 | E | 0.566713 | K | 0.551343 | 0.01537 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 112 | S | 0.509764 | F | 0.281048 | 0.228716 | D to O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 115 | S | 0.288394 | F | 0.123095 | 0.165299 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 131 | D | 0.087786 | N | 0.087345 | 4.41E-04 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 176 | E | 0.360258 | K | 0.334676 | 0.025582 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 234 | S | 0.058834 | F | 0.020463 | 0.038371 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 257 | I | 0.109594 | F | 0.106598 | 0.002996 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 305 | G | 0.236204 | E | 0.25776 | -0.021556 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 345 | D | 0.53523 | N | 0.52221 | 0.01302 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 403 | G | 0.447316 | D | 0.471307 | -0.023991 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 434 | G | 0.690891 | D | 0.726985 | -0.036094 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 503 | E | 0.461942 | K | 0.458829 | 0.003113 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF5 | ADA29_HUMAN Disintegrin and metalloproteinase domain-containing protein 29 OS=Homo sapiens GN=ADAM29 PE=1 SV=3 | 533 | H | 0.195451 | Y | 0.130992 | 0.064459 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9UKF2 | ADA30_HUMAN Disintegrin and metalloproteinase domain-containing protein 30 OS=Homo sapiens GN=ADAM30 PE=2 SV=2 | 359 | L | 0.16096 | P | 0.297623 | -0.136663 | No Change: Both O | - |
| Q9UKF2 | ADA30_HUMAN Disintegrin and metalloproteinase domain-containing protein 30 OS=Homo sapiens GN=ADAM30 PE=2 SV=2 | 737 | T | 0.974679 | A | 0.969713 | 0.004966 | No Change: Both D | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 467 | T | 0.617621 | S | 0.689902 | -0.072281 | No Change: Both D | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 98 | Q | 0.237607 | R | 0.205283 | 0.032324 | No Change: Both O | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 160 | S | 0.352646 | G | 0.286806 | 0.06584 | No Change: Both O | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 327 | L | 0.194879 | V | 0.187115 | 0.007764 | No Change: Both O | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 658 | K | 0.567606 | N | 0.532243 | 0.035363 | No Change: Both D | - |
| Q8TC27 | ADA32_HUMAN Disintegrin and metalloproteinase domain-containing protein 32 OS=Homo sapiens GN=ADAM32 PE=1 SV=2 | 778 | D | 0.99958 | E | 0.999647 | -6.70E-05 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 764 | M | 0.932648 | T | 0.942837 | -0.010189 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 178 | T | 0.528958 | A | 0.478334 | 0.050624 | D to O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 774 | P | 0.962429 | S | 0.955133 | 0.007296 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 109 | N | 0.373955 | S | 0.417462 | -0.043507 | No Change: Both O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 272 | T | 0.493969 | M | 0.431856 | 0.062113 | No Change: Both O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 316 | V | 0.43275 | I | 0.385162 | 0.047588 | No Change: Both O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 336 | P | 0.620726 | S | 0.658023 | -0.037297 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 365 | A | 0.50391 | S | 0.593371 | -0.089461 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 441 | D | 0.684283 | E | 0.715321 | -0.031038 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 515 | W | 0.426961 | R | 0.637407 | -0.210446 | O to D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 612 | L | 0.40983 | H | 0.447878 | -0.038048 | No Change: Both O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 710 | V | 0.089245 | I | 0.075678 | 0.013567 | No Change: Both O | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 739 | C | 0.587535 | G | 0.65822 | -0.070685 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 742 | D | 0.707386 | Y | 0.547177 | 0.160209 | No Change: Both D | - |
| Q9BZ11 | ADA33_HUMAN Disintegrin and metalloproteinase domain-containing protein 33 OS=Homo sapiens GN=ADAM33 PE=1 SV=2 | 305 | A | 0.292863 | V | 0.214801 | 0.078062 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 25 | E | 0.253374 | Q | 0.234821 | 0.018553 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 205 | I | 0.102366 | V | 0.124605 | -0.022239 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 244 | V | 0.044764 | M | 0.057082 | -0.012318 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 453 | I | 0.806856 | T | 0.870792 | -0.063936 | No Change: Both D | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 570 | L | 0.49303 | V | 0.469585 | 0.023445 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 638 | N | 0.669586 | H | 0.635923 | 0.033663 | No Change: Both D | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 735 | L | 0.545009 | P | 0.723343 | -0.178334 | No Change: Both D | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 14 | P | 0.110015 | S | 0.095324 | 0.014691 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 31 | R | 0.422997 | C | 0.259003 | 0.163994 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 36 | P | 0.457423 | S | 0.459357 | -0.001934 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 106 | H | 0.161054 | Y | 0.099699 | 0.061355 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 173 | L | 0.270386 | P | 0.424093 | -0.153707 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 180 | V | 0.568784 | A | 0.631008 | -0.062224 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 243 | H | 0.05677 | Y | 0.034543 | 0.022227 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 302 | G | 0.240995 | E | 0.264966 | -0.023971 | No Change: Both O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 359 | M | 0.544921 | I | 0.437014 | 0.107907 | D to O | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 533 | G | 0.534988 | E | 0.604328 | -0.06934 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 593 | F | 0.13189 | L | 0.174136 | -0.042246 | No Change: Both O | - |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 639 | E | 0.67227 | K | 0.641825 | 0.030445 | No Change: Both D | A cutaneous metastatic melanoma sample |
| Q9H2U9 | ADAM7_HUMAN Disintegrin and metalloproteinase domain-containing protein 7 OS=Homo sapiens GN=ADAM7 PE=1 SV=3 | 703 | S | 0.551948 | N | 0.505627 | 0.046321 | No Change: Both D | A cutaneous metastatic melanoma sample |
| P78325 | ADAM8_HUMAN Disintegrin and metalloproteinase domain-containing protein 8 OS=Homo sapiens GN=ADAM8 PE=1 SV=1 | 101 | G | 0.536343 | R | 0.536056 | 2.87E-04 | No Change: Both D | - |
| P78325 | ADAM8_HUMAN Disintegrin and metalloproteinase domain-containing protein 8 OS=Homo sapiens GN=ADAM8 PE=1 SV=1 | 189 | R | 0.590984 | W | 0.352599 | 0.238385 | D to O | - |
| P78325 | ADAM8_HUMAN Disintegrin and metalloproteinase domain-containing protein 8 OS=Homo sapiens GN=ADAM8 PE=1 SV=1 | 433 | R | 0.800507 | C | 0.775051 | 0.025456 | No Change: Both D | - |
| P78325 | ADAM8_HUMAN Disintegrin and metalloproteinase domain-containing protein 8 OS=Homo sapiens GN=ADAM8 PE=1 SV=1 | 775 | I | 0.959368 | T | 0.978456 | -0.019088 | No Change: Both D | - |
| O15204 | ADEC1_HUMAN ADAM DEC1 OS=Homo sapiens GN=ADAMDEC1 PE=1 SV=2 | 444 | N | 0.759751 | S | 0.777286 | -0.017535 | No Change: Both D | - |
| O15204 | ADEC1_HUMAN ADAM DEC1 OS=Homo sapiens GN=ADAMDEC1 PE=1 SV=2 | 121 | M | 0.49217 | T | 0.558681 | -0.066511 | O to D | - |
| Q9UHI8 | ATS1_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 1 OS=Homo sapiens GN=ADAMTS1 PE=1 SV=4 | 227 | A | 0.916009 | P | 0.943374 | -0.027365 | No Change: Both D | - |
| Q9H324 | ATS10_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 10 OS=Homo sapiens GN=ADAMTS10 PE=1 SV=2 | 25 | A | 0.226911 | T | 0.266122 | -0.039211 | No Change: Both O | Weill-Marchesani syndrome autosomal recessive (ARWMS) [MIM:277600] |
| Q9H324 | ATS10_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 10 OS=Homo sapiens GN=ADAMTS10 PE=1 SV=2 | 119 | R | 0.174407 | Q | 0.187805 | -0.013398 | No Change: Both O | - |
| Q9H324 | ATS10_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 10 OS=Homo sapiens GN=ADAMTS10 PE=1 SV=2 | 134 | T | 0.539353 | S | 0.627274 | -0.087921 | No Change: Both D | - |
| P58397 | ATS12_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens GN=ADAMTS12 PE=1 SV=2 | 110 | Q | 0.181828 | E | 0.218312 | -0.036484 | No Change: Both O | - |
| P58397 | ATS12_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens GN=ADAMTS12 PE=1 SV=2 | 1000 | R | 0.921218 | Q | 0.919446 | 0.001772 | No Change: Both D | - |
| P58397 | ATS12_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens GN=ADAMTS12 PE=1 SV=2 | 1495 | T | 0.595872 | I | 0.439161 | 0.156711 | D to O | - |
| P58397 | ATS12_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens GN=ADAMTS12 PE=1 SV=2 | 1177 | W | 0.832531 | R | 0.921751 | -0.08922 | No Change: Both D | - |
| P58397 | ATS12_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Homo sapiens GN=ADAMTS12 PE=1 SV=2 | 1591 | S | 0.940465 | P | 0.944088 | -0.003623 | No Change: Both D | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 7 | R | 0.555104 | W | 0.383835 | 0.171269 | D to O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 88 | V | 0.252403 | M | 0.282794 | -0.030391 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 96 | H | 0.385269 | D | 0.418771 | -0.033502 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 102 | R | 0.348038 | C | 0.203727 | 0.144311 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 193 | R | 0.360934 | W | 0.175702 | 0.185232 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 196 | T | 0.322425 | I | 0.196477 | 0.125948 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 234 | H | 0.635496 | Q | 0.626641 | 0.008855 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 250 | A | 0.746755 | V | 0.659625 | 0.08713 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 268 | R | 0.860671 | P | 0.875108 | -0.014437 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 390 | W | 0.711449 | C | 0.801606 | -0.090157 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 398 | R | 0.76923 | H | 0.709345 | 0.059885 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 448 | Q | 0.571292 | E | 0.583451 | -0.012159 | No Change: Both D | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 475 | P | 0.368423 | S | 0.401721 | -0.033298 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 508 | C | 0.763563 | Y | 0.668025 | 0.095538 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 528 | R | 0.854448 | G | 0.84465 | 0.009798 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 618 | P | 0.450003 | A | 0.349504 | 0.100499 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 625 | R | 0.335204 | H | 0.313524 | 0.02168 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 673 | I | 0.175994 | F | 0.19236 | -0.016366 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 692 | R | 0.105901 | C | 0.055726 | 0.050175 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 732 | A | 0.502549 | V | 0.420946 | 0.081603 | D to O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 900 | A | 0.347353 | V | 0.270859 | 0.076494 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 903 | S | 0.350144 | L | 0.193391 | 0.156753 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 908 | C | 0.350344 | Y | 0.335206 | 0.015138 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 951 | C | 0.315045 | G | 0.37326 | -0.058215 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1024 | C | 0.7216 | G | 0.743444 | -0.021844 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1033 | A | 0.634281 | T | 0.633356 | 9.25E-04 | No Change: Both D | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1095 | R | 0.395758 | W | 0.190442 | 0.205316 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1123 | R | 0.578693 | C | 0.552756 | 0.025937 | No Change: Both D | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1213 | C | 0.349354 | Y | 0.311529 | 0.037825 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1239 | G | 0.211628 | V | 0.125222 | 0.086406 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1336 | R | 0.158652 | W | 0.064149 | 0.094503 | No Change: Both O | Thrombotic thrombocytopenic purpura congenital (TTP) [MIM:274150] |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 456 | Q | 0.682614 | H | 0.639097 | 0.043517 | No Change: Both D | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 457 | P | 0.677559 | L | 0.55794 | 0.119619 | No Change: Both D | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 740 | E | 0.530717 | K | 0.485814 | 0.044903 | D to O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 982 | G | 0.475322 | R | 0.491321 | -0.015999 | No Change: Both O | - |
| Q76LX8 | ATS13_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 13 OS=Homo sapiens GN=ADAMTS13 PE=1 SV=1 | 1226 | T | 0.20179 | I | 0.118284 | 0.083506 | No Change: Both O | - |
| Q8WXS8 | ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14 OS=Homo sapiens GN=ADAMTS14 PE=2 SV=2 | 179 | R | 0.219311 | C | 0.125802 | 0.093509 | No Change: Both O | - |
| Q8WXS8 | ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14 OS=Homo sapiens GN=ADAMTS14 PE=2 SV=2 | 590 | L | 0.675668 | P | 0.802731 | -0.127063 | No Change: Both D | - |
| Q8WXS8 | ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14 OS=Homo sapiens GN=ADAMTS14 PE=2 SV=2 | 937 | L | 0.334852 | M | 0.392844 | -0.057992 | No Change: Both O | - |
| Q8WXS8 | ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14 OS=Homo sapiens GN=ADAMTS14 PE=2 SV=2 | 1017 | S | 0.391221 | N | 0.368037 | 0.023184 | No Change: Both O | - |
| Q8WXS8 | ATS14_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 14 OS=Homo sapiens GN=ADAMTS14 PE=2 SV=2 | 1049 | E | 0.495678 | G | 0.441795 | 0.053883 | No Change: Both O | - |
| Q8TE58 | ATS15_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 15 OS=Homo sapiens GN=ADAMTS15 PE=2 SV=1 | 770 | Q | 0.439869 | R | 0.447654 | -0.007785 | No Change: Both O | A colorectal cancer sample |
| Q8TE58 | ATS15_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 15 OS=Homo sapiens GN=ADAMTS15 PE=2 SV=1 | 878 | C | 0.771491 | G | 0.79706 | -0.025569 | No Change: Both D | A colorectal cancer sample |
| Q8TE58 | ATS15_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 15 OS=Homo sapiens GN=ADAMTS15 PE=2 SV=1 | 623 | N | 0.088018 | S | 0.11421 | -0.026192 | No Change: Both O | - |
| Q8TE57 | ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens GN=ADAMTS16 PE=1 SV=3 | 110 | M | 0.582865 | V | 0.54226 | 0.040605 | No Change: Both D | - |
| Q8TE57 | ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens GN=ADAMTS16 PE=1 SV=3 | 486 | A | 0.15789 | T | 0.173989 | -0.016099 | No Change: Both O | - |
| Q8TE57 | ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens GN=ADAMTS16 PE=1 SV=3 | 789 | R | 0.261367 | C | 0.12361 | 0.137757 | No Change: Both O | - |
| Q8TE57 | ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens GN=ADAMTS16 PE=1 SV=3 | 859 | R | 0.410661 | L | 0.309591 | 0.10107 | No Change: Both O | - |
| Q8TE57 | ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens GN=ADAMTS16 PE=1 SV=3 | 863 | E | 0.629411 | K | 0.634189 | -0.004778 | No Change: Both D | - |
| Q8TE56 | ATS17_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 17 OS=Homo sapiens GN=ADAMTS17 PE=2 SV=2 | 216 | S | 0.675912 | L | 0.561064 | 0.114848 | No Change: Both D | - |
| Q8TE56 | ATS17_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 17 OS=Homo sapiens GN=ADAMTS17 PE=2 SV=2 | 482 | M | 0.091224 | T | 0.104411 | -0.013187 | No Change: Both O | - |
| Q8TE56 | ATS17_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 17 OS=Homo sapiens GN=ADAMTS17 PE=2 SV=2 | 1094 | N | 0.872314 | S | 0.884074 | -0.01176 | No Change: Both D | - |
| Q8TE56 | ATS17_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 17 OS=Homo sapiens GN=ADAMTS17 PE=2 SV=2 | 566 | R | 0.719674 | T | 0.694636 | 0.025038 | No Change: Both D | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 382 | R | 0.468921 | K | 0.534599 | -0.065678 | O to D | A colorectal cancer sample |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 455 | K | 0.577146 | T | 0.516528 | 0.060618 | No Change: Both D | A colorectal cancer sample |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 769 | L | 0.098484 | I | 0.093436 | 0.005048 | No Change: Both O | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 946 | A | 0.570031 | S | 0.668393 | -0.098362 | No Change: Both D | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 1080 | S | 0.685889 | R | 0.677762 | 0.008127 | No Change: Both D | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 1159 | S | 0.761145 | T | 0.704233 | 0.056912 | No Change: Both D | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 191 | Y | 0.62221 | H | 0.700625 | -0.078415 | No Change: Both D | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 626 | L | 0.476635 | I | 0.456876 | 0.019759 | No Change: Both O | - |
| Q8TE60 | ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens GN=ADAMTS18 PE=1 SV=3 | 179 | S | 0.284843 | L | 0.165237 | 0.119606 | No Change: Both O | Knobloch syndrome type 2 (KNO2) [MIM:608454] |
| Q8TE59 | ATS19_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 19 OS=Homo sapiens GN=ADAMTS19 PE=1 SV=2 | 1089 | Y | 0.338535 | F | 0.310945 | 0.02759 | No Change: Both O | - |
| Q8TE59 | ATS19_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 19 OS=Homo sapiens GN=ADAMTS19 PE=1 SV=2 | 360 | L | 0.139936 | I | 0.117845 | 0.022091 | No Change: Both O | A breast cancer sample |
| Q8TE59 | ATS19_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 19 OS=Homo sapiens GN=ADAMTS19 PE=1 SV=2 | 582 | E | 0.164113 | G | 0.137846 | 0.026267 | No Change: Both O | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 245 | V | 0.785699 | I | 0.76514 | 0.020559 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 1177 | P | 0.833981 | S | 0.807818 | 0.026163 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 74 | V | 0.680004 | M | 0.698574 | -0.01857 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 241 | R | 0.786237 | H | 0.746096 | 0.040141 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 331 | E | 0.515186 | K | 0.526123 | -0.010937 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 665 | G | 0.602432 | R | 0.652303 | -0.049871 | No Change: Both D | - |
| O95450 | ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens GN=ADAMTS2 PE=2 SV=2 | 827 | R | 0.173439 | Q | 0.189439 | -0.016 | No Change: Both O | - |
| P59510 | ATS20_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 20 OS=Homo sapiens GN=ADAMTS20 PE=2 SV=2 | 876 | K | 0.453213 | M | 0.349242 | 0.103971 | No Change: Both O | - |
| P59510 | ATS20_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 20 OS=Homo sapiens GN=ADAMTS20 PE=2 SV=2 | 1000 | R | 0.672686 | H | 0.622707 | 0.049979 | No Change: Both D | - |
| P59510 | ATS20_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 20 OS=Homo sapiens GN=ADAMTS20 PE=2 SV=2 | 1273 | S | 0.813517 | F | 0.677228 | 0.136289 | No Change: Both D | - |
| O15072 | ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens GN=ADAMTS3 PE=2 SV=4 | 138 | R | 0.385676 | K | 0.423772 | -0.038096 | No Change: Both O | - |
| O15072 | ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens GN=ADAMTS3 PE=2 SV=4 | 1074 | S | 0.815979 | P | 0.822486 | -0.006507 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 626 | Q | 0.166071 | R | 0.148396 | 0.017675 | No Change: Both O | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 4 | T | 0.856 | I | 0.85395 | 0.00205 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 304 | D | 0.549723 | N | 0.531609 | 0.018114 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 369 | M | 0.293129 | V | 0.247541 | 0.045588 | No Change: Both O | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 552 | P | 0.841223 | T | 0.805875 | 0.035348 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 564 | T | 0.826611 | A | 0.792564 | 0.034047 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 836 | R | 0.815581 | K | 0.783154 | 0.032427 | No Change: Both D | - |
| O75173 | ATS4_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 4 OS=Homo sapiens GN=ADAMTS4 PE=1 SV=3 | 77 | A | 0.516053 | T | 0.52729 | -0.011237 | No Change: Both D | - |
| Q9UNA0 | ATS5_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 5 OS=Homo sapiens GN=ADAMTS5 PE=1 SV=2 | 614 | R | 0.590678 | H | 0.52046 | 0.070218 | No Change: Both D | - |
| Q9UNA0 | ATS5_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 5 OS=Homo sapiens GN=ADAMTS5 PE=1 SV=2 | 138 | G | 0.43838 | A | 0.376758 | 0.061622 | No Change: Both O | - |
| Q9UNA0 | ATS5_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 5 OS=Homo sapiens GN=ADAMTS5 PE=1 SV=2 | 692 | L | 0.238526 | P | 0.393724 | -0.155198 | No Change: Both O | - |
| Q9UKP4 | ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens GN=ADAMTS7 PE=1 SV=2 | 214 | S | 0.916612 | P | 0.919927 | -0.003315 | No Change: Both D | - |
| Q9UKP4 | ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens GN=ADAMTS7 PE=1 SV=2 | 307 | T | 0.484998 | M | 0.429809 | 0.055189 | No Change: Both O | - |
| Q9UKP4 | ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens GN=ADAMTS7 PE=1 SV=2 | 1319 | T | 0.754786 | A | 0.710957 | 0.043829 | No Change: Both D | - |
| Q9UKP4 | ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens GN=ADAMTS7 PE=1 SV=2 | 1414 | G | 0.429965 | S | 0.486718 | -0.056753 | No Change: Both O | - |
| Q9UKP4 | ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens GN=ADAMTS7 PE=1 SV=2 | 1583 | G | 0.650332 | A | 0.553022 | 0.09731 | No Change: Both D | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 96 | S | 0.811047 | P | 0.78883 | 0.022217 | No Change: Both D | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1579 | K | 0.513411 | E | 0.531805 | -0.018394 | No Change: Both D | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1674 | D | 0.239363 | E | 0.278172 | -0.038809 | No Change: Both O | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1740 | K | 0.478213 | R | 0.423407 | 0.054806 | No Change: Both O | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1791 | E | 0.531064 | Q | 0.473051 | 0.058013 | D to O | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1933 | R | 0.737832 | Q | 0.712496 | 0.025336 | No Change: Both D | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 96 | S | 0.811047 | T | 0.775107 | 0.03594 | No Change: Both D | - |
| Q9P2N4 | ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens GN=ADAMTS9 PE=2 SV=4 | 1921 | K | 0.516229 | E | 0.494167 | 0.022062 | D to O | - |
| Q8N6G6 | ATL1_HUMAN ADAMTS-like protein 1 OS=Homo sapiens GN=ADAMTSL1 PE=1 SV=4 | 242 | S | 0.601269 | N | 0.557362 | 0.043907 | No Change: Both D | - |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 364 | V | 0.473618 | I | 0.476043 | -0.002425 | No Change: Both O | - |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 113 | R | 0.582957 | H | 0.549825 | 0.033132 | No Change: Both D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 114 | E | 0.573746 | K | 0.560391 | 0.013355 | No Change: Both D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 147 | P | 0.38373 | L | 0.246318 | 0.137412 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 811 | G | 0.354715 | R | 0.381112 | -0.026397 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 50 | W | 0.343289 | C | 0.449294 | -0.106005 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 72 | R | 0.653364 | Q | 0.6679 | -0.014536 | No Change: Both D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 159 | R | 0.420856 | W | 0.20715 | 0.213706 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 165 | A | 0.427622 | T | 0.511093 | -0.083471 | O to D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 171 | C | 0.45459 | R | 0.575032 | -0.120442 | O to D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 221 | R | 0.500308 | C | 0.348758 | 0.15155 | D to O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 239 | A | 0.243614 | T | 0.266963 | -0.023349 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 593 | R | 0.21236 | C | 0.157595 | 0.054765 | No Change: Both O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 635 | S | 0.552532 | L | 0.339479 | 0.213053 | D to O | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| Q86TH1 | ATL2_HUMAN ADAMTS-like protein 2 OS=Homo sapiens GN=ADAMTSL2 PE=1 SV=1 | 906 | P | 0.702428 | L | 0.516814 | 0.185614 | No Change: Both D | Geleophysic dysplasia type 1 (GPHYSD1) [MIM:231050] |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 146 | H | 0.183242 | R | 0.208242 | -0.025 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 290 | L | 0.323383 | V | 0.342091 | -0.018708 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 661 | V | 0.203224 | L | 0.202625 | 5.99E-04 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 855 | R | 0.693619 | H | 0.595803 | 0.097816 | No Change: Both D | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 869 | L | 0.83422 | F | 0.781258 | 0.052962 | No Change: Both D | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 1370 | T | 0.101514 | A | 0.093453 | 0.008061 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 1558 | M | 0.885092 | T | 0.879561 | 0.005531 | No Change: Both D | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 1660 | T | 0.451202 | I | 0.310459 | 0.140743 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 1679 | R | 0.459122 | H | 0.414843 | 0.044279 | No Change: Both O | - |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 330 | V | 0.150196 | M | 0.180921 | -0.030725 | No Change: Both O | A colorectal cancer sample |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 587 | R | 0.680679 | H | 0.608974 | 0.071705 | No Change: Both D | A colorectal cancer sample |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 855 | R | 0.693619 | C | 0.61944 | 0.074179 | No Change: Both D | A colorectal cancer sample |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 1315 | A | 0.12388 | E | 0.183264 | -0.059384 | No Change: Both O | A colorectal cancer sample |
| P82987 | ATL3_HUMAN ADAMTS-like protein 3 OS=Homo sapiens GN=ADAMTSL3 PE=2 SV=4 | 713 | G | 0.498457 | R | 0.523133 | -0.024676 | O to D | - |
| Q6UY14 | ATL4_HUMAN ADAMTS-like protein 4 OS=Homo sapiens GN=ADAMTSL4 PE=1 SV=2 | 193 | A | 0.986883 | P | 0.99229 | -0.005407 | No Change: Both D | - |
| Q6UY14 | ATL4_HUMAN ADAMTS-like protein 4 OS=Homo sapiens GN=ADAMTSL4 PE=1 SV=2 | 1028 | R | 0.957494 | H | 0.948817 | 0.008677 | No Change: Both D | - |
| O75689 | ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens GN=ADAP1 PE=1 SV=2 | 241 | G | 0.320474 | S | 0.360066 | -0.039592 | No Change: Both O | - |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 384 | K | 0.788367 | R | 0.783504 | 0.004863 | No Change: Both D | - |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 923 | L | 0.128225 | P | 0.217593 | -0.089368 | No Change: Both O | Dyschromatosis symmetrical hereditaria (DSH) [MIM:127400] |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 1165 | F | 0.181789 | S | 0.34508 | -0.163291 | No Change: Both O | Dyschromatosis symmetrical hereditaria (DSH) [MIM:127400] |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 966 | C | 0.300061 | F | 0.290587 | 0.009474 | No Change: Both O | Dyschromatosis symmetrical hereditaria (DSH) [MIM:127400] |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 587 | Y | 0.99082 | C | 0.993395 | -0.002575 | No Change: Both D | - |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 1155 | R | 0.516744 | W | 0.287625 | 0.229119 | D to O | Dyschromatosis symmetrical hereditaria (DSH) [MIM:127400] |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 806 | E | 0.583221 | V | 0.432178 | 0.151043 | D to O | A breast cancer sample |
| P55265 | DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens GN=ADAR PE=1 SV=4 | 100 | R | 0.880897 | G | 0.863955 | 0.016942 | No Change: Both D | - |
| Q9NS39 | RED2_HUMAN Double-stranded RNA-specific editase B2 OS=Homo sapiens GN=ADARB2 PE=1 SV=1 | 44 | A | 0.795319 | T | 0.840454 | -0.045135 | No Change: Both D | - |
| Q9NS39 | RED2_HUMAN Double-stranded RNA-specific editase B2 OS=Homo sapiens GN=ADARB2 PE=1 SV=1 | 210 | T | 0.744024 | M | 0.743972 | 5.20E-05 | No Change: Both D | A colorectal cancer sample |
| Q9NS39 | RED2_HUMAN Double-stranded RNA-specific editase B2 OS=Homo sapiens GN=ADARB2 PE=1 SV=1 | 512 | V | 0.532595 | I | 0.50858 | 0.024015 | No Change: Both D | A colorectal cancer sample |
| Q9NS39 | RED2_HUMAN Double-stranded RNA-specific editase B2 OS=Homo sapiens GN=ADARB2 PE=1 SV=1 | 626 | A | 0.65665 | T | 0.654507 | 0.002143 | No Change: Both D | - |
| Q9BUB4 | ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens GN=ADAT1 PE=2 SV=1 | 167 | H | 0.610062 | N | 0.669227 | -0.059165 | No Change: Both D | - |
| Q9BUB4 | ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens GN=ADAT1 PE=2 SV=1 | 203 | T | 0.795046 | N | 0.799657 | -0.004611 | No Change: Both D | - |
| Q9BUB4 | ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens GN=ADAT1 PE=2 SV=1 | 242 | T | 0.238164 | P | 0.289765 | -0.051601 | No Change: Both O | - |
| Q9BUB4 | ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens GN=ADAT1 PE=2 SV=1 | 226 | I | 0.590262 | V | 0.601211 | -0.010949 | No Change: Both D | - |
| Q96EY9 | ADAT3_HUMAN tRNA-specific adenosine deaminase-like protein 3 OS=Homo sapiens GN=ADAT3 PE=1 SV=1 | 332 | R | 0.232073 | C | 0.114322 | 0.117751 | No Change: Both O | A breast cancer sample |
| Q96A70 | ADC_HUMAN Arginine decarboxylase OS=Homo sapiens GN=ADC PE=2 SV=1 | 288 | A | 0.106261 | S | 0.168616 | -0.062355 | No Change: Both O | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 307 | S | 0.172022 | P | 0.169804 | 0.002218 | No Change: Both O | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 418 | V | 0.278759 | M | 0.339364 | -0.060605 | No Change: Both O | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 622 | P | 0.514583 | L | 0.324791 | 0.189792 | D to O | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 418 | V | 0.278759 | L | 0.292261 | -0.013502 | No Change: Both O | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 626 | P | 0.696336 | L | 0.617283 | 0.079053 | No Change: Both D | - |
| Q7Z695 | ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1 | 66 | S | 0.5593 | G | 0.519399 | 0.039901 | No Change: Both D | - |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 85 | H | 0.798616 | Q | 0.817205 | -0.018589 | No Change: Both D | - |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 213 | R | 0.348708 | W | 0.158617 | 0.190091 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 272 | G | 0.180307 | D | 0.19444 | -0.014133 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 272 | G | 0.180307 | V | 0.111163 | 0.069144 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 514 | Y | 0.350419 | C | 0.298574 | 0.051845 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 9 (SCAR9) [MIM:612016] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 549 | G | 0.19144 | S | 0.242517 | -0.051077 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 9 (SCAR9) [MIM:612016] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 551 | E | 0.227449 | K | 0.230797 | -0.003348 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q8NI60 | ADCK3_HUMAN Chaperone activity of bc1 complex-like mitochondrial OS=Homo sapiens GN=ADCK3 PE=1 SV=1 | 341 | I | 0.244654 | T | 0.362468 | -0.117814 | No Change: Both O | - |
| Q96D53 | ADCK4_HUMAN Uncharacterized aarF domain-containing protein kinase 4 OS=Homo sapiens GN=ADCK4 PE=1 SV=2 | 174 | H | 0.262901 | R | 0.311841 | -0.04894 | No Change: Both O | - |
| Q96D53 | ADCK4_HUMAN Uncharacterized aarF domain-containing protein kinase 4 OS=Homo sapiens GN=ADCK4 PE=1 SV=2 | 78 | R | 0.880981 | C | 0.819344 | 0.061637 | No Change: Both D | - |
| Q96D53 | ADCK4_HUMAN Uncharacterized aarF domain-containing protein kinase 4 OS=Homo sapiens GN=ADCK4 PE=1 SV=2 | 318 | T | 0.141441 | M | 0.124705 | 0.016736 | No Change: Both O | - |
| Q96D53 | ADCK4_HUMAN Uncharacterized aarF domain-containing protein kinase 4 OS=Homo sapiens GN=ADCK4 PE=1 SV=2 | 352 | T | 0.044172 | R | 0.056706 | -0.012534 | No Change: Both O | - |
| Q96D53 | ADCK4_HUMAN Uncharacterized aarF domain-containing protein kinase 4 OS=Homo sapiens GN=ADCK4 PE=1 SV=2 | 462 | T | 0.402865 | M | 0.361301 | 0.041564 | No Change: Both O | - |
| Q3MIX3 | ADCK5_HUMAN Uncharacterized aarF domain-containing protein kinase 5 OS=Homo sapiens GN=ADCK5 PE=2 SV=2 | 17 | R | 0.541391 | S | 0.563573 | -0.022182 | No Change: Both D | - |
| Q08828 | ADCY1_HUMAN Adenylate cyclase type 1 OS=Homo sapiens GN=ADCY1 PE=1 SV=2 | 456 | P | 0.554781 | L | 0.405204 | 0.149577 | D to O | - |
| Q08828 | ADCY1_HUMAN Adenylate cyclase type 1 OS=Homo sapiens GN=ADCY1 PE=1 SV=2 | 940 | A | 0.7651 | T | 0.774445 | -0.009345 | No Change: Both D | - |
| Q08828 | ADCY1_HUMAN Adenylate cyclase type 1 OS=Homo sapiens GN=ADCY1 PE=1 SV=2 | 984 | V | 0.128578 | M | 0.149856 | -0.021278 | No Change: Both O | - |
| Q96PN6 | ADCYA_HUMAN Adenylate cyclase type 10 OS=Homo sapiens GN=ADCY10 PE=1 SV=3 | 234 | T | 0.204094 | M | 0.188526 | 0.015568 | No Change: Both O | - |
| Q96PN6 | ADCYA_HUMAN Adenylate cyclase type 10 OS=Homo sapiens GN=ADCY10 PE=1 SV=3 | 697 | I | 0.102318 | V | 0.11856 | -0.016242 | No Change: Both O | - |
| Q08462 | ADCY2_HUMAN Adenylate cyclase type 2 OS=Homo sapiens GN=ADCY2 PE=1 SV=5 | 147 | V | 0.010338 | L | 0.010407 | -6.90E-05 | No Change: Both O | - |
| Q08462 | ADCY2_HUMAN Adenylate cyclase type 2 OS=Homo sapiens GN=ADCY2 PE=1 SV=5 | 163 | V | 0.353104 | I | 0.340532 | 0.012572 | No Change: Both O | - |
| O60266 | ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens GN=ADCY3 PE=1 SV=3 | 107 | S | 0.26849 | P | 0.225316 | 0.043174 | No Change: Both O | - |
| O43306 | ADCY6_HUMAN Adenylate cyclase type 6 OS=Homo sapiens GN=ADCY6 PE=1 SV=2 | 674 | A | 0.020349 | S | 0.031118 | -0.010769 | No Change: Both O | - |
| P40145 | ADCY8_HUMAN Adenylate cyclase type 8 OS=Homo sapiens GN=ADCY8 PE=1 SV=1 | 80 | A | 0.899311 | T | 0.903542 | -0.004231 | No Change: Both D | - |
| P40145 | ADCY8_HUMAN Adenylate cyclase type 8 OS=Homo sapiens GN=ADCY8 PE=1 SV=1 | 881 | F | 0.08095 | L | 0.102529 | -0.021579 | No Change: Both O | A colorectal cancer sample |
| O60503 | ADCY9_HUMAN Adenylate cyclase type 9 OS=Homo sapiens GN=ADCY9 PE=1 SV=4 | 772 | I | 0.509606 | M | 0.607753 | -0.098147 | No Change: Both D | - |
| P18509 | PACA_HUMAN Pituitary adenylate cyclase-activating polypeptide OS=Homo sapiens GN=ADCYAP1 PE=1 SV=3 | 54 | D | 0.946988 | G | 0.945599 | 0.001389 | No Change: Both D | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 460 | G | 0.959016 | W | 0.926628 | 0.032388 | No Change: Both D | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 586 | S | 0.963082 | C | 0.947476 | 0.015606 | No Change: Both D | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 270 | Y | 0.21249 | N | 0.315885 | -0.103395 | No Change: Both O | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 376 | E | 0.500318 | D | 0.455933 | 0.044385 | D to O | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 510 | N | 0.56493 | I | 0.400436 | 0.164494 | D to O | - |
| P35611 | ADDA_HUMAN Alpha-adducin OS=Homo sapiens GN=ADD1 PE=1 SV=2 | 6 | R | 0.823348 | C | 0.700969 | 0.122379 | No Change: Both D | - |
| P35612 | ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 | 28 | D | 0.862843 | N | 0.846576 | 0.016267 | No Change: Both D | - |
| P35612 | ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 | 335 | E | 0.536637 | D | 0.495788 | 0.040849 | D to O | - |
| P35612 | ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 | 663 | S | 0.930982 | R | 0.916047 | 0.014935 | No Change: Both D | - |
| P35612 | ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 | 439 | T | 0.503967 | A | 0.467144 | 0.036823 | D to O | - |
| P35612 | ADDB_HUMAN Beta-adducin OS=Homo sapiens GN=ADD2 PE=1 SV=3 | 98 | S | 0.446973 | C | 0.230225 | 0.216748 | No Change: Both O | - |
| P00325 | ADH1B_HUMAN Alcohol dehydrogenase 1B OS=Homo sapiens GN=ADH1B PE=1 SV=2 | 48 | R | 0.172814 | H | 0.185151 | -0.012337 | No Change: Both O | - |
| P00325 | ADH1B_HUMAN Alcohol dehydrogenase 1B OS=Homo sapiens GN=ADH1B PE=1 SV=2 | 370 | R | 0.511394 | C | 0.31379 | 0.197604 | D to O | - |
| P00325 | ADH1B_HUMAN Alcohol dehydrogenase 1B OS=Homo sapiens GN=ADH1B PE=1 SV=2 | 57 | N | 0.260123 | K | 0.291734 | -0.031611 | No Change: Both O | - |
| P00325 | ADH1B_HUMAN Alcohol dehydrogenase 1B OS=Homo sapiens GN=ADH1B PE=1 SV=2 | 60 | T | 0.173316 | S | 0.240468 | -0.067152 | No Change: Both O | - |
| P00326 | ADH1G_HUMAN Alcohol dehydrogenase 1C OS=Homo sapiens GN=ADH1C PE=1 SV=2 | 272 | R | 0.164725 | Q | 0.182547 | -0.017822 | No Change: Both O | - |
| P00326 | ADH1G_HUMAN Alcohol dehydrogenase 1C OS=Homo sapiens GN=ADH1C PE=1 SV=2 | 350 | I | 0.113472 | V | 0.1174 | -0.003928 | No Change: Both O | - |
| P00326 | ADH1G_HUMAN Alcohol dehydrogenase 1C OS=Homo sapiens GN=ADH1C PE=1 SV=2 | 48 | R | 0.280705 | H | 0.293615 | -0.01291 | No Change: Both O | - |
| P00326 | ADH1G_HUMAN Alcohol dehydrogenase 1C OS=Homo sapiens GN=ADH1C PE=1 SV=2 | 166 | P | 0.214141 | S | 0.249942 | -0.035801 | No Change: Both O | - |
| P00326 | ADH1G_HUMAN Alcohol dehydrogenase 1C OS=Homo sapiens GN=ADH1C PE=1 SV=2 | 352 | P | 0.14733 | T | 0.127397 | 0.019933 | No Change: Both O | - |
| P08319 | ADH4_HUMAN Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4 PE=1 SV=5 | 309 | I | 0.184935 | V | 0.198532 | -0.013597 | No Change: Both O | - |
| P08319 | ADH4_HUMAN Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4 PE=1 SV=5 | 318 | R | 0.126659 | H | 0.128021 | -0.001362 | No Change: Both O | - |
| P08319 | ADH4_HUMAN Alcohol dehydrogenase 4 OS=Homo sapiens GN=ADH4 PE=1 SV=5 | 374 | V | 0.265985 | I | 0.256786 | 0.009199 | No Change: Both O | - |
| P11766 | ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4 | 163 | L | 0.216871 | S | 0.372948 | -0.156077 | No Change: Both O | - |
| P11766 | ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4 | 309 | V | 0.169131 | I | 0.150297 | 0.018834 | No Change: Both O | - |
| P11766 | ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4 | 353 | D | 0.296174 | E | 0.341795 | -0.045621 | No Change: Both O | - |
| P28332 | ADH6_HUMAN Alcohol dehydrogenase 6 OS=Homo sapiens GN=ADH6 PE=2 SV=2 | 102 | C | 0.364895 | G | 0.472239 | -0.107344 | No Change: Both O | - |
| P28332 | ADH6_HUMAN Alcohol dehydrogenase 6 OS=Homo sapiens GN=ADH6 PE=2 SV=2 | 114 | I | 0.426056 | V | 0.443443 | -0.017387 | No Change: Both O | - |
| P28332 | ADH6_HUMAN Alcohol dehydrogenase 6 OS=Homo sapiens GN=ADH6 PE=2 SV=2 | 151 | T | 0.127611 | P | 0.145133 | -0.017522 | No Change: Both O | - |
| P40394 | ADH7_HUMAN Alcohol dehydrogenase class 4 mu/sigma chain OS=Homo sapiens GN=ADH7 PE=1 SV=2 | 92 | G | 0.40883 | A | 0.333863 | 0.074967 | No Change: Both O | - |
| Q8IWW8 | HOT_HUMAN Hydroxyacid-oxoacid transhydrogenase mitochondrial OS=Homo sapiens GN=ADHFE1 PE=1 SV=1 | 242 | D | 0.146535 | V | 0.089361 | 0.057174 | No Change: Both O | A breast cancer sample |
| Q8IWW8 | HOT_HUMAN Hydroxyacid-oxoacid transhydrogenase mitochondrial OS=Homo sapiens GN=ADHFE1 PE=1 SV=1 | 449 | C | 0.500516 | R | 0.661318 | -0.160802 | No Change: Both D | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 84 | G | 0.916764 | R | 0.915844 | 9.20E-04 | No Change: Both D | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 112 | R | 0.248337 | C | 0.142151 | 0.106186 | No Change: Both O | Adiponectin deficiency (ADPND) [MIM:612556] |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 117 | V | 0.178588 | M | 0.215731 | -0.037143 | No Change: Both O | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 164 | I | 0.04313 | T | 0.087806 | -0.044676 | No Change: Both O | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 221 | R | 0.455212 | S | 0.513199 | -0.057987 | O to D | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 241 | H | 0.621158 | P | 0.644103 | -0.022945 | No Change: Both D | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 90 | G | 0.84942 | S | 0.847127 | 0.002293 | No Change: Both D | - |
| Q15848 | ADIPO_HUMAN Adiponectin OS=Homo sapiens GN=ADIPOQ PE=1 SV=1 | 111 | Y | 0.284789 | H | 0.358788 | -0.073999 | No Change: Both O | - |
| Q86V24 | ADR2_HUMAN Adiponectin receptor protein 2 OS=Homo sapiens GN=ADIPOR2 PE=1 SV=1 | 39 | Q | 0.895054 | R | 0.904705 | -0.009651 | No Change: Both D | - |
| P55263 | ADK_HUMAN Adenosine kinase OS=Homo sapiens GN=ADK PE=1 SV=2 | 30 | G | 0.295321 | E | 0.365449 | -0.070128 | No Change: Both O | Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300] |
| P55263 | ADK_HUMAN Adenosine kinase OS=Homo sapiens GN=ADK PE=1 SV=2 | 235 | D | 0.096158 | A | 0.07432 | 0.021838 | No Change: Both O | Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300] |
| P55263 | ADK_HUMAN Adenosine kinase OS=Homo sapiens GN=ADK PE=1 SV=2 | 318 | A | 0.237999 | E | 0.327698 | -0.089699 | No Change: Both O | Hypermethioninemia due to adenosine kinase deficiency (HMAKD) [MIM:614300] |
| P35318 | ADML_HUMAN ADM OS=Homo sapiens GN=ADM PE=1 SV=1 | 50 | S | 0.616059 | R | 0.594543 | 0.021516 | No Change: Both D | - |
| P35318 | ADML_HUMAN ADM OS=Homo sapiens GN=ADM PE=1 SV=1 | 85 | P | 0.852397 | R | 0.85254 | -1.43E-04 | No Change: Both D | - |
| Q96SZ5 | AEDO_HUMAN 2-aminoethanethiol dioxygenase OS=Homo sapiens GN=ADO PE=1 SV=2 | 25 | G | 0.846636 | W | 0.673934 | 0.172702 | No Change: Both D | - |
| Q96SZ5 | AEDO_HUMAN 2-aminoethanethiol dioxygenase OS=Homo sapiens GN=ADO PE=1 SV=2 | 39 | P | 0.878982 | A | 0.837448 | 0.041534 | No Change: Both D | - |
| Q96SZ5 | AEDO_HUMAN 2-aminoethanethiol dioxygenase OS=Homo sapiens GN=ADO PE=1 SV=2 | 266 | P | 0.681612 | S | 0.669607 | 0.012005 | No Change: Both D | - |
| P30542 | AA1R_HUMAN Adenosine receptor A1 OS=Homo sapiens GN=ADORA1 PE=1 SV=1 | 170 | E | 0.234011 | K | 0.230838 | 0.003173 | No Change: Both O | A colorectal cancer sample |
| P30542 | AA1R_HUMAN Adenosine receptor A1 OS=Homo sapiens GN=ADORA1 PE=1 SV=1 | 43 | A | 0.059861 | S | 0.095403 | -0.035542 | No Change: Both O | - |
| P30542 | AA1R_HUMAN Adenosine receptor A1 OS=Homo sapiens GN=ADORA1 PE=1 SV=1 | 50 | S | 0.030931 | P | 0.02708 | 0.003851 | No Change: Both O | - |
| P30542 | AA1R_HUMAN Adenosine receptor A1 OS=Homo sapiens GN=ADORA1 PE=1 SV=1 | 105 | R | 0.066529 | H | 0.062367 | 0.004162 | No Change: Both O | - |
| P30542 | AA1R_HUMAN Adenosine receptor A1 OS=Homo sapiens GN=ADORA1 PE=1 SV=1 | 261 | P | 0.101194 | Q | 0.087053 | 0.014141 | No Change: Both O | - |
| P29274 | AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens GN=ADORA2A PE=1 SV=2 | 392 | G | 0.771694 | R | 0.736125 | 0.035569 | No Change: Both D | - |
| P29274 | AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens GN=ADORA2A PE=1 SV=2 | 50 | A | 0.088741 | V | 0.061811 | 0.02693 | No Change: Both O | - |
| P29274 | AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens GN=ADORA2A PE=1 SV=2 | 300 | R | 0.246621 | H | 0.236094 | 0.010527 | No Change: Both O | - |
| P33765 | AA3R_HUMAN Adenosine receptor A3 OS=Homo sapiens GN=ADORA3 PE=2 SV=2 | 105 | A | 0.076555 | T | 0.081167 | -0.004612 | No Change: Both O | A colorectal cancer sample |
| P33765 | AA3R_HUMAN Adenosine receptor A3 OS=Homo sapiens GN=ADORA3 PE=2 SV=2 | 248 | I | 0.0198 | L | 0.022638 | -0.002838 | No Change: Both O | - |
| P33765 | AA3R_HUMAN Adenosine receptor A3 OS=Homo sapiens GN=ADORA3 PE=2 SV=2 | 266 | M | 0.067993 | K | 0.119593 | -0.0516 | No Change: Both O | - |
| Q9BRR6 | ADPGK_HUMAN ADP-dependent glucokinase OS=Homo sapiens GN=ADPGK PE=1 SV=1 | 184 | K | 0.339308 | R | 0.273912 | 0.065396 | No Change: Both O | - |
| Q8NDY3 | ARHL1_HUMAN [Protein ADP-ribosylarginine] hydrolase-like protein 1 OS=Homo sapiens GN=ADPRHL1 PE=2 SV=1 | 7 | A | 0.380194 | V | 0.310644 | 0.06955 | No Change: Both O | - |
| Q9NX46 | ARHL2_HUMAN Poly(ADP-ribose) glycohydrolase ARH3 OS=Homo sapiens GN=ADPRHL2 PE=1 SV=1 | 209 | E | 0.614072 | K | 0.607306 | 0.006766 | No Change: Both D | - |
| P35348 | ADA1A_HUMAN Alpha-1A adrenergic receptor OS=Homo sapiens GN=ADRA1A PE=2 SV=2 | 347 | C | 0.28615 | R | 0.42243 | -0.13628 | No Change: Both O | - |
| P35348 | ADA1A_HUMAN Alpha-1A adrenergic receptor OS=Homo sapiens GN=ADRA1A PE=2 SV=2 | 40 | G | 0.026977 | W | 0.008129 | 0.018848 | No Change: Both O | A breast cancer sample |
| P35348 | ADA1A_HUMAN Alpha-1A adrenergic receptor OS=Homo sapiens GN=ADRA1A PE=2 SV=2 | 200 | I | 0.014613 | S | 0.040353 | -0.02574 | No Change: Both O | - |
| P35348 | ADA1A_HUMAN Alpha-1A adrenergic receptor OS=Homo sapiens GN=ADRA1A PE=2 SV=2 | 414 | K | 0.727223 | R | 0.719604 | 0.007619 | No Change: Both D | - |
| P35348 | ADA1A_HUMAN Alpha-1A adrenergic receptor OS=Homo sapiens GN=ADRA1A PE=2 SV=2 | 465 | E | 0.745489 | D | 0.724956 | 0.020533 | No Change: Both D | - |
| P35368 | ADA1B_HUMAN Alpha-1B adrenergic receptor OS=Homo sapiens GN=ADRA1B PE=2 SV=3 | 51 | V | 0.037402 | G | 0.070617 | -0.033215 | No Change: Both O | - |
| P08913 | ADA2A_HUMAN Alpha-2A adrenergic receptor OS=Homo sapiens GN=ADRA2A PE=1 SV=3 | 251 | N | 0.983116 | K | 0.985673 | -0.002557 | No Change: Both D | - |
| P08913 | ADA2A_HUMAN Alpha-2A adrenergic receptor OS=Homo sapiens GN=ADRA2A PE=1 SV=3 | 401 | C | 0.127186 | S | 0.334882 | -0.207696 | No Change: Both O | - |
| P18089 | ADA2B_HUMAN Alpha-2B adrenergic receptor OS=Homo sapiens GN=ADRA2B PE=2 SV=2 | 211 | G | 0.816877 | A | 0.800401 | 0.016476 | No Change: Both D | - |
| P18089 | ADA2B_HUMAN Alpha-2B adrenergic receptor OS=Homo sapiens GN=ADRA2B PE=2 SV=2 | 379 | V | 0.004692 | G | 0.008757 | -0.004065 | No Change: Both O | - |
| P18089 | ADA2B_HUMAN Alpha-2B adrenergic receptor OS=Homo sapiens GN=ADRA2B PE=2 SV=2 | 376 | V | 0.009452 | I | 0.007631 | 0.001821 | No Change: Both O | - |
| P18089 | ADA2B_HUMAN Alpha-2B adrenergic receptor OS=Homo sapiens GN=ADRA2B PE=2 SV=2 | 379 | V | 0.004692 | I | 0.003797 | 8.95E-04 | No Change: Both O | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 49 | S | 0.779213 | G | 0.752528 | 0.026685 | No Change: Both D | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 389 | R | 0.239682 | G | 0.203479 | 0.036203 | No Change: Both O | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 389 | R | 0.239682 | L | 0.145111 | 0.094571 | No Change: Both O | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 26 | A | 0.891207 | V | 0.852465 | 0.038742 | No Change: Both D | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 29 | A | 0.885647 | T | 0.878853 | 0.006794 | No Change: Both D | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 31 | R | 0.897271 | Q | 0.908069 | -0.010798 | No Change: Both D | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 399 | R | 0.801217 | H | 0.76528 | 0.035937 | No Change: Both D | - |
| P08588 | ADRB1_HUMAN Beta-1 adrenergic receptor OS=Homo sapiens GN=ADRB1 PE=1 SV=2 | 405 | H | 0.91233 | Y | 0.876754 | 0.035576 | No Change: Both D | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 16 | G | 0.598715 | R | 0.584031 | 0.014684 | No Change: Both D | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 27 | E | 0.509615 | Q | 0.455441 | 0.054174 | D to O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 34 | V | 0.074425 | M | 0.095817 | -0.021392 | No Change: Both O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 164 | T | 0.074607 | I | 0.042721 | 0.031886 | No Change: Both O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 159 | I | 0.02186 | L | 0.025635 | -0.003775 | No Change: Both O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 159 | I | 0.02186 | F | 0.021123 | 7.37E-04 | No Change: Both O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 375 | K | 0.6791 | R | 0.629725 | 0.049375 | No Change: Both D | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 220 | S | 0.076304 | C | 0.027646 | 0.048658 | No Change: Both O | - |
| P07550 | ADRB2_HUMAN Beta-2 adrenergic receptor OS=Homo sapiens GN=ADRB2 PE=1 SV=3 | 15 | N | 0.570133 | S | 0.631527 | -0.061394 | No Change: Both D | - |
| P13945 | ADRB3_HUMAN Beta-3 adrenergic receptor OS=Homo sapiens GN=ADRB3 PE=2 SV=3 | 64 | W | 0.05458 | R | 0.140359 | -0.085779 | No Change: Both O | - |
| P13945 | ADRB3_HUMAN Beta-3 adrenergic receptor OS=Homo sapiens GN=ADRB3 PE=2 SV=3 | 265 | T | 0.952278 | M | 0.950729 | 0.001549 | No Change: Both D | - |
| P13945 | ADRB3_HUMAN Beta-3 adrenergic receptor OS=Homo sapiens GN=ADRB3 PE=2 SV=3 | 353 | R | 0.471096 | C | 0.374165 | 0.096931 | No Change: Both O | - |
| P13945 | ADRB3_HUMAN Beta-3 adrenergic receptor OS=Homo sapiens GN=ADRB3 PE=2 SV=3 | 249 | E | 0.8441 | K | 0.821538 | 0.022562 | No Change: Both D | - |
| P25098 | ARBK1_HUMAN Beta-adrenergic receptor kinase 1 OS=Homo sapiens GN=ADRBK1 PE=1 SV=2 | 184 | I | 0.130618 | T | 0.236 | -0.105382 | No Change: Both O | - |
| P25098 | ARBK1_HUMAN Beta-adrenergic receptor kinase 1 OS=Homo sapiens GN=ADRBK1 PE=1 SV=2 | 578 | R | 0.089238 | Q | 0.097566 | -0.008328 | No Change: Both O | A colorectal adenocarcinoma sample |
| P35626 | ARBK2_HUMAN Beta-adrenergic receptor kinase 2 OS=Homo sapiens GN=ADRBK2 PE=2 SV=2 | 409 | V | 0.41384 | M | 0.521057 | -0.107217 | O to D | - |
| P35626 | ARBK2_HUMAN Beta-adrenergic receptor kinase 2 OS=Homo sapiens GN=ADRBK2 PE=2 SV=2 | 50 | R | 0.266725 | S | 0.323887 | -0.057162 | No Change: Both O | - |
| P35626 | ARBK2_HUMAN Beta-adrenergic receptor kinase 2 OS=Homo sapiens GN=ADRBK2 PE=2 SV=2 | 60 | N | 0.115734 | S | 0.133632 | -0.017898 | No Change: Both O | - |
| P35626 | ARBK2_HUMAN Beta-adrenergic receptor kinase 2 OS=Homo sapiens GN=ADRBK2 PE=2 SV=2 | 104 | R | 0.364794 | K | 0.405789 | -0.040995 | No Change: Both O | A lung bronchoalveolar carcinoma sample |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 438 | S | 0.361674 | P | 0.34279 | 0.018884 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 72 | I | 0.456412 | V | 0.486111 | -0.029699 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 141 | R | 0.179848 | W | 0.069086 | 0.110762 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 190 | R | 0.365599 | Q | 0.373075 | -0.007476 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 246 | K | 0.230178 | E | 0.244108 | -0.01393 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 303 | R | 0.582424 | C | 0.468024 | 0.1144 | D to O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 395 | S | 0.493612 | R | 0.459958 | 0.033654 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 426 | R | 0.271086 | H | 0.258476 | 0.01261 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 2 | A | 0.881351 | V | 0.844618 | 0.036733 | No Change: Both D | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 26 | M | 0.233097 | L | 0.185995 | 0.047102 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 450 | T | 0.575602 | S | 0.674548 | -0.098946 | No Change: Both D | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 3 | A | 0.865679 | V | 0.822778 | 0.042901 | No Change: Both D | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 100 | P | 0.175868 | A | 0.138861 | 0.037007 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 114 | Y | 0.15639 | H | 0.25467 | -0.09828 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 194 | R | 0.36969 | C | 0.222641 | 0.147049 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 268 | D | 0.125575 | N | 0.126725 | -0.00115 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 311 | L | 0.314085 | V | 0.291591 | 0.022494 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 318 | P | 0.316449 | L | 0.209696 | 0.106753 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 364 | V | 0.119701 | M | 0.143028 | -0.023327 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 374 | R | 0.250994 | W | 0.102555 | 0.148439 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 396 | R | 0.475791 | C | 0.365754 | 0.110037 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 396 | R | 0.475791 | H | 0.480378 | -0.004587 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 422 | D | 0.398308 | Y | 0.239779 | 0.158529 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 423 | L | 0.371419 | V | 0.384955 | -0.013536 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 430 | D | 0.229547 | N | 0.200128 | 0.029419 | No Change: Both O | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 447 | S | 0.54993 | P | 0.522987 | 0.026943 | No Change: Both D | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 452 | R | 0.556629 | P | 0.596126 | -0.039497 | No Change: Both D | Adenylosuccinase deficiency (ADSL deficiency) [MIM:103050] |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 31 | S | 0.135339 | N | 0.10326 | 0.032079 | No Change: Both O | - |
| P30566 | PUR8_HUMAN Adenylosuccinate lyase OS=Homo sapiens GN=ADSL PE=1 SV=2 | 147 | K | 0.436833 | M | 0.308448 | 0.128385 | No Change: Both O | - |
| P30520 | PURA2_HUMAN Adenylosuccinate synthetase isozyme 2 OS=Homo sapiens GN=ADSS PE=1 SV=3 | 179 | L | 0.335222 | F | 0.30469 | 0.030532 | No Change: Both O | - |
| Q96IZ2 | ADTRP_HUMAN Androgen-dependent TPF1-regulating protein OS=Homo sapiens GN=ADTRP PE=2 SV=1 | 202 | V | 0.035164 | I | 0.033596 | 0.001568 | No Change: Both O | - |
| Q8IUX7 | AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens GN=AEBP1 PE=1 SV=1 | 273 | P | 0.997194 | T | 0.994481 | 0.002713 | No Change: Both D | - |
| Q8IUX7 | AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens GN=AEBP1 PE=1 SV=1 | 648 | D | 0.420431 | E | 0.464086 | -0.043655 | No Change: Both O | - |
| Q8IUX7 | AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens GN=AEBP1 PE=1 SV=1 | 1001 | P | 0.684919 | L | 0.541598 | 0.143321 | No Change: Both D | - |
| Q8IUX7 | AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens GN=AEBP1 PE=1 SV=1 | 1133 | K | 0.952319 | E | 0.969617 | -0.017298 | No Change: Both D | - |
| Q8IUX7 | AEBP1_HUMAN Adipocyte enhancer-binding protein 1 OS=Homo sapiens GN=AEBP1 PE=1 SV=1 | 1148 | V | 0.652623 | I | 0.639797 | 0.012826 | No Change: Both D | - |
| Q8WTP8 | AEN_HUMAN Apoptosis-enhancing nuclease OS=Homo sapiens GN=AEN PE=1 SV=2 | 15 | P | 0.792491 | L | 0.649254 | 0.143237 | No Change: Both D | - |
| Q8WTP8 | AEN_HUMAN Apoptosis-enhancing nuclease OS=Homo sapiens GN=AEN PE=1 SV=2 | 88 | S | 0.968401 | C | 0.951886 | 0.016515 | No Change: Both D | - |
| Q8WTP8 | AEN_HUMAN Apoptosis-enhancing nuclease OS=Homo sapiens GN=AEN PE=1 SV=2 | 140 | N | 0.139117 | D | 0.160849 | -0.021732 | No Change: Both O | - |
| Q08117 | AES_HUMAN Amino-terminal enhancer of split OS=Homo sapiens GN=AES PE=1 SV=4 | 168 | A | 0.873058 | E | 0.898487 | -0.025429 | No Change: Both D | - |
| Q9NQ60 | AFAF_HUMAN Acrosome formation-associated factor OS=Homo sapiens GN=AFAF PE=2 SV=2 | 101 | N | 0.761582 | D | 0.760867 | 7.15E-04 | No Change: Both D | - |
| Q9NQ60 | AFAF_HUMAN Acrosome formation-associated factor OS=Homo sapiens GN=AFAF PE=2 SV=2 | 274 | T | 0.95852 | K | 0.962953 | -0.004433 | No Change: Both D | - |
| Q9NQ60 | AFAF_HUMAN Acrosome formation-associated factor OS=Homo sapiens GN=AFAF PE=2 SV=2 | 110 | I | 0.833767 | T | 0.899449 | -0.065682 | No Change: Both D | - |
| Q8N556 | AFAP1_HUMAN Actin filament-associated protein 1 OS=Homo sapiens GN=AFAP1 PE=1 SV=2 | 403 | S | 0.3553 | C | 0.168869 | 0.186431 | No Change: Both O | - |
| Q8N556 | AFAP1_HUMAN Actin filament-associated protein 1 OS=Homo sapiens GN=AFAP1 PE=1 SV=2 | 518 | V | 0.792191 | M | 0.814888 | -0.022697 | No Change: Both D | - |
| Q8N4X5 | AF1L2_HUMAN Actin filament-associated protein 1-like 2 OS=Homo sapiens GN=AFAP1L2 PE=1 SV=1 | 138 | G | 0.935265 | R | 0.935803 | -5.38E-04 | No Change: Both D | - |
| Q8N4X5 | AF1L2_HUMAN Actin filament-associated protein 1-like 2 OS=Homo sapiens GN=AFAP1L2 PE=1 SV=1 | 366 | S | 0.34918 | R | 0.306128 | 0.043052 | No Change: Both O | - |
| Q8N4X5 | AF1L2_HUMAN Actin filament-associated protein 1-like 2 OS=Homo sapiens GN=AFAP1L2 PE=1 SV=1 | 522 | T | 0.8453 | S | 0.871436 | -0.026136 | No Change: Both D | - |
| Q8N4X5 | AF1L2_HUMAN Actin filament-associated protein 1-like 2 OS=Homo sapiens GN=AFAP1L2 PE=1 SV=1 | 726 | E | 0.844821 | K | 0.834101 | 0.01072 | No Change: Both D | - |
| P51825 | AFF1_HUMAN AF4/FMR2 family member 1 OS=Homo sapiens GN=AFF1 PE=1 SV=1 | 209 | P | 0.952507 | A | 0.919307 | 0.0332 | No Change: Both D | - |
| P51825 | AFF1_HUMAN AF4/FMR2 family member 1 OS=Homo sapiens GN=AFF1 PE=1 SV=1 | 1204 | Q | 0.575388 | K | 0.597404 | -0.022016 | No Change: Both D | A breast cancer sample |
| P51816 | AFF2_HUMAN AF4/FMR2 family member 2 OS=Homo sapiens GN=AFF2 PE=1 SV=4 | 1185 | L | 0.421184 | M | 0.520294 | -0.09911 | O to D | - |
| P51826 | AFF3_HUMAN AF4/FMR2 family member 3 OS=Homo sapiens GN=AFF3 PE=1 SV=2 | 358 | S | 0.988199 | N | 0.985383 | 0.002816 | No Change: Both D | - |
| P51826 | AFF3_HUMAN AF4/FMR2 family member 3 OS=Homo sapiens GN=AFF3 PE=1 SV=2 | 494 | N | 0.763308 | S | 0.790365 | -0.027057 | No Change: Both D | - |
| Q9UHB7 | AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens GN=AFF4 PE=1 SV=1 | 136 | T | 0.998783 | P | 0.998946 | -1.63E-04 | No Change: Both D | - |
| Q9UHB7 | AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens GN=AFF4 PE=1 SV=1 | 757 | S | 0.994826 | T | 0.993918 | 9.08E-04 | No Change: Both D | - |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 432 | N | 0.412398 | T | 0.376001 | 0.036397 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 691 | E | 0.386215 | K | 0.383347 | 0.002868 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 694 | A | 0.314038 | E | 0.422048 | -0.10801 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 702 | R | 0.147692 | Q | 0.147453 | 2.39E-04 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 654 | T | 0.337099 | I | 0.231934 | 0.105165 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 666 | M | 0.254426 | R | 0.30621 | -0.051784 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 666 | M | 0.254426 | T | 0.290114 | -0.035688 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 666 | M | 0.254426 | V | 0.219079 | 0.035347 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 671 | G | 0.29825 | E | 0.345949 | -0.047699 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 671 | G | 0.29825 | R | 0.29165 | 0.0066 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| Q9Y4W6 | AFG32_HUMAN AFG3-like protein 2 OS=Homo sapiens GN=AFG3L2 PE=1 SV=2 | 700 | E | 0.180225 | K | 0.180035 | 1.90E-04 | No Change: Both O | Spinocerebellar ataxia type 28 (SCA28) [MIM:610246] |
| P43652 | AFAM_HUMAN Afamin OS=Homo sapiens GN=AFM PE=1 SV=1 | 404 | T | 0.64174 | S | 0.692884 | -0.051144 | No Change: Both D | - |
| P43652 | AFAM_HUMAN Afamin OS=Homo sapiens GN=AFM PE=1 SV=1 | 395 | R | 0.347705 | H | 0.329697 | 0.018008 | No Change: Both O | - |
| P02771 | FETA_HUMAN Alpha-fetoprotein OS=Homo sapiens GN=AFP PE=1 SV=1 | 570 | A | 0.388287 | G | 0.427499 | -0.039212 | No Change: Both O | - |
| P02771 | FETA_HUMAN Alpha-fetoprotein OS=Homo sapiens GN=AFP PE=1 SV=1 | 187 | K | 0.099671 | Q | 0.07837 | 0.021301 | No Change: Both O | - |
| Q6ULP2 | AFTIN_HUMAN Aftiphilin OS=Homo sapiens GN=AFTPH PE=1 SV=2 | 233 | D | 0.556522 | G | 0.492342 | 0.06418 | D to O | - |
| Q6ULP2 | AFTIN_HUMAN Aftiphilin OS=Homo sapiens GN=AFTPH PE=1 SV=2 | 301 | E | 0.414242 | K | 0.402133 | 0.012109 | No Change: Both O | - |
| Q6ULP2 | AFTIN_HUMAN Aftiphilin OS=Homo sapiens GN=AFTPH PE=1 SV=2 | 550 | N | 0.676173 | S | 0.725157 | -0.048984 | No Change: Both D | - |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 60 | G | 0.438136 | D | 0.472332 | -0.034196 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 72 | S | 0.689545 | P | 0.66931 | 0.020235 | No Change: Both D | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 101 | A | 0.327971 | V | 0.276461 | 0.05151 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 161 | R | 0.190077 | Q | 0.213735 | -0.023658 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 163 | C | 0.161148 | S | 0.334068 | -0.17292 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 302 | G | 0.061249 | R | 0.05776 | 0.003489 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 306 | C | 0.065827 | R | 0.12694 | -0.061113 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 12 | V | 0.091874 | L | 0.107231 | -0.015357 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 100 | G | 0.337575 | E | 0.369625 | -0.03205 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 135 | F | 0.318252 | S | 0.544502 | -0.22625 | O to D | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 252 | G | 0.522879 | E | 0.534881 | -0.012002 | No Change: Both D | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 252 | G | 0.522879 | R | 0.498693 | 0.024186 | D to O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 257 | T | 0.411352 | I | 0.284573 | 0.126779 | No Change: Both O | Aspartylglucosaminuria (AGU) [MIM:208400] |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 149 | T | 0.511758 | S | 0.594152 | -0.082394 | No Change: Both D | - |
| P20933 | ASPG_HUMAN N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase OS=Homo sapiens GN=AGA PE=1 SV=2 | 322 | T | 0.193217 | I | 0.103903 | 0.089314 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 829 | E | 0.24013 | K | 0.224464 | 0.015666 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 82 | S | 0.393088 | G | 0.351636 | 0.041452 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 148 | D | 0.217363 | G | 0.195557 | 0.021806 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 671 | V | 0.198684 | I | 0.181136 | 0.017548 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 798 | R | 0.355821 | G | 0.392363 | -0.036542 | No Change: Both O | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 854 | P | 0.812903 | T | 0.787411 | 0.025492 | No Change: Both D | - |
| Q9UPQ3 | AGAP1_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=AGAP1 PE=1 SV=4 | 522 | P | 0.987936 | L | 0.976672 | 0.011264 | No Change: Both D | - |
| Q8TF27 | AGA11_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 11 OS=Homo sapiens GN=AGAP11 PE=2 SV=2 | 82 | I | 0.697288 | V | 0.721838 | -0.02455 | No Change: Both D | - |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 507 | G | 0.519495 | S | 0.572081 | -0.052586 | No Change: Both D | - |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 455 | V | 0.161795 | A | 0.22447 | -0.062675 | No Change: Both O | A glioblastoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 518 | R | 0.578409 | G | 0.567171 | 0.011238 | No Change: Both D | A sarcoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 568 | T | 0.385159 | I | 0.248768 | 0.136391 | No Change: Both O | - |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 651 | A | 0.912086 | V | 0.869823 | 0.042263 | No Change: Both D | A glioblastoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 767 | E | 0.898436 | V | 0.860624 | 0.037812 | No Change: Both D | A glioblastoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 939 | N | 0.331513 | D | 0.337475 | -0.005962 | No Change: Both O | A glioblastoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 947 | V | 0.205919 | M | 0.25839 | -0.052471 | No Change: Both O | A sarcoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 1022 | S | 0.840586 | P | 0.831411 | 0.009175 | No Change: Both D | A glioblastoma cell line |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 339 | T | 0.94425 | A | 0.937447 | 0.006803 | No Change: Both D | A breast cancer sample |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 816 | D | 0.983384 | Y | 0.964725 | 0.018659 | No Change: Both D | A breast cancer sample |
| Q99490 | AGAP2_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 | 1124 | G | 0.336905 | V | 0.220156 | 0.116749 | No Change: Both O | - |
| Q96P64 | AGAP4_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 4 OS=Homo sapiens GN=AGAP4 PE=2 SV=2 | 661 | K | 0.636137 | E | 0.647067 | -0.01093 | No Change: Both D | - |
| Q5SRD3 | AGAP8_HUMAN Arf-GAP with GTPase ANK repeat and PH domain-containing protein 8 OS=Homo sapiens GN=AGAP8 PE=2 SV=1 | 567 | Q | 0.217051 | H | 0.177199 | 0.039852 | No Change: Both O | - |
| Q96MI9 | CBPC4_HUMAN Cytosolic carboxypeptidase 4 OS=Homo sapiens GN=AGBL1 PE=2 SV=2 | 417 | P | 0.662981 | L | 0.489211 | 0.17377 | D to O | - |
| Q96MI9 | CBPC4_HUMAN Cytosolic carboxypeptidase 4 OS=Homo sapiens GN=AGBL1 PE=2 SV=2 | 435 | S | 0.488033 | P | 0.469621 | 0.018412 | No Change: Both O | - |
| Q96MI9 | CBPC4_HUMAN Cytosolic carboxypeptidase 4 OS=Homo sapiens GN=AGBL1 PE=2 SV=2 | 1010 | Q | 0.408792 | R | 0.370816 | 0.037976 | No Change: Both O | - |
| Q5U5Z8 | CBPC2_HUMAN Cytosolic carboxypeptidase 2 OS=Homo sapiens GN=AGBL2 PE=2 SV=2 | 349 | R | 0.298724 | H | 0.282176 | 0.016548 | No Change: Both O | - |
| Q5U5Z8 | CBPC2_HUMAN Cytosolic carboxypeptidase 2 OS=Homo sapiens GN=AGBL2 PE=2 SV=2 | 90 | I | 0.329067 | R | 0.456588 | -0.127521 | No Change: Both O | - |
| Q5U5Z8 | CBPC2_HUMAN Cytosolic carboxypeptidase 2 OS=Homo sapiens GN=AGBL2 PE=2 SV=2 | 333 | T | 0.266007 | P | 0.339448 | -0.073441 | No Change: Both O | - |
| Q5U5Z8 | CBPC2_HUMAN Cytosolic carboxypeptidase 2 OS=Homo sapiens GN=AGBL2 PE=2 SV=2 | 368 | D | 0.555298 | G | 0.529197 | 0.026101 | No Change: Both D | - |
| Q5U5Z8 | CBPC2_HUMAN Cytosolic carboxypeptidase 2 OS=Homo sapiens GN=AGBL2 PE=2 SV=2 | 671 | M | 0.274259 | I | 0.203385 | 0.070874 | No Change: Both O | - |
| Q8NEM8 | CBPC3_HUMAN Cytosolic carboxypeptidase 3 OS=Homo sapiens GN=AGBL3 PE=2 SV=2 | 45 | F | 0.303003 | Y | 0.294499 | 0.008504 | No Change: Both O | - |
| Q8NEM8 | CBPC3_HUMAN Cytosolic carboxypeptidase 3 OS=Homo sapiens GN=AGBL3 PE=2 SV=2 | 122 | E | 0.518205 | Q | 0.452943 | 0.065262 | D to O | - |
| Q8NEM8 | CBPC3_HUMAN Cytosolic carboxypeptidase 3 OS=Homo sapiens GN=AGBL3 PE=2 SV=2 | 360 | T | 0.211668 | I | 0.125745 | 0.085923 | No Change: Both O | - |
| Q5VU57 | CBPC6_HUMAN Cytosolic carboxypeptidase 6 OS=Homo sapiens GN=AGBL4 PE=2 SV=3 | 443 | V | 0.253523 | M | 0.31151 | -0.057987 | No Change: Both O | - |
| Q8NDL9 | CBPC5_HUMAN Cytosolic carboxypeptidase-like protein 5 OS=Homo sapiens GN=AGBL5 PE=2 SV=1 | 649 | G | 0.990195 | D | 0.988424 | 0.001771 | No Change: Both D | - |
| Q15109 | RAGE_HUMAN Advanced glycosylation end product-specific receptor OS=Homo sapiens GN=AGER PE=1 SV=1 | 100 | Q | 0.221586 | R | 0.222207 | -6.21E-04 | No Change: Both O | - |
| Q15109 | RAGE_HUMAN Advanced glycosylation end product-specific receptor OS=Homo sapiens GN=AGER PE=1 SV=1 | 82 | G | 0.215826 | S | 0.262077 | -0.046251 | No Change: Both O | - |
| O95081 | AGFG2_HUMAN Arf-GAP domain and FG repeats-containing protein 2 OS=Homo sapiens GN=AGFG2 PE=1 SV=2 | 365 | T | 0.890263 | N | 0.890107 | 1.56E-04 | No Change: Both D | - |
| Q8N302 | AGGF1_HUMAN Angiogenic factor with G patch and FHA domains 1 OS=Homo sapiens GN=AGGF1 PE=1 SV=2 | 133 | E | 0.519297 | K | 0.525813 | -0.006516 | No Change: Both D | Klippel-Trenaunay syndrome (KTS) [MIM:149000] |
| Q8N302 | AGGF1_HUMAN Angiogenic factor with G patch and FHA domains 1 OS=Homo sapiens GN=AGGF1 PE=1 SV=2 | 698 | P | 0.885296 | T | 0.85775 | 0.027546 | No Change: Both D | - |
| Q8N302 | AGGF1_HUMAN Angiogenic factor with G patch and FHA domains 1 OS=Homo sapiens GN=AGGF1 PE=1 SV=2 | 180 | T | 0.806598 | A | 0.801392 | 0.005206 | No Change: Both D | - |
| Q8N302 | AGGF1_HUMAN Angiogenic factor with G patch and FHA domains 1 OS=Homo sapiens GN=AGGF1 PE=1 SV=2 | 471 | L | 0.320756 | P | 0.469083 | -0.148327 | No Change: Both O | - |
| Q53H12 | AGK_HUMAN Acylglycerol kinase mitochondrial OS=Homo sapiens GN=AGK PE=1 SV=2 | 3 | V | 0.542576 | M | 0.641521 | -0.098945 | No Change: Both D | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1115 | G | 0.078819 | R | 0.077495 | 0.001324 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1448 | G | 0.157853 | R | 0.138924 | 0.018929 | No Change: Both O | Glycogen storage disease type 3 (GSD3) [MIM:232400] |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 387 | R | 0.479279 | Q | 0.51419 | -0.034911 | O to D | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1343 | E | 0.552671 | K | 0.553501 | -8.30E-04 | No Change: Both D | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1067 | P | 0.180365 | S | 0.194988 | -0.014623 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 229 | Q | 0.345757 | R | 0.324561 | 0.021196 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 701 | A | 0.114892 | S | 0.179483 | -0.064591 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1144 | I | 0.12914 | N | 0.279038 | -0.149898 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1253 | R | 0.350149 | H | 0.267458 | 0.082691 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1487 | R | 0.221044 | G | 0.223432 | -0.002388 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 38 | T | 0.277345 | A | 0.248222 | 0.029123 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 962 | S | 0.169598 | C | 0.066082 | 0.103516 | No Change: Both O | - |
| P35573 | GDE_HUMAN Glycogen debranching enzyme OS=Homo sapiens GN=AGL PE=1 SV=3 | 1207 | A | 0.515293 | T | 0.542595 | -0.027302 | No Change: Both D | - |
| Q9BSE5 | SPEB_HUMAN Agmatinase mitochondrial OS=Homo sapiens GN=AGMAT PE=1 SV=2 | 105 | G | 0.429045 | R | 0.434878 | -0.005833 | No Change: Both O | - |
| Q9BSE5 | SPEB_HUMAN Agmatinase mitochondrial OS=Homo sapiens GN=AGMAT PE=1 SV=2 | 140 | R | 0.25034 | Q | 0.273458 | -0.023118 | No Change: Both O | - |
| Q6ZNB7 | ALKMO_HUMAN Alkylglycerol monooxygenase OS=Homo sapiens GN=AGMO PE=1 SV=1 | 279 | F | 0.041344 | L | 0.045443 | -0.004099 | No Change: Both O | - |
| Q6ZNB7 | ALKMO_HUMAN Alkylglycerol monooxygenase OS=Homo sapiens GN=AGMO PE=1 SV=1 | 280 | S | 0.03963 | Y | 0.016491 | 0.023139 | No Change: Both O | - |
| Q99943 | PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens GN=AGPAT1 PE=2 SV=2 | 30 | P | 0.112999 | S | 0.134676 | -0.021677 | No Change: Both O | - |
| O15120 | PLCB_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase beta OS=Homo sapiens GN=AGPAT2 PE=1 SV=1 | 239 | A | 0.276783 | V | 0.212112 | 0.064671 | No Change: Both O | Congenital generalized lipodystrophy type 1 (CGL1) [MIM:608594] |
| O15120 | PLCB_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase beta OS=Homo sapiens GN=AGPAT2 PE=1 SV=1 | 228 | L | 0.220148 | P | 0.387183 | -0.167035 | No Change: Both O | Congenital generalized lipodystrophy type 1 (CGL1) [MIM:608594] |
| O15120 | PLCB_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase beta OS=Homo sapiens GN=AGPAT2 PE=1 SV=1 | 136 | G | 0.035146 | R | 0.033955 | 0.001191 | No Change: Both O | Congenital generalized lipodystrophy type 1 (CGL1) [MIM:608594] |
| Q9NUQ2 | PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens GN=AGPAT5 PE=1 SV=3 | 77 | Y | 0.137779 | C | 0.110716 | 0.027063 | No Change: Both O | - |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 419 | R | 0.252238 | H | 0.239745 | 0.012493 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 309 | T | 0.30818 | I | 0.182764 | 0.125416 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 469 | L | 0.184575 | P | 0.305565 | -0.12099 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 182 | R | 0.44667 | Q | 0.4674 | -0.02073 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 471 | E | 0.264823 | K | 0.264983 | -1.60E-04 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00116 | ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase peroxisomal OS=Homo sapiens GN=AGPS PE=1 SV=1 | 568 | T | 0.186247 | M | 0.142261 | 0.043986 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 3 (RCDP3) [MIM:600121] |
| O00468 | AGRIN_HUMAN Agrin OS=Homo sapiens GN=AGRN PE=1 SV=4 | 1666 | V | 0.127007 | I | 0.102374 | 0.024633 | No Change: Both O | - |
| O00253 | AGRP_HUMAN Agouti-related protein OS=Homo sapiens GN=AGRP PE=1 SV=1 | 67 | A | 0.879224 | T | 0.879661 | -4.37E-04 | No Change: Both D | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 207 | T | 0.137209 | M | 0.109069 | 0.02814 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 242 | T | 0.248441 | I | 0.147296 | 0.101145 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 244 | L | 0.258466 | R | 0.371623 | -0.113157 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 268 | M | 0.288179 | T | 0.356724 | -0.068545 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 281 | Y | 0.127357 | C | 0.109641 | 0.017716 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 392 | L | 0.284886 | M | 0.319434 | -0.034548 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 43 | L | 0.115793 | F | 0.109844 | 0.005949 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 98 | E | 0.522327 | K | 0.545651 | -0.023324 | No Change: Both D | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 268 | M | 0.288179 | I | 0.210285 | 0.077894 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 137 | T | 0.247932 | M | 0.191057 | 0.056875 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 335 | P | 0.214821 | S | 0.25114 | -0.036319 | No Change: Both O | - |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 375 | R | 0.340091 | Q | 0.371762 | -0.031671 | No Change: Both O | Renal tubular dysgenesis (RTD) [MIM:267430] |
| P01019 | ANGT_HUMAN Angiotensinogen OS=Homo sapiens GN=AGT PE=1 SV=1 | 114 | G | 0.073957 | C | 0.028897 | 0.04506 | No Change: Both O | - |
| Q9UPW5 | CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens GN=AGTPBP1 PE=1 SV=3 | 423 | E | 0.407584 | K | 0.405638 | 0.001946 | No Change: Both O | A colorectal cancer sample |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 48 | L | 0.026584 | V | 0.03085 | -0.004266 | No Change: Both O | - |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 289 | C | 0.02463 | W | 0.019893 | 0.004737 | No Change: Both O | - |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 336 | T | 0.837601 | P | 0.8778 | -0.040199 | No Change: Both D | - |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 163 | A | 0.106973 | T | 0.111338 | -0.004365 | No Change: Both O | - |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 244 | A | 0.009376 | S | 0.016306 | -0.00693 | No Change: Both O | - |
| P30556 | AGTR1_HUMAN Type-1 angiotensin II receptor OS=Homo sapiens GN=AGTR1 PE=1 SV=1 | 282 | T | 0.096256 | M | 0.078104 | 0.018152 | No Change: Both O | Renal tubular dysgenesis (RTD) [MIM:267430] |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 248 | R | 0.476373 | K | 0.561253 | -0.08488 | O to D | - |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 268 | C | 0.005206 | W | 0.004681 | 5.25E-04 | No Change: Both O | - |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 231 | Y | 0.02366 | H | 0.044738 | -0.021078 | No Change: Both O | - |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 21 | G | 0.337017 | V | 0.210185 | 0.126832 | No Change: Both O | Mental retardation X-linked type 88 (MRX88) [MIM:300852] |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 324 | R | 0.138386 | Q | 0.153334 | -0.014948 | No Change: Both O | Mental retardation X-linked type 88 (MRX88) [MIM:300852] |
| P50052 | AGTR2_HUMAN Type-2 angiotensin II receptor OS=Homo sapiens GN=AGTR2 PE=1 SV=1 | 337 | I | 0.237576 | V | 0.306413 | -0.068837 | No Change: Both O | Mental retardation X-linked type 88 (MRX88) [MIM:300852] |
| Q6RW13 | ATRAP_HUMAN Type-1 angiotensin II receptor-associated protein OS=Homo sapiens GN=AGTRAP PE=1 SV=1 | 143 | A | 0.683558 | V | 0.583032 | 0.100526 | No Change: Both D | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 11 | P | 0.775397 | L | 0.618494 | 0.156903 | No Change: Both D | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 41 | G | 0.490177 | R | 0.49016 | 1.70E-05 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 152 | F | 0.244872 | I | 0.235699 | 0.009173 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 170 | G | 0.187529 | R | 0.180806 | 0.006723 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 187 | S | 0.245384 | F | 0.101605 | 0.143779 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 205 | S | 0.3665 | P | 0.340624 | 0.025876 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 340 | I | 0.063024 | M | 0.091053 | -0.028029 | No Change: Both O | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 82 | G | 0.22849 | E | 0.276871 | -0.048381 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 233 | R | 0.596207 | C | 0.466515 | 0.129692 | D to O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 233 | R | 0.596207 | H | 0.598567 | -0.00236 | No Change: Both D | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 244 | I | 0.056958 | T | 0.104489 | -0.047531 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 41 | G | 0.490177 | V | 0.329061 | 0.161116 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 116 | G | 0.303431 | R | 0.297632 | 0.005799 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 156 | G | 0.402209 | R | 0.374264 | 0.027945 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 183 | D | 0.134943 | N | 0.124431 | 0.010512 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 22 | N | 0.764888 | S | 0.820313 | -0.055425 | No Change: Both D | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 295 | A | 0.395592 | T | 0.400755 | -0.005163 | No Change: Both O | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 9 | T | 0.78413 | N | 0.838427 | -0.054297 | No Change: Both D | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 82 | G | 0.22849 | R | 0.2045 | 0.02399 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 108 | W | 0.126307 | R | 0.283863 | -0.157556 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 112 | A | 0.173602 | D | 0.241415 | -0.067813 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 153 | L | 0.275457 | V | 0.266145 | 0.009312 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 158 | S | 0.472265 | L | 0.308094 | 0.164171 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 161 | G | 0.487802 | R | 0.456587 | 0.031215 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 173 | C | 0.100994 | Y | 0.120645 | -0.019651 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 190 | G | 0.33183 | R | 0.312333 | 0.019497 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 195 | M | 0.240753 | R | 0.307103 | -0.06635 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 201 | D | 0.278115 | E | 0.280194 | -0.002079 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 218 | S | 0.512477 | L | 0.31171 | 0.200767 | D to O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 233 | R | 0.596207 | L | 0.506669 | 0.089538 | No Change: Both D | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 243 | D | 0.066345 | H | 0.051166 | 0.015179 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 253 | C | 0.152125 | R | 0.267363 | -0.115238 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 279 | I | 0.279158 | M | 0.377057 | -0.097899 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 279 | I | 0.279158 | T | 0.425999 | -0.146841 | No Change: Both O | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 280 | A | 0.305158 | V | 0.218393 | 0.086765 | No Change: Both O | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 287 | S | 0.511961 | T | 0.424762 | 0.087199 | D to O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 289 | R | 0.476551 | C | 0.283077 | 0.193474 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 298 | L | 0.292079 | P | 0.429352 | -0.137273 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 326 | V | 0.150851 | I | 0.122093 | 0.028758 | No Change: Both O | - |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 336 | V | 0.079025 | D | 0.168961 | -0.089936 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| P21549 | SPYA_HUMAN Serine--pyruvate aminotransferase OS=Homo sapiens GN=AGXT PE=1 SV=1 | 350 | G | 0.342379 | D | 0.359639 | -0.01726 | No Change: Both O | Hyperoxaluria primary type 1 (HP1) [MIM:259900] |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 140 | V | 0.194808 | I | 0.170739 | 0.024069 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 212 | T | 0.311039 | I | 0.178985 | 0.132054 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 102 | S | 0.209929 | N | 0.172669 | 0.03726 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 498 | V | 0.198721 | L | 0.190048 | 0.008673 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 132 | G | 0.233469 | R | 0.235425 | -0.001956 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 492 | P | 0.249545 | R | 0.223448 | 0.026097 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 102 | S | 0.209929 | I | 0.081335 | 0.128594 | No Change: Both O | - |
| Q9BYV1 | AGT2_HUMAN Alanine--glyoxylate aminotransferase 2 mitochondrial OS=Homo sapiens GN=AGXT2 PE=1 SV=1 | 102 | S | 0.209929 | T | 0.146166 | 0.063763 | No Change: Both O | - |
| Q8TBG4 | AT2L1_HUMAN Alanine--glyoxylate aminotransferase 2-like 1 OS=Homo sapiens GN=AGXT2L1 PE=2 SV=1 | 185 | S | 0.65767 | P | 0.638365 | 0.019305 | No Change: Both D | - |
| Q8IUZ5 | AT2L2_HUMAN Alanine--glyoxylate aminotransferase 2-like 2 OS=Homo sapiens GN=AGXT2L2 PE=2 SV=1 | 126 | H | 0.249874 | R | 0.252098 | -0.002224 | No Change: Both O | - |
| Q8WYP5 | ELYS_HUMAN Protein ELYS OS=Homo sapiens GN=AHCTF1 PE=1 SV=3 | 874 | N | 0.386429 | S | 0.451667 | -0.065238 | No Change: Both O | - |
| Q8WYP5 | ELYS_HUMAN Protein ELYS OS=Homo sapiens GN=AHCTF1 PE=1 SV=3 | 2185 | L | 0.96041 | V | 0.957844 | 0.002566 | No Change: Both D | - |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 86 | D | 0.347756 | N | 0.344544 | 0.003212 | No Change: Both O | - |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 38 | R | 0.598774 | W | 0.353194 | 0.24558 | D to O | - |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 49 | R | 0.288747 | C | 0.180608 | 0.108139 | No Change: Both O | Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752] |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 86 | D | 0.347756 | G | 0.31945 | 0.028306 | No Change: Both O | Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752] |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 89 | A | 0.346631 | V | 0.23695 | 0.109681 | No Change: Both O | Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752] |
| P23526 | SAHH_HUMAN Adenosylhomocysteinase OS=Homo sapiens GN=AHCY PE=1 SV=4 | 143 | Y | 0.241223 | C | 0.204094 | 0.037129 | No Change: Both O | Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD) [MIM:613752] |
| Q5TGY3 | AHDC1_HUMAN AT-hook DNA-binding motif-containing protein 1 OS=Homo sapiens GN=AHDC1 PE=1 SV=1 | 935 | A | 0.850115 | T | 0.855693 | -0.005578 | No Change: Both D | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 443 | V | 0.213368 | D | 0.341932 | -0.128564 | No Change: Both O | Joubert syndrome type 3 (JBTS3) [MIM:608629] |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 49 | I | 0.896355 | N | 0.935013 | -0.038658 | No Change: Both D | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 548 | R | 0.486361 | H | 0.464634 | 0.021727 | No Change: Both O | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 723 | R | 0.080731 | Q | 0.084569 | -0.003838 | No Change: Both O | Joubert syndrome type 3 (JBTS3) [MIM:608629] |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 761 | S | 0.390058 | L | 0.204048 | 0.18601 | No Change: Both O | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 830 | R | 0.075623 | W | 0.026321 | 0.049302 | No Change: Both O | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 856 | T | 0.153806 | S | 0.210372 | -0.056566 | No Change: Both O | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 933 | Y | 0.285751 | C | 0.247961 | 0.03779 | No Change: Both O | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 1018 | Q | 0.715732 | P | 0.711027 | 0.004705 | No Change: Both D | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 1123 | S | 0.917505 | F | 0.869755 | 0.04775 | No Change: Both D | - |
| Q8N157 | AHI1_HUMAN Jouberin OS=Homo sapiens GN=AHI1 PE=1 SV=1 | 1140 | P | 0.990806 | S | 0.991257 | -4.51E-04 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 962 | G | 0.867722 | V | 0.830477 | 0.037245 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 2114 | A | 0.904209 | T | 0.917583 | -0.013374 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 2439 | P | 0.900637 | L | 0.825442 | 0.075195 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 3003 | Q | 0.759044 | K | 0.793339 | -0.034295 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 3190 | V | 0.851751 | I | 0.827726 | 0.024025 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 3724 | S | 0.852145 | P | 0.881976 | -0.029831 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 4561 | G | 0.908573 | D | 0.921438 | -0.012865 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 4611 | M | 0.869467 | V | 0.835904 | 0.033563 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 4613 | I | 0.867971 | V | 0.888016 | -0.020045 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 4631 | D | 0.848593 | G | 0.813491 | 0.035102 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 5415 | T | 0.674884 | A | 0.690037 | -0.015153 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 2247 | K | 0.87697 | T | 0.805876 | 0.071094 | No Change: Both D | - |
| Q09666 | AHNK_HUMAN Neuroblast differentiation-associated protein AHNAK OS=Homo sapiens GN=AHNAK PE=1 SV=2 | 4304 | D | 0.840591 | G | 0.813083 | 0.027508 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 1266 | V | 0.761148 | M | 0.807265 | -0.046117 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 1470 | L | 0.863871 | V | 0.862852 | 0.001019 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2115 | S | 0.777639 | R | 0.756591 | 0.021048 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2429 | D | 0.900914 | E | 0.89708 | 0.003834 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2430 | L | 0.893108 | V | 0.898886 | -0.005778 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2616 | V | 0.806613 | A | 0.848095 | -0.041482 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5028 | L | 0.933787 | M | 0.954075 | -0.020288 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5564 | G | 0.786085 | R | 0.77186 | 0.014225 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 525 | T | 0.955791 | A | 0.953274 | 0.002517 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2107 | M | 0.879656 | V | 0.853159 | 0.026497 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2410 | K | 0.903671 | R | 0.859045 | 0.044626 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3796 | V | 0.853426 | L | 0.86436 | -0.010934 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3961 | M | 0.899685 | V | 0.86297 | 0.036715 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4071 | I | 0.894755 | M | 0.946806 | -0.052051 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4138 | F | 0.904009 | L | 0.908776 | -0.004767 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4232 | K | 0.91529 | N | 0.867479 | 0.047811 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4278 | V | 0.833229 | A | 0.863544 | -0.030315 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4536 | M | 0.70443 | L | 0.662946 | 0.041484 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4664 | T | 0.58604 | A | 0.520021 | 0.066019 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5072 | G | 0.811959 | R | 0.812017 | -5.80E-05 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5184 | Y | 0.873263 | D | 0.933098 | -0.059835 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5397 | P | 0.548089 | A | 0.448093 | 0.099996 | D to O | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5732 | T | 0.895618 | M | 0.878885 | 0.016733 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 1856 | E | 0.733651 | D | 0.728961 | 0.00469 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2146 | L | 0.764019 | V | 0.743655 | 0.020364 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2503 | E | 0.86205 | A | 0.839092 | 0.022958 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 2862 | R | 0.600487 | S | 0.693228 | -0.092741 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3176 | D | 0.72023 | E | 0.736724 | -0.016494 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3177 | L | 0.695807 | V | 0.698351 | -0.002544 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3336 | P | 0.855768 | L | 0.762195 | 0.093573 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3363 | V | 0.618363 | A | 0.664802 | -0.046439 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3793 | D | 0.847061 | N | 0.790183 | 0.056878 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3869 | M | 0.576545 | V | 0.509433 | 0.067112 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3902 | K | 0.862409 | N | 0.79163 | 0.070779 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4085 | A | 0.858798 | V | 0.839834 | 0.018964 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4198 | D | 0.821037 | N | 0.774893 | 0.046144 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4326 | L | 0.734854 | P | 0.831636 | -0.096782 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 4478 | P | 0.910171 | L | 0.84761 | 0.062561 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 1298 | M | 0.636838 | I | 0.515267 | 0.121571 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 3654 | G | 0.932622 | E | 0.949607 | -0.016985 | No Change: Both D | - |
| Q8IVF2 | AHNK2_HUMAN Protein AHNAK2 OS=Homo sapiens GN=AHNAK2 PE=1 SV=2 | 5139 | G | 0.900716 | E | 0.915563 | -0.014847 | No Change: Both D | - |
| P35869 | AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens GN=AHR PE=1 SV=2 | 554 | R | 0.325983 | K | 0.394971 | -0.068988 | No Change: Both O | - |
| P35869 | AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens GN=AHR PE=1 SV=2 | 570 | V | 0.354725 | I | 0.355806 | -0.001081 | No Change: Both O | - |
| P35869 | AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens GN=AHR PE=1 SV=2 | 517 | P | 0.559537 | S | 0.579007 | -0.01947 | No Change: Both D | - |
| P35869 | AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens GN=AHR PE=1 SV=2 | 786 | M | 0.508418 | V | 0.450664 | 0.057754 | D to O | - |
| A9YTQ3 | AHRR_HUMAN Aryl hydrocarbon receptor repressor OS=Homo sapiens GN=AHRR PE=2 SV=3 | 114 | L | 0.356633 | P | 0.501507 | -0.144874 | O to D | - |
| A9YTQ3 | AHRR_HUMAN Aryl hydrocarbon receptor repressor OS=Homo sapiens GN=AHRR PE=2 SV=3 | 189 | P | 0.510563 | A | 0.395274 | 0.115289 | D to O | - |
| A9YTQ3 | AHRR_HUMAN Aryl hydrocarbon receptor repressor OS=Homo sapiens GN=AHRR PE=2 SV=3 | 373 | G | 0.862328 | V | 0.80873 | 0.053598 | No Change: Both D | - |
| A9YTQ3 | AHRR_HUMAN Aryl hydrocarbon receptor repressor OS=Homo sapiens GN=AHRR PE=2 SV=3 | 627 | D | 0.92404 | H | 0.934466 | -0.010426 | No Change: Both D | - |
| Q719I0 | AHSA2_HUMAN Activator of 90 kDa heat shock protein ATPase homolog 2 OS=Homo sapiens GN=AHSA2 PE=2 SV=2 | 248 | M | 0.107101 | T | 0.133184 | -0.026083 | No Change: Both O | A breast cancer sample |
| P02765 | FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 | 248 | T | 0.510853 | M | 0.441052 | 0.069801 | D to O | - |
| P02765 | FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 | 256 | T | 0.808312 | S | 0.824633 | -0.016321 | No Change: Both D | - |
| P02765 | FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 | 276 | D | 0.987162 | N | 0.985709 | 0.001453 | No Change: Both D | - |
| P02765 | FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 | 317 | R | 0.530303 | C | 0.398147 | 0.132156 | D to O | - |
| P02765 | FETUA_HUMAN Alpha-2-HS-glycoprotein OS=Homo sapiens GN=AHSG PE=1 SV=1 | 142 | V | 0.558112 | L | 0.554309 | 0.003803 | No Change: Both D | - |
| Q9NZD4 | AHSP_HUMAN Alpha-hemoglobin-stabilizing protein OS=Homo sapiens GN=AHSP PE=1 SV=1 | 100 | P | 0.904958 | T | 0.862141 | 0.042817 | No Change: Both D | - |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 24 | R | 0.201023 | W | 0.086296 | 0.114727 | No Change: Both O | Immunodeficiency with hyper-IgM type 2 (HIGM2) [MIM:605258] |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 80 | W | 0.054422 | R | 0.138103 | -0.083681 | No Change: Both O | Immunodeficiency with hyper-IgM type 2 (HIGM2) [MIM:605258] |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 106 | L | 0.164143 | P | 0.291203 | -0.12706 | No Change: Both O | Immunodeficiency with hyper-IgM type 2 (HIGM2) [MIM:605258] |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 139 | M | 0.049198 | V | 0.039407 | 0.009791 | No Change: Both O | Immunodeficiency with hyper-IgM type 2 (HIGM2) [MIM:605258] |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 151 | F | 0.105133 | S | 0.230615 | -0.125482 | No Change: Both O | Immunodeficiency with hyper-IgM type 2 (HIGM2) [MIM:605258] |
| Q9GZX7 | AICDA_HUMAN Activation-induced cytidine deaminase OS=Homo sapiens GN=AICDA PE=1 SV=1 | 25 | R | 0.174963 | C | 0.091051 | 0.083912 | No Change: Both O | - |
| P55008 | AIF1_HUMAN Allograft inflammatory factor 1 OS=Homo sapiens GN=AIF1 PE=1 SV=1 | 14 | G | 0.732569 | R | 0.765707 | -0.033138 | No Change: Both D | - |
| Q9BRQ8 | AIFM2_HUMAN Apoptosis-inducing factor 2 OS=Homo sapiens GN=AIFM2 PE=1 SV=1 | 135 | M | 0.35072 | T | 0.391563 | -0.040843 | No Change: Both O | - |
| Q9BRQ8 | AIFM2_HUMAN Apoptosis-inducing factor 2 OS=Homo sapiens GN=AIFM2 PE=1 SV=1 | 288 | D | 0.176962 | N | 0.158093 | 0.018869 | No Change: Both O | - |
| Q96NN9 | AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens GN=AIFM3 PE=1 SV=1 | 508 | S | 0.277739 | T | 0.225516 | 0.052223 | No Change: Both O | - |
| Q9NVV5 | AIG1_HUMAN Androgen-induced gene 1 protein OS=Homo sapiens GN=AIG1 PE=1 SV=2 | 151 | Q | 0.780761 | E | 0.818987 | -0.038226 | No Change: Both D | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 267 | G | 0.808029 | D | 0.828825 | -0.020796 | No Change: Both D | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 293 | Q | 0.846472 | P | 0.878534 | -0.032062 | No Change: Both D | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 491 | C | 0.734746 | R | 0.768608 | -0.033862 | No Change: Both D | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 1096 | L | 0.437134 | V | 0.424023 | 0.013111 | No Change: Both O | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 1196 | E | 0.281844 | A | 0.18948 | 0.092364 | No Change: Both O | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 1395 | C | 0.318594 | Y | 0.360454 | -0.04186 | No Change: Both O | - |
| Q9Y4K1 | AIM1_HUMAN Absent in melanoma 1 protein OS=Homo sapiens GN=AIM1 PE=1 SV=3 | 1445 | T | 0.622733 | S | 0.698238 | -0.075505 | No Change: Both D | - |
| Q8N1P7 | AIM1L_HUMAN Absent in melanoma 1-like protein OS=Homo sapiens GN=AIM1L PE=2 SV=1 | 249 | S | 0.466056 | N | 0.417622 | 0.048434 | No Change: Both O | - |
| O14862 | AIM2_HUMAN Interferon-inducible protein AIM2 OS=Homo sapiens GN=AIM2 PE=1 SV=1 | 32 | E | 0.188305 | K | 0.200056 | -0.011751 | No Change: Both O | - |
| O14862 | AIM2_HUMAN Interferon-inducible protein AIM2 OS=Homo sapiens GN=AIM2 PE=1 SV=1 | 304 | C | 0.637273 | Y | 0.606388 | 0.030885 | No Change: Both D | - |
| Q12904 | AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens GN=AIMP1 PE=1 SV=2 | 79 | P | 0.557658 | A | 0.451963 | 0.105695 | D to O | - |
| Q12904 | AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens GN=AIMP1 PE=1 SV=2 | 104 | T | 0.800466 | A | 0.768757 | 0.031709 | No Change: Both D | - |
| Q12904 | AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens GN=AIMP1 PE=1 SV=2 | 117 | T | 0.948581 | A | 0.940355 | 0.008226 | No Change: Both D | - |
| Q13155 | AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens GN=AIMP2 PE=1 SV=2 | 129 | A | 0.419969 | G | 0.45942 | -0.039451 | No Change: Both O | - |
| Q13155 | AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens GN=AIMP2 PE=1 SV=2 | 166 | L | 0.311224 | I | 0.254967 | 0.056257 | No Change: Both O | - |
| Q13155 | AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens GN=AIMP2 PE=1 SV=2 | 92 | I | 0.264445 | V | 0.289853 | -0.025408 | No Change: Both O | A lung cancer cell line |
| Q13155 | AIMP2_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 OS=Homo sapiens GN=AIMP2 PE=1 SV=2 | 209 | G | 0.299364 | S | 0.340851 | -0.041487 | No Change: Both O | A lung cancer cell line |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 16 | R | 0.487 | H | 0.430996 | 0.056004 | No Change: Both O | - |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 228 | Q | 0.173564 | K | 0.191107 | -0.017543 | No Change: Both O | - |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 241 | K | 0.073144 | E | 0.081645 | -0.008501 | No Change: Both O | - |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 271 | R | 0.382186 | W | 0.19695 | 0.185236 | No Change: Both O | - |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 304 | R | 0.457837 | Q | 0.477482 | -0.019645 | No Change: Both O | - |
| O00170 | AIP_HUMAN AH receptor-interacting protein OS=Homo sapiens GN=AIP PE=1 SV=2 | 307 | Q | 0.480086 | R | 0.490851 | -0.010765 | No Change: Both O | - |
| Q9NZN9 | AIPL1_HUMAN Aryl-hydrocarbon-interacting protein-like 1 OS=Homo sapiens GN=AIPL1 PE=1 SV=2 | 239 | C | 0.078932 | R | 0.144054 | -0.065122 | No Change: Both O | Leber congenital amaurosis type 4 (LCA4) [MIM:604393] |
| Q9NZN9 | AIPL1_HUMAN Aryl-hydrocarbon-interacting protein-like 1 OS=Homo sapiens GN=AIPL1 PE=1 SV=2 | 90 | D | 0.063885 | H | 0.058718 | 0.005167 | No Change: Both O | - |
| Q9NZN9 | AIPL1_HUMAN Aryl-hydrocarbon-interacting protein-like 1 OS=Homo sapiens GN=AIPL1 PE=1 SV=2 | 33 | V | 0.110935 | A | 0.15123 | -0.040295 | No Change: Both O | - |
| Q9NZN9 | AIPL1_HUMAN Aryl-hydrocarbon-interacting protein-like 1 OS=Homo sapiens GN=AIPL1 PE=1 SV=2 | 134 | Y | 0.305063 | F | 0.267347 | 0.037716 | No Change: Both O | - |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 28 | L | 0.245859 | P | 0.388541 | -0.142682 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 83 | K | 0.090166 | E | 0.095281 | -0.005115 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 278 | S | 0.895648 | R | 0.89171 | 0.003938 | No Change: Both D | - |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 15 | R | 0.225931 | L | 0.135073 | 0.090858 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 16 | T | 0.236123 | M | 0.213957 | 0.022166 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 29 | L | 0.242234 | P | 0.389418 | -0.147184 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 78 | W | 0.032086 | R | 0.089669 | -0.057583 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 80 | V | 0.036547 | L | 0.043487 | -0.00694 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 85 | Y | 0.155434 | C | 0.130072 | 0.025362 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 90 | Y | 0.245341 | C | 0.212182 | 0.033159 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 93 | L | 0.267761 | R | 0.386089 | -0.118328 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 301 | V | 0.602337 | M | 0.679869 | -0.077532 | No Change: Both D | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 305 | G | 0.510422 | S | 0.561566 | -0.051144 | No Change: Both D | - |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 311 | C | 0.444283 | Y | 0.290317 | 0.153966 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 326 | P | 0.573608 | Q | 0.523284 | 0.050324 | No Change: Both D | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 228 | G | 0.574594 | W | 0.3501 | 0.224494 | D to O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 15 | R | 0.225931 | C | 0.104086 | 0.121845 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 21 | A | 0.208982 | V | 0.14639 | 0.062592 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 77 | F | 0.037081 | S | 0.099032 | -0.061951 | No Change: Both O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 252 | P | 0.947229 | L | 0.90286 | 0.044369 | No Change: Both D | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 326 | P | 0.573608 | L | 0.430876 | 0.142732 | D to O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| O43918 | AIRE_HUMAN Autoimmune regulator OS=Homo sapiens GN=AIRE PE=1 SV=1 | 539 | P | 0.530423 | L | 0.397327 | 0.133096 | D to O | Autoimmune poly-endocrinopathy candidiasis ectodermal dystrophy (APECED) [MIM:240300] |
| Q9UKB5 | AJAP1_HUMAN Adherens junction-associated protein 1 OS=Homo sapiens GN=AJAP1 PE=1 SV=1 | 263 | G | 0.793384 | R | 0.799873 | -0.006489 | No Change: Both D | - |
| P00568 | KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3 | 128 | R | 0.615562 | W | 0.354631 | 0.260931 | D to O | Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631] |
| P00568 | KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3 | 123 | E | 0.555122 | Q | 0.529891 | 0.025231 | No Change: Both D | - |
| P00568 | KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3 | 40 | G | 0.532219 | R | 0.531642 | 5.77E-04 | No Change: Both D | Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631] |
| P00568 | KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3 | 64 | G | 0.462352 | R | 0.467956 | -0.005604 | No Change: Both O | Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631] |
| P00568 | KAD1_HUMAN Adenylate kinase isoenzyme 1 OS=Homo sapiens GN=AK1 PE=1 SV=3 | 164 | Y | 0.172359 | C | 0.161398 | 0.010961 | No Change: Both O | Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631] |
| P54819 | KAD2_HUMAN Adenylate kinase 2 mitochondrial OS=Homo sapiens GN=AK2 PE=1 SV=2 | 209 | A | 0.456374 | T | 0.485874 | -0.0295 | No Change: Both O | - |
| P54819 | KAD2_HUMAN Adenylate kinase 2 mitochondrial OS=Homo sapiens GN=AK2 PE=1 SV=2 | 103 | R | 0.341562 | W | 0.147529 | 0.194033 | No Change: Both O | Reticular dysgenesis (RDYS) [MIM:267500] |
| P54819 | KAD2_HUMAN Adenylate kinase 2 mitochondrial OS=Homo sapiens GN=AK2 PE=1 SV=2 | 165 | D | 0.797437 | G | 0.769152 | 0.028285 | No Change: Both D | Reticular dysgenesis (RDYS) [MIM:267500] |
| Q9Y6K8 | KAD5_HUMAN Adenylate kinase isoenzyme 5 OS=Homo sapiens GN=AK5 PE=1 SV=2 | 465 | R | 0.366276 | Q | 0.398687 | -0.032411 | No Change: Both O | - |
| Q96M32 | KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens GN=AK7 PE=1 SV=3 | 102 | R | 0.330927 | Q | 0.334993 | -0.004066 | No Change: Both O | - |
| Q96M32 | KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens GN=AK7 PE=1 SV=3 | 389 | N | 0.294704 | K | 0.355639 | -0.060935 | No Change: Both O | - |
| Q96MA6 | KAD8_HUMAN Adenylate kinase 8 OS=Homo sapiens GN=AK8 PE=1 SV=1 | 5 | I | 0.724856 | T | 0.804126 | -0.07927 | No Change: Both D | - |
| Q96MA6 | KAD8_HUMAN Adenylate kinase 8 OS=Homo sapiens GN=AK8 PE=1 SV=1 | 130 | D | 0.241816 | G | 0.230975 | 0.010841 | No Change: Both O | - |
| Q92667 | AKAP1_HUMAN A-kinase anchor protein 1 mitochondrial OS=Homo sapiens GN=AKAP1 PE=1 SV=1 | 60 | V | 0.84806 | M | 0.855422 | -0.007362 | No Change: Both D | - |
| Q92667 | AKAP1_HUMAN A-kinase anchor protein 1 mitochondrial OS=Homo sapiens GN=AKAP1 PE=1 SV=1 | 18 | A | 0.025688 | V | 0.016259 | 0.009429 | No Change: Both O | - |
| Q92667 | AKAP1_HUMAN A-kinase anchor protein 1 mitochondrial OS=Homo sapiens GN=AKAP1 PE=1 SV=1 | 102 | C | 0.949009 | Y | 0.931181 | 0.017828 | No Change: Both D | - |
| Q92667 | AKAP1_HUMAN A-kinase anchor protein 1 mitochondrial OS=Homo sapiens GN=AKAP1 PE=1 SV=1 | 124 | R | 0.904661 | C | 0.864822 | 0.039839 | No Change: Both D | - |
| O43572 | AKA10_HUMAN A-kinase anchor protein 10 mitochondrial OS=Homo sapiens GN=AKAP10 PE=1 SV=2 | 249 | R | 0.828823 | H | 0.815768 | 0.013055 | No Change: Both D | - |
| O43572 | AKA10_HUMAN A-kinase anchor protein 10 mitochondrial OS=Homo sapiens GN=AKAP10 PE=1 SV=2 | 646 | I | 0.433617 | V | 0.449457 | -0.01584 | No Change: Both O | - |
| Q9UKA4 | AKA11_HUMAN A-kinase anchor protein 11 OS=Homo sapiens GN=AKAP11 PE=1 SV=1 | 721 | S | 0.419279 | C | 0.211203 | 0.208076 | No Change: Both O | - |
| Q9UKA4 | AKA11_HUMAN A-kinase anchor protein 11 OS=Homo sapiens GN=AKAP11 PE=1 SV=1 | 1070 | H | 0.627423 | R | 0.621142 | 0.006281 | No Change: Both D | - |
| Q9UKA4 | AKA11_HUMAN A-kinase anchor protein 11 OS=Homo sapiens GN=AKAP11 PE=1 SV=1 | 1410 | L | 0.833727 | F | 0.834721 | -9.94E-04 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 117 | K | 0.923448 | E | 0.932514 | -0.009066 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 216 | K | 0.963271 | Q | 0.957225 | 0.006046 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 920 | E | 0.728024 | G | 0.627272 | 0.100752 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 1096 | V | 0.890278 | I | 0.850028 | 0.04025 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 1296 | R | 0.641169 | L | 0.574484 | 0.066685 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 1355 | E | 0.89124 | K | 0.880575 | 0.010665 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 1600 | E | 0.98497 | D | 0.982257 | 0.002713 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 1689 | E | 0.907309 | D | 0.897225 | 0.010084 | No Change: Both D | - |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 240 | E | 0.995717 | K | 0.995395 | 3.22E-04 | No Change: Both D | A colorectal cancer sample |
| Q02952 | AKA12_HUMAN A-kinase anchor protein 12 OS=Homo sapiens GN=AKAP12 PE=1 SV=4 | 987 | A | 0.969414 | S | 0.975037 | -0.005623 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 452 | M | 0.782376 | T | 0.806117 | -0.023741 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 494 | W | 0.359265 | R | 0.597114 | -0.237849 | O to D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 574 | R | 0.927868 | C | 0.904251 | 0.023617 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 624 | G | 0.675333 | V | 0.572008 | 0.103325 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 689 | E | 0.900801 | K | 0.900435 | 3.66E-04 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 845 | V | 0.880308 | A | 0.926743 | -0.046435 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 897 | V | 0.679558 | M | 0.724448 | -0.04489 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 1062 | P | 0.844804 | A | 0.783466 | 0.061338 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 1086 | D | 0.524772 | N | 0.511651 | 0.013121 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 1216 | M | 0.908908 | T | 0.90652 | 0.002388 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 2457 | G | 0.556389 | S | 0.617751 | -0.061362 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 2801 | A | 0.967944 | T | 0.971918 | -0.003974 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 526 | K | 0.677511 | Q | 0.631848 | 0.045663 | No Change: Both D | - |
| Q12802 | AKP13_HUMAN A-kinase anchor protein 13 OS=Homo sapiens GN=AKAP13 PE=1 SV=2 | 1525 | S | 0.950907 | G | 0.939754 | 0.011153 | No Change: Both D | - |
| Q02040 | AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens GN=AKAP17A PE=1 SV=2 | 194 | P | 0.388845 | S | 0.398809 | -0.009964 | No Change: Both O | - |
| Q9Y2D5 | AKAP2_HUMAN A-kinase anchor protein 2 OS=Homo sapiens GN=AKAP2 PE=1 SV=3 | 561 | L | 0.561278 | S | 0.686892 | -0.125614 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 831 | R | 0.520969 | C | 0.337938 | 0.183031 | D to O | A colorectal cancer sample |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 118 | G | 0.498571 | E | 0.522144 | -0.023573 | O to D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 500 | I | 0.634191 | T | 0.732272 | -0.098081 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 661 | I | 0.519572 | T | 0.642571 | -0.122999 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 700 | S | 0.732688 | F | 0.574456 | 0.158232 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 725 | S | 0.459186 | L | 0.331794 | 0.127392 | No Change: Both O | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 700 | S | 0.732688 | P | 0.704771 | 0.027917 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 464 | T | 0.561482 | S | 0.61099 | -0.049508 | No Change: Both D | - |
| O75969 | AKAP3_HUMAN A-kinase anchor protein 3 OS=Homo sapiens GN=AKAP3 PE=1 SV=2 | 525 | E | 0.256949 | K | 0.251153 | 0.005796 | No Change: Both O | - |
| Q5JQC9 | AKAP4_HUMAN A-kinase anchor protein 4 OS=Homo sapiens GN=AKAP4 PE=1 SV=1 | 673 | A | 0.940956 | G | 0.944943 | -0.003987 | No Change: Both D | - |
| Q5JQC9 | AKAP4_HUMAN A-kinase anchor protein 4 OS=Homo sapiens GN=AKAP4 PE=1 SV=1 | 233 | H | 0.464172 | R | 0.492712 | -0.02854 | No Change: Both O | - |
| P24588 | AKAP5_HUMAN A-kinase anchor protein 5 OS=Homo sapiens GN=AKAP5 PE=1 SV=3 | 100 | P | 0.94934 | L | 0.918952 | 0.030388 | No Change: Both D | - |
| P24588 | AKAP5_HUMAN A-kinase anchor protein 5 OS=Homo sapiens GN=AKAP5 PE=1 SV=3 | 314 | E | 0.970116 | K | 0.968097 | 0.002019 | No Change: Both D | - |
| P24588 | AKAP5_HUMAN A-kinase anchor protein 5 OS=Homo sapiens GN=AKAP5 PE=1 SV=3 | 203 | T | 0.780813 | I | 0.701062 | 0.079751 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 337 | A | 0.977816 | V | 0.970909 | 0.006907 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 408 | N | 0.877514 | S | 0.892642 | -0.015128 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1492 | A | 0.665941 | V | 0.637992 | 0.027949 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 2035 | N | 0.592658 | D | 0.603725 | -0.011067 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 2171 | F | 0.948895 | Y | 0.93317 | 0.015725 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 2209 | D | 0.953532 | H | 0.930665 | 0.022867 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 910 | K | 0.55727 | M | 0.458741 | 0.098529 | D to O | A breast cancer sample |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1192 | M | 0.6239 | I | 0.573092 | 0.050808 | No Change: Both D | A breast cancer sample |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1702 | E | 0.801821 | Q | 0.745942 | 0.055879 | No Change: Both D | A breast cancer sample |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1839 | P | 0.939169 | T | 0.941323 | -0.002154 | No Change: Both D | A colorectal cancer sample |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 558 | N | 0.93508 | D | 0.922542 | 0.012538 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 892 | E | 0.255414 | K | 0.259488 | -0.004074 | No Change: Both O | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1516 | T | 0.716893 | A | 0.693575 | 0.023318 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 1522 | V | 0.647619 | I | 0.65712 | -0.009501 | No Change: Both D | - |
| Q13023 | AKAP6_HUMAN A-kinase anchor protein 6 OS=Homo sapiens GN=AKAP6 PE=1 SV=3 | 2267 | E | 0.976905 | D | 0.974286 | 0.002619 | No Change: Both D | - |
| Q9P0M2 | AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens GN=AKAP7 PE=2 SV=2 | 26 | E | 0.783121 | K | 0.778374 | 0.004747 | No Change: Both D | - |
| Q9P0M2 | AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens GN=AKAP7 PE=2 SV=2 | 215 | S | 0.442173 | N | 0.385055 | 0.057118 | No Change: Both O | - |
| O43823 | AKAP8_HUMAN A-kinase anchor protein 8 OS=Homo sapiens GN=AKAP8 PE=1 SV=1 | 664 | Q | 0.971244 | H | 0.964405 | 0.006839 | No Change: Both D | A breast cancer sample |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 475 | M | 0.825144 | I | 0.746863 | 0.078281 | No Change: Both D | - |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 2804 | N | 0.746279 | S | 0.802959 | -0.05668 | No Change: Both D | - |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 2983 | P | 0.441842 | S | 0.492923 | -0.051081 | No Change: Both O | - |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 2421 | M | 0.704113 | I | 0.578824 | 0.125289 | No Change: Both D | A colorectal cancer sample |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 3301 | E | 0.870738 | Q | 0.860927 | 0.009811 | No Change: Both D | A breast cancer sample |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 1582 | S | 0.768529 | L | 0.624296 | 0.144233 | No Change: Both D | Long QT syndrome type 11 (LQT11) [MIM:611820] |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 2496 | K | 0.511411 | R | 0.444327 | 0.067084 | D to O | - |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 3448 | Q | 0.912702 | R | 0.908166 | 0.004536 | No Change: Both D | - |
| Q99996 | AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens GN=AKAP9 PE=1 SV=3 | 3618 | M | 0.38455 | V | 0.292588 | 0.091962 | No Change: Both O | - |
| Q9NQ31 | AKIP1_HUMAN A-kinase-interacting protein 1 OS=Homo sapiens GN=AKIP1 PE=1 SV=2 | 23 | R | 0.519759 | K | 0.521001 | -0.001242 | No Change: Both D | - |
| Q9NQ31 | AKIP1_HUMAN A-kinase-interacting protein 1 OS=Homo sapiens GN=AKIP1 PE=1 SV=2 | 132 | I | 0.494573 | T | 0.634232 | -0.139659 | O to D | - |
| Q7Z591 | AKNA_HUMAN AT-hook-containing transcription factor OS=Homo sapiens GN=AKNA PE=1 SV=2 | 624 | P | 0.780148 | L | 0.657846 | 0.122302 | No Change: Both D | - |
| Q7Z591 | AKNA_HUMAN AT-hook-containing transcription factor OS=Homo sapiens GN=AKNA PE=1 SV=2 | 1097 | Q | 0.887115 | R | 0.892968 | -0.005853 | No Change: Both D | - |
| Q7Z591 | AKNA_HUMAN AT-hook-containing transcription factor OS=Homo sapiens GN=AKNA PE=1 SV=2 | 1119 | R | 0.954341 | Q | 0.947889 | 0.006452 | No Change: Both D | - |
| Q7Z591 | AKNA_HUMAN AT-hook-containing transcription factor OS=Homo sapiens GN=AKNA PE=1 SV=2 | 1303 | S | 0.994169 | P | 0.994492 | -3.23E-04 | No Change: Both D | - |
| Q7Z591 | AKNA_HUMAN AT-hook-containing transcription factor OS=Homo sapiens GN=AKNA PE=1 SV=2 | 1327 | Y | 0.91695 | C | 0.921553 | -0.004603 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 61 | S | 0.491446 | N | 0.48806 | 0.003386 | No Change: Both O | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 104 | A | 0.694593 | V | 0.616854 | 0.077739 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 167 | E | 0.844968 | G | 0.793938 | 0.05103 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 255 | H | 0.596617 | Y | 0.5607 | 0.035917 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 352 | L | 0.917608 | V | 0.904293 | 0.013315 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 616 | N | 0.455473 | K | 0.506033 | -0.05056 | O to D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 654 | C | 0.90552 | Y | 0.857272 | 0.048248 | No Change: Both D | - |
| Q5T1N1 | AKND1_HUMAN Protein AKNAD1 OS=Homo sapiens GN=AKNAD1 PE=2 SV=3 | 582 | G | 0.863892 | V | 0.815332 | 0.04856 | No Change: Both D | - |
| P14550 | AK1A1_HUMAN Alcohol dehydrogenase [NADP+] OS=Homo sapiens GN=AKR1A1 PE=1 SV=3 | 52 | N | 0.32909 | S | 0.366444 | -0.037354 | No Change: Both O | - |
| P14550 | AK1A1_HUMAN Alcohol dehydrogenase [NADP+] OS=Homo sapiens GN=AKR1A1 PE=1 SV=3 | 55 | E | 0.450403 | D | 0.410343 | 0.04006 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 15 | I | 0.204476 | F | 0.204692 | -2.16E-04 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 42 | H | 0.113437 | L | 0.062887 | 0.05055 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 73 | L | 0.163189 | V | 0.173168 | -0.009979 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 204 | G | 0.222063 | S | 0.29045 | -0.068387 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 288 | T | 0.353618 | I | 0.21119 | 0.142428 | No Change: Both O | - |
| P15121 | ALDR_HUMAN Aldose reductase OS=Homo sapiens GN=AKR1B1 PE=1 SV=3 | 90 | K | 0.346619 | E | 0.341718 | 0.004901 | No Change: Both O | - |
| O60218 | AK1BA_HUMAN Aldo-keto reductase family 1 member B10 OS=Homo sapiens GN=AKR1B10 PE=1 SV=2 | 313 | N | 0.795092 | D | 0.818524 | -0.023432 | No Change: Both D | - |
| O60218 | AK1BA_HUMAN Aldo-keto reductase family 1 member B10 OS=Homo sapiens GN=AKR1B10 PE=1 SV=2 | 87 | P | 0.182974 | S | 0.193091 | -0.010117 | No Change: Both O | - |
| O60218 | AK1BA_HUMAN Aldo-keto reductase family 1 member B10 OS=Homo sapiens GN=AKR1B10 PE=1 SV=2 | 286 | M | 0.351323 | T | 0.413895 | -0.062572 | No Change: Both O | - |
| Q04828 | AK1C1_HUMAN Aldo-keto reductase family 1 member C1 OS=Homo sapiens GN=AKR1C1 PE=1 SV=1 | 170 | R | 0.285747 | H | 0.272608 | 0.013139 | No Change: Both O | - |
| Q04828 | AK1C1_HUMAN Aldo-keto reductase family 1 member C1 OS=Homo sapiens GN=AKR1C1 PE=1 SV=1 | 172 | Q | 0.275421 | L | 0.176962 | 0.098459 | No Change: Both O | - |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 172 | L | 0.172894 | Q | 0.269141 | -0.096247 | No Change: Both O | - |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 46 | F | 0.227457 | Y | 0.261482 | -0.034025 | No Change: Both O | - |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 79 | I | 0.259331 | V | 0.296232 | -0.036901 | No Change: Both O | 46 XY sex reversal type 8 (SRXY8) [MIM:614279] |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 90 | H | 0.509443 | Q | 0.525948 | -0.016505 | No Change: Both D | 46 XY sex reversal type 8 (SRXY8) [MIM:614279] |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 222 | H | 0.410634 | Q | 0.419668 | -0.009034 | No Change: Both O | 46 XY sex reversal type 8 (SRXY8) [MIM:614279] |
| P52895 | AK1C2_HUMAN Aldo-keto reductase family 1 member C2 OS=Homo sapiens GN=AKR1C2 PE=1 SV=3 | 300 | N | 0.21352 | T | 0.18274 | 0.03078 | No Change: Both O | 46 XY sex reversal type 8 (SRXY8) [MIM:614279] |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 5 | H | 0.641958 | Q | 0.630841 | 0.011117 | No Change: Both D | - |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 175 | M | 0.277357 | I | 0.209303 | 0.068054 | No Change: Both O | - |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 66 | R | 0.279262 | Q | 0.310399 | -0.031137 | No Change: Both O | - |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 170 | R | 0.288912 | C | 0.156798 | 0.132114 | No Change: Both O | - |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 180 | P | 0.314291 | S | 0.321422 | -0.007131 | No Change: Both O | - |
| P42330 | AK1C3_HUMAN Aldo-keto reductase family 1 member C3 OS=Homo sapiens GN=AKR1C3 PE=1 SV=4 | 77 | E | 0.313549 | G | 0.285347 | 0.028202 | No Change: Both O | - |
| P17516 | AK1C4_HUMAN Aldo-keto reductase family 1 member C4 OS=Homo sapiens GN=AKR1C4 PE=1 SV=3 | 145 | S | 0.170535 | C | 0.088217 | 0.082318 | No Change: Both O | - |
| P17516 | AK1C4_HUMAN Aldo-keto reductase family 1 member C4 OS=Homo sapiens GN=AKR1C4 PE=1 SV=3 | 311 | L | 0.174296 | V | 0.191035 | -0.016739 | No Change: Both O | - |
| P17516 | AK1C4_HUMAN Aldo-keto reductase family 1 member C4 OS=Homo sapiens GN=AKR1C4 PE=1 SV=3 | 135 | G | 0.439364 | E | 0.507213 | -0.067849 | O to D | - |
| P17516 | AK1C4_HUMAN Aldo-keto reductase family 1 member C4 OS=Homo sapiens GN=AKR1C4 PE=1 SV=3 | 170 | C | 0.161914 | Y | 0.178104 | -0.01619 | No Change: Both O | - |
| P17516 | AK1C4_HUMAN Aldo-keto reductase family 1 member C4 OS=Homo sapiens GN=AKR1C4 PE=1 SV=3 | 250 | Q | 0.399183 | R | 0.383816 | 0.015367 | No Change: Both O | - |
| Q5T2L2 | AKCL1_HUMAN Aldo-keto reductase family 1 member C-like protein 1 OS=Homo sapiens GN=AKR1CL1 PE=2 SV=2 | 50 | R | 0.120889 | H | 0.130847 | -0.009958 | No Change: Both O | - |
| P51857 | AK1D1_HUMAN 3-oxo-5-beta-steroid 4-dehydrogenase OS=Homo sapiens GN=AKR1D1 PE=1 SV=1 | 106 | L | 0.183231 | F | 0.14848 | 0.034751 | No Change: Both O | Congenital bile acid synthesis defect type 2 (CBAS2) [MIM:235555] |
| P51857 | AK1D1_HUMAN 3-oxo-5-beta-steroid 4-dehydrogenase OS=Homo sapiens GN=AKR1D1 PE=1 SV=1 | 198 | P | 0.249772 | L | 0.134387 | 0.115385 | No Change: Both O | Congenital bile acid synthesis defect type 2 (CBAS2) [MIM:235555] |
| P51857 | AK1D1_HUMAN 3-oxo-5-beta-steroid 4-dehydrogenase OS=Homo sapiens GN=AKR1D1 PE=1 SV=1 | 133 | P | 0.470911 | R | 0.43031 | 0.040601 | No Change: Both O | Congenital bile acid synthesis defect type 2 (CBAS2) [MIM:235555] |
| P51857 | AK1D1_HUMAN 3-oxo-5-beta-steroid 4-dehydrogenase OS=Homo sapiens GN=AKR1D1 PE=1 SV=1 | 261 | R | 0.078026 | C | 0.034271 | 0.043755 | No Change: Both O | Congenital bile acid synthesis defect type 2 (CBAS2) [MIM:235555] |
| Q96JD6 | AKCL2_HUMAN 1 5-anhydro-D-fructose reductase OS=Homo sapiens GN=AKR1E2 PE=1 SV=2 | 52 | C | 0.265517 | G | 0.475366 | -0.209849 | No Change: Both O | - |
| Q96JD6 | AKCL2_HUMAN 1 5-anhydro-D-fructose reductase OS=Homo sapiens GN=AKR1E2 PE=1 SV=2 | 86 | K | 0.332645 | R | 0.262687 | 0.069958 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 142 | A | 0.351901 | T | 0.409994 | -0.058093 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 157 | Q | 0.29558 | H | 0.284783 | 0.010797 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 214 | C | 0.091061 | Y | 0.114594 | -0.023533 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 135 | V | 0.307121 | M | 0.363178 | -0.056057 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 198 | G | 0.174537 | S | 0.211864 | -0.037327 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 255 | S | 0.216024 | N | 0.199253 | 0.016771 | No Change: Both O | - |
| O43488 | ARK72_HUMAN Aflatoxin B1 aldehyde reductase member 2 OS=Homo sapiens GN=AKR7A2 PE=1 SV=3 | 180 | E | 0.077632 | K | 0.07618 | 0.001452 | No Change: Both O | - |
| O95154 | ARK73_HUMAN Aflatoxin B1 aldehyde reductase member 3 OS=Homo sapiens GN=AKR7A3 PE=1 SV=2 | 138 | V | 0.370536 | M | 0.438199 | -0.067663 | No Change: Both O | - |
| O95154 | ARK73_HUMAN Aflatoxin B1 aldehyde reductase member 3 OS=Homo sapiens GN=AKR7A3 PE=1 SV=2 | 215 | N | 0.702479 | D | 0.727225 | -0.024746 | No Change: Both D | - |
| O95154 | ARK73_HUMAN Aflatoxin B1 aldehyde reductase member 3 OS=Homo sapiens GN=AKR7A3 PE=1 SV=2 | 323 | T | 0.124937 | A | 0.127807 | -0.00287 | No Change: Both O | - |
| P31749 | AKT1_HUMAN RAC-alpha serine/threonine-protein kinase OS=Homo sapiens GN=AKT1 PE=1 SV=2 | 167 | V | 0.240266 | A | 0.308888 | -0.068622 | No Change: Both O | - |
| P31749 | AKT1_HUMAN RAC-alpha serine/threonine-protein kinase OS=Homo sapiens GN=AKT1 PE=1 SV=2 | 17 | E | 0.26155 | K | 0.274988 | -0.013438 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P31749 | AKT1_HUMAN RAC-alpha serine/threonine-protein kinase OS=Homo sapiens GN=AKT1 PE=1 SV=2 | 17 | E | 0.26155 | K | 0.274988 | -0.013438 | No Change: Both O | Proteus syndrome (PROTEUSS) [MIM:176920] |
| Q96B36 | AKTS1_HUMAN Proline-rich AKT1 substrate 1 OS=Homo sapiens GN=AKT1S1 PE=1 SV=1 | 47 | A | 0.853847 | P | 0.892832 | -0.038985 | No Change: Both D | - |
| P31751 | AKT2_HUMAN RAC-beta serine/threonine-protein kinase OS=Homo sapiens GN=AKT2 PE=1 SV=2 | 188 | I | 0.190752 | V | 0.212645 | -0.021893 | No Change: Both O | - |
| P31751 | AKT2_HUMAN RAC-beta serine/threonine-protein kinase OS=Homo sapiens GN=AKT2 PE=1 SV=2 | 208 | R | 0.299686 | K | 0.357789 | -0.058103 | No Change: Both O | - |
| Q9Y243 | AKT3_HUMAN RAC-gamma serine/threonine-protein kinase OS=Homo sapiens GN=AKT3 PE=1 SV=1 | 171 | G | 0.328533 | R | 0.334154 | -0.005621 | No Change: Both O | A glioblastoma multiforme sample |
| Q9Y243 | AKT3_HUMAN RAC-gamma serine/threonine-protein kinase OS=Homo sapiens GN=AKT3 PE=1 SV=1 | 17 | E | 0.2525 | K | 0.265488 | -0.012988 | No Change: Both O | Melanoma |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 59 | K | 0.315999 | N | 0.277416 | 0.038583 | No Change: Both O | - |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 133 | G | 0.37179 | R | 0.346855 | 0.024935 | No Change: Both O | Acute hepatic porphyria (AHEPP) [MIM:612740] |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 240 | R | 0.599511 | W | 0.326503 | 0.273008 | D to O | Acute hepatic porphyria (AHEPP) [MIM:612740] |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 274 | A | 0.237804 | T | 0.26031 | -0.022506 | No Change: Both O | Acute hepatic porphyria (AHEPP) [MIM:612740] |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 275 | V | 0.18956 | M | 0.228457 | -0.038897 | No Change: Both O | Acute hepatic porphyria (AHEPP) [MIM:612740] |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 12 | F | 0.175963 | L | 0.216897 | -0.040934 | No Change: Both O | - |
| P13716 | HEM2_HUMAN Delta-aminolevulinic acid dehydratase OS=Homo sapiens GN=ALAD PE=1 SV=1 | 153 | V | 0.29507 | M | 0.373637 | -0.078567 | No Change: Both O | Acute hepatic porphyria (AHEPP) [MIM:612740] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 388 | T | 0.180487 | S | 0.255736 | -0.075249 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 411 | R | 0.146442 | C | 0.070367 | 0.076075 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 476 | I | 0.146004 | N | 0.269239 | -0.123235 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 199 | Y | 0.254517 | H | 0.391066 | -0.136549 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 204 | R | 0.362324 | Q | 0.404188 | -0.041864 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 448 | R | 0.559756 | Q | 0.57298 | -0.013224 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 452 | R | 0.585292 | C | 0.421859 | 0.163433 | D to O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 159 | D | 0.473197 | Y | 0.332351 | 0.140846 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 560 | R | 0.110684 | H | 0.112324 | -0.00164 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 156 | K | 0.60063 | E | 0.598101 | 0.002529 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 170 | R | 0.116164 | H | 0.111435 | 0.004729 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 218 | R | 0.591168 | H | 0.600501 | -0.009333 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 242 | E | 0.537719 | K | 0.525842 | 0.011877 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 263 | D | 0.187457 | N | 0.185985 | 0.001472 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 339 | P | 0.174027 | L | 0.096853 | 0.077174 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 375 | R | 0.525451 | C | 0.340962 | 0.184489 | D to O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 411 | R | 0.146442 | H | 0.14173 | 0.004712 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 452 | R | 0.585292 | G | 0.554891 | 0.030401 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 452 | R | 0.585292 | H | 0.561221 | 0.024071 | No Change: Both D | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 520 | P | 0.67347 | L | 0.50999 | 0.16348 | No Change: Both D | - |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 572 | R | 0.363271 | H | 0.373124 | -0.009853 | No Change: Both O | Anemia sideroblastic X-linked (XLSA) [MIM:300751] |
| P22557 | HEM0_HUMAN 5-aminolevulinate synthase erythroid-specific mitochondrial OS=Homo sapiens GN=ALAS2 PE=1 SV=2 | 586 | Y | 0.78302 | F | 0.720116 | 0.062904 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 23 | R | 0.513822 | C | 0.300408 | 0.213414 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 23 | R | 0.513822 | H | 0.512666 | 0.001156 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 24 | R | 0.544978 | L | 0.374616 | 0.170362 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 24 | R | 0.544978 | P | 0.565801 | -0.020823 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 24 | R | 0.544978 | Q | 0.543313 | 0.001665 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 25 | D | 0.575532 | V | 0.409304 | 0.166228 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 27 | H | 0.640589 | Q | 0.638359 | 0.00223 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 27 | H | 0.640589 | Y | 0.490902 | 0.149687 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 84 | E | 0.570926 | K | 0.571177 | -2.51E-04 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 87 | D | 0.506006 | N | 0.491202 | 0.014804 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 106 | E | 0.413028 | K | 0.400407 | 0.012621 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 138 | R | 0.506384 | G | 0.469511 | 0.036873 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 143 | E | 0.363918 | K | 0.355926 | 0.007992 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 152 | H | 0.270095 | R | 0.278082 | -0.007987 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 201 | C | 0.516897 | F | 0.473735 | 0.043162 | D to O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 242 | R | 0.355216 | H | 0.299091 | 0.056125 | No Change: Both O | Familial dysalbuminemic hyperthyroxinemia (FDH) [MIM:103600] |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 249 | K | 0.435594 | Q | 0.406902 | 0.028692 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 264 | K | 0.28752 | E | 0.297302 | -0.009782 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 292 | Q | 0.665275 | R | 0.682631 | -0.017356 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 293 | D | 0.696564 | G | 0.629718 | 0.066846 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 300 | K | 0.776986 | N | 0.730558 | 0.046428 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 337 | K | 0.373837 | N | 0.333257 | 0.04058 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 342 | N | 0.336421 | K | 0.405633 | -0.069212 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 344 | A | 0.282378 | T | 0.292909 | -0.010531 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 345 | E | 0.231368 | K | 0.246856 | -0.015488 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 357 | E | 0.144029 | K | 0.143851 | 1.78E-04 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 378 | E | 0.275137 | K | 0.279909 | -0.004772 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 382 | E | 0.290055 | K | 0.293045 | -0.00299 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 389 | D | 0.278975 | H | 0.251557 | 0.027418 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 389 | D | 0.278975 | V | 0.161453 | 0.117522 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 396 | K | 0.259292 | E | 0.271883 | -0.012591 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 399 | D | 0.297902 | N | 0.291868 | 0.006034 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 400 | E | 0.331278 | K | 0.326739 | 0.004539 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 400 | E | 0.331278 | Q | 0.282562 | 0.048716 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 406 | E | 0.426337 | K | 0.422339 | 0.003998 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 503 | E | 0.3186 | K | 0.322999 | -0.004399 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 518 | D | 0.376185 | N | 0.369058 | 0.007127 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 525 | E | 0.388224 | K | 0.376826 | 0.011398 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 529 | E | 0.321626 | K | 0.31639 | 0.005236 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 560 | K | 0.702575 | E | 0.692164 | 0.010411 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 565 | K | 0.739547 | E | 0.728272 | 0.011275 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 574 | D | 0.683723 | G | 0.611621 | 0.072102 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 574 | D | 0.683723 | A | 0.647932 | 0.035791 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 587 | D | 0.709597 | N | 0.639075 | 0.070522 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 589 | E | 0.715176 | K | 0.733609 | -0.018433 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 594 | E | 0.661434 | K | 0.68633 | -0.024896 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 597 | K | 0.647376 | E | 0.640322 | 0.007054 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 598 | K | 0.631309 | N | 0.506202 | 0.125107 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 73 | F | 0.240364 | Y | 0.263307 | -0.022943 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 90 | L | 0.382805 | P | 0.50181 | -0.119005 | O to D | Familial dysalbuminemic hyperthyroxinemia (FDH) [MIM:103600] |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 146 | V | 0.272154 | E | 0.434103 | -0.161949 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 242 | R | 0.355216 | P | 0.370633 | -0.015417 | No Change: Both O | Familial dysalbuminemic hyperthyroxinemia (FDH) [MIM:103600] |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 338 | D | 0.349623 | G | 0.303106 | 0.046517 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 338 | D | 0.349623 | V | 0.213835 | 0.135788 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 383 | K | 0.297775 | N | 0.250815 | 0.04696 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 434 | R | 0.223388 | C | 0.157692 | 0.065696 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 557 | V | 0.622455 | M | 0.689698 | -0.067243 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 584 | K | 0.66263 | E | 0.654566 | 0.008064 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 121 | E | 0.618742 | G | 0.530125 | 0.088617 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 215 | A | 0.825354 | T | 0.804722 | 0.020632 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 215 | A | 0.825354 | V | 0.746676 | 0.078678 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 220 | Q | 0.811916 | L | 0.742037 | 0.069879 | No Change: Both D | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 420 | E | 0.258405 | K | 0.25505 | 0.003355 | No Change: Both O | - |
| P02768 | ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 | 490 | K | 0.427457 | E | 0.445293 | -0.017836 | No Change: Both O | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 258 | N | 0.407243 | S | 0.427227 | -0.019984 | No Change: Both O | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 301 | T | 0.426324 | M | 0.354216 | 0.072108 | No Change: Both O | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 229 | G | 0.538789 | D | 0.537853 | 9.36E-04 | No Change: Both D | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 315 | L | 0.314422 | M | 0.38469 | -0.070268 | No Change: Both O | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 352 | V | 0.219532 | M | 0.276736 | -0.057204 | No Change: Both O | - |
| Q13740 | CD166_HUMAN CD166 antigen OS=Homo sapiens GN=ALCAM PE=1 SV=2 | 367 | M | 0.182966 | I | 0.136256 | 0.04671 | No Change: Both O | - |
| Q8IZ83 | A16A1_HUMAN Aldehyde dehydrogenase family 16 member A1 OS=Homo sapiens GN=ALDH16A1 PE=1 SV=2 | 110 | E | 0.29231 | K | 0.305217 | -0.012907 | No Change: Both O | - |
| Q8IZ83 | A16A1_HUMAN Aldehyde dehydrogenase family 16 member A1 OS=Homo sapiens GN=ALDH16A1 PE=1 SV=2 | 227 | L | 0.39698 | V | 0.377315 | 0.019665 | No Change: Both O | - |
| P54886 | P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens GN=ALDH18A1 PE=1 SV=2 | 84 | R | 0.292397 | Q | 0.296769 | -0.004372 | No Change: Both O | Mental retardation-joint hypermobility-skin laxity with or without metabolic abnormalities (MRJHSL) [MIM:612652] |
| P54886 | P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens GN=ALDH18A1 PE=1 SV=2 | 299 | T | 0.53016 | I | 0.377181 | 0.152979 | D to O | - |
| P54886 | P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens GN=ALDH18A1 PE=1 SV=2 | 372 | S | 0.675775 | Y | 0.481096 | 0.194679 | D to O | - |
| P54886 | P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens GN=ALDH18A1 PE=1 SV=2 | 784 | H | 0.399971 | Y | 0.279483 | 0.120488 | No Change: Both O | Mental retardation-joint hypermobility-skin laxity with or without metabolic abnormalities (MRJHSL) [MIM:612652] |
| P00352 | AL1A1_HUMAN Retinal dehydrogenase 1 OS=Homo sapiens GN=ALDH1A1 PE=1 SV=2 | 177 | I | 0.027691 | F | 0.027065 | 6.26E-04 | No Change: Both O | - |
| P00352 | AL1A1_HUMAN Retinal dehydrogenase 1 OS=Homo sapiens GN=ALDH1A1 PE=1 SV=2 | 121 | N | 0.137516 | S | 0.162802 | -0.025286 | No Change: Both O | - |
| P00352 | AL1A1_HUMAN Retinal dehydrogenase 1 OS=Homo sapiens GN=ALDH1A1 PE=1 SV=2 | 125 | G | 0.088453 | R | 0.088474 | -2.10E-05 | No Change: Both O | - |
| O94788 | AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens GN=ALDH1A2 PE=1 SV=3 | 50 | E | 0.455379 | G | 0.410177 | 0.045202 | No Change: Both O | - |
| O94788 | AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens GN=ALDH1A2 PE=1 SV=3 | 110 | A | 0.363454 | V | 0.293251 | 0.070203 | No Change: Both O | - |
| O94788 | AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens GN=ALDH1A2 PE=1 SV=3 | 348 | V | 0.561212 | I | 0.522052 | 0.03916 | No Change: Both D | - |
| O94788 | AL1A2_HUMAN Retinal dehydrogenase 2 OS=Homo sapiens GN=ALDH1A2 PE=1 SV=3 | 436 | E | 0.365055 | K | 0.358282 | 0.006773 | No Change: Both O | - |
| P47895 | AL1A3_HUMAN Aldehyde dehydrogenase family 1 member A3 OS=Homo sapiens GN=ALDH1A3 PE=1 SV=2 | 386 | M | 0.527417 | V | 0.45178 | 0.075637 | D to O | - |
| P30837 | AL1B1_HUMAN Aldehyde dehydrogenase X mitochondrial OS=Homo sapiens GN=ALDH1B1 PE=1 SV=3 | 86 | A | 0.493476 | V | 0.404934 | 0.088542 | No Change: Both O | - |
| P30837 | AL1B1_HUMAN Aldehyde dehydrogenase X mitochondrial OS=Homo sapiens GN=ALDH1B1 PE=1 SV=3 | 107 | L | 0.310462 | R | 0.441685 | -0.131223 | No Change: Both O | - |
| P30837 | AL1B1_HUMAN Aldehyde dehydrogenase X mitochondrial OS=Homo sapiens GN=ALDH1B1 PE=1 SV=3 | 202 | T | 0.201666 | I | 0.107072 | 0.094594 | No Change: Both O | - |
| P30837 | AL1B1_HUMAN Aldehyde dehydrogenase X mitochondrial OS=Homo sapiens GN=ALDH1B1 PE=1 SV=3 | 253 | V | 0.22518 | M | 0.260217 | -0.035037 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 511 | A | 0.159841 | V | 0.109461 | 0.05038 | No Change: Both O | A colorectal cancer sample |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 254 | L | 0.415481 | P | 0.551999 | -0.136518 | O to D | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 330 | V | 0.120915 | F | 0.099002 | 0.021913 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 429 | E | 0.21939 | A | 0.149494 | 0.069896 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 436 | A | 0.583492 | T | 0.615214 | -0.031722 | No Change: Both D | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 436 | A | 0.583492 | V | 0.508596 | 0.074896 | No Change: Both D | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 448 | S | 0.257571 | N | 0.221413 | 0.036158 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 481 | S | 0.408042 | G | 0.387918 | 0.020124 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 793 | D | 0.23715 | G | 0.205703 | 0.031447 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 803 | E | 0.3853 | K | 0.382518 | 0.002782 | No Change: Both O | - |
| O75891 | AL1L1_HUMAN Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Homo sapiens GN=ALDH1L1 PE=1 SV=2 | 812 | I | 0.148458 | V | 0.168092 | -0.019634 | No Change: Both O | - |
| P05091 | ALDH2_HUMAN Aldehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH2 PE=1 SV=2 | 504 | E | 0.352505 | K | 0.381898 | -0.029393 | No Change: Both O | - |
| P05091 | ALDH2_HUMAN Aldehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH2 PE=1 SV=2 | 496 | E | 0.496033 | K | 0.478829 | 0.017204 | No Change: Both O | - |
| P05091 | ALDH2_HUMAN Aldehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH2 PE=1 SV=2 | 337 | E | 0.380579 | V | 0.226669 | 0.15391 | No Change: Both O | - |
| P30838 | AL3A1_HUMAN Aldehyde dehydrogenase dimeric NADP-preferring OS=Homo sapiens GN=ALDH3A1 PE=1 SV=3 | 329 | P | 0.452435 | A | 0.356312 | 0.096123 | No Change: Both O | - |
| P30838 | AL3A1_HUMAN Aldehyde dehydrogenase dimeric NADP-preferring OS=Homo sapiens GN=ALDH3A1 PE=1 SV=3 | 134 | S | 0.297248 | A | 0.207377 | 0.089871 | No Change: Both O | - |
| P30838 | AL3A1_HUMAN Aldehyde dehydrogenase dimeric NADP-preferring OS=Homo sapiens GN=ALDH3A1 PE=1 SV=3 | 309 | G | 0.390608 | E | 0.41494 | -0.024332 | No Change: Both O | - |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 106 | L | 0.02845 | R | 0.047954 | -0.019504 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 214 | C | 0.257806 | Y | 0.312009 | -0.054203 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 226 | C | 0.041718 | W | 0.032817 | 0.008901 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 245 | D | 0.065781 | N | 0.06197 | 0.003811 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 315 | P | 0.1858 | S | 0.195187 | -0.009387 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 365 | S | 0.153059 | L | 0.07525 | 0.077809 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 412 | G | 0.592412 | R | 0.565118 | 0.027294 | No Change: Both D | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 45 | I | 0.142827 | F | 0.141612 | 0.001215 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 64 | V | 0.091854 | D | 0.174756 | -0.082902 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 114 | P | 0.022916 | L | 0.010715 | 0.012201 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 121 | P | 0.062207 | L | 0.030501 | 0.031706 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 184 | T | 0.13498 | M | 0.103147 | 0.031833 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 184 | T | 0.13498 | R | 0.138977 | -0.003997 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 185 | G | 0.150107 | A | 0.117861 | 0.032246 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 228 | R | 0.039188 | C | 0.019957 | 0.019231 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 237 | C | 0.09465 | Y | 0.118021 | -0.023371 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 266 | K | 0.277835 | N | 0.233114 | 0.044721 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 279 | Y | 0.404249 | N | 0.539493 | -0.135244 | O to D | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 328 | M | 0.35598 | I | 0.29889 | 0.05709 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 386 | N | 0.379949 | S | 0.433853 | -0.053904 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 406 | G | 0.565815 | R | 0.537156 | 0.028659 | No Change: Both D | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 411 | H | 0.594671 | Y | 0.47358 | 0.121091 | D to O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 415 | S | 0.577429 | N | 0.519924 | 0.057505 | No Change: Both D | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 419 | F | 0.505312 | S | 0.68109 | -0.175778 | No Change: Both D | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 423 | R | 0.436969 | H | 0.430356 | 0.006613 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P51648 | AL3A2_HUMAN Fatty aldehyde dehydrogenase OS=Homo sapiens GN=ALDH3A2 PE=1 SV=1 | 447 | K | 0.45923 | E | 0.441259 | 0.017971 | No Change: Both O | Sjoegren-Larsson syndrome (SLS) [MIM:270200] |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 50 | A | 0.10733 | T | 0.111234 | -0.003904 | No Change: Both O | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 302 | S | 0.645022 | R | 0.590354 | 0.054668 | No Change: Both D | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 52 | S | 0.138076 | N | 0.110382 | 0.027694 | No Change: Both O | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 203 | H | 0.430969 | R | 0.505098 | -0.074129 | O to D | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 220 | S | 0.187695 | G | 0.15987 | 0.027825 | No Change: Both O | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 276 | R | 0.277814 | W | 0.131369 | 0.146445 | No Change: Both O | - |
| P48448 | AL3B2_HUMAN Aldehyde dehydrogenase family 3 member B2 OS=Homo sapiens GN=ALDH3B2 PE=2 SV=3 | 361 | H | 0.301406 | R | 0.299206 | 0.0022 | No Change: Both O | - |
| P30038 | AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH4A1 PE=1 SV=3 | 16 | P | 0.372151 | L | 0.214958 | 0.157193 | No Change: Both O | - |
| P30038 | AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH4A1 PE=1 SV=3 | 352 | S | 0.21852 | L | 0.104386 | 0.114134 | No Change: Both O | Hyperprolinemia type 2 (HP-2) [MIM:239510] |
| P30038 | AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH4A1 PE=1 SV=3 | 470 | V | 0.398119 | I | 0.361633 | 0.036486 | No Change: Both O | - |
| P30038 | AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH4A1 PE=1 SV=3 | 473 | T | 0.408081 | A | 0.356688 | 0.051393 | No Change: Both O | - |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 180 | H | 0.273942 | Y | 0.18553 | 0.088412 | No Change: Both O | - |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 182 | P | 0.349625 | L | 0.205309 | 0.144316 | No Change: Both O | - |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 93 | C | 0.30078 | F | 0.287182 | 0.013598 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 176 | G | 0.228138 | R | 0.234906 | -0.006768 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 223 | C | 0.121995 | Y | 0.13826 | -0.016265 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 233 | T | 0.395129 | M | 0.348538 | 0.046591 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 255 | N | 0.199875 | S | 0.255054 | -0.055179 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 268 | G | 0.36153 | E | 0.431731 | -0.070201 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 335 | N | 0.348196 | K | 0.398838 | -0.050642 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 382 | P | 0.516526 | L | 0.379771 | 0.136755 | D to O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 382 | P | 0.516526 | Q | 0.534737 | -0.018211 | No Change: Both D | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 409 | G | 0.470088 | D | 0.472061 | -0.001973 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 487 | V | 0.21688 | E | 0.38841 | -0.17153 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 533 | G | 0.4497 | R | 0.407558 | 0.042142 | No Change: Both O | Succinate semialdehyde dehydrogenase deficiency (SSADH deficiency) [MIM:271980] |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 36 | G | 0.79222 | R | 0.805726 | -0.013506 | No Change: Both D | - |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 237 | A | 0.29062 | S | 0.374597 | -0.083977 | No Change: Both O | - |
| P51649 | SSDH_HUMAN Succinate-semialdehyde dehydrogenase mitochondrial OS=Homo sapiens GN=ALDH5A1 PE=1 SV=2 | 406 | V | 0.458626 | I | 0.398996 | 0.05963 | No Change: Both O | - |
| Q02252 | MMSA_HUMAN Methylmalonate-semialdehyde dehydrogenase [acylating] mitochondrial OS=Homo sapiens GN=ALDH6A1 PE=1 SV=2 | 446 | G | 0.353435 | R | 0.321349 | 0.032086 | No Change: Both O | Methylmalonate semialdehyde dehydrogenase deficiency (MMSDHD) [MIM:614105] |
| P49419 | AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens GN=ALDH7A1 PE=1 SV=5 | 412 | T | 0.250748 | A | 0.214577 | 0.036171 | No Change: Both O | - |
| P49419 | AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens GN=ALDH7A1 PE=1 SV=5 | 439 | K | 0.218244 | Q | 0.173699 | 0.044545 | No Change: Both O | - |
| P49419 | AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens GN=ALDH7A1 PE=1 SV=5 | 199 | A | 0.045035 | V | 0.030837 | 0.014198 | No Change: Both O | Pyridoxine-dependent epilepsy (PDE) [MIM:266100] |
| P49419 | AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens GN=ALDH7A1 PE=1 SV=5 | 427 | E | 0.236657 | Q | 0.20115 | 0.035507 | No Change: Both O | Pyridoxine-dependent epilepsy (PDE) [MIM:266100] |
| Q9H2A2 | AL8A1_HUMAN Aldehyde dehydrogenase family 8 member A1 OS=Homo sapiens GN=ALDH8A1 PE=1 SV=1 | 402 | F | 0.285847 | S | 0.512461 | -0.226614 | O to D | - |
| P49189 | AL9A1_HUMAN 4-trimethylaminobutyraldehyde dehydrogenase OS=Homo sapiens GN=ALDH9A1 PE=1 SV=3 | 116 | C | 0.051173 | S | 0.134151 | -0.082978 | No Change: Both O | - |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 129 | D | 0.467487 | G | 0.465759 | 0.001728 | No Change: Both O | Glycogen storage disease type 12 (GSD12) [MIM:611881] |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 207 | E | 0.137662 | K | 0.153169 | -0.015507 | No Change: Both O | Glycogen storage disease type 12 (GSD12) [MIM:611881] |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 339 | C | 0.4475 | Y | 0.468161 | -0.020661 | No Change: Both O | Glycogen storage disease type 12 (GSD12) [MIM:611881] |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 347 | G | 0.585809 | S | 0.644075 | -0.058266 | No Change: Both D | Glycogen storage disease type 12 (GSD12) [MIM:611881] |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 82 | E | 0.104045 | Q | 0.094749 | 0.009296 | No Change: Both O | - |
| P04075 | ALDOA_HUMAN Fructose-bisphosphate aldolase A OS=Homo sapiens GN=ALDOA PE=1 SV=2 | 142 | G | 0.36769 | V | 0.249461 | 0.118229 | No Change: Both O | - |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 135 | C | 0.357837 | R | 0.527459 | -0.169622 | O to D | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 148 | W | 0.13346 | R | 0.314248 | -0.180788 | No Change: Both O | - |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 150 | A | 0.093179 | P | 0.124016 | -0.030837 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 175 | A | 0.16848 | D | 0.213248 | -0.044768 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 257 | L | 0.244618 | P | 0.417316 | -0.172698 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 304 | R | 0.319678 | W | 0.176172 | 0.143506 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 335 | N | 0.484308 | K | 0.568022 | -0.083714 | O to D | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 338 | A | 0.50707 | V | 0.380533 | 0.126537 | D to O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 74 | I | 0.280627 | T | 0.380513 | -0.099886 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 185 | P | 0.185114 | R | 0.148085 | 0.037029 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 207 | E | 0.164902 | Q | 0.13993 | 0.024972 | No Change: Both O | - |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 222 | V | 0.18105 | F | 0.157408 | 0.023642 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 229 | L | 0.281644 | P | 0.426405 | -0.144761 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 304 | R | 0.319678 | Q | 0.356881 | -0.037203 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 134 | R | 0.348114 | S | 0.429468 | -0.081354 | No Change: Both O | - |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 268 | I | 0.121909 | N | 0.238651 | -0.116742 | No Change: Both O | - |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 178 | C | 0.1481 | R | 0.278359 | -0.130259 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| P05062 | ALDOB_HUMAN Fructose-bisphosphate aldolase B OS=Homo sapiens GN=ALDOB PE=1 SV=2 | 284 | L | 0.200871 | P | 0.334692 | -0.133821 | No Change: Both O | Hereditary fructose intolerance (HFI) [MIM:229600] |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 150 | S | 0.051731 | R | 0.037908 | 0.013823 | No Change: Both O | Congenital disorder of glycosylation type 1K (CDG1K) [MIM:608540] |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 258 | S | 0.869422 | L | 0.76928 | 0.100142 | No Change: Both D | Congenital disorder of glycosylation type 1K (CDG1K) [MIM:608540] |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 342 | Q | 0.098344 | P | 0.104916 | -0.006572 | No Change: Both O | Congenital disorder of glycosylation type 1K (CDG1K) [MIM:608540] |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 429 | D | 0.503373 | E | 0.546552 | -0.043179 | No Change: Both D | - |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 267 | S | 0.776091 | N | 0.69816 | 0.077931 | No Change: Both D | - |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 325 | L | 0.309589 | M | 0.3698 | -0.060211 | No Change: Both O | - |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 455 | Q | 0.200181 | R | 0.198228 | 0.001953 | No Change: Both O | - |
| Q9BT22 | ALG1_HUMAN Chitobiosyldiphosphodolichol beta-mannosyltransferase OS=Homo sapiens GN=ALG1 PE=1 SV=2 | 438 | R | 0.538295 | W | 0.311602 | 0.226693 | D to O | - |
| Q5I7T1 | AG10B_HUMAN Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1 2-glucosyltransferase OS=Homo sapiens GN=ALG10B PE=1 SV=2 | 446 | I | 0.013902 | V | 0.016216 | -0.002314 | No Change: Both O | - |
| Q5I7T1 | AG10B_HUMAN Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1 2-glucosyltransferase OS=Homo sapiens GN=ALG10B PE=1 SV=2 | 84 | A | 0.027879 | G | 0.034065 | -0.006186 | No Change: Both O | - |
| Q5I7T1 | AG10B_HUMAN Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1 2-glucosyltransferase OS=Homo sapiens GN=ALG10B PE=1 SV=2 | 383 | S | 0.137755 | N | 0.104439 | 0.033316 | No Change: Both O | - |
| Q2TAA5 | ALG11_HUMAN GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1 2-mannosyltransferase OS=Homo sapiens GN=ALG11 PE=1 SV=2 | 108 | N | 0.287446 | S | 0.314412 | -0.026966 | No Change: Both O | - |
| Q2TAA5 | ALG11_HUMAN GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1 2-mannosyltransferase OS=Homo sapiens GN=ALG11 PE=1 SV=2 | 86 | L | 0.055212 | S | 0.117842 | -0.06263 | No Change: Both O | Congenital disorder of glycosylation type 1P (CDG1P) [MIM:613661] |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 67 | T | 0.120825 | M | 0.098866 | 0.021959 | No Change: Both O | Congenital disorder of glycosylation type 1G (CDG1G) [MIM:607143] |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 142 | F | 0.047401 | V | 0.052395 | -0.004994 | No Change: Both O | Congenital disorder of glycosylation type 1G (CDG1G) [MIM:607143] |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 146 | R | 0.068429 | Q | 0.075757 | -0.007328 | No Change: Both O | Congenital disorder of glycosylation type 1G (CDG1G) [MIM:607143] |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 158 | L | 0.035388 | P | 0.071257 | -0.035869 | No Change: Both O | Congenital disorder of glycosylation type 1G (CDG1G) [MIM:607143] |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 393 | I | 0.131503 | V | 0.165823 | -0.03432 | No Change: Both O | - |
| Q9BV10 | ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1 6-mannosyltransferase OS=Homo sapiens GN=ALG12 PE=1 SV=1 | 101 | G | 0.060178 | R | 0.054855 | 0.005323 | No Change: Both O | Congenital disorder of glycosylation type 1G (CDG1G) [MIM:607143] |
| Q96F25 | ALG14_HUMAN UDP-N-acetylglucosamine transferase subunit ALG14 homolog OS=Homo sapiens GN=ALG14 PE=2 SV=1 | 14 | V | 0.044151 | M | 0.05454 | -0.010389 | No Change: Both O | - |
| Q6GMV1 | ALG1L_HUMAN Putative glycosyltransferase ALG1-like OS=Homo sapiens GN=ALG1L PE=2 SV=2 | 135 | N | 0.329553 | D | 0.333938 | -0.004385 | No Change: Both O | - |
| Q6GMV1 | ALG1L_HUMAN Putative glycosyltransferase ALG1-like OS=Homo sapiens GN=ALG1L PE=2 SV=2 | 159 | I | 0.318062 | T | 0.471272 | -0.15321 | No Change: Both O | - |
| Q6GMV1 | ALG1L_HUMAN Putative glycosyltransferase ALG1-like OS=Homo sapiens GN=ALG1L PE=2 SV=2 | 184 | G | 0.90944 | S | 0.936111 | -0.026671 | No Change: Both D | - |
| Q9H553 | ALG2_HUMAN Alpha-1 3/1 6-mannosyltransferase ALG2 OS=Homo sapiens GN=ALG2 PE=2 SV=1 | 11 | S | 0.702302 | P | 0.71344 | -0.011138 | No Change: Both D | - |
| Q9H553 | ALG2_HUMAN Alpha-1 3/1 6-mannosyltransferase ALG2 OS=Homo sapiens GN=ALG2 PE=2 SV=1 | 367 | V | 0.30857 | A | 0.394785 | -0.086215 | No Change: Both O | - |
| Q92685 | ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1 3-mannosyltransferase OS=Homo sapiens GN=ALG3 PE=1 SV=1 | 118 | G | 0.384243 | D | 0.42801 | -0.043767 | No Change: Both O | Congenital disorder of glycosylation type 1D (CDG1D) [MIM:601110] |
| Q92685 | ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1 3-mannosyltransferase OS=Homo sapiens GN=ALG3 PE=1 SV=1 | 107 | I | 0.021496 | V | 0.027159 | -0.005663 | No Change: Both O | - |
| Q92685 | ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1 3-mannosyltransferase OS=Homo sapiens GN=ALG3 PE=1 SV=1 | 171 | R | 0.061061 | Q | 0.065341 | -0.00428 | No Change: Both O | Congenital disorder of glycosylation type 1D (CDG1D) [MIM:601110] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 304 | F | 0.026027 | S | 0.072516 | -0.046489 | No Change: Both O | - |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 333 | A | 0.063422 | V | 0.051368 | 0.012054 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 478 | S | 0.012516 | P | 0.010694 | 0.001822 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 131 | Y | 0.009131 | H | 0.015889 | -0.006758 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 170 | S | 0.132193 | I | 0.046163 | 0.08603 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 227 | G | 0.211565 | E | 0.238005 | -0.02644 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 308 | S | 0.030542 | R | 0.020903 | 0.009639 | No Change: Both O | Congenital disorder of glycosylation type 1C (CDG1C) [MIM:603147] |
| Q9Y672 | ALG6_HUMAN Dolichyl pyrophosphate Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG6 PE=1 SV=1 | 226 | K | 0.27927 | N | 0.218435 | 0.060835 | No Change: Both O | - |
| Q9BVK2 | ALG8_HUMAN Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG8 PE=1 SV=2 | 47 | T | 0.122299 | P | 0.163817 | -0.041518 | No Change: Both O | Congenital disorder of glycosylation type 1H (CDG1H) [MIM:608104] |
| Q9BVK2 | ALG8_HUMAN Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG8 PE=1 SV=2 | 222 | N | 0.332181 | S | 0.39879 | -0.066609 | No Change: Both O | - |
| Q9BVK2 | ALG8_HUMAN Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG8 PE=1 SV=2 | 275 | G | 0.092467 | D | 0.105731 | -0.013264 | No Change: Both O | Congenital disorder of glycosylation type 1H (CDG1H) [MIM:608104] |
| Q9BVK2 | ALG8_HUMAN Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1 3-glucosyltransferase OS=Homo sapiens GN=ALG8 PE=1 SV=2 | 439 | I | 0.072126 | T | 0.1326 | -0.060474 | No Change: Both O | - |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 287 | Y | 0.063606 | C | 0.05006 | 0.013546 | No Change: Both O | Congenital disorder of glycosylation type 1L (CDG1L) [MIM:608776] |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 289 | V | 0.090208 | I | 0.07831 | 0.011898 | No Change: Both O | - |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 506 | P | 0.360407 | L | 0.205743 | 0.154664 | No Change: Both O | - |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 523 | E | 0.523015 | K | 0.509925 | 0.01309 | No Change: Both D | Congenital disorder of glycosylation type 1L (CDG1L) [MIM:608776] |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 232 | A | 0.081261 | P | 0.117575 | -0.036314 | No Change: Both O | - |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 255 | S | 0.032408 | L | 0.013508 | 0.0189 | No Change: Both O | - |
| Q9H6U8 | ALG9_HUMAN Alpha-1 2-mannosyltransferase ALG9 OS=Homo sapiens GN=ALG9 PE=1 SV=2 | 528 | I | 0.409333 | S | 0.594017 | -0.184684 | O to D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1461 | I | 0.870095 | V | 0.904676 | -0.034581 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1491 | K | 0.756879 | R | 0.742211 | 0.014668 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1529 | D | 0.741473 | E | 0.797598 | -0.056125 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 90 | S | 0.758578 | L | 0.651857 | 0.106721 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 163 | V | 0.220167 | L | 0.243049 | -0.022882 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 296 | E | 0.770191 | Q | 0.748787 | 0.021404 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 476 | V | 0.140284 | A | 0.193441 | -0.053157 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 560 | L | 0.124668 | F | 0.098437 | 0.026231 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 680 | T | 0.479644 | I | 0.342897 | 0.136747 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 704 | A | 0.499185 | T | 0.526792 | -0.027607 | O to D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 877 | A | 0.695419 | S | 0.7678 | -0.072381 | No Change: Both D | An ovarian serous carcinoma sample |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1012 | T | 0.243017 | M | 0.234671 | 0.008346 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1121 | G | 0.183649 | D | 0.186184 | -0.002535 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1274 | A | 0.20274 | T | 0.210742 | -0.008002 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1328 | M | 0.274278 | L | 0.239195 | 0.035083 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1416 | K | 0.891995 | N | 0.878029 | 0.013966 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1419 | E | 0.917035 | K | 0.910285 | 0.00675 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1429 | Q | 0.981107 | R | 0.982242 | -0.001135 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1376 | F | 0.261552 | S | 0.429154 | -0.167602 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1599 | P | 0.522906 | H | 0.486394 | 0.036512 | D to O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 868 | L | 0.596509 | Q | 0.689765 | -0.093256 | No Change: Both D | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1091 | D | 0.370179 | N | 0.386431 | -0.016252 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1128 | G | 0.343139 | A | 0.284849 | 0.05829 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1151 | T | 0.301094 | M | 0.28499 | 0.016104 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1166 | M | 0.136385 | R | 0.167782 | -0.031397 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1171 | I | 0.13263 | N | 0.254922 | -0.122292 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1174 | F | 0.147108 | C | 0.144546 | 0.002562 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1174 | F | 0.147108 | I | 0.162696 | -0.015588 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1174 | F | 0.147108 | L | 0.176263 | -0.029155 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1174 | F | 0.147108 | V | 0.174194 | -0.027086 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1192 | R | 0.150044 | P | 0.178965 | -0.028921 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1234 | A | 0.121905 | T | 0.126234 | -0.004329 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1245 | F | 0.181018 | C | 0.186605 | -0.005587 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1245 | F | 0.181018 | V | 0.203401 | -0.022383 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1250 | I | 0.154294 | T | 0.250018 | -0.095724 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1275 | R | 0.212524 | L | 0.119938 | 0.092586 | No Change: Both O | - |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1275 | R | 0.212524 | Q | 0.212747 | -2.23E-04 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q9UM73 | ALK_HUMAN ALK tyrosine kinase receptor OS=Homo sapiens GN=ALK PE=1 SV=3 | 1278 | Y | 0.231234 | S | 0.38655 | -0.155316 | No Change: Both O | Neuroblastoma type 3 (NBLST3) [MIM:613014] |
| Q13686 | ALKB1_HUMAN Alkylated DNA repair protein alkB homolog 1 OS=Homo sapiens GN=ALKBH1 PE=1 SV=2 | 135 | M | 0.623027 | I | 0.531643 | 0.091384 | No Change: Both D | - |
| Q13686 | ALKB1_HUMAN Alkylated DNA repair protein alkB homolog 1 OS=Homo sapiens GN=ALKBH1 PE=1 SV=2 | 324 | M | 0.385396 | L | 0.31278 | 0.072616 | No Change: Both O | - |
| Q6NS38 | ALKB2_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2 OS=Homo sapiens GN=ALKBH2 PE=1 SV=1 | 203 | R | 0.724713 | H | 0.700665 | 0.024048 | No Change: Both D | - |
| Q96Q83 | ALKB3_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 OS=Homo sapiens GN=ALKBH3 PE=1 SV=1 | 228 | D | 0.530361 | E | 0.576909 | -0.046548 | No Change: Both D | - |
| Q96Q83 | ALKB3_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 OS=Homo sapiens GN=ALKBH3 PE=1 SV=1 | 164 | R | 0.530377 | C | 0.344921 | 0.185456 | D to O | - |
| Q9NXW9 | ALKB4_HUMAN Probable alpha-ketoglutarate-dependent dioxygenase ABH4 OS=Homo sapiens GN=ALKBH4 PE=1 SV=1 | 247 | A | 0.195771 | V | 0.143457 | 0.052314 | No Change: Both O | - |
| Q9BT30 | ALKB7_HUMAN Probable alpha-ketoglutarate-dependent dioxygenase ABH7 OS=Homo sapiens GN=ALKBH7 PE=2 SV=1 | 191 | R | 0.783624 | Q | 0.734158 | 0.049466 | No Change: Both D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 671 | V | 0.459552 | G | 0.545527 | -0.085975 | O to D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 2111 | S | 0.623064 | R | 0.54796 | 0.075104 | No Change: Both D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 2574 | S | 0.431307 | N | 0.325132 | 0.106175 | No Change: Both O | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 2672 | D | 0.652019 | H | 0.595083 | 0.056936 | No Change: Both D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 1412 | G | 0.657422 | A | 0.617701 | 0.039721 | No Change: Both D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 1875 | I | 0.403013 | V | 0.431342 | -0.028329 | No Change: Both O | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 2284 | R | 0.308306 | P | 0.34562 | -0.037314 | No Change: Both O | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 2856 | N | 0.735953 | S | 0.788383 | -0.05243 | No Change: Both D | - |
| Q8TCU4 | ALMS1_HUMAN Alstrom syndrome protein 1 OS=Homo sapiens GN=ALMS1 PE=1 SV=3 | 3434 | K | 0.852382 | E | 0.858066 | -0.005684 | No Change: Both D | - |
| Q96L16 | ALM1L_HUMAN Putative ALMS1-like protein OS=Homo sapiens GN=ALMS1P PE=5 SV=1 | 52 | N | 0.42877 | S | 0.486945 | -0.058175 | No Change: Both O | - |
| P18054 | LOX12_HUMAN Arachidonate 12-lipoxygenase 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4 | 298 | A | 0.27202 | T | 0.273161 | -0.001141 | No Change: Both O | - |
| P18054 | LOX12_HUMAN Arachidonate 12-lipoxygenase 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4 | 261 | Q | 0.620987 | R | 0.593675 | 0.027312 | No Change: Both D | - |
| P18054 | LOX12_HUMAN Arachidonate 12-lipoxygenase 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4 | 322 | N | 0.80091 | S | 0.839701 | -0.038791 | No Change: Both D | - |
| P18054 | LOX12_HUMAN Arachidonate 12-lipoxygenase 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4 | 430 | R | 0.269733 | H | 0.261825 | 0.007908 | No Change: Both O | - |
| P18054 | LOX12_HUMAN Arachidonate 12-lipoxygenase 12S-type OS=Homo sapiens GN=ALOX12 PE=1 SV=4 | 259 | E | 0.595962 | K | 0.573505 | 0.022457 | No Change: Both D | - |
| O75342 | LX12B_HUMAN Arachidonate 12-lipoxygenase 12R-type OS=Homo sapiens GN=ALOX12B PE=1 SV=1 | 426 | L | 0.156709 | P | 0.290737 | -0.134028 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| O75342 | LX12B_HUMAN Arachidonate 12-lipoxygenase 12R-type OS=Homo sapiens GN=ALOX12B PE=1 SV=1 | 578 | H | 0.251242 | Q | 0.264898 | -0.013656 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| O75342 | LX12B_HUMAN Arachidonate 12-lipoxygenase 12R-type OS=Homo sapiens GN=ALOX12B PE=1 SV=1 | 94 | G | 0.127697 | S | 0.159791 | -0.032094 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 90 | D | 0.397834 | H | 0.362375 | 0.035459 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 103 | N | 0.239957 | K | 0.27904 | -0.039083 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 205 | R | 0.052966 | Q | 0.061229 | -0.008263 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 102 | G | 0.201437 | V | 0.124635 | 0.076802 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 239 | V | 0.252917 | M | 0.299128 | -0.046211 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 461 | A | 0.17535 | P | 0.222181 | -0.046831 | No Change: Both O | - |
| P16050 | LOX15_HUMAN Arachidonate 15-lipoxygenase OS=Homo sapiens GN=ALOX15 PE=1 SV=3 | 560 | T | 0.315147 | M | 0.281625 | 0.033522 | No Change: Both O | - |
| O15296 | LX15B_HUMAN Arachidonate 15-lipoxygenase B OS=Homo sapiens GN=ALOX15B PE=2 SV=3 | 656 | Q | 0.320636 | R | 0.313904 | 0.006732 | No Change: Both O | - |
| O15296 | LX15B_HUMAN Arachidonate 15-lipoxygenase B OS=Homo sapiens GN=ALOX15B PE=2 SV=3 | 676 | I | 0.791866 | V | 0.803437 | -0.011571 | No Change: Both D | - |
| O15296 | LX15B_HUMAN Arachidonate 15-lipoxygenase B OS=Homo sapiens GN=ALOX15B PE=2 SV=3 | 486 | R | 0.081284 | H | 0.077791 | 0.003493 | No Change: Both O | - |
| P09917 | LOX5_HUMAN Arachidonate 5-lipoxygenase OS=Homo sapiens GN=ALOX5 PE=1 SV=2 | 254 | E | 0.465217 | K | 0.454308 | 0.010909 | No Change: Both O | - |
| Q9BYJ1 | LOXE3_HUMAN Epidermis-type lipoxygenase 3 OS=Homo sapiens GN=ALOXE3 PE=1 SV=1 | 396 | R | 0.147152 | S | 0.199725 | -0.052573 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| Q9BYJ1 | LOXE3_HUMAN Epidermis-type lipoxygenase 3 OS=Homo sapiens GN=ALOXE3 PE=1 SV=1 | 500 | V | 0.18149 | F | 0.160029 | 0.021461 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| P09923 | PPBI_HUMAN Intestinal-type alkaline phosphatase OS=Homo sapiens GN=ALPI PE=1 SV=2 | 298 | H | 0.507697 | L | 0.433958 | 0.073739 | D to O | - |
| P09923 | PPBI_HUMAN Intestinal-type alkaline phosphatase OS=Homo sapiens GN=ALPI PE=1 SV=2 | 144 | R | 0.375461 | H | 0.352652 | 0.022809 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 175 | N | 0.362702 | D | 0.363278 | -5.76E-04 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 565 | G | 0.775268 | D | 0.801263 | -0.025995 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 642 | H | 0.933041 | R | 0.939722 | -0.006681 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 732 | M | 0.825411 | I | 0.789018 | 0.036393 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 861 | M | 0.709353 | T | 0.747973 | -0.03862 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 870 | G | 0.583068 | S | 0.646666 | -0.063598 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 916 | N | 0.860284 | D | 0.851929 | 0.008355 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 67 | Q | 0.307649 | R | 0.276161 | 0.031488 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 292 | T | 0.093877 | M | 0.073037 | 0.02084 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 320 | L | 0.484611 | M | 0.51856 | -0.033949 | O to D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 339 | K | 0.4292 | E | 0.447728 | -0.018528 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 383 | K | 0.410478 | E | 0.41971 | -0.009232 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 660 | P | 0.971974 | L | 0.949674 | 0.0223 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 681 | G | 0.825649 | D | 0.805708 | 0.019941 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 873 | R | 0.555857 | I | 0.393192 | 0.162665 | D to O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 910 | E | 0.841211 | D | 0.821761 | 0.01945 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 935 | P | 0.920692 | L | 0.869898 | 0.050794 | No Change: Both D | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 1084 | R | 0.433755 | Q | 0.474905 | -0.04115 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 1117 | L | 0.083988 | P | 0.159349 | -0.075361 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 1160 | A | 0.222321 | G | 0.281364 | -0.059043 | No Change: Both O | - |
| Q96QP1 | ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens GN=ALPK1 PE=2 SV=3 | 1008 | H | 0.445966 | P | 0.486401 | -0.040435 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 942 | E | 0.927328 | K | 0.920052 | 0.007276 | No Change: Both D | An ovarian undifferentiated carcinoma sample |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1296 | L | 0.760171 | V | 0.756754 | 0.003417 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1476 | K | 0.883554 | T | 0.872269 | 0.011285 | No Change: Both D | A melanoma metastatic sample |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1969 | E | 0.413991 | K | 0.42298 | -0.008989 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 2 | K | 0.856329 | T | 0.83305 | 0.023279 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 136 | R | 0.960416 | S | 0.963638 | -0.003222 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 719 | H | 0.793142 | Q | 0.831332 | -0.03819 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 810 | G | 0.435554 | S | 0.488681 | -0.053127 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 825 | R | 0.429837 | T | 0.437839 | -0.008002 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 829 | K | 0.46954 | N | 0.438091 | 0.031449 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 884 | S | 0.794318 | L | 0.649811 | 0.144507 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 891 | T | 0.595929 | I | 0.421567 | 0.174362 | D to O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 916 | N | 0.692057 | K | 0.706688 | -0.014631 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 977 | S | 0.803435 | T | 0.767889 | 0.035546 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1057 | L | 0.485459 | V | 0.484674 | 7.85E-04 | No Change: Both O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1134 | K | 0.956773 | N | 0.956067 | 7.06E-04 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1174 | H | 0.913962 | P | 0.947791 | -0.033829 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1449 | P | 0.739748 | S | 0.744778 | -0.00503 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1551 | A | 0.484339 | S | 0.626719 | -0.14238 | O to D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1579 | Q | 0.57584 | R | 0.585235 | -0.009395 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1729 | K | 0.783775 | E | 0.779807 | 0.003968 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1730 | K | 0.773576 | E | 0.768885 | 0.004691 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1767 | H | 0.945172 | Y | 0.916651 | 0.028521 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 2157 | I | 0.980988 | V | 0.982577 | -0.001589 | No Change: Both D | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1884 | R | 0.612098 | C | 0.450977 | 0.161121 | D to O | - |
| Q86TB3 | ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens GN=ALPK2 PE=1 SV=3 | 1063 | G | 0.473818 | V | 0.389541 | 0.084277 | No Change: Both O | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 414 | T | 0.776926 | S | 0.840712 | -0.063786 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 579 | G | 0.985447 | E | 0.985822 | -3.75E-04 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 761 | T | 0.910352 | M | 0.899824 | 0.010528 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1299 | P | 0.978636 | L | 0.962107 | 0.016529 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1622 | L | 0.357215 | P | 0.508321 | -0.151106 | O to D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 336 | R | 0.369754 | H | 0.381407 | -0.011653 | No Change: Both O | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 338 | T | 0.34075 | I | 0.212276 | 0.128474 | No Change: Both O | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 433 | Q | 0.91476 | E | 0.922481 | -0.007721 | No Change: Both D | A lung large cell carcinoma sample |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 602 | Q | 0.844007 | R | 0.836613 | 0.007394 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 663 | G | 0.982749 | D | 0.979633 | 0.003116 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 836 | R | 0.98322 | L | 0.963493 | 0.019727 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 929 | E | 0.971316 | D | 0.959709 | 0.011607 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1364 | G | 0.907483 | E | 0.930091 | -0.022608 | No Change: Both D | A metastatic melanoma sample |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1412 | R | 0.990531 | W | 0.975286 | 0.015245 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1557 | A | 0.467214 | D | 0.539611 | -0.072397 | O to D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1013 | E | 0.922453 | K | 0.903685 | 0.018768 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1137 | A | 0.800593 | G | 0.828541 | -0.027948 | No Change: Both D | - |
| Q96L96 | ALPK3_HUMAN Alpha-protein kinase 3 OS=Homo sapiens GN=ALPK3 PE=2 SV=2 | 1873 | A | 0.997078 | V | 0.996049 | 0.001029 | No Change: Both D | - |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 33 | A | 0.369547 | V | 0.281267 | 0.08828 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 62 | M | 0.224287 | L | 0.181094 | 0.043193 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 71 | R | 0.24441 | C | 0.131499 | 0.112911 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 71 | R | 0.24441 | P | 0.277341 | -0.032931 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 111 | A | 0.415803 | T | 0.440544 | -0.024741 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 136 | R | 0.573824 | H | 0.546244 | 0.02758 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 162 | G | 0.329839 | V | 0.238417 | 0.091422 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 171 | H | 0.446576 | Y | 0.34403 | 0.102546 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 177 | A | 0.570931 | T | 0.585339 | -0.014408 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 179 | A | 0.527087 | T | 0.541471 | -0.014384 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 191 | E | 0.601455 | G | 0.53655 | 0.064905 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 191 | E | 0.601455 | K | 0.585592 | 0.015863 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 201 | C | 0.297031 | Y | 0.342835 | -0.045804 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 207 | Q | 0.146922 | P | 0.163708 | -0.016786 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 263 | Y | 0.392563 | H | 0.521773 | -0.12921 | O to D | - |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 289 | L | 0.180057 | F | 0.157085 | 0.022972 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 294 | D | 0.349548 | A | 0.266455 | 0.083093 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 306 | D | 0.564975 | V | 0.404089 | 0.160886 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 327 | F | 0.163376 | L | 0.187905 | -0.024529 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 334 | G | 0.371597 | D | 0.387233 | -0.015636 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 378 | D | 0.306016 | V | 0.190409 | 0.115607 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 382 | V | 0.254661 | I | 0.22332 | 0.031341 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 436 | Y | 0.337529 | H | 0.454285 | -0.116756 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 476 | E | 0.392573 | K | 0.394141 | -0.001568 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 40 | A | 0.313679 | V | 0.234583 | 0.079096 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 134 | T | 0.5483 | N | 0.56707 | -0.01877 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 176 | A | 0.6053 | T | 0.619924 | -0.014624 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 224 | K | 0.400402 | E | 0.38464 | 0.015762 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 246 | R | 0.469437 | S | 0.521824 | -0.052387 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 348 | A | 0.596775 | T | 0.596501 | 2.74E-04 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 381 | H | 0.254391 | R | 0.254983 | -5.92E-04 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 406 | D | 0.531328 | G | 0.498113 | 0.033215 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 426 | G | 0.49343 | C | 0.301116 | 0.192314 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 450 | R | 0.532965 | H | 0.562388 | -0.029423 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 456 | G | 0.510676 | R | 0.496214 | 0.014462 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 478 | N | 0.359472 | I | 0.214442 | 0.14503 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 489 | C | 0.110708 | S | 0.248147 | -0.137439 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 522 | V | 0.421851 | A | 0.598552 | -0.176701 | O to D | - |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 132 | A | 0.526207 | V | 0.459037 | 0.06717 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 28 | Y | 0.551262 | C | 0.496175 | 0.055087 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 51 | A | 0.180517 | V | 0.145349 | 0.035168 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 63 | G | 0.234944 | V | 0.145344 | 0.0896 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 71 | R | 0.24441 | H | 0.258618 | -0.014208 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 75 | G | 0.378103 | S | 0.42035 | -0.042247 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 116 | A | 0.283207 | T | 0.313523 | -0.030316 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 120 | G | 0.291227 | R | 0.287579 | 0.003648 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 129 | G | 0.508606 | R | 0.510123 | -0.001517 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 152 | R | 0.28414 | H | 0.243123 | 0.041017 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 170 | N | 0.401848 | D | 0.423784 | -0.021936 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 181 | S | 0.492445 | L | 0.28071 | 0.211735 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 184 | R | 0.500797 | W | 0.319944 | 0.180853 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 211 | N | 0.169371 | D | 0.204393 | -0.035022 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 220 | G | 0.271604 | V | 0.175423 | 0.096181 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 223 | R | 0.360478 | W | 0.179809 | 0.180669 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 235 | E | 0.678848 | G | 0.62528 | 0.053568 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 249 | G | 0.328463 | V | 0.217891 | 0.110572 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 291 | E | 0.235888 | K | 0.225509 | 0.010379 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 294 | D | 0.349548 | Y | 0.217945 | 0.131603 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 326 | G | 0.178713 | R | 0.177206 | 0.001507 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 327 | F | 0.163376 | G | 0.294559 | -0.131183 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 391 | R | 0.316757 | C | 0.190535 | 0.126222 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 399 | A | 0.253071 | S | 0.380668 | -0.127597 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 423 | V | 0.465346 | A | 0.520619 | -0.055273 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 445 | S | 0.462241 | P | 0.450151 | 0.01209 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 450 | R | 0.532965 | C | 0.367247 | 0.165718 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 459 | V | 0.475359 | M | 0.522381 | -0.047022 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 473 | G | 0.31309 | S | 0.353364 | -0.040274 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 490 | I | 0.128957 | F | 0.135703 | -0.006746 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 491 | G | 0.143779 | R | 0.125749 | 0.01803 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 17 | S | 0.292755 | F | 0.137694 | 0.155061 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 51 | A | 0.180517 | S | 0.258869 | -0.078352 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 62 | M | 0.224287 | V | 0.187476 | 0.036811 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 63 | G | 0.234944 | R | 0.215292 | 0.019652 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 68 | T | 0.204803 | M | 0.172191 | 0.032612 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 71 | R | 0.24441 | S | 0.310098 | -0.065688 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 76 | Q | 0.413821 | R | 0.413184 | 6.37E-04 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 108 | P | 0.477205 | L | 0.366722 | 0.110483 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 114 | A | 0.324523 | G | 0.356235 | -0.031712 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 128 | V | 0.492004 | M | 0.529047 | -0.037043 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 134 | T | 0.5483 | H | 0.524951 | 0.023349 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 148 | T | 0.295338 | I | 0.174141 | 0.121197 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 162 | G | 0.329839 | S | 0.394755 | -0.064916 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 171 | H | 0.446576 | R | 0.461979 | -0.015403 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 189 | D | 0.592706 | E | 0.615761 | -0.023055 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 212 | I | 0.174072 | F | 0.14959 | 0.024482 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 220 | G | 0.271604 | A | 0.218812 | 0.052792 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 223 | R | 0.360478 | Q | 0.36997 | -0.009492 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 272 | R | 0.168944 | H | 0.18462 | -0.015676 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 272 | R | 0.168944 | L | 0.111464 | 0.05748 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 275 | L | 0.1763 | P | 0.303614 | -0.127314 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 292 | P | 0.285548 | T | 0.237708 | 0.04784 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 295 | M | 0.365188 | T | 0.414561 | -0.049373 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 297 | Y | 0.418982 | D | 0.604964 | -0.185982 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 298 | E | 0.434524 | K | 0.422694 | 0.01183 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 299 | L | 0.461381 | P | 0.646036 | -0.184655 | O to D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 311 | E | 0.248808 | K | 0.248364 | 4.44E-04 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 339 | G | 0.63043 | R | 0.614261 | 0.016169 | No Change: Both D | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 354 | E | 0.435863 | D | 0.408936 | 0.026927 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 391 | R | 0.316757 | H | 0.321182 | -0.004425 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 411 | T | 0.251638 | A | 0.229193 | 0.022445 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 414 | L | 0.173933 | M | 0.226348 | -0.052415 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 417 | N | 0.227831 | S | 0.262594 | -0.034763 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 426 | G | 0.49343 | D | 0.498241 | -0.004811 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 452 | E | 0.506347 | K | 0.491228 | 0.015119 | D to O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05186 | PPBT_HUMAN Alkaline phosphatase tissue-nonspecific isozyme OS=Homo sapiens GN=ALPL PE=1 SV=4 | 468 | A | 0.336999 | T | 0.360838 | -0.023839 | No Change: Both O | Hypophosphatasia (HOPS) [MIM:146300] |
| P05187 | PPB1_HUMAN Alkaline phosphatase placental type OS=Homo sapiens GN=ALPP PE=1 SV=2 | 25 | P | 0.278909 | L | 0.162112 | 0.116797 | No Change: Both O | - |
| P05187 | PPB1_HUMAN Alkaline phosphatase placental type OS=Homo sapiens GN=ALPP PE=1 SV=2 | 89 | I | 0.354658 | L | 0.406078 | -0.05142 | No Change: Both O | - |
| P05187 | PPB1_HUMAN Alkaline phosphatase placental type OS=Homo sapiens GN=ALPP PE=1 SV=2 | 231 | R | 0.398157 | P | 0.446277 | -0.04812 | No Change: Both O | - |
| P05187 | PPB1_HUMAN Alkaline phosphatase placental type OS=Homo sapiens GN=ALPP PE=1 SV=2 | 263 | R | 0.213573 | H | 0.185825 | 0.027748 | No Change: Both O | - |
| P05187 | PPB1_HUMAN Alkaline phosphatase placental type OS=Homo sapiens GN=ALPP PE=1 SV=2 | 451 | E | 0.700085 | G | 0.652641 | 0.047444 | No Change: Both D | - |
| P10696 | PPBN_HUMAN Alkaline phosphatase placental-like OS=Homo sapiens GN=ALPPL2 PE=1 SV=4 | 34 | Q | 0.296968 | E | 0.361979 | -0.065011 | No Change: Both O | - |
| P10696 | PPBN_HUMAN Alkaline phosphatase placental-like OS=Homo sapiens GN=ALPPL2 PE=1 SV=4 | 273 | L | 0.247857 | M | 0.284134 | -0.036277 | No Change: Both O | - |
| P10696 | PPBN_HUMAN Alkaline phosphatase placental-like OS=Homo sapiens GN=ALPPL2 PE=1 SV=4 | 316 | L | 0.258762 | R | 0.372408 | -0.113646 | No Change: Both O | - |
| P10696 | PPBN_HUMAN Alkaline phosphatase placental-like OS=Homo sapiens GN=ALPPL2 PE=1 SV=4 | 527 | G | 0.688345 | E | 0.673493 | 0.014852 | No Change: Both D | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 102 | H | 0.401036 | R | 0.395077 | 0.005959 | No Change: Both O | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 368 | V | 0.882727 | M | 0.89992 | -0.017193 | No Change: Both D | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 1406 | R | 0.240699 | K | 0.295827 | -0.055128 | No Change: Both O | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 94 | I | 0.098855 | V | 0.125359 | -0.026504 | No Change: Both O | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 159 | E | 0.253427 | K | 0.238756 | 0.014671 | No Change: Both O | - |
| Q96Q42 | ALS2_HUMAN Alsin OS=Homo sapiens GN=ALS2 PE=1 SV=2 | 1255 | S | 0.3245 | F | 0.158766 | 0.165734 | No Change: Both O | - |
| Q60I27 | AL2CL_HUMAN ALS2 C-terminal-like protein OS=Homo sapiens GN=ALS2CL PE=1 SV=1 | 45 | E | 0.483072 | Q | 0.479132 | 0.00394 | No Change: Both O | - |
| Q60I27 | AL2CL_HUMAN ALS2 C-terminal-like protein OS=Homo sapiens GN=ALS2CL PE=1 SV=1 | 280 | Q | 0.194625 | E | 0.232105 | -0.03748 | No Change: Both O | A breast cancer sample |
| Q60I27 | AL2CL_HUMAN ALS2 C-terminal-like protein OS=Homo sapiens GN=ALS2CL PE=1 SV=1 | 576 | L | 0.561936 | F | 0.528304 | 0.033632 | No Change: Both D | A breast cancer sample |
| Q60I27 | AL2CL_HUMAN ALS2 C-terminal-like protein OS=Homo sapiens GN=ALS2CL PE=1 SV=1 | 29 | Q | 0.402423 | R | 0.406348 | -0.003925 | No Change: Both O | - |
| Q53TS8 | AL2SA_HUMAN Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein OS=Homo sapiens GN=ALS2CR11 PE=2 SV=1 | 376 | H | 0.913942 | Q | 0.919762 | -0.00582 | No Change: Both D | - |
| Q53TS8 | AL2SA_HUMAN Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein OS=Homo sapiens GN=ALS2CR11 PE=2 SV=1 | 123 | K | 0.263707 | M | 0.171013 | 0.092694 | No Change: Both O | A colorectal cancer sample |
| Q96Q35 | AL2SB_HUMAN Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein OS=Homo sapiens GN=ALS2CR12 PE=1 SV=2 | 43 | V | 0.860213 | L | 0.882664 | -0.022451 | No Change: Both D | - |
| O95076 | ALX3_HUMAN Homeobox protein aristaless-like 3 OS=Homo sapiens GN=ALX3 PE=1 SV=2 | 234 | P | 0.49155 | A | 0.399846 | 0.091704 | No Change: Both O | - |
| O95076 | ALX3_HUMAN Homeobox protein aristaless-like 3 OS=Homo sapiens GN=ALX3 PE=1 SV=2 | 168 | L | 0.556686 | V | 0.542805 | 0.013881 | No Change: Both D | Frontonasal dysplasia type 1 (FND1) [MIM:136760] |
| O95076 | ALX3_HUMAN Homeobox protein aristaless-like 3 OS=Homo sapiens GN=ALX3 PE=1 SV=2 | 183 | R | 0.334779 | W | 0.162025 | 0.172754 | No Change: Both O | Frontonasal dysplasia type 1 (FND1) [MIM:136760] |
| O95076 | ALX3_HUMAN Homeobox protein aristaless-like 3 OS=Homo sapiens GN=ALX3 PE=1 SV=2 | 196 | R | 0.216014 | W | 0.088767 | 0.127247 | No Change: Both O | Frontonasal dysplasia type 1 (FND1) [MIM:136760] |
| O95076 | ALX3_HUMAN Homeobox protein aristaless-like 3 OS=Homo sapiens GN=ALX3 PE=1 SV=2 | 203 | N | 0.215169 | S | 0.246387 | -0.031218 | No Change: Both O | Frontonasal dysplasia type 1 (FND1) [MIM:136760] |
| Q9H161 | ALX4_HUMAN Homeobox protein aristaless-like 4 OS=Homo sapiens GN=ALX4 PE=1 SV=2 | 35 | R | 0.751046 | T | 0.730932 | 0.020114 | No Change: Both D | - |
| Q9H161 | ALX4_HUMAN Homeobox protein aristaless-like 4 OS=Homo sapiens GN=ALX4 PE=1 SV=2 | 102 | P | 0.999474 | S | 0.99936 | 1.14E-04 | No Change: Both D | - |
| Q9H161 | ALX4_HUMAN Homeobox protein aristaless-like 4 OS=Homo sapiens GN=ALX4 PE=1 SV=2 | 218 | R | 0.791871 | Q | 0.793065 | -0.001194 | No Change: Both D | Parietal foramina 2 (PFM2) [MIM:609597] |
| Q9H161 | ALX4_HUMAN Homeobox protein aristaless-like 4 OS=Homo sapiens GN=ALX4 PE=1 SV=2 | 272 | R | 0.510969 | P | 0.50119 | 0.009779 | No Change: Both D | Parietal foramina 2 (PFM2) [MIM:609597] |
| Q9H161 | ALX4_HUMAN Homeobox protein aristaless-like 4 OS=Homo sapiens GN=ALX4 PE=1 SV=2 | 257 | R | 0.291302 | T | 0.257125 | 0.034177 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 9 | V | 0.24171 | M | 0.295227 | -0.053517 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 52 | S | 0.669803 | P | 0.672215 | -0.002412 | No Change: Both D | Alpha-methylacyl-CoA racemase deficiency (AMACRD) [MIM:614307] |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 52 | S | 0.669803 | P | 0.672215 | -0.002412 | No Change: Both D | Congenital bile acid synthesis defect type 4 (CBAS4) [MIM:214950] |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 175 | G | 0.425119 | D | 0.461275 | -0.036156 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 201 | L | 0.203885 | S | 0.356178 | -0.152293 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 277 | E | 0.355436 | K | 0.367431 | -0.011995 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 107 | L | 0.259398 | P | 0.40599 | -0.146592 | No Change: Both O | Congenital bile acid synthesis defect type 4 (CBAS4) [MIM:214950] |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 118 | R | 0.205768 | Q | 0.226261 | -0.020493 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 238 | P | 0.150948 | S | 0.15623 | -0.005282 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 239 | Q | 0.148099 | H | 0.122145 | 0.025954 | No Change: Both O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 261 | M | 0.585542 | I | 0.461361 | 0.124181 | D to O | - |
| Q9UHK6 | AMACR_HUMAN Alpha-methylacyl-CoA racemase OS=Homo sapiens GN=AMACR PE=1 SV=2 | 261 | M | 0.585542 | T | 0.591229 | -0.005687 | No Change: Both D | - |
| Q9NP70 | AMBN_HUMAN Ameloblastin OS=Homo sapiens GN=AMBN PE=2 SV=1 | 11 | M | 0.219737 | T | 0.200681 | 0.019056 | No Change: Both O | - |
| Q9NP70 | AMBN_HUMAN Ameloblastin OS=Homo sapiens GN=AMBN PE=2 SV=1 | 354 | L | 0.871461 | P | 0.928055 | -0.056594 | No Change: Both D | - |
| Q9NP70 | AMBN_HUMAN Ameloblastin OS=Homo sapiens GN=AMBN PE=2 SV=1 | 439 | H | 0.908931 | R | 0.908717 | 2.14E-04 | No Change: Both D | - |
| Q9NP70 | AMBN_HUMAN Ameloblastin OS=Homo sapiens GN=AMBN PE=2 SV=1 | 255 | A | 0.497949 | V | 0.410349 | 0.0876 | No Change: Both O | - |
| Q96NU7 | HUTI_HUMAN Probable imidazolonepropionase OS=Homo sapiens GN=AMDHD1 PE=2 SV=2 | 3 | S | 0.715889 | G | 0.729286 | -0.013397 | No Change: Both D | - |
| Q96NU7 | HUTI_HUMAN Probable imidazolonepropionase OS=Homo sapiens GN=AMDHD1 PE=2 SV=2 | 360 | P | 0.37984 | H | 0.348447 | 0.031393 | No Change: Both O | - |
| Q9Y303 | NAGA_HUMAN Putative N-acetylglucosamine-6-phosphate deacetylase OS=Homo sapiens GN=AMDHD2 PE=2 SV=2 | 294 | D | 0.13597 | N | 0.130182 | 0.005788 | No Change: Both O | A colorectal cancer sample |
| Q99217 | AMELX_HUMAN Amelogenin X isoform OS=Homo sapiens GN=AMELX PE=1 SV=1 | 4 | W | 0.12554 | S | 0.38568 | -0.26014 | No Change: Both O | Amelogenesis imperfecta type 1E (AI1E) [MIM:301200] |
| Q99217 | AMELX_HUMAN Amelogenin X isoform OS=Homo sapiens GN=AMELX PE=1 SV=1 | 37 | T | 0.107124 | I | 0.064345 | 0.042779 | No Change: Both O | Amelogenesis imperfecta type 1E (AI1E) [MIM:301200] |
| Q99217 | AMELX_HUMAN Amelogenin X isoform OS=Homo sapiens GN=AMELX PE=1 SV=1 | 56 | P | 0.429536 | T | 0.357708 | 0.071828 | No Change: Both O | Amelogenesis imperfecta type 1E (AI1E) [MIM:301200] |
| P26442 | AMFR1_HUMAN Autocrine motility factor receptor isoform 1 OS=Homo sapiens GN=AMFR PE=1 SV=1 | 181 | I | 0.743032 | V | 0.79445 | -0.051418 | No Change: Both D | - |
| Q9UKV5 | AMFR2_HUMAN E3 ubiquitin-protein ligase AMFR OS=Homo sapiens GN=AMFR PE=1 SV=2 | 605 | D | 0.944129 | V | 0.906222 | 0.037907 | No Change: Both D | A breast cancer sample |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 12 | V | 0.235989 | G | 0.409587 | -0.173598 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 49 | S | 0.588185 | I | 0.364964 | 0.223221 | D to O | - |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 70 | L | 0.523543 | P | 0.631336 | -0.107793 | No Change: Both D | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 101 | G | 0.201098 | V | 0.120585 | 0.080513 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 123 | R | 0.39056 | W | 0.207043 | 0.183517 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 167 | Y | 0.696535 | C | 0.751853 | -0.055318 | No Change: Both D | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 185 | Q | 0.540186 | E | 0.582299 | -0.042113 | No Change: Both D | - |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 194 | R | 0.417383 | C | 0.303865 | 0.113518 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 325 | Q | 0.688078 | R | 0.740705 | -0.052627 | No Change: Both D | - |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 477 | V | 0.347482 | A | 0.432094 | -0.084612 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 506 | H | 0.180268 | Q | 0.210493 | -0.030225 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 525 | C | 0.172633 | Y | 0.187194 | -0.014561 | No Change: Both O | Persistent Muellerian duct syndrome type 1 (PMDS1) [MIM:261550] |
| P03971 | MIS_HUMAN Muellerian-inhibiting factor OS=Homo sapiens GN=AMH PE=1 SV=3 | 515 | V | 0.193728 | A | 0.265469 | -0.071741 | No Change: Both O | - |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 54 | R | 0.115456 | C | 0.068869 | 0.046587 | No Change: Both O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 142 | G | 0.454061 | V | 0.311414 | 0.142647 | No Change: Both O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 282 | H | 0.317765 | Q | 0.327256 | -0.009491 | No Change: Both O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 406 | R | 0.175549 | Q | 0.178024 | -0.002475 | No Change: Both O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 426 | D | 0.514761 | G | 0.471164 | 0.043597 | D to O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 458 | V | 0.340552 | A | 0.46624 | -0.125688 | No Change: Both O | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 491 | D | 0.603665 | H | 0.525206 | 0.078459 | No Change: Both D | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q16671 | AMHR2_HUMAN Anti-Muellerian hormone type-2 receptor OS=Homo sapiens GN=AMHR2 PE=1 SV=1 | 504 | R | 0.80011 | C | 0.772465 | 0.027645 | No Change: Both D | Persistent Muellerian duct syndrome type 2 (PMDS2) [MIM:261550] |
| Q86YT9 | JAML1_HUMAN Junctional adhesion molecule-like OS=Homo sapiens GN=AMICA1 PE=1 SV=1 | 94 | I | 0.159754 | N | 0.327572 | -0.167818 | No Change: Both O | - |
| Q86YT9 | JAML1_HUMAN Junctional adhesion molecule-like OS=Homo sapiens GN=AMICA1 PE=1 SV=1 | 193 | V | 0.421617 | A | 0.510232 | -0.088615 | O to D | - |
| Q86YT9 | JAML1_HUMAN Junctional adhesion molecule-like OS=Homo sapiens GN=AMICA1 PE=1 SV=1 | 322 | I | 0.799736 | M | 0.831828 | -0.032092 | No Change: Both D | - |
| Q9BXJ7 | AMNLS_HUMAN Protein amnionless OS=Homo sapiens GN=AMN PE=1 SV=2 | 41 | T | 0.326028 | I | 0.204652 | 0.121376 | No Change: Both O | Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100] |
| Q8IY63 | AMOL1_HUMAN Angiomotin-like protein 1 OS=Homo sapiens GN=AMOTL1 PE=1 SV=1 | 847 | P | 0.945962 | L | 0.913564 | 0.032398 | No Change: Both D | - |
| Q9Y2J4 | AMOL2_HUMAN Angiomotin-like protein 2 OS=Homo sapiens GN=AMOTL2 PE=1 SV=3 | 731 | E | 0.983752 | D | 0.983922 | -1.70E-04 | No Change: Both D | - |
| Q9Y2J4 | AMOL2_HUMAN Angiomotin-like protein 2 OS=Homo sapiens GN=AMOTL2 PE=1 SV=3 | 227 | T | 0.675972 | I | 0.556447 | 0.119525 | No Change: Both D | - |
| Q9Y2J4 | AMOL2_HUMAN Angiomotin-like protein 2 OS=Homo sapiens GN=AMOTL2 PE=1 SV=3 | 342 | A | 0.971165 | P | 0.972983 | -0.001818 | No Change: Both D | - |
| Q9Y2J4 | AMOL2_HUMAN Angiomotin-like protein 2 OS=Homo sapiens GN=AMOTL2 PE=1 SV=3 | 415 | G | 0.926197 | S | 0.953862 | -0.027665 | No Change: Both D | - |
| P23109 | AMPD1_HUMAN AMP deaminase 1 OS=Homo sapiens GN=AMPD1 PE=1 SV=1 | 48 | P | 0.426036 | L | 0.266129 | 0.159907 | No Change: Both O | - |
| P23109 | AMPD1_HUMAN AMP deaminase 1 OS=Homo sapiens GN=AMPD1 PE=1 SV=1 | 388 | R | 0.2826 | W | 0.130338 | 0.152262 | No Change: Both O | Adenosine monophosphate deaminase deficiency muscle type (AMPDDM) [MIM:102770] |
| P23109 | AMPD1_HUMAN AMP deaminase 1 OS=Homo sapiens GN=AMPD1 PE=1 SV=1 | 425 | R | 0.479075 | H | 0.487863 | -0.008788 | No Change: Both O | Adenosine monophosphate deaminase deficiency muscle type (AMPDDM) [MIM:102770] |
| P23109 | AMPD1_HUMAN AMP deaminase 1 OS=Homo sapiens GN=AMPD1 PE=1 SV=1 | 633 | P | 0.192668 | H | 0.152463 | 0.040205 | No Change: Both O | A colorectal cancer sample |
| P23109 | AMPD1_HUMAN AMP deaminase 1 OS=Homo sapiens GN=AMPD1 PE=1 SV=1 | 22 | E | 0.545122 | K | 0.543183 | 0.001939 | No Change: Both D | - |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 573 | R | 0.335183 | C | 0.167977 | 0.167206 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 185 | R | 0.695107 | W | 0.50041 | 0.194697 | No Change: Both D | - |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 310 | N | 0.381122 | K | 0.42857 | -0.047448 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 311 | V | 0.367108 | L | 0.36706 | 4.80E-05 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 320 | A | 0.22528 | V | 0.168085 | 0.057195 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 324 | M | 0.245377 | T | 0.287101 | -0.041724 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 331 | R | 0.189546 | C | 0.105161 | 0.084385 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 402 | R | 0.277162 | C | 0.157523 | 0.119639 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 450 | W | 0.267182 | R | 0.455077 | -0.187895 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 455 | Y | 0.054515 | H | 0.091688 | -0.037173 | No Change: Both O | - |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 585 | P | 0.196493 | L | 0.106572 | 0.089921 | No Change: Both O | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| Q01432 | AMPD3_HUMAN AMP deaminase 3 OS=Homo sapiens GN=AMPD3 PE=1 SV=1 | 712 | Q | 0.627794 | P | 0.623464 | 0.00433 | No Change: Both D | Adenosine monophosphate deaminase deficiency erythrocyte type (AMPDDE) [MIM:612874] |
| P49418 | AMPH_HUMAN Amphiphysin OS=Homo sapiens GN=AMPH PE=1 SV=1 | 218 | K | 0.263834 | E | 0.271278 | -0.007444 | No Change: Both O | - |
| P49418 | AMPH_HUMAN Amphiphysin OS=Homo sapiens GN=AMPH PE=1 SV=1 | 376 | M | 0.622609 | I | 0.507942 | 0.114667 | No Change: Both D | - |
| P49418 | AMPH_HUMAN Amphiphysin OS=Homo sapiens GN=AMPH PE=1 SV=1 | 496 | K | 0.931603 | T | 0.931331 | 2.72E-04 | No Change: Both D | - |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 42 | H | 0.198573 | R | 0.199341 | -7.68E-04 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 47 | G | 0.225891 | R | 0.20881 | 0.017081 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 269 | G | 0.153701 | D | 0.173759 | -0.020058 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 276 | D | 0.281434 | H | 0.252007 | 0.029427 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 320 | R | 0.396885 | H | 0.330709 | 0.066176 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 145 | N | 0.129712 | I | 0.058602 | 0.07111 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P48728 | GCST_HUMAN Aminomethyltransferase mitochondrial OS=Homo sapiens GN=AMT PE=1 SV=1 | 211 | E | 0.183998 | K | 0.184329 | -3.31E-04 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| Q6UX39 | AMTN_HUMAN Amelotin OS=Homo sapiens GN=AMTN PE=1 SV=1 | 78 | G | 0.699239 | S | 0.711876 | -0.012637 | No Change: Both D | A colorectal cancer sample |
| Q6UX39 | AMTN_HUMAN Amelotin OS=Homo sapiens GN=AMTN PE=1 SV=1 | 45 | N | 0.846657 | S | 0.872951 | -0.026294 | No Change: Both D | - |
| Q6UX39 | AMTN_HUMAN Amelotin OS=Homo sapiens GN=AMTN PE=1 SV=1 | 50 | S | 0.785304 | P | 0.81197 | -0.026666 | No Change: Both D | - |
| Q400G9 | AMZ1_HUMAN Archaemetzincin-1 OS=Homo sapiens GN=AMZ1 PE=1 SV=1 | 491 | R | 0.943425 | H | 0.902914 | 0.040511 | No Change: Both D | - |
| Q86W34 | AMZ2_HUMAN Archaemetzincin-2 OS=Homo sapiens GN=AMZ2 PE=1 SV=2 | 30 | N | 0.481779 | D | 0.485762 | -0.003983 | No Change: Both O | - |
| Q86W34 | AMZ2_HUMAN Archaemetzincin-2 OS=Homo sapiens GN=AMZ2 PE=1 SV=2 | 146 | H | 0.400797 | Q | 0.418076 | -0.017279 | No Change: Both O | - |
| Q9UM13 | APC10_HUMAN Anaphase-promoting complex subunit 10 OS=Homo sapiens GN=ANAPC10 PE=1 SV=1 | 46 | R | 0.340884 | Q | 0.377986 | -0.037102 | No Change: Both O | - |
| Q9UJX5 | APC4_HUMAN Anaphase-promoting complex subunit 4 OS=Homo sapiens GN=ANAPC4 PE=1 SV=2 | 155 | I | 0.689782 | V | 0.703971 | -0.014189 | No Change: Both D | A colorectal cancer sample |
| Q9UJX5 | APC4_HUMAN Anaphase-promoting complex subunit 4 OS=Homo sapiens GN=ANAPC4 PE=1 SV=2 | 465 | R | 0.322728 | Q | 0.334958 | -0.01223 | No Change: Both O | - |
| Q9UJX5 | APC4_HUMAN Anaphase-promoting complex subunit 4 OS=Homo sapiens GN=ANAPC4 PE=1 SV=2 | 800 | E | 0.683692 | G | 0.575645 | 0.108047 | No Change: Both D | - |
| Q9UJX4 | APC5_HUMAN Anaphase-promoting complex subunit 5 OS=Homo sapiens GN=ANAPC5 PE=1 SV=2 | 617 | Q | 0.243269 | H | 0.228688 | 0.014581 | No Change: Both O | A breast cancer sample |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 84 | K | 0.679135 | E | 0.672645 | 0.00649 | No Change: Both D | - |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 12 | F | 0.030833 | S | 0.086469 | -0.055636 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 20 | P | 0.318254 | S | 0.335659 | -0.017405 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 36 | Q | 0.353571 | L | 0.225673 | 0.127898 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 41 | K | 0.629719 | E | 0.634643 | -0.004924 | No Change: Both D | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 41 | K | 0.629719 | I | 0.425441 | 0.204278 | D to O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 52 | S | 0.459678 | N | 0.413374 | 0.046304 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 55 | R | 0.465306 | K | 0.483255 | -0.017949 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 63 | C | 0.502216 | W | 0.37446 | 0.127756 | D to O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 64 | K | 0.52294 | I | 0.360412 | 0.162528 | D to O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 70 | I | 0.588022 | V | 0.532781 | 0.055241 | No Change: Both D | - |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 136 | P | 0.171878 | L | 0.095034 | 0.076844 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 137 | V | 0.181387 | I | 0.162955 | 0.018432 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| P03950 | ANGI_HUMAN Angiogenin OS=Homo sapiens GN=ANG PE=1 SV=1 | 138 | H | 0.191354 | R | 0.212726 | -0.021372 | No Change: Both O | Amyotrophic lateral sclerosis type 9 (ALS9) [MIM:611895] |
| Q9UNK9 | ANGE1_HUMAN Protein angel homolog 1 OS=Homo sapiens GN=ANGEL1 PE=1 SV=1 | 141 | G | 0.607073 | W | 0.414534 | 0.192539 | D to O | - |
| Q9UNK9 | ANGE1_HUMAN Protein angel homolog 1 OS=Homo sapiens GN=ANGEL1 PE=1 SV=1 | 515 | F | 0.090399 | C | 0.118483 | -0.028084 | No Change: Both O | - |
| Q9UNK9 | ANGE1_HUMAN Protein angel homolog 1 OS=Homo sapiens GN=ANGEL1 PE=1 SV=1 | 383 | V | 0.15735 | L | 0.156528 | 8.22E-04 | No Change: Both O | - |
| Q5VTE6 | ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens GN=ANGEL2 PE=2 SV=1 | 97 | P | 0.350835 | S | 0.381505 | -0.03067 | No Change: Both O | - |
| O15123 | ANGP2_HUMAN Angiopoietin-2 OS=Homo sapiens GN=ANGPT2 PE=1 SV=1 | 333 | V | 0.398664 | I | 0.376426 | 0.022238 | No Change: Both O | - |
| Q9Y264 | ANGP4_HUMAN Angiopoietin-4 OS=Homo sapiens GN=ANGPT4 PE=1 SV=1 | 395 | E | 0.391612 | K | 0.370971 | 0.020641 | No Change: Both O | - |
| Q9Y5C1 | ANGL3_HUMAN Angiopoietin-related protein 3 OS=Homo sapiens GN=ANGPTL3 PE=1 SV=1 | 418 | N | 0.765218 | Y | 0.657872 | 0.107346 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 266 | T | 0.480808 | M | 0.429788 | 0.05102 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 5 | P | 0.719846 | L | 0.633214 | 0.086632 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 40 | E | 0.32556 | K | 0.322696 | 0.002864 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 41 | M | 0.329923 | I | 0.223148 | 0.106775 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 67 | S | 0.812407 | R | 0.797319 | 0.015088 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 72 | R | 0.829874 | L | 0.753086 | 0.076788 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 77 | G | 0.870934 | R | 0.889306 | -0.018372 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 167 | E | 0.778884 | K | 0.788973 | -0.010089 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 174 | P | 0.73797 | S | 0.728701 | 0.009269 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 190 | E | 0.645128 | Q | 0.65073 | -0.005602 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 196 | E | 0.542278 | K | 0.50924 | 0.033038 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 230 | R | 0.324364 | C | 0.175286 | 0.149078 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 233 | G | 0.397309 | R | 0.409065 | -0.011756 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 237 | F | 0.360806 | V | 0.408376 | -0.04757 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 251 | P | 0.292843 | T | 0.247149 | 0.045694 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 278 | R | 0.218391 | Q | 0.235791 | -0.0174 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 291 | V | 0.218966 | M | 0.27035 | -0.051384 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 293 | L | 0.288179 | M | 0.321633 | -0.033454 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 296 | E | 0.396583 | V | 0.257307 | 0.139276 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 307 | P | 0.309033 | S | 0.338325 | -0.029292 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 308 | V | 0.331595 | M | 0.386862 | -0.055267 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 336 | R | 0.51276 | C | 0.378554 | 0.134206 | D to O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 338 | D | 0.587903 | E | 0.584455 | 0.003448 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 349 | W | 0.24081 | C | 0.330335 | -0.089525 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 361 | G | 0.414772 | R | 0.420643 | -0.005871 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 361 | G | 0.414772 | S | 0.486385 | -0.071613 | No Change: Both O | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 371 | R | 0.513921 | Q | 0.545717 | -0.031796 | No Change: Both D | - |
| Q9BY76 | ANGL4_HUMAN Angiopoietin-related protein 4 OS=Homo sapiens GN=ANGPTL4 PE=1 SV=2 | 384 | R | 0.10534 | W | 0.040207 | 0.065133 | No Change: Both O | - |
| Q86XS5 | ANGL5_HUMAN Angiopoietin-related protein 5 OS=Homo sapiens GN=ANGPTL5 PE=2 SV=3 | 175 | S | 0.384821 | P | 0.370652 | 0.014169 | No Change: Both O | - |
| O43827 | ANGL7_HUMAN Angiopoietin-related protein 7 OS=Homo sapiens GN=ANGPTL7 PE=1 SV=1 | 51 | E | 0.709647 | D | 0.652217 | 0.05743 | No Change: Both D | - |
| O43827 | ANGL7_HUMAN Angiopoietin-related protein 7 OS=Homo sapiens GN=ANGPTL7 PE=1 SV=1 | 140 | R | 0.252247 | H | 0.251934 | 3.13E-04 | No Change: Both O | - |
| O43827 | ANGL7_HUMAN Angiopoietin-related protein 7 OS=Homo sapiens GN=ANGPTL7 PE=1 SV=1 | 175 | Q | 0.259733 | H | 0.246072 | 0.013661 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 21 | R | 0.429868 | T | 0.403207 | 0.026661 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 463 | V | 0.545012 | I | 0.515166 | 0.029846 | No Change: Both D | Spherocytosis type 1 (SPH1) [MIM:182900] |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 619 | R | 0.31152 | H | 0.318441 | -0.006921 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 750 | V | 0.212935 | A | 0.300764 | -0.087829 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 845 | D | 0.751381 | E | 0.777153 | -0.025772 | No Change: Both D | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1392 | S | 0.766107 | T | 0.715778 | 0.050329 | No Change: Both D | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1286 | E | 0.35002 | D | 0.319972 | 0.030048 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1592 | D | 0.865084 | N | 0.826727 | 0.038357 | No Change: Both D | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 991 | V | 0.210001 | L | 0.219546 | -0.009545 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 733 | L | 0.432158 | I | 0.386658 | 0.0455 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1126 | A | 0.318429 | P | 0.457834 | -0.139405 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1192 | T | 0.168058 | P | 0.185019 | -0.016961 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1325 | M | 0.577683 | V | 0.514654 | 0.063029 | No Change: Both D | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1546 | V | 0.132515 | I | 0.118574 | 0.013941 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 332 | D | 0.275563 | H | 0.233563 | 0.042 | No Change: Both O | A breast cancer sample |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1075 | T | 0.338315 | I | 0.230486 | 0.107829 | No Change: Both O | - |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 276 | L | 0.294595 | R | 0.412213 | -0.117618 | No Change: Both O | Spherocytosis type 1 (SPH1) [MIM:182900] |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 1054 | I | 0.084486 | T | 0.151118 | -0.066632 | No Change: Both O | Spherocytosis type 1 (SPH1) [MIM:182900] |
| P16157 | ANK1_HUMAN Ankyrin-1 OS=Homo sapiens GN=ANK1 PE=1 SV=3 | 832 | R | 0.870329 | Q | 0.856472 | 0.013857 | No Change: Both D | - |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 1425 | E | 0.737664 | G | 0.680056 | 0.057608 | No Change: Both D | Long QT syndrome type 4 (LQT4) [MIM:600919] |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 3707 | L | 0.780083 | I | 0.768594 | 0.011489 | No Change: Both D | Long QT syndrome type 4 (LQT4) [MIM:600919] |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 3711 | T | 0.79248 | N | 0.765163 | 0.027317 | No Change: Both D | Long QT syndrome type 4 (LQT4) [MIM:600919] |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 3873 | R | 0.667535 | W | 0.414014 | 0.253521 | D to O | Long QT syndrome type 4 (LQT4) [MIM:600919] |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 3898 | E | 0.761197 | K | 0.74885 | 0.012347 | No Change: Both D | Long QT syndrome type 4 (LQT4) [MIM:600919] |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 685 | G | 0.374646 | E | 0.427463 | -0.052817 | No Change: Both O | A breast cancer sample |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 1234 | G | 0.249553 | R | 0.236882 | 0.012671 | No Change: Both O | A colorectal cancer sample |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 3620 | T | 0.522318 | K | 0.5584 | -0.036082 | No Change: Both D | A colorectal cancer sample |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 687 | N | 0.409724 | S | 0.485727 | -0.076003 | No Change: Both O | - |
| Q01484 | ANK2_HUMAN Ankyrin-2 OS=Homo sapiens GN=ANK2 PE=1 SV=3 | 2336 | V | 0.961723 | A | 0.975311 | -0.013588 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 4257 | I | 0.789688 | V | 0.790063 | -3.75E-04 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 2885 | H | 0.769444 | Q | 0.783383 | -0.013939 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 3117 | I | 0.741032 | V | 0.764008 | -0.022976 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 3123 | K | 0.793963 | R | 0.764961 | 0.029002 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 2318 | K | 0.826477 | R | 0.79677 | 0.029707 | No Change: Both D | - |
| Q12955 | ANK3_HUMAN Ankyrin-3 OS=Homo sapiens GN=ANK3 PE=1 SV=3 | 2996 | Q | 0.913873 | H | 0.896421 | 0.017452 | No Change: Both D | - |
| Q7Z5J8 | ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens GN=ANKAR PE=2 SV=3 | 675 | I | 0.185295 | V | 0.203546 | -0.018251 | No Change: Both O | - |
| Q7Z5J8 | ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens GN=ANKAR PE=2 SV=3 | 1077 | L | 0.358125 | F | 0.33858 | 0.019545 | No Change: Both O | - |
| Q495B1 | AKD1A_HUMAN Ankyrin repeat and death domain-containing protein 1A OS=Homo sapiens GN=ANKDD1A PE=2 SV=2 | 355 | K | 0.527436 | E | 0.510387 | 0.017049 | No Change: Both D | - |
| Q8N957 | ANKF1_HUMAN Ankyrin repeat and fibronectin type-III domain-containing protein 1 OS=Homo sapiens GN=ANKFN1 PE=2 SV=2 | 445 | V | 0.023451 | I | 0.022543 | 9.08E-04 | No Change: Both O | - |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 292 | W | 0.102336 | R | 0.229894 | -0.127558 | No Change: Both O | Craniometaphyseal dysplasia Jackson type (CMDJ) [MIM:123000] |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 331 | C | 0.037664 | R | 0.074546 | -0.036882 | No Change: Both O | Craniometaphyseal dysplasia Jackson type (CMDJ) [MIM:123000] |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 389 | G | 0.102281 | R | 0.103161 | -8.80E-04 | No Change: Both O | Craniometaphyseal dysplasia Jackson type (CMDJ) [MIM:123000] |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 48 | M | 0.260814 | T | 0.305567 | -0.044753 | No Change: Both O | Chondrocalcinosis 2 (CCAL2) [MIM:118600] |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 5 | P | 0.396676 | L | 0.244035 | 0.152641 | No Change: Both O | Chondrocalcinosis 2 (CCAL2) [MIM:118600] |
| Q9HCJ1 | ANKH_HUMAN Progressive ankylosis protein homolog OS=Homo sapiens GN=ANKH PE=1 SV=2 | 5 | P | 0.396676 | T | 0.352779 | 0.043897 | No Change: Both O | Chondrocalcinosis 2 (CCAL2) [MIM:118600] |
| Q8IWZ3 | ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens GN=ANKHD1 PE=1 SV=1 | 175 | L | 0.46248 | M | 0.515914 | -0.053434 | O to D | - |
| Q8IWZ3 | ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens GN=ANKHD1 PE=1 SV=1 | 228 | G | 0.613885 | C | 0.494528 | 0.119357 | D to O | - |
| Q8IWZ3 | ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens GN=ANKHD1 PE=1 SV=1 | 1760 | N | 0.209212 | S | 0.24503 | -0.035818 | No Change: Both O | - |
| Q8IWZ3 | ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens GN=ANKHD1 PE=1 SV=1 | 1586 | G | 0.934237 | S | 0.944953 | -0.010716 | No Change: Both D | - |
| Q9P2G1 | AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens GN=ANKIB1 PE=1 SV=3 | 1016 | L | 0.639282 | M | 0.705743 | -0.066461 | No Change: Both D | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 713 | E | 0.153571 | K | 0.166919 | -0.013348 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 239 | A | 0.158326 | T | 0.166183 | -0.007857 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 318 | G | 0.723466 | R | 0.778921 | -0.055455 | No Change: Both D | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 442 | G | 0.451831 | R | 0.450757 | 0.001074 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 490 | H | 0.621083 | R | 0.61796 | 0.003123 | No Change: Both D | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 4 | D | 0.709501 | Y | 0.685288 | 0.024213 | No Change: Both D | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 122 | R | 0.069427 | H | 0.07044 | -0.001013 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 276 | P | 0.377231 | L | 0.243249 | 0.133982 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 347 | K | 0.504298 | T | 0.431307 | 0.072991 | D to O | A breast infiltrating ductal carcinoma sample |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 366 | L | 0.110244 | F | 0.096435 | 0.013809 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 367 | H | 0.112913 | Q | 0.134493 | -0.02158 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 376 | E | 0.252279 | K | 0.246289 | 0.00599 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 426 | E | 0.44281 | K | 0.439309 | 0.003501 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 451 | G | 0.219612 | R | 0.23104 | -0.011428 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 595 | T | 0.255434 | I | 0.14032 | 0.115114 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 596 | P | 0.242778 | L | 0.134867 | 0.107911 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 653 | N | 0.492079 | S | 0.550776 | -0.058697 | O to D | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 670 | S | 0.170496 | G | 0.130033 | 0.040463 | No Change: Both O | - |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 717 | Q | 0.288638 | L | 0.176914 | 0.111724 | No Change: Both O | A lung large cell carcinoma sample |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 736 | R | 0.46204 | L | 0.359807 | 0.102233 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q8NFD2 | ANKK1_HUMAN Ankyrin repeat and protein kinase domain-containing protein 1 OS=Homo sapiens GN=ANKK1 PE=1 SV=1 | 764 | E | 0.839311 | K | 0.843024 | -0.003713 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 94 | L | 0.45023 | Q | 0.556572 | -0.106342 | O to D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 184 | L | 0.859262 | W | 0.791662 | 0.0676 | No Change: Both D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 311 | T | 0.903798 | P | 0.924384 | -0.020586 | No Change: Both D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 435 | Q | 0.590044 | R | 0.581702 | 0.008342 | No Change: Both D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 447 | V | 0.445152 | M | 0.500836 | -0.055684 | O to D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 160 | P | 0.949451 | S | 0.942301 | 0.00715 | No Change: Both D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 31 | A | 0.572985 | T | 0.517979 | 0.055006 | No Change: Both D | - |
| Q8NAG6 | ANKL1_HUMAN Ankyrin repeat and LEM domain-containing protein 1 OS=Homo sapiens GN=ANKLE1 PE=2 SV=2 | 71 | A | 0.533206 | V | 0.457929 | 0.075277 | D to O | - |
| Q86XL3 | ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens GN=ANKLE2 PE=1 SV=4 | 122 | H | 0.373515 | Y | 0.266943 | 0.106572 | No Change: Both O | - |
| Q86XL3 | ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens GN=ANKLE2 PE=1 SV=4 | 148 | Q | 0.682282 | E | 0.715559 | -0.033277 | No Change: Both D | - |
| Q86XL3 | ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens GN=ANKLE2 PE=1 SV=4 | 720 | R | 0.783949 | H | 0.762504 | 0.021445 | No Change: Both D | - |
| Q9P2S6 | ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens GN=ANKMY1 PE=2 SV=2 | 89 | D | 0.485754 | N | 0.459367 | 0.026387 | No Change: Both O | - |
| Q9P2S6 | ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens GN=ANKMY1 PE=2 SV=2 | 424 | I | 0.862016 | M | 0.909439 | -0.047423 | No Change: Both D | - |
| Q9P2S6 | ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens GN=ANKMY1 PE=2 SV=2 | 451 | D | 0.653492 | V | 0.526685 | 0.126807 | No Change: Both D | - |
| Q9P2S6 | ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens GN=ANKMY1 PE=2 SV=2 | 472 | V | 0.408247 | L | 0.434876 | -0.026629 | No Change: Both O | - |
| Q9P2S6 | ANKY1_HUMAN Ankyrin repeat and MYND domain-containing protein 1 OS=Homo sapiens GN=ANKMY1 PE=2 SV=2 | 649 | T | 0.715046 | M | 0.691757 | 0.023289 | No Change: Both D | - |
| Q15327 | ANKR1_HUMAN Ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=ANKRD1 PE=1 SV=2 | 116 | T | 0.700644 | M | 0.655243 | 0.045401 | No Change: Both D | Total anomalous pulmonary venous return (TAPVR) [MIM:106700] |
| Q9NXR5 | ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens GN=ANKRD10 PE=1 SV=2 | 320 | P | 0.922876 | L | 0.86645 | 0.056426 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 171 | S | 0.975468 | T | 0.970291 | 0.005177 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 818 | S | 0.982704 | N | 0.974218 | 0.008486 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 906 | K | 0.996451 | R | 0.995918 | 5.33E-04 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 277 | P | 0.570522 | A | 0.498993 | 0.071529 | D to O | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 390 | E | 0.938904 | D | 0.928368 | 0.010536 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 507 | T | 0.877765 | I | 0.812042 | 0.065723 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 531 | T | 0.871692 | S | 0.897066 | -0.025374 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 998 | L | 0.978413 | S | 0.988005 | -0.009592 | No Change: Both D | - |
| Q6UB98 | ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens GN=ANKRD12 PE=1 SV=3 | 1758 | S | 0.933435 | P | 0.927938 | 0.005497 | No Change: Both D | - |
| Q8IZ07 | AN13A_HUMAN Ankyrin repeat domain-containing protein 13A OS=Homo sapiens GN=ANKRD13A PE=1 SV=3 | 505 | L | 0.824727 | P | 0.876068 | -0.051341 | No Change: Both D | - |
| Q8N6S4 | AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens GN=ANKRD13C PE=2 SV=2 | 413 | T | 0.661696 | S | 0.722441 | -0.060745 | No Change: Both D | - |
| Q6P6B7 | ANR16_HUMAN Ankyrin repeat domain-containing protein 16 OS=Homo sapiens GN=ANKRD16 PE=2 SV=1 | 353 | Q | 0.644992 | R | 0.641172 | 0.00382 | No Change: Both D | - |
| Q6P6B7 | ANR16_HUMAN Ankyrin repeat domain-containing protein 16 OS=Homo sapiens GN=ANKRD16 PE=2 SV=1 | 128 | A | 0.374672 | G | 0.452871 | -0.078199 | No Change: Both O | - |
| O75179 | ANR17_HUMAN Ankyrin repeat domain-containing protein 17 OS=Homo sapiens GN=ANKRD17 PE=1 SV=3 | 2560 | H | 0.52955 | Y | 0.418449 | 0.111101 | D to O | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 130 | E | 0.317479 | K | 0.311196 | 0.006283 | No Change: Both O | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 277 | A | 0.959193 | E | 0.970017 | -0.010824 | No Change: Both D | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 484 | N | 0.5827 | S | 0.632678 | -0.049978 | No Change: Both D | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 688 | Y | 0.370931 | C | 0.438965 | -0.068034 | No Change: Both O | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 942 | T | 0.60598 | I | 0.467927 | 0.138053 | D to O | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 945 | E | 0.649786 | D | 0.586819 | 0.062967 | No Change: Both D | - |
| Q8IVF6 | AN18A_HUMAN Ankyrin repeat domain-containing protein 18A OS=Homo sapiens GN=ANKRD18A PE=1 SV=3 | 838 | E | 0.883333 | D | 0.854106 | 0.029227 | No Change: Both D | - |
| Q9GZV1 | ANKR2_HUMAN Ankyrin repeat domain-containing protein 2 OS=Homo sapiens GN=ANKRD2 PE=1 SV=3 | 62 | A | 0.835611 | T | 0.828467 | 0.007144 | No Change: Both D | - |
| Q5VYY1 | ANR22_HUMAN Ankyrin repeat domain-containing protein 22 OS=Homo sapiens GN=ANKRD22 PE=2 SV=1 | 73 | E | 0.452867 | G | 0.394806 | 0.058061 | No Change: Both O | - |
| Q5VYY1 | ANR22_HUMAN Ankyrin repeat domain-containing protein 22 OS=Homo sapiens GN=ANKRD22 PE=2 SV=1 | 79 | Y | 0.144052 | H | 0.247572 | -0.10352 | No Change: Both O | - |
| Q5VYY1 | ANR22_HUMAN Ankyrin repeat domain-containing protein 22 OS=Homo sapiens GN=ANKRD22 PE=2 SV=1 | 148 | Q | 0.246288 | P | 0.27989 | -0.033602 | No Change: Both O | - |
| Q5VYY1 | ANR22_HUMAN Ankyrin repeat domain-containing protein 22 OS=Homo sapiens GN=ANKRD22 PE=2 SV=1 | 177 | R | 0.410871 | I | 0.23787 | 0.173001 | No Change: Both O | - |
| Q8TF21 | ANR24_HUMAN Ankyrin repeat domain-containing protein 24 OS=Homo sapiens GN=ANKRD24 PE=2 SV=2 | 111 | A | 0.512066 | T | 0.52569 | -0.013624 | No Change: Both D | - |
| Q8TF21 | ANR24_HUMAN Ankyrin repeat domain-containing protein 24 OS=Homo sapiens GN=ANKRD24 PE=2 SV=2 | 349 | R | 0.964531 | Q | 0.965522 | -9.91E-04 | No Change: Both D | - |
| Q8TF21 | ANR24_HUMAN Ankyrin repeat domain-containing protein 24 OS=Homo sapiens GN=ANKRD24 PE=2 SV=2 | 585 | E | 0.988191 | K | 0.985528 | 0.002663 | No Change: Both D | - |
| Q8TF21 | ANR24_HUMAN Ankyrin repeat domain-containing protein 24 OS=Homo sapiens GN=ANKRD24 PE=2 SV=2 | 684 | S | 0.887791 | A | 0.850003 | 0.037788 | No Change: Both D | - |
| Q9UPS8 | ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens GN=ANKRD26 PE=1 SV=3 | 20 | Q | 0.92558 | R | 0.935501 | -0.009921 | No Change: Both D | - |
| Q9UPS8 | ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens GN=ANKRD26 PE=1 SV=3 | 1304 | V | 0.937705 | I | 0.931123 | 0.006582 | No Change: Both D | - |
| Q9UPS8 | ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens GN=ANKRD26 PE=1 SV=3 | 1513 | F | 0.886309 | L | 0.899014 | -0.012705 | No Change: Both D | - |
| Q9UPS8 | ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens GN=ANKRD26 PE=1 SV=3 | 425 | I | 0.692987 | V | 0.705329 | -0.012342 | No Change: Both D | - |
| Q9UPS8 | ANR26_HUMAN Ankyrin repeat domain-containing protein 26 OS=Homo sapiens GN=ANKRD26 PE=1 SV=3 | 1219 | V | 0.794905 | L | 0.809864 | -0.014959 | No Change: Both D | - |
| Q6NSI1 | AR26L_HUMAN Putative ankyrin repeat domain-containing protein 26-like protein OS=Homo sapiens GN=ANKRD26P1 PE=5 SV=2 | 265 | K | 0.763337 | T | 0.701013 | 0.062324 | No Change: Both D | - |
| Q96NW4 | ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens GN=ANKRD27 PE=1 SV=2 | 657 | S | 0.945266 | G | 0.923781 | 0.021485 | No Change: Both D | - |
| Q96NW4 | ANR27_HUMAN Ankyrin repeat domain-containing protein 27 OS=Homo sapiens GN=ANKRD27 PE=1 SV=2 | 761 | P | 0.279757 | R | 0.253776 | 0.025981 | No Change: Both O | - |
| Q8N6D5 | ANR29_HUMAN Ankyrin repeat domain-containing protein 29 OS=Homo sapiens GN=ANKRD29 PE=2 SV=2 | 112 | G | 0.489646 | E | 0.537916 | -0.04827 | O to D | - |
| Q8N6D5 | ANR29_HUMAN Ankyrin repeat domain-containing protein 29 OS=Homo sapiens GN=ANKRD29 PE=2 SV=2 | 95 | V | 0.147829 | M | 0.184051 | -0.036222 | No Change: Both O | A breast cancer sample |
| Q9BXX3 | AN30A_HUMAN Ankyrin repeat domain-containing protein 30A OS=Homo sapiens GN=ANKRD30A PE=1 SV=3 | 611 | T | 0.709857 | A | 0.691954 | 0.017903 | No Change: Both D | - |
| Q9BXX3 | AN30A_HUMAN Ankyrin repeat domain-containing protein 30A OS=Homo sapiens GN=ANKRD30A PE=1 SV=3 | 917 | K | 0.94047 | N | 0.927926 | 0.012544 | No Change: Both D | - |
| Q9BXX3 | AN30A_HUMAN Ankyrin repeat domain-containing protein 30A OS=Homo sapiens GN=ANKRD30A PE=1 SV=3 | 227 | Q | 0.121547 | E | 0.141933 | -0.020386 | No Change: Both O | A breast cancer sample |
| Q9BXX3 | AN30A_HUMAN Ankyrin repeat domain-containing protein 30A OS=Homo sapiens GN=ANKRD30A PE=1 SV=3 | 985 | R | 0.90158 | C | 0.879212 | 0.022368 | No Change: Both D | - |
| Q9BXX2 | AN30B_HUMAN Ankyrin repeat domain-containing protein 30B OS=Homo sapiens GN=ANKRD30B PE=2 SV=2 | 375 | V | 0.851011 | M | 0.879285 | -0.028274 | No Change: Both D | - |
| Q9BXX2 | AN30B_HUMAN Ankyrin repeat domain-containing protein 30B OS=Homo sapiens GN=ANKRD30B PE=2 SV=2 | 477 | F | 0.753829 | L | 0.777305 | -0.023476 | No Change: Both D | - |
| Q8N7Z5 | ANR31_HUMAN Ankyrin repeat domain-containing protein 31 OS=Homo sapiens GN=ANKRD31 PE=5 SV=2 | 702 | D | 0.668007 | N | 0.665977 | 0.00203 | No Change: Both D | - |
| Q8N7Z5 | ANR31_HUMAN Ankyrin repeat domain-containing protein 31 OS=Homo sapiens GN=ANKRD31 PE=5 SV=2 | 758 | R | 0.530027 | G | 0.444209 | 0.085818 | D to O | - |
| Q8N7Z5 | ANR31_HUMAN Ankyrin repeat domain-containing protein 31 OS=Homo sapiens GN=ANKRD31 PE=5 SV=2 | 1609 | D | 0.603556 | E | 0.614098 | -0.010542 | No Change: Both D | - |
| Q8N7Z5 | ANR31_HUMAN Ankyrin repeat domain-containing protein 31 OS=Homo sapiens GN=ANKRD31 PE=5 SV=2 | 1777 | R | 0.200556 | K | 0.269918 | -0.069362 | No Change: Both O | - |
| Q9BQI6 | ANR32_HUMAN Ankyrin repeat domain-containing protein 32 OS=Homo sapiens GN=ANKRD32 PE=1 SV=2 | 288 | S | 0.783826 | R | 0.762556 | 0.02127 | No Change: Both D | - |
| Q7Z3H0 | ANR33_HUMAN Ankyrin repeat domain-containing protein 33 OS=Homo sapiens GN=ANKRD33 PE=2 SV=3 | 5 | Y | 0.306567 | F | 0.280884 | 0.025683 | No Change: Both O | - |
| Q7Z3H0 | ANR33_HUMAN Ankyrin repeat domain-containing protein 33 OS=Homo sapiens GN=ANKRD33 PE=2 SV=3 | 132 | Q | 0.489169 | R | 0.457956 | 0.031213 | No Change: Both O | - |
| Q7Z3H0 | ANR33_HUMAN Ankyrin repeat domain-containing protein 33 OS=Homo sapiens GN=ANKRD33 PE=2 SV=3 | 188 | T | 0.599322 | N | 0.537102 | 0.06222 | No Change: Both D | - |
| Q7Z3H0 | ANR33_HUMAN Ankyrin repeat domain-containing protein 33 OS=Homo sapiens GN=ANKRD33 PE=2 SV=3 | 261 | V | 0.956233 | I | 0.964124 | -0.007891 | No Change: Both D | - |
| A5PLL1 | AN34B_HUMAN Ankyrin repeat domain-containing protein 34B OS=Homo sapiens GN=ANKRD34B PE=2 SV=3 | 156 | L | 0.325446 | S | 0.466282 | -0.140836 | No Change: Both O | - |
| P0C6C1 | AN34C_HUMAN Ankyrin repeat domain-containing protein 34C OS=Homo sapiens GN=ANKRD34C PE=2 SV=1 | 369 | P | 0.783145 | R | 0.728135 | 0.05501 | No Change: Both D | - |
| P0C6C1 | AN34C_HUMAN Ankyrin repeat domain-containing protein 34C OS=Homo sapiens GN=ANKRD34C PE=2 SV=1 | 427 | P | 0.972911 | H | 0.964289 | 0.008622 | No Change: Both D | - |
| P0C6C1 | AN34C_HUMAN Ankyrin repeat domain-containing protein 34C OS=Homo sapiens GN=ANKRD34C PE=2 SV=1 | 442 | L | 0.93505 | I | 0.91479 | 0.02026 | No Change: Both D | - |
| Q8N283 | ANR35_HUMAN Ankyrin repeat domain-containing protein 35 OS=Homo sapiens GN=ANKRD35 PE=2 SV=2 | 428 | P | 0.955986 | S | 0.953039 | 0.002947 | No Change: Both D | - |
| Q8N283 | ANR35_HUMAN Ankyrin repeat domain-containing protein 35 OS=Homo sapiens GN=ANKRD35 PE=2 SV=2 | 978 | N | 0.2948 | D | 0.289838 | 0.004962 | No Change: Both O | - |
| Q8N283 | ANR35_HUMAN Ankyrin repeat domain-containing protein 35 OS=Homo sapiens GN=ANKRD35 PE=2 SV=2 | 53 | N | 0.667911 | K | 0.716574 | -0.048663 | No Change: Both D | - |
| Q8N283 | ANR35_HUMAN Ankyrin repeat domain-containing protein 35 OS=Homo sapiens GN=ANKRD35 PE=2 SV=2 | 592 | R | 0.942528 | Q | 0.94314 | -6.12E-04 | No Change: Both D | - |
| Q8N2N9 | AN36B_HUMAN Ankyrin repeat domain-containing protein 36B OS=Homo sapiens GN=ANKRD36B PE=2 SV=4 | 496 | E | 0.875249 | D | 0.866847 | 0.008402 | No Change: Both D | - |
| Q8N2N9 | AN36B_HUMAN Ankyrin repeat domain-containing protein 36B OS=Homo sapiens GN=ANKRD36B PE=2 SV=4 | 483 | E | 0.880359 | G | 0.850278 | 0.030081 | No Change: Both D | - |
| Q8N2N9 | AN36B_HUMAN Ankyrin repeat domain-containing protein 36B OS=Homo sapiens GN=ANKRD36B PE=2 SV=4 | 534 | S | 0.952855 | A | 0.930241 | 0.022614 | No Change: Both D | - |
| Q7Z713 | ANR37_HUMAN Ankyrin repeat domain-containing protein 37 OS=Homo sapiens GN=ANKRD37 PE=2 SV=1 | 152 | T | 0.813466 | S | 0.870289 | -0.056823 | No Change: Both D | - |
| Q53RE8 | ANR39_HUMAN Ankyrin repeat domain-containing protein 39 OS=Homo sapiens GN=ANKRD39 PE=1 SV=1 | 113 | A | 0.299166 | T | 0.331379 | -0.032213 | No Change: Both O | - |
| Q8N9B4 | ANR42_HUMAN Ankyrin repeat domain-containing protein 42 OS=Homo sapiens GN=ANKRD42 PE=2 SV=2 | 198 | N | 0.361478 | D | 0.374782 | -0.013304 | No Change: Both O | - |
| Q2M3V2 | ANR43_HUMAN Ankyrin repeat domain-containing protein 43 OS=Homo sapiens GN=ANKRD43 PE=2 SV=3 | 124 | R | 0.987822 | P | 0.991195 | -0.003373 | No Change: Both D | - |
| Q2M3V2 | ANR43_HUMAN Ankyrin repeat domain-containing protein 43 OS=Homo sapiens GN=ANKRD43 PE=2 SV=3 | 545 | F | 0.937289 | L | 0.9476 | -0.010311 | No Change: Both D | - |
| Q9NU02 | ANKR5_HUMAN Ankyrin repeat domain-containing protein 5 OS=Homo sapiens GN=ANKRD5 PE=2 SV=2 | 324 | L | 0.343205 | Q | 0.42439 | -0.081185 | No Change: Both O | - |
| Q9NU02 | ANKR5_HUMAN Ankyrin repeat domain-containing protein 5 OS=Homo sapiens GN=ANKRD5 PE=2 SV=2 | 74 | P | 0.367429 | T | 0.321503 | 0.045926 | No Change: Both O | - |
| Q9NU02 | ANKR5_HUMAN Ankyrin repeat domain-containing protein 5 OS=Homo sapiens GN=ANKRD5 PE=2 SV=2 | 412 | G | 0.709068 | E | 0.735233 | -0.026165 | No Change: Both D | - |
| Q9NU02 | ANKR5_HUMAN Ankyrin repeat domain-containing protein 5 OS=Homo sapiens GN=ANKRD5 PE=2 SV=2 | 742 | R | 0.580089 | Q | 0.546827 | 0.033262 | No Change: Both D | - |
| Q9NU02 | ANKR5_HUMAN Ankyrin repeat domain-containing protein 5 OS=Homo sapiens GN=ANKRD5 PE=2 SV=2 | 694 | K | 0.63385 | N | 0.612396 | 0.021454 | No Change: Both D | A breast cancer sample |
| Q8N9V6 | ANR53_HUMAN Ankyrin repeat domain-containing protein 53 OS=Homo sapiens GN=ANKRD53 PE=2 SV=2 | 153 | L | 0.06274 | I | 0.051001 | 0.011739 | No Change: Both O | - |
| Q8N9V6 | ANR53_HUMAN Ankyrin repeat domain-containing protein 53 OS=Homo sapiens GN=ANKRD53 PE=2 SV=2 | 243 | M | 0.285143 | T | 0.32808 | -0.042937 | No Change: Both O | - |
| Q8N9V6 | ANR53_HUMAN Ankyrin repeat domain-containing protein 53 OS=Homo sapiens GN=ANKRD53 PE=2 SV=2 | 105 | A | 0.338168 | G | 0.35857 | -0.020402 | No Change: Both O | - |
| Q3KP44 | ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens GN=ANKRD55 PE=2 SV=2 | 344 | V | 0.970366 | M | 0.978292 | -0.007926 | No Change: Both D | - |
| Q3KP44 | ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens GN=ANKRD55 PE=2 SV=2 | 593 | R | 0.904753 | Q | 0.901239 | 0.003514 | No Change: Both D | - |
| A6NEL2 | ANR56_HUMAN Ankyrin repeat domain-containing protein 56 OS=Homo sapiens GN=ANKRD56 PE=2 SV=1 | 377 | P | 0.565372 | T | 0.500412 | 0.06496 | No Change: Both D | - |
| A6NEL2 | ANR56_HUMAN Ankyrin repeat domain-containing protein 56 OS=Homo sapiens GN=ANKRD56 PE=2 SV=1 | 152 | D | 0.991718 | G | 0.992575 | -8.57E-04 | No Change: Both D | - |
| A6NJG2 | ANR58_HUMAN Ankyrin repeat domain-containing protein 58 OS=Homo sapiens GN=ANKRD58 PE=2 SV=1 | 254 | T | 0.778981 | A | 0.76652 | 0.012461 | No Change: Both D | - |
| Q9Y2G4 | ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens GN=ANKRD6 PE=1 SV=3 | 122 | Q | 0.354887 | E | 0.394325 | -0.039438 | No Change: Both O | - |
| Q9Y2G4 | ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens GN=ANKRD6 PE=1 SV=3 | 128 | I | 0.340501 | V | 0.392442 | -0.051941 | No Change: Both O | - |
| Q9Y2G4 | ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens GN=ANKRD6 PE=1 SV=3 | 233 | T | 0.280585 | M | 0.228362 | 0.052223 | No Change: Both O | - |
| Q9Y2G4 | ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens GN=ANKRD6 PE=1 SV=3 | 545 | T | 0.889902 | A | 0.884574 | 0.005328 | No Change: Both D | - |
| Q9Y2G4 | ANKR6_HUMAN Ankyrin repeat domain-containing protein 6 OS=Homo sapiens GN=ANKRD6 PE=1 SV=3 | 550 | A | 0.917468 | T | 0.924897 | -0.007429 | No Change: Both D | - |
| Q9BZ19 | ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens GN=ANKRD60 PE=2 SV=3 | 295 | R | 0.349971 | C | 0.200587 | 0.149384 | No Change: Both O | - |
| A6NC57 | ANR62_HUMAN Ankyrin repeat domain-containing protein 62 OS=Homo sapiens GN=ANKRD62 PE=2 SV=4 | 188 | A | 0.218186 | S | 0.308439 | -0.090253 | No Change: Both O | - |
| A6NC57 | ANR62_HUMAN Ankyrin repeat domain-containing protein 62 OS=Homo sapiens GN=ANKRD62 PE=2 SV=4 | 265 | C | 0.704675 | R | 0.767025 | -0.06235 | No Change: Both D | - |
| A6NC57 | ANR62_HUMAN Ankyrin repeat domain-containing protein 62 OS=Homo sapiens GN=ANKRD62 PE=2 SV=4 | 406 | E | 0.675597 | K | 0.670115 | 0.005482 | No Change: Both D | - |
| A6NC57 | ANR62_HUMAN Ankyrin repeat domain-containing protein 62 OS=Homo sapiens GN=ANKRD62 PE=2 SV=4 | 613 | A | 0.85014 | T | 0.900279 | -0.050139 | No Change: Both D | - |
| Q92625 | ANS1A_HUMAN Ankyrin repeat and SAM domain-containing protein 1A OS=Homo sapiens GN=ANKS1A PE=1 SV=4 | 694 | L | 0.55538 | S | 0.721244 | -0.165864 | No Change: Both D | - |
| Q92625 | ANS1A_HUMAN Ankyrin repeat and SAM domain-containing protein 1A OS=Homo sapiens GN=ANKS1A PE=1 SV=4 | 355 | A | 0.468103 | D | 0.521271 | -0.053168 | O to D | - |
| Q6ZW76 | ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens GN=ANKS3 PE=1 SV=1 | 404 | A | 0.906498 | T | 0.911997 | -0.005499 | No Change: Both D | - |
| Q6ZW76 | ANKS3_HUMAN Ankyrin repeat and SAM domain-containing protein 3 OS=Homo sapiens GN=ANKS3 PE=1 SV=1 | 593 | A | 0.755023 | T | 0.74706 | 0.007963 | No Change: Both D | - |
| Q68DC2 | ANKS6_HUMAN Ankyrin repeat and SAM domain-containing protein 6 OS=Homo sapiens GN=ANKS6 PE=1 SV=2 | 644 | V | 0.926965 | I | 0.921836 | 0.005129 | No Change: Both D | - |
| A6NFN9 | ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens GN=ANKUB1 PE=2 SV=2 | 217 | R | 0.487305 | W | 0.273637 | 0.213668 | No Change: Both O | - |
| A6NFN9 | ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens GN=ANKUB1 PE=2 SV=2 | 306 | I | 0.24423 | M | 0.336192 | -0.091962 | No Change: Both O | - |
| A6NFN9 | ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens GN=ANKUB1 PE=2 SV=2 | 386 | S | 0.917018 | G | 0.875975 | 0.041043 | No Change: Both D | - |
| Q9H8Y5 | ANKZ1_HUMAN Ankyrin repeat and zinc finger domain-containing protein 1 OS=Homo sapiens GN=ANKZF1 PE=1 SV=1 | 569 | R | 0.644384 | W | 0.38487 | 0.259514 | D to O | - |
| Q9H8Y5 | ANKZ1_HUMAN Ankyrin repeat and zinc finger domain-containing protein 1 OS=Homo sapiens GN=ANKZF1 PE=1 SV=1 | 676 | P | 0.552415 | L | 0.391504 | 0.160911 | D to O | - |
| Q9NQW6 | ANLN_HUMAN Actin-binding protein anillin OS=Homo sapiens GN=ANLN PE=1 SV=2 | 65 | S | 0.991958 | W | 0.974959 | 0.016999 | No Change: Both D | - |
| Q9NQW6 | ANLN_HUMAN Actin-binding protein anillin OS=Homo sapiens GN=ANLN PE=1 SV=2 | 185 | R | 0.880732 | K | 0.877212 | 0.00352 | No Change: Both D | - |
| Q5XXA6 | ANO1_HUMAN Anoctamin-1 OS=Homo sapiens GN=ANO1 PE=1 SV=1 | 608 | F | 0.08446 | S | 0.198442 | -0.113982 | No Change: Both O | - |
| Q5XXA6 | ANO1_HUMAN Anoctamin-1 OS=Homo sapiens GN=ANO1 PE=1 SV=1 | 983 | G | 0.809517 | R | 0.80306 | 0.006457 | No Change: Both D | - |
| Q9NW15 | ANO10_HUMAN Anoctamin-10 OS=Homo sapiens GN=ANO10 PE=1 SV=2 | 462 | R | 0.418889 | Q | 0.434772 | -0.015883 | No Change: Both O | - |
| Q9NW15 | ANO10_HUMAN Anoctamin-10 OS=Homo sapiens GN=ANO10 PE=1 SV=2 | 561 | T | 0.103249 | M | 0.09298 | 0.010269 | No Change: Both O | - |
| Q9NW15 | ANO10_HUMAN Anoctamin-10 OS=Homo sapiens GN=ANO10 PE=1 SV=2 | 583 | V | 0.374879 | A | 0.475651 | -0.100772 | No Change: Both O | - |
| Q9NW15 | ANO10_HUMAN Anoctamin-10 OS=Homo sapiens GN=ANO10 PE=1 SV=2 | 510 | L | 0.040298 | R | 0.067093 | -0.026795 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 10 (SCAR10) [MIM:613728] |
| Q9NQ90 | ANO2_HUMAN Anoctamin-2 OS=Homo sapiens GN=ANO2 PE=1 SV=2 | 505 | S | 0.879234 | A | 0.839952 | 0.039282 | No Change: Both D | - |
| Q9NQ90 | ANO2_HUMAN Anoctamin-2 OS=Homo sapiens GN=ANO2 PE=1 SV=2 | 112 | V | 0.283773 | A | 0.359658 | -0.075885 | No Change: Both O | - |
| Q9NQ90 | ANO2_HUMAN Anoctamin-2 OS=Homo sapiens GN=ANO2 PE=1 SV=2 | 147 | P | 0.838388 | S | 0.826131 | 0.012257 | No Change: Both D | - |
| Q9NQ90 | ANO2_HUMAN Anoctamin-2 OS=Homo sapiens GN=ANO2 PE=1 SV=2 | 401 | M | 0.4368 | I | 0.353194 | 0.083606 | No Change: Both O | - |
| Q9BYT9 | ANO3_HUMAN Anoctamin-3 OS=Homo sapiens GN=ANO3 PE=2 SV=2 | 781 | L | 0.066284 | V | 0.058855 | 0.007429 | No Change: Both O | - |
| Q32M45 | ANO4_HUMAN Anoctamin-4 OS=Homo sapiens GN=ANO4 PE=2 SV=1 | 115 | G | 0.304409 | A | 0.259367 | 0.045042 | No Change: Both O | - |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 356 | C | 0.055665 | G | 0.10434 | -0.048675 | No Change: Both O | Gnathodiaphyseal dysplasia (GDD) [MIM:166260] |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 356 | C | 0.055665 | R | 0.097855 | -0.04219 | No Change: Both O | Gnathodiaphyseal dysplasia (GDD) [MIM:166260] |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 322 | L | 0.014445 | F | 0.012854 | 0.001591 | No Change: Both O | - |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 882 | N | 0.404962 | K | 0.455256 | -0.050294 | No Change: Both O | - |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 231 | G | 0.455289 | V | 0.305752 | 0.149537 | No Change: Both O | Limb-girdle muscular dystrophy type 2L (LGMD2L) [MIM:611307] |
| Q75V66 | ANO5_HUMAN Anoctamin-5 OS=Homo sapiens GN=ANO5 PE=1 SV=1 | 758 | R | 0.062005 | C | 0.027921 | 0.034084 | No Change: Both O | Miyoshi muscular dystrophy type 3 (MMD3) [MIM:613319] |
| Q4KMQ2 | ANO6_HUMAN Anoctamin-6 OS=Homo sapiens GN=ANO6 PE=1 SV=2 | 128 | A | 0.054538 | T | 0.06417 | -0.009632 | No Change: Both O | - |
| Q6IWH7 | ANO7_HUMAN Anoctamin-7 OS=Homo sapiens GN=ANO7 PE=1 SV=2 | 67 | V | 0.870036 | I | 0.863159 | 0.006877 | No Change: Both D | - |
| Q6IWH7 | ANO7_HUMAN Anoctamin-7 OS=Homo sapiens GN=ANO7 PE=1 SV=2 | 912 | E | 0.742869 | K | 0.734928 | 0.007941 | No Change: Both D | - |
| A1A5B4 | ANO9_HUMAN Anoctamin-9 OS=Homo sapiens GN=ANO9 PE=2 SV=2 | 391 | I | 0.034158 | V | 0.038785 | -0.004627 | No Change: Both O | - |
| A1A5B4 | ANO9_HUMAN Anoctamin-9 OS=Homo sapiens GN=ANO9 PE=2 SV=2 | 399 | C | 0.04656 | R | 0.100682 | -0.054122 | No Change: Both O | - |
| A1A5B4 | ANO9_HUMAN Anoctamin-9 OS=Homo sapiens GN=ANO9 PE=2 SV=2 | 93 | F | 0.151719 | L | 0.178091 | -0.026372 | No Change: Both O | - |
| O43423 | AN32C_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member C OS=Homo sapiens GN=ANP32C PE=2 SV=1 | 71 | R | 0.386734 | K | 0.458665 | -0.071931 | No Change: Both O | - |
| O43423 | AN32C_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member C OS=Homo sapiens GN=ANP32C PE=2 SV=1 | 204 | E | 0.999566 | G | 0.999419 | 1.47E-04 | No Change: Both D | - |
| O43423 | AN32C_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member C OS=Homo sapiens GN=ANP32C PE=2 SV=1 | 23 | A | 0.829349 | V | 0.776743 | 0.052606 | No Change: Both D | - |
| O43423 | AN32C_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member C OS=Homo sapiens GN=ANP32C PE=2 SV=1 | 140 | Y | 0.080441 | H | 0.124718 | -0.044277 | No Change: Both O | - |
| O43423 | AN32C_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member C OS=Homo sapiens GN=ANP32C PE=2 SV=1 | 105 | L | 0.460068 | P | 0.597104 | -0.137036 | O to D | - |
| O95626 | AN32D_HUMAN Acidic leucine-rich nuclear phosphoprotein 32 family member D OS=Homo sapiens GN=ANP32D PE=1 SV=2 | 46 | L | 0.575578 | F | 0.519537 | 0.056041 | No Change: Both D | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 242 | D | 0.553962 | Y | 0.3461 | 0.207862 | D to O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 243 | L | 0.582205 | P | 0.733303 | -0.151098 | No Change: Both D | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 86 | R | 0.432914 | Q | 0.409381 | 0.023533 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 752 | S | 0.354545 | N | 0.325678 | 0.028867 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 20 | V | 0.026706 | M | 0.03432 | -0.007614 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 311 | A | 0.317646 | V | 0.220393 | 0.097253 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 321 | T | 0.126747 | M | 0.105469 | 0.021278 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 603 | I | 0.096769 | K | 0.239549 | -0.14278 | No Change: Both O | - |
| P15144 | AMPN_HUMAN Aminopeptidase N OS=Homo sapiens GN=ANPEP PE=1 SV=4 | 603 | I | 0.096769 | M | 0.145314 | -0.048545 | No Change: Both O | - |
| Q9H6X2 | ANTR1_HUMAN Anthrax toxin receptor 1 OS=Homo sapiens GN=ANTXR1 PE=1 SV=2 | 7 | R | 0.357798 | K | 0.405031 | -0.047233 | No Change: Both O | - |
| Q9H6X2 | ANTR1_HUMAN Anthrax toxin receptor 1 OS=Homo sapiens GN=ANTXR1 PE=1 SV=2 | 326 | A | 0.021864 | T | 0.023368 | -0.001504 | No Change: Both O | - |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 45 | L | 0.080426 | P | 0.156371 | -0.075945 | No Change: Both O | Infantile systemic hyalinosis (ISH) [MIM:236490] |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 105 | G | 0.555873 | D | 0.576072 | -0.020199 | No Change: Both D | Juvenile hyaline fibromatosis (JHF) [MIM:228600] |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 189 | I | 0.421314 | T | 0.537381 | -0.116067 | O to D | Infantile systemic hyalinosis (ISH) [MIM:236490] |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 218 | C | 0.200922 | R | 0.327292 | -0.12637 | No Change: Both O | Infantile systemic hyalinosis (ISH) [MIM:236490] |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 329 | L | 0.008689 | R | 0.013535 | -0.004846 | No Change: Both O | Juvenile hyaline fibromatosis (JHF) [MIM:228600] |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 357 | A | 0.861587 | P | 0.884485 | -0.022898 | No Change: Both D | - |
| P58335 | ANTR2_HUMAN Anthrax toxin receptor 2 OS=Homo sapiens GN=ANTXR2 PE=1 SV=5 | 381 | Y | 0.68035 | C | 0.707697 | -0.027347 | No Change: Both D | Juvenile hyaline fibromatosis (JHF) [MIM:228600] |
| A6NF34 | ANTRL_HUMAN Anthrax toxin receptor-like OS=Homo sapiens GN=ANTXRL PE=2 SV=2 | 547 | P | 0.990001 | R | 0.988004 | 0.001997 | No Change: Both D | - |
| Q86XD8 | ANUB1_HUMAN AN1-type zinc finger and ubiquitin domain-containing protein 1 OS=Homo sapiens GN=ANUBL1 PE=2 SV=2 | 118 | K | 0.49237 | T | 0.428505 | 0.063865 | No Change: Both O | - |
| Q86XD8 | ANUB1_HUMAN AN1-type zinc finger and ubiquitin domain-containing protein 1 OS=Homo sapiens GN=ANUBL1 PE=2 SV=2 | 358 | H | 0.551601 | Y | 0.387423 | 0.164178 | D to O | - |
| Q86XD8 | ANUB1_HUMAN AN1-type zinc finger and ubiquitin domain-containing protein 1 OS=Homo sapiens GN=ANUBL1 PE=2 SV=2 | 523 | T | 0.683311 | A | 0.616398 | 0.066913 | No Change: Both D | - |
| Q9UJ72 | ANX10_HUMAN Annexin A10 OS=Homo sapiens GN=ANXA10 PE=1 SV=3 | 71 | M | 0.465078 | L | 0.411111 | 0.053967 | No Change: Both O | - |
| P50995 | ANX11_HUMAN Annexin A11 OS=Homo sapiens GN=ANXA11 PE=1 SV=1 | 230 | R | 0.48402 | C | 0.358906 | 0.125114 | No Change: Both O | - |
| P50995 | ANX11_HUMAN Annexin A11 OS=Homo sapiens GN=ANXA11 PE=1 SV=1 | 457 | I | 0.316564 | V | 0.333107 | -0.016543 | No Change: Both O | - |
| P50995 | ANX11_HUMAN Annexin A11 OS=Homo sapiens GN=ANXA11 PE=1 SV=1 | 191 | R | 0.736228 | Q | 0.743752 | -0.007524 | No Change: Both D | - |
| P27216 | ANX13_HUMAN Annexin A13 OS=Homo sapiens GN=ANXA13 PE=1 SV=3 | 86 | R | 0.448063 | H | 0.412122 | 0.035941 | No Change: Both O | - |
| P27216 | ANX13_HUMAN Annexin A13 OS=Homo sapiens GN=ANXA13 PE=1 SV=3 | 108 | V | 0.202394 | I | 0.190245 | 0.012149 | No Change: Both O | - |
| P27216 | ANX13_HUMAN Annexin A13 OS=Homo sapiens GN=ANXA13 PE=1 SV=3 | 272 | V | 0.165175 | I | 0.153965 | 0.01121 | No Change: Both O | - |
| P07355 | ANXA2_HUMAN Annexin A2 OS=Homo sapiens GN=ANXA2 PE=1 SV=2 | 98 | V | 0.282282 | L | 0.370182 | -0.0879 | No Change: Both O | - |
| P12429 | ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA3 PE=1 SV=3 | 19 | S | 0.486218 | N | 0.435718 | 0.0505 | No Change: Both O | - |
| P12429 | ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA3 PE=1 SV=3 | 219 | I | 0.339855 | N | 0.518146 | -0.178291 | O to D | - |
| P12429 | ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA3 PE=1 SV=3 | 251 | P | 0.149905 | L | 0.082792 | 0.067113 | No Change: Both O | - |
| P12429 | ANXA3_HUMAN Annexin A3 OS=Homo sapiens GN=ANXA3 PE=1 SV=3 | 291 | F | 0.315728 | S | 0.545842 | -0.230114 | O to D | - |
| P09525 | ANXA4_HUMAN Annexin A4 OS=Homo sapiens GN=ANXA4 PE=1 SV=4 | 85 | T | 0.115311 | M | 0.101731 | 0.01358 | No Change: Both O | - |
| P20073 | ANXA7_HUMAN Annexin A7 OS=Homo sapiens GN=ANXA7 PE=1 SV=3 | 441 | R | 0.181592 | Q | 0.184917 | -0.003325 | No Change: Both O | - |
| P13928 | ANXA8_HUMAN Annexin A8 OS=Homo sapiens GN=ANXA8 PE=1 SV=3 | 6 | S | 0.232856 | A | 0.157124 | 0.075732 | No Change: Both O | - |
| P13928 | ANXA8_HUMAN Annexin A8 OS=Homo sapiens GN=ANXA8 PE=1 SV=3 | 177 | G | 0.34133 | A | 0.305414 | 0.035916 | No Change: Both O | - |
| Q5VT79 | AXA82_HUMAN Annexin A8-like protein 2 OS=Homo sapiens GN=ANXA8L2 PE=2 SV=1 | 177 | A | 0.304617 | G | 0.341074 | -0.036457 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 166 | D | 0.424956 | G | 0.388995 | 0.035961 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 225 | R | 0.363025 | Q | 0.385095 | -0.02207 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 28 | A | 0.279852 | T | 0.312115 | -0.032263 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 114 | T | 0.371907 | A | 0.375448 | -0.003541 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 119 | A | 0.442861 | T | 0.462446 | -0.019585 | No Change: Both O | - |
| O76027 | ANXA9_HUMAN Annexin A9 OS=Homo sapiens GN=ANXA9 PE=1 SV=3 | 232 | R | 0.296838 | Q | 0.31981 | -0.022972 | No Change: Both O | - |
| P28039 | AOAH_HUMAN Acyloxyacyl hydrolase OS=Homo sapiens GN=AOAH PE=1 SV=1 | 166 | A | 0.256109 | T | 0.271169 | -0.01506 | No Change: Both O | - |
| P28039 | AOAH_HUMAN Acyloxyacyl hydrolase OS=Homo sapiens GN=AOAH PE=1 SV=1 | 266 | A | 0.285667 | G | 0.345048 | -0.059381 | No Change: Both O | - |
| P28039 | AOAH_HUMAN Acyloxyacyl hydrolase OS=Homo sapiens GN=AOAH PE=1 SV=1 | 28 | D | 0.836891 | N | 0.834779 | 0.002112 | No Change: Both D | - |
| O75106 | AOC2_HUMAN Retina-specific copper amine oxidase OS=Homo sapiens GN=AOC2 PE=1 SV=2 | 5 | I | 0.221065 | V | 0.269958 | -0.048893 | No Change: Both O | - |
| O75106 | AOC2_HUMAN Retina-specific copper amine oxidase OS=Homo sapiens GN=AOC2 PE=1 SV=2 | 22 | Y | 0.075083 | C | 0.099967 | -0.024884 | No Change: Both O | - |
| O75106 | AOC2_HUMAN Retina-specific copper amine oxidase OS=Homo sapiens GN=AOC2 PE=1 SV=2 | 141 | P | 0.5369 | L | 0.379583 | 0.157317 | D to O | - |
| O75106 | AOC2_HUMAN Retina-specific copper amine oxidase OS=Homo sapiens GN=AOC2 PE=1 SV=2 | 273 | R | 0.450543 | Q | 0.467108 | -0.016565 | No Change: Both O | - |
| O75106 | AOC2_HUMAN Retina-specific copper amine oxidase OS=Homo sapiens GN=AOC2 PE=1 SV=2 | 427 | E | 0.175906 | D | 0.148806 | 0.0271 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 317 | Y | 0.670911 | H | 0.768707 | -0.097796 | No Change: Both D | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 329 | R | 0.553868 | Q | 0.569191 | -0.015323 | No Change: Both D | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 167 | H | 0.369935 | Y | 0.265989 | 0.103946 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 371 | I | 0.23538 | T | 0.353958 | -0.118578 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 408 | A | 0.045237 | S | 0.0746 | -0.029363 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 426 | R | 0.164953 | H | 0.166975 | -0.002022 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 441 | R | 0.548192 | W | 0.299159 | 0.249033 | D to O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 582 | A | 0.185368 | T | 0.2024 | -0.017032 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 700 | G | 0.159422 | S | 0.18081 | -0.021388 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 749 | A | 0.443137 | V | 0.291989 | 0.151148 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 5 | T | 0.357966 | R | 0.367549 | -0.009583 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 78 | R | 0.330361 | Q | 0.350357 | -0.019996 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 171 | V | 0.184645 | M | 0.242379 | -0.057734 | No Change: Both O | - |
| Q16853 | AOC3_HUMAN Membrane primary amine oxidase OS=Homo sapiens GN=AOC3 PE=1 SV=3 | 203 | H | 0.19417 | R | 0.197648 | -0.003478 | No Change: Both O | - |
| Q8N6M6 | AMPO_HUMAN Aminopeptidase O OS=Homo sapiens GN=AOPEP PE=1 SV=2 | 179 | V | 0.409236 | A | 0.473053 | -0.063817 | No Change: Both O | - |
| Q8N6M6 | AMPO_HUMAN Aminopeptidase O OS=Homo sapiens GN=AOPEP PE=1 SV=2 | 179 | V | 0.409236 | I | 0.362091 | 0.047145 | No Change: Both O | - |
| Q8N6M6 | AMPO_HUMAN Aminopeptidase O OS=Homo sapiens GN=AOPEP PE=1 SV=2 | 255 | R | 0.501845 | Q | 0.524209 | -0.022364 | No Change: Both D | - |
| Q8N6M6 | AMPO_HUMAN Aminopeptidase O OS=Homo sapiens GN=AOPEP PE=1 SV=2 | 386 | R | 0.324151 | C | 0.227834 | 0.096317 | No Change: Both O | - |
| Q06278 | ADO_HUMAN Aldehyde oxidase OS=Homo sapiens GN=AOX1 PE=2 SV=2 | 802 | R | 0.18845 | C | 0.093922 | 0.094528 | No Change: Both O | - |
| Q06278 | ADO_HUMAN Aldehyde oxidase OS=Homo sapiens GN=AOX1 PE=2 SV=2 | 1297 | H | 0.455124 | R | 0.476749 | -0.021625 | No Change: Both O | - |
| Q06278 | ADO_HUMAN Aldehyde oxidase OS=Homo sapiens GN=AOX1 PE=2 SV=2 | 314 | Q | 0.198294 | R | 0.182659 | 0.015635 | No Change: Both O | - |
| Q63HQ0 | AP1AR_HUMAN AP-1 complex-associated regulatory protein OS=Homo sapiens GN=AP1AR PE=1 SV=1 | 297 | T | 0.765032 | I | 0.712324 | 0.052708 | No Change: Both D | - |
| Q10567 | AP1B1_HUMAN AP-1 complex subunit beta-1 OS=Homo sapiens GN=AP1B1 PE=1 SV=2 | 777 | T | 0.373501 | A | 0.363996 | 0.009505 | No Change: Both O | - |
| O43747 | AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens GN=AP1G1 PE=1 SV=5 | 685 | P | 0.549614 | H | 0.413932 | 0.135682 | D to O | - |
| O43747 | AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens GN=AP1G1 PE=1 SV=5 | 195 | V | 0.196488 | G | 0.28387 | -0.087382 | No Change: Both O | - |
| O75843 | AP1G2_HUMAN AP-1 complex subunit gamma-like 2 OS=Homo sapiens GN=AP1G2 PE=1 SV=1 | 377 | S | 0.592325 | F | 0.3559 | 0.236425 | D to O | - |
| Q9BXS5 | AP1M1_HUMAN AP-1 complex subunit mu-1 OS=Homo sapiens GN=AP1M1 PE=1 SV=3 | 303 | R | 0.581171 | Q | 0.591267 | -0.010096 | No Change: Both D | A breast cancer sample |
| O95782 | AP2A1_HUMAN AP-2 complex subunit alpha-1 OS=Homo sapiens GN=AP2A1 PE=1 SV=3 | 270 | P | 0.350438 | L | 0.22163 | 0.128808 | No Change: Both O | - |
| O00203 | AP3B1_HUMAN AP-3 complex subunit beta-1 OS=Homo sapiens GN=AP3B1 PE=1 SV=3 | 580 | L | 0.128737 | R | 0.226275 | -0.097538 | No Change: Both O | Hermansky-Pudlak syndrome type 2 (HPS2) [MIM:608233] |
| O00203 | AP3B1_HUMAN AP-3 complex subunit beta-1 OS=Homo sapiens GN=AP3B1 PE=1 SV=3 | 585 | V | 0.281068 | E | 0.414 | -0.132932 | No Change: Both O | - |
| O14617 | AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens GN=AP3D1 PE=1 SV=1 | 541 | G | 0.678529 | R | 0.660886 | 0.017643 | No Change: Both D | - |
| O14617 | AP3D1_HUMAN AP-3 complex subunit delta-1 OS=Homo sapiens GN=AP3D1 PE=1 SV=1 | 1072 | I | 0.487833 | V | 0.517407 | -0.029574 | O to D | - |
| Q92572 | AP3S1_HUMAN AP-3 complex subunit sigma-1 OS=Homo sapiens GN=AP3S1 PE=1 SV=1 | 158 | P | 0.512035 | L | 0.360824 | 0.151211 | D to O | - |
| Q9Y6B7 | AP4B1_HUMAN AP-4 complex subunit beta-1 OS=Homo sapiens GN=AP4B1 PE=2 SV=2 | 480 | L | 0.093431 | S | 0.179621 | -0.08619 | No Change: Both O | - |
| Q9UPM8 | AP4E1_HUMAN AP-4 complex subunit epsilon-1 OS=Homo sapiens GN=AP4E1 PE=1 SV=2 | 163 | C | 0.08401 | R | 0.168901 | -0.084891 | No Change: Both O | - |
| Q02410 | APBA1_HUMAN Amyloid beta A4 precursor protein-binding family A member 1 OS=Homo sapiens GN=APBA1 PE=1 SV=3 | 184 | S | 0.582038 | A | 0.536479 | 0.045559 | No Change: Both D | - |
| Q99767 | APBA2_HUMAN Amyloid beta A4 precursor protein-binding family A member 2 OS=Homo sapiens GN=APBA2 PE=1 SV=3 | 311 | L | 0.925252 | P | 0.959565 | -0.034313 | No Change: Both D | - |
| O96018 | APBA3_HUMAN Amyloid beta A4 precursor protein-binding family A member 3 OS=Homo sapiens GN=APBA3 PE=1 SV=1 | 527 | I | 0.219278 | F | 0.197867 | 0.021411 | No Change: Both O | - |
| O96018 | APBA3_HUMAN Amyloid beta A4 precursor protein-binding family A member 3 OS=Homo sapiens GN=APBA3 PE=1 SV=1 | 276 | K | 0.331996 | T | 0.274839 | 0.057157 | No Change: Both O | - |
| O96018 | APBA3_HUMAN Amyloid beta A4 precursor protein-binding family A member 3 OS=Homo sapiens GN=APBA3 PE=1 SV=1 | 376 | C | 0.544983 | R | 0.66736 | -0.122377 | No Change: Both D | - |
| O96018 | APBA3_HUMAN Amyloid beta A4 precursor protein-binding family A member 3 OS=Homo sapiens GN=APBA3 PE=1 SV=1 | 154 | W | 0.996076 | L | 0.997292 | -0.001216 | No Change: Both D | - |
| O00213 | APBB1_HUMAN Amyloid beta A4 precursor protein-binding family B member 1 OS=Homo sapiens GN=APBB1 PE=1 SV=2 | 327 | M | 0.931886 | V | 0.901635 | 0.030251 | No Change: Both D | - |
| O00213 | APBB1_HUMAN Amyloid beta A4 precursor protein-binding family B member 1 OS=Homo sapiens GN=APBB1 PE=1 SV=2 | 396 | N | 0.224804 | S | 0.268938 | -0.044134 | No Change: Both O | - |
| Q7Z5R6 | AB1IP_HUMAN Amyloid beta A4 precursor protein-binding family B member 1-interacting protein OS=Homo sapiens GN=APBB1IP PE=1 SV=1 | 404 | T | 0.105838 | A | 0.085714 | 0.020124 | No Change: Both O | - |
| Q7Z5R6 | AB1IP_HUMAN Amyloid beta A4 precursor protein-binding family B member 1-interacting protein OS=Homo sapiens GN=APBB1IP PE=1 SV=1 | 617 | A | 0.998718 | T | 0.998414 | 3.04E-04 | No Change: Both D | - |
| O95704 | APBB3_HUMAN Amyloid beta A4 precursor protein-binding family B member 3 OS=Homo sapiens GN=APBB3 PE=1 SV=2 | 231 | C | 0.105075 | R | 0.1451 | -0.040025 | No Change: Both O | - |
| O95704 | APBB3_HUMAN Amyloid beta A4 precursor protein-binding family B member 3 OS=Homo sapiens GN=APBB3 PE=1 SV=2 | 165 | G | 0.511785 | R | 0.517498 | -0.005713 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 171 | S | 0.45499 | I | 0.265601 | 0.189389 | No Change: Both O | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 414 | R | 0.193734 | C | 0.138649 | 0.055085 | No Change: Both O | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 784 | S | 0.76678 | T | 0.713639 | 0.053141 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 817 | G | 0.75857 | C | 0.709779 | 0.048791 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 880 | I | 0.666851 | T | 0.76431 | -0.097459 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 880 | I | 0.666851 | T | 0.76431 | -0.097459 | No Change: Both D | Colorectal carcinoma |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 906 | S | 0.84633 | Y | 0.708976 | 0.137354 | No Change: Both D | Colorectal tumor |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 911 | E | 0.820237 | G | 0.766479 | 0.053758 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 942 | N | 0.888801 | D | 0.879028 | 0.009773 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1027 | Y | 0.57071 | C | 0.567317 | 0.003393 | No Change: Both D | Colorectal tumor |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1118 | N | 0.797869 | D | 0.788546 | 0.009323 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1120 | G | 0.820594 | E | 0.850694 | -0.0301 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1171 | R | 0.849064 | H | 0.840221 | 0.008843 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1176 | P | 0.844709 | L | 0.754655 | 0.090054 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1197 | F | 0.969681 | S | 0.984565 | -0.014884 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1259 | I | 0.716901 | T | 0.80586 | -0.088959 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1292 | T | 0.795354 | M | 0.74841 | 0.046944 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1304 | I | 0.800726 | V | 0.797847 | 0.002879 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1307 | I | 0.805865 | K | 0.885776 | -0.079911 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1312 | G | 0.826132 | E | 0.879672 | -0.05354 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1313 | T | 0.829983 | A | 0.820527 | 0.009456 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1326 | V | 0.913975 | A | 0.934584 | -0.020609 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1348 | R | 0.987722 | W | 0.970598 | 0.017124 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1422 | D | 0.99004 | H | 0.986109 | 0.003931 | No Change: Both D | Colorectal tumor |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 2502 | G | 0.760058 | S | 0.819234 | -0.059176 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 2621 | S | 0.856538 | C | 0.733661 | 0.122877 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 2839 | L | 0.977083 | F | 0.976211 | 8.72E-04 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1171 | R | 0.849064 | C | 0.797852 | 0.051212 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1822 | V | 0.828809 | D | 0.889251 | -0.060442 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 2738 | I | 0.804633 | T | 0.860047 | -0.055414 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 99 | R | 0.965757 | W | 0.916389 | 0.049368 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 722 | S | 0.54261 | G | 0.47848 | 0.06413 | D to O | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1057 | E | 0.891287 | G | 0.842534 | 0.048753 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1184 | A | 0.869938 | P | 0.924309 | -0.054371 | No Change: Both D | Familial adenomatous polyposis (FAP) [MIM:175100] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1317 | E | 0.855057 | Q | 0.846128 | 0.008929 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 890 | V | 0.641898 | I | 0.639628 | 0.00227 | No Change: Both D | Colorectal carcinoma |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1508 | A | 0.650112 | V | 0.592027 | 0.058085 | No Change: Both D | Colorectal carcinoma from a patient with MMRCS |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1296 | A | 0.818363 | V | 0.751362 | 0.067001 | No Change: Both D | Medulloblastoma (MDB) [MIM:155255] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1472 | V | 0.723172 | I | 0.661962 | 0.06121 | No Change: Both D | Medulloblastoma (MDB) [MIM:155255] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1495 | S | 0.58232 | G | 0.509364 | 0.072956 | No Change: Both D | Medulloblastoma (MDB) [MIM:155255] |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1496 | T | 0.622004 | S | 0.694664 | -0.07266 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1973 | S | 0.876556 | T | 0.846811 | 0.029745 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1254 | I | 0.787641 | F | 0.780789 | 0.006852 | No Change: Both D | A colorectal cancer sample |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 870 | P | 0.745186 | S | 0.76037 | -0.015184 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1882 | R | 0.953766 | T | 0.947899 | 0.005867 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 2499 | V | 0.791718 | L | 0.82836 | -0.036642 | No Change: Both D | - |
| P25054 | APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens GN=APC PE=1 SV=2 | 1395 | S | 0.92341 | C | 0.867192 | 0.056218 | No Change: Both D | - |
| O95996 | APC2_HUMAN Adenomatous polyposis coli protein 2 OS=Homo sapiens GN=APC2 PE=1 SV=1 | 562 | A | 0.390013 | S | 0.497438 | -0.107425 | No Change: Both O | A breast cancer sample |
| O95996 | APC2_HUMAN Adenomatous polyposis coli protein 2 OS=Homo sapiens GN=APC2 PE=1 SV=1 | 2003 | G | 0.97778 | S | 0.984731 | -0.006951 | No Change: Both D | A breast cancer sample |
| O95996 | APC2_HUMAN Adenomatous polyposis coli protein 2 OS=Homo sapiens GN=APC2 PE=1 SV=1 | 2241 | S | 0.681021 | A | 0.614406 | 0.066615 | No Change: Both D | - |
| Q8J025 | APCD1_HUMAN Protein APCDD1 OS=Homo sapiens GN=APCDD1 PE=1 SV=1 | 150 | V | 0.124409 | I | 0.10855 | 0.015859 | No Change: Both O | - |
| Q8J025 | APCD1_HUMAN Protein APCDD1 OS=Homo sapiens GN=APCDD1 PE=1 SV=1 | 9 | L | 0.332337 | R | 0.466655 | -0.134318 | No Change: Both O | Hypotrichosis type 1 (HYPT1) [MIM:605389] |
| Q8NCL9 | APCDL_HUMAN Protein APCDD1-like OS=Homo sapiens GN=APCDD1L PE=2 SV=1 | 30 | C | 0.378674 | R | 0.523104 | -0.14443 | O to D | - |
| Q8NCL9 | APCDL_HUMAN Protein APCDD1-like OS=Homo sapiens GN=APCDD1L PE=2 SV=1 | 80 | Y | 0.18512 | H | 0.272685 | -0.087565 | No Change: Both O | - |
| Q8NCL9 | APCDL_HUMAN Protein APCDD1-like OS=Homo sapiens GN=APCDD1L PE=2 SV=1 | 261 | R | 0.463319 | C | 0.365905 | 0.097414 | No Change: Both O | - |
| Q8NCL9 | APCDL_HUMAN Protein APCDD1-like OS=Homo sapiens GN=APCDD1L PE=2 SV=1 | 83 | R | 0.198508 | Q | 0.205228 | -0.00672 | No Change: Both O | - |
| P02743 | SAMP_HUMAN Serum amyloid P-component OS=Homo sapiens GN=APCS PE=1 SV=2 | 155 | E | 0.487301 | G | 0.458676 | 0.028625 | No Change: Both O | - |
| P02743 | SAMP_HUMAN Serum amyloid P-component OS=Homo sapiens GN=APCS PE=1 SV=2 | 158 | S | 0.556544 | G | 0.526641 | 0.029903 | No Change: Both D | - |
| P02743 | SAMP_HUMAN Serum amyloid P-component OS=Homo sapiens GN=APCS PE=1 SV=2 | 141 | G | 0.208236 | S | 0.239118 | -0.030882 | No Change: Both O | A breast cancer sample |
| P13798 | ACPH_HUMAN Acylamino-acid-releasing enzyme OS=Homo sapiens GN=APEH PE=1 SV=4 | 541 | T | 0.37208 | M | 0.322312 | 0.049768 | No Change: Both O | - |
| P27695 | APEX1_HUMAN DNA-(apurinic or apyrimidinic site) lyase OS=Homo sapiens GN=APEX1 PE=1 SV=2 | 51 | Q | 0.753635 | H | 0.735394 | 0.018241 | No Change: Both D | - |
| P27695 | APEX1_HUMAN DNA-(apurinic or apyrimidinic site) lyase OS=Homo sapiens GN=APEX1 PE=1 SV=2 | 64 | I | 0.305742 | V | 0.331139 | -0.025397 | No Change: Both O | - |
| P27695 | APEX1_HUMAN DNA-(apurinic or apyrimidinic site) lyase OS=Homo sapiens GN=APEX1 PE=1 SV=2 | 148 | D | 0.634997 | E | 0.659208 | -0.024211 | No Change: Both D | - |
| Q9UBZ4 | APEX2_HUMAN DNA-(apurinic or apyrimidinic site) lyase 2 OS=Homo sapiens GN=APEX2 PE=1 SV=1 | 141 | R | 0.337096 | C | 0.201724 | 0.135372 | No Change: Both O | - |
| Q9UBZ4 | APEX2_HUMAN DNA-(apurinic or apyrimidinic site) lyase 2 OS=Homo sapiens GN=APEX2 PE=1 SV=1 | 141 | R | 0.337096 | W | 0.17874 | 0.158356 | No Change: Both O | - |
| Q9UBZ4 | APEX2_HUMAN DNA-(apurinic or apyrimidinic site) lyase 2 OS=Homo sapiens GN=APEX2 PE=1 SV=1 | 269 | H | 0.29226 | Y | 0.200873 | 0.091387 | No Change: Both O | - |
| Q9UBZ4 | APEX2_HUMAN DNA-(apurinic or apyrimidinic site) lyase 2 OS=Homo sapiens GN=APEX2 PE=1 SV=1 | 392 | N | 0.968126 | H | 0.963346 | 0.00478 | No Change: Both D | - |
| Q8WW43 | APH1B_HUMAN Gamma-secretase subunit APH-1B OS=Homo sapiens GN=APH1B PE=1 SV=3 | 217 | F | 0.024008 | L | 0.031117 | -0.007109 | No Change: Both O | - |
| Q9BZZ5 | API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens GN=API5 PE=1 SV=3 | 276 | P | 0.286415 | S | 0.30678 | -0.020365 | No Change: Both O | - |
| Q9BZZ5 | API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens GN=API5 PE=1 SV=3 | 300 | M | 0.523427 | V | 0.431698 | 0.091729 | D to O | - |
| Q9BZZ5 | API5_HUMAN Apoptosis inhibitor 5 OS=Homo sapiens GN=API5 PE=1 SV=3 | 493 | G | 0.870463 | S | 0.889929 | -0.019466 | No Change: Both D | - |
| Q96GX9 | MTNB_HUMAN Probable methylthioribulose-1-phosphate dehydratase OS=Homo sapiens GN=APIP PE=1 SV=1 | 7 | R | 0.764599 | W | 0.506742 | 0.257857 | No Change: Both D | - |
| Q96GX9 | MTNB_HUMAN Probable methylthioribulose-1-phosphate dehydratase OS=Homo sapiens GN=APIP PE=1 SV=1 | 23 | H | 0.453016 | R | 0.483102 | -0.030086 | No Change: Both O | - |
| Q96GX9 | MTNB_HUMAN Probable methylthioribulose-1-phosphate dehydratase OS=Homo sapiens GN=APIP PE=1 SV=1 | 76 | C | 0.413455 | Y | 0.380579 | 0.032876 | No Change: Both O | - |
| Q96GX9 | MTNB_HUMAN Probable methylthioribulose-1-phosphate dehydratase OS=Homo sapiens GN=APIP PE=1 SV=1 | 181 | M | 0.458436 | V | 0.376567 | 0.081869 | No Change: Both O | - |
| Q8IW19 | APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens GN=APLF PE=1 SV=1 | 100 | I | 0.101728 | V | 0.111597 | -0.009869 | No Change: Both O | - |
| Q8IW19 | APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens GN=APLF PE=1 SV=1 | 336 | L | 0.98743 | F | 0.985935 | 0.001495 | No Change: Both D | - |
| Q8IW19 | APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens GN=APLF PE=1 SV=1 | 224 | S | 0.853569 | T | 0.821147 | 0.032422 | No Change: Both D | - |
| P35414 | APJ_HUMAN Apelin receptor OS=Homo sapiens GN=APLNR PE=1 SV=1 | 300 | V | 0.063501 | I | 0.060236 | 0.003265 | No Change: Both O | - |
| Q06481 | APLP2_HUMAN Amyloid-like protein 2 OS=Homo sapiens GN=APLP2 PE=1 SV=2 | 632 | D | 0.696389 | N | 0.688135 | 0.008254 | No Change: Both D | - |
| Q9HDC9 | APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens GN=APMAP PE=1 SV=2 | 65 | I | 0.516645 | V | 0.567336 | -0.050691 | No Change: Both D | - |
| Q9HDC9 | APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens GN=APMAP PE=1 SV=2 | 282 | R | 0.168634 | Q | 0.16288 | 0.005754 | No Change: Both O | - |
| Q9HDC9 | APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens GN=APMAP PE=1 SV=2 | 374 | R | 0.572771 | W | 0.336044 | 0.236727 | D to O | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 27 | P | 0.620355 | H | 0.591804 | 0.028551 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 27 | P | 0.620355 | R | 0.584936 | 0.035419 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 28 | P | 0.638699 | R | 0.604985 | 0.033714 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 34 | R | 0.376376 | L | 0.271667 | 0.104709 | No Change: Both O | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 50 | G | 0.439449 | R | 0.447066 | -0.007617 | No Change: Both O | Amyloid polyneuropathy-nephropathy Iowa type (AMYLIOWA) |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 84 | L | 0.528684 | R | 0.607485 | -0.078801 | No Change: Both D | Amyloidosis type 8 (AMYL8) [MIM:105200] |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 113 | D | 0.783127 | E | 0.81763 | -0.034503 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 119 | A | 0.74696 | D | 0.831317 | -0.084357 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 127 | D | 0.795146 | N | 0.753459 | 0.041687 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 131 | K | 0.815779 | M | 0.769569 | 0.04621 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 132 | W | 0.818064 | R | 0.922499 | -0.104435 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 134 | E | 0.827649 | K | 0.823825 | 0.003824 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 160 | E | 0.876611 | K | 0.86898 | 0.007631 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 163 | E | 0.884965 | G | 0.846351 | 0.038614 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 167 | P | 0.86448 | R | 0.871518 | -0.007038 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 168 | L | 0.857317 | R | 0.904949 | -0.047632 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 171 | E | 0.846062 | V | 0.732622 | 0.11344 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 189 | P | 0.670125 | R | 0.699491 | -0.029366 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 197 | R | 0.638114 | C | 0.469551 | 0.168563 | D to O | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 222 | E | 0.70114 | K | 0.696702 | 0.004438 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 184 | R | 0.698119 | P | 0.700065 | -0.001946 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 126 | D | 0.762666 | H | 0.683737 | 0.078929 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 92 | T | 0.504062 | I | 0.331447 | 0.172615 | D to O | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 180 | V | 0.75697 | E | 0.887771 | -0.130801 | No Change: Both D | - |
| P02647 | APOA1_HUMAN Apolipoprotein A-I OS=Homo sapiens GN=APOA1 PE=1 SV=1 | 61 | A | 0.413546 | T | 0.454015 | -0.040469 | No Change: Both O | - |
| Q8NCW5 | AIBP_HUMAN Apolipoprotein A-I-binding protein OS=Homo sapiens GN=APOA1BP PE=1 SV=2 | 19 | V | 0.378726 | L | 0.408699 | -0.029973 | No Change: Both O | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 13 | V | 0.078453 | M | 0.094717 | -0.016264 | No Change: Both O | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 44 | E | 0.615581 | K | 0.61706 | -0.001479 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 147 | N | 0.821288 | S | 0.836977 | -0.015689 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 161 | A | 0.808296 | S | 0.849434 | -0.041138 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 178 | S | 0.689611 | L | 0.575564 | 0.114047 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 185 | E | 0.613543 | K | 0.619498 | -0.005955 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 187 | K | 0.607639 | E | 0.619726 | -0.012087 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 250 | E | 0.726409 | K | 0.721549 | 0.00486 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 264 | R | 0.732334 | Q | 0.735268 | -0.002934 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 305 | R | 0.602293 | C | 0.44445 | 0.157843 | D to O | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 367 | T | 0.953509 | S | 0.965971 | -0.012462 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 380 | Q | 0.997481 | H | 0.995202 | 0.002279 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 74 | G | 0.391297 | S | 0.444759 | -0.053462 | No Change: Both O | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 307 | V | 0.60086 | L | 0.62209 | -0.02123 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 279 | R | 0.730404 | K | 0.722637 | 0.007767 | No Change: Both D | - |
| P06727 | APOA4_HUMAN Apolipoprotein A-IV OS=Homo sapiens GN=APOA4 PE=1 SV=3 | 77 | Q | 0.426098 | H | 0.386115 | 0.039983 | No Change: Both O | - |
| Q6Q788 | APOA5_HUMAN Apolipoprotein A-V OS=Homo sapiens GN=APOA5 PE=1 SV=1 | 19 | S | 0.257354 | W | 0.084048 | 0.173306 | No Change: Both O | - |
| Q6Q788 | APOA5_HUMAN Apolipoprotein A-V OS=Homo sapiens GN=APOA5 PE=1 SV=1 | 153 | V | 0.43108 | M | 0.494972 | -0.063892 | No Change: Both O | - |
| Q6Q788 | APOA5_HUMAN Apolipoprotein A-V OS=Homo sapiens GN=APOA5 PE=1 SV=1 | 185 | G | 0.332975 | C | 0.185922 | 0.147053 | No Change: Both O | - |
| Q6Q788 | APOA5_HUMAN Apolipoprotein A-V OS=Homo sapiens GN=APOA5 PE=1 SV=1 | 37 | D | 0.624083 | E | 0.646593 | -0.02251 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1437 | F | 0.384715 | L | 0.422186 | -0.037471 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1914 | N | 0.428422 | S | 0.453353 | -0.024931 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1923 | H | 0.227253 | R | 0.223712 | 0.003541 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2566 | E | 0.234875 | K | 0.245803 | -0.010928 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2739 | P | 0.300792 | L | 0.171437 | 0.129355 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3121 | A | 0.256082 | T | 0.275825 | -0.019743 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3319 | D | 0.274052 | H | 0.247553 | 0.026499 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3427 | T | 0.575268 | K | 0.613149 | -0.037881 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3432 | Q | 0.555917 | E | 0.593789 | -0.037872 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3527 | R | 0.657999 | Q | 0.675941 | -0.017942 | No Change: Both D | Familial ligand-defective apolipoprotein B-100 (FDB) [MIM:144010] |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3558 | R | 0.150248 | C | 0.0811 | 0.069148 | No Change: Both O | Familial ligand-defective apolipoprotein B-100 (FDB) [MIM:144010] |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3921 | V | 0.228799 | I | 0.199095 | 0.029704 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3945 | T | 0.54006 | A | 0.518051 | 0.022009 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4128 | V | 0.236075 | M | 0.291882 | -0.055807 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4338 | S | 0.081206 | N | 0.074226 | 0.00698 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4481 | A | 0.433959 | T | 0.462446 | -0.028487 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 98 | T | 0.286015 | I | 0.179586 | 0.106429 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 733 | V | 0.264915 | I | 0.219218 | 0.045697 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3638 | R | 0.409727 | Q | 0.445066 | -0.035339 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4181 | E | 0.245399 | K | 0.263932 | -0.018533 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4270 | R | 0.193095 | T | 0.178148 | 0.014947 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 273 | K | 0.252142 | N | 0.219883 | 0.032259 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 618 | A | 0.564918 | V | 0.512794 | 0.052124 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1218 | Q | 0.401851 | E | 0.439663 | -0.037812 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2092 | L | 0.12961 | V | 0.138149 | -0.008539 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2365 | A | 0.239329 | T | 0.274893 | -0.035564 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2680 | L | 0.219032 | Q | 0.359946 | -0.140914 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3732 | I | 0.103249 | T | 0.171436 | -0.068187 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3949 | F | 0.47699 | L | 0.499116 | -0.022126 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3964 | Y | 0.535895 | F | 0.524541 | 0.011354 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 554 | P | 0.551194 | L | 0.440187 | 0.111007 | D to O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 730 | V | 0.361206 | I | 0.30492 | 0.056286 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 741 | T | 0.507375 | N | 0.530334 | -0.022959 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2456 | A | 0.386737 | D | 0.457489 | -0.070752 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3294 | S | 0.214681 | P | 0.202638 | 0.012043 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4484 | T | 0.460326 | M | 0.416036 | 0.04429 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 103 | Y | 0.31427 | H | 0.425012 | -0.110742 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 145 | P | 0.320056 | S | 0.32087 | -8.14E-04 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2785 | N | 0.576288 | H | 0.548854 | 0.027434 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 490 | R | 0.136871 | W | 0.055827 | 0.081044 | No Change: Both O | Familial hypobetalipoproteinemia type 1 (FHBL1) [MIM:107730] |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1128 | R | 0.314216 | H | 0.292547 | 0.021669 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 408 | I | 0.069661 | T | 0.132877 | -0.063216 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 877 | P | 0.371171 | L | 0.238295 | 0.132876 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1086 | G | 0.588179 | S | 0.626561 | -0.038382 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1113 | D | 0.477066 | H | 0.464772 | 0.012294 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1388 | R | 0.352448 | H | 0.358723 | -0.006275 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2299 | D | 0.124133 | H | 0.100394 | 0.023739 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3182 | H | 0.569378 | N | 0.579938 | -0.01056 | No Change: Both D | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3279 | S | 0.296519 | G | 0.239522 | 0.056997 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 3801 | S | 0.540437 | T | 0.478947 | 0.06149 | D to O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 4394 | V | 0.084557 | A | 0.11088 | -0.026323 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2564 | F | 0.274359 | C | 0.26046 | 0.013899 | No Change: Both O | A colorectal cancer sample |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 194 | T | 0.420067 | M | 0.365556 | 0.054511 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 955 | P | 0.313561 | S | 0.333769 | -0.020208 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 2313 | I | 0.206639 | V | 0.232147 | -0.025508 | No Change: Both O | - |
| P04114 | APOB_HUMAN Apolipoprotein B-100 OS=Homo sapiens GN=APOB PE=1 SV=2 | 1422 | Y | 0.394156 | C | 0.366021 | 0.028135 | No Change: Both O | - |
| P41238 | ABEC1_HUMAN C->U-editing enzyme APOBEC-1 OS=Homo sapiens GN=APOBEC1 PE=1 SV=3 | 80 | M | 0.338372 | I | 0.273128 | 0.065244 | No Change: Both O | - |
| P41238 | ABEC1_HUMAN C->U-editing enzyme APOBEC-1 OS=Homo sapiens GN=APOBEC1 PE=1 SV=3 | 236 | R | 0.765117 | K | 0.827461 | -0.062344 | No Change: Both D | - |
| Q9Y235 | ABEC2_HUMAN Probable C->U-editing enzyme APOBEC-2 OS=Homo sapiens GN=APOBEC2 PE=1 SV=1 | 136 | I | 0.213464 | T | 0.347483 | -0.134019 | No Change: Both O | - |
| P31941 | ABC3A_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3A OS=Homo sapiens GN=APOBEC3A PE=1 SV=3 | 19 | T | 0.323107 | A | 0.296575 | 0.026532 | No Change: Both O | - |
| Q9UH17 | ABC3B_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens GN=APOBEC3B PE=1 SV=1 | 62 | K | 0.223581 | E | 0.23484 | -0.011259 | No Change: Both O | - |
| Q9UH17 | ABC3B_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens GN=APOBEC3B PE=1 SV=1 | 98 | P | 0.08404 | L | 0.038733 | 0.045307 | No Change: Both O | - |
| Q9UH17 | ABC3B_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens GN=APOBEC3B PE=1 SV=1 | 146 | T | 0.170293 | K | 0.235092 | -0.064799 | No Change: Both O | - |
| Q9UH17 | ABC3B_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens GN=APOBEC3B PE=1 SV=1 | 109 | S | 0.313903 | A | 0.228328 | 0.085575 | No Change: Both O | - |
| Q9UH17 | ABC3B_HUMAN Probable DNA dC->dU-editing enzyme APOBEC-3B OS=Homo sapiens GN=APOBEC3B PE=1 SV=1 | 351 | R | 0.06609 | H | 0.065284 | 8.06E-04 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 61 | Q | 0.549085 | L | 0.36296 | 0.186125 | D to O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 97 | P | 0.084084 | L | 0.038733 | 0.045351 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 108 | A | 0.228328 | S | 0.313903 | -0.085575 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 231 | V | 0.456195 | I | 0.401579 | 0.054616 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 178 | A | 0.121484 | T | 0.146669 | -0.025185 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 307 | Y | 0.029568 | C | 0.021802 | 0.007766 | No Change: Both O | - |
| Q8IUX4 | ABC3F_HUMAN DNA dC->dU-editing enzyme APOBEC-3F OS=Homo sapiens GN=APOBEC3F PE=1 SV=3 | 48 | R | 0.509825 | P | 0.550289 | -0.040464 | No Change: Both D | - |
| Q9HC16 | ABC3G_HUMAN DNA dC->dU-editing enzyme APOBEC-3G OS=Homo sapiens GN=APOBEC3G PE=1 SV=1 | 186 | H | 0.037055 | R | 0.037821 | -7.66E-04 | No Change: Both O | - |
| Q9HC16 | ABC3G_HUMAN DNA dC->dU-editing enzyme APOBEC-3G OS=Homo sapiens GN=APOBEC3G PE=1 SV=1 | 275 | Q | 0.136032 | E | 0.163087 | -0.027055 | No Change: Both O | - |
| Q9HC16 | ABC3G_HUMAN DNA dC->dU-editing enzyme APOBEC-3G OS=Homo sapiens GN=APOBEC3G PE=1 SV=1 | 256 | R | 0.305768 | H | 0.329131 | -0.023363 | No Change: Both O | - |
| Q6NTF7 | ABC3H_HUMAN DNA dC->dU-editing enzyme APOBEC-3H OS=Homo sapiens GN=APOBEC3H PE=1 SV=3 | 18 | R | 0.569468 | L | 0.410421 | 0.159047 | D to O | - |
| Q6NTF7 | ABC3H_HUMAN DNA dC->dU-editing enzyme APOBEC-3H OS=Homo sapiens GN=APOBEC3H PE=1 SV=3 | 105 | G | 0.1605 | R | 0.164068 | -0.003568 | No Change: Both O | - |
| Q6NTF7 | ABC3H_HUMAN DNA dC->dU-editing enzyme APOBEC-3H OS=Homo sapiens GN=APOBEC3H PE=1 SV=3 | 121 | K | 0.295876 | E | 0.280656 | 0.01522 | No Change: Both O | - |
| Q6NTF7 | ABC3H_HUMAN DNA dC->dU-editing enzyme APOBEC-3H OS=Homo sapiens GN=APOBEC3H PE=1 SV=3 | 121 | K | 0.295876 | N | 0.241677 | 0.054199 | No Change: Both O | - |
| Q6NTF7 | ABC3H_HUMAN DNA dC->dU-editing enzyme APOBEC-3H OS=Homo sapiens GN=APOBEC3H PE=1 SV=3 | 178 | E | 0.376766 | D | 0.351796 | 0.02497 | No Change: Both O | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 75 | S | 0.557988 | F | 0.331109 | 0.226879 | D to O | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 271 | F | 0.590989 | S | 0.749748 | -0.158759 | No Change: Both D | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 275 | P | 0.726808 | S | 0.695917 | 0.030891 | No Change: Both D | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 331 | K | 0.710932 | E | 0.732995 | -0.022063 | No Change: Both D | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 345 | V | 0.712964 | M | 0.783296 | -0.070332 | No Change: Both D | - |
| Q8WW27 | ABEC4_HUMAN Putative C->U-editing enzyme APOBEC-4 OS=Homo sapiens GN=APOBEC4 PE=2 SV=1 | 300 | D | 0.775966 | G | 0.76094 | 0.015026 | No Change: Both D | - |
| Q0VD83 | APOBR_HUMAN Apolipoprotein B receptor OS=Homo sapiens GN=APOBR PE=1 SV=1 | 419 | A | 0.909876 | P | 0.934426 | -0.02455 | No Change: Both D | - |
| P02654 | APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 | 16 | I | 0.109892 | M | 0.196597 | -0.086705 | No Change: Both O | - |
| P02654 | APOC1_HUMAN Apolipoprotein C-I OS=Homo sapiens GN=APOC1 PE=1 SV=1 | 71 | T | 0.715984 | S | 0.818394 | -0.10241 | No Change: Both D | - |
| P02655 | APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 | 41 | K | 0.586992 | T | 0.540553 | 0.046439 | No Change: Both D | - |
| P02655 | APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 | 48 | W | 0.619259 | R | 0.771688 | -0.152429 | No Change: Both D | Hyperlipoproteinemia type 1B (HLPP1B) [MIM:207750] |
| P02655 | APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 | 60 | E | 0.38553 | K | 0.400057 | -0.014527 | No Change: Both O | - |
| P02655 | APOC2_HUMAN Apolipoprotein C-II OS=Homo sapiens GN=APOC2 PE=1 SV=1 | 77 | K | 0.544617 | Q | 0.493563 | 0.051054 | D to O | - |
| P02656 | APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 | 78 | K | 0.32568 | E | 0.323455 | 0.002225 | No Change: Both O | Hyperalphalipoproteinemia type 2 (HALP2) [MIM:614028] |
| P02656 | APOC3_HUMAN Apolipoprotein C-III OS=Homo sapiens GN=APOC3 PE=1 SV=1 | 94 | T | 0.593803 | A | 0.601239 | -0.007436 | No Change: Both D | - |
| P55056 | APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 | 96 | L | 0.222448 | R | 0.323102 | -0.100654 | No Change: Both O | - |
| P55056 | APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 | 126 | Q | 0.789114 | L | 0.783457 | 0.005657 | No Change: Both D | - |
| P55056 | APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 | 36 | L | 0.657175 | P | 0.75749 | -0.100315 | No Change: Both D | - |
| P55056 | APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 | 52 | G | 0.377011 | D | 0.398438 | -0.021427 | No Change: Both O | - |
| P55056 | APOC4_HUMAN Apolipoprotein C-IV OS=Homo sapiens GN=APOC4 PE=1 SV=1 | 75 | P | 0.136042 | Q | 0.136759 | -7.17E-04 | No Change: Both O | A breast cancer sample |
| P05090 | APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 | 15 | F | 0.238462 | S | 0.463219 | -0.224757 | No Change: Both O | - |
| P05090 | APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 | 115 | S | 0.074358 | L | 0.029709 | 0.044649 | No Change: Both O | - |
| P05090 | APOD_HUMAN Apolipoprotein D OS=Homo sapiens GN=APOD PE=1 SV=1 | 178 | T | 0.57156 | K | 0.652112 | -0.080552 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 21 | E | 0.460977 | K | 0.447862 | 0.013115 | No Change: Both O | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 31 | E | 0.759873 | K | 0.736205 | 0.023668 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 46 | L | 0.373871 | P | 0.491484 | -0.117613 | No Change: Both O | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 60 | T | 0.364067 | A | 0.328132 | 0.035935 | No Change: Both O | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 99 | Q | 0.882392 | K | 0.891216 | -0.008824 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 102 | P | 0.859719 | R | 0.876935 | -0.017216 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 117 | A | 0.707877 | T | 0.708128 | -2.51E-04 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 130 | C | 0.498082 | R | 0.663955 | -0.165873 | O to D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 145 | G | 0.600094 | D | 0.634145 | -0.034051 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 152 | R | 0.596299 | Q | 0.596594 | -2.95E-04 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 154 | R | 0.563709 | S | 0.582605 | -0.018896 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 154 | R | 0.563709 | C | 0.388981 | 0.174728 | D to O | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 160 | R | 0.667391 | C | 0.502295 | 0.165096 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 163 | R | 0.702666 | C | 0.528208 | 0.174458 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 163 | R | 0.702666 | H | 0.638286 | 0.06438 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 164 | K | 0.702775 | Q | 0.692805 | 0.00997 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 164 | K | 0.702775 | E | 0.708929 | -0.006154 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 170 | A | 0.725066 | P | 0.752673 | -0.027607 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 176 | R | 0.697644 | C | 0.534774 | 0.16287 | No Change: Both D | Hyperlipoproteinemia type 3 (HLPP3) [MIM:107741] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 242 | R | 0.914026 | Q | 0.911341 | 0.002685 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 246 | R | 0.91553 | C | 0.848601 | 0.066929 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 254 | V | 0.865889 | E | 0.930517 | -0.064628 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 269 | R | 0.646305 | G | 0.59013 | 0.056175 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 270 | L | 0.631546 | E | 0.769886 | -0.13834 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 292 | R | 0.280543 | H | 0.249117 | 0.031426 | No Change: Both O | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 314 | S | 0.699341 | R | 0.677577 | 0.021764 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 64 | Q | 0.523162 | H | 0.457044 | 0.066118 | D to O | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 124 | A | 0.642073 | V | 0.573504 | 0.068569 | No Change: Both D | - |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 43 | R | 0.429648 | C | 0.3041 | 0.125548 | No Change: Both O | Lipoprotein glomerulopathy (LPG) [MIM:611771] |
| P02649 | APOE_HUMAN Apolipoprotein E OS=Homo sapiens GN=APOE PE=1 SV=1 | 163 | R | 0.702666 | P | 0.660498 | 0.042168 | No Change: Both D | Lipoprotein glomerulopathy (LPG) [MIM:611771] |
| Q13790 | APOF_HUMAN Apolipoprotein F OS=Homo sapiens GN=APOF PE=1 SV=2 | 178 | A | 0.448035 | G | 0.500238 | -0.052203 | O to D | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 266 | V | 0.404906 | L | 0.382407 | 0.022499 | No Change: Both O | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 107 | S | 0.208661 | N | 0.184689 | 0.023972 | No Change: Both O | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 325 | C | 0.418749 | G | 0.487408 | -0.068659 | No Change: Both O | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 335 | W | 0.424698 | S | 0.734258 | -0.30956 | O to D | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 154 | R | 0.249937 | H | 0.238303 | 0.011634 | No Change: Both O | - |
| P02749 | APOH_HUMAN Beta-2-glycoprotein 1 OS=Homo sapiens GN=APOH PE=1 SV=3 | 5 | V | 0.318015 | A | 0.393748 | -0.075733 | No Change: Both O | - |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 150 | E | 0.525589 | K | 0.521836 | 0.003753 | No Change: Both D | - |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 228 | M | 0.366455 | I | 0.291149 | 0.075306 | No Change: Both O | - |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 255 | R | 0.361349 | K | 0.448585 | -0.087236 | No Change: Both O | - |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 188 | I | 0.286632 | T | 0.422259 | -0.135627 | No Change: Both O | A breast cancer sample |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 337 | D | 0.238258 | N | 0.227691 | 0.010567 | No Change: Both O | - |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 384 | I | 0.639887 | M | 0.731246 | -0.091359 | No Change: Both D | Focal segmental glomerulosclerosis type 4 (FSGS4) [MIM:612551] |
| O14791 | APOL1_HUMAN Apolipoprotein L1 OS=Homo sapiens GN=APOL1 PE=1 SV=5 | 342 | S | 0.086106 | G | 0.064683 | 0.021423 | No Change: Both O | Focal segmental glomerulosclerosis type 4 (FSGS4) [MIM:612551] |
| Q9BQE5 | APOL2_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=1 | 245 | I | 0.554235 | V | 0.55742 | -0.003185 | No Change: Both D | - |
| Q9BQE5 | APOL2_HUMAN Apolipoprotein L2 OS=Homo sapiens GN=APOL2 PE=1 SV=1 | 182 | R | 0.522158 | C | 0.344297 | 0.177861 | D to O | - |
| O95236 | APOL3_HUMAN Apolipoprotein L3 OS=Homo sapiens GN=APOL3 PE=2 SV=3 | 135 | A | 0.330713 | V | 0.250369 | 0.080344 | No Change: Both O | - |
| O95236 | APOL3_HUMAN Apolipoprotein L3 OS=Homo sapiens GN=APOL3 PE=2 SV=3 | 39 | S | 0.440846 | R | 0.353432 | 0.087414 | No Change: Both O | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 9 | I | 0.017307 | V | 0.020975 | -0.003668 | No Change: Both O | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 12 | V | 0.008401 | L | 0.008215 | 1.86E-04 | No Change: Both O | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 159 | M | 0.077074 | V | 0.064827 | 0.012247 | No Change: Both O | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 223 | R | 0.297397 | H | 0.237529 | 0.059868 | No Change: Both O | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 319 | A | 0.716423 | E | 0.752375 | -0.035952 | No Change: Both D | - |
| Q9BPW4 | APOL4_HUMAN Apolipoprotein L4 OS=Homo sapiens GN=APOL4 PE=2 SV=3 | 326 | S | 0.673173 | L | 0.489819 | 0.183354 | D to O | - |
| Q9BWW9 | APOL5_HUMAN Apolipoprotein L5 OS=Homo sapiens GN=APOL5 PE=1 SV=1 | 272 | T | 0.123662 | M | 0.103579 | 0.020083 | No Change: Both O | - |
| Q9BWW9 | APOL5_HUMAN Apolipoprotein L5 OS=Homo sapiens GN=APOL5 PE=1 SV=1 | 323 | T | 0.695601 | M | 0.683693 | 0.011908 | No Change: Both D | - |
| Q9BWW9 | APOL5_HUMAN Apolipoprotein L5 OS=Homo sapiens GN=APOL5 PE=1 SV=1 | 406 | S | 0.94641 | C | 0.921056 | 0.025354 | No Change: Both D | - |
| Q9BWW9 | APOL5_HUMAN Apolipoprotein L5 OS=Homo sapiens GN=APOL5 PE=1 SV=1 | 81 | E | 0.242767 | K | 0.237477 | 0.00529 | No Change: Both O | - |
| Q9BWW8 | APOL6_HUMAN Apolipoprotein L6 OS=Homo sapiens GN=APOL6 PE=1 SV=1 | 173 | N | 0.215185 | K | 0.258141 | -0.042956 | No Change: Both O | - |
| Q96IL0 | APOP1_HUMAN Apoptogenic protein 1 mitochondrial OS=Homo sapiens GN=APOPT1 PE=2 SV=3 | 27 | P | 0.621172 | A | 0.550642 | 0.07053 | No Change: Both D | - |
| Q96IL0 | APOP1_HUMAN Apoptogenic protein 1 mitochondrial OS=Homo sapiens GN=APOPT1 PE=2 SV=3 | 88 | N | 0.607544 | S | 0.657151 | -0.049607 | No Change: Both D | - |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 692 | A | 0.240178 | G | 0.306935 | -0.066757 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 693 | E | 0.256015 | Q | 0.222871 | 0.033144 | No Change: Both O | Cerebral amyloid angiopathy APP-related (CAA-APP) [MIM:605714] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 713 | A | 0.028136 | V | 0.022204 | 0.005932 | No Change: Both O | - |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 713 | A | 0.028136 | T | 0.035684 | -0.007548 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 716 | I | 0.02048 | V | 0.024865 | -0.004385 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 717 | V | 0.02153 | I | 0.018474 | 0.003056 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 717 | V | 0.02153 | G | 0.037505 | -0.015975 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 717 | V | 0.02153 | F | 0.016318 | 0.005212 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 665 | E | 0.562285 | D | 0.529882 | 0.032403 | No Change: Both D | - |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 715 | V | 0.021821 | M | 0.027558 | -0.005737 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 723 | L | 0.192401 | P | 0.298849 | -0.106448 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 693 | E | 0.256015 | G | 0.226205 | 0.02981 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 693 | E | 0.256015 | K | 0.273978 | -0.017963 | No Change: Both O | Cerebral amyloid angiopathy APP-related (CAA-APP) [MIM:605714] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 694 | D | 0.269805 | N | 0.269603 | 2.02E-04 | No Change: Both O | Cerebral amyloid angiopathy APP-related (CAA-APP) [MIM:605714] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 714 | T | 0.024626 | I | 0.013049 | 0.011577 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 717 | V | 0.02153 | L | 0.020653 | 8.77E-04 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 501 | E | 0.590535 | K | 0.616777 | -0.026242 | No Change: Both D | - |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 705 | L | 0.089987 | V | 0.100974 | -0.010987 | No Change: Both O | Cerebral amyloid angiopathy APP-related (CAA-APP) [MIM:605714] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 714 | T | 0.024626 | A | 0.021343 | 0.003283 | No Change: Both O | Alzheimer disease type 1 (AD1) [MIM:104300] |
| P05067 | A4_HUMAN Amyloid beta A4 protein OS=Homo sapiens GN=APP PE=1 SV=3 | 678 | D | 0.542584 | N | 0.516489 | 0.026095 | No Change: Both D | Alzheimer disease type 1 (AD1) [MIM:104300] |
| Q92624 | APBP2_HUMAN Amyloid protein-binding protein 2 OS=Homo sapiens GN=APPBP2 PE=1 SV=2 | 561 | S | 0.700038 | N | 0.649221 | 0.050817 | No Change: Both D | - |
| Q9UKG1 | DP13A_HUMAN DCC-interacting protein 13-alpha OS=Homo sapiens GN=APPL1 PE=1 SV=1 | 643 | E | 0.949106 | Q | 0.945795 | 0.003311 | No Change: Both D | A breast cancer sample |
| Q9UKG1 | DP13A_HUMAN DCC-interacting protein 13-alpha OS=Homo sapiens GN=APPL1 PE=1 SV=1 | 108 | A | 0.254048 | V | 0.19553 | 0.058518 | No Change: Both O | - |
| Q9UKG1 | DP13A_HUMAN DCC-interacting protein 13-alpha OS=Homo sapiens GN=APPL1 PE=1 SV=1 | 700 | E | 0.985351 | G | 0.981392 | 0.003959 | No Change: Both D | - |
| Q8NEU8 | DP13B_HUMAN DCC-interacting protein 13-beta OS=Homo sapiens GN=APPL2 PE=1 SV=3 | 433 | A | 0.7181 | V | 0.656727 | 0.061373 | No Change: Both D | - |
| Q6UW56 | APR3_HUMAN Apoptosis-related protein 3 OS=Homo sapiens GN=APR3 PE=1 SV=2 | 209 | A | 0.093547 | S | 0.163053 | -0.069506 | No Change: Both O | - |
| Q8IVJ8 | APRG1_HUMAN AP20 region protein 1 OS=Homo sapiens GN=APRG1 PE=2 SV=2 | 107 | H | 0.465446 | Y | 0.336969 | 0.128477 | No Change: Both O | - |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 65 | D | 0.185736 | V | 0.095406 | 0.09033 | No Change: Both O | Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:102600] |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 110 | L | 0.438423 | P | 0.578069 | -0.139646 | O to D | Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:102600] |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 136 | M | 0.272703 | T | 0.328502 | -0.055799 | No Change: Both O | Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:102600] |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 121 | Q | 0.276246 | R | 0.267078 | 0.009168 | No Change: Both O | - |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 150 | V | 0.178678 | F | 0.146702 | 0.031976 | No Change: Both O | Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:102600] |
| P07741 | APT_HUMAN Adenine phosphoribosyltransferase OS=Homo sapiens GN=APRT PE=1 SV=2 | 153 | C | 0.152694 | R | 0.284733 | -0.132039 | No Change: Both O | Adenine phosphoribosyltransferase deficiency (APRTD) [MIM:102600] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 211 | K | 0.212833 | Q | 0.167641 | 0.045192 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 212 | A | 0.168842 | V | 0.138161 | 0.030681 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 213 | R | 0.132183 | H | 0.141166 | -0.008983 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 215 | H | 0.078501 | R | 0.085552 | -0.007051 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 220 | P | 0.08479 | L | 0.045189 | 0.039601 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 277 | V | 0.338284 | G | 0.469559 | -0.131275 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 281 | D | 0.35005 | G | 0.306546 | 0.043504 | No Change: Both O | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 293 | W | 0.381127 | R | 0.569263 | -0.188136 | O to D | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| Q7Z2E3 | APTX_HUMAN Aprataxin OS=Homo sapiens GN=APTX PE=1 SV=2 | 237 | L | 0.447157 | P | 0.603503 | -0.156346 | O to D | Ataxia-oculomotor apraxia syndrome (AOA) [MIM:208920] |
| P29972 | AQP1_HUMAN Aquaporin-1 OS=Homo sapiens GN=AQP1 PE=1 SV=3 | 45 | A | 0.44277 | V | 0.381813 | 0.060957 | No Change: Both O | - |
| P29972 | AQP1_HUMAN Aquaporin-1 OS=Homo sapiens GN=AQP1 PE=1 SV=3 | 38 | P | 0.296225 | L | 0.166636 | 0.129589 | No Change: Both O | - |
| P29972 | AQP1_HUMAN Aquaporin-1 OS=Homo sapiens GN=AQP1 PE=1 SV=3 | 165 | G | 0.546021 | D | 0.572977 | -0.026956 | No Change: Both D | - |
| Q96PS8 | AQP10_HUMAN Aquaporin-10 OS=Homo sapiens GN=AQP10 PE=2 SV=2 | 15 | R | 0.16591 | Q | 0.170165 | -0.004255 | No Change: Both O | - |
| Q96PS8 | AQP10_HUMAN Aquaporin-10 OS=Homo sapiens GN=AQP10 PE=2 SV=2 | 123 | H | 0.153152 | Y | 0.101524 | 0.051628 | No Change: Both O | - |
| Q8NBQ7 | AQP11_HUMAN Aquaporin-11 OS=Homo sapiens GN=AQP11 PE=2 SV=1 | 102 | G | 0.375946 | S | 0.43941 | -0.063464 | No Change: Both O | - |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 64 | G | 0.298216 | R | 0.26928 | 0.028936 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 187 | R | 0.427942 | C | 0.260368 | 0.167574 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 216 | S | 0.06019 | P | 0.055785 | 0.004405 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 22 | L | 0.019954 | V | 0.019373 | 5.81E-04 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 28 | L | 0.056754 | P | 0.112291 | -0.055537 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 47 | A | 0.06483 | V | 0.044345 | 0.020485 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 68 | N | 0.231286 | S | 0.28106 | -0.049774 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 71 | V | 0.102874 | M | 0.123967 | -0.021093 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 125 | T | 0.511657 | M | 0.447486 | 0.064171 | D to O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 126 | T | 0.483581 | M | 0.419882 | 0.063699 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 147 | A | 0.132028 | T | 0.15734 | -0.025312 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 168 | V | 0.140562 | M | 0.185063 | -0.044501 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 175 | G | 0.116277 | R | 0.101127 | 0.01515 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 181 | C | 0.263142 | W | 0.230824 | 0.032318 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 185 | P | 0.44189 | A | 0.361734 | 0.080156 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 190 | A | 0.333104 | T | 0.356151 | -0.023047 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 194 | V | 0.230411 | I | 0.19311 | 0.037301 | No Change: Both O | - |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 202 | W | 0.038781 | C | 0.042838 | -0.004057 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 258 | E | 0.912166 | K | 0.905846 | 0.00632 | No Change: Both D | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 262 | P | 0.912095 | L | 0.837319 | 0.074776 | No Change: Both D | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 57 | Q | 0.163929 | P | 0.176315 | -0.012386 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 100 | G | 0.168445 | V | 0.095608 | 0.072837 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 121 | L | 0.433291 | F | 0.387754 | 0.045537 | No Change: Both O | - |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 70 | A | 0.139851 | D | 0.180564 | -0.040713 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 100 | G | 0.168445 | R | 0.1505 | 0.017945 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 180 | G | 0.235436 | S | 0.284189 | -0.048753 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 187 | R | 0.427942 | H | 0.430985 | -0.003043 | No Change: Both O | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 254 | R | 0.866057 | L | 0.795797 | 0.07026 | No Change: Both D | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| P41181 | AQP2_HUMAN Aquaporin-2 OS=Homo sapiens GN=AQP2 PE=1 SV=1 | 254 | R | 0.866057 | Q | 0.857348 | 0.008709 | No Change: Both D | Diabetes insipidus nephrogenic autosomal (ANDI) [MIM:125800] |
| Q92482 | AQP3_HUMAN Aquaporin-3 OS=Homo sapiens GN=AQP3 PE=2 SV=2 | 43 | V | 0.125501 | M | 0.155767 | -0.030266 | No Change: Both O | - |
| Q13520 | AQP6_HUMAN Aquaporin-6 OS=Homo sapiens GN=AQP6 PE=2 SV=2 | 234 | V | 0.044652 | I | 0.041465 | 0.003187 | No Change: Both O | - |
| O14520 | AQP7_HUMAN Aquaporin-7 OS=Homo sapiens GN=AQP7 PE=2 SV=1 | 38 | L | 0.185316 | V | 0.197399 | -0.012083 | No Change: Both O | - |
| O14520 | AQP7_HUMAN Aquaporin-7 OS=Homo sapiens GN=AQP7 PE=2 SV=1 | 63 | K | 0.35881 | T | 0.264183 | 0.094627 | No Change: Both O | - |
| O94778 | AQP8_HUMAN Aquaporin-8 OS=Homo sapiens GN=AQP8 PE=2 SV=2 | 260 | A | 0.841356 | P | 0.884466 | -0.04311 | No Change: Both D | - |
| O94778 | AQP8_HUMAN Aquaporin-8 OS=Homo sapiens GN=AQP8 PE=2 SV=2 | 229 | I | 0.013265 | M | 0.021075 | -0.00781 | No Change: Both O | A breast cancer sample |
| O43315 | AQP9_HUMAN Aquaporin-9 OS=Homo sapiens GN=AQP9 PE=1 SV=2 | 279 | T | 0.788579 | A | 0.766602 | 0.021977 | No Change: Both D | - |
| Q6Q4G3 | AMPQ_HUMAN Aminopeptidase Q OS=Homo sapiens GN=AQPEP PE=1 SV=4 | 640 | V | 0.586028 | F | 0.551181 | 0.034847 | No Change: Both D | - |
| Q6Q4G3 | AMPQ_HUMAN Aminopeptidase Q OS=Homo sapiens GN=AQPEP PE=1 SV=4 | 689 | L | 0.143727 | F | 0.124499 | 0.019228 | No Change: Both O | - |
| Q6Q4G3 | AMPQ_HUMAN Aminopeptidase Q OS=Homo sapiens GN=AQPEP PE=1 SV=4 | 936 | V | 0.142078 | I | 0.132003 | 0.010075 | No Change: Both O | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 2 | E | 0.646819 | K | 0.654768 | -0.007949 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 54 | L | 0.964592 | S | 0.975212 | -0.01062 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 57 | L | 0.986586 | Q | 0.991861 | -0.005275 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 607 | R | 0.567488 | Q | 0.531624 | 0.035864 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 608 | R | 0.585491 | K | 0.619986 | -0.034495 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 645 | A | 0.875797 | D | 0.890753 | -0.014956 | No Change: Both D | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 664 | I | 0.379084 | N | 0.51307 | -0.133986 | O to D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 664 | I | 0.379084 | N | 0.51307 | -0.133986 | O to D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 677 | L | 0.140095 | P | 0.25186 | -0.111765 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 695 | D | 0.576976 | H | 0.539628 | 0.037348 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 695 | D | 0.576976 | N | 0.565934 | 0.011042 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 695 | D | 0.576976 | V | 0.385566 | 0.19141 | D to O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 703 | S | 0.379189 | G | 0.322172 | 0.057017 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 703 | S | 0.379189 | G | 0.322172 | 0.057017 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 707 | L | 0.479416 | R | 0.590086 | -0.11067 | O to D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 730 | V | 0.209213 | M | 0.265995 | -0.056782 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 732 | D | 0.208841 | N | 0.195727 | 0.013114 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 732 | D | 0.208841 | Y | 0.106766 | 0.102075 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 742 | M | 0.039243 | I | 0.024202 | 0.015041 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 743 | G | 0.036638 | V | 0.019971 | 0.016667 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 743 | G | 0.036638 | V | 0.019971 | 0.016667 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 749 | M | 0.061886 | V | 0.045938 | 0.015948 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 749 | M | 0.061886 | V | 0.045938 | 0.015948 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 750 | G | 0.083941 | D | 0.091495 | -0.007554 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 752 | R | 0.139858 | Q | 0.146512 | -0.006654 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 754 | F | 0.210476 | V | 0.243867 | -0.033391 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 762 | L | 0.115101 | F | 0.108178 | 0.006923 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 763 | Y | 0.096969 | C | 0.083976 | 0.012993 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 765 | A | 0.095524 | T | 0.109566 | -0.014042 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 774 | R | 0.358943 | H | 0.364136 | -0.005193 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 774 | R | 0.358943 | H | 0.364136 | -0.005193 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 774 | R | 0.358943 | C | 0.194092 | 0.164851 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 779 | R | 0.46173 | W | 0.237659 | 0.224071 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 780 | M | 0.484603 | I | 0.361675 | 0.122928 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 780 | M | 0.484603 | I | 0.361675 | 0.122928 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 784 | C | 0.386757 | Y | 0.463141 | -0.076384 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 787 | M | 0.269033 | V | 0.21842 | 0.050613 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 794 | F | 0.198888 | S | 0.424901 | -0.226013 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 798 | Q | 0.113431 | E | 0.137359 | -0.023928 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 798 | Q | 0.113431 | E | 0.137359 | -0.023928 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 807 | M | 0.05614 | R | 0.072793 | -0.016653 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 807 | M | 0.05614 | V | 0.040275 | 0.015865 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 814 | S | 0.041793 | N | 0.035472 | 0.006321 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 814 | S | 0.041793 | N | 0.035472 | 0.006321 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 831 | R | 0.190305 | L | 0.124004 | 0.066301 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 831 | R | 0.190305 | Q | 0.205221 | -0.014916 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 840 | R | 0.149406 | C | 0.078831 | 0.070575 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 840 | R | 0.149406 | G | 0.136616 | 0.01279 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 840 | R | 0.149406 | H | 0.129308 | 0.020098 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 842 | I | 0.18718 | T | 0.28708 | -0.0999 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 855 | R | 0.274173 | C | 0.156616 | 0.117557 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 855 | R | 0.274173 | H | 0.251252 | 0.022921 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 864 | D | 0.217099 | N | 0.202618 | 0.014481 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 866 | V | 0.269714 | E | 0.447147 | -0.177433 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 866 | V | 0.269714 | L | 0.302344 | -0.03263 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 866 | V | 0.269714 | M | 0.337424 | -0.06771 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 869 | I | 0.273966 | M | 0.363189 | -0.089223 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 877 | T | 0.133042 | A | 0.121533 | 0.011509 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 892 | P | 0.337893 | L | 0.197626 | 0.140267 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 895 | M | 0.23086 | T | 0.252374 | -0.021514 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 907 | L | 0.298006 | F | 0.277209 | 0.020797 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 913 | P | 0.342028 | S | 0.381702 | -0.039674 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 194 | Q | 0.918023 | R | 0.895889 | 0.022134 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 255 | L | 0.509564 | P | 0.622464 | -0.1129 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 390 | P | 0.630422 | R | 0.581395 | 0.049027 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 390 | P | 0.630422 | S | 0.605526 | 0.024896 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 443 | Q | 0.940744 | R | 0.939359 | 0.001385 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 840 | R | 0.149406 | S | 0.177032 | -0.027626 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 64 | Q | 0.99911 | R | 0.998842 | 2.68E-04 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 112 | Q | 0.946765 | H | 0.932055 | 0.01471 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 180 | K | 0.908618 | R | 0.907458 | 0.00116 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 205 | S | 0.959835 | R | 0.949909 | 0.009926 | No Change: Both D | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 214 | G | 0.914015 | R | 0.919915 | -0.0059 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 266 | M | 0.452212 | T | 0.453225 | -0.001013 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 269 | P | 0.482621 | S | 0.452175 | 0.030446 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 340 | P | 0.706135 | L | 0.59224 | 0.113895 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 491 | G | 0.666331 | S | 0.690597 | -0.024266 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 528 | D | 0.556508 | G | 0.542474 | 0.014034 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 547 | L | 0.156891 | F | 0.143413 | 0.013478 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 548 | P | 0.154834 | S | 0.156892 | -0.002058 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 559 | C | 0.125501 | Y | 0.143853 | -0.018352 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 568 | G | 0.22691 | V | 0.125526 | 0.101384 | No Change: Both O | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 568 | G | 0.22691 | W | 0.08781 | 0.1391 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 571 | Y | 0.208958 | C | 0.209582 | -6.24E-04 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 573 | A | 0.180925 | D | 0.236981 | -0.056056 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 574 | L | 0.149309 | P | 0.268669 | -0.11936 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 575 | T | 0.138415 | A | 0.133595 | 0.00482 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 576 | C | 0.123171 | F | 0.118247 | 0.004924 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 576 | C | 0.123171 | R | 0.206485 | -0.083314 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 579 | C | 0.148068 | F | 0.136597 | 0.011471 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 579 | C | 0.148068 | Y | 0.14112 | 0.006948 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 580 | K | 0.167907 | R | 0.138136 | 0.029771 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 581 | V | 0.182115 | F | 0.211362 | -0.029247 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 582 | F | 0.232385 | S | 0.402854 | -0.170469 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 582 | F | 0.232385 | Y | 0.23296 | -5.75E-04 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 585 | R | 0.352212 | K | 0.413419 | -0.061207 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 586 | A | 0.370146 | V | 0.292991 | 0.077155 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 587 | A | 0.391088 | S | 0.473598 | -0.08251 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 596 | A | 0.366619 | T | 0.396395 | -0.029776 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 597 | S | 0.374679 | G | 0.329118 | 0.045561 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 597 | S | 0.374679 | T | 0.318879 | 0.0558 | No Change: Both O | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 601 | C | 0.44308 | F | 0.388709 | 0.054371 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 604 | D | 0.549685 | Y | 0.390677 | 0.159008 | D to O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 610 | N | 0.583854 | T | 0.565663 | 0.018191 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 611 | C | 0.567385 | Y | 0.498389 | 0.068996 | D to O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 615 | R | 0.622205 | H | 0.503611 | 0.118594 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 615 | R | 0.622205 | H | 0.503611 | 0.118594 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 615 | R | 0.622205 | P | 0.618213 | 0.003992 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 616 | L | 0.623179 | P | 0.738797 | -0.115618 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 616 | L | 0.623179 | R | 0.74484 | -0.121661 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 617 | R | 0.643605 | P | 0.641729 | 0.001876 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 617 | R | 0.643605 | P | 0.641729 | 0.001876 | No Change: Both D | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 619 | C | 0.650789 | Y | 0.565877 | 0.084912 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 629 | R | 0.799393 | Q | 0.783852 | 0.015541 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 630 | K | 0.812757 | T | 0.770964 | 0.041793 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 647 | S | 0.877719 | N | 0.851644 | 0.026075 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 670 | Q | 0.241082 | R | 0.202544 | 0.038538 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 671 | P | 0.196569 | H | 0.152905 | 0.043664 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 672 | I | 0.172128 | T | 0.259882 | -0.087754 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 681 | E | 0.169094 | K | 0.149515 | 0.019579 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 683 | G | 0.191257 | A | 0.161062 | 0.030195 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 684 | V | 0.190721 | I | 0.168402 | 0.022319 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 686 | C | 0.238416 | R | 0.394161 | -0.155745 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 687 | A | 0.306335 | V | 0.253203 | 0.053132 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 688 | G | 0.372028 | E | 0.418802 | -0.046774 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 700 | L | 0.334536 | M | 0.378392 | -0.043856 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 701 | L | 0.340545 | F | 0.302685 | 0.03786 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 701 | L | 0.340545 | H | 0.456214 | -0.115669 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 702 | S | 0.344597 | A | 0.240522 | 0.104075 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 703 | S | 0.379189 | C | 0.163262 | 0.215927 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 705 | N | 0.423037 | S | 0.488621 | -0.065584 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 708 | G | 0.44626 | A | 0.394065 | 0.052195 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 708 | G | 0.44626 | V | 0.336558 | 0.109702 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 710 | R | 0.330505 | T | 0.322312 | 0.008193 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 712 | L | 0.17208 | F | 0.144984 | 0.027096 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 715 | V | 0.105379 | M | 0.128338 | -0.022959 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 717 | K | 0.110272 | E | 0.107055 | 0.003217 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 720 | K | 0.143521 | E | 0.135188 | 0.008333 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 721 | A | 0.158557 | T | 0.167964 | -0.009407 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 722 | L | 0.171466 | F | 0.153385 | 0.018081 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 723 | P | 0.163276 | S | 0.182414 | -0.019138 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 724 | G | 0.18038 | D | 0.210439 | -0.030059 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 725 | F | 0.200979 | L | 0.242496 | -0.041517 | No Change: Both O | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 726 | R | 0.21143 | L | 0.138268 | 0.073162 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 727 | N | 0.215156 | K | 0.26061 | -0.045454 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 728 | L | 0.223849 | S | 0.407213 | -0.183364 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 733 | Q | 0.197175 | H | 0.184315 | 0.01286 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 737 | I | 0.10025 | T | 0.180163 | -0.079913 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 741 | W | 0.048309 | R | 0.122001 | -0.073692 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 742 | M | 0.039243 | V | 0.028822 | 0.010421 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 744 | L | 0.038606 | F | 0.036409 | 0.002197 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 745 | M | 0.04009 | T | 0.045015 | -0.004925 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 746 | V | 0.039911 | M | 0.060783 | -0.020872 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 748 | A | 0.057439 | D | 0.084025 | -0.026586 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 748 | A | 0.057439 | T | 0.068927 | -0.011488 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 748 | A | 0.057439 | V | 0.042957 | 0.014482 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 749 | M | 0.061886 | I | 0.036372 | 0.025514 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 750 | G | 0.083941 | S | 0.10999 | -0.026049 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 751 | W | 0.112694 | R | 0.260801 | -0.148107 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 754 | F | 0.210476 | L | 0.232916 | -0.02244 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 755 | T | 0.217271 | A | 0.200638 | 0.016633 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 756 | N | 0.213226 | S | 0.252826 | -0.0396 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 757 | V | 0.226528 | A | 0.306821 | -0.080293 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 758 | N | 0.21974 | T | 0.189014 | 0.030726 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 759 | S | 0.189888 | F | 0.078135 | 0.111753 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 759 | S | 0.189888 | P | 0.16842 | 0.021468 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 763 | Y | 0.096969 | H | 0.158779 | -0.06181 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 764 | F | 0.096036 | L | 0.110697 | -0.014661 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 765 | A | 0.095524 | V | 0.073264 | 0.02226 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 766 | P | 0.098922 | S | 0.117557 | -0.018635 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 767 | D | 0.106483 | E | 0.128512 | -0.022029 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 768 | L | 0.114776 | P | 0.221694 | -0.106918 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 771 | N | 0.226423 | H | 0.221657 | 0.004766 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 772 | E | 0.261371 | A | 0.180925 | 0.080446 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 772 | E | 0.261371 | G | 0.216633 | 0.044738 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 782 | S | 0.431749 | N | 0.369431 | 0.062318 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 788 | R | 0.225521 | S | 0.287211 | -0.06169 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 790 | L | 0.198352 | F | 0.182691 | 0.015661 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 791 | S | 0.199181 | P | 0.176521 | 0.02266 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 793 | E | 0.203969 | D | 0.18394 | 0.020029 | No Change: Both O | - |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 806 | C | 0.065474 | Y | 0.078884 | -0.01341 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 807 | M | 0.05614 | T | 0.069702 | -0.013562 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 812 | L | 0.02963 | F | 0.024931 | 0.004699 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 820 | G | 0.20552 | A | 0.167854 | 0.037666 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 821 | L | 0.232583 | V | 0.243132 | -0.010549 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 830 | L | 0.191254 | P | 0.316155 | -0.124901 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 834 | Y | 0.183135 | C | 0.175955 | 0.00718 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 841 | I | 0.16364 | S | 0.32612 | -0.16248 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 846 | R | 0.401222 | G | 0.385924 | 0.015298 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 854 | R | 0.314246 | K | 0.368368 | -0.054122 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 856 | F | 0.246998 | L | 0.293529 | -0.046531 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 863 | L | 0.227559 | R | 0.335431 | -0.107872 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 864 | D | 0.217099 | G | 0.189033 | 0.028066 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 865 | S | 0.240701 | P | 0.234298 | 0.006403 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 870 | A | 0.263066 | G | 0.310468 | -0.047402 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 870 | A | 0.263066 | V | 0.215216 | 0.04785 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 871 | R | 0.22933 | G | 0.234265 | -0.004935 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 874 | H | 0.156161 | Y | 0.096558 | 0.059603 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 877 | T | 0.133042 | S | 0.193311 | -0.060269 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 880 | L | 0.165233 | Q | 0.273784 | -0.108551 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 881 | L | 0.167012 | V | 0.165903 | 0.001109 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 886 | M | 0.201853 | V | 0.164996 | 0.036857 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 889 | V | 0.324415 | M | 0.395438 | -0.071023 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 889 | V | 0.324415 | M | 0.395438 | -0.071023 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 890 | D | 0.336741 | N | 0.3227 | 0.014041 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 891 | F | 0.348723 | L | 0.376628 | -0.027905 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 896 | A | 0.207675 | T | 0.234878 | -0.027203 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 898 | I | 0.176708 | T | 0.275838 | -0.09913 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 902 | Q | 0.184267 | R | 0.169436 | 0.014831 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 903 | V | 0.206134 | M | 0.253632 | -0.047498 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 904 | P | 0.241508 | H | 0.208743 | 0.032765 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 904 | P | 0.241508 | S | 0.280762 | -0.039254 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 909 | G | 0.306075 | E | 0.357699 | -0.051624 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 909 | G | 0.306075 | R | 0.296623 | 0.009452 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 910 | K | 0.298374 | R | 0.221545 | 0.076829 | No Change: Both O | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 911 | V | 0.295555 | L | 0.299758 | -0.004203 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 916 | F | 0.577158 | L | 0.616159 | -0.039001 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 917 | H | 0.682602 | R | 0.648616 | 0.033986 | No Change: Both D | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 919 | Q | 0.760784 | R | 0.745374 | 0.01541 | No Change: Both D | Prostate cancer |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 682 | P | 0.177096 | T | 0.139159 | 0.037937 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 705 | N | 0.423037 | Y | 0.289306 | 0.133731 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 711 | Q | 0.256726 | E | 0.311815 | -0.055089 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 743 | G | 0.036638 | E | 0.045273 | -0.008635 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 827 | F | 0.266183 | V | 0.281539 | -0.015356 | No Change: Both O | Androgen insensitivity syndrome partial (PAIS) [MIM:312300] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 874 | H | 0.156161 | R | 0.179502 | -0.023341 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10275 | ANDR_HUMAN Androgen receptor OS=Homo sapiens GN=AR PE=1 SV=2 | 879 | D | 0.161765 | Y | 0.081643 | 0.080122 | No Change: Both O | Androgen insensitivity syndrome (AIS) [MIM:300068] |
| P10398 | ARAF_HUMAN Serine/threonine-protein kinase A-Raf OS=Homo sapiens GN=ARAF PE=1 SV=2 | 98 | M | 0.157553 | T | 0.203593 | -0.04604 | No Change: Both O | - |
| P10398 | ARAF_HUMAN Serine/threonine-protein kinase A-Raf OS=Homo sapiens GN=ARAF PE=1 SV=2 | 331 | G | 0.159289 | C | 0.070987 | 0.088302 | No Change: Both O | A colorectal adenocarcinoma sample |
| P10398 | ARAF_HUMAN Serine/threonine-protein kinase A-Raf OS=Homo sapiens GN=ARAF PE=1 SV=2 | 578 | E | 0.843333 | D | 0.814216 | 0.029117 | No Change: Both D | - |
| Q96P48 | ARAP1_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ARAP1 PE=1 SV=3 | 358 | R | 0.288995 | Q | 0.299658 | -0.010663 | No Change: Both O | - |
| Q96P48 | ARAP1_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ARAP1 PE=1 SV=3 | 1047 | Q | 0.334422 | E | 0.416326 | -0.081904 | No Change: Both O | - |
| Q8WZ64 | ARAP2_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ARAP2 PE=1 SV=3 | 1523 | R | 0.342548 | Q | 0.375434 | -0.032886 | No Change: Both O | - |
| Q8WZ64 | ARAP2_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ARAP2 PE=1 SV=3 | 384 | K | 0.637334 | N | 0.609229 | 0.028105 | No Change: Both D | - |
| Q8WZ64 | ARAP2_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ARAP2 PE=1 SV=3 | 1006 | F | 0.159095 | L | 0.182014 | -0.022919 | No Change: Both O | - |
| Q8WWN8 | ARAP3_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ARAP3 PE=1 SV=1 | 471 | R | 0.493728 | W | 0.312872 | 0.180856 | No Change: Both O | A colorectal cancer sample |
| Q8WWN8 | ARAP3_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ARAP3 PE=1 SV=1 | 1085 | I | 0.098612 | M | 0.134032 | -0.03542 | No Change: Both O | A breast cancer sample |
| Q8WWN8 | ARAP3_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ARAP3 PE=1 SV=1 | 1428 | T | 0.754866 | P | 0.79293 | -0.038064 | No Change: Both D | A breast cancer sample |
| Q8WWN8 | ARAP3_HUMAN Arf-GAP with Rho-GAP domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ARAP3 PE=1 SV=1 | 218 | D | 0.749497 | H | 0.728627 | 0.02087 | No Change: Both D | - |
| P48444 | COPD_HUMAN Coatomer subunit delta OS=Homo sapiens GN=ARCN1 PE=1 SV=1 | 186 | F | 0.835174 | L | 0.82421 | 0.010964 | No Change: Both D | - |
| P48444 | COPD_HUMAN Coatomer subunit delta OS=Homo sapiens GN=ARCN1 PE=1 SV=1 | 309 | K | 0.397164 | N | 0.358107 | 0.039057 | No Change: Both O | - |
| P15514 | AREG_HUMAN Amphiregulin OS=Homo sapiens GN=AREG PE=1 SV=2 | 80 | D | 0.955865 | V | 0.934129 | 0.021736 | No Change: Both D | - |
| P15514 | AREG_HUMAN Amphiregulin OS=Homo sapiens GN=AREG PE=1 SV=2 | 81 | Y | 0.946893 | C | 0.948578 | -0.001685 | No Change: Both D | - |
| P18085 | ARF4_HUMAN ADP-ribosylation factor 4 OS=Homo sapiens GN=ARF4 PE=1 SV=3 | 68 | V | 0.106982 | A | 0.139906 | -0.032924 | No Change: Both O | - |
| Q8N6T3 | ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens GN=ARFGAP1 PE=1 SV=2 | 184 | V | 0.451548 | M | 0.558228 | -0.10668 | O to D | - |
| Q8N6H7 | ARFG2_HUMAN ADP-ribosylation factor GTPase-activating protein 2 OS=Homo sapiens GN=ARFGAP2 PE=1 SV=1 | 411 | S | 0.947219 | N | 0.927101 | 0.020118 | No Change: Both D | - |
| Q8N6H7 | ARFG2_HUMAN ADP-ribosylation factor GTPase-activating protein 2 OS=Homo sapiens GN=ARFGAP2 PE=1 SV=1 | 143 | P | 0.647922 | R | 0.617323 | 0.030599 | No Change: Both D | - |
| Q8N6H7 | ARFG2_HUMAN ADP-ribosylation factor GTPase-activating protein 2 OS=Homo sapiens GN=ARFGAP2 PE=1 SV=1 | 339 | R | 0.760476 | H | 0.740498 | 0.019978 | No Change: Both D | - |
| Q8N6H7 | ARFG2_HUMAN ADP-ribosylation factor GTPase-activating protein 2 OS=Homo sapiens GN=ARFGAP2 PE=1 SV=1 | 406 | R | 0.941856 | W | 0.855714 | 0.086142 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 355 | S | 0.958246 | R | 0.944647 | 0.013599 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 290 | E | 0.77307 | G | 0.74127 | 0.0318 | No Change: Both D | A breast cancer sample |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 231 | S | 0.842667 | G | 0.832277 | 0.01039 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 370 | S | 0.971004 | G | 0.950437 | 0.020567 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 468 | Q | 0.806237 | H | 0.754485 | 0.051752 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 482 | A | 0.56419 | T | 0.554449 | 0.009741 | No Change: Both D | - |
| Q9NP61 | ARFG3_HUMAN ADP-ribosylation factor GTPase-activating protein 3 OS=Homo sapiens GN=ARFGAP3 PE=1 SV=1 | 490 | Q | 0.432047 | R | 0.416273 | 0.015774 | No Change: Both O | - |
| Q9Y6D6 | BIG1_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Homo sapiens GN=ARFGEF1 PE=1 SV=2 | 273 | D | 0.920102 | Y | 0.831535 | 0.088567 | No Change: Both D | - |
| Q9Y6D6 | BIG1_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Homo sapiens GN=ARFGEF1 PE=1 SV=2 | 316 | G | 0.627696 | E | 0.718783 | -0.091087 | No Change: Both D | A colorectal cancer sample |
| Q9Y6D5 | BIG2_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 2 OS=Homo sapiens GN=ARFGEF2 PE=1 SV=3 | 527 | A | 0.117816 | V | 0.081695 | 0.036121 | No Change: Both O | - |
| Q9Y6D5 | BIG2_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 2 OS=Homo sapiens GN=ARFGEF2 PE=1 SV=3 | 794 | K | 0.585072 | E | 0.574578 | 0.010494 | No Change: Both D | A breast cancer sample |
| Q9Y6D5 | BIG2_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 2 OS=Homo sapiens GN=ARFGEF2 PE=1 SV=3 | 209 | E | 0.757068 | K | 0.756176 | 8.92E-04 | No Change: Both D | Autosomal recessive periventricular nodular heterotopia type 2 (PVNH2) [MIM:608097] |
| Q5TH69 | BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens GN=ARFGEF3 PE=1 SV=3 | 689 | S | 0.344622 | A | 0.234892 | 0.10973 | No Change: Both O | - |
| Q5TH69 | BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens GN=ARFGEF3 PE=1 SV=3 | 1571 | A | 0.052244 | T | 0.060494 | -0.00825 | No Change: Both O | - |
| Q5TH69 | BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens GN=ARFGEF3 PE=1 SV=3 | 2031 | K | 0.682646 | R | 0.640549 | 0.042097 | No Change: Both D | - |
| Q5TH69 | BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens GN=ARFGEF3 PE=1 SV=3 | 413 | E | 0.315347 | D | 0.302255 | 0.013092 | No Change: Both O | - |
| Q13795 | ARFRP_HUMAN ADP-ribosylation factor-related protein 1 OS=Homo sapiens GN=ARFRP1 PE=1 SV=1 | 108 | L | 0.676154 | V | 0.680179 | -0.004025 | No Change: Both D | A breast cancer sample |
| P05089 | ARGI1_HUMAN Arginase-1 OS=Homo sapiens GN=ARG1 PE=1 SV=2 | 235 | G | 0.408731 | R | 0.398027 | 0.010704 | No Change: Both O | Argininemia (ARGIN) [MIM:207800] |
| P05089 | ARGI1_HUMAN Arginase-1 OS=Homo sapiens GN=ARG1 PE=1 SV=2 | 290 | T | 0.469452 | S | 0.522183 | -0.052731 | O to D | - |
| P05089 | ARGI1_HUMAN Arginase-1 OS=Homo sapiens GN=ARG1 PE=1 SV=2 | 11 | I | 0.623554 | T | 0.752163 | -0.128609 | No Change: Both D | Argininemia (ARGIN) [MIM:207800] |
| P05089 | ARGI1_HUMAN Arginase-1 OS=Homo sapiens GN=ARG1 PE=1 SV=2 | 138 | G | 0.588788 | V | 0.435748 | 0.15304 | D to O | Argininemia (ARGIN) [MIM:207800] |
| P78540 | ARGI2_HUMAN Arginase-2 mitochondrial OS=Homo sapiens GN=ARG2 PE=1 SV=1 | 240 | G | 0.252565 | R | 0.26832 | -0.015755 | No Change: Both O | - |
| A6NJG6 | ARGFX_HUMAN Arginine-fifty homeobox OS=Homo sapiens GN=ARGFX PE=2 SV=1 | 145 | R | 0.93683 | Q | 0.944787 | -0.007957 | No Change: Both D | - |
| Q07960 | RHG01_HUMAN Rho GTPase-activating protein 1 OS=Homo sapiens GN=ARHGAP1 PE=1 SV=1 | 369 | R | 0.061121 | C | 0.029783 | 0.031338 | No Change: Both O | - |
| A1A4S6 | RHG10_HUMAN Rho GTPase-activating protein 10 OS=Homo sapiens GN=ARHGAP10 PE=1 SV=1 | 684 | M | 0.77672 | V | 0.743943 | 0.032777 | No Change: Both D | - |
| A1A4S6 | RHG10_HUMAN Rho GTPase-activating protein 10 OS=Homo sapiens GN=ARHGAP10 PE=1 SV=1 | 488 | P | 0.642877 | S | 0.673675 | -0.030798 | No Change: Both D | - |
| Q6P4F7 | RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens GN=ARHGAP11A PE=1 SV=2 | 605 | E | 0.738466 | K | 0.75215 | -0.013684 | No Change: Both D | A breast cancer sample |
| Q8IWW6 | RHG12_HUMAN Rho GTPase-activating protein 12 OS=Homo sapiens GN=ARHGAP12 PE=1 SV=1 | 442 | F | 0.926331 | S | 0.967644 | -0.041313 | No Change: Both D | - |
| Q8N392 | RHG18_HUMAN Rho GTPase-activating protein 18 OS=Homo sapiens GN=ARHGAP18 PE=1 SV=3 | 23 | T | 0.702565 | A | 0.694422 | 0.008143 | No Change: Both D | - |
| Q8N392 | RHG18_HUMAN Rho GTPase-activating protein 18 OS=Homo sapiens GN=ARHGAP18 PE=1 SV=3 | 91 | N | 0.905807 | S | 0.927513 | -0.021706 | No Change: Both D | - |
| Q8N392 | RHG18_HUMAN Rho GTPase-activating protein 18 OS=Homo sapiens GN=ARHGAP18 PE=1 SV=3 | 165 | Q | 0.701888 | H | 0.605081 | 0.096807 | No Change: Both D | - |
| Q14CB8 | RHG19_HUMAN Rho GTPase-activating protein 19 OS=Homo sapiens GN=ARHGAP19 PE=1 SV=1 | 305 | Q | 0.340351 | R | 0.3218 | 0.018551 | No Change: Both O | - |
| Q9P2F6 | RHG20_HUMAN Rho GTPase-activating protein 20 OS=Homo sapiens GN=ARHGAP20 PE=1 SV=2 | 522 | A | 0.590571 | T | 0.610517 | -0.019946 | No Change: Both D | - |
| Q9P2F6 | RHG20_HUMAN Rho GTPase-activating protein 20 OS=Homo sapiens GN=ARHGAP20 PE=1 SV=2 | 632 | G | 0.583713 | D | 0.675409 | -0.091696 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 712 | N | 0.949457 | S | 0.961502 | -0.012045 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 1593 | T | 0.897686 | A | 0.876457 | 0.021229 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 1610 | V | 0.948381 | A | 0.95969 | -0.011309 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 1628 | E | 0.940038 | K | 0.927531 | 0.012507 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 1726 | A | 0.912158 | T | 0.926809 | -0.014651 | No Change: Both D | - |
| Q5T5U3 | RHG21_HUMAN Rho GTPase-activating protein 21 OS=Homo sapiens GN=ARHGAP21 PE=1 SV=1 | 1949 | S | 0.900885 | N | 0.875774 | 0.025111 | No Change: Both D | - |
| Q7Z5H3 | RHG22_HUMAN Rho GTPase-activating protein 22 OS=Homo sapiens GN=ARHGAP22 PE=1 SV=1 | 410 | T | 0.915035 | K | 0.925675 | -0.01064 | No Change: Both D | - |
| Q7Z5H3 | RHG22_HUMAN Rho GTPase-activating protein 22 OS=Homo sapiens GN=ARHGAP22 PE=1 SV=1 | 612 | R | 0.901947 | C | 0.8574 | 0.044547 | No Change: Both D | - |
| P42331 | RHG25_HUMAN Rho GTPase-activating protein 25 OS=Homo sapiens GN=ARHGAP25 PE=1 SV=2 | 192 | R | 0.384458 | W | 0.199288 | 0.18517 | No Change: Both O | - |
| P42331 | RHG25_HUMAN Rho GTPase-activating protein 25 OS=Homo sapiens GN=ARHGAP25 PE=1 SV=2 | 555 | R | 0.891908 | S | 0.906863 | -0.014955 | No Change: Both D | - |
| P42331 | RHG25_HUMAN Rho GTPase-activating protein 25 OS=Homo sapiens GN=ARHGAP25 PE=1 SV=2 | 556 | M | 0.858912 | T | 0.864917 | -0.006005 | No Change: Both D | - |
| Q9UNA1 | RHG26_HUMAN Rho GTPase-activating protein 26 OS=Homo sapiens GN=ARHGAP26 PE=1 SV=1 | 417 | N | 0.204956 | S | 0.254163 | -0.049207 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q6ZUM4 | RHG27_HUMAN Rho GTPase-activating protein 27 OS=Homo sapiens GN=ARHGAP27 PE=1 SV=3 | 889 | H | 0.74591 | Q | 0.704799 | 0.041111 | No Change: Both D | - |
| Q9P2N2 | RHG28_HUMAN Rho GTPase-activating protein 28 OS=Homo sapiens GN=ARHGAP28 PE=2 SV=3 | 190 | T | 0.817351 | S | 0.847608 | -0.030257 | No Change: Both D | - |
| Q9P2N2 | RHG28_HUMAN Rho GTPase-activating protein 28 OS=Homo sapiens GN=ARHGAP28 PE=2 SV=3 | 727 | Q | 0.891387 | P | 0.881724 | 0.009663 | No Change: Both D | - |
| Q9P2N2 | RHG28_HUMAN Rho GTPase-activating protein 28 OS=Homo sapiens GN=ARHGAP28 PE=2 SV=3 | 168 | I | 0.668208 | V | 0.699876 | -0.031668 | No Change: Both D | - |
| Q52LW3 | RHG29_HUMAN Rho GTPase-activating protein 29 OS=Homo sapiens GN=ARHGAP29 PE=1 SV=2 | 552 | S | 0.98202 | C | 0.963027 | 0.018993 | No Change: Both D | A breast cancer sample |
| Q52LW3 | RHG29_HUMAN Rho GTPase-activating protein 29 OS=Homo sapiens GN=ARHGAP29 PE=1 SV=2 | 1255 | G | 0.846953 | D | 0.886576 | -0.039623 | No Change: Both D | - |
| Q52LW3 | RHG29_HUMAN Rho GTPase-activating protein 29 OS=Homo sapiens GN=ARHGAP29 PE=1 SV=2 | 1192 | P | 0.850283 | L | 0.732611 | 0.117672 | No Change: Both D | - |
| Q7Z6I6 | RHG30_HUMAN Rho GTPase-activating protein 30 OS=Homo sapiens GN=ARHGAP30 PE=1 SV=3 | 70 | F | 0.664642 | L | 0.706808 | -0.042166 | No Change: Both D | - |
| Q7Z6I6 | RHG30_HUMAN Rho GTPase-activating protein 30 OS=Homo sapiens GN=ARHGAP30 PE=1 SV=3 | 591 | L | 0.813793 | V | 0.803602 | 0.010191 | No Change: Both D | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 221 | P | 0.529688 | L | 0.381583 | 0.148105 | D to O | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 803 | G | 0.9707 | S | 0.979922 | -0.009222 | No Change: Both D | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 1115 | I | 0.365512 | L | 0.419345 | -0.053833 | No Change: Both O | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 1366 | V | 0.822608 | M | 0.860826 | -0.038218 | No Change: Both D | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 1380 | T | 0.627921 | I | 0.488926 | 0.138995 | D to O | - |
| Q2M1Z3 | RHG31_HUMAN Rho GTPase-activating protein 31 OS=Homo sapiens GN=ARHGAP31 PE=1 SV=2 | 727 | T | 0.907286 | I | 0.840576 | 0.06671 | No Change: Both D | - |
| P98171 | RHG04_HUMAN Rho GTPase-activating protein 4 OS=Homo sapiens GN=ARHGAP4 PE=1 SV=2 | 104 | A | 0.664964 | V | 0.603069 | 0.061895 | No Change: Both D | - |
| Q5TG30 | RHG40_HUMAN Rho GTPase-activating protein 40 OS=Homo sapiens GN=ARHGAP40 PE=2 SV=3 | 133 | G | 0.740273 | R | 0.760872 | -0.020599 | No Change: Both D | - |
| Q5TG30 | RHG40_HUMAN Rho GTPase-activating protein 40 OS=Homo sapiens GN=ARHGAP40 PE=2 SV=3 | 413 | R | 0.409346 | L | 0.29787 | 0.111476 | No Change: Both O | - |
| Q5TG30 | RHG40_HUMAN Rho GTPase-activating protein 40 OS=Homo sapiens GN=ARHGAP40 PE=2 SV=3 | 463 | H | 0.061803 | N | 0.069668 | -0.007865 | No Change: Both O | - |
| Q17R89 | RHG44_HUMAN Rho GTPase-activating protein 44 OS=Homo sapiens GN=ARHGAP44 PE=1 SV=1 | 463 | V | 0.549564 | M | 0.60607 | -0.056506 | No Change: Both D | - |
| Q13017 | RHG05_HUMAN Rho GTPase-activating protein 5 OS=Homo sapiens GN=ARHGAP5 PE=1 SV=2 | 17 | I | 0.576028 | V | 0.613847 | -0.037819 | No Change: Both D | - |
| O43182 | RHG06_HUMAN Rho GTPase-activating protein 6 OS=Homo sapiens GN=ARHGAP6 PE=1 SV=3 | 791 | D | 0.914763 | E | 0.922794 | -0.008031 | No Change: Both D | - |
| P85298 | RHG08_HUMAN Rho GTPase-activating protein 8 OS=Homo sapiens GN=ARHGAP8 PE=1 SV=1 | 172 | Y | 0.137797 | C | 0.104995 | 0.032802 | No Change: Both O | - |
| P85298 | RHG08_HUMAN Rho GTPase-activating protein 8 OS=Homo sapiens GN=ARHGAP8 PE=1 SV=1 | 333 | G | 0.196584 | R | 0.207105 | -0.010521 | No Change: Both O | - |
| P85298 | RHG08_HUMAN Rho GTPase-activating protein 8 OS=Homo sapiens GN=ARHGAP8 PE=1 SV=1 | 415 | P | 0.484345 | L | 0.356357 | 0.127988 | No Change: Both O | - |
| P85298 | RHG08_HUMAN Rho GTPase-activating protein 8 OS=Homo sapiens GN=ARHGAP8 PE=1 SV=1 | 418 | P | 0.57733 | R | 0.534479 | 0.042851 | No Change: Both D | - |
| Q9BRR9 | RHG09_HUMAN Rho GTPase-activating protein 9 OS=Homo sapiens GN=ARHGAP9 PE=1 SV=2 | 50 | R | 0.226843 | G | 0.229041 | -0.002198 | No Change: Both O | - |
| Q9BRR9 | RHG09_HUMAN Rho GTPase-activating protein 9 OS=Homo sapiens GN=ARHGAP9 PE=1 SV=2 | 137 | R | 0.974716 | C | 0.965646 | 0.00907 | No Change: Both D | - |
| Q9BRR9 | RHG09_HUMAN Rho GTPase-activating protein 9 OS=Homo sapiens GN=ARHGAP9 PE=1 SV=2 | 370 | S | 0.781887 | A | 0.715281 | 0.066606 | No Change: Both D | - |
| Q92888 | ARHG1_HUMAN Rho guanine nucleotide exchange factor 1 OS=Homo sapiens GN=ARHGEF1 PE=1 SV=2 | 375 | P | 0.998269 | L | 0.996876 | 0.001393 | No Change: Both D | - |
| Q92888 | ARHG1_HUMAN Rho guanine nucleotide exchange factor 1 OS=Homo sapiens GN=ARHGEF1 PE=1 SV=2 | 165 | M | 0.48623 | V | 0.404014 | 0.082216 | No Change: Both O | A colorectal cancer sample |
| O15013 | ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens GN=ARHGEF10 PE=1 SV=4 | 357 | T | 0.753079 | I | 0.653396 | 0.099683 | No Change: Both D | Slowed nerve conduction velocity (SNCV) [MIM:608236] |
| O15013 | ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens GN=ARHGEF10 PE=1 SV=4 | 700 | V | 0.250721 | I | 0.21277 | 0.037951 | No Change: Both O | - |
| O15013 | ARHGA_HUMAN Rho guanine nucleotide exchange factor 10 OS=Homo sapiens GN=ARHGEF10 PE=1 SV=4 | 725 | V | 0.574411 | I | 0.533196 | 0.041215 | No Change: Both D | - |
| Q9HCE6 | ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein OS=Homo sapiens GN=ARHGEF10L PE=1 SV=3 | 69 | D | 0.87074 | N | 0.832443 | 0.038297 | No Change: Both D | - |
| Q9HCE6 | ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein OS=Homo sapiens GN=ARHGEF10L PE=1 SV=3 | 96 | A | 0.666974 | V | 0.575827 | 0.091147 | No Change: Both D | A colorectal cancer sample |
| Q9HCE6 | ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein OS=Homo sapiens GN=ARHGEF10L PE=1 SV=3 | 991 | W | 0.148872 | R | 0.292027 | -0.143155 | No Change: Both O | - |
| Q9HCE6 | ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein OS=Homo sapiens GN=ARHGEF10L PE=1 SV=3 | 1219 | I | 0.510656 | V | 0.520941 | -0.010285 | No Change: Both D | - |
| Q9HCE6 | ARGAL_HUMAN Rho guanine nucleotide exchange factor 10-like protein OS=Homo sapiens GN=ARHGEF10L PE=1 SV=3 | 47 | S | 0.954457 | N | 0.932489 | 0.021968 | No Change: Both D | - |
| O15085 | ARHGB_HUMAN Rho guanine nucleotide exchange factor 11 OS=Homo sapiens GN=ARHGEF11 PE=1 SV=1 | 1427 | H | 0.448156 | R | 0.533294 | -0.085138 | O to D | - |
| O15085 | ARHGB_HUMAN Rho guanine nucleotide exchange factor 11 OS=Homo sapiens GN=ARHGEF11 PE=1 SV=1 | 1416 | S | 0.753331 | G | 0.715844 | 0.037487 | No Change: Both D | - |
| Q9NZN5 | ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens GN=ARHGEF12 PE=1 SV=1 | 973 | Y | 0.334854 | F | 0.301728 | 0.033126 | No Change: Both O | - |
| O94989 | ARHGF_HUMAN Rho guanine nucleotide exchange factor 15 OS=Homo sapiens GN=ARHGEF15 PE=1 SV=4 | 155 | G | 0.832064 | V | 0.750736 | 0.081328 | No Change: Both D | - |
| O94989 | ARHGF_HUMAN Rho guanine nucleotide exchange factor 15 OS=Homo sapiens GN=ARHGEF15 PE=1 SV=4 | 277 | L | 0.801541 | P | 0.878327 | -0.076786 | No Change: Both D | - |
| O94989 | ARHGF_HUMAN Rho guanine nucleotide exchange factor 15 OS=Homo sapiens GN=ARHGEF15 PE=1 SV=4 | 831 | S | 0.893761 | P | 0.903169 | -0.009408 | No Change: Both D | - |
| O94989 | ARHGF_HUMAN Rho guanine nucleotide exchange factor 15 OS=Homo sapiens GN=ARHGEF15 PE=1 SV=4 | 73 | P | 0.975825 | S | 0.973214 | 0.002611 | No Change: Both D | - |
| Q5VV41 | ARHGG_HUMAN Rho guanine nucleotide exchange factor 16 OS=Homo sapiens GN=ARHGEF16 PE=1 SV=1 | 137 | V | 0.869772 | M | 0.92433 | -0.054558 | No Change: Both D | - |
| Q5VV41 | ARHGG_HUMAN Rho guanine nucleotide exchange factor 16 OS=Homo sapiens GN=ARHGEF16 PE=1 SV=1 | 370 | H | 0.351396 | Y | 0.247987 | 0.103409 | No Change: Both O | - |
| Q5VV41 | ARHGG_HUMAN Rho guanine nucleotide exchange factor 16 OS=Homo sapiens GN=ARHGEF16 PE=1 SV=1 | 681 | E | 0.21599 | K | 0.194467 | 0.021523 | No Change: Both O | - |
| Q96PE2 | ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens GN=ARHGEF17 PE=1 SV=1 | 450 | G | 0.936178 | E | 0.947444 | -0.011266 | No Change: Both D | - |
| Q96PE2 | ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens GN=ARHGEF17 PE=1 SV=1 | 1465 | A | 0.576939 | D | 0.644074 | -0.067135 | No Change: Both D | - |
| Q6ZSZ5 | ARHGI_HUMAN Rho guanine nucleotide exchange factor 18 OS=Homo sapiens GN=ARHGEF18 PE=1 SV=3 | 701 | Q | 0.666306 | R | 0.655841 | 0.010465 | No Change: Both D | - |
| Q6ZSZ5 | ARHGI_HUMAN Rho guanine nucleotide exchange factor 18 OS=Homo sapiens GN=ARHGEF18 PE=1 SV=3 | 752 | R | 0.973037 | Q | 0.967646 | 0.005391 | No Change: Both D | - |
| Q6ZSZ5 | ARHGI_HUMAN Rho guanine nucleotide exchange factor 18 OS=Homo sapiens GN=ARHGEF18 PE=1 SV=3 | 1019 | N | 0.803157 | S | 0.848334 | -0.045177 | No Change: Both D | - |
| Q8IW93 | ARHGJ_HUMAN Rho guanine nucleotide exchange factor 19 OS=Homo sapiens GN=ARHGEF19 PE=2 SV=1 | 163 | G | 0.731725 | R | 0.770426 | -0.038701 | No Change: Both D | - |
| Q8IW93 | ARHGJ_HUMAN Rho guanine nucleotide exchange factor 19 OS=Homo sapiens GN=ARHGEF19 PE=2 SV=1 | 238 | E | 0.965363 | Q | 0.954166 | 0.011197 | No Change: Both D | - |
| Q86VW2 | ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 OS=Homo sapiens GN=ARHGEF25 PE=1 SV=2 | 253 | C | 0.243145 | Y | 0.292624 | -0.049479 | No Change: Both O | - |
| Q86VW2 | ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 OS=Homo sapiens GN=ARHGEF25 PE=1 SV=2 | 397 | G | 0.408151 | R | 0.385746 | 0.022405 | No Change: Both O | - |
| Q86VW2 | ARHGP_HUMAN Rho guanine nucleotide exchange factor 25 OS=Homo sapiens GN=ARHGEF25 PE=1 SV=2 | 506 | Q | 0.874933 | R | 0.872788 | 0.002145 | No Change: Both D | - |
| Q96DR7 | ARHGQ_HUMAN Rho guanine nucleotide exchange factor 26 OS=Homo sapiens GN=ARHGEF26 PE=1 SV=4 | 29 | V | 0.772459 | L | 0.798822 | -0.026363 | No Change: Both D | - |
| Q96DR7 | ARHGQ_HUMAN Rho guanine nucleotide exchange factor 26 OS=Homo sapiens GN=ARHGEF26 PE=1 SV=4 | 203 | F | 0.987922 | S | 0.995305 | -0.007383 | No Change: Both D | - |
| Q96DR7 | ARHGQ_HUMAN Rho guanine nucleotide exchange factor 26 OS=Homo sapiens GN=ARHGEF26 PE=1 SV=4 | 60 | L | 0.432466 | P | 0.592561 | -0.160095 | O to D | - |
| Q9NR81 | ARHG3_HUMAN Rho guanine nucleotide exchange factor 3 OS=Homo sapiens GN=ARHGEF3 PE=2 SV=1 | 13 | K | 0.439449 | R | 0.411008 | 0.028441 | No Change: Both O | - |
| Q9NR81 | ARHG3_HUMAN Rho guanine nucleotide exchange factor 3 OS=Homo sapiens GN=ARHGEF3 PE=2 SV=1 | 335 | L | 0.169054 | V | 0.166366 | 0.002688 | No Change: Both O | - |
| A1IGU5 | ARH37_HUMAN Rho guanine nucleotide exchange factor 37 OS=Homo sapiens GN=ARHGEF37 PE=2 SV=2 | 421 | M | 0.038545 | L | 0.029164 | 0.009381 | No Change: Both O | - |
| A1IGU5 | ARH37_HUMAN Rho guanine nucleotide exchange factor 37 OS=Homo sapiens GN=ARHGEF37 PE=2 SV=2 | 489 | P | 0.81975 | L | 0.687968 | 0.131782 | No Change: Both D | - |
| A1IGU5 | ARH37_HUMAN Rho guanine nucleotide exchange factor 37 OS=Homo sapiens GN=ARHGEF37 PE=2 SV=2 | 518 | S | 0.406145 | R | 0.351615 | 0.05453 | No Change: Both O | - |
| A1IGU5 | ARH37_HUMAN Rho guanine nucleotide exchange factor 37 OS=Homo sapiens GN=ARHGEF37 PE=2 SV=2 | 586 | P | 0.562487 | T | 0.481762 | 0.080725 | D to O | - |
| A1IGU5 | ARH37_HUMAN Rho guanine nucleotide exchange factor 37 OS=Homo sapiens GN=ARHGEF37 PE=2 SV=2 | 604 | M | 0.377039 | V | 0.345117 | 0.031922 | No Change: Both O | - |
| Q9NXL2 | ARH38_HUMAN Rho guanine nucleotide exchange factor 38 OS=Homo sapiens GN=ARHGEF38 PE=2 SV=1 | 67 | K | 0.929904 | N | 0.916908 | 0.012996 | No Change: Both D | A breast cancer sample |
| Q9NXL2 | ARH38_HUMAN Rho guanine nucleotide exchange factor 38 OS=Homo sapiens GN=ARHGEF38 PE=2 SV=1 | 88 | M | 0.826617 | V | 0.754815 | 0.071802 | No Change: Both D | - |
| Q9NR80 | ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens GN=ARHGEF4 PE=1 SV=3 | 100 | K | 0.321349 | R | 0.297679 | 0.02367 | No Change: Both O | A breast cancer sample |
| Q9NR80 | ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens GN=ARHGEF4 PE=1 SV=3 | 441 | T | 0.375436 | R | 0.40765 | -0.032214 | No Change: Both O | A breast cancer sample |
| Q9NR80 | ARHG4_HUMAN Rho guanine nucleotide exchange factor 4 OS=Homo sapiens GN=ARHGEF4 PE=1 SV=3 | 33 | D | 0.392688 | H | 0.408251 | -0.015563 | No Change: Both O | - |
| Q8TER5 | ARH40_HUMAN Rho guanine nucleotide exchange factor 40 OS=Homo sapiens GN=ARHGEF40 PE=1 SV=3 | 956 | V | 0.894781 | L | 0.919159 | -0.024378 | No Change: Both D | - |
| Q8TER5 | ARH40_HUMAN Rho guanine nucleotide exchange factor 40 OS=Homo sapiens GN=ARHGEF40 PE=1 SV=3 | 1189 | L | 0.630168 | S | 0.735444 | -0.105276 | No Change: Both D | - |
| Q8TER5 | ARH40_HUMAN Rho guanine nucleotide exchange factor 40 OS=Homo sapiens GN=ARHGEF40 PE=1 SV=3 | 1312 | M | 0.365322 | T | 0.413838 | -0.048516 | No Change: Both O | - |
| Q8TER5 | ARH40_HUMAN Rho guanine nucleotide exchange factor 40 OS=Homo sapiens GN=ARHGEF40 PE=1 SV=3 | 1418 | T | 0.569111 | P | 0.620385 | -0.051274 | No Change: Both D | - |
| Q15052 | ARHG6_HUMAN Rho guanine nucleotide exchange factor 6 OS=Homo sapiens GN=ARHGEF6 PE=1 SV=2 | 297 | Q | 0.292988 | H | 0.22553 | 0.067458 | No Change: Both O | - |
| Q14155 | ARHG7_HUMAN Rho guanine nucleotide exchange factor 7 OS=Homo sapiens GN=ARHGEF7 PE=1 SV=2 | 790 | T | 0.809739 | A | 0.785147 | 0.024592 | No Change: Both D | - |
| O43307 | ARHG9_HUMAN Rho guanine nucleotide exchange factor 9 OS=Homo sapiens GN=ARHGEF9 PE=1 SV=3 | 55 | G | 0.235968 | A | 0.19604 | 0.039928 | No Change: Both O | Startle disease with epilepsy (STHEE) [MIM:300607] |
| O14497 | ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens GN=ARID1A PE=1 SV=3 | 1020 | R | 0.564447 | K | 0.598492 | -0.034045 | No Change: Both D | - |
| O14497 | ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens GN=ARID1A PE=1 SV=3 | 2089 | L | 0.072716 | P | 0.148181 | -0.075465 | No Change: Both O | - |
| Q8NFD5 | ARI1B_HUMAN AT-rich interactive domain-containing protein 1B OS=Homo sapiens GN=ARID1B PE=1 SV=2 | 814 | G | 0.990431 | A | 0.987974 | 0.002457 | No Change: Both D | A breast cancer sample |
| Q99856 | ARI3A_HUMAN AT-rich interactive domain-containing protein 3A OS=Homo sapiens GN=ARID3A PE=1 SV=2 | 36 | P | 0.99714 | H | 0.994678 | 0.002462 | No Change: Both D | - |
| Q99856 | ARI3A_HUMAN AT-rich interactive domain-containing protein 3A OS=Homo sapiens GN=ARID3A PE=1 SV=2 | 320 | K | 0.195412 | E | 0.206761 | -0.011349 | No Change: Both O | - |
| Q99856 | ARI3A_HUMAN AT-rich interactive domain-containing protein 3A OS=Homo sapiens GN=ARID3A PE=1 SV=2 | 556 | G | 0.964471 | S | 0.967942 | -0.003471 | No Change: Both D | - |
| A6NKF2 | ARI3C_HUMAN AT-rich interactive domain-containing protein 3C OS=Homo sapiens GN=ARID3C PE=2 SV=1 | 310 | R | 0.933484 | Q | 0.931006 | 0.002478 | No Change: Both D | - |
| A6NKF2 | ARI3C_HUMAN AT-rich interactive domain-containing protein 3C OS=Homo sapiens GN=ARID3C PE=2 SV=1 | 335 | C | 0.967596 | G | 0.977834 | -0.010238 | No Change: Both D | - |
| P29374 | ARI4A_HUMAN AT-rich interactive domain-containing protein 4A OS=Homo sapiens GN=ARID4A PE=1 SV=3 | 412 | H | 0.530184 | P | 0.56573 | -0.035546 | No Change: Both D | - |
| P29374 | ARI4A_HUMAN AT-rich interactive domain-containing protein 4A OS=Homo sapiens GN=ARID4A PE=1 SV=3 | 724 | N | 0.978687 | S | 0.97977 | -0.001083 | No Change: Both D | - |
| P29374 | ARI4A_HUMAN AT-rich interactive domain-containing protein 4A OS=Homo sapiens GN=ARID4A PE=1 SV=3 | 779 | T | 0.929938 | A | 0.91801 | 0.011928 | No Change: Both D | - |
| O95376 | ARI2_HUMAN E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens GN=ARIH2 PE=1 SV=1 | 24 | E | 0.987169 | K | 0.980216 | 0.006953 | No Change: Both D | - |
| O95376 | ARI2_HUMAN E3 ubiquitin-protein ligase ARIH2 OS=Homo sapiens GN=ARIH2 PE=1 SV=1 | 29 | E | 0.974115 | D | 0.971783 | 0.002332 | No Change: Both D | - |
| Q969Q4 | ARL11_HUMAN ADP-ribosylation factor-like protein 11 OS=Homo sapiens GN=ARL11 PE=1 SV=1 | 22 | S | 0.394276 | L | 0.244709 | 0.149567 | No Change: Both O | - |
| Q969Q4 | ARL11_HUMAN ADP-ribosylation factor-like protein 11 OS=Homo sapiens GN=ARL11 PE=1 SV=1 | 131 | P | 0.290402 | L | 0.170841 | 0.119561 | No Change: Both O | - |
| Q969Q4 | ARL11_HUMAN ADP-ribosylation factor-like protein 11 OS=Homo sapiens GN=ARL11 PE=1 SV=1 | 148 | C | 0.229036 | R | 0.350466 | -0.12143 | No Change: Both O | - |
| Q969Q4 | ARL11_HUMAN ADP-ribosylation factor-like protein 11 OS=Homo sapiens GN=ARL11 PE=1 SV=1 | 164 | E | 0.520874 | K | 0.501957 | 0.018917 | No Change: Both D | - |
| Q969Q4 | ARL11_HUMAN ADP-ribosylation factor-like protein 11 OS=Homo sapiens GN=ARL11 PE=1 SV=1 | 120 | L | 0.287442 | M | 0.333652 | -0.04621 | No Change: Both O | - |
| Q3SXY8 | AR13B_HUMAN ADP-ribosylation factor-like protein 13B OS=Homo sapiens GN=ARL13B PE=1 SV=1 | 348 | T | 0.954386 | S | 0.962943 | -0.008557 | No Change: Both D | - |
| Q3SXY8 | AR13B_HUMAN ADP-ribosylation factor-like protein 13B OS=Homo sapiens GN=ARL13B PE=1 SV=1 | 79 | R | 0.097638 | Q | 0.098833 | -0.001195 | No Change: Both O | Joubert syndrome type 8 (JBTS8) [MIM:612291] |
| Q3SXY8 | AR13B_HUMAN ADP-ribosylation factor-like protein 13B OS=Homo sapiens GN=ARL13B PE=1 SV=1 | 200 | R | 0.526364 | C | 0.415269 | 0.111095 | D to O | Joubert syndrome type 8 (JBTS8) [MIM:612291] |
| Q8N4G2 | ARL14_HUMAN ADP-ribosylation factor-like protein 14 OS=Homo sapiens GN=ARL14 PE=1 SV=2 | 83 | D | 0.130611 | N | 0.122721 | 0.00789 | No Change: Both O | - |
| Q8N4G2 | ARL14_HUMAN ADP-ribosylation factor-like protein 14 OS=Homo sapiens GN=ARL14 PE=1 SV=2 | 117 | P | 0.200164 | T | 0.167732 | 0.032432 | No Change: Both O | - |
| Q0P5N6 | ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens GN=ARL16 PE=2 SV=1 | 10 | S | 0.604755 | R | 0.638624 | -0.033869 | No Change: Both D | - |
| Q8IVW1 | ARL17_HUMAN ADP-ribosylation factor-like protein 17 OS=Homo sapiens GN=ARL17A PE=1 SV=2 | 170 | L | 0.257204 | I | 0.22431 | 0.032894 | No Change: Both O | - |
| P36404 | ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=Homo sapiens GN=ARL2 PE=1 SV=4 | 141 | V | 0.349968 | A | 0.455058 | -0.10509 | No Change: Both O | - |
| Q9Y2Y0 | AR2BP_HUMAN ADP-ribosylation factor-like protein 2-binding protein OS=Homo sapiens GN=ARL2BP PE=1 SV=1 | 87 | E | 0.207749 | K | 0.200862 | 0.006887 | No Change: Both O | - |
| P36405 | ARL3_HUMAN ADP-ribosylation factor-like protein 3 OS=Homo sapiens GN=ARL3 PE=1 SV=2 | 34 | L | 0.376667 | M | 0.410253 | -0.033586 | No Change: Both O | - |
| P40617 | ARL4A_HUMAN ADP-ribosylation factor-like protein 4A OS=Homo sapiens GN=ARL4A PE=1 SV=2 | 139 | R | 0.467086 | K | 0.527361 | -0.060275 | O to D | - |
| P49703 | ARL4D_HUMAN ADP-ribosylation factor-like protein 4D OS=Homo sapiens GN=ARL4D PE=1 SV=2 | 91 | T | 0.239657 | N | 0.25366 | -0.014003 | No Change: Both O | - |
| Q9H0F7 | ARL6_HUMAN ADP-ribosylation factor-like protein 6 OS=Homo sapiens GN=ARL6 PE=1 SV=1 | 31 | T | 0.446074 | M | 0.389596 | 0.056478 | No Change: Both O | Bardet-Biedl syndrome type 3 (BBS3) [MIM:209900] |
| Q9H0F7 | ARL6_HUMAN ADP-ribosylation factor-like protein 6 OS=Homo sapiens GN=ARL6 PE=1 SV=1 | 31 | T | 0.446074 | R | 0.44339 | 0.002684 | No Change: Both O | Bardet-Biedl syndrome type 3 (BBS3) [MIM:209900] |
| Q9H0F7 | ARL6_HUMAN ADP-ribosylation factor-like protein 6 OS=Homo sapiens GN=ARL6 PE=1 SV=1 | 169 | G | 0.4067 | A | 0.349749 | 0.056951 | No Change: Both O | Bardet-Biedl syndrome type 3 (BBS3) [MIM:209900] |
| Q9H0F7 | ARL6_HUMAN ADP-ribosylation factor-like protein 6 OS=Homo sapiens GN=ARL6 PE=1 SV=1 | 170 | L | 0.390277 | W | 0.319832 | 0.070445 | No Change: Both O | Bardet-Biedl syndrome type 3 (BBS3) [MIM:209900] |
| Q9H0F7 | ARL6_HUMAN ADP-ribosylation factor-like protein 6 OS=Homo sapiens GN=ARL6 PE=1 SV=1 | 89 | A | 0.107579 | V | 0.081944 | 0.025635 | No Change: Both O | Retinitis pigmentosa type 55 (RP55) [MIM:613575] |
| Q66PJ3 | AR6P4_HUMAN ADP-ribosylation factor-like protein 6-interacting protein 4 OS=Homo sapiens GN=ARL6IP4 PE=1 SV=1 | 225 | K | 0.999923 | R | 0.999912 | 1.10E-05 | No Change: Both D | - |
| Q66PJ3 | AR6P4_HUMAN ADP-ribosylation factor-like protein 6-interacting protein 4 OS=Homo sapiens GN=ARL6IP4 PE=1 SV=1 | 88 | P | 0.980246 | A | 0.973146 | 0.0071 | No Change: Both D | - |
| Q8N2F6 | ARM10_HUMAN Armadillo repeat-containing protein 10 OS=Homo sapiens GN=ARMC10 PE=1 SV=1 | 190 | P | 0.289725 | S | 0.337842 | -0.048117 | No Change: Both O | - |
| Q8NEN0 | ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens GN=ARMC2 PE=1 SV=4 | 166 | M | 0.602204 | T | 0.620722 | -0.018518 | No Change: Both D | - |
| Q8NEN0 | ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens GN=ARMC2 PE=1 SV=4 | 433 | N | 0.299195 | D | 0.296545 | 0.00265 | No Change: Both O | - |
| Q5W041 | ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens GN=ARMC3 PE=2 SV=2 | 345 | E | 0.530132 | G | 0.491374 | 0.038758 | D to O | - |
| Q5W041 | ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens GN=ARMC3 PE=2 SV=2 | 608 | S | 0.787063 | P | 0.783813 | 0.00325 | No Change: Both D | - |
| Q5W041 | ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens GN=ARMC3 PE=2 SV=2 | 626 | R | 0.968009 | Q | 0.962961 | 0.005048 | No Change: Both D | - |
| Q5T2S8 | ARMC4_HUMAN Armadillo repeat-containing protein 4 OS=Homo sapiens GN=ARMC4 PE=2 SV=1 | 935 | N | 0.65933 | K | 0.682036 | -0.022706 | No Change: Both D | - |
| Q5T2S8 | ARMC4_HUMAN Armadillo repeat-containing protein 4 OS=Homo sapiens GN=ARMC4 PE=2 SV=1 | 343 | I | 0.821112 | T | 0.867605 | -0.046493 | No Change: Both D | - |
| Q5T2S8 | ARMC4_HUMAN Armadillo repeat-containing protein 4 OS=Homo sapiens GN=ARMC4 PE=2 SV=1 | 1041 | A | 0.702963 | S | 0.713467 | -0.010504 | No Change: Both D | - |
| Q96C12 | ARMC5_HUMAN Armadillo repeat-containing protein 5 OS=Homo sapiens GN=ARMC5 PE=2 SV=2 | 170 | I | 0.386976 | V | 0.408799 | -0.021823 | No Change: Both O | - |
| Q7Z3E5 | ARMC9_HUMAN LisH domain-containing protein ARMC9 OS=Homo sapiens GN=ARMC9 PE=2 SV=2 | 108 | L | 0.068582 | F | 0.06051 | 0.008072 | No Change: Both O | - |
| Q7Z3E5 | ARMC9_HUMAN LisH domain-containing protein ARMC9 OS=Homo sapiens GN=ARMC9 PE=2 SV=2 | 209 | I | 0.587506 | T | 0.69997 | -0.112464 | No Change: Both D | - |
| Q7Z3E5 | ARMC9_HUMAN LisH domain-containing protein ARMC9 OS=Homo sapiens GN=ARMC9 PE=2 SV=2 | 222 | R | 0.410859 | H | 0.40057 | 0.010289 | No Change: Both O | - |
| Q7Z3E5 | ARMC9_HUMAN LisH domain-containing protein ARMC9 OS=Homo sapiens GN=ARMC9 PE=2 SV=2 | 180 | I | 0.183831 | V | 0.184399 | -5.68E-04 | No Change: Both O | - |
| Q5H9R4 | ARMX4_HUMAN Armadillo repeat-containing X-linked protein 4 OS=Homo sapiens GN=ARMCX4 PE=2 SV=2 | 188 | R | 0.797438 | G | 0.78569 | 0.011748 | No Change: Both D | - |
| P0C7Q2 | ARMS2_HUMAN Age-related maculopathy susceptibility protein 2 OS=Homo sapiens GN=ARMS2 PE=2 SV=1 | 3 | R | 0.815238 | H | 0.787581 | 0.027657 | No Change: Both D | - |
| P0C7Q2 | ARMS2_HUMAN Age-related maculopathy susceptibility protein 2 OS=Homo sapiens GN=ARMS2 PE=2 SV=1 | 69 | A | 0.531965 | S | 0.640669 | -0.108704 | No Change: Both D | - |
| P27540 | ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens GN=ARNT PE=1 SV=1 | 511 | D | 0.851163 | N | 0.845219 | 0.005944 | No Change: Both D | - |
| P27540 | ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens GN=ARNT PE=1 SV=1 | 517 | D | 0.774562 | E | 0.793135 | -0.018573 | No Change: Both D | - |
| P27540 | ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens GN=ARNT PE=1 SV=1 | 706 | P | 0.811437 | L | 0.685784 | 0.125653 | No Change: Both D | - |
| P27540 | ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens GN=ARNT PE=1 SV=1 | 430 | R | 0.230478 | Q | 0.249736 | -0.019258 | No Change: Both O | - |
| P27540 | ARNT_HUMAN Aryl hydrocarbon receptor nuclear translocator OS=Homo sapiens GN=ARNT PE=1 SV=1 | 435 | E | 0.274571 | K | 0.291236 | -0.016665 | No Change: Both O | - |
| Q9HBZ2 | ARNT2_HUMAN Aryl hydrocarbon receptor nuclear translocator 2 OS=Homo sapiens GN=ARNT2 PE=1 SV=2 | 679 | G | 0.926136 | S | 0.93722 | -0.011084 | No Change: Both D | - |
| Q8WYA1 | BMAL2_HUMAN Aryl hydrocarbon receptor nuclear translocator-like protein 2 OS=Homo sapiens GN=ARNTL2 PE=1 SV=2 | 340 | N | 0.556015 | S | 0.583307 | -0.027292 | No Change: Both D | - |
| Q8WYA1 | BMAL2_HUMAN Aryl hydrocarbon receptor nuclear translocator-like protein 2 OS=Homo sapiens GN=ARNTL2 PE=1 SV=2 | 574 | A | 0.810404 | V | 0.769742 | 0.040662 | No Change: Both D | - |
| O15143 | ARC1B_HUMAN Actin-related protein 2/3 complex subunit 1B OS=Homo sapiens GN=ARPC1B PE=1 SV=3 | 37 | K | 0.4325 | N | 0.381797 | 0.050703 | No Change: Both O | - |
| Q9BYD9 | ARPM1_HUMAN Actin-related protein M1 OS=Homo sapiens GN=ARPM1 PE=2 SV=1 | 234 | E | 0.34001 | K | 0.356222 | -0.016212 | No Change: Both O | - |
| P36575 | ARRC_HUMAN Arrestin-C OS=Homo sapiens GN=ARR3 PE=1 SV=2 | 44 | L | 0.114566 | F | 0.097202 | 0.017364 | No Change: Both O | - |
| Q8N5I2 | ARRD1_HUMAN Arrestin domain-containing protein 1 OS=Homo sapiens GN=ARRDC1 PE=2 SV=1 | 363 | G | 0.924557 | C | 0.91129 | 0.013267 | No Change: Both D | - |
| Q8TBH0 | ARRD2_HUMAN Arrestin domain-containing protein 2 OS=Homo sapiens GN=ARRDC2 PE=2 SV=2 | 181 | R | 0.13049 | H | 0.121006 | 0.009484 | No Change: Both O | - |
| Q8TBH0 | ARRD2_HUMAN Arrestin domain-containing protein 2 OS=Homo sapiens GN=ARRDC2 PE=2 SV=2 | 192 | R | 0.440042 | H | 0.458578 | -0.018536 | No Change: Both O | - |
| Q8TBH0 | ARRD2_HUMAN Arrestin domain-containing protein 2 OS=Homo sapiens GN=ARRDC2 PE=2 SV=2 | 244 | A | 0.556078 | T | 0.547898 | 0.00818 | No Change: Both D | - |
| Q8TBH0 | ARRD2_HUMAN Arrestin domain-containing protein 2 OS=Homo sapiens GN=ARRDC2 PE=2 SV=2 | 396 | L | 0.794835 | P | 0.903433 | -0.108598 | No Change: Both D | - |
| Q8NCT1 | ARRD4_HUMAN Arrestin domain-containing protein 4 OS=Homo sapiens GN=ARRDC4 PE=1 SV=3 | 79 | T | 0.440934 | A | 0.446386 | -0.005452 | No Change: Both O | - |
| Q8NCT1 | ARRD4_HUMAN Arrestin domain-containing protein 4 OS=Homo sapiens GN=ARRDC4 PE=1 SV=3 | 347 | P | 0.678743 | S | 0.673405 | 0.005338 | No Change: Both D | - |
| Q8NCT1 | ARRD4_HUMAN Arrestin domain-containing protein 4 OS=Homo sapiens GN=ARRDC4 PE=1 SV=3 | 358 | S | 0.724849 | P | 0.740599 | -0.01575 | No Change: Both D | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 76 | L | 0.328113 | P | 0.493283 | -0.16517 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 82 | P | 0.307093 | L | 0.179636 | 0.127457 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 84 | R | 0.326166 | Q | 0.29671 | 0.029456 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 86 | G | 0.309896 | D | 0.305516 | 0.00438 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 95 | S | 0.505789 | N | 0.435463 | 0.070326 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 96 | S | 0.521036 | F | 0.282575 | 0.238461 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 96 | S | 0.521036 | L | 0.347679 | 0.173357 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 99 | G | 0.515988 | D | 0.515463 | 5.25E-04 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 119 | G | 0.200496 | R | 0.187599 | 0.012897 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 122 | G | 0.2267 | S | 0.247929 | -0.021229 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 135 | L | 0.440099 | P | 0.620181 | -0.180082 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 136 | P | 0.408408 | L | 0.244389 | 0.164019 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 152 | D | 0.449356 | Y | 0.301852 | 0.147504 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 154 | G | 0.45733 | D | 0.487716 | -0.030386 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 155 | P | 0.471533 | R | 0.394205 | 0.077328 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 167 | P | 0.464596 | R | 0.368222 | 0.096374 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 169 | D | 0.465843 | N | 0.437398 | 0.028445 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 172 | C | 0.391502 | Y | 0.370267 | 0.021235 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 179 | I | 0.219661 | S | 0.436626 | -0.216965 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 193 | W | 0.295874 | C | 0.366513 | -0.070639 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 201 | Y | 0.170113 | C | 0.154766 | 0.015347 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 212 | A | 0.461963 | V | 0.362147 | 0.099816 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 224 | A | 0.356743 | V | 0.244467 | 0.112276 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 231 | P | 0.601618 | T | 0.564647 | 0.036971 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 244 | R | 0.629514 | C | 0.475727 | 0.153787 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 244 | R | 0.629514 | H | 0.619003 | 0.010511 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 245 | G | 0.621994 | R | 0.616321 | 0.005673 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 250 | S | 0.465354 | Y | 0.265574 | 0.19978 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 274 | T | 0.23227 | M | 0.223011 | 0.009259 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 288 | R | 0.625384 | C | 0.4632 | 0.162184 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 295 | S | 0.419078 | Y | 0.221213 | 0.197865 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 309 | G | 0.386037 | S | 0.407932 | -0.021895 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 311 | R | 0.326167 | Q | 0.324397 | 0.00177 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 314 | A | 0.246233 | T | 0.266678 | -0.020445 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 335 | D | 0.350655 | V | 0.212775 | 0.13788 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 350 | N | 0.354052 | S | 0.444716 | -0.090664 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 367 | K | 0.542477 | N | 0.515018 | 0.027459 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 370 | R | 0.478946 | Q | 0.513576 | -0.03463 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 370 | R | 0.478946 | W | 0.269597 | 0.209349 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 377 | P | 0.288538 | L | 0.160947 | 0.127591 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 382 | E | 0.29506 | K | 0.32432 | -0.02926 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 384 | R | 0.280095 | C | 0.165524 | 0.114571 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 390 | R | 0.281938 | Q | 0.287964 | -0.006026 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 390 | R | 0.281938 | W | 0.121361 | 0.160577 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 391 | T | 0.299707 | S | 0.369869 | -0.070162 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 397 | H | 0.406217 | Y | 0.308478 | 0.097739 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 426 | P | 0.583 | L | 0.419926 | 0.163074 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 464 | A | 0.313167 | V | 0.231684 | 0.081483 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 496 | R | 0.809652 | H | 0.799178 | 0.010474 | No Change: Both D | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 300 | C | 0.362741 | F | 0.349651 | 0.01309 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 425 | P | 0.613715 | T | 0.547713 | 0.066002 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 356 | F | 0.338789 | V | 0.372865 | -0.034076 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 440 | N | 0.43205 | S | 0.479736 | -0.047686 | No Change: Both O | - |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 18 | A | 0.159299 | D | 0.195403 | -0.036104 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 29 | D | 0.093513 | N | 0.082308 | 0.011205 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 30 | D | 0.104198 | H | 0.079644 | 0.024554 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 32 | G | 0.144642 | S | 0.162151 | -0.017509 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 68 | L | 0.230719 | P | 0.383076 | -0.152357 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 84 | R | 0.326166 | W | 0.129728 | 0.196438 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 94 | P | 0.485863 | A | 0.377966 | 0.107897 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 99 | G | 0.515988 | V | 0.39506 | 0.120928 | D to O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 136 | P | 0.408408 | S | 0.416287 | -0.007879 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 143 | R | 0.285603 | G | 0.321069 | -0.035466 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 148 | P | 0.371701 | L | 0.221939 | 0.149762 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 153 | Q | 0.45534 | H | 0.42604 | 0.0293 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 155 | P | 0.471533 | L | 0.301638 | 0.169895 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 156 | C | 0.461872 | R | 0.547621 | -0.085749 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 181 | L | 0.244715 | Q | 0.35489 | -0.110175 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 190 | Q | 0.324237 | H | 0.295339 | 0.028898 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 191 | P | 0.319301 | T | 0.24459 | 0.074711 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 212 | A | 0.461963 | P | 0.527549 | -0.065586 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 217 | R | 0.347184 | H | 0.325747 | 0.021437 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 219 | F | 0.342982 | V | 0.302843 | 0.040139 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 227 | H | 0.426382 | Y | 0.321363 | 0.105019 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 247 | F | 0.597915 | S | 0.780891 | -0.182976 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 253 | E | 0.33422 | K | 0.323772 | 0.010448 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 255 | D | 0.325532 | H | 0.270681 | 0.054851 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 281 | D | 0.368931 | Y | 0.223286 | 0.145645 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 282 | N | 0.41829 | S | 0.491308 | -0.073018 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 286 | T | 0.579312 | P | 0.6139 | -0.034588 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 288 | R | 0.625384 | H | 0.615445 | 0.009939 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 293 | G | 0.479589 | D | 0.479318 | 2.71E-04 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 293 | G | 0.479589 | S | 0.532387 | -0.052798 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 294 | C | 0.454216 | Y | 0.476508 | -0.022292 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 298 | L | 0.345593 | S | 0.549193 | -0.2036 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 302 | K | 0.389122 | N | 0.358836 | 0.030286 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 306 | Y | 0.465955 | H | 0.58185 | -0.115895 | O to D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 308 | G | 0.438813 | D | 0.427307 | 0.011506 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 308 | G | 0.438813 | V | 0.312517 | 0.126296 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 312 | E | 0.29796 | D | 0.258727 | 0.039233 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 325 | G | 0.320473 | S | 0.367163 | -0.04669 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 327 | T | 0.393777 | I | 0.276282 | 0.117495 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 376 | Y | 0.28884 | N | 0.402682 | -0.113842 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 381 | D | 0.293002 | E | 0.326175 | -0.033173 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 408 | T | 0.680582 | I | 0.559256 | 0.121326 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 409 | T | 0.717794 | I | 0.597607 | 0.120187 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 428 | L | 0.557699 | P | 0.708183 | -0.150484 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 429 | Y | 0.566802 | S | 0.748067 | -0.181265 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 469 | A | 0.318908 | G | 0.352708 | -0.0338 | No Change: Both O | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15289 | ARSA_HUMAN Arylsulfatase A OS=Homo sapiens GN=ARSA PE=1 SV=3 | 489 | C | 0.613222 | G | 0.648736 | -0.035514 | No Change: Both D | Leukodystrophy metachromatic (MLD) [MIM:250100] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 92 | T | 0.40482 | M | 0.340631 | 0.064189 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 95 | R | 0.44615 | Q | 0.475023 | -0.028873 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 117 | C | 0.172907 | R | 0.260097 | -0.08719 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 137 | G | 0.306436 | V | 0.196049 | 0.110387 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 152 | R | 0.240448 | W | 0.110481 | 0.129967 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 160 | R | 0.213964 | Q | 0.214847 | -8.83E-04 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 210 | Y | 0.275352 | C | 0.217585 | 0.057767 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 236 | L | 0.10966 | P | 0.21224 | -0.10258 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 302 | G | 0.449581 | R | 0.410674 | 0.038907 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 376 | V | 0.252277 | M | 0.311222 | -0.058945 | No Change: Both O | - |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 393 | H | 0.602277 | P | 0.714801 | -0.112524 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 405 | C | 0.744674 | Y | 0.72959 | 0.015084 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 498 | L | 0.227375 | P | 0.376304 | -0.148929 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 358 | V | 0.169356 | M | 0.209648 | -0.040292 | No Change: Both O | - |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 65 | S | 0.323673 | F | 0.168388 | 0.155285 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 116 | P | 0.157274 | H | 0.115462 | 0.041812 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 142 | M | 0.230742 | I | 0.154553 | 0.076189 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 144 | G | 0.231915 | R | 0.213013 | 0.018902 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 146 | W | 0.213265 | L | 0.296988 | -0.083723 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 146 | W | 0.213265 | R | 0.412536 | -0.199271 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 146 | W | 0.213265 | S | 0.453018 | -0.239753 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 192 | C | 0.102968 | R | 0.222304 | -0.119336 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 239 | Q | 0.167612 | R | 0.149392 | 0.01822 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 312 | W | 0.314947 | C | 0.343039 | -0.028092 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 315 | R | 0.234566 | Q | 0.236548 | -0.001982 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 321 | L | 0.223113 | P | 0.371921 | -0.148808 | No Change: Both O | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 384 | S | 0.565948 | N | 0.522822 | 0.043126 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 399 | F | 0.697024 | L | 0.72749 | -0.030466 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 484 | R | 0.690102 | G | 0.673202 | 0.0169 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 521 | C | 0.456711 | Y | 0.523199 | -0.066488 | O to D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 531 | P | 0.567058 | R | 0.503844 | 0.063214 | No Change: Both D | Mucopolysaccharidosis type 6 (MPS6) [MIM:253200] |
| P15848 | ARSB_HUMAN Arylsulfatase B OS=Homo sapiens GN=ARSB PE=1 SV=1 | 358 | V | 0.169356 | L | 0.188269 | -0.018913 | No Change: Both O | - |
| P51689 | ARSD_HUMAN Arylsulfatase D OS=Homo sapiens GN=ARSD PE=1 SV=2 | 224 | S | 0.181127 | C | 0.065238 | 0.115889 | No Change: Both O | - |
| P51689 | ARSD_HUMAN Arylsulfatase D OS=Homo sapiens GN=ARSD PE=1 SV=2 | 500 | V | 0.397564 | I | 0.332747 | 0.064817 | No Change: Both O | - |
| P51689 | ARSD_HUMAN Arylsulfatase D OS=Homo sapiens GN=ARSD PE=1 SV=2 | 564 | M | 0.2411 | T | 0.280589 | -0.039489 | No Change: Both O | - |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 12 | R | 0.204848 | S | 0.289497 | -0.084649 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 111 | R | 0.15176 | P | 0.175097 | -0.023337 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 117 | G | 0.245606 | R | 0.227723 | 0.017883 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 137 | G | 0.302941 | V | 0.174535 | 0.128406 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 245 | G | 0.066527 | R | 0.0624 | 0.004127 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 492 | C | 0.195957 | Y | 0.21281 | -0.016853 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 80 | I | 0.279146 | N | 0.448736 | -0.16959 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 481 | T | 0.130836 | M | 0.115764 | 0.015072 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 578 | P | 0.311627 | S | 0.230117 | 0.08151 | No Change: Both O | Chondrodysplasia punctata X-linked recessive type 1 (CDPX1) [MIM:302950] |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 183 | R | 0.204209 | H | 0.198706 | 0.005503 | No Change: Both O | - |
| P51690 | ARSE_HUMAN Arylsulfatase E OS=Homo sapiens GN=ARSE PE=1 SV=2 | 424 | G | 0.338614 | S | 0.372941 | -0.034327 | No Change: Both O | - |
| P54793 | ARSF_HUMAN Arylsulfatase F OS=Homo sapiens GN=ARSF PE=1 SV=4 | 527 | H | 0.359449 | Y | 0.247363 | 0.112086 | No Change: Both O | - |
| Q96EG1 | ARSG_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1 | 11 | A | 0.06754 | V | 0.051275 | 0.016265 | No Change: Both O | - |
| Q96EG1 | ARSG_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1 | 236 | T | 0.337051 | S | 0.4185 | -0.081449 | No Change: Both O | - |
| Q96EG1 | ARSG_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1 | 274 | W | 0.17416 | R | 0.367524 | -0.193364 | No Change: Both O | - |
| Q96EG1 | ARSG_HUMAN Arylsulfatase G OS=Homo sapiens GN=ARSG PE=1 SV=1 | 385 | R | 0.432606 | H | 0.413906 | 0.0187 | No Change: Both O | - |
| Q5FYB0 | ARSJ_HUMAN Arylsulfatase J OS=Homo sapiens GN=ARSJ PE=2 SV=1 | 565 | S | 0.985342 | R | 0.985654 | -3.12E-04 | No Change: Both D | - |
| Q6UWY0 | ARSK_HUMAN Arylsulfatase K OS=Homo sapiens GN=ARSK PE=2 SV=1 | 525 | Q | 0.233767 | R | 0.227708 | 0.006059 | No Change: Both O | - |
| P52961 | NAR1_HUMAN GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 OS=Homo sapiens GN=ART1 PE=2 SV=2 | 105 | P | 0.740593 | L | 0.610698 | 0.129895 | No Change: Both D | - |
| P52961 | NAR1_HUMAN GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 OS=Homo sapiens GN=ART1 PE=2 SV=2 | 126 | P | 0.413031 | R | 0.389053 | 0.023978 | No Change: Both O | - |
| P52961 | NAR1_HUMAN GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 OS=Homo sapiens GN=ART1 PE=2 SV=2 | 257 | L | 0.24804 | P | 0.399854 | -0.151814 | No Change: Both O | - |
| Q13508 | NAR3_HUMAN Ecto-ADP-ribosyltransferase 3 OS=Homo sapiens GN=ART3 PE=1 SV=2 | 363 | S | 0.681733 | L | 0.57903 | 0.102703 | No Change: Both D | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 108 | G | 0.260917 | V | 0.163179 | 0.097738 | No Change: Both O | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 117 | T | 0.226556 | I | 0.128633 | 0.097923 | No Change: Both O | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 265 | N | 0.313371 | D | 0.318923 | -0.005552 | No Change: Both O | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 300 | L | 0.203001 | V | 0.191692 | 0.011309 | No Change: Both O | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 135 | D | 0.44628 | E | 0.470449 | -0.024169 | No Change: Both O | - |
| Q93070 | NAR4_HUMAN Ecto-ADP-ribosyltransferase 4 OS=Homo sapiens GN=ART4 PE=2 SV=2 | 189 | T | 0.256446 | M | 0.212745 | 0.043701 | No Change: Both O | - |
| Q5T4W7 | ARTN_HUMAN Artemin OS=Homo sapiens GN=ARTN PE=1 SV=1 | 19 | Q | 0.542094 | R | 0.542816 | -7.22E-04 | No Change: Both D | - |
| Q9H2C2 | ARV1_HUMAN Protein ARV1 OS=Homo sapiens GN=ARV1 PE=2 SV=1 | 101 | G | 0.048089 | E | 0.061894 | -0.013805 | No Change: Both O | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 175 | V | 0.745502 | A | 0.830189 | -0.084687 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 906 | R | 0.940301 | Q | 0.920366 | 0.019935 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 220 | P | 0.977088 | L | 0.957084 | 0.020004 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 909 | R | 0.955261 | W | 0.890388 | 0.064873 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 909 | R | 0.955261 | Q | 0.939881 | 0.01538 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 912 | R | 0.966542 | W | 0.91707 | 0.049472 | No Change: Both D | - |
| O00192 | ARVC_HUMAN Armadillo repeat protein deleted in velo-cardio-facial syndrome OS=Homo sapiens GN=ARVCF PE=1 SV=1 | 539 | R | 0.572724 | Q | 0.539364 | 0.03336 | No Change: Both D | - |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 332 | R | 0.684179 | H | 0.610214 | 0.073965 | No Change: Both D | Lissencephaly X-linked type 2 (LISX2) [MIM:300215] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 343 | L | 0.572843 | Q | 0.678872 | -0.106029 | No Change: Both D | Lissencephaly X-linked type 2 (LISX2) [MIM:300215] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 353 | P | 0.3795 | L | 0.265669 | 0.113831 | No Change: Both O | Epileptic encephalopathy early infantile type 1 (EIEE1) [MIM:308350] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 33 | L | 0.808125 | P | 0.880124 | -0.071999 | No Change: Both D | Mental retardation X-linked ARX-related (MRXARX) [MIM:300419] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 286 | G | 0.840154 | S | 0.86209 | -0.021936 | No Change: Both D | Mental retardation X-linked ARX-related (MRXARX) [MIM:300419] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 332 | R | 0.684179 | P | 0.673576 | 0.010603 | No Change: Both D | Lissencephaly X-linked type 2 (LISX2) [MIM:300215] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 333 | T | 0.667149 | N | 0.628739 | 0.03841 | No Change: Both D | Agenesis of the corpus callosum with abnormal genitalia (ACCAG) [MIM:300004] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 353 | P | 0.3795 | R | 0.403582 | -0.024082 | No Change: Both O | Lissencephaly X-linked type 2 (LISX2) [MIM:300215] |
| Q96QS3 | ARX_HUMAN Homeobox protein ARX OS=Homo sapiens GN=ARX PE=1 SV=1 | 521 | A | 0.760221 | T | 0.754281 | 0.00594 | No Change: Both D | Lissencephaly X-linked type 2 (LISX2) [MIM:300215] |
| Q9HBK9 | AS3MT_HUMAN Arsenite methyltransferase OS=Homo sapiens GN=AS3MT PE=1 SV=3 | 173 | R | 0.24538 | W | 0.106898 | 0.138482 | No Change: Both O | - |
| Q9HBK9 | AS3MT_HUMAN Arsenite methyltransferase OS=Homo sapiens GN=AS3MT PE=1 SV=3 | 287 | M | 0.294726 | T | 0.354041 | -0.059315 | No Change: Both O | - |
| Q9HBK9 | AS3MT_HUMAN Arsenite methyltransferase OS=Homo sapiens GN=AS3MT PE=1 SV=3 | 306 | T | 0.333912 | I | 0.237898 | 0.096014 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 72 | V | 0.160075 | M | 0.198932 | -0.038857 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 93 | I | 0.261717 | V | 0.309097 | -0.04738 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 222 | T | 0.208464 | K | 0.289757 | -0.081293 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 36 | Y | 0.664515 | C | 0.628524 | 0.035991 | No Change: Both D | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 97 | V | 0.316612 | E | 0.494922 | -0.17831 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 138 | E | 0.025754 | V | 0.00995 | 0.015804 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 235 | G | 0.053534 | R | 0.045807 | 0.007727 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 254 | R | 0.106296 | G | 0.119804 | -0.013508 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 320 | N | 0.138473 | D | 0.16074 | -0.022267 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 362 | P | 0.260402 | R | 0.239139 | 0.021263 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 369 | V | 0.105352 | I | 0.091791 | 0.013561 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 22 | Q | 0.251738 | H | 0.250302 | 0.001436 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 23 | H | 0.262957 | D | 0.319206 | -0.056249 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 124 | D | 0.136275 | E | 0.163768 | -0.027493 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 182 | L | 0.18071 | V | 0.184213 | -0.003503 | No Change: Both O | Farber lipogranulomatosis (FL) [MIM:228000] |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 246 | V | 0.058572 | A | 0.083404 | -0.024832 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 70 | A | 0.182254 | V | 0.146341 | 0.035913 | No Change: Both O | - |
| Q13510 | ASAH1_HUMAN Acid ceramidase OS=Homo sapiens GN=ASAH1 PE=1 SV=5 | 88 | V | 0.226895 | M | 0.298079 | -0.071184 | No Change: Both O | - |
| Q9NR71 | ASAH2_HUMAN Neutral ceramidase OS=Homo sapiens GN=ASAH2 PE=1 SV=2 | 51 | T | 0.67198 | A | 0.643155 | 0.028825 | No Change: Both D | - |
| Q9NR71 | ASAH2_HUMAN Neutral ceramidase OS=Homo sapiens GN=ASAH2 PE=1 SV=2 | 346 | A | 0.330637 | S | 0.439111 | -0.108474 | No Change: Both O | - |
| Q9ULH1 | ASAP1_HUMAN Arf-GAP with SH3 domain ANK repeat and PH domain-containing protein 1 OS=Homo sapiens GN=ASAP1 PE=1 SV=4 | 728 | I | 0.96389 | V | 0.965772 | -0.001882 | No Change: Both D | - |
| O43150 | ASAP2_HUMAN Arf-GAP with SH3 domain ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=ASAP2 PE=1 SV=3 | 748 | E | 0.615931 | D | 0.606736 | 0.009195 | No Change: Both D | - |
| Q8TDY4 | ASAP3_HUMAN Arf-GAP with SH3 domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ASAP3 PE=1 SV=1 | 617 | A | 0.569613 | T | 0.58739 | -0.017777 | No Change: Both D | A colorectal cancer sample |
| Q8TDY4 | ASAP3_HUMAN Arf-GAP with SH3 domain ANK repeat and PH domain-containing protein 3 OS=Homo sapiens GN=ASAP3 PE=1 SV=1 | 377 | E | 0.484869 | A | 0.392119 | 0.09275 | No Change: Both O | - |
| Q8WXI3 | ASB10_HUMAN Ankyrin repeat and SOCS box protein 10 OS=Homo sapiens GN=ASB10 PE=2 SV=2 | 453 | R | 0.55312 | C | 0.386401 | 0.166719 | D to O | - |
| Q8WXH4 | ASB11_HUMAN Ankyrin repeat and SOCS box protein 11 OS=Homo sapiens GN=ASB11 PE=2 SV=1 | 249 | D | 0.189052 | N | 0.190223 | -0.001171 | No Change: Both O | - |
| Q8WXH4 | ASB11_HUMAN Ankyrin repeat and SOCS box protein 11 OS=Homo sapiens GN=ASB11 PE=2 SV=1 | 263 | S | 0.58247 | G | 0.540096 | 0.042374 | No Change: Both D | - |
| Q8WXK1 | ASB15_HUMAN Ankyrin repeat and SOCS box protein 15 OS=Homo sapiens GN=ASB15 PE=2 SV=3 | 57 | P | 0.322135 | L | 0.198724 | 0.123411 | No Change: Both O | - |
| Q8WXK1 | ASB15_HUMAN Ankyrin repeat and SOCS box protein 15 OS=Homo sapiens GN=ASB15 PE=2 SV=3 | 357 | G | 0.184876 | A | 0.157863 | 0.027013 | No Change: Both O | - |
| Q96NS5 | ASB16_HUMAN Ankyrin repeat and SOCS box protein 16 OS=Homo sapiens GN=ASB16 PE=1 SV=2 | 240 | T | 0.531827 | I | 0.38017 | 0.151657 | D to O | - |
| Q96NS5 | ASB16_HUMAN Ankyrin repeat and SOCS box protein 16 OS=Homo sapiens GN=ASB16 PE=1 SV=2 | 173 | T | 0.436256 | P | 0.469522 | -0.033266 | No Change: Both O | - |
| Q8WXJ9 | ASB17_HUMAN Ankyrin repeat and SOCS box protein 17 OS=Homo sapiens GN=ASB17 PE=2 SV=2 | 2 | S | 0.833122 | N | 0.800191 | 0.032931 | No Change: Both D | - |
| Q8WXJ9 | ASB17_HUMAN Ankyrin repeat and SOCS box protein 17 OS=Homo sapiens GN=ASB17 PE=2 SV=2 | 101 | V | 0.028172 | A | 0.043161 | -0.014989 | No Change: Both O | - |
| Q6ZVZ8 | ASB18_HUMAN Ankyrin repeat and SOCS box protein 18 OS=Homo sapiens GN=ASB18 PE=2 SV=2 | 127 | A | 0.190463 | P | 0.250472 | -0.060009 | No Change: Both O | - |
| Q6ZVZ8 | ASB18_HUMAN Ankyrin repeat and SOCS box protein 18 OS=Homo sapiens GN=ASB18 PE=2 SV=2 | 104 | A | 0.268183 | T | 0.311773 | -0.04359 | No Change: Both O | - |
| Q6ZVZ8 | ASB18_HUMAN Ankyrin repeat and SOCS box protein 18 OS=Homo sapiens GN=ASB18 PE=2 SV=2 | 407 | H | 0.257861 | N | 0.278226 | -0.020365 | No Change: Both O | - |
| Q6ZVZ8 | ASB18_HUMAN Ankyrin repeat and SOCS box protein 18 OS=Homo sapiens GN=ASB18 PE=2 SV=2 | 261 | G | 0.786008 | S | 0.803097 | -0.017089 | No Change: Both D | - |
| Q96Q27 | ASB2_HUMAN Ankyrin repeat and SOCS box protein 2 OS=Homo sapiens GN=ASB2 PE=1 SV=1 | 160 | P | 0.482991 | S | 0.519458 | -0.036467 | O to D | - |
| Q9Y574 | ASB4_HUMAN Ankyrin repeat and SOCS box protein 4 OS=Homo sapiens GN=ASB4 PE=2 SV=1 | 17 | V | 0.336319 | L | 0.361663 | -0.025344 | No Change: Both O | - |
| Q8N9N2 | ASCC1_HUMAN Activating signal cointegrator 1 complex subunit 1 OS=Homo sapiens GN=ASCC1 PE=1 SV=1 | 34 | D | 0.795854 | N | 0.769929 | 0.025925 | No Change: Both D | - |
| Q8N9N2 | ASCC1_HUMAN Activating signal cointegrator 1 complex subunit 1 OS=Homo sapiens GN=ASCC1 PE=1 SV=1 | 318 | N | 0.488328 | S | 0.509415 | -0.021087 | O to D | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 509 | R | 0.340705 | Q | 0.36621 | -0.025505 | No Change: Both O | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 407 | D | 0.519935 | H | 0.447979 | 0.071956 | D to O | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 423 | P | 0.794627 | S | 0.794299 | 3.28E-04 | No Change: Both D | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 639 | R | 0.66358 | L | 0.567994 | 0.095586 | No Change: Both D | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 96 | R | 0.133596 | C | 0.063579 | 0.070017 | No Change: Both O | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 123 | V | 0.184827 | I | 0.161028 | 0.023799 | No Change: Both O | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 546 | D | 0.806478 | G | 0.743697 | 0.062781 | No Change: Both D | - |
| Q9H1I8 | ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens GN=ASCC2 PE=1 SV=3 | 588 | E | 0.571933 | K | 0.543918 | 0.028015 | No Change: Both D | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 146 | L | 0.328083 | F | 0.314331 | 0.013752 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1050 | V | 0.460922 | I | 0.453073 | 0.007849 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1800 | C | 0.143715 | W | 0.121338 | 0.022377 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1930 | V | 0.112903 | M | 0.14652 | -0.033617 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1995 | S | 0.451173 | C | 0.272168 | 0.179005 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 2176 | Y | 0.14437 | C | 0.110733 | 0.033637 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 344 | E | 0.88533 | K | 0.884458 | 8.72E-04 | No Change: Both D | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 478 | N | 0.202656 | S | 0.247555 | -0.044899 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1425 | V | 0.188241 | A | 0.259953 | -0.071712 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1497 | R | 0.212477 | T | 0.212233 | 2.44E-04 | No Change: Both O | - |
| Q8N3C0 | HELC1_HUMAN Activating signal cointegrator 1 complex subunit 3 OS=Homo sapiens GN=ASCC3 PE=1 SV=3 | 1016 | S | 0.253946 | C | 0.117189 | 0.136757 | No Change: Both O | - |
| P50553 | ASCL1_HUMAN Achaete-scute homolog 1 OS=Homo sapiens GN=ASCL1 PE=1 SV=2 | 158 | E | 0.498509 | G | 0.440598 | 0.057911 | No Change: Both O | - |
| Q9NQ33 | ASCL3_HUMAN Achaete-scute homolog 3 OS=Homo sapiens GN=ASCL3 PE=2 SV=2 | 54 | R | 0.791757 | L | 0.731913 | 0.059844 | No Change: Both D | - |
| Q9NR48 | ASH1L_HUMAN Histone-lysine N-methyltransferase ASH1L OS=Homo sapiens GN=ASH1L PE=1 SV=2 | 1771 | T | 0.885368 | A | 0.872753 | 0.012615 | No Change: Both D | - |
| Q9NR48 | ASH1L_HUMAN Histone-lysine N-methyltransferase ASH1L OS=Homo sapiens GN=ASH1L PE=1 SV=2 | 1416 | S | 0.942152 | P | 0.953158 | -0.011006 | No Change: Both D | - |
| Q9UBL3 | ASH2L_HUMAN Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Homo sapiens GN=ASH2L PE=1 SV=1 | 478 | S | 0.534094 | F | 0.346166 | 0.187928 | D to O | - |
| P42127 | ASIP_HUMAN Agouti-signaling protein OS=Homo sapiens GN=ASIP PE=1 SV=1 | 61 | Q | 0.9292 | P | 0.945407 | -0.016207 | No Change: Both D | - |
| P42127 | ASIP_HUMAN Agouti-signaling protein OS=Homo sapiens GN=ASIP PE=1 SV=1 | 13 | V | 0.089535 | A | 0.128691 | -0.039156 | No Change: Both O | - |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 95 | R | 0.464677 | C | 0.285913 | 0.178764 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 111 | R | 0.554328 | W | 0.349176 | 0.205152 | D to O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 193 | R | 0.241111 | Q | 0.234586 | 0.006525 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 286 | Q | 0.731065 | R | 0.726646 | 0.004419 | No Change: Both D | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 178 | V | 0.182764 | M | 0.227969 | -0.045205 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 379 | R | 0.165265 | C | 0.081991 | 0.083274 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 385 | R | 0.425681 | C | 0.273842 | 0.151839 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 181 | T | 0.370725 | S | 0.471464 | -0.100739 | No Change: Both O | A breast cancer sample |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 200 | G | 0.265088 | V | 0.158429 | 0.106659 | No Change: Both O | A breast cancer sample |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 31 | D | 0.114573 | N | 0.108906 | 0.005667 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 113 | R | 0.527953 | Q | 0.539593 | -0.01164 | No Change: Both D | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 186 | R | 0.432249 | Q | 0.425975 | 0.006274 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 236 | R | 0.388502 | W | 0.214361 | 0.174141 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 335 | V | 0.400287 | L | 0.383487 | 0.0168 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 382 | M | 0.27207 | R | 0.337141 | -0.065071 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P04424 | ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens GN=ASL PE=1 SV=4 | 456 | R | 0.194603 | W | 0.076771 | 0.117832 | No Change: Both O | Arginosuccinicaciduria (ARGINSA) [MIM:207900] |
| P46597 | ASMT_HUMAN Acetylserotonin O-methyltransferase OS=Homo sapiens GN=ASMT PE=1 SV=1 | 17 | N | 0.147742 | K | 0.162458 | -0.014716 | No Change: Both O | - |
| O95671 | ASML_HUMAN N-acetylserotonin O-methyltransferase-like protein OS=Homo sapiens GN=ASMTL PE=1 SV=3 | 458 | V | 0.270911 | M | 0.337603 | -0.066692 | No Change: Both O | - |
| O95671 | ASML_HUMAN N-acetylserotonin O-methyltransferase-like protein OS=Homo sapiens GN=ASMTL PE=1 SV=3 | 541 | R | 0.361552 | K | 0.444351 | -0.082799 | No Change: Both O | - |
| O43681 | ASNA_HUMAN ATPase ASNA1 OS=Homo sapiens GN=ASNA1 PE=1 SV=2 | 332 | N | 0.28634 | S | 0.351802 | -0.065462 | No Change: Both O | - |
| P08243 | ASNS_HUMAN Asparagine synthetase [glutamine-hydrolyzing] OS=Homo sapiens GN=ASNS PE=1 SV=4 | 210 | V | 0.226657 | E | 0.402816 | -0.176159 | No Change: Both O | - |
| Q9NWL6 | ASND1_HUMAN Asparagine synthetase domain-containing protein 1 OS=Homo sapiens GN=ASNSD1 PE=2 SV=2 | 190 | G | 0.052662 | R | 0.050915 | 0.001747 | No Change: Both O | - |
| Q9NWL6 | ASND1_HUMAN Asparagine synthetase domain-containing protein 1 OS=Homo sapiens GN=ASNSD1 PE=2 SV=2 | 434 | M | 0.32084 | T | 0.362445 | -0.041605 | No Change: Both O | - |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 143 | I | 0.109753 | T | 0.194183 | -0.08443 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 152 | C | 0.058016 | R | 0.12379 | -0.065774 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 274 | G | 0.170997 | R | 0.151201 | 0.019796 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 285 | E | 0.188392 | A | 0.125542 | 0.06285 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 295 | F | 0.521891 | S | 0.712276 | -0.190385 | No Change: Both D | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 305 | A | 0.285386 | E | 0.395387 | -0.110001 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 21 | H | 0.302691 | P | 0.337844 | -0.035153 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 57 | A | 0.258792 | T | 0.307549 | -0.048757 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 168 | R | 0.320551 | H | 0.329044 | -0.008493 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 181 | P | 0.441701 | T | 0.364996 | 0.076705 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 24 | E | 0.325262 | G | 0.301197 | 0.024065 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 68 | D | 0.12116 | A | 0.079497 | 0.041663 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 114 | D | 0.222443 | Y | 0.114481 | 0.107962 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 152 | C | 0.058016 | W | 0.048408 | 0.009608 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 231 | Y | 0.361537 | C | 0.331149 | 0.030388 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 244 | H | 0.205876 | R | 0.21631 | -0.010434 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 249 | D | 0.46264 | V | 0.286431 | 0.176209 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 16 | I | 0.233873 | T | 0.371085 | -0.137212 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 27 | G | 0.198016 | R | 0.17568 | 0.022336 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 114 | D | 0.222443 | E | 0.232801 | -0.010358 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 123 | G | 0.251718 | E | 0.312869 | -0.061151 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 152 | C | 0.058016 | Y | 0.080504 | -0.022488 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 168 | R | 0.320551 | C | 0.18005 | 0.140501 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 183 | P | 0.401837 | H | 0.348806 | 0.053031 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 186 | V | 0.275247 | F | 0.241114 | 0.034133 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 195 | M | 0.319007 | R | 0.382663 | -0.063656 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 280 | P | 0.075368 | L | 0.035696 | 0.039672 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 280 | P | 0.075368 | S | 0.078901 | -0.003533 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 287 | A | 0.25089 | T | 0.259331 | -0.008441 | No Change: Both O | Canavan disease (CAND) [MIM:271900] |
| P45381 | ACY2_HUMAN Aspartoacylase OS=Homo sapiens GN=ASPA PE=1 SV=1 | 310 | C | 0.421741 | G | 0.614353 | -0.192612 | O to D | - |
| A6ND91 | ASPD_HUMAN Putative L-aspartate dehydrogenase OS=Homo sapiens GN=ASPDH PE=2 SV=2 | 266 | Q | 0.137265 | R | 0.147292 | -0.010027 | No Change: Both O | - |
| Q86U10 | LPP60_HUMAN 60 kDa lysophospholipase OS=Homo sapiens GN=ASPG PE=2 SV=3 | 95 | C | 0.038498 | R | 0.086938 | -0.04844 | No Change: Both O | - |
| Q86U10 | LPP60_HUMAN 60 kDa lysophospholipase OS=Homo sapiens GN=ASPG PE=2 SV=3 | 96 | L | 0.04905 | V | 0.053227 | -0.004177 | No Change: Both O | - |
| Q86U10 | LPP60_HUMAN 60 kDa lysophospholipase OS=Homo sapiens GN=ASPG PE=2 SV=3 | 344 | S | 0.47371 | R | 0.440517 | 0.033193 | No Change: Both O | - |
| Q12797 | ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens GN=ASPH PE=1 SV=3 | 354 | R | 0.756569 | M | 0.690635 | 0.065934 | No Change: Both D | - |
| Q6ICH7 | ASPH2_HUMAN Aspartate beta-hydroxylase domain-containing protein 2 OS=Homo sapiens GN=ASPHD2 PE=2 SV=1 | 235 | N | 0.068439 | S | 0.080512 | -0.012073 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 2562 | S | 0.207925 | G | 0.1592 | 0.048725 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 2647 | L | 0.153386 | I | 0.144981 | 0.008405 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 3132 | L | 0.148921 | R | 0.237052 | -0.088131 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 430 | R | 0.920667 | G | 0.905913 | 0.014754 | No Change: Both D | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 869 | T | 0.373637 | S | 0.465051 | -0.091414 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 1090 | S | 0.534678 | F | 0.303687 | 0.230991 | D to O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 2494 | Y | 0.092998 | H | 0.139619 | -0.046621 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 2620 | Q | 0.607166 | H | 0.566985 | 0.040181 | No Change: Both D | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 3258 | H | 0.110641 | R | 0.115719 | -0.005078 | No Change: Both O | - |
| Q8IZT6 | ASPM_HUMAN Abnormal spindle-like microcephaly-associated protein OS=Homo sapiens GN=ASPM PE=1 SV=2 | 313 | I | 0.533188 | V | 0.56407 | -0.030882 | No Change: Both D | - |
| Q53RT3 | APRV1_HUMAN Retroviral-like aspartic protease 1 OS=Homo sapiens GN=ASPRV1 PE=1 SV=1 | 49 | T | 0.374292 | A | 0.374722 | -4.30E-04 | No Change: Both O | - |
| Q9BZE9 | ASPC1_HUMAN Tether containing UBX domain for GLUT4 OS=Homo sapiens GN=ASPSCR1 PE=1 SV=1 | 252 | L | 0.973851 | Q | 0.984868 | -0.011017 | No Change: Both D | - |
| Q9BZE9 | ASPC1_HUMAN Tether containing UBX domain for GLUT4 OS=Homo sapiens GN=ASPSCR1 PE=1 SV=1 | 487 | D | 0.631799 | E | 0.681449 | -0.04965 | No Change: Both D | - |
| Q9BZE9 | ASPC1_HUMAN Tether containing UBX domain for GLUT4 OS=Homo sapiens GN=ASPSCR1 PE=1 SV=1 | 318 | V | 0.968906 | M | 0.97106 | -0.002154 | No Change: Both D | - |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 14 | G | 0.188237 | S | 0.235118 | -0.046881 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 18 | S | 0.07231 | L | 0.031085 | 0.041225 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 86 | R | 0.27269 | C | 0.146503 | 0.126187 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 118 | A | 0.557734 | T | 0.590024 | -0.03229 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 157 | R | 0.367553 | H | 0.359068 | 0.008485 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 180 | S | 0.467585 | N | 0.450031 | 0.017554 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 192 | A | 0.491796 | V | 0.399041 | 0.092755 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 272 | R | 0.18386 | C | 0.083511 | 0.100349 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 280 | G | 0.359875 | R | 0.342901 | 0.016974 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 304 | R | 0.306434 | W | 0.133306 | 0.173128 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 324 | G | 0.079094 | S | 0.106448 | -0.027354 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 363 | R | 0.303557 | L | 0.214325 | 0.089232 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 363 | R | 0.303557 | W | 0.139177 | 0.16438 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 390 | G | 0.221974 | R | 0.219727 | 0.002247 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 19 | C | 0.057967 | R | 0.121492 | -0.063525 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 86 | R | 0.27269 | H | 0.274017 | -0.001327 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 95 | R | 0.168178 | S | 0.210404 | -0.042226 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 96 | P | 0.164397 | S | 0.196599 | -0.032202 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 117 | G | 0.569476 | S | 0.610981 | -0.041505 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 117 | G | 0.569476 | D | 0.581913 | -0.012437 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 157 | R | 0.367553 | C | 0.210406 | 0.157147 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 179 | W | 0.459926 | R | 0.623419 | -0.163493 | O to D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 191 | E | 0.489657 | K | 0.493092 | -0.003435 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 265 | R | 0.239344 | H | 0.252853 | -0.013509 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 269 | V | 0.173836 | M | 0.21677 | -0.042934 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 283 | E | 0.346513 | K | 0.359346 | -0.012833 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 310 | K | 0.38442 | R | 0.313383 | 0.071037 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 362 | G | 0.256956 | V | 0.161428 | 0.095528 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 270 | E | 0.178757 | Q | 0.148355 | 0.030402 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 279 | R | 0.358269 | Q | 0.372713 | -0.014444 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 310 | K | 0.38442 | Q | 0.329348 | 0.055072 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 363 | R | 0.303557 | G | 0.334047 | -0.03049 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 363 | R | 0.303557 | Q | 0.332619 | -0.029062 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 389 | T | 0.260879 | I | 0.15965 | 0.101229 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 69 | V | 0.160646 | A | 0.2137 | -0.053054 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 108 | R | 0.4105 | L | 0.299548 | 0.110952 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 119 | T | 0.550421 | I | 0.430465 | 0.119956 | D to O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 65 | S | 0.248823 | I | 0.118777 | 0.130046 | No Change: Both O | - |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 40 | Q | 0.397948 | L | 0.277737 | 0.120211 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 79 | S | 0.16689 | P | 0.151209 | 0.015681 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 96 | P | 0.164397 | H | 0.14191 | 0.022487 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 124 | D | 0.456059 | N | 0.451645 | 0.004414 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 127 | R | 0.239484 | Q | 0.269132 | -0.029648 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 127 | R | 0.239484 | W | 0.109312 | 0.130172 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 160 | L | 0.403916 | P | 0.565508 | -0.161592 | O to D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 190 | Y | 0.456792 | D | 0.608519 | -0.151727 | O to D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 191 | E | 0.489657 | Q | 0.467747 | 0.02191 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 202 | A | 0.659091 | E | 0.732054 | -0.072963 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 206 | L | 0.657686 | P | 0.80875 | -0.151064 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 263 | V | 0.269165 | M | 0.31845 | -0.049285 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 265 | R | 0.239344 | C | 0.120461 | 0.118883 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 277 | K | 0.302049 | T | 0.23801 | 0.064039 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 284 | T | 0.313794 | I | 0.197167 | 0.116627 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 291 | Y | 0.125263 | S | 0.251234 | -0.125971 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 296 | D | 0.183151 | G | 0.15727 | 0.025881 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 302 | M | 0.256759 | V | 0.217238 | 0.039521 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 307 | R | 0.399755 | C | 0.217974 | 0.181781 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 324 | G | 0.079094 | V | 0.04616 | 0.032934 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 341 | S | 0.468361 | F | 0.254369 | 0.213992 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 345 | V | 0.580311 | G | 0.693087 | -0.112776 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 347 | G | 0.569506 | R | 0.56795 | 0.001556 | No Change: Both D | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| P00966 | ASSY_HUMAN Argininosuccinate synthase OS=Homo sapiens GN=ASS1 PE=1 SV=2 | 359 | Y | 0.200165 | D | 0.335488 | -0.135323 | No Change: Both O | Citrullinemia type 1 (CTLN1) [MIM:215700] |
| Q6HA08 | ASTL_HUMAN Astacin-like metalloendopeptidase OS=Homo sapiens GN=ASTL PE=1 SV=4 | 222 | Q | 0.453906 | R | 0.425158 | 0.028748 | No Change: Both O | - |
| Q6HA08 | ASTL_HUMAN Astacin-like metalloendopeptidase OS=Homo sapiens GN=ASTL PE=1 SV=4 | 277 | K | 0.462615 | Q | 0.477812 | -0.015197 | No Change: Both O | - |
| Q6HA08 | ASTL_HUMAN Astacin-like metalloendopeptidase OS=Homo sapiens GN=ASTL PE=1 SV=4 | 204 | R | 0.129612 | H | 0.11979 | 0.009822 | No Change: Both O | - |
| O14525 | ASTN1_HUMAN Astrotactin-1 OS=Homo sapiens GN=ASTN1 PE=1 SV=3 | 1270 | G | 0.326826 | R | 0.372402 | -0.045576 | No Change: Both O | - |
| O14525 | ASTN1_HUMAN Astrotactin-1 OS=Homo sapiens GN=ASTN1 PE=1 SV=3 | 1278 | R | 0.372681 | G | 0.351135 | 0.021546 | No Change: Both O | - |
| O75129 | ASTN2_HUMAN Astrotactin-2 OS=Homo sapiens GN=ASTN2 PE=2 SV=2 | 70 | V | 0.670276 | I | 0.651569 | 0.018707 | No Change: Both D | - |
| O75129 | ASTN2_HUMAN Astrotactin-2 OS=Homo sapiens GN=ASTN2 PE=2 SV=2 | 865 | R | 0.190855 | H | 0.180761 | 0.010094 | No Change: Both O | - |
| O75129 | ASTN2_HUMAN Astrotactin-2 OS=Homo sapiens GN=ASTN2 PE=2 SV=2 | 1149 | V | 0.329907 | I | 0.304149 | 0.025758 | No Change: Both O | - |
| O75129 | ASTN2_HUMAN Astrotactin-2 OS=Homo sapiens GN=ASTN2 PE=2 SV=2 | 1293 | V | 0.164182 | L | 0.166112 | -0.00193 | No Change: Both O | A breast cancer sample |
| O75129 | ASTN2_HUMAN Astrotactin-2 OS=Homo sapiens GN=ASTN2 PE=2 SV=2 | 229 | A | 0.12458 | V | 0.090944 | 0.033636 | No Change: Both O | - |
| Q8IXJ9 | ASXL1_HUMAN Putative Polycomb group protein ASXL1 OS=Homo sapiens GN=ASXL1 PE=1 SV=3 | 815 | L | 0.759692 | P | 0.864301 | -0.104609 | No Change: Both D | - |
| Q8IXJ9 | ASXL1_HUMAN Putative Polycomb group protein ASXL1 OS=Homo sapiens GN=ASXL1 PE=1 SV=3 | 1325 | L | 0.844879 | F | 0.836784 | 0.008095 | No Change: Both D | - |
| Q8IXJ9 | ASXL1_HUMAN Putative Polycomb group protein ASXL1 OS=Homo sapiens GN=ASXL1 PE=1 SV=3 | 751 | V | 0.804779 | I | 0.758436 | 0.046343 | No Change: Both D | - |
| Q8IXJ9 | ASXL1_HUMAN Putative Polycomb group protein ASXL1 OS=Homo sapiens GN=ASXL1 PE=1 SV=3 | 983 | L | 0.629749 | R | 0.709849 | -0.0801 | No Change: Both D | - |
| Q76L83 | ASXL2_HUMAN Putative Polycomb group protein ASXL2 OS=Homo sapiens GN=ASXL2 PE=1 SV=1 | 731 | L | 0.981824 | P | 0.989891 | -0.008067 | No Change: Both D | - |
| Q76L83 | ASXL2_HUMAN Putative Polycomb group protein ASXL2 OS=Homo sapiens GN=ASXL2 PE=1 SV=1 | 796 | A | 0.863423 | V | 0.834222 | 0.029201 | No Change: Both D | - |
| Q76L83 | ASXL2_HUMAN Putative Polycomb group protein ASXL2 OS=Homo sapiens GN=ASXL2 PE=1 SV=1 | 1210 | T | 0.952584 | P | 0.960468 | -0.007884 | No Change: Both D | - |
| Q76L83 | ASXL2_HUMAN Putative Polycomb group protein ASXL2 OS=Homo sapiens GN=ASXL2 PE=1 SV=1 | 1242 | T | 0.543769 | P | 0.573014 | -0.029245 | No Change: Both D | - |
| Q9C0F0 | ASXL3_HUMAN Putative Polycomb group protein ASXL3 OS=Homo sapiens GN=ASXL3 PE=2 SV=3 | 954 | N | 0.98891 | S | 0.993461 | -0.004551 | No Change: Both D | - |
| Q9C0F0 | ASXL3_HUMAN Putative Polycomb group protein ASXL3 OS=Homo sapiens GN=ASXL3 PE=2 SV=3 | 1415 | M | 0.352031 | R | 0.365995 | -0.013964 | No Change: Both O | - |
| Q9C0F0 | ASXL3_HUMAN Putative Polycomb group protein ASXL3 OS=Homo sapiens GN=ASXL3 PE=2 SV=3 | 1652 | V | 0.443409 | M | 0.498355 | -0.054946 | No Change: Both O | - |
| Q9C0F0 | ASXL3_HUMAN Putative Polycomb group protein ASXL3 OS=Homo sapiens GN=ASXL3 PE=2 SV=3 | 1708 | M | 0.935091 | V | 0.909185 | 0.025906 | No Change: Both D | - |
| Q8WWH4 | ASZ1_HUMAN Ankyrin repeat SAM and basic leucine zipper domain-containing protein 1 OS=Homo sapiens GN=ASZ1 PE=2 SV=1 | 216 | K | 0.631287 | T | 0.565657 | 0.06563 | No Change: Both D | - |
| Q8NBU5 | ATAD1_HUMAN ATPase family AAA domain-containing protein 1 OS=Homo sapiens GN=ATAD1 PE=1 SV=1 | 107 | V | 0.190355 | I | 0.18015 | 0.010205 | No Change: Both O | A colorectal cancer sample |
| Q6PL18 | ATAD2_HUMAN ATPase family AAA domain-containing protein 2 OS=Homo sapiens GN=ATAD2 PE=1 SV=1 | 1280 | I | 0.699391 | T | 0.776372 | -0.076981 | No Change: Both D | - |
| Q9ULI0 | ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens GN=ATAD2B PE=1 SV=3 | 118 | S | 0.920245 | P | 0.917613 | 0.002632 | No Change: Both D | - |
| Q9NVI7 | ATD3A_HUMAN ATPase family AAA domain-containing protein 3A OS=Homo sapiens GN=ATAD3A PE=1 SV=2 | 15 | G | 0.966244 | D | 0.955827 | 0.010417 | No Change: Both D | - |
| Q9NVI7 | ATD3A_HUMAN ATPase family AAA domain-containing protein 3A OS=Homo sapiens GN=ATAD3A PE=1 SV=2 | 101 | S | 0.343427 | N | 0.273477 | 0.06995 | No Change: Both O | - |
| Q5T9A4 | ATD3B_HUMAN ATPase family AAA domain-containing protein 3B OS=Homo sapiens GN=ATAD3B PE=1 SV=1 | 7 | V | 0.946543 | I | 0.942138 | 0.004405 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 35 | T | 0.861707 | S | 0.881895 | -0.020188 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 87 | P | 0.896072 | S | 0.896902 | -8.30E-04 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 135 | E | 0.801363 | G | 0.709285 | 0.092078 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 249 | R | 0.739777 | K | 0.790158 | -0.050381 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 699 | N | 0.893313 | H | 0.884033 | 0.00928 | No Change: Both D | - |
| Q96QE3 | ATAD5_HUMAN ATPase family AAA domain-containing protein 5 OS=Homo sapiens GN=ATAD5 PE=1 SV=4 | 1419 | Y | 0.347776 | H | 0.468834 | -0.121058 | No Change: Both O | - |
| Q86WG3 | ATCAY_HUMAN Caytaxin OS=Homo sapiens GN=ATCAY PE=1 SV=2 | 301 | S | 0.21644 | R | 0.169156 | 0.047284 | No Change: Both O | Cerebellar ataxia cayman type (ATCAY) [MIM:601238] |
| P18846 | ATF1_HUMAN Cyclic AMP-dependent transcription factor ATF-1 OS=Homo sapiens GN=ATF1 PE=1 SV=2 | 191 | P | 0.854952 | A | 0.78837 | 0.066582 | No Change: Both D | - |
| P15336 | ATF2_HUMAN Cyclic AMP-dependent transcription factor ATF-2 OS=Homo sapiens GN=ATF2 PE=1 SV=4 | 352 | D | 0.975905 | H | 0.969069 | 0.006836 | No Change: Both D | A breast cancer sample |
| P18847 | ATF3_HUMAN Cyclic AMP-dependent transcription factor ATF-3 OS=Homo sapiens GN=ATF3 PE=1 SV=2 | 38 | T | 0.213338 | M | 0.205137 | 0.008201 | No Change: Both O | - |
| P18848 | ATF4_HUMAN Cyclic AMP-dependent transcription factor ATF-4 OS=Homo sapiens GN=ATF4 PE=1 SV=3 | 322 | E | 0.891929 | D | 0.870581 | 0.021348 | No Change: Both D | - |
| P18848 | ATF4_HUMAN Cyclic AMP-dependent transcription factor ATF-4 OS=Homo sapiens GN=ATF4 PE=1 SV=3 | 22 | Q | 0.633684 | P | 0.693052 | -0.059368 | No Change: Both D | - |
| P18848 | ATF4_HUMAN Cyclic AMP-dependent transcription factor ATF-4 OS=Homo sapiens GN=ATF4 PE=1 SV=3 | 258 | P | 0.953471 | A | 0.927933 | 0.025538 | No Change: Both D | - |
| Q9Y2D1 | ATF5_HUMAN Cyclic AMP-dependent transcription factor ATF-5 OS=Homo sapiens GN=ATF5 PE=1 SV=4 | 121 | P | 0.997812 | L | 0.996028 | 0.001784 | No Change: Both D | - |
| P18850 | ATF6A_HUMAN Cyclic AMP-dependent transcription factor ATF-6 alpha OS=Homo sapiens GN=ATF6 PE=1 SV=3 | 67 | M | 0.210864 | L | 0.190486 | 0.020378 | No Change: Both O | - |
| P18850 | ATF6A_HUMAN Cyclic AMP-dependent transcription factor ATF-6 alpha OS=Homo sapiens GN=ATF6 PE=1 SV=3 | 67 | M | 0.210864 | V | 0.160929 | 0.049935 | No Change: Both O | - |
| P18850 | ATF6A_HUMAN Cyclic AMP-dependent transcription factor ATF-6 alpha OS=Homo sapiens GN=ATF6 PE=1 SV=3 | 145 | A | 0.968789 | P | 0.984319 | -0.01553 | No Change: Both D | - |
| P18850 | ATF6A_HUMAN Cyclic AMP-dependent transcription factor ATF-6 alpha OS=Homo sapiens GN=ATF6 PE=1 SV=3 | 157 | P | 0.965137 | S | 0.963499 | 0.001638 | No Change: Both D | - |
| Q6VMQ6 | MCAF1_HUMAN Activating transcription factor 7-interacting protein 1 OS=Homo sapiens GN=ATF7IP PE=1 SV=3 | 278 | E | 0.928137 | K | 0.915087 | 0.01305 | No Change: Both D | - |
| Q6VMQ6 | MCAF1_HUMAN Activating transcription factor 7-interacting protein 1 OS=Homo sapiens GN=ATF7IP PE=1 SV=3 | 348 | N | 0.959341 | I | 0.936196 | 0.023145 | No Change: Both D | - |
| Q6VMQ6 | MCAF1_HUMAN Activating transcription factor 7-interacting protein 1 OS=Homo sapiens GN=ATF7IP PE=1 SV=3 | 530 | K | 0.995447 | R | 0.994665 | 7.82E-04 | No Change: Both D | - |
| Q5U623 | MCAF2_HUMAN Activating transcription factor 7-interacting protein 2 OS=Homo sapiens GN=ATF7IP2 PE=1 SV=2 | 537 | T | 0.958197 | I | 0.92652 | 0.031677 | No Change: Both D | - |
| Q5U623 | MCAF2_HUMAN Activating transcription factor 7-interacting protein 2 OS=Homo sapiens GN=ATF7IP2 PE=1 SV=2 | 543 | A | 0.959627 | T | 0.964638 | -0.005011 | No Change: Both D | - |
| Q5U623 | MCAF2_HUMAN Activating transcription factor 7-interacting protein 2 OS=Homo sapiens GN=ATF7IP2 PE=1 SV=2 | 527 | S | 0.933196 | L | 0.886284 | 0.046912 | No Change: Both D | - |
| Q9H0Y0 | ATG10_HUMAN Ubiquitin-like-conjugating enzyme ATG10 OS=Homo sapiens GN=ATG10 PE=1 SV=1 | 212 | T | 0.630335 | M | 0.587404 | 0.042931 | No Change: Both D | - |
| Q9H0Y0 | ATG10_HUMAN Ubiquitin-like-conjugating enzyme ATG10 OS=Homo sapiens GN=ATG10 PE=1 SV=1 | 220 | P | 0.896014 | H | 0.95107 | -0.055056 | No Change: Both D | - |
| Q9H0Y0 | ATG10_HUMAN Ubiquitin-like-conjugating enzyme ATG10 OS=Homo sapiens GN=ATG10 PE=1 SV=1 | 62 | S | 0.50332 | P | 0.47136 | 0.03196 | D to O | - |
| Q6ZNE5 | BAKOR_HUMAN Beclin 1-associated autophagy-related key regulator OS=Homo sapiens GN=ATG14 PE=1 SV=1 | 131 | N | 0.858612 | K | 0.890233 | -0.031621 | No Change: Both D | - |
| Q6ZNE5 | BAKOR_HUMAN Beclin 1-associated autophagy-related key regulator OS=Homo sapiens GN=ATG14 PE=1 SV=1 | 59 | V | 0.30277 | I | 0.266121 | 0.036649 | No Change: Both O | - |
| Q676U5 | A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens GN=ATG16L1 PE=1 SV=2 | 300 | T | 0.640804 | A | 0.617525 | 0.023279 | No Change: Both D | - |
| Q676U5 | A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens GN=ATG16L1 PE=1 SV=2 | 307 | E | 0.543186 | K | 0.557379 | -0.014193 | No Change: Both D | - |
| Q8NAA4 | A16L2_HUMAN Autophagy-related protein 16-2 OS=Homo sapiens GN=ATG16L2 PE=2 SV=2 | 220 | R | 0.950185 | W | 0.862716 | 0.087469 | No Change: Both D | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 175 | V | 0.237217 | I | 0.19466 | 0.042557 | No Change: Both O | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 627 | A | 0.743663 | V | 0.666472 | 0.077191 | No Change: Both D | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 948 | G | 0.58626 | R | 0.580005 | 0.006255 | No Change: Both D | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 394 | R | 0.915656 | C | 0.854436 | 0.06122 | No Change: Both D | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 404 | A | 0.892084 | V | 0.848493 | 0.043591 | No Change: Both D | - |
| Q2TAZ0 | ATG2A_HUMAN Autophagy-related protein 2 homolog A OS=Homo sapiens GN=ATG2A PE=1 SV=3 | 656 | P | 0.773626 | R | 0.757517 | 0.016109 | No Change: Both D | - |
| Q96BY7 | ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens GN=ATG2B PE=1 SV=5 | 1383 | Q | 0.752656 | E | 0.746492 | 0.006164 | No Change: Both D | - |
| Q96BY7 | ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens GN=ATG2B PE=1 SV=5 | 1567 | I | 0.395231 | T | 0.536359 | -0.141128 | O to D | - |
| Q96BY7 | ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens GN=ATG2B PE=1 SV=5 | 1124 | N | 0.164298 | D | 0.185003 | -0.020705 | No Change: Both O | - |
| Q9Y4P1 | ATG4B_HUMAN Cysteine protease ATG4B OS=Homo sapiens GN=ATG4B PE=1 SV=2 | 354 | L | 0.351416 | Q | 0.462433 | -0.111017 | No Change: Both O | - |
| Q9H1Y0 | ATG5_HUMAN Autophagy protein 5 OS=Homo sapiens GN=ATG5 PE=1 SV=2 | 58 | K | 0.470202 | M | 0.324878 | 0.145324 | No Change: Both O | A colorectal cancer sample |
| O95352 | ATG7_HUMAN Ubiquitin-like modifier-activating enzyme ATG7 OS=Homo sapiens GN=ATG7 PE=1 SV=1 | 471 | V | 0.133728 | A | 0.17171 | -0.037982 | No Change: Both O | - |
| Q7Z3C6 | ATG9A_HUMAN Autophagy-related protein 9A OS=Homo sapiens GN=ATG9A PE=1 SV=3 | 592 | S | 0.501669 | G | 0.462115 | 0.039554 | D to O | - |
| Q7Z3C6 | ATG9A_HUMAN Autophagy-related protein 9A OS=Homo sapiens GN=ATG9A PE=1 SV=3 | 659 | Q | 0.921528 | H | 0.906394 | 0.015134 | No Change: Both D | - |
| Q674R7 | ATG9B_HUMAN Autophagy-related protein 9B OS=Homo sapiens GN=ATG9B PE=2 SV=1 | 166 | P | 0.857393 | L | 0.782354 | 0.075039 | No Change: Both D | - |
| P31939 | PUR9_HUMAN Bifunctional purine biosynthesis protein PURH OS=Homo sapiens GN=ATIC PE=1 SV=3 | 116 | T | 0.428216 | S | 0.528079 | -0.099863 | O to D | - |
| P31939 | PUR9_HUMAN Bifunctional purine biosynthesis protein PURH OS=Homo sapiens GN=ATIC PE=1 SV=3 | 426 | K | 0.185913 | R | 0.146249 | 0.039664 | No Change: Both O | AICA-ribosuria (AICAR) [MIM:608688] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 217 | R | 0.049969 | Q | 0.056955 | -0.006986 | No Change: Both O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 239 | R | 0.508564 | C | 0.31914 | 0.189424 | D to O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 258 | H | 0.199399 | R | 0.208225 | -0.008826 | No Change: Both O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 259 | S | 0.172606 | Y | 0.0708 | 0.101806 | No Change: Both O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 161 | A | 0.398001 | P | 0.462832 | -0.064831 | No Change: Both O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 247 | H | 0.651532 | P | 0.663368 | -0.011836 | No Change: Both D | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 43 | D | 0.348859 | E | 0.380263 | -0.031404 | No Change: Both O | - |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 193 | F | 0.193512 | C | 0.183422 | 0.01009 | No Change: Both O | - |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 66 | E | 0.397526 | Q | 0.33674 | 0.060786 | No Change: Both O | Hereditary sensory neuropathy type 1D (HSN1D) [MIM:613708] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 157 | L | 0.524927 | W | 0.44523 | 0.079697 | D to O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 355 | N | 0.441048 | K | 0.476496 | -0.035448 | No Change: Both O | Hereditary sensory neuropathy type 1D (HSN1D) [MIM:613708] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 408 | M | 0.589554 | V | 0.546767 | 0.042787 | No Change: Both D | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8WXF7 | ATLA1_HUMAN Atlastin-1 OS=Homo sapiens GN=ATL1 PE=1 SV=1 | 415 | R | 0.485104 | W | 0.254535 | 0.230569 | No Change: Both O | Spastic paraplegia autosomal dominant type 3 (SPG3) [MIM:182600] |
| Q8NHH9 | ATLA2_HUMAN Atlastin-2 OS=Homo sapiens GN=ATL2 PE=1 SV=2 | 18 | W | 0.793889 | R | 0.930416 | -0.136527 | No Change: Both D | - |
| Q8NHH9 | ATLA2_HUMAN Atlastin-2 OS=Homo sapiens GN=ATL2 PE=1 SV=2 | 272 | N | 0.64357 | S | 0.66915 | -0.02558 | No Change: Both D | - |
| Q8NHH9 | ATLA2_HUMAN Atlastin-2 OS=Homo sapiens GN=ATL2 PE=1 SV=2 | 420 | D | 0.43919 | H | 0.392497 | 0.046693 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 49 | S | 0.542473 | C | 0.419974 | 0.122499 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 126 | D | 0.274064 | E | 0.290383 | -0.016319 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 182 | V | 0.254946 | L | 0.253804 | 0.001142 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 224 | K | 0.652131 | E | 0.664045 | -0.011914 | No Change: Both D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 292 | P | 0.45963 | L | 0.303801 | 0.155829 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 323 | I | 0.253995 | V | 0.28271 | -0.028715 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 332 | Y | 0.644467 | C | 0.588531 | 0.055936 | No Change: Both D | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 350 | A | 0.121883 | T | 0.147676 | -0.025793 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 352 | I | 0.13044 | T | 0.203724 | -0.073284 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 514 | G | 0.140085 | D | 0.154653 | -0.014568 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 570 | F | 0.377043 | S | 0.61747 | -0.240427 | O to D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 707 | S | 0.61029 | P | 0.556689 | 0.053601 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 768 | N | 0.63668 | D | 0.594101 | 0.042579 | No Change: Both D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 785 | R | 0.426108 | C | 0.355001 | 0.071107 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 858 | F | 0.871659 | L | 0.893121 | -0.021462 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 950 | L | 0.401829 | R | 0.475158 | -0.073329 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1001 | L | 0.51281 | Q | 0.646033 | -0.133223 | No Change: Both D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1040 | M | 0.042005 | V | 0.034384 | 0.007621 | No Change: Both O | B-cell non-Hodgkin lymphoma |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1054 | P | 0.201462 | R | 0.172596 | 0.028866 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1082 | H | 0.268061 | L | 0.172138 | 0.095923 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1091 | E | 0.271607 | D | 0.263686 | 0.007921 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1407 | I | 0.448186 | T | 0.55905 | -0.110864 | O to D | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1420 | L | 0.100131 | F | 0.080756 | 0.019375 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1420 | L | 0.100131 | P | 0.187023 | -0.086892 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1454 | K | 0.328854 | N | 0.2703 | 0.058554 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1463 | F | 0.037039 | S | 0.104144 | -0.067105 | No Change: Both O | B-cell non-Hodgkin lymphoma |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1465 | L | 0.023114 | P | 0.047333 | -0.024219 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1566 | P | 0.177593 | R | 0.146332 | 0.031261 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1570 | V | 0.155148 | A | 0.200664 | -0.045516 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1682 | D | 0.177089 | H | 0.15932 | 0.017769 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1691 | S | 0.531825 | R | 0.443716 | 0.088109 | D to O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1691 | S | 0.531825 | R | 0.443716 | 0.088109 | D to O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1743 | T | 0.218679 | I | 0.125851 | 0.092828 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1853 | D | 0.260845 | N | 0.251637 | 0.009208 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1853 | D | 0.260845 | V | 0.136475 | 0.12437 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1910 | L | 0.278971 | H | 0.373048 | -0.094077 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1913 | V | 0.231571 | G | 0.333593 | -0.102022 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1953 | T | 0.08661 | R | 0.095254 | -0.008644 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2016 | D | 0.46115 | G | 0.465465 | -0.004315 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2063 | G | 0.310766 | E | 0.363794 | -0.053028 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2067 | A | 0.146935 | D | 0.191924 | -0.044989 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2079 | V | 0.066725 | I | 0.062583 | 0.004142 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2139 | E | 0.46539 | G | 0.375066 | 0.090324 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2164 | E | 0.451045 | K | 0.4373 | 0.013745 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2218 | S | 0.364757 | C | 0.18026 | 0.184497 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2227 | R | 0.129463 | C | 0.08247 | 0.046993 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2274 | A | 0.199261 | T | 0.232597 | -0.033336 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2287 | G | 0.251123 | A | 0.221326 | 0.029797 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2396 | T | 0.506167 | S | 0.638176 | -0.132009 | No Change: Both D | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2420 | A | 0.575594 | P | 0.628107 | -0.052513 | No Change: Both D | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2423 | E | 0.585654 | G | 0.499201 | 0.086453 | D to O | Mantle cell lymphoma |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2424 | V | 0.575042 | G | 0.68184 | -0.106798 | No Change: Both D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2424 | V | 0.575042 | G | 0.68184 | -0.106798 | No Change: Both D | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2438 | T | 0.502859 | I | 0.379502 | 0.123357 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2442 | Q | 0.458803 | P | 0.451622 | 0.007181 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2470 | Y | 0.097583 | D | 0.20041 | -0.102827 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2486 | R | 0.04056 | G | 0.040803 | -2.43E-04 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2491 | W | 0.115786 | R | 0.251168 | -0.135382 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2554 | H | 0.234357 | D | 0.255362 | -0.021005 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2625 | D | 0.09915 | Q | 0.100818 | -0.001668 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2656 | L | 0.378111 | P | 0.565774 | -0.187663 | O to D | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2668 | E | 0.32777 | G | 0.274336 | 0.053434 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2695 | G | 0.164454 | A | 0.134527 | 0.029927 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2695 | G | 0.164454 | A | 0.134527 | 0.029927 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2702 | I | 0.199325 | R | 0.332837 | -0.133512 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2722 | L | 0.587266 | R | 0.716282 | -0.129016 | No Change: Both D | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2725 | D | 0.525373 | G | 0.475799 | 0.049574 | D to O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2725 | D | 0.525373 | V | 0.362469 | 0.162904 | D to O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2726 | A | 0.497615 | V | 0.483781 | 0.013834 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2732 | F | 0.393186 | L | 0.480313 | -0.087127 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2765 | G | 0.199814 | S | 0.249973 | -0.050159 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2824 | C | 0.194026 | Y | 0.188366 | 0.00566 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2827 | F | 0.163776 | C | 0.174228 | -0.010452 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2829 | P | 0.134468 | L | 0.072783 | 0.061685 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2832 | R | 0.077816 | C | 0.054541 | 0.023275 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2849 | R | 0.129443 | P | 0.147596 | -0.018153 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2855 | S | 0.337035 | R | 0.266803 | 0.070232 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2867 | G | 0.144883 | R | 0.133484 | 0.011399 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2890 | L | 0.121271 | V | 0.125416 | -0.004145 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2904 | E | 0.346489 | G | 0.301292 | 0.045197 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2909 | R | 0.236899 | G | 0.233831 | 0.003068 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 3006 | A | 0.382795 | P | 0.485573 | -0.102778 | No Change: Both O | T-prolymphocytic leukemia |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 3008 | R | 0.339071 | C | 0.219018 | 0.120053 | No Change: Both O | Ataxia telangiectasia (AT) [MIM:208900] |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 3008 | R | 0.339071 | H | 0.290947 | 0.048124 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 3018 | K | 0.477082 | N | 0.437147 | 0.039935 | No Change: Both O | B-cell chronic lymphocytic leukemia (BCLL) |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 23 | R | 0.695871 | Q | 0.679818 | 0.016053 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 140 | D | 0.158779 | H | 0.133779 | 0.025 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 250 | R | 0.053089 | Q | 0.054143 | -0.001054 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 333 | S | 0.588712 | F | 0.353182 | 0.23553 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 337 | R | 0.316241 | C | 0.170045 | 0.146196 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 337 | R | 0.316241 | H | 0.31305 | 0.003191 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 410 | V | 0.100473 | A | 0.146626 | -0.046153 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 504 | N | 0.258582 | S | 0.305043 | -0.046461 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 540 | C | 0.062644 | Y | 0.059749 | 0.002895 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 546 | L | 0.09834 | V | 0.098331 | 9.00E-06 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 582 | F | 0.068782 | L | 0.087449 | -0.018667 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 848 | E | 0.838309 | Q | 0.816033 | 0.022276 | No Change: Both D | A lung adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 872 | P | 0.762245 | S | 0.77755 | -0.015305 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 924 | R | 0.205599 | W | 0.077696 | 0.127903 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 935 | T | 0.531526 | A | 0.481752 | 0.049774 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1179 | S | 0.299451 | F | 0.151362 | 0.148089 | No Change: Both O | A gastric adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1321 | M | 0.354238 | I | 0.258592 | 0.095646 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1380 | H | 0.608344 | Y | 0.488733 | 0.119611 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1382 | P | 0.563309 | S | 0.562807 | 5.02E-04 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1469 | I | 0.023538 | M | 0.033812 | -0.010274 | No Change: Both O | A renal papillary cancer sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1475 | Y | 0.074651 | C | 0.058297 | 0.016354 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1650 | N | 0.156241 | S | 0.189586 | -0.033345 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1739 | N | 0.177365 | T | 0.167736 | 0.009629 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1916 | M | 0.354891 | I | 0.263658 | 0.091233 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1945 | A | 0.219348 | T | 0.227106 | -0.007758 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1961 | Y | 0.311239 | C | 0.278328 | 0.032911 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1983 | N | 0.823747 | S | 0.88266 | -0.058913 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1991 | E | 0.878999 | D | 0.861386 | 0.017613 | No Change: Both D | A renal clear cell carcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2307 | L | 0.312289 | F | 0.267059 | 0.04523 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2332 | L | 0.229761 | P | 0.357417 | -0.127656 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2356 | I | 0.118701 | F | 0.122545 | -0.003844 | No Change: Both O | A renal clear cell carcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2408 | S | 0.648859 | L | 0.49994 | 0.148919 | D to O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2443 | R | 0.450563 | Q | 0.455908 | -0.005345 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2464 | C | 0.147287 | R | 0.284829 | -0.137542 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2492 | L | 0.166872 | R | 0.2515 | -0.084628 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2666 | T | 0.255502 | A | 0.223814 | 0.031688 | No Change: Both O | A lung adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2719 | R | 0.627447 | H | 0.556059 | 0.071388 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2842 | P | 0.072732 | R | 0.063779 | 0.008953 | No Change: Both O | A lung adenocarcinoma sample |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2870 | D | 0.146964 | N | 0.147258 | -2.94E-04 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 45 | R | 0.593228 | W | 0.459406 | 0.133822 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 761 | T | 0.427718 | S | 0.516958 | -0.08924 | O to D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 788 | S | 0.469483 | R | 0.428784 | 0.040699 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 814 | D | 0.360186 | E | 0.357026 | 0.00316 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 935 | T | 0.531526 | M | 0.496071 | 0.035455 | D to O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 942 | L | 0.492476 | F | 0.424982 | 0.067494 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1313 | E | 0.551631 | Q | 0.526724 | 0.024907 | No Change: Both D | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1427 | A | 0.270854 | T | 0.291328 | -0.020474 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1541 | L | 0.095083 | F | 0.073852 | 0.021231 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 1729 | V | 0.16897 | L | 0.161172 | 0.007798 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2034 | R | 0.260726 | Q | 0.275642 | -0.014916 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2335 | T | 0.128126 | K | 0.174887 | -0.046761 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2570 | E | 0.420592 | G | 0.34855 | 0.072042 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2640 | T | 0.318466 | I | 0.213437 | 0.105029 | No Change: Both O | - |
| Q13315 | ATM_HUMAN Serine-protein kinase ATM OS=Homo sapiens GN=ATM PE=1 SV=3 | 2709 | G | 0.546711 | S | 0.590253 | -0.043542 | No Change: Both D | - |
| O43313 | ATMIN_HUMAN ATM interactor OS=Homo sapiens GN=ATMIN PE=1 SV=2 | 240 | S | 0.942121 | P | 0.946292 | -0.004171 | No Change: Both D | - |
| O43313 | ATMIN_HUMAN ATM interactor OS=Homo sapiens GN=ATMIN PE=1 SV=2 | 305 | K | 0.545662 | E | 0.476603 | 0.069059 | D to O | - |
| P54259 | ATN1_HUMAN Atrophin-1 OS=Homo sapiens GN=ATN1 PE=1 SV=3 | 339 | M | 0.994487 | I | 0.989581 | 0.004906 | No Change: Both D | - |
| Q92858 | ATOH1_HUMAN Protein atonal homolog 1 OS=Homo sapiens GN=ATOH1 PE=2 SV=1 | 237 | H | 0.894419 | Q | 0.911485 | -0.017066 | No Change: Both D | - |
| Q96SQ7 | ATOH8_HUMAN Protein atonal homolog 8 OS=Homo sapiens GN=ATOH8 PE=2 SV=2 | 150 | L | 0.997666 | P | 0.998905 | -0.001239 | No Change: Both D | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 532 | T | 0.860126 | M | 0.870624 | -0.010498 | No Change: Both D | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 784 | A | 0.528162 | T | 0.556918 | -0.028756 | No Change: Both D | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1172 | W | 0.102126 | C | 0.122691 | -0.020565 | No Change: Both O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1179 | A | 0.091425 | T | 0.096088 | -0.004663 | No Change: Both O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1188 | I | 0.044482 | V | 0.055387 | -0.010905 | No Change: Both O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1298 | R | 0.411246 | S | 0.434616 | -0.02337 | No Change: Both O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 353 | S | 0.618484 | Y | 0.394336 | 0.224148 | D to O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 834 | E | 0.690504 | K | 0.668155 | 0.022349 | No Change: Both D | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1198 | V | 0.113738 | M | 0.149437 | -0.035699 | No Change: Both O | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 1397 | A | 0.951512 | V | 0.937807 | 0.013705 | No Change: Both D | - |
| O60312 | AT10A_HUMAN Probable phospholipid-transporting ATPase VA OS=Homo sapiens GN=ATP10A PE=2 SV=2 | 504 | R | 0.965846 | H | 0.958727 | 0.007119 | No Change: Both D | - |
| O94823 | AT10B_HUMAN Probable phospholipid-transporting ATPase VB OS=Homo sapiens GN=ATP10B PE=2 SV=2 | 217 | C | 0.261221 | R | 0.411005 | -0.149784 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 1240 | V | 0.01927 | I | 0.016919 | 0.002351 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 1389 | S | 0.657195 | T | 0.564359 | 0.092836 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 43 | T | 0.678202 | I | 0.620821 | 0.057381 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 171 | C | 0.13325 | R | 0.262164 | -0.128914 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 320 | T | 0.137689 | I | 0.076595 | 0.061094 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 337 | A | 0.061051 | T | 0.074741 | -0.01369 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 511 | N | 0.840087 | S | 0.868644 | -0.028557 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 522 | F | 0.824272 | L | 0.850988 | -0.026716 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 716 | P | 0.581333 | T | 0.505212 | 0.076121 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 720 | N | 0.472192 | S | 0.539603 | -0.067411 | O to D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 959 | S | 0.396204 | N | 0.346966 | 0.049238 | No Change: Both O | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 1183 | R | 0.540884 | K | 0.629772 | -0.088888 | No Change: Both D | - |
| Q9P241 | AT10D_HUMAN Probable phospholipid-transporting ATPase VD OS=Homo sapiens GN=ATP10D PE=2 SV=3 | 1392 | A | 0.677882 | G | 0.69728 | -0.019398 | No Change: Both D | - |
| P98196 | AT11A_HUMAN Probable phospholipid-transporting ATPase IH OS=Homo sapiens GN=ATP11A PE=2 SV=3 | 1091 | V | 0.145194 | I | 0.124446 | 0.020748 | No Change: Both O | - |
| P98196 | AT11A_HUMAN Probable phospholipid-transporting ATPase IH OS=Homo sapiens GN=ATP11A PE=2 SV=3 | 317 | M | 0.126598 | V | 0.103813 | 0.022785 | No Change: Both O | - |
| Q8NB49 | AT11C_HUMAN Probable phospholipid-transporting ATPase IG OS=Homo sapiens GN=ATP11C PE=1 SV=3 | 114 | C | 0.274388 | W | 0.243178 | 0.03121 | No Change: Both O | - |
| Q8NB49 | AT11C_HUMAN Probable phospholipid-transporting ATPase IG OS=Homo sapiens GN=ATP11C PE=1 SV=3 | 157 | T | 0.20459 | I | 0.123066 | 0.081524 | No Change: Both O | A colorectal cancer sample |
| Q8NB49 | AT11C_HUMAN Probable phospholipid-transporting ATPase IG OS=Homo sapiens GN=ATP11C PE=1 SV=3 | 931 | Q | 0.17439 | P | 0.189447 | -0.015057 | No Change: Both O | A colorectal cancer sample |
| Q8NB49 | AT11C_HUMAN Probable phospholipid-transporting ATPase IG OS=Homo sapiens GN=ATP11C PE=1 SV=3 | 522 | Y | 0.362352 | C | 0.315944 | 0.046408 | No Change: Both O | - |
| Q8NB49 | AT11C_HUMAN Probable phospholipid-transporting ATPase IG OS=Homo sapiens GN=ATP11C PE=1 SV=3 | 972 | V | 0.052603 | M | 0.070203 | -0.0176 | No Change: Both O | - |
| P54707 | AT12A_HUMAN Potassium-transporting ATPase alpha chain 2 OS=Homo sapiens GN=ATP12A PE=2 SV=3 | 863 | P | 0.20117 | L | 0.114179 | 0.086991 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 12 | T | 0.855683 | M | 0.830827 | 0.024856 | No Change: Both D | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 49 | G | 0.038315 | S | 0.050413 | -0.012098 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 294 | R | 0.28475 | Q | 0.286661 | -0.001911 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 389 | P | 0.129201 | L | 0.067889 | 0.061312 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 504 | G | 0.149668 | R | 0.143073 | 0.006595 | No Change: Both O | Kufor-Rakeb syndrome (KRS) [MIM:606693] |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 533 | G | 0.286807 | R | 0.289973 | -0.003166 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 578 | V | 0.369897 | G | 0.503894 | -0.133997 | O to D | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 746 | A | 0.195127 | T | 0.233245 | -0.038118 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 762 | R | 0.195777 | W | 0.076671 | 0.119106 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 776 | V | 0.27446 | I | 0.257643 | 0.016817 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 946 | I | 0.040523 | F | 0.040246 | 2.77E-04 | No Change: Both O | - |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 182 | F | 0.115908 | L | 0.142552 | -0.026644 | No Change: Both O | Kufor-Rakeb syndrome (KRS) [MIM:606693] |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 877 | G | 0.235693 | R | 0.210997 | 0.024696 | No Change: Both O | Kufor-Rakeb syndrome (KRS) [MIM:606693] |
| Q9NQ11 | AT132_HUMAN Probable cation-transporting ATPase 13A2 OS=Homo sapiens GN=ATP13A2 PE=1 SV=2 | 1059 | L | 0.08937 | R | 0.140083 | -0.050713 | No Change: Both O | Kufor-Rakeb syndrome (KRS) [MIM:606693] |
| Q4VNC1 | AT134_HUMAN Probable cation-transporting ATPase 13A4 OS=Homo sapiens GN=ATP13A4 PE=2 SV=3 | 181 | I | 0.13857 | M | 0.185946 | -0.047376 | No Change: Both O | - |
| Q4VNC1 | AT134_HUMAN Probable cation-transporting ATPase 13A4 OS=Homo sapiens GN=ATP13A4 PE=2 SV=3 | 353 | V | 0.128961 | A | 0.181554 | -0.052593 | No Change: Both O | - |
| Q4VNC1 | AT134_HUMAN Probable cation-transporting ATPase 13A4 OS=Homo sapiens GN=ATP13A4 PE=2 SV=3 | 646 | E | 0.250229 | D | 0.224843 | 0.025386 | No Change: Both O | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 133 | E | 0.141884 | Q | 0.123871 | 0.018013 | No Change: Both O | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 739 | G | 0.398554 | S | 0.484171 | -0.085617 | No Change: Both O | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 1053 | I | 0.042711 | V | 0.047372 | -0.004661 | No Change: Both O | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 1131 | V | 0.073578 | A | 0.104196 | -0.030618 | No Change: Both O | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 1204 | K | 0.598858 | Q | 0.567726 | 0.031132 | No Change: Both D | - |
| Q4VNC0 | AT135_HUMAN Probable cation-transporting ATPase 13A5 OS=Homo sapiens GN=ATP13A5 PE=2 SV=1 | 96 | S | 0.093061 | Y | 0.040892 | 0.052169 | No Change: Both O | - |
| P05023 | AT1A1_HUMAN Sodium/potassium-transporting ATPase subunit alpha-1 OS=Homo sapiens GN=ATP1A1 PE=1 SV=1 | 47 | S | 0.84747 | I | 0.746769 | 0.100701 | No Change: Both D | - |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 378 | T | 0.451855 | N | 0.459416 | -0.007561 | No Change: Both O | Alternating hemiplegia of childhood (AHC) [MIM:104290] |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 689 | R | 0.277842 | Q | 0.316961 | -0.039119 | No Change: Both O | Familial hemiplegic migraine type 2 (FHM2) [MIM:602481] |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 731 | M | 0.350968 | T | 0.385091 | -0.034123 | No Change: Both O | Familial hemiplegic migraine type 2 (FHM2) [MIM:602481] |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 764 | L | 0.174747 | P | 0.295738 | -0.120991 | No Change: Both O | Familial hemiplegic migraine type 2 (FHM2) [MIM:602481] |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 887 | W | 0.246102 | R | 0.490165 | -0.244063 | No Change: Both O | Familial hemiplegic migraine type 2 (FHM2) [MIM:602481] |
| P50993 | AT1A2_HUMAN Sodium/potassium-transporting ATPase subunit alpha-2 OS=Homo sapiens GN=ATP1A2 PE=1 SV=1 | 715 | G | 0.417053 | R | 0.393566 | 0.023487 | No Change: Both O | Familial hemiplegic migraine type 2 (FHM2) [MIM:602481] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 274 | I | 0.220782 | T | 0.345917 | -0.125135 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 277 | E | 0.128648 | K | 0.126348 | 0.0023 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 613 | T | 0.332573 | M | 0.301697 | 0.030876 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 758 | I | 0.188577 | S | 0.395633 | -0.207056 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 780 | F | 0.058016 | L | 0.068071 | -0.010055 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| P13637 | AT1A3_HUMAN Sodium/potassium-transporting ATPase subunit alpha-3 OS=Homo sapiens GN=ATP1A3 PE=1 SV=3 | 801 | D | 0.078759 | Y | 0.035133 | 0.043626 | No Change: Both O | Dystonia type 12 (DYT12) [MIM:128235] |
| Q13733 | AT1A4_HUMAN Sodium/potassium-transporting ATPase subunit alpha-4 OS=Homo sapiens GN=ATP1A4 PE=1 SV=3 | 83 | G | 0.508098 | D | 0.517139 | -0.009041 | No Change: Both D | - |
| Q13733 | AT1A4_HUMAN Sodium/potassium-transporting ATPase subunit alpha-4 OS=Homo sapiens GN=ATP1A4 PE=1 SV=3 | 297 | E | 0.151192 | K | 0.142046 | 0.009146 | No Change: Both O | - |
| Q13733 | AT1A4_HUMAN Sodium/potassium-transporting ATPase subunit alpha-4 OS=Homo sapiens GN=ATP1A4 PE=1 SV=3 | 541 | M | 0.588411 | R | 0.618257 | -0.029846 | No Change: Both D | - |
| Q13733 | AT1A4_HUMAN Sodium/potassium-transporting ATPase subunit alpha-4 OS=Homo sapiens GN=ATP1A4 PE=1 SV=3 | 586 | M | 0.179694 | I | 0.126207 | 0.053487 | No Change: Both O | - |
| P14415 | AT1B2_HUMAN Sodium/potassium-transporting ATPase subunit beta-2 OS=Homo sapiens GN=ATP1B2 PE=1 SV=3 | 199 | T | 0.350904 | A | 0.343926 | 0.006978 | No Change: Both O | - |
| P14415 | AT1B2_HUMAN Sodium/potassium-transporting ATPase subunit beta-2 OS=Homo sapiens GN=ATP1B2 PE=1 SV=3 | 124 | Q | 0.469464 | L | 0.312177 | 0.157287 | No Change: Both O | - |
| Q9UN42 | AT1B4_HUMAN Protein ATP1B4 OS=Homo sapiens GN=ATP1B4 PE=2 SV=1 | 48 | V | 0.98995 | A | 0.992154 | -0.002204 | No Change: Both D | - |
| O14983 | AT2A1_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 OS=Homo sapiens GN=ATP2A1 PE=1 SV=1 | 789 | P | 0.050852 | L | 0.024772 | 0.02608 | No Change: Both O | Brody myopathy (BRM) [MIM:601003] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 23 | G | 0.578414 | E | 0.654059 | -0.075645 | No Change: Both D | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 39 | N | 0.604749 | T | 0.578993 | 0.025756 | No Change: Both D | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 65 | L | 0.017936 | S | 0.040651 | -0.022715 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 131 | R | 0.542233 | Q | 0.557841 | -0.015608 | No Change: Both D | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 160 | P | 0.328939 | L | 0.202871 | 0.126068 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 186 | S | 0.481726 | P | 0.468083 | 0.013643 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 211 | G | 0.321786 | D | 0.347342 | -0.025556 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 223 | V | 0.270253 | M | 0.344572 | -0.074319 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 268 | C | 0.008981 | F | 0.009584 | -6.03E-04 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 310 | G | 0.188114 | V | 0.115917 | 0.072197 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 318 | C | 0.079579 | R | 0.175058 | -0.095479 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 348 | I | 0.307564 | T | 0.480822 | -0.173258 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 412 | E | 0.079746 | G | 0.065946 | 0.0138 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 495 | S | 0.700878 | F | 0.503004 | 0.197874 | No Change: Both D | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 560 | C | 0.236703 | R | 0.403728 | -0.167025 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 675 | F | 0.282841 | S | 0.472736 | -0.189895 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 683 | K | 0.439776 | E | 0.454317 | -0.014541 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 702 | D | 0.401065 | N | 0.381565 | 0.0195 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 745 | A | 0.211667 | D | 0.2721 | -0.060433 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 765 | S | 0.112357 | L | 0.04645 | 0.065907 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 767 | N | 0.107183 | S | 0.14073 | -0.033547 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 769 | G | 0.087759 | R | 0.085755 | 0.002004 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 803 | A | 0.257256 | T | 0.290867 | -0.033611 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 838 | A | 0.016142 | P | 0.022782 | -0.00664 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 843 | V | 0.068376 | F | 0.05572 | 0.012656 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 875 | C | 0.384645 | G | 0.572632 | -0.187987 | O to D | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 920 | S | 0.524757 | Y | 0.314709 | 0.210048 | D to O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 943 | H | 0.044842 | R | 0.044927 | -8.50E-05 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 975 | P | 0.076059 | R | 0.063701 | 0.012358 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 357 | T | 0.432478 | K | 0.477804 | -0.045326 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 749 | G | 0.301098 | R | 0.303301 | -0.002203 | No Change: Both O | Darier disease (DD) [MIM:124200] |
| P16615 | AT2A2_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 OS=Homo sapiens GN=ATP2A2 PE=1 SV=1 | 602 | P | 0.317614 | L | 0.179674 | 0.13794 | No Change: Both O | Acrokeratosis verruciformis (AKV) [MIM:101900] |
| Q93084 | AT2A3_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3 PE=1 SV=2 | 674 | R | 0.399815 | H | 0.325143 | 0.074672 | No Change: Both O | A breast cancer sample |
| Q93084 | AT2A3_HUMAN Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 OS=Homo sapiens GN=ATP2A3 PE=1 SV=2 | 869 | Q | 0.10264 | H | 0.102371 | 2.69E-04 | No Change: Both O | - |
| P20020 | AT2B1_HUMAN Plasma membrane calcium-transporting ATPase 1 OS=Homo sapiens GN=ATP2B1 PE=1 SV=3 | 267 | M | 0.510159 | R | 0.551377 | -0.041218 | No Change: Both D | - |
| Q16720 | AT2B3_HUMAN Plasma membrane calcium-transporting ATPase 3 OS=Homo sapiens GN=ATP2B3 PE=1 SV=3 | 198 | I | 0.177632 | M | 0.249608 | -0.071976 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 304 | A | 0.142791 | T | 0.151059 | -0.008268 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 318 | L | 0.06171 | P | 0.123795 | -0.062085 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 641 | M | 0.366112 | R | 0.417372 | -0.05126 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 645 | G | 0.385713 | R | 0.357431 | 0.028282 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 709 | T | 0.154225 | M | 0.121212 | 0.033013 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 744 | P | 0.318879 | R | 0.266869 | 0.05201 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 201 | P | 0.599354 | L | 0.421462 | 0.177892 | D to O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 344 | C | 0.072365 | Y | 0.062197 | 0.010168 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 570 | T | 0.437778 | I | 0.32049 | 0.117288 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 490 | C | 0.280818 | F | 0.25336 | 0.027458 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 584 | L | 0.376168 | P | 0.515771 | -0.139603 | O to D | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 309 | G | 0.151905 | C | 0.068678 | 0.083227 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 341 | L | 0.072247 | P | 0.144786 | -0.072539 | No Change: Both O | Hailey-Hailey disease (HHD) [MIM:169600] |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 411 | C | 0.085945 | R | 0.171314 | -0.085369 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 580 | I | 0.361282 | V | 0.394587 | -0.033305 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 742 | D | 0.196779 | Y | 0.102167 | 0.094612 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 789 | G | 0.011786 | R | 0.013082 | -0.001296 | No Change: Both O | - |
| P98194 | AT2C1_HUMAN Calcium-transporting ATPase type 2C member 1 OS=Homo sapiens GN=ATP2C1 PE=1 SV=3 | 450 | A | 0.382269 | T | 0.405593 | -0.023324 | No Change: Both O | - |
| O75185 | AT2C2_HUMAN Calcium-transporting ATPase type 2C member 2 OS=Homo sapiens GN=ATP2C2 PE=1 SV=2 | 411 | G | 0.300131 | S | 0.343429 | -0.043298 | No Change: Both O | - |
| O75185 | AT2C2_HUMAN Calcium-transporting ATPase type 2C member 2 OS=Homo sapiens GN=ATP2C2 PE=1 SV=2 | 466 | M | 0.318272 | L | 0.248448 | 0.069824 | No Change: Both O | - |
| O75185 | AT2C2_HUMAN Calcium-transporting ATPase type 2C member 2 OS=Homo sapiens GN=ATP2C2 PE=1 SV=2 | 907 | L | 0.11015 | P | 0.19347 | -0.08332 | No Change: Both O | - |
| O75185 | AT2C2_HUMAN Calcium-transporting ATPase type 2C member 2 OS=Homo sapiens GN=ATP2C2 PE=1 SV=2 | 165 | M | 0.394859 | L | 0.354728 | 0.040131 | No Change: Both O | - |
| P20648 | ATP4A_HUMAN Potassium-transporting ATPase alpha chain 1 OS=Homo sapiens GN=ATP4A PE=2 SV=5 | 265 | V | 0.215065 | A | 0.2548 | -0.039735 | No Change: Both O | - |
| P25705 | ATPA_HUMAN ATP synthase subunit alpha mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1 SV=1 | 32 | A | 0.36596 | S | 0.478652 | -0.112692 | No Change: Both O | - |
| P25705 | ATPA_HUMAN ATP synthase subunit alpha mitochondrial OS=Homo sapiens GN=ATP5A1 PE=1 SV=1 | 223 | I | 0.255428 | V | 0.250656 | 0.004772 | No Change: Both O | - |
| P06576 | ATPB_HUMAN ATP synthase subunit beta mitochondrial OS=Homo sapiens GN=ATP5B PE=1 SV=3 | 274 | E | 0.545468 | Q | 0.515067 | 0.030401 | No Change: Both D | - |
| P56381 | ATP5E_HUMAN ATP synthase subunit epsilon mitochondrial OS=Homo sapiens GN=ATP5E PE=1 SV=2 | 12 | Y | 0.122796 | C | 0.099985 | 0.022811 | No Change: Both O | Mitochondrial complex V deficiency nuclear type 3 (MC5DN3) [MIM:614053] |
| P24539 | AT5F1_HUMAN ATP synthase subunit b mitochondrial OS=Homo sapiens GN=ATP5F1 PE=1 SV=2 | 152 | T | 0.586178 | N | 0.636765 | -0.050587 | No Change: Both D | - |
| P24539 | AT5F1_HUMAN ATP synthase subunit b mitochondrial OS=Homo sapiens GN=ATP5F1 PE=1 SV=2 | 152 | T | 0.586178 | M | 0.566727 | 0.019451 | No Change: Both D | - |
| Q06055 | AT5G2_HUMAN ATP synthase lipid-binding protein mitochondrial OS=Homo sapiens GN=ATP5G2 PE=2 SV=1 | 58 | S | 0.638263 | I | 0.399738 | 0.238525 | D to O | - |
| Q06055 | AT5G2_HUMAN ATP synthase lipid-binding protein mitochondrial OS=Homo sapiens GN=ATP5G2 PE=2 SV=1 | 141 | M | 0.26785 | K | 0.455214 | -0.187364 | No Change: Both O | - |
| P48201 | AT5G3_HUMAN ATP synthase lipid-binding protein mitochondrial OS=Homo sapiens GN=ATP5G3 PE=1 SV=1 | 93 | G | 0.252418 | E | 0.272825 | -0.020407 | No Change: Both O | - |
| P48047 | ATPO_HUMAN ATP synthase subunit O mitochondrial OS=Homo sapiens GN=ATP5O PE=1 SV=1 | 98 | K | 0.440747 | R | 0.392743 | 0.048004 | No Change: Both O | - |
| Q99766 | ATP5S_HUMAN ATP synthase subunit s mitochondrial OS=Homo sapiens GN=ATP5S PE=1 SV=3 | 18 | P | 0.265263 | L | 0.145892 | 0.119371 | No Change: Both O | - |
| Q9NW81 | AT5SL_HUMAN ATP synthase subunit s-like protein OS=Homo sapiens GN=ATP5SL PE=2 SV=3 | 9 | R | 0.175853 | C | 0.083123 | 0.09273 | No Change: Both O | - |
| Q9NW81 | AT5SL_HUMAN ATP synthase subunit s-like protein OS=Homo sapiens GN=ATP5SL PE=2 SV=3 | 23 | H | 0.19935 | R | 0.221198 | -0.021848 | No Change: Both O | - |
| Q9NW81 | AT5SL_HUMAN ATP synthase subunit s-like protein OS=Homo sapiens GN=ATP5SL PE=2 SV=3 | 34 | N | 0.703208 | S | 0.734989 | -0.031781 | No Change: Both D | - |
| Q9NW81 | AT5SL_HUMAN ATP synthase subunit s-like protein OS=Homo sapiens GN=ATP5SL PE=2 SV=3 | 230 | E | 0.305638 | K | 0.272014 | 0.033624 | No Change: Both O | - |
| Q9NW81 | AT5SL_HUMAN ATP synthase subunit s-like protein OS=Homo sapiens GN=ATP5SL PE=2 SV=3 | 159 | C | 0.169939 | S | 0.302079 | -0.13214 | No Change: Both O | - |
| O75787 | RENR_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=2 | 90 | P | 0.329608 | A | 0.249233 | 0.080375 | No Change: Both O | - |
| O75787 | RENR_HUMAN Renin receptor OS=Homo sapiens GN=ATP6AP2 PE=1 SV=2 | 290 | A | 0.634962 | P | 0.711277 | -0.076315 | No Change: Both D | - |
| Q9Y487 | VPP2_HUMAN V-type proton ATPase 116 kDa subunit a isoform 2 OS=Homo sapiens GN=ATP6V0A2 PE=1 SV=2 | 685 | R | 0.234992 | Q | 0.236752 | -0.00176 | No Change: Both O | - |
| Q9Y487 | VPP2_HUMAN V-type proton ATPase 116 kDa subunit a isoform 2 OS=Homo sapiens GN=ATP6V0A2 PE=1 SV=2 | 813 | A | 0.09548 | V | 0.061395 | 0.034085 | No Change: Both O | - |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 524 | P | 0.111817 | L | 0.052037 | 0.05978 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 580 | M | 0.016146 | T | 0.020236 | -0.00409 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 820 | G | 0.238594 | R | 0.214046 | 0.024548 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 2 | V | 0.794576 | A | 0.800799 | -0.006223 | No Change: Both D | - |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 175 | G | 0.11417 | D | 0.117666 | -0.003496 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 449 | R | 0.028595 | H | 0.03111 | -0.002515 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 807 | R | 0.061496 | Q | 0.07031 | -0.008814 | No Change: Both O | Distal renal tubular acidosis with preserved hearing (RTADR) [MIM:602722] |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 554 | F | 0.026578 | L | 0.03239 | -0.005812 | No Change: Both O | - |
| Q9HBG4 | VPP4_HUMAN V-type proton ATPase 116 kDa subunit a isoform 4 OS=Homo sapiens GN=ATP6V0A4 PE=1 SV=2 | 604 | H | 0.107952 | Q | 0.115938 | -0.007986 | No Change: Both O | - |
| Q99437 | VATO_HUMAN V-type proton ATPase 21 kDa proteolipid subunit OS=Homo sapiens GN=ATP6V0B PE=2 SV=1 | 155 | V | 0.043925 | M | 0.053656 | -0.009731 | No Change: Both O | A breast cancer sample |
| Q8N8Y2 | VA0D2_HUMAN V-type proton ATPase subunit d 2 OS=Homo sapiens GN=ATP6V0D2 PE=2 SV=1 | 272 | G | 0.159658 | R | 0.151454 | 0.008204 | No Change: Both O | - |
| Q8N8Y2 | VA0D2_HUMAN V-type proton ATPase subunit d 2 OS=Homo sapiens GN=ATP6V0D2 PE=2 SV=1 | 295 | E | 0.225539 | K | 0.212685 | 0.012854 | No Change: Both O | - |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 81 | L | 0.360563 | P | 0.521444 | -0.160881 | O to D | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 124 | R | 0.377693 | W | 0.184555 | 0.193138 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 174 | M | 0.30542 | R | 0.371893 | -0.066473 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 275 | T | 0.131009 | P | 0.158826 | -0.027817 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 316 | G | 0.412262 | E | 0.465186 | -0.052924 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 346 | P | 0.239768 | R | 0.203163 | 0.036605 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 364 | G | 0.230064 | S | 0.261314 | -0.03125 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 30 | T | 0.334705 | I | 0.210122 | 0.124583 | No Change: Both O | - |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 123 | G | 0.383446 | V | 0.26312 | 0.120326 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 157 | R | 0.430987 | C | 0.304627 | 0.12636 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 161 | E | 0.455854 | K | 0.436784 | 0.01907 | No Change: Both O | - |
| P15313 | VATB1_HUMAN V-type proton ATPase subunit B kidney isoform OS=Homo sapiens GN=ATP6V1B1 PE=1 SV=3 | 465 | R | 0.411104 | H | 0.422041 | -0.010937 | No Change: Both O | Distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300] |
| Q8NEY4 | VATC2_HUMAN V-type proton ATPase subunit C 2 OS=Homo sapiens GN=ATP6V1C2 PE=2 SV=2 | 143 | N | 0.436012 | D | 0.441259 | -0.005247 | No Change: Both O | - |
| P36543 | VATE1_HUMAN V-type proton ATPase subunit E 1 OS=Homo sapiens GN=ATP6V1E1 PE=1 SV=1 | 50 | R | 0.842163 | G | 0.816526 | 0.025637 | No Change: Both D | A colorectal cancer sample |
| Q16864 | VATF_HUMAN V-type proton ATPase subunit F OS=Homo sapiens GN=ATP6V1F PE=1 SV=2 | 24 | G | 0.222856 | V | 0.127191 | 0.095665 | No Change: Both O | - |
| Q96LB4 | VATG3_HUMAN V-type proton ATPase subunit G 3 OS=Homo sapiens GN=ATP6V1G3 PE=2 SV=1 | 54 | E | 0.880673 | Q | 0.880028 | 6.45E-04 | No Change: Both D | - |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 629 | A | 0.393406 | P | 0.480011 | -0.086605 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 727 | G | 0.018248 | R | 0.01585 | 0.002398 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1006 | L | 0.156059 | P | 0.284372 | -0.128313 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1019 | G | 0.243878 | D | 0.243093 | 7.85E-04 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 637 | S | 0.736845 | L | 0.581905 | 0.15494 | No Change: Both D | Occipital horn syndrome (OHS) [MIM:304150] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 767 | V | 0.032699 | L | 0.035124 | -0.002425 | No Change: Both O | - |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 873 | L | 0.443436 | R | 0.577677 | -0.134241 | O to D | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 876 | G | 0.375358 | E | 0.450558 | -0.0752 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1000 | C | 0.037757 | R | 0.070581 | -0.032824 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1300 | G | 0.359422 | E | 0.401333 | -0.041911 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1302 | G | 0.399321 | R | 0.3798 | 0.019521 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1302 | G | 0.399321 | V | 0.275121 | 0.1242 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1305 | D | 0.427695 | A | 0.357706 | 0.069989 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1362 | A | 0.013486 | V | 0.010054 | 0.003432 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 669 | I | 0.074301 | T | 0.125379 | -0.051078 | No Change: Both O | - |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 703 | R | 0.287289 | H | 0.297276 | -0.009987 | No Change: Both O | - |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1464 | I | 0.581252 | V | 0.620266 | -0.039014 | No Change: Both D | - |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 706 | L | 0.187665 | R | 0.289188 | -0.101523 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 844 | R | 0.198262 | H | 0.191466 | 0.006796 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 853 | G | 0.30635 | R | 0.289834 | 0.016516 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 860 | G | 0.386652 | V | 0.266295 | 0.120357 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 876 | G | 0.375358 | R | 0.361656 | 0.013702 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 924 | Q | 0.513347 | R | 0.476341 | 0.037006 | D to O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1007 | A | 0.177449 | V | 0.130689 | 0.04676 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1015 | G | 0.292406 | D | 0.296134 | -0.003728 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1044 | D | 0.268948 | G | 0.266387 | 0.002561 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1100 | L | 0.371234 | P | 0.510461 | -0.139227 | O to D | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1118 | G | 0.102743 | D | 0.111817 | -0.009074 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1255 | G | 0.400107 | R | 0.392326 | 0.007781 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1282 | K | 0.401923 | E | 0.39464 | 0.007283 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1304 | N | 0.433743 | K | 0.472972 | -0.039229 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1315 | G | 0.168515 | R | 0.15097 | 0.017545 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1325 | A | 0.211167 | V | 0.1562 | 0.054967 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1344 | S | 0.217178 | R | 0.167943 | 0.049235 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1345 | I | 0.256588 | F | 0.257214 | -6.26E-04 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1369 | G | 0.037305 | R | 0.032832 | 0.004473 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1397 | S | 0.494527 | F | 0.246101 | 0.248426 | No Change: Both O | Menkes disease (MNKD) [MIM:309400] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 994 | T | 0.03244 | I | 0.018302 | 0.014138 | No Change: Both O | Distal spinal muscular atrophy X-linked type 3 (DSMAX3) [MIM:300489] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1304 | N | 0.433743 | S | 0.49057 | -0.056827 | No Change: Both O | Occipital horn syndrome (OHS) [MIM:304150] |
| Q04656 | ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens GN=ATP7A PE=1 SV=3 | 1386 | P | 0.131337 | S | 0.152026 | -0.020689 | No Change: Both O | Distal spinal muscular atrophy X-linked type 3 (DSMAX3) [MIM:300489] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 85 | G | 0.315922 | V | 0.225102 | 0.09082 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 96 | G | 0.456359 | D | 0.479525 | -0.023166 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 390 | I | 0.355003 | V | 0.402595 | -0.047592 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 406 | S | 0.357857 | A | 0.260192 | 0.097665 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 446 | V | 0.777781 | L | 0.776504 | 0.001277 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 456 | V | 0.803324 | L | 0.802594 | 7.30E-04 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 466 | L | 0.680686 | V | 0.687648 | -0.006962 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 492 | L | 0.202139 | S | 0.37646 | -0.174321 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 565 | N | 0.409008 | S | 0.47205 | -0.063042 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 626 | G | 0.161074 | A | 0.144195 | 0.016879 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 642 | D | 0.529184 | H | 0.515849 | 0.013335 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 645 | M | 0.536284 | R | 0.599541 | -0.063257 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 665 | M | 0.034758 | I | 0.021423 | 0.013335 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 691 | G | 0.106755 | R | 0.100621 | 0.006134 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 708 | L | 0.014314 | P | 0.028918 | -0.014604 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 710 | G | 0.019521 | R | 0.016917 | 0.002604 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 710 | G | 0.019521 | S | 0.02343 | -0.003909 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 711 | G | 0.021622 | E | 0.026135 | -0.004513 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 713 | Y | 0.026078 | C | 0.018439 | 0.007639 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 723 | R | 0.455314 | G | 0.452752 | 0.002562 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 747 | I | 0.023401 | F | 0.022882 | 5.19E-04 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 765 | D | 0.196946 | N | 0.184895 | 0.012051 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 769 | M | 0.059887 | V | 0.048671 | 0.011216 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 776 | L | 0.037843 | V | 0.035958 | 0.001885 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 778 | R | 0.066522 | G | 0.070859 | -0.004337 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 778 | R | 0.066522 | L | 0.045033 | 0.021489 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 778 | R | 0.066522 | Q | 0.072038 | -0.005516 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 778 | R | 0.066522 | W | 0.027687 | 0.038835 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 795 | L | 0.429276 | F | 0.371107 | 0.058169 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 832 | K | 0.280891 | R | 0.235055 | 0.045836 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 840 | P | 0.445371 | L | 0.296497 | 0.148874 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 857 | I | 0.45663 | T | 0.611988 | -0.155358 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 864 | V | 0.538697 | I | 0.520816 | 0.017881 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 869 | G | 0.534781 | R | 0.509599 | 0.025182 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 874 | A | 0.407282 | V | 0.332419 | 0.074863 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 918 | D | 0.202761 | N | 0.190642 | 0.012119 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 919 | R | 0.15779 | G | 0.1774 | -0.01961 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 919 | R | 0.15779 | W | 0.063597 | 0.094193 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 921 | S | 0.096598 | N | 0.080537 | 0.016061 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 933 | T | 0.01816 | P | 0.022993 | -0.004833 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 935 | T | 0.013808 | M | 0.011047 | 0.002761 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 943 | G | 0.010936 | D | 0.012484 | -0.001548 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 943 | G | 0.010936 | S | 0.013122 | -0.002186 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 952 | R | 0.150174 | K | 0.204323 | -0.054149 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 969 | R | 0.083712 | Q | 0.100297 | -0.016585 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 977 | T | 0.034287 | M | 0.025765 | 0.008522 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 992 | P | 0.214189 | L | 0.118771 | 0.095418 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 995 | V | 0.233158 | A | 0.311618 | -0.07846 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1003 | A | 0.206451 | T | 0.231093 | -0.024642 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1018 | A | 0.379264 | V | 0.316613 | 0.062651 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1035 | G | 0.269152 | V | 0.170887 | 0.098265 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1041 | R | 0.135626 | W | 0.047752 | 0.087874 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1043 | L | 0.116498 | P | 0.212162 | -0.095664 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1064 | E | 0.556103 | A | 0.463554 | 0.092549 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1064 | E | 0.556103 | K | 0.544624 | 0.011479 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1069 | H | 0.573539 | Q | 0.579369 | -0.00583 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1083 | L | 0.417461 | F | 0.372272 | 0.045189 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1089 | G | 0.188337 | E | 0.232513 | -0.044176 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1089 | G | 0.188337 | V | 0.111186 | 0.077151 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1101 | G | 0.150907 | R | 0.134002 | 0.016905 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1102 | I | 0.173928 | T | 0.281029 | -0.107101 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1109 | V | 0.31891 | M | 0.359393 | -0.040483 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1140 | V | 0.41074 | A | 0.490761 | -0.080021 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1142 | Q | 0.304541 | H | 0.298809 | 0.005732 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1146 | V | 0.251261 | M | 0.318926 | -0.067665 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1148 | I | 0.224762 | T | 0.349497 | -0.124735 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1153 | W | 0.208015 | C | 0.267672 | -0.059657 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1169 | M | 0.695062 | V | 0.638574 | 0.056488 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1183 | A | 0.060064 | G | 0.076296 | -0.016232 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1183 | A | 0.060064 | T | 0.067716 | -0.007652 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1186 | G | 0.056007 | C | 0.033165 | 0.022842 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1186 | G | 0.056007 | S | 0.06939 | -0.013383 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1213 | G | 0.178244 | V | 0.110648 | 0.067596 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1216 | V | 0.14581 | M | 0.183752 | -0.037942 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1220 | T | 0.230856 | M | 0.188744 | 0.042112 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1222 | D | 0.309386 | Y | 0.175092 | 0.134294 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1266 | G | 0.481835 | V | 0.35613 | 0.125705 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1267 | D | 0.484864 | A | 0.412903 | 0.071961 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1270 | N | 0.51586 | S | 0.573798 | -0.057938 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1273 | P | 0.510022 | L | 0.362799 | 0.147223 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1278 | A | 0.348978 | V | 0.269784 | 0.079194 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1310 | S | 0.186455 | R | 0.143214 | 0.043241 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1322 | R | 0.091066 | P | 0.098158 | -0.007092 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1341 | G | 0.057002 | D | 0.059127 | -0.002125 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1353 | W | 0.148618 | R | 0.316992 | -0.168374 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1358 | A | 0.42487 | S | 0.550214 | -0.125344 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 616 | R | 0.186008 | Q | 0.197683 | -0.011675 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 711 | G | 0.021622 | R | 0.018521 | 0.003101 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 711 | G | 0.021622 | W | 0.007302 | 0.01432 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 744 | S | 0.027511 | P | 0.022605 | 0.004906 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 769 | M | 0.059887 | R | 0.079208 | -0.019321 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 795 | L | 0.429276 | R | 0.534541 | -0.105265 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 869 | G | 0.534781 | V | 0.420799 | 0.113982 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 985 | C | 0.06682 | Y | 0.069635 | -0.002815 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1003 | A | 0.206451 | V | 0.156418 | 0.050033 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1033 | T | 0.303427 | A | 0.25595 | 0.047477 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1041 | R | 0.135626 | P | 0.160745 | -0.025119 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1052 | P | 0.150681 | L | 0.085409 | 0.065272 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1061 | G | 0.339783 | E | 0.407445 | -0.067662 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1063 | A | 0.478469 | V | 0.411525 | 0.066944 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1068 | E | 0.609673 | G | 0.56936 | 0.040313 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1095 | Q | 0.137595 | P | 0.17953 | -0.041935 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1104 | C | 0.207854 | F | 0.187777 | 0.020077 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1151 | R | 0.219721 | H | 0.190464 | 0.029257 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1169 | M | 0.695062 | T | 0.734903 | -0.039841 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1173 | E | 0.59977 | K | 0.61256 | -0.01279 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1207 | H | 0.219058 | R | 0.216607 | 0.002451 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1239 | V | 0.172194 | G | 0.26099 | -0.088796 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1262 | V | 0.515565 | F | 0.456713 | 0.058852 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1266 | G | 0.481835 | R | 0.443042 | 0.038793 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1297 | V | 0.097424 | I | 0.085929 | 0.011495 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1327 | L | 0.023765 | V | 0.023541 | 2.24E-04 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1363 | S | 0.5139 | F | 0.256608 | 0.257292 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1434 | T | 0.836937 | M | 0.834162 | 0.002775 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 710 | G | 0.019521 | A | 0.014125 | 0.005396 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 741 | Y | 0.035933 | C | 0.026136 | 0.009797 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 891 | G | 0.273194 | V | 0.190969 | 0.082225 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 967 | I | 0.116156 | F | 0.11642 | -2.64E-04 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1031 | T | 0.332454 | I | 0.201889 | 0.130565 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1038 | R | 0.17861 | K | 0.211083 | -0.032473 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1106 | V | 0.247433 | D | 0.354516 | -0.107083 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1153 | W | 0.208015 | R | 0.433455 | -0.22544 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1176 | G | 0.406248 | R | 0.390882 | 0.015366 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1222 | D | 0.309386 | V | 0.184406 | 0.12498 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1355 | G | 0.248522 | S | 0.313064 | -0.064542 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 14 | A | 0.678222 | D | 0.716167 | -0.037945 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 41 | N | 0.288781 | S | 0.372278 | -0.083497 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 616 | R | 0.186008 | W | 0.077678 | 0.10833 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 641 | L | 0.542525 | S | 0.72683 | -0.184305 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 690 | P | 0.123676 | L | 0.066262 | 0.057414 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 693 | S | 0.06583 | C | 0.021846 | 0.043984 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 721 | S | 0.377352 | P | 0.330608 | 0.046744 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 737 | T | 0.04571 | R | 0.048989 | -0.003279 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 760 | P | 0.439326 | L | 0.252136 | 0.18719 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 765 | D | 0.196946 | G | 0.17674 | 0.020206 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 768 | P | 0.091127 | H | 0.072029 | 0.019098 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 769 | M | 0.059887 | I | 0.041372 | 0.018515 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 875 | G | 0.402687 | R | 0.366363 | 0.036324 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 890 | V | 0.272405 | M | 0.324418 | -0.052013 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 898 | Q | 0.156769 | R | 0.141861 | 0.014908 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 918 | D | 0.202761 | E | 0.223392 | -0.020631 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 949 | V | 0.058806 | G | 0.110819 | -0.052013 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 975 | S | 0.038728 | Y | 0.01565 | 0.023078 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1033 | T | 0.303427 | S | 0.359764 | -0.056337 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1094 | F | 0.146144 | L | 0.186072 | -0.039928 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1098 | P | 0.128842 | R | 0.106901 | 0.021941 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1099 | G | 0.130191 | S | 0.153779 | -0.023588 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1111 | G | 0.358707 | D | 0.37001 | -0.011303 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1143 | T | 0.295562 | N | 0.339846 | -0.044284 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1168 | A | 0.686448 | S | 0.782578 | -0.09613 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1232 | T | 0.185279 | P | 0.214269 | -0.02899 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1245 | P | 0.315286 | S | 0.35435 | -0.039064 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1248 | K | 0.404199 | N | 0.353884 | 0.050315 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1255 | L | 0.58181 | I | 0.552377 | 0.029433 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1271 | D | 0.528271 | N | 0.508957 | 0.019314 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1279 | D | 0.326362 | G | 0.311324 | 0.015038 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1305 | L | 0.117872 | P | 0.210238 | -0.092366 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1336 | I | 0.047494 | T | 0.082146 | -0.034652 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1355 | G | 0.248522 | C | 0.122607 | 0.125915 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1373 | L | 0.308573 | P | 0.467833 | -0.15926 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1373 | L | 0.308573 | R | 0.409934 | -0.101361 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 290 | V | 0.333457 | L | 0.338477 | -0.00502 | No Change: Both O | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 486 | A | 0.412602 | S | 0.513922 | -0.10132 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 532 | Y | 0.354641 | H | 0.481054 | -0.126413 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 591 | G | 0.277499 | D | 0.301388 | -0.023889 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 604 | A | 0.258715 | P | 0.324516 | -0.065801 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 639 | H | 0.580372 | Y | 0.433189 | 0.147183 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 653 | S | 0.141235 | Y | 0.063451 | 0.077784 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 703 | C | 0.006132 | Y | 0.007885 | -0.001753 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 710 | G | 0.019521 | V | 0.010098 | 0.009423 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 756 | A | 0.497557 | G | 0.540665 | -0.043108 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 766 | T | 0.162629 | M | 0.134898 | 0.027731 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 766 | T | 0.162629 | R | 0.167302 | -0.004673 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 776 | L | 0.037843 | P | 0.075187 | -0.037344 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 861 | A | 0.469815 | T | 0.52382 | -0.054005 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 875 | G | 0.402687 | V | 0.276602 | 0.126085 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 943 | G | 0.010936 | C | 0.004182 | 0.006754 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 988 | G | 0.128729 | R | 0.12191 | 0.006819 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 991 | T | 0.210783 | M | 0.175634 | 0.035149 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 992 | P | 0.214189 | H | 0.182541 | 0.031648 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 996 | M | 0.234301 | T | 0.300925 | -0.066624 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1000 | G | 0.230374 | R | 0.203486 | 0.026888 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1029 | T | 0.372086 | I | 0.23393 | 0.138156 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1065 | A | 0.598046 | P | 0.647583 | -0.049537 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1104 | C | 0.207854 | Y | 0.205198 | 0.002656 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1106 | V | 0.247433 | I | 0.231026 | 0.016407 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1176 | G | 0.406248 | E | 0.47278 | -0.066532 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1221 | G | 0.26267 | E | 0.299956 | -0.037286 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1222 | D | 0.309386 | N | 0.301392 | 0.007994 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1252 | V | 0.52049 | I | 0.472634 | 0.047856 | D to O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1256 | Q | 0.594671 | R | 0.556359 | 0.038312 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1279 | D | 0.326362 | Y | 0.176198 | 0.150164 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1287 | G | 0.263154 | S | 0.291394 | -0.02824 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1296 | D | 0.111061 | N | 0.100088 | 0.010973 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1331 | Y | 0.021793 | S | 0.052761 | -0.030968 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1341 | G | 0.057002 | S | 0.06691 | -0.009908 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1341 | G | 0.057002 | V | 0.030176 | 0.026826 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1352 | P | 0.116635 | S | 0.135197 | -0.018562 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1368 | L | 0.328306 | P | 0.482759 | -0.154453 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1375 | C | 0.371044 | S | 0.604947 | -0.233903 | O to D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1379 | P | 0.458927 | S | 0.490889 | -0.031962 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1407 | D | 0.526916 | E | 0.507131 | 0.019785 | No Change: Both D | - |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 536 | V | 0.240525 | A | 0.324958 | -0.084433 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 657 | S | 0.049133 | R | 0.034274 | 0.014859 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 971 | A | 0.062359 | V | 0.046769 | 0.01559 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 974 | T | 0.041907 | M | 0.031382 | 0.010525 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1004 | Q | 0.220885 | P | 0.248061 | -0.027176 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1149 | G | 0.225106 | A | 0.208956 | 0.01615 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1164 | D | 0.572015 | N | 0.547703 | 0.024312 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1173 | E | 0.59977 | G | 0.56627 | 0.0335 | No Change: Both D | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1228 | R | 0.32569 | T | 0.319702 | 0.005988 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1230 | I | 0.243641 | V | 0.2736 | -0.029959 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1267 | D | 0.484864 | V | 0.338542 | 0.146322 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1328 | A | 0.020723 | T | 0.023866 | -0.003143 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| P35670 | ATP7B_HUMAN Copper-transporting ATPase 2 OS=Homo sapiens GN=ATP7B PE=1 SV=4 | 1359 | M | 0.451592 | I | 0.32828 | 0.123312 | No Change: Both O | Wilson disease (WD) [MIM:277900] |
| Q9Y2Q0 | AT8A1_HUMAN Probable phospholipid-transporting ATPase IA OS=Homo sapiens GN=ATP8A1 PE=1 SV=1 | 673 | T | 0.282397 | M | 0.246584 | 0.035813 | No Change: Both O | - |
| Q9NTI2 | AT8A2_HUMAN Probable phospholipid-transporting ATPase IB OS=Homo sapiens GN=ATP8A2 PE=2 SV=2 | 1029 | A | 0.097917 | T | 0.112018 | -0.014101 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 288 | L | 0.206257 | S | 0.364062 | -0.157805 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 308 | G | 0.048508 | V | 0.026011 | 0.022497 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 661 | I | 0.350445 | T | 0.505223 | -0.154778 | O to D | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 661 | I | 0.350445 | T | 0.505223 | -0.154778 | O to D | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 892 | G | 0.224321 | R | 0.204627 | 0.019694 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 892 | G | 0.224321 | R | 0.204627 | 0.019694 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 554 | D | 0.546716 | N | 0.549398 | -0.002682 | No Change: Both D | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 78 | H | 0.388536 | Q | 0.419542 | -0.031006 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 577 | I | 0.291622 | V | 0.305804 | -0.014182 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 952 | R | 0.028251 | Q | 0.029105 | -8.54E-04 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 886 | A | 0.185692 | V | 0.134459 | 0.051233 | No Change: Both O | A breast cancer sample |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 1178 | I | 0.682142 | M | 0.723611 | -0.041469 | No Change: Both D | A breast cancer sample |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 45 | N | 0.945806 | T | 0.937423 | 0.008383 | No Change: Both D | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 70 | D | 0.561393 | N | 0.596149 | -0.034756 | No Change: Both D | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 127 | L | 0.021459 | P | 0.043454 | -0.021995 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 203 | K | 0.25841 | E | 0.245959 | 0.012451 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 305 | F | 0.05882 | I | 0.061669 | -0.002849 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 308 | G | 0.048508 | D | 0.057423 | -0.008915 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 344 | I | 0.010157 | F | 0.010183 | -2.60E-05 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 384 | R | 0.145965 | H | 0.147945 | -0.00198 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 393 | I | 0.007956 | V | 0.009126 | -0.00117 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 403 | S | 0.091068 | Y | 0.038523 | 0.052545 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 412 | R | 0.160446 | P | 0.187212 | -0.026766 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 429 | E | 0.455811 | A | 0.370247 | 0.085564 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 453 | S | 0.275441 | Y | 0.15725 | 0.118191 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 454 | D | 0.30415 | G | 0.297596 | 0.006554 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 456 | T | 0.3376 | M | 0.285797 | 0.051803 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 500 | Y | 0.154818 | H | 0.239372 | -0.084554 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 535 | H | 0.044396 | L | 0.02741 | 0.016986 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 580 | S | 0.386217 | N | 0.364193 | 0.022024 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 600 | R | 0.396195 | Q | 0.398535 | -0.00234 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 600 | R | 0.396195 | W | 0.192142 | 0.204053 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 628 | R | 0.230977 | W | 0.09398 | 0.136997 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 674 | M | 0.318974 | T | 0.384973 | -0.065999 | No Change: Both O | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 688 | D | 0.443375 | G | 0.395412 | 0.047963 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 694 | I | 0.338059 | T | 0.45432 | -0.116261 | No Change: Both O | Benign recurrent intrahepatic cholestasis type 1 (BRIC1) [MIM:243300] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 733 | G | 0.280153 | R | 0.269306 | 0.010847 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 814 | K | 0.631618 | N | 0.598886 | 0.032732 | No Change: Both D | - |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 853 | F | 0.647762 | S | 0.774147 | -0.126385 | No Change: Both D | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 867 | R | 0.205184 | C | 0.156578 | 0.048606 | No Change: Both O | Intrahepatic cholestasis of pregnancy (ICP) [MIM:147480] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 1040 | G | 0.074559 | R | 0.072639 | 0.00192 | No Change: Both O | Progressive familial intrahepatic cholestasis type 1 (PFIC1) [MIM:211600] |
| O43520 | AT8B1_HUMAN Probable phospholipid-transporting ATPase IC OS=Homo sapiens GN=ATP8B1 PE=1 SV=3 | 1152 | A | 0.007288 | T | 0.008426 | -0.001138 | No Change: Both O | - |
| O60423 | AT8B3_HUMAN Probable phospholipid-transporting ATPase IK OS=Homo sapiens GN=ATP8B3 PE=2 SV=4 | 45 | G | 0.962316 | R | 0.965324 | -0.003008 | No Change: Both D | - |
| O60423 | AT8B3_HUMAN Probable phospholipid-transporting ATPase IK OS=Homo sapiens GN=ATP8B3 PE=2 SV=4 | 618 | V | 0.272818 | I | 0.25694 | 0.015878 | No Change: Both O | - |
| Q8TF62 | AT8B4_HUMAN Probable phospholipid-transporting ATPase IM OS=Homo sapiens GN=ATP8B4 PE=2 SV=3 | 225 | N | 0.547258 | S | 0.5969 | -0.049642 | No Change: Both D | - |
| Q8TF62 | AT8B4_HUMAN Probable phospholipid-transporting ATPase IM OS=Homo sapiens GN=ATP8B4 PE=2 SV=3 | 452 | H | 0.38321 | N | 0.371519 | 0.011691 | No Change: Both O | - |
| Q8TF62 | AT8B4_HUMAN Probable phospholipid-transporting ATPase IM OS=Homo sapiens GN=ATP8B4 PE=2 SV=3 | 1165 | N | 0.614817 | K | 0.670594 | -0.055777 | No Change: Both D | - |
| Q8TF62 | AT8B4_HUMAN Probable phospholipid-transporting ATPase IM OS=Homo sapiens GN=ATP8B4 PE=2 SV=3 | 1190 | V | 0.785579 | G | 0.807189 | -0.02161 | No Change: Both D | - |
| O43861 | ATP9B_HUMAN Probable phospholipid-transporting ATPase IIB OS=Homo sapiens GN=ATP9B PE=2 SV=4 | 39 | S | 0.868962 | G | 0.838061 | 0.030901 | No Change: Both D | - |
| O43861 | ATP9B_HUMAN Probable phospholipid-transporting ATPase IIB OS=Homo sapiens GN=ATP9B PE=2 SV=4 | 504 | D | 0.683775 | N | 0.669303 | 0.014472 | No Change: Both D | - |
| O43861 | ATP9B_HUMAN Probable phospholipid-transporting ATPase IIB OS=Homo sapiens GN=ATP9B PE=2 SV=4 | 732 | M | 0.351674 | L | 0.30715 | 0.044524 | No Change: Both O | - |
| O43861 | ATP9B_HUMAN Probable phospholipid-transporting ATPase IIB OS=Homo sapiens GN=ATP9B PE=2 SV=4 | 108 | R | 0.203117 | Q | 0.19232 | 0.010797 | No Change: Both O | - |
| Q5TC12 | ATPF1_HUMAN ATP synthase mitochondrial F1 complex assembly factor 1 OS=Homo sapiens GN=ATPAF1 PE=1 SV=1 | 62 | S | 0.781551 | G | 0.760166 | 0.021385 | No Change: Both D | - |
| Q6PEX7 | ATAS1_HUMAN Uncharacterized protein ATPAF1-AS1 OS=Homo sapiens GN=ATPAF1-AS1 PE=2 SV=3 | 104 | D | 0.521936 | E | 0.540549 | -0.018613 | No Change: Both D | - |
| Q6PEX7 | ATAS1_HUMAN Uncharacterized protein ATPAF1-AS1 OS=Homo sapiens GN=ATPAF1-AS1 PE=2 SV=3 | 199 | A | 0.643375 | V | 0.570816 | 0.072559 | No Change: Both D | - |
| Q8N5M1 | ATPF2_HUMAN ATP synthase mitochondrial F1 complex assembly factor 2 OS=Homo sapiens GN=ATPAF2 PE=1 SV=1 | 94 | W | 0.277556 | R | 0.432578 | -0.155022 | No Change: Both O | Mitochondrial complex V deficiency nuclear type 1 (MC5DN1) [MIM:604273] |
| Q7L8W6 | ATBD4_HUMAN ATP-binding domain-containing protein 4 OS=Homo sapiens GN=ATPBD4 PE=1 SV=3 | 41 | G | 0.604038 | E | 0.658128 | -0.05409 | No Change: Both D | - |
| Q7L8W6 | ATBD4_HUMAN ATP-binding domain-containing protein 4 OS=Homo sapiens GN=ATPBD4 PE=1 SV=3 | 236 | P | 0.116217 | R | 0.105189 | 0.011028 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 64 | T | 0.416146 | A | 0.37214 | 0.044006 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 90 | H | 0.54863 | Y | 0.436889 | 0.111741 | D to O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 297 | K | 0.291874 | N | 0.236736 | 0.055138 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 316 | V | 0.127939 | I | 0.121105 | 0.006834 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 959 | V | 0.522577 | M | 0.590982 | -0.068405 | No Change: Both D | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1087 | Y | 0.188976 | H | 0.300458 | -0.111482 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1213 | S | 0.094108 | G | 0.074555 | 0.019553 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1488 | A | 0.302285 | P | 0.362533 | -0.060248 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1607 | S | 0.695133 | N | 0.672899 | 0.022234 | No Change: Both D | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1612 | N | 0.723462 | S | 0.749373 | -0.025911 | No Change: Both D | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2002 | A | 0.156804 | G | 0.205545 | -0.048741 | No Change: Both O | A lung adenocarcinoma sample |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2120 | G | 0.359177 | A | 0.298891 | 0.060286 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2132 | Y | 0.172229 | D | 0.286354 | -0.114125 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2233 | S | 0.694358 | I | 0.497786 | 0.196572 | D to O | A lung large cell carcinoma sample |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2425 | R | 0.279609 | Q | 0.268983 | 0.010626 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2434 | P | 0.235135 | A | 0.152307 | 0.082828 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2438 | E | 0.169937 | K | 0.170594 | -6.57E-04 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 2537 | E | 0.32134 | Q | 0.27469 | 0.04665 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 211 | M | 0.023965 | T | 0.032644 | -0.008679 | No Change: Both O | - |
| Q13535 | ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens GN=ATR PE=1 SV=3 | 1526 | I | 0.075824 | V | 0.089684 | -0.01386 | No Change: Both O | - |
| Q8WXE1 | ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens GN=ATRIP PE=1 SV=1 | 125 | K | 0.690715 | Q | 0.66314 | 0.027575 | No Change: Both D | - |
| Q8WXE1 | ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens GN=ATRIP PE=1 SV=1 | 240 | P | 0.876268 | L | 0.764004 | 0.112264 | No Change: Both D | - |
| O75882 | ATRN_HUMAN Attractin OS=Homo sapiens GN=ATRN PE=1 SV=2 | 303 | D | 0.582696 | A | 0.493644 | 0.089052 | D to O | - |
| O75882 | ATRN_HUMAN Attractin OS=Homo sapiens GN=ATRN PE=1 SV=2 | 426 | I | 0.108295 | T | 0.201958 | -0.093663 | No Change: Both O | - |
| O75882 | ATRN_HUMAN Attractin OS=Homo sapiens GN=ATRN PE=1 SV=2 | 1152 | R | 0.234947 | K | 0.276579 | -0.041632 | No Change: Both O | - |
| O75882 | ATRN_HUMAN Attractin OS=Homo sapiens GN=ATRN PE=1 SV=2 | 1226 | V | 0.45963 | I | 0.429286 | 0.030344 | No Change: Both O | - |
| Q5VV63 | ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens GN=ATRNL1 PE=2 SV=2 | 989 | S | 0.397567 | N | 0.3622 | 0.035367 | No Change: Both O | - |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 190 | P | 0.208853 | A | 0.155265 | 0.053588 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 192 | L | 0.146556 | F | 0.129812 | 0.016744 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 200 | C | 0.098425 | S | 0.201486 | -0.103061 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 220 | C | 0.29514 | R | 0.436246 | -0.141106 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 222 | W | 0.195332 | S | 0.466607 | -0.271275 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 243 | C | 0.112975 | F | 0.106512 | 0.006463 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 246 | R | 0.16228 | C | 0.092579 | 0.069701 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 249 | G | 0.28813 | D | 0.316087 | -0.027957 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1609 | H | 0.052995 | R | 0.05276 | 2.35E-04 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1614 | C | 0.117934 | R | 0.225657 | -0.107723 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1650 | K | 0.638777 | N | 0.589429 | 0.049348 | No Change: Both D | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1860 | N | 0.773542 | S | 0.797998 | -0.024456 | No Change: Both D | - |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2035 | D | 0.252277 | V | 0.152831 | 0.099446 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2084 | Y | 0.250835 | H | 0.320284 | -0.069449 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2131 | R | 0.049803 | Q | 0.054537 | -0.004734 | No Change: Both O | Mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2163 | Y | 0.076186 | C | 0.058453 | 0.017733 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 246 | R | 0.16228 | L | 0.103554 | 0.058726 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 175 | G | 0.243186 | E | 0.282517 | -0.039331 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 179 | N | 0.280626 | S | 0.336624 | -0.055998 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 190 | P | 0.208853 | L | 0.129441 | 0.079412 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 190 | P | 0.208853 | S | 0.253906 | -0.045053 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 194 | V | 0.1036 | I | 0.103329 | 2.71E-04 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 219 | Q | 0.363215 | P | 0.381958 | -0.018743 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 249 | G | 0.28813 | C | 0.155586 | 0.132544 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1538 | V | 0.662836 | G | 0.700272 | -0.037436 | No Change: Both D | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1552 | V | 0.367739 | F | 0.31512 | 0.052619 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1645 | L | 0.552273 | S | 0.650671 | -0.098398 | No Change: Both D | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1713 | P | 0.248191 | S | 0.257741 | -0.00955 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1742 | R | 0.325685 | K | 0.368372 | -0.042687 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1847 | Y | 0.098859 | C | 0.079807 | 0.019052 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2050 | I | 0.219459 | T | 0.32657 | -0.107111 | No Change: Both O | Mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 596 | S | 0.663417 | P | 0.667461 | -0.004044 | No Change: Both D | - |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 740 | E | 0.883355 | G | 0.840213 | 0.043142 | No Change: Both D | - |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 1621 | T | 0.077793 | M | 0.06297 | 0.014823 | No Change: Both O | Alpha-thalassemia mental retardation syndrome X-linked (ATRX) [MIM:301040] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 929 | Q | 0.914992 | E | 0.924012 | -0.00902 | No Change: Both D | - |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 220 | C | 0.29514 | Y | 0.303015 | -0.007875 | No Change: Both O | Mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 409 | L | 0.603575 | S | 0.723557 | -0.119982 | No Change: Both D | Mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 2271 | R | 0.739801 | G | 0.739169 | 6.32E-04 | No Change: Both D | Mental retardation syndromic X-linked with hypotonic facies syndrome type 1 (MRXSHF1) [MIM:309580] |
| P46100 | ATRX_HUMAN Transcriptional regulator ATRX OS=Homo sapiens GN=ATRX PE=1 SV=5 | 545 | Q | 0.917474 | E | 0.928091 | -0.010617 | No Change: Both D | - |
| P54253 | ATX1_HUMAN Ataxin-1 OS=Homo sapiens GN=ATXN1 PE=1 SV=2 | 209 | H | 0.99976 | Q | 0.999841 | -8.10E-05 | No Change: Both D | - |
| P54253 | ATX1_HUMAN Ataxin-1 OS=Homo sapiens GN=ATXN1 PE=1 SV=2 | 753 | P | 0.82522 | S | 0.815929 | 0.009291 | No Change: Both D | - |
| P0C7T5 | ATX1L_HUMAN Ataxin-1-like OS=Homo sapiens GN=ATXN1L PE=1 SV=1 | 313 | S | 0.561445 | P | 0.57961 | -0.018165 | No Change: Both D | - |
| Q99700 | ATX2_HUMAN Ataxin-2 OS=Homo sapiens GN=ATXN2 PE=1 SV=2 | 107 | L | 0.92985 | V | 0.919513 | 0.010337 | No Change: Both D | - |
| Q99700 | ATX2_HUMAN Ataxin-2 OS=Homo sapiens GN=ATXN2 PE=1 SV=2 | 248 | S | 0.674341 | N | 0.649125 | 0.025216 | No Change: Both D | - |
| P54252 | ATX3_HUMAN Ataxin-3 OS=Homo sapiens GN=ATXN3 PE=1 SV=4 | 212 | V | 0.756121 | M | 0.826882 | -0.070761 | No Change: Both D | - |
| Q9H3M9 | ATX3L_HUMAN Putative ataxin-3-like protein OS=Homo sapiens GN=ATXN3L PE=5 SV=2 | 266 | L | 0.930251 | F | 0.919856 | 0.010395 | No Change: Both D | - |
| Q9H3M9 | ATX3L_HUMAN Putative ataxin-3-like protein OS=Homo sapiens GN=ATXN3L PE=5 SV=2 | 332 | G | 0.573085 | D | 0.64721 | -0.074125 | No Change: Both D | - |
| O15265 | ATX7_HUMAN Ataxin-7 OS=Homo sapiens GN=ATXN7 PE=1 SV=1 | 264 | K | 0.69218 | R | 0.647053 | 0.045127 | No Change: Both D | - |
| O15265 | ATX7_HUMAN Ataxin-7 OS=Homo sapiens GN=ATXN7 PE=1 SV=1 | 663 | P | 0.999526 | S | 0.999574 | -4.80E-05 | No Change: Both D | - |
| O15265 | ATX7_HUMAN Ataxin-7 OS=Homo sapiens GN=ATXN7 PE=1 SV=1 | 862 | V | 0.819351 | M | 0.865034 | -0.045683 | No Change: Both D | - |
| O15265 | ATX7_HUMAN Ataxin-7 OS=Homo sapiens GN=ATXN7 PE=1 SV=1 | 573 | I | 0.718491 | V | 0.734694 | -0.016203 | No Change: Both D | - |
| Q5T6C5 | AT7L2_HUMAN Ataxin-7-like protein 2 OS=Homo sapiens GN=ATXN7L2 PE=2 SV=1 | 495 | P | 0.965361 | S | 0.962233 | 0.003128 | No Change: Both D | - |
| Q13825 | AUHM_HUMAN Methylglutaconyl-CoA hydratase mitochondrial OS=Homo sapiens GN=AUH PE=1 SV=1 | 240 | A | 0.1756 | V | 0.126196 | 0.049404 | No Change: Both O | 3-methylglutaconic aciduria type 1 (MGA1) [MIM:250950] |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 11 | G | 0.647154 | R | 0.687771 | -0.040617 | No Change: Both D | - |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 31 | F | 0.737173 | I | 0.748332 | -0.011159 | No Change: Both D | - |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 57 | V | 0.959292 | I | 0.942445 | 0.016847 | No Change: Both D | - |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 50 | P | 0.940773 | L | 0.898047 | 0.042726 | No Change: Both D | - |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 155 | S | 0.293857 | R | 0.273543 | 0.020314 | No Change: Both O | A colorectal adenocarcinoma sample |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 174 | V | 0.506145 | M | 0.568342 | -0.062197 | No Change: Both D | A metastatic melanoma sample |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 373 | M | 0.593305 | V | 0.554895 | 0.03841 | No Change: Both D | - |
| O14965 | AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2 | 104 | S | 0.992612 | L | 0.987378 | 0.005234 | No Change: Both D | - |
| Q9NWT8 | AKIP_HUMAN Aurora kinase A-interacting protein OS=Homo sapiens GN=AURKAIP1 PE=1 SV=1 | 107 | Q | 0.731151 | H | 0.656589 | 0.074562 | No Change: Both D | - |
| Q96GD4 | AURKB_HUMAN Aurora kinase B OS=Homo sapiens GN=AURKB PE=1 SV=3 | 100 | H | 0.222063 | Q | 0.242805 | -0.020742 | No Change: Both O | - |
| Q96GD4 | AURKB_HUMAN Aurora kinase B OS=Homo sapiens GN=AURKB PE=1 SV=3 | 298 | M | 0.323298 | T | 0.355435 | -0.032137 | No Change: Both O | - |
| Q96GD4 | AURKB_HUMAN Aurora kinase B OS=Homo sapiens GN=AURKB PE=1 SV=3 | 52 | A | 0.663583 | V | 0.620898 | 0.042685 | No Change: Both D | - |
| Q96GD4 | AURKB_HUMAN Aurora kinase B OS=Homo sapiens GN=AURKB PE=1 SV=3 | 179 | T | 0.324377 | M | 0.280593 | 0.043784 | No Change: Both O | - |
| Q9UQB9 | AURKC_HUMAN Aurora kinase C OS=Homo sapiens GN=AURKC PE=1 SV=1 | 52 | G | 0.3471 | E | 0.371979 | -0.024879 | No Change: Both O | A lung adenocarcinoma sample |
| Q9UQB9 | AURKC_HUMAN Aurora kinase C OS=Homo sapiens GN=AURKC PE=1 SV=1 | 148 | E | 0.292375 | Q | 0.244421 | 0.047954 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q9UQB9 | AURKC_HUMAN Aurora kinase C OS=Homo sapiens GN=AURKC PE=1 SV=1 | 244 | H | 0.662768 | Q | 0.670089 | -0.007321 | No Change: Both D | A lung adenocarcinoma sample |
| Q8WXX7 | AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens GN=AUTS2 PE=1 SV=1 | 303 | A | 0.971513 | S | 0.981795 | -0.010282 | No Change: Both D | - |
| Q9NQS1 | AVEN_HUMAN Cell death regulator Aven OS=Homo sapiens GN=AVEN PE=1 SV=1 | 228 | Q | 0.748292 | R | 0.749597 | -0.001305 | No Change: Both D | - |
| O75366 | AVIL_HUMAN Advillin OS=Homo sapiens GN=AVIL PE=1 SV=3 | 204 | K | 0.658918 | E | 0.670103 | -0.011185 | No Change: Both D | - |
| Q8NBF6 | AVL9_HUMAN Late secretory pathway protein AVL9 homolog OS=Homo sapiens GN=AVL9 PE=1 SV=1 | 257 | C | 0.594109 | S | 0.752245 | -0.158136 | No Change: Both D | - |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 17 | S | 0.278982 | F | 0.160586 | 0.118396 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 19 | A | 0.310904 | T | 0.312024 | -0.00112 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 19 | A | 0.310904 | V | 0.192585 | 0.118319 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 45 | G | 0.580346 | R | 0.604735 | -0.024389 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 48 | G | 0.643975 | V | 0.486695 | 0.15728 | D to O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 51 | R | 0.553501 | C | 0.477667 | 0.075834 | D to O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 55 | P | 0.544622 | L | 0.403488 | 0.141134 | D to O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 78 | E | 0.602777 | G | 0.559975 | 0.042802 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 81 | L | 0.630734 | P | 0.768376 | -0.137642 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 88 | G | 0.736675 | R | 0.743184 | -0.006509 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 88 | G | 0.736675 | S | 0.770966 | -0.034291 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 92 | C | 0.747926 | S | 0.805259 | -0.057333 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 93 | G | 0.741867 | W | 0.512751 | 0.229116 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 96 | G | 0.726454 | C | 0.701008 | 0.025446 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 82 | P | 0.643464 | L | 0.487447 | 0.156017 | D to O | - |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 119 | G | 0.738701 | V | 0.625219 | 0.113482 | No Change: Both D | - |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 21 | Y | 0.36357 | H | 0.478895 | -0.115325 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 26 | P | 0.508594 | L | 0.374208 | 0.134386 | D to O | Autosomal recessive neurohypophyseal diabetes insipidus (ARNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 52 | C | 0.555587 | R | 0.625174 | -0.069587 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 54 | G | 0.54931 | R | 0.564431 | -0.015121 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 54 | G | 0.54931 | V | 0.401796 | 0.147514 | D to O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 59 | C | 0.492871 | R | 0.532646 | -0.039775 | O to D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 59 | C | 0.492871 | Y | 0.351908 | 0.140963 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 87 | S | 0.712749 | F | 0.5462 | 0.166549 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 92 | C | 0.747926 | Y | 0.665935 | 0.081991 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 96 | G | 0.726454 | V | 0.619653 | 0.106801 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 97 | R | 0.745226 | C | 0.722307 | 0.022919 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 97 | R | 0.745226 | P | 0.771676 | -0.02645 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 98 | C | 0.756677 | G | 0.776433 | -0.019756 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 104 | C | 0.806145 | F | 0.738896 | 0.067249 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 105 | C | 0.787899 | R | 0.817701 | -0.029802 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 116 | C | 0.783093 | G | 0.817078 | -0.033985 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 116 | C | 0.783093 | R | 0.840549 | -0.057456 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 105 | C | 0.787899 | Y | 0.675263 | 0.112636 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 67 | V | 0.515955 | A | 0.646087 | -0.130132 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 96 | G | 0.726454 | D | 0.717359 | 0.009095 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 104 | C | 0.806145 | G | 0.813975 | -0.00783 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 116 | C | 0.783093 | W | 0.644298 | 0.138795 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 58 | C | 0.494066 | F | 0.401782 | 0.092284 | No Change: Both O | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 98 | C | 0.756677 | S | 0.805234 | -0.048557 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| P01185 | NEU2_HUMAN Vasopressin-neurophysin 2-copeptin OS=Homo sapiens GN=AVP PE=1 SV=2 | 99 | A | 0.768555 | P | 0.82093 | -0.052375 | No Change: Both D | Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) [MIM:125700] |
| Q5T686 | AVPI1_HUMAN Arginine vasopressin-induced protein 1 OS=Homo sapiens GN=AVPI1 PE=2 SV=3 | 41 | A | 0.376783 | G | 0.395288 | -0.018505 | No Change: Both O | - |
| P37288 | V1AR_HUMAN Vasopressin V1a receptor OS=Homo sapiens GN=AVPR1A PE=1 SV=1 | 6 | G | 0.916123 | S | 0.937559 | -0.021436 | No Change: Both D | - |
| P47901 | V1BR_HUMAN Vasopressin V1b receptor OS=Homo sapiens GN=AVPR1B PE=2 SV=1 | 65 | K | 0.532054 | N | 0.48427 | 0.047784 | D to O | - |
| P47901 | V1BR_HUMAN Vasopressin V1b receptor OS=Homo sapiens GN=AVPR1B PE=2 SV=1 | 191 | G | 0.059297 | R | 0.054666 | 0.004631 | No Change: Both O | - |
| P47901 | V1BR_HUMAN Vasopressin V1b receptor OS=Homo sapiens GN=AVPR1B PE=2 SV=1 | 267 | S | 0.530902 | G | 0.455546 | 0.075356 | D to O | - |
| P47901 | V1BR_HUMAN Vasopressin V1b receptor OS=Homo sapiens GN=AVPR1B PE=2 SV=1 | 364 | R | 0.864896 | H | 0.837562 | 0.027334 | No Change: Both D | - |
| P47901 | V1BR_HUMAN Vasopressin V1b receptor OS=Homo sapiens GN=AVPR1B PE=2 SV=1 | 224 | H | 0.052356 | Q | 0.056549 | -0.004193 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 7 | T | 0.974748 | S | 0.984194 | -0.009446 | No Change: Both D | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 44 | L | 0.1999 | P | 0.295791 | -0.095891 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 64 | R | 0.333027 | W | 0.14843 | 0.184597 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 80 | H | 0.032471 | R | 0.030632 | 0.001839 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 88 | V | 0.045077 | M | 0.056342 | -0.011265 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 106 | R | 0.287547 | C | 0.147457 | 0.14009 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 112 | C | 0.122693 | R | 0.255877 | -0.133184 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 113 | R | 0.102093 | W | 0.037011 | 0.065082 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 126 | S | 0.157837 | F | 0.05643 | 0.101407 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 128 | Y | 0.155565 | S | 0.303021 | -0.147456 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 132 | A | 0.170045 | D | 0.232339 | -0.062294 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 137 | R | 0.169332 | H | 0.167138 | 0.002194 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 143 | R | 0.198404 | P | 0.222217 | -0.023813 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 147 | A | 0.232299 | V | 0.158988 | 0.073311 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 164 | W | 0.034631 | S | 0.127532 | -0.092901 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 167 | S | 0.043321 | L | 0.018569 | 0.024752 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 167 | S | 0.043321 | T | 0.027376 | 0.015945 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 181 | R | 0.228222 | C | 0.115822 | 0.1124 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 185 | G | 0.418097 | C | 0.215216 | 0.202881 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 202 | R | 0.078283 | C | 0.034832 | 0.043451 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 203 | R | 0.067647 | C | 0.029481 | 0.038166 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 205 | Y | 0.044411 | C | 0.034217 | 0.010194 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 280 | Y | 0.004576 | C | 0.00443 | 1.46E-04 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 285 | A | 0.005867 | P | 0.009424 | -0.003557 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 286 | P | 0.006837 | L | 0.003439 | 0.003398 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 286 | P | 0.006837 | R | 0.005647 | 0.00119 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 292 | L | 0.023751 | P | 0.053517 | -0.029766 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 309 | L | 0.064521 | P | 0.127072 | -0.062551 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 317 | N | 0.1497 | K | 0.162562 | -0.012862 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 323 | W | 0.276888 | S | 0.557381 | -0.280493 | O to D | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 42 | A | 0.250843 | V | 0.195236 | 0.055607 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 12 | G | 0.968657 | E | 0.979936 | -0.011279 | No Change: Both D | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 43 | L | 0.244216 | P | 0.33285 | -0.088634 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 46 | I | 0.118644 | K | 0.221063 | -0.102419 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 53 | L | 0.086818 | R | 0.136039 | -0.049221 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 55 | N | 0.118071 | D | 0.128528 | -0.010457 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 55 | N | 0.118071 | H | 0.108287 | 0.009784 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 59 | L | 0.167913 | P | 0.281505 | -0.113592 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 61 | A | 0.235453 | V | 0.169672 | 0.065781 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 62 | L | 0.254301 | P | 0.39855 | -0.144249 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 81 | L | 0.0339 | F | 0.028684 | 0.005216 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 83 | L | 0.035772 | P | 0.06804 | -0.032268 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 83 | L | 0.035772 | Q | 0.063458 | -0.027686 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 84 | A | 0.041463 | D | 0.058567 | -0.017104 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 85 | D | 0.041768 | N | 0.03848 | 0.003288 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 92 | Q | 0.052464 | R | 0.045069 | 0.007395 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 94 | L | 0.064478 | Q | 0.121645 | -0.057167 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 95 | P | 0.073936 | L | 0.039339 | 0.034597 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 99 | W | 0.151635 | R | 0.343974 | -0.192339 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 104 | R | 0.277764 | C | 0.137725 | 0.140039 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 105 | F | 0.291413 | V | 0.32247 | -0.031057 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 107 | G | 0.291016 | E | 0.346478 | -0.055462 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 112 | C | 0.122693 | Y | 0.160827 | -0.038134 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 122 | G | 0.155044 | R | 0.153674 | 0.00137 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 123 | M | 0.149951 | K | 0.227785 | -0.077834 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 127 | S | 0.162092 | F | 0.058195 | 0.103897 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 130 | I | 0.144094 | F | 0.143897 | 1.97E-04 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 135 | L | 0.169192 | P | 0.289558 | -0.120366 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 139 | R | 0.176488 | S | 0.209017 | -0.032529 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 163 | A | 0.035838 | P | 0.052124 | -0.016286 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 173 | P | 0.071959 | S | 0.089241 | -0.017282 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 174 | Q | 0.072689 | L | 0.039762 | 0.032927 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 191 | D | 0.092357 | G | 0.090988 | 0.001369 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 201 | G | 0.078966 | D | 0.089698 | -0.010732 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 204 | T | 0.052975 | N | 0.059358 | -0.006383 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 206 | V | 0.034005 | D | 0.070663 | -0.036658 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 207 | T | 0.025487 | N | 0.028324 | -0.002837 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 209 | I | 0.017298 | F | 0.018702 | -0.001404 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 214 | F | 0.022519 | S | 0.061763 | -0.039244 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 215 | V | 0.030676 | M | 0.041159 | -0.010483 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 217 | P | 0.047065 | T | 0.039225 | 0.00784 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 219 | L | 0.051678 | P | 0.110317 | -0.058639 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 219 | L | 0.051678 | R | 0.08786 | -0.036182 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 252 | R | 0.851664 | W | 0.71639 | 0.135274 | No Change: Both D | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 272 | M | 0.083623 | K | 0.145183 | -0.06156 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 277 | V | 0.01237 | A | 0.016062 | -0.003692 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 282 | L | 0.004142 | P | 0.009294 | -0.005152 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 286 | P | 0.006837 | S | 0.007794 | -9.57E-04 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 287 | F | 0.006806 | L | 0.008224 | -0.001418 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 289 | L | 0.009026 | P | 0.019918 | -0.010892 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 294 | A | 0.052751 | P | 0.076132 | -0.023381 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 309 | L | 0.064521 | R | 0.098684 | -0.034163 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 315 | S | 0.128096 | R | 0.090755 | 0.037341 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 318 | S | 0.165264 | T | 0.115881 | 0.049383 | No Change: Both O | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 319 | C | 0.186247 | R | 0.301129 | -0.114882 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 321 | N | 0.226967 | D | 0.225928 | 0.001039 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 321 | N | 0.226967 | K | 0.234829 | -0.007862 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 321 | N | 0.226967 | Y | 0.134295 | 0.092672 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 322 | P | 0.2501 | H | 0.188104 | 0.061996 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 322 | P | 0.2501 | S | 0.285395 | -0.035295 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 323 | W | 0.276888 | R | 0.477202 | -0.200314 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 352 | G | 0.927781 | D | 0.936816 | -0.009035 | No Change: Both D | - |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 137 | R | 0.169332 | C | 0.080987 | 0.088345 | No Change: Both O | Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 137 | R | 0.169332 | L | 0.099628 | 0.069704 | No Change: Both O | Nephrogenic syndrome of inappropriate antidiuresis (NSIAD) [MIM:300539] |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 247 | R | 0.850775 | H | 0.83245 | 0.018325 | No Change: Both D | A breast cancer sample |
| P30518 | V2R_HUMAN Vasopressin V2 receptor OS=Homo sapiens GN=AVPR2 PE=1 SV=1 | 122 | G | 0.155044 | D | 0.17207 | -0.017026 | No Change: Both O | Diabetes insipidus nephrogenic X-linked (XNDI) [MIM:304800] |
| Q3ZCQ2 | AX2R_HUMAN Annexin-2 receptor OS=Homo sapiens GN=AX2R PE=2 SV=2 | 119 | Q | 0.851225 | R | 0.841781 | 0.009444 | No Change: Both D | - |
| Q3ZCQ2 | AX2R_HUMAN Annexin-2 receptor OS=Homo sapiens GN=AX2R PE=2 SV=2 | 186 | R | 0.079682 | W | 0.034117 | 0.045565 | No Change: Both O | - |
| Q5T1B0 | AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens GN=AXDND1 PE=1 SV=1 | 742 | A | 0.236489 | V | 0.173639 | 0.06285 | No Change: Both O | - |
| Q5T1B0 | AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens GN=AXDND1 PE=1 SV=1 | 991 | E | 0.999479 | Q | 0.999368 | 1.11E-04 | No Change: Both D | - |
| Q5T1B0 | AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens GN=AXDND1 PE=1 SV=1 | 522 | I | 0.33419 | L | 0.379876 | -0.045686 | No Change: Both O | - |
| Q5T1B0 | AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens GN=AXDND1 PE=1 SV=1 | 993 | Q | 0.999525 | E | 0.999636 | -1.11E-04 | No Change: Both D | - |
| O15169 | AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AXIN1 PE=1 SV=2 | 106 | L | 0.179087 | R | 0.259804 | -0.080717 | No Change: Both O | Hepatocellular carcinoma (HCC) [MIM:114550] |
| O15169 | AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AXIN1 PE=1 SV=2 | 345 | P | 0.759137 | L | 0.616649 | 0.142488 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| O15169 | AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AXIN1 PE=1 SV=2 | 425 | G | 0.975829 | S | 0.979454 | -0.003625 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| O15169 | AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AXIN1 PE=1 SV=2 | 650 | G | 0.92637 | S | 0.94155 | -0.01518 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| O15169 | AXIN1_HUMAN Axin-1 OS=Homo sapiens GN=AXIN1 PE=1 SV=2 | 841 | R | 0.397984 | Q | 0.406513 | -0.008529 | No Change: Both O | - |
| Q9Y2T1 | AXIN2_HUMAN Axin-2 OS=Homo sapiens GN=AXIN2 PE=1 SV=1 | 50 | S | 0.967667 | P | 0.970119 | -0.002452 | No Change: Both D | Polymorphism associated with increased risk of lung cancer |
| P30530 | UFO_HUMAN Tyrosine-protein kinase receptor UFO OS=Homo sapiens GN=AXL PE=1 SV=3 | 499 | R | 0.548289 | C | 0.364348 | 0.183941 | D to O | A gastric adenocarcinoma sample |
| P30530 | UFO_HUMAN Tyrosine-protein kinase receptor UFO OS=Homo sapiens GN=AXL PE=1 SV=3 | 515 | S | 0.587586 | G | 0.523681 | 0.063905 | No Change: Both D | - |
| P30530 | UFO_HUMAN Tyrosine-protein kinase receptor UFO OS=Homo sapiens GN=AXL PE=1 SV=3 | 112 | T | 0.300161 | M | 0.251687 | 0.048474 | No Change: Both O | - |
| P30530 | UFO_HUMAN Tyrosine-protein kinase receptor UFO OS=Homo sapiens GN=AXL PE=1 SV=3 | 295 | R | 0.792912 | W | 0.638397 | 0.154515 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| P30530 | UFO_HUMAN Tyrosine-protein kinase receptor UFO OS=Homo sapiens GN=AXL PE=1 SV=3 | 266 | N | 0.462151 | D | 0.514305 | -0.052154 | O to D | - |
| Q9UPN4 | AZI1_HUMAN 5-azacytidine-induced protein 1 OS=Homo sapiens GN=AZI1 PE=1 SV=3 | 43 | V | 0.826352 | I | 0.797242 | 0.02911 | No Change: Both D | - |
| Q9UPN4 | AZI1_HUMAN 5-azacytidine-induced protein 1 OS=Homo sapiens GN=AZI1 PE=1 SV=3 | 70 | I | 0.892832 | V | 0.914437 | -0.021605 | No Change: Both D | - |
| Q9UPN4 | AZI1_HUMAN 5-azacytidine-induced protein 1 OS=Homo sapiens GN=AZI1 PE=1 SV=3 | 272 | T | 0.376994 | A | 0.354501 | 0.022493 | No Change: Both O | - |
| Q9UPN4 | AZI1_HUMAN 5-azacytidine-induced protein 1 OS=Homo sapiens GN=AZI1 PE=1 SV=3 | 397 | T | 0.947542 | A | 0.945336 | 0.002206 | No Change: Both D | - |
| Q9UPN4 | AZI1_HUMAN 5-azacytidine-induced protein 1 OS=Homo sapiens GN=AZI1 PE=1 SV=3 | 473 | V | 0.730157 | A | 0.792099 | -0.061942 | No Change: Both D | - |
| P61769 | B2MG_HUMAN Beta-2-microglobulin OS=Homo sapiens GN=B2M PE=1 SV=1 | 11 | A | 0.187363 | P | 0.251941 | -0.064578 | No Change: Both O | Hypercatabolic hypoproteinemia (HYCATHYP) [MIM:241600] |
| O75752 | B3GL1_HUMAN UDP-GalNAc:beta-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B3GALNT1 PE=1 SV=1 | 266 | E | 0.162824 | A | 0.107662 | 0.055162 | No Change: Both O | - |
| O75752 | B3GL1_HUMAN UDP-GalNAc:beta-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B3GALNT1 PE=1 SV=1 | 271 | G | 0.024475 | R | 0.023115 | 0.00136 | No Change: Both O | - |
| O75752 | B3GL1_HUMAN UDP-GalNAc:beta-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B3GALNT1 PE=1 SV=1 | 126 | D | 0.704723 | N | 0.687513 | 0.01721 | No Change: Both D | - |
| Q8NCR0 | B3GL2_HUMAN UDP-GalNAc:beta-1 3-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B3GALNT2 PE=1 SV=1 | 203 | N | 0.15897 | S | 0.199573 | -0.040603 | No Change: Both O | A breast cancer sample |
| Q9Y2C3 | B3GT5_HUMAN Beta-1 3-galactosyltransferase 5 OS=Homo sapiens GN=B3GALT5 PE=1 SV=1 | 85 | M | 0.480671 | T | 0.522959 | -0.042288 | O to D | - |
| Q9Y2C3 | B3GT5_HUMAN Beta-1 3-galactosyltransferase 5 OS=Homo sapiens GN=B3GALT5 PE=1 SV=1 | 144 | R | 0.047857 | H | 0.052244 | -0.004387 | No Change: Both O | - |
| Q9Y2C3 | B3GT5_HUMAN Beta-1 3-galactosyltransferase 5 OS=Homo sapiens GN=B3GALT5 PE=1 SV=1 | 27 | S | 0.187691 | R | 0.138894 | 0.048797 | No Change: Both O | - |
| Q96L58 | B3GT6_HUMAN Beta-1 3-galactosyltransferase 6 OS=Homo sapiens GN=B3GALT6 PE=2 SV=2 | 174 | E | 0.587656 | D | 0.560416 | 0.02724 | No Change: Both D | - |
| Q6Y288 | B3GLT_HUMAN Beta-1 3-glucosyltransferase OS=Homo sapiens GN=B3GALTL PE=1 SV=2 | 370 | E | 0.326604 | K | 0.312651 | 0.013953 | No Change: Both O | - |
| Q9P2W7 | B3GA1_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 OS=Homo sapiens GN=B3GAT1 PE=1 SV=2 | 131 | A | 0.414474 | T | 0.473346 | -0.058872 | No Change: Both O | - |
| O94766 | B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens GN=B3GAT3 PE=1 SV=2 | 277 | R | 0.623297 | Q | 0.64315 | -0.019853 | No Change: Both D | Multiple joint dislocations short stature craniofacial dysmorphism and congenital heart defects (JDSSDHD) [MIM:245600] |
| O43505 | B3GN1_HUMAN N-acetyllactosaminide beta-1 3-N-acetylglucosaminyltransferase OS=Homo sapiens GN=B3GNT1 PE=1 SV=1 | 253 | T | 0.176206 | S | 0.250549 | -0.074343 | No Change: Both O | - |
| Q9Y2A9 | B3GN3_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 3 OS=Homo sapiens GN=B3GNT3 PE=1 SV=2 | 328 | R | 0.538366 | H | 0.526276 | 0.01209 | No Change: Both D | - |
| Q9C0J1 | B3GN4_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=B3GNT4 PE=2 SV=1 | 6 | P | 0.879673 | A | 0.840453 | 0.03922 | No Change: Both D | - |
| Q9C0J1 | B3GN4_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=B3GNT4 PE=2 SV=1 | 83 | S | 0.860521 | T | 0.817072 | 0.043449 | No Change: Both D | - |
| Q9C0J1 | B3GN4_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=B3GNT4 PE=2 SV=1 | 87 | L | 0.809688 | P | 0.868058 | -0.05837 | No Change: Both D | - |
| Q8NFL0 | B3GN7_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 7 OS=Homo sapiens GN=B3GNT7 PE=2 SV=1 | 233 | V | 0.050913 | I | 0.048683 | 0.00223 | No Change: Both O | - |
| Q7Z7M8 | B3GN8_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase 8 OS=Homo sapiens GN=B3GNT8 PE=1 SV=1 | 137 | S | 0.585041 | G | 0.544137 | 0.040904 | No Change: Both D | - |
| Q67FW5 | B3GNL_HUMAN UDP-GlcNAc:betaGal beta-1 3-N-acetylglucosaminyltransferase-like protein 1 OS=Homo sapiens GN=B3GNTL1 PE=2 SV=2 | 341 | A | 0.304301 | T | 0.34639 | -0.042089 | No Change: Both O | - |
| Q00973 | B4GN1_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B4GALNT1 PE=1 SV=2 | 35 | L | 0.659142 | V | 0.60749 | 0.051652 | No Change: Both D | - |
| Q00973 | B4GN1_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B4GALNT1 PE=1 SV=2 | 172 | G | 0.420466 | R | 0.405179 | 0.015287 | No Change: Both O | - |
| Q00973 | B4GN1_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B4GALNT1 PE=1 SV=2 | 516 | A | 0.457325 | V | 0.367059 | 0.090266 | No Change: Both O | - |
| Q8NHY0 | B4GN2_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT2 PE=2 SV=2 | 459 | P | 0.225085 | H | 0.191209 | 0.033876 | No Change: Both O | A colorectal cancer sample |
| Q8NHY0 | B4GN2_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT2 PE=2 SV=2 | 40 | A | 0.342147 | D | 0.381193 | -0.039046 | No Change: Both O | - |
| Q8NHY0 | B4GN2_HUMAN Beta-1 4 N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT2 PE=2 SV=2 | 466 | C | 0.166339 | R | 0.286728 | -0.120389 | No Change: Both O | - |
| Q6L9W6 | B4GN3_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT3 PE=1 SV=2 | 59 | G | 0.305354 | S | 0.369058 | -0.063704 | No Change: Both O | - |
| Q6L9W6 | B4GN3_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT3 PE=1 SV=2 | 265 | R | 0.315009 | Q | 0.318721 | -0.003712 | No Change: Both O | - |
| Q6L9W6 | B4GN3_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT3 PE=1 SV=2 | 411 | K | 0.50609 | R | 0.460233 | 0.045857 | D to O | - |
| Q6L9W6 | B4GN3_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT3 PE=1 SV=2 | 768 | R | 0.376551 | Q | 0.394389 | -0.017838 | No Change: Both O | - |
| Q6L9W6 | B4GN3_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=B4GALNT3 PE=1 SV=2 | 992 | R | 0.621227 | H | 0.614233 | 0.006994 | No Change: Both D | - |
| Q76KP1 | B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B4GALNT4 PE=1 SV=1 | 67 | A | 0.944788 | V | 0.926169 | 0.018619 | No Change: Both D | - |
| Q76KP1 | B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=B4GALNT4 PE=1 SV=1 | 88 | G | 0.886809 | V | 0.825686 | 0.061123 | No Change: Both D | - |
| P15291 | B4GT1_HUMAN Beta-1 4-galactosyltransferase 1 OS=Homo sapiens GN=B4GALT1 PE=1 SV=5 | 21 | R | 0.239753 | W | 0.090436 | 0.149317 | No Change: Both O | - |
| P15291 | B4GT1_HUMAN Beta-1 4-galactosyltransferase 1 OS=Homo sapiens GN=B4GALT1 PE=1 SV=5 | 257 | H | 0.232906 | R | 0.243488 | -0.010582 | No Change: Both O | - |
| O60909 | B4GT2_HUMAN Beta-1 4-galactosyltransferase 2 OS=Homo sapiens GN=B4GALT2 PE=1 SV=1 | 122 | Q | 0.656435 | H | 0.613585 | 0.04285 | No Change: Both D | - |
| O60909 | B4GT2_HUMAN Beta-1 4-galactosyltransferase 2 OS=Homo sapiens GN=B4GALT2 PE=1 SV=1 | 338 | G | 0.431676 | R | 0.46789 | -0.036214 | No Change: Both O | - |
| O60513 | B4GT4_HUMAN Beta-1 4-galactosyltransferase 4 OS=Homo sapiens GN=B4GALT4 PE=1 SV=1 | 116 | Q | 0.499404 | E | 0.539096 | -0.039692 | O to D | - |
| O43286 | B4GT5_HUMAN Beta-1 4-galactosyltransferase 5 OS=Homo sapiens GN=B4GALT5 PE=2 SV=1 | 61 | G | 0.162211 | S | 0.201402 | -0.039191 | No Change: Both O | - |
| O43286 | B4GT5_HUMAN Beta-1 4-galactosyltransferase 5 OS=Homo sapiens GN=B4GALT5 PE=2 SV=1 | 371 | Y | 0.12718 | D | 0.234284 | -0.107104 | No Change: Both O | - |
| O43286 | B4GT5_HUMAN Beta-1 4-galactosyltransferase 5 OS=Homo sapiens GN=B4GALT5 PE=2 SV=1 | 368 | D | 0.096402 | N | 0.100822 | -0.00442 | No Change: Both O | - |
| Q9UBX8 | B4GT6_HUMAN Beta-1 4-galactosyltransferase 6 OS=Homo sapiens GN=B4GALT6 PE=1 SV=1 | 379 | I | 0.76218 | V | 0.790816 | -0.028636 | No Change: Both D | - |
| Q9UBV7 | B4GT7_HUMAN Beta-1 4-galactosyltransferase 7 OS=Homo sapiens GN=B4GALT7 PE=1 SV=1 | 186 | A | 0.480795 | D | 0.559536 | -0.078741 | O to D | Ehlers-Danlos syndrome progeroid type (EDSP) [MIM:130070] |
| Q9UBV7 | B4GT7_HUMAN Beta-1 4-galactosyltransferase 7 OS=Homo sapiens GN=B4GALT7 PE=1 SV=1 | 206 | L | 0.148439 | P | 0.253572 | -0.105133 | No Change: Both O | Ehlers-Danlos syndrome progeroid type (EDSP) [MIM:130070] |
| Q9BPU9 | B9D2_HUMAN B9 domain-containing protein 2 OS=Homo sapiens GN=B9D2 PE=2 SV=2 | 11 | I | 0.248407 | M | 0.314554 | -0.066147 | No Change: Both O | - |
| Q8WXS3 | BAALC_HUMAN Brain and acute leukemia cytoplasmic protein OS=Homo sapiens GN=BAALC PE=2 SV=3 | 164 | S | 0.795058 | T | 0.779038 | 0.01602 | No Change: Both D | - |
| Q14032 | BAAT_HUMAN Bile acid-CoA:amino acid N-acyltransferase OS=Homo sapiens GN=BAAT PE=1 SV=1 | 76 | M | 0.146451 | V | 0.110009 | 0.036442 | No Change: Both O | Familial hypercholanemia (FHCA) [MIM:607748] |
| Q14032 | BAAT_HUMAN Bile acid-CoA:amino acid N-acyltransferase OS=Homo sapiens GN=BAAT PE=1 SV=1 | 20 | R | 0.138594 | Q | 0.156142 | -0.017548 | No Change: Both O | - |
| P56817 | BACE1_HUMAN Beta-secretase 1 OS=Homo sapiens GN=BACE1 PE=1 SV=2 | 481 | C | 0.017675 | R | 0.032571 | -0.014896 | No Change: Both O | - |
| P56817 | BACE1_HUMAN Beta-secretase 1 OS=Homo sapiens GN=BACE1 PE=1 SV=2 | 265 | V | 0.04578 | A | 0.059678 | -0.013898 | No Change: Both O | - |
| O14867 | BACH1_HUMAN Transcription regulator protein BACH1 OS=Homo sapiens GN=BACH1 PE=1 SV=2 | 314 | S | 0.606692 | P | 0.60421 | 0.002482 | No Change: Both D | - |
| Q9BYV9 | BACH2_HUMAN Transcription regulator protein BACH2 OS=Homo sapiens GN=BACH2 PE=1 SV=1 | 418 | A | 0.500237 | T | 0.556696 | -0.056459 | No Change: Both D | - |
| Q92934 | BAD_HUMAN Bcl2 antagonist of cell death OS=Homo sapiens GN=BAD PE=1 SV=3 | 107 | A | 0.832894 | S | 0.87689 | -0.043996 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 71 | R | 0.959423 | Q | 0.954052 | 0.005371 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 151 | C | 0.98076 | R | 0.987656 | -0.006896 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 405 | A | 0.985609 | V | 0.980961 | 0.004648 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 407 | P | 0.978171 | L | 0.960481 | 0.01769 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 209 | P | 0.73231 | L | 0.603005 | 0.129305 | No Change: Both D | Myopathy myofibrillar type 6 (MFM6) [MIM:612954] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 71 | R | 0.959423 | W | 0.906421 | 0.053002 | No Change: Both D | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 477 | R | 0.620859 | H | 0.5641 | 0.056759 | No Change: Both D | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 77 | P | 0.929955 | L | 0.872659 | 0.057296 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 94 | I | 0.660613 | F | 0.672444 | -0.011831 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 115 | P | 0.667645 | S | 0.617416 | 0.050229 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 155 | A | 0.985869 | T | 0.985386 | 4.83E-04 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 218 | R | 0.686015 | W | 0.469482 | 0.216533 | D to O | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 258 | R | 0.759491 | W | 0.599687 | 0.159804 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 300 | D | 0.977995 | N | 0.978886 | -8.91E-04 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 380 | P | 0.999357 | S | 0.999266 | 9.10E-05 | No Change: Both D | - |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 455 | E | 0.334054 | K | 0.337824 | -0.00377 | No Change: Both O | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 462 | L | 0.349381 | P | 0.486961 | -0.13758 | No Change: Both O | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 468 | V | 0.512617 | M | 0.577971 | -0.065354 | No Change: Both D | Cardiomyopathy dilated type 1HH (CMD1HH) [MIM:613881] |
| O95817 | BAG3_HUMAN BAG family molecular chaperone regulator 3 OS=Homo sapiens GN=BAG3 PE=1 SV=3 | 553 | E | 0.974271 | D | 0.972108 | 0.002163 | No Change: Both D | - |
| Q9UL15 | BAG5_HUMAN BAG family molecular chaperone regulator 5 OS=Homo sapiens GN=BAG5 PE=1 SV=1 | 157 | C | 0.129403 | W | 0.085294 | 0.044109 | No Change: Both O | - |
| P46379 | BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6 PE=1 SV=2 | 625 | S | 0.729159 | P | 0.75581 | -0.026651 | No Change: Both D | - |
| P46379 | BAG6_HUMAN Large proline-rich protein BAG6 OS=Homo sapiens GN=BAG6 PE=1 SV=2 | 728 | A | 0.462924 | V | 0.34574 | 0.117184 | No Change: Both O | - |
| Q86Y30 | BAGE2_HUMAN B melanoma antigen 2 OS=Homo sapiens GN=BAGE2 PE=2 SV=1 | 95 | R | 0.595487 | T | 0.583785 | 0.011702 | No Change: Both D | - |
| Q86Y30 | BAGE2_HUMAN B melanoma antigen 2 OS=Homo sapiens GN=BAGE2 PE=2 SV=1 | 106 | R | 0.818573 | Q | 0.824151 | -0.005578 | No Change: Both D | - |
| Q86Y29 | BAGE3_HUMAN B melanoma antigen 3 OS=Homo sapiens GN=BAGE3 PE=2 SV=1 | 95 | R | 0.629417 | T | 0.625808 | 0.003609 | No Change: Both D | - |
| Q86Y29 | BAGE3_HUMAN B melanoma antigen 3 OS=Homo sapiens GN=BAGE3 PE=2 SV=1 | 106 | Q | 0.826271 | R | 0.820697 | 0.005574 | No Change: Both D | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 2479 | R | 0.208434 | C | 0.107567 | 0.100867 | No Change: Both O | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 1137 | T | 0.942692 | A | 0.943252 | -5.60E-04 | No Change: Both D | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 272 | A | 0.793392 | T | 0.805296 | -0.011904 | No Change: Both D | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 1403 | R | 0.617447 | Q | 0.617038 | 4.09E-04 | No Change: Both D | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 1647 | T | 0.629292 | A | 0.644484 | -0.015192 | No Change: Both D | - |
| Q9P281 | BAHC1_HUMAN BAH and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=BAHCC1 PE=1 SV=3 | 1998 | V | 0.349717 | I | 0.316842 | 0.032875 | No Change: Both O | - |
| Q8TBE0 | BAHD1_HUMAN Bromo adjacent homology domain-containing 1 protein OS=Homo sapiens GN=BAHD1 PE=1 SV=2 | 26 | E | 0.966991 | G | 0.960146 | 0.006845 | No Change: Both D | - |
| Q8TBE0 | BAHD1_HUMAN Bromo adjacent homology domain-containing 1 protein OS=Homo sapiens GN=BAHD1 PE=1 SV=2 | 182 | D | 0.990109 | H | 0.985165 | 0.004944 | No Change: Both D | - |
| Q8TBE0 | BAHD1_HUMAN Bromo adjacent homology domain-containing 1 protein OS=Homo sapiens GN=BAHD1 PE=1 SV=2 | 298 | Q | 0.955602 | K | 0.954944 | 6.58E-04 | No Change: Both D | - |
| O60242 | BAI3_HUMAN Brain-specific angiogenesis inhibitor 3 OS=Homo sapiens GN=BAI3 PE=1 SV=2 | 503 | N | 0.591657 | S | 0.648073 | -0.056416 | No Change: Both D | - |
| Q9UQB8 | BAIP2_HUMAN Brain-specific angiogenesis inhibitor 1-associated protein 2 OS=Homo sapiens GN=BAIAP2 PE=1 SV=1 | 519 | Q | 0.48656 | R | 0.500231 | -0.013671 | O to D | - |
| Q9UHR4 | BI2L1_HUMAN Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 OS=Homo sapiens GN=BAIAP2L1 PE=1 SV=2 | 460 | S | 0.888472 | T | 0.865526 | 0.022946 | No Change: Both D | - |
| O94812 | BAIP3_HUMAN BAI1-associated protein 3 OS=Homo sapiens GN=BAIAP3 PE=1 SV=2 | 582 | D | 0.553335 | A | 0.46366 | 0.089675 | D to O | - |
| O94812 | BAIP3_HUMAN BAI1-associated protein 3 OS=Homo sapiens GN=BAIAP3 PE=1 SV=2 | 879 | S | 0.357621 | I | 0.183294 | 0.174327 | No Change: Both O | - |
| Q16611 | BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens GN=BAK1 PE=1 SV=1 | 28 | A | 0.877032 | V | 0.852074 | 0.024958 | No Change: Both D | - |
| Q16611 | BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens GN=BAK1 PE=1 SV=1 | 69 | S | 0.603525 | R | 0.562499 | 0.041026 | No Change: Both D | - |
| Q16611 | BAK_HUMAN Bcl-2 homologous antagonist/killer OS=Homo sapiens GN=BAK1 PE=1 SV=1 | 42 | R | 0.732789 | H | 0.702779 | 0.03001 | No Change: Both D | - |
| O75531 | BAF_HUMAN Barrier-to-autointegration factor OS=Homo sapiens GN=BANF1 PE=1 SV=1 | 12 | A | 0.561854 | T | 0.606215 | -0.044361 | No Change: Both D | Nestor-Guillermo progeria syndrome (NGPS) [MIM:614008] |
| Q9H503 | BAFL_HUMAN Barrier-to-autointegration factor-like protein OS=Homo sapiens GN=BANF2 PE=1 SV=1 | 78 | T | 0.359144 | S | 0.440535 | -0.081391 | No Change: Both O | - |
| Q9H503 | BAFL_HUMAN Barrier-to-autointegration factor-like protein OS=Homo sapiens GN=BANF2 PE=1 SV=1 | 3 | N | 0.860162 | D | 0.847725 | 0.012437 | No Change: Both D | - |
| Q8NDB2 | BANK1_HUMAN B-cell scaffold protein with ankyrin repeats OS=Homo sapiens GN=BANK1 PE=1 SV=3 | 61 | R | 0.106717 | H | 0.103888 | 0.002829 | No Change: Both O | - |
| Q8NDB2 | BANK1_HUMAN B-cell scaffold protein with ankyrin repeats OS=Homo sapiens GN=BANK1 PE=1 SV=3 | 383 | A | 0.650666 | T | 0.65709 | -0.006424 | No Change: Both D | - |
| Q8NDB2 | BANK1_HUMAN B-cell scaffold protein with ankyrin repeats OS=Homo sapiens GN=BANK1 PE=1 SV=3 | 650 | C | 0.800437 | R | 0.87196 | -0.071523 | No Change: Both D | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 616 | V | 0.827673 | E | 0.910436 | -0.082763 | No Change: Both D | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 95 | A | 0.141431 | D | 0.190414 | -0.048983 | No Change: Both O | A lung cancer sample |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 178 | G | 0.102588 | V | 0.06059 | 0.041998 | No Change: Both O | A lung cancer sample |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 63 | S | 0.59343 | C | 0.315802 | 0.277628 | D to O | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 81 | F | 0.095267 | V | 0.109427 | -0.01416 | No Change: Both O | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 91 | C | 0.221702 | W | 0.189844 | 0.031858 | No Change: Both O | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 315 | E | 0.954148 | A | 0.945485 | 0.008663 | No Change: Both D | - |
| Q92560 | BAP1_HUMAN Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Homo sapiens GN=BAP1 PE=1 SV=2 | 685 | E | 0.232139 | V | 0.12919 | 0.102949 | No Change: Both O | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 24 | P | 0.928901 | S | 0.928263 | 6.38E-04 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 153 | K | 0.718107 | E | 0.665675 | 0.052432 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 507 | V | 0.231093 | M | 0.271674 | -0.040581 | No Change: Both O | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 557 | C | 0.753385 | S | 0.854148 | -0.100763 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 564 | Q | 0.693207 | H | 0.65998 | 0.033227 | No Change: Both D | An ovarian clear cell adenocarcinoma |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 658 | R | 0.67935 | C | 0.49352 | 0.18583 | D to O | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 695 | V | 0.202515 | L | 0.219854 | -0.017339 | No Change: Both O | A breast cancer sample |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 761 | S | 0.09157 | N | 0.07015 | 0.02142 | No Change: Both O | An uterine cancer sample |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 241 | S | 0.809918 | C | 0.694264 | 0.115654 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 378 | R | 0.972344 | S | 0.97877 | -0.006426 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 728 | S | 0.474318 | F | 0.288643 | 0.185675 | No Change: Both O | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 186 | S | 0.947062 | G | 0.916641 | 0.030421 | No Change: Both D | - |
| Q99728 | BARD1_HUMAN BRCA1-associated RING domain protein 1 OS=Homo sapiens GN=BARD1 PE=1 SV=2 | 645 | C | 0.400735 | R | 0.544391 | -0.143656 | O to D | - |
| Q9HBU1 | BARX1_HUMAN Homeobox protein BarH-like 1 OS=Homo sapiens GN=BARX1 PE=1 SV=2 | 48 | A | 0.622928 | T | 0.601916 | 0.021012 | No Change: Both D | - |
| P80723 | BASP1_HUMAN Brain acid soluble protein 1 OS=Homo sapiens GN=BASP1 PE=1 SV=2 | 76 | A | 0.999697 | V | 0.99942 | 2.77E-04 | No Change: Both D | - |
| Q8N1L9 | BATF2_HUMAN Basic leucine zipper transcriptional factor ATF-like 2 OS=Homo sapiens GN=BATF2 PE=1 SV=1 | 6 | G | 0.926605 | S | 0.92931 | -0.002705 | No Change: Both D | - |
| Q9NR55 | BATF3_HUMAN Basic leucine zipper transcriptional factor ATF-like 3 OS=Homo sapiens GN=BATF3 PE=1 SV=1 | 11 | V | 0.980593 | I | 0.972361 | 0.008232 | No Change: Both D | - |
| Q07812 | BAX_HUMAN Apoptosis regulator BAX OS=Homo sapiens GN=BAX PE=1 SV=1 | 67 | G | 0.590599 | R | 0.655404 | -0.064805 | No Change: Both D | A T-cell acute lymphoblastic leukemia cell line |
| Q07812 | BAX_HUMAN Apoptosis regulator BAX OS=Homo sapiens GN=BAX PE=1 SV=1 | 11 | G | 0.909077 | E | 0.915266 | -0.006189 | No Change: Both D | - |
| Q07812 | BAX_HUMAN Apoptosis regulator BAX OS=Homo sapiens GN=BAX PE=1 SV=1 | 108 | G | 0.068883 | V | 0.037994 | 0.030889 | No Change: Both O | A Burkitt lymphoma |
| Q07812 | BAX_HUMAN Apoptosis regulator BAX OS=Homo sapiens GN=BAX PE=1 SV=1 | 39 | G | 0.668834 | R | 0.684367 | -0.015533 | No Change: Both D | - |
| Q9NRL2 | BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens GN=BAZ1A PE=1 SV=2 | 344 | D | 0.999214 | E | 0.999425 | -2.11E-04 | No Change: Both D | - |
| Q9NRL2 | BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens GN=BAZ1A PE=1 SV=2 | 1366 | N | 0.912849 | K | 0.917401 | -0.004552 | No Change: Both D | - |
| Q9UIF9 | BAZ2A_HUMAN Bromodomain adjacent to zinc finger domain protein 2A OS=Homo sapiens GN=BAZ2A PE=1 SV=4 | 498 | V | 0.943503 | E | 0.964653 | -0.02115 | No Change: Both D | - |
| Q9UIF8 | BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens GN=BAZ2B PE=1 SV=3 | 71 | M | 0.525348 | T | 0.590639 | -0.065291 | No Change: Both D | - |
| Q9UIF8 | BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens GN=BAZ2B PE=1 SV=3 | 422 | L | 0.890445 | S | 0.930668 | -0.040223 | No Change: Both D | - |
| Q9UIF8 | BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens GN=BAZ2B PE=1 SV=3 | 530 | P | 0.872289 | L | 0.781527 | 0.090762 | No Change: Both D | - |
| Q9UIF8 | BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens GN=BAZ2B PE=1 SV=3 | 702 | G | 0.932834 | V | 0.897017 | 0.035817 | No Change: Both D | - |
| Q9UIF8 | BAZ2B_HUMAN Bromodomain adjacent to zinc finger domain protein 2B OS=Homo sapiens GN=BAZ2B PE=1 SV=3 | 2024 | S | 0.987822 | N | 0.9845 | 0.003322 | No Change: Both D | - |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 234 | E | 0.155471 | K | 0.156471 | -0.001 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 390 | M | 0.264835 | R | 0.341043 | -0.076208 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 518 | L | 0.028149 | P | 0.057785 | -0.029636 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 35 | H | 0.191694 | R | 0.183555 | 0.008139 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 53 | K | 0.365821 | E | 0.381949 | -0.016128 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 148 | D | 0.705249 | N | 0.687778 | 0.017471 | No Change: Both D | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 160 | R | 0.768578 | Q | 0.786379 | -0.017801 | No Change: Both D | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 305 | G | 0.352646 | S | 0.418295 | -0.065649 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 434 | Y | 0.383687 | S | 0.576149 | -0.192462 | O to D | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 503 | L | 0.309581 | H | 0.41139 | -0.101809 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 518 | L | 0.028149 | Q | 0.048304 | -0.020155 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 559 | G | 0.34146 | D | 0.377995 | -0.036535 | No Change: Both O | - |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 330 | I | 0.110317 | T | 0.211372 | -0.101055 | No Change: Both O | Bardet-Biedl syndrome type 1 (BBS1) [MIM:209900] |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 206 | L | 0.420095 | V | 0.412089 | 0.008006 | No Change: Both O | - |
| Q8NFJ9 | BBS1_HUMAN Bardet-Biedl syndrome 1 protein OS=Homo sapiens GN=BBS1 PE=1 SV=1 | 245 | P | 0.218693 | L | 0.115992 | 0.102701 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 34 | R | 0.299544 | P | 0.357227 | -0.057683 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 49 | R | 0.379851 | W | 0.182653 | 0.197198 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 91 | C | 0.026981 | W | 0.017999 | 0.008982 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 170 | L | 0.238867 | S | 0.413544 | -0.174677 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 195 | C | 0.045544 | W | 0.035161 | 0.010383 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 197 | Y | 0.040096 | C | 0.038504 | 0.001592 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 240 | V | 0.100945 | G | 0.179123 | -0.078178 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 308 | L | 0.376964 | F | 0.328606 | 0.048358 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 311 | S | 0.331906 | A | 0.215426 | 0.11648 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 329 | S | 0.186851 | L | 0.085663 | 0.101188 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 363 | P | 0.1778 | L | 0.094901 | 0.082899 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 376 | L | 0.136757 | F | 0.11726 | 0.019497 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 414 | L | 0.399491 | S | 0.570253 | -0.170762 | O to D | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 579 | K | 0.525229 | R | 0.485744 | 0.039485 | D to O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 613 | Y | 0.040752 | C | 0.034171 | 0.006581 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 613 | Y | 0.040752 | H | 0.069 | -0.028248 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 677 | G | 0.547791 | V | 0.410802 | 0.136989 | D to O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 689 | T | 0.131669 | P | 0.156468 | -0.024799 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 539 | P | 0.451133 | L | 0.333175 | 0.117958 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 55 | L | 0.347255 | P | 0.456213 | -0.108958 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 142 | D | 0.16511 | N | 0.144736 | 0.020374 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 188 | K | 0.26326 | T | 0.198567 | 0.064693 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 255 | M | 0.262819 | I | 0.190617 | 0.072202 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 296 | A | 0.385414 | T | 0.434193 | -0.048779 | No Change: Both O | - |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 410 | H | 0.561031 | Q | 0.570617 | -0.009586 | No Change: Both D | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 600 | L | 0.201744 | S | 0.33667 | -0.134926 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 636 | A | 0.070846 | V | 0.049003 | 0.021843 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 687 | L | 0.171334 | P | 0.279948 | -0.108614 | No Change: Both O | Bardet-Biedl syndrome type 10 (BBS10) [MIM:209900] |
| Q8TAM1 | BBS10_HUMAN Bardet-Biedl syndrome 10 protein OS=Homo sapiens GN=BBS10 PE=1 SV=2 | 715 | H | 0.756486 | R | 0.743491 | 0.012995 | No Change: Both D | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 39 | I | 0.39467 | T | 0.519742 | -0.125072 | O to D | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 126 | E | 0.298797 | D | 0.261286 | 0.037511 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 159 | P | 0.218499 | L | 0.122889 | 0.09561 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 170 | I | 0.430427 | V | 0.477556 | -0.047129 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 195 | K | 0.534792 | R | 0.491292 | 0.0435 | D to O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 238 | N | 0.490764 | K | 0.51266 | -0.021896 | O to D | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 289 | A | 0.340533 | P | 0.414936 | -0.074403 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 386 | R | 0.558486 | Q | 0.593349 | -0.034863 | No Change: Both D | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 429 | S | 0.204339 | T | 0.141723 | 0.062616 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 461 | N | 0.182376 | H | 0.167349 | 0.015027 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 467 | D | 0.118586 | N | 0.110259 | 0.008327 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 484 | R | 0.283204 | K | 0.333562 | -0.050358 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 540 | G | 0.122057 | V | 0.067272 | 0.054785 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 615 | A | 0.520645 | V | 0.434081 | 0.086564 | D to O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 346 | I | 0.462637 | T | 0.587859 | -0.125222 | O to D | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 501 | T | 0.115348 | M | 0.08544 | 0.029908 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 88 | L | 0.070839 | R | 0.116044 | -0.045205 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 119 | G | 0.290144 | S | 0.373846 | -0.083702 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 263 | Y | 0.26721 | H | 0.414595 | -0.147385 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 293 | Q | 0.210066 | E | 0.242259 | -0.032193 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 355 | R | 0.126237 | Q | 0.14945 | -0.023213 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 400 | V | 0.071036 | M | 0.089125 | -0.018089 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 408 | K | 0.067155 | R | 0.052444 | 0.014711 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 524 | Y | 0.027315 | C | 0.020923 | 0.006392 | No Change: Both O | - |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 525 | R | 0.030592 | H | 0.02996 | 6.32E-04 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 539 | G | 0.148799 | D | 0.152108 | -0.003309 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q6ZW61 | BBS12_HUMAN Bardet-Biedl syndrome 12 protein OS=Homo sapiens GN=BBS12 PE=1 SV=2 | 674 | R | 0.092063 | C | 0.040532 | 0.051531 | No Change: Both O | Bardet-Biedl syndrome type 12 (BBS12) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 70 | N | 0.21689 | S | 0.260462 | -0.043572 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 75 | V | 0.132347 | G | 0.214798 | -0.082451 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 104 | D | 0.171955 | A | 0.123225 | 0.04873 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 123 | I | 0.142463 | V | 0.1711 | -0.028637 | No Change: Both O | - |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 315 | R | 0.249014 | Q | 0.264007 | -0.014993 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 315 | R | 0.249014 | W | 0.108115 | 0.140899 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 558 | T | 0.31207 | I | 0.197008 | 0.115062 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 632 | R | 0.460882 | P | 0.457127 | 0.003755 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 122 | A | 0.157706 | V | 0.11227 | 0.045436 | No Change: Both O | - |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 504 | A | 0.139894 | V | 0.103937 | 0.035957 | No Change: Both O | - |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 23 | R | 0.249102 | P | 0.28627 | -0.037168 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 174 | D | 0.424332 | E | 0.438444 | -0.014112 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 349 | L | 0.667658 | W | 0.512955 | 0.154703 | No Change: Both D | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 643 | R | 0.48699 | H | 0.448234 | 0.038756 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 81 | G | 0.151825 | C | 0.077628 | 0.074197 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 125 | L | 0.149683 | R | 0.230567 | -0.080884 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 136 | A | 0.170957 | P | 0.238417 | -0.06746 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 307 | C | 0.078301 | W | 0.056057 | 0.022244 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 317 | Y | 0.310453 | C | 0.309957 | 4.96E-04 | No Change: Both O | Bardet-Biedl syndrome type 2 (BBS2) [MIM:209900] |
| Q9BXC9 | BBS2_HUMAN Bardet-Biedl syndrome 2 protein OS=Homo sapiens GN=BBS2 PE=1 SV=1 | 629 | E | 0.443395 | K | 0.462198 | -0.018803 | No Change: Both O | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 295 | R | 0.118684 | P | 0.14769 | -0.029006 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 165 | N | 0.317376 | H | 0.293253 | 0.024123 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 327 | L | 0.140244 | P | 0.271947 | -0.131703 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 364 | A | 0.246194 | E | 0.331598 | -0.085404 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 457 | S | 0.901678 | I | 0.748394 | 0.153284 | No Change: Both D | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 472 | M | 0.93485 | V | 0.907901 | 0.026949 | No Change: Both D | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 354 | I | 0.448999 | T | 0.622145 | -0.173146 | O to D | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 268 | E | 0.252608 | K | 0.250447 | 0.002161 | No Change: Both O | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 393 | A | 0.56158 | V | 0.488278 | 0.073302 | D to O | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 46 | K | 0.195206 | R | 0.154122 | 0.041084 | No Change: Both O | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 351 | L | 0.274308 | R | 0.383558 | -0.10925 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 368 | D | 0.211797 | G | 0.191442 | 0.020355 | No Change: Both O | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 503 | P | 0.984496 | L | 0.96849 | 0.016006 | No Change: Both D | Bardet-Biedl syndrome type 4 (BBS4) [MIM:209900] |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 61 | E | 0.345188 | K | 0.341431 | 0.003757 | No Change: Both O | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 412 | E | 0.688224 | D | 0.662988 | 0.025236 | No Change: Both D | - |
| Q96RK4 | BBS4_HUMAN Bardet-Biedl syndrome 4 protein OS=Homo sapiens GN=BBS4 PE=1 SV=2 | 488 | T | 0.947465 | K | 0.952452 | -0.004987 | No Change: Both D | - |
| Q8N3I7 | BBS5_HUMAN Bardet-Biedl syndrome 5 protein OS=Homo sapiens GN=BBS5 PE=1 SV=1 | 184 | N | 0.037008 | S | 0.042424 | -0.005416 | No Change: Both O | - |
| Q8N3I7 | BBS5_HUMAN Bardet-Biedl syndrome 5 protein OS=Homo sapiens GN=BBS5 PE=1 SV=1 | 207 | R | 0.201086 | H | 0.190832 | 0.010254 | No Change: Both O | - |
| Q8N3I7 | BBS5_HUMAN Bardet-Biedl syndrome 5 protein OS=Homo sapiens GN=BBS5 PE=1 SV=1 | 72 | G | 0.09385 | S | 0.129054 | -0.035204 | No Change: Both O | Bardet-Biedl syndrome type 5 (BBS5) [MIM:209900] |
| Q8N3I7 | BBS5_HUMAN Bardet-Biedl syndrome 5 protein OS=Homo sapiens GN=BBS5 PE=1 SV=1 | 251 | N | 0.47306 | D | 0.502218 | -0.029158 | O to D | - |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 211 | T | 0.361013 | I | 0.236713 | 0.1243 | No Change: Both O | Bardet-Biedl syndrome type 7 (BBS7) [MIM:209900] |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 323 | H | 0.665116 | R | 0.673007 | -0.007891 | No Change: Both D | Bardet-Biedl syndrome type 7 (BBS7) [MIM:209900] |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 66 | I | 0.29138 | F | 0.298656 | -0.007276 | No Change: Both O | Bardet-Biedl syndrome type 7 (BBS7) [MIM:209900] |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 671 | Y | 0.134456 | C | 0.116261 | 0.018195 | No Change: Both O | - |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 63 | G | 0.293306 | R | 0.295735 | -0.002429 | No Change: Both O | Bardet-Biedl syndrome type 7 (BBS7) [MIM:209900] |
| Q8IWZ6 | BBS7_HUMAN Bardet-Biedl syndrome 7 protein OS=Homo sapiens GN=BBS7 PE=1 SV=2 | 293 | Q | 0.393726 | P | 0.413204 | -0.019478 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 141 | G | 0.253128 | R | 0.235987 | 0.017141 | No Change: Both O | Bardet-Biedl syndrome type 9 (BBS9) [MIM:209900] |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 455 | A | 0.223362 | V | 0.199119 | 0.024243 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 12 | T | 0.119342 | A | 0.111516 | 0.007826 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 455 | A | 0.223362 | T | 0.267959 | -0.044597 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 521 | R | 0.32745 | Q | 0.3264 | 0.00105 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 549 | T | 0.607544 | I | 0.478159 | 0.129385 | D to O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 665 | L | 0.458652 | F | 0.419061 | 0.039591 | No Change: Both O | - |
| Q3SYG4 | PTHB1_HUMAN Protein PTHB1 OS=Homo sapiens GN=BBS9 PE=1 SV=1 | 779 | L | 0.367137 | Q | 0.490105 | -0.122968 | No Change: Both O | - |
| Q8WY36 | BBX_HUMAN HMG box transcription factor BBX OS=Homo sapiens GN=BBX PE=1 SV=1 | 576 | P | 0.94425 | S | 0.941814 | 0.002436 | No Change: Both D | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 77 | R | 0.602635 | H | 0.580581 | 0.022054 | No Change: Both D | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 196 | V | 0.522768 | I | 0.478109 | 0.044659 | D to O | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 204 | M | 0.557887 | K | 0.602487 | -0.0446 | No Change: Both D | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 282 | R | 0.339259 | H | 0.318207 | 0.021052 | No Change: Both O | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 381 | V | 0.399308 | I | 0.326393 | 0.072915 | No Change: Both O | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 451 | K | 0.546349 | Q | 0.526334 | 0.020015 | No Change: Both D | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 539 | T | 0.433586 | A | 0.389153 | 0.044433 | No Change: Both O | - |
| P50895 | BCAM_HUMAN Basal cell adhesion molecule OS=Homo sapiens GN=BCAM PE=1 SV=2 | 581 | Q | 0.665441 | L | 0.571293 | 0.094148 | No Change: Both D | - |
| Q96GW7 | PGCB_HUMAN Brevican core protein OS=Homo sapiens GN=BCAN PE=1 SV=2 | 504 | E | 0.987233 | K | 0.98184 | 0.005393 | No Change: Both D | - |
| Q96GW7 | PGCB_HUMAN Brevican core protein OS=Homo sapiens GN=BCAN PE=1 SV=2 | 356 | S | 0.440572 | L | 0.257719 | 0.182853 | No Change: Both O | - |
| P56945 | BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens GN=BCAR1 PE=1 SV=2 | 407 | S | 0.881745 | T | 0.860995 | 0.02075 | No Change: Both D | A breast cancer sample |
| P56945 | BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens GN=BCAR1 PE=1 SV=2 | 491 | R | 0.716326 | L | 0.655618 | 0.060708 | No Change: Both D | - |
| P56945 | BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens GN=BCAR1 PE=1 SV=2 | 558 | H | 0.524494 | R | 0.569349 | -0.044855 | No Change: Both D | - |
| P56945 | BCAR1_HUMAN Breast cancer anti-estrogen resistance protein 1 OS=Homo sapiens GN=BCAR1 PE=1 SV=2 | 76 | P | 0.860497 | S | 0.837824 | 0.022673 | No Change: Both D | - |
| O75815 | BCAR3_HUMAN Breast cancer anti-estrogen resistance protein 3 OS=Homo sapiens GN=BCAR3 PE=1 SV=1 | 464 | E | 0.656383 | G | 0.630628 | 0.025755 | No Change: Both D | - |
| O75815 | BCAR3_HUMAN Breast cancer anti-estrogen resistance protein 3 OS=Homo sapiens GN=BCAR3 PE=1 SV=1 | 593 | Q | 0.242277 | H | 0.25276 | -0.010483 | No Change: Both O | - |
| O75363 | BCAS1_HUMAN Breast carcinoma-amplified sequence 1 OS=Homo sapiens GN=BCAS1 PE=1 SV=2 | 255 | G | 0.891915 | E | 0.91242 | -0.020505 | No Change: Both D | - |
| O75363 | BCAS1_HUMAN Breast carcinoma-amplified sequence 1 OS=Homo sapiens GN=BCAS1 PE=1 SV=2 | 24 | Q | 0.691953 | K | 0.68579 | 0.006163 | No Change: Both D | - |
| O75363 | BCAS1_HUMAN Breast carcinoma-amplified sequence 1 OS=Homo sapiens GN=BCAS1 PE=1 SV=2 | 163 | V | 0.922434 | A | 0.950142 | -0.027708 | No Change: Both D | - |
| O75363 | BCAS1_HUMAN Breast carcinoma-amplified sequence 1 OS=Homo sapiens GN=BCAS1 PE=1 SV=2 | 583 | S | 0.825361 | P | 0.837867 | -0.012506 | No Change: Both D | - |
| O75363 | BCAS1_HUMAN Breast carcinoma-amplified sequence 1 OS=Homo sapiens GN=BCAS1 PE=1 SV=2 | 472 | Q | 0.936644 | H | 0.928148 | 0.008496 | No Change: Both D | - |
| O75934 | SPF27_HUMAN Pre-mRNA-splicing factor SPF27 OS=Homo sapiens GN=BCAS2 PE=1 SV=1 | 139 | N | 0.218126 | S | 0.225616 | -0.00749 | No Change: Both O | A colorectal cancer sample |
| Q9H6U6 | BCAS3_HUMAN Breast carcinoma-amplified sequence 3 OS=Homo sapiens GN=BCAS3 PE=1 SV=3 | 106 | I | 0.228001 | V | 0.249775 | -0.021774 | No Change: Both O | - |
| Q9H6U6 | BCAS3_HUMAN Breast carcinoma-amplified sequence 3 OS=Homo sapiens GN=BCAS3 PE=1 SV=3 | 87 | N | 0.518624 | S | 0.570754 | -0.05213 | No Change: Both D | - |
| Q8TDM0 | BCAS4_HUMAN Breast carcinoma-amplified sequence 4 OS=Homo sapiens GN=BCAS4 PE=2 SV=1 | 56 | E | 0.66562 | D | 0.607913 | 0.057707 | No Change: Both D | - |
| Q8TDM0 | BCAS4_HUMAN Breast carcinoma-amplified sequence 4 OS=Homo sapiens GN=BCAS4 PE=2 SV=1 | 173 | R | 0.544458 | H | 0.441577 | 0.102881 | D to O | - |
| P54687 | BCAT1_HUMAN Branched-chain-amino-acid aminotransferase cytosolic OS=Homo sapiens GN=BCAT1 PE=1 SV=3 | 321 | E | 0.397979 | K | 0.383926 | 0.014053 | No Change: Both O | - |
| P54687 | BCAT1_HUMAN Branched-chain-amino-acid aminotransferase cytosolic OS=Homo sapiens GN=BCAT1 PE=1 SV=3 | 59 | T | 0.201241 | M | 0.170417 | 0.030824 | No Change: Both O | - |
| P54687 | BCAT1_HUMAN Branched-chain-amino-acid aminotransferase cytosolic OS=Homo sapiens GN=BCAT1 PE=1 SV=3 | 330 | G | 0.245663 | S | 0.288525 | -0.042862 | No Change: Both O | - |
| O15382 | BCAT2_HUMAN Branched-chain-amino-acid aminotransferase mitochondrial OS=Homo sapiens GN=BCAT2 PE=1 SV=2 | 186 | T | 0.208555 | R | 0.229717 | -0.021162 | No Change: Both O | - |
| Q9P287 | BCCIP_HUMAN BRCA2 and CDKN1A-interacting protein OS=Homo sapiens GN=BCCIP PE=1 SV=1 | 254 | E | 0.489109 | Q | 0.430268 | 0.058841 | No Change: Both O | - |
| Q7Z5W3 | BN3D2_HUMAN Probable methyltransferase BCDIN3D OS=Homo sapiens GN=BCDIN3D PE=2 SV=1 | 288 | S | 0.856281 | R | 0.850624 | 0.005657 | No Change: Both D | - |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 98 | D | 0.327232 | G | 0.318036 | 0.009196 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 358 | L | 0.133966 | I | 0.119793 | 0.014173 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 567 | A | 0.299997 | T | 0.325391 | -0.025394 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 52 | T | 0.106404 | M | 0.084061 | 0.022343 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 56 | F | 0.098114 | I | 0.100856 | -0.002742 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 61 | Y | 0.181273 | C | 0.153414 | 0.027859 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 65 | P | 0.289581 | S | 0.293123 | -0.003542 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 98 | D | 0.327232 | H | 0.300495 | 0.026737 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 124 | N | 0.041317 | Y | 0.022311 | 0.019006 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 128 | P | 0.181202 | S | 0.182697 | -0.001495 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 143 | G | 0.086687 | D | 0.087339 | -6.52E-04 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 153 | L | 0.368686 | F | 0.350217 | 0.018469 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 156 | Y | 0.275255 | C | 0.227338 | 0.047917 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 170 | V | 0.104242 | M | 0.130663 | -0.026421 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 198 | D | 0.19658 | E | 0.22376 | -0.02718 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 226 | S | 0.49894 | G | 0.444556 | 0.054384 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 227 | A | 0.48627 | V | 0.406655 | 0.079615 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 229 | A | 0.472271 | T | 0.4862 | -0.013929 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 271 | T | 0.334934 | M | 0.279731 | 0.055203 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 278 | T | 0.372775 | P | 0.413683 | -0.040908 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 283 | E | 0.454396 | D | 0.403711 | 0.050685 | No Change: Both O | - |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 295 | K | 0.33952 | R | 0.295716 | 0.043804 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 335 | L | 0.164309 | P | 0.291062 | -0.126753 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 356 | A | 0.190176 | D | 0.258442 | -0.068266 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 393 | G | 0.348572 | R | 0.322605 | 0.025967 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 414 | R | 0.482995 | C | 0.284717 | 0.198278 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 418 | G | 0.266835 | V | 0.164109 | 0.102726 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 446 | F | 0.10673 | S | 0.254713 | -0.147983 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 488 | E | 0.495457 | K | 0.496573 | -0.001116 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 499 | W | 0.18556 | R | 0.396551 | -0.210991 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 502 | F | 0.241389 | L | 0.265338 | -0.023949 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 525 | E | 0.460195 | V | 0.281915 | 0.17828 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 543 | R | 0.238961 | C | 0.140981 | 0.09798 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P06276 | CHLE_HUMAN Cholinesterase OS=Homo sapiens GN=BCHE PE=1 SV=1 | 546 | Q | 0.130182 | L | 0.069268 | 0.060914 | No Change: Both O | Butyrylcholinesterase deficiency (BChE deficiency) [MIM:177400] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 159 | R | 0.158387 | W | 0.063089 | 0.095298 | No Change: Both O | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 190 | Q | 0.407038 | K | 0.475644 | -0.068606 | No Change: Both O | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 253 | A | 0.121548 | T | 0.130961 | -0.009413 | No Change: Both O | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 326 | I | 0.14671 | T | 0.255153 | -0.108443 | No Change: Both O | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 413 | Y | 0.668885 | C | 0.691901 | -0.023016 | No Change: Both D | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 438 | Y | 0.50506 | N | 0.624846 | -0.119786 | No Change: Both D | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 290 | G | 0.314069 | R | 0.300992 | 0.013077 | No Change: Both O | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 409 | F | 0.728396 | C | 0.748861 | -0.020465 | No Change: Both D | Maple syrup urine disease type IA (MSUD1A) [MIM:248600] |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 39 | P | 0.892695 | H | 0.855435 | 0.03726 | No Change: Both D | - |
| P12694 | ODBA_HUMAN 2-oxoisovalerate dehydrogenase subunit alpha mitochondrial OS=Homo sapiens GN=BCKDHA PE=1 SV=2 | 151 | T | 0.23507 | M | 0.199629 | 0.035441 | No Change: Both O | - |
| P21953 | ODBB_HUMAN 2-oxoisovalerate dehydrogenase subunit beta mitochondrial OS=Homo sapiens GN=BCKDHB PE=1 SV=2 | 206 | H | 0.124372 | R | 0.128218 | -0.003846 | No Change: Both O | Maple syrup urine disease type IB (MSUD1B) [MIM:248600] |
| P21953 | ODBB_HUMAN 2-oxoisovalerate dehydrogenase subunit beta mitochondrial OS=Homo sapiens GN=BCKDHB PE=1 SV=2 | 183 | R | 0.155201 | P | 0.191189 | -0.035988 | No Change: Both O | Maple syrup urine disease type IB (MSUD1B) [MIM:248600] |
| P21953 | ODBB_HUMAN 2-oxoisovalerate dehydrogenase subunit beta mitochondrial OS=Homo sapiens GN=BCKDHB PE=1 SV=2 | 278 | G | 0.090891 | S | 0.117068 | -0.026177 | No Change: Both O | Maple syrup urine disease type IB (MSUD1B) [MIM:248600] |
| P21953 | ODBB_HUMAN 2-oxoisovalerate dehydrogenase subunit beta mitochondrial OS=Homo sapiens GN=BCKDHB PE=1 SV=2 | 41 | T | 0.544501 | I | 0.388886 | 0.155615 | D to O | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 5 | A | 0.803851 | S | 0.833178 | -0.029327 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 16 | V | 0.611153 | E | 0.754419 | -0.143266 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 31 | K | 0.359599 | E | 0.383535 | -0.023936 | No Change: Both O | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 45 | K | 0.588304 | Q | 0.520616 | 0.067688 | No Change: Both D | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 52 | T | 0.698802 | I | 0.599964 | 0.098838 | No Change: Both D | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 57 | C | 0.739733 | R | 0.847169 | -0.107436 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 58 | R | 0.746033 | G | 0.705981 | 0.040052 | No Change: Both D | Germ cell tumor |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 58 | R | 0.746033 | Q | 0.721028 | 0.025005 | No Change: Both D | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 64 | R | 0.724749 | K | 0.742621 | -0.017872 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 93 | N | 0.383763 | S | 0.432498 | -0.048735 | No Change: Both O | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 101 | D | 0.297364 | E | 0.351103 | -0.053739 | No Change: Both O | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 134 | S | 0.880019 | P | 0.871311 | 0.008708 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 153 | M | 0.841531 | V | 0.818352 | 0.023179 | No Change: Both D | - |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 168 | T | 0.821287 | A | 0.767656 | 0.053631 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 174 | L | 0.798736 | S | 0.880947 | -0.082211 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 213 | G | 0.920611 | E | 0.948268 | -0.027657 | No Change: Both D | MALT lymphoma |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 218 | S | 0.918172 | F | 0.832423 | 0.085749 | No Change: Both D | Germ cell tumor |
| O95999 | BCL10_HUMAN B-cell lymphoma/leukemia 10 OS=Homo sapiens GN=BCL10 PE=1 SV=1 | 230 | V | 0.905474 | I | 0.899474 | 0.006 | No Change: Both D | MALT lymphoma |
| Q9H165 | BC11A_HUMAN B-cell lymphoma/leukemia 11A OS=Homo sapiens GN=BCL11A PE=1 SV=2 | 142 | S | 0.598457 | F | 0.380063 | 0.218394 | D to O | A breast cancer sample |
| Q9C0K0 | BC11B_HUMAN B-cell lymphoma/leukemia 11B OS=Homo sapiens GN=BCL11B PE=1 SV=1 | 331 | S | 0.853829 | P | 0.872404 | -0.018575 | No Change: Both D | A colorectal cancer sample |
| Q9C0K0 | BC11B_HUMAN B-cell lymphoma/leukemia 11B OS=Homo sapiens GN=BCL11B PE=1 SV=1 | 32 | E | 0.746788 | V | 0.571632 | 0.175156 | No Change: Both D | - |
| Q9C0K0 | BC11B_HUMAN B-cell lymphoma/leukemia 11B OS=Homo sapiens GN=BCL11B PE=1 SV=1 | 229 | P | 0.244582 | S | 0.258855 | -0.014273 | No Change: Both O | - |
| P10415 | BCL2_HUMAN Apoptosis regulator Bcl-2 OS=Homo sapiens GN=BCL2 PE=1 SV=2 | 7 | T | 0.616693 | S | 0.675967 | -0.059274 | No Change: Both D | - |
| P10415 | BCL2_HUMAN Apoptosis regulator Bcl-2 OS=Homo sapiens GN=BCL2 PE=1 SV=2 | 59 | P | 0.958304 | S | 0.953037 | 0.005267 | No Change: Both D | Non-Hodgkin lymphoma |
| P10415 | BCL2_HUMAN Apoptosis regulator Bcl-2 OS=Homo sapiens GN=BCL2 PE=1 SV=2 | 93 | V | 0.688721 | I | 0.622424 | 0.066297 | No Change: Both D | Non-Hodgkin lymphoma |
| P10415 | BCL2_HUMAN Apoptosis regulator Bcl-2 OS=Homo sapiens GN=BCL2 PE=1 SV=2 | 43 | A | 0.649906 | T | 0.6427 | 0.007206 | No Change: Both D | - |
| Q16548 | B2LA1_HUMAN Bcl-2-related protein A1 OS=Homo sapiens GN=BCL2A1 PE=1 SV=1 | 19 | C | 0.103721 | Y | 0.125385 | -0.021664 | No Change: Both O | - |
| Q16548 | B2LA1_HUMAN Bcl-2-related protein A1 OS=Homo sapiens GN=BCL2A1 PE=1 SV=1 | 39 | N | 0.346 | K | 0.410305 | -0.064305 | No Change: Both O | - |
| Q16548 | B2LA1_HUMAN Bcl-2-related protein A1 OS=Homo sapiens GN=BCL2A1 PE=1 SV=1 | 82 | G | 0.193072 | D | 0.213091 | -0.020019 | No Change: Both O | - |
| Q16548 | B2LA1_HUMAN Bcl-2-related protein A1 OS=Homo sapiens GN=BCL2A1 PE=1 SV=1 | 117 | E | 0.197977 | D | 0.188254 | 0.009723 | No Change: Both O | - |
| Q9HD36 | B2L10_HUMAN Bcl-2-like protein 10 OS=Homo sapiens GN=BCL2L10 PE=1 SV=2 | 11 | L | 0.714193 | R | 0.8195 | -0.105307 | No Change: Both D | - |
| Q9HB09 | B2L12_HUMAN Bcl-2-like protein 12 OS=Homo sapiens GN=BCL2L12 PE=1 SV=1 | 47 | G | 0.518948 | V | 0.427798 | 0.09115 | D to O | - |
| Q9BXK5 | B2L13_HUMAN Bcl-2-like protein 13 OS=Homo sapiens GN=BCL2L13 PE=1 SV=1 | 55 | I | 0.764419 | V | 0.771986 | -0.007567 | No Change: Both D | - |
| Q9BXK5 | B2L13_HUMAN Bcl-2-like protein 13 OS=Homo sapiens GN=BCL2L13 PE=1 SV=1 | 360 | P | 0.755091 | S | 0.74691 | 0.008181 | No Change: Both D | - |
| Q9BXK5 | B2L13_HUMAN Bcl-2-like protein 13 OS=Homo sapiens GN=BCL2L13 PE=1 SV=1 | 46 | I | 0.722592 | R | 0.803278 | -0.080686 | No Change: Both D | - |
| Q9BXK5 | B2L13_HUMAN Bcl-2-like protein 13 OS=Homo sapiens GN=BCL2L13 PE=1 SV=1 | 46 | I | 0.722592 | T | 0.803676 | -0.081084 | No Change: Both D | - |
| Q5TBC7 | B2L15_HUMAN Bcl-2-like protein 15 OS=Homo sapiens GN=BCL2L15 PE=2 SV=1 | 90 | D | 0.340131 | N | 0.323851 | 0.01628 | No Change: Both O | - |
| Q92843 | B2CL2_HUMAN Bcl-2-like protein 2 OS=Homo sapiens GN=BCL2L2 PE=1 SV=2 | 133 | Q | 0.124736 | R | 0.114714 | 0.010022 | No Change: Both O | - |
| P41182 | BCL6_HUMAN B-cell lymphoma 6 protein OS=Homo sapiens GN=BCL6 PE=1 SV=1 | 676 | H | 0.47586 | Y | 0.34048 | 0.13538 | No Change: Both O | - |
| P41182 | BCL6_HUMAN B-cell lymphoma 6 protein OS=Homo sapiens GN=BCL6 PE=1 SV=1 | 493 | A | 0.927732 | T | 0.941187 | -0.013455 | No Change: Both D | - |
| P41182 | BCL6_HUMAN B-cell lymphoma 6 protein OS=Homo sapiens GN=BCL6 PE=1 SV=1 | 252 | N | 0.715716 | S | 0.773332 | -0.057616 | No Change: Both D | - |
| Q4VC05 | BCL7A_HUMAN B-cell CLL/lymphoma 7 protein family member A OS=Homo sapiens GN=BCL7A PE=1 SV=1 | 120 | N | 0.993009 | T | 0.992007 | 0.001002 | No Change: Both D | - |
| O00512 | BCL9_HUMAN B-cell CLL/lymphoma 9 protein OS=Homo sapiens GN=BCL9 PE=1 SV=4 | 671 | P | 0.967925 | S | 0.962683 | 0.005242 | No Change: Both D | - |
| O00512 | BCL9_HUMAN B-cell CLL/lymphoma 9 protein OS=Homo sapiens GN=BCL9 PE=1 SV=4 | 782 | R | 0.952912 | K | 0.951776 | 0.001136 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 209 | S | 0.945546 | C | 0.898683 | 0.046863 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 459 | Y | 0.925214 | D | 0.954162 | -0.028948 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 461 | L | 0.925032 | H | 0.940639 | -0.015607 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 629 | N | 0.528847 | S | 0.635835 | -0.106988 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 875 | R | 0.716202 | C | 0.536495 | 0.179707 | No Change: Both D | - |
| Q9NYF8 | BCLF1_HUMAN Bcl-2-associated transcription factor 1 OS=Homo sapiens GN=BCLAF1 PE=1 SV=2 | 66 | G | 0.986509 | A | 0.977835 | 0.008674 | No Change: Both D | - |
| Q9HAY6 | BCDO1_HUMAN Beta beta-carotene 15 15'-monooxygenase OS=Homo sapiens GN=BCMO1 PE=1 SV=1 | 267 | R | 0.121468 | S | 0.165475 | -0.044007 | No Change: Both O | - |
| Q9HAY6 | BCDO1_HUMAN Beta beta-carotene 15 15'-monooxygenase OS=Homo sapiens GN=BCMO1 PE=1 SV=1 | 379 | A | 0.297502 | V | 0.227858 | 0.069644 | No Change: Both O | - |
| Q9HAY6 | BCDO1_HUMAN Beta beta-carotene 15 15'-monooxygenase OS=Homo sapiens GN=BCMO1 PE=1 SV=1 | 170 | T | 0.353942 | M | 0.308763 | 0.045179 | No Change: Both O | Autosomal dominant hypercarotenemia and vitamin A deficiency (ADHVAD) [MIM:115300] |
| Q9BYV7 | BCDO2_HUMAN Beta beta-carotene 9' 10'-oxygenase OS=Homo sapiens GN=BCO2 PE=1 SV=5 | 231 | L | 0.48623 | P | 0.646946 | -0.160716 | O to D | - |
| Q9BYV7 | BCDO2_HUMAN Beta beta-carotene 9' 10'-oxygenase OS=Homo sapiens GN=BCO2 PE=1 SV=5 | 289 | G | 0.218818 | E | 0.260015 | -0.041197 | No Change: Both O | - |
| Q9BYV7 | BCDO2_HUMAN Beta beta-carotene 9' 10'-oxygenase OS=Homo sapiens GN=BCO2 PE=1 SV=5 | 548 | I | 0.152805 | L | 0.184739 | -0.031934 | No Change: Both O | - |
| Q6W2J9 | BCOR_HUMAN BCL-6 corepressor OS=Homo sapiens GN=BCOR PE=1 SV=1 | 85 | P | 0.251951 | L | 0.164522 | 0.087429 | No Change: Both O | Microphthalmia syndromic type 2 (MCOPS2) [MIM:300166] |
| Q5H9F3 | BCORL_HUMAN BCL-6 corepressor-like protein 1 OS=Homo sapiens GN=BCORL1 PE=1 SV=1 | 209 | G | 0.867949 | S | 0.902839 | -0.03489 | No Change: Both D | - |
| Q5H9F3 | BCORL_HUMAN BCL-6 corepressor-like protein 1 OS=Homo sapiens GN=BCORL1 PE=1 SV=1 | 832 | G | 0.400037 | D | 0.388208 | 0.011829 | No Change: Both O | A breast cancer sample |
| Q5H9F3 | BCORL_HUMAN BCL-6 corepressor-like protein 1 OS=Homo sapiens GN=BCORL1 PE=1 SV=1 | 111 | F | 0.79292 | L | 0.844233 | -0.051313 | No Change: Both D | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 796 | N | 0.781256 | S | 0.811707 | -0.030451 | No Change: Both D | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1037 | E | 0.512103 | K | 0.537889 | -0.025786 | No Change: Both D | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1127 | T | 0.106655 | M | 0.09991 | 0.006745 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 400 | S | 0.492901 | P | 0.51779 | -0.024889 | O to D | A bladder transitional cell carcinoma sample |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 413 | I | 0.332145 | M | 0.410909 | -0.078764 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 752 | D | 0.190012 | E | 0.205115 | -0.015103 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 910 | Y | 0.180172 | C | 0.15516 | 0.025012 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 949 | V | 0.324102 | I | 0.286865 | 0.037237 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1091 | V | 0.201663 | M | 0.248387 | -0.046724 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1096 | T | 0.1923 | A | 0.195928 | -0.003628 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1104 | A | 0.239037 | G | 0.266719 | -0.027682 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1106 | D | 0.281296 | N | 0.271452 | 0.009844 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1149 | A | 0.209525 | T | 0.225076 | -0.015551 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1161 | E | 0.312726 | K | 0.324738 | -0.012012 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1187 | K | 0.260465 | E | 0.267151 | -0.006686 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1189 | V | 0.364696 | M | 0.423178 | -0.058482 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1204 | A | 0.364201 | G | 0.395231 | -0.03103 | No Change: Both O | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 1235 | W | 0.438212 | R | 0.639245 | -0.201033 | O to D | - |
| P11274 | BCR_HUMAN Breakpoint cluster region protein OS=Homo sapiens GN=BCR PE=1 SV=2 | 558 | K | 0.210833 | T | 0.156642 | 0.054191 | No Change: Both O | - |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 78 | S | 0.606769 | G | 0.527455 | 0.079314 | No Change: Both D | GRACILE syndrome (GRACILE) [MIM:603358] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 99 | P | 0.303565 | L | 0.176115 | 0.12745 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 144 | R | 0.166366 | Q | 0.178238 | -0.011872 | No Change: Both O | GRACILE syndrome (GRACILE) [MIM:603358] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 155 | R | 0.313716 | P | 0.34365 | -0.029934 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 277 | S | 0.344686 | N | 0.284597 | 0.060089 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 327 | V | 0.172122 | A | 0.2369 | -0.064778 | No Change: Both O | GRACILE syndrome (GRACILE) [MIM:603358] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 353 | V | 0.146695 | M | 0.175585 | -0.02889 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 35 | G | 0.211819 | R | 0.200612 | 0.011207 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 45 | R | 0.05991 | C | 0.024972 | 0.034938 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 114 | R | 0.222157 | W | 0.103532 | 0.118625 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 183 | R | 0.405551 | H | 0.376413 | 0.029138 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 184 | R | 0.421254 | C | 0.239009 | 0.182245 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 184 | R | 0.421254 | C | 0.239009 | 0.182245 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 302 | Q | 0.260959 | E | 0.316171 | -0.055212 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 306 | R | 0.196405 | H | 0.196885 | -4.80E-04 | No Change: Both O | Bjoernstad syndrome (BJS) [MIM:262000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 50 | T | 0.183662 | A | 0.175306 | 0.008356 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 73 | R | 0.575917 | C | 0.406198 | 0.169719 | D to O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 183 | R | 0.405551 | C | 0.239947 | 0.165604 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9Y276 | BCS1_HUMAN Mitochondrial chaperone BCS1 OS=Homo sapiens GN=BCS1L PE=1 SV=1 | 368 | F | 0.233803 | I | 0.220256 | 0.013547 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| Q9BUT1 | BDH2_HUMAN 3-hydroxybutyrate dehydrogenase type 2 OS=Homo sapiens GN=BDH2 PE=1 SV=2 | 70 | N | 0.263764 | S | 0.29848 | -0.034716 | No Change: Both O | - |
| P46663 | BKRB1_HUMAN B1 bradykinin receptor OS=Homo sapiens GN=BDKRB1 PE=1 SV=3 | 250 | A | 0.217577 | V | 0.170004 | 0.047573 | No Change: Both O | - |
| P46663 | BKRB1_HUMAN B1 bradykinin receptor OS=Homo sapiens GN=BDKRB1 PE=1 SV=3 | 317 | R | 0.034692 | Q | 0.035263 | -5.71E-04 | No Change: Both O | - |
| P30411 | BKRB2_HUMAN B2 bradykinin receptor OS=Homo sapiens GN=BDKRB2 PE=1 SV=2 | 14 | R | 0.430674 | C | 0.289925 | 0.140749 | No Change: Both O | - |
| P30411 | BKRB2_HUMAN B2 bradykinin receptor OS=Homo sapiens GN=BDKRB2 PE=1 SV=2 | 354 | G | 0.409064 | E | 0.46131 | -0.052246 | No Change: Both O | - |
| P23560 | BDNF_HUMAN Brain-derived neurotrophic factor OS=Homo sapiens GN=BDNF PE=1 SV=1 | 66 | V | 0.408405 | M | 0.48006 | -0.071655 | No Change: Both O | - |
| P23560 | BDNF_HUMAN Brain-derived neurotrophic factor OS=Homo sapiens GN=BDNF PE=1 SV=1 | 75 | Q | 0.65157 | H | 0.637555 | 0.014015 | No Change: Both D | - |
| P23560 | BDNF_HUMAN Brain-derived neurotrophic factor OS=Homo sapiens GN=BDNF PE=1 SV=1 | 125 | R | 0.565217 | M | 0.512305 | 0.052912 | No Change: Both D | - |
| P23560 | BDNF_HUMAN Brain-derived neurotrophic factor OS=Homo sapiens GN=BDNF PE=1 SV=1 | 127 | R | 0.633902 | L | 0.497765 | 0.136137 | D to O | - |
| P23560 | BDNF_HUMAN Brain-derived neurotrophic factor OS=Homo sapiens GN=BDNF PE=1 SV=1 | 2 | T | 0.382061 | I | 0.194329 | 0.187732 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 38 | D | 0.993892 | E | 0.99427 | -3.78E-04 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 757 | R | 0.941558 | C | 0.929112 | 0.012446 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 778 | V | 0.898373 | M | 0.913913 | -0.01554 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1264 | I | 0.780096 | M | 0.851483 | -0.071387 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1347 | V | 0.832884 | M | 0.887414 | -0.05453 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1469 | K | 0.931314 | E | 0.934552 | -0.003238 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 2013 | I | 0.283008 | L | 0.301411 | -0.018403 | No Change: Both O | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 26 | N | 0.984356 | S | 0.988846 | -0.00449 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 125 | A | 0.945976 | V | 0.926246 | 0.01973 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 722 | K | 0.863941 | E | 0.870948 | -0.007007 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1180 | G | 0.962716 | S | 0.97145 | -0.008734 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1244 | F | 0.790137 | I | 0.831359 | -0.041222 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 1676 | Q | 0.755437 | E | 0.776931 | -0.021494 | No Change: Both D | - |
| A6H8Y1 | BDP1_HUMAN Transcription factor TFIIIB component B'' homolog OS=Homo sapiens GN=BDP1 PE=1 SV=3 | 2555 | N | 0.975338 | S | 0.981353 | -0.006015 | No Change: Both D | - |
| Q14457 | BECN1_HUMAN Beclin-1 OS=Homo sapiens GN=BECN1 PE=1 SV=2 | 403 | I | 0.650497 | T | 0.726856 | -0.076359 | No Change: Both D | - |
| Q14457 | BECN1_HUMAN Beclin-1 OS=Homo sapiens GN=BECN1 PE=1 SV=2 | 103 | A | 0.639739 | V | 0.584647 | 0.055092 | No Change: Both D | - |
| Q8NDZ0 | BEND2_HUMAN BEN domain-containing protein 2 OS=Homo sapiens GN=BEND2 PE=2 SV=2 | 154 | F | 0.557963 | L | 0.56428 | -0.006317 | No Change: Both D | - |
| Q8NDZ0 | BEND2_HUMAN BEN domain-containing protein 2 OS=Homo sapiens GN=BEND2 PE=2 SV=2 | 188 | S | 0.799638 | F | 0.609171 | 0.190467 | No Change: Both D | - |
| Q8N7W2 | BEND7_HUMAN BEN domain-containing protein 7 OS=Homo sapiens GN=BEND7 PE=1 SV=2 | 313 | R | 0.208405 | T | 0.182465 | 0.02594 | No Change: Both O | A breast cancer sample |
| Q8N7W2 | BEND7_HUMAN BEN domain-containing protein 7 OS=Homo sapiens GN=BEND7 PE=1 SV=2 | 341 | N | 0.624764 | S | 0.639772 | -0.015008 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 6 | T | 0.507461 | P | 0.540881 | -0.03342 | No Change: Both D | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 6 | T | 0.507461 | P | 0.540881 | -0.03342 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 9 | V | 0.328735 | A | 0.441741 | -0.113006 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 9 | V | 0.328735 | M | 0.403615 | -0.07488 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 10 | A | 0.338709 | T | 0.377754 | -0.039045 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 21 | L | 0.071048 | V | 0.064298 | 0.00675 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 24 | W | 0.042834 | C | 0.054911 | -0.012077 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 25 | R | 0.04298 | Q | 0.044573 | -0.001593 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 25 | R | 0.04298 | W | 0.016181 | 0.026799 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 27 | S | 0.048297 | R | 0.037798 | 0.010499 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 58 | Q | 0.355354 | L | 0.220074 | 0.13528 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 67 | L | 0.068751 | V | 0.063005 | 0.005746 | No Change: Both O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 85 | Y | 0.018568 | H | 0.033316 | -0.014748 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 92 | R | 0.036455 | S | 0.049701 | -0.013246 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 93 | W | 0.043224 | C | 0.047493 | -0.004269 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 99 | N | 0.175016 | K | 0.193871 | -0.018855 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 100 | L | 0.207571 | R | 0.325148 | -0.117577 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 104 | D | 0.243068 | E | 0.279261 | -0.036193 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 141 | R | 0.125501 | H | 0.124018 | 0.001483 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 141 | R | 0.125501 | H | 0.124018 | 0.001483 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 209 | S | 0.200643 | N | 0.184585 | 0.016058 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 218 | R | 0.274052 | C | 0.152851 | 0.121201 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 218 | R | 0.274052 | Q | 0.308889 | -0.034837 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 218 | R | 0.274052 | S | 0.345308 | -0.071256 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 224 | L | 0.056075 | M | 0.073058 | -0.016983 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 227 | Y | 0.040431 | C | 0.031415 | 0.009016 | No Change: Both O | Retinitis pigmentosa type 50 (RP50) [MIM:613194] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 227 | Y | 0.040431 | N | 0.073812 | -0.033381 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 231 | S | 0.038697 | R | 0.028177 | 0.01052 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 235 | V | 0.039072 | M | 0.046956 | -0.007884 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 237 | T | 0.048599 | R | 0.048318 | 2.81E-04 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 243 | A | 0.035815 | V | 0.027836 | 0.007979 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 243 | A | 0.035815 | V | 0.027836 | 0.007979 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 297 | P | 0.356179 | A | 0.285858 | 0.070321 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 299 | G | 0.498556 | E | 0.580228 | -0.081672 | O to D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 300 | E | 0.535981 | K | 0.517033 | 0.018948 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 301 | D | 0.574157 | E | 0.599508 | -0.025351 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 301 | D | 0.574157 | N | 0.54938 | 0.024777 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 305 | F | 0.394283 | S | 0.619412 | -0.225129 | O to D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 310 | I | 0.128527 | T | 0.23698 | -0.108453 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 311 | V | 0.116239 | G | 0.192487 | -0.076248 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 312 | D | 0.11845 | N | 0.115011 | 0.003439 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 312 | D | 0.11845 | N | 0.115011 | 0.003439 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 578 | E | 0.572371 | V | 0.352153 | 0.220218 | D to O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 10 | A | 0.338709 | V | 0.258107 | 0.080602 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 13 | R | 0.370426 | H | 0.357179 | 0.013247 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 16 | S | 0.203779 | F | 0.081998 | 0.121781 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 17 | F | 0.153017 | C | 0.150944 | 0.002073 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 73 | I | 0.048174 | N | 0.100801 | -0.052627 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 82 | L | 0.02083 | V | 0.021793 | -9.63E-04 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 92 | R | 0.036455 | C | 0.016222 | 0.020233 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 92 | R | 0.036455 | H | 0.036964 | -5.09E-04 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 96 | Q | 0.106888 | H | 0.100406 | 0.006482 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 119 | E | 0.623529 | Q | 0.574941 | 0.048588 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 135 | G | 0.094521 | S | 0.125025 | -0.030504 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 146 | A | 0.225841 | K | 0.317237 | -0.091396 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 216 | T | 0.330434 | I | 0.186319 | 0.144115 | No Change: Both O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 218 | R | 0.274052 | H | 0.292221 | -0.018169 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 235 | V | 0.039072 | L | 0.037012 | 0.00206 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 293 | Q | 0.124802 | K | 0.161799 | -0.036997 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 296 | N | 0.268411 | S | 0.307708 | -0.039297 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 297 | P | 0.356179 | S | 0.386337 | -0.030158 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 300 | E | 0.535981 | D | 0.519211 | 0.01677 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 307 | T | 0.268172 | I | 0.17039 | 0.097782 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 525 | E | 0.75863 | A | 0.665461 | 0.093169 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 557 | E | 0.772211 | K | 0.760918 | 0.011293 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 561 | T | 0.696915 | A | 0.640196 | 0.056719 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 567 | L | 0.604657 | F | 0.54887 | 0.055787 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 6 | T | 0.507461 | R | 0.504667 | 0.002794 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 11 | N | 0.364096 | I | 0.196023 | 0.168073 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 26 | G | 0.045481 | R | 0.045145 | 3.36E-04 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 29 | Y | 0.047862 | H | 0.078121 | -0.030259 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 30 | K | 0.049447 | R | 0.039122 | 0.010325 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 41 | L | 0.003725 | P | 0.00753 | -0.003805 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 41 | L | 0.003725 | P | 0.00753 | -0.003805 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 47 | R | 0.00819 | H | 0.00768 | 5.10E-04 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 80 | F | 0.024365 | L | 0.028886 | -0.004521 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 89 | V | 0.016092 | A | 0.021354 | -0.005262 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 91 | T | 0.027173 | I | 0.012737 | 0.014436 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 101 | P | 0.208138 | T | 0.158597 | 0.049541 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 102 | W | 0.226983 | R | 0.450572 | -0.223589 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 104 | D | 0.243068 | H | 0.210637 | 0.032431 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 133 | N | 0.091772 | K | 0.103381 | -0.011609 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 140 | L | 0.113918 | R | 0.185051 | -0.071133 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 195 | A | 0.131418 | V | 0.089776 | 0.041642 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 105 | R | 0.212187 | C | 0.104616 | 0.107571 | No Change: Both O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 113 | F | 0.404375 | L | 0.455931 | -0.051556 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 201 | I | 0.144311 | T | 0.238066 | -0.093755 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 207 | L | 0.18143 | I | 0.157892 | 0.023538 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 221 | C | 0.148241 | W | 0.129282 | 0.018959 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 222 | G | 0.106353 | V | 0.05799 | 0.048363 | No Change: Both O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 224 | L | 0.056075 | P | 0.114892 | -0.058817 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 241 | T | 0.047849 | N | 0.05302 | -0.005171 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 243 | A | 0.035815 | T | 0.046061 | -0.010246 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 275 | V | 0.035616 | I | 0.027764 | 0.007852 | No Change: Both O | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 276 | F | 0.024784 | L | 0.028208 | -0.003424 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 294 | L | 0.172499 | V | 0.17652 | -0.004021 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 295 | I | 0.220108 | T | 0.348509 | -0.128401 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 296 | N | 0.268411 | H | 0.248177 | 0.020234 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 298 | F | 0.433775 | S | 0.661376 | -0.227601 | O to D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 302 | D | 0.546749 | G | 0.505952 | 0.040797 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 302 | D | 0.546749 | H | 0.476188 | 0.070561 | D to O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 302 | D | 0.546749 | V | 0.334028 | 0.212721 | D to O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 303 | D | 0.491695 | E | 0.514572 | -0.022877 | O to D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 306 | E | 0.319992 | D | 0.311224 | 0.008768 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 306 | E | 0.319992 | G | 0.266663 | 0.053329 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 307 | T | 0.268172 | A | 0.243257 | 0.024915 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 308 | N | 0.221764 | S | 0.246336 | -0.024572 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 152 | P | 0.320323 | A | 0.263428 | 0.056895 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 317 | V | 0.197133 | M | 0.264435 | -0.067302 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 325 | M | 0.458023 | T | 0.467604 | -0.009581 | No Change: Both O | Bestrophinopathy autosomal recessive (ARB) [MIM:611809] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 357 | A | 0.732878 | V | 0.621521 | 0.111357 | No Change: Both D | - |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 3 | I | 0.78984 | T | 0.890535 | -0.100695 | No Change: Both D | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 86 | V | 0.017638 | M | 0.021249 | -0.003611 | No Change: Both O | Vitreoretinochoroidopathy autosomal dominant (ADVIRC) [MIM:193220] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 236 | Y | 0.044688 | C | 0.033899 | 0.010789 | No Change: Both O | Vitreoretinochoroidopathy autosomal dominant (ADVIRC) [MIM:193220] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 239 | V | 0.054349 | M | 0.064153 | -0.009804 | No Change: Both O | Vitreoretinochoroidopathy autosomal dominant (ADVIRC) [MIM:193220] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 242 | V | 0.042933 | M | 0.050942 | -0.008009 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 299 | G | 0.498556 | A | 0.439894 | 0.058662 | No Change: Both O | Vitelliform macular dystrophy type 2 (VMD2) [MIM:153700] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 140 | L | 0.113918 | V | 0.116164 | -0.002246 | No Change: Both O | Retinitis pigmentosa type 50 (RP50) [MIM:613194] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 205 | I | 0.16697 | T | 0.271912 | -0.104942 | No Change: Both O | Retinitis pigmentosa type 50 (RP50) [MIM:613194] |
| O76090 | BEST1_HUMAN Bestrophin-1 OS=Homo sapiens GN=BEST1 PE=1 SV=1 | 228 | D | 0.040664 | N | 0.037699 | 0.002965 | No Change: Both O | Retinitis pigmentosa type 50 (RP50) [MIM:613194] |
| Q8N1M1 | BEST3_HUMAN Bestrophin-3 OS=Homo sapiens GN=BEST3 PE=2 SV=1 | 43 | Y | 0.020691 | H | 0.035194 | -0.014503 | No Change: Both O | - |
| Q8N1M1 | BEST3_HUMAN Bestrophin-3 OS=Homo sapiens GN=BEST3 PE=2 SV=1 | 622 | E | 0.664924 | G | 0.626831 | 0.038093 | No Change: Both D | - |
| Q8NFU0 | BEST4_HUMAN Bestrophin-4 OS=Homo sapiens GN=BEST4 PE=2 SV=1 | 62 | Y | 0.142791 | C | 0.10888 | 0.033911 | No Change: Both O | - |
| Q8NFU0 | BEST4_HUMAN Bestrophin-4 OS=Homo sapiens GN=BEST4 PE=2 SV=1 | 217 | Y | 0.291103 | S | 0.520071 | -0.228968 | O to D | - |
| Q8NFU0 | BEST4_HUMAN Bestrophin-4 OS=Homo sapiens GN=BEST4 PE=2 SV=1 | 331 | Q | 0.342468 | E | 0.366228 | -0.02376 | No Change: Both O | - |
| Q8NFU0 | BEST4_HUMAN Bestrophin-4 OS=Homo sapiens GN=BEST4 PE=2 SV=1 | 402 | R | 0.878418 | L | 0.833827 | 0.044591 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 40 | A | 0.513687 | V | 0.448944 | 0.064743 | D to O | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 66 | M | 0.64128 | I | 0.518391 | 0.122889 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 9 | V | 0.979783 | L | 0.983088 | -0.003305 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 11 | S | 0.966862 | N | 0.965531 | 0.001331 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 13 | S | 0.9525 | I | 0.876802 | 0.075698 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 14 | M | 0.947288 | V | 0.931093 | 0.016195 | No Change: Both D | - |
| Q9HBH7 | BEX1_HUMAN Protein BEX1 OS=Homo sapiens GN=BEX1 PE=2 SV=2 | 17 | A | 0.946917 | V | 0.931689 | 0.015228 | No Change: Both D | - |
| Q9NZS9 | BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens GN=BFAR PE=1 SV=1 | 140 | M | 0.508766 | R | 0.586715 | -0.077949 | No Change: Both D | - |
| Q9NZS9 | BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens GN=BFAR PE=1 SV=1 | 245 | R | 0.261378 | H | 0.249708 | 0.01167 | No Change: Both O | - |
| Q12934 | BFSP1_HUMAN Filensin OS=Homo sapiens GN=BFSP1 PE=1 SV=3 | 345 | G | 0.629989 | S | 0.673217 | -0.043228 | No Change: Both D | - |
| Q12934 | BFSP1_HUMAN Filensin OS=Homo sapiens GN=BFSP1 PE=1 SV=3 | 656 | D | 0.962262 | E | 0.97608 | -0.013818 | No Change: Both D | - |
| Q13515 | BFSP2_HUMAN Phakinin OS=Homo sapiens GN=BFSP2 PE=1 SV=1 | 287 | R | 0.480731 | W | 0.283475 | 0.197256 | No Change: Both O | Cataract autosomal dominant BFSP2-related (ADC-BFSP2) [MIM:611597] |
| P02818 | OSTCN_HUMAN Osteocalcin OS=Homo sapiens GN=BGLAP PE=1 SV=2 | 94 | R | 0.300824 | Q | 0.300698 | 1.26E-04 | No Change: Both O | - |
| P21810 | PGS1_HUMAN Biglycan OS=Homo sapiens GN=BGN PE=1 SV=2 | 266 | R | 0.338232 | T | 0.318619 | 0.019613 | No Change: Both O | A breast cancer sample |
| P21810 | PGS1_HUMAN Biglycan OS=Homo sapiens GN=BGN PE=1 SV=2 | 288 | K | 0.461828 | N | 0.443673 | 0.018155 | No Change: Both O | A breast cancer sample |
| Q6PI77 | BHLH9_HUMAN Protein BHLHb9 OS=Homo sapiens GN=BHLHB9 PE=2 SV=1 | 132 | S | 0.604188 | G | 0.570811 | 0.033377 | No Change: Both D | - |
| Q6PI77 | BHLH9_HUMAN Protein BHLHb9 OS=Homo sapiens GN=BHLHB9 PE=2 SV=1 | 318 | C | 0.290239 | R | 0.414868 | -0.124629 | No Change: Both O | - |
| Q8NFJ8 | BHE22_HUMAN Class E basic helix-loop-helix protein 22 OS=Homo sapiens GN=BHLHE22 PE=2 SV=1 | 28 | S | 0.878908 | A | 0.848299 | 0.030609 | No Change: Both D | - |
| Q9C0J9 | BHE41_HUMAN Class E basic helix-loop-helix protein 41 OS=Homo sapiens GN=BHLHE41 PE=2 SV=1 | 384 | P | 0.625082 | R | 0.522058 | 0.103024 | No Change: Both D | - |
| Q93088 | BHMT1_HUMAN Betaine--homocysteine S-methyltransferase 1 OS=Homo sapiens GN=BHMT PE=1 SV=2 | 239 | R | 0.417693 | Q | 0.444757 | -0.027064 | No Change: Both O | - |
| Q93088 | BHMT1_HUMAN Betaine--homocysteine S-methyltransferase 1 OS=Homo sapiens GN=BHMT PE=1 SV=2 | 199 | G | 0.33776 | S | 0.371211 | -0.033451 | No Change: Both O | - |
| Q9H694 | BICC1_HUMAN Protein bicaudal C homolog 1 OS=Homo sapiens GN=BICC1 PE=1 SV=2 | 8 | G | 0.937234 | D | 0.945001 | -0.007767 | No Change: Both D | - |
| Q9H694 | BICC1_HUMAN Protein bicaudal C homolog 1 OS=Homo sapiens GN=BICC1 PE=1 SV=2 | 943 | S | 0.646573 | P | 0.631901 | 0.014672 | No Change: Both D | - |
| Q9H694 | BICC1_HUMAN Protein bicaudal C homolog 1 OS=Homo sapiens GN=BICC1 PE=1 SV=2 | 945 | N | 0.592661 | S | 0.662525 | -0.069864 | No Change: Both D | - |
| Q9H694 | BICC1_HUMAN Protein bicaudal C homolog 1 OS=Homo sapiens GN=BICC1 PE=1 SV=2 | 711 | N | 0.857543 | T | 0.844763 | 0.01278 | No Change: Both D | - |
| Q9H694 | BICC1_HUMAN Protein bicaudal C homolog 1 OS=Homo sapiens GN=BICC1 PE=1 SV=2 | 932 | E | 0.54036 | G | 0.489493 | 0.050867 | D to O | - |
| P55957 | BID_HUMAN BH3-interacting domain death agonist OS=Homo sapiens GN=BID PE=1 SV=1 | 10 | S | 0.4299 | G | 0.371063 | 0.058837 | No Change: Both O | - |
| P55957 | BID_HUMAN BH3-interacting domain death agonist OS=Homo sapiens GN=BID PE=1 SV=1 | 162 | H | 0.399999 | Q | 0.41122 | -0.011221 | No Change: Both O | - |
| P55957 | BID_HUMAN BH3-interacting domain death agonist OS=Homo sapiens GN=BID PE=1 SV=1 | 194 | M | 0.834358 | T | 0.813611 | 0.020747 | No Change: Both D | - |
| Q13323 | BIK_HUMAN Bcl-2-interacting killer OS=Homo sapiens GN=BIK PE=1 SV=2 | 19 | E | 0.810888 | K | 0.747952 | 0.062936 | No Change: Both D | - |
| Q13323 | BIK_HUMAN Bcl-2-interacting killer OS=Homo sapiens GN=BIK PE=1 SV=2 | 148 | L | 0.100948 | P | 0.183634 | -0.082686 | No Change: Both O | - |
| Q13323 | BIK_HUMAN Bcl-2-interacting killer OS=Homo sapiens GN=BIK PE=1 SV=2 | 26 | T | 0.855691 | I | 0.775364 | 0.080327 | No Change: Both D | - |
| O00499 | BIN1_HUMAN Myc box-dependent-interacting protein 1 OS=Homo sapiens GN=BIN1 PE=1 SV=1 | 35 | K | 0.827191 | N | 0.785114 | 0.042077 | No Change: Both D | Centronuclear myopathy autosomal recessive (ARCNM) [MIM:255200] |
| O00499 | BIN1_HUMAN Myc box-dependent-interacting protein 1 OS=Homo sapiens GN=BIN1 PE=1 SV=1 | 151 | D | 0.543358 | N | 0.495192 | 0.048166 | D to O | Centronuclear myopathy autosomal recessive (ARCNM) [MIM:255200] |
| Q9UBW5 | BIN2_HUMAN Bridging integrator 2 OS=Homo sapiens GN=BIN2 PE=1 SV=3 | 48 | S | 0.675715 | N | 0.637946 | 0.037769 | No Change: Both D | - |
| Q9UBW5 | BIN2_HUMAN Bridging integrator 2 OS=Homo sapiens GN=BIN2 PE=1 SV=3 | 529 | N | 0.960483 | D | 0.962461 | -0.001978 | No Change: Both D | - |
| Q13490 | BIRC2_HUMAN Baculoviral IAP repeat-containing protein 2 OS=Homo sapiens GN=BIRC2 PE=1 SV=2 | 453 | M | 0.776991 | V | 0.721418 | 0.055573 | No Change: Both D | - |
| Q13490 | BIRC2_HUMAN Baculoviral IAP repeat-containing protein 2 OS=Homo sapiens GN=BIRC2 PE=1 SV=2 | 506 | A | 0.231507 | V | 0.171779 | 0.059728 | No Change: Both O | - |
| Q13490 | BIRC2_HUMAN Baculoviral IAP repeat-containing protein 2 OS=Homo sapiens GN=BIRC2 PE=1 SV=2 | 549 | P | 0.38692 | S | 0.437869 | -0.050949 | No Change: Both O | - |
| Q13490 | BIRC2_HUMAN Baculoviral IAP repeat-containing protein 2 OS=Homo sapiens GN=BIRC2 PE=1 SV=2 | 453 | M | 0.776991 | I | 0.709012 | 0.067979 | No Change: Both D | - |
| Q13489 | BIRC3_HUMAN Baculoviral IAP repeat-containing protein 3 OS=Homo sapiens GN=BIRC3 PE=1 SV=2 | 260 | K | 0.200727 | R | 0.170685 | 0.030042 | No Change: Both O | - |
| Q13489 | BIRC3_HUMAN Baculoviral IAP repeat-containing protein 3 OS=Homo sapiens GN=BIRC3 PE=1 SV=2 | 401 | R | 0.270315 | K | 0.334173 | -0.063858 | No Change: Both O | - |
| Q13489 | BIRC3_HUMAN Baculoviral IAP repeat-containing protein 3 OS=Homo sapiens GN=BIRC3 PE=1 SV=2 | 386 | V | 0.24296 | M | 0.310272 | -0.067312 | No Change: Both O | - |
| O15392 | BIRC5_HUMAN Baculoviral IAP repeat-containing protein 5 OS=Homo sapiens GN=BIRC5 PE=1 SV=2 | 129 | E | 0.918939 | K | 0.923826 | -0.004887 | No Change: Both D | - |
| Q96CA5 | BIRC7_HUMAN Baculoviral IAP repeat-containing protein 7 OS=Homo sapiens GN=BIRC7 PE=1 SV=2 | 223 | E | 0.865845 | Q | 0.858239 | 0.007606 | No Change: Both D | - |
| Q96P09 | BIRC8_HUMAN Baculoviral IAP repeat-containing protein 8 OS=Homo sapiens GN=BIRC8 PE=1 SV=2 | 196 | H | 0.159756 | Y | 0.089715 | 0.070041 | No Change: Both O | - |
| Q96P09 | BIRC8_HUMAN Baculoviral IAP repeat-containing protein 8 OS=Homo sapiens GN=BIRC8 PE=1 SV=2 | 156 | A | 0.649137 | T | 0.703214 | -0.054077 | No Change: Both D | - |
| Q96P09 | BIRC8_HUMAN Baculoviral IAP repeat-containing protein 8 OS=Homo sapiens GN=BIRC8 PE=1 SV=2 | 165 | L | 0.791861 | S | 0.860994 | -0.069133 | No Change: Both D | - |
| Q96P09 | BIRC8_HUMAN Baculoviral IAP repeat-containing protein 8 OS=Homo sapiens GN=BIRC8 PE=1 SV=2 | 225 | A | 0.108218 | T | 0.118502 | -0.010284 | No Change: Both O | - |
| Q96P09 | BIRC8_HUMAN Baculoviral IAP repeat-containing protein 8 OS=Homo sapiens GN=BIRC8 PE=1 SV=2 | 225 | A | 0.108218 | V | 0.081444 | 0.026774 | No Change: Both O | - |
| Q8IZY5 | BLID_HUMAN BH3-like motif-containing cell death inducer OS=Homo sapiens GN=BLID PE=1 SV=2 | 76 | A | 0.552794 | D | 0.600617 | -0.047823 | No Change: Both D | - |
| P51451 | BLK_HUMAN Tyrosine-protein kinase Blk OS=Homo sapiens GN=BLK PE=1 SV=3 | 48 | T | 0.654691 | I | 0.514862 | 0.139829 | No Change: Both D | - |
| P51451 | BLK_HUMAN Tyrosine-protein kinase Blk OS=Homo sapiens GN=BLK PE=1 SV=3 | 71 | A | 0.235769 | T | 0.266459 | -0.03069 | No Change: Both O | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 672 | Q | 0.280569 | R | 0.280224 | 3.45E-04 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 843 | T | 0.283258 | I | 0.200871 | 0.082387 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1055 | C | 0.451397 | S | 0.629671 | -0.178274 | O to D | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 891 | G | 0.231083 | E | 0.281756 | -0.050673 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 901 | C | 0.29074 | Y | 0.329994 | -0.039254 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1036 | C | 0.117574 | F | 0.110991 | 0.006583 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1209 | S | 0.593714 | T | 0.515289 | 0.078425 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 841 | I | 0.301743 | T | 0.436354 | -0.134611 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 878 | C | 0.091659 | R | 0.190565 | -0.098906 | No Change: Both O | Bloom syndrome (BLM) [MIM:210900] |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 137 | K | 0.887048 | R | 0.863616 | 0.023432 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 298 | T | 0.912297 | M | 0.900149 | 0.012148 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 591 | R | 0.688202 | Q | 0.706494 | -0.018292 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 868 | P | 0.429351 | L | 0.27073 | 0.158621 | No Change: Both O | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1205 | V | 0.687889 | I | 0.606563 | 0.081326 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1213 | E | 0.53972 | K | 0.549973 | -0.010253 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1321 | V | 0.951787 | I | 0.958777 | -0.00699 | No Change: Both D | - |
| P54132 | BLM_HUMAN Bloom syndrome protein OS=Homo sapiens GN=BLM PE=1 SV=1 | 1043 | A | 0.103779 | D | 0.161378 | -0.057599 | No Change: Both O | - |
| Q13867 | BLMH_HUMAN Bleomycin hydrolase OS=Homo sapiens GN=BLMH PE=1 SV=1 | 443 | I | 0.137849 | V | 0.154089 | -0.01624 | No Change: Both O | - |
| Q6QNY1 | BL1S2_HUMAN Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Homo sapiens GN=BLOC1S2 PE=1 SV=1 | 13 | S | 0.921466 | R | 0.938042 | -0.016576 | No Change: Both D | - |
| P53004 | BIEA_HUMAN Biliverdin reductase A OS=Homo sapiens GN=BLVRA PE=1 SV=2 | 56 | Q | 0.448413 | R | 0.428462 | 0.019951 | No Change: Both O | - |
| P53004 | BIEA_HUMAN Biliverdin reductase A OS=Homo sapiens GN=BLVRA PE=1 SV=2 | 3 | A | 0.732008 | T | 0.718277 | 0.013731 | No Change: Both D | - |
| P53004 | BIEA_HUMAN Biliverdin reductase A OS=Homo sapiens GN=BLVRA PE=1 SV=2 | 37 | L | 0.298957 | V | 0.29671 | 0.002247 | No Change: Both O | - |
| P30043 | BLVRB_HUMAN Flavin reductase (NADPH) OS=Homo sapiens GN=BLVRB PE=1 SV=3 | 46 | R | 0.600734 | Q | 0.608572 | -0.007838 | No Change: Both D | - |
| Q9H2G9 | GO45_HUMAN Golgin-45 OS=Homo sapiens GN=BLZF1 PE=1 SV=2 | 40 | Q | 0.912984 | R | 0.911852 | 0.001132 | No Change: Both D | - |
| Q9H2G9 | GO45_HUMAN Golgin-45 OS=Homo sapiens GN=BLZF1 PE=1 SV=2 | 196 | R | 0.46837 | Q | 0.503951 | -0.035581 | O to D | - |
| P35226 | BMI1_HUMAN Polycomb complex protein BMI-1 OS=Homo sapiens GN=BMI1 PE=1 SV=2 | 18 | C | 0.037294 | Y | 0.045541 | -0.008247 | No Change: Both O | - |
| P13497 | BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens GN=BMP1 PE=1 SV=2 | 45 | D | 0.517234 | H | 0.423398 | 0.093836 | D to O | A breast cancer sample |
| P13497 | BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens GN=BMP1 PE=1 SV=2 | 719 | V | 0.636588 | I | 0.579802 | 0.056786 | No Change: Both D | - |
| O95393 | BMP10_HUMAN Bone morphogenetic protein 10 OS=Homo sapiens GN=BMP10 PE=2 SV=1 | 200 | T | 0.288379 | S | 0.351523 | -0.063144 | No Change: Both O | - |
| O95393 | BMP10_HUMAN Bone morphogenetic protein 10 OS=Homo sapiens GN=BMP10 PE=2 SV=1 | 250 | N | 0.758541 | K | 0.790088 | -0.031547 | No Change: Both D | - |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 235 | Y | 0.096811 | C | 0.120311 | -0.0235 | No Change: Both O | Ovarian dysgenesis type 2 (ODG2) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 5 | S | 0.120484 | R | 0.093813 | 0.026671 | No Change: Both O | - |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 61 | R | 0.839196 | Q | 0.827353 | 0.011843 | No Change: Both D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 61 | R | 0.839196 | W | 0.639984 | 0.199212 | No Change: Both D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 68 | R | 0.655264 | W | 0.394506 | 0.260758 | D to O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 76 | R | 0.652535 | C | 0.509509 | 0.143026 | No Change: Both D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 76 | R | 0.652535 | H | 0.61734 | 0.035195 | No Change: Both D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 103 | N | 0.329795 | S | 0.366957 | -0.037162 | No Change: Both O | - |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 138 | R | 0.133933 | H | 0.136262 | -0.002329 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 148 | L | 0.204191 | P | 0.321628 | -0.117437 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 180 | A | 0.500669 | F | 0.435306 | 0.065363 | D to O | - |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 180 | A | 0.500669 | T | 0.566482 | -0.065813 | No Change: Both D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 196 | N | 0.292263 | K | 0.329853 | -0.03759 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 206 | R | 0.12943 | H | 0.124137 | 0.005293 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 221 | W | 0.360475 | R | 0.541078 | -0.180603 | O to D | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 243 | I | 0.414602 | V | 0.438351 | -0.023749 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 200 | H | 0.226323 | Y | 0.143914 | 0.082409 | No Change: Both O | - |
| O95972 | BMP15_HUMAN Bone morphogenetic protein 15 OS=Homo sapiens GN=BMP15 PE=1 SV=2 | 329 | R | 0.257605 | C | 0.140848 | 0.116757 | No Change: Both O | Premature ovarian failure type 4 (POF4) [MIM:300510] |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 37 | S | 0.831288 | A | 0.775098 | 0.05619 | No Change: Both D | - |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 106 | A | 0.853495 | T | 0.866317 | -0.012822 | No Change: Both D | - |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 190 | R | 0.202941 | S | 0.251851 | -0.04891 | No Change: Both O | - |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 77 | P | 0.671685 | S | 0.660681 | 0.011004 | No Change: Both D | - |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 161 | L | 0.548852 | S | 0.665846 | -0.116994 | No Change: Both D | - |
| P12643 | BMP2_HUMAN Bone morphogenetic protein 2 OS=Homo sapiens GN=BMP2 PE=1 SV=1 | 387 | D | 0.176416 | G | 0.170293 | 0.006123 | No Change: Both O | - |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 68 | V | 0.128052 | M | 0.156508 | -0.028456 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 212 | D | 0.419233 | V | 0.289843 | 0.12939 | No Change: Both O | - |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 288 | R | 0.265992 | H | 0.264409 | 0.001583 | No Change: Both O | - |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 405 | G | 0.758495 | S | 0.786251 | -0.027756 | No Change: Both D | - |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 1002 | T | 0.98825 | S | 0.989858 | -0.001608 | No Change: Both D | - |
| Q9NSY1 | BMP2K_HUMAN BMP-2-inducible protein kinase OS=Homo sapiens GN=BMP2K PE=1 SV=2 | 486 | Q | 0.999742 | H | 0.999676 | 6.60E-05 | No Change: Both D | - |
| P12645 | BMP3_HUMAN Bone morphogenetic protein 3 OS=Homo sapiens GN=BMP3 PE=1 SV=2 | 192 | R | 0.426219 | Q | 0.447445 | -0.021226 | No Change: Both O | - |
| P12645 | BMP3_HUMAN Bone morphogenetic protein 3 OS=Homo sapiens GN=BMP3 PE=1 SV=2 | 176 | Q | 0.461701 | K | 0.496332 | -0.034631 | No Change: Both O | - |
| P12645 | BMP3_HUMAN Bone morphogenetic protein 3 OS=Homo sapiens GN=BMP3 PE=1 SV=2 | 176 | Q | 0.461701 | L | 0.333475 | 0.128226 | No Change: Both O | - |
| P12645 | BMP3_HUMAN Bone morphogenetic protein 3 OS=Homo sapiens GN=BMP3 PE=1 SV=2 | 205 | L | 0.369555 | F | 0.327621 | 0.041934 | No Change: Both O | - |
| P12645 | BMP3_HUMAN Bone morphogenetic protein 3 OS=Homo sapiens GN=BMP3 PE=1 SV=2 | 222 | T | 0.310782 | M | 0.282753 | 0.028029 | No Change: Both O | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 152 | V | 0.528459 | A | 0.604551 | -0.076092 | No Change: Both D | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 91 | S | 0.757343 | C | 0.605754 | 0.151589 | No Change: Both D | Non-syndromic orofacial cleft type 11 (OFC11) [MIM:600625] |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 93 | E | 0.793521 | G | 0.745587 | 0.047934 | No Change: Both D | Microphthalmia syndromic type 6 (MCOPS6) [MIM:607932] |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 116 | T | 0.800442 | S | 0.852185 | -0.051743 | No Change: Both D | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 150 | N | 0.582484 | K | 0.586972 | -0.004488 | No Change: Both D | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 225 | T | 0.28076 | A | 0.268988 | 0.011772 | No Change: Both O | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 226 | R | 0.304078 | W | 0.149994 | 0.154084 | No Change: Both O | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 367 | S | 0.364038 | T | 0.274798 | 0.08924 | No Change: Both O | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 102 | T | 0.798404 | A | 0.786595 | 0.011809 | No Change: Both D | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 162 | R | 0.34509 | Q | 0.363293 | -0.018203 | No Change: Both O | Non-syndromic orofacial cleft type 11 (OFC11) [MIM:600625] |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 168 | G | 0.491317 | A | 0.423875 | 0.067442 | No Change: Both O | - |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 287 | R | 0.841573 | H | 0.813653 | 0.02792 | No Change: Both D | Non-syndromic orofacial cleft type 11 (OFC11) [MIM:600625] |
| P12644 | BMP4_HUMAN Bone morphogenetic protein 4 OS=Homo sapiens GN=BMP4 PE=1 SV=1 | 346 | A | 0.338933 | V | 0.259461 | 0.079472 | No Change: Both O | Non-syndromic orofacial cleft type 11 (OFC11) [MIM:600625] |
| P22003 | BMP5_HUMAN Bone morphogenetic protein 5 OS=Homo sapiens GN=BMP5 PE=2 SV=1 | 2 | H | 0.521152 | Y | 0.311589 | 0.209563 | D to O | - |
| P22003 | BMP5_HUMAN Bone morphogenetic protein 5 OS=Homo sapiens GN=BMP5 PE=2 SV=1 | 121 | N | 0.869309 | S | 0.903099 | -0.03379 | No Change: Both D | - |
| P22004 | BMP6_HUMAN Bone morphogenetic protein 6 OS=Homo sapiens GN=BMP6 PE=1 SV=1 | 343 | A | 0.41779 | D | 0.505082 | -0.087292 | O to D | A colorectal cancer sample |
| P22004 | BMP6_HUMAN Bone morphogenetic protein 6 OS=Homo sapiens GN=BMP6 PE=1 SV=1 | 476 | P | 0.270202 | L | 0.140147 | 0.130055 | No Change: Both O | A colorectal cancer sample |
| P22004 | BMP6_HUMAN Bone morphogenetic protein 6 OS=Homo sapiens GN=BMP6 PE=1 SV=1 | 257 | R | 0.103736 | C | 0.058562 | 0.045174 | No Change: Both O | - |
| P18075 | BMP7_HUMAN Bone morphogenetic protein 7 OS=Homo sapiens GN=BMP7 PE=1 SV=1 | 198 | L | 0.253383 | P | 0.394693 | -0.14131 | No Change: Both O | - |
| P18075 | BMP7_HUMAN Bone morphogenetic protein 7 OS=Homo sapiens GN=BMP7 PE=1 SV=1 | 321 | N | 0.701771 | S | 0.723698 | -0.021927 | No Change: Both D | - |
| Q7Z5Y6 | BMP8A_HUMAN Bone morphogenetic protein 8A OS=Homo sapiens GN=BMP8A PE=2 SV=2 | 293 | R | 0.448181 | H | 0.434591 | 0.01359 | No Change: Both O | - |
| Q7Z5Y6 | BMP8A_HUMAN Bone morphogenetic protein 8A OS=Homo sapiens GN=BMP8A PE=2 SV=2 | 84 | M | 0.729524 | V | 0.641441 | 0.088083 | No Change: Both D | - |
| P34820 | BMP8B_HUMAN Bone morphogenetic protein 8B OS=Homo sapiens GN=BMP8B PE=2 SV=2 | 293 | H | 0.434591 | R | 0.448181 | -0.01359 | No Change: Both O | - |
| Q8N8U9 | BMPER_HUMAN BMP-binding endothelial regulator protein OS=Homo sapiens GN=BMPER PE=1 SV=3 | 555 | R | 0.41005 | W | 0.20448 | 0.20557 | No Change: Both O | - |
| Q8N8U9 | BMPER_HUMAN BMP-binding endothelial regulator protein OS=Homo sapiens GN=BMPER PE=1 SV=3 | 370 | P | 0.302926 | L | 0.17204 | 0.130886 | No Change: Both O | Diaphanospondylodysostosis (DSD) [MIM:608022] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 124 | C | 0.181331 | R | 0.291797 | -0.110466 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 338 | A | 0.114043 | D | 0.146169 | -0.032126 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 376 | C | 0.131174 | Y | 0.126751 | 0.004423 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 62 | Y | 0.281552 | D | 0.495477 | -0.213925 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 82 | C | 0.210647 | Y | 0.156501 | 0.054146 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 130 | C | 0.142744 | R | 0.248045 | -0.105301 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 443 | R | 0.05998 | C | 0.028052 | 0.031928 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 470 | M | 0.427775 | T | 0.461525 | -0.03375 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 2 | P | 0.561496 | T | 0.485651 | 0.075845 | D to O | - |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 58 | F | 0.293791 | Y | 0.306788 | -0.012997 | No Change: Both O | A renal clear cell carcinoma sample |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 450 | V | 0.158532 | M | 0.203912 | -0.04538 | No Change: Both O | - |
| P36894 | BMR1A_HUMAN Bone morphogenetic protein receptor type-1A OS=Homo sapiens GN=BMPR1A PE=1 SV=2 | 486 | R | 0.339037 | Q | 0.312206 | 0.026831 | No Change: Both O | A gastric adenocarcinoma sample |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 200 | I | 0.342726 | K | 0.539852 | -0.197126 | O to D | Brachydactyly type A2 (BDA2) [MIM:112600] |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 486 | R | 0.482972 | W | 0.243831 | 0.239141 | No Change: Both O | Brachydactyly type A2 (BDA2) [MIM:112600] |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 486 | R | 0.482972 | Q | 0.481024 | 0.001948 | No Change: Both O | Brachydactyly type A2 (BDA2) [MIM:112600] |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 31 | R | 0.627542 | H | 0.61426 | 0.013282 | No Change: Both D | A gastric adenocarcinoma sample |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 149 | R | 0.096969 | W | 0.037154 | 0.059815 | No Change: Both O | - |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 224 | R | 0.232161 | H | 0.233247 | -0.001086 | No Change: Both O | - |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 297 | D | 0.464743 | N | 0.442187 | 0.022556 | No Change: Both O | A metastatic melanoma sample |
| O00238 | BMR1B_HUMAN Bone morphogenetic protein receptor type-1B OS=Homo sapiens GN=BMPR1B PE=1 SV=1 | 371 | R | 0.441137 | Q | 0.442019 | -8.82E-04 | No Change: Both O | - |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 60 | C | 0.338546 | Y | 0.370103 | -0.031557 | No Change: Both O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 117 | C | 0.525437 | Y | 0.422865 | 0.102572 | D to O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 118 | C | 0.551693 | W | 0.368243 | 0.18345 | D to O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 123 | C | 0.553766 | R | 0.59559 | -0.041824 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 123 | C | 0.553766 | S | 0.637579 | -0.083813 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 224 | E | 0.374259 | D | 0.367063 | 0.007196 | No Change: Both O | - |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 347 | C | 0.190774 | Y | 0.190939 | -1.65E-04 | No Change: Both O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 420 | C | 0.053537 | R | 0.115458 | -0.061921 | No Change: Both O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 483 | C | 0.564633 | R | 0.674171 | -0.109538 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 485 | D | 0.565845 | G | 0.466228 | 0.099617 | D to O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 491 | R | 0.533881 | Q | 0.550304 | -0.016423 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 491 | R | 0.533881 | W | 0.323735 | 0.210146 | D to O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 512 | K | 0.708639 | T | 0.696608 | 0.012031 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 519 | N | 0.798199 | K | 0.80749 | -0.009291 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 775 | S | 0.812734 | N | 0.804181 | 0.008553 | No Change: Both D | - |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 82 | Q | 0.217543 | H | 0.205582 | 0.011961 | No Change: Both O | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 182 | G | 0.628624 | D | 0.653663 | -0.025039 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q13873 | BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens GN=BMPR2 PE=1 SV=2 | 899 | R | 0.942513 | P | 0.946077 | -0.003564 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q14692 | BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens GN=BMS1 PE=1 SV=1 | 237 | R | 0.108254 | H | 0.115157 | -0.006903 | No Change: Both O | - |
| Q14692 | BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens GN=BMS1 PE=1 SV=1 | 552 | S | 0.839531 | P | 0.829489 | 0.010042 | No Change: Both D | - |
| Q14692 | BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens GN=BMS1 PE=1 SV=1 | 652 | K | 0.935655 | R | 0.916799 | 0.018856 | No Change: Both D | - |
| Q14692 | BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens GN=BMS1 PE=1 SV=1 | 884 | M | 0.231604 | V | 0.192089 | 0.039515 | No Change: Both O | - |
| Q14692 | BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens GN=BMS1 PE=1 SV=1 | 1141 | V | 0.329811 | I | 0.311945 | 0.017866 | No Change: Both O | - |
| P51813 | BMX_HUMAN Cytoplasmic tyrosine-protein kinase BMX OS=Homo sapiens GN=BMX PE=1 SV=1 | 284 | S | 0.882352 | L | 0.802293 | 0.080059 | No Change: Both D | - |
| P51813 | BMX_HUMAN Cytoplasmic tyrosine-protein kinase BMX OS=Homo sapiens GN=BMX PE=1 SV=1 | 670 | R | 0.796327 | W | 0.695979 | 0.100348 | No Change: Both D | A lung large cell carcinoma sample |
| Q6ZN30 | BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens GN=BNC2 PE=2 SV=1 | 782 | T | 0.379427 | A | 0.336537 | 0.04289 | No Change: Both O | - |
| Q6ZN30 | BNC2_HUMAN Zinc finger protein basonuclin-2 OS=Homo sapiens GN=BNC2 PE=2 SV=1 | 550 | L | 0.810652 | V | 0.797943 | 0.012709 | No Change: Both D | - |
| Q12981 | SEC20_HUMAN Vesicle transport protein SEC20 OS=Homo sapiens GN=BNIP1 PE=1 SV=3 | 14 | Q | 0.113734 | H | 0.107832 | 0.005902 | No Change: Both O | - |
| Q12982 | BNIP2_HUMAN BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 OS=Homo sapiens GN=BNIP2 PE=1 SV=1 | 24 | S | 0.678927 | T | 0.625031 | 0.053896 | No Change: Both D | - |
| Q7Z465 | BNIPL_HUMAN Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein OS=Homo sapiens GN=BNIPL PE=1 SV=1 | 65 | S | 0.962914 | N | 0.945284 | 0.01763 | No Change: Both D | - |
| Q7Z465 | BNIPL_HUMAN Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein OS=Homo sapiens GN=BNIPL PE=1 SV=1 | 226 | S | 0.292003 | N | 0.248523 | 0.04348 | No Change: Both O | - |
| Q9BWV1 | BOC_HUMAN Brother of CDO OS=Homo sapiens GN=BOC PE=1 SV=1 | 883 | K | 0.309073 | N | 0.256023 | 0.05305 | No Change: Both O | - |
| Q9BWV1 | BOC_HUMAN Brother of CDO OS=Homo sapiens GN=BOC PE=1 SV=1 | 915 | Q | 0.678538 | H | 0.65565 | 0.022888 | No Change: Both D | - |
| Q9BWV1 | BOC_HUMAN Brother of CDO OS=Homo sapiens GN=BOC PE=1 SV=1 | 713 | V | 0.257727 | M | 0.302474 | -0.044747 | No Change: Both O | A breast cancer sample |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 429 | T | 0.985757 | M | 0.984312 | 0.001445 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 650 | L | 0.954579 | I | 0.949905 | 0.004674 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 1369 | A | 0.508802 | G | 0.550082 | -0.04128 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 1448 | T | 0.454374 | A | 0.427949 | 0.026425 | No Change: Both O | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 1515 | T | 0.930459 | A | 0.919771 | 0.010688 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 1645 | V | 0.672869 | I | 0.62549 | 0.047379 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 2361 | G | 0.775537 | S | 0.827317 | -0.05178 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 2396 | P | 0.87051 | L | 0.77487 | 0.09564 | No Change: Both D | - |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 246 | S | 0.996988 | I | 0.992297 | 0.004691 | No Change: Both D | A breast cancer sample |
| Q8NFC6 | BOD1L_HUMAN Biorientation of chromosomes in cell division protein 1-like OS=Homo sapiens GN=BOD1L PE=1 SV=2 | 2944 | V | 0.958052 | M | 0.966287 | -0.008235 | No Change: Both D | - |
| Q9Y3E2 | BOLA1_HUMAN BolA-like protein 1 OS=Homo sapiens GN=BOLA1 PE=1 SV=1 | 98 | G | 0.449306 | A | 0.428373 | 0.020933 | No Change: Both O | - |
| Q6PGQ7 | BORA_HUMAN Protein aurora borealis OS=Homo sapiens GN=BORA PE=1 SV=2 | 210 | S | 0.886015 | L | 0.819682 | 0.066333 | No Change: Both D | - |
| Q6PGQ7 | BORA_HUMAN Protein aurora borealis OS=Homo sapiens GN=BORA PE=1 SV=2 | 308 | S | 0.739574 | F | 0.549047 | 0.190527 | No Change: Both D | - |
| P07738 | PMGE_HUMAN Bisphosphoglycerate mutase OS=Homo sapiens GN=BPGM PE=1 SV=2 | 62 | R | 0.131267 | Q | 0.142341 | -0.011074 | No Change: Both O | Bisphosphoglycerate mutase deficiency (BPGMD) [MIM:222800] |
| P07738 | PMGE_HUMAN Bisphosphoglycerate mutase OS=Homo sapiens GN=BPGM PE=1 SV=2 | 90 | R | 0.257583 | C | 0.131196 | 0.126387 | No Change: Both O | Bisphosphoglycerate mutase deficiency (BPGMD) [MIM:222800] |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 16 | A | 0.123234 | V | 0.086714 | 0.03652 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 196 | A | 0.502134 | V | 0.447911 | 0.054223 | D to O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 216 | E | 0.50093 | K | 0.503382 | -0.002452 | No Change: Both D | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 12 | A | 0.296652 | T | 0.302815 | -0.006163 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 12 | A | 0.296652 | V | 0.215926 | 0.080726 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 90 | R | 0.349164 | C | 0.219853 | 0.129311 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 140 | E | 0.627085 | Q | 0.639811 | -0.012726 | No Change: Both D | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 280 | A | 0.281933 | V | 0.219335 | 0.062598 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 377 | V | 0.218406 | I | 0.183202 | 0.035204 | No Change: Both O | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 404 | N | 0.507866 | D | 0.525714 | -0.017848 | No Change: Both D | - |
| P17213 | BPI_HUMAN Bactericidal permeability-increasing protein OS=Homo sapiens GN=BPI PE=1 SV=4 | 451 | K | 0.409714 | E | 0.409306 | 4.08E-04 | No Change: Both O | - |
| Q96DR5 | BPIA2_HUMAN BPI fold-containing family A member 2 OS=Homo sapiens GN=BPIFA2 PE=1 SV=2 | 43 | G | 0.452536 | R | 0.432061 | 0.020475 | No Change: Both O | - |
| Q96DR5 | BPIA2_HUMAN BPI fold-containing family A member 2 OS=Homo sapiens GN=BPIFA2 PE=1 SV=2 | 113 | K | 0.331117 | E | 0.339448 | -0.008331 | No Change: Both O | - |
| Q96DR5 | BPIA2_HUMAN BPI fold-containing family A member 2 OS=Homo sapiens GN=BPIFA2 PE=1 SV=2 | 221 | R | 0.051888 | C | 0.035138 | 0.01675 | No Change: Both O | - |
| Q9BQP9 | BPIA3_HUMAN BPI fold-containing family A member 3 OS=Homo sapiens GN=BPIFA3 PE=2 SV=3 | 41 | A | 0.283968 | E | 0.349395 | -0.065427 | No Change: Both O | - |
| Q9BQP9 | BPIA3_HUMAN BPI fold-containing family A member 3 OS=Homo sapiens GN=BPIFA3 PE=2 SV=3 | 136 | V | 0.208449 | I | 0.196984 | 0.011465 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 84 | I | 0.035116 | V | 0.041039 | -0.005923 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 479 | S | 0.79923 | T | 0.745346 | 0.053884 | No Change: Both D | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 298 | S | 0.250255 | P | 0.242225 | 0.00803 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 313 | S | 0.546927 | I | 0.307346 | 0.239581 | D to O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 140 | T | 0.498107 | A | 0.465355 | 0.032752 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 284 | V | 0.151261 | M | 0.186679 | -0.035418 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 287 | D | 0.195478 | H | 0.164687 | 0.030791 | No Change: Both O | - |
| Q8TDL5 | BPIB1_HUMAN BPI fold-containing family B member 1 OS=Homo sapiens GN=BPIFB1 PE=2 SV=1 | 464 | T | 0.567337 | S | 0.659776 | -0.092439 | No Change: Both D | - |
| Q8N4F0 | BPIB2_HUMAN BPI fold-containing family B member 2 OS=Homo sapiens GN=BPIFB2 PE=1 SV=2 | 31 | K | 0.24624 | M | 0.150309 | 0.095931 | No Change: Both O | - |
| Q8N4F0 | BPIB2_HUMAN BPI fold-containing family B member 2 OS=Homo sapiens GN=BPIFB2 PE=1 SV=2 | 20 | A | 0.271882 | V | 0.222985 | 0.048897 | No Change: Both O | A colorectal cancer sample |
| Q8N4F0 | BPIB2_HUMAN BPI fold-containing family B member 2 OS=Homo sapiens GN=BPIFB2 PE=1 SV=2 | 63 | A | 0.272463 | V | 0.204189 | 0.068274 | No Change: Both O | - |
| P59826 | BPIB3_HUMAN BPI fold-containing family B member 3 OS=Homo sapiens GN=BPIFB3 PE=2 SV=2 | 228 | V | 0.274863 | M | 0.332935 | -0.058072 | No Change: Both O | - |
| P59826 | BPIB3_HUMAN BPI fold-containing family B member 3 OS=Homo sapiens GN=BPIFB3 PE=2 SV=2 | 290 | T | 0.186775 | M | 0.168827 | 0.017948 | No Change: Both O | - |
| P59826 | BPIB3_HUMAN BPI fold-containing family B member 3 OS=Homo sapiens GN=BPIFB3 PE=2 SV=2 | 334 | H | 0.246666 | Q | 0.302151 | -0.055485 | No Change: Both O | - |
| P59826 | BPIB3_HUMAN BPI fold-containing family B member 3 OS=Homo sapiens GN=BPIFB3 PE=2 SV=2 | 369 | Y | 0.123804 | C | 0.116137 | 0.007667 | No Change: Both O | - |
| P59826 | BPIB3_HUMAN BPI fold-containing family B member 3 OS=Homo sapiens GN=BPIFB3 PE=2 SV=2 | 449 | P | 0.123324 | S | 0.129813 | -0.006489 | No Change: Both O | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 199 | D | 0.744679 | G | 0.781162 | -0.036483 | No Change: Both D | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 206 | G | 0.542903 | W | 0.253058 | 0.289845 | D to O | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 268 | I | 0.054998 | V | 0.063822 | -0.008824 | No Change: Both O | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 320 | N | 0.146026 | T | 0.113824 | 0.032202 | No Change: Both O | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 167 | G | 0.692846 | W | 0.4106 | 0.282246 | D to O | - |
| P59827 | BPIB4_HUMAN BPI fold-containing family B member 4 OS=Homo sapiens GN=BPIFB4 PE=2 SV=2 | 229 | I | 0.129045 | V | 0.151338 | -0.022293 | No Change: Both O | - |
| Q8NFQ5 | BPIB6_HUMAN BPI fold-containing family B member 6 OS=Homo sapiens GN=BPIFB6 PE=2 SV=1 | 97 | V | 0.421275 | I | 0.378355 | 0.04292 | No Change: Both O | - |
| Q8NFQ5 | BPIB6_HUMAN BPI fold-containing family B member 6 OS=Homo sapiens GN=BPIFB6 PE=2 SV=1 | 16 | T | 0.337584 | M | 0.301403 | 0.036181 | No Change: Both O | - |
| Q8NFQ5 | BPIB6_HUMAN BPI fold-containing family B member 6 OS=Homo sapiens GN=BPIFB6 PE=2 SV=1 | 149 | P | 0.435429 | T | 0.382206 | 0.053223 | No Change: Both O | - |
| Q8NFQ5 | BPIB6_HUMAN BPI fold-containing family B member 6 OS=Homo sapiens GN=BPIFB6 PE=2 SV=1 | 347 | S | 0.321143 | G | 0.255856 | 0.065287 | No Change: Both O | - |
| Q8NFQ5 | BPIB6_HUMAN BPI fold-containing family B member 6 OS=Homo sapiens GN=BPIFB6 PE=2 SV=1 | 296 | R | 0.340474 | H | 0.33103 | 0.009444 | No Change: Both O | - |
| Q8NFQ6 | BPIFC_HUMAN BPI fold-containing family C protein OS=Homo sapiens GN=BPIFC PE=1 SV=1 | 269 | V | 0.405438 | A | 0.476865 | -0.071427 | No Change: Both O | - |
| Q8NFQ6 | BPIFC_HUMAN BPI fold-containing family C protein OS=Homo sapiens GN=BPIFC PE=1 SV=1 | 451 | S | 0.378885 | P | 0.372107 | 0.006778 | No Change: Both O | - |
| Q8NFQ6 | BPIFC_HUMAN BPI fold-containing family C protein OS=Homo sapiens GN=BPIFC PE=1 SV=1 | 302 | V | 0.205356 | L | 0.203691 | 0.001665 | No Change: Both O | - |
| Q8NFQ6 | BPIFC_HUMAN BPI fold-containing family C protein OS=Homo sapiens GN=BPIFC PE=1 SV=1 | 479 | E | 0.619566 | A | 0.550144 | 0.069422 | No Change: Both D | - |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 466 | G | 0.384901 | V | 0.264226 | 0.120675 | No Change: Both O | Lung cancer (LNCR) [MIM:211980] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 597 | L | 0.163822 | R | 0.269141 | -0.105319 | No Change: Both O | Lung cancer (LNCR) [MIM:211980] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 462 | R | 0.422176 | I | 0.307131 | 0.115045 | No Change: Both O | Colorectal cancer (CRC) [MIM:114500] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 463 | I | 0.405689 | S | 0.5697 | -0.164011 | O to D | Colorectal cancer (CRC) [MIM:114500] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 464 | G | 0.394229 | E | 0.410711 | -0.016482 | No Change: Both O | Colorectal cancer (CRC) [MIM:114500] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 464 | G | 0.394229 | V | 0.280953 | 0.113276 | No Change: Both O | A colorectal cancer cell line |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 466 | G | 0.384901 | A | 0.308541 | 0.07636 | No Change: Both O | Melanoma |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 466 | G | 0.384901 | E | 0.402201 | -0.0173 | No Change: Both O | Melanoma |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 469 | G | 0.343966 | A | 0.270255 | 0.073711 | No Change: Both O | Non-Hodgkin lymphoma (NHL) [MIM:605027] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 469 | G | 0.343966 | E | 0.362254 | -0.018288 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 469 | G | 0.343966 | R | 0.319466 | 0.0245 | No Change: Both O | Non-Hodgkin lymphoma (NHL) [MIM:605027] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 586 | E | 0.160681 | K | 0.174168 | -0.013487 | No Change: Both O | Ovarian cancer |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 594 | D | 0.185219 | G | 0.174637 | 0.010582 | No Change: Both O | Non-Hodgkin lymphoma (NHL) [MIM:605027] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 595 | F | 0.159994 | L | 0.193503 | -0.033509 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 595 | F | 0.159994 | L | 0.193503 | -0.033509 | No Change: Both O | Colon cancer |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 596 | G | 0.160656 | R | 0.148768 | 0.011888 | No Change: Both O | A colorectal adenocarcinoma sample |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 597 | L | 0.163822 | V | 0.175406 | -0.011584 | No Change: Both O | Noonan syndrome type 7 (NS7) [MIM:613706] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 600 | V | 0.309688 | D | 0.464272 | -0.154584 | No Change: Both O | A melanoma cell line |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 600 | V | 0.309688 | E | 0.474412 | -0.164724 | No Change: Both O | Sarcoma |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 601 | K | 0.365465 | E | 0.366347 | -8.82E-04 | No Change: Both O | Colorectal cancer (CRC) [MIM:114500] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 246 | A | 0.03544 | P | 0.061361 | -0.025921 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 257 | Q | 0.077544 | R | 0.074588 | 0.002956 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 485 | L | 0.234632 | F | 0.212142 | 0.02249 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 499 | K | 0.330789 | E | 0.342244 | -0.011455 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 501 | E | 0.324745 | G | 0.287121 | 0.037624 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 501 | E | 0.324745 | K | 0.344439 | -0.019694 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 581 | N | 0.320526 | D | 0.339609 | -0.019083 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 467 | S | 0.360411 | A | 0.25204 | 0.108371 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 468 | F | 0.347357 | S | 0.557205 | -0.209848 | O to D | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 596 | G | 0.160656 | V | 0.09129 | 0.069366 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 301 | P | 0.607299 | S | 0.631706 | -0.024407 | No Change: Both D | - |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 469 | G | 0.343966 | V | 0.224933 | 0.119033 | No Change: Both O | A colorectal adenocarcinoma sample |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 581 | N | 0.320526 | S | 0.360135 | -0.039609 | No Change: Both O | A colorectal adenocarcinoma sample |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 241 | T | 0.107495 | M | 0.079739 | 0.027756 | No Change: Both O | - |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 241 | T | 0.107495 | P | 0.121626 | -0.014131 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 241 | T | 0.107495 | P | 0.121626 | -0.014131 | No Change: Both O | LEOPARD syndrome type 3 (LEOPARD3) [MIM:613707] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 241 | T | 0.107495 | R | 0.111381 | -0.003886 | No Change: Both O | - |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 245 | L | 0.040472 | F | 0.041751 | -0.001279 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 275 | E | 0.19099 | K | 0.197515 | -0.006525 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 499 | K | 0.330789 | N | 0.299514 | 0.031275 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 525 | L | 0.162412 | P | 0.306375 | -0.143963 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 531 | W | 0.132484 | C | 0.163021 | -0.030537 | No Change: Both O | Noonan syndrome type 7 (NS7) [MIM:613706] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 599 | T | 0.247819 | R | 0.271773 | -0.023954 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 601 | K | 0.365465 | Q | 0.328087 | 0.037378 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 638 | D | 0.17552 | E | 0.189109 | -0.013589 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 709 | Q | 0.735985 | R | 0.778022 | -0.042037 | No Change: Both D | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 244 | T | 0.043094 | P | 0.050863 | -0.007769 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 262 | Q | 0.116069 | K | 0.136987 | -0.020918 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P15056 | BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens GN=BRAF PE=1 SV=4 | 580 | N | 0.377504 | D | 0.39601 | -0.018506 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| Q6PJG6 | BRAT1_HUMAN BRCA1-associated ATM activator 1 OS=Homo sapiens GN=BRAT1 PE=1 SV=2 | 20 | R | 0.344244 | G | 0.348907 | -0.004663 | No Change: Both O | - |
| Q6PJG6 | BRAT1_HUMAN BRCA1-associated ATM activator 1 OS=Homo sapiens GN=BRAT1 PE=1 SV=2 | 737 | R | 0.654584 | W | 0.468851 | 0.185733 | D to O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 11 | V | 0.279682 | A | 0.35086 | -0.071178 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 21 | I | 0.114567 | V | 0.12431 | -0.009743 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 22 | L | 0.095849 | S | 0.190398 | -0.094549 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 61 | C | 0.605391 | G | 0.666478 | -0.061087 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 61 | C | 0.605391 | G | 0.666478 | -0.061087 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 64 | C | 0.535343 | G | 0.622563 | -0.08722 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 64 | C | 0.535343 | Y | 0.457862 | 0.077481 | D to O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 239 | H | 0.867424 | R | 0.88066 | -0.013236 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 271 | V | 0.7757 | M | 0.82268 | -0.04698 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 356 | Q | 0.805734 | R | 0.820997 | -0.015263 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 379 | I | 0.620456 | M | 0.688862 | -0.068406 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 461 | F | 0.402928 | L | 0.446221 | -0.043293 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 465 | Y | 0.418951 | D | 0.575313 | -0.156362 | O to D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 507 | R | 0.713167 | I | 0.590166 | 0.123001 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 552 | G | 0.932132 | V | 0.901706 | 0.030426 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 693 | D | 0.946592 | N | 0.949626 | -0.003034 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 772 | V | 0.723176 | A | 0.755923 | -0.032747 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 820 | K | 0.584287 | E | 0.59441 | -0.010123 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 826 | T | 0.599486 | K | 0.669901 | -0.070415 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 841 | R | 0.680788 | W | 0.513131 | 0.167657 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 871 | P | 0.763684 | L | 0.639011 | 0.124673 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 892 | L | 0.934941 | S | 0.970526 | -0.035585 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 960 | G | 0.456872 | D | 0.4564 | 4.72E-04 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1008 | M | 0.913904 | I | 0.878179 | 0.035725 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1025 | T | 0.94481 | I | 0.922574 | 0.022236 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1038 | E | 0.954019 | G | 0.939038 | 0.014981 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1040 | S | 0.948909 | N | 0.940429 | 0.00848 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1047 | V | 0.945822 | A | 0.95471 | -0.008888 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1150 | P | 0.769187 | S | 0.797407 | -0.02822 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1183 | K | 0.831097 | R | 0.814998 | 0.016099 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1219 | E | 0.780969 | D | 0.746498 | 0.034471 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1347 | R | 0.97053 | G | 0.972378 | -0.001848 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1431 | S | 0.885395 | P | 0.877022 | 0.008373 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1443 | R | 0.94333 | G | 0.942948 | 3.82E-04 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1512 | S | 0.784652 | I | 0.629306 | 0.155346 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1561 | T | 0.879698 | I | 0.827112 | 0.052586 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1606 | K | 0.833435 | E | 0.845095 | -0.01166 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1613 | S | 0.820627 | G | 0.764593 | 0.056034 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1628 | M | 0.849993 | V | 0.815986 | 0.034007 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1628 | M | 0.849993 | T | 0.871981 | -0.021988 | No Change: Both D | Some patients with sporadic breast cancer |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1637 | P | 0.863686 | L | 0.793129 | 0.070557 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1652 | M | 0.482952 | I | 0.350133 | 0.132819 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1708 | A | 0.067972 | E | 0.110667 | -0.042695 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1713 | V | 0.03916 | G | 0.074688 | -0.035528 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1749 | P | 0.649375 | R | 0.669572 | -0.020197 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1775 | M | 0.221454 | R | 0.261663 | -0.040209 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 227 | E | 0.724996 | K | 0.716495 | 0.008501 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 346 | P | 0.833911 | S | 0.829691 | 0.00422 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1406 | K | 0.771961 | N | 0.785391 | -0.01343 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1641 | A | 0.790086 | P | 0.845956 | -0.05587 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1692 | D | 0.291201 | N | 0.274898 | 0.016303 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1776 | P | 0.247867 | S | 0.257297 | -0.00943 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1812 | P | 0.185496 | S | 0.19655 | -0.011054 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 275 | G | 0.737587 | S | 0.818637 | -0.08105 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1140 | S | 0.716956 | G | 0.650293 | 0.066663 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1620 | T | 0.805102 | A | 0.798686 | 0.006416 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 723 | N | 0.940613 | D | 0.939076 | 0.001537 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 989 | F | 0.592157 | S | 0.721558 | -0.129401 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1443 | R | 0.94333 | Q | 0.957965 | -0.014635 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 10 | E | 0.271903 | K | 0.260116 | 0.011787 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 10 | E | 0.271903 | K | 0.260116 | 0.011787 | No Change: Both O | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 23 | E | 0.091241 | K | 0.093591 | -0.00235 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 23 | E | 0.091241 | K | 0.093591 | -0.00235 | No Change: Both O | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 71 | R | 0.592045 | K | 0.660202 | -0.068157 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 656 | N | 0.88872 | I | 0.83017 | 0.05855 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 749 | D | 0.860931 | Y | 0.760472 | 0.100459 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 835 | H | 0.565684 | Y | 0.440443 | 0.125241 | D to O | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 856 | Y | 0.564685 | H | 0.69092 | -0.126235 | No Change: Both D | A patient with sporadic breast cancer |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 866 | R | 0.728048 | Q | 0.770511 | -0.042463 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 888 | H | 0.906759 | Y | 0.874161 | 0.032598 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1060 | E | 0.835342 | A | 0.766128 | 0.069214 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1139 | S | 0.713563 | I | 0.53686 | 0.176703 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1187 | S | 0.83631 | I | 0.689745 | 0.146565 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1187 | S | 0.83631 | I | 0.689745 | 0.146565 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1200 | Q | 0.792285 | H | 0.778326 | 0.013959 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1200 | Q | 0.792285 | H | 0.778326 | 0.013959 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1204 | R | 0.791021 | I | 0.638241 | 0.15278 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1207 | K | 0.814335 | N | 0.78933 | 0.025005 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1210 | E | 0.822983 | G | 0.787697 | 0.035286 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1217 | S | 0.799155 | Y | 0.672128 | 0.127027 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1217 | S | 0.799155 | Y | 0.672128 | 0.127027 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1226 | F | 0.542515 | L | 0.593426 | -0.050911 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1243 | R | 0.689788 | G | 0.689996 | -2.08E-04 | No Change: Both D | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1297 | S | 0.823652 | P | 0.784507 | 0.039145 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1411 | M | 0.757081 | T | 0.762772 | -0.005691 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1665 | V | 0.204803 | M | 0.280178 | -0.075375 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1690 | K | 0.336496 | Q | 0.288336 | 0.04816 | No Change: Both O | Some patients with sporadic breast cancer |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1697 | C | 0.122566 | R | 0.253875 | -0.131309 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1699 | R | 0.084415 | W | 0.032855 | 0.05156 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1786 | L | 0.065485 | P | 0.126085 | -0.0606 | No Change: Both O | Familial breast-ovarian cancer type 1 (BROVCA1) [MIM:604370] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 925 | I | 0.630006 | L | 0.622576 | 0.00743 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 30 | L | 0.2035 | F | 0.171751 | 0.031749 | No Change: Both O | A breast cancer sample |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 758 | L | 0.822048 | F | 0.768462 | 0.053586 | No Change: Both D | A breast cancer sample |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 778 | G | 0.654249 | C | 0.549746 | 0.104503 | No Change: Both D | A breast cancer sample |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 153 | S | 0.803073 | R | 0.769324 | 0.033749 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1236 | N | 0.665809 | K | 0.685483 | -0.019674 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1250 | E | 0.648642 | K | 0.649466 | -8.24E-04 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1662 | F | 0.268059 | C | 0.272895 | -0.004836 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1775 | M | 0.221454 | K | 0.311944 | -0.09049 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 18 | M | 0.15712 | T | 0.176019 | -0.018899 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1495 | R | 0.950559 | M | 0.944624 | 0.005935 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1623 | A | 0.822423 | G | 0.814685 | 0.007738 | No Change: Both D | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1685 | T | 0.352839 | A | 0.300955 | 0.051884 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1685 | T | 0.352839 | I | 0.20997 | 0.142869 | No Change: Both O | - |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1689 | M | 0.337023 | R | 0.406475 | -0.069452 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1706 | G | 0.064361 | E | 0.076228 | -0.011867 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1715 | S | 0.034869 | R | 0.024233 | 0.010636 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1738 | G | 0.458091 | R | 0.457525 | 5.66E-04 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1764 | L | 0.117605 | P | 0.238818 | -0.121213 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1766 | I | 0.090784 | S | 0.19946 | -0.108676 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P38398 | BRCA1_HUMAN Breast cancer type 1 susceptibility protein OS=Homo sapiens GN=BRCA1 PE=1 SV=2 | 1788 | G | 0.112765 | V | 0.071562 | 0.041203 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 32 | F | 0.659747 | L | 0.676927 | -0.01718 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 53 | K | 0.933507 | R | 0.924019 | 0.009488 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 75 | A | 0.588317 | P | 0.729573 | -0.141256 | No Change: Both D | Ovarian cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 81 | F | 0.4508 | L | 0.503314 | -0.052514 | O to D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 201 | P | 0.725224 | R | 0.681566 | 0.043658 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 211 | V | 0.599567 | A | 0.66036 | -0.060793 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 222 | P | 0.575395 | S | 0.623441 | -0.048046 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 289 | N | 0.562905 | H | 0.539517 | 0.023388 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 355 | V | 0.862509 | L | 0.84997 | 0.012539 | No Change: Both D | Lung cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 372 | H | 0.77263 | N | 0.820953 | -0.048323 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 554 | C | 0.476169 | W | 0.376737 | 0.099432 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 630 | T | 0.548121 | I | 0.43648 | 0.111641 | D to O | Ovarian cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 728 | D | 0.770178 | A | 0.725138 | 0.04504 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 991 | N | 0.328242 | D | 0.33498 | -0.006738 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1147 | N | 0.476123 | S | 0.553482 | -0.077359 | O to D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1529 | G | 0.639306 | R | 0.63763 | 0.001676 | No Change: Both D | Bladder cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1880 | N | 0.669046 | K | 0.70538 | -0.036334 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1915 | T | 0.598715 | M | 0.598104 | 6.11E-04 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2034 | R | 0.522996 | C | 0.39547 | 0.127526 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2274 | G | 0.629716 | V | 0.515148 | 0.114568 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2415 | H | 0.52418 | N | 0.550044 | -0.025864 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2421 | Q | 0.541134 | H | 0.520197 | 0.020937 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3095 | D | 0.083493 | E | 0.100609 | -0.017116 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3103 | I | 0.023778 | M | 0.034687 | -0.010909 | No Change: Both O | Melanoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3118 | M | 0.151163 | T | 0.182331 | -0.031168 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3357 | T | 0.67511 | R | 0.679752 | -0.004642 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3412 | I | 0.962075 | V | 0.953294 | 0.008781 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 108 | N | 0.609415 | H | 0.581193 | 0.028222 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 327 | K | 0.841928 | E | 0.835918 | 0.00601 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 582 | T | 0.418647 | P | 0.449467 | -0.03082 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 707 | D | 0.689376 | Y | 0.51473 | 0.174646 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 784 | M | 0.489032 | V | 0.411472 | 0.07756 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 886 | N | 0.628371 | I | 0.437906 | 0.190465 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 935 | D | 0.449665 | N | 0.425912 | 0.023753 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1290 | C | 0.623606 | Y | 0.569948 | 0.053658 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1414 | T | 0.757761 | M | 0.695177 | 0.062584 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1420 | D | 0.746303 | Y | 0.563082 | 0.183221 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1513 | D | 0.63506 | N | 0.639154 | -0.004094 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1593 | E | 0.603585 | D | 0.575234 | 0.028351 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1771 | G | 0.686588 | D | 0.748277 | -0.061689 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1805 | N | 0.526346 | S | 0.566305 | -0.039959 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1902 | D | 0.591354 | N | 0.568777 | 0.022577 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2074 | H | 0.471508 | N | 0.491738 | -0.02023 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2089 | E | 0.492139 | D | 0.460787 | 0.031352 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2138 | V | 0.852831 | F | 0.848435 | 0.004396 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2466 | A | 0.593208 | V | 0.501942 | 0.091266 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2480 | L | 0.516767 | V | 0.490607 | 0.02616 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2490 | I | 0.58093 | T | 0.697448 | -0.116518 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2502 | R | 0.617275 | H | 0.54314 | 0.074135 | No Change: Both D | Ovarian cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2515 | T | 0.479959 | I | 0.343376 | 0.136583 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2787 | R | 0.399169 | H | 0.327177 | 0.071992 | No Change: Both O | Ovarian cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2944 | I | 0.539307 | F | 0.525928 | 0.013379 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2951 | A | 0.711286 | T | 0.726884 | -0.015598 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2969 | V | 0.353482 | M | 0.42484 | -0.071358 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3098 | Y | 0.049573 | H | 0.080829 | -0.031256 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3257 | K | 0.891973 | R | 0.879265 | 0.012708 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3276 | R | 0.780514 | S | 0.804859 | -0.024345 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2722 | T | 0.10837 | R | 0.104325 | 0.004045 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 322 | K | 0.824887 | Q | 0.796433 | 0.028454 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 929 | L | 0.248455 | S | 0.422565 | -0.17411 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 976 | S | 0.422205 | F | 0.196761 | 0.225444 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 987 | N | 0.486144 | I | 0.334806 | 0.151338 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1561 | H | 0.411494 | N | 0.459261 | -0.047767 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2162 | K | 0.546145 | R | 0.466195 | 0.07995 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2440 | H | 0.86576 | R | 0.87944 | -0.01368 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2835 | S | 0.268024 | P | 0.242568 | 0.025456 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2856 | E | 0.708286 | A | 0.606288 | 0.101998 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3244 | V | 0.857931 | I | 0.849535 | 0.008396 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 42 | Y | 0.870136 | C | 0.901131 | -0.030995 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 60 | N | 0.858521 | S | 0.870392 | -0.011871 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 405 | G | 0.441564 | R | 0.430306 | 0.011258 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 431 | T | 0.846568 | I | 0.807608 | 0.03896 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 448 | R | 0.95864 | H | 0.949648 | 0.008992 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 462 | E | 0.851888 | G | 0.789383 | 0.062505 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 598 | T | 0.511029 | A | 0.496246 | 0.014783 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 613 | L | 0.476478 | R | 0.584331 | -0.107853 | O to D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1036 | E | 0.392609 | K | 0.404542 | -0.011933 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1106 | S | 0.750392 | R | 0.674639 | 0.075753 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1179 | S | 0.562849 | N | 0.515852 | 0.046997 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1279 | N | 0.730211 | S | 0.756144 | -0.025933 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1445 | K | 0.527425 | T | 0.438362 | 0.089063 | D to O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1524 | F | 0.563994 | V | 0.588925 | -0.024931 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1580 | C | 0.320555 | Y | 0.270546 | 0.050009 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1679 | T | 0.566072 | I | 0.454342 | 0.11173 | D to O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1804 | V | 0.529753 | A | 0.583383 | -0.05363 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1901 | E | 0.581384 | K | 0.572623 | 0.008761 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1929 | I | 0.664625 | V | 0.674297 | -0.009672 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2031 | T | 0.580395 | A | 0.540791 | 0.039604 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2072 | S | 0.496372 | C | 0.259806 | 0.236566 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2094 | Y | 0.618947 | C | 0.666813 | -0.047866 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2096 | P | 0.658112 | L | 0.562459 | 0.095653 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2118 | V | 0.865757 | L | 0.871106 | -0.005349 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2128 | K | 0.879606 | N | 0.869296 | 0.01031 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2275 | E | 0.613187 | G | 0.547628 | 0.065559 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2293 | F | 0.573018 | L | 0.644088 | -0.07107 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2353 | G | 0.562807 | R | 0.595445 | -0.032638 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2488 | R | 0.554263 | K | 0.595825 | -0.041562 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2706 | N | 0.766616 | S | 0.800824 | -0.034208 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2723 | D | 0.094716 | H | 0.07088 | 0.023836 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2728 | V | 0.149869 | I | 0.135381 | 0.014488 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2729 | K | 0.17147 | N | 0.145268 | 0.026202 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2793 | G | 0.247443 | R | 0.276748 | -0.029305 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2950 | K | 0.664506 | N | 0.602099 | 0.062407 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3013 | T | 0.636004 | I | 0.537155 | 0.098849 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3063 | P | 0.469199 | S | 0.505584 | -0.036385 | O to D | A patient with ovarian cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3076 | G | 0.08493 | E | 0.115161 | -0.030231 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3124 | N | 0.26966 | I | 0.144918 | 0.124742 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3196 | K | 0.602571 | E | 0.588627 | 0.013944 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3374 | T | 0.84441 | I | 0.771414 | 0.072996 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 25 | G | 0.522125 | R | 0.583248 | -0.061123 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 31 | W | 0.633096 | C | 0.752346 | -0.11925 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 31 | W | 0.633096 | R | 0.803502 | -0.170406 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 64 | T | 0.828835 | I | 0.775325 | 0.05351 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 118 | R | 0.728639 | H | 0.701061 | 0.027578 | No Change: Both D | One patient with esophageal carcinoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 192 | M | 0.696444 | T | 0.747141 | -0.050697 | No Change: Both D | One patient with pancreatic cancer |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 225 | T | 0.581599 | A | 0.538944 | 0.042655 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 315 | C | 0.723931 | S | 0.813282 | -0.089351 | No Change: Both D | One patient with esophageal carcinoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 326 | S | 0.83324 | R | 0.817355 | 0.015885 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 505 | I | 0.611014 | T | 0.708595 | -0.097581 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 729 | I | 0.751692 | M | 0.820057 | -0.068365 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1172 | S | 0.394794 | L | 0.229328 | 0.165466 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1522 | L | 0.571663 | F | 0.555458 | 0.016205 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1690 | K | 0.312775 | N | 0.26317 | 0.049605 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1730 | N | 0.765112 | Y | 0.671198 | 0.093914 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1887 | T | 0.501941 | M | 0.507061 | -0.00512 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1988 | V | 0.695027 | I | 0.666717 | 0.02831 | No Change: Both D | One patient with esophageal carcinoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2044 | G | 0.434367 | V | 0.345204 | 0.089163 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2108 | R | 0.684133 | C | 0.571632 | 0.112501 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2135 | N | 0.841873 | H | 0.805606 | 0.036267 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2222 | Y | 0.599953 | C | 0.646267 | -0.046314 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2336 | R | 0.41301 | H | 0.380714 | 0.032296 | No Change: Both O | Fanconi anemia complementation group D type 1 (FANCD1) [MIM:605724] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2456 | Q | 0.767082 | E | 0.78824 | -0.021158 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2510 | L | 0.500895 | P | 0.668516 | -0.167621 | No Change: Both D | Fanconi anemia complementation group D type 1 (FANCD1) [MIM:605724] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2626 | W | 0.014284 | C | 0.015781 | -0.001497 | No Change: Both O | Fanconi anemia complementation group D type 1 (FANCD1) [MIM:605724] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2842 | R | 0.44197 | C | 0.27321 | 0.16876 | No Change: Both O | One patient with esophageal carcinoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3300 | P | 0.820513 | S | 0.806948 | 0.013565 | No Change: Both D | One patient with esophageal carcinoma |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 599 | S | 0.552595 | F | 0.366734 | 0.185861 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 513 | K | 0.759675 | R | 0.741719 | 0.017956 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 982 | I | 0.527442 | L | 0.551606 | -0.024164 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1542 | V | 0.633113 | M | 0.697983 | -0.06487 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1643 | V | 0.658459 | A | 0.698331 | -0.039872 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 1979 | S | 0.633432 | R | 0.533908 | 0.099524 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2238 | D | 0.657985 | E | 0.69334 | -0.035355 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2336 | R | 0.41301 | Q | 0.42769 | -0.01468 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2447 | N | 0.882284 | D | 0.882161 | 1.23E-04 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2686 | L | 0.526333 | P | 0.617323 | -0.09099 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2792 | L | 0.270265 | P | 0.460409 | -0.190144 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3101 | L | 0.024344 | R | 0.040678 | -0.016334 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2116 | H | 0.844782 | R | 0.876754 | -0.031972 | No Change: Both D | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2502 | R | 0.617275 | C | 0.457137 | 0.160138 | D to O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2627 | I | 0.016863 | F | 0.015672 | 0.001191 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2653 | L | 0.204787 | P | 0.341267 | -0.13648 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2659 | R | 0.299276 | K | 0.338218 | -0.038942 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2663 | E | 0.528004 | V | 0.34914 | 0.178864 | D to O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2723 | D | 0.094716 | G | 0.085061 | 0.009655 | No Change: Both O | - |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 2748 | G | 0.213262 | D | 0.220142 | -0.00688 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| P51587 | BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens GN=BRCA2 PE=1 SV=2 | 3052 | R | 0.328461 | W | 0.151689 | 0.176772 | No Change: Both O | - |
| P46736 | BRCC3_HUMAN Lys-63-specific deubiquitinase BRCC36 OS=Homo sapiens GN=BRCC3 PE=1 SV=2 | 74 | I | 0.293402 | V | 0.31588 | -0.022478 | No Change: Both O | - |
| O95696 | BRD1_HUMAN Bromodomain-containing protein 1 OS=Homo sapiens GN=BRD1 PE=1 SV=1 | 38 | R | 0.370948 | G | 0.34135 | 0.029598 | No Change: Both O | - |
| O95696 | BRD1_HUMAN Bromodomain-containing protein 1 OS=Homo sapiens GN=BRD1 PE=1 SV=1 | 321 | A | 0.128624 | S | 0.200794 | -0.07217 | No Change: Both O | - |
| O95696 | BRD1_HUMAN Bromodomain-containing protein 1 OS=Homo sapiens GN=BRD1 PE=1 SV=1 | 730 | A | 0.742118 | T | 0.756993 | -0.014875 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 238 | L | 0.762086 | F | 0.697791 | 0.064295 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 474 | A | 0.985517 | V | 0.982533 | 0.002984 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 547 | R | 0.990299 | K | 0.991259 | -9.60E-04 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 30 | G | 0.710806 | E | 0.745676 | -0.03487 | No Change: Both D | A glioblastoma multiforme sample |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 49 | A | 0.808925 | G | 0.822166 | -0.013241 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 49 | A | 0.808925 | S | 0.852716 | -0.043791 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 212 | A | 0.659869 | P | 0.739636 | -0.079767 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 260 | P | 0.868545 | Q | 0.824447 | 0.044098 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 558 | R | 0.997641 | G | 0.997018 | 6.23E-04 | No Change: Both D | A gastric adenocarcinoma sample |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 569 | A | 0.998942 | T | 0.998699 | 2.43E-04 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 599 | A | 0.996187 | P | 0.997466 | -0.001279 | No Change: Both D | - |
| P25440 | BRD2_HUMAN Bromodomain-containing protein 2 OS=Homo sapiens GN=BRD2 PE=1 SV=2 | 714 | P | 0.870769 | L | 0.794311 | 0.076458 | No Change: Both D | A glioblastoma multiforme sample |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 36 | T | 0.667042 | N | 0.695501 | -0.028459 | No Change: Both D | A renal clear cell carcinoma sample |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 161 | A | 0.944857 | T | 0.94263 | 0.002227 | No Change: Both D | A gastric adenocarcinoma sample |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 172 | A | 0.957495 | V | 0.944747 | 0.012748 | No Change: Both D | - |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 435 | K | 0.988414 | Q | 0.987709 | 7.05E-04 | No Change: Both D | - |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 441 | R | 0.997125 | H | 0.996119 | 0.001006 | No Change: Both D | - |
| Q15059 | BRD3_HUMAN Bromodomain-containing protein 3 OS=Homo sapiens GN=BRD3 PE=1 SV=1 | 447 | S | 0.997915 | P | 0.997269 | 6.46E-04 | No Change: Both D | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 37 | P | 0.985887 | S | 0.98464 | 0.001247 | No Change: Both D | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 371 | A | 0.199466 | G | 0.211691 | -0.012225 | No Change: Both O | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 563 | S | 0.999913 | N | 0.999903 | 1.00E-05 | No Change: Both D | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 598 | T | 0.994207 | S | 0.996492 | -0.002285 | No Change: Both D | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 669 | R | 0.712204 | H | 0.624246 | 0.087958 | No Change: Both D | - |
| O60885 | BRD4_HUMAN Bromodomain-containing protein 4 OS=Homo sapiens GN=BRD4 PE=1 SV=2 | 1097 | R | 0.934458 | H | 0.930399 | 0.004059 | No Change: Both D | - |
| Q9H0E9 | BRD8_HUMAN Bromodomain-containing protein 8 OS=Homo sapiens GN=BRD8 PE=1 SV=2 | 490 | T | 0.813635 | M | 0.821645 | -0.00801 | No Change: Both D | - |
| Q9H0E9 | BRD8_HUMAN Bromodomain-containing protein 8 OS=Homo sapiens GN=BRD8 PE=1 SV=2 | 896 | L | 0.909631 | P | 0.938851 | -0.02922 | No Change: Both D | - |
| Q9H0E9 | BRD8_HUMAN Bromodomain-containing protein 8 OS=Homo sapiens GN=BRD8 PE=1 SV=2 | 1198 | Q | 0.338191 | R | 0.313646 | 0.024545 | No Change: Both O | - |
| Q9H8M2 | BRD9_HUMAN Bromodomain-containing protein 9 OS=Homo sapiens GN=BRD9 PE=1 SV=2 | 266 | A | 0.827536 | T | 0.845768 | -0.018232 | No Change: Both D | - |
| Q9H8M2 | BRD9_HUMAN Bromodomain-containing protein 9 OS=Homo sapiens GN=BRD9 PE=1 SV=2 | 389 | A | 0.526593 | T | 0.57832 | -0.051727 | No Change: Both D | - |
| Q9H8M2 | BRD9_HUMAN Bromodomain-containing protein 9 OS=Homo sapiens GN=BRD9 PE=1 SV=2 | 170 | A | 0.185811 | T | 0.206517 | -0.020706 | No Change: Both O | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 62 | Q | 0.17995 | K | 0.223184 | -0.043234 | No Change: Both O | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 238 | K | 0.849961 | N | 0.82024 | 0.029721 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 410 | N | 0.948259 | K | 0.953922 | -0.005663 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 2 | S | 0.796251 | F | 0.661923 | 0.134328 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 6 | R | 0.692826 | Q | 0.724186 | -0.03136 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 89 | A | 0.33774 | V | 0.246727 | 0.091013 | No Change: Both O | A gastric adenocarcinoma sample |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 288 | H | 0.198222 | Y | 0.131527 | 0.066695 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 357 | E | 0.34341 | K | 0.352334 | -0.008924 | No Change: Both O | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 542 | P | 0.686306 | A | 0.607953 | 0.078353 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 336 | K | 0.258318 | T | 0.186331 | 0.071987 | No Change: Both O | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 605 | R | 0.967037 | Q | 0.969504 | -0.002467 | No Change: Both D | - |
| Q58F21 | BRDT_HUMAN Bromodomain testis-specific protein OS=Homo sapiens GN=BRDT PE=1 SV=4 | 696 | P | 0.724738 | L | 0.57461 | 0.150128 | No Change: Both D | - |
| Q92994 | TF3B_HUMAN Transcription factor IIIB 90 kDa subunit OS=Homo sapiens GN=BRF1 PE=1 SV=1 | 542 | V | 0.800052 | M | 0.87501 | -0.074958 | No Change: Both D | A colorectal cancer sample |
| O95415 | BRI3_HUMAN Brain protein I3 OS=Homo sapiens GN=BRI3 PE=2 SV=1 | 123 | T | 0.687224 | A | 0.673147 | 0.014077 | No Change: Both D | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 47 | P | 0.664267 | A | 0.606927 | 0.05734 | No Change: Both D | Breast cancer (BC) [MIM:114480] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 173 | R | 0.422829 | C | 0.296082 | 0.126747 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 193 | V | 0.660901 | I | 0.644155 | 0.016746 | No Change: Both D | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 195 | L | 0.685991 | P | 0.783369 | -0.097378 | No Change: Both D | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 299 | M | 0.374661 | I | 0.28486 | 0.089801 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 419 | R | 0.355254 | W | 0.159358 | 0.195896 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 531 | F | 0.047252 | V | 0.055864 | -0.008612 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 540 | Q | 0.210578 | L | 0.130989 | 0.079589 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 832 | C | 0.169213 | Y | 0.202203 | -0.03299 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 919 | P | 0.464563 | S | 0.491915 | -0.027352 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 935 | V | 0.516551 | G | 0.57223 | -0.055679 | No Change: Both D | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 1034 | P | 0.941582 | L | 0.893219 | 0.048363 | No Change: Both D | A patient with ovarian cancer |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 255 | Q | 0.445234 | H | 0.419082 | 0.026152 | No Change: Both O | Fanconi anemia complementation group J (FANCJ) [MIM:609054] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 264 | R | 0.334352 | W | 0.146812 | 0.18754 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 349 | A | 0.243557 | P | 0.326508 | -0.082951 | No Change: Both O | Fanconi anemia complementation group J (FANCJ) [MIM:609054] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 647 | W | 0.170581 | C | 0.212411 | -0.04183 | No Change: Both O | Fanconi anemia complementation group J (FANCJ) [MIM:609054] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 707 | R | 0.277721 | C | 0.15109 | 0.126631 | No Change: Both O | Fanconi anemia complementation group J (FANCJ) [MIM:609054] |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 633 | I | 0.144314 | M | 0.201277 | -0.056963 | No Change: Both O | - |
| Q9BX63 | FANCJ_HUMAN Fanconi anemia group J protein OS=Homo sapiens GN=BRIP1 PE=1 SV=1 | 1148 | D | 0.820213 | E | 0.829631 | -0.009418 | No Change: Both D | - |
| Q96NH3 | BROMI_HUMAN Protein broad-minded OS=Homo sapiens GN=BROMI PE=2 SV=4 | 82 | R | 0.7187 | Q | 0.742113 | -0.023413 | No Change: Both D | - |
| Q96NH3 | BROMI_HUMAN Protein broad-minded OS=Homo sapiens GN=BROMI PE=2 SV=4 | 280 | I | 0.332262 | V | 0.376903 | -0.044641 | No Change: Both O | - |
| Q96NH3 | BROMI_HUMAN Protein broad-minded OS=Homo sapiens GN=BROMI PE=2 SV=4 | 375 | T | 0.317766 | K | 0.401046 | -0.08328 | No Change: Both O | - |
| Q96NH3 | BROMI_HUMAN Protein broad-minded OS=Homo sapiens GN=BROMI PE=2 SV=4 | 599 | I | 0.338078 | V | 0.353448 | -0.01537 | No Change: Both O | - |
| Q9Y5U8 | BR44L_HUMAN Brain protein 44-like protein OS=Homo sapiens GN=BRP44L PE=1 SV=1 | 36 | L | 0.077448 | I | 0.074893 | 0.002555 | No Change: Both O | - |
| P55201 | BRPF1_HUMAN Peregrin OS=Homo sapiens GN=BRPF1 PE=1 SV=2 | 1117 | G | 0.334935 | E | 0.396092 | -0.061157 | No Change: Both O | - |
| P55201 | BRPF1_HUMAN Peregrin OS=Homo sapiens GN=BRPF1 PE=1 SV=2 | 1193 | H | 0.673317 | Q | 0.741807 | -0.06849 | No Change: Both D | - |
| Q9ULD4 | BRPF3_HUMAN Bromodomain and PHD finger-containing protein 3 OS=Homo sapiens GN=BRPF3 PE=1 SV=2 | 278 | A | 0.483304 | G | 0.571649 | -0.088345 | O to D | - |
| Q9ULD4 | BRPF3_HUMAN Bromodomain and PHD finger-containing protein 3 OS=Homo sapiens GN=BRPF3 PE=1 SV=2 | 177 | S | 0.512982 | G | 0.442727 | 0.070255 | D to O | - |
| P32247 | BRS3_HUMAN Bombesin receptor subtype-3 OS=Homo sapiens GN=BRS3 PE=1 SV=1 | 53 | T | 0.016868 | P | 0.022147 | -0.005279 | No Change: Both O | - |
| P32247 | BRS3_HUMAN Bombesin receptor subtype-3 OS=Homo sapiens GN=BRS3 PE=1 SV=1 | 162 | L | 0.192304 | Q | 0.334737 | -0.142433 | No Change: Both O | - |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 303 | R | 0.753025 | W | 0.526725 | 0.2263 | No Change: Both D | A gastric adenocarcinoma sample |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 319 | V | 0.881886 | I | 0.870079 | 0.011807 | No Change: Both D | A lung large cell carcinoma sample |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 391 | G | 0.96419 | E | 0.970596 | -0.006406 | No Change: Both D | A metastatic melanoma sample |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 531 | T | 0.986512 | N | 0.985533 | 9.79E-04 | No Change: Both D | - |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 749 | G | 0.995946 | S | 0.99695 | -0.001004 | No Change: Both D | - |
| Q8TDC3 | BRSK1_HUMAN Serine/threonine-protein kinase BRSK1 OS=Homo sapiens GN=BRSK1 PE=1 SV=2 | 764 | P | 0.99706 | A | 0.993876 | 0.003184 | No Change: Both D | - |
| Q9NSI6 | BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens GN=BRWD1 PE=1 SV=4 | 83 | Q | 0.198674 | E | 0.223862 | -0.025188 | No Change: Both O | - |
| Q9NSI6 | BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens GN=BRWD1 PE=1 SV=4 | 1511 | S | 0.98409 | P | 0.980267 | 0.003823 | No Change: Both D | - |
| Q9NSI6 | BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens GN=BRWD1 PE=1 SV=4 | 1699 | L | 0.976347 | P | 0.98477 | -0.008423 | No Change: Both D | - |
| Q9NSI6 | BRWD1_HUMAN Bromodomain and WD repeat-containing protein 1 OS=Homo sapiens GN=BRWD1 PE=1 SV=4 | 2156 | K | 0.973226 | R | 0.970633 | 0.002593 | No Change: Both D | - |
| Q6RI45 | BRWD3_HUMAN Bromodomain and WD repeat-containing protein 3 OS=Homo sapiens GN=BRWD3 PE=1 SV=2 | 1288 | K | 0.864812 | R | 0.856716 | 0.008096 | No Change: Both D | - |
| Q6RI45 | BRWD3_HUMAN Bromodomain and WD repeat-containing protein 3 OS=Homo sapiens GN=BRWD3 PE=1 SV=2 | 1596 | K | 0.99692 | E | 0.997097 | -1.77E-04 | No Change: Both D | Mental retardation X-linked type 93 (MRX93) [MIM:300659] |
| Q96G97 | BSCL2_HUMAN Seipin OS=Homo sapiens GN=BSCL2 PE=1 SV=3 | 88 | N | 0.291108 | S | 0.387124 | -0.096016 | No Change: Both O | Spastic paraplegia type 17 (SPG17) [MIM:270685] |
| Q96G97 | BSCL2_HUMAN Seipin OS=Homo sapiens GN=BSCL2 PE=1 SV=3 | 90 | S | 0.335975 | L | 0.189826 | 0.146149 | No Change: Both O | Spastic paraplegia type 17 (SPG17) [MIM:270685] |
| Q96G97 | BSCL2_HUMAN Seipin OS=Homo sapiens GN=BSCL2 PE=1 SV=3 | 212 | A | 0.116481 | P | 0.157454 | -0.040973 | No Change: Both O | Congenital generalized lipodystrophy type 2 (CGL2) [MIM:269700] |
| P35613 | BASI_HUMAN Basigin OS=Homo sapiens GN=BSG PE=1 SV=2 | 269 | G | 0.549149 | V | 0.437899 | 0.11125 | D to O | - |
| P35613 | BASI_HUMAN Basigin OS=Homo sapiens GN=BSG PE=1 SV=2 | 208 | E | 0.234732 | K | 0.23183 | 0.002902 | No Change: Both O | - |
| Q9UPA5 | BSN_HUMAN Protein bassoon OS=Homo sapiens GN=BSN PE=1 SV=4 | 741 | A | 0.968822 | T | 0.97223 | -0.003408 | No Change: Both D | - |
| Q9UPA5 | BSN_HUMAN Protein bassoon OS=Homo sapiens GN=BSN PE=1 SV=4 | 1213 | G | 0.955528 | D | 0.951281 | 0.004247 | No Change: Both D | - |
| Q9UPA5 | BSN_HUMAN Protein bassoon OS=Homo sapiens GN=BSN PE=1 SV=4 | 3863 | A | 0.997101 | T | 0.996957 | 1.44E-04 | No Change: Both D | - |
| Q8WZ55 | BSND_HUMAN Barttin OS=Homo sapiens GN=BSND PE=1 SV=1 | 8 | R | 0.140765 | L | 0.088053 | 0.052712 | No Change: Both O | Bartter syndrome type 4A (BS4A) [MIM:602522] |
| Q8WZ55 | BSND_HUMAN Barttin OS=Homo sapiens GN=BSND PE=1 SV=1 | 8 | R | 0.140765 | W | 0.059777 | 0.080988 | No Change: Both O | Bartter syndrome type 4A (BS4A) [MIM:602522] |
| Q8WZ55 | BSND_HUMAN Barttin OS=Homo sapiens GN=BSND PE=1 SV=1 | 10 | G | 0.04025 | S | 0.047836 | -0.007586 | No Change: Both O | Bartter syndrome type 4A (BS4A) [MIM:602522] |
| Q8WZ55 | BSND_HUMAN Barttin OS=Homo sapiens GN=BSND PE=1 SV=1 | 47 | G | 0.060533 | R | 0.051689 | 0.008844 | No Change: Both O | Bartter syndrome type 4A (BS4A) [MIM:602522] |
| Q8WZ55 | BSND_HUMAN Barttin OS=Homo sapiens GN=BSND PE=1 SV=1 | 43 | V | 0.084135 | I | 0.075094 | 0.009041 | No Change: Both O | - |
| Q5W0U4 | BSPRY_HUMAN B box and SPRY domain-containing protein OS=Homo sapiens GN=BSPRY PE=2 SV=1 | 293 | Q | 0.135204 | H | 0.130725 | 0.004479 | No Change: Both O | - |
| Q5W0U4 | BSPRY_HUMAN B box and SPRY domain-containing protein OS=Homo sapiens GN=BSPRY PE=2 SV=1 | 374 | T | 0.212755 | I | 0.121016 | 0.091739 | No Change: Both O | - |
| Q5W0U4 | BSPRY_HUMAN B box and SPRY domain-containing protein OS=Homo sapiens GN=BSPRY PE=2 SV=1 | 261 | A | 0.623382 | P | 0.690625 | -0.067243 | No Change: Both D | - |
| Q10588 | BST1_HUMAN ADP-ribosyl cyclase 2 OS=Homo sapiens GN=BST1 PE=1 SV=2 | 125 | R | 0.285911 | H | 0.274816 | 0.011095 | No Change: Both O | - |
| Q10588 | BST1_HUMAN ADP-ribosyl cyclase 2 OS=Homo sapiens GN=BST1 PE=1 SV=2 | 145 | R | 0.275935 | Q | 0.296837 | -0.020902 | No Change: Both O | - |
| Q10588 | BST1_HUMAN ADP-ribosyl cyclase 2 OS=Homo sapiens GN=BST1 PE=1 SV=2 | 77 | A | 0.172279 | V | 0.128609 | 0.04367 | No Change: Both O | - |
| Q10588 | BST1_HUMAN ADP-ribosyl cyclase 2 OS=Homo sapiens GN=BST1 PE=1 SV=2 | 101 | I | 0.411003 | V | 0.430502 | -0.019499 | No Change: Both O | - |
| Q10589 | BST2_HUMAN Bone marrow stromal antigen 2 OS=Homo sapiens GN=BST2 PE=1 SV=1 | 143 | V | 0.47235 | F | 0.404886 | 0.067464 | No Change: Both O | - |
| Q9BSF8 | BTBDA_HUMAN BTB/POZ domain-containing protein 10 OS=Homo sapiens GN=BTBD10 PE=1 SV=2 | 145 | T | 0.780213 | A | 0.7734 | 0.006813 | No Change: Both D | - |
| A6QL63 | BTBDB_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 OS=Homo sapiens GN=BTBD11 PE=2 SV=3 | 1002 | A | 0.166572 | D | 0.21526 | -0.048688 | No Change: Both O | - |
| A6QL63 | BTBDB_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 OS=Homo sapiens GN=BTBD11 PE=2 SV=3 | 1076 | G | 0.572394 | S | 0.599712 | -0.027318 | No Change: Both D | - |
| A6QL63 | BTBDB_HUMAN Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 OS=Homo sapiens GN=BTBD11 PE=2 SV=3 | 448 | G | 0.713101 | S | 0.733612 | -0.020511 | No Change: Both D | - |
| Q32M84 | BTBDG_HUMAN BTB/POZ domain-containing protein 16 OS=Homo sapiens GN=BTBD16 PE=2 SV=2 | 318 | R | 0.190094 | Q | 0.186308 | 0.003786 | No Change: Both O | - |
| Q32M84 | BTBDG_HUMAN BTB/POZ domain-containing protein 16 OS=Homo sapiens GN=BTBD16 PE=2 SV=2 | 331 | G | 0.159269 | D | 0.176865 | -0.017596 | No Change: Both O | - |
| Q32M84 | BTBDG_HUMAN BTB/POZ domain-containing protein 16 OS=Homo sapiens GN=BTBD16 PE=2 SV=2 | 439 | H | 0.380688 | P | 0.403549 | -0.022861 | No Change: Both O | - |
| Q32M84 | BTBDG_HUMAN BTB/POZ domain-containing protein 16 OS=Homo sapiens GN=BTBD16 PE=2 SV=2 | 472 | Q | 0.464504 | R | 0.436631 | 0.027873 | No Change: Both O | - |
| B2RXH4 | BTBDI_HUMAN BTB/POZ domain-containing protein 18 OS=Homo sapiens GN=BTBD18 PE=2 SV=1 | 302 | S | 0.970798 | T | 0.961343 | 0.009455 | No Change: Both D | - |
| B2RXH4 | BTBDI_HUMAN BTB/POZ domain-containing protein 18 OS=Homo sapiens GN=BTBD18 PE=2 SV=1 | 352 | E | 0.757664 | G | 0.729455 | 0.028209 | No Change: Both D | - |
| C9JJ37 | BTBDJ_HUMAN BTB/POZ domain-containing protein 19 OS=Homo sapiens GN=BTBD19 PE=2 SV=1 | 110 | E | 0.215293 | G | 0.169058 | 0.046235 | No Change: Both O | - |
| Q5XKL5 | BTBD8_HUMAN BTB/POZ domain-containing protein 8 OS=Homo sapiens GN=BTBD8 PE=2 SV=2 | 136 | K | 0.459115 | R | 0.404929 | 0.054186 | No Change: Both O | - |
| Q5XKL5 | BTBD8_HUMAN BTB/POZ domain-containing protein 8 OS=Homo sapiens GN=BTBD8 PE=2 SV=2 | 60 | V | 0.204881 | I | 0.169199 | 0.035682 | No Change: Both O | - |
| P35070 | BTC_HUMAN Probetacellulin OS=Homo sapiens GN=BTC PE=1 SV=1 | 7 | C | 0.618497 | G | 0.739694 | -0.121197 | No Change: Both D | - |
| P35070 | BTC_HUMAN Probetacellulin OS=Homo sapiens GN=BTC PE=1 SV=1 | 124 | L | 0.007631 | M | 0.010687 | -0.003056 | No Change: Both O | - |
| P35070 | BTC_HUMAN Probetacellulin OS=Homo sapiens GN=BTC PE=1 SV=1 | 44 | L | 0.505721 | F | 0.451381 | 0.05434 | D to O | - |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 128 | F | 0.16396 | V | 0.17257 | -0.00861 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 171 | A | 0.204239 | T | 0.246685 | -0.042446 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 228 | D | 0.112172 | Y | 0.04946 | 0.062712 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 323 | H | 0.326936 | R | 0.318168 | 0.008768 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 444 | D | 0.159614 | H | 0.148202 | 0.011412 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 451 | G | 0.100847 | D | 0.112479 | -0.011632 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 456 | Q | 0.039133 | H | 0.039118 | 1.50E-05 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 532 | T | 0.224047 | M | 0.192021 | 0.032026 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 538 | R | 0.410282 | C | 0.244146 | 0.166136 | No Change: Both O | Biotinidase deficiency (BTD deficiency) [MIM:253260] |
| P43251 | BTD_HUMAN Biotinidase OS=Homo sapiens GN=BTD PE=1 SV=2 | 391 | P | 0.39466 | S | 0.425818 | -0.031158 | No Change: Both O | - |
| P62324 | BTG1_HUMAN Protein BTG1 OS=Homo sapiens GN=BTG1 PE=2 SV=1 | 139 | N | 0.610151 | S | 0.663067 | -0.052916 | No Change: Both D | - |
| P62324 | BTG1_HUMAN Protein BTG1 OS=Homo sapiens GN=BTG1 PE=2 SV=1 | 141 | Q | 0.555846 | E | 0.590806 | -0.03496 | No Change: Both D | - |
| P78543 | BTG2_HUMAN Protein BTG2 OS=Homo sapiens GN=BTG2 PE=1 SV=1 | 153 | V | 0.717389 | M | 0.75378 | -0.036391 | No Change: Both D | - |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 11 | L | 0.360337 | P | 0.520882 | -0.160545 | O to D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 12 | K | 0.454429 | R | 0.384138 | 0.070291 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 14 | S | 0.656866 | F | 0.441008 | 0.215858 | D to O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 25 | F | 0.427584 | S | 0.621489 | -0.193905 | O to D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 28 | R | 0.271156 | H | 0.252015 | 0.019141 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 28 | R | 0.271156 | P | 0.305504 | -0.034348 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 33 | T | 0.179083 | P | 0.222897 | -0.043814 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 64 | V | 0.706739 | F | 0.682464 | 0.024275 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 113 | V | 0.230832 | D | 0.379926 | -0.149094 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 288 | R | 0.526522 | W | 0.345662 | 0.18086 | D to O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 295 | L | 0.623207 | P | 0.694516 | -0.071309 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 302 | G | 0.525261 | E | 0.578023 | -0.052762 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 307 | R | 0.477957 | G | 0.515885 | -0.037928 | O to D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 334 | Y | 0.121484 | S | 0.267614 | -0.14613 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 358 | L | 0.293175 | F | 0.270469 | 0.022706 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 361 | Y | 0.305686 | C | 0.264366 | 0.04132 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 362 | H | 0.3191 | Q | 0.336431 | -0.017331 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 364 | H | 0.338428 | P | 0.36438 | -0.025952 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 365 | N | 0.388366 | Y | 0.253457 | 0.134909 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 370 | I | 0.344314 | M | 0.433146 | -0.088832 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 408 | L | 0.25965 | P | 0.37494 | -0.11529 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 418 | Y | 0.211516 | H | 0.3062 | -0.094684 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 429 | I | 0.233167 | N | 0.363547 | -0.13038 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 430 | K | 0.286817 | E | 0.289489 | -0.002672 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 476 | Y | 0.053362 | D | 0.104213 | -0.050851 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 477 | M | 0.054965 | R | 0.071728 | -0.016763 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 502 | C | 0.226596 | F | 0.210787 | 0.015809 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 502 | C | 0.226596 | W | 0.163706 | 0.06289 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 506 | C | 0.243344 | R | 0.367942 | -0.124598 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 506 | C | 0.243344 | Y | 0.253798 | -0.010454 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 509 | M | 0.289218 | V | 0.227229 | 0.061989 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 520 | R | 0.243707 | Q | 0.26083 | -0.017123 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 521 | D | 0.22274 | H | 0.20143 | 0.02131 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 521 | D | 0.22274 | N | 0.219811 | 0.002929 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 525 | R | 0.1911 | P | 0.20177 | -0.01067 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 525 | R | 0.1911 | Q | 0.204262 | -0.013162 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 526 | N | 0.183887 | K | 0.207938 | -0.024051 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 542 | L | 0.212563 | P | 0.345408 | -0.132845 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 544 | R | 0.23228 | K | 0.291032 | -0.058752 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 562 | R | 0.360085 | P | 0.429319 | -0.069234 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 562 | R | 0.360085 | W | 0.192033 | 0.168052 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 567 | E | 0.306432 | K | 0.323066 | -0.016634 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 581 | W | 0.126432 | R | 0.244591 | -0.118159 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 582 | A | 0.075493 | V | 0.060511 | 0.014982 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 587 | M | 0.029716 | L | 0.022295 | 0.007421 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 589 | E | 0.051122 | G | 0.043492 | 0.00763 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 592 | S | 0.12177 | P | 0.115887 | 0.005883 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 594 | G | 0.186562 | E | 0.238432 | -0.05187 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 594 | G | 0.186562 | R | 0.187346 | -7.84E-04 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 598 | Y | 0.410161 | C | 0.343758 | 0.066403 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 607 | A | 0.533053 | D | 0.607797 | -0.074744 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 613 | G | 0.278562 | D | 0.305017 | -0.026455 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 619 | P | 0.247001 | S | 0.286227 | -0.039226 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 630 | M | 0.081672 | I | 0.056886 | 0.024786 | No Change: Both O | - |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 630 | M | 0.081672 | K | 0.148688 | -0.067016 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 633 | C | 0.11615 | Y | 0.15059 | -0.03444 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 641 | R | 0.411015 | C | 0.251919 | 0.159096 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 641 | R | 0.411015 | H | 0.432721 | -0.021706 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 644 | F | 0.264354 | S | 0.479098 | -0.214744 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 647 | L | 0.117281 | P | 0.223103 | -0.105822 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 652 | L | 0.266788 | P | 0.39001 | -0.123222 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 19 | K | 0.766756 | E | 0.751865 | 0.014891 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 27 | K | 0.329381 | R | 0.274203 | 0.055178 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 28 | R | 0.271156 | C | 0.150157 | 0.120999 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 40 | Y | 0.342145 | C | 0.341449 | 6.96E-04 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 40 | Y | 0.342145 | N | 0.452747 | -0.110602 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 61 | I | 0.647304 | N | 0.723175 | -0.075871 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 64 | V | 0.706739 | D | 0.778303 | -0.071564 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 115 | S | 0.287089 | F | 0.138651 | 0.148438 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 117 | T | 0.338951 | P | 0.410924 | -0.071973 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 127 | Q | 0.139245 | H | 0.139765 | -5.20E-04 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 154 | C | 0.088493 | S | 0.203492 | -0.114999 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 155 | C | 0.140715 | G | 0.244682 | -0.103967 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 155 | C | 0.140715 | R | 0.225705 | -0.08499 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 184 | T | 0.95637 | P | 0.968727 | -0.012357 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 288 | R | 0.526522 | Q | 0.570233 | -0.043711 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 302 | G | 0.525261 | R | 0.525261 | 0 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 307 | R | 0.477957 | T | 0.465317 | 0.01264 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 308 | D | 0.500217 | E | 0.543422 | -0.043205 | No Change: Both D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 319 | V | 0.361882 | A | 0.432234 | -0.070352 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 366 | S | 0.394298 | F | 0.187573 | 0.206725 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 369 | L | 0.371836 | F | 0.327439 | 0.044397 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 372 | R | 0.325809 | G | 0.355141 | -0.029332 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 414 | G | 0.19008 | R | 0.168931 | 0.021149 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 430 | K | 0.286817 | R | 0.224472 | 0.062345 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 445 | E | 0.477067 | D | 0.439126 | 0.037941 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 462 | G | 0.108864 | D | 0.122388 | -0.013524 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 462 | G | 0.108864 | V | 0.067942 | 0.040922 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 508 | A | 0.278492 | D | 0.375278 | -0.096786 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 509 | M | 0.289218 | I | 0.182915 | 0.106303 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 518 | L | 0.294946 | R | 0.413037 | -0.118091 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 521 | D | 0.22274 | G | 0.196502 | 0.026238 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 523 | A | 0.19112 | E | 0.269772 | -0.078652 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 525 | R | 0.1911 | G | 0.187587 | 0.003513 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 535 | V | 0.257577 | F | 0.225705 | 0.031872 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 559 | F | 0.493628 | S | 0.710138 | -0.21651 | O to D | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 563 | W | 0.315095 | L | 0.416556 | -0.101461 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 583 | F | 0.051113 | S | 0.134614 | -0.083501 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 589 | E | 0.051122 | D | 0.044819 | 0.006303 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 619 | P | 0.247001 | A | 0.197426 | 0.049575 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 619 | P | 0.247001 | T | 0.208706 | 0.038295 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 622 | A | 0.27491 | P | 0.36344 | -0.08853 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 626 | V | 0.220175 | G | 0.330675 | -0.1105 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 630 | M | 0.081672 | T | 0.105815 | -0.024143 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 644 | F | 0.264354 | L | 0.30944 | -0.045086 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 39 | Y | 0.281951 | S | 0.47019 | -0.188239 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 512 | L | 0.355704 | P | 0.491202 | -0.135498 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 512 | L | 0.355704 | Q | 0.499063 | -0.143359 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 544 | R | 0.23228 | G | 0.249886 | -0.017606 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 578 | S | 0.299798 | Y | 0.167587 | 0.132211 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 589 | E | 0.051122 | K | 0.05427 | -0.003148 | No Change: Both O | X-linked agammaglobulinemia (XLA) [MIM:300755] |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 82 | R | 0.916796 | K | 0.91006 | 0.006736 | No Change: Both D | - |
| Q06187 | BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens GN=BTK PE=1 SV=3 | 190 | P | 0.970405 | K | 0.968572 | 0.001833 | No Change: Both D | A lung large cell carcinoma sample |
| Q7Z6A9 | BTLA_HUMAN B- and T-lymphocyte attenuator OS=Homo sapiens GN=BTLA PE=1 SV=3 | 157 | R | 0.110136 | S | 0.135844 | -0.025708 | No Change: Both O | - |
| Q7Z6A9 | BTLA_HUMAN B- and T-lymphocyte attenuator OS=Homo sapiens GN=BTLA PE=1 SV=3 | 267 | P | 0.466423 | L | 0.332378 | 0.134045 | No Change: Both O | - |
| Q7Z6A9 | BTLA_HUMAN B- and T-lymphocyte attenuator OS=Homo sapiens GN=BTLA PE=1 SV=3 | 124 | I | 0.486896 | V | 0.526321 | -0.039425 | O to D | - |
| Q13410 | BT1A1_HUMAN Butyrophilin subfamily 1 member A1 OS=Homo sapiens GN=BTN1A1 PE=1 SV=3 | 213 | A | 0.270342 | T | 0.299829 | -0.029487 | No Change: Both O | - |
| Q13410 | BT1A1_HUMAN Butyrophilin subfamily 1 member A1 OS=Homo sapiens GN=BTN1A1 PE=1 SV=3 | 503 | D | 0.821138 | E | 0.826517 | -0.005379 | No Change: Both D | - |
| Q13410 | BT1A1_HUMAN Butyrophilin subfamily 1 member A1 OS=Homo sapiens GN=BTN1A1 PE=1 SV=3 | 303 | V | 0.496305 | A | 0.568203 | -0.071898 | O to D | - |
| Q13410 | BT1A1_HUMAN Butyrophilin subfamily 1 member A1 OS=Homo sapiens GN=BTN1A1 PE=1 SV=3 | 521 | P | 0.952356 | S | 0.948943 | 0.003413 | No Change: Both D | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 124 | R | 0.19887 | C | 0.102045 | 0.096825 | No Change: Both O | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 207 | V | 0.103286 | M | 0.137306 | -0.03402 | No Change: Both O | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 378 | R | 0.405197 | Q | 0.420838 | -0.015641 | No Change: Both O | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 451 | G | 0.072676 | A | 0.057852 | 0.014824 | No Change: Both O | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 178 | W | 0.167315 | C | 0.19761 | -0.030295 | No Change: Both O | - |
| Q7KYR7 | BT2A1_HUMAN Butyrophilin subfamily 2 member A1 OS=Homo sapiens GN=BTN2A1 PE=1 SV=3 | 178 | W | 0.167315 | L | 0.234816 | -0.067501 | No Change: Both O | - |
| Q8WVV5 | BT2A2_HUMAN Butyrophilin subfamily 2 member A2 OS=Homo sapiens GN=BTN2A2 PE=2 SV=2 | 479 | P | 0.201058 | S | 0.214345 | -0.013287 | No Change: Both O | - |
| Q96KV6 | BT2A3_HUMAN Putative butyrophilin subfamily 2 member A3 OS=Homo sapiens GN=BTN2A3P PE=5 SV=2 | 79 | G | 0.566246 | D | 0.58571 | -0.019464 | No Change: Both D | - |
| Q96KV6 | BT2A3_HUMAN Putative butyrophilin subfamily 2 member A3 OS=Homo sapiens GN=BTN2A3P PE=5 SV=2 | 148 | V | 0.503489 | I | 0.476965 | 0.026524 | D to O | - |
| Q96KV6 | BT2A3_HUMAN Putative butyrophilin subfamily 2 member A3 OS=Homo sapiens GN=BTN2A3P PE=5 SV=2 | 300 | N | 0.154078 | S | 0.182396 | -0.028318 | No Change: Both O | - |
| O00481 | BT3A1_HUMAN Butyrophilin subfamily 3 member A1 OS=Homo sapiens GN=BTN3A1 PE=1 SV=3 | 224 | S | 0.277729 | N | 0.214713 | 0.063016 | No Change: Both O | - |
| O00481 | BT3A1_HUMAN Butyrophilin subfamily 3 member A1 OS=Homo sapiens GN=BTN3A1 PE=1 SV=3 | 456 | P | 0.622936 | T | 0.568409 | 0.054527 | No Change: Both D | - |
| O00481 | BT3A1_HUMAN Butyrophilin subfamily 3 member A1 OS=Homo sapiens GN=BTN3A1 PE=1 SV=3 | 15 | R | 0.026776 | H | 0.025483 | 0.001293 | No Change: Both O | - |
| O00481 | BT3A1_HUMAN Butyrophilin subfamily 3 member A1 OS=Homo sapiens GN=BTN3A1 PE=1 SV=3 | 282 | R | 0.787758 | T | 0.776488 | 0.01127 | No Change: Both D | - |
| P78410 | BT3A2_HUMAN Butyrophilin subfamily 3 member A2 OS=Homo sapiens GN=BTN3A2 PE=1 SV=2 | 181 | N | 0.441795 | D | 0.440371 | 0.001424 | No Change: Both O | - |
| P78410 | BT3A2_HUMAN Butyrophilin subfamily 3 member A2 OS=Homo sapiens GN=BTN3A2 PE=1 SV=2 | 167 | R | 0.212744 | T | 0.214034 | -0.00129 | No Change: Both O | - |
| P78410 | BT3A2_HUMAN Butyrophilin subfamily 3 member A2 OS=Homo sapiens GN=BTN3A2 PE=1 SV=2 | 182 | A | 0.449656 | T | 0.472339 | -0.022683 | No Change: Both O | - |
| P78410 | BT3A2_HUMAN Butyrophilin subfamily 3 member A2 OS=Homo sapiens GN=BTN3A2 PE=1 SV=2 | 211 | R | 0.418618 | K | 0.472741 | -0.054123 | No Change: Both O | - |
| P78410 | BT3A2_HUMAN Butyrophilin subfamily 3 member A2 OS=Homo sapiens GN=BTN3A2 PE=1 SV=2 | 307 | S | 0.951421 | N | 0.929126 | 0.022295 | No Change: Both D | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 196 | K | 0.417719 | E | 0.436194 | -0.018475 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 334 | S | 0.476877 | L | 0.319898 | 0.156979 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 94 | W | 0.131931 | R | 0.285012 | -0.153081 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 283 | D | 0.420285 | V | 0.276564 | 0.143721 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 352 | A | 0.418902 | T | 0.463848 | -0.044946 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 379 | P | 0.705253 | L | 0.544139 | 0.161114 | No Change: Both D | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 380 | M | 0.70423 | I | 0.58836 | 0.11587 | No Change: Both D | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 393 | P | 0.58446 | Q | 0.558816 | 0.025644 | No Change: Both D | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 188 | V | 0.320405 | M | 0.38712 | -0.066715 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 360 | S | 0.488789 | G | 0.421206 | 0.067583 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 181 | R | 0.193963 | Q | 0.217312 | -0.023349 | No Change: Both O | - |
| Q9UIR0 | BTNL2_HUMAN Butyrophilin-like protein 2 OS=Homo sapiens GN=BTNL2 PE=2 SV=1 | 202 | A | 0.113118 | V | 0.08201 | 0.031108 | No Change: Both O | - |
| Q6UX41 | BTNL8_HUMAN Butyrophilin-like protein 8 OS=Homo sapiens GN=BTNL8 PE=1 SV=1 | 143 | T | 0.130352 | A | 0.116762 | 0.01359 | No Change: Both O | - |
| Q6UX41 | BTNL8_HUMAN Butyrophilin-like protein 8 OS=Homo sapiens GN=BTNL8 PE=1 SV=1 | 229 | E | 0.123628 | K | 0.124954 | -0.001326 | No Change: Both O | - |
| Q6UXG8 | BTNL9_HUMAN Butyrophilin-like protein 9 OS=Homo sapiens GN=BTNL9 PE=2 SV=1 | 511 | G | 0.563112 | R | 0.571503 | -0.008391 | No Change: Both D | - |
| Q9Y297 | FBW1A_HUMAN F-box/WD repeat-containing protein 1A OS=Homo sapiens GN=BTRC PE=1 SV=1 | 592 | P | 0.730579 | H | 0.715244 | 0.015335 | No Change: Both D | - |
| Q9Y297 | FBW1A_HUMAN F-box/WD repeat-containing protein 1A OS=Homo sapiens GN=BTRC PE=1 SV=1 | 543 | A | 0.264125 | S | 0.347504 | -0.083379 | No Change: Both O | - |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 36 | E | 0.270679 | D | 0.228416 | 0.042263 | No Change: Both O | Colorectal cancer |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 492 | S | 0.629181 | Y | 0.412557 | 0.216624 | D to O | Colorectal cancer |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 648 | P | 0.643359 | R | 0.607669 | 0.03569 | No Change: Both D | Colorectal cancer |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 259 | Y | 0.682081 | C | 0.69642 | -0.014339 | No Change: Both D | Pancreatic cancer |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 265 | H | 0.736339 | N | 0.770237 | -0.033898 | No Change: Both D | Pancreatic cancer |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 20 | G | 0.561077 | D | 0.578495 | -0.017418 | No Change: Both D | - |
| O43683 | BUB1_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 OS=Homo sapiens GN=BUB1 PE=1 SV=1 | 534 | N | 0.537052 | D | 0.536898 | 1.54E-04 | No Change: Both D | - |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 15 | M | 0.733285 | T | 0.719587 | 0.013698 | No Change: Both D | A colorectal cancer cell line |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 349 | R | 0.496245 | Q | 0.511541 | -0.015296 | O to D | - |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 618 | V | 0.417103 | A | 0.516188 | -0.099085 | O to D | Colorectal cancer |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 36 | R | 0.571386 | Q | 0.612042 | -0.040656 | No Change: Both D | Premature chromatid separation trait (PCS) [MIM:176430] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 390 | E | 0.871758 | D | 0.84022 | 0.031538 | No Change: Both D | - |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 550 | R | 0.857477 | Q | 0.855013 | 0.002464 | No Change: Both D | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 814 | R | 0.41269 | H | 0.427961 | -0.015271 | No Change: Both O | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 844 | L | 0.105173 | F | 0.090318 | 0.014855 | No Change: Both O | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 909 | I | 0.185451 | T | 0.302049 | -0.116598 | No Change: Both O | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 921 | Q | 0.128847 | H | 0.119718 | 0.009129 | No Change: Both O | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 1012 | L | 0.293635 | P | 0.448677 | -0.155042 | No Change: Both O | Mosaic variegated aneuploidy syndrome type 1 (MVA1) [MIM:257300] |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 40 | T | 0.479651 | M | 0.477361 | 0.00229 | No Change: Both O | - |
| O60566 | BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens GN=BUB1B PE=1 SV=3 | 378 | P | 0.880658 | S | 0.882803 | -0.002145 | No Change: Both D | - |
| Q9BRD0 | BUD13_HUMAN BUD13 homolog OS=Homo sapiens GN=BUD13 PE=1 SV=1 | 120 | R | 0.911262 | C | 0.863439 | 0.047823 | No Change: Both D | - |
| Q9BRD0 | BUD13_HUMAN BUD13 homolog OS=Homo sapiens GN=BUD13 PE=1 SV=1 | 148 | P | 0.999555 | L | 0.99899 | 5.65E-04 | No Change: Both D | - |
| Q9BRD0 | BUD13_HUMAN BUD13 homolog OS=Homo sapiens GN=BUD13 PE=1 SV=1 | 242 | R | 0.995863 | I | 0.991584 | 0.004279 | No Change: Both D | - |
| Q9BRD0 | BUD13_HUMAN BUD13 homolog OS=Homo sapiens GN=BUD13 PE=1 SV=1 | 388 | S | 0.999776 | C | 0.999576 | 2.00E-04 | No Change: Both D | - |
| Q8NE79 | POPD1_HUMAN Blood vessel epicardial substance OS=Homo sapiens GN=BVES PE=1 SV=1 | 129 | R | 0.239993 | W | 0.091711 | 0.148282 | No Change: Both O | - |
| Q8NE79 | POPD1_HUMAN Blood vessel epicardial substance OS=Homo sapiens GN=BVES PE=1 SV=1 | 127 | M | 0.279069 | I | 0.204261 | 0.074808 | No Change: Both O | - |
| Q13895 | BYST_HUMAN Bystin OS=Homo sapiens GN=BYSL PE=1 SV=3 | 103 | E | 0.894793 | K | 0.878265 | 0.016528 | No Change: Both D | - |
| Q13895 | BYST_HUMAN Bystin OS=Homo sapiens GN=BYSL PE=1 SV=3 | 426 | P | 0.80734 | S | 0.790895 | 0.016445 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 514 | Q | 0.771644 | R | 0.75494 | 0.016704 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 586 | A | 0.985706 | T | 0.988145 | -0.002439 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 1118 | H | 0.998272 | L | 0.998013 | 2.59E-04 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 1140 | A | 0.99302 | P | 0.995215 | -0.002195 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 1253 | R | 0.885052 | C | 0.846 | 0.039052 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 1830 | G | 0.807936 | E | 0.823594 | -0.015658 | No Change: Both D | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 817 | Q | 0.385614 | R | 0.373846 | 0.011768 | No Change: Both O | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 851 | W | 0.143182 | R | 0.327478 | -0.184296 | No Change: Both O | - |
| O95153 | RIMB1_HUMAN Peripheral-type benzodiazepine receptor-associated protein 1 OS=Homo sapiens GN=BZRAP1 PE=1 SV=2 | 1728 | H | 0.816233 | R | 0.864256 | -0.048023 | No Change: Both D | - |
| Q9Y6E2 | BZW2_HUMAN Basic leucine zipper and W2 domain-containing protein 2 OS=Homo sapiens GN=BZW2 PE=1 SV=1 | 44 | D | 0.441913 | A | 0.37046 | 0.071453 | No Change: Both O | - |
| Q9H2I8 | CJ011_HUMAN Leucine-rich repeat-containing protein C10orf11 OS=Homo sapiens GN=C10orf11 PE=1 SV=1 | 153 | S | 0.800531 | F | 0.625268 | 0.175263 | No Change: Both D | - |
| Q8N326 | CJ111_HUMAN Uncharacterized protein C10orf111 OS=Homo sapiens GN=C10orf111 PE=2 SV=1 | 70 | R | 0.529945 | K | 0.577923 | -0.047978 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 562 | D | 0.419202 | A | 0.338074 | 0.081128 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 573 | I | 0.510622 | V | 0.533644 | -0.023022 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 653 | K | 0.298492 | N | 0.266501 | 0.031991 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 713 | V | 0.15927 | A | 0.20325 | -0.04398 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 809 | D | 0.698803 | G | 0.681946 | 0.016857 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 812 | E | 0.669969 | K | 0.653828 | 0.016141 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 917 | T | 0.3214 | M | 0.289689 | 0.031711 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 958 | V | 0.160457 | I | 0.160422 | 3.50E-05 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1033 | K | 0.856112 | E | 0.866135 | -0.010023 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1049 | L | 0.54321 | I | 0.509252 | 0.033958 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1087 | H | 0.706668 | Q | 0.712345 | -0.005677 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1173 | M | 0.090437 | T | 0.113376 | -0.022939 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1261 | P | 0.47089 | S | 0.474848 | -0.003958 | No Change: Both O | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1307 | S | 0.882411 | N | 0.845911 | 0.0365 | No Change: Both D | - |
| Q5VYJ5 | CJ112_HUMAN MAM and LDL-receptor class A domain-containing protein C10orf112 OS=Homo sapiens GN=C10orf112 PE=2 SV=3 | 1379 | M | 0.236487 | R | 0.289861 | -0.053374 | No Change: Both O | - |
| Q5VZT2 | CJ113_HUMAN Putative uncharacterized protein C10orf113 OS=Homo sapiens GN=C10orf113 PE=2 SV=2 | 110 | D | 0.675653 | H | 0.656427 | 0.019226 | No Change: Both D | - |
| Q5VZT2 | CJ113_HUMAN Putative uncharacterized protein C10orf113 OS=Homo sapiens GN=C10orf113 PE=2 SV=2 | 72 | R | 0.697604 | G | 0.668578 | 0.029026 | No Change: Both D | - |
| Q5T4H9 | CJ114_HUMAN Putative uncharacterized protein C10orf114 OS=Homo sapiens GN=C10orf114 PE=2 SV=1 | 73 | R | 0.939591 | P | 0.943913 | -0.004322 | No Change: Both D | - |
| Q7Z3E2 | CJ118_HUMAN Uncharacterized protein C10orf118 OS=Homo sapiens GN=C10orf118 PE=2 SV=2 | 85 | T | 0.83687 | I | 0.780879 | 0.055991 | No Change: Both D | - |
| Q7Z3E2 | CJ118_HUMAN Uncharacterized protein C10orf118 OS=Homo sapiens GN=C10orf118 PE=2 SV=2 | 179 | R | 0.48966 | Q | 0.512785 | -0.023125 | O to D | - |
| Q7Z3E2 | CJ118_HUMAN Uncharacterized protein C10orf118 OS=Homo sapiens GN=C10orf118 PE=2 SV=2 | 271 | Q | 0.785384 | K | 0.793704 | -0.00832 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 49 | N | 0.697545 | S | 0.729802 | -0.032257 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 314 | L | 0.939076 | P | 0.9666 | -0.027524 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 401 | P | 0.985802 | A | 0.976635 | 0.009167 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 535 | I | 0.966093 | L | 0.976635 | -0.010542 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 396 | E | 0.989987 | G | 0.986514 | 0.003473 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 556 | T | 0.959764 | P | 0.969793 | -0.010029 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 579 | N | 0.946586 | S | 0.960873 | -0.014287 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 614 | R | 0.621142 | G | 0.608135 | 0.013007 | No Change: Both D | - |
| Q8N655 | CJ012_HUMAN Uncharacterized protein C10orf12 OS=Homo sapiens GN=C10orf12 PE=1 SV=1 | 716 | A | 0.957055 | P | 0.969726 | -0.012671 | No Change: Both D | - |
| Q5SQS8 | CJ120_HUMAN Uncharacterized protein C10orf120 OS=Homo sapiens GN=C10orf120 PE=2 SV=1 | 20 | T | 0.854505 | K | 0.898546 | -0.044041 | No Change: Both D | - |
| Q5SQS8 | CJ120_HUMAN Uncharacterized protein C10orf120 OS=Homo sapiens GN=C10orf120 PE=2 SV=1 | 269 | A | 0.615161 | T | 0.642369 | -0.027208 | No Change: Both D | - |
| Q5VZQ5 | CJ122_HUMAN Putative uncharacterized protein C10orf122 OS=Homo sapiens GN=C10orf122 PE=2 SV=1 | 38 | E | 0.906641 | Q | 0.908977 | -0.002336 | No Change: Both D | - |
| Q5T292 | CJ128_HUMAN Putative uncharacterized protein C10orf128 OS=Homo sapiens GN=C10orf128 PE=2 SV=1 | 83 | P | 0.702104 | L | 0.539223 | 0.162881 | No Change: Both D | - |
| Q5T742 | CJ025_HUMAN Uncharacterized protein C10orf25 OS=Homo sapiens GN=C10orf25 PE=2 SV=3 | 63 | I | 0.077821 | N | 0.172583 | -0.094762 | No Change: Both O | - |
| Q5T742 | CJ025_HUMAN Uncharacterized protein C10orf25 OS=Homo sapiens GN=C10orf25 PE=2 SV=3 | 61 | P | 0.107175 | L | 0.055613 | 0.051562 | No Change: Both O | - |
| Q86WR7 | CJ047_HUMAN Uncharacterized protein C10orf47 OS=Homo sapiens GN=C10orf47 PE=1 SV=2 | 412 | A | 0.860057 | V | 0.809786 | 0.050271 | No Change: Both D | - |
| Q9H7M9 | GI24_HUMAN Platelet receptor Gi24 OS=Homo sapiens GN=C10orf54 PE=1 SV=3 | 187 | D | 0.755584 | E | 0.777192 | -0.021608 | No Change: Both D | - |
| Q5T681 | CJ062_HUMAN Uncharacterized protein C10orf62 OS=Homo sapiens GN=C10orf62 PE=1 SV=1 | 121 | E | 0.584235 | D | 0.564248 | 0.019987 | No Change: Both D | - |
| Q9H943 | CJ068_HUMAN Uncharacterized protein C10orf68 OS=Homo sapiens GN=C10orf68 PE=2 SV=2 | 510 | M | 0.445612 | T | 0.493659 | -0.048047 | No Change: Both O | - |
| Q9H943 | CJ068_HUMAN Uncharacterized protein C10orf68 OS=Homo sapiens GN=C10orf68 PE=2 SV=2 | 388 | G | 0.545566 | A | 0.517449 | 0.028117 | No Change: Both D | - |
| Q9H943 | CJ068_HUMAN Uncharacterized protein C10orf68 OS=Homo sapiens GN=C10orf68 PE=2 SV=2 | 607 | V | 0.420797 | I | 0.367858 | 0.052939 | No Change: Both O | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 208 | N | 0.731321 | K | 0.740705 | -0.009384 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 666 | H | 0.927475 | Q | 0.942932 | -0.015457 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 698 | F | 0.827071 | S | 0.905752 | -0.078681 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 741 | D | 0.961422 | G | 0.948646 | 0.012776 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 883 | D | 0.769256 | N | 0.75651 | 0.012746 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 958 | F | 0.937412 | Y | 0.933391 | 0.004021 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 1084 | G | 0.978876 | A | 0.980053 | -0.001177 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 1254 | V | 0.923417 | I | 0.898602 | 0.024815 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 1337 | G | 0.652958 | S | 0.742416 | -0.089458 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 320 | R | 0.836754 | L | 0.756497 | 0.080257 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 461 | D | 0.893203 | A | 0.875283 | 0.01792 | No Change: Both D | - |
| Q711Q0 | CJ071_HUMAN Uncharacterized protein C10orf71 OS=Homo sapiens GN=C10orf71 PE=2 SV=2 | 522 | V | 0.790042 | G | 0.848299 | -0.058257 | No Change: Both D | - |
| Q5SXH7 | CJ081_HUMAN PH domain-containing protein C10orf81 OS=Homo sapiens GN=C10orf81 PE=1 SV=2 | 337 | V | 0.247983 | I | 0.215185 | 0.032798 | No Change: Both O | - |
| Q8WW14 | CJ082_HUMAN Uncharacterized protein C10orf82 OS=Homo sapiens GN=C10orf82 PE=2 SV=2 | 124 | T | 0.150955 | M | 0.129755 | 0.0212 | No Change: Both O | - |
| Q96M02 | CJ090_HUMAN Centrosomal protein C10orf90 OS=Homo sapiens GN=C10orf90 PE=2 SV=2 | 134 | R | 0.836637 | H | 0.771674 | 0.064963 | No Change: Both D | - |
| Q96M02 | CJ090_HUMAN Centrosomal protein C10orf90 OS=Homo sapiens GN=C10orf90 PE=2 SV=2 | 262 | D | 0.571994 | N | 0.510394 | 0.0616 | No Change: Both D | - |
| Q96M02 | CJ090_HUMAN Centrosomal protein C10orf90 OS=Homo sapiens GN=C10orf90 PE=2 SV=2 | 57 | M | 0.742595 | I | 0.678763 | 0.063832 | No Change: Both D | - |
| Q96M02 | CJ090_HUMAN Centrosomal protein C10orf90 OS=Homo sapiens GN=C10orf90 PE=2 SV=2 | 531 | D | 0.938297 | E | 0.944057 | -0.00576 | No Change: Both D | - |
| Q5T1B1 | CJ091_HUMAN Uncharacterized protein C10orf91 OS=Homo sapiens GN=C10orf91 PE=2 SV=2 | 144 | E | 0.69341 | G | 0.683716 | 0.009694 | No Change: Both D | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 492 | A | 0.318408 | T | 0.36445 | -0.046042 | No Change: Both O | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 701 | S | 0.885205 | G | 0.849298 | 0.035907 | No Change: Both D | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 286 | C | 0.615837 | R | 0.745519 | -0.129682 | No Change: Both D | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 410 | E | 0.675592 | K | 0.64926 | 0.026332 | No Change: Both D | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 660 | L | 0.147071 | F | 0.119395 | 0.027676 | No Change: Both O | - |
| Q8IYW2 | CJ092_HUMAN Uncharacterized protein C10orf92 OS=Homo sapiens GN=C10orf92 PE=2 SV=2 | 819 | K | 0.880028 | Q | 0.882021 | -0.001993 | No Change: Both D | - |
| Q5SR76 | CJ093_HUMAN TPR repeat-containing protein C10orf93 OS=Homo sapiens GN=C10orf93 PE=2 SV=2 | 264 | S | 0.180246 | N | 0.160026 | 0.02022 | No Change: Both O | - |
| Q9H5F2 | CK001_HUMAN UPF0686 protein C11orf1 OS=Homo sapiens GN=C11orf1 PE=2 SV=1 | 49 | K | 0.118466 | Q | 0.108053 | 0.010413 | No Change: Both O | - |
| Q9H5F2 | CK001_HUMAN UPF0686 protein C11orf1 OS=Homo sapiens GN=C11orf1 PE=2 SV=1 | 85 | Q | 0.353929 | H | 0.322081 | 0.031848 | No Change: Both O | - |
| Q9H5F2 | CK001_HUMAN UPF0686 protein C11orf1 OS=Homo sapiens GN=C11orf1 PE=2 SV=1 | 40 | V | 0.255723 | A | 0.333248 | -0.077525 | No Change: Both O | - |
| Q9NQ32 | CK016_HUMAN Uncharacterized protein C11orf16 OS=Homo sapiens GN=C11orf16 PE=2 SV=3 | 144 | P | 0.412878 | L | 0.255322 | 0.157556 | No Change: Both O | - |
| Q9NQ32 | CK016_HUMAN Uncharacterized protein C11orf16 OS=Homo sapiens GN=C11orf16 PE=2 SV=3 | 210 | V | 0.243403 | L | 0.243315 | 8.80E-05 | No Change: Both O | - |
| Q9NTU4 | CK020_HUMAN Uncharacterized protein C11orf20 OS=Homo sapiens GN=C11orf20 PE=2 SV=1 | 68 | P | 0.717502 | L | 0.595367 | 0.122135 | No Change: Both D | - |
| Q96F05 | CK024_HUMAN Uncharacterized protein C11orf24 OS=Homo sapiens GN=C11orf24 PE=2 SV=2 | 97 | G | 0.927066 | V | 0.904689 | 0.022377 | No Change: Both D | - |
| Q96F05 | CK024_HUMAN Uncharacterized protein C11orf24 OS=Homo sapiens GN=C11orf24 PE=2 SV=2 | 150 | A | 0.995783 | T | 0.996374 | -5.91E-04 | No Change: Both D | - |
| Q8IXW0 | CK035_HUMAN Uncharacterized protein C11orf35 OS=Homo sapiens GN=C11orf35 PE=2 SV=2 | 44 | A | 0.87423 | T | 0.890191 | -0.015961 | No Change: Both D | - |
| Q2M3A8 | CK036_HUMAN Putative uncharacterized protein C11orf36 OS=Homo sapiens GN=C11orf36 PE=5 SV=1 | 6 | E | 0.765534 | A | 0.724293 | 0.041241 | No Change: Both D | - |
| Q2M3A8 | CK036_HUMAN Putative uncharacterized protein C11orf36 OS=Homo sapiens GN=C11orf36 PE=5 SV=1 | 135 | S | 0.737143 | F | 0.518537 | 0.218606 | No Change: Both D | - |
| Q2M3A8 | CK036_HUMAN Putative uncharacterized protein C11orf36 OS=Homo sapiens GN=C11orf36 PE=5 SV=1 | 142 | G | 0.880416 | V | 0.78454 | 0.095876 | No Change: Both D | - |
| Q8WZ69 | CK040_HUMAN Putative uncharacterized protein C11orf40 OS=Homo sapiens GN=C11orf40 PE=2 SV=1 | 100 | F | 0.126799 | S | 0.290312 | -0.163513 | No Change: Both O | - |
| Q8N5U0 | CK042_HUMAN Uncharacterized protein C11orf42 OS=Homo sapiens GN=C11orf42 PE=2 SV=2 | 242 | P | 0.930623 | S | 0.916911 | 0.013712 | No Change: Both D | - |
| Q8N8R7 | CK046_HUMAN Uncharacterized protein C11orf46 OS=Homo sapiens GN=C11orf46 PE=1 SV=1 | 180 | T | 0.64845 | P | 0.688786 | -0.040336 | No Change: Both D | - |
| Q96A22 | CK052_HUMAN Uncharacterized protein C11orf52 OS=Homo sapiens GN=C11orf52 PE=1 SV=2 | 23 | T | 0.969236 | R | 0.972951 | -0.003715 | No Change: Both D | - |
| Q6NUN7 | CK063_HUMAN Uncharacterized protein C11orf63 OS=Homo sapiens GN=C11orf63 PE=2 SV=1 | 486 | H | 0.62147 | R | 0.658185 | -0.036715 | No Change: Both D | - |
| Q9H7C9 | CK067_HUMAN UPF0366 protein C11orf67 OS=Homo sapiens GN=C11orf67 PE=1 SV=1 | 92 | V | 0.206065 | M | 0.244656 | -0.038591 | No Change: Both O | - |
| Q9H3H3 | CK068_HUMAN UPF0696 protein C11orf68 OS=Homo sapiens GN=C11orf68 PE=1 SV=2 | 154 | Q | 0.28777 | R | 0.26778 | 0.01999 | No Change: Both O | - |
| Q8NBR9 | CK072_HUMAN Uncharacterized protein C11orf72 OS=Homo sapiens GN=C11orf72 PE=2 SV=1 | 22 | P | 0.952547 | T | 0.932376 | 0.020171 | No Change: Both D | - |
| Q53FT3 | CK073_HUMAN Uncharacterized protein C11orf73 OS=Homo sapiens GN=C11orf73 PE=1 SV=2 | 47 | P | 0.363238 | A | 0.266619 | 0.096619 | No Change: Both O | - |
| Q9BUA3 | CK084_HUMAN Uncharacterized protein C11orf84 OS=Homo sapiens GN=C11orf84 PE=1 SV=3 | 58 | E | 0.964691 | Q | 0.961369 | 0.003322 | No Change: Both D | - |
| C9JXX5 | CK094_HUMAN Uncharacterized protein C11orf94 OS=Homo sapiens GN=C11orf94 PE=4 SV=1 | 80 | Q | 0.837044 | H | 0.809027 | 0.028017 | No Change: Both D | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 26 | T | 0.178711 | A | 0.154362 | 0.024349 | No Change: Both O | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 47 | S | 0.427806 | P | 0.396162 | 0.031644 | No Change: Both O | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 110 | R | 0.812224 | S | 0.813563 | -0.001339 | No Change: Both D | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 144 | R | 0.922492 | C | 0.881638 | 0.040854 | No Change: Both D | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 151 | F | 0.935789 | S | 0.969579 | -0.03379 | No Change: Both D | - |
| Q7Z7L8 | CK096_HUMAN Uncharacterized protein C11orf96 OS=Homo sapiens GN=C11orf96 PE=1 SV=3 | 352 | P | 0.787318 | S | 0.770157 | 0.017161 | No Change: Both D | - |
| Q9HB07 | MYG1_HUMAN UPF0160 protein MYG1 mitochondrial OS=Homo sapiens GN=C12orf10 PE=1 SV=2 | 349 | T | 0.497936 | I | 0.368985 | 0.128951 | No Change: Both O | - |
| Q9NVM9 | M89BB_HUMAN Cell cycle regulator Mat89Bb homolog OS=Homo sapiens GN=C12orf11 PE=1 SV=2 | 227 | S | 0.690825 | P | 0.660084 | 0.030741 | No Change: Both D | A colorectal cancer sample |
| Q9NVM9 | M89BB_HUMAN Cell cycle regulator Mat89Bb homolog OS=Homo sapiens GN=C12orf11 PE=1 SV=2 | 66 | M | 0.062779 | T | 0.072113 | -0.009334 | No Change: Both O | - |
| Q8TC90 | CL012_HUMAN Uncharacterized protein C12orf12 OS=Homo sapiens GN=C12orf12 PE=2 SV=1 | 379 | I | 0.423296 | M | 0.538196 | -0.1149 | O to D | - |
| Q8TC90 | CL012_HUMAN Uncharacterized protein C12orf12 OS=Homo sapiens GN=C12orf12 PE=2 SV=1 | 286 | D | 0.989036 | E | 0.991268 | -0.002232 | No Change: Both D | - |
| Q8WUB2 | CL024_HUMAN Uncharacterized protein C12orf24 OS=Homo sapiens GN=C12orf24 PE=2 SV=1 | 225 | R | 0.632605 | G | 0.581885 | 0.05072 | No Change: Both D | - |
| Q8N6Q8 | CL026_HUMAN Uncharacterized protein C12orf26 OS=Homo sapiens GN=C12orf26 PE=2 SV=2 | 249 | Q | 0.772475 | K | 0.810915 | -0.03844 | No Change: Both D | - |
| Q96LU7 | CL028_HUMAN Uncharacterized protein C12orf28 OS=Homo sapiens GN=C12orf28 PE=2 SV=1 | 118 | A | 0.5323 | S | 0.640668 | -0.108368 | No Change: Both D | - |
| Q96LU7 | CL028_HUMAN Uncharacterized protein C12orf28 OS=Homo sapiens GN=C12orf28 PE=2 SV=1 | 210 | M | 0.744131 | L | 0.722788 | 0.021343 | No Change: Both D | - |
| Q96LU7 | CL028_HUMAN Uncharacterized protein C12orf28 OS=Homo sapiens GN=C12orf28 PE=2 SV=1 | 88 | S | 0.850727 | L | 0.730597 | 0.12013 | No Change: Both D | - |
| Q8N999 | CL029_HUMAN Uncharacterized protein C12orf29 OS=Homo sapiens GN=C12orf29 PE=1 SV=2 | 23 | P | 0.829561 | L | 0.762647 | 0.066914 | No Change: Both D | - |
| Q8N999 | CL029_HUMAN Uncharacterized protein C12orf29 OS=Homo sapiens GN=C12orf29 PE=1 SV=2 | 238 | V | 0.185782 | L | 0.202996 | -0.017214 | No Change: Both O | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 59 | I | 0.736988 | V | 0.740709 | -0.003721 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 106 | H | 0.499404 | Q | 0.542368 | -0.042964 | O to D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 202 | I | 0.439827 | V | 0.485492 | -0.045665 | No Change: Both O | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 250 | L | 0.808593 | P | 0.875563 | -0.06697 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 309 | R | 0.859983 | Q | 0.879688 | -0.019705 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 346 | S | 0.759035 | N | 0.742924 | 0.016111 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 352 | S | 0.762126 | G | 0.697083 | 0.065043 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 433 | S | 0.647137 | T | 0.594013 | 0.053124 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 518 | S | 0.803029 | P | 0.80038 | 0.002649 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 954 | F | 0.906717 | S | 0.947887 | -0.04117 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 1010 | T | 0.796485 | K | 0.818553 | -0.022068 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 1208 | S | 0.944043 | C | 0.907477 | 0.036566 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 1226 | V | 0.919314 | I | 0.892232 | 0.027082 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 1338 | T | 0.849556 | A | 0.825159 | 0.024397 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 147 | P | 0.531124 | S | 0.541649 | -0.010525 | No Change: Both D | - |
| Q9HCM1 | CL035_HUMAN Uncharacterized protein C12orf35 OS=Homo sapiens GN=C12orf35 PE=1 SV=3 | 1479 | M | 0.87277 | T | 0.875578 | -0.002808 | No Change: Both D | - |
| Q495D7 | CL036_HUMAN Putative uncharacterized protein C12orf36 OS=Homo sapiens GN=C12orf36 PE=2 SV=1 | 38 | P | 0.311614 | L | 0.189538 | 0.122076 | No Change: Both O | - |
| Q495D7 | CL036_HUMAN Putative uncharacterized protein C12orf36 OS=Homo sapiens GN=C12orf36 PE=2 SV=1 | 76 | A | 0.121374 | E | 0.186701 | -0.065327 | No Change: Both O | - |
| Q495D7 | CL036_HUMAN Putative uncharacterized protein C12orf36 OS=Homo sapiens GN=C12orf36 PE=2 SV=1 | 84 | I | 0.079885 | V | 0.093013 | -0.013128 | No Change: Both O | - |
| Q86WS4 | CL040_HUMAN Uncharacterized protein C12orf40 OS=Homo sapiens GN=C12orf40 PE=2 SV=3 | 13 | I | 0.77263 | L | 0.837819 | -0.065189 | No Change: Both D | - |
| Q9H9L4 | CL041_HUMAN Uncharacterized protein C12orf41 OS=Homo sapiens GN=C12orf41 PE=1 SV=3 | 313 | N | 0.541818 | S | 0.618443 | -0.076625 | No Change: Both D | - |
| Q9H9L4 | CL041_HUMAN Uncharacterized protein C12orf41 OS=Homo sapiens GN=C12orf41 PE=1 SV=3 | 445 | P | 0.57547 | T | 0.492649 | 0.082821 | D to O | - |
| Q96LP6 | CL042_HUMAN Uncharacterized protein C12orf42 OS=Homo sapiens GN=C12orf42 PE=2 SV=2 | 11 | E | 0.332749 | D | 0.27538 | 0.057369 | No Change: Both O | - |
| Q96LP6 | CL042_HUMAN Uncharacterized protein C12orf42 OS=Homo sapiens GN=C12orf42 PE=2 SV=2 | 182 | P | 0.499482 | R | 0.465199 | 0.034283 | No Change: Both O | - |
| Q96C57 | CL043_HUMAN Uncharacterized protein C12orf43 OS=Homo sapiens GN=C12orf43 PE=1 SV=2 | 44 | G | 0.863458 | R | 0.886431 | -0.022973 | No Change: Both D | - |
| Q8N5I9 | CL045_HUMAN Uncharacterized protein C12orf45 OS=Homo sapiens GN=C12orf45 PE=1 SV=2 | 5 | G | 0.97997 | S | 0.987081 | -0.007111 | No Change: Both D | - |
| Q8N5I9 | CL045_HUMAN Uncharacterized protein C12orf45 OS=Homo sapiens GN=C12orf45 PE=1 SV=2 | 8 | K | 0.968643 | Q | 0.958832 | 0.009811 | No Change: Both D | - |
| Q9NWS1 | PR1BP_HUMAN PARP1-binding protein OS=Homo sapiens GN=C12orf48 PE=1 SV=3 | 400 | V | 0.49104 | M | 0.575704 | -0.084664 | O to D | - |
| Q9H741 | CL049_HUMAN UPF0454 protein C12orf49 OS=Homo sapiens GN=C12orf49 PE=2 SV=1 | 55 | Q | 0.388795 | R | 0.359857 | 0.028938 | No Change: Both O | - |
| Q8NA57 | CL050_HUMAN Uncharacterized protein C12orf50 OS=Homo sapiens GN=C12orf50 PE=2 SV=1 | 306 | Q | 0.808865 | R | 0.804747 | 0.004118 | No Change: Both D | - |
| Q8NA57 | CL050_HUMAN Uncharacterized protein C12orf50 OS=Homo sapiens GN=C12orf50 PE=2 SV=1 | 322 | R | 0.831248 | H | 0.806642 | 0.024606 | No Change: Both D | - |
| Q6X4T0 | CL054_HUMAN Uncharacterized protein C12orf54 OS=Homo sapiens GN=C12orf54 PE=2 SV=2 | 86 | P | 0.943026 | S | 0.943478 | -4.52E-04 | No Change: Both D | - |
| Q96N23 | CL055_HUMAN Uncharacterized protein C12orf55 OS=Homo sapiens GN=C12orf55 PE=2 SV=2 | 11 | P | 0.9993 | S | 0.999368 | -6.80E-05 | No Change: Both D | - |
| Q96N23 | CL055_HUMAN Uncharacterized protein C12orf55 OS=Homo sapiens GN=C12orf55 PE=2 SV=2 | 558 | T | 0.381139 | A | 0.356872 | 0.024267 | No Change: Both O | - |
| Q96N23 | CL055_HUMAN Uncharacterized protein C12orf55 OS=Homo sapiens GN=C12orf55 PE=2 SV=2 | 562 | L | 0.232675 | F | 0.209477 | 0.023198 | No Change: Both O | - |
| Q5U649 | CL060_HUMAN Uncharacterized protein C12orf60 OS=Homo sapiens GN=C12orf60 PE=2 SV=2 | 51 | K | 0.179724 | R | 0.131591 | 0.048133 | No Change: Both O | - |
| Q5U649 | CL060_HUMAN Uncharacterized protein C12orf60 OS=Homo sapiens GN=C12orf60 PE=2 SV=2 | 65 | K | 0.27711 | R | 0.217929 | 0.059181 | No Change: Both O | - |
| Q5U649 | CL060_HUMAN Uncharacterized protein C12orf60 OS=Homo sapiens GN=C12orf60 PE=2 SV=2 | 103 | N | 0.641943 | K | 0.704497 | -0.062554 | No Change: Both D | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 387 | G | 0.347224 | S | 0.420607 | -0.073383 | No Change: Both O | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 593 | L | 0.476903 | P | 0.609295 | -0.132392 | O to D | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 666 | E | 0.615467 | K | 0.630286 | -0.014819 | No Change: Both D | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 710 | E | 0.458424 | K | 0.44285 | 0.015574 | No Change: Both O | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 783 | V | 0.728519 | A | 0.754157 | -0.025638 | No Change: Both D | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 790 | S | 0.620423 | N | 0.588286 | 0.032137 | No Change: Both D | - |
| Q6ZTY8 | CL063_HUMAN Putative uncharacterized protein C12orf63 OS=Homo sapiens GN=C12orf63 PE=2 SV=2 | 1107 | P | 0.739802 | H | 0.679635 | 0.060167 | No Change: Both D | - |
| Q9H3J6 | CL065_HUMAN Probable peptide chain release factor C12orf65 mitochondrial OS=Homo sapiens GN=C12orf65 PE=2 SV=1 | 134 | A | 0.943111 | T | 0.939947 | 0.003164 | No Change: Both D | - |
| Q96MD2 | CL066_HUMAN UPF0536 protein C12orf66 OS=Homo sapiens GN=C12orf66 PE=2 SV=4 | 139 | M | 0.236979 | I | 0.153673 | 0.083306 | No Change: Both O | - |
| Q96MD2 | CL066_HUMAN UPF0536 protein C12orf66 OS=Homo sapiens GN=C12orf66 PE=2 SV=4 | 443 | A | 0.753831 | S | 0.791235 | -0.037404 | No Change: Both D | - |
| Q52MB2 | CL068_HUMAN Uncharacterized protein C12orf68 OS=Homo sapiens GN=C12orf68 PE=2 SV=2 | 140 | E | 0.997947 | D | 0.997497 | 4.50E-04 | No Change: Both D | - |
| A2RU48 | CL069_HUMAN Uncharacterized protein C12orf69 OS=Homo sapiens GN=C12orf69 PE=2 SV=1 | 49 | C | 0.164478 | R | 0.281475 | -0.116997 | No Change: Both O | - |
| A2RU48 | CL069_HUMAN Uncharacterized protein C12orf69 OS=Homo sapiens GN=C12orf69 PE=2 SV=1 | 75 | K | 0.419959 | R | 0.355562 | 0.064397 | No Change: Both O | - |
| A8MTZ7 | CL071_HUMAN Uncharacterized protein C12orf71 OS=Homo sapiens GN=C12orf71 PE=1 SV=3 | 140 | I | 0.283847 | V | 0.336073 | -0.052226 | No Change: Both O | - |
| Q69YU5 | CL073_HUMAN Uncharacterized protein C12orf73 OS=Homo sapiens GN=C12orf73 PE=2 SV=2 | 45 | R | 0.660589 | C | 0.555728 | 0.104861 | No Change: Both D | - |
| Q8N812 | CL076_HUMAN Uncharacterized protein C12orf76 OS=Homo sapiens GN=C12orf76 PE=2 SV=1 | 26 | A | 0.273521 | T | 0.291952 | -0.018431 | No Change: Both O | A colorectal cancer sample |
| C9JDV5 | CL097_HUMAN Putative uncharacterized protein C12orf77 OS=Homo sapiens GN=C12orf77 PE=2 SV=1 | 131 | L | 0.04233 | F | 0.037078 | 0.005252 | No Change: Both O | - |
| Q8N6G2 | CM026_HUMAN Uncharacterized protein C13orf26 OS=Homo sapiens GN=C13orf26 PE=2 SV=1 | 231 | K | 0.654924 | N | 0.638037 | 0.016887 | No Change: Both D | - |
| Q8N7L0 | CM030_HUMAN Uncharacterized protein C13orf30 OS=Homo sapiens GN=C13orf30 PE=2 SV=1 | 134 | R | 0.936204 | C | 0.88609 | 0.050114 | No Change: Both D | - |
| Q5VYS4 | CM033_HUMAN Uncharacterized protein C13orf33 OS=Homo sapiens GN=C13orf33 PE=2 SV=1 | 59 | R | 0.448808 | G | 0.461703 | -0.012895 | No Change: Both O | - |
| Q9NX78 | CN101_HUMAN UPF0679 protein C14orf101 OS=Homo sapiens GN=C14orf101 PE=1 SV=3 | 245 | A | 0.14395 | S | 0.237324 | -0.093374 | No Change: Both O | - |
| Q9NX78 | CN101_HUMAN UPF0679 protein C14orf101 OS=Homo sapiens GN=C14orf101 PE=1 SV=3 | 565 | S | 0.151657 | N | 0.135937 | 0.01572 | No Change: Both O | - |
| Q9H7Z3 | CN102_HUMAN UPF0614 protein C14orf102 OS=Homo sapiens GN=C14orf102 PE=1 SV=3 | 32 | C | 0.449943 | F | 0.453369 | -0.003426 | No Change: Both O | - |
| Q9H7Z3 | CN102_HUMAN UPF0614 protein C14orf102 OS=Homo sapiens GN=C14orf102 PE=1 SV=3 | 1118 | N | 0.071041 | S | 0.085711 | -0.01467 | No Change: Both O | - |
| Q9H7Z3 | CN102_HUMAN UPF0614 protein C14orf102 OS=Homo sapiens GN=C14orf102 PE=1 SV=3 | 928 | E | 0.123794 | K | 0.130252 | -0.006458 | No Change: Both O | - |
| Q9NVL8 | CN105_HUMAN Uncharacterized protein C14orf105 OS=Homo sapiens GN=C14orf105 PE=2 SV=2 | 235 | Y | 0.143712 | C | 0.181161 | -0.037449 | No Change: Both O | - |
| Q9NWQ4 | CN118_HUMAN Uncharacterized protein C14orf118 OS=Homo sapiens GN=C14orf118 PE=1 SV=3 | 132 | V | 0.750232 | E | 0.844802 | -0.09457 | No Change: Both D | - |
| Q9NWQ9 | CN119_HUMAN Uncharacterized protein C14orf119 OS=Homo sapiens GN=C14orf119 PE=2 SV=1 | 16 | L | 0.897946 | V | 0.880184 | 0.017762 | No Change: Both D | - |
| Q96FN9 | DTD2_HUMAN Probable D-tyrosyl-tRNA(Tyr) deacylase 2 OS=Homo sapiens GN=C14orf126 PE=2 SV=1 | 6 | R | 0.694812 | W | 0.491364 | 0.203448 | D to O | - |
| Q63HM2 | CN135_HUMAN Pecanex-like protein C14orf135 OS=Homo sapiens GN=C14orf135 PE=2 SV=4 | 770 | Q | 0.049221 | H | 0.046868 | 0.002353 | No Change: Both O | - |
| Q63HM2 | CN135_HUMAN Pecanex-like protein C14orf135 OS=Homo sapiens GN=C14orf135 PE=2 SV=4 | 811 | D | 0.889279 | Y | 0.764339 | 0.12494 | No Change: Both D | - |
| Q63HM2 | CN135_HUMAN Pecanex-like protein C14orf135 OS=Homo sapiens GN=C14orf135 PE=2 SV=4 | 1000 | G | 0.082507 | S | 0.102712 | -0.020205 | No Change: Both O | - |
| Q96EM0 | PRCM_HUMAN Probable proline racemase OS=Homo sapiens GN=C14orf149 PE=1 SV=2 | 42 | V | 0.392364 | A | 0.451975 | -0.059611 | No Change: Both O | - |
| Q96EM0 | PRCM_HUMAN Probable proline racemase OS=Homo sapiens GN=C14orf149 PE=1 SV=2 | 315 | A | 0.32237 | V | 0.250375 | 0.071995 | No Change: Both O | - |
| Q96EM0 | PRCM_HUMAN Probable proline racemase OS=Homo sapiens GN=C14orf149 PE=1 SV=2 | 341 | I | 0.324963 | V | 0.338152 | -0.013189 | No Change: Both O | - |
| Q96EM0 | PRCM_HUMAN Probable proline racemase OS=Homo sapiens GN=C14orf149 PE=1 SV=2 | 125 | P | 0.436161 | S | 0.440205 | -0.004044 | No Change: Both O | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 10 | R | 0.706394 | C | 0.527818 | 0.178576 | No Change: Both D | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 502 | D | 0.21065 | N | 0.185221 | 0.025429 | No Change: Both O | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 237 | S | 0.483658 | N | 0.377308 | 0.10635 | No Change: Both O | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 372 | A | 0.12891 | T | 0.133697 | -0.004787 | No Change: Both O | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 507 | D | 0.124052 | N | 0.105287 | 0.018765 | No Change: Both O | - |
| Q7Z3D6 | CN159_HUMAN UPF0317 protein C14orf159 mitochondrial OS=Homo sapiens GN=C14orf159 PE=2 SV=2 | 583 | G | 0.395798 | D | 0.394421 | 0.001377 | No Change: Both O | - |
| Q52M58 | CN177_HUMAN Putative uncharacterized protein C14orf177 OS=Homo sapiens GN=C14orf177 PE=2 SV=1 | 3 | R | 0.968986 | W | 0.900343 | 0.068643 | No Change: Both D | - |
| Q52M58 | CN177_HUMAN Putative uncharacterized protein C14orf177 OS=Homo sapiens GN=C14orf177 PE=2 SV=1 | 33 | V | 0.894063 | A | 0.932578 | -0.038515 | No Change: Both D | - |
| Q8N769 | CN178_HUMAN Uncharacterized protein C14orf178 OS=Homo sapiens GN=C14orf178 PE=2 SV=1 | 26 | H | 0.784811 | Y | 0.710767 | 0.074044 | No Change: Both D | - |
| A1A4T8 | CN182_HUMAN Uncharacterized protein C14orf182 OS=Homo sapiens GN=C14orf182 PE=2 SV=1 | 38 | P | 0.77358 | L | 0.669713 | 0.103867 | No Change: Both D | - |
| Q86U38 | CN021_HUMAN Pumilio domain-containing protein C14orf21 OS=Homo sapiens GN=C14orf21 PE=1 SV=1 | 308 | S | 0.314193 | N | 0.265496 | 0.048697 | No Change: Both O | - |
| Q86U38 | CN021_HUMAN Pumilio domain-containing protein C14orf21 OS=Homo sapiens GN=C14orf21 PE=1 SV=1 | 497 | S | 0.292965 | Y | 0.134439 | 0.158526 | No Change: Both O | A breast cancer sample |
| Q86U38 | CN021_HUMAN Pumilio domain-containing protein C14orf21 OS=Homo sapiens GN=C14orf21 PE=1 SV=1 | 626 | R | 0.472815 | Q | 0.484467 | -0.011652 | No Change: Both O | A breast cancer sample |
| Q86U38 | CN021_HUMAN Pumilio domain-containing protein C14orf21 OS=Homo sapiens GN=C14orf21 PE=1 SV=1 | 51 | P | 0.970556 | S | 0.967621 | 0.002935 | No Change: Both D | - |
| Q86TY3 | CN037_HUMAN Uncharacterized protein C14orf37 OS=Homo sapiens GN=C14orf37 PE=2 SV=1 | 96 | T | 0.856237 | I | 0.780714 | 0.075523 | No Change: Both D | - |
| Q86TY3 | CN037_HUMAN Uncharacterized protein C14orf37 OS=Homo sapiens GN=C14orf37 PE=2 SV=1 | 391 | A | 0.626273 | V | 0.56014 | 0.066133 | No Change: Both D | - |
| Q86TY3 | CN037_HUMAN Uncharacterized protein C14orf37 OS=Homo sapiens GN=C14orf37 PE=2 SV=1 | 528 | V | 0.635742 | F | 0.602177 | 0.033565 | No Change: Both D | - |
| Q86TY3 | CN037_HUMAN Uncharacterized protein C14orf37 OS=Homo sapiens GN=C14orf37 PE=2 SV=1 | 613 | Q | 0.978465 | E | 0.982896 | -0.004431 | No Change: Both D | - |
| P0C221 | CN038_HUMAN Uncharacterized protein C14orf38 OS=Homo sapiens GN=C14orf38 PE=2 SV=1 | 164 | G | 0.628774 | R | 0.689234 | -0.06046 | No Change: Both D | - |
| P0C221 | CN038_HUMAN Uncharacterized protein C14orf38 OS=Homo sapiens GN=C14orf38 PE=2 SV=1 | 507 | G | 0.568914 | E | 0.710595 | -0.141681 | No Change: Both D | - |
| P0C221 | CN038_HUMAN Uncharacterized protein C14orf38 OS=Homo sapiens GN=C14orf38 PE=2 SV=1 | 689 | S | 0.554737 | N | 0.489419 | 0.065318 | D to O | - |
| P0C221 | CN038_HUMAN Uncharacterized protein C14orf38 OS=Homo sapiens GN=C14orf38 PE=2 SV=1 | 689 | S | 0.554737 | R | 0.483347 | 0.07139 | D to O | - |
| Q6PJG2 | CN043_HUMAN Uncharacterized protein C14orf43 OS=Homo sapiens GN=C14orf43 PE=1 SV=2 | 86 | A | 0.702118 | V | 0.657913 | 0.044205 | No Change: Both D | - |
| Q6PJG2 | CN043_HUMAN Uncharacterized protein C14orf43 OS=Homo sapiens GN=C14orf43 PE=1 SV=2 | 554 | P | 0.843445 | L | 0.746674 | 0.096771 | No Change: Both D | - |
| Q6PJG2 | CN043_HUMAN Uncharacterized protein C14orf43 OS=Homo sapiens GN=C14orf43 PE=1 SV=2 | 895 | D | 0.686969 | N | 0.665545 | 0.021424 | No Change: Both D | - |
| Q8ND07 | CN045_HUMAN Uncharacterized protein C14orf45 OS=Homo sapiens GN=C14orf45 PE=1 SV=3 | 496 | K | 0.701349 | E | 0.713701 | -0.012352 | No Change: Both D | - |
| Q8ND07 | CN045_HUMAN Uncharacterized protein C14orf45 OS=Homo sapiens GN=C14orf45 PE=1 SV=3 | 58 | R | 0.626165 | Q | 0.607945 | 0.01822 | No Change: Both D | - |
| Q8ND07 | CN045_HUMAN Uncharacterized protein C14orf45 OS=Homo sapiens GN=C14orf45 PE=1 SV=3 | 183 | R | 0.895132 | K | 0.89568 | -5.48E-04 | No Change: Both D | - |
| Q8ND07 | CN045_HUMAN Uncharacterized protein C14orf45 OS=Homo sapiens GN=C14orf45 PE=1 SV=3 | 230 | D | 0.340365 | V | 0.216961 | 0.123404 | No Change: Both O | - |
| Q6ZMZ3 | SYNE3_HUMAN Nesprin-3 OS=Homo sapiens GN=C14orf49 PE=1 SV=2 | 668 | T | 0.315201 | M | 0.26746 | 0.047741 | No Change: Both O | - |
| Q6ZMZ3 | SYNE3_HUMAN Nesprin-3 OS=Homo sapiens GN=C14orf49 PE=1 SV=2 | 864 | R | 0.449037 | H | 0.401491 | 0.047546 | No Change: Both O | - |
| Q6ZMZ3 | SYNE3_HUMAN Nesprin-3 OS=Homo sapiens GN=C14orf49 PE=1 SV=2 | 923 | A | 0.123345 | V | 0.091199 | 0.032146 | No Change: Both O | - |
| Q6ZMZ3 | SYNE3_HUMAN Nesprin-3 OS=Homo sapiens GN=C14orf49 PE=1 SV=2 | 946 | I | 0.193094 | V | 0.216354 | -0.02326 | No Change: Both O | - |
| Q86TU6 | CN070_HUMAN Putative uncharacterized protein C14orf70 OS=Homo sapiens GN=C14orf70 PE=2 SV=1 | 21 | E | 0.450847 | D | 0.422802 | 0.028045 | No Change: Both O | - |
| P0C7T7 | CN082_HUMAN Putative uncharacterized protein C14orf82 OS=Homo sapiens GN=C14orf82 PE=5 SV=1 | 115 | G | 0.957997 | R | 0.96107 | -0.003073 | No Change: Both D | - |
| Q9H972 | CN093_HUMAN Uncharacterized protein C14orf93 OS=Homo sapiens GN=C14orf93 PE=2 SV=1 | 190 | A | 0.40043 | V | 0.305918 | 0.094512 | No Change: Both O | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 212 | V | 0.866442 | A | 0.902486 | -0.036044 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 253 | G | 0.909868 | R | 0.915668 | -0.0058 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 282 | N | 0.908023 | S | 0.938684 | -0.030661 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 406 | Q | 0.895769 | E | 0.886832 | 0.008937 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 37 | R | 0.985925 | Q | 0.979606 | 0.006319 | No Change: Both D | A colorectal cancer sample |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 114 | V | 0.873093 | I | 0.872672 | 4.21E-04 | No Change: Both D | A colorectal cancer sample |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 34 | P | 0.98803 | Q | 0.980884 | 0.007146 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 152 | W | 0.84825 | R | 0.941369 | -0.093119 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 343 | P | 0.899909 | A | 0.838366 | 0.061543 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 757 | A | 0.963697 | T | 0.967076 | -0.003379 | No Change: Both D | - |
| Q9NZP6 | CO002_HUMAN Protein C15orf2 OS=Homo sapiens GN=C15orf2 PE=2 SV=2 | 929 | T | 0.723622 | P | 0.792836 | -0.069214 | No Change: Both D | - |
| Q6P656 | CO026_HUMAN Uncharacterized protein C15orf26 OS=Homo sapiens GN=C15orf26 PE=2 SV=1 | 284 | P | 0.905692 | S | 0.900335 | 0.005357 | No Change: Both D | - |
| Q2M3C6 | CO027_HUMAN Transmembrane protein C15orf27 OS=Homo sapiens GN=C15orf27 PE=2 SV=2 | 391 | R | 0.951269 | H | 0.941862 | 0.009407 | No Change: Both D | - |
| Q2M3C6 | CO027_HUMAN Transmembrane protein C15orf27 OS=Homo sapiens GN=C15orf27 PE=2 SV=2 | 427 | P | 0.99709 | L | 0.994547 | 0.002543 | No Change: Both D | - |
| Q32M92 | CO032_HUMAN Uncharacterized protein C15orf32 OS=Homo sapiens GN=C15orf32 PE=2 SV=2 | 17 | A | 0.958153 | T | 0.96575 | -0.007597 | No Change: Both D | - |
| Q8NBB2 | CO037_HUMAN Putative uncharacterized protein C15orf37 OS=Homo sapiens GN=C15orf37 PE=2 SV=1 | 62 | V | 0.982578 | A | 0.988629 | -0.006051 | No Change: Both D | - |
| Q6ZRI6 | CO039_HUMAN Uncharacterized protein C15orf39 OS=Homo sapiens GN=C15orf39 PE=1 SV=3 | 119 | A | 0.752164 | P | 0.838078 | -0.085914 | No Change: Both D | - |
| Q6ZRI6 | CO039_HUMAN Uncharacterized protein C15orf39 OS=Homo sapiens GN=C15orf39 PE=1 SV=3 | 491 | G | 0.909282 | D | 0.934917 | -0.025635 | No Change: Both D | - |
| Q6ZRI6 | CO039_HUMAN Uncharacterized protein C15orf39 OS=Homo sapiens GN=C15orf39 PE=1 SV=3 | 536 | S | 0.958941 | A | 0.948761 | 0.01018 | No Change: Both D | - |
| Q6ZRI6 | CO039_HUMAN Uncharacterized protein C15orf39 OS=Homo sapiens GN=C15orf39 PE=1 SV=3 | 945 | G | 0.877619 | D | 0.889947 | -0.012328 | No Change: Both D | - |
| Q9Y2V0 | CO041_HUMAN Uncharacterized protein C15orf41 OS=Homo sapiens GN=C15orf41 PE=2 SV=2 | 73 | L | 0.175757 | V | 0.192634 | -0.016877 | No Change: Both O | - |
| Q8NHR7 | CO043_HUMAN Uncharacterized protein C15orf43 OS=Homo sapiens GN=C15orf43 PE=2 SV=1 | 31 | P | 0.379152 | R | 0.358179 | 0.020973 | No Change: Both O | - |
| Q6ZUT6 | CO052_HUMAN Uncharacterized protein C15orf52 OS=Homo sapiens GN=C15orf52 PE=1 SV=1 | 189 | G | 0.867854 | E | 0.888579 | -0.020725 | No Change: Both D | A colorectal cancer sample |
| Q8NAA6 | CO053_HUMAN Uncharacterized protein C15orf53 OS=Homo sapiens GN=C15orf53 PE=2 SV=1 | 3 | L | 0.9155 | V | 0.878065 | 0.037435 | No Change: Both D | - |
| Q8NAA6 | CO053_HUMAN Uncharacterized protein C15orf53 OS=Homo sapiens GN=C15orf53 PE=2 SV=1 | 39 | A | 0.453317 | V | 0.36316 | 0.090157 | No Change: Both O | - |
| Q8N8G6 | CO054_HUMAN Putative uncharacterized protein C15orf54 OS=Homo sapiens GN=C15orf54 PE=2 SV=1 | 59 | T | 0.318806 | M | 0.276663 | 0.042143 | No Change: Both O | - |
| Q8N8G6 | CO054_HUMAN Putative uncharacterized protein C15orf54 OS=Homo sapiens GN=C15orf54 PE=2 SV=1 | 77 | E | 0.526133 | K | 0.505256 | 0.020877 | No Change: Both D | - |
| Q8N910 | CO056_HUMAN Putative uncharacterized protein C15orf56 OS=Homo sapiens GN=C15orf56 PE=2 SV=1 | 119 | P | 0.643516 | S | 0.615208 | 0.028308 | No Change: Both D | - |
| Q8N910 | CO056_HUMAN Putative uncharacterized protein C15orf56 OS=Homo sapiens GN=C15orf56 PE=2 SV=1 | 151 | P | 0.871386 | R | 0.846891 | 0.024495 | No Change: Both D | - |
| Q8N910 | CO056_HUMAN Putative uncharacterized protein C15orf56 OS=Homo sapiens GN=C15orf56 PE=2 SV=1 | 160 | I | 0.903343 | T | 0.954666 | -0.051323 | No Change: Both D | - |
| Q9BV29 | CO057_HUMAN Uncharacterized protein C15orf57 OS=Homo sapiens GN=C15orf57 PE=2 SV=2 | 2 | K | 0.719345 | I | 0.683343 | 0.036002 | No Change: Both D | - |
| Q6ZNW5 | VTC2_HUMAN GDP-D-glucose phosphorylase C15orf58 OS=Homo sapiens GN=C15orf58 PE=1 SV=2 | 37 | M | 0.250105 | T | 0.28446 | -0.034355 | No Change: Both O | - |
| Q6ZNW5 | VTC2_HUMAN GDP-D-glucose phosphorylase C15orf58 OS=Homo sapiens GN=C15orf58 PE=1 SV=2 | 264 | P | 0.443077 | T | 0.398308 | 0.044769 | No Change: Both O | - |
| Q6ZNW5 | VTC2_HUMAN GDP-D-glucose phosphorylase C15orf58 OS=Homo sapiens GN=C15orf58 PE=1 SV=2 | 307 | T | 0.256548 | I | 0.160298 | 0.09625 | No Change: Both O | - |
| Q7Z4M0 | CO060_HUMAN Uncharacterized protein C15orf60 OS=Homo sapiens GN=C15orf60 PE=2 SV=2 | 148 | V | 0.383581 | M | 0.422654 | -0.039073 | No Change: Both O | - |
| Q96S19 | CP013_HUMAN UPF0585 protein C16orf13 OS=Homo sapiens GN=C16orf13 PE=1 SV=2 | 136 | L | 0.104987 | P | 0.195407 | -0.09042 | No Change: Both O | - |
| O95177 | CP003_HUMAN Uncharacterized protein C16orf3 OS=Homo sapiens GN=C16orf3 PE=2 SV=1 | 72 | V | 0.85869 | I | 0.829438 | 0.029252 | No Change: Both D | - |
| Q6P387 | CP046_HUMAN Uncharacterized protein C16orf46 OS=Homo sapiens GN=C16orf46 PE=2 SV=2 | 77 | T | 0.235105 | S | 0.315997 | -0.080892 | No Change: Both O | - |
| Q6P387 | CP046_HUMAN Uncharacterized protein C16orf46 OS=Homo sapiens GN=C16orf46 PE=2 SV=2 | 288 | I | 0.778673 | T | 0.869704 | -0.091031 | No Change: Both D | - |
| Q6P387 | CP046_HUMAN Uncharacterized protein C16orf46 OS=Homo sapiens GN=C16orf46 PE=2 SV=2 | 335 | Y | 0.695656 | H | 0.757249 | -0.061593 | No Change: Both D | - |
| Q6P387 | CP046_HUMAN Uncharacterized protein C16orf46 OS=Homo sapiens GN=C16orf46 PE=2 SV=2 | 357 | K | 0.810634 | E | 0.800379 | 0.010255 | No Change: Both D | - |
| Q6P387 | CP046_HUMAN Uncharacterized protein C16orf46 OS=Homo sapiens GN=C16orf46 PE=2 SV=2 | 388 | P | 0.425411 | S | 0.426563 | -0.001152 | No Change: Both O | - |
| Q96N06 | CP055_HUMAN Uncharacterized protein C16orf55 OS=Homo sapiens GN=C16orf55 PE=2 SV=1 | 45 | S | 0.976916 | L | 0.960262 | 0.016654 | No Change: Both D | - |
| Q9BQ65 | CP057_HUMAN UPF0406 protein C16orf57 OS=Homo sapiens GN=C16orf57 PE=1 SV=1 | 250 | Q | 0.344263 | E | 0.408682 | -0.064419 | No Change: Both O | - |
| Q9BQ65 | CP057_HUMAN UPF0406 protein C16orf57 OS=Homo sapiens GN=C16orf57 PE=1 SV=1 | 115 | R | 0.142491 | K | 0.185671 | -0.04318 | No Change: Both O | - |
| Q96GQ5 | CP058_HUMAN UPF0420 protein C16orf58 OS=Homo sapiens GN=C16orf58 PE=1 SV=2 | 185 | Y | 0.041104 | C | 0.036767 | 0.004337 | No Change: Both O | - |
| Q96GQ5 | CP058_HUMAN UPF0420 protein C16orf58 OS=Homo sapiens GN=C16orf58 PE=1 SV=2 | 43 | G | 0.266639 | E | 0.294331 | -0.027692 | No Change: Both O | A breast cancer sample |
| Q7L2K0 | CP059_HUMAN Uncharacterized protein C16orf59 OS=Homo sapiens GN=C16orf59 PE=2 SV=1 | 346 | R | 0.804853 | K | 0.80403 | 8.23E-04 | No Change: Both D | - |
| Q9NRP2 | CP061_HUMAN Uncharacterized protein C16orf61 OS=Homo sapiens GN=C16orf61 PE=1 SV=1 | 11 | T | 0.41312 | S | 0.52653 | -0.11341 | O to D | - |
| Q7Z3J2 | CP062_HUMAN UPF0505 protein C16orf62 OS=Homo sapiens GN=C16orf62 PE=1 SV=2 | 32 | Y | 0.42191 | C | 0.472355 | -0.050445 | No Change: Both O | - |
| Q7Z3J2 | CP062_HUMAN UPF0505 protein C16orf62 OS=Homo sapiens GN=C16orf62 PE=1 SV=2 | 186 | N | 0.458275 | I | 0.306503 | 0.151772 | No Change: Both O | - |
| Q7Z3J2 | CP062_HUMAN UPF0505 protein C16orf62 OS=Homo sapiens GN=C16orf62 PE=1 SV=2 | 506 | A | 0.06257 | V | 0.048479 | 0.014091 | No Change: Both O | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 88 | E | 0.816065 | D | 0.793705 | 0.02236 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 143 | P | 0.823159 | S | 0.821925 | 0.001234 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 190 | S | 0.872621 | L | 0.789938 | 0.082683 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 232 | E | 0.87347 | K | 0.878004 | -0.004534 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 241 | A | 0.879178 | V | 0.838276 | 0.040902 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 302 | R | 0.533892 | C | 0.397124 | 0.136768 | D to O | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 354 | Q | 0.927241 | R | 0.925371 | 0.00187 | No Change: Both D | - |
| Q8IYS4 | CP071_HUMAN Uncharacterized protein C16orf71 OS=Homo sapiens GN=C16orf71 PE=2 SV=3 | 465 | P | 0.965156 | L | 0.937836 | 0.02732 | No Change: Both D | - |
| Q14CZ0 | CP072_HUMAN UPF0472 protein C16orf72 OS=Homo sapiens GN=C16orf72 PE=1 SV=1 | 221 | N | 0.852853 | S | 0.880359 | -0.027506 | No Change: Both D | - |
| Q8N635 | CP073_HUMAN Uncharacterized protein C16orf73 OS=Homo sapiens GN=C16orf73 PE=2 SV=3 | 261 | I | 0.33964 | T | 0.458709 | -0.119069 | No Change: Both O | - |
| Q8N635 | CP073_HUMAN Uncharacterized protein C16orf73 OS=Homo sapiens GN=C16orf73 PE=2 SV=3 | 75 | K | 0.391781 | T | 0.322766 | 0.069015 | No Change: Both O | - |
| Q8N635 | CP073_HUMAN Uncharacterized protein C16orf73 OS=Homo sapiens GN=C16orf73 PE=2 SV=3 | 18 | T | 0.274414 | P | 0.300624 | -0.02621 | No Change: Both O | - |
| Q8WTQ4 | CP078_HUMAN Uncharacterized protein C16orf78 OS=Homo sapiens GN=C16orf78 PE=2 SV=1 | 152 | R | 0.708368 | Q | 0.717518 | -0.00915 | No Change: Both D | - |
| Q6PL45 | CP079_HUMAN BRICHOS domain-containing protein C16orf79 OS=Homo sapiens GN=C16orf79 PE=2 SV=3 | 46 | V | 0.258603 | I | 0.196008 | 0.062595 | No Change: Both O | - |
| Q6PL45 | CP079_HUMAN BRICHOS domain-containing protein C16orf79 OS=Homo sapiens GN=C16orf79 PE=2 SV=3 | 31 | S | 0.255053 | G | 0.236101 | 0.018952 | No Change: Both O | - |
| Q6PL45 | CP079_HUMAN BRICHOS domain-containing protein C16orf79 OS=Homo sapiens GN=C16orf79 PE=2 SV=3 | 122 | H | 0.160045 | Y | 0.104096 | 0.055949 | No Change: Both O | - |
| Q6ZSH3 | CP085_HUMAN Putative uncharacterized protein C16orf85 OS=Homo sapiens GN=C16orf85 PE=2 SV=1 | 145 | E | 0.641674 | D | 0.606878 | 0.034796 | No Change: Both D | - |
| Q1ED39 | CP088_HUMAN Protein C16orf88 OS=Homo sapiens GN=C16orf88 PE=1 SV=1 | 266 | A | 0.993444 | V | 0.992098 | 0.001346 | No Change: Both D | - |
| Q1ED39 | CP088_HUMAN Protein C16orf88 OS=Homo sapiens GN=C16orf88 PE=1 SV=1 | 28 | R | 0.665726 | Q | 0.667691 | -0.001965 | No Change: Both D | - |
| Q1ED39 | CP088_HUMAN Protein C16orf88 OS=Homo sapiens GN=C16orf88 PE=1 SV=1 | 276 | V | 0.991736 | A | 0.993597 | -0.001861 | No Change: Both D | - |
| Q6UX73 | CP089_HUMAN UPF0764 protein C16orf89 OS=Homo sapiens GN=C16orf89 PE=2 SV=2 | 296 | L | 0.704471 | S | 0.799898 | -0.095427 | No Change: Both D | - |
| Q6UX73 | CP089_HUMAN UPF0764 protein C16orf89 OS=Homo sapiens GN=C16orf89 PE=2 SV=2 | 363 | Y | 0.08935 | H | 0.13395 | -0.0446 | No Change: Both O | - |
| Q6UX73 | CP089_HUMAN UPF0764 protein C16orf89 OS=Homo sapiens GN=C16orf89 PE=2 SV=2 | 215 | G | 0.47985 | A | 0.409649 | 0.070201 | No Change: Both O | - |
| Q6PK18 | CQ101_HUMAN PKHD domain-containing transmembrane protein C17orf101 OS=Homo sapiens GN=C17orf101 PE=2 SV=2 | 67 | D | 0.358789 | E | 0.385326 | -0.026537 | No Change: Both O | - |
| Q6PK18 | CQ101_HUMAN PKHD domain-containing transmembrane protein C17orf101 OS=Homo sapiens GN=C17orf101 PE=2 SV=2 | 272 | P | 0.524118 | R | 0.512211 | 0.011907 | No Change: Both D | - |
| A2RUQ5 | CQ102_HUMAN Uncharacterized protein C17orf102 OS=Homo sapiens GN=C17orf102 PE=2 SV=1 | 98 | G | 0.58685 | R | 0.58217 | 0.00468 | No Change: Both D | - |
| A2RUQ5 | CQ102_HUMAN Uncharacterized protein C17orf102 OS=Homo sapiens GN=C17orf102 PE=2 SV=1 | 155 | R | 0.337868 | K | 0.409876 | -0.072008 | No Change: Both O | - |
| A2RUB1 | CQ104_HUMAN Uncharacterized protein C17orf104 OS=Homo sapiens GN=C17orf104 PE=2 SV=3 | 311 | M | 0.30237 | L | 0.26298 | 0.03939 | No Change: Both O | - |
| A2RUB1 | CQ104_HUMAN Uncharacterized protein C17orf104 OS=Homo sapiens GN=C17orf104 PE=2 SV=3 | 320 | N | 0.307985 | T | 0.248444 | 0.059541 | No Change: Both O | - |
| Q96LK8 | CQ046_HUMAN Uncharacterized protein C17orf46 OS=Homo sapiens GN=C17orf46 PE=2 SV=3 | 142 | V | 0.583223 | M | 0.666368 | -0.083145 | No Change: Both D | - |
| Q8NEP4 | CQ047_HUMAN Uncharacterized protein C17orf47 OS=Homo sapiens GN=C17orf47 PE=1 SV=3 | 88 | P | 0.983839 | T | 0.979 | 0.004839 | No Change: Both D | - |
| Q8NEP4 | CQ047_HUMAN Uncharacterized protein C17orf47 OS=Homo sapiens GN=C17orf47 PE=1 SV=3 | 461 | G | 0.908264 | S | 0.947165 | -0.038901 | No Change: Both D | - |
| Q8NEP4 | CQ047_HUMAN Uncharacterized protein C17orf47 OS=Homo sapiens GN=C17orf47 PE=1 SV=3 | 546 | C | 0.146402 | G | 0.30518 | -0.158778 | No Change: Both O | - |
| Q3LIE5 | ADPRM_HUMAN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Homo sapiens GN=C17orf48 PE=2 SV=1 | 92 | L | 0.316037 | R | 0.43931 | -0.123273 | No Change: Both O | - |
| Q3LIE5 | ADPRM_HUMAN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Homo sapiens GN=C17orf48 PE=2 SV=1 | 337 | E | 0.592227 | G | 0.557514 | 0.034713 | No Change: Both D | - |
| Q8WW18 | CQ050_HUMAN Uncharacterized protein C17orf50 OS=Homo sapiens GN=C17orf50 PE=2 SV=2 | 22 | D | 0.979006 | E | 0.984528 | -0.005522 | No Change: Both D | - |
| Q8N3J3 | CQ053_HUMAN Uncharacterized protein C17orf53 OS=Homo sapiens GN=C17orf53 PE=2 SV=1 | 126 | T | 0.725708 | P | 0.771977 | -0.046269 | No Change: Both D | - |
| Q8IY85 | CQ057_HUMAN EF-hand domain-containing protein C17orf57 OS=Homo sapiens GN=C17orf57 PE=1 SV=2 | 312 | V | 0.699479 | I | 0.708106 | -0.008627 | No Change: Both D | - |
| Q8IY85 | CQ057_HUMAN EF-hand domain-containing protein C17orf57 OS=Homo sapiens GN=C17orf57 PE=1 SV=2 | 617 | M | 0.530818 | V | 0.466286 | 0.064532 | D to O | - |
| Q8IY85 | CQ057_HUMAN EF-hand domain-containing protein C17orf57 OS=Homo sapiens GN=C17orf57 PE=1 SV=2 | 286 | Q | 0.338339 | H | 0.306061 | 0.032278 | No Change: Both O | A breast cancer sample |
| Q8IY85 | CQ057_HUMAN EF-hand domain-containing protein C17orf57 OS=Homo sapiens GN=C17orf57 PE=1 SV=2 | 279 | I | 0.111061 | V | 0.115231 | -0.00417 | No Change: Both O | - |
| Q2M2W7 | CQ058_HUMAN UPF0450 protein C17orf58 OS=Homo sapiens GN=C17orf58 PE=2 SV=2 | 92 | I | 0.462779 | V | 0.464886 | -0.002107 | No Change: Both O | - |
| Q8WU58 | CQ063_HUMAN Uncharacterized protein C17orf63 OS=Homo sapiens GN=C17orf63 PE=1 SV=1 | 471 | L | 0.728242 | S | 0.83356 | -0.105318 | No Change: Both D | - |
| Q8WU58 | CQ063_HUMAN Uncharacterized protein C17orf63 OS=Homo sapiens GN=C17orf63 PE=1 SV=1 | 542 | G | 0.778056 | S | 0.830898 | -0.052842 | No Change: Both D | - |
| Q495Z4 | CQ065_HUMAN Uncharacterized protein C17orf65 OS=Homo sapiens GN=C17orf65 PE=2 SV=2 | 32 | S | 0.972666 | R | 0.972273 | 3.93E-04 | No Change: Both D | - |
| Q495Z4 | CQ065_HUMAN Uncharacterized protein C17orf65 OS=Homo sapiens GN=C17orf65 PE=2 SV=2 | 114 | C | 0.974971 | R | 0.981676 | -0.006705 | No Change: Both D | - |
| A2RTY3 | CQ066_HUMAN Uncharacterized protein C17orf66 OS=Homo sapiens GN=C17orf66 PE=2 SV=2 | 480 | S | 0.427989 | F | 0.273091 | 0.154898 | No Change: Both O | - |
| A2RTY3 | CQ066_HUMAN Uncharacterized protein C17orf66 OS=Homo sapiens GN=C17orf66 PE=2 SV=2 | 330 | I | 0.207204 | M | 0.294229 | -0.087025 | No Change: Both O | A breast cancer sample |
| Q96LR1 | CQ069_HUMAN Putative uncharacterized protein C17orf69 OS=Homo sapiens GN=C17orf69 PE=2 SV=1 | 132 | Y | 0.878794 | C | 0.899836 | -0.021042 | No Change: Both D | - |
| Q0P670 | CQ074_HUMAN Uncharacterized protein C17orf74 OS=Homo sapiens GN=C17orf74 PE=2 SV=2 | 108 | S | 0.813487 | A | 0.718566 | 0.094921 | No Change: Both D | - |
| Q0P670 | CQ074_HUMAN Uncharacterized protein C17orf74 OS=Homo sapiens GN=C17orf74 PE=2 SV=2 | 376 | Q | 0.86999 | R | 0.89045 | -0.02046 | No Change: Both D | - |
| Q8N1F1 | C1AS1_HUMAN Putative uncharacterized protein C17orf76-AS1 mitochondrial OS=Homo sapiens GN=C17orf76-AS1 PE=5 SV=1 | 36 | Y | 0.211946 | C | 0.290672 | -0.078726 | No Change: Both O | - |
| Q8N1F1 | C1AS1_HUMAN Putative uncharacterized protein C17orf76-AS1 mitochondrial OS=Homo sapiens GN=C17orf76-AS1 PE=5 SV=1 | 78 | S | 0.717623 | T | 0.672958 | 0.044665 | No Change: Both D | - |
| Q96MU5 | CQ077_HUMAN Uncharacterized protein C17orf77 OS=Homo sapiens GN=C17orf77 PE=2 SV=2 | 47 | R | 0.66539 | S | 0.702757 | -0.037367 | No Change: Both D | - |
| Q8N4C9 | CQ078_HUMAN Uncharacterized protein C17orf78 OS=Homo sapiens GN=C17orf78 PE=2 SV=2 | 152 | T | 0.835761 | S | 0.862494 | -0.026733 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 226 | G | 0.589327 | S | 0.663951 | -0.074624 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 322 | K | 0.911467 | Q | 0.907153 | 0.004314 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 356 | F | 0.64094 | L | 0.66712 | -0.02618 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 395 | H | 0.78702 | N | 0.795541 | -0.008521 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 396 | C | 0.796177 | R | 0.829182 | -0.033005 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 420 | Q | 0.932065 | H | 0.917651 | 0.014414 | No Change: Both D | - |
| Q9BSJ5 | CQ080_HUMAN Uncharacterized protein C17orf80 OS=Homo sapiens GN=C17orf80 PE=1 SV=2 | 522 | A | 0.564833 | T | 0.61253 | -0.047697 | No Change: Both D | - |
| Q86X59 | CQ082_HUMAN Putative uncharacterized protein C17orf82 OS=Homo sapiens GN=C17orf82 PE=2 SV=2 | 186 | L | 0.975363 | P | 0.987127 | -0.011764 | No Change: Both D | - |
| Q6ZQX7 | CQ097_HUMAN Uncharacterized protein C17orf97 OS=Homo sapiens GN=C17orf97 PE=2 SV=2 | 56 | E | 0.963621 | K | 0.959459 | 0.004162 | No Change: Both D | - |
| Q6ZQX7 | CQ097_HUMAN Uncharacterized protein C17orf97 OS=Homo sapiens GN=C17orf97 PE=2 SV=2 | 220 | D | 0.874451 | E | 0.874606 | -1.55E-04 | No Change: Both D | - |
| A8MV24 | CQ098_HUMAN Uncharacterized protein C17orf98 OS=Homo sapiens GN=C17orf98 PE=4 SV=1 | 61 | P | 0.294205 | L | 0.170039 | 0.124166 | No Change: Both O | - |
| Q96FQ7 | CR018_HUMAN Putative uncharacterized protein C18orf18 OS=Homo sapiens GN=C18orf18 PE=5 SV=1 | 16 | P | 0.295676 | A | 0.222017 | 0.073659 | No Change: Both O | - |
| Q32NC0 | CR021_HUMAN UPF0711 protein C18orf21 OS=Homo sapiens GN=C18orf21 PE=1 SV=1 | 132 | T | 0.946253 | A | 0.931718 | 0.014535 | No Change: Both D | - |
| Q8N1N2 | CR026_HUMAN Uncharacterized protein C18orf26 OS=Homo sapiens GN=C18orf26 PE=2 SV=1 | 38 | V | 0.536074 | A | 0.63593 | -0.099856 | No Change: Both D | - |
| Q8N1N2 | CR026_HUMAN Uncharacterized protein C18orf26 OS=Homo sapiens GN=C18orf26 PE=2 SV=1 | 189 | T | 0.992573 | P | 0.993179 | -6.06E-04 | No Change: Both D | - |
| Q8TCD1 | CR032_HUMAN UPF0729 protein C18orf32 OS=Homo sapiens GN=C18orf32 PE=2 SV=1 | 37 | P | 0.285633 | H | 0.245826 | 0.039807 | No Change: Both O | - |
| Q5BJE1 | CR034_HUMAN Uncharacterized protein C18orf34 OS=Homo sapiens GN=C18orf34 PE=1 SV=3 | 42 | A | 0.602843 | T | 0.638305 | -0.035462 | No Change: Both D | - |
| Q5BJE1 | CR034_HUMAN Uncharacterized protein C18orf34 OS=Homo sapiens GN=C18orf34 PE=1 SV=3 | 465 | V | 0.670843 | E | 0.842784 | -0.171941 | No Change: Both D | - |
| Q5BJE1 | CR034_HUMAN Uncharacterized protein C18orf34 OS=Homo sapiens GN=C18orf34 PE=1 SV=3 | 600 | L | 0.694689 | R | 0.77914 | -0.084451 | No Change: Both D | - |
| Q5BJE1 | CR034_HUMAN Uncharacterized protein C18orf34 OS=Homo sapiens GN=C18orf34 PE=1 SV=3 | 601 | D | 0.692203 | N | 0.678637 | 0.013566 | No Change: Both D | - |
| Q5BJE1 | CR034_HUMAN Uncharacterized protein C18orf34 OS=Homo sapiens GN=C18orf34 PE=1 SV=3 | 420 | D | 0.170302 | N | 0.16799 | 0.002312 | No Change: Both O | - |
| Q24JQ0 | CR045_HUMAN Transmembrane protein C18orf45 OS=Homo sapiens GN=C18orf45 PE=2 SV=1 | 131 | L | 0.063046 | F | 0.04941 | 0.013636 | No Change: Both O | - |
| Q8IYD9 | CR054_HUMAN Uncharacterized protein C18orf54 OS=Homo sapiens GN=C18orf54 PE=2 SV=1 | 147 | R | 0.699472 | P | 0.724272 | -0.0248 | No Change: Both D | - |
| Q8IYD9 | CR054_HUMAN Uncharacterized protein C18orf54 OS=Homo sapiens GN=C18orf54 PE=2 SV=1 | 196 | C | 0.393318 | F | 0.369251 | 0.024067 | No Change: Both O | - |
| Q8TAI1 | CR056_HUMAN Putative uncharacterized protein C18orf56 OS=Homo sapiens GN=C18orf56 PE=2 SV=2 | 62 | R | 0.856943 | G | 0.827748 | 0.029195 | No Change: Both D | - |
| Q969H8 | CS010_HUMAN UPF0556 protein C19orf10 OS=Homo sapiens GN=C19orf10 PE=1 SV=1 | 12 | G | 0.210208 | R | 0.187519 | 0.022689 | No Change: Both O | - |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 11 | T | 0.68469 | M | 0.734439 | -0.049749 | No Change: Both D | Neurodegeneration with brain iron accumulation type 4 (NBIA4) [MIM:614298] |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 53 | G | 0.332543 | R | 0.287987 | 0.044556 | No Change: Both O | Neurodegeneration with brain iron accumulation type 4 (NBIA4) [MIM:614298] |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 65 | G | 0.398564 | E | 0.396871 | 0.001693 | No Change: Both O | Neurodegeneration with brain iron accumulation type 4 (NBIA4) [MIM:614298] |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 69 | G | 0.296341 | R | 0.252553 | 0.043788 | No Change: Both O | Neurodegeneration with brain iron accumulation type 4 (NBIA4) [MIM:614298] |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 142 | K | 0.197817 | E | 0.216582 | -0.018765 | No Change: Both O | Neurodegeneration with brain iron accumulation type 4 (NBIA4) [MIM:614298] |
| Q9NSK7 | CS012_HUMAN Protein C19orf12 OS=Homo sapiens GN=C19orf12 PE=1 SV=3 | 142 | K | 0.197817 | T | 0.15422 | 0.043597 | No Change: Both O | - |
| Q8NEA5 | CS018_HUMAN Uncharacterized protein C19orf18 OS=Homo sapiens GN=C19orf18 PE=2 SV=1 | 208 | H | 0.96271 | Y | 0.934788 | 0.027922 | No Change: Both D | - |
| Q8IVT2 | CS021_HUMAN Uncharacterized protein C19orf21 OS=Homo sapiens GN=C19orf21 PE=1 SV=1 | 156 | S | 0.683251 | G | 0.654981 | 0.02827 | No Change: Both D | - |
| Q8IVT2 | CS021_HUMAN Uncharacterized protein C19orf21 OS=Homo sapiens GN=C19orf21 PE=1 SV=1 | 232 | K | 0.81708 | R | 0.797674 | 0.019406 | No Change: Both D | - |
| Q8IVT2 | CS021_HUMAN Uncharacterized protein C19orf21 OS=Homo sapiens GN=C19orf21 PE=1 SV=1 | 653 | E | 0.346682 | G | 0.280268 | 0.066414 | No Change: Both O | - |
| Q8IVT2 | CS021_HUMAN Uncharacterized protein C19orf21 OS=Homo sapiens GN=C19orf21 PE=1 SV=1 | 269 | S | 0.433722 | N | 0.382631 | 0.051091 | No Change: Both O | - |
| Q8IVT2 | CS021_HUMAN Uncharacterized protein C19orf21 OS=Homo sapiens GN=C19orf21 PE=1 SV=1 | 99 | A | 0.575973 | T | 0.599096 | -0.023123 | No Change: Both D | - |
| Q8NA69 | CS045_HUMAN Uncharacterized protein C19orf45 OS=Homo sapiens GN=C19orf45 PE=2 SV=2 | 256 | D | 0.624615 | G | 0.583404 | 0.041211 | No Change: Both D | - |
| Q8NA69 | CS045_HUMAN Uncharacterized protein C19orf45 OS=Homo sapiens GN=C19orf45 PE=2 SV=2 | 396 | Y | 0.455363 | N | 0.594238 | -0.138875 | O to D | - |
| Q8NA69 | CS045_HUMAN Uncharacterized protein C19orf45 OS=Homo sapiens GN=C19orf45 PE=2 SV=2 | 434 | Y | 0.60114 | N | 0.702505 | -0.101365 | No Change: Both D | - |
| Q8NA69 | CS045_HUMAN Uncharacterized protein C19orf45 OS=Homo sapiens GN=C19orf45 PE=2 SV=2 | 497 | P | 0.811384 | S | 0.761607 | 0.049777 | No Change: Both D | - |
| Q8NA69 | CS045_HUMAN Uncharacterized protein C19orf45 OS=Homo sapiens GN=C19orf45 PE=2 SV=2 | 500 | L | 0.868932 | P | 0.94328 | -0.074348 | No Change: Both D | - |
| Q8N205 | SYNE4_HUMAN Nesprin-4 OS=Homo sapiens GN=C19orf46 PE=2 SV=2 | 224 | S | 0.5957 | L | 0.450688 | 0.145012 | D to O | - |
| Q8N205 | SYNE4_HUMAN Nesprin-4 OS=Homo sapiens GN=C19orf46 PE=2 SV=2 | 278 | Q | 0.837842 | H | 0.783371 | 0.054471 | No Change: Both D | - |
| Q6RUI8 | CS048_HUMAN Uncharacterized protein C19orf48 OS=Homo sapiens GN=C19orf48 PE=2 SV=1 | 7 | V | 0.275443 | I | 0.254912 | 0.020531 | No Change: Both O | - |
| Q6RUI8 | CS048_HUMAN Uncharacterized protein C19orf48 OS=Homo sapiens GN=C19orf48 PE=2 SV=1 | 84 | R | 0.326997 | C | 0.221643 | 0.105354 | No Change: Both O | - |
| Q6RUI8 | CS048_HUMAN Uncharacterized protein C19orf48 OS=Homo sapiens GN=C19orf48 PE=2 SV=1 | 104 | G | 0.340563 | E | 0.376366 | -0.035803 | No Change: Both O | - |
| Q9BQD3 | CS050_HUMAN UPF0459 protein C19orf50 OS=Homo sapiens GN=C19orf50 PE=1 SV=2 | 157 | P | 0.925518 | A | 0.879944 | 0.045574 | No Change: Both D | - |
| Q8N9W5 | CS051_HUMAN UPF0470 protein C19orf51 OS=Homo sapiens GN=C19orf51 PE=2 SV=3 | 292 | E | 0.487353 | G | 0.438763 | 0.04859 | No Change: Both O | - |
| Q8N9W5 | CS051_HUMAN UPF0470 protein C19orf51 OS=Homo sapiens GN=C19orf51 PE=2 SV=3 | 331 | G | 0.684707 | W | 0.513273 | 0.171434 | No Change: Both D | - |
| Q8N9W5 | CS051_HUMAN UPF0470 protein C19orf51 OS=Homo sapiens GN=C19orf51 PE=2 SV=3 | 365 | D | 0.4283 | N | 0.421963 | 0.006337 | No Change: Both O | - |
| Q9UNZ5 | L10K_HUMAN Leydig cell tumor 10 kDa protein homolog OS=Homo sapiens GN=C19orf53 PE=1 SV=1 | 39 | K | 0.843818 | R | 0.823977 | 0.019841 | No Change: Both D | - |
| Q2NL68 | CS055_HUMAN Uncharacterized protein C19orf55 OS=Homo sapiens GN=C19orf55 PE=2 SV=1 | 302 | S | 0.741755 | R | 0.756333 | -0.014578 | No Change: Both D | - |
| Q2NL68 | CS055_HUMAN Uncharacterized protein C19orf55 OS=Homo sapiens GN=C19orf55 PE=2 SV=1 | 365 | K | 0.957723 | N | 0.947864 | 0.009859 | No Change: Both D | - |
| Q9Y284 | CS056_HUMAN UPF0139 membrane protein C19orf56 OS=Homo sapiens GN=C19orf56 PE=2 SV=1 | 104 | P | 0.814791 | A | 0.723285 | 0.091506 | No Change: Both D | - |
| Q0VDD7 | CS057_HUMAN Uncharacterized protein C19orf57 OS=Homo sapiens GN=C19orf57 PE=1 SV=2 | 267 | G | 0.980982 | R | 0.979557 | 0.001425 | No Change: Both D | - |
| Q0VDD7 | CS057_HUMAN Uncharacterized protein C19orf57 OS=Homo sapiens GN=C19orf57 PE=1 SV=2 | 500 | Q | 0.797758 | R | 0.77658 | 0.021178 | No Change: Both D | - |
| A6NCJ1 | CS071_HUMAN Uncharacterized protein C19orf71 OS=Homo sapiens GN=C19orf71 PE=4 SV=2 | 83 | P | 0.393512 | L | 0.243687 | 0.149825 | No Change: Both O | - |
| A6NCJ1 | CS071_HUMAN Uncharacterized protein C19orf71 OS=Homo sapiens GN=C19orf71 PE=4 SV=2 | 137 | A | 0.255573 | V | 0.186848 | 0.068725 | No Change: Both O | - |
| Q9NVV2 | CS073_HUMAN Putative uncharacterized protein C19orf73 OS=Homo sapiens GN=C19orf73 PE=2 SV=2 | 106 | S | 0.821689 | G | 0.79189 | 0.029799 | No Change: Both D | - |
| Q6UXH0 | TD26_HUMAN Hepatocellular carcinoma-associated protein TD26 OS=Homo sapiens GN=C19orf80 PE=1 SV=1 | 59 | R | 0.511919 | W | 0.290325 | 0.221594 | D to O | - |
| Q6UXH0 | TD26_HUMAN Hepatocellular carcinoma-associated protein TD26 OS=Homo sapiens GN=C19orf80 PE=1 SV=1 | 147 | R | 0.182113 | Q | 0.192898 | -0.010785 | No Change: Both O | - |
| Q13901 | C1D_HUMAN Nuclear nucleic acid-binding protein C1D OS=Homo sapiens GN=C1D PE=1 SV=1 | 127 | S | 0.896999 | P | 0.8919 | 0.005099 | No Change: Both D | - |
| Q96EU7 | C1GLC_HUMAN C1GALT1-specific chaperone 1 OS=Homo sapiens GN=C1GALT1C1 PE=1 SV=1 | 131 | D | 0.273542 | E | 0.282312 | -0.00877 | No Change: Both O | - |
| Q96EU7 | C1GLC_HUMAN C1GALT1-specific chaperone 1 OS=Homo sapiens GN=C1GALT1C1 PE=1 SV=1 | 152 | E | 0.079581 | K | 0.086844 | -0.007263 | No Change: Both O | Tn syndrome (TNSYN) [MIM:300622] |
| Q5SY80 | CA101_HUMAN Uncharacterized protein C1orf101 OS=Homo sapiens GN=C1orf101 PE=1 SV=1 | 66 | T | 0.580526 | K | 0.620816 | -0.04029 | No Change: Both D | - |
| Q5SY80 | CA101_HUMAN Uncharacterized protein C1orf101 OS=Homo sapiens GN=C1orf101 PE=1 SV=1 | 653 | T | 0.099612 | I | 0.047646 | 0.051966 | No Change: Both O | A breast cancer sample |
| Q5SY80 | CA101_HUMAN Uncharacterized protein C1orf101 OS=Homo sapiens GN=C1orf101 PE=1 SV=1 | 56 | T | 0.283751 | S | 0.35152 | -0.067769 | No Change: Both O | - |
| O95561 | CA105_HUMAN Uncharacterized protein C1orf105 OS=Homo sapiens GN=C1orf105 PE=1 SV=1 | 97 | M | 0.881276 | V | 0.811655 | 0.069621 | No Change: Both D | - |
| O95561 | CA105_HUMAN Uncharacterized protein C1orf105 OS=Homo sapiens GN=C1orf105 PE=1 SV=1 | 137 | S | 0.368514 | N | 0.322735 | 0.045779 | No Change: Both O | - |
| Q3KP66 | CA106_HUMAN Uncharacterized protein C1orf106 OS=Homo sapiens GN=C1orf106 PE=2 SV=2 | 538 | R | 0.733052 | C | 0.586764 | 0.146288 | No Change: Both D | - |
| Q5T0L3 | CA111_HUMAN Uncharacterized protein C1orf111 OS=Homo sapiens GN=C1orf111 PE=2 SV=3 | 69 | A | 0.410814 | V | 0.335861 | 0.074953 | No Change: Both O | - |
| Q5T0L3 | CA111_HUMAN Uncharacterized protein C1orf111 OS=Homo sapiens GN=C1orf111 PE=2 SV=3 | 217 | R | 0.21439 | H | 0.180469 | 0.033921 | No Change: Both O | - |
| Q9NSG2 | CA112_HUMAN Uncharacterized protein C1orf112 OS=Homo sapiens GN=C1orf112 PE=1 SV=1 | 481 | A | 0.114712 | S | 0.187236 | -0.072524 | No Change: Both O | - |
| Q5TID7 | CA114_HUMAN Uncharacterized protein C1orf114 OS=Homo sapiens GN=C1orf114 PE=2 SV=1 | 172 | F | 0.48841 | S | 0.626586 | -0.138176 | O to D | - |
| Q5TID7 | CA114_HUMAN Uncharacterized protein C1orf114 OS=Homo sapiens GN=C1orf114 PE=2 SV=1 | 238 | F | 0.608852 | I | 0.621592 | -0.01274 | No Change: Both D | - |
| Q5TID7 | CA114_HUMAN Uncharacterized protein C1orf114 OS=Homo sapiens GN=C1orf114 PE=2 SV=1 | 323 | S | 0.910324 | C | 0.861762 | 0.048562 | No Change: Both D | - |
| Q9H040 | CA124_HUMAN Zinc finger RAD18 domain-containing protein C1orf124 OS=Homo sapiens GN=C1orf124 PE=1 SV=2 | 296 | P | 0.772303 | L | 0.680362 | 0.091941 | No Change: Both D | - |
| Q8N9H9 | CA127_HUMAN Uncharacterized protein C1orf127 OS=Homo sapiens GN=C1orf127 PE=2 SV=2 | 530 | A | 0.896255 | V | 0.875019 | 0.021236 | No Change: Both D | - |
| Q8N9H9 | CA127_HUMAN Uncharacterized protein C1orf127 OS=Homo sapiens GN=C1orf127 PE=2 SV=2 | 256 | R | 0.652285 | Q | 0.663893 | -0.011608 | No Change: Both D | - |
| Q8N9H9 | CA127_HUMAN Uncharacterized protein C1orf127 OS=Homo sapiens GN=C1orf127 PE=2 SV=2 | 366 | V | 0.981087 | D | 0.987262 | -0.006175 | No Change: Both D | - |
| Q5TGP6 | CA129_HUMAN Uncharacterized protein C1orf129 OS=Homo sapiens GN=C1orf129 PE=2 SV=1 | 29 | N | 0.398728 | S | 0.462465 | -0.063737 | No Change: Both O | - |
| Q5TGP6 | CA129_HUMAN Uncharacterized protein C1orf129 OS=Homo sapiens GN=C1orf129 PE=2 SV=1 | 74 | V | 0.206553 | A | 0.248147 | -0.041594 | No Change: Both O | - |
| Q5TGP6 | CA129_HUMAN Uncharacterized protein C1orf129 OS=Homo sapiens GN=C1orf129 PE=2 SV=1 | 160 | Y | 0.179712 | H | 0.277696 | -0.097984 | No Change: Both O | - |
| Q8NDD1 | CA131_HUMAN Uncharacterized protein C1orf131 OS=Homo sapiens GN=C1orf131 PE=1 SV=3 | 28 | L | 0.86273 | V | 0.828808 | 0.033922 | No Change: Both D | - |
| Q5TG53 | CA133_HUMAN Putative uncharacterized protein C1orf133 OS=Homo sapiens GN=C1orf133 PE=5 SV=2 | 91 | R | 0.905354 | Q | 0.897915 | 0.007439 | No Change: Both D | - |
| Q9H7T9 | CA135_HUMAN Uncharacterized protein C1orf135 OS=Homo sapiens GN=C1orf135 PE=1 SV=1 | 82 | K | 0.882552 | T | 0.872774 | 0.009778 | No Change: Both D | - |
| Q5JVX7 | CA141_HUMAN Uncharacterized protein C1orf141 OS=Homo sapiens GN=C1orf141 PE=2 SV=1 | 85 | E | 0.936941 | G | 0.899712 | 0.037229 | No Change: Both D | - |
| Q5JVX7 | CA141_HUMAN Uncharacterized protein C1orf141 OS=Homo sapiens GN=C1orf141 PE=2 SV=1 | 189 | V | 0.466702 | I | 0.432896 | 0.033806 | No Change: Both O | - |
| Q96MC9 | CA147_HUMAN Uncharacterized protein C1orf147 OS=Homo sapiens GN=C1orf147 PE=2 SV=2 | 213 | G | 0.772118 | A | 0.733783 | 0.038335 | No Change: Both D | - |
| Q96MC9 | CA147_HUMAN Uncharacterized protein C1orf147 OS=Homo sapiens GN=C1orf147 PE=2 SV=2 | 233 | P | 0.610561 | S | 0.631891 | -0.02133 | No Change: Both D | - |
| Q96MC9 | CA147_HUMAN Uncharacterized protein C1orf147 OS=Homo sapiens GN=C1orf147 PE=2 SV=2 | 259 | T | 0.522248 | M | 0.5101 | 0.012148 | No Change: Both D | - |
| Q8N1D5 | CA158_HUMAN Uncharacterized protein C1orf158 OS=Homo sapiens GN=C1orf158 PE=2 SV=2 | 191 | F | 0.833714 | L | 0.847204 | -0.01349 | No Change: Both D | - |
| Q8NEQ5 | CA162_HUMAN Transmembrane protein C1orf162 OS=Homo sapiens GN=C1orf162 PE=2 SV=1 | 3 | G | 0.958848 | S | 0.969416 | -0.010568 | No Change: Both D | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 453 | P | 0.87073 | S | 0.861368 | 0.009362 | No Change: Both D | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 544 | R | 0.104474 | Q | 0.109785 | -0.005311 | No Change: Both O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 602 | R | 0.638098 | W | 0.360215 | 0.277883 | D to O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 782 | W | 0.105071 | R | 0.224487 | -0.119416 | No Change: Both O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 800 | R | 0.138651 | C | 0.070202 | 0.068449 | No Change: Both O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 848 | S | 0.886351 | I | 0.714069 | 0.172282 | No Change: Both D | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 944 | R | 0.13712 | H | 0.113216 | 0.023904 | No Change: Both O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 955 | W | 0.134121 | R | 0.295132 | -0.161011 | No Change: Both O | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 1215 | R | 0.624547 | H | 0.521269 | 0.103278 | No Change: Both D | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 1295 | C | 0.891359 | S | 0.942791 | -0.051432 | No Change: Both D | - |
| Q5SNV9 | CA167_HUMAN Uncharacterized protein C1orf167 OS=Homo sapiens GN=C1orf167 PE=2 SV=2 | 1451 | R | 0.95323 | G | 0.951807 | 0.001423 | No Change: Both D | - |
| Q5VWT5 | CA168_HUMAN Uncharacterized protein C1orf168 OS=Homo sapiens GN=C1orf168 PE=2 SV=1 | 125 | I | 0.493668 | M | 0.609696 | -0.116028 | O to D | - |
| Q5SV97 | CA170_HUMAN Uncharacterized protein C1orf170 OS=Homo sapiens GN=C1orf170 PE=2 SV=3 | 20 | W | 0.991939 | R | 0.997534 | -0.005595 | No Change: Both D | - |
| Q8NAX2 | CA172_HUMAN Uncharacterized protein C1orf172 OS=Homo sapiens GN=C1orf172 PE=2 SV=2 | 100 | Q | 0.331825 | R | 0.406549 | -0.074724 | No Change: Both O | - |
| Q8NAX2 | CA172_HUMAN Uncharacterized protein C1orf172 OS=Homo sapiens GN=C1orf172 PE=2 SV=2 | 107 | R | 0.344387 | W | 0.170726 | 0.173661 | No Change: Both O | - |
| Q8NAX2 | CA172_HUMAN Uncharacterized protein C1orf172 OS=Homo sapiens GN=C1orf172 PE=2 SV=2 | 189 | K | 0.912506 | R | 0.90655 | 0.005956 | No Change: Both D | - |
| Q8NAX2 | CA172_HUMAN Uncharacterized protein C1orf172 OS=Homo sapiens GN=C1orf172 PE=2 SV=2 | 312 | R | 0.89671 | H | 0.865559 | 0.031151 | No Change: Both D | A colorectal cancer sample |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 264 | P | 0.784308 | A | 0.716348 | 0.06796 | No Change: Both D | - |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 555 | R | 0.99254 | H | 0.991351 | 0.001189 | No Change: Both D | - |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 636 | I | 0.956452 | V | 0.953377 | 0.003075 | No Change: Both D | - |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 691 | H | 0.967714 | R | 0.97171 | -0.003996 | No Change: Both D | - |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 1056 | L | 0.979167 | V | 0.976642 | 0.002525 | No Change: Both D | - |
| Q5RHP9 | CA173_HUMAN Uncharacterized protein C1orf173 OS=Homo sapiens GN=C1orf173 PE=2 SV=1 | 1528 | V | 0.877551 | M | 0.911809 | -0.034258 | No Change: Both D | - |
| Q8IYL3 | CA174_HUMAN UPF0688 protein C1orf174 OS=Homo sapiens GN=C1orf174 PE=1 SV=2 | 53 | T | 0.927971 | R | 0.928082 | -1.11E-04 | No Change: Both D | - |
| Q8IYL3 | CA174_HUMAN UPF0688 protein C1orf174 OS=Homo sapiens GN=C1orf174 PE=1 SV=2 | 101 | A | 0.786478 | S | 0.847221 | -0.060743 | No Change: Both D | - |
| Q8IYL3 | CA174_HUMAN UPF0688 protein C1orf174 OS=Homo sapiens GN=C1orf174 PE=1 SV=2 | 165 | P | 0.961687 | A | 0.938216 | 0.023471 | No Change: Both D | - |
| Q3ZCV2 | CA177_HUMAN Uncharacterized protein C1orf177 OS=Homo sapiens GN=C1orf177 PE=2 SV=3 | 126 | G | 0.649293 | C | 0.555377 | 0.093916 | No Change: Both D | - |
| Q3ZCV2 | CA177_HUMAN Uncharacterized protein C1orf177 OS=Homo sapiens GN=C1orf177 PE=2 SV=3 | 205 | Y | 0.691951 | H | 0.760758 | -0.068807 | No Change: Both D | - |
| Q8NAE3 | CA180_HUMAN Putative uncharacterized protein C1orf180 OS=Homo sapiens GN=C1orf180 PE=2 SV=1 | 96 | F | 0.115654 | V | 0.120449 | -0.004795 | No Change: Both O | - |
| Q96A04 | CA182_HUMAN Uncharacterized protein C1orf182 OS=Homo sapiens GN=C1orf182 PE=2 SV=1 | 54 | S | 0.529157 | L | 0.417822 | 0.111335 | D to O | - |
| Q8NBI3 | DRAXI_HUMAN Draxin OS=Homo sapiens GN=C1orf187 PE=1 SV=2 | 37 | L | 0.610131 | F | 0.550564 | 0.059567 | No Change: Both D | - |
| Q9H425 | CA198_HUMAN Uncharacterized protein C1orf198 OS=Homo sapiens GN=C1orf198 PE=1 SV=1 | 274 | A | 0.9442 | S | 0.961505 | -0.017305 | No Change: Both D | - |
| Q9H425 | CA198_HUMAN Uncharacterized protein C1orf198 OS=Homo sapiens GN=C1orf198 PE=1 SV=1 | 306 | K | 0.590959 | R | 0.548386 | 0.042573 | No Change: Both D | - |
| Q5TH74 | CA201_HUMAN UPF0490 protein C1orf201 OS=Homo sapiens GN=C1orf201 PE=1 SV=1 | 254 | S | 0.861978 | F | 0.773444 | 0.088534 | No Change: Both D | A breast cancer sample |
| Q8IVY1 | CA210_HUMAN Putative uncharacterized protein C1orf210 OS=Homo sapiens GN=C1orf210 PE=5 SV=1 | 12 | S | 0.629043 | L | 0.440798 | 0.188245 | D to O | - |
| Q5T0J3 | CA220_HUMAN Putative uncharacterized protein C1orf220 OS=Homo sapiens GN=C1orf220 PE=2 SV=1 | 3 | P | 0.302407 | L | 0.164832 | 0.137575 | No Change: Both O | - |
| Q537H7 | CA227_HUMAN UPF0732 protein C1orf227 OS=Homo sapiens GN=C1orf227 PE=2 SV=1 | 8 | I | 0.608184 | T | 0.712372 | -0.104188 | No Change: Both D | - |
| Q5T0J7 | CA049_HUMAN Uncharacterized protein C1orf49 OS=Homo sapiens GN=C1orf49 PE=2 SV=1 | 55 | E | 0.834473 | G | 0.776683 | 0.05779 | No Change: Both D | - |
| Q5T0J7 | CA049_HUMAN Uncharacterized protein C1orf49 OS=Homo sapiens GN=C1orf49 PE=2 SV=1 | 146 | A | 0.89747 | G | 0.910959 | -0.013489 | No Change: Both D | - |
| Q5T0J7 | CA049_HUMAN Uncharacterized protein C1orf49 OS=Homo sapiens GN=C1orf49 PE=2 SV=1 | 171 | L | 0.723077 | R | 0.770384 | -0.047307 | No Change: Both D | - |
| Q5T0J7 | CA049_HUMAN Uncharacterized protein C1orf49 OS=Homo sapiens GN=C1orf49 PE=2 SV=1 | 171 | L | 0.723077 | P | 0.810797 | -0.08772 | No Change: Both D | - |
| Q9BV19 | CA050_HUMAN Uncharacterized protein C1orf50 OS=Homo sapiens GN=C1orf50 PE=2 SV=2 | 178 | T | 0.362709 | M | 0.34486 | 0.017849 | No Change: Both O | - |
| Q6IQ49 | CA055_HUMAN UPF0667 protein C1orf55 OS=Homo sapiens GN=C1orf55 PE=1 SV=1 | 312 | M | 0.961516 | I | 0.941437 | 0.020079 | No Change: Both D | - |
| Q9BUV0 | CA063_HUMAN UPF0471 protein C1orf63 OS=Homo sapiens GN=C1orf63 PE=2 SV=2 | 147 | Y | 0.814953 | H | 0.853184 | -0.038231 | No Change: Both D | - |
| Q9BUV0 | CA063_HUMAN UPF0471 protein C1orf63 OS=Homo sapiens GN=C1orf63 PE=2 SV=2 | 239 | E | 0.948974 | G | 0.936132 | 0.012842 | No Change: Both D | - |
| Q8NEQ6 | CA064_HUMAN Uncharacterized protein C1orf64 OS=Homo sapiens GN=C1orf64 PE=2 SV=1 | 112 | L | 0.408888 | F | 0.373253 | 0.035635 | No Change: Both O | - |
| Q8NEQ6 | CA064_HUMAN Uncharacterized protein C1orf64 OS=Homo sapiens GN=C1orf64 PE=2 SV=1 | 52 | G | 0.415276 | W | 0.214241 | 0.201035 | No Change: Both O | A breast cancer sample |
| Q8NEQ6 | CA064_HUMAN Uncharacterized protein C1orf64 OS=Homo sapiens GN=C1orf64 PE=2 SV=1 | 100 | G | 0.306229 | W | 0.139992 | 0.166237 | No Change: Both O | A breast cancer sample |
| Q8N715 | CA065_HUMAN Uncharacterized protein C1orf65 OS=Homo sapiens GN=C1orf65 PE=2 SV=2 | 195 | V | 0.920498 | A | 0.932572 | -0.012074 | No Change: Both D | - |
| Q8N715 | CA065_HUMAN Uncharacterized protein C1orf65 OS=Homo sapiens GN=C1orf65 PE=2 SV=2 | 329 | G | 0.995699 | D | 0.996493 | -7.94E-04 | No Change: Both D | - |
| Q8N715 | CA065_HUMAN Uncharacterized protein C1orf65 OS=Homo sapiens GN=C1orf65 PE=2 SV=2 | 331 | R | 0.995707 | W | 0.989991 | 0.005716 | No Change: Both D | - |
| Q8N715 | CA065_HUMAN Uncharacterized protein C1orf65 OS=Homo sapiens GN=C1orf65 PE=2 SV=2 | 380 | R | 0.98011 | L | 0.96833 | 0.01178 | No Change: Both D | - |
| Q96LT6 | CA074_HUMAN UPF0739 protein C1orf74 OS=Homo sapiens GN=C1orf74 PE=2 SV=1 | 146 | L | 0.175905 | F | 0.140834 | 0.035071 | No Change: Both O | - |
| Q8WWB7 | NCUG1_HUMAN Lysosomal protein NCU-G1 OS=Homo sapiens GN=C1orf85 PE=1 SV=1 | 94 | V | 0.344274 | I | 0.308001 | 0.036273 | No Change: Both O | - |
| Q8WWB7 | NCUG1_HUMAN Lysosomal protein NCU-G1 OS=Homo sapiens GN=C1orf85 PE=1 SV=1 | 203 | P | 0.726609 | S | 0.731369 | -0.00476 | No Change: Both D | - |
| Q8WWB7 | NCUG1_HUMAN Lysosomal protein NCU-G1 OS=Homo sapiens GN=C1orf85 PE=1 SV=1 | 223 | I | 0.446078 | V | 0.515325 | -0.069247 | O to D | - |
| Q6NZ36 | CA086_HUMAN Uncharacterized protein C1orf86 OS=Homo sapiens GN=C1orf86 PE=2 SV=2 | 126 | P | 0.960648 | S | 0.955536 | 0.005112 | No Change: Both D | - |
| Q8N0U7 | CA087_HUMAN Uncharacterized protein C1orf87 OS=Homo sapiens GN=C1orf87 PE=2 SV=1 | 185 | L | 0.725721 | V | 0.67829 | 0.047431 | No Change: Both D | - |
| Q8N0U7 | CA087_HUMAN Uncharacterized protein C1orf87 OS=Homo sapiens GN=C1orf87 PE=2 SV=1 | 301 | N | 0.805824 | D | 0.803873 | 0.001951 | No Change: Both D | - |
| Q8N0U7 | CA087_HUMAN Uncharacterized protein C1orf87 OS=Homo sapiens GN=C1orf87 PE=2 SV=1 | 403 | K | 0.892554 | E | 0.896049 | -0.003495 | No Change: Both D | - |
| Q8N0U7 | CA087_HUMAN Uncharacterized protein C1orf87 OS=Homo sapiens GN=C1orf87 PE=2 SV=1 | 406 | A | 0.941679 | P | 0.960056 | -0.018377 | No Change: Both D | - |
| Q8N0U7 | CA087_HUMAN Uncharacterized protein C1orf87 OS=Homo sapiens GN=C1orf87 PE=2 SV=1 | 151 | Q | 0.588681 | E | 0.627338 | -0.038657 | No Change: Both D | A breast cancer sample |
| Q6P1W5 | CA094_HUMAN Uncharacterized protein C1orf94 OS=Homo sapiens GN=C1orf94 PE=1 SV=2 | 235 | Q | 0.654425 | E | 0.683083 | -0.028658 | No Change: Both D | - |
| Q6P1W5 | CA094_HUMAN Uncharacterized protein C1orf94 OS=Homo sapiens GN=C1orf94 PE=1 SV=2 | 302 | D | 0.973188 | E | 0.97752 | -0.004332 | No Change: Both D | - |
| Q6P1W5 | CA094_HUMAN Uncharacterized protein C1orf94 OS=Homo sapiens GN=C1orf94 PE=1 SV=2 | 438 | Y | 0.526223 | H | 0.647005 | -0.120782 | No Change: Both D | - |
| Q6IQ19 | CA096_HUMAN Uncharacterized protein C1orf96 OS=Homo sapiens GN=C1orf96 PE=1 SV=2 | 123 | A | 0.988114 | V | 0.983022 | 0.005092 | No Change: Both D | - |
| P02745 | C1QA_HUMAN Complement C1q subcomponent subunit A OS=Homo sapiens GN=C1QA PE=1 SV=2 | 23 | E | 0.446559 | K | 0.450179 | -0.00362 | No Change: Both O | - |
| P02746 | C1QB_HUMAN Complement C1q subcomponent subunit B OS=Homo sapiens GN=C1QB PE=1 SV=3 | 42 | G | 0.844979 | D | 0.845551 | -5.72E-04 | No Change: Both D | Complement component C1q deficiency (C1QD) [MIM:613652] |
| P02746 | C1QB_HUMAN Complement C1q subcomponent subunit B OS=Homo sapiens GN=C1QB PE=1 SV=3 | 123 | A | 0.489119 | T | 0.5257 | -0.036581 | O to D | A breast cancer sample |
| P02747 | C1QC_HUMAN Complement C1q subcomponent subunit C OS=Homo sapiens GN=C1QC PE=1 SV=3 | 34 | G | 0.630206 | R | 0.609766 | 0.02044 | No Change: Both D | Complement component C1q deficiency (C1QD) [MIM:613652] |
| Q9BXJ0 | C1QT5_HUMAN Complement C1q tumor necrosis factor-related protein 5 OS=Homo sapiens GN=C1QTNF5 PE=1 SV=1 | 44 | Q | 0.983805 | R | 0.987063 | -0.003258 | No Change: Both D | - |
| Q9BXJ0 | C1QT5_HUMAN Complement C1q tumor necrosis factor-related protein 5 OS=Homo sapiens GN=C1QTNF5 PE=1 SV=1 | 163 | S | 0.149051 | R | 0.121038 | 0.028013 | No Change: Both O | Late-onset retinal degeneration (LORD) [MIM:605670] |
| Q9BXI9 | C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 OS=Homo sapiens GN=C1QTNF6 PE=1 SV=3 | 2 | G | 0.807615 | V | 0.6737 | 0.133915 | No Change: Both D | - |
| Q9BXI9 | C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 OS=Homo sapiens GN=C1QTNF6 PE=1 SV=3 | 23 | P | 0.083877 | R | 0.072559 | 0.011318 | No Change: Both O | - |
| Q9BXI9 | C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 OS=Homo sapiens GN=C1QTNF6 PE=1 SV=3 | 36 | G | 0.368948 | D | 0.430888 | -0.06194 | No Change: Both O | - |
| Q9BXI9 | C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 OS=Homo sapiens GN=C1QTNF6 PE=1 SV=3 | 119 | P | 0.737557 | L | 0.640439 | 0.097118 | No Change: Both D | - |
| Q9BXI9 | C1QT6_HUMAN Complement C1q tumor necrosis factor-related protein 6 OS=Homo sapiens GN=C1QTNF6 PE=1 SV=3 | 207 | R | 0.628491 | H | 0.639178 | -0.010687 | No Change: Both D | - |
| P0C862 | C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens GN=C1QTNF9 PE=1 SV=1 | 219 | M | 0.472514 | V | 0.405697 | 0.066817 | No Change: Both O | - |
| P0C862 | C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens GN=C1QTNF9 PE=1 SV=1 | 301 | V | 0.153699 | M | 0.187593 | -0.033894 | No Change: Both O | - |
| P0C862 | C1T9A_HUMAN Complement C1q and tumor necrosis factor-related protein 9A OS=Homo sapiens GN=C1QTNF9 PE=1 SV=1 | 6 | L | 0.026995 | F | 0.019217 | 0.007778 | No Change: Both O | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 152 | S | 0.779443 | L | 0.702449 | 0.076994 | No Change: Both D | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 131 | Y | 0.134789 | H | 0.189316 | -0.054527 | No Change: Both O | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 163 | H | 0.446682 | Y | 0.348968 | 0.097714 | No Change: Both O | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 184 | E | 0.64806 | K | 0.59059 | 0.05747 | No Change: Both D | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 261 | G | 0.263099 | R | 0.246151 | 0.016948 | No Change: Both O | - |
| P00736 | C1R_HUMAN Complement C1r subcomponent OS=Homo sapiens GN=C1R PE=1 SV=2 | 186 | T | 0.651786 | R | 0.686708 | -0.034922 | No Change: Both D | - |
| Q9NZP8 | C1RL_HUMAN Complement C1r subcomponent-like protein OS=Homo sapiens GN=C1RL PE=1 SV=2 | 285 | I | 0.248237 | V | 0.279627 | -0.03139 | No Change: Both O | - |
| P09871 | C1S_HUMAN Complement C1s subcomponent OS=Homo sapiens GN=C1S PE=1 SV=1 | 383 | R | 0.17967 | H | 0.175446 | 0.004224 | No Change: Both O | - |
| P09871 | C1S_HUMAN Complement C1s subcomponent OS=Homo sapiens GN=C1S PE=1 SV=1 | 119 | R | 0.377466 | H | 0.378962 | -0.001496 | No Change: Both O | - |
| P09871 | C1S_HUMAN Complement C1s subcomponent OS=Homo sapiens GN=C1S PE=1 SV=1 | 327 | V | 0.180446 | L | 0.175076 | 0.00537 | No Change: Both O | - |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 131 | C | 0.379009 | Y | 0.381391 | -0.002382 | No Change: Both O | Complement component 2 deficiency (C2D) [MIM:217000] |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 209 | S | 0.340659 | F | 0.183931 | 0.156728 | No Change: Both O | Complement component 2 deficiency (C2D) [MIM:217000] |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 464 | G | 0.230421 | R | 0.22089 | 0.009531 | No Change: Both O | Complement component 2 deficiency (C2D) [MIM:217000] |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 533 | F | 0.211948 | L | 0.247784 | -0.035836 | No Change: Both O | - |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 318 | E | 0.522651 | D | 0.50321 | 0.019441 | No Change: Both D | - |
| P06681 | CO2_HUMAN Complement C2 OS=Homo sapiens GN=C2 PE=1 SV=2 | 734 | R | 0.353286 | C | 0.231045 | 0.122241 | No Change: Both O | - |
| Q9NX31 | CT111_HUMAN Uncharacterized protein C20orf111 OS=Homo sapiens GN=C20orf111 PE=2 SV=2 | 74 | V | 0.965594 | G | 0.976265 | -0.010671 | No Change: Both D | - |
| A0PJX2 | CT118_HUMAN Uncharacterized protein C20orf118 OS=Homo sapiens GN=C20orf118 PE=2 SV=1 | 102 | G | 0.221776 | R | 0.218906 | 0.00287 | No Change: Both O | - |
| Q9BR26 | CT123_HUMAN Transmembrane protein C20orf123 OS=Homo sapiens GN=C20orf123 PE=2 SV=2 | 565 | P | 0.833981 | S | 0.837994 | -0.004013 | No Change: Both D | - |
| Q9BQM9 | CT144_HUMAN Uncharacterized protein C20orf144 OS=Homo sapiens GN=C20orf144 PE=2 SV=1 | 62 | Q | 0.537204 | R | 0.556399 | -0.019195 | No Change: Both D | - |
| Q8NC74 | CT151_HUMAN Uncharacterized protein C20orf151 OS=Homo sapiens GN=C20orf151 PE=2 SV=3 | 348 | D | 0.724254 | N | 0.695739 | 0.028515 | No Change: Both D | - |
| Q8NC74 | CT151_HUMAN Uncharacterized protein C20orf151 OS=Homo sapiens GN=C20orf151 PE=2 SV=3 | 408 | A | 0.935399 | T | 0.937802 | -0.002403 | No Change: Both D | - |
| Q8NC74 | CT151_HUMAN Uncharacterized protein C20orf151 OS=Homo sapiens GN=C20orf151 PE=2 SV=3 | 607 | E | 0.980717 | K | 0.978771 | 0.001946 | No Change: Both D | - |
| Q8NC74 | CT151_HUMAN Uncharacterized protein C20orf151 OS=Homo sapiens GN=C20orf151 PE=2 SV=3 | 637 | L | 0.996459 | R | 0.998436 | -0.001977 | No Change: Both D | - |
| Q96M20 | CT152_HUMAN Uncharacterized protein C20orf152 OS=Homo sapiens GN=C20orf152 PE=2 SV=2 | 37 | R | 0.143683 | H | 0.131901 | 0.011782 | No Change: Both O | - |
| Q96M20 | CT152_HUMAN Uncharacterized protein C20orf152 OS=Homo sapiens GN=C20orf152 PE=2 SV=2 | 208 | T | 0.211559 | A | 0.185767 | 0.025792 | No Change: Both O | - |
| Q96M20 | CT152_HUMAN Uncharacterized protein C20orf152 OS=Homo sapiens GN=C20orf152 PE=2 SV=2 | 375 | P | 0.743726 | S | 0.749119 | -0.005393 | No Change: Both D | - |
| Q96NR2 | C2AS1_HUMAN Putative uncharacterized protein C20orf166-AS1 OS=Homo sapiens GN=C20orf166-AS1 PE=1 SV=3 | 121 | I | 0.286224 | V | 0.300196 | -0.013972 | No Change: Both O | - |
| Q9H1L0 | CT166_HUMAN Uncharacterized protein C20orf166 OS=Homo sapiens GN=C20orf166 PE=2 SV=1 | 27 | V | 0.890329 | A | 0.923376 | -0.033047 | No Change: Both D | - |
| Q96LM9 | CT173_HUMAN Uncharacterized protein C20orf173 OS=Homo sapiens GN=C20orf173 PE=2 SV=1 | 141 | K | 0.399045 | E | 0.415236 | -0.016191 | No Change: Both O | - |
| Q9NTX9 | CT177_HUMAN Uncharacterized protein C20orf177 OS=Homo sapiens GN=C20orf177 PE=2 SV=1 | 95 | S | 0.907827 | G | 0.868389 | 0.039438 | No Change: Both D | A breast cancer sample |
| Q9NTX9 | CT177_HUMAN Uncharacterized protein C20orf177 OS=Homo sapiens GN=C20orf177 PE=2 SV=1 | 380 | Y | 0.915065 | C | 0.954104 | -0.039039 | No Change: Both D | - |
| Q5TEA3 | CT194_HUMAN Uncharacterized protein C20orf194 OS=Homo sapiens GN=C20orf194 PE=2 SV=1 | 481 | T | 0.239788 | P | 0.282559 | -0.042771 | No Change: Both O | - |
| Q5TEA3 | CT194_HUMAN Uncharacterized protein C20orf194 OS=Homo sapiens GN=C20orf194 PE=2 SV=1 | 577 | R | 0.293242 | G | 0.292245 | 9.97E-04 | No Change: Both O | - |
| Q5TEA3 | CT194_HUMAN Uncharacterized protein C20orf194 OS=Homo sapiens GN=C20orf194 PE=2 SV=1 | 86 | T | 0.635537 | M | 0.575924 | 0.059613 | No Change: Both D | - |
| Q5TEA3 | CT194_HUMAN Uncharacterized protein C20orf194 OS=Homo sapiens GN=C20orf194 PE=2 SV=1 | 265 | F | 0.563222 | L | 0.572464 | -0.009242 | No Change: Both D | - |
| Q8IYI0 | CT196_HUMAN Uncharacterized protein C20orf196 OS=Homo sapiens GN=C20orf196 PE=2 SV=1 | 23 | A | 0.696693 | V | 0.590499 | 0.106194 | No Change: Both D | - |
| Q8TD35 | CT201_HUMAN Uncharacterized protein C20orf201 OS=Homo sapiens GN=C20orf201 PE=2 SV=3 | 9 | G | 0.998967 | W | 0.997039 | 0.001928 | No Change: Both D | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 74 | P | 0.141053 | R | 0.119678 | 0.021375 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 254 | H | 0.194144 | R | 0.214392 | -0.020248 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 369 | V | 0.414595 | I | 0.367877 | 0.046718 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 371 | P | 0.402921 | L | 0.253077 | 0.149844 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 505 | D | 0.490569 | E | 0.498284 | -0.007715 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 660 | P | 0.346477 | L | 0.222045 | 0.124432 | No Change: Both O | - |
| Q8NHU2 | CT026_HUMAN Uncharacterized protein C20orf26 OS=Homo sapiens GN=C20orf26 PE=2 SV=3 | 671 | V | 0.143126 | I | 0.127187 | 0.015939 | No Change: Both O | - |
| Q9Y312 | CT004_HUMAN Uncharacterized protein C20orf4 OS=Homo sapiens GN=C20orf4 PE=1 SV=2 | 124 | P | 0.188088 | T | 0.151982 | 0.036106 | No Change: Both O | - |
| Q9BY42 | CT043_HUMAN UPF0549 protein C20orf43 OS=Homo sapiens GN=C20orf43 PE=1 SV=3 | 159 | T | 0.170136 | A | 0.170134 | 2.00E-06 | No Change: Both O | - |
| Q9BY42 | CT043_HUMAN UPF0549 protein C20orf43 OS=Homo sapiens GN=C20orf43 PE=1 SV=3 | 171 | M | 0.378927 | V | 0.328082 | 0.050845 | No Change: Both O | - |
| Q5TEU4 | CT007_HUMAN Probable methyltransferase C20orf7 mitochondrial OS=Homo sapiens GN=C20orf7 PE=1 SV=1 | 337 | L | 0.623518 | F | 0.601787 | 0.021731 | No Change: Both D | - |
| Q5TEU4 | CT007_HUMAN Probable methyltransferase C20orf7 mitochondrial OS=Homo sapiens GN=C20orf7 PE=1 SV=1 | 229 | L | 0.205518 | P | 0.323461 | -0.117943 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q9BQP7 | CT072_HUMAN Uncharacterized protein C20orf72 OS=Homo sapiens GN=C20orf72 PE=1 SV=1 | 15 | S | 0.588129 | C | 0.401626 | 0.186503 | D to O | - |
| Q9UJQ7 | CT079_HUMAN Uncharacterized protein C20orf79 OS=Homo sapiens GN=C20orf79 PE=2 SV=1 | 99 | P | 0.484722 | S | 0.50363 | -0.018908 | O to D | - |
| Q9H1P6 | CT085_HUMAN Uncharacterized protein C20orf85 OS=Homo sapiens GN=C20orf85 PE=2 SV=1 | 26 | R | 0.301715 | H | 0.284343 | 0.017372 | No Change: Both O | - |
| Q9H1P6 | CT085_HUMAN Uncharacterized protein C20orf85 OS=Homo sapiens GN=C20orf85 PE=2 SV=1 | 99 | I | 0.190839 | V | 0.224177 | -0.033338 | No Change: Both O | - |
| Q9H1P6 | CT085_HUMAN Uncharacterized protein C20orf85 OS=Homo sapiens GN=C20orf85 PE=2 SV=1 | 34 | R | 0.40814 | Q | 0.433084 | -0.024944 | No Change: Both O | - |
| Q5VYV7 | CT094_HUMAN UPF0492 protein C20orf94 OS=Homo sapiens GN=C20orf94 PE=1 SV=1 | 317 | R | 0.595213 | Q | 0.564836 | 0.030377 | No Change: Both D | - |
| Q9NUD7 | CT096_HUMAN Uncharacterized protein C20orf96 OS=Homo sapiens GN=C20orf96 PE=2 SV=2 | 305 | I | 0.485645 | F | 0.521099 | -0.035454 | O to D | - |
| Q8N2C9 | CU128_HUMAN Uncharacterized protein C21orf128 OS=Homo sapiens GN=C21orf128 PE=2 SV=3 | 98 | V | 0.264645 | F | 0.251723 | 0.012922 | No Change: Both O | - |
| O43822 | CU002_HUMAN Uncharacterized protein C21orf2 OS=Homo sapiens GN=C21orf2 PE=1 SV=1 | 150 | T | 0.91472 | I | 0.866088 | 0.048632 | No Change: Both D | - |
| O43822 | CU002_HUMAN Uncharacterized protein C21orf2 OS=Homo sapiens GN=C21orf2 PE=1 SV=1 | 153 | G | 0.918814 | S | 0.933275 | -0.014461 | No Change: Both D | - |
| P30042 | ES1_HUMAN ES1 protein homolog mitochondrial OS=Homo sapiens GN=C21orf33 PE=1 SV=3 | 248 | L | 0.104851 | V | 0.106793 | -0.001942 | No Change: Both O | - |
| P30042 | ES1_HUMAN ES1 protein homolog mitochondrial OS=Homo sapiens GN=C21orf33 PE=1 SV=3 | 6 | V | 0.63999 | A | 0.762033 | -0.122043 | No Change: Both D | - |
| P30042 | ES1_HUMAN ES1 protein homolog mitochondrial OS=Homo sapiens GN=C21orf33 PE=1 SV=3 | 148 | V | 0.276594 | M | 0.325847 | -0.049253 | No Change: Both O | - |
| Q9H0A9 | CU056_HUMAN Uncharacterized protein C21orf56 OS=Homo sapiens GN=C21orf56 PE=2 SV=3 | 113 | P | 0.959324 | L | 0.928687 | 0.030637 | No Change: Both D | - |
| Q9H0A9 | CU056_HUMAN Uncharacterized protein C21orf56 OS=Homo sapiens GN=C21orf56 PE=2 SV=3 | 298 | S | 0.56069 | N | 0.518782 | 0.041908 | No Change: Both D | - |
| Q9NV44 | CU077_HUMAN Putative uncharacterized protein C21orf77 OS=Homo sapiens GN=C21orf77 PE=5 SV=1 | 2 | E | 0.708614 | G | 0.704946 | 0.003668 | No Change: Both D | - |
| Q9BZE7 | EVG1_HUMAN UPF0193 protein EVG1 OS=Homo sapiens GN=C22orf23 PE=2 SV=1 | 136 | M | 0.948526 | L | 0.942018 | 0.006508 | No Change: Both D | - |
| Q9Y442 | CV024_HUMAN Uncharacterized protein C22orf24 OS=Homo sapiens GN=C22orf24 PE=2 SV=1 | 11 | H | 0.547894 | L | 0.45069 | 0.097204 | D to O | - |
| Q6ICL3 | CV025_HUMAN Uncharacterized protein C22orf25 OS=Homo sapiens GN=C22orf25 PE=2 SV=1 | 125 | D | 0.213443 | N | 0.206973 | 0.00647 | No Change: Both O | - |
| Q6ICL3 | CV025_HUMAN Uncharacterized protein C22orf25 OS=Homo sapiens GN=C22orf25 PE=2 SV=1 | 200 | E | 0.497558 | K | 0.477716 | 0.019842 | No Change: Both O | - |
| Q6ICL3 | CV025_HUMAN Uncharacterized protein C22orf25 OS=Homo sapiens GN=C22orf25 PE=2 SV=1 | 245 | D | 0.164197 | E | 0.173111 | -0.008914 | No Change: Both O | - |
| Q9NV39 | CV026_HUMAN Putative uncharacterized protein C22orf26 OS=Homo sapiens GN=C22orf26 PE=2 SV=1 | 28 | P | 0.995174 | L | 0.989728 | 0.005446 | No Change: Both D | - |
| Q9NV39 | CV026_HUMAN Putative uncharacterized protein C22orf26 OS=Homo sapiens GN=C22orf26 PE=2 SV=1 | 137 | Q | 0.768349 | R | 0.738971 | 0.029378 | No Change: Both D | - |
| Q9Y3I0 | RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=Homo sapiens GN=C22orf28 PE=1 SV=1 | 343 | L | 0.269817 | F | 0.23918 | 0.030637 | No Change: Both O | - |
| Q9Y3I0 | RTCB_HUMAN tRNA-splicing ligase RtcB homolog OS=Homo sapiens GN=C22orf28 PE=1 SV=1 | 153 | V | 0.256392 | A | 0.316426 | -0.060034 | No Change: Both O | - |
| Q7L3V2 | CV029_HUMAN Uncharacterized protein C22orf29 OS=Homo sapiens GN=C22orf29 PE=2 SV=1 | 116 | R | 0.105856 | H | 0.101308 | 0.004548 | No Change: Both O | - |
| Q7L3V2 | CV029_HUMAN Uncharacterized protein C22orf29 OS=Homo sapiens GN=C22orf29 PE=2 SV=1 | 123 | D | 0.186438 | Y | 0.101469 | 0.084969 | No Change: Both O | - |
| O95567 | CV031_HUMAN Uncharacterized protein C22orf31 OS=Homo sapiens GN=C22orf31 PE=2 SV=1 | 46 | C | 0.167196 | R | 0.301081 | -0.133885 | No Change: Both O | - |
| O95567 | CV031_HUMAN Uncharacterized protein C22orf31 OS=Homo sapiens GN=C22orf31 PE=2 SV=1 | 210 | T | 0.335367 | R | 0.335197 | 1.70E-04 | No Change: Both O | - |
| Q9H4I9 | CV032_HUMAN UPF0466 protein C22orf32 mitochondrial OS=Homo sapiens GN=C22orf32 PE=2 SV=1 | 46 | R | 0.601538 | G | 0.587437 | 0.014101 | No Change: Both D | - |
| Q6NVV7 | CV040_HUMAN UPF0595 protein C22orf40 OS=Homo sapiens GN=C22orf40 PE=2 SV=1 | 5 | V | 0.51423 | A | 0.559497 | -0.045267 | No Change: Both D | - |
| Q6NVV7 | CV040_HUMAN UPF0595 protein C22orf40 OS=Homo sapiens GN=C22orf40 PE=2 SV=1 | 70 | L | 0.209314 | R | 0.315951 | -0.106637 | No Change: Both O | - |
| Q6IC83 | CV042_HUMAN Uncharacterized protein C22orf42 OS=Homo sapiens GN=C22orf42 PE=2 SV=1 | 73 | L | 0.683509 | P | 0.77419 | -0.090681 | No Change: Both D | - |
| Q6IC83 | CV042_HUMAN Uncharacterized protein C22orf42 OS=Homo sapiens GN=C22orf42 PE=2 SV=1 | 217 | E | 0.601923 | K | 0.584241 | 0.017682 | No Change: Both D | - |
| Q6PGQ1 | CV043_HUMAN Uncharacterized protein C22orf43 OS=Homo sapiens GN=C22orf43 PE=2 SV=1 | 4 | I | 0.368842 | T | 0.54004 | -0.171198 | O to D | - |
| Q9Y426 | CU025_HUMAN C2 domain-containing protein 2 OS=Homo sapiens GN=C2CD2 PE=1 SV=2 | 211 | V | 0.408586 | A | 0.492985 | -0.084399 | No Change: Both O | - |
| Q9Y426 | CU025_HUMAN C2 domain-containing protein 2 OS=Homo sapiens GN=C2CD2 PE=1 SV=2 | 618 | T | 0.778038 | A | 0.796931 | -0.018893 | No Change: Both D | - |
| O14523 | C2C2L_HUMAN C2 domain-containing protein 2-like OS=Homo sapiens GN=C2CD2L PE=1 SV=3 | 413 | R | 0.87509 | W | 0.741286 | 0.133804 | No Change: Both D | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 773 | P | 0.863426 | R | 0.828267 | 0.035159 | No Change: Both D | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 997 | R | 0.479509 | Q | 0.493892 | -0.014383 | No Change: Both O | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 1219 | R | 0.472541 | Q | 0.504499 | -0.031958 | O to D | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 1297 | Y | 0.19574 | C | 0.166304 | 0.029436 | No Change: Both O | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 1663 | S | 0.205488 | N | 0.15303 | 0.052458 | No Change: Both O | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 1831 | G | 0.917991 | W | 0.839088 | 0.078903 | No Change: Both D | - |
| Q4AC94 | C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens GN=C2CD3 PE=1 SV=4 | 1832 | R | 0.921092 | G | 0.903105 | 0.017987 | No Change: Both D | - |
| A6NLJ0 | C2C4B_HUMAN C2 calcium-dependent domain-containing protein 4B OS=Homo sapiens GN=C2CD4B PE=2 SV=1 | 276 | F | 0.670734 | V | 0.720196 | -0.049462 | No Change: Both D | - |
| A6NLJ0 | C2C4B_HUMAN C2 calcium-dependent domain-containing protein 4B OS=Homo sapiens GN=C2CD4B PE=2 SV=1 | 346 | D | 0.855635 | E | 0.870558 | -0.014923 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 357 | R | 0.790109 | G | 0.814321 | -0.024212 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 505 | D | 0.545343 | V | 0.497753 | 0.04759 | D to O | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 655 | T | 0.675112 | S | 0.739039 | -0.063927 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 660 | A | 0.800671 | E | 0.868498 | -0.067827 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 685 | V | 0.629702 | A | 0.675035 | -0.045333 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 767 | I | 0.389643 | T | 0.529896 | -0.140253 | O to D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 774 | I | 0.405523 | V | 0.410158 | -0.004635 | No Change: Both O | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 1500 | S | 0.903729 | F | 0.830692 | 0.073037 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 1559 | H | 0.990314 | Y | 0.983621 | 0.006693 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 1613 | N | 0.999482 | S | 0.999685 | -2.03E-04 | No Change: Both D | - |
| Q68DN1 | CB016_HUMAN Uncharacterized protein C2orf16 OS=Homo sapiens GN=C2orf16 PE=1 SV=3 | 1665 | S | 0.999987 | P | 0.999986 | 1.00E-06 | No Change: Both D | - |
| Q580R0 | CB027_HUMAN Uncharacterized protein C2orf27 OS=Homo sapiens GN=C2orf27A PE=2 SV=1 | 203 | P | 0.936152 | L | 0.817466 | 0.118686 | No Change: Both D | - |
| Q9H1Z8 | AUGN_HUMAN Augurin OS=Homo sapiens GN=C2orf40 PE=1 SV=1 | 52 | A | 0.632677 | T | 0.667044 | -0.034367 | No Change: Both D | - |
| Q9NWW7 | CB042_HUMAN Uncharacterized protein C2orf42 OS=Homo sapiens GN=C2orf42 PE=2 SV=1 | 314 | Q | 0.943442 | P | 0.949433 | -0.005991 | No Change: Both D | - |
| Q9H6R7 | CB044_HUMAN WD repeat-containing protein C2orf44 OS=Homo sapiens GN=C2orf44 PE=1 SV=1 | 102 | T | 0.412063 | M | 0.36478 | 0.047283 | No Change: Both O | - |
| Q9H6R7 | CB044_HUMAN WD repeat-containing protein C2orf44 OS=Homo sapiens GN=C2orf44 PE=1 SV=1 | 454 | P | 0.595169 | S | 0.639862 | -0.044693 | No Change: Both D | A breast cancer sample |
| Q8WWC4 | CB047_HUMAN Uncharacterized protein C2orf47 mitochondrial OS=Homo sapiens GN=C2orf47 PE=1 SV=1 | 290 | L | 0.880229 | I | 0.881151 | -9.22E-04 | No Change: Both D | - |
| Q96LS8 | CB048_HUMAN Uncharacterized protein C2orf48 OS=Homo sapiens GN=C2orf48 PE=2 SV=1 | 90 | P | 0.463429 | L | 0.28947 | 0.173959 | No Change: Both O | - |
| Q96LS8 | CB048_HUMAN Uncharacterized protein C2orf48 OS=Homo sapiens GN=C2orf48 PE=2 SV=1 | 119 | W | 0.488052 | S | 0.732349 | -0.244297 | O to D | - |
| Q9BVC5 | ASHWN_HUMAN Ashwin OS=Homo sapiens GN=C2orf49 PE=1 SV=1 | 185 | G | 0.96309 | D | 0.969415 | -0.006325 | No Change: Both D | - |
| Q53SZ7 | CB053_HUMAN Uncharacterized protein C2orf53 OS=Homo sapiens GN=C2orf53 PE=2 SV=1 | 194 | R | 0.581407 | G | 0.577774 | 0.003633 | No Change: Both D | - |
| Q53SZ7 | CB053_HUMAN Uncharacterized protein C2orf53 OS=Homo sapiens GN=C2orf53 PE=2 SV=1 | 222 | R | 0.220707 | C | 0.108333 | 0.112374 | No Change: Both O | - |
| Q08AI8 | CB054_HUMAN Uncharacterized protein C2orf54 OS=Homo sapiens GN=C2orf54 PE=1 SV=2 | 309 | L | 0.073282 | P | 0.140325 | -0.067043 | No Change: Both O | - |
| Q08AI8 | CB054_HUMAN Uncharacterized protein C2orf54 OS=Homo sapiens GN=C2orf54 PE=1 SV=2 | 170 | A | 0.456461 | T | 0.469406 | -0.012945 | No Change: Both O | - |
| Q6NV74 | CB055_HUMAN Uncharacterized protein C2orf55 OS=Homo sapiens GN=C2orf55 PE=1 SV=3 | 315 | S | 0.98362 | C | 0.971631 | 0.011989 | No Change: Both D | - |
| Q7L592 | MIDA_HUMAN Protein midA homolog mitochondrial OS=Homo sapiens GN=C2orf56 PE=1 SV=1 | 39 | P | 0.610431 | A | 0.524419 | 0.086012 | No Change: Both D | - |
| Q53QW1 | CB057_HUMAN Uncharacterized protein C2orf57 OS=Homo sapiens GN=C2orf57 PE=2 SV=1 | 11 | V | 0.817472 | L | 0.837269 | -0.019797 | No Change: Both D | - |
| Q53QW1 | CB057_HUMAN Uncharacterized protein C2orf57 OS=Homo sapiens GN=C2orf57 PE=2 SV=1 | 79 | Q | 0.880432 | R | 0.875651 | 0.004781 | No Change: Both D | - |
| Q53QW1 | CB057_HUMAN Uncharacterized protein C2orf57 OS=Homo sapiens GN=C2orf57 PE=2 SV=1 | 168 | E | 0.966106 | K | 0.959831 | 0.006275 | No Change: Both D | - |
| Q53QW1 | CB057_HUMAN Uncharacterized protein C2orf57 OS=Homo sapiens GN=C2orf57 PE=2 SV=1 | 261 | S | 0.840518 | P | 0.834419 | 0.006099 | No Change: Both D | - |
| Q8N801 | CB061_HUMAN Uncharacterized protein C2orf61 OS=Homo sapiens GN=C2orf61 PE=2 SV=1 | 17 | L | 0.498638 | M | 0.610079 | -0.111441 | O to D | - |
| Q8N801 | CB061_HUMAN Uncharacterized protein C2orf61 OS=Homo sapiens GN=C2orf61 PE=2 SV=1 | 31 | Q | 0.67904 | R | 0.683779 | -0.004739 | No Change: Both D | - |
| Q8NHS4 | CB063_HUMAN Uncharacterized protein C2orf63 OS=Homo sapiens GN=C2orf63 PE=2 SV=3 | 178 | A | 0.463675 | V | 0.375567 | 0.088108 | No Change: Both O | - |
| Q8NHS4 | CB063_HUMAN Uncharacterized protein C2orf63 OS=Homo sapiens GN=C2orf63 PE=2 SV=3 | 426 | V | 0.091564 | I | 0.087334 | 0.00423 | No Change: Both O | - |
| Q8NHS4 | CB063_HUMAN Uncharacterized protein C2orf63 OS=Homo sapiens GN=C2orf63 PE=2 SV=3 | 503 | A | 0.208209 | V | 0.161093 | 0.047116 | No Change: Both O | - |
| Q8NHS4 | CB063_HUMAN Uncharacterized protein C2orf63 OS=Homo sapiens GN=C2orf63 PE=2 SV=3 | 552 | D | 0.395728 | Y | 0.248766 | 0.146962 | No Change: Both O | - |
| Q8TC57 | CB065_HUMAN Uncharacterized protein C2orf65 OS=Homo sapiens GN=C2orf65 PE=2 SV=1 | 5 | R | 0.84733 | Q | 0.855957 | -0.008627 | No Change: Both D | - |
| Q8TC57 | CB065_HUMAN Uncharacterized protein C2orf65 OS=Homo sapiens GN=C2orf65 PE=2 SV=1 | 195 | T | 0.764816 | P | 0.783164 | -0.018348 | No Change: Both D | - |
| A6NJV1 | CB070_HUMAN UPF0573 protein C2orf70 OS=Homo sapiens GN=C2orf70 PE=2 SV=1 | 66 | Q | 0.578573 | H | 0.586875 | -0.008302 | No Change: Both D | - |
| A6NJV1 | CB070_HUMAN UPF0573 protein C2orf70 OS=Homo sapiens GN=C2orf70 PE=2 SV=1 | 177 | Q | 0.602954 | L | 0.497107 | 0.105847 | D to O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 13 | S | 0.560565 | C | 0.389146 | 0.171419 | D to O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 421 | K | 0.880118 | R | 0.895092 | -0.014974 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 580 | T | 0.970514 | M | 0.965389 | 0.005125 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 792 | L | 0.768825 | V | 0.712952 | 0.055873 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 1254 | P | 0.95521 | L | 0.920651 | 0.034559 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 201 | I | 0.126744 | F | 0.117767 | 0.008977 | No Change: Both O | Retinitis pigmentosa type 54 (RP54) [MIM:613428] |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 867 | P | 0.982878 | L | 0.969522 | 0.013356 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 227 | E | 0.105962 | K | 0.096461 | 0.009501 | No Change: Both O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 247 | V | 0.404 | A | 0.473155 | -0.069155 | No Change: Both O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 252 | A | 0.441161 | D | 0.575775 | -0.134614 | O to D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 258 | R | 0.686236 | I | 0.542199 | 0.144037 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 312 | S | 0.669721 | N | 0.631879 | 0.037842 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 320 | R | 0.627011 | C | 0.510282 | 0.116729 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 372 | D | 0.738472 | N | 0.706299 | 0.032173 | No Change: Both D | Retinitis pigmentosa type 54 (RP54) [MIM:613428] |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 378 | E | 0.800534 | K | 0.792708 | 0.007826 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 612 | L | 0.789314 | P | 0.852732 | -0.063418 | No Change: Both D | Retinitis pigmentosa type 54 (RP54) [MIM:613428] |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 615 | V | 0.760645 | D | 0.842782 | -0.082137 | No Change: Both D | Retinitis pigmentosa type 54 (RP54) [MIM:613428] |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 628 | A | 0.40894 | T | 0.412607 | -0.003667 | No Change: Both O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 648 | A | 0.361831 | P | 0.460741 | -0.09891 | No Change: Both O | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 688 | C | 0.855643 | Y | 0.813454 | 0.042189 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 954 | P | 0.845802 | S | 0.851097 | -0.005295 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 955 | R | 0.850408 | Q | 0.86081 | -0.010402 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 959 | A | 0.880906 | T | 0.890923 | -0.010017 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 1020 | Q | 0.995 | R | 0.995511 | -5.11E-04 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 1160 | A | 0.847316 | T | 0.841829 | 0.005487 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 1177 | R | 0.813943 | Q | 0.80287 | 0.011073 | No Change: Both D | - |
| A6NGG8 | CB071_HUMAN Uncharacterized protein C2orf71 OS=Homo sapiens GN=C2orf71 PE=1 SV=1 | 1247 | G | 0.965696 | S | 0.972144 | -0.006448 | No Change: Both D | - |
| Q8N5S3 | CB073_HUMAN Uncharacterized protein C2orf73 OS=Homo sapiens GN=C2orf73 PE=2 SV=3 | 254 | P | 0.912368 | L | 0.852846 | 0.059522 | No Change: Both D | - |
| Q8N5S3 | CB073_HUMAN Uncharacterized protein C2orf73 OS=Homo sapiens GN=C2orf73 PE=2 SV=3 | 275 | R | 0.807506 | T | 0.824536 | -0.01703 | No Change: Both D | - |
| Q8N5S3 | CB073_HUMAN Uncharacterized protein C2orf73 OS=Homo sapiens GN=C2orf73 PE=2 SV=3 | 29 | H | 0.799729 | N | 0.798728 | 0.001001 | No Change: Both D | - |
| Q3KRA6 | CB076_HUMAN UPF0538 protein C2orf76 OS=Homo sapiens GN=C2orf76 PE=2 SV=3 | 46 | I | 0.178366 | V | 0.201963 | -0.023597 | No Change: Both O | - |
| Q3KRA6 | CB076_HUMAN UPF0538 protein C2orf76 OS=Homo sapiens GN=C2orf76 PE=2 SV=3 | 116 | K | 0.376441 | R | 0.301091 | 0.07535 | No Change: Both O | - |
| Q0P641 | CB080_HUMAN Uncharacterized protein C2orf80 OS=Homo sapiens GN=C2orf80 PE=2 SV=2 | 82 | R | 0.56036 | H | 0.546052 | 0.014308 | No Change: Both D | - |
| Q0P641 | CB080_HUMAN Uncharacterized protein C2orf80 OS=Homo sapiens GN=C2orf80 PE=2 SV=2 | 130 | C | 0.265954 | R | 0.421171 | -0.155217 | No Change: Both O | - |
| Q0P641 | CB080_HUMAN Uncharacterized protein C2orf80 OS=Homo sapiens GN=C2orf80 PE=2 SV=2 | 152 | S | 0.74917 | G | 0.659343 | 0.089827 | No Change: Both D | - |
| Q53S99 | CB083_HUMAN Folate transporter-like protein C2orf83 OS=Homo sapiens GN=C2orf83 PE=2 SV=1 | 104 | E | 0.635225 | Q | 0.598801 | 0.036424 | No Change: Both D | - |
| Q53S99 | CB083_HUMAN Folate transporter-like protein C2orf83 OS=Homo sapiens GN=C2orf83 PE=2 SV=1 | 45 | S | 0.815572 | L | 0.753946 | 0.061626 | No Change: Both D | - |
| Q86W67 | CB084_HUMAN UPF0638 protein C2orf84 OS=Homo sapiens GN=C2orf84 PE=2 SV=1 | 140 | Y | 0.809315 | C | 0.827476 | -0.018161 | No Change: Both D | - |
| Q14D33 | CB085_HUMAN Uncharacterized protein C2orf85 OS=Homo sapiens GN=C2orf85 PE=2 SV=2 | 101 | G | 0.370414 | E | 0.418473 | -0.048059 | No Change: Both O | - |
| Q9BSF0 | CB088_HUMAN UPF0733 protein C2orf88 OS=Homo sapiens GN=C2orf88 PE=2 SV=2 | 56 | T | 0.310373 | I | 0.205814 | 0.104559 | No Change: Both O | - |
| Q86V40 | CB089_HUMAN UPF0632 protein C2orf89 OS=Homo sapiens GN=C2orf89 PE=2 SV=3 | 143 | R | 0.413748 | H | 0.421685 | -0.007937 | No Change: Both O | - |
| Q86V40 | CB089_HUMAN UPF0632 protein C2orf89 OS=Homo sapiens GN=C2orf89 PE=2 SV=3 | 428 | R | 0.947636 | Q | 0.94417 | 0.003466 | No Change: Both D | - |
| Q86V40 | CB089_HUMAN UPF0632 protein C2orf89 OS=Homo sapiens GN=C2orf89 PE=2 SV=3 | 430 | P | 0.931166 | L | 0.887678 | 0.043488 | No Change: Both D | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 102 | R | 0.580271 | G | 0.598712 | -0.018441 | No Change: Both D | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 314 | P | 0.389621 | L | 0.285764 | 0.103857 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 549 | D | 0.232908 | N | 0.202543 | 0.030365 | No Change: Both O | Complement component 3 deficiency (C3D) [MIM:613779] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1320 | R | 0.678217 | Q | 0.68977 | -0.011553 | No Change: Both D | Complement component 3 deficiency (C3D) [MIM:613779] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 863 | R | 0.310436 | K | 0.357216 | -0.04678 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1224 | G | 0.444251 | D | 0.486374 | -0.042123 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1367 | I | 0.490784 | T | 0.659734 | -0.16895 | O to D | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 469 | E | 0.355546 | D | 0.315816 | 0.03973 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1216 | D | 0.520764 | N | 0.510711 | 0.010053 | No Change: Both D | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1619 | S | 0.20558 | R | 0.165761 | 0.039819 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1521 | Q | 0.51594 | R | 0.556878 | -0.040938 | No Change: Both D | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1601 | H | 0.328933 | N | 0.34991 | -0.020977 | No Change: Both O | - |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 592 | R | 0.207369 | Q | 0.232324 | -0.024955 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 592 | R | 0.207369 | W | 0.090172 | 0.117197 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 735 | R | 0.320195 | W | 0.153061 | 0.167134 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1094 | A | 0.0706 | V | 0.049932 | 0.020668 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1115 | D | 0.486907 | N | 0.454585 | 0.032322 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1158 | C | 0.371848 | W | 0.339469 | 0.032379 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1161 | Q | 0.391374 | K | 0.445779 | -0.054405 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1464 | H | 0.066349 | D | 0.083634 | -0.017285 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 603 | F | 0.16464 | V | 0.20995 | -0.04531 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| P01024 | CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 | 1042 | R | 0.391701 | L | 0.29384 | 0.097861 | No Change: Both O | Hemolytic uremic syndrome atypical type 5 (AHUS5) [MIM:612925] |
| Q16581 | C3AR_HUMAN C3a anaphylatoxin chemotactic receptor OS=Homo sapiens GN=C3AR1 PE=1 SV=2 | 136 | V | 0.138637 | A | 0.208842 | -0.070205 | No Change: Both O | - |
| Q6NW34 | CC017_HUMAN Uncharacterized protein C3orf17 OS=Homo sapiens GN=C3orf17 PE=1 SV=3 | 101 | E | 0.482814 | K | 0.493851 | -0.011037 | No Change: Both O | - |
| Q6NW34 | CC017_HUMAN Uncharacterized protein C3orf17 OS=Homo sapiens GN=C3orf17 PE=1 SV=3 | 352 | P | 0.570761 | S | 0.639456 | -0.068695 | No Change: Both D | - |
| Q6NW34 | CC017_HUMAN Uncharacterized protein C3orf17 OS=Homo sapiens GN=C3orf17 PE=1 SV=3 | 357 | F | 0.513332 | I | 0.49053 | 0.022802 | D to O | - |
| Q6NW34 | CC017_HUMAN Uncharacterized protein C3orf17 OS=Homo sapiens GN=C3orf17 PE=1 SV=3 | 476 | T | 0.754984 | A | 0.724014 | 0.03097 | No Change: Both D | - |
| Q6NW34 | CC017_HUMAN Uncharacterized protein C3orf17 OS=Homo sapiens GN=C3orf17 PE=1 SV=3 | 490 | S | 0.397251 | P | 0.366475 | 0.030776 | No Change: Both O | - |
| Q9UK00 | CC018_HUMAN Uncharacterized protein C3orf18 OS=Homo sapiens GN=C3orf18 PE=2 SV=2 | 8 | A | 0.978841 | D | 0.983664 | -0.004823 | No Change: Both D | - |
| Q9UK00 | CC018_HUMAN Uncharacterized protein C3orf18 OS=Homo sapiens GN=C3orf18 PE=2 SV=2 | 162 | A | 0.664956 | V | 0.639722 | 0.025234 | No Change: Both D | - |
| Q6PII3 | CC019_HUMAN Uncharacterized protein C3orf19 OS=Homo sapiens GN=C3orf19 PE=2 SV=3 | 436 | T | 0.971289 | M | 0.96869 | 0.002599 | No Change: Both D | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 176 | A | 0.230923 | T | 0.258348 | -0.027425 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 42 | G | 0.20454 | D | 0.214529 | -0.009989 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 65 | D | 0.430844 | N | 0.406595 | 0.024249 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 230 | S | 0.315186 | Y | 0.156949 | 0.158237 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 298 | A | 0.401808 | T | 0.420713 | -0.018905 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 407 | I | 0.06217 | V | 0.068182 | -0.006012 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 422 | L | 0.117455 | V | 0.109641 | 0.007814 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 205 | Q | 0.493712 | R | 0.488279 | 0.005433 | No Change: Both O | - |
| Q8ND61 | CC020_HUMAN Uncharacterized protein C3orf20 OS=Homo sapiens GN=C3orf20 PE=1 SV=2 | 689 | A | 0.211131 | V | 0.16985 | 0.041281 | No Change: Both O | - |
| Q8N3R3 | CC023_HUMAN Uncharacterized protein C3orf23 OS=Homo sapiens GN=C3orf23 PE=2 SV=2 | 4 | H | 0.493856 | P | 0.543429 | -0.049573 | O to D | - |
| Q6NXP0 | CC025_HUMAN EF-hand domain-containing protein C3orf25 OS=Homo sapiens GN=C3orf25 PE=2 SV=1 | 66 | E | 0.877669 | G | 0.840997 | 0.036672 | No Change: Both D | - |
| Q6NXP0 | CC025_HUMAN EF-hand domain-containing protein C3orf25 OS=Homo sapiens GN=C3orf25 PE=2 SV=1 | 215 | R | 0.511445 | G | 0.532346 | -0.020901 | No Change: Both D | - |
| Q6NXP0 | CC025_HUMAN EF-hand domain-containing protein C3orf25 OS=Homo sapiens GN=C3orf25 PE=2 SV=1 | 541 | P | 0.445723 | S | 0.453838 | -0.008115 | No Change: Both O | - |
| Q6NXP0 | CC025_HUMAN EF-hand domain-containing protein C3orf25 OS=Homo sapiens GN=C3orf25 PE=2 SV=1 | 36 | P | 0.308453 | L | 0.162228 | 0.146225 | No Change: Both O | - |
| Q6NXP0 | CC025_HUMAN EF-hand domain-containing protein C3orf25 OS=Homo sapiens GN=C3orf25 PE=2 SV=1 | 280 | H | 0.411235 | R | 0.446757 | -0.035522 | No Change: Both O | - |
| Q9BQ75 | CC026_HUMAN Uncharacterized protein C3orf26 OS=Homo sapiens GN=C3orf26 PE=1 SV=2 | 166 | V | 0.12928 | I | 0.126688 | 0.002592 | No Change: Both O | - |
| Q9BQ75 | CC026_HUMAN Uncharacterized protein C3orf26 OS=Homo sapiens GN=C3orf26 PE=1 SV=2 | 138 | E | 0.268152 | G | 0.202873 | 0.065279 | No Change: Both O | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 45 | N | 0.871788 | T | 0.873184 | -0.001396 | No Change: Both D | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 99 | D | 0.938539 | G | 0.930364 | 0.008175 | No Change: Both D | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 193 | Q | 0.994461 | H | 0.992994 | 0.001467 | No Change: Both D | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 312 | G | 0.499632 | S | 0.56847 | -0.068838 | O to D | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 473 | D | 0.556094 | E | 0.585238 | -0.029144 | No Change: Both D | - |
| Q96M34 | CC030_HUMAN Uncharacterized protein C3orf30 OS=Homo sapiens GN=C3orf30 PE=2 SV=2 | 447 | S | 0.670355 | L | 0.503886 | 0.166469 | No Change: Both D | - |
| Q9Y2M2 | CC032_HUMAN Uncharacterized protein C3orf32 OS=Homo sapiens GN=C3orf32 PE=2 SV=1 | 29 | P | 0.87964 | L | 0.80205 | 0.07759 | No Change: Both D | - |
| Q6P1S2 | CC033_HUMAN Uncharacterized protein C3orf33 OS=Homo sapiens GN=C3orf33 PE=1 SV=2 | 47 | A | 0.109389 | T | 0.125833 | -0.016444 | No Change: Both O | - |
| Q6P1S2 | CC033_HUMAN Uncharacterized protein C3orf33 OS=Homo sapiens GN=C3orf33 PE=1 SV=2 | 160 | S | 0.104836 | N | 0.085191 | 0.019645 | No Change: Both O | - |
| Q147U7 | CC043_HUMAN Uncharacterized protein C3orf43 OS=Homo sapiens GN=C3orf43 PE=2 SV=2 | 20 | H | 0.611968 | Y | 0.457109 | 0.154859 | D to O | - |
| Q147U7 | CC043_HUMAN Uncharacterized protein C3orf43 OS=Homo sapiens GN=C3orf43 PE=2 SV=2 | 64 | R | 0.146938 | W | 0.064161 | 0.082777 | No Change: Both O | - |
| A1A4F0 | CC055_HUMAN Putative uncharacterized protein C3orf55 OS=Homo sapiens GN=C3orf55 PE=2 SV=2 | 4 | V | 0.686576 | L | 0.658339 | 0.028237 | No Change: Both D | - |
| Q6ZUJ4 | CC062_HUMAN Uncharacterized protein C3orf62 OS=Homo sapiens GN=C3orf62 PE=2 SV=1 | 110 | E | 0.800315 | K | 0.798845 | 0.00147 | No Change: Both D | - |
| Q6ZVT6 | CC067_HUMAN Uncharacterized protein C3orf67 OS=Homo sapiens GN=C3orf67 PE=2 SV=2 | 158 | S | 0.838495 | R | 0.817104 | 0.021391 | No Change: Both D | - |
| Q6ZVT6 | CC067_HUMAN Uncharacterized protein C3orf67 OS=Homo sapiens GN=C3orf67 PE=2 SV=2 | 304 | D | 0.524693 | E | 0.547947 | -0.023254 | No Change: Both D | - |
| Q6ZVT6 | CC067_HUMAN Uncharacterized protein C3orf67 OS=Homo sapiens GN=C3orf67 PE=2 SV=2 | 387 | V | 0.890848 | M | 0.931841 | -0.040993 | No Change: Both D | - |
| Q6ZVT6 | CC067_HUMAN Uncharacterized protein C3orf67 OS=Homo sapiens GN=C3orf67 PE=2 SV=2 | 404 | S | 0.921585 | N | 0.898579 | 0.023006 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 43 | C | 0.961709 | R | 0.974097 | -0.012388 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 88 | P | 0.980128 | Q | 0.976852 | 0.003276 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 196 | V | 0.611637 | I | 0.630545 | -0.018908 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 483 | Q | 0.533106 | R | 0.591842 | -0.058736 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 673 | P | 0.142309 | A | 0.110517 | 0.031792 | No Change: Both O | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 796 | K | 0.765867 | E | 0.783785 | -0.017918 | No Change: Both D | - |
| Q8N9V7 | CC077_HUMAN Uncharacterized protein C3orf77 OS=Homo sapiens GN=C3orf77 PE=2 SV=3 | 1352 | Q | 0.730982 | R | 0.719928 | 0.011054 | No Change: Both D | - |
| Q6ZMU1 | C3P1_HUMAN Putative protein C3P1 OS=Homo sapiens GN=C3P1 PE=5 SV=3 | 172 | Q | 0.344755 | R | 0.327019 | 0.017736 | No Change: Both O | - |
| Q6ZMU1 | C3P1_HUMAN Putative protein C3P1 OS=Homo sapiens GN=C3P1 PE=5 SV=3 | 230 | D | 0.142005 | N | 0.13162 | 0.010385 | No Change: Both O | - |
| Q6ZMU1 | C3P1_HUMAN Putative protein C3P1 OS=Homo sapiens GN=C3P1 PE=5 SV=3 | 251 | D | 0.598759 | G | 0.593747 | 0.005012 | No Change: Both D | - |
| Q6ZMU1 | C3P1_HUMAN Putative protein C3P1 OS=Homo sapiens GN=C3P1 PE=5 SV=3 | 262 | L | 0.241643 | R | 0.326526 | -0.084883 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 477 | R | 0.71025 | W | 0.495629 | 0.214621 | D to O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 726 | P | 0.90465 | L | 0.847801 | 0.056849 | No Change: Both D | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1073 | D | 0.296456 | G | 0.27654 | 0.019916 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1176 | N | 0.5223 | S | 0.595982 | -0.073682 | No Change: Both D | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1201 | S | 0.1902 | T | 0.152005 | 0.038195 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1207 | V | 0.239197 | A | 0.318658 | -0.079461 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1210 | L | 0.20313 | R | 0.280463 | -0.077333 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 1286 | S | 0.344824 | A | 0.258593 | 0.086231 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 347 | S | 0.473738 | Y | 0.328044 | 0.145694 | No Change: Both O | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 727 | D | 0.899829 | N | 0.877361 | 0.022468 | No Change: Both D | - |
| P0C0L4 | CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 | 907 | A | 0.289982 | T | 0.289058 | 9.24E-04 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 347 | S | 0.473738 | Y | 0.328044 | 0.145694 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 907 | A | 0.289982 | T | 0.289058 | 9.24E-04 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1073 | D | 0.296456 | G | 0.27654 | 0.019916 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1176 | N | 0.5223 | S | 0.595982 | -0.073682 | No Change: Both D | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1201 | S | 0.1902 | T | 0.152005 | 0.038195 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1207 | V | 0.239197 | A | 0.318658 | -0.079461 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1210 | L | 0.20313 | R | 0.280463 | -0.077333 | No Change: Both O | - |
| P0C0L5 | CO4B_HUMAN Complement C4-B OS=Homo sapiens GN=C4B PE=1 SV=1 | 1286 | S | 0.344824 | A | 0.258593 | 0.086231 | No Change: Both O | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 357 | Y | 0.355392 | H | 0.469741 | -0.114349 | No Change: Both O | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 473 | W | 0.398244 | L | 0.500663 | -0.102419 | O to D | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 300 | I | 0.365474 | T | 0.507022 | -0.141548 | O to D | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 60 | A | 0.301217 | V | 0.216317 | 0.0849 | No Change: Both O | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 4 | P | 0.827126 | Q | 0.814785 | 0.012341 | No Change: Both D | - |
| P04003 | C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 | 240 | R | 0.454896 | H | 0.46366 | -0.008764 | No Change: Both O | - |
| P20851 | C4BPB_HUMAN C4b-binding protein beta chain OS=Homo sapiens GN=C4BPB PE=1 SV=1 | 198 | P | 0.612793 | S | 0.614295 | -0.001502 | No Change: Both D | - |
| P20851 | C4BPB_HUMAN C4b-binding protein beta chain OS=Homo sapiens GN=C4BPB PE=1 SV=1 | 102 | K | 0.283601 | Q | 0.253001 | 0.0306 | No Change: Both O | - |
| Q53FE4 | CD017_HUMAN Uncharacterized protein C4orf17 OS=Homo sapiens GN=C4orf17 PE=2 SV=3 | 64 | G | 0.139804 | E | 0.166476 | -0.026672 | No Change: Both O | - |
| Q53FE4 | CD017_HUMAN Uncharacterized protein C4orf17 OS=Homo sapiens GN=C4orf17 PE=2 SV=3 | 85 | S | 0.601359 | P | 0.601449 | -9.00E-05 | No Change: Both D | - |
| Q53FE4 | CD017_HUMAN Uncharacterized protein C4orf17 OS=Homo sapiens GN=C4orf17 PE=2 SV=3 | 91 | E | 0.760458 | K | 0.761876 | -0.001418 | No Change: Both D | - |
| Q8IY42 | CD019_HUMAN Uncharacterized protein C4orf19 OS=Homo sapiens GN=C4orf19 PE=2 SV=1 | 151 | A | 0.468344 | T | 0.513709 | -0.045365 | O to D | - |
| Q8IY42 | CD019_HUMAN Uncharacterized protein C4orf19 OS=Homo sapiens GN=C4orf19 PE=2 SV=1 | 274 | E | 0.758629 | G | 0.745397 | 0.013232 | No Change: Both D | - |
| Q8IY42 | CD019_HUMAN Uncharacterized protein C4orf19 OS=Homo sapiens GN=C4orf19 PE=2 SV=1 | 39 | D | 0.756419 | E | 0.759358 | -0.002939 | No Change: Both D | - |
| Q86YA3 | CD021_HUMAN Uncharacterized protein C4orf21 OS=Homo sapiens GN=C4orf21 PE=1 SV=2 | 410 | N | 0.791599 | S | 0.828958 | -0.037359 | No Change: Both D | - |
| Q86YA3 | CD021_HUMAN Uncharacterized protein C4orf21 OS=Homo sapiens GN=C4orf21 PE=1 SV=2 | 451 | G | 0.633092 | E | 0.704641 | -0.071549 | No Change: Both D | - |
| Q86YA3 | CD021_HUMAN Uncharacterized protein C4orf21 OS=Homo sapiens GN=C4orf21 PE=1 SV=2 | 978 | T | 0.795745 | I | 0.680579 | 0.115166 | No Change: Both D | - |
| Q6V702 | CD022_HUMAN Uncharacterized protein C4orf22 OS=Homo sapiens GN=C4orf22 PE=2 SV=4 | 138 | T | 0.311698 | M | 0.262106 | 0.049592 | No Change: Both O | - |
| Q6V702 | CD022_HUMAN Uncharacterized protein C4orf22 OS=Homo sapiens GN=C4orf22 PE=2 SV=4 | 220 | V | 0.051753 | I | 0.050341 | 0.001412 | No Change: Both O | - |
| Q17RF5 | CD026_HUMAN Uncharacterized protein C4orf26 OS=Homo sapiens GN=C4orf26 PE=2 SV=1 | 30 | P | 0.610819 | L | 0.453337 | 0.157482 | D to O | - |
| Q17RF5 | CD026_HUMAN Uncharacterized protein C4orf26 OS=Homo sapiens GN=C4orf26 PE=2 SV=1 | 109 | R | 0.689118 | H | 0.609127 | 0.079991 | No Change: Both D | - |
| Q9NWY4 | CD027_HUMAN UPF0609 protein C4orf27 OS=Homo sapiens GN=C4orf27 PE=1 SV=2 | 174 | R | 0.407231 | K | 0.502532 | -0.095301 | O to D | - |
| Q9NWY4 | CD027_HUMAN UPF0609 protein C4orf27 OS=Homo sapiens GN=C4orf27 PE=1 SV=2 | 331 | E | 0.360125 | D | 0.30939 | 0.050735 | No Change: Both O | - |
| Q8WVX3 | CD003_HUMAN Uncharacterized protein C4orf3 OS=Homo sapiens GN=C4orf3 PE=2 SV=2 | 17 | R | 0.806857 | Q | 0.793097 | 0.01376 | No Change: Both D | - |
| Q8WVX3 | CD003_HUMAN Uncharacterized protein C4orf3 OS=Homo sapiens GN=C4orf3 PE=2 SV=2 | 32 | P | 0.575577 | H | 0.532195 | 0.043382 | No Change: Both D | - |
| Q8N8J7 | CD032_HUMAN Uncharacterized protein C4orf32 OS=Homo sapiens GN=C4orf32 PE=1 SV=2 | 46 | P | 0.960564 | Q | 0.958665 | 0.001899 | No Change: Both D | - |
| Q8N1A6 | CD033_HUMAN UPF0462 protein C4orf33 OS=Homo sapiens GN=C4orf33 PE=1 SV=2 | 40 | R | 0.446273 | M | 0.404865 | 0.041408 | No Change: Both O | - |
| Q8N1A6 | CD033_HUMAN UPF0462 protein C4orf33 OS=Homo sapiens GN=C4orf33 PE=1 SV=2 | 104 | S | 0.335433 | L | 0.180205 | 0.155228 | No Change: Both O | - |
| Q8N1A6 | CD033_HUMAN UPF0462 protein C4orf33 OS=Homo sapiens GN=C4orf33 PE=1 SV=2 | 107 | M | 0.427373 | V | 0.35855 | 0.068823 | No Change: Both O | - |
| Q8N1A6 | CD033_HUMAN UPF0462 protein C4orf33 OS=Homo sapiens GN=C4orf33 PE=1 SV=2 | 166 | H | 0.231813 | R | 0.238153 | -0.00634 | No Change: Both O | - |
| Q96KX1 | CD036_HUMAN Uncharacterized protein C4orf36 OS=Homo sapiens GN=C4orf36 PE=2 SV=2 | 36 | S | 0.164658 | Y | 0.077641 | 0.087017 | No Change: Both O | - |
| Q96KX1 | CD036_HUMAN Uncharacterized protein C4orf36 OS=Homo sapiens GN=C4orf36 PE=2 SV=2 | 18 | S | 0.123882 | N | 0.111558 | 0.012324 | No Change: Both O | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 111 | C | 0.215318 | W | 0.146577 | 0.068741 | No Change: Both O | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 112 | F | 0.216548 | V | 0.239343 | -0.022795 | No Change: Both O | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 125 | Y | 0.298885 | H | 0.390187 | -0.091302 | No Change: Both O | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 178 | I | 0.453675 | V | 0.478492 | -0.024817 | No Change: Both O | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 279 | K | 0.538943 | R | 0.502937 | 0.036006 | No Change: Both D | - |
| Q8N412 | CD037_HUMAN Uncharacterized protein C4orf37 OS=Homo sapiens GN=C4orf37 PE=2 SV=1 | 420 | V | 0.569017 | A | 0.653658 | -0.084641 | No Change: Both D | - |
| Q96MZ4 | CD039_HUMAN Uncharacterized protein C4orf39 OS=Homo sapiens GN=C4orf39 PE=2 SV=1 | 54 | H | 0.57269 | R | 0.60931 | -0.03662 | No Change: Both D | - |
| Q6MZM9 | CD040_HUMAN Uncharacterized protein C4orf40 OS=Homo sapiens GN=C4orf40 PE=1 SV=1 | 44 | I | 0.501412 | L | 0.551199 | -0.049787 | No Change: Both D | - |
| Q6MZM9 | CD040_HUMAN Uncharacterized protein C4orf40 OS=Homo sapiens GN=C4orf40 PE=1 SV=1 | 91 | R | 0.180549 | C | 0.107807 | 0.072742 | No Change: Both O | - |
| Q0VAR9 | CD042_HUMAN Uncharacterized protein C4orf42 OS=Homo sapiens GN=C4orf42 PE=2 SV=2 | 19 | S | 0.656541 | G | 0.610695 | 0.045846 | No Change: Both D | - |
| Q0VAR9 | CD042_HUMAN Uncharacterized protein C4orf42 OS=Homo sapiens GN=C4orf42 PE=2 SV=2 | 173 | Y | 0.917906 | C | 0.953894 | -0.035988 | No Change: Both D | - |
| Q96EY4 | CD043_HUMAN UPF0534 protein C4orf43 OS=Homo sapiens GN=C4orf43 PE=1 SV=2 | 65 | Q | 0.586275 | P | 0.589709 | -0.003434 | No Change: Both D | - |
| Q96EY4 | CD043_HUMAN UPF0534 protein C4orf43 OS=Homo sapiens GN=C4orf43 PE=1 SV=2 | 176 | I | 0.433444 | T | 0.575343 | -0.141899 | O to D | - |
| Q96EY4 | CD043_HUMAN UPF0534 protein C4orf43 OS=Homo sapiens GN=C4orf43 PE=1 SV=2 | 12 | R | 0.962077 | Q | 0.96084 | 0.001237 | No Change: Both D | - |
| Q96LM5 | CD045_HUMAN Uncharacterized protein C4orf45 OS=Homo sapiens GN=C4orf45 PE=2 SV=3 | 46 | A | 0.374568 | V | 0.310384 | 0.064184 | No Change: Both O | - |
| Q96LM5 | CD045_HUMAN Uncharacterized protein C4orf45 OS=Homo sapiens GN=C4orf45 PE=2 SV=3 | 75 | S | 0.216433 | G | 0.187917 | 0.028516 | No Change: Both O | - |
| Q96LM5 | CD045_HUMAN Uncharacterized protein C4orf45 OS=Homo sapiens GN=C4orf45 PE=2 SV=3 | 84 | Y | 0.122453 | C | 0.103699 | 0.018754 | No Change: Both O | - |
| Q96LM5 | CD045_HUMAN Uncharacterized protein C4orf45 OS=Homo sapiens GN=C4orf45 PE=2 SV=3 | 93 | G | 0.323783 | E | 0.360573 | -0.03679 | No Change: Both O | - |
| Q96LM5 | CD045_HUMAN Uncharacterized protein C4orf45 OS=Homo sapiens GN=C4orf45 PE=2 SV=3 | 134 | R | 0.484146 | H | 0.483166 | 9.80E-04 | No Change: Both O | - |
| Q8TDB4 | CD049_HUMAN Uncharacterized protein C4orf49 OS=Homo sapiens GN=C4orf49 PE=1 SV=1 | 128 | A | 0.875354 | T | 0.87755 | -0.002196 | No Change: Both D | - |
| Q6ZRC1 | CD050_HUMAN Uncharacterized protein C4orf50 OS=Homo sapiens GN=C4orf50 PE=2 SV=1 | 86 | R | 0.442391 | W | 0.211346 | 0.231045 | No Change: Both O | - |
| Q6ZRC1 | CD050_HUMAN Uncharacterized protein C4orf50 OS=Homo sapiens GN=C4orf50 PE=2 SV=1 | 150 | A | 0.398646 | P | 0.484229 | -0.085583 | No Change: Both O | A breast cancer sample |
| Q6ZRC1 | CD050_HUMAN Uncharacterized protein C4orf50 OS=Homo sapiens GN=C4orf50 PE=2 SV=1 | 177 | I | 0.801406 | V | 0.837759 | -0.036353 | No Change: Both D | - |
| Q6ZRC1 | CD050_HUMAN Uncharacterized protein C4orf50 OS=Homo sapiens GN=C4orf50 PE=2 SV=1 | 199 | V | 0.625814 | M | 0.6868 | -0.060986 | No Change: Both D | - |
| Q8N5G0 | CD052_HUMAN Uncharacterized protein C4orf52 OS=Homo sapiens GN=C4orf52 PE=1 SV=2 | 41 | A | 0.995631 | T | 0.996227 | -5.96E-04 | No Change: Both D | - |
| Q8N5G0 | CD052_HUMAN Uncharacterized protein C4orf52 OS=Homo sapiens GN=C4orf52 PE=1 SV=2 | 65 | S | 0.995979 | N | 0.994198 | 0.001781 | No Change: Both D | - |
| Q8N5G0 | CD052_HUMAN Uncharacterized protein C4orf52 OS=Homo sapiens GN=C4orf52 PE=1 SV=2 | 76 | H | 0.9842 | N | 0.987783 | -0.003583 | No Change: Both D | - |
| Q8N5G0 | CD052_HUMAN Uncharacterized protein C4orf52 OS=Homo sapiens GN=C4orf52 PE=1 SV=2 | 109 | A | 0.156813 | T | 0.166902 | -0.010089 | No Change: Both O | - |
| Q99440 | CD006_HUMAN Uncharacterized protein C4orf6 OS=Homo sapiens GN=C4orf6 PE=2 SV=1 | 15 | N | 0.416519 | K | 0.466774 | -0.050255 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 518 | F | 0.553968 | S | 0.72653 | -0.172562 | No Change: Both D | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 802 | V | 0.178472 | I | 0.1717 | 0.006772 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1053 | M | 0.443674 | L | 0.382339 | 0.061335 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1310 | S | 0.235539 | N | 0.19079 | 0.044749 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1437 | E | 0.477185 | D | 0.457366 | 0.019819 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 389 | T | 0.312766 | I | 0.201935 | 0.110831 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 145 | V | 0.302019 | I | 0.256276 | 0.045743 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 449 | R | 0.566372 | G | 0.580387 | -0.014015 | No Change: Both D | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 928 | R | 0.17315 | Q | 0.178133 | -0.004983 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 933 | G | 0.532131 | V | 0.412462 | 0.119669 | D to O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1033 | I | 0.168934 | T | 0.281545 | -0.112611 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1037 | D | 0.266594 | N | 0.268759 | -0.002165 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1043 | Q | 0.708636 | K | 0.757013 | -0.048377 | No Change: Both D | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 354 | L | 0.152841 | M | 0.179297 | -0.026456 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 966 | D | 0.220534 | Y | 0.131618 | 0.088916 | No Change: Both O | - |
| P01031 | CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 | 1365 | V | 0.521798 | A | 0.582071 | -0.060273 | No Change: Both D | - |
| P21730 | C5AR_HUMAN C5a anaphylatoxin chemotactic receptor OS=Homo sapiens GN=C5AR1 PE=1 SV=2 | 2 | D | 0.759131 | N | 0.730209 | 0.028922 | No Change: Both D | - |
| P21730 | C5AR_HUMAN C5a anaphylatoxin chemotactic receptor OS=Homo sapiens GN=C5AR1 PE=1 SV=2 | 279 | K | 0.234318 | N | 0.188093 | 0.046225 | No Change: Both O | - |
| Q16612 | NP311_HUMAN Neuronal protein 3.1 OS=Homo sapiens GN=C5orf13 PE=1 SV=1 | 43 | E | 0.802615 | G | 0.768423 | 0.034192 | No Change: Both D | - |
| Q49AR2 | CE022_HUMAN UPF0489 protein C5orf22 OS=Homo sapiens GN=C5orf22 PE=1 SV=2 | 235 | T | 0.526557 | P | 0.566048 | -0.039491 | No Change: Both D | - |
| Q49AR2 | CE022_HUMAN UPF0489 protein C5orf22 OS=Homo sapiens GN=C5orf22 PE=1 SV=2 | 405 | D | 0.460846 | E | 0.462998 | -0.002152 | No Change: Both O | - |
| Q8NDZ2 | CE025_HUMAN Uncharacterized protein C5orf25 OS=Homo sapiens GN=C5orf25 PE=1 SV=2 | 221 | S | 0.998367 | F | 0.996153 | 0.002214 | No Change: Both D | - |
| Q8NDZ2 | CE025_HUMAN Uncharacterized protein C5orf25 OS=Homo sapiens GN=C5orf25 PE=1 SV=2 | 463 | K | 0.680317 | R | 0.66213 | 0.018187 | No Change: Both D | - |
| Q8NDZ2 | CE025_HUMAN Uncharacterized protein C5orf25 OS=Homo sapiens GN=C5orf25 PE=1 SV=2 | 772 | H | 0.179853 | R | 0.193877 | -0.014024 | No Change: Both O | - |
| Q8NDZ2 | CE025_HUMAN Uncharacterized protein C5orf25 OS=Homo sapiens GN=C5orf25 PE=1 SV=2 | 636 | S | 0.762952 | F | 0.597077 | 0.165875 | No Change: Both D | - |
| Q52M75 | CE027_HUMAN Putative uncharacterized protein C5orf27 OS=Homo sapiens GN=C5orf27 PE=2 SV=2 | 85 | R | 0.941992 | C | 0.905564 | 0.036428 | No Change: Both D | - |
| Q9H1C7 | CE032_HUMAN UPF0467 protein C5orf32 OS=Homo sapiens GN=C5orf32 PE=2 SV=1 | 90 | C | 0.038713 | S | 0.060182 | -0.021469 | No Change: Both O | - |
| Q96MH7 | CE034_HUMAN Uncharacterized protein C5orf34 OS=Homo sapiens GN=C5orf34 PE=2 SV=2 | 266 | S | 0.522176 | R | 0.435139 | 0.087037 | D to O | A breast cancer sample |
| Q96MH7 | CE034_HUMAN Uncharacterized protein C5orf34 OS=Homo sapiens GN=C5orf34 PE=2 SV=2 | 32 | T | 0.360282 | S | 0.460155 | -0.099873 | No Change: Both O | - |
| Q8NE22 | CE035_HUMAN Uncharacterized protein C5orf35 OS=Homo sapiens GN=C5orf35 PE=2 SV=2 | 76 | S | 0.453421 | T | 0.345192 | 0.108229 | No Change: Both O | - |
| Q8NE22 | CE035_HUMAN Uncharacterized protein C5orf35 OS=Homo sapiens GN=C5orf35 PE=2 SV=2 | 209 | K | 0.488874 | E | 0.492521 | -0.003647 | No Change: Both O | - |
| Q96IV6 | CE004_HUMAN Uncharacterized protein C5orf4 OS=Homo sapiens GN=C5orf4 PE=1 SV=1 | 133 | R | 0.130578 | H | 0.119527 | 0.011051 | No Change: Both O | - |
| Q8IUR6 | CE041_HUMAN UPF0474 protein C5orf41 OS=Homo sapiens GN=C5orf41 PE=1 SV=2 | 483 | T | 0.613792 | A | 0.575564 | 0.038228 | No Change: Both D | - |
| Q9H799 | CE042_HUMAN Uncharacterized protein C5orf42 OS=Homo sapiens GN=C5orf42 PE=2 SV=3 | 318 | I | 0.524972 | T | 0.614061 | -0.089089 | No Change: Both D | - |
| Q9H799 | CE042_HUMAN Uncharacterized protein C5orf42 OS=Homo sapiens GN=C5orf42 PE=2 SV=3 | 913 | F | 0.795204 | C | 0.829431 | -0.034227 | No Change: Both D | - |
| Q9H799 | CE042_HUMAN Uncharacterized protein C5orf42 OS=Homo sapiens GN=C5orf42 PE=2 SV=3 | 1023 | I | 0.908317 | V | 0.914573 | -0.006256 | No Change: Both D | - |
| Q9H799 | CE042_HUMAN Uncharacterized protein C5orf42 OS=Homo sapiens GN=C5orf42 PE=2 SV=3 | 1472 | P | 0.684546 | L | 0.603212 | 0.081334 | No Change: Both D | - |
| Q9H799 | CE042_HUMAN Uncharacterized protein C5orf42 OS=Homo sapiens GN=C5orf42 PE=2 SV=3 | 1960 | G | 0.776507 | R | 0.783099 | -0.006592 | No Change: Both D | - |
| Q7Z3B0 | CE043_HUMAN UPF0542 protein C5orf43 OS=Homo sapiens GN=C5orf43 PE=2 SV=1 | 23 | L | 0.061849 | F | 0.053436 | 0.008413 | No Change: Both O | - |
| Q6NTE8 | CE045_HUMAN UPF0544 protein C5orf45 OS=Homo sapiens GN=C5orf45 PE=2 SV=2 | 97 | Q | 0.919038 | R | 0.906114 | 0.012924 | No Change: Both D | - |
| Q6NTE8 | CE045_HUMAN UPF0544 protein C5orf45 OS=Homo sapiens GN=C5orf45 PE=2 SV=2 | 154 | R | 0.939382 | G | 0.932795 | 0.006587 | No Change: Both D | - |
| Q6NTE8 | CE045_HUMAN UPF0544 protein C5orf45 OS=Homo sapiens GN=C5orf45 PE=2 SV=2 | 231 | Q | 0.725227 | R | 0.718035 | 0.007192 | No Change: Both D | - |
| Q6NTE8 | CE045_HUMAN UPF0544 protein C5orf45 OS=Homo sapiens GN=C5orf45 PE=2 SV=2 | 42 | Q | 0.457269 | R | 0.427297 | 0.029972 | No Change: Both O | - |
| Q6UWT4 | CE046_HUMAN Uncharacterized protein C5orf46 OS=Homo sapiens GN=C5orf46 PE=1 SV=2 | 18 | F | 0.314831 | I | 0.278311 | 0.03652 | No Change: Both O | - |
| A4QMS7 | CE049_HUMAN Uncharacterized protein C5orf49 OS=Homo sapiens GN=C5orf49 PE=2 SV=1 | 68 | Q | 0.557082 | H | 0.564533 | -0.007451 | No Change: Both D | - |
| A4QMS7 | CE049_HUMAN Uncharacterized protein C5orf49 OS=Homo sapiens GN=C5orf49 PE=2 SV=1 | 87 | E | 0.64219 | K | 0.625363 | 0.016827 | No Change: Both D | - |
| A4QMS7 | CE049_HUMAN Uncharacterized protein C5orf49 OS=Homo sapiens GN=C5orf49 PE=2 SV=1 | 139 | P | 0.488967 | S | 0.50733 | -0.018363 | O to D | - |
| A6NLE4 | CE050_HUMAN Uncharacterized protein C5orf50 OS=Homo sapiens GN=C5orf50 PE=2 SV=2 | 36 | T | 0.250072 | M | 0.223312 | 0.02676 | No Change: Both O | - |
| A6NDU8 | CE051_HUMAN UPF0600 protein C5orf51 OS=Homo sapiens GN=C5orf51 PE=1 SV=1 | 20 | Q | 0.395829 | H | 0.35289 | 0.042939 | No Change: Both O | - |
| Q8IZ13 | CE054_HUMAN Transposon-derived Buster3 transposase-like protein OS=Homo sapiens GN=C5orf54 PE=2 SV=1 | 523 | A | 0.08899 | S | 0.124823 | -0.035833 | No Change: Both O | - |
| Q8N2X6 | CE055_HUMAN Uncharacterized protein C5orf55 OS=Homo sapiens GN=C5orf55 PE=2 SV=1 | 50 | P | 0.727983 | S | 0.747985 | -0.020002 | No Change: Both D | - |
| Q8N2X6 | CE055_HUMAN Uncharacterized protein C5orf55 OS=Homo sapiens GN=C5orf55 PE=2 SV=1 | 118 | R | 0.89883 | G | 0.887137 | 0.011693 | No Change: Both D | - |
| A6NFR6 | CE060_HUMAN Putative uncharacterized protein C5orf60 OS=Homo sapiens GN=C5orf60 PE=2 SV=2 | 55 | R | 0.0563 | C | 0.027293 | 0.029007 | No Change: Both O | - |
| A6NFR6 | CE060_HUMAN Putative uncharacterized protein C5orf60 OS=Homo sapiens GN=C5orf60 PE=2 SV=2 | 56 | L | 0.082184 | P | 0.164408 | -0.082224 | No Change: Both O | - |
| Q2M2E5 | CE064_HUMAN Uncharacterized protein C5orf64 OS=Homo sapiens GN=C5orf64 PE=2 SV=2 | 57 | A | 0.343726 | T | 0.391172 | -0.047446 | No Change: Both O | - |
| Q2M2E5 | CE064_HUMAN Uncharacterized protein C5orf64 OS=Homo sapiens GN=C5orf64 PE=2 SV=2 | 101 | R | 0.490774 | W | 0.273863 | 0.216911 | No Change: Both O | - |
| P13671 | CO6_HUMAN Complement component C6 OS=Homo sapiens GN=C6 PE=1 SV=3 | 119 | A | 0.559154 | E | 0.642333 | -0.083179 | No Change: Both D | - |
| P13671 | CO6_HUMAN Complement component C6 OS=Homo sapiens GN=C6 PE=1 SV=3 | 397 | K | 0.551642 | E | 0.566867 | -0.015225 | No Change: Both D | - |
| P13671 | CO6_HUMAN Complement component C6 OS=Homo sapiens GN=C6 PE=1 SV=3 | 470 | S | 0.485228 | F | 0.26804 | 0.217188 | No Change: Both O | - |
| Q86T20 | CF001_HUMAN Uncharacterized protein C6orf1 OS=Homo sapiens GN=C6orf1 PE=2 SV=2 | 141 | M | 0.459819 | I | 0.336004 | 0.123815 | No Change: Both O | - |
| Q86T20 | CF001_HUMAN Uncharacterized protein C6orf1 OS=Homo sapiens GN=C6orf1 PE=2 SV=2 | 150 | G | 0.473058 | A | 0.421211 | 0.051847 | No Change: Both O | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 30 | C | 0.205796 | R | 0.363414 | -0.157618 | No Change: Both O | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 36 | Y | 0.495109 | H | 0.596017 | -0.100908 | O to D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 69 | Y | 0.914135 | C | 0.918676 | -0.004541 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 128 | P | 0.73206 | L | 0.611785 | 0.120275 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 150 | I | 0.808611 | F | 0.798813 | 0.009798 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 170 | S | 0.905699 | P | 0.921443 | -0.015744 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 227 | S | 0.486495 | P | 0.450096 | 0.036399 | No Change: Both O | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 315 | I | 0.917787 | V | 0.920336 | -0.002549 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 400 | K | 0.989087 | Q | 0.988955 | 1.32E-04 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 161 | P | 0.837008 | L | 0.699269 | 0.137739 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 266 | L | 0.775616 | W | 0.690007 | 0.085609 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 274 | P | 0.844449 | S | 0.87011 | -0.025661 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 433 | A | 0.987236 | T | 0.989109 | -0.001873 | No Change: Both D | - |
| Q5SRN2 | CF010_HUMAN Uncharacterized protein C6orf10 OS=Homo sapiens GN=C6orf10 PE=1 SV=3 | 479 | G | 0.983642 | V | 0.978674 | 0.004968 | No Change: Both D | - |
| Q5JQF7 | CF100_HUMAN Putative uncharacterized protein C6orf100 OS=Homo sapiens GN=C6orf100 PE=4 SV=2 | 41 | G | 0.486934 | E | 0.542903 | -0.055969 | O to D | - |
| Q8N7X0 | CAN7L_HUMAN Calpain-7-like protein OS=Homo sapiens GN=C6orf103 PE=2 SV=3 | 310 | I | 0.857011 | T | 0.877702 | -0.020691 | No Change: Both D | - |
| Q8N7X0 | CAN7L_HUMAN Calpain-7-like protein OS=Homo sapiens GN=C6orf103 PE=2 SV=3 | 1637 | T | 0.830909 | A | 0.839915 | -0.009006 | No Change: Both D | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 256 | I | 0.304573 | M | 0.400481 | -0.095908 | No Change: Both O | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 363 | V | 0.864411 | L | 0.891586 | -0.027175 | No Change: Both D | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 166 | R | 0.948297 | L | 0.916504 | 0.031793 | No Change: Both D | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 271 | G | 0.114371 | E | 0.153901 | -0.03953 | No Change: Both O | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 301 | T | 0.250696 | M | 0.235712 | 0.014984 | No Change: Both O | - |
| Q5T5N4 | CF118_HUMAN Uncharacterized protein C6orf118 OS=Homo sapiens GN=C6orf118 PE=2 SV=1 | 385 | R | 0.802011 | Q | 0.801766 | 2.45E-04 | No Change: Both D | - |
| A2RUU4 | CF127_HUMAN Colipase-like protein C6orf127 OS=Homo sapiens GN=C6orf127 PE=2 SV=1 | 15 | F | 0.012773 | S | 0.032711 | -0.019938 | No Change: Both O | - |
| Q5T0Z8 | CF132_HUMAN Uncharacterized protein C6orf132 OS=Homo sapiens GN=C6orf132 PE=1 SV=4 | 4 | K | 0.885866 | N | 0.850332 | 0.035534 | No Change: Both D | - |
| Q5SZD1 | CF141_HUMAN Uncharacterized protein C6orf141 OS=Homo sapiens GN=C6orf141 PE=2 SV=3 | 137 | Q | 0.768036 | E | 0.788928 | -0.020892 | No Change: Both D | - |
| Q5SZD1 | CF141_HUMAN Uncharacterized protein C6orf141 OS=Homo sapiens GN=C6orf141 PE=2 SV=3 | 235 | P | 0.633183 | L | 0.459053 | 0.17413 | D to O | - |
| Q8IXS0 | CF146_HUMAN Uncharacterized protein C6orf146 OS=Homo sapiens GN=C6orf146 PE=2 SV=2 | 431 | V | 0.687478 | I | 0.681196 | 0.006282 | No Change: Both D | - |
| Q8IXS0 | CF146_HUMAN Uncharacterized protein C6orf146 OS=Homo sapiens GN=C6orf146 PE=2 SV=2 | 258 | A | 0.502702 | T | 0.543838 | -0.041136 | No Change: Both D | - |
| Q8IXS0 | CF146_HUMAN Uncharacterized protein C6orf146 OS=Homo sapiens GN=C6orf146 PE=2 SV=2 | 309 | Q | 0.780654 | P | 0.804395 | -0.023741 | No Change: Both D | - |
| Q8IXS0 | CF146_HUMAN Uncharacterized protein C6orf146 OS=Homo sapiens GN=C6orf146 PE=2 SV=2 | 360 | C | 0.907386 | S | 0.94431 | -0.036924 | No Change: Both D | - |
| Q8IXS0 | CF146_HUMAN Uncharacterized protein C6orf146 OS=Homo sapiens GN=C6orf146 PE=2 SV=2 | 442 | M | 0.712545 | V | 0.636011 | 0.076534 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 40 | L | 0.611923 | F | 0.569796 | 0.042127 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 43 | N | 0.681042 | D | 0.669755 | 0.011287 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 83 | A | 0.859674 | P | 0.907297 | -0.047623 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 165 | K | 0.964737 | E | 0.968027 | -0.00329 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 81 | V | 0.863825 | A | 0.897694 | -0.033869 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 145 | A | 0.95598 | P | 0.969157 | -0.013177 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 291 | G | 0.654316 | D | 0.603862 | 0.050454 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 48 | G | 0.832251 | R | 0.832878 | -6.27E-04 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 232 | M | 0.733272 | I | 0.680007 | 0.053265 | No Change: Both D | - |
| Q6UXA7 | CF015_HUMAN Uncharacterized protein C6orf15 OS=Homo sapiens GN=C6orf15 PE=2 SV=3 | 5 | V | 0.648675 | M | 0.702392 | -0.053717 | No Change: Both D | - |
| Q8IYR0 | CF165_HUMAN UPF0704 protein C6orf165 OS=Homo sapiens GN=C6orf165 PE=2 SV=2 | 154 | R | 0.321282 | K | 0.378275 | -0.056993 | No Change: Both O | - |
| Q8IYR0 | CF165_HUMAN UPF0704 protein C6orf165 OS=Homo sapiens GN=C6orf165 PE=2 SV=2 | 170 | G | 0.29584 | A | 0.271806 | 0.024034 | No Change: Both O | - |
| Q5JXM2 | CF186_HUMAN UPF0624 protein C6orf186 OS=Homo sapiens GN=C6orf186 PE=2 SV=1 | 281 | L | 0.105034 | F | 0.083452 | 0.021582 | No Change: Both O | - |
| Q5VVB8 | CF191_HUMAN Putative transmembrane protein C6orf191 OS=Homo sapiens GN=C6orf191 PE=2 SV=1 | 80 | F | 0.01453 | L | 0.016248 | -0.001718 | No Change: Both O | - |
| Q5VVB8 | CF191_HUMAN Putative transmembrane protein C6orf191 OS=Homo sapiens GN=C6orf191 PE=2 SV=1 | 86 | E | 0.032816 | G | 0.024189 | 0.008627 | No Change: Both O | - |
| Q5VVB8 | CF191_HUMAN Putative transmembrane protein C6orf191 OS=Homo sapiens GN=C6orf191 PE=2 SV=1 | 111 | F | 0.160289 | V | 0.193103 | -0.032814 | No Change: Both O | - |
| Q5VVB8 | CF191_HUMAN Putative transmembrane protein C6orf191 OS=Homo sapiens GN=C6orf191 PE=2 SV=1 | 60 | N | 0.108692 | I | 0.046705 | 0.061987 | No Change: Both O | - |
| Q6NT16 | CF192_HUMAN MFS-type transporter C6orf192 OS=Homo sapiens GN=C6orf192 PE=2 SV=1 | 204 | V | 0.013326 | I | 0.010868 | 0.002458 | No Change: Both O | - |
| Q6NT16 | CF192_HUMAN MFS-type transporter C6orf192 OS=Homo sapiens GN=C6orf192 PE=2 SV=1 | 11 | R | 0.809976 | L | 0.735996 | 0.07398 | No Change: Both D | - |
| Q6NT16 | CF192_HUMAN MFS-type transporter C6orf192 OS=Homo sapiens GN=C6orf192 PE=2 SV=1 | 30 | S | 0.288538 | P | 0.289391 | -8.53E-04 | No Change: Both O | - |
| Q96MT4 | CF195_HUMAN Uncharacterized protein C6orf195 OS=Homo sapiens GN=C6orf195 PE=1 SV=2 | 2 | I | 0.455548 | F | 0.472215 | -0.016667 | No Change: Both O | - |
| Q96MT4 | CF195_HUMAN Uncharacterized protein C6orf195 OS=Homo sapiens GN=C6orf195 PE=1 SV=2 | 43 | P | 0.705753 | S | 0.694062 | 0.011691 | No Change: Both D | - |
| Q7Z4U5 | CF201_HUMAN Uncharacterized protein C6orf201 OS=Homo sapiens GN=C6orf201 PE=2 SV=3 | 20 | R | 0.885008 | P | 0.906341 | -0.021333 | No Change: Both D | - |
| Q7Z4U5 | CF201_HUMAN Uncharacterized protein C6orf201 OS=Homo sapiens GN=C6orf201 PE=2 SV=3 | 25 | D | 0.907821 | Y | 0.873703 | 0.034118 | No Change: Both D | - |
| Q7Z4U5 | CF201_HUMAN Uncharacterized protein C6orf201 OS=Homo sapiens GN=C6orf201 PE=2 SV=3 | 117 | N | 0.858061 | K | 0.887453 | -0.029392 | No Change: Both D | - |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 137 | S | 0.903114 | G | 0.871159 | 0.031955 | No Change: Both D | - |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 166 | D | 0.709538 | V | 0.582634 | 0.126904 | No Change: Both D | - |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 251 | P | 0.863512 | T | 0.836926 | 0.026586 | No Change: Both D | - |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 345 | S | 0.770776 | F | 0.610394 | 0.160382 | No Change: Both D | A breast cancer sample |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 532 | Q | 0.827911 | H | 0.74765 | 0.080261 | No Change: Both D | - |
| Q5SZL2 | CF204_HUMAN Coiled-coil domain-containing protein C6orf204 OS=Homo sapiens GN=C6orf204 PE=1 SV=1 | 640 | M | 0.939972 | V | 0.896446 | 0.043526 | No Change: Both D | - |
| Q9H8X3 | CF208_HUMAN Putative uncharacterized protein C6orf208 OS=Homo sapiens GN=C6orf208 PE=5 SV=1 | 91 | W | 0.556386 | R | 0.736959 | -0.180573 | No Change: Both D | - |
| Q9H8X3 | CF208_HUMAN Putative uncharacterized protein C6orf208 OS=Homo sapiens GN=C6orf208 PE=5 SV=1 | 119 | K | 0.446621 | R | 0.39682 | 0.049801 | No Change: Both O | - |
| Q9H8X3 | CF208_HUMAN Putative uncharacterized protein C6orf208 OS=Homo sapiens GN=C6orf208 PE=5 SV=1 | 27 | S | 0.624648 | C | 0.489798 | 0.13485 | D to O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 77 | P | 0.196542 | R | 0.16678 | 0.029762 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 73 | K | 0.326599 | N | 0.289341 | 0.037258 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 150 | G | 0.414223 | E | 0.477487 | -0.063264 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 154 | S | 0.21215 | A | 0.139679 | 0.072471 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 161 | H | 0.086383 | P | 0.117707 | -0.031324 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 264 | I | 0.063939 | V | 0.078888 | -0.014949 | No Change: Both O | - |
| Q9H993 | CF211_HUMAN UPF0364 protein C6orf211 OS=Homo sapiens GN=C6orf211 PE=1 SV=1 | 317 | A | 0.219003 | T | 0.244278 | -0.025275 | No Change: Both O | - |
| P0C671 | CF222_HUMAN Uncharacterized protein C6orf222 OS=Homo sapiens GN=C6orf222 PE=2 SV=1 | 582 | L | 0.556886 | V | 0.545153 | 0.011733 | No Change: Both D | - |
| Q8N319 | CF223_HUMAN Uncharacterized protein C6orf223 OS=Homo sapiens GN=C6orf223 PE=2 SV=2 | 48 | K | 0.851572 | E | 0.830629 | 0.020943 | No Change: Both D | - |
| Q8N319 | CF223_HUMAN Uncharacterized protein C6orf223 OS=Homo sapiens GN=C6orf223 PE=2 SV=2 | 107 | V | 0.849104 | M | 0.891514 | -0.04241 | No Change: Both D | - |
| Q5SSQ6 | G7D_HUMAN Protein G7d OS=Homo sapiens GN=C6orf26 PE=2 SV=2 | 30 | P | 0.485871 | S | 0.511563 | -0.025692 | O to D | - |
| Q5SSQ6 | G7D_HUMAN Protein G7d OS=Homo sapiens GN=C6orf26 PE=2 SV=2 | 99 | P | 0.510986 | L | 0.386497 | 0.124489 | D to O | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 139 | R | 0.499664 | H | 0.432857 | 0.066807 | No Change: Both O | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 488 | R | 0.184131 | Q | 0.21003 | -0.025899 | No Change: Both O | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 680 | R | 0.772464 | Q | 0.786595 | -0.014131 | No Change: Both D | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 704 | G | 0.709312 | V | 0.627574 | 0.081738 | No Change: Both D | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 711 | R | 0.667163 | C | 0.523102 | 0.144061 | No Change: Both D | - |
| Q9Y334 | G7C_HUMAN Protein G7c OS=Homo sapiens GN=C6orf27 PE=2 SV=4 | 861 | T | 0.362547 | A | 0.336872 | 0.025675 | No Change: Both O | - |
| O95873 | CF047_HUMAN Uncharacterized protein C6orf47 OS=Homo sapiens GN=C6orf47 PE=1 SV=2 | 68 | G | 0.945705 | R | 0.95041 | -0.004705 | No Change: Both D | - |
| O95873 | CF047_HUMAN Uncharacterized protein C6orf47 OS=Homo sapiens GN=C6orf47 PE=1 SV=2 | 92 | K | 0.886772 | N | 0.844701 | 0.042071 | No Change: Both D | - |
| Q5T4I8 | CF052_HUMAN Putative uncharacterized protein C6orf52 OS=Homo sapiens GN=C6orf52 PE=2 SV=2 | 13 | A | 0.290224 | D | 0.351464 | -0.06124 | No Change: Both O | - |
| Q5VUM1 | CF057_HUMAN UPF0369 protein C6orf57 OS=Homo sapiens GN=C6orf57 PE=2 SV=1 | 46 | Q | 0.952985 | R | 0.955866 | -0.002881 | No Change: Both D | - |
| Q5VUM1 | CF057_HUMAN UPF0369 protein C6orf57 OS=Homo sapiens GN=C6orf57 PE=2 SV=1 | 57 | R | 0.969561 | C | 0.958948 | 0.010613 | No Change: Both D | - |
| Q6P5S2 | CF058_HUMAN UPF0762 protein C6orf58 OS=Homo sapiens GN=C6orf58 PE=1 SV=2 | 308 | C | 0.262322 | G | 0.440737 | -0.178415 | No Change: Both O | - |
| Q9GZU0 | CF062_HUMAN Uncharacterized protein C6orf62 OS=Homo sapiens GN=C6orf62 PE=2 SV=1 | 116 | W | 0.08314 | C | 0.113538 | -0.030398 | No Change: Both O | - |
| Q9GZU0 | CF062_HUMAN Uncharacterized protein C6orf62 OS=Homo sapiens GN=C6orf62 PE=2 SV=1 | 140 | R | 0.449788 | S | 0.533277 | -0.083489 | O to D | - |
| Q5T6L9 | CF070_HUMAN Transmembrane protein C6orf70 OS=Homo sapiens GN=C6orf70 PE=2 SV=1 | 540 | S | 0.549469 | G | 0.422424 | 0.127045 | D to O | - |
| Q5TFG8 | F164B_HUMAN Protein FAM164B OS=Homo sapiens GN=C6orf94 PE=2 SV=2 | 6 | P | 0.569035 | S | 0.593276 | -0.024241 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 269 | A | 0.70754 | V | 0.650638 | 0.056902 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 324 | F | 0.677633 | S | 0.816812 | -0.139179 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 331 | A | 0.683326 | T | 0.72087 | -0.037544 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 604 | V | 0.975488 | I | 0.975064 | 4.24E-04 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 683 | V | 0.282662 | I | 0.259322 | 0.02334 | No Change: Both O | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 479 | N | 0.497997 | K | 0.539493 | -0.041496 | O to D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 553 | R | 0.661653 | Q | 0.674397 | -0.012744 | No Change: Both D | - |
| Q8IYT3 | CF097_HUMAN Coiled-coil domain-containing protein C6orf97 OS=Homo sapiens GN=C6orf97 PE=2 SV=3 | 345 | E | 0.778974 | K | 0.767863 | 0.011111 | No Change: Both D | - |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 220 | R | 0.922881 | Q | 0.918245 | 0.004636 | No Change: Both D | Complement component 7 deficiency (C7D) [MIM:610102] |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 379 | G | 0.305523 | R | 0.296738 | 0.008785 | No Change: Both O | Complement component 7 deficiency (C7D) [MIM:610102] |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 521 | R | 0.905072 | S | 0.921372 | -0.0163 | No Change: Both D | Complement component 7 deficiency (C7D) [MIM:610102] |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 682 | E | 0.706931 | Q | 0.694092 | 0.012839 | No Change: Both D | Complement component 7 deficiency (C7D) [MIM:610102] |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 687 | R | 0.723646 | H | 0.665854 | 0.057792 | No Change: Both D | Complement component 7 deficiency (C7D) [MIM:610102] |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 420 | K | 0.271929 | Q | 0.237371 | 0.034558 | No Change: Both O | - |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 389 | S | 0.210835 | T | 0.146962 | 0.063873 | No Change: Both O | - |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 587 | T | 0.315472 | P | 0.381713 | -0.066241 | No Change: Both O | - |
| P10643 | CO7_HUMAN Complement component C7 OS=Homo sapiens GN=C7 PE=1 SV=2 | 128 | C | 0.901576 | R | 0.932576 | -0.031 | No Change: Both D | - |
| Q9HAC7 | CG010_HUMAN CaiB/baiF CoA-transferase family protein C7orf10 OS=Homo sapiens GN=C7orf10 PE=1 SV=2 | 336 | R | 0.418504 | W | 0.230269 | 0.188235 | No Change: Both O | Glutaric aciduria type 3 (GA3) [MIM:231690] |
| Q9BPX7 | CG025_HUMAN UPF0415 protein C7orf25 OS=Homo sapiens GN=C7orf25 PE=1 SV=1 | 265 | G | 0.099653 | E | 0.123575 | -0.023922 | No Change: Both O | - |
| Q96N11 | CG026_HUMAN Uncharacterized protein C7orf26 OS=Homo sapiens GN=C7orf26 PE=2 SV=1 | 245 | R | 0.041887 | C | 0.024677 | 0.01721 | No Change: Both O | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 82 | Y | 0.696024 | C | 0.686645 | 0.009379 | No Change: Both D | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 158 | A | 0.301595 | T | 0.380655 | -0.07906 | No Change: Both O | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 187 | T | 0.541786 | S | 0.577423 | -0.035637 | No Change: Both D | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 300 | H | 0.485789 | R | 0.508161 | -0.022372 | O to D | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 13 | E | 0.203096 | K | 0.186763 | 0.016333 | No Change: Both O | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 86 | R | 0.67709 | C | 0.517589 | 0.159501 | No Change: Both D | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 238 | P | 0.52898 | Q | 0.473737 | 0.055243 | D to O | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 249 | A | 0.568173 | T | 0.620208 | -0.052035 | No Change: Both D | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 143 | P | 0.214894 | Q | 0.173798 | 0.041096 | No Change: Both O | - |
| Q8N865 | CG031_HUMAN Uncharacterized protein C7orf31 OS=Homo sapiens GN=C7orf31 PE=2 SV=3 | 518 | N | 0.60455 | D | 0.579512 | 0.025038 | No Change: Both D | - |
| Q9NRH1 | CG036_HUMAN Uncharacterized protein C7orf36 OS=Homo sapiens GN=C7orf36 PE=1 SV=1 | 68 | K | 0.369026 | E | 0.370087 | -0.001061 | No Change: Both O | - |
| Q8WVR3 | CG043_HUMAN Uncharacterized protein C7orf43 OS=Homo sapiens GN=C7orf43 PE=1 SV=2 | 295 | R | 0.403603 | H | 0.397524 | 0.006079 | No Change: Both O | - |
| Q8WWF3 | CG045_HUMAN Uncharacterized protein C7orf45 OS=Homo sapiens GN=C7orf45 PE=2 SV=1 | 88 | R | 0.978065 | W | 0.960061 | 0.018004 | No Change: Both D | - |
| A4D161 | CG046_HUMAN Uncharacterized protein C7orf46 OS=Homo sapiens GN=C7orf46 PE=2 SV=1 | 20 | Y | 0.269694 | H | 0.345872 | -0.076178 | No Change: Both O | - |
| A4D161 | CG046_HUMAN Uncharacterized protein C7orf46 OS=Homo sapiens GN=C7orf46 PE=2 SV=1 | 90 | A | 0.383786 | T | 0.448187 | -0.064401 | No Change: Both O | - |
| A4D161 | CG046_HUMAN Uncharacterized protein C7orf46 OS=Homo sapiens GN=C7orf46 PE=2 SV=1 | 95 | C | 0.275771 | R | 0.372614 | -0.096843 | No Change: Both O | - |
| A4D161 | CG046_HUMAN Uncharacterized protein C7orf46 OS=Homo sapiens GN=C7orf46 PE=2 SV=1 | 128 | H | 0.398364 | R | 0.434608 | -0.036244 | No Change: Both O | - |
| A4D161 | CG046_HUMAN Uncharacterized protein C7orf46 OS=Homo sapiens GN=C7orf46 PE=2 SV=1 | 240 | S | 0.890771 | G | 0.84567 | 0.045101 | No Change: Both D | - |
| Q96HJ9 | CG055_HUMAN UPF0562 protein C7orf55 OS=Homo sapiens GN=C7orf55 PE=1 SV=2 | 8 | S | 0.553152 | A | 0.459786 | 0.093366 | D to O | - |
| Q8NEG2 | CG057_HUMAN Uncharacterized protein C7orf57 OS=Homo sapiens GN=C7orf57 PE=1 SV=3 | 74 | A | 0.455463 | S | 0.56462 | -0.109157 | O to D | - |
| A4D0V7 | CG058_HUMAN Uncharacterized protein C7orf58 OS=Homo sapiens GN=C7orf58 PE=2 SV=1 | 326 | I | 0.303972 | T | 0.422293 | -0.118321 | No Change: Both O | - |
| A4D0V7 | CG058_HUMAN Uncharacterized protein C7orf58 OS=Homo sapiens GN=C7orf58 PE=2 SV=1 | 551 | A | 0.76931 | G | 0.751731 | 0.017579 | No Change: Both D | - |
| A4D0V7 | CG058_HUMAN Uncharacterized protein C7orf58 OS=Homo sapiens GN=C7orf58 PE=2 SV=1 | 708 | E | 0.308277 | G | 0.246833 | 0.061444 | No Change: Both O | - |
| A4D0V7 | CG058_HUMAN Uncharacterized protein C7orf58 OS=Homo sapiens GN=C7orf58 PE=2 SV=1 | 949 | K | 0.228021 | T | 0.159042 | 0.068979 | No Change: Both O | - |
| Q8TBZ9 | CG062_HUMAN Uncharacterized protein C7orf62 OS=Homo sapiens GN=C7orf62 PE=2 SV=1 | 48 | D | 0.11958 | H | 0.105641 | 0.013939 | No Change: Both O | - |
| Q8TBZ9 | CG062_HUMAN Uncharacterized protein C7orf62 OS=Homo sapiens GN=C7orf62 PE=2 SV=1 | 126 | I | 0.063582 | V | 0.073337 | -0.009755 | No Change: Both O | - |
| Q8TBZ9 | CG062_HUMAN Uncharacterized protein C7orf62 OS=Homo sapiens GN=C7orf62 PE=2 SV=1 | 186 | C | 0.16299 | S | 0.362325 | -0.199335 | No Change: Both O | - |
| Q8TBZ9 | CG062_HUMAN Uncharacterized protein C7orf62 OS=Homo sapiens GN=C7orf62 PE=2 SV=1 | 221 | E | 0.273819 | K | 0.277937 | -0.004118 | No Change: Both O | - |
| Q8TBZ9 | CG062_HUMAN Uncharacterized protein C7orf62 OS=Homo sapiens GN=C7orf62 PE=2 SV=1 | 221 | E | 0.273819 | A | 0.182051 | 0.091768 | No Change: Both O | - |
| A5D8W1 | CG063_HUMAN Uncharacterized protein C7orf63 OS=Homo sapiens GN=C7orf63 PE=2 SV=3 | 22 | S | 0.808849 | R | 0.773081 | 0.035768 | No Change: Both D | - |
| A5D8W1 | CG063_HUMAN Uncharacterized protein C7orf63 OS=Homo sapiens GN=C7orf63 PE=2 SV=3 | 306 | R | 0.299846 | C | 0.14771 | 0.152136 | No Change: Both O | - |
| A5D8W1 | CG063_HUMAN Uncharacterized protein C7orf63 OS=Homo sapiens GN=C7orf63 PE=2 SV=3 | 459 | P | 0.432822 | L | 0.283541 | 0.149281 | No Change: Both O | - |
| A5D8W1 | CG063_HUMAN Uncharacterized protein C7orf63 OS=Homo sapiens GN=C7orf63 PE=2 SV=3 | 490 | V | 0.092608 | M | 0.115892 | -0.023284 | No Change: Both O | - |
| A5D8W1 | CG063_HUMAN Uncharacterized protein C7orf63 OS=Homo sapiens GN=C7orf63 PE=2 SV=3 | 885 | T | 0.407527 | M | 0.343272 | 0.064255 | No Change: Both O | - |
| Q9H7B7 | CG069_HUMAN Uncharacterized protein C7orf69 OS=Homo sapiens GN=C7orf69 PE=2 SV=3 | 32 | K | 0.389148 | E | 0.389912 | -7.64E-04 | No Change: Both O | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 93 | Q | 0.580066 | K | 0.579962 | 1.04E-04 | No Change: Both D | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 407 | T | 0.61965 | I | 0.536804 | 0.082846 | No Change: Both D | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 485 | R | 0.313022 | L | 0.205332 | 0.10769 | No Change: Both O | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 561 | E | 0.841679 | Q | 0.845429 | -0.00375 | No Change: Both D | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 458 | D | 0.153628 | N | 0.156259 | -0.002631 | No Change: Both O | - |
| P07357 | CO8A_HUMAN Complement component C8 alpha chain OS=Homo sapiens GN=C8A PE=1 SV=2 | 575 | P | 0.896692 | L | 0.73601 | 0.160682 | No Change: Both D | - |
| P07358 | CO8B_HUMAN Complement component C8 beta chain OS=Homo sapiens GN=C8B PE=1 SV=3 | 117 | R | 0.571491 | G | 0.533076 | 0.038415 | No Change: Both D | - |
| P07358 | CO8B_HUMAN Complement component C8 beta chain OS=Homo sapiens GN=C8B PE=1 SV=3 | 108 | E | 0.584115 | K | 0.575065 | 0.00905 | No Change: Both D | - |
| P07358 | CO8B_HUMAN Complement component C8 beta chain OS=Homo sapiens GN=C8B PE=1 SV=3 | 261 | P | 0.393185 | L | 0.284902 | 0.108283 | No Change: Both O | - |
| P07360 | CO8G_HUMAN Complement component C8 gamma chain OS=Homo sapiens GN=C8G PE=1 SV=3 | 69 | R | 0.539538 | Q | 0.573838 | -0.0343 | No Change: Both D | - |
| P07360 | CO8G_HUMAN Complement component C8 gamma chain OS=Homo sapiens GN=C8G PE=1 SV=3 | 124 | H | 0.195181 | N | 0.211753 | -0.016572 | No Change: Both O | - |
| P07360 | CO8G_HUMAN Complement component C8 gamma chain OS=Homo sapiens GN=C8G PE=1 SV=3 | 118 | D | 0.284409 | G | 0.277814 | 0.006595 | No Change: Both O | - |
| Q9NRJ1 | MOST1_HUMAN Protein MOST-1 OS=Homo sapiens GN=C8orf17 PE=1 SV=1 | 19 | T | 0.563039 | M | 0.530342 | 0.032697 | No Change: Both D | - |
| Q9NRJ1 | MOST1_HUMAN Protein MOST-1 OS=Homo sapiens GN=C8orf17 PE=1 SV=1 | 49 | K | 0.427052 | R | 0.357611 | 0.069441 | No Change: Both O | - |
| Q9NRJ1 | MOST1_HUMAN Protein MOST-1 OS=Homo sapiens GN=C8orf17 PE=1 SV=1 | 57 | T | 0.294942 | I | 0.181315 | 0.113627 | No Change: Both O | - |
| Q8N9H6 | CH031_HUMAN Uncharacterized protein C8orf31 OS=Homo sapiens GN=C8orf31 PE=2 SV=1 | 39 | L | 0.549077 | P | 0.686668 | -0.137591 | No Change: Both D | - |
| Q49A92 | CH034_HUMAN Uncharacterized protein C8orf34 OS=Homo sapiens GN=C8orf34 PE=1 SV=2 | 75 | K | 0.893655 | N | 0.870595 | 0.02306 | No Change: Both D | A colorectal cancer sample |
| Q49A92 | CH034_HUMAN Uncharacterized protein C8orf34 OS=Homo sapiens GN=C8orf34 PE=1 SV=2 | 426 | A | 0.756332 | T | 0.777496 | -0.021164 | No Change: Both D | - |
| Q96NL8 | CH037_HUMAN Uncharacterized protein C8orf37 OS=Homo sapiens GN=C8orf37 PE=2 SV=1 | 19 | P | 0.656667 | A | 0.559794 | 0.096873 | No Change: Both D | - |
| Q330K2 | CH038_HUMAN UPF0551 protein C8orf38 mitochondrial OS=Homo sapiens GN=C8orf38 PE=1 SV=2 | 99 | Q | 0.375299 | R | 0.362483 | 0.012816 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q9NR00 | CH004_HUMAN Uncharacterized protein C8orf4 OS=Homo sapiens GN=C8orf4 PE=1 SV=2 | 10 | V | 0.474163 | I | 0.458009 | 0.016154 | No Change: Both O | - |
| Q96CB5 | CH044_HUMAN Putative uncharacterized protein C8orf44 OS=Homo sapiens GN=C8orf44 PE=2 SV=2 | 131 | Q | 0.870761 | R | 0.887259 | -0.016498 | No Change: Both D | - |
| Q96CB5 | CH044_HUMAN Putative uncharacterized protein C8orf44 OS=Homo sapiens GN=C8orf44 PE=2 SV=2 | 148 | F | 0.787018 | S | 0.898187 | -0.111169 | No Change: Both D | - |
| Q4G0Z9 | CH045_HUMAN Uncharacterized protein C8orf45 OS=Homo sapiens GN=C8orf45 PE=1 SV=3 | 137 | M | 0.105693 | K | 0.178642 | -0.072949 | No Change: Both O | - |
| Q4G0Z9 | CH045_HUMAN Uncharacterized protein C8orf45 OS=Homo sapiens GN=C8orf45 PE=1 SV=3 | 322 | L | 0.100117 | V | 0.087432 | 0.012685 | No Change: Both O | - |
| Q4G0Z9 | CH045_HUMAN Uncharacterized protein C8orf45 OS=Homo sapiens GN=C8orf45 PE=1 SV=3 | 583 | S | 0.401904 | A | 0.298923 | 0.102981 | No Change: Both O | - |
| Q6P6B1 | CH047_HUMAN Uncharacterized protein C8orf47 OS=Homo sapiens GN=C8orf47 PE=2 SV=1 | 59 | R | 0.888449 | H | 0.861064 | 0.027385 | No Change: Both D | - |
| Q6P6B1 | CH047_HUMAN Uncharacterized protein C8orf47 OS=Homo sapiens GN=C8orf47 PE=2 SV=1 | 244 | Q | 0.912164 | P | 0.914184 | -0.00202 | No Change: Both D | - |
| Q6P6B1 | CH047_HUMAN Uncharacterized protein C8orf47 OS=Homo sapiens GN=C8orf47 PE=2 SV=1 | 287 | H | 0.826986 | R | 0.858158 | -0.031172 | No Change: Both D | - |
| Q96LL4 | CH048_HUMAN Uncharacterized protein C8orf48 OS=Homo sapiens GN=C8orf48 PE=1 SV=2 | 28 | S | 0.945888 | F | 0.887823 | 0.058065 | No Change: Both D | - |
| Q96LL4 | CH048_HUMAN Uncharacterized protein C8orf48 OS=Homo sapiens GN=C8orf48 PE=1 SV=2 | 285 | L | 0.679029 | M | 0.710382 | -0.031353 | No Change: Both D | - |
| Q96NF6 | CH049_HUMAN Putative uncharacterized protein C8orf49 OS=Homo sapiens GN=C8orf49 PE=2 SV=1 | 26 | R | 0.486299 | G | 0.452375 | 0.033924 | No Change: Both O | - |
| Q96NF6 | CH049_HUMAN Putative uncharacterized protein C8orf49 OS=Homo sapiens GN=C8orf49 PE=2 SV=1 | 81 | I | 0.535229 | V | 0.572314 | -0.037085 | No Change: Both D | - |
| Q96NF6 | CH049_HUMAN Putative uncharacterized protein C8orf49 OS=Homo sapiens GN=C8orf49 PE=2 SV=1 | 95 | R | 0.499834 | G | 0.529391 | -0.029557 | O to D | - |
| Q8WUY1 | CH055_HUMAN UPF0670 protein C8orf55 OS=Homo sapiens GN=C8orf55 PE=1 SV=2 | 93 | E | 0.329799 | Q | 0.27407 | 0.055729 | No Change: Both O | - |
| A6NGR9 | CH073_HUMAN Putative uncharacterized protein C8orf73 OS=Homo sapiens GN=C8orf73 PE=2 SV=2 | 97 | H | 0.765536 | Q | 0.817696 | -0.05216 | No Change: Both D | - |
| A6NGR9 | CH073_HUMAN Putative uncharacterized protein C8orf73 OS=Homo sapiens GN=C8orf73 PE=2 SV=2 | 132 | V | 0.314746 | A | 0.430492 | -0.115746 | No Change: Both O | - |
| A6NGR9 | CH073_HUMAN Putative uncharacterized protein C8orf73 OS=Homo sapiens GN=C8orf73 PE=2 SV=2 | 134 | T | 0.327215 | I | 0.178642 | 0.148573 | No Change: Both O | - |
| A6NGR9 | CH073_HUMAN Putative uncharacterized protein C8orf73 OS=Homo sapiens GN=C8orf73 PE=2 SV=2 | 619 | A | 0.125018 | T | 0.126226 | -0.001208 | No Change: Both O | - |
| Q6P047 | CH074_HUMAN Uncharacterized protein C8orf74 OS=Homo sapiens GN=C8orf74 PE=2 SV=3 | 15 | L | 0.666098 | F | 0.629287 | 0.036811 | No Change: Both D | - |
| Q6P047 | CH074_HUMAN Uncharacterized protein C8orf74 OS=Homo sapiens GN=C8orf74 PE=2 SV=3 | 222 | I | 0.417805 | V | 0.456472 | -0.038667 | No Change: Both O | - |
| Q0IIN9 | CH077_HUMAN Putative uncharacterized protein C8orf77 OS=Homo sapiens GN=C8orf77 PE=5 SV=1 | 84 | L | 0.513884 | I | 0.4686 | 0.045284 | D to O | - |
| Q96M78 | CH078_HUMAN Uncharacterized protein C8orf78 OS=Homo sapiens GN=C8orf78 PE=2 SV=2 | 92 | L | 0.285341 | S | 0.384976 | -0.099635 | No Change: Both O | - |
| Q68CJ6 | SLIP_HUMAN GTPase SLIP-GC OS=Homo sapiens GN=C8orf80 PE=1 SV=3 | 23 | R | 0.934727 | P | 0.936076 | -0.001349 | No Change: Both D | - |
| Q68CJ6 | SLIP_HUMAN GTPase SLIP-GC OS=Homo sapiens GN=C8orf80 PE=1 SV=3 | 180 | S | 0.687611 | G | 0.642802 | 0.044809 | No Change: Both D | - |
| Q68CJ6 | SLIP_HUMAN GTPase SLIP-GC OS=Homo sapiens GN=C8orf80 PE=1 SV=3 | 328 | Q | 0.467932 | R | 0.462905 | 0.005027 | No Change: Both O | - |
| Q68CJ6 | SLIP_HUMAN GTPase SLIP-GC OS=Homo sapiens GN=C8orf80 PE=1 SV=3 | 474 | S | 0.323029 | N | 0.293717 | 0.029312 | No Change: Both O | - |
| Q68CJ6 | SLIP_HUMAN GTPase SLIP-GC OS=Homo sapiens GN=C8orf80 PE=1 SV=3 | 492 | R | 0.328791 | W | 0.142211 | 0.18658 | No Change: Both O | - |
| Q6ZUL3 | CH086_HUMAN Uncharacterized protein C8orf86 OS=Homo sapiens GN=C8orf86 PE=2 SV=1 | 81 | R | 0.705449 | H | 0.643144 | 0.062305 | No Change: Both D | - |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 119 | C | 0.934299 | G | 0.934893 | -5.94E-04 | No Change: Both D | Complement component 9 deficiency (C9D) [MIM:613825] |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 5 | R | 0.368131 | W | 0.213866 | 0.154265 | No Change: Both O | - |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 203 | I | 0.190749 | V | 0.220554 | -0.029805 | No Change: Both O | - |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 279 | T | 0.494016 | S | 0.619029 | -0.125013 | O to D | - |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 127 | D | 0.950985 | Y | 0.883576 | 0.067409 | No Change: Both D | - |
| P02748 | CO9_HUMAN Complement component C9 OS=Homo sapiens GN=C9 PE=1 SV=2 | 427 | S | 0.167451 | T | 0.129381 | 0.03807 | No Change: Both O | - |
| Q8N4T4 | CI100_HUMAN Vav-like protein C9orf100 OS=Homo sapiens GN=C9orf100 PE=2 SV=1 | 306 | H | 0.417868 | R | 0.422314 | -0.004446 | No Change: Both O | - |
| Q8N4T4 | CI100_HUMAN Vav-like protein C9orf100 OS=Homo sapiens GN=C9orf100 PE=2 SV=1 | 5 | C | 0.94498 | F | 0.898989 | 0.045991 | No Change: Both D | - |
| Q5T6J7 | GNTK_HUMAN Probable gluconokinase OS=Homo sapiens GN=C9orf103 PE=2 SV=1 | 185 | K | 0.656462 | T | 0.654595 | 0.001867 | No Change: Both D | - |
| Q5T280 | CI114_HUMAN Uncharacterized protein C9orf114 OS=Homo sapiens GN=C9orf114 PE=1 SV=3 | 130 | T | 0.503096 | R | 0.504045 | -9.49E-04 | No Change: Both D | - |
| Q5T280 | CI114_HUMAN Uncharacterized protein C9orf114 OS=Homo sapiens GN=C9orf114 PE=1 SV=3 | 369 | I | 0.40782 | T | 0.556075 | -0.148255 | O to D | - |
| Q5T280 | CI114_HUMAN Uncharacterized protein C9orf114 OS=Homo sapiens GN=C9orf114 PE=1 SV=3 | 63 | A | 0.91273 | V | 0.881817 | 0.030913 | No Change: Both D | - |
| Q5JU67 | CI117_HUMAN Uncharacterized protein C9orf117 OS=Homo sapiens GN=C9orf117 PE=2 SV=1 | 483 | Y | 0.327831 | S | 0.562109 | -0.234278 | O to D | - |
| Q96GE9 | CI123_HUMAN Transmembrane protein C9orf123 OS=Homo sapiens GN=C9orf123 PE=2 SV=1 | 28 | P | 0.930815 | T | 0.906565 | 0.02425 | No Change: Both D | - |
| A6H8Z2 | CI128_HUMAN Uncharacterized protein C9orf128 OS=Homo sapiens GN=C9orf128 PE=2 SV=2 | 34 | H | 0.981693 | R | 0.979578 | 0.002115 | No Change: Both D | - |
| A6H8Z2 | CI128_HUMAN Uncharacterized protein C9orf128 OS=Homo sapiens GN=C9orf128 PE=2 SV=2 | 41 | K | 0.988419 | E | 0.990731 | -0.002312 | No Change: Both D | - |
| Q5T035 | CI129_HUMAN Putative uncharacterized protein C9orf129 OS=Homo sapiens GN=C9orf129 PE=1 SV=1 | 191 | R | 0.900778 | H | 0.876197 | 0.024581 | No Change: Both D | - |
| Q5VYM1 | CI131_HUMAN Uncharacterized protein C9orf131 OS=Homo sapiens GN=C9orf131 PE=2 SV=3 | 222 | W | 0.43198 | L | 0.551361 | -0.119381 | O to D | - |
| Q5VYM1 | CI131_HUMAN Uncharacterized protein C9orf131 OS=Homo sapiens GN=C9orf131 PE=2 SV=3 | 285 | L | 0.892902 | F | 0.871376 | 0.021526 | No Change: Both D | - |
| Q5VYM1 | CI131_HUMAN Uncharacterized protein C9orf131 OS=Homo sapiens GN=C9orf131 PE=2 SV=3 | 437 | L | 0.714833 | V | 0.704731 | 0.010102 | No Change: Both D | - |
| Q5VYM1 | CI131_HUMAN Uncharacterized protein C9orf131 OS=Homo sapiens GN=C9orf131 PE=2 SV=3 | 623 | S | 0.710643 | T | 0.608126 | 0.102517 | No Change: Both D | - |
| Q5VYM1 | CI131_HUMAN Uncharacterized protein C9orf131 OS=Homo sapiens GN=C9orf131 PE=2 SV=3 | 916 | P | 0.915601 | S | 0.916894 | -0.001293 | No Change: Both D | - |
| Q6ZV77 | CI139_HUMAN Uncharacterized protein C9orf139 OS=Homo sapiens GN=C9orf139 PE=2 SV=1 | 168 | K | 0.971821 | E | 0.975476 | -0.003655 | No Change: Both D | - |
| Q5SQ13 | CI141_HUMAN Putative uncharacterized protein C9orf141 OS=Homo sapiens GN=C9orf141 PE=2 SV=1 | 8 | L | 0.604024 | F | 0.478918 | 0.125106 | D to O | - |
| Q5SQ13 | CI141_HUMAN Putative uncharacterized protein C9orf141 OS=Homo sapiens GN=C9orf141 PE=2 SV=1 | 37 | Q | 0.963137 | R | 0.96561 | -0.002473 | No Change: Both D | - |
| Q5SQ13 | CI141_HUMAN Putative uncharacterized protein C9orf141 OS=Homo sapiens GN=C9orf141 PE=2 SV=1 | 220 | W | 0.441335 | G | 0.705808 | -0.264473 | O to D | - |
| Q8IV03 | CI150_HUMAN Uncharacterized protein C9orf150 OS=Homo sapiens GN=C9orf150 PE=2 SV=2 | 62 | S | 0.999196 | G | 0.999045 | 1.51E-04 | No Change: Both D | - |
| Q9BU70 | NAP1_HUMAN Nef-associated protein 1 OS=Homo sapiens GN=C9orf156 PE=1 SV=2 | 7 | S | 0.867971 | P | 0.899574 | -0.031603 | No Change: Both D | - |
| Q9BU70 | NAP1_HUMAN Nef-associated protein 1 OS=Homo sapiens GN=C9orf156 PE=1 SV=2 | 252 | V | 0.579022 | A | 0.675937 | -0.096915 | No Change: Both D | - |
| Q9BU70 | NAP1_HUMAN Nef-associated protein 1 OS=Homo sapiens GN=C9orf156 PE=1 SV=2 | 324 | V | 0.542214 | M | 0.610079 | -0.067865 | No Change: Both D | - |
| Q8N9P6 | CI163_HUMAN Uncharacterized protein C9orf163 OS=Homo sapiens GN=C9orf163 PE=2 SV=1 | 5 | L | 0.588956 | P | 0.74543 | -0.156474 | No Change: Both D | - |
| Q6ZQR2 | CI171_HUMAN Uncharacterized protein C9orf171 OS=Homo sapiens GN=C9orf171 PE=2 SV=1 | 137 | G | 0.132477 | R | 0.125848 | 0.006629 | No Change: Both O | - |
| Q6ZQR2 | CI171_HUMAN Uncharacterized protein C9orf171 OS=Homo sapiens GN=C9orf171 PE=2 SV=1 | 172 | R | 0.309114 | W | 0.139916 | 0.169198 | No Change: Both O | A colorectal cancer sample |
| Q6ZQR2 | CI171_HUMAN Uncharacterized protein C9orf171 OS=Homo sapiens GN=C9orf171 PE=2 SV=1 | 184 | R | 0.584711 | H | 0.504371 | 0.08034 | No Change: Both D | - |
| Q6ZQR2 | CI171_HUMAN Uncharacterized protein C9orf171 OS=Homo sapiens GN=C9orf171 PE=2 SV=1 | 244 | K | 0.548502 | Q | 0.502815 | 0.045687 | No Change: Both D | - |
| Q8N7X2 | CI173_HUMAN Uncharacterized protein C9orf173 OS=Homo sapiens GN=C9orf173 PE=2 SV=1 | 126 | S | 0.745902 | G | 0.696184 | 0.049718 | No Change: Both D | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 301 | P | 0.68114 | H | 0.657538 | 0.023602 | No Change: Both D | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 322 | S | 0.612391 | R | 0.559286 | 0.053105 | No Change: Both D | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 373 | L | 0.330537 | H | 0.423672 | -0.093135 | No Change: Both O | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 917 | E | 0.999965 | K | 0.999959 | 6.00E-06 | No Change: Both D | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 995 | S | 0.364334 | C | 0.164457 | 0.199877 | No Change: Both O | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 1146 | F | 0.383162 | L | 0.446899 | -0.063737 | No Change: Both O | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 1518 | D | 0.278792 | N | 0.244899 | 0.033893 | No Change: Both O | - |
| Q9P1Z9 | CI174_HUMAN Uncharacterized protein C9orf174 OS=Homo sapiens GN=C9orf174 PE=1 SV=2 | 548 | P | 0.390423 | R | 0.354198 | 0.036225 | No Change: Both O | - |
| Q7RTV5 | CI021_HUMAN UPF0308 protein C9orf21 OS=Homo sapiens GN=C9orf21 PE=2 SV=1 | 83 | R | 0.236809 | K | 0.317006 | -0.080197 | No Change: Both O | - |
| Q8NCR6 | CI024_HUMAN Uncharacterized protein C9orf24 OS=Homo sapiens GN=C9orf24 PE=2 SV=2 | 233 | P | 0.515759 | Q | 0.457465 | 0.058294 | D to O | - |
| Q8TAL5 | CI043_HUMAN Uncharacterized protein C9orf43 OS=Homo sapiens GN=C9orf43 PE=1 SV=1 | 252 | D | 0.73857 | G | 0.72047 | 0.0181 | No Change: Both D | - |
| Q9H330 | CI005_HUMAN Transmembrane protein C9orf5 OS=Homo sapiens GN=C9orf5 PE=1 SV=2 | 314 | A | 0.988149 | T | 0.989823 | -0.001674 | No Change: Both D | - |
| Q9H330 | CI005_HUMAN Transmembrane protein C9orf5 OS=Homo sapiens GN=C9orf5 PE=1 SV=2 | 787 | T | 0.041994 | A | 0.036131 | 0.005863 | No Change: Both O | - |
| Q9H330 | CI005_HUMAN Transmembrane protein C9orf5 OS=Homo sapiens GN=C9orf5 PE=1 SV=2 | 9 | D | 0.994169 | E | 0.994056 | 1.13E-04 | No Change: Both D | - |
| Q5SZB4 | CI050_HUMAN Uncharacterized protein C9orf50 OS=Homo sapiens GN=C9orf50 PE=2 SV=1 | 248 | R | 0.727959 | K | 0.74011 | -0.012151 | No Change: Both D | - |
| Q5SZB4 | CI050_HUMAN Uncharacterized protein C9orf50 OS=Homo sapiens GN=C9orf50 PE=2 SV=1 | 312 | R | 0.413229 | Q | 0.41917 | -0.005941 | No Change: Both O | - |
| Q5SZB4 | CI050_HUMAN Uncharacterized protein C9orf50 OS=Homo sapiens GN=C9orf50 PE=2 SV=1 | 381 | R | 0.75279 | Q | 0.75656 | -0.00377 | No Change: Both D | - |
| Q5SZB4 | CI050_HUMAN Uncharacterized protein C9orf50 OS=Homo sapiens GN=C9orf50 PE=2 SV=1 | 415 | K | 0.413251 | R | 0.374496 | 0.038755 | No Change: Both O | - |
| B1ANY3 | CI051_HUMAN Putative SIPAR-like protein C9orf51 OS=Homo sapiens GN=C9orf51 PE=5 SV=1 | 162 | W | 0.783976 | R | 0.905654 | -0.121678 | No Change: Both D | - |
| B1ANY3 | CI051_HUMAN Putative SIPAR-like protein C9orf51 OS=Homo sapiens GN=C9orf51 PE=5 SV=1 | 199 | K | 0.345293 | N | 0.289495 | 0.055798 | No Change: Both O | - |
| B1ANY3 | CI051_HUMAN Putative SIPAR-like protein C9orf51 OS=Homo sapiens GN=C9orf51 PE=5 SV=1 | 203 | K | 0.311509 | N | 0.25772 | 0.053789 | No Change: Both O | - |
| Q5T8R8 | CI066_HUMAN Uncharacterized protein C9orf66 OS=Homo sapiens GN=C9orf66 PE=2 SV=1 | 43 | L | 0.841366 | R | 0.897141 | -0.055775 | No Change: Both D | - |
| Q5T8R8 | CI066_HUMAN Uncharacterized protein C9orf66 OS=Homo sapiens GN=C9orf66 PE=2 SV=1 | 178 | R | 0.864196 | Q | 0.847967 | 0.016229 | No Change: Both D | - |
| Q5T8R8 | CI066_HUMAN Uncharacterized protein C9orf66 OS=Homo sapiens GN=C9orf66 PE=2 SV=1 | 231 | R | 0.956518 | G | 0.948638 | 0.00788 | No Change: Both D | - |
| Q8N4H0 | CI068_HUMAN Uncharacterized protein C9orf68 OS=Homo sapiens GN=C9orf68 PE=2 SV=2 | 243 | R | 0.882588 | G | 0.844983 | 0.037605 | No Change: Both D | - |
| Q8N4H0 | CI068_HUMAN Uncharacterized protein C9orf68 OS=Homo sapiens GN=C9orf68 PE=2 SV=2 | 310 | A | 0.885534 | T | 0.898449 | -0.012915 | No Change: Both D | - |
| Q96LT7 | CI072_HUMAN Uncharacterized protein C9orf72 OS=Homo sapiens GN=C9orf72 PE=1 SV=2 | 207 | N | 0.394202 | S | 0.463908 | -0.069706 | No Change: Both O | - |
| Q9NZ63 | CI078_HUMAN Uncharacterized protein C9orf78 OS=Homo sapiens GN=C9orf78 PE=1 SV=1 | 70 | Q | 0.671533 | H | 0.61541 | 0.056123 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 335 | T | 0.626683 | P | 0.687294 | -0.060611 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 682 | D | 0.952513 | E | 0.949605 | 0.002908 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 704 | D | 0.961024 | E | 0.954859 | 0.006165 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 1202 | D | 0.986348 | G | 0.988117 | -0.001769 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 1350 | R | 0.608106 | H | 0.587027 | 0.021079 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 409 | V | 0.539752 | M | 0.629037 | -0.089285 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 586 | K | 0.809743 | E | 0.794019 | 0.015724 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 671 | T | 0.973233 | M | 0.971736 | 0.001497 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 700 | G | 0.956763 | R | 0.960744 | -0.003981 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 736 | A | 0.907096 | V | 0.891748 | 0.015348 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 924 | P | 0.973411 | L | 0.946306 | 0.027105 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 1019 | V | 0.562574 | E | 0.728083 | -0.165509 | No Change: Both D | - |
| Q6ZUB1 | CI079_HUMAN FAM75-like protein C9orf79 OS=Homo sapiens GN=C9orf79 PE=2 SV=2 | 208 | T | 0.987776 | S | 0.990831 | -0.003055 | No Change: Both D | - |
| Q9H8G2 | CI082_HUMAN Uncharacterized protein C9orf82 OS=Homo sapiens GN=C9orf82 PE=1 SV=2 | 233 | V | 0.882316 | M | 0.909953 | -0.027637 | No Change: Both D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 226 | T | 0.506243 | S | 0.584298 | -0.078055 | No Change: Both D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 416 | H | 0.719446 | R | 0.703131 | 0.016315 | No Change: Both D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 649 | I | 0.483342 | T | 0.638329 | -0.154987 | O to D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 734 | M | 0.242949 | L | 0.203614 | 0.039335 | No Change: Both O | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 788 | R | 0.38651 | K | 0.463066 | -0.076556 | No Change: Both O | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 809 | N | 0.098846 | K | 0.115789 | -0.016943 | No Change: Both O | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 932 | Y | 0.504105 | C | 0.440929 | 0.063176 | D to O | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 968 | L | 0.461175 | P | 0.626811 | -0.165636 | O to D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 1162 | I | 0.509161 | T | 0.653963 | -0.144802 | No Change: Both D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 1174 | E | 0.501663 | G | 0.425878 | 0.075785 | D to O | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 1380 | N | 0.598637 | K | 0.635325 | -0.036688 | No Change: Both D | - |
| Q5VXU9 | CI084_HUMAN Uncharacterized protein C9orf84 OS=Homo sapiens GN=C9orf84 PE=2 SV=1 | 1425 | R | 0.55131 | C | 0.40431 | 0.147 | D to O | - |
| Q96E40 | CI009_HUMAN Uncharacterized protein C9orf9 OS=Homo sapiens GN=C9orf9 PE=2 SV=1 | 104 | V | 0.470704 | I | 0.419104 | 0.0516 | No Change: Both O | - |
| Q6TFL3 | CI093_HUMAN Uncharacterized protein C9orf93 OS=Homo sapiens GN=C9orf93 PE=2 SV=1 | 17 | I | 0.52085 | N | 0.712225 | -0.191375 | No Change: Both D | - |
| Q6TFL3 | CI093_HUMAN Uncharacterized protein C9orf93 OS=Homo sapiens GN=C9orf93 PE=2 SV=1 | 121 | S | 0.903888 | T | 0.897604 | 0.006284 | No Change: Both D | - |
| Q6TFL3 | CI093_HUMAN Uncharacterized protein C9orf93 OS=Homo sapiens GN=C9orf93 PE=2 SV=1 | 1069 | K | 0.906214 | R | 0.889854 | 0.01636 | No Change: Both D | - |
| Q6TFL3 | CI093_HUMAN Uncharacterized protein C9orf93 OS=Homo sapiens GN=C9orf93 PE=2 SV=1 | 495 | N | 0.84678 | I | 0.770972 | 0.075808 | No Change: Both D | - |
| Q6TFL3 | CI093_HUMAN Uncharacterized protein C9orf93 OS=Homo sapiens GN=C9orf93 PE=2 SV=1 | 821 | C | 0.111484 | Y | 0.133626 | -0.022142 | No Change: Both O | - |
| P00915 | CAH1_HUMAN Carbonic anhydrase 1 OS=Homo sapiens GN=CA1 PE=1 SV=2 | 68 | H | 0.306569 | R | 0.297772 | 0.008797 | No Change: Both O | - |
| P00915 | CAH1_HUMAN Carbonic anhydrase 1 OS=Homo sapiens GN=CA1 PE=1 SV=2 | 254 | G | 0.704124 | R | 0.7692 | -0.065076 | No Change: Both D | - |
| P00915 | CAH1_HUMAN Carbonic anhydrase 1 OS=Homo sapiens GN=CA1 PE=1 SV=2 | 143 | A | 0.189672 | V | 0.13443 | 0.055242 | No Change: Both O | - |
| O43570 | CAH12_HUMAN Carbonic anhydrase 12 OS=Homo sapiens GN=CA12 PE=1 SV=1 | 143 | E | 0.251014 | K | 0.246703 | 0.004311 | No Change: Both O | Hyperchlorhidrosis isolated (HCHLH) [MIM:143860] |
| Q8N1Q1 | CAH13_HUMAN Carbonic anhydrase 13 OS=Homo sapiens GN=CA13 PE=1 SV=1 | 68 | N | 0.537701 | S | 0.597067 | -0.059366 | No Change: Both D | - |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 18 | K | 0.465622 | E | 0.459831 | 0.005791 | No Change: Both O | - |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 92 | Q | 0.071262 | P | 0.078325 | -0.007063 | No Change: Both O | Osteopetrosis autosomal recessive type 3 (OPTB3) [MIM:259730] |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 107 | H | 0.696525 | Y | 0.602616 | 0.093909 | No Change: Both D | Osteopetrosis autosomal recessive type 3 (OPTB3) [MIM:259730] |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 236 | P | 0.61795 | H | 0.57808 | 0.03987 | No Change: Both D | - |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 252 | N | 0.610951 | D | 0.609582 | 0.001369 | No Change: Both D | - |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 94 | H | 0.074601 | Y | 0.041771 | 0.03283 | No Change: Both O | Osteopetrosis autosomal recessive type 3 (OPTB3) [MIM:259730] |
| P00918 | CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens GN=CA2 PE=1 SV=2 | 144 | G | 0.0823 | R | 0.069414 | 0.012886 | No Change: Both O | Osteopetrosis autosomal recessive type 3 (OPTB3) [MIM:259730] |
| P07451 | CAH3_HUMAN Carbonic anhydrase 3 OS=Homo sapiens GN=CA3 PE=1 SV=3 | 31 | V | 0.569959 | I | 0.557285 | 0.012674 | No Change: Both D | - |
| P22748 | CAH4_HUMAN Carbonic anhydrase 4 OS=Homo sapiens GN=CA4 PE=1 SV=2 | 14 | R | 0.651355 | W | 0.449926 | 0.201429 | D to O | Retinitis pigmentosa type 17 (RP17) [MIM:600852] |
| P22748 | CAH4_HUMAN Carbonic anhydrase 4 OS=Homo sapiens GN=CA4 PE=1 SV=2 | 219 | R | 0.221276 | S | 0.265552 | -0.044276 | No Change: Both O | Retinitis pigmentosa type 17 (RP17) [MIM:600852] |
| P22748 | CAH4_HUMAN Carbonic anhydrase 4 OS=Homo sapiens GN=CA4 PE=1 SV=2 | 237 | V | 0.072876 | L | 0.07209 | 7.86E-04 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 55 | T | 0.410022 | M | 0.379384 | 0.030638 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 68 | M | 0.435318 | L | 0.381606 | 0.053712 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 70 | G | 0.428463 | A | 0.37318 | 0.055283 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 90 | S | 0.397474 | G | 0.34858 | 0.048894 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 37 | Q | 0.294762 | L | 0.175654 | 0.119108 | No Change: Both O | - |
| P23280 | CAH6_HUMAN Carbonic anhydrase 6 OS=Homo sapiens GN=CA6 PE=1 SV=3 | 58 | R | 0.402587 | W | 0.195994 | 0.206593 | No Change: Both O | - |
| P35219 | CAH8_HUMAN Carbonic anhydrase-related protein OS=Homo sapiens GN=CA8 PE=1 SV=3 | 100 | S | 0.55128 | P | 0.526717 | 0.024563 | No Change: Both D | Cerebellar ataxia mental retardation and dysequilibrium syndrome type 3 (CMARQ3) [MIM:613227] |
| Q16790 | CAH9_HUMAN Carbonic anhydrase 9 OS=Homo sapiens GN=CA9 PE=1 SV=2 | 33 | V | 0.688623 | M | 0.754844 | -0.066221 | No Change: Both D | - |
| Q16790 | CAH9_HUMAN Carbonic anhydrase 9 OS=Homo sapiens GN=CA9 PE=1 SV=2 | 326 | Q | 0.330514 | R | 0.325045 | 0.005469 | No Change: Both O | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 56 | A | 0.736003 | T | 0.711549 | 0.024454 | No Change: Both D | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 225 | D | 0.359205 | N | 0.312487 | 0.046718 | No Change: Both O | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 517 | S | 0.322983 | R | 0.267287 | 0.055696 | No Change: Both O | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 660 | R | 0.304813 | S | 0.340604 | -0.035791 | No Change: Both O | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 853 | R | 0.072836 | Q | 0.107746 | -0.03491 | No Change: Both O | - |
| Q9Y6J0 | CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens GN=CABIN1 PE=1 SV=1 | 921 | Q | 0.243843 | E | 0.298216 | -0.054373 | No Change: Both O | - |
| Q9BTV7 | CABL2_HUMAN CDK5 and ABL1 enzyme substrate 2 OS=Homo sapiens GN=CABLES2 PE=1 SV=3 | 428 | T | 0.350612 | K | 0.456424 | -0.105812 | No Change: Both O | - |
| Q9NPB3 | CABP2_HUMAN Calcium-binding protein 2 OS=Homo sapiens GN=CABP2 PE=1 SV=4 | 94 | R | 0.450989 | Q | 0.45278 | -0.001791 | No Change: Both O | - |
| P57796 | CABP4_HUMAN Calcium-binding protein 4 OS=Homo sapiens GN=CABP4 PE=1 SV=2 | 124 | R | 0.622592 | C | 0.481247 | 0.141345 | D to O | Congenital stationary night blindness type 2B (CSNB2B) [MIM:610427] |
| Q9NP86 | CABP5_HUMAN Calcium-binding protein 5 OS=Homo sapiens GN=CABP5 PE=2 SV=1 | 128 | V | 0.378891 | A | 0.472895 | -0.094004 | No Change: Both O | - |
| Q9NP86 | CABP5_HUMAN Calcium-binding protein 5 OS=Homo sapiens GN=CABP5 PE=2 SV=1 | 65 | T | 0.40277 | R | 0.435433 | -0.032663 | No Change: Both O | - |
| Q9NP86 | CABP5_HUMAN Calcium-binding protein 5 OS=Homo sapiens GN=CABP5 PE=2 SV=1 | 80 | L | 0.291679 | P | 0.432663 | -0.140984 | No Change: Both O | - |
| Q9NP86 | CABP5_HUMAN Calcium-binding protein 5 OS=Homo sapiens GN=CABP5 PE=2 SV=1 | 140 | E | 0.483761 | K | 0.439669 | 0.044092 | No Change: Both O | - |
| Q9NP86 | CABP5_HUMAN Calcium-binding protein 5 OS=Homo sapiens GN=CABP5 PE=2 SV=1 | 147 | I | 0.522795 | S | 0.715842 | -0.193047 | No Change: Both D | - |
| Q96KC9 | CABS1_HUMAN Calcium-binding and spermatid-specific protein 1 OS=Homo sapiens GN=CABS1 PE=2 SV=3 | 76 | K | 0.906703 | Q | 0.88122 | 0.025483 | No Change: Both D | - |
| Q96KC9 | CABS1_HUMAN Calcium-binding and spermatid-specific protein 1 OS=Homo sapiens GN=CABS1 PE=2 SV=3 | 211 | T | 0.880693 | I | 0.831088 | 0.049605 | No Change: Both D | - |
| Q96KC9 | CABS1_HUMAN Calcium-binding and spermatid-specific protein 1 OS=Homo sapiens GN=CABS1 PE=2 SV=3 | 298 | W | 0.584594 | G | 0.74142 | -0.156826 | No Change: Both D | - |
| O75952 | CABYR_HUMAN Calcium-binding tyrosine phosphorylation-regulated protein OS=Homo sapiens GN=CABYR PE=1 SV=2 | 490 | S | 0.992304 | A | 0.989073 | 0.003231 | No Change: Both D | - |
| O75952 | CABYR_HUMAN Calcium-binding tyrosine phosphorylation-regulated protein OS=Homo sapiens GN=CABYR PE=1 SV=2 | 74 | T | 0.719751 | M | 0.703944 | 0.015807 | No Change: Both D | - |
| O75952 | CABYR_HUMAN Calcium-binding tyrosine phosphorylation-regulated protein OS=Homo sapiens GN=CABYR PE=1 SV=2 | 448 | K | 0.937014 | R | 0.927634 | 0.00938 | No Change: Both D | - |
| O75952 | CABYR_HUMAN Calcium-binding tyrosine phosphorylation-regulated protein OS=Homo sapiens GN=CABYR PE=1 SV=2 | 186 | I | 0.62664 | V | 0.690829 | -0.064189 | No Change: Both D | - |
| Q5VU97 | CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens GN=CACHD1 PE=1 SV=2 | 414 | M | 0.234828 | T | 0.262147 | -0.027319 | No Change: Both O | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 192 | R | 0.191489 | Q | 0.190673 | 8.16E-04 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 666 | T | 0.10829 | M | 0.091371 | 0.016919 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 666 | T | 0.10829 | M | 0.091371 | 0.016919 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 714 | V | 0.115132 | A | 0.16979 | -0.054658 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1810 | I | 0.039456 | L | 0.050211 | -0.010755 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 21 | A | 0.928474 | V | 0.903736 | 0.024738 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 914 | P | 0.951175 | S | 0.953034 | -0.001859 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 918 | E | 0.958158 | D | 0.948744 | 0.009414 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1015 | E | 0.98732 | K | 0.98636 | 9.60E-04 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1105 | G | 0.957286 | S | 0.965735 | -0.008449 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 2394 | P | 0.97537 | S | 0.973434 | 0.001936 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 195 | R | 0.141927 | K | 0.170306 | -0.028379 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 218 | S | 0.172078 | L | 0.078421 | 0.093657 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 253 | H | 0.19846 | Y | 0.134403 | 0.064057 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 256 | C | 0.308707 | R | 0.47436 | -0.165653 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 287 | C | 0.435963 | Y | 0.439441 | -0.003478 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 293 | G | 0.358219 | R | 0.337301 | 0.020918 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 293 | G | 0.358219 | R | 0.337301 | 0.020918 | No Change: Both O | Spinocerebellar ataxia type 6 (SCA6) [MIM:183086] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 583 | R | 0.080582 | Q | 0.080555 | 2.70E-05 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 715 | D | 0.156877 | E | 0.184984 | -0.028107 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 993 | E | 0.998713 | V | 0.996987 | 0.001726 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1335 | K | 0.601038 | E | 0.590669 | 0.010369 | No Change: Both D | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1346 | R | 0.153223 | Q | 0.145424 | 0.007799 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1384 | Y | 0.00663 | C | 0.005618 | 0.001012 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1403 | F | 0.167766 | C | 0.155433 | 0.012333 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1456 | V | 0.131187 | L | 0.140537 | -0.00935 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1482 | G | 0.620845 | R | 0.60622 | 0.014625 | No Change: Both D | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1490 | F | 0.037275 | S | 0.099212 | -0.061937 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1493 | V | 0.012241 | I | 0.010023 | 0.002218 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1661 | R | 0.062471 | H | 0.057938 | 0.004533 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1667 | R | 0.095463 | W | 0.032468 | 0.062995 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1683 | W | 0.018013 | R | 0.052052 | -0.034039 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1736 | H | 0.361768 | L | 0.236962 | 0.124806 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1756 | E | 0.1941 | K | 0.193002 | 0.001098 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 2135 | R | 0.931153 | C | 0.884229 | 0.046924 | No Change: Both D | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 732 | E | 0.837678 | A | 0.794167 | 0.043511 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1173 | P | 0.908921 | L | 0.826131 | 0.08279 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 248 | Y | 0.087255 | C | 0.086122 | 0.001133 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 389 | L | 0.488042 | F | 0.462686 | 0.025356 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 405 | A | 0.50022 | T | 0.533997 | -0.033777 | No Change: Both D | Spinocerebellar ataxia type 6 (SCA6) [MIM:183086] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 454 | A | 0.55932 | T | 0.567723 | -0.008403 | No Change: Both D | - |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 501 | T | 0.037909 | M | 0.029707 | 0.008202 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 638 | G | 0.224897 | D | 0.240016 | -0.015119 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 798 | M | 0.685592 | T | 0.689679 | -0.004087 | No Change: Both D | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 897 | P | 0.955408 | R | 0.955383 | 2.50E-05 | No Change: Both D | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1664 | R | 0.067766 | Q | 0.067055 | 7.11E-04 | No Change: Both O | Spinocerebellar ataxia type 6 (SCA6) [MIM:183086] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1679 | R | 0.028564 | C | 0.011985 | 0.016579 | No Change: Both O | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1869 | C | 0.38913 | R | 0.560501 | -0.171371 | O to D | Episodic ataxia type 2 (EA2) [MIM:108500] |
| O00555 | CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens GN=CACNA1A PE=1 SV=2 | 1695 | V | 0.021005 | I | 0.01899 | 0.002015 | No Change: Both O | Familial hemiplegic migraine type 1 (FHM1) [MIM:141500] |
| Q00975 | CAC1B_HUMAN Voltage-dependent N-type calcium channel subunit alpha-1B OS=Homo sapiens GN=CACNA1B PE=1 SV=1 | 167 | N | 0.081595 | K | 0.093563 | -0.011968 | No Change: Both O | - |
| Q00975 | CAC1B_HUMAN Voltage-dependent N-type calcium channel subunit alpha-1B OS=Homo sapiens GN=CACNA1B PE=1 SV=1 | 1436 | E | 0.365169 | K | 0.361015 | 0.004154 | No Change: Both O | - |
| Q00975 | CAC1B_HUMAN Voltage-dependent N-type calcium channel subunit alpha-1B OS=Homo sapiens GN=CACNA1B PE=1 SV=1 | 1500 | E | 0.118583 | K | 0.11927 | -6.87E-04 | No Change: Both O | - |
| Q00975 | CAC1B_HUMAN Voltage-dependent N-type calcium channel subunit alpha-1B OS=Homo sapiens GN=CACNA1B PE=1 SV=1 | 862 | A | 0.995394 | S | 0.995608 | -2.14E-04 | No Change: Both D | - |
| Q00975 | CAC1B_HUMAN Voltage-dependent N-type calcium channel subunit alpha-1B OS=Homo sapiens GN=CACNA1B PE=1 SV=1 | 996 | T | 0.991625 | A | 0.991578 | 4.70E-05 | No Change: Both D | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 752 | A | 0.087943 | T | 0.089714 | -0.001771 | No Change: Both O | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 2169 | A | 0.650782 | T | 0.641585 | 0.009197 | No Change: Both D | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 402 | G | 0.113022 | S | 0.142745 | -0.029723 | No Change: Both O | Timothy syndrome (TS) [MIM:601005] |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 406 | G | 0.434863 | R | 0.419703 | 0.01516 | No Change: Both O | Timothy syndrome (TS) [MIM:601005] |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 39 | A | 0.669852 | V | 0.514882 | 0.15497 | No Change: Both D | Brugada syndrome type 3 (BRS3) [MIM:611875] |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 490 | G | 0.530883 | R | 0.575655 | -0.044772 | No Change: Both D | Brugada syndrome type 3 (BRS3) [MIM:611875] |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 84 | Q | 0.904168 | R | 0.9016 | 0.002568 | No Change: Both D | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 391 | I | 0.012923 | L | 0.014941 | -0.002018 | No Change: Both O | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 1868 | P | 0.576225 | L | 0.440188 | 0.136037 | D to O | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 1869 | M | 0.58663 | V | 0.545724 | 0.040906 | No Change: Both D | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 1893 | K | 0.838923 | R | 0.862039 | -0.023116 | No Change: Both D | - |
| Q13936 | CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens GN=CACNA1C PE=1 SV=4 | 878 | S | 0.393356 | R | 0.354671 | 0.038685 | No Change: Both O | - |
| Q01668 | CAC1D_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1D OS=Homo sapiens GN=CACNA1D PE=1 SV=2 | 2097 | D | 0.397563 | N | 0.365488 | 0.032075 | No Change: Both O | - |
| Q15878 | CAC1E_HUMAN Voltage-dependent R-type calcium channel subunit alpha-1E OS=Homo sapiens GN=CACNA1E PE=1 SV=3 | 859 | D | 0.896993 | E | 0.906936 | -0.009943 | No Change: Both D | - |
| Q15878 | CAC1E_HUMAN Voltage-dependent R-type calcium channel subunit alpha-1E OS=Homo sapiens GN=CACNA1E PE=1 SV=3 | 1955 | A | 0.814804 | T | 0.812249 | 0.002555 | No Change: Both D | - |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 369 | G | 0.14315 | D | 0.150721 | -0.007571 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 519 | R | 0.357973 | Q | 0.321842 | 0.036131 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1060 | R | 0.187372 | W | 0.078818 | 0.108554 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1375 | L | 0.064928 | H | 0.082845 | -0.017917 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 746 | N | 0.009495 | T | 0.007276 | 0.002219 | No Change: Both O | - |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 14 | P | 0.990827 | L | 0.978071 | 0.012756 | No Change: Both D | - |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 74 | C | 0.12102 | R | 0.232669 | -0.111649 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 150 | G | 0.065599 | R | 0.061655 | 0.003944 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 229 | S | 0.127773 | P | 0.116221 | 0.011552 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 261 | G | 0.089589 | R | 0.086221 | 0.003368 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 635 | V | 0.091466 | I | 0.083617 | 0.007849 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 674 | G | 0.060115 | D | 0.062681 | -0.002566 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 753 | F | 0.020868 | C | 0.02067 | 1.98E-04 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 756 | I | 0.060997 | T | 0.109311 | -0.048314 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 860 | L | 0.370201 | P | 0.542161 | -0.17196 | O to D | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 928 | A | 0.08628 | D | 0.125902 | -0.039622 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1018 | G | 0.031915 | R | 0.028033 | 0.003882 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1079 | L | 0.108617 | P | 0.202969 | -0.094352 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1499 | C | 0.177909 | R | 0.316951 | -0.139042 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1500 | P | 0.15137 | R | 0.135098 | 0.016272 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1508 | L | 0.175049 | P | 0.317585 | -0.142536 | No Change: Both O | Congenital stationary night blindness type 2A (CSNB2A) [MIM:300071] |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1270 | A | 0.173075 | T | 0.20574 | -0.032665 | No Change: Both O | - |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1930 | R | 0.25058 | H | 0.216832 | 0.033748 | No Change: Both O | - |
| O60840 | CAC1F_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1F OS=Homo sapiens GN=CACNA1F PE=1 SV=2 | 1259 | A | 0.047411 | T | 0.055807 | -0.008396 | No Change: Both O | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 1974 | E | 0.864222 | G | 0.842815 | 0.021407 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 161 | F | 0.07725 | L | 0.098102 | -0.020852 | No Change: Both O | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 282 | E | 0.568034 | K | 0.53922 | 0.028814 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 313 | M | 0.344672 | V | 0.257296 | 0.087376 | No Change: Both O | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 456 | C | 0.411718 | S | 0.583744 | -0.172026 | O to D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 499 | G | 0.828017 | S | 0.855937 | -0.02792 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 640 | P | 0.929859 | L | 0.866301 | 0.063558 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 648 | P | 0.89579 | L | 0.82782 | 0.06797 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 664 | V | 0.78155 | A | 0.819939 | -0.038389 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 684 | P | 0.824538 | S | 0.811625 | 0.012913 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 744 | R | 0.969962 | Q | 0.967052 | 0.00291 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 748 | A | 0.97672 | V | 0.972882 | 0.003838 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 773 | G | 0.556812 | D | 0.556871 | -5.90E-05 | No Change: Both D | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 784 | G | 0.194498 | S | 0.236451 | -0.041953 | No Change: Both O | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 788 | R | 0.247598 | C | 0.129856 | 0.117742 | No Change: Both O | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 812 | V | 0.390901 | M | 0.457736 | -0.066835 | No Change: Both O | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 831 | V | 0.096165 | M | 0.13738 | -0.041215 | No Change: Both O | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 848 | G | 0.077571 | S | 0.091767 | -0.014196 | No Change: Both O | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 1463 | D | 0.407347 | N | 0.406395 | 9.52E-04 | No Change: Both O | Idiopathic generalized epilepsy type 6 (IGE6) [MIM:611942] |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 2060 | R | 0.985148 | H | 0.97937 | 0.005778 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 2077 | R | 0.960188 | H | 0.951278 | 0.00891 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 2173 | P | 0.965416 | S | 0.961611 | 0.003805 | No Change: Both D | - |
| O95180 | CAC1H_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1H OS=Homo sapiens GN=CACNA1H PE=1 SV=4 | 1871 | R | 0.738801 | Q | 0.754022 | -0.015221 | No Change: Both D | - |
| Q9P0X4 | CAC1I_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1I OS=Homo sapiens GN=CACNA1I PE=1 SV=1 | 1040 | I | 0.888333 | V | 0.912416 | -0.024083 | No Change: Both D | - |
| Q9P0X4 | CAC1I_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1I OS=Homo sapiens GN=CACNA1I PE=1 SV=1 | 1782 | G | 0.813852 | A | 0.785033 | 0.028819 | No Change: Both D | - |
| Q9P0X4 | CAC1I_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1I OS=Homo sapiens GN=CACNA1I PE=1 SV=1 | 1782 | G | 0.813852 | R | 0.81079 | 0.003062 | No Change: Both D | - |
| Q9P0X4 | CAC1I_HUMAN Voltage-dependent T-type calcium channel subunit alpha-1I OS=Homo sapiens GN=CACNA1I PE=1 SV=1 | 1513 | T | 0.557889 | M | 0.487973 | 0.069916 | D to O | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 458 | L | 0.257303 | H | 0.389987 | -0.132684 | No Change: Both O | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 528 | R | 0.038327 | H | 0.035046 | 0.003281 | No Change: Both O | Periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400] |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1086 | R | 0.294233 | H | 0.29537 | -0.001137 | No Change: Both O | Malignant hyperthermia susceptibility type 5 (MHS5) [MIM:601887] |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1239 | R | 0.046927 | G | 0.044097 | 0.00283 | No Change: Both O | Periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400] |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1239 | R | 0.046927 | H | 0.040282 | 0.006645 | No Change: Both O | Periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400] |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1539 | R | 0.470916 | C | 0.309064 | 0.161852 | No Change: Both O | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 69 | A | 0.046844 | G | 0.055655 | -0.008811 | No Change: Both O | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1658 | R | 0.755515 | H | 0.72728 | 0.028235 | No Change: Both D | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1800 | L | 0.249502 | S | 0.360349 | -0.110847 | No Change: Both O | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 1840 | E | 0.781669 | D | 0.740427 | 0.041242 | No Change: Both D | - |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 528 | R | 0.038327 | G | 0.039744 | -0.001417 | No Change: Both O | Periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400] |
| Q13698 | CAC1S_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1S OS=Homo sapiens GN=CACNA1S PE=1 SV=4 | 900 | R | 0.070789 | S | 0.086351 | -0.015562 | No Change: Both O | Periodic paralysis hypokalemic type 1 (HOKPP1) [MIM:170400] |
| P54289 | CA2D1_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-1 OS=Homo sapiens GN=CACNA2D1 PE=1 SV=3 | 1057 | D | 0.338719 | A | 0.242238 | 0.096481 | No Change: Both O | - |
| P54289 | CA2D1_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-1 OS=Homo sapiens GN=CACNA2D1 PE=1 SV=3 | 1019 | E | 0.20377 | D | 0.197432 | 0.006338 | No Change: Both O | - |
| Q9NY47 | CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens GN=CACNA2D2 PE=1 SV=1 | 138 | A | 0.40934 | V | 0.319499 | 0.089841 | No Change: Both O | - |
| Q9NY47 | CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens GN=CACNA2D2 PE=1 SV=1 | 334 | E | 0.415698 | K | 0.429712 | -0.014014 | No Change: Both O | - |
| Q7Z3S7 | CA2D4_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-4 OS=Homo sapiens GN=CACNA2D4 PE=1 SV=2 | 327 | I | 0.095643 | V | 0.100675 | -0.005032 | No Change: Both O | - |
| Q7Z3S7 | CA2D4_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-4 OS=Homo sapiens GN=CACNA2D4 PE=1 SV=2 | 863 | R | 0.168369 | H | 0.140188 | 0.028181 | No Change: Both O | - |
| Q7Z3S7 | CA2D4_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-4 OS=Homo sapiens GN=CACNA2D4 PE=1 SV=2 | 869 | T | 0.175109 | M | 0.142979 | 0.03213 | No Change: Both O | - |
| Q02641 | CACB1_HUMAN Voltage-dependent L-type calcium channel subunit beta-1 OS=Homo sapiens GN=CACNB1 PE=1 SV=3 | 339 | P | 0.134195 | L | 0.073448 | 0.060747 | No Change: Both O | A colorectal cancer sample |
| Q08289 | CACB2_HUMAN Voltage-dependent L-type calcium channel subunit beta-2 OS=Homo sapiens GN=CACNB2 PE=1 SV=3 | 99 | A | 0.911243 | G | 0.892632 | 0.018611 | No Change: Both D | A colorectal cancer sample |
| Q08289 | CACB2_HUMAN Voltage-dependent L-type calcium channel subunit beta-2 OS=Homo sapiens GN=CACNB2 PE=1 SV=3 | 535 | S | 0.992515 | L | 0.984151 | 0.008364 | No Change: Both D | Brugada syndrome type 4 (BRS4) [MIM:611876] |
| P54284 | CACB3_HUMAN Voltage-dependent L-type calcium channel subunit beta-3 OS=Homo sapiens GN=CACNB3 PE=1 SV=1 | 423 | R | 0.934174 | H | 0.926384 | 0.00779 | No Change: Both D | - |
| O00305 | CACB4_HUMAN Voltage-dependent L-type calcium channel subunit beta-4 OS=Homo sapiens GN=CACNB4 PE=1 SV=2 | 104 | C | 0.197773 | F | 0.202567 | -0.004794 | No Change: Both O | Episodic ataxia type 5 (EA5) [MIM:613855] |
| Q06432 | CCG1_HUMAN Voltage-dependent calcium channel gamma-1 subunit OS=Homo sapiens GN=CACNG1 PE=2 SV=1 | 196 | G | 0.035355 | S | 0.045641 | -0.010286 | No Change: Both O | - |
| Q9Y698 | CCG2_HUMAN Voltage-dependent calcium channel gamma-2 subunit OS=Homo sapiens GN=CACNG2 PE=1 SV=1 | 143 | V | 0.087418 | L | 0.09414 | -0.006722 | No Change: Both O | Mental retardation autosomal dominant type 10 (MRD10) [MIM:614256] |
| Q9BXT2 | CCG6_HUMAN Voltage-dependent calcium channel gamma-6 subunit OS=Homo sapiens GN=CACNG6 PE=2 SV=1 | 252 | C | 0.37464 | S | 0.624491 | -0.249851 | O to D | - |
| P27708 | PYR1_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=3 | 177 | R | 0.154609 | Q | 0.160971 | -0.006362 | No Change: Both O | A colorectal cancer sample |
| P27708 | PYR1_HUMAN CAD protein OS=Homo sapiens GN=CAD PE=1 SV=3 | 735 | Y | 0.086853 | C | 0.088728 | -0.001875 | No Change: Both O | A colorectal cancer sample |
| Q9BY67 | CADM1_HUMAN Cell adhesion molecule 1 OS=Homo sapiens GN=CADM1 PE=1 SV=2 | 285 | D | 0.325457 | E | 0.347455 | -0.021998 | No Change: Both O | - |
| Q8N126 | CADM3_HUMAN Cell adhesion molecule 3 OS=Homo sapiens GN=CADM3 PE=1 SV=1 | 162 | R | 0.693031 | W | 0.483716 | 0.209315 | D to O | - |
| Q8NFZ8 | CADM4_HUMAN Cell adhesion molecule 4 OS=Homo sapiens GN=CADM4 PE=1 SV=1 | 225 | T | 0.338815 | A | 0.334264 | 0.004551 | No Change: Both O | - |
| Q86UW7 | CAPS2_HUMAN Calcium-dependent secretion activator 2 OS=Homo sapiens GN=CADPS2 PE=1 SV=2 | 298 | A | 0.551838 | T | 0.532071 | 0.019767 | No Change: Both D | - |
| Q8TC20 | CAGE1_HUMAN Cancer-associated gene 1 protein OS=Homo sapiens GN=CAGE1 PE=2 SV=2 | 169 | T | 0.817594 | I | 0.743415 | 0.074179 | No Change: Both D | - |
| Q8TC20 | CAGE1_HUMAN Cancer-associated gene 1 protein OS=Homo sapiens GN=CAGE1 PE=2 SV=2 | 282 | E | 0.688097 | A | 0.573332 | 0.114765 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 57 | N | 0.778011 | D | 0.816186 | -0.038175 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 76 | S | 0.885271 | R | 0.867072 | 0.018199 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 2 | G | 0.745229 | R | 0.707769 | 0.03746 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 67 | E | 0.873366 | K | 0.858741 | 0.014625 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 123 | S | 0.774417 | T | 0.733524 | 0.040893 | No Change: Both D | - |
| P01258 | CALC_HUMAN Calcitonin OS=Homo sapiens GN=CALCA PE=1 SV=2 | 138 | Q | 0.905835 | P | 0.928238 | -0.022403 | No Change: Both D | - |
| P06881 | CALCA_HUMAN Calcitonin gene-related peptide 1 OS=Homo sapiens GN=CALCA PE=1 SV=3 | 57 | N | 0.597224 | D | 0.663045 | -0.065821 | No Change: Both D | - |
| Q9P1Z2 | CACO1_HUMAN Calcium-binding and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=CALCOCO1 PE=1 SV=2 | 393 | R | 0.574302 | K | 0.587947 | -0.013645 | No Change: Both D | - |
| Q13137 | CACO2_HUMAN Calcium-binding and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=CALCOCO2 PE=1 SV=1 | 140 | G | 0.625267 | E | 0.715144 | -0.089877 | No Change: Both D | - |
| Q13137 | CACO2_HUMAN Calcium-binding and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=CALCOCO2 PE=1 SV=1 | 227 | G | 0.929551 | R | 0.945491 | -0.01594 | No Change: Both D | - |
| Q13137 | CACO2_HUMAN Calcium-binding and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=CALCOCO2 PE=1 SV=1 | 248 | V | 0.962091 | A | 0.97119 | -0.009099 | No Change: Both D | - |
| Q13137 | CACO2_HUMAN Calcium-binding and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=CALCOCO2 PE=1 SV=1 | 273 | T | 0.97388 | A | 0.964707 | 0.009173 | No Change: Both D | - |
| Q13137 | CACO2_HUMAN Calcium-binding and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=CALCOCO2 PE=1 SV=1 | 389 | P | 0.851581 | A | 0.787703 | 0.063878 | No Change: Both D | - |
| P30988 | CALCR_HUMAN Calcitonin receptor OS=Homo sapiens GN=CALCR PE=1 SV=1 | 463 | P | 0.84635 | L | 0.712685 | 0.133665 | No Change: Both D | - |
| Q16602 | CALRL_HUMAN Calcitonin gene-related peptide type 1 receptor OS=Homo sapiens GN=CALCRL PE=1 SV=2 | 16 | F | 0.022886 | L | 0.028621 | -0.005735 | No Change: Both O | - |
| Q16602 | CALRL_HUMAN Calcitonin gene-related peptide type 1 receptor OS=Homo sapiens GN=CALCRL PE=1 SV=2 | 274 | R | 0.092428 | I | 0.04943 | 0.042998 | No Change: Both O | - |
| Q16602 | CALRL_HUMAN Calcitonin gene-related peptide type 1 receptor OS=Homo sapiens GN=CALCRL PE=1 SV=2 | 8 | N | 0.099472 | Y | 0.052547 | 0.046925 | No Change: Both O | - |
| Q05682 | CALD1_HUMAN Caldesmon OS=Homo sapiens GN=CALD1 PE=1 SV=3 | 397 | H | 0.987278 | R | 0.990185 | -0.002907 | No Change: Both D | - |
| Q8IU99 | CAHM1_HUMAN Calcium homeostasis modulator protein 1 OS=Homo sapiens GN=CALHM1 PE=1 SV=2 | 86 | L | 0.478268 | P | 0.659945 | -0.181677 | O to D | - |
| Q9HA72 | CAHM2_HUMAN Calcium homeostasis modulator protein 2 OS=Homo sapiens GN=CALHM2 PE=2 SV=1 | 194 | V | 0.00851 | M | 0.01046 | -0.00195 | No Change: Both O | - |
| Q9HA72 | CAHM2_HUMAN Calcium homeostasis modulator protein 2 OS=Homo sapiens GN=CALHM2 PE=2 SV=1 | 136 | V | 0.342118 | G | 0.452901 | -0.110783 | No Change: Both O | - |
| P62158 | CALM_HUMAN Calmodulin OS=Homo sapiens GN=CALM1 PE=1 SV=2 | 73 | M | 0.545443 | T | 0.553999 | -0.008556 | No Change: Both D | - |
| Q96GE6 | CALL4_HUMAN Calmodulin-like protein 4 OS=Homo sapiens GN=CALML4 PE=2 SV=3 | 28 | R | 0.952109 | C | 0.928946 | 0.023163 | No Change: Both D | - |
| Q96GE6 | CALL4_HUMAN Calmodulin-like protein 4 OS=Homo sapiens GN=CALML4 PE=2 SV=3 | 154 | T | 0.606733 | K | 0.683298 | -0.076565 | No Change: Both D | - |
| Q9NZT1 | CALL5_HUMAN Calmodulin-like protein 5 OS=Homo sapiens GN=CALML5 PE=1 SV=2 | 58 | S | 0.613359 | G | 0.568774 | 0.044585 | No Change: Both D | - |
| Q9NZT1 | CALL5_HUMAN Calmodulin-like protein 5 OS=Homo sapiens GN=CALML5 PE=1 SV=2 | 74 | K | 0.461095 | R | 0.43236 | 0.028735 | No Change: Both O | - |
| Q8TD86 | CALL6_HUMAN Calmodulin-like protein 6 OS=Homo sapiens GN=CALML6 PE=2 SV=2 | 60 | W | 0.274321 | R | 0.499489 | -0.225168 | No Change: Both O | - |
| Q96L12 | CALR3_HUMAN Calreticulin-3 OS=Homo sapiens GN=CALR3 PE=1 SV=2 | 8 | L | 0.03525 | F | 0.027929 | 0.007321 | No Change: Both O | - |
| Q96L12 | CALR3_HUMAN Calreticulin-3 OS=Homo sapiens GN=CALR3 PE=1 SV=2 | 248 | D | 0.628618 | G | 0.576402 | 0.052216 | No Change: Both D | - |
| Q96L12 | CALR3_HUMAN Calreticulin-3 OS=Homo sapiens GN=CALR3 PE=1 SV=2 | 274 | V | 0.268807 | I | 0.266602 | 0.002205 | No Change: Both O | - |
| Q96L12 | CALR3_HUMAN Calreticulin-3 OS=Homo sapiens GN=CALR3 PE=1 SV=2 | 284 | D | 0.388708 | N | 0.376306 | 0.012402 | No Change: Both O | - |
| Q96L12 | CALR3_HUMAN Calreticulin-3 OS=Homo sapiens GN=CALR3 PE=1 SV=2 | 82 | K | 0.35621 | R | 0.303288 | 0.052922 | No Change: Both O | Familial hypertrophic cardiomyopathy type 19 (CMH19) [MIM:613875] |
| O43852 | CALU_HUMAN Calumenin OS=Homo sapiens GN=CALU PE=1 SV=2 | 4 | R | 0.506282 | Q | 0.542621 | -0.036339 | No Change: Both D | - |
| Q14012 | KCC1A_HUMAN Calcium/calmodulin-dependent protein kinase type 1 OS=Homo sapiens GN=CAMK1 PE=1 SV=1 | 217 | P | 0.133818 | S | 0.140732 | -0.006914 | No Change: Both O | A metastatic melanoma sample |
| Q14012 | KCC1A_HUMAN Calcium/calmodulin-dependent protein kinase type 1 OS=Homo sapiens GN=CAMK1 PE=1 SV=1 | 361 | E | 0.774586 | K | 0.735478 | 0.039108 | No Change: Both D | - |
| Q8IU85 | KCC1D_HUMAN Calcium/calmodulin-dependent protein kinase type 1D OS=Homo sapiens GN=CAMK1D PE=1 SV=1 | 66 | I | 0.574703 | M | 0.635787 | -0.061084 | No Change: Both D | - |
| Q96NX5 | KCC1G_HUMAN Calcium/calmodulin-dependent protein kinase type 1G OS=Homo sapiens GN=CAMK1G PE=1 SV=3 | 329 | V | 0.776295 | I | 0.737778 | 0.038517 | No Change: Both D | - |
| Q96NX5 | KCC1G_HUMAN Calcium/calmodulin-dependent protein kinase type 1G OS=Homo sapiens GN=CAMK1G PE=1 SV=3 | 259 | E | 0.31441 | Q | 0.254681 | 0.059729 | No Change: Both O | - |
| Q96NX5 | KCC1G_HUMAN Calcium/calmodulin-dependent protein kinase type 1G OS=Homo sapiens GN=CAMK1G PE=1 SV=3 | 443 | A | 0.809722 | T | 0.829613 | -0.019891 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q13554 | KCC2B_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit beta OS=Homo sapiens GN=CAMK2B PE=1 SV=3 | 489 | P | 0.980011 | L | 0.964475 | 0.015536 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q13554 | KCC2B_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit beta OS=Homo sapiens GN=CAMK2B PE=1 SV=3 | 510 | E | 0.990524 | K | 0.988926 | 0.001598 | No Change: Both D | - |
| Q13557 | KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens GN=CAMK2D PE=1 SV=3 | 463 | Q | 0.567635 | E | 0.598273 | -0.030638 | No Change: Both D | - |
| Q13557 | KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens GN=CAMK2D PE=1 SV=3 | 167 | D | 0.19201 | E | 0.219098 | -0.027088 | No Change: Both O | - |
| Q13557 | KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens GN=CAMK2D PE=1 SV=3 | 493 | T | 0.582435 | I | 0.460331 | 0.122104 | D to O | - |
| Q13555 | KCC2G_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit gamma OS=Homo sapiens GN=CAMK2G PE=1 SV=3 | 36 | S | 0.4378 | P | 0.408008 | 0.029792 | No Change: Both O | - |
| Q16566 | KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens GN=CAMK4 PE=1 SV=1 | 150 | E | 0.142954 | G | 0.110781 | 0.032173 | No Change: Both O | A lung adenocarcinoma sample |
| Q16566 | KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens GN=CAMK4 PE=1 SV=1 | 178 | D | 0.389034 | N | 0.36404 | 0.024994 | No Change: Both O | - |
| Q16566 | KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens GN=CAMK4 PE=1 SV=1 | 465 | Q | 0.49649 | R | 0.463484 | 0.033006 | No Change: Both O | - |
| Q16566 | KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens GN=CAMK4 PE=1 SV=1 | 469 | I | 0.586058 | M | 0.716361 | -0.130303 | No Change: Both D | A lung large cell carcinoma sample |
| Q8N5S9 | KKCC1_HUMAN Calcium/calmodulin-dependent protein kinase kinase 1 OS=Homo sapiens GN=CAMKK1 PE=1 SV=2 | 375 | E | 0.643723 | G | 0.569813 | 0.07391 | No Change: Both D | - |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 85 | T | 0.856178 | S | 0.898423 | -0.042245 | No Change: Both D | - |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 363 | R | 0.532145 | C | 0.35952 | 0.172625 | D to O | - |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 10 | S | 0.993818 | N | 0.989765 | 0.004053 | No Change: Both D | - |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 123 | C | 0.857887 | Y | 0.818246 | 0.039641 | No Change: Both D | - |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 127 | P | 0.899944 | L | 0.821741 | 0.078203 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 182 | A | 0.274978 | T | 0.311428 | -0.03645 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q96RR4 | KKCC2_HUMAN Calcium/calmodulin-dependent protein kinase kinase 2 OS=Homo sapiens GN=CAMKK2 PE=1 SV=2 | 492 | R | 0.510274 | H | 0.442236 | 0.068038 | D to O | - |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 491 | Y | 0.995707 | C | 0.997156 | -0.001449 | No Change: Both D | - |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 40 | R | 0.519436 | W | 0.296533 | 0.222903 | D to O | A colorectal adenocarcinoma sample |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 60 | G | 0.665804 | S | 0.693646 | -0.027842 | No Change: Both D | An ovarian serous carcinoma sample |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 274 | R | 0.482668 | W | 0.274574 | 0.208094 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 279 | E | 0.449635 | D | 0.412955 | 0.03668 | No Change: Both O | - |
| Q8NCB2 | CAMKV_HUMAN CaM kinase-like vesicle-associated protein OS=Homo sapiens GN=CAMKV PE=2 SV=2 | 472 | P | 0.993271 | L | 0.984778 | 0.008493 | No Change: Both D | - |
| P49069 | CAMLG_HUMAN Calcium signal-modulating cyclophilin ligand OS=Homo sapiens GN=CAMLG PE=1 SV=1 | 78 | V | 0.909687 | I | 0.875788 | 0.033899 | No Change: Both D | - |
| P49069 | CAMLG_HUMAN Calcium signal-modulating cyclophilin ligand OS=Homo sapiens GN=CAMLG PE=1 SV=1 | 100 | G | 0.761129 | S | 0.800082 | -0.038953 | No Change: Both D | - |
| Q5T5Y3 | CAMP1_HUMAN Calmodulin-regulated spectrin-associated protein 1 OS=Homo sapiens GN=CAMSAP1 PE=1 SV=2 | 476 | A | 0.738293 | V | 0.652312 | 0.085981 | No Change: Both D | - |
| Q08AD1 | CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens GN=CAMSAP2 PE=1 SV=3 | 361 | I | 0.515161 | L | 0.587128 | -0.071967 | No Change: Both D | A colorectal cancer sample |
| Q08AD1 | CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens GN=CAMSAP2 PE=1 SV=3 | 958 | P | 0.991872 | L | 0.98222 | 0.009652 | No Change: Both D | - |
| Q08AD1 | CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens GN=CAMSAP2 PE=1 SV=3 | 1028 | R | 0.899421 | P | 0.914222 | -0.014801 | No Change: Both D | - |
| Q08AD1 | CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens GN=CAMSAP2 PE=1 SV=3 | 969 | P | 0.994393 | L | 0.988437 | 0.005956 | No Change: Both D | - |
| Q08AD1 | CAMP2_HUMAN Calmodulin-regulated spectrin-associated protein 2 OS=Homo sapiens GN=CAMSAP2 PE=1 SV=3 | 1039 | P | 0.946191 | R | 0.939066 | 0.007125 | No Change: Both D | - |
| Q9P1Y5 | CAMP3_HUMAN Calmodulin-regulated spectrin-associated protein 3 OS=Homo sapiens GN=CAMSAP3 PE=1 SV=2 | 335 | P | 0.763855 | S | 0.764607 | -7.52E-04 | No Change: Both D | - |
| Q9Y6Y1 | CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens GN=CAMTA1 PE=1 SV=4 | 1177 | N | 0.739687 | K | 0.788458 | -0.048771 | No Change: Both D | - |
| Q9Y6Y1 | CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens GN=CAMTA1 PE=1 SV=4 | 1218 | N | 0.852268 | T | 0.856653 | -0.004385 | No Change: Both D | - |
| Q9Y6Y1 | CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens GN=CAMTA1 PE=1 SV=4 | 1336 | T | 0.60262 | I | 0.466578 | 0.136042 | D to O | - |
| O94983 | CMTA2_HUMAN Calmodulin-binding transcription activator 2 OS=Homo sapiens GN=CAMTA2 PE=1 SV=3 | 267 | A | 0.9743 | P | 0.984962 | -0.010662 | No Change: Both D | - |
| O94983 | CMTA2_HUMAN Calmodulin-binding transcription activator 2 OS=Homo sapiens GN=CAMTA2 PE=1 SV=3 | 903 | S | 0.925133 | P | 0.931044 | -0.005911 | No Change: Both D | - |
| Q86VP6 | CAND1_HUMAN Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1 PE=1 SV=2 | 952 | A | 0.170772 | V | 0.132186 | 0.038586 | No Change: Both O | - |
| Q86VP6 | CAND1_HUMAN Cullin-associated NEDD8-dissociated protein 1 OS=Homo sapiens GN=CAND1 PE=1 SV=2 | 803 | V | 0.129269 | A | 0.191811 | -0.062542 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 408 | Q | 0.286185 | R | 0.271334 | 0.014851 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 476 | P | 0.228869 | L | 0.138453 | 0.090416 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 533 | S | 0.111196 | P | 0.108099 | 0.003097 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 655 | H | 0.130564 | R | 0.175688 | -0.045124 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 845 | L | 0.358968 | F | 0.314686 | 0.044282 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 858 | H | 0.499423 | P | 0.579233 | -0.07981 | O to D | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 990 | V | 0.259776 | I | 0.24122 | 0.018556 | No Change: Both O | - |
| O75155 | CAND2_HUMAN Cullin-associated NEDD8-dissociated protein 2 OS=Homo sapiens GN=CAND2 PE=1 SV=3 | 1225 | A | 0.923789 | T | 0.925141 | -0.001352 | No Change: Both D | - |
| Q8WVQ1 | CANT1_HUMAN Soluble calcium-activated nucleotidase 1 OS=Homo sapiens GN=CANT1 PE=1 SV=1 | 299 | P | 0.282348 | L | 0.176281 | 0.106067 | No Change: Both O | Desbuquois dysplasia (DBQD) [MIM:251450] |
| Q8WVQ1 | CANT1_HUMAN Soluble calcium-activated nucleotidase 1 OS=Homo sapiens GN=CANT1 PE=1 SV=1 | 300 | R | 0.321088 | C | 0.190606 | 0.130482 | No Change: Both O | Desbuquois dysplasia (DBQD) [MIM:251450] |
| Q8WVQ1 | CANT1_HUMAN Soluble calcium-activated nucleotidase 1 OS=Homo sapiens GN=CANT1 PE=1 SV=1 | 300 | R | 0.321088 | H | 0.275876 | 0.045212 | No Change: Both O | Desbuquois dysplasia (DBQD) [MIM:251450] |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 229 | C | 0.983708 | G | 0.987219 | -0.003511 | No Change: Both D | - |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 236 | C | 0.994498 | G | 0.994827 | -3.29E-04 | No Change: Both D | - |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 245 | I | 0.920365 | S | 0.954998 | -0.034633 | No Change: Both D | - |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 247 | C | 0.892125 | G | 0.901893 | -0.009768 | No Change: Both D | - |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 249 | Y | 0.870923 | D | 0.920903 | -0.04998 | No Change: Both D | - |
| Q01518 | CAP1_HUMAN Adenylyl cyclase-associated protein 1 OS=Homo sapiens GN=CAP1 PE=1 SV=5 | 256 | S | 0.773246 | A | 0.708359 | 0.064887 | No Change: Both D | - |
| P40123 | CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens GN=CAP2 PE=1 SV=1 | 311 | T | 0.951931 | A | 0.944521 | 0.00741 | No Change: Both D | - |
| P40123 | CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens GN=CAP2 PE=1 SV=1 | 316 | Y | 0.911459 | C | 0.920851 | -0.009392 | No Change: Both D | - |
| P40121 | CAPG_HUMAN Macrophage-capping protein OS=Homo sapiens GN=CAPG PE=1 SV=2 | 41 | V | 0.297371 | I | 0.252571 | 0.0448 | No Change: Both O | - |
| P40121 | CAPG_HUMAN Macrophage-capping protein OS=Homo sapiens GN=CAPG PE=1 SV=2 | 198 | R | 0.462878 | W | 0.240031 | 0.222847 | No Change: Both O | - |
| P40121 | CAPG_HUMAN Macrophage-capping protein OS=Homo sapiens GN=CAPG PE=1 SV=2 | 335 | H | 0.389974 | R | 0.394756 | -0.004782 | No Change: Both O | - |
| P07384 | CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1 | 103 | T | 0.172954 | A | 0.154983 | 0.017971 | No Change: Both O | - |
| P07384 | CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1 | 433 | R | 0.555364 | P | 0.548686 | 0.006678 | No Change: Both D | - |
| P07384 | CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1 | 492 | G | 0.398727 | R | 0.460479 | -0.061752 | No Change: Both O | - |
| P07384 | CAN1_HUMAN Calpain-1 catalytic subunit OS=Homo sapiens GN=CAPN1 PE=1 SV=1 | 676 | V | 0.026414 | I | 0.020567 | 0.005847 | No Change: Both O | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 200 | P | 0.645235 | T | 0.623943 | 0.021292 | No Change: Both D | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 202 | R | 0.548407 | H | 0.533829 | 0.014578 | No Change: Both D | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 341 | A | 0.137862 | V | 0.096798 | 0.041064 | No Change: Both O | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 504 | T | 0.428783 | A | 0.418518 | 0.010265 | No Change: Both O | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 529 | A | 0.503735 | S | 0.600492 | -0.096757 | No Change: Both D | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 613 | S | 0.256486 | N | 0.208993 | 0.047493 | No Change: Both O | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 666 | I | 0.260982 | V | 0.310117 | -0.049135 | No Change: Both O | - |
| Q9HC96 | CAN10_HUMAN Calpain-10 OS=Homo sapiens GN=CAPN10 PE=2 SV=2 | 276 | E | 0.319897 | G | 0.285154 | 0.034743 | No Change: Both O | A colorectal cancer sample |
| Q9UMQ6 | CAN11_HUMAN Calpain-11 OS=Homo sapiens GN=CAPN11 PE=1 SV=2 | 728 | S | 0.11479 | N | 0.099847 | 0.014943 | No Change: Both O | - |
| Q9UMQ6 | CAN11_HUMAN Calpain-11 OS=Homo sapiens GN=CAPN11 PE=1 SV=2 | 266 | V | 0.588346 | M | 0.686713 | -0.098367 | No Change: Both D | - |
| Q9UMQ6 | CAN11_HUMAN Calpain-11 OS=Homo sapiens GN=CAPN11 PE=1 SV=2 | 441 | V | 0.055177 | A | 0.076451 | -0.021274 | No Change: Both O | - |
| Q9UMQ6 | CAN11_HUMAN Calpain-11 OS=Homo sapiens GN=CAPN11 PE=1 SV=2 | 521 | I | 0.257468 | V | 0.261104 | -0.003636 | No Change: Both O | - |
| Q9UMQ6 | CAN11_HUMAN Calpain-11 OS=Homo sapiens GN=CAPN11 PE=1 SV=2 | 544 | S | 0.520663 | R | 0.465809 | 0.054854 | D to O | - |
| Q6ZSI9 | CAN12_HUMAN Calpain-12 OS=Homo sapiens GN=CAPN12 PE=2 SV=1 | 287 | C | 0.073544 | R | 0.1563 | -0.082756 | No Change: Both O | - |
| Q6MZZ7 | CAN13_HUMAN Calpain-13 OS=Homo sapiens GN=CAPN13 PE=1 SV=2 | 249 | H | 0.18437 | Y | 0.121803 | 0.062567 | No Change: Both O | - |
| Q6MZZ7 | CAN13_HUMAN Calpain-13 OS=Homo sapiens GN=CAPN13 PE=1 SV=2 | 280 | A | 0.293554 | T | 0.333815 | -0.040261 | No Change: Both O | - |
| Q6MZZ7 | CAN13_HUMAN Calpain-13 OS=Homo sapiens GN=CAPN13 PE=1 SV=2 | 596 | I | 0.201208 | T | 0.344274 | -0.143066 | No Change: Both O | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 22 | D | 0.420256 | E | 0.460114 | -0.039858 | No Change: Both O | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 568 | K | 0.478424 | Q | 0.441537 | 0.036887 | No Change: Both O | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 68 | S | 0.479215 | G | 0.436863 | 0.042352 | No Change: Both O | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 476 | K | 0.268627 | R | 0.250057 | 0.01857 | No Change: Both O | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 521 | E | 0.579024 | Q | 0.513671 | 0.065353 | No Change: Both D | - |
| P17655 | CAN2_HUMAN Calpain-2 catalytic subunit OS=Homo sapiens GN=CAPN2 PE=1 SV=6 | 677 | K | 0.245234 | Q | 0.206143 | 0.039091 | No Change: Both O | - |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 182 | L | 0.09565 | Q | 0.182336 | -0.086686 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 234 | G | 0.284563 | E | 0.348433 | -0.06387 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 354 | V | 0.219361 | G | 0.336112 | -0.116751 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 490 | R | 0.591008 | W | 0.412256 | 0.178752 | D to O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 572 | R | 0.535484 | Q | 0.527378 | 0.008106 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 744 | S | 0.503944 | G | 0.444527 | 0.059417 | D to O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 769 | R | 0.173983 | Q | 0.191662 | -0.017679 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 4 | V | 0.975509 | I | 0.971552 | 0.003957 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 26 | P | 0.889741 | L | 0.757332 | 0.132409 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 77 | D | 0.390846 | N | 0.356947 | 0.033899 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 86 | S | 0.454361 | F | 0.285928 | 0.168433 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 107 | E | 0.238235 | K | 0.232444 | 0.005791 | No Change: Both O | - |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 118 | R | 0.211549 | G | 0.235285 | -0.023736 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 137 | C | 0.029535 | R | 0.063434 | -0.033899 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 162 | I | 0.048521 | L | 0.052109 | -0.003588 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 183 | P | 0.104638 | L | 0.054141 | 0.050497 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 184 | T | 0.121169 | M | 0.096138 | 0.025031 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 189 | L | 0.279009 | P | 0.462991 | -0.183982 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 214 | G | 0.417878 | S | 0.477167 | -0.059289 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 215 | S | 0.463105 | P | 0.431141 | 0.031964 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 217 | E | 0.49591 | K | 0.511654 | -0.015744 | O to D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 222 | G | 0.560652 | R | 0.533214 | 0.027438 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 226 | E | 0.548272 | K | 0.541412 | 0.00686 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 232 | T | 0.35839 | I | 0.2382 | 0.12019 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 236 | A | 0.253865 | T | 0.28047 | -0.026605 | No Change: Both O | - |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 319 | P | 0.354248 | L | 0.212601 | 0.141647 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 334 | H | 0.195664 | Q | 0.22134 | -0.025676 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 336 | Y | 0.208403 | N | 0.319449 | -0.111046 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 360 | W | 0.184414 | C | 0.203391 | -0.018977 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 437 | R | 0.23486 | C | 0.122748 | 0.112112 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 440 | R | 0.223177 | W | 0.098946 | 0.124231 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 441 | G | 0.218868 | D | 0.223589 | -0.004721 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 445 | G | 0.223405 | R | 0.231781 | -0.008376 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 448 | R | 0.226784 | C | 0.139231 | 0.087553 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 448 | R | 0.226784 | G | 0.241705 | -0.014921 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 448 | R | 0.226784 | H | 0.212686 | 0.014098 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 479 | S | 0.089484 | G | 0.064971 | 0.024513 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 486 | Q | 0.331422 | E | 0.37307 | -0.041648 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 489 | R | 0.533684 | Q | 0.540049 | -0.006365 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 489 | R | 0.533684 | W | 0.354906 | 0.178778 | D to O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 490 | R | 0.591008 | Q | 0.600178 | -0.00917 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 493 | R | 0.469459 | W | 0.333686 | 0.135773 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 496 | G | 0.31426 | R | 0.32206 | -0.0078 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 502 | I | 0.060273 | T | 0.109659 | -0.049386 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 541 | R | 0.365389 | Q | 0.37471 | -0.009321 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 567 | G | 0.528622 | W | 0.359145 | 0.169477 | D to O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 572 | R | 0.535484 | W | 0.288871 | 0.246613 | D to O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 606 | S | 0.875426 | L | 0.796209 | 0.079217 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 638 | Q | 0.99596 | P | 0.995983 | -2.30E-05 | No Change: Both D | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 698 | R | 0.224086 | P | 0.257001 | -0.032915 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 702 | A | 0.269327 | V | 0.206296 | 0.063031 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 705 | D | 0.410154 | G | 0.388186 | 0.021968 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 705 | D | 0.410154 | H | 0.355475 | 0.054679 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 731 | F | 0.218 | S | 0.425073 | -0.207073 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 748 | R | 0.39635 | Q | 0.416671 | -0.020321 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 774 | H | 0.293855 | D | 0.349212 | -0.055357 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 798 | A | 0.264839 | E | 0.368725 | -0.103886 | No Change: Both O | Limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600] |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 160 | A | 0.111079 | G | 0.147926 | -0.036847 | No Change: Both O | - |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 21 | G | 0.938173 | E | 0.948086 | -0.009913 | No Change: Both D | - |
| P20807 | CAN3_HUMAN Calpain-3 OS=Homo sapiens GN=CAPN3 PE=1 SV=2 | 622 | E | 0.971596 | A | 0.959489 | 0.012107 | No Change: Both D | - |
| Q9Y6Q1 | CAN6_HUMAN Calpain-6 OS=Homo sapiens GN=CAPN6 PE=1 SV=2 | 277 | V | 0.17541 | L | 0.173439 | 0.001971 | No Change: Both O | - |
| Q9Y6Q1 | CAN6_HUMAN Calpain-6 OS=Homo sapiens GN=CAPN6 PE=1 SV=2 | 358 | G | 0.123991 | R | 0.131633 | -0.007642 | No Change: Both O | A colorectal cancer sample |
| Q9Y6Q1 | CAN6_HUMAN Calpain-6 OS=Homo sapiens GN=CAPN6 PE=1 SV=2 | 518 | T | 0.211479 | I | 0.12359 | 0.087889 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 102 | A | 0.042576 | V | 0.026108 | 0.016468 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 122 | S | 0.400178 | R | 0.337738 | 0.06244 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 164 | D | 0.268042 | N | 0.265775 | 0.002267 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 234 | I | 0.192592 | T | 0.323425 | -0.130833 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 239 | A | 0.493726 | T | 0.514647 | -0.020921 | O to D | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 277 | R | 0.156246 | W | 0.064867 | 0.091379 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 322 | K | 0.190536 | Q | 0.150414 | 0.040122 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 327 | H | 0.201254 | Q | 0.212688 | -0.011434 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 342 | E | 0.397185 | K | 0.390801 | 0.006384 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 458 | R | 0.37053 | W | 0.178372 | 0.192158 | No Change: Both O | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 522 | R | 0.83592 | W | 0.6599 | 0.17602 | No Change: Both D | - |
| O14815 | CAN9_HUMAN Calpain-9 OS=Homo sapiens GN=CAPN9 PE=1 SV=1 | 611 | M | 0.547795 | I | 0.438786 | 0.109009 | D to O | - |
| P04632 | CPNS1_HUMAN Calpain small subunit 1 OS=Homo sapiens GN=CAPNS1 PE=1 SV=1 | 224 | M | 0.490258 | V | 0.43157 | 0.058688 | No Change: Both O | - |
| Q14444 | CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPRIN1 PE=1 SV=2 | 263 | A | 0.789292 | D | 0.805987 | -0.016695 | No Change: Both D | - |
| Q14444 | CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPRIN1 PE=1 SV=2 | 588 | Q | 0.966342 | H | 0.955265 | 0.011077 | No Change: Both D | - |
| Q14444 | CAPR1_HUMAN Caprin-1 OS=Homo sapiens GN=CAPRIN1 PE=1 SV=2 | 616 | R | 0.92663 | H | 0.888421 | 0.038209 | No Change: Both D | - |
| Q6IMN6 | CAPR2_HUMAN Caprin-2 OS=Homo sapiens GN=CAPRIN2 PE=1 SV=1 | 519 | M | 0.994849 | V | 0.992319 | 0.00253 | No Change: Both D | - |
| Q6IMN6 | CAPR2_HUMAN Caprin-2 OS=Homo sapiens GN=CAPRIN2 PE=1 SV=1 | 114 | P | 0.694382 | S | 0.729021 | -0.034639 | No Change: Both D | - |
| Q6IMN6 | CAPR2_HUMAN Caprin-2 OS=Homo sapiens GN=CAPRIN2 PE=1 SV=1 | 237 | K | 0.416643 | R | 0.351007 | 0.065636 | No Change: Both O | - |
| Q6IMN6 | CAPR2_HUMAN Caprin-2 OS=Homo sapiens GN=CAPRIN2 PE=1 SV=1 | 655 | S | 0.958542 | L | 0.924941 | 0.033601 | No Change: Both D | - |
| Q13938 | CAYP1_HUMAN Calcyphosin OS=Homo sapiens GN=CAPS PE=1 SV=1 | 39 | R | 0.735125 | G | 0.71565 | 0.019475 | No Change: Both D | - |
| Q9BXY5 | CAYP2_HUMAN Calcyphosin-2 OS=Homo sapiens GN=CAPS2 PE=2 SV=2 | 125 | L | 0.554319 | F | 0.487802 | 0.066517 | D to O | - |
| Q8WWF8 | CAPSL_HUMAN Calcyphosin-like protein OS=Homo sapiens GN=CAPSL PE=2 SV=4 | 85 | R | 0.457205 | Q | 0.424672 | 0.032533 | No Change: Both O | - |
| Q8WWF8 | CAPSL_HUMAN Calcyphosin-like protein OS=Homo sapiens GN=CAPSL PE=2 SV=4 | 201 | M | 0.034103 | V | 0.024821 | 0.009282 | No Change: Both O | - |
| Q9BWT7 | CAR10_HUMAN Caspase recruitment domain-containing protein 10 OS=Homo sapiens GN=CARD10 PE=2 SV=2 | 289 | R | 0.940806 | Q | 0.942794 | -0.001988 | No Change: Both D | - |
| Q9BXL7 | CAR11_HUMAN Caspase recruitment domain-containing protein 11 OS=Homo sapiens GN=CARD11 PE=1 SV=3 | 670 | T | 0.706919 | M | 0.654811 | 0.052108 | No Change: Both D | - |
| Q9BXL7 | CAR11_HUMAN Caspase recruitment domain-containing protein 11 OS=Homo sapiens GN=CARD11 PE=1 SV=3 | 694 | S | 0.549179 | L | 0.37769 | 0.171489 | D to O | - |
| Q9BXL6 | CAR14_HUMAN Caspase recruitment domain-containing protein 14 OS=Homo sapiens GN=CARD14 PE=1 SV=2 | 883 | R | 0.240211 | H | 0.236309 | 0.003902 | No Change: Both O | - |
| Q9BXL6 | CAR14_HUMAN Caspase recruitment domain-containing protein 14 OS=Homo sapiens GN=CARD14 PE=1 SV=2 | 547 | R | 0.779524 | S | 0.819812 | -0.040288 | No Change: Both D | - |
| Q9BXL6 | CAR14_HUMAN Caspase recruitment domain-containing protein 14 OS=Homo sapiens GN=CARD14 PE=1 SV=2 | 585 | V | 0.139676 | I | 0.137106 | 0.00257 | No Change: Both O | - |
| Q9BXL6 | CAR14_HUMAN Caspase recruitment domain-containing protein 14 OS=Homo sapiens GN=CARD14 PE=1 SV=2 | 820 | R | 0.409545 | W | 0.204376 | 0.205169 | No Change: Both O | - |
| Q9BXL6 | CAR14_HUMAN Caspase recruitment domain-containing protein 14 OS=Homo sapiens GN=CARD14 PE=1 SV=2 | 962 | R | 0.658126 | Q | 0.675633 | -0.017507 | No Change: Both D | - |
| Q5EG05 | CAR16_HUMAN Caspase recruitment domain-containing protein 16 OS=Homo sapiens GN=CARD16 PE=1 SV=1 | 33 | R | 0.409823 | S | 0.449099 | -0.039276 | No Change: Both O | - |
| Q5EG05 | CAR16_HUMAN Caspase recruitment domain-containing protein 16 OS=Homo sapiens GN=CARD16 PE=1 SV=1 | 37 | Q | 0.561217 | K | 0.598081 | -0.036864 | No Change: Both D | - |
| Q5EG05 | CAR16_HUMAN Caspase recruitment domain-containing protein 16 OS=Homo sapiens GN=CARD16 PE=1 SV=1 | 56 | A | 0.270382 | D | 0.354256 | -0.083874 | No Change: Both O | - |
| Q5EG05 | CAR16_HUMAN Caspase recruitment domain-containing protein 16 OS=Homo sapiens GN=CARD16 PE=1 SV=1 | 167 | N | 0.04691 | I | 0.022944 | 0.023966 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 86 | S | 0.267419 | L | 0.156102 | 0.111317 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 93 | R | 0.324807 | K | 0.407122 | -0.082315 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 395 | M | 0.413131 | K | 0.48831 | -0.075179 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 426 | D | 0.447239 | V | 0.303949 | 0.14329 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 575 | A | 0.079158 | D | 0.107071 | -0.027913 | No Change: Both O | - |
| Q9BX69 | CARD6_HUMAN Caspase recruitment domain-containing protein 6 OS=Homo sapiens GN=CARD6 PE=1 SV=2 | 576 | I | 0.078676 | V | 0.094075 | -0.015399 | No Change: Both O | - |
| Q9Y2G2 | CARD8_HUMAN Caspase recruitment domain-containing protein 8 OS=Homo sapiens GN=CARD8 PE=1 SV=1 | 68 | I | 0.413237 | V | 0.47435 | -0.061113 | No Change: Both O | - |
| Q9Y2G2 | CARD8_HUMAN Caspase recruitment domain-containing protein 8 OS=Homo sapiens GN=CARD8 PE=1 SV=1 | 99 | E | 0.116523 | A | 0.075446 | 0.041077 | No Change: Both O | - |
| Q9H257 | CARD9_HUMAN Caspase recruitment domain-containing protein 9 OS=Homo sapiens GN=CARD9 PE=1 SV=2 | 12 | S | 0.137358 | N | 0.119375 | 0.017983 | No Change: Both O | - |
| Q8IW45 | CARKD_HUMAN Carbohydrate kinase domain-containing protein OS=Homo sapiens GN=CARKD PE=1 SV=1 | 140 | K | 0.296139 | E | 0.318856 | -0.022717 | No Change: Both O | - |
| Q8IW45 | CARKD_HUMAN Carbohydrate kinase domain-containing protein OS=Homo sapiens GN=CARKD PE=1 SV=1 | 149 | V | 0.183431 | I | 0.151194 | 0.032237 | No Change: Both O | - |
| Q8IW45 | CARKD_HUMAN Carbohydrate kinase domain-containing protein OS=Homo sapiens GN=CARKD PE=1 SV=1 | 152 | P | 0.296866 | T | 0.246802 | 0.050064 | No Change: Both O | - |
| A5YM72 | CRNS1_HUMAN Carnosine synthase 1 OS=Homo sapiens GN=CARNS1 PE=1 SV=3 | 14 | P | 0.417323 | T | 0.32527 | 0.092053 | No Change: Both O | - |
| A5YM72 | CRNS1_HUMAN Carnosine synthase 1 OS=Homo sapiens GN=CARNS1 PE=1 SV=3 | 498 | M | 0.516473 | L | 0.48351 | 0.032963 | D to O | - |
| Q9HA77 | SYCM_HUMAN Probable cysteine--tRNA ligase mitochondrial OS=Homo sapiens GN=CARS2 PE=1 SV=1 | 440 | E | 0.756744 | K | 0.760431 | -0.003687 | No Change: Both D | - |
| Q9HA77 | SYCM_HUMAN Probable cysteine--tRNA ligase mitochondrial OS=Homo sapiens GN=CARS2 PE=1 SV=1 | 555 | Q | 0.745369 | P | 0.733386 | 0.011983 | No Change: Both D | - |
| Q16568 | CART_HUMAN Cocaine- and amphetamine-regulated transcript protein OS=Homo sapiens GN=CARTPT PE=1 SV=1 | 61 | L | 0.523323 | F | 0.447901 | 0.075422 | D to O | - |
| Q16568 | CART_HUMAN Cocaine- and amphetamine-regulated transcript protein OS=Homo sapiens GN=CARTPT PE=1 SV=1 | 66 | S | 0.531238 | T | 0.440451 | 0.090787 | D to O | - |
| Q16568 | CART_HUMAN Cocaine- and amphetamine-regulated transcript protein OS=Homo sapiens GN=CARTPT PE=1 SV=1 | 113 | L | 0.485305 | M | 0.540594 | -0.055289 | O to D | - |
| Q6TDU7 | CASC1_HUMAN Cancer susceptibility candidate protein 1 OS=Homo sapiens GN=CASC1 PE=2 SV=2 | 33 | R | 0.994294 | S | 0.993011 | 0.001283 | No Change: Both D | - |
| Q6TDU7 | CASC1_HUMAN Cancer susceptibility candidate protein 1 OS=Homo sapiens GN=CASC1 PE=2 SV=2 | 633 | A | 0.341342 | E | 0.455674 | -0.114332 | No Change: Both O | - |
| Q6XLA1 | CSC2A_HUMAN Protein CASC2 isoform 3 OS=Homo sapiens GN=CASC2 PE=2 SV=1 | 8 | P | 0.58968 | S | 0.642525 | -0.052845 | No Change: Both D | Some patients with endometrial cancer |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 43 | R | 0.858128 | T | 0.822009 | 0.036119 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 70 | T | 0.562853 | A | 0.541648 | 0.021205 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 113 | T | 0.560315 | A | 0.501352 | 0.058963 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 486 | A | 0.724221 | S | 0.808653 | -0.084432 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 936 | R | 0.388971 | G | 0.344888 | 0.044083 | No Change: Both O | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 1285 | K | 0.273157 | E | 0.276843 | -0.003686 | No Change: Both O | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 1473 | T | 0.690095 | A | 0.670237 | 0.019858 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 598 | M | 0.815235 | T | 0.850148 | -0.034913 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 177 | M | 0.624022 | V | 0.550903 | 0.073119 | No Change: Both D | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 1190 | L | 0.454694 | V | 0.471522 | -0.016828 | No Change: Both O | - |
| Q8NG31 | CASC5_HUMAN Protein CASC5 OS=Homo sapiens GN=CASC5 PE=1 SV=3 | 2338 | C | 0.416497 | Y | 0.509931 | -0.093434 | O to D | - |
| Q96PB1 | CASD1_HUMAN CAS1 domain-containing protein 1 OS=Homo sapiens GN=CASD1 PE=2 SV=1 | 386 | R | 0.097555 | S | 0.129974 | -0.032419 | No Change: Both O | - |
| O14936 | CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3 | 96 | G | 0.085791 | V | 0.049374 | 0.036417 | No Change: Both O | A lung large cell carcinoma sample |
| O14936 | CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3 | 28 | R | 0.165737 | L | 0.090189 | 0.075548 | No Change: Both O | FG syndrome type 4 (FGS4) [MIM:300422] |
| O14936 | CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3 | 268 | Y | 0.177816 | H | 0.285052 | -0.107236 | No Change: Both O | Mental retardation X-linked CASK-related (MRXCASK) [MIM:300749] |
| O14936 | CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3 | 396 | P | 0.694272 | S | 0.707852 | -0.01358 | No Change: Both D | Mental retardation X-linked CASK-related (MRXCASK) [MIM:300749] |
| O14936 | CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3 | 710 | D | 0.609887 | G | 0.598194 | 0.011693 | No Change: Both D | Mental retardation X-linked CASK-related (MRXCASK) [MIM:300749] |
| Q8WXE0 | CSKI2_HUMAN Caskin-2 OS=Homo sapiens GN=CASKIN2 PE=1 SV=2 | 891 | E | 0.999485 | G | 0.999409 | 7.60E-05 | No Change: Both D | - |
| P29466 | CASP1_HUMAN Caspase-1 OS=Homo sapiens GN=CASP1 PE=1 SV=1 | 15 | R | 0.469146 | H | 0.370335 | 0.098811 | No Change: Both O | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 285 | L | 0.220028 | F | 0.201688 | 0.01834 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 2A (ALPS2A) [MIM:603909] |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 410 | V | 0.586727 | I | 0.619307 | -0.03258 | No Change: Both D | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 147 | M | 0.535996 | T | 0.57958 | -0.043584 | No Change: Both D | Gastric cancer (GASC) [MIM:613659] |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 406 | I | 0.597027 | L | 0.618515 | -0.021488 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 2A (ALPS2A) [MIM:603909] |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 414 | A | 0.624854 | V | 0.535992 | 0.088862 | No Change: Both D | Familial non-Hodgkin lymphoma (NHL) [MIM:605027] |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 446 | Y | 0.180364 | C | 0.149471 | 0.030893 | No Change: Both O | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 239 | S | 0.731771 | C | 0.605646 | 0.126125 | No Change: Both D | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 444 | P | 0.135858 | S | 0.160379 | -0.024521 | No Change: Both O | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 14 | K | 0.620819 | T | 0.529049 | 0.09177 | No Change: Both D | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 21 | R | 0.23416 | C | 0.167652 | 0.066508 | No Change: Both O | - |
| Q92851 | CASPA_HUMAN Caspase-10 OS=Homo sapiens GN=CASP10 PE=1 SV=3 | 285 | L | 0.220028 | P | 0.343093 | -0.123065 | No Change: Both O | - |
| P42575 | CASP2_HUMAN Caspase-2 OS=Homo sapiens GN=CASP2 PE=1 SV=2 | 172 | V | 0.344841 | L | 0.363093 | -0.018252 | No Change: Both O | - |
| P42575 | CASP2_HUMAN Caspase-2 OS=Homo sapiens GN=CASP2 PE=1 SV=2 | 178 | P | 0.233247 | A | 0.150403 | 0.082844 | No Change: Both O | - |
| P42575 | CASP2_HUMAN Caspase-2 OS=Homo sapiens GN=CASP2 PE=1 SV=2 | 441 | R | 0.20172 | G | 0.183039 | 0.018681 | No Change: Both O | - |
| P42575 | CASP2_HUMAN Caspase-2 OS=Homo sapiens GN=CASP2 PE=1 SV=2 | 105 | A | 0.301819 | G | 0.342234 | -0.040415 | No Change: Both O | - |
| P42574 | CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3 PE=1 SV=2 | 190 | E | 0.150155 | D | 0.14589 | 0.004265 | No Change: Both O | - |
| P42574 | CASP3_HUMAN Caspase-3 OS=Homo sapiens GN=CASP3 PE=1 SV=2 | 22 | H | 0.797938 | R | 0.817025 | -0.019087 | No Change: Both D | - |
| P49662 | CASP4_HUMAN Caspase-4 OS=Homo sapiens GN=CASP4 PE=1 SV=1 | 47 | D | 0.694685 | N | 0.671368 | 0.023317 | No Change: Both D | - |
| P49662 | CASP4_HUMAN Caspase-4 OS=Homo sapiens GN=CASP4 PE=1 SV=1 | 284 | E | 0.752119 | D | 0.739256 | 0.012863 | No Change: Both D | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 29 | F | 0.275452 | L | 0.311777 | -0.036325 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 168 | R | 0.501392 | H | 0.429197 | 0.072195 | D to O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 217 | V | 0.168598 | L | 0.182897 | -0.014299 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 19 | K | 0.306573 | N | 0.267583 | 0.03899 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 26 | L | 0.289032 | W | 0.189803 | 0.099229 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 106 | T | 0.512676 | A | 0.495906 | 0.01677 | D to O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 334 | L | 0.593959 | V | 0.580934 | 0.013025 | No Change: Both D | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 353 | E | 0.38151 | K | 0.378456 | 0.003054 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 75 | L | 0.389728 | R | 0.458223 | -0.068495 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 298 | R | 0.146917 | H | 0.148877 | -0.00196 | No Change: Both O | - |
| P51878 | CASP5_HUMAN Caspase-5 OS=Homo sapiens GN=CASP5 PE=2 SV=3 | 382 | E | 0.070877 | Q | 0.062655 | 0.008222 | No Change: Both O | - |
| P55212 | CASP6_HUMAN Caspase-6 OS=Homo sapiens GN=CASP6 PE=1 SV=2 | 109 | A | 0.26995 | T | 0.294913 | -0.024963 | No Change: Both O | - |
| P55212 | CASP6_HUMAN Caspase-6 OS=Homo sapiens GN=CASP6 PE=1 SV=2 | 182 | T | 0.518471 | S | 0.583321 | -0.06485 | No Change: Both D | - |
| P55212 | CASP6_HUMAN Caspase-6 OS=Homo sapiens GN=CASP6 PE=1 SV=2 | 35 | E | 0.581092 | K | 0.583046 | -0.001954 | No Change: Both D | - |
| P55210 | CASP7_HUMAN Caspase-7 OS=Homo sapiens GN=CASP7 PE=1 SV=1 | 4 | D | 0.908284 | E | 0.914284 | -0.006 | No Change: Both D | - |
| P55210 | CASP7_HUMAN Caspase-7 OS=Homo sapiens GN=CASP7 PE=1 SV=1 | 255 | D | 0.390165 | E | 0.439678 | -0.049513 | No Change: Both O | - |
| Q14790 | CASP8_HUMAN Caspase-8 OS=Homo sapiens GN=CASP8 PE=1 SV=1 | 248 | R | 0.53441 | W | 0.358393 | 0.176017 | D to O | Caspase-8 deficiency (CASP8D) [MIM:607271] |
| Q14790 | CASP8_HUMAN Caspase-8 OS=Homo sapiens GN=CASP8 PE=1 SV=1 | 285 | D | 0.339841 | H | 0.308106 | 0.031735 | No Change: Both O | - |
| Q14790 | CASP8_HUMAN Caspase-8 OS=Homo sapiens GN=CASP8 PE=1 SV=1 | 219 | S | 0.740125 | T | 0.692411 | 0.047714 | No Change: Both D | - |
| Q9UKL3 | C8AP2_HUMAN CASP8-associated protein 2 OS=Homo sapiens GN=CASP8AP2 PE=1 SV=1 | 1659 | P | 0.575524 | S | 0.601448 | -0.025924 | No Change: Both D | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 28 | A | 0.508563 | V | 0.450993 | 0.05757 | D to O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 99 | S | 0.63809 | L | 0.539032 | 0.099058 | No Change: Both D | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 102 | T | 0.626425 | I | 0.488284 | 0.138141 | D to O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 106 | L | 0.613066 | V | 0.596021 | 0.017045 | No Change: Both D | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 114 | E | 0.681177 | D | 0.638779 | 0.042398 | No Change: Both D | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 173 | R | 0.288012 | H | 0.262428 | 0.025584 | No Change: Both O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 221 | Q | 0.306836 | R | 0.272341 | 0.034495 | No Change: Both O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 176 | G | 0.443536 | R | 0.456266 | -0.01273 | No Change: Both O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 192 | R | 0.35476 | C | 0.20781 | 0.14695 | No Change: Both O | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 185 | I | 0.449358 | M | 0.559992 | -0.110634 | O to D | - |
| P55211 | CASP9_HUMAN Caspase-9 OS=Homo sapiens GN=CASP9 PE=1 SV=3 | 136 | F | 0.424332 | L | 0.484893 | -0.060561 | No Change: Both O | - |
| P31415 | CASQ1_HUMAN Calsequestrin-1 OS=Homo sapiens GN=CASQ1 PE=1 SV=3 | 140 | Y | 0.330462 | F | 0.327607 | 0.002855 | No Change: Both O | - |
| O14958 | CASQ2_HUMAN Calsequestrin-2 OS=Homo sapiens GN=CASQ2 PE=1 SV=2 | 307 | D | 0.125723 | H | 0.095816 | 0.029907 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2) [MIM:611938] |
| O14958 | CASQ2_HUMAN Calsequestrin-2 OS=Homo sapiens GN=CASQ2 PE=1 SV=2 | 66 | T | 0.606019 | A | 0.572951 | 0.033068 | No Change: Both D | - |
| O14958 | CASQ2_HUMAN Calsequestrin-2 OS=Homo sapiens GN=CASQ2 PE=1 SV=2 | 76 | V | 0.141886 | M | 0.172434 | -0.030548 | No Change: Both O | - |
| O14958 | CASQ2_HUMAN Calsequestrin-2 OS=Homo sapiens GN=CASQ2 PE=1 SV=2 | 167 | L | 0.128787 | H | 0.202868 | -0.074081 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2) [MIM:611938] |
| O14958 | CASQ2_HUMAN Calsequestrin-2 OS=Homo sapiens GN=CASQ2 PE=1 SV=2 | 33 | R | 0.456851 | Q | 0.480459 | -0.023608 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2) [MIM:611938] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 39 | P | 0.065581 | A | 0.04767 | 0.017911 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 62 | R | 0.123028 | M | 0.087443 | 0.035585 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 62 | R | 0.123028 | M | 0.087443 | 0.035585 | No Change: Both O | Neonatal severe primary hyperparathyroidism (NSHPT) [MIM:239200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 66 | R | 0.044668 | C | 0.019607 | 0.025061 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 116 | A | 0.224742 | T | 0.246699 | -0.021957 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 127 | E | 0.236677 | A | 0.152304 | 0.084373 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 138 | T | 0.260765 | M | 0.212686 | 0.048079 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 143 | G | 0.349709 | E | 0.379104 | -0.029395 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 174 | L | 0.654974 | R | 0.741272 | -0.086298 | No Change: Both D | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 185 | R | 0.284601 | Q | 0.321968 | -0.037367 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 227 | R | 0.651031 | L | 0.513353 | 0.137678 | No Change: Both D | Neonatal severe primary hyperparathyroidism (NSHPT) [MIM:239200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 227 | R | 0.651031 | Q | 0.650542 | 4.89E-04 | No Change: Both D | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 297 | E | 0.237048 | K | 0.247941 | -0.010893 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 297 | E | 0.237048 | K | 0.247941 | -0.010893 | No Change: Both O | Neonatal severe primary hyperparathyroidism (NSHPT) [MIM:239200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 582 | C | 0.622111 | Y | 0.555654 | 0.066457 | No Change: Both D | Neonatal severe primary hyperparathyroidism (NSHPT) [MIM:239200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 681 | Q | 0.105402 | H | 0.094748 | 0.010654 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 795 | R | 0.349577 | W | 0.174961 | 0.174616 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 806 | F | 0.149628 | S | 0.315763 | -0.166135 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 851 | C | 0.015403 | S | 0.050344 | -0.034941 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 557 | G | 0.560116 | E | 0.630203 | -0.070087 | No Change: Both D | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 986 | A | 0.777331 | S | 0.844608 | -0.067277 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 1011 | Q | 0.841472 | E | 0.842195 | -7.23E-04 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 616 | L | 0.035759 | V | 0.035412 | 3.47E-04 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 951 | P | 0.985014 | T | 0.981439 | 0.003575 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 990 | R | 0.791065 | G | 0.782656 | 0.008409 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 767 | E | 0.105357 | K | 0.102918 | 0.002439 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 11 | L | 0.016514 | S | 0.041757 | -0.025243 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 13 | L | 0.031345 | P | 0.062281 | -0.030936 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 14 | T | 0.049415 | A | 0.04437 | 0.005045 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 21 | G | 0.551432 | R | 0.550807 | 6.25E-04 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 47 | K | 0.459553 | N | 0.404859 | 0.054694 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 118 | N | 0.305267 | K | 0.34765 | -0.042383 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 125 | L | 0.248795 | P | 0.387948 | -0.139153 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 128 | F | 0.231822 | L | 0.274342 | -0.04252 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 131 | C | 0.240278 | W | 0.196178 | 0.0441 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 151 | T | 0.321546 | M | 0.268763 | 0.052783 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 171 | S | 0.615595 | N | 0.56562 | 0.049975 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 180 | F | 0.465839 | C | 0.43303 | 0.032809 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 191 | E | 0.532911 | K | 0.531484 | 0.001427 | No Change: Both D | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 221 | P | 0.457269 | Q | 0.439709 | 0.01756 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 225 | K | 0.619578 | T | 0.543643 | 0.075935 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 250 | E | 0.55242 | K | 0.526049 | 0.026371 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 271 | S | 0.211507 | F | 0.085456 | 0.126051 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 397 | G | 0.382331 | R | 0.3949 | -0.012569 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 465 | R | 0.166896 | Q | 0.189237 | -0.022341 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 509 | G | 0.119979 | R | 0.110135 | 0.009844 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 553 | G | 0.512304 | R | 0.531959 | -0.019655 | No Change: Both D | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 555 | I | 0.553661 | V | 0.566128 | -0.012467 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 562 | C | 0.585242 | Y | 0.458742 | 0.1265 | D to O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 582 | C | 0.622111 | F | 0.571352 | 0.050759 | No Change: Both D | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 604 | E | 0.15729 | K | 0.154035 | 0.003255 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 612 | F | 0.084828 | S | 0.211349 | -0.126521 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 623 | G | 0.017565 | D | 0.019796 | -0.002231 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 670 | G | 0.156466 | E | 0.207615 | -0.051149 | No Change: Both O | Neonatal severe primary hyperparathyroidism (NSHPT) [MIM:239200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 670 | G | 0.156466 | R | 0.155013 | 0.001453 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 727 | L | 0.009766 | Q | 0.019266 | -0.0095 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 728 | V | 0.009554 | F | 0.009182 | 3.72E-04 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 742 | W | 0.01426 | R | 0.038021 | -0.023761 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 773 | L | 0.081205 | R | 0.126495 | -0.04529 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 788 | F | 0.014353 | C | 0.012986 | 0.001367 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 788 | F | 0.014353 | L | 0.016133 | -0.00178 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 820 | S | 0.015764 | F | 0.005686 | 0.010078 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 843 | A | 0.045954 | E | 0.072919 | -0.026965 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 881 | F | 0.44596 | L | 0.47068 | -0.02472 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 886 | R | 0.666912 | W | 0.470919 | 0.195993 | D to O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 354 | E | 0.271904 | A | 0.180929 | 0.090975 | No Change: Both O | Idiopathic generalized epilepsy type 8 (IGE8) [MIM:612899] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 686 | I | 0.045607 | V | 0.053297 | -0.00769 | No Change: Both O | Idiopathic generalized epilepsy type 8 (IGE8) [MIM:612899] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 898 | R | 0.951996 | Q | 0.936468 | 0.015528 | No Change: Both D | Idiopathic generalized epilepsy type 8 (IGE8) [MIM:612899] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 988 | A | 0.780426 | G | 0.795822 | -0.015396 | No Change: Both D | Idiopathic generalized epilepsy type 8 (IGE8) [MIM:612899] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 988 | A | 0.780426 | V | 0.72809 | 0.052336 | No Change: Both D | Idiopathic generalized epilepsy type 8 (IGE8) [MIM:612899] |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 27 | Q | 0.615212 | R | 0.594706 | 0.020506 | No Change: Both D | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 100 | T | 0.105198 | I | 0.055533 | 0.049665 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 339 | P | 0.518667 | T | 0.472778 | 0.045889 | D to O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 650 | L | 0.167072 | P | 0.284623 | -0.117551 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 689 | V | 0.019216 | M | 0.025647 | -0.006431 | No Change: Both O | - |
| P41180 | CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens GN=CASR PE=1 SV=2 | 697 | V | 0.037102 | M | 0.045558 | -0.008456 | No Change: Both O | Familial hypocalciuric hypercalcemia type 1 (FHH) [MIM:145980] |
| Q9NQ75 | CASS4_HUMAN Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4 PE=1 SV=2 | 491 | R | 0.327026 | K | 0.371511 | -0.044485 | No Change: Both O | - |
| Q9NQ75 | CASS4_HUMAN Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4 PE=1 SV=2 | 629 | T | 0.977997 | N | 0.978772 | -7.75E-04 | No Change: Both D | - |
| Q9NQ75 | CASS4_HUMAN Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4 PE=1 SV=2 | 660 | P | 0.862078 | S | 0.856918 | 0.00516 | No Change: Both D | - |
| Q9NQ75 | CASS4_HUMAN Cas scaffolding protein family member 4 OS=Homo sapiens GN=CASS4 PE=1 SV=2 | 780 | Q | 0.626863 | H | 0.599695 | 0.027168 | No Change: Both D | - |
| P20810 | ICAL_HUMAN Calpastatin OS=Homo sapiens GN=CAST PE=1 SV=4 | 592 | E | 0.982031 | G | 0.975272 | 0.006759 | No Change: Both D | - |
| P20810 | ICAL_HUMAN Calpastatin OS=Homo sapiens GN=CAST PE=1 SV=4 | 408 | C | 0.930592 | S | 0.952427 | -0.021835 | No Change: Both D | - |
| P20810 | ICAL_HUMAN Calpastatin OS=Homo sapiens GN=CAST PE=1 SV=4 | 380 | E | 0.995715 | K | 0.995512 | 2.03E-04 | No Change: Both D | - |
| P20810 | ICAL_HUMAN Calpastatin OS=Homo sapiens GN=CAST PE=1 SV=4 | 537 | A | 0.791784 | V | 0.726016 | 0.065768 | No Change: Both D | - |
| Q8NEC5 | CTSR1_HUMAN Cation channel sperm-associated protein 1 OS=Homo sapiens GN=CATSPER1 PE=1 SV=3 | 133 | G | 0.945788 | S | 0.957123 | -0.011335 | No Change: Both D | - |
| Q8NEC5 | CTSR1_HUMAN Cation channel sperm-associated protein 1 OS=Homo sapiens GN=CATSPER1 PE=1 SV=3 | 652 | V | 0.00432 | I | 0.004383 | -6.30E-05 | No Change: Both O | - |
| Q8NEC5 | CTSR1_HUMAN Cation channel sperm-associated protein 1 OS=Homo sapiens GN=CATSPER1 PE=1 SV=3 | 730 | T | 0.578484 | P | 0.602743 | -0.024259 | No Change: Both D | - |
| Q96P56 | CTSR2_HUMAN Cation channel sperm-associated protein 2 OS=Homo sapiens GN=CATSPER2 PE=1 SV=2 | 8 | E | 0.682315 | G | 0.61568 | 0.066635 | No Change: Both D | - |
| Q96P56 | CTSR2_HUMAN Cation channel sperm-associated protein 2 OS=Homo sapiens GN=CATSPER2 PE=1 SV=2 | 57 | V | 0.582678 | I | 0.573775 | 0.008903 | No Change: Both D | - |
| Q86XQ3 | CTSR3_HUMAN Cation channel sperm-associated protein 3 OS=Homo sapiens GN=CATSPER3 PE=1 SV=1 | 204 | N | 0.627701 | K | 0.653743 | -0.026042 | No Change: Both D | - |
| Q7RTX7 | CTSR4_HUMAN Cation channel sperm-associated protein 4 OS=Homo sapiens GN=CATSPER4 PE=1 SV=1 | 77 | Q | 0.194324 | R | 0.180115 | 0.014209 | No Change: Both O | - |
| Q7RTX7 | CTSR4_HUMAN Cation channel sperm-associated protein 4 OS=Homo sapiens GN=CATSPER4 PE=1 SV=1 | 124 | L | 0.210221 | F | 0.19029 | 0.019931 | No Change: Both O | - |
| Q7RTX7 | CTSR4_HUMAN Cation channel sperm-associated protein 4 OS=Homo sapiens GN=CATSPER4 PE=1 SV=1 | 293 | I | 0.019569 | V | 0.019793 | -2.24E-04 | No Change: Both O | - |
| Q7RTX7 | CTSR4_HUMAN Cation channel sperm-associated protein 4 OS=Homo sapiens GN=CATSPER4 PE=1 SV=1 | 436 | D | 0.954273 | N | 0.948359 | 0.005914 | No Change: Both D | - |
| Q9H7T0 | CTSRB_HUMAN Cation channel sperm-associated protein subunit beta OS=Homo sapiens GN=CATSPERB PE=1 SV=2 | 318 | F | 0.276594 | Y | 0.320878 | -0.044284 | No Change: Both O | - |
| Q6ZRH7 | CTSRG_HUMAN Cation channel sperm-associated protein subunit gamma OS=Homo sapiens GN=CATSPERG PE=2 SV=3 | 29 | L | 0.019593 | P | 0.037619 | -0.018026 | No Change: Both O | - |
| Q6ZRH7 | CTSRG_HUMAN Cation channel sperm-associated protein subunit gamma OS=Homo sapiens GN=CATSPERG PE=2 SV=3 | 650 | S | 0.682554 | R | 0.661731 | 0.020823 | No Change: Both D | - |
| Q6ZRH7 | CTSRG_HUMAN Cation channel sperm-associated protein subunit gamma OS=Homo sapiens GN=CATSPERG PE=2 SV=3 | 1137 | M | 0.903134 | T | 0.898712 | 0.004422 | No Change: Both D | - |
| Q03135 | CAV1_HUMAN Caveolin-1 OS=Homo sapiens GN=CAV1 PE=1 SV=4 | 132 | P | 0.02133 | L | 0.010342 | 0.010988 | No Change: Both O | Breast cancer |
| P51636 | CAV2_HUMAN Caveolin-2 OS=Homo sapiens GN=CAV2 PE=1 SV=2 | 130 | Q | 0.125649 | E | 0.152894 | -0.027245 | No Change: Both O | - |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 105 | P | 0.022981 | L | 0.010917 | 0.012064 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 105 | P | 0.022981 | L | 0.010917 | 0.012064 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 57 | V | 0.168977 | M | 0.202812 | -0.033835 | No Change: Both O | HyperCKmia (HYPCK) [MIM:123320] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 72 | C | 0.043346 | W | 0.039176 | 0.00417 | No Change: Both O | - |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 27 | R | 0.408515 | Q | 0.43238 | -0.023865 | No Change: Both O | HyperCKmia (HYPCK) [MIM:123320] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 27 | R | 0.408515 | Q | 0.43238 | -0.023865 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 27 | R | 0.408515 | Q | 0.43238 | -0.023865 | No Change: Both O | Myopathy distal Tateyama type (MPDT) [MIM:614321] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 27 | R | 0.408515 | Q | 0.43238 | -0.023865 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 46 | A | 0.216427 | T | 0.255846 | -0.039419 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 46 | A | 0.216427 | T | 0.255846 | -0.039419 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 46 | A | 0.216427 | V | 0.173752 | 0.042675 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 28 | D | 0.460882 | E | 0.486482 | -0.0256 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 28 | D | 0.460882 | E | 0.486482 | -0.0256 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 87 | L | 0.014713 | P | 0.030669 | -0.015956 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 93 | A | 0.006962 | T | 0.007681 | -7.19E-04 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 33 | N | 0.448396 | K | 0.493604 | -0.045208 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 33 | N | 0.448396 | K | 0.493604 | -0.045208 | No Change: Both O | Myopathy distal Tateyama type (MPDT) [MIM:614321] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 44 | V | 0.198958 | E | 0.376417 | -0.177459 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 64 | T | 0.116563 | P | 0.134241 | -0.017678 | No Change: Both O | Limb-girdle muscular dystrophy type 1C (LGMD1C) [MIM:607801] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 61 | S | 0.150361 | R | 0.106763 | 0.043598 | No Change: Both O | - |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 29 | P | 0.491521 | L | 0.335828 | 0.155693 | No Change: Both O | HyperCKmia (HYPCK) [MIM:123320] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 53 | S | 0.150008 | G | 0.127595 | 0.022413 | No Change: Both O | Rippling muscle disease (RMD) [MIM:606072] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 56 | G | 0.176821 | S | 0.224318 | -0.047497 | No Change: Both O | - |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 64 | T | 0.116563 | S | 0.162624 | -0.046061 | No Change: Both O | Familial hypertrophic cardiomyopathy (CMH) [MIM:192600] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 126 | R | 0.035393 | H | 0.037808 | -0.002415 | No Change: Both O | - |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 14 | V | 0.324847 | L | 0.339027 | -0.01418 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 78 | T | 0.0539 | M | 0.043445 | 0.010455 | No Change: Both O | Long QT syndrome type 9 (LQT9) [MIM:611818] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 78 | T | 0.0539 | M | 0.043445 | 0.010455 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 79 | L | 0.059066 | R | 0.098672 | -0.039606 | No Change: Both O | Long QT syndrome type 9 (LQT9) [MIM:611818] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 79 | L | 0.059066 | R | 0.098672 | -0.039606 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 85 | A | 0.029036 | T | 0.034905 | -0.005869 | No Change: Both O | Long QT syndrome type 9 (LQT9) [MIM:611818] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 97 | F | 0.007655 | C | 0.007257 | 3.98E-04 | No Change: Both O | Long QT syndrome type 9 (LQT9) [MIM:611818] |
| P56539 | CAV3_HUMAN Caveolin-3 OS=Homo sapiens GN=CAV3 PE=1 SV=1 | 141 | S | 0.125592 | R | 0.092496 | 0.033096 | No Change: Both O | Long QT syndrome type 9 (LQT9) [MIM:611818] |
| O75081 | MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens GN=CBFA2T3 PE=1 SV=2 | 429 | E | 0.672465 | G | 0.588706 | 0.083759 | No Change: Both D | - |
| O75081 | MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens GN=CBFA2T3 PE=1 SV=2 | 306 | R | 0.97521 | H | 0.969334 | 0.005876 | No Change: Both D | A colorectal cancer sample |
| O75081 | MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens GN=CBFA2T3 PE=1 SV=2 | 518 | E | 0.868318 | K | 0.86228 | 0.006038 | No Change: Both D | A colorectal cancer sample |
| O75081 | MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens GN=CBFA2T3 PE=1 SV=2 | 534 | A | 0.858809 | V | 0.798742 | 0.060067 | No Change: Both D | A colorectal cancer sample |
| Q13951 | PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens GN=CBFB PE=1 SV=2 | 100 | P | 0.102494 | A | 0.079045 | 0.023449 | No Change: Both O | A breast cancer sample |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 620 | L | 0.928087 | F | 0.919171 | 0.008916 | No Change: Both D | - |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 782 | P | 0.646512 | L | 0.480698 | 0.165814 | D to O | - |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 904 | V | 0.844547 | I | 0.83096 | 0.013587 | No Change: Both D | - |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 367 | Q | 0.353158 | P | 0.364596 | -0.011438 | No Change: Both O | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 382 | K | 0.236806 | E | 0.255265 | -0.018459 | No Change: Both O | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 390 | D | 0.433543 | Y | 0.275589 | 0.157954 | No Change: Both O | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
| P22681 | CBL_HUMAN E3 ubiquitin-protein ligase CBL OS=Homo sapiens GN=CBL PE=1 SV=2 | 420 | R | 0.441829 | Q | 0.475523 | -0.033694 | No Change: Both O | Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia (NSLL) [MIM:613563] |
| Q13191 | CBLB_HUMAN E3 ubiquitin-protein ligase CBL-B OS=Homo sapiens GN=CBLB PE=1 SV=2 | 584 | R | 0.729497 | K | 0.702432 | 0.027065 | No Change: Both D | - |
| Q13191 | CBLB_HUMAN E3 ubiquitin-protein ligase CBL-B OS=Homo sapiens GN=CBLB PE=1 SV=2 | 883 | N | 0.886655 | D | 0.903159 | -0.016504 | No Change: Both D | - |
| Q9ULV8 | CBLC_HUMAN Signal transduction protein CBL-C OS=Homo sapiens GN=CBLC PE=1 SV=3 | 405 | H | 0.35874 | Y | 0.274475 | 0.084265 | No Change: Both O | - |
| P16152 | CBR1_HUMAN Carbonyl reductase [NADPH] 1 OS=Homo sapiens GN=CBR1 PE=1 SV=3 | 131 | P | 0.28404 | S | 0.297741 | -0.013701 | No Change: Both O | - |
| P16152 | CBR1_HUMAN Carbonyl reductase [NADPH] 1 OS=Homo sapiens GN=CBR1 PE=1 SV=3 | 88 | V | 0.119665 | I | 0.10452 | 0.015145 | No Change: Both O | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 4 | C | 0.707584 | Y | 0.776661 | -0.069077 | No Change: Both D | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 84 | L | 0.182219 | V | 0.184053 | -0.001834 | No Change: Both O | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 93 | V | 0.253277 | I | 0.216486 | 0.036791 | No Change: Both O | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 131 | P | 0.283781 | S | 0.296176 | -0.012395 | No Change: Both O | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 235 | M | 0.601574 | L | 0.5723 | 0.029274 | No Change: Both D | - |
| O75828 | CBR3_HUMAN Carbonyl reductase [NADPH] 3 OS=Homo sapiens GN=CBR3 PE=1 SV=3 | 244 | V | 0.560382 | M | 0.618758 | -0.058376 | No Change: Both D | - |
| Q8N4T8 | CBR4_HUMAN Carbonyl reductase family member 4 OS=Homo sapiens GN=CBR4 PE=1 SV=3 | 70 | L | 0.457097 | M | 0.488018 | -0.030921 | No Change: Both O | - |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 78 | P | 0.569908 | R | 0.506283 | 0.063625 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 88 | P | 0.399458 | S | 0.393568 | 0.00589 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 102 | K | 0.264391 | N | 0.206758 | 0.057633 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 114 | A | 0.286061 | V | 0.225484 | 0.060577 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 125 | R | 0.398304 | Q | 0.373747 | 0.024557 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 131 | E | 0.555018 | D | 0.541859 | 0.013159 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 144 | E | 0.48807 | K | 0.490714 | -0.002644 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 145 | P | 0.477903 | L | 0.350374 | 0.127529 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 165 | C | 0.078414 | Y | 0.086111 | -0.007697 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 168 | V | 0.172629 | M | 0.231767 | -0.059138 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 224 | R | 0.43648 | H | 0.462011 | -0.025531 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 239 | E | 0.30818 | K | 0.314997 | -0.006817 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 257 | T | 0.314305 | M | 0.266616 | 0.047689 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 278 | I | 0.265246 | T | 0.391294 | -0.126048 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 290 | P | 0.621145 | L | 0.489462 | 0.131683 | D to O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 307 | G | 0.16001 | S | 0.185629 | -0.025619 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 331 | A | 0.318534 | V | 0.232537 | 0.085997 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 336 | R | 0.099796 | C | 0.048028 | 0.051768 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 369 | R | 0.165954 | H | 0.164073 | 0.001881 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 371 | V | 0.121186 | M | 0.150478 | -0.029292 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 384 | K | 0.212438 | E | 0.21288 | -4.42E-04 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 444 | D | 0.321697 | N | 0.29333 | 0.028367 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 454 | V | 0.120418 | E | 0.241627 | -0.121209 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 539 | L | 0.063059 | S | 0.142769 | -0.07971 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 49 | P | 0.898282 | L | 0.826819 | 0.071463 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 58 | R | 0.844789 | W | 0.735913 | 0.108876 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 85 | G | 0.44712 | R | 0.465727 | -0.018607 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 102 | K | 0.264391 | Q | 0.189696 | 0.074695 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 116 | G | 0.352962 | R | 0.366004 | -0.013042 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 121 | R | 0.423574 | C | 0.300345 | 0.123229 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 121 | R | 0.423574 | H | 0.37263 | 0.050944 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 121 | R | 0.423574 | L | 0.311898 | 0.111676 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 125 | R | 0.398304 | W | 0.181654 | 0.21665 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 126 | M | 0.426277 | V | 0.360904 | 0.065373 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 128 | E | 0.486493 | D | 0.47098 | 0.015513 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 139 | G | 0.550896 | R | 0.534204 | 0.016692 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 148 | G | 0.411245 | R | 0.396802 | 0.014443 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 151 | G | 0.324002 | R | 0.307106 | 0.016896 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 152 | I | 0.297247 | M | 0.376302 | -0.079055 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 155 | A | 0.183809 | T | 0.201083 | -0.017274 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 176 | E | 0.547316 | K | 0.552247 | -0.004931 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 180 | V | 0.326889 | A | 0.4074 | -0.080511 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 191 | T | 0.316824 | M | 0.27028 | 0.046544 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 198 | D | 0.531054 | V | 0.440777 | 0.090277 | D to O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 226 | A | 0.470494 | T | 0.488124 | -0.01763 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 234 | D | 0.374929 | N | 0.35537 | 0.019559 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 262 | T | 0.345066 | M | 0.29558 | 0.049486 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 266 | R | 0.384192 | G | 0.412981 | -0.028789 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 266 | R | 0.384192 | K | 0.458438 | -0.074246 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 302 | E | 0.374249 | K | 0.348509 | 0.02574 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 305 | G | 0.232268 | R | 0.214742 | 0.017526 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 320 | V | 0.17153 | A | 0.212077 | -0.040547 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 331 | A | 0.318534 | E | 0.436062 | -0.117528 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 336 | R | 0.099796 | H | 0.099206 | 5.90E-04 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 352 | S | 0.355133 | N | 0.295883 | 0.05925 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 353 | T | 0.351532 | M | 0.306428 | 0.045104 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 354 | V | 0.345891 | M | 0.389171 | -0.04328 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 369 | R | 0.165954 | C | 0.092001 | 0.073953 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 370 | C | 0.139018 | Y | 0.160397 | -0.021379 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 384 | K | 0.212438 | N | 0.192875 | 0.019563 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 391 | M | 0.150837 | I | 0.098535 | 0.052302 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 434 | T | 0.139867 | N | 0.151067 | -0.0112 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 435 | I | 0.164181 | T | 0.28313 | -0.118949 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 439 | R | 0.305092 | Q | 0.338852 | -0.03376 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 466 | S | 0.267962 | L | 0.138221 | 0.129741 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 491 | R | 0.198748 | C | 0.096209 | 0.102539 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 534 | V | 0.058487 | D | 0.116676 | -0.058189 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 65 | H | 0.831837 | R | 0.84543 | -0.013593 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 101 | L | 0.261994 | P | 0.386898 | -0.124904 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 109 | C | 0.21348 | R | 0.309487 | -0.096007 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 143 | I | 0.496718 | M | 0.562579 | -0.065861 | O to D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 228 | N | 0.446841 | K | 0.467409 | -0.020568 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 262 | T | 0.345066 | R | 0.357154 | -0.012088 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 275 | C | 0.316909 | Y | 0.263539 | 0.05337 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 338 | L | 0.089012 | P | 0.162516 | -0.073504 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 347 | G | 0.326292 | S | 0.374302 | -0.04801 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 349 | S | 0.362503 | N | 0.30465 | 0.057853 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 355 | A | 0.327274 | P | 0.382274 | -0.055 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 379 | R | 0.178456 | Q | 0.191687 | -0.013231 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 422 | P | 0.19188 | L | 0.106013 | 0.085867 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 456 | L | 0.092837 | P | 0.174943 | -0.082106 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 18 | R | 0.97619 | C | 0.970373 | 0.005817 | No Change: Both D | - |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 69 | A | 0.806315 | P | 0.863738 | -0.057423 | No Change: Both D | - |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 125 | R | 0.398304 | P | 0.417227 | -0.018923 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 154 | L | 0.216523 | Q | 0.308487 | -0.091964 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 155 | A | 0.183809 | V | 0.131906 | 0.051903 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 168 | V | 0.172629 | A | 0.224813 | -0.052184 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 173 | M | 0.458125 | V | 0.423452 | 0.034673 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 228 | N | 0.446841 | S | 0.484511 | -0.03767 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 231 | A | 0.44025 | P | 0.522133 | -0.081883 | O to D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 288 | A | 0.544757 | P | 0.654638 | -0.109881 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 288 | A | 0.544757 | T | 0.599468 | -0.054711 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 361 | A | 0.432531 | T | 0.444397 | -0.011866 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 376 | D | 0.144081 | N | 0.142897 | 0.001184 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 379 | R | 0.178456 | W | 0.076875 | 0.101581 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 526 | Q | 0.625191 | K | 0.660576 | -0.035385 | No Change: Both D | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 548 | R | 0.756679 | Q | 0.764349 | -0.00767 | No Change: Both D | - |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 200 | P | 0.46087 | L | 0.352488 | 0.108382 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 278 | I | 0.265246 | S | 0.463139 | -0.197893 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 281 | D | 0.336775 | N | 0.323919 | 0.012856 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 321 | D | 0.219776 | V | 0.1201 | 0.099676 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| P35520 | CBS_HUMAN Cystathionine beta-synthase OS=Homo sapiens GN=CBS PE=1 SV=2 | 446 | A | 0.316853 | S | 0.405972 | -0.089119 | No Change: Both O | Cystathionine beta-synthase deficiency (CBSD) [MIM:236200] |
| Q9BRT8 | CBWD1_HUMAN COBW domain-containing protein 1 OS=Homo sapiens GN=CBWD1 PE=1 SV=1 | 8 | A | 0.964704 | V | 0.951431 | 0.013273 | No Change: Both D | - |
| Q14781 | CBX2_HUMAN Chromobox protein homolog 2 OS=Homo sapiens GN=CBX2 PE=1 SV=2 | 98 | P | 0.999128 | L | 0.998502 | 6.26E-04 | No Change: Both D | 46 XY sex reversal type 5 (SRXY5) [MIM:613080] |
| Q14781 | CBX2_HUMAN Chromobox protein homolog 2 OS=Homo sapiens GN=CBX2 PE=1 SV=2 | 443 | R | 0.987354 | P | 0.989552 | -0.002198 | No Change: Both D | 46 XY sex reversal type 5 (SRXY5) [MIM:613080] |
| Q9HC52 | CBX8_HUMAN Chromobox protein homolog 8 OS=Homo sapiens GN=CBX8 PE=1 SV=3 | 317 | G | 0.809285 | V | 0.716594 | 0.092691 | No Change: Both D | - |
| Q6P1N0 | C2D1A_HUMAN Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens GN=CC2D1A PE=1 SV=1 | 339 | T | 0.986393 | P | 0.989723 | -0.00333 | No Change: Both D | - |
| Q6P1N0 | C2D1A_HUMAN Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens GN=CC2D1A PE=1 SV=1 | 635 | T | 0.394583 | S | 0.453496 | -0.058913 | No Change: Both O | - |
| Q6P1N0 | C2D1A_HUMAN Coiled-coil and C2 domain-containing protein 1A OS=Homo sapiens GN=CC2D1A PE=1 SV=1 | 801 | T | 0.563086 | M | 0.524215 | 0.038871 | No Change: Both D | - |
| Q5T0F9 | C2D1B_HUMAN Coiled-coil and C2 domain-containing protein 1B OS=Homo sapiens GN=CC2D1B PE=1 SV=1 | 35 | M | 0.889986 | T | 0.870265 | 0.019721 | No Change: Both D | - |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 376 | E | 0.477387 | A | 0.380309 | 0.097078 | No Change: Both O | - |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 660 | V | 0.720497 | I | 0.660846 | 0.059651 | No Change: Both D | - |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1096 | Q | 0.359833 | H | 0.338167 | 0.021666 | No Change: Both O | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1122 | P | 0.6333 | S | 0.651562 | -0.018262 | No Change: Both D | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1528 | R | 0.191322 | C | 0.111106 | 0.080216 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1528 | R | 0.191322 | C | 0.111106 | 0.080216 | No Change: Both O | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1551 | L | 0.417052 | P | 0.557536 | -0.140484 | O to D | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1114 | T | 0.394411 | M | 0.326467 | 0.067944 | No Change: Both O | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1114 | T | 0.394411 | M | 0.326467 | 0.067944 | No Change: Both O | Meckel syndrome type 6 (MKS6) [MIM:612284] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 721 | P | 0.128861 | S | 0.152893 | -0.024032 | No Change: Both O | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 800 | K | 0.441388 | E | 0.442686 | -0.001298 | No Change: Both O | - |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1556 | D | 0.260778 | V | 0.140344 | 0.120434 | No Change: Both O | Joubert syndrome type 9 (JBTS9) [MIM:612285] |
| Q9P2K1 | C2D2A_HUMAN Coiled-coil and C2 domain-containing protein 2A OS=Homo sapiens GN=CC2D2A PE=1 SV=3 | 1116 | T | 0.464688 | M | 0.401851 | 0.062837 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q6DHV5 | C2D2B_HUMAN Protein CC2D2B OS=Homo sapiens GN=CC2D2B PE=2 SV=2 | 64 | N | 0.180636 | D | 0.182787 | -0.002151 | No Change: Both O | - |
| Q6DHV5 | C2D2B_HUMAN Protein CC2D2B OS=Homo sapiens GN=CC2D2B PE=2 SV=2 | 237 | Y | 0.197883 | H | 0.295737 | -0.097854 | No Change: Both O | - |
| Q6DHV5 | C2D2B_HUMAN Protein CC2D2B OS=Homo sapiens GN=CC2D2B PE=2 SV=2 | 322 | Q | 0.906018 | L | 0.795947 | 0.110071 | No Change: Both D | - |
| Q8IX12 | CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens GN=CCAR1 PE=1 SV=2 | 607 | E | 0.911462 | K | 0.906336 | 0.005126 | No Change: Both D | A colorectal cancer sample |
| Q8IX12 | CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens GN=CCAR1 PE=1 SV=2 | 588 | T | 0.442009 | I | 0.328286 | 0.113723 | No Change: Both O | - |
| Q8IX12 | CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens GN=CCAR1 PE=1 SV=2 | 681 | E | 0.997399 | G | 0.99593 | 0.001469 | No Change: Both D | - |
| Q8IX12 | CCAR1_HUMAN Cell division cycle and apoptosis regulator protein 1 OS=Homo sapiens GN=CCAR1 PE=1 SV=2 | 747 | M | 0.155519 | V | 0.126734 | 0.028785 | No Change: Both O | - |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 193 | V | 0.577433 | G | 0.700939 | -0.123506 | No Change: Both D | - |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 75 | C | 0.360379 | S | 0.443058 | -0.082679 | No Change: Both O | Hennekam lymphangiectasia-lymphedema syndrome (HLLS) [MIM:235510] |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 102 | C | 0.366349 | S | 0.434549 | -0.0682 | No Change: Both O | Hennekam lymphangiectasia-lymphedema syndrome (HLLS) [MIM:235510] |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 158 | R | 0.418665 | C | 0.363908 | 0.054757 | No Change: Both O | Hennekam lymphangiectasia-lymphedema syndrome (HLLS) [MIM:235510] |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 174 | C | 0.702891 | R | 0.772898 | -0.070007 | No Change: Both D | Hennekam lymphangiectasia-lymphedema syndrome (HLLS) [MIM:235510] |
| Q6UXH8 | CCBE1_HUMAN Collagen and calcium-binding EGF domain-containing protein 1 OS=Homo sapiens GN=CCBE1 PE=1 SV=1 | 327 | G | 0.842886 | R | 0.850578 | -0.007692 | No Change: Both D | Hennekam lymphangiectasia-lymphedema syndrome (HLLS) [MIM:235510] |
| Q6YP21 | KAT3_HUMAN Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens GN=CCBL2 PE=1 SV=1 | 206 | S | 0.506517 | P | 0.473886 | 0.032631 | D to O | - |
| O00590 | CCBP2_HUMAN Chemokine-binding protein 2 OS=Homo sapiens GN=CCBP2 PE=2 SV=2 | 373 | Y | 0.89504 | S | 0.963039 | -0.067999 | No Change: Both D | - |
| O00590 | CCBP2_HUMAN Chemokine-binding protein 2 OS=Homo sapiens GN=CCBP2 PE=2 SV=2 | 41 | V | 0.119975 | A | 0.165634 | -0.045659 | No Change: Both O | - |
| O00590 | CCBP2_HUMAN Chemokine-binding protein 2 OS=Homo sapiens GN=CCBP2 PE=2 SV=2 | 248 | A | 0.334593 | V | 0.235899 | 0.098694 | No Change: Both O | - |
| O00590 | CCBP2_HUMAN Chemokine-binding protein 2 OS=Homo sapiens GN=CCBP2 PE=2 SV=2 | 311 | L | 0.098573 | V | 0.097339 | 0.001234 | No Change: Both O | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 346 | C | 0.836116 | F | 0.803945 | 0.032171 | No Change: Both D | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 429 | A | 0.438698 | P | 0.502782 | -0.064084 | O to D | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 153 | K | 0.853405 | N | 0.791533 | 0.061872 | No Change: Both D | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 298 | K | 0.589993 | R | 0.518952 | 0.071041 | No Change: Both D | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 370 | E | 0.925344 | G | 0.887127 | 0.038217 | No Change: Both D | - |
| Q68D86 | C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens GN=CCDC102B PE=2 SV=4 | 425 | N | 0.553521 | K | 0.57827 | -0.024749 | No Change: Both D | - |
| Q96G28 | CC104_HUMAN Coiled-coil domain-containing protein 104 OS=Homo sapiens GN=CCDC104 PE=1 SV=2 | 243 | D | 0.725446 | G | 0.747124 | -0.021678 | No Change: Both D | - |
| Q96G28 | CC104_HUMAN Coiled-coil domain-containing protein 104 OS=Homo sapiens GN=CCDC104 PE=1 SV=2 | 246 | I | 0.646139 | F | 0.623781 | 0.022358 | No Change: Both D | - |
| Q96G28 | CC104_HUMAN Coiled-coil domain-containing protein 104 OS=Homo sapiens GN=CCDC104 PE=1 SV=2 | 6 | E | 0.771174 | D | 0.758768 | 0.012406 | No Change: Both D | - |
| Q8IYK2 | CC105_HUMAN Coiled-coil domain-containing protein 105 OS=Homo sapiens GN=CCDC105 PE=2 SV=3 | 434 | D | 0.371423 | E | 0.419347 | -0.047924 | No Change: Both O | - |
| Q8IYK2 | CC105_HUMAN Coiled-coil domain-containing protein 105 OS=Homo sapiens GN=CCDC105 PE=2 SV=3 | 444 | S | 0.206577 | T | 0.165494 | 0.041083 | No Change: Both O | - |
| Q8IYK2 | CC105_HUMAN Coiled-coil domain-containing protein 105 OS=Homo sapiens GN=CCDC105 PE=2 SV=3 | 499 | P | 0.972789 | T | 0.9565 | 0.016289 | No Change: Both D | - |
| Q8IYK2 | CC105_HUMAN Coiled-coil domain-containing protein 105 OS=Homo sapiens GN=CCDC105 PE=2 SV=3 | 245 | V | 0.349803 | M | 0.446516 | -0.096713 | No Change: Both O | - |
| Q8IYK2 | CC105_HUMAN Coiled-coil domain-containing protein 105 OS=Homo sapiens GN=CCDC105 PE=2 SV=3 | 248 | M | 0.377476 | T | 0.422135 | -0.044659 | No Change: Both O | - |
| Q8WV48 | CC107_HUMAN Coiled-coil domain-containing protein 107 OS=Homo sapiens GN=CCDC107 PE=2 SV=2 | 190 | S | 0.909819 | F | 0.846825 | 0.062994 | No Change: Both D | - |
| Q8WV48 | CC107_HUMAN Coiled-coil domain-containing protein 107 OS=Homo sapiens GN=CCDC107 PE=2 SV=2 | 220 | I | 0.704975 | V | 0.72418 | -0.019205 | No Change: Both D | - |
| Q8WV48 | CC107_HUMAN Coiled-coil domain-containing protein 107 OS=Homo sapiens GN=CCDC107 PE=2 SV=2 | 242 | S | 0.381357 | C | 0.251408 | 0.129949 | No Change: Both O | - |
| Q6ZU64 | CC108_HUMAN Coiled-coil domain-containing protein 108 OS=Homo sapiens GN=CCDC108 PE=2 SV=2 | 66 | M | 0.773221 | L | 0.722918 | 0.050303 | No Change: Both D | - |
| Q6ZU64 | CC108_HUMAN Coiled-coil domain-containing protein 108 OS=Homo sapiens GN=CCDC108 PE=2 SV=2 | 672 | V | 0.389514 | I | 0.358029 | 0.031485 | No Change: Both O | - |
| Q6ZU64 | CC108_HUMAN Coiled-coil domain-containing protein 108 OS=Homo sapiens GN=CCDC108 PE=2 SV=2 | 806 | K | 0.177912 | M | 0.10631 | 0.071602 | No Change: Both O | - |
| Q6ZU64 | CC108_HUMAN Coiled-coil domain-containing protein 108 OS=Homo sapiens GN=CCDC108 PE=2 SV=2 | 1858 | N | 0.388721 | S | 0.411928 | -0.023207 | No Change: Both O | - |
| Q9NWR8 | C109B_HUMAN Coiled-coil domain-containing protein 109B OS=Homo sapiens GN=CCDC109B PE=1 SV=2 | 253 | Y | 0.0533 | F | 0.049487 | 0.003813 | No Change: Both O | - |
| Q9NWR8 | C109B_HUMAN Coiled-coil domain-containing protein 109B OS=Homo sapiens GN=CCDC109B PE=1 SV=2 | 255 | I | 0.056077 | V | 0.068841 | -0.012764 | No Change: Both O | - |
| Q9NWR8 | C109B_HUMAN Coiled-coil domain-containing protein 109B OS=Homo sapiens GN=CCDC109B PE=1 SV=2 | 63 | I | 0.115674 | N | 0.216871 | -0.101197 | No Change: Both O | - |
| Q96M91 | CCD11_HUMAN Coiled-coil domain-containing protein 11 OS=Homo sapiens GN=CCDC11 PE=2 SV=2 | 231 | R | 0.864719 | C | 0.783149 | 0.08157 | No Change: Both D | - |
| Q96M91 | CCD11_HUMAN Coiled-coil domain-containing protein 11 OS=Homo sapiens GN=CCDC11 PE=2 SV=2 | 294 | E | 0.890727 | K | 0.888345 | 0.002382 | No Change: Both D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 209 | P | 0.394407 | Q | 0.371833 | 0.022574 | No Change: Both O | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 299 | L | 0.627203 | M | 0.693185 | -0.065982 | No Change: Both D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 382 | L | 0.492071 | M | 0.563683 | -0.071612 | O to D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 409 | S | 0.6606 | F | 0.44952 | 0.21108 | D to O | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 614 | I | 0.932202 | M | 0.947322 | -0.01512 | No Change: Both D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 669 | Q | 0.790967 | R | 0.768936 | 0.022031 | No Change: Both D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 817 | S | 0.678759 | L | 0.490669 | 0.18809 | D to O | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 819 | L | 0.619695 | M | 0.672824 | -0.053129 | No Change: Both D | - |
| Q8TBZ0 | CC110_HUMAN Coiled-coil domain-containing protein 110 OS=Homo sapiens GN=CCDC110 PE=2 SV=1 | 500 | Y | 0.901792 | D | 0.929917 | -0.028125 | No Change: Both D | - |
| Q96LW4 | CC111_HUMAN Coiled-coil domain-containing protein 111 OS=Homo sapiens GN=CCDC111 PE=1 SV=2 | 168 | Q | 0.361551 | R | 0.328576 | 0.032975 | No Change: Both O | - |
| Q96LW4 | CC111_HUMAN Coiled-coil domain-containing protein 111 OS=Homo sapiens GN=CCDC111 PE=1 SV=2 | 505 | T | 0.704084 | K | 0.721195 | -0.017111 | No Change: Both D | - |
| Q8NEF3 | CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens GN=CCDC112 PE=2 SV=2 | 32 | H | 0.75496 | L | 0.689938 | 0.065022 | No Change: Both D | - |
| Q8NEF3 | CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens GN=CCDC112 PE=2 SV=2 | 144 | S | 0.51677 | N | 0.464772 | 0.051998 | D to O | - |
| Q8NEF3 | CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens GN=CCDC112 PE=2 SV=2 | 341 | K | 0.970664 | N | 0.958932 | 0.011732 | No Change: Both D | - |
| Q8NEF3 | CC112_HUMAN Coiled-coil domain-containing protein 112 OS=Homo sapiens GN=CCDC112 PE=2 SV=2 | 354 | E | 0.969704 | G | 0.946756 | 0.022948 | No Change: Both D | - |
| Q9H0I3 | CC113_HUMAN Coiled-coil domain-containing protein 113 OS=Homo sapiens GN=CCDC113 PE=2 SV=1 | 4 | D | 0.889816 | E | 0.906334 | -0.016518 | No Change: Both D | - |
| Q9H0I3 | CC113_HUMAN Coiled-coil domain-containing protein 113 OS=Homo sapiens GN=CCDC113 PE=2 SV=1 | 6 | S | 0.889374 | T | 0.860569 | 0.028805 | No Change: Both D | - |
| Q96M63 | CC114_HUMAN Coiled-coil domain-containing protein 114 OS=Homo sapiens GN=CCDC114 PE=2 SV=3 | 329 | R | 0.879932 | H | 0.878887 | 0.001045 | No Change: Both D | - |
| Q96M63 | CC114_HUMAN Coiled-coil domain-containing protein 114 OS=Homo sapiens GN=CCDC114 PE=2 SV=3 | 468 | P | 0.922968 | L | 0.869117 | 0.053851 | No Change: Both D | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 96 | R | 0.613312 | C | 0.484508 | 0.128804 | D to O | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 121 | G | 0.830645 | R | 0.860542 | -0.029897 | No Change: Both D | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 122 | R | 0.836781 | W | 0.635326 | 0.201455 | No Change: Both D | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 199 | R | 0.870756 | W | 0.728805 | 0.141951 | No Change: Both D | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 436 | A | 0.434799 | T | 0.459857 | -0.025058 | No Change: Both O | - |
| Q8IYX3 | CC116_HUMAN Coiled-coil domain-containing protein 116 OS=Homo sapiens GN=CCDC116 PE=2 SV=2 | 293 | P | 0.398765 | L | 0.256108 | 0.142657 | No Change: Both O | - |
| Q8IWD4 | CC117_HUMAN Coiled-coil domain-containing protein 117 OS=Homo sapiens GN=CCDC117 PE=1 SV=1 | 147 | R | 0.592702 | S | 0.619617 | -0.026915 | No Change: Both D | - |
| Q8IWD4 | CC117_HUMAN Coiled-coil domain-containing protein 117 OS=Homo sapiens GN=CCDC117 PE=1 SV=1 | 272 | S | 0.933835 | N | 0.913274 | 0.020561 | No Change: Both D | - |
| Q5T0U0 | CC122_HUMAN Coiled-coil domain-containing protein 122 OS=Homo sapiens GN=CCDC122 PE=1 SV=1 | 269 | I | 0.607798 | T | 0.730776 | -0.122978 | No Change: Both D | - |
| Q96CT7 | CC124_HUMAN Coiled-coil domain-containing protein 124 OS=Homo sapiens GN=CCDC124 PE=1 SV=1 | 138 | E | 0.738706 | Q | 0.660478 | 0.078228 | No Change: Both D | - |
| Q86Z20 | CC125_HUMAN Coiled-coil domain-containing protein 125 OS=Homo sapiens GN=CCDC125 PE=2 SV=2 | 13 | V | 0.765421 | M | 0.84342 | -0.077999 | No Change: Both D | - |
| Q96BQ5 | CC127_HUMAN Coiled-coil domain-containing protein 127 OS=Homo sapiens GN=CCDC127 PE=1 SV=1 | 60 | R | 0.54827 | H | 0.507525 | 0.040745 | No Change: Both D | - |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 32 | A | 0.890055 | D | 0.917723 | -0.027668 | No Change: Both D | - |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 490 | A | 0.931695 | V | 0.909021 | 0.022674 | No Change: Both D | - |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 809 | C | 0.766422 | Y | 0.635993 | 0.130429 | No Change: Both D | - |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 887 | H | 0.741969 | Y | 0.676429 | 0.06554 | No Change: Both D | - |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 105 | L | 0.347931 | V | 0.356906 | -0.008975 | No Change: Both O | A colorectal cancer sample |
| Q6ZRS4 | CC129_HUMAN Coiled-coil domain-containing protein 129 OS=Homo sapiens GN=CCDC129 PE=2 SV=2 | 377 | H | 0.832414 | R | 0.865557 | -0.033143 | No Change: Both D | - |
| Q8IYE1 | CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens GN=CCDC13 PE=2 SV=2 | 547 | S | 0.573765 | T | 0.516118 | 0.057647 | No Change: Both D | - |
| Q8IYE1 | CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens GN=CCDC13 PE=2 SV=2 | 25 | R | 0.98526 | W | 0.9583 | 0.02696 | No Change: Both D | - |
| Q8IYE1 | CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens GN=CCDC13 PE=2 SV=2 | 375 | E | 0.805294 | V | 0.670196 | 0.135098 | No Change: Both D | - |
| P13994 | CC130_HUMAN Coiled-coil domain-containing protein 130 OS=Homo sapiens GN=CCDC130 PE=1 SV=2 | 22 | S | 0.704076 | C | 0.527044 | 0.177032 | No Change: Both D | - |
| P13994 | CC130_HUMAN Coiled-coil domain-containing protein 130 OS=Homo sapiens GN=CCDC130 PE=1 SV=2 | 336 | C | 0.997184 | S | 0.998164 | -9.80E-04 | No Change: Both D | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 186 | C | 0.172937 | S | 0.362409 | -0.189472 | No Change: Both O | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 433 | P | 0.351268 | L | 0.206311 | 0.144957 | No Change: Both O | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 581 | N | 0.655186 | K | 0.709925 | -0.054739 | No Change: Both D | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 766 | C | 0.148234 | R | 0.267974 | -0.11974 | No Change: Both O | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 120 | L | 0.240246 | M | 0.278652 | -0.038406 | No Change: Both O | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 521 | P | 0.505339 | H | 0.471267 | 0.034072 | D to O | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 51 | D | 0.722113 | N | 0.68508 | 0.037033 | No Change: Both D | - |
| Q8IY82 | CC135_HUMAN Coiled-coil domain-containing protein 135 OS=Homo sapiens GN=CCDC135 PE=2 SV=3 | 241 | V | 0.858231 | E | 0.912531 | -0.0543 | No Change: Both D | - |
| Q96JN2 | CC136_HUMAN Coiled-coil domain-containing protein 136 OS=Homo sapiens GN=CCDC136 PE=2 SV=3 | 218 | D | 0.898277 | H | 0.8869 | 0.011377 | No Change: Both D | - |
| Q96JN2 | CC136_HUMAN Coiled-coil domain-containing protein 136 OS=Homo sapiens GN=CCDC136 PE=2 SV=3 | 1049 | Q | 0.995327 | E | 0.996379 | -0.001052 | No Change: Both D | - |
| Q6PK04 | CC137_HUMAN Coiled-coil domain-containing protein 137 OS=Homo sapiens GN=CCDC137 PE=1 SV=1 | 127 | H | 0.588701 | Q | 0.667973 | -0.079272 | No Change: Both D | - |
| Q6PK04 | CC137_HUMAN Coiled-coil domain-containing protein 137 OS=Homo sapiens GN=CCDC137 PE=1 SV=1 | 177 | R | 0.964212 | W | 0.913844 | 0.050368 | No Change: Both D | - |
| Q6PK04 | CC137_HUMAN Coiled-coil domain-containing protein 137 OS=Homo sapiens GN=CCDC137 PE=1 SV=1 | 229 | R | 0.91646 | Q | 0.917051 | -5.91E-04 | No Change: Both D | - |
| Q6PK04 | CC137_HUMAN Coiled-coil domain-containing protein 137 OS=Homo sapiens GN=CCDC137 PE=1 SV=1 | 282 | R | 0.976081 | W | 0.925177 | 0.050904 | No Change: Both D | - |
| Q96M89 | CC138_HUMAN Coiled-coil domain-containing protein 138 OS=Homo sapiens GN=CCDC138 PE=1 SV=1 | 99 | D | 0.671056 | Y | 0.501642 | 0.169414 | No Change: Both D | - |
| Q96M89 | CC138_HUMAN Coiled-coil domain-containing protein 138 OS=Homo sapiens GN=CCDC138 PE=1 SV=1 | 115 | R | 0.727882 | K | 0.791786 | -0.063904 | No Change: Both D | - |
| Q49A88 | CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens GN=CCDC14 PE=2 SV=3 | 365 | T | 0.729286 | P | 0.749201 | -0.019915 | No Change: Both D | - |
| Q6ZP82 | CC141_HUMAN Coiled-coil domain-containing protein 141 OS=Homo sapiens GN=CCDC141 PE=1 SV=1 | 253 | R | 0.430621 | W | 0.197498 | 0.233123 | No Change: Both O | - |
| Q6ZP82 | CC141_HUMAN Coiled-coil domain-containing protein 141 OS=Homo sapiens GN=CCDC141 PE=1 SV=1 | 360 | R | 0.795633 | W | 0.637553 | 0.15808 | No Change: Both D | - |
| Q6ZP82 | CC141_HUMAN Coiled-coil domain-containing protein 141 OS=Homo sapiens GN=CCDC141 PE=1 SV=1 | 595 | N | 0.556361 | S | 0.579285 | -0.022924 | No Change: Both D | - |
| Q17RM4 | CC142_HUMAN Coiled-coil domain-containing protein 142 OS=Homo sapiens GN=CCDC142 PE=2 SV=1 | 534 | R | 0.305666 | Q | 0.30314 | 0.002526 | No Change: Both O | - |
| Q6NUI1 | C144L_HUMAN Putative coiled-coil domain-containing protein 144 N-terminal-like OS=Homo sapiens GN=CCDC144NL PE=5 SV=1 | 82 | G | 0.644416 | D | 0.682343 | -0.037927 | No Change: Both D | - |
| Q8IYE0 | CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens GN=CCDC146 PE=2 SV=2 | 345 | N | 0.726284 | S | 0.760355 | -0.034071 | No Change: Both D | - |
| Q8IYE0 | CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens GN=CCDC146 PE=2 SV=2 | 263 | E | 0.821299 | Q | 0.790148 | 0.031151 | No Change: Both D | - |
| Q8IYE0 | CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens GN=CCDC146 PE=2 SV=2 | 466 | I | 0.79223 | T | 0.848925 | -0.056695 | No Change: Both D | - |
| Q5T655 | CC147_HUMAN Coiled-coil domain-containing protein 147 OS=Homo sapiens GN=CCDC147 PE=2 SV=1 | 496 | S | 0.501785 | T | 0.413942 | 0.087843 | D to O | - |
| Q5T655 | CC147_HUMAN Coiled-coil domain-containing protein 147 OS=Homo sapiens GN=CCDC147 PE=2 SV=1 | 804 | Q | 0.815112 | H | 0.764362 | 0.05075 | No Change: Both D | - |
| Q8NFR7 | CC148_HUMAN Coiled-coil domain-containing protein 148 OS=Homo sapiens GN=CCDC148 PE=2 SV=2 | 75 | Q | 0.413812 | R | 0.391146 | 0.022666 | No Change: Both O | - |
| Q8NFR7 | CC148_HUMAN Coiled-coil domain-containing protein 148 OS=Homo sapiens GN=CCDC148 PE=2 SV=2 | 157 | M | 0.397508 | V | 0.362165 | 0.035343 | No Change: Both O | - |
| Q8NFR7 | CC148_HUMAN Coiled-coil domain-containing protein 148 OS=Homo sapiens GN=CCDC148 PE=2 SV=2 | 329 | K | 0.408993 | R | 0.336766 | 0.072227 | No Change: Both O | - |
| Q0P6D6 | CCD15_HUMAN Coiled-coil domain-containing protein 15 OS=Homo sapiens GN=CCDC15 PE=2 SV=2 | 529 | G | 0.741701 | D | 0.827602 | -0.085901 | No Change: Both D | - |
| Q0P6D6 | CCD15_HUMAN Coiled-coil domain-containing protein 15 OS=Homo sapiens GN=CCDC15 PE=2 SV=2 | 813 | C | 0.828639 | R | 0.880925 | -0.052286 | No Change: Both D | - |
| Q8NCX0 | CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens GN=CCDC150 PE=2 SV=2 | 156 | E | 0.628142 | K | 0.634591 | -0.006449 | No Change: Both D | - |
| A5D8V7 | CC151_HUMAN Coiled-coil domain-containing protein 151 OS=Homo sapiens GN=CCDC151 PE=2 SV=1 | 545 | R | 0.337534 | P | 0.378782 | -0.041248 | No Change: Both O | - |
| Q4G0S7 | CC152_HUMAN Coiled-coil domain-containing protein 152 OS=Homo sapiens GN=CCDC152 PE=2 SV=3 | 251 | R | 0.759916 | H | 0.719868 | 0.040048 | No Change: Both D | - |
| Q494R4 | CC153_HUMAN Coiled-coil domain-containing protein 153 OS=Homo sapiens GN=CCDC153 PE=2 SV=2 | 101 | R | 0.895376 | H | 0.871451 | 0.023925 | No Change: Both D | - |
| Q8N6L0 | CC155_HUMAN Coiled-coil domain-containing protein 155 OS=Homo sapiens GN=CCDC155 PE=2 SV=2 | 116 | L | 0.492813 | P | 0.554125 | -0.061312 | O to D | - |
| Q8N6L0 | CC155_HUMAN Coiled-coil domain-containing protein 155 OS=Homo sapiens GN=CCDC155 PE=2 SV=2 | 129 | R | 0.684351 | Q | 0.715 | -0.030649 | No Change: Both D | - |
| Q569K6 | CC157_HUMAN Coiled-coil domain-containing protein 157 OS=Homo sapiens GN=CCDC157 PE=2 SV=3 | 191 | P | 0.677332 | L | 0.512997 | 0.164335 | No Change: Both D | - |
| Q569K6 | CC157_HUMAN Coiled-coil domain-containing protein 157 OS=Homo sapiens GN=CCDC157 PE=2 SV=3 | 587 | S | 0.748786 | A | 0.625077 | 0.123709 | No Change: Both D | - |
| Q569K6 | CC157_HUMAN Coiled-coil domain-containing protein 157 OS=Homo sapiens GN=CCDC157 PE=2 SV=3 | 51 | D | 0.140313 | N | 0.118043 | 0.02227 | No Change: Both O | - |
| Q5M9N0 | CD158_HUMAN Coiled-coil domain-containing protein 158 OS=Homo sapiens GN=CCDC158 PE=2 SV=2 | 232 | E | 0.342172 | D | 0.31323 | 0.028942 | No Change: Both O | - |
| Q5M9N0 | CD158_HUMAN Coiled-coil domain-containing protein 158 OS=Homo sapiens GN=CCDC158 PE=2 SV=2 | 297 | I | 0.915602 | V | 0.909447 | 0.006155 | No Change: Both D | - |
| P0C7I6 | CC159_HUMAN Coiled-coil domain-containing protein 159 OS=Homo sapiens GN=CCDC159 PE=2 SV=1 | 393 | C | 0.987529 | S | 0.992436 | -0.004907 | No Change: Both D | - |
| A2VCL2 | CC162_HUMAN Coiled-coil domain-containing protein 162 OS=Homo sapiens GN=CCDC162P PE=2 SV=3 | 84 | I | 0.403524 | T | 0.530808 | -0.127284 | O to D | - |
| Q96MC2 | CC164_HUMAN Coiled-coil domain-containing protein 164 OS=Homo sapiens GN=CCDC164 PE=2 SV=2 | 357 | K | 0.66949 | E | 0.655276 | 0.014214 | No Change: Both D | - |
| Q96MC2 | CC164_HUMAN Coiled-coil domain-containing protein 164 OS=Homo sapiens GN=CCDC164 PE=2 SV=2 | 399 | W | 0.082291 | R | 0.191479 | -0.109188 | No Change: Both O | - |
| Q96MC2 | CC164_HUMAN Coiled-coil domain-containing protein 164 OS=Homo sapiens GN=CCDC164 PE=2 SV=2 | 633 | V | 0.38734 | F | 0.360693 | 0.026647 | No Change: Both O | - |
| Q96MC2 | CC164_HUMAN Coiled-coil domain-containing protein 164 OS=Homo sapiens GN=CCDC164 PE=2 SV=2 | 702 | S | 0.631133 | I | 0.412712 | 0.218421 | D to O | - |
| Q96MC2 | CC164_HUMAN Coiled-coil domain-containing protein 164 OS=Homo sapiens GN=CCDC164 PE=2 SV=2 | 734 | V | 0.71424 | M | 0.762225 | -0.047985 | No Change: Both D | - |
| Q9Y4B5 | CC165_HUMAN Coiled-coil domain-containing protein 165 OS=Homo sapiens GN=CCDC165 PE=1 SV=4 | 852 | Q | 0.929009 | R | 0.91464 | 0.014369 | No Change: Both D | - |
| Q9Y4B5 | CC165_HUMAN Coiled-coil domain-containing protein 165 OS=Homo sapiens GN=CCDC165 PE=1 SV=4 | 889 | D | 0.45344 | G | 0.456237 | -0.002797 | No Change: Both O | - |
| Q9Y4B5 | CC165_HUMAN Coiled-coil domain-containing protein 165 OS=Homo sapiens GN=CCDC165 PE=1 SV=4 | 1088 | G | 0.873496 | S | 0.891492 | -0.017996 | No Change: Both D | - |
| Q9Y4B5 | CC165_HUMAN Coiled-coil domain-containing protein 165 OS=Homo sapiens GN=CCDC165 PE=1 SV=4 | 1202 | K | 0.801923 | Q | 0.782634 | 0.019289 | No Change: Both D | - |
| Q9Y4B5 | CC165_HUMAN Coiled-coil domain-containing protein 165 OS=Homo sapiens GN=CCDC165 PE=1 SV=4 | 593 | M | 0.904658 | T | 0.894016 | 0.010642 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 30 | P | 0.641698 | S | 0.678046 | -0.036348 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 94 | M | 0.84033 | V | 0.805757 | 0.034573 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 264 | G | 0.484791 | S | 0.525071 | -0.04028 | O to D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 314 | S | 0.815044 | P | 0.832289 | -0.017245 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 347 | L | 0.772333 | P | 0.869902 | -0.097569 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 382 | G | 0.766271 | A | 0.73164 | 0.034631 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1015 | R | 0.75228 | T | 0.719629 | 0.032651 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1121 | N | 0.560623 | S | 0.650971 | -0.090348 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1209 | R | 0.443817 | Q | 0.467416 | -0.023599 | No Change: Both O | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1287 | F | 0.392833 | L | 0.431156 | -0.038323 | No Change: Both O | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1382 | L | 0.90313 | P | 0.935551 | -0.032421 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1446 | R | 0.681803 | C | 0.562914 | 0.118889 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1483 | T | 0.479841 | M | 0.448972 | 0.030869 | No Change: Both O | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1879 | E | 0.809369 | A | 0.748475 | 0.060894 | No Change: Both D | - |
| Q8NDH2 | CC168_HUMAN Coiled-coil domain-containing protein 168 OS=Homo sapiens GN=CCDC168 PE=2 SV=2 | 1915 | K | 0.62122 | E | 0.617702 | 0.003518 | No Change: Both D | - |
| A6NNP5 | CC169_HUMAN Coiled-coil domain-containing protein 169 OS=Homo sapiens GN=CCDC169 PE=2 SV=4 | 120 | K | 0.807965 | R | 0.781582 | 0.026383 | No Change: Both D | - |
| Q96LX7 | CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens GN=CCDC17 PE=2 SV=2 | 353 | P | 0.973581 | L | 0.949018 | 0.024563 | No Change: Both D | - |
| Q96LX7 | CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens GN=CCDC17 PE=2 SV=2 | 557 | I | 0.383651 | V | 0.447519 | -0.063868 | No Change: Both O | - |
| Q96LX7 | CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens GN=CCDC17 PE=2 SV=2 | 470 | V | 0.594957 | I | 0.541398 | 0.053559 | No Change: Both D | - |
| Q96LX7 | CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens GN=CCDC17 PE=2 SV=2 | 580 | S | 0.745321 | N | 0.674473 | 0.070848 | No Change: Both D | - |
| Q9UL16 | CCD19_HUMAN Coiled-coil domain-containing protein 19 mitochondrial OS=Homo sapiens GN=CCDC19 PE=1 SV=2 | 291 | E | 0.994933 | G | 0.990414 | 0.004519 | No Change: Both D | - |
| O60826 | CCD22_HUMAN Coiled-coil domain-containing protein 22 OS=Homo sapiens GN=CCDC22 PE=1 SV=1 | 17 | T | 0.394456 | A | 0.383254 | 0.011202 | No Change: Both O | - |
| Q2M243 | CCD27_HUMAN Coiled-coil domain-containing protein 27 OS=Homo sapiens GN=CCDC27 PE=2 SV=2 | 54 | Q | 0.967814 | E | 0.967798 | 1.60E-05 | No Change: Both D | - |
| Q2M243 | CCD27_HUMAN Coiled-coil domain-containing protein 27 OS=Homo sapiens GN=CCDC27 PE=2 SV=2 | 267 | M | 0.881318 | T | 0.879243 | 0.002075 | No Change: Both D | - |
| Q2M243 | CCD27_HUMAN Coiled-coil domain-containing protein 27 OS=Homo sapiens GN=CCDC27 PE=2 SV=2 | 353 | T | 0.98242 | M | 0.986007 | -0.003587 | No Change: Both D | - |
| Q2M243 | CCD27_HUMAN Coiled-coil domain-containing protein 27 OS=Homo sapiens GN=CCDC27 PE=2 SV=2 | 390 | P | 0.996241 | L | 0.994763 | 0.001478 | No Change: Both D | - |
| Q8IWP9 | CC28A_HUMAN Coiled-coil domain-containing protein 28A OS=Homo sapiens GN=CCDC28A PE=1 SV=1 | 42 | S | 0.534587 | Y | 0.370762 | 0.163825 | D to O | - |
| Q8IWP9 | CC28A_HUMAN Coiled-coil domain-containing protein 28A OS=Homo sapiens GN=CCDC28A PE=1 SV=1 | 82 | P | 0.259334 | L | 0.162573 | 0.096761 | No Change: Both O | - |
| Q9BUN5 | CC28B_HUMAN Coiled-coil domain-containing protein 28B OS=Homo sapiens GN=CCDC28B PE=1 SV=2 | 25 | R | 0.940343 | W | 0.855928 | 0.084415 | No Change: Both D | - |
| Q5VVM6 | CCD30_HUMAN Coiled-coil domain-containing protein 30 OS=Homo sapiens GN=CCDC30 PE=2 SV=1 | 772 | H | 0.689426 | N | 0.763221 | -0.073795 | No Change: Both D | - |
| Q8N5R6 | CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens GN=CCDC33 PE=1 SV=3 | 683 | S | 0.926187 | N | 0.912703 | 0.013484 | No Change: Both D | - |
| Q8N5R6 | CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens GN=CCDC33 PE=1 SV=3 | 635 | M | 0.867415 | V | 0.797596 | 0.069819 | No Change: Both D | - |
| Q8N5R6 | CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens GN=CCDC33 PE=1 SV=3 | 640 | R | 0.829365 | L | 0.750742 | 0.078623 | No Change: Both D | - |
| Q8N5R6 | CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens GN=CCDC33 PE=1 SV=3 | 940 | S | 0.990166 | Y | 0.969743 | 0.020423 | No Change: Both D | - |
| Q96HJ3 | CCD34_HUMAN Coiled-coil domain-containing protein 34 OS=Homo sapiens GN=CCDC34 PE=2 SV=2 | 53 | P | 0.958308 | S | 0.959546 | -0.001238 | No Change: Both D | - |
| Q96HJ3 | CCD34_HUMAN Coiled-coil domain-containing protein 34 OS=Homo sapiens GN=CCDC34 PE=2 SV=2 | 264 | E | 0.987815 | A | 0.983891 | 0.003924 | No Change: Both D | - |
| Q96HJ3 | CCD34_HUMAN Coiled-coil domain-containing protein 34 OS=Homo sapiens GN=CCDC34 PE=2 SV=2 | 319 | I | 0.606866 | V | 0.592452 | 0.014414 | No Change: Both D | - |
| Q96HJ3 | CCD34_HUMAN Coiled-coil domain-containing protein 34 OS=Homo sapiens GN=CCDC34 PE=2 SV=2 | 192 | H | 0.995069 | N | 0.996249 | -0.00118 | No Change: Both D | - |
| Q8IYA8 | CCD36_HUMAN Coiled-coil domain-containing protein 36 OS=Homo sapiens GN=CCDC36 PE=1 SV=2 | 440 | D | 0.86322 | E | 0.873185 | -0.009965 | No Change: Both D | - |
| Q502W7 | CCD38_HUMAN Coiled-coil domain-containing protein 38 OS=Homo sapiens GN=CCDC38 PE=2 SV=1 | 36 | V | 0.469036 | F | 0.500988 | -0.031952 | O to D | - |
| Q502W7 | CCD38_HUMAN Coiled-coil domain-containing protein 38 OS=Homo sapiens GN=CCDC38 PE=2 SV=1 | 227 | M | 0.197157 | V | 0.142953 | 0.054204 | No Change: Both O | - |
| Q4G0X9 | CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens GN=CCDC40 PE=2 SV=2 | 8 | A | 0.994321 | P | 0.996458 | -0.002137 | No Change: Both D | - |
| Q9Y592 | CCD41_HUMAN Coiled-coil domain-containing protein 41 OS=Homo sapiens GN=CCDC41 PE=1 SV=2 | 70 | Q | 0.925252 | R | 0.911058 | 0.014194 | No Change: Both D | - |
| Q96M95 | CCD42_HUMAN Coiled-coil domain-containing protein 42A OS=Homo sapiens GN=CCDC42 PE=2 SV=2 | 144 | A | 0.374818 | T | 0.397906 | -0.023088 | No Change: Both O | - |
| Q96M95 | CCD42_HUMAN Coiled-coil domain-containing protein 42A OS=Homo sapiens GN=CCDC42 PE=2 SV=2 | 51 | T | 0.741962 | P | 0.781063 | -0.039101 | No Change: Both D | - |
| Q96M95 | CCD42_HUMAN Coiled-coil domain-containing protein 42A OS=Homo sapiens GN=CCDC42 PE=2 SV=2 | 75 | R | 0.65503 | C | 0.532761 | 0.122269 | No Change: Both D | - |
| Q9HA90 | CCD48_HUMAN Coiled-coil domain-containing protein 48 OS=Homo sapiens GN=CCDC48 PE=2 SV=2 | 528 | R | 0.358049 | Q | 0.36112 | -0.003071 | No Change: Both O | - |
| Q8IVM0 | CCD50_HUMAN Coiled-coil domain-containing protein 50 OS=Homo sapiens GN=CCDC50 PE=1 SV=1 | 121 | L | 0.887892 | F | 0.883303 | 0.004589 | No Change: Both D | - |
| Q8IVM0 | CCD50_HUMAN Coiled-coil domain-containing protein 50 OS=Homo sapiens GN=CCDC50 PE=1 SV=1 | 156 | M | 0.649838 | T | 0.64309 | 0.006748 | No Change: Both D | - |
| Q96ER9 | CCD51_HUMAN Coiled-coil domain-containing protein 51 OS=Homo sapiens GN=CCDC51 PE=1 SV=2 | 360 | F | 0.369035 | S | 0.624431 | -0.255396 | O to D | - |
| Q8NEL0 | CCD54_HUMAN Coiled-coil domain-containing protein 54 OS=Homo sapiens GN=CCDC54 PE=1 SV=2 | 38 | R | 0.540653 | Q | 0.576229 | -0.035576 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 237 | E | 0.930896 | Q | 0.920807 | 0.010089 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 321 | Q | 0.597331 | R | 0.584438 | 0.012893 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 480 | V | 0.706724 | M | 0.770996 | -0.064272 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 775 | R | 0.91773 | G | 0.90718 | 0.01055 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 777 | D | 0.921585 | N | 0.90459 | 0.016995 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 778 | A | 0.923639 | T | 0.933287 | -0.009648 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 811 | Q | 0.98745 | K | 0.986614 | 8.36E-04 | No Change: Both D | - |
| Q2TAC2 | CCD57_HUMAN Coiled-coil domain-containing protein 57 OS=Homo sapiens GN=CCDC57 PE=2 SV=2 | 834 | M | 0.940872 | T | 0.950868 | -0.009996 | No Change: Both D | - |
| Q16204 | CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens GN=CCDC6 PE=1 SV=2 | 470 | P | 0.999898 | T | 0.999831 | 6.70E-05 | No Change: Both D | - |
| Q8IWA6 | CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens GN=CCDC60 PE=2 SV=2 | 46 | I | 0.347737 | V | 0.350773 | -0.003036 | No Change: Both O | - |
| Q8IWA6 | CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens GN=CCDC60 PE=2 SV=2 | 115 | T | 0.455407 | A | 0.406894 | 0.048513 | No Change: Both O | - |
| Q8IWA6 | CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens GN=CCDC60 PE=2 SV=2 | 393 | V | 0.21421 | I | 0.204523 | 0.009687 | No Change: Both O | - |
| Q6P9F0 | CCD62_HUMAN Coiled-coil domain-containing protein 62 OS=Homo sapiens GN=CCDC62 PE=1 SV=2 | 394 | T | 0.471421 | K | 0.535909 | -0.064488 | O to D | - |
| Q6P9F0 | CCD62_HUMAN Coiled-coil domain-containing protein 62 OS=Homo sapiens GN=CCDC62 PE=1 SV=2 | 31 | Q | 0.452494 | E | 0.501396 | -0.048902 | O to D | A colorectal cancer sample |
| Q6P9F0 | CCD62_HUMAN Coiled-coil domain-containing protein 62 OS=Homo sapiens GN=CCDC62 PE=1 SV=2 | 141 | T | 0.655603 | M | 0.628978 | 0.026625 | No Change: Both D | - |
| Q8NA47 | CCD63_HUMAN Coiled-coil domain-containing protein 63 OS=Homo sapiens GN=CCDC63 PE=1 SV=1 | 212 | L | 0.55989 | S | 0.681964 | -0.122074 | No Change: Both D | - |
| A1A5D9 | BICR2_HUMAN Bicaudal D-related protein 2 OS=Homo sapiens GN=CCDC64B PE=2 SV=2 | 273 | Q | 0.982491 | R | 0.984759 | -0.002268 | No Change: Both D | - |
| A1A5D9 | BICR2_HUMAN Bicaudal D-related protein 2 OS=Homo sapiens GN=CCDC64B PE=2 SV=2 | 55 | Q | 0.866098 | E | 0.886764 | -0.020666 | No Change: Both D | - |
| Q8IXS2 | CCD65_HUMAN Coiled-coil domain-containing protein 65 OS=Homo sapiens GN=CCDC65 PE=1 SV=2 | 133 | H | 0.496991 | R | 0.547841 | -0.05085 | O to D | - |
| Q8IXS2 | CCD65_HUMAN Coiled-coil domain-containing protein 65 OS=Homo sapiens GN=CCDC65 PE=1 SV=2 | 408 | Y | 0.231085 | C | 0.213839 | 0.017246 | No Change: Both O | - |
| A2RUB6 | CCD66_HUMAN Coiled-coil domain-containing protein 66 OS=Homo sapiens GN=CCDC66 PE=1 SV=4 | 383 | Q | 0.774191 | R | 0.73552 | 0.038671 | No Change: Both D | - |
| A2RUB6 | CCD66_HUMAN Coiled-coil domain-containing protein 66 OS=Homo sapiens GN=CCDC66 PE=1 SV=4 | 460 | R | 0.871272 | Q | 0.873522 | -0.00225 | No Change: Both D | - |
| A2RUB6 | CCD66_HUMAN Coiled-coil domain-containing protein 66 OS=Homo sapiens GN=CCDC66 PE=1 SV=4 | 592 | E | 0.811032 | K | 0.825465 | -0.014433 | No Change: Both D | - |
| Q05D60 | CCD67_HUMAN Coiled-coil domain-containing protein 67 OS=Homo sapiens GN=CCDC67 PE=2 SV=2 | 175 | S | 0.749674 | F | 0.610048 | 0.139626 | No Change: Both D | - |
| Q05D60 | CCD67_HUMAN Coiled-coil domain-containing protein 67 OS=Homo sapiens GN=CCDC67 PE=2 SV=2 | 440 | E | 0.679407 | Q | 0.657475 | 0.021932 | No Change: Both D | - |
| Q05D60 | CCD67_HUMAN Coiled-coil domain-containing protein 67 OS=Homo sapiens GN=CCDC67 PE=2 SV=2 | 504 | Q | 0.742582 | K | 0.741264 | 0.001318 | No Change: Both D | - |
| Q05D60 | CCD67_HUMAN Coiled-coil domain-containing protein 67 OS=Homo sapiens GN=CCDC67 PE=2 SV=2 | 440 | E | 0.679407 | G | 0.637447 | 0.04196 | No Change: Both D | - |
| Q9H2F9 | CCD68_HUMAN Coiled-coil domain-containing protein 68 OS=Homo sapiens GN=CCDC68 PE=2 SV=1 | 249 | V | 0.513062 | A | 0.57758 | -0.064518 | No Change: Both D | - |
| A6NI79 | CCD69_HUMAN Coiled-coil domain-containing protein 69 OS=Homo sapiens GN=CCDC69 PE=2 SV=1 | 197 | R | 0.388813 | K | 0.432686 | -0.043873 | No Change: Both O | - |
| Q96M83 | CCDC7_HUMAN Coiled-coil domain-containing protein 7 OS=Homo sapiens GN=CCDC7 PE=2 SV=2 | 449 | K | 0.931355 | T | 0.918525 | 0.01283 | No Change: Both D | - |
| Q96M83 | CCDC7_HUMAN Coiled-coil domain-containing protein 7 OS=Homo sapiens GN=CCDC7 PE=2 SV=2 | 148 | K | 0.537822 | Q | 0.5344 | 0.003422 | No Change: Both D | - |
| Q6NSX1 | CCD70_HUMAN Coiled-coil domain-containing protein 70 OS=Homo sapiens GN=CCDC70 PE=2 SV=1 | 206 | I | 0.507039 | V | 0.531338 | -0.024299 | No Change: Both D | - |
| Q6NSX1 | CCD70_HUMAN Coiled-coil domain-containing protein 70 OS=Homo sapiens GN=CCDC70 PE=2 SV=1 | 126 | R | 0.692293 | C | 0.583618 | 0.108675 | No Change: Both D | - |
| Q8IV32 | CCD71_HUMAN Coiled-coil domain-containing protein 71 OS=Homo sapiens GN=CCDC71 PE=2 SV=3 | 317 | Q | 0.996973 | L | 0.994119 | 0.002854 | No Change: Both D | - |
| Q8IV32 | CCD71_HUMAN Coiled-coil domain-containing protein 71 OS=Homo sapiens GN=CCDC71 PE=2 SV=3 | 339 | W | 0.98929 | R | 0.996003 | -0.006713 | No Change: Both D | - |
| Q96AQ1 | CC74A_HUMAN Coiled-coil domain-containing protein 74A OS=Homo sapiens GN=CCDC74A PE=2 SV=1 | 302 | G | 0.786677 | R | 0.840166 | -0.053489 | No Change: Both D | - |
| Q96LY2 | CC74B_HUMAN Coiled-coil domain-containing protein 74B OS=Homo sapiens GN=CCDC74B PE=2 SV=1 | 169 | T | 0.959816 | M | 0.954461 | 0.005355 | No Change: Both D | - |
| Q96LY2 | CC74B_HUMAN Coiled-coil domain-containing protein 74B OS=Homo sapiens GN=CCDC74B PE=2 SV=1 | 346 | R | 0.768175 | H | 0.723762 | 0.044413 | No Change: Both D | - |
| Q9NUP7 | TRM13_HUMAN tRNA guanosine-2'-O-methyltransferase TRM13 homolog OS=Homo sapiens GN=CCDC76 PE=1 SV=2 | 48 | A | 0.658268 | V | 0.589055 | 0.069213 | No Change: Both D | - |
| Q9BR77 | CCD77_HUMAN Coiled-coil domain-containing protein 77 OS=Homo sapiens GN=CCDC77 PE=2 SV=1 | 25 | S | 0.887872 | R | 0.886719 | 0.001153 | No Change: Both D | - |
| Q9BR77 | CCD77_HUMAN Coiled-coil domain-containing protein 77 OS=Homo sapiens GN=CCDC77 PE=2 SV=1 | 335 | M | 0.687758 | T | 0.657224 | 0.030534 | No Change: Both D | - |
| A2IDD5 | CCD78_HUMAN Coiled-coil domain-containing protein 78 OS=Homo sapiens GN=CCDC78 PE=2 SV=1 | 252 | W | 0.213041 | R | 0.446055 | -0.233014 | No Change: Both O | - |
| Q9H0W5 | CCDC8_HUMAN Coiled-coil domain-containing protein 8 OS=Homo sapiens GN=CCDC8 PE=1 SV=2 | 507 | K | 0.742108 | N | 0.713111 | 0.028997 | No Change: Both D | - |
| Q9H0W5 | CCDC8_HUMAN Coiled-coil domain-containing protein 8 OS=Homo sapiens GN=CCDC8 PE=1 SV=2 | 296 | G | 0.954317 | R | 0.962241 | -0.007924 | No Change: Both D | - |
| Q9H0W5 | CCDC8_HUMAN Coiled-coil domain-containing protein 8 OS=Homo sapiens GN=CCDC8 PE=1 SV=2 | 383 | H | 0.992358 | Y | 0.98792 | 0.004438 | No Change: Both D | - |
| Q6ZN84 | CCD81_HUMAN Coiled-coil domain-containing protein 81 OS=Homo sapiens GN=CCDC81 PE=2 SV=2 | 449 | Y | 0.895296 | C | 0.913539 | -0.018243 | No Change: Both D | - |
| Q8N4S0 | CCD82_HUMAN Coiled-coil domain-containing protein 82 OS=Homo sapiens GN=CCDC82 PE=1 SV=2 | 149 | Q | 0.973379 | E | 0.974263 | -8.84E-04 | No Change: Both D | - |
| Q8N4S0 | CCD82_HUMAN Coiled-coil domain-containing protein 82 OS=Homo sapiens GN=CCDC82 PE=1 SV=2 | 327 | Q | 0.486697 | R | 0.451941 | 0.034756 | No Change: Both O | - |
| Q8N4S0 | CCD82_HUMAN Coiled-coil domain-containing protein 82 OS=Homo sapiens GN=CCDC82 PE=1 SV=2 | 128 | K | 0.9322 | R | 0.920151 | 0.012049 | No Change: Both D | - |
| Q8IWF9 | CCD83_HUMAN Coiled-coil domain-containing protein 83 OS=Homo sapiens GN=CCDC83 PE=2 SV=2 | 49 | T | 0.42904 | A | 0.408171 | 0.020869 | No Change: Both O | - |
| Q86UT8 | CCD84_HUMAN Coiled-coil domain-containing protein 84 OS=Homo sapiens GN=CCDC84 PE=2 SV=1 | 244 | W | 0.313555 | G | 0.545099 | -0.231544 | O to D | - |
| Q9H6F5 | CCD86_HUMAN Coiled-coil domain-containing protein 86 OS=Homo sapiens GN=CCDC86 PE=1 SV=1 | 153 | Q | 0.983383 | H | 0.977175 | 0.006208 | No Change: Both D | - |
| Q9NVE4 | CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens GN=CCDC87 PE=2 SV=2 | 217 | F | 0.243477 | L | 0.274696 | -0.031219 | No Change: Both O | - |
| Q9NVE4 | CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens GN=CCDC87 PE=2 SV=2 | 156 | A | 0.272576 | T | 0.302236 | -0.02966 | No Change: Both O | - |
| A6NC98 | CC88B_HUMAN Coiled-coil domain-containing protein 88B OS=Homo sapiens GN=CCDC88B PE=1 SV=1 | 193 | D | 0.735734 | E | 0.795903 | -0.060169 | No Change: Both D | - |
| A6NC98 | CC88B_HUMAN Coiled-coil domain-containing protein 88B OS=Homo sapiens GN=CCDC88B PE=1 SV=1 | 639 | W | 0.967401 | R | 0.986854 | -0.019453 | No Change: Both D | - |
| A6NC98 | CC88B_HUMAN Coiled-coil domain-containing protein 88B OS=Homo sapiens GN=CCDC88B PE=1 SV=1 | 886 | D | 0.956251 | A | 0.95842 | -0.002169 | No Change: Both D | - |
| Q9P219 | DAPLE_HUMAN Protein Daple OS=Homo sapiens GN=CCDC88C PE=1 SV=3 | 811 | A | 0.951746 | E | 0.966035 | -0.014289 | No Change: Both D | - |
| Q9P219 | DAPLE_HUMAN Protein Daple OS=Homo sapiens GN=CCDC88C PE=1 SV=3 | 1028 | A | 0.809693 | V | 0.738373 | 0.07132 | No Change: Both D | - |
| Q9P219 | DAPLE_HUMAN Protein Daple OS=Homo sapiens GN=CCDC88C PE=1 SV=3 | 1992 | L | 0.949237 | P | 0.972454 | -0.023217 | No Change: Both D | - |
| Q9P219 | DAPLE_HUMAN Protein Daple OS=Homo sapiens GN=CCDC88C PE=1 SV=3 | 637 | L | 0.972822 | V | 0.967107 | 0.005715 | No Change: Both D | - |
| Q9Y3X0 | CCDC9_HUMAN Coiled-coil domain-containing protein 9 OS=Homo sapiens GN=CCDC9 PE=1 SV=1 | 215 | E | 0.989399 | D | 0.987682 | 0.001717 | No Change: Both D | - |
| Q9Y3X0 | CCDC9_HUMAN Coiled-coil domain-containing protein 9 OS=Homo sapiens GN=CCDC9 PE=1 SV=1 | 456 | A | 0.9857 | V | 0.979869 | 0.005831 | No Change: Both D | - |
| Q9Y3X0 | CCDC9_HUMAN Coiled-coil domain-containing protein 9 OS=Homo sapiens GN=CCDC9 PE=1 SV=1 | 478 | L | 0.98569 | P | 0.99372 | -0.00803 | No Change: Both D | - |
| Q96AQ8 | CC90A_HUMAN Coiled-coil domain-containing protein 90A mitochondrial OS=Homo sapiens GN=CCDC90A PE=2 SV=1 | 108 | S | 0.808202 | G | 0.776195 | 0.032007 | No Change: Both D | - |
| Q96AQ8 | CC90A_HUMAN Coiled-coil domain-containing protein 90A mitochondrial OS=Homo sapiens GN=CCDC90A PE=2 SV=1 | 216 | T | 0.376464 | A | 0.346445 | 0.030019 | No Change: Both O | - |
| Q9GZT6 | CC90B_HUMAN Coiled-coil domain-containing protein 90B mitochondrial OS=Homo sapiens GN=CCDC90B PE=1 SV=2 | 10 | F | 0.508428 | L | 0.540895 | -0.032467 | No Change: Both D | - |
| Q7Z6B0 | CCD91_HUMAN Coiled-coil domain-containing protein 91 OS=Homo sapiens GN=CCDC91 PE=1 SV=2 | 261 | M | 0.825805 | V | 0.765614 | 0.060191 | No Change: Both D | - |
| Q7Z6B0 | CCD91_HUMAN Coiled-coil domain-containing protein 91 OS=Homo sapiens GN=CCDC91 PE=1 SV=2 | 314 | V | 0.932572 | M | 0.939227 | -0.006655 | No Change: Both D | - |
| Q53HC0 | CCD92_HUMAN Coiled-coil domain-containing protein 92 OS=Homo sapiens GN=CCDC92 PE=2 SV=2 | 70 | S | 0.866773 | C | 0.803859 | 0.062914 | No Change: Both D | - |
| Q53HC0 | CCD92_HUMAN Coiled-coil domain-containing protein 92 OS=Homo sapiens GN=CCDC92 PE=2 SV=2 | 281 | R | 0.883439 | H | 0.880436 | 0.003003 | No Change: Both D | - |
| Q53HC0 | CCD92_HUMAN Coiled-coil domain-containing protein 92 OS=Homo sapiens GN=CCDC92 PE=2 SV=2 | 253 | A | 0.661448 | T | 0.663218 | -0.00177 | No Change: Both D | - |
| Q567U6 | CCD93_HUMAN Coiled-coil domain-containing protein 93 OS=Homo sapiens GN=CCDC93 PE=1 SV=2 | 315 | H | 0.823503 | R | 0.858654 | -0.035151 | No Change: Both D | A colorectal cancer sample |
| Q567U6 | CCD93_HUMAN Coiled-coil domain-containing protein 93 OS=Homo sapiens GN=CCDC93 PE=1 SV=2 | 179 | R | 0.640403 | C | 0.480487 | 0.159916 | D to O | - |
| Q567U6 | CCD93_HUMAN Coiled-coil domain-containing protein 93 OS=Homo sapiens GN=CCDC93 PE=1 SV=2 | 213 | R | 0.759255 | C | 0.651074 | 0.108181 | No Change: Both D | - |
| Q567U6 | CCD93_HUMAN Coiled-coil domain-containing protein 93 OS=Homo sapiens GN=CCDC93 PE=1 SV=2 | 228 | P | 0.830281 | L | 0.765378 | 0.064903 | No Change: Both D | - |
| Q567U6 | CCD93_HUMAN Coiled-coil domain-containing protein 93 OS=Homo sapiens GN=CCDC93 PE=1 SV=2 | 465 | Y | 0.548172 | H | 0.663046 | -0.114874 | No Change: Both D | - |
| Q2M329 | CCD96_HUMAN Coiled-coil domain-containing protein 96 OS=Homo sapiens GN=CCDC96 PE=2 SV=2 | 96 | E | 0.999598 | K | 0.999445 | 1.53E-04 | No Change: Both D | - |
| Q96EA4 | SPDLY_HUMAN Protein Spindly OS=Homo sapiens GN=CCDC99 PE=1 SV=2 | 508 | Y | 0.639902 | H | 0.750425 | -0.110523 | No Change: Both D | - |
| Q96EA4 | SPDLY_HUMAN Protein Spindly OS=Homo sapiens GN=CCDC99 PE=1 SV=2 | 586 | L | 0.950059 | S | 0.973994 | -0.023935 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 102 | R | 0.912407 | Q | 0.915868 | -0.003461 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 103 | R | 0.915577 | W | 0.795728 | 0.119849 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 109 | R | 0.912987 | W | 0.784214 | 0.128773 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 164 | S | 0.940135 | R | 0.942894 | -0.002759 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 275 | E | 0.593469 | D | 0.538657 | 0.054812 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 417 | R | 0.809657 | W | 0.613803 | 0.195854 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 417 | R | 0.809657 | Q | 0.824102 | -0.014445 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 546 | K | 0.977773 | R | 0.98193 | -0.004157 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 575 | G | 0.979824 | C | 0.972835 | 0.006989 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 627 | R | 0.927969 | Q | 0.925094 | 0.002875 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 639 | Q | 0.971786 | H | 0.962334 | 0.009452 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 776 | S | 0.938703 | C | 0.886824 | 0.051879 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 179 | L | 0.956436 | Q | 0.972368 | -0.015932 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 367 | A | 0.812094 | T | 0.819655 | -0.007561 | No Change: Both D | - |
| Q8TD31 | CCHCR_HUMAN Coiled-coil alpha-helical rod protein 1 OS=Homo sapiens GN=CCHCR1 PE=1 SV=2 | 733 | A | 0.825759 | V | 0.787335 | 0.038424 | No Change: Both D | - |
| Q13939 | CALI_HUMAN Calicin OS=Homo sapiens GN=CCIN PE=2 SV=3 | 75 | S | 0.175777 | N | 0.139279 | 0.036498 | No Change: Both O | - |
| P06307 | CCKN_HUMAN Cholecystokinin OS=Homo sapiens GN=CCK PE=1 SV=1 | 32 | G | 0.803384 | E | 0.835167 | -0.031783 | No Change: Both D | - |
| P06307 | CCKN_HUMAN Cholecystokinin OS=Homo sapiens GN=CCK PE=1 SV=1 | 95 | R | 0.51346 | W | 0.281303 | 0.232157 | D to O | - |
| P32239 | GASR_HUMAN Gastrin/cholecystokinin type B receptor OS=Homo sapiens GN=CCKBR PE=1 SV=1 | 37 | L | 0.638964 | F | 0.593461 | 0.045503 | No Change: Both D | - |
| P32239 | GASR_HUMAN Gastrin/cholecystokinin type B receptor OS=Homo sapiens GN=CCKBR PE=1 SV=1 | 125 | V | 0.032339 | I | 0.028618 | 0.003721 | No Change: Both O | - |
| P32239 | GASR_HUMAN Gastrin/cholecystokinin type B receptor OS=Homo sapiens GN=CCKBR PE=1 SV=1 | 215 | R | 0.19995 | H | 0.194333 | 0.005617 | No Change: Both O | - |
| P32239 | GASR_HUMAN Gastrin/cholecystokinin type B receptor OS=Homo sapiens GN=CCKBR PE=1 SV=1 | 319 | R | 0.754003 | Q | 0.774855 | -0.020852 | No Change: Both D | - |
| P32239 | GASR_HUMAN Gastrin/cholecystokinin type B receptor OS=Homo sapiens GN=CCKBR PE=1 SV=1 | 77 | V | 0.048943 | G | 0.09357 | -0.044627 | No Change: Both O | - |
| P51671 | CCL11_HUMAN Eotaxin OS=Homo sapiens GN=CCL11 PE=1 SV=1 | 7 | L | 0.08892 | P | 0.157781 | -0.068861 | No Change: Both O | - |
| P51671 | CCL11_HUMAN Eotaxin OS=Homo sapiens GN=CCL11 PE=1 SV=1 | 23 | A | 0.520688 | T | 0.541151 | -0.020463 | No Change: Both D | - |
| P51671 | CCL11_HUMAN Eotaxin OS=Homo sapiens GN=CCL11 PE=1 SV=1 | 51 | R | 0.402963 | S | 0.456367 | -0.053404 | No Change: Both O | - |
| P51671 | CCL11_HUMAN Eotaxin OS=Homo sapiens GN=CCL11 PE=1 SV=1 | 79 | K | 0.753071 | R | 0.687186 | 0.065885 | No Change: Both D | - |
| P51671 | CCL11_HUMAN Eotaxin OS=Homo sapiens GN=CCL11 PE=1 SV=1 | 86 | K | 0.879499 | T | 0.83177 | 0.047729 | No Change: Both D | - |
| Q99616 | CCL13_HUMAN C-C motif chemokine 13 OS=Homo sapiens GN=CCL13 PE=1 SV=1 | 5 | A | 0.261535 | S | 0.362483 | -0.100948 | No Change: Both O | - |
| Q99616 | CCL13_HUMAN C-C motif chemokine 13 OS=Homo sapiens GN=CCL13 PE=1 SV=1 | 29 | N | 0.270795 | S | 0.337581 | -0.066786 | No Change: Both O | - |
| Q16627 | CCL14_HUMAN C-C motif chemokine 14 OS=Homo sapiens GN=CCL14 PE=1 SV=1 | 61 | K | 0.307418 | E | 0.307243 | 1.75E-04 | No Change: Both O | - |
| Q16663 | CCL15_HUMAN C-C motif chemokine 15 OS=Homo sapiens GN=CCL15 PE=1 SV=2 | 24 | I | 0.305829 | T | 0.456454 | -0.150625 | No Change: Both O | - |
| Q92583 | CCL17_HUMAN C-C motif chemokine 17 OS=Homo sapiens GN=CCL17 PE=1 SV=1 | 5 | K | 0.446687 | N | 0.410596 | 0.036091 | No Change: Both O | - |
| Q92583 | CCL17_HUMAN C-C motif chemokine 17 OS=Homo sapiens GN=CCL17 PE=1 SV=1 | 67 | V | 0.08543 | M | 0.101815 | -0.016385 | No Change: Both O | - |
| P78556 | CCL20_HUMAN C-C motif chemokine 20 OS=Homo sapiens GN=CCL20 PE=1 SV=1 | 47 | V | 0.091344 | M | 0.118897 | -0.027553 | No Change: Both O | - |
| O00626 | CCL22_HUMAN C-C motif chemokine 22 OS=Homo sapiens GN=CCL22 PE=1 SV=2 | 2 | D | 0.77 | A | 0.702961 | 0.067039 | No Change: Both D | - |
| P55773 | CCL23_HUMAN C-C motif chemokine 23 OS=Homo sapiens GN=CCL23 PE=1 SV=3 | 106 | V | 0.429053 | M | 0.528528 | -0.099475 | O to D | - |
| O00175 | CCL24_HUMAN C-C motif chemokine 24 OS=Homo sapiens GN=CCL24 PE=1 SV=2 | 29 | I | 0.137192 | L | 0.146768 | -0.009576 | No Change: Both O | - |
| O00175 | CCL24_HUMAN C-C motif chemokine 24 OS=Homo sapiens GN=CCL24 PE=1 SV=2 | 31 | S | 0.116226 | F | 0.044433 | 0.071793 | No Change: Both O | - |
| O00175 | CCL24_HUMAN C-C motif chemokine 24 OS=Homo sapiens GN=CCL24 PE=1 SV=2 | 102 | A | 0.709773 | T | 0.712516 | -0.002743 | No Change: Both D | - |
| O00175 | CCL24_HUMAN C-C motif chemokine 24 OS=Homo sapiens GN=CCL24 PE=1 SV=2 | 110 | Q | 0.701172 | E | 0.677283 | 0.023889 | No Change: Both D | - |
| O15444 | CCL25_HUMAN C-C motif chemokine 25 OS=Homo sapiens GN=CCL25 PE=1 SV=2 | 23 | T | 0.141271 | A | 0.13785 | 0.003421 | No Change: Both O | - |
| O15444 | CCL25_HUMAN C-C motif chemokine 25 OS=Homo sapiens GN=CCL25 PE=1 SV=2 | 101 | H | 0.5827 | R | 0.617274 | -0.034574 | No Change: Both D | - |
| O15444 | CCL25_HUMAN C-C motif chemokine 25 OS=Homo sapiens GN=CCL25 PE=1 SV=2 | 104 | T | 0.622643 | M | 0.613607 | 0.009036 | No Change: Both D | - |
| Q9Y258 | CCL26_HUMAN C-C motif chemokine 26 OS=Homo sapiens GN=CCL26 PE=1 SV=1 | 18 | L | 0.269279 | R | 0.375533 | -0.106254 | No Change: Both O | - |
| Q9Y4X3 | CCL27_HUMAN C-C motif chemokine 27 OS=Homo sapiens GN=CCL27 PE=1 SV=1 | 78 | I | 0.323454 | V | 0.337029 | -0.013575 | No Change: Both O | - |
| Q9Y4X3 | CCL27_HUMAN C-C motif chemokine 27 OS=Homo sapiens GN=CCL27 PE=1 SV=1 | 96 | L | 0.528549 | F | 0.4893 | 0.039249 | D to O | - |
| P10147 | CCL3_HUMAN C-C motif chemokine 3 OS=Homo sapiens GN=CCL3 PE=1 SV=1 | 78 | E | 0.400601 | D | 0.377527 | 0.023074 | No Change: Both O | - |
| P13236 | CCL4_HUMAN C-C motif chemokine 4 OS=Homo sapiens GN=CCL4 PE=1 SV=1 | 12 | M | 0.215666 | V | 0.134887 | 0.080779 | No Change: Both O | - |
| P13236 | CCL4_HUMAN C-C motif chemokine 4 OS=Homo sapiens GN=CCL4 PE=1 SV=1 | 20 | P | 0.334373 | L | 0.192221 | 0.142152 | No Change: Both O | - |
| P13236 | CCL4_HUMAN C-C motif chemokine 4 OS=Homo sapiens GN=CCL4 PE=1 SV=1 | 80 | S | 0.324822 | T | 0.237683 | 0.087139 | No Change: Both O | - |
| P13501 | CCL5_HUMAN C-C motif chemokine 5 OS=Homo sapiens GN=CCL5 PE=1 SV=3 | 24 | S | 0.658294 | F | 0.435099 | 0.223195 | D to O | - |
| P80075 | CCL8_HUMAN C-C motif chemokine 8 OS=Homo sapiens GN=CCL8 PE=1 SV=2 | 69 | K | 0.372729 | Q | 0.319309 | 0.05342 | No Change: Both O | - |
| P80075 | CCL8_HUMAN C-C motif chemokine 8 OS=Homo sapiens GN=CCL8 PE=1 SV=2 | 14 | A | 0.09738 | V | 0.060691 | 0.036689 | No Change: Both O | - |
| Q9BSQ5 | CCM2_HUMAN Malcavernin OS=Homo sapiens GN=CCM2 PE=1 SV=1 | 53 | V | 0.607748 | I | 0.571763 | 0.035985 | No Change: Both D | - |
| Q9BSQ5 | CCM2_HUMAN Malcavernin OS=Homo sapiens GN=CCM2 PE=1 SV=1 | 120 | V | 0.153685 | I | 0.13115 | 0.022535 | No Change: Both O | - |
| Q9BSQ5 | CCM2_HUMAN Malcavernin OS=Homo sapiens GN=CCM2 PE=1 SV=1 | 198 | L | 0.176838 | R | 0.235276 | -0.058438 | No Change: Both O | Cerebral cavernous malformations type 2 (CCM2) [MIM:603284] |
| Q9BSQ5 | CCM2_HUMAN Malcavernin OS=Homo sapiens GN=CCM2 PE=1 SV=1 | 289 | S | 0.769105 | N | 0.70118 | 0.067925 | No Change: Both D | - |
| P20248 | CCNA2_HUMAN Cyclin-A2 OS=Homo sapiens GN=CCNA2 PE=1 SV=2 | 163 | I | 0.64048 | V | 0.671224 | -0.030744 | No Change: Both D | - |
| O95067 | CCNB2_HUMAN G2/mitotic-specific cyclin-B2 OS=Homo sapiens GN=CCNB2 PE=1 SV=1 | 100 | M | 0.808876 | T | 0.817098 | -0.008222 | No Change: Both D | - |
| O95067 | CCNB2_HUMAN G2/mitotic-specific cyclin-B2 OS=Homo sapiens GN=CCNB2 PE=1 SV=1 | 395 | I | 0.715366 | T | 0.750464 | -0.035098 | No Change: Both D | - |
| O95067 | CCNB2_HUMAN G2/mitotic-specific cyclin-B2 OS=Homo sapiens GN=CCNB2 PE=1 SV=1 | 135 | V | 0.169685 | I | 0.16306 | 0.006625 | No Change: Both O | - |
| Q8WWL7 | CCNB3_HUMAN G2/mitotic-specific cyclin-B3 OS=Homo sapiens GN=CCNB3 PE=1 SV=2 | 597 | K | 0.895101 | T | 0.867754 | 0.027347 | No Change: Both D | A colorectal cancer sample |
| Q8WWL7 | CCNB3_HUMAN G2/mitotic-specific cyclin-B3 OS=Homo sapiens GN=CCNB3 PE=1 SV=2 | 1001 | G | 0.708582 | R | 0.692913 | 0.015669 | No Change: Both D | - |
| P30279 | CCND2_HUMAN G1/S-specific cyclin-D2 OS=Homo sapiens GN=CCND2 PE=1 SV=1 | 268 | G | 0.879407 | R | 0.913684 | -0.034277 | No Change: Both D | - |
| P30281 | CCND3_HUMAN G1/S-specific cyclin-D3 OS=Homo sapiens GN=CCND3 PE=1 SV=2 | 259 | S | 0.949613 | A | 0.93538 | 0.014233 | No Change: Both D | - |
| P30281 | CCND3_HUMAN G1/S-specific cyclin-D3 OS=Homo sapiens GN=CCND3 PE=1 SV=2 | 134 | P | 0.332001 | S | 0.379846 | -0.047845 | No Change: Both O | - |
| P30281 | CCND3_HUMAN G1/S-specific cyclin-D3 OS=Homo sapiens GN=CCND3 PE=1 SV=2 | 253 | E | 0.895159 | D | 0.876444 | 0.018715 | No Change: Both D | - |
| O96020 | CCNE2_HUMAN G1/S-specific cyclin-E2 OS=Homo sapiens GN=CCNE2 PE=1 SV=1 | 387 | N | 0.447798 | S | 0.496391 | -0.048593 | No Change: Both O | - |
| P51959 | CCNG1_HUMAN Cyclin-G1 OS=Homo sapiens GN=CCNG1 PE=1 SV=2 | 178 | N | 0.408502 | H | 0.368956 | 0.039546 | No Change: Both O | - |
| P51959 | CCNG1_HUMAN Cyclin-G1 OS=Homo sapiens GN=CCNG1 PE=1 SV=2 | 179 | F | 0.396006 | L | 0.452558 | -0.056552 | No Change: Both O | - |
| Q16589 | CCNG2_HUMAN Cyclin-G2 OS=Homo sapiens GN=CCNG2 PE=1 SV=1 | 4 | L | 0.762804 | V | 0.769246 | -0.006442 | No Change: Both D | - |
| Q16589 | CCNG2_HUMAN Cyclin-G2 OS=Homo sapiens GN=CCNG2 PE=1 SV=1 | 28 | E | 0.491553 | G | 0.423092 | 0.068461 | No Change: Both O | - |
| P51946 | CCNH_HUMAN Cyclin-H OS=Homo sapiens GN=CCNH PE=1 SV=1 | 28 | R | 0.438953 | L | 0.301794 | 0.137159 | No Change: Both O | - |
| P51946 | CCNH_HUMAN Cyclin-H OS=Homo sapiens GN=CCNH PE=1 SV=1 | 54 | M | 0.323727 | V | 0.272361 | 0.051366 | No Change: Both O | - |
| P51946 | CCNH_HUMAN Cyclin-H OS=Homo sapiens GN=CCNH PE=1 SV=1 | 138 | K | 0.516998 | R | 0.46094 | 0.056058 | D to O | - |
| P51946 | CCNH_HUMAN Cyclin-H OS=Homo sapiens GN=CCNH PE=1 SV=1 | 270 | V | 0.603675 | A | 0.665623 | -0.061948 | No Change: Both D | - |
| Q14094 | CCNI_HUMAN Cyclin-I OS=Homo sapiens GN=CCNI PE=1 SV=1 | 207 | V | 0.223272 | I | 0.210399 | 0.012873 | No Change: Both O | - |
| Q6ZMN8 | CCNI2_HUMAN Cyclin-I2 OS=Homo sapiens GN=CCNI2 PE=2 SV=1 | 91 | A | 0.973533 | P | 0.980707 | -0.007174 | No Change: Both D | - |
| Q8IV13 | CCNJL_HUMAN Cyclin-J-like protein OS=Homo sapiens GN=CCNJL PE=2 SV=3 | 234 | H | 0.097434 | Y | 0.062165 | 0.035269 | No Change: Both O | - |
| P22674 | CCNO_HUMAN Cyclin-O OS=Homo sapiens GN=CCNO PE=1 SV=2 | 161 | L | 0.15511 | M | 0.182968 | -0.027858 | No Change: Both O | - |
| O60563 | CCNT1_HUMAN Cyclin-T1 OS=Homo sapiens GN=CCNT1 PE=1 SV=1 | 362 | H | 0.700093 | R | 0.735415 | -0.035322 | No Change: Both D | - |
| Q5T2Q4 | CCYL2_HUMAN Cyclin-Y-like protein 2 OS=Homo sapiens GN=CCNYL2 PE=2 SV=2 | 57 | V | 0.388988 | E | 0.545042 | -0.156054 | O to D | - |
| Q5T2Q4 | CCYL2_HUMAN Cyclin-Y-like protein 2 OS=Homo sapiens GN=CCNYL2 PE=2 SV=2 | 176 | R | 0.348875 | Q | 0.379048 | -0.030173 | No Change: Both O | - |
| Q5T2Q4 | CCYL2_HUMAN Cyclin-Y-like protein 2 OS=Homo sapiens GN=CCNYL2 PE=2 SV=2 | 288 | I | 0.363917 | V | 0.401261 | -0.037344 | No Change: Both O | - |
| O43303 | CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens GN=CCP110 PE=1 SV=3 | 252 | I | 0.659631 | M | 0.743376 | -0.083745 | No Change: Both D | - |
| O43303 | CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens GN=CCP110 PE=1 SV=3 | 375 | M | 0.908 | I | 0.872353 | 0.035647 | No Change: Both D | - |
| O43303 | CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens GN=CCP110 PE=1 SV=3 | 69 | R | 0.732243 | S | 0.73466 | -0.002417 | No Change: Both D | - |
| O43303 | CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens GN=CCP110 PE=1 SV=3 | 171 | P | 0.814802 | L | 0.715468 | 0.099334 | No Change: Both D | - |
| O43303 | CP110_HUMAN Centriolar coiled-coil protein of 110 kDa OS=Homo sapiens GN=CCP110 PE=1 SV=3 | 347 | F | 0.376786 | I | 0.38111 | -0.004324 | No Change: Both O | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 44 | S | 0.903572 | P | 0.900667 | 0.002905 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 161 | E | 0.996238 | V | 0.993363 | 0.002875 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 418 | Y | 0.630894 | H | 0.742618 | -0.111724 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 436 | R | 0.608196 | L | 0.493364 | 0.114832 | D to O | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 477 | A | 0.922385 | V | 0.904132 | 0.018253 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 517 | A | 0.859608 | D | 0.888269 | -0.028661 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 553 | G | 0.700844 | D | 0.73941 | -0.038566 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 553 | G | 0.700844 | S | 0.745907 | -0.045063 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 590 | N | 0.876044 | K | 0.892771 | -0.016727 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 627 | K | 0.660069 | E | 0.680705 | -0.020636 | No Change: Both D | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 646 | T | 0.2127 | I | 0.139634 | 0.073066 | No Change: Both O | - |
| Q9ULG6 | CCPG1_HUMAN Cell cycle progression protein 1 OS=Homo sapiens GN=CCPG1 PE=1 SV=3 | 673 | H | 0.073888 | R | 0.073808 | 8.00E-05 | No Change: Both O | - |
| P41597 | CCR2_HUMAN C-C chemokine receptor type 2 OS=Homo sapiens GN=CCR2 PE=1 SV=1 | 64 | V | 0.016091 | I | 0.013923 | 0.002168 | No Change: Both O | - |
| P41597 | CCR2_HUMAN C-C chemokine receptor type 2 OS=Homo sapiens GN=CCR2 PE=1 SV=1 | 355 | G | 0.823191 | E | 0.822925 | 2.66E-04 | No Change: Both D | - |
| P41597 | CCR2_HUMAN C-C chemokine receptor type 2 OS=Homo sapiens GN=CCR2 PE=1 SV=1 | 45 | L | 0.13601 | V | 0.132471 | 0.003539 | No Change: Both O | - |
| P51677 | CCR3_HUMAN C-C chemokine receptor type 3 OS=Homo sapiens GN=CCR3 PE=1 SV=1 | 218 | C | 0.01695 | S | 0.05272 | -0.03577 | No Change: Both O | - |
| P51677 | CCR3_HUMAN C-C chemokine receptor type 3 OS=Homo sapiens GN=CCR3 PE=1 SV=1 | 21 | G | 0.177383 | D | 0.214869 | -0.037486 | No Change: Both O | - |
| P51677 | CCR3_HUMAN C-C chemokine receptor type 3 OS=Homo sapiens GN=CCR3 PE=1 SV=1 | 39 | P | 0.089278 | L | 0.043362 | 0.045916 | No Change: Both O | - |
| P51679 | CCR4_HUMAN C-C chemokine receptor type 4 OS=Homo sapiens GN=CCR4 PE=1 SV=1 | 130 | L | 0.03544 | V | 0.036795 | -0.001355 | No Change: Both O | - |
| P51679 | CCR4_HUMAN C-C chemokine receptor type 4 OS=Homo sapiens GN=CCR4 PE=1 SV=1 | 178 | C | 0.159078 | S | 0.379907 | -0.220829 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 10 | Y | 0.256735 | D | 0.413903 | -0.157168 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 31 | R | 0.121995 | H | 0.123517 | -0.001522 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 34 | P | 0.089195 | L | 0.044288 | 0.044907 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 62 | K | 0.178512 | R | 0.135249 | 0.043263 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 68 | Y | 0.098517 | H | 0.164824 | -0.066307 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 95 | D | 0.136272 | N | 0.135692 | 5.80E-04 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 97 | G | 0.125619 | E | 0.155239 | -0.02962 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 122 | L | 0.012882 | P | 0.026216 | -0.013334 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 158 | F | 0.027352 | S | 0.079567 | -0.052215 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 176 | Y | 0.426893 | C | 0.379944 | 0.046949 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 177 | T | 0.381784 | A | 0.348766 | 0.033018 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 185 | S | 0.2543 | N | 0.2088 | 0.0455 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 210 | M | 0.015672 | V | 0.012963 | 0.002709 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 214 | Y | 0.027898 | C | 0.023646 | 0.004252 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 239 | T | 0.013572 | S | 0.019952 | -0.00638 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 246 | L | 0.005159 | P | 0.012298 | -0.007139 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 288 | T | 0.093688 | M | 0.076019 | 0.017669 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 302 | E | 0.084309 | G | 0.07156 | 0.012749 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 303 | K | 0.082882 | E | 0.088836 | -0.005954 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 306 | N | 0.065334 | S | 0.079776 | -0.014442 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 322 | K | 0.082441 | R | 0.063581 | 0.01886 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 333 | E | 0.632408 | G | 0.568129 | 0.064279 | No Change: Both D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 335 | A | 0.666705 | V | 0.593091 | 0.073614 | No Change: Both D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 339 | Y | 0.633288 | F | 0.625123 | 0.008165 | No Change: Both D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 345 | E | 0.705418 | G | 0.657975 | 0.047443 | No Change: Both D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 29 | A | 0.145479 | S | 0.212927 | -0.067448 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 55 | L | 0.025255 | Q | 0.04485 | -0.019595 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 60 | R | 0.1419 | S | 0.198078 | -0.056178 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 223 | R | 0.267798 | Q | 0.266901 | 8.97E-04 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 301 | G | 0.076956 | V | 0.044675 | 0.032281 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 178 | C | 0.367004 | R | 0.568493 | -0.201489 | O to D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 12 | I | 0.255126 | L | 0.266634 | -0.011508 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 20 | C | 0.319123 | S | 0.605129 | -0.286006 | O to D | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 42 | I | 0.022303 | F | 0.025248 | -0.002945 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 73 | A | 0.042041 | V | 0.028649 | 0.013392 | No Change: Both O | - |
| P51681 | CCR5_HUMAN C-C chemokine receptor type 5 OS=Homo sapiens GN=CCR5 PE=1 SV=1 | 215 | S | 0.033547 | L | 0.015049 | 0.018498 | No Change: Both O | - |
| P32248 | CCR7_HUMAN C-C chemokine receptor type 7 OS=Homo sapiens GN=CCR7 PE=1 SV=2 | 7 | M | 0.523485 | V | 0.475743 | 0.047742 | D to O | - |
| P51685 | CCR8_HUMAN C-C chemokine receptor type 8 OS=Homo sapiens GN=CCR8 PE=1 SV=1 | 27 | A | 0.29178 | G | 0.362928 | -0.071148 | No Change: Both O | - |
| P51686 | CCR9_HUMAN C-C chemokine receptor type 9 OS=Homo sapiens GN=CCR9 PE=1 SV=2 | 284 | M | 0.056317 | V | 0.044989 | 0.011328 | No Change: Both O | - |
| P51686 | CCR9_HUMAN C-C chemokine receptor type 9 OS=Homo sapiens GN=CCR9 PE=1 SV=2 | 92 | I | 0.033637 | V | 0.040566 | -0.006929 | No Change: Both O | - |
| O00421 | CCRL2_HUMAN C-C chemokine receptor-like 2 OS=Homo sapiens GN=CCRL2 PE=1 SV=2 | 167 | F | 0.115691 | Y | 0.144521 | -0.02883 | No Change: Both O | - |
| O00421 | CCRL2_HUMAN C-C chemokine receptor-like 2 OS=Homo sapiens GN=CCRL2 PE=1 SV=2 | 168 | V | 0.139888 | M | 0.178204 | -0.038316 | No Change: Both O | - |
| O00421 | CCRL2_HUMAN C-C chemokine receptor-like 2 OS=Homo sapiens GN=CCRL2 PE=1 SV=2 | 243 | I | 0.009583 | V | 0.012623 | -0.00304 | No Change: Both O | - |
| O00421 | CCRL2_HUMAN C-C chemokine receptor-like 2 OS=Homo sapiens GN=CCRL2 PE=1 SV=2 | 4 | Y | 0.671044 | C | 0.644955 | 0.026089 | No Change: Both D | - |
| Q9UK39 | NOCT_HUMAN Nocturnin OS=Homo sapiens GN=CCRN4L PE=2 SV=2 | 140 | H | 0.395219 | Y | 0.282497 | 0.112722 | No Change: Both O | - |
| P49368 | TCPG_HUMAN T-complex protein 1 subunit gamma OS=Homo sapiens GN=CCT3 PE=1 SV=4 | 391 | L | 0.375293 | F | 0.329366 | 0.045927 | No Change: Both O | - |
| P50991 | TCPD_HUMAN T-complex protein 1 subunit delta OS=Homo sapiens GN=CCT4 PE=1 SV=4 | 112 | I | 0.149905 | V | 0.168451 | -0.018546 | No Change: Both O | - |
| P48643 | TCPE_HUMAN T-complex protein 1 subunit epsilon OS=Homo sapiens GN=CCT5 PE=1 SV=1 | 147 | H | 0.303546 | R | 0.327068 | -0.023522 | No Change: Both O | Hereditary sensory neuropathy autosomal recessive with spastic paraplegia (HSNSP) [MIM:256840] |
| P48643 | TCPE_HUMAN T-complex protein 1 subunit epsilon OS=Homo sapiens GN=CCT5 PE=1 SV=1 | 146 | E | 0.271034 | V | 0.147617 | 0.123417 | No Change: Both O | - |
| P40227 | TCPZ_HUMAN T-complex protein 1 subunit zeta OS=Homo sapiens GN=CCT6A PE=1 SV=3 | 229 | Y | 0.157035 | C | 0.182114 | -0.025079 | No Change: Both O | - |
| Q92526 | TCPW_HUMAN T-complex protein 1 subunit zeta-2 OS=Homo sapiens GN=CCT6B PE=1 SV=5 | 247 | G | 0.345042 | A | 0.325665 | 0.019377 | No Change: Both O | - |
| Q92526 | TCPW_HUMAN T-complex protein 1 subunit zeta-2 OS=Homo sapiens GN=CCT6B PE=1 SV=5 | 17 | R | 0.311422 | Q | 0.296315 | 0.015107 | No Change: Both O | - |
| Q92526 | TCPW_HUMAN T-complex protein 1 subunit zeta-2 OS=Homo sapiens GN=CCT6B PE=1 SV=5 | 48 | V | 0.354617 | A | 0.452486 | -0.097869 | No Change: Both O | - |
| Q99832 | TCPH_HUMAN T-complex protein 1 subunit eta OS=Homo sapiens GN=CCT7 PE=1 SV=2 | 259 | T | 0.218214 | A | 0.214215 | 0.003999 | No Change: Both O | - |
| P50990 | TCPQ_HUMAN T-complex protein 1 subunit theta OS=Homo sapiens GN=CCT8 PE=1 SV=4 | 4 | H | 0.720558 | Q | 0.718984 | 0.001574 | No Change: Both D | - |
| P50990 | TCPQ_HUMAN T-complex protein 1 subunit theta OS=Homo sapiens GN=CCT8 PE=1 SV=4 | 409 | V | 0.403009 | I | 0.37522 | 0.027789 | No Change: Both O | - |
| A6NM43 | TCPQL_HUMAN Putative T-complex protein 1 subunit theta-like 1 OS=Homo sapiens GN=CCT8L1P PE=5 SV=1 | 217 | C | 0.234986 | S | 0.466419 | -0.231433 | No Change: Both O | - |
| A6NM43 | TCPQL_HUMAN Putative T-complex protein 1 subunit theta-like 1 OS=Homo sapiens GN=CCT8L1P PE=5 SV=1 | 308 | D | 0.147958 | N | 0.133989 | 0.013969 | No Change: Both O | - |
| A6NM43 | TCPQL_HUMAN Putative T-complex protein 1 subunit theta-like 1 OS=Homo sapiens GN=CCT8L1P PE=5 SV=1 | 395 | S | 0.19461 | G | 0.156658 | 0.037952 | No Change: Both O | - |
| Q96SF2 | TCPQM_HUMAN Putative T-complex protein 1 subunit theta-like 2 OS=Homo sapiens GN=CCT8L2 PE=5 SV=2 | 320 | W | 0.061849 | R | 0.163668 | -0.101819 | No Change: Both O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 225 | N | 0.357175 | S | 0.425296 | -0.068121 | No Change: Both O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 415 | M | 0.508622 | V | 0.478985 | 0.029637 | D to O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 518 | R | 0.621938 | Q | 0.63035 | -0.008412 | No Change: Both D | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 525 | S | 0.521818 | R | 0.469519 | 0.052299 | D to O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 965 | V | 0.016718 | I | 0.017423 | -7.05E-04 | No Change: Both O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 988 | R | 0.635218 | C | 0.434293 | 0.200925 | D to O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 157 | G | 0.752812 | S | 0.790731 | -0.037919 | No Change: Both D | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 631 | T | 0.51304 | S | 0.57972 | -0.06668 | No Change: Both D | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 933 | R | 0.432231 | Q | 0.480134 | -0.047903 | No Change: Both O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 955 | L | 0.06842 | F | 0.059271 | 0.009149 | No Change: Both O | - |
| Q93033 | IGSF2_HUMAN Immunoglobulin superfamily member 2 OS=Homo sapiens GN=CD101 PE=1 SV=2 | 992 | R | 0.550459 | W | 0.350572 | 0.199887 | D to O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 45 | G | 0.201872 | V | 0.121523 | 0.080349 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 703 | Y | 0.090668 | S | 0.181639 | -0.090971 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 797 | N | 0.375919 | S | 0.42319 | -0.047271 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 845 | V | 0.279445 | I | 0.260438 | 0.019007 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 1241 | T | 0.200258 | M | 0.16746 | 0.032798 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 1007 | Q | 0.214787 | E | 0.257741 | -0.042954 | No Change: Both O | A colorectal cancer sample |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 1065 | N | 0.345027 | K | 0.404862 | -0.059835 | No Change: Both O | A colorectal cancer sample |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 377 | G | 0.439623 | D | 0.486981 | -0.047358 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 641 | L | 0.057783 | F | 0.046605 | 0.011178 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 1009 | V | 0.144538 | M | 0.184488 | -0.03995 | No Change: Both O | - |
| Q6YHK3 | CD109_HUMAN CD109 antigen OS=Homo sapiens GN=CD109 PE=1 SV=2 | 1296 | H | 0.397536 | R | 0.463507 | -0.065971 | No Change: Both O | - |
| P08571 | CD14_HUMAN Monocyte differentiation antigen CD14 OS=Homo sapiens GN=CD14 PE=1 SV=2 | 204 | N | 0.565443 | D | 0.603876 | -0.038433 | No Change: Both D | - |
| P08571 | CD14_HUMAN Monocyte differentiation antigen CD14 OS=Homo sapiens GN=CD14 PE=1 SV=2 | 341 | E | 0.595154 | K | 0.58426 | 0.010894 | No Change: Both D | - |
| P48509 | CD151_HUMAN CD151 antigen OS=Homo sapiens GN=CD151 PE=1 SV=3 | 132 | K | 0.59166 | R | 0.526527 | 0.065133 | No Change: Both D | - |
| P48509 | CD151_HUMAN CD151 antigen OS=Homo sapiens GN=CD151 PE=1 SV=3 | 137 | P | 0.576761 | S | 0.609435 | -0.032674 | No Change: Both D | - |
| P48509 | CD151_HUMAN CD151 antigen OS=Homo sapiens GN=CD151 PE=1 SV=3 | 178 | R | 0.397932 | H | 0.375071 | 0.022861 | No Change: Both O | - |
| P48509 | CD151_HUMAN CD151 antigen OS=Homo sapiens GN=CD151 PE=1 SV=3 | 120 | T | 0.451359 | M | 0.394753 | 0.056606 | No Change: Both O | - |
| O95971 | BY55_HUMAN CD160 antigen OS=Homo sapiens GN=CD160 PE=2 SV=1 | 91 | I | 0.483489 | V | 0.497628 | -0.014139 | No Change: Both O | - |
| Q86VB7 | C163A_HUMAN Scavenger receptor cysteine-rich type 1 protein M130 OS=Homo sapiens GN=CD163 PE=1 SV=2 | 342 | I | 0.26268 | V | 0.294969 | -0.032289 | No Change: Both O | - |
| Q9NR16 | C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens GN=CD163L1 PE=1 SV=2 | 578 | D | 0.132141 | N | 0.121042 | 0.011099 | No Change: Both O | - |
| Q9NR16 | C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens GN=CD163L1 PE=1 SV=2 | 582 | G | 0.178924 | A | 0.136359 | 0.042565 | No Change: Both O | - |
| Q9NR16 | C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens GN=CD163L1 PE=1 SV=2 | 1055 | G | 0.0753 | S | 0.087395 | -0.012095 | No Change: Both O | - |
| Q9NR16 | C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens GN=CD163L1 PE=1 SV=2 | 1108 | M | 0.219524 | T | 0.26989 | -0.050366 | No Change: Both O | - |
| Q9NR16 | C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens GN=CD163L1 PE=1 SV=2 | 523 | L | 0.163772 | M | 0.212369 | -0.048597 | No Change: Both O | - |
| Q6UWJ8 | C16L2_HUMAN CD164 sialomucin-like 2 protein OS=Homo sapiens GN=CD164L2 PE=1 SV=2 | 76 | M | 0.503192 | V | 0.46177 | 0.041422 | D to O | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 3 | A | 0.553434 | P | 0.626711 | -0.073277 | No Change: Both D | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 251 | L | 0.311059 | I | 0.236035 | 0.075024 | No Change: Both O | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 348 | A | 0.634896 | T | 0.702631 | -0.067735 | No Change: Both D | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 119 | L | 0.334912 | F | 0.291269 | 0.043643 | No Change: Both O | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 323 | R | 0.913676 | Q | 0.92474 | -0.011064 | No Change: Both D | - |
| Q8N6Q3 | CD177_HUMAN CD177 antigen OS=Homo sapiens GN=CD177 PE=1 SV=2 | 379 | F | 0.313014 | S | 0.54261 | -0.229596 | O to D | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 53 | N | 0.43178 | K | 0.457586 | -0.025806 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 99 | S | 0.450246 | R | 0.371175 | 0.079071 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 20 | V | 0.079015 | L | 0.079276 | -2.61E-04 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 259 | D | 0.499128 | N | 0.461073 | 0.038055 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 430 | T | 0.159303 | A | 0.153578 | 0.005725 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 648 | F | 0.010848 | L | 0.013471 | -0.002623 | No Change: Both O | - |
| Q99467 | CD180_HUMAN CD180 antigen OS=Homo sapiens GN=CD180 PE=1 SV=2 | 356 | V | 0.272826 | M | 0.327166 | -0.05434 | No Change: Both O | - |
| P15391 | CD19_HUMAN B-lymphocyte antigen CD19 OS=Homo sapiens GN=CD19 PE=1 SV=6 | 174 | L | 0.746299 | V | 0.711407 | 0.034892 | No Change: Both D | - |
| P15391 | CD19_HUMAN B-lymphocyte antigen CD19 OS=Homo sapiens GN=CD19 PE=1 SV=6 | 514 | R | 0.775072 | H | 0.73057 | 0.044502 | No Change: Both D | - |
| P06126 | CD1A_HUMAN T-cell surface glycoprotein CD1a OS=Homo sapiens GN=CD1A PE=1 SV=4 | 30 | T | 0.063472 | I | 0.03548 | 0.027992 | No Change: Both O | - |
| P06126 | CD1A_HUMAN T-cell surface glycoprotein CD1a OS=Homo sapiens GN=CD1A PE=1 SV=4 | 68 | C | 0.090516 | W | 0.079402 | 0.011114 | No Change: Both O | - |
| P06126 | CD1A_HUMAN T-cell surface glycoprotein CD1a OS=Homo sapiens GN=CD1A PE=1 SV=4 | 22 | K | 0.557006 | N | 0.528423 | 0.028583 | No Change: Both D | - |
| P29017 | CD1C_HUMAN T-cell surface glycoprotein CD1c OS=Homo sapiens GN=CD1C PE=1 SV=2 | 70 | N | 0.171979 | T | 0.144114 | 0.027865 | No Change: Both O | - |
| P29017 | CD1C_HUMAN T-cell surface glycoprotein CD1c OS=Homo sapiens GN=CD1C PE=1 SV=2 | 300 | F | 0.037998 | S | 0.113648 | -0.07565 | No Change: Both O | - |
| P15813 | CD1D_HUMAN Antigen-presenting glycoprotein CD1d OS=Homo sapiens GN=CD1D PE=1 SV=1 | 64 | T | 0.56648 | S | 0.638723 | -0.072243 | No Change: Both D | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 106 | Q | 0.115862 | R | 0.095505 | 0.020357 | No Change: Both O | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 164 | R | 0.235555 | W | 0.10539 | 0.130165 | No Change: Both O | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 194 | L | 0.217526 | P | 0.345993 | -0.128467 | No Change: Both O | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 15 | G | 0.320649 | E | 0.388428 | -0.067779 | No Change: Both O | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 102 | H | 0.056333 | R | 0.058915 | -0.002582 | No Change: Both O | - |
| P15812 | CD1E_HUMAN T-cell surface glycoprotein CD1e membrane-associated OS=Homo sapiens GN=CD1E PE=1 SV=2 | 149 | S | 0.238805 | N | 0.185346 | 0.053459 | No Change: Both O | - |
| P06729 | CD2_HUMAN T-cell surface antigen CD2 OS=Homo sapiens GN=CD2 PE=1 SV=2 | 266 | H | 0.979912 | Q | 0.983748 | -0.003836 | No Change: Both D | - |
| P06729 | CD2_HUMAN T-cell surface antigen CD2 OS=Homo sapiens GN=CD2 PE=1 SV=2 | 339 | H | 0.996073 | N | 0.99682 | -7.47E-04 | No Change: Both D | - |
| P06729 | CD2_HUMAN T-cell surface antigen CD2 OS=Homo sapiens GN=CD2 PE=1 SV=2 | 217 | C | 0.060481 | Y | 0.072943 | -0.012462 | No Change: Both O | A breast cancer sample |
| P41217 | OX2G_HUMAN OX-2 membrane glycoprotein OS=Homo sapiens GN=CD200 PE=1 SV=4 | 11 | S | 0.188183 | C | 0.063485 | 0.124698 | No Change: Both O | - |
| P41217 | OX2G_HUMAN OX-2 membrane glycoprotein OS=Homo sapiens GN=CD200 PE=1 SV=4 | 46 | P | 0.349306 | T | 0.315098 | 0.034208 | No Change: Both O | - |
| P41217 | OX2G_HUMAN OX-2 membrane glycoprotein OS=Homo sapiens GN=CD200 PE=1 SV=4 | 76 | V | 0.443653 | G | 0.543377 | -0.099724 | O to D | - |
| Q8TD46 | MO2R1_HUMAN Cell surface glycoprotein CD200 receptor 1 OS=Homo sapiens GN=CD200R1 PE=1 SV=2 | 89 | R | 0.614564 | K | 0.658379 | -0.043815 | No Change: Both D | - |
| Q8TD46 | MO2R1_HUMAN Cell surface glycoprotein CD200 receptor 1 OS=Homo sapiens GN=CD200R1 PE=1 SV=2 | 121 | P | 0.231926 | T | 0.203164 | 0.028762 | No Change: Both O | - |
| Q8TD46 | MO2R1_HUMAN Cell surface glycoprotein CD200 receptor 1 OS=Homo sapiens GN=CD200R1 PE=1 SV=2 | 177 | Q | 0.243351 | H | 0.228419 | 0.014932 | No Change: Both O | - |
| Q8TD46 | MO2R1_HUMAN Cell surface glycoprotein CD200 receptor 1 OS=Homo sapiens GN=CD200R1 PE=1 SV=2 | 312 | E | 0.686065 | Q | 0.66291 | 0.023155 | No Change: Both D | - |
| Q6Q8B3 | MO2R2_HUMAN Cell surface glycoprotein CD200 receptor 2 OS=Homo sapiens GN=CD200R1L PE=2 SV=2 | 113 | R | 0.45428 | L | 0.338647 | 0.115633 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 55 | A | 0.057002 | V | 0.045068 | 0.011934 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 213 | P | 0.102218 | S | 0.126521 | -0.024303 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 278 | V | 0.130331 | A | 0.170757 | -0.040426 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 288 | N | 0.630943 | D | 0.619424 | 0.011519 | No Change: Both D | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 136 | Q | 0.308211 | E | 0.344149 | -0.035938 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 300 | A | 0.325031 | P | 0.412002 | -0.086971 | No Change: Both O | - |
| Q9UJ71 | CLC4K_HUMAN C-type lectin domain family 4 member K OS=Homo sapiens GN=CD207 PE=1 SV=2 | 264 | W | 0.255195 | R | 0.435332 | -0.180137 | No Change: Both O | Birbeck granule deficiency (BIRGD) [MIM:613393] |
| Q9NNX6 | CD209_HUMAN CD209 antigen OS=Homo sapiens GN=CD209 PE=1 SV=1 | 214 | E | 0.851945 | D | 0.789545 | 0.0624 | No Change: Both D | - |
| Q9NNX6 | CD209_HUMAN CD209 antigen OS=Homo sapiens GN=CD209 PE=1 SV=1 | 242 | L | 0.365776 | V | 0.355926 | 0.00985 | No Change: Both O | - |
| Q9NNX6 | CD209_HUMAN CD209 antigen OS=Homo sapiens GN=CD209 PE=1 SV=1 | 168 | E | 0.649059 | D | 0.556203 | 0.092856 | No Change: Both D | - |
| Q9NNX6 | CD209_HUMAN CD209 antigen OS=Homo sapiens GN=CD209 PE=1 SV=1 | 382 | A | 0.725561 | S | 0.790403 | -0.064842 | No Change: Both D | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 152 | Q | 0.581799 | E | 0.613923 | -0.032124 | No Change: Both D | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 664 | S | 0.40762 | G | 0.371553 | 0.036067 | No Change: Both O | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 669 | R | 0.65304 | C | 0.506694 | 0.146346 | No Change: Both D | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 745 | G | 0.615258 | D | 0.619893 | -0.004635 | No Change: Both D | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 34 | A | 0.081381 | T | 0.092341 | -0.01096 | No Change: Both O | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 203 | E | 0.418079 | K | 0.443633 | -0.025554 | No Change: Both O | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 639 | Y | 0.406881 | H | 0.520013 | -0.113132 | O to D | - |
| P20273 | CD22_HUMAN B-cell receptor CD22 OS=Homo sapiens GN=CD22 PE=1 SV=2 | 551 | G | 0.505336 | R | 0.509764 | -0.004428 | No Change: Both D | - |
| Q15762 | CD226_HUMAN CD226 antigen OS=Homo sapiens GN=CD226 PE=1 SV=2 | 307 | S | 0.896894 | G | 0.837922 | 0.058972 | No Change: Both D | - |
| P25063 | CD24_HUMAN Signal transducer CD24 OS=Homo sapiens GN=CD24 PE=1 SV=2 | 57 | A | 0.715168 | V | 0.663831 | 0.051337 | No Change: Both D | - |
| P25063 | CD24_HUMAN Signal transducer CD24 OS=Homo sapiens GN=CD24 PE=1 SV=2 | 44 | T | 0.935852 | S | 0.949076 | -0.013224 | No Change: Both D | - |
| Q9BZW8 | CD244_HUMAN Natural killer cell receptor 2B4 OS=Homo sapiens GN=CD244 PE=1 SV=2 | 89 | N | 0.133013 | D | 0.141889 | -0.008876 | No Change: Both O | - |
| Q9BZW8 | CD244_HUMAN Natural killer cell receptor 2B4 OS=Homo sapiens GN=CD244 PE=1 SV=2 | 323 | S | 0.881969 | F | 0.768783 | 0.113186 | No Change: Both D | - |
| Q9HCU0 | CD248_HUMAN Endosialin OS=Homo sapiens GN=CD248 PE=1 SV=1 | 457 | H | 0.857514 | R | 0.865079 | -0.007565 | No Change: Both D | - |
| Q9HCU0 | CD248_HUMAN Endosialin OS=Homo sapiens GN=CD248 PE=1 SV=1 | 6 | L | 0.213359 | F | 0.142315 | 0.071044 | No Change: Both O | A colorectal cancer sample |
| P26842 | CD27_HUMAN CD27 antigen OS=Homo sapiens GN=CD27 PE=1 SV=2 | 59 | A | 0.612169 | T | 0.637793 | -0.025624 | No Change: Both D | - |
| P26842 | CD27_HUMAN CD27 antigen OS=Homo sapiens GN=CD27 PE=1 SV=2 | 233 | H | 0.818366 | R | 0.854793 | -0.036427 | No Change: Both D | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 97 | P | 0.21258 | L | 0.129503 | 0.083077 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 111 | R | 0.299586 | S | 0.348098 | -0.048512 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 137 | Q | 0.340903 | L | 0.2414 | 0.099503 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 160 | T | 0.350696 | M | 0.298452 | 0.052244 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 267 | R | 0.293057 | H | 0.28607 | 0.006987 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 279 | A | 0.14097 | T | 0.163029 | -0.022059 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 315 | P | 0.212441 | L | 0.129907 | 0.082534 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 329 | R | 0.298884 | S | 0.346615 | -0.047731 | No Change: Both O | - |
| Q5ZPR3 | CD276_HUMAN CD276 antigen OS=Homo sapiens GN=CD276 PE=1 SV=1 | 378 | T | 0.348374 | M | 0.295406 | 0.052968 | No Change: Both O | - |
| Q9Y5K6 | CD2AP_HUMAN CD2-associated protein OS=Homo sapiens GN=CD2AP PE=1 SV=1 | 581 | N | 0.565308 | K | 0.63654 | -0.071232 | No Change: Both D | - |
| O95400 | CD2B2_HUMAN CD2 antigen cytoplasmic tail-binding protein 2 OS=Homo sapiens GN=CD2BP2 PE=1 SV=1 | 231 | G | 0.555786 | D | 0.564003 | -0.008217 | No Change: Both D | - |
| O95400 | CD2B2_HUMAN CD2 antigen cytoplasmic tail-binding protein 2 OS=Homo sapiens GN=CD2BP2 PE=1 SV=1 | 262 | T | 0.847782 | I | 0.746208 | 0.101574 | No Change: Both D | - |
| Q9UGN4 | CLM8_HUMAN CMRF35-like molecule 8 OS=Homo sapiens GN=CD300A PE=1 SV=2 | 111 | R | 0.163585 | Q | 0.175154 | -0.011569 | No Change: Both O | - |
| Q08708 | CLM6_HUMAN CMRF35-like molecule 6 OS=Homo sapiens GN=CD300C PE=2 SV=1 | 71 | T | 0.490048 | I | 0.38059 | 0.109458 | No Change: Both O | - |
| Q496F6 | CLM2_HUMAN CMRF35-like molecule 2 OS=Homo sapiens GN=CD300E PE=1 SV=2 | 19 | K | 0.503404 | T | 0.435202 | 0.068202 | D to O | - |
| Q496F6 | CLM2_HUMAN CMRF35-like molecule 2 OS=Homo sapiens GN=CD300E PE=1 SV=2 | 27 | T | 0.51359 | A | 0.480953 | 0.032637 | D to O | A colorectal cancer sample |
| Q496F6 | CLM2_HUMAN CMRF35-like molecule 2 OS=Homo sapiens GN=CD300E PE=1 SV=2 | 158 | G | 0.502014 | R | 0.515896 | -0.013882 | No Change: Both D | - |
| Q6UXZ3 | CLM4_HUMAN CMRF35-like molecule 4 OS=Homo sapiens GN=CD300LD PE=1 SV=1 | 6 | S | 0.236887 | A | 0.144694 | 0.092193 | No Change: Both O | - |
| Q6UXZ3 | CLM4_HUMAN CMRF35-like molecule 4 OS=Homo sapiens GN=CD300LD PE=1 SV=1 | 89 | V | 0.305247 | M | 0.371563 | -0.066316 | No Change: Both O | - |
| Q8TDQ1 | CLM1_HUMAN CMRF35-like molecule 1 OS=Homo sapiens GN=CD300LF PE=1 SV=3 | 218 | Q | 0.669871 | R | 0.618065 | 0.051806 | No Change: Both D | - |
| Q8TDQ1 | CLM1_HUMAN CMRF35-like molecule 1 OS=Homo sapiens GN=CD300LF PE=1 SV=3 | 19 | V | 0.170586 | A | 0.225142 | -0.054556 | No Change: Both O | - |
| Q6UXG3 | CLM9_HUMAN CMRF35-like molecule 9 OS=Homo sapiens GN=CD300LG PE=1 SV=2 | 221 | D | 0.983057 | N | 0.978917 | 0.00414 | No Change: Both D | - |
| Q6UXG3 | CLM9_HUMAN CMRF35-like molecule 9 OS=Homo sapiens GN=CD300LG PE=1 SV=2 | 228 | T | 0.946657 | A | 0.946363 | 2.94E-04 | No Change: Both D | - |
| Q8IX05 | CD302_HUMAN CD302 antigen OS=Homo sapiens GN=CD302 PE=1 SV=1 | 200 | R | 0.524306 | S | 0.626474 | -0.102168 | No Change: Both D | - |
| Q9NPF0 | CD320_HUMAN CD320 antigen OS=Homo sapiens GN=CD320 PE=1 SV=1 | 8 | Q | 0.24604 | R | 0.25502 | -0.00898 | No Change: Both O | - |
| Q9NPF0 | CD320_HUMAN CD320 antigen OS=Homo sapiens GN=CD320 PE=1 SV=1 | 220 | G | 0.806634 | R | 0.794339 | 0.012295 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 69 | R | 0.362722 | G | 0.380054 | -0.017332 | No Change: Both O | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 202 | R | 0.440797 | W | 0.247283 | 0.193514 | No Change: Both O | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 242 | I | 0.471995 | L | 0.500141 | -0.028146 | O to D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 243 | F | 0.517576 | L | 0.546902 | -0.029326 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 294 | V | 0.567909 | L | 0.573624 | -0.005715 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 14 | A | 0.074697 | V | 0.046416 | 0.028281 | No Change: Both O | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 22 | W | 0.115814 | R | 0.263624 | -0.14781 | No Change: Both O | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 128 | S | 0.621413 | N | 0.567964 | 0.053449 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 304 | G | 0.817988 | R | 0.835378 | -0.01739 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 331 | T | 0.816721 | A | 0.799553 | 0.017168 | No Change: Both D | - |
| P20138 | CD33_HUMAN Myeloid cell surface antigen CD33 OS=Homo sapiens GN=CD33 PE=1 SV=2 | 267 | V | 0.138425 | I | 0.128174 | 0.010251 | No Change: Both O | - |
| P28906 | CD34_HUMAN Hematopoietic progenitor cell antigen CD34 OS=Homo sapiens GN=CD34 PE=1 SV=2 | 367 | A | 0.8893 | S | 0.920627 | -0.031327 | No Change: Both D | - |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 154 | V | 0.12309 | F | 0.115996 | 0.007094 | No Change: Both O | - |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 90 | P | 0.284706 | S | 0.310362 | -0.025656 | No Change: Both O | Platelet glycoprotein IV deficiency (PG4D) [MIM:608404] |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 123 | E | 0.343705 | K | 0.329385 | 0.01432 | No Change: Both O | - |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 174 | T | 0.155144 | A | 0.137597 | 0.017547 | No Change: Both O | - |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 254 | F | 0.3652 | L | 0.379748 | -0.014548 | No Change: Both O | Platelet glycoprotein IV deficiency (PG4D) [MIM:608404] |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 271 | I | 0.10415 | T | 0.17074 | -0.06659 | No Change: Both O | - |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 413 | I | 0.039015 | L | 0.046487 | -0.007472 | No Change: Both O | Platelet glycoprotein IV deficiency (PG4D) [MIM:608404] |
| P16671 | CD36_HUMAN Platelet glycoprotein 4 OS=Homo sapiens GN=CD36 PE=1 SV=2 | 127 | S | 0.367536 | L | 0.196726 | 0.17081 | No Change: Both O | - |
| P28907 | CD38_HUMAN ADP-ribosyl cyclase 1 OS=Homo sapiens GN=CD38 PE=1 SV=2 | 140 | R | 0.280834 | W | 0.12582 | 0.155014 | No Change: Both O | - |
| P04234 | CD3D_HUMAN T-cell surface glycoprotein CD3 delta chain OS=Homo sapiens GN=CD3D PE=1 SV=1 | 147 | Q | 0.346309 | R | 0.332826 | 0.013483 | No Change: Both O | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 259 | K | 0.978472 | T | 0.974299 | 0.004173 | No Change: Both D | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 282 | T | 0.981146 | A | 0.970229 | 0.010917 | No Change: Both D | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 373 | K | 0.995478 | E | 0.995578 | -1.00E-04 | No Change: Both D | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 394 | D | 0.991638 | N | 0.989247 | 0.002391 | No Change: Both D | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 503 | K | 0.996811 | Q | 0.997126 | -3.15E-04 | No Change: Both D | - |
| O15446 | RPA34_HUMAN DNA-directed RNA polymerase I subunit RPA34 OS=Homo sapiens GN=CD3EAP PE=1 SV=1 | 504 | Q | 0.996735 | K | 0.996694 | 4.10E-05 | No Change: Both D | - |
| P09693 | CD3G_HUMAN T-cell surface glycoprotein CD3 gamma chain OS=Homo sapiens GN=CD3G PE=1 SV=1 | 131 | V | 0.018829 | F | 0.016205 | 0.002624 | No Change: Both O | - |
| P01730 | CD4_HUMAN T-cell surface glycoprotein CD4 OS=Homo sapiens GN=CD4 PE=1 SV=1 | 265 | R | 0.53167 | W | 0.3251 | 0.20657 | D to O | - |
| P01730 | CD4_HUMAN T-cell surface glycoprotein CD4 OS=Homo sapiens GN=CD4 PE=1 SV=1 | 191 | K | 0.292565 | E | 0.28703 | 0.005535 | No Change: Both O | - |
| P01730 | CD4_HUMAN T-cell surface glycoprotein CD4 OS=Homo sapiens GN=CD4 PE=1 SV=1 | 227 | F | 0.171745 | S | 0.354743 | -0.182998 | No Change: Both O | - |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 83 | C | 0.491373 | R | 0.563166 | -0.071793 | O to D | Immunodeficiency with hyper-IgM type 3 (HIGM3) [MIM:606843] |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 124 | S | 0.40386 | L | 0.223636 | 0.180224 | No Change: Both O | - |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 227 | P | 0.793253 | A | 0.764371 | 0.028882 | No Change: Both D | - |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 26 | C | 0.43091 | Q | 0.586427 | -0.155517 | O to D | Bladder carcinoma cell line Hu549 |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 35 | S | 0.411631 | G | 0.349504 | 0.062127 | No Change: Both O | Bladder carcinoma cell line Hu549 |
| P25942 | TNR5_HUMAN Tumor necrosis factor receptor superfamily member 5 OS=Homo sapiens GN=CD40 PE=1 SV=1 | 39 | S | 0.364167 | T | 0.309744 | 0.054423 | No Change: Both O | Bladder carcinoma cell line Hu549 |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 36 | M | 0.053275 | R | 0.070445 | -0.01717 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 123 | A | 0.46825 | E | 0.578438 | -0.110188 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 126 | V | 0.489031 | A | 0.580255 | -0.091224 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 140 | W | 0.27456 | C | 0.330434 | -0.055874 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 140 | W | 0.27456 | G | 0.503717 | -0.229157 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 140 | W | 0.27456 | R | 0.478453 | -0.203893 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 144 | G | 0.254236 | E | 0.318608 | -0.064372 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 155 | L | 0.380662 | P | 0.515066 | -0.134404 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 211 | T | 0.490966 | N | 0.544651 | -0.053685 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 219 | G | 0.582402 | R | 0.572929 | 0.009473 | No Change: Both D | - |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 227 | G | 0.303283 | V | 0.199732 | 0.103551 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 231 | L | 0.293463 | S | 0.493703 | -0.20024 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 235 | A | 0.247381 | P | 0.357927 | -0.110546 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 254 | T | 0.392615 | M | 0.328352 | 0.064263 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 147 | T | 0.22768 | N | 0.270691 | -0.043011 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 170 | Y | 0.053138 | C | 0.046692 | 0.006446 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 258 | L | 0.602767 | S | 0.737636 | -0.134869 | No Change: Both D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 38 | G | 0.059803 | R | 0.056982 | 0.002821 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 125 | H | 0.455997 | R | 0.476573 | -0.020576 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 174 | Q | 0.055795 | R | 0.053377 | 0.002418 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 257 | G | 0.539361 | S | 0.595288 | -0.055927 | No Change: Both D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 116 | G | 0.729171 | R | 0.728663 | 5.08E-04 | No Change: Both D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 116 | G | 0.729171 | S | 0.788953 | -0.059782 | No Change: Both D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 126 | V | 0.489031 | D | 0.615008 | -0.125977 | O to D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 143 | K | 0.266139 | T | 0.215908 | 0.050231 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 173 | A | 0.052176 | D | 0.068587 | -0.016411 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 176 | T | 0.101014 | I | 0.059738 | 0.041276 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 195 | L | 0.266747 | P | 0.42412 | -0.157373 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 208 | A | 0.435793 | D | 0.454791 | -0.018998 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 224 | H | 0.283168 | Y | 0.17243 | 0.110738 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 226 | G | 0.291457 | A | 0.23996 | 0.051497 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 237 | V | 0.244869 | E | 0.396481 | -0.151612 | No Change: Both O | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P29965 | CD40L_HUMAN CD40 ligand OS=Homo sapiens GN=CD40LG PE=1 SV=1 | 257 | G | 0.539361 | D | 0.548373 | -0.009012 | No Change: Both D | X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [MIM:308230] |
| P16070 | CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3 | 46 | R | 0.406386 | P | 0.424949 | -0.018563 | No Change: Both O | - |
| P16070 | CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3 | 417 | K | 0.895511 | R | 0.903482 | -0.007971 | No Change: Both D | - |
| P16070 | CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3 | 393 | T | 0.946454 | M | 0.927777 | 0.018677 | No Change: Both D | - |
| P16070 | CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3 | 479 | I | 0.830794 | T | 0.905913 | -0.075119 | No Change: Both D | - |
| P16070 | CD44_HUMAN CD44 antigen OS=Homo sapiens GN=CD44 PE=1 SV=3 | 494 | D | 0.896372 | H | 0.876381 | 0.019991 | No Change: Both D | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 266 | D | 0.329312 | N | 0.297784 | 0.031528 | No Change: Both O | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 324 | P | 0.715518 | L | 0.600029 | 0.115489 | No Change: Both D | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 353 | A | 0.011081 | V | 0.008001 | 0.00308 | No Change: Both O | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 355 | V | 0.012788 | G | 0.023025 | -0.010237 | No Change: Both O | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 13 | S | 0.422668 | F | 0.275622 | 0.147046 | No Change: Both O | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 59 | R | 0.296213 | Q | 0.314247 | -0.018034 | No Change: Both O | - |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 165 | P | 0.434166 | S | 0.432367 | 0.001799 | No Change: Both O | Hemolytic uremic syndrome atypical type 2 (AHUS2) [MIM:612922] |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 240 | S | 0.401212 | P | 0.376639 | 0.024573 | No Change: Both O | Hemolytic uremic syndrome atypical type 2 (AHUS2) [MIM:612922] |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 228 | C | 0.129018 | Y | 0.137561 | -0.008543 | No Change: Both O | A colorectal cancer sample |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 35 | C | 0.422768 | Y | 0.472471 | -0.049703 | No Change: Both O | Hemolytic uremic syndrome atypical type 2 (AHUS2) [MIM:612922] |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 216 | W | 0.230617 | C | 0.332673 | -0.102056 | No Change: Both O | Hemolytic uremic syndrome atypical type 2 (AHUS2) [MIM:612922] |
| P15529 | MCP_HUMAN Membrane cofactor protein OS=Homo sapiens GN=CD46 PE=1 SV=3 | 231 | P | 0.147576 | R | 0.134557 | 0.013019 | No Change: Both O | Hemolytic uremic syndrome atypical type 2 (AHUS2) [MIM:612922] |
| P09326 | CD48_HUMAN CD48 antigen OS=Homo sapiens GN=CD48 PE=1 SV=2 | 102 | E | 0.479222 | Q | 0.470148 | 0.009074 | No Change: Both O | - |
| P09326 | CD48_HUMAN CD48 antigen OS=Homo sapiens GN=CD48 PE=1 SV=2 | 241 | L | 0.496979 | S | 0.705602 | -0.208623 | O to D | - |
| P06127 | CD5_HUMAN T-cell surface glycoprotein CD5 OS=Homo sapiens GN=CD5 PE=1 SV=2 | 224 | P | 0.806884 | L | 0.715784 | 0.0911 | No Change: Both D | - |
| P06127 | CD5_HUMAN T-cell surface glycoprotein CD5 OS=Homo sapiens GN=CD5 PE=1 SV=2 | 461 | H | 0.889905 | R | 0.902481 | -0.012576 | No Change: Both D | - |
| P06127 | CD5_HUMAN T-cell surface glycoprotein CD5 OS=Homo sapiens GN=CD5 PE=1 SV=2 | 471 | A | 0.896181 | V | 0.839319 | 0.056862 | No Change: Both D | - |
| P31358 | CD52_HUMAN CAMPATH-1 antigen OS=Homo sapiens GN=CD52 PE=1 SV=1 | 41 | I | 0.519872 | M | 0.582706 | -0.062834 | No Change: Both D | - |
| P31358 | CD52_HUMAN CAMPATH-1 antigen OS=Homo sapiens GN=CD52 PE=1 SV=1 | 40 | N | 0.623852 | S | 0.678702 | -0.05485 | No Change: Both D | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 52 | R | 0.534704 | L | 0.419655 | 0.115049 | D to O | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 52 | R | 0.534704 | P | 0.597841 | -0.063137 | No Change: Both D | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 82 | L | 0.355651 | R | 0.499366 | -0.143715 | No Change: Both O | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 199 | S | 0.27555 | L | 0.135449 | 0.140101 | No Change: Both O | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 227 | A | 0.270816 | P | 0.409805 | -0.138989 | No Change: Both O | - |
| P08174 | DAF_HUMAN Complement decay-accelerating factor OS=Homo sapiens GN=CD55 PE=1 SV=4 | 240 | R | 0.447186 | H | 0.455084 | -0.007898 | No Change: Both O | - |
| P19256 | LFA3_HUMAN Lymphocyte function-associated antigen 3 OS=Homo sapiens GN=CD58 PE=1 SV=1 | 15 | S | 0.049425 | G | 0.042461 | 0.006964 | No Change: Both O | - |
| O43866 | CD5L_HUMAN CD5 antigen-like OS=Homo sapiens GN=CD5L PE=1 SV=1 | 117 | D | 0.84875 | E | 0.868669 | -0.019919 | No Change: Both D | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 225 | R | 0.402823 | W | 0.203653 | 0.19917 | No Change: Both O | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 271 | A | 0.35095 | T | 0.393208 | -0.042258 | No Change: Both O | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 351 | S | 0.599259 | N | 0.547035 | 0.052224 | No Change: Both D | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 606 | G | 0.944002 | S | 0.963077 | -0.019075 | No Change: Both D | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 217 | T | 0.38214 | M | 0.343761 | 0.038379 | No Change: Both O | - |
| P30203 | CD6_HUMAN T-cell differentiation antigen CD6 OS=Homo sapiens GN=CD6 PE=1 SV=3 | 257 | A | 0.478214 | V | 0.397043 | 0.081171 | No Change: Both O | - |
| P34810 | CD68_HUMAN Macrosialin OS=Homo sapiens GN=CD68 PE=1 SV=2 | 254 | Q | 0.25127 | K | 0.276305 | -0.025035 | No Change: Both O | - |
| P34810 | CD68_HUMAN Macrosialin OS=Homo sapiens GN=CD68 PE=1 SV=2 | 340 | A | 0.014651 | T | 0.014654 | -3.00E-06 | No Change: Both O | - |
| P34810 | CD68_HUMAN Macrosialin OS=Homo sapiens GN=CD68 PE=1 SV=2 | 329 | I | 0.021352 | T | 0.036301 | -0.014949 | No Change: Both O | - |
| P34810 | CD68_HUMAN Macrosialin OS=Homo sapiens GN=CD68 PE=1 SV=2 | 350 | A | 0.6387 | T | 0.653187 | -0.014487 | No Change: Both D | - |
| P09564 | CD7_HUMAN T-cell antigen CD7 OS=Homo sapiens GN=CD7 PE=1 SV=1 | 113 | T | 0.202645 | A | 0.169744 | 0.032901 | No Change: Both O | - |
| P21854 | CD72_HUMAN B-cell differentiation antigen CD72 OS=Homo sapiens GN=CD72 PE=1 SV=1 | 234 | P | 0.317115 | L | 0.209241 | 0.107874 | No Change: Both O | - |
| P40259 | CD79B_HUMAN B-cell antigen receptor complex-associated protein beta chain OS=Homo sapiens GN=CD79B PE=1 SV=1 | 137 | G | 0.239626 | S | 0.280987 | -0.041361 | No Change: Both O | Agammaglobulinemia type 6 (AGM6) [MIM:612692] |
| P27701 | CD82_HUMAN CD82 antigen OS=Homo sapiens GN=CD82 PE=1 SV=1 | 241 | I | 0.056812 | V | 0.068593 | -0.011781 | No Change: Both O | - |
| Q01151 | CD83_HUMAN CD83 antigen OS=Homo sapiens GN=CD83 PE=1 SV=1 | 182 | R | 0.323171 | Q | 0.344181 | -0.02101 | No Change: Both O | - |
| P42081 | CD86_HUMAN T-lymphocyte activation antigen CD86 OS=Homo sapiens GN=CD86 PE=1 SV=2 | 310 | A | 0.969458 | T | 0.980883 | -0.011425 | No Change: Both D | - |
| P42081 | CD86_HUMAN T-lymphocyte activation antigen CD86 OS=Homo sapiens GN=CD86 PE=1 SV=2 | 170 | S | 0.474607 | N | 0.433737 | 0.04087 | No Change: Both O | - |
| P42081 | CD86_HUMAN T-lymphocyte activation antigen CD86 OS=Homo sapiens GN=CD86 PE=1 SV=2 | 323 | D | 0.975385 | N | 0.964977 | 0.010408 | No Change: Both D | - |
| P42081 | CD86_HUMAN T-lymphocyte activation antigen CD86 OS=Homo sapiens GN=CD86 PE=1 SV=2 | 185 | V | 0.453195 | I | 0.432282 | 0.020913 | No Change: Both O | - |
| P01732 | CD8A_HUMAN T-cell surface glycoprotein CD8 alpha chain OS=Homo sapiens GN=CD8A PE=1 SV=1 | 111 | G | 0.279706 | S | 0.344964 | -0.065258 | No Change: Both O | Familial CD8 deficiency (CD8 deficiency) [MIM:608957] |
| Q9NPY3 | C1QR1_HUMAN Complement component C1q receptor OS=Homo sapiens GN=CD93 PE=1 SV=3 | 318 | V | 0.595983 | A | 0.668694 | -0.072711 | No Change: Both D | - |
| Q9NPY3 | C1QR1_HUMAN Complement component C1q receptor OS=Homo sapiens GN=CD93 PE=1 SV=3 | 220 | A | 0.349297 | V | 0.26585 | 0.083447 | No Change: Both O | A colorectal cancer sample |
| Q9NPY3 | C1QR1_HUMAN Complement component C1q receptor OS=Homo sapiens GN=CD93 PE=1 SV=3 | 541 | P | 0.888969 | S | 0.887835 | 0.001134 | No Change: Both D | - |
| P40200 | TACT_HUMAN T-cell surface protein tactile OS=Homo sapiens GN=CD96 PE=1 SV=2 | 142 | A | 0.353825 | P | 0.428168 | -0.074343 | No Change: Both O | - |
| P40200 | TACT_HUMAN T-cell surface protein tactile OS=Homo sapiens GN=CD96 PE=1 SV=2 | 280 | T | 0.317583 | M | 0.274068 | 0.043515 | No Change: Both O | C syndrome (CSYN) [MIM:211750] |
| P48960 | CD97_HUMAN CD97 antigen OS=Homo sapiens GN=CD97 PE=1 SV=4 | 367 | R | 0.454177 | Q | 0.484293 | -0.030116 | No Change: Both O | - |
| P14209 | CD99_HUMAN CD99 antigen OS=Homo sapiens GN=CD99 PE=1 SV=1 | 166 | M | 0.701715 | V | 0.667029 | 0.034686 | No Change: Both D | - |
| P14209 | CD99_HUMAN CD99 antigen OS=Homo sapiens GN=CD99 PE=1 SV=1 | 173 | N | 0.697346 | I | 0.513285 | 0.184061 | No Change: Both D | - |
| P32320 | CDD_HUMAN Cytidine deaminase OS=Homo sapiens GN=CDA PE=1 SV=2 | 27 | K | 0.503783 | Q | 0.475198 | 0.028585 | D to O | - |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 599 | N | 0.444865 | S | 0.513068 | -0.068203 | O to D | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 672 | P | 0.331602 | L | 0.196145 | 0.135457 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 698 | E | 0.049378 | K | 0.048972 | 4.06E-04 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 714 | R | 0.053269 | W | 0.019398 | 0.033871 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 868 | F | 0.269093 | I | 0.273673 | -0.00458 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 869 | V | 0.256286 | M | 0.290862 | -0.034576 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 1042 | R | 0.709741 | W | 0.498328 | 0.211413 | D to O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 1043 | D | 0.729298 | V | 0.628841 | 0.100457 | No Change: Both D | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 1130 | P | 0.270548 | L | 0.161284 | 0.109264 | No Change: Both O | Congenital dyserythropoietic anemia type 1 (CDA1) [MIM:224120] |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 596 | Q | 0.479745 | R | 0.43805 | 0.041695 | No Change: Both O | - |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 891 | R | 0.290362 | C | 0.188076 | 0.102286 | No Change: Both O | - |
| Q8IWY9 | CDAN1_HUMAN Codanin-1 OS=Homo sapiens GN=CDAN1 PE=1 SV=4 | 107 | Q | 0.992663 | L | 0.989783 | 0.00288 | No Change: Both D | - |
| Q9UNH5 | CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens GN=CDC14A PE=1 SV=1 | 345 | R | 0.716469 | Q | 0.726439 | -0.00997 | No Change: Both D | - |
| Q9UNH5 | CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens GN=CDC14A PE=1 SV=1 | 589 | S | 0.777338 | F | 0.524003 | 0.253335 | No Change: Both D | - |
| Q9UNH5 | CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens GN=CDC14A PE=1 SV=1 | 493 | D | 0.930376 | Y | 0.8693 | 0.061076 | No Change: Both D | A colorectal cancer sample |
| O60729 | CC14B_HUMAN Dual specificity protein phosphatase CDC14B OS=Homo sapiens GN=CDC14B PE=1 SV=1 | 302 | I | 0.132041 | T | 0.214877 | -0.082836 | No Change: Both O | - |
| O60729 | CC14B_HUMAN Dual specificity protein phosphatase CDC14B OS=Homo sapiens GN=CDC14B PE=1 SV=1 | 341 | I | 0.083697 | T | 0.154695 | -0.070998 | No Change: Both O | - |
| A4D256 | CC14C_HUMAN Dual specificity protein phosphatase CDC14C OS=Homo sapiens GN=CDC14C PE=1 SV=2 | 238 | P | 0.111208 | S | 0.11735 | -0.006142 | No Change: Both O | - |
| A4D256 | CC14C_HUMAN Dual specificity protein phosphatase CDC14C OS=Homo sapiens GN=CDC14C PE=1 SV=2 | 296 | I | 0.067416 | L | 0.07563 | -0.008214 | No Change: Both O | - |
| Q12834 | CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens GN=CDC20 PE=1 SV=2 | 402 | V | 0.171664 | M | 0.209559 | -0.037895 | No Change: Both O | - |
| Q12834 | CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens GN=CDC20 PE=1 SV=2 | 479 | R | 0.725654 | Q | 0.687307 | 0.038347 | No Change: Both D | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 8 | T | 0.844766 | P | 0.882995 | -0.038229 | No Change: Both D | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 17 | E | 0.786356 | K | 0.776657 | 0.009699 | No Change: Both D | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 97 | T | 0.91652 | S | 0.93542 | -0.0189 | No Change: Both D | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 121 | R | 0.909326 | C | 0.886881 | 0.022445 | No Change: Both D | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 496 | S | 0.417973 | A | 0.290174 | 0.127799 | No Change: Both O | - |
| Q86Y33 | CD20B_HUMAN Cell division cycle protein 20 homolog B OS=Homo sapiens GN=CDC20B PE=2 SV=3 | 503 | R | 0.434466 | W | 0.233114 | 0.201352 | No Change: Both O | - |
| Q9UJX2 | CDC23_HUMAN Cell division cycle protein 23 homolog OS=Homo sapiens GN=CDC23 PE=1 SV=3 | 78 | E | 0.713159 | Q | 0.690351 | 0.022808 | No Change: Both D | - |
| Q9UJX2 | CDC23_HUMAN Cell division cycle protein 23 homolog OS=Homo sapiens GN=CDC23 PE=1 SV=3 | 9 | P | 0.380973 | L | 0.218424 | 0.162549 | No Change: Both O | - |
| P30304 | MPIP1_HUMAN M-phase inducer phosphatase 1 OS=Homo sapiens GN=CDC25A PE=1 SV=2 | 88 | S | 0.910519 | F | 0.812316 | 0.098203 | No Change: Both D | - |
| P30304 | MPIP1_HUMAN M-phase inducer phosphatase 1 OS=Homo sapiens GN=CDC25A PE=1 SV=2 | 182 | R | 0.855616 | G | 0.837969 | 0.017647 | No Change: Both D | - |
| P30304 | MPIP1_HUMAN M-phase inducer phosphatase 1 OS=Homo sapiens GN=CDC25A PE=1 SV=2 | 182 | R | 0.855616 | W | 0.66787 | 0.187746 | No Change: Both D | - |
| P30305 | MPIP2_HUMAN M-phase inducer phosphatase 2 OS=Homo sapiens GN=CDC25B PE=1 SV=2 | 548 | E | 0.571183 | K | 0.571983 | -8.00E-04 | No Change: Both D | - |
| P30307 | MPIP3_HUMAN M-phase inducer phosphatase 3 OS=Homo sapiens GN=CDC25C PE=1 SV=2 | 297 | G | 0.4023 | R | 0.389502 | 0.012798 | No Change: Both O | - |
| P30307 | MPIP3_HUMAN M-phase inducer phosphatase 3 OS=Homo sapiens GN=CDC25C PE=1 SV=2 | 14 | S | 0.96706 | N | 0.956099 | 0.010961 | No Change: Both D | - |
| P30307 | MPIP3_HUMAN M-phase inducer phosphatase 3 OS=Homo sapiens GN=CDC25C PE=1 SV=2 | 70 | R | 0.605486 | C | 0.520914 | 0.084572 | No Change: Both D | - |
| P30307 | MPIP3_HUMAN M-phase inducer phosphatase 3 OS=Homo sapiens GN=CDC25C PE=1 SV=2 | 78 | S | 0.652029 | N | 0.586107 | 0.065922 | No Change: Both D | - |
| P30260 | CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens GN=CDC27 PE=1 SV=2 | 496 | Y | 0.236766 | H | 0.375765 | -0.138999 | No Change: Both O | - |
| P30260 | CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens GN=CDC27 PE=1 SV=2 | 270 | G | 0.781732 | A | 0.742336 | 0.039396 | No Change: Both D | A breast cancer sample |
| P30260 | CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens GN=CDC27 PE=1 SV=2 | 320 | S | 0.806642 | P | 0.807719 | -0.001077 | No Change: Both D | - |
| P49427 | UB2R1_HUMAN Ubiquitin-conjugating enzyme E2 R1 OS=Homo sapiens GN=CDC34 PE=1 SV=2 | 227 | D | 0.976151 | H | 0.956502 | 0.019649 | No Change: Both D | - |
| Q16543 | CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens GN=CDC37 PE=1 SV=1 | 360 | G | 0.807996 | E | 0.847805 | -0.039809 | No Change: Both D | - |
| Q7L3B6 | CD37L_HUMAN Hsp90 co-chaperone Cdc37-like 1 OS=Homo sapiens GN=CDC37L1 PE=1 SV=1 | 291 | S | 0.516972 | F | 0.28098 | 0.235992 | D to O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 50 | E | 0.455284 | K | 0.451817 | 0.003467 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 231 | T | 0.3779 | M | 0.355898 | 0.022002 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 537 | I | 0.840349 | T | 0.890536 | -0.050187 | No Change: Both D | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1418 | I | 0.167957 | K | 0.3425 | -0.174543 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 780 | T | 0.880088 | M | 0.854339 | 0.025749 | No Change: Both D | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 790 | Y | 0.666332 | C | 0.70479 | -0.038458 | No Change: Both D | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1148 | A | 0.439654 | T | 0.443711 | -0.004057 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1211 | R | 0.355119 | H | 0.342858 | 0.012261 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1317 | V | 0.479283 | I | 0.432424 | 0.046859 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1469 | A | 0.212881 | V | 0.179718 | 0.033163 | No Change: Both O | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1618 | T | 0.964865 | A | 0.958565 | 0.0063 | No Change: Both D | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1699 | A | 0.997636 | V | 0.996289 | 0.001347 | No Change: Both D | - |
| Q5VT25 | MRCKA_HUMAN Serine/threonine-protein kinase MRCK alpha OS=Homo sapiens GN=CDC42BPA PE=1 SV=1 | 1712 | A | 0.998008 | V | 0.997033 | 9.75E-04 | No Change: Both D | - |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 1077 | I | 0.554702 | V | 0.608411 | -0.053709 | No Change: Both D | - |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 500 | K | 0.934602 | E | 0.939627 | -0.005025 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 555 | R | 0.96369 | Q | 0.967436 | -0.003746 | No Change: Both D | - |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 671 | R | 0.804382 | Q | 0.833988 | -0.029606 | No Change: Both D | - |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 876 | R | 0.777713 | W | 0.565319 | 0.212394 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 1315 | E | 0.464152 | K | 0.473432 | -0.00928 | No Change: Both O | A lung large cell carcinoma sample |
| Q9Y5S2 | MRCKB_HUMAN Serine/threonine-protein kinase MRCK beta OS=Homo sapiens GN=CDC42BPB PE=1 SV=2 | 1633 | S | 0.960285 | Y | 0.917596 | 0.042689 | No Change: Both D | - |
| Q6DT37 | MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2 | 168 | P | 0.380398 | L | 0.229674 | 0.150724 | No Change: Both O | - |
| Q6DT37 | MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2 | 280 | S | 0.242417 | F | 0.109882 | 0.132535 | No Change: Both O | A glioblastoma multiforme sample |
| Q6DT37 | MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2 | 362 | T | 0.611928 | P | 0.67949 | -0.067562 | No Change: Both D | - |
| Q6DT37 | MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2 | 537 | A | 0.994084 | D | 0.993101 | 9.83E-04 | No Change: Both D | - |
| Q6DT37 | MRCKG_HUMAN Serine/threonine-protein kinase MRCK gamma OS=Homo sapiens GN=CDC42BPG PE=1 SV=2 | 1135 | Q | 0.307998 | R | 0.295257 | 0.012741 | No Change: Both O | - |
| O14613 | BORG1_HUMAN Cdc42 effector protein 2 OS=Homo sapiens GN=CDC42EP2 PE=1 SV=1 | 176 | N | 0.691667 | S | 0.77413 | -0.082463 | No Change: Both D | - |
| O14613 | BORG1_HUMAN Cdc42 effector protein 2 OS=Homo sapiens GN=CDC42EP2 PE=1 SV=1 | 191 | I | 0.564807 | F | 0.5382 | 0.026607 | No Change: Both D | - |
| O75419 | CDC45_HUMAN Cell division control protein 45 homolog OS=Homo sapiens GN=CDC45 PE=1 SV=1 | 81 | V | 0.078233 | I | 0.074708 | 0.003525 | No Change: Both O | - |
| O75419 | CDC45_HUMAN Cell division control protein 45 homolog OS=Homo sapiens GN=CDC45 PE=1 SV=1 | 376 | V | 0.261207 | M | 0.364545 | -0.103338 | No Change: Both O | - |
| O75419 | CDC45_HUMAN Cell division control protein 45 homolog OS=Homo sapiens GN=CDC45 PE=1 SV=1 | 356 | M | 0.374938 | R | 0.404257 | -0.029319 | No Change: Both O | - |
| Q99459 | CDC5L_HUMAN Cell division cycle 5-like protein OS=Homo sapiens GN=CDC5L PE=1 SV=2 | 459 | Y | 0.743091 | C | 0.761164 | -0.018073 | No Change: Both D | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 238 | T | 0.227943 | A | 0.229117 | -0.001174 | No Change: Both O | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 295 | D | 0.270216 | N | 0.242543 | 0.027673 | No Change: Both O | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 299 | T | 0.049365 | M | 0.041155 | 0.00821 | No Change: Both O | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 378 | R | 0.306479 | H | 0.250275 | 0.056204 | No Change: Both O | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 441 | V | 0.456282 | I | 0.448712 | 0.00757 | No Change: Both O | - |
| Q99741 | CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens GN=CDC6 PE=1 SV=1 | 323 | T | 0.211931 | R | 0.228336 | -0.016405 | No Change: Both O | Meier-Gorlin syndrome type 5 (MGORS5) [MIM:613805] |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 23 | Q | 0.745498 | P | 0.758435 | -0.012937 | No Change: Both D | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 99 | I | 0.24465 | V | 0.25341 | -0.00876 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 112 | G | 0.231388 | W | 0.089342 | 0.142046 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 162 | F | 0.128109 | L | 0.157243 | -0.029134 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 441 | K | 0.406367 | R | 0.368447 | 0.03792 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 208 | I | 0.319354 | M | 0.414971 | -0.095617 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 209 | E | 0.307094 | D | 0.291845 | 0.015249 | No Change: Both O | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 472 | T | 0.799355 | I | 0.718466 | 0.080889 | No Change: Both D | - |
| O00311 | CDC7_HUMAN Cell division cycle 7-related protein kinase OS=Homo sapiens GN=CDC7 PE=1 SV=1 | 498 | S | 0.774923 | A | 0.684567 | 0.090356 | No Change: Both D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 64 | L | 0.124098 | P | 0.214815 | -0.090717 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 384 | L | 0.54669 | P | 0.665272 | -0.118582 | No Change: Both D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 2 | A | 0.776738 | S | 0.86951 | -0.092772 | No Change: Both D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 34 | K | 0.250221 | Q | 0.198032 | 0.052189 | No Change: Both O | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 59 | S | 0.076599 | F | 0.030155 | 0.046444 | No Change: Both O | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 63 | L | 0.09928 | P | 0.169824 | -0.070544 | No Change: Both O | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 91 | R | 0.442528 | P | 0.475103 | -0.032575 | No Change: Both O | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 95 | L | 0.409975 | P | 0.56668 | -0.156705 | O to D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 272 | N | 0.846896 | S | 0.863709 | -0.016813 | No Change: Both D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 292 | R | 0.65648 | K | 0.687979 | -0.031499 | No Change: Both D | - |
| Q6P1J9 | CDC73_HUMAN Parafibromin OS=Homo sapiens GN=CDC73 PE=1 SV=1 | 379 | D | 0.502279 | N | 0.487734 | 0.014545 | D to O | Hyperparathyroidism-jaw tumor syndrome (HPT-JT) [MIM:145001] |
| Q69YH5 | CDCA2_HUMAN Cell division cycle-associated protein 2 OS=Homo sapiens GN=CDCA2 PE=1 SV=2 | 717 | V | 0.930398 | I | 0.912312 | 0.018086 | No Change: Both D | - |
| Q69YH5 | CDCA2_HUMAN Cell division cycle-associated protein 2 OS=Homo sapiens GN=CDCA2 PE=1 SV=2 | 884 | R | 0.767932 | S | 0.791577 | -0.023645 | No Change: Both D | - |
| Q96FF9 | CDCA5_HUMAN Sororin OS=Homo sapiens GN=CDCA5 PE=1 SV=1 | 156 | S | 0.845304 | Y | 0.706241 | 0.139063 | No Change: Both D | - |
| Q96GN5 | CDA7L_HUMAN Cell division cycle-associated 7-like protein OS=Homo sapiens GN=CDCA7L PE=1 SV=2 | 187 | R | 0.978405 | S | 0.981164 | -0.002759 | No Change: Both D | - |
| Q53HL2 | BOREA_HUMAN Borealin OS=Homo sapiens GN=CDCA8 PE=1 SV=2 | 12 | K | 0.854847 | N | 0.818547 | 0.0363 | No Change: Both D | - |
| Q9H5V8 | CDCP1_HUMAN CUB domain-containing protein 1 OS=Homo sapiens GN=CDCP1 PE=1 SV=3 | 525 | Q | 0.489592 | R | 0.473717 | 0.015875 | No Change: Both O | - |
| Q9H5V8 | CDCP1_HUMAN CUB domain-containing protein 1 OS=Homo sapiens GN=CDCP1 PE=1 SV=3 | 709 | D | 0.416704 | G | 0.404708 | 0.011996 | No Change: Both O | - |
| Q9H5V8 | CDCP1_HUMAN CUB domain-containing protein 1 OS=Homo sapiens GN=CDCP1 PE=1 SV=3 | 673 | A | 0.064189 | V | 0.049429 | 0.01476 | No Change: Both O | - |
| Q5VXM1 | CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens GN=CDCP2 PE=2 SV=1 | 244 | G | 0.243182 | R | 0.231334 | 0.011848 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 123 | H | 0.638738 | Y | 0.531853 | 0.106885 | No Change: Both D | A gastric cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 193 | T | 0.333009 | P | 0.39072 | -0.057711 | No Change: Both O | A diffuse gastric cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 315 | N | 0.412687 | S | 0.436217 | -0.02353 | No Change: Both O | Lobular breast carcinoma |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 336 | E | 0.361781 | D | 0.356068 | 0.005713 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 370 | D | 0.523752 | A | 0.445702 | 0.07805 | D to O | A diffuse gastric cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 463 | E | 0.274466 | Q | 0.23381 | 0.040656 | No Change: Both O | A gastric carcinoma sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 470 | T | 0.359182 | I | 0.206293 | 0.152889 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 473 | V | 0.287675 | D | 0.438425 | -0.15075 | No Change: Both O | A diffuse gastric cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 592 | A | 0.457633 | T | 0.498918 | -0.041285 | No Change: Both O | A thyroid cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 598 | R | 0.364949 | Q | 0.368817 | -0.003868 | No Change: Both O | A gastric cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 617 | A | 0.3892 | T | 0.436229 | -0.047029 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 711 | L | 0.071859 | V | 0.064966 | 0.006893 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 838 | S | 0.748554 | G | 0.689866 | 0.058688 | No Change: Both D | An ovarian carcinoma sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 244 | D | 0.367044 | G | 0.351375 | 0.015669 | No Change: Both O | Hereditary diffuse gastric cancer (HDGC) [MIM:137215] |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 487 | V | 0.377318 | A | 0.429594 | -0.052276 | No Change: Both O | Hereditary diffuse gastric cancer (HDGC) [MIM:137215] |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 270 | S | 0.452378 | A | 0.372183 | 0.080195 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 340 | T | 0.201604 | A | 0.171083 | 0.030521 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 630 | L | 0.459393 | V | 0.457916 | 0.001477 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 695 | C | 0.285594 | R | 0.467353 | -0.181759 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 478 | L | 0.20013 | P | 0.372255 | -0.172125 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 832 | V | 0.628459 | M | 0.717501 | -0.089042 | No Change: Both D | Hereditary diffuse gastric cancer (HDGC) [MIM:137215] |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 880 | E | 0.678827 | K | 0.697791 | -0.018964 | No Change: Both D | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 282 | M | 0.431521 | I | 0.329621 | 0.1019 | No Change: Both O | A breast cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 777 | D | 0.626911 | N | 0.592688 | 0.034223 | No Change: Both D | A breast cancer sample |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 72 | D | 0.23062 | N | 0.21193 | 0.01869 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 393 | I | 0.253086 | N | 0.428825 | -0.175739 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 473 | V | 0.287675 | I | 0.236753 | 0.050922 | No Change: Both O | - |
| P12830 | CADH1_HUMAN Cadherin-1 OS=Homo sapiens GN=CDH1 PE=1 SV=3 | 634 | A | 0.291124 | V | 0.207813 | 0.083311 | No Change: Both O | - |
| Q9Y6N8 | CAD10_HUMAN Cadherin-10 OS=Homo sapiens GN=CDH10 PE=1 SV=2 | 413 | S | 0.619529 | F | 0.390787 | 0.228742 | D to O | - |
| Q9Y6N8 | CAD10_HUMAN Cadherin-10 OS=Homo sapiens GN=CDH10 PE=1 SV=2 | 371 | V | 0.214571 | L | 0.207476 | 0.007095 | No Change: Both O | A breast cancer sample |
| P55287 | CAD11_HUMAN Cadherin-11 OS=Homo sapiens GN=CDH11 PE=1 SV=2 | 255 | T | 0.367845 | M | 0.328677 | 0.039168 | No Change: Both O | - |
| P55287 | CAD11_HUMAN Cadherin-11 OS=Homo sapiens GN=CDH11 PE=1 SV=2 | 275 | M | 0.491479 | I | 0.391257 | 0.100222 | No Change: Both O | - |
| P55287 | CAD11_HUMAN Cadherin-11 OS=Homo sapiens GN=CDH11 PE=1 SV=2 | 373 | S | 0.422945 | A | 0.333271 | 0.089674 | No Change: Both O | - |
| P55289 | CAD12_HUMAN Cadherin-12 OS=Homo sapiens GN=CDH12 PE=1 SV=2 | 86 | E | 0.663788 | K | 0.685155 | -0.021367 | No Change: Both D | - |
| P55289 | CAD12_HUMAN Cadherin-12 OS=Homo sapiens GN=CDH12 PE=1 SV=2 | 68 | V | 0.31749 | M | 0.36097 | -0.04348 | No Change: Both O | - |
| P55289 | CAD12_HUMAN Cadherin-12 OS=Homo sapiens GN=CDH12 PE=1 SV=2 | 284 | I | 0.536418 | V | 0.553735 | -0.017317 | No Change: Both D | - |
| P55289 | CAD12_HUMAN Cadherin-12 OS=Homo sapiens GN=CDH12 PE=1 SV=2 | 475 | I | 0.124464 | T | 0.204521 | -0.080057 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 121 | L | 0.299362 | S | 0.489904 | -0.190542 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 65 | R | 0.468746 | C | 0.305817 | 0.162929 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 103 | A | 0.471874 | V | 0.383336 | 0.088538 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 113 | G | 0.226609 | R | 0.208154 | 0.018455 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 246 | R | 0.352816 | W | 0.167769 | 0.185047 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 367 | E | 0.549322 | Q | 0.517346 | 0.031976 | No Change: Both D | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 376 | A | 0.238887 | T | 0.273746 | -0.034859 | No Change: Both O | - |
| P55290 | CAD13_HUMAN Cadherin-13 OS=Homo sapiens GN=CDH13 PE=1 SV=1 | 643 | L | 0.21599 | R | 0.283347 | -0.067357 | No Change: Both O | - |
| P55291 | CAD15_HUMAN Cadherin-15 OS=Homo sapiens GN=CDH15 PE=1 SV=1 | 8 | V | 0.062883 | L | 0.077197 | -0.014314 | No Change: Both O | Mental retardation autosomal dominant type 3 (MRD3) [MIM:612580] |
| P55291 | CAD15_HUMAN Cadherin-15 OS=Homo sapiens GN=CDH15 PE=1 SV=1 | 60 | R | 0.450731 | C | 0.288108 | 0.162623 | No Change: Both O | Mental retardation autosomal dominant type 3 (MRD3) [MIM:612580] |
| P55291 | CAD15_HUMAN Cadherin-15 OS=Homo sapiens GN=CDH15 PE=1 SV=1 | 92 | R | 0.430889 | W | 0.259493 | 0.171396 | No Change: Both O | Mental retardation autosomal dominant type 3 (MRD3) [MIM:612580] |
| P55291 | CAD15_HUMAN Cadherin-15 OS=Homo sapiens GN=CDH15 PE=1 SV=1 | 122 | A | 0.214769 | V | 0.157073 | 0.057696 | No Change: Both O | Mental retardation autosomal dominant type 3 (MRD3) [MIM:612580] |
| O75309 | CAD16_HUMAN Cadherin-16 OS=Homo sapiens GN=CDH16 PE=1 SV=1 | 191 | L | 0.633464 | F | 0.576593 | 0.056871 | No Change: Both D | - |
| O75309 | CAD16_HUMAN Cadherin-16 OS=Homo sapiens GN=CDH16 PE=1 SV=1 | 257 | H | 0.205964 | Y | 0.124115 | 0.081849 | No Change: Both O | - |
| O75309 | CAD16_HUMAN Cadherin-16 OS=Homo sapiens GN=CDH16 PE=1 SV=1 | 717 | R | 0.27356 | H | 0.267686 | 0.005874 | No Change: Both O | - |
| Q12864 | CAD17_HUMAN Cadherin-17 OS=Homo sapiens GN=CDH17 PE=1 SV=3 | 446 | I | 0.198176 | T | 0.292691 | -0.094515 | No Change: Both O | - |
| Q12864 | CAD17_HUMAN Cadherin-17 OS=Homo sapiens GN=CDH17 PE=1 SV=3 | 734 | E | 0.569808 | D | 0.526182 | 0.043626 | No Change: Both D | - |
| Q12864 | CAD17_HUMAN Cadherin-17 OS=Homo sapiens GN=CDH17 PE=1 SV=3 | 739 | E | 0.271432 | A | 0.172847 | 0.098585 | No Change: Both O | - |
| Q12864 | CAD17_HUMAN Cadherin-17 OS=Homo sapiens GN=CDH17 PE=1 SV=3 | 115 | K | 0.290903 | E | 0.285706 | 0.005197 | No Change: Both O | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 21 | A | 0.308241 | T | 0.311507 | -0.003266 | No Change: Both O | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 118 | A | 0.405959 | T | 0.448406 | -0.042447 | No Change: Both O | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 196 | S | 0.496787 | T | 0.4243 | 0.072487 | No Change: Both O | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 212 | I | 0.2127 | L | 0.224576 | -0.011876 | No Change: Both O | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 845 | N | 0.623708 | S | 0.666921 | -0.043213 | No Change: Both D | - |
| P19022 | CADH2_HUMAN Cadherin-2 OS=Homo sapiens GN=CDH2 PE=1 SV=4 | 454 | T | 0.17917 | A | 0.153839 | 0.025331 | No Change: Both O | - |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 228 | M | 0.248788 | I | 0.176377 | 0.072411 | No Change: Both O | A breast cancer sample |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 416 | P | 0.493499 | T | 0.461422 | 0.032077 | No Change: Both O | A breast cancer sample |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 746 | Q | 0.301525 | H | 0.268473 | 0.033052 | No Change: Both O | A breast cancer sample |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 328 | P | 0.257418 | H | 0.221115 | 0.036303 | No Change: Both O | - |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 371 | Q | 0.292546 | R | 0.294804 | -0.002258 | No Change: Both O | - |
| Q9HBT6 | CAD20_HUMAN Cadherin-20 OS=Homo sapiens GN=CDH20 PE=2 SV=2 | 391 | P | 0.248639 | L | 0.114155 | 0.134484 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3 | R | 0.882619 | C | 0.768909 | 0.11371 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 490 | G | 0.371284 | A | 0.317692 | 0.053592 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 496 | S | 0.26909 | N | 0.220993 | 0.048097 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 990 | D | 0.348784 | N | 0.332102 | 0.016682 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1222 | A | 0.331404 | T | 0.381296 | -0.049892 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1349 | R | 0.170656 | C | 0.083626 | 0.08703 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1351 | D | 0.220131 | N | 0.214734 | 0.005397 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1496 | Q | 0.156851 | H | 0.153628 | 0.003223 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1575 | T | 0.410384 | A | 0.370136 | 0.040248 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1671 | T | 0.163488 | S | 0.20953 | -0.046042 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1675 | V | 0.084815 | I | 0.0744 | 0.010415 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1746 | R | 0.43097 | Q | 0.443394 | -0.012424 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1804 | R | 0.332229 | Q | 0.328854 | 0.003375 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1999 | T | 0.070561 | S | 0.103089 | -0.032528 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2044 | E | 0.154075 | K | 0.140627 | 0.013448 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2045 | D | 0.181041 | N | 0.178336 | 0.002705 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2202 | D | 0.302336 | N | 0.29193 | 0.010406 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2358 | R | 0.245228 | Q | 0.262503 | -0.017275 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2380 | P | 0.654593 | L | 0.524307 | 0.130286 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2588 | E | 0.380179 | Q | 0.345306 | 0.034873 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2950 | I | 0.064194 | N | 0.128531 | -0.064337 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2956 | R | 0.15756 | C | 0.070013 | 0.087547 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3059 | P | 0.409796 | T | 0.342293 | 0.067503 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3125 | F | 0.335821 | L | 0.36263 | -0.026809 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 366 | A | 0.047693 | T | 0.052583 | -0.00489 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1209 | T | 0.291275 | A | 0.278589 | 0.012686 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1507 | R | 0.664629 | Q | 0.674734 | -0.010105 | No Change: Both D | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3189 | R | 0.248547 | W | 0.09999 | 0.148557 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3189 | R | 0.248547 | W | 0.09999 | 0.148557 | No Change: Both O | Usher syndrome type 1D/F (USH1DF) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3245 | S | 0.646399 | F | 0.433152 | 0.213247 | D to O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 124 | D | 0.365516 | G | 0.337331 | 0.028185 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 247 | E | 0.565385 | K | 0.561116 | 0.004269 | No Change: Both D | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 452 | N | 0.291374 | S | 0.31364 | -0.022266 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 480 | L | 0.180816 | Q | 0.279163 | -0.098347 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 484 | A | 0.255239 | P | 0.31328 | -0.058041 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 582 | R | 0.338514 | Q | 0.357985 | -0.019471 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1060 | R | 0.298738 | W | 0.131566 | 0.167172 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1186 | G | 0.423118 | D | 0.468188 | -0.04507 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1206 | P | 0.330775 | R | 0.296652 | 0.034123 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1341 | D | 0.187436 | N | 0.191192 | -0.003756 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1437 | R | 0.276944 | Q | 0.309756 | -0.032812 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1586 | A | 0.549877 | P | 0.646915 | -0.097038 | No Change: Both D | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1595 | E | 0.641494 | K | 0.630967 | 0.010527 | No Change: Both D | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1620 | V | 0.200872 | M | 0.243343 | -0.042471 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1846 | D | 0.310814 | N | 0.300558 | 0.010256 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1887 | T | 0.202983 | I | 0.12135 | 0.081633 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1888 | F | 0.218575 | S | 0.401233 | -0.182658 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2017 | G | 0.316218 | S | 0.384594 | -0.068376 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2066 | R | 0.56183 | Q | 0.574543 | -0.012713 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2148 | D | 0.324473 | N | 0.30823 | 0.016243 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2283 | V | 0.251849 | I | 0.208854 | 0.042995 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2376 | D | 0.542949 | N | 0.549262 | -0.006313 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2465 | R | 0.515705 | W | 0.346079 | 0.169626 | D to O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2517 | S | 0.570381 | G | 0.495462 | 0.074919 | D to O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2608 | R | 0.332154 | H | 0.319658 | 0.012496 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2744 | G | 0.491853 | S | 0.537055 | -0.045202 | O to D | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2833 | R | 0.281484 | G | 0.256291 | 0.025193 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2933 | V | 0.099032 | E | 0.198659 | -0.099627 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2954 | D | 0.138833 | N | 0.125377 | 0.013456 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2962 | N | 0.19419 | S | 0.227482 | -0.033292 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3175 | R | 0.528236 | H | 0.531827 | -0.003591 | No Change: Both D | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 240 | P | 0.15913 | L | 0.082752 | 0.076378 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 301 | R | 0.412721 | Q | 0.435222 | -0.022501 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 746 | V | 0.096679 | I | 0.088982 | 0.007697 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 755 | H | 0.506848 | Y | 0.374573 | 0.132275 | D to O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 944 | S | 0.326226 | G | 0.269942 | 0.056284 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 960 | E | 0.311903 | K | 0.289688 | 0.022215 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1090 | V | 0.105727 | I | 0.083892 | 0.021835 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1098 | N | 0.241301 | S | 0.276035 | -0.034734 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1236 | R | 0.529879 | Q | 0.558971 | -0.029092 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1282 | N | 0.441898 | S | 0.509698 | -0.0678 | O to D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1417 | R | 0.577028 | W | 0.396047 | 0.180981 | D to O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1520 | I | 0.230682 | M | 0.291659 | -0.060977 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1574 | M | 0.425337 | T | 0.472228 | -0.046891 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1711 | V | 0.106825 | I | 0.101595 | 0.00523 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1716 | Q | 0.175798 | P | 0.202961 | -0.027163 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1788 | P | 0.31384 | L | 0.182875 | 0.130965 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1807 | V | 0.380458 | M | 0.425321 | -0.044863 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1876 | S | 0.403799 | N | 0.358469 | 0.04533 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1908 | V | 0.230553 | I | 0.227996 | 0.002557 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1912 | R | 0.334591 | W | 0.145171 | 0.18942 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 1930 | D | 0.567802 | N | 0.570474 | -0.002672 | No Change: Both D | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2029 | R | 0.263215 | W | 0.111174 | 0.152041 | No Change: Both O | Deafness autosomal recessive type 12 (DFNB12) [MIM:601386] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2125 | I | 0.101231 | M | 0.137427 | -0.036196 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2171 | R | 0.412643 | C | 0.260564 | 0.152079 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2227 | Q | 0.376972 | P | 0.407696 | -0.030724 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2376 | D | 0.542949 | V | 0.448796 | 0.094153 | D to O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2473 | L | 0.224786 | P | 0.370087 | -0.145301 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2489 | R | 0.554056 | H | 0.539176 | 0.01488 | No Change: Both D | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2530 | T | 0.46595 | I | 0.305117 | 0.160833 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2669 | I | 0.090564 | V | 0.092495 | -0.001931 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2771 | G | 0.27203 | S | 0.312149 | -0.040119 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2801 | F | 0.259205 | V | 0.281103 | -0.021898 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2853 | A | 0.339715 | Q | 0.38153 | -0.041815 | No Change: Both O | - |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 2968 | V | 0.311479 | A | 0.389236 | -0.077757 | No Change: Both O | Usher syndrome type 1D (USH1D) [MIM:601067] |
| Q9H251 | CAD23_HUMAN Cadherin-23 OS=Homo sapiens GN=CDH23 PE=1 SV=1 | 3175 | R | 0.528236 | C | 0.369678 | 0.158558 | D to O | - |
| Q8IXH8 | CAD26_HUMAN Cadherin-like protein 26 OS=Homo sapiens GN=CDH26 PE=2 SV=3 | 144 | I | 0.29117 | T | 0.423573 | -0.132403 | No Change: Both O | - |
| Q8IXH8 | CAD26_HUMAN Cadherin-like protein 26 OS=Homo sapiens GN=CDH26 PE=2 SV=3 | 301 | R | 0.341296 | G | 0.338176 | 0.00312 | No Change: Both O | - |
| Q8IXH8 | CAD26_HUMAN Cadherin-like protein 26 OS=Homo sapiens GN=CDH26 PE=2 SV=3 | 448 | V | 0.218388 | A | 0.262029 | -0.043641 | No Change: Both O | - |
| Q8IXH8 | CAD26_HUMAN Cadherin-like protein 26 OS=Homo sapiens GN=CDH26 PE=2 SV=3 | 479 | P | 0.450604 | L | 0.299126 | 0.151478 | No Change: Both O | - |
| Q8IXH8 | CAD26_HUMAN Cadherin-like protein 26 OS=Homo sapiens GN=CDH26 PE=2 SV=3 | 615 | V | 0.099937 | L | 0.100148 | -2.11E-04 | No Change: Both O | - |
| P22223 | CADH3_HUMAN Cadherin-3 OS=Homo sapiens GN=CDH3 PE=1 SV=2 | 503 | R | 0.421016 | H | 0.422131 | -0.001115 | No Change: Both O | Hypotrichosis with juvenile macular dystrophy (HJMD) [MIM:601553] |
| P22223 | CADH3_HUMAN Cadherin-3 OS=Homo sapiens GN=CDH3 PE=1 SV=2 | 237 | V | 0.338629 | M | 0.389623 | -0.050994 | No Change: Both O | - |
| P22223 | CADH3_HUMAN Cadherin-3 OS=Homo sapiens GN=CDH3 PE=1 SV=2 | 477 | R | 0.269227 | H | 0.22478 | 0.044447 | No Change: Both O | - |
| P22223 | CADH3_HUMAN Cadherin-3 OS=Homo sapiens GN=CDH3 PE=1 SV=2 | 563 | Q | 0.317914 | H | 0.266399 | 0.051515 | No Change: Both O | - |
| P22223 | CADH3_HUMAN Cadherin-3 OS=Homo sapiens GN=CDH3 PE=1 SV=2 | 322 | N | 0.348411 | I | 0.207079 | 0.141332 | No Change: Both O | Ectodermal dysplasia with ectrodactyly and macular dystrophy (EEM) [MIM:225280] |
| P55283 | CADH4_HUMAN Cadherin-4 OS=Homo sapiens GN=CDH4 PE=2 SV=2 | 625 | K | 0.372583 | R | 0.296815 | 0.075768 | No Change: Both O | - |
| P55283 | CADH4_HUMAN Cadherin-4 OS=Homo sapiens GN=CDH4 PE=2 SV=2 | 141 | A | 0.854891 | V | 0.827771 | 0.02712 | No Change: Both D | - |
| P33151 | CADH5_HUMAN Cadherin-5 OS=Homo sapiens GN=CDH5 PE=1 SV=5 | 503 | I | 0.219496 | T | 0.310349 | -0.090853 | No Change: Both O | - |
| P33151 | CADH5_HUMAN Cadherin-5 OS=Homo sapiens GN=CDH5 PE=1 SV=5 | 517 | I | 0.176849 | T | 0.311912 | -0.135063 | No Change: Both O | - |
| Q9ULB5 | CADH7_HUMAN Cadherin-7 OS=Homo sapiens GN=CDH7 PE=2 SV=2 | 576 | N | 0.445597 | S | 0.508399 | -0.062802 | O to D | - |
| Q9ULB5 | CADH7_HUMAN Cadherin-7 OS=Homo sapiens GN=CDH7 PE=2 SV=2 | 370 | D | 0.378815 | E | 0.409158 | -0.030343 | No Change: Both O | - |
| Q9ULB4 | CADH9_HUMAN Cadherin-9 OS=Homo sapiens GN=CDH9 PE=2 SV=2 | 6 | Y | 0.121054 | C | 0.087512 | 0.033542 | No Change: Both O | - |
| Q9ULB4 | CADH9_HUMAN Cadherin-9 OS=Homo sapiens GN=CDH9 PE=2 SV=2 | 38 | A | 0.573823 | V | 0.482188 | 0.091635 | D to O | - |
| Q96JP9 | CDHR1_HUMAN Cadherin-related family member 1 OS=Homo sapiens GN=CDHR1 PE=1 SV=2 | 53 | H | 0.425408 | Q | 0.43952 | -0.014112 | No Change: Both O | - |
| Q96JP9 | CDHR1_HUMAN Cadherin-related family member 1 OS=Homo sapiens GN=CDHR1 PE=1 SV=2 | 212 | A | 0.31545 | T | 0.359545 | -0.044095 | No Change: Both O | - |
| Q96JP9 | CDHR1_HUMAN Cadherin-related family member 1 OS=Homo sapiens GN=CDHR1 PE=1 SV=2 | 243 | A | 0.203868 | V | 0.169292 | 0.034576 | No Change: Both O | - |
| Q96JP9 | CDHR1_HUMAN Cadherin-related family member 1 OS=Homo sapiens GN=CDHR1 PE=1 SV=2 | 532 | P | 0.163726 | A | 0.125926 | 0.0378 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 1164 | L | 0.022011 | M | 0.029245 | -0.007234 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 107 | Q | 0.170816 | H | 0.147073 | 0.023743 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 415 | A | 0.560268 | G | 0.609653 | -0.049385 | No Change: Both D | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 424 | V | 0.54585 | A | 0.60936 | -0.06351 | No Change: Both D | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 766 | L | 0.381972 | P | 0.564838 | -0.182866 | O to D | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 901 | T | 0.230836 | M | 0.19594 | 0.034896 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 948 | V | 0.393782 | M | 0.43538 | -0.041598 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 1128 | T | 0.350635 | M | 0.317161 | 0.033474 | No Change: Both O | - |
| Q9BYE9 | CDHR2_HUMAN Cadherin-related family member 2 OS=Homo sapiens GN=CDHR2 PE=1 SV=2 | 1004 | P | 0.391907 | L | 0.251918 | 0.139989 | No Change: Both O | An acute myeloid leukemia sample |
| Q6ZTQ4 | CDHR3_HUMAN Cadherin-related family member 3 OS=Homo sapiens GN=CDHR3 PE=2 SV=1 | 55 | V | 0.336145 | M | 0.383216 | -0.047071 | No Change: Both O | - |
| Q6ZTQ4 | CDHR3_HUMAN Cadherin-related family member 3 OS=Homo sapiens GN=CDHR3 PE=2 SV=1 | 61 | Q | 0.29004 | H | 0.27371 | 0.01633 | No Change: Both O | - |
| Q6ZTQ4 | CDHR3_HUMAN Cadherin-related family member 3 OS=Homo sapiens GN=CDHR3 PE=2 SV=1 | 529 | C | 0.157382 | Y | 0.196451 | -0.039069 | No Change: Both O | - |
| A6H8M9 | CDHR4_HUMAN Cadherin-related family member 4 OS=Homo sapiens GN=CDHR4 PE=2 SV=1 | 5 | R | 0.089297 | K | 0.118225 | -0.028928 | No Change: Both O | - |
| Q9HBB8 | CDHR5_HUMAN Cadherin-related family member 5 OS=Homo sapiens GN=CDHR5 PE=1 SV=3 | 357 | R | 0.50219 | S | 0.51738 | -0.01519 | No Change: Both D | - |
| Q9HBB8 | CDHR5_HUMAN Cadherin-related family member 5 OS=Homo sapiens GN=CDHR5 PE=1 SV=3 | 389 | D | 0.524272 | N | 0.501693 | 0.022579 | No Change: Both D | - |
| Q9HBB8 | CDHR5_HUMAN Cadherin-related family member 5 OS=Homo sapiens GN=CDHR5 PE=1 SV=3 | 702 | C | 0.334865 | S | 0.492769 | -0.157904 | No Change: Both O | - |
| Q9HBB8 | CDHR5_HUMAN Cadherin-related family member 5 OS=Homo sapiens GN=CDHR5 PE=1 SV=3 | 165 | Q | 0.210573 | P | 0.230867 | -0.020294 | No Change: Both O | - |
| Q9HBB8 | CDHR5_HUMAN Cadherin-related family member 5 OS=Homo sapiens GN=CDHR5 PE=1 SV=3 | 521 | P | 0.998804 | S | 0.998666 | 1.38E-04 | No Change: Both D | - |
| O14735 | CDIPT_HUMAN CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens GN=CDIPT PE=1 SV=1 | 199 | R | 0.222737 | C | 0.112431 | 0.110306 | No Change: Both O | - |
| Q15131 | CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens GN=CDK10 PE=1 SV=1 | 96 | P | 0.181924 | L | 0.106206 | 0.075718 | No Change: Both O | - |
| Q15131 | CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens GN=CDK10 PE=1 SV=1 | 168 | N | 0.256766 | S | 0.310246 | -0.05348 | No Change: Both O | - |
| Q15131 | CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens GN=CDK10 PE=1 SV=1 | 342 | R | 0.933593 | H | 0.924688 | 0.008905 | No Change: Both D | - |
| Q15131 | CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens GN=CDK10 PE=1 SV=1 | 358 | C | 0.982534 | Y | 0.969364 | 0.01317 | No Change: Both D | - |
| Q9UQ88 | CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | 93 | R | 0.985121 | W | 0.964384 | 0.020737 | No Change: Both D | - |
| Q9UQ88 | CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | 402 | L | 0.596513 | S | 0.713112 | -0.116599 | No Change: Both D | - |
| Q9UQ88 | CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | 57 | C | 0.955229 | R | 0.974518 | -0.019289 | No Change: Both D | - |
| Q9UQ88 | CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | 658 | V | 0.322481 | A | 0.376189 | -0.053708 | No Change: Both O | - |
| Q9UQ88 | CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | 92 | S | 0.983407 | P | 0.98456 | -0.001153 | No Change: Both D | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 57 | R | 0.974518 | C | 0.955229 | 0.019289 | No Change: Both D | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 201 | R | 0.997923 | W | 0.994828 | 0.003095 | No Change: Both D | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 414 | S | 0.713112 | L | 0.596513 | 0.116599 | No Change: Both D | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 463 | I | 0.421155 | V | 0.460108 | -0.038953 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 601 | L | 0.043582 | Q | 0.081017 | -0.037435 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 641 | K | 0.481487 | N | 0.434308 | 0.047179 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 670 | A | 0.368671 | V | 0.316857 | 0.051814 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 452 | V | 0.279406 | A | 0.34656 | -0.067154 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 506 | G | 0.170461 | S | 0.221057 | -0.050596 | No Change: Both O | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 93 | R | 0.988714 | W | 0.970809 | 0.017905 | No Change: Both D | - |
| P21127 | CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens GN=CDK11B PE=1 SV=3 | 109 | R | 0.997223 | C | 0.995245 | 0.001978 | No Change: Both D | - |
| Q9NYV4 | CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | 530 | P | 0.997834 | A | 0.996447 | 0.001387 | No Change: Both D | - |
| Q9NYV4 | CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | 912 | R | 0.269903 | H | 0.276951 | -0.007048 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9NYV4 | CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | 1189 | L | 0.912242 | Q | 0.941896 | -0.029654 | No Change: Both D | - |
| Q9NYV4 | CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | 1275 | P | 0.998575 | L | 0.997222 | 0.001353 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 356 | P | 0.99946 | A | 0.999044 | 4.16E-04 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 403 | L | 0.999251 | F | 0.999225 | 2.60E-05 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 410 | R | 0.999678 | Q | 0.999523 | 1.55E-04 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 500 | T | 0.974646 | A | 0.971546 | 0.0031 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 624 | S | 0.81266 | G | 0.77095 | 0.04171 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 700 | R | 0.28477 | L | 0.166333 | 0.118437 | No Change: Both O | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 1062 | V | 0.905255 | M | 0.92685 | -0.021595 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 494 | T | 0.982261 | A | 0.980897 | 0.001364 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 670 | T | 0.939095 | R | 0.948811 | -0.009716 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 1170 | V | 0.834832 | M | 0.853374 | -0.018542 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 340 | S | 0.998199 | F | 0.995481 | 0.002718 | No Change: Both D | - |
| Q14004 | CDK13_HUMAN Cyclin-dependent kinase 13 OS=Homo sapiens GN=CDK13 PE=1 SV=2 | 103 | Q | 0.990219 | R | 0.992199 | -0.00198 | No Change: Both D | - |
| O94921 | CDK14_HUMAN Cyclin-dependent kinase 14 OS=Homo sapiens GN=CDK14 PE=1 SV=3 | 432 | M | 0.259371 | I | 0.184509 | 0.074862 | No Change: Both O | An ovarian mucinous carcinoma |
| O94921 | CDK14_HUMAN Cyclin-dependent kinase 14 OS=Homo sapiens GN=CDK14 PE=1 SV=3 | 463 | S | 0.835981 | R | 0.81294 | 0.023041 | No Change: Both D | - |
| Q96Q40 | CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=2 SV=2 | 64 | R | 0.871063 | G | 0.843163 | 0.0279 | No Change: Both D | - |
| Q96Q40 | CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=2 SV=2 | 93 | K | 0.456679 | E | 0.461069 | -0.00439 | No Change: Both O | A renal clear cell carcinoma sample |
| Q96Q40 | CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=2 SV=2 | 127 | Q | 0.146238 | R | 0.14676 | -5.22E-04 | No Change: Both O | - |
| Q96Q40 | CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=2 SV=2 | 255 | T | 0.54164 | I | 0.410297 | 0.131343 | D to O | - |
| Q96Q40 | CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=2 SV=2 | 276 | E | 0.370873 | D | 0.348225 | 0.022648 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q00537 | CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens GN=CDK17 PE=1 SV=2 | 214 | T | 0.399308 | I | 0.264793 | 0.134515 | No Change: Both O | - |
| Q07002 | CDK18_HUMAN Cyclin-dependent kinase 18 OS=Homo sapiens GN=CDK18 PE=1 SV=3 | 46 | G | 0.911253 | S | 0.931383 | -0.02013 | No Change: Both D | - |
| Q07002 | CDK18_HUMAN Cyclin-dependent kinase 18 OS=Homo sapiens GN=CDK18 PE=1 SV=3 | 65 | G | 0.975511 | R | 0.979604 | -0.004093 | No Change: Both D | - |
| Q07002 | CDK18_HUMAN Cyclin-dependent kinase 18 OS=Homo sapiens GN=CDK18 PE=1 SV=3 | 164 | T | 0.373509 | M | 0.324143 | 0.049366 | No Change: Both O | - |
| P24941 | CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 | 15 | Y | 0.25445 | S | 0.409457 | -0.155007 | No Change: Both O | - |
| P24941 | CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 | 290 | T | 0.395444 | S | 0.49779 | -0.102346 | No Change: Both O | - |
| P24941 | CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 | 45 | P | 0.495763 | L | 0.340998 | 0.154765 | No Change: Both O | A glioblastoma multiforme sample |
| P24941 | CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2 | 18 | V | 0.23398 | L | 0.226052 | 0.007928 | No Change: Both O | - |
| Q8IZL9 | CDK20_HUMAN Cyclin-dependent kinase 20 OS=Homo sapiens GN=CDK20 PE=1 SV=1 | 86 | S | 0.141629 | L | 0.07293 | 0.068699 | No Change: Both O | - |
| Q8IZL9 | CDK20_HUMAN Cyclin-dependent kinase 20 OS=Homo sapiens GN=CDK20 PE=1 SV=1 | 137 | A | 0.265101 | T | 0.275412 | -0.010311 | No Change: Both O | - |
| Q8IZL9 | CDK20_HUMAN Cyclin-dependent kinase 20 OS=Homo sapiens GN=CDK20 PE=1 SV=1 | 281 | K | 0.386975 | R | 0.392644 | -0.005669 | No Change: Both O | - |
| Q8IZL9 | CDK20_HUMAN Cyclin-dependent kinase 20 OS=Homo sapiens GN=CDK20 PE=1 SV=1 | 106 | S | 0.253972 | N | 0.217162 | 0.03681 | No Change: Both O | - |
| Q00526 | CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | 226 | T | 0.473752 | I | 0.326415 | 0.147337 | No Change: Both O | - |
| Q00526 | CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | 264 | M | 0.380241 | T | 0.431016 | -0.050775 | No Change: Both O | - |
| Q00526 | CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | 106 | S | 0.114825 | N | 0.092437 | 0.022388 | No Change: Both O | A glioblastoma multiforme sample |
| Q00526 | CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | 124 | I | 0.331652 | T | 0.481053 | -0.149401 | No Change: Both O | - |
| Q00526 | CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1 | 214 | R | 0.0889 | H | 0.080587 | 0.008313 | No Change: Both O | - |
| P11802 | CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2 | 24 | R | 0.497457 | C | 0.347102 | 0.150355 | No Change: Both O | Cutaneous malignant melanoma type 3 (CMM3) [MIM:609048] |
| P11802 | CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2 | 24 | R | 0.497457 | H | 0.52962 | -0.032163 | O to D | Cutaneous malignant melanoma type 3 (CMM3) [MIM:609048] |
| P11802 | CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2 | 41 | N | 0.597066 | S | 0.645959 | -0.048893 | No Change: Both D | Cutaneous malignant melanoma type 3 (CMM3) [MIM:609048] |
| P11802 | CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2 | 82 | R | 0.325769 | Q | 0.322337 | 0.003432 | No Change: Both O | - |
| P11802 | CDK4_HUMAN Cyclin-dependent kinase 4 OS=Homo sapiens GN=CDK4 PE=1 SV=2 | 122 | R | 0.160274 | H | 0.148809 | 0.011465 | No Change: Both O | - |
| Q00535 | CDK5_HUMAN Cyclin-dependent kinase 5 OS=Homo sapiens GN=CDK5 PE=1 SV=3 | 225 | E | 0.538884 | D | 0.513515 | 0.025369 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 289 | E | 0.976432 | Q | 0.972038 | 0.004394 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 1540 | V | 0.923657 | L | 0.934774 | -0.011117 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 1045 | R | 0.898748 | T | 0.890986 | 0.007762 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 183 | A | 0.736553 | P | 0.755229 | -0.018676 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 1607 | R | 0.750468 | S | 0.780712 | -0.030244 | No Change: Both D | - |
| Q96SN8 | CK5P2_HUMAN CDK5 regulatory subunit-associated protein 2 OS=Homo sapiens GN=CDK5RAP2 PE=1 SV=5 | 1330 | N | 0.658256 | I | 0.49756 | 0.160696 | D to O | - |
| Q96JB5 | CK5P3_HUMAN CDK5 regulatory subunit-associated protein 3 OS=Homo sapiens GN=CDK5RAP3 PE=1 SV=2 | 324 | L | 0.262223 | V | 0.262268 | -4.50E-05 | No Change: Both O | - |
| Q00534 | CDK6_HUMAN Cyclin-dependent kinase 6 OS=Homo sapiens GN=CDK6 PE=1 SV=1 | 110 | D | 0.412602 | N | 0.362749 | 0.049853 | No Change: Both O | - |
| Q00534 | CDK6_HUMAN Cyclin-dependent kinase 6 OS=Homo sapiens GN=CDK6 PE=1 SV=1 | 199 | P | 0.187116 | L | 0.102472 | 0.084644 | No Change: Both O | A metastatic melanoma sample |
| P50613 | CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens GN=CDK7 PE=1 SV=1 | 163 | G | 0.526453 | A | 0.474187 | 0.052266 | D to O | - |
| P50613 | CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens GN=CDK7 PE=1 SV=1 | 285 | T | 0.183716 | M | 0.165213 | 0.018503 | No Change: Both O | - |
| P49336 | CDK8_HUMAN Cyclin-dependent kinase 8 OS=Homo sapiens GN=CDK8 PE=1 SV=1 | 189 | D | 0.263005 | N | 0.242834 | 0.020171 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P49336 | CDK8_HUMAN Cyclin-dependent kinase 8 OS=Homo sapiens GN=CDK8 PE=1 SV=1 | 424 | R | 0.891062 | C | 0.854884 | 0.036178 | No Change: Both D | A colorectal adenocarcinoma sample |
| P50750 | CDK9_HUMAN Cyclin-dependent kinase 9 OS=Homo sapiens GN=CDK9 PE=1 SV=3 | 231 | G | 0.549785 | A | 0.50119 | 0.048595 | No Change: Both D | - |
| P50750 | CDK9_HUMAN Cyclin-dependent kinase 9 OS=Homo sapiens GN=CDK9 PE=1 SV=3 | 59 | F | 0.36011 | L | 0.414519 | -0.054409 | No Change: Both O | - |
| Q5VV42 | CDKAL_HUMAN CDK5 regulatory subunit-associated protein 1-like 1 OS=Homo sapiens GN=CDKAL1 PE=1 SV=1 | 484 | K | 0.43842 | R | 0.353958 | 0.084462 | No Change: Both O | - |
| Q00532 | CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=2 SV=5 | 66 | L | 0.207933 | P | 0.338707 | -0.130774 | No Change: Both O | - |
| Q00532 | CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=2 SV=5 | 274 | Q | 0.354568 | E | 0.396538 | -0.04197 | No Change: Both O | - |
| Q00532 | CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=2 SV=5 | 329 | L | 0.461102 | V | 0.390723 | 0.070379 | No Change: Both O | - |
| Q00532 | CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=2 SV=5 | 341 | K | 0.356868 | N | 0.308776 | 0.048092 | No Change: Both O | - |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 98 | L | 0.16562 | I | 0.135859 | 0.029761 | No Change: Both O | An ovarian papillary serous adenocarcinoma sample |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 149 | R | 0.116302 | Q | 0.126717 | -0.010415 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 197 | M | 0.206071 | T | 0.243258 | -0.037187 | No Change: Both O | - |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 411 | A | 0.619233 | V | 0.575523 | 0.04371 | No Change: Both D | - |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 77 | Y | 0.065887 | S | 0.144102 | -0.078215 | No Change: Both O | - |
| Q92772 | CDKL2_HUMAN Cyclin-dependent kinase-like 2 OS=Homo sapiens GN=CDKL2 PE=2 SV=1 | 132 | I | 0.356213 | T | 0.494713 | -0.1385 | No Change: Both O | - |
| Q8IVW4 | CDKL3_HUMAN Cyclin-dependent kinase-like 3 OS=Homo sapiens GN=CDKL3 PE=2 SV=1 | 394 | M | 0.836483 | T | 0.862172 | -0.025689 | No Change: Both D | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 38 | S | 0.535588 | P | 0.52794 | 0.007648 | No Change: Both D | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 53 | R | 0.265817 | H | 0.251149 | 0.014668 | No Change: Both O | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 228 | F | 0.378265 | C | 0.349759 | 0.028506 | No Change: Both O | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 288 | S | 0.620779 | Y | 0.420504 | 0.200275 | D to O | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 307 | R | 0.883102 | C | 0.78815 | 0.094952 | No Change: Both D | - |
| Q5MAI5 | CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | 118 | H | 0.061377 | Y | 0.031481 | 0.029896 | No Change: Both O | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 152 | C | 0.102546 | F | 0.119072 | -0.016526 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 175 | R | 0.148253 | S | 0.193191 | -0.044938 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 791 | Q | 0.979798 | P | 0.982215 | -0.002417 | No Change: Both D | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 368 | N | 0.670681 | H | 0.628737 | 0.041944 | No Change: Both D | A colorectal cancer sample |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 180 | P | 0.215008 | L | 0.117777 | 0.097231 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 793 | V | 0.978803 | A | 0.984687 | -0.005884 | No Change: Both D | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 999 | V | 0.161127 | M | 0.21241 | -0.051283 | No Change: Both O | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 374 | A | 0.685924 | T | 0.706821 | -0.020897 | No Change: Both D | A metastatic melanoma sample |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 574 | P | 0.971126 | Q | 0.963442 | 0.007684 | No Change: Both D | An ovarian serous carcinoma sample |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 734 | T | 0.964548 | A | 0.958409 | 0.006139 | No Change: Both D | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 1023 | E | 0.389841 | G | 0.34738 | 0.042461 | No Change: Both O | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 40 | A | 0.457773 | V | 0.416788 | 0.040985 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 72 | I | 0.587115 | N | 0.730024 | -0.142909 | No Change: Both D | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 72 | I | 0.587115 | T | 0.715939 | -0.128824 | No Change: Both D | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 127 | H | 0.141054 | R | 0.13565 | 0.005404 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 178 | R | 0.175704 | P | 0.20436 | -0.028656 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 220 | L | 0.256218 | P | 0.420793 | -0.164575 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 288 | T | 0.365621 | I | 0.229841 | 0.13578 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 291 | C | 0.403605 | Y | 0.425951 | -0.022346 | No Change: Both O | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 399 | N | 0.89591 | T | 0.892268 | 0.003642 | No Change: Both D | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 444 | R | 0.964974 | C | 0.944078 | 0.020896 | No Change: Both D | - |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 718 | V | 0.911731 | M | 0.921046 | -0.009315 | No Change: Both D | Epileptic encephalopathy early infantile type 2 (EIEE2) [MIM:300672] |
| O76039 | CDKL5_HUMAN Cyclin-dependent kinase-like 5 OS=Homo sapiens GN=CDKL5 PE=1 SV=1 | 923 | R | 0.894115 | C | 0.862368 | 0.031747 | No Change: Both D | - |
| P38936 | CDN1A_HUMAN Cyclin-dependent kinase inhibitor 1 OS=Homo sapiens GN=CDKN1A PE=1 SV=3 | 31 | S | 0.531239 | R | 0.514299 | 0.01694 | No Change: Both D | - |
| P38936 | CDN1A_HUMAN Cyclin-dependent kinase inhibitor 1 OS=Homo sapiens GN=CDKN1A PE=1 SV=3 | 149 | D | 0.945619 | G | 0.945889 | -2.70E-04 | No Change: Both D | - |
| P38936 | CDN1A_HUMAN Cyclin-dependent kinase inhibitor 1 OS=Homo sapiens GN=CDKN1A PE=1 SV=3 | 4 | P | 0.873877 | L | 0.77123 | 0.102647 | No Change: Both D | - |
| P38936 | CDN1A_HUMAN Cyclin-dependent kinase inhibitor 1 OS=Homo sapiens GN=CDKN1A PE=1 SV=3 | 63 | F | 0.29948 | L | 0.337396 | -0.037916 | No Change: Both O | - |
| P46527 | CDN1B_HUMAN Cyclin-dependent kinase inhibitor 1B OS=Homo sapiens GN=CDKN1B PE=1 SV=1 | 15 | R | 0.888355 | W | 0.69241 | 0.195945 | No Change: Both D | - |
| P46527 | CDN1B_HUMAN Cyclin-dependent kinase inhibitor 1B OS=Homo sapiens GN=CDKN1B PE=1 SV=1 | 109 | V | 0.902566 | G | 0.931013 | -0.028447 | No Change: Both D | - |
| P46527 | CDN1B_HUMAN Cyclin-dependent kinase inhibitor 1B OS=Homo sapiens GN=CDKN1B PE=1 SV=1 | 69 | P | 0.61808 | L | 0.480789 | 0.137291 | D to O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 14 | D | 0.766534 | E | 0.837616 | -0.071082 | No Change: Both D | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 16 | L | 0.730446 | P | 0.853694 | -0.123248 | No Change: Both D | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 20 | A | 0.643968 | P | 0.708685 | -0.064717 | No Change: Both D | A lung tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 20 | A | 0.643968 | S | 0.698526 | -0.054558 | No Change: Both D | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 23 | G | 0.646378 | D | 0.660633 | -0.014255 | No Change: Both D | A pancreas tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 24 | R | 0.657802 | C | 0.512391 | 0.145411 | No Change: Both D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 24 | R | 0.657802 | P | 0.681329 | -0.023527 | No Change: Both D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 26 | E | 0.659455 | D | 0.609587 | 0.049868 | No Change: Both D | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 32 | L | 0.574418 | P | 0.708863 | -0.134445 | No Change: Both D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 33 | E | 0.541087 | D | 0.481201 | 0.059886 | D to O | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 35 | G | 0.530613 | A | 0.525391 | 0.005222 | No Change: Both D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 35 | G | 0.530613 | E | 0.601356 | -0.070743 | No Change: Both D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 48 | P | 0.468532 | L | 0.311895 | 0.156637 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 49 | I | 0.451446 | S | 0.672782 | -0.221336 | O to D | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 49 | I | 0.451446 | T | 0.589496 | -0.13805 | O to D | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 50 | Q | 0.444854 | R | 0.502157 | -0.057303 | O to D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 53 | M | 0.390763 | I | 0.265956 | 0.124807 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 56 | S | 0.371934 | I | 0.211842 | 0.160092 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 57 | A | 0.367395 | V | 0.286856 | 0.080539 | No Change: Both O | Pancreas carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 59 | V | 0.373748 | G | 0.498814 | -0.125066 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 60 | A | 0.33833 | T | 0.332088 | 0.006242 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 62 | L | 0.317186 | P | 0.476537 | -0.159351 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 66 | H | 0.282608 | Y | 0.185501 | 0.097107 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 68 | A | 0.355759 | L | 0.286555 | 0.069204 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 68 | A | 0.355759 | T | 0.364268 | -0.008509 | No Change: Both O | An esophagus tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 68 | A | 0.355759 | V | 0.262223 | 0.093536 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 69 | E | 0.393374 | K | 0.369975 | 0.023399 | No Change: Both O | A bladder tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 69 | E | 0.393374 | V | 0.225535 | 0.167839 | No Change: Both O | A lung tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 71 | N | 0.444293 | K | 0.481576 | -0.037283 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 71 | N | 0.444293 | S | 0.495042 | -0.050749 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 72 | C | 0.466638 | G | 0.625766 | -0.159128 | O to D | An esophagus tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 74 | D | 0.460635 | N | 0.457323 | 0.003312 | No Change: Both O | A bladder tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 74 | D | 0.460635 | V | 0.306342 | 0.154293 | No Change: Both O | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 80 | R | 0.438574 | L | 0.316504 | 0.12207 | No Change: Both O | Neck tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 81 | P | 0.435289 | L | 0.278758 | 0.156531 | No Change: Both O | Some patients with melanoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 83 | H | 0.413897 | Y | 0.285555 | 0.128342 | No Change: Both O | A head and neck tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 83 | H | 0.413897 | N | 0.429745 | -0.015848 | No Change: Both O | A lung tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 84 | D | 0.404482 | E | 0.432992 | -0.02851 | No Change: Both O | A bladder tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 84 | D | 0.404482 | H | 0.373915 | 0.030567 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 84 | D | 0.404482 | N | 0.373124 | 0.031358 | No Change: Both O | Neck and a lung tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 84 | D | 0.404482 | Y | 0.237812 | 0.16667 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 85 | A | 0.393057 | T | 0.420116 | -0.027059 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 87 | R | 0.372404 | P | 0.408305 | -0.035901 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 88 | E | 0.349352 | D | 0.358299 | -0.008947 | No Change: Both O | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 89 | G | 0.312524 | D | 0.369116 | -0.056592 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 89 | G | 0.312524 | S | 0.343216 | -0.030692 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 93 | T | 0.228756 | A | 0.234728 | -0.005972 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 95 | V | 0.240221 | A | 0.317572 | -0.077351 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 97 | L | 0.245265 | R | 0.362258 | -0.116993 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 98 | H | 0.27002 | P | 0.344641 | -0.074621 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 98 | H | 0.27002 | Q | 0.272455 | -0.002435 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 99 | R | 0.260278 | P | 0.272008 | -0.01173 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 99 | R | 0.260278 | Q | 0.220629 | 0.039649 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 100 | A | 0.277669 | L | 0.223532 | 0.054137 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 100 | A | 0.277669 | P | 0.344234 | -0.066565 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 101 | G | 0.291257 | W | 0.139771 | 0.151486 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 101 | G | 0.291257 | W | 0.139771 | 0.151486 | No Change: Both O | Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome (FAMMMPC) [MIM:606719] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 107 | R | 0.329295 | C | 0.180255 | 0.14904 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 107 | R | 0.329295 | H | 0.290265 | 0.03903 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 108 | D | 0.311759 | Y | 0.158354 | 0.153405 | No Change: Both O | Neck tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 108 | D | 0.311759 | H | 0.258034 | 0.053725 | No Change: Both O | A bladder tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 114 | P | 0.307781 | L | 0.226373 | 0.081408 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 117 | L | 0.382459 | M | 0.414982 | -0.032523 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 118 | A | 0.413924 | T | 0.424831 | -0.010907 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 119 | E | 0.443802 | Q | 0.378472 | 0.06533 | No Change: Both O | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 120 | E | 0.456567 | A | 0.365836 | 0.090731 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 120 | E | 0.456567 | K | 0.428479 | 0.028088 | No Change: Both O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 122 | G | 0.43505 | S | 0.467439 | -0.032389 | No Change: Both O | A biliary tract tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 123 | H | 0.433188 | Q | 0.443322 | -0.010134 | No Change: Both O | Leukemia |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 124 | R | 0.412722 | H | 0.380278 | 0.032444 | No Change: Both O | An esophagus tumor |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 126 | V | 0.437513 | D | 0.609897 | -0.172384 | O to D | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 127 | A | 0.454926 | S | 0.505372 | -0.050446 | O to D | Squamous cell carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 132 | A | 0.50605 | P | 0.57027 | -0.06422 | No Change: Both D | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 134 | A | 0.561347 | V | 0.449011 | 0.112336 | D to O | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 142 | H | 0.682934 | Y | 0.57541 | 0.107524 | No Change: Both D | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 144 | R | 0.697052 | C | 0.522393 | 0.174659 | No Change: Both D | Squamous cell carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 148 | A | 0.752816 | T | 0.745032 | 0.007784 | No Change: Both D | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 150 | G | 0.787617 | V | 0.67562 | 0.111997 | No Change: Both D | Non-small cell lung carcinoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 87 | R | 0.372404 | W | 0.176445 | 0.195959 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 102 | A | 0.311919 | E | 0.384569 | -0.07265 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 94 | L | 0.233438 | Q | 0.291239 | -0.057801 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 122 | G | 0.43505 | R | 0.472887 | -0.037837 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 58 | R | 0.364549 | Q | 0.35711 | 0.007439 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 60 | A | 0.33833 | V | 0.25501 | 0.08332 | No Change: Both O | Melanoma |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 83 | H | 0.413897 | Q | 0.425146 | -0.011249 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 99 | R | 0.260278 | W | 0.103247 | 0.157031 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 102 | A | 0.311919 | T | 0.316902 | -0.004983 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 124 | R | 0.412722 | C | 0.238995 | 0.173727 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 24 | R | 0.657802 | Q | 0.618512 | 0.03929 | No Change: Both D | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 35 | G | 0.530613 | V | 0.42051 | 0.110103 | D to O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 67 | G | 0.308742 | R | 0.328596 | -0.019854 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 69 | E | 0.393374 | G | 0.350323 | 0.043051 | No Change: Both O | - |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 74 | D | 0.460635 | Y | 0.292729 | 0.167906 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 77 | T | 0.408039 | P | 0.481892 | -0.073853 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 80 | R | 0.438574 | P | 0.489112 | -0.050538 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 81 | P | 0.435289 | T | 0.386616 | 0.048673 | No Change: Both O | Cutaneous malignant melanoma type 2 (CMM2) [MIM:155601] |
| P42771 | CD2A1_HUMAN Cyclin-dependent kinase inhibitor 2A isoforms 1/2/3 OS=Homo sapiens GN=CDKN2A PE=1 SV=2 | 114 | P | 0.307781 | S | 0.321145 | -0.013364 | No Change: Both O | - |
| Q8N726 | CD2A2_HUMAN Cyclin-dependent kinase inhibitor 2A isoform 4 OS=Homo sapiens GN=CDKN2A PE=1 SV=1 | 58 | P | 0.262509 | S | 0.244971 | 0.017538 | No Change: Both O | - |
| Q8N726 | CD2A2_HUMAN Cyclin-dependent kinase inhibitor 2A isoform 4 OS=Homo sapiens GN=CDKN2A PE=1 SV=1 | 147 | G | 0.993249 | R | 0.994214 | -9.65E-04 | No Change: Both D | - |
| Q8N726 | CD2A2_HUMAN Cyclin-dependent kinase inhibitor 2A isoform 4 OS=Homo sapiens GN=CDKN2A PE=1 SV=1 | 154 | P | 0.993468 | L | 0.986681 | 0.006787 | No Change: Both D | - |
| Q8N726 | CD2A2_HUMAN Cyclin-dependent kinase inhibitor 2A isoform 4 OS=Homo sapiens GN=CDKN2A PE=1 SV=1 | 157 | G | 0.993695 | D | 0.991132 | 0.002563 | No Change: Both D | - |
| P42772 | CDN2B_HUMAN Cyclin-dependent kinase 4 inhibitor B OS=Homo sapiens GN=CDKN2B PE=1 SV=1 | 47 | G | 0.332811 | E | 0.373697 | -0.040886 | No Change: Both O | Lung adenocarcinoma |
| P42772 | CDN2B_HUMAN Cyclin-dependent kinase 4 inhibitor B OS=Homo sapiens GN=CDKN2B PE=1 SV=1 | 50 | A | 0.291273 | V | 0.229789 | 0.061484 | No Change: Both O | Lung adenocarcinoma |
| P42773 | CDN2C_HUMAN Cyclin-dependent kinase 4 inhibitor C OS=Homo sapiens GN=CDKN2C PE=1 SV=1 | 72 | A | 0.207186 | P | 0.259881 | -0.052695 | No Change: Both O | Breast cancer |
| P42773 | CDN2C_HUMAN Cyclin-dependent kinase 4 inhibitor C OS=Homo sapiens GN=CDKN2C PE=1 SV=1 | 126 | T | 0.356168 | M | 0.312198 | 0.04397 | No Change: Both O | - |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 31 | W | 0.354327 | R | 0.558571 | -0.204244 | O to D | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 78 | F | 0.05672 | L | 0.06467 | -0.00795 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 79 | C | 0.067657 | Y | 0.076028 | -0.008371 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 91 | N | 0.162989 | K | 0.199053 | -0.036064 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 94 | D | 0.093673 | V | 0.048607 | 0.045066 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 95 | L | 0.087563 | F | 0.07033 | 0.017233 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 108 | I | 0.49224 | V | 0.503623 | -0.011383 | O to D | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 187 | N | 0.328346 | S | 0.442262 | -0.113916 | No Change: Both O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 195 | K | 0.57116 | I | 0.382696 | 0.188464 | D to O | Patients with hepatocellular carcinoma (HCC) [MIM:114550] |
| Q16667 | CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens GN=CDKN3 PE=1 SV=1 | 159 | S | 0.146446 | F | 0.05228 | 0.094166 | No Change: Both O | - |
| Q16878 | CDO1_HUMAN Cysteine dioxygenase type 1 OS=Homo sapiens GN=CDO1 PE=1 SV=2 | 45 | T | 0.41319 | I | 0.274052 | 0.139138 | No Change: Both O | - |
| Q16878 | CDO1_HUMAN Cysteine dioxygenase type 1 OS=Homo sapiens GN=CDO1 PE=1 SV=2 | 143 | E | 0.400752 | Q | 0.351683 | 0.049069 | No Change: Both O | A colorectal cancer sample |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 66 | K | 0.392393 | R | 0.332652 | 0.059741 | No Change: Both O | - |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 162 | E | 0.267186 | K | 0.269274 | -0.002088 | No Change: Both O | - |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 351 | P | 0.398776 | A | 0.321464 | 0.077312 | No Change: Both O | - |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 686 | A | 0.82483 | V | 0.794492 | 0.030338 | No Change: Both D | - |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 684 | T | 0.842322 | S | 0.875576 | -0.033254 | No Change: Both D | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 689 | P | 0.791118 | A | 0.725314 | 0.065804 | No Change: Both D | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 691 | V | 0.758017 | M | 0.79 | -0.031983 | No Change: Both D | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 780 | V | 0.515546 | E | 0.634702 | -0.119156 | No Change: Both D | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 790 | T | 0.322339 | A | 0.312662 | 0.009677 | No Change: Both O | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q4KMG0 | CDON_HUMAN Cell adhesion molecule-related/down-regulated by oncogenes OS=Homo sapiens GN=CDON PE=1 SV=2 | 940 | S | 0.739557 | R | 0.68346 | 0.056097 | No Change: Both D | Holoprosencephaly type 11 (HPE11) [MIM:614226] |
| Q86X02 | CDR2L_HUMAN Cerebellar degeneration-related protein 2-like OS=Homo sapiens GN=CDR2L PE=1 SV=2 | 300 | D | 0.87637 | E | 0.859459 | 0.016911 | No Change: Both D | - |
| O95170 | CDRT1_HUMAN CMT1A duplicated region transcript 1 protein OS=Homo sapiens GN=CDRT1 PE=2 SV=3 | 643 | F | 0.074419 | L | 0.07856 | -0.004141 | No Change: Both O | - |
| Q96T59 | CDRTF_HUMAN CMT1A duplicated region transcript 15 protein OS=Homo sapiens GN=CDRT15 PE=2 SV=1 | 24 | R | 0.825467 | Q | 0.795111 | 0.030356 | No Change: Both D | - |
| Q8N9R6 | CDRT4_HUMAN CMT1A duplicated region transcript 4 protein OS=Homo sapiens GN=CDRT4 PE=2 SV=2 | 72 | V | 0.937709 | I | 0.935774 | 0.001935 | No Change: Both D | - |
| Q8N9R6 | CDRT4_HUMAN CMT1A duplicated region transcript 4 protein OS=Homo sapiens GN=CDRT4 PE=2 SV=2 | 121 | H | 0.517305 | Q | 0.513743 | 0.003562 | No Change: Both D | - |
| Q92903 | CDS1_HUMAN Phosphatidate cytidylyltransferase 1 OS=Homo sapiens GN=CDS1 PE=2 SV=2 | 204 | K | 0.142038 | T | 0.092772 | 0.049266 | No Change: Both O | A breast cancer sample |
| Q92903 | CDS1_HUMAN Phosphatidate cytidylyltransferase 1 OS=Homo sapiens GN=CDS1 PE=2 SV=2 | 99 | L | 0.017659 | F | 0.015214 | 0.002445 | No Change: Both O | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 18 | M | 0.336638 | L | 0.262813 | 0.073825 | No Change: Both O | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 143 | N | 0.999885 | S | 0.999939 | -5.40E-05 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 202 | S | 0.99689 | F | 0.992384 | 0.004506 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 408 | S | 0.999518 | A | 0.999013 | 5.05E-04 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 410 | S | 0.999597 | L | 0.999044 | 5.53E-04 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 527 | D | 0.800558 | N | 0.774309 | 0.026249 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 56 | L | 0.958569 | F | 0.956116 | 0.002453 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 150 | S | 0.99968 | N | 0.999544 | 1.36E-04 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 401 | S | 0.998351 | G | 0.997818 | 5.33E-04 | No Change: Both D | - |
| Q15517 | CDSN_HUMAN Corneodesmosin OS=Homo sapiens GN=CDSN PE=1 SV=3 | 145 | G | 0.999891 | S | 0.999926 | -3.50E-05 | No Change: Both D | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 537 | A | 0.400185 | V | 0.286158 | 0.114027 | No Change: Both O | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 135 | A | 0.858365 | V | 0.799734 | 0.058631 | No Change: Both D | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 172 | R | 0.540541 | C | 0.468496 | 0.072045 | D to O | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 456 | E | 0.830903 | A | 0.777958 | 0.052945 | No Change: Both D | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 234 | C | 0.428788 | R | 0.598454 | -0.169666 | O to D | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 262 | T | 0.599592 | A | 0.556083 | 0.043509 | No Change: Both D | - |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 66 | A | 0.992976 | T | 0.992796 | 1.80E-04 | No Change: Both D | Meier-Gorlin syndrome type 4 (MGORS4) [MIM:613804] |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 117 | Q | 0.867925 | H | 0.830735 | 0.03719 | No Change: Both D | Meier-Gorlin syndrome type 4 (MGORS4) [MIM:613804] |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 453 | R | 0.879492 | W | 0.714003 | 0.165489 | No Change: Both D | Meier-Gorlin syndrome type 4 (MGORS4) [MIM:613804] |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 462 | R | 0.757993 | Q | 0.737557 | 0.020436 | No Change: Both D | Meier-Gorlin syndrome type 4 (MGORS4) [MIM:613804] |
| Q9H211 | CDT1_HUMAN DNA replication factor Cdt1 OS=Homo sapiens GN=CDT1 PE=1 SV=3 | 468 | E | 0.726425 | K | 0.708268 | 0.018157 | No Change: Both D | Meier-Gorlin syndrome type 4 (MGORS4) [MIM:613804] |
| P47902 | CDX1_HUMAN Homeobox protein CDX-1 OS=Homo sapiens GN=CDX1 PE=2 SV=2 | 130 | P | 0.928795 | R | 0.921268 | 0.007527 | No Change: Both D | - |
| Q99626 | CDX2_HUMAN Homeobox protein CDX-2 OS=Homo sapiens GN=CDX2 PE=1 SV=3 | 293 | P | 0.955347 | S | 0.952548 | 0.002799 | No Change: Both D | - |
| Q9Y232 | CDYL1_HUMAN Chromodomain Y-like protein OS=Homo sapiens GN=CDYL PE=1 SV=2 | 2 | T | 0.724084 | A | 0.72841 | -0.004326 | No Change: Both D | - |
| Q9Y232 | CDYL1_HUMAN Chromodomain Y-like protein OS=Homo sapiens GN=CDYL PE=1 SV=2 | 9 | S | 0.62497 | P | 0.593279 | 0.031691 | No Change: Both D | - |
| Q9Y232 | CDYL1_HUMAN Chromodomain Y-like protein OS=Homo sapiens GN=CDYL PE=1 SV=2 | 48 | V | 0.911694 | A | 0.928612 | -0.016918 | No Change: Both D | - |
| Q9Y232 | CDYL1_HUMAN Chromodomain Y-like protein OS=Homo sapiens GN=CDYL PE=1 SV=2 | 60 | A | 0.7909 | G | 0.819198 | -0.028298 | No Change: Both D | - |
| P13688 | CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 PE=1 SV=2 | 35 | Q | 0.466222 | K | 0.51289 | -0.046668 | O to D | - |
| P13688 | CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 PE=1 SV=2 | 83 | A | 0.215771 | V | 0.160216 | 0.055555 | No Change: Both O | - |
| P13688 | CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 PE=1 SV=2 | 123 | Q | 0.145702 | H | 0.12381 | 0.021892 | No Change: Both O | - |
| P13688 | CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens GN=CEACAM1 PE=1 SV=2 | 376 | Q | 0.591807 | R | 0.59582 | -0.004013 | No Change: Both D | - |
| Q2WEN9 | CEA16_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 16 OS=Homo sapiens GN=CEACAM16 PE=2 SV=1 | 31 | V | 0.282903 | F | 0.241353 | 0.04155 | No Change: Both O | - |
| A8MTB9 | CEA18_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 18 OS=Homo sapiens GN=CEACAM18 PE=2 SV=3 | 221 | L | 0.185574 | H | 0.251261 | -0.065687 | No Change: Both O | - |
| A8MTB9 | CEA18_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 18 OS=Homo sapiens GN=CEACAM18 PE=2 SV=3 | 222 | T | 0.16082 | A | 0.137764 | 0.023056 | No Change: Both O | - |
| A8MTB9 | CEA18_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 18 OS=Homo sapiens GN=CEACAM18 PE=2 SV=3 | 14 | A | 0.809415 | P | 0.869808 | -0.060393 | No Change: Both D | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 41 | A | 0.483805 | V | 0.408739 | 0.075066 | No Change: Both O | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 113 | R | 0.29216 | H | 0.312083 | -0.019923 | No Change: Both O | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 127 | I | 0.10413 | V | 0.114932 | -0.010802 | No Change: Both O | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 355 | S | 0.55986 | L | 0.378015 | 0.181845 | D to O | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 369 | S | 0.386014 | F | 0.176519 | 0.209495 | No Change: Both O | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 512 | C | 0.932607 | R | 0.955359 | -0.022752 | No Change: Both D | - |
| Q6UY09 | CEA20_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 20 OS=Homo sapiens GN=CEACAM20 PE=2 SV=1 | 87 | T | 0.121104 | I | 0.063356 | 0.057748 | No Change: Both O | - |
| Q3KPI0 | CEA21_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 21 OS=Homo sapiens GN=CEACAM21 PE=2 SV=2 | 121 | T | 0.211316 | N | 0.222147 | -0.010831 | No Change: Both O | - |
| Q3KPI0 | CEA21_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 21 OS=Homo sapiens GN=CEACAM21 PE=2 SV=2 | 198 | M | 0.125503 | V | 0.08999 | 0.035513 | No Change: Both O | - |
| P40198 | CEAM3_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 3 OS=Homo sapiens GN=CEACAM3 PE=1 SV=2 | 7 | S | 0.618392 | P | 0.617151 | 0.001241 | No Change: Both D | - |
| O75871 | CEAM4_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 4 OS=Homo sapiens GN=CEACAM4 PE=1 SV=2 | 29 | H | 0.155081 | D | 0.178616 | -0.023535 | No Change: Both O | - |
| O75871 | CEAM4_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 4 OS=Homo sapiens GN=CEACAM4 PE=1 SV=2 | 69 | K | 0.345055 | R | 0.277431 | 0.067624 | No Change: Both O | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 398 | K | 0.385774 | E | 0.406028 | -0.020254 | No Change: Both O | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 340 | A | 0.433505 | D | 0.516086 | -0.082581 | O to D | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 664 | R | 0.411216 | S | 0.500592 | -0.089376 | O to D | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 137 | Q | 0.30173 | P | 0.345562 | -0.043832 | No Change: Both O | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 678 | G | 0.67574 | R | 0.6516 | 0.02414 | No Change: Both D | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 80 | I | 0.134905 | V | 0.15075 | -0.015845 | No Change: Both O | - |
| P06731 | CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens GN=CEACAM5 PE=1 SV=3 | 83 | V | 0.140497 | A | 0.204068 | -0.063571 | No Change: Both O | - |
| P40199 | CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens GN=CEACAM6 PE=1 SV=3 | 239 | G | 0.613745 | V | 0.516684 | 0.097061 | No Change: Both D | - |
| Q14002 | CEAM7_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 7 OS=Homo sapiens GN=CEACAM7 PE=1 SV=1 | 120 | F | 0.167706 | I | 0.17553 | -0.007824 | No Change: Both O | - |
| Q14002 | CEAM7_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 7 OS=Homo sapiens GN=CEACAM7 PE=1 SV=1 | 263 | A | 0.431593 | V | 0.319928 | 0.111665 | No Change: Both O | - |
| Q14002 | CEAM7_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 7 OS=Homo sapiens GN=CEACAM7 PE=1 SV=1 | 236 | Y | 0.41286 | H | 0.535042 | -0.122182 | O to D | - |
| P31997 | CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 OS=Homo sapiens GN=CEACAM8 PE=1 SV=2 | 114 | R | 0.423668 | K | 0.451796 | -0.028128 | No Change: Both O | - |
| P31997 | CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 OS=Homo sapiens GN=CEACAM8 PE=1 SV=2 | 17 | G | 0.079695 | V | 0.041574 | 0.038121 | No Change: Both O | - |
| P31997 | CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 OS=Homo sapiens GN=CEACAM8 PE=1 SV=2 | 45 | A | 0.522644 | V | 0.433569 | 0.089075 | D to O | - |
| P31997 | CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 OS=Homo sapiens GN=CEACAM8 PE=1 SV=2 | 322 | L | 0.446558 | V | 0.467852 | -0.021294 | No Change: Both O | - |
| P31997 | CEAM8_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 8 OS=Homo sapiens GN=CEACAM8 PE=1 SV=2 | 340 | I | 0.117949 | M | 0.198116 | -0.080167 | No Change: Both O | - |
| P17676 | CEBPB_HUMAN CCAAT/enhancer-binding protein beta OS=Homo sapiens GN=CEBPB PE=1 SV=2 | 195 | G | 0.81945 | S | 0.822847 | -0.003397 | No Change: Both D | - |
| P49716 | CEBPD_HUMAN CCAAT/enhancer-binding protein delta OS=Homo sapiens GN=CEBPD PE=1 SV=2 | 248 | R | 0.550386 | W | 0.262909 | 0.287477 | D to O | - |
| Q03701 | CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=Homo sapiens GN=CEBPZ PE=1 SV=3 | 102 | V | 0.781923 | I | 0.795127 | -0.013204 | No Change: Both D | - |
| Q03701 | CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=Homo sapiens GN=CEBPZ PE=1 SV=3 | 15 | P | 0.921579 | S | 0.89906 | 0.022519 | No Change: Both D | - |
| Q03701 | CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=Homo sapiens GN=CEBPZ PE=1 SV=3 | 303 | K | 0.524456 | R | 0.500044 | 0.024412 | No Change: Both D | - |
| Q03701 | CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=Homo sapiens GN=CEBPZ PE=1 SV=3 | 639 | N | 0.92044 | S | 0.933814 | -0.013374 | No Change: Both D | - |
| Q9NZK5 | CECR1_HUMAN Adenosine deaminase CECR1 OS=Homo sapiens GN=CECR1 PE=1 SV=2 | 335 | H | 0.532352 | R | 0.505023 | 0.027329 | No Change: Both D | - |
| Q9BXF3 | CECR2_HUMAN Cat eye syndrome critical region protein 2 OS=Homo sapiens GN=CECR2 PE=1 SV=2 | 293 | R | 0.632591 | H | 0.605645 | 0.026946 | No Change: Both D | - |
| Q9BXF3 | CECR2_HUMAN Cat eye syndrome critical region protein 2 OS=Homo sapiens GN=CECR2 PE=1 SV=2 | 674 | P | 0.908652 | L | 0.829721 | 0.078931 | No Change: Both D | - |
| Q9BXW7 | CECR5_HUMAN Cat eye syndrome critical region protein 5 OS=Homo sapiens GN=CECR5 PE=1 SV=1 | 369 | R | 0.642727 | S | 0.694841 | -0.052114 | No Change: Both D | - |
| Q9BXW7 | CECR5_HUMAN Cat eye syndrome critical region protein 5 OS=Homo sapiens GN=CECR5 PE=1 SV=1 | 179 | T | 0.53405 | M | 0.484893 | 0.049157 | D to O | - |
| Q9BXW7 | CECR5_HUMAN Cat eye syndrome critical region protein 5 OS=Homo sapiens GN=CECR5 PE=1 SV=1 | 416 | R | 0.184306 | C | 0.093347 | 0.090959 | No Change: Both O | - |
| Q9UNI1 | CELA1_HUMAN Chymotrypsin-like elastase family member 1 OS=Homo sapiens GN=CELA1 PE=1 SV=2 | 10 | Q | 0.455418 | H | 0.465994 | -0.010576 | No Change: Both O | - |
| Q9UNI1 | CELA1_HUMAN Chymotrypsin-like elastase family member 1 OS=Homo sapiens GN=CELA1 PE=1 SV=2 | 44 | R | 0.5134 | W | 0.288522 | 0.224878 | D to O | - |
| Q9UNI1 | CELA1_HUMAN Chymotrypsin-like elastase family member 1 OS=Homo sapiens GN=CELA1 PE=1 SV=2 | 59 | M | 0.067111 | V | 0.05537 | 0.011741 | No Change: Both O | - |
| Q9UNI1 | CELA1_HUMAN Chymotrypsin-like elastase family member 1 OS=Homo sapiens GN=CELA1 PE=1 SV=2 | 243 | Q | 0.149777 | R | 0.149845 | -6.80E-05 | No Change: Both O | - |
| Q9UNI1 | CELA1_HUMAN Chymotrypsin-like elastase family member 1 OS=Homo sapiens GN=CELA1 PE=1 SV=2 | 76 | G | 0.318273 | A | 0.274415 | 0.043858 | No Change: Both O | A breast cancer sample |
| P08217 | CEL2A_HUMAN Chymotrypsin-like elastase family member 2A OS=Homo sapiens GN=CELA2A PE=1 SV=1 | 257 | N | 0.095482 | S | 0.12115 | -0.025668 | No Change: Both O | - |
| P08218 | CEL2B_HUMAN Chymotrypsin-like elastase family member 2B OS=Homo sapiens GN=CELA2B PE=2 SV=2 | 79 | G | 0.234057 | R | 0.228998 | 0.005059 | No Change: Both O | - |
| P08218 | CEL2B_HUMAN Chymotrypsin-like elastase family member 2B OS=Homo sapiens GN=CELA2B PE=2 SV=2 | 114 | D | 0.557261 | N | 0.544183 | 0.013078 | No Change: Both D | - |
| P08218 | CEL2B_HUMAN Chymotrypsin-like elastase family member 2B OS=Homo sapiens GN=CELA2B PE=2 SV=2 | 177 | Q | 0.220053 | R | 0.193986 | 0.026067 | No Change: Both O | - |
| P08218 | CEL2B_HUMAN Chymotrypsin-like elastase family member 2B OS=Homo sapiens GN=CELA2B PE=2 SV=2 | 235 | G | 0.22207 | S | 0.267139 | -0.045069 | No Change: Both O | - |
| P09093 | CEL3A_HUMAN Chymotrypsin-like elastase family member 3A OS=Homo sapiens GN=CELA3A PE=1 SV=3 | 241 | A | 0.076707 | G | 0.107493 | -0.030786 | No Change: Both O | - |
| P09093 | CEL3A_HUMAN Chymotrypsin-like elastase family member 3A OS=Homo sapiens GN=CELA3A PE=1 SV=3 | 24 | H | 0.802804 | R | 0.803961 | -0.001157 | No Change: Both D | - |
| P09093 | CEL3A_HUMAN Chymotrypsin-like elastase family member 3A OS=Homo sapiens GN=CELA3A PE=1 SV=3 | 25 | S | 0.81602 | P | 0.804046 | 0.011974 | No Change: Both D | - |
| P09093 | CEL3A_HUMAN Chymotrypsin-like elastase family member 3A OS=Homo sapiens GN=CELA3A PE=1 SV=3 | 31 | H | 0.631067 | N | 0.625526 | 0.005541 | No Change: Both D | - |
| P08861 | CEL3B_HUMAN Chymotrypsin-like elastase family member 3B OS=Homo sapiens GN=CELA3B PE=1 SV=3 | 79 | R | 0.304975 | W | 0.144866 | 0.160109 | No Change: Both O | - |
| O95319 | CELF2_HUMAN CUGBP Elav-like family member 2 OS=Homo sapiens GN=CELF2 PE=1 SV=1 | 438 | D | 0.266931 | H | 0.23093 | 0.036001 | No Change: Both O | - |
| Q9BZC1 | CELF4_HUMAN CUGBP Elav-like family member 4 OS=Homo sapiens GN=CELF4 PE=1 SV=1 | 388 | G | 0.828422 | S | 0.84871 | -0.020288 | No Change: Both D | - |
| Q8N6W0 | CELF5_HUMAN CUGBP Elav-like family member 5 OS=Homo sapiens GN=CELF5 PE=1 SV=1 | 65 | F | 0.238796 | L | 0.269083 | -0.030287 | No Change: Both O | - |
| Q96J87 | CELF6_HUMAN CUGBP Elav-like family member 6 OS=Homo sapiens GN=CELF6 PE=1 SV=1 | 152 | R | 0.462263 | P | 0.493459 | -0.031196 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 664 | S | 0.720485 | W | 0.5121 | 0.208385 | No Change: Both D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 1126 | C | 0.174812 | R | 0.29953 | -0.124718 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2107 | I | 0.117186 | V | 0.161079 | -0.043893 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2268 | T | 0.394238 | A | 0.375978 | 0.01826 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 587 | I | 0.159083 | V | 0.198441 | -0.039358 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 1242 | V | 0.206589 | I | 0.166753 | 0.039836 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 1894 | Y | 0.398247 | H | 0.51579 | -0.117543 | O to D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 1994 | L | 0.503868 | P | 0.66104 | -0.157172 | No Change: Both D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 1995 | L | 0.505242 | P | 0.657763 | -0.152521 | No Change: Both D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2045 | T | 0.123735 | M | 0.101981 | 0.021754 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2219 | R | 0.221041 | H | 0.20494 | 0.016101 | No Change: Both O | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2797 | C | 0.967459 | S | 0.981764 | -0.014305 | No Change: Both D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2903 | E | 0.948833 | Q | 0.945497 | 0.003336 | No Change: Both D | - |
| Q9NYQ6 | CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens GN=CELSR1 PE=1 SV=1 | 2948 | G | 0.887747 | S | 0.915702 | -0.027955 | No Change: Both D | - |
| Q9HCU4 | CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=2 SV=1 | 1639 | Y | 0.109328 | H | 0.183231 | -0.073903 | No Change: Both O | - |
| Q9HCU4 | CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=2 SV=1 | 1066 | R | 0.469448 | Q | 0.442617 | 0.026831 | No Change: Both O | - |
| Q9HCU4 | CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=2 SV=1 | 1992 | G | 0.200409 | R | 0.215427 | -0.015018 | No Change: Both O | - |
| Q9HCU4 | CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens GN=CELSR2 PE=2 SV=1 | 2387 | T | 0.053083 | A | 0.047624 | 0.005459 | No Change: Both O | - |
| Q9NYQ7 | CELR3_HUMAN Cadherin EGF LAG seven-pass G-type receptor 3 OS=Homo sapiens GN=CELSR3 PE=1 SV=2 | 157 | A | 0.948537 | P | 0.975051 | -0.026514 | No Change: Both D | - |
| Q9NYQ7 | CELR3_HUMAN Cadherin EGF LAG seven-pass G-type receptor 3 OS=Homo sapiens GN=CELSR3 PE=1 SV=2 | 805 | S | 0.295954 | T | 0.241721 | 0.054233 | No Change: Both O | - |
| Q9NYQ7 | CELR3_HUMAN Cadherin EGF LAG seven-pass G-type receptor 3 OS=Homo sapiens GN=CELSR3 PE=1 SV=2 | 1758 | Q | 0.361696 | R | 0.361943 | -2.47E-04 | No Change: Both O | - |
| Q6PRD7 | CEMP1_HUMAN Cementoblastoma-derived protein 1 OS=Homo sapiens GN=CEMP1 PE=2 SV=1 | 55 | K | 0.676502 | E | 0.677711 | -0.001209 | No Change: Both D | - |
| Q02224 | CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens GN=CENPE PE=1 SV=2 | 1535 | F | 0.878232 | L | 0.895484 | -0.017252 | No Change: Both D | - |
| Q02224 | CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens GN=CENPE PE=1 SV=2 | 1581 | S | 0.950871 | R | 0.948191 | 0.00268 | No Change: Both D | - |
| Q02224 | CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens GN=CENPE PE=1 SV=2 | 1925 | E | 0.940907 | D | 0.93063 | 0.010277 | No Change: Both D | - |
| Q02224 | CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens GN=CENPE PE=1 SV=2 | 2090 | T | 0.797513 | M | 0.808437 | -0.010924 | No Change: Both D | - |
| Q02224 | CENPE_HUMAN Centromere-associated protein E OS=Homo sapiens GN=CENPE PE=1 SV=2 | 1911 | S | 0.963275 | T | 0.960169 | 0.003106 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 3202 | N | 0.947132 | K | 0.961055 | -0.013923 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 300 | R | 0.816821 | C | 0.713801 | 0.10302 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 494 | H | 0.947696 | Q | 0.960681 | -0.012985 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 701 | M | 0.613522 | V | 0.543538 | 0.069984 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 754 | Q | 0.528297 | E | 0.571492 | -0.043195 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 815 | R | 0.867967 | H | 0.842351 | 0.025616 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1018 | Y | 0.772463 | D | 0.860845 | -0.088382 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1033 | G | 0.752592 | R | 0.810552 | -0.05796 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1105 | T | 0.797939 | I | 0.676762 | 0.121177 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1412 | L | 0.730649 | S | 0.83582 | -0.105171 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1515 | A | 0.498174 | T | 0.51942 | -0.021246 | O to D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1539 | K | 0.347664 | R | 0.310081 | 0.037583 | No Change: Both O | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 2011 | E | 0.537364 | A | 0.428049 | 0.109315 | D to O | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 250 | Q | 0.858398 | L | 0.79308 | 0.065318 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 272 | D | 0.831882 | G | 0.805536 | 0.026346 | No Change: Both D | - |
| P49454 | CENPF_HUMAN Centromere protein F OS=Homo sapiens GN=CENPF PE=1 SV=2 | 1864 | D | 0.419299 | N | 0.422817 | -0.003518 | No Change: Both O | - |
| Q9H3R5 | CENPH_HUMAN Centromere protein H OS=Homo sapiens GN=CENPH PE=1 SV=1 | 2 | E | 0.996159 | K | 0.99464 | 0.001519 | No Change: Both D | A colorectal cancer sample |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 21 | M | 0.277093 | V | 0.211035 | 0.066058 | No Change: Both O | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 55 | P | 0.494392 | A | 0.422666 | 0.071726 | No Change: Both O | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 63 | D | 0.631069 | H | 0.584094 | 0.046975 | No Change: Both D | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 85 | P | 0.894073 | T | 0.864704 | 0.029369 | No Change: Both D | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 151 | E | 0.950939 | G | 0.929078 | 0.021861 | No Change: Both D | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 879 | S | 0.954482 | A | 0.927736 | 0.026746 | No Change: Both D | - |
| Q9HC77 | CENPJ_HUMAN Centromere protein J OS=Homo sapiens GN=CENPJ PE=1 SV=2 | 1235 | E | 0.621671 | V | 0.432462 | 0.189209 | D to O | Microcephaly primary type 6 (MCPH6) [MIM:608393] |
| Q8N0S6 | CENPL_HUMAN Centromere protein L OS=Homo sapiens GN=CENPL PE=1 SV=2 | 117 | I | 0.123303 | F | 0.127818 | -0.004515 | No Change: Both O | - |
| Q96H22 | CENPN_HUMAN Centromere protein N OS=Homo sapiens GN=CENPN PE=1 SV=2 | 84 | E | 0.288811 | D | 0.270211 | 0.0186 | No Change: Both O | - |
| Q96H22 | CENPN_HUMAN Centromere protein N OS=Homo sapiens GN=CENPN PE=1 SV=2 | 223 | Q | 0.559592 | R | 0.557727 | 0.001865 | No Change: Both D | - |
| Q96H22 | CENPN_HUMAN Centromere protein N OS=Homo sapiens GN=CENPN PE=1 SV=2 | 288 | E | 0.501414 | K | 0.492338 | 0.009076 | D to O | - |
| Q9BU64 | CENPO_HUMAN Centromere protein O OS=Homo sapiens GN=CENPO PE=1 SV=1 | 34 | Q | 0.913977 | R | 0.913389 | 5.88E-04 | No Change: Both D | - |
| Q7L2Z9 | CENPQ_HUMAN Centromere protein Q OS=Homo sapiens GN=CENPQ PE=1 SV=1 | 63 | G | 0.896504 | R | 0.917722 | -0.021218 | No Change: Both D | - |
| Q7L2Z9 | CENPQ_HUMAN Centromere protein Q OS=Homo sapiens GN=CENPQ PE=1 SV=1 | 266 | D | 0.803157 | G | 0.783689 | 0.019468 | No Change: Both D | - |
| Q96BT3 | CENPT_HUMAN Centromere protein T OS=Homo sapiens GN=CENPT PE=1 SV=2 | 115 | P | 0.91708 | L | 0.856769 | 0.060311 | No Change: Both D | - |
| O60308 | CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens GN=CEP104 PE=1 SV=1 | 686 | A | 0.895606 | V | 0.828484 | 0.067122 | No Change: Both D | - |
| O60308 | CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens GN=CEP104 PE=1 SV=1 | 414 | L | 0.706609 | I | 0.673178 | 0.033431 | No Change: Both D | - |
| Q8N8E3 | CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens GN=CEP112 PE=1 SV=2 | 551 | K | 0.952437 | E | 0.951076 | 0.001361 | No Change: Both D | - |
| Q8N960 | CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens GN=CEP120 PE=2 SV=2 | 602 | L | 0.192054 | V | 0.194483 | -0.002429 | No Change: Both O | - |
| Q8N960 | CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens GN=CEP120 PE=2 SV=2 | 879 | Q | 0.954289 | H | 0.926945 | 0.027344 | No Change: Both D | - |
| Q8N960 | CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens GN=CEP120 PE=2 SV=2 | 936 | V | 0.642405 | I | 0.650778 | -0.008373 | No Change: Both D | - |
| Q8N960 | CE120_HUMAN Centrosomal protein of 120 kDa OS=Homo sapiens GN=CEP120 PE=2 SV=2 | 947 | R | 0.414308 | H | 0.364697 | 0.049611 | No Change: Both O | - |
| Q6ZU80 | CE128_HUMAN Centrosomal protein of 128 kDa OS=Homo sapiens GN=CEP128 PE=1 SV=2 | 16 | R | 0.807125 | L | 0.680937 | 0.126188 | No Change: Both D | - |
| Q6ZU80 | CE128_HUMAN Centrosomal protein of 128 kDa OS=Homo sapiens GN=CEP128 PE=1 SV=2 | 732 | H | 0.918248 | R | 0.928437 | -0.010189 | No Change: Both D | - |
| Q66GS9 | CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens GN=CEP135 PE=1 SV=2 | 769 | I | 0.69154 | L | 0.723026 | -0.031486 | No Change: Both D | - |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 54 | S | 0.961339 | L | 0.93318 | 0.028159 | No Change: Both D | - |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 793 | S | 0.868194 | I | 0.774107 | 0.094087 | No Change: Both D | - |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 914 | L | 0.851291 | V | 0.846991 | 0.0043 | No Change: Both D | - |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 1106 | V | 0.359295 | A | 0.458163 | -0.098868 | No Change: Both O | - |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 265 | Q | 0.563933 | P | 0.536712 | 0.027221 | No Change: Both D | Microcephaly primary type 4 (MCPH4) [MIM:604321] |
| O94986 | CE152_HUMAN Centrosomal protein of 152 kDa OS=Homo sapiens GN=CEP152 PE=1 SV=3 | 667 | K | 0.830502 | R | 0.830709 | -2.07E-04 | No Change: Both D | Seckel syndrome type 5 (SCKL5) [MIM:613823] |
| Q9UPV0 | CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens GN=CEP164 PE=1 SV=3 | 94 | S | 0.357325 | N | 0.324343 | 0.032982 | No Change: Both O | - |
| Q9UPV0 | CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens GN=CEP164 PE=1 SV=3 | 988 | T | 0.909248 | S | 0.93336 | -0.024112 | No Change: Both D | - |
| Q9UPV0 | CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens GN=CEP164 PE=1 SV=3 | 1119 | Q | 0.513714 | R | 0.509782 | 0.003932 | No Change: Both D | - |
| Q5SW79 | CE170_HUMAN Centrosomal protein of 170 kDa OS=Homo sapiens GN=CEP170 PE=1 SV=1 | 213 | G | 0.644206 | S | 0.694685 | -0.050479 | No Change: Both D | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 457 | T | 0.86666 | A | 0.844697 | 0.021963 | No Change: Both D | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 769 | V | 0.440492 | M | 0.48463 | -0.044138 | No Change: Both O | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 513 | Q | 0.795294 | P | 0.822354 | -0.02706 | No Change: Both D | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 948 | R | 0.05332 | H | 0.051899 | 0.001421 | No Change: Both O | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 956 | S | 0.387005 | P | 0.360199 | 0.026806 | No Change: Both O | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 1105 | L | 0.503976 | F | 0.463206 | 0.04077 | D to O | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 1455 | S | 0.067007 | N | 0.052086 | 0.014921 | No Change: Both O | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 1525 | L | 0.667687 | P | 0.783859 | -0.116172 | No Change: Both D | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 1675 | K | 0.926061 | E | 0.927135 | -0.001074 | No Change: Both D | - |
| Q8TEP8 | CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens GN=CEP192 PE=1 SV=2 | 1853 | R | 0.408338 | L | 0.27371 | 0.134628 | No Change: Both O | - |
| Q9BV73 | CP250_HUMAN Centrosome-associated protein CEP250 OS=Homo sapiens GN=CEP250 PE=1 SV=2 | 995 | Q | 0.962082 | H | 0.945527 | 0.016555 | No Change: Both D | - |
| Q9BV73 | CP250_HUMAN Centrosome-associated protein CEP250 OS=Homo sapiens GN=CEP250 PE=1 SV=2 | 1441 | R | 0.904714 | Q | 0.918082 | -0.013368 | No Change: Both D | - |
| Q9BV73 | CP250_HUMAN Centrosome-associated protein CEP250 OS=Homo sapiens GN=CEP250 PE=1 SV=2 | 1072 | Q | 0.917569 | E | 0.923402 | -0.005833 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 7 | W | 0.633832 | C | 0.751847 | -0.118015 | No Change: Both D | Joubert syndrome type 5 (JBTS5) [MIM:610188] |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 7 | W | 0.633832 | C | 0.751847 | -0.118015 | No Change: Both D | Senior-Loken syndrome type 6 (SLSN6) [MIM:610189] |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 838 | K | 0.811277 | E | 0.812485 | -0.001208 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 906 | L | 0.707336 | W | 0.56333 | 0.144006 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 1237 | R | 0.586293 | H | 0.536855 | 0.049438 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 1836 | I | 0.936499 | V | 0.926648 | 0.009851 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 277 | E | 0.639041 | Q | 0.640237 | -0.001196 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 664 | D | 0.71674 | G | 0.708122 | 0.008618 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 1566 | A | 0.844667 | P | 0.871619 | -0.026952 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 1694 | L | 0.886924 | P | 0.923475 | -0.036551 | No Change: Both D | - |
| O15078 | CE290_HUMAN Centrosomal protein of 290 kDa OS=Homo sapiens GN=CEP290 PE=1 SV=2 | 2228 | N | 0.778638 | K | 0.813991 | -0.035353 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 945 | E | 0.901577 | Q | 0.908337 | -0.00676 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 1445 | T | 0.634372 | A | 0.614845 | 0.019527 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 892 | R | 0.316091 | T | 0.33027 | -0.014179 | No Change: Both O | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 1213 | G | 0.945093 | V | 0.922408 | 0.022685 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 1446 | T | 0.577682 | A | 0.555571 | 0.022111 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 1517 | S | 0.974229 | A | 0.954961 | 0.019268 | No Change: Both D | - |
| Q5VT06 | CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens GN=CEP350 PE=1 SV=1 | 2044 | T | 0.89321 | P | 0.900319 | -0.007109 | No Change: Both D | - |
| Q9C0F1 | CEP44_HUMAN Centrosomal protein of 44 kDa OS=Homo sapiens GN=CEP44 PE=1 SV=2 | 147 | G | 0.812302 | S | 0.841175 | -0.028873 | No Change: Both D | - |
| Q53EZ4 | CEP55_HUMAN Centrosomal protein of 55 kDa OS=Homo sapiens GN=CEP55 PE=1 SV=3 | 99 | T | 0.912426 | A | 0.894076 | 0.01835 | No Change: Both D | - |
| Q53EZ4 | CEP55_HUMAN Centrosomal protein of 55 kDa OS=Homo sapiens GN=CEP55 PE=1 SV=3 | 378 | H | 0.4048 | L | 0.328243 | 0.076557 | No Change: Both O | - |
| Q53EZ4 | CEP55_HUMAN Centrosomal protein of 55 kDa OS=Homo sapiens GN=CEP55 PE=1 SV=3 | 57 | H | 0.775892 | Q | 0.809042 | -0.03315 | No Change: Both D | - |
| Q53EZ4 | CEP55_HUMAN Centrosomal protein of 55 kDa OS=Homo sapiens GN=CEP55 PE=1 SV=3 | 236 | C | 0.787747 | R | 0.849866 | -0.062119 | No Change: Both D | - |
| Q86XR8 | CEP57_HUMAN Centrosomal protein of 57 kDa OS=Homo sapiens GN=CEP57 PE=1 SV=2 | 448 | R | 0.97733 | G | 0.973132 | 0.004198 | No Change: Both D | - |
| Q8IYX8 | CE57L_HUMAN Centrosomal protein CEP57L1 OS=Homo sapiens GN=CEP57L1 PE=2 SV=1 | 194 | D | 0.909016 | E | 0.927665 | -0.018649 | No Change: Both D | - |
| Q96MT8 | CEP63_HUMAN Centrosomal protein of 63 kDa OS=Homo sapiens GN=CEP63 PE=1 SV=1 | 651 | S | 0.762543 | L | 0.623853 | 0.13869 | No Change: Both D | - |
| Q76N32 | CEP68_HUMAN Centrosomal protein of 68 kDa OS=Homo sapiens GN=CEP68 PE=1 SV=2 | 74 | G | 0.786843 | S | 0.81112 | -0.024277 | No Change: Both D | - |
| Q76N32 | CEP68_HUMAN Centrosomal protein of 68 kDa OS=Homo sapiens GN=CEP68 PE=1 SV=2 | 27 | R | 0.912301 | G | 0.907232 | 0.005069 | No Change: Both D | - |
| Q76N32 | CEP68_HUMAN Centrosomal protein of 68 kDa OS=Homo sapiens GN=CEP68 PE=1 SV=2 | 397 | L | 0.887513 | P | 0.93881 | -0.051297 | No Change: Both D | - |
| Q76N32 | CEP68_HUMAN Centrosomal protein of 68 kDa OS=Homo sapiens GN=CEP68 PE=1 SV=2 | 462 | R | 0.979252 | C | 0.967738 | 0.011514 | No Change: Both D | - |
| Q76N32 | CEP68_HUMAN Centrosomal protein of 68 kDa OS=Homo sapiens GN=CEP68 PE=1 SV=2 | 473 | E | 0.858232 | Q | 0.84237 | 0.015862 | No Change: Both D | - |
| Q8NHQ1 | CEP70_HUMAN Centrosomal protein of 70 kDa OS=Homo sapiens GN=CEP70 PE=1 SV=2 | 135 | S | 0.890974 | N | 0.869515 | 0.021459 | No Change: Both D | - |
| Q8NHQ1 | CEP70_HUMAN Centrosomal protein of 70 kDa OS=Homo sapiens GN=CEP70 PE=1 SV=2 | 537 | N | 0.316305 | S | 0.349698 | -0.033393 | No Change: Both O | - |
| Q9P209 | CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens GN=CEP72 PE=1 SV=2 | 238 | P | 0.942028 | L | 0.915372 | 0.026656 | No Change: Both D | - |
| Q9P209 | CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens GN=CEP72 PE=1 SV=2 | 412 | P | 0.766985 | T | 0.744154 | 0.022831 | No Change: Both D | - |
| Q9P209 | CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens GN=CEP72 PE=1 SV=2 | 509 | T | 0.938023 | A | 0.93459 | 0.003433 | No Change: Both D | - |
| Q6P2H3 | CEP85_HUMAN Centrosomal protein of 85 kDa OS=Homo sapiens GN=CEP85 PE=1 SV=1 | 542 | A | 0.931814 | T | 0.93905 | -0.007236 | No Change: Both D | - |
| Q6P2H3 | CEP85_HUMAN Centrosomal protein of 85 kDa OS=Homo sapiens GN=CEP85 PE=1 SV=1 | 48 | R | 0.819661 | H | 0.762954 | 0.056707 | No Change: Both D | - |
| Q6P2H3 | CEP85_HUMAN Centrosomal protein of 85 kDa OS=Homo sapiens GN=CEP85 PE=1 SV=1 | 213 | S | 0.730544 | N | 0.687293 | 0.043251 | No Change: Both D | - |
| Q6P2H3 | CEP85_HUMAN Centrosomal protein of 85 kDa OS=Homo sapiens GN=CEP85 PE=1 SV=1 | 668 | Q | 0.788475 | H | 0.738787 | 0.049688 | No Change: Both D | - |
| Q96ST8 | CEP89_HUMAN Centrosomal protein of 89 kDa OS=Homo sapiens GN=CEP89 PE=1 SV=3 | 194 | R | 0.949197 | W | 0.903956 | 0.045241 | No Change: Both D | - |
| Q96ST8 | CEP89_HUMAN Centrosomal protein of 89 kDa OS=Homo sapiens GN=CEP89 PE=1 SV=3 | 398 | V | 0.80594 | A | 0.841017 | -0.035077 | No Change: Both D | - |
| Q96GE4 | CEP95_HUMAN Centrosomal protein of 95 kDa OS=Homo sapiens GN=CEP95 PE=1 SV=1 | 165 | M | 0.797147 | I | 0.757608 | 0.039539 | No Change: Both D | - |
| Q96GE4 | CEP95_HUMAN Centrosomal protein of 95 kDa OS=Homo sapiens GN=CEP95 PE=1 SV=1 | 811 | A | 0.67808 | V | 0.594363 | 0.083717 | No Change: Both D | - |
| O95813 | CER1_HUMAN Cerberus OS=Homo sapiens GN=CER1 PE=1 SV=1 | 19 | R | 0.69491 | W | 0.464961 | 0.229949 | D to O | - |
| O95813 | CER1_HUMAN Cerberus OS=Homo sapiens GN=CER1 PE=1 SV=1 | 65 | A | 0.680953 | G | 0.709305 | -0.028352 | No Change: Both D | - |
| O95813 | CER1_HUMAN Cerberus OS=Homo sapiens GN=CER1 PE=1 SV=1 | 179 | V | 0.251945 | I | 0.215768 | 0.036177 | No Change: Both O | - |
| Q8TCT0 | CERK1_HUMAN Ceramide kinase OS=Homo sapiens GN=CERK PE=1 SV=1 | 191 | I | 0.111403 | V | 0.130293 | -0.01889 | No Change: Both O | - |
| Q8TCT0 | CERK1_HUMAN Ceramide kinase OS=Homo sapiens GN=CERK PE=1 SV=1 | 211 | T | 0.418453 | M | 0.370803 | 0.04765 | No Change: Both O | - |
| Q8TCT0 | CERK1_HUMAN Ceramide kinase OS=Homo sapiens GN=CERK PE=1 SV=1 | 306 | L | 0.219419 | F | 0.191572 | 0.027847 | No Change: Both O | - |
| Q49MI3 | CERKL_HUMAN Ceramide kinase-like protein OS=Homo sapiens GN=CERKL PE=1 SV=1 | 232 | L | 0.195342 | F | 0.188355 | 0.006987 | No Change: Both O | - |
| Q49MI3 | CERKL_HUMAN Ceramide kinase-like protein OS=Homo sapiens GN=CERKL PE=1 SV=1 | 514 | E | 0.735157 | G | 0.692909 | 0.042248 | No Change: Both D | - |
| Q49MI3 | CERKL_HUMAN Ceramide kinase-like protein OS=Homo sapiens GN=CERKL PE=1 SV=1 | 106 | R | 0.466164 | S | 0.514885 | -0.048721 | O to D | Retinitis pigmentosa type 26 (RP26) [MIM:608380] |
| Q96G23 | CERS2_HUMAN Ceramide synthase 2 OS=Homo sapiens GN=CERS2 PE=1 SV=1 | 115 | E | 0.570651 | A | 0.439285 | 0.131366 | D to O | - |
| Q8IU89 | CERS3_HUMAN Ceramide synthase 3 OS=Homo sapiens GN=CERS3 PE=2 SV=2 | 370 | R | 0.847425 | G | 0.835138 | 0.012287 | No Change: Both D | - |
| Q8IU89 | CERS3_HUMAN Ceramide synthase 3 OS=Homo sapiens GN=CERS3 PE=2 SV=2 | 342 | D | 0.773659 | G | 0.754859 | 0.0188 | No Change: Both D | - |
| Q8IU89 | CERS3_HUMAN Ceramide synthase 3 OS=Homo sapiens GN=CERS3 PE=2 SV=2 | 45 | Y | 0.027179 | C | 0.02006 | 0.007119 | No Change: Both O | - |
| Q9HA82 | CERS4_HUMAN Ceramide synthase 4 OS=Homo sapiens GN=CERS4 PE=1 SV=2 | 301 | G | 0.083435 | S | 0.102788 | -0.019353 | No Change: Both O | - |
| Q9HA82 | CERS4_HUMAN Ceramide synthase 4 OS=Homo sapiens GN=CERS4 PE=1 SV=2 | 366 | A | 0.947741 | T | 0.948982 | -0.001241 | No Change: Both D | - |
| Q9HA82 | CERS4_HUMAN Ceramide synthase 4 OS=Homo sapiens GN=CERS4 PE=1 SV=2 | 119 | R | 0.54704 | Q | 0.560677 | -0.013637 | No Change: Both D | - |
| Q9HA82 | CERS4_HUMAN Ceramide synthase 4 OS=Homo sapiens GN=CERS4 PE=1 SV=2 | 353 | A | 0.914751 | V | 0.882645 | 0.032106 | No Change: Both D | - |
| Q9HA82 | CERS4_HUMAN Ceramide synthase 4 OS=Homo sapiens GN=CERS4 PE=1 SV=2 | 379 | R | 0.955611 | Q | 0.947104 | 0.008507 | No Change: Both D | - |
| Q8N5B7 | CERS5_HUMAN Ceramide synthase 5 OS=Homo sapiens GN=CERS5 PE=1 SV=1 | 75 | C | 0.0735 | R | 0.14117 | -0.06767 | No Change: Both O | - |
| P23141 | EST1_HUMAN Liver carboxylesterase 1 OS=Homo sapiens GN=CES1 PE=1 SV=2 | 75 | S | 0.566506 | N | 0.52947 | 0.037036 | No Change: Both D | - |
| P23141 | EST1_HUMAN Liver carboxylesterase 1 OS=Homo sapiens GN=CES1 PE=1 SV=2 | 199 | R | 0.096558 | H | 0.100258 | -0.0037 | No Change: Both O | - |
| P23141 | EST1_HUMAN Liver carboxylesterase 1 OS=Homo sapiens GN=CES1 PE=1 SV=2 | 203 | D | 0.137789 | E | 0.153358 | -0.015569 | No Change: Both O | - |
| P23141 | EST1_HUMAN Liver carboxylesterase 1 OS=Homo sapiens GN=CES1 PE=1 SV=2 | 143 | G | 0.148822 | E | 0.167557 | -0.018735 | No Change: Both O | - |
| O00748 | EST2_HUMAN Cocaine esterase OS=Homo sapiens GN=CES2 PE=1 SV=1 | 34 | R | 0.560695 | W | 0.356133 | 0.204562 | D to O | - |
| O00748 | EST2_HUMAN Cocaine esterase OS=Homo sapiens GN=CES2 PE=1 SV=1 | 206 | R | 0.078765 | H | 0.083409 | -0.004644 | No Change: Both O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 129 | V | 0.143298 | I | 0.114682 | 0.028616 | No Change: Both O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 151 | A | 0.123892 | T | 0.139496 | -0.015604 | No Change: Both O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 160 | Y | 0.463784 | H | 0.584481 | -0.120697 | O to D | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 191 | E | 0.591083 | K | 0.593562 | -0.002479 | No Change: Both D | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 213 | I | 0.139162 | N | 0.287447 | -0.148285 | No Change: Both O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 367 | R | 0.563835 | W | 0.354327 | 0.209508 | D to O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 523 | A | 0.369064 | V | 0.282671 | 0.086393 | No Change: Both O | - |
| Q6UWW8 | EST3_HUMAN Carboxylesterase 3 OS=Homo sapiens GN=CES3 PE=1 SV=1 | 555 | I | 0.577583 | V | 0.604463 | -0.02688 | No Change: Both D | - |
| Q6NT32 | EST5A_HUMAN Carboxylesterase 5A OS=Homo sapiens GN=CES5A PE=2 SV=1 | 71 | R | 0.478151 | Q | 0.515894 | -0.037743 | O to D | - |
| Q6NT32 | EST5A_HUMAN Carboxylesterase 5A OS=Homo sapiens GN=CES5A PE=2 SV=1 | 261 | E | 0.235421 | K | 0.230604 | 0.004817 | No Change: Both O | - |
| Q6NT32 | EST5A_HUMAN Carboxylesterase 5A OS=Homo sapiens GN=CES5A PE=2 SV=1 | 344 | H | 0.176753 | Q | 0.206762 | -0.030009 | No Change: Both O | - |
| Q6NT32 | EST5A_HUMAN Carboxylesterase 5A OS=Homo sapiens GN=CES5A PE=2 SV=1 | 499 | G | 0.439572 | R | 0.431001 | 0.008571 | No Change: Both O | - |
| Q6NT32 | EST5A_HUMAN Carboxylesterase 5A OS=Homo sapiens GN=CES5A PE=2 SV=1 | 537 | D | 0.206047 | E | 0.233173 | -0.027126 | No Change: Both O | - |
| O15182 | CETN3_HUMAN Centrin-3 OS=Homo sapiens GN=CETN3 PE=2 SV=2 | 10 | V | 0.918401 | L | 0.933981 | -0.01558 | No Change: Both D | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 459 | D | 0.119386 | G | 0.113772 | 0.005614 | No Change: Both O | Hyperalphalipoproteinemia type 1 (HALP1) [MIM:143470] |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 331 | G | 0.286787 | S | 0.335783 | -0.048996 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 390 | A | 0.346223 | P | 0.43577 | -0.089547 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 422 | V | 0.718888 | I | 0.703753 | 0.015135 | No Change: Both D | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 468 | R | 0.105389 | Q | 0.12015 | -0.014761 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 486 | V | 0.210342 | M | 0.267564 | -0.057222 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 15 | A | 0.298298 | G | 0.349754 | -0.051456 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 385 | V | 0.238354 | M | 0.280532 | -0.042178 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 455 | V | 0.209003 | M | 0.276182 | -0.067179 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 154 | R | 0.383779 | W | 0.186174 | 0.197605 | No Change: Both O | - |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 168 | L | 0.18268 | P | 0.297741 | -0.115061 | No Change: Both O | Hyperalphalipoproteinemia type 1 (HALP1) [MIM:143470] |
| P11597 | CETP_HUMAN Cholesteryl ester transfer protein OS=Homo sapiens GN=CETP PE=1 SV=2 | 299 | R | 0.205468 | C | 0.101894 | 0.103574 | No Change: Both O | Hyperalphalipoproteinemia type 1 (HALP1) [MIM:143470] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 28 | W | 0.388399 | R | 0.626773 | -0.238374 | O to D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 28 | W | 0.388399 | Q | 0.641188 | -0.252789 | O to D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 32 | R | 0.440565 | Q | 0.481831 | -0.041266 | No Change: Both O | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 736 | A | 0.451479 | S | 0.538382 | -0.086903 | O to D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 9 | L | 0.351767 | H | 0.365883 | -0.014116 | No Change: Both O | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 32 | R | 0.440565 | W | 0.254175 | 0.18639 | No Change: Both O | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 252 | G | 0.722338 | S | 0.738941 | -0.016603 | No Change: Both D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 565 | K | 0.568704 | E | 0.576001 | -0.007297 | No Change: Both D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 651 | D | 0.625071 | E | 0.652168 | -0.027097 | No Change: Both D | - |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 286 | F | 0.373395 | L | 0.41279 | -0.039395 | No Change: Both O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 323 | K | 0.290001 | E | 0.290466 | -4.65E-04 | No Change: Both O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 166 | S | 0.326499 | P | 0.324396 | 0.002103 | No Change: Both O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 203 | R | 0.784176 | Q | 0.790146 | -0.00597 | No Change: Both D | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 242 | I | 0.554885 | L | 0.61003 | -0.055145 | No Change: Both D | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 323 | K | 0.290001 | Q | 0.238004 | 0.051997 | No Change: Both O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 458 | M | 0.421039 | I | 0.320362 | 0.100677 | No Change: Both O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P00751 | CFAB_HUMAN Complement factor B OS=Homo sapiens GN=CFB PE=1 SV=2 | 533 | K | 0.500415 | R | 0.420143 | 0.080272 | D to O | Hemolytic uremic syndrome atypical type 4 (AHUS4) [MIM:612924] |
| P0CG37 | CFC1_HUMAN Cryptic protein OS=Homo sapiens GN=CFC1 PE=1 SV=1 | 78 | R | 0.686722 | W | 0.461533 | 0.225189 | D to O | - |
| P0CG37 | CFC1_HUMAN Cryptic protein OS=Homo sapiens GN=CFC1 PE=1 SV=1 | 112 | R | 0.356102 | C | 0.270903 | 0.085199 | No Change: Both O | Visceral heterotaxy autosomal type 2 (HTX2) [MIM:605376] |
| P0CG37 | CFC1_HUMAN Cryptic protein OS=Homo sapiens GN=CFC1 PE=1 SV=1 | 189 | R | 0.830732 | C | 0.77809 | 0.052642 | No Change: Both D | - |
| P00746 | CFAD_HUMAN Complement factor D OS=Homo sapiens GN=CFD PE=1 SV=5 | 213 | V | 0.49472 | G | 0.627506 | -0.132786 | O to D | Complement factor D deficiency (CFDD) [MIM:613912] |
| P00746 | CFAD_HUMAN Complement factor D OS=Homo sapiens GN=CFD PE=1 SV=5 | 214 | C | 0.427744 | R | 0.556329 | -0.128585 | O to D | Complement factor D deficiency (CFDD) [MIM:613912] |
| P00746 | CFAD_HUMAN Complement factor D OS=Homo sapiens GN=CFD PE=1 SV=5 | 248 | I | 0.265238 | M | 0.356757 | -0.091519 | No Change: Both O | - |
| Q9UEE9 | CFDP1_HUMAN Craniofacial development protein 1 OS=Homo sapiens GN=CFDP1 PE=1 SV=1 | 60 | A | 0.985422 | T | 0.987601 | -0.002179 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 402 | Y | 0.397145 | H | 0.503116 | -0.105971 | O to D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 536 | C | 0.396146 | R | 0.578093 | -0.181947 | O to D | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 959 | C | 0.180462 | Y | 0.196025 | -0.015563 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1189 | L | 0.395404 | R | 0.505181 | -0.109777 | O to D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1191 | S | 0.438496 | L | 0.254896 | 0.1836 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 936 | E | 0.613013 | D | 0.575091 | 0.037922 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 62 | V | 0.131939 | I | 0.118066 | 0.013873 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 551 | I | 0.283895 | T | 0.443014 | -0.159119 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 890 | S | 0.806777 | I | 0.651528 | 0.155249 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1007 | V | 0.52374 | I | 0.492621 | 0.031119 | D to O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1017 | T | 0.167154 | I | 0.086083 | 0.081071 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1050 | N | 0.538491 | Y | 0.403099 | 0.135392 | D to O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1059 | I | 0.505207 | T | 0.673562 | -0.168355 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 78 | R | 0.274972 | G | 0.279658 | -0.004686 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 630 | C | 0.590753 | W | 0.47578 | 0.114973 | D to O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 850 | E | 0.381317 | K | 0.367911 | 0.013406 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 950 | Q | 0.450609 | H | 0.454379 | -0.00377 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 951 | Y | 0.396823 | H | 0.46623 | -0.069407 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 956 | T | 0.246967 | M | 0.245817 | 0.00115 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 978 | W | 0.386344 | C | 0.495408 | -0.109064 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1021 | Y | 0.218431 | F | 0.183356 | 0.035075 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1043 | C | 0.457416 | R | 0.583389 | -0.125973 | O to D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1076 | Q | 0.540106 | E | 0.583973 | -0.043867 | No Change: Both D | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1119 | D | 0.569274 | G | 0.548124 | 0.02115 | No Change: Both D | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1134 | V | 0.379229 | G | 0.47911 | -0.099881 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1142 | Y | 0.286903 | D | 0.409772 | -0.122869 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1157 | W | 0.40287 | R | 0.622038 | -0.219168 | O to D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1163 | C | 0.275456 | W | 0.228344 | 0.047112 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1183 | W | 0.146895 | L | 0.218018 | -0.071123 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1183 | W | 0.146895 | R | 0.322831 | -0.175936 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1184 | T | 0.173322 | R | 0.199174 | -0.025852 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1194 | G | 0.398283 | D | 0.423992 | -0.025709 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1197 | V | 0.349938 | A | 0.417407 | -0.067469 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1198 | E | 0.30785 | A | 0.199481 | 0.108369 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1210 | R | 0.560603 | C | 0.422113 | 0.13849 | D to O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1215 | R | 0.460796 | G | 0.420033 | 0.040763 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1215 | R | 0.460796 | Q | 0.415963 | 0.044833 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1226 | P | 0.545761 | S | 0.605956 | -0.060195 | No Change: Both D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 127 | R | 0.218341 | L | 0.143345 | 0.074996 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 400 | Q | 0.372128 | K | 0.429415 | -0.057287 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 431 | C | 0.26453 | S | 0.473798 | -0.209268 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 673 | C | 0.179534 | S | 0.359271 | -0.179737 | No Change: Both O | Complement factor H deficiency (CFH deficiency) [MIM:609814] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 673 | C | 0.179534 | Y | 0.205537 | -0.026003 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 893 | H | 0.757846 | R | 0.794632 | -0.036786 | No Change: Both D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 915 | C | 0.659239 | S | 0.783222 | -0.123983 | No Change: Both D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1199 | F | 0.284493 | S | 0.533218 | -0.248725 | O to D | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 493 | T | 0.467577 | R | 0.459826 | 0.007751 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 567 | R | 0.200212 | G | 0.208759 | -0.008547 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1007 | V | 0.52374 | L | 0.513657 | 0.010083 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1078 | R | 0.521917 | S | 0.562357 | -0.04044 | No Change: Both D | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1143 | Q | 0.278983 | E | 0.309496 | -0.030513 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 997 | N | 0.389104 | T | 0.37695 | 0.012154 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1010 | A | 0.408354 | T | 0.450354 | -0.042 | No Change: Both O | - |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 325 | C | 0.297608 | Y | 0.333435 | -0.035827 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 609 | V | 0.277297 | I | 0.251723 | 0.025574 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1169 | I | 0.1534 | L | 0.172156 | -0.018756 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| P08603 | CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 | 1183 | W | 0.146895 | C | 0.208916 | -0.062021 | No Change: Both O | Hemolytic uremic syndrome atypical type 1 (AHUS1) [MIM:235400] |
| Q03591 | FHR1_HUMAN Complement factor H-related protein 1 OS=Homo sapiens GN=CFHR1 PE=1 SV=2 | 157 | H | 0.629122 | Y | 0.572053 | 0.057069 | No Change: Both D | - |
| Q03591 | FHR1_HUMAN Complement factor H-related protein 1 OS=Homo sapiens GN=CFHR1 PE=1 SV=2 | 159 | L | 0.62193 | V | 0.671609 | -0.049679 | No Change: Both D | - |
| Q03591 | FHR1_HUMAN Complement factor H-related protein 1 OS=Homo sapiens GN=CFHR1 PE=1 SV=2 | 175 | E | 0.574297 | Q | 0.530461 | 0.043836 | No Change: Both D | - |
| Q03591 | FHR1_HUMAN Complement factor H-related protein 1 OS=Homo sapiens GN=CFHR1 PE=1 SV=2 | 296 | A | 0.307446 | V | 0.247439 | 0.060007 | No Change: Both O | - |
| Q02985 | FHR3_HUMAN Complement factor H-related protein 3 OS=Homo sapiens GN=CFHR3 PE=1 SV=2 | 71 | H | 0.095623 | Y | 0.061345 | 0.034278 | No Change: Both O | - |
| Q92496 | FHR4_HUMAN Complement factor H-related protein 4 OS=Homo sapiens GN=CFHR4 PE=1 SV=2 | 306 | G | 0.148933 | E | 0.188325 | -0.039392 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 216 | N | 0.698255 | S | 0.738329 | -0.040074 | No Change: Both D | A breast cancer sample |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 46 | P | 0.294274 | S | 0.3223 | -0.028026 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 356 | R | 0.268254 | H | 0.260231 | 0.008023 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 521 | L | 0.35747 | I | 0.336614 | 0.020856 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 529 | L | 0.322873 | R | 0.428685 | -0.105812 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 277 | Y | 0.245876 | N | 0.358847 | -0.112971 | No Change: Both O | - |
| Q9BXR6 | FHR5_HUMAN Complement factor H-related protein 5 OS=Homo sapiens GN=CFHR5 PE=1 SV=1 | 379 | V | 0.495626 | L | 0.467726 | 0.0279 | No Change: Both O | - |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 418 | H | 0.141644 | L | 0.081847 | 0.059797 | No Change: Both O | Complement factor I deficiency (CFI deficiency) [MIM:610984] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 340 | I | 0.431619 | T | 0.541969 | -0.11035 | O to D | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 524 | D | 0.44408 | V | 0.298083 | 0.145997 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 243 | G | 0.534075 | D | 0.588594 | -0.054519 | No Change: Both D | Complement factor I deficiency (CFI deficiency) [MIM:610984] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 300 | T | 0.43327 | A | 0.404676 | 0.028594 | No Change: Both O | - |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 64 | P | 0.228098 | L | 0.11904 | 0.109058 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 119 | G | 0.549759 | R | 0.523894 | 0.025865 | No Change: Both D | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 183 | H | 0.204354 | R | 0.229345 | -0.024991 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 287 | G | 0.410918 | R | 0.385723 | 0.025195 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 317 | R | 0.52926 | W | 0.277204 | 0.252056 | D to O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 416 | I | 0.084529 | L | 0.088381 | -0.003852 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 519 | D | 0.487401 | N | 0.445744 | 0.041657 | No Change: Both O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| P05156 | CFAI_HUMAN Complement factor I OS=Homo sapiens GN=CFI PE=1 SV=2 | 522 | K | 0.519103 | T | 0.447191 | 0.071912 | D to O | Hemolytic uremic syndrome atypical type 3 (AHUS3) [MIM:612923] |
| Q9Y281 | COF2_HUMAN Cofilin-2 OS=Homo sapiens GN=CFL2 PE=1 SV=1 | 35 | A | 0.400361 | T | 0.451862 | -0.051501 | No Change: Both O | Nemaline myopathy type 7 (NEM7) [MIM:610687] |
| Q9Y281 | COF2_HUMAN Cofilin-2 OS=Homo sapiens GN=CFL2 PE=1 SV=1 | 47 | I | 0.327811 | M | 0.393269 | -0.065458 | No Change: Both O | A breast cancer sample |
| O15519 | CFLAR_HUMAN CASP8 and FADD-like apoptosis regulator OS=Homo sapiens GN=CFLAR PE=1 SV=1 | 203 | L | 0.785058 | I | 0.754603 | 0.030455 | No Change: Both D | - |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 100 | R | 0.406219 | W | 0.224537 | 0.181682 | No Change: Both O | Properdin deficiency (PFD) [MIM:312060] |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 343 | Q | 0.836124 | R | 0.838029 | -0.001905 | No Change: Both D | Properdin deficiency (PFD) [MIM:312060] |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 414 | Y | 0.668741 | D | 0.784221 | -0.11548 | No Change: Both D | Properdin deficiency (PFD) [MIM:312060] |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 298 | G | 0.4746 | V | 0.347472 | 0.127128 | No Change: Both O | Properdin deficiency (PFD) [MIM:312060] |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 53 | V | 0.284975 | M | 0.335326 | -0.050351 | No Change: Both O | - |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 204 | P | 0.891088 | L | 0.781376 | 0.109712 | No Change: Both D | - |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 250 | G | 0.881694 | S | 0.886615 | -0.004921 | No Change: Both D | - |
| P27918 | PROP_HUMAN Properdin OS=Homo sapiens GN=CFP PE=1 SV=2 | 3 | T | 0.787116 | I | 0.72812 | 0.058996 | No Change: Both D | A breast cancer sample |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 13 | S | 0.271508 | F | 0.11791 | 0.153598 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 31 | R | 0.334095 | C | 0.195557 | 0.138538 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 31 | R | 0.334095 | L | 0.234054 | 0.100041 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 42 | S | 0.460675 | F | 0.235047 | 0.225628 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 44 | D | 0.524162 | G | 0.464997 | 0.059165 | D to O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 44 | D | 0.524162 | V | 0.358523 | 0.165639 | D to O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 50 | S | 0.657339 | Y | 0.476092 | 0.181247 | D to O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 57 | W | 0.596262 | G | 0.770493 | -0.174231 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 67 | P | 0.587437 | L | 0.432528 | 0.154909 | D to O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 74 | R | 0.041951 | W | 0.01528 | 0.026671 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 75 | R | 0.029236 | Q | 0.027511 | 0.001725 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 85 | G | 0.010766 | E | 0.013975 | -0.003209 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 87 | F | 0.019122 | L | 0.022047 | -0.002925 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 91 | G | 0.074041 | R | 0.066048 | 0.007993 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 92 | E | 0.09538 | K | 0.102257 | -0.006877 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 98 | Q | 0.150115 | R | 0.144774 | 0.005341 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 105 | I | 0.114398 | S | 0.27734 | -0.162942 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 109 | Y | 0.420857 | C | 0.371659 | 0.049198 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 110 | D | 0.531664 | H | 0.475243 | 0.056421 | D to O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 111 | P | 0.645354 | L | 0.46981 | 0.175544 | D to O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 117 | R | 0.468856 | C | 0.305054 | 0.163802 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 117 | R | 0.468856 | H | 0.470938 | -0.002082 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 117 | R | 0.468856 | H | 0.470938 | -0.002082 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 117 | R | 0.468856 | L | 0.355428 | 0.113428 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 117 | R | 0.468856 | P | 0.520627 | -0.051771 | O to D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 120 | A | 0.137883 | T | 0.154607 | -0.016724 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 139 | H | 0.075844 | R | 0.074456 | 0.001388 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 141 | A | 0.109163 | D | 0.157125 | -0.047962 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 148 | I | 0.145554 | T | 0.235978 | -0.090424 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 149 | G | 0.159741 | R | 0.151474 | 0.008267 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 178 | G | 0.204837 | R | 0.20073 | 0.004107 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 193 | E | 0.327412 | K | 0.341276 | -0.013864 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 193 | E | 0.327412 | K | 0.341276 | -0.013864 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 199 | H | 0.029199 | Q | 0.032668 | -0.003469 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 199 | H | 0.029199 | Y | 0.016278 | 0.012921 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 205 | P | 0.032738 | S | 0.037348 | -0.00461 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 206 | L | 0.032189 | W | 0.021038 | 0.011151 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 225 | C | 0.039174 | R | 0.085584 | -0.04641 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 244 | M | 0.350318 | K | 0.481423 | -0.131105 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 258 | R | 0.326108 | G | 0.339695 | -0.013587 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 287 | N | 0.439228 | Y | 0.29266 | 0.146568 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 297 | R | 0.290648 | Q | 0.303651 | -0.013003 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 301 | Y | 0.172062 | C | 0.130597 | 0.041465 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 307 | S | 0.162288 | N | 0.133891 | 0.028397 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 311 | F | 0.086334 | L | 0.086299 | 3.50E-05 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 314 | G | 0.052915 | E | 0.068299 | -0.015384 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 314 | G | 0.052915 | R | 0.049711 | 0.003204 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 334 | R | 0.053146 | W | 0.019663 | 0.033483 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 336 | I | 0.045904 | K | 0.122536 | -0.076632 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 338 | T | 0.030813 | I | 0.016679 | 0.014134 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 346 | L | 0.032659 | P | 0.07248 | -0.039821 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 347 | R | 0.034057 | H | 0.032038 | 0.002019 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 347 | R | 0.034057 | L | 0.018462 | 0.015595 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 347 | R | 0.034057 | P | 0.039341 | -0.005284 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 352 | R | 0.083675 | Q | 0.093378 | -0.009703 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 359 | Q | 0.064024 | K | 0.074745 | -0.010721 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 455 | A | 0.254612 | E | 0.341836 | -0.087224 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 456 | V | 0.300069 | F | 0.277758 | 0.022311 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 458 | G | 0.413977 | V | 0.276414 | 0.137563 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 467 | L | 0.265759 | F | 0.229941 | 0.035818 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 470 | V | 0.194814 | M | 0.28322 | -0.088406 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 480 | G | 0.736673 | C | 0.609933 | 0.12674 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 492 | S | 0.156778 | F | 0.059359 | 0.097419 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 504 | E | 0.161776 | Q | 0.136076 | 0.0257 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 506 | I | 0.141284 | V | 0.15138 | -0.010096 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 507 | I | 0.120449 | V | 0.130006 | -0.009557 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 508 | F | 0.110232 | C | 0.109692 | 5.40E-04 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 513 | D | 0.197173 | G | 0.189291 | 0.007882 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 520 | V | 0.165127 | F | 0.146267 | 0.01886 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 544 | G | 0.314759 | V | 0.190469 | 0.12429 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 549 | S | 0.453026 | N | 0.403562 | 0.049464 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 549 | S | 0.453026 | I | 0.243203 | 0.209823 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 549 | S | 0.453026 | R | 0.399017 | 0.054009 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 551 | G | 0.464767 | D | 0.469133 | -0.004366 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 551 | G | 0.464767 | S | 0.52015 | -0.055383 | O to D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 553 | R | 0.417933 | Q | 0.436995 | -0.019062 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 558 | L | 0.239439 | S | 0.43833 | -0.198891 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 559 | A | 0.216306 | T | 0.220697 | -0.004391 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 560 | R | 0.201078 | K | 0.25128 | -0.050202 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 560 | R | 0.201078 | S | 0.251786 | -0.050708 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 560 | R | 0.201078 | T | 0.176253 | 0.024825 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 562 | V | 0.194837 | I | 0.181513 | 0.013324 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 562 | V | 0.194837 | L | 0.210873 | -0.016036 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 563 | Y | 0.191128 | N | 0.299314 | -0.108186 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 569 | Y | 0.160736 | C | 0.123845 | 0.036891 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 569 | Y | 0.160736 | D | 0.295551 | -0.134815 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 569 | Y | 0.160736 | H | 0.240189 | -0.079453 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 571 | L | 0.153149 | S | 0.303624 | -0.150475 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 572 | D | 0.156413 | N | 0.133064 | 0.023349 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 574 | P | 0.150804 | H | 0.130846 | 0.019958 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 576 | G | 0.1329 | A | 0.105602 | 0.027298 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 579 | D | 0.135072 | G | 0.124511 | 0.010561 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 601 | I | 0.248756 | F | 0.250547 | -0.001791 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 610 | L | 0.497062 | S | 0.657716 | -0.160654 | O to D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 613 | A | 0.426253 | T | 0.457762 | -0.031509 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 614 | D | 0.408481 | G | 0.392883 | 0.015598 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 618 | I | 0.227206 | T | 0.336038 | -0.108832 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 619 | L | 0.218704 | S | 0.38418 | -0.165476 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 620 | H | 0.219441 | P | 0.25488 | -0.035439 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 620 | H | 0.219441 | Q | 0.239624 | -0.020183 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 622 | G | 0.240268 | D | 0.262976 | -0.022708 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 628 | G | 0.316349 | R | 0.304067 | 0.012282 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 633 | L | 0.387587 | P | 0.527631 | -0.140044 | O to D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 648 | D | 0.448166 | V | 0.256551 | 0.191615 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 651 | D | 0.486215 | N | 0.457961 | 0.028254 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 665 | T | 0.515713 | S | 0.5978 | -0.082087 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 668 | R | 0.524807 | C | 0.418134 | 0.106673 | D to O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 693 | F | 0.723523 | L | 0.731337 | -0.007814 | No Change: Both D | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 754 | V | 0.604329 | M | 0.679856 | -0.075527 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 766 | R | 0.603147 | M | 0.532779 | 0.070368 | No Change: Both D | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 792 | R | 0.637509 | G | 0.600433 | 0.037076 | No Change: Both D | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 800 | A | 0.499937 | G | 0.527122 | -0.027185 | O to D | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 807 | I | 0.473015 | M | 0.575418 | -0.102403 | O to D | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 822 | E | 0.647733 | K | 0.621698 | 0.026035 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 826 | E | 0.592655 | K | 0.577026 | 0.015629 | No Change: Both D | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 866 | C | 0.002096 | Y | 0.002695 | -5.99E-04 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 912 | S | 0.112343 | L | 0.04258 | 0.069763 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 913 | Y | 0.090869 | C | 0.064817 | 0.026052 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 917 | Y | 0.038344 | C | 0.026802 | 0.011542 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 949 | H | 0.310542 | Y | 0.18487 | 0.125672 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 952 | M | 0.31612 | I | 0.238459 | 0.077661 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 997 | L | 0.011037 | F | 0.009511 | 0.001526 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1005 | I | 0.022407 | R | 0.042706 | -0.020299 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1006 | A | 0.022836 | E | 0.035478 | -0.012642 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1013 | P | 0.035952 | L | 0.016851 | 0.019101 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1028 | M | 0.017197 | I | 0.012099 | 0.005098 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1052 | F | 0.284269 | V | 0.329001 | -0.044732 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1061 | G | 0.14416 | R | 0.14633 | -0.00217 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1065 | L | 0.105309 | P | 0.193247 | -0.087938 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1065 | L | 0.105309 | R | 0.175597 | -0.070288 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1066 | R | 0.106461 | C | 0.047758 | 0.058703 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1066 | R | 0.106461 | H | 0.100033 | 0.006428 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1066 | R | 0.106461 | L | 0.064112 | 0.042349 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1067 | A | 0.106255 | T | 0.131827 | -0.025572 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1067 | A | 0.106255 | V | 0.075949 | 0.030306 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1070 | R | 0.153181 | Q | 0.165643 | -0.012462 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1070 | R | 0.153181 | P | 0.176419 | -0.023238 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1071 | Q | 0.178093 | P | 0.203367 | -0.025274 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1072 | P | 0.188866 | L | 0.101721 | 0.087145 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1077 | L | 0.165657 | P | 0.302953 | -0.137296 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1085 | H | 0.107941 | R | 0.099474 | 0.008467 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1098 | W | 0.041021 | R | 0.113622 | -0.072601 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1101 | M | 0.0404 | K | 0.069512 | -0.029112 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1137 | M | 0.070351 | V | 0.049852 | 0.020499 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1152 | D | 0.373065 | H | 0.324232 | 0.048833 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1162 | R | 0.279002 | L | 0.191194 | 0.087808 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1220 | T | 0.379604 | I | 0.250954 | 0.12865 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1234 | I | 0.338669 | V | 0.362448 | -0.023779 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1235 | S | 0.35509 | R | 0.303433 | 0.051657 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1244 | G | 0.531676 | E | 0.55133 | -0.019654 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1249 | G | 0.622111 | E | 0.639232 | -0.017121 | No Change: Both D | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1251 | S | 0.526336 | N | 0.455885 | 0.070451 | D to O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1255 | S | 0.248004 | P | 0.20797 | 0.040034 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1270 | D | 0.25934 | N | 0.237786 | 0.021554 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1282 | W | 0.112917 | R | 0.262822 | -0.149905 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1283 | R | 0.110147 | M | 0.085295 | 0.024852 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1286 | F | 0.103396 | S | 0.245372 | -0.141976 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1291 | Q | 0.095039 | H | 0.086972 | 0.008067 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1291 | Q | 0.095039 | R | 0.089099 | 0.00594 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1303 | N | 0.320908 | H | 0.302383 | 0.018525 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1303 | N | 0.320908 | K | 0.371878 | -0.05097 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1349 | G | 0.263626 | D | 0.278671 | -0.015045 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1364 | A | 0.269423 | V | 0.207289 | 0.062134 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1397 | V | 0.046741 | E | 0.118364 | -0.071623 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 138 | L | 0.055871 | P | 0.107995 | -0.052124 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 170 | R | 0.360437 | H | 0.363414 | -0.002977 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 182 | S | 0.212181 | G | 0.168902 | 0.043279 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 322 | V | 0.027067 | M | 0.033055 | -0.005988 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 351 | T | 0.070438 | S | 0.098095 | -0.027657 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 353 | Q | 0.089532 | H | 0.077352 | 0.01218 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 506 | I | 0.141284 | M | 0.187478 | -0.046194 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 654 | S | 0.538254 | G | 0.45455 | 0.083704 | D to O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 903 | Y | 0.476004 | H | 0.629302 | -0.153298 | O to D | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 909 | S | 0.210249 | I | 0.081382 | 0.128867 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 967 | L | 0.33317 | S | 0.539984 | -0.206814 | O to D | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1070 | R | 0.153181 | W | 0.060515 | 0.092666 | No Change: Both O | Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1101 | M | 0.0404 | R | 0.0557 | -0.0153 | No Change: Both O | Cystic fibrosis (CF) [MIM:219700] |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 532 | K | 0.415142 | E | 0.426198 | -0.011056 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 605 | S | 0.389913 | F | 0.187435 | 0.202478 | No Change: Both O | - |
| P13569 | CFTR_HUMAN Cystic fibrosis transmembrane conductance regulator OS=Homo sapiens GN=CFTR PE=1 SV=3 | 1453 | R | 0.821326 | W | 0.608684 | 0.212642 | No Change: Both D | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 137 | D | 0.988661 | A | 0.985342 | 0.003319 | No Change: Both D | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 4 | F | 0.480202 | L | 0.567871 | -0.087669 | O to D | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 22 | K | 0.527273 | R | 0.499676 | 0.027597 | D to O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 35 | T | 0.241319 | I | 0.148409 | 0.09291 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 97 | N | 0.286628 | D | 0.31443 | -0.027802 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 18 | T | 0.332757 | A | 0.319342 | 0.013415 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 24 | P | 0.473201 | M | 0.360878 | 0.112323 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 28 | R | 0.370278 | W | 0.167986 | 0.202292 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 30 | R | 0.298325 | H | 0.269558 | 0.028767 | No Change: Both O | - |
| P01233 | CGHB_HUMAN Choriogonadotropin subunit beta OS=Homo sapiens GN=CGB PE=1 SV=1 | 147 | S | 0.998451 | C | 0.99728 | 0.001171 | No Change: Both D | - |
| A6NKQ9 | CGB1_HUMAN Choriogonadotropin subunit beta variant 1 OS=Homo sapiens GN=CGB1 PE=2 SV=3 | 185 | P | 0.999313 | S | 0.999256 | 5.70E-05 | No Change: Both D | - |
| Q9P2M7 | CING_HUMAN Cingulin OS=Homo sapiens GN=CGN PE=1 SV=2 | 479 | R | 0.935379 | Q | 0.935658 | -2.79E-04 | No Change: Both D | - |
| Q0VF96 | CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens GN=CGNL1 PE=1 SV=2 | 380 | T | 0.871341 | P | 0.909129 | -0.037788 | No Change: Both D | - |
| Q0VF96 | CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens GN=CGNL1 PE=1 SV=2 | 459 | S | 0.75434 | F | 0.592032 | 0.162308 | No Change: Both D | - |
| Q0VF96 | CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens GN=CGNL1 PE=1 SV=2 | 511 | T | 0.833334 | A | 0.816902 | 0.016432 | No Change: Both D | - |
| Q0VF96 | CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens GN=CGNL1 PE=1 SV=2 | 1101 | L | 0.979145 | V | 0.969836 | 0.009309 | No Change: Both D | - |
| Q0VF96 | CGNL1_HUMAN Cingulin-like protein 1 OS=Homo sapiens GN=CGNL1 PE=1 SV=2 | 1270 | M | 0.894941 | V | 0.866096 | 0.028845 | No Change: Both D | - |
| Q99674 | CGRE1_HUMAN Cell growth regulator with EF hand domain protein 1 OS=Homo sapiens GN=CGREF1 PE=2 SV=2 | 212 | A | 0.991325 | V | 0.988534 | 0.002791 | No Change: Both D | - |
| Q99674 | CGRE1_HUMAN Cell growth regulator with EF hand domain protein 1 OS=Homo sapiens GN=CGREF1 PE=2 SV=2 | 232 | K | 0.996662 | N | 0.996284 | 3.78E-04 | No Change: Both D | - |
| Q99674 | CGRE1_HUMAN Cell growth regulator with EF hand domain protein 1 OS=Homo sapiens GN=CGREF1 PE=2 SV=2 | 243 | G | 0.997889 | E | 0.9982 | -3.11E-04 | No Change: Both D | - |
| Q99674 | CGRE1_HUMAN Cell growth regulator with EF hand domain protein 1 OS=Homo sapiens GN=CGREF1 PE=2 SV=2 | 116 | I | 0.170204 | M | 0.248609 | -0.078405 | No Change: Both O | - |
| Q99675 | CGRF1_HUMAN Cell growth regulator with RING finger domain protein 1 OS=Homo sapiens GN=CGRRF1 PE=1 SV=1 | 117 | C | 0.071462 | Y | 0.094341 | -0.022879 | No Change: Both O | - |
| O95992 | CH25H_HUMAN Cholesterol 25-hydroxylase OS=Homo sapiens GN=CH25H PE=1 SV=1 | 133 | L | 0.014849 | P | 0.029434 | -0.014585 | No Change: Both O | - |
| Q8WUX2 | CHAC2_HUMAN Cation transport regulator-like protein 2 OS=Homo sapiens GN=CHAC2 PE=2 SV=1 | 82 | R | 0.385322 | G | 0.407394 | -0.022072 | No Change: Both O | - |
| O15335 | CHAD_HUMAN Chondroadherin OS=Homo sapiens GN=CHAD PE=2 SV=2 | 350 | T | 0.949537 | I | 0.915631 | 0.033906 | No Change: Both D | - |
| O15335 | CHAD_HUMAN Chondroadherin OS=Homo sapiens GN=CHAD PE=2 SV=2 | 312 | R | 0.375681 | Q | 0.369703 | 0.005978 | No Change: Both O | - |
| Q6NUI6 | CHADL_HUMAN Chondroadherin-like protein OS=Homo sapiens GN=CHADL PE=2 SV=2 | 710 | Q | 0.534294 | R | 0.56387 | -0.029576 | No Change: Both D | - |
| Q6NUI6 | CHADL_HUMAN Chondroadherin-like protein OS=Homo sapiens GN=CHADL PE=2 SV=2 | 721 | D | 0.697009 | N | 0.714503 | -0.017494 | No Change: Both D | - |
| Q13111 | CAF1A_HUMAN Chromatin assembly factor 1 subunit A OS=Homo sapiens GN=CHAF1A PE=1 SV=2 | 167 | D | 0.667102 | V | 0.507903 | 0.159199 | No Change: Both D | - |
| Q13111 | CAF1A_HUMAN Chromatin assembly factor 1 subunit A OS=Homo sapiens GN=CHAF1A PE=1 SV=2 | 239 | M | 0.331677 | V | 0.275548 | 0.056129 | No Change: Both O | - |
| Q13111 | CAF1A_HUMAN Chromatin assembly factor 1 subunit A OS=Homo sapiens GN=CHAF1A PE=1 SV=2 | 850 | K | 0.8693 | R | 0.864974 | 0.004326 | No Change: Both D | - |
| Q13111 | CAF1A_HUMAN Chromatin assembly factor 1 subunit A OS=Homo sapiens GN=CHAF1A PE=1 SV=2 | 923 | A | 0.800343 | V | 0.754588 | 0.045755 | No Change: Both D | - |
| Q13111 | CAF1A_HUMAN Chromatin assembly factor 1 subunit A OS=Homo sapiens GN=CHAF1A PE=1 SV=2 | 950 | S | 0.861916 | A | 0.81831 | 0.043606 | No Change: Both D | - |
| Q13112 | CAF1B_HUMAN Chromatin assembly factor 1 subunit B OS=Homo sapiens GN=CHAF1B PE=1 SV=1 | 506 | K | 0.940123 | Q | 0.939037 | 0.001086 | No Change: Both D | - |
| Q96JM3 | CHAP1_HUMAN Chromosome alignment-maintaining phosphoprotein 1 OS=Homo sapiens GN=CHAMP1 PE=1 SV=2 | 568 | L | 0.765289 | V | 0.738022 | 0.027267 | No Change: Both D | - |
| Q96JM3 | CHAP1_HUMAN Chromosome alignment-maintaining phosphoprotein 1 OS=Homo sapiens GN=CHAMP1 PE=1 SV=2 | 604 | P | 0.816611 | R | 0.780587 | 0.036024 | No Change: Both D | - |
| Q96JM3 | CHAP1_HUMAN Chromosome alignment-maintaining phosphoprotein 1 OS=Homo sapiens GN=CHAMP1 PE=1 SV=2 | 591 | K | 0.671586 | R | 0.592786 | 0.0788 | No Change: Both D | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 210 | L | 0.312205 | P | 0.471891 | -0.159686 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 211 | P | 0.321771 | A | 0.24935 | 0.072421 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 305 | I | 0.088174 | T | 0.148988 | -0.060814 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 420 | R | 0.354762 | C | 0.207808 | 0.146954 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 441 | E | 0.173442 | K | 0.173679 | -2.37E-04 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 482 | R | 0.452783 | G | 0.400442 | 0.052341 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 498 | S | 0.524813 | L | 0.341354 | 0.183459 | D to O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 506 | V | 0.151825 | L | 0.162152 | -0.010327 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 560 | R | 0.398942 | H | 0.380222 | 0.01872 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 120 | A | 0.90531 | T | 0.918072 | -0.012762 | No Change: Both D | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 392 | A | 0.150753 | G | 0.198048 | -0.047295 | No Change: Both O | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 336 | I | 0.257826 | T | 0.404655 | -0.146829 | No Change: Both O | Congenital myasthenic syndrome with episodic apnea (CMSEA) [MIM:254210] |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 47 | D | 0.963265 | E | 0.966267 | -0.003002 | No Change: Both D | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 222 | R | 0.224117 | P | 0.278174 | -0.054057 | No Change: Both O | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 243 | L | 0.223775 | F | 0.18866 | 0.035115 | No Change: Both O | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 299 | P | 0.536252 | L | 0.339606 | 0.196646 | D to O | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 400 | D | 0.43558 | N | 0.416103 | 0.019477 | No Change: Both O | - |
| P28329 | CLAT_HUMAN Choline O-acetyltransferase OS=Homo sapiens GN=CHAT PE=1 SV=4 | 461 | V | 0.460508 | M | 0.510591 | -0.050083 | O to D | - |
| Q9Y6H1 | CHCH2_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 mitochondrial OS=Homo sapiens GN=CHCHD2 PE=1 SV=1 | 78 | H | 0.524717 | N | 0.535094 | -0.010377 | No Change: Both D | - |
| Q9BRQ6 | CHCH6_HUMAN Coiled-coil-helix-coiled-coil-helix domain-containing protein 6 OS=Homo sapiens GN=CHCHD6 PE=1 SV=1 | 95 | A | 0.799648 | S | 0.84405 | -0.044402 | No Change: Both D | - |
| O14646 | CHD1_HUMAN Chromodomain-helicase-DNA-binding protein 1 OS=Homo sapiens GN=CHD1 PE=1 SV=2 | 264 | P | 0.801707 | T | 0.776897 | 0.02481 | No Change: Both D | - |
| Q86WJ1 | CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens GN=CHD1L PE=1 SV=2 | 25 | R | 0.574222 | P | 0.577666 | -0.003444 | No Change: Both D | - |
| Q86WJ1 | CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens GN=CHD1L PE=1 SV=2 | 350 | H | 0.294772 | Q | 0.305469 | -0.010697 | No Change: Both O | - |
| Q86WJ1 | CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens GN=CHD1L PE=1 SV=2 | 649 | E | 0.973803 | A | 0.9623 | 0.011503 | No Change: Both D | - |
| Q86WJ1 | CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens GN=CHD1L PE=1 SV=2 | 743 | S | 0.300113 | C | 0.145896 | 0.154217 | No Change: Both O | - |
| Q86WJ1 | CHD1L_HUMAN Chromodomain-helicase-DNA-binding protein 1-like OS=Homo sapiens GN=CHD1L PE=1 SV=2 | 885 | A | 0.756253 | S | 0.800796 | -0.044543 | No Change: Both D | - |
| O14647 | CHD2_HUMAN Chromodomain-helicase-DNA-binding protein 2 OS=Homo sapiens GN=CHD2 PE=1 SV=2 | 1574 | G | 0.969808 | A | 0.965641 | 0.004167 | No Change: Both D | - |
| Q12873 | CHD3_HUMAN Chromodomain-helicase-DNA-binding protein 3 OS=Homo sapiens GN=CHD3 PE=1 SV=3 | 3 | A | 0.603176 | V | 0.545366 | 0.05781 | No Change: Both D | - |
| Q14839 | CHD4_HUMAN Chromodomain-helicase-DNA-binding protein 4 OS=Homo sapiens GN=CHD4 PE=1 SV=2 | 139 | E | 0.995934 | D | 0.995663 | 2.71E-04 | No Change: Both D | - |
| Q14839 | CHD4_HUMAN Chromodomain-helicase-DNA-binding protein 4 OS=Homo sapiens GN=CHD4 PE=1 SV=2 | 1648 | S | 0.975406 | L | 0.967477 | 0.007929 | No Change: Both D | - |
| Q14839 | CHD4_HUMAN Chromodomain-helicase-DNA-binding protein 4 OS=Homo sapiens GN=CHD4 PE=1 SV=2 | 1655 | I | 0.975198 | V | 0.979661 | -0.004463 | No Change: Both D | - |
| Q8TDI0 | CHD5_HUMAN Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens GN=CHD5 PE=1 SV=1 | 45 | V | 0.981043 | M | 0.987251 | -0.006208 | No Change: Both D | A breast cancer sample |
| Q8TDI0 | CHD5_HUMAN Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens GN=CHD5 PE=1 SV=1 | 119 | D | 0.981195 | N | 0.975768 | 0.005427 | No Change: Both D | A breast cancer sample |
| Q8TDI0 | CHD5_HUMAN Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens GN=CHD5 PE=1 SV=1 | 667 | R | 0.898842 | G | 0.894225 | 0.004617 | No Change: Both D | A breast cancer sample |
| Q8TDI0 | CHD5_HUMAN Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens GN=CHD5 PE=1 SV=1 | 1253 | S | 0.744217 | I | 0.587499 | 0.156718 | No Change: Both D | - |
| Q8TDI0 | CHD5_HUMAN Chromodomain-helicase-DNA-binding protein 5 OS=Homo sapiens GN=CHD5 PE=1 SV=1 | 1539 | S | 0.880023 | P | 0.886724 | -0.006701 | No Change: Both D | - |
| Q8TD26 | CHD6_HUMAN Chromodomain-helicase-DNA-binding protein 6 OS=Homo sapiens GN=CHD6 PE=1 SV=4 | 2161 | H | 0.587654 | Q | 0.633421 | -0.045767 | No Change: Both D | - |
| Q8TD26 | CHD6_HUMAN Chromodomain-helicase-DNA-binding protein 6 OS=Homo sapiens GN=CHD6 PE=1 SV=4 | 780 | Q | 0.154133 | H | 0.129251 | 0.024882 | No Change: Both O | - |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1028 | I | 0.187617 | V | 0.208056 | -0.020439 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1257 | L | 0.237126 | R | 0.335453 | -0.098327 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1031 | W | 0.285239 | G | 0.517159 | -0.23192 | O to D | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1214 | Q | 0.261409 | R | 0.270707 | -0.009298 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1294 | L | 0.130614 | P | 0.230515 | -0.099901 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 1815 | L | 0.152487 | P | 0.275211 | -0.122724 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2096 | H | 0.20816 | R | 0.232889 | -0.024729 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2319 | R | 0.121006 | S | 0.1485 | -0.027494 | No Change: Both O | CHARGE syndrome (CHARGES) [MIM:214800] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2750 | F | 0.299131 | L | 0.379972 | -0.080841 | No Change: Both O | - |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 340 | M | 0.8493 | V | 0.798863 | 0.050437 | No Change: Both D | - |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 55 | H | 0.827152 | R | 0.810401 | 0.016751 | No Change: Both D | Kallmann syndrome type 5 (KAL5) [MIM:612370] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 834 | S | 0.302529 | F | 0.182545 | 0.119984 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2789 | A | 0.693863 | T | 0.694212 | -3.49E-04 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2880 | P | 0.803375 | L | 0.685597 | 0.117778 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q9P2D1 | CHD7_HUMAN Chromodomain-helicase-DNA-binding protein 7 OS=Homo sapiens GN=CHD7 PE=1 SV=3 | 2948 | K | 0.937784 | E | 0.944608 | -0.006824 | No Change: Both D | Kallmann syndrome type 5 (KAL5) [MIM:612370] |
| Q3L8U1 | CHD9_HUMAN Chromodomain-helicase-DNA-binding protein 9 OS=Homo sapiens GN=CHD9 PE=1 SV=2 | 2312 | D | 0.824827 | E | 0.835383 | -0.010556 | No Change: Both D | - |
| Q8NE62 | CHDH_HUMAN Choline dehydrogenase mitochondrial OS=Homo sapiens GN=CHDH PE=2 SV=2 | 40 | E | 0.648899 | A | 0.590658 | 0.058241 | No Change: Both D | - |
| Q8NE62 | CHDH_HUMAN Choline dehydrogenase mitochondrial OS=Homo sapiens GN=CHDH PE=2 SV=2 | 441 | N | 0.428535 | S | 0.478602 | -0.050067 | No Change: Both O | - |
| Q8NE62 | CHDH_HUMAN Choline dehydrogenase mitochondrial OS=Homo sapiens GN=CHDH PE=2 SV=2 | 78 | L | 0.440211 | R | 0.566489 | -0.126278 | O to D | - |
| O14757 | CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens GN=CHEK1 PE=1 SV=2 | 156 | R | 0.170801 | Q | 0.160785 | 0.010016 | No Change: Both O | - |
| O14757 | CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens GN=CHEK1 PE=1 SV=2 | 471 | I | 0.329573 | V | 0.364822 | -0.035249 | No Change: Both O | - |
| O14757 | CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens GN=CHEK1 PE=1 SV=2 | 223 | E | 0.502029 | V | 0.305976 | 0.196053 | D to O | - |
| O14757 | CHK1_HUMAN Serine/threonine-protein kinase Chk1 OS=Homo sapiens GN=CHEK1 PE=1 SV=2 | 312 | V | 0.882622 | M | 0.901062 | -0.01844 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 145 | R | 0.250947 | W | 0.102058 | 0.148889 | No Change: Both O | Li-Fraumeni syndrome 2 (LFS2) [MIM:609265] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 145 | R | 0.250947 | W | 0.102058 | 0.148889 | No Change: Both O | Colon cancer |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 157 | I | 0.262763 | T | 0.358682 | -0.095919 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 17 | A | 0.996938 | S | 0.998567 | -0.001629 | No Change: Both D | An osteogenic sarcoma sample |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 85 | P | 0.838089 | L | 0.783976 | 0.054113 | No Change: Both D | An osteogenic sarcoma sample |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 180 | R | 0.611327 | C | 0.442807 | 0.16852 | D to O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 181 | R | 0.609932 | C | 0.439159 | 0.170773 | D to O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 181 | R | 0.609932 | H | 0.603777 | 0.006155 | No Change: Both D | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 239 | E | 0.32605 | K | 0.351219 | -0.025169 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 64 | E | 0.990151 | K | 0.985795 | 0.004356 | No Change: Both D | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 145 | R | 0.250947 | P | 0.274854 | -0.023907 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 167 | G | 0.370194 | R | 0.359824 | 0.01037 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 180 | R | 0.611327 | H | 0.606002 | 0.005325 | No Change: Both D | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 251 | I | 0.330484 | F | 0.321276 | 0.009208 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 318 | R | 0.387148 | H | 0.390859 | -0.003711 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 323 | T | 0.17777 | P | 0.21524 | -0.03747 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 327 | Y | 0.047542 | C | 0.038094 | 0.009448 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 476 | T | 0.459857 | K | 0.534567 | -0.07471 | O to D | Prostate cancer (PC) [MIM:176807] |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 436 | L | 0.576107 | M | 0.645366 | -0.069259 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 446 | N | 0.157921 | K | 0.199209 | -0.041288 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 447 | F | 0.130458 | I | 0.140794 | -0.010336 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 448 | I | 0.131606 | S | 0.305705 | -0.174099 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 501 | E | 0.852473 | K | 0.84326 | 0.009213 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 512 | L | 0.899415 | V | 0.890191 | 0.009224 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 117 | R | 0.175127 | G | 0.192354 | -0.017227 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 137 | R | 0.536892 | Q | 0.541247 | -0.004355 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 428 | S | 0.514575 | F | 0.275399 | 0.239176 | D to O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 406 | R | 0.136583 | H | 0.138952 | -0.002369 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 59 | T | 0.996774 | K | 0.996249 | 5.25E-04 | No Change: Both D | Multiple cancers |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 347 | D | 0.352349 | N | 0.357531 | -0.005182 | No Change: Both O | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 500 | S | 0.838744 | C | 0.759376 | 0.079368 | No Change: Both D | - |
| O96017 | CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens GN=CHEK2 PE=1 SV=1 | 371 | H | 0.297207 | Y | 0.198898 | 0.098309 | No Change: Both O | - |
| Q8IWX8 | CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens GN=CHERP PE=1 SV=3 | 199 | N | 0.320191 | H | 0.318045 | 0.002146 | No Change: Both O | - |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 166 | P | 0.936793 | L | 0.872131 | 0.064662 | No Change: Both D | A patient with non small cell lung carcinomas |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 202 | R | 0.995545 | P | 0.996581 | -0.001036 | No Change: Both D | A patient with non small cell lung carcinomas |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 270 | G | 0.744529 | R | 0.776671 | -0.032142 | No Change: Both D | - |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 497 | A | 0.760362 | V | 0.717523 | 0.042839 | No Change: Both D | - |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 536 | F | 0.064946 | S | 0.165021 | -0.100075 | No Change: Both O | A patient with non small cell lung carcinomas |
| Q96EP1 | CHFR_HUMAN E3 ubiquitin-protein ligase CHFR OS=Homo sapiens GN=CHFR PE=1 SV=2 | 580 | V | 0.13982 | M | 0.181032 | -0.041212 | No Change: Both O | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 176 | E | 0.996258 | K | 0.995241 | 0.001017 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 264 | E | 0.866258 | D | 0.835176 | 0.031082 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 271 | R | 0.868448 | W | 0.749713 | 0.118735 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 274 | A | 0.879002 | G | 0.894071 | -0.015069 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 315 | G | 0.97273 | S | 0.977982 | -0.005252 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 332 | L | 0.96375 | P | 0.975359 | -0.011609 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 369 | D | 0.940655 | N | 0.935466 | 0.005189 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 382 | G | 0.881242 | S | 0.903873 | -0.022631 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 388 | P | 0.901678 | L | 0.840678 | 0.061 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 399 | R | 0.923624 | W | 0.839072 | 0.084552 | No Change: Both D | - |
| P10645 | CMGA_HUMAN Chromogranin-A OS=Homo sapiens GN=CHGA PE=1 SV=7 | 61 | R | 0.424315 | Q | 0.440389 | -0.016074 | No Change: Both O | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 178 | R | 0.990371 | Q | 0.991468 | -0.001097 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 417 | R | 0.963965 | H | 0.956814 | 0.007151 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 117 | K | 0.932875 | N | 0.913771 | 0.019104 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 243 | T | 0.998627 | A | 0.99849 | 1.37E-04 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 353 | A | 0.895078 | G | 0.915571 | -0.020493 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 145 | D | 0.943937 | N | 0.928401 | 0.015536 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 200 | N | 0.924436 | H | 0.921804 | 0.002632 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 232 | R | 0.993376 | Q | 0.993944 | -5.68E-04 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 413 | P | 0.971745 | L | 0.954691 | 0.017054 | No Change: Both D | - |
| P05060 | SCG1_HUMAN Secretogranin-1 OS=Homo sapiens GN=CHGB PE=1 SV=2 | 93 | S | 0.940979 | T | 0.927276 | 0.013703 | No Change: Both D | - |
| P36222 | CH3L1_HUMAN Chitinase-3-like protein 1 OS=Homo sapiens GN=CHI3L1 PE=1 SV=2 | 145 | R | 0.320457 | G | 0.328437 | -0.00798 | No Change: Both O | - |
| P36222 | CH3L1_HUMAN Chitinase-3-like protein 1 OS=Homo sapiens GN=CHI3L1 PE=1 SV=2 | 311 | I | 0.169356 | T | 0.301883 | -0.132527 | No Change: Both O | - |
| Q15782 | CH3L2_HUMAN Chitinase-3-like protein 2 OS=Homo sapiens GN=CHI3L2 PE=1 SV=1 | 184 | V | 0.258457 | I | 0.240089 | 0.018368 | No Change: Both O | - |
| Q15782 | CH3L2_HUMAN Chitinase-3-like protein 2 OS=Homo sapiens GN=CHI3L2 PE=1 SV=1 | 182 | A | 0.258632 | V | 0.19216 | 0.066472 | No Change: Both O | - |
| Q15782 | CH3L2_HUMAN Chitinase-3-like protein 2 OS=Homo sapiens GN=CHI3L2 PE=1 SV=1 | 318 | R | 0.290947 | W | 0.136033 | 0.154914 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 324 | V | 0.320564 | G | 0.483838 | -0.163274 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 102 | G | 0.137526 | R | 0.120264 | 0.017262 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 339 | I | 0.158346 | V | 0.180234 | -0.021888 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 354 | F | 0.189448 | S | 0.392848 | -0.2034 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 377 | F | 0.226689 | L | 0.255884 | -0.029195 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 432 | V | 0.511646 | G | 0.615115 | -0.103469 | No Change: Both D | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 45 | N | 0.21564 | D | 0.24797 | -0.03233 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 47 | D | 0.156306 | N | 0.146236 | 0.01007 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 61 | R | 0.249525 | M | 0.20146 | 0.048065 | No Change: Both O | - |
| Q9BZP6 | CHIA_HUMAN Acidic mammalian chitinase OS=Homo sapiens GN=CHIA PE=1 SV=1 | 125 | K | 0.085515 | R | 0.073383 | 0.012132 | No Change: Both O | - |
| Q9BWS9 | CHID1_HUMAN Chitinase domain-containing protein 1 OS=Homo sapiens GN=CHID1 PE=1 SV=1 | 331 | R | 0.366073 | Q | 0.385464 | -0.019391 | No Change: Both O | - |
| Q9BWS9 | CHID1_HUMAN Chitinase domain-containing protein 1 OS=Homo sapiens GN=CHID1 PE=1 SV=1 | 338 | A | 0.360985 | V | 0.314883 | 0.046102 | No Change: Both O | - |
| Q13231 | CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens GN=CHIT1 PE=1 SV=1 | 102 | G | 0.176282 | S | 0.196463 | -0.020181 | No Change: Both O | - |
| Q13231 | CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens GN=CHIT1 PE=1 SV=1 | 442 | A | 0.464443 | G | 0.519754 | -0.055311 | O to D | - |
| Q13231 | CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens GN=CHIT1 PE=1 SV=1 | 40 | R | 0.359319 | H | 0.346061 | 0.013258 | No Change: Both O | - |
| Q13231 | CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens GN=CHIT1 PE=1 SV=1 | 171 | Q | 0.563426 | H | 0.528585 | 0.034841 | No Change: Both D | - |
| Q13231 | CHIT1_HUMAN Chitotriosidase-1 OS=Homo sapiens GN=CHIT1 PE=1 SV=1 | 74 | E | 0.374707 | K | 0.353086 | 0.021621 | No Change: Both O | - |
| P35790 | CHKA_HUMAN Choline kinase alpha OS=Homo sapiens GN=CHKA PE=1 SV=3 | 220 | S | 0.5684 | G | 0.499248 | 0.069152 | D to O | - |
| P35790 | CHKA_HUMAN Choline kinase alpha OS=Homo sapiens GN=CHKA PE=1 SV=3 | 422 | L | 0.033787 | Q | 0.066256 | -0.032469 | No Change: Both O | - |
| O00533 | CHL1_HUMAN Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1 PE=1 SV=4 | 17 | L | 0.026885 | F | 0.022744 | 0.004141 | No Change: Both O | - |
| O00533 | CHL1_HUMAN Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1 PE=1 SV=4 | 287 | T | 0.72319 | A | 0.697104 | 0.026086 | No Change: Both D | - |
| O00533 | CHL1_HUMAN Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1 PE=1 SV=4 | 1034 | I | 0.386089 | V | 0.424607 | -0.038518 | No Change: Both O | - |
| O00533 | CHL1_HUMAN Neural cell adhesion molecule L1-like protein OS=Homo sapiens GN=CHL1 PE=1 SV=4 | 411 | L | 0.181577 | I | 0.176387 | 0.00519 | No Change: Both O | A colorectal cancer sample |
| P24386 | RAE1_HUMAN Rab proteins geranylgeranyltransferase component A 1 OS=Homo sapiens GN=CHM PE=1 SV=3 | 471 | Q | 0.399817 | L | 0.280218 | 0.119599 | No Change: Both O | Choroideremia (CHM) [MIM:303100] |
| P24386 | RAE1_HUMAN Rab proteins geranylgeranyltransferase component A 1 OS=Homo sapiens GN=CHM PE=1 SV=3 | 507 | H | 0.212879 | R | 0.257655 | -0.044776 | No Change: Both O | Choroideremia (CHM) [MIM:303100] |
| P24386 | RAE1_HUMAN Rab proteins geranylgeranyltransferase component A 1 OS=Homo sapiens GN=CHM PE=1 SV=3 | 550 | L | 0.074657 | P | 0.153739 | -0.079082 | No Change: Both O | Choroideremia (CHM) [MIM:303100] |
| Q9UQN3 | CHM2B_HUMAN Charged multivesicular body protein 2b OS=Homo sapiens GN=CHMP2B PE=1 SV=1 | 148 | D | 0.874607 | Y | 0.738941 | 0.135666 | No Change: Both D | Frontotemporal dementia chromosome 3-linked (FTD3) [MIM:600795] |
| Q9UQN3 | CHM2B_HUMAN Charged multivesicular body protein 2b OS=Homo sapiens GN=CHMP2B PE=1 SV=1 | 29 | I | 0.706441 | V | 0.705213 | 0.001228 | No Change: Both D | - |
| Q9UQN3 | CHM2B_HUMAN Charged multivesicular body protein 2b OS=Homo sapiens GN=CHMP2B PE=1 SV=1 | 206 | Q | 0.819878 | H | 0.782183 | 0.037695 | No Change: Both D | - |
| Q9BY43 | CHM4A_HUMAN Charged multivesicular body protein 4a OS=Homo sapiens GN=CHMP4A PE=1 SV=3 | 153 | G | 0.834656 | R | 0.849308 | -0.014652 | No Change: Both D | - |
| Q9H444 | CHM4B_HUMAN Charged multivesicular body protein 4b OS=Homo sapiens GN=CHMP4B PE=1 SV=1 | 129 | D | 0.590162 | V | 0.399023 | 0.191139 | D to O | Cataract posterior polar type 3 (CTPP3) [MIM:605387] |
| Q9H444 | CHM4B_HUMAN Charged multivesicular body protein 4b OS=Homo sapiens GN=CHMP4B PE=1 SV=1 | 161 | E | 0.851955 | K | 0.821421 | 0.030534 | No Change: Both D | Cataract posterior polar type 3 (CTPP3) [MIM:605387] |
| Q96CF2 | CHM4C_HUMAN Charged multivesicular body protein 4c OS=Homo sapiens GN=CHMP4C PE=1 SV=1 | 232 | A | 0.928052 | T | 0.927432 | 6.20E-04 | No Change: Both D | - |
| Q9NZZ3 | CHMP5_HUMAN Charged multivesicular body protein 5 OS=Homo sapiens GN=CHMP5 PE=1 SV=1 | 86 | S | 0.715844 | P | 0.699638 | 0.016206 | No Change: Both D | - |
| Q96FZ7 | CHMP6_HUMAN Charged multivesicular body protein 6 OS=Homo sapiens GN=CHMP6 PE=1 SV=3 | 55 | G | 0.944543 | S | 0.961088 | -0.016545 | No Change: Both D | - |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 20 | L | 0.186054 | F | 0.158198 | 0.027856 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 126 | I | 0.123231 | M | 0.168464 | -0.045233 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 143 | Y | 0.183255 | H | 0.275211 | -0.091956 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 223 | A | 0.027622 | V | 0.018926 | 0.008696 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 228 | G | 0.032324 | S | 0.038305 | -0.005981 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 252 | P | 0.518133 | Q | 0.495015 | 0.023118 | D to O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P15882 | CHIN_HUMAN N-chimaerin OS=Homo sapiens GN=CHN1 PE=1 SV=3 | 313 | E | 0.288888 | K | 0.298084 | -0.009196 | No Change: Both O | Duane retraction syndrome type 2 (DURS2) [MIM:604356] |
| P52757 | CHIO_HUMAN Beta-chimaerin OS=Homo sapiens GN=CHN2 PE=1 SV=2 | 204 | H | 0.409913 | R | 0.417164 | -0.007251 | No Change: Both O | - |
| P52757 | CHIO_HUMAN Beta-chimaerin OS=Homo sapiens GN=CHN2 PE=1 SV=2 | 438 | P | 0.556484 | S | 0.577785 | -0.021301 | No Change: Both D | - |
| Q9UHD1 | CHRD1_HUMAN Cysteine and histidine-rich domain-containing protein 1 OS=Homo sapiens GN=CHORDC1 PE=1 SV=2 | 329 | A | 0.952997 | D | 0.959435 | -0.006438 | No Change: Both D | - |
| O43745 | CHP2_HUMAN Calcineurin B homologous protein 2 OS=Homo sapiens GN=CHP2 PE=1 SV=3 | 127 | R | 0.425198 | P | 0.434024 | -0.008826 | No Change: Both O | - |
| Q8IZ52 | CHSS2_HUMAN Chondroitin sulfate synthase 2 OS=Homo sapiens GN=CHPF PE=1 SV=2 | 371 | Q | 0.306324 | R | 0.290371 | 0.015953 | No Change: Both O | - |
| Q8WUD6 | CHPT1_HUMAN Cholinephosphotransferase 1 OS=Homo sapiens GN=CHPT1 PE=1 SV=1 | 162 | F | 0.012975 | S | 0.035613 | -0.022638 | No Change: Both O | - |
| Q8WUD6 | CHPT1_HUMAN Cholinephosphotransferase 1 OS=Homo sapiens GN=CHPT1 PE=1 SV=1 | 323 | Y | 0.257621 | S | 0.473227 | -0.215606 | No Change: Both O | - |
| Q9NRG0 | CHRC1_HUMAN Chromatin accessibility complex protein 1 OS=Homo sapiens GN=CHRAC1 PE=1 SV=1 | 55 | C | 0.110517 | Y | 0.125168 | -0.014651 | No Change: Both O | - |
| Q9NRG0 | CHRC1_HUMAN Chromatin accessibility complex protein 1 OS=Homo sapiens GN=CHRAC1 PE=1 SV=1 | 126 | H | 0.99446 | R | 0.996151 | -0.001691 | No Change: Both D | - |
| Q9H2X0 | CHRD_HUMAN Chordin OS=Homo sapiens GN=CHRD PE=1 SV=2 | 630 | M | 0.397689 | L | 0.334153 | 0.063536 | No Change: Both O | - |
| Q9H2X0 | CHRD_HUMAN Chordin OS=Homo sapiens GN=CHRD PE=1 SV=2 | 94 | P | 0.7135 | S | 0.692932 | 0.020568 | No Change: Both D | - |
| Q6WN34 | CRDL2_HUMAN Chordin-like protein 2 OS=Homo sapiens GN=CHRDL2 PE=1 SV=1 | 335 | P | 0.740973 | L | 0.602879 | 0.138094 | No Change: Both D | - |
| P20309 | ACM3_HUMAN Muscarinic acetylcholine receptor M3 OS=Homo sapiens GN=CHRM3 PE=1 SV=1 | 65 | V | 0.064708 | I | 0.053152 | 0.011556 | No Change: Both O | - |
| P20309 | ACM3_HUMAN Muscarinic acetylcholine receptor M3 OS=Homo sapiens GN=CHRM3 PE=1 SV=1 | 431 | L | 0.790431 | P | 0.872585 | -0.082154 | No Change: Both D | - |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 198 | G | 0.159504 | S | 0.203501 | -0.043997 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 201 | V | 0.254973 | M | 0.301867 | -0.046894 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 262 | N | 0.010638 | K | 0.013068 | -0.00243 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 299 | T | 0.035643 | I | 0.019695 | 0.015948 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 314 | S | 0.338382 | I | 0.14901 | 0.189372 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 278 | F | 0.083632 | V | 0.097402 | -0.01377 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 294 | V | 0.127583 | F | 0.110458 | 0.017125 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 301 | F | 0.021547 | L | 0.028943 | -0.007396 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 330 | V | 0.014496 | I | 0.013102 | 0.001394 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 177 | V | 0.052846 | L | 0.052355 | 4.91E-04 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 383 | D | 0.796571 | V | 0.703655 | 0.092916 | No Change: Both D | - |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 463 | C | 0.008812 | W | 0.007323 | 0.001489 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P02708 | ACHA_HUMAN Acetylcholine receptor subunit alpha OS=Homo sapiens GN=CHRNA1 PE=1 SV=2 | 254 | R | 0.049024 | L | 0.02972 | 0.019304 | No Change: Both O | Multiple pterygium syndrome lethal type (MUPSL) [MIM:253290] |
| Q9GZZ6 | ACH10_HUMAN Neuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens GN=CHRNA10 PE=1 SV=1 | 355 | E | 0.88494 | A | 0.869528 | 0.015412 | No Change: Both D | - |
| Q15822 | ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens GN=CHRNA2 PE=1 SV=2 | 22 | T | 0.594796 | I | 0.471412 | 0.123384 | D to O | - |
| Q15822 | ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens GN=CHRNA2 PE=1 SV=2 | 125 | T | 0.221278 | A | 0.188336 | 0.032942 | No Change: Both O | - |
| Q15822 | ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens GN=CHRNA2 PE=1 SV=2 | 279 | I | 0.01124 | N | 0.025265 | -0.014025 | No Change: Both O | Nocturnal frontal lobe epilepsy type 4 (ENFL4) [MIM:610353] |
| P32297 | ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens GN=CHRNA3 PE=1 SV=4 | 37 | R | 0.426618 | H | 0.413554 | 0.013064 | No Change: Both O | - |
| P43681 | ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens GN=CHRNA4 PE=1 SV=2 | 280 | S | 0.038419 | F | 0.012541 | 0.025878 | No Change: Both O | Nocturnal frontal lobe epilepsy type 1 (ENFL1) [MIM:600513] |
| P43681 | ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens GN=CHRNA4 PE=1 SV=2 | 280 | S | 0.038419 | L | 0.016331 | 0.022088 | No Change: Both O | Nocturnal frontal lobe epilepsy type 1 (ENFL1) [MIM:600513] |
| P43681 | ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens GN=CHRNA4 PE=1 SV=2 | 387 | E | 0.877811 | G | 0.848086 | 0.029725 | No Change: Both D | - |
| P43681 | ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens GN=CHRNA4 PE=1 SV=2 | 517 | S | 0.949035 | L | 0.912102 | 0.036933 | No Change: Both D | - |
| P30532 | ACHA5_HUMAN Neuronal acetylcholine receptor subunit alpha-5 OS=Homo sapiens GN=CHRNA5 PE=2 SV=2 | 134 | V | 0.096988 | I | 0.085243 | 0.011745 | No Change: Both O | - |
| P30532 | ACHA5_HUMAN Neuronal acetylcholine receptor subunit alpha-5 OS=Homo sapiens GN=CHRNA5 PE=2 SV=2 | 398 | D | 0.287961 | N | 0.27754 | 0.010421 | No Change: Both O | - |
| Q15825 | ACHA6_HUMAN Neuronal acetylcholine receptor subunit alpha-6 OS=Homo sapiens GN=CHRNA6 PE=1 SV=1 | 447 | N | 0.76984 | S | 0.795622 | -0.025782 | No Change: Both D | - |
| Q9UGM1 | ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens GN=CHRNA9 PE=1 SV=2 | 442 | N | 0.763648 | S | 0.802553 | -0.038905 | No Change: Both D | - |
| Q9UGM1 | ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens GN=CHRNA9 PE=1 SV=2 | 96 | R | 0.271745 | Q | 0.305409 | -0.033664 | No Change: Both O | - |
| Q9UGM1 | ACHA9_HUMAN Neuronal acetylcholine receptor subunit alpha-9 OS=Homo sapiens GN=CHRNA9 PE=1 SV=2 | 315 | A | 0.132797 | V | 0.092361 | 0.040436 | No Change: Both O | - |
| P11230 | ACHB_HUMAN Acetylcholine receptor subunit beta OS=Homo sapiens GN=CHRNB1 PE=1 SV=3 | 285 | L | 0.026116 | M | 0.032363 | -0.006247 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P11230 | ACHB_HUMAN Acetylcholine receptor subunit beta OS=Homo sapiens GN=CHRNB1 PE=1 SV=3 | 289 | V | 0.020985 | M | 0.028405 | -0.00742 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| P11230 | ACHB_HUMAN Acetylcholine receptor subunit beta OS=Homo sapiens GN=CHRNB1 PE=1 SV=3 | 32 | E | 0.649887 | G | 0.608343 | 0.041544 | No Change: Both D | - |
| P17787 | ACHB2_HUMAN Neuronal acetylcholine receptor subunit beta-2 OS=Homo sapiens GN=CHRNB2 PE=1 SV=1 | 287 | V | 0.207494 | L | 0.216246 | -0.008752 | No Change: Both O | Nocturnal frontal lobe epilepsy type 3 (ENFL3) [MIM:605375] |
| P17787 | ACHB2_HUMAN Neuronal acetylcholine receptor subunit beta-2 OS=Homo sapiens GN=CHRNB2 PE=1 SV=1 | 287 | V | 0.207494 | M | 0.247302 | -0.039808 | No Change: Both O | Nocturnal frontal lobe epilepsy type 3 (ENFL3) [MIM:605375] |
| P17787 | ACHB2_HUMAN Neuronal acetylcholine receptor subunit beta-2 OS=Homo sapiens GN=CHRNB2 PE=1 SV=1 | 397 | Q | 0.635269 | H | 0.582671 | 0.052598 | No Change: Both D | - |
| Q05901 | ACHB3_HUMAN Neuronal acetylcholine receptor subunit beta-3 OS=Homo sapiens GN=CHRNB3 PE=2 SV=2 | 451 | K | 0.152988 | E | 0.154419 | -0.001431 | No Change: Both O | - |
| P30926 | ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 OS=Homo sapiens GN=CHRNB4 PE=1 SV=2 | 136 | R | 0.171435 | W | 0.073807 | 0.097628 | No Change: Both O | - |
| P30926 | ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 OS=Homo sapiens GN=CHRNB4 PE=1 SV=2 | 140 | S | 0.151076 | G | 0.121216 | 0.02986 | No Change: Both O | - |
| P30926 | ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 OS=Homo sapiens GN=CHRNB4 PE=1 SV=2 | 467 | M | 0.004696 | V | 0.003887 | 8.09E-04 | No Change: Both O | - |
| P30926 | ACHB4_HUMAN Neuronal acetylcholine receptor subunit beta-4 OS=Homo sapiens GN=CHRNB4 PE=1 SV=2 | 91 | T | 0.228449 | I | 0.122162 | 0.106287 | No Change: Both O | - |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 289 | S | 0.05708 | F | 0.019648 | 0.037432 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 80 | E | 0.128107 | K | 0.127857 | 2.50E-04 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 271 | P | 0.222917 | Q | 0.209378 | 0.013539 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 288 | Q | 0.064421 | E | 0.079534 | -0.015113 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 398 | D | 0.754764 | E | 0.813435 | -0.058671 | No Change: Both D | A breast cancer sample |
| Q07001 | ACHD_HUMAN Acetylcholine receptor subunit delta OS=Homo sapiens GN=CHRND PE=1 SV=1 | 95 | F | 0.205877 | L | 0.24504 | -0.039163 | No Change: Both O | Multiple pterygium syndrome lethal type (MUPSL) [MIM:253290] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 141 | P | 0.113387 | L | 0.05422 | 0.059167 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 167 | R | 0.157203 | L | 0.098717 | 0.058486 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 265 | P | 0.132424 | L | 0.07207 | 0.060354 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 284 | T | 0.024673 | P | 0.031867 | -0.007194 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 289 | L | 0.040599 | F | 0.03635 | 0.004249 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 331 | R | 0.43884 | W | 0.260671 | 0.178169 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 98 | L | 0.222641 | P | 0.383749 | -0.161108 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 241 | L | 0.04665 | F | 0.041676 | 0.004974 | No Change: Both O | Congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 13 | G | 0.144087 | R | 0.154094 | -0.010007 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 163 | S | 0.076524 | L | 0.031106 | 0.045418 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 431 | A | 0.338952 | P | 0.397464 | -0.058512 | No Change: Both O | Congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930] |
| Q04844 | ACHE_HUMAN Acetylcholine receptor subunit epsilon OS=Homo sapiens GN=CHRNE PE=1 SV=2 | 18 | G | 0.36506 | V | 0.243453 | 0.121607 | No Change: Both O | - |
| P07510 | ACHG_HUMAN Acetylcholine receptor subunit gamma OS=Homo sapiens GN=CHRNG PE=1 SV=2 | 107 | V | 0.102578 | G | 0.167515 | -0.064937 | No Change: Both O | Multiple pterygium syndrome Escobar variant (MUPSE) [MIM:265000] |
| P07510 | ACHG_HUMAN Acetylcholine receptor subunit gamma OS=Homo sapiens GN=CHRNG PE=1 SV=2 | 107 | V | 0.102578 | G | 0.167515 | -0.064937 | No Change: Both O | Multiple pterygium syndrome lethal type (MUPSL) [MIM:253290] |
| P07510 | ACHG_HUMAN Acetylcholine receptor subunit gamma OS=Homo sapiens GN=CHRNG PE=1 SV=2 | 149 | A | 0.129044 | T | 0.14489 | -0.015846 | No Change: Both O | - |
| P07510 | ACHG_HUMAN Acetylcholine receptor subunit gamma OS=Homo sapiens GN=CHRNG PE=1 SV=2 | 239 | R | 0.046914 | C | 0.021448 | 0.025466 | No Change: Both O | Multiple pterygium syndrome Escobar variant (MUPSE) [MIM:265000] |
| P07510 | ACHG_HUMAN Acetylcholine receptor subunit gamma OS=Homo sapiens GN=CHRNG PE=1 SV=2 | 239 | R | 0.046914 | C | 0.021448 | 0.025466 | No Change: Both O | Multiple pterygium syndrome lethal type (MUPSL) [MIM:253290] |
| O43529 | CHSTA_HUMAN Carbohydrate sulfotransferase 10 OS=Homo sapiens GN=CHST10 PE=1 SV=1 | 258 | D | 0.065531 | N | 0.056808 | 0.008723 | No Change: Both O | - |
| O43529 | CHSTA_HUMAN Carbohydrate sulfotransferase 10 OS=Homo sapiens GN=CHST10 PE=1 SV=1 | 20 | V | 0.030645 | L | 0.030898 | -2.53E-04 | No Change: Both O | - |
| Q9NRB3 | CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens GN=CHST12 PE=1 SV=2 | 52 | P | 0.810241 | H | 0.779521 | 0.03072 | No Change: Both D | - |
| Q9NRB3 | CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens GN=CHST12 PE=1 SV=2 | 61 | T | 0.886605 | S | 0.911892 | -0.025287 | No Change: Both D | - |
| Q9NRB3 | CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens GN=CHST12 PE=1 SV=2 | 109 | R | 0.944325 | S | 0.947221 | -0.002896 | No Change: Both D | - |
| Q9NRB3 | CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens GN=CHST12 PE=1 SV=2 | 145 | A | 0.436854 | P | 0.521083 | -0.084229 | O to D | - |
| Q9NRB3 | CHSTC_HUMAN Carbohydrate sulfotransferase 12 OS=Homo sapiens GN=CHST12 PE=1 SV=2 | 94 | P | 0.937177 | L | 0.894598 | 0.042579 | No Change: Both D | - |
| Q8NET6 | CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens GN=CHST13 PE=2 SV=1 | 271 | A | 0.272284 | V | 0.210567 | 0.061717 | No Change: Both O | - |
| Q8NET6 | CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens GN=CHST13 PE=2 SV=1 | 317 | R | 0.273553 | Q | 0.254924 | 0.018629 | No Change: Both O | - |
| Q8NET6 | CHSTD_HUMAN Carbohydrate sulfotransferase 13 OS=Homo sapiens GN=CHST13 PE=2 SV=1 | 146 | P | 0.597792 | S | 0.618177 | -0.020385 | No Change: Both D | - |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 135 | R | 0.242545 | G | 0.237707 | 0.004838 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 137 | L | 0.199089 | Q | 0.310628 | -0.111539 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 213 | R | 0.165931 | P | 0.184929 | -0.018998 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 293 | Y | 0.097081 | C | 0.088599 | 0.008482 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 281 | P | 0.132617 | L | 0.066367 | 0.06625 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q8NCH0 | CHSTE_HUMAN Carbohydrate sulfotransferase 14 OS=Homo sapiens GN=CHST14 PE=1 SV=2 | 289 | C | 0.085925 | S | 0.200431 | -0.114506 | No Change: Both O | Ehlers-Danlos syndrome musculocontractural type (EDSMC) [MIM:601776] |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 304 | R | 0.258464 | Q | 0.264286 | -0.005822 | No Change: Both O | Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDC-JD) [MIM:143095] |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 348 | I | 0.413965 | M | 0.55215 | -0.138185 | O to D | - |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 357 | R | 0.393251 | Q | 0.380852 | 0.012399 | No Change: Both O | - |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 222 | R | 0.44991 | W | 0.231029 | 0.218881 | No Change: Both O | Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDC-JD) [MIM:143095] |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 259 | L | 0.298367 | P | 0.465306 | -0.166939 | No Change: Both O | Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDC-JD) [MIM:143095] |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 307 | L | 0.233771 | P | 0.37296 | -0.139189 | No Change: Both O | Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDC-JD) [MIM:143095] |
| Q7LGC8 | CHST3_HUMAN Carbohydrate sulfotransferase 3 OS=Homo sapiens GN=CHST3 PE=1 SV=3 | 372 | E | 0.246135 | K | 0.245185 | 9.50E-04 | No Change: Both O | Spondyloepiphyseal dysplasia with congenital joint dislocations (SEDC-JD) [MIM:143095] |
| Q8NCG5 | CHST4_HUMAN Carbohydrate sulfotransferase 4 OS=Homo sapiens GN=CHST4 PE=1 SV=2 | 361 | H | 0.359745 | Q | 0.400464 | -0.040719 | No Change: Both O | - |
| Q9GZS9 | CHST5_HUMAN Carbohydrate sulfotransferase 5 OS=Homo sapiens GN=CHST5 PE=2 SV=3 | 318 | T | 0.153187 | M | 0.11697 | 0.036217 | No Change: Both O | - |
| Q9GZS9 | CHST5_HUMAN Carbohydrate sulfotransferase 5 OS=Homo sapiens GN=CHST5 PE=2 SV=3 | 311 | A | 0.084659 | T | 0.098414 | -0.013755 | No Change: Both O | - |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 15 | L | 0.115879 | P | 0.213187 | -0.097308 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 22 | L | 0.104446 | R | 0.167595 | -0.063149 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 31 | P | 0.676653 | S | 0.694816 | -0.018163 | No Change: Both D | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 42 | H | 0.236888 | Y | 0.151053 | 0.085835 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 50 | R | 0.426808 | C | 0.253352 | 0.173456 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 51 | S | 0.43574 | L | 0.237201 | 0.198539 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 52 | G | 0.449721 | D | 0.459423 | -0.009702 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 53 | S | 0.433738 | L | 0.242448 | 0.19129 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 59 | L | 0.309505 | P | 0.453546 | -0.144041 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 61 | N | 0.206345 | T | 0.182877 | 0.023468 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 66 | V | 0.14352 | L | 0.153937 | -0.010417 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 68 | Y | 0.102221 | H | 0.18137 | -0.079149 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 70 | M | 0.095013 | L | 0.076313 | 0.0187 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 72 | P | 0.064193 | S | 0.071379 | -0.007186 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 76 | V | 0.093824 | M | 0.128129 | -0.034305 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 93 | R | 0.173655 | H | 0.175989 | -0.002334 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 97 | R | 0.091397 | P | 0.101292 | -0.009895 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 98 | S | 0.083113 | W | 0.023374 | 0.059739 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 102 | C | 0.061252 | G | 0.132023 | -0.070771 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 102 | C | 0.061252 | Y | 0.077178 | -0.015926 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 104 | M | 0.062143 | V | 0.051032 | 0.011111 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 107 | F | 0.068421 | S | 0.162097 | -0.093676 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 110 | Y | 0.099291 | C | 0.121211 | -0.02192 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 121 | F | 0.152966 | L | 0.183229 | -0.030263 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 122 | Q | 0.143681 | P | 0.184005 | -0.040324 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 127 | R | 0.22187 | C | 0.156417 | 0.065453 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 128 | A | 0.225766 | V | 0.162922 | 0.062844 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 131 | S | 0.354176 | P | 0.337588 | 0.016588 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 152 | L | 0.328815 | P | 0.491534 | -0.162719 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 162 | R | 0.354905 | G | 0.334346 | 0.020559 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 166 | R | 0.267438 | P | 0.285493 | -0.018055 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 174 | K | 0.164386 | R | 0.143484 | 0.020902 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 177 | R | 0.102455 | H | 0.105547 | -0.003092 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 198 | V | 0.115506 | E | 0.230328 | -0.114822 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 200 | L | 0.132241 | R | 0.221574 | -0.089333 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 202 | R | 0.218389 | S | 0.257563 | -0.039174 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 203 | D | 0.281101 | E | 0.308414 | -0.027313 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 204 | P | 0.342932 | Q | 0.327646 | 0.015286 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 205 | R | 0.377079 | L | 0.245076 | 0.132003 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 205 | R | 0.377079 | Q | 0.375497 | 0.001582 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 206 | A | 0.397098 | T | 0.431286 | -0.034188 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 206 | A | 0.397098 | V | 0.329736 | 0.067362 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 210 | S | 0.497245 | F | 0.282384 | 0.214861 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 211 | R | 0.545172 | Q | 0.549629 | -0.004457 | No Change: Both D | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 211 | R | 0.545172 | W | 0.304403 | 0.240769 | D to O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 217 | A | 0.417021 | T | 0.437818 | -0.020797 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 221 | D | 0.272594 | E | 0.297399 | -0.024805 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 221 | D | 0.272594 | Y | 0.150606 | 0.121988 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 249 | H | 0.236793 | P | 0.302543 | -0.06575 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 268 | Y | 0.23191 | C | 0.241324 | -0.009414 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 274 | E | 0.286509 | K | 0.267056 | 0.019453 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 276 | L | 0.298092 | P | 0.462811 | -0.164719 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 358 | Y | 0.180762 | D | 0.310098 | -0.129336 | No Change: Both O | Macular corneal dystrophy (MCD) [MIM:217800] |
| Q9GZX3 | CHST6_HUMAN Carbohydrate sulfotransferase 6 OS=Homo sapiens GN=CHST6 PE=1 SV=1 | 369 | N | 0.353608 | D | 0.391902 | -0.038294 | No Change: Both O | - |
| Q9H2A9 | CHST8_HUMAN Carbohydrate sulfotransferase 8 OS=Homo sapiens GN=CHST8 PE=1 SV=2 | 247 | R | 0.19789 | H | 0.197554 | 3.36E-04 | No Change: Both O | A colorectal cancer sample |
| Q7L1S5 | CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens GN=CHST9 PE=2 SV=2 | 122 | S | 0.857384 | N | 0.830992 | 0.026392 | No Change: Both D | - |
| Q86X52 | CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens GN=CHSY1 PE=1 SV=3 | 359 | P | 0.31032 | S | 0.331976 | -0.021656 | No Change: Both O | - |
| Q86X52 | CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens GN=CHSY1 PE=1 SV=3 | 652 | Q | 0.071698 | H | 0.061937 | 0.009761 | No Change: Both O | - |
| Q86X52 | CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens GN=CHSY1 PE=1 SV=3 | 539 | P | 0.269318 | R | 0.236148 | 0.03317 | No Change: Both O | Temtamy preaxial brachydactyly syndrome (TPBS) [MIM:605282] |
| Q70JA7 | CHSS3_HUMAN Chondroitin sulfate synthase 3 OS=Homo sapiens GN=CHSY3 PE=1 SV=3 | 764 | D | 0.369511 | G | 0.345381 | 0.02413 | No Change: Both O | - |
| Q70JA7 | CHSS3_HUMAN Chondroitin sulfate synthase 3 OS=Homo sapiens GN=CHSY3 PE=1 SV=3 | 615 | G | 0.624113 | E | 0.634966 | -0.010853 | No Change: Both D | - |
| Q8WVB6 | CTF18_HUMAN Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens GN=CHTF18 PE=1 SV=1 | 63 | S | 0.958491 | F | 0.918298 | 0.040193 | No Change: Both D | - |
| Q8WVB6 | CTF18_HUMAN Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens GN=CHTF18 PE=1 SV=1 | 82 | Q | 0.901972 | P | 0.914211 | -0.012239 | No Change: Both D | - |
| Q8WVB6 | CTF18_HUMAN Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens GN=CHTF18 PE=1 SV=1 | 244 | K | 0.916263 | R | 0.918552 | -0.002289 | No Change: Both D | - |
| Q8WVB6 | CTF18_HUMAN Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens GN=CHTF18 PE=1 SV=1 | 466 | A | 0.766523 | S | 0.824761 | -0.058238 | No Change: Both D | - |
| Q8WVB6 | CTF18_HUMAN Chromosome transmission fidelity protein 18 homolog OS=Homo sapiens GN=CHTF18 PE=1 SV=1 | 928 | P | 0.740535 | L | 0.559957 | 0.180578 | No Change: Both D | - |
| O15111 | IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens GN=CHUK PE=1 SV=2 | 268 | V | 0.390026 | I | 0.335012 | 0.055014 | No Change: Both O | - |
| O15111 | IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens GN=CHUK PE=1 SV=2 | 126 | S | 0.351965 | C | 0.184635 | 0.16733 | No Change: Both O | - |
| O15111 | IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens GN=CHUK PE=1 SV=2 | 155 | V | 0.183872 | A | 0.236913 | -0.053041 | No Change: Both O | - |
| Q6FI81 | CPIN1_HUMAN Anamorsin OS=Homo sapiens GN=CIAPIN1 PE=1 SV=2 | 34 | A | 0.325396 | E | 0.455965 | -0.130569 | No Change: Both O | - |
| Q6FI81 | CPIN1_HUMAN Anamorsin OS=Homo sapiens GN=CIAPIN1 PE=1 SV=2 | 52 | Q | 0.494638 | E | 0.534892 | -0.040254 | O to D | - |
| Q99828 | CIB1_HUMAN Calcium and integrin-binding protein 1 OS=Homo sapiens GN=CIB1 PE=1 SV=4 | 44 | S | 0.708994 | T | 0.629653 | 0.079341 | No Change: Both D | - |
| Q99828 | CIB1_HUMAN Calcium and integrin-binding protein 1 OS=Homo sapiens GN=CIB1 PE=1 SV=4 | 106 | I | 0.420203 | T | 0.544163 | -0.12396 | O to D | - |
| Q96Q77 | CIB3_HUMAN Calcium and integrin-binding family member 3 OS=Homo sapiens GN=CIB3 PE=2 SV=3 | 139 | G | 0.490465 | E | 0.552019 | -0.061554 | O to D | - |
| A0PJX0 | CIB4_HUMAN Calcium and integrin-binding family member 4 OS=Homo sapiens GN=CIB4 PE=2 SV=1 | 181 | H | 0.249865 | R | 0.288149 | -0.038284 | No Change: Both O | - |
| Q96RK0 | CIC_HUMAN Protein capicua homolog OS=Homo sapiens GN=CIC PE=1 SV=2 | 982 | S | 0.949541 | G | 0.93422 | 0.015321 | No Change: Both D | - |
| Q96RK0 | CIC_HUMAN Protein capicua homolog OS=Homo sapiens GN=CIC PE=1 SV=2 | 104 | E | 0.997231 | K | 0.996581 | 6.50E-04 | No Change: Both D | A breast cancer sample |
| Q96RK0 | CIC_HUMAN Protein capicua homolog OS=Homo sapiens GN=CIC PE=1 SV=2 | 652 | A | 0.863359 | T | 0.861211 | 0.002148 | No Change: Both D | A breast cancer sample |
| Q96RK0 | CIC_HUMAN Protein capicua homolog OS=Homo sapiens GN=CIC PE=1 SV=2 | 492 | R | 0.937449 | W | 0.858102 | 0.079347 | No Change: Both D | - |
| O60543 | CIDEA_HUMAN Cell death activator CIDE-A OS=Homo sapiens GN=CIDEA PE=1 SV=1 | 115 | V | 0.53549 | F | 0.507529 | 0.027961 | No Change: Both D | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 500 | G | 0.226121 | A | 0.200677 | 0.025444 | No Change: Both O | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 469 | L | 0.183419 | P | 0.316469 | -0.13305 | No Change: Both O | Bare lymphocyte syndrome type 2 (BLS2) [MIM:209920] |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 658 | A | 0.389223 | G | 0.425404 | -0.036181 | No Change: Both O | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 962 | F | 0.426839 | S | 0.616613 | -0.189774 | O to D | Bare lymphocyte syndrome type 2 (BLS2) [MIM:209920] |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 45 | L | 0.291918 | V | 0.220668 | 0.07125 | No Change: Both O | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 174 | R | 0.596755 | G | 0.587056 | 0.009699 | No Change: Both D | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 900 | Q | 0.374984 | R | 0.341239 | 0.033745 | No Change: Both O | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 782 | V | 0.536767 | A | 0.619543 | -0.082776 | No Change: Both D | - |
| P33076 | C2TA_HUMAN MHC class II transactivator OS=Homo sapiens GN=CIITA PE=1 SV=3 | 781 | S | 0.509392 | L | 0.352657 | 0.156735 | D to O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 59 | W | 0.125306 | L | 0.167095 | -0.041789 | No Change: Both O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 327 | S | 0.304612 | F | 0.13719 | 0.167422 | No Change: Both O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 395 | I | 0.172441 | T | 0.271892 | -0.099451 | No Change: Both O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 575 | K | 0.451197 | E | 0.454773 | -0.003576 | No Change: Both O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 895 | A | 0.513369 | V | 0.389527 | 0.123842 | D to O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 979 | Q | 0.443525 | R | 0.452003 | -0.008478 | No Change: Both O | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 1101 | D | 0.599545 | N | 0.578821 | 0.020724 | No Change: Both D | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 1166 | G | 0.930931 | S | 0.943857 | -0.012926 | No Change: Both D | - |
| O75339 | CILP1_HUMAN Cartilage intermediate layer protein 1 OS=Homo sapiens GN=CILP PE=1 SV=4 | 1168 | V | 0.908637 | A | 0.931182 | -0.022545 | No Change: Both D | - |
| Q9BW66 | CINP_HUMAN Cyclin-dependent kinase 2-interacting protein OS=Homo sapiens GN=CINP PE=1 SV=1 | 164 | R | 0.315109 | H | 0.314474 | 6.35E-04 | No Change: Both O | - |
| Q9BW66 | CINP_HUMAN Cyclin-dependent kinase 2-interacting protein OS=Homo sapiens GN=CINP PE=1 SV=1 | 177 | D | 0.400905 | N | 0.366829 | 0.034076 | No Change: Both O | A colorectal cancer sample |
| Q969X6 | CIR1A_HUMAN Cirhin OS=Homo sapiens GN=CIRH1A PE=1 SV=1 | 565 | R | 0.360308 | W | 0.20133 | 0.158978 | No Change: Both O | North American Indian childhood cirrhosis (NAIC) [MIM:604901] |
| Q969X6 | CIR1A_HUMAN Cirhin OS=Homo sapiens GN=CIRH1A PE=1 SV=1 | 438 | R | 0.153081 | H | 0.150195 | 0.002886 | No Change: Both O | - |
| O14578 | CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens GN=CIT PE=1 SV=2 | 7 | G | 0.468239 | E | 0.519152 | -0.050913 | O to D | - |
| O14578 | CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens GN=CIT PE=1 SV=2 | 9 | R | 0.44541 | Q | 0.435342 | 0.010068 | No Change: Both O | - |
| O14578 | CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens GN=CIT PE=1 SV=2 | 183 | L | 0.288291 | F | 0.238505 | 0.049786 | No Change: Both O | - |
| Q99966 | CITE1_HUMAN Cbp/p300-interacting transactivator 1 OS=Homo sapiens GN=CITED1 PE=1 SV=2 | 96 | H | 0.801824 | Q | 0.841423 | -0.039599 | No Change: Both D | - |
| Q9ULV3 | CIZ1_HUMAN Cip1-interacting zinc finger protein OS=Homo sapiens GN=CIZ1 PE=1 SV=2 | 219 | A | 0.997814 | T | 0.998118 | -3.04E-04 | No Change: Both D | - |
| Q9ULV3 | CIZ1_HUMAN Cip1-interacting zinc finger protein OS=Homo sapiens GN=CIZ1 PE=1 SV=2 | 578 | S | 0.932286 | F | 0.865603 | 0.066683 | No Change: Both D | - |
| Q9ULV3 | CIZ1_HUMAN Cip1-interacting zinc finger protein OS=Homo sapiens GN=CIZ1 PE=1 SV=2 | 638 | V | 0.506671 | M | 0.617807 | -0.111136 | No Change: Both D | - |
| Q9ULV3 | CIZ1_HUMAN Cip1-interacting zinc finger protein OS=Homo sapiens GN=CIZ1 PE=1 SV=2 | 370 | E | 0.998188 | G | 0.99739 | 7.98E-04 | No Change: Both D | - |
| Q9ULV3 | CIZ1_HUMAN Cip1-interacting zinc finger protein OS=Homo sapiens GN=CIZ1 PE=1 SV=2 | 847 | R | 0.748062 | Q | 0.737204 | 0.010858 | No Change: Both D | - |
| Q8WWK9 | CKAP2_HUMAN Cytoskeleton-associated protein 2 OS=Homo sapiens GN=CKAP2 PE=1 SV=1 | 323 | I | 0.791881 | V | 0.801171 | -0.00929 | No Change: Both D | - |
| Q8WWK9 | CKAP2_HUMAN Cytoskeleton-associated protein 2 OS=Homo sapiens GN=CKAP2 PE=1 SV=1 | 236 | M | 0.95984 | K | 0.972863 | -0.013023 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 19 | L | 0.808999 | F | 0.755533 | 0.053466 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 26 | K | 0.858388 | R | 0.836098 | 0.02229 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 62 | N | 0.940005 | S | 0.948716 | -0.008711 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 104 | T | 0.969663 | I | 0.948955 | 0.020708 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 263 | R | 0.794099 | S | 0.818902 | -0.024803 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 375 | I | 0.815173 | V | 0.824628 | -0.009455 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 379 | P | 0.821935 | A | 0.751163 | 0.070772 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 519 | S | 0.747577 | G | 0.674616 | 0.072961 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 614 | L | 0.665996 | S | 0.785335 | -0.119339 | No Change: Both D | - |
| Q8IYA6 | CKP2L_HUMAN Cytoskeleton-associated protein 2-like OS=Homo sapiens GN=CKAP2L PE=1 SV=4 | 706 | E | 0.38265 | D | 0.35104 | 0.03161 | No Change: Both O | - |
| Q07065 | CKAP4_HUMAN Cytoskeleton-associated protein 4 OS=Homo sapiens GN=CKAP4 PE=1 SV=2 | 348 | A | 0.838983 | T | 0.851874 | -0.012891 | No Change: Both D | - |
| Q14008 | CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens GN=CKAP5 PE=1 SV=3 | 785 | Y | 0.075791 | C | 0.06069 | 0.015101 | No Change: Both O | - |
| P12277 | KCRB_HUMAN Creatine kinase B-type OS=Homo sapiens GN=CKB PE=1 SV=1 | 177 | K | 0.380575 | R | 0.350648 | 0.029927 | No Change: Both O | - |
| P12277 | KCRB_HUMAN Creatine kinase B-type OS=Homo sapiens GN=CKB PE=1 SV=1 | 309 | S | 0.515397 | L | 0.34195 | 0.173447 | D to O | - |
| P12277 | KCRB_HUMAN Creatine kinase B-type OS=Homo sapiens GN=CKB PE=1 SV=1 | 360 | L | 0.255426 | F | 0.214256 | 0.04117 | No Change: Both O | - |
| P06732 | KCRM_HUMAN Creatine kinase M-type OS=Homo sapiens GN=CKM PE=1 SV=2 | 83 | E | 0.332389 | G | 0.277959 | 0.05443 | No Change: Both O | - |
| P06732 | KCRM_HUMAN Creatine kinase M-type OS=Homo sapiens GN=CKM PE=1 SV=2 | 127 | L | 0.596892 | V | 0.585717 | 0.011175 | No Change: Both D | - |
| P06732 | KCRM_HUMAN Creatine kinase M-type OS=Homo sapiens GN=CKM PE=1 SV=2 | 243 | G | 0.570762 | A | 0.496201 | 0.074561 | D to O | - |
| P06732 | KCRM_HUMAN Creatine kinase M-type OS=Homo sapiens GN=CKM PE=1 SV=2 | 166 | T | 0.454927 | M | 0.424434 | 0.030493 | No Change: Both O | - |
| Q7Z460 | CLAP1_HUMAN CLIP-associating protein 1 OS=Homo sapiens GN=CLASP1 PE=1 SV=1 | 233 | I | 0.766084 | T | 0.82255 | -0.056466 | No Change: Both D | - |
| Q8N2M8 | CLASR_HUMAN CLK4-associating serine/arginine rich protein OS=Homo sapiens GN=CLASRP PE=1 SV=4 | 174 | K | 0.955339 | E | 0.957166 | -0.001827 | No Change: Both D | - |
| Q8N2M8 | CLASR_HUMAN CLK4-associating serine/arginine rich protein OS=Homo sapiens GN=CLASRP PE=1 SV=4 | 213 | L | 0.683475 | S | 0.750707 | -0.067232 | No Change: Both D | A breast cancer sample |
| Q05315 | LPPL_HUMAN Eosinophil lysophospholipase OS=Homo sapiens GN=CLC PE=1 SV=3 | 28 | A | 0.09325 | V | 0.068743 | 0.024507 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 357 | N | 0.318419 | S | 0.365503 | -0.047084 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 524 | M | 0.091387 | T | 0.119141 | -0.027754 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 65 | L | 0.167152 | F | 0.144112 | 0.02304 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 152 | R | 0.268893 | K | 0.334029 | -0.065136 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 406 | E | 0.32979 | V | 0.186046 | 0.143744 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 426 | K | 0.294826 | R | 0.245757 | 0.049069 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 661 | Y | 0.255475 | H | 0.336494 | -0.081019 | No Change: Both O | - |
| A8K7I4 | CLCA1_HUMAN Calcium-activated chloride channel regulator 1 OS=Homo sapiens GN=CLCA1 PE=1 SV=3 | 760 | K | 0.401306 | N | 0.368221 | 0.033085 | No Change: Both O | - |
| Q9UQC9 | CLCA2_HUMAN Calcium-activated chloride channel regulator 2 OS=Homo sapiens GN=CLCA2 PE=1 SV=2 | 306 | Q | 0.263775 | E | 0.303584 | -0.039809 | No Change: Both O | - |
| Q9UQC9 | CLCA2_HUMAN Calcium-activated chloride channel regulator 2 OS=Homo sapiens GN=CLCA2 PE=1 SV=2 | 754 | G | 0.521142 | E | 0.560813 | -0.039671 | No Change: Both D | A breast cancer sample |
| Q9UQC9 | CLCA2_HUMAN Calcium-activated chloride channel regulator 2 OS=Homo sapiens GN=CLCA2 PE=1 SV=2 | 80 | V | 0.11467 | I | 0.123585 | -0.008915 | No Change: Both O | - |
| Q9UQC9 | CLCA2_HUMAN Calcium-activated chloride channel regulator 2 OS=Homo sapiens GN=CLCA2 PE=1 SV=2 | 534 | G | 0.188786 | D | 0.213913 | -0.025127 | No Change: Both O | - |
| Q9Y6N3 | CLCA3_HUMAN Calcium-activated chloride channel regulator family member 3 OS=Homo sapiens GN=CLCA3P PE=1 SV=1 | 84 | Y | 0.355336 | T | 0.468359 | -0.113023 | No Change: Both O | - |
| Q9Y6N3 | CLCA3_HUMAN Calcium-activated chloride channel regulator family member 3 OS=Homo sapiens GN=CLCA3P PE=1 SV=1 | 104 | I | 0.106004 | T | 0.19523 | -0.089226 | No Change: Both O | - |
| Q14CN2 | CLCA4_HUMAN Calcium-activated chloride channel regulator 4 OS=Homo sapiens GN=CLCA4 PE=1 SV=2 | 43 | P | 0.466404 | S | 0.49426 | -0.027856 | No Change: Both O | - |
| Q14CN2 | CLCA4_HUMAN Calcium-activated chloride channel regulator 4 OS=Homo sapiens GN=CLCA4 PE=1 SV=2 | 443 | D | 0.264867 | V | 0.16076 | 0.104107 | No Change: Both O | - |
| Q14CN2 | CLCA4_HUMAN Calcium-activated chloride channel regulator 4 OS=Homo sapiens GN=CLCA4 PE=1 SV=2 | 449 | M | 0.399504 | L | 0.33487 | 0.064634 | No Change: Both O | - |
| Q14CN2 | CLCA4_HUMAN Calcium-activated chloride channel regulator 4 OS=Homo sapiens GN=CLCA4 PE=1 SV=2 | 810 | V | 0.471755 | L | 0.507821 | -0.036066 | O to D | - |
| Q96S66 | CLCC1_HUMAN Chloride channel CLIC-like protein 1 OS=Homo sapiens GN=CLCC1 PE=1 SV=1 | 368 | S | 0.747873 | R | 0.731857 | 0.016016 | No Change: Both D | - |
| Q9UBD9 | CLCF1_HUMAN Cardiotrophin-like cytokine factor 1 OS=Homo sapiens GN=CLCF1 PE=1 SV=1 | 197 | R | 0.161562 | L | 0.1072 | 0.054362 | No Change: Both O | Cold-induced sweating syndrome type 2 (CISS2) [MIM:610313] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 105 | R | 0.188076 | C | 0.110518 | 0.077558 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 118 | G | 0.133336 | W | 0.047459 | 0.085877 | No Change: Both O | - |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 136 | D | 0.258849 | G | 0.234346 | 0.024503 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 150 | Y | 0.312996 | C | 0.247039 | 0.065957 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 161 | F | 0.053367 | V | 0.064711 | -0.011344 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 161 | F | 0.053367 | V | 0.064711 | -0.011344 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 165 | V | 0.013083 | G | 0.022169 | -0.009086 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 167 | F | 0.011267 | L | 0.013677 | -0.00241 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 200 | G | 0.107617 | R | 0.108836 | -0.001219 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 200 | G | 0.107617 | R | 0.108836 | -0.001219 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 230 | G | 0.497876 | E | 0.542258 | -0.044382 | O to D | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 230 | G | 0.497876 | E | 0.542258 | -0.044382 | O to D | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 236 | V | 0.139531 | L | 0.131071 | 0.00846 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 261 | Y | 0.109954 | C | 0.081206 | 0.028748 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 285 | G | 0.104302 | E | 0.125585 | -0.021283 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 286 | V | 0.120163 | A | 0.159092 | -0.038929 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 290 | I | 0.138879 | M | 0.204135 | -0.065256 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 291 | E | 0.128589 | K | 0.128473 | 1.16E-04 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 300 | R | 0.068376 | Q | 0.069713 | -0.001337 | No Change: Both O | - |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 307 | F | 0.054231 | S | 0.1431 | -0.088869 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 313 | A | 0.048864 | T | 0.054113 | -0.005249 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 313 | A | 0.048864 | T | 0.054113 | -0.005249 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 317 | R | 0.027065 | Q | 0.029597 | -0.002532 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 327 | V | 0.08525 | I | 0.074473 | 0.010777 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 329 | I | 0.082929 | T | 0.169577 | -0.086648 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 338 | R | 0.148865 | Q | 0.151564 | -0.002699 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 338 | R | 0.148865 | Q | 0.151564 | -0.002699 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 413 | F | 0.355771 | C | 0.331394 | 0.024377 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 415 | A | 0.382172 | V | 0.293044 | 0.089128 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 437 | A | 0.482425 | T | 0.531591 | -0.049166 | O to D | - |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 480 | P | 0.151623 | L | 0.066775 | 0.084848 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 482 | G | 0.122957 | R | 0.108109 | 0.014848 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 485 | M | 0.066827 | V | 0.052958 | 0.013869 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 496 | R | 0.098161 | S | 0.130481 | -0.03232 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 552 | Q | 0.072395 | R | 0.066125 | 0.00627 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 552 | Q | 0.072395 | R | 0.066125 | 0.00627 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 556 | I | 0.074886 | N | 0.151335 | -0.076449 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 556 | I | 0.074886 | N | 0.151335 | -0.076449 | No Change: Both O | Thomsen disease (THD) [MIM:160800] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 563 | V | 0.061983 | I | 0.053541 | 0.008442 | No Change: Both O | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 708 | F | 0.932165 | L | 0.942466 | -0.010301 | No Change: Both D | Autosomal recessive myotonia congenita (MCR) [MIM:255700] |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 548 | E | 0.06205 | K | 0.061996 | 5.40E-05 | No Change: Both O | A breast cancer sample |
| P35523 | CLCN1_HUMAN Chloride channel protein 1 OS=Homo sapiens GN=CLCN1 PE=1 SV=3 | 727 | P | 0.980445 | L | 0.964791 | 0.015654 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 715 | G | 0.91114 | E | 0.924534 | -0.013394 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 668 | T | 0.925139 | S | 0.93909 | -0.013951 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 718 | E | 0.913099 | D | 0.884376 | 0.028723 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 48 | P | 0.755482 | R | 0.734846 | 0.020636 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 68 | R | 0.351524 | H | 0.297347 | 0.054177 | No Change: Both O | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 199 | G | 0.379031 | A | 0.312162 | 0.066869 | No Change: Both O | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 235 | R | 0.560787 | Q | 0.580431 | -0.019644 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 577 | R | 0.246033 | Q | 0.262218 | -0.016185 | No Change: Both O | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 644 | R | 0.883111 | C | 0.813791 | 0.06932 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 646 | R | 0.899152 | Q | 0.902154 | -0.003002 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 725 | R | 0.900495 | W | 0.779653 | 0.120842 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 747 | R | 0.922711 | H | 0.888338 | 0.034373 | No Change: Both D | - |
| P51788 | CLCN2_HUMAN Chloride channel protein 2 OS=Homo sapiens GN=CLCN2 PE=1 SV=2 | 719 | S | 0.911619 | L | 0.859651 | 0.051968 | No Change: Both D | - |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 57 | G | 0.102924 | V | 0.061302 | 0.041622 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 200 | L | 0.114734 | R | 0.174626 | -0.059892 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 244 | S | 0.420511 | L | 0.236441 | 0.18407 | No Change: Both O | Hypophosphatemic rickets X-linked recessive (XLRH) [MIM:300554] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 280 | R | 0.048044 | P | 0.061034 | -0.01299 | No Change: Both O | Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis (LMWPHN) [MIM:308990] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 506 | G | 0.100798 | E | 0.116292 | -0.015494 | No Change: Both O | Nephrolithiasis type 1 (NPHL1) [MIM:310468] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 512 | G | 0.163844 | R | 0.152135 | 0.011709 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 520 | S | 0.075703 | P | 0.067165 | 0.008538 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 527 | E | 0.06591 | D | 0.055021 | 0.010889 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 142 | M | 0.006586 | I | 0.004459 | 0.002127 | No Change: Both O | - |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 179 | G | 0.070818 | D | 0.073945 | -0.003127 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 203 | S | 0.279004 | L | 0.139353 | 0.139651 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 212 | G | 0.425639 | A | 0.369506 | 0.056133 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 219 | C | 0.032594 | R | 0.058273 | -0.025679 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 221 | C | 0.036575 | R | 0.061177 | -0.024602 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 225 | L | 0.040918 | P | 0.082061 | -0.041143 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 260 | G | 0.134172 | V | 0.075476 | 0.058696 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 267 | E | 0.17094 | A | 0.101758 | 0.069182 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 270 | S | 0.141528 | G | 0.108848 | 0.03268 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 270 | S | 0.141528 | R | 0.098884 | 0.042644 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 272 | Y | 0.112446 | C | 0.085186 | 0.02726 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 273 | F | 0.097749 | L | 0.119739 | -0.02199 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 278 | L | 0.062187 | F | 0.056598 | 0.005589 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 340 | N | 0.040741 | K | 0.053918 | -0.013177 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 462 | G | 0.133387 | D | 0.137712 | -0.004325 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 469 | L | 0.14917 | P | 0.264478 | -0.115308 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 513 | G | 0.163635 | E | 0.188309 | -0.024674 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 513 | G | 0.163635 | R | 0.152395 | 0.01124 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 516 | R | 0.122501 | W | 0.048851 | 0.07365 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 524 | I | 0.054213 | K | 0.143358 | -0.089145 | No Change: Both O | Low molecular weight proteinuria with hypercalciuria and nephrocalcinosis (LMWPHN) [MIM:308990] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 545 | S | 0.236021 | N | 0.201927 | 0.034094 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 546 | K | 0.244127 | E | 0.246551 | -0.002424 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 547 | W | 0.241685 | G | 0.48791 | -0.246225 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51795 | CLCN5_HUMAN H(+)/Cl(-) exchange transporter 5 OS=Homo sapiens GN=CLCN5 PE=1 SV=1 | 657 | T | 0.228724 | S | 0.302701 | -0.073977 | No Change: Both O | Nephrolithiasis type 2 (NPHL2) [MIM:300009] |
| P51797 | CLCN6_HUMAN Chloride transport protein 6 OS=Homo sapiens GN=CLCN6 PE=1 SV=2 | 198 | E | 0.403701 | G | 0.363237 | 0.040464 | No Change: Both O | - |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 762 | R | 0.117619 | Q | 0.114319 | 0.0033 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 762 | R | 0.117619 | Q | 0.114319 | 0.0033 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 766 | L | 0.095886 | P | 0.169446 | -0.07356 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 767 | R | 0.102826 | W | 0.033906 | 0.06892 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 767 | R | 0.102826 | W | 0.033906 | 0.06892 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 215 | G | 0.100732 | R | 0.097995 | 0.002737 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 240 | G | 0.165648 | R | 0.144786 | 0.020862 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 249 | P | 0.532921 | R | 0.495286 | 0.037635 | D to O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 286 | R | 0.513864 | Q | 0.50319 | 0.010674 | No Change: Both D | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 332 | M | 0.062036 | V | 0.046871 | 0.015165 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 418 | V | 0.057119 | M | 0.067909 | -0.01079 | No Change: Both O | - |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 490 | L | 0.120115 | F | 0.103357 | 0.016758 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 526 | R | 0.06719 | W | 0.027292 | 0.039898 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 614 | L | 0.147154 | P | 0.275894 | -0.12874 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 677 | G | 0.219492 | V | 0.135338 | 0.084154 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 744 | S | 0.540635 | F | 0.320373 | 0.220262 | D to O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 767 | R | 0.102826 | Q | 0.099372 | 0.003454 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 261 | I | 0.504726 | F | 0.488528 | 0.016198 | D to O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 132 | L | 0.010563 | P | 0.021527 | -0.010964 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 214 | N | 0.089525 | S | 0.10766 | -0.018135 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 318 | F | 0.12732 | L | 0.144901 | -0.017581 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 403 | R | 0.033271 | Q | 0.033285 | -1.40E-05 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 521 | G | 0.05127 | R | 0.047335 | 0.003935 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 526 | R | 0.06719 | Q | 0.073513 | -0.006323 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 549 | L | 0.246415 | P | 0.426254 | -0.179839 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 651 | L | 0.297501 | P | 0.444479 | -0.146978 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 758 | F | 0.175158 | L | 0.202796 | -0.027638 | No Change: Both O | Osteopetrosis autosomal dominant type 2 (OPTA2) [MIM:166600] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 762 | R | 0.117619 | W | 0.038939 | 0.07868 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51798 | CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens GN=CLCN7 PE=1 SV=2 | 767 | R | 0.102826 | P | 0.110075 | -0.007249 | No Change: Both O | Osteopetrosis autosomal recessive type 4 (OPTB4) [MIM:611490] |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 447 | A | 0.134943 | T | 0.144603 | -0.00966 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 83 | R | 0.211856 | G | 0.226013 | -0.014157 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 315 | Y | 0.409572 | F | 0.377495 | 0.032077 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 67 | M | 0.048986 | I | 0.032024 | 0.016962 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 45 | R | 0.082601 | H | 0.084115 | -0.001514 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 287 | A | 0.019313 | V | 0.014516 | 0.004797 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 8 | R | 0.472339 | H | 0.481148 | -0.008809 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 534 | R | 0.159187 | W | 0.061077 | 0.09811 | No Change: Both O | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 683 | P | 0.740205 | L | 0.698731 | 0.041474 | No Change: Both D | - |
| P51800 | CLCKA_HUMAN Chloride channel protein ClC-Ka OS=Homo sapiens GN=CLCNKA PE=1 SV=1 | 80 | W | 0.082339 | C | 0.099098 | -0.016759 | No Change: Both O | Bartter syndrome type 4B (BS4B) [MIM:613090] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 124 | P | 0.587324 | L | 0.429163 | 0.158161 | D to O | Bartter syndrome type 3 (BS3) [MIM:607364] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 204 | A | 0.157375 | T | 0.164339 | -0.006964 | No Change: Both O | Bartter syndrome type 3 (BS3) [MIM:607364] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 349 | A | 0.413107 | D | 0.471794 | -0.058687 | No Change: Both O | Bartter syndrome type 3 (BS3) [MIM:607364] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 432 | Y | 0.040127 | H | 0.067472 | -0.027345 | No Change: Both O | Bartter syndrome type 3 (BS3) [MIM:607364] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 438 | R | 0.103548 | C | 0.048184 | 0.055364 | No Change: Both O | Bartter syndrome type 3 (BS3) [MIM:607364] |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 88 | S | 0.203171 | R | 0.16489 | 0.038281 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 143 | N | 0.155588 | H | 0.142293 | 0.013295 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 334 | V | 0.13798 | L | 0.160436 | -0.022456 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 562 | M | 0.361907 | T | 0.421422 | -0.059515 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 578 | K | 0.375643 | E | 0.392852 | -0.017209 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 4 | F | 0.687587 | L | 0.744594 | -0.057007 | No Change: Both D | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 104 | V | 0.208485 | I | 0.173521 | 0.034964 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 214 | A | 0.119248 | G | 0.147724 | -0.028476 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 419 | I | 0.106953 | V | 0.114443 | -0.00749 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 27 | R | 0.22134 | L | 0.127886 | 0.093454 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 126 | V | 0.427425 | L | 0.430985 | -0.00356 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 395 | R | 0.037975 | W | 0.015966 | 0.022009 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 481 | T | 0.213578 | S | 0.283602 | -0.070024 | No Change: Both O | - |
| P51801 | CLCKB_HUMAN Chloride channel protein ClC-Kb OS=Homo sapiens GN=CLCNKB PE=1 SV=3 | 660 | S | 0.249112 | L | 0.13492 | 0.114192 | No Change: Both O | - |
| O95500 | CLD14_HUMAN Claudin-14 OS=Homo sapiens GN=CLDN14 PE=1 SV=1 | 85 | V | 0.064379 | D | 0.133022 | -0.068643 | No Change: Both O | Deafness autosomal recessive type 29 (DFNB29) [MIM:614035] |
| O95500 | CLD14_HUMAN Claudin-14 OS=Homo sapiens GN=CLDN14 PE=1 SV=1 | 4 | T | 0.612541 | M | 0.584622 | 0.027919 | No Change: Both D | - |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 239 | G | 0.057393 | R | 0.048127 | 0.009266 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 71 | M | 0.148117 | R | 0.20032 | -0.052203 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 167 | L | 0.031429 | P | 0.06001 | -0.028581 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 191 | G | 0.034275 | R | 0.032125 | 0.00215 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 198 | G | 0.15097 | D | 0.154474 | -0.003504 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 232 | F | 0.030178 | C | 0.029137 | 0.001041 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 233 | G | 0.030932 | D | 0.032095 | -0.001163 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 235 | S | 0.03729 | F | 0.013338 | 0.023952 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 141 | H | 0.229054 | D | 0.275014 | -0.04596 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 145 | L | 0.148359 | P | 0.272935 | -0.124576 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 149 | R | 0.078986 | L | 0.049893 | 0.029093 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 151 | L | 0.060176 | F | 0.048122 | 0.012054 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 151 | L | 0.060176 | P | 0.115907 | -0.055731 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 151 | L | 0.060176 | W | 0.037845 | 0.022331 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 198 | G | 0.15097 | A | 0.116891 | 0.034079 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 209 | A | 0.05333 | T | 0.062729 | -0.009399 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 216 | R | 0.153866 | T | 0.154342 | -4.76E-04 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| Q9Y5I7 | CLD16_HUMAN Claudin-16 OS=Homo sapiens GN=CLDN16 PE=1 SV=1 | 235 | S | 0.03729 | P | 0.03157 | 0.00572 | No Change: Both O | Hypomagnesemia type 3 (HOMG3) [MIM:248250] |
| P56750 | CLD17_HUMAN Claudin-17 OS=Homo sapiens GN=CLDN17 PE=1 SV=1 | 82 | A | 0.116411 | T | 0.124724 | -0.008313 | No Change: Both O | - |
| P56856 | CLD18_HUMAN Claudin-18 OS=Homo sapiens GN=CLDN18 PE=1 SV=1 | 149 | M | 0.132598 | L | 0.095882 | 0.036716 | No Change: Both O | - |
| Q8N6F1 | CLD19_HUMAN Claudin-19 OS=Homo sapiens GN=CLDN19 PE=1 SV=2 | 13 | L | 0.031085 | F | 0.025628 | 0.005457 | No Change: Both O | - |
| Q8N6F1 | CLD19_HUMAN Claudin-19 OS=Homo sapiens GN=CLDN19 PE=1 SV=2 | 20 | G | 0.054383 | D | 0.055957 | -0.001574 | No Change: Both O | Hypomagnesemia renal with ocular involvement (HOMG5) [MIM:248190] |
| Q8N6F1 | CLD19_HUMAN Claudin-19 OS=Homo sapiens GN=CLDN19 PE=1 SV=2 | 57 | Q | 0.395626 | E | 0.42843 | -0.032804 | No Change: Both O | Hypomagnesemia renal with ocular involvement (HOMG5) [MIM:248190] |
| Q8N6F1 | CLD19_HUMAN Claudin-19 OS=Homo sapiens GN=CLDN19 PE=1 SV=2 | 90 | L | 0.031668 | P | 0.061088 | -0.02942 | No Change: Both O | Hypomagnesemia renal with ocular involvement (HOMG5) [MIM:248190] |
| Q96B33 | CLD23_HUMAN Claudin-23 OS=Homo sapiens GN=CLDN23 PE=1 SV=2 | 210 | V | 0.825096 | M | 0.856748 | -0.031652 | No Change: Both D | - |
| A6NM45 | CLD24_HUMAN Putative claudin-24 OS=Homo sapiens GN=CLDN24 PE=5 SV=1 | 18 | L | 0.045922 | F | 0.034772 | 0.01115 | No Change: Both O | - |
| C9JDP6 | CLD25_HUMAN Putative claudin-25 OS=Homo sapiens GN=CLDN25 PE=5 SV=1 | 219 | H | 0.375446 | Y | 0.256106 | 0.11934 | No Change: Both O | - |
| P56747 | CLD6_HUMAN Claudin-6 OS=Homo sapiens GN=CLDN6 PE=1 SV=2 | 143 | I | 0.035228 | V | 0.04013 | -0.004902 | No Change: Both O | - |
| O95471 | CLD7_HUMAN Claudin-7 OS=Homo sapiens GN=CLDN7 PE=1 SV=4 | 197 | V | 0.669634 | A | 0.749939 | -0.080305 | No Change: Both D | - |
| O95471 | CLD7_HUMAN Claudin-7 OS=Homo sapiens GN=CLDN7 PE=1 SV=4 | 133 | A | 0.029006 | T | 0.029558 | -5.52E-04 | No Change: Both O | - |
| P56748 | CLD8_HUMAN Claudin-8 OS=Homo sapiens GN=CLDN8 PE=2 SV=1 | 151 | S | 0.11593 | P | 0.102698 | 0.013232 | No Change: Both O | - |
| P56748 | CLD8_HUMAN Claudin-8 OS=Homo sapiens GN=CLDN8 PE=2 SV=1 | 129 | T | 0.017509 | A | 0.015404 | 0.002105 | No Change: Both O | - |
| P56748 | CLD8_HUMAN Claudin-8 OS=Homo sapiens GN=CLDN8 PE=2 SV=1 | 25 | T | 0.113858 | A | 0.100674 | 0.013184 | No Change: Both O | - |
| Q8IUN9 | CLC10_HUMAN C-type lectin domain family 10 member A OS=Homo sapiens GN=CLEC10A PE=2 SV=1 | 35 | C | 0.226852 | R | 0.384364 | -0.157512 | No Change: Both O | - |
| Q8IUN9 | CLC10_HUMAN C-type lectin domain family 10 member A OS=Homo sapiens GN=CLEC10A PE=2 SV=1 | 73 | R | 0.268247 | K | 0.316874 | -0.048627 | No Change: Both O | - |
| Q8IUN9 | CLC10_HUMAN C-type lectin domain family 10 member A OS=Homo sapiens GN=CLEC10A PE=2 SV=1 | 100 | T | 0.727984 | M | 0.679238 | 0.048746 | No Change: Both D | - |
| Q8IUN9 | CLC10_HUMAN C-type lectin domain family 10 member A OS=Homo sapiens GN=CLEC10A PE=2 SV=1 | 203 | A | 0.397588 | G | 0.45631 | -0.058722 | No Change: Both O | - |
| Q9Y240 | CLC11_HUMAN C-type lectin domain family 11 member A OS=Homo sapiens GN=CLEC11A PE=1 SV=1 | 104 | P | 0.739808 | R | 0.711264 | 0.028544 | No Change: Both D | - |
| Q5QGZ9 | CL12A_HUMAN C-type lectin domain family 12 member A OS=Homo sapiens GN=CLEC12A PE=1 SV=3 | 244 | K | 0.235827 | Q | 0.185812 | 0.050015 | No Change: Both O | - |
| Q2HXU8 | CL12B_HUMAN C-type lectin domain family 12 member B OS=Homo sapiens GN=CLEC12B PE=1 SV=1 | 6 | T | 0.569349 | N | 0.59865 | -0.029301 | No Change: Both D | - |
| Q2HXU8 | CL12B_HUMAN C-type lectin domain family 12 member B OS=Homo sapiens GN=CLEC12B PE=1 SV=1 | 116 | V | 0.708333 | L | 0.766277 | -0.057944 | No Change: Both D | - |
| Q2KHT3 | CL16A_HUMAN Protein CLEC16A OS=Homo sapiens GN=CLEC16A PE=2 SV=2 | 906 | G | 0.995694 | E | 0.995205 | 4.89E-04 | No Change: Both D | - |
| A5D8T8 | CL18A_HUMAN C-type lectin domain family 18 member A OS=Homo sapiens GN=CLEC18A PE=2 SV=3 | 118 | V | 0.091689 | A | 0.123767 | -0.032078 | No Change: Both O | - |
| Q8NC01 | CLC1A_HUMAN C-type lectin domain family 1 member A OS=Homo sapiens GN=CLEC1A PE=2 SV=2 | 26 | G | 0.951755 | A | 0.953449 | -0.001694 | No Change: Both D | - |
| Q9P126 | CLC1B_HUMAN C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1B PE=1 SV=2 | 20 | I | 0.444177 | V | 0.491398 | -0.047221 | No Change: Both O | - |
| Q9P126 | CLC1B_HUMAN C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1B PE=1 SV=2 | 24 | S | 0.398616 | P | 0.343257 | 0.055359 | No Change: Both O | - |
| Q9P126 | CLC1B_HUMAN C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1B PE=1 SV=2 | 28 | S | 0.261492 | F | 0.098425 | 0.163067 | No Change: Both O | - |
| Q9P126 | CLC1B_HUMAN C-type lectin domain family 1 member B OS=Homo sapiens GN=CLEC1B PE=1 SV=2 | 64 | G | 0.664042 | D | 0.684387 | -0.020345 | No Change: Both D | - |
| Q6UVW9 | CLC2A_HUMAN C-type lectin domain family 2 member A OS=Homo sapiens GN=CLEC2A PE=1 SV=2 | 136 | G | 0.113744 | D | 0.116569 | -0.002825 | No Change: Both O | - |
| Q9UHP7 | CLC2D_HUMAN C-type lectin domain family 2 member D OS=Homo sapiens GN=CLEC2D PE=1 SV=1 | 19 | N | 0.589147 | K | 0.642661 | -0.053514 | No Change: Both D | - |
| Q9UHP7 | CLC2D_HUMAN C-type lectin domain family 2 member D OS=Homo sapiens GN=CLEC2D PE=1 SV=1 | 23 | L | 0.561569 | V | 0.553558 | 0.008011 | No Change: Both D | - |
| O75596 | CLC3A_HUMAN C-type lectin domain family 3 member A OS=Homo sapiens GN=CLEC3A PE=1 SV=1 | 197 | Q | 0.649586 | K | 0.675823 | -0.026237 | No Change: Both D | - |
| P05452 | TETN_HUMAN Tetranectin OS=Homo sapiens GN=CLEC3B PE=1 SV=3 | 55 | A | 0.422051 | S | 0.513659 | -0.091608 | O to D | - |
| P05452 | TETN_HUMAN Tetranectin OS=Homo sapiens GN=CLEC3B PE=1 SV=3 | 58 | V | 0.398919 | M | 0.486834 | -0.087915 | No Change: Both O | - |
| P05452 | TETN_HUMAN Tetranectin OS=Homo sapiens GN=CLEC3B PE=1 SV=3 | 106 | G | 0.628479 | S | 0.669739 | -0.04126 | No Change: Both D | - |
| Q9UMR7 | CLC4A_HUMAN C-type lectin domain family 4 member A OS=Homo sapiens GN=CLEC4A PE=1 SV=1 | 36 | H | 0.744904 | L | 0.653244 | 0.09166 | No Change: Both D | - |
| Q8WXI8 | CLC4D_HUMAN C-type lectin domain family 4 member D OS=Homo sapiens GN=CLEC4D PE=2 SV=2 | 32 | S | 0.013722 | G | 0.009817 | 0.003905 | No Change: Both O | - |
| Q8N1N0 | CLC4F_HUMAN C-type lectin domain family 4 member F OS=Homo sapiens GN=CLEC4F PE=2 SV=2 | 101 | R | 0.409412 | Q | 0.430164 | -0.020752 | No Change: Both O | - |
| Q8N1N0 | CLC4F_HUMAN C-type lectin domain family 4 member F OS=Homo sapiens GN=CLEC4F PE=2 SV=2 | 351 | R | 0.610531 | H | 0.60153 | 0.009001 | No Change: Both D | - |
| Q8N1N0 | CLC4F_HUMAN C-type lectin domain family 4 member F OS=Homo sapiens GN=CLEC4F PE=2 SV=2 | 564 | K | 0.219183 | R | 0.185479 | 0.033704 | No Change: Both O | - |
| Q9H2X3 | CLC4M_HUMAN C-type lectin domain family 4 member M OS=Homo sapiens GN=CLEC4M PE=1 SV=1 | 291 | D | 0.347298 | N | 0.353646 | -0.006348 | No Change: Both O | - |
| Q9H2X3 | CLC4M_HUMAN C-type lectin domain family 4 member M OS=Homo sapiens GN=CLEC4M PE=1 SV=1 | 164 | R | 0.587314 | Q | 0.630809 | -0.043495 | No Change: Both D | - |
| Q9H2X3 | CLC4M_HUMAN C-type lectin domain family 4 member M OS=Homo sapiens GN=CLEC4M PE=1 SV=1 | 205 | Y | 0.757249 | C | 0.779337 | -0.022088 | No Change: Both D | - |
| Q9H2X3 | CLC4M_HUMAN C-type lectin domain family 4 member M OS=Homo sapiens GN=CLEC4M PE=1 SV=1 | 251 | Y | 0.484299 | C | 0.481955 | 0.002344 | No Change: Both O | - |
| Q9NY25 | CLC5A_HUMAN C-type lectin domain family 5 member A OS=Homo sapiens GN=CLEC5A PE=1 SV=1 | 141 | R | 0.192879 | H | 0.189131 | 0.003748 | No Change: Both O | - |
| Q9BXN2 | CLC7A_HUMAN C-type lectin domain family 7 member A OS=Homo sapiens GN=CLEC7A PE=1 SV=1 | 223 | I | 0.056203 | S | 0.152408 | -0.096205 | No Change: Both O | - |
| Q6UXN8 | CLC9A_HUMAN C-type lectin domain family 9 member A OS=Homo sapiens GN=CLEC9A PE=1 SV=1 | 107 | A | 0.768028 | G | 0.79303 | -0.025002 | No Change: Both D | - |
| O14967 | CLGN_HUMAN Calmegin OS=Homo sapiens GN=CLGN PE=1 SV=1 | 160 | A | 0.148933 | S | 0.216353 | -0.06742 | No Change: Both O | - |
| O14967 | CLGN_HUMAN Calmegin OS=Homo sapiens GN=CLGN PE=1 SV=1 | 290 | V | 0.968191 | I | 0.967707 | 4.84E-04 | No Change: Both D | - |
| O14967 | CLGN_HUMAN Calmegin OS=Homo sapiens GN=CLGN PE=1 SV=1 | 352 | R | 0.438169 | W | 0.312666 | 0.125503 | No Change: Both O | - |
| O95833 | CLIC3_HUMAN Chloride intracellular channel protein 3 OS=Homo sapiens GN=CLIC3 PE=1 SV=2 | 38 | P | 0.163464 | H | 0.124955 | 0.038509 | No Change: Both O | - |
| Q9NZA1 | CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens GN=CLIC5 PE=1 SV=3 | 257 | P | 0.56775 | H | 0.512395 | 0.055355 | No Change: Both D | - |
| Q9NZA1 | CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens GN=CLIC5 PE=1 SV=3 | 114 | T | 0.816037 | A | 0.822148 | -0.006111 | No Change: Both D | - |
| Q96NY7 | CLIC6_HUMAN Chloride intracellular channel protein 6 OS=Homo sapiens GN=CLIC6 PE=2 SV=3 | 632 | D | 0.368356 | G | 0.342974 | 0.025382 | No Change: Both O | - |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 1080 | D | 0.962677 | E | 0.970171 | -0.007494 | No Change: Both D | - |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 1213 | M | 0.896523 | I | 0.867283 | 0.02924 | No Change: Both D | A breast cancer sample |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 780 | R | 0.864049 | W | 0.730949 | 0.1331 | No Change: Both D | - |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 941 | S | 0.914965 | P | 0.897462 | 0.017503 | No Change: Both D | - |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 1224 | A | 0.903066 | S | 0.934197 | -0.031131 | No Change: Both D | - |
| P30622 | CLIP1_HUMAN CAP-Gly domain-containing linker protein 1 OS=Homo sapiens GN=CLIP1 PE=1 SV=2 | 162 | S | 0.992061 | P | 0.992033 | 2.80E-05 | No Change: Both D | - |
| Q9UDT6 | CLIP2_HUMAN CAP-Gly domain-containing linker protein 2 OS=Homo sapiens GN=CLIP2 PE=1 SV=1 | 977 | R | 0.85944 | P | 0.859964 | -5.24E-04 | No Change: Both D | - |
| Q9UDT6 | CLIP2_HUMAN CAP-Gly domain-containing linker protein 2 OS=Homo sapiens GN=CLIP2 PE=1 SV=1 | 961 | D | 0.880927 | E | 0.891714 | -0.010787 | No Change: Both D | - |
| Q96DZ5 | CLIP3_HUMAN CAP-Gly domain-containing linker protein 3 OS=Homo sapiens GN=CLIP3 PE=1 SV=3 | 175 | D | 0.090685 | V | 0.044825 | 0.04586 | No Change: Both O | - |
| Q8N3C7 | CLIP4_HUMAN CAP-Gly domain-containing linker protein 4 OS=Homo sapiens GN=CLIP4 PE=1 SV=1 | 486 | R | 0.464246 | L | 0.349342 | 0.114904 | No Change: Both O | - |
| Q8N3C7 | CLIP4_HUMAN CAP-Gly domain-containing linker protein 4 OS=Homo sapiens GN=CLIP4 PE=1 SV=1 | 613 | T | 0.695432 | P | 0.731874 | -0.036442 | No Change: Both D | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 61 | S | 0.853624 | F | 0.716654 | 0.13697 | No Change: Both D | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 118 | R | 0.996691 | G | 0.99564 | 0.001051 | No Change: Both D | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 307 | P | 0.487758 | S | 0.514703 | -0.026945 | O to D | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 440 | M | 0.400246 | T | 0.421181 | -0.020935 | No Change: Both O | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 99 | N | 0.985207 | D | 0.987602 | -0.002395 | No Change: Both D | - |
| P49759 | CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | 459 | E | 0.305804 | G | 0.226114 | 0.07969 | No Change: Both O | - |
| P49761 | CLK3_HUMAN Dual specificity protein kinase CLK3 OS=Homo sapiens GN=CLK3 PE=1 SV=3 | 486 | R | 0.342841 | C | 0.179612 | 0.163229 | No Change: Both O | - |
| P49761 | CLK3_HUMAN Dual specificity protein kinase CLK3 OS=Homo sapiens GN=CLK3 PE=1 SV=3 | 607 | Q | 0.341726 | R | 0.362565 | -0.020839 | No Change: Both O | - |
| P49761 | CLK3_HUMAN Dual specificity protein kinase CLK3 OS=Homo sapiens GN=CLK3 PE=1 SV=3 | 628 | R | 0.748734 | W | 0.508247 | 0.240487 | No Change: Both D | - |
| Q9HAZ1 | CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | 352 | L | 0.065267 | F | 0.053107 | 0.01216 | No Change: Both O | - |
| Q9HAZ1 | CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | 363 | I | 0.021748 | V | 0.024551 | -0.002803 | No Change: Both O | - |
| Q5K131 | CLLU1_HUMAN Chronic lymphocytic leukemia up-regulated protein 1 OS=Homo sapiens GN=CLLU1 PE=2 SV=1 | 9 | S | 0.337431 | F | 0.148126 | 0.189305 | No Change: Both O | - |
| Q96JQ2 | CLMN_HUMAN Calmin OS=Homo sapiens GN=CLMN PE=1 SV=1 | 963 | P | 0.816506 | L | 0.741254 | 0.075252 | No Change: Both D | - |
| Q9H6B4 | CLMP_HUMAN CXADR-like membrane protein OS=Homo sapiens GN=CLMP PE=1 SV=1 | 69 | R | 0.264959 | H | 0.283539 | -0.01858 | No Change: Both O | - |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 101 | L | 0.159782 | P | 0.272273 | -0.112491 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 170 | L | 0.124359 | P | 0.223163 | -0.098804 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 295 | E | 0.029995 | K | 0.029348 | 6.47E-04 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 330 | V | 0.22063 | F | 0.207957 | 0.012673 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 334 | R | 0.273125 | C | 0.139966 | 0.133159 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 334 | R | 0.273125 | H | 0.256576 | 0.016549 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 134 | C | 0.090506 | R | 0.185751 | -0.095245 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 187 | G | 0.328243 | A | 0.272747 | 0.055496 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| Q13286 | CLN3_HUMAN Battenin OS=Homo sapiens GN=CLN3 PE=1 SV=1 | 189 | G | 0.363449 | R | 0.325471 | 0.037978 | No Change: Both O | Neuronal ceroid lipofuscinosis type 3 (CLN3) [MIM:204200] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 230 | D | 0.128214 | N | 0.11398 | 0.014234 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 319 | K | 0.039486 | R | 0.028726 | 0.01076 | No Change: Both O | - |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 63 | R | 0.511189 | H | 0.484033 | 0.027156 | D to O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 209 | Y | 0.159333 | D | 0.281466 | -0.122133 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 63 | R | 0.511189 | P | 0.566005 | -0.054816 | No Change: Both D | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 219 | E | 0.567286 | A | 0.471154 | 0.096132 | D to O | - |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 330 | W | 0.025127 | C | 0.030259 | -0.005132 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 26 | W | 0.11109 | R | 0.252184 | -0.141094 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 77 | C | 0.279816 | Y | 0.288984 | -0.009168 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 143 | N | 0.110028 | S | 0.129678 | -0.01965 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 149 | L | 0.268453 | P | 0.456398 | -0.187945 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 156 | P | 0.181999 | S | 0.189821 | -0.007822 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 158 | W | 0.101466 | R | 0.239237 | -0.137771 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 158 | W | 0.101466 | S | 0.291841 | -0.190375 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 193 | N | 0.201521 | K | 0.236877 | -0.035356 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| O75503 | CLN5_HUMAN Ceroid-lipofuscinosis neuronal protein 5 OS=Homo sapiens GN=CLN5 PE=1 SV=2 | 325 | Y | 0.022004 | C | 0.015567 | 0.006437 | No Change: Both O | Neuronal ceroid lipofuscinosis type 5 (CLN5) [MIM:256731] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 123 | G | 0.056184 | D | 0.06268 | -0.006496 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 300 | W | 0.076508 | R | 0.185696 | -0.109188 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 62 | R | 0.053909 | H | 0.054675 | -7.66E-04 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 72 | E | 0.069032 | Q | 0.055576 | 0.013456 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 221 | Y | 0.035475 | S | 0.081891 | -0.046416 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 241 | M | 0.022246 | T | 0.029935 | -0.007689 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 299 | P | 0.075413 | L | 0.033626 | 0.041787 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 159 | P | 0.37204 | L | 0.218281 | 0.153759 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 221 | Y | 0.035475 | C | 0.024993 | 0.010482 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 6 | R | 0.851112 | T | 0.821809 | 0.029303 | No Change: Both D | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 34 | A | 0.667304 | T | 0.675061 | -0.007757 | No Change: Both D | - |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 47 | L | 0.031464 | F | 0.028338 | 0.003126 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 67 | L | 0.037223 | P | 0.080937 | -0.043714 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 77 | N | 0.256413 | K | 0.312261 | -0.055848 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 103 | R | 0.397793 | Q | 0.399244 | -0.001451 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 149 | R | 0.426244 | H | 0.455164 | -0.02892 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 238 | F | 0.008524 | T | 0.015916 | -0.007392 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4A (CLN4A) [MIM:204300] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 308 | S | 0.75643 | T | 0.693164 | 0.063266 | No Change: Both D | - |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 12 | A | 0.820075 | T | 0.828381 | -0.008306 | No Change: Both D | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 17 | G | 0.716943 | S | 0.745974 | -0.029031 | No Change: Both D | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 90 | N | 0.04925 | K | 0.06072 | -0.01147 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 104 | S | 0.459925 | F | 0.225548 | 0.234377 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 149 | R | 0.426244 | C | 0.246912 | 0.179332 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 169 | L | 0.09304 | P | 0.167936 | -0.074896 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 186 | F | 0.006595 | S | 0.01759 | -0.010995 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 234 | F | 0.008593 | L | 0.00938 | -7.87E-04 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 252 | R | 0.366946 | H | 0.369829 | -0.002883 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 259 | G | 0.188859 | S | 0.251596 | -0.062737 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9NWW5 | CLN6_HUMAN Ceroid-lipofuscinosis neuronal protein 6 OS=Homo sapiens GN=CLN6 PE=1 SV=1 | 297 | P | 0.082342 | T | 0.062087 | 0.020255 | No Change: Both O | Neuronal ceroid lipofuscinosis type 6 (CLN6) [MIM:601780] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 24 | R | 0.117559 | G | 0.135367 | -0.017808 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 Northern epilepsy variant (CLN8NE) [MIM:610003] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 155 | A | 0.113036 | V | 0.078555 | 0.034481 | No Change: Both O | - |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 16 | L | 0.195306 | M | 0.251359 | -0.056053 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 170 | T | 0.167569 | M | 0.136648 | 0.030921 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 204 | R | 0.05367 | C | 0.025239 | 0.028431 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 263 | W | 0.220787 | C | 0.261999 | -0.041212 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 92 | H | 0.377271 | Y | 0.262258 | 0.115013 | No Change: Both O | - |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 158 | Y | 0.116465 | C | 0.094152 | 0.022313 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 237 | G | 0.032772 | R | 0.03076 | 0.002012 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 30 | A | 0.03637 | P | 0.053563 | -0.017193 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 194 | Q | 0.05401 | R | 0.049331 | 0.004679 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 70 | R | 0.0948 | H | 0.095965 | -0.001165 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 76 | Q | 0.206238 | R | 0.201466 | 0.004772 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 107 | I | 0.026214 | S | 0.074557 | -0.048343 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 125 | N | 0.079942 | S | 0.098511 | -0.018569 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 139 | H | 0.018474 | Y | 0.00948 | 0.008994 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 221 | G | 0.052662 | S | 0.073482 | -0.02082 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 229 | P | 0.097432 | A | 0.067216 | 0.030216 | No Change: Both O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q9UBY8 | CLN8_HUMAN Protein CLN8 OS=Homo sapiens GN=CLN8 PE=1 SV=3 | 269 | E | 0.625914 | V | 0.451942 | 0.173972 | D to O | Neuronal ceroid lipofuscinosis type 8 (CLN8) [MIM:600143] |
| Q7Z7G1 | CLNK_HUMAN Cytokine-dependent hematopoietic cell linker OS=Homo sapiens GN=CLNK PE=2 SV=2 | 65 | S | 0.586525 | G | 0.580566 | 0.005959 | No Change: Both D | - |
| P54105 | ICLN_HUMAN Methylosome subunit pICln OS=Homo sapiens GN=CLNS1A PE=1 SV=1 | 20 | Q | 0.565814 | H | 0.504938 | 0.060876 | No Change: Both D | - |
| P54105 | ICLN_HUMAN Methylosome subunit pICln OS=Homo sapiens GN=CLNS1A PE=1 SV=1 | 218 | M | 0.644574 | T | 0.692934 | -0.04836 | No Change: Both D | - |
| O15516 | CLOCK_HUMAN Circadian locomoter output cycles protein kaput OS=Homo sapiens GN=CLOCK PE=1 SV=1 | 395 | L | 0.71784 | I | 0.702666 | 0.015174 | No Change: Both D | - |
| O15516 | CLOCK_HUMAN Circadian locomoter output cycles protein kaput OS=Homo sapiens GN=CLOCK PE=1 SV=1 | 542 | H | 0.82431 | R | 0.859287 | -0.034977 | No Change: Both D | - |
| O15516 | CLOCK_HUMAN Circadian locomoter output cycles protein kaput OS=Homo sapiens GN=CLOCK PE=1 SV=1 | 208 | S | 0.440692 | C | 0.2717 | 0.168992 | No Change: Both O | - |
| O15516 | CLOCK_HUMAN Circadian locomoter output cycles protein kaput OS=Homo sapiens GN=CLOCK PE=1 SV=1 | 380 | E | 0.430408 | K | 0.408146 | 0.022262 | No Change: Both O | - |
| Q9H078 | CLPB_HUMAN Caseinolytic peptidase B protein homolog OS=Homo sapiens GN=CLPB PE=1 SV=1 | 295 | R | 0.57225 | T | 0.566513 | 0.005737 | No Change: Both D | - |
| P04118 | COL_HUMAN Colipase OS=Homo sapiens GN=CLPS PE=1 SV=2 | 109 | R | 0.629522 | C | 0.603394 | 0.026128 | No Change: Both D | - |
| P04118 | COL_HUMAN Colipase OS=Homo sapiens GN=CLPS PE=1 SV=2 | 8 | L | 0.038793 | P | 0.073643 | -0.03485 | No Change: Both O | - |
| Q96KA5 | CLP1L_HUMAN Cleft lip and palate transmembrane protein 1-like protein OS=Homo sapiens GN=CLPTM1L PE=1 SV=1 | 313 | K | 0.493341 | N | 0.430151 | 0.06319 | No Change: Both O | A breast cancer sample |
| Q96KA5 | CLP1L_HUMAN Cleft lip and palate transmembrane protein 1-like protein OS=Homo sapiens GN=CLPTM1L PE=1 SV=1 | 537 | T | 0.868644 | M | 0.874941 | -0.006297 | No Change: Both D | - |
| O76031 | CLPX_HUMAN ATP-dependent Clp protease ATP-binding subunit clpX-like mitochondrial OS=Homo sapiens GN=CLPX PE=1 SV=2 | 488 | I | 0.193421 | T | 0.28968 | -0.096259 | No Change: Both O | - |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 120 | M | 0.079099 | K | 0.140722 | -0.061623 | No Change: Both O | Usher syndrome type 3 (USH3) [MIM:276902] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 48 | N | 0.261789 | K | 0.314321 | -0.052532 | No Change: Both O | Usher syndrome type 3 (USH3) [MIM:276902] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 150 | L | 0.036009 | P | 0.071807 | -0.035798 | No Change: Both O | Usher syndrome type 3 (USH3) [MIM:276902] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 7 | K | 0.408869 | I | 0.242542 | 0.166327 | No Change: Both O | - |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 40 | C | 0.073346 | G | 0.165727 | -0.092381 | No Change: Both O | Usher syndrome type 3 (USH3) [MIM:276902] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 105 | S | 0.021293 | P | 0.018311 | 0.002982 | No Change: Both O | Usher syndrome type 3 (USH3) [MIM:276902] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 31 | P | 0.071942 | L | 0.038054 | 0.033888 | No Change: Both O | Retinitis pigmentosa type 61 (RP61) [MIM:614180] |
| P58418 | CLRN1_HUMAN Clarin-1 OS=Homo sapiens GN=CLRN1 PE=1 SV=2 | 154 | L | 0.042214 | W | 0.026476 | 0.015738 | No Change: Both O | Retinitis pigmentosa type 61 (RP61) [MIM:614180] |
| A0PK11 | CLRN2_HUMAN Clarin-2 OS=Homo sapiens GN=CLRN2 PE=2 SV=1 | 113 | L | 0.048504 | V | 0.046432 | 0.002072 | No Change: Both O | - |
| A0PK11 | CLRN2_HUMAN Clarin-2 OS=Homo sapiens GN=CLRN2 PE=2 SV=1 | 153 | A | 0.070296 | T | 0.070635 | -3.39E-04 | No Change: Both O | - |
| Q8NCR9 | CLRN3_HUMAN Clarin-3 OS=Homo sapiens GN=CLRN3 PE=2 SV=1 | 75 | F | 0.334856 | I | 0.346149 | -0.011293 | No Change: Both O | - |
| Q9HAW4 | CLSPN_HUMAN Claspin OS=Homo sapiens GN=CLSPN PE=1 SV=3 | 525 | N | 0.466017 | S | 0.511128 | -0.045111 | O to D | - |
| Q9HAW4 | CLSPN_HUMAN Claspin OS=Homo sapiens GN=CLSPN PE=1 SV=3 | 439 | H | 0.834977 | R | 0.847832 | -0.012855 | No Change: Both D | A breast cancer sample |
| Q9HAW4 | CLSPN_HUMAN Claspin OS=Homo sapiens GN=CLSPN PE=1 SV=3 | 892 | P | 0.523819 | T | 0.44986 | 0.073959 | D to O | - |
| Q9HAW4 | CLSPN_HUMAN Claspin OS=Homo sapiens GN=CLSPN PE=1 SV=3 | 1280 | S | 0.781624 | L | 0.677039 | 0.104585 | No Change: Both D | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 474 | V | 0.340217 | A | 0.405061 | -0.064844 | No Change: Both O | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 524 | S | 0.437312 | C | 0.218921 | 0.218391 | No Change: Both O | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 583 | P | 0.321547 | R | 0.297192 | 0.024355 | No Change: Both O | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 857 | P | 0.243361 | H | 0.209233 | 0.034128 | No Change: Both O | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 870 | F | 0.008624 | S | 0.023981 | -0.015357 | No Change: Both O | - |
| O94985 | CSTN1_HUMAN Calsyntenin-1 OS=Homo sapiens GN=CLSTN1 PE=1 SV=1 | 332 | A | 0.448454 | T | 0.485848 | -0.037394 | No Change: Both O | - |
| Q9H4D0 | CSTN2_HUMAN Calsyntenin-2 OS=Homo sapiens GN=CLSTN2 PE=1 SV=2 | 193 | S | 0.236154 | I | 0.103046 | 0.133108 | No Change: Both O | A colorectal cancer sample |
| Q9H4D0 | CSTN2_HUMAN Calsyntenin-2 OS=Homo sapiens GN=CLSTN2 PE=1 SV=2 | 765 | R | 0.284742 | Q | 0.276905 | 0.007837 | No Change: Both O | A colorectal cancer sample |
| Q9H4D0 | CSTN2_HUMAN Calsyntenin-2 OS=Homo sapiens GN=CLSTN2 PE=1 SV=2 | 366 | V | 0.403075 | I | 0.380158 | 0.022917 | No Change: Both O | - |
| Q9H4D0 | CSTN2_HUMAN Calsyntenin-2 OS=Homo sapiens GN=CLSTN2 PE=1 SV=2 | 331 | I | 0.356594 | T | 0.487875 | -0.131281 | No Change: Both O | - |
| Q9BQT9 | CSTN3_HUMAN Calsyntenin-3 OS=Homo sapiens GN=CLSTN3 PE=1 SV=1 | 874 | H | 0.403373 | Y | 0.270881 | 0.132492 | No Change: Both O | A colorectal cancer sample |
| Q9BQT9 | CSTN3_HUMAN Calsyntenin-3 OS=Homo sapiens GN=CLSTN3 PE=1 SV=1 | 209 | S | 0.406579 | G | 0.368486 | 0.038093 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 61 | P | 0.562519 | L | 0.355681 | 0.206838 | D to O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 205 | K | 0.50434 | R | 0.423619 | 0.080721 | D to O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 279 | Y | 0.069811 | C | 0.049116 | 0.020695 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 691 | E | 0.418242 | K | 0.432129 | -0.013887 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 941 | K | 0.317332 | R | 0.280842 | 0.03649 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 945 | R | 0.2135 | H | 0.200387 | 0.013113 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1046 | R | 0.218853 | C | 0.1062 | 0.112653 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1195 | N | 0.371852 | S | 0.391777 | -0.019925 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1316 | M | 0.171857 | V | 0.123278 | 0.048579 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1394 | I | 0.172973 | T | 0.29307 | -0.120097 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1592 | V | 0.077379 | M | 0.109281 | -0.031902 | No Change: Both O | - |
| P53675 | CLH2_HUMAN Clathrin heavy chain 2 OS=Homo sapiens GN=CLTCL1 PE=1 SV=2 | 1620 | R | 0.649312 | H | 0.670612 | -0.0213 | No Change: Both D | - |
| P10909 | CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE=1 SV=1 | 317 | N | 0.774881 | H | 0.730731 | 0.04415 | No Change: Both D | - |
| P10909 | CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE=1 SV=1 | 328 | D | 0.72575 | N | 0.733872 | -0.008122 | No Change: Both D | - |
| P10909 | CLUS_HUMAN Clusterin OS=Homo sapiens GN=CLU PE=1 SV=1 | 396 | S | 0.75328 | L | 0.623747 | 0.129533 | No Change: Both D | - |
| Q96AJ1 | CLUA1_HUMAN Clusterin-associated protein 1 OS=Homo sapiens GN=CLUAP1 PE=1 SV=4 | 68 | A | 0.072775 | S | 0.105141 | -0.032366 | No Change: Both O | - |
| Q96AJ1 | CLUA1_HUMAN Clusterin-associated protein 1 OS=Homo sapiens GN=CLUAP1 PE=1 SV=4 | 401 | R | 0.991762 | W | 0.96894 | 0.022822 | No Change: Both D | - |
| Q8N0X4 | CLYBL_HUMAN Citrate lyase subunit beta-like protein mitochondrial OS=Homo sapiens GN=CLYBL PE=2 SV=2 | 28 | D | 0.495768 | Y | 0.363504 | 0.132264 | No Change: Both O | - |
| Q8N0X4 | CLYBL_HUMAN Citrate lyase subunit beta-like protein mitochondrial OS=Homo sapiens GN=CLYBL PE=2 SV=2 | 128 | V | 0.531966 | I | 0.48954 | 0.042426 | D to O | - |
| Q8N0X4 | CLYBL_HUMAN Citrate lyase subunit beta-like protein mitochondrial OS=Homo sapiens GN=CLYBL PE=2 SV=2 | 241 | I | 0.048088 | V | 0.054793 | -0.006705 | No Change: Both O | - |
| P23946 | CMA1_HUMAN Chymase OS=Homo sapiens GN=CMA1 PE=1 SV=1 | 46 | G | 0.335181 | R | 0.311796 | 0.023385 | No Change: Both O | - |
| P23946 | CMA1_HUMAN Chymase OS=Homo sapiens GN=CMA1 PE=1 SV=1 | 66 | H | 0.132364 | R | 0.140869 | -0.008505 | No Change: Both O | - |
| P23946 | CMA1_HUMAN Chymase OS=Homo sapiens GN=CMA1 PE=1 SV=1 | 98 | R | 0.31279 | H | 0.334168 | -0.021378 | No Change: Both O | - |
| Q96DG6 | CMBL_HUMAN Carboxymethylenebutenolidase homolog OS=Homo sapiens GN=CMBL PE=1 SV=1 | 155 | Y | 0.189426 | C | 0.151749 | 0.037677 | No Change: Both O | - |
| Q5EBM0 | CMPK2_HUMAN UMP-CMP kinase 2 mitochondrial OS=Homo sapiens GN=CMPK2 PE=1 SV=3 | 433 | K | 0.530741 | R | 0.535861 | -0.00512 | No Change: Both D | - |
| Q8IZ96 | CKLF1_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 1 OS=Homo sapiens GN=CMTM1 PE=2 SV=1 | 10 | S | 0.890103 | T | 0.866077 | 0.024026 | No Change: Both D | - |
| Q8TAZ6 | CKLF2_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 2 OS=Homo sapiens GN=CMTM2 PE=2 SV=1 | 122 | I | 0.044917 | T | 0.083444 | -0.038527 | No Change: Both O | - |
| Q9NX76 | CKLF6_HUMAN CKLF-like MARVEL transmembrane domain-containing protein 6 OS=Homo sapiens GN=CMTM6 PE=1 SV=1 | 91 | T | 0.02976 | A | 0.024347 | 0.005413 | No Change: Both O | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 64 | Y | 0.847774 | C | 0.882356 | -0.034582 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 175 | Q | 0.87864 | H | 0.845866 | 0.032774 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 190 | D | 0.747988 | G | 0.756067 | -0.008079 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 349 | G | 0.813791 | D | 0.833952 | -0.020161 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 591 | G | 0.815426 | D | 0.844031 | -0.028605 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1006 | V | 0.874292 | A | 0.915037 | -0.040745 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1295 | A | 0.852196 | V | 0.827246 | 0.02495 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1309 | I | 0.71853 | V | 0.747525 | -0.028995 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1333 | A | 0.78137 | V | 0.736113 | 0.045257 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1380 | I | 0.728302 | V | 0.770179 | -0.041877 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1567 | A | 0.935922 | E | 0.954247 | -0.018325 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1599 | S | 0.857109 | A | 0.811953 | 0.045156 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1669 | L | 0.94755 | S | 0.971993 | -0.024443 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1713 | I | 0.968623 | N | 0.978842 | -0.010219 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1721 | I | 0.951901 | V | 0.95049 | 0.001411 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1875 | A | 0.819886 | V | 0.802021 | 0.017865 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1917 | D | 0.807596 | G | 0.802626 | 0.00497 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 1920 | S | 0.838431 | G | 0.791907 | 0.046524 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 2262 | V | 0.75849 | L | 0.767976 | -0.009486 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 2383 | K | 0.9206 | E | 0.915596 | 0.005004 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 2693 | T | 0.878349 | I | 0.816346 | 0.062003 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 2906 | K | 0.894193 | N | 0.882231 | 0.011962 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 2935 | G | 0.640195 | R | 0.630422 | 0.009773 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 3358 | H | 0.666511 | Q | 0.671514 | -0.005003 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 3583 | K | 0.889904 | E | 0.903171 | -0.013267 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 3927 | R | 0.409417 | Q | 0.395517 | 0.0139 | No Change: Both O | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 4063 | P | 0.653933 | L | 0.548315 | 0.105618 | No Change: Both D | - |
| Q8N3K9 | CMYA5_HUMAN Cardiomyopathy-associated protein 5 OS=Homo sapiens GN=CMYA5 PE=1 SV=3 | 651 | S | 0.983358 | R | 0.973065 | 0.010293 | No Change: Both D | - |
| Q8NA66 | CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 OS=Homo sapiens GN=CNBD1 PE=2 SV=1 | 64 | D | 0.387037 | N | 0.414054 | -0.027017 | No Change: Both O | - |
| Q8NA66 | CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 OS=Homo sapiens GN=CNBD1 PE=2 SV=1 | 69 | Q | 0.464815 | K | 0.500688 | -0.035873 | O to D | - |
| Q8NA66 | CNBD1_HUMAN Cyclic nucleotide-binding domain-containing protein 1 OS=Homo sapiens GN=CNBD1 PE=2 SV=1 | 257 | M | 0.473909 | V | 0.378039 | 0.09587 | No Change: Both O | - |
| Q96KN2 | CNDP1_HUMAN Beta-Ala-His dipeptidase OS=Homo sapiens GN=CNDP1 PE=1 SV=4 | 6 | G | 0.68424 | R | 0.753697 | -0.069457 | No Change: Both D | - |
| Q96KN2 | CNDP1_HUMAN Beta-Ala-His dipeptidase OS=Homo sapiens GN=CNDP1 PE=1 SV=4 | 113 | I | 0.349206 | V | 0.367019 | -0.017813 | No Change: Both O | - |
| Q96KP4 | CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens GN=CNDP2 PE=1 SV=2 | 126 | Y | 0.550625 | H | 0.65363 | -0.103005 | No Change: Both D | - |
| P29973 | CNGA1_HUMAN cGMP-gated cation channel alpha-1 OS=Homo sapiens GN=CNGA1 PE=1 SV=3 | 32 | R | 0.741119 | Q | 0.750102 | -0.008983 | No Change: Both D | - |
| P29973 | CNGA1_HUMAN cGMP-gated cation channel alpha-1 OS=Homo sapiens GN=CNGA1 PE=1 SV=3 | 118 | D | 0.999706 | N | 0.999725 | -1.90E-05 | No Change: Both D | - |
| P29973 | CNGA1_HUMAN cGMP-gated cation channel alpha-1 OS=Homo sapiens GN=CNGA1 PE=1 SV=3 | 320 | S | 0.071735 | F | 0.026567 | 0.045168 | No Change: Both O | Retinitis pigmentosa type 49 (RP49) [MIM:613756] |
| P29973 | CNGA1_HUMAN cGMP-gated cation channel alpha-1 OS=Homo sapiens GN=CNGA1 PE=1 SV=3 | 122 | N | 0.999957 | D | 0.999957 | 0 | No Change: Both D | - |
| Q16280 | CNGA2_HUMAN Cyclic nucleotide-gated olfactory channel OS=Homo sapiens GN=CNGA2 PE=2 SV=2 | 97 | R | 0.771246 | H | 0.691972 | 0.079274 | No Change: Both D | A breast cancer sample |
| Q16280 | CNGA2_HUMAN Cyclic nucleotide-gated olfactory channel OS=Homo sapiens GN=CNGA2 PE=2 SV=2 | 399 | R | 0.407111 | Q | 0.444277 | -0.037166 | No Change: Both O | A breast cancer sample |
| Q16280 | CNGA2_HUMAN Cyclic nucleotide-gated olfactory channel OS=Homo sapiens GN=CNGA2 PE=2 SV=2 | 118 | D | 0.831703 | H | 0.837598 | -0.005895 | No Change: Both D | - |
| Q16280 | CNGA2_HUMAN Cyclic nucleotide-gated olfactory channel OS=Homo sapiens GN=CNGA2 PE=2 SV=2 | 663 | E | 0.886922 | K | 0.881738 | 0.005184 | No Change: Both D | - |
| Q16280 | CNGA2_HUMAN Cyclic nucleotide-gated olfactory channel OS=Homo sapiens GN=CNGA2 PE=2 SV=2 | 139 | W | 0.020252 | L | 0.030819 | -0.010567 | No Change: Both O | - |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 153 | T | 0.761958 | M | 0.751162 | 0.010796 | No Change: Both D | - |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 163 | P | 0.281379 | L | 0.16169 | 0.119689 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 283 | R | 0.12902 | Q | 0.12818 | 8.40E-04 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 283 | R | 0.12902 | W | 0.045656 | 0.083364 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 291 | T | 0.44481 | R | 0.463285 | -0.018475 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 529 | V | 0.178566 | M | 0.211091 | -0.032525 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 547 | F | 0.210268 | L | 0.247689 | -0.037421 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 557 | G | 0.636038 | R | 0.622866 | 0.013172 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 410 | R | 0.534281 | W | 0.30273 | 0.231551 | D to O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 198 | E | 0.096912 | K | 0.090342 | 0.00657 | No Change: Both O | - |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 48 | P | 0.724346 | L | 0.636412 | 0.087934 | No Change: Both D | - |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 162 | D | 0.319658 | V | 0.17946 | 0.140198 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 181 | Y | 0.009916 | C | 0.007451 | 0.002465 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 182 | N | 0.007966 | Y | 0.004408 | 0.003558 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 186 | L | 0.005869 | F | 0.005122 | 7.47E-04 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 191 | C | 0.047822 | Y | 0.06057 | -0.012748 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 194 | E | 0.128451 | K | 0.120165 | 0.008286 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 223 | R | 0.128929 | W | 0.047626 | 0.081303 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 224 | T | 0.146152 | R | 0.169345 | -0.023193 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 228 | E | 0.265697 | K | 0.26309 | 0.002607 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 249 | F | 0.267535 | S | 0.499167 | -0.231632 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 260 | D | 0.148502 | N | 0.137931 | 0.010571 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 263 | Y | 0.166203 | D | 0.290767 | -0.124564 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 267 | G | 0.202704 | D | 0.236222 | -0.033518 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 277 | R | 0.176724 | C | 0.080007 | 0.096717 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 277 | R | 0.176724 | H | 0.160755 | 0.015969 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 341 | S | 0.315993 | P | 0.293734 | 0.022259 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 369 | T | 0.621806 | S | 0.676513 | -0.054707 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 372 | P | 0.639481 | S | 0.646771 | -0.00729 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 380 | F | 0.061196 | S | 0.143578 | -0.082382 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 401 | S | 0.360324 | P | 0.311953 | 0.048371 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 406 | M | 0.572821 | T | 0.606404 | -0.033583 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 427 | R | 0.292906 | C | 0.161898 | 0.131008 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 436 | R | 0.125956 | W | 0.05297 | 0.072986 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 439 | R | 0.057829 | W | 0.0218 | 0.036029 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 469 | A | 0.175873 | T | 0.191946 | -0.016073 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 471 | N | 0.136255 | S | 0.162586 | -0.026331 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 485 | D | 0.096867 | V | 0.050877 | 0.04599 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 510 | C | 0.31672 | S | 0.576856 | -0.260136 | O to D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 513 | G | 0.385706 | E | 0.437556 | -0.05185 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 516 | G | 0.315217 | E | 0.370629 | -0.055412 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 522 | I | 0.175987 | T | 0.275819 | -0.099832 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 525 | G | 0.191358 | D | 0.217635 | -0.026277 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 548 | G | 0.209116 | R | 0.187901 | 0.021215 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 563 | R | 0.673272 | H | 0.670184 | 0.003088 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 565 | T | 0.609357 | M | 0.569926 | 0.039431 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 569 | R | 0.363411 | H | 0.330047 | 0.033364 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 573 | Y | 0.285094 | C | 0.345631 | -0.060537 | No Change: Both O | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 590 | E | 0.543453 | K | 0.543244 | 2.09E-04 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 593 | E | 0.625718 | K | 0.623734 | 0.001984 | No Change: Both D | Achromatopsia type 2 (ACHM2) [MIM:216900] |
| Q16281 | CNGA3_HUMAN Cyclic nucleotide-gated cation channel alpha-3 OS=Homo sapiens GN=CNGA3 PE=1 SV=2 | 527 | L | 0.168795 | M | 0.222635 | -0.05384 | No Change: Both O | Leber congenital amaurosis (LCA) |
| Q8IV77 | CNGA4_HUMAN Cyclic nucleotide-gated cation channel alpha-4 OS=Homo sapiens GN=CNGA4 PE=1 SV=3 | 553 | E | 0.958128 | V | 0.912659 | 0.045469 | No Change: Both D | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 100 | R | 0.462396 | H | 0.414957 | 0.047439 | No Change: Both O | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 479 | L | 0.959959 | I | 0.952235 | 0.007724 | No Change: Both D | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 535 | V | 0.919406 | A | 0.945838 | -0.026432 | No Change: Both D | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 731 | N | 0.566274 | K | 0.620956 | -0.054682 | No Change: Both D | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 745 | L | 0.125124 | I | 0.093179 | 0.031945 | No Change: Both O | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 911 | K | 0.341622 | R | 0.273382 | 0.06824 | No Change: Both O | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 961 | A | 0.087036 | S | 0.147478 | -0.060442 | No Change: Both O | - |
| Q14028 | CNGB1_HUMAN Cyclic nucleotide-gated cation channel beta-1 OS=Homo sapiens GN=CNGB1 PE=1 SV=2 | 993 | G | 0.326099 | V | 0.207472 | 0.118627 | No Change: Both O | Retinitis pigmentosa type 45 (RP45) [MIM:613767] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 234 | C | 0.010904 | W | 0.009094 | 0.00181 | No Change: Both O | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 298 | T | 0.416921 | P | 0.452171 | -0.03525 | No Change: Both O | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 435 | S | 0.120998 | F | 0.045368 | 0.07563 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 755 | E | 0.963727 | G | 0.949982 | 0.013745 | No Change: Both D | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 307 | I | 0.045715 | V | 0.051247 | -0.005532 | No Change: Both O | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 203 | R | 0.312241 | Q | 0.332735 | -0.020494 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 750 | P | 0.986806 | S | 0.98518 | 0.001626 | No Change: Both D | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 25 | R | 0.986808 | H | 0.983674 | 0.003134 | No Change: Both D | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 27 | N | 0.988992 | S | 0.990685 | -0.001693 | No Change: Both D | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 107 | G | 0.964493 | R | 0.965707 | -0.001214 | No Change: Both D | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 148 | K | 0.632051 | E | 0.62479 | 0.007261 | No Change: Both D | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 156 | S | 0.778451 | F | 0.635346 | 0.143105 | No Change: Both D | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 199 | E | 0.269271 | K | 0.296542 | -0.027271 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 309 | P | 0.027208 | L | 0.013459 | 0.013749 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 403 | R | 0.02231 | Q | 0.023638 | -0.001328 | No Change: Both O | - |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 466 | M | 0.169235 | T | 0.207481 | -0.038246 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 469 | Y | 0.196244 | D | 0.32117 | -0.124926 | No Change: Both O | Stargardt disease type 1 (STGD1) [MIM:248200] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 494 | D | 0.503218 | N | 0.4627 | 0.040518 | D to O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 513 | D | 0.071068 | Y | 0.033671 | 0.037397 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 525 | F | 0.159058 | N | 0.300977 | -0.141919 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 558 | G | 0.353601 | C | 0.192159 | 0.161442 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 595 | L | 0.22446 | F | 0.204649 | 0.019811 | No Change: Both O | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9NQW8 | CNGB3_HUMAN Cyclic nucleotide-gated cation channel beta-3 OS=Homo sapiens GN=CNGB3 PE=1 SV=2 | 672 | T | 0.895259 | P | 0.919684 | -0.024425 | No Change: Both D | Achromatopsia type 3 (ACHM3) [MIM:262300] |
| Q9P003 | CNIH4_HUMAN Protein cornichon homolog 4 OS=Homo sapiens GN=CNIH4 PE=2 SV=1 | 3 | A | 0.512309 | G | 0.580538 | -0.068229 | No Change: Both D | - |
| Q969H4 | CNKR1_HUMAN Connector enhancer of kinase suppressor of ras 1 OS=Homo sapiens GN=CNKSR1 PE=1 SV=1 | 662 | R | 0.506055 | W | 0.331329 | 0.174726 | D to O | - |
| Q8WXI2 | CNKR2_HUMAN Connector enhancer of kinase suppressor of ras 2 OS=Homo sapiens GN=CNKSR2 PE=1 SV=1 | 46 | R | 0.27916 | H | 0.294976 | -0.015816 | No Change: Both O | A colorectal cancer sample |
| Q9NRU3 | CNNM1_HUMAN Metal transporter CNNM1 OS=Homo sapiens GN=CNNM1 PE=2 SV=3 | 819 | R | 0.960517 | Q | 0.963514 | -0.002997 | No Change: Both D | - |
| Q9H8M5 | CNNM2_HUMAN Metal transporter CNNM2 OS=Homo sapiens GN=CNNM2 PE=1 SV=2 | 38 | R | 0.586745 | Q | 0.579533 | 0.007212 | No Change: Both D | - |
| Q9H8M5 | CNNM2_HUMAN Metal transporter CNNM2 OS=Homo sapiens GN=CNNM2 PE=1 SV=2 | 568 | T | 0.104716 | I | 0.065448 | 0.039268 | No Change: Both O | Hypomagnesemia type 6 (HOMG6) [MIM:613882] |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 126 | G | 0.403341 | R | 0.404538 | -0.001197 | No Change: Both O | - |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 134 | V | 0.132765 | L | 0.13744 | -0.004675 | No Change: Both O | A breast cancer sample |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 196 | S | 0.064023 | P | 0.052811 | 0.011212 | No Change: Both O | Jalili syndrome (JALIS) [MIM:217080] |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 200 | S | 0.129438 | Y | 0.052928 | 0.07651 | No Change: Both O | Jalili syndrome (JALIS) [MIM:217080] |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 236 | R | 0.340354 | Q | 0.335999 | 0.004355 | No Change: Both O | Jalili syndrome (JALIS) [MIM:217080] |
| Q6P4Q7 | CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens GN=CNNM4 PE=1 SV=3 | 324 | L | 0.116512 | P | 0.21843 | -0.101918 | No Change: Both O | Jalili syndrome (JALIS) [MIM:217080] |
| A5YKK6 | CNOT1_HUMAN CCR4-NOT transcription complex subunit 1 OS=Homo sapiens GN=CNOT1 PE=1 SV=2 | 603 | D | 0.328725 | A | 0.236031 | 0.092694 | No Change: Both O | - |
| Q9H9A5 | CNOTA_HUMAN CCR4-NOT transcription complex subunit 10 OS=Homo sapiens GN=CNOT10 PE=1 SV=1 | 736 | P | 0.712176 | S | 0.64866 | 0.063516 | No Change: Both D | - |
| Q9H9A5 | CNOTA_HUMAN CCR4-NOT transcription complex subunit 10 OS=Homo sapiens GN=CNOT10 PE=1 SV=1 | 348 | T | 0.205649 | S | 0.267891 | -0.062242 | No Change: Both O | - |
| Q9NZN8 | CNOT2_HUMAN CCR4-NOT transcription complex subunit 2 OS=Homo sapiens GN=CNOT2 PE=1 SV=1 | 460 | A | 0.070458 | T | 0.075211 | -0.004753 | No Change: Both O | - |
| O95628 | CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens GN=CNOT4 PE=1 SV=3 | 7 | A | 0.825509 | G | 0.843254 | -0.017745 | No Change: Both D | - |
| Q9UFF9 | CNOT8_HUMAN CCR4-NOT transcription complex subunit 8 OS=Homo sapiens GN=CNOT8 PE=1 SV=1 | 32 | L | 0.107381 | P | 0.21 | -0.102619 | No Change: Both O | - |
| P09543 | CN37_HUMAN 2' 3'-cyclic-nucleotide 3'-phosphodiesterase OS=Homo sapiens GN=CNP PE=1 SV=2 | 207 | Q | 0.373486 | R | 0.387678 | -0.014192 | No Change: Both O | - |
| Q9BV87 | CNPD1_HUMAN Protein CNPPD1 OS=Homo sapiens GN=CNPPD1 PE=2 SV=2 | 262 | I | 0.433343 | T | 0.561537 | -0.128194 | O to D | - |
| Q9BV87 | CNPD1_HUMAN Protein CNPPD1 OS=Homo sapiens GN=CNPPD1 PE=2 SV=2 | 292 | L | 0.784395 | P | 0.863952 | -0.079557 | No Change: Both D | - |
| Q9BV87 | CNPD1_HUMAN Protein CNPPD1 OS=Homo sapiens GN=CNPPD1 PE=2 SV=2 | 366 | P | 0.425859 | L | 0.269047 | 0.156812 | No Change: Both O | - |
| Q9BV87 | CNPD1_HUMAN Protein CNPPD1 OS=Homo sapiens GN=CNPPD1 PE=2 SV=2 | 383 | L | 0.306467 | P | 0.500612 | -0.194145 | O to D | - |
| Q9BV87 | CNPD1_HUMAN Protein CNPPD1 OS=Homo sapiens GN=CNPPD1 PE=2 SV=2 | 344 | R | 0.769312 | T | 0.7728 | -0.003488 | No Change: Both D | - |
| Q9BT09 | CNPY3_HUMAN Protein canopy homolog 3 OS=Homo sapiens GN=CNPY3 PE=1 SV=1 | 145 | M | 0.115308 | I | 0.081128 | 0.03418 | No Change: Both O | - |
| Q9BT09 | CNPY3_HUMAN Protein canopy homolog 3 OS=Homo sapiens GN=CNPY3 PE=1 SV=1 | 231 | S | 0.99053 | I | 0.97753 | 0.013 | No Change: Both D | - |
| Q8N129 | CNPY4_HUMAN Protein canopy homolog 4 OS=Homo sapiens GN=CNPY4 PE=2 SV=1 | 168 | G | 0.142257 | R | 0.136745 | 0.005512 | No Change: Both O | - |
| P34972 | CNR2_HUMAN Cannabinoid receptor 2 OS=Homo sapiens GN=CNR2 PE=1 SV=1 | 316 | H | 0.269126 | Y | 0.16361 | 0.105516 | No Change: Both O | - |
| P34972 | CNR2_HUMAN Cannabinoid receptor 2 OS=Homo sapiens GN=CNR2 PE=1 SV=1 | 63 | Q | 0.403426 | R | 0.403967 | -5.41E-04 | No Change: Both O | - |
| Q6PJW8 | CNST_HUMAN Consortin OS=Homo sapiens GN=CNST PE=2 SV=3 | 28 | S | 0.813802 | N | 0.763823 | 0.049979 | No Change: Both D | - |
| Q6PJW8 | CNST_HUMAN Consortin OS=Homo sapiens GN=CNST PE=2 SV=3 | 87 | L | 0.784473 | S | 0.864855 | -0.080382 | No Change: Both D | - |
| Q6PJW8 | CNST_HUMAN Consortin OS=Homo sapiens GN=CNST PE=2 SV=3 | 399 | R | 0.871185 | C | 0.84652 | 0.024665 | No Change: Both D | - |
| Q6PJW8 | CNST_HUMAN Consortin OS=Homo sapiens GN=CNST PE=2 SV=3 | 183 | Q | 0.413107 | R | 0.410626 | 0.002481 | No Change: Both O | - |
| Q8N815 | CNTD1_HUMAN Cyclin N-terminal domain-containing protein 1 OS=Homo sapiens GN=CNTD1 PE=2 SV=2 | 145 | T | 0.068739 | P | 0.085715 | -0.016976 | No Change: Both O | - |
| P26441 | CNTF_HUMAN Ciliary neurotrophic factor OS=Homo sapiens GN=CNTF PE=1 SV=1 | 182 | H | 0.412731 | R | 0.422637 | -0.009906 | No Change: Both O | - |
| P26441 | CNTF_HUMAN Ciliary neurotrophic factor OS=Homo sapiens GN=CNTF PE=1 SV=1 | 49 | N | 0.445944 | S | 0.480947 | -0.035003 | No Change: Both O | - |
| Q9NXG0 | CNTLN_HUMAN Centlein OS=Homo sapiens GN=CNTLN PE=2 SV=5 | 562 | R | 0.88632 | C | 0.822879 | 0.063441 | No Change: Both D | - |
| Q9NXG0 | CNTLN_HUMAN Centlein OS=Homo sapiens GN=CNTLN PE=2 SV=5 | 695 | T | 0.964431 | I | 0.933296 | 0.031135 | No Change: Both D | - |
| Q9NXG0 | CNTLN_HUMAN Centlein OS=Homo sapiens GN=CNTLN PE=2 SV=5 | 1376 | T | 0.423202 | A | 0.413572 | 0.00963 | No Change: Both O | - |
| Q9NXG0 | CNTLN_HUMAN Centlein OS=Homo sapiens GN=CNTLN PE=2 SV=5 | 284 | T | 0.640973 | A | 0.625094 | 0.015879 | No Change: Both D | - |
| Q9NXG0 | CNTLN_HUMAN Centlein OS=Homo sapiens GN=CNTLN PE=2 SV=5 | 291 | E | 0.640177 | D | 0.604004 | 0.036173 | No Change: Both D | - |
| Q12860 | CNTN1_HUMAN Contactin-1 OS=Homo sapiens GN=CNTN1 PE=1 SV=1 | 798 | V | 0.325897 | L | 0.308655 | 0.017242 | No Change: Both O | - |
| Q12860 | CNTN1_HUMAN Contactin-1 OS=Homo sapiens GN=CNTN1 PE=1 SV=1 | 794 | P | 0.40016 | H | 0.330773 | 0.069387 | No Change: Both O | A colorectal cancer sample |
| Q12860 | CNTN1_HUMAN Contactin-1 OS=Homo sapiens GN=CNTN1 PE=1 SV=1 | 824 | E | 0.449664 | G | 0.392549 | 0.057115 | No Change: Both O | - |
| Q02246 | CNTN2_HUMAN Contactin-2 OS=Homo sapiens GN=CNTN2 PE=1 SV=1 | 145 | A | 0.445613 | T | 0.470481 | -0.024868 | No Change: Both O | - |
| Q02246 | CNTN2_HUMAN Contactin-2 OS=Homo sapiens GN=CNTN2 PE=1 SV=1 | 657 | R | 0.383529 | W | 0.206642 | 0.176887 | No Change: Both O | - |
| Q02246 | CNTN2_HUMAN Contactin-2 OS=Homo sapiens GN=CNTN2 PE=1 SV=1 | 366 | P | 0.438376 | L | 0.298805 | 0.139571 | No Change: Both O | - |
| Q02246 | CNTN2_HUMAN Contactin-2 OS=Homo sapiens GN=CNTN2 PE=1 SV=1 | 1024 | V | 0.443829 | I | 0.415743 | 0.028086 | No Change: Both O | - |
| Q9P232 | CNTN3_HUMAN Contactin-3 OS=Homo sapiens GN=CNTN3 PE=1 SV=3 | 630 | S | 0.342219 | N | 0.29404 | 0.048179 | No Change: Both O | - |
| Q9P232 | CNTN3_HUMAN Contactin-3 OS=Homo sapiens GN=CNTN3 PE=1 SV=3 | 708 | N | 0.817892 | S | 0.848043 | -0.030151 | No Change: Both D | - |
| Q8IWV2 | CNTN4_HUMAN Contactin-4 OS=Homo sapiens GN=CNTN4 PE=1 SV=1 | 176 | T | 0.268221 | P | 0.315659 | -0.047438 | No Change: Both O | A colorectal cancer sample |
| Q8IWV2 | CNTN4_HUMAN Contactin-4 OS=Homo sapiens GN=CNTN4 PE=1 SV=1 | 420 | K | 0.176284 | N | 0.137411 | 0.038873 | No Change: Both O | A colorectal cancer sample |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 23 | S | 0.678227 | A | 0.568922 | 0.109305 | No Change: Both D | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 70 | L | 0.610903 | R | 0.674299 | -0.063396 | No Change: Both D | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 81 | N | 0.38593 | S | 0.459637 | -0.073707 | No Change: Both O | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 530 | I | 0.384946 | V | 0.3966 | -0.011654 | No Change: Both O | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 1065 | Y | 0.628728 | F | 0.593011 | 0.035717 | No Change: Both D | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 1079 | S | 0.8783 | T | 0.837682 | 0.040618 | No Change: Both D | - |
| O94779 | CNTN5_HUMAN Contactin-5 OS=Homo sapiens GN=CNTN5 PE=2 SV=2 | 1094 | M | 0.766879 | V | 0.696041 | 0.070838 | No Change: Both D | - |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 440 | A | 0.245842 | S | 0.343152 | -0.09731 | No Change: Both O | - |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 150 | F | 0.234119 | S | 0.428839 | -0.19472 | No Change: Both O | - |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 108 | T | 0.163371 | A | 0.147318 | 0.016053 | No Change: Both O | A breast cancer sample |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 585 | S | 0.287687 | C | 0.147682 | 0.140005 | No Change: Both O | A breast cancer sample |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 303 | R | 0.282345 | Q | 0.292743 | -0.010398 | No Change: Both O | - |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 314 | F | 0.105418 | V | 0.116277 | -0.010859 | No Change: Both O | - |
| Q9UQ52 | CNTN6_HUMAN Contactin-6 OS=Homo sapiens GN=CNTN6 PE=1 SV=1 | 954 | E | 0.515428 | V | 0.338647 | 0.176781 | D to O | - |
| P78357 | CNTP1_HUMAN Contactin-associated protein 1 OS=Homo sapiens GN=CNTNAP1 PE=1 SV=1 | 522 | V | 0.156723 | L | 0.163081 | -0.006358 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 114 | R | 0.195668 | Q | 0.218174 | -0.022506 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 218 | T | 0.4099 | M | 0.362552 | 0.047348 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 226 | L | 0.478043 | M | 0.537641 | -0.059598 | O to D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 283 | R | 0.353682 | C | 0.195736 | 0.157946 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 382 | S | 0.155905 | N | 0.140427 | 0.015478 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 407 | N | 0.143343 | S | 0.171123 | -0.02778 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 418 | N | 0.217668 | D | 0.233682 | -0.016014 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 680 | E | 0.29126 | K | 0.274411 | 0.016849 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 699 | P | 0.438327 | Q | 0.402853 | 0.035474 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 716 | Y | 0.337069 | C | 0.273891 | 0.063178 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 731 | G | 0.156258 | S | 0.184556 | -0.028298 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 779 | G | 0.594239 | D | 0.612869 | -0.01863 | No Change: Both D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 869 | I | 0.298589 | T | 0.456749 | -0.15816 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 906 | R | 0.554967 | H | 0.542102 | 0.012865 | No Change: Both D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1038 | D | 0.805834 | N | 0.799358 | 0.006476 | No Change: Both D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1102 | V | 0.400504 | A | 0.498532 | -0.098028 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1114 | S | 0.495669 | G | 0.469501 | 0.026168 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1119 | R | 0.362964 | H | 0.385048 | -0.022084 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1129 | D | 0.283595 | H | 0.266134 | 0.017461 | No Change: Both O | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1227 | A | 0.638542 | T | 0.67238 | -0.033838 | No Change: Both D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1253 | I | 0.533641 | T | 0.684588 | -0.150947 | No Change: Both D | - |
| Q9UHC6 | CNTP2_HUMAN Contactin-associated protein-like 2 OS=Homo sapiens GN=CNTNAP2 PE=1 SV=1 | 1278 | T | 0.006192 | I | 0.003258 | 0.002934 | No Change: Both O | - |
| Q9BZ76 | CNTP3_HUMAN Contactin-associated protein-like 3 OS=Homo sapiens GN=CNTNAP3 PE=2 SV=3 | 628 | A | 0.129069 | S | 0.177655 | -0.048586 | No Change: Both O | - |
| Q9BZ76 | CNTP3_HUMAN Contactin-associated protein-like 3 OS=Homo sapiens GN=CNTNAP3 PE=2 SV=3 | 845 | R | 0.186498 | H | 0.172297 | 0.014201 | No Change: Both O | - |
| Q9C0A0 | CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens GN=CNTNAP4 PE=1 SV=3 | 513 | Q | 0.325803 | H | 0.254288 | 0.071515 | No Change: Both O | - |
| Q9C0A0 | CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens GN=CNTNAP4 PE=1 SV=3 | 1155 | D | 0.484571 | E | 0.490672 | -0.006101 | No Change: Both O | - |
| Q9C0A0 | CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens GN=CNTNAP4 PE=1 SV=3 | 1300 | N | 0.593214 | S | 0.620818 | -0.027604 | No Change: Both D | - |
| Q9C0A0 | CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens GN=CNTNAP4 PE=1 SV=3 | 276 | L | 0.167828 | V | 0.168223 | -3.95E-04 | No Change: Both O | - |
| Q9C0A0 | CNTP4_HUMAN Contactin-associated protein-like 4 OS=Homo sapiens GN=CNTNAP4 PE=1 SV=3 | 786 | Q | 0.164584 | R | 0.165292 | -7.08E-04 | No Change: Both O | - |
| Q8WYK1 | CNTP5_HUMAN Contactin-associated protein-like 5 OS=Homo sapiens GN=CNTNAP5 PE=2 SV=1 | 452 | S | 0.239354 | L | 0.116522 | 0.122832 | No Change: Both O | - |
| Q8WYK1 | CNTP5_HUMAN Contactin-associated protein-like 5 OS=Homo sapiens GN=CNTNAP5 PE=2 SV=1 | 1195 | T | 0.401272 | M | 0.356024 | 0.045248 | No Change: Both O | - |
| Q7Z7A1 | CNTRL_HUMAN Centriolin OS=Homo sapiens GN=CNTRL PE=1 SV=2 | 56 | V | 0.284219 | I | 0.283967 | 2.52E-04 | No Change: Both O | - |
| Q7Z7A1 | CNTRL_HUMAN Centriolin OS=Homo sapiens GN=CNTRL PE=1 SV=2 | 216 | P | 0.381255 | L | 0.249634 | 0.131621 | No Change: Both O | - |
| Q7Z7A1 | CNTRL_HUMAN Centriolin OS=Homo sapiens GN=CNTRL PE=1 SV=2 | 889 | A | 0.893856 | T | 0.891236 | 0.00262 | No Change: Both D | - |
| Q7Z7A1 | CNTRL_HUMAN Centriolin OS=Homo sapiens GN=CNTRL PE=1 SV=2 | 1146 | M | 0.624734 | V | 0.546201 | 0.078533 | No Change: Both D | - |
| Q8N137 | CNTRB_HUMAN Centrobin OS=Homo sapiens GN=CNTROB PE=1 SV=1 | 578 | P | 0.967622 | Q | 0.961211 | 0.006411 | No Change: Both D | - |
| Q8N137 | CNTRB_HUMAN Centrobin OS=Homo sapiens GN=CNTROB PE=1 SV=1 | 439 | R | 0.888171 | Q | 0.892793 | -0.004622 | No Change: Both D | - |
| Q86WW8 | COA5_HUMAN Cytochrome c oxidase assembly factor 5 OS=Homo sapiens GN=COA5 PE=1 SV=1 | 53 | A | 0.279177 | P | 0.376243 | -0.097066 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q13057 | COASY_HUMAN Bifunctional coenzyme A synthase OS=Homo sapiens GN=COASY PE=1 SV=4 | 55 | S | 0.731183 | Y | 0.557566 | 0.173617 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 577 | D | 0.899679 | A | 0.882147 | 0.017532 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 607 | V | 0.594265 | I | 0.575254 | 0.019011 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 927 | D | 0.660057 | N | 0.636779 | 0.023278 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 1015 | A | 0.992488 | P | 0.995272 | -0.002784 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 526 | P | 0.661772 | L | 0.506934 | 0.154838 | No Change: Both D | - |
| O75128 | COBL_HUMAN Protein cordon-bleu OS=Homo sapiens GN=COBL PE=1 SV=2 | 919 | H | 0.753283 | Q | 0.789961 | -0.036678 | No Change: Both D | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 51 | P | 0.186557 | S | 0.195568 | -0.009011 | No Change: Both O | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 66 | V | 0.1479 | G | 0.238652 | -0.090752 | No Change: Both O | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 88 | G | 0.485267 | E | 0.513 | -0.027733 | O to D | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 109 | I | 0.534856 | N | 0.696806 | -0.16195 | No Change: Both D | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 117 | W | 0.556928 | R | 0.772221 | -0.215293 | No Change: Both D | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 352 | T | 0.239285 | S | 0.318736 | -0.079451 | No Change: Both O | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 532 | P | 0.21695 | S | 0.250443 | -0.033493 | No Change: Both O | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 119 | A | 0.568183 | T | 0.620706 | -0.052523 | No Change: Both D | Deafness autosomal dominant type 9 (DFNA9) [MIM:601369] |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 135 | G | 0.87921 | R | 0.887806 | -0.008596 | No Change: Both D | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 281 | D | 0.384527 | N | 0.34865 | 0.035877 | No Change: Both O | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 402 | I | 0.203511 | V | 0.215364 | -0.011853 | No Change: Both O | - |
| O43405 | COCH_HUMAN Cochlin OS=Homo sapiens GN=COCH PE=1 SV=1 | 518 | E | 0.653219 | G | 0.615933 | 0.037286 | No Change: Both D | - |
| Q8WTW3 | COG1_HUMAN Conserved oligomeric Golgi complex subunit 1 OS=Homo sapiens GN=COG1 PE=1 SV=1 | 392 | N | 0.454762 | S | 0.507232 | -0.05247 | O to D | - |
| Q8WTW3 | COG1_HUMAN Conserved oligomeric Golgi complex subunit 1 OS=Homo sapiens GN=COG1 PE=1 SV=1 | 744 | Y | 0.150745 | C | 0.17687 | -0.026125 | No Change: Both O | - |
| Q8WTW3 | COG1_HUMAN Conserved oligomeric Golgi complex subunit 1 OS=Homo sapiens GN=COG1 PE=1 SV=1 | 357 | M | 0.112036 | L | 0.088257 | 0.023779 | No Change: Both O | - |
| Q14746 | COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens GN=COG2 PE=1 SV=1 | 304 | N | 0.531087 | K | 0.581665 | -0.050578 | No Change: Both D | - |
| Q14746 | COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens GN=COG2 PE=1 SV=1 | 288 | R | 0.145923 | H | 0.1511 | -0.005177 | No Change: Both O | - |
| Q14746 | COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens GN=COG2 PE=1 SV=1 | 589 | V | 0.338515 | I | 0.3076 | 0.030915 | No Change: Both O | - |
| Q96JB2 | COG3_HUMAN Conserved oligomeric Golgi complex subunit 3 OS=Homo sapiens GN=COG3 PE=1 SV=3 | 620 | R | 0.162468 | C | 0.093217 | 0.069251 | No Change: Both O | A breast cancer sample |
| Q96JB2 | COG3_HUMAN Conserved oligomeric Golgi complex subunit 3 OS=Homo sapiens GN=COG3 PE=1 SV=3 | 747 | N | 0.441977 | S | 0.523143 | -0.081166 | O to D | - |
| Q9H9E3 | COG4_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 PE=1 SV=3 | 158 | T | 0.236605 | I | 0.1453 | 0.091305 | No Change: Both O | - |
| Q9H9E3 | COG4_HUMAN Conserved oligomeric Golgi complex subunit 4 OS=Homo sapiens GN=COG4 PE=1 SV=3 | 729 | R | 0.201729 | W | 0.081566 | 0.120163 | No Change: Both O | Congenital disorder of glycosylation type 2J (CDG2J) [MIM:613489] |
| Q9UP83 | COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens GN=COG5 PE=1 SV=3 | 330 | F | 0.207469 | L | 0.252204 | -0.044735 | No Change: Both O | - |
| Q9UP83 | COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens GN=COG5 PE=1 SV=3 | 558 | S | 0.566184 | P | 0.515919 | 0.050265 | No Change: Both D | - |
| Q9UP83 | COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens GN=COG5 PE=1 SV=3 | 365 | I | 0.099772 | V | 0.113217 | -0.013445 | No Change: Both O | - |
| Q9UP83 | COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens GN=COG5 PE=1 SV=3 | 452 | H | 0.391712 | R | 0.401203 | -0.009491 | No Change: Both O | - |
| Q9Y2V7 | COG6_HUMAN Conserved oligomeric Golgi complex subunit 6 OS=Homo sapiens GN=COG6 PE=2 SV=2 | 10 | A | 0.688911 | T | 0.708429 | -0.019518 | No Change: Both D | - |
| Q9Y2V7 | COG6_HUMAN Conserved oligomeric Golgi complex subunit 6 OS=Homo sapiens GN=COG6 PE=2 SV=2 | 32 | C | 0.582792 | S | 0.735246 | -0.152454 | No Change: Both D | - |
| Q9Y2V7 | COG6_HUMAN Conserved oligomeric Golgi complex subunit 6 OS=Homo sapiens GN=COG6 PE=2 SV=2 | 300 | H | 0.537238 | Y | 0.416841 | 0.120397 | D to O | - |
| Q9Y2V7 | COG6_HUMAN Conserved oligomeric Golgi complex subunit 6 OS=Homo sapiens GN=COG6 PE=2 SV=2 | 447 | M | 0.45401 | T | 0.473018 | -0.019008 | No Change: Both O | - |
| P83436 | COG7_HUMAN Conserved oligomeric Golgi complex subunit 7 OS=Homo sapiens GN=COG7 PE=1 SV=1 | 605 | T | 0.311267 | M | 0.266589 | 0.044678 | No Change: Both O | - |
| Q96MW5 | COG8_HUMAN Conserved oligomeric Golgi complex subunit 8 OS=Homo sapiens GN=COG8 PE=1 SV=2 | 517 | L | 0.083511 | R | 0.139303 | -0.055792 | No Change: Both O | - |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 18 | G | 0.071879 | E | 0.097833 | -0.025954 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 18 | G | 0.071879 | R | 0.071986 | -1.07E-04 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 545 | G | 0.430131 | R | 0.411079 | 0.019052 | No Change: Both O | - |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 591 | C | 0.066108 | R | 0.14744 | -0.081332 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 595 | G | 0.057352 | E | 0.071058 | -0.013706 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 597 | Y | 0.059629 | H | 0.102011 | -0.042382 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 598 | Y | 0.065822 | D | 0.121466 | -0.055644 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 600 | S | 0.096176 | P | 0.08904 | 0.007136 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 614 | L | 0.161757 | P | 0.314723 | -0.152966 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 617 | N | 0.210689 | K | 0.260648 | -0.049959 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 618 | G | 0.233957 | V | 0.137179 | 0.096778 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 644 | L | 0.246922 | R | 0.355904 | -0.108982 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 648 | D | 0.185184 | G | 0.156788 | 0.028396 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 597 | Y | 0.059629 | C | 0.044966 | 0.014663 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 27 | M | 0.284408 | T | 0.345845 | -0.061437 | No Change: Both O | - |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 198 | R | 0.993822 | H | 0.991122 | 0.0027 | No Change: Both D | - |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 582 | Y | 0.376028 | D | 0.564524 | -0.188496 | O to D | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 595 | G | 0.057352 | R | 0.052542 | 0.00481 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 603 | V | 0.14823 | M | 0.1771 | -0.02887 | No Change: Both O | - |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 651 | W | 0.19257 | R | 0.385942 | -0.193372 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 653 | Q | 0.231771 | P | 0.248077 | -0.016306 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 671 | S | 0.392579 | P | 0.339856 | 0.052723 | No Change: Both O | Schmid type metaphyseal chondrodysplasia (SMCD) [MIM:156500] |
| Q03692 | COAA1_HUMAN Collagen alpha-1(X) chain OS=Homo sapiens GN=COL10A1 PE=1 SV=2 | 98 | G | 0.998019 | R | 0.997719 | 3.00E-04 | No Change: Both D | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 625 | G | 0.99794 | V | 0.995464 | 0.002476 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 676 | G | 0.99811 | R | 0.997963 | 1.47E-04 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1516 | G | 0.998348 | V | 0.996961 | 0.001387 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1326 | A | 0.999515 | V | 0.999498 | 1.70E-05 | No Change: Both D | A breast cancer sample |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1328 | Q | 0.999532 | K | 0.99959 | -5.80E-05 | No Change: Both D | A breast cancer sample |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1328 | Q | 0.999532 | L | 0.999191 | 3.41E-04 | No Change: Both D | A breast cancer sample |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 8 | W | 0.33089 | G | 0.492961 | -0.162071 | No Change: Both O | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 46 | D | 0.289414 | E | 0.312312 | -0.022898 | No Change: Both O | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 559 | G | 0.998503 | S | 0.998548 | -4.50E-05 | No Change: Both D | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1323 | P | 0.999488 | L | 0.998638 | 8.50E-04 | No Change: Both D | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1535 | S | 0.977622 | P | 0.981181 | -0.003559 | No Change: Both D | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1805 | L | 0.466537 | F | 0.450955 | 0.015582 | No Change: Both O | - |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 565 | G | 0.999064 | V | 0.998336 | 7.28E-04 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1027 | G | 0.985149 | R | 0.984194 | 9.55E-04 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1513 | G | 0.998915 | D | 0.998749 | 1.66E-04 | No Change: Both D | Stickler syndrome type 2 (STL2) [MIM:604841] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 796 | G | 0.973046 | R | 0.972319 | 7.27E-04 | No Change: Both D | Fibrochondrogenesis (FCG) [MIM:228520] |
| P12107 | COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens GN=COL11A1 PE=1 SV=4 | 1042 | G | 0.991433 | R | 0.990779 | 6.54E-04 | No Change: Both D | Fibrochondrogenesis (FCG) [MIM:228520] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 661 | G | 0.998439 | R | 0.99793 | 5.09E-04 | No Change: Both D | Autosomal recessive otospondylomegaepiphyseal dysplasia (OSMED) [MIM:215150] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 808 | G | 0.978897 | E | 0.977829 | 0.001068 | No Change: Both D | Deafness autosomal dominant type 13 (DFNA13) [MIM:601868] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1034 | R | 0.998496 | C | 0.997822 | 6.74E-04 | No Change: Both D | Deafness autosomal dominant type 13 (DFNA13) [MIM:601868] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 593 | D | 0.994824 | G | 0.995032 | -2.08E-04 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 824 | E | 0.987536 | K | 0.989731 | -0.002195 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 879 | P | 0.997752 | L | 0.995325 | 0.002427 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1441 | G | 0.994547 | E | 0.99458 | -3.30E-05 | No Change: Both D | Weissenbacher-Zweymueller syndrome (WZS) [MIM:277610] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1316 | P | 0.998187 | T | 0.997137 | 0.00105 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1600 | R | 0.136069 | Q | 0.141732 | -0.005663 | No Change: Both O | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 621 | P | 0.99762 | T | 0.995408 | 0.002212 | No Change: Both D | Deafness autosomal recessive type 53 (DFNB53) [MIM:609706] |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1628 | E | 0.538248 | D | 0.536126 | 0.002122 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 236 | P | 0.977545 | S | 0.975278 | 0.002267 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 276 | E | 0.945445 | K | 0.926734 | 0.018711 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 894 | L | 0.997525 | P | 0.998854 | -0.001329 | No Change: Both D | - |
| P13942 | COBA2_HUMAN Collagen alpha-2(XI) chain OS=Homo sapiens GN=COL11A2 PE=1 SV=5 | 1722 | P | 0.547297 | L | 0.379522 | 0.167775 | D to O | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 3058 | G | 0.974021 | S | 0.980811 | -0.00679 | No Change: Both D | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 461 | A | 0.061304 | P | 0.08646 | -0.025156 | No Change: Both O | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 1738 | I | 0.603404 | T | 0.701021 | -0.097617 | No Change: Both D | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 2160 | E | 0.499955 | V | 0.313675 | 0.18628 | No Change: Both O | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 2596 | I | 0.166669 | V | 0.17278 | -0.006111 | No Change: Both O | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 2021 | R | 0.722678 | Q | 0.72442 | -0.001742 | No Change: Both D | - |
| Q99715 | COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens GN=COL12A1 PE=1 SV=2 | 3048 | Q | 0.981361 | H | 0.96992 | 0.011441 | No Change: Both D | - |
| Q5TAT6 | CODA1_HUMAN Collagen alpha-1(XIII) chain OS=Homo sapiens GN=COL13A1 PE=1 SV=1 | 531 | H | 0.999102 | Q | 0.999373 | -2.71E-04 | No Change: Both D | - |
| Q05707 | COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens GN=COL14A1 PE=1 SV=3 | 563 | N | 0.252622 | H | 0.210316 | 0.042306 | No Change: Both O | - |
| Q05707 | COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens GN=COL14A1 PE=1 SV=3 | 855 | P | 0.452475 | L | 0.283261 | 0.169214 | No Change: Both O | - |
| Q05707 | COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens GN=COL14A1 PE=1 SV=3 | 922 | V | 0.139808 | I | 0.114691 | 0.025117 | No Change: Both O | - |
| Q05707 | COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens GN=COL14A1 PE=1 SV=3 | 1342 | V | 0.337759 | L | 0.335732 | 0.002027 | No Change: Both O | - |
| Q05707 | COEA1_HUMAN Collagen alpha-1(XIV) chain OS=Homo sapiens GN=COL14A1 PE=1 SV=3 | 636 | T | 0.292846 | A | 0.248549 | 0.044297 | No Change: Both O | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 163 | R | 0.105421 | H | 0.104982 | 4.39E-04 | No Change: Both O | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 204 | M | 0.430368 | V | 0.360891 | 0.069477 | No Change: Both O | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 391 | T | 0.969565 | M | 0.96715 | 0.002415 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 442 | A | 0.944756 | T | 0.946403 | -0.001647 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 446 | G | 0.948747 | R | 0.942317 | 0.00643 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 506 | E | 0.953306 | D | 0.947921 | 0.005385 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 531 | P | 0.958732 | R | 0.945397 | 0.013335 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 989 | K | 0.75255 | R | 0.704262 | 0.048288 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 1001 | K | 0.857715 | R | 0.830413 | 0.027302 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 1332 | V | 0.329293 | I | 0.285789 | 0.043504 | No Change: Both O | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 504 | G | 0.947698 | V | 0.925412 | 0.022286 | No Change: Both D | - |
| P39059 | COFA1_HUMAN Collagen alpha-1(XV) chain OS=Homo sapiens GN=COL15A1 PE=1 SV=2 | 705 | P | 0.997465 | L | 0.994971 | 0.002494 | No Change: Both D | - |
| Q07092 | COGA1_HUMAN Collagen alpha-1(XVI) chain OS=Homo sapiens GN=COL16A1 PE=1 SV=2 | 62 | T | 0.445851 | K | 0.539475 | -0.093624 | O to D | - |
| Q07092 | COGA1_HUMAN Collagen alpha-1(XVI) chain OS=Homo sapiens GN=COL16A1 PE=1 SV=2 | 27 | Q | 0.643248 | H | 0.617392 | 0.025856 | No Change: Both D | - |
| Q07092 | COGA1_HUMAN Collagen alpha-1(XVI) chain OS=Homo sapiens GN=COL16A1 PE=1 SV=2 | 418 | R | 0.975874 | Q | 0.976522 | -6.48E-04 | No Change: Both D | - |
| Q07092 | COGA1_HUMAN Collagen alpha-1(XVI) chain OS=Homo sapiens GN=COL16A1 PE=1 SV=2 | 745 | G | 0.988363 | S | 0.987802 | 5.61E-04 | No Change: Both D | - |
| Q07092 | COGA1_HUMAN Collagen alpha-1(XVI) chain OS=Homo sapiens GN=COL16A1 PE=1 SV=2 | 909 | P | 0.991675 | L | 0.982338 | 0.009337 | No Change: Both D | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 210 | T | 0.41567 | M | 0.36325 | 0.05242 | No Change: Both O | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 231 | M | 0.700368 | I | 0.588146 | 0.112222 | No Change: Both D | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 238 | M | 0.755932 | T | 0.77913 | -0.023198 | No Change: Both D | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 265 | S | 0.792776 | C | 0.685336 | 0.10744 | No Change: Both D | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 428 | G | 0.915171 | S | 0.926015 | -0.010844 | No Change: Both D | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 627 | G | 0.998965 | V | 0.998081 | 8.84E-04 | No Change: Both D | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 633 | G | 0.999148 | D | 0.998938 | 2.10E-04 | No Change: Both D | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 703 | M | 0.995326 | V | 0.994155 | 0.001171 | No Change: Both D | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 1303 | R | 0.996608 | Q | 0.9958 | 8.08E-04 | No Change: Both D | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 1370 | D | 0.330216 | G | 0.317865 | 0.012351 | No Change: Both O | - |
| Q9UMD9 | COHA1_HUMAN Collagen alpha-1(XVII) chain OS=Homo sapiens GN=COL17A1 PE=1 SV=3 | 4 | T | 0.929318 | A | 0.874331 | 0.054987 | No Change: Both D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 1675 | D | 0.356685 | N | 0.319329 | 0.037356 | No Change: Both O | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 49 | Q | 0.673847 | L | 0.604867 | 0.06898 | No Change: Both D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 111 | G | 0.388315 | R | 0.394603 | -0.006288 | No Change: Both O | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 1076 | V | 0.972292 | I | 0.968826 | 0.003466 | No Change: Both D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 1121 | P | 0.987877 | R | 0.982829 | 0.005048 | No Change: Both D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 288 | A | 0.481132 | T | 0.50414 | -0.023008 | O to D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 1195 | Q | 0.982818 | H | 0.979856 | 0.002962 | No Change: Both D | - |
| P39060 | COIA1_HUMAN Collagen alpha-1(XVIII) chain OS=Homo sapiens GN=COL18A1 PE=1 SV=5 | 379 | T | 0.126514 | M | 0.118646 | 0.007868 | No Change: Both O | - |
| Q14993 | COJA1_HUMAN Collagen alpha-1(XIX) chain OS=Homo sapiens GN=COL19A1 PE=1 SV=3 | 352 | A | 0.987019 | G | 0.991124 | -0.004105 | No Change: Both D | - |
| Q14993 | COJA1_HUMAN Collagen alpha-1(XIX) chain OS=Homo sapiens GN=COL19A1 PE=1 SV=3 | 361 | G | 0.989489 | D | 0.988878 | 6.11E-04 | No Change: Both D | A breast cancer sample |
| Q14993 | COJA1_HUMAN Collagen alpha-1(XIX) chain OS=Homo sapiens GN=COL19A1 PE=1 SV=3 | 1019 | K | 0.366487 | N | 0.331629 | 0.034858 | No Change: Both O | A breast cancer sample |
| Q14993 | COJA1_HUMAN Collagen alpha-1(XIX) chain OS=Homo sapiens GN=COL19A1 PE=1 SV=3 | 406 | G | 0.999036 | E | 0.998986 | 5.00E-05 | No Change: Both D | - |
| Q14993 | COJA1_HUMAN Collagen alpha-1(XIX) chain OS=Homo sapiens GN=COL19A1 PE=1 SV=3 | 496 | E | 0.988133 | G | 0.987832 | 3.01E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 197 | G | 0.996643 | C | 0.994851 | 0.001792 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 205 | P | 0.999555 | A | 0.999201 | 3.54E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 221 | G | 0.999711 | C | 0.999529 | 1.82E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 224 | G | 0.999672 | C | 0.999474 | 1.98E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 263 | G | 0.979958 | R | 0.979217 | 7.41E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 263 | G | 0.979958 | V | 0.957843 | 0.022115 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 272 | G | 0.979105 | C | 0.965514 | 0.013591 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 275 | G | 0.980448 | D | 0.978927 | 0.001521 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 332 | G | 0.996934 | R | 0.996686 | 2.48E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 350 | G | 0.996728 | R | 0.996405 | 3.23E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 353 | G | 0.996976 | C | 0.995026 | 0.00195 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 356 | G | 0.997401 | C | 0.99582 | 0.001581 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 383 | G | 0.997416 | C | 0.995628 | 0.001788 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 389 | G | 0.996851 | C | 0.994768 | 0.002083 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 389 | G | 0.996851 | R | 0.996407 | 4.44E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 398 | G | 0.996642 | A | 0.996125 | 5.17E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 398 | G | 0.996642 | D | 0.996089 | 5.53E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 401 | G | 0.996726 | C | 0.994617 | 0.002109 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 404 | G | 0.996974 | C | 0.995011 | 0.001963 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 422 | G | 0.998678 | C | 0.997834 | 8.44E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 425 | G | 0.998799 | S | 0.998806 | -7.00E-06 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 434 | G | 0.998984 | V | 0.998068 | 9.16E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 476 | G | 0.997942 | R | 0.99793 | 1.20E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 527 | G | 0.998131 | C | 0.996953 | 0.001178 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 530 | G | 0.998136 | S | 0.9982 | -6.40E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 530 | G | 0.998136 | S | 0.9982 | -6.40E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 530 | G | 0.998136 | S | 0.9982 | -6.40E-05 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 533 | G | 0.998221 | D | 0.997856 | 3.65E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 560 | G | 0.998825 | S | 0.998709 | 1.16E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 560 | G | 0.998825 | C | 0.997965 | 8.60E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 560 | G | 0.998825 | R | 0.998745 | 8.00E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 564 | R | 0.998668 | H | 0.998174 | 4.94E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 569 | G | 0.998179 | R | 0.998121 | 5.80E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 593 | G | 0.995103 | C | 0.991959 | 0.003144 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 593 | G | 0.995103 | C | 0.991959 | 0.003144 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 593 | G | 0.995103 | S | 0.993785 | 0.001318 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 593 | G | 0.995103 | S | 0.993785 | 0.001318 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 656 | G | 0.995778 | S | 0.99556 | 2.18E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 701 | G | 0.995149 | C | 0.991882 | 0.003267 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 704 | G | 0.994648 | C | 0.991152 | 0.003496 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 719 | G | 0.993915 | D | 0.993542 | 3.73E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 719 | G | 0.993915 | S | 0.993548 | 3.67E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 728 | G | 0.992959 | R | 0.992419 | 5.40E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 737 | G | 0.991334 | D | 0.991174 | 1.60E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 743 | G | 0.99221 | S | 0.991806 | 4.04E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 743 | G | 0.99221 | V | 0.985027 | 0.007183 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 764 | G | 0.993226 | V | 0.987724 | 0.005502 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 767 | G | 0.994188 | S | 0.994147 | 4.10E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 776 | G | 0.995879 | S | 0.995934 | -5.50E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 809 | G | 0.998899 | S | 0.998728 | 1.71E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 815 | G | 0.999018 | V | 0.997847 | 0.001171 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 821 | G | 0.999041 | S | 0.998792 | 2.49E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 823 | P | 0.998968 | A | 0.99849 | 4.78E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 839 | G | 0.998272 | S | 0.997965 | 3.07E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 842 | G | 0.99794 | R | 0.997507 | 4.33E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 845 | G | 0.997735 | R | 0.99729 | 4.45E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 851 | G | 0.996323 | D | 0.995475 | 8.48E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 869 | G | 0.994693 | C | 0.99136 | 0.003333 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 884 | G | 0.99666 | S | 0.996647 | 1.30E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 884 | G | 0.99666 | S | 0.996647 | 1.30E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 896 | G | 0.999115 | C | 0.998541 | 5.74E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 926 | G | 0.99911 | C | 0.998561 | 5.49E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 980 | G | 0.994824 | V | 0.991381 | 0.003443 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1010 | G | 0.999298 | S | 0.999337 | -3.90E-05 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1022 | G | 0.999182 | S | 0.99922 | -3.80E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1022 | G | 0.999182 | V | 0.998238 | 9.44E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1025 | G | 0.999125 | R | 0.999108 | 1.70E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1040 | G | 0.998822 | S | 0.998817 | 5.00E-06 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1040 | G | 0.998822 | S | 0.998817 | 5.00E-06 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1043 | G | 0.998779 | S | 0.998762 | 1.70E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1049 | G | 0.998632 | S | 0.998593 | 3.90E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1058 | G | 0.998064 | S | 0.997973 | 9.10E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1058 | G | 0.998064 | S | 0.997973 | 9.10E-05 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1061 | G | 0.997842 | D | 0.997567 | 2.75E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1061 | G | 0.997842 | S | 0.997722 | 1.20E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1075 | T | 0.996099 | A | 0.996009 | 9.00E-05 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1076 | G | 0.995807 | S | 0.99522 | 5.87E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1079 | G | 0.994327 | S | 0.993501 | 8.26E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1079 | G | 0.994327 | S | 0.993501 | 8.26E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1082 | G | 0.991683 | C | 0.986105 | 0.005578 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1088 | G | 0.988734 | A | 0.984897 | 0.003837 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1091 | G | 0.98886 | S | 0.987734 | 0.001126 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1100 | G | 0.988816 | D | 0.987993 | 8.23E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1106 | G | 0.988822 | A | 0.984391 | 0.004431 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1124 | G | 0.997218 | C | 0.995528 | 0.00169 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1142 | G | 0.998618 | S | 0.998674 | -5.60E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1151 | G | 0.997964 | S | 0.99795 | 1.40E-05 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1151 | G | 0.997964 | V | 0.995975 | 0.001989 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1154 | G | 0.99792 | R | 0.997819 | 1.01E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1166 | G | 0.998323 | C | 0.997299 | 0.001024 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1172 | G | 0.998567 | D | 0.998452 | 1.15E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1181 | G | 0.998565 | S | 0.998597 | -3.20E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1184 | G | 0.997757 | V | 0.996116 | 0.001641 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1187 | G | 0.996163 | S | 0.996459 | -2.96E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1187 | G | 0.996163 | S | 0.996459 | -2.96E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1187 | G | 0.996163 | V | 0.993119 | 0.003044 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1195 | G | 0.962392 | C | 0.948974 | 0.013418 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1277 | D | 0.224542 | H | 0.187624 | 0.036918 | No Change: Both O | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1312 | W | 0.32611 | C | 0.37125 | -0.04514 | No Change: Both O | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1388 | L | 0.334139 | R | 0.421811 | -0.087672 | No Change: Both O | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1434 | T | 0.349452 | S | 0.425665 | -0.076213 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1464 | L | 0.377708 | P | 0.644921 | -0.267213 | O to D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 866 | G | 0.994611 | S | 0.994455 | 1.56E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 866 | G | 0.994611 | S | 0.994455 | 1.56E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 312 | R | 0.998013 | C | 0.996768 | 0.001245 | No Change: Both D | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1019 | G | 0.999215 | A | 0.999021 | 1.94E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1251 | S | 0.784198 | T | 0.737383 | 0.046815 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1391 | Q | 0.28338 | K | 0.334573 | -0.051193 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1438 | P | 0.222943 | R | 0.195969 | 0.026974 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1460 | P | 0.225395 | H | 0.201743 | 0.023652 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1014 | R | 0.999261 | C | 0.998878 | 3.83E-04 | No Change: Both D | Caffey disease (CAFFD) [MIM:114000] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1141 | R | 0.998722 | Q | 0.998718 | 4.00E-06 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1177 | V | 0.998801 | I | 0.99886 | -5.90E-05 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1430 | K | 0.40483 | N | 0.346815 | 0.058015 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1431 | T | 0.406194 | P | 0.437009 | -0.030815 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 22 | G | 0.55565 | R | 0.522874 | 0.032776 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 146 | P | 0.994165 | T | 0.990254 | 0.003911 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 194 | G | 0.994326 | R | 0.993802 | 5.24E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 197 | G | 0.996643 | R | 0.99631 | 3.33E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 200 | G | 0.998744 | V | 0.997778 | 9.66E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 203 | G | 0.999454 | V | 0.998971 | 4.83E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 242 | G | 0.995788 | D | 0.995146 | 6.42E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 257 | G | 0.982661 | R | 0.982299 | 3.62E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 266 | G | 0.979064 | E | 0.977223 | 0.001841 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 287 | G | 0.990527 | S | 0.990546 | -1.90E-05 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 288 | E | 0.991312 | K | 0.99206 | -7.48E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 288 | E | 0.991312 | V | 0.983156 | 0.008156 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 320 | G | 0.997539 | V | 0.994897 | 0.002642 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 338 | G | 0.996839 | C | 0.994771 | 0.002068 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 349 | V | 0.996636 | F | 0.997022 | -3.86E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 353 | G | 0.996976 | D | 0.996129 | 8.47E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 353 | G | 0.996976 | S | 0.996613 | 3.63E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 368 | G | 0.998155 | V | 0.996782 | 0.001373 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 390 | A | 0.996739 | T | 0.995692 | 0.001047 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 455 | G | 0.997813 | D | 0.997432 | 3.81E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 470 | G | 0.997886 | V | 0.996312 | 0.001574 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 509 | G | 0.997986 | V | 0.996339 | 0.001647 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 548 | G | 0.998678 | A | 0.998316 | 3.62E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 555 | P | 0.998733 | R | 0.998278 | 4.55E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 574 | R | 0.997754 | C | 0.996689 | 0.001065 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 581 | G | 0.996018 | R | 0.995789 | 2.29E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 602 | G | 0.995414 | R | 0.994978 | 4.36E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 605 | G | 0.995637 | D | 0.994808 | 8.29E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 614 | G | 0.997136 | R | 0.996808 | 3.28E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 647 | G | 0.996985 | S | 0.99686 | 1.25E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 683 | G | 0.994191 | S | 0.993665 | 5.26E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 722 | G | 0.993617 | S | 0.993261 | 3.56E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 734 | G | 0.991876 | V | 0.983564 | 0.008312 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 740 | G | 0.99151 | R | 0.991202 | 3.08E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 824 | G | 0.998944 | R | 0.998729 | 2.15E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 833 | G | 0.99862 | D | 0.998541 | 7.90E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 855 | N | 0.995472 | H | 0.995133 | 3.39E-04 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 875 | G | 0.995053 | S | 0.994947 | 1.06E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 896 | G | 0.999115 | D | 0.998767 | 3.48E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 906 | G | 0.999422 | S | 0.99937 | 5.20E-05 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 947 | G | 0.987436 | C | 0.979752 | 0.007684 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 977 | G | 0.993131 | D | 0.99052 | 0.002611 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1001 | G | 0.999496 | C | 0.999165 | 3.31E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1055 | G | 0.998236 | D | 0.998027 | 2.09E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1066 | R | 0.997335 | C | 0.996131 | 0.001204 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1093 | R | 0.988989 | C | 0.982347 | 0.006642 | No Change: Both D | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1094 | G | 0.989021 | S | 0.987929 | 0.001092 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1157 | G | 0.997937 | D | 0.997739 | 1.98E-04 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1219 | D | 0.586836 | E | 0.583006 | 0.00383 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1356 | R | 0.162314 | H | 0.163265 | -9.51E-04 | No Change: Both O | - |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1413 | D | 0.337597 | N | 0.323351 | 0.014246 | No Change: Both O | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 848 | G | 0.997146 | R | 0.996656 | 4.90E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P02452 | CO1A1_HUMAN Collagen alpha-1(I) chain OS=Homo sapiens GN=COL1A1 PE=1 SV=5 | 1219 | D | 0.586836 | N | 0.544488 | 0.042348 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 211 | G | 0.981223 | D | 0.977829 | 0.003394 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 249 | I | 0.989669 | N | 0.993179 | -0.00351 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 276 | A | 0.982409 | T | 0.979627 | 0.002782 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 328 | G | 0.963732 | S | 0.95788 | 0.005852 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 334 | G | 0.964205 | C | 0.939948 | 0.024257 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 337 | G | 0.968378 | C | 0.947721 | 0.020657 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 337 | G | 0.968378 | S | 0.964904 | 0.003474 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 349 | G | 0.985409 | C | 0.976591 | 0.008818 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 409 | G | 0.996316 | V | 0.993542 | 0.002774 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 433 | G | 0.993116 | E | 0.992445 | 6.71E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 460 | G | 0.984211 | S | 0.983325 | 8.86E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 511 | G | 0.987384 | D | 0.986694 | 6.90E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 517 | G | 0.989889 | R | 0.98868 | 0.001209 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 547 | G | 0.997645 | R | 0.997235 | 4.10E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 549 | P | 0.997442 | A | 0.995492 | 0.00195 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 562 | G | 0.995615 | C | 0.992749 | 0.002866 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 586 | G | 0.99502 | R | 0.994984 | 3.60E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 592 | G | 0.996198 | S | 0.996158 | 4.00E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 634 | G | 0.982547 | V | 0.971466 | 0.011081 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 637 | G | 0.982054 | D | 0.977053 | 0.005001 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 640 | G | 0.982079 | S | 0.982263 | -1.84E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 670 | G | 0.985288 | D | 0.983563 | 0.001725 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 676 | G | 0.986177 | V | 0.974697 | 0.01148 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 676 | G | 0.986177 | V | 0.974697 | 0.01148 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 708 | R | 0.996129 | Q | 0.995487 | 6.42E-04 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 715 | G | 0.995467 | D | 0.994146 | 0.001321 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 730 | G | 0.990203 | C | 0.983796 | 0.006407 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 736 | G | 0.989779 | C | 0.982999 | 0.00678 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 743 | A | 0.989935 | G | 0.991703 | -0.001768 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 751 | G | 0.990877 | S | 0.98888 | 0.001997 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 754 | G | 0.991556 | R | 0.990527 | 0.001029 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 766 | G | 0.995647 | V | 0.992647 | 0.003 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 778 | G | 0.997572 | S | 0.997442 | 1.30E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 784 | G | 0.998112 | R | 0.997937 | 1.75E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 787 | G | 0.998356 | C | 0.997269 | 0.001087 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 790 | G | 0.99837 | D | 0.998047 | 3.23E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 796 | G | 0.998337 | S | 0.998361 | -2.40E-05 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 822 | R | 0.987962 | H | 0.982375 | 0.005587 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 835 | G | 0.983568 | S | 0.982381 | 0.001187 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 877 | G | 0.963302 | C | 0.94061 | 0.022692 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 892 | G | 0.967021 | D | 0.955462 | 0.011559 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 892 | G | 0.967021 | D | 0.955462 | 0.011559 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 895 | G | 0.969179 | D | 0.95866 | 0.010519 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 949 | G | 0.983538 | S | 0.979452 | 0.004086 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 955 | G | 0.979695 | S | 0.975833 | 0.003862 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 997 | G | 0.989466 | D | 0.987534 | 0.001932 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1012 | G | 0.980119 | S | 0.977578 | 0.002541 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1012 | G | 0.980119 | S | 0.977578 | 0.002541 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1022 | L | 0.962697 | F | 0.949814 | 0.012883 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1066 | G | 0.994332 | D | 0.993657 | 6.75E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1078 | G | 0.996202 | C | 0.993856 | 0.002346 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1096 | G | 0.993612 | A | 0.991461 | 0.002151 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1102 | G | 0.981166 | R | 0.981452 | -2.86E-04 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1101 | P | 0.985243 | L | 0.967217 | 0.018026 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1148 | T | 0.637811 | P | 0.700155 | -0.062344 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1189 | D | 0.121552 | E | 0.126956 | -0.005404 | No Change: Both O | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1198 | S | 0.13283 | P | 0.121543 | 0.011287 | No Change: Both O | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 331 | G | 0.96237 | D | 0.949039 | 0.013331 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 973 | G | 0.982777 | V | 0.971955 | 0.010822 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 59 | T | 0.998186 | P | 0.999066 | -8.80E-04 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 270 | V | 0.984934 | I | 0.983939 | 9.95E-04 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 483 | A | 0.982752 | V | 0.976251 | 0.006501 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 678 | P | 0.987201 | H | 0.976918 | 0.010283 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1354 | Q | 0.226415 | H | 0.212998 | 0.013417 | No Change: Both O | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 528 | N | 0.99519 | S | 0.994758 | 4.32E-04 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 564 | A | 0.995517 | T | 0.995573 | -5.60E-05 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 344 | L | 0.980168 | V | 0.981569 | -0.001401 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 193 | G | 0.945591 | S | 0.932565 | 0.013026 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 202 | G | 0.970095 | R | 0.967569 | 0.002526 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 234 | R | 0.988396 | C | 0.981616 | 0.00678 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 247 | G | 0.988107 | R | 0.986513 | 0.001594 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 253 | G | 0.989326 | D | 0.986998 | 0.002328 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 256 | G | 0.988151 | V | 0.980243 | 0.007908 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 283 | G | 0.979885 | R | 0.977329 | 0.002556 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 319 | G | 0.964283 | R | 0.960168 | 0.004115 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 325 | G | 0.966301 | E | 0.960338 | 0.005963 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 358 | G | 0.993647 | S | 0.99391 | -2.63E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 397 | G | 0.998157 | E | 0.998031 | 1.26E-04 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 454 | G | 0.987074 | C | 0.97815 | 0.008924 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 457 | G | 0.985852 | L | 0.977379 | 0.008473 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 526 | G | 0.993891 | E | 0.992465 | 0.001426 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 562 | G | 0.995615 | V | 0.992193 | 0.003422 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 601 | G | 0.995626 | S | 0.995795 | -1.69E-04 | No Change: Both D | - |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 625 | G | 0.987684 | D | 0.985445 | 0.002239 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 676 | G | 0.986177 | D | 0.984652 | 0.001525 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 733 | G | 0.989902 | C | 0.983032 | 0.00687 | No Change: Both D | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 739 | G | 0.989771 | R | 0.988704 | 0.001067 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 748 | G | 0.990084 | V | 0.984246 | 0.005838 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 754 | G | 0.991556 | C | 0.986115 | 0.005441 | No Change: Both D | Osteogenesis imperfecta type 4 (OI4) [MIM:166220] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 820 | G | 0.989752 | S | 0.989061 | 6.91E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 835 | G | 0.983568 | C | 0.973092 | 0.010476 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 856 | G | 0.979923 | R | 0.97665 | 0.003273 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 856 | G | 0.979923 | V | 0.963478 | 0.016445 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 955 | G | 0.979695 | D | 0.975274 | 0.004421 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 982 | G | 0.987509 | D | 0.983686 | 0.003823 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 991 | G | 0.991309 | V | 0.985405 | 0.005904 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1003 | G | 0.987519 | D | 0.985623 | 0.001896 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1027 | G | 0.959982 | E | 0.956089 | 0.003893 | No Change: Both D | Osteogenesis imperfecta type 2 (OI2) [MIM:166210] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1087 | G | 0.995403 | D | 0.994988 | 4.15E-04 | No Change: Both D | Osteogenesis imperfecta type 3 (OI3) [MIM:259420] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1195 | C | 0.103998 | Y | 0.123112 | -0.019114 | No Change: Both O | Osteogenesis imperfecta type 1 (OI1) [MIM:166200] |
| P08123 | CO1A2_HUMAN Collagen alpha-2(I) chain OS=Homo sapiens GN=COL1A2 PE=1 SV=7 | 1119 | A | 0.726617 | T | 0.740217 | -0.0136 | No Change: Both D | - |
| Q9P218 | COKA1_HUMAN Collagen alpha-1(XX) chain OS=Homo sapiens GN=COL20A1 PE=1 SV=4 | 134 | P | 0.97812 | L | 0.963103 | 0.015017 | No Change: Both D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 277 | L | 0.359605 | P | 0.531725 | -0.17212 | O to D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 343 | T | 0.208275 | M | 0.170573 | 0.037702 | No Change: Both O | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 495 | I | 0.951792 | T | 0.968006 | -0.016214 | No Change: Both D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 560 | G | 0.978853 | S | 0.978313 | 5.40E-04 | No Change: Both D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 747 | A | 0.970757 | D | 0.976204 | -0.005447 | No Change: Both D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 821 | L | 0.707459 | P | 0.80446 | -0.097001 | No Change: Both D | - |
| Q96P44 | COLA1_HUMAN Collagen alpha-1(XXI) chain OS=Homo sapiens GN=COL21A1 PE=2 SV=1 | 827 | P | 0.874228 | A | 0.811168 | 0.06306 | No Change: Both D | - |
| Q8NFW1 | COMA1_HUMAN Collagen alpha-1(XXII) chain OS=Homo sapiens GN=COL22A1 PE=1 SV=2 | 320 | S | 0.162511 | G | 0.122707 | 0.039804 | No Change: Both O | - |
| Q8NFW1 | COMA1_HUMAN Collagen alpha-1(XXII) chain OS=Homo sapiens GN=COL22A1 PE=1 SV=2 | 703 | P | 0.996381 | T | 0.993061 | 0.00332 | No Change: Both D | - |
| Q8NFW1 | COMA1_HUMAN Collagen alpha-1(XXII) chain OS=Homo sapiens GN=COL22A1 PE=1 SV=2 | 938 | A | 0.993009 | D | 0.993453 | -4.44E-04 | No Change: Both D | - |
| Q86Y22 | CONA1_HUMAN Collagen alpha-1(XXIII) chain OS=Homo sapiens GN=COL23A1 PE=2 SV=1 | 287 | T | 0.920113 | A | 0.921212 | -0.001099 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 1423 | G | 0.88536 | R | 0.878995 | 0.006365 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 151 | P | 0.276091 | L | 0.148759 | 0.127332 | No Change: Both O | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 293 | I | 0.699275 | T | 0.779547 | -0.080272 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 481 | M | 0.574354 | L | 0.519271 | 0.055083 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 546 | P | 0.995285 | S | 0.994209 | 0.001076 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 731 | P | 0.965177 | S | 0.957576 | 0.007601 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 641 | R | 0.956332 | H | 0.93553 | 0.020802 | No Change: Both D | - |
| Q17RW2 | COOA1_HUMAN Collagen alpha-1(XXIV) chain OS=Homo sapiens GN=COL24A1 PE=2 SV=2 | 61 | A | 0.732262 | V | 0.668545 | 0.063717 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 89 | V | 0.253157 | I | 0.242054 | 0.011103 | No Change: Both O | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 120 | Q | 0.375867 | R | 0.361593 | 0.014274 | No Change: Both O | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 265 | A | 0.627189 | T | 0.671142 | -0.043953 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 349 | R | 0.957677 | C | 0.938571 | 0.019106 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 422 | A | 0.995152 | T | 0.995914 | -7.62E-04 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 537 | I | 0.996802 | T | 0.998313 | -0.001511 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 611 | I | 0.872824 | F | 0.904939 | -0.032115 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 720 | P | 0.996292 | R | 0.99486 | 0.001432 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 1116 | P | 0.994894 | Q | 0.993622 | 0.001272 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 1348 | R | 0.998654 | Q | 0.99867 | -1.60E-05 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 1354 | R | 0.99847 | Q | 0.998519 | -4.90E-05 | No Change: Both D | - |
| Q8IZC6 | CORA1_HUMAN Collagen alpha-1(XXVII) chain OS=Homo sapiens GN=COL27A1 PE=1 SV=1 | 1808 | M | 0.390517 | V | 0.351258 | 0.039259 | No Change: Both O | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 189 | A | 0.213546 | G | 0.257314 | -0.043768 | No Change: Both O | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 239 | I | 0.877179 | V | 0.873235 | 0.003944 | No Change: Both D | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 327 | T | 0.996074 | S | 0.997297 | -0.001223 | No Change: Both D | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 433 | E | 0.982958 | D | 0.981094 | 0.001864 | No Change: Both D | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 472 | A | 0.994973 | P | 0.997701 | -0.002728 | No Change: Both D | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 741 | R | 0.9883 | Q | 0.991323 | -0.003023 | No Change: Both D | - |
| Q2UY09 | COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens GN=COL28A1 PE=2 SV=2 | 437 | I | 0.98394 | M | 0.98837 | -0.00443 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 267 | G | 0.99203 | D | 0.990777 | 0.001253 | No Change: Both D | Stickler syndrome type 1 non-syndromic ocular (STL1O) [MIM:609508] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 275 | R | 0.982043 | C | 0.973368 | 0.008675 | No Change: Both D | Czech dysplasia (CZECHD) [MIM:609162] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 303 | G | 0.968474 | D | 0.963753 | 0.004721 | No Change: Both D | Kniest dysplasia (KD) [MIM:156550] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 354 | G | 0.997653 | R | 0.997514 | 1.39E-04 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 375 | G | 0.998457 | R | 0.998318 | 1.39E-04 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 447 | G | 0.995262 | S | 0.994392 | 8.70E-04 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 492 | G | 0.997087 | V | 0.994766 | 0.002321 | No Change: Both D | Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-STR) [MIM:184250] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 504 | G | 0.994081 | C | 0.990141 | 0.00394 | No Change: Both D | Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-STR) [MIM:184250] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 510 | G | 0.992436 | D | 0.991088 | 0.001348 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 719 | R | 0.993907 | C | 0.990275 | 0.003632 | No Change: Both D | Osteoarthritis with mild chondrodysplasia (OACD) [MIM:604864] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 774 | G | 0.989272 | S | 0.986299 | 0.002973 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 804 | G | 0.99493 | A | 0.993784 | 0.001146 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 891 | G | 0.996462 | R | 0.996225 | 2.37E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 891 | G | 0.996462 | R | 0.996225 | 2.37E-04 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 909 | G | 0.997903 | C | 0.996628 | 0.001275 | No Change: Both D | Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-STR) [MIM:184250] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 969 | G | 0.993755 | S | 0.99346 | 2.95E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 989 | R | 0.988161 | C | 0.98175 | 0.006411 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1005 | G | 0.992984 | S | 0.992963 | 2.10E-05 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1017 | G | 0.997894 | V | 0.996312 | 0.001582 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1053 | G | 0.995186 | E | 0.995107 | 7.90E-05 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1110 | G | 0.990154 | C | 0.983174 | 0.00698 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1113 | G | 0.989463 | C | 0.982032 | 0.007431 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1143 | G | 0.992362 | S | 0.992401 | -3.90E-05 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1176 | G | 0.998971 | S | 0.999015 | -4.40E-05 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1188 | G | 0.999268 | R | 0.999245 | 2.30E-05 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1197 | G | 0.999154 | S | 0.999166 | -1.20E-05 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1439 | T | 0.425349 | M | 0.357381 | 0.067968 | No Change: Both O | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 9 | T | 0.137372 | S | 0.17199 | -0.034618 | No Change: Both O | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 453 | G | 0.99601 | D | 0.994461 | 0.001549 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 453 | G | 0.99601 | V | 0.991536 | 0.004474 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 771 | G | 0.989347 | D | 0.988877 | 4.70E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 780 | G | 0.990177 | R | 0.989659 | 5.18E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 795 | G | 0.992848 | R | 0.992247 | 6.01E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 894 | G | 0.996543 | E | 0.99553 | 0.001013 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 904 | R | 0.997034 | C | 0.995726 | 0.001308 | No Change: Both D | Multiple epiphyseal dysplasia with myopia and conductive deafness (EDMMD) [MIM:132450] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 904 | R | 0.997034 | C | 0.995726 | 0.001308 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 948 | G | 0.999214 | D | 0.999171 | 4.30E-05 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 981 | G | 0.988826 | S | 0.988471 | 3.55E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1065 | G | 0.995698 | V | 0.992558 | 0.00314 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1119 | G | 0.988861 | R | 0.988961 | -1.00E-04 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1173 | G | 0.998955 | R | 0.99889 | 6.50E-05 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1331 | V | 0.447593 | I | 0.411823 | 0.03577 | No Change: Both O | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 158 | P | 0.999154 | L | 0.99807 | 0.001084 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 318 | G | 0.992266 | R | 0.991866 | 4.00E-04 | No Change: Both D | Rhegmatogenous retinal detachment autosomal dominant (DRRD) [MIM:609508] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 516 | G | 0.991015 | D | 0.989696 | 0.001319 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 565 | R | 0.994665 | C | 0.991598 | 0.003067 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 667 | L | 0.99829 | F | 0.998395 | -1.05E-04 | No Change: Both D | Rhegmatogenous retinal detachment autosomal dominant (DRRD) [MIM:609508] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 717 | G | 0.993464 | S | 0.993237 | 2.27E-04 | No Change: Both D | Primary avascular necrosis of femoral head (ANFH) [MIM:608805] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 855 | G | 0.998301 | S | 0.998073 | 2.28E-04 | No Change: Both D | Spondyloepiphyseal dysplasia congenital type (SEDC) [MIM:183900] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 897 | G | 0.996603 | V | 0.994128 | 0.002475 | No Change: Both D | Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-STR) [MIM:184250] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 992 | R | 0.989198 | G | 0.989779 | -5.81E-04 | No Change: Both D | Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-STR) [MIM:184250] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1170 | G | 0.998949 | S | 0.999009 | -6.00E-05 | No Change: Both D | Primary avascular necrosis of femoral head (ANFH) [MIM:608805] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1305 | G | 0.192177 | D | 0.229366 | -0.037189 | No Change: Both O | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1391 | Y | 0.279552 | C | 0.248939 | 0.030613 | No Change: Both O | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 513 | G | 0.991746 | S | 0.990341 | 0.001405 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 717 | G | 0.993464 | V | 0.987733 | 0.005731 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 771 | G | 0.989347 | A | 0.986373 | 0.002974 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1390 | T | 0.320038 | N | 0.364339 | -0.044301 | No Change: Both O | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1448 | T | 0.335015 | P | 0.365542 | -0.030527 | No Change: Both O | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1469 | D | 0.328788 | H | 0.276863 | 0.051925 | No Change: Both O | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1485 | C | 0.273412 | G | 0.541218 | -0.267806 | O to D | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) [MIM:151210] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 142 | E | 0.999293 | D | 0.999323 | -3.00E-05 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 638 | T | 0.995233 | I | 0.992884 | 0.002349 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1051 | A | 0.995466 | T | 0.995495 | -2.90E-05 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1405 | G | 0.312131 | S | 0.366118 | -0.053987 | No Change: Both O | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 57 | C | 0.317482 | Y | 0.207431 | 0.110051 | No Change: Both O | Stickler syndrome type 1 non-syndromic ocular (STL1O) [MIM:609508] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 240 | G | 0.999521 | D | 0.999463 | 5.80E-05 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 270 | G | 0.989205 | R | 0.989124 | 8.10E-05 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 282 | G | 0.965225 | D | 0.960216 | 0.005009 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 453 | G | 0.99601 | A | 0.994983 | 0.001027 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 501 | G | 0.995238 | R | 0.99526 | -2.20E-05 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 547 | D | 0.993878 | V | 0.989594 | 0.004284 | No Change: Both D | Achondrogenesis type 2 (ACG2) [MIM:200610] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1158 | G | 0.997981 | A | 0.997268 | 7.13E-04 | No Change: Both D | Stickler syndrome type 1 (STL1) [MIM:108300] |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1176 | G | 0.998971 | V | 0.998137 | 8.34E-04 | No Change: Both D | - |
| P02458 | CO2A1_HUMAN Collagen alpha-1(II) chain OS=Homo sapiens GN=COL2A1 PE=1 SV=3 | 1179 | G | 0.998993 | R | 0.998937 | 5.60E-05 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 169 | L | 0.918536 | F | 0.917131 | 0.001405 | No Change: Both D | Aortic aneurysm abdominal (AAA) [MIM:100070] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 183 | G | 0.990424 | C | 0.985695 | 0.004729 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 201 | G | 0.999759 | R | 0.999682 | 7.70E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 228 | G | 0.998773 | E | 0.998742 | 3.10E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 303 | G | 0.996748 | R | 0.996798 | -5.00E-05 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 540 | G | 0.99961 | R | 0.999599 | 1.10E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 567 | G | 0.999337 | E | 0.99929 | 4.70E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 582 | G | 0.998874 | S | 0.998769 | 1.05E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 602 | P | 0.999424 | T | 0.999027 | 3.97E-04 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 635 | P | 0.999533 | L | 0.999051 | 4.82E-04 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 666 | G | 0.998878 | D | 0.99876 | 1.18E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 698 | A | 0.998845 | T | 0.998639 | 2.06E-04 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 726 | G | 0.997595 | R | 0.997254 | 3.41E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 756 | G | 0.998454 | E | 0.99833 | 1.24E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 762 | G | 0.998256 | C | 0.997062 | 0.001194 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 786 | G | 0.997152 | R | 0.996942 | 2.10E-04 | No Change: Both D | Aortic aneurysm abdominal (AAA) [MIM:100070] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 804 | G | 0.997581 | S | 0.997391 | 1.90E-04 | No Change: Both D | Ehlers-Danlos syndrome type 3 (EDS3) [MIM:130020] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 828 | G | 0.999262 | R | 0.999168 | 9.40E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 909 | G | 0.999425 | D | 0.999367 | 5.80E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 936 | G | 0.992456 | R | 0.991213 | 0.001243 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 936 | G | 0.992456 | S | 0.992422 | 3.40E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 939 | G | 0.992131 | D | 0.990553 | 0.001578 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 957 | G | 0.987599 | S | 0.987529 | 7.00E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 960 | G | 0.988294 | V | 0.97794 | 0.010354 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 996 | G | 0.993537 | E | 0.993589 | -5.20E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1014 | G | 0.995294 | E | 0.99515 | 1.44E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1050 | G | 0.998948 | D | 0.998849 | 9.90E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1071 | G | 0.998924 | V | 0.997872 | 0.001052 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1077 | G | 0.997989 | V | 0.995818 | 0.002171 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1101 | G | 0.988656 | E | 0.988443 | 2.13E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1104 | G | 0.987998 | A | 0.985256 | 0.002742 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1164 | G | 0.999456 | S | 0.999486 | -3.00E-05 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1167 | G | 0.999486 | V | 0.99902 | 4.66E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1170 | G | 0.999409 | D | 0.999256 | 1.53E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1173 | G | 0.999044 | E | 0.999014 | 3.00E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1176 | G | 0.998671 | V | 0.997595 | 0.001076 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1182 | G | 0.997075 | E | 0.996916 | 1.59E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1185 | G | 0.994517 | D | 0.99241 | 0.002107 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1185 | G | 0.994517 | V | 0.990449 | 0.004068 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1188 | G | 0.989978 | E | 0.989308 | 6.70E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1188 | G | 0.989978 | R | 0.987115 | 0.002863 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 183 | G | 0.990424 | D | 0.98975 | 6.74E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 183 | G | 0.990424 | S | 0.991433 | -0.001009 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 192 | G | 0.998966 | V | 0.998299 | 6.67E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 204 | G | 0.999736 | D | 0.99967 | 6.60E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 204 | G | 0.999736 | S | 0.999755 | -1.90E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 210 | G | 0.999677 | D | 0.99961 | 6.70E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 219 | G | 0.999536 | C | 0.999236 | 3.00E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 225 | G | 0.99903 | V | 0.997927 | 0.001103 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 240 | G | 0.995977 | R | 0.996071 | -9.40E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 243 | G | 0.99453 | V | 0.988313 | 0.006217 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 249 | G | 0.988164 | D | 0.986409 | 0.001755 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 249 | G | 0.988164 | V | 0.974539 | 0.013625 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 252 | G | 0.985517 | D | 0.983315 | 0.002202 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 252 | G | 0.985517 | R | 0.985302 | 2.15E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 252 | G | 0.985517 | V | 0.969656 | 0.015861 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 255 | G | 0.979061 | V | 0.956501 | 0.02256 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 264 | G | 0.97221 | R | 0.971196 | 0.001014 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 267 | G | 0.971577 | V | 0.93984 | 0.031737 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 321 | G | 0.996818 | V | 0.993476 | 0.003342 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 327 | G | 0.996635 | D | 0.996362 | 2.73E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 345 | G | 0.996331 | R | 0.99599 | 3.41E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 417 | G | 0.995063 | R | 0.99469 | 3.73E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 444 | G | 0.996114 | R | 0.995995 | 1.19E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 489 | G | 0.993388 | E | 0.993609 | -2.21E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 501 | G | 0.996507 | R | 0.996479 | 2.80E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 519 | G | 0.998492 | V | 0.99712 | 0.001372 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 549 | G | 0.999761 | E | 0.999737 | 2.40E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 552 | G | 0.999776 | E | 0.999754 | 2.20E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 588 | G | 0.998913 | D | 0.998722 | 1.91E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 636 | G | 0.999509 | R | 0.999328 | 1.81E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 657 | G | 0.999089 | E | 0.999073 | 1.60E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 660 | G | 0.99902 | D | 0.998928 | 9.20E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 668 | P | 0.998809 | T | 0.99788 | 9.29E-04 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 699 | G | 0.998816 | R | 0.998702 | 1.14E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 738 | G | 0.997566 | S | 0.997374 | 1.92E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 738 | G | 0.997566 | V | 0.995201 | 0.002365 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 744 | G | 0.997937 | V | 0.996185 | 0.001752 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 828 | G | 0.999262 | W | 0.998033 | 0.001229 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 852 | G | 0.999083 | C | 0.998468 | 6.15E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 879 | G | 0.998858 | V | 0.997839 | 0.001019 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 882 | G | 0.998929 | D | 0.998552 | 3.77E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 900 | G | 0.999605 | D | 0.999554 | 5.10E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 903 | G | 0.999523 | E | 0.999419 | 1.04E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 909 | G | 0.999425 | V | 0.998953 | 4.72E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 918 | G | 0.998598 | E | 0.998445 | 1.53E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 924 | G | 0.995875 | C | 0.993472 | 0.002403 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 942 | G | 0.991522 | E | 0.990586 | 9.36E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 966 | G | 0.990189 | V | 0.981867 | 0.008322 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 972 | G | 0.990466 | A | 0.987775 | 0.002691 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 984 | G | 0.993192 | T | 0.991126 | 0.002066 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 999 | G | 0.993269 | R | 0.992896 | 3.73E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1011 | G | 0.994658 | E | 0.994517 | 1.41E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1032 | G | 0.997855 | V | 0.995605 | 0.00225 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1035 | G | 0.99833 | C | 0.997286 | 0.001044 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1044 | G | 0.9989 | D | 0.998817 | 8.30E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1050 | G | 0.998948 | V | 0.998085 | 8.63E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1089 | G | 0.994915 | D | 0.994155 | 7.60E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1098 | G | 0.990084 | D | 0.988532 | 0.001552 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1098 | G | 0.990084 | V | 0.979167 | 0.010917 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1161 | G | 0.999378 | V | 0.998835 | 5.43E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1164 | G | 0.999456 | E | 0.99942 | 3.60E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1164 | G | 0.999456 | R | 0.999459 | -3.00E-06 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1170 | G | 0.999409 | V | 0.99889 | 5.19E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1173 | G | 0.999044 | R | 0.999029 | 1.50E-05 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1179 | G | 0.998103 | R | 0.997869 | 2.34E-04 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1205 | I | 0.738253 | V | 0.735742 | 0.002511 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1353 | H | 0.096715 | Q | 0.106422 | -0.009707 | No Change: Both O | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 420 | G | 0.995302 | S | 0.994322 | 9.80E-04 | No Change: Both D | A colorectal cancer sample |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 1434 | R | 0.225878 | C | 0.109947 | 0.115931 | No Change: Both O | A colorectal cancer sample |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 297 | G | 0.994799 | R | 0.994801 | -2.00E-06 | No Change: Both D | Ehlers-Danlos syndrome type 4 (EDS4) [MIM:130050] |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 534 | G | 0.999403 | E | 0.999372 | 3.10E-05 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 679 | A | 0.99879 | T | 0.998465 | 3.25E-04 | No Change: Both D | - |
| P02461 | CO3A1_HUMAN Collagen alpha-1(III) chain OS=Homo sapiens GN=COL3A1 PE=1 SV=4 | 686 | P | 0.998794 | A | 0.998255 | 5.39E-04 | No Change: Both D | - |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 1334 | Q | 0.98728 | H | 0.980431 | 0.006849 | No Change: Both D | - |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 7 | V | 0.24104 | L | 0.358091 | -0.117051 | No Change: Both O | - |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 562 | G | 0.982111 | E | 0.980365 | 0.001746 | No Change: Both D | Brain small vessel disease with hemorrhage (BSVDH) [MIM:607595] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 749 | G | 0.966049 | S | 0.963526 | 0.002523 | No Change: Both D | Familial porencephaly (PCEPH) [MIM:175780] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 1130 | G | 0.981595 | D | 0.980314 | 0.001281 | No Change: Both D | Familial porencephaly (PCEPH) [MIM:175780] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 1236 | G | 0.996235 | R | 0.995797 | 4.38E-04 | No Change: Both D | Familial porencephaly (PCEPH) [MIM:175780] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 1423 | G | 0.992545 | R | 0.992185 | 3.60E-04 | No Change: Both D | Familial porencephaly (PCEPH) [MIM:175780] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 555 | T | 0.968696 | P | 0.982691 | -0.013995 | No Change: Both D | - |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 304 | P | 0.99496 | L | 0.989278 | 0.005682 | No Change: Both D | - |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 498 | G | 0.970848 | V | 0.947324 | 0.023524 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 519 | G | 0.890001 | R | 0.884512 | 0.005489 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 528 | G | 0.87328 | E | 0.874767 | -0.001487 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 498 | G | 0.970848 | R | 0.969893 | 9.55E-04 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 510 | G | 0.912474 | R | 0.91009 | 0.002384 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 525 | G | 0.876029 | L | 0.820438 | 0.055591 | No Change: Both D | Hereditary angiopathy with nephropathy aneurysms and muscle cramps (HANAC) [MIM:611773] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 720 | G | 0.988587 | D | 0.986319 | 0.002268 | No Change: Both D | Brain small vessel disease with hemorrhage (BSVDH) [MIM:607595] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 755 | G | 0.968556 | R | 0.96049 | 0.008066 | No Change: Both D | Brain small vessel disease with hemorrhage (BSVDH) [MIM:607595] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 805 | G | 0.997442 | R | 0.997145 | 2.97E-04 | No Change: Both D | Brain small vessel disease with hemorrhage (BSVDH) [MIM:607595] |
| P02462 | CO4A1_HUMAN Collagen alpha-1(IV) chain OS=Homo sapiens GN=COL4A1 PE=1 SV=3 | 1580 | G | 0.194863 | R | 0.181944 | 0.012919 | No Change: Both O | Familial porencephaly (PCEPH) [MIM:175780] |
| P08572 | CO4A2_HUMAN Collagen alpha-2(IV) chain OS=Homo sapiens GN=COL4A2 PE=1 SV=4 | 517 | R | 0.953046 | K | 0.958265 | -0.005219 | No Change: Both D | - |
| P08572 | CO4A2_HUMAN Collagen alpha-2(IV) chain OS=Homo sapiens GN=COL4A2 PE=1 SV=4 | 683 | G | 0.906766 | A | 0.881606 | 0.02516 | No Change: Both D | - |
| P08572 | CO4A2_HUMAN Collagen alpha-2(IV) chain OS=Homo sapiens GN=COL4A2 PE=1 SV=4 | 718 | P | 0.985556 | S | 0.979509 | 0.006047 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1474 | L | 0.165037 | P | 0.293441 | -0.128404 | No Change: Both O | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1495 | Q | 0.154749 | R | 0.15238 | 0.002369 | No Change: Both O | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 43 | G | 0.848302 | R | 0.825733 | 0.022569 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 162 | E | 0.951846 | G | 0.950697 | 0.001149 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 297 | G | 0.981845 | E | 0.98185 | -5.00E-06 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 326 | D | 0.890773 | Y | 0.819363 | 0.07141 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 407 | G | 0.994524 | R | 0.994566 | -4.20E-05 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 408 | R | 0.994301 | H | 0.991482 | 0.002819 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 451 | H | 0.933698 | R | 0.948756 | -0.015058 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 574 | P | 0.977908 | L | 0.960573 | 0.017335 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 640 | G | 0.997442 | R | 0.997167 | 2.75E-04 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1167 | G | 0.984041 | R | 0.98438 | -3.39E-04 | No Change: Both D | Alport syndrome autosomal dominant (APSAD) [MIM:104200] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1207 | G | 0.981982 | E | 0.980038 | 0.001944 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1215 | R | 0.979126 | Q | 0.97777 | 0.001356 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1269 | D | 0.994712 | E | 0.994237 | 4.75E-04 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1277 | G | 0.99503 | S | 0.995003 | 2.70E-05 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1330 | I | 0.977043 | T | 0.98327 | -0.006227 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1334 | G | 0.980604 | E | 0.97901 | 0.001594 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1347 | D | 0.985839 | E | 0.988529 | -0.00269 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1661 | R | 0.316462 | C | 0.214615 | 0.101847 | No Change: Both O | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 141 | L | 0.817681 | P | 0.904568 | -0.086887 | No Change: Both D | - |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 532 | G | 0.974007 | D | 0.971234 | 0.002773 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 739 | G | 0.988336 | R | 0.985771 | 0.002565 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 853 | G | 0.973253 | R | 0.972243 | 0.00101 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 985 | G | 0.987338 | V | 0.976263 | 0.011075 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1015 | G | 0.985048 | E | 0.983078 | 0.00197 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 1216 | G | 0.978615 | R | 0.978143 | 4.72E-04 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| Q01955 | CO4A3_HUMAN Collagen alpha-3(IV) chain OS=Homo sapiens GN=COL4A3 PE=1 SV=3 | 834 | K | 0.980764 | R | 0.981225 | -4.61E-04 | No Change: Both D | - |
| Q9Y5P4 | C43BP_HUMAN Collagen type IV alpha-3-binding protein OS=Homo sapiens GN=COL4A3BP PE=1 SV=1 | 67 | G | 0.194024 | E | 0.239893 | -0.045869 | No Change: Both O | - |
| Q9Y5P4 | C43BP_HUMAN Collagen type IV alpha-3-binding protein OS=Homo sapiens GN=COL4A3BP PE=1 SV=1 | 599 | K | 0.33332 | R | 0.274843 | 0.058477 | No Change: Both O | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 897 | G | 0.998 | E | 0.997667 | 3.33E-04 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1201 | G | 0.957895 | S | 0.958567 | -6.72E-04 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 545 | G | 0.986298 | A | 0.981821 | 0.004477 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 570 | E | 0.985829 | Q | 0.986571 | -7.42E-04 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 931 | A | 0.993683 | T | 0.992858 | 8.25E-04 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1004 | P | 0.998477 | L | 0.996154 | 0.002323 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1030 | G | 0.997689 | V | 0.995023 | 0.002666 | No Change: Both D | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1402 | P | 0.993494 | S | 0.991753 | 0.001741 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1572 | P | 0.377867 | L | 0.215043 | 0.162824 | No Change: Both O | Alport syndrome autosomal recessive (APSAR) [MIM:203780] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 482 | P | 0.976728 | S | 0.973055 | 0.003673 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 6 | I | 0.123556 | T | 0.229326 | -0.10577 | No Change: Both O | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 116 | G | 0.987971 | E | 0.986033 | 0.001938 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 960 | G | 0.97237 | R | 0.971213 | 0.001157 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 999 | G | 0.997492 | E | 0.997606 | -1.14E-04 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1132 | P | 0.998905 | L | 0.997699 | 0.001206 | No Change: Both D | Benign familial hematuria (BFH) [MIM:141200] |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1327 | V | 0.998167 | M | 0.998784 | -6.17E-04 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 1403 | S | 0.993757 | P | 0.995785 | -0.002028 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 594 | E | 0.996603 | G | 0.996878 | -2.75E-04 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 670 | V | 0.928737 | I | 0.92619 | 0.002547 | No Change: Both D | - |
| P53420 | CO4A4_HUMAN Collagen alpha-4(IV) chain OS=Homo sapiens GN=COL4A4 PE=1 SV=3 | 759 | P | 0.980499 | L | 0.961032 | 0.019467 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 54 | G | 0.961151 | D | 0.957404 | 0.003747 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 129 | G | 0.987497 | E | 0.986537 | 9.60E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 129 | G | 0.987497 | V | 0.97366 | 0.013837 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 174 | G | 0.99604 | R | 0.994745 | 0.001295 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 177 | G | 0.996249 | R | 0.995027 | 0.001222 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 216 | G | 0.998405 | R | 0.997957 | 4.48E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 219 | G | 0.997303 | S | 0.997058 | 2.45E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 289 | G | 0.999595 | V | 0.999144 | 4.51E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 292 | G | 0.999532 | V | 0.999 | 5.32E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 325 | G | 0.995385 | E | 0.995471 | -8.60E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 325 | G | 0.995385 | R | 0.995114 | 2.71E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 365 | G | 0.959134 | E | 0.961085 | -0.001951 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 371 | G | 0.967189 | E | 0.968423 | -0.001234 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 374 | G | 0.967838 | A | 0.950518 | 0.01732 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 383 | G | 0.985402 | D | 0.980588 | 0.004814 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 400 | G | 0.996498 | E | 0.996521 | -2.30E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 406 | G | 0.996949 | V | 0.994401 | 0.002548 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 409 | G | 0.997234 | D | 0.996969 | 2.65E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 430 | A | 0.9984 | D | 0.998861 | -4.61E-04 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 444 | I | 0.998245 | S | 0.999052 | -8.07E-04 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 466 | G | 0.978799 | E | 0.978562 | 2.37E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 494 | G | 0.955934 | D | 0.952086 | 0.003848 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 521 | G | 0.989574 | C | 0.983202 | 0.006372 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 521 | G | 0.989574 | S | 0.989145 | 4.29E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 567 | G | 0.984565 | A | 0.978157 | 0.006408 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 609 | G | 0.993314 | V | 0.986816 | 0.006498 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 638 | G | 0.991583 | V | 0.985576 | 0.006007 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 638 | G | 0.991583 | A | 0.987683 | 0.0039 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 653 | G | 0.992414 | R | 0.990665 | 0.001749 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 664 | K | 0.992806 | N | 0.992297 | 5.09E-04 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 684 | G | 0.994385 | V | 0.989804 | 0.004581 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 740 | G | 0.998901 | E | 0.998873 | 2.80E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 772 | G | 0.997492 | D | 0.997315 | 1.77E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 796 | G | 0.99688 | R | 0.996561 | 3.19E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 852 | G | 0.997642 | R | 0.997247 | 3.95E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 866 | G | 0.99719 | E | 0.997084 | 1.06E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 869 | G | 0.997209 | R | 0.996796 | 4.13E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 872 | G | 0.997521 | R | 0.997103 | 4.18E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1104 | G | 0.989474 | V | 0.981034 | 0.00844 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1143 | G | 0.999298 | D | 0.999054 | 2.44E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1143 | G | 0.999298 | S | 0.999237 | 6.10E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1182 | G | 0.998116 | R | 0.997431 | 6.85E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1241 | G | 0.998527 | C | 0.997666 | 8.61E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1270 | G | 0.999351 | S | 0.999183 | 1.68E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1379 | G | 0.996181 | V | 0.991873 | 0.004308 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1410 | R | 0.997633 | C | 0.996513 | 0.00112 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1421 | G | 0.997507 | W | 0.993514 | 0.003993 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1422 | R | 0.997564 | C | 0.996359 | 0.001205 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1451 | G | 0.952136 | S | 0.957447 | -0.005311 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1498 | A | 0.463416 | D | 0.526974 | -0.063558 | O to D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1517 | P | 0.125939 | T | 0.105528 | 0.020411 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1538 | W | 0.402754 | S | 0.69855 | -0.295796 | O to D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1563 | R | 0.191822 | Q | 0.248034 | -0.056212 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1564 | C | 0.164722 | S | 0.315639 | -0.150917 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1596 | G | 0.119377 | D | 0.131836 | -0.012459 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1649 | L | 0.093073 | R | 0.158358 | -0.065285 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1677 | R | 0.381521 | Q | 0.373842 | 0.007679 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 114 | G | 0.98763 | S | 0.985926 | 0.001704 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 331 | G | 0.989864 | V | 0.982238 | 0.007626 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 472 | G | 0.963947 | R | 0.953139 | 0.010808 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 545 | G | 0.975773 | R | 0.967932 | 0.007841 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 545 | G | 0.975773 | V | 0.949509 | 0.026264 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 561 | G | 0.981963 | R | 0.976107 | 0.005856 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 579 | G | 0.989505 | R | 0.986585 | 0.00292 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 635 | G | 0.991826 | D | 0.989714 | 0.002112 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 638 | G | 0.991583 | S | 0.989447 | 0.002136 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 669 | G | 0.993757 | A | 0.989878 | 0.003879 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 687 | G | 0.994215 | E | 0.993432 | 7.83E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 743 | G | 0.998897 | D | 0.998492 | 4.05E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 808 | G | 0.998164 | E | 0.997609 | 5.55E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 852 | G | 0.997642 | E | 0.9976 | 4.20E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 878 | G | 0.997516 | R | 0.997036 | 4.80E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1107 | G | 0.99066 | R | 0.987353 | 0.003307 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1161 | G | 0.99941 | R | 0.999187 | 2.23E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1211 | G | 0.994826 | R | 0.992929 | 0.001897 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1220 | G | 0.994809 | D | 0.993739 | 0.00107 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1333 | G | 0.993213 | S | 0.99325 | -3.70E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1427 | G | 0.997317 | V | 0.99436 | 0.002957 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1442 | G | 0.985329 | D | 0.985449 | -1.20E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1486 | G | 0.179532 | A | 0.140848 | 0.038684 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1559 | P | 0.318748 | A | 0.21961 | 0.099138 | No Change: Both O | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 177 | G | 0.996249 | C | 0.993937 | 0.002312 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 192 | G | 0.998559 | R | 0.998068 | 4.91E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 204 | G | 0.999027 | V | 0.997774 | 0.001253 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 230 | G | 0.992086 | R | 0.991415 | 6.71E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 239 | G | 0.990262 | E | 0.991302 | -0.00104 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 264 | G | 0.996652 | R | 0.996696 | -4.40E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 292 | G | 0.999532 | R | 0.999491 | 4.10E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 295 | G | 0.999411 | D | 0.999359 | 5.20E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 298 | G | 0.999255 | S | 0.999047 | 2.08E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 319 | G | 0.997315 | R | 0.997114 | 2.01E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 412 | G | 0.99729 | V | 0.994905 | 0.002385 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 415 | G | 0.997506 | R | 0.997172 | 3.34E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 420 | G | 0.99735 | E | 0.997367 | -1.70E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 420 | G | 0.99735 | V | 0.994586 | 0.002764 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 423 | G | 0.997741 | E | 0.997738 | 3.00E-06 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 491 | G | 0.953461 | E | 0.949537 | 0.003924 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 497 | G | 0.962582 | C | 0.950005 | 0.012577 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 524 | G | 0.986292 | D | 0.983487 | 0.002805 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 558 | G | 0.979682 | R | 0.973064 | 0.006618 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 573 | G | 0.986815 | D | 0.986024 | 7.91E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 579 | G | 0.989505 | E | 0.989302 | 2.03E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 603 | G | 0.994392 | V | 0.988643 | 0.005749 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 609 | G | 0.993314 | R | 0.992308 | 0.001006 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 619 | P | 0.992673 | S | 0.988204 | 0.004469 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 621 | G | 0.992693 | C | 0.987429 | 0.005264 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 624 | G | 0.99228 | D | 0.989742 | 0.002538 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 629 | G | 0.991849 | D | 0.989401 | 0.002448 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 632 | G | 0.992061 | D | 0.989833 | 0.002228 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 633 | E | 0.992193 | K | 0.993543 | -0.00135 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 681 | G | 0.994038 | D | 0.993924 | 1.14E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 722 | G | 0.998518 | E | 0.998432 | 8.60E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 739 | P | 0.998902 | A | 0.99799 | 9.12E-04 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 739 | P | 0.998902 | S | 0.998159 | 7.43E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 802 | G | 0.997845 | R | 0.997533 | 3.12E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 811 | G | 0.998077 | V | 0.996618 | 0.001459 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 822 | G | 0.997765 | R | 0.997007 | 7.58E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 898 | M | 0.992683 | V | 0.987853 | 0.00483 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 902 | G | 0.992309 | V | 0.985597 | 0.006712 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 911 | G | 0.990902 | E | 0.990275 | 6.27E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 941 | G | 0.996486 | C | 0.99427 | 0.002216 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 947 | G | 0.99741 | D | 0.997179 | 2.31E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 953 | G | 0.996579 | V | 0.993325 | 0.003254 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1006 | G | 0.997099 | A | 0.994924 | 0.002175 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1006 | G | 0.997099 | V | 0.994115 | 0.002984 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1015 | G | 0.994589 | E | 0.993703 | 8.86E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1015 | G | 0.994589 | V | 0.989733 | 0.004856 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1030 | G | 0.991642 | S | 0.990893 | 7.49E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1036 | G | 0.991901 | V | 0.986043 | 0.005858 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1039 | G | 0.992712 | S | 0.992395 | 3.17E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1045 | G | 0.993943 | E | 0.993442 | 5.01E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1066 | G | 0.995158 | R | 0.993527 | 0.001631 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1066 | G | 0.995158 | S | 0.995418 | -2.60E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1086 | G | 0.989103 | D | 0.987975 | 0.001128 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1158 | G | 0.99943 | R | 0.999215 | 2.15E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1167 | G | 0.999319 | S | 0.999164 | 1.55E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1170 | G | 0.999223 | S | 0.999063 | 1.60E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1196 | G | 0.996734 | R | 0.995532 | 0.001202 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1205 | G | 0.994523 | C | 0.990934 | 0.003589 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1211 | G | 0.994826 | E | 0.994338 | 4.88E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1229 | G | 0.995774 | D | 0.994831 | 9.43E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1244 | G | 0.998924 | D | 0.998515 | 4.09E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1252 | G | 0.999409 | S | 0.999348 | 6.10E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1261 | G | 0.99957 | E | 0.999559 | 1.10E-05 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1357 | G | 0.994891 | S | 0.995213 | -3.22E-04 | No Change: Both D | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1428 | L | 0.997075 | M | 0.997371 | -2.96E-04 | No Change: Both D | - |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1488 | S | 0.1449 | F | 0.064185 | 0.080715 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1511 | R | 0.229903 | H | 0.217916 | 0.011987 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1567 | C | 0.131618 | R | 0.211736 | -0.080118 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1677 | R | 0.381521 | P | 0.384071 | -0.00255 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| P29400 | CO4A5_HUMAN Collagen alpha-5(IV) chain OS=Homo sapiens GN=COL4A5 PE=1 SV=2 | 1678 | C | 0.456396 | W | 0.304889 | 0.151507 | No Change: Both O | Alport syndrome X-linked (APSX) [MIM:301050] |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 455 | S | 0.921776 | A | 0.894758 | 0.027018 | No Change: Both D | - |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 1110 | N | 0.834941 | K | 0.863263 | -0.028322 | No Change: Both D | - |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 1126 | P | 0.812418 | S | 0.794534 | 0.017884 | No Change: Both D | - |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 1162 | I | 0.930783 | V | 0.927295 | 0.003488 | No Change: Both D | - |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 1362 | L | 0.969817 | P | 0.985093 | -0.015276 | No Change: Both D | - |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 1130 | G | 0.836064 | E | 0.83213 | 0.003934 | No Change: Both D | A colorectal cancer sample |
| Q14031 | CO4A6_HUMAN Collagen alpha-6(IV) chain OS=Homo sapiens GN=COL4A6 PE=2 SV=3 | 455 | S | 0.921776 | P | 0.930529 | -0.008753 | No Change: Both D | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 1639 | C | 0.47588 | S | 0.623781 | -0.147901 | O to D | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 530 | G | 0.874891 | S | 0.886686 | -0.011795 | No Change: Both D | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 530 | G | 0.874891 | S | 0.886686 | -0.011795 | No Change: Both D | Ehlers-Danlos syndrome type 2 (EDS2) [MIM:130010] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 1489 | G | 0.993095 | D | 0.992403 | 6.92E-04 | No Change: Both D | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 25 | L | 0.320622 | P | 0.492394 | -0.171772 | No Change: Both O | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 25 | L | 0.320622 | P | 0.492394 | -0.171772 | No Change: Both O | Ehlers-Danlos syndrome type 2 (EDS2) [MIM:130010] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 25 | L | 0.320622 | R | 0.420092 | -0.09947 | No Change: Both O | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 25 | L | 0.320622 | R | 0.420092 | -0.09947 | No Change: Both O | Ehlers-Danlos syndrome type 2 (EDS2) [MIM:130010] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 114 | A | 0.245514 | D | 0.300223 | -0.054709 | No Change: Both O | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 192 | D | 0.521071 | N | 0.486453 | 0.034618 | D to O | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 229 | D | 0.186073 | N | 0.159081 | 0.026992 | No Change: Both O | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 393 | P | 0.962238 | S | 0.959342 | 0.002896 | No Change: Both D | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 951 | N | 0.999325 | S | 0.999416 | -9.10E-05 | No Change: Both D | - |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 1486 | G | 0.994053 | C | 0.990128 | 0.003925 | No Change: Both D | Ehlers-Danlos syndrome type 1 (EDS1) [MIM:130000] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 1486 | G | 0.994053 | C | 0.990128 | 0.003925 | No Change: Both D | Ehlers-Danlos syndrome type 2 (EDS2) [MIM:130010] |
| P20908 | CO5A1_HUMAN Collagen alpha-1(V) chain OS=Homo sapiens GN=COL5A1 PE=1 SV=3 | 908 | P | 0.998309 | L | 0.995738 | 0.002571 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 963 | G | 0.999068 | R | 0.999034 | 3.40E-05 | No Change: Both D | Ehlers-Danlos syndrome type 2 (EDS2) [MIM:130010] |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 460 | P | 0.997633 | S | 0.997055 | 5.78E-04 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 956 | R | 0.99886 | P | 0.999152 | -2.92E-04 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 512 | V | 0.995838 | A | 0.99672 | -8.82E-04 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 833 | P | 0.992793 | L | 0.984542 | 0.008251 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 1230 | T | 0.965213 | S | 0.971555 | -0.006342 | No Change: Both D | - |
| P05997 | CO5A2_HUMAN Collagen alpha-2(V) chain OS=Homo sapiens GN=COL5A2 PE=1 SV=3 | 1432 | D | 0.363978 | V | 0.209035 | 0.154943 | No Change: Both O | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 134 | R | 0.329689 | H | 0.327979 | 0.00171 | No Change: Both O | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1207 | R | 0.994647 | P | 0.996684 | -0.002037 | No Change: Both D | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1428 | V | 0.99144 | M | 0.994189 | -0.002749 | No Change: Both D | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1594 | I | 0.214749 | M | 0.299974 | -0.085225 | No Change: Both O | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1691 | V | 0.430105 | I | 0.37168 | 0.058425 | No Change: Both O | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1042 | R | 0.996165 | P | 0.99724 | -0.001075 | No Change: Both D | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 1488 | A | 0.966607 | P | 0.979696 | -0.013089 | No Change: Both D | - |
| P25940 | CO5A3_HUMAN Collagen alpha-3(V) chain OS=Homo sapiens GN=COL5A3 PE=1 SV=3 | 322 | R | 0.864015 | G | 0.867276 | -0.003261 | No Change: Both D | - |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 121 | K | 0.308298 | R | 0.235179 | 0.073119 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 305 | G | 0.98993 | V | 0.982645 | 0.007285 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 341 | G | 0.944657 | D | 0.942865 | 0.001792 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 439 | R | 0.999282 | Q | 0.999218 | 6.40E-05 | No Change: Both D | - |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 850 | R | 0.436121 | H | 0.424764 | 0.011357 | No Change: Both O | - |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 116 | S | 0.468298 | N | 0.407342 | 0.060956 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 272 | G | 0.975159 | D | 0.973832 | 0.001327 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 274 | P | 0.983635 | L | 0.969106 | 0.014529 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 275 | G | 0.986115 | R | 0.986313 | -1.98E-04 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 281 | G | 0.991788 | R | 0.991709 | 7.90E-05 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 284 | G | 0.992028 | R | 0.991911 | 1.17E-04 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 290 | G | 0.990768 | R | 0.990588 | 1.80E-04 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 290 | G | 0.990768 | R | 0.990588 | 1.80E-04 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 332 | G | 0.957841 | S | 0.956201 | 0.00164 | No Change: Both D | - |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 341 | G | 0.944657 | V | 0.905486 | 0.039171 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 571 | K | 0.959773 | T | 0.941367 | 0.018406 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 881 | T | 0.560015 | M | 0.516034 | 0.043981 | No Change: Both D | - |
| P12109 | CO6A1_HUMAN Collagen alpha-1(VI) chain OS=Homo sapiens GN=COL6A1 PE=1 SV=3 | 890 | S | 0.405497 | L | 0.262297 | 0.1432 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 271 | G | 0.961774 | S | 0.962722 | -9.48E-04 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 621 | D | 0.235418 | N | 0.217442 | 0.017976 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 399 | S | 0.995696 | N | 0.994714 | 9.82E-04 | No Change: Both D | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 680 | R | 0.474124 | H | 0.484685 | -0.010561 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 227 | D | 0.452015 | N | 0.433361 | 0.018654 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 935 | G | 0.577253 | R | 0.574692 | 0.002561 | No Change: Both D | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 1015 | I | 0.072801 | L | 0.078192 | -0.005391 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 106 | E | 0.467957 | K | 0.469319 | -0.001362 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 283 | G | 0.990629 | R | 0.989926 | 7.03E-04 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 489 | R | 0.996665 | Q | 0.996703 | -3.80E-05 | No Change: Both D | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 498 | R | 0.998745 | H | 0.998086 | 6.59E-04 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 518 | P | 0.998832 | S | 0.998521 | 3.11E-04 | No Change: Both D | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 531 | G | 0.998888 | R | 0.998911 | -2.30E-05 | No Change: Both D | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 700 | G | 0.135424 | S | 0.170477 | -0.035053 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 724 | R | 0.264295 | C | 0.134406 | 0.129889 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 777 | C | 0.264838 | R | 0.433085 | -0.168247 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 784 | R | 0.27325 | H | 0.273798 | -5.48E-04 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 804 | V | 0.406104 | G | 0.451691 | -0.045587 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 837 | L | 0.237063 | P | 0.375268 | -0.138205 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 853 | R | 0.38329 | Q | 0.39276 | -0.00947 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 876 | R | 0.331101 | S | 0.339753 | -0.008652 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 895 | S | 0.251295 | R | 0.202073 | 0.049222 | No Change: Both O | - |
| P12110 | CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens GN=COL6A2 PE=1 SV=4 | 932 | P | 0.496514 | L | 0.352332 | 0.144182 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1679 | G | 0.253072 | E | 0.299725 | -0.046653 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2831 | D | 0.223423 | H | 0.178229 | 0.045194 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 538 | T | 0.292678 | M | 0.25355 | 0.039128 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 659 | R | 0.105958 | H | 0.105094 | 8.64E-04 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 886 | V | 0.568404 | E | 0.671714 | -0.10331 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1088 | K | 0.342578 | Q | 0.325607 | 0.016971 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2218 | P | 0.994799 | L | 0.98846 | 0.006339 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2805 | N | 0.534021 | T | 0.521865 | 0.012156 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2927 | M | 0.986237 | T | 0.989147 | -0.00291 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2988 | M | 0.808159 | V | 0.772609 | 0.03555 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 3012 | A | 0.421969 | P | 0.488097 | -0.066128 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 3069 | T | 0.446512 | I | 0.300981 | 0.145531 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 411 | L | 0.294498 | V | 0.28348 | 0.011018 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 491 | D | 0.18384 | H | 0.159293 | 0.024547 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 492 | T | 0.193315 | S | 0.253198 | -0.059883 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 677 | R | 0.171294 | H | 0.172084 | -7.90E-04 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 807 | A | 0.343551 | T | 0.37372 | -0.030169 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 830 | A | 0.527244 | S | 0.620987 | -0.093743 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1014 | K | 0.305729 | E | 0.308134 | -0.002405 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1064 | R | 0.307218 | Q | 0.322936 | -0.015718 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1386 | E | 0.327748 | K | 0.327101 | 6.47E-04 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1395 | R | 0.459357 | Q | 0.497934 | -0.038577 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1467 | N | 0.273978 | D | 0.291489 | -0.017511 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1576 | R | 0.405347 | Q | 0.406122 | -7.75E-04 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1632 | R | 0.821074 | Q | 0.811645 | 0.009429 | No Change: Both D | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1674 | D | 0.325442 | N | 0.293655 | 0.031787 | No Change: Both O | Ullrich congenital muscular dystrophy (UCMD) [MIM:254090] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1687 | P | 0.396294 | S | 0.4433 | -0.047006 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1726 | L | 0.222233 | R | 0.335542 | -0.113309 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 1985 | V | 0.176247 | M | 0.227486 | -0.051239 | No Change: Both O | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2047 | G | 0.873278 | D | 0.875266 | -0.001988 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2056 | G | 0.953664 | R | 0.953739 | -7.50E-05 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2080 | G | 0.967898 | D | 0.963303 | 0.004595 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2431 | D | 0.150812 | V | 0.083199 | 0.067613 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2453 | E | 0.269717 | K | 0.258394 | 0.011323 | No Change: Both O | - |
| P12111 | CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens GN=COL6A3 PE=1 SV=5 | 2941 | A | 0.994294 | V | 0.992261 | 0.002033 | No Change: Both D | Bethlem myopathy (BM) [MIM:158810] |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 2188 | Q | 0.383856 | R | 0.352108 | 0.031748 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 2205 | G | 0.335177 | D | 0.355676 | -0.020499 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 455 | E | 0.594881 | K | 0.595035 | -1.54E-04 | No Change: Both D | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 641 | N | 0.400105 | H | 0.363667 | 0.036438 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 805 | H | 0.059341 | R | 0.06516 | -0.005819 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 982 | D | 0.199547 | G | 0.166688 | 0.032859 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 1114 | I | 0.205812 | M | 0.288399 | -0.082587 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 1280 | T | 0.316135 | P | 0.381153 | -0.065018 | No Change: Both O | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 1477 | C | 0.948435 | S | 0.968993 | -0.020558 | No Change: Both D | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 1589 | S | 0.995125 | P | 0.9959 | -7.75E-04 | No Change: Both D | - |
| A8TX70 | CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens GN=COL6A5 PE=1 SV=1 | 2175 | D | 0.21405 | N | 0.215177 | -0.001127 | No Change: Both O | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 345 | E | 0.544232 | K | 0.555376 | -0.011144 | No Change: Both D | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 370 | A | 0.344036 | T | 0.387052 | -0.043016 | No Change: Both O | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 461 | E | 0.163394 | A | 0.101263 | 0.062131 | No Change: Both O | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 1739 | R | 0.539164 | Q | 0.52839 | 0.010774 | No Change: Both D | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 1799 | H | 0.140893 | R | 0.148816 | -0.007923 | No Change: Both O | - |
| A6NMZ7 | CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens GN=COL6A6 PE=1 SV=2 | 556 | P | 0.456973 | S | 0.500055 | -0.043082 | O to D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 142 | K | 0.117245 | R | 0.09614 | 0.021105 | No Change: Both O | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 595 | P | 0.705699 | L | 0.559054 | 0.146645 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1277 | P | 0.992323 | L | 0.983386 | 0.008937 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1557 | G | 0.983225 | R | 0.982784 | 4.41E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1782 | G | 0.995019 | R | 0.994961 | 5.80E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1982 | G | 0.957542 | W | 0.924184 | 0.033358 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2003 | G | 0.995886 | R | 0.995905 | -1.90E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2008 | R | 0.996382 | G | 0.996615 | -2.33E-04 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2025 | G | 0.995282 | A | 0.993636 | 0.001646 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2034 | G | 0.996098 | R | 0.996001 | 9.70E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2034 | G | 0.996098 | R | 0.996001 | 9.70E-05 | No Change: Both D | Epidermolysis bullosa dystrophica with subcorneal cleavage (EBDSC) [MIM:607600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2040 | G | 0.996169 | S | 0.995816 | 3.53E-04 | No Change: Both D | Epidermolysis bullosa dystrophica Pasini type (P-DEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2043 | G | 0.996092 | R | 0.996077 | 1.50E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2049 | G | 0.99627 | E | 0.996542 | -2.72E-04 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2055 | G | 0.997492 | E | 0.997703 | -2.11E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2063 | R | 0.998259 | W | 0.995392 | 0.002867 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2073 | G | 0.998906 | D | 0.998759 | 1.47E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2076 | G | 0.99906 | D | 0.99895 | 1.10E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2079 | G | 0.999174 | E | 0.999239 | -6.50E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2242 | G | 0.992849 | R | 0.991864 | 9.85E-04 | No Change: Both D | Epidermolysis bullosa pruriginosa (EBP) [MIM:604129] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2351 | G | 0.997169 | R | 0.997051 | 1.18E-04 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2569 | G | 0.993365 | R | 0.992745 | 6.20E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2575 | G | 0.990241 | R | 0.989202 | 0.001039 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2623 | G | 0.951078 | C | 0.931514 | 0.019564 | No Change: Both D | Epidermolysis bullosa dystrophica pretibial type (PR-DEB) [MIM:131850] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2653 | G | 0.985053 | R | 0.983721 | 0.001332 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2671 | G | 0.9857 | V | 0.974067 | 0.011633 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2674 | G | 0.985442 | R | 0.984077 | 0.001365 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2749 | G | 0.997641 | R | 0.997697 | -5.60E-05 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2798 | M | 0.593011 | K | 0.645131 | -0.05212 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1347 | G | 0.998422 | R | 0.998415 | 7.00E-06 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1519 | G | 0.997942 | D | 0.997447 | 4.95E-04 | No Change: Both D | Transient bullous dermolysis of the newborn (TBDN) [MIM:131705] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1522 | G | 0.997917 | E | 0.998 | -8.30E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1604 | G | 0.997948 | R | 0.997933 | 1.50E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1652 | G | 0.995533 | R | 0.995597 | -6.40E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1703 | G | 0.998878 | E | 0.998928 | -5.00E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1772 | R | 0.994938 | W | 0.98707 | 0.007868 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1776 | G | 0.994902 | R | 0.994912 | -1.00E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1791 | G | 0.993501 | E | 0.992718 | 7.83E-04 | No Change: Both D | Epidermolysis bullosa pruriginosa (EBP) [MIM:604129] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1812 | G | 0.994853 | R | 0.994622 | 2.31E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2006 | G | 0.996408 | A | 0.994774 | 0.001634 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2006 | G | 0.996408 | D | 0.99619 | 2.18E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2008 | R | 0.996382 | C | 0.994491 | 0.001891 | No Change: Both D | Epidermolysis bullosa dystrophica Hallopeau-Siemens type (HS-DEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2009 | G | 0.996324 | R | 0.996278 | 4.60E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2015 | G | 0.996109 | E | 0.996222 | -1.13E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2028 | G | 0.995549 | A | 0.994105 | 0.001444 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2028 | G | 0.995549 | R | 0.995453 | 9.60E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2028 | G | 0.995549 | R | 0.995453 | 9.60E-05 | No Change: Both D | Epidermolysis bullosa pruriginosa (EBP) [MIM:604129] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2031 | G | 0.995988 | S | 0.995737 | 2.51E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2034 | G | 0.996098 | W | 0.989455 | 0.006643 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2037 | G | 0.99605 | E | 0.996209 | -1.59E-04 | No Change: Both D | Epidermolysis bullosa dystrophica Pasini type (P-DEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2040 | G | 0.996169 | D | 0.994833 | 0.001336 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2040 | G | 0.996169 | V | 0.992817 | 0.003352 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2043 | G | 0.996092 | W | 0.989681 | 0.006411 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2046 | G | 0.995953 | V | 0.992555 | 0.003398 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2064 | G | 0.998364 | R | 0.998451 | -8.70E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2079 | G | 0.999174 | R | 0.999173 | 1.00E-06 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2132 | G | 0.994701 | D | 0.994638 | 6.30E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2192 | G | 0.998228 | S | 0.998037 | 1.91E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2207 | G | 0.996902 | R | 0.99645 | 4.52E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2251 | G | 0.992829 | E | 0.992188 | 6.41E-04 | No Change: Both D | Transient bullous dermolysis of the newborn (TBDN) [MIM:131705] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2263 | G | 0.995099 | V | 0.991897 | 0.003202 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2287 | G | 0.993718 | R | 0.992284 | 0.001434 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2316 | G | 0.9737 | R | 0.969333 | 0.004367 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2348 | G | 0.996464 | R | 0.996321 | 1.43E-04 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2366 | G | 0.997508 | S | 0.997238 | 2.70E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2369 | G | 0.997268 | S | 0.997026 | 2.42E-04 | No Change: Both D | Epidermolysis bullosa pruriginosa (EBP) [MIM:604129] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2674 | G | 0.985442 | D | 0.98418 | 0.001262 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2713 | G | 0.995675 | D | 0.995295 | 3.80E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2713 | G | 0.995675 | R | 0.995313 | 3.62E-04 | No Change: Both D | Epidermolysis bullosa pruriginosa (EBP) [MIM:604129] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2740 | G | 0.997312 | A | 0.996267 | 0.001045 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2775 | G | 0.950957 | S | 0.950174 | 7.83E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2791 | R | 0.698251 | W | 0.506704 | 0.191547 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1595 | G | 0.994216 | R | 0.994249 | -3.30E-05 | No Change: Both D | Nail disorder non-syndromic congenital type 8 (NDNC8) [MIM:607523] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1815 | G | 0.995943 | R | 0.995714 | 2.29E-04 | No Change: Both D | Nail disorder non-syndromic congenital type 8 (NDNC8) [MIM:607523] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2429 | P | 0.99604 | L | 0.991701 | 0.004339 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 119 | T | 0.373143 | P | 0.408682 | -0.035539 | No Change: Both O | A breast cancer sample |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1364 | P | 0.999065 | T | 0.998186 | 8.79E-04 | No Change: Both D | A breast cancer sample |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1366 | R | 0.999145 | W | 0.997893 | 0.001252 | No Change: Both D | A breast cancer sample |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 547 | V | 0.346909 | F | 0.298373 | 0.048536 | No Change: Both O | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1120 | R | 0.205782 | K | 0.220013 | -0.014231 | No Change: Both O | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1845 | G | 0.999014 | R | 0.998951 | 6.30E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 1981 | K | 0.951264 | R | 0.956024 | -0.00476 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2069 | R | 0.998783 | C | 0.997968 | 8.15E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2070 | G | 0.998793 | R | 0.998854 | -6.10E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal dominant (DDEB) [MIM:131750] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2221 | G | 0.99514 | A | 0.9931 | 0.00204 | No Change: Both D | - |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2296 | G | 0.986917 | E | 0.986806 | 1.11E-04 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2557 | G | 0.996823 | R | 0.996807 | 1.60E-05 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| Q02388 | CO7A1_HUMAN Collagen alpha-1(VII) chain OS=Homo sapiens GN=COL7A1 PE=1 SV=2 | 2622 | R | 0.94971 | W | 0.882949 | 0.066761 | No Change: Both D | Epidermolysis bullosa dystrophica autosomal recessive (RDEB) [MIM:226600] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 3 | G | 0.691525 | R | 0.689703 | 0.001822 | No Change: Both D | - |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 155 | R | 0.99518 | Q | 0.995453 | -2.73E-04 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 304 | R | 0.984115 | Q | 0.985095 | -9.80E-04 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 357 | G | 0.998467 | R | 0.998359 | 1.08E-04 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 434 | R | 0.984306 | H | 0.980521 | 0.003785 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 455 | Q | 0.978252 | K | 0.977891 | 3.61E-04 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 455 | Q | 0.978252 | K | 0.977891 | 3.61E-04 | No Change: Both D | Posterior polymorphous corneal dystrophy type 2 (PPCD2) [MIM:609140] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 575 | P | 0.383281 | L | 0.230149 | 0.153132 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 1 (FECD1) [MIM:136800] |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 645 | T | 0.296422 | I | 0.164613 | 0.131809 | No Change: Both O | - |
| P25067 | CO8A2_HUMAN Collagen alpha-2(VIII) chain OS=Homo sapiens GN=COL8A2 PE=1 SV=2 | 502 | T | 0.998824 | M | 0.998656 | 1.68E-04 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 870 | R | 0.986677 | K | 0.983814 | 0.002863 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 882 | V | 0.974147 | L | 0.975588 | -0.001441 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 339 | S | 0.994892 | P | 0.995686 | -7.94E-04 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 621 | Q | 0.997421 | R | 0.997492 | -7.10E-05 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 684 | E | 0.990159 | K | 0.988739 | 0.00142 | No Change: Both D | - |
| P20849 | CO9A1_HUMAN Collagen alpha-1(IX) chain OS=Homo sapiens GN=COL9A1 PE=1 SV=3 | 767 | M | 0.557985 | V | 0.484902 | 0.073083 | D to O | - |
| Q14055 | CO9A2_HUMAN Collagen alpha-2(IX) chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 | 326 | Q | 0.992554 | W | 0.980819 | 0.011735 | No Change: Both D | Intervertebral disc disease (IDD) [MIM:603932] |
| Q14055 | CO9A2_HUMAN Collagen alpha-2(IX) chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 | 326 | Q | 0.992554 | R | 0.989937 | 0.002617 | No Change: Both D | - |
| Q14055 | CO9A2_HUMAN Collagen alpha-2(IX) chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 | 581 | V | 0.977255 | I | 0.975432 | 0.001823 | No Change: Both D | - |
| Q14055 | CO9A2_HUMAN Collagen alpha-2(IX) chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 | 246 | T | 0.968343 | M | 0.974122 | -0.005779 | No Change: Both D | - |
| Q14055 | CO9A2_HUMAN Collagen alpha-2(IX) chain OS=Homo sapiens GN=COL9A2 PE=1 SV=2 | 335 | L | 0.993642 | V | 0.994219 | -5.77E-04 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 103 | R | 0.997855 | Q | 0.997538 | 3.17E-04 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 103 | R | 0.997855 | W | 0.995139 | 0.002716 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 296 | P | 0.991102 | L | 0.98147 | 0.009632 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 402 | R | 0.983959 | Q | 0.985476 | -0.001517 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 435 | A | 0.981365 | E | 0.984238 | -0.002873 | No Change: Both D | - |
| Q14050 | CO9A3_HUMAN Collagen alpha-3(IX) chain OS=Homo sapiens GN=COL9A3 PE=2 SV=2 | 94 | P | 0.997263 | S | 0.996229 | 0.001034 | No Change: Both D | - |
| Q9BWP8 | COL11_HUMAN Collectin-11 OS=Homo sapiens GN=COLEC11 PE=1 SV=1 | 219 | H | 0.391883 | R | 0.405328 | -0.013445 | No Change: Both O | - |
| Q9BWP8 | COL11_HUMAN Collectin-11 OS=Homo sapiens GN=COLEC11 PE=1 SV=1 | 169 | S | 0.412956 | P | 0.3879 | 0.025056 | No Change: Both O | 3MC syndrome type 2 (3MC2) [MIM:265050] |
| Q9BWP8 | COL11_HUMAN Collectin-11 OS=Homo sapiens GN=COLEC11 PE=1 SV=1 | 204 | G | 0.106225 | S | 0.123472 | -0.017247 | No Change: Both O | 3MC syndrome type 2 (3MC2) [MIM:265050] |
| Q5KU26 | COL12_HUMAN Collectin-12 OS=Homo sapiens GN=COLEC12 PE=1 SV=3 | 91 | K | 0.754347 | E | 0.746964 | 0.007383 | No Change: Both D | - |
| Q5KU26 | COL12_HUMAN Collectin-12 OS=Homo sapiens GN=COLEC12 PE=1 SV=3 | 487 | I | 0.999588 | V | 0.999606 | -1.80E-05 | No Change: Both D | - |
| Q5KU26 | COL12_HUMAN Collectin-12 OS=Homo sapiens GN=COLEC12 PE=1 SV=3 | 522 | S | 0.99982 | P | 0.999858 | -3.80E-05 | No Change: Both D | - |
| Q5KU26 | COL12_HUMAN Collectin-12 OS=Homo sapiens GN=COLEC12 PE=1 SV=3 | 606 | G | 0.601828 | S | 0.660203 | -0.058375 | No Change: Both D | - |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 59 | P | 0.894356 | Q | 0.852605 | 0.041751 | No Change: Both D | Congenital myasthenic syndrome Engel type (CMSE) [MIM:603034] |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 342 | D | 0.283653 | E | 0.302578 | -0.018925 | No Change: Both O | Congenital myasthenic syndrome Engel type (CMSE) [MIM:603034] |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 410 | R | 0.627227 | Q | 0.617288 | 0.009939 | No Change: Both D | Congenital myasthenic syndrome Engel type (CMSE) [MIM:603034] |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 430 | Y | 0.253784 | S | 0.428068 | -0.174284 | No Change: Both O | Congenital myasthenic syndrome Engel type (CMSE) [MIM:603034] |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 444 | C | 0.126669 | Y | 0.127676 | -0.001007 | No Change: Both O | Congenital myasthenic syndrome Engel type (CMSE) [MIM:603034] |
| Q9Y215 | COLQ_HUMAN Acetylcholinesterase collagenic tail peptide OS=Homo sapiens GN=COLQ PE=1 SV=2 | 312 | S | 0.644687 | G | 0.594124 | 0.050563 | No Change: Both D | - |
| Q9Y6G5 | COMDA_HUMAN COMM domain-containing protein 10 OS=Homo sapiens GN=COMMD10 PE=1 SV=1 | 128 | I | 0.162086 | S | 0.343846 | -0.18176 | No Change: Both O | - |
| Q86X83 | COMD2_HUMAN COMM domain-containing protein 2 OS=Homo sapiens GN=COMMD2 PE=1 SV=2 | 113 | I | 0.296253 | L | 0.342725 | -0.046472 | No Change: Both O | - |
| Q86X83 | COMD2_HUMAN COMM domain-containing protein 2 OS=Homo sapiens GN=COMMD2 PE=1 SV=2 | 177 | Q | 0.343926 | H | 0.304168 | 0.039758 | No Change: Both O | - |
| Q9UBI1 | COMD3_HUMAN COMM domain-containing protein 3 OS=Homo sapiens GN=COMMD3 PE=1 SV=1 | 18 | R | 0.518966 | G | 0.508588 | 0.010378 | No Change: Both D | - |
| Q9GZQ3 | COMD5_HUMAN COMM domain-containing protein 5 OS=Homo sapiens GN=COMMD5 PE=1 SV=1 | 6 | A | 0.609144 | T | 0.623357 | -0.014213 | No Change: Both D | - |
| Q9GZQ3 | COMD5_HUMAN COMM domain-containing protein 5 OS=Homo sapiens GN=COMMD5 PE=1 SV=1 | 69 | Q | 0.355821 | H | 0.305072 | 0.050749 | No Change: Both O | - |
| Q7Z4G1 | COMD6_HUMAN COMM domain-containing protein 6 OS=Homo sapiens GN=COMMD6 PE=1 SV=1 | 52 | H | 0.401261 | N | 0.422077 | -0.020816 | No Change: Both O | - |
| Q9NX08 | COMD8_HUMAN COMM domain-containing protein 8 OS=Homo sapiens GN=COMMD8 PE=1 SV=1 | 17 | A | 0.384444 | P | 0.504672 | -0.120228 | O to D | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 290 | D | 0.805329 | N | 0.78357 | 0.021759 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 299 | G | 0.908246 | R | 0.920615 | -0.012369 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 328 | C | 0.951794 | R | 0.963765 | -0.011971 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 342 | D | 0.970105 | Y | 0.929188 | 0.040917 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 349 | D | 0.978161 | V | 0.956131 | 0.02203 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 361 | D | 0.989657 | V | 0.977505 | 0.012152 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 361 | D | 0.989657 | Y | 0.973554 | 0.016103 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 371 | C | 0.990075 | S | 0.992573 | -0.002498 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 387 | C | 0.986588 | G | 0.988417 | -0.001829 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 408 | D | 0.976638 | Y | 0.939387 | 0.037251 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 440 | G | 0.98906 | E | 0.989437 | -3.77E-04 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 440 | G | 0.98906 | R | 0.989876 | -8.16E-04 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 453 | N | 0.99112 | S | 0.992984 | -0.001864 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 468 | C | 0.991585 | Y | 0.985889 | 0.005696 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 472 | D | 0.989786 | Y | 0.973422 | 0.016364 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 473 | D | 0.989265 | G | 0.985931 | 0.003334 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 482 | D | 0.975691 | G | 0.968691 | 0.007 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 518 | D | 0.465857 | N | 0.410642 | 0.055215 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 523 | N | 0.355012 | K | 0.416706 | -0.061694 | No Change: Both O | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 585 | T | 0.254333 | M | 0.199103 | 0.05523 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 585 | T | 0.254333 | R | 0.249622 | 0.004711 | No Change: Both O | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 585 | T | 0.254333 | R | 0.249622 | 0.004711 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 50 | E | 0.520878 | D | 0.494954 | 0.025924 | D to O | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 51 | L | 0.507332 | W | 0.367418 | 0.139914 | D to O | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 109 | A | 0.570998 | G | 0.624201 | -0.053203 | No Change: Both D | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 224 | R | 0.890344 | G | 0.880978 | 0.009366 | No Change: Both D | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 285 | R | 0.70051 | P | 0.72364 | -0.02313 | No Change: Both D | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 348 | C | 0.976655 | R | 0.982581 | -0.005926 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 719 | G | 0.220465 | D | 0.237276 | -0.016811 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 276 | P | 0.618691 | R | 0.619219 | -5.28E-04 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 420 | D | 0.978849 | A | 0.968253 | 0.010596 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 381 | R | 0.986804 | C | 0.983701 | 0.003103 | No Change: Both D | - |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 167 | G | 0.36 | E | 0.393989 | -0.033989 | No Change: Both O | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 234 | P | 0.831032 | S | 0.841558 | -0.010526 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 290 | D | 0.805329 | G | 0.779928 | 0.025401 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 298 | S | 0.902004 | L | 0.868427 | 0.033577 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 311 | A | 0.939655 | D | 0.962523 | -0.022868 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 317 | D | 0.93863 | G | 0.924599 | 0.014031 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 326 | D | 0.946365 | G | 0.933315 | 0.01305 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 326 | D | 0.946365 | Y | 0.873939 | 0.072426 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 348 | C | 0.976655 | F | 0.962569 | 0.014086 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 371 | C | 0.990075 | Y | 0.983236 | 0.006839 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 374 | D | 0.98789 | N | 0.984902 | 0.002988 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 376 | D | 0.987878 | N | 0.985105 | 0.002773 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 378 | D | 0.987519 | V | 0.973742 | 0.013777 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 385 | D | 0.986303 | N | 0.983618 | 0.002685 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 385 | D | 0.986303 | Y | 0.964696 | 0.021607 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 387 | C | 0.986588 | R | 0.989916 | -0.003328 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 397 | D | 0.980117 | H | 0.968853 | 0.011264 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 404 | G | 0.976244 | R | 0.976855 | -6.11E-04 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 410 | C | 0.977706 | Y | 0.961881 | 0.015825 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 415 | N | 0.980135 | K | 0.981898 | -0.001763 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 427 | G | 0.980321 | E | 0.980352 | -3.10E-05 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 446 | D | 0.99012 | N | 0.987409 | 0.002711 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 448 | C | 0.990287 | S | 0.993536 | -0.003249 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 473 | D | 0.989265 | H | 0.983108 | 0.006157 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 475 | D | 0.988476 | N | 0.985771 | 0.002705 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 501 | G | 0.808812 | D | 0.854963 | -0.046151 | No Change: Both D | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 507 | D | 0.655946 | G | 0.590443 | 0.065503 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 511 | D | 0.597136 | G | 0.521749 | 0.075387 | No Change: Both D | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 515 | D | 0.512059 | G | 0.435826 | 0.076233 | D to O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 529 | T | 0.225691 | I | 0.128579 | 0.097112 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 718 | R | 0.250661 | P | 0.270285 | -0.019624 | No Change: Both O | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 718 | R | 0.250661 | W | 0.106626 | 0.144035 | No Change: Both O | Multiple epiphyseal dysplasia type 1 (EDM1) [MIM:132400] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 719 | G | 0.220465 | S | 0.249101 | -0.028636 | No Change: Both O | Pseudoachondroplasia (PSACH) [MIM:177170] |
| P49747 | COMP_HUMAN Cartilage oligomeric matrix protein OS=Homo sapiens GN=COMP PE=1 SV=2 | 756 | Q | 0.877606 | R | 0.86635 | 0.011256 | No Change: Both D | - |
| P21964 | COMT_HUMAN Catechol O-methyltransferase OS=Homo sapiens GN=COMT PE=1 SV=2 | 158 | V | 0.254406 | M | 0.299474 | -0.045068 | No Change: Both O | - |
| P21964 | COMT_HUMAN Catechol O-methyltransferase OS=Homo sapiens GN=COMT PE=1 SV=2 | 34 | C | 0.014901 | S | 0.046752 | -0.031851 | No Change: Both O | - |
| P21964 | COMT_HUMAN Catechol O-methyltransferase OS=Homo sapiens GN=COMT PE=1 SV=2 | 72 | A | 0.495623 | S | 0.586207 | -0.090584 | O to D | - |
| P21964 | COMT_HUMAN Catechol O-methyltransferase OS=Homo sapiens GN=COMT PE=1 SV=2 | 102 | A | 0.292935 | T | 0.322353 | -0.029418 | No Change: Both O | - |
| P21964 | COMT_HUMAN Catechol O-methyltransferase OS=Homo sapiens GN=COMT PE=1 SV=2 | 146 | A | 0.135223 | V | 0.094273 | 0.04095 | No Change: Both O | - |
| P53621 | COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2 | 1040 | V | 0.141739 | G | 0.214704 | -0.072965 | No Change: Both O | - |
| P53621 | COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens GN=COPA PE=1 SV=2 | 164 | I | 0.176381 | V | 0.217226 | -0.040845 | No Change: Both O | - |
| O14579 | COPE_HUMAN Coatomer subunit epsilon OS=Homo sapiens GN=COPE PE=1 SV=3 | 13 | S | 0.69721 | C | 0.496054 | 0.201156 | D to O | - |
| O14579 | COPE_HUMAN Coatomer subunit epsilon OS=Homo sapiens GN=COPE PE=1 SV=3 | 117 | T | 0.236657 | I | 0.13612 | 0.100537 | No Change: Both O | - |
| Q9Y678 | COPG_HUMAN Coatomer subunit gamma OS=Homo sapiens GN=COPG PE=1 SV=1 | 681 | M | 0.423133 | T | 0.493414 | -0.070281 | No Change: Both O | - |
| Q9UBF2 | COPG2_HUMAN Coatomer subunit gamma-2 OS=Homo sapiens GN=COPG2 PE=1 SV=1 | 547 | I | 0.095359 | L | 0.12976 | -0.034401 | No Change: Both O | - |
| Q9UBF2 | COPG2_HUMAN Coatomer subunit gamma-2 OS=Homo sapiens GN=COPG2 PE=1 SV=1 | 626 | P | 0.282716 | L | 0.158814 | 0.123902 | No Change: Both O | - |
| Q9NQ92 | COPR5_HUMAN Cooperator of PRMT5 OS=Homo sapiens GN=COPR5 PE=1 SV=3 | 43 | S | 0.967184 | G | 0.958985 | 0.008199 | No Change: Both D | - |
| Q96MF6 | CQ10A_HUMAN Coenzyme Q-binding protein COQ10 homolog A mitochondrial OS=Homo sapiens GN=COQ10A PE=2 SV=2 | 79 | P | 0.443144 | H | 0.352076 | 0.091068 | No Change: Both O | - |
| Q96MF6 | CQ10A_HUMAN Coenzyme Q-binding protein COQ10 homolog A mitochondrial OS=Homo sapiens GN=COQ10A PE=2 SV=2 | 231 | P | 0.487719 | S | 0.485832 | 0.001887 | No Change: Both O | - |
| Q9H8M1 | CQ10B_HUMAN Coenzyme Q-binding protein COQ10 homolog B mitochondrial OS=Homo sapiens GN=COQ10B PE=2 SV=1 | 48 | L | 0.269765 | F | 0.22684 | 0.042925 | No Change: Both O | - |
| Q96H96 | COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase mitochondrial OS=Homo sapiens GN=COQ2 PE=1 SV=1 | 247 | Y | 0.048024 | C | 0.035234 | 0.01279 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q9NZJ6 | COQ3_HUMAN Hexaprenyldihydroxybenzoate methyltransferase mitochondrial OS=Homo sapiens GN=COQ3 PE=1 SV=3 | 272 | S | 0.250088 | G | 0.209189 | 0.040899 | No Change: Both O | - |
| Q9NZJ6 | COQ3_HUMAN Hexaprenyldihydroxybenzoate methyltransferase mitochondrial OS=Homo sapiens GN=COQ3 PE=1 SV=3 | 329 | Y | 0.248517 | H | 0.353331 | -0.104814 | No Change: Both O | - |
| Q9NZJ6 | COQ3_HUMAN Hexaprenyldihydroxybenzoate methyltransferase mitochondrial OS=Homo sapiens GN=COQ3 PE=1 SV=3 | 134 | K | 0.317109 | E | 0.31176 | 0.005349 | No Change: Both O | - |
| Q9Y3A0 | COQ4_HUMAN Ubiquinone biosynthesis protein COQ4 homolog mitochondrial OS=Homo sapiens GN=COQ4 PE=2 SV=3 | 20 | R | 0.788956 | Q | 0.773014 | 0.015942 | No Change: Both D | - |
| Q9Y3A0 | COQ4_HUMAN Ubiquinone biosynthesis protein COQ4 homolog mitochondrial OS=Homo sapiens GN=COQ4 PE=2 SV=3 | 50 | G | 0.506346 | A | 0.487064 | 0.019282 | D to O | - |
| Q5HYK3 | COQ5_HUMAN 2-methoxy-6-polyprenyl-1 4-benzoquinol methylase mitochondrial OS=Homo sapiens GN=COQ5 PE=1 SV=2 | 152 | A | 0.591589 | T | 0.599636 | -0.008047 | No Change: Both D | - |
| Q9Y2Z9 | COQ6_HUMAN Ubiquinone biosynthesis monooxygenase COQ6 OS=Homo sapiens GN=COQ6 PE=1 SV=2 | 406 | V | 0.439619 | M | 0.513966 | -0.074347 | O to D | - |
| Q9Y2Z9 | COQ6_HUMAN Ubiquinone biosynthesis monooxygenase COQ6 OS=Homo sapiens GN=COQ6 PE=1 SV=2 | 339 | D | 0.42188 | V | 0.29603 | 0.12585 | No Change: Both O | - |
| Q9Y2Z9 | COQ6_HUMAN Ubiquinone biosynthesis monooxygenase COQ6 OS=Homo sapiens GN=COQ6 PE=1 SV=2 | 395 | T | 0.38923 | M | 0.350854 | 0.038376 | No Change: Both O | - |
| Q9Y2Z9 | COQ6_HUMAN Ubiquinone biosynthesis monooxygenase COQ6 OS=Homo sapiens GN=COQ6 PE=1 SV=2 | 300 | D | 0.342761 | Y | 0.188376 | 0.154385 | No Change: Both O | - |
| Q99807 | COQ7_HUMAN Ubiquinone biosynthesis protein COQ7 homolog OS=Homo sapiens GN=COQ7 PE=1 SV=3 | 103 | T | 0.112657 | M | 0.095407 | 0.01725 | No Change: Both O | - |
| Q9Y5Q5 | CORIN_HUMAN Atrial natriuretic peptide-converting enzyme OS=Homo sapiens GN=CORIN PE=1 SV=2 | 13 | C | 0.907558 | Y | 0.863938 | 0.04362 | No Change: Both D | - |
| Q9Y5Q5 | CORIN_HUMAN Atrial natriuretic peptide-converting enzyme OS=Homo sapiens GN=CORIN PE=1 SV=2 | 525 | H | 0.290865 | R | 0.303939 | -0.013074 | No Change: Both O | - |
| P31146 | COR1A_HUMAN Coronin-1A OS=Homo sapiens GN=CORO1A PE=1 SV=4 | 415 | R | 0.877822 | K | 0.873812 | 0.00401 | No Change: Both D | - |
| P31146 | COR1A_HUMAN Coronin-1A OS=Homo sapiens GN=CORO1A PE=1 SV=4 | 443 | T | 0.93609 | P | 0.947764 | -0.011674 | No Change: Both D | - |
| Q9BR76 | COR1B_HUMAN Coronin-1B OS=Homo sapiens GN=CORO1B PE=1 SV=1 | 411 | V | 0.803677 | M | 0.856231 | -0.052554 | No Change: Both D | A colorectal cancer sample |
| Q9BR76 | COR1B_HUMAN Coronin-1B OS=Homo sapiens GN=CORO1B PE=1 SV=1 | 476 | R | 0.771928 | L | 0.647031 | 0.124897 | No Change: Both D | - |
| Q92828 | COR2A_HUMAN Coronin-2A OS=Homo sapiens GN=CORO2A PE=2 SV=2 | 296 | R | 0.2774 | H | 0.281817 | -0.004417 | No Change: Both O | - |
| Q92828 | COR2A_HUMAN Coronin-2A OS=Homo sapiens GN=CORO2A PE=2 SV=2 | 495 | R | 0.712725 | L | 0.604898 | 0.107827 | No Change: Both D | - |
| Q9UQ03 | COR2B_HUMAN Coronin-2B OS=Homo sapiens GN=CORO2B PE=2 SV=4 | 318 | P | 0.525644 | L | 0.360688 | 0.164956 | D to O | A colorectal cancer sample |
| Q9UQ03 | COR2B_HUMAN Coronin-2B OS=Homo sapiens GN=CORO2B PE=2 SV=4 | 238 | L | 0.216269 | V | 0.215475 | 7.94E-04 | No Change: Both O | - |
| P57737 | CORO7_HUMAN Coronin-7 OS=Homo sapiens GN=CORO7 PE=1 SV=2 | 174 | A | 0.273885 | V | 0.216194 | 0.057691 | No Change: Both O | - |
| P57737 | CORO7_HUMAN Coronin-7 OS=Homo sapiens GN=CORO7 PE=1 SV=2 | 193 | R | 0.432528 | Q | 0.443156 | -0.010628 | No Change: Both O | - |
| P57737 | CORO7_HUMAN Coronin-7 OS=Homo sapiens GN=CORO7 PE=1 SV=2 | 257 | L | 0.293965 | S | 0.475665 | -0.1817 | No Change: Both O | - |
| P57737 | CORO7_HUMAN Coronin-7 OS=Homo sapiens GN=CORO7 PE=1 SV=2 | 403 | A | 0.838163 | T | 0.850986 | -0.012823 | No Change: Both D | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 196 | T | 0.211054 | K | 0.254094 | -0.04304 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 204 | N | 0.218049 | K | 0.232338 | -0.014289 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 225 | P | 0.461948 | L | 0.314658 | 0.14729 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 336 | D | 0.385605 | G | 0.383162 | 0.002443 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 336 | D | 0.385605 | V | 0.221102 | 0.164503 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 28 | T | 0.299817 | I | 0.192746 | 0.107071 | No Change: Both O | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 62 | T | 0.367744 | S | 0.452786 | -0.085042 | No Change: Both O | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 97 | Y | 0.922477 | C | 0.941072 | -0.018595 | No Change: Both D | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 159 | R | 0.163597 | Q | 0.176066 | -0.012469 | No Change: Both O | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 340 | G | 0.357633 | D | 0.385805 | -0.028172 | No Change: Both O | - |
| Q12887 | COX10_HUMAN Protoheme IX farnesyltransferase mitochondrial OS=Homo sapiens GN=COX10 PE=1 SV=3 | 258 | L | 0.168944 | H | 0.252348 | -0.083404 | No Change: Both O | - |
| Q9Y6N1 | COX11_HUMAN Cytochrome c oxidase assembly protein COX11 mitochondrial OS=Homo sapiens GN=COX11 PE=1 SV=3 | 74 | P | 0.91356 | L | 0.846986 | 0.066574 | No Change: Both D | - |
| Q7KZN9 | COX15_HUMAN Cytochrome c oxidase assembly protein COX15 homolog OS=Homo sapiens GN=COX15 PE=1 SV=1 | 217 | R | 0.520087 | W | 0.280661 | 0.239426 | D to O | Leigh syndrome (LS) [MIM:256000] |
| Q7KZN9 | COX15_HUMAN Cytochrome c oxidase assembly protein COX15 homolog OS=Homo sapiens GN=COX15 PE=1 SV=1 | 217 | R | 0.520087 | W | 0.280661 | 0.239426 | D to O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| Q7KZN9 | COX15_HUMAN Cytochrome c oxidase assembly protein COX15 homolog OS=Homo sapiens GN=COX15 PE=1 SV=1 | 344 | S | 0.105721 | P | 0.103081 | 0.00264 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P13073 | COX41_HUMAN Cytochrome c oxidase subunit 4 isoform 1 mitochondrial OS=Homo sapiens GN=COX4I1 PE=1 SV=1 | 38 | Y | 0.581557 | F | 0.624685 | -0.043128 | No Change: Both D | - |
| P13073 | COX41_HUMAN Cytochrome c oxidase subunit 4 isoform 1 mitochondrial OS=Homo sapiens GN=COX4I1 PE=1 SV=1 | 3 | A | 0.535388 | T | 0.581608 | -0.04622 | No Change: Both D | - |
| Q96KJ9 | COX42_HUMAN Cytochrome c oxidase subunit 4 isoform 2 mitochondrial OS=Homo sapiens GN=COX4I2 PE=1 SV=2 | 161 | R | 0.4919 | H | 0.391157 | 0.100743 | No Change: Both O | - |
| Q96KJ9 | COX42_HUMAN Cytochrome c oxidase subunit 4 isoform 2 mitochondrial OS=Homo sapiens GN=COX4I2 PE=1 SV=2 | 138 | E | 0.594448 | K | 0.614193 | -0.019745 | No Change: Both D | Exocrine pancreatic insufficiency dyserythropoietic anemia and calvarial hyperostosis (EPIDACH) [MIM:612714] |
| P14854 | CX6B1_HUMAN Cytochrome c oxidase subunit 6B1 OS=Homo sapiens GN=COX6B1 PE=1 SV=2 | 20 | R | 0.567656 | H | 0.535663 | 0.031993 | No Change: Both D | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| P14406 | CX7A2_HUMAN Cytochrome c oxidase subunit 7A2 mitochondrial OS=Homo sapiens GN=COX7A2 PE=1 SV=1 | 40 | E | 0.334738 | D | 0.315981 | 0.018757 | No Change: Both O | - |
| Q8TF08 | CX7B2_HUMAN Cytochrome c oxidase subunit 7B2 mitochondrial OS=Homo sapiens GN=COX7B2 PE=2 SV=2 | 27 | H | 0.715271 | Q | 0.714717 | 5.54E-04 | No Change: Both D | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 63 | I | 0.303077 | T | 0.452298 | -0.149221 | No Change: Both O | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 477 | P | 0.228946 | L | 0.119241 | 0.109705 | No Change: Both O | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 544 | D | 0.280837 | E | 0.287707 | -0.00687 | No Change: Both O | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 551 | T | 0.16625 | I | 0.097712 | 0.068538 | No Change: Both O | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 793 | R | 0.352414 | H | 0.337441 | 0.014973 | No Change: Both O | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 841 | T | 0.620249 | R | 0.613198 | 0.007051 | No Change: Both D | - |
| P00450 | CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 | 367 | R | 0.657738 | C | 0.498248 | 0.15949 | D to O | - |
| P15085 | CBPA1_HUMAN Carboxypeptidase A1 OS=Homo sapiens GN=CPA1 PE=1 SV=2 | 208 | A | 0.098213 | T | 0.11185 | -0.013637 | No Change: Both O | - |
| P15085 | CBPA1_HUMAN Carboxypeptidase A1 OS=Homo sapiens GN=CPA1 PE=1 SV=2 | 276 | H | 0.482107 | R | 0.480111 | 0.001996 | No Change: Both O | - |
| P48052 | CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens GN=CPA2 PE=1 SV=3 | 82 | E | 0.168778 | G | 0.1448 | 0.023978 | No Change: Both O | - |
| P15088 | CBPA3_HUMAN Mast cell carboxypeptidase A OS=Homo sapiens GN=CPA3 PE=1 SV=2 | 171 | T | 0.155547 | M | 0.128819 | 0.026728 | No Change: Both O | - |
| P15088 | CBPA3_HUMAN Mast cell carboxypeptidase A OS=Homo sapiens GN=CPA3 PE=1 SV=2 | 81 | A | 0.555319 | S | 0.662805 | -0.107486 | No Change: Both D | - |
| Q9UI42 | CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens GN=CPA4 PE=1 SV=2 | 157 | P | 0.270813 | T | 0.230364 | 0.040449 | No Change: Both O | - |
| Q9UI42 | CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens GN=CPA4 PE=1 SV=2 | 303 | G | 0.289019 | C | 0.145972 | 0.143047 | No Change: Both O | - |
| Q9UI42 | CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens GN=CPA4 PE=1 SV=2 | 27 | L | 0.149116 | F | 0.143688 | 0.005428 | No Change: Both O | - |
| Q9UI42 | CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens GN=CPA4 PE=1 SV=2 | 183 | R | 0.241223 | L | 0.154232 | 0.086991 | No Change: Both O | - |
| Q8WXQ8 | CBPA5_HUMAN Carboxypeptidase A5 OS=Homo sapiens GN=CPA5 PE=2 SV=1 | 79 | P | 0.449208 | S | 0.461065 | -0.011857 | No Change: Both O | - |
| Q8WXQ8 | CBPA5_HUMAN Carboxypeptidase A5 OS=Homo sapiens GN=CPA5 PE=2 SV=1 | 336 | L | 0.289931 | S | 0.497526 | -0.207595 | No Change: Both O | - |
| Q8WXQ8 | CBPA5_HUMAN Carboxypeptidase A5 OS=Homo sapiens GN=CPA5 PE=2 SV=1 | 338 | E | 0.367931 | D | 0.329249 | 0.038682 | No Change: Both O | - |
| Q8WXQ8 | CBPA5_HUMAN Carboxypeptidase A5 OS=Homo sapiens GN=CPA5 PE=2 SV=1 | 378 | S | 0.111904 | G | 0.090099 | 0.021805 | No Change: Both O | - |
| Q8N4T0 | CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens GN=CPA6 PE=1 SV=2 | 45 | F | 0.203057 | L | 0.225921 | -0.022864 | No Change: Both O | - |
| Q8N4T0 | CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens GN=CPA6 PE=1 SV=2 | 173 | S | 0.244931 | C | 0.091217 | 0.153714 | No Change: Both O | - |
| Q8N4T0 | CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens GN=CPA6 PE=1 SV=2 | 249 | N | 0.216158 | S | 0.262708 | -0.04655 | No Change: Both O | - |
| Q8N4T0 | CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens GN=CPA6 PE=1 SV=2 | 267 | G | 0.392903 | R | 0.447503 | -0.0546 | No Change: Both O | - |
| Q8N4T0 | CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens GN=CPA6 PE=1 SV=2 | 270 | A | 0.409033 | V | 0.366152 | 0.042881 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 251 | R | 0.219754 | W | 0.086885 | 0.132869 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 265 | M | 0.12268 | T | 0.147522 | -0.024842 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 294 | R | 0.182183 | Q | 0.184362 | -0.002179 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 539 | D | 0.489963 | E | 0.572388 | -0.082425 | O to D | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 546 | H | 0.248389 | R | 0.286039 | -0.03765 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 736 | P | 0.656785 | H | 0.63712 | 0.019665 | No Change: Both D | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 1156 | V | 0.076326 | I | 0.064671 | 0.011655 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 1268 | T | 0.180998 | I | 0.104792 | 0.076206 | No Change: Both O | - |
| Q8IZJ3 | CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens GN=CPAMD8 PE=1 SV=2 | 1843 | Q | 0.787148 | R | 0.793455 | -0.006307 | No Change: Both D | - |
| P15086 | CBPB1_HUMAN Carboxypeptidase B OS=Homo sapiens GN=CPB1 PE=1 SV=4 | 208 | D | 0.131991 | N | 0.115238 | 0.016753 | No Change: Both O | - |
| Q96IY4 | CBPB2_HUMAN Carboxypeptidase B2 OS=Homo sapiens GN=CPB2 PE=1 SV=2 | 347 | I | 0.525415 | T | 0.646151 | -0.120736 | No Change: Both D | - |
| Q96IY4 | CBPB2_HUMAN Carboxypeptidase B2 OS=Homo sapiens GN=CPB2 PE=1 SV=2 | 169 | A | 0.426409 | T | 0.435466 | -0.009057 | No Change: Both O | - |
| O75976 | CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens GN=CPD PE=1 SV=2 | 36 | K | 0.657264 | E | 0.666455 | -0.009191 | No Change: Both D | - |
| O75976 | CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens GN=CPD PE=1 SV=2 | 454 | E | 0.408303 | G | 0.355423 | 0.05288 | No Change: Both O | - |
| O75976 | CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens GN=CPD PE=1 SV=2 | 505 | H | 0.374935 | N | 0.368452 | 0.006483 | No Change: Both O | - |
| O75976 | CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens GN=CPD PE=1 SV=2 | 899 | T | 0.908208 | I | 0.863115 | 0.045093 | No Change: Both D | - |
| P16870 | CBPE_HUMAN Carboxypeptidase E OS=Homo sapiens GN=CPE PE=1 SV=1 | 297 | R | 0.865272 | Q | 0.859648 | 0.005624 | No Change: Both D | A colorectal cancer sample |
| P16870 | CBPE_HUMAN Carboxypeptidase E OS=Homo sapiens GN=CPE PE=1 SV=1 | 235 | W | 0.041955 | R | 0.105292 | -0.063337 | No Change: Both O | - |
| Q8NE35 | CPEB3_HUMAN Cytoplasmic polyadenylation element-binding protein 3 OS=Homo sapiens GN=CPEB3 PE=1 SV=2 | 324 | R | 0.61626 | W | 0.400583 | 0.215677 | D to O | - |
| P14384 | CBPM_HUMAN Carboxypeptidase M OS=Homo sapiens GN=CPM PE=1 SV=2 | 24 | R | 0.331058 | H | 0.350476 | -0.019418 | No Change: Both O | - |
| P14384 | CBPM_HUMAN Carboxypeptidase M OS=Homo sapiens GN=CPM PE=1 SV=2 | 133 | V | 0.377311 | I | 0.375539 | 0.001772 | No Change: Both O | - |
| P15169 | CBPN_HUMAN Carboxypeptidase N catalytic chain OS=Homo sapiens GN=CPN1 PE=1 SV=1 | 178 | G | 0.564686 | D | 0.574952 | -0.010266 | No Change: Both D | Carboxypeptidase N deficiency (CPND) [MIM:212070] |
| P22792 | CPN2_HUMAN Carboxypeptidase N subunit 2 OS=Homo sapiens GN=CPN2 PE=1 SV=3 | 536 | V | 0.441058 | M | 0.568512 | -0.127454 | O to D | - |
| P22792 | CPN2_HUMAN Carboxypeptidase N subunit 2 OS=Homo sapiens GN=CPN2 PE=1 SV=3 | 305 | A | 0.403371 | T | 0.443324 | -0.039953 | No Change: Both O | - |
| P22792 | CPN2_HUMAN Carboxypeptidase N subunit 2 OS=Homo sapiens GN=CPN2 PE=1 SV=3 | 509 | Q | 0.524088 | R | 0.48633 | 0.037758 | D to O | - |
| Q99829 | CPNE1_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1 | 211 | Q | 0.446918 | R | 0.404431 | 0.042487 | No Change: Both O | - |
| Q99829 | CPNE1_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1 | 347 | P | 0.331566 | R | 0.276906 | 0.05466 | No Change: Both O | - |
| Q99829 | CPNE1_HUMAN Copine-1 OS=Homo sapiens GN=CPNE1 PE=1 SV=1 | 535 | P | 0.89833 | L | 0.841351 | 0.056979 | No Change: Both D | - |
| O75131 | CPNE3_HUMAN Copine-3 OS=Homo sapiens GN=CPNE3 PE=1 SV=1 | 412 | T | 0.522848 | M | 0.454799 | 0.068049 | D to O | - |
| O75131 | CPNE3_HUMAN Copine-3 OS=Homo sapiens GN=CPNE3 PE=1 SV=1 | 252 | E | 0.742971 | D | 0.698293 | 0.044678 | No Change: Both D | - |
| Q9HCH3 | CPNE5_HUMAN Copine-5 OS=Homo sapiens GN=CPNE5 PE=1 SV=2 | 33 | N | 0.281795 | S | 0.364307 | -0.082512 | No Change: Both O | - |
| Q9HCH3 | CPNE5_HUMAN Copine-5 OS=Homo sapiens GN=CPNE5 PE=1 SV=2 | 582 | R | 0.991924 | H | 0.990949 | 9.75E-04 | No Change: Both D | - |
| Q9UBL6 | CPNE7_HUMAN Copine-7 OS=Homo sapiens GN=CPNE7 PE=2 SV=1 | 77 | F | 0.122293 | L | 0.128636 | -0.006343 | No Change: Both O | - |
| Q9UBL6 | CPNE7_HUMAN Copine-7 OS=Homo sapiens GN=CPNE7 PE=2 SV=1 | 633 | P | 0.855575 | L | 0.785573 | 0.070002 | No Change: Both D | - |
| Q9UBL6 | CPNE7_HUMAN Copine-7 OS=Homo sapiens GN=CPNE7 PE=2 SV=1 | 397 | R | 0.661121 | Q | 0.679188 | -0.018067 | No Change: Both D | - |
| Q9UBL6 | CPNE7_HUMAN Copine-7 OS=Homo sapiens GN=CPNE7 PE=2 SV=1 | 507 | K | 0.487578 | E | 0.505283 | -0.017705 | O to D | - |
| Q8IVL8 | CBPO_HUMAN Carboxypeptidase O OS=Homo sapiens GN=CPO PE=2 SV=1 | 85 | M | 0.20192 | I | 0.147564 | 0.054356 | No Change: Both O | - |
| Q8IVL8 | CBPO_HUMAN Carboxypeptidase O OS=Homo sapiens GN=CPO PE=2 SV=1 | 134 | S | 0.641976 | R | 0.571775 | 0.070201 | No Change: Both D | - |
| Q8IVL8 | CBPO_HUMAN Carboxypeptidase O OS=Homo sapiens GN=CPO PE=2 SV=1 | 273 | K | 0.416957 | N | 0.381665 | 0.035292 | No Change: Both O | A colorectal cancer sample |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 189 | G | 0.324424 | S | 0.362368 | -0.037944 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 197 | G | 0.185578 | W | 0.072039 | 0.113539 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 201 | E | 0.247506 | K | 0.255845 | -0.008339 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 249 | P | 0.599018 | S | 0.627318 | -0.0283 | No Change: Both D | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 272 | N | 0.29997 | H | 0.279836 | 0.020134 | No Change: Both O | - |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 280 | G | 0.094808 | R | 0.084358 | 0.01045 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 294 | V | 0.28291 | I | 0.258276 | 0.024634 | No Change: Both O | - |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 295 | H | 0.236037 | D | 0.269191 | -0.033154 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 331 | R | 0.34164 | W | 0.162945 | 0.178695 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 404 | K | 0.246082 | E | 0.249904 | -0.003822 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 427 | W | 0.350359 | R | 0.608125 | -0.257766 | O to D | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 208 | S | 0.317093 | F | 0.147699 | 0.169394 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 328 | R | 0.257487 | C | 0.140993 | 0.116494 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 447 | R | 0.328241 | C | 0.15825 | 0.169991 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 135 | V | 0.751879 | A | 0.816841 | -0.064962 | No Change: Both D | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 214 | L | 0.486732 | R | 0.589309 | -0.102577 | O to D | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 249 | P | 0.599018 | R | 0.549846 | 0.049172 | No Change: Both D | Hereditary coproporphyria (HCP) [MIM:121300] |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 352 | R | 0.254204 | C | 0.154822 | 0.099382 | No Change: Both O | - |
| P36551 | HEM6_HUMAN Coproporphyrinogen-III oxidase mitochondrial OS=Homo sapiens GN=CPOX PE=1 SV=3 | 279 | G | 0.094855 | R | 0.084368 | 0.010487 | No Change: Both O | Hereditary coproporphyria (HCP) [MIM:121300] |
| Q9BRF8 | CPPED_HUMAN Calcineurin-like phosphoesterase domain-containing protein 1 OS=Homo sapiens GN=CPPED1 PE=1 SV=3 | 19 | A | 0.393379 | D | 0.454327 | -0.060948 | No Change: Both O | - |
| Q9BRF8 | CPPED_HUMAN Calcineurin-like phosphoesterase domain-containing protein 1 OS=Homo sapiens GN=CPPED1 PE=1 SV=3 | 86 | V | 0.094148 | I | 0.08908 | 0.005068 | No Change: Both O | - |
| Q9BRF8 | CPPED_HUMAN Calcineurin-like phosphoesterase domain-containing protein 1 OS=Homo sapiens GN=CPPED1 PE=1 SV=3 | 241 | K | 0.195869 | R | 0.149602 | 0.046267 | No Change: Both O | - |
| Q9BRF8 | CPPED_HUMAN Calcineurin-like phosphoesterase domain-containing protein 1 OS=Homo sapiens GN=CPPED1 PE=1 SV=3 | 290 | H | 0.154228 | P | 0.184506 | -0.030278 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 344 | T | 0.235498 | A | 0.229076 | 0.006422 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 544 | T | 0.425475 | M | 0.387716 | 0.037759 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 337 | H | 0.230776 | R | 0.235369 | -0.004593 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 457 | V | 0.487964 | G | 0.59299 | -0.105026 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 810 | Q | 0.514352 | R | 0.56992 | -0.055568 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 843 | L | 0.71794 | S | 0.796426 | -0.078486 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 875 | K | 0.185802 | E | 0.185156 | 6.46E-04 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1266 | F | 0.30733 | S | 0.546361 | -0.239031 | O to D | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1283 | M | 0.215643 | L | 0.170633 | 0.04501 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1376 | G | 0.238241 | S | 0.290475 | -0.052234 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1406 | T | 0.351055 | N | 0.421009 | -0.069954 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 850 | R | 0.421962 | H | 0.396009 | 0.025953 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 918 | S | 0.494561 | P | 0.470587 | 0.023974 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 344 | T | 0.235498 | S | 0.300425 | -0.064927 | No Change: Both O | - |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 79 | G | 0.257514 | E | 0.292921 | -0.035407 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 212 | Y | 0.4923 | N | 0.611934 | -0.119634 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 280 | K | 0.317906 | N | 0.287575 | 0.030331 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 438 | A | 0.455654 | P | 0.515718 | -0.060064 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 587 | R | 0.121947 | H | 0.119397 | 0.00255 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 593 | G | 0.238231 | R | 0.217968 | 0.020263 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 651 | E | 0.26603 | K | 0.261041 | 0.004989 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 674 | N | 0.385221 | I | 0.214075 | 0.171146 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 780 | R | 0.333611 | H | 0.320017 | 0.013594 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 850 | R | 0.421962 | C | 0.270007 | 0.151955 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 982 | G | 0.218742 | D | 0.224255 | -0.005513 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1103 | Q | 0.202526 | R | 0.192275 | 0.010251 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1141 | V | 0.347081 | G | 0.465304 | -0.118223 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1195 | H | 0.55538 | P | 0.564301 | -0.008921 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1215 | I | 0.332459 | V | 0.353806 | -0.021347 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1241 | N | 0.116609 | K | 0.14459 | -0.027981 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 123 | S | 0.471693 | F | 0.22357 | 0.248123 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 471 | T | 0.344651 | N | 0.396265 | -0.051614 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 678 | Q | 0.314066 | P | 0.323373 | -0.009307 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 774 | P | 0.193133 | L | 0.107113 | 0.08602 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1411 | P | 0.518941 | L | 0.339529 | 0.179412 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1453 | R | 0.181059 | Q | 0.183521 | -0.002462 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1453 | R | 0.181059 | W | 0.070423 | 0.110636 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1491 | Y | 0.363178 | H | 0.505967 | -0.142789 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 301 | G | 0.265199 | E | 0.291294 | -0.026095 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 389 | Y | 0.206075 | C | 0.213759 | -0.007684 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 390 | L | 0.179905 | R | 0.264044 | -0.084139 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 718 | R | 0.325641 | K | 0.375025 | -0.049384 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 721 | R | 0.569148 | Q | 0.57142 | -0.002272 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 724 | A | 0.659398 | P | 0.703234 | -0.043836 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 726 | A | 0.62385 | T | 0.646882 | -0.023032 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 767 | D | 0.176067 | V | 0.101084 | 0.074983 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 792 | M | 0.622446 | I | 0.560158 | 0.062288 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 978 | V | 0.171048 | E | 0.337494 | -0.166446 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 982 | G | 0.218742 | V | 0.121637 | 0.097105 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 984 | Y | 0.209635 | H | 0.336632 | -0.126997 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 986 | I | 0.188935 | T | 0.316671 | -0.127736 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 987 | G | 0.191365 | C | 0.087492 | 0.103873 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 992 | F | 0.156318 | S | 0.35807 | -0.201752 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1016 | N | 0.34119 | S | 0.385363 | -0.044173 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1017 | P | 0.359557 | L | 0.212639 | 0.146918 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1022 | T | 0.398396 | I | 0.241293 | 0.157103 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1034 | E | 0.214862 | G | 0.160919 | 0.053943 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1045 | H | 0.107382 | R | 0.114589 | -0.007207 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1059 | Q | 0.209178 | R | 0.194289 | 0.014889 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1065 | A | 0.191802 | E | 0.284949 | -0.093147 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1089 | R | 0.363606 | C | 0.200417 | 0.163189 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1155 | A | 0.521102 | E | 0.637586 | -0.116484 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1155 | A | 0.521102 | V | 0.476427 | 0.044675 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1203 | S | 0.449508 | L | 0.30558 | 0.143928 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1228 | R | 0.37855 | Q | 0.397287 | -0.018737 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1255 | E | 0.11054 | D | 0.106356 | 0.004184 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1262 | R | 0.270758 | P | 0.30537 | -0.034612 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1262 | R | 0.270758 | Q | 0.2742 | -0.003442 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1274 | D | 0.119776 | H | 0.09459 | 0.025186 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1327 | C | 0.228293 | R | 0.406124 | -0.177831 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1333 | G | 0.253346 | E | 0.310039 | -0.056693 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1371 | R | 0.183389 | L | 0.110936 | 0.072453 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1391 | T | 0.243606 | M | 0.198497 | 0.045109 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1398 | L | 0.336258 | V | 0.345421 | -0.009163 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1439 | P | 0.274986 | L | 0.168678 | 0.106308 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1462 | P | 0.16489 | R | 0.148628 | 0.016262 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 589 | A | 0.162352 | T | 0.170924 | -0.008572 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 640 | A | 0.264695 | S | 0.366044 | -0.101349 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 716 | N | 0.205692 | K | 0.240647 | -0.034955 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 803 | R | 0.406278 | C | 0.273165 | 0.133113 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 803 | R | 0.406278 | G | 0.402771 | 0.003507 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 803 | R | 0.406278 | S | 0.471152 | -0.064874 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 805 | F | 0.466583 | L | 0.474416 | -0.007833 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 805 | F | 0.466583 | S | 0.652412 | -0.185829 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 814 | R | 0.510111 | W | 0.290081 | 0.22003 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 816 | C | 0.521582 | R | 0.661397 | -0.139815 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 911 | G | 0.62886 | E | 0.705911 | -0.077051 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 911 | G | 0.62886 | V | 0.493077 | 0.135783 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 913 | S | 0.617951 | L | 0.470739 | 0.147212 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 914 | D | 0.588669 | G | 0.594941 | -0.006272 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 914 | D | 0.588669 | H | 0.558527 | 0.030142 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 932 | R | 0.420104 | T | 0.407363 | 0.012741 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 949 | A | 0.222485 | T | 0.251497 | -0.029012 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 958 | L | 0.144554 | P | 0.28332 | -0.138766 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 959 | Y | 0.146143 | C | 0.106761 | 0.039382 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 962 | Y | 0.238628 | C | 0.180427 | 0.058201 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 982 | G | 0.218742 | S | 0.258261 | -0.039519 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 998 | S | 0.092644 | F | 0.034348 | 0.058296 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1054 | I | 0.116585 | R | 0.200384 | -0.083799 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1089 | R | 0.363606 | L | 0.248023 | 0.115583 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1203 | S | 0.449508 | P | 0.431745 | 0.017763 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1205 | D | 0.431596 | N | 0.390073 | 0.041523 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1331 | S | 0.231556 | P | 0.217534 | 0.014022 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1378 | A | 0.26776 | T | 0.294617 | -0.026857 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 1443 | T | 0.347611 | A | 0.322583 | 0.025028 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 43 | A | 0.210404 | V | 0.158782 | 0.051622 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 58 | G | 0.592813 | D | 0.606361 | -0.013548 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 65 | S | 0.523513 | F | 0.287278 | 0.236235 | D to O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 71 | V | 0.303954 | G | 0.441224 | -0.13727 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 87 | P | 0.332219 | S | 0.340778 | -0.008559 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 89 | Y | 0.281233 | D | 0.440293 | -0.15906 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 165 | D | 0.132445 | G | 0.1272 | 0.005245 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 224 | D | 0.131989 | V | 0.075599 | 0.05639 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 233 | R | 0.099282 | C | 0.044801 | 0.054481 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 243 | H | 0.146127 | P | 0.167374 | -0.021247 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 258 | G | 0.182267 | E | 0.215049 | -0.032782 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 263 | G | 0.30815 | E | 0.343403 | -0.035253 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 304 | A | 0.29678 | V | 0.209977 | 0.086803 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 317 | G | 0.495445 | E | 0.528423 | -0.032978 | O to D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 358 | D | 0.310257 | H | 0.290895 | 0.019362 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 382 | P | 0.41685 | L | 0.249996 | 0.166854 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 401 | G | 0.443888 | R | 0.432827 | 0.011061 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 431 | G | 0.33727 | R | 0.306282 | 0.030988 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 432 | G | 0.348628 | V | 0.222961 | 0.125667 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 438 | A | 0.455654 | T | 0.476609 | -0.020955 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 450 | K | 0.542393 | E | 0.549081 | -0.006688 | No Change: Both D | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 498 | A | 0.309761 | P | 0.399493 | -0.089732 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 531 | V | 0.274709 | E | 0.443652 | -0.168943 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 531 | V | 0.274709 | G | 0.400398 | -0.125689 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 587 | R | 0.121947 | C | 0.063837 | 0.05811 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 587 | R | 0.121947 | L | 0.078414 | 0.043533 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 597 | S | 0.267602 | L | 0.141447 | 0.126155 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 622 | V | 0.208185 | M | 0.256723 | -0.048538 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 628 | G | 0.245612 | D | 0.27285 | -0.027238 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 632 | I | 0.254718 | R | 0.392679 | -0.137961 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 638 | R | 0.251227 | P | 0.283643 | -0.032416 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 648 | C | 0.173589 | Y | 0.186139 | -0.01255 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 654 | D | 0.364432 | V | 0.234934 | 0.129498 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 674 | N | 0.385221 | K | 0.430693 | -0.045472 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| P31327 | CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia] mitochondrial OS=Homo sapiens GN=CPS1 PE=1 SV=2 | 698 | N | 0.099422 | S | 0.120259 | -0.020837 | No Change: Both O | Carbamoyl phosphate synthetase 1 deficiency (CPS1D) [MIM:237300] |
| Q9UKF6 | CPSF3_HUMAN Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens GN=CPSF3 PE=1 SV=1 | 578 | D | 0.246106 | N | 0.23636 | 0.009746 | No Change: Both O | A breast cancer sample |
| Q9UKF6 | CPSF3_HUMAN Cleavage and polyadenylation specificity factor subunit 3 OS=Homo sapiens GN=CPSF3 PE=1 SV=1 | 142 | E | 0.251495 | G | 0.201164 | 0.050331 | No Change: Both O | - |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 123 | R | 0.062966 | C | 0.029065 | 0.033901 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 275 | A | 0.179743 | T | 0.180838 | -0.001095 | No Change: Both O | - |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 304 | C | 0.182264 | W | 0.149671 | 0.032593 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 314 | T | 0.368765 | I | 0.255456 | 0.113309 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 357 | R | 0.609855 | W | 0.412518 | 0.197337 | D to O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 360 | E | 0.593413 | G | 0.534634 | 0.058779 | No Change: Both D | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 414 | A | 0.305763 | V | 0.236622 | 0.069141 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 454 | D | 0.112859 | G | 0.09605 | 0.016809 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 479 | P | 0.164269 | L | 0.088423 | 0.075846 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 484 | L | 0.053812 | P | 0.119631 | -0.065819 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 498 | Y | 0.367263 | C | 0.324396 | 0.042867 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 709 | G | 0.555526 | E | 0.589654 | -0.034128 | No Change: Both D | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 710 | G | 0.537924 | E | 0.573094 | -0.03517 | No Change: Both D | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 316 | R | 0.480324 | G | 0.496607 | -0.016283 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 343 | F | 0.119146 | V | 0.149864 | -0.030718 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| P50416 | CPT1A_HUMAN Carnitine O-palmitoyltransferase 1 liver isoform OS=Homo sapiens GN=CPT1A PE=1 SV=2 | 465 | G | 0.339391 | W | 0.146826 | 0.192565 | No Change: Both O | Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120] |
| Q92523 | CPT1B_HUMAN Carnitine O-palmitoyltransferase 1 muscle isoform OS=Homo sapiens GN=CPT1B PE=2 SV=2 | 531 | E | 0.269161 | K | 0.286982 | -0.017821 | No Change: Both O | - |
| Q92523 | CPT1B_HUMAN Carnitine O-palmitoyltransferase 1 muscle isoform OS=Homo sapiens GN=CPT1B PE=2 SV=2 | 664 | S | 0.09262 | Y | 0.041083 | 0.051537 | No Change: Both O | - |
| Q92523 | CPT1B_HUMAN Carnitine O-palmitoyltransferase 1 muscle isoform OS=Homo sapiens GN=CPT1B PE=2 SV=2 | 66 | I | 0.06509 | V | 0.083622 | -0.018532 | No Change: Both O | - |
| Q92523 | CPT1B_HUMAN Carnitine O-palmitoyltransferase 1 muscle isoform OS=Homo sapiens GN=CPT1B PE=2 SV=2 | 320 | G | 0.479541 | D | 0.530278 | -0.050737 | O to D | - |
| Q92523 | CPT1B_HUMAN Carnitine O-palmitoyltransferase 1 muscle isoform OS=Homo sapiens GN=CPT1B PE=2 SV=2 | 427 | S | 0.648101 | C | 0.430721 | 0.21738 | D to O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 50 | P | 0.5664 | H | 0.471082 | 0.095318 | D to O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 113 | S | 0.228315 | L | 0.105989 | 0.122326 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 174 | E | 0.280635 | K | 0.271971 | 0.008664 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 352 | F | 0.221304 | C | 0.197813 | 0.023491 | No Change: Both O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 368 | V | 0.358393 | I | 0.331837 | 0.026556 | No Change: Both O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 383 | F | 0.141262 | Y | 0.117694 | 0.023568 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 553 | D | 0.274687 | N | 0.2599 | 0.014787 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 628 | Y | 0.348194 | S | 0.538523 | -0.190329 | O to D | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 631 | R | 0.404296 | C | 0.237472 | 0.166824 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 647 | M | 0.328885 | V | 0.270708 | 0.058177 | No Change: Both O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 214 | M | 0.16929 | T | 0.201863 | -0.032573 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 227 | P | 0.641835 | L | 0.472116 | 0.169719 | D to O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 448 | F | 0.317551 | L | 0.341167 | -0.023616 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 479 | Y | 0.220268 | F | 0.226068 | -0.0058 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 503 | R | 0.523464 | C | 0.389008 | 0.134456 | D to O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 549 | G | 0.397707 | D | 0.419579 | -0.021872 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 588 | S | 0.535705 | C | 0.259111 | 0.276594 | D to O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 151 | R | 0.379806 | Q | 0.408993 | -0.029187 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 210 | Y | 0.133122 | D | 0.228356 | -0.095234 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 296 | R | 0.328872 | Q | 0.340887 | -0.012015 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 550 | Q | 0.361482 | R | 0.354677 | 0.006805 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 600 | G | 0.284099 | R | 0.257118 | 0.026981 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 604 | P | 0.20269 | S | 0.23474 | -0.03205 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 213 | D | 0.158478 | G | 0.138835 | 0.019643 | No Change: Both O | Carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D) [MIM:255110] |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 504 | P | 0.531271 | L | 0.365067 | 0.166204 | D to O | - |
| P23786 | CPT2_HUMAN Carnitine O-palmitoyltransferase 2 mitochondrial OS=Homo sapiens GN=CPT2 PE=1 SV=2 | 605 | V | 0.211958 | L | 0.202974 | 0.008984 | No Change: Both O | - |
| Q9H3G5 | CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens GN=CPVL PE=1 SV=2 | 435 | A | 0.214812 | V | 0.16102 | 0.053792 | No Change: Both O | - |
| Q9H3G5 | CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens GN=CPVL PE=1 SV=2 | 11 | S | 0.075858 | L | 0.035037 | 0.040821 | No Change: Both O | - |
| Q9H3G5 | CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens GN=CPVL PE=1 SV=2 | 25 | R | 0.239392 | H | 0.217947 | 0.021445 | No Change: Both O | - |
| Q9H3G5 | CPVL_HUMAN Probable serine carboxypeptidase CPVL OS=Homo sapiens GN=CPVL PE=1 SV=2 | 398 | R | 0.259717 | H | 0.26038 | -6.63E-04 | No Change: Both O | - |
| Q8N123 | CPXCR_HUMAN CPX chromosomal region candidate gene 1 protein OS=Homo sapiens GN=CPXCR1 PE=2 SV=2 | 3 | Y | 0.977342 | S | 0.993665 | -0.016323 | No Change: Both D | - |
| Q8N123 | CPXCR_HUMAN CPX chromosomal region candidate gene 1 protein OS=Homo sapiens GN=CPXCR1 PE=2 SV=2 | 131 | R | 0.391367 | H | 0.376549 | 0.014818 | No Change: Both O | - |
| Q8N436 | CPXM2_HUMAN Inactive carboxypeptidase-like protein X2 OS=Homo sapiens GN=CPXM2 PE=2 SV=3 | 750 | Q | 0.942637 | R | 0.950818 | -0.008181 | No Change: Both D | - |
| Q66K79 | CBPZ_HUMAN Carboxypeptidase Z OS=Homo sapiens GN=CPZ PE=1 SV=2 | 5 | L | 0.644717 | P | 0.791487 | -0.14677 | No Change: Both D | - |
| Q66K79 | CBPZ_HUMAN Carboxypeptidase Z OS=Homo sapiens GN=CPZ PE=1 SV=2 | 501 | T | 0.15405 | M | 0.127158 | 0.026892 | No Change: Both O | - |
| Q66K79 | CBPZ_HUMAN Carboxypeptidase Z OS=Homo sapiens GN=CPZ PE=1 SV=2 | 6 | P | 0.629819 | L | 0.447154 | 0.182665 | D to O | - |
| Q66K79 | CBPZ_HUMAN Carboxypeptidase Z OS=Homo sapiens GN=CPZ PE=1 SV=2 | 130 | Q | 0.13547 | L | 0.084698 | 0.050772 | No Change: Both O | - |
| Q66K79 | CBPZ_HUMAN Carboxypeptidase Z OS=Homo sapiens GN=CPZ PE=1 SV=2 | 486 | I | 0.096898 | T | 0.175676 | -0.078778 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1208 | H | 0.765149 | R | 0.768077 | -0.002928 | No Change: Both D | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1408 | T | 0.313018 | I | 0.214423 | 0.098595 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1590 | K | 0.459021 | E | 0.495504 | -0.036483 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1601 | R | 0.398631 | G | 0.391436 | 0.007195 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1610 | S | 0.249057 | T | 0.204585 | 0.044472 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1615 | I | 0.138086 | V | 0.152803 | -0.014717 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1827 | P | 0.591762 | R | 0.559453 | 0.032309 | No Change: Both D | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1850 | H | 0.475156 | D | 0.489519 | -0.014363 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1408 | T | 0.313018 | M | 0.278272 | 0.034746 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1540 | N | 0.375231 | S | 0.419625 | -0.044394 | No Change: Both O | - |
| P17927 | CR1_HUMAN Complement receptor type 1 OS=Homo sapiens GN=CR1 PE=1 SV=3 | 1969 | T | 0.27299 | A | 0.248299 | 0.024691 | No Change: Both O | - |
| Q2VPA4 | CR1L_HUMAN Complement component receptor 1-like protein OS=Homo sapiens GN=CR1L PE=1 SV=3 | 116 | R | 0.324117 | G | 0.315163 | 0.008954 | No Change: Both O | - |
| Q2VPA4 | CR1L_HUMAN Complement component receptor 1-like protein OS=Homo sapiens GN=CR1L PE=1 SV=3 | 139 | I | 0.178033 | V | 0.192933 | -0.0149 | No Change: Both O | - |
| Q2VPA4 | CR1L_HUMAN Complement component receptor 1-like protein OS=Homo sapiens GN=CR1L PE=1 SV=3 | 402 | N | 0.309402 | D | 0.328571 | -0.019169 | No Change: Both O | - |
| Q2VPA4 | CR1L_HUMAN Complement component receptor 1-like protein OS=Homo sapiens GN=CR1L PE=1 SV=3 | 455 | I | 0.374618 | V | 0.394286 | -0.019668 | No Change: Both O | - |
| Q2VPA4 | CR1L_HUMAN Complement component receptor 1-like protein OS=Homo sapiens GN=CR1L PE=1 SV=3 | 491 | L | 0.4657 | P | 0.629865 | -0.164165 | O to D | - |
| P20023 | CR2_HUMAN Complement receptor type 2 OS=Homo sapiens GN=CR2 PE=1 SV=2 | 639 | S | 0.383528 | N | 0.329372 | 0.054156 | No Change: Both O | - |
| P20023 | CR2_HUMAN Complement receptor type 2 OS=Homo sapiens GN=CR2 PE=1 SV=2 | 993 | I | 0.014854 | V | 0.01717 | -0.002316 | No Change: Both O | - |
| P20023 | CR2_HUMAN Complement receptor type 2 OS=Homo sapiens GN=CR2 PE=1 SV=2 | 1003 | A | 0.369503 | E | 0.496878 | -0.127375 | No Change: Both O | - |
| P43155 | CACP_HUMAN Carnitine O-acetyltransferase OS=Homo sapiens GN=CRAT PE=1 SV=5 | 372 | L | 0.456893 | M | 0.523283 | -0.06639 | O to D | - |
| P43155 | CACP_HUMAN Carnitine O-acetyltransferase OS=Homo sapiens GN=CRAT PE=1 SV=5 | 624 | A | 0.72568 | P | 0.746358 | -0.020678 | No Change: Both D | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 161 | A | 0.36841 | V | 0.300426 | 0.067984 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 250 | C | 0.206832 | W | 0.110767 | 0.096065 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 745 | T | 0.218195 | M | 0.19231 | 0.025885 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 764 | R | 0.070035 | C | 0.028849 | 0.041186 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 764 | R | 0.070035 | C | 0.028849 | 0.041186 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 948 | C | 0.131429 | Y | 0.104252 | 0.027177 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 948 | C | 0.131429 | Y | 0.104252 | 0.027177 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1041 | M | 0.528272 | T | 0.577245 | -0.048973 | No Change: Both D | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1071 | L | 0.276092 | P | 0.406437 | -0.130345 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1100 | I | 0.132563 | R | 0.222444 | -0.089881 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1181 | C | 0.25029 | R | 0.332244 | -0.081954 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 144 | F | 0.306906 | V | 0.340854 | -0.033948 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 162 | V | 0.374567 | M | 0.438539 | -0.063972 | No Change: Both O | Pigmented paravenous chorioretinal atrophy (PPCRA) [MIM:172870] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 195 | C | 0.450223 | F | 0.427181 | 0.023042 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 205 | I | 0.205876 | T | 0.323426 | -0.11755 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 289 | T | 0.493406 | M | 0.454059 | 0.039347 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 383 | C | 0.288081 | Y | 0.226529 | 0.061552 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 433 | Y | 0.409254 | C | 0.527189 | -0.117935 | O to D | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 480 | C | 0.231455 | G | 0.401387 | -0.169932 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 480 | C | 0.231455 | R | 0.366899 | -0.135444 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 578 | V | 0.073573 | E | 0.165543 | -0.09197 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 584 | D | 0.213091 | Y | 0.104214 | 0.108877 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 587 | C | 0.30113 | Y | 0.328921 | -0.027791 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 679 | Q | 0.418064 | E | 0.452941 | -0.034877 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 681 | C | 0.40667 | Y | 0.389983 | 0.016687 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 710 | E | 0.184741 | Q | 0.157012 | 0.027729 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 741 | M | 0.172024 | T | 0.223506 | -0.051482 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 769 | R | 0.112303 | H | 0.103552 | 0.008751 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 769 | R | 0.112303 | Q | 0.113514 | -0.001211 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 836 | P | 0.379765 | T | 0.349274 | 0.030491 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 837 | D | 0.462815 | H | 0.432169 | 0.030646 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 846 | G | 0.242799 | R | 0.221505 | 0.021294 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 850 | G | 0.149389 | S | 0.167162 | -0.017773 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 852 | I | 0.147007 | T | 0.253584 | -0.106577 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 891 | C | 0.692406 | G | 0.73 | -0.037594 | No Change: Both D | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 894 | N | 0.679 | S | 0.713861 | -0.034861 | No Change: Both D | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 905 | R | 0.525071 | Q | 0.578227 | -0.053156 | No Change: Both D | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 959 | G | 0.323442 | S | 0.374597 | -0.051155 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 986 | N | 0.152835 | I | 0.083753 | 0.069082 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 989 | I | 0.153657 | T | 0.250267 | -0.09661 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1025 | S | 0.381556 | I | 0.170301 | 0.211255 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1100 | I | 0.132563 | T | 0.223879 | -0.091316 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1103 | G | 0.118505 | R | 0.103612 | 0.014893 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1103 | G | 0.118505 | R | 0.103612 | 0.014893 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1107 | L | 0.090848 | P | 0.179188 | -0.08834 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1107 | L | 0.090848 | R | 0.153715 | -0.062867 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1205 | G | 0.306709 | R | 0.299133 | 0.007576 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1218 | C | 0.326778 | F | 0.292418 | 0.03436 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1317 | N | 0.137697 | H | 0.111886 | 0.025811 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1321 | C | 0.077818 | S | 0.146012 | -0.068194 | No Change: Both O | Leber congenital amaurosis type 8 (LCA8) [MIM:613835] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1331 | R | 0.205497 | H | 0.208674 | -0.003177 | No Change: Both O | - |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1354 | A | 0.035013 | T | 0.043837 | -0.008824 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1383 | R | 0.805787 | H | 0.814386 | -0.008599 | No Change: Both D | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 27 | C | 0.435326 | F | 0.409175 | 0.026151 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| P82279 | CRUM1_HUMAN Crumbs homolog 1 OS=Homo sapiens GN=CRB1 PE=1 SV=2 | 1165 | C | 0.353747 | W | 0.250716 | 0.103031 | No Change: Both O | Retinitis pigmentosa type 12 (RP12) [MIM:600105] |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 46 | P | 0.875521 | L | 0.77905 | 0.096471 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 97 | V | 0.579806 | L | 0.612739 | -0.032933 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 116 | P | 0.492586 | L | 0.322737 | 0.169849 | No Change: Both O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 145 | M | 0.399678 | T | 0.448802 | -0.049124 | No Change: Both O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 159 | G | 0.397574 | A | 0.330207 | 0.067367 | No Change: Both O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 187 | E | 0.528946 | D | 0.561599 | -0.032653 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 351 | A | 0.63943 | T | 0.693297 | -0.053867 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 534 | R | 0.139083 | Q | 0.145932 | -0.006849 | No Change: Both O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 610 | R | 0.509575 | W | 0.267344 | 0.242231 | D to O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 746 | H | 0.368734 | Q | 0.424226 | -0.055492 | No Change: Both O | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 1110 | T | 0.938063 | M | 0.939655 | -0.001592 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 90 | T | 0.68602 | N | 0.670571 | 0.015449 | No Change: Both D | - |
| Q5IJ48 | CRUM2_HUMAN Crumbs homolog 2 OS=Homo sapiens GN=CRB2 PE=1 SV=2 | 709 | V | 0.441878 | A | 0.510542 | -0.068664 | O to D | - |
| Q9UGL9 | CRCT1_HUMAN Cysteine-rich C-terminal protein 1 OS=Homo sapiens GN=CRCT1 PE=2 SV=1 | 96 | C | 0.999763 | Y | 0.999348 | 4.15E-04 | No Change: Both D | - |
| Q96BA8 | CR3L1_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 1 OS=Homo sapiens GN=CREB3L1 PE=1 SV=1 | 411 | A | 0.389843 | T | 0.420738 | -0.030895 | No Change: Both O | - |
| Q70SY1 | CR3L2_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 2 OS=Homo sapiens GN=CREB3L2 PE=1 SV=3 | 130 | V | 0.881412 | I | 0.876557 | 0.004855 | No Change: Both D | - |
| Q8TEY5 | CR3L4_HUMAN Cyclic AMP-responsive element-binding protein 3-like protein 4 OS=Homo sapiens GN=CREB3L4 PE=1 SV=1 | 95 | P | 0.919129 | S | 0.91911 | 1.90E-05 | No Change: Both D | - |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1378 | R | 0.647011 | P | 0.689031 | -0.04202 | No Change: Both D | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1414 | V | 0.178166 | I | 0.155456 | 0.02271 | No Change: Both O | - |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1278 | E | 0.50619 | K | 0.523658 | -0.017468 | No Change: Both D | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1447 | T | 0.087324 | I | 0.049059 | 0.038265 | No Change: Both O | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1450 | Y | 0.058932 | H | 0.104192 | -0.04526 | No Change: Both O | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1470 | H | 0.079756 | R | 0.079427 | 3.29E-04 | No Change: Both O | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1664 | R | 0.258627 | H | 0.249497 | 0.00913 | No Change: Both O | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q92793 | CBP_HUMAN CREB-binding protein OS=Homo sapiens GN=CREBBP PE=1 SV=3 | 1175 | Y | 0.234693 | C | 0.199719 | 0.034974 | No Change: Both O | Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849] |
| Q8IUH2 | CREG2_HUMAN Protein CREG2 OS=Homo sapiens GN=CREG2 PE=1 SV=1 | 96 | P | 0.962722 | Q | 0.953276 | 0.009446 | No Change: Both D | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 107 | R | 0.395715 | H | 0.394966 | 7.49E-04 | No Change: Both O | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 162 | P | 0.894345 | A | 0.838878 | 0.055467 | No Change: Both D | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 311 | T | 0.79512 | I | 0.713474 | 0.081646 | No Change: Both D | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 329 | R | 0.540858 | C | 0.55106 | -0.010202 | No Change: Both D | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 13 | M | 0.615313 | V | 0.522215 | 0.093098 | No Change: Both D | - |
| Q96HD1 | CREL1_HUMAN Cysteine-rich with EGF-like domain protein 1 OS=Homo sapiens GN=CRELD1 PE=1 SV=3 | 128 | P | 0.36453 | R | 0.319953 | 0.044577 | No Change: Both O | - |
| Q6UXH1 | CREL2_HUMAN Cysteine-rich with EGF-like domain protein 2 OS=Homo sapiens GN=CRELD2 PE=1 SV=1 | 182 | D | 0.661835 | E | 0.66395 | -0.002115 | No Change: Both D | - |
| Q6UXH1 | CREL2_HUMAN Cysteine-rich with EGF-like domain protein 2 OS=Homo sapiens GN=CRELD2 PE=1 SV=1 | 295 | S | 0.506887 | A | 0.430998 | 0.075889 | D to O | - |
| Q6UXH1 | CREL2_HUMAN Cysteine-rich with EGF-like domain protein 2 OS=Homo sapiens GN=CRELD2 PE=1 SV=1 | 325 | E | 0.801947 | G | 0.750321 | 0.051626 | No Change: Both D | - |
| Q03060 | CREM_HUMAN cAMP-responsive element modulator OS=Homo sapiens GN=CREM PE=1 SV=5 | 270 | Q | 0.633665 | R | 0.610421 | 0.023244 | No Change: Both D | - |
| Q13324 | CRFR2_HUMAN Corticotropin-releasing factor receptor 2 OS=Homo sapiens GN=CRHR2 PE=1 SV=2 | 220 | E | 0.192527 | D | 0.173501 | 0.019026 | No Change: Both O | - |
| Q9NZV1 | CRIM1_HUMAN Cysteine-rich motor neuron 1 protein OS=Homo sapiens GN=CRIM1 PE=1 SV=1 | 502 | E | 0.659079 | K | 0.649777 | 0.009302 | No Change: Both D | - |
| Q9NZV1 | CRIM1_HUMAN Cysteine-rich motor neuron 1 protein OS=Homo sapiens GN=CRIM1 PE=1 SV=1 | 781 | V | 0.355646 | I | 0.35586 | -2.14E-04 | No Change: Both O | - |
| Q8N1N5 | CRPAK_HUMAN Cysteine-rich PAK1 inhibitor OS=Homo sapiens GN=CRIPAK PE=1 SV=1 | 89 | C | 0.273141 | Y | 0.184564 | 0.088577 | No Change: Both O | - |
| Q8N1N5 | CRPAK_HUMAN Cysteine-rich PAK1 inhibitor OS=Homo sapiens GN=CRIPAK PE=1 SV=1 | 95 | H | 0.249102 | P | 0.31666 | -0.067558 | No Change: Both O | - |
| Q8N1N5 | CRPAK_HUMAN Cysteine-rich PAK1 inhibitor OS=Homo sapiens GN=CRIPAK PE=1 SV=1 | 120 | V | 0.635062 | M | 0.711372 | -0.07631 | No Change: Both D | - |
| Q8N1N5 | CRPAK_HUMAN Cysteine-rich PAK1 inhibitor OS=Homo sapiens GN=CRIPAK PE=1 SV=1 | 95 | H | 0.249102 | R | 0.261522 | -0.01242 | No Change: Both O | - |
| P16562 | CRIS2_HUMAN Cysteine-rich secretory protein 2 OS=Homo sapiens GN=CRISP2 PE=1 SV=1 | 131 | N | 0.513836 | S | 0.565074 | -0.051238 | No Change: Both D | - |
| P54108 | CRIS3_HUMAN Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3 PE=1 SV=1 | 106 | S | 0.647152 | P | 0.596791 | 0.050361 | No Change: Both D | - |
| P54108 | CRIS3_HUMAN Cysteine-rich secretory protein 3 OS=Homo sapiens GN=CRISP3 PE=1 SV=1 | 134 | A | 0.378093 | S | 0.489387 | -0.111294 | No Change: Both O | - |
| Q9H336 | CRLD1_HUMAN Cysteine-rich secretory protein LCCL domain-containing 1 OS=Homo sapiens GN=CRISPLD1 PE=1 SV=1 | 286 | A | 0.812634 | S | 0.885249 | -0.072615 | No Change: Both D | - |
| Q9H0B8 | CRLD2_HUMAN Cysteine-rich secretory protein LCCL domain-containing 2 OS=Homo sapiens GN=CRISPLD2 PE=1 SV=1 | 105 | S | 0.205428 | G | 0.170542 | 0.034886 | No Change: Both O | - |
| Q9H0B8 | CRLD2_HUMAN Cysteine-rich secretory protein LCCL domain-containing 2 OS=Homo sapiens GN=CRISPLD2 PE=1 SV=1 | 322 | T | 0.206919 | S | 0.293987 | -0.087068 | No Change: Both O | - |
| O75462 | CRLF1_HUMAN Cytokine receptor-like factor 1 OS=Homo sapiens GN=CRLF1 PE=1 SV=1 | 81 | R | 0.365115 | H | 0.321179 | 0.043936 | No Change: Both O | Cold-induced sweating syndrome type 1 (CISS1) [MIM:272430] |
| O75462 | CRLF1_HUMAN Cytokine receptor-like factor 1 OS=Homo sapiens GN=CRLF1 PE=1 SV=1 | 374 | L | 0.276359 | R | 0.372863 | -0.096504 | No Change: Both O | Cold-induced sweating syndrome type 1 (CISS1) [MIM:272430] |
| O75462 | CRLF1_HUMAN Cytokine receptor-like factor 1 OS=Homo sapiens GN=CRLF1 PE=1 SV=1 | 176 | R | 0.150773 | K | 0.208164 | -0.057391 | No Change: Both O | - |
| O75462 | CRLF1_HUMAN Cytokine receptor-like factor 1 OS=Homo sapiens GN=CRLF1 PE=1 SV=1 | 76 | W | 0.241836 | G | 0.49168 | -0.249844 | No Change: Both O | Crisponi syndrome (CRISPS) [MIM:601378] |
| Q8IUI8 | CRLF3_HUMAN Cytokine receptor-like factor 3 OS=Homo sapiens GN=CRLF3 PE=1 SV=2 | 389 | L | 0.325924 | P | 0.493904 | -0.16798 | No Change: Both O | - |
| Q8IUI8 | CRLF3_HUMAN Cytokine receptor-like factor 3 OS=Homo sapiens GN=CRLF3 PE=1 SV=2 | 202 | V | 0.115028 | M | 0.138766 | -0.023738 | No Change: Both O | - |
| Q14194 | DPYL1_HUMAN Dihydropyrimidinase-related protein 1 OS=Homo sapiens GN=CRMP1 PE=1 SV=1 | 461 | V | 0.354364 | I | 0.336096 | 0.018268 | No Change: Both O | - |
| Q9BZJ0 | CRNL1_HUMAN Crooked neck-like protein 1 OS=Homo sapiens GN=CRNKL1 PE=1 SV=4 | 35 | G | 0.555842 | R | 0.55324 | 0.002602 | No Change: Both D | - |
| Q9BZJ0 | CRNL1_HUMAN Crooked neck-like protein 1 OS=Homo sapiens GN=CRNKL1 PE=1 SV=4 | 51 | F | 0.141465 | L | 0.194774 | -0.053309 | No Change: Both O | - |
| Q9BZJ0 | CRNL1_HUMAN Crooked neck-like protein 1 OS=Homo sapiens GN=CRNKL1 PE=1 SV=4 | 111 | Q | 0.776405 | H | 0.736228 | 0.040177 | No Change: Both D | - |
| Q9BZJ0 | CRNL1_HUMAN Crooked neck-like protein 1 OS=Homo sapiens GN=CRNKL1 PE=1 SV=4 | 158 | T | 0.751303 | A | 0.756279 | -0.004976 | No Change: Both D | - |
| Q9BZJ0 | CRNL1_HUMAN Crooked neck-like protein 1 OS=Homo sapiens GN=CRNKL1 PE=1 SV=4 | 843 | V | 0.97752 | I | 0.97634 | 0.00118 | No Change: Both D | - |
| Q9UBG3 | CRNN_HUMAN Cornulin OS=Homo sapiens GN=CRNN PE=1 SV=1 | 27 | A | 0.323733 | V | 0.241133 | 0.0826 | No Change: Both O | - |
| Q9UBG3 | CRNN_HUMAN Cornulin OS=Homo sapiens GN=CRNN PE=1 SV=1 | 374 | Q | 0.975163 | H | 0.965258 | 0.009905 | No Change: Both D | - |
| Q9UBG3 | CRNN_HUMAN Cornulin OS=Homo sapiens GN=CRNN PE=1 SV=1 | 480 | G | 0.703922 | S | 0.784172 | -0.08025 | No Change: Both D | - |
| Q5TZA2 | CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC PE=1 SV=1 | 439 | A | 0.917735 | V | 0.886975 | 0.03076 | No Change: Both D | - |
| Q5TZA2 | CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC PE=1 SV=1 | 586 | D | 0.940435 | H | 0.932631 | 0.007804 | No Change: Both D | - |
| Q5TZA2 | CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC PE=1 SV=1 | 1097 | R | 0.953872 | P | 0.943335 | 0.010537 | No Change: Both D | - |
| Q5TZA2 | CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC PE=1 SV=1 | 7 | R | 0.495356 | G | 0.515202 | -0.019846 | O to D | - |
| Q5TZA2 | CROCC_HUMAN Rootletin OS=Homo sapiens GN=CROCC PE=1 SV=1 | 372 | R | 0.927993 | Q | 0.935892 | -0.007899 | No Change: Both D | - |
| Q9UKG9 | OCTC_HUMAN Peroxisomal carnitine O-octanoyltransferase OS=Homo sapiens GN=CROT PE=1 SV=2 | 94 | R | 0.117543 | H | 0.119417 | -0.001874 | No Change: Both O | - |
| Q9UKG9 | OCTC_HUMAN Peroxisomal carnitine O-octanoyltransferase OS=Homo sapiens GN=CROT PE=1 SV=2 | 474 | V | 0.672657 | L | 0.68655 | -0.013893 | No Change: Both D | - |
| Q9NQ79 | CRAC1_HUMAN Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 PE=1 SV=2 | 253 | A | 0.396565 | T | 0.427413 | -0.030848 | No Change: Both O | - |
| Q9NQ79 | CRAC1_HUMAN Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 PE=1 SV=2 | 569 | V | 0.418695 | M | 0.50631 | -0.087615 | O to D | - |
| Q9NQ79 | CRAC1_HUMAN Cartilage acidic protein 1 OS=Homo sapiens GN=CRTAC1 PE=1 SV=2 | 658 | E | 0.71369 | K | 0.715148 | -0.001458 | No Change: Both D | - |
| O95727 | CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule OS=Homo sapiens GN=CRTAM PE=1 SV=2 | 321 | K | 0.534486 | R | 0.471811 | 0.062675 | D to O | - |
| O95727 | CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule OS=Homo sapiens GN=CRTAM PE=1 SV=2 | 368 | A | 0.811813 | G | 0.834986 | -0.023173 | No Change: Both D | - |
| O95727 | CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule OS=Homo sapiens GN=CRTAM PE=1 SV=2 | 16 | E | 0.284617 | A | 0.204527 | 0.08009 | No Change: Both O | - |
| O95727 | CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule OS=Homo sapiens GN=CRTAM PE=1 SV=2 | 78 | A | 0.394776 | D | 0.483552 | -0.088776 | No Change: Both O | - |
| O95727 | CRTAM_HUMAN Cytotoxic and regulatory T-cell molecule OS=Homo sapiens GN=CRTAM PE=1 SV=2 | 173 | D | 0.589652 | G | 0.595705 | -0.006053 | No Change: Both D | - |
| O75718 | CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens GN=CRTAP PE=1 SV=1 | 137 | E | 0.592721 | D | 0.577399 | 0.015322 | No Change: Both D | - |
| O75718 | CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens GN=CRTAP PE=1 SV=1 | 261 | L | 0.118125 | V | 0.123795 | -0.00567 | No Change: Both O | - |
| O75718 | CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens GN=CRTAP PE=1 SV=1 | 67 | L | 0.275644 | P | 0.384307 | -0.108663 | No Change: Both O | Osteogenesis imperfecta type 7 (OI7) [MIM:610682] |
| O75718 | CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens GN=CRTAP PE=1 SV=1 | 13 | A | 0.348319 | E | 0.40681 | -0.058491 | No Change: Both O | Osteogenesis imperfecta type 7 (OI7) [MIM:610682] |
| O75718 | CRTAP_HUMAN Cartilage-associated protein OS=Homo sapiens GN=CRTAP PE=1 SV=1 | 157 | K | 0.259885 | E | 0.249996 | 0.009889 | No Change: Both O | Osteogenesis imperfecta type 7 (OI7) [MIM:610682] |
| Q6UUV9 | CRTC1_HUMAN CREB-regulated transcription coactivator 1 OS=Homo sapiens GN=CRTC1 PE=1 SV=2 | 286 | T | 0.899582 | A | 0.891592 | 0.00799 | No Change: Both D | - |
| Q6UUV9 | CRTC1_HUMAN CREB-regulated transcription coactivator 1 OS=Homo sapiens GN=CRTC1 PE=1 SV=2 | 311 | V | 0.93924 | I | 0.941125 | -0.001885 | No Change: Both D | - |
| Q6UUV9 | CRTC1_HUMAN CREB-regulated transcription coactivator 1 OS=Homo sapiens GN=CRTC1 PE=1 SV=2 | 328 | T | 0.893462 | A | 0.891066 | 0.002396 | No Change: Both D | - |
| Q53ET0 | CRTC2_HUMAN CREB-regulated transcription coactivator 2 OS=Homo sapiens GN=CRTC2 PE=1 SV=2 | 147 | M | 0.6303 | V | 0.528466 | 0.101834 | No Change: Both D | - |
| Q53ET0 | CRTC2_HUMAN CREB-regulated transcription coactivator 2 OS=Homo sapiens GN=CRTC2 PE=1 SV=2 | 379 | R | 0.993679 | C | 0.992266 | 0.001413 | No Change: Both D | - |
| Q6UUV7 | CRTC3_HUMAN CREB-regulated transcription coactivator 3 OS=Homo sapiens GN=CRTC3 PE=1 SV=2 | 72 | S | 0.788996 | N | 0.742302 | 0.046694 | No Change: Both D | - |
| Q6UUV7 | CRTC3_HUMAN CREB-regulated transcription coactivator 3 OS=Homo sapiens GN=CRTC3 PE=1 SV=2 | 346 | L | 0.944868 | S | 0.968862 | -0.023994 | No Change: Both D | - |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 41 | R | 0.774121 | W | 0.566899 | 0.207222 | No Change: Both D | Cone-rod dystrophy type 2 (CORD2) [MIM:120970] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 80 | E | 0.490046 | A | 0.432362 | 0.057684 | No Change: Both O | Cone-rod dystrophy type 2 (CORD2) [MIM:120970] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 41 | R | 0.774121 | Q | 0.774332 | -2.11E-04 | No Change: Both D | Retinitis pigmentosa (RP) [MIM:268000] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 158 | A | 0.923995 | T | 0.932851 | -0.008856 | No Change: Both D | - |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 242 | V | 0.959087 | M | 0.969765 | -0.010678 | No Change: Both D | Cone-rod dystrophy type 2 (CORD2) [MIM:120970] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 122 | G | 0.99162 | D | 0.992635 | -0.001015 | No Change: Both D | Retinitis pigmentosa (RP) [MIM:268000] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 90 | R | 0.782413 | W | 0.67948 | 0.102933 | No Change: Both D | Leber congenital amaurosis type 7 (LCA7) [MIM:613829] |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 141 | S | 0.970235 | F | 0.924575 | 0.04566 | No Change: Both D | A breast cancer sample |
| O43186 | CRX_HUMAN Cone-rod homeobox protein OS=Homo sapiens GN=CRX PE=1 SV=1 | 88 | K | 0.708475 | N | 0.683494 | 0.024981 | No Change: Both D | Leber congenital amaurosis type 7 (LCA7) [MIM:613829] |
| P02489 | CRYAA_HUMAN Alpha-crystallin A chain OS=Homo sapiens GN=CRYAA PE=1 SV=2 | 116 | R | 0.405204 | C | 0.232847 | 0.172357 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P02489 | CRYAA_HUMAN Alpha-crystallin A chain OS=Homo sapiens GN=CRYAA PE=1 SV=2 | 105 | D | 0.623582 | H | 0.616555 | 0.007027 | No Change: Both D | A breast cancer sample |
| P02489 | CRYAA_HUMAN Alpha-crystallin A chain OS=Homo sapiens GN=CRYAA PE=1 SV=2 | 49 | R | 0.285877 | C | 0.149775 | 0.136102 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P02489 | CRYAA_HUMAN Alpha-crystallin A chain OS=Homo sapiens GN=CRYAA PE=1 SV=2 | 21 | R | 0.184755 | L | 0.118499 | 0.066256 | No Change: Both O | - |
| P02489 | CRYAA_HUMAN Alpha-crystallin A chain OS=Homo sapiens GN=CRYAA PE=1 SV=2 | 116 | R | 0.405204 | H | 0.388084 | 0.01712 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P02511 | CRYAB_HUMAN Alpha-crystallin B chain OS=Homo sapiens GN=CRYAB PE=1 SV=2 | 120 | R | 0.373276 | G | 0.352815 | 0.020461 | No Change: Both O | Myopathy myofibrillar type 2 (MFM2) [MIM:608810] |
| P02511 | CRYAB_HUMAN Alpha-crystallin B chain OS=Homo sapiens GN=CRYAB PE=1 SV=2 | 41 | S | 0.736102 | Y | 0.545137 | 0.190965 | No Change: Both D | - |
| P02511 | CRYAB_HUMAN Alpha-crystallin B chain OS=Homo sapiens GN=CRYAB PE=1 SV=2 | 51 | P | 0.560433 | L | 0.391176 | 0.169257 | D to O | - |
| P53673 | CRBA4_HUMAN Beta-crystallin A4 OS=Homo sapiens GN=CRYBA4 PE=1 SV=3 | 84 | T | 0.290893 | M | 0.245468 | 0.045425 | No Change: Both O | - |
| P53673 | CRBA4_HUMAN Beta-crystallin A4 OS=Homo sapiens GN=CRYBA4 PE=1 SV=3 | 69 | L | 0.284936 | P | 0.46704 | -0.182104 | No Change: Both O | Microphthalmia isolated with cataract type 4 (MCOPCT4) [MIM:610426] |
| P53673 | CRBA4_HUMAN Beta-crystallin A4 OS=Homo sapiens GN=CRYBA4 PE=1 SV=3 | 94 | F | 0.323161 | S | 0.540421 | -0.21726 | O to D | Cataract zonular type 2 (CZ2) [MIM:610425] |
| P53673 | CRBA4_HUMAN Beta-crystallin A4 OS=Homo sapiens GN=CRYBA4 PE=1 SV=3 | 36 | V | 0.205297 | M | 0.250393 | -0.045096 | No Change: Both O | - |
| P53674 | CRBB1_HUMAN Beta-crystallin B1 OS=Homo sapiens GN=CRYBB1 PE=1 SV=2 | 129 | S | 0.476138 | R | 0.411778 | 0.06436 | No Change: Both O | Cataract-microcornea syndrome (CAMIS) [MIM:116150] |
| P43320 | CRBB2_HUMAN Beta-crystallin B2 OS=Homo sapiens GN=CRYBB2 PE=1 SV=2 | 65 | A | 0.283352 | S | 0.379366 | -0.096014 | No Change: Both O | - |
| P26998 | CRBB3_HUMAN Beta-crystallin B3 OS=Homo sapiens GN=CRYBB3 PE=1 SV=4 | 105 | R | 0.565717 | Q | 0.553404 | 0.012313 | No Change: Both D | - |
| P26998 | CRBB3_HUMAN Beta-crystallin B3 OS=Homo sapiens GN=CRYBB3 PE=1 SV=4 | 113 | H | 0.542711 | D | 0.584908 | -0.042197 | No Change: Both D | - |
| P26998 | CRBB3_HUMAN Beta-crystallin B3 OS=Homo sapiens GN=CRYBB3 PE=1 SV=4 | 159 | V | 0.093624 | I | 0.086036 | 0.007588 | No Change: Both O | - |
| P26998 | CRBB3_HUMAN Beta-crystallin B3 OS=Homo sapiens GN=CRYBB3 PE=1 SV=4 | 165 | G | 0.220533 | R | 0.210325 | 0.010208 | No Change: Both O | Cataract congenital nuclear autosomal recessive type 2 (CATCN2) [MIM:609741] |
| Q68DQ2 | CRBG3_HUMAN Beta/gamma crystallin domain-containing protein 3 OS=Homo sapiens GN=CRYBG3 PE=2 SV=2 | 433 | R | 0.235783 | H | 0.211381 | 0.024402 | No Change: Both O | - |
| Q68DQ2 | CRBG3_HUMAN Beta/gamma crystallin domain-containing protein 3 OS=Homo sapiens GN=CRYBG3 PE=2 SV=2 | 761 | Y | 0.036026 | C | 0.03322 | 0.002806 | No Change: Both O | - |
| Q68DQ2 | CRBG3_HUMAN Beta/gamma crystallin domain-containing protein 3 OS=Homo sapiens GN=CRYBG3 PE=2 SV=2 | 926 | N | 0.213174 | H | 0.200715 | 0.012459 | No Change: Both O | - |
| P11844 | CRGA_HUMAN Gamma-crystallin A OS=Homo sapiens GN=CRYGA PE=2 SV=3 | 148 | P | 0.400937 | L | 0.252457 | 0.14848 | No Change: Both O | - |
| P07316 | CRGB_HUMAN Gamma-crystallin B OS=Homo sapiens GN=CRYGB PE=1 SV=3 | 73 | S | 0.278271 | I | 0.126308 | 0.151963 | No Change: Both O | - |
| P07316 | CRGB_HUMAN Gamma-crystallin B OS=Homo sapiens GN=CRYGB PE=1 SV=3 | 111 | I | 0.255299 | L | 0.298044 | -0.042745 | No Change: Both O | - |
| P07316 | CRGB_HUMAN Gamma-crystallin B OS=Homo sapiens GN=CRYGB PE=1 SV=3 | 90 | R | 0.391995 | T | 0.346168 | 0.045827 | No Change: Both O | - |
| P07315 | CRGC_HUMAN Gamma-crystallin C OS=Homo sapiens GN=CRYGC PE=1 SV=2 | 5 | T | 0.457902 | P | 0.490837 | -0.032935 | No Change: Both O | Cataract Coppock-like (CCL) [MIM:604307] |
| P07315 | CRGC_HUMAN Gamma-crystallin C OS=Homo sapiens GN=CRYGC PE=1 SV=2 | 48 | R | 0.293379 | H | 0.24932 | 0.044059 | No Change: Both O | - |
| P07315 | CRGC_HUMAN Gamma-crystallin C OS=Homo sapiens GN=CRYGC PE=1 SV=2 | 169 | R | 0.387014 | W | 0.179653 | 0.207361 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P07315 | CRGC_HUMAN Gamma-crystallin C OS=Homo sapiens GN=CRYGC PE=1 SV=2 | 6 | F | 0.397092 | L | 0.405725 | -0.008633 | No Change: Both O | - |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 15 | R | 0.493381 | C | 0.323922 | 0.169459 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 37 | R | 0.306695 | S | 0.362966 | -0.056271 | No Change: Both O | - |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 59 | R | 0.244305 | H | 0.233478 | 0.010827 | No Change: Both O | Cataract crystalline aculeiform (CACA) [MIM:115700] |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 24 | P | 0.561911 | T | 0.494735 | 0.067176 | D to O | Cataract congenital cerulean type 3 (CCA3) [MIM:608983] |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 102 | M | 0.369949 | V | 0.302714 | 0.067235 | No Change: Both O | - |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 24 | P | 0.561911 | S | 0.595609 | -0.033698 | No Change: Both D | Cataract congenital non-nuclear polymorphic autosomal dominant (CCP) [MIM:601286] |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 107 | E | 0.259156 | A | 0.150928 | 0.108228 | No Change: Both O | Cataract congenital non-nuclear polymorphic autosomal dominant (CCP) [MIM:601286] |
| P07320 | CRGD_HUMAN Gamma-crystallin D OS=Homo sapiens GN=CRYGD PE=1 SV=3 | 43 | W | 0.177588 | R | 0.385078 | -0.20749 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q08257 | QOR_HUMAN Quinone oxidoreductase OS=Homo sapiens GN=CRYZ PE=1 SV=1 | 66 | P | 0.447704 | S | 0.477082 | -0.029378 | No Change: Both O | - |
| Q08257 | QOR_HUMAN Quinone oxidoreductase OS=Homo sapiens GN=CRYZ PE=1 SV=1 | 176 | I | 0.221165 | V | 0.242757 | -0.021592 | No Change: Both O | - |
| Q08257 | QOR_HUMAN Quinone oxidoreductase OS=Homo sapiens GN=CRYZ PE=1 SV=1 | 183 | E | 0.51829 | K | 0.519282 | -9.92E-04 | No Change: Both D | - |
| O95825 | QORL1_HUMAN Quinone oxidoreductase-like protein 1 OS=Homo sapiens GN=CRYZL1 PE=1 SV=2 | 39 | A | 0.201 | T | 0.226699 | -0.025699 | No Change: Both O | - |
| Q6PB30 | CSAG1_HUMAN Putative chondrosarcoma-associated gene 1 protein OS=Homo sapiens GN=CSAG1 PE=2 SV=2 | 28 | Y | 0.37918 | F | 0.423473 | -0.044293 | No Change: Both O | - |
| Q6PB30 | CSAG1_HUMAN Putative chondrosarcoma-associated gene 1 protein OS=Homo sapiens GN=CSAG1 PE=2 SV=2 | 62 | K | 0.994287 | R | 0.994166 | 1.21E-04 | No Change: Both D | - |
| P16989 | DBPA_HUMAN DNA-binding protein A OS=Homo sapiens GN=CSDA PE=1 SV=4 | 75 | T | 0.654716 | A | 0.655626 | -9.10E-04 | No Change: Both D | - |
| P55060 | XPO2_HUMAN Exportin-2 OS=Homo sapiens GN=CSE1L PE=1 SV=3 | 754 | I | 0.209499 | V | 0.222571 | -0.013072 | No Change: Both O | - |
| P55060 | XPO2_HUMAN Exportin-2 OS=Homo sapiens GN=CSE1L PE=1 SV=3 | 842 | C | 0.171551 | F | 0.164856 | 0.006695 | No Change: Both O | A colorectal cancer sample |
| P55060 | XPO2_HUMAN Exportin-2 OS=Homo sapiens GN=CSE1L PE=1 SV=3 | 968 | V | 0.528857 | L | 0.561893 | -0.033036 | No Change: Both D | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 408 | L | 0.984071 | P | 0.991755 | -0.007684 | No Change: Both D | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 496 | S | 0.362332 | F | 0.193145 | 0.169187 | No Change: Both O | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 531 | A | 0.783503 | V | 0.762339 | 0.021164 | No Change: Both D | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 438 | G | 0.990149 | R | 0.992012 | -0.001863 | No Change: Both D | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 341 | S | 0.968901 | N | 0.957386 | 0.011515 | No Change: Both D | - |
| P09603 | CSF1_HUMAN Macrophage colony-stimulating factor 1 OS=Homo sapiens GN=CSF1 PE=1 SV=2 | 489 | F | 0.715466 | S | 0.78238 | -0.066914 | No Change: Both D | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 969 | Y | 0.708235 | C | 0.84057 | -0.132335 | No Change: Both D | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 32 | V | 0.339178 | G | 0.471217 | -0.132039 | No Change: Both O | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 362 | H | 0.420068 | R | 0.479752 | -0.059684 | No Change: Both O | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 413 | G | 0.084979 | S | 0.108213 | -0.023234 | No Change: Both O | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 536 | L | 0.054156 | V | 0.046892 | 0.007264 | No Change: Both O | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 693 | P | 0.686669 | H | 0.667282 | 0.019387 | No Change: Both D | A lung squamous cell carcinoma sample |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 920 | E | 0.880384 | D | 0.87285 | 0.007534 | No Change: Both D | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 921 | R | 0.899049 | Q | 0.903956 | -0.004907 | No Change: Both D | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 279 | V | 0.325806 | M | 0.369526 | -0.04372 | No Change: Both O | - |
| P07333 | CSF1R_HUMAN Macrophage colony-stimulating factor 1 receptor OS=Homo sapiens GN=CSF1R PE=1 SV=2 | 245 | A | 0.451796 | S | 0.57764 | -0.125844 | O to D | - |
| P04141 | CSF2_HUMAN Granulocyte-macrophage colony-stimulating factor OS=Homo sapiens GN=CSF2 PE=1 SV=1 | 117 | I | 0.25376 | T | 0.401276 | -0.147516 | No Change: Both O | - |
| P04141 | CSF2_HUMAN Granulocyte-macrophage colony-stimulating factor OS=Homo sapiens GN=CSF2 PE=1 SV=1 | 115 | T | 0.307885 | I | 0.189495 | 0.11839 | No Change: Both O | - |
| P15509 | CSF2R_HUMAN Granulocyte-macrophage colony-stimulating factor receptor subunit alpha OS=Homo sapiens GN=CSF2RA PE=1 SV=1 | 196 | G | 0.224516 | R | 0.221633 | 0.002883 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 4 (SMDP4) [MIM:300770] |
| P32927 | IL3RB_HUMAN Cytokine receptor common subunit beta OS=Homo sapiens GN=CSF2RB PE=1 SV=2 | 603 | P | 0.967872 | T | 0.94628 | 0.021592 | No Change: Both D | - |
| P32927 | IL3RB_HUMAN Cytokine receptor common subunit beta OS=Homo sapiens GN=CSF2RB PE=1 SV=2 | 647 | G | 0.898587 | V | 0.863179 | 0.035408 | No Change: Both D | - |
| P32927 | IL3RB_HUMAN Cytokine receptor common subunit beta OS=Homo sapiens GN=CSF2RB PE=1 SV=2 | 652 | V | 0.914192 | M | 0.93383 | -0.019638 | No Change: Both D | - |
| P32927 | IL3RB_HUMAN Cytokine receptor common subunit beta OS=Homo sapiens GN=CSF2RB PE=1 SV=2 | 249 | E | 0.374441 | Q | 0.353087 | 0.021354 | No Change: Both O | - |
| P32927 | IL3RB_HUMAN Cytokine receptor common subunit beta OS=Homo sapiens GN=CSF2RB PE=1 SV=2 | 696 | P | 0.883873 | S | 0.887044 | -0.003171 | No Change: Both D | - |
| P09919 | CSF3_HUMAN Granulocyte colony-stimulating factor OS=Homo sapiens GN=CSF3 PE=1 SV=1 | 157 | L | 0.454616 | M | 0.549239 | -0.094623 | O to D | - |
| P09919 | CSF3_HUMAN Granulocyte colony-stimulating factor OS=Homo sapiens GN=CSF3 PE=1 SV=1 | 174 | A | 0.398976 | T | 0.404624 | -0.005648 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 231 | M | 0.70766 | T | 0.70937 | -0.00171 | No Change: Both D | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 320 | D | 0.392918 | N | 0.373434 | 0.019484 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 346 | Q | 0.352412 | R | 0.35394 | -0.001528 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 405 | E | 0.400632 | K | 0.36084 | 0.039792 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 440 | R | 0.376315 | Q | 0.368233 | 0.008082 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 510 | D | 0.359913 | H | 0.338412 | 0.021501 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 562 | Y | 0.105961 | H | 0.191874 | -0.085913 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 583 | R | 0.283372 | C | 0.15819 | 0.125182 | No Change: Both O | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 229 | P | 0.709056 | H | 0.593526 | 0.11553 | No Change: Both D | - |
| Q99062 | CSF3R_HUMAN Granulocyte colony-stimulating factor receptor OS=Homo sapiens GN=CSF3R PE=1 SV=1 | 640 | T | 0.044302 | N | 0.047119 | -0.002817 | No Change: Both O | Hereditary neutrophilia (NEUTROPHILIA) [MIM:162830] |
| Q8N6G5 | CGAT2_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=CSGALNACT2 PE=2 SV=1 | 215 | E | 0.526749 | K | 0.501433 | 0.025316 | No Change: Both D | - |
| Q8N6G5 | CGAT2_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=CSGALNACT2 PE=2 SV=1 | 479 | P | 0.098561 | S | 0.10344 | -0.004879 | No Change: Both O | - |
| Q8TDX6 | CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=CSGALNACT1 PE=1 SV=2 | 137 | V | 0.283527 | I | 0.240034 | 0.043493 | No Change: Both O | - |
| Q8TDX6 | CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=CSGALNACT1 PE=1 SV=2 | 473 | F | 0.105401 | Y | 0.123598 | -0.018197 | No Change: Both O | - |
| Q8TDX6 | CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=CSGALNACT1 PE=1 SV=2 | 193 | S | 0.739166 | N | 0.716292 | 0.022874 | No Change: Both D | - |
| P01243 | CSH_HUMAN Chorionic somatomammotropin hormone OS=Homo sapiens GN=CSH1 PE=1 SV=2 | 3 | P | 0.799323 | A | 0.825261 | -0.025938 | No Change: Both D | - |
| Q14406 | CSHL_HUMAN Chorionic somatomammotropin hormone-like 1 OS=Homo sapiens GN=CSHL1 PE=1 SV=2 | 141 | D | 0.547539 | E | 0.550093 | -0.002554 | No Change: Both D | - |
| P41240 | CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1 | 287 | G | 0.270696 | D | 0.290884 | -0.020188 | No Change: Both O | - |
| P41240 | CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1 | 398 | R | 0.367852 | Q | 0.38514 | -0.017288 | No Change: Both O | - |
| P41240 | CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1 | 442 | H | 0.534918 | R | 0.526297 | 0.008621 | No Change: Both D | - |
| P41240 | CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens GN=CSK PE=1 SV=1 | 45 | P | 0.289075 | L | 0.164111 | 0.124964 | No Change: Both O | - |
| Q96PZ7 | CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens GN=CSMD1 PE=1 SV=2 | 3312 | G | 0.382889 | W | 0.179461 | 0.203428 | No Change: Both O | - |
| Q96PZ7 | CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens GN=CSMD1 PE=1 SV=2 | 2041 | M | 0.452504 | I | 0.374683 | 0.077821 | No Change: Both O | - |
| Q96PZ7 | CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens GN=CSMD1 PE=1 SV=2 | 3370 | Q | 0.262983 | H | 0.254772 | 0.008211 | No Change: Both O | - |
| Q96PZ7 | CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens GN=CSMD1 PE=1 SV=2 | 3479 | S | 0.837784 | N | 0.82004 | 0.017744 | No Change: Both D | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 538 | H | 0.501568 | R | 0.524523 | -0.022955 | No Change: Both D | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 167 | L | 0.102455 | P | 0.182557 | -0.080102 | No Change: Both O | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 2096 | R | 0.548517 | K | 0.57206 | -0.023543 | No Change: Both D | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 2117 | A | 0.304633 | V | 0.240111 | 0.064522 | No Change: Both O | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 2554 | M | 0.346914 | V | 0.298631 | 0.048283 | No Change: Both O | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 2661 | L | 0.301694 | R | 0.441366 | -0.139672 | No Change: Both O | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 3406 | S | 0.65958 | F | 0.405871 | 0.253709 | D to O | - |
| Q7Z408 | CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens GN=CSMD2 PE=1 SV=2 | 2661 | L | 0.301694 | V | 0.30178 | -8.60E-05 | No Change: Both O | - |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 219 | I | 0.191824 | M | 0.267275 | -0.075451 | No Change: Both O | - |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 3000 | V | 0.374975 | L | 0.372472 | 0.002503 | No Change: Both O | - |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 3621 | N | 0.898871 | H | 0.903206 | -0.004335 | No Change: Both D | - |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 322 | W | 0.156127 | G | 0.323777 | -0.16765 | No Change: Both O | A colorectal cancer sample |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 3079 | R | 0.450613 | H | 0.404353 | 0.04626 | No Change: Both O | A colorectal cancer sample |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 3359 | R | 0.753883 | Q | 0.796722 | -0.042839 | No Change: Both D | A colorectal cancer sample |
| Q7Z407 | CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens GN=CSMD3 PE=2 SV=3 | 2020 | S | 0.456526 | C | 0.213444 | 0.243082 | No Change: Both O | - |
| P47710 | CASA1_HUMAN Alpha-S1-casein OS=Homo sapiens GN=CSN1S1 PE=1 SV=1 | 117 | A | 0.677846 | V | 0.590015 | 0.087831 | No Change: Both D | - |
| P07498 | CASK_HUMAN Kappa-casein OS=Homo sapiens GN=CSN3 PE=1 SV=3 | 75 | Y | 0.376225 | C | 0.349137 | 0.027088 | No Change: Both O | - |
| P07498 | CASK_HUMAN Kappa-casein OS=Homo sapiens GN=CSN3 PE=1 SV=3 | 110 | R | 0.643035 | L | 0.502674 | 0.140361 | No Change: Both D | - |
| P07498 | CASK_HUMAN Kappa-casein OS=Homo sapiens GN=CSN3 PE=1 SV=3 | 145 | A | 0.855952 | T | 0.881131 | -0.025179 | No Change: Both D | - |
| P48729 | KC1A_HUMAN Casein kinase I isoform alpha OS=Homo sapiens GN=CSNK1A1 PE=1 SV=2 | 297 | D | 0.243121 | H | 0.204829 | 0.038292 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 170 | R | 0.516446 | S | 0.55873 | -0.042284 | No Change: Both D | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 21 | R | 0.363387 | Q | 0.377302 | -0.013915 | No Change: Both O | A colorectal cancer sample |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 5 | S | 0.842121 | G | 0.819294 | 0.022827 | No Change: Both D | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 21 | R | 0.363387 | W | 0.188187 | 0.1752 | No Change: Both O | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 42 | D | 0.428222 | E | 0.47502 | -0.046798 | No Change: Both O | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 177 | E | 0.425566 | K | 0.440971 | -0.015405 | No Change: Both O | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 220 | P | 0.228656 | L | 0.136858 | 0.091798 | No Change: Both O | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 230 | K | 0.581587 | N | 0.525929 | 0.055658 | No Change: Both D | - |
| Q8N752 | KC1AL_HUMAN Casein kinase I isoform alpha-like OS=Homo sapiens GN=CSNK1A1L PE=2 SV=2 | 257 | A | 0.094109 | T | 0.105658 | -0.011549 | No Change: Both O | - |
| P48730 | KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | 44 | T | 0.361993 | A | 0.338645 | 0.023348 | No Change: Both O | Familial advanced sleep-phase syndrome (FASPS) [MIM:604348] |
| P48730 | KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | 97 | S | 0.161503 | C | 0.05698 | 0.104523 | No Change: Both O | Breast cancer samples |
| P48730 | KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | 401 | P | 0.91172 | A | 0.877908 | 0.033812 | No Change: Both D | - |
| P49674 | KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | 256 | R | 0.193743 | L | 0.119 | 0.074743 | No Change: Both O | A lung adenocarcinoma sample |
| P49674 | KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | 413 | H | 0.74482 | R | 0.814068 | -0.069248 | No Change: Both D | - |
| Q9HCP0 | KC1G1_HUMAN Casein kinase I isoform gamma-1 OS=Homo sapiens GN=CSNK1G1 PE=1 SV=1 | 206 | R | 0.551088 | K | 0.604338 | -0.05325 | No Change: Both D | - |
| Q9HCP0 | KC1G1_HUMAN Casein kinase I isoform gamma-1 OS=Homo sapiens GN=CSNK1G1 PE=1 SV=1 | 329 | V | 0.131807 | I | 0.120019 | 0.011788 | No Change: Both O | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 189 | F | 0.130126 | L | 0.156939 | -0.026813 | No Change: Both O | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 194 | E | 0.292704 | G | 0.250778 | 0.041926 | No Change: Both O | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 196 | I | 0.420334 | T | 0.547468 | -0.127134 | O to D | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 206 | Y | 0.540737 | C | 0.525494 | 0.015243 | No Change: Both D | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 206 | Y | 0.540737 | H | 0.630896 | -0.090159 | No Change: Both D | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 207 | R | 0.545943 | S | 0.59295 | -0.047007 | No Change: Both D | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 208 | E | 0.555703 | Q | 0.518297 | 0.037406 | No Change: Both D | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 217 | R | 0.384228 | C | 0.22628 | 0.157948 | No Change: Both O | - |
| P78368 | KC1G2_HUMAN Casein kinase I isoform gamma-2 OS=Homo sapiens GN=CSNK1G2 PE=1 SV=1 | 223 | T | 0.429225 | M | 0.406334 | 0.022891 | No Change: Both O | - |
| P19784 | CSK22_HUMAN Casein kinase II subunit alpha' OS=Homo sapiens GN=CSNK2A2 PE=1 SV=1 | 188 | E | 0.344315 | A | 0.248752 | 0.095563 | No Change: Both O | - |
| Q6UVK1 | CSPG4_HUMAN Chondroitin sulfate proteoglycan 4 OS=Homo sapiens GN=CSPG4 PE=1 SV=2 | 1703 | R | 0.33884 | H | 0.349816 | -0.010976 | No Change: Both O | - |
| Q96PW8 | K1920_HUMAN Uncharacterized protein KIAA1920 OS=Homo sapiens GN=CSPG4P5 PE=5 SV=2 | 431 | V | 0.263575 | I | 0.232224 | 0.031351 | No Change: Both O | - |
| O95196 | CSPG5_HUMAN Chondroitin sulfate proteoglycan 5 OS=Homo sapiens GN=CSPG5 PE=1 SV=3 | 188 | G | 0.769285 | V | 0.673556 | 0.095729 | No Change: Both D | - |
| O95196 | CSPG5_HUMAN Chondroitin sulfate proteoglycan 5 OS=Homo sapiens GN=CSPG5 PE=1 SV=3 | 417 | T | 0.083412 | P | 0.105354 | -0.021942 | No Change: Both O | - |
| Q1MSJ5 | CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 OS=Homo sapiens GN=CSPP1 PE=1 SV=4 | 907 | R | 0.897452 | H | 0.875772 | 0.02168 | No Change: Both D | - |
| Q1MSJ5 | CSPP1_HUMAN Centrosome and spindle pole-associated protein 1 OS=Homo sapiens GN=CSPP1 PE=1 SV=4 | 1135 | W | 0.775109 | R | 0.90444 | -0.129331 | No Change: Both D | - |
| Q96S65 | CSRN1_HUMAN Cysteine/serine-rich nuclear protein 1 OS=Homo sapiens GN=CSRNP1 PE=2 SV=2 | 453 | V | 0.430556 | I | 0.411408 | 0.019148 | No Change: Both O | - |
| Q9H175 | CSRN2_HUMAN Cysteine/serine-rich nuclear protein 2 OS=Homo sapiens GN=CSRNP2 PE=2 SV=1 | 436 | T | 0.744459 | M | 0.734102 | 0.010357 | No Change: Both D | - |
| Q8WYN3 | CSRN3_HUMAN Cysteine/serine-rich nuclear protein 3 OS=Homo sapiens GN=CSRNP3 PE=1 SV=1 | 474 | P | 0.299437 | L | 0.165639 | 0.133798 | No Change: Both O | A colorectal cancer sample |
| P21291 | CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Homo sapiens GN=CSRP1 PE=1 SV=3 | 108 | K | 0.727875 | I | 0.566084 | 0.161791 | No Change: Both D | - |
| Q9H8E8 | CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens GN=CSRP2BP PE=1 SV=3 | 442 | R | 0.981643 | T | 0.979663 | 0.00198 | No Change: Both D | - |
| Q9H8E8 | CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens GN=CSRP2BP PE=1 SV=3 | 214 | P | 0.761282 | L | 0.67548 | 0.085802 | No Change: Both D | - |
| Q9H8E8 | CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens GN=CSRP2BP PE=1 SV=3 | 400 | V | 0.907574 | G | 0.929185 | -0.021611 | No Change: Both D | - |
| Q9H8E8 | CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens GN=CSRP2BP PE=1 SV=3 | 600 | P | 0.373187 | R | 0.350787 | 0.0224 | No Change: Both O | - |
| Q9H8E8 | CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens GN=CSRP2BP PE=1 SV=3 | 738 | A | 0.392322 | S | 0.52974 | -0.137418 | O to D | - |
| P50461 | CSRP3_HUMAN Cysteine and glycine-rich protein 3 OS=Homo sapiens GN=CSRP3 PE=1 SV=1 | 4 | W | 0.636933 | R | 0.689379 | -0.052446 | No Change: Both D | Cardiomyopathy dilated type 1M (CMD1M) [MIM:607482] |
| P50461 | CSRP3_HUMAN Cysteine and glycine-rich protein 3 OS=Homo sapiens GN=CSRP3 PE=1 SV=1 | 44 | L | 0.326812 | P | 0.474831 | -0.148019 | No Change: Both O | Familial hypertrophic cardiomyopathy type 12 (CMH12) [MIM:612124] |
| P50461 | CSRP3_HUMAN Cysteine and glycine-rich protein 3 OS=Homo sapiens GN=CSRP3 PE=1 SV=1 | 58 | C | 0.147053 | G | 0.257289 | -0.110236 | No Change: Both O | Familial hypertrophic cardiomyopathy type 12 (CMH12) [MIM:612124] |
| P01037 | CYTN_HUMAN Cystatin-SN OS=Homo sapiens GN=CST1 PE=1 SV=3 | 4 | Y | 0.53302 | H | 0.66884 | -0.13582 | No Change: Both D | - |
| P01037 | CYTN_HUMAN Cystatin-SN OS=Homo sapiens GN=CST1 PE=1 SV=3 | 31 | P | 0.267848 | L | 0.142332 | 0.125516 | No Change: Both O | - |
| P01037 | CYTN_HUMAN Cystatin-SN OS=Homo sapiens GN=CST1 PE=1 SV=3 | 129 | N | 0.551248 | D | 0.567137 | -0.015889 | No Change: Both D | - |
| P01037 | CYTN_HUMAN Cystatin-SN OS=Homo sapiens GN=CST1 PE=1 SV=3 | 131 | R | 0.556712 | M | 0.437002 | 0.11971 | D to O | - |
| P01037 | CYTN_HUMAN Cystatin-SN OS=Homo sapiens GN=CST1 PE=1 SV=3 | 135 | K | 0.704666 | N | 0.676363 | 0.028303 | No Change: Both D | - |
| P01034 | CYTC_HUMAN Cystatin-C OS=Homo sapiens GN=CST3 PE=1 SV=1 | 94 | L | 0.170114 | Q | 0.268773 | -0.098659 | No Change: Both O | Amyloidosis type 6 (AMYL6) [MIM:105150] |
| P01034 | CYTC_HUMAN Cystatin-C OS=Homo sapiens GN=CST3 PE=1 SV=1 | 25 | A | 0.77926 | T | 0.743082 | 0.036178 | No Change: Both D | - |
| P01036 | CYTS_HUMAN Cystatin-S OS=Homo sapiens GN=CST4 PE=1 SV=3 | 77 | T | 0.240158 | N | 0.28757 | -0.047412 | No Change: Both O | A breast cancer sample |
| P01036 | CYTS_HUMAN Cystatin-S OS=Homo sapiens GN=CST4 PE=1 SV=3 | 36 | D | 0.188199 | N | 0.1741 | 0.014099 | No Change: Both O | - |
| P28325 | CYTD_HUMAN Cystatin-D OS=Homo sapiens GN=CST5 PE=1 SV=1 | 46 | C | 0.151211 | R | 0.273424 | -0.122213 | No Change: Both O | - |
| O60676 | CST8_HUMAN Cystatin-8 OS=Homo sapiens GN=CST8 PE=1 SV=1 | 142 | A | 0.712425 | P | 0.647422 | 0.065003 | No Change: Both D | - |
| O60676 | CST8_HUMAN Cystatin-8 OS=Homo sapiens GN=CST8 PE=1 SV=1 | 52 | A | 0.141178 | V | 0.111218 | 0.02996 | No Change: Both O | - |
| Q5W186 | CST9_HUMAN Cystatin-9 OS=Homo sapiens GN=CST9 PE=2 SV=1 | 48 | L | 0.082541 | F | 0.077079 | 0.005462 | No Change: Both O | - |
| Q9H4G1 | CST9L_HUMAN Cystatin-9-like OS=Homo sapiens GN=CST9L PE=1 SV=1 | 109 | H | 0.371979 | P | 0.437325 | -0.065346 | No Change: Both O | - |
| P01040 | CYTA_HUMAN Cystatin-A OS=Homo sapiens GN=CSTA PE=1 SV=1 | 96 | T | 0.791414 | M | 0.7905 | 9.14E-04 | No Change: Both D | - |
| P04080 | CYTB_HUMAN Cystatin-B OS=Homo sapiens GN=CSTB PE=1 SV=2 | 4 | G | 0.837696 | R | 0.886777 | -0.049081 | No Change: Both D | Progressive myoclonic epilepsy type 1 (EPM1) [MIM:254800] |
| Q9H114 | CST1L_HUMAN Cystatin-like 1 OS=Homo sapiens GN=CSTL1 PE=2 SV=2 | 88 | W | 0.213212 | R | 0.437146 | -0.223934 | No Change: Both O | - |
| Q9H114 | CST1L_HUMAN Cystatin-like 1 OS=Homo sapiens GN=CSTL1 PE=2 SV=2 | 96 | T | 0.65867 | M | 0.615402 | 0.043268 | No Change: Both D | - |
| Q9H114 | CST1L_HUMAN Cystatin-like 1 OS=Homo sapiens GN=CSTL1 PE=2 SV=2 | 59 | T | 0.31997 | A | 0.306856 | 0.013114 | No Change: Both O | - |
| Q9H114 | CST1L_HUMAN Cystatin-like 1 OS=Homo sapiens GN=CSTL1 PE=2 SV=2 | 62 | Y | 0.16747 | F | 0.142553 | 0.024917 | No Change: Both O | - |
| Q9H114 | CST1L_HUMAN Cystatin-like 1 OS=Homo sapiens GN=CSTL1 PE=2 SV=2 | 66 | R | 0.177305 | K | 0.205714 | -0.028409 | No Change: Both O | - |
| O75638 | CTAG2_HUMAN Cancer/testis antigen 2 OS=Homo sapiens GN=CTAG2 PE=2 SV=2 | 6 | Q | 0.994096 | R | 0.992487 | 0.001609 | No Change: Both D | - |
| O75638 | CTAG2_HUMAN Cancer/testis antigen 2 OS=Homo sapiens GN=CTAG2 PE=2 SV=2 | 89 | Q | 0.792408 | E | 0.813783 | -0.021375 | No Change: Both D | - |
| O75638 | CTAG2_HUMAN Cancer/testis antigen 2 OS=Homo sapiens GN=CTAG2 PE=2 SV=2 | 99 | P | 0.651814 | A | 0.567247 | 0.084567 | No Change: Both D | - |
| Q96RT6 | CTGE2_HUMAN Protein cTAGE-2 OS=Homo sapiens GN=CTAGE1 PE=1 SV=2 | 682 | I | 0.938458 | V | 0.946816 | -0.008358 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 6 | V | 0.701706 | A | 0.745133 | -0.043427 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 11 | Y | 0.372912 | D | 0.566642 | -0.19373 | O to D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 205 | K | 0.75588 | N | 0.720405 | 0.035475 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 250 | K | 0.676004 | E | 0.681484 | -0.00548 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 360 | E | 0.876515 | Q | 0.868388 | 0.008127 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 375 | N | 0.930459 | S | 0.932224 | -0.001765 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 699 | I | 0.906629 | V | 0.929568 | -0.022939 | No Change: Both D | - |
| O15320 | CTGE5_HUMAN Cutaneous T-cell lymphoma-associated antigen 5 OS=Homo sapiens GN=CTAGE5 PE=1 SV=4 | 738 | G | 0.989418 | R | 0.990936 | -0.001518 | No Change: Both D | - |
| P56545 | CTBP2_HUMAN C-terminal-binding protein 2 OS=Homo sapiens GN=CTBP2 PE=1 SV=1 | 47 | E | 0.181445 | D | 0.182124 | -6.79E-04 | No Change: Both O | - |
| Q01459 | DIAC_HUMAN Di-N-acetylchitobiase OS=Homo sapiens GN=CTBS PE=1 SV=1 | 310 | D | 0.356836 | Y | 0.232205 | 0.124631 | No Change: Both O | - |
| Q01459 | DIAC_HUMAN Di-N-acetylchitobiase OS=Homo sapiens GN=CTBS PE=1 SV=1 | 274 | V | 0.156299 | I | 0.140485 | 0.015814 | No Change: Both O | - |
| Q2NKJ3 | CTC1_HUMAN CST complex subunit CTC1 OS=Homo sapiens GN=CTC1 PE=1 SV=2 | 820 | I | 0.219947 | V | 0.257725 | -0.037778 | No Change: Both O | - |
| Q2NKJ3 | CTC1_HUMAN CST complex subunit CTC1 OS=Homo sapiens GN=CTC1 PE=1 SV=2 | 1005 | I | 0.262623 | V | 0.271522 | -0.008899 | No Change: Both O | - |
| P49711 | CTCF_HUMAN Transcriptional repressor CTCF OS=Homo sapiens GN=CTCF PE=1 SV=1 | 339 | R | 0.545344 | W | 0.29509 | 0.250254 | D to O | A Wilms' tumor |
| P49711 | CTCF_HUMAN Transcriptional repressor CTCF OS=Homo sapiens GN=CTCF PE=1 SV=1 | 344 | K | 0.616044 | E | 0.614076 | 0.001968 | No Change: Both D | A breast tumor |
| P49711 | CTCF_HUMAN Transcriptional repressor CTCF OS=Homo sapiens GN=CTCF PE=1 SV=1 | 345 | H | 0.621695 | R | 0.650058 | -0.028363 | No Change: Both D | A prostate tumor |
| P49711 | CTCF_HUMAN Transcriptional repressor CTCF OS=Homo sapiens GN=CTCF PE=1 SV=1 | 448 | R | 0.289211 | Q | 0.301362 | -0.012151 | No Change: Both O | A Wilms' tumor |
| Q8NI51 | CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens GN=CTCFL PE=1 SV=2 | 50 | E | 0.918684 | Q | 0.897414 | 0.02127 | No Change: Both D | - |
| Q8NI51 | CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens GN=CTCFL PE=1 SV=2 | 177 | T | 0.592244 | A | 0.57483 | 0.017414 | No Change: Both D | - |
| Q8NI51 | CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens GN=CTCFL PE=1 SV=2 | 525 | Q | 0.279855 | E | 0.294291 | -0.014436 | No Change: Both O | - |
| Q8NI51 | CTCFL_HUMAN Transcriptional repressor CTCFL OS=Homo sapiens GN=CTCFL PE=1 SV=2 | 448 | R | 0.309012 | H | 0.317143 | -0.008131 | No Change: Both O | - |
| O95476 | CNEP1_HUMAN CTD nuclear envelope phosphatase 1 OS=Homo sapiens GN=CTDNEP1 PE=1 SV=2 | 12 | T | 0.041487 | A | 0.038994 | 0.002493 | No Change: Both O | - |
| Q9Y5B0 | CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens GN=CTDP1 PE=1 SV=3 | 340 | T | 0.787425 | M | 0.784843 | 0.002582 | No Change: Both D | - |
| Q9Y5B0 | CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens GN=CTDP1 PE=1 SV=3 | 755 | L | 0.595371 | S | 0.730141 | -0.13477 | No Change: Both D | - |
| Q9Y5B0 | CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens GN=CTDP1 PE=1 SV=3 | 282 | S | 0.356725 | F | 0.176999 | 0.179726 | No Change: Both O | - |
| Q9Y5B0 | CTDP1_HUMAN RNA polymerase II subunit A C-terminal domain phosphatase OS=Homo sapiens GN=CTDP1 PE=1 SV=3 | 519 | P | 0.989624 | H | 0.984203 | 0.005421 | No Change: Both D | - |
| Q9GZU7 | CTDS1_HUMAN Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 OS=Homo sapiens GN=CTDSP1 PE=1 SV=1 | 56 | A | 0.485473 | T | 0.47839 | 0.007083 | No Change: Both O | - |
| O15194 | CTDSL_HUMAN CTD small phosphatase-like protein OS=Homo sapiens GN=CTDSPL PE=1 SV=2 | 121 | S | 0.422781 | P | 0.382762 | 0.040019 | No Change: Both O | - |
| O15194 | CTDSL_HUMAN CTD small phosphatase-like protein OS=Homo sapiens GN=CTDSPL PE=1 SV=2 | 127 | N | 0.293444 | S | 0.350872 | -0.057428 | No Change: Both O | - |
| O15194 | CTDSL_HUMAN CTD small phosphatase-like protein OS=Homo sapiens GN=CTDSPL PE=1 SV=2 | 132 | V | 0.12043 | G | 0.206317 | -0.085887 | No Change: Both O | - |
| Q05D32 | CTSL2_HUMAN CTD small phosphatase-like protein 2 OS=Homo sapiens GN=CTDSPL2 PE=1 SV=2 | 244 | A | 0.555577 | V | 0.486856 | 0.068721 | D to O | - |
| Q16619 | CTF1_HUMAN Cardiotrophin-1 OS=Homo sapiens GN=CTF1 PE=1 SV=1 | 92 | A | 0.827783 | T | 0.786296 | 0.041487 | No Change: Both D | - |
| P29279 | CTGF_HUMAN Connective tissue growth factor OS=Homo sapiens GN=CTGF PE=1 SV=2 | 83 | H | 0.309369 | D | 0.365044 | -0.055675 | No Change: Both O | - |
| P32929 | CGL_HUMAN Cystathionine gamma-lyase OS=Homo sapiens GN=CTH PE=1 SV=3 | 67 | T | 0.517378 | I | 0.376548 | 0.14083 | D to O | Cystathioninuria (CSTNU) [MIM:219500] |
| P32929 | CGL_HUMAN Cystathionine gamma-lyase OS=Homo sapiens GN=CTH PE=1 SV=3 | 240 | Q | 0.28994 | E | 0.333056 | -0.043116 | No Change: Both O | Cystathioninuria (CSTNU) [MIM:219500] |
| P32929 | CGL_HUMAN Cystathionine gamma-lyase OS=Homo sapiens GN=CTH PE=1 SV=3 | 403 | S | 0.906442 | I | 0.861757 | 0.044685 | No Change: Both D | - |
| Q96CG8 | CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens GN=CTHRC1 PE=1 SV=1 | 44 | Q | 0.583994 | P | 0.607098 | -0.023104 | No Change: Both D | - |
| O43310 | CTIF_HUMAN CBP80/20-dependent translation initiation factor OS=Homo sapiens GN=CTIF PE=1 SV=1 | 82 | P | 0.825706 | L | 0.744463 | 0.081243 | No Change: Both D | - |
| O43310 | CTIF_HUMAN CBP80/20-dependent translation initiation factor OS=Homo sapiens GN=CTIF PE=1 SV=1 | 389 | V | 0.781884 | L | 0.802342 | -0.020458 | No Change: Both D | A breast cancer sample |
| O43310 | CTIF_HUMAN CBP80/20-dependent translation initiation factor OS=Homo sapiens GN=CTIF PE=1 SV=1 | 438 | M | 0.146897 | I | 0.086353 | 0.060544 | No Change: Both O | A breast cancer sample |
| P16410 | CTLA4_HUMAN Cytotoxic T-lymphocyte protein 4 OS=Homo sapiens GN=CTLA4 PE=1 SV=3 | 17 | T | 0.139597 | A | 0.122761 | 0.016836 | No Change: Both O | - |
| P35221 | CTNA1_HUMAN Catenin alpha-1 OS=Homo sapiens GN=CTNNA1 PE=1 SV=1 | 179 | A | 0.392081 | V | 0.326812 | 0.065269 | No Change: Both O | - |
| P35221 | CTNA1_HUMAN Catenin alpha-1 OS=Homo sapiens GN=CTNNA1 PE=1 SV=1 | 219 | P | 0.158376 | S | 0.174697 | -0.016321 | No Change: Both O | - |
| Q9UI47 | CTNA3_HUMAN Catenin alpha-3 OS=Homo sapiens GN=CTNNA3 PE=1 SV=2 | 596 | S | 0.51783 | N | 0.466768 | 0.051062 | D to O | - |
| Q9UI47 | CTNA3_HUMAN Catenin alpha-3 OS=Homo sapiens GN=CTNNA3 PE=1 SV=2 | 535 | R | 0.467038 | C | 0.279836 | 0.187202 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 91 | N | 0.260539 | T | 0.216309 | 0.04423 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 203 | E | 0.45006 | K | 0.445516 | 0.004544 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 527 | E | 0.418425 | Q | 0.362963 | 0.055462 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 593 | I | 0.401257 | N | 0.572444 | -0.171187 | O to D | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 716 | M | 0.36194 | R | 0.390242 | -0.028302 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 424 | T | 0.284829 | S | 0.351435 | -0.066606 | No Change: Both O | - |
| Q9UBT7 | CTNL1_HUMAN Alpha-catulin OS=Homo sapiens GN=CTNNAL1 PE=1 SV=2 | 555 | D | 0.90013 | E | 0.910301 | -0.010171 | No Change: Both D | - |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 23 | S | 0.579806 | R | 0.521984 | 0.057822 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 32 | D | 0.623545 | A | 0.574182 | 0.049363 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 32 | D | 0.623545 | G | 0.602624 | 0.020921 | No Change: Both D | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 32 | D | 0.623545 | Y | 0.473529 | 0.150016 | D to O | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 33 | S | 0.619847 | F | 0.377951 | 0.241896 | D to O | Medulloblastoma (MDB) [MIM:155255] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 33 | S | 0.619847 | F | 0.377951 | 0.241896 | D to O | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 33 | S | 0.619847 | L | 0.450083 | 0.169764 | D to O | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 33 | S | 0.619847 | Y | 0.417944 | 0.201903 | D to O | Colorectal cancer (CRC) [MIM:114500] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 33 | S | 0.619847 | Y | 0.417944 | 0.201903 | D to O | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 34 | G | 0.616885 | E | 0.665328 | -0.048443 | No Change: Both D | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 34 | G | 0.616885 | R | 0.611127 | 0.005758 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 34 | G | 0.616885 | V | 0.491786 | 0.125099 | D to O | - |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 35 | I | 0.617212 | S | 0.809188 | -0.191976 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 37 | S | 0.62775 | A | 0.520358 | 0.107392 | No Change: Both D | Medulloblastoma (MDB) [MIM:155255] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 37 | S | 0.62775 | C | 0.399087 | 0.228663 | D to O | Ovarian cancer (OC) [MIM:167000] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 37 | S | 0.62775 | C | 0.399087 | 0.228663 | D to O | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 37 | S | 0.62775 | F | 0.373592 | 0.254158 | D to O | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 37 | S | 0.62775 | Y | 0.41581 | 0.21194 | D to O | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 41 | T | 0.688274 | A | 0.663153 | 0.025121 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 41 | T | 0.688274 | I | 0.560141 | 0.128133 | No Change: Both D | Ovarian cancer (OC) [MIM:167000] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 41 | T | 0.688274 | I | 0.560141 | 0.128133 | No Change: Both D | Pilomatrixoma (PTR) [MIM:132600] |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 45 | S | 0.728155 | F | 0.537321 | 0.190834 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 45 | S | 0.728155 | P | 0.71502 | 0.013135 | No Change: Both D | Hepatocellular carcinoma |
| P35222 | CTNB1_HUMAN Catenin beta-1 OS=Homo sapiens GN=CTNNB1 PE=1 SV=1 | 688 | M | 0.361554 | V | 0.291037 | 0.070517 | No Change: Both O | - |
| Q8WYA6 | CTBL1_HUMAN Beta-catenin-like protein 1 OS=Homo sapiens GN=CTNNBL1 PE=1 SV=1 | 507 | N | 0.194293 | D | 0.194649 | -3.56E-04 | No Change: Both O | - |
| O60716 | CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=1 | 217 | Y | 0.703653 | C | 0.688457 | 0.015196 | No Change: Both D | - |
| O60716 | CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=1 | 464 | R | 0.310554 | C | 0.159057 | 0.151497 | No Change: Both O | - |
| O60716 | CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=1 | 915 | R | 0.95399 | K | 0.953857 | 1.33E-04 | No Change: Both D | - |
| O60716 | CTND1_HUMAN Catenin delta-1 OS=Homo sapiens GN=CTNND1 PE=1 SV=1 | 171 | S | 0.478897 | F | 0.273898 | 0.204999 | No Change: Both O | - |
| Q9UQB3 | CTND2_HUMAN Catenin delta-2 OS=Homo sapiens GN=CTNND2 PE=1 SV=3 | 1159 | P | 0.784393 | S | 0.787209 | -0.002816 | No Change: Both D | A colorectal cancer sample |
| Q9UQB3 | CTND2_HUMAN Catenin delta-2 OS=Homo sapiens GN=CTNND2 PE=1 SV=3 | 275 | G | 0.984155 | C | 0.976587 | 0.007568 | No Change: Both D | - |
| Q9UQB3 | CTND2_HUMAN Catenin delta-2 OS=Homo sapiens GN=CTNND2 PE=1 SV=3 | 482 | A | 0.805046 | T | 0.805893 | -8.47E-04 | No Change: Both D | - |
| Q9UQB3 | CTND2_HUMAN Catenin delta-2 OS=Homo sapiens GN=CTNND2 PE=1 SV=3 | 810 | G | 0.928823 | R | 0.914416 | 0.014407 | No Change: Both D | - |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 42 | V | 0.553394 | I | 0.521214 | 0.03218 | No Change: Both D | - |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 169 | G | 0.054547 | D | 0.064152 | -0.009605 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 280 | K | 0.072503 | R | 0.051046 | 0.021457 | No Change: Both O | Cystinosis late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 323 | N | 0.181896 | K | 0.201195 | -0.019299 | No Change: Both O | Cystinosis late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 133 | I | 0.008665 | F | 0.008404 | 2.61E-04 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 139 | S | 0.024491 | F | 0.008672 | 0.015819 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 158 | L | 0.097972 | P | 0.190917 | -0.092945 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 182 | W | 0.019955 | R | 0.053058 | -0.033103 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 197 | G | 0.398531 | R | 0.38313 | 0.015401 | No Change: Both O | Cystinosis adult non-nephropathic type (CTNSANN) [MIM:219750] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 205 | D | 0.325563 | N | 0.334551 | -0.008988 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 305 | D | 0.156448 | G | 0.155286 | 0.001162 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 305 | D | 0.156448 | Y | 0.079042 | 0.077406 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 308 | G | 0.200709 | R | 0.177611 | 0.023098 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 338 | L | 0.108323 | P | 0.224924 | -0.116601 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 339 | G | 0.086566 | R | 0.074875 | 0.011691 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 346 | D | 0.019802 | N | 0.018241 | 0.001561 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 292 | K | 0.246894 | R | 0.192878 | 0.054016 | No Change: Both O | - |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 298 | S | 0.172901 | N | 0.145674 | 0.027227 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 110 | G | 0.477838 | V | 0.336493 | 0.141345 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 177 | N | 0.02244 | T | 0.018922 | 0.003518 | No Change: Both O | Cystinosis late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 200 | P | 0.482229 | L | 0.285438 | 0.196791 | No Change: Both O | Cystinosis late-onset juvenile or adolescent nephropathic type (CTNSJAN) [MIM:219900] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 222 | Q | 0.01251 | R | 0.011879 | 6.31E-04 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 288 | N | 0.140243 | K | 0.179751 | -0.039508 | No Change: Both O | Cystinosis nephropathic type (CTNS) [MIM:219800] |
| O60931 | CTNS_HUMAN Cystinosin OS=Homo sapiens GN=CTNS PE=1 SV=2 | 260 | T | 0.026955 | I | 0.013218 | 0.013737 | No Change: Both O | - |
| P17812 | PYRG1_HUMAN CTP synthase 1 OS=Homo sapiens GN=CTPS PE=1 SV=2 | 571 | S | 0.91025 | I | 0.821975 | 0.088275 | No Change: Both D | - |
| P17538 | CTRB1_HUMAN Chymotrypsinogen B OS=Homo sapiens GN=CTRB1 PE=2 SV=1 | 250 | T | 0.090331 | A | 0.084803 | 0.005528 | No Change: Both O | - |
| P17538 | CTRB1_HUMAN Chymotrypsinogen B OS=Homo sapiens GN=CTRB1 PE=2 SV=1 | 222 | D | 0.235148 | H | 0.180472 | 0.054676 | No Change: Both O | - |
| Q6GPI1 | CTRB2_HUMAN Chymotrypsinogen B2 OS=Homo sapiens GN=CTRB2 PE=2 SV=2 | 250 | A | 0.071725 | T | 0.077671 | -0.005946 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 80 | R | 0.234972 | W | 0.096152 | 0.13882 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 35 | D | 0.544758 | H | 0.527393 | 0.017365 | No Change: Both D | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 35 | D | 0.544758 | N | 0.52984 | 0.014918 | No Change: Both D | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 37 | R | 0.420556 | Q | 0.443164 | -0.022608 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 48 | Q | 0.124927 | R | 0.112502 | 0.012425 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 73 | A | 0.11222 | T | 0.129971 | -0.017751 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 172 | K | 0.373087 | E | 0.375143 | -0.002056 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 217 | G | 0.4466 | R | 0.412623 | 0.033977 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 217 | G | 0.4466 | S | 0.490986 | -0.044386 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 218 | G | 0.463742 | S | 0.508375 | -0.044633 | O to D | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 220 | L | 0.431235 | R | 0.525924 | -0.094689 | O to D | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 225 | E | 0.283777 | A | 0.192008 | 0.091769 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 235 | V | 0.166324 | I | 0.147194 | 0.01913 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 249 | P | 0.399026 | L | 0.241675 | 0.157351 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 254 | R | 0.103185 | W | 0.039807 | 0.063378 | No Change: Both O | - |
| Q99895 | CTRC_HUMAN Chymotrypsin-C OS=Homo sapiens GN=CTRC PE=1 SV=2 | 260 | D | 0.092772 | N | 0.093387 | -6.15E-04 | No Change: Both O | - |
| P40313 | CTRL_HUMAN Chymotrypsin-like protease CTRL-1 OS=Homo sapiens GN=CTRL PE=2 SV=1 | 173 | H | 0.264462 | R | 0.266506 | -0.002044 | No Change: Both O | - |
| P40313 | CTRL_HUMAN Chymotrypsin-like protease CTRL-1 OS=Homo sapiens GN=CTRL PE=2 SV=1 | 150 | T | 0.385268 | I | 0.234627 | 0.150641 | No Change: Both O | - |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 49 | Q | 0.472742 | R | 0.453977 | 0.018765 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 65 | W | 0.252891 | R | 0.464583 | -0.211692 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 90 | S | 0.461038 | L | 0.272715 | 0.188323 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 249 | Y | 0.267657 | N | 0.451026 | -0.183369 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 395 | Y | 0.125717 | C | 0.110613 | 0.015104 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 440 | F | 0.283411 | V | 0.312477 | -0.029066 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 51 | S | 0.519557 | Y | 0.33751 | 0.182047 | D to O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 132 | V | 0.373355 | M | 0.44049 | -0.067135 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 236 | L | 0.233021 | P | 0.369166 | -0.136145 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 406 | M | 0.111681 | T | 0.119321 | -0.00764 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 439 | G | 0.290053 | S | 0.343689 | -0.053636 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P10619 | PPGB_HUMAN Lysosomal protective protein OS=Homo sapiens GN=CTSA PE=1 SV=2 | 453 | K | 0.216023 | E | 0.216374 | -3.51E-04 | No Change: Both O | Galactosialidosis (GSL) [MIM:256540] |
| P07858 | CATB_HUMAN Cathepsin B OS=Homo sapiens GN=CTSB PE=1 SV=3 | 26 | L | 0.50352 | V | 0.509806 | -0.006286 | No Change: Both D | - |
| P07858 | CATB_HUMAN Cathepsin B OS=Homo sapiens GN=CTSB PE=1 SV=3 | 235 | S | 0.589643 | N | 0.558889 | 0.030754 | No Change: Both D | - |
| P07858 | CATB_HUMAN Cathepsin B OS=Homo sapiens GN=CTSB PE=1 SV=3 | 53 | S | 0.141218 | G | 0.121419 | 0.019799 | No Change: Both O | - |
| P07858 | CATB_HUMAN Cathepsin B OS=Homo sapiens GN=CTSB PE=1 SV=3 | 91 | P | 0.357076 | L | 0.195443 | 0.161633 | No Change: Both O | - |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 249 | V | 0.318384 | F | 0.290152 | 0.028232 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 252 | Q | 0.380373 | L | 0.242176 | 0.138197 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 272 | R | 0.27546 | P | 0.309796 | -0.034336 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 301 | G | 0.188124 | S | 0.216054 | -0.02793 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 339 | R | 0.243753 | C | 0.146406 | 0.097347 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 347 | Y | 0.238665 | C | 0.189015 | 0.04965 | No Change: Both O | Aggressive periodontititis type 1 (AP1) [MIM:170650] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 347 | Y | 0.238665 | C | 0.189015 | 0.04965 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 39 | W | 0.079065 | S | 0.256257 | -0.177192 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 127 | H | 0.10725 | P | 0.12592 | -0.01867 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 286 | Q | 0.436648 | R | 0.39597 | 0.040678 | No Change: Both O | Haim-Munk syndrome (HMS) [MIM:245010] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 286 | Q | 0.436648 | R | 0.39597 | 0.040678 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 429 | W | 0.155577 | C | 0.166255 | -0.010678 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 153 | I | 0.223202 | T | 0.364201 | -0.140999 | No Change: Both O | - |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 340 | Y | 0.24569 | C | 0.207894 | 0.037796 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 401 | E | 0.273595 | K | 0.27318 | 4.15E-04 | No Change: Both O | - |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 453 | I | 0.184658 | V | 0.205485 | -0.020827 | No Change: Both O | - |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 129 | V | 0.077211 | E | 0.164767 | -0.087556 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 139 | G | 0.235373 | R | 0.217397 | 0.017976 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 236 | D | 0.165547 | Y | 0.089632 | 0.075915 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 272 | R | 0.27546 | H | 0.231323 | 0.044137 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 291 | C | 0.323177 | Y | 0.378233 | -0.055056 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 300 | G | 0.205574 | D | 0.207568 | -0.001994 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 300 | G | 0.205574 | S | 0.237603 | -0.032029 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 301 | G | 0.188124 | V | 0.100628 | 0.087496 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 304 | Y | 0.14641 | N | 0.222791 | -0.076381 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 312 | Q | 0.171287 | R | 0.156005 | 0.015282 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 319 | E | 0.146488 | G | 0.1193 | 0.027188 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 412 | Y | 0.298506 | C | 0.249791 | 0.048715 | No Change: Both O | Aggressive periodontititis type 1 (AP1) [MIM:170650] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 447 | E | 0.288707 | G | 0.238836 | 0.049871 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 405 | H | 0.113584 | N | 0.135596 | -0.022012 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 405 | H | 0.113584 | R | 0.112196 | 0.001388 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P53634 | CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens GN=CTSC PE=1 SV=2 | 294 | Y | 0.307321 | H | 0.435852 | -0.128531 | No Change: Both O | Papillon-Lefevre syndrome (PLS) [MIM:245000] |
| P07339 | CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 | 58 | A | 0.430003 | V | 0.362661 | 0.067342 | No Change: Both O | - |
| P07339 | CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 | 229 | F | 0.151089 | I | 0.147294 | 0.003795 | No Change: Both O | Neuronal ceroid lipofuscinosis type 10 (CLN10) [MIM:610127] |
| P07339 | CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 | 383 | W | 0.106979 | C | 0.127534 | -0.020555 | No Change: Both O | Neuronal ceroid lipofuscinosis type 10 (CLN10) [MIM:610127] |
| P07339 | CATD_HUMAN Cathepsin D OS=Homo sapiens GN=CTSD PE=1 SV=1 | 282 | G | 0.19187 | R | 0.178434 | 0.013436 | No Change: Both O | - |
| P14091 | CATE_HUMAN Cathepsin E OS=Homo sapiens GN=CTSE PE=1 SV=2 | 329 | T | 0.137855 | I | 0.074589 | 0.063266 | No Change: Both O | - |
| P14091 | CATE_HUMAN Cathepsin E OS=Homo sapiens GN=CTSE PE=1 SV=2 | 82 | I | 0.260704 | V | 0.267828 | -0.007124 | No Change: Both O | - |
| Q9UBX1 | CATF_HUMAN Cathepsin F OS=Homo sapiens GN=CTSF PE=1 SV=1 | 153 | Q | 0.767542 | R | 0.762551 | 0.004991 | No Change: Both D | - |
| P08311 | CATG_HUMAN Cathepsin G OS=Homo sapiens GN=CTSG PE=1 SV=2 | 125 | N | 0.606818 | S | 0.62322 | -0.016402 | No Change: Both D | - |
| P09668 | CATH_HUMAN Pro-cathepsin H OS=Homo sapiens GN=CTSH PE=1 SV=4 | 126 | G | 0.449954 | R | 0.458724 | -0.00877 | No Change: Both O | A colorectal cancer sample |
| P09668 | CATH_HUMAN Pro-cathepsin H OS=Homo sapiens GN=CTSH PE=1 SV=4 | 11 | G | 0.032555 | R | 0.02842 | 0.004135 | No Change: Both O | - |
| P09668 | CATH_HUMAN Pro-cathepsin H OS=Homo sapiens GN=CTSH PE=1 SV=4 | 23 | A | 0.113618 | T | 0.120574 | -0.006956 | No Change: Both O | - |
| P09668 | CATH_HUMAN Pro-cathepsin H OS=Homo sapiens GN=CTSH PE=1 SV=4 | 26 | C | 0.137218 | S | 0.32604 | -0.188822 | No Change: Both O | - |
| P43235 | CATK_HUMAN Cathepsin K OS=Homo sapiens GN=CTSK PE=1 SV=1 | 146 | G | 0.363473 | R | 0.338958 | 0.024515 | No Change: Both O | Pycnodysostosis (PKND) [MIM:265800] |
| P43235 | CATK_HUMAN Cathepsin K OS=Homo sapiens GN=CTSK PE=1 SV=1 | 309 | L | 0.190221 | P | 0.338307 | -0.148086 | No Change: Both O | Pycnodysostosis (PKND) [MIM:265800] |
| P43235 | CATK_HUMAN Cathepsin K OS=Homo sapiens GN=CTSK PE=1 SV=1 | 79 | G | 0.435527 | E | 0.51628 | -0.080753 | O to D | Pycnodysostosis (PKND) [MIM:265800] |
| P43235 | CATK_HUMAN Cathepsin K OS=Homo sapiens GN=CTSK PE=1 SV=1 | 277 | A | 0.182501 | V | 0.136296 | 0.046205 | No Change: Both O | Pycnodysostosis (PKND) [MIM:265800] |
| Q5NE16 | CATL3_HUMAN Putative cathepsin L-like protein 3 OS=Homo sapiens GN=CTSL3 PE=5 SV=1 | 123 | S | 0.314061 | G | 0.250279 | 0.063782 | No Change: Both O | - |
| P25774 | CATS_HUMAN Cathepsin S OS=Homo sapiens GN=CTSS PE=1 SV=3 | 113 | R | 0.435291 | W | 0.247253 | 0.188038 | No Change: Both O | - |
| P25774 | CATS_HUMAN Cathepsin S OS=Homo sapiens GN=CTSS PE=1 SV=3 | 161 | S | 0.31614 | T | 0.242688 | 0.073452 | No Change: Both O | - |
| P56202 | CATW_HUMAN Cathepsin W OS=Homo sapiens GN=CTSW PE=1 SV=2 | 218 | Q | 0.451775 | R | 0.452256 | -4.81E-04 | No Change: Both O | - |
| P56202 | CATW_HUMAN Cathepsin W OS=Homo sapiens GN=CTSW PE=1 SV=2 | 139 | S | 0.394225 | G | 0.320675 | 0.07355 | No Change: Both O | - |
| Q9UBR2 | CATZ_HUMAN Cathepsin Z OS=Homo sapiens GN=CTSZ PE=1 SV=1 | 36 | P | 0.400362 | S | 0.391368 | 0.008994 | No Change: Both O | - |
| Q9UBR2 | CATZ_HUMAN Cathepsin Z OS=Homo sapiens GN=CTSZ PE=1 SV=1 | 129 | A | 0.343335 | R | 0.384951 | -0.041616 | No Change: Both O | - |
| Q9UBR2 | CATZ_HUMAN Cathepsin Z OS=Homo sapiens GN=CTSZ PE=1 SV=1 | 286 | A | 0.441942 | T | 0.468167 | -0.026225 | No Change: Both O | - |
| Q8WZ74 | CTTB2_HUMAN Cortactin-binding protein 2 OS=Homo sapiens GN=CTTNBP2 PE=1 SV=1 | 1213 | L | 0.516622 | V | 0.447653 | 0.068969 | D to O | - |
| Q8WZ74 | CTTB2_HUMAN Cortactin-binding protein 2 OS=Homo sapiens GN=CTTNBP2 PE=1 SV=1 | 1148 | Q | 0.18361 | K | 0.230035 | -0.046425 | No Change: Both O | - |
| Q9P2B4 | CT2NL_HUMAN CTTNBP2 N-terminal-like protein OS=Homo sapiens GN=CTTNBP2NL PE=1 SV=2 | 296 | V | 0.761415 | M | 0.821102 | -0.059687 | No Change: Both D | - |
| Q9P2B4 | CT2NL_HUMAN CTTNBP2 N-terminal-like protein OS=Homo sapiens GN=CTTNBP2NL PE=1 SV=2 | 409 | S | 0.991272 | G | 0.988036 | 0.003236 | No Change: Both D | - |
| Q7Z7A3 | CTU1_HUMAN Cytoplasmic tRNA 2-thiolation protein 1 OS=Homo sapiens GN=CTU1 PE=1 SV=1 | 107 | A | 0.194562 | V | 0.138275 | 0.056287 | No Change: Both O | - |
| Q2VPK5 | CTU2_HUMAN Cytoplasmic tRNA 2-thiolation protein 2 OS=Homo sapiens GN=CTU2 PE=1 SV=1 | 253 | M | 0.23952 | V | 0.189215 | 0.050305 | No Change: Both O | - |
| Q2VPK5 | CTU2_HUMAN Cytoplasmic tRNA 2-thiolation protein 2 OS=Homo sapiens GN=CTU2 PE=1 SV=1 | 332 | V | 0.431083 | I | 0.387413 | 0.04367 | No Change: Both O | - |
| Q2VPK5 | CTU2_HUMAN Cytoplasmic tRNA 2-thiolation protein 2 OS=Homo sapiens GN=CTU2 PE=1 SV=1 | 416 | Q | 0.853822 | R | 0.849411 | 0.004411 | No Change: Both D | - |
| Q2VPK5 | CTU2_HUMAN Cytoplasmic tRNA 2-thiolation protein 2 OS=Homo sapiens GN=CTU2 PE=1 SV=1 | 186 | H | 0.673191 | Y | 0.628396 | 0.044795 | No Change: Both D | - |
| Q4LDR2 | CTXN3_HUMAN Cortexin-3 OS=Homo sapiens GN=CTXN3 PE=2 SV=1 | 17 | E | 0.779811 | V | 0.631509 | 0.148302 | No Change: Both D | - |
| Q4LDR2 | CTXN3_HUMAN Cortexin-3 OS=Homo sapiens GN=CTXN3 PE=2 SV=1 | 23 | M | 0.762446 | I | 0.674055 | 0.088391 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 124 | F | 0.46052 | I | 0.473655 | -0.013135 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 253 | F | 0.360959 | S | 0.586997 | -0.226038 | O to D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 389 | P | 0.49789 | T | 0.442112 | 0.055778 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1032 | Y | 0.135974 | H | 0.204642 | -0.068668 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1297 | P | 0.500766 | L | 0.320234 | 0.180532 | D to O | Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100] |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1545 | N | 0.180374 | Y | 0.100436 | 0.079938 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1559 | P | 0.306495 | S | 0.350384 | -0.043889 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1769 | V | 0.183167 | I | 0.164509 | 0.018658 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2153 | L | 0.416467 | F | 0.394729 | 0.021738 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2162 | C | 0.633083 | Y | 0.585832 | 0.047251 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2575 | P | 0.610844 | R | 0.557997 | 0.052847 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2691 | G | 0.230535 | R | 0.197932 | 0.032603 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2717 | S | 0.406307 | W | 0.159527 | 0.24678 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2879 | L | 0.207323 | I | 0.179762 | 0.027561 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2984 | I | 0.153047 | V | 0.176389 | -0.023342 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3002 | E | 0.295834 | G | 0.261983 | 0.033851 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3422 | T | 0.311071 | I | 0.180881 | 0.13019 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3552 | N | 0.038385 | K | 0.044265 | -0.00588 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 786 | H | 0.353025 | Q | 0.363095 | -0.01007 | No Change: Both O | A breast cancer sample |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2252 | A | 0.09731 | V | 0.06314 | 0.03417 | No Change: Both O | A colorectal cancer sample |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2914 | A | 0.560634 | V | 0.480058 | 0.080576 | D to O | A breast cancer sample |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3189 | I | 0.01763 | V | 0.020414 | -0.002784 | No Change: Both O | A breast cancer sample |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 66 | G | 0.366581 | R | 0.37914 | -0.012559 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 504 | I | 0.056657 | M | 0.090745 | -0.034088 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 730 | H | 0.380784 | Y | 0.295183 | 0.085601 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 969 | L | 0.100386 | V | 0.099118 | 0.001268 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1775 | R | 0.360006 | W | 0.186413 | 0.173593 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1840 | G | 0.644037 | S | 0.686901 | -0.042864 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1935 | S | 0.743751 | G | 0.695923 | 0.047828 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 1971 | P | 0.255428 | T | 0.2075 | 0.047928 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2263 | F | 0.254379 | C | 0.258525 | -0.004146 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2444 | R | 0.553592 | Q | 0.541774 | 0.011818 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 2968 | E | 0.284785 | Q | 0.24222 | 0.042565 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3432 | T | 0.259184 | S | 0.328473 | -0.069289 | No Change: Both O | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 335 | A | 0.712155 | T | 0.756803 | -0.044648 | No Change: Both D | - |
| O60494 | CUBN_HUMAN Cubilin OS=Homo sapiens GN=CUBN PE=1 SV=5 | 3258 | S | 0.137839 | G | 0.115582 | 0.022257 | No Change: Both O | - |
| Q9NWM3 | CUED1_HUMAN CUE domain-containing protein 1 OS=Homo sapiens GN=CUEDC1 PE=1 SV=1 | 205 | P | 0.906102 | S | 0.89392 | 0.012182 | No Change: Both D | - |
| Q9NWM3 | CUED1_HUMAN CUE domain-containing protein 1 OS=Homo sapiens GN=CUEDC1 PE=1 SV=1 | 316 | R | 0.823091 | Q | 0.791375 | 0.031716 | No Change: Both D | - |
| Q9NWM3 | CUED1_HUMAN CUE domain-containing protein 1 OS=Homo sapiens GN=CUEDC1 PE=1 SV=1 | 169 | R | 0.742748 | H | 0.670193 | 0.072555 | No Change: Both D | - |
| Q13617 | CUL2_HUMAN Cullin-2 OS=Homo sapiens GN=CUL2 PE=1 SV=2 | 109 | N | 0.09023 | S | 0.10241 | -0.01218 | No Change: Both O | - |
| Q13618 | CUL3_HUMAN Cullin-3 OS=Homo sapiens GN=CUL3 PE=1 SV=2 | 13 | D | 0.708271 | H | 0.679204 | 0.029067 | No Change: Both D | - |
| Q13618 | CUL3_HUMAN Cullin-3 OS=Homo sapiens GN=CUL3 PE=1 SV=2 | 567 | V | 0.48876 | I | 0.455132 | 0.033628 | No Change: Both O | - |
| Q13618 | CUL3_HUMAN Cullin-3 OS=Homo sapiens GN=CUL3 PE=1 SV=2 | 184 | R | 0.173448 | S | 0.195326 | -0.021878 | No Change: Both O | - |
| Q13619 | CUL4A_HUMAN Cullin-4A OS=Homo sapiens GN=CUL4A PE=1 SV=3 | 644 | K | 0.602123 | R | 0.558216 | 0.043907 | No Change: Both D | - |
| Q13620 | CUL4B_HUMAN Cullin-4B OS=Homo sapiens GN=CUL4B PE=1 SV=4 | 103 | L | 0.731368 | P | 0.809731 | -0.078363 | No Change: Both D | - |
| Q13620 | CUL4B_HUMAN Cullin-4B OS=Homo sapiens GN=CUL4B PE=1 SV=4 | 213 | T | 0.585756 | I | 0.450265 | 0.135491 | D to O | Mental retardation syndromic X-linked Cabezas type (MRXC) [MIM:300354] |
| Q13620 | CUL4B_HUMAN Cullin-4B OS=Homo sapiens GN=CUL4B PE=1 SV=4 | 572 | R | 0.521775 | C | 0.373682 | 0.148093 | D to O | Mental retardation syndromic X-linked Cabezas type (MRXC) [MIM:300354] |
| Q13620 | CUL4B_HUMAN Cullin-4B OS=Homo sapiens GN=CUL4B PE=1 SV=4 | 745 | V | 0.343376 | A | 0.408142 | -0.064766 | No Change: Both O | Mental retardation syndromic X-linked Cabezas type (MRXC) [MIM:300354] |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 813 | Q | 0.39655 | R | 0.394699 | 0.001851 | No Change: Both O | - |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 1014 | L | 0.579442 | R | 0.696218 | -0.116776 | No Change: Both D | 3M syndrome type 1 (3M1) [MIM:273750] |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 1246 | Q | 0.209306 | G | 0.179304 | 0.030002 | No Change: Both O | 3M syndrome type 1 (3M1) [MIM:273750] |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 1464 | H | 0.199546 | P | 0.225082 | -0.025536 | No Change: Both O | 3M syndrome type 1 (3M1) [MIM:273750] |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 616 | S | 0.869207 | G | 0.843126 | 0.026081 | No Change: Both D | - |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 852 | R | 0.712599 | Q | 0.725649 | -0.01305 | No Change: Both D | - |
| Q14999 | CUL7_HUMAN Cullin-7 OS=Homo sapiens GN=CUL7 PE=1 SV=2 | 1246 | Q | 0.209306 | H | 0.169872 | 0.039434 | No Change: Both O | - |
| Q8IWT3 | CUL9_HUMAN Cullin-9 OS=Homo sapiens GN=CUL9 PE=1 SV=2 | 2058 | H | 0.427841 | P | 0.534928 | -0.107087 | O to D | - |
| Q8IWT3 | CUL9_HUMAN Cullin-9 OS=Homo sapiens GN=CUL9 PE=1 SV=2 | 2180 | T | 0.246677 | I | 0.134822 | 0.111855 | No Change: Both O | - |
| Q9NTM9 | CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens GN=CUTC PE=1 SV=1 | 77 | P | 0.137054 | L | 0.066643 | 0.070411 | No Change: Both O | A breast cancer sample |
| Q13948 | CASP_HUMAN Protein CASP OS=Homo sapiens GN=CUX1 PE=1 SV=2 | 464 | A | 0.729472 | T | 0.723906 | 0.005566 | No Change: Both D | - |
| Q13948 | CASP_HUMAN Protein CASP OS=Homo sapiens GN=CUX1 PE=1 SV=2 | 545 | I | 0.487912 | V | 0.46541 | 0.022502 | No Change: Both O | - |
| Q13948 | CASP_HUMAN Protein CASP OS=Homo sapiens GN=CUX1 PE=1 SV=2 | 490 | S | 0.625963 | G | 0.585429 | 0.040534 | No Change: Both D | A breast cancer sample |
| Q13948 | CASP_HUMAN Protein CASP OS=Homo sapiens GN=CUX1 PE=1 SV=2 | 609 | R | 0.263842 | C | 0.135722 | 0.12812 | No Change: Both O | A colorectal cancer sample |
| O14529 | CUX2_HUMAN Homeobox protein cut-like 2 OS=Homo sapiens GN=CUX2 PE=1 SV=4 | 1472 | V | 0.365379 | L | 0.413043 | -0.047664 | No Change: Both O | - |
| Q86UP6 | CUZD1_HUMAN CUB and zona pellucida-like domain-containing protein 1 OS=Homo sapiens GN=CUZD1 PE=2 SV=1 | 156 | G | 0.182015 | S | 0.223535 | -0.04152 | No Change: Both O | - |
| Q9HCG8 | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens GN=CWC22 PE=1 SV=3 | 656 | A | 0.716661 | V | 0.709424 | 0.007237 | No Change: Both D | - |
| Q9HCG8 | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens GN=CWC22 PE=1 SV=3 | 741 | D | 0.98858 | V | 0.982371 | 0.006209 | No Change: Both D | - |
| Q9HCG8 | CWC22_HUMAN Pre-mRNA-splicing factor CWC22 homolog OS=Homo sapiens GN=CWC22 PE=1 SV=3 | 794 | R | 0.869646 | Q | 0.861394 | 0.008252 | No Change: Both D | - |
| Q6UX04 | CWC27_HUMAN Peptidyl-prolyl cis-trans isomerase CWC27 homolog OS=Homo sapiens GN=CWC27 PE=1 SV=1 | 256 | P | 0.941869 | A | 0.921625 | 0.020244 | No Change: Both D | - |
| Q69YN2 | C19L1_HUMAN CWF19-like protein 1 OS=Homo sapiens GN=CWF19L1 PE=1 SV=2 | 160 | C | 0.343573 | Y | 0.304789 | 0.038784 | No Change: Both O | - |
| Q69YN2 | C19L1_HUMAN CWF19-like protein 1 OS=Homo sapiens GN=CWF19L1 PE=1 SV=2 | 259 | P | 0.536469 | L | 0.386833 | 0.149636 | D to O | - |
| Q69YN2 | C19L1_HUMAN CWF19-like protein 1 OS=Homo sapiens GN=CWF19L1 PE=1 SV=2 | 523 | R | 0.559349 | H | 0.479693 | 0.079656 | D to O | - |
| Q69YN2 | C19L1_HUMAN CWF19-like protein 1 OS=Homo sapiens GN=CWF19L1 PE=1 SV=2 | 526 | R | 0.597976 | Q | 0.58041 | 0.017566 | No Change: Both D | - |
| Q2TBE0 | C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens GN=CWF19L2 PE=1 SV=4 | 210 | P | 0.576593 | T | 0.524876 | 0.051717 | No Change: Both D | - |
| Q2TBE0 | C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens GN=CWF19L2 PE=1 SV=4 | 443 | H | 0.993732 | Y | 0.988107 | 0.005625 | No Change: Both D | - |
| Q2TBE0 | C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens GN=CWF19L2 PE=1 SV=4 | 445 | H | 0.992942 | Q | 0.994073 | -0.001131 | No Change: Both D | - |
| Q2TBE0 | C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens GN=CWF19L2 PE=1 SV=4 | 537 | G | 0.729574 | R | 0.751376 | -0.021802 | No Change: Both D | - |
| Q2TBE0 | C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens GN=CWF19L2 PE=1 SV=4 | 894 | Y | 0.783202 | C | 0.761519 | 0.021683 | No Change: Both D | - |
| Q9H720 | PG2IP_HUMAN PGAP2-interacting protein OS=Homo sapiens GN=CWH43 PE=2 SV=2 | 2 | P | 0.743229 | T | 0.679952 | 0.063277 | No Change: Both D | - |
| Q9H720 | PG2IP_HUMAN PGAP2-interacting protein OS=Homo sapiens GN=CWH43 PE=2 SV=2 | 689 | H | 0.57619 | N | 0.600929 | -0.024739 | No Change: Both D | - |
| P78423 | X3CL1_HUMAN Fractalkine OS=Homo sapiens GN=CX3CL1 PE=1 SV=1 | 240 | A | 0.990914 | V | 0.98757 | 0.003344 | No Change: Both D | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 57 | T | 0.33812 | A | 0.321652 | 0.016468 | No Change: Both O | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 122 | V | 0.028315 | I | 0.027952 | 3.63E-04 | No Change: Both O | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 249 | V | 0.023127 | I | 0.021444 | 0.001683 | No Change: Both O | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 280 | T | 0.187117 | M | 0.146186 | 0.040931 | No Change: Both O | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 147 | V | 0.186915 | I | 0.160544 | 0.026371 | No Change: Both O | - |
| P49238 | CX3C1_HUMAN CX3C chemokine receptor 1 OS=Homo sapiens GN=CX3CR1 PE=1 SV=1 | 13 | E | 0.389634 | D | 0.35903 | 0.030604 | No Change: Both O | - |
| P78310 | CXAR_HUMAN Coxsackievirus and adenovirus receptor OS=Homo sapiens GN=CXADR PE=1 SV=1 | 323 | S | 0.868121 | R | 0.84561 | 0.022511 | No Change: Both D | - |
| O14625 | CXL11_HUMAN C-X-C motif chemokine 11 OS=Homo sapiens GN=CXCL11 PE=1 SV=1 | 55 | N | 0.321683 | S | 0.364149 | -0.042466 | No Change: Both O | - |
| Q9H2A7 | CXL16_HUMAN C-X-C motif chemokine 16 OS=Homo sapiens GN=CXCL16 PE=2 SV=4 | 123 | I | 0.742395 | T | 0.803996 | -0.061601 | No Change: Both D | - |
| Q9H2A7 | CXL16_HUMAN C-X-C motif chemokine 16 OS=Homo sapiens GN=CXCL16 PE=2 SV=4 | 181 | A | 0.843997 | V | 0.786712 | 0.057285 | No Change: Both D | - |
| P19876 | CXCL3_HUMAN C-X-C motif chemokine 3 OS=Homo sapiens GN=CXCL3 PE=1 SV=1 | 3 | H | 0.734933 | R | 0.809491 | -0.074558 | No Change: Both D | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 276 | S | 0.472946 | T | 0.391877 | 0.081069 | No Change: Both O | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 71 | R | 0.206544 | C | 0.094487 | 0.112057 | No Change: Both O | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 306 | A | 0.049384 | T | 0.05637 | -0.006986 | No Change: Both O | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 335 | R | 0.402099 | C | 0.217388 | 0.184711 | No Change: Both O | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 31 | M | 0.350228 | R | 0.417351 | -0.067123 | No Change: Both O | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 342 | S | 0.749143 | L | 0.57986 | 0.169283 | No Change: Both D | - |
| P25024 | CXCR1_HUMAN C-X-C chemokine receptor type 1 OS=Homo sapiens GN=CXCR1 PE=1 SV=2 | 268 | M | 0.133116 | L | 0.111863 | 0.021253 | No Change: Both O | - |
| P25025 | CXCR2_HUMAN C-X-C chemokine receptor type 2 OS=Homo sapiens GN=CXCR2 PE=1 SV=2 | 80 | R | 0.206758 | C | 0.09455 | 0.112208 | No Change: Both O | - |
| P49682 | CXCR3_HUMAN C-X-C chemokine receptor type 3 OS=Homo sapiens GN=CXCR3 PE=1 SV=2 | 292 | R | 0.452321 | Q | 0.451071 | 0.00125 | No Change: Both O | - |
| P49682 | CXCR3_HUMAN C-X-C chemokine receptor type 3 OS=Homo sapiens GN=CXCR3 PE=1 SV=2 | 363 | A | 0.979412 | T | 0.985427 | -0.006015 | No Change: Both D | - |
| P32302 | CXCR5_HUMAN C-X-C chemokine receptor type 5 OS=Homo sapiens GN=CXCR5 PE=1 SV=1 | 344 | G | 0.352027 | S | 0.434381 | -0.082354 | No Change: Both O | - |
| P32302 | CXCR5_HUMAN C-X-C chemokine receptor type 5 OS=Homo sapiens GN=CXCR5 PE=1 SV=1 | 34 | E | 0.321972 | K | 0.314125 | 0.007847 | No Change: Both O | A breast cancer sample |
| O00574 | CXCR6_HUMAN C-X-C chemokine receptor type 6 OS=Homo sapiens GN=CXCR6 PE=2 SV=1 | 25 | D | 0.546577 | A | 0.458365 | 0.088212 | D to O | - |
| O00574 | CXCR6_HUMAN C-X-C chemokine receptor type 6 OS=Homo sapiens GN=CXCR6 PE=2 SV=1 | 3 | E | 0.85836 | K | 0.835563 | 0.022797 | No Change: Both D | - |
| P25106 | CXCR7_HUMAN C-X-C chemokine receptor type 7 OS=Homo sapiens GN=CXCR7 PE=1 SV=3 | 219 | L | 0.053093 | W | 0.033833 | 0.01926 | No Change: Both O | - |
| O96002 | CX001_HUMAN Uncharacterized protein CXorf1 OS=Homo sapiens GN=CXorf1 PE=2 SV=1 | 36 | S | 0.105628 | A | 0.063346 | 0.042282 | No Change: Both O | - |
| Q6ZTR5 | CX022_HUMAN Uncharacterized protein CXorf22 OS=Homo sapiens GN=CXorf22 PE=2 SV=3 | 236 | V | 0.148137 | M | 0.194984 | -0.046847 | No Change: Both O | - |
| Q6ZTR5 | CX022_HUMAN Uncharacterized protein CXorf22 OS=Homo sapiens GN=CXorf22 PE=2 SV=3 | 345 | C | 0.053292 | R | 0.108527 | -0.055235 | No Change: Both O | - |
| Q6ZTR5 | CX022_HUMAN Uncharacterized protein CXorf22 OS=Homo sapiens GN=CXorf22 PE=2 SV=3 | 561 | A | 0.334644 | T | 0.356706 | -0.022062 | No Change: Both O | - |
| Q6ZTR5 | CX022_HUMAN Uncharacterized protein CXorf22 OS=Homo sapiens GN=CXorf22 PE=2 SV=3 | 634 | H | 0.453066 | Y | 0.364501 | 0.088565 | No Change: Both O | - |
| Q6ZTR5 | CX022_HUMAN Uncharacterized protein CXorf22 OS=Homo sapiens GN=CXorf22 PE=2 SV=3 | 964 | F | 0.063659 | L | 0.070891 | -0.007232 | No Change: Both O | - |
| O75409 | HYPM_HUMAN Huntingtin-interacting protein M OS=Homo sapiens GN=CXorf27 PE=1 SV=2 | 68 | V | 0.562771 | I | 0.564074 | -0.001303 | No Change: Both D | - |
| A6PW82 | CX030_HUMAN Putative uncharacterized protein CXorf30 OS=Homo sapiens GN=CXorf30 PE=2 SV=2 | 332 | I | 0.165452 | V | 0.170886 | -0.005434 | No Change: Both O | - |
| A6PW82 | CX030_HUMAN Putative uncharacterized protein CXorf30 OS=Homo sapiens GN=CXorf30 PE=2 SV=2 | 363 | I | 0.208586 | M | 0.257151 | -0.048565 | No Change: Both O | - |
| A6PW82 | CX030_HUMAN Putative uncharacterized protein CXorf30 OS=Homo sapiens GN=CXorf30 PE=2 SV=2 | 606 | H | 0.554167 | R | 0.60219 | -0.048023 | No Change: Both D | - |
| Q9H7Y0 | CX036_HUMAN UPF0672 protein CXorf36 OS=Homo sapiens GN=CXorf36 PE=2 SV=3 | 128 | R | 0.416741 | K | 0.453835 | -0.037094 | No Change: Both O | - |
| Q9H7Y0 | CX036_HUMAN UPF0672 protein CXorf36 OS=Homo sapiens GN=CXorf36 PE=2 SV=3 | 146 | R | 0.426092 | Q | 0.426326 | -2.34E-04 | No Change: Both O | - |
| Q8TB03 | CX038_HUMAN Uncharacterized protein CXorf38 OS=Homo sapiens GN=CXorf38 PE=1 SV=1 | 176 | T | 0.327145 | A | 0.296706 | 0.030439 | No Change: Both O | - |
| Q6NSI4 | CX057_HUMAN Uncharacterized protein CXorf57 OS=Homo sapiens GN=CXorf57 PE=1 SV=2 | 593 | I | 0.874056 | M | 0.907097 | -0.033041 | No Change: Both D | - |
| Q96LI9 | CX058_HUMAN Putative uncharacterized protein CXorf58 OS=Homo sapiens GN=CXorf58 PE=2 SV=2 | 24 | R | 0.494119 | C | 0.304109 | 0.19001 | No Change: Both O | - |
| Q96LI9 | CX058_HUMAN Putative uncharacterized protein CXorf58 OS=Homo sapiens GN=CXorf58 PE=2 SV=2 | 187 | R | 0.196684 | H | 0.191458 | 0.005226 | No Change: Both O | - |
| B1ATL7 | CX064_HUMAN Uncharacterized protein CXorf64 OS=Homo sapiens GN=CXorf64 PE=2 SV=1 | 193 | M | 0.539511 | T | 0.575949 | -0.036438 | No Change: Both D | - |
| B1ATL7 | CX064_HUMAN Uncharacterized protein CXorf64 OS=Homo sapiens GN=CXorf64 PE=2 SV=1 | 115 | L | 0.449893 | V | 0.465121 | -0.015228 | No Change: Both O | - |
| A6NEN9 | CX065_HUMAN Uncharacterized protein CXorf65 OS=Homo sapiens GN=CXorf65 PE=4 SV=1 | 156 | R | 0.989688 | H | 0.984252 | 0.005436 | No Change: Both D | - |
| Q5JRM2 | CX066_HUMAN Uncharacterized protein CXorf66 OS=Homo sapiens GN=CXorf66 PE=2 SV=1 | 233 | P | 0.949248 | L | 0.906943 | 0.042305 | No Change: Both D | - |
| Q86X51 | CX067_HUMAN Uncharacterized protein CXorf67 OS=Homo sapiens GN=CXorf67 PE=2 SV=1 | 470 | R | 0.936671 | K | 0.929471 | 0.0072 | No Change: Both D | - |
| Q6P9G0 | CB5D1_HUMAN Cytochrome b5 domain-containing protein 1 OS=Homo sapiens GN=CYB5D1 PE=2 SV=1 | 20 | F | 0.211635 | L | 0.227745 | -0.01611 | No Change: Both O | - |
| Q8WUJ1 | NEUFC_HUMAN Neuferricin OS=Homo sapiens GN=CYB5D2 PE=2 SV=1 | 7 | R | 0.352142 | G | 0.357665 | -0.005523 | No Change: Both O | A colorectal cancer sample |
| Q8WUJ1 | NEUFC_HUMAN Neuferricin OS=Homo sapiens GN=CYB5D2 PE=2 SV=1 | 7 | R | 0.352142 | P | 0.355402 | -0.00326 | No Change: Both O | A colorectal cancer sample |
| Q9UHQ9 | NB5R1_HUMAN NADH-cytochrome b5 reductase 1 OS=Homo sapiens GN=CYB5R1 PE=1 SV=1 | 44 | N | 0.360348 | S | 0.41193 | -0.051582 | No Change: Both O | - |
| Q6BCY4 | NB5R2_HUMAN NADH-cytochrome b5 reductase 2 OS=Homo sapiens GN=CYB5R2 PE=1 SV=1 | 15 | E | 0.747555 | A | 0.645665 | 0.10189 | No Change: Both D | - |
| Q6BCY4 | NB5R2_HUMAN NADH-cytochrome b5 reductase 2 OS=Homo sapiens GN=CYB5R2 PE=1 SV=1 | 209 | N | 0.149693 | D | 0.174635 | -0.024942 | No Change: Both O | - |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 58 | R | 0.311407 | Q | 0.3025 | 0.008907 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 106 | V | 0.203237 | M | 0.240519 | -0.037282 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 128 | S | 0.468991 | P | 0.447828 | 0.021163 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 149 | L | 0.284319 | P | 0.45639 | -0.172071 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 73 | L | 0.252529 | P | 0.39651 | -0.143981 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 117 | T | 0.337767 | S | 0.410521 | -0.072754 | No Change: Both O | - |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 179 | A | 0.303621 | V | 0.247806 | 0.055815 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 204 | C | 0.147317 | R | 0.267683 | -0.120366 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 204 | C | 0.147317 | Y | 0.164396 | -0.017079 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 66 | S | 0.283222 | P | 0.282756 | 4.66E-04 | No Change: Both O | - |
| P00387 | NB5R3_HUMAN NADH-cytochrome b5 reductase 3 OS=Homo sapiens GN=CYB5R3 PE=1 SV=3 | 292 | G | 0.324134 | D | 0.361477 | -0.037343 | No Change: Both O | Methemoglobinemia CYB5R3-related (METHB-CYB5R3) [MIM:250800] |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 187 | Q | 0.276295 | R | 0.258142 | 0.018153 | No Change: Both O | - |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 223 | H | 0.321318 | R | 0.302891 | 0.018427 | No Change: Both O | - |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 282 | S | 0.371772 | P | 0.346604 | 0.025168 | No Change: Both O | - |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 371 | D | 0.275588 | Y | 0.142952 | 0.132636 | No Change: Both O | A breast cancer sample |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 390 | L | 0.224781 | M | 0.258103 | -0.033322 | No Change: Both O | A breast cancer sample |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 140 | R | 0.541891 | H | 0.537056 | 0.004835 | No Change: Both D | - |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 267 | P | 0.462649 | A | 0.372079 | 0.09057 | No Change: Both O | - |
| Q7L1T6 | NB5R4_HUMAN Cytochrome b5 reductase 4 OS=Homo sapiens GN=CYB5R4 PE=1 SV=1 | 316 | P | 0.193108 | S | 0.199337 | -0.006229 | No Change: Both O | - |
| Q6IPT4 | NB5R5_HUMAN NADH-cytochrome b5 reductase-like OS=Homo sapiens GN=CYB5RL PE=1 SV=3 | 47 | R | 0.556751 | K | 0.548768 | 0.007983 | No Change: Both D | - |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 72 | Y | 0.177502 | H | 0.27091 | -0.093408 | No Change: Both O | - |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 90 | R | 0.068564 | Q | 0.069719 | -0.001155 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 94 | H | 0.05881 | R | 0.062689 | -0.003879 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 118 | S | 0.058955 | R | 0.045576 | 0.013379 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 156 | P | 0.994711 | Q | 0.993281 | 0.00143 | No Change: Both D | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 24 | G | 0.093629 | R | 0.081335 | 0.012294 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 174 | V | 0.968721 | A | 0.976366 | -0.007645 | No Change: Both D | - |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 25 | G | 0.098295 | V | 0.050298 | 0.047997 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 52 | L | 0.082834 | P | 0.161608 | -0.078774 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 53 | E | 0.135555 | V | 0.067021 | 0.068534 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 90 | R | 0.068564 | W | 0.024264 | 0.0443 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 124 | A | 0.10516 | V | 0.072506 | 0.032654 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 125 | A | 0.131906 | T | 0.143785 | -0.011879 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-negative (ARCGD) [MIM:233690] |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 171 | E | 0.978857 | G | 0.974806 | 0.004051 | No Change: Both D | - |
| P13498 | CY24A_HUMAN Cytochrome b-245 light chain OS=Homo sapiens GN=CYBA PE=1 SV=3 | 193 | E | 0.905495 | D | 0.897456 | 0.008039 | No Change: Both D | - |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 101 | H | 0.090505 | R | 0.09788 | -0.007375 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 156 | A | 0.336257 | T | 0.366212 | -0.029955 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 209 | H | 0.013439 | Y | 0.007555 | 0.005884 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 225 | E | 0.264517 | V | 0.130715 | 0.133802 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 244 | C | 0.186254 | S | 0.420588 | -0.234334 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 244 | C | 0.186254 | Y | 0.2239 | -0.037646 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 339 | P | 0.256734 | H | 0.229517 | 0.027217 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 389 | G | 0.306375 | A | 0.258638 | 0.047737 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 415 | P | 0.131144 | H | 0.11093 | 0.020214 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 500 | D | 0.556212 | G | 0.531954 | 0.024258 | No Change: Both D | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 20 | G | 0.006351 | R | 0.005942 | 4.09E-04 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 54 | R | 0.194677 | S | 0.262292 | -0.067615 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 59 | C | 0.088794 | R | 0.168688 | -0.079894 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 101 | H | 0.090505 | Y | 0.052081 | 0.038424 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 119 | H | 0.064094 | R | 0.057862 | 0.006232 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 209 | H | 0.013439 | Q | 0.01347 | -3.10E-05 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 222 | H | 0.107572 | N | 0.117206 | -0.009634 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 222 | H | 0.107572 | R | 0.115165 | -0.007593 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 222 | H | 0.107572 | Y | 0.063927 | 0.043645 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 223 | G | 0.162285 | L | 0.090128 | 0.072157 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 244 | C | 0.186254 | R | 0.331806 | -0.145552 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 309 | E | 0.388604 | K | 0.420192 | -0.031588 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 322 | G | 0.201069 | E | 0.261864 | -0.060795 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 325 | I | 0.102386 | F | 0.120356 | -0.01797 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 333 | S | 0.248404 | P | 0.247004 | 0.0014 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 356 | R | 0.055189 | P | 0.068055 | -0.012866 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 405 | M | 0.068471 | R | 0.089472 | -0.021001 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 408 | G | 0.08431 | E | 0.102763 | -0.018453 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 408 | G | 0.08431 | R | 0.07204 | 0.01227 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 415 | P | 0.131144 | L | 0.066525 | 0.064619 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 422 | S | 0.074137 | P | 0.063624 | 0.010513 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 453 | W | 0.071367 | R | 0.183517 | -0.11215 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 516 | W | 0.284702 | C | 0.322147 | -0.037445 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 534 | V | 0.154339 | D | 0.269101 | -0.114762 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 537 | C | 0.150062 | R | 0.265654 | -0.115592 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 57 | A | 0.130072 | E | 0.17906 | -0.048988 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 303 | H | 0.181107 | N | 0.19669 | -0.015583 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 304 | P | 0.2128 | R | 0.186384 | 0.026416 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 41 | Y | 0.13074 | D | 0.254129 | -0.123389 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 54 | R | 0.194677 | M | 0.151726 | 0.042951 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 55 | A | 0.181419 | D | 0.224057 | -0.042638 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 209 | H | 0.013439 | R | 0.012263 | 0.001176 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 224 | A | 0.209655 | G | 0.264405 | -0.05475 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 338 | H | 0.248497 | Y | 0.156866 | 0.091631 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 344 | S | 0.413723 | F | 0.225259 | 0.188464 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 364 | G | 0.087815 | R | 0.078741 | 0.009074 | No Change: Both O | - |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 389 | G | 0.306375 | E | 0.353802 | -0.047427 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 420 | L | 0.083725 | P | 0.182901 | -0.099176 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 516 | W | 0.284702 | R | 0.487122 | -0.20242 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 517 | D | 0.303458 | E | 0.341386 | -0.037928 | No Change: Both O | - |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 18 | W | 0.006735 | C | 0.00808 | -0.001345 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 59 | C | 0.088794 | W | 0.063206 | 0.025588 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 179 | G | 0.036184 | R | 0.031623 | 0.004561 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 193 | S | 0.306193 | F | 0.125507 | 0.180686 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 205 | F | 0.054251 | I | 0.052269 | 0.001982 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 307 | T | 0.336404 | P | 0.390125 | -0.053721 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 342 | L | 0.303549 | Q | 0.445184 | -0.141635 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 472 | G | 0.283204 | S | 0.344948 | -0.061744 | No Change: Both O | - |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 505 | L | 0.345081 | R | 0.467928 | -0.122847 | No Change: Both O | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 546 | L | 0.57483 | P | 0.686025 | -0.111195 | No Change: Both D | Chronic granulomatous disease X-linked (XCGD) [MIM:306400] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 178 | T | 0.046108 | P | 0.053588 | -0.00748 | No Change: Both O | Mycobacteriosis atypical X-linked type 2 (AMCBX2) [MIM:300645] |
| P04839 | CY24B_HUMAN Cytochrome b-245 heavy chain OS=Homo sapiens GN=CYBB PE=1 SV=2 | 231 | Q | 0.433281 | P | 0.455625 | -0.022344 | No Change: Both O | Mycobacteriosis atypical X-linked type 2 (AMCBX2) [MIM:300645] |
| Q53TN4 | CYBR1_HUMAN Cytochrome b reductase 1 OS=Homo sapiens GN=CYBRD1 PE=1 SV=1 | 156 | M | 0.07652 | T | 0.094863 | -0.018343 | No Change: Both O | - |
| Q53TN4 | CYBR1_HUMAN Cytochrome b reductase 1 OS=Homo sapiens GN=CYBRD1 PE=1 SV=1 | 226 | R | 0.607399 | H | 0.606297 | 0.001102 | No Change: Both D | - |
| Q53TN4 | CYBR1_HUMAN Cytochrome b reductase 1 OS=Homo sapiens GN=CYBRD1 PE=1 SV=1 | 266 | S | 0.885654 | N | 0.867466 | 0.018188 | No Change: Both D | - |
| P08574 | CY1_HUMAN Cytochrome c1 heme protein mitochondrial OS=Homo sapiens GN=CYC1 PE=1 SV=3 | 89 | L | 0.607243 | V | 0.59406 | 0.013183 | No Change: Both D | - |
| P08574 | CY1_HUMAN Cytochrome c1 heme protein mitochondrial OS=Homo sapiens GN=CYC1 PE=1 SV=3 | 76 | M | 0.641608 | V | 0.5497 | 0.091908 | No Change: Both D | - |
| P99999 | CYC_HUMAN Cytochrome c OS=Homo sapiens GN=CYCS PE=1 SV=2 | 66 | M | 0.239002 | L | 0.202915 | 0.036087 | No Change: Both O | - |
| P99999 | CYC_HUMAN Cytochrome c OS=Homo sapiens GN=CYCS PE=1 SV=2 | 42 | G | 0.494524 | S | 0.526249 | -0.031725 | O to D | Thrombocytopenia type 4 (THC4) [MIM:612004] |
| P99999 | CYC_HUMAN Cytochrome c OS=Homo sapiens GN=CYCS PE=1 SV=2 | 56 | K | 0.329358 | R | 0.257891 | 0.071467 | No Change: Both O | - |
| Q7L576 | CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens GN=CYFIP1 PE=1 SV=1 | 532 | A | 0.588618 | P | 0.675575 | -0.086957 | No Change: Both D | - |
| Q7L576 | CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens GN=CYFIP1 PE=1 SV=1 | 820 | G | 0.171035 | D | 0.207397 | -0.036362 | No Change: Both O | - |
| Q7L576 | CYFP1_HUMAN Cytoplasmic FMR1-interacting protein 1 OS=Homo sapiens GN=CYFIP1 PE=1 SV=1 | 820 | G | 0.171035 | S | 0.217874 | -0.046839 | No Change: Both O | - |
| Q96F07 | CYFP2_HUMAN Cytoplasmic FMR1-interacting protein 2 OS=Homo sapiens GN=CYFIP2 PE=1 SV=2 | 320 | K | 0.303612 | E | 0.322215 | -0.018603 | No Change: Both O | - |
| P35663 | CYLC1_HUMAN Cylicin-1 OS=Homo sapiens GN=CYLC1 PE=1 SV=2 | 399 | D | 0.996349 | H | 0.994119 | 0.00223 | No Change: Both D | - |
| Q14093 | CYLC2_HUMAN Cylicin-2 OS=Homo sapiens GN=CYLC2 PE=2 SV=1 | 190 | K | 0.999745 | E | 0.999721 | 2.40E-05 | No Change: Both D | - |
| Q14093 | CYLC2_HUMAN Cylicin-2 OS=Homo sapiens GN=CYLC2 PE=2 SV=1 | 208 | G | 0.999138 | D | 0.999241 | -1.03E-04 | No Change: Both D | - |
| Q14093 | CYLC2_HUMAN Cylicin-2 OS=Homo sapiens GN=CYLC2 PE=2 SV=1 | 319 | A | 0.999857 | E | 0.99988 | -2.30E-05 | No Change: Both D | - |
| Q14093 | CYLC2_HUMAN Cylicin-2 OS=Homo sapiens GN=CYLC2 PE=2 SV=1 | 146 | D | 0.999387 | Y | 0.998587 | 8.00E-04 | No Change: Both D | - |
| Q14093 | CYLC2_HUMAN Cylicin-2 OS=Homo sapiens GN=CYLC2 PE=2 SV=1 | 184 | G | 0.999724 | D | 0.999773 | -4.90E-05 | No Change: Both D | - |
| Q9NQC7 | CYLD_HUMAN Ubiquitin carboxyl-terminal hydrolase CYLD OS=Homo sapiens GN=CYLD PE=1 SV=1 | 747 | E | 0.199642 | G | 0.162879 | 0.036763 | No Change: Both O | Brooke-Spiegler syndrome (BRSS) [MIM:605041] |
| Q9NQC7 | CYLD_HUMAN Ubiquitin carboxyl-terminal hydrolase CYLD OS=Homo sapiens GN=CYLD PE=1 SV=1 | 747 | E | 0.199642 | G | 0.162879 | 0.036763 | No Change: Both O | Multiple familial trichoepithelioma type 1 (MFT1) [MIM:601606] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 314 | E | 0.486758 | K | 0.504046 | -0.017288 | O to D | - |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 189 | A | 0.609617 | V | 0.555552 | 0.054065 | No Change: Both D | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 353 | R | 0.266143 | W | 0.112466 | 0.153677 | No Change: Both O | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 141 | L | 0.204597 | W | 0.152076 | 0.052521 | No Change: Both O | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 222 | L | 0.380164 | P | 0.536974 | -0.15681 | O to D | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 359 | A | 0.359061 | V | 0.274006 | 0.085055 | No Change: Both O | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P05108 | CP11A_HUMAN Cholesterol side-chain cleavage enzyme mitochondrial OS=Homo sapiens GN=CYP11A1 PE=1 SV=2 | 415 | V | 0.073201 | E | 0.153935 | -0.080734 | No Change: Both O | Adrenal insufficiency congenital with 46 XY sex reversal (AICSR) [MIM:613743] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 42 | P | 0.425686 | S | 0.419007 | 0.006679 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 133 | N | 0.134669 | H | 0.120743 | 0.013926 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 318 | T | 0.243637 | M | 0.218385 | 0.025252 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 319 | T | 0.214865 | M | 0.191435 | 0.02343 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 374 | R | 0.15832 | Q | 0.162489 | -0.004169 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 448 | R | 0.167525 | H | 0.156387 | 0.011138 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 494 | F | 0.109923 | C | 0.095015 | 0.014908 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 10 | C | 0.239277 | Y | 0.181908 | 0.057369 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 43 | R | 0.416351 | Q | 0.408572 | 0.007779 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 160 | M | 0.2436 | I | 0.159095 | 0.084505 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 293 | L | 0.16605 | V | 0.160016 | 0.006034 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 348 | A | 0.632678 | T | 0.637442 | -0.004764 | No Change: Both D | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 386 | A | 0.209224 | V | 0.168473 | 0.040751 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 63 | D | 0.348822 | H | 0.333568 | 0.015254 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 173 | K | 0.44687 | R | 0.384582 | 0.062288 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 257 | F | 0.109923 | L | 0.120069 | -0.010146 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 281 | S | 0.321021 | N | 0.270261 | 0.05076 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 439 | Y | 0.216573 | H | 0.335319 | -0.118746 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 248 | T | 0.402245 | I | 0.256268 | 0.145977 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 404 | R | 0.063711 | H | 0.062043 | 0.001668 | No Change: Both O | - |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 379 | G | 0.101113 | V | 0.063933 | 0.03718 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 454 | R | 0.253669 | C | 0.129573 | 0.124096 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 94 | P | 0.231612 | L | 0.13549 | 0.096122 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P15538 | C11B1_HUMAN Cytochrome P450 11B1 mitochondrial OS=Homo sapiens GN=CYP11B1 PE=1 SV=5 | 318 | T | 0.243637 | R | 0.241626 | 0.002011 | No Change: Both O | Adrenal hyperplasia type 4 (AH4) [MIM:202010] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 173 | K | 0.452649 | R | 0.391201 | 0.061448 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 181 | R | 0.337598 | W | 0.163845 | 0.173753 | No Change: Both O | Corticosterone methyloxidase type 2 deficiency (CMO-2 deficiency) [MIM:610600] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 198 | E | 0.176823 | D | 0.159052 | 0.017771 | No Change: Both O | Corticosterone methyloxidase type 2 deficiency (CMO-2 deficiency) [MIM:610600] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 386 | V | 0.169887 | A | 0.21159 | -0.041703 | No Change: Both O | Corticosterone methyloxidase type 2 deficiency (CMO-2 deficiency) [MIM:610600] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 29 | A | 0.491087 | T | 0.506217 | -0.01513 | O to D | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 30 | R | 0.464175 | Q | 0.451059 | 0.013116 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 248 | I | 0.256242 | T | 0.402209 | -0.145967 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 281 | N | 0.248844 | S | 0.288327 | -0.039483 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 339 | I | 0.431584 | T | 0.584181 | -0.152597 | O to D | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 435 | G | 0.391282 | S | 0.442443 | -0.051161 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 222 | N | 0.406162 | T | 0.371993 | 0.034169 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 383 | E | 0.134514 | V | 0.066196 | 0.068318 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 403 | V | 0.067694 | E | 0.144267 | -0.076573 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 487 | F | 0.099228 | V | 0.120017 | -0.020789 | No Change: Both O | - |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 185 | T | 0.303372 | I | 0.191499 | 0.111873 | No Change: Both O | Corticosterone methyloxidase type 2 deficiency (CMO-2 deficiency) [MIM:610600] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 461 | L | 0.208762 | P | 0.32402 | -0.115258 | No Change: Both O | Corticosterone methyloxidase type 1 deficiency (CMO-1 deficiency) [MIM:203400] |
| P19099 | C11B2_HUMAN Cytochrome P450 11B2 mitochondrial OS=Homo sapiens GN=CYP11B2 PE=1 SV=3 | 498 | T | 0.388627 | A | 0.354796 | 0.033831 | No Change: Both O | Corticosterone methyloxidase type 2 deficiency (CMO-2 deficiency) [MIM:610600] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 64 | Y | 0.270454 | S | 0.447878 | -0.177424 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 106 | S | 0.370341 | P | 0.346905 | 0.023436 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 342 | P | 0.465947 | T | 0.436357 | 0.02959 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 347 | R | 0.375163 | H | 0.351679 | 0.023484 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 358 | R | 0.177056 | Q | 0.166561 | 0.010495 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 373 | H | 0.369488 | L | 0.261263 | 0.108225 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 440 | R | 0.229149 | H | 0.228947 | 2.02E-04 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 496 | R | 0.238451 | C | 0.122275 | 0.116176 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 22 | C | 0.28398 | W | 0.263518 | 0.020462 | No Change: Both O | - |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 93 | F | 0.561737 | C | 0.548607 | 0.01313 | No Change: Both D | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 35 | P | 0.288884 | L | 0.162435 | 0.126449 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 96 | R | 0.466221 | W | 0.273069 | 0.193152 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 114 | F | 0.327612 | V | 0.343848 | -0.016236 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 116 | D | 0.277861 | V | 0.155384 | 0.122477 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 177 | N | 0.032359 | D | 0.033903 | -0.001544 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 329 | Y | 0.45251 | D | 0.605133 | -0.152623 | O to D | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 347 | R | 0.375163 | C | 0.208899 | 0.166264 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 362 | R | 0.185211 | C | 0.086861 | 0.09835 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 406 | W | 0.630072 | R | 0.740731 | -0.110659 | No Change: Both D | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 417 | F | 0.314443 | C | 0.289188 | 0.025255 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 428 | P | 0.333393 | L | 0.192143 | 0.14125 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P05093 | CP17A_HUMAN Steroid 17-alpha-hydroxylase/17 20 lyase OS=Homo sapiens GN=CYP17A1 PE=1 SV=1 | 496 | R | 0.238451 | H | 0.215926 | 0.022525 | No Change: Both O | Adrenal hyperplasia type 5 (AH5) [MIM:202110] |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 365 | R | 0.166295 | Q | 0.188976 | -0.022681 | No Change: Both O | Aromatase deficiency (AROD) [MIM:613546] |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 375 | R | 0.202214 | C | 0.103213 | 0.099001 | No Change: Both O | Aromatase deficiency (AROD) [MIM:613546] |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 435 | R | 0.223764 | C | 0.124269 | 0.099495 | No Change: Both O | Aromatase deficiency (AROD) [MIM:613546] |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 437 | C | 0.189106 | Y | 0.24282 | -0.053714 | No Change: Both O | Aromatase deficiency (AROD) [MIM:613546] |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 264 | R | 0.564213 | C | 0.401744 | 0.162469 | D to O | - |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 39 | W | 0.062197 | R | 0.152408 | -0.090211 | No Change: Both O | - |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 201 | T | 0.161557 | M | 0.132444 | 0.029113 | No Change: Both O | - |
| P11511 | CP19A_HUMAN Cytochrome P450 19A1 OS=Homo sapiens GN=CYP19A1 PE=1 SV=3 | 375 | R | 0.202214 | L | 0.134099 | 0.068115 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 462 | I | 0.074549 | V | 0.085105 | -0.010556 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 461 | T | 0.1097 | N | 0.128963 | -0.019263 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 279 | R | 0.364389 | W | 0.1898 | 0.174589 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 331 | M | 0.067006 | I | 0.043563 | 0.023443 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 448 | I | 0.124378 | N | 0.238406 | -0.114028 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 464 | R | 0.034907 | C | 0.016204 | 0.018703 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 464 | R | 0.034907 | S | 0.046249 | -0.011342 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 477 | R | 0.072249 | W | 0.027624 | 0.044625 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 492 | P | 0.181559 | R | 0.153012 | 0.028547 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 286 | I | 0.315004 | T | 0.456301 | -0.141297 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 45 | G | 0.230617 | D | 0.233317 | -0.0027 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 78 | I | 0.164142 | T | 0.267911 | -0.103769 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 93 | R | 0.239398 | W | 0.096016 | 0.143382 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 173 | T | 0.228608 | R | 0.240409 | -0.011801 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 482 | V | 0.163232 | M | 0.194336 | -0.031104 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 66 | M | 0.434642 | V | 0.377395 | 0.057247 | No Change: Both O | - |
| P04798 | CP1A1_HUMAN Cytochrome P450 1A1 OS=Homo sapiens GN=CYP1A1 PE=1 SV=1 | 470 | F | 0.010512 | V | 0.012337 | -0.001825 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 21 | F | 0.020497 | L | 0.026937 | -0.00644 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 348 | D | 0.392223 | N | 0.363953 | 0.02827 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 386 | I | 0.424592 | F | 0.4491 | -0.024508 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 406 | C | 0.054699 | Y | 0.052502 | 0.002197 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 431 | R | 0.421411 | W | 0.224691 | 0.19672 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 83 | T | 0.189265 | M | 0.1643 | 0.024965 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 168 | E | 0.553206 | Q | 0.501228 | 0.051978 | No Change: Both D | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 186 | F | 0.296925 | L | 0.334038 | -0.037113 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 212 | S | 0.604773 | C | 0.385491 | 0.219282 | D to O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 299 | G | 0.52061 | S | 0.566897 | -0.046287 | No Change: Both D | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 438 | T | 0.350799 | I | 0.225684 | 0.125115 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 18 | S | 0.046074 | C | 0.017872 | 0.028202 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 298 | S | 0.618912 | R | 0.564335 | 0.054577 | No Change: Both D | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 314 | I | 0.093369 | V | 0.112755 | -0.019386 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 42 | P | 0.621434 | R | 0.565028 | 0.056406 | No Change: Both D | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 73 | G | 0.289451 | R | 0.300059 | -0.010608 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 104 | D | 0.504246 | N | 0.456367 | 0.047879 | D to O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 111 | L | 0.406116 | F | 0.37306 | 0.033056 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 205 | F | 0.155093 | V | 0.168468 | -0.013375 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 281 | R | 0.306417 | W | 0.147011 | 0.159406 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 377 | R | 0.258239 | Q | 0.256318 | 0.001921 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 456 | R | 0.196637 | H | 0.186129 | 0.010508 | No Change: Both O | - |
| P05177 | CP1A2_HUMAN Cytochrome P450 1A2 OS=Homo sapiens GN=CYP1A2 PE=1 SV=3 | 457 | R | 0.163458 | W | 0.064325 | 0.099133 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 61 | G | 0.233833 | E | 0.237963 | -0.00413 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 61 | G | 0.233833 | E | 0.237963 | -0.00413 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 365 | G | 0.271295 | W | 0.113001 | 0.158294 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 374 | D | 0.348935 | N | 0.339168 | 0.009767 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 469 | R | 0.253649 | W | 0.110998 | 0.142651 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 432 | L | 0.436566 | V | 0.455859 | -0.019293 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 57 | W | 0.236836 | C | 0.308166 | -0.07133 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 379 | P | 0.128184 | L | 0.066076 | 0.062108 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 387 | E | 0.093368 | K | 0.092693 | 6.75E-04 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 387 | E | 0.093368 | K | 0.092693 | 6.75E-04 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 390 | R | 0.118838 | H | 0.119527 | -6.89E-04 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 437 | P | 0.523426 | L | 0.347925 | 0.175501 | D to O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 453 | N | 0.36187 | S | 0.42194 | -0.06007 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 48 | R | 0.626324 | G | 0.614693 | 0.011631 | No Change: Both D | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 119 | A | 0.325672 | S | 0.433001 | -0.107329 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 368 | R | 0.307547 | H | 0.292824 | 0.014723 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 443 | A | 0.351085 | G | 0.420286 | -0.069201 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 443 | A | 0.351085 | G | 0.420286 | -0.069201 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 206 | S | 0.089377 | N | 0.076325 | 0.013052 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 266 | R | 0.257637 | L | 0.167761 | 0.089876 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 68 | Q | 0.306315 | R | 0.301253 | 0.005062 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 81 | Y | 0.146019 | N | 0.245915 | -0.099896 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 441 | D | 0.402238 | H | 0.345843 | 0.056395 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 449 | D | 0.347284 | E | 0.348164 | -8.80E-04 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 28 | S | 0.341849 | W | 0.149469 | 0.19238 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 52 | P | 0.459254 | L | 0.295174 | 0.16408 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 77 | L | 0.209265 | P | 0.336391 | -0.127126 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 115 | A | 0.386342 | P | 0.460623 | -0.074281 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 132 | M | 0.493717 | R | 0.567068 | -0.073351 | O to D | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 144 | Q | 0.565061 | H | 0.564854 | 2.07E-04 | No Change: Both D | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 144 | Q | 0.565061 | P | 0.586297 | -0.021236 | No Change: Both D | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 144 | Q | 0.565061 | R | 0.593172 | -0.028111 | No Change: Both D | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 145 | R | 0.557168 | W | 0.335163 | 0.222005 | D to O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 184 | G | 0.247023 | S | 0.298652 | -0.051629 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 189 | A | 0.345449 | P | 0.421372 | -0.075923 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 192 | D | 0.291353 | V | 0.17285 | 0.118503 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 193 | P | 0.25342 | L | 0.146117 | 0.107303 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 198 | V | 0.140861 | I | 0.107116 | 0.033745 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 203 | N | 0.109372 | S | 0.151775 | -0.042403 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 215 | S | 0.270844 | I | 0.128748 | 0.142096 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 229 | E | 0.518858 | K | 0.492547 | 0.026311 | D to O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 229 | E | 0.518858 | K | 0.492547 | 0.026311 | D to O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 232 | G | 0.472902 | R | 0.453187 | 0.019715 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 232 | G | 0.472902 | R | 0.453187 | 0.019715 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 239 | S | 0.192253 | R | 0.164966 | 0.027287 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 320 | V | 0.247175 | L | 0.274993 | -0.027818 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 330 | A | 0.330761 | F | 0.237872 | 0.092889 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 330 | A | 0.330761 | S | 0.442673 | -0.111912 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 345 | L | 0.050995 | F | 0.041032 | 0.009963 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 364 | V | 0.278967 | M | 0.33294 | -0.053973 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 388 | A | 0.109128 | T | 0.116058 | -0.00693 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 390 | R | 0.118838 | C | 0.056674 | 0.062164 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 390 | R | 0.118838 | S | 0.170283 | -0.051445 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 399 | I | 0.284832 | S | 0.546865 | -0.262033 | O to D | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 409 | V | 0.295664 | F | 0.271965 | 0.023699 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 422 | V | 0.126733 | G | 0.19201 | -0.065277 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 423 | N | 0.135966 | Y | 0.067282 | 0.068684 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 423 | N | 0.135966 | Y | 0.067282 | 0.068684 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 444 | R | 0.328254 | Q | 0.34349 | -0.015236 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 445 | F | 0.296696 | C | 0.278464 | 0.018232 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 466 | G | 0.192667 | D | 0.207767 | -0.0151 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 499 | E | 0.563685 | G | 0.546658 | 0.017027 | No Change: Both D | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 515 | S | 0.360267 | L | 0.219972 | 0.140295 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 518 | V | 0.362552 | A | 0.428528 | -0.065976 | No Change: Both O | - |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 523 | R | 0.393644 | T | 0.405194 | -0.01155 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q16678 | CP1B1_HUMAN Cytochrome P450 1B1 OS=Homo sapiens GN=CYP1B1 PE=1 SV=2 | 530 | D | 0.45139 | G | 0.427686 | 0.023704 | No Change: Both O | Primary open angle glaucoma (POAG) [MIM:137760] |
| Q6UW02 | CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens GN=CYP20A1 PE=1 SV=1 | 97 | S | 0.640722 | L | 0.488534 | 0.152188 | D to O | - |
| Q6UW02 | CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens GN=CYP20A1 PE=1 SV=1 | 346 | L | 0.329254 | F | 0.294707 | 0.034547 | No Change: Both O | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 30 | P | 0.278061 | L | 0.156948 | 0.121113 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 98 | K | 0.340893 | R | 0.272801 | 0.068092 | No Change: Both O | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 102 | K | 0.375263 | R | 0.301631 | 0.073632 | No Change: Both O | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 105 | P | 0.413191 | L | 0.281424 | 0.131767 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 169 | C | 0.047248 | Y | 0.049771 | -0.002523 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 172 | I | 0.025082 | N | 0.050454 | -0.025372 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 183 | D | 0.450573 | E | 0.454433 | -0.00386 | No Change: Both O | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 236 | I | 0.366585 | N | 0.539964 | -0.173379 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 237 | V | 0.385244 | E | 0.596787 | -0.211543 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 239 | M | 0.452908 | K | 0.580292 | -0.127384 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 268 | S | 0.638901 | T | 0.562224 | 0.076677 | No Change: Both D | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 281 | V | 0.244534 | L | 0.25236 | -0.007826 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 291 | G | 0.236874 | S | 0.266413 | -0.029539 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 339 | R | 0.560171 | H | 0.501853 | 0.058318 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 341 | R | 0.530132 | W | 0.273734 | 0.256398 | D to O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 356 | R | 0.342923 | P | 0.374528 | -0.031605 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 356 | R | 0.342923 | Q | 0.286077 | 0.056846 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 356 | R | 0.342923 | W | 0.126461 | 0.216462 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 380 | E | 0.283237 | D | 0.274134 | 0.009103 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 453 | P | 0.326011 | S | 0.341361 | -0.01535 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 483 | R | 0.820788 | P | 0.861063 | -0.040275 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 493 | N | 0.89144 | S | 0.928944 | -0.037504 | No Change: Both D | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 64 | G | 0.092356 | E | 0.112387 | -0.020031 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 362 | A | 0.383 | V | 0.326416 | 0.056584 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 62 | H | 0.085745 | L | 0.053421 | 0.032324 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 291 | G | 0.236874 | R | 0.213721 | 0.023153 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 301 | S | 0.114042 | Y | 0.050017 | 0.064025 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 341 | R | 0.530132 | P | 0.565038 | -0.034906 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 483 | R | 0.820788 | Q | 0.848034 | -0.027246 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 15 | A | 0.065765 | T | 0.063117 | 0.002648 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 30 | P | 0.278061 | Q | 0.242188 | 0.035873 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 90 | G | 0.265141 | V | 0.163416 | 0.101725 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 124 | R | 0.298223 | H | 0.304898 | -0.006675 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 178 | G | 0.147326 | A | 0.116425 | 0.030901 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 211 | V | 0.039312 | L | 0.039128 | 1.84E-04 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 261 | L | 0.408194 | P | 0.574764 | -0.16657 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 281 | V | 0.244534 | G | 0.374995 | -0.130461 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 283 | M | 0.163822 | L | 0.136792 | 0.02703 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 291 | G | 0.236874 | C | 0.120043 | 0.116831 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 300 | L | 0.152538 | F | 0.136514 | 0.016024 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 304 | V | 0.071359 | M | 0.091601 | -0.020242 | No Change: Both O | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 317 | L | 0.615832 | M | 0.65086 | -0.035028 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 354 | R | 0.330218 | C | 0.195907 | 0.134311 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 354 | R | 0.330218 | H | 0.260442 | 0.069776 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 363 | L | 0.407074 | W | 0.294736 | 0.112338 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 365 | H | 0.481197 | Y | 0.369745 | 0.111452 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 375 | G | 0.548303 | S | 0.611773 | -0.06347 | No Change: Both D | - |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 408 | R | 0.337949 | C | 0.190878 | 0.147071 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 424 | G | 0.115736 | S | 0.137165 | -0.021429 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 426 | R | 0.108691 | H | 0.095131 | 0.01356 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 435 | R | 0.145405 | C | 0.090983 | 0.054422 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 479 | R | 0.710293 | L | 0.610172 | 0.100121 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 482 | P | 0.801608 | S | 0.786235 | 0.015373 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 483 | R | 0.820788 | W | 0.609827 | 0.210961 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 56 | G | 0.166755 | R | 0.157461 | 0.009294 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 77 | I | 0.379975 | T | 0.549256 | -0.169281 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 107 | L | 0.374423 | R | 0.463061 | -0.088638 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 121 | K | 0.339475 | Q | 0.283544 | 0.055931 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 142 | L | 0.347856 | P | 0.544392 | -0.196536 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 167 | L | 0.078009 | P | 0.14763 | -0.069621 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 230 | I | 0.478154 | T | 0.609004 | -0.13085 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 233 | R | 0.422999 | K | 0.500316 | -0.077317 | O to D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 292 | G | 0.274105 | D | 0.293309 | -0.019204 | No Change: Both O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 320 | E | 0.616146 | K | 0.592118 | 0.024028 | No Change: Both D | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| P08686 | CP21A_HUMAN Steroid 21-hydroxylase OS=Homo sapiens GN=CYP21A2 PE=1 SV=1 | 369 | R | 0.626014 | W | 0.424408 | 0.201606 | D to O | Adrenal hyperplasia type 3 (AH3) [MIM:201910] |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 157 | R | 0.259798 | Q | 0.278642 | -0.018844 | No Change: Both O | - |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 374 | M | 0.562104 | T | 0.579037 | -0.016933 | No Change: Both D | - |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 409 | L | 0.306537 | S | 0.432586 | -0.126049 | No Change: Both O | Hypercalcemia infantile (HCAI) [MIM:143880] |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 159 | R | 0.285555 | Q | 0.307177 | -0.021622 | No Change: Both O | Hypercalcemia infantile (HCAI) [MIM:143880] |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 322 | E | 0.186559 | K | 0.179964 | 0.006595 | No Change: Both O | Hypercalcemia infantile (HCAI) [MIM:143880] |
| Q07973 | CP24A_HUMAN 1 25-dihydroxyvitamin D(3) 24-hydroxylase mitochondrial OS=Homo sapiens GN=CYP24A1 PE=1 SV=2 | 396 | R | 0.39091 | W | 0.194268 | 0.196642 | No Change: Both O | Hypercalcemia infantile (HCAI) [MIM:143880] |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 264 | L | 0.538975 | S | 0.651872 | -0.112897 | No Change: Both D | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 181 | V | 0.334184 | M | 0.39826 | -0.064076 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 185 | A | 0.242912 | V | 0.178988 | 0.063924 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 191 | R | 0.088441 | H | 0.083707 | 0.004734 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 227 | D | 0.221373 | N | 0.211251 | 0.010122 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 380 | E | 0.158335 | K | 0.163206 | -0.004871 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 420 | A | 0.700467 | G | 0.742334 | -0.041867 | No Change: Both D | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 473 | R | 0.146665 | C | 0.068559 | 0.078106 | No Change: Both O | - |
| Q9NR63 | CP26B_HUMAN Cytochrome P450 26B1 OS=Homo sapiens GN=CYP26B1 PE=2 SV=1 | 479 | V | 0.125351 | I | 0.106466 | 0.018885 | No Change: Both O | - |
| Q6V0L0 | CP26C_HUMAN Cytochrome P450 26C1 OS=Homo sapiens GN=CYP26C1 PE=2 SV=2 | 245 | R | 0.49735 | Q | 0.499121 | -0.001771 | No Change: Both O | - |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 395 | R | 0.153177 | C | 0.075983 | 0.077194 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 479 | R | 0.149391 | C | 0.073046 | 0.076345 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 395 | R | 0.153177 | S | 0.19885 | -0.045673 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 405 | R | 0.29693 | Q | 0.315311 | -0.018381 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 474 | R | 0.121582 | Q | 0.120962 | 6.20E-04 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 474 | R | 0.121582 | W | 0.043437 | 0.078145 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 145 | G | 0.429016 | E | 0.481847 | -0.052831 | No Change: Both O | Cerebrotendinous xanthomatosis (CTX) [MIM:213700] |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 175 | T | 0.188456 | M | 0.164908 | 0.023548 | No Change: Both O | - |
| Q02318 | CP27A_HUMAN Sterol 26-hydroxylase mitochondrial OS=Homo sapiens GN=CYP27A1 PE=1 SV=1 | 169 | A | 0.315295 | V | 0.224945 | 0.09035 | No Change: Both O | - |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 107 | R | 0.686201 | H | 0.639793 | 0.046408 | No Change: Both D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 125 | G | 0.778275 | E | 0.83092 | -0.052645 | No Change: Both D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 189 | E | 0.180445 | G | 0.161499 | 0.018946 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 321 | T | 0.216205 | R | 0.214464 | 0.001741 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 335 | R | 0.358793 | P | 0.41975 | -0.060957 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 343 | L | 0.453751 | F | 0.404385 | 0.049366 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 382 | P | 0.185286 | S | 0.1973 | -0.012014 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 389 | R | 0.49627 | H | 0.516977 | -0.020707 | O to D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 389 | R | 0.49627 | G | 0.529919 | -0.033649 | O to D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 409 | T | 0.114275 | I | 0.061816 | 0.052459 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 189 | E | 0.180445 | K | 0.181224 | -7.79E-04 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 389 | R | 0.49627 | C | 0.33788 | 0.15839 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 65 | Q | 0.392722 | H | 0.382775 | 0.009947 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 323 | S | 0.195685 | Y | 0.088654 | 0.107031 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 429 | R | 0.497401 | P | 0.554451 | -0.05705 | O to D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 453 | R | 0.523229 | C | 0.422527 | 0.100702 | D to O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 478 | V | 0.435348 | G | 0.561094 | -0.125746 | O to D | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 497 | P | 0.369619 | R | 0.343186 | 0.026433 | No Change: Both O | Rickets vitamin D-dependent type 1A (VDDR1A) [MIM:264700] |
| O15528 | CP27B_HUMAN 25-hydroxyvitamin D-1 alpha hydroxylase mitochondrial OS=Homo sapiens GN=CYP27B1 PE=1 SV=1 | 166 | V | 0.295517 | L | 0.314792 | -0.019275 | No Change: Both O | - |
| Q4G0S4 | C27C1_HUMAN Cytochrome P450 27C1 OS=Homo sapiens GN=CYP27C1 PE=2 SV=2 | 359 | T | 0.443747 | M | 0.376511 | 0.067236 | No Change: Both O | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 257 | R | 0.620748 | C | 0.498315 | 0.122433 | D to O | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 25 | R | 0.333719 | Q | 0.345762 | -0.012043 | No Change: Both O | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 101 | R | 0.546992 | Q | 0.584946 | -0.037954 | No Change: Both D | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 158 | D | 0.199036 | E | 0.234348 | -0.035312 | No Change: Both O | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 453 | F | 0.05636 | Y | 0.049631 | 0.006729 | No Change: Both O | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 494 | R | 0.56001 | C | 0.510074 | 0.049936 | No Change: Both D | - |
| Q16696 | CP2AD_HUMAN Cytochrome P450 2A13 OS=Homo sapiens GN=CYP2A13 PE=1 SV=3 | 323 | V | 0.49417 | L | 0.49164 | 0.00253 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 160 | L | 0.218552 | H | 0.310141 | -0.091589 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 479 | G | 0.285103 | V | 0.210992 | 0.074111 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 128 | R | 0.321962 | Q | 0.330326 | -0.008364 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 471 | I | 0.679809 | T | 0.724937 | -0.045128 | No Change: Both D | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 485 | R | 0.324406 | L | 0.195206 | 0.1292 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 5 | G | 0.367772 | R | 0.365599 | 0.002173 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 29 | S | 0.656144 | N | 0.617789 | 0.038355 | No Change: Both D | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 194 | K | 0.373026 | E | 0.372486 | 5.40E-04 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 203 | R | 0.104066 | S | 0.14455 | -0.040484 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 419 | E | 0.613814 | D | 0.613728 | 8.60E-05 | No Change: Both D | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 118 | F | 0.223583 | L | 0.235396 | -0.011813 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 224 | S | 0.384916 | P | 0.363018 | 0.021898 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 365 | V | 0.244128 | M | 0.337783 | -0.093655 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 418 | N | 0.594499 | D | 0.607949 | -0.01345 | No Change: Both D | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 476 | K | 0.387292 | R | 0.337983 | 0.049309 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 294 | T | 0.099677 | S | 0.121313 | -0.021636 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 392 | F | 0.446899 | Y | 0.373989 | 0.07291 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 203 | R | 0.104066 | C | 0.055044 | 0.049022 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 110 | V | 0.082384 | L | 0.077039 | 0.005345 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 128 | R | 0.321962 | L | 0.21234 | 0.109622 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 131 | S | 0.204757 | A | 0.150235 | 0.054522 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 438 | N | 0.262526 | Y | 0.152266 | 0.11026 | No Change: Both O | - |
| P11509 | CP2A6_HUMAN Cytochrome P450 2A6 OS=Homo sapiens GN=CYP2A6 PE=1 SV=3 | 292 | V | 0.133312 | M | 0.206209 | -0.072897 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 61 | F | 0.182709 | I | 0.191945 | -0.009236 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 64 | C | 0.128055 | R | 0.236673 | -0.108618 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 274 | H | 0.397514 | R | 0.422724 | -0.02521 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 301 | A | 0.187832 | G | 0.244057 | -0.056225 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 311 | R | 0.134989 | C | 0.068875 | 0.066114 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 368 | M | 0.264383 | T | 0.281127 | -0.016744 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 169 | D | 0.293304 | E | 0.321615 | -0.028311 | No Change: Both O | - |
| P20853 | CP2A7_HUMAN Cytochrome P450 2A7 OS=Homo sapiens GN=CYP2A7 PE=1 SV=2 | 479 | V | 0.210992 | G | 0.285103 | -0.074111 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 167 | P | 0.221726 | A | 0.179956 | 0.04177 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 172 | Q | 0.092941 | H | 0.083606 | 0.009335 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 262 | K | 0.509151 | R | 0.455454 | 0.053697 | D to O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 22 | R | 0.454223 | C | 0.301727 | 0.152496 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 259 | S | 0.576915 | R | 0.539994 | 0.036921 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 487 | R | 0.468703 | C | 0.29712 | 0.171583 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 139 | K | 0.569181 | E | 0.593819 | -0.024638 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 21 | Q | 0.405097 | L | 0.34336 | 0.061737 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 46 | M | 0.489491 | V | 0.435462 | 0.054029 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 99 | G | 0.33814 | E | 0.389106 | -0.050966 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 140 | R | 0.590631 | Q | 0.597854 | -0.007223 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 391 | I | 0.109696 | N | 0.218043 | -0.108347 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 328 | I | 0.325007 | T | 0.439831 | -0.114824 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 26 | T | 0.659265 | S | 0.708533 | -0.049268 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 28 | D | 0.732658 | G | 0.735602 | -0.002944 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 29 | R | 0.754325 | S | 0.761004 | -0.006679 | No Change: Both D | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 289 | N | 0.442954 | K | 0.464253 | -0.021299 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 306 | T | 0.305875 | S | 0.368275 | -0.0624 | No Change: Both O | - |
| P20813 | CP2B6_HUMAN Cytochrome P450 2B6 OS=Homo sapiens GN=CYP2B6 PE=1 SV=1 | 29 | R | 0.754325 | P | 0.78386 | -0.029535 | No Change: Both D | - |
| P33260 | CP2CI_HUMAN Cytochrome P450 2C18 OS=Homo sapiens GN=CYP2C18 PE=1 SV=3 | 385 | T | 0.232625 | M | 0.181497 | 0.051128 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 331 | V | 0.421112 | I | 0.382482 | 0.03863 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 120 | W | 0.377601 | R | 0.628565 | -0.250964 | O to D | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 132 | R | 0.404777 | Q | 0.368717 | 0.03606 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 433 | R | 0.187336 | W | 0.076914 | 0.110422 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 227 | P | 0.175006 | L | 0.093355 | 0.081651 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 17 | L | 0.085099 | P | 0.160255 | -0.075156 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 19 | I | 0.162691 | L | 0.209051 | -0.04636 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 92 | E | 0.433952 | D | 0.404948 | 0.029004 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 122 | E | 0.368817 | A | 0.270689 | 0.098128 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 144 | R | 0.568469 | H | 0.505774 | 0.062695 | No Change: Both D | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 150 | R | 0.417768 | H | 0.348179 | 0.069589 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 410 | R | 0.459949 | C | 0.31087 | 0.149079 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 442 | R | 0.092071 | C | 0.046296 | 0.045775 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 51 | S | 0.450615 | G | 0.379893 | 0.070722 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 161 | A | 0.479875 | P | 0.569212 | -0.089337 | O to D | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 329 | R | 0.436896 | H | 0.411735 | 0.025161 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 74 | M | 0.088839 | T | 0.112182 | -0.023343 | No Change: Both O | - |
| P33261 | CP2CJ_HUMAN Cytochrome P450 2C19 OS=Homo sapiens GN=CYP2C19 PE=1 SV=3 | 168 | F | 0.162691 | L | 0.188538 | -0.025847 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 154 | E | 0.401291 | D | 0.353781 | 0.04751 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 193 | N | 0.244955 | K | 0.299335 | -0.05438 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 249 | K | 0.523896 | R | 0.480908 | 0.042988 | D to O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 411 | H | 0.36705 | L | 0.27731 | 0.08974 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 264 | I | 0.139903 | M | 0.204954 | -0.065051 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 139 | R | 0.50871 | K | 0.543414 | -0.034704 | No Change: Both D | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 269 | I | 0.17671 | F | 0.185649 | -0.008939 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 399 | K | 0.483294 | R | 0.430376 | 0.052918 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 390 | L | 0.167413 | S | 0.295938 | -0.128525 | No Change: Both O | - |
| P10632 | CP2C8_HUMAN Cytochrome P450 2C8 OS=Homo sapiens GN=CYP2C8 PE=1 SV=2 | 244 | I | 0.348699 | V | 0.396014 | -0.047315 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 144 | R | 0.564452 | C | 0.432363 | 0.132089 | D to O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 358 | Y | 0.161511 | C | 0.146251 | 0.01526 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 359 | I | 0.169615 | L | 0.20749 | -0.037875 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 417 | G | 0.604315 | D | 0.629719 | -0.025404 | No Change: Both D | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 359 | I | 0.169615 | T | 0.295778 | -0.126163 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 360 | D | 0.179569 | E | 0.206153 | -0.026584 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 19 | L | 0.235498 | I | 0.180468 | 0.05503 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 150 | R | 0.414802 | H | 0.346904 | 0.067898 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 251 | H | 0.607651 | R | 0.606716 | 9.35E-04 | No Change: Both D | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 272 | E | 0.704846 | G | 0.626462 | 0.078384 | No Change: Both D | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 335 | R | 0.456947 | W | 0.227939 | 0.229008 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 489 | P | 0.234796 | S | 0.26485 | -0.030054 | No Change: Both O | - |
| P11712 | CP2C9_HUMAN Cytochrome P450 2C9 OS=Homo sapiens GN=CYP2C9 PE=1 SV=3 | 413 | L | 0.483201 | P | 0.659502 | -0.176301 | O to D | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 42 | G | 0.396873 | R | 0.365008 | 0.031865 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 34 | P | 0.403847 | S | 0.406548 | -0.002701 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 107 | T | 0.222483 | I | 0.138865 | 0.083618 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 169 | G | 0.459413 | R | 0.459385 | 2.80E-05 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 212 | G | 0.546786 | E | 0.607334 | -0.060548 | No Change: Both D | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 296 | R | 0.207644 | C | 0.124896 | 0.082748 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 486 | S | 0.367242 | T | 0.259441 | 0.107801 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 324 | H | 0.143013 | P | 0.1816 | -0.038587 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 11 | V | 0.019879 | M | 0.027446 | -0.007567 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 26 | R | 0.225117 | H | 0.220469 | 0.004648 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 28 | R | 0.308212 | C | 0.150232 | 0.15798 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 85 | A | 0.133069 | V | 0.098623 | 0.034446 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 237 | A | 0.147464 | S | 0.201602 | -0.054138 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 297 | I | 0.151777 | L | 0.194653 | -0.042876 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 343 | R | 0.442264 | G | 0.456093 | -0.013829 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 369 | I | 0.173611 | T | 0.291927 | -0.118316 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 410 | E | 0.291699 | K | 0.292809 | -0.00111 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 311 | S | 0.210852 | L | 0.102455 | 0.108397 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 91 | L | 0.309318 | M | 0.365744 | -0.056426 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 94 | H | 0.484882 | R | 0.495639 | -0.010757 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 120 | F | 0.232455 | I | 0.22115 | 0.011305 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 155 | E | 0.194577 | K | 0.18915 | 0.005427 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 418 | E | 0.328021 | K | 0.329476 | -0.001455 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 469 | P | 0.558568 | A | 0.469319 | 0.089249 | D to O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 478 | H | 0.434402 | Y | 0.292127 | 0.142275 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 231 | L | 0.083711 | P | 0.159645 | -0.075934 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 300 | A | 0.102209 | G | 0.122944 | -0.020735 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 365 | R | 0.168844 | H | 0.170099 | -0.001255 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 329 | R | 0.386611 | L | 0.261567 | 0.125044 | No Change: Both O | - |
| P10635 | CP2D6_HUMAN Cytochrome P450 2D6 OS=Homo sapiens GN=CYP2D6 PE=1 SV=2 | 373 | G | 0.20619 | S | 0.2471 | -0.04091 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 76 | R | 0.202961 | H | 0.219045 | -0.016084 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 179 | V | 0.034925 | I | 0.035459 | -5.34E-04 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 389 | V | 0.170655 | I | 0.146075 | 0.02458 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 457 | H | 0.062898 | L | 0.04207 | 0.020828 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 219 | N | 0.126976 | D | 0.126985 | -9.00E-06 | No Change: Both O | - |
| P05181 | CP2E1_HUMAN Cytochrome P450 2E1 OS=Homo sapiens GN=CYP2E1 PE=1 SV=1 | 366 | S | 0.285252 | C | 0.125938 | 0.159314 | No Change: Both O | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 38 | S | 0.413723 | P | 0.420576 | -0.006853 | No Change: Both O | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 98 | R | 0.474956 | P | 0.528555 | -0.053599 | O to D | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 218 | D | 0.116408 | N | 0.105865 | 0.010543 | No Change: Both O | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 266 | Q | 0.323773 | H | 0.30395 | 0.019823 | No Change: Both O | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 391 | L | 0.149328 | P | 0.268909 | -0.119581 | No Change: Both O | - |
| P24903 | CP2F1_HUMAN Cytochrome P450 2F1 OS=Homo sapiens GN=CYP2F1 PE=1 SV=2 | 490 | P | 0.852808 | L | 0.724609 | 0.128199 | No Change: Both D | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 143 | T | 0.384836 | A | 0.359902 | 0.024934 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 158 | R | 0.699384 | C | 0.572963 | 0.126421 | No Change: Both D | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 192 | I | 0.083318 | N | 0.172931 | -0.089613 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 342 | D | 0.328811 | N | 0.321347 | 0.007464 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 404 | N | 0.225638 | Y | 0.126433 | 0.099205 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 124 | N | 0.407613 | S | 0.465817 | -0.058204 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 49 | R | 0.196542 | S | 0.244976 | -0.048434 | No Change: Both O | - |
| P51589 | CP2J2_HUMAN Cytochrome P450 2J2 OS=Homo sapiens GN=CYP2J2 PE=1 SV=2 | 113 | V | 0.42854 | M | 0.514367 | -0.085827 | O to D | - |
| Q6VVX0 | CP2R1_HUMAN Vitamin D 25-hydroxylase OS=Homo sapiens GN=CYP2R1 PE=1 SV=1 | 99 | L | 0.139403 | P | 0.255676 | -0.116273 | No Change: Both O | Rickets vitamin D-dependent type 1B (VDDR1B) [MIM:600081] |
| Q96SQ9 | CP2S1_HUMAN Cytochrome P450 2S1 OS=Homo sapiens GN=CYP2S1 PE=2 SV=2 | 466 | P | 0.476169 | L | 0.325474 | 0.150695 | No Change: Both O | - |
| Q8TAV3 | CP2W1_HUMAN Cytochrome P450 2W1 OS=Homo sapiens GN=CYP2W1 PE=2 SV=2 | 181 | A | 0.063346 | T | 0.074446 | -0.0111 | No Change: Both O | - |
| Q9NYL5 | CP39A_HUMAN 24-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP39A1 PE=2 SV=2 | 23 | R | 0.211821 | P | 0.241185 | -0.029364 | No Change: Both O | - |
| Q9NYL5 | CP39A_HUMAN 24-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP39A1 PE=2 SV=2 | 103 | R | 0.1278 | H | 0.128734 | -9.34E-04 | No Change: Both O | - |
| Q9NYL5 | CP39A_HUMAN 24-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP39A1 PE=2 SV=2 | 288 | Y | 0.055468 | H | 0.101625 | -0.046157 | No Change: Both O | - |
| Q9NYL5 | CP39A_HUMAN 24-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP39A1 PE=2 SV=2 | 324 | N | 0.157473 | K | 0.202681 | -0.045208 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 222 | S | 0.056502 | P | 0.065249 | -0.008747 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 445 | M | 0.15696 | T | 0.16203 | -0.00507 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 15 | L | 0.028878 | P | 0.05437 | -0.025492 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 56 | G | 0.110261 | D | 0.126824 | -0.016563 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 118 | I | 0.307406 | V | 0.330442 | -0.023036 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 130 | R | 0.363345 | Q | 0.363206 | 1.39E-04 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 162 | R | 0.440007 | Q | 0.437895 | 0.002112 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 170 | V | 0.378576 | I | 0.336777 | 0.041799 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 174 | D | 0.231845 | H | 0.195187 | 0.036658 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 185 | T | 0.260412 | S | 0.340712 | -0.0803 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 218 | P | 0.070359 | R | 0.059105 | 0.011254 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 363 | T | 0.119207 | M | 0.113701 | 0.005506 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 373 | L | 0.12603 | F | 0.113958 | 0.012072 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 416 | P | 0.521054 | L | 0.358808 | 0.162246 | D to O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 189 | F | 0.276776 | S | 0.485084 | -0.208308 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 293 | L | 0.378227 | P | 0.498868 | -0.120641 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 467 | P | 0.34912 | S | 0.365264 | -0.016144 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 96 | K | 0.104895 | E | 0.105058 | -1.63E-04 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 252 | S | 0.525419 | A | 0.405348 | 0.120071 | D to O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 349 | T | 0.286095 | N | 0.308335 | -0.02224 | No Change: Both O | - |
| P08684 | CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens GN=CYP3A4 PE=1 SV=4 | 431 | I | 0.250538 | T | 0.383538 | -0.133 | No Change: Both O | - |
| Q9HB55 | CP343_HUMAN Cytochrome P450 3A43 OS=Homo sapiens GN=CYP3A43 PE=1 SV=1 | 340 | P | 0.29527 | A | 0.226737 | 0.068533 | No Change: Both O | - |
| Q9HB55 | CP343_HUMAN Cytochrome P450 3A43 OS=Homo sapiens GN=CYP3A43 PE=1 SV=1 | 27 | T | 0.170403 | A | 0.151454 | 0.018949 | No Change: Both O | - |
| Q9HB55 | CP343_HUMAN Cytochrome P450 3A43 OS=Homo sapiens GN=CYP3A43 PE=1 SV=1 | 145 | M | 0.250708 | I | 0.189693 | 0.061015 | No Change: Both O | - |
| Q9HB55 | CP343_HUMAN Cytochrome P450 3A43 OS=Homo sapiens GN=CYP3A43 PE=1 SV=1 | 275 | M | 0.620156 | I | 0.541271 | 0.078885 | No Change: Both D | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 398 | T | 0.196715 | N | 0.212995 | -0.01628 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 30 | H | 0.206837 | Y | 0.136501 | 0.070336 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 277 | D | 0.60762 | E | 0.63371 | -0.02609 | No Change: Both D | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 337 | A | 0.358717 | T | 0.38301 | -0.024293 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 28 | R | 0.162556 | C | 0.073347 | 0.089209 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 200 | Q | 0.586158 | R | 0.566215 | 0.019943 | No Change: Both D | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 446 | F | 0.123699 | S | 0.244078 | -0.120379 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 371 | I | 0.096619 | V | 0.118877 | -0.022258 | No Change: Both O | - |
| P20815 | CP3A5_HUMAN Cytochrome P450 3A5 OS=Homo sapiens GN=CYP3A5 PE=1 SV=1 | 488 | I | 0.579981 | T | 0.738603 | -0.158622 | No Change: Both D | - |
| P24462 | CP3A7_HUMAN Cytochrome P450 3A7 OS=Homo sapiens GN=CYP3A7 PE=1 SV=2 | 409 | R | 0.458721 | T | 0.435032 | 0.023689 | No Change: Both O | - |
| P24462 | CP3A7_HUMAN Cytochrome P450 3A7 OS=Homo sapiens GN=CYP3A7 PE=1 SV=2 | 71 | V | 0.091701 | A | 0.128791 | -0.03709 | No Change: Both O | - |
| Q02928 | CP4AB_HUMAN Cytochrome P450 4A11 OS=Homo sapiens GN=CYP4A11 PE=1 SV=1 | 434 | F | 0.296016 | S | 0.500339 | -0.204323 | O to D | - |
| Q02928 | CP4AB_HUMAN Cytochrome P450 4A11 OS=Homo sapiens GN=CYP4A11 PE=1 SV=1 | 353 | S | 0.354147 | G | 0.313812 | 0.040335 | No Change: Both O | - |
| Q02928 | CP4AB_HUMAN Cytochrome P450 4A11 OS=Homo sapiens GN=CYP4A11 PE=1 SV=1 | 226 | N | 0.18788 | S | 0.224742 | -0.036862 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 11 | R | 0.564682 | C | 0.365659 | 0.199023 | D to O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 121 | K | 0.40998 | R | 0.345208 | 0.064772 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 126 | R | 0.116474 | W | 0.046842 | 0.069632 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 130 | G | 0.078458 | S | 0.091197 | -0.012739 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 152 | N | 0.181515 | Y | 0.106259 | 0.075256 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 185 | V | 0.30215 | F | 0.278864 | 0.023286 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 226 | S | 0.088751 | N | 0.072516 | 0.016235 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 230 | C | 0.066135 | S | 0.155862 | -0.089727 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 231 | C | 0.07236 | R | 0.132642 | -0.060282 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 276 | K | 0.668238 | T | 0.573968 | 0.09427 | No Change: Both D | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 428 | L | 0.259176 | P | 0.430607 | -0.171431 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 491 | M | 0.317571 | I | 0.24936 | 0.068211 | No Change: Both O | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 509 | L | 0.645594 | F | 0.542036 | 0.103558 | No Change: Both D | - |
| Q5TCH4 | CP4AM_HUMAN Cytochrome P450 4A22 OS=Homo sapiens GN=CYP4A22 PE=1 SV=1 | 104 | Y | 0.175348 | F | 0.141753 | 0.033595 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 173 | R | 0.543559 | W | 0.362311 | 0.181248 | D to O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 322 | S | 0.241277 | G | 0.208415 | 0.032862 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 331 | M | 0.046209 | I | 0.029315 | 0.016894 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 340 | R | 0.472019 | C | 0.287038 | 0.184981 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 345 | V | 0.452071 | I | 0.431831 | 0.02024 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 375 | R | 0.160727 | C | 0.084421 | 0.076306 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 264 | R | 0.493075 | W | 0.251486 | 0.241589 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 329 | Y | 0.027728 | S | 0.070435 | -0.042707 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 354 | F | 0.159554 | C | 0.142899 | 0.016655 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 482 | R | 0.441636 | Q | 0.458853 | -0.017217 | No Change: Both O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 111 | A | 0.513633 | V | 0.440988 | 0.072645 | D to O | - |
| P13584 | CP4B1_HUMAN Cytochrome P450 4B1 OS=Homo sapiens GN=CYP4B1 PE=1 SV=2 | 274 | R | 0.6616 | Q | 0.663242 | -0.001642 | No Change: Both D | - |
| Q9HBI6 | CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens GN=CYP4F11 PE=2 SV=3 | 146 | R | 0.46336 | C | 0.270289 | 0.193071 | No Change: Both O | - |
| Q9HBI6 | CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens GN=CYP4F11 PE=2 SV=3 | 276 | C | 0.230021 | R | 0.408926 | -0.178905 | No Change: Both O | - |
| Q9HBI6 | CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens GN=CYP4F11 PE=2 SV=3 | 284 | D | 0.353271 | N | 0.322674 | 0.030597 | No Change: Both O | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 13 | P | 0.137684 | L | 0.068548 | 0.069136 | No Change: Both O | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 76 | N | 0.698262 | D | 0.704078 | -0.005816 | No Change: Both D | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 90 | I | 0.05231 | V | 0.054458 | -0.002148 | No Change: Both O | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 188 | C | 0.435436 | R | 0.579979 | -0.144543 | O to D | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 16 | T | 0.1068 | M | 0.087185 | 0.019615 | No Change: Both O | - |
| Q9HCS2 | CP4FC_HUMAN Cytochrome P450 4F12 OS=Homo sapiens GN=CYP4F12 PE=1 SV=2 | 522 | S | 0.637941 | G | 0.608062 | 0.029879 | No Change: Both D | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 7 | S | 0.244585 | Y | 0.109218 | 0.135367 | No Change: Both O | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 12 | W | 0.072884 | G | 0.186546 | -0.113662 | No Change: Both O | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 185 | G | 0.284151 | V | 0.176291 | 0.10786 | No Change: Both O | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 433 | V | 0.375342 | M | 0.42323 | -0.047888 | No Change: Both O | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 519 | L | 0.765861 | M | 0.777425 | -0.011564 | No Change: Both D | - |
| P78329 | CP4F2_HUMAN Leukotriene-B(4) omega-hydroxylase 1 OS=Homo sapiens GN=CYP4F2 PE=1 SV=1 | 269 | A | 0.259119 | D | 0.363709 | -0.10459 | No Change: Both O | - |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 178 | S | 0.274645 | C | 0.113677 | 0.160968 | No Change: Both O | - |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 505 | K | 0.535137 | Q | 0.472473 | 0.062664 | D to O | - |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 59 | F | 0.25781 | L | 0.301361 | -0.043551 | No Change: Both O | Ichthyosis lamellar type 3 (LI3) [MIM:604777] |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 243 | R | 0.335532 | H | 0.339469 | -0.003937 | No Change: Both O | Ichthyosis lamellar type 3 (LI3) [MIM:604777] |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 372 | R | 0.538506 | W | 0.332317 | 0.206189 | D to O | Ichthyosis lamellar type 3 (LI3) [MIM:604777] |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 435 | H | 0.229204 | Y | 0.153663 | 0.075541 | No Change: Both O | Ichthyosis lamellar type 3 (LI3) [MIM:604777] |
| Q6NT55 | CP4FN_HUMAN Cytochrome P450 4F22 OS=Homo sapiens GN=CYP4F22 PE=2 SV=1 | 436 | H | 0.265672 | D | 0.290716 | -0.025044 | No Change: Both O | Ichthyosis lamellar type 3 (LI3) [MIM:604777] |
| Q08477 | CP4F3_HUMAN Leukotriene-B(4) omega-hydroxylase 2 OS=Homo sapiens GN=CYP4F3 PE=2 SV=2 | 269 | A | 0.256145 | D | 0.360905 | -0.10476 | No Change: Both O | - |
| Q08477 | CP4F3_HUMAN Leukotriene-B(4) omega-hydroxylase 2 OS=Homo sapiens GN=CYP4F3 PE=2 SV=2 | 270 | V | 0.295867 | I | 0.27338 | 0.022487 | No Change: Both O | - |
| Q08477 | CP4F3_HUMAN Leukotriene-B(4) omega-hydroxylase 2 OS=Homo sapiens GN=CYP4F3 PE=2 SV=2 | 271 | I | 0.324146 | T | 0.500134 | -0.175988 | O to D | - |
| Q08477 | CP4F3_HUMAN Leukotriene-B(4) omega-hydroxylase 2 OS=Homo sapiens GN=CYP4F3 PE=2 SV=2 | 96 | H | 0.021333 | Q | 0.021666 | -3.33E-04 | No Change: Both O | - |
| Q08477 | CP4F3_HUMAN Leukotriene-B(4) omega-hydroxylase 2 OS=Homo sapiens GN=CYP4F3 PE=2 SV=2 | 106 | Y | 0.086515 | C | 0.068486 | 0.018029 | No Change: Both O | - |
| P98187 | CP4F8_HUMAN Cytochrome P450 4F8 OS=Homo sapiens GN=CYP4F8 PE=1 SV=1 | 125 | Y | 0.090641 | F | 0.08298 | 0.007661 | No Change: Both O | - |
| P98187 | CP4F8_HUMAN Cytochrome P450 4F8 OS=Homo sapiens GN=CYP4F8 PE=1 SV=1 | 447 | P | 0.567936 | Q | 0.536891 | 0.031045 | No Change: Both D | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 44 | W | 0.324648 | R | 0.566362 | -0.241714 | O to D | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 61 | G | 0.146023 | S | 0.178009 | -0.031986 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 79 | E | 0.244433 | D | 0.205195 | 0.039238 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 111 | I | 0.250108 | T | 0.390683 | -0.140575 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 123 | M | 0.36404 | V | 0.312211 | 0.051829 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 331 | H | 0.309251 | P | 0.33302 | -0.023769 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 341 | S | 0.099579 | P | 0.090149 | 0.00943 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 508 | R | 0.239644 | H | 0.198156 | 0.041488 | No Change: Both O | Bietti crystalline corneoretinal dystrophy (BCD) [MIM:210370] |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 259 | Q | 0.314458 | K | 0.382761 | -0.068303 | No Change: Both O | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 22 | L | 0.281816 | V | 0.266444 | 0.015372 | No Change: Both O | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 213 | S | 0.70378 | N | 0.668639 | 0.035141 | No Change: Both D | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 275 | E | 0.580406 | K | 0.562881 | 0.017525 | No Change: Both D | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 372 | V | 0.491975 | I | 0.456856 | 0.035119 | No Change: Both O | - |
| Q6ZWL3 | CP4V2_HUMAN Cytochrome P450 4V2 OS=Homo sapiens GN=CYP4V2 PE=1 SV=2 | 443 | R | 0.604624 | Q | 0.628698 | -0.024074 | No Change: Both D | - |
| Q86W10 | CP4Z1_HUMAN Cytochrome P450 4Z1 OS=Homo sapiens GN=CYP4Z1 PE=2 SV=1 | 393 | P | 0.404955 | L | 0.233701 | 0.171254 | No Change: Both O | - |
| Q16850 | CP51A_HUMAN Lanosterol 14-alpha demethylase OS=Homo sapiens GN=CYP51A1 PE=1 SV=3 | 13 | V | 0.371335 | A | 0.482197 | -0.110862 | No Change: Both O | - |
| P22680 | CP7A1_HUMAN Cholesterol 7-alpha-monooxygenase OS=Homo sapiens GN=CYP7A1 PE=1 SV=2 | 100 | F | 0.210734 | S | 0.413016 | -0.202282 | No Change: Both O | - |
| P22680 | CP7A1_HUMAN Cholesterol 7-alpha-monooxygenase OS=Homo sapiens GN=CYP7A1 PE=1 SV=2 | 233 | N | 0.464838 | S | 0.51049 | -0.045652 | O to D | - |
| P22680 | CP7A1_HUMAN Cholesterol 7-alpha-monooxygenase OS=Homo sapiens GN=CYP7A1 PE=1 SV=2 | 347 | D | 0.358864 | N | 0.34851 | 0.010354 | No Change: Both O | - |
| P22680 | CP7A1_HUMAN Cholesterol 7-alpha-monooxygenase OS=Homo sapiens GN=CYP7A1 PE=1 SV=2 | 86 | H | 0.18311 | N | 0.195706 | -0.012596 | No Change: Both O | - |
| O75881 | CP7B1_HUMAN 25-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP7B1 PE=1 SV=2 | 57 | G | 0.066373 | R | 0.07311 | -0.006737 | No Change: Both O | Spastic paraplegia autosomal recessive type 5A (SPG5A) [MIM:270800] |
| O75881 | CP7B1_HUMAN 25-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP7B1 PE=1 SV=2 | 216 | F | 0.286612 | S | 0.516917 | -0.230305 | O to D | Spastic paraplegia autosomal recessive type 5A (SPG5A) [MIM:270800] |
| O75881 | CP7B1_HUMAN 25-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP7B1 PE=1 SV=2 | 363 | S | 0.348535 | F | 0.160875 | 0.18766 | No Change: Both O | Spastic paraplegia autosomal recessive type 5A (SPG5A) [MIM:270800] |
| O75881 | CP7B1_HUMAN 25-hydroxycholesterol 7-alpha-hydroxylase OS=Homo sapiens GN=CYP7B1 PE=1 SV=2 | 417 | R | 0.431459 | H | 0.386739 | 0.04472 | No Change: Both O | Spastic paraplegia autosomal recessive type 5A (SPG5A) [MIM:270800] |
| Q9UNU6 | CP8B1_HUMAN 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase OS=Homo sapiens GN=CYP8B1 PE=2 SV=2 | 234 | R | 0.175374 | H | 0.171369 | 0.004005 | No Change: Both O | - |
| Q9UNU6 | CP8B1_HUMAN 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase OS=Homo sapiens GN=CYP8B1 PE=2 SV=2 | 88 | S | 0.281402 | P | 0.26007 | 0.021332 | No Change: Both O | - |
| Q9UNU6 | CP8B1_HUMAN 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase OS=Homo sapiens GN=CYP8B1 PE=2 SV=2 | 238 | K | 0.37222 | R | 0.328823 | 0.043397 | No Change: Both O | - |
| Q9UNU6 | CP8B1_HUMAN 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase OS=Homo sapiens GN=CYP8B1 PE=2 SV=2 | 357 | L | 0.178813 | F | 0.14341 | 0.035403 | No Change: Both O | - |
| O00622 | CYR61_HUMAN Protein CYR61 OS=Homo sapiens GN=CYR61 PE=1 SV=1 | 334 | R | 0.47432 | W | 0.219567 | 0.254753 | No Change: Both O | - |
| Q9UIA0 | CYH4_HUMAN Cytohesin-4 OS=Homo sapiens GN=CYTH4 PE=1 SV=1 | 74 | M | 0.39503 | V | 0.321951 | 0.073079 | No Change: Both O | - |
| O60759 | CYTIP_HUMAN Cytohesin-interacting protein OS=Homo sapiens GN=CYTIP PE=1 SV=2 | 37 | D | 0.536866 | N | 0.515281 | 0.021585 | No Change: Both D | - |
| O60759 | CYTIP_HUMAN Cytohesin-interacting protein OS=Homo sapiens GN=CYTIP PE=1 SV=2 | 83 | Q | 0.559821 | E | 0.581198 | -0.021377 | No Change: Both D | - |
| O60759 | CYTIP_HUMAN Cytohesin-interacting protein OS=Homo sapiens GN=CYTIP PE=1 SV=2 | 329 | P | 0.802524 | S | 0.819298 | -0.016774 | No Change: Both D | - |
| Q9NRR1 | CYTL1_HUMAN Cytokine-like protein 1 OS=Homo sapiens GN=CYTL1 PE=1 SV=1 | 51 | S | 0.445533 | L | 0.304352 | 0.141181 | No Change: Both O | - |
| Q9NRR1 | CYTL1_HUMAN Cytokine-like protein 1 OS=Homo sapiens GN=CYTL1 PE=1 SV=1 | 136 | R | 0.808422 | C | 0.805801 | 0.002621 | No Change: Both D | - |
| Q96J86 | CYYR1_HUMAN Cysteine and tyrosine-rich protein 1 OS=Homo sapiens GN=CYYR1 PE=1 SV=1 | 95 | R | 0.287359 | H | 0.286677 | 6.82E-04 | No Change: Both O | - |
| Q96J86 | CYYR1_HUMAN Cysteine and tyrosine-rich protein 1 OS=Homo sapiens GN=CYYR1 PE=1 SV=1 | 111 | P | 0.612123 | S | 0.612636 | -5.13E-04 | No Change: Both D | - |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 15 | R | 0.758115 | G | 0.715682 | 0.042433 | No Change: Both D | - |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 147 | I | 0.136827 | S | 0.301712 | -0.164885 | No Change: Both O | D-2-hydroxyglutaric aciduria type 1 (D2HGA1) [MIM:600721] |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 375 | D | 0.441225 | Y | 0.272429 | 0.168796 | No Change: Both O | D-2-hydroxyglutaric aciduria type 1 (D2HGA1) [MIM:600721] |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 436 | G | 0.422605 | V | 0.27702 | 0.145585 | No Change: Both O | - |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 439 | N | 0.397353 | D | 0.413632 | -0.016279 | No Change: Both O | D-2-hydroxyglutaric aciduria type 1 (D2HGA1) [MIM:600721] |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 444 | V | 0.283591 | A | 0.382893 | -0.099302 | No Change: Both O | D-2-hydroxyglutaric aciduria type 1 (D2HGA1) [MIM:600721] |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 338 | V | 0.206158 | I | 0.187883 | 0.018275 | No Change: Both O | - |
| Q8N465 | D2HDH_HUMAN D-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=D2HGDH PE=1 SV=3 | 361 | A | 0.325901 | V | 0.260613 | 0.065288 | No Change: Both O | - |
| Q86T65 | DAAM2_HUMAN Disheveled-associated activator of morphogenesis 2 OS=Homo sapiens GN=DAAM2 PE=2 SV=3 | 105 | R | 0.309762 | H | 0.277589 | 0.032173 | No Change: Both O | - |
| Q86T65 | DAAM2_HUMAN Disheveled-associated activator of morphogenesis 2 OS=Homo sapiens GN=DAAM2 PE=2 SV=3 | 617 | R | 0.316124 | H | 0.303607 | 0.012517 | No Change: Both O | - |
| O75553 | DAB1_HUMAN Disabled homolog 1 OS=Homo sapiens GN=DAB1 PE=1 SV=3 | 71 | V | 0.442509 | I | 0.408293 | 0.034216 | No Change: Both O | - |
| P98082 | DAB2_HUMAN Disabled homolog 2 OS=Homo sapiens GN=DAB2 PE=1 SV=3 | 586 | T | 0.888435 | I | 0.826948 | 0.061487 | No Change: Both D | - |
| P98082 | DAB2_HUMAN Disabled homolog 2 OS=Homo sapiens GN=DAB2 PE=1 SV=3 | 634 | S | 0.90603 | N | 0.870696 | 0.035334 | No Change: Both D | - |
| Q5VWQ8 | DAB2P_HUMAN Disabled homolog 2-interacting protein OS=Homo sapiens GN=DAB2IP PE=1 SV=2 | 59 | S | 0.989086 | F | 0.979752 | 0.009334 | No Change: Both D | - |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 124 | G | 0.724051 | C | 0.723896 | 1.55E-04 | No Change: Both D | A colorectal cancer sample |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 682 | S | 0.76325 | L | 0.628296 | 0.134954 | No Change: Both D | A colorectal cancer sample |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 446 | D | 0.962201 | N | 0.960122 | 0.002079 | No Change: Both D | - |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 464 | A | 0.966426 | V | 0.946239 | 0.020187 | No Change: Both D | - |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 628 | S | 0.978281 | A | 0.970429 | 0.007852 | No Change: Both D | - |
| Q9NYF0 | DACT1_HUMAN Dapper homolog 1 OS=Homo sapiens GN=DACT1 PE=2 SV=2 | 697 | G | 0.725961 | S | 0.788591 | -0.06263 | No Change: Both D | - |
| Q5SW24 | DACT2_HUMAN Dapper homolog 2 OS=Homo sapiens GN=DACT2 PE=2 SV=1 | 351 | E | 0.79843 | G | 0.786165 | 0.012265 | No Change: Both D | - |
| Q5SW24 | DACT2_HUMAN Dapper homolog 2 OS=Homo sapiens GN=DACT2 PE=2 SV=1 | 541 | T | 0.722937 | P | 0.810106 | -0.087169 | No Change: Both D | - |
| P61803 | DAD1_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 OS=Homo sapiens GN=DAD1 PE=1 SV=3 | 83 | A | 0.518677 | T | 0.553198 | -0.034521 | No Change: Both D | - |
| Q14118 | DAG1_HUMAN Dystroglycan OS=Homo sapiens GN=DAG1 PE=1 SV=2 | 14 | S | 0.285565 | W | 0.080215 | 0.20535 | No Change: Both O | - |
| Q14118 | DAG1_HUMAN Dystroglycan OS=Homo sapiens GN=DAG1 PE=1 SV=2 | 192 | T | 0.290914 | M | 0.273342 | 0.017572 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C7 (MDDGC7) [MIM:613818] |
| Q9Y4D2 | DGLA_HUMAN Sn1-specific diacylglycerol lipase alpha OS=Homo sapiens GN=DAGLA PE=1 SV=3 | 889 | P | 0.887125 | L | 0.835007 | 0.052118 | No Change: Both D | - |
| Q9Y4D2 | DGLA_HUMAN Sn1-specific diacylglycerol lipase alpha OS=Homo sapiens GN=DAGLA PE=1 SV=3 | 735 | G | 0.832611 | V | 0.782129 | 0.050482 | No Change: Both D | - |
| Q9Y4D2 | DGLA_HUMAN Sn1-specific diacylglycerol lipase alpha OS=Homo sapiens GN=DAGLA PE=1 SV=3 | 945 | D | 0.762204 | E | 0.789015 | -0.026811 | No Change: Both D | - |
| Q8NCG7 | DGLB_HUMAN Sn1-specific diacylglycerol lipase beta OS=Homo sapiens GN=DAGLB PE=1 SV=2 | 664 | Q | 0.556812 | R | 0.605141 | -0.048329 | No Change: Both D | - |
| Q3LXA3 | DHAK_HUMAN Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing) OS=Homo sapiens GN=DAK PE=1 SV=2 | 185 | A | 0.262046 | T | 0.280992 | -0.018946 | No Change: Both O | - |
| Q3LXA3 | DHAK_HUMAN Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing) OS=Homo sapiens GN=DAK PE=1 SV=2 | 334 | A | 0.297466 | G | 0.297431 | 3.50E-05 | No Change: Both O | - |
| Q5D0E6 | DALD3_HUMAN DALR anticodon-binding domain-containing protein 3 OS=Homo sapiens GN=DALRD3 PE=2 SV=2 | 299 | Q | 0.183319 | R | 0.160018 | 0.023301 | No Change: Both O | - |
| P59103 | DAOA_HUMAN D-amino acid oxidase activator OS=Homo sapiens GN=DAOA PE=1 SV=2 | 30 | R | 0.262787 | K | 0.302533 | -0.039746 | No Change: Both O | - |
| P59103 | DAOA_HUMAN D-amino acid oxidase activator OS=Homo sapiens GN=DAOA PE=1 SV=2 | 62 | K | 0.662127 | E | 0.68159 | -0.019463 | No Change: Both D | - |
| P51398 | RT29_HUMAN 28S ribosomal protein S29 mitochondrial OS=Homo sapiens GN=DAP3 PE=1 SV=1 | 240 | V | 0.168744 | F | 0.138875 | 0.029869 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 416 | V | 0.249684 | I | 0.218698 | 0.030986 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 461 | A | 0.170691 | S | 0.250441 | -0.07975 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 519 | S | 0.331978 | A | 0.257147 | 0.074831 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 540 | C | 0.470358 | Y | 0.540455 | -0.070097 | O to D | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 941 | M | 0.582926 | T | 0.616551 | -0.033625 | No Change: Both D | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 977 | R | 0.35604 | W | 0.198502 | 0.157538 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 978 | K | 0.38923 | N | 0.376751 | 0.012479 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 993 | Y | 0.232303 | C | 0.24937 | -0.017067 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 994 | D | 0.248811 | E | 0.264433 | -0.015622 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1005 | E | 0.556398 | Q | 0.533459 | 0.022939 | No Change: Both D | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1007 | D | 0.499063 | Y | 0.340975 | 0.158088 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1008 | L | 0.496406 | P | 0.611662 | -0.115256 | O to D | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1010 | R | 0.464149 | C | 0.292896 | 0.171253 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1018 | T | 0.428576 | A | 0.408743 | 0.019833 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1272 | M | 0.553401 | I | 0.4625 | 0.090901 | D to O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1346 | S | 0.467509 | N | 0.450543 | 0.016966 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 1405 | G | 0.45749 | V | 0.335831 | 0.121659 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 591 | P | 0.108961 | L | 0.058498 | 0.050463 | No Change: Both O | - |
| P53355 | DAPK1_HUMAN Death-associated protein kinase 1 OS=Homo sapiens GN=DAPK1 PE=1 SV=6 | 622 | I | 0.121659 | M | 0.176963 | -0.055304 | No Change: Both O | - |
| Q9UIK4 | DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens GN=DAPK2 PE=1 SV=1 | 60 | R | 0.752548 | W | 0.527051 | 0.225497 | No Change: Both D | - |
| Q9UIK4 | DAPK2_HUMAN Death-associated protein kinase 2 OS=Homo sapiens GN=DAPK2 PE=1 SV=1 | 271 | R | 0.385913 | W | 0.186092 | 0.199821 | No Change: Both O | - |
| O43293 | DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | 112 | T | 0.657261 | M | 0.609737 | 0.047524 | No Change: Both D | A colorectal adenocarcinoma sample |
| O43293 | DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | 161 | D | 0.141385 | N | 0.142504 | -0.001119 | No Change: Both O | An ovarian mucinous carcinoma sample |
| O43293 | DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | 216 | P | 0.337909 | S | 0.388719 | -0.05081 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| A0PJW8 | DAPL1_HUMAN Death-associated protein-like 1 OS=Homo sapiens GN=DAPL1 PE=1 SV=2 | 60 | L | 0.279821 | P | 0.399415 | -0.119594 | No Change: Both O | - |
| A0PJW8 | DAPL1_HUMAN Death-associated protein-like 1 OS=Homo sapiens GN=DAPL1 PE=1 SV=2 | 66 | A | 0.306887 | T | 0.327385 | -0.020498 | No Change: Both O | - |
| Q16570 | DUFFY_HUMAN Duffy antigen/chemokine receptor OS=Homo sapiens GN=DARC PE=1 SV=3 | 42 | G | 0.448938 | D | 0.49132 | -0.042382 | No Change: Both O | - |
| Q16570 | DUFFY_HUMAN Duffy antigen/chemokine receptor OS=Homo sapiens GN=DARC PE=1 SV=3 | 89 | R | 0.032772 | C | 0.015065 | 0.017707 | No Change: Both O | - |
| Q16570 | DUFFY_HUMAN Duffy antigen/chemokine receptor OS=Homo sapiens GN=DARC PE=1 SV=3 | 100 | A | 0.088922 | T | 0.09271 | -0.003788 | No Change: Both O | - |
| Q16570 | DUFFY_HUMAN Duffy antigen/chemokine receptor OS=Homo sapiens GN=DARC PE=1 SV=3 | 203 | L | 0.289881 | Q | 0.434918 | -0.145037 | No Change: Both O | - |
| Q16570 | DUFFY_HUMAN Duffy antigen/chemokine receptor OS=Homo sapiens GN=DARC PE=1 SV=3 | 326 | S | 0.573362 | F | 0.312308 | 0.261054 | D to O | - |
| P14868 | SYDC_HUMAN Aspartate--tRNA ligase cytoplasmic OS=Homo sapiens GN=DARS PE=1 SV=2 | 426 | L | 0.45537 | F | 0.435318 | 0.020052 | No Change: Both O | - |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 10 | L | 0.489165 | V | 0.387644 | 0.101521 | No Change: Both O | - |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 196 | K | 0.258749 | R | 0.232571 | 0.026178 | No Change: Both O | - |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 45 | S | 0.469394 | G | 0.384004 | 0.08539 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 152 | C | 0.292622 | F | 0.307875 | -0.015253 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 179 | R | 0.225214 | H | 0.202189 | 0.023025 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 184 | Q | 0.286392 | K | 0.310646 | -0.024254 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 248 | Q | 0.554724 | K | 0.548007 | 0.006717 | No Change: Both D | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 263 | R | 0.348965 | Q | 0.367785 | -0.01882 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 560 | D | 0.355443 | V | 0.215265 | 0.140178 | No Change: Both O | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 613 | L | 0.588598 | F | 0.581984 | 0.006614 | No Change: Both D | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 626 | L | 0.792756 | Q | 0.842406 | -0.04965 | No Change: Both D | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 626 | L | 0.792756 | V | 0.805736 | -0.01298 | No Change: Both D | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q6PI48 | SYDM_HUMAN Aspartate--tRNA ligase mitochondrial OS=Homo sapiens GN=DARS2 PE=1 SV=1 | 629 | Y | 0.781289 | C | 0.827112 | -0.045823 | No Change: Both D | Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) [MIM:611105] |
| Q96EP5 | DAZP1_HUMAN DAZ-associated protein 1 OS=Homo sapiens GN=DAZAP1 PE=1 SV=1 | 381 | S | 0.987016 | T | 0.97775 | 0.009266 | No Change: Both D | A breast cancer sample |
| Q15038 | DAZP2_HUMAN DAZ-associated protein 2 OS=Homo sapiens GN=DAZAP2 PE=1 SV=1 | 102 | S | 0.399065 | A | 0.342603 | 0.056462 | No Change: Both O | - |
| Q92904 | DAZL_HUMAN Deleted in azoospermia-like OS=Homo sapiens GN=DAZL PE=1 SV=1 | 12 | T | 0.938644 | A | 0.929639 | 0.009005 | No Change: Both D | - |
| Q92904 | DAZL_HUMAN Deleted in azoospermia-like OS=Homo sapiens GN=DAZL PE=1 SV=1 | 54 | T | 0.356291 | A | 0.335771 | 0.02052 | No Change: Both O | - |
| O60477 | DBC1_HUMAN Deleted in bladder cancer protein 1 OS=Homo sapiens GN=DBC1 PE=2 SV=2 | 437 | A | 0.353695 | T | 0.383958 | -0.030263 | No Change: Both O | - |
| O60477 | DBC1_HUMAN Deleted in bladder cancer protein 1 OS=Homo sapiens GN=DBC1 PE=2 SV=2 | 347 | S | 0.441753 | R | 0.406992 | 0.034761 | No Change: Both O | - |
| O60477 | DBC1_HUMAN Deleted in bladder cancer protein 1 OS=Homo sapiens GN=DBC1 PE=2 SV=2 | 358 | R | 0.47335 | H | 0.435813 | 0.037537 | No Change: Both O | - |
| O60477 | DBC1_HUMAN Deleted in bladder cancer protein 1 OS=Homo sapiens GN=DBC1 PE=2 SV=2 | 712 | P | 0.487039 | T | 0.404683 | 0.082356 | No Change: Both O | A colorectal cancer sample |
| Q9UBU7 | DBF4A_HUMAN Protein DBF4 homolog A OS=Homo sapiens GN=DBF4 PE=1 SV=1 | 112 | Y | 0.846487 | N | 0.895911 | -0.049424 | No Change: Both D | - |
| Q9UBU7 | DBF4A_HUMAN Protein DBF4 homolog A OS=Homo sapiens GN=DBF4 PE=1 SV=1 | 575 | H | 0.654973 | R | 0.720775 | -0.065802 | No Change: Both D | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 318 | A | 0.44985 | S | 0.554874 | -0.105024 | O to D | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 211 | A | 0.495833 | T | 0.542904 | -0.047071 | O to D | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 549 | R | 0.19682 | C | 0.112462 | 0.084358 | No Change: Both O | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 181 | E | 0.374854 | Q | 0.325077 | 0.049777 | No Change: Both O | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 239 | K | 0.328064 | N | 0.274056 | 0.054008 | No Change: Both O | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 250 | E | 0.300696 | Q | 0.252739 | 0.047957 | No Change: Both O | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 290 | D | 0.47255 | N | 0.460312 | 0.012238 | No Change: Both O | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 317 | L | 0.421163 | P | 0.592423 | -0.17126 | O to D | - |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 101 | V | 0.098036 | M | 0.121007 | -0.022971 | No Change: Both O | Dopamine beta-hydroxylase deficiency (DBH deficiency) [MIM:223360] |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 114 | D | 0.251621 | E | 0.252736 | -0.001115 | No Change: Both O | Dopamine beta-hydroxylase deficiency (DBH deficiency) [MIM:223360] |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 345 | D | 0.487662 | N | 0.485005 | 0.002657 | No Change: Both O | Dopamine beta-hydroxylase deficiency (DBH deficiency) [MIM:223360] |
| P09172 | DOPO_HUMAN Dopamine beta-hydroxylase OS=Homo sapiens GN=DBH PE=1 SV=3 | 12 | G | 0.519317 | S | 0.594722 | -0.075405 | No Change: Both D | - |
| P07108 | ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapiens GN=DBI PE=1 SV=2 | 39 | D | 0.347466 | N | 0.348474 | -0.001008 | No Change: Both O | - |
| P07108 | ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapiens GN=DBI PE=1 SV=2 | 71 | M | 0.518554 | V | 0.451522 | 0.067032 | D to O | - |
| P07108 | ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapiens GN=DBI PE=1 SV=2 | 86 | G | 0.824627 | R | 0.818759 | 0.005868 | No Change: Both D | - |
| Q16643 | DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 PE=1 SV=4 | 278 | E | 0.921198 | K | 0.912496 | 0.008702 | No Change: Both D | A breast cancer sample |
| Q16643 | DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 PE=1 SV=4 | 640 | E | 0.784986 | Q | 0.710661 | 0.074325 | No Change: Both D | A breast cancer sample |
| Q16643 | DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 PE=1 SV=4 | 446 | I | 0.824206 | V | 0.841696 | -0.01749 | No Change: Both D | - |
| Q16643 | DREB_HUMAN Drebrin OS=Homo sapiens GN=DBN1 PE=1 SV=4 | 553 | S | 0.956581 | P | 0.967763 | -0.011182 | No Change: Both D | - |
| P11182 | ODB2_HUMAN Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex mitochondrial OS=Homo sapiens GN=DBT PE=1 SV=3 | 276 | F | 0.120004 | C | 0.130339 | -0.010335 | No Change: Both O | Maple syrup urine disease type 2 (MSUD2) [MIM:248600] |
| P11182 | ODB2_HUMAN Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex mitochondrial OS=Homo sapiens GN=DBT PE=1 SV=3 | 98 | I | 0.358328 | M | 0.456423 | -0.098095 | No Change: Both O | Maple syrup urine disease type 2 (MSUD2) [MIM:248600] |
| P11182 | ODB2_HUMAN Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex mitochondrial OS=Homo sapiens GN=DBT PE=1 SV=3 | 384 | G | 0.480833 | S | 0.543987 | -0.063154 | O to D | Maple syrup urine disease type 2 (MSUD2) [MIM:248600] |
| Q6ZNG2 | DBX2_HUMAN Homeobox protein DBX2 OS=Homo sapiens GN=DBX2 PE=2 SV=2 | 171 | M | 0.820393 | V | 0.763441 | 0.056952 | No Change: Both D | - |
| Q8TEB1 | DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens GN=DCAF11 PE=1 SV=1 | 207 | R | 0.27638 | H | 0.258039 | 0.018341 | No Change: Both O | - |
| Q5T6F0 | DCA12_HUMAN DDB1- and CUL4-associated factor 12 OS=Homo sapiens GN=DCAF12 PE=1 SV=1 | 131 | R | 0.46767 | Q | 0.501221 | -0.033551 | O to D | - |
| Q5VU92 | DC121_HUMAN DDB1- and CUL4-associated factor 12-like protein 1 OS=Homo sapiens GN=DCAF12L1 PE=2 SV=1 | 19 | D | 0.956161 | G | 0.956007 | 1.54E-04 | No Change: Both D | - |
| Q5VW00 | DC122_HUMAN DDB1- and CUL4-associated factor 12-like protein 2 OS=Homo sapiens GN=DCAF12L2 PE=2 SV=1 | 147 | H | 0.341807 | Q | 0.374274 | -0.032467 | No Change: Both O | - |
| Q9NV06 | DCA13_HUMAN DDB1- and CUL4-associated factor 13 OS=Homo sapiens GN=DCAF13 PE=1 SV=2 | 42 | I | 0.215656 | V | 0.266362 | -0.050706 | No Change: Both O | - |
| Q9NV06 | DCA13_HUMAN DDB1- and CUL4-associated factor 13 OS=Homo sapiens GN=DCAF13 PE=1 SV=2 | 70 | N | 0.362348 | S | 0.412538 | -0.05019 | No Change: Both O | - |
| Q9NXF7 | DCA16_HUMAN DDB1- and CUL4-associated factor 16 OS=Homo sapiens GN=DCAF16 PE=1 SV=1 | 45 | N | 0.719432 | S | 0.767541 | -0.048109 | No Change: Both D | - |
| Q9NXF7 | DCA16_HUMAN DDB1- and CUL4-associated factor 16 OS=Homo sapiens GN=DCAF16 PE=1 SV=1 | 129 | T | 0.781711 | I | 0.675637 | 0.106074 | No Change: Both D | - |
| Q5H9S7 | DCA17_HUMAN DDB1- and CUL4-associated factor 17 OS=Homo sapiens GN=DCAF17 PE=1 SV=1 | 185 | H | 0.094413 | Q | 0.113487 | -0.019074 | No Change: Both O | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 22 | W | 0.986478 | C | 0.990621 | -0.004143 | No Change: Both D | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 193 | K | 0.313641 | T | 0.242643 | 0.070998 | No Change: Both O | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 266 | N | 0.299481 | S | 0.363825 | -0.064344 | No Change: Both O | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 334 | L | 0.089784 | F | 0.077385 | 0.012399 | No Change: Both O | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 345 | S | 0.127654 | C | 0.054064 | 0.07359 | No Change: Both O | - |
| Q8WV16 | DCAF4_HUMAN DDB1- and CUL4-associated factor 4 OS=Homo sapiens GN=DCAF4 PE=1 SV=3 | 439 | R | 0.079454 | I | 0.040337 | 0.039117 | No Change: Both O | - |
| Q58WW2 | DCAF6_HUMAN DDB1- and CUL4-associated factor 6 OS=Homo sapiens GN=DCAF6 PE=1 SV=1 | 547 | V | 0.92719 | A | 0.940095 | -0.012905 | No Change: Both D | - |
| A6NGE4 | DC8L1_HUMAN DDB1- and CUL4-associated factor 8-like protein 1 OS=Homo sapiens GN=DCAF8L1 PE=2 SV=1 | 549 | R | 0.293904 | W | 0.123101 | 0.170803 | No Change: Both O | - |
| P0C7V8 | DC8L2_HUMAN DDB1- and CUL4-associated factor 8-like protein 2 OS=Homo sapiens GN=DCAF8L2 PE=2 SV=1 | 316 | T | 0.16838 | A | 0.155289 | 0.013091 | No Change: Both O | - |
| Q8WVC6 | DCAKD_HUMAN Dephospho-CoA kinase domain-containing protein OS=Homo sapiens GN=DCAKD PE=1 SV=1 | 84 | N | 0.295634 | I | 0.163488 | 0.132146 | No Change: Both O | - |
| Q96PD2 | DCBD2_HUMAN Discoidin CUB and LCCL domain-containing protein 2 OS=Homo sapiens GN=DCBLD2 PE=1 SV=1 | 144 | I | 0.253054 | M | 0.327581 | -0.074527 | No Change: Both O | - |
| Q96PD2 | DCBD2_HUMAN Discoidin CUB and LCCL domain-containing protein 2 OS=Homo sapiens GN=DCBLD2 PE=1 SV=1 | 723 | D | 0.788825 | N | 0.7816 | 0.007225 | No Change: Both D | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 168 | M | 0.232065 | T | 0.279006 | -0.046941 | No Change: Both O | A esophageal carcinoma |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 201 | R | 0.414306 | G | 0.425624 | -0.011318 | No Change: Both O | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 1375 | P | 0.864751 | H | 0.798568 | 0.066183 | No Change: Both D | A colorectal carcinoma |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 1017 | M | 0.077939 | V | 0.054009 | 0.02393 | No Change: Both O | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 1039 | F | 0.17684 | S | 0.385237 | -0.208397 | No Change: Both O | A colorectal cancer sample |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 759 | I | 0.088183 | M | 0.120973 | -0.03279 | No Change: Both O | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 23 | F | 0.146183 | L | 0.167769 | -0.021586 | No Change: Both O | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 679 | L | 0.197196 | R | 0.291924 | -0.094728 | No Change: Both O | - |
| P43146 | DCC_HUMAN Netrin receptor DCC OS=Homo sapiens GN=DCC PE=1 SV=2 | 1191 | H | 0.976891 | L | 0.972681 | 0.00421 | No Change: Both D | - |
| P59894 | DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens GN=DCDC1 PE=2 SV=2 | 83 | V | 0.482622 | M | 0.544191 | -0.061569 | O to D | - |
| P59894 | DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens GN=DCDC1 PE=2 SV=2 | 7 | E | 0.893407 | G | 0.857998 | 0.035409 | No Change: Both D | - |
| Q9UHG0 | DCDC2_HUMAN Doublecortin domain-containing protein 2 OS=Homo sapiens GN=DCDC2 PE=1 SV=2 | 221 | S | 0.451614 | G | 0.399162 | 0.052452 | No Change: Both O | - |
| Q9UHG0 | DCDC2_HUMAN Doublecortin domain-containing protein 2 OS=Homo sapiens GN=DCDC2 PE=1 SV=2 | 152 | P | 0.237242 | A | 0.182499 | 0.054743 | No Change: Both O | - |
| Q9UHG0 | DCDC2_HUMAN Doublecortin domain-containing protein 2 OS=Homo sapiens GN=DCDC2 PE=1 SV=2 | 456 | K | 0.96502 | N | 0.962804 | 0.002216 | No Change: Both D | - |
| Q96JQ0 | PCD16_HUMAN Protocadherin-16 OS=Homo sapiens GN=DCHS1 PE=2 SV=1 | 1583 | R | 0.620511 | W | 0.366486 | 0.254025 | D to O | A colorectal cancer sample |
| Q96JQ0 | PCD16_HUMAN Protocadherin-16 OS=Homo sapiens GN=DCHS1 PE=2 SV=1 | 1949 | T | 0.558346 | M | 0.48781 | 0.070536 | D to O | - |
| Q96JQ0 | PCD16_HUMAN Protocadherin-16 OS=Homo sapiens GN=DCHS1 PE=2 SV=1 | 2331 | V | 0.411432 | I | 0.350676 | 0.060756 | No Change: Both O | - |
| Q96JQ0 | PCD16_HUMAN Protocadherin-16 OS=Homo sapiens GN=DCHS1 PE=2 SV=1 | 2359 | R | 0.461819 | C | 0.308348 | 0.153471 | No Change: Both O | - |
| Q96JQ0 | PCD16_HUMAN Protocadherin-16 OS=Homo sapiens GN=DCHS1 PE=2 SV=1 | 2172 | L | 0.272576 | Q | 0.387906 | -0.11533 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 153 | V | 0.295106 | A | 0.388164 | -0.093058 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 174 | H | 0.463028 | R | 0.462721 | 3.07E-04 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 344 | S | 0.434676 | L | 0.238114 | 0.196562 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 827 | V | 0.195111 | I | 0.164104 | 0.031007 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 897 | N | 0.464764 | S | 0.516296 | -0.051532 | O to D | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 1205 | S | 0.376509 | L | 0.217602 | 0.158907 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 1480 | T | 0.440891 | R | 0.469006 | -0.028115 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 2112 | T | 0.197579 | M | 0.15687 | 0.040709 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 2303 | S | 0.182667 | N | 0.153467 | 0.0292 | No Change: Both O | - |
| Q6V1P9 | PCD23_HUMAN Protocadherin-23 OS=Homo sapiens GN=DCHS2 PE=2 SV=1 | 1595 | E | 0.588354 | Q | 0.568603 | 0.019751 | No Change: Both D | - |
| O15075 | DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens GN=DCLK1 PE=1 SV=2 | 29 | G | 0.762918 | C | 0.717364 | 0.045554 | No Change: Both D | A gastric adenocarcinoma sample |
| O15075 | DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens GN=DCLK1 PE=1 SV=2 | 46 | T | 0.46163 | M | 0.389758 | 0.071872 | No Change: Both O | A gastric adenocarcinoma sample |
| O15075 | DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens GN=DCLK1 PE=1 SV=2 | 93 | R | 0.262435 | Q | 0.27725 | -0.014815 | No Change: Both O | A gastric adenocarcinoma sample |
| O15075 | DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens GN=DCLK1 PE=1 SV=2 | 291 | S | 0.942069 | F | 0.901626 | 0.040443 | No Change: Both D | A gastric adenocarcinoma sample |
| O15075 | DCLK1_HUMAN Serine/threonine-protein kinase DCLK1 OS=Homo sapiens GN=DCLK1 PE=1 SV=2 | 292 | R | 0.954135 | H | 0.934658 | 0.019477 | No Change: Both D | - |
| Q8N568 | DCLK2_HUMAN Serine/threonine-protein kinase DCLK2 OS=Homo sapiens GN=DCLK2 PE=2 SV=4 | 119 | G | 0.220547 | C | 0.124429 | 0.096118 | No Change: Both O | - |
| Q8N568 | DCLK2_HUMAN Serine/threonine-protein kinase DCLK2 OS=Homo sapiens GN=DCLK2 PE=2 SV=4 | 372 | R | 0.743273 | H | 0.695543 | 0.04773 | No Change: Both D | - |
| Q8N568 | DCLK2_HUMAN Serine/threonine-protein kinase DCLK2 OS=Homo sapiens GN=DCLK2 PE=2 SV=4 | 583 | I | 0.014182 | V | 0.016379 | -0.002197 | No Change: Both O | - |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 24 | R | 0.515655 | Q | 0.525279 | -0.009624 | No Change: Both D | - |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 108 | P | 0.965084 | L | 0.93713 | 0.027954 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 422 | E | 0.201455 | K | 0.194826 | 0.006629 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 472 | S | 0.482064 | N | 0.442105 | 0.039959 | No Change: Both O | A lung large cell carcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 554 | R | 0.49172 | C | 0.320048 | 0.171672 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 570 | G | 0.069388 | R | 0.068194 | 0.001194 | No Change: Both O | A renal clear cell carcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 596 | V | 0.284454 | A | 0.345038 | -0.060584 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9C098 | DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens GN=DCLK3 PE=1 SV=2 | 633 | E | 0.87337 | D | 0.84793 | 0.02544 | No Change: Both D | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 58 | K | 0.870568 | E | 0.870129 | 4.39E-04 | No Change: Both D | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 59 | E | 0.865299 | D | 0.854528 | 0.010771 | No Change: Both D | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 71 | G | 0.852012 | D | 0.865944 | -0.013932 | No Change: Both D | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 287 | P | 0.521278 | L | 0.386289 | 0.134989 | D to O | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 317 | D | 0.97244 | H | 0.96233 | 0.01011 | No Change: Both D | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 859 | I | 0.091553 | F | 0.094306 | -0.002753 | No Change: Both O | - |
| Q6PJP8 | DCR1A_HUMAN DNA cross-link repair 1A protein OS=Homo sapiens GN=DCLRE1A PE=1 SV=3 | 582 | G | 0.768364 | W | 0.594916 | 0.173448 | No Change: Both D | - |
| Q9H816 | DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens GN=DCLRE1B PE=1 SV=1 | 46 | R | 0.17259 | L | 0.111155 | 0.061435 | No Change: Both O | - |
| Q9H816 | DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens GN=DCLRE1B PE=1 SV=1 | 61 | H | 0.234463 | Y | 0.137354 | 0.097109 | No Change: Both O | - |
| Q9H816 | DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens GN=DCLRE1B PE=1 SV=1 | 462 | D | 0.78912 | N | 0.758314 | 0.030806 | No Change: Both D | - |
| Q9H816 | DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens GN=DCLRE1B PE=1 SV=1 | 510 | N | 0.128755 | Y | 0.085697 | 0.043058 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 35 | H | 0.379552 | D | 0.412269 | -0.032717 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 118 | G | 0.167597 | V | 0.098144 | 0.069453 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 135 | G | 0.174514 | E | 0.204724 | -0.03021 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 171 | P | 0.146965 | R | 0.130796 | 0.016169 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 243 | H | 0.289195 | R | 0.289785 | -5.90E-04 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 320 | S | 0.319254 | C | 0.13476 | 0.184494 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 140 | A | 0.323255 | V | 0.234417 | 0.088838 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 153 | G | 0.406638 | R | 0.395693 | 0.010945 | No Change: Both O | - |
| Q96SD1 | DCR1C_HUMAN Protein artemis OS=Homo sapiens GN=DCLRE1C PE=1 SV=2 | 329 | L | 0.142191 | M | 0.171087 | -0.028896 | No Change: Both O | - |
| P07585 | PGS2_HUMAN Decorin OS=Homo sapiens GN=DCN PE=1 SV=1 | 273 | E | 0.442695 | Q | 0.395201 | 0.047494 | No Change: Both O | - |
| P07585 | PGS2_HUMAN Decorin OS=Homo sapiens GN=DCN PE=1 SV=1 | 268 | T | 0.48165 | M | 0.433406 | 0.048244 | No Change: Both O | - |
| Q8TF63 | DCNP1_HUMAN Dendritic cell nuclear protein 1 OS=Homo sapiens GN=DCNP1 PE=2 SV=1 | 75 | T | 0.589277 | P | 0.706851 | -0.117574 | No Change: Both D | - |
| Q8TF63 | DCNP1_HUMAN Dendritic cell nuclear protein 1 OS=Homo sapiens GN=DCNP1 PE=2 SV=1 | 97 | N | 0.747972 | D | 0.738579 | 0.009393 | No Change: Both D | - |
| Q8IZD4 | DCP1B_HUMAN mRNA-decapping enzyme 1B OS=Homo sapiens GN=DCP1B PE=1 SV=2 | 195 | N | 0.895108 | D | 0.900787 | -0.005679 | No Change: Both D | - |
| Q8IZD4 | DCP1B_HUMAN mRNA-decapping enzyme 1B OS=Homo sapiens GN=DCP1B PE=1 SV=2 | 216 | N | 0.916039 | S | 0.930388 | -0.014349 | No Change: Both D | - |
| Q8IZD4 | DCP1B_HUMAN mRNA-decapping enzyme 1B OS=Homo sapiens GN=DCP1B PE=1 SV=2 | 301 | S | 0.702022 | T | 0.619424 | 0.082598 | No Change: Both D | - |
| Q8IZD4 | DCP1B_HUMAN mRNA-decapping enzyme 1B OS=Homo sapiens GN=DCP1B PE=1 SV=2 | 344 | R | 0.810891 | H | 0.792227 | 0.018664 | No Change: Both D | - |
| Q8IU60 | DCP2_HUMAN mRNA-decapping enzyme 2 OS=Homo sapiens GN=DCP2 PE=1 SV=2 | 16 | F | 0.112829 | L | 0.129704 | -0.016875 | No Change: Both O | - |
| Q96C86 | DCPS_HUMAN Scavenger mRNA-decapping enzyme DcpS OS=Homo sapiens GN=DCPS PE=1 SV=2 | 73 | G | 0.61107 | E | 0.617848 | -0.006778 | No Change: Both D | - |
| Q5T197 | DCST1_HUMAN DC-STAMP domain-containing protein 1 OS=Homo sapiens GN=DCST1 PE=2 SV=1 | 512 | M | 0.316117 | L | 0.275595 | 0.040522 | No Change: Both O | - |
| Q5T197 | DCST1_HUMAN DC-STAMP domain-containing protein 1 OS=Homo sapiens GN=DCST1 PE=2 SV=1 | 158 | T | 0.18588 | I | 0.107725 | 0.078155 | No Change: Both O | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 163 | A | 0.995419 | P | 0.996836 | -0.001417 | No Change: Both D | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 59 | G | 0.080015 | S | 0.091882 | -0.011867 | No Change: Both O | Distal hereditary motor neuronopathy type 7B (HMN7B) [MIM:607641] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 287 | L | 0.982526 | M | 0.988396 | -0.00587 | No Change: Both D | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 495 | R | 0.834977 | Q | 0.844048 | -0.009071 | No Change: Both D | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 71 | G | 0.616164 | A | 0.55388 | 0.062284 | No Change: Both D | Perry syndrome (PERRYS) [MIM:168605] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 71 | G | 0.616164 | E | 0.647657 | -0.031493 | No Change: Both D | Perry syndrome (PERRYS) [MIM:168605] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 71 | G | 0.616164 | R | 0.597232 | 0.018932 | No Change: Both D | Perry syndrome (PERRYS) [MIM:168605] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 72 | T | 0.551288 | P | 0.596417 | -0.045129 | No Change: Both D | Perry syndrome (PERRYS) [MIM:168605] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 74 | Q | 0.405458 | P | 0.427192 | -0.021734 | No Change: Both O | Perry syndrome (PERRYS) [MIM:168605] |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 571 | M | 0.585566 | T | 0.580242 | 0.005324 | No Change: Both D | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 785 | R | 0.318727 | W | 0.127289 | 0.191438 | No Change: Both O | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 1101 | R | 0.576819 | K | 0.654929 | -0.07811 | No Change: Both D | - |
| Q14203 | DCTN1_HUMAN Dynactin subunit 1 OS=Homo sapiens GN=DCTN1 PE=1 SV=3 | 1249 | T | 0.190712 | I | 0.098759 | 0.091953 | No Change: Both O | - |
| Q9UJW0 | DCTN4_HUMAN Dynactin subunit 4 OS=Homo sapiens GN=DCTN4 PE=1 SV=1 | 342 | F | 0.30153 | L | 0.367887 | -0.066357 | No Change: Both O | - |
| Q9UJW0 | DCTN4_HUMAN Dynactin subunit 4 OS=Homo sapiens GN=DCTN4 PE=1 SV=1 | 438 | S | 0.491588 | N | 0.461193 | 0.030395 | No Change: Both O | - |
| Q9UJW0 | DCTN4_HUMAN Dynactin subunit 4 OS=Homo sapiens GN=DCTN4 PE=1 SV=1 | 263 | Y | 0.475223 | C | 0.575856 | -0.100633 | O to D | - |
| Q9UJW0 | DCTN4_HUMAN Dynactin subunit 4 OS=Homo sapiens GN=DCTN4 PE=1 SV=1 | 95 | P | 0.612654 | T | 0.589015 | 0.023639 | No Change: Both D | - |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 124 | L | 0.431806 | S | 0.607127 | -0.175321 | O to D | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 128 | S | 0.556974 | R | 0.532088 | 0.024886 | No Change: Both D | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 128 | S | 0.556974 | R | 0.532088 | 0.024886 | No Change: Both D | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 140 | R | 0.287404 | L | 0.170363 | 0.117041 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 140 | R | 0.287404 | L | 0.170363 | 0.117041 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 140 | R | 0.287404 | H | 0.257425 | 0.029979 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 143 | D | 0.24662 | N | 0.245123 | 0.001497 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 143 | D | 0.24662 | N | 0.245123 | 0.001497 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 159 | R | 0.33441 | L | 0.223119 | 0.111291 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 167 | D | 0.286205 | H | 0.233631 | 0.052574 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 181 | G | 0.182964 | A | 0.147292 | 0.035672 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 181 | G | 0.182964 | A | 0.147292 | 0.035672 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 183 | R | 0.160625 | S | 0.199963 | -0.039338 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 206 | Y | 0.482333 | H | 0.590545 | -0.108212 | O to D | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 206 | Y | 0.482333 | H | 0.590545 | -0.108212 | O to D | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 206 | Y | 0.482333 | D | 0.647059 | -0.164726 | O to D | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 259 | R | 0.517283 | L | 0.390996 | 0.126287 | D to O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 267 | R | 0.378733 | C | 0.239256 | 0.139477 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 272 | P | 0.408083 | R | 0.408748 | -6.65E-04 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 273 | R | 0.398551 | W | 0.198669 | 0.199882 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 273 | R | 0.398551 | W | 0.198669 | 0.199882 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 281 | N | 0.362314 | K | 0.431287 | -0.068973 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 284 | T | 0.369913 | R | 0.391381 | -0.021468 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 284 | T | 0.369913 | R | 0.391381 | -0.021468 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 295 | I | 0.215574 | T | 0.35096 | -0.135386 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 303 | T | 0.236484 | I | 0.138287 | 0.098197 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 304 | G | 0.215289 | E | 0.279239 | -0.06395 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 317 | V | 0.177098 | I | 0.158809 | 0.018289 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 331 | I | 0.11823 | N | 0.237125 | -0.118895 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 331 | I | 0.11823 | T | 0.214141 | -0.095911 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 334 | G | 0.167575 | D | 0.204275 | -0.0367 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 159 | R | 0.33441 | H | 0.318837 | 0.015573 | No Change: Both O | - |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 170 | R | 0.321607 | G | 0.331745 | -0.010138 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 123 | T | 0.410515 | I | 0.260574 | 0.149941 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 131 | K | 0.555001 | N | 0.528111 | 0.02689 | No Change: Both D | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 141 | N | 0.269692 | D | 0.302671 | -0.032979 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 148 | G | 0.176813 | E | 0.207761 | -0.030948 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 152 | A | 0.189951 | S | 0.291901 | -0.10195 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 178 | L | 0.309371 | R | 0.437374 | -0.128003 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 185 | I | 0.166945 | T | 0.261396 | -0.094451 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 259 | R | 0.517283 | C | 0.372618 | 0.144665 | D to O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 272 | P | 0.408083 | L | 0.285599 | 0.122484 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 277 | R | 0.293584 | H | 0.271657 | 0.021927 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 277 | R | 0.293584 | S | 0.332743 | -0.039159 | No Change: Both O | - |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 281 | N | 0.362314 | I | 0.217513 | 0.144801 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 284 | T | 0.369913 | A | 0.355052 | 0.014861 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 304 | G | 0.215289 | V | 0.137283 | 0.078006 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 324 | F | 0.127309 | L | 0.139139 | -0.01183 | No Change: Both O | Lissencephaly X-linked type 1 (LISX1) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 332 | A | 0.126714 | S | 0.188715 | -0.062001 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| O43602 | DCX_HUMAN Neuronal migration protein doublecortin OS=Homo sapiens GN=DCX PE=1 SV=3 | 332 | A | 0.126714 | V | 0.097398 | 0.029316 | No Change: Both O | Subcortical band heterotopia X-linked (SBHX) [MIM:300067] |
| Q16531 | DDB1_HUMAN DNA damage-binding protein 1 OS=Homo sapiens GN=DDB1 PE=1 SV=1 | 427 | L | 0.244941 | F | 0.216755 | 0.028186 | No Change: Both O | - |
| Q92466 | DDB2_HUMAN DNA damage-binding protein 2 OS=Homo sapiens GN=DDB2 PE=1 SV=1 | 244 | K | 0.446948 | E | 0.424471 | 0.022477 | No Change: Both O | Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740] |
| Q92466 | DDB2_HUMAN DNA damage-binding protein 2 OS=Homo sapiens GN=DDB2 PE=1 SV=1 | 273 | R | 0.145533 | H | 0.138624 | 0.006909 | No Change: Both O | Xeroderma pigmentosum complementation group E (XP-E) [MIM:278740] |
| Q92466 | DDB2_HUMAN DNA damage-binding protein 2 OS=Homo sapiens GN=DDB2 PE=1 SV=1 | 215 | M | 0.437278 | T | 0.512503 | -0.075225 | O to D | - |
| Q92466 | DDB2_HUMAN DNA damage-binding protein 2 OS=Homo sapiens GN=DDB2 PE=1 SV=1 | 293 | A | 0.351101 | T | 0.3624 | -0.011299 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 17 | M | 0.427675 | V | 0.310062 | 0.117613 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 210 | P | 0.367682 | L | 0.243863 | 0.123819 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 217 | M | 0.345452 | V | 0.284499 | 0.060953 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 61 | E | 0.192458 | D | 0.182934 | 0.009524 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 239 | M | 0.056096 | I | 0.037939 | 0.018157 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 239 | M | 0.056096 | L | 0.045305 | 0.010791 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 462 | R | 0.301972 | Q | 0.329707 | -0.027735 | No Change: Both O | - |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 102 | G | 0.068642 | S | 0.089022 | -0.02038 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 47 | P | 0.514999 | H | 0.452576 | 0.062423 | D to O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 91 | A | 0.158169 | V | 0.103252 | 0.054917 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 147 | S | 0.485821 | R | 0.409683 | 0.076138 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 250 | S | 0.123431 | F | 0.049665 | 0.073766 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 275 | A | 0.110383 | T | 0.112308 | -0.001925 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 309 | F | 0.046289 | L | 0.058662 | -0.012373 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 347 | R | 0.124307 | Q | 0.139617 | -0.01531 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| P20711 | DDC_HUMAN Aromatic-L-amino-acid decarboxylase OS=Homo sapiens GN=DDC PE=1 SV=2 | 408 | L | 0.034311 | I | 0.028873 | 0.005438 | No Change: Both O | Aromatic L-amino-acid decarboxylase deficiency (AADCD) [MIM:608643] |
| O94830 | DDHD2_HUMAN Phospholipase DDHD2 OS=Homo sapiens GN=DDHD2 PE=1 SV=2 | 186 | T | 0.648751 | M | 0.607533 | 0.041218 | No Change: Both D | - |
| Q8WTU0 | DDI1_HUMAN Protein DDI1 homolog 1 OS=Homo sapiens GN=DDI1 PE=1 SV=1 | 136 | G | 0.826959 | S | 0.858167 | -0.031208 | No Change: Both D | - |
| Q8WTU0 | DDI1_HUMAN Protein DDI1 homolog 1 OS=Homo sapiens GN=DDI1 PE=1 SV=1 | 142 | S | 0.753352 | G | 0.71196 | 0.041392 | No Change: Both D | - |
| Q8WTU0 | DDI1_HUMAN Protein DDI1 homolog 1 OS=Homo sapiens GN=DDI1 PE=1 SV=1 | 239 | G | 0.278855 | E | 0.356335 | -0.07748 | No Change: Both O | - |
| P35638 | DDIT3_HUMAN DNA damage-inducible transcript 3 protein OS=Homo sapiens GN=DDIT3 PE=2 SV=1 | 115 | A | 0.99397 | V | 0.99151 | 0.00246 | No Change: Both D | A colorectal cancer sample |
| Q96D03 | DDT4L_HUMAN DNA damage-inducible transcript 4-like protein OS=Homo sapiens GN=DDIT4L PE=2 SV=1 | 161 | S | 0.479478 | F | 0.258062 | 0.221416 | No Change: Both O | - |
| O94850 | DEND_HUMAN Dendrin OS=Homo sapiens GN=DDN PE=1 SV=3 | 661 | E | 0.907769 | G | 0.884412 | 0.023357 | No Change: Both D | - |
| Q99489 | OXDD_HUMAN D-aspartate oxidase OS=Homo sapiens GN=DDO PE=2 SV=1 | 189 | Q | 0.486976 | E | 0.53795 | -0.050974 | O to D | - |
| Q99489 | OXDD_HUMAN D-aspartate oxidase OS=Homo sapiens GN=DDO PE=2 SV=1 | 230 | H | 0.341799 | Y | 0.248184 | 0.093615 | No Change: Both O | - |
| Q99489 | OXDD_HUMAN D-aspartate oxidase OS=Homo sapiens GN=DDO PE=2 SV=1 | 255 | L | 0.393057 | R | 0.534503 | -0.141446 | O to D | - |
| Q99489 | OXDD_HUMAN D-aspartate oxidase OS=Homo sapiens GN=DDO PE=2 SV=1 | 136 | F | 0.087126 | L | 0.098111 | -0.010985 | No Change: Both O | A breast cancer sample |
| P39656 | OST48_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens GN=DDOST PE=1 SV=4 | 8 | R | 0.395265 | G | 0.38647 | 0.008795 | No Change: Both O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 17 | S | 0.33058 | G | 0.287433 | 0.043147 | No Change: Both O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 100 | V | 0.276611 | A | 0.351486 | -0.074875 | No Change: Both O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 169 | R | 0.191046 | Q | 0.185521 | 0.005525 | No Change: Both O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 170 | A | 0.203449 | D | 0.284942 | -0.081493 | No Change: Both O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 306 | R | 0.507829 | W | 0.269429 | 0.2384 | D to O | - |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 496 | S | 0.944799 | A | 0.929262 | 0.015537 | No Change: Both D | A lung squamous cell carcinoma sample |
| Q08345 | DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | 833 | L | 0.020775 | V | 0.021395 | -6.20E-04 | No Change: Both O | - |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 105 | R | 0.506258 | S | 0.580917 | -0.074659 | No Change: Both D | A lung large cell carcinoma sample |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 441 | M | 0.608416 | I | 0.504133 | 0.104283 | No Change: Both D | - |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 478 | R | 0.863954 | C | 0.815521 | 0.048433 | No Change: Both D | - |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 543 | V | 0.232669 | F | 0.198017 | 0.034652 | No Change: Both O | - |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 713 | T | 0.16183 | I | 0.089221 | 0.072609 | No Change: Both O | Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665] |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 726 | I | 0.180588 | R | 0.30967 | -0.129082 | No Change: Both O | Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665] |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 752 | R | 0.062445 | C | 0.02643 | 0.036015 | No Change: Both O | Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665] |
| Q16832 | DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | 113 | E | 0.320193 | K | 0.331765 | -0.011572 | No Change: Both O | Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665] |
| Q96HY6 | DDRGK_HUMAN DDRGK domain-containing protein 1 OS=Homo sapiens GN=DDRGK1 PE=1 SV=2 | 303 | A | 0.513715 | T | 0.461886 | 0.051829 | D to O | - |
| Q13206 | DDX10_HUMAN Probable ATP-dependent RNA helicase DDX10 OS=Homo sapiens GN=DDX10 PE=1 SV=2 | 566 | L | 0.833428 | V | 0.823352 | 0.010076 | No Change: Both D | A breast cancer sample |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 39 | I | 0.233993 | S | 0.444403 | -0.21041 | No Change: Both O | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 567 | Q | 0.460733 | E | 0.447711 | 0.013022 | No Change: Both O | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 575 | T | 0.328243 | M | 0.295341 | 0.032902 | No Change: Both O | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 856 | R | 0.958079 | H | 0.953094 | 0.004985 | No Change: Both D | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 864 | C | 0.925355 | R | 0.939868 | -0.014513 | No Change: Both D | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 951 | C | 0.751553 | R | 0.825338 | -0.073785 | No Change: Both D | - |
| Q96FC9 | DDX11_HUMAN Probable ATP-dependent RNA helicase DDX11 OS=Homo sapiens GN=DDX11 PE=1 SV=1 | 966 | W | 0.952398 | C | 0.976476 | -0.024078 | No Change: Both D | - |
| Q9NVP1 | DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=Homo sapiens GN=DDX18 PE=1 SV=2 | 94 | T | 0.951993 | S | 0.962744 | -0.010751 | No Change: Both D | - |
| Q9NVP1 | DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=Homo sapiens GN=DDX18 PE=1 SV=2 | 647 | K | 0.911215 | R | 0.884765 | 0.02645 | No Change: Both D | - |
| Q9NVP1 | DDX18_HUMAN ATP-dependent RNA helicase DDX18 OS=Homo sapiens GN=DDX18 PE=1 SV=2 | 41 | G | 0.910202 | R | 0.923749 | -0.013547 | No Change: Both D | A breast cancer sample |
| Q9UMR2 | DD19B_HUMAN ATP-dependent RNA helicase DDX19B OS=Homo sapiens GN=DDX19B PE=1 SV=1 | 149 | V | 0.325037 | L | 0.360036 | -0.034999 | No Change: Both O | - |
| Q9UHI6 | DDX20_HUMAN Probable ATP-dependent RNA helicase DDX20 OS=Homo sapiens GN=DDX20 PE=1 SV=2 | 636 | I | 0.649276 | T | 0.728514 | -0.079238 | No Change: Both D | - |
| Q9UHI6 | DDX20_HUMAN Probable ATP-dependent RNA helicase DDX20 OS=Homo sapiens GN=DDX20 PE=1 SV=2 | 693 | R | 0.977645 | S | 0.984338 | -0.006693 | No Change: Both D | - |
| Q9UHI6 | DDX20_HUMAN Probable ATP-dependent RNA helicase DDX20 OS=Homo sapiens GN=DDX20 PE=1 SV=2 | 762 | I | 0.331896 | T | 0.48795 | -0.156054 | No Change: Both O | - |
| Q9NR30 | DDX21_HUMAN Nucleolar RNA helicase 2 OS=Homo sapiens GN=DDX21 PE=1 SV=5 | 27 | T | 0.995726 | I | 0.991801 | 0.003925 | No Change: Both D | - |
| Q9GZR7 | DDX24_HUMAN ATP-dependent RNA helicase DDX24 OS=Homo sapiens GN=DDX24 PE=1 SV=1 | 316 | E | 0.757426 | K | 0.743554 | 0.013872 | No Change: Both D | - |
| Q96GQ7 | DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens GN=DDX27 PE=1 SV=2 | 766 | G | 0.88951 | S | 0.91109 | -0.02158 | No Change: Both D | - |
| Q9NUL7 | DDX28_HUMAN Probable ATP-dependent RNA helicase DDX28 OS=Homo sapiens GN=DDX28 PE=2 SV=2 | 4 | T | 0.709328 | A | 0.677083 | 0.032245 | No Change: Both D | - |
| Q9H8H2 | DDX31_HUMAN Probable ATP-dependent RNA helicase DDX31 OS=Homo sapiens GN=DDX31 PE=1 SV=2 | 799 | I | 0.768251 | V | 0.788504 | -0.020253 | No Change: Both D | - |
| Q9H8H2 | DDX31_HUMAN Probable ATP-dependent RNA helicase DDX31 OS=Homo sapiens GN=DDX31 PE=1 SV=2 | 843 | R | 0.954965 | Q | 0.958816 | -0.003851 | No Change: Both D | - |
| Q9H8H2 | DDX31_HUMAN Probable ATP-dependent RNA helicase DDX31 OS=Homo sapiens GN=DDX31 PE=1 SV=2 | 153 | E | 0.972928 | K | 0.97672 | -0.003792 | No Change: Both D | - |
| Q9H8H2 | DDX31_HUMAN Probable ATP-dependent RNA helicase DDX31 OS=Homo sapiens GN=DDX31 PE=1 SV=2 | 687 | R | 0.41551 | Q | 0.436778 | -0.021268 | No Change: Both O | - |
| O00148 | DX39A_HUMAN ATP-dependent RNA helicase DDX39A OS=Homo sapiens GN=DDX39A PE=1 SV=2 | 142 | V | 0.311901 | I | 0.264982 | 0.046919 | No Change: Both O | - |
| O00571 | DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens GN=DDX3X PE=1 SV=3 | 294 | R | 0.258629 | T | 0.224424 | 0.034205 | No Change: Both O | A breast cancer sample |
| Q9NQI0 | DDX4_HUMAN Probable ATP-dependent RNA helicase DDX4 OS=Homo sapiens GN=DDX4 PE=2 SV=2 | 148 | G | 0.960013 | D | 0.959344 | 6.69E-04 | No Change: Both D | - |
| Q9NQI0 | DDX4_HUMAN Probable ATP-dependent RNA helicase DDX4 OS=Homo sapiens GN=DDX4 PE=2 SV=2 | 287 | I | 0.273082 | V | 0.30875 | -0.035668 | No Change: Both O | - |
| Q9NXZ2 | DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens GN=DDX43 PE=1 SV=2 | 625 | K | 0.845238 | E | 0.858996 | -0.013758 | No Change: Both D | - |
| Q9NXZ2 | DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens GN=DDX43 PE=1 SV=2 | 629 | Q | 0.93343 | R | 0.936849 | -0.003419 | No Change: Both D | - |
| Q7L014 | DDX46_HUMAN Probable ATP-dependent RNA helicase DDX46 OS=Homo sapiens GN=DDX46 PE=1 SV=2 | 207 | E | 0.992491 | Q | 0.989943 | 0.002548 | No Change: Both D | - |
| Q9Y6V7 | DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens GN=DDX49 PE=1 SV=1 | 222 | R | 0.216121 | H | 0.217871 | -0.00175 | No Change: Both O | - |
| Q9Y6V7 | DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens GN=DDX49 PE=1 SV=1 | 296 | S | 0.183769 | A | 0.124777 | 0.058992 | No Change: Both O | - |
| Q9Y6V7 | DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens GN=DDX49 PE=1 SV=1 | 413 | R | 0.748268 | W | 0.554315 | 0.193953 | No Change: Both D | - |
| P17844 | DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens GN=DDX5 PE=1 SV=1 | 480 | S | 0.827432 | A | 0.765311 | 0.062121 | No Change: Both D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 41 | R | 0.99058 | Q | 0.990257 | 3.23E-04 | No Change: Both D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 134 | E | 0.991252 | V | 0.984844 | 0.006408 | No Change: Both D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 175 | Q | 0.432556 | K | 0.510566 | -0.07801 | O to D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 249 | P | 0.361574 | L | 0.22297 | 0.138604 | No Change: Both O | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 295 | Q | 0.301765 | R | 0.268849 | 0.032916 | No Change: Both O | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 406 | Q | 0.636288 | K | 0.605113 | 0.031175 | No Change: Both D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 652 | Q | 0.945055 | K | 0.948296 | -0.003241 | No Change: Both D | - |
| Q8N8A6 | DDX51_HUMAN ATP-dependent RNA helicase DDX51 OS=Homo sapiens GN=DDX51 PE=1 SV=3 | 322 | A | 0.645867 | V | 0.615125 | 0.030742 | No Change: Both D | - |
| Q9Y2R4 | DDX52_HUMAN Probable ATP-dependent RNA helicase DDX52 OS=Homo sapiens GN=DDX52 PE=1 SV=3 | 403 | M | 0.270409 | V | 0.231315 | 0.039094 | No Change: Both O | - |
| Q86TM3 | DDX53_HUMAN Probable ATP-dependent RNA helicase DDX53 OS=Homo sapiens GN=DDX53 PE=1 SV=3 | 62 | V | 0.188865 | A | 0.233736 | -0.044871 | No Change: Both O | - |
| Q86TM3 | DDX53_HUMAN Probable ATP-dependent RNA helicase DDX53 OS=Homo sapiens GN=DDX53 PE=1 SV=3 | 381 | M | 0.353558 | I | 0.267607 | 0.085951 | No Change: Both O | - |
| Q86TM3 | DDX53_HUMAN Probable ATP-dependent RNA helicase DDX53 OS=Homo sapiens GN=DDX53 PE=1 SV=3 | 391 | R | 0.233197 | M | 0.194568 | 0.038629 | No Change: Both O | - |
| Q86TM3 | DDX53_HUMAN Probable ATP-dependent RNA helicase DDX53 OS=Homo sapiens GN=DDX53 PE=1 SV=3 | 141 | N | 0.448443 | T | 0.395458 | 0.052985 | No Change: Both O | - |
| Q8TDD1 | DDX54_HUMAN ATP-dependent RNA helicase DDX54 OS=Homo sapiens GN=DDX54 PE=1 SV=2 | 821 | P | 0.94689 | L | 0.916044 | 0.030846 | No Change: Both D | - |
| Q8TDD1 | DDX54_HUMAN ATP-dependent RNA helicase DDX54 OS=Homo sapiens GN=DDX54 PE=1 SV=2 | 570 | R | 0.432879 | H | 0.356274 | 0.076605 | No Change: Both O | - |
| Q8TDD1 | DDX54_HUMAN ATP-dependent RNA helicase DDX54 OS=Homo sapiens GN=DDX54 PE=1 SV=2 | 693 | R | 0.718266 | Q | 0.729288 | -0.011022 | No Change: Both D | - |
| Q8TDD1 | DDX54_HUMAN ATP-dependent RNA helicase DDX54 OS=Homo sapiens GN=DDX54 PE=1 SV=2 | 712 | V | 0.464937 | A | 0.602193 | -0.137256 | O to D | - |
| Q8NHQ9 | DDX55_HUMAN ATP-dependent RNA helicase DDX55 OS=Homo sapiens GN=DDX55 PE=1 SV=3 | 101 | V | 0.193106 | L | 0.208426 | -0.01532 | No Change: Both O | - |
| Q8NHQ9 | DDX55_HUMAN ATP-dependent RNA helicase DDX55 OS=Homo sapiens GN=DDX55 PE=1 SV=3 | 154 | E | 0.385235 | G | 0.34493 | 0.040305 | No Change: Both O | - |
| Q8NHQ9 | DDX55_HUMAN ATP-dependent RNA helicase DDX55 OS=Homo sapiens GN=DDX55 PE=1 SV=3 | 264 | N | 0.428623 | S | 0.463083 | -0.03446 | No Change: Both O | - |
| Q8NHQ9 | DDX55_HUMAN ATP-dependent RNA helicase DDX55 OS=Homo sapiens GN=DDX55 PE=1 SV=3 | 556 | N | 0.970583 | S | 0.975766 | -0.005183 | No Change: Both D | - |
| O95786 | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 OS=Homo sapiens GN=DDX58 PE=1 SV=2 | 7 | R | 0.568884 | C | 0.432733 | 0.136151 | D to O | - |
| O95786 | DDX58_HUMAN Probable ATP-dependent RNA helicase DDX58 OS=Homo sapiens GN=DDX58 PE=1 SV=2 | 580 | D | 0.456942 | E | 0.483585 | -0.026643 | No Change: Both O | - |
| Q5T1V6 | DDX59_HUMAN Probable ATP-dependent RNA helicase DDX59 OS=Homo sapiens GN=DDX59 PE=1 SV=1 | 107 | I | 0.370124 | V | 0.416789 | -0.046665 | No Change: Both O | - |
| Q5T1V6 | DDX59_HUMAN Probable ATP-dependent RNA helicase DDX59 OS=Homo sapiens GN=DDX59 PE=1 SV=1 | 472 | S | 0.501133 | R | 0.405887 | 0.095246 | D to O | - |
| Q5T1V6 | DDX59_HUMAN Probable ATP-dependent RNA helicase DDX59 OS=Homo sapiens GN=DDX59 PE=1 SV=1 | 77 | P | 0.912206 | T | 0.881662 | 0.030544 | No Change: Both D | A breast cancer sample |
| Q8IY21 | DDX60_HUMAN Probable ATP-dependent RNA helicase DDX60 OS=Homo sapiens GN=DDX60 PE=2 SV=3 | 672 | V | 0.266382 | M | 0.356848 | -0.090466 | No Change: Both O | - |
| Q8IY21 | DDX60_HUMAN Probable ATP-dependent RNA helicase DDX60 OS=Homo sapiens GN=DDX60 PE=2 SV=3 | 998 | I | 0.322369 | V | 0.342447 | -0.020078 | No Change: Both O | - |
| Q5H9U9 | DDX6L_HUMAN Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens GN=DDX60L PE=2 SV=2 | 336 | C | 0.056001 | Y | 0.075292 | -0.019291 | No Change: Both O | - |
| Q5H9U9 | DDX6L_HUMAN Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens GN=DDX60L PE=2 SV=2 | 355 | N | 0.132864 | K | 0.14326 | -0.010396 | No Change: Both O | - |
| Q5H9U9 | DDX6L_HUMAN Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens GN=DDX60L PE=2 SV=2 | 409 | V | 0.328179 | L | 0.330543 | -0.002364 | No Change: Both O | - |
| Q5H9U9 | DDX6L_HUMAN Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens GN=DDX60L PE=2 SV=2 | 583 | A | 0.867727 | T | 0.890346 | -0.022619 | No Change: Both D | - |
| Q5H9U9 | DDX6L_HUMAN Probable ATP-dependent RNA helicase DDX60-like OS=Homo sapiens GN=DDX60L PE=2 SV=2 | 1080 | S | 0.729786 | C | 0.547146 | 0.18264 | No Change: Both D | - |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 186 | E | 0.783378 | V | 0.690025 | 0.093353 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 191 | K | 0.691625 | I | 0.539169 | 0.152456 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 191 | K | 0.691625 | N | 0.672295 | 0.01933 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 202 | E | 0.497702 | D | 0.502338 | -0.004636 | O to D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 218 | R | 0.527019 | K | 0.567288 | -0.040269 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 356 | E | 0.634499 | H | 0.537407 | 0.097092 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 364 | S | 0.675916 | N | 0.576696 | 0.09922 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 367 | Q | 0.681214 | H | 0.618179 | 0.063035 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 370 | V | 0.661644 | L | 0.626753 | 0.034891 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 397 | Y | 0.713373 | F | 0.715518 | -0.002145 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 442 | V | 0.610917 | A | 0.695065 | -0.084148 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 449 | E | 0.494377 | K | 0.480575 | 0.013802 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 468 | Q | 0.36419 | H | 0.313946 | 0.050244 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 479 | H | 0.545868 | L | 0.460983 | 0.084885 | D to O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 498 | E | 0.710039 | K | 0.70918 | 8.59E-04 | No Change: Both D | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 526 | T | 0.292055 | N | 0.317596 | -0.025541 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 530 | R | 0.371294 | L | 0.253265 | 0.118029 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 542 | Q | 0.330375 | H | 0.307419 | 0.022956 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 545 | A | 0.30383 | G | 0.34348 | -0.03965 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 545 | A | 0.30383 | V | 0.240202 | 0.063628 | No Change: Both O | A primary colorectal cancer |
| O75398 | DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens GN=DEAF1 PE=1 SV=1 | 228 | I | 0.429822 | S | 0.662232 | -0.23241 | O to D | - |
| Q9P2X7 | DEC1_HUMAN Deleted in esophageal cancer 1 OS=Homo sapiens GN=DEC1 PE=2 SV=1 | 60 | A | 0.33343 | V | 0.246274 | 0.087156 | No Change: Both O | - |
| Q16698 | DECR_HUMAN 2 4-dienoyl-CoA reductase mitochondrial OS=Homo sapiens GN=DECR1 PE=1 SV=1 | 333 | K | 0.763469 | N | 0.75795 | 0.005519 | No Change: Both D | - |
| Q9H4E7 | DEFI6_HUMAN Differentially expressed in FDCP 6 homolog OS=Homo sapiens GN=DEF6 PE=1 SV=1 | 287 | N | 0.342349 | T | 0.358963 | -0.016614 | No Change: Both O | - |
| Q9H4E7 | DEFI6_HUMAN Differentially expressed in FDCP 6 homolog OS=Homo sapiens GN=DEF6 PE=1 SV=1 | 578 | R | 0.870207 | H | 0.844454 | 0.025753 | No Change: Both D | - |
| Q6ZN54 | DEFI8_HUMAN Differentially expressed in FDCP 8 homolog OS=Homo sapiens GN=DEF8 PE=2 SV=2 | 90 | Q | 0.91286 | E | 0.918554 | -0.005694 | No Change: Both D | - |
| P12838 | DEF4_HUMAN Neutrophil defensin 4 OS=Homo sapiens GN=DEFA4 PE=1 SV=2 | 74 | R | 0.132641 | Q | 0.122663 | 0.009978 | No Change: Both O | A colorectal cancer sample |
| P12838 | DEF4_HUMAN Neutrophil defensin 4 OS=Homo sapiens GN=DEFA4 PE=1 SV=2 | 8 | A | 0.220155 | P | 0.295302 | -0.075147 | No Change: Both O | - |
| P12838 | DEF4_HUMAN Neutrophil defensin 4 OS=Homo sapiens GN=DEFA4 PE=1 SV=2 | 8 | A | 0.220155 | V | 0.143517 | 0.076638 | No Change: Both O | - |
| Q01523 | DEF5_HUMAN Defensin-5 OS=Homo sapiens GN=DEFA5 PE=1 SV=1 | 71 | R | 0.594583 | H | 0.466377 | 0.128206 | D to O | - |
| P60022 | DEFB1_HUMAN Beta-defensin 1 OS=Homo sapiens GN=DEFB1 PE=1 SV=1 | 48 | A | 0.134648 | V | 0.093217 | 0.041431 | No Change: Both O | - |
| P60022 | DEFB1_HUMAN Beta-defensin 1 OS=Homo sapiens GN=DEFB1 PE=1 SV=1 | 67 | C | 0.65357 | S | 0.680912 | -0.027342 | No Change: Both D | - |
| P60022 | DEFB1_HUMAN Beta-defensin 1 OS=Homo sapiens GN=DEFB1 PE=1 SV=1 | 38 | V | 0.415644 | I | 0.385152 | 0.030492 | No Change: Both O | - |
| Q8WTQ1 | D104A_HUMAN Beta-defensin 104 OS=Homo sapiens GN=DEFB104A PE=2 SV=2 | 10 | I | 0.039192 | V | 0.05012 | -0.010928 | No Change: Both O | - |
| Q8NET1 | D108B_HUMAN Beta-defensin 108B OS=Homo sapiens GN=DEFB108B PE=2 SV=3 | 36 | R | 0.28298 | W | 0.113454 | 0.169526 | No Change: Both O | - |
| Q8NET1 | D108B_HUMAN Beta-defensin 108B OS=Homo sapiens GN=DEFB108B PE=2 SV=3 | 27 | I | 0.422612 | V | 0.455358 | -0.032746 | No Change: Both O | - |
| Q8NET1 | D108B_HUMAN Beta-defensin 108B OS=Homo sapiens GN=DEFB108B PE=2 SV=3 | 45 | H | 0.502406 | L | 0.469753 | 0.032653 | D to O | - |
| Q8NET1 | D108B_HUMAN Beta-defensin 108B OS=Homo sapiens GN=DEFB108B PE=2 SV=3 | 53 | Q | 0.62973 | R | 0.657996 | -0.028266 | No Change: Both D | - |
| Q30KQ4 | DB116_HUMAN Beta-defensin 116 OS=Homo sapiens GN=DEFB116 PE=2 SV=1 | 19 | Q | 0.2157 | L | 0.146615 | 0.069085 | No Change: Both O | - |
| Q96PH6 | DB118_HUMAN Beta-defensin 118 OS=Homo sapiens GN=DEFB118 PE=2 SV=1 | 56 | I | 0.694883 | V | 0.718866 | -0.023983 | No Change: Both D | - |
| Q8N687 | DB125_HUMAN Beta-defensin 125 OS=Homo sapiens GN=DEFB125 PE=2 SV=2 | 62 | H | 0.222961 | Y | 0.152558 | 0.070403 | No Change: Both O | - |
| Q9H1M4 | DB127_HUMAN Beta-defensin 127 OS=Homo sapiens GN=DEFB127 PE=1 SV=1 | 31 | G | 0.105863 | R | 0.114215 | -0.008352 | No Change: Both O | - |
| Q9H1M4 | DB127_HUMAN Beta-defensin 127 OS=Homo sapiens GN=DEFB127 PE=1 SV=1 | 71 | R | 0.644794 | S | 0.670287 | -0.025493 | No Change: Both D | - |
| Q7Z7B8 | DB128_HUMAN Beta-defensin 128 OS=Homo sapiens GN=DEFB128 PE=2 SV=1 | 27 | K | 0.185813 | N | 0.149618 | 0.036195 | No Change: Both O | - |
| Q9H1M3 | DB129_HUMAN Beta-defensin 129 OS=Homo sapiens GN=DEFB129 PE=2 SV=1 | 149 | T | 0.970351 | S | 0.973763 | -0.003412 | No Change: Both D | - |
| Q6QHC5 | DEGS2_HUMAN Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 OS=Homo sapiens GN=DEGS2 PE=2 SV=2 | 57 | A | 0.013056 | T | 0.014676 | -0.00162 | No Change: Both O | - |
| Q6QHC5 | DEGS2_HUMAN Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 OS=Homo sapiens GN=DEGS2 PE=2 SV=2 | 8 | S | 0.493835 | N | 0.446491 | 0.047344 | No Change: Both O | - |
| P35659 | DEK_HUMAN Protein DEK OS=Homo sapiens GN=DEK PE=1 SV=1 | 140 | V | 0.662835 | A | 0.705931 | -0.043096 | No Change: Both D | - |
| Q9H790 | EXO5_HUMAN Probable exonuclease V OS=Homo sapiens GN=DEM1 PE=2 SV=1 | 115 | D | 0.301889 | N | 0.286147 | 0.015742 | No Change: Both O | - |
| Q9H790 | EXO5_HUMAN Probable exonuclease V OS=Homo sapiens GN=DEM1 PE=2 SV=1 | 172 | G | 0.269275 | V | 0.161087 | 0.108188 | No Change: Both O | - |
| Q6P3S1 | DEN1B_HUMAN DENN domain-containing protein 1B OS=Homo sapiens GN=DENND1B PE=1 SV=1 | 216 | V | 0.219863 | M | 0.286625 | -0.066762 | No Change: Both O | - |
| Q8IV53 | DEN1C_HUMAN DENN domain-containing protein 1C OS=Homo sapiens GN=DENND1C PE=1 SV=1 | 23 | A | 0.609212 | T | 0.565419 | 0.043793 | No Change: Both D | - |
| Q8IV53 | DEN1C_HUMAN DENN domain-containing protein 1C OS=Homo sapiens GN=DENND1C PE=1 SV=1 | 489 | R | 0.875807 | C | 0.792736 | 0.083071 | No Change: Both D | - |
| Q8IV53 | DEN1C_HUMAN DENN domain-containing protein 1C OS=Homo sapiens GN=DENND1C PE=1 SV=1 | 542 | A | 0.941372 | V | 0.907783 | 0.033589 | No Change: Both D | - |
| Q9ULE3 | DEN2A_HUMAN DENN domain-containing protein 2A OS=Homo sapiens GN=DENND2A PE=2 SV=4 | 156 | P | 0.756814 | H | 0.648376 | 0.108438 | No Change: Both D | - |
| Q9ULE3 | DEN2A_HUMAN DENN domain-containing protein 2A OS=Homo sapiens GN=DENND2A PE=2 SV=4 | 729 | E | 0.241955 | K | 0.22583 | 0.016125 | No Change: Both O | - |
| Q9ULE3 | DEN2A_HUMAN DENN domain-containing protein 2A OS=Homo sapiens GN=DENND2A PE=2 SV=4 | 777 | I | 0.132495 | T | 0.22114 | -0.088645 | No Change: Both O | - |
| Q68D51 | DEN2C_HUMAN DENN domain-containing protein 2C OS=Homo sapiens GN=DENND2C PE=2 SV=2 | 2 | D | 0.730578 | E | 0.725942 | 0.004636 | No Change: Both D | - |
| Q68D51 | DEN2C_HUMAN DENN domain-containing protein 2C OS=Homo sapiens GN=DENND2C PE=2 SV=2 | 170 | D | 0.507276 | G | 0.478243 | 0.029033 | D to O | - |
| Q9H6A0 | DEN2D_HUMAN DENN domain-containing protein 2D OS=Homo sapiens GN=DENND2D PE=2 SV=2 | 282 | S | 0.063953 | N | 0.052705 | 0.011248 | No Change: Both O | - |
| A2RUS2 | DEND3_HUMAN DENN domain-containing protein 3 OS=Homo sapiens GN=DENND3 PE=2 SV=2 | 143 | S | 0.397667 | N | 0.341884 | 0.055783 | No Change: Both O | - |
| A2RUS2 | DEND3_HUMAN DENN domain-containing protein 3 OS=Homo sapiens GN=DENND3 PE=2 SV=2 | 364 | Q | 0.144996 | R | 0.131757 | 0.013239 | No Change: Both O | - |
| Q7Z401 | MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens GN=DENND4A PE=1 SV=2 | 284 | L | 0.59696 | P | 0.694666 | -0.097706 | No Change: Both D | - |
| Q5VZ89 | DEN4C_HUMAN DENN domain-containing protein 4C OS=Homo sapiens GN=DENND4C PE=1 SV=2 | 1030 | T | 0.907216 | A | 0.903883 | 0.003333 | No Change: Both D | - |
| Q5VZ89 | DEN4C_HUMAN DENN domain-containing protein 4C OS=Homo sapiens GN=DENND4C PE=1 SV=2 | 1107 | N | 0.72708 | H | 0.709947 | 0.017133 | No Change: Both D | - |
| Q5VZ89 | DEN4C_HUMAN DENN domain-containing protein 4C OS=Homo sapiens GN=DENND4C PE=1 SV=2 | 991 | V | 0.520748 | G | 0.658351 | -0.137603 | No Change: Both D | - |
| Q6IQ26 | DEN5A_HUMAN DENN domain-containing protein 5A OS=Homo sapiens GN=DENND5A PE=1 SV=2 | 224 | E | 0.30513 | Q | 0.290304 | 0.014826 | No Change: Both O | - |
| Q6ZUT9 | DEN5B_HUMAN DENN domain-containing protein 5B OS=Homo sapiens GN=DENND5B PE=1 SV=2 | 52 | R | 0.45123 | K | 0.52441 | -0.07318 | O to D | - |
| Q6ZUT9 | DEN5B_HUMAN DENN domain-containing protein 5B OS=Homo sapiens GN=DENND5B PE=1 SV=2 | 487 | H | 0.483649 | N | 0.521979 | -0.03833 | O to D | - |
| Q5TB30 | DEP1A_HUMAN DEP domain-containing protein 1A OS=Homo sapiens GN=DEPDC1 PE=1 SV=2 | 404 | I | 0.615898 | R | 0.756677 | -0.140779 | No Change: Both D | - |
| Q8WUY9 | DEP1B_HUMAN DEP domain-containing protein 1B OS=Homo sapiens GN=DEPDC1B PE=2 SV=2 | 332 | R | 0.315796 | M | 0.288614 | 0.027182 | No Change: Both O | - |
| Q8WUY9 | DEP1B_HUMAN DEP domain-containing protein 1B OS=Homo sapiens GN=DEPDC1B PE=2 SV=2 | 395 | V | 0.154236 | L | 0.169586 | -0.01535 | No Change: Both O | - |
| Q8N2C3 | DEPD4_HUMAN DEP domain-containing protein 4 OS=Homo sapiens GN=DEPDC4 PE=2 SV=1 | 122 | H | 0.167331 | R | 0.161123 | 0.006208 | No Change: Both O | - |
| O75140 | DEPD5_HUMAN DEP domain-containing protein 5 OS=Homo sapiens GN=DEPDC5 PE=2 SV=1 | 491 | S | 0.952023 | T | 0.938366 | 0.013657 | No Change: Both D | - |
| O75140 | DEPD5_HUMAN DEP domain-containing protein 5 OS=Homo sapiens GN=DEPDC5 PE=2 SV=1 | 641 | A | 0.752143 | V | 0.677455 | 0.074688 | No Change: Both D | - |
| O75140 | DEPD5_HUMAN DEP domain-containing protein 5 OS=Homo sapiens GN=DEPDC5 PE=2 SV=1 | 712 | S | 0.852851 | F | 0.724303 | 0.128548 | No Change: Both D | - |
| Q96QD5 | DEPD7_HUMAN DEP domain-containing protein 7 OS=Homo sapiens GN=DEPDC7 PE=1 SV=1 | 192 | A | 0.390262 | T | 0.43071 | -0.040448 | No Change: Both O | - |
| Q96QD5 | DEPD7_HUMAN DEP domain-containing protein 7 OS=Homo sapiens GN=DEPDC7 PE=1 SV=1 | 464 | T | 0.713885 | I | 0.631035 | 0.08285 | No Change: Both D | - |
| Q9NTK1 | DEPP_HUMAN Protein DEPP OS=Homo sapiens GN=DEPP PE=1 SV=2 | 44 | I | 0.891619 | M | 0.932774 | -0.041155 | No Change: Both D | - |
| Q8TB45 | DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens GN=DEPTOR PE=1 SV=2 | 148 | N | 0.598883 | S | 0.660987 | -0.062104 | No Change: Both D | - |
| Q8TB45 | DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens GN=DEPTOR PE=1 SV=2 | 204 | N | 0.386531 | S | 0.433722 | -0.047191 | No Change: Both O | - |
| Q8TB45 | DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens GN=DEPTOR PE=1 SV=2 | 389 | S | 0.17498 | N | 0.157737 | 0.017243 | No Change: Both O | - |
| Q9BUN8 | DERL1_HUMAN Derlin-1 OS=Homo sapiens GN=DERL1 PE=1 SV=1 | 171 | I | 0.138771 | V | 0.154167 | -0.015396 | No Change: Both O | - |
| Q96Q80 | DERL3_HUMAN Derlin-3 OS=Homo sapiens GN=DERL3 PE=1 SV=2 | 211 | A | 0.679077 | V | 0.626714 | 0.052363 | No Change: Both D | - |
| Q96Q80 | DERL3_HUMAN Derlin-3 OS=Homo sapiens GN=DERL3 PE=1 SV=2 | 149 | F | 0.049301 | L | 0.056708 | -0.007407 | No Change: Both O | - |
| Q8TE02 | DERP6_HUMAN Dermal papilla-derived protein 6 OS=Homo sapiens GN=DERP6 PE=1 SV=2 | 303 | D | 0.782151 | Y | 0.595652 | 0.186499 | No Change: Both D | - |
| Q8TE02 | DERP6_HUMAN Dermal papilla-derived protein 6 OS=Homo sapiens GN=DERP6 PE=1 SV=2 | 14 | E | 0.655325 | K | 0.616341 | 0.038984 | No Change: Both D | - |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 337 | A | 0.549947 | P | 0.591811 | -0.041864 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 360 | A | 0.669279 | P | 0.699412 | -0.030133 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 393 | N | 0.209058 | I | 0.115629 | 0.093429 | No Change: Both O | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 345 | L | 0.63465 | P | 0.709198 | -0.074548 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 385 | L | 0.402771 | P | 0.508042 | -0.105271 | O to D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 389 | Q | 0.316383 | P | 0.331002 | -0.014619 | No Change: Both O | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 451 | I | 0.612722 | M | 0.733014 | -0.120292 | No Change: Both D | Cardiomyopathy dilated type 1I (CMD1I) [MIM:604765] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 2 | S | 0.950788 | I | 0.846601 | 0.104187 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 46 | S | 0.950636 | F | 0.905311 | 0.045325 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 46 | S | 0.950636 | Y | 0.892444 | 0.058192 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 213 | A | 0.510447 | V | 0.394823 | 0.115624 | D to O | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 245 | E | 0.701262 | D | 0.650929 | 0.050333 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 342 | N | 0.621228 | D | 0.674932 | -0.053704 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 350 | R | 0.65409 | P | 0.626581 | 0.027509 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 350 | R | 0.65409 | P | 0.626581 | 0.027509 | No Change: Both D | Neurogenic scapuloperoneal syndrome Kaeser type (Kaeser syndrome) [MIM:181400] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 355 | R | 0.679763 | P | 0.657281 | 0.022482 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 357 | A | 0.676644 | P | 0.707346 | -0.030702 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 370 | L | 0.578401 | P | 0.668473 | -0.090072 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 406 | R | 0.270144 | W | 0.123225 | 0.146919 | No Change: Both O | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 442 | T | 0.670448 | I | 0.541759 | 0.128689 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 449 | K | 0.597079 | M | 0.501874 | 0.095205 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 449 | K | 0.597079 | T | 0.553053 | 0.044026 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 454 | R | 0.663089 | W | 0.402424 | 0.260665 | D to O | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| P17661 | DESM_HUMAN Desmin OS=Homo sapiens GN=DES PE=1 SV=3 | 460 | S | 0.725436 | I | 0.586747 | 0.138689 | No Change: Both D | Myopathy myofibrillar type 1 (MFM1) [MIM:601419] |
| O76075 | DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens GN=DFFB PE=1 SV=1 | 196 | R | 0.415934 | K | 0.423185 | -0.007251 | No Change: Both O | - |
| O76075 | DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens GN=DFFB PE=1 SV=1 | 277 | K | 0.429587 | R | 0.373528 | 0.056059 | No Change: Both O | - |
| O60443 | DFNA5_HUMAN Non-syndromic hearing impairment protein 5 OS=Homo sapiens GN=DFNA5 PE=1 SV=2 | 142 | P | 0.335963 | T | 0.326276 | 0.009687 | No Change: Both O | - |
| O60443 | DFNA5_HUMAN Non-syndromic hearing impairment protein 5 OS=Homo sapiens GN=DFNA5 PE=1 SV=2 | 207 | V | 0.284108 | M | 0.325797 | -0.041689 | No Change: Both O | - |
| O60443 | DFNA5_HUMAN Non-syndromic hearing impairment protein 5 OS=Homo sapiens GN=DFNA5 PE=1 SV=2 | 174 | M | 0.455275 | T | 0.496491 | -0.041216 | No Change: Both O | - |
| Q96PD7 | DGAT2_HUMAN Diacylglycerol O-acyltransferase 2 OS=Homo sapiens GN=DGAT2 PE=2 SV=2 | 317 | R | 0.156505 | G | 0.180584 | -0.024079 | No Change: Both O | - |
| Q96PD7 | DGAT2_HUMAN Diacylglycerol O-acyltransferase 2 OS=Homo sapiens GN=DGAT2 PE=2 SV=2 | 361 | M | 0.140392 | I | 0.0902 | 0.050192 | No Change: Both O | - |
| Q96DF8 | DGC14_HUMAN Protein DGCR14 OS=Homo sapiens GN=DGCR14 PE=1 SV=1 | 31 | A | 0.760577 | V | 0.700932 | 0.059645 | No Change: Both D | - |
| Q96DF8 | DGC14_HUMAN Protein DGCR14 OS=Homo sapiens GN=DGCR14 PE=1 SV=1 | 336 | V | 0.722421 | M | 0.790705 | -0.068284 | No Change: Both D | - |
| Q96DF8 | DGC14_HUMAN Protein DGCR14 OS=Homo sapiens GN=DGCR14 PE=1 SV=1 | 423 | A | 0.95697 | V | 0.936773 | 0.020197 | No Change: Both D | - |
| P98153 | IDD_HUMAN Integral membrane protein DGCR2/IDD OS=Homo sapiens GN=DGCR2 PE=1 SV=1 | 473 | V | 0.850889 | A | 0.888319 | -0.03743 | No Change: Both D | - |
| Q14129 | DGCR6_HUMAN Protein DGCR6 OS=Homo sapiens GN=DGCR6 PE=1 SV=3 | 117 | A | 0.881804 | V | 0.849646 | 0.032158 | No Change: Both D | - |
| Q9BY27 | DGC6L_HUMAN Protein DGCR6L OS=Homo sapiens GN=DGCR6L PE=1 SV=2 | 115 | V | 0.868147 | L | 0.877476 | -0.009329 | No Change: Both D | - |
| Q9BY27 | DGC6L_HUMAN Protein DGCR6L OS=Homo sapiens GN=DGCR6L PE=1 SV=2 | 195 | N | 0.53658 | K | 0.580337 | -0.043757 | No Change: Both D | - |
| Q8WYQ5 | DGCR8_HUMAN Microprocessor complex subunit DGCR8 OS=Homo sapiens GN=DGCR8 PE=1 SV=1 | 174 | I | 0.688705 | V | 0.757078 | -0.068373 | No Change: Both D | - |
| Q8WYQ5 | DGCR8_HUMAN Microprocessor complex subunit DGCR8 OS=Homo sapiens GN=DGCR8 PE=1 SV=1 | 725 | N | 0.833734 | D | 0.83699 | -0.003256 | No Change: Both D | - |
| P23743 | DGKA_HUMAN Diacylglycerol kinase alpha OS=Homo sapiens GN=DGKA PE=1 SV=3 | 538 | H | 0.224438 | Y | 0.142464 | 0.081974 | No Change: Both O | - |
| Q9Y6T7 | DGKB_HUMAN Diacylglycerol kinase beta OS=Homo sapiens GN=DGKB PE=2 SV=2 | 789 | G | 0.703006 | S | 0.757977 | -0.054971 | No Change: Both D | - |
| P52429 | DGKE_HUMAN Diacylglycerol kinase epsilon OS=Homo sapiens GN=DGKE PE=2 SV=1 | 99 | L | 0.315489 | R | 0.46234 | -0.146851 | No Change: Both O | A breast cancer sample |
| P49619 | DGKG_HUMAN Diacylglycerol kinase gamma OS=Homo sapiens GN=DGKG PE=2 SV=3 | 142 | T | 0.887755 | S | 0.924491 | -0.036736 | No Change: Both D | - |
| P49619 | DGKG_HUMAN Diacylglycerol kinase gamma OS=Homo sapiens GN=DGKG PE=2 SV=3 | 370 | R | 0.11303 | W | 0.040512 | 0.072518 | No Change: Both O | - |
| P49619 | DGKG_HUMAN Diacylglycerol kinase gamma OS=Homo sapiens GN=DGKG PE=2 SV=3 | 316 | R | 0.238735 | K | 0.287759 | -0.049024 | No Change: Both O | - |
| P49619 | DGKG_HUMAN Diacylglycerol kinase gamma OS=Homo sapiens GN=DGKG PE=2 SV=3 | 706 | E | 0.267289 | K | 0.255355 | 0.011934 | No Change: Both O | A breast cancer sample |
| Q86XP1 | DGKH_HUMAN Diacylglycerol kinase eta OS=Homo sapiens GN=DGKH PE=1 SV=1 | 1201 | V | 0.330195 | A | 0.390387 | -0.060192 | No Change: Both O | - |
| O75912 | DGKI_HUMAN Diacylglycerol kinase iota OS=Homo sapiens GN=DGKI PE=1 SV=1 | 153 | L | 0.49566 | F | 0.433929 | 0.061731 | No Change: Both O | - |
| Q5KSL6 | DGKK_HUMAN Diacylglycerol kinase kappa OS=Homo sapiens GN=DGKK PE=1 SV=1 | 1118 | D | 0.175672 | N | 0.173264 | 0.002408 | No Change: Both O | - |
| P52824 | DGKQ_HUMAN Diacylglycerol kinase theta OS=Homo sapiens GN=DGKQ PE=1 SV=2 | 27 | P | 0.988795 | L | 0.977331 | 0.011464 | No Change: Both D | - |
| Q13574 | DGKZ_HUMAN Diacylglycerol kinase zeta OS=Homo sapiens GN=DGKZ PE=1 SV=3 | 21 | Q | 0.963401 | R | 0.969224 | -0.005823 | No Change: Both D | - |
| Q13574 | DGKZ_HUMAN Diacylglycerol kinase zeta OS=Homo sapiens GN=DGKZ PE=1 SV=3 | 69 | G | 0.913994 | C | 0.908735 | 0.005259 | No Change: Both D | - |
| Q16854 | DGUOK_HUMAN Deoxyguanosine kinase mitochondrial OS=Homo sapiens GN=DGUOK PE=1 SV=2 | 142 | R | 0.250167 | K | 0.303755 | -0.053588 | No Change: Both O | Mitochondrial DNA depletion syndrome type 3 (MTDPS3) [MIM:251880] |
| Q16854 | DGUOK_HUMAN Deoxyguanosine kinase mitochondrial OS=Homo sapiens GN=DGUOK PE=1 SV=2 | 227 | E | 0.302673 | K | 0.30606 | -0.003387 | No Change: Both O | Mitochondrial DNA depletion syndrome type 3 (MTDPS3) [MIM:251880] |
| Q16854 | DGUOK_HUMAN Deoxyguanosine kinase mitochondrial OS=Homo sapiens GN=DGUOK PE=1 SV=2 | 250 | L | 0.133909 | S | 0.255709 | -0.1218 | No Change: Both O | Mitochondrial DNA depletion syndrome type 3 (MTDPS3) [MIM:251880] |
| Q15392 | DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens GN=DHCR24 PE=1 SV=2 | 191 | E | 0.067646 | K | 0.067554 | 9.20E-05 | No Change: Both O | Desmosterolosis (DESMOS) [MIM:602398] |
| Q15392 | DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens GN=DHCR24 PE=1 SV=2 | 294 | N | 0.521432 | T | 0.466115 | 0.055317 | D to O | Desmosterolosis (DESMOS) [MIM:602398] |
| Q15392 | DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens GN=DHCR24 PE=1 SV=2 | 306 | K | 0.111471 | N | 0.093573 | 0.017898 | No Change: Both O | Desmosterolosis (DESMOS) [MIM:602398] |
| Q15392 | DHC24_HUMAN Delta(24)-sterol reductase OS=Homo sapiens GN=DHCR24 PE=1 SV=2 | 471 | Y | 0.118586 | S | 0.229982 | -0.111396 | No Change: Both O | Desmosterolosis (DESMOS) [MIM:602398] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 51 | P | 0.007748 | S | 0.009059 | -0.001311 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 93 | T | 0.352829 | M | 0.287959 | 0.06487 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 99 | L | 0.075295 | P | 0.148053 | -0.072758 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 119 | H | 0.123807 | L | 0.076878 | 0.046929 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 157 | L | 0.032969 | P | 0.062327 | -0.029358 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 244 | G | 0.060753 | R | 0.057178 | 0.003575 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 247 | A | 0.041465 | V | 0.029942 | 0.011523 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 248 | W | 0.038934 | C | 0.04641 | -0.007476 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 289 | T | 0.027706 | I | 0.014152 | 0.013554 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 326 | V | 0.086376 | L | 0.09003 | -0.003654 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 352 | R | 0.06437 | W | 0.024341 | 0.040029 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 380 | C | 0.28373 | S | 0.565105 | -0.281375 | O to D | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 404 | R | 0.073228 | C | 0.032663 | 0.040565 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 410 | G | 0.179976 | S | 0.22043 | -0.040454 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 448 | E | 0.439217 | K | 0.453961 | -0.014744 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 68 | L | 0.102551 | P | 0.214697 | -0.112146 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 107 | Q | 0.028734 | H | 0.026161 | 0.002573 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 109 | L | 0.033905 | P | 0.069804 | -0.035899 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 113 | S | 0.088578 | C | 0.031513 | 0.057065 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 138 | G | 0.237662 | V | 0.14213 | 0.095532 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 145 | I | 0.134843 | L | 0.162867 | -0.028024 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 147 | G | 0.098307 | D | 0.109411 | -0.011104 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 154 | T | 0.023437 | M | 0.018706 | 0.004731 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 169 | S | 0.065852 | L | 0.026746 | 0.039106 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 182 | W | 0.009105 | C | 0.010928 | -0.001823 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 182 | W | 0.009105 | L | 0.014159 | -0.005054 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 183 | C | 0.012009 | Y | 0.016436 | -0.004427 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 198 | K | 0.14566 | E | 0.145735 | -7.50E-05 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 235 | F | 0.073632 | S | 0.169794 | -0.096162 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 242 | R | 0.079187 | C | 0.035925 | 0.043262 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 242 | R | 0.079187 | H | 0.080122 | -9.35E-04 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 255 | F | 0.183651 | L | 0.22004 | -0.036389 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 281 | V | 0.011282 | M | 0.014368 | -0.003086 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 297 | I | 0.060067 | T | 0.114744 | -0.054677 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 311 | C | 0.015735 | G | 0.042516 | -0.026781 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 311 | C | 0.015735 | Y | 0.022575 | -0.00684 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 324 | Y | 0.073196 | H | 0.121894 | -0.048698 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 344 | G | 0.03328 | R | 0.028941 | 0.004339 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 352 | R | 0.06437 | Q | 0.075605 | -0.011235 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 353 | V | 0.08767 | A | 0.128625 | -0.040955 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 362 | R | 0.303255 | C | 0.158246 | 0.145009 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 380 | C | 0.28373 | R | 0.480171 | -0.196441 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 380 | C | 0.28373 | Y | 0.354328 | -0.070598 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 397 | S | 0.179958 | L | 0.08133 | 0.098628 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 404 | R | 0.073228 | S | 0.103751 | -0.030523 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 405 | H | 0.082215 | Y | 0.050674 | 0.031541 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 408 | Y | 0.140544 | H | 0.238492 | -0.097948 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 410 | G | 0.179976 | R | 0.167819 | 0.012157 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 426 | H | 0.06267 | P | 0.079132 | -0.016462 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 443 | R | 0.126506 | C | 0.059282 | 0.067224 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 446 | R | 0.328257 | Q | 0.3277 | 5.57E-04 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 448 | E | 0.439217 | Q | 0.384411 | 0.054806 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 450 | R | 0.411983 | L | 0.268802 | 0.143181 | No Change: Both O | Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400] |
| Q9UBM7 | DHCR7_HUMAN 7-dehydrocholesterol reductase OS=Homo sapiens GN=DHCR7 PE=1 SV=1 | 425 | G | 0.074337 | S | 0.085757 | -0.01142 | No Change: Both O | - |
| Q86SQ9 | DHDDS_HUMAN Dehydrodolichyl diphosphate synthase OS=Homo sapiens GN=DHDDS PE=1 SV=3 | 253 | V | 0.348922 | M | 0.437498 | -0.088576 | No Change: Both O | - |
| Q86SQ9 | DHDDS_HUMAN Dehydrodolichyl diphosphate synthase OS=Homo sapiens GN=DHDDS PE=1 SV=3 | 42 | K | 0.484879 | E | 0.4888 | -0.003921 | No Change: Both O | Retinitis pigmentosa type 59 (RP59) [MIM:613861] |
| Q9UQ10 | DHDH_HUMAN Trans-1 2-dihydrobenzene-1 2-diol dehydrogenase OS=Homo sapiens GN=DHDH PE=1 SV=1 | 2 | A | 0.452753 | P | 0.579437 | -0.126684 | O to D | - |
| Q9UQ10 | DHDH_HUMAN Trans-1 2-dihydrobenzene-1 2-diol dehydrogenase OS=Homo sapiens GN=DHDH PE=1 SV=1 | 66 | S | 0.377725 | N | 0.331335 | 0.04639 | No Change: Both O | - |
| Q9UQ10 | DHDH_HUMAN Trans-1 2-dihydrobenzene-1 2-diol dehydrogenase OS=Homo sapiens GN=DHDH PE=1 SV=1 | 200 | V | 0.476027 | M | 0.525725 | -0.049698 | O to D | - |
| Q9UQ10 | DHDH_HUMAN Trans-1 2-dihydrobenzene-1 2-diol dehydrogenase OS=Homo sapiens GN=DHDH PE=1 SV=1 | 247 | V | 0.261729 | A | 0.298645 | -0.036916 | No Change: Both O | - |
| Q9UQ10 | DHDH_HUMAN Trans-1 2-dihydrobenzene-1 2-diol dehydrogenase OS=Homo sapiens GN=DHDH PE=1 SV=1 | 282 | G | 0.429135 | R | 0.424336 | 0.004799 | No Change: Both O | - |
| P00374 | DYR_HUMAN Dihydrofolate reductase OS=Homo sapiens GN=DHFR PE=1 SV=2 | 80 | L | 0.587162 | F | 0.542543 | 0.044619 | No Change: Both D | Megaloblastic anemia due to dihydrofolate reductase deficiency (DHFRD) [MIM:613839] |
| P00374 | DYR_HUMAN Dihydrofolate reductase OS=Homo sapiens GN=DHFR PE=1 SV=2 | 153 | D | 0.29572 | V | 0.163189 | 0.132531 | No Change: Both O | Megaloblastic anemia due to dihydrofolate reductase deficiency (DHFRD) [MIM:613839] |
| Q86XF0 | DYRL1_HUMAN Dihydrofolate reductase mitochondrial OS=Homo sapiens GN=DHFRL1 PE=1 SV=1 | 166 | V | 0.368001 | I | 0.326948 | 0.041053 | No Change: Both O | - |
| O43323 | DHH_HUMAN Desert hedgehog protein OS=Homo sapiens GN=DHH PE=1 SV=1 | 162 | L | 0.160793 | P | 0.26326 | -0.102467 | No Change: Both O | Complete pure gonadal dysgenesis 46 XY type (GDXYM) [MIM:233420] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 7 | K | 0.514957 | Q | 0.465646 | 0.049311 | D to O | - |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 19 | G | 0.092494 | E | 0.105122 | -0.012628 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 135 | R | 0.385465 | C | 0.214529 | 0.170936 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 152 | G | 0.407507 | R | 0.445284 | -0.037777 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 199 | R | 0.23307 | C | 0.13649 | 0.09658 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 202 | G | 0.18639 | A | 0.163352 | 0.023038 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 202 | G | 0.18639 | D | 0.210244 | -0.023854 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 244 | R | 0.489919 | W | 0.237533 | 0.252386 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 284 | T | 0.359432 | I | 0.24762 | 0.111812 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 346 | R | 0.320919 | W | 0.159509 | 0.16141 | No Change: Both O | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| Q02127 | PYRD_HUMAN Dihydroorotate dehydrogenase (quinone) mitochondrial OS=Homo sapiens GN=DHODH PE=1 SV=3 | 392 | D | 0.631654 | G | 0.621758 | 0.009896 | No Change: Both D | Postaxial acrofacial dysostosis (POADS) [MIM:263750] |
| P49366 | DHYS_HUMAN Deoxyhypusine synthase OS=Homo sapiens GN=DHPS PE=1 SV=1 | 174 | E | 0.177057 | D | 0.156398 | 0.020659 | No Change: Both O | - |
| Q96LJ7 | DHRS1_HUMAN Dehydrogenase/reductase SDR family member 1 OS=Homo sapiens GN=DHRS1 PE=1 SV=1 | 241 | T | 0.275231 | I | 0.176956 | 0.098275 | No Change: Both O | - |
| Q6UX07 | DHR13_HUMAN Dehydrogenase/reductase SDR family member 13 OS=Homo sapiens GN=DHRS13 PE=1 SV=1 | 191 | R | 0.188799 | Q | 0.195171 | -0.006372 | No Change: Both O | - |
| Q6UX07 | DHR13_HUMAN Dehydrogenase/reductase SDR family member 13 OS=Homo sapiens GN=DHRS13 PE=1 SV=1 | 336 | L | 0.99662 | Q | 0.997864 | -0.001244 | No Change: Both D | - |
| Q13268 | DHRS2_HUMAN Dehydrogenase/reductase SDR family member 2 OS=Homo sapiens GN=DHRS2 PE=1 SV=3 | 250 | A | 0.278142 | V | 0.211534 | 0.066608 | No Change: Both O | A colorectal cancer sample |
| Q9BTZ2 | DHRS4_HUMAN Dehydrogenase/reductase SDR family member 4 OS=Homo sapiens GN=DHRS4 PE=1 SV=3 | 31 | A | 0.377712 | T | 0.40724 | -0.029528 | No Change: Both O | - |
| Q9BTZ2 | DHRS4_HUMAN Dehydrogenase/reductase SDR family member 4 OS=Homo sapiens GN=DHRS4 PE=1 SV=3 | 202 | P | 0.187506 | S | 0.200332 | -0.012826 | No Change: Both O | - |
| Q6PKH6 | DR4L2_HUMAN Dehydrogenase/reductase SDR family member 4-like 2 OS=Homo sapiens GN=DHRS4L2 PE=2 SV=1 | 17 | L | 0.542539 | M | 0.628533 | -0.085994 | No Change: Both D | - |
| Q9Y394 | DHRS7_HUMAN Dehydrogenase/reductase SDR family member 7 OS=Homo sapiens GN=DHRS7 PE=1 SV=1 | 218 | R | 0.200942 | Q | 0.208943 | -0.008001 | No Change: Both O | - |
| A6NNS2 | DRS7C_HUMAN Dehydrogenase/reductase SDR family member 7C OS=Homo sapiens GN=DHRS7C PE=2 SV=3 | 227 | S | 0.233311 | L | 0.099875 | 0.133436 | No Change: Both O | - |
| Q9BPW9 | DHRS9_HUMAN Dehydrogenase/reductase SDR family member 9 OS=Homo sapiens GN=DHRS9 PE=1 SV=1 | 286 | D | 0.235391 | H | 0.217831 | 0.01756 | No Change: Both O | - |
| Q8N5I4 | DHRSX_HUMAN Dehydrogenase/reductase SDR family member on chromosome X OS=Homo sapiens GN=DHRSX PE=2 SV=2 | 297 | E | 0.60278 | K | 0.606769 | -0.003989 | No Change: Both D | - |
| Q8N5I4 | DHRSX_HUMAN Dehydrogenase/reductase SDR family member on chromosome X OS=Homo sapiens GN=DHRSX PE=2 SV=2 | 247 | V | 0.13638 | L | 0.120879 | 0.015501 | No Change: Both O | - |
| Q8N5I4 | DHRSX_HUMAN Dehydrogenase/reductase SDR family member on chromosome X OS=Homo sapiens GN=DHRSX PE=2 SV=2 | 292 | H | 0.327823 | R | 0.323945 | 0.003878 | No Change: Both O | - |
| Q96HY7 | DHTK1_HUMAN Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial OS=Homo sapiens GN=DHTKD1 PE=2 SV=2 | 20 | F | 0.498084 | L | 0.585117 | -0.087033 | O to D | - |
| Q96HY7 | DHTK1_HUMAN Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial OS=Homo sapiens GN=DHTKD1 PE=2 SV=2 | 272 | Y | 0.325929 | D | 0.504204 | -0.178275 | O to D | - |
| Q96HY7 | DHTK1_HUMAN Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial OS=Homo sapiens GN=DHTKD1 PE=2 SV=2 | 308 | R | 0.810446 | L | 0.730949 | 0.079497 | No Change: Both D | - |
| Q96HY7 | DHTK1_HUMAN Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial OS=Homo sapiens GN=DHTKD1 PE=2 SV=2 | 350 | N | 0.228112 | D | 0.239672 | -0.01156 | No Change: Both O | - |
| Q96HY7 | DHTK1_HUMAN Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 mitochondrial OS=Homo sapiens GN=DHTKD1 PE=2 SV=2 | 607 | I | 0.152755 | M | 0.22469 | -0.071935 | No Change: Both O | - |
| O60231 | DHX16_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens GN=DHX16 PE=1 SV=2 | 352 | K | 0.711423 | E | 0.754904 | -0.043481 | No Change: Both D | - |
| O60231 | DHX16_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens GN=DHX16 PE=1 SV=2 | 502 | L | 0.255594 | F | 0.224256 | 0.031338 | No Change: Both O | - |
| O60231 | DHX16_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens GN=DHX16 PE=1 SV=2 | 566 | D | 0.222314 | G | 0.188251 | 0.034063 | No Change: Both O | - |
| Q7Z478 | DHX29_HUMAN ATP-dependent RNA helicase DHX29 OS=Homo sapiens GN=DHX29 PE=1 SV=2 | 630 | P | 0.228888 | H | 0.185123 | 0.043765 | No Change: Both O | - |
| Q7Z478 | DHX29_HUMAN ATP-dependent RNA helicase DHX29 OS=Homo sapiens GN=DHX29 PE=1 SV=2 | 309 | D | 0.851356 | A | 0.853181 | -0.001825 | No Change: Both D | - |
| Q7L7V1 | DHX32_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 OS=Homo sapiens GN=DHX32 PE=1 SV=1 | 209 | P | 0.168051 | R | 0.152944 | 0.015107 | No Change: Both O | A breast cancer sample |
| Q7L7V1 | DHX32_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 OS=Homo sapiens GN=DHX32 PE=1 SV=1 | 271 | E | 0.431885 | D | 0.410886 | 0.020999 | No Change: Both O | - |
| Q7L7V1 | DHX32_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 OS=Homo sapiens GN=DHX32 PE=1 SV=1 | 301 | D | 0.362028 | A | 0.283159 | 0.078869 | No Change: Both O | - |
| Q7L7V1 | DHX32_HUMAN Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 OS=Homo sapiens GN=DHX32 PE=1 SV=1 | 430 | V | 0.173937 | L | 0.228346 | -0.054409 | No Change: Both O | - |
| Q9H6R0 | DHX33_HUMAN Putative ATP-dependent RNA helicase DHX33 OS=Homo sapiens GN=DHX33 PE=1 SV=2 | 118 | R | 0.253353 | C | 0.140544 | 0.112809 | No Change: Both O | - |
| Q9H6R0 | DHX33_HUMAN Putative ATP-dependent RNA helicase DHX33 OS=Homo sapiens GN=DHX33 PE=1 SV=2 | 483 | H | 0.508965 | D | 0.579219 | -0.070254 | No Change: Both D | - |
| Q14147 | DHX34_HUMAN Probable ATP-dependent RNA helicase DHX34 OS=Homo sapiens GN=DHX34 PE=2 SV=2 | 17 | R | 0.947976 | W | 0.893321 | 0.054655 | No Change: Both D | - |
| Q14147 | DHX34_HUMAN Probable ATP-dependent RNA helicase DHX34 OS=Homo sapiens GN=DHX34 PE=2 SV=2 | 117 | G | 0.57954 | D | 0.578075 | 0.001465 | No Change: Both D | - |
| Q9H5Z1 | DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens GN=DHX35 PE=1 SV=2 | 703 | P | 0.803993 | L | 0.849796 | -0.045803 | No Change: Both D | - |
| Q9H5Z1 | DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens GN=DHX35 PE=1 SV=2 | 189 | I | 0.108153 | T | 0.185409 | -0.077256 | No Change: Both O | - |
| Q9H2U1 | DHX36_HUMAN Probable ATP-dependent RNA helicase DHX36 OS=Homo sapiens GN=DHX36 PE=1 SV=2 | 151 | E | 0.69871 | K | 0.708987 | -0.010277 | No Change: Both D | - |
| Q9H2U1 | DHX36_HUMAN Probable ATP-dependent RNA helicase DHX36 OS=Homo sapiens GN=DHX36 PE=1 SV=2 | 416 | S | 0.660765 | C | 0.468439 | 0.192326 | D to O | - |
| Q9H2U1 | DHX36_HUMAN Probable ATP-dependent RNA helicase DHX36 OS=Homo sapiens GN=DHX36 PE=1 SV=2 | 583 | I | 0.467707 | N | 0.638995 | -0.171288 | O to D | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 458 | R | 0.156911 | Q | 0.162011 | -0.0051 | No Change: Both O | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 508 | K | 0.94994 | N | 0.932358 | 0.017582 | No Change: Both D | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 717 | V | 0.238455 | I | 0.220635 | 0.01782 | No Change: Both O | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 869 | S | 0.151528 | G | 0.132545 | 0.018983 | No Change: Both O | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 1081 | R | 0.281096 | Q | 0.290359 | -0.009263 | No Change: Both O | - |
| Q8IY37 | DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens GN=DHX37 PE=1 SV=1 | 96 | M | 0.91198 | I | 0.858096 | 0.053884 | No Change: Both D | - |
| Q92620 | PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens GN=DHX38 PE=1 SV=2 | 1217 | T | 0.956201 | A | 0.941681 | 0.01452 | No Change: Both D | - |
| Q6P158 | DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens GN=DHX57 PE=1 SV=2 | 433 | S | 0.561191 | G | 0.490881 | 0.07031 | D to O | - |
| Q6P158 | DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens GN=DHX57 PE=1 SV=2 | 410 | S | 0.16458 | F | 0.061679 | 0.102901 | No Change: Both O | - |
| Q6P158 | DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens GN=DHX57 PE=1 SV=2 | 587 | N | 0.446555 | S | 0.49373 | -0.047175 | No Change: Both O | - |
| Q96C10 | DHX58_HUMAN Probable ATP-dependent RNA helicase DHX58 OS=Homo sapiens GN=DHX58 PE=1 SV=1 | 425 | Q | 0.41425 | R | 0.373789 | 0.040461 | No Change: Both O | - |
| Q96C10 | DHX58_HUMAN Probable ATP-dependent RNA helicase DHX58 OS=Homo sapiens GN=DHX58 PE=1 SV=1 | 523 | R | 0.769873 | Q | 0.803571 | -0.033698 | No Change: Both D | - |
| Q96C10 | DHX58_HUMAN Probable ATP-dependent RNA helicase DHX58 OS=Homo sapiens GN=DHX58 PE=1 SV=1 | 76 | T | 0.218035 | A | 0.178696 | 0.039339 | No Change: Both O | - |
| Q96C10 | DHX58_HUMAN Probable ATP-dependent RNA helicase DHX58 OS=Homo sapiens GN=DHX58 PE=1 SV=1 | 95 | R | 0.152854 | Q | 0.149654 | 0.0032 | No Change: Both O | - |
| Q14562 | DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens GN=DHX8 PE=1 SV=1 | 1069 | A | 0.197717 | G | 0.230114 | -0.032397 | No Change: Both O | - |
| Q08211 | DHX9_HUMAN ATP-dependent RNA helicase A OS=Homo sapiens GN=DHX9 PE=1 SV=4 | 894 | I | 0.270881 | V | 0.29845 | -0.027569 | No Change: Both O | - |
| Q9NR28 | DBLOH_HUMAN Diablo homolog mitochondrial OS=Homo sapiens GN=DIABLO PE=1 SV=1 | 126 | S | 0.612853 | L | 0.477071 | 0.135782 | D to O | Deafness autosomal dominant type 64 (DFNA64) [MIM:614152] |
| O60879 | DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens GN=DIAPH2 PE=1 SV=1 | 425 | F | 0.115331 | L | 0.139256 | -0.023925 | No Change: Both O | - |
| O60879 | DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens GN=DIAPH2 PE=1 SV=1 | 426 | L | 0.092111 | V | 0.085714 | 0.006397 | No Change: Both O | - |
| Q9NSV4 | DIAP3_HUMAN Protein diaphanous homolog 3 OS=Homo sapiens GN=DIAPH3 PE=1 SV=4 | 363 | N | 0.164472 | S | 0.19069 | -0.026218 | No Change: Both O | - |
| Q9NSV4 | DIAP3_HUMAN Protein diaphanous homolog 3 OS=Homo sapiens GN=DIAPH3 PE=1 SV=4 | 773 | F | 0.643775 | L | 0.694583 | -0.050808 | No Change: Both D | - |
| Q9NSV4 | DIAP3_HUMAN Protein diaphanous homolog 3 OS=Homo sapiens GN=DIAPH3 PE=1 SV=4 | 1041 | E | 0.966375 | G | 0.952504 | 0.013871 | No Change: Both D | - |
| Q9UPY3 | DICER_HUMAN Endoribonuclease Dicer OS=Homo sapiens GN=DICER1 PE=1 SV=3 | 1583 | L | 0.086154 | R | 0.133339 | -0.047185 | No Change: Both O | Pleuropulmonary blastoma (PPB) [MIM:601200] |
| Q9UPY3 | DICER_HUMAN Endoribonuclease Dicer OS=Homo sapiens GN=DICER1 PE=1 SV=3 | 839 | S | 0.195311 | F | 0.083902 | 0.111409 | No Change: Both O | Goiter multinodular type 1 with or without Sertoli-Leydig cell tumors (MNG1) [MIM:138800] |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 13 | P | 0.938171 | L | 0.857596 | 0.080575 | No Change: Both D | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 276 | P | 0.315602 | L | 0.189335 | 0.126267 | No Change: Both O | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 544 | M | 0.972248 | T | 0.976666 | -0.004418 | No Change: Both D | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 556 | A | 0.960719 | T | 0.959405 | 0.001314 | No Change: Both D | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 793 | A | 0.9666 | G | 0.961264 | 0.005336 | No Change: Both D | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 1220 | P | 0.79987 | Q | 0.778873 | 0.020997 | No Change: Both D | - |
| Q9BTC0 | DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens GN=DIDO1 PE=1 SV=5 | 1708 | S | 0.944096 | C | 0.913588 | 0.030508 | No Change: Both D | - |
| Q68CQ4 | DIEXF_HUMAN Digestive organ expansion factor homolog OS=Homo sapiens GN=DIEXF PE=1 SV=2 | 67 | Q | 0.986428 | E | 0.988112 | -0.001684 | No Change: Both D | - |
| Q14689 | DIP2A_HUMAN Disco-interacting protein 2 homolog A OS=Homo sapiens GN=DIP2A PE=1 SV=2 | 191 | P | 0.975865 | A | 0.96727 | 0.008595 | No Change: Both D | - |
| Q14689 | DIP2A_HUMAN Disco-interacting protein 2 homolog A OS=Homo sapiens GN=DIP2A PE=1 SV=2 | 372 | S | 0.24925 | N | 0.203514 | 0.045736 | No Change: Both O | - |
| Q9P265 | DIP2B_HUMAN Disco-interacting protein 2 homolog B OS=Homo sapiens GN=DIP2B PE=1 SV=3 | 792 | I | 0.181935 | V | 0.226925 | -0.04499 | No Change: Both O | - |
| Q9Y2E4 | DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens GN=DIP2C PE=2 SV=2 | 586 | A | 0.183894 | E | 0.249373 | -0.065479 | No Change: Both O | A breast cancer sample |
| Q9Y2E4 | DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens GN=DIP2C PE=2 SV=2 | 622 | G | 0.199624 | S | 0.267952 | -0.068328 | No Change: Both O | A colorectal cancer sample |
| Q9Y2E4 | DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens GN=DIP2C PE=2 SV=2 | 1264 | V | 0.258892 | M | 0.302934 | -0.044042 | No Change: Both O | A breast cancer sample |
| Q969H9 | DIRC1_HUMAN Disrupted in renal carcinoma protein 1 OS=Homo sapiens GN=DIRC1 PE=2 SV=1 | 51 | S | 0.541573 | A | 0.446019 | 0.095554 | D to O | - |
| Q969H9 | DIRC1_HUMAN Disrupted in renal carcinoma protein 1 OS=Homo sapiens GN=DIRC1 PE=2 SV=1 | 92 | L | 0.23812 | S | 0.412899 | -0.174779 | No Change: Both O | - |
| Q9Y2L1 | RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens GN=DIS3 PE=1 SV=2 | 269 | N | 0.465784 | S | 0.492336 | -0.026552 | No Change: Both O | - |
| Q9Y2L1 | RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens GN=DIS3 PE=1 SV=2 | 326 | T | 0.810112 | R | 0.828509 | -0.018397 | No Change: Both D | - |
| Q8TF46 | DI3L1_HUMAN DIS3-like exonuclease 1 OS=Homo sapiens GN=DIS3L PE=1 SV=2 | 518 | I | 0.255987 | V | 0.280082 | -0.024095 | No Change: Both O | - |
| Q8TF46 | DI3L1_HUMAN DIS3-like exonuclease 1 OS=Homo sapiens GN=DIS3L PE=1 SV=2 | 614 | D | 0.63015 | G | 0.600953 | 0.029197 | No Change: Both D | - |
| Q8TF46 | DI3L1_HUMAN DIS3-like exonuclease 1 OS=Homo sapiens GN=DIS3L PE=1 SV=2 | 747 | N | 0.62511 | S | 0.655173 | -0.030063 | No Change: Both D | - |
| Q8IYB7 | DI3L2_HUMAN DIS3-like exonuclease 2 OS=Homo sapiens GN=DIS3L2 PE=1 SV=4 | 12 | P | 0.779662 | S | 0.76667 | 0.012992 | No Change: Both D | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 264 | R | 0.865843 | Q | 0.860435 | 0.005408 | No Change: Both D | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 704 | S | 0.478853 | C | 0.374869 | 0.103984 | No Change: Both O | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 607 | L | 0.383519 | F | 0.348495 | 0.035024 | No Change: Both O | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 5 | G | 0.97591 | V | 0.954326 | 0.021584 | No Change: Both D | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 330 | L | 0.465087 | F | 0.379187 | 0.0859 | No Change: Both O | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 116 | A | 0.491183 | V | 0.423676 | 0.067507 | No Change: Both O | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 328 | T | 0.522567 | N | 0.571351 | -0.048784 | No Change: Both D | - |
| Q9NRI5 | DISC1_HUMAN Disrupted in schizophrenia 1 protein OS=Homo sapiens GN=DISC1 PE=1 SV=3 | 531 | G | 0.497513 | R | 0.519621 | -0.022108 | O to D | - |
| Q96F81 | DISP1_HUMAN Protein dispatched homolog 1 OS=Homo sapiens GN=DISP1 PE=2 SV=3 | 103 | E | 0.977262 | K | 0.971564 | 0.005698 | No Change: Both D | - |
| A7MBM2 | DISP2_HUMAN Protein dispatched homolog 2 OS=Homo sapiens GN=DISP2 PE=2 SV=2 | 47 | P | 0.995737 | A | 0.993094 | 0.002643 | No Change: Both D | - |
| A7MBM2 | DISP2_HUMAN Protein dispatched homolog 2 OS=Homo sapiens GN=DISP2 PE=2 SV=2 | 56 | C | 0.995779 | S | 0.997338 | -0.001559 | No Change: Both D | - |
| A7MBM2 | DISP2_HUMAN Protein dispatched homolog 2 OS=Homo sapiens GN=DISP2 PE=2 SV=2 | 388 | G | 0.597579 | E | 0.610291 | -0.012712 | No Change: Both D | - |
| A7MBM2 | DISP2_HUMAN Protein dispatched homolog 2 OS=Homo sapiens GN=DISP2 PE=2 SV=2 | 1145 | G | 0.816577 | S | 0.82191 | -0.005333 | No Change: Both D | - |
| A7MBM2 | DISP2_HUMAN Protein dispatched homolog 2 OS=Homo sapiens GN=DISP2 PE=2 SV=2 | 1247 | R | 0.968702 | W | 0.930542 | 0.03816 | No Change: Both D | - |
| Q155Q3 | DIXC1_HUMAN Dixin OS=Homo sapiens GN=DIXDC1 PE=1 SV=2 | 300 | K | 0.839107 | R | 0.806578 | 0.032529 | No Change: Both D | - |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 36 | F | 0.589347 | V | 0.620026 | -0.030679 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 40 | P | 0.561515 | R | 0.525902 | 0.035613 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 72 | L | 0.281097 | Y | 0.287084 | -0.005987 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 402 | G | 0.715452 | E | 0.745854 | -0.030402 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 353 | A | 0.10798 | V | 0.074548 | 0.033432 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 353 | A | 0.10798 | V | 0.074548 | 0.033432 | No Change: Both O | Hoyeraal-Hreidarsson syndrome (HHS) [MIM:300240] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 2 | A | 0.937457 | V | 0.90983 | 0.027627 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 39 | K | 0.572491 | E | 0.575862 | -0.003371 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 41 | E | 0.543102 | K | 0.549872 | -0.00677 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 65 | R | 0.265446 | T | 0.276385 | -0.010939 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 66 | T | 0.236719 | A | 0.20243 | 0.034289 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 321 | L | 0.13718 | V | 0.141509 | -0.004329 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 350 | M | 0.065114 | I | 0.04351 | 0.021604 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 350 | M | 0.065114 | T | 0.08289 | -0.017776 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 402 | G | 0.715452 | R | 0.709302 | 0.00615 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 38 | I | 0.590203 | T | 0.674653 | -0.08445 | No Change: Both D | Hoyeraal-Hreidarsson syndrome (HHS) [MIM:300240] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 49 | T | 0.343755 | M | 0.306518 | 0.037237 | No Change: Both O | Hoyeraal-Hreidarsson syndrome (HHS) [MIM:300240] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 121 | S | 0.530025 | G | 0.51196 | 0.018065 | No Change: Both D | Hoyeraal-Hreidarsson syndrome (HHS) [MIM:300240] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 223 | G | 0.065798 | D | 0.072529 | -0.006731 | No Change: Both O | - |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 56 | L | 0.171271 | S | 0.313694 | -0.142423 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 72 | L | 0.281097 | F | 0.249642 | 0.031455 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 317 | L | 0.095763 | F | 0.078958 | 0.016805 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 322 | R | 0.161935 | Q | 0.179441 | -0.017506 | No Change: Both O | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| O60832 | DKC1_HUMAN H/ACA ribonucleoprotein complex subunit 4 OS=Homo sapiens GN=DKC1 PE=1 SV=3 | 409 | P | 0.662705 | L | 0.500135 | 0.16257 | No Change: Both D | Dyskeratosis congenita X-linked recessive (XDKC) [MIM:305000] |
| Q9UBU2 | DKK2_HUMAN Dickkopf-related protein 2 OS=Homo sapiens GN=DKK2 PE=1 SV=1 | 146 | R | 0.606628 | Q | 0.590345 | 0.016283 | No Change: Both D | - |
| Q9UBP4 | DKK3_HUMAN Dickkopf-related protein 3 OS=Homo sapiens GN=DKK3 PE=1 SV=2 | 335 | R | 0.834004 | G | 0.81532 | 0.018684 | No Change: Both D | - |
| Q9UBP4 | DKK3_HUMAN Dickkopf-related protein 3 OS=Homo sapiens GN=DKK3 PE=1 SV=2 | 49 | E | 0.872511 | D | 0.835388 | 0.037123 | No Change: Both D | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 109 | M | 0.587278 | R | 0.615388 | -0.02811 | No Change: Both D | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 214 | E | 0.856515 | K | 0.857062 | -5.47E-04 | No Change: Both D | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 29 | A | 0.3776 | T | 0.386942 | -0.009342 | No Change: Both O | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 24 | L | 0.30556 | R | 0.388294 | -0.082734 | No Change: Both O | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 104 | L | 0.548979 | I | 0.513014 | 0.035965 | No Change: Both D | - |
| Q9UK85 | DKKL1_HUMAN Dickkopf-like protein 1 OS=Homo sapiens GN=DKKL1 PE=1 SV=1 | 187 | G | 0.518664 | S | 0.575159 | -0.056495 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 43 | A | 0.793998 | V | 0.753929 | 0.040069 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 98 | S | 0.650575 | F | 0.4171 | 0.233475 | D to O | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 99 | L | 0.623311 | F | 0.561248 | 0.062063 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 209 | Q | 0.97053 | R | 0.967584 | 0.002946 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 313 | D | 0.796652 | V | 0.7462 | 0.050452 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 318 | V | 0.893055 | A | 0.908813 | -0.015758 | No Change: Both D | - |
| P10515 | ODP2_HUMAN Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLAT PE=1 SV=3 | 451 | D | 0.140279 | N | 0.140999 | -7.20E-04 | No Change: Both O | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 712 | N | 0.507713 | S | 0.559719 | -0.052006 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 791 | V | 0.454746 | M | 0.513669 | -0.058923 | O to D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 959 | T | 0.973413 | A | 0.965826 | 0.007587 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 998 | H | 0.875312 | Q | 0.894912 | -0.0196 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 1025 | V | 0.385294 | A | 0.470119 | -0.084825 | No Change: Both O | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 1199 | E | 0.268386 | V | 0.133966 | 0.13442 | No Change: Both O | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 1209 | S | 0.102946 | C | 0.042512 | 0.060434 | No Change: Both O | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 27 | R | 0.482691 | C | 0.393293 | 0.089398 | No Change: Both O | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 81 | L | 0.827107 | V | 0.822268 | 0.004839 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 254 | Q | 0.733085 | H | 0.647315 | 0.08577 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 255 | N | 0.739098 | D | 0.749307 | -0.010209 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 260 | T | 0.723 | I | 0.578394 | 0.144606 | No Change: Both D | - |
| Q96QB1 | RHG07_HUMAN Rho GTPase-activating protein 7 OS=Homo sapiens GN=DLC1 PE=1 SV=4 | 320 | Q | 0.875224 | H | 0.826785 | 0.048439 | No Change: Both D | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 72 | K | 0.321787 | E | 0.331745 | -0.009958 | No Change: Both O | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 488 | P | 0.301084 | L | 0.188938 | 0.112146 | No Change: Both O | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 331 | L | 0.396943 | V | 0.383359 | 0.013584 | No Change: Both O | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 229 | G | 0.134368 | C | 0.055538 | 0.07883 | No Change: Both O | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 495 | R | 0.425057 | G | 0.439178 | -0.014121 | No Change: Both O | - |
| P09622 | DLDH_HUMAN Dihydrolipoyl dehydrogenase mitochondrial OS=Homo sapiens GN=DLD PE=1 SV=2 | 104 | K | 0.504857 | T | 0.432439 | 0.072418 | D to O | - |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 351 | P | 0.776467 | R | 0.714052 | 0.062415 | No Change: Both D | A breast cancer sample |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 79 | L | 0.640535 | R | 0.755693 | -0.115158 | No Change: Both D | - |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 192 | S | 0.234558 | F | 0.087388 | 0.14717 | No Change: Both O | - |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 1022 | K | 0.446988 | N | 0.397135 | 0.049853 | No Change: Both O | - |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 1150 | N | 0.779849 | D | 0.776629 | 0.00322 | No Change: Both D | - |
| Q9Y238 | DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens GN=DLEC1 PE=2 SV=2 | 1227 | L | 0.130602 | P | 0.247682 | -0.11708 | No Change: Both O | - |
| Q6UYE1 | LEU7_HUMAN Leukemia-associated protein 7 OS=Homo sapiens GN=DLEU7 PE=2 SV=1 | 83 | A | 0.963139 | V | 0.952433 | 0.010706 | No Change: Both D | - |
| Q12959 | DLG1_HUMAN Disks large homolog 1 OS=Homo sapiens GN=DLG1 PE=1 SV=2 | 140 | K | 0.677368 | R | 0.644173 | 0.033195 | No Change: Both D | - |
| Q12959 | DLG1_HUMAN Disks large homolog 1 OS=Homo sapiens GN=DLG1 PE=1 SV=2 | 278 | R | 0.128271 | Q | 0.127533 | 7.38E-04 | No Change: Both O | - |
| Q12959 | DLG1_HUMAN Disks large homolog 1 OS=Homo sapiens GN=DLG1 PE=1 SV=2 | 899 | P | 0.433318 | L | 0.291405 | 0.141913 | No Change: Both O | - |
| Q92796 | DLG3_HUMAN Disks large homolog 3 OS=Homo sapiens GN=DLG3 PE=1 SV=2 | 40 | G | 0.724409 | R | 0.719226 | 0.005183 | No Change: Both D | A colorectal cancer sample |
| Q8TDM6 | DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens GN=DLG5 PE=1 SV=4 | 140 | Q | 0.835273 | R | 0.836992 | -0.001719 | No Change: Both D | - |
| Q8TDM6 | DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens GN=DLG5 PE=1 SV=4 | 1481 | P | 0.910194 | Q | 0.899202 | 0.010992 | No Change: Both D | - |
| Q8TDM6 | DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens GN=DLG5 PE=1 SV=4 | 1600 | A | 0.144415 | V | 0.108053 | 0.036362 | No Change: Both O | - |
| O14490 | DLGP1_HUMAN Disks large-associated protein 1 OS=Homo sapiens GN=DLGAP1 PE=1 SV=1 | 816 | R | 0.668574 | Q | 0.682787 | -0.014213 | No Change: Both D | - |
| Q9P1A6 | DLGP2_HUMAN Disks large-associated protein 2 OS=Homo sapiens GN=DLGAP2 PE=1 SV=4 | 419 | P | 0.613978 | Q | 0.587271 | 0.026707 | No Change: Both D | - |
| Q9P1A6 | DLGP2_HUMAN Disks large-associated protein 2 OS=Homo sapiens GN=DLGAP2 PE=1 SV=4 | 620 | T | 0.956585 | M | 0.944529 | 0.012056 | No Change: Both D | - |
| Q9Y2H0 | DLGP4_HUMAN Disks large-associated protein 4 OS=Homo sapiens GN=DLGAP4 PE=1 SV=3 | 486 | A | 0.816589 | T | 0.815395 | 0.001194 | No Change: Both D | - |
| Q9Y2H0 | DLGP4_HUMAN Disks large-associated protein 4 OS=Homo sapiens GN=DLGAP4 PE=1 SV=3 | 861 | R | 0.409123 | Q | 0.477259 | -0.068136 | No Change: Both O | - |
| Q15398 | DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens GN=DLGAP5 PE=1 SV=2 | 69 | G | 0.547354 | E | 0.621448 | -0.074094 | No Change: Both D | - |
| Q15398 | DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens GN=DLGAP5 PE=1 SV=2 | 324 | Q | 0.442266 | H | 0.377461 | 0.064805 | No Change: Both O | - |
| Q15398 | DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens GN=DLGAP5 PE=1 SV=2 | 469 | T | 0.289947 | I | 0.184789 | 0.105158 | No Change: Both O | - |
| Q15398 | DLGP5_HUMAN Disks large-associated protein 5 OS=Homo sapiens GN=DLGAP5 PE=1 SV=2 | 753 | E | 0.725734 | Q | 0.692246 | 0.033488 | No Change: Both D | - |
| P80370 | DLK1_HUMAN Protein delta homolog 1 OS=Homo sapiens GN=DLK1 PE=1 SV=3 | 73 | Q | 0.605328 | L | 0.507698 | 0.09763 | No Change: Both D | - |
| P80370 | DLK1_HUMAN Protein delta homolog 1 OS=Homo sapiens GN=DLK1 PE=1 SV=3 | 104 | V | 0.510939 | M | 0.576981 | -0.066042 | No Change: Both D | - |
| P80370 | DLK1_HUMAN Protein delta homolog 1 OS=Homo sapiens GN=DLK1 PE=1 SV=3 | 260 | S | 0.391483 | N | 0.324473 | 0.06701 | No Change: Both O | - |
| P80370 | DLK1_HUMAN Protein delta homolog 1 OS=Homo sapiens GN=DLK1 PE=1 SV=3 | 101 | R | 0.60772 | G | 0.60187 | 0.00585 | No Change: Both D | - |
| P80370 | DLK1_HUMAN Protein delta homolog 1 OS=Homo sapiens GN=DLK1 PE=1 SV=3 | 108 | D | 0.615227 | G | 0.579677 | 0.03555 | No Change: Both D | - |
| Q6UY11 | DLK2_HUMAN Protein delta homolog 2 OS=Homo sapiens GN=DLK2 PE=2 SV=1 | 301 | G | 0.488072 | R | 0.483681 | 0.004391 | No Change: Both O | - |
| O00548 | DLL1_HUMAN Delta-like protein 1 OS=Homo sapiens GN=DLL1 PE=2 SV=2 | 444 | V | 0.760818 | M | 0.803555 | -0.042737 | No Change: Both D | - |
| Q9NYJ7 | DLL3_HUMAN Delta-like protein 3 OS=Homo sapiens GN=DLL3 PE=1 SV=1 | 385 | G | 0.76956 | D | 0.786966 | -0.017406 | No Change: Both D | Spondylocostal dysostosis type 1 (SCDO1) [MIM:277300] |
| Q9NYJ7 | DLL3_HUMAN Delta-like protein 3 OS=Homo sapiens GN=DLL3 PE=1 SV=1 | 218 | L | 0.913739 | P | 0.951507 | -0.037768 | No Change: Both D | - |
| Q9NYJ7 | DLL3_HUMAN Delta-like protein 3 OS=Homo sapiens GN=DLL3 PE=1 SV=1 | 115 | A | 0.187808 | T | 0.215838 | -0.02803 | No Change: Both O | - |
| Q9NYJ7 | DLL3_HUMAN Delta-like protein 3 OS=Homo sapiens GN=DLL3 PE=1 SV=1 | 142 | L | 0.178013 | Q | 0.284989 | -0.106976 | No Change: Both O | - |
| Q9NYJ7 | DLL3_HUMAN Delta-like protein 3 OS=Homo sapiens GN=DLL3 PE=1 SV=1 | 172 | F | 0.531556 | C | 0.641891 | -0.110335 | No Change: Both D | - |
| P36957 | ODO2_HUMAN Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLST PE=1 SV=4 | 213 | P | 0.949524 | A | 0.931613 | 0.017911 | No Change: Both D | - |
| P36957 | ODO2_HUMAN Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex mitochondrial OS=Homo sapiens GN=DLST PE=1 SV=4 | 384 | P | 0.247475 | T | 0.201037 | 0.046438 | No Change: Both O | - |
| P56177 | DLX1_HUMAN Homeobox protein DLX-1 OS=Homo sapiens GN=DLX1 PE=2 SV=3 | 136 | S | 0.443439 | C | 0.253382 | 0.190057 | No Change: Both O | - |
| P56178 | DLX5_HUMAN Homeobox protein DLX-5 OS=Homo sapiens GN=DLX5 PE=1 SV=2 | 234 | S | 0.985766 | R | 0.980587 | 0.005179 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 42 | P | 0.654822 | T | 0.601578 | 0.053244 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 52 | S | 0.905107 | W | 0.761342 | 0.143765 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 54 | S | 0.927318 | L | 0.87931 | 0.048008 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 60 | V | 0.964992 | A | 0.973131 | -0.008139 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 65 | P | 0.97476 | L | 0.957911 | 0.016849 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 337 | Q | 0.770667 | L | 0.700299 | 0.070368 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 357 | P | 0.727292 | S | 0.747141 | -0.019849 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 364 | R | 0.518474 | G | 0.507317 | 0.011157 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 420 | Q | 0.434978 | H | 0.420752 | 0.014226 | No Change: Both O | A glioma sample |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 607 | G | 0.340839 | V | 0.222595 | 0.118244 | No Change: Both O | A glioma sample |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 649 | T | 0.265421 | M | 0.227598 | 0.037823 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 656 | R | 0.531977 | W | 0.342867 | 0.18911 | D to O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 780 | T | 0.265309 | M | 0.227496 | 0.037813 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 856 | P | 0.719451 | S | 0.740754 | -0.021303 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1084 | H | 0.584631 | Y | 0.453161 | 0.13147 | D to O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1169 | M | 0.222765 | T | 0.260939 | -0.038174 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1176 | R | 0.558694 | W | 0.34694 | 0.211754 | D to O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1545 | V | 0.113115 | M | 0.140606 | -0.027491 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1732 | H | 0.365633 | S | 0.407073 | -0.04144 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1961 | T | 0.289819 | P | 0.326297 | -0.036478 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 322 | N | 0.441744 | D | 0.468388 | -0.026644 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1860 | R | 0.278927 | L | 0.173562 | 0.105365 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 670 | R | 0.268015 | C | 0.167922 | 0.100093 | No Change: Both O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 719 | T | 0.772483 | M | 0.711527 | 0.060956 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 162 | G | 0.265991 | E | 0.289822 | -0.023831 | No Change: Both O | A glioma cell line |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 546 | N | 0.347706 | S | 0.394193 | -0.046487 | No Change: Both O | A glioma cell line |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1095 | S | 0.776582 | P | 0.766992 | 0.00959 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1102 | S | 0.87769 | T | 0.84745 | 0.03024 | No Change: Both D | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 1434 | R | 0.564144 | W | 0.355413 | 0.208731 | D to O | - |
| Q9UGM3 | DMBT1_HUMAN Deleted in malignant brain tumors 1 protein OS=Homo sapiens GN=DMBT1 PE=1 SV=2 | 2255 | V | 0.195903 | M | 0.2409 | -0.044997 | No Change: Both O | - |
| Q8NFW5 | DMBX1_HUMAN Diencephalon/mesencephalon homeobox protein 1 OS=Homo sapiens GN=DMBX1 PE=2 SV=1 | 205 | A | 0.997674 | P | 0.998423 | -7.49E-04 | No Change: Both D | - |
| Q14565 | DMC1_HUMAN Meiotic recombination protein DMC1/LIM15 homolog OS=Homo sapiens GN=DMC1 PE=1 SV=2 | 200 | M | 0.36124 | V | 0.308155 | 0.053085 | No Change: Both O | - |
| Q14565 | DMC1_HUMAN Meiotic recombination protein DMC1/LIM15 homolog OS=Homo sapiens GN=DMC1 PE=1 SV=2 | 150 | G | 0.366327 | D | 0.361798 | 0.004529 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 54 | L | 0.359413 | R | 0.489557 | -0.130144 | No Change: Both O | Duchenne muscular dystrophy (DMD) [MIM:310200] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 133 | Q | 0.431487 | P | 0.434982 | -0.003495 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 168 | A | 0.226154 | D | 0.301345 | -0.075191 | No Change: Both O | Becker muscular dystrophy (BMD) [MIM:300376] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 231 | Y | 0.126562 | N | 0.206292 | -0.07973 | No Change: Both O | Becker muscular dystrophy (BMD) [MIM:300376] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 365 | Q | 0.473707 | H | 0.445396 | 0.028311 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 623 | L | 0.655849 | I | 0.563472 | 0.092377 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 773 | K | 0.796451 | E | 0.8033 | -0.006849 | No Change: Both D | Duchenne muscular dystrophy (DMD) [MIM:310200] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 784 | A | 0.716825 | G | 0.715831 | 9.94E-04 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 882 | D | 0.544257 | G | 0.491898 | 0.052359 | D to O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1197 | V | 0.910676 | F | 0.905034 | 0.005642 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1245 | T | 0.172143 | I | 0.0844 | 0.087743 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1278 | A | 0.325317 | P | 0.404188 | -0.078871 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1377 | K | 0.695333 | N | 0.643296 | 0.052037 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1469 | Q | 0.654806 | L | 0.515968 | 0.138838 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1745 | R | 0.457785 | H | 0.428844 | 0.028941 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1844 | R | 0.930577 | S | 0.919989 | 0.010588 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2155 | R | 0.346612 | W | 0.169307 | 0.177305 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2191 | R | 0.607447 | W | 0.409521 | 0.197926 | D to O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2366 | K | 0.491849 | Q | 0.479871 | 0.011978 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2910 | E | 0.749517 | V | 0.585067 | 0.16445 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2912 | N | 0.749804 | D | 0.756912 | -0.007108 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2921 | H | 0.67689 | R | 0.768074 | -0.091184 | No Change: Both D | Becker muscular dystrophy (BMD) [MIM:300376] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2937 | Q | 0.624433 | R | 0.607296 | 0.017137 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 3421 | A | 0.505722 | V | 0.444005 | 0.061717 | D to O | Becker muscular dystrophy (BMD) [MIM:300376] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 18 | K | 0.417275 | N | 0.360607 | 0.056668 | No Change: Both O | Cardiomyopathy dilated X-linked type 3B (CMD3B) [MIM:302045] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 165 | D | 0.20102 | V | 0.106504 | 0.094516 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 171 | A | 0.25193 | P | 0.320332 | -0.068402 | No Change: Both O | Becker muscular dystrophy (BMD) [MIM:300376] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 279 | T | 0.536473 | A | 0.504045 | 0.032428 | No Change: Both D | Cardiomyopathy dilated X-linked type 3B (CMD3B) [MIM:302045] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 645 | D | 0.270504 | G | 0.213823 | 0.056681 | No Change: Both O | Duchenne muscular dystrophy (DMD) [MIM:310200] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1672 | N | 0.140889 | K | 0.173146 | -0.032257 | No Change: Both O | Cardiomyopathy dilated X-linked type 3B (CMD3B) [MIM:302045] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2299 | N | 0.662941 | T | 0.646967 | 0.015974 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 3228 | F | 0.288262 | L | 0.32812 | -0.039858 | No Change: Both O | Cardiomyopathy dilated X-linked type 3B (CMD3B) [MIM:302045] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 3313 | C | 0.261642 | F | 0.25728 | 0.004362 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 3335 | D | 0.108802 | H | 0.105315 | 0.003487 | No Change: Both O | Duchenne muscular dystrophy (DMD) [MIM:310200] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 3340 | C | 0.085632 | Y | 0.094037 | -0.008405 | No Change: Both O | Duchenne muscular dystrophy (DMD) [MIM:310200] |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 334 | L | 0.692889 | F | 0.667222 | 0.025667 | No Change: Both D | A colorectal cancer sample |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1219 | E | 0.755632 | Q | 0.742076 | 0.013556 | No Change: Both D | A breast cancer sample |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1470 | R | 0.652586 | H | 0.620963 | 0.031623 | No Change: Both D | A breast cancer sample |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2164 | A | 0.334754 | V | 0.28038 | 0.054374 | No Change: Both O | A colorectal cancer sample |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 409 | T | 0.566256 | S | 0.653927 | -0.087671 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 573 | A | 0.160548 | V | 0.114726 | 0.045822 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 715 | T | 0.743702 | S | 0.789271 | -0.045569 | No Change: Both D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1136 | T | 0.425522 | S | 0.490206 | -0.064684 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 1388 | F | 0.464221 | V | 0.509948 | -0.045727 | O to D | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 2108 | R | 0.149271 | C | 0.068754 | 0.080517 | No Change: Both O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 666 | S | 0.597734 | L | 0.418497 | 0.179237 | D to O | - |
| P11532 | DMD_HUMAN Dystrophin OS=Homo sapiens GN=DMD PE=1 SV=3 | 118 | W | 0.044395 | R | 0.104044 | -0.059649 | No Change: Both O | - |
| Q9UI17 | M2GD_HUMAN Dimethylglycine dehydrogenase mitochondrial OS=Homo sapiens GN=DMGDH PE=1 SV=2 | 109 | H | 0.266458 | R | 0.257762 | 0.008696 | No Change: Both O | DMGDH deficiency (DMGDHD) [MIM:605850] |
| Q9UI17 | M2GD_HUMAN Dimethylglycine dehydrogenase mitochondrial OS=Homo sapiens GN=DMGDH PE=1 SV=2 | 279 | S | 0.351619 | P | 0.310207 | 0.041412 | No Change: Both O | - |
| Q9UI17 | M2GD_HUMAN Dimethylglycine dehydrogenase mitochondrial OS=Homo sapiens GN=DMGDH PE=1 SV=2 | 530 | A | 0.194973 | G | 0.248604 | -0.053631 | No Change: Both O | - |
| Q9UI17 | M2GD_HUMAN Dimethylglycine dehydrogenase mitochondrial OS=Homo sapiens GN=DMGDH PE=1 SV=2 | 646 | S | 0.545984 | P | 0.500677 | 0.045307 | No Change: Both D | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 13 | A | 0.329067 | D | 0.328372 | 6.95E-04 | No Change: Both O | A colorectal cancer sample |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 415 | A | 0.36979 | S | 0.472642 | -0.102852 | No Change: Both O | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 427 | D | 0.60834 | A | 0.554012 | 0.054328 | No Change: Both D | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 69 | E | 0.720688 | D | 0.68569 | 0.034998 | No Change: Both D | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 139 | N | 0.553184 | S | 0.622619 | -0.069435 | No Change: Both D | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 91 | V | 0.356043 | A | 0.441492 | -0.085449 | No Change: Both O | - |
| Q6E0U4 | DMKN_HUMAN Dermokine OS=Homo sapiens GN=DMKN PE=1 SV=3 | 280 | G | 0.999992 | S | 0.999994 | -2.00E-06 | No Change: Both D | - |
| Q13316 | DMP1_HUMAN Dentin matrix acidic phosphoprotein 1 OS=Homo sapiens GN=DMP1 PE=1 SV=2 | 69 | S | 0.9505 | C | 0.91444 | 0.03606 | No Change: Both D | - |
| Q13316 | DMP1_HUMAN Dentin matrix acidic phosphoprotein 1 OS=Homo sapiens GN=DMP1 PE=1 SV=2 | 117 | D | 0.996073 | N | 0.994126 | 0.001947 | No Change: Both D | One individual with tumoral calcinosis |
| Q13316 | DMP1_HUMAN Dentin matrix acidic phosphoprotein 1 OS=Homo sapiens GN=DMP1 PE=1 SV=2 | 272 | R | 0.970959 | H | 0.962193 | 0.008766 | No Change: Both D | - |
| Q13316 | DMP1_HUMAN Dentin matrix acidic phosphoprotein 1 OS=Homo sapiens GN=DMP1 PE=1 SV=2 | 463 | K | 0.9985 | R | 0.998434 | 6.60E-05 | No Change: Both D | - |
| Q09013 | DMPK_HUMAN Myotonin-protein kinase OS=Homo sapiens GN=DMPK PE=1 SV=3 | 428 | L | 0.836868 | V | 0.832875 | 0.003993 | No Change: Both D | A lung small cell carcinoma sample |
| Q09013 | DMPK_HUMAN Myotonin-protein kinase OS=Homo sapiens GN=DMPK PE=1 SV=3 | 423 | L | 0.764516 | V | 0.755712 | 0.008804 | No Change: Both D | - |
| Q9Y5R6 | DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 OS=Homo sapiens GN=DMRT1 PE=1 SV=2 | 45 | S | 0.991478 | T | 0.985223 | 0.006255 | No Change: Both D | - |
| Q9Y5R6 | DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 OS=Homo sapiens GN=DMRT1 PE=1 SV=2 | 221 | Y | 0.238016 | S | 0.415801 | -0.177785 | No Change: Both O | - |
| Q9Y5R6 | DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 OS=Homo sapiens GN=DMRT1 PE=1 SV=2 | 281 | R | 0.758488 | S | 0.798108 | -0.03962 | No Change: Both D | - |
| Q9Y5R6 | DMRT1_HUMAN Doublesex- and mab-3-related transcription factor 1 OS=Homo sapiens GN=DMRT1 PE=1 SV=2 | 295 | P | 0.722494 | L | 0.535793 | 0.186701 | No Change: Both D | - |
| Q9NQL9 | DMRT3_HUMAN Doublesex- and mab-3-related transcription factor 3 OS=Homo sapiens GN=DMRT3 PE=1 SV=1 | 164 | A | 0.885196 | T | 0.897311 | -0.012115 | No Change: Both D | - |
| Q9NQL9 | DMRT3_HUMAN Doublesex- and mab-3-related transcription factor 3 OS=Homo sapiens GN=DMRT3 PE=1 SV=1 | 261 | N | 0.362963 | T | 0.352524 | 0.010439 | No Change: Both O | - |
| Q9NQL9 | DMRT3_HUMAN Doublesex- and mab-3-related transcription factor 3 OS=Homo sapiens GN=DMRT3 PE=1 SV=1 | 356 | G | 0.902534 | V | 0.882914 | 0.01962 | No Change: Both D | - |
| Q5VZB9 | DMRTA_HUMAN Doublesex- and mab-3-related transcription factor A1 OS=Homo sapiens GN=DMRTA1 PE=2 SV=1 | 342 | R | 0.286222 | C | 0.163112 | 0.12311 | No Change: Both O | A colorectal cancer sample |
| Q9Y222 | DMTF1_HUMAN Cyclin-D-binding Myb-like transcription factor 1 OS=Homo sapiens GN=DMTF1 PE=1 SV=1 | 479 | V | 0.638838 | I | 0.64288 | -0.004042 | No Change: Both D | - |
| Q9Y485 | DMXL1_HUMAN DmX-like protein 1 OS=Homo sapiens GN=DMXL1 PE=1 SV=3 | 221 | I | 0.375792 | M | 0.456288 | -0.080496 | No Change: Both O | - |
| Q9Y485 | DMXL1_HUMAN DmX-like protein 1 OS=Homo sapiens GN=DMXL1 PE=1 SV=3 | 851 | S | 0.632409 | N | 0.590483 | 0.041926 | No Change: Both D | - |
| Q9Y485 | DMXL1_HUMAN DmX-like protein 1 OS=Homo sapiens GN=DMXL1 PE=1 SV=3 | 2067 | V | 0.126918 | M | 0.165872 | -0.038954 | No Change: Both O | - |
| Q9Y485 | DMXL1_HUMAN DmX-like protein 1 OS=Homo sapiens GN=DMXL1 PE=1 SV=3 | 2107 | T | 0.596105 | S | 0.675939 | -0.079834 | No Change: Both D | - |
| Q8TDJ6 | DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens GN=DMXL2 PE=1 SV=2 | 497 | T | 0.216644 | M | 0.179786 | 0.036858 | No Change: Both O | - |
| Q8TDJ6 | DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens GN=DMXL2 PE=1 SV=2 | 903 | N | 0.466621 | D | 0.473732 | -0.007111 | No Change: Both O | - |
| Q8TDJ6 | DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens GN=DMXL2 PE=1 SV=2 | 1288 | S | 0.76028 | P | 0.74029 | 0.01999 | No Change: Both D | - |
| Q8TDJ6 | DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens GN=DMXL2 PE=1 SV=2 | 1481 | D | 0.682322 | G | 0.623085 | 0.059237 | No Change: Both D | - |
| Q8TDJ6 | DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens GN=DMXL2 PE=1 SV=2 | 144 | E | 0.641 | Q | 0.577641 | 0.063359 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 387 | D | 0.984581 | E | 0.988655 | -0.004074 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 393 | K | 0.988776 | R | 0.987507 | 0.001269 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 432 | E | 0.989217 | D | 0.987281 | 0.001936 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 502 | P | 0.979412 | L | 0.958407 | 0.021005 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 545 | F | 0.633251 | C | 0.687193 | -0.053942 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 633 | L | 0.838287 | S | 0.906878 | -0.068591 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 659 | L | 0.950814 | P | 0.973928 | -0.023114 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 659 | L | 0.950814 | V | 0.934728 | 0.016086 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 675 | S | 0.95359 | T | 0.939577 | 0.014013 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 703 | G | 0.842855 | R | 0.866559 | -0.023704 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 712 | P | 0.768046 | A | 0.680712 | 0.087334 | No Change: Both D | - |
| Q8NEP3 | DAAF1_HUMAN Dynein assembly factor 1 axonemal OS=Homo sapiens GN=DNAAF1 PE=1 SV=5 | 175 | L | 0.39798 | R | 0.479295 | -0.081315 | No Change: Both O | Primary ciliary dyskinesia type 13 (CILD13) [MIM:613193] |
| Q9NVR5 | KTU_HUMAN Protein kintoun OS=Homo sapiens GN=DNAAF2 PE=1 SV=2 | 768 | D | 0.93193 | G | 0.920965 | 0.010965 | No Change: Both D | - |
| Q9NVR5 | KTU_HUMAN Protein kintoun OS=Homo sapiens GN=DNAAF2 PE=1 SV=2 | 62 | E | 0.57754 | D | 0.515212 | 0.062328 | No Change: Both D | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 205 | E | 0.52953 | D | 0.516522 | 0.013008 | No Change: Both D | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 441 | V | 0.564307 | L | 0.590483 | -0.026176 | No Change: Both D | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 1502 | V | 0.270185 | M | 0.309286 | -0.039101 | No Change: Both O | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 1663 | R | 0.285632 | C | 0.150616 | 0.135016 | No Change: Both O | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 2384 | N | 0.087833 | S | 0.115119 | -0.027286 | No Change: Both O | - |
| Q9P2D7 | DYH1_HUMAN Dynein heavy chain 1 axonemal OS=Homo sapiens GN=DNAH1 PE=1 SV=4 | 3897 | H | 0.382761 | R | 0.382517 | 2.44E-04 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 480 | I | 0.10038 | V | 0.11642 | -0.01604 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 167 | S | 0.742746 | P | 0.706832 | 0.035914 | No Change: Both D | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 1724 | T | 0.263126 | M | 0.255835 | 0.007291 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 1767 | D | 0.259515 | E | 0.308686 | -0.049171 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 1865 | R | 0.200194 | K | 0.265238 | -0.065044 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 2403 | R | 0.282853 | W | 0.139633 | 0.14322 | No Change: Both O | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 2483 | N | 0.477353 | S | 0.527023 | -0.04967 | O to D | - |
| Q8IVF4 | DYH10_HUMAN Dynein heavy chain 10 axonemal OS=Homo sapiens GN=DNAH10 PE=1 SV=4 | 1986 | T | 0.233206 | M | 0.198884 | 0.034322 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 34 | E | 0.921303 | L | 0.855703 | 0.0656 | No Change: Both D | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 639 | Q | 0.219196 | R | 0.196782 | 0.022414 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 654 | S | 0.06796 | C | 0.021853 | 0.046107 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 1023 | V | 0.111941 | A | 0.139253 | -0.027312 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 1038 | T | 0.131242 | A | 0.107969 | 0.023273 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 1640 | D | 0.172069 | G | 0.148283 | 0.023786 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 2641 | S | 0.341895 | N | 0.287607 | 0.054288 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 2682 | I | 0.307813 | V | 0.331531 | -0.023718 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 3004 | R | 0.18746 | Q | 0.184859 | 0.002601 | No Change: Both O | Primary ciliary dyskinesia type 7 (CILD7) [MIM:611884] |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 3474 | A | 0.236355 | T | 0.260398 | -0.024043 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 3715 | L | 0.247786 | V | 0.236897 | 0.010889 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 3765 | S | 0.253395 | P | 0.219226 | 0.034169 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 4177 | T | 0.511995 | I | 0.361294 | 0.150701 | D to O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 34 | E | 0.921303 | V | 0.848163 | 0.07314 | No Change: Both D | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 1316 | M | 0.455185 | V | 0.396813 | 0.058372 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 4172 | M | 0.315505 | V | 0.266256 | 0.049249 | No Change: Both O | - |
| Q96DT5 | DYH11_HUMAN Dynein heavy chain 11 axonemal OS=Homo sapiens GN=DNAH11 PE=1 SV=3 | 2593 | Y | 0.276548 | H | 0.406518 | -0.12997 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 32 | V | 0.502424 | A | 0.574687 | -0.072263 | No Change: Both D | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 139 | S | 0.690579 | N | 0.632888 | 0.057691 | No Change: Both D | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 224 | D | 0.10932 | E | 0.11249 | -0.00317 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 231 | T | 0.125468 | A | 0.111612 | 0.013856 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 2740 | Y | 0.418329 | F | 0.377179 | 0.04115 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 2893 | G | 0.34962 | S | 0.415519 | -0.065899 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 467 | T | 0.043354 | P | 0.058447 | -0.015093 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 1549 | D | 0.175839 | N | 0.174942 | 8.97E-04 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 1704 | Y | 0.241519 | H | 0.35387 | -0.112351 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 1748 | R | 0.041317 | C | 0.018604 | 0.022713 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 1754 | K | 0.104943 | N | 0.086877 | 0.018066 | No Change: Both O | - |
| Q6ZR08 | DYH12_HUMAN Dynein heavy chain 12 axonemal OS=Homo sapiens GN=DNAH12 PE=1 SV=2 | 1763 | T | 0.062702 | I | 0.032807 | 0.029895 | No Change: Both O | - |
| Q0VDD8 | DYH14_HUMAN Dynein heavy chain 14 axonemal OS=Homo sapiens GN=DNAH14 PE=2 SV=3 | 220 | T | 0.934045 | S | 0.938251 | -0.004206 | No Change: Both D | - |
| Q0VDD8 | DYH14_HUMAN Dynein heavy chain 14 axonemal OS=Homo sapiens GN=DNAH14 PE=2 SV=3 | 274 | P | 0.285241 | L | 0.185679 | 0.099562 | No Change: Both O | - |
| Q0VDD8 | DYH14_HUMAN Dynein heavy chain 14 axonemal OS=Homo sapiens GN=DNAH14 PE=2 SV=3 | 2671 | K | 0.68529 | E | 0.682529 | 0.002761 | No Change: Both D | - |
| Q9UFH2 | DYH17_HUMAN Dynein heavy chain 17 axonemal OS=Homo sapiens GN=DNAH17 PE=2 SV=2 | 492 | D | 0.277621 | N | 0.235547 | 0.042074 | No Change: Both O | - |
| Q9UFH2 | DYH17_HUMAN Dynein heavy chain 17 axonemal OS=Homo sapiens GN=DNAH17 PE=2 SV=2 | 792 | I | 0.494463 | V | 0.496557 | -0.002094 | No Change: Both O | - |
| Q9UFH2 | DYH17_HUMAN Dynein heavy chain 17 axonemal OS=Homo sapiens GN=DNAH17 PE=2 SV=2 | 963 | I | 0.518685 | T | 0.649397 | -0.130712 | No Change: Both D | - |
| Q9UFH2 | DYH17_HUMAN Dynein heavy chain 17 axonemal OS=Homo sapiens GN=DNAH17 PE=2 SV=2 | 1958 | M | 0.061916 | V | 0.047379 | 0.014537 | No Change: Both O | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 100 | A | 0.250844 | V | 0.182347 | 0.068497 | No Change: Both O | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 312 | S | 0.323816 | T | 0.229513 | 0.094303 | No Change: Both O | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 1326 | E | 0.718439 | G | 0.630227 | 0.088212 | No Change: Both D | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 2548 | R | 0.300609 | H | 0.244236 | 0.056373 | No Change: Both O | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 3600 | T | 0.518815 | I | 0.362651 | 0.156164 | D to O | - |
| Q9P225 | DYH2_HUMAN Dynein heavy chain 2 axonemal OS=Homo sapiens GN=DNAH2 PE=1 SV=3 | 2904 | R | 0.074911 | H | 0.070479 | 0.004432 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 484 | I | 0.094735 | L | 0.105491 | -0.010756 | No Change: Both O | A colorectal cancer sample |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 545 | R | 0.341629 | W | 0.16472 | 0.176909 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 1565 | I | 0.140375 | M | 0.20324 | -0.062865 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 1583 | V | 0.16101 | I | 0.152618 | 0.008392 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 1608 | S | 0.259587 | F | 0.107348 | 0.152239 | No Change: Both O | A colorectal cancer sample |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 1752 | T | 0.12638 | M | 0.111566 | 0.014814 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 2399 | I | 0.411475 | N | 0.582273 | -0.170798 | O to D | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 2804 | I | 0.690659 | V | 0.706386 | -0.015727 | No Change: Both D | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 2949 | K | 0.733508 | T | 0.676352 | 0.057156 | No Change: Both D | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 3457 | E | 0.426618 | K | 0.416186 | 0.010432 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 3639 | L | 0.474687 | I | 0.42556 | 0.049127 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 3645 | R | 0.247999 | C | 0.132687 | 0.115312 | No Change: Both O | - |
| Q8TD57 | DYH3_HUMAN Dynein heavy chain 3 axonemal OS=Homo sapiens GN=DNAH3 PE=2 SV=1 | 3744 | R | 0.473533 | W | 0.258292 | 0.215241 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 12 | H | 0.275531 | Q | 0.333195 | -0.057664 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 24 | G | 0.652811 | E | 0.696761 | -0.04395 | No Change: Both D | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 558 | T | 0.310122 | A | 0.281093 | 0.029029 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2463 | Q | 0.172499 | R | 0.146684 | 0.025815 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2862 | L | 0.230049 | F | 0.217246 | 0.012803 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 3519 | G | 0.167427 | R | 0.179439 | -0.012012 | No Change: Both O | Kartagener syndrome (KTGS) [MIM:244400] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 4134 | A | 0.214496 | V | 0.160508 | 0.053988 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 4220 | T | 0.179586 | A | 0.174006 | 0.00558 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 4450 | I | 0.127773 | V | 0.145154 | -0.017381 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 766 | I | 0.347061 | L | 0.370728 | -0.023667 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 1006 | S | 0.516275 | G | 0.411923 | 0.104352 | D to O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 1081 | M | 0.785214 | V | 0.749707 | 0.035507 | No Change: Both D | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 3791 | T | 0.653601 | I | 0.514413 | 0.139188 | No Change: Both D | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 1716 | R | 0.065211 | L | 0.037895 | 0.027316 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2264 | S | 0.553396 | N | 0.528571 | 0.024825 | No Change: Both D | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2347 | E | 0.111947 | K | 0.112099 | -1.52E-04 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2501 | R | 0.384178 | P | 0.400743 | -0.016565 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2843 | F | 0.161374 | S | 0.36328 | -0.201906 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 3409 | W | 0.133806 | S | 0.371872 | -0.238066 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 3843 | S | 0.188929 | L | 0.097174 | 0.091755 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 4205 | G | 0.097094 | V | 0.049296 | 0.047798 | No Change: Both O | Primary ciliary dyskinesia type 3 (CILD3) [MIM:608644] |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 591 | L | 0.178636 | R | 0.250944 | -0.072308 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 591 | L | 0.178636 | V | 0.147413 | 0.031223 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 620 | Q | 0.433238 | K | 0.487345 | -0.054107 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 765 | K | 0.375173 | N | 0.320621 | 0.054552 | No Change: Both O | - |
| Q8TE73 | DYH5_HUMAN Dynein heavy chain 5 axonemal OS=Homo sapiens GN=DNAH5 PE=1 SV=3 | 2425 | R | 0.28515 | H | 0.282377 | 0.002773 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 169 | H | 0.132493 | P | 0.143 | -0.010507 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 280 | A | 0.094424 | T | 0.111476 | -0.017052 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 315 | I | 0.258585 | V | 0.274421 | -0.015836 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 438 | S | 0.120933 | N | 0.100707 | 0.020226 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 545 | R | 0.157069 | C | 0.083773 | 0.073296 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 565 | D | 0.097291 | H | 0.081807 | 0.015484 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 675 | K | 0.525977 | E | 0.539512 | -0.013535 | No Change: Both D | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 825 | K | 0.449649 | E | 0.436335 | 0.013314 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 1422 | P | 0.141718 | T | 0.125079 | 0.016639 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 1525 | E | 0.356117 | K | 0.347101 | 0.009016 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 1886 | R | 0.638389 | Q | 0.645864 | -0.007475 | No Change: Both D | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 1940 | P | 0.404414 | L | 0.234354 | 0.17006 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 1971 | P | 0.41248 | L | 0.248191 | 0.164289 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 2020 | M | 0.380407 | T | 0.44099 | -0.060583 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 2459 | N | 0.218246 | K | 0.275726 | -0.05748 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 2569 | T | 0.270278 | I | 0.170544 | 0.099734 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 2809 | I | 0.324101 | V | 0.353504 | -0.029403 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 3319 | L | 0.079585 | P | 0.16119 | -0.081605 | No Change: Both O | - |
| Q8WXX0 | DYH7_HUMAN Dynein heavy chain 7 axonemal OS=Homo sapiens GN=DNAH7 PE=1 SV=2 | 3386 | R | 0.11927 | H | 0.092687 | 0.026583 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 71 | N | 0.207431 | S | 0.23225 | -0.024819 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 473 | G | 0.121354 | R | 0.122569 | -0.001215 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 573 | I | 0.106596 | V | 0.120968 | -0.014372 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 727 | A | 0.187788 | T | 0.231059 | -0.043271 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 807 | G | 0.691965 | E | 0.73935 | -0.047385 | No Change: Both D | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 1202 | E | 0.363928 | K | 0.341896 | 0.022032 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 2444 | T | 0.167978 | N | 0.198629 | -0.030651 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 4106 | T | 0.109638 | M | 0.095737 | 0.013901 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 4271 | I | 0.332691 | V | 0.346393 | -0.013702 | No Change: Both O | - |
| Q96JB1 | DYH8_HUMAN Dynein heavy chain 8 axonemal OS=Homo sapiens GN=DNAH8 PE=1 SV=2 | 2226 | T | 0.346013 | M | 0.289985 | 0.056028 | No Change: Both O | A colorectal cancer sample |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 771 | R | 0.275042 | L | 0.180172 | 0.09487 | No Change: Both O | A breast cancer sample |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2653 | D | 0.124947 | H | 0.111676 | 0.013271 | No Change: Both O | A breast cancer sample |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 3664 | T | 0.514755 | N | 0.568583 | -0.053828 | No Change: Both D | A breast cancer sample |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 151 | R | 0.32166 | H | 0.34017 | -0.01851 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 445 | Q | 0.127364 | R | 0.122339 | 0.005025 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 842 | R | 0.599234 | W | 0.373212 | 0.226022 | D to O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 1158 | R | 0.569937 | W | 0.402794 | 0.167143 | D to O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 1221 | T | 0.288154 | A | 0.278124 | 0.01003 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2087 | M | 0.329104 | V | 0.250452 | 0.078652 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2195 | N | 0.152472 | S | 0.175776 | -0.023304 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2438 | Q | 0.302872 | H | 0.279058 | 0.023814 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2961 | K | 0.394388 | R | 0.339302 | 0.055086 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 2968 | K | 0.252727 | N | 0.224137 | 0.02859 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 3726 | R | 0.367334 | Q | 0.369903 | -0.002569 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 3726 | R | 0.367334 | W | 0.165762 | 0.201572 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 4036 | D | 0.345541 | N | 0.331988 | 0.013553 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 4374 | M | 0.271487 | I | 0.172744 | 0.098743 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 4443 | R | 0.310244 | C | 0.217717 | 0.092527 | No Change: Both O | - |
| Q9NYC9 | DYH9_HUMAN Dynein heavy chain 9 axonemal OS=Homo sapiens GN=DNAH9 PE=1 SV=3 | 4462 | W | 0.109049 | R | 0.259182 | -0.150133 | No Change: Both O | - |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 8 | A | 0.953254 | S | 0.969858 | -0.016604 | No Change: Both D | - |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 515 | G | 0.171634 | S | 0.199711 | -0.028077 | No Change: Both O | Kartagener syndrome (KTGS) [MIM:244400] |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 60 | A | 0.57032 | V | 0.495519 | 0.074801 | D to O | - |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 326 | Q | 0.290956 | H | 0.279042 | 0.011914 | No Change: Both O | - |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 335 | V | 0.125195 | I | 0.109741 | 0.015454 | No Change: Both O | - |
| Q9UI46 | DNAI1_HUMAN Dynein intermediate chain 1 axonemal OS=Homo sapiens GN=DNAI1 PE=1 SV=1 | 487 | V | 0.634067 | G | 0.752682 | -0.118615 | No Change: Both D | - |
| Q9GZS0 | DNAI2_HUMAN Dynein intermediate chain 2 axonemal OS=Homo sapiens GN=DNAI2 PE=1 SV=2 | 558 | A | 0.728425 | T | 0.729313 | -8.88E-04 | No Change: Both D | - |
| Q9GZS0 | DNAI2_HUMAN Dynein intermediate chain 2 axonemal OS=Homo sapiens GN=DNAI2 PE=1 SV=2 | 495 | V | 0.776526 | I | 0.766728 | 0.009798 | No Change: Both D | - |
| Q96EY1 | DNJA3_HUMAN DnaJ homolog subfamily A member 3 mitochondrial OS=Homo sapiens GN=DNAJA3 PE=1 SV=2 | 75 | N | 0.31382 | Y | 0.199679 | 0.114141 | No Change: Both O | - |
| Q9UBS4 | DJB11_HUMAN DnaJ homolog subfamily B member 11 OS=Homo sapiens GN=DNAJB11 PE=1 SV=1 | 264 | I | 0.138945 | V | 0.170039 | -0.031094 | No Change: Both O | - |
| Q9NXW2 | DJB12_HUMAN DnaJ homolog subfamily B member 12 OS=Homo sapiens GN=DNAJB12 PE=1 SV=4 | 304 | E | 0.59408 | K | 0.585968 | 0.008112 | No Change: Both D | - |
| P25686 | DNJB2_HUMAN DnaJ homolog subfamily B member 2 OS=Homo sapiens GN=DNAJB2 PE=2 SV=3 | 270 | G | 0.939753 | R | 0.945828 | -0.006075 | No Change: Both D | - |
| Q8WWF6 | DNJB3_HUMAN DnaJ homolog subfamily B member 3 OS=Homo sapiens GN=DNAJB3 PE=1 SV=1 | 85 | D | 0.481252 | E | 0.519341 | -0.038089 | O to D | - |
| Q8WWF6 | DNJB3_HUMAN DnaJ homolog subfamily B member 3 OS=Homo sapiens GN=DNAJB3 PE=1 SV=1 | 98 | D | 0.436942 | E | 0.466167 | -0.029225 | No Change: Both O | - |
| Q7Z6W7 | DNJB7_HUMAN DnaJ homolog subfamily B member 7 OS=Homo sapiens GN=DNAJB7 PE=2 SV=2 | 41 | E | 0.809824 | A | 0.756877 | 0.052947 | No Change: Both D | - |
| Q8NHS0 | DNJB8_HUMAN DnaJ homolog subfamily B member 8 OS=Homo sapiens GN=DNAJB8 PE=1 SV=1 | 153 | M | 0.86429 | L | 0.816509 | 0.047781 | No Change: Both D | - |
| Q9UBS3 | DNJB9_HUMAN DnaJ homolog subfamily B member 9 OS=Homo sapiens GN=DNAJB9 PE=1 SV=1 | 136 | R | 0.917299 | H | 0.907303 | 0.009996 | No Change: Both D | - |
| Q8IXB1 | DJC10_HUMAN DnaJ homolog subfamily C member 10 OS=Homo sapiens GN=DNAJC10 PE=1 SV=2 | 76 | D | 0.58505 | N | 0.588509 | -0.003459 | No Change: Both D | - |
| Q8IXB1 | DJC10_HUMAN DnaJ homolog subfamily C member 10 OS=Homo sapiens GN=DNAJC10 PE=1 SV=2 | 414 | Y | 0.087803 | C | 0.082349 | 0.005454 | No Change: Both O | - |
| Q8IXB1 | DJC10_HUMAN DnaJ homolog subfamily C member 10 OS=Homo sapiens GN=DNAJC10 PE=1 SV=2 | 646 | H | 0.4688 | Q | 0.466098 | 0.002702 | No Change: Both O | - |
| Q8IXB1 | DJC10_HUMAN DnaJ homolog subfamily C member 10 OS=Homo sapiens GN=DNAJC10 PE=1 SV=2 | 347 | L | 0.161598 | I | 0.139649 | 0.021949 | No Change: Both O | - |
| Q9NVH1 | DJC11_HUMAN DnaJ homolog subfamily C member 11 OS=Homo sapiens GN=DNAJC11 PE=1 SV=2 | 267 | V | 0.133526 | M | 0.171016 | -0.03749 | No Change: Both O | - |
| Q9NVH1 | DJC11_HUMAN DnaJ homolog subfamily C member 11 OS=Homo sapiens GN=DNAJC11 PE=1 SV=2 | 290 | T | 0.394928 | A | 0.357015 | 0.037913 | No Change: Both O | - |
| Q9NVH1 | DJC11_HUMAN DnaJ homolog subfamily C member 11 OS=Homo sapiens GN=DNAJC11 PE=1 SV=2 | 290 | T | 0.394928 | S | 0.468328 | -0.0734 | No Change: Both O | - |
| Q9UKB3 | DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens GN=DNAJC12 PE=1 SV=1 | 124 | M | 0.948893 | I | 0.910441 | 0.038452 | No Change: Both D | - |
| Q9UKB3 | DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens GN=DNAJC12 PE=1 SV=1 | 129 | C | 0.978798 | W | 0.971226 | 0.007572 | No Change: Both D | - |
| O75165 | DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens GN=DNAJC13 PE=1 SV=5 | 1463 | A | 0.426614 | S | 0.513144 | -0.08653 | O to D | - |
| O75165 | DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens GN=DNAJC13 PE=1 SV=5 | 1487 | F | 0.289627 | C | 0.316931 | -0.027304 | No Change: Both O | - |
| O75165 | DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens GN=DNAJC13 PE=1 SV=5 | 1995 | V | 0.09337 | I | 0.089383 | 0.003987 | No Change: Both O | - |
| O75165 | DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens GN=DNAJC13 PE=1 SV=5 | 1515 | P | 0.15101 | S | 0.180138 | -0.029128 | No Change: Both O | - |
| Q9Y5T4 | DJC15_HUMAN DnaJ homolog subfamily C member 15 OS=Homo sapiens GN=DNAJC15 PE=1 SV=2 | 35 | R | 0.306787 | G | 0.302655 | 0.004132 | No Change: Both O | - |
| Q5F1R6 | DJC21_HUMAN DnaJ homolog subfamily C member 21 OS=Homo sapiens GN=DNAJC21 PE=1 SV=2 | 214 | D | 0.923611 | N | 0.928487 | -0.004876 | No Change: Both D | A breast cancer sample |
| Q5F1R6 | DJC21_HUMAN DnaJ homolog subfamily C member 21 OS=Homo sapiens GN=DNAJC21 PE=1 SV=2 | 433 | E | 0.946774 | K | 0.944399 | 0.002375 | No Change: Both D | - |
| Q6P3W2 | DJC24_HUMAN DnaJ homolog subfamily C member 24 OS=Homo sapiens GN=DNAJC24 PE=2 SV=1 | 22 | N | 0.49131 | D | 0.547898 | -0.056588 | O to D | A breast cancer sample |
| Q96LL9 | DJC30_HUMAN DnaJ homolog subfamily C member 30 OS=Homo sapiens GN=DNAJC30 PE=1 SV=3 | 34 | G | 0.4964 | R | 0.502538 | -0.006138 | O to D | - |
| Q96LL9 | DJC30_HUMAN DnaJ homolog subfamily C member 30 OS=Homo sapiens GN=DNAJC30 PE=1 SV=3 | 167 | F | 0.778187 | L | 0.781526 | -0.003339 | No Change: Both D | - |
| Q9H3Z4 | DNJC5_HUMAN DnaJ homolog subfamily C member 5 OS=Homo sapiens GN=DNAJC5 PE=1 SV=1 | 115 | L | 0.043037 | R | 0.055303 | -0.012266 | No Change: Both O | Neuronal ceroid lipofuscinosis type 4B (CLN4B) [MIM:162350] |
| Q8N7S2 | DNJ5G_HUMAN DnaJ homolog subfamily C member 5G OS=Homo sapiens GN=DNAJC5G PE=1 SV=1 | 4 | V | 0.797416 | G | 0.83402 | -0.036604 | No Change: Both D | - |
| Q8N7S2 | DNJ5G_HUMAN DnaJ homolog subfamily C member 5G OS=Homo sapiens GN=DNAJC5G PE=1 SV=1 | 51 | H | 0.463392 | R | 0.488335 | -0.024943 | No Change: Both O | - |
| O75061 | AUXI_HUMAN Putative tyrosine-protein phosphatase auxilin OS=Homo sapiens GN=DNAJC6 PE=1 SV=3 | 671 | S | 0.97154 | N | 0.953967 | 0.017573 | No Change: Both D | - |
| Q4LDG9 | DNAL1_HUMAN Dynein light chain 1 axonemal OS=Homo sapiens GN=DNAL1 PE=1 SV=1 | 150 | N | 0.346181 | S | 0.387987 | -0.041806 | No Change: Both O | Primary ciliary dyskinesia type 16 (CILD16) [MIM:614017] |
| O14645 | IDLC_HUMAN Axonemal dynein light intermediate polypeptide 1 OS=Homo sapiens GN=DNALI1 PE=2 SV=2 | 65 | A | 0.786013 | V | 0.768117 | 0.017896 | No Change: Both D | - |
| O14645 | IDLC_HUMAN Axonemal dynein light intermediate polypeptide 1 OS=Homo sapiens GN=DNALI1 PE=2 SV=2 | 120 | I | 0.36835 | M | 0.47086 | -0.10251 | No Change: Both O | A colorectal cancer sample |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 31 | Q | 0.190988 | E | 0.238872 | -0.047884 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 154 | P | 0.149539 | A | 0.110935 | 0.038604 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 244 | R | 0.136976 | Q | 0.147002 | -0.010026 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 114 | V | 0.366502 | M | 0.415778 | -0.049276 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 207 | R | 0.237555 | C | 0.120782 | 0.116773 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 2 | R | 0.814836 | S | 0.837106 | -0.02227 | No Change: Both D | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 127 | G | 0.417984 | R | 0.403364 | 0.01462 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 107 | R | 0.192198 | G | 0.187181 | 0.005017 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 231 | C | 0.187011 | Y | 0.237983 | -0.050972 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 246 | A | 0.188878 | P | 0.253734 | -0.064856 | No Change: Both O | - |
| P24855 | DNAS1_HUMAN Deoxyribonuclease-1 OS=Homo sapiens GN=DNASE1 PE=1 SV=1 | 262 | G | 0.226158 | D | 0.264219 | -0.038061 | No Change: Both O | - |
| P49184 | DNSL1_HUMAN Deoxyribonuclease-1-like 1 OS=Homo sapiens GN=DNASE1L1 PE=1 SV=1 | 122 | V | 0.321345 | I | 0.27757 | 0.043775 | No Change: Both O | - |
| Q13609 | DNSL3_HUMAN Deoxyribonuclease gamma OS=Homo sapiens GN=DNASE1L3 PE=1 SV=1 | 19 | L | 0.143041 | V | 0.130038 | 0.013003 | No Change: Both O | A breast cancer sample |
| Q13609 | DNSL3_HUMAN Deoxyribonuclease gamma OS=Homo sapiens GN=DNASE1L3 PE=1 SV=1 | 82 | G | 0.351753 | R | 0.374385 | -0.022632 | No Change: Both O | A breast cancer sample |
| Q13609 | DNSL3_HUMAN Deoxyribonuclease gamma OS=Homo sapiens GN=DNASE1L3 PE=1 SV=1 | 117 | Y | 0.42832 | S | 0.619456 | -0.191136 | O to D | A colorectal cancer sample |
| Q13609 | DNSL3_HUMAN Deoxyribonuclease gamma OS=Homo sapiens GN=DNASE1L3 PE=1 SV=1 | 96 | N | 0.40523 | K | 0.464165 | -0.058935 | No Change: Both O | - |
| Q13609 | DNSL3_HUMAN Deoxyribonuclease gamma OS=Homo sapiens GN=DNASE1L3 PE=1 SV=1 | 206 | R | 0.204571 | C | 0.096274 | 0.108297 | No Change: Both O | - |
| O00115 | DNS2A_HUMAN Deoxyribonuclease-2-alpha OS=Homo sapiens GN=DNASE2 PE=1 SV=2 | 314 | R | 0.564426 | L | 0.454336 | 0.11009 | D to O | - |
| O00115 | DNS2A_HUMAN Deoxyribonuclease-2-alpha OS=Homo sapiens GN=DNASE2 PE=1 SV=2 | 39 | R | 0.409516 | I | 0.260395 | 0.149121 | No Change: Both O | - |
| O00115 | DNS2A_HUMAN Deoxyribonuclease-2-alpha OS=Homo sapiens GN=DNASE2 PE=1 SV=2 | 204 | H | 0.471898 | R | 0.449625 | 0.022273 | No Change: Both O | - |
| Q8WZ79 | DNS2B_HUMAN Deoxyribonuclease-2-beta OS=Homo sapiens GN=DNASE2B PE=2 SV=1 | 47 | K | 0.189034 | R | 0.150158 | 0.038876 | No Change: Both O | - |
| Q8WZ79 | DNS2B_HUMAN Deoxyribonuclease-2-beta OS=Homo sapiens GN=DNASE2B PE=2 SV=1 | 3 | Q | 0.792988 | H | 0.818999 | -0.026011 | No Change: Both D | - |
| Q8WZ79 | DNS2B_HUMAN Deoxyribonuclease-2-beta OS=Homo sapiens GN=DNASE2B PE=2 SV=1 | 51 | R | 0.588563 | K | 0.642998 | -0.054435 | No Change: Both D | - |
| Q8NFT8 | DNER_HUMAN Delta and Notch-like epidermal growth factor-related receptor OS=Homo sapiens GN=DNER PE=1 SV=1 | 433 | P | 0.658464 | L | 0.463191 | 0.195273 | D to O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 1358 | R | 0.076093 | C | 0.039428 | 0.036665 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 1896 | K | 0.694177 | N | 0.655894 | 0.038283 | No Change: Both D | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 2041 | F | 0.269828 | L | 0.316623 | -0.046795 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 3830 | R | 0.263459 | H | 0.256886 | 0.006573 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 4666 | I | 0.56381 | T | 0.655886 | -0.092076 | No Change: Both D | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 240 | V | 0.699024 | E | 0.801369 | -0.102345 | No Change: Both D | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 317 | D | 0.472169 | N | 0.469598 | 0.002571 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 418 | H | 0.264332 | Y | 0.166689 | 0.097643 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 560 | Q | 0.326756 | E | 0.348369 | -0.021613 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 279 | Q | 0.367313 | P | 0.399179 | -0.031866 | No Change: Both O | - |
| Q96M86 | DNHD1_HUMAN Dynein heavy chain domain-containing protein 1 OS=Homo sapiens GN=DNHD1 PE=1 SV=2 | 403 | F | 0.155719 | L | 0.196171 | -0.040452 | No Change: Both O | - |
| Q5SXM8 | DNLZ_HUMAN DNL-type zinc finger protein OS=Homo sapiens GN=DNLZ PE=2 SV=1 | 169 | P | 0.984527 | H | 0.975042 | 0.009485 | No Change: Both D | - |
| Q5SXM8 | DNLZ_HUMAN DNL-type zinc finger protein OS=Homo sapiens GN=DNLZ PE=2 SV=1 | 178 | S | 0.99641 | T | 0.995778 | 6.32E-04 | No Change: Both D | - |
| Q05193 | DYN1_HUMAN Dynamin-1 OS=Homo sapiens GN=DNM1 PE=1 SV=2 | 744 | D | 0.393387 | N | 0.372848 | 0.020539 | No Change: Both O | - |
| O00429 | DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=2 | 71 | S | 0.465929 | T | 0.423311 | 0.042618 | No Change: Both O | - |
| O00429 | DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=2 | 426 | E | 0.49024 | D | 0.412846 | 0.077394 | No Change: Both O | - |
| O00429 | DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens GN=DNM1L PE=1 SV=2 | 395 | A | 0.160932 | D | 0.224626 | -0.063694 | No Change: Both O | - |
| Q6ZS02 | DMP46_HUMAN Putative GED domain-containing protein DNM1P46 OS=Homo sapiens GN=DNM1P46 PE=5 SV=1 | 147 | L | 0.863327 | V | 0.864577 | -0.00125 | No Change: Both D | - |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 263 | P | 0.347777 | L | 0.220378 | 0.127399 | No Change: Both O | - |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 368 | E | 0.179774 | K | 0.170198 | 0.009576 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 369 | R | 0.194734 | Q | 0.182484 | 0.01225 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 369 | R | 0.194734 | W | 0.069259 | 0.125475 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 465 | R | 0.479585 | W | 0.235059 | 0.244526 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 562 | K | 0.601967 | E | 0.606539 | -0.004572 | No Change: Both D | Charcot-Marie-Tooth disease dominant intermediate type B (CMTDIB) [MIM:606482] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 618 | A | 0.362191 | T | 0.363747 | -0.001556 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 619 | S | 0.355899 | L | 0.220341 | 0.135558 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 619 | S | 0.355899 | W | 0.160983 | 0.194916 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 537 | G | 0.325445 | C | 0.172331 | 0.153114 | No Change: Both O | - |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 570 | L | 0.26574 | H | 0.367128 | -0.101388 | No Change: Both O | - |
| P50570 | DYN2_HUMAN Dynamin-2 OS=Homo sapiens GN=DNM2 PE=1 SV=2 | 650 | E | 0.469391 | K | 0.448964 | 0.020427 | No Change: Both O | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| Q6XZF7 | DNMBP_HUMAN Dynamin-binding protein OS=Homo sapiens GN=DNMBP PE=1 SV=1 | 1413 | C | 0.990241 | W | 0.981712 | 0.008529 | No Change: Both D | - |
| Q6XZF7 | DNMBP_HUMAN Dynamin-binding protein OS=Homo sapiens GN=DNMBP PE=1 SV=1 | 81 | E | 0.339489 | D | 0.315878 | 0.023611 | No Change: Both O | - |
| Q6XZF7 | DNMBP_HUMAN Dynamin-binding protein OS=Homo sapiens GN=DNMBP PE=1 SV=1 | 373 | N | 0.889234 | K | 0.90006 | -0.010826 | No Change: Both D | - |
| Q6XZF7 | DNMBP_HUMAN Dynamin-binding protein OS=Homo sapiens GN=DNMBP PE=1 SV=1 | 914 | N | 0.066455 | K | 0.077489 | -0.011034 | No Change: Both O | - |
| P26358 | DNMT1_HUMAN DNA (cytosine-5)-methyltransferase 1 OS=Homo sapiens GN=DNMT1 PE=1 SV=2 | 97 | H | 0.717709 | R | 0.797503 | -0.079794 | No Change: Both D | - |
| P26358 | DNMT1_HUMAN DNA (cytosine-5)-methyltransferase 1 OS=Homo sapiens GN=DNMT1 PE=1 SV=2 | 311 | I | 0.998664 | V | 0.998953 | -2.89E-04 | No Change: Both D | - |
| P26358 | DNMT1_HUMAN DNA (cytosine-5)-methyltransferase 1 OS=Homo sapiens GN=DNMT1 PE=1 SV=2 | 495 | Y | 0.29938 | C | 0.249382 | 0.049998 | No Change: Both O | Hereditary sensory neuropathy type 1E (HSN1E) [MIM:614116] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 603 | A | 0.250626 | T | 0.274722 | -0.024096 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 663 | G | 0.396229 | S | 0.428809 | -0.03258 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 726 | V | 0.255894 | G | 0.369079 | -0.113185 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 817 | D | 0.325968 | G | 0.320666 | 0.005302 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 818 | V | 0.406141 | M | 0.47277 | -0.066629 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 585 | A | 0.078294 | V | 0.059091 | 0.019203 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 606 | V | 0.310916 | A | 0.394987 | -0.084071 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 699 | V | 0.090173 | G | 0.15211 | -0.061937 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 766 | A | 0.284084 | P | 0.387071 | -0.102987 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 814 | H | 0.142947 | R | 0.14838 | -0.005433 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 270 | S | 0.417121 | P | 0.371243 | 0.045878 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 664 | L | 0.403923 | P | 0.548877 | -0.144954 | O to D | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 840 | R | 0.085246 | Q | 0.089771 | -0.004525 | No Change: Both O | Immunodeficiency-centromeric instability-facial anomalies syndrome type 1 (ICF1) [MIM:242860] |
| Q9UBC3 | DNM3B_HUMAN DNA (cytosine-5)-methyltransferase 3B OS=Homo sapiens GN=DNMT3B PE=1 SV=1 | 54 | R | 0.948345 | P | 0.949027 | -6.82E-04 | No Change: Both D | - |
| Q9UJW3 | DNM3L_HUMAN DNA (cytosine-5)-methyltransferase 3-like OS=Homo sapiens GN=DNMT3L PE=1 SV=3 | 278 | R | 0.324496 | G | 0.338043 | -0.013547 | No Change: Both O | - |
| P04053 | TDT_HUMAN DNA nucleotidylexotransferase OS=Homo sapiens GN=DNTT PE=1 SV=3 | 112 | R | 0.167186 | G | 0.169833 | -0.002647 | No Change: Both O | - |
| Q9H147 | TDIF1_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 1 OS=Homo sapiens GN=DNTTIP1 PE=1 SV=2 | 183 | A | 0.786547 | T | 0.782629 | 0.003918 | No Change: Both D | - |
| Q5QJE6 | TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens GN=DNTTIP2 PE=1 SV=2 | 309 | E | 0.918816 | D | 0.911336 | 0.00748 | No Change: Both D | - |
| Q5QJE6 | TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens GN=DNTTIP2 PE=1 SV=2 | 341 | T | 0.871036 | A | 0.857379 | 0.013657 | No Change: Both D | - |
| Q5QJE6 | TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens GN=DNTTIP2 PE=1 SV=2 | 430 | A | 0.81544 | V | 0.825995 | -0.010555 | No Change: Both D | - |
| Q5QJE6 | TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens GN=DNTTIP2 PE=1 SV=2 | 676 | Y | 0.647585 | F | 0.664554 | -0.016969 | No Change: Both D | - |
| Q5QJE6 | TDIF2_HUMAN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Homo sapiens GN=DNTTIP2 PE=1 SV=2 | 477 | G | 0.714269 | E | 0.746187 | -0.031918 | No Change: Both D | - |
| Q14183 | DOC2A_HUMAN Double C2-like domain-containing protein alpha OS=Homo sapiens GN=DOC2A PE=1 SV=5 | 48 | G | 0.863964 | S | 0.861386 | 0.002578 | No Change: Both D | - |
| Q14184 | DOC2B_HUMAN Double C2-like domain-containing protein beta OS=Homo sapiens GN=DOC2B PE=1 SV=1 | 209 | R | 0.288298 | L | 0.192316 | 0.095982 | No Change: Both O | - |
| Q14185 | DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens GN=DOCK1 PE=1 SV=2 | 1793 | A | 0.725842 | T | 0.745205 | -0.019363 | No Change: Both D | - |
| Q5JSL3 | DOC11_HUMAN Dedicator of cytokinesis protein 11 OS=Homo sapiens GN=DOCK11 PE=1 SV=2 | 813 | I | 0.438125 | F | 0.432956 | 0.005169 | No Change: Both O | - |
| Q92608 | DOCK2_HUMAN Dedicator of cytokinesis protein 2 OS=Homo sapiens GN=DOCK2 PE=1 SV=2 | 1746 | S | 0.599897 | T | 0.48072 | 0.119177 | D to O | - |
| Q92608 | DOCK2_HUMAN Dedicator of cytokinesis protein 2 OS=Homo sapiens GN=DOCK2 PE=1 SV=2 | 1779 | T | 0.638826 | S | 0.699532 | -0.060706 | No Change: Both D | - |
| Q92608 | DOCK2_HUMAN Dedicator of cytokinesis protein 2 OS=Homo sapiens GN=DOCK2 PE=1 SV=2 | 1558 | D | 0.565022 | A | 0.455816 | 0.109206 | D to O | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 87 | T | 0.444071 | I | 0.286092 | 0.157979 | No Change: Both O | A CNS cancer cell line |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 606 | E | 0.414786 | Q | 0.369389 | 0.045397 | No Change: Both O | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1059 | K | 0.205953 | T | 0.152827 | 0.053126 | No Change: Both O | A CNS cancer cell line |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1718 | P | 0.874803 | L | 0.790968 | 0.083835 | No Change: Both D | Ovarian cancer cell lines |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1733 | P | 0.736277 | A | 0.639223 | 0.097054 | No Change: Both D | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1755 | S | 0.805607 | P | 0.815486 | -0.009879 | No Change: Both D | Colorectal cancer cell line |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1884 | V | 0.951807 | M | 0.955375 | -0.003568 | No Change: Both D | A prostate cancer cell line |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1914 | V | 0.961592 | I | 0.955517 | 0.006075 | No Change: Both D | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1917 | P | 0.955634 | L | 0.91416 | 0.041474 | No Change: Both D | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1926 | S | 0.971013 | L | 0.952801 | 0.018212 | No Change: Both D | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 535 | N | 0.452204 | D | 0.466947 | -0.014743 | No Change: Both O | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 853 | R | 0.041328 | H | 0.041228 | 1.00E-04 | No Change: Both O | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1570 | R | 0.419912 | K | 0.502751 | -0.082839 | O to D | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1580 | F | 0.254924 | L | 0.276682 | -0.021758 | No Change: Both O | - |
| Q8N1I0 | DOCK4_HUMAN Dedicator of cytokinesis protein 4 OS=Homo sapiens GN=DOCK4 PE=1 SV=3 | 1822 | Q | 0.953757 | K | 0.960802 | -0.007045 | No Change: Both D | - |
| Q9H7D0 | DOCK5_HUMAN Dedicator of cytokinesis protein 5 OS=Homo sapiens GN=DOCK5 PE=1 SV=3 | 250 | Q | 0.366556 | R | 0.345172 | 0.021384 | No Change: Both O | - |
| Q9H7D0 | DOCK5_HUMAN Dedicator of cytokinesis protein 5 OS=Homo sapiens GN=DOCK5 PE=1 SV=3 | 1836 | E | 0.992976 | K | 0.993219 | -2.43E-04 | No Change: Both D | - |
| Q9H7D0 | DOCK5_HUMAN Dedicator of cytokinesis protein 5 OS=Homo sapiens GN=DOCK5 PE=1 SV=3 | 1023 | Q | 0.085912 | R | 0.08647 | -5.58E-04 | No Change: Both O | - |
| Q9H7D0 | DOCK5_HUMAN Dedicator of cytokinesis protein 5 OS=Homo sapiens GN=DOCK5 PE=1 SV=3 | 1285 | K | 0.295757 | R | 0.233674 | 0.062083 | No Change: Both O | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 250 | P | 0.748525 | L | 0.639828 | 0.108697 | No Change: Both D | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 555 | P | 0.223887 | L | 0.131648 | 0.092239 | No Change: Both O | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 665 | G | 0.246291 | R | 0.263 | -0.016709 | No Change: Both O | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 1420 | V | 0.11591 | L | 0.117732 | -0.001822 | No Change: Both O | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 826 | R | 0.416745 | C | 0.281792 | 0.134953 | No Change: Both O | - |
| Q96HP0 | DOCK6_HUMAN Dedicator of cytokinesis protein 6 OS=Homo sapiens GN=DOCK6 PE=1 SV=3 | 1442 | A | 0.255643 | T | 0.282285 | -0.026642 | No Change: Both O | - |
| Q96N67 | DOCK7_HUMAN Dedicator of cytokinesis protein 7 OS=Homo sapiens GN=DOCK7 PE=1 SV=4 | 824 | I | 0.23587 | T | 0.359021 | -0.123151 | No Change: Both O | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 97 | P | 0.377296 | T | 0.328056 | 0.04924 | No Change: Both O | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 237 | E | 0.674022 | K | 0.640535 | 0.033487 | No Change: Both D | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 413 | N | 0.305848 | S | 0.389969 | -0.084121 | No Change: Both O | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 597 | A | 0.283577 | V | 0.217663 | 0.065914 | No Change: Both O | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 1008 | R | 0.634612 | W | 0.37164 | 0.262972 | D to O | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 1970 | A | 0.504032 | P | 0.603751 | -0.099719 | No Change: Both D | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 169 | E | 0.694124 | K | 0.686512 | 0.007612 | No Change: Both D | - |
| Q8NF50 | DOCK8_HUMAN Dedicator of cytokinesis protein 8 OS=Homo sapiens GN=DOCK8 PE=1 SV=3 | 473 | K | 0.787243 | R | 0.778617 | 0.008626 | No Change: Both D | Hyperimmunoglobulin E recurrent infection syndrome autosomal recessive (AR-HIES) [MIM:243700] |
| Q9BZ29 | DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens GN=DOCK9 PE=1 SV=2 | 1416 | K | 0.19429 | E | 0.194784 | -4.94E-04 | No Change: Both O | - |
| Q9BZ29 | DOCK9_HUMAN Dedicator of cytokinesis protein 9 OS=Homo sapiens GN=DOCK9 PE=1 SV=2 | 455 | A | 0.274154 | T | 0.288639 | -0.014485 | No Change: Both O | - |
| O60496 | DOK2_HUMAN Docking protein 2 OS=Homo sapiens GN=DOK2 PE=1 SV=2 | 152 | A | 0.609291 | P | 0.699473 | -0.090182 | No Change: Both D | - |
| O60496 | DOK2_HUMAN Docking protein 2 OS=Homo sapiens GN=DOK2 PE=1 SV=2 | 394 | S | 0.557638 | A | 0.474642 | 0.082996 | D to O | - |
| O60496 | DOK2_HUMAN Docking protein 2 OS=Homo sapiens GN=DOK2 PE=1 SV=2 | 274 | P | 0.994288 | L | 0.987641 | 0.006647 | No Change: Both D | - |
| Q7L591 | DOK3_HUMAN Docking protein 3 OS=Homo sapiens GN=DOK3 PE=1 SV=2 | 12 | R | 0.891582 | P | 0.882568 | 0.009014 | No Change: Both D | - |
| Q7L591 | DOK3_HUMAN Docking protein 3 OS=Homo sapiens GN=DOK3 PE=1 SV=2 | 22 | G | 0.880944 | R | 0.881934 | -9.90E-04 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 180 | G | 0.04707 | A | 0.035806 | 0.011264 | No Change: Both O | Familial limb-girdle myasthenia autosomal recessive (LGM) [MIM:254300] |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 197 | D | 0.120014 | N | 0.10197 | 0.018044 | No Change: Both O | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 261 | R | 0.979328 | H | 0.975182 | 0.004146 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 296 | Q | 0.990109 | R | 0.990035 | 7.40E-05 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 415 | P | 0.905345 | S | 0.902877 | 0.002468 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 427 | G | 0.962481 | D | 0.9652 | -0.002719 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 451 | R | 0.913086 | W | 0.835091 | 0.077995 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 461 | G | 0.920878 | D | 0.907594 | 0.013284 | No Change: Both D | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 158 | R | 0.250734 | Q | 0.263585 | -0.012851 | No Change: Both O | - |
| Q18PE1 | DOK7_HUMAN Protein Dok-7 OS=Homo sapiens GN=DOK7 PE=1 SV=1 | 379 | G | 0.642624 | R | 0.658407 | -0.015783 | No Change: Both D | - |
| Q9UPQ8 | DOLK_HUMAN Dolichol kinase OS=Homo sapiens GN=DOLK PE=1 SV=1 | 99 | C | 0.249355 | S | 0.456593 | -0.207238 | No Change: Both O | Congenital disorder of glycosylation type 1M (CDG1M) [MIM:610768] |
| Q9UPQ8 | DOLK_HUMAN Dolichol kinase OS=Homo sapiens GN=DOLK PE=1 SV=1 | 441 | Y | 0.120082 | S | 0.246947 | -0.126865 | No Change: Both O | Congenital disorder of glycosylation type 1M (CDG1M) [MIM:610768] |
| Q9UPQ8 | DOLK_HUMAN Dolichol kinase OS=Homo sapiens GN=DOLK PE=1 SV=1 | 224 | D | 0.117539 | V | 0.060302 | 0.057237 | No Change: Both O | - |
| O77932 | DOM3Z_HUMAN Protein Dom3Z OS=Homo sapiens GN=DOM3Z PE=2 SV=2 | 28 | S | 0.904589 | T | 0.882602 | 0.021987 | No Change: Both D | - |
| O77932 | DOM3Z_HUMAN Protein Dom3Z OS=Homo sapiens GN=DOM3Z PE=2 SV=2 | 63 | D | 0.674865 | E | 0.670737 | 0.004128 | No Change: Both D | - |
| O77932 | DOM3Z_HUMAN Protein Dom3Z OS=Homo sapiens GN=DOM3Z PE=2 SV=2 | 261 | H | 0.605895 | Q | 0.625225 | -0.01933 | No Change: Both D | - |
| O77932 | DOM3Z_HUMAN Protein Dom3Z OS=Homo sapiens GN=DOM3Z PE=2 SV=2 | 332 | A | 0.06079 | V | 0.043055 | 0.017735 | No Change: Both O | - |
| Q5JWR5 | DOP1_HUMAN Protein dopey-1 OS=Homo sapiens GN=DOPEY1 PE=1 SV=1 | 596 | R | 0.93456 | Q | 0.939389 | -0.004829 | No Change: Both D | - |
| Q5JWR5 | DOP1_HUMAN Protein dopey-1 OS=Homo sapiens GN=DOPEY1 PE=1 SV=1 | 1781 | Q | 0.343252 | L | 0.244784 | 0.098468 | No Change: Both O | - |
| Q5JWR5 | DOP1_HUMAN Protein dopey-1 OS=Homo sapiens GN=DOPEY1 PE=1 SV=1 | 1155 | D | 0.634509 | H | 0.52492 | 0.109589 | No Change: Both D | A breast cancer sample |
| Q9Y3R5 | DOP2_HUMAN Protein dopey-2 OS=Homo sapiens GN=DOPEY2 PE=1 SV=5 | 1118 | C | 0.980316 | G | 0.984023 | -0.003707 | No Change: Both D | - |
| Q9Y3R5 | DOP2_HUMAN Protein dopey-2 OS=Homo sapiens GN=DOPEY2 PE=1 SV=5 | 1149 | P | 0.618937 | H | 0.522706 | 0.096231 | No Change: Both D | - |
| Q9Y3R5 | DOP2_HUMAN Protein dopey-2 OS=Homo sapiens GN=DOPEY2 PE=1 SV=5 | 1217 | R | 0.59287 | S | 0.613115 | -0.020245 | No Change: Both D | - |
| Q9Y3R5 | DOP2_HUMAN Protein dopey-2 OS=Homo sapiens GN=DOPEY2 PE=1 SV=5 | 2139 | G | 0.496399 | E | 0.54231 | -0.045911 | O to D | - |
| Q9Y3R5 | DOP2_HUMAN Protein dopey-2 OS=Homo sapiens GN=DOPEY2 PE=1 SV=5 | 1021 | S | 0.51928 | W | 0.296539 | 0.222741 | D to O | - |
| Q8TEK3 | DOT1L_HUMAN Histone-lysine N-methyltransferase H3 lysine-79 specific OS=Homo sapiens GN=DOT1L PE=1 SV=2 | 726 | L | 0.67941 | M | 0.730903 | -0.051493 | No Change: Both D | - |
| Q8TEK3 | DOT1L_HUMAN Histone-lysine N-methyltransferase H3 lysine-79 specific OS=Homo sapiens GN=DOT1L PE=1 SV=2 | 1386 | G | 0.937715 | S | 0.942438 | -0.004723 | No Change: Both D | - |
| Q8TEK3 | DOT1L_HUMAN Histone-lysine N-methyltransferase H3 lysine-79 specific OS=Homo sapiens GN=DOT1L PE=1 SV=2 | 1418 | V | 0.616255 | L | 0.668058 | -0.051803 | No Change: Both D | - |
| Q9H3H5 | GPT_HUMAN UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Homo sapiens GN=DPAGT1 PE=1 SV=2 | 393 | I | 0.083382 | V | 0.088043 | -0.004661 | No Change: Both O | - |
| Q9H3H5 | GPT_HUMAN UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Homo sapiens GN=DPAGT1 PE=1 SV=2 | 170 | Y | 0.021393 | C | 0.015032 | 0.006361 | No Change: Both O | Congenital disorder of glycosylation type 1J (CDG1J) [MIM:608093] |
| Q9H3H5 | GPT_HUMAN UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Homo sapiens GN=DPAGT1 PE=1 SV=2 | 9 | M | 0.113967 | I | 0.078154 | 0.035813 | No Change: Both O | A breast cancer sample |
| Q9BVM2 | DPCD_HUMAN Protein DPCD OS=Homo sapiens GN=DPCD PE=1 SV=2 | 56 | S | 0.266683 | R | 0.239651 | 0.027032 | No Change: Both O | - |
| Q9BVM2 | DPCD_HUMAN Protein DPCD OS=Homo sapiens GN=DPCD PE=1 SV=2 | 156 | L | 0.259407 | S | 0.421415 | -0.162008 | No Change: Both O | - |
| Q3MIW9 | DPCR1_HUMAN Diffuse panbronchiolitis critical region protein 1 OS=Homo sapiens GN=DPCR1 PE=2 SV=2 | 337 | G | 0.975881 | R | 0.978074 | -0.002193 | No Change: Both D | - |
| Q3MIW9 | DPCR1_HUMAN Diffuse panbronchiolitis critical region protein 1 OS=Homo sapiens GN=DPCR1 PE=2 SV=2 | 419 | E | 0.692096 | K | 0.692933 | -8.37E-04 | No Change: Both D | - |
| Q3MIW9 | DPCR1_HUMAN Diffuse panbronchiolitis critical region protein 1 OS=Homo sapiens GN=DPCR1 PE=2 SV=2 | 517 | R | 0.850618 | Q | 0.890168 | -0.03955 | No Change: Both D | - |
| P16444 | DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens GN=DPEP1 PE=1 SV=3 | 246 | R | 0.370974 | H | 0.353271 | 0.017703 | No Change: Both O | A colorectal cancer sample |
| P16444 | DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens GN=DPEP1 PE=1 SV=3 | 351 | E | 0.239901 | K | 0.216709 | 0.023192 | No Change: Both O | - |
| P16444 | DPEP1_HUMAN Dipeptidase 1 OS=Homo sapiens GN=DPEP1 PE=1 SV=3 | 351 | E | 0.239901 | Q | 0.203958 | 0.035943 | No Change: Both O | - |
| Q9H4A9 | DPEP2_HUMAN Dipeptidase 2 OS=Homo sapiens GN=DPEP2 PE=1 SV=2 | 468 | H | 0.54633 | D | 0.580864 | -0.034534 | No Change: Both D | - |
| Q9H4A9 | DPEP2_HUMAN Dipeptidase 2 OS=Homo sapiens GN=DPEP2 PE=1 SV=2 | 201 | P | 0.103678 | R | 0.090318 | 0.01336 | No Change: Both O | - |
| Q92784 | DPF3_HUMAN Zinc finger protein DPF3 OS=Homo sapiens GN=DPF3 PE=1 SV=3 | 177 | R | 0.949328 | H | 0.932898 | 0.01643 | No Change: Both D | - |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 7 | A | 0.877451 | V | 0.830742 | 0.046709 | No Change: Both D | Ovarian cancer |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 34 | A | 0.669291 | D | 0.702506 | -0.033215 | No Change: Both D | Ovarian cancer |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 335 | L | 0.234334 | V | 0.235428 | -0.001094 | No Change: Both O | Ovarian cancer |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 389 | S | 0.336121 | R | 0.304649 | 0.031472 | No Change: Both O | Ovarian cancer |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 226 | K | 0.433153 | R | 0.393132 | 0.040021 | No Change: Both O | - |
| Q9BZG8 | DPH1_HUMAN Diphthamide biosynthesis protein 1 OS=Homo sapiens GN=DPH1 PE=1 SV=2 | 51 | I | 0.335303 | M | 0.406591 | -0.071288 | No Change: Both O | - |
| O60762 | DPM1_HUMAN Dolichol-phosphate mannosyltransferase OS=Homo sapiens GN=DPM1 PE=1 SV=1 | 92 | R | 0.460868 | G | 0.471347 | -0.010479 | No Change: Both O | Congenital disorder of glycosylation type 1E (CDG1E) [MIM:608799] |
| O60762 | DPM1_HUMAN Dolichol-phosphate mannosyltransferase OS=Homo sapiens GN=DPM1 PE=1 SV=1 | 248 | S | 0.15291 | P | 0.133714 | 0.019196 | No Change: Both O | Congenital disorder of glycosylation type 1E (CDG1E) [MIM:608799] |
| O94777 | DPM2_HUMAN Dolichol phosphate-mannose biosynthesis regulatory protein OS=Homo sapiens GN=DPM2 PE=1 SV=3 | 76 | T | 0.368434 | S | 0.444953 | -0.076519 | No Change: Both O | - |
| Q9P2X0 | DPM3_HUMAN Dolichol-phosphate mannosyltransferase subunit 3 OS=Homo sapiens GN=DPM3 PE=1 SV=2 | 85 | L | 0.542128 | S | 0.707299 | -0.165171 | No Change: Both D | Congenital disorder of glycosylation type 1O (CDG1O) [MIM:612937] |
| Q8N608 | DPP10_HUMAN Inactive dipeptidyl peptidase 10 OS=Homo sapiens GN=DPP10 PE=1 SV=2 | 340 | A | 0.116004 | P | 0.161462 | -0.045458 | No Change: Both O | - |
| Q8N608 | DPP10_HUMAN Inactive dipeptidyl peptidase 10 OS=Homo sapiens GN=DPP10 PE=1 SV=2 | 517 | S | 0.302904 | N | 0.263477 | 0.039427 | No Change: Both O | - |
| Q8N608 | DPP10_HUMAN Inactive dipeptidyl peptidase 10 OS=Homo sapiens GN=DPP10 PE=1 SV=2 | 401 | V | 0.139317 | I | 0.129778 | 0.009539 | No Change: Both O | - |
| Q9NY33 | DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=2 | 678 | R | 0.42448 | H | 0.375704 | 0.048776 | No Change: Both O | - |
| Q9NY33 | DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=2 | 76 | R | 0.502518 | H | 0.518386 | -0.015868 | No Change: Both D | - |
| Q9NY33 | DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=2 | 145 | Q | 0.198708 | H | 0.173186 | 0.025522 | No Change: Both O | - |
| Q9NY33 | DPP3_HUMAN Dipeptidyl peptidase 3 OS=Homo sapiens GN=DPP3 PE=1 SV=2 | 690 | E | 0.439582 | K | 0.395777 | 0.043805 | No Change: Both O | - |
| P42658 | DPP6_HUMAN Dipeptidyl aminopeptidase-like protein 6 OS=Homo sapiens GN=DPP6 PE=1 SV=2 | 854 | L | 0.208608 | P | 0.339383 | -0.130775 | No Change: Both O | - |
| Q9UHL4 | DPP2_HUMAN Dipeptidyl peptidase 2 OS=Homo sapiens GN=DPP7 PE=1 SV=3 | 89 | A | 0.181607 | G | 0.202575 | -0.020968 | No Change: Both O | - |
| Q7Z7J5 | DPPA2_HUMAN Developmental pluripotency-associated protein 2 OS=Homo sapiens GN=DPPA2 PE=2 SV=2 | 131 | R | 0.741589 | Q | 0.748001 | -0.006412 | No Change: Both D | - |
| Q6W0C5 | DPPA3_HUMAN Developmental pluripotency-associated protein 3 OS=Homo sapiens GN=DPPA3 PE=2 SV=1 | 51 | E | 0.790997 | Q | 0.745957 | 0.04504 | No Change: Both D | - |
| Q7L190 | DPPA4_HUMAN Developmental pluripotency-associated protein 4 OS=Homo sapiens GN=DPPA4 PE=1 SV=2 | 55 | I | 0.951377 | V | 0.95284 | -0.001463 | No Change: Both D | - |
| Q7L190 | DPPA4_HUMAN Developmental pluripotency-associated protein 4 OS=Homo sapiens GN=DPPA4 PE=1 SV=2 | 226 | S | 0.390776 | F | 0.18979 | 0.200986 | No Change: Both O | - |
| Q07507 | DERM_HUMAN Dermatopontin OS=Homo sapiens GN=DPT PE=2 SV=2 | 201 | V | 0.700863 | I | 0.672599 | 0.028264 | No Change: Both D | - |
| Q2PZI1 | D19L1_HUMAN Protein dpy-19 homolog 1 OS=Homo sapiens GN=DPY19L1 PE=2 SV=1 | 502 | G | 0.041898 | V | 0.023779 | 0.018119 | No Change: Both O | - |
| Q6NUT2 | D19L2_HUMAN Protein dpy-19 homolog 2 OS=Homo sapiens GN=DPY19L2 PE=1 SV=2 | 37 | M | 0.982987 | V | 0.979018 | 0.003969 | No Change: Both D | - |
| Q6NUT2 | D19L2_HUMAN Protein dpy-19 homolog 2 OS=Homo sapiens GN=DPY19L2 PE=1 SV=2 | 41 | A | 0.971949 | V | 0.966942 | 0.005007 | No Change: Both D | - |
| Q6NUT2 | D19L2_HUMAN Protein dpy-19 homolog 2 OS=Homo sapiens GN=DPY19L2 PE=1 SV=2 | 51 | S | 0.866005 | A | 0.815375 | 0.05063 | No Change: Both D | - |
| Q6NUT2 | D19L2_HUMAN Protein dpy-19 homolog 2 OS=Homo sapiens GN=DPY19L2 PE=1 SV=2 | 757 | V | 0.760885 | I | 0.723764 | 0.037121 | No Change: Both D | - |
| Q6ZN68 | D19P2_HUMAN Putative protein dpy-19 homolog 2-like 2 OS=Homo sapiens GN=DPY19L2P2 PE=5 SV=2 | 66 | M | 0.029125 | V | 0.020571 | 0.008554 | No Change: Both O | - |
| Q6ZN68 | D19P2_HUMAN Putative protein dpy-19 homolog 2-like 2 OS=Homo sapiens GN=DPY19L2P2 PE=5 SV=2 | 333 | N | 0.051972 | I | 0.024079 | 0.027893 | No Change: Both O | - |
| Q6ZPD9 | D19L3_HUMAN Protein dpy-19 homolog 3 OS=Homo sapiens GN=DPY19L3 PE=2 SV=1 | 350 | M | 0.019293 | V | 0.01488 | 0.004413 | No Change: Both O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 29 | C | 0.6545 | R | 0.757209 | -0.102709 | No Change: Both D | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 235 | R | 0.17484 | W | 0.073498 | 0.101342 | No Change: Both O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 534 | S | 0.136459 | N | 0.113886 | 0.022573 | No Change: Both O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 543 | I | 0.153882 | V | 0.175085 | -0.021203 | No Change: Both O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 886 | R | 0.528299 | H | 0.466555 | 0.061744 | D to O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 995 | V | 0.14702 | F | 0.121135 | 0.025885 | No Change: Both O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 732 | V | 0.520507 | I | 0.475477 | 0.04503 | D to O | - |
| Q12882 | DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP+] OS=Homo sapiens GN=DPYD PE=1 SV=2 | 166 | M | 0.323451 | V | 0.258486 | 0.064965 | No Change: Both O | - |
| Q14117 | DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens GN=DPYS PE=1 SV=1 | 68 | T | 0.362182 | R | 0.373098 | -0.010916 | No Change: Both O | Dihydropyrimidinase deficiency (DHPD) [MIM:222748] |
| Q14117 | DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens GN=DPYS PE=1 SV=1 | 334 | Q | 0.387568 | R | 0.393154 | -0.005586 | No Change: Both O | Dihydropyrimidinase deficiency (DHPD) [MIM:222748] |
| Q14117 | DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens GN=DPYS PE=1 SV=1 | 360 | W | 0.320028 | R | 0.546709 | -0.226681 | O to D | Dihydropyrimidinase deficiency (DHPD) [MIM:222748] |
| Q14117 | DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens GN=DPYS PE=1 SV=1 | 435 | G | 0.090239 | R | 0.082555 | 0.007684 | No Change: Both O | Dihydropyrimidinase deficiency (DHPD) [MIM:222748] |
| Q14117 | DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens GN=DPYS PE=1 SV=1 | 490 | R | 0.720308 | T | 0.703895 | 0.016413 | No Change: Both D | Dihydropyrimidinase deficiency (DHPD) [MIM:222748] |
| Q16555 | DPYL2_HUMAN Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 | 118 | A | 0.134113 | T | 0.151093 | -0.01698 | No Change: Both O | - |
| Q16555 | DPYL2_HUMAN Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 | 481 | R | 0.31254 | C | 0.175754 | 0.136786 | No Change: Both O | A colorectal cancer sample |
| Q14195 | DPYL3_HUMAN Dihydropyrimidinase-related protein 3 OS=Homo sapiens GN=DPYSL3 PE=1 SV=1 | 442 | A | 0.110213 | S | 0.173251 | -0.063038 | No Change: Both O | - |
| Q01658 | NC2B_HUMAN Protein Dr1 OS=Homo sapiens GN=DR1 PE=1 SV=1 | 171 | E | 0.993 | D | 0.993755 | -7.55E-04 | No Change: Both D | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 37 | T | 0.078465 | P | 0.093039 | -0.014574 | No Change: Both O | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 37 | T | 0.078465 | R | 0.07829 | 1.75E-04 | No Change: Both O | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 50 | R | 0.070114 | S | 0.091217 | -0.021103 | No Change: Both O | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 199 | S | 0.232931 | A | 0.151577 | 0.081354 | No Change: Both O | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 81 | K | 0.067449 | R | 0.048762 | 0.018687 | No Change: Both O | - |
| P21728 | DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens GN=DRD1 PE=1 SV=1 | 259 | S | 0.718245 | Y | 0.522398 | 0.195847 | No Change: Both D | - |
| P14416 | DRD2_HUMAN D(2) dopamine receptor OS=Homo sapiens GN=DRD2 PE=1 SV=2 | 311 | S | 0.973502 | C | 0.949671 | 0.023831 | No Change: Both D | - |
| P14416 | DRD2_HUMAN D(2) dopamine receptor OS=Homo sapiens GN=DRD2 PE=1 SV=2 | 310 | P | 0.976213 | S | 0.974257 | 0.001956 | No Change: Both D | - |
| P14416 | DRD2_HUMAN D(2) dopamine receptor OS=Homo sapiens GN=DRD2 PE=1 SV=2 | 154 | V | 0.115681 | I | 0.101161 | 0.01452 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| P14416 | DRD2_HUMAN D(2) dopamine receptor OS=Homo sapiens GN=DRD2 PE=1 SV=2 | 327 | K | 0.936599 | E | 0.930887 | 0.005712 | No Change: Both D | - |
| P35462 | DRD3_HUMAN D(3) dopamine receptor OS=Homo sapiens GN=DRD3 PE=1 SV=2 | 9 | S | 0.581463 | G | 0.483844 | 0.097619 | D to O | - |
| P21917 | DRD4_HUMAN D(4) dopamine receptor OS=Homo sapiens GN=DRD4 PE=1 SV=2 | 194 | V | 0.141107 | G | 0.222406 | -0.081299 | No Change: Both O | - |
| P21917 | DRD4_HUMAN D(4) dopamine receptor OS=Homo sapiens GN=DRD4 PE=1 SV=2 | 329 | P | 0.999523 | A | 0.999214 | 3.09E-04 | No Change: Both D | - |
| P21917 | DRD4_HUMAN D(4) dopamine receptor OS=Homo sapiens GN=DRD4 PE=1 SV=2 | 332 | G | 0.999409 | S | 0.999404 | 5.00E-06 | No Change: Both D | - |
| P21917 | DRD4_HUMAN D(4) dopamine receptor OS=Homo sapiens GN=DRD4 PE=1 SV=2 | 281 | A | 0.999544 | P | 0.999726 | -1.82E-04 | No Change: Both D | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 269 | A | 0.725328 | V | 0.642608 | 0.08272 | No Change: Both D | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 330 | P | 0.646517 | Q | 0.603609 | 0.042908 | No Change: Both D | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 351 | N | 0.090037 | D | 0.091209 | -0.001172 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 453 | S | 0.366801 | C | 0.227748 | 0.139053 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 88 | L | 0.056998 | R | 0.091404 | -0.034406 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 238 | V | 0.034332 | I | 0.032639 | 0.001693 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 62 | C | 0.04198 | S | 0.128567 | -0.086587 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 110 | G | 0.026427 | E | 0.032794 | -0.006367 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 207 | F | 0.286919 | V | 0.33179 | -0.044871 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 233 | S | 0.100945 | N | 0.074982 | 0.025963 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 247 | R | 0.084395 | H | 0.065721 | 0.018674 | No Change: Both O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 286 | A | 0.523673 | V | 0.433517 | 0.090156 | D to O | - |
| P21918 | DRD5_HUMAN D(1B) dopamine receptor OS=Homo sapiens GN=DRD5 PE=1 SV=2 | 297 | T | 0.205576 | P | 0.234881 | -0.029305 | No Change: Both O | - |
| Q9NRR4 | RNC_HUMAN Ribonuclease 3 OS=Homo sapiens GN=DROSHA PE=1 SV=2 | 67 | P | 0.987009 | T | 0.980139 | 0.00687 | No Change: Both D | - |
| Q9NRR4 | RNC_HUMAN Ribonuclease 3 OS=Homo sapiens GN=DROSHA PE=1 SV=2 | 321 | S | 0.702497 | L | 0.564948 | 0.137549 | No Change: Both D | - |
| Q13474 | DRP2_HUMAN Dystrophin-related protein 2 OS=Homo sapiens GN=DRP2 PE=2 SV=2 | 68 | V | 0.631955 | L | 0.679255 | -0.0473 | No Change: Both D | - |
| Q08554 | DSC1_HUMAN Desmocollin-1 OS=Homo sapiens GN=DSC1 PE=1 SV=2 | 460 | V | 0.411351 | I | 0.390535 | 0.020816 | No Change: Both O | - |
| Q08554 | DSC1_HUMAN Desmocollin-1 OS=Homo sapiens GN=DSC1 PE=1 SV=2 | 848 | C | 0.372375 | F | 0.31266 | 0.059715 | No Change: Both O | - |
| Q08554 | DSC1_HUMAN Desmocollin-1 OS=Homo sapiens GN=DSC1 PE=1 SV=2 | 93 | S | 0.613269 | F | 0.42836 | 0.184909 | D to O | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 776 | I | 0.658823 | V | 0.70342 | -0.044597 | No Change: Both D | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 11 | N | 0.268371 | S | 0.328915 | -0.060544 | No Change: Both O | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 358 | T | 0.377282 | I | 0.220656 | 0.156626 | No Change: Both O | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 798 | R | 0.765207 | Q | 0.779348 | -0.014141 | No Change: Both D | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 203 | R | 0.380909 | C | 0.233926 | 0.146983 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 11 (ARVD11) [MIM:610476] |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 231 | I | 0.25413 | T | 0.374045 | -0.119915 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 11 (ARVD11) [MIM:610476] |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 275 | T | 0.558401 | M | 0.527078 | 0.031323 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 11 (ARVD11) [MIM:610476] |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 340 | T | 0.118507 | A | 0.086614 | 0.031893 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 11 (ARVD11) [MIM:610476] |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 596 | A | 0.506579 | V | 0.448374 | 0.058205 | D to O | - |
| Q02487 | DSC2_HUMAN Desmocollin-2 OS=Homo sapiens GN=DSC2 PE=1 SV=1 | 638 | Q | 0.423181 | H | 0.417388 | 0.005793 | No Change: Both O | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 28 | A | 0.138687 | D | 0.180511 | -0.041824 | No Change: Both O | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 78 | S | 0.291929 | T | 0.230366 | 0.061563 | No Change: Both O | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 102 | R | 0.612301 | K | 0.654581 | -0.04228 | No Change: Both D | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 180 | K | 0.378849 | Q | 0.331784 | 0.047065 | No Change: Both O | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 199 | R | 0.215698 | W | 0.086692 | 0.129006 | No Change: Both O | - |
| Q14574 | DSC3_HUMAN Desmocollin-3 OS=Homo sapiens GN=DSC3 PE=1 SV=3 | 239 | N | 0.512327 | S | 0.534716 | -0.022389 | No Change: Both D | - |
| O60469 | DSCAM_HUMAN Down syndrome cell adhesion molecule OS=Homo sapiens GN=DSCAM PE=1 SV=2 | 232 | D | 0.44441 | E | 0.453204 | -0.008794 | No Change: Both O | - |
| Q8TD84 | DSCL1_HUMAN Down syndrome cell adhesion molecule-like protein 1 OS=Homo sapiens GN=DSCAML1 PE=1 SV=2 | 659 | V | 0.540446 | I | 0.526383 | 0.014063 | No Change: Both D | A colorectal cancer sample |
| Q8TD84 | DSCL1_HUMAN Down syndrome cell adhesion molecule-like protein 1 OS=Homo sapiens GN=DSCAML1 PE=1 SV=2 | 1702 | V | 0.363098 | I | 0.349349 | 0.013749 | No Change: Both O | A colorectal cancer sample |
| Q9BVC3 | DCC1_HUMAN Sister chromatid cohesion protein DCC1 OS=Homo sapiens GN=DSCC1 PE=1 SV=2 | 376 | H | 0.529387 | R | 0.529628 | -2.41E-04 | No Change: Both D | - |
| P59020 | DSCR9_HUMAN Down syndrome critical region protein 9 OS=Homo sapiens GN=DSCR9 PE=2 SV=1 | 76 | R | 0.520215 | L | 0.35586 | 0.164355 | D to O | - |
| P59020 | DSCR9_HUMAN Down syndrome critical region protein 9 OS=Homo sapiens GN=DSCR9 PE=2 SV=1 | 23 | G | 0.923346 | V | 0.879045 | 0.044301 | No Change: Both D | - |
| Q9UL01 | DSE_HUMAN Dermatan-sulfate epimerase OS=Homo sapiens GN=DSE PE=1 SV=1 | 25 | T | 0.213997 | I | 0.140666 | 0.073331 | No Change: Both O | - |
| Q9UL01 | DSE_HUMAN Dermatan-sulfate epimerase OS=Homo sapiens GN=DSE PE=1 SV=1 | 34 | P | 0.248094 | L | 0.123815 | 0.124279 | No Change: Both O | - |
| Q9UL01 | DSE_HUMAN Dermatan-sulfate epimerase OS=Homo sapiens GN=DSE PE=1 SV=1 | 282 | I | 0.179969 | V | 0.21345 | -0.033481 | No Change: Both O | - |
| Q8IZU8 | DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens GN=DSEL PE=2 SV=2 | 673 | P | 0.164735 | S | 0.18207 | -0.017335 | No Change: Both O | - |
| Q8IZU8 | DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens GN=DSEL PE=2 SV=2 | 730 | Y | 0.141253 | C | 0.112303 | 0.02895 | No Change: Both O | - |
| Q8IZU8 | DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens GN=DSEL PE=2 SV=2 | 1090 | K | 0.715169 | E | 0.718525 | -0.003356 | No Change: Both D | A colorectal cancer sample |
| Q8IZU8 | DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens GN=DSEL PE=2 SV=2 | 832 | T | 0.312193 | S | 0.397502 | -0.085309 | No Change: Both O | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 841 | Y | 0.566813 | F | 0.537497 | 0.029316 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 493 | N | 0.894353 | T | 0.894948 | -5.95E-04 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 498 | T | 0.947409 | N | 0.948567 | -0.001158 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 395 | T | 0.443924 | S | 0.531477 | -0.087553 | O to D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 528 | Y | 0.775179 | S | 0.850621 | -0.075442 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 538 | D | 0.559574 | N | 0.552282 | 0.007292 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 665 | M | 0.785188 | I | 0.679844 | 0.105344 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 821 | L | 0.646388 | Q | 0.706779 | -0.060391 | No Change: Both D | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 11 | M | 0.009209 | V | 0.007664 | 0.001545 | No Change: Both O | - |
| Q02413 | DSG1_HUMAN Desmoglein-1 OS=Homo sapiens GN=DSG1 PE=1 SV=2 | 828 | D | 0.534074 | N | 0.531975 | 0.002099 | No Change: Both D | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 46 | R | 0.324711 | Q | 0.338482 | -0.013771 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 10 (ARVD10) [MIM:610193] |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 49 | R | 0.30102 | H | 0.283464 | 0.017556 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 10 (ARVD10) [MIM:610193] |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 507 | C | 0.152445 | Y | 0.169623 | -0.017178 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 10 (ARVD10) [MIM:610193] |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 812 | G | 0.206282 | C | 0.158956 | 0.047326 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 10 (ARVD10) [MIM:610193] |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 89 | Y | 0.333496 | C | 0.302247 | 0.031249 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 293 | I | 0.155077 | V | 0.191464 | -0.036387 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 515 | V | 0.301239 | I | 0.266285 | 0.034954 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 773 | R | 0.374606 | K | 0.423784 | -0.049178 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 863 | M | 0.794872 | L | 0.756418 | 0.038454 | No Change: Both D | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 903 | T | 0.858195 | I | 0.782493 | 0.075702 | No Change: Both D | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 56 | V | 0.285422 | M | 0.347857 | -0.062435 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 158 | V | 0.247814 | G | 0.352402 | -0.104588 | No Change: Both O | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 713 | E | 0.807216 | K | 0.794715 | 0.012501 | No Change: Both D | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 920 | V | 0.80232 | G | 0.822678 | -0.020358 | No Change: Both D | - |
| Q14126 | DSG2_HUMAN Desmoglein-2 OS=Homo sapiens GN=DSG2 PE=1 SV=2 | 335 | T | 0.151578 | A | 0.131189 | 0.020389 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 10 (ARVD10) [MIM:610193] |
| P32926 | DSG3_HUMAN Desmoglein-3 OS=Homo sapiens GN=DSG3 PE=1 SV=2 | 509 | V | 0.507041 | M | 0.544919 | -0.037878 | No Change: Both D | - |
| P32926 | DSG3_HUMAN Desmoglein-3 OS=Homo sapiens GN=DSG3 PE=1 SV=2 | 912 | T | 0.733147 | A | 0.721572 | 0.011575 | No Change: Both D | - |
| Q86SJ6 | DSG4_HUMAN Desmoglein-4 OS=Homo sapiens GN=DSG4 PE=1 SV=1 | 644 | I | 0.048194 | L | 0.06795 | -0.019756 | No Change: Both O | - |
| Q86SJ6 | DSG4_HUMAN Desmoglein-4 OS=Homo sapiens GN=DSG4 PE=1 SV=1 | 535 | I | 0.234073 | T | 0.363674 | -0.129601 | No Change: Both O | - |
| Q86SJ6 | DSG4_HUMAN Desmoglein-4 OS=Homo sapiens GN=DSG4 PE=1 SV=1 | 154 | A | 0.34748 | T | 0.380045 | -0.032565 | No Change: Both O | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 299 | S | 0.410236 | R | 0.365205 | 0.045031 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 8 (ARVD8) [MIM:607450] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 287 | N | 0.250408 | K | 0.28037 | -0.029962 | No Change: Both O | Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 2366 | R | 0.21572 | C | 0.11215 | 0.10357 | No Change: Both O | Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 2375 | G | 0.254752 | R | 0.23778 | 0.016972 | No Change: Both O | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1512 | Y | 0.708936 | C | 0.766976 | -0.05804 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1255 | R | 0.887881 | K | 0.887012 | 8.69E-04 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 8 (ARVD8) [MIM:607450] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1738 | R | 0.859842 | Q | 0.845498 | 0.014344 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1775 | R | 0.87813 | I | 0.79961 | 0.07852 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 8 (ARVD8) [MIM:607450] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 305 | I | 0.549508 | F | 0.547823 | 0.001685 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 445 | I | 0.749292 | V | 0.766047 | -0.016755 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 8 (ARVD8) [MIM:607450] |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1505 | A | 0.801038 | V | 0.758462 | 0.042576 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1526 | N | 0.729191 | K | 0.772698 | -0.043507 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1537 | R | 0.670508 | C | 0.519639 | 0.150869 | No Change: Both D | - |
| P15924 | DESP_HUMAN Desmoplakin OS=Homo sapiens GN=DSP PE=1 SV=3 | 1833 | E | 0.873134 | V | 0.780358 | 0.092776 | No Change: Both D | - |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 17 | P | 0.156841 | T | 0.118218 | 0.038623 | No Change: Both O | Deafness autosomal dominant type 39 with dentinogenesis imperfecta 1 (DFNA39/DGI1) [MIM:605594] |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 18 | V | 0.246943 | F | 0.215628 | 0.031315 | No Change: Both O | Deafness autosomal dominant type 39 with dentinogenesis imperfecta 1 (DFNA39/DGI1) [MIM:605594] |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 18 | V | 0.246943 | F | 0.215628 | 0.031315 | No Change: Both O | Dentinogenesis imperfecta Shields type 3 (DGI3) [MIM:125500] |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 68 | R | 0.793274 | W | 0.64433 | 0.148944 | No Change: Both D | - |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 6 | Y | 0.027298 | D | 0.060979 | -0.033681 | No Change: Both O | Dentin dysplasia type 2 (DTDP2) [MIM:125420] |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 15 | A | 0.050651 | V | 0.035241 | 0.01541 | No Change: Both O | - |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 243 | D | 0.983748 | N | 0.983209 | 5.39E-04 | No Change: Both D | - |
| Q9NZW4 | DSPP_HUMAN Dentin sialophosphoprotein OS=Homo sapiens GN=DSPP PE=1 SV=2 | 17 | P | 0.156841 | S | 0.170228 | -0.013387 | No Change: Both O | - |
| Q03001 | DYST_HUMAN Dystonin OS=Homo sapiens GN=DST PE=1 SV=4 | 1319 | N | 0.773484 | K | 0.797221 | -0.023737 | No Change: Both D | - |
| Q03001 | DYST_HUMAN Dystonin OS=Homo sapiens GN=DST PE=1 SV=4 | 2332 | Q | 0.868669 | R | 0.840621 | 0.028048 | No Change: Both D | - |
| Q03001 | DYST_HUMAN Dystonin OS=Homo sapiens GN=DST PE=1 SV=4 | 3720 | Q | 0.893005 | R | 0.861546 | 0.031459 | No Change: Both D | - |
| Q03001 | DYST_HUMAN Dystonin OS=Homo sapiens GN=DST PE=1 SV=4 | 5138 | T | 0.692404 | A | 0.677921 | 0.014483 | No Change: Both D | - |
| P60981 | DEST_HUMAN Destrin OS=Homo sapiens GN=DSTN PE=1 SV=3 | 139 | G | 0.50779 | E | 0.566692 | -0.058902 | No Change: Both D | A colorectal cancer sample |
| Q6XUX3 | DUSTY_HUMAN Dual serine/threonine and tyrosine protein kinase OS=Homo sapiens GN=DSTYK PE=1 SV=2 | 432 | L | 0.649483 | V | 0.641858 | 0.007625 | No Change: Both D | - |
| Q6ZMT9 | DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens GN=DTHD1 PE=2 SV=3 | 26 | G | 0.481909 | R | 0.533141 | -0.051232 | O to D | - |
| Q6ZMT9 | DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens GN=DTHD1 PE=2 SV=3 | 179 | V | 0.270769 | D | 0.417717 | -0.146948 | No Change: Both O | - |
| Q6ZMT9 | DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens GN=DTHD1 PE=2 SV=3 | 552 | R | 0.65529 | C | 0.489025 | 0.166265 | D to O | - |
| Q6ZMT9 | DTHD1_HUMAN Death domain-containing protein 1 OS=Homo sapiens GN=DTHD1 PE=2 SV=3 | 662 | R | 0.703322 | H | 0.694496 | 0.008826 | No Change: Both D | - |
| Q9NZJ0 | DTL_HUMAN Denticleless protein homolog OS=Homo sapiens GN=DTL PE=1 SV=3 | 436 | A | 0.982712 | V | 0.976344 | 0.006368 | No Change: Both D | - |
| Q9NZJ0 | DTL_HUMAN Denticleless protein homolog OS=Homo sapiens GN=DTL PE=1 SV=3 | 694 | K | 0.955636 | T | 0.949609 | 0.006027 | No Change: Both D | - |
| Q9NZJ0 | DTL_HUMAN Denticleless protein homolog OS=Homo sapiens GN=DTL PE=1 SV=3 | 425 | S | 0.962623 | N | 0.947634 | 0.014989 | No Change: Both D | - |
| Q9Y4J8 | DTNA_HUMAN Dystrobrevin alpha OS=Homo sapiens GN=DTNA PE=1 SV=2 | 121 | P | 0.340319 | L | 0.209109 | 0.13121 | No Change: Both O | Left ventricular non-compaction type 1 (LVNC1) [MIM:604169] |
| Q9Y4J8 | DTNA_HUMAN Dystrobrevin alpha OS=Homo sapiens GN=DTNA PE=1 SV=2 | 180 | A | 0.214842 | E | 0.336808 | -0.121966 | No Change: Both O | - |
| Q96EV8 | DTBP1_HUMAN Dysbindin OS=Homo sapiens GN=DTNBP1 PE=1 SV=1 | 272 | P | 0.810869 | S | 0.821055 | -0.010186 | No Change: Both D | - |
| Q96EV8 | DTBP1_HUMAN Dysbindin OS=Homo sapiens GN=DTNBP1 PE=1 SV=1 | 214 | G | 0.623466 | D | 0.677369 | -0.053903 | No Change: Both D | - |
| Q8N5C7 | DTWD1_HUMAN DTW domain-containing protein 1 OS=Homo sapiens GN=DTWD1 PE=2 SV=1 | 9 | L | 0.897881 | P | 0.952638 | -0.054757 | No Change: Both D | - |
| Q8N5C7 | DTWD1_HUMAN DTW domain-containing protein 1 OS=Homo sapiens GN=DTWD1 PE=2 SV=1 | 13 | E | 0.902915 | K | 0.90694 | -0.004025 | No Change: Both D | - |
| Q8N5C7 | DTWD1_HUMAN DTW domain-containing protein 1 OS=Homo sapiens GN=DTWD1 PE=2 SV=1 | 25 | S | 0.894794 | P | 0.88393 | 0.010864 | No Change: Both D | - |
| Q86UW9 | DTX2_HUMAN Protein deltex-2 OS=Homo sapiens GN=DTX2 PE=1 SV=3 | 94 | A | 0.327294 | T | 0.379924 | -0.05263 | No Change: Both O | - |
| Q86UW9 | DTX2_HUMAN Protein deltex-2 OS=Homo sapiens GN=DTX2 PE=1 SV=3 | 384 | G | 0.930011 | E | 0.954045 | -0.024034 | No Change: Both D | - |
| Q86UW9 | DTX2_HUMAN Protein deltex-2 OS=Homo sapiens GN=DTX2 PE=1 SV=3 | 421 | T | 0.439316 | A | 0.415939 | 0.023377 | No Change: Both O | - |
| Q8TDB6 | DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens GN=DTX3L PE=1 SV=1 | 209 | K | 0.980979 | N | 0.975862 | 0.005117 | No Change: Both D | A breast cancer sample |
| Q8TDB6 | DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens GN=DTX3L PE=1 SV=1 | 425 | R | 0.406113 | K | 0.481854 | -0.075741 | No Change: Both O | - |
| Q8TDB6 | DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens GN=DTX3L PE=1 SV=1 | 668 | K | 0.523658 | M | 0.391106 | 0.132552 | D to O | - |
| Q9NRD9 | DUOX1_HUMAN Dual oxidase 1 OS=Homo sapiens GN=DUOX1 PE=1 SV=1 | 1026 | C | 0.321612 | R | 0.508687 | -0.187075 | O to D | - |
| Q9NRD9 | DUOX1_HUMAN Dual oxidase 1 OS=Homo sapiens GN=DUOX1 PE=1 SV=1 | 1178 | L | 0.371886 | F | 0.351681 | 0.020205 | No Change: Both O | - |
| Q9NRD9 | DUOX1_HUMAN Dual oxidase 1 OS=Homo sapiens GN=DUOX1 PE=1 SV=1 | 962 | I | 0.607259 | T | 0.692214 | -0.084955 | No Change: Both D | - |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 36 | Q | 0.130307 | H | 0.115433 | 0.014874 | No Change: Both O | Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200] |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 138 | P | 0.579217 | L | 0.405737 | 0.17348 | D to O | - |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 376 | R | 0.257326 | W | 0.129442 | 0.127884 | No Change: Both O | Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200] |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 1067 | S | 0.404941 | L | 0.20361 | 0.201331 | No Change: Both O | - |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 678 | H | 0.177872 | R | 0.250101 | -0.072229 | No Change: Both O | - |
| Q9NRD8 | DUOX2_HUMAN Dual oxidase 2 OS=Homo sapiens GN=DUOX2 PE=1 SV=2 | 1518 | G | 0.355368 | S | 0.405118 | -0.04975 | No Change: Both O | Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200] |
| Q1HG43 | DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens GN=DUOXA1 PE=1 SV=1 | 313 | S | 0.913422 | G | 0.876773 | 0.036649 | No Change: Both D | - |
| Q1HG43 | DOXA1_HUMAN Dual oxidase maturation factor 1 OS=Homo sapiens GN=DUOXA1 PE=1 SV=1 | 19 | P | 0.403037 | L | 0.236937 | 0.1661 | No Change: Both O | - |
| Q1HG44 | DOXA2_HUMAN Dual oxidase maturation factor 2 OS=Homo sapiens GN=DUOXA2 PE=1 SV=2 | 100 | R | 0.112122 | G | 0.117637 | -0.005515 | No Change: Both O | - |
| Q68J44 | DUPD1_HUMAN Dual specificity phosphatase DUPD1 OS=Homo sapiens GN=DUPD1 PE=1 SV=1 | 137 | S | 0.442209 | R | 0.369342 | 0.072867 | No Change: Both O | - |
| Q68J44 | DUPD1_HUMAN Dual specificity phosphatase DUPD1 OS=Homo sapiens GN=DUPD1 PE=1 SV=1 | 66 | D | 0.212385 | N | 0.189988 | 0.022397 | No Change: Both O | - |
| Q96G46 | DUS3L_HUMAN tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens GN=DUS3L PE=1 SV=2 | 185 | R | 0.429216 | G | 0.431404 | -0.002188 | No Change: Both O | - |
| Q96G46 | DUS3L_HUMAN tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Homo sapiens GN=DUS3L PE=1 SV=2 | 609 | D | 0.227802 | N | 0.215304 | 0.012498 | No Change: Both O | - |
| O95620 | DUS4L_HUMAN tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Homo sapiens GN=DUS4L PE=2 SV=2 | 230 | R | 0.155655 | Q | 0.166703 | -0.011048 | No Change: Both O | - |
| O95620 | DUS4L_HUMAN tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Homo sapiens GN=DUS4L PE=2 SV=2 | 178 | T | 0.189383 | A | 0.17423 | 0.015153 | No Change: Both O | - |
| P28562 | DUS1_HUMAN Dual specificity protein phosphatase 1 OS=Homo sapiens GN=DUSP1 PE=1 SV=3 | 56 | A | 0.394064 | T | 0.424473 | -0.030409 | No Change: Both O | - |
| P28562 | DUS1_HUMAN Dual specificity protein phosphatase 1 OS=Homo sapiens GN=DUSP1 PE=1 SV=3 | 187 | Y | 0.289806 | H | 0.406219 | -0.116413 | No Change: Both O | - |
| Q9UNI6 | DUS12_HUMAN Dual specificity protein phosphatase 12 OS=Homo sapiens GN=DUSP12 PE=1 SV=1 | 51 | A | 0.291605 | E | 0.399013 | -0.107408 | No Change: Both O | - |
| Q6B8I1 | MDSP_HUMAN Dual specificity protein phosphatase 13 isoform MDSP OS=Homo sapiens GN=DUSP13 PE=1 SV=1 | 73 | K | 0.244085 | R | 0.189207 | 0.054878 | No Change: Both O | - |
| Q9UII6 | DUS13_HUMAN Dual specificity protein phosphatase 13 OS=Homo sapiens GN=DUSP13 PE=1 SV=3 | 156 | C | 0.046882 | Y | 0.054384 | -0.007502 | No Change: Both O | - |
| Q9UII6 | DUS13_HUMAN Dual specificity protein phosphatase 13 OS=Homo sapiens GN=DUSP13 PE=1 SV=3 | 62 | R | 0.405123 | Q | 0.43605 | -0.030927 | No Change: Both O | - |
| Q9UII6 | DUS13_HUMAN Dual specificity protein phosphatase 13 OS=Homo sapiens GN=DUSP13 PE=1 SV=3 | 190 | R | 0.423194 | G | 0.425848 | -0.002654 | No Change: Both O | - |
| Q9BY84 | DUS16_HUMAN Dual specificity protein phosphatase 16 OS=Homo sapiens GN=DUSP16 PE=1 SV=1 | 23 | T | 0.331096 | M | 0.28498 | 0.046116 | No Change: Both O | - |
| Q9BY84 | DUS16_HUMAN Dual specificity protein phosphatase 16 OS=Homo sapiens GN=DUSP16 PE=1 SV=1 | 366 | V | 0.932806 | M | 0.939834 | -0.007028 | No Change: Both D | - |
| Q8WTR2 | DUS19_HUMAN Dual specificity protein phosphatase 19 OS=Homo sapiens GN=DUSP19 PE=2 SV=1 | 216 | S | 0.93289 | R | 0.92808 | 0.00481 | No Change: Both D | - |
| Q9H596 | DUS21_HUMAN Dual specificity protein phosphatase 21 OS=Homo sapiens GN=DUSP21 PE=1 SV=1 | 186 | M | 0.582221 | T | 0.598189 | -0.015968 | No Change: Both D | - |
| Q9H596 | DUS21_HUMAN Dual specificity protein phosphatase 21 OS=Homo sapiens GN=DUSP21 PE=1 SV=1 | 167 | R | 0.252652 | C | 0.141357 | 0.111295 | No Change: Both O | A colorectal cancer sample |
| Q9NRW4 | DUS22_HUMAN Dual specificity protein phosphatase 22 OS=Homo sapiens GN=DUSP22 PE=1 SV=1 | 119 | R | 0.293142 | H | 0.296391 | -0.003249 | No Change: Both O | - |
| Q9BVJ7 | DUS23_HUMAN Dual specificity protein phosphatase 23 OS=Homo sapiens GN=DUSP23 PE=1 SV=1 | 131 | G | 0.437393 | S | 0.508248 | -0.070855 | O to D | - |
| Q9BVJ7 | DUS23_HUMAN Dual specificity protein phosphatase 23 OS=Homo sapiens GN=DUSP23 PE=1 SV=1 | 124 | E | 0.295419 | V | 0.145502 | 0.149917 | No Change: Both O | - |
| Q5VZP5 | DUS27_HUMAN Inactive dual specificity phosphatase 27 OS=Homo sapiens GN=DUSP27 PE=2 SV=1 | 265 | E | 0.346999 | D | 0.302529 | 0.04447 | No Change: Both O | - |
| Q5VZP5 | DUS27_HUMAN Inactive dual specificity phosphatase 27 OS=Homo sapiens GN=DUSP27 PE=2 SV=1 | 466 | R | 0.78963 | H | 0.759999 | 0.029631 | No Change: Both D | - |
| Q5VZP5 | DUS27_HUMAN Inactive dual specificity phosphatase 27 OS=Homo sapiens GN=DUSP27 PE=2 SV=1 | 505 | A | 0.969216 | T | 0.965992 | 0.003224 | No Change: Both D | - |
| Q5VZP5 | DUS27_HUMAN Inactive dual specificity phosphatase 27 OS=Homo sapiens GN=DUSP27 PE=2 SV=1 | 855 | K | 0.966051 | Q | 0.957333 | 0.008718 | No Change: Both D | - |
| Q5VZP5 | DUS27_HUMAN Inactive dual specificity phosphatase 27 OS=Homo sapiens GN=DUSP27 PE=2 SV=1 | 1124 | T | 0.988795 | N | 0.987914 | 8.81E-04 | No Change: Both D | - |
| Q16690 | DUS5_HUMAN Dual specificity protein phosphatase 5 OS=Homo sapiens GN=DUSP5 PE=1 SV=2 | 154 | E | 0.524023 | D | 0.481262 | 0.042761 | D to O | - |
| Q16690 | DUS5_HUMAN Dual specificity protein phosphatase 5 OS=Homo sapiens GN=DUSP5 PE=1 SV=2 | 322 | P | 0.833341 | L | 0.723657 | 0.109684 | No Change: Both D | - |
| Q16690 | DUS5_HUMAN Dual specificity protein phosphatase 5 OS=Homo sapiens GN=DUSP5 PE=1 SV=2 | 220 | A | 0.280818 | T | 0.310496 | -0.029678 | No Change: Both O | - |
| Q16690 | DUS5_HUMAN Dual specificity protein phosphatase 5 OS=Homo sapiens GN=DUSP5 PE=1 SV=2 | 220 | A | 0.280818 | V | 0.213252 | 0.067566 | No Change: Both O | - |
| Q16828 | DUS6_HUMAN Dual specificity protein phosphatase 6 OS=Homo sapiens GN=DUSP6 PE=1 SV=2 | 114 | V | 0.373628 | L | 0.419891 | -0.046263 | No Change: Both O | - |
| Q16828 | DUS6_HUMAN Dual specificity protein phosphatase 6 OS=Homo sapiens GN=DUSP6 PE=1 SV=2 | 144 | S | 0.401395 | A | 0.283568 | 0.117827 | No Change: Both O | - |
| Q16828 | DUS6_HUMAN Dual specificity protein phosphatase 6 OS=Homo sapiens GN=DUSP6 PE=1 SV=2 | 313 | N | 0.28379 | I | 0.137479 | 0.146311 | No Change: Both O | - |
| Q16829 | DUS7_HUMAN Dual specificity protein phosphatase 7 OS=Homo sapiens GN=DUSP7 PE=1 SV=4 | 235 | S | 0.83533 | N | 0.797522 | 0.037808 | No Change: Both D | - |
| P33316 | DUT_HUMAN Deoxyuridine 5'-triphosphate nucleotidohydrolase mitochondrial OS=Homo sapiens GN=DUT PE=1 SV=4 | 100 | P | 0.941149 | S | 0.936875 | 0.004274 | No Change: Both D | - |
| Q96PT3 | DUX5_HUMAN Double homeobox protein 5 OS=Homo sapiens GN=DUX5 PE=2 SV=1 | 60 | A | 0.471657 | V | 0.361047 | 0.11061 | No Change: Both O | - |
| Q96PT3 | DUX5_HUMAN Double homeobox protein 5 OS=Homo sapiens GN=DUX5 PE=2 SV=1 | 118 | P | 0.921069 | L | 0.860321 | 0.060748 | No Change: Both D | - |
| Q96PT3 | DUX5_HUMAN Double homeobox protein 5 OS=Homo sapiens GN=DUX5 PE=2 SV=1 | 119 | Q | 0.915318 | P | 0.925682 | -0.010364 | No Change: Both D | - |
| Q96PT3 | DUX5_HUMAN Double homeobox protein 5 OS=Homo sapiens GN=DUX5 PE=2 SV=1 | 180 | S | 0.853287 | A | 0.82286 | 0.030427 | No Change: Both D | - |
| Q96PT3 | DUX5_HUMAN Double homeobox protein 5 OS=Homo sapiens GN=DUX5 PE=2 SV=1 | 180 | S | 0.853287 | T | 0.823647 | 0.02964 | No Change: Both D | - |
| O14641 | DVL2_HUMAN Segment polarity protein dishevelled homolog DVL-2 OS=Homo sapiens GN=DVL2 PE=1 SV=1 | 282 | I | 0.216346 | T | 0.317241 | -0.100895 | No Change: Both O | - |
| Q92997 | DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens GN=DVL3 PE=1 SV=2 | 433 | W | 0.083663 | L | 0.130927 | -0.047264 | No Change: Both O | - |
| Q92997 | DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens GN=DVL3 PE=1 SV=2 | 216 | R | 0.993802 | T | 0.992057 | 0.001745 | No Change: Both D | A breast cancer sample |
| Q96IM9 | DYDC2_HUMAN DPY30 domain-containing protein 2 OS=Homo sapiens GN=DYDC2 PE=2 SV=1 | 143 | G | 0.864222 | S | 0.898382 | -0.03416 | No Change: Both D | - |
| Q7RTS9 | DYM_HUMAN Dymeclin OS=Homo sapiens GN=DYM PE=1 SV=1 | 87 | E | 0.473146 | K | 0.483729 | -0.010583 | No Change: Both O | Smith-McCort dysplasia (SMC) [MIM:607326] |
| Q7RTS9 | DYM_HUMAN Dymeclin OS=Homo sapiens GN=DYM PE=1 SV=1 | 469 | N | 0.250826 | Y | 0.142355 | 0.108471 | No Change: Both O | Dyggve-Melchior-Clausen syndrome (DMC) [MIM:223800] |
| Q7RTS9 | DYM_HUMAN Dymeclin OS=Homo sapiens GN=DYM PE=1 SV=1 | 542 | C | 0.230281 | R | 0.378767 | -0.148486 | No Change: Both O | Smith-McCort dysplasia (SMC) [MIM:607326] |
| Q14204 | DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 | 3902 | D | 0.365977 | N | 0.352534 | 0.013443 | No Change: Both O | - |
| Q14204 | DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 | 4029 | H | 0.204008 | Q | 0.233592 | -0.029584 | No Change: Both O | - |
| Q14204 | DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 | 3822 | H | 0.134826 | P | 0.156881 | -0.022055 | No Change: Both O | - |
| Q14204 | DYHC1_HUMAN Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 | 306 | H | 0.302813 | R | 0.302308 | 5.05E-04 | No Change: Both O | Charcot-Marie-Tooth disease type 2O (CMT2O) [MIM:614228] |
| O14576 | DC1I1_HUMAN Cytoplasmic dynein 1 intermediate chain 1 OS=Homo sapiens GN=DYNC1I1 PE=1 SV=2 | 582 | N | 0.211639 | T | 0.183535 | 0.028104 | No Change: Both O | - |
| O14576 | DC1I1_HUMAN Cytoplasmic dynein 1 intermediate chain 1 OS=Homo sapiens GN=DYNC1I1 PE=1 SV=2 | 373 | H | 0.428517 | L | 0.312965 | 0.115552 | No Change: Both O | - |
| Q9Y6G9 | DC1L1_HUMAN Cytoplasmic dynein 1 light intermediate chain 1 OS=Homo sapiens GN=DYNC1LI1 PE=1 SV=3 | 277 | Q | 0.06105 | R | 0.059857 | 0.001193 | No Change: Both O | - |
| Q9Y6G9 | DC1L1_HUMAN Cytoplasmic dynein 1 light intermediate chain 1 OS=Homo sapiens GN=DYNC1LI1 PE=1 SV=3 | 147 | M | 0.119669 | T | 0.144723 | -0.025054 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 302 | T | 0.062595 | P | 0.081055 | -0.01846 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 304 | Q | 0.118371 | L | 0.063624 | 0.054747 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 341 | H | 0.095748 | Y | 0.062456 | 0.033292 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 456 | R | 0.352716 | Q | 0.308024 | 0.044692 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 789 | R | 0.365917 | K | 0.41266 | -0.046743 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1221 | R | 0.31456 | K | 0.383313 | -0.068753 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1288 | T | 0.48141 | A | 0.448688 | 0.032722 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1413 | K | 0.365907 | R | 0.3276 | 0.038307 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 2871 | R | 0.275156 | Q | 0.288436 | -0.01328 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 3680 | A | 0.169255 | V | 0.131396 | 0.037859 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 3976 | S | 0.293097 | N | 0.235364 | 0.057733 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 4139 | Q | 0.25797 | P | 0.287996 | -0.030026 | No Change: Both O | - |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 209 | F | 0.169944 | I | 0.171444 | -0.0015 | No Change: Both O | Short rib-polydactyly syndrome type 3 (SRPS3) [MIM:263510] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 587 | R | 0.12642 | C | 0.056237 | 0.070183 | No Change: Both O | Short rib-polydactyly syndrome type 3 (SRPS3) [MIM:263510] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1240 | I | 0.185949 | T | 0.321401 | -0.135452 | No Change: Both O | Asphyxiating thoracic dystrophy type 3 (ATD3) [MIM:613091] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1537 | Q | 0.234476 | R | 0.202212 | 0.032264 | No Change: Both O | Asphyxiating thoracic dystrophy type 3 (ATD3) [MIM:613091] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1987 | T | 0.318961 | A | 0.311896 | 0.007065 | No Change: Both O | Short rib-polydactyly syndrome type 3 (SRPS3) [MIM:263510] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 1991 | M | 0.124031 | L | 0.09993 | 0.024101 | No Change: Both O | Asphyxiating thoracic dystrophy type 3 (ATD3) [MIM:613091] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 2205 | R | 0.402261 | H | 0.409957 | -0.007696 | No Change: Both O | Short rib-polydactyly syndrome type 3 (SRPS3) [MIM:263510] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 2461 | G | 0.412187 | V | 0.268981 | 0.143206 | No Change: Both O | Short rib-polydactyly syndrome type 3 (SRPS3) [MIM:263510] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 3015 | D | 0.199951 | G | 0.18427 | 0.015681 | No Change: Both O | Asphyxiating thoracic dystrophy type 3 (ATD3) [MIM:613091] |
| Q8NCM8 | DYHC2_HUMAN Cytoplasmic dynein 2 heavy chain 1 OS=Homo sapiens GN=DYNC2H1 PE=1 SV=4 | 3762 | L | 0.269497 | V | 0.258951 | 0.010546 | No Change: Both O | Asphyxiating thoracic dystrophy type 3 (ATD3) [MIM:613091] |
| Q8TCX1 | DC2L1_HUMAN Cytoplasmic dynein 2 light intermediate chain 1 OS=Homo sapiens GN=DYNC2LI1 PE=2 SV=1 | 33 | F | 0.237177 | S | 0.402915 | -0.165738 | No Change: Both O | - |
| Q8TCX1 | DC2L1_HUMAN Cytoplasmic dynein 2 light intermediate chain 1 OS=Homo sapiens GN=DYNC2LI1 PE=2 SV=1 | 58 | P | 0.621848 | S | 0.627348 | -0.0055 | No Change: Both D | - |
| Q8TCX1 | DC2L1_HUMAN Cytoplasmic dynein 2 light intermediate chain 1 OS=Homo sapiens GN=DYNC2LI1 PE=2 SV=1 | 230 | I | 0.112511 | L | 0.133207 | -0.020696 | No Change: Both O | - |
| Q9NP97 | DLRB1_HUMAN Dynein light chain roadblock-type 1 OS=Homo sapiens GN=DYNLRB1 PE=1 SV=3 | 13 | S | 0.498984 | R | 0.473633 | 0.025351 | No Change: Both O | - |
| Q9NP97 | DLRB1_HUMAN Dynein light chain roadblock-type 1 OS=Homo sapiens GN=DYNLRB1 PE=1 SV=3 | 71 | I | 0.262608 | F | 0.267925 | -0.005317 | No Change: Both O | - |
| Q8TF09 | DLRB2_HUMAN Dynein light chain roadblock-type 2 OS=Homo sapiens GN=DYNLRB2 PE=1 SV=1 | 14 | H | 0.387647 | R | 0.411261 | -0.023614 | No Change: Both O | - |
| Q13627 | DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens GN=DYRK1A PE=1 SV=2 | 415 | Y | 0.81138 | F | 0.833823 | -0.022443 | No Change: Both D | - |
| Q13627 | DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens GN=DYRK1A PE=1 SV=2 | 681 | Q | 0.815397 | H | 0.760737 | 0.05466 | No Change: Both D | - |
| Q13627 | DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens GN=DYRK1A PE=1 SV=2 | 679 | A | 0.85624 | P | 0.884347 | -0.028107 | No Change: Both D | - |
| Q9Y463 | DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | 28 | L | 0.481323 | P | 0.653294 | -0.171971 | O to D | - |
| Q9Y463 | DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | 102 | R | 0.31745 | H | 0.303487 | 0.013963 | No Change: Both O | - |
| Q9Y463 | DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | 234 | S | 0.1309 | G | 0.102361 | 0.028539 | No Change: Both O | - |
| Q9Y463 | DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | 275 | Q | 0.218932 | R | 0.207123 | 0.011809 | No Change: Both O | A metastatic melanoma sample |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 98 | S | 0.558551 | G | 0.527516 | 0.031035 | No Change: Both D | - |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 198 | P | 0.765263 | L | 0.624785 | 0.140478 | No Change: Both D | A glioblastoma multiforme sample |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 245 | H | 0.345418 | N | 0.343739 | 0.001679 | No Change: Both O | - |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 295 | N | 0.11585 | S | 0.123953 | -0.008103 | No Change: Both O | - |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 451 | R | 0.546163 | Q | 0.5667 | -0.020537 | No Change: Both D | - |
| Q92630 | DYRK2_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Homo sapiens GN=DYRK2 PE=1 SV=3 | 455 | F | 0.544483 | Y | 0.584949 | -0.040466 | No Change: Both D | - |
| O43781 | DYRK3_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 3 OS=Homo sapiens GN=DYRK3 PE=1 SV=3 | 239 | M | 0.267058 | L | 0.228265 | 0.038793 | No Change: Both O | - |
| Q9NR20 | DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | 95 | V | 0.147785 | I | 0.14005 | 0.007735 | No Change: Both O | - |
| Q9NR20 | DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | 189 | N | 0.095581 | S | 0.106286 | -0.010705 | No Change: Both O | - |
| Q9NR20 | DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | 454 | D | 0.957921 | V | 0.93305 | 0.024871 | No Change: Both D | - |
| Q9NR20 | DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | 61 | A | 0.150315 | T | 0.16738 | -0.017065 | No Change: Both O | - |
| Q9NR20 | DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | 70 | A | 0.303306 | S | 0.390432 | -0.087126 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 791 | P | 0.18844 | R | 0.159214 | 0.029226 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 791 | P | 0.18844 | R | 0.159214 | 0.029226 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1298 | I | 0.639256 | V | 0.655488 | -0.016232 | No Change: Both D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1298 | I | 0.639256 | V | 0.655488 | -0.016232 | No Change: Both D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1857 | H | 0.508165 | R | 0.509877 | -0.001712 | No Change: Both D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 2042 | R | 0.01389 | C | 0.005497 | 0.008393 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 2042 | R | 0.01389 | C | 0.005497 | 0.008393 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1242 | R | 0.184395 | H | 0.158168 | 0.026227 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 170 | A | 0.965925 | E | 0.978179 | -0.012254 | No Change: Both D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 170 | A | 0.965925 | E | 0.978179 | -0.012254 | No Change: Both D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 189 | L | 0.982107 | V | 0.976857 | 0.00525 | No Change: Both D | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 253 | R | 0.542483 | W | 0.337666 | 0.204817 | D to O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 266 | L | 0.162256 | P | 0.29188 | -0.129624 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 299 | G | 0.23057 | E | 0.282464 | -0.051894 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 456 | C | 0.243752 | W | 0.210408 | 0.033344 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 555 | R | 0.2774 | W | 0.107008 | 0.170392 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 555 | R | 0.2774 | W | 0.107008 | 0.170392 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 959 | R | 0.26813 | W | 0.135605 | 0.132525 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 959 | R | 0.26813 | W | 0.135605 | 0.132525 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1022 | R | 0.516833 | Q | 0.521639 | -0.004806 | No Change: Both D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1038 | R | 0.542079 | Q | 0.505311 | 0.036768 | No Change: Both D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1046 | R | 0.55072 | H | 0.483014 | 0.067706 | D to O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1208 | I | 0.077757 | M | 0.107061 | -0.029304 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1276 | L | 0.496687 | V | 0.442183 | 0.054504 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1331 | R | 0.201411 | L | 0.138333 | 0.063078 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1335 | E | 0.113057 | K | 0.115992 | -0.002935 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1335 | E | 0.113057 | K | 0.115992 | -0.002935 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1351 | N | 0.410919 | S | 0.474917 | -0.063998 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1693 | R | 0.450591 | Q | 0.479822 | -0.029231 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1748 | E | 0.514596 | V | 0.339688 | 0.174908 | D to O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 2000 | R | 0.858475 | Q | 0.858922 | -4.47E-04 | No Change: Both D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1325 | I | 0.348241 | M | 0.439652 | -0.091411 | No Change: Both O | A breast cancer sample |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1349 | L | 0.400371 | V | 0.39331 | 0.007061 | No Change: Both O | A breast cancer sample |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 834 | I | 0.107376 | V | 0.125974 | -0.018598 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1072 | A | 0.371718 | P | 0.42449 | -0.052772 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 52 | W | 0.150285 | R | 0.303229 | -0.152944 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 67 | V | 0.374121 | D | 0.539051 | -0.16493 | O to D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 67 | V | 0.374121 | D | 0.539051 | -0.16493 | O to D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 84 | A | 0.378657 | V | 0.327603 | 0.051054 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 155 | G | 0.964746 | R | 0.959971 | 0.004775 | No Change: Both D | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 234 | G | 0.395573 | E | 0.439596 | -0.044023 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 284 | I | 0.126884 | T | 0.219355 | -0.092471 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 299 | G | 0.23057 | R | 0.23744 | -0.00687 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 299 | G | 0.23057 | W | 0.095376 | 0.135194 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 335 | G | 0.385902 | A | 0.351335 | 0.034567 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 340 | S | 0.466505 | R | 0.45016 | 0.016345 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 374 | V | 0.389985 | L | 0.424622 | -0.034637 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 389 | E | 0.261139 | Q | 0.243797 | 0.017342 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 390 | D | 0.300583 | N | 0.269528 | 0.031055 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 426 | G | 0.201672 | R | 0.200616 | 0.001056 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 426 | G | 0.201672 | V | 0.14012 | 0.061552 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 519 | G | 0.21058 | R | 0.201555 | 0.009025 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 618 | G | 0.218047 | R | 0.194847 | 0.0232 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 618 | G | 0.218047 | R | 0.194847 | 0.0232 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 621 | G | 0.269564 | R | 0.241611 | 0.027953 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 625 | D | 0.188594 | Y | 0.10382 | 0.084774 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 731 | P | 0.535978 | R | 0.496556 | 0.039422 | D to O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 819 | R | 0.222599 | Q | 0.236859 | -0.01426 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 930 | W | 0.045884 | C | 0.060803 | -0.014919 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 999 | W | 0.358309 | C | 0.40055 | -0.042241 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1029 | P | 0.460202 | L | 0.283694 | 0.176508 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1041 | R | 0.517292 | C | 0.31722 | 0.200072 | D to O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1228 | L | 0.235596 | P | 0.41796 | -0.182364 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1325 | I | 0.348241 | V | 0.359245 | -0.011004 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1341 | L | 0.114631 | P | 0.206713 | -0.092082 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1361 | C | 0.3135 | R | 0.48765 | -0.17415 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1505 | Y | 0.266163 | C | 0.24363 | 0.022533 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1526 | K | 0.239811 | T | 0.191863 | 0.047948 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1543 | G | 0.399104 | D | 0.435941 | -0.036837 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1581 | R | 0.171426 | H | 0.133879 | 0.037547 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1662 | T | 0.349761 | R | 0.373509 | -0.023748 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1678 | C | 0.174988 | S | 0.361829 | -0.186841 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1679 | G | 0.171144 | E | 0.200116 | -0.028972 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1693 | R | 0.450591 | W | 0.246108 | 0.204483 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1734 | E | 0.4697 | G | 0.408831 | 0.060869 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1768 | R | 0.613945 | W | 0.405008 | 0.208937 | D to O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1837 | D | 0.265114 | N | 0.251464 | 0.01365 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1842 | G | 0.096196 | D | 0.10884 | -0.012644 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1922 | L | 0.302124 | P | 0.443298 | -0.141174 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1942 | C | 0.511404 | G | 0.636577 | -0.125173 | No Change: Both D | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1967 | G | 0.136866 | S | 0.175152 | -0.038286 | No Change: Both O | - |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1970 | P | 0.157101 | S | 0.168813 | -0.011712 | No Change: Both O | Limb-girdle muscular dystrophy type 2B (LGMD2B) [MIM:253601] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 2068 | P | 0.053135 | L | 0.026037 | 0.027098 | No Change: Both O | Miyoshi muscular dystrophy type 1 (MMD1) [MIM:254130] |
| O75923 | DYSF_HUMAN Dysferlin OS=Homo sapiens GN=DYSF PE=1 SV=1 | 1096 | R | 0.516386 | H | 0.457204 | 0.059182 | D to O | - |
| A2CJ06 | DYTN_HUMAN Dystrotelin OS=Homo sapiens GN=DYTN PE=2 SV=1 | 241 | Y | 0.107737 | C | 0.194654 | -0.086917 | No Change: Both O | - |
| A2CJ06 | DYTN_HUMAN Dystrotelin OS=Homo sapiens GN=DYTN PE=2 SV=1 | 474 | Q | 0.896688 | K | 0.897041 | -3.53E-04 | No Change: Both D | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 2 | P | 0.781045 | S | 0.806654 | -0.025609 | No Change: Both D | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 91 | V | 0.471583 | I | 0.458481 | 0.013102 | No Change: Both O | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 191 | E | 0.959216 | G | 0.941547 | 0.017669 | No Change: Both D | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 420 | S | 0.712616 | C | 0.703125 | 0.009491 | No Change: Both D | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 38 | N | 0.12501 | K | 0.1487 | -0.02369 | No Change: Both O | - |
| Q8WXU2 | DYXC1_HUMAN Dyslexia susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=DYX1C1 PE=1 SV=2 | 332 | A | 0.191994 | V | 0.120776 | 0.071218 | No Change: Both O | - |
| Q86YF9 | DZIP1_HUMAN Zinc finger protein DZIP1 OS=Homo sapiens GN=DZIP1 PE=1 SV=1 | 736 | P | 0.939554 | S | 0.934836 | 0.004718 | No Change: Both D | - |
| Q86YF9 | DZIP1_HUMAN Zinc finger protein DZIP1 OS=Homo sapiens GN=DZIP1 PE=1 SV=1 | 172 | T | 0.785649 | M | 0.774182 | 0.011467 | No Change: Both D | - |
| Q86YF9 | DZIP1_HUMAN Zinc finger protein DZIP1 OS=Homo sapiens GN=DZIP1 PE=1 SV=1 | 664 | M | 0.913333 | L | 0.892864 | 0.020469 | No Change: Both D | - |
| Q8IYY4 | DZI1L_HUMAN Zinc finger protein DZIP1L OS=Homo sapiens GN=DZIP1L PE=2 SV=2 | 321 | R | 0.919416 | W | 0.831929 | 0.087487 | No Change: Both D | - |
| Q8IYY4 | DZI1L_HUMAN Zinc finger protein DZIP1L OS=Homo sapiens GN=DZIP1L PE=2 SV=2 | 545 | T | 0.965627 | A | 0.960762 | 0.004865 | No Change: Both D | - |
| Q8IYY4 | DZI1L_HUMAN Zinc finger protein DZIP1L OS=Homo sapiens GN=DZIP1L PE=2 SV=2 | 551 | A | 0.971693 | V | 0.967612 | 0.004081 | No Change: Both D | - |
| Q8IYY4 | DZI1L_HUMAN Zinc finger protein DZIP1L OS=Homo sapiens GN=DZIP1L PE=2 SV=2 | 593 | R | 0.99747 | H | 0.997443 | 2.70E-05 | No Change: Both D | - |
| Q8IYY4 | DZI1L_HUMAN Zinc finger protein DZIP1L OS=Homo sapiens GN=DZIP1L PE=2 SV=2 | 645 | K | 0.949832 | E | 0.95558 | -0.005748 | No Change: Both D | - |
| Q01094 | E2F1_HUMAN Transcription factor E2F1 OS=Homo sapiens GN=E2F1 PE=1 SV=1 | 252 | R | 0.367475 | H | 0.324853 | 0.042622 | No Change: Both O | - |
| Q01094 | E2F1_HUMAN Transcription factor E2F1 OS=Homo sapiens GN=E2F1 PE=1 SV=1 | 276 | V | 0.590783 | M | 0.661994 | -0.071211 | No Change: Both D | - |
| Q01094 | E2F1_HUMAN Transcription factor E2F1 OS=Homo sapiens GN=E2F1 PE=1 SV=1 | 311 | T | 0.888896 | N | 0.884555 | 0.004341 | No Change: Both D | - |
| Q01094 | E2F1_HUMAN Transcription factor E2F1 OS=Homo sapiens GN=E2F1 PE=1 SV=1 | 393 | G | 0.609293 | S | 0.694932 | -0.085639 | No Change: Both D | - |
| Q01094 | E2F1_HUMAN Transcription factor E2F1 OS=Homo sapiens GN=E2F1 PE=1 SV=1 | 200 | G | 0.468954 | S | 0.504628 | -0.035674 | O to D | - |
| Q14209 | E2F2_HUMAN Transcription factor E2F2 OS=Homo sapiens GN=E2F2 PE=1 SV=1 | 205 | G | 0.73463 | R | 0.742741 | -0.008111 | No Change: Both D | - |
| Q14209 | E2F2_HUMAN Transcription factor E2F2 OS=Homo sapiens GN=E2F2 PE=1 SV=1 | 226 | Q | 0.461693 | H | 0.381887 | 0.079806 | No Change: Both O | - |
| O00716 | E2F3_HUMAN Transcription factor E2F3 OS=Homo sapiens GN=E2F3 PE=1 SV=1 | 344 | G | 0.497556 | R | 0.531686 | -0.03413 | O to D | - |
| O00716 | E2F3_HUMAN Transcription factor E2F3 OS=Homo sapiens GN=E2F3 PE=1 SV=1 | 389 | D | 0.907127 | N | 0.911719 | -0.004592 | No Change: Both D | - |
| Q16254 | E2F4_HUMAN Transcription factor E2F4 OS=Homo sapiens GN=E2F4 PE=1 SV=2 | 293 | T | 0.978611 | P | 0.983 | -0.004389 | No Change: Both D | - |
| Q15329 | E2F5_HUMAN Transcription factor E2F5 OS=Homo sapiens GN=E2F5 PE=1 SV=1 | 18 | G | 0.999754 | A | 0.99975 | 4.00E-06 | No Change: Both D | - |
| Q96AV8 | E2F7_HUMAN Transcription factor E2F7 OS=Homo sapiens GN=E2F7 PE=1 SV=3 | 72 | F | 0.6901 | L | 0.717743 | -0.027643 | No Change: Both D | - |
| Q96AV8 | E2F7_HUMAN Transcription factor E2F7 OS=Homo sapiens GN=E2F7 PE=1 SV=3 | 626 | M | 0.920712 | V | 0.892199 | 0.028513 | No Change: Both D | - |
| Q96AV8 | E2F7_HUMAN Transcription factor E2F7 OS=Homo sapiens GN=E2F7 PE=1 SV=3 | 854 | H | 0.801392 | Q | 0.83265 | -0.031258 | No Change: Both D | - |
| A0AVK6 | E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens GN=E2F8 PE=1 SV=1 | 674 | I | 0.442669 | V | 0.468742 | -0.026073 | No Change: Both O | - |
| Q66K89 | E4F1_HUMAN Transcription factor E4F1 OS=Homo sapiens GN=E4F1 PE=1 SV=2 | 167 | R | 0.740258 | H | 0.733138 | 0.00712 | No Change: Both D | - |
| Q66K89 | E4F1_HUMAN Transcription factor E4F1 OS=Homo sapiens GN=E4F1 PE=1 SV=2 | 355 | V | 0.789972 | I | 0.766221 | 0.023751 | No Change: Both D | - |
| Q56P03 | EAPP_HUMAN E2F-associated phosphoprotein OS=Homo sapiens GN=EAPP PE=1 SV=4 | 168 | Q | 0.796421 | E | 0.771114 | 0.025307 | No Change: Both D | - |
| Q5JPH6 | SYEM_HUMAN Probable glutamate--tRNA ligase mitochondrial OS=Homo sapiens GN=EARS2 PE=1 SV=2 | 457 | S | 0.558773 | G | 0.496354 | 0.062419 | D to O | - |
| Q9HAK2 | COE2_HUMAN Transcription factor COE2 OS=Homo sapiens GN=EBF2 PE=1 SV=4 | 559 | G | 0.859224 | S | 0.891206 | -0.031982 | No Change: Both D | - |
| Q14213 | IL27B_HUMAN Interleukin-27 subunit beta OS=Homo sapiens GN=EBI3 PE=1 SV=2 | 201 | V | 0.168363 | I | 0.138587 | 0.029776 | No Change: Both O | - |
| Q14213 | IL27B_HUMAN Interleukin-27 subunit beta OS=Homo sapiens GN=EBI3 PE=1 SV=2 | 174 | A | 0.29933 | V | 0.226464 | 0.072866 | No Change: Both O | - |
| Q99848 | EBP2_HUMAN Probable rRNA-processing protein EBP2 OS=Homo sapiens GN=EBNA1BP2 PE=1 SV=2 | 223 | R | 0.927969 | H | 0.913468 | 0.014501 | No Change: Both D | - |
| Q15125 | EBP_HUMAN 3-beta-hydroxysteroid-Delta(8) Delta(7)-isomerase OS=Homo sapiens GN=EBP PE=1 SV=3 | 80 | E | 0.016801 | K | 0.016217 | 5.84E-04 | No Change: Both O | Chondrodysplasia punctata X-linked dominant type 2 (CDPX2) [MIM:302960] |
| Q15125 | EBP_HUMAN 3-beta-hydroxysteroid-Delta(8) Delta(7)-isomerase OS=Homo sapiens GN=EBP PE=1 SV=3 | 110 | R | 0.288324 | Q | 0.307549 | -0.019225 | No Change: Both O | Chondrodysplasia punctata X-linked dominant type 2 (CDPX2) [MIM:302960] |
| Q15125 | EBP_HUMAN 3-beta-hydroxysteroid-Delta(8) Delta(7)-isomerase OS=Homo sapiens GN=EBP PE=1 SV=3 | 147 | R | 0.074462 | G | 0.073642 | 8.20E-04 | No Change: Both O | Chondrodysplasia punctata X-linked dominant type 2 (CDPX2) [MIM:302960] |
| Q15125 | EBP_HUMAN 3-beta-hydroxysteroid-Delta(8) Delta(7)-isomerase OS=Homo sapiens GN=EBP PE=1 SV=3 | 147 | R | 0.074462 | H | 0.075658 | -0.001196 | No Change: Both O | Chondrodysplasia punctata X-linked dominant type 2 (CDPX2) [MIM:302960] |
| Q587J8 | ECAT1_HUMAN ES cell-associated transcript 1 protein OS=Homo sapiens GN=ECAT1 PE=2 SV=1 | 97 | E | 0.352792 | Q | 0.326878 | 0.025914 | No Change: Both O | - |
| Q587J8 | ECAT1_HUMAN ES cell-associated transcript 1 protein OS=Homo sapiens GN=ECAT1 PE=2 SV=1 | 201 | A | 0.924105 | G | 0.918478 | 0.005627 | No Change: Both D | - |
| O95905 | SGT1_HUMAN Protein SGT1 OS=Homo sapiens GN=ECD PE=1 SV=1 | 281 | R | 0.510766 | G | 0.499558 | 0.011208 | D to O | - |
| O95905 | SGT1_HUMAN Protein SGT1 OS=Homo sapiens GN=ECD PE=1 SV=1 | 45 | R | 0.06642 | Q | 0.069219 | -0.002799 | No Change: Both O | - |
| O95905 | SGT1_HUMAN Protein SGT1 OS=Homo sapiens GN=ECD PE=1 SV=1 | 452 | E | 0.856302 | Q | 0.830662 | 0.02564 | No Change: Both D | - |
| O95905 | SGT1_HUMAN Protein SGT1 OS=Homo sapiens GN=ECD PE=1 SV=1 | 501 | N | 0.895178 | S | 0.918634 | -0.023456 | No Change: Both D | - |
| O95905 | SGT1_HUMAN Protein SGT1 OS=Homo sapiens GN=ECD PE=1 SV=1 | 634 | D | 0.856945 | G | 0.847588 | 0.009357 | No Change: Both D | - |
| P42892 | ECE1_HUMAN Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1 PE=1 SV=2 | 341 | T | 0.186007 | I | 0.108507 | 0.0775 | No Change: Both O | - |
| P42892 | ECE1_HUMAN Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1 PE=1 SV=2 | 754 | R | 0.885785 | C | 0.836803 | 0.048982 | No Change: Both D | Hirschsprung disease cardiac defects and autonomic dysfunction (HSCRCDAD) [MIM:613870] |
| P42892 | ECE1_HUMAN Endothelin-converting enzyme 1 OS=Homo sapiens GN=ECE1 PE=1 SV=2 | 630 | W | 0.282877 | R | 0.497969 | -0.215092 | No Change: Both O | - |
| O60344 | ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens GN=ECE2 PE=1 SV=4 | 571 | R | 0.416992 | Q | 0.450985 | -0.033993 | No Change: Both O | - |
| O60344 | ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens GN=ECE2 PE=1 SV=4 | 101 | H | 0.321981 | Y | 0.199595 | 0.122386 | No Change: Both O | - |
| O95672 | ECEL1_HUMAN Endothelin-converting enzyme-like 1 OS=Homo sapiens GN=ECEL1 PE=2 SV=3 | 10 | H | 0.31298 | Q | 0.37644 | -0.06346 | No Change: Both O | - |
| O95672 | ECEL1_HUMAN Endothelin-converting enzyme-like 1 OS=Homo sapiens GN=ECEL1 PE=2 SV=3 | 328 | H | 0.524585 | Y | 0.402512 | 0.122073 | D to O | - |
| Q13011 | ECH1_HUMAN Delta(3 5)-Delta(2 4)-dienoyl-CoA isomerase mitochondrial OS=Homo sapiens GN=ECH1 PE=1 SV=2 | 41 | E | 0.753148 | A | 0.694899 | 0.058249 | No Change: Both D | - |
| Q13011 | ECH1_HUMAN Delta(3 5)-Delta(2 4)-dienoyl-CoA isomerase mitochondrial OS=Homo sapiens GN=ECH1 PE=1 SV=2 | 217 | G | 0.262786 | R | 0.264175 | -0.001389 | No Change: Both O | - |
| Q86YB7 | ECHD2_HUMAN Enoyl-CoA hydratase domain-containing protein 2 mitochondrial OS=Homo sapiens GN=ECHDC2 PE=2 SV=2 | 119 | N | 0.178339 | D | 0.211228 | -0.032889 | No Change: Both O | - |
| Q96DC8 | ECHD3_HUMAN Enoyl-CoA hydratase domain-containing protein 3 mitochondrial OS=Homo sapiens GN=ECHDC3 PE=1 SV=2 | 69 | A | 0.627784 | T | 0.620371 | 0.007413 | No Change: Both D | - |
| Q96DC8 | ECHD3_HUMAN Enoyl-CoA hydratase domain-containing protein 3 mitochondrial OS=Homo sapiens GN=ECHDC3 PE=1 SV=2 | 151 | A | 0.141285 | T | 0.140108 | 0.001177 | No Change: Both O | - |
| Q96DC8 | ECHD3_HUMAN Enoyl-CoA hydratase domain-containing protein 3 mitochondrial OS=Homo sapiens GN=ECHDC3 PE=1 SV=2 | 162 | D | 0.188786 | N | 0.172607 | 0.016179 | No Change: Both O | - |
| P30084 | ECHM_HUMAN Enoyl-CoA hydratase mitochondrial OS=Homo sapiens GN=ECHS1 PE=1 SV=4 | 11 | V | 0.259425 | A | 0.347088 | -0.087663 | No Change: Both O | - |
| P30084 | ECHM_HUMAN Enoyl-CoA hydratase mitochondrial OS=Homo sapiens GN=ECHS1 PE=1 SV=4 | 75 | T | 0.391023 | I | 0.265979 | 0.125044 | No Change: Both O | - |
| O75521 | ECI2_HUMAN Enoyl-CoA delta isomerase 2 mitochondrial OS=Homo sapiens GN=ECI2 PE=1 SV=4 | 47 | M | 0.602962 | I | 0.453978 | 0.148984 | D to O | - |
| O75521 | ECI2_HUMAN Enoyl-CoA delta isomerase 2 mitochondrial OS=Homo sapiens GN=ECI2 PE=1 SV=4 | 344 | A | 0.370953 | V | 0.294675 | 0.076278 | No Change: Both O | - |
| Q16610 | ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2 | 415 | G | 0.216541 | S | 0.244257 | -0.027716 | No Change: Both O | - |
| Q16610 | ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2 | 528 | G | 0.866323 | R | 0.858403 | 0.00792 | No Change: Both D | - |
| Q16610 | ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2 | 535 | S | 0.956777 | F | 0.905779 | 0.050998 | No Change: Both D | - |
| Q16610 | ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2 | 130 | T | 0.967878 | M | 0.969257 | -0.001379 | No Change: Both D | - |
| Q16610 | ECM1_HUMAN Extracellular matrix protein 1 OS=Homo sapiens GN=ECM1 PE=1 SV=2 | 167 | F | 0.785388 | I | 0.797993 | -0.012605 | No Change: Both D | Lipoid proteinosis (LiP) [MIM:247100] |
| O94769 | ECM2_HUMAN Extracellular matrix protein 2 OS=Homo sapiens GN=ECM2 PE=2 SV=1 | 56 | Q | 0.472233 | P | 0.489677 | -0.017444 | No Change: Both O | - |
| O94769 | ECM2_HUMAN Extracellular matrix protein 2 OS=Homo sapiens GN=ECM2 PE=2 SV=1 | 109 | T | 0.164784 | S | 0.227794 | -0.06301 | No Change: Both O | - |
| O94769 | ECM2_HUMAN Extracellular matrix protein 2 OS=Homo sapiens GN=ECM2 PE=2 SV=1 | 204 | R | 0.920053 | Q | 0.924693 | -0.00464 | No Change: Both D | - |
| Q5VYK3 | ECM29_HUMAN Proteasome-associated protein ECM29 homolog OS=Homo sapiens GN=ECM29 PE=1 SV=2 | 472 | T | 0.35671 | S | 0.435369 | -0.078659 | No Change: Both O | - |
| Q9BQ95 | ECSIT_HUMAN Evolutionarily conserved signaling intermediate in Toll pathway mitochondrial OS=Homo sapiens GN=ECSIT PE=1 SV=1 | 278 | R | 0.474054 | C | 0.310098 | 0.163956 | No Change: Both O | - |
| Q9BQ95 | ECSIT_HUMAN Evolutionarily conserved signaling intermediate in Toll pathway mitochondrial OS=Homo sapiens GN=ECSIT PE=1 SV=1 | 406 | G | 0.857013 | R | 0.875168 | -0.018155 | No Change: Both D | - |
| Q9H8V3 | ECT2_HUMAN Protein ECT2 OS=Homo sapiens GN=ECT2 PE=1 SV=4 | 833 | T | 0.887215 | P | 0.898007 | -0.010792 | No Change: Both D | A breast cancer sample |
| Q9H8V3 | ECT2_HUMAN Protein ECT2 OS=Homo sapiens GN=ECT2 PE=1 SV=4 | 15 | S | 0.717954 | T | 0.650367 | 0.067587 | No Change: Both D | - |
| Q008S8 | ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens GN=ECT2L PE=2 SV=2 | 527 | E | 0.755996 | K | 0.745653 | 0.010343 | No Change: Both D | - |
| Q008S8 | ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens GN=ECT2L PE=2 SV=2 | 594 | A | 0.162493 | T | 0.164628 | -0.002135 | No Change: Both O | - |
| Q008S8 | ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens GN=ECT2L PE=2 SV=2 | 483 | Q | 0.39643 | H | 0.362271 | 0.034159 | No Change: Both O | - |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 61 | Y | 0.43371 | H | 0.562482 | -0.128772 | O to D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 63 | E | 0.516496 | K | 0.45694 | 0.059556 | D to O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 69 | R | 0.744375 | L | 0.677302 | 0.067073 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 155 | R | 0.947774 | C | 0.917408 | 0.030366 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 156 | R | 0.953657 | C | 0.926356 | 0.027301 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 156 | R | 0.953657 | H | 0.938572 | 0.015085 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 209 | P | 0.999418 | L | 0.998686 | 7.32E-04 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 224 | G | 0.995867 | A | 0.994939 | 9.28E-04 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 252 | H | 0.550035 | L | 0.534555 | 0.01548 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 299 | G | 0.084005 | S | 0.10992 | -0.025915 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 349 | A | 0.066864 | T | 0.080824 | -0.01396 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 356 | A | 0.144074 | D | 0.186172 | -0.042098 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 357 | R | 0.171559 | P | 0.197846 | -0.026287 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 54 | H | 0.310837 | Y | 0.262024 | 0.048813 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 55 | L | 0.314597 | R | 0.393883 | -0.079286 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 291 | G | 0.451291 | R | 0.445638 | 0.005653 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 291 | G | 0.451291 | W | 0.21806 | 0.233231 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 298 | D | 0.096505 | H | 0.081444 | 0.015061 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 255 | G | 0.469149 | C | 0.345177 | 0.123972 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 255 | G | 0.469149 | D | 0.484094 | -0.014945 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 274 | W | 0.223707 | G | 0.464605 | -0.240898 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 332 | C | 0.213938 | Y | 0.258925 | -0.044987 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 60 | C | 0.37681 | R | 0.462744 | -0.085934 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 252 | H | 0.550035 | Y | 0.46941 | 0.080625 | D to O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 269 | G | 0.273102 | V | 0.178276 | 0.094826 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 302 | F | 0.055886 | S | 0.158479 | -0.102593 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 378 | T | 0.202487 | M | 0.173047 | 0.02944 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 65 | R | 0.602857 | G | 0.584843 | 0.018014 | No Change: Both D | Tooth agenesis selective X-linked type 1 (STHAGX1) [MIM:313500] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 118 | P | 0.93309 | L | 0.883409 | 0.049681 | No Change: Both D | A colorectal cancer sample |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 153 | R | 0.929651 | C | 0.88947 | 0.040181 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 156 | R | 0.953657 | S | 0.95674 | -0.003083 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 158 | K | 0.962895 | N | 0.959999 | 0.002896 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 189 | G | 0.999801 | E | 0.999767 | 3.40E-05 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 198 | G | 0.999859 | A | 0.99979 | 6.90E-05 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 207 | G | 0.999581 | R | 0.999445 | 1.36E-04 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 218 | G | 0.997578 | D | 0.997272 | 3.06E-04 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 298 | D | 0.096505 | Y | 0.051223 | 0.045282 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 306 | Q | 0.065782 | H | 0.060695 | 0.005087 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 307 | V | 0.06359 | G | 0.112879 | -0.049289 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 320 | Y | 0.159768 | C | 0.127795 | 0.031973 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 343 | Y | 0.341852 | C | 0.29415 | 0.047702 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 358 | Q | 0.198854 | E | 0.235488 | -0.036634 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 360 | I | 0.226222 | N | 0.386935 | -0.160713 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 372 | N | 0.445768 | D | 0.484369 | -0.038601 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 373 | M | 0.427956 | I | 0.344014 | 0.083942 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 374 | S | 0.371139 | R | 0.287671 | 0.083468 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 378 | T | 0.202487 | P | 0.233682 | -0.031195 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 156 | R | 0.953657 | G | 0.942304 | 0.011353 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 207 | G | 0.999581 | V | 0.999275 | 3.06E-04 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 211 | T | 0.999178 | R | 0.999168 | 1.00E-05 | No Change: Both D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 266 | L | 0.352278 | R | 0.44859 | -0.096312 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 274 | W | 0.223707 | R | 0.446676 | -0.222969 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 293 | L | 0.422295 | P | 0.597621 | -0.175326 | O to D | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 296 | L | 0.197743 | V | 0.203504 | -0.005761 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 299 | G | 0.084005 | D | 0.098388 | -0.014383 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 323 | V | 0.199844 | G | 0.305289 | -0.105445 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 338 | T | 0.47264 | M | 0.394473 | 0.078167 | No Change: Both O | Tooth agenesis selective X-linked type 1 (STHAGX1) [MIM:313500] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 346 | C | 0.144309 | Y | 0.180958 | -0.036649 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 356 | A | 0.144074 | V | 0.104641 | 0.039433 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q92838 | EDA_HUMAN Ectodysplasin-A OS=Homo sapiens GN=EDA PE=1 SV=2 | 381 | G | 0.176328 | R | 0.172106 | 0.004222 | No Change: Both O | Ectodermal dysplasia type 1 (ED1) [MIM:305100] |
| Q9HAV5 | TNR27_HUMAN Tumor necrosis factor receptor superfamily member 27 OS=Homo sapiens GN=EDA2R PE=1 SV=2 | 57 | R | 0.264254 | K | 0.313727 | -0.049473 | No Change: Both O | - |
| Q9HAV5 | TNR27_HUMAN Tumor necrosis factor receptor superfamily member 27 OS=Homo sapiens GN=EDA2R PE=1 SV=2 | 129 | T | 0.54664 | A | 0.516388 | 0.030252 | No Change: Both D | - |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 87 | C | 0.314692 | R | 0.442426 | -0.127734 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 89 | R | 0.330262 | H | 0.297776 | 0.032486 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 420 | R | 0.177656 | Q | 0.204002 | -0.026346 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 420 | R | 0.177656 | Q | 0.204002 | -0.026346 | No Change: Both O | Ectodermal dysplasia type 3 (ED3) [MIM:129490] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 370 | V | 0.367389 | A | 0.436174 | -0.068785 | No Change: Both O | - |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 47 | C | 0.749355 | Y | 0.699479 | 0.049876 | No Change: Both D | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 110 | D | 0.52523 | A | 0.444198 | 0.081032 | D to O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 148 | C | 0.540338 | R | 0.64117 | -0.100832 | No Change: Both D | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 375 | R | 0.218002 | H | 0.207973 | 0.010029 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 377 | L | 0.215527 | F | 0.197717 | 0.01781 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 382 | G | 0.360329 | S | 0.414751 | -0.054422 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 403 | T | 0.204467 | M | 0.177955 | 0.026512 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 413 | T | 0.147015 | P | 0.192674 | -0.045659 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 418 | I | 0.173486 | T | 0.29642 | -0.122934 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 434 | W | 0.10509 | C | 0.167566 | -0.062476 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 98 | R | 0.245596 | Q | 0.233673 | 0.011923 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 358 | R | 0.516346 | Q | 0.537154 | -0.020808 | No Change: Both D | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 408 | I | 0.253295 | F | 0.245177 | 0.008118 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9UNE0 | EDAR_HUMAN Tumor necrosis factor receptor superfamily member EDAR OS=Homo sapiens GN=EDAR PE=1 SV=1 | 434 | W | 0.10509 | R | 0.266266 | -0.161176 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q8WWZ3 | EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein OS=Homo sapiens GN=EDARADD PE=1 SV=3 | 152 | E | 0.166334 | K | 0.162024 | 0.00431 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q8WWZ3 | EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein OS=Homo sapiens GN=EDARADD PE=1 SV=3 | 9 | M | 0.917866 | I | 0.817929 | 0.099937 | No Change: Both D | - |
| Q8WWZ3 | EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein OS=Homo sapiens GN=EDARADD PE=1 SV=3 | 103 | S | 0.658943 | F | 0.461033 | 0.19791 | D to O | - |
| Q8WWZ3 | EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein OS=Homo sapiens GN=EDARADD PE=1 SV=3 | 122 | L | 0.223113 | R | 0.313198 | -0.090085 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q8WWZ3 | EDAD_HUMAN Ectodysplasin-A receptor-associated adapter protein OS=Homo sapiens GN=EDARADD PE=1 SV=3 | 114 | D | 0.444464 | Y | 0.246114 | 0.19835 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q14507 | EP3A_HUMAN Epididymal secretory protein E3-alpha OS=Homo sapiens GN=EDDM3A PE=2 SV=2 | 62 | G | 0.457548 | C | 0.303913 | 0.153635 | No Change: Both O | - |
| P56851 | EP3B_HUMAN Epididymal secretory protein E3-beta OS=Homo sapiens GN=EDDM3B PE=2 SV=2 | 5 | L | 0.516301 | V | 0.502416 | 0.013885 | No Change: Both D | - |
| Q9BV94 | EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like 2 OS=Homo sapiens GN=EDEM2 PE=1 SV=2 | 456 | A | 0.196819 | T | 0.237411 | -0.040592 | No Change: Both O | - |
| Q9BV94 | EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like 2 OS=Homo sapiens GN=EDEM2 PE=1 SV=2 | 510 | R | 0.680576 | Q | 0.682888 | -0.002312 | No Change: Both D | - |
| Q9BV94 | EDEM2_HUMAN ER degradation-enhancing alpha-mannosidase-like 2 OS=Homo sapiens GN=EDEM2 PE=1 SV=2 | 556 | L | 0.822 | F | 0.802635 | 0.019365 | No Change: Both D | - |
| Q9BZQ6 | EDEM3_HUMAN ER degradation-enhancing alpha-mannosidase-like 3 OS=Homo sapiens GN=EDEM3 PE=1 SV=2 | 820 | I | 0.997788 | S | 0.999176 | -0.001388 | No Change: Both D | - |
| P05305 | EDN1_HUMAN Endothelin-1 OS=Homo sapiens GN=EDN1 PE=1 SV=1 | 198 | K | 0.820726 | N | 0.781472 | 0.039254 | No Change: Both D | - |
| P05305 | EDN1_HUMAN Endothelin-1 OS=Homo sapiens GN=EDN1 PE=1 SV=1 | 186 | V | 0.882807 | I | 0.866694 | 0.016113 | No Change: Both D | - |
| P20800 | EDN2_HUMAN Endothelin-2 OS=Homo sapiens GN=EDN2 PE=1 SV=2 | 168 | P | 0.893602 | L | 0.85114 | 0.042462 | No Change: Both D | - |
| P20800 | EDN2_HUMAN Endothelin-2 OS=Homo sapiens GN=EDN2 PE=1 SV=2 | 131 | F | 0.616142 | L | 0.653379 | -0.037237 | No Change: Both D | - |
| P14138 | EDN3_HUMAN Endothelin-3 OS=Homo sapiens GN=EDN3 PE=1 SV=1 | 159 | C | 0.345669 | F | 0.285439 | 0.06023 | No Change: Both O | Waardenburg syndrome type 4 (WS4B) [MIM:613265] |
| P14138 | EDN3_HUMAN Endothelin-3 OS=Homo sapiens GN=EDN3 PE=1 SV=1 | 17 | A | 0.305593 | T | 0.334878 | -0.029285 | No Change: Both O | Hirschsprung disease type 4 (HSCR4) [MIM:613712] |
| P14138 | EDN3_HUMAN Endothelin-3 OS=Homo sapiens GN=EDN3 PE=1 SV=1 | 224 | A | 0.714193 | T | 0.729245 | -0.015052 | No Change: Both D | Hirschsprung disease type 4 (HSCR4) [MIM:613712] |
| P14138 | EDN3_HUMAN Endothelin-3 OS=Homo sapiens GN=EDN3 PE=1 SV=1 | 127 | Y | 0.368863 | C | 0.301984 | 0.066879 | No Change: Both O | Waardenburg syndrome type 4 (WS4B) [MIM:613265] |
| P25101 | EDNRA_HUMAN Endothelin-1 receptor OS=Homo sapiens GN=EDNRA PE=1 SV=1 | 136 | I | 0.037384 | L | 0.044473 | -0.007089 | No Change: Both O | A breast cancer sample |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 57 | G | 0.813691 | S | 0.855582 | -0.041891 | No Change: Both D | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 183 | A | 0.144483 | G | 0.194274 | -0.049791 | No Change: Both O | Waardenburg syndrome type 4A (WS4A) [MIM:277580] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 276 | W | 0.027609 | C | 0.031442 | -0.003833 | No Change: Both O | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 305 | S | 0.476376 | N | 0.437555 | 0.038821 | No Change: Both O | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 319 | R | 0.420565 | W | 0.206123 | 0.214442 | No Change: Both O | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 374 | M | 0.131726 | I | 0.097497 | 0.034229 | No Change: Both O | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 383 | P | 0.099218 | L | 0.055827 | 0.043391 | No Change: Both O | Hirschsprung disease type 2 (HSCR2) [MIM:600155] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 7 | L | 0.445462 | Q | 0.547122 | -0.10166 | O to D | - |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 17 | L | 0.157664 | F | 0.118091 | 0.039573 | No Change: Both O | - |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 112 | F | 0.023715 | V | 0.030452 | -0.006737 | No Change: Both O | - |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 244 | T | 0.128898 | M | 0.112949 | 0.015949 | No Change: Both O | - |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 292 | F | 0.027269 | L | 0.032305 | -0.005036 | No Change: Both O | Waardenburg syndrome type 4A (WS4A) [MIM:277580] |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 5 | P | 0.576488 | T | 0.562885 | 0.013603 | No Change: Both D | - |
| P24530 | EDNRB_HUMAN Endothelin B receptor OS=Homo sapiens GN=EDNRB PE=1 SV=1 | 76 | R | 0.867334 | M | 0.837714 | 0.02962 | No Change: Both D | - |
| Q3B7T1 | EDRF1_HUMAN Erythroid differentiation-related factor 1 OS=Homo sapiens GN=EDRF1 PE=1 SV=1 | 45 | N | 0.720753 | S | 0.802839 | -0.082086 | No Change: Both D | A colorectal cancer sample |
| Q3B7T1 | EDRF1_HUMAN Erythroid differentiation-related factor 1 OS=Homo sapiens GN=EDRF1 PE=1 SV=1 | 95 | L | 0.562632 | F | 0.541734 | 0.020898 | No Change: Both D | A colorectal cancer sample |
| Q15075 | EEA1_HUMAN Early endosome antigen 1 OS=Homo sapiens GN=EEA1 PE=1 SV=2 | 810 | K | 0.96426 | Q | 0.961633 | 0.002627 | No Change: Both D | - |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 23 | H | 0.882525 | R | 0.915039 | -0.032514 | No Change: Both D | - |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 75 | P | 0.732875 | A | 0.700531 | 0.032344 | No Change: Both D | - |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 291 | T | 0.576723 | M | 0.50038 | 0.076343 | No Change: Both D | A colorectal adenocarcinoma sample |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 433 | R | 0.926653 | W | 0.867777 | 0.058876 | No Change: Both D | - |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 609 | D | 0.394598 | H | 0.353918 | 0.04068 | No Change: Both O | - |
| O00418 | EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens GN=EEF2K PE=1 SV=2 | 361 | Q | 0.867203 | R | 0.878423 | -0.01122 | No Change: Both D | - |
| P57772 | SELB_HUMAN Selenocysteine-specific elongation factor OS=Homo sapiens GN=EEFSEC PE=1 SV=4 | 435 | A | 0.262418 | V | 0.203351 | 0.059067 | No Change: Both O | - |
| Q7L9B9 | EEPD1_HUMAN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Homo sapiens GN=EEPD1 PE=1 SV=2 | 358 | A | 0.416861 | S | 0.495688 | -0.078827 | No Change: Both O | - |
| Q7L9B9 | EEPD1_HUMAN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Homo sapiens GN=EEPD1 PE=1 SV=2 | 416 | P | 0.795373 | S | 0.820617 | -0.025244 | No Change: Both D | - |
| Q7L9B9 | EEPD1_HUMAN Endonuclease/exonuclease/phosphatase family domain-containing protein 1 OS=Homo sapiens GN=EEPD1 PE=1 SV=2 | 343 | S | 0.551194 | N | 0.513087 | 0.038107 | No Change: Both D | - |
| Q9BUY7 | EFC11_HUMAN EF-hand calcium-binding domain-containing protein 11 OS=Homo sapiens GN=EFCAB11 PE=2 SV=1 | 15 | A | 0.718696 | V | 0.661381 | 0.057315 | No Change: Both D | - |
| Q9BUY7 | EFC11_HUMAN EF-hand calcium-binding domain-containing protein 11 OS=Homo sapiens GN=EFCAB11 PE=2 SV=1 | 31 | D | 0.36491 | G | 0.333784 | 0.031126 | No Change: Both O | - |
| Q9BUY7 | EFC11_HUMAN EF-hand calcium-binding domain-containing protein 11 OS=Homo sapiens GN=EFCAB11 PE=2 SV=1 | 45 | T | 0.176299 | A | 0.170489 | 0.00581 | No Change: Both O | - |
| Q8N7B9 | EFCB3_HUMAN EF-hand calcium-binding domain-containing protein 3 OS=Homo sapiens GN=EFCAB3 PE=1 SV=1 | 341 | G | 0.228411 | R | 0.243613 | -0.015202 | No Change: Both O | - |
| Q8N7B9 | EFCB3_HUMAN EF-hand calcium-binding domain-containing protein 3 OS=Homo sapiens GN=EFCAB3 PE=1 SV=1 | 364 | M | 0.438692 | I | 0.358242 | 0.08045 | No Change: Both O | - |
| Q8N7B9 | EFCB3_HUMAN EF-hand calcium-binding domain-containing protein 3 OS=Homo sapiens GN=EFCAB3 PE=1 SV=1 | 370 | S | 0.519258 | A | 0.372195 | 0.147063 | D to O | - |
| Q8N4Y2 | EFC4A_HUMAN EF-hand calcium-binding domain-containing protein 4A OS=Homo sapiens GN=EFCAB4A PE=2 SV=3 | 77 | R | 0.295646 | Q | 0.314501 | -0.018855 | No Change: Both O | - |
| Q8N4Y2 | EFC4A_HUMAN EF-hand calcium-binding domain-containing protein 4A OS=Homo sapiens GN=EFCAB4A PE=2 SV=3 | 153 | K | 0.418065 | E | 0.48946 | -0.071395 | No Change: Both O | - |
| Q8N4Y2 | EFC4A_HUMAN EF-hand calcium-binding domain-containing protein 4A OS=Homo sapiens GN=EFCAB4A PE=2 SV=3 | 173 | G | 0.500134 | S | 0.56025 | -0.060116 | No Change: Both D | - |
| Q8N4Y2 | EFC4A_HUMAN EF-hand calcium-binding domain-containing protein 4A OS=Homo sapiens GN=EFCAB4A PE=2 SV=3 | 248 | S | 0.991972 | I | 0.98116 | 0.010812 | No Change: Both D | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 7 | R | 0.938103 | G | 0.934624 | 0.003479 | No Change: Both D | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 98 | A | 0.384454 | T | 0.419861 | -0.035407 | No Change: Both O | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 128 | A | 0.745975 | V | 0.712763 | 0.033212 | No Change: Both D | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 136 | H | 0.77611 | P | 0.821614 | -0.045504 | No Change: Both D | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 154 | E | 0.863588 | K | 0.846741 | 0.016847 | No Change: Both D | - |
| Q9BSW2 | EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens GN=EFCAB4B PE=1 SV=1 | 212 | H | 0.667267 | Q | 0.710214 | -0.042947 | No Change: Both D | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 237 | L | 0.406804 | V | 0.416684 | -0.00988 | No Change: Both O | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 278 | K | 0.628504 | I | 0.415081 | 0.213423 | D to O | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 561 | R | 0.966704 | S | 0.972367 | -0.005663 | No Change: Both D | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 1145 | A | 0.133071 | D | 0.179293 | -0.046222 | No Change: Both O | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 1252 | V | 0.196895 | A | 0.253758 | -0.056863 | No Change: Both O | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 1274 | R | 0.123775 | T | 0.115711 | 0.008064 | No Change: Both O | - |
| A4FU69 | EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens GN=EFCAB5 PE=1 SV=2 | 1488 | D | 0.586299 | Y | 0.442077 | 0.144222 | D to O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 166 | V | 0.266627 | A | 0.319267 | -0.05264 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 199 | R | 0.204659 | G | 0.189502 | 0.015157 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 351 | T | 0.217996 | A | 0.193131 | 0.024865 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 384 | S | 0.829379 | A | 0.741439 | 0.08794 | No Change: Both D | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 400 | H | 0.605346 | Y | 0.468974 | 0.136372 | D to O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 680 | T | 0.387684 | A | 0.352379 | 0.035305 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 780 | D | 0.351853 | N | 0.337128 | 0.014725 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 800 | R | 0.254655 | W | 0.101705 | 0.15295 | No Change: Both O | - |
| Q5THR3 | EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens GN=EFCAB6 PE=1 SV=1 | 1059 | A | 0.619137 | V | 0.559241 | 0.059896 | No Change: Both D | - |
| A8K855 | EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens GN=EFCAB7 PE=2 SV=1 | 27 | F | 0.711616 | I | 0.702618 | 0.008998 | No Change: Both D | - |
| A8K855 | EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens GN=EFCAB7 PE=2 SV=1 | 186 | S | 0.575934 | G | 0.539168 | 0.036766 | No Change: Both D | - |
| A8K855 | EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens GN=EFCAB7 PE=2 SV=1 | 248 | T | 0.533867 | I | 0.369066 | 0.164801 | D to O | - |
| A8K855 | EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens GN=EFCAB7 PE=2 SV=1 | 262 | M | 0.48034 | T | 0.509574 | -0.029234 | O to D | - |
| A8K855 | EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens GN=EFCAB7 PE=2 SV=1 | 375 | R | 0.287285 | K | 0.35247 | -0.065185 | No Change: Both O | - |
| Q12805 | FBLN3_HUMAN EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1 PE=1 SV=2 | 220 | I | 0.286369 | F | 0.29761 | -0.011241 | No Change: Both O | - |
| Q12805 | FBLN3_HUMAN EGF-containing fibulin-like extracellular matrix protein 1 OS=Homo sapiens GN=EFEMP1 PE=1 SV=2 | 345 | R | 0.604742 | W | 0.385804 | 0.218938 | D to O | Doyne honeycomb retinal dystrophy (DHRD) [MIM:126600] |
| O95967 | FBLN4_HUMAN EGF-containing fibulin-like extracellular matrix protein 2 OS=Homo sapiens GN=EFEMP2 PE=1 SV=3 | 57 | E | 0.333025 | K | 0.315463 | 0.017562 | No Change: Both O | Cutis laxa autosomal recessive type 1 (ARCL1) [MIM:219100] |
| O95967 | FBLN4_HUMAN EGF-containing fibulin-like extracellular matrix protein 2 OS=Homo sapiens GN=EFEMP2 PE=1 SV=3 | 259 | I | 0.362739 | V | 0.34117 | 0.021569 | No Change: Both O | - |
| Q8IYU8 | EFHA1_HUMAN EF-hand domain-containing family member A1 OS=Homo sapiens GN=EFHA1 PE=1 SV=2 | 260 | Q | 0.526014 | L | 0.371874 | 0.15414 | D to O | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 331 | V | 0.212971 | I | 0.217798 | -0.004827 | No Change: Both O | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 382 | T | 0.536759 | I | 0.388093 | 0.148666 | D to O | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 663 | Q | 0.692093 | P | 0.769114 | -0.077021 | No Change: Both D | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 99 | G | 0.730668 | V | 0.649391 | 0.081277 | No Change: Both D | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 269 | P | 0.164114 | S | 0.168188 | -0.004074 | No Change: Both O | - |
| Q8N7U6 | EFHB_HUMAN EF-hand domain-containing family member B OS=Homo sapiens GN=EFHB PE=2 SV=4 | 826 | R | 0.364797 | W | 0.163553 | 0.201244 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 77 | P | 0.540888 | T | 0.473005 | 0.067883 | D to O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 159 | R | 0.585276 | W | 0.376691 | 0.208585 | D to O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 182 | R | 0.086248 | H | 0.086537 | -2.89E-04 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 210 | D | 0.496561 | N | 0.472304 | 0.024257 | No Change: Both O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 221 | R | 0.468759 | H | 0.436459 | 0.0323 | No Change: Both O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 229 | F | 0.376872 | L | 0.412369 | -0.035497 | No Change: Both O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 253 | D | 0.246567 | Y | 0.132424 | 0.114143 | No Change: Both O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 619 | I | 0.235459 | L | 0.280206 | -0.044747 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 285 | R | 0.598108 | I | 0.415352 | 0.182756 | D to O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 174 | I | 0.115574 | V | 0.121154 | -0.00558 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 259 | C | 0.177968 | Y | 0.234819 | -0.056851 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 294 | R | 0.288811 | H | 0.267175 | 0.021636 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 353 | R | 0.237139 | W | 0.097269 | 0.13987 | No Change: Both O | Juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770] |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 394 | A | 0.295885 | S | 0.38173 | -0.085845 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 448 | M | 0.103822 | T | 0.133949 | -0.030127 | No Change: Both O | - |
| Q5JVL4 | EFHC1_HUMAN EF-hand domain-containing protein 1 OS=Homo sapiens GN=EFHC1 PE=1 SV=1 | 357 | E | 0.35778 | K | 0.381615 | -0.023835 | No Change: Both O | - |
| Q5JST6 | EFHC2_HUMAN EF-hand domain-containing family member C2 OS=Homo sapiens GN=EFHC2 PE=1 SV=2 | 31 | N | 0.215915 | S | 0.249707 | -0.033792 | No Change: Both O | - |
| Q5JST6 | EFHC2_HUMAN EF-hand domain-containing family member C2 OS=Homo sapiens GN=EFHC2 PE=1 SV=2 | 208 | E | 0.456631 | K | 0.43056 | 0.026071 | No Change: Both O | - |
| Q5JST6 | EFHC2_HUMAN EF-hand domain-containing family member C2 OS=Homo sapiens GN=EFHC2 PE=1 SV=2 | 430 | S | 0.5347 | Y | 0.35029 | 0.18441 | D to O | - |
| Q5JST6 | EFHC2_HUMAN EF-hand domain-containing family member C2 OS=Homo sapiens GN=EFHC2 PE=1 SV=2 | 507 | E | 0.186753 | Q | 0.143979 | 0.042774 | No Change: Both O | - |
| Q5JST6 | EFHC2_HUMAN EF-hand domain-containing family member C2 OS=Homo sapiens GN=EFHC2 PE=1 SV=2 | 57 | C | 0.459668 | Y | 0.50477 | -0.045102 | O to D | - |
| Q9BUP0 | EFHD1_HUMAN EF-hand domain-containing protein D1 OS=Homo sapiens GN=EFHD1 PE=1 SV=1 | 186 | K | 0.540493 | R | 0.462527 | 0.077966 | D to O | - |
| P20827 | EFNA1_HUMAN Ephrin-A1 OS=Homo sapiens GN=EFNA1 PE=1 SV=2 | 159 | D | 0.675206 | V | 0.587686 | 0.08752 | No Change: Both D | - |
| P52797 | EFNA3_HUMAN Ephrin-A3 OS=Homo sapiens GN=EFNA3 PE=1 SV=1 | 190 | V | 0.577055 | M | 0.64622 | -0.069165 | No Change: Both D | - |
| P52803 | EFNA5_HUMAN Ephrin-A5 OS=Homo sapiens GN=EFNA5 PE=1 SV=1 | 55 | N | 0.054965 | K | 0.066812 | -0.011847 | No Change: Both O | - |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 27 | P | 0.183961 | R | 0.160952 | 0.023009 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 54 | P | 0.180559 | L | 0.0995 | 0.081059 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 62 | I | 0.153521 | T | 0.236717 | -0.083196 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 98 | L | 0.167512 | S | 0.310174 | -0.142662 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 111 | T | 0.234395 | I | 0.150736 | 0.083659 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 115 | Q | 0.236519 | P | 0.26595 | -0.029431 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 119 | P | 0.256123 | H | 0.226515 | 0.029608 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 119 | P | 0.256123 | S | 0.29208 | -0.035957 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 119 | P | 0.256123 | T | 0.22319 | 0.032933 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 137 | T | 0.532804 | A | 0.490092 | 0.042712 | D to O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 138 | S | 0.553323 | F | 0.326902 | 0.226421 | D to O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 151 | G | 0.485097 | S | 0.52757 | -0.042473 | O to D | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 151 | G | 0.485097 | V | 0.352176 | 0.132921 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 153 | C | 0.436074 | S | 0.623359 | -0.187285 | O to D | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 153 | C | 0.436074 | Y | 0.430555 | 0.005519 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 154 | R | 0.428188 | H | 0.369079 | 0.059109 | No Change: Both O | - |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 155 | T | 0.42665 | P | 0.465834 | -0.039184 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 158 | M | 0.466583 | I | 0.366702 | 0.099881 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 158 | M | 0.466583 | V | 0.385329 | 0.081254 | No Change: Both O | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 182 | S | 0.875751 | R | 0.868864 | 0.006887 | No Change: Both D | Craniofrontonasal syndrome (CFNS) [MIM:304110] |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 189 | V | 0.903649 | A | 0.929988 | -0.026339 | No Change: Both D | - |
| P98172 | EFNB1_HUMAN Ephrin-B1 OS=Homo sapiens GN=EFNB1 PE=1 SV=1 | 172 | T | 0.776797 | M | 0.765291 | 0.011506 | No Change: Both D | - |
| Q15768 | EFNB3_HUMAN Ephrin-B3 OS=Homo sapiens GN=EFNB3 PE=1 SV=1 | 166 | R | 0.577 | Q | 0.572208 | 0.004792 | No Change: Both D | - |
| Q14156 | EFR3A_HUMAN Protein EFR3 homolog A OS=Homo sapiens GN=EFR3A PE=1 SV=2 | 358 | G | 0.520233 | R | 0.487339 | 0.032894 | D to O | - |
| Q14156 | EFR3A_HUMAN Protein EFR3 homolog A OS=Homo sapiens GN=EFR3A PE=1 SV=2 | 365 | N | 0.649888 | D | 0.656091 | -0.006203 | No Change: Both D | - |
| O43281 | EFS_HUMAN Embryonal Fyn-associated substrate OS=Homo sapiens GN=EFS PE=2 SV=1 | 361 | M | 0.93705 | I | 0.905286 | 0.031764 | No Change: Both D | A colorectal cancer sample |
| O43281 | EFS_HUMAN Embryonal Fyn-associated substrate OS=Homo sapiens GN=EFS PE=2 SV=1 | 7 | T | 0.461568 | A | 0.446712 | 0.014856 | No Change: Both O | - |
| O43281 | EFS_HUMAN Embryonal Fyn-associated substrate OS=Homo sapiens GN=EFS PE=2 SV=1 | 100 | V | 0.979557 | M | 0.982529 | -0.002972 | No Change: Both D | - |
| Q7Z2Z2 | ETUD1_HUMAN Elongation factor Tu GTP-binding domain-containing protein 1 OS=Homo sapiens GN=EFTUD1 PE=1 SV=2 | 478 | E | 0.941499 | D | 0.928222 | 0.013277 | No Change: Both D | - |
| Q7Z2Z2 | ETUD1_HUMAN Elongation factor Tu GTP-binding domain-containing protein 1 OS=Homo sapiens GN=EFTUD1 PE=1 SV=2 | 617 | I | 0.277734 | V | 0.329146 | -0.051412 | No Change: Both O | - |
| Q7Z2Z2 | ETUD1_HUMAN Elongation factor Tu GTP-binding domain-containing protein 1 OS=Homo sapiens GN=EFTUD1 PE=1 SV=2 | 711 | K | 0.657273 | R | 0.583867 | 0.073406 | No Change: Both D | - |
| Q15029 | U5S1_HUMAN 116 kDa U5 small nuclear ribonucleoprotein component OS=Homo sapiens GN=EFTUD2 PE=1 SV=1 | 773 | G | 0.219347 | V | 0.127422 | 0.091925 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 708 | M | 0.327094 | I | 0.226745 | 0.100349 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 16 | S | 0.259366 | R | 0.187682 | 0.071684 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 431 | R | 0.890972 | K | 0.905805 | -0.014833 | No Change: Both D | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 723 | G | 0.521309 | R | 0.533993 | -0.012684 | No Change: Both D | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 784 | D | 0.256391 | V | 0.136674 | 0.119717 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 842 | M | 0.297054 | T | 0.301634 | -0.00458 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 1043 | L | 0.009749 | F | 0.007268 | 0.002481 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 257 | D | 0.093301 | H | 0.079545 | 0.013756 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 638 | S | 0.142754 | R | 0.106176 | 0.036578 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 920 | E | 0.580695 | V | 0.346628 | 0.234067 | D to O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 981 | D | 0.396144 | E | 0.410211 | -0.014067 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 1084 | A | 0.797518 | G | 0.833965 | -0.036447 | No Change: Both D | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 151 | H | 0.344144 | Y | 0.234494 | 0.10965 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 292 | L | 0.306204 | H | 0.412144 | -0.10594 | No Change: Both O | - |
| P01133 | EGF_HUMAN Pro-epidermal growth factor OS=Homo sapiens GN=EGF PE=1 SV=2 | 1070 | P | 0.818685 | L | 0.741523 | 0.077162 | No Change: Both D | Hypomagnesemia type 4 (HOMG4) [MIM:611718] |
| Q0D2K5 | EGFEM_HUMAN EGF-like and EMI domain-containing protein 1 OS=Homo sapiens GN=EGFEM1P PE=5 SV=1 | 59 | G | 0.738438 | D | 0.706938 | 0.0315 | No Change: Both D | - |
| Q0D2K5 | EGFEM_HUMAN EGF-like and EMI domain-containing protein 1 OS=Homo sapiens GN=EGFEM1P PE=5 SV=1 | 157 | P | 0.826387 | L | 0.763843 | 0.062544 | No Change: Both D | - |
| Q8IUX8 | EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens GN=EGFL6 PE=2 SV=1 | 66 | E | 0.496488 | K | 0.510658 | -0.01417 | O to D | - |
| Q8IUX8 | EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens GN=EGFL6 PE=2 SV=1 | 164 | R | 0.609346 | C | 0.547115 | 0.062231 | No Change: Both D | - |
| Q8IUX8 | EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens GN=EGFL6 PE=2 SV=1 | 508 | L | 0.348613 | F | 0.326441 | 0.022172 | No Change: Both O | - |
| Q8IUX8 | EGFL6_HUMAN Epidermal growth factor-like protein 6 OS=Homo sapiens GN=EGFL6 PE=2 SV=1 | 535 | D | 0.171475 | N | 0.149733 | 0.021742 | No Change: Both O | - |
| Q9UHF1 | EGFL7_HUMAN Epidermal growth factor-like protein 7 OS=Homo sapiens GN=EGFL7 PE=1 SV=3 | 153 | V | 0.496859 | I | 0.438374 | 0.058485 | No Change: Both O | - |
| Q9UHF1 | EGFL7_HUMAN Epidermal growth factor-like protein 7 OS=Homo sapiens GN=EGFL7 PE=1 SV=3 | 183 | P | 0.634286 | S | 0.626285 | 0.008001 | No Change: Both D | - |
| Q9UHF1 | EGFL7_HUMAN Epidermal growth factor-like protein 7 OS=Homo sapiens GN=EGFL7 PE=1 SV=3 | 186 | A | 0.677455 | G | 0.727331 | -0.049876 | No Change: Both D | - |
| Q99944 | EGFL8_HUMAN Epidermal growth factor-like protein 8 OS=Homo sapiens GN=EGFL8 PE=1 SV=1 | 86 | R | 0.362869 | K | 0.395208 | -0.032339 | No Change: Both O | - |
| Q99944 | EGFL8_HUMAN Epidermal growth factor-like protein 8 OS=Homo sapiens GN=EGFL8 PE=1 SV=1 | 204 | A | 0.733733 | E | 0.803455 | -0.069722 | No Change: Both D | - |
| Q99944 | EGFL8_HUMAN Epidermal growth factor-like protein 8 OS=Homo sapiens GN=EGFL8 PE=1 SV=1 | 277 | G | 0.418434 | C | 0.333541 | 0.084893 | No Change: Both O | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 111 | R | 0.421597 | H | 0.38261 | 0.038987 | No Change: Both O | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 229 | W | 0.573673 | R | 0.751612 | -0.177939 | No Change: Both D | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 473 | T | 0.078669 | M | 0.067788 | 0.010881 | No Change: Both O | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 576 | H | 0.234619 | N | 0.247291 | -0.012672 | No Change: Both O | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 26 | R | 0.333707 | P | 0.38144 | -0.047733 | No Change: Both O | - |
| Q63HQ2 | EGFLA_HUMAN Pikachurin OS=Homo sapiens GN=EGFLAM PE=1 SV=2 | 745 | V | 0.59484 | M | 0.624836 | -0.029996 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 98 | R | 0.166736 | Q | 0.188096 | -0.02136 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 266 | P | 0.445694 | R | 0.393772 | 0.051922 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 521 | R | 0.73996 | K | 0.741517 | -0.001557 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 674 | V | 0.354703 | I | 0.33976 | 0.014943 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 719 | G | 0.235039 | S | 0.269903 | -0.034864 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 858 | L | 0.168131 | R | 0.246347 | -0.078216 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 962 | R | 0.30636 | G | 0.289494 | 0.016866 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 988 | H | 0.560673 | P | 0.648905 | -0.088232 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 709 | E | 0.335297 | A | 0.239667 | 0.09563 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 709 | E | 0.335297 | K | 0.343219 | -0.007922 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 719 | G | 0.235039 | A | 0.194032 | 0.041007 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 719 | G | 0.235039 | C | 0.124589 | 0.11045 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 719 | G | 0.235039 | D | 0.229792 | 0.005247 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 724 | G | 0.172562 | S | 0.197925 | -0.025363 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 734 | E | 0.273474 | K | 0.281619 | -0.008145 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 747 | L | 0.455831 | F | 0.423341 | 0.03249 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 748 | R | 0.51155 | P | 0.579141 | -0.067591 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 787 | Q | 0.09665 | R | 0.082562 | 0.014088 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 790 | T | 0.090422 | M | 0.071655 | 0.018767 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 833 | L | 0.286133 | V | 0.283023 | 0.00311 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 834 | V | 0.28465 | L | 0.303182 | -0.018532 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 858 | L | 0.168131 | M | 0.198905 | -0.030774 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 861 | L | 0.282411 | Q | 0.40682 | -0.124409 | No Change: Both O | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 873 | G | 0.526151 | E | 0.590991 | -0.06484 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 1034 | L | 0.795031 | R | 0.847408 | -0.052377 | No Change: Both D | - |
| P00533 | EGFR_HUMAN Epidermal growth factor receptor OS=Homo sapiens GN=EGFR PE=1 SV=2 | 1210 | A | 0.700359 | V | 0.730439 | -0.03008 | No Change: Both D | - |
| Q9GZT9 | EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens GN=EGLN1 PE=1 SV=1 | 317 | P | 0.584444 | R | 0.568494 | 0.01595 | No Change: Both D | Familial erythrocytosis type 3 (ECYT3) [MIM:609820] |
| Q9GZT9 | EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens GN=EGLN1 PE=1 SV=1 | 371 | R | 0.355541 | H | 0.362805 | -0.007264 | No Change: Both O | Familial erythrocytosis type 3 (ECYT3) [MIM:609820] |
| Q9H6Z9 | EGLN3_HUMAN Egl nine homolog 3 OS=Homo sapiens GN=EGLN3 PE=1 SV=1 | 136 | V | 0.500013 | L | 0.478684 | 0.021329 | D to O | - |
| Q9H6Z9 | EGLN3_HUMAN Egl nine homolog 3 OS=Homo sapiens GN=EGLN3 PE=1 SV=1 | 234 | S | 0.794892 | T | 0.799094 | -0.004202 | No Change: Both D | - |
| P18146 | EGR1_HUMAN Early growth response protein 1 OS=Homo sapiens GN=EGR1 PE=1 SV=1 | 144 | N | 0.703359 | K | 0.695761 | 0.007598 | No Change: Both D | - |
| P18146 | EGR1_HUMAN Early growth response protein 1 OS=Homo sapiens GN=EGR1 PE=1 SV=1 | 145 | S | 0.711361 | R | 0.672553 | 0.038808 | No Change: Both D | - |
| P18146 | EGR1_HUMAN Early growth response protein 1 OS=Homo sapiens GN=EGR1 PE=1 SV=1 | 219 | E | 0.896838 | D | 0.908143 | -0.011305 | No Change: Both D | - |
| P18146 | EGR1_HUMAN Early growth response protein 1 OS=Homo sapiens GN=EGR1 PE=1 SV=1 | 28 | T | 0.795774 | I | 0.738889 | 0.056885 | No Change: Both D | - |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 268 | I | 0.874944 | N | 0.930722 | -0.055778 | No Change: Both D | Congenital hypomyelination neuropathy (CHN) [MIM:605253] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 355 | D | 0.799818 | V | 0.683457 | 0.116361 | No Change: Both D | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 409 | R | 0.823437 | W | 0.637115 | 0.186322 | No Change: Both D | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 359 | R | 0.746971 | W | 0.488915 | 0.258056 | D to O | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 359 | R | 0.746971 | W | 0.488915 | 0.258056 | D to O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 381 | R | 0.573511 | H | 0.545071 | 0.02844 | No Change: Both D | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 381 | R | 0.573511 | C | 0.46367 | 0.109841 | D to O | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| P11161 | EGR2_HUMAN E3 SUMO-protein ligase EGR2 OS=Homo sapiens GN=EGR2 PE=1 SV=3 | 383 | D | 0.601583 | Y | 0.447007 | 0.154576 | D to O | Charcot-Marie-Tooth disease type 1D (CMT1D) [MIM:607678] |
| Q8NDI1 | EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens GN=EHBP1 PE=1 SV=3 | 755 | K | 0.966288 | Q | 0.955808 | 0.01048 | No Change: Both D | - |
| Q8NDI1 | EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens GN=EHBP1 PE=1 SV=3 | 395 | R | 0.932506 | T | 0.926968 | 0.005538 | No Change: Both D | A breast cancer sample |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 307 | R | 0.991262 | Q | 0.991079 | 1.83E-04 | No Change: Both D | - |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 538 | V | 0.696866 | G | 0.806224 | -0.109358 | No Change: Both D | - |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 569 | D | 0.749719 | V | 0.696251 | 0.053468 | No Change: Both D | - |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 599 | T | 0.701375 | I | 0.582885 | 0.11849 | No Change: Both D | - |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 648 | T | 0.88255 | I | 0.795863 | 0.086687 | No Change: Both D | - |
| Q8N3D4 | EH1L1_HUMAN EH domain-binding protein 1-like protein 1 OS=Homo sapiens GN=EHBP1L1 PE=1 SV=2 | 133 | V | 0.474504 | L | 0.475774 | -0.00127 | No Change: Both O | - |
| Q9NZN4 | EHD2_HUMAN EH domain-containing protein 2 OS=Homo sapiens GN=EHD2 PE=1 SV=2 | 57 | G | 0.348013 | S | 0.391579 | -0.043566 | No Change: Both O | - |
| Q9H223 | EHD4_HUMAN EH domain-containing protein 4 OS=Homo sapiens GN=EHD4 PE=1 SV=1 | 154 | V | 0.320788 | I | 0.308927 | 0.011861 | No Change: Both O | - |
| Q9NZC4 | EHF_HUMAN ETS homologous factor OS=Homo sapiens GN=EHF PE=1 SV=1 | 96 | A | 0.344106 | V | 0.256305 | 0.087801 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 75 | T | 0.15815 | I | 0.084117 | 0.074033 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 274 | A | 0.243692 | T | 0.249038 | -0.005346 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 606 | T | 0.506514 | P | 0.570265 | -0.063751 | No Change: Both D | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 685 | Q | 0.470713 | K | 0.502797 | -0.032084 | O to D | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 715 | L | 0.943972 | S | 0.971262 | -0.02729 | No Change: Both D | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 40 | V | 0.199569 | G | 0.321953 | -0.122384 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 41 | I | 0.165478 | R | 0.262426 | -0.096948 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 325 | A | 0.236221 | G | 0.260214 | -0.023993 | No Change: Both O | - |
| Q08426 | ECHP_HUMAN Peroxisomal bifunctional enzyme OS=Homo sapiens GN=EHHADH PE=1 SV=3 | 598 | K | 0.33037 | T | 0.247874 | 0.082496 | No Change: Both O | - |
| Q9H9B1 | EHMT1_HUMAN Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens GN=EHMT1 PE=1 SV=4 | 388 | A | 0.995832 | T | 0.996067 | -2.35E-04 | No Change: Both D | - |
| Q9H9B1 | EHMT1_HUMAN Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens GN=EHMT1 PE=1 SV=4 | 43 | A | 0.952587 | V | 0.926182 | 0.026405 | No Change: Both D | A breast cancer sample |
| Q9H9B1 | EHMT1_HUMAN Histone-lysine N-methyltransferase EHMT1 OS=Homo sapiens GN=EHMT1 PE=1 SV=4 | 1173 | Y | 0.37295 | F | 0.352482 | 0.020468 | No Change: Both O | A breast cancer sample |
| Q96KQ7 | EHMT2_HUMAN Histone-lysine N-methyltransferase EHMT2 OS=Homo sapiens GN=EHMT2 PE=1 SV=3 | 55 | T | 0.964909 | N | 0.954879 | 0.01003 | No Change: Both D | - |
| Q96KQ7 | EHMT2_HUMAN Histone-lysine N-methyltransferase EHMT2 OS=Homo sapiens GN=EHMT2 PE=1 SV=3 | 1165 | Y | 0.197871 | F | 0.221988 | -0.024117 | No Change: Both O | - |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 30 | D | 0.588115 | G | 0.555946 | 0.032169 | No Change: Both D | Some patients with early onset breast cancer |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 195 | P | 0.061344 | W | 0.019041 | 0.042303 | No Change: Both O | Some patients with early onset breast cancer |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 196 | I | 0.066281 | D | 0.156399 | -0.090118 | No Change: Both O | Some patients with early onset breast cancer |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 197 | H | 0.066622 | Y | 0.037771 | 0.028851 | No Change: Both O | Some patients with early onset breast cancer |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 199 | V | 0.089149 | H | 0.155313 | -0.066164 | No Change: Both O | Some patients with early onset breast cancer |
| O14681 | EI24_HUMAN Etoposide-induced protein 2.4 homolog OS=Homo sapiens GN=EI24 PE=1 SV=4 | 319 | T | 0.787417 | A | 0.780288 | 0.007129 | No Change: Both D | Some patients with early onset breast cancer |
| Q8N6I1 | EID2_HUMAN EP300-interacting inhibitor of differentiation 2 OS=Homo sapiens GN=EID2 PE=1 SV=3 | 6 | A | 0.926324 | T | 0.928547 | -0.002223 | No Change: Both D | - |
| Q8N6I1 | EID2_HUMAN EP300-interacting inhibitor of differentiation 2 OS=Homo sapiens GN=EID2 PE=1 SV=3 | 60 | E | 0.994449 | A | 0.994642 | -1.93E-04 | No Change: Both D | - |
| P41567 | EIF1_HUMAN Eukaryotic translation initiation factor 1 OS=Homo sapiens GN=EIF1 PE=1 SV=1 | 59 | L | 0.482524 | P | 0.608172 | -0.125648 | O to D | - |
| P41567 | EIF1_HUMAN Eukaryotic translation initiation factor 1 OS=Homo sapiens GN=EIF1 PE=1 SV=1 | 90 | R | 0.280088 | G | 0.306369 | -0.026281 | No Change: Both O | - |
| Q8N9N8 | EIF1A_HUMAN Probable RNA-binding protein EIF1AD OS=Homo sapiens GN=EIF1AD PE=1 SV=1 | 23 | D | 0.44076 | N | 0.447077 | -0.006317 | No Change: Both O | - |
| Q8N9N8 | EIF1A_HUMAN Probable RNA-binding protein EIF1AD OS=Homo sapiens GN=EIF1AD PE=1 SV=1 | 159 | S | 0.985801 | N | 0.982392 | 0.003409 | No Change: Both D | - |
| Q9BY44 | EIF2A_HUMAN Eukaryotic translation initiation factor 2A OS=Homo sapiens GN=EIF2A PE=1 SV=3 | 97 | T | 0.387329 | S | 0.448743 | -0.061414 | No Change: Both O | - |
| Q9BY44 | EIF2A_HUMAN Eukaryotic translation initiation factor 2A OS=Homo sapiens GN=EIF2A PE=1 SV=3 | 582 | E | 0.883097 | K | 0.884682 | -0.001585 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 558 | K | 0.59897 | R | 0.620404 | -0.021434 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 117 | R | 0.471117 | T | 0.438707 | 0.03241 | No Change: Both O | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 132 | K | 0.669725 | T | 0.640705 | 0.02902 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 134 | R | 0.691858 | K | 0.690888 | 9.70E-04 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 139 | P | 0.685378 | S | 0.742423 | -0.057045 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 145 | R | 0.55802 | H | 0.493764 | 0.064256 | D to O | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 202 | G | 0.191026 | S | 0.233534 | -0.042508 | No Change: Both O | A lung adenocarcinoma sample |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 292 | F | 0.917307 | L | 0.921549 | -0.004242 | No Change: Both D | - |
| Q9BQI3 | E2AK1_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Homo sapiens GN=EIF2AK1 PE=1 SV=2 | 319 | L | 0.761958 | H | 0.766165 | -0.004207 | No Change: Both D | - |
| P19525 | E2AK2_HUMAN Interferon-induced double-stranded RNA-activated protein kinase OS=Homo sapiens GN=EIF2AK2 PE=1 SV=2 | 428 | V | 0.274661 | E | 0.403852 | -0.129191 | No Change: Both O | - |
| P19525 | E2AK2_HUMAN Interferon-induced double-stranded RNA-activated protein kinase OS=Homo sapiens GN=EIF2AK2 PE=1 SV=2 | 439 | L | 0.51631 | V | 0.510889 | 0.005421 | No Change: Both D | A lung adenocarcinoma sample |
| P19525 | E2AK2_HUMAN Interferon-induced double-stranded RNA-activated protein kinase OS=Homo sapiens GN=EIF2AK2 PE=1 SV=2 | 506 | I | 0.431743 | V | 0.425526 | 0.006217 | No Change: Both O | - |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 588 | R | 0.186549 | Q | 0.204751 | -0.018202 | No Change: Both O | Wolcott-Rallison syndrome (WRS) [MIM:226980] |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 136 | S | 0.641688 | C | 0.372443 | 0.269245 | D to O | - |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 166 | Q | 0.390934 | R | 0.375527 | 0.015407 | No Change: Both O | - |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 704 | A | 0.826701 | S | 0.886521 | -0.05982 | No Change: Both D | - |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 566 | D | 0.683141 | V | 0.545508 | 0.137633 | No Change: Both D | - |
| Q9NZJ5 | E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens GN=EIF2AK3 PE=1 SV=3 | 716 | P | 0.892855 | L | 0.797233 | 0.095622 | No Change: Both D | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 137 | H | 0.715273 | R | 0.723892 | -0.008619 | No Change: Both D | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 166 | R | 0.997022 | W | 0.991943 | 0.005079 | No Change: Both D | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 441 | I | 0.303344 | L | 0.323819 | -0.020475 | No Change: Both O | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 872 | D | 0.403204 | V | 0.233014 | 0.17019 | No Change: Both O | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 939 | H | 0.194187 | Y | 0.137218 | 0.056969 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 1060 | T | 0.313901 | R | 0.346523 | -0.032622 | No Change: Both O | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 1306 | G | 0.152752 | C | 0.066099 | 0.086653 | No Change: Both O | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 1336 | K | 0.151763 | R | 0.12823 | 0.023533 | No Change: Both O | - |
| Q9P2K8 | E2AK4_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 4 OS=Homo sapiens GN=EIF2AK4 PE=1 SV=3 | 1406 | Q | 0.308408 | H | 0.293121 | 0.015287 | No Change: Both O | - |
| Q14232 | EI2BA_HUMAN Translation initiation factor eIF-2B subunit alpha OS=Homo sapiens GN=EIF2B1 PE=1 SV=1 | 208 | N | 0.307271 | Y | 0.167435 | 0.139836 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| P49770 | EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta OS=Homo sapiens GN=EIF2B2 PE=1 SV=3 | 213 | E | 0.325411 | G | 0.289833 | 0.035578 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| P49770 | EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta OS=Homo sapiens GN=EIF2B2 PE=1 SV=3 | 316 | V | 0.103607 | D | 0.200479 | -0.096872 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| P49770 | EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta OS=Homo sapiens GN=EIF2B2 PE=1 SV=3 | 273 | K | 0.260578 | R | 0.21006 | 0.050518 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| P49770 | EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta OS=Homo sapiens GN=EIF2B2 PE=1 SV=3 | 329 | G | 0.238735 | V | 0.132166 | 0.106569 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| P49770 | EI2BB_HUMAN Translation initiation factor eIF-2B subunit beta OS=Homo sapiens GN=EIF2B2 PE=1 SV=3 | 171 | S | 0.142987 | F | 0.064384 | 0.078603 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9NR50 | EI2BG_HUMAN Translation initiation factor eIF-2B subunit gamma OS=Homo sapiens GN=EIF2B3 PE=1 SV=1 | 87 | A | 0.376705 | V | 0.288323 | 0.088382 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9NR50 | EI2BG_HUMAN Translation initiation factor eIF-2B subunit gamma OS=Homo sapiens GN=EIF2B3 PE=1 SV=1 | 225 | R | 0.342752 | Q | 0.358528 | -0.015776 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9NR50 | EI2BG_HUMAN Translation initiation factor eIF-2B subunit gamma OS=Homo sapiens GN=EIF2B3 PE=1 SV=1 | 288 | D | 0.259552 | E | 0.280462 | -0.02091 | No Change: Both O | - |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 228 | A | 0.120647 | V | 0.085333 | 0.035314 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 306 | R | 0.225332 | G | 0.209157 | 0.016175 | No Change: Both O | - |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 357 | R | 0.149034 | Q | 0.145988 | 0.003046 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 374 | R | 0.310706 | C | 0.158153 | 0.152553 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 465 | C | 0.458415 | R | 0.624609 | -0.166194 | O to D | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 489 | Y | 0.123063 | H | 0.200639 | -0.077576 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q9UI10 | EI2BD_HUMAN Translation initiation factor eIF-2B subunit delta OS=Homo sapiens GN=EIF2B4 PE=1 SV=2 | 93 | A | 0.955014 | V | 0.940335 | 0.014679 | No Change: Both D | - |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 91 | T | 0.050004 | A | 0.042935 | 0.007069 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 113 | R | 0.224835 | H | 0.230057 | -0.005222 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 386 | G | 0.173138 | V | 0.098123 | 0.075015 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 628 | W | 0.094637 | R | 0.236653 | -0.142016 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 73 | V | 0.059878 | G | 0.105102 | -0.045224 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 106 | L | 0.273881 | F | 0.233405 | 0.040476 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 299 | R | 0.39377 | H | 0.418455 | -0.024685 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 315 | R | 0.043543 | G | 0.040762 | 0.002781 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 315 | R | 0.043543 | H | 0.039971 | 0.003572 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 339 | R | 0.513448 | P | 0.548434 | -0.034986 | No Change: Both D | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 339 | R | 0.513448 | Q | 0.532079 | -0.018631 | No Change: Both D | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 339 | R | 0.513448 | W | 0.275292 | 0.238156 | D to O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 430 | V | 0.380229 | A | 0.419394 | -0.039165 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 587 | I | 0.178689 | V | 0.214378 | -0.035689 | No Change: Both O | - |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 650 | E | 0.192286 | K | 0.175354 | 0.016932 | No Change: Both O | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 195 | R | 0.615295 | C | 0.51141 | 0.103885 | No Change: Both D | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 195 | R | 0.615295 | H | 0.620289 | -0.004994 | No Change: Both D | Leukodystrophy with vanishing white matter (VWM) [MIM:603896] |
| Q13144 | EI2BE_HUMAN Translation initiation factor eIF-2B subunit epsilon OS=Homo sapiens GN=EIF2B5 PE=1 SV=3 | 200 | N | 0.410282 | T | 0.402754 | 0.007528 | No Change: Both O | - |
| P41214 | EIF2D_HUMAN Eukaryotic translation initiation factor 2D OS=Homo sapiens GN=EIF2D PE=1 SV=3 | 210 | T | 0.912704 | I | 0.866184 | 0.04652 | No Change: Both D | - |
| P20042 | IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens GN=EIF2S2 PE=1 SV=2 | 177 | E | 0.338969 | D | 0.317433 | 0.021536 | No Change: Both O | - |
| P41091 | IF2G_HUMAN Eukaryotic translation initiation factor 2 subunit 3 OS=Homo sapiens GN=EIF2S3 PE=1 SV=3 | 125 | K | 0.344828 | R | 0.313011 | 0.031817 | No Change: Both O | - |
| Q14152 | EIF3A_HUMAN Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens GN=EIF3A PE=1 SV=1 | 386 | E | 0.138002 | K | 0.144625 | -0.006623 | No Change: Both O | - |
| Q14152 | EIF3A_HUMAN Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens GN=EIF3A PE=1 SV=1 | 694 | K | 0.87943 | N | 0.843205 | 0.036225 | No Change: Both D | - |
| Q14152 | EIF3A_HUMAN Eukaryotic translation initiation factor 3 subunit A OS=Homo sapiens GN=EIF3A PE=1 SV=1 | 993 | D | 0.996144 | E | 0.995653 | 4.91E-04 | No Change: Both D | - |
| P55884 | EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens GN=EIF3B PE=1 SV=3 | 64 | S | 0.995096 | P | 0.995661 | -5.65E-04 | No Change: Both D | - |
| P55884 | EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens GN=EIF3B PE=1 SV=3 | 793 | D | 0.551469 | E | 0.592757 | -0.041288 | No Change: Both D | - |
| P60228 | EIF3E_HUMAN Eukaryotic translation initiation factor 3 subunit E OS=Homo sapiens GN=EIF3E PE=1 SV=1 | 185 | A | 0.289274 | V | 0.211596 | 0.077678 | No Change: Both O | - |
| O00303 | EIF3F_HUMAN Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens GN=EIF3F PE=1 SV=1 | 172 | W | 0.086318 | L | 0.13525 | -0.048932 | No Change: Both O | - |
| O00303 | EIF3F_HUMAN Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens GN=EIF3F PE=1 SV=1 | 39 | P | 0.99933 | L | 0.99823 | 0.0011 | No Change: Both D | - |
| O75822 | EIF3J_HUMAN Eukaryotic translation initiation factor 3 subunit J OS=Homo sapiens GN=EIF3J PE=1 SV=2 | 141 | A | 0.248078 | T | 0.274234 | -0.026156 | No Change: Both O | - |
| Q9Y262 | EIF3L_HUMAN Eukaryotic translation initiation factor 3 subunit L OS=Homo sapiens GN=EIF3L PE=1 SV=1 | 239 | N | 0.419803 | S | 0.466312 | -0.046509 | No Change: Both O | - |
| Q7L2H7 | EIF3M_HUMAN Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens GN=EIF3M PE=1 SV=1 | 37 | G | 0.535922 | R | 0.531483 | 0.004439 | No Change: Both D | - |
| Q7L2H7 | EIF3M_HUMAN Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens GN=EIF3M PE=1 SV=1 | 80 | E | 0.534416 | G | 0.420367 | 0.114049 | D to O | A breast cancer sample |
| Q7L2H7 | EIF3M_HUMAN Eukaryotic translation initiation factor 3 subunit M OS=Homo sapiens GN=EIF3M PE=1 SV=1 | 346 | Q | 0.360882 | R | 0.328072 | 0.03281 | No Change: Both O | - |
| Q14240 | IF4A2_HUMAN Eukaryotic initiation factor 4A-II OS=Homo sapiens GN=EIF4A2 PE=1 SV=2 | 181 | V | 0.108496 | L | 0.117289 | -0.008793 | No Change: Both O | A breast cancer sample |
| Q14240 | IF4A2_HUMAN Eukaryotic initiation factor 4A-II OS=Homo sapiens GN=EIF4A2 PE=1 SV=2 | 93 | Q | 0.155711 | H | 0.122635 | 0.033076 | No Change: Both O | - |
| P23588 | IF4B_HUMAN Eukaryotic translation initiation factor 4B OS=Homo sapiens GN=EIF4B PE=1 SV=2 | 203 | P | 0.988313 | R | 0.989015 | -7.02E-04 | No Change: Both D | - |
| A6NMX2 | I4E1B_HUMAN Eukaryotic translation initiation factor 4E type 1B OS=Homo sapiens GN=EIF4E1B PE=2 SV=3 | 227 | D | 0.507929 | Y | 0.363735 | 0.144194 | D to O | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 696 | P | 0.963469 | L | 0.928469 | 0.035 | No Change: Both D | A colorectal cancer sample |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 311 | Y | 0.939022 | C | 0.953011 | -0.013989 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1233 | L | 0.851657 | P | 0.914166 | -0.062509 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 161 | T | 0.679831 | A | 0.659638 | 0.020193 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1229 | P | 0.878321 | A | 0.840545 | 0.037776 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 432 | M | 0.990649 | V | 0.989134 | 0.001515 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 71 | P | 0.962531 | S | 0.961118 | 0.001413 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 502 | A | 0.758752 | V | 0.70143 | 0.057322 | No Change: Both D | Parkinson disease type 18 (PARK18) [MIM:614251] |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 686 | G | 0.969866 | C | 0.959243 | 0.010623 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 806 | I | 0.256194 | V | 0.275922 | -0.019728 | No Change: Both O | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 829 | T | 0.438575 | S | 0.464984 | -0.026409 | No Change: Both O | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1164 | S | 0.994263 | R | 0.99475 | -4.87E-04 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1197 | R | 0.990636 | W | 0.973125 | 0.017511 | No Change: Both D | - |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1205 | R | 0.983261 | H | 0.972613 | 0.010648 | No Change: Both D | Parkinson disease type 18 (PARK18) [MIM:614251] |
| Q04637 | IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens GN=EIF4G1 PE=1 SV=4 | 1257 | N | 0.336463 | S | 0.40787 | -0.071407 | No Change: Both O | - |
| P78344 | IF4G2_HUMAN Eukaryotic translation initiation factor 4 gamma 2 OS=Homo sapiens GN=EIF4G2 PE=1 SV=1 | 236 | L | 0.447629 | M | 0.504152 | -0.056523 | O to D | - |
| O43432 | IF4G3_HUMAN Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens GN=EIF4G3 PE=1 SV=2 | 496 | P | 0.724628 | A | 0.648936 | 0.075692 | No Change: Both D | - |
| O43432 | IF4G3_HUMAN Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens GN=EIF4G3 PE=1 SV=2 | 378 | Q | 0.599097 | R | 0.591178 | 0.007919 | No Change: Both D | - |
| O43432 | IF4G3_HUMAN Eukaryotic translation initiation factor 4 gamma 3 OS=Homo sapiens GN=EIF4G3 PE=1 SV=2 | 1185 | D | 0.915379 | E | 0.934557 | -0.019178 | No Change: Both D | - |
| P55010 | IF5_HUMAN Eukaryotic translation initiation factor 5 OS=Homo sapiens GN=EIF5 PE=1 SV=2 | 418 | K | 0.862147 | M | 0.784584 | 0.077563 | No Change: Both D | A breast cancer sample |
| Q9GZV4 | IF5A2_HUMAN Eukaryotic translation initiation factor 5A-2 OS=Homo sapiens GN=EIF5A2 PE=1 SV=3 | 42 | E | 0.458934 | D | 0.436643 | 0.022291 | No Change: Both O | - |
| O60841 | IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens GN=EIF5B PE=1 SV=4 | 337 | S | 0.998987 | G | 0.998969 | 1.80E-05 | No Change: Both D | - |
| O60841 | IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens GN=EIF5B PE=1 SV=4 | 360 | R | 0.99842 | G | 0.997785 | 6.35E-04 | No Change: Both D | - |
| O60841 | IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens GN=EIF5B PE=1 SV=4 | 522 | K | 0.986565 | T | 0.984609 | 0.001956 | No Change: Both D | - |
| Q9H777 | RNZ1_HUMAN Zinc phosphodiesterase ELAC protein 1 OS=Homo sapiens GN=ELAC1 PE=1 SV=2 | 355 | M | 0.146912 | V | 0.120458 | 0.026454 | No Change: Both O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 211 | R | 0.983715 | Q | 0.98242 | 0.001295 | No Change: Both D | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 217 | S | 0.948804 | L | 0.923 | 0.025804 | No Change: Both D | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 487 | G | 0.238574 | R | 0.256882 | -0.018308 | No Change: Both O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 541 | A | 0.11229 | T | 0.126588 | -0.014298 | No Change: Both O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 622 | E | 0.423479 | V | 0.248404 | 0.175075 | No Change: Both O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 627 | S | 0.218959 | L | 0.112329 | 0.10663 | No Change: Both O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 781 | R | 0.834386 | H | 0.783015 | 0.051371 | No Change: Both D | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 806 | G | 0.958289 | R | 0.968109 | -0.00982 | No Change: Both D | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 52 | S | 0.64991 | F | 0.496262 | 0.153648 | D to O | - |
| Q9BQ52 | RNZ2_HUMAN Zinc phosphodiesterase ELAC protein 2 OS=Homo sapiens GN=ELAC2 PE=1 SV=2 | 436 | D | 0.254553 | N | 0.271703 | -0.01715 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 32 | G | 0.4062 | V | 0.272605 | 0.133595 | No Change: Both O | Cyclic haematopoiesis (CH) [MIM:162800] |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 177 | V | 0.168174 | F | 0.133094 | 0.03508 | No Change: Both O | Cyclic haematopoiesis (CH) [MIM:162800] |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 191 | R | 0.189841 | Q | 0.194346 | -0.004505 | No Change: Both O | Cyclic haematopoiesis (CH) [MIM:162800] |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 219 | V | 0.173436 | I | 0.165086 | 0.00835 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 257 | P | 0.820912 | L | 0.681586 | 0.139326 | No Change: Both D | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 262 | P | 0.887483 | L | 0.822007 | 0.065476 | No Change: Both D | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 55 | C | 0.106966 | Y | 0.131519 | -0.024553 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 57 | A | 0.097025 | T | 0.109309 | -0.012284 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 60 | I | 0.089276 | T | 0.171289 | -0.082013 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 71 | C | 0.143344 | R | 0.277529 | -0.134185 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 71 | C | 0.143344 | S | 0.347025 | -0.203681 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 85 | G | 0.235764 | E | 0.291371 | -0.055607 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 98 | V | 0.243142 | L | 0.232612 | 0.01053 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 101 | V | 0.123741 | L | 0.115032 | 0.008709 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 101 | V | 0.123741 | M | 0.150244 | -0.026503 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 126 | S | 0.221268 | L | 0.113998 | 0.10727 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 139 | P | 0.399348 | L | 0.257438 | 0.14191 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 151 | C | 0.125086 | S | 0.26804 | -0.142954 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 205 | P | 0.264644 | R | 0.24113 | 0.023514 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 210 | G | 0.131019 | V | 0.072876 | 0.058143 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 214 | G | 0.087016 | R | 0.080616 | 0.0064 | No Change: Both O | - |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 25 | A | 0.202076 | V | 0.144858 | 0.057218 | No Change: Both O | Neutropenia severe congenital autosomal dominant type 1 (SCN1) [MIM:202700] |
| P08246 | ELNE_HUMAN Neutrophil elastase OS=Homo sapiens GN=ELANE PE=1 SV=1 | 166 | A | 0.236694 | T | 0.265786 | -0.029092 | No Change: Both O | Neutropenia severe congenital autosomal dominant type 1 (SCN1) [MIM:202700] |
| P26378 | ELAV4_HUMAN ELAV-like protein 4 OS=Homo sapiens GN=ELAVL4 PE=1 SV=2 | 270 | P | 0.517367 | S | 0.530789 | -0.013422 | No Change: Both D | - |
| P26378 | ELAV4_HUMAN ELAV-like protein 4 OS=Homo sapiens GN=ELAVL4 PE=1 SV=2 | 166 | D | 0.204752 | G | 0.201672 | 0.00308 | No Change: Both O | - |
| P26378 | ELAV4_HUMAN ELAV-like protein 4 OS=Homo sapiens GN=ELAVL4 PE=1 SV=2 | 356 | A | 0.200212 | T | 0.202988 | -0.002776 | No Change: Both O | - |
| P32519 | ELF1_HUMAN ETS-related transcription factor Elf-1 OS=Homo sapiens GN=ELF1 PE=1 SV=2 | 58 | N | 0.476926 | S | 0.533131 | -0.056205 | O to D | - |
| P32519 | ELF1_HUMAN ETS-related transcription factor Elf-1 OS=Homo sapiens GN=ELF1 PE=1 SV=2 | 343 | T | 0.956458 | S | 0.966927 | -0.010469 | No Change: Both D | - |
| P32519 | ELF1_HUMAN ETS-related transcription factor Elf-1 OS=Homo sapiens GN=ELF1 PE=1 SV=2 | 403 | T | 0.76706 | I | 0.643843 | 0.123217 | No Change: Both D | - |
| P78545 | ELF3_HUMAN ETS-related transcription factor Elf-3 OS=Homo sapiens GN=ELF3 PE=1 SV=1 | 317 | Q | 0.489659 | K | 0.530041 | -0.040382 | O to D | - |
| P19419 | ELK1_HUMAN ETS domain-containing protein Elk-1 OS=Homo sapiens GN=ELK1 PE=1 SV=2 | 144 | G | 0.840342 | S | 0.865518 | -0.025176 | No Change: Both D | - |
| P19419 | ELK1_HUMAN ETS domain-containing protein Elk-1 OS=Homo sapiens GN=ELK1 PE=1 SV=2 | 183 | S | 0.948547 | N | 0.926711 | 0.021836 | No Change: Both D | - |
| P41970 | ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens GN=ELK3 PE=1 SV=2 | 169 | P | 0.864982 | L | 0.782068 | 0.082914 | No Change: Both D | - |
| P55199 | ELL_HUMAN RNA polymerase II elongation factor ELL OS=Homo sapiens GN=ELL PE=1 SV=1 | 297 | S | 0.83237 | N | 0.777372 | 0.054998 | No Change: Both D | - |
| P55199 | ELL_HUMAN RNA polymerase II elongation factor ELL OS=Homo sapiens GN=ELL PE=1 SV=1 | 387 | R | 0.9683 | W | 0.921377 | 0.046923 | No Change: Both D | - |
| O00472 | ELL2_HUMAN RNA polymerase II elongation factor ELL2 OS=Homo sapiens GN=ELL2 PE=1 SV=2 | 298 | A | 0.910434 | T | 0.918224 | -0.00779 | No Change: Both D | - |
| Q9HB65 | ELL3_HUMAN RNA polymerase II elongation factor ELL3 OS=Homo sapiens GN=ELL3 PE=2 SV=2 | 11 | Q | 0.624798 | E | 0.639427 | -0.014629 | No Change: Both D | - |
| Q9HB65 | ELL3_HUMAN RNA polymerase II elongation factor ELL3 OS=Homo sapiens GN=ELL3 PE=2 SV=2 | 140 | W | 0.667956 | R | 0.802635 | -0.134679 | No Change: Both D | - |
| Q92556 | ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens GN=ELMO1 PE=1 SV=2 | 362 | I | 0.320249 | S | 0.528958 | -0.208709 | O to D | - |
| Q96JJ3 | ELMO2_HUMAN Engulfment and cell motility protein 2 OS=Homo sapiens GN=ELMO2 PE=1 SV=2 | 695 | E | 0.507652 | D | 0.486855 | 0.020797 | D to O | - |
| Q96BJ8 | ELMO3_HUMAN Engulfment and cell motility protein 3 OS=Homo sapiens GN=ELMO3 PE=1 SV=3 | 13 | K | 0.256965 | Q | 0.225236 | 0.031729 | No Change: Both O | - |
| Q96BJ8 | ELMO3_HUMAN Engulfment and cell motility protein 3 OS=Homo sapiens GN=ELMO3 PE=1 SV=3 | 95 | N | 0.741465 | D | 0.760369 | -0.018904 | No Change: Both D | - |
| Q96BJ8 | ELMO3_HUMAN Engulfment and cell motility protein 3 OS=Homo sapiens GN=ELMO3 PE=1 SV=3 | 316 | R | 0.799372 | C | 0.707391 | 0.091981 | No Change: Both D | - |
| Q96FG2 | ELMD3_HUMAN ELMO domain-containing protein 3 OS=Homo sapiens GN=ELMOD3 PE=2 SV=2 | 66 | R | 0.340196 | C | 0.207636 | 0.13256 | No Change: Both O | - |
| Q96FG2 | ELMD3_HUMAN ELMO domain-containing protein 3 OS=Homo sapiens GN=ELMOD3 PE=2 SV=2 | 70 | T | 0.415742 | I | 0.308798 | 0.106944 | No Change: Both O | - |
| P15502 | ELN_HUMAN Elastin OS=Homo sapiens GN=ELN PE=1 SV=3 | 422 | G | 0.809045 | S | 0.797495 | 0.01155 | No Change: Both D | - |
| P15502 | ELN_HUMAN Elastin OS=Homo sapiens GN=ELN PE=1 SV=3 | 610 | G | 0.858564 | R | 0.844641 | 0.013923 | No Change: Both D | - |
| Q9NXB9 | ELOV2_HUMAN Elongation of very long chain fatty acids protein 2 OS=Homo sapiens GN=ELOVL2 PE=2 SV=2 | 216 | T | 0.086294 | A | 0.07344 | 0.012854 | No Change: Both O | - |
| Q9NXB9 | ELOV2_HUMAN Elongation of very long chain fatty acids protein 2 OS=Homo sapiens GN=ELOVL2 PE=2 SV=2 | 225 | V | 0.212969 | M | 0.269707 | -0.056738 | No Change: Both O | - |
| Q9GZR5 | ELOV4_HUMAN Elongation of very long chain fatty acids protein 4 OS=Homo sapiens GN=ELOVL4 PE=1 SV=1 | 299 | M | 0.947931 | V | 0.924438 | 0.023493 | No Change: Both D | - |
| Q9GZR5 | ELOV4_HUMAN Elongation of very long chain fatty acids protein 4 OS=Homo sapiens GN=ELOVL4 PE=1 SV=1 | 267 | I | 0.081555 | T | 0.148852 | -0.067297 | No Change: Both O | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 128 | T | 0.123406 | P | 0.157822 | -0.034416 | No Change: Both O | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 305 | V | 0.279279 | M | 0.337246 | -0.057967 | No Change: Both O | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 359 | H | 0.167045 | R | 0.15297 | 0.014075 | No Change: Both O | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 795 | E | 0.612805 | G | 0.587432 | 0.025373 | No Change: Both D | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 806 | H | 0.220418 | P | 0.240495 | -0.020077 | No Change: Both O | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 541 | I | 0.43604 | T | 0.593009 | -0.156969 | O to D | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 543 | T | 0.5139 | P | 0.57144 | -0.05754 | No Change: Both D | - |
| Q6IA86 | ELP2_HUMAN Elongator complex protein 2 OS=Homo sapiens GN=ELP2 PE=1 SV=2 | 815 | T | 0.343304 | P | 0.389656 | -0.046352 | No Change: Both O | - |
| Q96EB1 | ELP4_HUMAN Elongator complex protein 4 OS=Homo sapiens GN=ELP4 PE=1 SV=2 | 300 | I | 0.119685 | L | 0.137885 | -0.0182 | No Change: Both O | - |
| Q96BH3 | ESPB1_HUMAN Epididymal sperm-binding protein 1 OS=Homo sapiens GN=ELSPBP1 PE=1 SV=2 | 100 | C | 0.094844 | W | 0.081993 | 0.012851 | No Change: Both O | - |
| Q96BH3 | ESPB1_HUMAN Epididymal sperm-binding protein 1 OS=Homo sapiens GN=ELSPBP1 PE=1 SV=2 | 170 | D | 0.180385 | N | 0.172654 | 0.007731 | No Change: Both O | - |
| Q96BH3 | ESPB1_HUMAN Epididymal sperm-binding protein 1 OS=Homo sapiens GN=ELSPBP1 PE=1 SV=2 | 199 | E | 0.473559 | K | 0.474131 | -5.72E-04 | No Change: Both O | - |
| Q96BH3 | ESPB1_HUMAN Epididymal sperm-binding protein 1 OS=Homo sapiens GN=ELSPBP1 PE=1 SV=2 | 215 | D | 0.242215 | N | 0.226807 | 0.015408 | No Change: Both O | - |
| Q9HBW9 | ELTD1_HUMAN EGF latrophilin and seven transmembrane domain-containing protein 1 OS=Homo sapiens GN=ELTD1 PE=1 SV=3 | 300 | V | 0.09854 | L | 0.100393 | -0.001853 | No Change: Both O | - |
| Q9HBW9 | ELTD1_HUMAN EGF latrophilin and seven transmembrane domain-containing protein 1 OS=Homo sapiens GN=ELTD1 PE=1 SV=3 | 599 | H | 0.140613 | Q | 0.149565 | -0.008952 | No Change: Both O | - |
| Q9HBW9 | ELTD1_HUMAN EGF latrophilin and seven transmembrane domain-containing protein 1 OS=Homo sapiens GN=ELTD1 PE=1 SV=3 | 620 | A | 0.086231 | G | 0.109104 | -0.022873 | No Change: Both O | - |
| P50402 | EMD_HUMAN Emerin OS=Homo sapiens GN=EMD PE=1 SV=1 | 54 | S | 0.8904 | F | 0.79918 | 0.09122 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 1 (EDMD1) [MIM:310300] |
| P50402 | EMD_HUMAN Emerin OS=Homo sapiens GN=EMD PE=1 SV=1 | 183 | P | 0.963103 | H | 0.948309 | 0.014794 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 1 (EDMD1) [MIM:310300] |
| P50402 | EMD_HUMAN Emerin OS=Homo sapiens GN=EMD PE=1 SV=1 | 183 | P | 0.963103 | T | 0.955636 | 0.007467 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 1 (EDMD1) [MIM:310300] |
| P50402 | EMD_HUMAN Emerin OS=Homo sapiens GN=EMD PE=1 SV=1 | 133 | Q | 0.803229 | H | 0.795454 | 0.007775 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 1 (EDMD1) [MIM:310300] |
| P50402 | EMD_HUMAN Emerin OS=Homo sapiens GN=EMD PE=1 SV=1 | 149 | D | 0.840004 | H | 0.814752 | 0.025252 | No Change: Both D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 49 | I | 0.874483 | V | 0.890235 | -0.015752 | No Change: Both D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 69 | E | 0.871662 | D | 0.848273 | 0.023389 | No Change: Both D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 350 | I | 0.354737 | T | 0.520015 | -0.165278 | O to D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 5 | K | 0.986545 | N | 0.976681 | 0.009864 | No Change: Both D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 63 | F | 0.897733 | L | 0.916828 | -0.019095 | No Change: Both D | - |
| Q96AY2 | EME1_HUMAN Crossover junction endonuclease EME1 OS=Homo sapiens GN=EME1 PE=1 SV=2 | 347 | V | 0.314581 | I | 0.303022 | 0.011559 | No Change: Both O | - |
| Q92979 | NEP1_HUMAN Ribosomal RNA small subunit methyltransferase NEP1 OS=Homo sapiens GN=EMG1 PE=1 SV=4 | 34 | A | 0.575734 | G | 0.628962 | -0.053228 | No Change: Both D | - |
| Q92979 | NEP1_HUMAN Ribosomal RNA small subunit methyltransferase NEP1 OS=Homo sapiens GN=EMG1 PE=1 SV=4 | 86 | D | 0.522974 | G | 0.503299 | 0.019675 | No Change: Both D | Bowen-Conradi syndrome (BWCNS) [MIM:211180] |
| Q96A84 | EMID1_HUMAN EMI domain-containing protein 1 OS=Homo sapiens GN=EMID1 PE=2 SV=1 | 107 | A | 0.734911 | G | 0.75716 | -0.022249 | No Change: Both D | - |
| Q96A83 | EMID2_HUMAN Collagen alpha-1(XXVI) chain OS=Homo sapiens GN=EMID2 PE=2 SV=1 | 427 | P | 0.905953 | L | 0.839228 | 0.066725 | No Change: Both D | - |
| Q9Y6C2 | EMIL1_HUMAN EMILIN-1 OS=Homo sapiens GN=EMILIN1 PE=1 SV=2 | 149 | Q | 0.977364 | R | 0.979255 | -0.001891 | No Change: Both D | - |
| Q9Y6C2 | EMIL1_HUMAN EMILIN-1 OS=Homo sapiens GN=EMILIN1 PE=1 SV=2 | 536 | Q | 0.638142 | R | 0.63533 | 0.002812 | No Change: Both D | - |
| Q9Y6C2 | EMIL1_HUMAN EMILIN-1 OS=Homo sapiens GN=EMILIN1 PE=1 SV=2 | 903 | E | 0.359215 | K | 0.356577 | 0.002638 | No Change: Both O | - |
| Q9BXX0 | EMIL2_HUMAN EMILIN-2 OS=Homo sapiens GN=EMILIN2 PE=1 SV=3 | 215 | A | 0.803278 | T | 0.827684 | -0.024406 | No Change: Both D | - |
| Q9BXX0 | EMIL2_HUMAN EMILIN-2 OS=Homo sapiens GN=EMILIN2 PE=1 SV=3 | 259 | M | 0.912406 | V | 0.900329 | 0.012077 | No Change: Both D | - |
| Q9BXX0 | EMIL2_HUMAN EMILIN-2 OS=Homo sapiens GN=EMILIN2 PE=1 SV=3 | 903 | P | 0.802012 | S | 0.79854 | 0.003472 | No Change: Both D | - |
| Q9NT22 | EMIL3_HUMAN EMILIN-3 OS=Homo sapiens GN=EMILIN3 PE=2 SV=2 | 532 | S | 0.40589 | N | 0.307007 | 0.098883 | No Change: Both O | - |
| O00423 | EMAL1_HUMAN Echinoderm microtubule-associated protein-like 1 OS=Homo sapiens GN=EML1 PE=1 SV=3 | 377 | A | 0.247181 | V | 0.179897 | 0.067284 | No Change: Both O | - |
| O00423 | EMAL1_HUMAN Echinoderm microtubule-associated protein-like 1 OS=Homo sapiens GN=EML1 PE=1 SV=3 | 552 | H | 0.17125 | N | 0.184549 | -0.013299 | No Change: Both O | - |
| O00423 | EMAL1_HUMAN Echinoderm microtubule-associated protein-like 1 OS=Homo sapiens GN=EML1 PE=1 SV=3 | 556 | S | 0.332666 | P | 0.289848 | 0.042818 | No Change: Both O | - |
| O95834 | EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=2 SV=1 | 357 | R | 0.305029 | H | 0.311518 | -0.006489 | No Change: Both O | - |
| O95834 | EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=2 SV=1 | 235 | E | 0.256773 | D | 0.235142 | 0.021631 | No Change: Both O | - |
| O95834 | EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=2 SV=1 | 33 | M | 0.371707 | V | 0.294337 | 0.07737 | No Change: Both O | - |
| O95834 | EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=2 SV=1 | 187 | L | 0.206817 | F | 0.18553 | 0.021287 | No Change: Both O | - |
| O95834 | EMAL2_HUMAN Echinoderm microtubule-associated protein-like 2 OS=Homo sapiens GN=EML2 PE=2 SV=1 | 484 | V | 0.142519 | L | 0.137216 | 0.005303 | No Change: Both O | A colorectal cancer sample |
| Q32P44 | EMAL3_HUMAN Echinoderm microtubule-associated protein-like 3 OS=Homo sapiens GN=EML3 PE=1 SV=1 | 620 | Q | 0.137064 | K | 0.157957 | -0.020893 | No Change: Both O | - |
| Q9HC35 | EMAL4_HUMAN Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens GN=EML4 PE=1 SV=3 | 283 | K | 0.054617 | E | 0.054651 | -3.40E-05 | No Change: Both O | - |
| Q9HC35 | EMAL4_HUMAN Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens GN=EML4 PE=1 SV=3 | 382 | I | 0.195895 | V | 0.219625 | -0.02373 | No Change: Both O | - |
| Q9HC35 | EMAL4_HUMAN Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens GN=EML4 PE=1 SV=3 | 398 | K | 0.305896 | R | 0.229863 | 0.076033 | No Change: Both O | - |
| Q9HC35 | EMAL4_HUMAN Echinoderm microtubule-associated protein-like 4 OS=Homo sapiens GN=EML4 PE=1 SV=3 | 978 | S | 0.975228 | L | 0.955047 | 0.020181 | No Change: Both D | - |
| Q05BV3 | EMAL5_HUMAN Echinoderm microtubule-associated protein-like 5 OS=Homo sapiens GN=EML5 PE=2 SV=3 | 269 | I | 0.089433 | V | 0.102254 | -0.012821 | No Change: Both O | - |
| P54849 | EMP1_HUMAN Epithelial membrane protein 1 OS=Homo sapiens GN=EMP1 PE=2 SV=3 | 57 | S | 0.628463 | N | 0.551952 | 0.076511 | No Change: Both D | - |
| P54852 | EMP3_HUMAN Epithelial membrane protein 3 OS=Homo sapiens GN=EMP3 PE=2 SV=1 | 125 | I | 0.51281 | V | 0.527591 | -0.014781 | No Change: Both D | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 57 | A | 0.353169 | T | 0.409741 | -0.056572 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 140 | S | 0.690769 | R | 0.595428 | 0.095341 | No Change: Both D | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 174 | D | 0.708032 | N | 0.701323 | 0.006709 | No Change: Both D | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 254 | N | 0.640818 | S | 0.677497 | -0.036679 | No Change: Both D | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 298 | A | 0.441336 | V | 0.374663 | 0.066673 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 389 | T | 0.427529 | M | 0.359221 | 0.068308 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 424 | I | 0.314361 | V | 0.356781 | -0.04242 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 496 | K | 0.357271 | Q | 0.340672 | 0.016599 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 539 | I | 0.340934 | V | 0.353137 | -0.012203 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 589 | V | 0.143308 | I | 0.134188 | 0.00912 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 691 | F | 0.01911 | C | 0.017823 | 0.001287 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 724 | V | 0.060028 | L | 0.058699 | 0.001329 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 2 | R | 0.49546 | L | 0.400301 | 0.095159 | No Change: Both O | - |
| Q14246 | EMR1_HUMAN EGF-like module-containing mucin-like hormone receptor-like 1 OS=Homo sapiens GN=EMR1 PE=2 SV=3 | 663 | M | 0.268688 | T | 0.328482 | -0.059794 | No Change: Both O | - |
| Q9UHX3 | EMR2_HUMAN EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 | 605 | T | 0.047609 | I | 0.026028 | 0.021581 | No Change: Both O | - |
| Q9UHX3 | EMR2_HUMAN EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 | 614 | L | 0.037118 | F | 0.028043 | 0.009075 | No Change: Both O | - |
| Q9UHX3 | EMR2_HUMAN EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 | 665 | S | 0.404737 | F | 0.181352 | 0.223385 | No Change: Both O | - |
| Q9UHX3 | EMR2_HUMAN EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 | 314 | A | 0.470209 | V | 0.379953 | 0.090256 | No Change: Both O | - |
| Q9UHX3 | EMR2_HUMAN EGF-like module-containing mucin-like hormone receptor-like 2 OS=Homo sapiens GN=EMR2 PE=1 SV=2 | 720 | E | 0.723015 | D | 0.698704 | 0.024311 | No Change: Both D | - |
| Q9BY15 | EMR3_HUMAN EGF-like module-containing mucin-like hormone receptor-like 3 OS=Homo sapiens GN=EMR3 PE=1 SV=2 | 127 | E | 0.873262 | Q | 0.866723 | 0.006539 | No Change: Both D | - |
| Q9BY15 | EMR3_HUMAN EGF-like module-containing mucin-like hormone receptor-like 3 OS=Homo sapiens GN=EMR3 PE=1 SV=2 | 236 | A | 0.32999 | V | 0.244132 | 0.085858 | No Change: Both O | - |
| Q9BY15 | EMR3_HUMAN EGF-like module-containing mucin-like hormone receptor-like 3 OS=Homo sapiens GN=EMR3 PE=1 SV=2 | 385 | R | 0.258832 | Q | 0.281032 | -0.0222 | No Change: Both O | - |
| P19622 | HME2_HUMAN Homeobox protein engrailed-2 OS=Homo sapiens GN=EN2 PE=1 SV=3 | 121 | L | 0.995345 | F | 0.994076 | 0.001269 | No Change: Both D | - |
| Q9NRM1 | ENAM_HUMAN Enamelin OS=Homo sapiens GN=ENAM PE=2 SV=3 | 724 | P | 0.768193 | L | 0.587544 | 0.180649 | No Change: Both D | - |
| Q9NRM1 | ENAM_HUMAN Enamelin OS=Homo sapiens GN=ENAM PE=2 SV=3 | 576 | F | 0.890308 | L | 0.888557 | 0.001751 | No Change: Both D | - |
| Q9NRM1 | ENAM_HUMAN Enamelin OS=Homo sapiens GN=ENAM PE=2 SV=3 | 648 | I | 0.806561 | T | 0.877361 | -0.0708 | No Change: Both D | - |
| Q9NRM1 | ENAM_HUMAN Enamelin OS=Homo sapiens GN=ENAM PE=2 SV=3 | 763 | R | 0.574307 | Q | 0.576328 | -0.002021 | No Change: Both D | - |
| Q9NRM1 | ENAM_HUMAN Enamelin OS=Homo sapiens GN=ENAM PE=2 SV=3 | 767 | D | 0.546978 | G | 0.538786 | 0.008192 | No Change: Both D | - |
| O14682 | ENC1_HUMAN Ectoderm-neural cortex protein 1 OS=Homo sapiens GN=ENC1 PE=1 SV=2 | 256 | I | 0.473222 | S | 0.692991 | -0.219769 | O to D | - |
| O94919 | ENDD1_HUMAN Endonuclease domain-containing 1 protein OS=Homo sapiens GN=ENDOD1 PE=1 SV=2 | 350 | V | 0.01051 | M | 0.013102 | -0.002592 | No Change: Both O | - |
| O94919 | ENDD1_HUMAN Endonuclease domain-containing 1 protein OS=Homo sapiens GN=ENDOD1 PE=1 SV=2 | 446 | G | 0.059203 | V | 0.034458 | 0.024745 | No Change: Both O | - |
| Q14249 | NUCG_HUMAN Endonuclease G mitochondrial OS=Homo sapiens GN=ENDOG PE=1 SV=4 | 12 | S | 0.598926 | L | 0.515802 | 0.083124 | No Change: Both D | - |
| P21128 | ENDOU_HUMAN Poly(U)-specific endoribonuclease OS=Homo sapiens GN=ENDOU PE=1 SV=2 | 72 | E | 0.882528 | Q | 0.859504 | 0.023024 | No Change: Both D | - |
| P21128 | ENDOU_HUMAN Poly(U)-specific endoribonuclease OS=Homo sapiens GN=ENDOU PE=1 SV=2 | 72 | E | 0.882528 | V | 0.739683 | 0.142845 | No Change: Both D | - |
| Q8N8Q3 | ENDOV_HUMAN Endonuclease V OS=Homo sapiens GN=ENDOV PE=2 SV=1 | 29 | V | 0.392004 | I | 0.324782 | 0.067222 | No Change: Both O | - |
| Q8N8Q3 | ENDOV_HUMAN Endonuclease V OS=Homo sapiens GN=ENDOV PE=2 SV=1 | 112 | R | 0.498787 | Q | 0.53992 | -0.041133 | O to D | - |
| Q8N8Q3 | ENDOV_HUMAN Endonuclease V OS=Homo sapiens GN=ENDOV PE=2 SV=1 | 114 | K | 0.619281 | R | 0.571624 | 0.047657 | No Change: Both D | - |
| Q8N8Q3 | ENDOV_HUMAN Endonuclease V OS=Homo sapiens GN=ENDOV PE=2 SV=1 | 141 | H | 0.095866 | Y | 0.050894 | 0.044972 | No Change: Both O | - |
| Q8N8Q3 | ENDOV_HUMAN Endonuclease V OS=Homo sapiens GN=ENDOV PE=2 SV=1 | 201 | D | 0.549355 | N | 0.526717 | 0.022638 | No Change: Both D | - |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 5 | T | 0.576933 | M | 0.565227 | 0.011706 | No Change: Both D | - |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 52 | G | 0.381378 | V | 0.286234 | 0.095144 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 53 | C | 0.335533 | R | 0.467712 | -0.132179 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 149 | W | 0.341049 | C | 0.447995 | -0.106946 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 306 | L | 0.207388 | P | 0.338098 | -0.13071 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 160 | A | 0.534748 | D | 0.582661 | -0.047913 | No Change: Both D | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 221 | L | 0.3197 | P | 0.481833 | -0.162133 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 366 | D | 0.378331 | H | 0.320753 | 0.057578 | No Change: Both O | - |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 8 | L | 0.378398 | P | 0.571261 | -0.192863 | O to D | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 49 | V | 0.400273 | F | 0.358204 | 0.042069 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 107 | L | 0.129814 | R | 0.187656 | -0.057842 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 263 | I | 0.115969 | T | 0.202816 | -0.086847 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 412 | C | 0.455396 | S | 0.661552 | -0.206156 | O to D | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 504 | V | 0.399922 | M | 0.456051 | -0.056129 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 615 | S | 0.24311 | L | 0.118082 | 0.125028 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| P17813 | EGLN_HUMAN Endoglin OS=Homo sapiens GN=ENG PE=1 SV=2 | 413 | G | 0.483762 | V | 0.371046 | 0.112716 | No Change: Both O | Hereditary hemorrhagic telangiectasia type 1 (HHT1) [MIM:187300] |
| Q8NFI3 | ENASE_HUMAN Cytosolic endo-beta-N-acetylglucosaminidase OS=Homo sapiens GN=ENGASE PE=1 SV=1 | 596 | S | 0.564472 | N | 0.511659 | 0.052813 | No Change: Both D | - |
| Q8NFI3 | ENASE_HUMAN Cytosolic endo-beta-N-acetylglucosaminidase OS=Homo sapiens GN=ENGASE PE=1 SV=1 | 731 | E | 0.276619 | K | 0.264261 | 0.012358 | No Change: Both O | - |
| P06733 | ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=ENO1 PE=1 SV=2 | 177 | N | 0.20209 | K | 0.232939 | -0.030849 | No Change: Both O | - |
| P06733 | ENOA_HUMAN Alpha-enolase OS=Homo sapiens GN=ENO1 PE=1 SV=2 | 325 | P | 0.370794 | Q | 0.356972 | 0.013822 | No Change: Both O | - |
| P09104 | ENOG_HUMAN Gamma-enolase OS=Homo sapiens GN=ENO2 PE=1 SV=3 | 264 | P | 0.606486 | A | 0.515911 | 0.090575 | No Change: Both D | - |
| P09104 | ENOG_HUMAN Gamma-enolase OS=Homo sapiens GN=ENO2 PE=1 SV=3 | 395 | T | 0.338221 | A | 0.310988 | 0.027233 | No Change: Both O | - |
| P13929 | ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO3 PE=1 SV=4 | 71 | S | 0.305144 | N | 0.286521 | 0.018623 | No Change: Both O | - |
| P13929 | ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO3 PE=1 SV=4 | 85 | A | 0.486896 | V | 0.426993 | 0.059903 | No Change: Both O | - |
| P13929 | ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO3 PE=1 SV=4 | 156 | G | 0.420038 | D | 0.423846 | -0.003808 | No Change: Both O | Glycogen storage disease type 13 (GSD13) [MIM:612932] |
| P13929 | ENOB_HUMAN Beta-enolase OS=Homo sapiens GN=ENO3 PE=1 SV=4 | 374 | G | 0.553189 | E | 0.587338 | -0.034149 | No Change: Both D | Glycogen storage disease type 13 (GSD13) [MIM:612932] |
| Q7L5Y1 | ENOF1_HUMAN Mitochondrial enolase superfamily member 1 OS=Homo sapiens GN=ENOSF1 PE=1 SV=1 | 31 | D | 0.561609 | E | 0.561528 | 8.10E-05 | No Change: Both D | - |
| Q7L5Y1 | ENOF1_HUMAN Mitochondrial enolase superfamily member 1 OS=Homo sapiens GN=ENOSF1 PE=1 SV=1 | 145 | M | 0.123178 | T | 0.1404 | -0.017222 | No Change: Both O | - |
| Q7L5Y1 | ENOF1_HUMAN Mitochondrial enolase superfamily member 1 OS=Homo sapiens GN=ENOSF1 PE=1 SV=1 | 428 | Y | 0.751677 | S | 0.881242 | -0.129565 | No Change: Both D | - |
| Q8TC92 | ENOX1_HUMAN Ecto-NOX disulfide-thiol exchanger 1 OS=Homo sapiens GN=ENOX1 PE=1 SV=1 | 16 | E | 0.530577 | D | 0.523446 | 0.007131 | No Change: Both D | - |
| Q07075 | AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapiens GN=ENPEP PE=1 SV=3 | 213 | Q | 0.444595 | R | 0.429436 | 0.015159 | No Change: Both O | - |
| Q07075 | AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapiens GN=ENPEP PE=1 SV=3 | 218 | V | 0.422344 | A | 0.509091 | -0.086747 | O to D | - |
| Q07075 | AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapiens GN=ENPEP PE=1 SV=3 | 887 | R | 0.267388 | T | 0.254435 | 0.012953 | No Change: Both O | A breast cancer sample |
| Q07075 | AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapiens GN=ENPEP PE=1 SV=3 | 437 | R | 0.323922 | H | 0.333956 | -0.010034 | No Change: Both O | - |
| Q07075 | AMPE_HUMAN Glutamyl aminopeptidase OS=Homo sapiens GN=ENPEP PE=1 SV=3 | 861 | S | 0.258621 | R | 0.199248 | 0.059373 | No Change: Both O | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 173 | K | 0.672231 | Q | 0.629725 | 0.042506 | No Change: Both D | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 91 | L | 0.072919 | P | 0.131537 | -0.058618 | No Change: Both O | Increased susceptibility for ossification of the posterior longitudinal ligament of the spine (OPLL) [MIM:602475] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 268 | Y | 0.319073 | H | 0.420307 | -0.101234 | No Change: Both O | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 287 | S | 0.581665 | F | 0.351265 | 0.2304 | D to O | Increased susceptibility for ossification of the posterior longitudinal ligament of the spine (OPLL) [MIM:602475] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 779 | T | 0.114776 | P | 0.140527 | -0.025751 | No Change: Both O | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 579 | L | 0.276809 | F | 0.233195 | 0.043614 | No Change: Both O | Idiopathic infantile arterial calcification (IIAC) [MIM:208000] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 774 | R | 0.034984 | C | 0.015088 | 0.019896 | No Change: Both O | Idiopathic infantile arterial calcification (IIAC) [MIM:208000] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 179 | N | 0.668289 | S | 0.733716 | -0.065427 | No Change: Both D | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 342 | G | 0.250242 | V | 0.15516 | 0.095082 | No Change: Both O | Idiopathic infantile arterial calcification (IIAC) [MIM:208000] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 371 | Y | 0.367219 | F | 0.336145 | 0.031074 | No Change: Both O | Idiopathic infantile arterial calcification (IIAC) [MIM:208000] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 886 | R | 0.15776 | T | 0.147784 | 0.009976 | No Change: Both O | - |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 266 | G | 0.307608 | V | 0.221743 | 0.085865 | No Change: Both O | Rickets hypophosphatemic autosomal recessive type 2 (ARHR2) [MIM:613312] |
| P22413 | ENPP1_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 OS=Homo sapiens GN=ENPP1 PE=1 SV=2 | 901 | Y | 0.324723 | S | 0.51896 | -0.194237 | O to D | Rickets hypophosphatemic autosomal recessive type 2 (ARHR2) [MIM:613312] |
| Q13822 | ENPP2_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 OS=Homo sapiens GN=ENPP2 PE=1 SV=3 | 577 | N | 0.689144 | S | 0.713816 | -0.024672 | No Change: Both D | - |
| Q13822 | ENPP2_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 OS=Homo sapiens GN=ENPP2 PE=1 SV=3 | 726 | S | 0.437567 | L | 0.243623 | 0.193944 | No Change: Both O | - |
| Q13822 | ENPP2_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 OS=Homo sapiens GN=ENPP2 PE=1 SV=3 | 493 | S | 0.251475 | P | 0.241147 | 0.010328 | No Change: Both O | - |
| O14638 | ENPP3_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Homo sapiens GN=ENPP3 PE=1 SV=2 | 620 | V | 0.209876 | M | 0.246496 | -0.03662 | No Change: Both O | - |
| O14638 | ENPP3_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Homo sapiens GN=ENPP3 PE=1 SV=2 | 786 | S | 0.306051 | N | 0.27407 | 0.031981 | No Change: Both O | - |
| O14638 | ENPP3_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Homo sapiens GN=ENPP3 PE=1 SV=2 | 744 | N | 0.331202 | H | 0.304277 | 0.026925 | No Change: Both O | - |
| Q9Y6X5 | ENPP4_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 4 OS=Homo sapiens GN=ENPP4 PE=1 SV=3 | 144 | H | 0.295595 | Q | 0.31486 | -0.019265 | No Change: Both O | - |
| Q9Y6X5 | ENPP4_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 4 OS=Homo sapiens GN=ENPP4 PE=1 SV=3 | 255 | I | 0.159285 | V | 0.168513 | -0.009228 | No Change: Both O | - |
| Q9Y6X5 | ENPP4_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 4 OS=Homo sapiens GN=ENPP4 PE=1 SV=3 | 439 | S | 0.44895 | A | 0.309518 | 0.139432 | No Change: Both O | - |
| Q9UJA9 | ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens GN=ENPP5 PE=1 SV=1 | 6 | L | 0.27191 | I | 0.225936 | 0.045974 | No Change: Both O | - |
| Q9UJA9 | ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens GN=ENPP5 PE=1 SV=1 | 171 | I | 0.11911 | V | 0.133764 | -0.014654 | No Change: Both O | - |
| Q9UJA9 | ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens GN=ENPP5 PE=1 SV=1 | 39 | R | 0.059159 | P | 0.073212 | -0.014053 | No Change: Both O | - |
| Q9UJA9 | ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens GN=ENPP5 PE=1 SV=1 | 69 | I | 0.188944 | V | 0.232163 | -0.043219 | No Change: Both O | - |
| Q9UJA9 | ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens GN=ENPP5 PE=1 SV=1 | 283 | Y | 0.368334 | C | 0.318499 | 0.049835 | No Change: Both O | - |
| Q6UWR7 | ENPP6_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 OS=Homo sapiens GN=ENPP6 PE=2 SV=2 | 419 | S | 0.391025 | G | 0.346897 | 0.044128 | No Change: Both O | - |
| Q6UWR7 | ENPP6_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 OS=Homo sapiens GN=ENPP6 PE=2 SV=2 | 357 | D | 0.340144 | N | 0.32571 | 0.014434 | No Change: Both O | - |
| Q6UWV6 | ENPP7_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 OS=Homo sapiens GN=ENPP7 PE=1 SV=3 | 4 | L | 0.436883 | P | 0.577075 | -0.140192 | O to D | - |
| Q8IYW4 | ENTD1_HUMAN ENTH domain-containing protein 1 OS=Homo sapiens GN=ENTHD1 PE=2 SV=1 | 109 | I | 0.42716 | T | 0.561517 | -0.134357 | O to D | - |
| P49961 | ENTP1_HUMAN Ectonucleoside triphosphate diphosphohydrolase 1 OS=Homo sapiens GN=ENTPD1 PE=1 SV=1 | 293 | V | 0.276028 | I | 0.230084 | 0.045944 | No Change: Both O | - |
| Q9Y5L3 | ENTP2_HUMAN Ectonucleoside triphosphate diphosphohydrolase 2 OS=Homo sapiens GN=ENTPD2 PE=1 SV=1 | 103 | A | 0.399444 | V | 0.330383 | 0.069061 | No Change: Both O | - |
| O75355 | ENTP3_HUMAN Ectonucleoside triphosphate diphosphohydrolase 3 OS=Homo sapiens GN=ENTPD3 PE=1 SV=2 | 440 | E | 0.266015 | D | 0.228035 | 0.03798 | No Change: Both O | - |
| O75355 | ENTP3_HUMAN Ectonucleoside triphosphate diphosphohydrolase 3 OS=Homo sapiens GN=ENTPD3 PE=1 SV=2 | 496 | A | 0.043643 | V | 0.02645 | 0.017193 | No Change: Both O | - |
| O75355 | ENTP3_HUMAN Ectonucleoside triphosphate diphosphohydrolase 3 OS=Homo sapiens GN=ENTPD3 PE=1 SV=2 | 505 | L | 0.040567 | F | 0.03526 | 0.005307 | No Change: Both O | - |
| O75355 | ENTP3_HUMAN Ectonucleoside triphosphate diphosphohydrolase 3 OS=Homo sapiens GN=ENTPD3 PE=1 SV=2 | 264 | R | 0.368316 | Q | 0.403805 | -0.035489 | No Change: Both O | - |
| Q9Y227 | ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens GN=ENTPD4 PE=1 SV=1 | 354 | K | 0.462606 | E | 0.452423 | 0.010183 | No Change: Both O | - |
| Q9Y227 | ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens GN=ENTPD4 PE=1 SV=1 | 341 | I | 0.232937 | V | 0.244661 | -0.011724 | No Change: Both O | - |
| O75356 | ENTP5_HUMAN Ectonucleoside triphosphate diphosphohydrolase 5 OS=Homo sapiens GN=ENTPD5 PE=1 SV=1 | 314 | K | 0.414226 | R | 0.371719 | 0.042507 | No Change: Both O | - |
| O75354 | ENTP6_HUMAN Ectonucleoside triphosphate diphosphohydrolase 6 OS=Homo sapiens GN=ENTPD6 PE=1 SV=3 | 138 | L | 0.481307 | V | 0.464161 | 0.017146 | No Change: Both O | - |
| O75354 | ENTP6_HUMAN Ectonucleoside triphosphate diphosphohydrolase 6 OS=Homo sapiens GN=ENTPD6 PE=1 SV=3 | 14 | S | 0.583635 | N | 0.505437 | 0.078198 | No Change: Both D | - |
| O75354 | ENTP6_HUMAN Ectonucleoside triphosphate diphosphohydrolase 6 OS=Homo sapiens GN=ENTPD6 PE=1 SV=3 | 202 | K | 0.376792 | E | 0.348167 | 0.028625 | No Change: Both O | - |
| O75354 | ENTP6_HUMAN Ectonucleoside triphosphate diphosphohydrolase 6 OS=Homo sapiens GN=ENTPD6 PE=1 SV=3 | 323 | S | 0.44502 | N | 0.365461 | 0.079559 | No Change: Both O | - |
| O75354 | ENTP6_HUMAN Ectonucleoside triphosphate diphosphohydrolase 6 OS=Homo sapiens GN=ENTPD6 PE=1 SV=3 | 157 | R | 0.294683 | Q | 0.333282 | -0.038599 | No Change: Both O | - |
| Q9NQZ7 | ENTP7_HUMAN Ectonucleoside triphosphate diphosphohydrolase 7 OS=Homo sapiens GN=ENTPD7 PE=2 SV=1 | 276 | V | 0.521309 | A | 0.604986 | -0.083677 | No Change: Both D | - |
| Q5MY95 | ENTP8_HUMAN Ectonucleoside triphosphate diphosphohydrolase 8 OS=Homo sapiens GN=ENTPD8 PE=1 SV=2 | 62 | L | 0.129002 | P | 0.221404 | -0.092402 | No Change: Both O | - |
| Q5MY95 | ENTP8_HUMAN Ectonucleoside triphosphate diphosphohydrolase 8 OS=Homo sapiens GN=ENTPD8 PE=1 SV=2 | 428 | E | 0.384258 | K | 0.383723 | 5.35E-04 | No Change: Both O | - |
| O95936 | EOMES_HUMAN Eomesodermin homolog OS=Homo sapiens GN=EOMES PE=1 SV=3 | 667 | E | 0.746893 | Q | 0.699943 | 0.04695 | No Change: Both D | A breast cancer sample |
| O95936 | EOMES_HUMAN Eomesodermin homolog OS=Homo sapiens GN=EOMES PE=1 SV=3 | 120 | A | 0.947362 | G | 0.942345 | 0.005017 | No Change: Both D | - |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 827 | L | 0.994366 | P | 0.997487 | -0.003121 | No Change: Both D | A breast cancer sample |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 1013 | E | 0.996679 | G | 0.993939 | 0.00274 | No Change: Both D | A breast cancer sample |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 1650 | S | 0.21338 | Y | 0.09136 | 0.12202 | No Change: Both O | A pancreatic cancer sample |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 2221 | P | 0.994736 | Q | 0.995211 | -4.75E-04 | No Change: Both D | A colorectal cancer sample |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 997 | I | 0.994604 | V | 0.995567 | -9.63E-04 | No Change: Both D | - |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 2174 | T | 0.992497 | S | 0.994947 | -0.00245 | No Change: Both D | - |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 2223 | Q | 0.993336 | P | 0.992969 | 3.67E-04 | No Change: Both D | - |
| Q09472 | EP300_HUMAN Histone acetyltransferase p300 OS=Homo sapiens GN=EP300 PE=1 SV=2 | 289 | M | 0.767587 | V | 0.710982 | 0.056605 | No Change: Both D | - |
| Q96L91 | EP400_HUMAN E1A-binding protein p400 OS=Homo sapiens GN=EP400 PE=1 SV=4 | 1308 | T | 0.400707 | I | 0.279483 | 0.121224 | No Change: Both O | - |
| Q99814 | EPAS1_HUMAN Endothelial PAS domain-containing protein 1 OS=Homo sapiens GN=EPAS1 PE=1 SV=3 | 537 | G | 0.627261 | W | 0.481363 | 0.145898 | D to O | Familial erythrocytosis type 4 (ECYT4) [MIM:611783] |
| Q99814 | EPAS1_HUMAN Endothelial PAS domain-containing protein 1 OS=Homo sapiens GN=EPAS1 PE=1 SV=3 | 766 | T | 0.880729 | P | 0.931531 | -0.050802 | No Change: Both D | - |
| Q99814 | EPAS1_HUMAN Endothelial PAS domain-containing protein 1 OS=Homo sapiens GN=EPAS1 PE=1 SV=3 | 785 | P | 0.89798 | T | 0.84611 | 0.05187 | No Change: Both D | - |
| P11171 | 41_HUMAN Protein 4.1 OS=Homo sapiens GN=EPB41 PE=1 SV=4 | 214 | V | 0.455125 | I | 0.409737 | 0.045388 | No Change: Both O | - |
| Q9H4G0 | E41L1_HUMAN Band 4.1-like protein 1 OS=Homo sapiens GN=EPB41L1 PE=1 SV=2 | 854 | P | 0.540379 | S | 0.531322 | 0.009057 | No Change: Both D | Mental retardation autosomal dominant type 11 (MRD11) [MIM:614257] |
| O43491 | E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens GN=EPB41L2 PE=1 SV=1 | 17 | Q | 0.974746 | H | 0.96468 | 0.010066 | No Change: Both D | - |
| Q9Y2J2 | E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=2 | 555 | A | 0.841055 | T | 0.850152 | -0.009097 | No Change: Both D | - |
| Q9Y2J2 | E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=2 | 575 | Y | 0.613173 | C | 0.633293 | -0.02012 | No Change: Both D | - |
| Q9Y2J2 | E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens GN=EPB41L3 PE=1 SV=2 | 859 | E | 0.528936 | Q | 0.480603 | 0.048333 | D to O | - |
| Q9HCS5 | E41LA_HUMAN Band 4.1-like protein 4A OS=Homo sapiens GN=EPB41L4A PE=1 SV=2 | 132 | V | 0.209207 | I | 0.184786 | 0.024421 | No Change: Both O | - |
| Q9H329 | E41LB_HUMAN Band 4.1-like protein 4B OS=Homo sapiens GN=EPB41L4B PE=2 SV=2 | 816 | N | 0.690377 | T | 0.753178 | -0.062801 | No Change: Both D | - |
| Q9HCM4 | E41L5_HUMAN Band 4.1-like protein 5 OS=Homo sapiens GN=EPB41L5 PE=1 SV=3 | 462 | A | 0.31422 | T | 0.364137 | -0.049917 | No Change: Both O | - |
| Q9HCM4 | E41L5_HUMAN Band 4.1-like protein 5 OS=Homo sapiens GN=EPB41L5 PE=1 SV=3 | 334 | H | 0.567901 | Y | 0.473086 | 0.094815 | D to O | - |
| P16452 | EPB42_HUMAN Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42 PE=1 SV=3 | 112 | A | 0.239794 | T | 0.271497 | -0.031703 | No Change: Both O | Spherocytosis type 5 (SPH5) [MIM:612690] |
| P16452 | EPB42_HUMAN Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42 PE=1 SV=3 | 280 | R | 0.034456 | Q | 0.036006 | -0.00155 | No Change: Both O | Spherocytosis type 5 (SPH5) [MIM:612690] |
| P16452 | EPB42_HUMAN Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42 PE=1 SV=3 | 145 | D | 0.20474 | Y | 0.106021 | 0.098719 | No Change: Both O | Spherocytosis type 5 (SPH5) [MIM:612690] |
| P16452 | EPB42_HUMAN Erythrocyte membrane protein band 4.2 OS=Homo sapiens GN=EPB42 PE=1 SV=3 | 287 | R | 0.088282 | C | 0.042565 | 0.045717 | No Change: Both O | Spherocytosis type 5 (SPH5) [MIM:612690] |
| P16422 | EPCAM_HUMAN Epithelial cell adhesion molecule OS=Homo sapiens GN=EPCAM PE=1 SV=2 | 115 | M | 0.134609 | T | 0.180335 | -0.045726 | No Change: Both O | - |
| P16422 | EPCAM_HUMAN Epithelial cell adhesion molecule OS=Homo sapiens GN=EPCAM PE=1 SV=2 | 66 | C | 0.310758 | Y | 0.25162 | 0.059138 | No Change: Both O | Diarrhea type 5 (DIAR5) [MIM:613217] |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 844 | E | 0.260284 | D | 0.257214 | 0.00307 | No Change: Both O | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1058 | V | 0.143489 | A | 0.181526 | -0.038037 | No Change: Both O | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1131 | I | 0.360719 | V | 0.398445 | -0.037726 | No Change: Both O | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1511 | A | 0.756274 | V | 0.698765 | 0.057509 | No Change: Both D | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1864 | S | 0.642309 | N | 0.526015 | 0.116294 | No Change: Both D | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1985 | R | 0.555094 | Q | 0.590117 | -0.035023 | No Change: Both D | - |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1511 | A | 0.756274 | T | 0.780456 | -0.024182 | No Change: Both D | A breast cancer sample |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 1865 | C | 0.668853 | Y | 0.562489 | 0.106364 | No Change: Both D | A breast cancer sample |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 2056 | R | 0.239105 | W | 0.118537 | 0.120568 | No Change: Both O | A breast cancer sample |
| Q9HCE0 | EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens GN=EPG5 PE=2 SV=2 | 182 | K | 0.829253 | E | 0.841668 | -0.012415 | No Change: Both D | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 160 | V | 0.259925 | A | 0.314302 | -0.054377 | No Change: Both O | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 492 | R | 0.459793 | Q | 0.487152 | -0.027359 | No Change: Both O | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 900 | M | 0.362042 | V | 0.284389 | 0.077653 | No Change: Both O | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 351 | R | 0.807092 | C | 0.7534 | 0.053692 | No Change: Both D | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 575 | R | 0.797346 | Q | 0.805843 | -0.008497 | No Change: Both D | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 585 | A | 0.767117 | T | 0.789724 | -0.022607 | No Change: Both D | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 697 | P | 0.206014 | L | 0.108931 | 0.097083 | No Change: Both O | - |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 703 | E | 0.152251 | K | 0.146147 | 0.006104 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| P21709 | EPHA1_HUMAN Ephrin type-A receptor 1 OS=Homo sapiens GN=EPHA1 PE=1 SV=4 | 807 | S | 0.131485 | R | 0.098494 | 0.032991 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 150 | R | 0.605483 | H | 0.542932 | 0.062551 | No Change: Both D | A gastric adenocarcinoma sample |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 220 | T | 0.265679 | K | 0.313329 | -0.04765 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 281 | F | 0.693523 | I | 0.634785 | 0.058738 | No Change: Both D | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 630 | L | 0.209124 | P | 0.330184 | -0.12106 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 775 | H | 0.238915 | R | 0.25776 | -0.018845 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 956 | A | 0.280526 | T | 0.285717 | -0.005191 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 103 | V | 0.124843 | L | 0.134605 | -0.009762 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 629 | L | 0.230528 | P | 0.356545 | -0.126017 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 645 | V | 0.437801 | I | 0.400752 | 0.037049 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 749 | G | 0.208157 | E | 0.233423 | -0.025266 | No Change: Both O | - |
| Q5JZY3 | EPHAA_HUMAN Ephrin type-A receptor 10 OS=Homo sapiens GN=EPHA10 PE=2 SV=1 | 807 | R | 0.406129 | Q | 0.424112 | -0.017983 | No Change: Both O | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 391 | G | 0.664712 | R | 0.690906 | -0.026194 | No Change: Both D | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 511 | T | 0.464357 | M | 0.414911 | 0.049446 | No Change: Both O | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 568 | R | 0.712976 | H | 0.703859 | 0.009117 | No Change: Both D | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 777 | G | 0.392218 | S | 0.448425 | -0.056207 | No Change: Both O | A gastric adenocarcinoma sample |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 876 | R | 0.365822 | H | 0.317511 | 0.048311 | No Change: Both O | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 99 | K | 0.088473 | N | 0.077593 | 0.01088 | No Change: Both O | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 631 | M | 0.519577 | T | 0.575118 | -0.055541 | No Change: Both D | - |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 940 | T | 0.296986 | I | 0.194533 | 0.102453 | No Change: Both O | Cataract posterior polar type 1 (CTPP1) [MIM:116600] |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 948 | G | 0.295982 | W | 0.119894 | 0.176088 | No Change: Both O | Cataract posterior polar type 1 (CTPP1) [MIM:116600] |
| P29317 | EPHA2_HUMAN Ephrin type-A receptor 2 OS=Homo sapiens GN=EPHA2 PE=1 SV=2 | 721 | R | 0.120792 | Q | 0.138403 | -0.017611 | No Change: Both O | Cataract cortical age-related type 2 (ARCC2) [MIM:613020] |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 914 | R | 0.167434 | H | 0.169335 | -0.001901 | No Change: Both O | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 37 | T | 0.315222 | K | 0.413049 | -0.097827 | No Change: Both O | A colorectal cancer sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 85 | N | 0.224473 | S | 0.254023 | -0.02955 | No Change: Both O | A colorectal cancer sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 621 | I | 0.237821 | L | 0.265071 | -0.02725 | No Change: Both O | A colorectal cancer sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 806 | D | 0.185321 | N | 0.174298 | 0.011023 | No Change: Both O | A colorectal cancer sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 229 | S | 0.583691 | Y | 0.3574 | 0.226291 | D to O | A lung large cell carcinoma sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 449 | S | 0.629522 | F | 0.413988 | 0.215534 | D to O | A lung neuroendocrine carcinoma sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 518 | G | 0.457189 | L | 0.320998 | 0.136191 | No Change: Both O | A lung squamous cell carcinoma sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 564 | I | 0.020181 | V | 0.024354 | -0.004173 | No Change: Both O | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 568 | C | 0.135551 | S | 0.325827 | -0.190276 | No Change: Both O | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 590 | L | 0.349843 | P | 0.515897 | -0.166054 | O to D | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 766 | G | 0.215693 | E | 0.27145 | -0.055757 | No Change: Both O | A lung adenocarcinoma sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 777 | A | 0.50752 | G | 0.564094 | -0.056574 | No Change: Both D | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 924 | W | 0.060395 | R | 0.134785 | -0.07439 | No Change: Both O | - |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 660 | T | 0.396673 | K | 0.48446 | -0.087787 | No Change: Both O | A lung carcinoma sample |
| P29320 | EPHA3_HUMAN Ephrin type-A receptor 3 OS=Homo sapiens GN=EPHA3 PE=1 SV=2 | 933 | T | 0.189948 | M | 0.152309 | 0.037639 | No Change: Both O | A lung carcinoma sample |
| P54764 | EPHA4_HUMAN Ephrin type-A receptor 4 OS=Homo sapiens GN=EPHA4 PE=1 SV=1 | 269 | R | 0.505937 | Q | 0.528078 | -0.022141 | No Change: Both D | - |
| P54764 | EPHA4_HUMAN Ephrin type-A receptor 4 OS=Homo sapiens GN=EPHA4 PE=1 SV=1 | 370 | G | 0.574094 | E | 0.583796 | -0.009702 | No Change: Both D | A bladder carcinoma NOS sample |
| P54764 | EPHA4_HUMAN Ephrin type-A receptor 4 OS=Homo sapiens GN=EPHA4 PE=1 SV=1 | 399 | S | 0.297479 | F | 0.143826 | 0.153653 | No Change: Both O | A metastatic melanoma sample |
| P54764 | EPHA4_HUMAN Ephrin type-A receptor 4 OS=Homo sapiens GN=EPHA4 PE=1 SV=1 | 953 | R | 0.189506 | K | 0.230302 | -0.040796 | No Change: Both O | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 81 | N | 0.18504 | T | 0.160455 | 0.024585 | No Change: Both O | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 235 | S | 0.179022 | A | 0.120423 | 0.058599 | No Change: Both O | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 330 | E | 0.854152 | Q | 0.84117 | 0.012982 | No Change: Both D | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 417 | R | 0.458079 | Q | 0.479227 | -0.021148 | No Change: Both O | A lung adenocarcinoma sample |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 503 | E | 0.301382 | K | 0.303987 | -0.002605 | No Change: Both O | A lung large cell carcinoma sample |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 582 | G | 0.053843 | E | 0.067557 | -0.013714 | No Change: Both O | A lung adenocarcinoma sample |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 672 | A | 0.226324 | T | 0.248809 | -0.022485 | No Change: Both O | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 673 | S | 0.207582 | T | 0.170956 | 0.036626 | No Change: Both O | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 856 | T | 0.236819 | I | 0.148688 | 0.088131 | No Change: Both O | A lung squamous cell carcinoma sample |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 959 | H | 0.516855 | R | 0.521675 | -0.00482 | No Change: Both D | - |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 1032 | N | 0.432554 | S | 0.48524 | -0.052686 | No Change: Both O | A lung large cell carcinoma sample |
| P54756 | EPHA5_HUMAN Ephrin type-A receptor 5 OS=Homo sapiens GN=EPHA5 PE=1 SV=3 | 506 | Y | 0.378064 | C | 0.360913 | 0.017151 | No Change: Both O | - |
| Q9UF33 | EPHA6_HUMAN Ephrin type-A receptor 6 OS=Homo sapiens GN=EPHA6 PE=2 SV=2 | 703 | F | 0.260267 | S | 0.454053 | -0.193786 | No Change: Both O | - |
| Q9UF33 | EPHA6_HUMAN Ephrin type-A receptor 6 OS=Homo sapiens GN=EPHA6 PE=2 SV=2 | 710 | A | 0.162281 | V | 0.121661 | 0.04062 | No Change: Both O | - |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 138 | I | 0.300389 | V | 0.333659 | -0.03327 | No Change: Both O | - |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 278 | P | 0.623407 | S | 0.640526 | -0.017119 | No Change: Both D | - |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 371 | R | 0.133725 | W | 0.053666 | 0.080059 | No Change: Both O | A colorectal cancer sample |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 170 | E | 0.444731 | K | 0.447751 | -0.00302 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 232 | G | 0.388366 | R | 0.401974 | -0.013608 | No Change: Both O | A metastatic melanoma sample |
| Q15375 | EPHA7_HUMAN Ephrin type-A receptor 7 OS=Homo sapiens GN=EPHA7 PE=1 SV=3 | 903 | P | 0.546036 | S | 0.560276 | -0.01424 | No Change: Both D | A metastatic melanoma sample |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 444 | V | 0.388877 | M | 0.421207 | -0.03233 | No Change: Both O | - |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 612 | E | 0.778351 | Q | 0.738132 | 0.040219 | No Change: Both D | - |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 45 | G | 0.127656 | S | 0.154723 | -0.027067 | No Change: Both O | - |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 60 | V | 0.484047 | L | 0.480942 | 0.003105 | No Change: Both O | - |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 123 | N | 0.150365 | K | 0.190996 | -0.040631 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 179 | R | 0.250663 | C | 0.129634 | 0.121029 | No Change: Both O | A gastric adenocarcinoma sample |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 198 | R | 0.052042 | L | 0.032657 | 0.019385 | No Change: Both O | A lung adenocarcinoma sample |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 860 | P | 0.362529 | L | 0.210293 | 0.152236 | No Change: Both O | A metastatic melanoma sample |
| P29322 | EPHA8_HUMAN Ephrin type-A receptor 8 OS=Homo sapiens GN=EPHA8 PE=1 SV=2 | 321 | P | 0.796112 | L | 0.683203 | 0.112909 | No Change: Both D | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 87 | T | 0.234376 | S | 0.29269 | -0.058314 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 152 | G | 0.288821 | R | 0.277992 | 0.010829 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 367 | R | 0.49265 | G | 0.460405 | 0.032245 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 485 | R | 0.623157 | S | 0.675674 | -0.052517 | No Change: Both D | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 847 | M | 0.426869 | T | 0.448954 | -0.022085 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 18 | M | 0.410548 | V | 0.338658 | 0.07189 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 387 | T | 0.23968 | M | 0.207582 | 0.032098 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 707 | S | 0.332754 | T | 0.254459 | 0.078295 | No Change: Both O | An ovarian undifferentiated carcinoma sample |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 719 | I | 0.089699 | V | 0.110924 | -0.021225 | No Change: Both O | A gastric adenocarcinoma sample |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 743 | R | 0.192141 | Q | 0.195247 | -0.003106 | No Change: Both O | A gastric adenocarcinoma sample |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 912 | A | 0.171559 | T | 0.210866 | -0.039307 | No Change: Both O | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 981 | T | 0.795729 | M | 0.7973 | -0.001571 | No Change: Both D | - |
| P54762 | EPHB1_HUMAN Ephrin type-B receptor 1 OS=Homo sapiens GN=EPHB1 PE=1 SV=1 | 973 | R | 0.48802 | W | 0.261012 | 0.227008 | No Change: Both O | - |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 199 | R | 0.095092 | H | 0.088021 | 0.007071 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 279 | A | 0.594338 | S | 0.667305 | -0.072967 | No Change: Both D | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 650 | V | 0.14542 | A | 0.208902 | -0.063482 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 679 | H | 0.268941 | N | 0.285732 | -0.016791 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 883 | M | 0.406408 | V | 0.330091 | 0.076317 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 909 | I | 0.248405 | M | 0.331558 | -0.083153 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 289 | C | 0.477098 | G | 0.583576 | -0.106478 | O to D | - |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 361 | I | 0.193421 | V | 0.21544 | -0.022019 | No Change: Both O | - |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 678 | D | 0.290676 | N | 0.290418 | 2.58E-04 | No Change: Both O | - |
| P29323 | EPHB2_HUMAN Ephrin type-B receptor 2 OS=Homo sapiens GN=EPHB2 PE=1 SV=5 | 844 | R | 0.352984 | W | 0.174954 | 0.17803 | No Change: Both O | - |
| P54753 | EPHB3_HUMAN Ephrin type-B receptor 3 OS=Homo sapiens GN=EPHB3 PE=1 SV=2 | 168 | R | 0.42474 | L | 0.310457 | 0.114283 | No Change: Both O | A lung small cell carcinoma sample |
| P54753 | EPHB3_HUMAN Ephrin type-B receptor 3 OS=Homo sapiens GN=EPHB3 PE=1 SV=2 | 440 | R | 0.421291 | C | 0.27842 | 0.142871 | No Change: Both O | - |
| P54753 | EPHB3_HUMAN Ephrin type-B receptor 3 OS=Homo sapiens GN=EPHB3 PE=1 SV=2 | 579 | I | 0.024871 | V | 0.03085 | -0.005979 | No Change: Both O | - |
| P54753 | EPHB3_HUMAN Ephrin type-B receptor 3 OS=Homo sapiens GN=EPHB3 PE=1 SV=2 | 601 | I | 0.195559 | L | 0.225531 | -0.029972 | No Change: Both O | - |
| P54753 | EPHB3_HUMAN Ephrin type-B receptor 3 OS=Homo sapiens GN=EPHB3 PE=1 SV=2 | 724 | R | 0.156664 | W | 0.063915 | 0.092749 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 67 | P | 0.276249 | L | 0.161102 | 0.115147 | No Change: Both O | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 113 | V | 0.147198 | I | 0.129214 | 0.017984 | No Change: Both O | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 346 | P | 0.792172 | L | 0.705842 | 0.08633 | No Change: Both D | A metastatic melanoma sample |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 371 | A | 0.622461 | V | 0.566355 | 0.056106 | No Change: Both D | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 576 | D | 0.648192 | E | 0.693435 | -0.045243 | No Change: Both D | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 678 | R | 0.213117 | H | 0.217865 | -0.004748 | No Change: Both O | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 882 | A | 0.345549 | T | 0.336354 | 0.009195 | No Change: Both O | - |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 889 | R | 0.45307 | W | 0.260508 | 0.192562 | No Change: Both O | A gastric adenocarcinoma sample |
| P54760 | EPHB4_HUMAN Ephrin type-B receptor 4 OS=Homo sapiens GN=EPHB4 PE=1 SV=2 | 890 | E | 0.469849 | D | 0.462985 | 0.006864 | No Change: Both O | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 122 | G | 0.393516 | S | 0.459781 | -0.066265 | No Change: Both O | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 282 | P | 0.679579 | R | 0.644709 | 0.03487 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 324 | S | 0.907965 | A | 0.888309 | 0.019656 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 499 | R | 0.573887 | Q | 0.622248 | -0.048361 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 360 | D | 0.839166 | N | 0.83761 | 0.001556 | No Change: Both D | A colorectal cancer sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 603 | A | 0.050496 | P | 0.068727 | -0.018231 | No Change: Both O | A colorectal cancer sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 719 | R | 0.159023 | Q | 0.180203 | -0.02118 | No Change: Both O | A colorectal cancer sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 930 | D | 0.691386 | G | 0.675188 | 0.016198 | No Change: Both D | A colorectal cancer sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 170 | S | 0.94741 | T | 0.921694 | 0.025716 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 221 | A | 0.053981 | V | 0.037087 | 0.016894 | No Change: Both O | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 282 | P | 0.679579 | H | 0.622338 | 0.057241 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 309 | R | 0.770712 | Q | 0.781379 | -0.010667 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 332 | S | 0.953735 | L | 0.915347 | 0.038388 | No Change: Both D | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 662 | A | 0.296403 | V | 0.23298 | 0.063423 | No Change: Both O | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 743 | P | 0.292109 | S | 0.320959 | -0.02885 | No Change: Both O | An ovarian mucinous carcinoma sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 813 | R | 0.331072 | H | 0.348515 | -0.017443 | No Change: Both O | - |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 875 | E | 0.373643 | K | 0.34 | 0.033643 | No Change: Both O | A glioblastoma multiforme sample |
| O15197 | EPHB6_HUMAN Ephrin type-B receptor 6 OS=Homo sapiens GN=EPHB6 PE=1 SV=4 | 993 | I | 0.223393 | V | 0.250111 | -0.026718 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 113 | Y | 0.19781 | H | 0.31681 | -0.119 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 139 | H | 0.550909 | R | 0.53592 | 0.014989 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 396 | T | 0.172297 | I | 0.095445 | 0.076852 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 49 | R | 0.663205 | C | 0.540923 | 0.122282 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 260 | L | 0.145531 | P | 0.244772 | -0.099241 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 454 | R | 0.782474 | Q | 0.801575 | -0.019101 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 44 | E | 0.680837 | Q | 0.645383 | 0.035454 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 43 | R | 0.677294 | T | 0.661685 | 0.015609 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 285 | V | 0.208282 | L | 0.210531 | -0.002249 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 408 | T | 0.182818 | M | 0.154926 | 0.027892 | No Change: Both O | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 452 | L | 0.645531 | Q | 0.739587 | -0.094056 | No Change: Both D | - |
| P07099 | HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens GN=EPHX1 PE=1 SV=1 | 275 | T | 0.226088 | A | 0.203806 | 0.022282 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 287 | R | 0.160457 | Q | 0.183971 | -0.023514 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 103 | R | 0.349502 | C | 0.215114 | 0.134388 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 55 | K | 0.444094 | R | 0.422593 | 0.021501 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 21 | G | 0.142322 | A | 0.122251 | 0.020071 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 52 | R | 0.479688 | Q | 0.497278 | -0.01759 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 154 | C | 0.127691 | Y | 0.150459 | -0.022768 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 225 | P | 0.386767 | L | 0.232472 | 0.154295 | No Change: Both O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 369 | M | 0.560702 | V | 0.495092 | 0.06561 | D to O | - |
| P34913 | HYES_HUMAN Epoxide hydrolase 2 OS=Homo sapiens GN=EPHX2 PE=1 SV=2 | 470 | E | 0.156234 | G | 0.127685 | 0.028549 | No Change: Both O | - |
| Q8IUS5 | EPHX4_HUMAN Epoxide hydrolase 4 OS=Homo sapiens GN=EPHX4 PE=2 SV=2 | 321 | Y | 0.110904 | F | 0.094279 | 0.016625 | No Change: Both O | - |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 25 | S | 0.620443 | P | 0.700642 | -0.080199 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 28 | E | 0.684344 | K | 0.629688 | 0.054656 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 32 | W | 0.67265 | G | 0.847469 | -0.174819 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 46 | A | 0.71182 | P | 0.772109 | -0.060289 | No Change: Both D | - |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 84 | F | 0.169247 | L | 0.196856 | -0.027609 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 88 | F | 0.198071 | L | 0.224885 | -0.026814 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 91 | R | 0.343479 | P | 0.393011 | -0.049532 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 108 | R | 0.342879 | C | 0.211385 | 0.131494 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 114 | E | 0.247391 | D | 0.242254 | 0.005137 | No Change: Both O | - |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 171 | R | 0.175662 | H | 0.189596 | -0.013934 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 187 | T | 0.126588 | A | 0.114694 | 0.011894 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 194 | T | 0.143778 | I | 0.083634 | 0.060144 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 240 | G | 0.551438 | S | 0.616212 | -0.064774 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 279 | G | 0.0407 | S | 0.051857 | -0.011157 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 293 | Q | 0.083262 | L | 0.047088 | 0.036174 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 294 | Y | 0.085095 | N | 0.164937 | -0.079842 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 301 | P | 0.146675 | L | 0.077453 | 0.069222 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 140 | K | 0.60422 | N | 0.576437 | 0.027783 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 148 | N | 0.182348 | Y | 0.107135 | 0.075213 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 210 | E | 0.536489 | K | 0.539375 | -0.002886 | No Change: Both D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| O95278 | EPM2A_HUMAN Laforin OS=Homo sapiens GN=EPM2A PE=1 SV=2 | 310 | L | 0.321046 | W | 0.244401 | 0.076645 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q7L775 | EPMIP_HUMAN EPM2A-interacting protein 1 OS=Homo sapiens GN=EPM2AIP1 PE=1 SV=1 | 333 | V | 0.543528 | F | 0.524963 | 0.018565 | No Change: Both D | - |
| Q7L775 | EPMIP_HUMAN EPM2A-interacting protein 1 OS=Homo sapiens GN=EPM2AIP1 PE=1 SV=1 | 360 | A | 0.221423 | S | 0.330658 | -0.109235 | No Change: Both O | - |
| O95208 | EPN2_HUMAN Epsin-2 OS=Homo sapiens GN=EPN2 PE=1 SV=3 | 531 | P | 0.873828 | T | 0.827004 | 0.046824 | No Change: Both D | - |
| O95208 | EPN2_HUMAN Epsin-2 OS=Homo sapiens GN=EPN2 PE=1 SV=3 | 401 | V | 0.881445 | A | 0.913439 | -0.031994 | No Change: Both D | - |
| O95208 | EPN2_HUMAN Epsin-2 OS=Homo sapiens GN=EPN2 PE=1 SV=3 | 532 | P | 0.875049 | T | 0.828062 | 0.046987 | No Change: Both D | - |
| Q9H201 | EPN3_HUMAN Epsin-3 OS=Homo sapiens GN=EPN3 PE=1 SV=1 | 544 | P | 0.90248 | T | 0.874028 | 0.028452 | No Change: Both D | - |
| P01588 | EPO_HUMAN Erythropoietin OS=Homo sapiens GN=EPO PE=1 SV=1 | 149 | P | 0.651602 | Q | 0.629784 | 0.021818 | No Change: Both D | An hepatocellular carcinoma |
| P19235 | EPOR_HUMAN Erythropoietin receptor OS=Homo sapiens GN=EPOR PE=1 SV=1 | 487 | N | 0.835073 | S | 0.881689 | -0.046616 | No Change: Both D | Familial erythrocytosis type 1 (ECYT1) [MIM:133100] |
| P19235 | EPOR_HUMAN Erythropoietin receptor OS=Homo sapiens GN=EPOR PE=1 SV=1 | 488 | P | 0.839376 | S | 0.844608 | -0.005232 | No Change: Both D | Familial erythrocytosis type 1 (ECYT1) [MIM:133100] |
| P19235 | EPOR_HUMAN Erythropoietin receptor OS=Homo sapiens GN=EPOR PE=1 SV=1 | 380 | P | 0.660697 | A | 0.559969 | 0.100728 | No Change: Both D | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 296 | A | 0.709772 | P | 0.770101 | -0.060329 | No Change: Both D | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 308 | D | 0.847654 | E | 0.874937 | -0.027283 | No Change: Both D | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 334 | Q | 0.705352 | H | 0.634268 | 0.071084 | No Change: Both D | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 893 | P | 0.925275 | H | 0.878822 | 0.046453 | No Change: Both D | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 1043 | I | 0.138174 | V | 0.143897 | -0.005723 | No Change: Both O | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 1107 | S | 0.356739 | F | 0.176702 | 0.180037 | No Change: Both O | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 1399 | T | 0.455192 | N | 0.48324 | -0.028048 | No Change: Both O | - |
| P07814 | SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens GN=EPRS PE=1 SV=5 | 913 | E | 0.688356 | G | 0.624928 | 0.063428 | No Change: Both D | - |
| P42566 | EPS15_HUMAN Epidermal growth factor receptor substrate 15 OS=Homo sapiens GN=EPS15 PE=1 SV=2 | 822 | I | 0.95452 | M | 0.970561 | -0.016041 | No Change: Both D | - |
| Q12929 | EPS8_HUMAN Epidermal growth factor receptor kinase substrate 8 OS=Homo sapiens GN=EPS8 PE=1 SV=1 | 761 | D | 0.310428 | E | 0.352759 | -0.042331 | No Change: Both O | - |
| Q12929 | EPS8_HUMAN Epidermal growth factor receptor kinase substrate 8 OS=Homo sapiens GN=EPS8 PE=1 SV=1 | 806 | A | 0.937897 | S | 0.962558 | -0.024661 | No Change: Both D | - |
| Q8TE68 | ES8L1_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens GN=EPS8L1 PE=1 SV=3 | 457 | Q | 0.867106 | E | 0.87393 | -0.006824 | No Change: Both D | - |
| Q8TE68 | ES8L1_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens GN=EPS8L1 PE=1 SV=3 | 4 | A | 0.906281 | T | 0.915154 | -0.008873 | No Change: Both D | - |
| Q8TE68 | ES8L1_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens GN=EPS8L1 PE=1 SV=3 | 288 | R | 0.860252 | G | 0.831101 | 0.029151 | No Change: Both D | - |
| Q8TE68 | ES8L1_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens GN=EPS8L1 PE=1 SV=3 | 669 | K | 0.50408 | R | 0.48776 | 0.01632 | D to O | - |
| Q8TE68 | ES8L1_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 1 OS=Homo sapiens GN=EPS8L1 PE=1 SV=3 | 703 | L | 0.903828 | P | 0.942288 | -0.03846 | No Change: Both D | - |
| Q8TE67 | ES8L3_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 3 OS=Homo sapiens GN=EPS8L3 PE=1 SV=2 | 163 | G | 0.95839 | S | 0.959997 | -0.001607 | No Change: Both D | - |
| Q8TE67 | ES8L3_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 3 OS=Homo sapiens GN=EPS8L3 PE=1 SV=2 | 293 | H | 0.184524 | Y | 0.121651 | 0.062873 | No Change: Both O | - |
| Q8TE67 | ES8L3_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 3 OS=Homo sapiens GN=EPS8L3 PE=1 SV=2 | 356 | P | 0.435158 | S | 0.452576 | -0.017418 | No Change: Both O | - |
| Q8TE67 | ES8L3_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 3 OS=Homo sapiens GN=EPS8L3 PE=1 SV=2 | 35 | M | 0.481535 | I | 0.353595 | 0.12794 | No Change: Both O | - |
| Q8TE67 | ES8L3_HUMAN Epidermal growth factor receptor kinase substrate 8-like protein 3 OS=Homo sapiens GN=EPS8L3 PE=1 SV=2 | 581 | R | 0.728593 | Q | 0.711233 | 0.01736 | No Change: Both D | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 286 | R | 0.658515 | H | 0.569482 | 0.089033 | No Change: Both D | Eosinophil peroxidase deficiency (EPD) [MIM:261500] |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 572 | N | 0.281426 | Y | 0.168012 | 0.113414 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 40 | I | 0.16119 | M | 0.23227 | -0.07108 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 122 | Q | 0.439569 | H | 0.372624 | 0.066945 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 249 | A | 0.312678 | E | 0.399526 | -0.086848 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 276 | K | 0.814105 | R | 0.819402 | -0.005297 | No Change: Both D | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 292 | P | 0.694308 | L | 0.557157 | 0.137151 | No Change: Both D | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 326 | R | 0.333712 | P | 0.345378 | -0.011666 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 358 | P | 0.386945 | L | 0.248624 | 0.138321 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 364 | R | 0.343268 | H | 0.297704 | 0.045564 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 441 | K | 0.286869 | T | 0.22976 | 0.057109 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 496 | H | 0.605382 | Q | 0.614171 | -0.008789 | No Change: Both D | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 35 | V | 0.22044 | I | 0.19617 | 0.02427 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 458 | V | 0.286783 | M | 0.331806 | -0.045023 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 326 | R | 0.333712 | H | 0.312395 | 0.021317 | No Change: Both O | - |
| P11678 | PERE_HUMAN Eosinophil peroxidase OS=Homo sapiens GN=EPX PE=1 SV=2 | 326 | R | 0.333712 | L | 0.228584 | 0.105128 | No Change: Both O | - |
| Q99645 | EPYC_HUMAN Epiphycan OS=Homo sapiens GN=EPYC PE=2 SV=3 | 150 | S | 0.193151 | C | 0.09077 | 0.102381 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 127 | R | 0.504141 | P | 0.566199 | -0.062058 | No Change: Both D | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 276 | I | 0.330255 | M | 0.432457 | -0.102202 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 346 | G | 0.48997 | D | 0.51603 | -0.02606 | O to D | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 349 | M | 0.276437 | V | 0.234493 | 0.041944 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 528 | K | 0.204594 | R | 0.184192 | 0.020402 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 730 | Q | 0.174766 | E | 0.215557 | -0.040791 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 575 | D | 0.30982 | N | 0.294252 | 0.015568 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 725 | R | 0.529012 | Q | 0.547457 | -0.018445 | No Change: Both D | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 56 | E | 0.112797 | K | 0.120494 | -0.007697 | No Change: Both O | - |
| Q9NZ08 | ERAP1_HUMAN Endoplasmic reticulum aminopeptidase 1 OS=Homo sapiens GN=ERAP1 PE=1 SV=3 | 575 | D | 0.30982 | G | 0.284486 | 0.025334 | No Change: Both O | - |
| Q6P179 | ERAP2_HUMAN Endoplasmic reticulum aminopeptidase 2 OS=Homo sapiens GN=ERAP2 PE=1 SV=2 | 214 | P | 0.219733 | L | 0.113898 | 0.105835 | No Change: Both O | - |
| Q6P179 | ERAP2_HUMAN Endoplasmic reticulum aminopeptidase 2 OS=Homo sapiens GN=ERAP2 PE=1 SV=2 | 392 | K | 0.088903 | N | 0.074174 | 0.014729 | No Change: Both O | - |
| Q6P179 | ERAP2_HUMAN Endoplasmic reticulum aminopeptidase 2 OS=Homo sapiens GN=ERAP2 PE=1 SV=2 | 669 | L | 0.105573 | Q | 0.18488 | -0.079307 | No Change: Both O | - |
| Q6P179 | ERAP2_HUMAN Endoplasmic reticulum aminopeptidase 2 OS=Homo sapiens GN=ERAP2 PE=1 SV=2 | 411 | L | 0.17809 | R | 0.275436 | -0.097346 | No Change: Both O | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 654 | I | 0.193458 | V | 0.217988 | -0.02453 | No Change: Both O | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 655 | I | 0.148442 | V | 0.168702 | -0.02026 | No Change: Both O | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 452 | W | 0.134693 | C | 0.160394 | -0.025701 | No Change: Both O | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 1170 | P | 0.778414 | A | 0.727338 | 0.051076 | No Change: Both D | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 768 | L | 0.353317 | S | 0.559182 | -0.205865 | O to D | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 776 | G | 0.23687 | S | 0.286667 | -0.049797 | No Change: Both O | A gastric adenocarcinoma sample |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 857 | N | 0.328922 | S | 0.373812 | -0.04489 | No Change: Both O | An ovarian cancer sample |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 1216 | A | 0.780276 | D | 0.808279 | -0.028003 | No Change: Both D | - |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 755 | L | 0.298461 | P | 0.481492 | -0.183031 | No Change: Both O | A lung adenocarcinoma sample |
| P04626 | ERBB2_HUMAN Receptor tyrosine-protein kinase erbB-2 OS=Homo sapiens GN=ERBB2 PE=1 SV=1 | 914 | E | 0.063017 | K | 0.065797 | -0.00278 | No Change: Both O | A glioblastoma sample |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 274 | S | 0.497101 | L | 0.342688 | 0.154413 | No Change: Both O | - |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 1112 | S | 0.834912 | L | 0.727923 | 0.106989 | No Change: Both D | - |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 1207 | K | 0.798609 | E | 0.795557 | 0.003052 | No Change: Both D | - |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 746 | K | 0.446633 | E | 0.464894 | -0.018261 | No Change: Both O | - |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 914 | K | 0.466739 | R | 0.416162 | 0.050577 | No Change: Both O | - |
| Q96RT1 | LAP2_HUMAN Protein LAP2 OS=Homo sapiens GN=ERBB2IP PE=1 SV=2 | 1089 | G | 0.798451 | V | 0.730255 | 0.068196 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 20 | S | 0.494081 | Y | 0.291301 | 0.20278 | No Change: Both O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 30 | P | 0.291096 | L | 0.17817 | 0.112926 | No Change: Both O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 104 | V | 0.199995 | M | 0.233386 | -0.033391 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 204 | T | 0.671561 | I | 0.553851 | 0.11771 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 683 | R | 0.553871 | W | 0.313956 | 0.239915 | D to O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 717 | S | 0.256235 | L | 0.142992 | 0.113243 | No Change: Both O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 744 | I | 0.285001 | T | 0.397594 | -0.112593 | No Change: Both O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 998 | K | 0.861972 | R | 0.846194 | 0.015778 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 1119 | S | 0.983238 | C | 0.971373 | 0.011865 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 1127 | R | 0.970016 | H | 0.962907 | 0.007109 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 1177 | L | 0.915391 | I | 0.881119 | 0.034272 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 1254 | T | 0.741308 | K | 0.732346 | 0.008962 | No Change: Both D | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 385 | N | 0.230851 | S | 0.266605 | -0.035754 | No Change: Both O | - |
| P21860 | ERBB3_HUMAN Receptor tyrosine-protein kinase erbB-3 OS=Homo sapiens GN=ERBB3 PE=1 SV=1 | 1271 | G | 0.867271 | S | 0.867437 | -1.66E-04 | No Change: Both D | - |
| Q15303 | ERBB4_HUMAN Receptor tyrosine-protein kinase erbB-4 OS=Homo sapiens GN=ERBB4 PE=1 SV=1 | 140 | T | 0.251006 | I | 0.154211 | 0.096795 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q15303 | ERBB4_HUMAN Receptor tyrosine-protein kinase erbB-4 OS=Homo sapiens GN=ERBB4 PE=1 SV=1 | 303 | S | 0.466474 | Y | 0.259342 | 0.207132 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q8IUD2 | RB6I2_HUMAN ELKS/Rab6-interacting/CAST family member 1 OS=Homo sapiens GN=ERC1 PE=1 SV=1 | 50 | S | 0.889461 | G | 0.867795 | 0.021666 | No Change: Both D | - |
| Q8IUD2 | RB6I2_HUMAN ELKS/Rab6-interacting/CAST family member 1 OS=Homo sapiens GN=ERC1 PE=1 SV=1 | 1032 | T | 0.232658 | A | 0.1952 | 0.037458 | No Change: Both O | - |
| O15083 | ERC2_HUMAN ERC protein 2 OS=Homo sapiens GN=ERC2 PE=1 SV=3 | 542 | N | 0.850149 | S | 0.85258 | -0.002431 | No Change: Both D | - |
| P07992 | ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens GN=ERCC1 PE=1 SV=1 | 266 | A | 0.335868 | T | 0.358609 | -0.022741 | No Change: Both O | - |
| P07992 | ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens GN=ERCC1 PE=1 SV=1 | 231 | F | 0.398727 | L | 0.473224 | -0.074497 | No Change: Both O | Cerebro-oculo-facio-skeletal syndrome type 4 (COFS4) [MIM:610758] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 112 | R | 0.313188 | H | 0.31969 | -0.006502 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 112 | R | 0.313188 | H | 0.31969 | -0.006502 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 461 | L | 0.253024 | V | 0.249835 | 0.003189 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 461 | L | 0.253024 | V | 0.249835 | 0.003189 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 541 | S | 0.126019 | R | 0.089155 | 0.036864 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 616 | R | 0.089254 | P | 0.108917 | -0.019663 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 616 | R | 0.089254 | P | 0.108917 | -0.019663 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 602 | G | 0.306364 | D | 0.326991 | -0.020627 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 675 | G | 0.175411 | R | 0.183816 | -0.008405 | No Change: Both O | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 722 | R | 0.206305 | W | 0.08556 | 0.120745 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 725 | A | 0.305109 | P | 0.396001 | -0.090892 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 47 | G | 0.495102 | R | 0.461021 | 0.034081 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 234 | D | 0.178578 | N | 0.171186 | 0.007392 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 259 | C | 0.426898 | Y | 0.445126 | -0.018228 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 542 | Y | 0.177795 | C | 0.136466 | 0.041329 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 601 | R | 0.282523 | L | 0.192734 | 0.089789 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 616 | R | 0.089254 | W | 0.034102 | 0.055152 | No Change: Both O | Cerebro-oculo-facio-skeletal syndrome type 2 (COFS2) [MIM:610756] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 616 | R | 0.089254 | W | 0.034102 | 0.055152 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 658 | R | 0.171188 | C | 0.093962 | 0.077226 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 658 | R | 0.171188 | H | 0.169708 | 0.00148 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 673 | D | 0.228012 | G | 0.217768 | 0.010244 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 683 | R | 0.333824 | Q | 0.331417 | 0.002407 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 683 | R | 0.333824 | W | 0.155777 | 0.178047 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 713 | G | 0.200584 | R | 0.203369 | -0.002785 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 199 | I | 0.063796 | M | 0.097137 | -0.033341 | No Change: Both O | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 201 | H | 0.087306 | Y | 0.054902 | 0.032404 | No Change: Both O | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 312 | D | 0.398431 | N | 0.39439 | 0.004041 | No Change: Both O | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 616 | R | 0.089254 | C | 0.04063 | 0.048624 | No Change: Both O | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 751 | K | 0.805403 | Q | 0.844157 | -0.038754 | No Change: Both D | - |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 76 | T | 0.15878 | A | 0.138229 | 0.020551 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 485 | L | 0.063481 | P | 0.12733 | -0.063849 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 487 | R | 0.043675 | G | 0.045587 | -0.001912 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 511 | R | 0.394245 | Q | 0.40709 | -0.012845 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 592 | R | 0.252591 | P | 0.285161 | -0.03257 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 594 | A | 0.19848 | P | 0.249933 | -0.051453 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 601 | R | 0.282523 | W | 0.12822 | 0.154303 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 658 | R | 0.171188 | G | 0.172669 | -0.001481 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 663 | C | 0.227322 | R | 0.385764 | -0.158442 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 666 | R | 0.240055 | W | 0.097954 | 0.142101 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 681 | D | 0.233298 | N | 0.205328 | 0.02797 | No Change: Both O | Cerebro-oculo-facio-skeletal syndrome type 2 (COFS2) [MIM:610756] |
| P18074 | ERCC2_HUMAN TFIIH basal transcription factor complex helicase XPD subunit OS=Homo sapiens GN=ERCC2 PE=1 SV=1 | 681 | D | 0.233298 | N | 0.205328 | 0.02797 | No Change: Both O | Xeroderma pigmentosum complementation group D (XP-D) [MIM:278730] |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 99 | F | 0.075005 | S | 0.192362 | -0.117357 | No Change: Both O | Xeroderma pigmentosum complementation group B (XP-B) [MIM:610651] |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 119 | T | 0.262967 | P | 0.306832 | -0.043865 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 735 | S | 0.861095 | P | 0.820261 | 0.040834 | No Change: Both D | - |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 117 | K | 0.33059 | R | 0.272622 | 0.057968 | No Change: Both O | - |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 402 | G | 0.326678 | C | 0.227113 | 0.099565 | No Change: Both O | - |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 704 | S | 0.647025 | L | 0.513758 | 0.133267 | No Change: Both D | - |
| P19447 | ERCC3_HUMAN TFIIH basal transcription factor complex helicase XPB subunit OS=Homo sapiens GN=ERCC3 PE=1 SV=1 | 418 | K | 0.494736 | Q | 0.447903 | 0.046833 | No Change: Both O | A breast cancer sample |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 703 | G | 0.304335 | D | 0.351677 | -0.047342 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 799 | R | 0.229529 | W | 0.10364 | 0.125889 | No Change: Both O | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 225 | I | 0.125011 | M | 0.185865 | -0.060854 | No Change: Both O | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 454 | R | 0.833212 | W | 0.717414 | 0.115798 | No Change: Both D | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 490 | R | 0.981139 | Q | 0.979966 | 0.001173 | No Change: Both D | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 502 | E | 0.973142 | K | 0.970682 | 0.00246 | No Change: Both D | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 513 | G | 0.94441 | R | 0.952652 | -0.008242 | No Change: Both D | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 529 | I | 0.780026 | T | 0.818147 | -0.038121 | No Change: Both D | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 567 | T | 0.185866 | A | 0.175901 | 0.009965 | No Change: Both O | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 379 | P | 0.88299 | S | 0.89012 | -0.00713 | No Change: Both D | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 415 | R | 0.298872 | Q | 0.316932 | -0.01806 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 576 | R | 0.186467 | T | 0.172034 | 0.014433 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 608 | L | 0.093124 | P | 0.176626 | -0.083502 | No Change: Both O | Xeroderma pigmentosum complementation group F (XP-F) [MIM:278760] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 717 | I | 0.173661 | T | 0.275274 | -0.101613 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 875 | E | 0.305295 | G | 0.252985 | 0.05231 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 168 | A | 0.161889 | V | 0.112716 | 0.049173 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 662 | S | 0.784569 | P | 0.763587 | 0.020982 | No Change: Both D | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 706 | I | 0.304319 | T | 0.42358 | -0.119261 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 912 | G | 0.784032 | E | 0.773241 | 0.010791 | No Change: Both D | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 873 | I | 0.343634 | V | 0.393048 | -0.049414 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 153 | R | 0.207701 | P | 0.220435 | -0.012734 | No Change: Both O | XFE progeroid syndrome (XFEPS) [MIM:610965] |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 33 | V | 0.10209 | L | 0.107873 | -0.005783 | No Change: Both O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 768 | S | 0.502764 | F | 0.28412 | 0.218644 | D to O | - |
| Q92889 | XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens GN=ERCC4 PE=1 SV=3 | 860 | A | 0.393484 | D | 0.459977 | -0.066493 | No Change: Both O | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 254 | M | 0.735324 | V | 0.697978 | 0.037346 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 792 | A | 0.241351 | V | 0.160609 | 0.080742 | No Change: Both O | Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780] |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1104 | D | 0.979462 | H | 0.971492 | 0.00797 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 311 | S | 0.82509 | C | 0.747223 | 0.077867 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 72 | P | 0.105752 | H | 0.076789 | 0.028963 | No Change: Both O | Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780] |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 874 | A | 0.088263 | T | 0.10991 | -0.021647 | No Change: Both O | Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780] |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 858 | L | 0.131518 | P | 0.229219 | -0.097701 | No Change: Both O | Xeroderma pigmentosum complementation group G (XP-G) [MIM:278780] |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 145 | V | 0.836294 | I | 0.824272 | 0.012022 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 256 | Q | 0.733516 | R | 0.713206 | 0.02031 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 529 | C | 0.842596 | S | 0.909988 | -0.067392 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 680 | Q | 0.980992 | R | 0.979977 | 0.001015 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 879 | N | 0.267206 | S | 0.303033 | -0.035827 | No Change: Both O | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1119 | A | 0.9829 | V | 0.977819 | 0.005081 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 181 | H | 0.847071 | R | 0.86116 | -0.014089 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 399 | E | 0.709486 | K | 0.71062 | -0.001134 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 590 | V | 0.73581 | I | 0.700725 | 0.035085 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 597 | V | 0.709877 | L | 0.681482 | 0.028395 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1009 | R | 0.806872 | H | 0.740311 | 0.066561 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1080 | G | 0.972206 | Q | 0.971653 | 5.53E-04 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 670 | F | 0.977499 | L | 0.979895 | -0.002396 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1053 | G | 0.871596 | R | 0.893058 | -0.021462 | No Change: Both D | - |
| P28715 | ERCC5_HUMAN DNA repair protein complementing XP-G cells OS=Homo sapiens GN=ERCC5 PE=1 SV=3 | 1080 | G | 0.972206 | R | 0.974843 | -0.002637 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 255 | K | 0.791584 | T | 0.751394 | 0.04019 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 399 | G | 0.932131 | D | 0.94256 | -0.010429 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 670 | R | 0.248888 | W | 0.100528 | 0.14836 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 851 | W | 0.176703 | R | 0.369875 | -0.193172 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 957 | V | 0.193859 | G | 0.31554 | -0.121681 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1042 | P | 0.640529 | L | 0.467989 | 0.17254 | D to O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1095 | P | 0.937663 | R | 0.931098 | 0.006565 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1097 | M | 0.934955 | V | 0.927829 | 0.007126 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1213 | R | 0.923782 | G | 0.902971 | 0.020811 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1413 | Q | 0.674514 | R | 0.682849 | -0.008335 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 425 | D | 0.865808 | A | 0.820756 | 0.045052 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 446 | G | 0.868924 | D | 0.877502 | -0.008578 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 942 | T | 0.549172 | M | 0.497532 | 0.05164 | D to O | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1002 | Y | 0.34493 | C | 0.366118 | -0.021188 | No Change: Both O | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1230 | R | 0.876176 | P | 0.88156 | -0.005384 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1308 | V | 0.300921 | L | 0.311181 | -0.01026 | No Change: Both O | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1322 | G | 0.717494 | V | 0.62451 | 0.092984 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1372 | G | 0.899376 | R | 0.91165 | -0.012274 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1382 | G | 0.90744 | R | 0.920974 | -0.013534 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1410 | G | 0.728891 | R | 0.771221 | -0.04233 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1441 | T | 0.439169 | I | 0.316675 | 0.122494 | No Change: Both O | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 591 | P | 0.061932 | A | 0.042136 | 0.019796 | No Change: Both O | A colorectal cancer sample |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 652 | R | 0.423403 | L | 0.307484 | 0.115919 | No Change: Both O | A colorectal cancer sample |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1038 | R | 0.616464 | T | 0.60057 | 0.015894 | No Change: Both D | A breast cancer sample |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1119 | E | 0.948716 | Q | 0.929153 | 0.019563 | No Change: Both D | A breast cancer sample |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1119 | E | 0.948716 | V | 0.911738 | 0.036978 | No Change: Both D | A breast cancer sample |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1220 | T | 0.883824 | I | 0.847673 | 0.036151 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 1355 | D | 0.935867 | E | 0.944521 | -0.008654 | No Change: Both D | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 134 | R | 0.435341 | W | 0.220678 | 0.214663 | No Change: Both O | - |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 680 | N | 0.392372 | D | 0.394127 | -0.001755 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 686 | W | 0.078432 | C | 0.098753 | -0.020321 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 687 | S | 0.055533 | L | 0.02572 | 0.029813 | No Change: Both O | Cockayne syndrome type B (CSB) [MIM:133540] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 871 | L | 0.119315 | P | 0.20852 | -0.089205 | No Change: Both O | Cerebro-oculo-facio-skeletal syndrome type 1 (COFS1) [MIM:214150] |
| Q03468 | ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1 | 987 | L | 0.390891 | P | 0.541274 | -0.150383 | O to D | Cerebro-oculo-facio-skeletal syndrome type 1 (COFS1) [MIM:214150] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 200 | Y | 0.170709 | C | 0.140299 | 0.03041 | No Change: Both O | - |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 160 | A | 0.213261 | V | 0.180873 | 0.032388 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 205 | A | 0.244402 | P | 0.293508 | -0.049106 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 150 | S | 0.554519 | C | 0.327738 | 0.226781 | D to O | - |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 160 | A | 0.213261 | T | 0.263818 | -0.050557 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 194 | W | 0.133329 | C | 0.170433 | -0.037104 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 202 | L | 0.209157 | S | 0.394474 | -0.185317 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| Q13216 | ERCC8_HUMAN DNA excision repair protein ERCC-8 OS=Homo sapiens GN=ERCC8 PE=1 SV=1 | 266 | D | 0.318149 | G | 0.319398 | -0.001249 | No Change: Both O | Cockayne syndrome type A (CSA) [MIM:216400] |
| O14944 | EREG_HUMAN Proepiregulin OS=Homo sapiens GN=EREG PE=1 SV=1 | 147 | R | 0.553113 | Q | 0.552404 | 7.09E-04 | No Change: Both D | - |
| O14944 | EREG_HUMAN Proepiregulin OS=Homo sapiens GN=EREG PE=1 SV=1 | 42 | G | 0.485213 | A | 0.443586 | 0.041627 | No Change: Both O | A breast cancer sample |
| P50548 | ERF_HUMAN ETS domain-containing transcription factor ERF OS=Homo sapiens GN=ERF PE=1 SV=2 | 205 | R | 0.975379 | H | 0.964441 | 0.010938 | No Change: Both D | - |
| Q9Y282 | ERGI3_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Homo sapiens GN=ERGIC3 PE=1 SV=1 | 297 | T | 0.325706 | K | 0.401508 | -0.075802 | No Change: Both O | A colorectal cancer sample |
| Q9Y282 | ERGI3_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Homo sapiens GN=ERGIC3 PE=1 SV=1 | 113 | I | 0.571605 | L | 0.634398 | -0.062793 | No Change: Both D | - |
| Q8IV48 | ERI1_HUMAN 3'-5' exoribonuclease 1 OS=Homo sapiens GN=ERI1 PE=1 SV=3 | 16 | L | 0.980414 | P | 0.9919 | -0.011486 | No Change: Both D | - |
| A8K979 | ERI2_HUMAN ERI1 exoribonuclease 2 OS=Homo sapiens GN=ERI2 PE=2 SV=2 | 206 | I | 0.425678 | T | 0.576371 | -0.150693 | O to D | A colorectal cancer sample |
| Q86X53 | ERIC1_HUMAN Glutamate-rich protein 1 OS=Homo sapiens GN=ERICH1 PE=1 SV=1 | 365 | L | 0.500472 | F | 0.452174 | 0.048298 | D to O | A colorectal cancer sample |
| Q86X53 | ERIC1_HUMAN Glutamate-rich protein 1 OS=Homo sapiens GN=ERICH1 PE=1 SV=1 | 403 | R | 0.387365 | S | 0.455436 | -0.068071 | No Change: Both O | - |
| Q96DZ1 | ERLEC_HUMAN Endoplasmic reticulum lectin 1 OS=Homo sapiens GN=ERLEC1 PE=1 SV=1 | 318 | V | 0.293762 | L | 0.303501 | -0.009739 | No Change: Both O | - |
| O94905 | ERLN2_HUMAN Erlin-2 OS=Homo sapiens GN=ERLIN2 PE=1 SV=1 | 71 | V | 0.467834 | A | 0.53796 | -0.070126 | O to D | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 4 | A | 0.834213 | V | 0.827342 | 0.006871 | No Change: Both D | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 26 | H | 0.276117 | Y | 0.172286 | 0.103831 | No Change: Both O | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 35 | G | 0.474723 | S | 0.509253 | -0.03453 | O to D | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 47 | E | 0.145461 | K | 0.147531 | -0.00207 | No Change: Both O | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 57 | G | 0.191606 | R | 0.199836 | -0.00823 | No Change: Both O | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 60 | P | 0.264138 | A | 0.182778 | 0.08136 | No Change: Both O | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 81 | R | 0.456199 | Q | 0.479774 | -0.023575 | No Change: Both O | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 259 | C | 0.341975 | R | 0.553601 | -0.211626 | O to D | - |
| Q96PL5 | ERMAP_HUMAN Erythroid membrane-associated protein OS=Homo sapiens GN=ERMAP PE=1 SV=1 | 263 | G | 0.457347 | E | 0.528726 | -0.071379 | O to D | - |
| Q7Z2K6 | ERMP1_HUMAN Endoplasmic reticulum metallopeptidase 1 OS=Homo sapiens GN=ERMP1 PE=1 SV=2 | 44 | S | 0.97546 | N | 0.963777 | 0.011683 | No Change: Both D | - |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 244 | N | 0.116729 | S | 0.139538 | -0.022809 | No Change: Both O | A renal clear cell carcinoma sample |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 418 | V | 0.831782 | M | 0.86184 | -0.030058 | No Change: Both D | - |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 474 | L | 0.676649 | R | 0.718707 | -0.042058 | No Change: Both D | A lung adenocarcinoma sample |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 635 | R | 0.189351 | W | 0.079237 | 0.110114 | No Change: Both O | A gastric adenocarcinoma sample |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 700 | N | 0.344917 | S | 0.396295 | -0.051378 | No Change: Both O | - |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 769 | S | 0.222802 | F | 0.1039 | 0.118902 | No Change: Both O | A glioblastoma multiforme sample |
| O75460 | ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | 830 | P | 0.334054 | L | 0.202675 | 0.131379 | No Change: Both O | An ovarian serous carcinoma sample |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 69 | V | 0.258929 | I | 0.239231 | 0.019698 | No Change: Both O | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 118 | R | 0.433683 | C | 0.297657 | 0.136026 | No Change: Both O | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 184 | R | 0.489189 | C | 0.329514 | 0.159675 | No Change: Both O | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 271 | R | 0.531091 | Q | 0.541328 | -0.010237 | No Change: Both D | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 318 | A | 0.472464 | T | 0.510125 | -0.037661 | O to D | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 410 | L | 0.695678 | F | 0.643837 | 0.051841 | No Change: Both D | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 487 | S | 0.957574 | T | 0.937946 | 0.019628 | No Change: Both D | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 504 | L | 0.833428 | F | 0.82319 | 0.010238 | No Change: Both D | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 537 | R | 0.257582 | Q | 0.265646 | -0.008064 | No Change: Both O | - |
| Q76MJ5 | ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | 858 | H | 0.441714 | Y | 0.341133 | 0.100581 | No Change: Both O | - |
| Q86YB8 | ERO1B_HUMAN ERO1-like protein beta OS=Homo sapiens GN=ERO1LB PE=1 SV=2 | 465 | H | 0.740873 | Q | 0.720166 | 0.020707 | No Change: Both D | - |
| Q86YB8 | ERO1B_HUMAN ERO1-like protein beta OS=Homo sapiens GN=ERO1LB PE=1 SV=2 | 129 | D | 0.605664 | V | 0.449221 | 0.156443 | D to O | - |
| Q96DN0 | ERP27_HUMAN Endoplasmic reticulum resident protein 27 OS=Homo sapiens GN=ERP27 PE=1 SV=1 | 52 | F | 0.176676 | L | 0.196439 | -0.019763 | No Change: Both O | - |
| Q9UJM3 | ERRFI_HUMAN ERBB receptor feedback inhibitor 1 OS=Homo sapiens GN=ERRFI1 PE=1 SV=1 | 158 | I | 0.893338 | L | 0.926977 | -0.033639 | No Change: Both D | - |
| Q9UJM3 | ERRFI_HUMAN ERBB receptor feedback inhibitor 1 OS=Homo sapiens GN=ERRFI1 PE=1 SV=1 | 109 | D | 0.651062 | N | 0.692457 | -0.041395 | No Change: Both D | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 90 | T | 0.34937 | I | 0.236418 | 0.112952 | No Change: Both O | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 192 | C | 0.538179 | Y | 0.499934 | 0.038245 | D to O | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 236 | Y | 0.053033 | C | 0.043661 | 0.009372 | No Change: Both O | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 481 | N | 0.373224 | S | 0.420201 | -0.046977 | No Change: Both O | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 522 | L | 0.091078 | P | 0.16769 | -0.076612 | No Change: Both O | - |
| Q14264 | ENR1_HUMAN HERV-R_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERV3-1 PE=1 SV=2 | 569 | N | 0.10829 | S | 0.117855 | -0.009565 | No Change: Both O | - |
| Q9UQF0 | ENW1_HUMAN HERV-W_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERVW-1 PE=1 SV=1 | 129 | V | 0.541629 | A | 0.607393 | -0.065764 | No Change: Both D | - |
| Q9UQF0 | ENW1_HUMAN HERV-W_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERVW-1 PE=1 SV=1 | 138 | R | 0.465403 | Q | 0.496493 | -0.03109 | No Change: Both O | - |
| Q9UQF0 | ENW1_HUMAN HERV-W_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERVW-1 PE=1 SV=1 | 307 | S | 0.200431 | N | 0.164323 | 0.036108 | No Change: Both O | - |
| Q9UQF0 | ENW1_HUMAN HERV-W_7q21.2 provirus ancestral Env polyprotein OS=Homo sapiens GN=ERVW-1 PE=1 SV=1 | 477 | S | 0.140411 | F | 0.054738 | 0.085673 | No Change: Both O | - |
| Q96AP7 | ESAM_HUMAN Endothelial cell-selective adhesion molecule OS=Homo sapiens GN=ESAM PE=1 SV=1 | 273 | R | 0.234713 | C | 0.123677 | 0.111036 | No Change: Both O | - |
| Q5FWF5 | ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens GN=ESCO1 PE=1 SV=3 | 221 | T | 0.940031 | M | 0.929341 | 0.01069 | No Change: Both D | - |
| Q5FWF5 | ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens GN=ESCO1 PE=1 SV=3 | 191 | N | 0.8936 | S | 0.912254 | -0.018654 | No Change: Both D | - |
| Q56NI9 | ESCO2_HUMAN N-acetyltransferase ESCO2 OS=Homo sapiens GN=ESCO2 PE=1 SV=1 | 539 | W | 0.150725 | G | 0.28012 | -0.129395 | No Change: Both O | Roberts syndrome (RBS) [MIM:268300] |
| Q56NI9 | ESCO2_HUMAN N-acetyltransferase ESCO2 OS=Homo sapiens GN=ESCO2 PE=1 SV=1 | 80 | A | 0.47256 | V | 0.411596 | 0.060964 | No Change: Both O | - |
| Q56NI9 | ESCO2_HUMAN N-acetyltransferase ESCO2 OS=Homo sapiens GN=ESCO2 PE=1 SV=1 | 359 | Q | 0.76856 | P | 0.746403 | 0.022157 | No Change: Both D | - |
| P10768 | ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens GN=ESD PE=1 SV=2 | 190 | G | 0.289284 | E | 0.318958 | -0.029674 | No Change: Both O | - |
| P10768 | ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens GN=ESD PE=1 SV=2 | 257 | G | 0.22678 | D | 0.264943 | -0.038163 | No Change: Both O | - |
| Q9H501 | ESF1_HUMAN ESF1 homolog OS=Homo sapiens GN=ESF1 PE=1 SV=1 | 550 | I | 0.917013 | T | 0.942553 | -0.02554 | No Change: Both D | - |
| Q9H501 | ESF1_HUMAN ESF1 homolog OS=Homo sapiens GN=ESF1 PE=1 SV=1 | 386 | P | 0.422833 | L | 0.279658 | 0.143175 | No Change: Both O | - |
| Q9H501 | ESF1_HUMAN ESF1 homolog OS=Homo sapiens GN=ESF1 PE=1 SV=1 | 824 | I | 0.973234 | L | 0.974606 | -0.001372 | No Change: Both D | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 614 | S | 0.420372 | R | 0.357417 | 0.062955 | No Change: Both O | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 699 | R | 0.57989 | Q | 0.592208 | -0.012318 | No Change: Both D | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 1136 | I | 0.666204 | V | 0.712495 | -0.046291 | No Change: Both D | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 1157 | T | 0.071046 | A | 0.066679 | 0.004367 | No Change: Both O | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 1237 | Q | 0.556234 | H | 0.531497 | 0.024737 | No Change: Both D | - |
| Q14674 | ESPL1_HUMAN Separin OS=Homo sapiens GN=ESPL1 PE=1 SV=3 | 1435 | K | 0.904797 | M | 0.863665 | 0.041132 | No Change: Both D | - |
| B1AK53 | ESPN_HUMAN Espin OS=Homo sapiens GN=ESPN PE=1 SV=1 | 322 | R | 0.353268 | H | 0.330214 | 0.023054 | No Change: Both O | - |
| B1AK53 | ESPN_HUMAN Espin OS=Homo sapiens GN=ESPN PE=1 SV=1 | 323 | Y | 0.377398 | C | 0.434853 | -0.057455 | No Change: Both O | - |
| B1AK53 | ESPN_HUMAN Espin OS=Homo sapiens GN=ESPN PE=1 SV=1 | 719 | S | 0.843405 | R | 0.838579 | 0.004826 | No Change: Both D | Deafness autosomal recessive type 36 with or without vestibular involvement (DFNB36) [MIM:609006] |
| B1AK53 | ESPN_HUMAN Espin OS=Homo sapiens GN=ESPN PE=1 SV=1 | 744 | D | 0.736022 | N | 0.706882 | 0.02914 | No Change: Both D | Deafness autosomal recessive type 36 with or without vestibular involvement (DFNB36) [MIM:609006] |
| B1AK53 | ESPN_HUMAN Espin OS=Homo sapiens GN=ESPN PE=1 SV=1 | 774 | R | 0.993602 | Q | 0.993573 | 2.90E-05 | No Change: Both D | Deafness autosomal recessive type 36 with or without vestibular involvement (DFNB36) [MIM:609006] |
| Q6ZVH7 | ESPNL_HUMAN Espin-like protein OS=Homo sapiens GN=ESPNL PE=1 SV=3 | 167 | R | 0.661836 | Q | 0.654718 | 0.007118 | No Change: Both D | - |
| Q6ZVH7 | ESPNL_HUMAN Espin-like protein OS=Homo sapiens GN=ESPNL PE=1 SV=3 | 568 | I | 0.753505 | V | 0.791364 | -0.037859 | No Change: Both D | - |
| Q6ZVH7 | ESPNL_HUMAN Espin-like protein OS=Homo sapiens GN=ESPNL PE=1 SV=3 | 574 | A | 0.792452 | S | 0.837093 | -0.044641 | No Change: Both D | - |
| Q6ZVH7 | ESPNL_HUMAN Espin-like protein OS=Homo sapiens GN=ESPNL PE=1 SV=3 | 761 | V | 0.383179 | A | 0.48719 | -0.104011 | No Change: Both O | - |
| Q6ZVH7 | ESPNL_HUMAN Espin-like protein OS=Homo sapiens GN=ESPNL PE=1 SV=3 | 829 | Q | 0.643433 | R | 0.648025 | -0.004592 | No Change: Both D | - |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 160 | G | 0.865452 | C | 0.813665 | 0.051787 | No Change: Both D | - |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 364 | V | 0.116144 | E | 0.231804 | -0.11566 | No Change: Both O | - |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 400 | G | 0.329797 | V | 0.206487 | 0.12331 | No Change: Both O | - |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 77 | G | 0.568179 | S | 0.602049 | -0.03387 | No Change: Both D | - |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 6 | H | 0.687384 | Y | 0.55087 | 0.136514 | No Change: Both D | A breast cancer sample |
| P03372 | ESR1_HUMAN Estrogen receptor OS=Homo sapiens GN=ESR1 PE=1 SV=2 | 264 | M | 0.9351 | I | 0.889722 | 0.045378 | No Change: Both D | A breast cancer sample |
| Q6NXG1 | ESRP1_HUMAN Epithelial splicing regulatory protein 1 OS=Homo sapiens GN=ESRP1 PE=1 SV=2 | 196 | Y | 0.377664 | C | 0.369223 | 0.008441 | No Change: Both O | - |
| Q9H6T0 | ESRP2_HUMAN Epithelial splicing regulatory protein 2 OS=Homo sapiens GN=ESRP2 PE=1 SV=1 | 111 | S | 0.289734 | L | 0.178016 | 0.111718 | No Change: Both O | - |
| Q9H6T0 | ESRP2_HUMAN Epithelial splicing regulatory protein 2 OS=Homo sapiens GN=ESRP2 PE=1 SV=1 | 528 | A | 0.426478 | V | 0.330363 | 0.096115 | No Change: Both O | - |
| Q9H6T0 | ESRP2_HUMAN Epithelial splicing regulatory protein 2 OS=Homo sapiens GN=ESRP2 PE=1 SV=1 | 627 | P | 0.627651 | S | 0.586054 | 0.041597 | No Change: Both D | - |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 110 | A | 0.137313 | V | 0.104103 | 0.03321 | No Change: Both O | Deafness autosomal recessive type 35 (DFNB35) [MIM:608565] |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 320 | L | 0.102847 | P | 0.171429 | -0.068582 | No Change: Both O | Deafness autosomal recessive type 35 (DFNB35) [MIM:608565] |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 342 | V | 0.263182 | L | 0.279226 | -0.016044 | No Change: Both O | Deafness autosomal recessive type 35 (DFNB35) [MIM:608565] |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 347 | L | 0.226467 | P | 0.348414 | -0.121947 | No Change: Both O | Deafness autosomal recessive type 35 (DFNB35) [MIM:608565] |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 386 | P | 0.526644 | S | 0.562781 | -0.036137 | No Change: Both D | - |
| O95718 | ERR2_HUMAN Steroid hormone receptor ERR2 OS=Homo sapiens GN=ESRRB PE=1 SV=2 | 389 | T | 0.384411 | M | 0.33225 | 0.052161 | No Change: Both O | Deafness autosomal recessive type 35 (DFNB35) [MIM:608565] |
| P62508 | ERR3_HUMAN Estrogen-related receptor gamma OS=Homo sapiens GN=ESRRG PE=1 SV=1 | 50 | T | 0.956871 | M | 0.956874 | -3.00E-06 | No Change: Both D | - |
| Q8N693 | ESX1_HUMAN Homeobox protein ESX1 OS=Homo sapiens GN=ESX1 PE=1 SV=3 | 314 | T | 0.999777 | P | 0.999895 | -1.18E-04 | No Change: Both D | - |
| Q9BSJ8 | ESYT1_HUMAN Extended synaptotagmin-1 OS=Homo sapiens GN=ESYT1 PE=1 SV=1 | 764 | R | 0.463201 | C | 0.28416 | 0.179041 | No Change: Both O | - |
| A0FGR8 | ESYT2_HUMAN Extended synaptotagmin-2 OS=Homo sapiens GN=ESYT2 PE=1 SV=1 | 210 | C | 0.028288 | S | 0.079829 | -0.051541 | No Change: Both O | - |
| A0FGR8 | ESYT2_HUMAN Extended synaptotagmin-2 OS=Homo sapiens GN=ESYT2 PE=1 SV=1 | 638 | S | 0.677051 | G | 0.602884 | 0.074167 | No Change: Both D | - |
| A0FGR9 | ESYT3_HUMAN Extended synaptotagmin-3 OS=Homo sapiens GN=ESYT3 PE=2 SV=1 | 246 | P | 0.109069 | Q | 0.110347 | -0.001278 | No Change: Both O | - |
| A0FGR9 | ESYT3_HUMAN Extended synaptotagmin-3 OS=Homo sapiens GN=ESYT3 PE=2 SV=1 | 416 | G | 0.301783 | R | 0.310903 | -0.00912 | No Change: Both O | - |
| A0FGR9 | ESYT3_HUMAN Extended synaptotagmin-3 OS=Homo sapiens GN=ESYT3 PE=2 SV=1 | 590 | G | 0.565671 | R | 0.580049 | -0.014378 | No Change: Both D | - |
| A0FGR9 | ESYT3_HUMAN Extended synaptotagmin-3 OS=Homo sapiens GN=ESYT3 PE=2 SV=1 | 662 | T | 0.974745 | S | 0.977889 | -0.003144 | No Change: Both D | - |
| Q9NY74 | ETAA1_HUMAN Ewing's tumor-associated antigen 1 OS=Homo sapiens GN=ETAA1 PE=1 SV=2 | 221 | M | 0.349988 | T | 0.395387 | -0.045399 | No Change: Both O | - |
| Q9NY74 | ETAA1_HUMAN Ewing's tumor-associated antigen 1 OS=Homo sapiens GN=ETAA1 PE=1 SV=2 | 389 | S | 0.418921 | N | 0.38815 | 0.030771 | No Change: Both O | - |
| Q9NY74 | ETAA1_HUMAN Ewing's tumor-associated antigen 1 OS=Homo sapiens GN=ETAA1 PE=1 SV=2 | 715 | P | 0.79381 | L | 0.697397 | 0.096413 | No Change: Both D | - |
| Q9NY74 | ETAA1_HUMAN Ewing's tumor-associated antigen 1 OS=Homo sapiens GN=ETAA1 PE=1 SV=2 | 771 | P | 0.666783 | S | 0.707819 | -0.041036 | No Change: Both D | - |
| Q9NY74 | ETAA1_HUMAN Ewing's tumor-associated antigen 1 OS=Homo sapiens GN=ETAA1 PE=1 SV=2 | 50 | E | 0.972532 | D | 0.961272 | 0.01126 | No Change: Both D | A colorectal cancer sample |
| P13804 | ETFA_HUMAN Electron transfer flavoprotein subunit alpha mitochondrial OS=Homo sapiens GN=ETFA PE=1 SV=1 | 116 | G | 0.271118 | R | 0.25614 | 0.014978 | No Change: Both O | Glutaric aciduria type 2A (GA2A) [MIM:231680] |
| P13804 | ETFA_HUMAN Electron transfer flavoprotein subunit alpha mitochondrial OS=Homo sapiens GN=ETFA PE=1 SV=1 | 157 | V | 0.174385 | G | 0.256556 | -0.082171 | No Change: Both O | Glutaric aciduria type 2A (GA2A) [MIM:231680] |
| P13804 | ETFA_HUMAN Electron transfer flavoprotein subunit alpha mitochondrial OS=Homo sapiens GN=ETFA PE=1 SV=1 | 266 | T | 0.327213 | M | 0.299678 | 0.027535 | No Change: Both O | Glutaric aciduria type 2A (GA2A) [MIM:231680] |
| P13804 | ETFA_HUMAN Electron transfer flavoprotein subunit alpha mitochondrial OS=Homo sapiens GN=ETFA PE=1 SV=1 | 171 | T | 0.511414 | I | 0.36424 | 0.147174 | D to O | - |
| P38117 | ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens GN=ETFB PE=1 SV=3 | 164 | R | 0.488277 | Q | 0.50496 | -0.016683 | O to D | Glutaric aciduria type 2B (GA2B) [MIM:231680] |
| P38117 | ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens GN=ETFB PE=1 SV=3 | 154 | T | 0.349096 | M | 0.30039 | 0.048706 | No Change: Both O | - |
| P38117 | ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens GN=ETFB PE=1 SV=3 | 128 | D | 0.373383 | N | 0.348233 | 0.02515 | No Change: Both O | Glutaric aciduria type 2B (GA2B) [MIM:231680] |
| Q16134 | ETFD_HUMAN Electron transfer flavoprotein-ubiquinone oxidoreductase mitochondrial OS=Homo sapiens GN=ETFDH PE=1 SV=2 | 565 | V | 0.128437 | L | 0.118946 | 0.009491 | No Change: Both O | A colorectal cancer sample |
| Q16134 | ETFD_HUMAN Electron transfer flavoprotein-ubiquinone oxidoreductase mitochondrial OS=Homo sapiens GN=ETFDH PE=1 SV=2 | 94 | H | 0.224619 | R | 0.243319 | -0.0187 | No Change: Both O | - |
| Q16134 | ETFD_HUMAN Electron transfer flavoprotein-ubiquinone oxidoreductase mitochondrial OS=Homo sapiens GN=ETFDH PE=1 SV=2 | 31 | T | 0.200247 | I | 0.10427 | 0.095977 | No Change: Both O | - |
| O95571 | ETHE1_HUMAN Protein ETHE1 mitochondrial OS=Homo sapiens GN=ETHE1 PE=1 SV=2 | 38 | Y | 0.185006 | C | 0.237951 | -0.052945 | No Change: Both O | Ethylmalonic encephalopathy (EE) [MIM:602473] |
| O95571 | ETHE1_HUMAN Protein ETHE1 mitochondrial OS=Homo sapiens GN=ETHE1 PE=1 SV=2 | 136 | T | 0.362861 | A | 0.33479 | 0.028071 | No Change: Both O | Ethylmalonic encephalopathy (EE) [MIM:602473] |
| O95571 | ETHE1_HUMAN Protein ETHE1 mitochondrial OS=Homo sapiens GN=ETHE1 PE=1 SV=2 | 163 | R | 0.1941 | W | 0.076889 | 0.117211 | No Change: Both O | Ethylmalonic encephalopathy (EE) [MIM:602473] |
| O95571 | ETHE1_HUMAN Protein ETHE1 mitochondrial OS=Homo sapiens GN=ETHE1 PE=1 SV=2 | 185 | L | 0.117059 | R | 0.179896 | -0.062837 | No Change: Both O | Ethylmalonic encephalopathy (EE) [MIM:602473] |
| Q9NVF9 | EKI2_HUMAN Ethanolamine kinase 2 OS=Homo sapiens GN=ETNK2 PE=2 SV=3 | 227 | R | 0.224288 | Q | 0.241337 | -0.017049 | No Change: Both O | - |
| P50549 | ETV1_HUMAN ETS translocation variant 1 OS=Homo sapiens GN=ETV1 PE=1 SV=2 | 100 | S | 0.794815 | G | 0.72201 | 0.072805 | No Change: Both D | - |
| Q6ZN32 | ETV3L_HUMAN ETS translocation variant 3-like protein OS=Homo sapiens GN=ETV3L PE=2 SV=1 | 19 | S | 0.143331 | A | 0.098387 | 0.044944 | No Change: Both O | - |
| Q6ZN32 | ETV3L_HUMAN ETS translocation variant 3-like protein OS=Homo sapiens GN=ETV3L PE=2 SV=1 | 263 | G | 0.83843 | A | 0.815922 | 0.022508 | No Change: Both D | - |
| Q6ZN32 | ETV3L_HUMAN ETS translocation variant 3-like protein OS=Homo sapiens GN=ETV3L PE=2 SV=1 | 318 | M | 0.790087 | V | 0.721658 | 0.068429 | No Change: Both D | - |
| Q6ZN32 | ETV3L_HUMAN ETS translocation variant 3-like protein OS=Homo sapiens GN=ETV3L PE=2 SV=1 | 151 | R | 0.161928 | W | 0.065216 | 0.096712 | No Change: Both O | - |
| P43268 | ETV4_HUMAN ETS translocation variant 4 OS=Homo sapiens GN=ETV4 PE=1 SV=3 | 437 | R | 0.517605 | C | 0.373055 | 0.14455 | D to O | - |
| P41161 | ETV5_HUMAN ETS translocation variant 5 OS=Homo sapiens GN=ETV5 PE=1 SV=1 | 348 | K | 0.643926 | R | 0.617417 | 0.026509 | No Change: Both D | - |
| Q9Y603 | ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens GN=ETV7 PE=1 SV=1 | 212 | P | 0.312589 | L | 0.160307 | 0.152282 | No Change: Both O | - |
| Q9Y603 | ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens GN=ETV7 PE=1 SV=1 | 138 | H | 0.665127 | Y | 0.589297 | 0.07583 | No Change: Both D | - |
| Q9Y603 | ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens GN=ETV7 PE=1 SV=1 | 199 | G | 0.175804 | S | 0.209871 | -0.034067 | No Change: Both O | - |
| Q9Y603 | ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens GN=ETV7 PE=1 SV=1 | 250 | A | 0.24894 | V | 0.198892 | 0.050048 | No Change: Both O | - |
| Q9Y603 | ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens GN=ETV7 PE=1 SV=1 | 86 | A | 0.119536 | T | 0.14334 | -0.023804 | No Change: Both O | - |
| Q9NYK6 | EURL_HUMAN Protein EURL homolog OS=Homo sapiens GN=EURL PE=2 SV=3 | 117 | Q | 0.603453 | R | 0.58557 | 0.017883 | No Change: Both D | - |
| Q9NYK6 | EURL_HUMAN Protein EURL homolog OS=Homo sapiens GN=EURL PE=2 SV=3 | 136 | D | 0.495358 | E | 0.527461 | -0.032103 | O to D | - |
| Q9NYK6 | EURL_HUMAN Protein EURL homolog OS=Homo sapiens GN=EURL PE=2 SV=3 | 115 | N | 0.667404 | K | 0.69802 | -0.030616 | No Change: Both D | - |
| Q9NYK6 | EURL_HUMAN Protein EURL homolog OS=Homo sapiens GN=EURL PE=2 SV=3 | 195 | Q | 0.685995 | H | 0.66122 | 0.024775 | No Change: Both D | - |
| Q9NYK6 | EURL_HUMAN Protein EURL homolog OS=Homo sapiens GN=EURL PE=2 SV=3 | 217 | Y | 0.761788 | H | 0.860579 | -0.098791 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 74 | Q | 0.944816 | P | 0.946891 | -0.002075 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 258 | Y | 0.786367 | H | 0.863535 | -0.077168 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 307 | S | 0.530871 | P | 0.506989 | 0.023882 | No Change: Both D | Acrofacial dysostosis Weyers type (WAD) [MIM:193530] |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 403 | G | 0.40368 | S | 0.456403 | -0.052723 | No Change: Both O | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 443 | R | 0.55783 | Q | 0.582119 | -0.024289 | No Change: Both D | Ellis-van Creveld syndrome (EVC) [MIM:225500] |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 449 | T | 0.539298 | K | 0.598341 | -0.059043 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 576 | R | 0.468252 | Q | 0.504547 | -0.036295 | O to D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 760 | R | 0.692753 | Q | 0.684303 | 0.00845 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 953 | D | 0.970377 | G | 0.968723 | 0.001654 | No Change: Both D | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 114 | A | 0.450196 | V | 0.379765 | 0.070431 | No Change: Both O | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 372 | T | 0.452284 | M | 0.456805 | -0.004521 | No Change: Both O | - |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 206 | S | 0.127057 | N | 0.101689 | 0.025368 | No Change: Both O | Ellis-van Creveld syndrome (EVC) [MIM:225500] |
| P57679 | EVC_HUMAN Ellis-van Creveld syndrome protein OS=Homo sapiens GN=EVC PE=1 SV=1 | 623 | L | 0.475645 | P | 0.584738 | -0.109093 | O to D | Ellis-van Creveld syndrome (EVC) [MIM:225500] |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 283 | I | 0.171747 | R | 0.307331 | -0.135584 | No Change: Both O | Ellis-van Creveld syndrome (EVC) [MIM:225500] |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 699 | T | 0.77591 | A | 0.778331 | -0.002421 | No Change: Both D | - |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 950 | R | 0.691351 | W | 0.405006 | 0.286345 | D to O | Ellis-van Creveld syndrome (EVC) [MIM:225500] |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 630 | A | 0.493012 | S | 0.579494 | -0.086482 | O to D | A colorectal cancer sample |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 994 | L | 0.511478 | V | 0.448358 | 0.06312 | D to O | A colorectal cancer sample |
| Q86UK5 | LBN_HUMAN Limbin OS=Homo sapiens GN=EVC2 PE=1 SV=1 | 230 | S | 0.337127 | G | 0.298281 | 0.038846 | No Change: Both O | - |
| P34910 | EVI2B_HUMAN Protein EVI2B OS=Homo sapiens GN=EVI2B PE=1 SV=2 | 53 | G | 0.933146 | R | 0.927397 | 0.005749 | No Change: Both D | - |
| O60447 | EVI5_HUMAN Ecotropic viral integration site 5 protein homolog OS=Homo sapiens GN=EVI5 PE=1 SV=3 | 336 | I | 0.071361 | V | 0.074891 | -0.00353 | No Change: Both O | - |
| O60447 | EVI5_HUMAN Ecotropic viral integration site 5 protein homolog OS=Homo sapiens GN=EVI5 PE=1 SV=3 | 612 | Q | 0.756813 | H | 0.676968 | 0.079845 | No Change: Both D | - |
| O60447 | EVI5_HUMAN Ecotropic viral integration site 5 protein homolog OS=Homo sapiens GN=EVI5 PE=1 SV=3 | 82 | D | 0.984233 | V | 0.971716 | 0.012517 | No Change: Both D | - |
| Q9UI08 | EVL_HUMAN Ena/VASP-like protein OS=Homo sapiens GN=EVL PE=1 SV=2 | 188 | P | 0.999839 | L | 0.999633 | 2.06E-04 | No Change: Both D | A colorectal cancer sample |
| Q9UI08 | EVL_HUMAN Ena/VASP-like protein OS=Homo sapiens GN=EVL PE=1 SV=2 | 247 | P | 0.978879 | L | 0.966896 | 0.011983 | No Change: Both D | A colorectal cancer sample |
| Q92817 | EVPL_HUMAN Envoplakin OS=Homo sapiens GN=EVPL PE=1 SV=3 | 49 | N | 0.845204 | S | 0.888962 | -0.043758 | No Change: Both D | - |
| Q92817 | EVPL_HUMAN Envoplakin OS=Homo sapiens GN=EVPL PE=1 SV=3 | 433 | Q | 0.33143 | R | 0.317312 | 0.014118 | No Change: Both O | - |
| Q92817 | EVPL_HUMAN Envoplakin OS=Homo sapiens GN=EVPL PE=1 SV=3 | 168 | Y | 0.413537 | C | 0.460727 | -0.04719 | No Change: Both O | - |
| Q92817 | EVPL_HUMAN Envoplakin OS=Homo sapiens GN=EVPL PE=1 SV=3 | 1814 | P | 0.80761 | S | 0.819679 | -0.012069 | No Change: Both D | - |
| A8MZ36 | EVPLL_HUMAN Envoplakin-like protein OS=Homo sapiens GN=EVPLL PE=2 SV=1 | 4 | S | 0.950913 | N | 0.93916 | 0.011753 | No Change: Both D | - |
| Q8NHP7 | EXD1_HUMAN Exonuclease 3'-5' domain-containing protein 1 OS=Homo sapiens GN=EXD1 PE=2 SV=4 | 489 | T | 0.441156 | A | 0.38346 | 0.057696 | No Change: Both O | - |
| Q9NVH0 | EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens GN=EXD2 PE=1 SV=1 | 106 | D | 0.26317 | N | 0.253369 | 0.009801 | No Change: Both O | - |
| Q9NVH0 | EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens GN=EXD2 PE=1 SV=1 | 393 | Q | 0.731842 | H | 0.658194 | 0.073648 | No Change: Both D | - |
| Q8N9H8 | MUT7_HUMAN Probable exonuclease mut-7 homolog OS=Homo sapiens GN=EXD3 PE=1 SV=3 | 220 | R | 0.310596 | Q | 0.312114 | -0.001518 | No Change: Both O | - |
| Q8N9H8 | MUT7_HUMAN Probable exonuclease mut-7 homolog OS=Homo sapiens GN=EXD3 PE=1 SV=3 | 20 | R | 0.749826 | Q | 0.742697 | 0.007129 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 27 | V | 0.116322 | A | 0.152366 | -0.036044 | No Change: Both O | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 76 | V | 0.154306 | I | 0.146586 | 0.00772 | No Change: Both O | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 93 | R | 0.749605 | G | 0.725281 | 0.024324 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 109 | E | 0.659624 | K | 0.666242 | -0.006618 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 137 | A | 0.348927 | S | 0.453092 | -0.104165 | No Change: Both O | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 279 | N | 0.087117 | S | 0.095621 | -0.008504 | No Change: Both O | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 299 | N | 0.245341 | S | 0.283629 | -0.038288 | No Change: Both O | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 354 | H | 0.688112 | R | 0.700213 | -0.012101 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 410 | L | 0.792002 | R | 0.86219 | -0.070188 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 428 | D | 0.867688 | N | 0.863407 | 0.004281 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 438 | F | 0.90224 | C | 0.907597 | -0.005357 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 439 | T | 0.916892 | M | 0.902616 | 0.014276 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 456 | S | 0.88848 | Y | 0.760752 | 0.127728 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 458 | V | 0.851327 | M | 0.870297 | -0.01897 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 460 | V | 0.856916 | L | 0.86384 | -0.006924 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 503 | R | 0.63429 | T | 0.617537 | 0.016753 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 589 | E | 0.750538 | K | 0.746353 | 0.004185 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 610 | S | 0.871763 | G | 0.837595 | 0.034168 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 634 | R | 0.979356 | Q | 0.97997 | -6.14E-04 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 640 | P | 0.985193 | A | 0.975979 | 0.009214 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 640 | P | 0.985193 | S | 0.986242 | -0.001049 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 670 | E | 0.997421 | G | 0.996046 | 0.001375 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 723 | R | 0.938792 | C | 0.920844 | 0.017948 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 726 | H | 0.92909 | P | 0.956266 | -0.027176 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 757 | P | 0.927315 | L | 0.876691 | 0.050624 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 759 | G | 0.927889 | E | 0.932729 | -0.00484 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 770 | P | 0.887962 | L | 0.817512 | 0.07045 | No Change: Both D | - |
| Q9UQ84 | EXO1_HUMAN Exonuclease 1 OS=Homo sapiens GN=EXO1 PE=1 SV=2 | 827 | A | 0.670655 | V | 0.62803 | 0.042625 | No Change: Both D | - |
| Q96KP1 | EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens GN=EXOC2 PE=1 SV=1 | 195 | N | 0.695518 | T | 0.677832 | 0.017686 | No Change: Both D | - |
| Q86VI1 | EX3L1_HUMAN Exocyst complex component 3-like protein OS=Homo sapiens GN=EXOC3L1 PE=2 SV=2 | 561 | Q | 0.419272 | E | 0.460305 | -0.041033 | No Change: Both O | - |
| Q86VI1 | EX3L1_HUMAN Exocyst complex component 3-like protein OS=Homo sapiens GN=EXOC3L1 PE=2 SV=2 | 634 | S | 0.367546 | G | 0.359125 | 0.008421 | No Change: Both O | - |
| Q86VI1 | EX3L1_HUMAN Exocyst complex component 3-like protein OS=Homo sapiens GN=EXOC3L1 PE=2 SV=2 | 75 | Y | 0.439668 | N | 0.551385 | -0.111717 | O to D | A breast cancer sample |
| Q86VI1 | EX3L1_HUMAN Exocyst complex component 3-like protein OS=Homo sapiens GN=EXOC3L1 PE=2 SV=2 | 514 | A | 0.481693 | D | 0.549324 | -0.067631 | O to D | A breast cancer sample |
| Q2M3D2 | EX3L2_HUMAN Exocyst complex component 3-like protein 2 OS=Homo sapiens GN=EXOC3L2 PE=2 SV=1 | 173 | N | 0.16886 | D | 0.185171 | -0.016311 | No Change: Both O | - |
| Q17RC7 | EX3L4_HUMAN Exocyst complex component 3-like protein 4 OS=Homo sapiens GN=EXOC3L4 PE=2 SV=2 | 77 | R | 0.772604 | W | 0.533224 | 0.23938 | No Change: Both D | - |
| Q17RC7 | EX3L4_HUMAN Exocyst complex component 3-like protein 4 OS=Homo sapiens GN=EXOC3L4 PE=2 SV=2 | 93 | D | 0.760785 | E | 0.789201 | -0.028416 | No Change: Both D | - |
| Q17RC7 | EX3L4_HUMAN Exocyst complex component 3-like protein 4 OS=Homo sapiens GN=EXOC3L4 PE=2 SV=2 | 185 | L | 0.091768 | H | 0.119281 | -0.027513 | No Change: Both O | - |
| Q17RC7 | EX3L4_HUMAN Exocyst complex component 3-like protein 4 OS=Homo sapiens GN=EXOC3L4 PE=2 SV=2 | 675 | Q | 0.590636 | R | 0.599188 | -0.008552 | No Change: Both D | - |
| Q17RC7 | EX3L4_HUMAN Exocyst complex component 3-like protein 4 OS=Homo sapiens GN=EXOC3L4 PE=2 SV=2 | 685 | Q | 0.475063 | E | 0.490345 | -0.015282 | No Change: Both O | - |
| Q96A65 | EXOC4_HUMAN Exocyst complex component 4 OS=Homo sapiens GN=EXOC4 PE=1 SV=1 | 220 | S | 0.545307 | F | 0.299873 | 0.245434 | D to O | A colorectal cancer sample |
| Q96A65 | EXOC4_HUMAN Exocyst complex component 4 OS=Homo sapiens GN=EXOC4 PE=1 SV=1 | 599 | A | 0.310322 | T | 0.343407 | -0.033085 | No Change: Both O | A colorectal cancer sample |
| O00471 | EXOC5_HUMAN Exocyst complex component 5 OS=Homo sapiens GN=EXOC5 PE=1 SV=1 | 10 | E | 0.299255 | D | 0.262272 | 0.036983 | No Change: Both O | - |
| Q8TAG9 | EXOC6_HUMAN Exocyst complex component 6 OS=Homo sapiens GN=EXOC6 PE=1 SV=3 | 396 | T | 0.071997 | I | 0.038453 | 0.033544 | No Change: Both O | - |
| Q8TAG9 | EXOC6_HUMAN Exocyst complex component 6 OS=Homo sapiens GN=EXOC6 PE=1 SV=3 | 523 | L | 0.410977 | V | 0.369865 | 0.041112 | No Change: Both O | - |
| Q8TAG9 | EXOC6_HUMAN Exocyst complex component 6 OS=Homo sapiens GN=EXOC6 PE=1 SV=3 | 578 | T | 0.390999 | I | 0.256507 | 0.134492 | No Change: Both O | - |
| Q9Y2C4 | EXOG_HUMAN Nuclease EXOG mitochondrial OS=Homo sapiens GN=EXOG PE=1 SV=2 | 277 | G | 0.193129 | V | 0.124117 | 0.069012 | No Change: Both O | - |
| Q9NQT5 | EXOS3_HUMAN Exosome complex component RRP40 OS=Homo sapiens GN=EXOSC3 PE=1 SV=3 | 225 | Y | 0.105708 | H | 0.174952 | -0.069244 | No Change: Both O | - |
| Q9NQT4 | EXOS5_HUMAN Exosome complex component RRP46 OS=Homo sapiens GN=EXOSC5 PE=1 SV=1 | 5 | T | 0.897399 | M | 0.897403 | -4.00E-06 | No Change: Both D | - |
| Q9NQT4 | EXOS5_HUMAN Exosome complex component RRP46 OS=Homo sapiens GN=EXOSC5 PE=1 SV=1 | 33 | C | 0.547796 | W | 0.408111 | 0.139685 | D to O | - |
| Q15024 | EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens GN=EXOSC7 PE=1 SV=3 | 274 | V | 0.676666 | L | 0.686623 | -0.009957 | No Change: Both D | - |
| Q15024 | EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens GN=EXOSC7 PE=1 SV=3 | 169 | R | 0.312913 | Q | 0.306456 | 0.006457 | No Change: Both O | - |
| Q06265 | EXOS9_HUMAN Exosome complex component RRP45 OS=Homo sapiens GN=EXOSC9 PE=1 SV=3 | 425 | S | 0.994696 | T | 0.993993 | 7.03E-04 | No Change: Both D | - |
| Q06265 | EXOS9_HUMAN Exosome complex component RRP45 OS=Homo sapiens GN=EXOSC9 PE=1 SV=3 | 366 | I | 0.713656 | V | 0.709442 | 0.004214 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 19 | R | 0.553949 | G | 0.46519 | 0.088759 | D to O | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 118 | R | 0.96937 | L | 0.951443 | 0.017927 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 137 | E | 0.892317 | V | 0.862736 | 0.029581 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 328 | R | 0.580188 | Q | 0.585125 | -0.004937 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 512 | M | 0.81491 | L | 0.714952 | 0.099958 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 525 | V | 0.759549 | F | 0.763322 | -0.003773 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 676 | S | 0.836066 | N | 0.806108 | 0.029958 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 777 | D | 0.869331 | N | 0.863213 | 0.006118 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 853 | L | 0.534553 | P | 0.650332 | -0.115779 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 892 | N | 0.984545 | Y | 0.97682 | 0.007725 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 899 | V | 0.981899 | A | 0.986087 | -0.004188 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1240 | D | 0.546927 | N | 0.5344 | 0.012527 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1311 | C | 0.883496 | R | 0.923585 | -0.040089 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1663 | G | 0.910878 | R | 0.924291 | -0.013413 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1967 | N | 0.958117 | D | 0.967591 | -0.009474 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1147 | M | 0.866363 | I | 0.818583 | 0.04778 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1236 | S | 0.594319 | A | 0.463948 | 0.130371 | D to O | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1343 | T | 0.73455 | A | 0.727695 | 0.006855 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1656 | E | 0.897641 | K | 0.893505 | 0.004136 | No Change: Both D | - |
| Q8NEV8 | EXPH5_HUMAN Exophilin-5 OS=Homo sapiens GN=EXPH5 PE=1 SV=3 | 1735 | I | 0.851903 | F | 0.887071 | -0.035168 | No Change: Both D | - |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 280 | R | 0.392275 | G | 0.431163 | -0.038888 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 280 | R | 0.392275 | S | 0.480539 | -0.088264 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 339 | G | 0.212029 | D | 0.224017 | -0.011988 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 340 | R | 0.22213 | C | 0.118344 | 0.103786 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 340 | R | 0.22213 | H | 0.202725 | 0.019405 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 340 | R | 0.22213 | L | 0.138863 | 0.083267 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 340 | R | 0.22213 | S | 0.26146 | -0.03933 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 27 | Q | 0.380088 | K | 0.417751 | -0.037663 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 164 | D | 0.539734 | H | 0.4812 | 0.058534 | D to O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 316 | N | 0.618447 | S | 0.659041 | -0.040594 | No Change: Both D | Chondrosarcoma (CHDSA) [MIM:215300] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 486 | A | 0.149486 | V | 0.112411 | 0.037075 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q16394 | EXT1_HUMAN Exostosin-1 OS=Homo sapiens GN=EXT1 PE=1 SV=2 | 496 | P | 0.319459 | L | 0.194453 | 0.125006 | No Change: Both O | Hereditary multiple exostoses type 1 (EXT1) [MIM:133700] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 227 | D | 0.218333 | N | 0.199529 | 0.018804 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 85 | C | 0.224414 | R | 0.377179 | -0.152765 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 152 | L | 0.06152 | R | 0.112099 | -0.050579 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 179 | R | 0.336298 | S | 0.395741 | -0.059443 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 202 | A | 0.430144 | V | 0.356574 | 0.07357 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 223 | R | 0.198437 | P | 0.23473 | -0.036293 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 380 | I | 0.369538 | T | 0.484362 | -0.114824 | No Change: Both O | Hereditary multiple exostoses type 2 (EXT2) [MIM:133701] |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 576 | E | 0.339832 | K | 0.350254 | -0.010422 | No Change: Both O | - |
| Q93063 | EXT2_HUMAN Exostosin-2 OS=Homo sapiens GN=EXT2 PE=1 SV=1 | 42 | M | 0.060058 | V | 0.045088 | 0.01497 | No Change: Both O | - |
| Q92935 | EXTL1_HUMAN Exostosin-like 1 OS=Homo sapiens GN=EXTL1 PE=2 SV=2 | 379 | H | 0.301603 | N | 0.337236 | -0.035633 | No Change: Both O | - |
| Q92935 | EXTL1_HUMAN Exostosin-like 1 OS=Homo sapiens GN=EXTL1 PE=2 SV=2 | 163 | R | 0.339288 | H | 0.313367 | 0.025921 | No Change: Both O | - |
| O43909 | EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens GN=EXTL3 PE=2 SV=1 | 706 | L | 0.270145 | P | 0.409159 | -0.139014 | No Change: Both O | - |
| O43909 | EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens GN=EXTL3 PE=2 SV=1 | 550 | A | 0.637132 | V | 0.538837 | 0.098295 | No Change: Both D | - |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 487 | S | 0.187106 | P | 0.157469 | 0.029637 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 505 | L | 0.104265 | R | 0.162196 | -0.057931 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 363 | E | 0.227884 | K | 0.212167 | 0.015717 | No Change: Both O | - |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 426 | G | 0.153182 | S | 0.171932 | -0.01875 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 429 | D | 0.154575 | G | 0.153212 | 0.001363 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 440 | R | 0.166551 | Q | 0.163949 | 0.002602 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 547 | R | 0.091405 | G | 0.095012 | -0.003607 | No Change: Both O | - |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 583 | L | 0.360629 | P | 0.498665 | -0.138036 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 20 | P | 0.992497 | A | 0.984694 | 0.007803 | No Change: Both D | - |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 242 | S | 0.94996 | G | 0.927347 | 0.022613 | No Change: Both D | Branchiootic syndrome type 1 (BOS1) [MIM:602588] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 95 | P | 0.911156 | S | 0.905417 | 0.005739 | No Change: Both D | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 140 | G | 0.548702 | S | 0.596079 | -0.047377 | No Change: Both D | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 363 | E | 0.227884 | V | 0.105258 | 0.122626 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 514 | L | 0.033948 | P | 0.069921 | -0.035973 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 527 | Y | 0.195813 | C | 0.161136 | 0.034677 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| Q99502 | EYA1_HUMAN Eyes absent homolog 1 OS=Homo sapiens GN=EYA1 PE=1 SV=2 | 569 | M | 0.31495 | T | 0.364463 | -0.049513 | No Change: Both O | Branchiootorenal syndrome type 1 (BOR1) [MIM:113650] |
| O00167 | EYA2_HUMAN Eyes absent homolog 2 OS=Homo sapiens GN=EYA2 PE=1 SV=2 | 83 | P | 0.752497 | S | 0.741593 | 0.010904 | No Change: Both D | - |
| O00167 | EYA2_HUMAN Eyes absent homolog 2 OS=Homo sapiens GN=EYA2 PE=1 SV=2 | 238 | T | 0.967641 | A | 0.966185 | 0.001456 | No Change: Both D | - |
| O95677 | EYA4_HUMAN Eyes absent homolog 4 OS=Homo sapiens GN=EYA4 PE=1 SV=2 | 277 | G | 0.805612 | S | 0.860141 | -0.054529 | No Change: Both D | - |
| O95677 | EYA4_HUMAN Eyes absent homolog 4 OS=Homo sapiens GN=EYA4 PE=1 SV=2 | 152 | L | 0.812651 | R | 0.873365 | -0.060714 | No Change: Both D | A colorectal cancer sample |
| O95677 | EYA4_HUMAN Eyes absent homolog 4 OS=Homo sapiens GN=EYA4 PE=1 SV=2 | 301 | D | 0.881716 | N | 0.897135 | -0.015419 | No Change: Both D | A colorectal cancer sample |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 120 | T | 0.290483 | M | 0.235103 | 0.05538 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 852 | L | 0.172569 | P | 0.298116 | -0.125547 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 94 | P | 0.41609 | Q | 0.406781 | 0.009309 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 112 | V | 0.257163 | I | 0.214401 | 0.042762 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 135 | T | 0.238577 | L | 0.172082 | 0.066495 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 136 | V | 0.286277 | F | 0.251223 | 0.035054 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 326 | S | 0.746266 | N | 0.713224 | 0.033042 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 532 | K | 0.364937 | N | 0.363245 | 0.001692 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 551 | R | 0.221844 | L | 0.154491 | 0.067353 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 571 | Q | 0.608313 | R | 0.595308 | 0.013005 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 618 | G | 0.209361 | S | 0.27286 | -0.063499 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 631 | G | 0.352539 | S | 0.432184 | -0.079645 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 641 | E | 0.359671 | V | 0.180116 | 0.179555 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 745 | N | 0.327572 | S | 0.366139 | -0.038567 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 834 | V | 0.287062 | I | 0.320459 | -0.033397 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 938 | K | 0.662017 | R | 0.666469 | -0.004452 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1110 | T | 0.174312 | S | 0.237098 | -0.062786 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1163 | N | 0.418473 | K | 0.428535 | -0.010062 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1176 | C | 0.46637 | R | 0.493576 | -0.027206 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1232 | I | 0.333394 | F | 0.331614 | 0.00178 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1263 | I | 0.610305 | V | 0.615349 | -0.005044 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1325 | Q | 0.213317 | E | 0.273925 | -0.060608 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1361 | I | 0.451789 | V | 0.47931 | -0.027521 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1365 | K | 0.537619 | E | 0.538871 | -0.001252 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1419 | L | 0.321345 | S | 0.50554 | -0.184195 | O to D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1451 | I | 0.258211 | T | 0.356232 | -0.098021 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1515 | R | 0.473649 | W | 0.27708 | 0.196569 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1517 | S | 0.520404 | G | 0.406992 | 0.113412 | D to O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1662 | D | 0.790707 | V | 0.698145 | 0.092562 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1664 | T | 0.756003 | I | 0.681052 | 0.074951 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1682 | D | 0.762201 | Y | 0.592537 | 0.169664 | No Change: Both D | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1739 | P | 0.612853 | L | 0.494369 | 0.118484 | D to O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1747 | E | 0.408662 | G | 0.342485 | 0.066177 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1748 | L | 0.372471 | F | 0.337562 | 0.034909 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1837 | W | 0.658573 | S | 0.829411 | -0.170838 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1869 | L | 0.46651 | M | 0.509813 | -0.043303 | O to D | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1873 | L | 0.354252 | V | 0.325913 | 0.028339 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1902 | N | 0.313018 | I | 0.158246 | 0.154772 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1915 | S | 0.162288 | G | 0.127947 | 0.034341 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1987 | T | 0.16783 | P | 0.2089 | -0.04107 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1993 | T | 0.20532 | A | 0.175581 | 0.029739 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1999 | I | 0.213334 | V | 0.235668 | -0.022334 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2040 | V | 0.072188 | D | 0.141578 | -0.06939 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2139 | C | 0.203462 | Y | 0.239422 | -0.03596 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2151 | N | 0.27889 | S | 0.325354 | -0.046464 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2189 | L | 0.311515 | P | 0.454629 | -0.143114 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2211 | S | 0.330108 | L | 0.1819 | 0.148208 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2326 | R | 0.295648 | Q | 0.313695 | -0.018047 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2556 | S | 0.287983 | C | 0.116244 | 0.171739 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2599 | H | 0.685921 | R | 0.708037 | -0.022116 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2757 | A | 0.126107 | P | 0.157515 | -0.031408 | No Change: Both O | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2829 | A | 0.663787 | T | 0.703654 | -0.039867 | No Change: Both D | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2831 | T | 0.681191 | I | 0.552475 | 0.128716 | No Change: Both D | - |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2911 | C | 0.527464 | Y | 0.461413 | 0.066051 | D to O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2928 | G | 0.350629 | E | 0.390178 | -0.039549 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 1484 | W | 0.459272 | R | 0.70022 | -0.240948 | O to D | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2017 | G | 0.261412 | V | 0.151737 | 0.109675 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2503 | E | 0.487427 | K | 0.484008 | 0.003419 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q5T1H1 | EYS_HUMAN Protein eyes shut homolog OS=Homo sapiens GN=EYS PE=1 SV=5 | 2945 | Q | 0.162594 | E | 0.170785 | -0.008191 | No Change: Both O | Retinitis pigmentosa type 25 (RP25) [MIM:602772] |
| Q15910 | EZH2_HUMAN Histone-lysine N-methyltransferase EZH2 OS=Homo sapiens GN=EZH2 PE=1 SV=2 | 185 | D | 0.856344 | H | 0.814982 | 0.041362 | No Change: Both D | - |
| P15311 | EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 SV=4 | 532 | L | 0.905892 | V | 0.892523 | 0.013369 | No Change: Both D | - |
| P15311 | EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 SV=4 | 180 | R | 0.314686 | C | 0.174628 | 0.140058 | No Change: Both O | - |
| P15311 | EZRI_HUMAN Ezrin OS=Homo sapiens GN=EZR PE=1 SV=4 | 494 | A | 0.891292 | P | 0.928077 | -0.036785 | No Change: Both D | - |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 7 | L | 0.305374 | I | 0.246317 | 0.059057 | No Change: Both O | - |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 30 | Q | 0.320193 | H | 0.3047 | 0.015493 | No Change: Both O | - |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 152 | A | 0.267465 | T | 0.308114 | -0.040649 | No Change: Both O | - |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 192 | G | 0.785808 | R | 0.818129 | -0.032321 | No Change: Both D | - |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 47 | E | 0.655044 | G | 0.586841 | 0.068203 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 51 | G | 0.712792 | V | 0.639594 | 0.073198 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 54 | E | 0.717003 | G | 0.630029 | 0.086974 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 54 | E | 0.717003 | K | 0.69771 | 0.019293 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 72 | E | 0.844677 | Q | 0.804349 | 0.040328 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 91 | E | 0.826503 | K | 0.828813 | -0.00231 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 142 | E | 0.414531 | K | 0.403014 | 0.011517 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 149 | C | 0.286281 | Y | 0.244882 | 0.041399 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 151 | C | 0.26404 | Y | 0.215754 | 0.048286 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 289 | G | 0.482595 | R | 0.492965 | -0.01037 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 304 | E | 0.400017 | K | 0.38502 | 0.014997 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 322 | D | 0.118918 | N | 0.106227 | 0.012691 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 327 | R | 0.090309 | W | 0.033575 | 0.056734 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 338 | V | 0.138076 | M | 0.192545 | -0.054469 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 350 | E | 0.360578 | K | 0.355209 | 0.005369 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 358 | T | 0.402206 | M | 0.364003 | 0.038203 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 363 | G | 0.448573 | S | 0.502781 | -0.054208 | O to D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 366 | R | 0.520676 | C | 0.377344 | 0.143332 | D to O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 374 | S | 0.582995 | P | 0.564954 | 0.018041 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 383 | P | 0.282763 | S | 0.340064 | -0.057301 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 390 | C | 0.372 | F | 0.384668 | -0.012668 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 404 | C | 0.151271 | R | 0.245748 | -0.094477 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 406 | G | 0.219815 | S | 0.268857 | -0.049042 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 420 | G | 0.561483 | R | 0.543556 | 0.017927 | No Change: Both D | Factor X deficiency (FA10D) [MIM:227600] |
| P00742 | FA10_HUMAN Coagulation factor X OS=Homo sapiens GN=F10 PE=1 SV=2 | 448 | K | 0.293476 | N | 0.247615 | 0.045861 | No Change: Both O | Factor X deficiency (FA10D) [MIM:227600] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 301 | F | 0.290144 | L | 0.321149 | -0.031005 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 66 | P | 0.553692 | L | 0.449059 | 0.104633 | D to O | - |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 244 | Q | 0.325586 | R | 0.317634 | 0.007952 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 308 | I | 0.267393 | F | 0.280323 | -0.01293 | No Change: Both O | - |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 339 | C | 0.482733 | F | 0.469363 | 0.01337 | No Change: Both O | - |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 399 | W | 0.219053 | R | 0.419867 | -0.200814 | No Change: Both O | - |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 34 | D | 0.232837 | H | 0.193133 | 0.039704 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 246 | W | 0.461279 | C | 0.547709 | -0.08643 | O to D | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 266 | S | 0.778536 | N | 0.709838 | 0.068698 | No Change: Both D | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 320 | L | 0.213777 | P | 0.352794 | -0.139017 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 322 | T | 0.14627 | I | 0.078975 | 0.067295 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 326 | R | 0.120814 | C | 0.109879 | 0.010935 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 341 | E | 0.495461 | K | 0.538474 | -0.043013 | O to D | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 404 | T | 0.219649 | N | 0.23027 | -0.010621 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 430 | A | 0.03108 | V | 0.021035 | 0.010045 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 460 | F | 0.249497 | V | 0.27636 | -0.026863 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 493 | T | 0.354153 | I | 0.210467 | 0.143686 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 594 | S | 0.139034 | R | 0.11336 | 0.025674 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 46 | C | 0.129991 | F | 0.127718 | 0.002273 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 56 | C | 0.096642 | R | 0.15261 | -0.055968 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 101 | K | 0.392705 | R | 0.324681 | 0.068024 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 151 | Y | 0.172117 | C | 0.224669 | -0.052552 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 255 | C | 0.541609 | Y | 0.484983 | 0.056626 | D to O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 263 | G | 0.765282 | E | 0.813816 | -0.048534 | No Change: Both D | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 270 | K | 0.756934 | I | 0.591971 | 0.164963 | No Change: Both D | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 418 | G | 0.197147 | V | 0.101934 | 0.095213 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 511 | Y | 0.072977 | H | 0.119563 | -0.046586 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 538 | P | 0.292503 | L | 0.179021 | 0.113482 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 565 | E | 0.440925 | K | 0.465999 | -0.025074 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 587 | W | 0.114066 | S | 0.322082 | -0.208016 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P03951 | FA11_HUMAN Coagulation factor XI OS=Homo sapiens GN=F11 PE=1 SV=1 | 618 | I | 0.133069 | S | 0.290504 | -0.157435 | No Change: Both O | Factor XI deficiency (FA11D) [MIM:612416] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 372 | R | 0.337652 | P | 0.363787 | -0.026135 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 590 | C | 0.398147 | S | 0.647234 | -0.249087 | O to D | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 207 | A | 0.191363 | P | 0.268214 | -0.076851 | No Change: Both O | - |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 545 | G | 0.328425 | D | 0.345454 | -0.017029 | No Change: Both O | - |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 605 | Y | 0.034688 | H | 0.058835 | -0.024147 | No Change: Both O | - |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 53 | Y | 0.368842 | C | 0.43363 | -0.064788 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 342 | P | 0.989537 | Q | 0.988103 | 0.001434 | No Change: Both D | - |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 142 | R | 0.252266 | P | 0.296457 | -0.044191 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 328 | T | 0.998418 | K | 0.998522 | -1.04E-04 | No Change: Both D | Hereditary angioedema type 3 (HAE3) [MIM:610618] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 328 | T | 0.998418 | R | 0.998546 | -1.28E-04 | No Change: Both D | Hereditary angioedema type 3 (HAE3) [MIM:610618] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 411 | A | 0.076651 | T | 0.084847 | -0.008196 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 414 | L | 0.256292 | M | 0.296365 | -0.040073 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 417 | R | 0.474261 | Q | 0.513035 | -0.038774 | O to D | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 440 | Q | 0.41242 | K | 0.394638 | 0.017782 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 461 | D | 0.339449 | N | 0.301222 | 0.038227 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 505 | W | 0.271178 | C | 0.429919 | -0.158741 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 589 | G | 0.335312 | R | 0.31244 | 0.022872 | No Change: Both O | Factor XII deficiency (FA12D) [MIM:234000] |
| P00748 | FA12_HUMAN Coagulation factor XII OS=Homo sapiens GN=F12 PE=1 SV=3 | 340 | A | 0.993601 | G | 0.994635 | -0.001034 | No Change: Both D | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 565 | P | 0.32224 | L | 0.190194 | 0.132046 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 651 | V | 0.230565 | I | 0.191132 | 0.039433 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 652 | Q | 0.236132 | E | 0.277105 | -0.040973 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 682 | R | 0.45209 | H | 0.427673 | 0.024417 | No Change: Both O | Factor XIII subunit A deficiency (FA13AD) [MIM:613225] |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 35 | V | 0.321795 | L | 0.320397 | 0.001398 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 551 | T | 0.206983 | I | 0.120879 | 0.086104 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 589 | L | 0.193521 | Q | 0.325128 | -0.131607 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 40 | V | 0.249391 | I | 0.191922 | 0.057469 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 205 | Y | 0.341147 | F | 0.308705 | 0.032442 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 351 | M | 0.257401 | K | 0.39029 | -0.132889 | No Change: Both O | - |
| P00488 | F13A_HUMAN Coagulation factor XIII A chain OS=Homo sapiens GN=F13A1 PE=1 SV=4 | 650 | T | 0.234304 | I | 0.127494 | 0.10681 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 450 | C | 0.246115 | F | 0.219845 | 0.02627 | No Change: Both O | Factor XIII subunit B deficiency (FA13BD) [MIM:613235] |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 49 | M | 0.219816 | V | 0.174675 | 0.045141 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 115 | R | 0.250211 | H | 0.234972 | 0.015239 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 350 | H | 0.297625 | R | 0.297534 | 9.10E-05 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 388 | E | 0.343155 | V | 0.176704 | 0.166451 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 543 | Y | 0.550455 | S | 0.658388 | -0.107933 | No Change: Both D | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 569 | D | 0.161424 | E | 0.195086 | -0.033662 | No Change: Both O | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 342 | I | 0.404956 | T | 0.532364 | -0.127408 | O to D | - |
| P05160 | F13B_HUMAN Coagulation factor XIII B chain OS=Homo sapiens GN=F13B PE=1 SV=3 | 529 | L | 0.359241 | P | 0.556502 | -0.197261 | O to D | - |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 200 | E | 0.803739 | K | 0.776338 | 0.027401 | No Change: Both D | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 314 | R | 0.694008 | C | 0.582822 | 0.111186 | No Change: Both D | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 314 | R | 0.694008 | H | 0.63105 | 0.062958 | No Change: Both D | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 380 | M | 0.174923 | T | 0.197519 | -0.022596 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 425 | R | 0.270269 | C | 0.131728 | 0.138541 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 431 | R | 0.498565 | H | 0.495743 | 0.002822 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 461 | R | 0.22771 | W | 0.101125 | 0.126585 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 509 | E | 0.249155 | A | 0.181213 | 0.067942 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 601 | G | 0.217607 | V | 0.127838 | 0.089769 | No Change: Both O | Factor II deficiency (FA2D) [MIM:613679] |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 165 | T | 0.652918 | M | 0.585255 | 0.067663 | No Change: Both D | - |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 386 | P | 0.309143 | T | 0.259927 | 0.049216 | No Change: Both O | - |
| P00734 | THRB_HUMAN Prothrombin OS=Homo sapiens GN=F2 PE=1 SV=2 | 72 | E | 0.625457 | G | 0.521119 | 0.104338 | No Change: Both D | Factor II deficiency (FA2D) [MIM:613679] |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 166 | S | 0.296333 | G | 0.243838 | 0.052495 | No Change: Both O | - |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 187 | Y | 0.038229 | N | 0.075554 | -0.037325 | No Change: Both O | - |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 257 | V | 0.178767 | L | 0.196101 | -0.017334 | No Change: Both O | - |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 412 | S | 0.843052 | Y | 0.636589 | 0.206463 | No Change: Both D | - |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 268 | A | 0.079108 | P | 0.105621 | -0.026513 | No Change: Both O | - |
| P25116 | PAR1_HUMAN Proteinase-activated receptor 1 OS=Homo sapiens GN=F2R PE=1 SV=2 | 335 | A | 0.094039 | V | 0.070574 | 0.023465 | No Change: Both O | - |
| P55085 | PAR2_HUMAN Proteinase-activated receptor 2 OS=Homo sapiens GN=F2RL1 PE=1 SV=1 | 21 | S | 0.404593 | F | 0.164383 | 0.24021 | No Change: Both O | - |
| P55085 | PAR2_HUMAN Proteinase-activated receptor 2 OS=Homo sapiens GN=F2RL1 PE=1 SV=1 | 270 | R | 0.375951 | Q | 0.380228 | -0.004277 | No Change: Both O | - |
| P55085 | PAR2_HUMAN Proteinase-activated receptor 2 OS=Homo sapiens GN=F2RL1 PE=1 SV=1 | 291 | T | 0.028985 | A | 0.028176 | 8.09E-04 | No Change: Both O | - |
| P55085 | PAR2_HUMAN Proteinase-activated receptor 2 OS=Homo sapiens GN=F2RL1 PE=1 SV=1 | 30 | N | 0.725525 | S | 0.786219 | -0.060694 | No Change: Both D | - |
| O00254 | PAR3_HUMAN Proteinase-activated receptor 3 OS=Homo sapiens GN=F2RL2 PE=1 SV=1 | 15 | L | 0.127727 | S | 0.217773 | -0.090046 | No Change: Both O | - |
| O00254 | PAR3_HUMAN Proteinase-activated receptor 3 OS=Homo sapiens GN=F2RL2 PE=1 SV=1 | 177 | M | 0.026209 | V | 0.020582 | 0.005627 | No Change: Both O | - |
| O00254 | PAR3_HUMAN Proteinase-activated receptor 3 OS=Homo sapiens GN=F2RL2 PE=1 SV=1 | 250 | N | 0.533908 | D | 0.571477 | -0.037569 | No Change: Both D | - |
| Q96RI0 | PAR4_HUMAN Proteinase-activated receptor 4 OS=Homo sapiens GN=F2RL3 PE=1 SV=3 | 296 | F | 0.080825 | V | 0.09573 | -0.014905 | No Change: Both O | - |
| Q96RI0 | PAR4_HUMAN Proteinase-activated receptor 4 OS=Homo sapiens GN=F2RL3 PE=1 SV=3 | 310 | P | 0.519158 | L | 0.351432 | 0.167726 | D to O | - |
| Q96RI0 | PAR4_HUMAN Proteinase-activated receptor 4 OS=Homo sapiens GN=F2RL3 PE=1 SV=3 | 120 | A | 0.150429 | T | 0.154229 | -0.0038 | No Change: Both O | - |
| Q96RI0 | PAR4_HUMAN Proteinase-activated receptor 4 OS=Homo sapiens GN=F2RL3 PE=1 SV=3 | 215 | R | 0.35278 | Q | 0.360452 | -0.007672 | No Change: Both O | - |
| P13726 | TF_HUMAN Tissue factor OS=Homo sapiens GN=F3 PE=1 SV=1 | 163 | R | 0.473355 | W | 0.239361 | 0.233994 | No Change: Both O | - |
| P13726 | TF_HUMAN Tissue factor OS=Homo sapiens GN=F3 PE=1 SV=1 | 36 | T | 0.462757 | A | 0.438797 | 0.02396 | No Change: Both O | - |
| P13726 | TF_HUMAN Tissue factor OS=Homo sapiens GN=F3 PE=1 SV=1 | 145 | I | 0.527275 | V | 0.612362 | -0.085087 | No Change: Both D | - |
| P13726 | TF_HUMAN Tissue factor OS=Homo sapiens GN=F3 PE=1 SV=1 | 281 | G | 0.420299 | E | 0.477173 | -0.056874 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 534 | R | 0.489599 | Q | 0.500448 | -0.010849 | O to D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 858 | K | 0.707285 | R | 0.677715 | 0.02957 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 865 | H | 0.748746 | R | 0.759957 | -0.011211 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 334 | R | 0.572234 | G | 0.574533 | -0.002299 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 334 | R | 0.572234 | T | 0.568903 | 0.003331 | No Change: Both D | Thrombophilia due to activated protein C resistance (THR-APCR) [MIM:188055] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 513 | R | 0.212797 | K | 0.263632 | -0.050835 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 107 | D | 0.5056 | H | 0.509415 | -0.003815 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 413 | M | 0.518088 | T | 0.570895 | -0.052807 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 809 | P | 0.782685 | S | 0.793093 | -0.010408 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 817 | N | 0.764369 | T | 0.758843 | 0.005526 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 925 | K | 0.880377 | E | 0.873256 | 0.007121 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1146 | H | 0.986874 | Q | 0.989305 | -0.002431 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1285 | L | 0.959876 | I | 0.935918 | 0.023958 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1327 | H | 0.933259 | R | 0.937932 | -0.004673 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1530 | E | 0.616478 | A | 0.500548 | 0.11593 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1685 | T | 0.786565 | S | 0.830513 | -0.043948 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1749 | L | 0.093901 | V | 0.083858 | 0.010043 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1764 | M | 0.413761 | V | 0.341249 | 0.072512 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1820 | M | 0.216679 | I | 0.150284 | 0.066395 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 2222 | D | 0.35676 | G | 0.336304 | 0.020456 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 2102 | R | 0.222005 | H | 0.207894 | 0.014111 | No Change: Both O | Thrombophilia due to activated protein C resistance (THR-APCR) [MIM:188055] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 15 | G | 0.045329 | S | 0.057565 | -0.012236 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 915 | T | 0.943391 | S | 0.964498 | -0.021107 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 969 | N | 0.285002 | S | 0.328299 | -0.043297 | No Change: Both O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 980 | R | 0.546301 | L | 0.453347 | 0.092954 | D to O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1404 | P | 0.933623 | S | 0.93234 | 0.001283 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 2148 | M | 0.467966 | T | 0.531863 | -0.063897 | O to D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 387 | I | 0.43005 | T | 0.551116 | -0.121066 | O to D | Thrombophilia due to activated protein C resistance (THR-APCR) [MIM:188055] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 613 | C | 0.088915 | R | 0.181805 | -0.09289 | No Change: Both O | Thrombophilia due to activated protein C resistance (THR-APCR) [MIM:188055] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1730 | Y | 0.136028 | C | 0.132946 | 0.003082 | No Change: Both O | Factor V deficiency (FA5D) [MIM:227400] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 2102 | R | 0.222005 | C | 0.11433 | 0.107675 | No Change: Both O | Factor V deficiency (FA5D) [MIM:227400] |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 2185 | K | 0.547465 | R | 0.462298 | 0.085167 | D to O | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 775 | S | 0.607761 | A | 0.492521 | 0.11524 | D to O | A colorectal cancer sample |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 781 | S | 0.667299 | R | 0.580992 | 0.086307 | No Change: Both D | - |
| P12259 | FA5_HUMAN Coagulation factor V OS=Homo sapiens GN=F5 PE=1 SV=4 | 1397 | L | 0.926781 | F | 0.910837 | 0.015944 | No Change: Both D | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 139 | R | 0.418342 | K | 0.478968 | -0.060626 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 139 | R | 0.418342 | Q | 0.477877 | -0.059535 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 139 | R | 0.418342 | W | 0.251813 | 0.166529 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 157 | G | 0.400716 | S | 0.45823 | -0.057514 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 157 | G | 0.400716 | C | 0.3137 | 0.087016 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 160 | Q | 0.499174 | R | 0.501348 | -0.002174 | O to D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 194 | P | 0.399589 | T | 0.334303 | 0.065286 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 197 | K | 0.386064 | E | 0.388241 | -0.002177 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 212 | R | 0.469112 | Q | 0.495958 | -0.026846 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 238 | C | 0.098686 | Y | 0.123948 | -0.025262 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 283 | R | 0.529329 | W | 0.326254 | 0.203075 | D to O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 304 | A | 0.212072 | V | 0.172659 | 0.039413 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 307 | R | 0.137658 | H | 0.145997 | -0.008339 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 325 | E | 0.28257 | K | 0.269656 | 0.012914 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 354 | A | 0.183555 | V | 0.143498 | 0.040057 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 358 | M | 0.133916 | I | 0.083917 | 0.049999 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 358 | M | 0.133916 | V | 0.107049 | 0.026867 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 364 | R | 0.147665 | Q | 0.173355 | -0.02569 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 370 | C | 0.348038 | F | 0.353286 | -0.005248 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 402 | G | 0.745103 | R | 0.735251 | 0.009852 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 402 | G | 0.745103 | E | 0.74468 | 4.23E-04 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 413 | R | 0.241725 | Q | 0.259573 | -0.017848 | No Change: Both O | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 419 | T | 0.066954 | M | 0.050077 | 0.016877 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 352 | A | 0.198598 | T | 0.225195 | -0.026597 | No Change: Both O | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 445 | E | 0.12084 | K | 0.126863 | -0.006023 | No Change: Both O | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 295 | V | 0.297096 | D | 0.448581 | -0.151485 | No Change: Both O | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 13 | L | 0.151699 | P | 0.250894 | -0.099195 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 389 | C | 0.237063 | G | 0.379957 | -0.142894 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 73 | L | 0.793404 | Q | 0.863981 | -0.070577 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 79 | E | 0.813255 | Q | 0.771521 | 0.041734 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 121 | C | 0.551303 | F | 0.522294 | 0.029009 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 125 | L | 0.338783 | P | 0.503568 | -0.164785 | O to D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 128 | Y | 0.205439 | C | 0.312681 | -0.107242 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 151 | C | 0.331314 | S | 0.47987 | -0.148556 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 157 | G | 0.400716 | V | 0.270722 | 0.129994 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 195 | C | 0.408632 | R | 0.48149 | -0.072858 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 241 | T | 0.064314 | N | 0.077591 | -0.013277 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 302 | D | 0.23765 | H | 0.227173 | 0.010477 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 302 | D | 0.23765 | N | 0.234697 | 0.002953 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 304 | A | 0.212072 | T | 0.256671 | -0.044599 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 307 | R | 0.137658 | C | 0.071007 | 0.066651 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 332 | T | 0.251712 | M | 0.201237 | 0.050475 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 391 | G | 0.356217 | S | 0.420053 | -0.063836 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 435 | G | 0.127216 | E | 0.146521 | -0.019305 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 64 | F | 0.732081 | L | 0.76173 | -0.029649 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 120 | S | 0.581587 | P | 0.55452 | 0.027067 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 154 | E | 0.341439 | K | 0.326119 | 0.01532 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 216 | G | 0.37754 | D | 0.367673 | 0.009867 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 254 | C | 0.087456 | Y | 0.108988 | -0.021532 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 266 | A | 0.09227 | T | 0.105008 | -0.012738 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 312 | V | 0.177177 | M | 0.205514 | -0.028337 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 341 | V | 0.103471 | F | 0.0935 | 0.009971 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 363 | P | 0.139166 | R | 0.128144 | 0.011022 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 403 | D | 0.73947 | H | 0.743659 | -0.004189 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 367 | T | 0.249194 | S | 0.332833 | -0.083639 | No Change: Both O | - |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 82 | C | 0.757899 | F | 0.739212 | 0.018687 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 82 | C | 0.757899 | R | 0.842067 | -0.084168 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 85 | E | 0.754744 | K | 0.733329 | 0.021415 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 88 | R | 0.731519 | G | 0.698762 | 0.032757 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 88 | R | 0.731519 | P | 0.739828 | -0.008309 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 117 | N | 0.591848 | D | 0.639934 | -0.048086 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 138 | G | 0.396344 | D | 0.435815 | -0.039471 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 156 | G | 0.37558 | S | 0.430907 | -0.055327 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 171 | S | 0.580374 | F | 0.353179 | 0.227195 | D to O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 177 | G | 0.377098 | R | 0.394098 | -0.017 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 181 | L | 0.395821 | P | 0.560642 | -0.164821 | O to D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 183 | D | 0.391164 | N | 0.38534 | 0.005824 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 186 | S | 0.359106 | F | 0.167502 | 0.191604 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 189 | P | 0.360858 | S | 0.36868 | -0.007822 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 194 | P | 0.399589 | L | 0.247229 | 0.15236 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 198 | I | 0.370887 | T | 0.494759 | -0.123872 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 240 | G | 0.078615 | R | 0.067346 | 0.011269 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 250 | S | 0.03646 | F | 0.013606 | 0.022854 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 251 | A | 0.042025 | P | 0.057374 | -0.015349 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 251 | A | 0.042025 | T | 0.047435 | -0.00541 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 254 | C | 0.087456 | R | 0.178276 | -0.09082 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 264 | L | 0.075911 | P | 0.145307 | -0.069396 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 272 | D | 0.589236 | N | 0.556786 | 0.03245 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 277 | D | 0.866584 | N | 0.853151 | 0.013433 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 298 | T | 0.320018 | I | 0.204883 | 0.115135 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 301 | H | 0.250198 | Q | 0.26445 | -0.014252 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 314 | L | 0.169648 | V | 0.174926 | -0.005278 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 321 | L | 0.138183 | F | 0.119164 | 0.019019 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 323 | L | 0.204012 | R | 0.316811 | -0.112799 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 326 | R | 0.287128 | Q | 0.292588 | -0.00546 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 337 | R | 0.100824 | C | 0.047138 | 0.053686 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 343 | G | 0.141712 | S | 0.178172 | -0.03646 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 344 | W | 0.172518 | R | 0.362139 | -0.189621 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 345 | G | 0.185455 | S | 0.225147 | -0.039692 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 350 | R | 0.218183 | C | 0.126333 | 0.09185 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 360 | L | 0.126675 | P | 0.231055 | -0.10438 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 363 | P | 0.139166 | H | 0.11597 | 0.023196 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 364 | R | 0.147665 | W | 0.059101 | 0.088564 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 375 | R | 0.495896 | W | 0.323334 | 0.172562 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 384 | T | 0.329129 | M | 0.329746 | -6.17E-04 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 387 | M | 0.219285 | T | 0.255268 | -0.035983 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 387 | M | 0.219285 | V | 0.161257 | 0.058028 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 388 | F | 0.214045 | S | 0.459998 | -0.245953 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 391 | G | 0.356217 | C | 0.242654 | 0.113563 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 398 | D | 0.738648 | E | 0.736529 | 0.002119 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 401 | K | 0.79357 | E | 0.791348 | 0.002222 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 404 | S | 0.750543 | N | 0.729825 | 0.020718 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 408 | H | 0.606416 | Q | 0.601499 | 0.004917 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 408 | H | 0.606416 | R | 0.600982 | 0.005434 | No Change: Both D | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 413 | R | 0.241725 | G | 0.27611 | -0.034385 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 414 | G | 0.196587 | C | 0.08926 | 0.107327 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 422 | V | 0.066511 | F | 0.057385 | 0.009126 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 425 | G | 0.122028 | A | 0.092554 | 0.029474 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 425 | G | 0.122028 | C | 0.054973 | 0.067055 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 429 | A | 0.120542 | T | 0.14581 | -0.025268 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 432 | G | 0.122721 | D | 0.1264 | -0.003679 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P08709 | FA7_HUMAN Coagulation factor VII OS=Homo sapiens GN=F7 PE=1 SV=1 | 437 | Y | 0.12815 | F | 0.110928 | 0.017222 | No Change: Both O | Factor VII deficiency (FA7D) [MIM:227500] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 26 | L | 0.10952 | R | 0.186469 | -0.076949 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 30 | E | 0.131424 | V | 0.062379 | 0.069045 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 41 | G | 0.366789 | C | 0.200366 | 0.166423 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 48 | R | 0.365028 | C | 0.195786 | 0.169242 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 75 | D | 0.095429 | V | 0.050513 | 0.044916 | No Change: Both O | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 89 | G | 0.196498 | D | 0.20525 | -0.008752 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 89 | G | 0.196498 | V | 0.103819 | 0.092679 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 99 | V | 0.128949 | D | 0.243366 | -0.114417 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 104 | V | 0.094833 | D | 0.181729 | -0.086896 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 108 | K | 0.258212 | T | 0.208913 | 0.049299 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 110 | M | 0.340531 | V | 0.305218 | 0.035313 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 117 | L | 0.341804 | R | 0.465785 | -0.123981 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 129 | E | 0.546729 | V | 0.338653 | 0.208076 | D to O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 130 | G | 0.603362 | R | 0.588252 | 0.01511 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 132 | E | 0.671053 | D | 0.657334 | 0.013719 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 133 | Y | 0.70963 | C | 0.67085 | 0.03878 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 135 | D | 0.726148 | G | 0.711606 | 0.014542 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 137 | T | 0.710946 | I | 0.646681 | 0.064265 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 164 | G | 0.373538 | V | 0.271762 | 0.101776 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 165 | P | 0.391038 | S | 0.418095 | -0.027057 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 181 | V | 0.243336 | M | 0.281704 | -0.038368 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 185 | K | 0.355693 | T | 0.274678 | 0.081015 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 189 | S | 0.198146 | L | 0.103356 | 0.09479 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 222 | D | 0.221176 | V | 0.134239 | 0.086937 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 224 | G | 0.384381 | W | 0.222989 | 0.161392 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 253 | V | 0.250587 | F | 0.214513 | 0.036074 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 266 | G | 0.181835 | E | 0.209423 | -0.027588 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 278 | G | 0.166173 | R | 0.149946 | 0.016227 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 285 | V | 0.339055 | G | 0.51421 | -0.175155 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 291 | E | 0.185238 | G | 0.153643 | 0.031595 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 294 | T | 0.169164 | I | 0.097152 | 0.072012 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 299 | N | 0.320977 | I | 0.167939 | 0.153038 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 301 | R | 0.357723 | H | 0.363757 | -0.006034 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 301 | R | 0.357723 | L | 0.236329 | 0.121394 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 308 | S | 0.255733 | L | 0.130631 | 0.125102 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 312 | F | 0.125853 | S | 0.297733 | -0.17188 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 314 | T | 0.105394 | A | 0.08991 | 0.015484 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 314 | T | 0.105394 | I | 0.055292 | 0.050102 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 327 | L | 0.085337 | P | 0.151324 | -0.065987 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 331 | I | 0.23163 | V | 0.25865 | -0.02702 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 345 | V | 0.493923 | L | 0.509964 | -0.016041 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 348 | C | 0.569292 | R | 0.678396 | -0.109104 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 348 | C | 0.569292 | S | 0.718555 | -0.149263 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 348 | C | 0.569292 | Y | 0.582658 | -0.013366 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 391 | R | 0.380807 | C | 0.239523 | 0.141284 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 391 | R | 0.380807 | H | 0.392185 | -0.011378 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 391 | R | 0.380807 | P | 0.432161 | -0.051354 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 392 | S | 0.368252 | L | 0.198572 | 0.16968 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 392 | S | 0.368252 | P | 0.349842 | 0.01841 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 405 | I | 0.156686 | S | 0.327699 | -0.171013 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 409 | E | 0.309615 | G | 0.247695 | 0.06192 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 431 | L | 0.548807 | F | 0.517435 | 0.031372 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 439 | G | 0.453075 | V | 0.316152 | 0.136923 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 444 | K | 0.319535 | R | 0.266841 | 0.052694 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 450 | Y | 0.242027 | N | 0.355446 | -0.113419 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 474 | G | 0.150846 | R | 0.130099 | 0.020747 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 488 | A | 0.240619 | G | 0.287807 | -0.047188 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 492 | Y | 0.337177 | H | 0.458661 | -0.121484 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 492 | Y | 0.337177 | C | 0.272026 | 0.065151 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 494 | I | 0.278672 | T | 0.410737 | -0.132065 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 498 | G | 0.219456 | R | 0.22555 | -0.006094 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 544 | D | 0.608236 | N | 0.581548 | 0.026688 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 546 | R | 0.465281 | W | 0.249262 | 0.216019 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 550 | R | 0.193139 | C | 0.099319 | 0.09382 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 550 | R | 0.193139 | G | 0.189971 | 0.003168 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 550 | R | 0.193139 | H | 0.181451 | 0.011688 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 554 | S | 0.194198 | G | 0.148732 | 0.045466 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 556 | V | 0.272248 | D | 0.447279 | -0.175031 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 577 | S | 0.287869 | F | 0.123637 | 0.164232 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 584 | Q | 0.565777 | K | 0.611078 | -0.045301 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 585 | I | 0.527179 | T | 0.651983 | -0.124804 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 596 | S | 0.10939 | P | 0.095007 | 0.014383 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 603 | S | 0.179908 | I | 0.075098 | 0.10481 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 604 | W | 0.169329 | C | 0.20897 | -0.039641 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 605 | Y | 0.152899 | S | 0.309025 | -0.156126 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 612 | R | 0.180988 | C | 0.091433 | 0.089555 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 631 | N | 0.366072 | K | 0.399627 | -0.033555 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 631 | N | 0.366072 | S | 0.422294 | -0.056222 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 644 | L | 0.120112 | V | 0.122268 | -0.002156 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 653 | V | 0.0258 | A | 0.038153 | -0.012353 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 653 | V | 0.0258 | M | 0.032558 | -0.006758 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 663 | A | 0.085002 | V | 0.061265 | 0.023737 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 677 | F | 0.225326 | L | 0.234659 | -0.009333 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 699 | M | 0.300677 | V | 0.245611 | 0.055066 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 717 | R | 0.392496 | W | 0.194102 | 0.198394 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 720 | G | 0.330294 | D | 0.374136 | -0.043842 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 723 | A | 0.255436 | T | 0.301421 | -0.045985 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 727 | V | 0.352374 | F | 0.32717 | 0.025204 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 739 | E | 0.493785 | K | 0.494443 | -6.58E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1057 | E | 0.423179 | K | 0.432394 | -0.009215 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1260 | D | 0.356918 | E | 0.385574 | -0.028656 | No Change: Both O | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1481 | L | 0.595827 | P | 0.679718 | -0.083891 | No Change: Both D | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1699 | Y | 0.652343 | C | 0.629606 | 0.022737 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1699 | Y | 0.652343 | F | 0.649453 | 0.00289 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1708 | R | 0.672076 | C | 0.58102 | 0.091056 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1708 | R | 0.672076 | H | 0.677434 | -0.005358 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1715 | R | 0.330687 | G | 0.303081 | 0.027606 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1723 | E | 0.14103 | K | 0.151103 | -0.010073 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1728 | Y | 0.303065 | C | 0.275818 | 0.027247 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1769 | G | 0.366407 | R | 0.357181 | 0.009226 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1775 | L | 0.266412 | V | 0.244072 | 0.02234 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1775 | L | 0.266412 | F | 0.221363 | 0.045049 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1779 | G | 0.165151 | E | 0.214353 | -0.049202 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1791 | M | 0.202457 | T | 0.243806 | -0.041349 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1800 | R | 0.438493 | H | 0.413255 | 0.025238 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1800 | R | 0.438493 | C | 0.28219 | 0.156303 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1800 | R | 0.438493 | G | 0.424447 | 0.014046 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1803 | S | 0.414277 | Y | 0.241209 | 0.173068 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1808 | L | 0.431669 | F | 0.43271 | -0.001041 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1842 | M | 0.319025 | I | 0.238897 | 0.080128 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1844 | P | 0.447651 | S | 0.471676 | -0.024025 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1845 | T | 0.512752 | P | 0.56294 | -0.050188 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1853 | A | 0.119273 | T | 0.132369 | -0.013096 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1853 | A | 0.119273 | V | 0.082556 | 0.036717 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1865 | D | 0.452936 | N | 0.414135 | 0.038801 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1865 | D | 0.452936 | Y | 0.273904 | 0.179032 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1867 | H | 0.34612 | R | 0.341328 | 0.004792 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1869 | G | 0.219432 | V | 0.131548 | 0.087884 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1873 | P | 0.144119 | R | 0.122609 | 0.02151 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1888 | R | 0.358874 | I | 0.217154 | 0.14172 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1894 | E | 0.1034 | G | 0.086793 | 0.016607 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1904 | E | 0.147146 | K | 0.147674 | -5.28E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1941 | N | 0.121832 | D | 0.131598 | -0.009766 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1941 | N | 0.121832 | S | 0.132329 | -0.010497 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1960 | R | 0.097592 | Q | 0.109168 | -0.011576 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1960 | R | 0.097592 | L | 0.056756 | 0.040836 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1967 | G | 0.377403 | D | 0.404307 | -0.026904 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1979 | G | 0.258327 | V | 0.165917 | 0.09241 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1980 | H | 0.255856 | Y | 0.148453 | 0.107403 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2016 | R | 0.061973 | W | 0.025331 | 0.036642 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2038 | N | 0.16994 | S | 0.213347 | -0.043407 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2065 | W | 0.293366 | R | 0.526802 | -0.233436 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2088 | S | 0.146735 | F | 0.058896 | 0.087839 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2093 | D | 0.069153 | G | 0.062715 | 0.006438 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2105 | T | 0.417826 | N | 0.459931 | -0.042105 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2107 | G | 0.488184 | S | 0.541149 | -0.052965 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2120 | F | 0.078435 | L | 0.094046 | -0.015611 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2124 | Y | 0.092825 | C | 0.074935 | 0.01789 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2135 | R | 0.425251 | P | 0.462704 | -0.037453 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2138 | S | 0.343546 | Y | 0.19337 | 0.150176 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2148 | N | 0.248166 | S | 0.300091 | -0.051925 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2169 | R | 0.169804 | H | 0.170397 | -5.93E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2172 | P | 0.26507 | Q | 0.245445 | 0.019625 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2173 | T | 0.31158 | I | 0.206209 | 0.105371 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2178 | R | 0.417929 | C | 0.265683 | 0.152246 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2178 | R | 0.417929 | H | 0.418315 | -3.86E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2178 | R | 0.417929 | L | 0.305602 | 0.112327 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2182 | R | 0.322135 | C | 0.209331 | 0.112804 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2182 | R | 0.322135 | H | 0.299866 | 0.022269 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2183 | M | 0.314313 | V | 0.211356 | 0.102957 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2185 | L | 0.296897 | S | 0.493083 | -0.196186 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2204 | I | 0.536923 | T | 0.653533 | -0.11661 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2209 | I | 0.439319 | N | 0.581546 | -0.142227 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2211 | A | 0.391314 | P | 0.467977 | -0.076663 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2228 | R | 0.445911 | G | 0.449466 | -0.003555 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2228 | R | 0.445911 | L | 0.342582 | 0.103329 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2228 | R | 0.445911 | Q | 0.464693 | -0.018782 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2242 | V | 0.394353 | M | 0.464892 | -0.070539 | No Change: Both O | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2248 | W | 0.308778 | C | 0.359382 | -0.050604 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2265 | Q | 0.426626 | R | 0.40185 | 0.024776 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2319 | P | 0.272051 | L | 0.153762 | 0.118289 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2319 | P | 0.272051 | S | 0.298425 | -0.026374 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2323 | R | 0.199711 | C | 0.092873 | 0.106838 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2323 | R | 0.199711 | H | 0.20192 | -0.002209 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2326 | R | 0.158071 | L | 0.096531 | 0.06154 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2326 | R | 0.158071 | Q | 0.171563 | -0.013492 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 202 | S | 0.403659 | R | 0.352282 | 0.051377 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 561 | D | 0.279992 | Y | 0.172883 | 0.107109 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2344 | G | 0.200807 | C | 0.105661 | 0.095146 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 255 | G | 0.282682 | V | 0.186063 | 0.096619 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 323 | G | 0.08071 | E | 0.106919 | -0.026209 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 586 | M | 0.457936 | V | 0.413352 | 0.044584 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1942 | G | 0.115468 | A | 0.098148 | 0.01732 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1963 | L | 0.114653 | P | 0.209618 | -0.094965 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2036 | Y | 0.133133 | C | 0.115925 | 0.017208 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2172 | P | 0.26507 | R | 0.253357 | 0.011713 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2307 | D | 0.405737 | A | 0.3175 | 0.088237 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 72 | E | 0.113902 | K | 0.128192 | -0.01429 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 97 | A | 0.166807 | P | 0.242417 | -0.07561 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 155 | Y | 0.169092 | H | 0.265829 | -0.096737 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 181 | V | 0.243336 | E | 0.399412 | -0.156076 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 254 | N | 0.271881 | I | 0.13699 | 0.134891 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 439 | G | 0.453075 | S | 0.494218 | -0.041143 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 529 | K | 0.134106 | E | 0.131143 | 0.002963 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 567 | I | 0.120523 | T | 0.187292 | -0.066769 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1804 | F | 0.413073 | S | 0.641934 | -0.228861 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2051 | I | 0.283882 | S | 0.522305 | -0.238423 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2141 | T | 0.218805 | N | 0.251303 | -0.032498 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2193 | C | 0.391956 | G | 0.574559 | -0.182603 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2257 | M | 0.375865 | V | 0.336348 | 0.039517 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 795 | R | 0.615658 | G | 0.562396 | 0.053262 | No Change: Both D | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 19 | S | 0.061854 | R | 0.051685 | 0.010169 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 22 | R | 0.089666 | T | 0.082537 | 0.007129 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 24 | Y | 0.103796 | C | 0.083453 | 0.020343 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 25 | Y | 0.105682 | C | 0.083738 | 0.021944 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 26 | L | 0.10952 | P | 0.198003 | -0.088483 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 33 | W | 0.184231 | G | 0.394922 | -0.210691 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 35 | Y | 0.234542 | C | 0.196478 | 0.038064 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 35 | Y | 0.234542 | H | 0.347079 | -0.112537 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 48 | R | 0.365028 | K | 0.428364 | -0.063336 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 67 | K | 0.192041 | E | 0.190103 | 0.001938 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 67 | K | 0.192041 | N | 0.160349 | 0.031692 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 69 | L | 0.164209 | P | 0.292208 | -0.127999 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 75 | D | 0.095429 | E | 0.114135 | -0.018706 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 75 | D | 0.095429 | Y | 0.04685 | 0.048579 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 92 | G | 0.151298 | A | 0.118918 | 0.03238 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 92 | G | 0.151298 | V | 0.080849 | 0.070449 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 98 | E | 0.147437 | K | 0.147284 | 1.53E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 101 | D | 0.102976 | G | 0.09371 | 0.009266 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 101 | D | 0.102976 | H | 0.088134 | 0.014842 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 101 | D | 0.102976 | V | 0.055866 | 0.04711 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 111 | A | 0.353997 | T | 0.389823 | -0.035826 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 111 | A | 0.353997 | V | 0.298686 | 0.055311 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 113 | H | 0.384881 | R | 0.356804 | 0.028077 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 113 | H | 0.384881 | Y | 0.262811 | 0.12207 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 117 | L | 0.341804 | F | 0.316768 | 0.025036 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 121 | G | 0.233026 | S | 0.300154 | -0.067128 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 135 | D | 0.726148 | Y | 0.629895 | 0.096253 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 137 | T | 0.710946 | A | 0.704536 | 0.00641 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 138 | S | 0.666989 | R | 0.650662 | 0.016327 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 141 | E | 0.675587 | K | 0.675045 | 5.42E-04 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 145 | D | 0.727646 | H | 0.711392 | 0.016254 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 147 | V | 0.649164 | D | 0.749935 | -0.100771 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 159 | V | 0.230747 | A | 0.282294 | -0.051547 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 163 | N | 0.374698 | K | 0.428881 | -0.054183 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 164 | G | 0.373538 | D | 0.407295 | -0.033757 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 172 | C | 0.200022 | W | 0.173585 | 0.026437 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 176 | S | 0.13244 | P | 0.115702 | 0.016738 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 179 | S | 0.142544 | P | 0.121259 | 0.021285 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 186 | D | 0.321949 | G | 0.298045 | 0.023904 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 186 | D | 0.321949 | Y | 0.173494 | 0.148455 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 193 | G | 0.087039 | R | 0.080938 | 0.006101 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 198 | C | 0.140432 | G | 0.287412 | -0.14698 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 202 | S | 0.403659 | N | 0.361923 | 0.041736 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 214 | F | 0.088129 | V | 0.094134 | -0.006005 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 217 | L | 0.056507 | H | 0.087852 | -0.031345 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 219 | A | 0.073358 | D | 0.106768 | -0.03341 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 219 | A | 0.073358 | T | 0.084352 | -0.010994 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 220 | V | 0.09982 | G | 0.179299 | -0.079479 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 223 | E | 0.300548 | K | 0.306502 | -0.005954 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 252 | T | 0.232383 | I | 0.136636 | 0.095747 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 262 | P | 0.225488 | L | 0.127195 | 0.098293 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 263 | G | 0.23375 | S | 0.280795 | -0.047045 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 267 | C | 0.164513 | Y | 0.210585 | -0.046072 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 274 | W | 0.093781 | C | 0.115921 | -0.02214 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 275 | H | 0.099759 | L | 0.053499 | 0.04626 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 284 | E | 0.344324 | K | 0.334097 | 0.010227 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 291 | E | 0.185238 | K | 0.178104 | 0.007134 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 295 | F | 0.190421 | L | 0.217916 | -0.027495 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 297 | V | 0.250236 | A | 0.339948 | -0.089712 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 301 | R | 0.357723 | C | 0.184352 | 0.173371 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 303 | A | 0.393905 | E | 0.538379 | -0.144474 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 303 | A | 0.393905 | P | 0.502125 | -0.10822 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 307 | I | 0.301911 | S | 0.512862 | -0.210951 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 315 | A | 0.110699 | V | 0.077306 | 0.033393 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 326 | L | 0.071397 | P | 0.129531 | -0.058134 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 327 | L | 0.085337 | V | 0.074842 | 0.010495 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 329 | C | 0.142759 | F | 0.155049 | -0.01229 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 339 | M | 0.536413 | T | 0.563781 | -0.027368 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 340 | E | 0.495112 | K | 0.506673 | -0.011561 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 345 | V | 0.493923 | A | 0.562794 | -0.068871 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 365 | Y | 0.858023 | C | 0.885826 | -0.027803 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 401 | W | 0.223637 | G | 0.396496 | -0.172859 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 405 | I | 0.156686 | F | 0.157442 | -7.56E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 412 | W | 0.270809 | G | 0.444454 | -0.173645 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 412 | W | 0.270809 | R | 0.441992 | -0.171183 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 427 | K | 0.583381 | I | 0.353407 | 0.229974 | D to O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 431 | L | 0.548807 | S | 0.736853 | -0.188046 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 437 | R | 0.450823 | P | 0.480658 | -0.029835 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 437 | R | 0.450823 | W | 0.24424 | 0.206583 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 438 | I | 0.450298 | F | 0.459731 | -0.009433 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 439 | G | 0.453075 | D | 0.46775 | -0.014675 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 442 | Y | 0.410107 | C | 0.354585 | 0.055522 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 450 | Y | 0.242027 | D | 0.383509 | -0.141482 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 454 | T | 0.420257 | I | 0.267036 | 0.153221 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 455 | F | 0.448959 | C | 0.427713 | 0.021246 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 466 | G | 0.309056 | E | 0.362489 | -0.053433 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 470 | P | 0.22302 | L | 0.12839 | 0.09463 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 470 | P | 0.22302 | R | 0.193335 | 0.029685 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 470 | P | 0.22302 | T | 0.184958 | 0.038062 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 474 | G | 0.150846 | E | 0.180317 | -0.029471 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 475 | E | 0.133185 | K | 0.133202 | -1.70E-05 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 477 | G | 0.106247 | V | 0.057162 | 0.049085 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 478 | D | 0.085515 | N | 0.081646 | 0.003869 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 479 | T | 0.069921 | R | 0.075279 | -0.005358 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 484 | F | 0.127375 | C | 0.121596 | 0.005779 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 490 | R | 0.319883 | G | 0.340806 | -0.020923 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 503 | R | 0.306679 | H | 0.301907 | 0.004772 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 513 | G | 0.47385 | S | 0.532364 | -0.058514 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 522 | I | 0.187649 | Y | 0.205558 | -0.017909 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 532 | W | 0.14875 | G | 0.335986 | -0.187236 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 540 | P | 0.605859 | T | 0.5839 | 0.021959 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 541 | T | 0.611491 | S | 0.65129 | -0.039799 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 553 | S | 0.174235 | P | 0.153338 | 0.020897 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 554 | S | 0.194198 | C | 0.077126 | 0.117072 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 560 | R | 0.309326 | T | 0.295669 | 0.013657 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 561 | D | 0.279992 | G | 0.274495 | 0.005497 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 561 | D | 0.279992 | H | 0.253891 | 0.026101 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 578 | V | 0.339934 | A | 0.422585 | -0.082651 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 579 | D | 0.395798 | A | 0.312245 | 0.083553 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 579 | D | 0.395798 | H | 0.360069 | 0.035729 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 583 | N | 0.567284 | S | 0.614543 | -0.047259 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 584 | Q | 0.565777 | H | 0.540439 | 0.025338 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 584 | Q | 0.565777 | R | 0.5491 | 0.016677 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 585 | I | 0.527179 | R | 0.674993 | -0.147814 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 588 | D | 0.36357 | G | 0.347605 | 0.015965 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 588 | D | 0.36357 | Y | 0.2204 | 0.14317 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 594 | L | 0.114964 | Q | 0.206587 | -0.091623 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 601 | N | 0.179363 | D | 0.195035 | -0.015672 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 601 | N | 0.179363 | K | 0.199568 | -0.020205 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 602 | R | 0.181529 | G | 0.186889 | -0.00536 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 603 | S | 0.179908 | R | 0.147652 | 0.032256 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 605 | Y | 0.152899 | H | 0.23084 | -0.077941 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 609 | N | 0.159433 | I | 0.076336 | 0.083097 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 633 | M | 0.263856 | I | 0.20244 | 0.061416 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 635 | S | 0.214543 | N | 0.184799 | 0.029744 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 637 | N | 0.197601 | D | 0.212097 | -0.014496 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 637 | N | 0.197601 | S | 0.239557 | -0.041956 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 639 | Y | 0.182334 | C | 0.148818 | 0.033516 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 650 | L | 0.049485 | F | 0.040128 | 0.009357 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 659 | L | 0.035558 | P | 0.075542 | -0.039984 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 664 | Q | 0.111857 | P | 0.121253 | -0.009396 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 681 | M | 0.277231 | I | 0.194316 | 0.082915 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 682 | V | 0.265112 | F | 0.252908 | 0.012204 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 683 | Y | 0.243274 | C | 0.194647 | 0.048627 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 683 | Y | 0.243274 | N | 0.385134 | -0.14186 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 686 | T | 0.193983 | R | 0.195041 | -0.001058 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 698 | F | 0.318222 | L | 0.344312 | -0.02609 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 699 | M | 0.300677 | T | 0.351959 | -0.051282 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 701 | M | 0.242443 | I | 0.166133 | 0.07631 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 705 | G | 0.150297 | V | 0.083448 | 0.066849 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 710 | G | 0.101965 | W | 0.03887 | 0.063095 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 713 | N | 0.197192 | I | 0.10067 | 0.096522 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 717 | R | 0.392496 | L | 0.274317 | 0.118179 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 720 | G | 0.330294 | S | 0.403938 | -0.073644 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 721 | M | 0.291908 | I | 0.212848 | 0.07906 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 721 | M | 0.291908 | L | 0.254002 | 0.037906 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 725 | L | 0.268899 | Q | 0.387746 | -0.118847 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 742 | Y | 0.499515 | C | 0.510723 | -0.011208 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 947 | P | 0.942485 | R | 0.918557 | 0.023928 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1012 | V | 0.514403 | L | 0.589617 | -0.075214 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1066 | H | 0.396906 | Y | 0.273911 | 0.122995 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1336 | Q | 0.573749 | K | 0.618662 | -0.044913 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1460 | N | 0.501832 | K | 0.550605 | -0.048773 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1610 | A | 0.767951 | S | 0.829531 | -0.06158 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1698 | I | 0.645697 | T | 0.746237 | -0.10054 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1701 | E | 0.679473 | K | 0.673806 | 0.005667 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1705 | Q | 0.622824 | H | 0.609263 | 0.013561 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1714 | T | 0.397426 | S | 0.494403 | -0.096977 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1727 | D | 0.253907 | V | 0.15905 | 0.094857 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1740 | R | 0.616907 | G | 0.629756 | -0.012849 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1751 | K | 0.323706 | Q | 0.299183 | 0.024523 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1768 | R | 0.359417 | H | 0.380969 | -0.021552 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1771 | L | 0.367987 | P | 0.477643 | -0.109656 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1777 | L | 0.183857 | P | 0.306577 | -0.12272 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1779 | G | 0.165151 | R | 0.162538 | 0.002613 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1780 | P | 0.158672 | L | 0.090996 | 0.067676 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1782 | I | 0.16138 | R | 0.298419 | -0.137039 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1788 | D | 0.225211 | H | 0.200112 | 0.025099 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1798 | A | 0.404474 | P | 0.488863 | -0.084389 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1799 | S | 0.427672 | H | 0.344681 | 0.082991 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1801 | P | 0.463049 | A | 0.398665 | 0.064384 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1802 | Y | 0.44363 | C | 0.400853 | 0.042777 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1848 | E | 0.423963 | G | 0.376116 | 0.047847 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1858 | S | 0.132847 | C | 0.053057 | 0.07979 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1864 | K | 0.50268 | E | 0.521264 | -0.018584 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1867 | H | 0.34612 | P | 0.386245 | -0.040125 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1869 | G | 0.219432 | D | 0.240906 | -0.021474 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1872 | G | 0.157385 | E | 0.185456 | -0.028071 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1875 | L | 0.103495 | P | 0.195947 | -0.092452 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1876 | V | 0.093513 | L | 0.104027 | -0.010514 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1877 | C | 0.112002 | R | 0.213609 | -0.101607 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1882 | L | 0.393057 | P | 0.585189 | -0.192132 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1901 | I | 0.068322 | F | 0.080712 | -0.01239 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1904 | E | 0.147146 | D | 0.134952 | 0.012194 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1907 | S | 0.203486 | C | 0.103091 | 0.100395 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1907 | S | 0.203486 | R | 0.178139 | 0.025347 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1908 | W | 0.222106 | L | 0.288265 | -0.066159 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1909 | Y | 0.227814 | C | 0.220395 | 0.007419 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1939 | A | 0.112559 | T | 0.133717 | -0.021158 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1939 | A | 0.112559 | V | 0.078639 | 0.03392 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1945 | M | 0.114726 | V | 0.086886 | 0.02784 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1951 | L | 0.176388 | F | 0.14775 | 0.028638 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1965 | S | 0.212934 | I | 0.091544 | 0.12139 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1966 | M | 0.273521 | I | 0.213125 | 0.060396 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1966 | M | 0.273521 | V | 0.222476 | 0.051045 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1968 | S | 0.47249 | R | 0.385361 | 0.087129 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1971 | N | 0.651203 | T | 0.593314 | 0.057889 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1973 | H | 0.584176 | L | 0.421279 | 0.162897 | D to O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1980 | H | 0.255856 | P | 0.270222 | -0.014366 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1982 | F | 0.287576 | I | 0.280703 | 0.006873 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1985 | R | 0.482139 | Q | 0.503649 | -0.02151 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1994 | L | 0.16954 | P | 0.293943 | -0.124403 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1998 | Y | 0.094609 | C | 0.071191 | 0.023418 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2000 | G | 0.106943 | A | 0.08675 | 0.020193 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2004 | T | 0.244851 | R | 0.255025 | -0.010174 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2007 | M | 0.252238 | I | 0.183546 | 0.068692 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2015 | W | 0.074784 | C | 0.096029 | -0.021245 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2016 | R | 0.061973 | P | 0.077177 | -0.015204 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2018 | E | 0.070457 | G | 0.057044 | 0.013413 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2022 | G | 0.15393 | D | 0.15946 | -0.00553 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2028 | G | 0.202892 | R | 0.183737 | 0.019155 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2030 | S | 0.191249 | N | 0.160409 | 0.03084 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2035 | V | 0.114881 | A | 0.164056 | -0.049175 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2040 | C | 0.24831 | Y | 0.310925 | -0.062615 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2045 | G | 0.362412 | E | 0.402888 | -0.040476 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2045 | G | 0.362412 | V | 0.215818 | 0.146594 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2056 | I | 0.285939 | N | 0.439745 | -0.153806 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2058 | A | 0.263738 | P | 0.332885 | -0.069147 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2067 | P | 0.27228 | L | 0.163104 | 0.109176 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2070 | A | 0.245509 | V | 0.171417 | 0.074092 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2082 | S | 0.363748 | N | 0.315331 | 0.048417 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2093 | D | 0.069153 | Y | 0.034029 | 0.035124 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2106 | Q | 0.478911 | E | 0.513556 | -0.034645 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2106 | Q | 0.478911 | R | 0.458003 | 0.020908 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2109 | R | 0.508937 | C | 0.329413 | 0.179524 | D to O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2117 | I | 0.108515 | F | 0.108803 | -2.88E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2117 | I | 0.108515 | S | 0.267356 | -0.158841 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2119 | Q | 0.087835 | R | 0.07915 | 0.008685 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2120 | F | 0.078435 | C | 0.071465 | 0.00697 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2145 | F | 0.152582 | C | 0.134613 | 0.017969 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2157 | N | 0.315433 | D | 0.323875 | -0.008442 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2162 | P | 0.129225 | L | 0.060601 | 0.068624 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2169 | R | 0.169804 | C | 0.083979 | 0.085825 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2173 | T | 0.31158 | A | 0.278762 | 0.032818 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2174 | H | 0.367616 | D | 0.38845 | -0.020834 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2182 | R | 0.322135 | P | 0.349687 | -0.027552 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2183 | M | 0.314313 | R | 0.366214 | -0.051901 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2185 | L | 0.296897 | W | 0.195089 | 0.101808 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2192 | S | 0.371125 | I | 0.163963 | 0.207162 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2196 | P | 0.486965 | R | 0.45603 | 0.030935 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2198 | G | 0.530608 | V | 0.392763 | 0.137845 | D to O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2200 | E | 0.573417 | D | 0.57379 | -3.73E-04 | No Change: Both D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2220 | A | 0.289216 | P | 0.375612 | -0.086396 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2224 | P | 0.380559 | L | 0.254197 | 0.126362 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2228 | R | 0.445911 | P | 0.479973 | -0.034062 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2229 | L | 0.445976 | F | 0.410351 | 0.035625 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2248 | W | 0.308778 | S | 0.560561 | -0.251783 | O to D | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2251 | V | 0.239017 | A | 0.296571 | -0.057554 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2251 | V | 0.239017 | E | 0.423762 | -0.184745 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2264 | T | 0.430168 | A | 0.36759 | 0.062578 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2279 | F | 0.309621 | C | 0.301514 | 0.008107 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2279 | F | 0.309621 | I | 0.315694 | -0.006073 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2281 | I | 0.346781 | T | 0.483899 | -0.137118 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2290 | W | 0.260253 | L | 0.362866 | -0.102613 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2304 | G | 0.425039 | V | 0.297 | 0.128039 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2323 | R | 0.199711 | G | 0.197727 | 0.001984 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2323 | R | 0.199711 | L | 0.124417 | 0.075294 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2326 | R | 0.158071 | G | 0.154502 | 0.003569 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2326 | R | 0.158071 | P | 0.187139 | -0.029068 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2330 | Q | 0.174262 | P | 0.188975 | -0.014713 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2332 | W | 0.151932 | R | 0.339245 | -0.187313 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2339 | R | 0.102882 | T | 0.096714 | 0.006168 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2344 | G | 0.200807 | S | 0.239307 | -0.0385 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2345 | C | 0.280286 | S | 0.490296 | -0.21001 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2345 | C | 0.280286 | Y | 0.344233 | -0.063947 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1289 | K | 0.780819 | Q | 0.756412 | 0.024407 | No Change: Both D | - |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 83 | P | 0.270761 | R | 0.233588 | 0.037173 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 186 | D | 0.321949 | N | 0.305636 | 0.016313 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 191 | L | 0.126385 | F | 0.099741 | 0.026644 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 195 | L | 0.083175 | P | 0.151142 | -0.067967 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 261 | L | 0.227443 | P | 0.381391 | -0.153948 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 280 | G | 0.271693 | D | 0.282334 | -0.010641 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 394 | A | 0.382813 | S | 0.482065 | -0.099252 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 474 | G | 0.150846 | V | 0.081521 | 0.069325 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 496 | P | 0.236409 | R | 0.206357 | 0.030052 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 513 | G | 0.47385 | V | 0.357395 | 0.116455 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 569 | P | 0.090041 | R | 0.082965 | 0.007076 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 637 | N | 0.197601 | I | 0.09596 | 0.101641 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1720 | A | 0.172108 | V | 0.137294 | 0.034814 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1762 | F | 0.32816 | L | 0.35298 | -0.02482 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 1877 | C | 0.112002 | Y | 0.137885 | -0.025883 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2013 | G | 0.124888 | R | 0.125259 | -3.71E-04 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2101 | H | 0.161157 | D | 0.187989 | -0.026832 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2106 | Q | 0.478911 | P | 0.484356 | -0.005445 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2143 | M | 0.15803 | V | 0.132128 | 0.025902 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2172 | P | 0.26507 | L | 0.156848 | 0.108222 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2286 | D | 0.38676 | G | 0.381164 | 0.005596 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2336 | I | 0.108172 | F | 0.106433 | 0.001739 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00451 | FA8_HUMAN Coagulation factor VIII OS=Homo sapiens GN=F8 PE=1 SV=1 | 2344 | G | 0.200807 | D | 0.231277 | -0.03047 | No Change: Both O | Hemophilia A (HEMA) [MIM:306700] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 7 | I | 0.426277 | F | 0.421611 | 0.004666 | No Change: Both O | - |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 17 | I | 0.038802 | N | 0.082339 | -0.043537 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 28 | C | 0.097235 | R | 0.192698 | -0.095463 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 30 | V | 0.136891 | I | 0.121524 | 0.015367 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 43 | R | 0.529752 | Q | 0.531889 | -0.002137 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 43 | R | 0.529752 | L | 0.41203 | 0.117722 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 43 | R | 0.529752 | W | 0.313307 | 0.216445 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 45 | K | 0.536377 | N | 0.507987 | 0.02839 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 46 | R | 0.528257 | S | 0.569245 | -0.040988 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 46 | R | 0.528257 | T | 0.494887 | 0.03337 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 48 | N | 0.555128 | I | 0.383816 | 0.171312 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 49 | S | 0.566811 | P | 0.566504 | 3.07E-04 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 53 | E | 0.613701 | A | 0.503472 | 0.110229 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 54 | E | 0.629559 | G | 0.561579 | 0.06798 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 55 | F | 0.64543 | C | 0.687874 | -0.042444 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 58 | G | 0.635666 | A | 0.602959 | 0.032707 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 58 | G | 0.635666 | R | 0.684936 | -0.04927 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 66 | E | 0.763092 | V | 0.558969 | 0.204123 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 67 | E | 0.773178 | K | 0.750072 | 0.023106 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 71 | F | 0.787748 | S | 0.870501 | -0.082753 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 73 | E | 0.769442 | K | 0.741864 | 0.027578 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 73 | E | 0.769442 | V | 0.599712 | 0.16973 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 91 | Y | 0.51356 | C | 0.629736 | -0.116176 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 93 | D | 0.483864 | G | 0.451843 | 0.032021 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 96 | Q | 0.518839 | P | 0.549885 | -0.031046 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 97 | C | 0.520008 | S | 0.626541 | -0.106533 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 101 | P | 0.514927 | R | 0.483758 | 0.031169 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 102 | C | 0.503897 | R | 0.57448 | -0.070583 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 106 | G | 0.490844 | S | 0.553715 | -0.062871 | O to D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 108 | C | 0.498428 | S | 0.625832 | -0.127404 | O to D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 110 | D | 0.466483 | N | 0.460409 | 0.006074 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 112 | I | 0.427891 | S | 0.649812 | -0.221921 | O to D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 113 | N | 0.389728 | K | 0.426618 | -0.03689 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 115 | Y | 0.311015 | C | 0.443033 | -0.132018 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 119 | C | 0.333246 | F | 0.258613 | 0.074633 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 119 | C | 0.333246 | R | 0.344594 | -0.011348 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 125 | G | 0.425099 | E | 0.489928 | -0.064829 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 125 | G | 0.425099 | V | 0.317983 | 0.107116 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 136 | I | 0.340905 | T | 0.499309 | -0.158404 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 139 | G | 0.390071 | D | 0.435051 | -0.04498 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 139 | G | 0.390071 | S | 0.45783 | -0.067759 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 155 | C | 0.511205 | F | 0.421311 | 0.089894 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 160 | G | 0.523623 | E | 0.615097 | -0.091474 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 167 | Q | 0.637626 | H | 0.568164 | 0.069462 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 178 | C | 0.508776 | R | 0.610945 | -0.102169 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 178 | C | 0.508776 | W | 0.354044 | 0.154732 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 191 | R | 0.494071 | H | 0.45772 | 0.036351 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 191 | R | 0.494071 | C | 0.379061 | 0.11501 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 226 | R | 0.284116 | W | 0.132705 | 0.151411 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 226 | R | 0.284116 | G | 0.318063 | -0.033947 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 226 | R | 0.284116 | Q | 0.319489 | -0.035373 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 227 | V | 0.301073 | D | 0.468246 | -0.167173 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 228 | V | 0.345167 | L | 0.32831 | 0.016857 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 241 | Q | 0.119697 | H | 0.101946 | 0.017751 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 253 | G | 0.122341 | E | 0.150216 | -0.027875 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 253 | G | 0.122341 | R | 0.107337 | 0.015004 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 265 | A | 0.079043 | T | 0.093751 | -0.014708 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 279 | A | 0.287397 | T | 0.337682 | -0.050285 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 283 | N | 0.597736 | D | 0.615147 | -0.017411 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 294 | R | 0.489649 | G | 0.481419 | 0.00823 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 294 | R | 0.489649 | Q | 0.507077 | -0.017428 | O to D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 302 | H | 0.199751 | R | 0.201885 | -0.002134 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 316 | I | 0.176163 | F | 0.169362 | 0.006801 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 321 | L | 0.223586 | Q | 0.330119 | -0.106533 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 333 | P | 0.065088 | H | 0.054814 | 0.010274 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 342 | T | 0.120172 | K | 0.182384 | -0.062212 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 342 | T | 0.120172 | M | 0.098462 | 0.02171 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 351 | G | 0.153391 | D | 0.155268 | -0.001877 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 356 | W | 0.27297 | C | 0.307611 | -0.034641 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 357 | G | 0.265932 | E | 0.29466 | -0.028728 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 362 | K | 0.25891 | E | 0.259488 | -5.78E-04 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 363 | G | 0.255505 | W | 0.102231 | 0.153274 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 366 | A | 0.191225 | D | 0.261199 | -0.069974 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 379 | R | 0.15723 | G | 0.154147 | 0.003083 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 379 | R | 0.15723 | Q | 0.159851 | -0.002621 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 382 | C | 0.151708 | Y | 0.188611 | -0.036903 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 387 | K | 0.163858 | E | 0.166729 | -0.002871 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 390 | I | 0.109306 | F | 0.127219 | -0.017913 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 394 | M | 0.097191 | K | 0.163419 | -0.066228 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 396 | C | 0.117131 | S | 0.271668 | -0.154537 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 404 | R | 0.619685 | T | 0.612532 | 0.007153 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 407 | C | 0.716482 | S | 0.786568 | -0.070086 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 413 | G | 0.652665 | R | 0.6246 | 0.028065 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 419 | V | 0.534491 | E | 0.681114 | -0.146623 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 424 | F | 0.199016 | V | 0.237389 | -0.038373 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 426 | T | 0.15086 | P | 0.177041 | -0.026181 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 430 | S | 0.139603 | T | 0.107381 | 0.032222 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 431 | W | 0.170294 | G | 0.357681 | -0.187387 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 431 | W | 0.170294 | R | 0.328839 | -0.158545 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 432 | G | 0.191543 | S | 0.226727 | -0.035184 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 432 | G | 0.191543 | V | 0.106308 | 0.085235 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 433 | E | 0.206681 | A | 0.134899 | 0.071782 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 433 | E | 0.206681 | K | 0.208749 | -0.002068 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 436 | A | 0.241721 | V | 0.184768 | 0.056953 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 449 | R | 0.106748 | Q | 0.115378 | -0.00863 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 449 | R | 0.106748 | W | 0.044658 | 0.06209 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 450 | Y | 0.128328 | C | 0.106819 | 0.021509 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 454 | I | 0.336088 | T | 0.493468 | -0.15738 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 194 | T | 0.417052 | A | 0.371524 | 0.045528 | No Change: Both O | - |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 461 | T | 0.847094 | P | 0.844384 | 0.00271 | No Change: Both D | - |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 37 | A | 0.378861 | T | 0.412047 | -0.033186 | No Change: Both O | - |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 75 | R | 0.753291 | Q | 0.760856 | -0.007565 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 79 | E | 0.731227 | D | 0.678821 | 0.052406 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 227 | V | 0.301073 | F | 0.279268 | 0.021805 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 228 | V | 0.345167 | F | 0.321145 | 0.024022 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 252 | C | 0.128691 | S | 0.328983 | -0.200292 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 268 | C | 0.107758 | W | 0.092016 | 0.015742 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 291 | E | 0.688089 | V | 0.483157 | 0.204932 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 306 | N | 0.370075 | S | 0.385913 | -0.015838 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 357 | G | 0.265932 | R | 0.247892 | 0.01804 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 397 | A | 0.164521 | P | 0.226776 | -0.062255 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 410 | D | 0.668489 | H | 0.661065 | 0.007424 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 411 | S | 0.674885 | I | 0.491372 | 0.183513 | D to O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 411 | S | 0.674885 | G | 0.651477 | 0.023408 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 414 | P | 0.644838 | T | 0.617547 | 0.027291 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 442 | G | 0.247202 | R | 0.231787 | 0.015415 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 443 | I | 0.239381 | T | 0.391142 | -0.151761 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 453 | W | 0.237986 | R | 0.450449 | -0.212463 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 28 | C | 0.097235 | Y | 0.126385 | -0.02915 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 52 | L | 0.593039 | S | 0.696875 | -0.103836 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 84 | T | 0.629841 | R | 0.658522 | -0.028681 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 106 | G | 0.490844 | D | 0.532841 | -0.041997 | O to D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 124 | E | 0.411943 | K | 0.413894 | -0.001951 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 125 | G | 0.425099 | R | 0.420922 | 0.004177 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 134 | C | 0.310816 | Y | 0.245 | 0.065816 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 169 | S | 0.617597 | C | 0.517504 | 0.100093 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 170 | C | 0.614971 | F | 0.559301 | 0.05567 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 241 | Q | 0.119697 | K | 0.145434 | -0.025737 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 252 | C | 0.128691 | Y | 0.161909 | -0.033218 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 318 | L | 0.185101 | R | 0.268897 | -0.083796 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 333 | P | 0.065088 | T | 0.05467 | 0.010418 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 344 | I | 0.11719 | L | 0.138401 | -0.021211 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 383 | L | 0.150202 | I | 0.134693 | 0.015509 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 383 | L | 0.150202 | F | 0.138542 | 0.01166 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 395 | F | 0.09872 | I | 0.094523 | 0.004197 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 395 | F | 0.09872 | L | 0.10151 | -0.00279 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 396 | C | 0.117131 | F | 0.131121 | -0.01399 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 407 | C | 0.716482 | R | 0.773496 | -0.057014 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 412 | G | 0.648376 | E | 0.670333 | -0.021957 | No Change: Both D | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 435 | C | 0.248691 | Y | 0.306856 | -0.058165 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 442 | G | 0.247202 | E | 0.287892 | -0.04069 | No Change: Both O | Recessive X-linked hemophilia B (HEMB) [MIM:306900] |
| P00740 | FA9_HUMAN Coagulation factor IX OS=Homo sapiens GN=F9 PE=1 SV=2 | 384 | R | 0.16444 | L | 0.100303 | 0.064137 | No Change: Both O | Thrombophilia due to factor IX defect (THR-FIX) [MIM:300807] |
| Q7L5A8 | FA2H_HUMAN Fatty acid 2-hydroxylase OS=Homo sapiens GN=FA2H PE=1 SV=1 | 97 | P | 0.712834 | A | 0.641794 | 0.07104 | No Change: Both D | - |
| Q7L5A8 | FA2H_HUMAN Fatty acid 2-hydroxylase OS=Homo sapiens GN=FA2H PE=1 SV=1 | 35 | D | 0.433677 | Y | 0.307326 | 0.126351 | No Change: Both O | Spastic paraplegia autosomal recessive type 35 (SPG35) [MIM:612319] |
| Q7L5A8 | FA2H_HUMAN Fatty acid 2-hydroxylase OS=Homo sapiens GN=FA2H PE=1 SV=1 | 235 | R | 0.05964 | C | 0.02761 | 0.03203 | No Change: Both O | Spastic paraplegia autosomal recessive type 35 (SPG35) [MIM:612319] |
| Q7L5A8 | FA2H_HUMAN Fatty acid 2-hydroxylase OS=Homo sapiens GN=FA2H PE=1 SV=1 | 154 | R | 0.205344 | C | 0.097106 | 0.108238 | No Change: Both O | Spastic paraplegia autosomal recessive type 35 (SPG35) [MIM:612319] |
| O00519 | FAAH1_HUMAN Fatty-acid amide hydrolase 1 OS=Homo sapiens GN=FAAH PE=1 SV=2 | 129 | P | 0.399703 | T | 0.357252 | 0.042451 | No Change: Both O | - |
| O00519 | FAAH1_HUMAN Fatty-acid amide hydrolase 1 OS=Homo sapiens GN=FAAH PE=1 SV=2 | 345 | A | 0.452262 | D | 0.507414 | -0.055152 | O to D | A breast cancer sample |
| Q0VG06 | FP100_HUMAN Fanconi anemia-associated protein of 100 kDa OS=Homo sapiens GN=FAAP100 PE=1 SV=3 | 660 | P | 0.79922 | L | 0.682883 | 0.116337 | No Change: Both D | - |
| Q0VG06 | FP100_HUMAN Fanconi anemia-associated protein of 100 kDa OS=Homo sapiens GN=FAAP100 PE=1 SV=3 | 817 | T | 0.62855 | A | 0.610705 | 0.017845 | No Change: Both D | - |
| Q9BTP7 | FAP24_HUMAN Fanconi anemia-associated protein of 24 kDa OS=Homo sapiens GN=FAAP24 PE=1 SV=2 | 158 | S | 0.649437 | L | 0.517883 | 0.131554 | No Change: Both D | - |
| Q9BTP7 | FAP24_HUMAN Fanconi anemia-associated protein of 24 kDa OS=Homo sapiens GN=FAAP24 PE=1 SV=2 | 192 | I | 0.449401 | T | 0.559731 | -0.11033 | O to D | - |
| Q9BTP7 | FAP24_HUMAN Fanconi anemia-associated protein of 24 kDa OS=Homo sapiens GN=FAAP24 PE=1 SV=2 | 126 | S | 0.278227 | F | 0.135926 | 0.142301 | No Change: Both O | - |
| P07148 | FABPL_HUMAN Fatty acid-binding protein liver OS=Homo sapiens GN=FABP1 PE=1 SV=1 | 54 | A | 0.334989 | T | 0.435997 | -0.101008 | No Change: Both O | - |
| P07148 | FABPL_HUMAN Fatty acid-binding protein liver OS=Homo sapiens GN=FABP1 PE=1 SV=1 | 94 | T | 0.371412 | A | 0.286129 | 0.085283 | No Change: Both O | - |
| P12104 | FABPI_HUMAN Fatty acid-binding protein intestinal OS=Homo sapiens GN=FABP2 PE=1 SV=2 | 55 | A | 0.338273 | T | 0.379632 | -0.041359 | No Change: Both O | - |
| P05413 | FABPH_HUMAN Fatty acid-binding protein heart OS=Homo sapiens GN=FABP3 PE=1 SV=4 | 53 | K | 0.409625 | R | 0.336195 | 0.07343 | No Change: Both O | - |
| P15090 | FABP4_HUMAN Fatty acid-binding protein adipocyte OS=Homo sapiens GN=FABP4 PE=1 SV=3 | 23 | E | 0.290695 | D | 0.280333 | 0.010362 | No Change: Both O | A breast cancer sample |
| P51161 | FABP6_HUMAN Gastrotropin OS=Homo sapiens GN=FABP6 PE=1 SV=2 | 33 | R | 0.274921 | H | 0.273312 | 0.001609 | No Change: Both O | - |
| P51161 | FABP6_HUMAN Gastrotropin OS=Homo sapiens GN=FABP6 PE=1 SV=2 | 55 | S | 0.498093 | Y | 0.327327 | 0.170766 | No Change: Both O | - |
| P51161 | FABP6_HUMAN Gastrotropin OS=Homo sapiens GN=FABP6 PE=1 SV=2 | 79 | T | 0.485697 | M | 0.449149 | 0.036548 | No Change: Both O | - |
| O15540 | FABP7_HUMAN Fatty acid-binding protein brain OS=Homo sapiens GN=FABP7 PE=1 SV=3 | 61 | T | 0.427411 | M | 0.359012 | 0.068399 | No Change: Both O | - |
| Q13158 | FADD_HUMAN Protein FADD OS=Homo sapiens GN=FADD PE=1 SV=1 | 105 | C | 0.119047 | W | 0.083256 | 0.035791 | No Change: Both O | Infections recurrent associated with encephalopathy hepatic dysfunction and cardiovascular malformations (IEHDCM) [MIM:613759] |
| O60427 | FADS1_HUMAN Fatty acid desaturase 1 OS=Homo sapiens GN=FADS1 PE=1 SV=1 | 272 | P | 0.076984 | S | 0.079192 | -0.002208 | No Change: Both O | - |
| Q9Y5Q0 | FADS3_HUMAN Fatty acid desaturase 3 OS=Homo sapiens GN=FADS3 PE=2 SV=1 | 192 | K | 0.244548 | N | 0.209087 | 0.035461 | No Change: Both O | - |
| Q9Y5Q0 | FADS3_HUMAN Fatty acid desaturase 3 OS=Homo sapiens GN=FADS3 PE=2 SV=1 | 216 | N | 0.15465 | K | 0.188333 | -0.033683 | No Change: Both O | - |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 16 | N | 0.209372 | I | 0.113694 | 0.095678 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 62 | F | 0.422608 | C | 0.399027 | 0.023581 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 64 | Q | 0.405703 | H | 0.38655 | 0.019153 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 134 | A | 0.336782 | D | 0.435202 | -0.09842 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 158 | G | 0.25863 | D | 0.269615 | -0.010985 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 166 | V | 0.462638 | G | 0.585463 | -0.122825 | O to D | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 193 | C | 0.397477 | R | 0.535483 | -0.138006 | O to D | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 207 | G | 0.25273 | D | 0.265197 | -0.012467 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 233 | D | 0.137644 | V | 0.067375 | 0.070269 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 234 | W | 0.145056 | G | 0.323878 | -0.178822 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 249 | P | 0.178517 | T | 0.141944 | 0.036573 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 261 | P | 0.204295 | L | 0.10062 | 0.103675 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 294 | T | 0.198367 | P | 0.2744 | -0.076033 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 337 | G | 0.390851 | S | 0.445898 | -0.055047 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 341 | R | 0.355276 | W | 0.178437 | 0.176839 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 342 | P | 0.335909 | L | 0.213642 | 0.122267 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 369 | G | 0.415632 | V | 0.264826 | 0.150806 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 381 | R | 0.33096 | G | 0.368562 | -0.037602 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 405 | F | 0.154714 | H | 0.278435 | -0.123721 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 35 | A | 0.177438 | T | 0.205018 | -0.02758 | No Change: Both O | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| P16930 | FAAA_HUMAN Fumarylacetoacetase OS=Homo sapiens GN=FAH PE=1 SV=2 | 279 | Q | 0.572666 | R | 0.576933 | -0.004267 | No Change: Both D | Tyrosinemia type 1 (TYRO1) [MIM:276700] |
| Q6P587 | FAHD1_HUMAN Acylpyruvase FAHD1 mitochondrial OS=Homo sapiens GN=FAHD1 PE=1 SV=2 | 110 | D | 0.457034 | N | 0.422977 | 0.034057 | No Change: Both O | - |
| Q96GK7 | FAH2A_HUMAN Fumarylacetoacetate hydrolase domain-containing protein 2A OS=Homo sapiens GN=FAHD2A PE=1 SV=1 | 198 | M | 0.323786 | T | 0.363919 | -0.040133 | No Change: Both O | - |
| Q9NVQ4 | FAIM1_HUMAN Fas apoptotic inhibitory molecule 1 OS=Homo sapiens GN=FAIM PE=1 SV=1 | 117 | A | 0.138881 | T | 0.166868 | -0.027987 | No Change: Both O | - |
| Q9NVQ4 | FAIM1_HUMAN Fas apoptotic inhibitory molecule 1 OS=Homo sapiens GN=FAIM PE=1 SV=1 | 127 | L | 0.324604 | S | 0.51695 | -0.192346 | O to D | - |
| Q5XKR9 | F104B_HUMAN Protein FAM104B OS=Homo sapiens GN=FAM104B PE=2 SV=1 | 60 | S | 0.740648 | G | 0.702431 | 0.038217 | No Change: Both D | - |
| Q9NUU6 | F105A_HUMAN Protein FAM105A OS=Homo sapiens GN=FAM105A PE=2 SV=1 | 319 | F | 0.122856 | L | 0.132965 | -0.010109 | No Change: Both O | - |
| Q96BN8 | F105B_HUMAN Protein FAM105B OS=Homo sapiens GN=FAM105B PE=1 SV=3 | 227 | S | 0.299366 | N | 0.281091 | 0.018275 | No Change: Both O | - |
| Q96BN8 | F105B_HUMAN Protein FAM105B OS=Homo sapiens GN=FAM105B PE=1 SV=3 | 155 | M | 0.25819 | L | 0.228428 | 0.029762 | No Change: Both O | - |
| Q96BN8 | F105B_HUMAN Protein FAM105B OS=Homo sapiens GN=FAM105B PE=1 SV=3 | 311 | N | 0.281959 | S | 0.34 | -0.058041 | No Change: Both O | - |
| O95990 | F107A_HUMAN Protein FAM107A OS=Homo sapiens GN=FAM107A PE=1 SV=1 | 15 | L | 0.49279 | M | 0.620401 | -0.127611 | O to D | Ovarian cancer |
| O95990 | F107A_HUMAN Protein FAM107A OS=Homo sapiens GN=FAM107A PE=1 SV=1 | 19 | P | 0.509887 | L | 0.335741 | 0.174146 | D to O | Renal cell carcinoma cell line |
| O95990 | F107A_HUMAN Protein FAM107A OS=Homo sapiens GN=FAM107A PE=1 SV=1 | 89 | A | 0.96192 | S | 0.975244 | -0.013324 | No Change: Both D | - |
| O95990 | F107A_HUMAN Protein FAM107A OS=Homo sapiens GN=FAM107A PE=1 SV=1 | 141 | E | 0.849972 | Q | 0.787755 | 0.062217 | No Change: Both D | - |
| Q5VST6 | F108B_HUMAN Abhydrolase domain-containing protein FAM108B1 OS=Homo sapiens GN=FAM108B1 PE=2 SV=1 | 169 | Q | 0.181286 | K | 0.215527 | -0.034241 | No Change: Both O | - |
| Q5VST6 | F108B_HUMAN Abhydrolase domain-containing protein FAM108B1 OS=Homo sapiens GN=FAM108B1 PE=2 SV=1 | 154 | R | 0.093166 | K | 0.11234 | -0.019174 | No Change: Both O | - |
| Q6ICB4 | SESQ2_HUMAN Sesquipedalian-2 OS=Homo sapiens GN=FAM109B PE=1 SV=1 | 188 | A | 0.703017 | G | 0.73924 | -0.036223 | No Change: Both D | - |
| Q9BQ89 | F110A_HUMAN Protein FAM110A OS=Homo sapiens GN=FAM110A PE=1 SV=1 | 284 | L | 0.253691 | I | 0.227973 | 0.025718 | No Change: Both O | - |
| Q8TC76 | F110B_HUMAN Protein FAM110B OS=Homo sapiens GN=FAM110B PE=1 SV=1 | 214 | A | 0.928685 | S | 0.955904 | -0.027219 | No Change: Both D | A colorectal cancer sample |
| Q6SJ93 | F111B_HUMAN Protein FAM111B OS=Homo sapiens GN=FAM111B PE=2 SV=1 | 731 | P | 0.954788 | A | 0.923573 | 0.031215 | No Change: Both D | - |
| Q6SJ93 | F111B_HUMAN Protein FAM111B OS=Homo sapiens GN=FAM111B PE=2 SV=1 | 218 | G | 0.232572 | D | 0.241162 | -0.00859 | No Change: Both O | - |
| Q9H1Q7 | F113A_HUMAN Protein FAM113A OS=Homo sapiens GN=FAM113A PE=1 SV=1 | 22 | Q | 0.378434 | H | 0.353404 | 0.02503 | No Change: Both O | - |
| Q96HM7 | F113B_HUMAN Protein FAM113B OS=Homo sapiens GN=FAM113B PE=2 SV=1 | 429 | P | 0.996897 | A | 0.994387 | 0.00251 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 84 | G | 0.755147 | R | 0.766504 | -0.011357 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 116 | L | 0.485783 | P | 0.660875 | -0.175092 | O to D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 201 | P | 0.880402 | L | 0.822923 | 0.057479 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 367 | R | 0.572058 | H | 0.55299 | 0.019068 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 443 | V | 0.79266 | I | 0.795925 | -0.003265 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 40 | S | 0.91754 | L | 0.842196 | 0.075344 | No Change: Both D | - |
| Q8IWE2 | NXP20_HUMAN Protein NOXP20 OS=Homo sapiens GN=FAM114A1 PE=1 SV=2 | 446 | S | 0.742579 | L | 0.671831 | 0.070748 | No Change: Both D | - |
| Q9NWS6 | F118A_HUMAN Protein FAM118A OS=Homo sapiens GN=FAM118A PE=2 SV=2 | 129 | V | 0.238393 | L | 0.249367 | -0.010974 | No Change: Both O | - |
| Q9NWS6 | F118A_HUMAN Protein FAM118A OS=Homo sapiens GN=FAM118A PE=2 SV=2 | 239 | R | 0.128395 | H | 0.130126 | -0.001731 | No Change: Both O | - |
| Q9NZB2 | F120A_HUMAN Constitutive coactivator of PPAR-gamma-like protein 1 OS=Homo sapiens GN=FAM120A PE=1 SV=2 | 327 | Y | 0.419001 | H | 0.537019 | -0.118018 | O to D | - |
| Q5T036 | F120S_HUMAN Putative FAM120A opposite strand protein OS=Homo sapiens GN=FAM120AOS PE=5 SV=1 | 22 | L | 0.759795 | F | 0.773549 | -0.013754 | No Change: Both D | - |
| Q5T036 | F120S_HUMAN Putative FAM120A opposite strand protein OS=Homo sapiens GN=FAM120AOS PE=5 SV=1 | 241 | K | 0.891428 | E | 0.866931 | 0.024497 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 370 | D | 0.993079 | Y | 0.988382 | 0.004697 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 379 | M | 0.995553 | T | 0.995827 | -2.74E-04 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 428 | Y | 0.988726 | C | 0.991524 | -0.002798 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 430 | D | 0.988559 | G | 0.986947 | 0.001612 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 431 | S | 0.988232 | P | 0.990516 | -0.002284 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 433 | P | 0.988067 | A | 0.978359 | 0.009708 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 440 | Y | 0.987798 | C | 0.989635 | -0.001837 | No Change: Both D | - |
| Q96EK7 | F120B_HUMAN Constitutive coactivator of peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=FAM120B PE=1 SV=1 | 511 | C | 0.734399 | G | 0.766422 | -0.032023 | No Change: Both D | - |
| Q9NX05 | F120C_HUMAN Constitutive coactivator of PPAR-gamma-like protein 2 OS=Homo sapiens GN=FAM120C PE=2 SV=3 | 82 | I | 0.954245 | T | 0.968068 | -0.013823 | No Change: Both D | - |
| Q9NX05 | F120C_HUMAN Constitutive coactivator of PPAR-gamma-like protein 2 OS=Homo sapiens GN=FAM120C PE=2 SV=3 | 934 | M | 0.844798 | I | 0.764126 | 0.080672 | No Change: Both D | - |
| Q8N7J2 | F123A_HUMAN Protein FAM123A OS=Homo sapiens GN=FAM123A PE=2 SV=3 | 659 | I | 0.517211 | M | 0.649538 | -0.132327 | No Change: Both D | - |
| Q8N7J2 | F123A_HUMAN Protein FAM123A OS=Homo sapiens GN=FAM123A PE=2 SV=3 | 457 | A | 0.830868 | T | 0.842027 | -0.011159 | No Change: Both D | A colorectal cancer sample |
| Q5JTC6 | F123B_HUMAN Protein FAM123B OS=Homo sapiens GN=FAM123B PE=1 SV=2 | 292 | K | 0.910937 | N | 0.906831 | 0.004106 | No Change: Both D | - |
| Q5JTC6 | F123B_HUMAN Protein FAM123B OS=Homo sapiens GN=FAM123B PE=1 SV=2 | 159 | F | 0.89997 | L | 0.901605 | -0.001635 | No Change: Both D | - |
| Q5JTC6 | F123B_HUMAN Protein FAM123B OS=Homo sapiens GN=FAM123B PE=1 SV=2 | 278 | A | 0.986042 | S | 0.98988 | -0.003838 | No Change: Both D | - |
| Q8N944 | F123C_HUMAN Protein FAM123C OS=Homo sapiens GN=FAM123C PE=2 SV=2 | 340 | S | 0.865963 | P | 0.869849 | -0.003886 | No Change: Both D | - |
| Q86V42 | F124A_HUMAN Protein FAM124A OS=Homo sapiens GN=FAM124A PE=2 SV=1 | 181 | D | 0.13372 | H | 0.106127 | 0.027593 | No Change: Both O | - |
| Q9H5Z6 | F124B_HUMAN Protein FAM124B OS=Homo sapiens GN=FAM124B PE=1 SV=3 | 257 | I | 0.389925 | T | 0.504353 | -0.114428 | O to D | - |
| Q96EY5 | F125A_HUMAN Multivesicular body subunit 12A OS=Homo sapiens GN=FAM125A PE=1 SV=1 | 106 | C | 0.589848 | Y | 0.525654 | 0.064194 | No Change: Both D | - |
| Q9BYI3 | HYCCI_HUMAN Hyccin OS=Homo sapiens GN=FAM126A PE=1 SV=2 | 53 | L | 0.448235 | P | 0.602476 | -0.154241 | O to D | Leukodystrophy hypomyelinating type 5 (HLD5) [MIM:610532] |
| A6ZKI3 | F127A_HUMAN Protein FAM127A OS=Homo sapiens GN=FAM127A PE=1 SV=1 | 60 | S | 0.326965 | N | 0.290384 | 0.036581 | No Change: Both O | - |
| O15255 | CXX1_HUMAN CAAX box protein 1 OS=Homo sapiens GN=FAM127A PE=1 SV=1 | 152 | S | 0.690536 | W | 0.508605 | 0.181931 | No Change: Both D | - |
| Q9BWD3 | F127B_HUMAN Protein FAM127B OS=Homo sapiens GN=FAM127B PE=1 SV=3 | 48 | S | 0.197308 | C | 0.082909 | 0.114399 | No Change: Both O | - |
| Q9BZQ8 | NIBAN_HUMAN Protein Niban OS=Homo sapiens GN=FAM129A PE=1 SV=1 | 633 | S | 0.969865 | L | 0.942135 | 0.02773 | No Change: Both D | - |
| Q9BZQ8 | NIBAN_HUMAN Protein Niban OS=Homo sapiens GN=FAM129A PE=1 SV=1 | 692 | D | 0.900959 | N | 0.889374 | 0.011585 | No Change: Both D | - |
| Q9BZQ8 | NIBAN_HUMAN Protein Niban OS=Homo sapiens GN=FAM129A PE=1 SV=1 | 720 | V | 0.838615 | M | 0.869075 | -0.03046 | No Change: Both D | - |
| Q9BZQ8 | NIBAN_HUMAN Protein Niban OS=Homo sapiens GN=FAM129A PE=1 SV=1 | 830 | G | 0.944719 | S | 0.950835 | -0.006116 | No Change: Both D | - |
| Q86XR2 | NIBL2_HUMAN Niban-like protein 2 OS=Homo sapiens GN=FAM129C PE=1 SV=2 | 229 | I | 0.241678 | T | 0.354246 | -0.112568 | No Change: Both O | - |
| Q86XR2 | NIBL2_HUMAN Niban-like protein 2 OS=Homo sapiens GN=FAM129C PE=1 SV=2 | 543 | L | 0.263488 | F | 0.238034 | 0.025454 | No Change: Both O | - |
| Q86XR2 | NIBL2_HUMAN Niban-like protein 2 OS=Homo sapiens GN=FAM129C PE=1 SV=2 | 603 | G | 0.140754 | S | 0.182523 | -0.041769 | No Change: Both O | - |
| Q86XR2 | NIBL2_HUMAN Niban-like protein 2 OS=Homo sapiens GN=FAM129C PE=1 SV=2 | 493 | T | 0.326319 | M | 0.31513 | 0.011189 | No Change: Both O | - |
| Q6UXB0 | F131A_HUMAN Protein FAM131A OS=Homo sapiens GN=FAM131A PE=2 SV=1 | 260 | S | 0.892904 | N | 0.851211 | 0.041693 | No Change: Both D | A breast cancer sample |
| Q6UXB0 | F131A_HUMAN Protein FAM131A OS=Homo sapiens GN=FAM131A PE=2 SV=1 | 52 | C | 0.53533 | R | 0.631456 | -0.096126 | No Change: Both D | - |
| Q86XD5 | F131B_HUMAN Protein FAM131B OS=Homo sapiens GN=FAM131B PE=1 SV=3 | 307 | A | 0.960552 | T | 0.967785 | -0.007233 | No Change: Both D | - |
| Q96AQ9 | F131C_HUMAN Protein FAM131C OS=Homo sapiens GN=FAM131C PE=2 SV=2 | 48 | K | 0.431486 | E | 0.394436 | 0.03705 | No Change: Both O | - |
| Q96AQ9 | F131C_HUMAN Protein FAM131C OS=Homo sapiens GN=FAM131C PE=2 SV=2 | 107 | R | 0.313173 | Q | 0.3168 | -0.003627 | No Change: Both O | - |
| Q96AQ9 | F131C_HUMAN Protein FAM131C OS=Homo sapiens GN=FAM131C PE=2 SV=2 | 123 | P | 0.30416 | R | 0.264023 | 0.040137 | No Change: Both O | - |
| Q96AQ9 | F131C_HUMAN Protein FAM131C OS=Homo sapiens GN=FAM131C PE=2 SV=2 | 215 | S | 0.997473 | I | 0.99449 | 0.002983 | No Change: Both D | - |
| Q96AQ9 | F131C_HUMAN Protein FAM131C OS=Homo sapiens GN=FAM131C PE=2 SV=2 | 226 | E | 0.998941 | D | 0.998825 | 1.16E-04 | No Change: Both D | - |
| Q5T7M4 | F132A_HUMAN Protein FAM132A OS=Homo sapiens GN=FAM132A PE=2 SV=2 | 14 | G | 0.244216 | R | 0.286911 | -0.042695 | No Change: Both O | - |
| Q8N9E0 | F133A_HUMAN Protein FAM133A OS=Homo sapiens GN=FAM133A PE=2 SV=1 | 67 | E | 0.979167 | K | 0.979289 | -1.22E-04 | No Change: Both D | - |
| Q8NC44 | F134A_HUMAN Protein FAM134A OS=Homo sapiens GN=FAM134A PE=1 SV=3 | 419 | P | 0.749873 | Q | 0.684809 | 0.065064 | No Change: Both D | - |
| Q8NC44 | F134A_HUMAN Protein FAM134A OS=Homo sapiens GN=FAM134A PE=1 SV=3 | 374 | R | 0.973582 | H | 0.964199 | 0.009383 | No Change: Both D | - |
| Q9H6L5 | F134B_HUMAN Protein FAM134B OS=Homo sapiens GN=FAM134B PE=2 SV=1 | 379 | Q | 0.934644 | E | 0.943106 | -0.008462 | No Change: Both D | - |
| Q9P2D6 | F135A_HUMAN Protein FAM135A OS=Homo sapiens GN=FAM135A PE=1 SV=2 | 725 | I | 0.542456 | V | 0.559431 | -0.016975 | No Change: Both D | - |
| Q9P2D6 | F135A_HUMAN Protein FAM135A OS=Homo sapiens GN=FAM135A PE=1 SV=2 | 954 | P | 0.864569 | S | 0.87921 | -0.014641 | No Change: Both D | - |
| Q9P2D6 | F135A_HUMAN Protein FAM135A OS=Homo sapiens GN=FAM135A PE=1 SV=2 | 1242 | D | 0.760067 | G | 0.755208 | 0.004859 | No Change: Both D | - |
| Q49AJ0 | F135B_HUMAN Protein FAM135B OS=Homo sapiens GN=FAM135B PE=2 SV=2 | 477 | I | 0.667079 | V | 0.707146 | -0.040067 | No Change: Both D | - |
| Q49AJ0 | F135B_HUMAN Protein FAM135B OS=Homo sapiens GN=FAM135B PE=2 SV=2 | 846 | D | 0.549385 | N | 0.514714 | 0.034671 | No Change: Both D | - |
| Q49AJ0 | F135B_HUMAN Protein FAM135B OS=Homo sapiens GN=FAM135B PE=2 SV=2 | 578 | S | 0.686896 | N | 0.647235 | 0.039661 | No Change: Both D | - |
| Q49AJ0 | F135B_HUMAN Protein FAM135B OS=Homo sapiens GN=FAM135B PE=2 SV=2 | 1142 | V | 0.084565 | I | 0.072587 | 0.011978 | No Change: Both O | - |
| O94988 | FA13A_HUMAN Protein FAM13A OS=Homo sapiens GN=FAM13A PE=1 SV=2 | 769 | V | 0.94091 | I | 0.943502 | -0.002592 | No Change: Both D | - |
| Q9NYF5 | FA13B_HUMAN Protein FAM13B OS=Homo sapiens GN=FAM13B PE=2 SV=2 | 802 | M | 0.75909 | V | 0.727864 | 0.031226 | No Change: Both D | - |
| Q8NE31 | FA13C_HUMAN Protein FAM13C OS=Homo sapiens GN=FAM13C PE=2 SV=2 | 82 | P | 0.669667 | H | 0.589225 | 0.080442 | No Change: Both D | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 332 | K | 0.41265 | E | 0.433911 | -0.021261 | No Change: Both O | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 437 | K | 0.550414 | E | 0.542442 | 0.007972 | No Change: Both D | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 505 | H | 0.546455 | R | 0.556397 | -0.009942 | No Change: Both D | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 532 | P | 0.620476 | L | 0.47768 | 0.142796 | D to O | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 722 | R | 0.906015 | W | 0.823064 | 0.082951 | No Change: Both D | - |
| A5PLN7 | F149A_HUMAN Protein FAM149A OS=Homo sapiens GN=FAM149A PE=2 SV=2 | 748 | L | 0.496883 | V | 0.493968 | 0.002915 | No Change: Both O | - |
| Q96BN6 | F149B_HUMAN Protein FAM149B1 OS=Homo sapiens GN=FAM149B1 PE=2 SV=2 | 571 | G | 0.985855 | R | 0.988215 | -0.00236 | No Change: Both D | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 51 | D | 0.303902 | N | 0.267052 | 0.03685 | No Change: Both O | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 87 | N | 0.281173 | D | 0.283 | -0.001827 | No Change: Both O | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 119 | I | 0.347863 | T | 0.50497 | -0.157107 | O to D | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 416 | A | 0.262729 | V | 0.181299 | 0.08143 | No Change: Both O | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 526 | G | 0.406701 | A | 0.358239 | 0.048462 | No Change: Both O | - |
| Q8WW52 | F151A_HUMAN Protein FAM151A OS=Homo sapiens GN=FAM151A PE=2 SV=2 | 546 | G | 0.505307 | D | 0.53149 | -0.026183 | No Change: Both D | - |
| Q6UXP7 | F151B_HUMAN Protein FAM151B OS=Homo sapiens GN=FAM151B PE=2 SV=2 | 155 | I | 0.093837 | T | 0.182283 | -0.088446 | No Change: Both O | - |
| Q8IYX7 | F154A_HUMAN Protein FAM154A OS=Homo sapiens GN=FAM154A PE=2 SV=2 | 27 | K | 0.64909 | E | 0.652425 | -0.003335 | No Change: Both D | - |
| Q8IYX7 | F154A_HUMAN Protein FAM154A OS=Homo sapiens GN=FAM154A PE=2 SV=2 | 63 | P | 0.654432 | S | 0.650187 | 0.004245 | No Change: Both D | - |
| Q8IYX7 | F154A_HUMAN Protein FAM154A OS=Homo sapiens GN=FAM154A PE=2 SV=2 | 385 | N | 0.503277 | S | 0.573109 | -0.069832 | No Change: Both D | - |
| Q658L1 | F154B_HUMAN Protein FAM154B OS=Homo sapiens GN=FAM154B PE=2 SV=1 | 8 | S | 0.306134 | G | 0.232761 | 0.073373 | No Change: Both O | - |
| Q658L1 | F154B_HUMAN Protein FAM154B OS=Homo sapiens GN=FAM154B PE=2 SV=1 | 34 | P | 0.646896 | L | 0.489479 | 0.157417 | D to O | - |
| Q658L1 | F154B_HUMAN Protein FAM154B OS=Homo sapiens GN=FAM154B PE=2 SV=1 | 225 | W | 0.549463 | R | 0.77483 | -0.225367 | No Change: Both D | - |
| O75949 | F155B_HUMAN Transmembrane protein FAM155B OS=Homo sapiens GN=FAM155B PE=2 SV=2 | 172 | L | 0.859462 | P | 0.911267 | -0.051805 | No Change: Both D | - |
| Q9Y3B6 | F158A_HUMAN UPF0172 protein FAM158A OS=Homo sapiens GN=FAM158A PE=2 SV=3 | 97 | A | 0.323077 | V | 0.236937 | 0.08614 | No Change: Both O | - |
| A6NKW6 | F159B_HUMAN Membrane protein FAM159B OS=Homo sapiens GN=FAM159B PE=2 SV=2 | 5 | S | 0.705921 | R | 0.664913 | 0.041008 | No Change: Both D | - |
| A6NKW6 | F159B_HUMAN Membrane protein FAM159B OS=Homo sapiens GN=FAM159B PE=2 SV=2 | 111 | A | 0.698946 | P | 0.753273 | -0.054327 | No Change: Both D | - |
| Q8N612 | F16A2_HUMAN FTS and Hook-interacting protein OS=Homo sapiens GN=FAM160A2 PE=1 SV=3 | 491 | T | 0.975694 | M | 0.970809 | 0.004885 | No Change: Both D | - |
| Q8N612 | F16A2_HUMAN FTS and Hook-interacting protein OS=Homo sapiens GN=FAM160A2 PE=1 SV=3 | 619 | R | 0.973907 | L | 0.95905 | 0.014857 | No Change: Both D | - |
| Q8N612 | F16A2_HUMAN FTS and Hook-interacting protein OS=Homo sapiens GN=FAM160A2 PE=1 SV=3 | 754 | Q | 0.177661 | H | 0.162475 | 0.015186 | No Change: Both O | - |
| Q8N612 | F16A2_HUMAN FTS and Hook-interacting protein OS=Homo sapiens GN=FAM160A2 PE=1 SV=3 | 462 | R | 0.660165 | W | 0.440629 | 0.219536 | D to O | - |
| Q5W0V3 | F16B1_HUMAN Protein FAM160B1 OS=Homo sapiens GN=FAM160B1 PE=2 SV=1 | 408 | L | 0.313744 | I | 0.280608 | 0.033136 | No Change: Both O | - |
| Q5W0V3 | F16B1_HUMAN Protein FAM160B1 OS=Homo sapiens GN=FAM160B1 PE=2 SV=1 | 631 | F | 0.113602 | L | 0.1286 | -0.014998 | No Change: Both O | - |
| Q86V87 | F16B2_HUMAN Protein FAM160B2 OS=Homo sapiens GN=FAM160B2 PE=2 SV=2 | 315 | T | 0.178959 | A | 0.189357 | -0.010398 | No Change: Both O | - |
| Q86V87 | F16B2_HUMAN Protein FAM160B2 OS=Homo sapiens GN=FAM160B2 PE=2 SV=2 | 667 | G | 0.116661 | R | 0.128504 | -0.011843 | No Change: Both O | - |
| Q3B820 | F161A_HUMAN Protein FAM161A OS=Homo sapiens GN=FAM161A PE=2 SV=2 | 236 | I | 0.694548 | V | 0.716991 | -0.022443 | No Change: Both D | - |
| Q3B820 | F161A_HUMAN Protein FAM161A OS=Homo sapiens GN=FAM161A PE=2 SV=2 | 273 | E | 0.856927 | K | 0.865004 | -0.008077 | No Change: Both D | - |
| Q3B820 | F161A_HUMAN Protein FAM161A OS=Homo sapiens GN=FAM161A PE=2 SV=2 | 107 | I | 0.419209 | M | 0.557559 | -0.13835 | O to D | - |
| Q96MY7 | F161B_HUMAN Protein FAM161B OS=Homo sapiens GN=FAM161B PE=2 SV=2 | 11 | G | 0.91074 | A | 0.890233 | 0.020507 | No Change: Both D | - |
| Q96MY7 | F161B_HUMAN Protein FAM161B OS=Homo sapiens GN=FAM161B PE=2 SV=2 | 622 | L | 0.927412 | P | 0.958762 | -0.03135 | No Change: Both D | - |
| Q96A26 | F162A_HUMAN Protein FAM162A OS=Homo sapiens GN=FAM162A PE=1 SV=2 | 50 | A | 0.675331 | V | 0.660605 | 0.014726 | No Change: Both D | - |
| Q5T6X4 | F162B_HUMAN Protein FAM162B OS=Homo sapiens GN=FAM162B PE=2 SV=1 | 71 | Q | 0.684261 | H | 0.640086 | 0.044175 | No Change: Both D | - |
| Q96GY0 | F164A_HUMAN Protein FAM164A OS=Homo sapiens GN=FAM164A PE=1 SV=2 | 156 | T | 0.837346 | A | 0.824684 | 0.012662 | No Change: Both D | - |
| P58511 | F165B_HUMAN Protein FAM165B OS=Homo sapiens GN=FAM165B PE=2 SV=1 | 51 | K | 0.931404 | R | 0.922577 | 0.008827 | No Change: Both D | - |
| Q96KS9 | F167A_HUMAN Protein FAM167A OS=Homo sapiens GN=FAM167A PE=2 SV=1 | 56 | H | 0.859317 | Q | 0.893749 | -0.034432 | No Change: Both D | - |
| Q96KS9 | F167A_HUMAN Protein FAM167A OS=Homo sapiens GN=FAM167A PE=2 SV=1 | 107 | T | 0.756856 | S | 0.819048 | -0.062192 | No Change: Both D | - |
| Q8N8A8 | F169B_HUMAN Protein FAM169B OS=Homo sapiens GN=FAM169B PE=2 SV=3 | 115 | S | 0.576367 | P | 0.575438 | 9.29E-04 | No Change: Both D | - |
| A1A519 | F170A_HUMAN Protein FAM170A OS=Homo sapiens GN=FAM170A PE=2 SV=1 | 173 | P | 0.961149 | S | 0.963299 | -0.00215 | No Change: Both D | - |
| A6NMN3 | F170B_HUMAN Putative protein FAM170B OS=Homo sapiens GN=FAM170B PE=2 SV=1 | 69 | R | 0.954058 | L | 0.919969 | 0.034089 | No Change: Both D | - |
| Q5VUB5 | F1711_HUMAN Protein FAM171A1 OS=Homo sapiens GN=FAM171A1 PE=1 SV=1 | 465 | P | 0.597317 | S | 0.642433 | -0.045116 | No Change: Both D | - |
| Q6P995 | F171B_HUMAN Protein FAM171B OS=Homo sapiens GN=FAM171B PE=1 SV=3 | 302 | V | 0.258627 | I | 0.222159 | 0.036468 | No Change: Both O | - |
| Q8WUF8 | F172A_HUMAN Protein FAM172A OS=Homo sapiens GN=FAM172A PE=2 SV=1 | 131 | S | 0.625376 | N | 0.567147 | 0.058229 | No Change: Both D | - |
| Q6P4H8 | F173B_HUMAN Protein FAM173B OS=Homo sapiens GN=FAM173B PE=2 SV=2 | 75 | T | 0.252076 | M | 0.206572 | 0.045504 | No Change: Both O | - |
| Q6P4H8 | F173B_HUMAN Protein FAM173B OS=Homo sapiens GN=FAM173B PE=2 SV=2 | 105 | A | 0.2008 | V | 0.141941 | 0.058859 | No Change: Both O | - |
| Q6P4H8 | F173B_HUMAN Protein FAM173B OS=Homo sapiens GN=FAM173B PE=2 SV=2 | 114 | V | 0.152159 | A | 0.223519 | -0.07136 | No Change: Both O | - |
| Q6P4H8 | F173B_HUMAN Protein FAM173B OS=Homo sapiens GN=FAM173B PE=2 SV=2 | 229 | L | 0.545518 | M | 0.61115 | -0.065632 | No Change: Both D | - |
| Q3ZCQ3 | F174B_HUMAN Membrane protein FAM174B OS=Homo sapiens GN=FAM174B PE=2 SV=2 | 116 | S | 0.335316 | L | 0.219629 | 0.115687 | No Change: Both O | - |
| Q6UWZ7 | F175A_HUMAN BRCA1-A complex subunit Abraxas OS=Homo sapiens GN=FAM175A PE=1 SV=2 | 239 | A | 0.781835 | T | 0.772927 | 0.008908 | No Change: Both D | - |
| Q6UWZ7 | F175A_HUMAN BRCA1-A complex subunit Abraxas OS=Homo sapiens GN=FAM175A PE=1 SV=2 | 348 | A | 0.543358 | T | 0.584477 | -0.041119 | No Change: Both D | - |
| Q6UWZ7 | F175A_HUMAN BRCA1-A complex subunit Abraxas OS=Homo sapiens GN=FAM175A PE=1 SV=2 | 373 | D | 0.958575 | N | 0.949173 | 0.009402 | No Change: Both D | - |
| Q9H8M9 | F176A_HUMAN Protein FAM176A OS=Homo sapiens GN=FAM176A PE=2 SV=1 | 150 | R | 0.652489 | H | 0.658417 | -0.005928 | No Change: Both D | - |
| A6PVY3 | F177B_HUMAN Protein FAM177B OS=Homo sapiens GN=FAM177B PE=2 SV=1 | 3 | I | 0.764204 | S | 0.839838 | -0.075634 | No Change: Both D | - |
| A6PVY3 | F177B_HUMAN Protein FAM177B OS=Homo sapiens GN=FAM177B PE=2 SV=1 | 143 | Q | 0.535475 | R | 0.478249 | 0.057226 | D to O | - |
| Q8IX21 | F178A_HUMAN Protein FAM178A OS=Homo sapiens GN=FAM178A PE=1 SV=2 | 541 | S | 0.928911 | Y | 0.85419 | 0.074721 | No Change: Both D | - |
| Q8IXR5 | F178B_HUMAN Protein FAM178B OS=Homo sapiens GN=FAM178B PE=2 SV=2 | 793 | R | 0.45751 | C | 0.318149 | 0.139361 | No Change: Both O | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 55 | A | 0.924538 | T | 0.936221 | -0.011683 | No Change: Both D | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 265 | Q | 0.953829 | R | 0.964703 | -0.010874 | No Change: Both D | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 362 | Q | 0.945105 | R | 0.943102 | 0.002003 | No Change: Both D | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 441 | I | 0.693667 | V | 0.696589 | -0.002922 | No Change: Both D | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 535 | V | 0.098631 | A | 0.123011 | -0.02438 | No Change: Both O | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 941 | T | 0.570478 | A | 0.540171 | 0.030307 | No Change: Both D | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 944 | G | 0.574647 | V | 0.438258 | 0.136389 | D to O | - |
| Q6ZUX3 | F179A_HUMAN Protein FAM179A OS=Homo sapiens GN=FAM179A PE=2 SV=2 | 724 | R | 0.539172 | C | 0.410659 | 0.128513 | D to O | - |
| Q9Y4F4 | F179B_HUMAN Protein FAM179B OS=Homo sapiens GN=FAM179B PE=1 SV=4 | 416 | E | 0.104571 | Q | 0.085144 | 0.019427 | No Change: Both O | - |
| Q9Y4F4 | F179B_HUMAN Protein FAM179B OS=Homo sapiens GN=FAM179B PE=1 SV=4 | 511 | L | 0.350206 | V | 0.330843 | 0.019363 | No Change: Both O | - |
| Q6UWF9 | F180A_HUMAN Protein FAM180A OS=Homo sapiens GN=FAM180A PE=2 SV=1 | 96 | V | 0.460655 | I | 0.483564 | -0.022909 | No Change: Both O | - |
| Q6P0A1 | F180B_HUMAN Protein FAM180B OS=Homo sapiens GN=FAM180B PE=2 SV=2 | 186 | A | 0.150143 | T | 0.15408 | -0.003937 | No Change: Both O | - |
| Q8N9Y4 | F181A_HUMAN Protein FAM181A OS=Homo sapiens GN=FAM181A PE=2 SV=3 | 28 | A | 0.909415 | T | 0.911789 | -0.002374 | No Change: Both D | - |
| Q8N9Y4 | F181A_HUMAN Protein FAM181A OS=Homo sapiens GN=FAM181A PE=2 SV=3 | 162 | L | 0.926196 | M | 0.933595 | -0.007399 | No Change: Both D | - |
| A6NEQ2 | F181B_HUMAN Protein FAM181B OS=Homo sapiens GN=FAM181B PE=1 SV=1 | 186 | V | 0.858703 | L | 0.8737 | -0.014997 | No Change: Both D | - |
| A6NEQ2 | F181B_HUMAN Protein FAM181B OS=Homo sapiens GN=FAM181B PE=1 SV=1 | 367 | R | 0.85494 | P | 0.897969 | -0.043029 | No Change: Both D | - |
| Q8NB25 | F184A_HUMAN Protein FAM184A OS=Homo sapiens GN=FAM184A PE=2 SV=3 | 174 | Q | 0.728646 | H | 0.65266 | 0.075986 | No Change: Both D | - |
| Q8NB25 | F184A_HUMAN Protein FAM184A OS=Homo sapiens GN=FAM184A PE=2 SV=3 | 177 | V | 0.75252 | G | 0.821182 | -0.068662 | No Change: Both D | - |
| Q8NB25 | F184A_HUMAN Protein FAM184A OS=Homo sapiens GN=FAM184A PE=2 SV=3 | 599 | D | 0.895013 | N | 0.886618 | 0.008395 | No Change: Both D | - |
| Q9ULE4 | F184B_HUMAN Protein FAM184B OS=Homo sapiens GN=FAM184B PE=2 SV=3 | 952 | N | 0.685403 | S | 0.744107 | -0.058704 | No Change: Both D | - |
| Q9ULE4 | F184B_HUMAN Protein FAM184B OS=Homo sapiens GN=FAM184B PE=2 SV=3 | 1042 | V | 0.857395 | A | 0.914529 | -0.057134 | No Change: Both D | - |
| Q8N0U4 | F185A_HUMAN Protein FAM185A OS=Homo sapiens GN=FAM185A PE=2 SV=3 | 60 | G | 0.824561 | A | 0.793603 | 0.030958 | No Change: Both D | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 187 | K | 0.721228 | Q | 0.687787 | 0.033441 | No Change: Both D | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 1204 | R | 0.932803 | G | 0.939604 | -0.006801 | No Change: Both D | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 1233 | L | 0.87778 | P | 0.926556 | -0.048776 | No Change: Both D | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 2166 | H | 0.177371 | Y | 0.117595 | 0.059776 | No Change: Both O | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 2193 | M | 0.328873 | I | 0.216743 | 0.11213 | No Change: Both O | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 2228 | H | 0.281797 | Q | 0.370427 | -0.08863 | No Change: Both O | - |
| A6NE01 | F186A_HUMAN Protein FAM186A OS=Homo sapiens GN=FAM186A PE=2 SV=3 | 2316 | Q | 0.226759 | E | 0.258166 | -0.031407 | No Change: Both O | - |
| Q8IYM0 | F186B_HUMAN Protein FAM186B OS=Homo sapiens GN=FAM186B PE=2 SV=2 | 397 | V | 0.521003 | M | 0.614105 | -0.093102 | No Change: Both D | - |
| Q8IYM0 | F186B_HUMAN Protein FAM186B OS=Homo sapiens GN=FAM186B PE=2 SV=2 | 553 | E | 0.928366 | Q | 0.919195 | 0.009171 | No Change: Both D | - |
| Q17R55 | F187B_HUMAN Protein FAM187B OS=Homo sapiens GN=FAM187B PE=2 SV=2 | 3 | P | 0.507334 | S | 0.528524 | -0.02119 | No Change: Both D | - |
| Q17R55 | F187B_HUMAN Protein FAM187B OS=Homo sapiens GN=FAM187B PE=2 SV=2 | 160 | C | 0.438926 | R | 0.620028 | -0.181102 | O to D | - |
| Q17R55 | F187B_HUMAN Protein FAM187B OS=Homo sapiens GN=FAM187B PE=2 SV=2 | 216 | V | 0.060495 | I | 0.052146 | 0.008349 | No Change: Both O | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 183 | D | 0.783307 | A | 0.745319 | 0.037988 | No Change: Both D | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 262 | S | 0.934806 | L | 0.89357 | 0.041236 | No Change: Both D | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 322 | T | 0.90505 | M | 0.906375 | -0.001325 | No Change: Both D | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 324 | R | 0.900786 | K | 0.895664 | 0.005122 | No Change: Both D | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 355 | A | 0.821975 | V | 0.783203 | 0.038772 | No Change: Both D | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 655 | M | 0.059411 | V | 0.047525 | 0.011886 | No Change: Both O | - |
| Q4G0A6 | F188B_HUMAN Protein FAM188B OS=Homo sapiens GN=FAM188B PE=2 SV=2 | 465 | C | 0.133132 | Y | 0.109581 | 0.023551 | No Change: Both O | - |
| O60320 | F1891_HUMAN Protein FAM189A1 OS=Homo sapiens GN=FAM189A1 PE=2 SV=4 | 375 | H | 0.993882 | R | 0.995563 | -0.001681 | No Change: Both D | - |
| O60320 | F1891_HUMAN Protein FAM189A1 OS=Homo sapiens GN=FAM189A1 PE=2 SV=4 | 393 | R | 0.987136 | H | 0.984696 | 0.00244 | No Change: Both D | - |
| O60320 | F1891_HUMAN Protein FAM189A1 OS=Homo sapiens GN=FAM189A1 PE=2 SV=4 | 228 | G | 0.616891 | S | 0.714527 | -0.097636 | No Change: Both D | - |
| O60320 | F1891_HUMAN Protein FAM189A1 OS=Homo sapiens GN=FAM189A1 PE=2 SV=4 | 314 | G | 0.882587 | D | 0.887479 | -0.004892 | No Change: Both D | - |
| O60320 | F1891_HUMAN Protein FAM189A1 OS=Homo sapiens GN=FAM189A1 PE=2 SV=4 | 431 | V | 0.948171 | A | 0.971067 | -0.022896 | No Change: Both D | - |
| Q15884 | F1892_HUMAN Protein FAM189A2 OS=Homo sapiens GN=FAM189A2 PE=2 SV=3 | 233 | T | 0.724728 | I | 0.640493 | 0.084235 | No Change: Both D | - |
| Q15884 | F1892_HUMAN Protein FAM189A2 OS=Homo sapiens GN=FAM189A2 PE=2 SV=3 | 261 | R | 0.948733 | K | 0.940127 | 0.008606 | No Change: Both D | - |
| P81408 | F189B_HUMAN Protein FAM189B OS=Homo sapiens GN=FAM189B PE=1 SV=2 | 358 | S | 0.469163 | F | 0.264563 | 0.2046 | No Change: Both O | A breast cancer sample |
| P81408 | F189B_HUMAN Protein FAM189B OS=Homo sapiens GN=FAM189B PE=1 SV=2 | 549 | R | 0.896961 | H | 0.853102 | 0.043859 | No Change: Both D | - |
| P81408 | F189B_HUMAN Protein FAM189B OS=Homo sapiens GN=FAM189B PE=1 SV=2 | 646 | R | 0.989317 | H | 0.984322 | 0.004995 | No Change: Both D | - |
| Q9NYZ1 | F18B1_HUMAN Protein FAM18B1 OS=Homo sapiens GN=FAM18B1 PE=2 SV=2 | 55 | G | 0.042206 | E | 0.053823 | -0.011617 | No Change: Both O | - |
| Q96ET8 | F18B2_HUMAN Protein FAM18B2 OS=Homo sapiens GN=FAM18B2 PE=1 SV=3 | 12 | D | 0.763157 | A | 0.67634 | 0.086817 | No Change: Both D | - |
| Q96ET8 | F18B2_HUMAN Protein FAM18B2 OS=Homo sapiens GN=FAM18B2 PE=1 SV=3 | 271 | L | 0.807108 | Q | 0.861925 | -0.054817 | No Change: Both D | - |
| Q9C0I3 | F190A_HUMAN Protein FAM190A OS=Homo sapiens GN=FAM190A PE=2 SV=2 | 382 | G | 0.613105 | S | 0.657253 | -0.044148 | No Change: Both D | - |
| Q9H7U1 | F190B_HUMAN Protein FAM190B OS=Homo sapiens GN=FAM190B PE=1 SV=2 | 84 | N | 0.667319 | S | 0.683942 | -0.016623 | No Change: Both D | - |
| Q9H7U1 | F190B_HUMAN Protein FAM190B OS=Homo sapiens GN=FAM190B PE=1 SV=2 | 755 | C | 0.616917 | Y | 0.578435 | 0.038482 | No Change: Both D | - |
| Q9H7U1 | F190B_HUMAN Protein FAM190B OS=Homo sapiens GN=FAM190B PE=1 SV=2 | 819 | S | 0.98588 | P | 0.987481 | -0.001601 | No Change: Both D | - |
| Q9H7U1 | F190B_HUMAN Protein FAM190B OS=Homo sapiens GN=FAM190B PE=1 SV=2 | 821 | P | 0.986348 | S | 0.985882 | 4.66E-04 | No Change: Both D | - |
| P78312 | F193A_HUMAN Protein FAM193A OS=Homo sapiens GN=FAM193A PE=1 SV=2 | 192 | M | 0.656145 | V | 0.539285 | 0.11686 | No Change: Both D | - |
| P78312 | F193A_HUMAN Protein FAM193A OS=Homo sapiens GN=FAM193A PE=1 SV=2 | 1115 | I | 0.976075 | V | 0.980117 | -0.004042 | No Change: Both D | - |
| Q96PV7 | F193B_HUMAN Protein FAM193B OS=Homo sapiens GN=FAM193B PE=2 SV=2 | 816 | P | 0.994999 | S | 0.994615 | 3.84E-04 | No Change: Both D | - |
| Q7L0X2 | F194A_HUMAN Protein FAM194A OS=Homo sapiens GN=FAM194A PE=2 SV=1 | 9 | G | 0.99108 | V | 0.979275 | 0.011805 | No Change: Both D | - |
| Q7L0X2 | F194A_HUMAN Protein FAM194A OS=Homo sapiens GN=FAM194A PE=2 SV=1 | 433 | G | 0.54982 | R | 0.53264 | 0.01718 | No Change: Both D | - |
| Q7L0X2 | F194A_HUMAN Protein FAM194A OS=Homo sapiens GN=FAM194A PE=2 SV=1 | 604 | R | 0.127592 | H | 0.125244 | 0.002348 | No Change: Both O | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 63 | E | 0.997852 | D | 0.997166 | 6.86E-04 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 99 | E | 0.994318 | G | 0.99139 | 0.002928 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 174 | S | 0.967459 | T | 0.960783 | 0.006676 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 178 | E | 0.979164 | K | 0.977306 | 0.001858 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 303 | L | 0.892 | P | 0.939384 | -0.047384 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 427 | T | 0.862379 | I | 0.79585 | 0.066529 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 439 | P | 0.948823 | R | 0.943904 | 0.004919 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 453 | H | 0.764768 | R | 0.789043 | -0.024275 | No Change: Both D | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 565 | R | 0.321033 | C | 0.179257 | 0.141776 | No Change: Both O | - |
| Q5W0A0 | F194B_HUMAN Protein FAM194B OS=Homo sapiens GN=FAM194B PE=2 SV=1 | 653 | V | 0.199423 | F | 0.181507 | 0.017916 | No Change: Both O | - |
| Q6ZSG2 | F196A_HUMAN Protein FAM196A OS=Homo sapiens GN=FAM196A PE=2 SV=1 | 147 | A | 0.768447 | V | 0.692627 | 0.07582 | No Change: Both D | - |
| Q9UFP1 | F198A_HUMAN Protein FAM198A OS=Homo sapiens GN=FAM198A PE=2 SV=3 | 227 | H | 0.562721 | Y | 0.446703 | 0.116018 | D to O | - |
| Q9UFP1 | F198A_HUMAN Protein FAM198A OS=Homo sapiens GN=FAM198A PE=2 SV=3 | 460 | Q | 0.586477 | R | 0.617552 | -0.031075 | No Change: Both D | - |
| Q6UWH4 | F198B_HUMAN Protein FAM198B OS=Homo sapiens GN=FAM198B PE=2 SV=1 | 432 | G | 0.293953 | S | 0.363614 | -0.069661 | No Change: Both O | - |
| Q63HN1 | F205B_HUMAN Protein FAM205B OS=Homo sapiens GN=FAM205B PE=2 SV=1 | 72 | N | 0.569113 | K | 0.556701 | 0.012412 | No Change: Both D | - |
| Q63HN1 | F205B_HUMAN Protein FAM205B OS=Homo sapiens GN=FAM205B PE=2 SV=1 | 203 | D | 0.87408 | E | 0.880042 | -0.005962 | No Change: Both D | - |
| Q63HN1 | F205B_HUMAN Protein FAM205B OS=Homo sapiens GN=FAM205B PE=2 SV=1 | 229 | V | 0.745686 | M | 0.782671 | -0.036985 | No Change: Both D | - |
| Q9NSI2 | F207A_HUMAN Protein FAM207A OS=Homo sapiens GN=FAM207A PE=1 SV=2 | 212 | V | 0.538031 | L | 0.646275 | -0.108244 | No Change: Both D | - |
| Q9UK61 | F208A_HUMAN Protein FAM208A OS=Homo sapiens GN=FAM208A PE=1 SV=3 | 831 | A | 0.56656 | G | 0.585062 | -0.018502 | No Change: Both D | - |
| Q9UK61 | F208A_HUMAN Protein FAM208A OS=Homo sapiens GN=FAM208A PE=1 SV=3 | 1046 | T | 0.449961 | R | 0.458842 | -0.008881 | No Change: Both O | - |
| Q9UK61 | F208A_HUMAN Protein FAM208A OS=Homo sapiens GN=FAM208A PE=1 SV=3 | 1435 | I | 0.120023 | V | 0.132713 | -0.01269 | No Change: Both O | - |
| Q9UK61 | F208A_HUMAN Protein FAM208A OS=Homo sapiens GN=FAM208A PE=1 SV=3 | 998 | V | 0.720231 | I | 0.652303 | 0.067928 | No Change: Both D | - |
| Q9UK61 | F208A_HUMAN Protein FAM208A OS=Homo sapiens GN=FAM208A PE=1 SV=3 | 38 | Q | 0.958911 | P | 0.961348 | -0.002437 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 1075 | R | 0.5458 | P | 0.602749 | -0.056949 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 1679 | V | 0.331982 | A | 0.426686 | -0.094704 | No Change: Both O | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 2404 | S | 0.235741 | N | 0.216385 | 0.019356 | No Change: Both O | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 499 | C | 0.768052 | G | 0.832609 | -0.064557 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 630 | A | 0.966693 | D | 0.971815 | -0.005122 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 1206 | V | 0.873099 | M | 0.896337 | -0.023238 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 1578 | P | 0.7067 | S | 0.715102 | -0.008402 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 1782 | T | 0.483289 | I | 0.347728 | 0.135561 | No Change: Both O | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 2288 | K | 0.207814 | R | 0.15985 | 0.047964 | No Change: Both O | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 724 | S | 0.926937 | Y | 0.841059 | 0.085878 | No Change: Both D | - |
| Q5VWN6 | F208B_HUMAN Protein FAM208B OS=Homo sapiens GN=FAM208B PE=1 SV=1 | 807 | I | 0.441541 | V | 0.464865 | -0.023324 | No Change: Both O | - |
| Q5JX71 | F209A_HUMAN Protein FAM209A OS=Homo sapiens GN=FAM209A PE=2 SV=1 | 66 | V | 0.016098 | A | 0.016521 | -4.23E-04 | No Change: Both O | - |
| Q5JX71 | F209A_HUMAN Protein FAM209A OS=Homo sapiens GN=FAM209A PE=2 SV=1 | 117 | M | 0.556035 | K | 0.631381 | -0.075346 | No Change: Both D | - |
| Q5JX71 | F209A_HUMAN Protein FAM209A OS=Homo sapiens GN=FAM209A PE=2 SV=1 | 135 | R | 0.516995 | G | 0.518105 | -0.00111 | No Change: Both D | - |
| Q5JX71 | F209A_HUMAN Protein FAM209A OS=Homo sapiens GN=FAM209A PE=2 SV=1 | 146 | R | 0.61185 | K | 0.639344 | -0.027494 | No Change: Both D | - |
| Q5JX71 | F209A_HUMAN Protein FAM209A OS=Homo sapiens GN=FAM209A PE=2 SV=1 | 95 | L | 0.773202 | F | 0.741754 | 0.031448 | No Change: Both D | - |
| Q5JX69 | F209B_HUMAN Protein FAM209B OS=Homo sapiens GN=FAM209B PE=1 SV=1 | 129 | E | 0.302787 | A | 0.213415 | 0.089372 | No Change: Both O | - |
| Q5JX69 | F209B_HUMAN Protein FAM209B OS=Homo sapiens GN=FAM209B PE=1 SV=1 | 74 | Q | 0.161831 | K | 0.181897 | -0.020066 | No Change: Both O | - |
| Q5JX69 | F209B_HUMAN Protein FAM209B OS=Homo sapiens GN=FAM209B PE=1 SV=1 | 84 | E | 0.834997 | K | 0.829869 | 0.005128 | No Change: Both D | - |
| Q96MK3 | FA20A_HUMAN Protein FAM20A OS=Homo sapiens GN=FAM20A PE=1 SV=4 | 332 | N | 0.224305 | K | 0.260895 | -0.03659 | No Change: Both O | - |
| Q96MK3 | FA20A_HUMAN Protein FAM20A OS=Homo sapiens GN=FAM20A PE=1 SV=4 | 530 | L | 0.517658 | S | 0.682011 | -0.164353 | No Change: Both D | - |
| Q8IXL6 | DMP4_HUMAN Dentin matrix protein 4 OS=Homo sapiens GN=FAM20C PE=1 SV=2 | 379 | G | 0.397161 | E | 0.458648 | -0.061487 | No Change: Both O | Raine syndrome (RNS) [MIM:259775] |
| Q8IXL6 | DMP4_HUMAN Dentin matrix protein 4 OS=Homo sapiens GN=FAM20C PE=1 SV=2 | 379 | G | 0.397161 | R | 0.371537 | 0.025624 | No Change: Both O | Raine syndrome (RNS) [MIM:259775] |
| Q8IXL6 | DMP4_HUMAN Dentin matrix protein 4 OS=Homo sapiens GN=FAM20C PE=1 SV=2 | 388 | L | 0.271734 | R | 0.368469 | -0.096735 | No Change: Both O | Raine syndrome (RNS) [MIM:259775] |
| Q8IXL6 | DMP4_HUMAN Dentin matrix protein 4 OS=Homo sapiens GN=FAM20C PE=1 SV=2 | 549 | R | 0.275333 | W | 0.105907 | 0.169426 | No Change: Both O | Raine syndrome (RNS) [MIM:259775] |
| Q96ND0 | F210A_HUMAN Protein FAM210A OS=Homo sapiens GN=FAM210A PE=2 SV=2 | 82 | R | 0.847348 | H | 0.832307 | 0.015041 | No Change: Both D | A breast cancer sample |
| Q96ND0 | F210A_HUMAN Protein FAM210A OS=Homo sapiens GN=FAM210A PE=2 SV=2 | 140 | V | 0.069441 | E | 0.147243 | -0.077802 | No Change: Both O | A breast cancer sample |
| Q96ND0 | F210A_HUMAN Protein FAM210A OS=Homo sapiens GN=FAM210A PE=2 SV=2 | 39 | Y | 0.197867 | N | 0.34802 | -0.150153 | No Change: Both O | - |
| Q96ND0 | F210A_HUMAN Protein FAM210A OS=Homo sapiens GN=FAM210A PE=2 SV=2 | 167 | E | 0.085051 | K | 0.086038 | -9.87E-04 | No Change: Both O | - |
| Q96KR6 | F210B_HUMAN Protein FAM210B OS=Homo sapiens GN=FAM210B PE=1 SV=2 | 126 | P | 0.178754 | S | 0.215372 | -0.036618 | No Change: Both O | - |
| Q2VPJ9 | F211B_HUMAN Leucine-rich repeat-containing protein FAM211B OS=Homo sapiens GN=FAM211B PE=2 SV=1 | 140 | S | 0.865401 | R | 0.839701 | 0.0257 | No Change: Both D | - |
| Q8N5W8 | FA24B_HUMAN Protein FAM24B OS=Homo sapiens GN=FAM24B PE=2 SV=2 | 2 | P | 0.67844 | L | 0.425129 | 0.253311 | D to O | - |
| Q5VTM1 | FAM25_HUMAN Protein FAM25 OS=Homo sapiens GN=FAM25A PE=2 SV=2 | 35 | V | 0.809351 | L | 0.789072 | 0.020279 | No Change: Both D | - |
| Q5R3K3 | FA26F_HUMAN Protein FAM26F OS=Homo sapiens GN=FAM26F PE=2 SV=1 | 80 | G | 0.167359 | R | 0.180537 | -0.013178 | No Change: Both O | - |
| Q5R3K3 | FA26F_HUMAN Protein FAM26F OS=Homo sapiens GN=FAM26F PE=2 SV=1 | 293 | E | 0.545952 | K | 0.546421 | -4.69E-04 | No Change: Both D | - |
| Q86V20 | FA35A_HUMAN Protein FAM35A OS=Homo sapiens GN=FAM35A PE=1 SV=1 | 132 | F | 0.679105 | L | 0.699559 | -0.020454 | No Change: Both D | - |
| Q86V20 | FA35A_HUMAN Protein FAM35A OS=Homo sapiens GN=FAM35A PE=1 SV=1 | 550 | S | 0.507103 | C | 0.289364 | 0.217739 | D to O | - |
| Q86V20 | FA35A_HUMAN Protein FAM35A OS=Homo sapiens GN=FAM35A PE=1 SV=1 | 747 | R | 0.169373 | H | 0.174171 | -0.004798 | No Change: Both O | - |
| P98173 | FAM3A_HUMAN Protein FAM3A OS=Homo sapiens GN=FAM3A PE=1 SV=2 | 213 | W | 0.587346 | C | 0.69206 | -0.104714 | No Change: Both D | - |
| P98173 | FAM3A_HUMAN Protein FAM3A OS=Homo sapiens GN=FAM3A PE=1 SV=2 | 21 | I | 0.033254 | M | 0.04975 | -0.016496 | No Change: Both O | - |
| P58499 | FAM3B_HUMAN Protein FAM3B OS=Homo sapiens GN=FAM3B PE=1 SV=2 | 14 | V | 0.017959 | M | 0.021709 | -0.00375 | No Change: Both O | - |
| Q96BQ1 | FAM3D_HUMAN Protein FAM3D OS=Homo sapiens GN=FAM3D PE=1 SV=1 | 60 | P | 0.132867 | S | 0.135463 | -0.002596 | No Change: Both O | - |
| Q96BQ1 | FAM3D_HUMAN Protein FAM3D OS=Homo sapiens GN=FAM3D PE=1 SV=1 | 118 | A | 0.291103 | S | 0.408078 | -0.116975 | No Change: Both O | - |
| Q9ULQ0 | FA40B_HUMAN Protein FAM40B OS=Homo sapiens GN=FAM40B PE=2 SV=2 | 383 | R | 0.95577 | Q | 0.958098 | -0.002328 | No Change: Both D | - |
| Q96IP4 | FA46A_HUMAN Protein FAM46A OS=Homo sapiens GN=FAM46A PE=2 SV=2 | 313 | T | 0.291604 | A | 0.279089 | 0.012515 | No Change: Both O | - |
| Q5VWP2 | FA46C_HUMAN Protein FAM46C OS=Homo sapiens GN=FAM46C PE=2 SV=1 | 67 | H | 0.280312 | Q | 0.296311 | -0.015999 | No Change: Both O | - |
| Q8NEK8 | FA46D_HUMAN Protein FAM46D OS=Homo sapiens GN=FAM46D PE=2 SV=1 | 185 | D | 0.211719 | E | 0.217012 | -0.005293 | No Change: Both O | - |
| Q5JRC9 | FA47A_HUMAN Protein FAM47A OS=Homo sapiens GN=FAM47A PE=1 SV=3 | 50 | F | 0.298251 | L | 0.302777 | -0.004526 | No Change: Both O | - |
| Q5JRC9 | FA47A_HUMAN Protein FAM47A OS=Homo sapiens GN=FAM47A PE=1 SV=3 | 232 | V | 0.994034 | E | 0.996709 | -0.002675 | No Change: Both D | - |
| Q5JRC9 | FA47A_HUMAN Protein FAM47A OS=Homo sapiens GN=FAM47A PE=1 SV=3 | 377 | A | 0.98632 | S | 0.992326 | -0.006006 | No Change: Both D | - |
| Q5JRC9 | FA47A_HUMAN Protein FAM47A OS=Homo sapiens GN=FAM47A PE=1 SV=3 | 531 | G | 0.999366 | R | 0.99964 | -2.74E-04 | No Change: Both D | - |
| Q5HY64 | FA47C_HUMAN Putative protein FAM47C OS=Homo sapiens GN=FAM47C PE=2 SV=1 | 924 | N | 0.595459 | T | 0.555445 | 0.040014 | No Change: Both D | - |
| Q8NEM7 | FA48A_HUMAN Protein FAM48A OS=Homo sapiens GN=FAM48A PE=1 SV=2 | 154 | M | 0.743586 | V | 0.72106 | 0.022526 | No Change: Both D | - |
| Q8NEM7 | FA48A_HUMAN Protein FAM48A OS=Homo sapiens GN=FAM48A PE=1 SV=2 | 773 | T | 0.980994 | M | 0.98071 | 2.84E-04 | No Change: Both D | - |
| Q9NUQ9 | FA49B_HUMAN Protein FAM49B OS=Homo sapiens GN=FAM49B PE=1 SV=1 | 169 | N | 0.470675 | K | 0.466285 | 0.00439 | No Change: Both O | - |
| Q9NYF3 | FA53C_HUMAN Protein FAM53C OS=Homo sapiens GN=FAM53C PE=1 SV=1 | 21 | R | 0.230891 | C | 0.152126 | 0.078765 | No Change: Both O | - |
| Q9H019 | FA54B_HUMAN Protein FAM54B OS=Homo sapiens GN=FAM54B PE=1 SV=2 | 58 | P | 0.274352 | S | 0.264154 | 0.010198 | No Change: Both O | - |
| Q8N323 | FA55A_HUMAN Protein FAM55A OS=Homo sapiens GN=FAM55A PE=2 SV=2 | 353 | G | 0.115526 | R | 0.110632 | 0.004894 | No Change: Both O | - |
| Q8N323 | FA55A_HUMAN Protein FAM55A OS=Homo sapiens GN=FAM55A PE=2 SV=2 | 423 | I | 0.4389 | T | 0.572323 | -0.133423 | O to D | - |
| Q96DL1 | FA55B_HUMAN Protein FAM55B OS=Homo sapiens GN=FAM55B PE=2 SV=2 | 103 | V | 0.586963 | A | 0.679932 | -0.092969 | No Change: Both D | - |
| Q969Y0 | FA55C_HUMAN Protein FAM55C OS=Homo sapiens GN=FAM55C PE=2 SV=1 | 507 | T | 0.090615 | I | 0.051138 | 0.039477 | No Change: Both O | - |
| Q6UWF7 | FA55D_HUMAN Protein FAM55D OS=Homo sapiens GN=FAM55D PE=2 SV=1 | 398 | Y | 0.053743 | H | 0.085206 | -0.031463 | No Change: Both O | - |
| Q6UWF7 | FA55D_HUMAN Protein FAM55D OS=Homo sapiens GN=FAM55D PE=2 SV=1 | 451 | A | 0.104999 | V | 0.077448 | 0.027551 | No Change: Both O | - |
| Q8N1B3 | FA58A_HUMAN Cyclin-related protein FAM58A OS=Homo sapiens GN=FAM58A PE=1 SV=2 | 183 | C | 0.114247 | S | 0.301792 | -0.187545 | No Change: Both O | - |
| P0C7Q3 | FA58B_HUMAN Putative cyclin-related protein FAM58B OS=Homo sapiens GN=FAM58BP PE=5 SV=1 | 48 | Q | 0.215582 | R | 0.200894 | 0.014688 | No Change: Both O | - |
| P0C7Q3 | FA58B_HUMAN Putative cyclin-related protein FAM58B OS=Homo sapiens GN=FAM58BP PE=5 SV=1 | 236 | T | 0.124198 | N | 0.137091 | -0.012893 | No Change: Both O | - |
| Q9H706 | FA59A_HUMAN Protein FAM59A OS=Homo sapiens GN=FAM59A PE=1 SV=2 | 243 | T | 0.489754 | N | 0.522787 | -0.033033 | O to D | - |
| Q9H706 | FA59A_HUMAN Protein FAM59A OS=Homo sapiens GN=FAM59A PE=1 SV=2 | 291 | K | 0.156213 | R | 0.127955 | 0.028258 | No Change: Both O | - |
| Q9H706 | FA59A_HUMAN Protein FAM59A OS=Homo sapiens GN=FAM59A PE=1 SV=2 | 490 | A | 0.855282 | V | 0.830507 | 0.024775 | No Change: Both D | - |
| Q9H706 | FA59A_HUMAN Protein FAM59A OS=Homo sapiens GN=FAM59A PE=1 SV=2 | 580 | V | 0.877964 | I | 0.865621 | 0.012343 | No Change: Both D | - |
| Q9H706 | FA59A_HUMAN Protein FAM59A OS=Homo sapiens GN=FAM59A PE=1 SV=2 | 720 | T | 0.903825 | M | 0.883486 | 0.020339 | No Change: Both D | - |
| Q9C0B6 | FAM5B_HUMAN Protein FAM5B OS=Homo sapiens GN=FAM5B PE=2 SV=2 | 71 | Y | 0.412624 | C | 0.349273 | 0.063351 | No Change: Both O | - |
| Q9C0B6 | FAM5B_HUMAN Protein FAM5B OS=Homo sapiens GN=FAM5B PE=2 SV=2 | 390 | L | 0.164173 | V | 0.143262 | 0.020911 | No Change: Both O | - |
| Q9NP50 | FA60A_HUMAN Protein FAM60A OS=Homo sapiens GN=FAM60A PE=1 SV=1 | 117 | R | 0.945922 | H | 0.943368 | 0.002554 | No Change: Both D | - |
| Q8N5J2 | FA63A_HUMAN Protein FAM63A OS=Homo sapiens GN=FAM63A PE=1 SV=2 | 385 | T | 0.812156 | K | 0.8478 | -0.035644 | No Change: Both D | - |
| Q9BSJ6 | FA64A_HUMAN Protein FAM64A OS=Homo sapiens GN=FAM64A PE=1 SV=1 | 199 | S | 0.918102 | C | 0.87238 | 0.045722 | No Change: Both D | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 145 | A | 0.19386 | G | 0.209213 | -0.015353 | No Change: Both O | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 320 | V | 0.246628 | M | 0.319102 | -0.072474 | No Change: Both O | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 424 | E | 0.775386 | K | 0.773039 | 0.002347 | No Change: Both D | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 452 | S | 0.932958 | C | 0.893934 | 0.039024 | No Change: Both D | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 495 | E | 0.990109 | K | 0.989125 | 9.84E-04 | No Change: Both D | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 520 | R | 0.957267 | C | 0.94611 | 0.011157 | No Change: Both D | - |
| Q9Y4F9 | FA65B_HUMAN Protein FAM65B OS=Homo sapiens GN=FAM65B PE=1 SV=4 | 868 | R | 0.382339 | Q | 0.413791 | -0.031452 | No Change: Both O | - |
| Q96MK2 | FA65C_HUMAN Protein FAM65C OS=Homo sapiens GN=FAM65C PE=2 SV=4 | 580 | L | 0.547276 | P | 0.635507 | -0.088231 | No Change: Both D | - |
| Q96MK2 | FA65C_HUMAN Protein FAM65C OS=Homo sapiens GN=FAM65C PE=2 SV=4 | 566 | C | 0.282186 | S | 0.480901 | -0.198715 | No Change: Both O | - |
| Q5VUD6 | FA69B_HUMAN Protein FAM69B OS=Homo sapiens GN=FAM69B PE=2 SV=3 | 158 | S | 0.301552 | G | 0.256648 | 0.044904 | No Change: Both O | - |
| Q5JRV8 | FA70A_HUMAN Protein FAM70A OS=Homo sapiens GN=FAM70A PE=2 SV=1 | 345 | P | 0.999231 | Q | 0.99852 | 7.11E-04 | No Change: Both D | - |
| Q8IYT1 | FA71A_HUMAN Protein FAM71A OS=Homo sapiens GN=FAM71A PE=2 SV=2 | 22 | N | 0.561958 | D | 0.579017 | -0.017059 | No Change: Both D | - |
| Q8IYT1 | FA71A_HUMAN Protein FAM71A OS=Homo sapiens GN=FAM71A PE=2 SV=2 | 253 | N | 0.495189 | S | 0.532006 | -0.036817 | O to D | - |
| Q8IYT1 | FA71A_HUMAN Protein FAM71A OS=Homo sapiens GN=FAM71A PE=2 SV=2 | 319 | G | 0.765552 | D | 0.724131 | 0.041421 | No Change: Both D | - |
| Q8IYT1 | FA71A_HUMAN Protein FAM71A OS=Homo sapiens GN=FAM71A PE=2 SV=2 | 551 | N | 0.47347 | D | 0.492037 | -0.018567 | No Change: Both O | - |
| Q8IYT1 | FA71A_HUMAN Protein FAM71A OS=Homo sapiens GN=FAM71A PE=2 SV=2 | 577 | T | 0.567089 | M | 0.547632 | 0.019457 | No Change: Both D | - |
| Q8TC56 | FA71B_HUMAN Protein FAM71B OS=Homo sapiens GN=FAM71B PE=1 SV=2 | 543 | A | 0.742198 | V | 0.69857 | 0.043628 | No Change: Both D | - |
| Q8TC56 | FA71B_HUMAN Protein FAM71B OS=Homo sapiens GN=FAM71B PE=1 SV=2 | 564 | M | 0.611089 | T | 0.642365 | -0.031276 | No Change: Both D | - |
| Q8TC56 | FA71B_HUMAN Protein FAM71B OS=Homo sapiens GN=FAM71B PE=1 SV=2 | 599 | V | 0.815513 | I | 0.835147 | -0.019634 | No Change: Both D | - |
| Q8NEG0 | FA71C_HUMAN Protein FAM71C OS=Homo sapiens GN=FAM71C PE=2 SV=1 | 30 | R | 0.3956 | G | 0.427192 | -0.031592 | No Change: Both O | - |
| Q8NEG0 | FA71C_HUMAN Protein FAM71C OS=Homo sapiens GN=FAM71C PE=2 SV=1 | 71 | M | 0.22172 | V | 0.176327 | 0.045393 | No Change: Both O | - |
| Q6IPT2 | F71E1_HUMAN Protein FAM71E1 OS=Homo sapiens GN=FAM71E1 PE=2 SV=2 | 206 | S | 0.214306 | I | 0.085674 | 0.128632 | No Change: Both O | - |
| Q96KD3 | F71F1_HUMAN Protein FAM71F1 OS=Homo sapiens GN=FAM71F1 PE=2 SV=1 | 228 | S | 0.841881 | L | 0.760821 | 0.08106 | No Change: Both D | - |
| Q96KD3 | F71F1_HUMAN Protein FAM71F1 OS=Homo sapiens GN=FAM71F1 PE=2 SV=1 | 242 | E | 0.849215 | K | 0.863139 | -0.013924 | No Change: Both D | - |
| Q6NXP2 | F71F2_HUMAN Protein FAM71F2 OS=Homo sapiens GN=FAM71F2 PE=2 SV=3 | 112 | P | 0.349162 | T | 0.305372 | 0.04379 | No Change: Both O | - |
| Q6NXP2 | F71F2_HUMAN Protein FAM71F2 OS=Homo sapiens GN=FAM71F2 PE=2 SV=3 | 114 | D | 0.327726 | V | 0.204383 | 0.123343 | No Change: Both O | - |
| Q6NXP2 | F71F2_HUMAN Protein FAM71F2 OS=Homo sapiens GN=FAM71F2 PE=2 SV=3 | 136 | R | 0.123181 | W | 0.042818 | 0.080363 | No Change: Both O | - |
| Q6NXP2 | F71F2_HUMAN Protein FAM71F2 OS=Homo sapiens GN=FAM71F2 PE=2 SV=3 | 251 | I | 0.531276 | V | 0.530291 | 9.85E-04 | No Change: Both D | - |
| Q86X60 | FA72B_HUMAN Protein FAM72B OS=Homo sapiens GN=FAM72B PE=2 SV=2 | 82 | G | 0.048124 | V | 0.02655 | 0.021574 | No Change: Both O | - |
| Q86X60 | FA72B_HUMAN Protein FAM72B OS=Homo sapiens GN=FAM72B PE=2 SV=2 | 94 | P | 0.253042 | L | 0.132905 | 0.120137 | No Change: Both O | - |
| Q7L4E1 | FA73B_HUMAN Protein FAM73B OS=Homo sapiens GN=FAM73B PE=1 SV=1 | 78 | E | 0.75055 | K | 0.768375 | -0.017825 | No Change: Both D | - |
| Q7L4E1 | FA73B_HUMAN Protein FAM73B OS=Homo sapiens GN=FAM73B PE=1 SV=1 | 100 | V | 0.872532 | A | 0.883249 | -0.010717 | No Change: Both D | - |
| Q7L4E1 | FA73B_HUMAN Protein FAM73B OS=Homo sapiens GN=FAM73B PE=1 SV=1 | 212 | G | 0.933082 | S | 0.948123 | -0.015041 | No Change: Both D | - |
| A6NL05 | F74A7_HUMAN Protein FAM74A7 OS=Homo sapiens GN=FAM74A7 PE=3 SV=3 | 12 | D | 0.878048 | Y | 0.784334 | 0.093714 | No Change: Both D | - |
| A6NL05 | F74A7_HUMAN Protein FAM74A7 OS=Homo sapiens GN=FAM74A7 PE=3 SV=3 | 72 | R | 0.93787 | K | 0.927352 | 0.010518 | No Change: Both D | - |
| A6NL05 | F74A7_HUMAN Protein FAM74A7 OS=Homo sapiens GN=FAM74A7 PE=3 SV=3 | 86 | R | 0.943094 | T | 0.926712 | 0.016382 | No Change: Both D | - |
| Q96LP2 | FA81B_HUMAN Protein FAM81B OS=Homo sapiens GN=FAM81B PE=2 SV=3 | 150 | R | 0.532409 | G | 0.544903 | -0.012494 | No Change: Both D | - |
| Q96LP2 | FA81B_HUMAN Protein FAM81B OS=Homo sapiens GN=FAM81B PE=2 SV=3 | 187 | A | 0.409875 | V | 0.31386 | 0.096015 | No Change: Both O | - |
| Q96LP2 | FA81B_HUMAN Protein FAM81B OS=Homo sapiens GN=FAM81B PE=2 SV=3 | 239 | R | 0.412114 | Q | 0.440318 | -0.028204 | No Change: Both O | - |
| Q96LP2 | FA81B_HUMAN Protein FAM81B OS=Homo sapiens GN=FAM81B PE=2 SV=3 | 275 | P | 0.599257 | S | 0.641533 | -0.042276 | No Change: Both D | - |
| Q96LZ7 | RMD2_HUMAN Regulator of microtubule dynamics protein 2 OS=Homo sapiens GN=FAM82A1 PE=1 SV=2 | 259 | G | 0.151927 | D | 0.169546 | -0.017619 | No Change: Both O | - |
| Q96TC7 | RMD3_HUMAN Regulator of microtubule dynamics protein 3 OS=Homo sapiens GN=FAM82A2 PE=1 SV=2 | 33 | Q | 0.301849 | H | 0.255222 | 0.046627 | No Change: Both O | - |
| Q96DB5 | RMD1_HUMAN Regulator of microtubule dynamics protein 1 OS=Homo sapiens GN=FAM82B PE=1 SV=1 | 52 | K | 0.323015 | N | 0.303013 | 0.020002 | No Change: Both O | - |
| Q86UY5 | FA83A_HUMAN Protein FAM83A OS=Homo sapiens GN=FAM83A PE=1 SV=1 | 237 | A | 0.367201 | T | 0.387121 | -0.01992 | No Change: Both O | - |
| Q5T0W9 | FA83B_HUMAN Protein FAM83B OS=Homo sapiens GN=FAM83B PE=1 SV=1 | 410 | N | 0.688183 | S | 0.7077 | -0.019517 | No Change: Both D | - |
| Q5T0W9 | FA83B_HUMAN Protein FAM83B OS=Homo sapiens GN=FAM83B PE=1 SV=1 | 435 | S | 0.806012 | R | 0.781052 | 0.02496 | No Change: Both D | - |
| Q5T0W9 | FA83B_HUMAN Protein FAM83B OS=Homo sapiens GN=FAM83B PE=1 SV=1 | 640 | K | 0.526307 | T | 0.475582 | 0.050725 | D to O | - |
| Q5T0W9 | FA83B_HUMAN Protein FAM83B OS=Homo sapiens GN=FAM83B PE=1 SV=1 | 907 | T | 0.902984 | N | 0.9071 | -0.004116 | No Change: Both D | - |
| Q9BQN1 | FA83C_HUMAN Protein FAM83C OS=Homo sapiens GN=FAM83C PE=1 SV=3 | 621 | R | 0.886989 | Q | 0.882329 | 0.00466 | No Change: Both D | - |
| Q9BQN1 | FA83C_HUMAN Protein FAM83C OS=Homo sapiens GN=FAM83C PE=1 SV=3 | 134 | E | 0.350567 | K | 0.355396 | -0.004829 | No Change: Both O | - |
| Q9BQN1 | FA83C_HUMAN Protein FAM83C OS=Homo sapiens GN=FAM83C PE=1 SV=3 | 600 | Y | 0.926065 | H | 0.950554 | -0.024489 | No Change: Both D | - |
| Q9BQN1 | FA83C_HUMAN Protein FAM83C OS=Homo sapiens GN=FAM83C PE=1 SV=3 | 645 | R | 0.834247 | C | 0.749914 | 0.084333 | No Change: Both D | - |
| Q2M2I3 | FA83E_HUMAN Protein FAM83E OS=Homo sapiens GN=FAM83E PE=2 SV=2 | 91 | T | 0.609909 | A | 0.595916 | 0.013993 | No Change: Both D | - |
| Q2M2I3 | FA83E_HUMAN Protein FAM83E OS=Homo sapiens GN=FAM83E PE=2 SV=2 | 311 | P | 0.96187 | L | 0.930947 | 0.030923 | No Change: Both D | - |
| Q2M2I3 | FA83E_HUMAN Protein FAM83E OS=Homo sapiens GN=FAM83E PE=2 SV=2 | 372 | R | 0.9703 | H | 0.953222 | 0.017078 | No Change: Both D | - |
| Q8NEG4 | FA83F_HUMAN Protein FAM83F OS=Homo sapiens GN=FAM83F PE=2 SV=1 | 245 | R | 0.252634 | S | 0.32679 | -0.074156 | No Change: Both O | - |
| Q8NEG4 | FA83F_HUMAN Protein FAM83F OS=Homo sapiens GN=FAM83F PE=2 SV=1 | 353 | G | 0.864499 | S | 0.876774 | -0.012275 | No Change: Both D | - |
| Q8NEG4 | FA83F_HUMAN Protein FAM83F OS=Homo sapiens GN=FAM83F PE=2 SV=1 | 418 | A | 0.960625 | V | 0.949223 | 0.011402 | No Change: Both D | A breast cancer sample |
| Q8NEG4 | FA83F_HUMAN Protein FAM83F OS=Homo sapiens GN=FAM83F PE=2 SV=1 | 436 | R | 0.977539 | G | 0.971193 | 0.006346 | No Change: Both D | - |
| A6ND36 | FA83G_HUMAN Protein FAM83G OS=Homo sapiens GN=FAM83G PE=1 SV=2 | 109 | I | 0.787091 | T | 0.831954 | -0.044863 | No Change: Both D | - |
| Q6ZRV2 | FA83H_HUMAN Protein FAM83H OS=Homo sapiens GN=FAM83H PE=1 SV=3 | 201 | Q | 0.121711 | H | 0.120973 | 7.38E-04 | No Change: Both O | - |
| Q96G04 | FA86A_HUMAN Protein FAM86A OS=Homo sapiens GN=FAM86A PE=2 SV=2 | 123 | S | 0.528749 | C | 0.261675 | 0.267074 | D to O | - |
| Q96G04 | FA86A_HUMAN Protein FAM86A OS=Homo sapiens GN=FAM86A PE=2 SV=2 | 270 | R | 0.350654 | W | 0.160164 | 0.19049 | No Change: Both O | - |
| P0C5J1 | F86B2_HUMAN Protein FAM86B2 OS=Homo sapiens GN=FAM86B2 PE=2 SV=1 | 43 | D | 0.678554 | Y | 0.517765 | 0.160789 | No Change: Both D | - |
| P0C5J1 | F86B2_HUMAN Protein FAM86B2 OS=Homo sapiens GN=FAM86B2 PE=2 SV=1 | 285 | R | 0.161886 | S | 0.203352 | -0.041466 | No Change: Both O | - |
| Q9NVL1 | FA86C_HUMAN Protein FAM86C1 OS=Homo sapiens GN=FAM86C1 PE=2 SV=3 | 7 | A | 0.773083 | S | 0.833144 | -0.060061 | No Change: Both D | - |
| Q9NVL1 | FA86C_HUMAN Protein FAM86C1 OS=Homo sapiens GN=FAM86C1 PE=2 SV=3 | 30 | R | 0.62968 | P | 0.614799 | 0.014881 | No Change: Both D | - |
| Q9NVL1 | FA86C_HUMAN Protein FAM86C1 OS=Homo sapiens GN=FAM86C1 PE=2 SV=3 | 70 | V | 0.251363 | A | 0.321201 | -0.069838 | No Change: Both O | - |
| Q9NVL1 | FA86C_HUMAN Protein FAM86C1 OS=Homo sapiens GN=FAM86C1 PE=2 SV=3 | 135 | P | 0.704498 | L | 0.548111 | 0.156387 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 234 | A | 0.821602 | E | 0.85366 | -0.032058 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 343 | R | 0.976571 | S | 0.979531 | -0.00296 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 410 | T | 0.7288 | A | 0.753395 | -0.024595 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 123 | R | 0.935399 | G | 0.925504 | 0.009895 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 334 | P | 0.9613 | L | 0.929846 | 0.031454 | No Change: Both D | - |
| Q86YD7 | F90A1_HUMAN Protein FAM90A1 OS=Homo sapiens GN=FAM90A1 PE=2 SV=3 | 348 | T | 0.979529 | I | 0.960081 | 0.019448 | No Change: Both D | - |
| Q658Y4 | F91A1_HUMAN Protein FAM91A1 OS=Homo sapiens GN=FAM91A1 PE=1 SV=3 | 704 | I | 0.565829 | V | 0.588387 | -0.022558 | No Change: Both D | - |
| A1XBS5 | F92A1_HUMAN Protein FAM92A1 OS=Homo sapiens GN=FAM92A1 PE=2 SV=2 | 222 | R | 0.2883 | Q | 0.30402 | -0.01572 | No Change: Both O | - |
| Q6ZTR7 | FA92B_HUMAN Protein FAM92B OS=Homo sapiens GN=FAM92B PE=2 SV=1 | 22 | E | 0.280116 | K | 0.283405 | -0.003289 | No Change: Both O | - |
| Q17RN3 | FA98C_HUMAN Protein FAM98C OS=Homo sapiens GN=FAM98C PE=2 SV=1 | 240 | T | 0.302088 | K | 0.363794 | -0.061706 | No Change: Both O | - |
| Q9Y2M0 | FAN1_HUMAN Fanconi-associated nuclease 1 OS=Homo sapiens GN=FAN1 PE=1 SV=4 | 233 | G | 0.777496 | E | 0.851309 | -0.073813 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 6 | V | 0.808517 | D | 0.887866 | -0.079349 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 8 | N | 0.78779 | K | 0.824862 | -0.037072 | No Change: Both D | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 181 | A | 0.120452 | V | 0.092655 | 0.027797 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 244 | L | 0.252495 | F | 0.245394 | 0.007101 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 252 | D | 0.493173 | G | 0.475584 | 0.017589 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 435 | R | 0.13539 | C | 0.068343 | 0.067047 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 492 | H | 0.166928 | R | 0.166684 | 2.44E-04 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 501 | G | 0.392062 | S | 0.469124 | -0.077062 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 739 | P | 0.523855 | L | 0.399875 | 0.12398 | D to O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 809 | G | 0.584842 | D | 0.606334 | -0.021492 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 817 | L | 0.2416 | P | 0.398691 | -0.157091 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 845 | L | 0.383545 | P | 0.525712 | -0.142167 | O to D | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1055 | R | 0.15231 | L | 0.090604 | 0.061706 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1110 | H | 0.155288 | P | 0.193253 | -0.037965 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1117 | R | 0.346549 | G | 0.366802 | -0.020253 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1128 | Q | 0.301135 | E | 0.344366 | -0.043231 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1131 | T | 0.174344 | A | 0.157667 | 0.016677 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1287 | V | 0.054082 | I | 0.052006 | 0.002076 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1302 | W | 0.087845 | R | 0.227156 | -0.139311 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1328 | T | 0.232823 | A | 0.225152 | 0.007671 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1417 | H | 0.432121 | D | 0.511785 | -0.079664 | O to D | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 266 | T | 0.285336 | A | 0.26095 | 0.024386 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 598 | D | 0.362862 | N | 0.337205 | 0.025657 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 858 | S | 0.393111 | R | 0.329897 | 0.063214 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1055 | R | 0.15231 | W | 0.056628 | 0.095682 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1082 | L | 0.187832 | P | 0.307816 | -0.119984 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1088 | S | 0.291704 | F | 0.12635 | 0.165354 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1262 | F | 0.045639 | L | 0.053434 | -0.007795 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1359 | D | 0.063183 | Y | 0.032335 | 0.030848 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1360 | M | 0.061739 | I | 0.039664 | 0.022075 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1324 | P | 0.301263 | L | 0.181741 | 0.119522 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 210 | L | 0.065973 | R | 0.109309 | -0.043336 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 660 | L | 0.64799 | P | 0.760111 | -0.112121 | No Change: Both D | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 761 | V | 0.167224 | E | 0.268201 | -0.100977 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 843 | Y | 0.290415 | D | 0.49431 | -0.203895 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 869 | Q | 0.289818 | P | 0.328424 | -0.038606 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 951 | R | 0.507175 | Q | 0.563297 | -0.056122 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 951 | R | 0.507175 | W | 0.3407 | 0.166475 | D to O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1249 | L | 0.458346 | P | 0.584163 | -0.125817 | O to D | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1346 | A | 0.333078 | T | 0.342751 | -0.009673 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 1400 | R | 0.226257 | H | 0.179661 | 0.046596 | No Change: Both O | Fanconi anemia (FA) [MIM:227650] |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 131 | T | 0.401658 | S | 0.48377 | -0.082112 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 176 | S | 0.127819 | F | 0.046229 | 0.08159 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 277 | A | 0.066058 | G | 0.078412 | -0.012354 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 286 | Q | 0.587843 | R | 0.57321 | 0.014633 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 412 | A | 0.107595 | V | 0.077014 | 0.030581 | No Change: Both O | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 643 | P | 0.82532 | A | 0.782397 | 0.042923 | No Change: Both D | - |
| O15360 | FANCA_HUMAN Fanconi anemia group A protein OS=Homo sapiens GN=FANCA PE=1 SV=2 | 717 | M | 0.355812 | I | 0.263849 | 0.091963 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 26 | S | 0.402769 | F | 0.211861 | 0.190908 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 139 | G | 0.12178 | E | 0.143241 | -0.021461 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 190 | L | 0.129116 | F | 0.103194 | 0.025922 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 195 | D | 0.160639 | V | 0.091773 | 0.068866 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 312 | I | 0.077771 | V | 0.086739 | -0.008968 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 449 | V | 0.283687 | M | 0.363603 | -0.079916 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 465 | Q | 0.707236 | R | 0.686227 | 0.021009 | No Change: Both D | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 496 | L | 0.058743 | R | 0.094537 | -0.035794 | No Change: Both O | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 554 | L | 0.683123 | P | 0.757328 | -0.074205 | No Change: Both D | - |
| Q00597 | FANCC_HUMAN Fanconi anemia group C protein OS=Homo sapiens GN=FANCC PE=1 SV=1 | 80 | I | 0.049439 | T | 0.089627 | -0.040188 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 126 | S | 0.676355 | G | 0.628471 | 0.047884 | No Change: Both D | Fanconi anemia complementation group D type 2 (FANCD2) [MIM:227646] |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 302 | R | 0.396012 | W | 0.211025 | 0.184987 | No Change: Both O | Fanconi anemia complementation group D type 2 (FANCD2) [MIM:227646] |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 714 | P | 0.659922 | L | 0.522086 | 0.137836 | No Change: Both D | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 1236 | R | 0.136766 | H | 0.122105 | 0.014661 | No Change: Both O | Fanconi anemia complementation group D type 2 (FANCD2) [MIM:227646] |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 33 | K | 0.841731 | R | 0.80841 | 0.033321 | No Change: Both D | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 61 | T | 0.387124 | M | 0.35434 | 0.032784 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 65 | Q | 0.420916 | H | 0.385301 | 0.035615 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 172 | I | 0.268812 | M | 0.338508 | -0.069696 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 193 | T | 0.270269 | A | 0.237347 | 0.032922 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 328 | R | 0.83787 | Q | 0.853445 | -0.015575 | No Change: Both D | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 446 | L | 0.409338 | V | 0.385622 | 0.023716 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 456 | L | 0.09835 | R | 0.155479 | -0.057129 | No Change: Both O | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 623 | Q | 0.652284 | P | 0.652514 | -2.30E-04 | No Change: Both D | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 865 | K | 0.752338 | R | 0.732197 | 0.020141 | No Change: Both D | - |
| Q9BXW9 | FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens GN=FANCD2 PE=1 SV=1 | 901 | G | 0.874264 | V | 0.833723 | 0.040541 | No Change: Both D | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 89 | R | 0.472692 | L | 0.369246 | 0.103446 | No Change: Both O | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 204 | S | 0.997394 | L | 0.99554 | 0.001854 | No Change: Both D | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 340 | G | 0.320715 | R | 0.375237 | -0.054522 | No Change: Both O | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 343 | R | 0.196626 | Q | 0.224693 | -0.028067 | No Change: Both O | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 502 | A | 0.342908 | T | 0.390484 | -0.047576 | No Change: Both O | - |
| Q9HB96 | FANCE_HUMAN Fanconi anemia group E protein OS=Homo sapiens GN=FANCE PE=1 SV=1 | 184 | P | 0.993324 | Q | 0.993031 | 2.93E-04 | No Change: Both D | - |
| Q9NPI8 | FANCF_HUMAN Fanconi anemia group F protein OS=Homo sapiens GN=FANCF PE=1 SV=1 | 320 | P | 0.437694 | L | 0.282062 | 0.155632 | No Change: Both O | - |
| Q9NPI8 | FANCF_HUMAN Fanconi anemia group F protein OS=Homo sapiens GN=FANCF PE=1 SV=1 | 295 | V | 0.188686 | I | 0.172138 | 0.016548 | No Change: Both O | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 71 | L | 0.087983 | P | 0.160564 | -0.072581 | No Change: Both O | Fanconi anemia complementation group G (FANCG) [MIM:614082] |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 297 | T | 0.486243 | I | 0.321218 | 0.165025 | No Change: Both O | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 294 | G | 0.435027 | E | 0.521883 | -0.086856 | O to D | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 330 | P | 0.484549 | S | 0.480201 | 0.004348 | No Change: Both O | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 378 | S | 0.734735 | L | 0.591583 | 0.143152 | No Change: Both D | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 430 | K | 0.502429 | E | 0.520585 | -0.018156 | No Change: Both D | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 513 | R | 0.343696 | Q | 0.38437 | -0.040674 | No Change: Both O | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 603 | S | 0.376487 | F | 0.188038 | 0.188449 | No Change: Both O | - |
| O15287 | FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens GN=FANCG PE=1 SV=1 | 607 | A | 0.445213 | T | 0.502306 | -0.057093 | O to D | A colorectal cancer sample |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 686 | Q | 0.502123 | K | 0.525945 | -0.023822 | No Change: Both D | - |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 742 | C | 0.062556 | S | 0.144312 | -0.081756 | No Change: Both O | - |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 55 | P | 0.412185 | L | 0.288895 | 0.12329 | No Change: Both O | - |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 86 | A | 0.313191 | V | 0.246803 | 0.066388 | No Change: Both O | - |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 858 | H | 0.634916 | Y | 0.506365 | 0.128551 | No Change: Both D | - |
| Q9NVI1 | FANCI_HUMAN Fanconi anemia group I protein OS=Homo sapiens GN=FANCI PE=1 SV=4 | 1285 | R | 0.550323 | Q | 0.576009 | -0.025686 | No Change: Both D | - |
| Q9NW38 | FANCL_HUMAN E3 ubiquitin-protein ligase FANCL OS=Homo sapiens GN=FANCL PE=1 SV=2 | 144 | S | 0.557362 | F | 0.322026 | 0.235336 | D to O | - |
| Q8IYD8 | FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens GN=FANCM PE=1 SV=2 | 175 | S | 0.50797 | F | 0.296129 | 0.211841 | D to O | - |
| Q8IYD8 | FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens GN=FANCM PE=1 SV=2 | 878 | V | 0.809837 | L | 0.814534 | -0.004697 | No Change: Both D | - |
| Q8IYD8 | FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens GN=FANCM PE=1 SV=2 | 1812 | P | 0.652388 | A | 0.592897 | 0.059491 | No Change: Both D | - |
| Q8IYD8 | FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens GN=FANCM PE=1 SV=2 | 208 | I | 0.111409 | M | 0.155558 | -0.044149 | No Change: Both O | - |
| Q8TC84 | FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens GN=FANK1 PE=2 SV=3 | 329 | L | 0.775716 | V | 0.786243 | -0.010527 | No Change: Both D | - |
| Q8TC84 | FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens GN=FANK1 PE=2 SV=3 | 46 | R | 0.274068 | S | 0.350974 | -0.076906 | No Change: Both O | - |
| Q8TC84 | FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens GN=FANK1 PE=2 SV=3 | 12 | P | 0.789147 | L | 0.65407 | 0.135077 | No Change: Both D | - |
| Q8TC84 | FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens GN=FANK1 PE=2 SV=3 | 343 | C | 0.918058 | F | 0.896909 | 0.021149 | No Change: Both D | - |
| Q8WVX9 | FACR1_HUMAN Fatty acyl-CoA reductase 1 OS=Homo sapiens GN=FAR1 PE=1 SV=1 | 96 | E | 0.475889 | K | 0.473132 | 0.002757 | No Change: Both O | - |
| Q96K12 | FACR2_HUMAN Fatty acyl-CoA reductase 2 OS=Homo sapiens GN=FAR2 PE=2 SV=1 | 326 | F | 0.173116 | S | 0.324344 | -0.151228 | No Change: Both O | - |
| Q96K12 | FACR2_HUMAN Fatty acyl-CoA reductase 2 OS=Homo sapiens GN=FAR2 PE=2 SV=1 | 329 | I | 0.27711 | T | 0.430019 | -0.152909 | No Change: Both O | - |
| Q9Y4F1 | FARP1_HUMAN FERM RhoGEF and pleckstrin domain-containing protein 1 OS=Homo sapiens GN=FARP1 PE=1 SV=1 | 714 | R | 0.271238 | L | 0.180959 | 0.090279 | No Change: Both O | A breast cancer sample |
| Q9Y4F1 | FARP1_HUMAN FERM RhoGEF and pleckstrin domain-containing protein 1 OS=Homo sapiens GN=FARP1 PE=1 SV=1 | 8 | P | 0.973502 | L | 0.940695 | 0.032807 | No Change: Both D | - |
| O94887 | FARP2_HUMAN FERM RhoGEF and pleckstrin domain-containing protein 2 OS=Homo sapiens GN=FARP2 PE=1 SV=3 | 185 | K | 0.400667 | N | 0.376343 | 0.024324 | No Change: Both O | - |
| O94887 | FARP2_HUMAN FERM RhoGEF and pleckstrin domain-containing protein 2 OS=Homo sapiens GN=FARP2 PE=1 SV=3 | 260 | T | 0.17531 | I | 0.097749 | 0.077561 | No Change: Both O | - |
| O94887 | FARP2_HUMAN FERM RhoGEF and pleckstrin domain-containing protein 2 OS=Homo sapiens GN=FARP2 PE=1 SV=3 | 643 | V | 0.433652 | I | 0.404129 | 0.029523 | No Change: Both O | - |
| O95363 | SYFM_HUMAN Phenylalanine--tRNA ligase mitochondrial OS=Homo sapiens GN=FARS2 PE=1 SV=1 | 57 | S | 0.558375 | C | 0.380502 | 0.177873 | D to O | - |
| O95363 | SYFM_HUMAN Phenylalanine--tRNA ligase mitochondrial OS=Homo sapiens GN=FARS2 PE=1 SV=1 | 280 | N | 0.23515 | S | 0.280745 | -0.045595 | No Change: Both O | - |
| Q9Y285 | SYFA_HUMAN Phenylalanine--tRNA ligase alpha chain OS=Homo sapiens GN=FARSA PE=1 SV=3 | 341 | Q | 0.346466 | R | 0.358989 | -0.012523 | No Change: Both O | - |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 25 | A | 0.513234 | T | 0.562897 | -0.049663 | No Change: Both D | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 28 | T | 0.449707 | A | 0.43143 | 0.018277 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 82 | C | 0.850107 | R | 0.875177 | -0.02507 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 121 | R | 0.676064 | W | 0.42197 | 0.254094 | D to O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 180 | L | 0.147687 | F | 0.097088 | 0.050599 | No Change: Both O | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 183 | P | 0.180365 | L | 0.117277 | 0.063088 | No Change: Both O | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 198 | T | 0.60345 | I | 0.481212 | 0.122238 | D to O | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 232 | Y | 0.187287 | C | 0.183314 | 0.003973 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 241 | T | 0.153752 | K | 0.202241 | -0.048489 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 241 | T | 0.153752 | P | 0.1732 | -0.019448 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 250 | R | 0.361241 | P | 0.399081 | -0.03784 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 250 | R | 0.361241 | Q | 0.397118 | -0.035877 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 257 | A | 0.506089 | D | 0.603738 | -0.097649 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 260 | D | 0.537394 | G | 0.502377 | 0.035017 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 260 | D | 0.537394 | Y | 0.358668 | 0.178726 | D to O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 260 | D | 0.537394 | V | 0.378023 | 0.159371 | D to O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 264 | N | 0.560174 | K | 0.599117 | -0.038943 | No Change: Both D | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 270 | T | 0.515791 | I | 0.400055 | 0.115736 | D to O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 272 | E | 0.471816 | G | 0.418616 | 0.0532 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 272 | E | 0.471816 | K | 0.492072 | -0.020256 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 278 | L | 0.295422 | F | 0.242551 | 0.052871 | No Change: Both O | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 299 | K | 0.333853 | N | 0.285548 | 0.048305 | No Change: Both O | Non-Hodgkin lymphoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 310 | I | 0.199142 | S | 0.375737 | -0.176595 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 118 | N | 0.662705 | S | 0.69076 | -0.028055 | No Change: Both D | Squamous cell carcinoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 178 | C | 0.173555 | R | 0.228801 | -0.055246 | No Change: Both O | Squamous cell carcinoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 255 | N | 0.452791 | D | 0.467673 | -0.014882 | No Change: Both O | Squamous cell carcinoma |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 16 | A | 0.353893 | T | 0.396136 | -0.042243 | No Change: Both O | - |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 122 | T | 0.708235 | I | 0.584629 | 0.123606 | No Change: Both D | - |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 305 | T | 0.191321 | I | 0.115919 | 0.075402 | No Change: Both O | - |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 184 | I | 0.20613 | V | 0.230095 | -0.023965 | No Change: Both O | - |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 262 | I | 0.559789 | S | 0.723291 | -0.163502 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 249 | V | 0.349583 | L | 0.334745 | 0.014838 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 253 | G | 0.400578 | D | 0.427328 | -0.02675 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 253 | G | 0.400578 | S | 0.440492 | -0.039914 | No Change: Both O | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 259 | I | 0.533235 | R | 0.65351 | -0.120275 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P25445 | TNR6_HUMAN Tumor necrosis factor receptor superfamily member 6 OS=Homo sapiens GN=FAS PE=1 SV=1 | 270 | T | 0.515791 | K | 0.605739 | -0.089948 | No Change: Both D | Autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859] |
| P48023 | TNFL6_HUMAN Tumor necrosis factor ligand superfamily member 6 OS=Homo sapiens GN=FASLG PE=1 SV=1 | 189 | Y | 0.0598 | S | 0.130627 | -0.070827 | No Change: Both O | - |
| P49327 | FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3 | 1483 | V | 0.703614 | I | 0.671743 | 0.031871 | No Change: Both D | - |
| P49327 | FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3 | 1694 | R | 0.103929 | H | 0.090997 | 0.012932 | No Change: Both O | - |
| P49327 | FAS_HUMAN Fatty acid synthase OS=Homo sapiens GN=FASN PE=1 SV=3 | 1888 | I | 0.16737 | V | 0.175966 | -0.008596 | No Change: Both O | - |
| Q14296 | FASTK_HUMAN Fas-activated serine/threonine kinase OS=Homo sapiens GN=FASTK PE=1 SV=1 | 436 | A | 0.40757 | V | 0.356643 | 0.050927 | No Change: Both O | - |
| Q14296 | FASTK_HUMAN Fas-activated serine/threonine kinase OS=Homo sapiens GN=FASTK PE=1 SV=1 | 424 | V | 0.255686 | L | 0.275577 | -0.019891 | No Change: Both O | A lung adenocarcinoma sample |
| Q53R41 | FAKD1_HUMAN FAST kinase domain-containing protein 1 OS=Homo sapiens GN=FASTKD1 PE=1 SV=1 | 384 | E | 0.179673 | Q | 0.156088 | 0.023585 | No Change: Both O | - |
| Q53R41 | FAKD1_HUMAN FAST kinase domain-containing protein 1 OS=Homo sapiens GN=FASTKD1 PE=1 SV=1 | 446 | C | 0.194987 | G | 0.362736 | -0.167749 | No Change: Both O | - |
| Q53R41 | FAKD1_HUMAN FAST kinase domain-containing protein 1 OS=Homo sapiens GN=FASTKD1 PE=1 SV=1 | 467 | M | 0.201552 | V | 0.14792 | 0.053632 | No Change: Both O | - |
| Q9NYY8 | FAKD2_HUMAN FAST kinase domain-containing protein 2 OS=Homo sapiens GN=FASTKD2 PE=1 SV=1 | 15 | S | 0.632963 | N | 0.590693 | 0.04227 | No Change: Both D | - |
| Q9NYY8 | FAKD2_HUMAN FAST kinase domain-containing protein 2 OS=Homo sapiens GN=FASTKD2 PE=1 SV=1 | 445 | V | 0.337736 | E | 0.561279 | -0.223543 | O to D | - |
| Q14CZ7 | FAKD3_HUMAN FAST kinase domain-containing protein 3 OS=Homo sapiens GN=FASTKD3 PE=2 SV=2 | 56 | K | 0.50533 | R | 0.452745 | 0.052585 | D to O | - |
| Q14CZ7 | FAKD3_HUMAN FAST kinase domain-containing protein 3 OS=Homo sapiens GN=FASTKD3 PE=2 SV=2 | 459 | E | 0.288158 | G | 0.238447 | 0.049711 | No Change: Both O | - |
| Q14CZ7 | FAKD3_HUMAN FAST kinase domain-containing protein 3 OS=Homo sapiens GN=FASTKD3 PE=2 SV=2 | 22 | L | 0.27655 | V | 0.255725 | 0.020825 | No Change: Both O | A breast cancer sample |
| Q14CZ7 | FAKD3_HUMAN FAST kinase domain-containing protein 3 OS=Homo sapiens GN=FASTKD3 PE=2 SV=2 | 3 | L | 0.502636 | F | 0.442264 | 0.060372 | D to O | - |
| Q7L8L6 | FAKD5_HUMAN FAST kinase domain-containing protein 5 OS=Homo sapiens GN=FASTKD5 PE=1 SV=1 | 256 | R | 0.101831 | C | 0.041752 | 0.060079 | No Change: Both O | - |
| Q7L8L6 | FAKD5_HUMAN FAST kinase domain-containing protein 5 OS=Homo sapiens GN=FASTKD5 PE=1 SV=1 | 288 | I | 0.148252 | T | 0.232387 | -0.084135 | No Change: Both O | - |
| Q7L8L6 | FAKD5_HUMAN FAST kinase domain-containing protein 5 OS=Homo sapiens GN=FASTKD5 PE=1 SV=1 | 377 | I | 0.25982 | V | 0.272447 | -0.012627 | No Change: Both O | - |
| Q14517 | FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2 | 131 | A | 0.446413 | V | 0.399773 | 0.04664 | No Change: Both O | - |
| Q14517 | FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2 | 1330 | N | 0.514891 | S | 0.602137 | -0.087246 | No Change: Both D | - |
| Q14517 | FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2 | 1564 | A | 0.274105 | T | 0.300484 | -0.026379 | No Change: Both O | - |
| Q14517 | FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2 | 1605 | N | 0.386537 | D | 0.393064 | -0.006527 | No Change: Both O | - |
| Q14517 | FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens GN=FAT1 PE=1 SV=2 | 3800 | P | 0.937982 | H | 0.918582 | 0.0194 | No Change: Both D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 201 | G | 0.235244 | A | 0.195516 | 0.039728 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 248 | P | 0.317564 | S | 0.322068 | -0.004504 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 574 | R | 0.244918 | C | 0.149492 | 0.095426 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 686 | F | 0.177379 | S | 0.345387 | -0.168008 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 992 | R | 0.305018 | Q | 0.305512 | -4.94E-04 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1004 | G | 0.430634 | S | 0.486588 | -0.055954 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1164 | P | 0.584492 | L | 0.472822 | 0.11167 | D to O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1462 | V | 0.322308 | M | 0.359428 | -0.03712 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1515 | G | 0.612741 | S | 0.655264 | -0.042523 | No Change: Both D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1571 | G | 0.296769 | S | 0.354518 | -0.057749 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1895 | R | 0.418828 | W | 0.235792 | 0.183036 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 2054 | G | 0.335606 | A | 0.313819 | 0.021787 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 2907 | A | 0.585601 | T | 0.60332 | -0.017719 | No Change: Both D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3318 | R | 0.532991 | Q | 0.565482 | -0.032491 | No Change: Both D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3318 | R | 0.532991 | W | 0.333931 | 0.19906 | D to O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3514 | L | 0.472124 | S | 0.644434 | -0.17231 | O to D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3631 | M | 0.110818 | I | 0.067819 | 0.042999 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3664 | A | 0.335363 | G | 0.377801 | -0.042438 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 3953 | Q | 0.341278 | H | 0.320341 | 0.020937 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 4117 | P | 0.883505 | L | 0.809527 | 0.073978 | No Change: Both D | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1295 | L | 0.299978 | P | 0.451846 | -0.151868 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 1181 | Y | 0.157794 | H | 0.256649 | -0.098855 | No Change: Both O | - |
| Q9NYQ8 | FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens GN=FAT2 PE=1 SV=2 | 2428 | F | 0.369795 | S | 0.587566 | -0.217771 | O to D | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 412 | S | 0.389264 | F | 0.217284 | 0.17198 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 462 | I | 0.406164 | V | 0.438351 | -0.032187 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 1167 | V | 0.543029 | G | 0.614761 | -0.071732 | No Change: Both D | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 1726 | Q | 0.294797 | R | 0.287273 | 0.007524 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 2293 | N | 0.380904 | S | 0.441606 | -0.060702 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 2622 | V | 0.283702 | F | 0.239257 | 0.044445 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 2755 | I | 0.305933 | V | 0.333293 | -0.02736 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 3518 | V | 0.152442 | L | 0.152951 | -5.09E-04 | No Change: Both O | - |
| Q8TDW7 | FAT3_HUMAN Protocadherin Fat 3 OS=Homo sapiens GN=FAT3 PE=2 SV=2 | 3812 | S | 0.743975 | G | 0.705699 | 0.038276 | No Change: Both D | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 2826 | D | 0.393492 | N | 0.379917 | 0.013575 | No Change: Both O | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 3524 | G | 0.62358 | D | 0.657701 | -0.034121 | No Change: Both D | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 3828 | K | 0.523126 | E | 0.544137 | -0.021011 | No Change: Both D | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 3873 | S | 0.502954 | N | 0.44941 | 0.053544 | D to O | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 4374 | E | 0.378521 | K | 0.403826 | -0.025305 | No Change: Both O | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 4972 | P | 0.82459 | S | 0.811594 | 0.012996 | No Change: Both D | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 4977 | A | 0.877967 | T | 0.885145 | -0.007178 | No Change: Both D | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 453 | Q | 0.488117 | L | 0.368363 | 0.119754 | No Change: Both O | - |
| Q6V0I7 | FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens GN=FAT4 PE=2 SV=2 | 807 | A | 0.119143 | V | 0.095603 | 0.02354 | No Change: Both O | - |
| Q969F0 | FATE1_HUMAN Fetal and adult testis-expressed transcript protein OS=Homo sapiens GN=FATE1 PE=2 SV=1 | 10 | A | 0.912033 | V | 0.864903 | 0.04713 | No Change: Both D | - |
| Q969F0 | FATE1_HUMAN Fetal and adult testis-expressed transcript protein OS=Homo sapiens GN=FATE1 PE=2 SV=1 | 34 | I | 0.907227 | T | 0.941878 | -0.034651 | No Change: Both D | - |
| Q969F0 | FATE1_HUMAN Fetal and adult testis-expressed transcript protein OS=Homo sapiens GN=FATE1 PE=2 SV=1 | 125 | S | 0.346383 | R | 0.318149 | 0.028234 | No Change: Both O | - |
| P35544 | UBIM_HUMAN Ubiquitin-like protein FUBI OS=Homo sapiens GN=FAU PE=1 SV=1 | 53 | T | 0.398394 | I | 0.255494 | 0.1429 | No Change: Both O | - |
| P62861 | RS30_HUMAN 40S ribosomal protein S30 OS=Homo sapiens GN=FAU PE=1 SV=1 | 19 | V | 0.954579 | M | 0.966774 | -0.012195 | No Change: Both D | - |
| Q8TES7 | FBF1_HUMAN Fas-binding factor 1 OS=Homo sapiens GN=FBF1 PE=1 SV=2 | 65 | G | 0.722446 | V | 0.633137 | 0.089309 | No Change: Both D | - |
| Q8TES7 | FBF1_HUMAN Fas-binding factor 1 OS=Homo sapiens GN=FBF1 PE=1 SV=2 | 151 | R | 0.895872 | G | 0.889947 | 0.005925 | No Change: Both D | - |
| Q8TES7 | FBF1_HUMAN Fas-binding factor 1 OS=Homo sapiens GN=FBF1 PE=1 SV=2 | 371 | P | 0.936533 | S | 0.933124 | 0.003409 | No Change: Both D | - |
| Q8TES7 | FBF1_HUMAN Fas-binding factor 1 OS=Homo sapiens GN=FBF1 PE=1 SV=2 | 574 | C | 0.866383 | S | 0.926125 | -0.059742 | No Change: Both D | - |
| Q8WUP2 | FBLI1_HUMAN Filamin-binding LIM protein 1 OS=Homo sapiens GN=FBLIM1 PE=1 SV=2 | 191 | S | 0.53728 | F | 0.420478 | 0.116802 | D to O | - |
| Q8WUP2 | FBLI1_HUMAN Filamin-binding LIM protein 1 OS=Homo sapiens GN=FBLIM1 PE=1 SV=2 | 39 | R | 0.804707 | C | 0.723148 | 0.081559 | No Change: Both D | - |
| P23142 | FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1 PE=1 SV=4 | 141 | Q | 0.264534 | R | 0.209231 | 0.055303 | No Change: Both O | - |
| P23142 | FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1 PE=1 SV=4 | 509 | C | 0.481186 | S | 0.627108 | -0.145922 | O to D | - |
| P23142 | FBLN1_HUMAN Fibulin-1 OS=Homo sapiens GN=FBLN1 PE=1 SV=4 | 695 | H | 0.105547 | R | 0.103955 | 0.001592 | No Change: Both O | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 1114 | G | 0.202097 | R | 0.186489 | 0.015608 | No Change: Both O | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 361 | S | 0.798583 | G | 0.766587 | 0.031996 | No Change: Both D | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 387 | N | 0.850815 | T | 0.8737 | -0.022885 | No Change: Both D | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 854 | T | 0.45065 | A | 0.436569 | 0.014081 | No Change: Both O | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 45 | I | 0.593059 | V | 0.659622 | -0.066563 | No Change: Both D | - |
| P98095 | FBLN2_HUMAN Fibulin-2 OS=Homo sapiens GN=FBLN2 PE=1 SV=2 | 144 | H | 0.410925 | R | 0.39137 | 0.019555 | No Change: Both O | - |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 227 | S | 0.319724 | P | 0.331284 | -0.01156 | No Change: Both O | Cutis laxa autosomal recessive type 1 (ARCL1) [MIM:219100] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 60 | V | 0.366976 | L | 0.396861 | -0.029885 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 71 | R | 0.467105 | Q | 0.457964 | 0.009141 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 87 | P | 0.800035 | S | 0.792203 | 0.007832 | No Change: Both D | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 169 | I | 0.153326 | T | 0.264499 | -0.111173 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 351 | R | 0.21412 | W | 0.077216 | 0.136904 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 363 | A | 0.302534 | T | 0.328368 | -0.025834 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 412 | G | 0.390357 | E | 0.453967 | -0.06361 | No Change: Both O | Age-related macular degeneration type 3 (ARMD3) [MIM:608895] |
| Q9UBX5 | FBLN5_HUMAN Fibulin-5 OS=Homo sapiens GN=FBLN5 PE=1 SV=1 | 364 | D | 0.291857 | Y | 0.165877 | 0.12598 | No Change: Both O | - |
| Q53RD9 | FBLN7_HUMAN Fibulin-7 OS=Homo sapiens GN=FBLN7 PE=2 SV=1 | 119 | V | 0.31326 | M | 0.345188 | -0.031928 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 111 | C | 0.847456 | R | 0.879737 | -0.032281 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 122 | R | 0.751163 | C | 0.739273 | 0.01189 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 129 | C | 0.710753 | Y | 0.609329 | 0.101424 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 166 | C | 0.330561 | F | 0.25115 | 0.079411 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 166 | C | 0.330561 | S | 0.410667 | -0.080106 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 217 | W | 0.234921 | G | 0.479253 | -0.244332 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 476 | C | 0.440058 | G | 0.521974 | -0.081916 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 490 | D | 0.613617 | Y | 0.44774 | 0.165877 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 545 | R | 0.422705 | C | 0.348439 | 0.074266 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 548 | N | 0.39713 | I | 0.246545 | 0.150585 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 587 | C | 0.418676 | Y | 0.311619 | 0.107057 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 627 | R | 0.241909 | C | 0.162843 | 0.079066 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 661 | C | 0.314873 | R | 0.465224 | -0.150351 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 705 | A | 0.811482 | T | 0.814864 | -0.003382 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 711 | C | 0.820673 | Y | 0.762936 | 0.057737 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 723 | D | 0.678472 | A | 0.638526 | 0.039946 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 746 | Y | 0.243897 | C | 0.336744 | -0.092847 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 750 | C | 0.255797 | G | 0.343854 | -0.088057 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 862 | C | 0.201345 | R | 0.275651 | -0.074306 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 926 | C | 0.25409 | R | 0.348339 | -0.094249 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 984 | V | 0.526925 | I | 0.550595 | -0.02367 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 996 | C | 0.752929 | R | 0.808171 | -0.055242 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1013 | G | 0.67797 | R | 0.692623 | -0.014653 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1023 | K | 0.667127 | N | 0.63202 | 0.035107 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1043 | K | 0.536193 | R | 0.503539 | 0.032654 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1048 | I | 0.580147 | T | 0.69205 | -0.111903 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1053 | C | 0.594599 | R | 0.652741 | -0.058142 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1055 | C | 0.576972 | G | 0.621205 | -0.044233 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1072 | D | 0.719609 | G | 0.683688 | 0.035921 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1073 | E | 0.717834 | K | 0.697595 | 0.020239 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1074 | C | 0.708806 | R | 0.756621 | -0.047815 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1086 | C | 0.691383 | W | 0.49988 | 0.191503 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1117 | C | 0.616464 | G | 0.654279 | -0.037815 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1117 | C | 0.616464 | Y | 0.512516 | 0.103948 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1127 | G | 0.500452 | S | 0.552779 | -0.052327 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1131 | N | 0.545838 | Y | 0.395317 | 0.150521 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1137 | R | 0.613628 | P | 0.673833 | -0.060205 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1148 | P | 0.491421 | A | 0.377241 | 0.11418 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1153 | C | 0.334601 | Y | 0.27144 | 0.063161 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1155 | D | 0.359943 | N | 0.415261 | -0.055318 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1170 | R | 0.177783 | H | 0.180168 | -0.002385 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1171 | C | 0.163909 | W | 0.101032 | 0.062877 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1173 | N | 0.115704 | K | 0.128831 | -0.013127 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1223 | C | 0.664698 | Y | 0.577835 | 0.086863 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1223 | C | 0.664698 | Y | 0.577835 | 0.086863 | No Change: Both D | Shprintzen-Goldberg craniosynostosis syndrome (SGS) [MIM:182212] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1242 | C | 0.731431 | Y | 0.654479 | 0.076952 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1249 | C | 0.57405 | S | 0.668017 | -0.093967 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1382 | N | 0.57042 | S | 0.635915 | -0.065495 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1404 | D | 0.562083 | Y | 0.391673 | 0.17041 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1513 | C | 0.574564 | R | 0.623032 | -0.048468 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1589 | C | 0.305216 | F | 0.280752 | 0.024464 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1610 | C | 0.318321 | G | 0.46778 | -0.149459 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1663 | C | 0.515852 | R | 0.558966 | -0.043114 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1837 | P | 0.604191 | S | 0.616484 | -0.012293 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1893 | N | 0.343115 | K | 0.359026 | -0.015911 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1928 | C | 0.462036 | R | 0.525382 | -0.063346 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2099 | C | 0.61667 | W | 0.488474 | 0.128196 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2111 | C | 0.464659 | Y | 0.364618 | 0.100041 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2127 | D | 0.572751 | E | 0.580792 | -0.008041 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2144 | N | 0.349522 | S | 0.413646 | -0.064124 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2151 | C | 0.3007 | W | 0.161234 | 0.139466 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2221 | C | 0.249531 | S | 0.287005 | -0.037474 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2258 | C | 0.860041 | R | 0.880619 | -0.020578 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2282 | R | 0.758756 | W | 0.557086 | 0.20167 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2307 | C | 0.786659 | S | 0.81717 | -0.030511 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2447 | E | 0.426924 | K | 0.449736 | -0.022812 | No Change: Both O | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2489 | C | 0.458898 | R | 0.515038 | -0.05614 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2511 | C | 0.462487 | R | 0.49417 | -0.031683 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2623 | H | 0.310222 | P | 0.348038 | -0.037816 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2627 | G | 0.299764 | R | 0.272401 | 0.027363 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2680 | R | 0.647446 | C | 0.638082 | 0.009364 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2726 | R | 0.870569 | W | 0.729321 | 0.141248 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 504 | C | 0.593296 | F | 0.480262 | 0.113034 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1129 | C | 0.525461 | Y | 0.436866 | 0.088595 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1261 | Y | 0.378732 | C | 0.50068 | -0.121948 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1833 | C | 0.476144 | S | 0.589482 | -0.113338 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2142 | C | 0.333004 | Y | 0.312755 | 0.020249 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 27 | A | 0.517346 | T | 0.529578 | -0.012232 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 62 | R | 0.35222 | C | 0.291181 | 0.061039 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 89 | C | 0.551683 | F | 0.463127 | 0.088556 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 114 | R | 0.842169 | C | 0.823037 | 0.019132 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 115 | S | 0.846495 | C | 0.804569 | 0.041926 | No Change: Both D | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 154 | C | 0.44298 | S | 0.538884 | -0.095904 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 240 | R | 0.395825 | C | 0.334624 | 0.061201 | No Change: Both O | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 240 | R | 0.395825 | C | 0.334624 | 0.061201 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 366 | W | 0.268112 | C | 0.453637 | -0.185525 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 560 | G | 0.3902 | S | 0.431329 | -0.041129 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 570 | C | 0.587897 | Y | 0.50951 | 0.078387 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 592 | G | 0.461721 | D | 0.504958 | -0.043237 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 596 | C | 0.472373 | Y | 0.346977 | 0.125396 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 598 | C | 0.464651 | W | 0.277346 | 0.187305 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 652 | C | 0.206915 | S | 0.408599 | -0.201684 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 654 | D | 0.228557 | N | 0.204496 | 0.024061 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 661 | C | 0.314873 | Y | 0.371455 | -0.056582 | No Change: Both O | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 681 | S | 0.372884 | Y | 0.20995 | 0.162934 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 683 | C | 0.413909 | R | 0.477519 | -0.06361 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 685 | C | 0.490418 | W | 0.318223 | 0.172195 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 723 | D | 0.678472 | V | 0.523422 | 0.15505 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 734 | C | 0.371641 | F | 0.265583 | 0.106058 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 748 | C | 0.25741 | Y | 0.210655 | 0.046755 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 776 | C | 0.263299 | G | 0.350654 | -0.087355 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 776 | C | 0.263299 | Y | 0.223243 | 0.040056 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 781 | C | 0.388839 | R | 0.471977 | -0.083138 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 816 | C | 0.780795 | S | 0.843683 | -0.062888 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 890 | C | 0.176593 | R | 0.23309 | -0.056497 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 908 | C | 0.373907 | R | 0.484176 | -0.110269 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 913 | E | 0.335347 | G | 0.296828 | 0.038519 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 921 | C | 0.241273 | G | 0.320111 | -0.078838 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 985 | G | 0.531994 | R | 0.572761 | -0.040767 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1044 | C | 0.548132 | Y | 0.422343 | 0.125789 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1055 | C | 0.576972 | W | 0.383279 | 0.193693 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1055 | C | 0.576972 | Y | 0.435852 | 0.14112 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1101 | Y | 0.670663 | C | 0.788736 | -0.118073 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1128 | V | 0.514451 | I | 0.554354 | -0.039903 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1200 | E | 0.198298 | G | 0.170003 | 0.028295 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1325 | E | 0.547583 | Q | 0.479697 | 0.067886 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1337 | A | 0.465471 | P | 0.539649 | -0.074178 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1339 | C | 0.454296 | Y | 0.362839 | 0.091457 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1366 | E | 0.54444 | K | 0.584214 | -0.039774 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1374 | C | 0.597967 | S | 0.705471 | -0.107504 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1389 | C | 0.54428 | R | 0.582808 | -0.038528 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1424 | P | 0.475533 | A | 0.393047 | 0.082486 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1429 | C | 0.354345 | S | 0.479369 | -0.125024 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1530 | R | 0.483666 | C | 0.41047 | 0.073196 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1564 | C | 0.310986 | Y | 0.23847 | 0.072516 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1770 | C | 0.244274 | F | 0.245005 | -7.31E-04 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1790 | R | 0.111354 | P | 0.143108 | -0.031754 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1791 | C | 0.122931 | Y | 0.107273 | 0.015658 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1793 | C | 0.125948 | W | 0.073693 | 0.052255 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1796 | G | 0.116977 | E | 0.156436 | -0.039459 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1806 | C | 0.155442 | S | 0.276155 | -0.120713 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1835 | C | 0.581567 | Y | 0.498474 | 0.083093 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1909 | I | 0.506712 | T | 0.642975 | -0.136263 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1915 | R | 0.467098 | S | 0.501802 | -0.034704 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1971 | C | 0.32193 | Y | 0.255326 | 0.066604 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1977 | C | 0.307602 | Y | 0.241512 | 0.06609 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1998 | C | 0.489687 | Y | 0.392785 | 0.096902 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2101 | T | 0.622404 | M | 0.641567 | -0.019163 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2111 | C | 0.464659 | R | 0.50957 | -0.044911 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2154 | P | 0.24561 | R | 0.216189 | 0.029421 | No Change: Both O | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2221 | C | 0.249531 | G | 0.259821 | -0.01029 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2223 | N | 0.285076 | H | 0.235771 | 0.049305 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2269 | I | 0.79908 | T | 0.859584 | -0.060504 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2335 | R | 0.551487 | W | 0.317381 | 0.234106 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2339 | C | 0.502334 | Y | 0.395353 | 0.106981 | D to O | Isolated ectopia lentis (EL) [MIM:129600] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2406 | C | 0.236994 | Y | 0.251042 | -0.014048 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2442 | C | 0.379262 | W | 0.229692 | 0.14957 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2474 | Y | 0.476152 | C | 0.587722 | -0.11157 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2581 | C | 0.549712 | F | 0.440506 | 0.109206 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2585 | I | 0.382457 | T | 0.487855 | -0.105398 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2618 | G | 0.260338 | R | 0.235358 | 0.02498 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2624 | N | 0.294552 | K | 0.337169 | -0.042617 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2652 | C | 0.577425 | G | 0.673425 | -0.096 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2668 | G | 0.611624 | C | 0.55757 | 0.054054 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 985 | G | 0.531994 | E | 0.61116 | -0.079166 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1265 | C | 0.28435 | R | 0.319261 | -0.034911 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 20 | Y | 0.282024 | C | 0.296511 | -0.014487 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 123 | C | 0.748658 | Y | 0.647605 | 0.101053 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 177 | C | 0.455181 | R | 0.548161 | -0.09298 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 224 | C | 0.483784 | R | 0.579707 | -0.095923 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 439 | R | 0.764258 | G | 0.72869 | 0.035568 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 541 | C | 0.388302 | Y | 0.308375 | 0.079927 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 628 | C | 0.266823 | K | 0.406829 | -0.140006 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 635 | Y | 0.234319 | C | 0.298331 | -0.064012 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 636 | R | 0.221677 | I | 0.114769 | 0.106908 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 781 | C | 0.388839 | Y | 0.349027 | 0.039812 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 832 | C | 0.718503 | Y | 0.626019 | 0.092484 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 890 | C | 0.176593 | G | 0.248088 | -0.071495 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1058 | G | 0.624344 | D | 0.676485 | -0.052141 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1113 | D | 0.653835 | V | 0.499268 | 0.154567 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1153 | C | 0.334601 | S | 0.474488 | -0.139887 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1219 | Y | 0.68415 | C | 0.792597 | -0.108447 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1261 | Y | 0.378732 | D | 0.553236 | -0.174504 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1278 | C | 0.316293 | S | 0.485097 | -0.168804 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1284 | C | 0.294635 | G | 0.378047 | -0.083412 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1333 | C | 0.445544 | S | 0.567223 | -0.121679 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1402 | C | 0.544791 | R | 0.596318 | -0.051527 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1424 | P | 0.475533 | S | 0.485653 | -0.01012 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1475 | G | 0.341514 | E | 0.401803 | -0.060289 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1475 | G | 0.341514 | S | 0.383602 | -0.042088 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1564 | C | 0.310986 | F | 0.21754 | 0.093446 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1576 | M | 0.283153 | T | 0.346684 | -0.063531 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1631 | C | 0.235848 | G | 0.305463 | -0.069615 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1663 | C | 0.515852 | Y | 0.438359 | 0.077493 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1791 | C | 0.122931 | R | 0.184763 | -0.061832 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1806 | C | 0.155442 | Y | 0.152788 | 0.002654 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1876 | C | 0.2239 | Y | 0.155476 | 0.068424 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1887 | T | 0.361319 | I | 0.244554 | 0.116765 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1895 | C | 0.380491 | R | 0.496088 | -0.115597 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1900 | C | 0.47001 | Y | 0.395568 | 0.074442 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1928 | C | 0.462036 | G | 0.520041 | -0.058005 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1928 | C | 0.462036 | Y | 0.346519 | 0.115517 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2038 | C | 0.663321 | Y | 0.56006 | 0.103261 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2085 | C | 0.691425 | R | 0.732147 | -0.040722 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2160 | A | 0.261923 | P | 0.413829 | -0.151906 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2221 | C | 0.249531 | F | 0.181903 | 0.067628 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2251 | C | 0.852801 | R | 0.880082 | -0.027281 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2385 | A | 0.225008 | T | 0.275569 | -0.050561 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2500 | C | 0.275915 | R | 0.291725 | -0.01581 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2500 | C | 0.275915 | Y | 0.171071 | 0.104844 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2535 | C | 0.740324 | W | 0.561875 | 0.178449 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2536 | G | 0.752048 | R | 0.74254 | 0.009508 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2570 | E | 0.76638 | K | 0.724367 | 0.042013 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2571 | C | 0.761956 | R | 0.793039 | -0.031083 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2592 | C | 0.358056 | S | 0.460433 | -0.102377 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2605 | C | 0.226566 | R | 0.319064 | -0.092498 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2605 | C | 0.226566 | Y | 0.234362 | -0.007796 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2610 | E | 0.245101 | K | 0.231286 | 0.013815 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2629 | Y | 0.284231 | C | 0.347916 | -0.063685 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2663 | C | 0.594082 | S | 0.705632 | -0.11155 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 133 | H | 0.632583 | Q | 0.688517 | -0.055934 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 329 | I | 0.382717 | T | 0.560869 | -0.178152 | O to D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 363 | G | 0.257536 | S | 0.322104 | -0.064568 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1048 | I | 0.580147 | V | 0.536618 | 0.043529 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1113 | D | 0.653835 | G | 0.628137 | 0.025698 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1282 | N | 0.287322 | S | 0.313121 | -0.025799 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1672 | C | 0.363943 | F | 0.237843 | 0.1261 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2018 | V | 0.671439 | I | 0.713836 | -0.042397 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2053 | C | 0.817728 | F | 0.773283 | 0.044445 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2113 | Y | 0.422705 | F | 0.481396 | -0.058691 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2170 | C | 0.489112 | F | 0.425965 | 0.063147 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2278 | P | 0.748088 | S | 0.698233 | 0.049855 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2329 | D | 0.62496 | E | 0.656605 | -0.031645 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 472 | C | 0.42127 | Y | 0.35157 | 0.0697 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1564 | C | 0.310986 | S | 0.456233 | -0.145247 | No Change: Both O | Stiff skin syndrome (SSKS) [MIM:184900] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1570 | W | 0.376864 | C | 0.580638 | -0.203774 | O to D | Stiff skin syndrome (SSKS) [MIM:184900] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1577 | C | 0.28509 | G | 0.410349 | -0.125259 | No Change: Both O | Stiff skin syndrome (SSKS) [MIM:184900] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1594 | G | 0.356712 | D | 0.363272 | -0.00656 | No Change: Both O | Stiff skin syndrome (SSKS) [MIM:184900] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1068 | C | 0.722476 | G | 0.749573 | -0.027097 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 80 | C | 0.314934 | G | 0.37547 | -0.060536 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 499 | C | 0.625634 | Y | 0.520659 | 0.104975 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 611 | C | 0.368106 | R | 0.451891 | -0.083785 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 617 | C | 0.325112 | G | 0.443926 | -0.118814 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 685 | C | 0.490418 | Y | 0.418806 | 0.071612 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 790 | C | 0.33226 | Y | 0.246986 | 0.085274 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 811 | C | 0.792547 | Y | 0.70715 | 0.085397 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 853 | C | 0.193616 | S | 0.312609 | -0.118993 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 926 | C | 0.25409 | Y | 0.206231 | 0.047859 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1090 | P | 0.714765 | S | 0.720654 | -0.005889 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1185 | G | 0.298472 | D | 0.329 | -0.030528 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1284 | C | 0.294635 | Y | 0.252103 | 0.042532 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1350 | C | 0.423759 | F | 0.344212 | 0.079547 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1401 | T | 0.542616 | A | 0.474925 | 0.067691 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1431 | C | 0.369196 | W | 0.216096 | 0.1531 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1431 | C | 0.369196 | Y | 0.297254 | 0.071942 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1481 | S | 0.472963 | G | 0.450636 | 0.022327 | No Change: Both O | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1487 | D | 0.481719 | A | 0.346576 | 0.135143 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1489 | N | 0.51036 | K | 0.486298 | 0.024062 | D to O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1838 | G | 0.603621 | C | 0.591043 | 0.012578 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1934 | C | 0.433161 | S | 0.57527 | -0.142109 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1976 | E | 0.302178 | G | 0.256265 | 0.045913 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1984 | C | 0.464081 | R | 0.54421 | -0.080129 | O to D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2166 | D | 0.389094 | N | 0.38749 | 0.001604 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2185 | I | 0.554658 | T | 0.692066 | -0.137408 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2247 | D | 0.793339 | G | 0.770095 | 0.023244 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2318 | C | 0.634047 | R | 0.693684 | -0.059637 | No Change: Both D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2442 | C | 0.379262 | S | 0.483863 | -0.104601 | No Change: Both O | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2646 | C | 0.565135 | R | 0.580285 | -0.01515 | No Change: Both D | Marfan syndrome (MFS) [MIM:154700] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 2793 | Y | 0.360531 | H | 0.505027 | -0.144496 | O to D | - |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1696 | Y | 0.259544 | C | 0.295118 | -0.035574 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1699 | Y | 0.246338 | C | 0.269974 | -0.023636 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1699 | Y | 0.246338 | C | 0.269974 | -0.023636 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1699 | Y | 0.246338 | D | 0.403361 | -0.157023 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1700 | Y | 0.262956 | C | 0.285301 | -0.022345 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1706 | C | 0.31308 | Y | 0.310217 | 0.002863 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1714 | M | 0.259997 | R | 0.287285 | -0.027288 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1719 | C | 0.184893 | W | 0.108869 | 0.076024 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1722 | S | 0.170032 | C | 0.125192 | 0.04484 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1726 | G | 0.162977 | V | 0.091536 | 0.071441 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1728 | A | 0.195356 | T | 0.230184 | -0.034828 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1728 | A | 0.195356 | T | 0.230184 | -0.034828 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1728 | A | 0.195356 | V | 0.139248 | 0.056108 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1733 | C | 0.289865 | Y | 0.301823 | -0.011958 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1750 | S | 0.21021 | R | 0.185496 | 0.024714 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1758 | D | 0.110384 | V | 0.057966 | 0.052418 | No Change: Both O | Acromicric dysplasia (ACMICD) [MIM:102370] |
| P35555 | FBN1_HUMAN Fibrillin-1 OS=Homo sapiens GN=FBN1 PE=1 SV=3 | 1762 | G | 0.138082 | S | 0.164219 | -0.026137 | No Change: Both O | Geleophysic dysplasia type 2 (GPHYSD2) [MIM:614185] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 965 | V | 0.459554 | I | 0.396995 | 0.062559 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1253 | C | 0.819219 | Y | 0.751499 | 0.06772 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1434 | C | 0.388765 | S | 0.533238 | -0.144473 | O to D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1115 | D | 0.578043 | H | 0.470128 | 0.107915 | D to O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1142 | C | 0.616966 | F | 0.551593 | 0.065373 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1253 | C | 0.819219 | W | 0.666024 | 0.153195 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2771 | S | 0.729304 | P | 0.718857 | 0.010447 | No Change: Both D | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 391 | E | 0.516111 | K | 0.492334 | 0.023777 | D to O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2428 | P | 0.424293 | T | 0.356878 | 0.067415 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 594 | T | 0.301132 | S | 0.351926 | -0.050794 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 681 | R | 0.390207 | H | 0.36662 | 0.023587 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1057 | G | 0.400436 | D | 0.412297 | -0.011861 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1093 | I | 0.356887 | T | 0.504892 | -0.148005 | O to D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1179 | G | 0.6861 | C | 0.676637 | 0.009463 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1198 | C | 0.638635 | Y | 0.546433 | 0.092202 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1240 | C | 0.706206 | R | 0.738808 | -0.032602 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1257 | C | 0.843274 | W | 0.707364 | 0.13591 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1268 | C | 0.842663 | R | 0.852751 | -0.010088 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1772 | W | 0.413287 | G | 0.66132 | -0.248033 | O to D | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2266 | F | 0.33747 | L | 0.358021 | -0.020551 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2581 | L | 0.662152 | S | 0.808004 | -0.145852 | No Change: Both D | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2278 | T | 0.272505 | M | 0.296041 | -0.023536 | No Change: Both O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2311 | M | 0.570762 | V | 0.412707 | 0.158055 | D to O | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2580 | S | 0.667286 | L | 0.511775 | 0.155511 | No Change: Both D | - |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 754 | G | 0.415839 | S | 0.471009 | -0.05517 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1091 | N | 0.328462 | S | 0.370161 | -0.041699 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1122 | S | 0.545841 | P | 0.539084 | 0.006757 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1142 | C | 0.616966 | R | 0.660022 | -0.043056 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1146 | Y | 0.601745 | C | 0.737618 | -0.135873 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1156 | C | 0.618981 | F | 0.54653 | 0.072451 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1161 | E | 0.611181 | K | 0.573647 | 0.037534 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1246 | C | 0.703891 | F | 0.572846 | 0.131045 | No Change: Both D | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1384 | C | 0.254441 | F | 0.227258 | 0.027183 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1384 | C | 0.254441 | Y | 0.237605 | 0.016836 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1408 | D | 0.284701 | N | 0.288501 | -0.0038 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 1425 | C | 0.349542 | R | 0.442311 | -0.092769 | No Change: Both O | Distal arthrogryposis type 9 (DA9) [MIM:121050] |
| P35556 | FBN2_HUMAN Fibrillin-2 OS=Homo sapiens GN=FBN2 PE=1 SV=3 | 2062 | E | 0.546608 | V | 0.357106 | 0.189502 | D to O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 119 | G | 0.829502 | A | 0.787364 | 0.042138 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 473 | R | 0.184043 | Q | 0.200498 | -0.016455 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 662 | D | 0.593324 | N | 0.566443 | 0.026881 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 935 | R | 0.158983 | L | 0.103437 | 0.055546 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 938 | V | 0.116771 | F | 0.102938 | 0.013833 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1083 | R | 0.554003 | W | 0.317993 | 0.23601 | D to O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1293 | S | 0.425793 | N | 0.381794 | 0.043999 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1326 | V | 0.599682 | I | 0.554855 | 0.044827 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1614 | G | 0.407203 | S | 0.461406 | -0.054203 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1806 | R | 0.457339 | Q | 0.43297 | 0.024369 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1869 | N | 0.078707 | K | 0.08671 | -0.008003 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1904 | L | 0.170196 | P | 0.276102 | -0.105906 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1958 | P | 0.43183 | H | 0.334538 | 0.097292 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2610 | E | 0.609501 | D | 0.612375 | -0.002874 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 329 | P | 0.584478 | L | 0.424533 | 0.159945 | D to O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 371 | M | 0.895157 | I | 0.851549 | 0.043608 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 542 | V | 0.237226 | I | 0.183891 | 0.053335 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 868 | D | 0.586476 | N | 0.576435 | 0.010041 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1209 | Q | 0.653183 | R | 0.689263 | -0.03608 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1293 | S | 0.425793 | G | 0.377945 | 0.047848 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1431 | N | 0.24001 | I | 0.141086 | 0.098924 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1850 | E | 0.339484 | K | 0.344525 | -0.005041 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1904 | L | 0.170196 | F | 0.166486 | 0.00371 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1939 | T | 0.300435 | N | 0.323385 | -0.02295 | No Change: Both O | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 1966 | H | 0.52026 | D | 0.629819 | -0.109559 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2005 | N | 0.52375 | T | 0.528742 | -0.004992 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2314 | S | 0.778359 | N | 0.694149 | 0.08421 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2471 | R | 0.526125 | H | 0.520728 | 0.005397 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2540 | H | 0.732872 | Q | 0.782899 | -0.050027 | No Change: Both D | - |
| Q75N90 | FBN3_HUMAN Fibrillin-3 OS=Homo sapiens GN=FBN3 PE=2 SV=3 | 2594 | V | 0.560158 | I | 0.501433 | 0.058725 | No Change: Both D | - |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 164 | G | 0.172627 | S | 0.20525 | -0.032623 | No Change: Both O | Fructose-1 6-bisphosphatase deficiency (FBPD) [MIM:229700] |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 177 | A | 0.06931 | D | 0.100294 | -0.030984 | No Change: Both O | Fructose-1 6-bisphosphatase deficiency (FBPD) [MIM:229700] |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 325 | V | 0.218563 | A | 0.270141 | -0.051578 | No Change: Both O | - |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 218 | R | 0.305268 | K | 0.365379 | -0.060111 | No Change: Both O | - |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 233 | F | 0.578882 | I | 0.593819 | -0.014937 | No Change: Both D | - |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 255 | R | 0.128074 | L | 0.081298 | 0.046776 | No Change: Both O | - |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 194 | F | 0.092235 | S | 0.224268 | -0.132033 | No Change: Both O | Fructose-1 6-bisphosphatase deficiency (FBPD) [MIM:229700] |
| P09467 | F16P1_HUMAN Fructose-1 6-bisphosphatase 1 OS=Homo sapiens GN=FBP1 PE=1 SV=5 | 284 | P | 0.136722 | R | 0.119501 | 0.017221 | No Change: Both O | Fructose-1 6-bisphosphatase deficiency (FBPD) [MIM:229700] |
| O00757 | F16P2_HUMAN Fructose-1 6-bisphosphatase isozyme 2 OS=Homo sapiens GN=FBP2 PE=1 SV=2 | 86 | V | 0.298598 | L | 0.296691 | 0.001907 | No Change: Both O | - |
| Q9HCM7 | FBSL_HUMAN Fibrosin-1-like protein OS=Homo sapiens GN=FBRSL1 PE=1 SV=4 | 367 | L | 0.932543 | P | 0.959283 | -0.02674 | No Change: Both D | - |
| Q9NXK8 | FXL12_HUMAN F-box/LRR-repeat protein 12 OS=Homo sapiens GN=FBXL12 PE=1 SV=1 | 63 | L | 0.13545 | H | 0.210578 | -0.075128 | No Change: Both O | - |
| Q8NEE6 | FXL13_HUMAN F-box/LRR-repeat protein 13 OS=Homo sapiens GN=FBXL13 PE=2 SV=3 | 74 | I | 0.211761 | M | 0.268061 | -0.0563 | No Change: Both O | - |
| Q8NEE6 | FXL13_HUMAN F-box/LRR-repeat protein 13 OS=Homo sapiens GN=FBXL13 PE=2 SV=3 | 313 | G | 0.236766 | A | 0.187539 | 0.049227 | No Change: Both O | - |
| Q8NEE6 | FXL13_HUMAN F-box/LRR-repeat protein 13 OS=Homo sapiens GN=FBXL13 PE=2 SV=3 | 535 | I | 0.202361 | V | 0.222907 | -0.020546 | No Change: Both O | - |
| Q8NEE6 | FXL13_HUMAN F-box/LRR-repeat protein 13 OS=Homo sapiens GN=FBXL13 PE=2 SV=3 | 565 | Y | 0.233563 | C | 0.272037 | -0.038474 | No Change: Both O | - |
| Q8NEE6 | FXL13_HUMAN F-box/LRR-repeat protein 13 OS=Homo sapiens GN=FBXL13 PE=2 SV=3 | 692 | D | 0.509671 | G | 0.484008 | 0.025663 | D to O | - |
| Q8N1E6 | FXL14_HUMAN F-box/LRR-repeat protein 14 OS=Homo sapiens GN=FBXL14 PE=1 SV=1 | 220 | L | 0.427635 | V | 0.369098 | 0.058537 | No Change: Both O | - |
| Q8N461 | FXL16_HUMAN F-box/LRR-repeat protein 16 OS=Homo sapiens GN=FBXL16 PE=1 SV=2 | 429 | L | 0.196804 | P | 0.315605 | -0.118801 | No Change: Both O | - |
| Q96ME1 | FXL18_HUMAN F-box/LRR-repeat protein 18 OS=Homo sapiens GN=FBXL18 PE=2 SV=2 | 552 | N | 0.170622 | K | 0.199772 | -0.02915 | No Change: Both O | - |
| Q9UKC9 | FBXL2_HUMAN F-box/LRR-repeat protein 2 OS=Homo sapiens GN=FBXL2 PE=1 SV=3 | 226 | V | 0.211377 | M | 0.257126 | -0.045749 | No Change: Both O | A colorectal cancer sample |
| Q9UKT6 | FXL21_HUMAN F-box/LRR-repeat protein 21 OS=Homo sapiens GN=FBXL21 PE=1 SV=1 | 76 | F | 0.081905 | L | 0.096652 | -0.014747 | No Change: Both O | - |
| Q9UKT6 | FXL21_HUMAN F-box/LRR-repeat protein 21 OS=Homo sapiens GN=FBXL21 PE=1 SV=1 | 209 | P | 0.583009 | L | 0.439706 | 0.143303 | D to O | - |
| Q6P050 | FXL22_HUMAN F-box/LRR-repeat protein 22 OS=Homo sapiens GN=FBXL22 PE=2 SV=1 | 109 | V | 0.486304 | L | 0.504588 | -0.018284 | O to D | - |
| Q9UK96 | FBX10_HUMAN F-box only protein 10 OS=Homo sapiens GN=FBXO10 PE=2 SV=3 | 212 | H | 0.345787 | N | 0.377951 | -0.032164 | No Change: Both O | - |
| Q86XK2 | FBX11_HUMAN F-box only protein 11 OS=Homo sapiens GN=FBXO11 PE=1 SV=3 | 126 | T | 0.876067 | S | 0.899657 | -0.02359 | No Change: Both D | - |
| Q8NCQ5 | FBX15_HUMAN F-box only protein 15 OS=Homo sapiens GN=FBXO15 PE=2 SV=1 | 420 | Y | 0.029888 | H | 0.054111 | -0.024223 | No Change: Both O | - |
| Q8IX29 | FBX16_HUMAN F-box only protein 16 OS=Homo sapiens GN=FBXO16 PE=1 SV=1 | 75 | R | 0.292929 | Q | 0.326329 | -0.0334 | No Change: Both O | - |
| Q8IX29 | FBX16_HUMAN F-box only protein 16 OS=Homo sapiens GN=FBXO16 PE=1 SV=1 | 254 | M | 0.935218 | I | 0.902284 | 0.032934 | No Change: Both D | - |
| Q8IX29 | FBX16_HUMAN F-box only protein 16 OS=Homo sapiens GN=FBXO16 PE=1 SV=1 | 255 | T | 0.941874 | N | 0.948243 | -0.006369 | No Change: Both D | - |
| Q9UK22 | FBX2_HUMAN F-box only protein 2 OS=Homo sapiens GN=FBXO2 PE=1 SV=2 | 118 | K | 0.372996 | T | 0.294007 | 0.078989 | No Change: Both O | - |
| O94952 | FBX21_HUMAN F-box only protein 21 OS=Homo sapiens GN=FBXO21 PE=2 SV=2 | 180 | N | 0.223767 | T | 0.18168 | 0.042087 | No Change: Both O | - |
| O75426 | FBX24_HUMAN F-box only protein 24 OS=Homo sapiens GN=FBXO24 PE=2 SV=2 | 302 | R | 0.174945 | H | 0.187881 | -0.012936 | No Change: Both O | - |
| Q8TCJ0 | FBX25_HUMAN F-box only protein 25 OS=Homo sapiens GN=FBXO25 PE=1 SV=3 | 36 | N | 0.755692 | D | 0.752233 | 0.003459 | No Change: Both D | - |
| Q8TCJ0 | FBX25_HUMAN F-box only protein 25 OS=Homo sapiens GN=FBXO25 PE=1 SV=3 | 38 | R | 0.746766 | H | 0.712804 | 0.033962 | No Change: Both D | - |
| Q9NVF7 | FBX28_HUMAN F-box only protein 28 OS=Homo sapiens GN=FBXO28 PE=1 SV=1 | 345 | P | 0.979299 | H | 0.973468 | 0.005831 | No Change: Both D | - |
| Q9UK99 | FBX3_HUMAN F-box only protein 3 OS=Homo sapiens GN=FBXO3 PE=1 SV=3 | 221 | V | 0.293478 | I | 0.264218 | 0.02926 | No Change: Both O | - |
| Q8TB52 | FBX30_HUMAN F-box only protein 30 OS=Homo sapiens GN=FBXO30 PE=1 SV=3 | 583 | H | 0.241331 | Q | 0.254908 | -0.013577 | No Change: Both O | - |
| Q8TB52 | FBX30_HUMAN F-box only protein 30 OS=Homo sapiens GN=FBXO30 PE=1 SV=3 | 375 | V | 0.333285 | M | 0.376461 | -0.043176 | No Change: Both O | - |
| Q8TB52 | FBX30_HUMAN F-box only protein 30 OS=Homo sapiens GN=FBXO30 PE=1 SV=3 | 8 | S | 0.665374 | C | 0.563718 | 0.101656 | No Change: Both D | A colorectal cancer sample |
| Q8TB52 | FBX30_HUMAN F-box only protein 30 OS=Homo sapiens GN=FBXO30 PE=1 SV=3 | 382 | S | 0.379963 | C | 0.21626 | 0.163703 | No Change: Both O | - |
| Q969P5 | FBX32_HUMAN F-box only protein 32 OS=Homo sapiens GN=FBXO32 PE=1 SV=1 | 56 | N | 0.361315 | S | 0.401749 | -0.040434 | No Change: Both O | - |
| Q969P5 | FBX32_HUMAN F-box only protein 32 OS=Homo sapiens GN=FBXO32 PE=1 SV=1 | 89 | G | 0.434103 | A | 0.376819 | 0.057284 | No Change: Both O | - |
| Q9NWN3 | FBX34_HUMAN F-box only protein 34 OS=Homo sapiens GN=FBXO34 PE=1 SV=2 | 470 | I | 0.640372 | N | 0.75812 | -0.117748 | No Change: Both D | - |
| Q9NWN3 | FBX34_HUMAN F-box only protein 34 OS=Homo sapiens GN=FBXO34 PE=1 SV=2 | 533 | L | 0.8564 | P | 0.90786 | -0.05146 | No Change: Both D | - |
| Q9NWN3 | FBX34_HUMAN F-box only protein 34 OS=Homo sapiens GN=FBXO34 PE=1 SV=2 | 432 | V | 0.570751 | A | 0.642449 | -0.071698 | No Change: Both D | - |
| Q9NWN3 | FBX34_HUMAN F-box only protein 34 OS=Homo sapiens GN=FBXO34 PE=1 SV=2 | 704 | G | 0.738163 | V | 0.696619 | 0.041544 | No Change: Both D | - |
| Q8NEA4 | FBX36_HUMAN F-box only protein 36 OS=Homo sapiens GN=FBXO36 PE=2 SV=2 | 86 | L | 0.056753 | F | 0.049606 | 0.007147 | No Change: Both O | - |
| Q6PIJ6 | FBX38_HUMAN F-box only protein 38 OS=Homo sapiens GN=FBXO38 PE=1 SV=3 | 592 | S | 0.6997 | P | 0.696399 | 0.003301 | No Change: Both D | - |
| Q6PIJ6 | FBX38_HUMAN F-box only protein 38 OS=Homo sapiens GN=FBXO38 PE=1 SV=3 | 894 | A | 0.912725 | T | 0.927545 | -0.01482 | No Change: Both D | - |
| Q8N4B4 | FBX39_HUMAN F-box only protein 39 OS=Homo sapiens GN=FBXO39 PE=2 SV=1 | 10 | P | 0.430058 | S | 0.47153 | -0.041472 | No Change: Both O | - |
| Q8N4B4 | FBX39_HUMAN F-box only protein 39 OS=Homo sapiens GN=FBXO39 PE=2 SV=1 | 231 | L | 0.161417 | F | 0.134143 | 0.027274 | No Change: Both O | - |
| Q8N4B4 | FBX39_HUMAN F-box only protein 39 OS=Homo sapiens GN=FBXO39 PE=2 SV=1 | 363 | I | 0.049952 | M | 0.070547 | -0.020595 | No Change: Both O | - |
| Q8N4B4 | FBX39_HUMAN F-box only protein 39 OS=Homo sapiens GN=FBXO39 PE=2 SV=1 | 166 | Y | 0.289711 | C | 0.262113 | 0.027598 | No Change: Both O | - |
| Q8N4B4 | FBX39_HUMAN F-box only protein 39 OS=Homo sapiens GN=FBXO39 PE=2 SV=1 | 221 | S | 0.366059 | T | 0.304863 | 0.061196 | No Change: Both O | - |
| Q9UKT5 | FBX4_HUMAN F-box only protein 4 OS=Homo sapiens GN=FBXO4 PE=1 SV=2 | 8 | S | 0.858777 | R | 0.842671 | 0.016106 | No Change: Both D | Esophagus cancer samples |
| Q9UKT5 | FBX4_HUMAN F-box only protein 4 OS=Homo sapiens GN=FBXO4 PE=1 SV=2 | 12 | S | 0.792808 | L | 0.693341 | 0.099467 | No Change: Both D | Esophagus cancer sample |
| Q9UKT5 | FBX4_HUMAN F-box only protein 4 OS=Homo sapiens GN=FBXO4 PE=1 SV=2 | 13 | P | 0.791646 | S | 0.796213 | -0.004567 | No Change: Both D | Esophagus cancer sample |
| Q9UKT5 | FBX4_HUMAN F-box only protein 4 OS=Homo sapiens GN=FBXO4 PE=1 SV=2 | 23 | L | 0.527635 | Q | 0.648391 | -0.120756 | No Change: Both D | Esophagus cancer samples |
| Q9UKT5 | FBX4_HUMAN F-box only protein 4 OS=Homo sapiens GN=FBXO4 PE=1 SV=2 | 76 | P | 0.188521 | T | 0.157879 | 0.030642 | No Change: Both O | Esophagus cancer samples |
| Q9UH90 | FBX40_HUMAN F-box only protein 40 OS=Homo sapiens GN=FBXO40 PE=1 SV=2 | 87 | V | 0.266328 | A | 0.326885 | -0.060557 | No Change: Both O | - |
| Q6P3S6 | FBX42_HUMAN F-box only protein 42 OS=Homo sapiens GN=FBXO42 PE=1 SV=1 | 471 | P | 0.852949 | A | 0.796062 | 0.056887 | No Change: Both D | - |
| Q4G163 | FBX43_HUMAN F-box only protein 43 OS=Homo sapiens GN=FBXO43 PE=1 SV=3 | 139 | P | 0.923732 | L | 0.872793 | 0.050939 | No Change: Both D | - |
| Q4G163 | FBX43_HUMAN F-box only protein 43 OS=Homo sapiens GN=FBXO43 PE=1 SV=3 | 139 | P | 0.923732 | R | 0.913644 | 0.010088 | No Change: Both D | - |
| Q5MNV8 | FBX47_HUMAN F-box only protein 47 OS=Homo sapiens GN=FBXO47 PE=2 SV=2 | 209 | Q | 0.476124 | R | 0.472821 | 0.003303 | No Change: Both O | - |
| Q5FWF7 | FBX48_HUMAN F-box only protein 48 OS=Homo sapiens GN=FBXO48 PE=2 SV=1 | 16 | T | 0.850731 | I | 0.766313 | 0.084418 | No Change: Both D | - |
| Q9UKT4 | FBX5_HUMAN F-box only protein 5 OS=Homo sapiens GN=FBXO5 PE=1 SV=1 | 107 | Q | 0.521017 | E | 0.583827 | -0.06281 | No Change: Both D | - |
| Q9UKT4 | FBX5_HUMAN F-box only protein 5 OS=Homo sapiens GN=FBXO5 PE=1 SV=1 | 164 | L | 0.865045 | F | 0.843446 | 0.021599 | No Change: Both D | - |
| Q9NRD1 | FBX6_HUMAN F-box only protein 6 OS=Homo sapiens GN=FBXO6 PE=1 SV=1 | 201 | P | 0.284667 | T | 0.231409 | 0.053258 | No Change: Both O | - |
| Q9NRD1 | FBX6_HUMAN F-box only protein 6 OS=Homo sapiens GN=FBXO6 PE=1 SV=1 | 60 | R | 0.126648 | Q | 0.128902 | -0.002254 | No Change: Both O | - |
| Q9Y3I1 | FBX7_HUMAN F-box only protein 7 OS=Homo sapiens GN=FBXO7 PE=1 SV=1 | 115 | M | 0.986912 | I | 0.977247 | 0.009665 | No Change: Both D | - |
| Q9Y3I1 | FBX7_HUMAN F-box only protein 7 OS=Homo sapiens GN=FBXO7 PE=1 SV=1 | 378 | R | 0.127565 | G | 0.100171 | 0.027394 | No Change: Both O | Parkinson disease type 15 (PARK15) [MIM:260300] |
| Q9Y3I1 | FBX7_HUMAN F-box only protein 7 OS=Homo sapiens GN=FBXO7 PE=1 SV=1 | 481 | R | 0.974927 | C | 0.960769 | 0.014158 | No Change: Both D | - |
| Q9NRD0 | FBX8_HUMAN F-box only protein 8 OS=Homo sapiens GN=FBXO8 PE=2 SV=1 | 269 | L | 0.069991 | I | 0.05946 | 0.010531 | No Change: Both O | A breast cancer sample |
| Q5XX13 | FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens GN=FBXW10 PE=2 SV=2 | 23 | I | 0.282402 | N | 0.454897 | -0.172495 | No Change: Both O | - |
| Q5XX13 | FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens GN=FBXW10 PE=2 SV=2 | 821 | A | 0.339983 | T | 0.372708 | -0.032725 | No Change: Both O | - |
| Q5XX13 | FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens GN=FBXW10 PE=2 SV=2 | 372 | R | 0.410815 | G | 0.413537 | -0.002722 | No Change: Both O | - |
| Q6X9E4 | FBW12_HUMAN F-box/WD repeat-containing protein 12 OS=Homo sapiens GN=FBXW12 PE=2 SV=2 | 6 | P | 0.410426 | L | 0.272235 | 0.138191 | No Change: Both O | - |
| Q6X9E4 | FBW12_HUMAN F-box/WD repeat-containing protein 12 OS=Homo sapiens GN=FBXW12 PE=2 SV=2 | 166 | R | 0.318162 | W | 0.157377 | 0.160785 | No Change: Both O | - |
| Q6X9E4 | FBW12_HUMAN F-box/WD repeat-containing protein 12 OS=Homo sapiens GN=FBXW12 PE=2 SV=2 | 273 | V | 0.542142 | D | 0.658703 | -0.116561 | No Change: Both D | - |
| Q969U6 | FBXW5_HUMAN F-box/WD repeat-containing protein 5 OS=Homo sapiens GN=FBXW5 PE=1 SV=1 | 340 | E | 0.691213 | K | 0.705926 | -0.014713 | No Change: Both D | - |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 115 | E | 0.999601 | K | 0.999366 | 2.35E-04 | No Change: Both D | - |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 133 | R | 0.979089 | G | 0.975595 | 0.003494 | No Change: Both D | - |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 144 | T | 0.898922 | R | 0.89812 | 8.02E-04 | No Change: Both D | - |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 465 | R | 0.305512 | C | 0.178209 | 0.127303 | No Change: Both O | A acute lymphoblastic leukemia cell line |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 505 | R | 0.116322 | L | 0.063593 | 0.052729 | No Change: Both O | An ovarian cancer cell line |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 668 | S | 0.337943 | G | 0.305137 | 0.032806 | No Change: Both O | - |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 117 | E | 0.999498 | K | 0.999218 | 2.80E-04 | No Change: Both D | A breast cancer sample |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 465 | R | 0.305512 | H | 0.327718 | -0.022206 | No Change: Both O | A colorectal cancer sample |
| Q969H0 | FBXW7_HUMAN F-box/WD repeat-containing protein 7 OS=Homo sapiens GN=FBXW7 PE=1 SV=1 | 582 | S | 0.547053 | L | 0.364977 | 0.182076 | D to O | A colorectal cancer sample |
| Q8N3Y1 | FBXW8_HUMAN F-box/WD repeat-containing protein 8 OS=Homo sapiens GN=FBXW8 PE=1 SV=2 | 211 | T | 0.302107 | A | 0.274973 | 0.027134 | No Change: Both O | - |
| Q8N3Y1 | FBXW8_HUMAN F-box/WD repeat-containing protein 8 OS=Homo sapiens GN=FBXW8 PE=1 SV=2 | 536 | T | 0.219017 | M | 0.18934 | 0.029677 | No Change: Both O | - |
| Q8N3Y1 | FBXW8_HUMAN F-box/WD repeat-containing protein 8 OS=Homo sapiens GN=FBXW8 PE=1 SV=2 | 192 | R | 0.348722 | Q | 0.347919 | 8.03E-04 | No Change: Both O | - |
| Q8N3Y1 | FBXW8_HUMAN F-box/WD repeat-containing protein 8 OS=Homo sapiens GN=FBXW8 PE=1 SV=2 | 563 | V | 0.136152 | M | 0.181039 | -0.044887 | No Change: Both O | - |
| Q5XUX1 | FBXW9_HUMAN F-box/WD repeat-containing protein 9 OS=Homo sapiens GN=FBXW9 PE=1 SV=2 | 70 | R | 0.904823 | K | 0.892635 | 0.012188 | No Change: Both D | - |
| Q5XUX1 | FBXW9_HUMAN F-box/WD repeat-containing protein 9 OS=Homo sapiens GN=FBXW9 PE=1 SV=2 | 219 | T | 0.445685 | A | 0.40072 | 0.044965 | No Change: Both O | - |
| P24071 | FCAR_HUMAN Immunoglobulin alpha Fc receptor OS=Homo sapiens GN=FCAR PE=1 SV=1 | 113 | D | 0.204141 | N | 0.191853 | 0.012288 | No Change: Both O | - |
| P24071 | FCAR_HUMAN Immunoglobulin alpha Fc receptor OS=Homo sapiens GN=FCAR PE=1 SV=1 | 269 | S | 0.464959 | G | 0.392582 | 0.072377 | No Change: Both O | - |
| P12319 | FCERA_HUMAN High affinity immunoglobulin epsilon receptor subunit alpha OS=Homo sapiens GN=FCER1A PE=1 SV=1 | 84 | K | 0.467279 | R | 0.38711 | 0.080169 | No Change: Both O | - |
| P12319 | FCERA_HUMAN High affinity immunoglobulin epsilon receptor subunit alpha OS=Homo sapiens GN=FCER1A PE=1 SV=1 | 101 | S | 0.498672 | N | 0.473151 | 0.025521 | No Change: Both O | - |
| P06734 | FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor OS=Homo sapiens GN=FCER2 PE=1 SV=1 | 62 | R | 0.572117 | W | 0.370023 | 0.202094 | D to O | - |
| P06734 | FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor OS=Homo sapiens GN=FCER2 PE=1 SV=1 | 284 | R | 0.619193 | Q | 0.580506 | 0.038687 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1340 | V | 0.141583 | L | 0.140262 | 0.001321 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1616 | G | 0.507407 | V | 0.385705 | 0.121702 | D to O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1617 | M | 0.524735 | V | 0.483915 | 0.04082 | D to O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 2089 | N | 0.17319 | D | 0.198744 | -0.025554 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 2646 | E | 0.982116 | D | 0.975459 | 0.006657 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 2647 | E | 0.981493 | K | 0.979581 | 0.001912 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 2793 | A | 0.275926 | V | 0.223921 | 0.052005 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 2814 | V | 0.314389 | A | 0.330323 | -0.015934 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 3264 | G | 0.532289 | S | 0.576108 | -0.043819 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 3920 | H | 0.325198 | Q | 0.357915 | -0.032717 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 4015 | V | 0.333148 | A | 0.32482 | 0.008328 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 4095 | G | 0.133022 | D | 0.152054 | -0.019032 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 4465 | G | 0.532289 | S | 0.576108 | -0.043819 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 4906 | D | 0.236951 | H | 0.206159 | 0.030792 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 732 | V | 0.292534 | A | 0.400794 | -0.10826 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 770 | N | 0.888611 | S | 0.91459 | -0.025979 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 929 | G | 0.365613 | R | 0.395828 | -0.030215 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 971 | V | 0.228985 | M | 0.266509 | -0.037524 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1019 | G | 0.539125 | R | 0.533931 | 0.005194 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1436 | P | 0.956672 | L | 0.905746 | 0.050926 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1445 | H | 0.967643 | D | 0.975637 | -0.007994 | No Change: Both D | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 1524 | T | 0.297801 | N | 0.317274 | -0.019473 | No Change: Both O | - |
| Q9Y6R7 | FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 | 5017 | A | 0.631214 | V | 0.542492 | 0.088722 | No Change: Both D | - |
| P12314 | FCGR1_HUMAN High affinity immunoglobulin gamma Fc receptor I OS=Homo sapiens GN=FCGR1A PE=1 SV=2 | 105 | L | 0.09662 | P | 0.175207 | -0.078587 | No Change: Both O | - |
| A6NKC4 | FCGRC_HUMAN Putative high affinity immunoglobulin gamma Fc receptor IC OS=Homo sapiens GN=FCGR1C PE=5 SV=2 | 105 | P | 0.175207 | L | 0.09662 | 0.078587 | No Change: Both O | - |
| A6NKC4 | FCGRC_HUMAN Putative high affinity immunoglobulin gamma Fc receptor IC OS=Homo sapiens GN=FCGR1C PE=5 SV=2 | 115 | T | 0.369046 | M | 0.320959 | 0.048087 | No Change: Both O | - |
| A6NKC4 | FCGRC_HUMAN Putative high affinity immunoglobulin gamma Fc receptor IC OS=Homo sapiens GN=FCGR1C PE=5 SV=2 | 171 | K | 0.772349 | M | 0.663549 | 0.1088 | No Change: Both D | - |
| A6NKC4 | FCGRC_HUMAN Putative high affinity immunoglobulin gamma Fc receptor IC OS=Homo sapiens GN=FCGR1C PE=5 SV=2 | 175 | H | 0.670877 | R | 0.650773 | 0.020104 | No Change: Both D | - |
| P12318 | FCG2A_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=4 | 167 | H | 0.543206 | R | 0.536225 | 0.006981 | No Change: Both D | - |
| P12318 | FCG2A_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=4 | 63 | Q | 0.428052 | R | 0.418633 | 0.009419 | No Change: Both O | - |
| P12318 | FCG2A_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=4 | 140 | M | 0.183194 | V | 0.148624 | 0.03457 | No Change: Both O | - |
| P12318 | FCG2A_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-a OS=Homo sapiens GN=FCGR2A PE=1 SV=4 | 218 | I | 0.194101 | V | 0.220123 | -0.026022 | No Change: Both O | - |
| P31994 | FCG2B_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-b OS=Homo sapiens GN=FCGR2B PE=1 SV=2 | 258 | Y | 0.445299 | D | 0.575973 | -0.130674 | O to D | - |
| P31994 | FCG2B_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-b OS=Homo sapiens GN=FCGR2B PE=1 SV=2 | 232 | I | 0.058625 | T | 0.105199 | -0.046574 | No Change: Both O | - |
| P31994 | FCG2B_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-b OS=Homo sapiens GN=FCGR2B PE=1 SV=2 | 205 | Y | 0.288551 | F | 0.253173 | 0.035378 | No Change: Both O | - |
| P31994 | FCG2B_HUMAN Low affinity immunoglobulin gamma Fc region receptor II-b OS=Homo sapiens GN=FCGR2B PE=1 SV=2 | 83 | Q | 0.376921 | P | 0.409299 | -0.032378 | No Change: Both O | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 176 | F | 0.289033 | V | 0.313408 | -0.024375 | No Change: Both O | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 66 | L | 0.479153 | R | 0.5811 | -0.101947 | O to D | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 66 | L | 0.479153 | H | 0.600096 | -0.120943 | O to D | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 147 | G | 0.570318 | D | 0.581172 | -0.010854 | No Change: Both D | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 158 | Y | 0.305344 | H | 0.438801 | -0.133457 | No Change: Both O | - |
| P08637 | FCG3A_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-A OS=Homo sapiens GN=FCGR3A PE=1 SV=2 | 203 | F | 0.279212 | S | 0.521981 | -0.242769 | O to D | - |
| O75015 | FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens GN=FCGR3B PE=1 SV=2 | 36 | S | 0.180179 | R | 0.132428 | 0.047751 | No Change: Both O | - |
| O75015 | FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens GN=FCGR3B PE=1 SV=2 | 82 | N | 0.344639 | D | 0.379041 | -0.034402 | No Change: Both O | - |
| O75015 | FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens GN=FCGR3B PE=1 SV=2 | 65 | S | 0.466264 | N | 0.412133 | 0.054131 | No Change: Both O | - |
| O75015 | FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens GN=FCGR3B PE=1 SV=2 | 106 | I | 0.054708 | V | 0.06938 | -0.014672 | No Change: Both O | - |
| O75015 | FCG3B_HUMAN Low affinity immunoglobulin gamma Fc region receptor III-B OS=Homo sapiens GN=FCGR3B PE=1 SV=2 | 78 | A | 0.308499 | D | 0.394642 | -0.086143 | No Change: Both O | - |
| Q0JRZ9 | FCHO2_HUMAN FCH domain only protein 2 OS=Homo sapiens GN=FCHO2 PE=1 SV=2 | 371 | M | 0.745386 | V | 0.670752 | 0.074634 | No Change: Both D | - |
| Q86WN1 | FCSD1_HUMAN FCH and double SH3 domains protein 1 OS=Homo sapiens GN=FCHSD1 PE=1 SV=1 | 344 | N | 0.708861 | K | 0.766682 | -0.057821 | No Change: Both D | - |
| Q86WN1 | FCSD1_HUMAN FCH and double SH3 domains protein 1 OS=Homo sapiens GN=FCHSD1 PE=1 SV=1 | 681 | P | 0.998389 | L | 0.996563 | 0.001826 | No Change: Both D | - |
| O00602 | FCN1_HUMAN Ficolin-1 OS=Homo sapiens GN=FCN1 PE=1 SV=2 | 126 | Y | 0.155837 | H | 0.238902 | -0.083065 | No Change: Both O | - |
| O00602 | FCN1_HUMAN Ficolin-1 OS=Homo sapiens GN=FCN1 PE=1 SV=2 | 175 | Y | 0.204558 | C | 0.164264 | 0.040294 | No Change: Both O | A colorectal cancer sample |
| O00602 | FCN1_HUMAN Ficolin-1 OS=Homo sapiens GN=FCN1 PE=1 SV=2 | 93 | R | 0.975393 | Q | 0.974307 | 0.001086 | No Change: Both D | - |
| Q15485 | FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2 | 80 | P | 0.997827 | L | 0.995682 | 0.002145 | No Change: Both D | A colorectal cancer sample |
| Q15485 | FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2 | 113 | H | 0.343708 | Y | 0.251082 | 0.092626 | No Change: Both O | - |
| Q15485 | FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2 | 117 | G | 0.198728 | S | 0.222844 | -0.024116 | No Change: Both O | - |
| Q15485 | FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2 | 236 | T | 0.532794 | M | 0.47903 | 0.053764 | D to O | - |
| Q15485 | FCN2_HUMAN Ficolin-2 OS=Homo sapiens GN=FCN2 PE=1 SV=2 | 258 | A | 0.122445 | S | 0.182204 | -0.059759 | No Change: Both O | - |
| Q96LA6 | FCRL1_HUMAN Fc receptor-like protein 1 OS=Homo sapiens GN=FCRL1 PE=1 SV=1 | 124 | V | 0.523873 | M | 0.593266 | -0.069393 | No Change: Both D | - |
| Q96LA5 | FCRL2_HUMAN Fc receptor-like protein 2 OS=Homo sapiens GN=FCRL2 PE=1 SV=1 | 202 | I | 0.292774 | N | 0.454143 | -0.161369 | No Change: Both O | - |
| Q96P31 | FCRL3_HUMAN Fc receptor-like protein 3 OS=Homo sapiens GN=FCRL3 PE=1 SV=1 | 28 | N | 0.159577 | D | 0.170753 | -0.011176 | No Change: Both O | - |
| Q96P31 | FCRL3_HUMAN Fc receptor-like protein 3 OS=Homo sapiens GN=FCRL3 PE=1 SV=1 | 307 | L | 0.146837 | F | 0.126127 | 0.02071 | No Change: Both O | - |
| Q96P31 | FCRL3_HUMAN Fc receptor-like protein 3 OS=Homo sapiens GN=FCRL3 PE=1 SV=1 | 445 | H | 0.581811 | N | 0.61944 | -0.037629 | No Change: Both D | A breast cancer sample |
| Q96P31 | FCRL3_HUMAN Fc receptor-like protein 3 OS=Homo sapiens GN=FCRL3 PE=1 SV=1 | 660 | P | 0.65548 | L | 0.488131 | 0.167349 | D to O | - |
| Q96P31 | FCRL3_HUMAN Fc receptor-like protein 3 OS=Homo sapiens GN=FCRL3 PE=1 SV=1 | 721 | N | 0.867815 | S | 0.896863 | -0.029048 | No Change: Both D | - |
| Q96PJ5 | FCRL4_HUMAN Fc receptor-like protein 4 OS=Homo sapiens GN=FCRL4 PE=1 SV=1 | 60 | R | 0.154365 | Q | 0.16533 | -0.010965 | No Change: Both O | - |
| Q96PJ5 | FCRL4_HUMAN Fc receptor-like protein 4 OS=Homo sapiens GN=FCRL4 PE=1 SV=1 | 255 | N | 0.251728 | S | 0.311487 | -0.059759 | No Change: Both O | - |
| Q96PJ5 | FCRL4_HUMAN Fc receptor-like protein 4 OS=Homo sapiens GN=FCRL4 PE=1 SV=1 | 457 | K | 0.504227 | R | 0.459755 | 0.044472 | D to O | - |
| Q96PJ5 | FCRL4_HUMAN Fc receptor-like protein 4 OS=Homo sapiens GN=FCRL4 PE=1 SV=1 | 493 | Y | 0.761954 | C | 0.799146 | -0.037192 | No Change: Both D | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 267 | Y | 0.302453 | H | 0.401822 | -0.099369 | No Change: Both O | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 269 | V | 0.401216 | I | 0.387082 | 0.014134 | No Change: Both O | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 418 | G | 0.427504 | D | 0.451287 | -0.023783 | No Change: Both O | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 466 | V | 0.412439 | I | 0.346817 | 0.065622 | No Change: Both O | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 687 | S | 0.146946 | C | 0.053532 | 0.093414 | No Change: Both O | A breast cancer sample |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 427 | N | 0.561098 | K | 0.599444 | -0.038346 | No Change: Both D | - |
| Q96RD9 | FCRL5_HUMAN Fc receptor-like protein 5 OS=Homo sapiens GN=FCRL5 PE=1 SV=3 | 457 | Q | 0.505684 | R | 0.508495 | -0.002811 | No Change: Both D | - |
| Q6DN72 | FCRL6_HUMAN Fc receptor-like protein 6 OS=Homo sapiens GN=FCRL6 PE=1 SV=2 | 427 | S | 0.836736 | G | 0.717065 | 0.119671 | No Change: Both D | - |
| Q7L513 | FCRLA_HUMAN Fc receptor-like A OS=Homo sapiens GN=FCRLA PE=1 SV=2 | 349 | R | 0.697407 | Q | 0.684699 | 0.012708 | No Change: Both D | - |
| P37268 | FDFT_HUMAN Squalene synthase OS=Homo sapiens GN=FDFT1 PE=1 SV=1 | 45 | K | 0.3362 | R | 0.268503 | 0.067697 | No Change: Both O | - |
| P37268 | FDFT_HUMAN Squalene synthase OS=Homo sapiens GN=FDFT1 PE=1 SV=1 | 392 | L | 0.03482 | P | 0.067657 | -0.032837 | No Change: Both O | - |
| P14324 | FPPS_HUMAN Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPS PE=1 SV=4 | 391 | I | 0.216061 | V | 0.228164 | -0.012103 | No Change: Both O | - |
| P14324 | FPPS_HUMAN Farnesyl pyrophosphate synthase OS=Homo sapiens GN=FDPS PE=1 SV=4 | 364 | V | 0.482059 | A | 0.576072 | -0.094013 | O to D | - |
| Q9BRP7 | FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 OS=Homo sapiens GN=FDXACB1 PE=2 SV=3 | 87 | I | 0.049753 | N | 0.101529 | -0.051776 | No Change: Both O | - |
| Q9BRP7 | FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 OS=Homo sapiens GN=FDXACB1 PE=2 SV=3 | 475 | T | 0.305482 | P | 0.341396 | -0.035914 | No Change: Both O | - |
| Q9BRP7 | FDXA1_HUMAN Ferredoxin-fold anticodon-binding domain-containing protein 1 OS=Homo sapiens GN=FDXACB1 PE=2 SV=3 | 28 | T | 0.540888 | A | 0.515912 | 0.024976 | No Change: Both D | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 123 | R | 0.31451 | Q | 0.325147 | -0.010637 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 7 | R | 0.364161 | L | 0.167072 | 0.197089 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 213 | G | 0.215519 | V | 0.140816 | 0.074703 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 248 | P | 0.316558 | L | 0.193394 | 0.123164 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 251 | R | 0.310741 | W | 0.136047 | 0.174694 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 301 | R | 0.822452 | C | 0.712016 | 0.110436 | No Change: Both D | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 345 | T | 0.55872 | M | 0.55202 | 0.0067 | No Change: Both D | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 352 | P | 0.367909 | S | 0.39084 | -0.022931 | No Change: Both O | - |
| P22570 | ADRO_HUMAN NADPH:adrenodoxin oxidoreductase mitochondrial OS=Homo sapiens GN=FDXR PE=1 SV=3 | 472 | T | 0.73125 | A | 0.747383 | -0.016133 | No Change: Both D | - |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 55 | G | 0.797643 | C | 0.707516 | 0.090127 | No Change: Both D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 186 | I | 0.185212 | T | 0.321979 | -0.136767 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 267 | M | 0.376616 | I | 0.28739 | 0.089226 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 386 | H | 0.36174 | P | 0.425648 | -0.063908 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 417 | F | 0.706749 | S | 0.858494 | -0.151745 | No Change: Both D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 96 | R | 0.18523 | Q | 0.185617 | -3.87E-04 | No Change: Both O | - |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 62 | P | 0.799682 | R | 0.775267 | 0.024415 | No Change: Both D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 71 | I | 0.51313 | K | 0.75126 | -0.23813 | No Change: Both D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 139 | Q | 0.399124 | L | 0.272087 | 0.127037 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 151 | S | 0.446978 | P | 0.441589 | 0.005389 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 178 | E | 0.562473 | K | 0.538184 | 0.024289 | No Change: Both D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 182 | L | 0.387096 | R | 0.52928 | -0.142184 | O to D | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 191 | Y | 0.233421 | H | 0.327182 | -0.093761 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 192 | P | 0.291174 | T | 0.26628 | 0.024894 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 236 | C | 0.071862 | Y | 0.089093 | -0.017231 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 260 | F | 0.189054 | L | 0.228594 | -0.03954 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 283 | T | 0.399459 | I | 0.265543 | 0.133916 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 288 | M | 0.267228 | K | 0.379418 | -0.11219 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 334 | P | 0.07822 | L | 0.040846 | 0.037374 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 362 | V | 0.291283 | G | 0.43785 | -0.146567 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 379 | K | 0.335763 | N | 0.321089 | 0.014674 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 406 | C | 0.312488 | S | 0.465647 | -0.153159 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 406 | C | 0.312488 | Y | 0.196336 | 0.116152 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| P22830 | HEMH_HUMAN Ferrochelatase mitochondrial OS=Homo sapiens GN=FECH PE=1 SV=2 | 264 | S | 0.242822 | L | 0.117714 | 0.125108 | No Change: Both O | Erythropoietic protoporphyria (EPP) [MIM:177000] |
| Q9BSK4 | FEM1A_HUMAN Protein fem-1 homolog A OS=Homo sapiens GN=FEM1A PE=1 SV=1 | 500 | H | 0.056151 | Y | 0.03406 | 0.022091 | No Change: Both O | - |
| Q96JP0 | FEM1C_HUMAN Protein fem-1 homolog C OS=Homo sapiens GN=FEM1C PE=2 SV=1 | 434 | D | 0.368468 | N | 0.37015 | -0.001682 | No Change: Both O | A breast cancer sample |
| Q96JP0 | FEM1C_HUMAN Protein fem-1 homolog C OS=Homo sapiens GN=FEM1C PE=2 SV=1 | 462 | D | 0.351276 | N | 0.339571 | 0.011705 | No Change: Both O | A breast cancer sample |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 439 | L | 0.744884 | V | 0.708944 | 0.03594 | No Change: Both D | - |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 128 | V | 0.560549 | F | 0.514271 | 0.046278 | No Change: Both D | - |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 404 | E | 0.831622 | Q | 0.79213 | 0.039492 | No Change: Both D | An ovarian Endometrioid carcinoma sample |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 412 | M | 0.843735 | V | 0.822733 | 0.021002 | No Change: Both D | - |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 443 | A | 0.698083 | P | 0.759534 | -0.061451 | No Change: Both D | - |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 460 | W | 0.357046 | C | 0.458545 | -0.101499 | No Change: Both O | A lung small cell carcinoma sample |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 813 | E | 0.648742 | Q | 0.619102 | 0.02964 | No Change: Both D | - |
| P16591 | FER_HUMAN Tyrosine-protein kinase Fer OS=Homo sapiens GN=FER PE=1 SV=2 | 507 | I | 0.104354 | T | 0.172839 | -0.068485 | No Change: Both O | - |
| A9Z1Z3 | FR1L4_HUMAN Fer-1-like protein 4 OS=Homo sapiens GN=FER1L4 PE=2 SV=1 | 1179 | K | 0.353565 | E | 0.365666 | -0.012101 | No Change: Both O | - |
| A9Z1Z3 | FR1L4_HUMAN Fer-1-like protein 4 OS=Homo sapiens GN=FER1L4 PE=2 SV=1 | 1183 | N | 0.273648 | S | 0.30289 | -0.029242 | No Change: Both O | - |
| A9Z1Z3 | FR1L4_HUMAN Fer-1-like protein 4 OS=Homo sapiens GN=FER1L4 PE=2 SV=1 | 1318 | V | 0.161655 | I | 0.133137 | 0.028518 | No Change: Both O | - |
| A0AVI2 | FR1L5_HUMAN Fer-1-like protein 5 OS=Homo sapiens GN=FER1L5 PE=2 SV=2 | 337 | I | 0.342761 | T | 0.511528 | -0.168767 | O to D | - |
| A0AVI2 | FR1L5_HUMAN Fer-1-like protein 5 OS=Homo sapiens GN=FER1L5 PE=2 SV=2 | 682 | T | 0.181471 | A | 0.174174 | 0.007297 | No Change: Both O | - |
| Q2WGJ9 | FR1L6_HUMAN Fer-1-like protein 6 OS=Homo sapiens GN=FER1L6 PE=2 SV=2 | 1110 | D | 0.688276 | E | 0.694568 | -0.006292 | No Change: Both D | - |
| Q96RJ6 | FER3L_HUMAN Fer3-like protein OS=Homo sapiens GN=FERD3L PE=2 SV=1 | 36 | G | 0.712022 | R | 0.750981 | -0.038959 | No Change: Both D | A colorectal cancer sample |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 526 | R | 0.680496 | K | 0.703036 | -0.02254 | No Change: Both D | - |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 534 | A | 0.485454 | T | 0.458946 | 0.026508 | No Change: Both O | - |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 160 | I | 0.899521 | T | 0.928161 | -0.02864 | No Change: Both D | - |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 241 | V | 0.555704 | A | 0.680737 | -0.125033 | No Change: Both D | - |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 400 | S | 0.139781 | P | 0.16134 | -0.021559 | No Change: Both O | Kindler syndrome (KINDS) [MIM:173650] |
| Q9BQL6 | FERM1_HUMAN Fermitin family homolog 1 OS=Homo sapiens GN=FERMT1 PE=1 SV=1 | 559 | W | 0.108502 | R | 0.258708 | -0.150206 | No Change: Both O | Kindler syndrome (KINDS) [MIM:173650] |
| P07332 | FES_HUMAN Tyrosine-protein kinase Fes/Fps OS=Homo sapiens GN=FES PE=1 SV=3 | 85 | R | 0.816064 | C | 0.721486 | 0.094578 | No Change: Both D | - |
| P07332 | FES_HUMAN Tyrosine-protein kinase Fes/Fps OS=Homo sapiens GN=FES PE=1 SV=3 | 246 | R | 0.294814 | Q | 0.31803 | -0.023216 | No Change: Both O | - |
| P07332 | FES_HUMAN Tyrosine-protein kinase Fes/Fps OS=Homo sapiens GN=FES PE=1 SV=3 | 323 | M | 0.714516 | V | 0.666413 | 0.048103 | No Change: Both D | - |
| Q9UGM5 | FETUB_HUMAN Fetuin-B OS=Homo sapiens GN=FETUB PE=1 SV=2 | 202 | G | 0.315083 | S | 0.448596 | -0.133513 | No Change: Both O | - |
| Q9UGM5 | FETUB_HUMAN Fetuin-B OS=Homo sapiens GN=FETUB PE=1 SV=2 | 33 | S | 0.404796 | P | 0.378882 | 0.025914 | No Change: Both O | - |
| Q9UGM5 | FETUB_HUMAN Fetuin-B OS=Homo sapiens GN=FETUB PE=1 SV=2 | 360 | K | 0.661665 | R | 0.625999 | 0.035666 | No Change: Both D | - |
| Q99689 | FEZ1_HUMAN Fasciculation and elongation protein zeta-1 OS=Homo sapiens GN=FEZ1 PE=1 SV=1 | 123 | D | 0.647056 | E | 0.675675 | -0.028619 | No Change: Both D | - |
| Q9UHY8 | FEZ2_HUMAN Fasciculation and elongation protein zeta-2 OS=Homo sapiens GN=FEZ2 PE=1 SV=2 | 50 | P | 0.91121 | L | 0.840318 | 0.070892 | No Change: Both D | - |
| Q9UHY8 | FEZ2_HUMAN Fasciculation and elongation protein zeta-2 OS=Homo sapiens GN=FEZ2 PE=1 SV=2 | 329 | R | 0.333717 | C | 0.235971 | 0.097746 | No Change: Both O | - |
| Q8TBJ5 | FEZF2_HUMAN Fez family zinc finger protein 2 OS=Homo sapiens GN=FEZF2 PE=2 SV=2 | 164 | P | 0.259803 | T | 0.216951 | 0.042852 | No Change: Both O | - |
| Q8TBJ5 | FEZF2_HUMAN Fez family zinc finger protein 2 OS=Homo sapiens GN=FEZF2 PE=2 SV=2 | 250 | S | 0.767089 | W | 0.543837 | 0.223252 | No Change: Both D | - |
| Q8TBJ5 | FEZF2_HUMAN Fez family zinc finger protein 2 OS=Homo sapiens GN=FEZF2 PE=2 SV=2 | 188 | G | 0.452801 | D | 0.467695 | -0.014894 | No Change: Both O | - |
| O14842 | FFAR1_HUMAN Free fatty acid receptor 1 OS=Homo sapiens GN=FFAR1 PE=2 SV=1 | 211 | R | 0.331683 | H | 0.328347 | 0.003336 | No Change: Both O | - |
| O15552 | FFAR2_HUMAN Free fatty acid receptor 2 OS=Homo sapiens GN=FFAR2 PE=2 SV=1 | 211 | L | 0.246169 | H | 0.350952 | -0.104783 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 44 | Q | 0.188873 | R | 0.189796 | -9.23E-04 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 45 | R | 0.191817 | C | 0.0867 | 0.105117 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 174 | R | 0.13928 | W | 0.055385 | 0.083895 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 227 | L | 0.11463 | V | 0.111053 | 0.003577 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 256 | A | 0.080389 | V | 0.060511 | 0.019878 | No Change: Both O | - |
| O14843 | FFAR3_HUMAN Free fatty acid receptor 3 OS=Homo sapiens GN=FFAR3 PE=1 SV=1 | 346 | S | 0.966028 | N | 0.940671 | 0.025357 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 26 | D | 0.517082 | N | 0.488841 | 0.028241 | D to O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 31 | G | 0.487815 | V | 0.33695 | 0.150865 | No Change: Both O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 35 | R | 0.502558 | C | 0.317791 | 0.184767 | D to O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 35 | R | 0.502558 | H | 0.489087 | 0.013471 | D to O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 37 | P | 0.563723 | L | 0.396826 | 0.166897 | D to O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 38 | R | 0.551588 | N | 0.539265 | 0.012323 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 38 | R | 0.551588 | S | 0.594728 | -0.04314 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 38 | R | 0.551588 | G | 0.561802 | -0.010214 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 66 | S | 0.302874 | T | 0.224907 | 0.077967 | No Change: Both O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 160 | R | 0.383327 | S | 0.40185 | -0.018523 | No Change: Both O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 453 | S | 0.97153 | N | 0.955927 | 0.015603 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 573 | R | 0.972576 | C | 0.960437 | 0.012139 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 39 | V | 0.529712 | D | 0.649949 | -0.120237 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 545 | E | 0.891409 | V | 0.811717 | 0.079692 | No Change: Both D | Amyloidosis type 8 (AMYL8) [MIM:105200] |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 573 | R | 0.972576 | L | 0.950866 | 0.02171 | No Change: Both D | Amyloidosis type 8 (AMYL8) [MIM:105200] |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 6 | I | 0.110646 | V | 0.144466 | -0.03382 | No Change: Both O | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 331 | T | 0.998638 | A | 0.998115 | 5.23E-04 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 456 | T | 0.970505 | A | 0.949558 | 0.020947 | No Change: Both D | - |
| P02671 | FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 | 446 | K | 0.96549 | E | 0.965046 | 4.44E-04 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 44 | R | 0.566004 | C | 0.407988 | 0.158016 | D to O | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 45 | G | 0.6115 | R | 0.635107 | -0.023607 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 74 | R | 0.904575 | C | 0.871531 | 0.033044 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 98 | A | 0.609671 | T | 0.614128 | -0.004457 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 365 | A | 0.373322 | T | 0.411981 | -0.038659 | No Change: Both O | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 478 | R | 0.449424 | K | 0.529473 | -0.080049 | O to D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 100 | P | 0.585203 | S | 0.538506 | 0.046697 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 170 | N | 0.615645 | H | 0.572292 | 0.043353 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 265 | P | 0.340065 | L | 0.194914 | 0.145151 | No Change: Both O | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 2 | K | 0.765229 | E | 0.806735 | -0.041506 | No Change: Both D | - |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 196 | R | 0.344849 | C | 0.226043 | 0.118806 | No Change: Both O | Congenital afibrinogenemia (CAFBN) [MIM:202400] |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 383 | L | 0.428276 | R | 0.544366 | -0.11609 | O to D | Congenital afibrinogenemia (CAFBN) [MIM:202400] |
| P02675 | FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 | 430 | G | 0.31032 | D | 0.331479 | -0.021159 | No Change: Both O | Congenital afibrinogenemia (CAFBN) [MIM:202400] |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 522 | R | 0.237855 | H | 0.224128 | 0.013727 | No Change: Both O | Aarskog-Scott syndrome (AAS) [MIM:305400] |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 610 | R | 0.173745 | Q | 0.194684 | -0.020939 | No Change: Both O | Aarskog-Scott syndrome (AAS) [MIM:305400] |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 205 | S | 0.956985 | I | 0.920445 | 0.03654 | No Change: Both D | Aarskog-Scott syndrome (AAS) [MIM:305400] |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 312 | P | 0.951241 | L | 0.907484 | 0.043757 | No Change: Both D | - |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 380 | E | 0.243193 | A | 0.168416 | 0.074777 | No Change: Both O | Aarskog-Scott syndrome (AAS) [MIM:305400] |
| P98174 | FGD1_HUMAN FYVE RhoGEF and PH domain-containing protein 1 OS=Homo sapiens GN=FGD1 PE=1 SV=2 | 443 | R | 0.527432 | H | 0.516738 | 0.010694 | No Change: Both D | Aarskog-Scott syndrome (AAS) [MIM:305400] |
| Q7Z6J4 | FGD2_HUMAN FYVE RhoGEF and PH domain-containing protein 2 OS=Homo sapiens GN=FGD2 PE=2 SV=1 | 32 | Q | 0.886739 | H | 0.891516 | -0.004777 | No Change: Both D | - |
| Q5JSP0 | FGD3_HUMAN FYVE RhoGEF and PH domain-containing protein 3 OS=Homo sapiens GN=FGD3 PE=1 SV=1 | 275 | V | 0.264195 | I | 0.235818 | 0.028377 | No Change: Both O | - |
| Q96M96 | FGD4_HUMAN FYVE RhoGEF and PH domain-containing protein 4 OS=Homo sapiens GN=FGD4 PE=1 SV=2 | 298 | M | 0.155861 | R | 0.188034 | -0.032173 | No Change: Both O | - |
| Q96M96 | FGD4_HUMAN FYVE RhoGEF and PH domain-containing protein 4 OS=Homo sapiens GN=FGD4 PE=1 SV=2 | 298 | M | 0.155861 | T | 0.175369 | -0.019508 | No Change: Both O | Charcot-Marie-Tooth disease type 4H (CMT4H) [MIM:609311] |
| Q6ZNL6 | FGD5_HUMAN FYVE RhoGEF and PH domain-containing protein 5 OS=Homo sapiens GN=FGD5 PE=1 SV=3 | 403 | G | 0.655481 | R | 0.627526 | 0.027955 | No Change: Both D | - |
| Q6ZNL6 | FGD5_HUMAN FYVE RhoGEF and PH domain-containing protein 5 OS=Homo sapiens GN=FGD5 PE=1 SV=3 | 828 | A | 0.760264 | T | 0.768449 | -0.008185 | No Change: Both D | - |
| Q6ZNL6 | FGD5_HUMAN FYVE RhoGEF and PH domain-containing protein 5 OS=Homo sapiens GN=FGD5 PE=1 SV=3 | 941 | E | 0.672425 | K | 0.617525 | 0.0549 | No Change: Both D | - |
| Q6ZV73 | FGD6_HUMAN FYVE RhoGEF and PH domain-containing protein 6 OS=Homo sapiens GN=FGD6 PE=1 SV=2 | 257 | Q | 0.953633 | R | 0.947624 | 0.006009 | No Change: Both D | - |
| Q6ZV73 | FGD6_HUMAN FYVE RhoGEF and PH domain-containing protein 6 OS=Homo sapiens GN=FGD6 PE=1 SV=2 | 1393 | E | 0.630975 | K | 0.636405 | -0.00543 | No Change: Both D | - |
| P05230 | FGF1_HUMAN Heparin-binding growth factor 1 OS=Homo sapiens GN=FGF1 PE=1 SV=1 | 21 | G | 0.531298 | E | 0.584031 | -0.052733 | No Change: Both D | - |
| O15520 | FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens GN=FGF10 PE=1 SV=1 | 106 | C | 0.389239 | F | 0.402846 | -0.013607 | No Change: Both O | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
| O15520 | FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens GN=FGF10 PE=1 SV=1 | 156 | I | 0.490233 | R | 0.635297 | -0.145064 | O to D | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
| Q92914 | FGF11_HUMAN Fibroblast growth factor 11 OS=Homo sapiens GN=FGF11 PE=2 SV=1 | 163 | R | 0.346349 | G | 0.352581 | -0.006232 | No Change: Both O | - |
| Q92913 | FGF13_HUMAN Fibroblast growth factor 13 OS=Homo sapiens GN=FGF13 PE=1 SV=1 | 197 | K | 0.573033 | Q | 0.474603 | 0.09843 | D to O | - |
| Q92915 | FGF14_HUMAN Fibroblast growth factor 14 OS=Homo sapiens GN=FGF14 PE=1 SV=1 | 42 | G | 0.684832 | C | 0.651507 | 0.033325 | No Change: Both D | - |
| Q92915 | FGF14_HUMAN Fibroblast growth factor 14 OS=Homo sapiens GN=FGF14 PE=1 SV=1 | 145 | F | 0.374629 | S | 0.616428 | -0.241799 | O to D | Spinocerebellar ataxia type 27 (SCA27) [MIM:609307] |
| Q9NP95 | FGF20_HUMAN Fibroblast growth factor 20 OS=Homo sapiens GN=FGF20 PE=1 SV=1 | 116 | G | 0.25203 | R | 0.235841 | 0.016189 | No Change: Both O | - |
| Q9NP95 | FGF20_HUMAN Fibroblast growth factor 20 OS=Homo sapiens GN=FGF20 PE=1 SV=1 | 175 | P | 0.653861 | A | 0.615236 | 0.038625 | No Change: Both D | - |
| Q9NP95 | FGF20_HUMAN Fibroblast growth factor 20 OS=Homo sapiens GN=FGF20 PE=1 SV=1 | 206 | D | 0.520978 | N | 0.456423 | 0.064555 | D to O | - |
| Q9NSA1 | FGF21_HUMAN Fibroblast growth factor 21 OS=Homo sapiens GN=FGF21 PE=1 SV=1 | 174 | L | 0.985932 | P | 0.992945 | -0.007013 | No Change: Both D | - |
| Q9NSA1 | FGF21_HUMAN Fibroblast growth factor 21 OS=Homo sapiens GN=FGF21 PE=1 SV=1 | 141 | G | 0.573996 | S | 0.625663 | -0.051667 | No Change: Both D | - |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 176 | R | 0.856241 | Q | 0.832462 | 0.023779 | No Change: Both D | Autosomal dominant hypophosphataemic rickets (ADHR) [MIM:193100] |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 179 | R | 0.88534 | W | 0.745315 | 0.140025 | No Change: Both D | Autosomal dominant hypophosphataemic rickets (ADHR) [MIM:193100] |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 179 | R | 0.88534 | Q | 0.864342 | 0.020998 | No Change: Both D | Autosomal dominant hypophosphataemic rickets (ADHR) [MIM:193100] |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 239 | T | 0.62226 | M | 0.597042 | 0.025218 | No Change: Both D | - |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 195 | P | 0.942188 | S | 0.937103 | 0.005085 | No Change: Both D | - |
| Q9GZV9 | FGF23_HUMAN Fibroblast growth factor 23 OS=Homo sapiens GN=FGF23 PE=1 SV=1 | 71 | S | 0.213219 | G | 0.169276 | 0.043943 | No Change: Both O | Hyperphosphatemic familial tumoral calcinosis (HFTC) [MIM:211900] |
| P11487 | FGF3_HUMAN Fibroblast growth factor 3 OS=Homo sapiens GN=FGF3 PE=1 SV=1 | 156 | S | 0.571311 | P | 0.574536 | -0.003225 | No Change: Both D | Deafness with labyrinthine aplasia microtia and microdontia (LAMM) [MIM:610706] |
| P11487 | FGF3_HUMAN Fibroblast growth factor 3 OS=Homo sapiens GN=FGF3 PE=1 SV=1 | 6 | L | 0.107953 | P | 0.22393 | -0.115977 | No Change: Both O | Deafness with labyrinthine aplasia microtia and microdontia (LAMM) [MIM:610706] |
| P12034 | FGF5_HUMAN Fibroblast growth factor 5 OS=Homo sapiens GN=FGF5 PE=1 SV=4 | 54 | M | 0.999349 | V | 0.999025 | 3.24E-04 | No Change: Both D | - |
| P10767 | FGF6_HUMAN Fibroblast growth factor 6 OS=Homo sapiens GN=FGF6 PE=1 SV=4 | 36 | V | 0.22005 | A | 0.278825 | -0.058775 | No Change: Both O | - |
| P10767 | FGF6_HUMAN Fibroblast growth factor 6 OS=Homo sapiens GN=FGF6 PE=1 SV=4 | 63 | A | 0.39544 | V | 0.300654 | 0.094786 | No Change: Both O | - |
| P10767 | FGF6_HUMAN Fibroblast growth factor 6 OS=Homo sapiens GN=FGF6 PE=1 SV=4 | 174 | D | 0.315882 | V | 0.186365 | 0.129517 | No Change: Both O | - |
| P10767 | FGF6_HUMAN Fibroblast growth factor 6 OS=Homo sapiens GN=FGF6 PE=1 SV=4 | 191 | R | 0.640858 | W | 0.403803 | 0.237055 | D to O | - |
| P21781 | FGF7_HUMAN Keratinocyte growth factor OS=Homo sapiens GN=FGF7 PE=1 SV=1 | 59 | M | 0.4698 | T | 0.513488 | -0.043688 | O to D | - |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 14 | H | 0.466157 | N | 0.503763 | -0.037606 | O to D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 26 | P | 0.73526 | L | 0.633024 | 0.102236 | No Change: Both D | Kallmann syndrome type 6 (KAL6) [MIM:612702] |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 40 | F | 0.657643 | L | 0.745702 | -0.088059 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 89 | K | 0.293467 | E | 0.297399 | -0.003932 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 116 | R | 0.324969 | G | 0.33411 | -0.009141 | No Change: Both O | Kallmann syndrome type 6 (KAL6) [MIM:612702] |
| P55075 | FGF8_HUMAN Fibroblast growth factor 8 OS=Homo sapiens GN=FGF8 PE=1 SV=1 | 218 | T | 0.741547 | M | 0.712416 | 0.029131 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P31371 | FGF9_HUMAN Glia-activating factor OS=Homo sapiens GN=FGF9 PE=1 SV=3 | 94 | I | 0.149354 | V | 0.158886 | -0.009532 | No Change: Both O | - |
| P31371 | FGF9_HUMAN Glia-activating factor OS=Homo sapiens GN=FGF9 PE=1 SV=3 | 99 | S | 0.050599 | N | 0.038841 | 0.011758 | No Change: Both O | Multiple synostoses syndrome type 3 (SYNS3) [MIM:612961] |
| Q9BYJ0 | FGFP2_HUMAN Fibroblast growth factor-binding protein 2 OS=Homo sapiens GN=FGFBP2 PE=1 SV=1 | 90 | P | 0.327862 | S | 0.320476 | 0.007386 | No Change: Both O | - |
| Q9BYJ0 | FGFP2_HUMAN Fibroblast growth factor-binding protein 2 OS=Homo sapiens GN=FGFBP2 PE=1 SV=1 | 84 | F | 0.29486 | L | 0.332648 | -0.037788 | No Change: Both O | - |
| Q9BYJ0 | FGFP2_HUMAN Fibroblast growth factor-binding protein 2 OS=Homo sapiens GN=FGFBP2 PE=1 SV=1 | 28 | S | 0.733861 | N | 0.692011 | 0.04185 | No Change: Both D | - |
| Q8TAT2 | FGFP3_HUMAN Fibroblast growth factor-binding protein 3 OS=Homo sapiens GN=FGFBP3 PE=1 SV=1 | 206 | E | 0.987725 | V | 0.977274 | 0.010451 | No Change: Both D | - |
| Q8TAT2 | FGFP3_HUMAN Fibroblast growth factor-binding protein 3 OS=Homo sapiens GN=FGFBP3 PE=1 SV=1 | 107 | A | 0.529015 | T | 0.467039 | 0.061976 | D to O | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 252 | P | 0.388322 | R | 0.358218 | 0.030104 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 97 | G | 0.59627 | D | 0.645786 | -0.049516 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 99 | Y | 0.645849 | C | 0.710985 | -0.065136 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 167 | A | 0.794559 | S | 0.843851 | -0.049292 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 277 | C | 0.184324 | Y | 0.232734 | -0.04841 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 607 | V | 0.210294 | M | 0.279915 | -0.069621 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 666 | W | 0.1769 | R | 0.388296 | -0.211396 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 719 | M | 0.601454 | R | 0.654205 | -0.052751 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 772 | P | 0.702602 | S | 0.716119 | -0.013517 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 22 | R | 0.437627 | S | 0.51827 | -0.080643 | O to D | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 818 | G | 0.924396 | R | 0.944361 | -0.019965 | No Change: Both D | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 822 | R | 0.929071 | C | 0.901697 | 0.027374 | No Change: Both D | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 48 | G | 0.270877 | S | 0.338456 | -0.067579 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 77 | N | 0.503861 | K | 0.518784 | -0.014923 | No Change: Both D | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 78 | R | 0.512717 | C | 0.367771 | 0.144946 | D to O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 101 | C | 0.701073 | F | 0.680481 | 0.020592 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 102 | V | 0.742705 | I | 0.698083 | 0.044622 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 129 | D | 0.989163 | A | 0.983988 | 0.005175 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 178 | C | 0.645986 | S | 0.76898 | -0.122994 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 213 | W | 0.072801 | G | 0.187569 | -0.114768 | No Change: Both O | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 224 | D | 0.419059 | H | 0.366461 | 0.052598 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 237 | G | 0.313099 | D | 0.34297 | -0.029871 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 237 | G | 0.313099 | S | 0.382725 | -0.069626 | No Change: Both O | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 245 | L | 0.303597 | P | 0.475459 | -0.171862 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 250 | R | 0.442911 | W | 0.225952 | 0.216959 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 254 | R | 0.389225 | Q | 0.407831 | -0.018606 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 270 | G | 0.219512 | D | 0.241887 | -0.022375 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 273 | V | 0.164794 | M | 0.207255 | -0.042461 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 274 | E | 0.144417 | G | 0.126458 | 0.017959 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 283 | P | 0.307481 | R | 0.259842 | 0.047639 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 300 | I | 0.476977 | T | 0.585965 | -0.108988 | O to D | Trigonocephaly non-syndromic (TRICEPH) [MIM:190440] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 330 | N | 0.256509 | I | 0.126764 | 0.129745 | No Change: Both O | Osteoglophonic dysplasia (OGD) [MIM:166250] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 332 | S | 0.311201 | C | 0.131412 | 0.179789 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 339 | Y | 0.231286 | C | 0.209662 | 0.021624 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 343 | A | 0.230074 | V | 0.171739 | 0.058335 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 346 | S | 0.364494 | C | 0.16719 | 0.197304 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 366 | P | 0.447766 | L | 0.282585 | 0.165181 | No Change: Both O | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 374 | Y | 0.062475 | C | 0.049631 | 0.012844 | No Change: Both O | Osteoglophonic dysplasia (OGD) [MIM:166250] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 381 | C | 0.014731 | R | 0.030908 | -0.016177 | No Change: Both O | Osteoglophonic dysplasia (OGD) [MIM:166250] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 520 | A | 0.678748 | T | 0.70831 | -0.029562 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 538 | I | 0.490428 | V | 0.496618 | -0.00619 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 621 | H | 0.229255 | R | 0.247541 | -0.018286 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 622 | R | 0.207851 | G | 0.204853 | 0.002998 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 622 | R | 0.207851 | Q | 0.210303 | -0.002452 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 685 | S | 0.066953 | F | 0.02384 | 0.043113 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 687 | G | 0.040366 | R | 0.038152 | 0.002214 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 693 | I | 0.047731 | F | 0.053422 | -0.005691 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 703 | G | 0.418436 | R | 0.380936 | 0.0375 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 703 | G | 0.418436 | S | 0.470998 | -0.052562 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 722 | P | 0.589502 | H | 0.584474 | 0.005028 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 722 | P | 0.589502 | S | 0.618135 | -0.028633 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 724 | N | 0.508743 | K | 0.546127 | -0.037384 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 745 | P | 0.341475 | S | 0.358292 | -0.016817 | No Change: Both O | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 769 | L | 0.611718 | V | 0.588254 | 0.023464 | No Change: Both D | - |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 795 | V | 0.938777 | I | 0.934394 | 0.004383 | No Change: Both D | Kallmann syndrome type 2 (KAL2) [MIM:147950] |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 125 | S | 0.980106 | L | 0.958524 | 0.021582 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 252 | P | 0.388322 | T | 0.32262 | 0.065702 | No Change: Both O | A lung bronchoalveolar carcinoma sample |
| P11362 | FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens GN=FGFR1 PE=1 SV=3 | 664 | V | 0.239871 | L | 0.253259 | -0.013388 | No Change: Both O | A lung large cell carcinoma sample |
| O95684 | FR1OP_HUMAN FGFR1 oncogene partner OS=Homo sapiens GN=FGFR1OP PE=1 SV=1 | 271 | K | 0.940752 | N | 0.91162 | 0.029132 | No Change: Both D | - |
| O95684 | FR1OP_HUMAN FGFR1 oncogene partner OS=Homo sapiens GN=FGFR1OP PE=1 SV=1 | 190 | A | 0.987192 | G | 0.989083 | -0.001891 | No Change: Both D | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 105 | Y | 0.301863 | C | 0.272589 | 0.029274 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 252 | S | 0.446299 | L | 0.273276 | 0.173023 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 252 | S | 0.446299 | F | 0.230687 | 0.215612 | No Change: Both O | Apert syndrome (APRS) [MIM:101200] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 252 | S | 0.446299 | W | 0.191514 | 0.254785 | No Change: Both O | Apert syndrome (APRS) [MIM:101200] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 252 | S | 0.446299 | W | 0.191514 | 0.254785 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 253 | P | 0.409322 | R | 0.379858 | 0.029464 | No Change: Both O | Apert syndrome (APRS) [MIM:101200] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 267 | S | 0.349348 | P | 0.335967 | 0.013381 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 276 | F | 0.122049 | V | 0.157384 | -0.035335 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 278 | C | 0.130151 | F | 0.145404 | -0.015253 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 278 | C | 0.130151 | F | 0.145404 | -0.015253 | No Change: Both O | Jackson-Weiss syndrome (JWS) [MIM:123150] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 278 | C | 0.130151 | F | 0.145404 | -0.015253 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 289 | Q | 0.202861 | P | 0.217914 | -0.015053 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 289 | Q | 0.202861 | P | 0.217914 | -0.015053 | No Change: Both O | Jackson-Weiss syndrome (JWS) [MIM:123150] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 290 | W | 0.237921 | C | 0.27235 | -0.034429 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 290 | W | 0.237921 | R | 0.433785 | -0.195864 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 292 | K | 0.297046 | E | 0.295809 | 0.001237 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 301 | Y | 0.676763 | C | 0.61148 | 0.065283 | No Change: Both D | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 314 | A | 0.247309 | S | 0.341444 | -0.094135 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 321 | D | 0.358372 | A | 0.293347 | 0.065025 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 328 | Y | 0.08024 | C | 0.063717 | 0.016523 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 331 | N | 0.089895 | I | 0.043099 | 0.046796 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 338 | G | 0.243987 | E | 0.304033 | -0.060046 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 340 | Y | 0.214044 | H | 0.319406 | -0.105362 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 341 | T | 0.187252 | P | 0.221299 | -0.034047 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 341 | T | 0.187252 | P | 0.221299 | -0.034047 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | F | 0.188279 | -0.012088 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | R | 0.311317 | -0.135126 | No Change: Both O | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | R | 0.311317 | -0.135126 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | R | 0.311317 | -0.135126 | No Change: Both O | Jackson-Weiss syndrome (JWS) [MIM:123150] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | R | 0.311317 | -0.135126 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | S | 0.396972 | -0.220781 | No Change: Both O | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | S | 0.396972 | -0.220781 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | S | 0.396972 | -0.220781 | No Change: Both O | Jackson-Weiss syndrome (JWS) [MIM:123150] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | S | 0.396972 | -0.220781 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | Y | 0.226206 | -0.050015 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | Y | 0.226206 | -0.050015 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 344 | A | 0.171728 | G | 0.225021 | -0.053293 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 344 | A | 0.171728 | G | 0.225021 | -0.053293 | No Change: Both O | Jackson-Weiss syndrome (JWS) [MIM:123150] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 344 | A | 0.171728 | P | 0.222757 | -0.051029 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 344 | A | 0.171728 | P | 0.222757 | -0.051029 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 347 | S | 0.21459 | C | 0.080152 | 0.134438 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 351 | S | 0.147858 | C | 0.047796 | 0.100062 | No Change: Both O | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (ABS2) [MIM:207410] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 351 | S | 0.147858 | C | 0.047796 | 0.100062 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 351 | S | 0.147858 | C | 0.047796 | 0.100062 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 354 | S | 0.094454 | C | 0.02928 | 0.065174 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 359 | V | 0.174732 | F | 0.159217 | 0.015515 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 359 | V | 0.174732 | F | 0.159217 | 0.015515 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 384 | G | 0.00652 | R | 0.006672 | -1.52E-04 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 338 | G | 0.243987 | R | 0.22916 | 0.014827 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 613 | G | 0.225607 | R | 0.231027 | -0.00542 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 6 | R | 0.071357 | P | 0.086592 | -0.015235 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 172 | A | 0.495796 | F | 0.404229 | 0.091567 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 186 | M | 0.43913 | T | 0.467465 | -0.028335 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 263 | P | 0.328767 | L | 0.19512 | 0.133647 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 278 | C | 0.130151 | Y | 0.167036 | -0.036885 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 281 | Y | 0.167367 | C | 0.152453 | 0.014914 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 288 | I | 0.222945 | S | 0.426738 | -0.203793 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 290 | W | 0.237921 | G | 0.451707 | -0.213786 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 315 | A | 0.269577 | S | 0.367353 | -0.097776 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 337 | A | 0.237717 | P | 0.301145 | -0.063428 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 340 | Y | 0.214044 | C | 0.184562 | 0.029482 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | G | 0.352046 | -0.175855 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 342 | C | 0.176191 | W | 0.15174 | 0.024451 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 354 | S | 0.094454 | Y | 0.037107 | 0.057347 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 362 | A | 0.310023 | S | 0.419047 | -0.109024 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 372 | S | 0.394263 | C | 0.179374 | 0.214889 | No Change: Both O | Beare-Stevenson cutis gyrata syndrome (BSCGS) [MIM:123790] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 375 | Y | 0.165676 | C | 0.132568 | 0.033108 | No Change: Both O | Beare-Stevenson cutis gyrata syndrome (BSCGS) [MIM:123790] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 375 | Y | 0.165676 | C | 0.132568 | 0.033108 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 549 | N | 0.152492 | H | 0.137214 | 0.015278 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 565 | E | 0.147615 | G | 0.126056 | 0.021559 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 641 | K | 0.166063 | R | 0.13143 | 0.034633 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 659 | K | 0.415517 | N | 0.375592 | 0.039925 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 663 | G | 0.333296 | E | 0.390582 | -0.057286 | No Change: Both O | Pfeiffer syndrome (PS) [MIM:101600] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 678 | R | 0.183327 | G | 0.19378 | -0.010453 | No Change: Both O | Crouzon syndrome (CS) [MIM:123500] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 526 | K | 0.726573 | E | 0.723965 | 0.002608 | No Change: Both D | Familial scaphocephaly syndrome (FSPC) [MIM:609579] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 628 | A | 0.161115 | T | 0.178233 | -0.017118 | No Change: Both O | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 648 | A | 0.138641 | T | 0.14737 | -0.008729 | No Change: Both O | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 203 | R | 0.422666 | C | 0.262991 | 0.159675 | No Change: Both O | Breast cancer samples |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 57 | S | 0.309778 | L | 0.186119 | 0.123659 | No Change: Both O | - |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 272 | G | 0.196262 | V | 0.120039 | 0.076223 | No Change: Both O | An ovarian serous carcinoma sample |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 283 | D | 0.171267 | N | 0.161055 | 0.010212 | No Change: Both O | A lung squamous cell carcinoma sample |
| P21802 | FGFR2_HUMAN Fibroblast growth factor receptor 2 OS=Homo sapiens GN=FGFR2 PE=1 SV=1 | 612 | R | 0.200397 | T | 0.198562 | 0.001835 | No Change: Both O | A lung adenocarcinoma sample |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 248 | R | 0.421531 | C | 0.240464 | 0.181067 | No Change: Both O | Bladder cancer (BLC) [MIM:109800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 248 | R | 0.421531 | C | 0.240464 | 0.181067 | No Change: Both O | Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 248 | R | 0.421531 | C | 0.240464 | 0.181067 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 248 | R | 0.421531 | C | 0.240464 | 0.181067 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 249 | S | 0.400874 | C | 0.191028 | 0.209846 | No Change: Both O | Bladder cancer (BLC) [MIM:109800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 249 | S | 0.400874 | C | 0.191028 | 0.209846 | No Change: Both O | Cervical cancer (CERCA) [MIM:603956] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 249 | S | 0.400874 | C | 0.191028 | 0.209846 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 249 | S | 0.400874 | C | 0.191028 | 0.209846 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 250 | P | 0.374942 | R | 0.345645 | 0.029297 | No Change: Both O | Muenke syndrome (MNKS) [MIM:602849] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 370 | G | 0.381491 | C | 0.199607 | 0.181884 | No Change: Both O | Bladder cancer (BLC) [MIM:109800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 370 | G | 0.381491 | C | 0.199607 | 0.181884 | No Change: Both O | Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 370 | G | 0.381491 | C | 0.199607 | 0.181884 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 370 | G | 0.381491 | C | 0.199607 | 0.181884 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 371 | S | 0.297356 | C | 0.116208 | 0.181148 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 371 | S | 0.297356 | C | 0.116208 | 0.181148 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 373 | Y | 0.233499 | C | 0.183347 | 0.050152 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 373 | Y | 0.233499 | C | 0.183347 | 0.050152 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 375 | G | 0.15565 | C | 0.063197 | 0.092453 | No Change: Both O | Achondroplasia (ACH) [MIM:100800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 380 | G | 0.03959 | R | 0.033917 | 0.005673 | No Change: Both O | Achondroplasia (ACH) [MIM:100800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 380 | G | 0.03959 | R | 0.033917 | 0.005673 | No Change: Both O | Keratinocytic non-epidermolytic nevus (KNEN) [MIM:162900] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 391 | A | 0.02231 | E | 0.03348 | -0.01117 | No Change: Both O | Crouzon syndrome with acanthosis nigricans (CAN) [MIM:612247] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 538 | I | 0.228521 | V | 0.237279 | -0.008758 | No Change: Both O | Hypochondroplasia (HCH) [MIM:146000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 540 | N | 0.151142 | K | 0.184967 | -0.033825 | No Change: Both O | Hypochondroplasia (HCH) [MIM:146000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 540 | N | 0.151142 | T | 0.130305 | 0.020837 | No Change: Both O | Hypochondroplasia (HCH) [MIM:146000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | E | 0.460882 | 0.0184 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | E | 0.460882 | 0.0184 | No Change: Both O | Testicular tumors (TEST) [MIM:273300] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | E | 0.460882 | 0.0184 | No Change: Both O | Thanatophoric dysplasia type 2 (TD2) [MIM:187601] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | M | 0.320204 | 0.159078 | No Change: Both O | Achondroplasia (ACH) [MIM:100800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | M | 0.320204 | 0.159078 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | M | 0.320204 | 0.159078 | No Change: Both O | Thanatophoric dysplasia type 1 (TD1) [MIM:187600] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 322 | E | 0.401713 | K | 0.400726 | 9.87E-04 | No Change: Both O | Colorectal cancer |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 540 | N | 0.151142 | S | 0.168636 | -0.017494 | No Change: Both O | Hypochondroplasia (HCH) [MIM:146000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | Q | 0.408253 | 0.071029 | No Change: Both O | Bladder cancer (BLC) [MIM:109800] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 650 | K | 0.479282 | Q | 0.408253 | 0.071029 | No Change: Both O | Hypochondroplasia (HCH) [MIM:146000] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 65 | G | 0.79002 | R | 0.774931 | 0.015089 | No Change: Both D | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 384 | F | 0.013989 | L | 0.016393 | -0.002404 | No Change: Both O | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 441 | A | 0.684661 | T | 0.715653 | -0.030992 | No Change: Both D | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 717 | A | 0.473346 | T | 0.510062 | -0.036716 | O to D | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 726 | I | 0.106529 | F | 0.11824 | -0.011711 | No Change: Both O | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 621 | R | 0.189243 | H | 0.18915 | 9.30E-05 | No Change: Both O | Camptodactyly tall stature and hearing loss syndrome (CATSHL syndrome) [MIM:610474] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 513 | D | 0.666061 | N | 0.613402 | 0.052659 | No Change: Both D | Lacrimo-auriculo-dento-digital syndrome (LADDS) [MIM:149730] |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 79 | T | 0.439518 | S | 0.536082 | -0.096564 | O to D | A lung adenocarcinoma sample |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 228 | C | 0.173494 | R | 0.324127 | -0.150633 | No Change: Both O | A colorectal adenocarcinoma sample |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 338 | T | 0.183227 | M | 0.150058 | 0.033169 | No Change: Both O | - |
| P22607 | FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens GN=FGFR3 PE=1 SV=1 | 646 | D | 0.338215 | N | 0.327662 | 0.010553 | No Change: Both O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 388 | G | 0.113311 | R | 0.116733 | -0.003422 | No Change: Both O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 10 | V | 0.590943 | I | 0.478435 | 0.112508 | D to O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 136 | P | 0.89529 | L | 0.831792 | 0.063498 | No Change: Both D | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 179 | T | 0.301188 | A | 0.281372 | 0.019816 | No Change: Both O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 516 | D | 0.4757 | N | 0.442872 | 0.032828 | No Change: Both O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 426 | G | 0.959689 | S | 0.971549 | -0.01186 | No Change: Both D | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 550 | V | 0.148686 | M | 0.186517 | -0.037831 | No Change: Both O | - |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 712 | P | 0.664748 | T | 0.573718 | 0.09103 | No Change: Both D | A lung adenocarcinoma sample |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 772 | S | 0.863458 | N | 0.812276 | 0.051182 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| P22455 | FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens GN=FGFR4 PE=1 SV=2 | 529 | R | 0.200167 | Q | 0.212795 | -0.012628 | No Change: Both O | - |
| Q8N441 | FGRL1_HUMAN Fibroblast growth factor receptor-like 1 OS=Homo sapiens GN=FGFRL1 PE=1 SV=1 | 362 | P | 0.798248 | Q | 0.773121 | 0.025127 | No Change: Both D | - |
| Q8N441 | FGRL1_HUMAN Fibroblast growth factor receptor-like 1 OS=Homo sapiens GN=FGFRL1 PE=1 SV=1 | 464 | P | 0.664528 | L | 0.503355 | 0.161173 | No Change: Both D | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 301 | R | 0.246331 | C | 0.147409 | 0.098922 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 301 | R | 0.246331 | H | 0.234685 | 0.011646 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 318 | G | 0.549887 | V | 0.374249 | 0.175638 | D to O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 334 | N | 0.627069 | K | 0.667176 | -0.040107 | No Change: Both D | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 334 | N | 0.627069 | I | 0.414242 | 0.212827 | D to O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 336 | M | 0.637527 | T | 0.676292 | -0.038765 | No Change: Both D | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 355 | Q | 0.417648 | R | 0.389742 | 0.027906 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 356 | D | 0.382346 | Y | 0.235363 | 0.146983 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 356 | D | 0.382346 | V | 0.232879 | 0.149467 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 363 | N | 0.238481 | K | 0.2757 | -0.037219 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 384 | S | 0.680638 | C | 0.436612 | 0.244026 | D to O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 401 | R | 0.142908 | G | 0.151153 | -0.008245 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 191 | G | 0.280012 | R | 0.255488 | 0.024524 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 410 | M | 0.27106 | V | 0.204199 | 0.066861 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 335 | G | 0.64136 | D | 0.690635 | -0.049275 | No Change: Both D | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 140 | Y | 0.3875 | H | 0.485761 | -0.098261 | No Change: Both O | - |
| P02679 | FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 | 77 | E | 0.535774 | G | 0.451801 | 0.083973 | D to O | - |
| Q96C11 | FGGY_HUMAN FGGY carbohydrate kinase domain-containing protein OS=Homo sapiens GN=FGGY PE=1 SV=2 | 134 | L | 0.245595 | V | 0.268615 | -0.02302 | No Change: Both O | - |
| Q96C11 | FGGY_HUMAN FGGY carbohydrate kinase domain-containing protein OS=Homo sapiens GN=FGGY PE=1 SV=2 | 43 | N | 0.405916 | K | 0.448202 | -0.042286 | No Change: Both O | - |
| Q96C11 | FGGY_HUMAN FGGY carbohydrate kinase domain-containing protein OS=Homo sapiens GN=FGGY PE=1 SV=2 | 246 | L | 0.279806 | V | 0.261954 | 0.017852 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 15 | T | 0.200735 | I | 0.115995 | 0.08474 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 72 | I | 0.387345 | V | 0.43123 | -0.043885 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 105 | P | 0.292298 | L | 0.17752 | 0.114778 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 111 | Y | 0.247401 | H | 0.354669 | -0.107268 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 121 | T | 0.310926 | S | 0.422066 | -0.11114 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 140 | Y | 0.371186 | F | 0.360366 | 0.01082 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 114 | M | 0.251716 | V | 0.213604 | 0.038112 | No Change: Both O | - |
| Q08830 | FGL1_HUMAN Fibrinogen-like protein 1 OS=Homo sapiens GN=FGL1 PE=1 SV=3 | 256 | W | 0.168577 | L | 0.215672 | -0.047095 | No Change: Both O | - |
| Q14314 | FGL2_HUMAN Fibroleukin OS=Homo sapiens GN=FGL2 PE=1 SV=1 | 53 | G | 0.660634 | E | 0.745621 | -0.084987 | No Change: Both D | - |
| P09769 | FGR_HUMAN Tyrosine-protein kinase Fgr OS=Homo sapiens GN=FGR PE=1 SV=2 | 110 | T | 0.251301 | I | 0.156694 | 0.094607 | No Change: Both O | - |
| P09769 | FGR_HUMAN Tyrosine-protein kinase Fgr OS=Homo sapiens GN=FGR PE=1 SV=2 | 130 | S | 0.25546 | R | 0.194313 | 0.061147 | No Change: Both O | - |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 230 | K | 0.248357 | R | 0.199129 | 0.049228 | No Change: Both O | Fumarase deficiency (FHD) [MIM:606812] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 230 | K | 0.248357 | R | 0.199129 | 0.049228 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 308 | A | 0.238109 | T | 0.260504 | -0.022395 | No Change: Both O | Fumarase deficiency (FHD) [MIM:606812] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 312 | F | 0.357414 | C | 0.338284 | 0.01913 | No Change: Both O | Fumarase deficiency (FHD) [MIM:606812] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 425 | D | 0.335293 | V | 0.213375 | 0.121918 | No Change: Both O | Fumarase deficiency (FHD) [MIM:606812] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 107 | N | 0.32204 | T | 0.290122 | 0.031918 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 117 | A | 0.279421 | P | 0.350947 | -0.071526 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 180 | H | 0.672648 | R | 0.655114 | 0.017534 | No Change: Both D | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 185 | Q | 0.716395 | R | 0.713293 | 0.003102 | No Change: Both D | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 233 | R | 0.252504 | H | 0.269654 | -0.01715 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 282 | G | 0.298836 | V | 0.18142 | 0.117416 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| P07954 | FUMH_HUMAN Fumarate hydratase mitochondrial OS=Homo sapiens GN=FH PE=1 SV=3 | 328 | M | 0.303658 | R | 0.3513 | -0.047642 | No Change: Both O | Hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:150800] |
| B1AJZ9 | FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens GN=FHAD1 PE=2 SV=2 | 763 | E | 0.972249 | K | 0.97055 | 0.001699 | No Change: Both D | - |
| Q9C0D6 | FHDC1_HUMAN FH2 domain-containing protein 1 OS=Homo sapiens GN=FHDC1 PE=2 SV=2 | 639 | R | 0.888962 | C | 0.824371 | 0.064591 | No Change: Both D | - |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 122 | W | 0.149987 | S | 0.370621 | -0.220634 | No Change: Both O | X-linked dominant scapuloperoneal myopathy (SPM) [MIM:300695] |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 224 | C | 0.400758 | W | 0.300185 | 0.100573 | No Change: Both O | X-linked myopathy with postural muscle atrophy (XMPMA) [MIM:300696] |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 123 | H | 0.147152 | Y | 0.103677 | 0.043475 | No Change: Both O | X-linked severe early-onset reducing body myopathy (RBM) [MIM:300717] |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 132 | C | 0.181789 | F | 0.178794 | 0.002995 | No Change: Both O | X-linked severe early-onset reducing body myopathy (RBM) [MIM:300717] |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 153 | C | 0.152855 | R | 0.217053 | -0.064198 | No Change: Both O | X-linked severe early-onset reducing body myopathy (RBM) [MIM:300717] |
| Q13642 | FHL1_HUMAN Four and a half LIM domains protein 1 OS=Homo sapiens GN=FHL1 PE=1 SV=4 | 153 | C | 0.152855 | Y | 0.14959 | 0.003265 | No Change: Both O | X-linked severe early-onset reducing body myopathy (RBM) [MIM:300717] |
| Q5TD97 | FHL5_HUMAN Four and a half LIM domains protein 5 OS=Homo sapiens GN=FHL5 PE=1 SV=1 | 211 | V | 0.089515 | M | 0.126339 | -0.036824 | No Change: Both O | - |
| Q5TD97 | FHL5_HUMAN Four and a half LIM domains protein 5 OS=Homo sapiens GN=FHL5 PE=1 SV=1 | 35 | R | 0.141985 | H | 0.132186 | 0.009799 | No Change: Both O | - |
| Q5TD97 | FHL5_HUMAN Four and a half LIM domains protein 5 OS=Homo sapiens GN=FHL5 PE=1 SV=1 | 204 | R | 0.277123 | G | 0.28642 | -0.009297 | No Change: Both O | - |
| Q5TD97 | FHL5_HUMAN Four and a half LIM domains protein 5 OS=Homo sapiens GN=FHL5 PE=1 SV=1 | 243 | S | 0.171951 | R | 0.120961 | 0.05099 | No Change: Both O | - |
| Q2V2M9 | FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens GN=FHOD3 PE=1 SV=2 | 475 | R | 0.982305 | W | 0.952064 | 0.030241 | No Change: Both D | - |
| O43427 | FIBP_HUMAN Acidic fibroblast growth factor intracellular-binding protein OS=Homo sapiens GN=FIBP PE=1 SV=3 | 152 | R | 0.31341 | W | 0.14466 | 0.16875 | No Change: Both O | - |
| O43427 | FIBP_HUMAN Acidic fibroblast growth factor intracellular-binding protein OS=Homo sapiens GN=FIBP PE=1 SV=3 | 351 | M | 0.117717 | V | 0.089242 | 0.028475 | No Change: Both O | - |
| O43427 | FIBP_HUMAN Acidic fibroblast growth factor intracellular-binding protein OS=Homo sapiens GN=FIBP PE=1 SV=3 | 359 | L | 0.24779 | R | 0.367038 | -0.119248 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 364 | M | 0.206954 | L | 0.173702 | 0.033252 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 654 | V | 0.065645 | A | 0.090824 | -0.025179 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 41 | I | 0.338495 | T | 0.494734 | -0.156239 | No Change: Both O | Charcot-Marie-Tooth disease type 4J (CMT4J) [MIM:611228] |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 48 | D | 0.343628 | G | 0.294406 | 0.049222 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 53 | D | 0.216873 | Y | 0.11039 | 0.106483 | No Change: Both O | Amyotrophic lateral sclerosis type 11 (ALS11) [MIM:612577] |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 388 | R | 0.620306 | G | 0.618062 | 0.002244 | No Change: Both D | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 411 | I | 0.079766 | V | 0.091388 | -0.011622 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 647 | Y | 0.121136 | C | 0.106212 | 0.014924 | No Change: Both O | - |
| Q92562 | FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens GN=FIG4 PE=1 SV=1 | 902 | I | 0.522929 | T | 0.643746 | -0.120817 | No Change: Both D | - |
| Q6QHK4 | FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens GN=FIGLA PE=1 SV=2 | 4 | A | 0.895973 | E | 0.915922 | -0.019949 | No Change: Both D | - |
| Q6QHK4 | FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens GN=FIGLA PE=1 SV=2 | 141 | S | 0.93637 | T | 0.914644 | 0.021726 | No Change: Both D | - |
| Q5HY92 | FIGN_HUMAN Fidgetin OS=Homo sapiens GN=FIGN PE=2 SV=2 | 96 | S | 0.656217 | L | 0.486081 | 0.170136 | D to O | - |
| Q5HY92 | FIGN_HUMAN Fidgetin OS=Homo sapiens GN=FIGN PE=2 SV=2 | 448 | R | 0.719569 | C | 0.586015 | 0.133554 | No Change: Both D | - |
| Q5HY92 | FIGN_HUMAN Fidgetin OS=Homo sapiens GN=FIGN PE=2 SV=2 | 565 | K | 0.217392 | R | 0.16271 | 0.054682 | No Change: Both O | - |
| Q6PIW4 | FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens GN=FIGNL1 PE=1 SV=2 | 137 | V | 0.400918 | M | 0.473968 | -0.07305 | No Change: Both O | - |
| Q6PIW4 | FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens GN=FIGNL1 PE=1 SV=2 | 216 | H | 0.450687 | Y | 0.310378 | 0.140309 | No Change: Both O | - |
| A6NMB9 | FIGL2_HUMAN Putative fidgetin-like protein 2 OS=Homo sapiens GN=FIGNL2 PE=5 SV=2 | 366 | T | 0.769537 | P | 0.832306 | -0.062769 | No Change: Both D | - |
| Q7Z7B0 | FLIP1_HUMAN Filamin-A-interacting protein 1 OS=Homo sapiens GN=FILIP1 PE=1 SV=1 | 1003 | P | 0.891507 | S | 0.891154 | 3.53E-04 | No Change: Both D | - |
| Q4L180 | FIL1L_HUMAN Filamin A-interacting protein 1-like OS=Homo sapiens GN=FILIP1L PE=1 SV=2 | 168 | R | 0.712558 | H | 0.66572 | 0.046838 | No Change: Both D | - |
| Q4L180 | FIL1L_HUMAN Filamin A-interacting protein 1-like OS=Homo sapiens GN=FILIP1L PE=1 SV=2 | 884 | A | 0.546328 | P | 0.691602 | -0.145274 | No Change: Both D | - |
| Q96SL8 | FIZ1_HUMAN Flt3-interacting zinc finger protein 1 OS=Homo sapiens GN=FIZ1 PE=1 SV=2 | 391 | T | 0.953201 | A | 0.962039 | -0.008838 | No Change: Both D | - |
| Q86VR8 | FJX1_HUMAN Four-jointed box protein 1 OS=Homo sapiens GN=FJX1 PE=2 SV=1 | 153 | M | 0.440941 | L | 0.398634 | 0.042307 | No Change: Both O | - |
| Q86VR8 | FJX1_HUMAN Four-jointed box protein 1 OS=Homo sapiens GN=FJX1 PE=2 SV=1 | 415 | R | 0.389167 | H | 0.351922 | 0.037245 | No Change: Both O | - |
| Q96AY3 | FKB10_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP10 OS=Homo sapiens GN=FKBP10 PE=1 SV=1 | 197 | K | 0.599143 | R | 0.548666 | 0.050477 | No Change: Both D | - |
| Q5T1M5 | FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2 | 106 | A | 0.206982 | T | 0.235506 | -0.028524 | No Change: Both O | - |
| Q5T1M5 | FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2 | 413 | H | 0.930563 | Q | 0.949146 | -0.018583 | No Change: Both D | - |
| Q5T1M5 | FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2 | 434 | L | 0.95036 | F | 0.941732 | 0.008628 | No Change: Both D | - |
| Q5T1M5 | FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2 | 847 | A | 0.681589 | S | 0.721034 | -0.039445 | No Change: Both D | - |
| Q5T1M5 | FKB15_HUMAN FK506-binding protein 15 OS=Homo sapiens GN=FKBP15 PE=1 SV=2 | 993 | P | 0.937983 | T | 0.916393 | 0.02159 | No Change: Both D | - |
| P26885 | FKBP2_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Homo sapiens GN=FKBP2 PE=1 SV=2 | 25 | A | 0.54754 | T | 0.570049 | -0.022509 | No Change: Both D | - |
| P26885 | FKBP2_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Homo sapiens GN=FKBP2 PE=1 SV=2 | 97 | C | 0.339549 | Y | 0.352143 | -0.012594 | No Change: Both O | - |
| P26885 | FKBP2_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP2 OS=Homo sapiens GN=FKBP2 PE=1 SV=2 | 7 | R | 0.082493 | Q | 0.082476 | 1.70E-05 | No Change: Both O | - |
| Q02790 | FKBP4_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Homo sapiens GN=FKBP4 PE=1 SV=3 | 436 | T | 0.97502 | P | 0.97931 | -0.00429 | No Change: Both D | - |
| Q14318 | FKBP8_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens GN=FKBP8 PE=1 SV=2 | 87 | A | 0.865278 | V | 0.812655 | 0.052623 | No Change: Both D | - |
| Q75LS8 | FKB9L_HUMAN Putative FK506-binding protein 9-like protein OS=Homo sapiens GN=FKBP9L PE=5 SV=1 | 125 | V | 0.693074 | G | 0.785804 | -0.09273 | No Change: Both D | - |
| Q9UIM3 | FKBPL_HUMAN FK506-binding protein-like OS=Homo sapiens GN=FKBPL PE=1 SV=1 | 90 | A | 0.506435 | T | 0.527379 | -0.020944 | No Change: Both D | - |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 114 | A | 0.605618 | G | 0.581738 | 0.02388 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 143 | R | 0.521822 | S | 0.535444 | -0.013622 | No Change: Both D | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 217 | P | 0.290253 | T | 0.245594 | 0.044659 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 221 | S | 0.22065 | R | 0.2041 | 0.01655 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 276 | L | 0.183868 | I | 0.151758 | 0.03211 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 309 | Y | 0.21359 | C | 0.194494 | 0.019096 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 312 | R | 0.181492 | C | 0.099791 | 0.081701 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 315 | P | 0.130113 | T | 0.104535 | 0.025578 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 316 | P | 0.122168 | R | 0.108763 | 0.013405 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 316 | P | 0.122168 | R | 0.108763 | 0.013405 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 328 | Y | 0.137558 | S | 0.272135 | -0.134577 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 339 | R | 0.111678 | L | 0.070103 | 0.041575 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 339 | R | 0.111678 | H | 0.112643 | -9.65E-04 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 401 | D | 0.183316 | N | 0.172323 | 0.010993 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 448 | P | 0.189903 | L | 0.095407 | 0.094496 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 465 | Y | 0.256005 | S | 0.424292 | -0.168287 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 54 | R | 0.430366 | W | 0.208599 | 0.221767 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 307 | Y | 0.210479 | N | 0.314393 | -0.103914 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A5 (MDDGA5) [MIM:613153] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 307 | Y | 0.210479 | N | 0.314393 | -0.103914 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 316 | P | 0.122168 | S | 0.124335 | -0.002167 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 318 | C | 0.119694 | Y | 0.132941 | -0.013247 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A5 (MDDGA5) [MIM:613153] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 360 | D | 0.10634 | N | 0.088712 | 0.017628 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 405 | V | 0.301724 | L | 0.298305 | 0.003419 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 455 | A | 0.155978 | D | 0.198825 | -0.042847 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 462 | P | 0.276328 | S | 0.284039 | -0.007711 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 79 | V | 0.415554 | M | 0.447584 | -0.03203 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 134 | R | 0.585608 | W | 0.33448 | 0.251128 | D to O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 160 | V | 0.516567 | F | 0.445369 | 0.071198 | D to O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 182 | Y | 0.343449 | C | 0.417505 | -0.074056 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 293 | T | 0.215048 | I | 0.114951 | 0.100097 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 300 | V | 0.170036 | A | 0.227095 | -0.057059 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 300 | V | 0.170036 | M | 0.204869 | -0.034833 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 358 | P | 0.140119 | L | 0.070716 | 0.069403 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C5 (MDDGC5) [MIM:607155] |
| Q9H9S5 | FKRP_HUMAN Fukutin-related protein OS=Homo sapiens GN=FKRP PE=1 SV=1 | 463 | N | 0.266253 | D | 0.258846 | 0.007407 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with or without mental retardation type B5 (MDDGB5) [MIM:606612] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 250 | C | 0.236162 | G | 0.392445 | -0.156283 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A4 (MDDGA4) [MIM:253800] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 446 | N | 0.366667 | D | 0.369724 | -0.003057 | No Change: Both O | - |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 125 | G | 0.169692 | S | 0.203484 | -0.033792 | No Change: Both O | - |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 203 | R | 0.200521 | Q | 0.211887 | -0.011366 | No Change: Both O | - |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 225 | D | 0.223318 | E | 0.257991 | -0.034673 | No Change: Both O | A breast cancer sample |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 225 | D | 0.223318 | N | 0.192321 | 0.030997 | No Change: Both O | A breast cancer sample |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 179 | R | 0.246875 | T | 0.235543 | 0.011332 | No Change: Both O | Cardiomyopathy dilated type 1X (CMD1X) [MIM:611615] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 307 | R | 0.041344 | Q | 0.048823 | -0.007479 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital without mental retardation type B4 (MDDGB4) [MIM:613152] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 307 | R | 0.041344 | Q | 0.048823 | -0.007479 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C4 (MDDGC4) [MIM:611588] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 358 | Q | 0.470462 | P | 0.487535 | -0.017073 | No Change: Both O | Cardiomyopathy dilated type 1X (CMD1X) [MIM:611615] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 56 | R | 0.133472 | C | 0.063819 | 0.069653 | No Change: Both O | - |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 114 | A | 0.06167 | T | 0.071055 | -0.009385 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C4 (MDDGC4) [MIM:611588] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 170 | A | 0.068784 | E | 0.106412 | -0.037628 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A4 (MDDGA4) [MIM:253800] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 176 | F | 0.149344 | S | 0.351274 | -0.20193 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C4 (MDDGC4) [MIM:611588] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 246 | R | 0.238922 | G | 0.23039 | 0.008532 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital without mental retardation type B4 (MDDGB4) [MIM:613152] |
| O75072 | FKTN_HUMAN Fukutin OS=Homo sapiens GN=FKTN PE=1 SV=2 | 371 | Y | 0.146315 | C | 0.148409 | -0.002094 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A4 (MDDGA4) [MIM:253800] |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 79 | S | 0.921986 | W | 0.792088 | 0.129898 | No Change: Both D | A sporadic colorectal carcinoma |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 238 | A | 0.56475 | V | 0.479051 | 0.085699 | D to O | A renal cell carcinoma cell line |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 320 | R | 0.962003 | Q | 0.964678 | -0.002675 | No Change: Both D | A primary colorectal cancer |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 392 | R | 0.098066 | G | 0.108705 | -0.010639 | No Change: Both O | A primary colorectal cancer |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 444 | A | 0.278691 | S | 0.372549 | -0.093858 | No Change: Both O | A primary clear-cell renal cell carcinoma |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 445 | A | 0.324522 | T | 0.345603 | -0.021081 | No Change: Both O | A sporadic colorectal carcinoma |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 108 | S | 0.58825 | I | 0.412434 | 0.175816 | D to O | Birt-Hogg-Dube syndrome (BHD) [MIM:135150] |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 132 | E | 0.298587 | K | 0.282216 | 0.016371 | No Change: Both O | Primary spontaneous pneumothorax (PSP) [MIM:173600] |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 239 | R | 0.556391 | C | 0.412784 | 0.143607 | D to O | Renal cell carcinoma (RCC) [MIM:144700] |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 362 | R | 0.122369 | C | 0.06042 | 0.061949 | No Change: Both O | - |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 429 | H | 0.359228 | Y | 0.243096 | 0.116132 | No Change: Both O | Primary spontaneous pneumothorax (PSP) [MIM:173600] |
| Q8NFG4 | FLCN_HUMAN Folliculin OS=Homo sapiens GN=FLCN PE=1 SV=1 | 508 | K | 0.13649 | R | 0.097204 | 0.039286 | No Change: Both O | Birt-Hogg-Dube syndrome (BHD) [MIM:135150] |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3436 | G | 0.995187 | A | 0.993588 | 0.001599 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1184 | S | 0.996756 | L | 0.99204 | 0.004716 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1376 | R | 0.995353 | G | 0.994841 | 5.12E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1437 | R | 0.990968 | C | 0.985591 | 0.005377 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1805 | A | 0.996262 | V | 0.994945 | 0.001317 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1961 | H | 0.992798 | Q | 0.993001 | -2.03E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2022 | I | 0.991205 | T | 0.99409 | -0.002885 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2507 | H | 0.997661 | Q | 0.997843 | -1.82E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2540 | R | 0.996947 | Q | 0.997033 | -8.60E-05 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2781 | D | 0.993403 | Y | 0.987127 | 0.006276 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3371 | S | 0.990154 | F | 0.978927 | 0.011227 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3396 | S | 0.988275 | P | 0.983647 | 0.004628 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3415 | H | 0.99384 | Y | 0.988959 | 0.004881 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3427 | S | 0.996144 | Y | 0.990729 | 0.005415 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3437 | H | 0.995062 | Q | 0.995919 | -8.57E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3490 | R | 0.998245 | C | 0.997038 | 0.001207 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3512 | Q | 0.997331 | R | 0.997238 | 9.30E-05 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3584 | D | 0.996905 | N | 0.996774 | 1.31E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3695 | S | 0.988386 | F | 0.974943 | 0.013443 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3696 | T | 0.987819 | A | 0.987467 | 3.52E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3720 | S | 0.9844 | P | 0.981359 | 0.003041 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3739 | H | 0.991665 | Y | 0.985803 | 0.005862 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3751 | S | 0.995197 | Y | 0.988628 | 0.006569 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3760 | G | 0.993951 | A | 0.991753 | 0.002198 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3761 | H | 0.993783 | Q | 0.99492 | -0.001137 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3814 | R | 0.999128 | C | 0.998539 | 5.89E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3827 | G | 0.999197 | W | 0.998178 | 0.001019 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3908 | D | 0.995161 | N | 0.993631 | 0.00153 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3935 | S | 0.9784 | P | 0.973325 | 0.005075 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3970 | S | 0.818976 | L | 0.686951 | 0.132025 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 454 | T | 0.992721 | A | 0.99168 | 0.001041 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 478 | P | 0.990168 | S | 0.993177 | -0.003009 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 725 | T | 0.996616 | I | 0.994653 | 0.001963 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1482 | S | 0.993706 | Y | 0.984916 | 0.00879 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1699 | R | 0.998228 | C | 0.997092 | 0.001136 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1750 | S | 0.9925 | F | 0.983745 | 0.008755 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1816 | H | 0.995185 | Q | 0.996076 | -8.91E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1891 | R | 0.998578 | Q | 0.998585 | -7.00E-06 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2108 | A | 0.986867 | V | 0.983246 | 0.003621 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2119 | Y | 0.988036 | H | 0.993445 | -0.005409 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2194 | Y | 0.994519 | H | 0.997311 | -0.002792 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 2545 | G | 0.996435 | R | 0.996886 | -4.51E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3105 | Y | 0.987127 | D | 0.993403 | -0.006276 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3179 | V | 0.995293 | G | 0.996935 | -0.001642 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3503 | W | 0.9974 | G | 0.998854 | -0.001454 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3564 | R | 0.997476 | H | 0.997094 | 3.82E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3593 | E | 0.997408 | D | 0.997044 | 3.64E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 3630 | H | 0.997451 | Y | 0.994615 | 0.002836 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 332 | G | 0.997698 | V | 0.995883 | 0.001815 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 444 | G | 0.993769 | R | 0.994463 | -6.94E-04 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 742 | S | 0.996937 | Y | 0.991316 | 0.005621 | No Change: Both D | - |
| P20930 | FILA_HUMAN Filaggrin OS=Homo sapiens GN=FLG PE=1 SV=3 | 1684 | R | 0.998398 | H | 0.998034 | 3.64E-04 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 41 | L | 0.599091 | F | 0.533679 | 0.065412 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 107 | R | 0.928255 | Q | 0.925958 | 0.002297 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 137 | G | 0.983891 | E | 0.986108 | -0.002217 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 276 | R | 0.990963 | Q | 0.990889 | 7.40E-05 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 298 | C | 0.97866 | S | 0.986088 | -0.007428 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 723 | E | 0.999225 | K | 0.999219 | 6.00E-06 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 881 | Y | 0.998795 | S | 0.999501 | -7.06E-04 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 1249 | H | 0.995442 | R | 0.996304 | -8.62E-04 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 1992 | E | 0.986954 | D | 0.985792 | 0.001162 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 2239 | Q | 0.989691 | H | 0.989015 | 6.76E-04 | No Change: Both D | - |
| Q5D862 | FILA2_HUMAN Filaggrin-2 OS=Homo sapiens GN=FLG2 PE=1 SV=1 | 958 | S | 0.999321 | Y | 0.998234 | 0.001087 | No Change: Both D | - |
| Q13045 | FLII_HUMAN Protein flightless-1 homolog OS=Homo sapiens GN=FLII PE=1 SV=2 | 1243 | R | 0.505878 | H | 0.482854 | 0.023024 | D to O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 320 | V | 0.34871 | A | 0.417732 | -0.069022 | No Change: Both O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 370 | F | 0.33288 | L | 0.361075 | -0.028195 | No Change: Both O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 552 | V | 0.071055 | A | 0.091718 | -0.020663 | No Change: Both O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 656 | L | 0.263015 | F | 0.254452 | 0.008563 | No Change: Both O | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1764 | A | 0.585349 | T | 0.617676 | -0.032327 | No Change: Both D | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 82 | E | 0.229438 | V | 0.123808 | 0.10563 | No Change: Both O | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 207 | P | 0.256705 | L | 0.143683 | 0.113022 | No Change: Both O | Otopalatodigital syndrome type 1 (OPD1) [MIM:311300] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 254 | E | 0.422355 | K | 0.419729 | 0.002626 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1159 | D | 0.288588 | A | 0.2388 | 0.049788 | No Change: Both O | Frontometaphyseal dysplasia (FMD) [MIM:305620] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1188 | A | 0.452857 | T | 0.476012 | -0.023155 | No Change: Both O | Melnick-Needles syndrome (MNS) [MIM:309350] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1199 | S | 0.250859 | L | 0.130315 | 0.120544 | No Change: Both O | Melnick-Needles syndrome (MNS) [MIM:309350] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 170 | Q | 0.427033 | P | 0.446662 | -0.019629 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 172 | L | 0.285448 | F | 0.240852 | 0.044596 | No Change: Both O | Otopalatodigital syndrome type 1 (OPD1) [MIM:311300] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 196 | R | 0.318662 | G | 0.323337 | -0.004675 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 196 | R | 0.318662 | W | 0.166447 | 0.152215 | No Change: Both O | Otopalatodigital syndrome type 1 (OPD1) [MIM:311300] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 200 | A | 0.257102 | S | 0.35998 | -0.102878 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 273 | A | 0.717903 | P | 0.799744 | -0.081841 | No Change: Both D | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 555 | T | 0.094222 | K | 0.11936 | -0.025138 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1184 | D | 0.450105 | E | 0.50703 | -0.056925 | O to D | Melnick-Needles syndrome (MNS) [MIM:309350] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1186 | S | 0.45617 | L | 0.275956 | 0.180214 | No Change: Both O | Frontometaphyseal dysplasia (FMD) [MIM:305620] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1645 | C | 0.359838 | F | 0.372221 | -0.012383 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 39 | A | 0.490547 | G | 0.505688 | -0.015141 | O to D | Periventricular nodular heterotopia type 4 (PVNH4) [MIM:300537] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 102 | M | 0.408516 | V | 0.352497 | 0.056019 | No Change: Both O | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 128 | A | 0.275747 | V | 0.221765 | 0.053982 | No Change: Both O | Periventricular nodular heterotopia type 4 (PVNH4) [MIM:300537] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 149 | S | 0.102849 | F | 0.036149 | 0.0667 | No Change: Both O | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 203 | D | 0.253184 | Y | 0.122521 | 0.130663 | No Change: Both O | Otopalatodigital syndrome type 1 (OPD1) [MIM:311300] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 528 | V | 0.694944 | M | 0.719034 | -0.02409 | No Change: Both D | Periventricular nodular heterotopia type 1 (PVNH1) [MIM:300049] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1012 | S | 0.620371 | L | 0.442195 | 0.178176 | D to O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1728 | G | 0.253874 | C | 0.155013 | 0.098861 | No Change: Both O | Frontometaphyseal dysplasia (FMD) [MIM:305620] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1419 | A | 0.265753 | G | 0.333921 | -0.068168 | No Change: Both O | - |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 210 | C | 0.271898 | F | 0.231753 | 0.040145 | No Change: Both O | Otopalatodigital syndrome type 2 (OPD2) [MIM:304120] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 1291 | P | 0.484841 | L | 0.331566 | 0.153275 | No Change: Both O | FG syndrome type 2 (FGS2) [MIM:300321] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 288 | G | 0.710657 | R | 0.728697 | -0.01804 | No Change: Both D | Cardiac valvular dysplasia X-linked (CVDX) [MIM:314400] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 637 | P | 0.250842 | Q | 0.246957 | 0.003885 | No Change: Both O | Cardiac valvular dysplasia X-linked (CVDX) [MIM:314400] |
| P21333 | FLNA_HUMAN Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 | 711 | V | 0.430582 | D | 0.566872 | -0.13629 | O to D | Cardiac valvular dysplasia X-linked (CVDX) [MIM:314400] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1018 | V | 0.370304 | M | 0.399122 | -0.028818 | No Change: Both O | - |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1157 | D | 0.615685 | N | 0.578659 | 0.037026 | No Change: Both D | - |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1179 | E | 0.586975 | K | 0.60175 | -0.014775 | No Change: Both D | - |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1471 | V | 0.401294 | M | 0.436199 | -0.034905 | No Change: Both O | - |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 161 | F | 0.199261 | C | 0.225375 | -0.026114 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 168 | G | 0.316568 | S | 0.349867 | -0.033299 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 171 | L | 0.264079 | R | 0.349956 | -0.085877 | No Change: Both O | Boomerang dysplasia (BOOMD) [MIM:112310] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 173 | A | 0.222927 | V | 0.160688 | 0.062239 | No Change: Both O | Atelosteogenesis type 1 (AO1) [MIM:108720] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 188 | S | 0.41647 | P | 0.447222 | -0.030752 | No Change: Both O | Atelosteogenesis type 1 (AO1) [MIM:108720] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 202 | M | 0.490048 | V | 0.441893 | 0.048155 | No Change: Both O | Atelosteogenesis type 1 (AO1) [MIM:108720] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 202 | M | 0.490048 | V | 0.441893 | 0.048155 | No Change: Both O | Atelosteogenesis type 3 (AO3) [MIM:108721] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 227 | E | 0.451804 | K | 0.450343 | 0.001461 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 234 | L | 0.367358 | V | 0.372126 | -0.004768 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 235 | S | 0.394043 | P | 0.416021 | -0.021978 | No Change: Both O | Boomerang dysplasia (BOOMD) [MIM:112310] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 361 | G | 0.54319 | S | 0.58536 | -0.04217 | No Change: Both D | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 363 | G | 0.451189 | E | 0.494152 | -0.042963 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 751 | G | 0.455257 | R | 0.440863 | 0.014394 | No Change: Both O | Atelosteogenesis type 3 (AO3) [MIM:108721] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1431 | L | 0.486882 | R | 0.632941 | -0.146059 | O to D | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1586 | G | 0.253407 | R | 0.255941 | -0.002534 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1592 | V | 0.220097 | D | 0.387072 | -0.166975 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1603 | P | 0.318791 | L | 0.182531 | 0.13626 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1691 | G | 0.107673 | S | 0.129557 | -0.021884 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1834 | G | 0.186919 | R | 0.162796 | 0.024123 | No Change: Both O | Autosomal dominant Larsen syndrome (LRS1) [MIM:150250] |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 566 | R | 0.281136 | Q | 0.301215 | -0.020079 | No Change: Both O | A breast cancer sample |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 663 | N | 0.14176 | K | 0.169542 | -0.027782 | No Change: Both O | A breast cancer sample |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 703 | T | 0.277914 | K | 0.354519 | -0.076605 | No Change: Both O | A breast cancer sample |
| O75369 | FLNB_HUMAN Filamin-B OS=Homo sapiens GN=FLNB PE=1 SV=2 | 1534 | A | 0.379305 | G | 0.424195 | -0.04489 | No Change: Both O | A breast cancer sample |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 1567 | R | 0.375311 | Q | 0.387397 | -0.012086 | No Change: Both O | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 1580 | D | 0.422992 | G | 0.40941 | 0.013582 | No Change: Both O | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 1599 | T | 0.34612 | A | 0.298322 | 0.047798 | No Change: Both O | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 2135 | K | 0.680422 | R | 0.653308 | 0.027114 | No Change: Both D | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 2203 | R | 0.882441 | P | 0.883718 | -0.001277 | No Change: Both D | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 2626 | S | 0.9234 | N | 0.879974 | 0.043426 | No Change: Both D | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 2637 | K | 0.810081 | Q | 0.794433 | 0.015648 | No Change: Both D | - |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 193 | A | 0.228381 | T | 0.228448 | -6.70E-05 | No Change: Both O | Myopathy distal type 4 (MPD4) [MIM:614065] |
| Q14315 | FLNC_HUMAN Filamin-C OS=Homo sapiens GN=FLNC PE=1 SV=3 | 251 | M | 0.333823 | T | 0.379903 | -0.04608 | No Change: Both O | Myopathy distal type 4 (MPD4) [MIM:614065] |
| O75955 | FLOT1_HUMAN Flotillin-1 OS=Homo sapiens GN=FLOT1 PE=1 SV=3 | 52 | S | 0.501018 | N | 0.476327 | 0.024691 | D to O | - |
| Q14254 | FLOT2_HUMAN Flotillin-2 OS=Homo sapiens GN=FLOT2 PE=1 SV=2 | 328 | A | 0.827075 | T | 0.783763 | 0.043312 | No Change: Both D | - |
| O43155 | FLRT2_HUMAN Leucine-rich repeat transmembrane protein FLRT2 OS=Homo sapiens GN=FLRT2 PE=1 SV=1 | 486 | R | 0.252738 | Q | 0.255819 | -0.003081 | No Change: Both O | - |
| Q9NZU0 | FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 OS=Homo sapiens GN=FLRT3 PE=1 SV=1 | 400 | H | 0.842018 | Q | 0.874593 | -0.032575 | No Change: Both D | - |
| Q9NZU0 | FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 OS=Homo sapiens GN=FLRT3 PE=1 SV=1 | 377 | A | 0.442116 | T | 0.487989 | -0.045873 | No Change: Both O | - |
| Q9NZU0 | FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 OS=Homo sapiens GN=FLRT3 PE=1 SV=1 | 460 | E | 0.382705 | D | 0.336385 | 0.04632 | No Change: Both O | - |
| Q9NZU0 | FLRT3_HUMAN Leucine-rich repeat transmembrane protein FLRT3 OS=Homo sapiens GN=FLRT3 PE=1 SV=1 | 452 | I | 0.35365 | V | 0.386609 | -0.032959 | No Change: Both O | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 60 | K | 0.562867 | T | 0.495533 | 0.067334 | D to O | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 144 | E | 0.326713 | K | 0.300095 | 0.026618 | No Change: Both O | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 281 | R | 0.597029 | Q | 0.599615 | -0.002586 | No Change: Both D | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 422 | L | 0.088617 | I | 0.079356 | 0.009261 | No Change: Both O | A lung adenocarcinoma sample |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 781 | R | 0.252226 | Q | 0.252119 | 1.07E-04 | No Change: Both O | A glioma low grade oligodendroglioma sample |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 938 | M | 0.70948 | V | 0.636622 | 0.072858 | No Change: Both D | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 982 | E | 0.869263 | A | 0.815717 | 0.053546 | No Change: Both D | - |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 1061 | L | 0.276284 | V | 0.272106 | 0.004178 | No Change: Both O | A bladder transitional cell carcinoma sample |
| P17948 | VGFR1_HUMAN Vascular endothelial growth factor receptor 1 OS=Homo sapiens GN=FLT1 PE=1 SV=2 | 128 | I | 0.138106 | L | 0.138948 | -8.42E-04 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 7 | D | 0.545181 | G | 0.53997 | 0.005211 | No Change: Both D | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 227 | T | 0.326382 | M | 0.281096 | 0.045286 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 158 | V | 0.071429 | A | 0.10341 | -0.031981 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 324 | D | 0.413433 | N | 0.41307 | 3.63E-04 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 358 | D | 0.548073 | V | 0.405948 | 0.142125 | D to O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 557 | V | 0.006397 | I | 0.005617 | 7.80E-04 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 194 | V | 0.292808 | M | 0.342246 | -0.049438 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 417 | I | 0.367298 | L | 0.392756 | -0.025458 | No Change: Both O | - |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 835 | D | 0.218111 | E | 0.222288 | -0.004177 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 835 | D | 0.218111 | H | 0.174498 | 0.043613 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 835 | D | 0.218111 | N | 0.199589 | 0.018522 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 835 | D | 0.218111 | V | 0.10649 | 0.111621 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 835 | D | 0.218111 | Y | 0.110197 | 0.107914 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P36888 | FLT3_HUMAN Receptor-type tyrosine-protein kinase FLT3 OS=Homo sapiens GN=FLT3 PE=1 SV=2 | 836 | I | 0.258801 | M | 0.363636 | -0.104835 | No Change: Both O | Acute lymphoblastic leukemia patients |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 494 | T | 0.363623 | A | 0.330244 | 0.033379 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 641 | P | 0.473889 | S | 0.499403 | -0.025514 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 857 | G | 0.211874 | R | 0.189868 | 0.022006 | No Change: Both O | Lymphedema hereditary type 1A (LMPH1A) [MIM:153100] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 890 | H | 0.559199 | Q | 0.565372 | -0.006173 | No Change: Both D | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 954 | P | 0.742461 | S | 0.752982 | -0.010521 | No Change: Both D | Hemangioma capillary infantile (HCI) [MIM:602089] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1035 | H | 0.205882 | R | 0.225245 | -0.019363 | No Change: Both O | Lymphedema hereditary type 1A (LMPH1A) [MIM:153100] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1041 | R | 0.231196 | P | 0.249135 | -0.017939 | No Change: Both O | Lymphedema hereditary type 1A (LMPH1A) [MIM:153100] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1044 | L | 0.250089 | P | 0.386143 | -0.136054 | No Change: Both O | Lymphedema hereditary type 1A (LMPH1A) [MIM:153100] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1114 | P | 0.30216 | L | 0.169714 | 0.132446 | No Change: Both O | Lymphedema hereditary type 1A (LMPH1A) [MIM:153100] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1137 | P | 0.485141 | S | 0.487462 | -0.002321 | No Change: Both O | Hemangioma capillary infantile (HCI) [MIM:602089] |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1146 | R | 0.205578 | H | 0.136978 | 0.0686 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 527 | N | 0.185072 | S | 0.218473 | -0.033401 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 149 | N | 0.203704 | D | 0.228394 | -0.02469 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 378 | R | 0.589255 | C | 0.429258 | 0.159997 | D to O | A renal clear cell carcinoma sample |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 868 | H | 0.393683 | Y | 0.2829 | 0.110783 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1010 | T | 0.169505 | I | 0.096272 | 0.073233 | No Change: Both O | A metastatic melanoma sample |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1031 | R | 0.225463 | Q | 0.223148 | 0.002315 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1049 | D | 0.177617 | N | 0.164338 | 0.013279 | No Change: Both O | - |
| P35916 | VGFR3_HUMAN Vascular endothelial growth factor receptor 3 OS=Homo sapiens GN=FLT4 PE=1 SV=3 | 1075 | R | 0.295613 | Q | 0.298978 | -0.003365 | No Change: Both O | - |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 52 | A | 0.755851 | P | 0.824079 | -0.068228 | No Change: Both D | - |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 544 | T | 0.746197 | M | 0.728635 | 0.017562 | No Change: Both D | - |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 121 | N | 0.043687 | D | 0.047215 | -0.003528 | No Change: Both O | Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033] |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 192 | C | 0.089865 | R | 0.178477 | -0.088612 | No Change: Both O | Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033] |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 241 | A | 0.170466 | T | 0.192147 | -0.021681 | No Change: Both O | Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033] |
| Q9Y5Y0 | FLVC1_HUMAN Feline leukemia virus subgroup C receptor-related protein 1 OS=Homo sapiens GN=FLVCR1 PE=1 SV=1 | 493 | G | 0.135166 | R | 0.120489 | 0.014677 | No Change: Both O | Posterior column ataxia with retinitis pigmentosa (PCARP) [MIM:609033] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 16 | V | 0.972396 | A | 0.977886 | -0.00549 | No Change: Both D | - |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 481 | A | 0.072345 | T | 0.082604 | -0.010259 | No Change: Both O | - |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 280 | P | 0.767895 | R | 0.733818 | 0.034077 | No Change: Both D | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 398 | L | 0.033409 | V | 0.034325 | -9.16E-04 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 430 | T | 0.332357 | R | 0.347303 | -0.014946 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 84 | R | 0.112648 | H | 0.101034 | 0.011614 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 326 | A | 0.107438 | V | 0.068561 | 0.038877 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 352 | T | 0.068036 | R | 0.077951 | -0.009915 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 412 | G | 0.102292 | R | 0.087748 | 0.014544 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q9UPI3 | FLVC2_HUMAN Feline leukemia virus subgroup C receptor-related protein 2 OS=Homo sapiens GN=FLVCR2 PE=1 SV=1 | 430 | T | 0.332357 | M | 0.284905 | 0.047452 | No Change: Both O | Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH) [MIM:225790] |
| Q68DA7 | FMN1_HUMAN Formin-1 OS=Homo sapiens GN=FMN1 PE=1 SV=3 | 686 | L | 0.802086 | P | 0.871285 | -0.069199 | No Change: Both D | - |
| Q9NZ56 | FMN2_HUMAN Formin-2 OS=Homo sapiens GN=FMN2 PE=1 SV=4 | 1468 | R | 0.265884 | H | 0.248151 | 0.017733 | No Change: Both O | - |
| Q9NZ56 | FMN2_HUMAN Formin-2 OS=Homo sapiens GN=FMN2 PE=1 SV=4 | 1291 | R | 0.687433 | G | 0.65375 | 0.033683 | No Change: Both D | - |
| Q9NZ56 | FMN2_HUMAN Formin-2 OS=Homo sapiens GN=FMN2 PE=1 SV=4 | 1148 | R | 0.99989 | G | 0.999912 | -2.20E-05 | No Change: Both D | - |
| Q96PY5 | FMNL2_HUMAN Formin-like protein 2 OS=Homo sapiens GN=FMNL2 PE=1 SV=3 | 352 | Y | 0.427671 | C | 0.370226 | 0.057445 | No Change: Both O | - |
| Q96PY5 | FMNL2_HUMAN Formin-like protein 2 OS=Homo sapiens GN=FMNL2 PE=1 SV=3 | 504 | M | 0.631597 | T | 0.649059 | -0.017462 | No Change: Both D | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 97 | H | 0.150954 | Q | 0.160194 | -0.00924 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 303 | I | 0.411731 | T | 0.521931 | -0.1102 | O to D | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 303 | I | 0.411731 | V | 0.442496 | -0.030765 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 223 | R | 0.111474 | Q | 0.121213 | -0.009739 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 227 | S | 0.124745 | T | 0.082142 | 0.042603 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 322 | I | 0.264009 | V | 0.284116 | -0.020107 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 327 | F | 0.046065 | L | 0.047655 | -0.00159 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 373 | K | 0.159095 | R | 0.123905 | 0.03519 | No Change: Both O | - |
| Q01740 | FMO1_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 1 OS=Homo sapiens GN=FMO1 PE=2 SV=3 | 474 | R | 0.244508 | H | 0.249337 | -0.004829 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 36 | D | 0.229438 | G | 0.224662 | 0.004776 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 81 | F | 0.349758 | S | 0.573542 | -0.223784 | O to D | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 182 | F | 0.436347 | S | 0.61891 | -0.182563 | O to D | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 195 | S | 0.38105 | L | 0.210349 | 0.170701 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 413 | N | 0.430224 | K | 0.501207 | -0.070983 | O to D | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 59 | V | 0.406234 | I | 0.376346 | 0.029888 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 238 | R | 0.193963 | Q | 0.192314 | 0.001649 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 391 | R | 0.074024 | T | 0.067268 | 0.006756 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 69 | F | 0.462696 | Y | 0.478455 | -0.015759 | No Change: Both O | - |
| Q99518 | FMO2_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Homo sapiens GN=FMO2 PE=1 SV=4 | 314 | E | 0.396726 | G | 0.334311 | 0.062415 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 66 | M | 0.514953 | I | 0.391213 | 0.12374 | D to O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 153 | P | 0.433578 | L | 0.288321 | 0.145257 | No Change: Both O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 158 | E | 0.493239 | K | 0.512828 | -0.019589 | O to D | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 257 | V | 0.113603 | M | 0.155634 | -0.042031 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 308 | E | 0.385249 | G | 0.314987 | 0.070262 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 492 | R | 0.299879 | W | 0.142856 | 0.157023 | No Change: Both O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 52 | A | 0.538486 | T | 0.546903 | -0.008417 | No Change: Both D | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 387 | R | 0.159724 | L | 0.10715 | 0.052574 | No Change: Both O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 277 | V | 0.251803 | A | 0.314707 | -0.062904 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 362 | E | 0.215142 | Q | 0.179434 | 0.035708 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 132 | D | 0.596606 | H | 0.573494 | 0.023112 | No Change: Both D | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 360 | L | 0.203907 | P | 0.360828 | -0.156921 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 503 | G | 0.206107 | R | 0.212615 | -0.006508 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 198 | D | 0.289922 | E | 0.331194 | -0.041272 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 205 | R | 0.37637 | C | 0.225512 | 0.150858 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 32 | E | 0.383692 | K | 0.377055 | 0.006637 | No Change: Both O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 61 | N | 0.618878 | S | 0.68921 | -0.070332 | No Change: Both D | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 434 | M | 0.148922 | I | 0.108538 | 0.040384 | No Change: Both O | Trimethylaminuria (TMAU) [MIM:602079] |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 24 | E | 0.370468 | D | 0.320239 | 0.050229 | No Change: Both O | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 61 | N | 0.618878 | K | 0.671392 | -0.052514 | No Change: Both D | - |
| P31513 | FMO3_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 3 OS=Homo sapiens GN=FMO3 PE=1 SV=5 | 416 | K | 0.624361 | N | 0.582475 | 0.041886 | No Change: Both D | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 37 | I | 0.328441 | T | 0.494346 | -0.165905 | No Change: Both O | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 323 | V | 0.130172 | A | 0.160952 | -0.03078 | No Change: Both O | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 339 | E | 0.331766 | Q | 0.270777 | 0.060989 | No Change: Both O | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 372 | G | 0.137741 | S | 0.166262 | -0.028521 | No Change: Both O | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 536 | F | 0.125901 | L | 0.178341 | -0.05244 | No Change: Both O | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 544 | L | 0.425364 | R | 0.566518 | -0.141154 | O to D | - |
| P31512 | FMO4_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 4 OS=Homo sapiens GN=FMO4 PE=2 SV=3 | 308 | T | 0.338194 | S | 0.420085 | -0.081891 | No Change: Both O | - |
| P49326 | FMO5_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 5 OS=Homo sapiens GN=FMO5 PE=2 SV=2 | 457 | P | 0.250367 | L | 0.151643 | 0.098724 | No Change: Both O | - |
| P49326 | FMO5_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 5 OS=Homo sapiens GN=FMO5 PE=2 SV=2 | 400 | P | 0.55762 | A | 0.496616 | 0.061004 | D to O | - |
| P49326 | FMO5_HUMAN Dimethylaniline monooxygenase [N-oxide-forming] 5 OS=Homo sapiens GN=FMO5 PE=2 SV=2 | 506 | R | 0.704344 | S | 0.752834 | -0.04849 | No Change: Both D | - |
| O60774 | FMO6_HUMAN Putative dimethylaniline monooxygenase [N-oxide-forming] 6 OS=Homo sapiens GN=FMO6P PE=5 SV=1 | 127 | V | 0.167094 | I | 0.136391 | 0.030703 | No Change: Both O | - |
| O60774 | FMO6_HUMAN Putative dimethylaniline monooxygenase [N-oxide-forming] 6 OS=Homo sapiens GN=FMO6P PE=5 SV=1 | 257 | V | 0.075779 | I | 0.069118 | 0.006661 | No Change: Both O | - |
| Q06787 | FMR1_HUMAN Fragile X mental retardation protein 1 OS=Homo sapiens GN=FMR1 PE=1 SV=1 | 304 | I | 0.373971 | N | 0.509657 | -0.135686 | O to D | Fragile X syndrome (FRAX) [MIM:300624] |
| Q06787 | FMR1_HUMAN Fragile X mental retardation protein 1 OS=Homo sapiens GN=FMR1 PE=1 SV=1 | 546 | R | 0.993323 | H | 0.989983 | 0.00334 | No Change: Both D | - |
| Q06787 | FMR1_HUMAN Fragile X mental retardation protein 1 OS=Homo sapiens GN=FMR1 PE=1 SV=1 | 145 | A | 0.467569 | S | 0.535667 | -0.068098 | O to D | - |
| Q06787 | FMR1_HUMAN Fragile X mental retardation protein 1 OS=Homo sapiens GN=FMR1 PE=1 SV=1 | 138 | R | 0.375653 | Q | 0.409404 | -0.033751 | No Change: Both O | - |
| Q8N0W7 | FMR1N_HUMAN Fragile X mental retardation 1 neighbor protein OS=Homo sapiens GN=FMR1NB PE=1 SV=1 | 142 | A | 0.636856 | V | 0.575708 | 0.061148 | No Change: Both D | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 940 | D | 0.138531 | N | 0.14002 | -0.001489 | No Change: Both O | A breast cancer sample |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 1120 | R | 0.498052 | P | 0.5514 | -0.053348 | O to D | A breast cancer sample |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 2380 | D | 0.682381 | N | 0.672971 | 0.00941 | No Change: Both D | A colorectal cancer sample |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 15 | Q | 0.66467 | L | 0.569797 | 0.094873 | No Change: Both D | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 973 | Y | 0.131106 | C | 0.129373 | 0.001733 | No Change: Both O | Glomerulopathy with fibronectin deposits type 2 (GFND2) [MIM:601894] |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 1834 | W | 0.516334 | R | 0.753467 | -0.237133 | No Change: Both D | Glomerulopathy with fibronectin deposits type 2 (GFND2) [MIM:601894] |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 1883 | L | 0.148858 | R | 0.23566 | -0.086802 | No Change: Both O | Glomerulopathy with fibronectin deposits type 2 (GFND2) [MIM:601894] |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 1960 | I | 0.560061 | V | 0.587969 | -0.027908 | No Change: Both D | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 1467 | S | 0.172967 | R | 0.131824 | 0.041143 | No Change: Both O | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 2121 | I | 0.295265 | V | 0.31629 | -0.021025 | No Change: Both O | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 817 | T | 0.745496 | P | 0.78762 | -0.042124 | No Change: Both D | - |
| P02751 | FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 | 2170 | V | 0.207036 | I | 0.172122 | 0.034914 | No Change: Both O | - |
| Q9HA64 | KT3K_HUMAN Ketosamine-3-kinase OS=Homo sapiens GN=FN3KRP PE=1 SV=2 | 57 | A | 0.333283 | V | 0.259506 | 0.073777 | No Change: Both O | - |
| Q96RU3 | FNBP1_HUMAN Formin-binding protein 1 OS=Homo sapiens GN=FNBP1 PE=1 SV=2 | 490 | S | 0.744942 | N | 0.714669 | 0.030273 | No Change: Both D | - |
| Q8N3X1 | FNBP4_HUMAN Formin-binding protein 4 OS=Homo sapiens GN=FNBP4 PE=1 SV=3 | 125 | E | 0.788805 | G | 0.758078 | 0.030727 | No Change: Both D | - |
| Q8N3X1 | FNBP4_HUMAN Formin-binding protein 4 OS=Homo sapiens GN=FNBP4 PE=1 SV=3 | 794 | T | 0.853967 | A | 0.841624 | 0.012343 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 438 | T | 0.29929 | A | 0.285059 | 0.014231 | No Change: Both O | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 463 | E | 0.819606 | Q | 0.813634 | 0.005972 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1003 | Q | 0.999117 | E | 0.998754 | 3.63E-04 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1180 | D | 0.98505 | E | 0.986665 | -0.001615 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1261 | L | 0.979924 | P | 0.991449 | -0.011525 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1280 | Q | 0.893203 | R | 0.907562 | -0.014359 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1504 | T | 0.989056 | K | 0.98526 | 0.003796 | No Change: Both D | - |
| Q4ZHG4 | FNDC1_HUMAN Fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=FNDC1 PE=1 SV=4 | 1574 | T | 0.944314 | A | 0.928999 | 0.015315 | No Change: Both D | - |
| Q9Y2H6 | FND3A_HUMAN Fibronectin type-III domain-containing protein 3A OS=Homo sapiens GN=FNDC3A PE=1 SV=4 | 107 | S | 0.735675 | G | 0.716641 | 0.019034 | No Change: Both D | - |
| Q53EP0 | FND3B_HUMAN Fibronectin type III domain-containing protein 3B OS=Homo sapiens GN=FNDC3B PE=1 SV=2 | 179 | T | 0.498699 | S | 0.561073 | -0.062374 | O to D | - |
| Q53EP0 | FND3B_HUMAN Fibronectin type III domain-containing protein 3B OS=Homo sapiens GN=FNDC3B PE=1 SV=2 | 927 | P | 0.287763 | S | 0.317079 | -0.029316 | No Change: Both O | A breast cancer sample |
| Q53EP0 | FND3B_HUMAN Fibronectin type III domain-containing protein 3B OS=Homo sapiens GN=FNDC3B PE=1 SV=2 | 1080 | M | 0.317459 | V | 0.282282 | 0.035177 | No Change: Both O | - |
| Q5VTL7 | FNDC7_HUMAN Fibronectin type III domain-containing protein 7 OS=Homo sapiens GN=FNDC7 PE=2 SV=2 | 310 | S | 0.244201 | N | 0.192935 | 0.051266 | No Change: Both O | - |
| Q5VTL7 | FNDC7_HUMAN Fibronectin type III domain-containing protein 7 OS=Homo sapiens GN=FNDC7 PE=2 SV=2 | 354 | V | 0.089333 | A | 0.124357 | -0.035024 | No Change: Both O | - |
| Q5VTL7 | FNDC7_HUMAN Fibronectin type III domain-containing protein 7 OS=Homo sapiens GN=FNDC7 PE=2 SV=2 | 368 | N | 0.140917 | S | 0.175567 | -0.03465 | No Change: Both O | - |
| Q5VTL7 | FNDC7_HUMAN Fibronectin type III domain-containing protein 7 OS=Homo sapiens GN=FNDC7 PE=2 SV=2 | 686 | P | 0.128194 | L | 0.062979 | 0.065215 | No Change: Both O | - |
| Q8TC99 | FNDC8_HUMAN Fibronectin type III domain-containing protein 8 OS=Homo sapiens GN=FNDC8 PE=2 SV=2 | 36 | S | 0.749357 | P | 0.764312 | -0.014955 | No Change: Both D | - |
| Q8TC99 | FNDC8_HUMAN Fibronectin type III domain-containing protein 8 OS=Homo sapiens GN=FNDC8 PE=2 SV=2 | 127 | A | 0.765584 | T | 0.76787 | -0.002286 | No Change: Both D | - |
| Q8TBE3 | FNDC9_HUMAN Fibronectin type III domain-containing protein 9 OS=Homo sapiens GN=FNDC9 PE=2 SV=2 | 50 | H | 0.482069 | N | 0.485355 | -0.003286 | No Change: Both O | - |
| Q8TBE3 | FNDC9_HUMAN Fibronectin type III domain-containing protein 9 OS=Homo sapiens GN=FNDC9 PE=2 SV=2 | 138 | V | 0.021505 | I | 0.018965 | 0.00254 | No Change: Both O | - |
| Q8TBE3 | FNDC9_HUMAN Fibronectin type III domain-containing protein 9 OS=Homo sapiens GN=FNDC9 PE=2 SV=2 | 166 | P | 0.708508 | A | 0.631576 | 0.076932 | No Change: Both D | - |
| Q8TF40 | FNIP1_HUMAN Folliculin-interacting protein 1 OS=Homo sapiens GN=FNIP1 PE=1 SV=3 | 76 | G | 0.734122 | C | 0.697724 | 0.036398 | No Change: Both D | - |
| Q8TF40 | FNIP1_HUMAN Folliculin-interacting protein 1 OS=Homo sapiens GN=FNIP1 PE=1 SV=3 | 354 | S | 0.490556 | L | 0.325727 | 0.164829 | No Change: Both O | - |
| Q8TF40 | FNIP1_HUMAN Folliculin-interacting protein 1 OS=Homo sapiens GN=FNIP1 PE=1 SV=3 | 648 | Q | 0.694042 | R | 0.673785 | 0.020257 | No Change: Both D | - |
| Q8TF40 | FNIP1_HUMAN Folliculin-interacting protein 1 OS=Homo sapiens GN=FNIP1 PE=1 SV=3 | 738 | V | 0.673069 | L | 0.668583 | 0.004486 | No Change: Both D | - |
| Q8TF40 | FNIP1_HUMAN Folliculin-interacting protein 1 OS=Homo sapiens GN=FNIP1 PE=1 SV=3 | 844 | I | 0.687525 | V | 0.697968 | -0.010443 | No Change: Both D | - |
| Q9P278 | FNIP2_HUMAN Folliculin-interacting protein 2 OS=Homo sapiens GN=FNIP2 PE=1 SV=2 | 298 | T | 0.677509 | S | 0.745966 | -0.068457 | No Change: Both D | - |
| Q04609 | FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1 PE=1 SV=1 | 475 | H | 0.29801 | Y | 0.238512 | 0.059498 | No Change: Both O | - |
| Q04609 | FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1 PE=1 SV=1 | 75 | Y | 0.177499 | H | 0.304403 | -0.126904 | No Change: Both O | - |
| Q04609 | FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1 PE=1 SV=1 | 627 | V | 0.379763 | L | 0.391958 | -0.012195 | No Change: Both O | - |
| Q04609 | FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens GN=FOLH1 PE=1 SV=1 | 23 | A | 0.059593 | T | 0.062691 | -0.003098 | No Change: Both O | A colorectal cancer sample |
| Q9HBA9 | FOH1B_HUMAN Putative N-acetylated-alpha-linked acidic dipeptidase OS=Homo sapiens GN=FOLH1B PE=2 SV=1 | 151 | N | 0.297668 | K | 0.324461 | -0.026793 | No Change: Both O | - |
| P15328 | FOLR1_HUMAN Folate receptor alpha OS=Homo sapiens GN=FOLR1 PE=1 SV=3 | 160 | W | 0.233422 | C | 0.25699 | -0.023568 | No Change: Both O | - |
| P15328 | FOLR1_HUMAN Folate receptor alpha OS=Homo sapiens GN=FOLR1 PE=1 SV=3 | 28 | W | 0.131778 | R | 0.292978 | -0.1612 | No Change: Both O | - |
| P14207 | FOLR2_HUMAN Folate receptor beta OS=Homo sapiens GN=FOLR2 PE=1 SV=4 | 236 | H | 0.383255 | N | 0.410823 | -0.027568 | No Change: Both O | A breast cancer sample |
| P53539 | FOSB_HUMAN Protein fosB OS=Homo sapiens GN=FOSB PE=1 SV=1 | 33 | G | 0.891106 | S | 0.919118 | -0.028012 | No Change: Both D | - |
| P55317 | FOXA1_HUMAN Hepatocyte nuclear factor 3-alpha OS=Homo sapiens GN=FOXA1 PE=1 SV=2 | 83 | A | 0.936801 | T | 0.937694 | -8.93E-04 | No Change: Both D | - |
| P55317 | FOXA1_HUMAN Hepatocyte nuclear factor 3-alpha OS=Homo sapiens GN=FOXA1 PE=1 SV=2 | 448 | S | 0.72955 | N | 0.644206 | 0.085344 | No Change: Both D | - |
| P55317 | FOXA1_HUMAN Hepatocyte nuclear factor 3-alpha OS=Homo sapiens GN=FOXA1 PE=1 SV=2 | 72 | G | 0.924772 | A | 0.917124 | 0.007648 | No Change: Both D | - |
| P55317 | FOXA1_HUMAN Hepatocyte nuclear factor 3-alpha OS=Homo sapiens GN=FOXA1 PE=1 SV=2 | 185 | Q | 0.35543 | R | 0.323232 | 0.032198 | No Change: Both O | - |
| P55317 | FOXA1_HUMAN Hepatocyte nuclear factor 3-alpha OS=Homo sapiens GN=FOXA1 PE=1 SV=2 | 87 | G | 0.941913 | E | 0.929898 | 0.012015 | No Change: Both D | - |
| Q9Y261 | FOXA2_HUMAN Hepatocyte nuclear factor 3-beta OS=Homo sapiens GN=FOXA2 PE=1 SV=1 | 328 | A | 0.988529 | V | 0.979317 | 0.009212 | No Change: Both D | - |
| P55318 | FOXA3_HUMAN Hepatocyte nuclear factor 3-gamma OS=Homo sapiens GN=FOXA3 PE=1 SV=2 | 91 | G | 0.938021 | R | 0.934475 | 0.003546 | No Change: Both D | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 112 | F | 0.123675 | S | 0.265505 | -0.14183 | No Change: Both O | Iridogoniodysgenesis anomaly (IGDA) [MIM:601631] |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 112 | F | 0.123675 | S | 0.265505 | -0.14183 | No Change: Both O | Peters anomaly (PAN) [MIM:604229] |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 126 | I | 0.365869 | M | 0.460281 | -0.094412 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 131 | S | 0.228532 | L | 0.113249 | 0.115283 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 82 | S | 0.257564 | T | 0.239668 | 0.017896 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 87 | I | 0.191808 | M | 0.275077 | -0.083269 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 161 | M | 0.661439 | K | 0.75724 | -0.095801 | No Change: Both D | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 79 | P | 0.467811 | L | 0.280535 | 0.187276 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 79 | P | 0.467811 | R | 0.391157 | 0.076654 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 79 | P | 0.467811 | T | 0.381909 | 0.085902 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 86 | L | 0.169293 | F | 0.166513 | 0.00278 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 91 | I | 0.233726 | S | 0.371538 | -0.137812 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 91 | I | 0.233726 | T | 0.328975 | -0.095249 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 115 | Y | 0.229742 | S | 0.387473 | -0.157731 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 127 | R | 0.313802 | H | 0.326989 | -0.013187 | No Change: Both O | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 130 | L | 0.240456 | F | 0.219772 | 0.020684 | No Change: Both O | Axenfeld-Rieger syndrome type 3 (RIEG3) [MIM:602482] |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 149 | G | 0.571963 | D | 0.612468 | -0.040505 | No Change: Both D | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 161 | M | 0.661439 | V | 0.613249 | 0.04819 | No Change: Both D | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 165 | G | 0.748639 | R | 0.797992 | -0.049353 | No Change: Both D | - |
| Q12948 | FOXC1_HUMAN Forkhead box protein C1 OS=Homo sapiens GN=FOXC1 PE=1 SV=3 | 169 | R | 0.823083 | P | 0.825905 | -0.002822 | No Change: Both D | - |
| Q99958 | FOXC2_HUMAN Forkhead box protein C2 OS=Homo sapiens GN=FOXC2 PE=1 SV=1 | 125 | S | 0.226775 | L | 0.111686 | 0.115089 | No Change: Both O | Lymphedema-distichiasis (LYD) [MIM:153400] |
| Q99958 | FOXC2_HUMAN Forkhead box protein C2 OS=Homo sapiens GN=FOXC2 PE=1 SV=1 | 191 | S | 0.982646 | F | 0.966408 | 0.016238 | No Change: Both D | - |
| O60548 | FOXD2_HUMAN Forkhead box protein D2 OS=Homo sapiens GN=FOXD2 PE=2 SV=2 | 368 | A | 0.744117 | P | 0.790174 | -0.046057 | No Change: Both D | - |
| Q12950 | FOXD4_HUMAN Forkhead box protein D4 OS=Homo sapiens GN=FOXD4 PE=2 SV=4 | 134 | I | 0.093487 | F | 0.096659 | -0.003172 | No Change: Both O | - |
| Q12950 | FOXD4_HUMAN Forkhead box protein D4 OS=Homo sapiens GN=FOXD4 PE=2 SV=4 | 136 | D | 0.110756 | G | 0.102139 | 0.008617 | No Change: Both O | - |
| Q12950 | FOXD4_HUMAN Forkhead box protein D4 OS=Homo sapiens GN=FOXD4 PE=2 SV=4 | 152 | I | 0.277549 | V | 0.303192 | -0.025643 | No Change: Both O | - |
| Q9NU39 | FX4L1_HUMAN Forkhead box protein D4-like 1 OS=Homo sapiens GN=FOXD4L1 PE=2 SV=1 | 29 | V | 0.981596 | I | 0.981207 | 3.89E-04 | No Change: Both D | - |
| O00358 | FOXE1_HUMAN Forkhead box protein E1 OS=Homo sapiens GN=FOXE1 PE=1 SV=3 | 65 | A | 0.23444 | V | 0.150801 | 0.083639 | No Change: Both O | Bamforth-Lazarus syndrome (BLS) [MIM:241850] |
| O00358 | FOXE1_HUMAN Forkhead box protein E1 OS=Homo sapiens GN=FOXE1 PE=1 SV=3 | 57 | S | 0.380369 | N | 0.346568 | 0.033801 | No Change: Both O | Bamforth-Lazarus syndrome (BLS) [MIM:241850] |
| O00358 | FOXE1_HUMAN Forkhead box protein E1 OS=Homo sapiens GN=FOXE1 PE=1 SV=3 | 102 | R | 0.256058 | C | 0.145722 | 0.110336 | No Change: Both O | - |
| Q13461 | FOXE3_HUMAN Forkhead box protein E3 OS=Homo sapiens GN=FOXE3 PE=2 SV=2 | 196 | G | 0.966828 | A | 0.969711 | -0.002883 | No Change: Both D | - |
| Q13461 | FOXE3_HUMAN Forkhead box protein E3 OS=Homo sapiens GN=FOXE3 PE=2 SV=2 | 300 | S | 0.824085 | G | 0.815727 | 0.008358 | No Change: Both D | - |
| Q13461 | FOXE3_HUMAN Forkhead box protein E3 OS=Homo sapiens GN=FOXE3 PE=2 SV=2 | 49 | G | 0.991024 | A | 0.990956 | 6.80E-05 | No Change: Both D | - |
| Q13461 | FOXE3_HUMAN Forkhead box protein E3 OS=Homo sapiens GN=FOXE3 PE=2 SV=2 | 82 | M | 0.363741 | V | 0.297422 | 0.066319 | No Change: Both O | - |
| Q13461 | FOXE3_HUMAN Forkhead box protein E3 OS=Homo sapiens GN=FOXE3 PE=2 SV=2 | 90 | R | 0.296396 | L | 0.212795 | 0.083601 | No Change: Both O | Anterior segment mesenchymal dysgenesis (ASMD) [MIM:107250] |
| P55316 | FOXG1_HUMAN Forkhead box protein G1 OS=Homo sapiens GN=FOXG1 PE=1 SV=2 | 215 | F | 0.181379 | L | 0.19161 | -0.010231 | No Change: Both O | Congenital variant of Rett syndrome (RTTCV) [MIM:613454] |
| P55316 | FOXG1_HUMAN Forkhead box protein G1 OS=Homo sapiens GN=FOXG1 PE=1 SV=2 | 109 | P | 0.997435 | L | 0.995203 | 0.002232 | No Change: Both D | - |
| P55316 | FOXG1_HUMAN Forkhead box protein G1 OS=Homo sapiens GN=FOXG1 PE=1 SV=2 | 244 | R | 0.315131 | C | 0.191418 | 0.123713 | No Change: Both O | Congenital variant of Rett syndrome (RTTCV) [MIM:613454] |
| O75593 | FOXH1_HUMAN Forkhead box protein H1 OS=Homo sapiens GN=FOXH1 PE=1 SV=1 | 113 | S | 0.151921 | T | 0.116345 | 0.035576 | No Change: Both O | Colorectal cancer |
| O75593 | FOXH1_HUMAN Forkhead box protein H1 OS=Homo sapiens GN=FOXH1 PE=1 SV=1 | 125 | T | 0.177787 | S | 0.237995 | -0.060208 | No Change: Both O | Colorectal cancer |
| Q12951 | FOXI1_HUMAN Forkhead box protein I1 OS=Homo sapiens GN=FOXI1 PE=2 SV=3 | 243 | P | 0.983946 | S | 0.984987 | -0.001041 | No Change: Both D | - |
| Q12951 | FOXI1_HUMAN Forkhead box protein I1 OS=Homo sapiens GN=FOXI1 PE=2 SV=3 | 362 | N | 0.425397 | S | 0.494547 | -0.06915 | No Change: Both O | - |
| Q9P0K8 | FOXJ2_HUMAN Forkhead box protein J2 OS=Homo sapiens GN=FOXJ2 PE=1 SV=1 | 310 | P | 0.999944 | S | 0.999932 | 1.20E-05 | No Change: Both D | - |
| Q9P0K8 | FOXJ2_HUMAN Forkhead box protein J2 OS=Homo sapiens GN=FOXJ2 PE=1 SV=1 | 229 | P | 0.697711 | R | 0.668251 | 0.02946 | No Change: Both D | - |
| Q9UPW0 | FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens GN=FOXJ3 PE=1 SV=2 | 162 | V | 0.771619 | A | 0.819994 | -0.048375 | No Change: Both D | - |
| Q9UPW0 | FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens GN=FOXJ3 PE=1 SV=2 | 377 | T | 0.99462 | P | 0.996327 | -0.001707 | No Change: Both D | - |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 187 | G | 0.534422 | D | 0.521145 | 0.013277 | No Change: Both D | Premature ovarian failure type 3 (POF3) [MIM:608996] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 285 | P | 0.986436 | S | 0.98296 | 0.003476 | No Change: Both D | - |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 84 | I | 0.050967 | S | 0.127796 | -0.076829 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 106 | L | 0.220825 | F | 0.197416 | 0.023409 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 109 | N | 0.193462 | K | 0.224922 | -0.03146 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 217 | S | 0.890766 | F | 0.792058 | 0.098708 | No Change: Both D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 58 | S | 0.527797 | L | 0.414445 | 0.113352 | D to O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 66 | A | 0.274673 | V | 0.201706 | 0.072967 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 69 | E | 0.38083 | K | 0.381221 | -3.91E-04 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 104 | H | 0.282251 | R | 0.297954 | -0.015703 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 105 | N | 0.260218 | S | 0.298762 | -0.038544 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 179 | A | 0.587991 | G | 0.636473 | -0.048482 | No Change: Both D | - |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 193 | K | 0.543923 | R | 0.503347 | 0.040576 | No Change: Both D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 215 | Y | 0.878543 | C | 0.899346 | -0.020803 | No Change: Both D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 258 | Y | 0.761317 | N | 0.82331 | -0.061993 | No Change: Both D | Premature ovarian failure type 3 (POF3) [MIM:608996] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 65 | M | 0.248293 | V | 0.206875 | 0.041418 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 80 | I | 0.080847 | T | 0.138105 | -0.057258 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 84 | I | 0.050967 | N | 0.101474 | -0.050507 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 90 | F | 0.193705 | S | 0.374156 | -0.180451 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 98 | W | 0.491955 | G | 0.631945 | -0.13999 | O to D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 101 | S | 0.4381 | R | 0.371446 | 0.066654 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 102 | I | 0.377194 | T | 0.513452 | -0.136258 | O to D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 103 | R | 0.314576 | C | 0.178658 | 0.135918 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 106 | L | 0.220825 | P | 0.363301 | -0.142476 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 63 | I | 0.275463 | T | 0.359469 | -0.084006 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 98 | W | 0.491955 | R | 0.623739 | -0.131784 | O to D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 108 | L | 0.205199 | P | 0.348473 | -0.143274 | No Change: Both O | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 134 | C | 0.589839 | W | 0.50706 | 0.082779 | No Change: Both D | Granulosa-cell tumors of the ovary |
| P58012 | FOXL2_HUMAN Forkhead box protein L2 OS=Homo sapiens GN=FOXL2 PE=1 SV=1 | 217 | S | 0.890766 | C | 0.829355 | 0.061411 | No Change: Both D | Blepharophimosis ptosis and epicanthus inversus syndrome (BPES) [MIM:110100] |
| Q08050 | FOXM1_HUMAN Forkhead box protein M1 OS=Homo sapiens GN=FOXM1 PE=1 SV=3 | 643 | S | 0.916163 | P | 0.924177 | -0.008014 | No Change: Both D | - |
| Q08050 | FOXM1_HUMAN Forkhead box protein M1 OS=Homo sapiens GN=FOXM1 PE=1 SV=3 | 402 | A | 0.578641 | E | 0.667207 | -0.088566 | No Change: Both D | - |
| Q08050 | FOXM1_HUMAN Forkhead box protein M1 OS=Homo sapiens GN=FOXM1 PE=1 SV=3 | 450 | F | 0.757023 | L | 0.795488 | -0.038465 | No Change: Both D | - |
| Q08050 | FOXM1_HUMAN Forkhead box protein M1 OS=Homo sapiens GN=FOXM1 PE=1 SV=3 | 669 | P | 0.967812 | R | 0.95547 | 0.012342 | No Change: Both D | - |
| Q08050 | FOXM1_HUMAN Forkhead box protein M1 OS=Homo sapiens GN=FOXM1 PE=1 SV=3 | 673 | P | 0.969762 | L | 0.947027 | 0.022735 | No Change: Both D | - |
| O15353 | FOXN1_HUMAN Forkhead box protein N1 OS=Homo sapiens GN=FOXN1 PE=2 SV=1 | 283 | A | 0.18895 | V | 0.140874 | 0.048076 | No Change: Both O | - |
| O15353 | FOXN1_HUMAN Forkhead box protein N1 OS=Homo sapiens GN=FOXN1 PE=2 SV=1 | 69 | R | 0.983122 | C | 0.978873 | 0.004249 | No Change: Both D | - |
| O15353 | FOXN1_HUMAN Forkhead box protein N1 OS=Homo sapiens GN=FOXN1 PE=2 SV=1 | 599 | A | 0.875532 | P | 0.907508 | -0.031976 | No Change: Both D | - |
| O15353 | FOXN1_HUMAN Forkhead box protein N1 OS=Homo sapiens GN=FOXN1 PE=2 SV=1 | 411 | R | 0.981024 | W | 0.956181 | 0.024843 | No Change: Both D | - |
| O00409 | FOXN3_HUMAN Forkhead box protein N3 OS=Homo sapiens GN=FOXN3 PE=1 SV=1 | 337 | Y | 0.985001 | H | 0.991213 | -0.006212 | No Change: Both D | - |
| Q96NZ1 | FOXN4_HUMAN Forkhead box protein N4 OS=Homo sapiens GN=FOXN4 PE=2 SV=2 | 137 | P | 0.962463 | L | 0.926043 | 0.03642 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 5 | S | 0.964551 | P | 0.950625 | 0.013926 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 101 | M | 0.952195 | V | 0.937146 | 0.015049 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 215 | P | 0.808315 | A | 0.736702 | 0.071613 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 261 | S | 0.872178 | P | 0.858242 | 0.013936 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 390 | T | 0.956072 | S | 0.967687 | -0.011615 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 445 | V | 0.439534 | M | 0.504798 | -0.065264 | O to D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 570 | N | 0.555888 | S | 0.612827 | -0.056939 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 597 | N | 0.751983 | T | 0.741578 | 0.010405 | No Change: Both D | - |
| Q9H334 | FOXP1_HUMAN Forkhead box protein P1 OS=Homo sapiens GN=FOXP1 PE=1 SV=1 | 613 | T | 0.909843 | N | 0.926125 | -0.016282 | No Change: Both D | - |
| O15409 | FOXP2_HUMAN Forkhead box protein P2 OS=Homo sapiens GN=FOXP2 PE=1 SV=2 | 553 | R | 0.262434 | H | 0.284944 | -0.02251 | No Change: Both O | Speech-language disorder 1 (SPCH1) [MIM:602081] |
| Q9BZS1 | FOXP3_HUMAN Forkhead box protein P3 OS=Homo sapiens GN=FOXP3 PE=1 SV=1 | 371 | F | 0.066352 | C | 0.055802 | 0.01055 | No Change: Both O | Immunodeficiency polyendocrinopathy enteropathy X-linked syndrome (IPEX) [MIM:304790] |
| Q9BZS1 | FOXP3_HUMAN Forkhead box protein P3 OS=Homo sapiens GN=FOXP3 PE=1 SV=1 | 384 | A | 0.344964 | T | 0.374346 | -0.029382 | No Change: Both O | Immunodeficiency polyendocrinopathy enteropathy X-linked syndrome (IPEX) [MIM:304790] |
| Q9BZS1 | FOXP3_HUMAN Forkhead box protein P3 OS=Homo sapiens GN=FOXP3 PE=1 SV=1 | 397 | R | 0.268664 | W | 0.133051 | 0.135613 | No Change: Both O | Immunodeficiency polyendocrinopathy enteropathy X-linked syndrome (IPEX) [MIM:304790] |
| Q9BZS1 | FOXP3_HUMAN Forkhead box protein P3 OS=Homo sapiens GN=FOXP3 PE=1 SV=1 | 363 | I | 0.11913 | V | 0.13423 | -0.0151 | No Change: Both O | Immunodeficiency polyendocrinopathy enteropathy X-linked syndrome (IPEX) [MIM:304790] |
| Q8IVH2 | FOXP4_HUMAN Forkhead box protein P4 OS=Homo sapiens GN=FOXP4 PE=1 SV=1 | 464 | A | 0.39725 | T | 0.421672 | -0.024422 | No Change: Both O | A breast cancer sample |
| Q9C009 | FOXQ1_HUMAN Forkhead box protein Q1 OS=Homo sapiens GN=FOXQ1 PE=2 SV=2 | 60 | T | 0.977345 | P | 0.986419 | -0.009074 | No Change: Both D | - |
| Q9C009 | FOXQ1_HUMAN Forkhead box protein Q1 OS=Homo sapiens GN=FOXQ1 PE=2 SV=2 | 61 | Q | 0.977019 | P | 0.98071 | -0.003691 | No Change: Both D | - |
| Q6PJQ5 | FOXR2_HUMAN Forkhead box protein R2 OS=Homo sapiens GN=FOXR2 PE=2 SV=1 | 286 | V | 0.306228 | A | 0.440985 | -0.134757 | No Change: Both O | - |
| Q96CU9 | FXRD1_HUMAN FAD-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens GN=FOXRED1 PE=1 SV=2 | 343 | A | 0.372992 | P | 0.465422 | -0.09243 | No Change: Both O | - |
| Q96CU9 | FXRD1_HUMAN FAD-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens GN=FOXRED1 PE=1 SV=2 | 145 | V | 0.160836 | I | 0.141404 | 0.019432 | No Change: Both O | - |
| Q96CU9 | FXRD1_HUMAN FAD-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens GN=FOXRED1 PE=1 SV=2 | 380 | H | 0.305452 | R | 0.32463 | -0.019178 | No Change: Both O | - |
| Q96CU9 | FXRD1_HUMAN FAD-dependent oxidoreductase domain-containing protein 1 OS=Homo sapiens GN=FOXRED1 PE=1 SV=2 | 430 | N | 0.100702 | S | 0.124053 | -0.023351 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q8IWF2 | FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=FOXRED2 PE=1 SV=1 | 179 | F | 0.089824 | L | 0.109938 | -0.020114 | No Change: Both O | - |
| Q8IWF2 | FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=FOXRED2 PE=1 SV=1 | 308 | N | 0.532493 | S | 0.576635 | -0.044142 | No Change: Both D | - |
| Q8IWF2 | FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=FOXRED2 PE=1 SV=1 | 374 | K | 0.5243 | R | 0.494339 | 0.029961 | D to O | - |
| Q8IWF2 | FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=FOXRED2 PE=1 SV=1 | 637 | E | 0.580015 | D | 0.564798 | 0.015217 | No Change: Both D | - |
| Q8IWF2 | FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=FOXRED2 PE=1 SV=1 | 71 | R | 0.37908 | C | 0.203523 | 0.175557 | No Change: Both O | - |
| O43638 | FOXS1_HUMAN Forkhead box protein S1 OS=Homo sapiens GN=FOXS1 PE=2 SV=2 | 292 | P | 0.784825 | A | 0.707323 | 0.077502 | No Change: Both D | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 437 | V | 0.075615 | D | 0.154255 | -0.07864 | No Change: Both O | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 489 | A | 0.83409 | V | 0.782406 | 0.051684 | No Change: Both D | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 528 | S | 0.498791 | T | 0.396934 | 0.101857 | No Change: Both O | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 22 | I | 0.471164 | V | 0.545079 | -0.073915 | O to D | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 13 | F | 0.517193 | L | 0.629179 | -0.111986 | No Change: Both D | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 466 | R | 0.296008 | C | 0.262852 | 0.033156 | No Change: Both O | - |
| Q05932 | FOLC_HUMAN Folylpolyglutamate synthase mitochondrial OS=Homo sapiens GN=FPGS PE=1 SV=3 | 499 | S | 0.842842 | F | 0.674966 | 0.167876 | No Change: Both D | - |
| O14772 | FPGT_HUMAN Fucose-1-phosphate guanylyltransferase OS=Homo sapiens GN=FPGT PE=1 SV=2 | 448 | P | 0.184958 | L | 0.103951 | 0.081007 | No Change: Both O | - |
| P21462 | FPR1_HUMAN fMet-Leu-Phe receptor OS=Homo sapiens GN=FPR1 PE=1 SV=3 | 101 | V | 0.008721 | L | 0.008724 | -3.00E-06 | No Change: Both O | - |
| P21462 | FPR1_HUMAN fMet-Leu-Phe receptor OS=Homo sapiens GN=FPR1 PE=1 SV=3 | 192 | N | 0.200429 | K | 0.235766 | -0.035337 | No Change: Both O | - |
| P21462 | FPR1_HUMAN fMet-Leu-Phe receptor OS=Homo sapiens GN=FPR1 PE=1 SV=3 | 346 | E | 0.940909 | A | 0.923387 | 0.017522 | No Change: Both D | - |
| P21462 | FPR1_HUMAN fMet-Leu-Phe receptor OS=Homo sapiens GN=FPR1 PE=1 SV=3 | 11 | I | 0.685897 | T | 0.81637 | -0.130473 | No Change: Both D | - |
| P21462 | FPR1_HUMAN fMet-Leu-Phe receptor OS=Homo sapiens GN=FPR1 PE=1 SV=3 | 190 | R | 0.345729 | W | 0.187 | 0.158729 | No Change: Both O | - |
| Q70Z53 | F10C1_HUMAN Protein FRA10AC1 OS=Homo sapiens GN=FRA10AC1 PE=1 SV=3 | 16 | R | 0.938469 | H | 0.9279 | 0.010569 | No Change: Both D | - |
| Q70Z53 | F10C1_HUMAN Protein FRA10AC1 OS=Homo sapiens GN=FRA10AC1 PE=1 SV=3 | 78 | T | 0.193035 | R | 0.223101 | -0.030066 | No Change: Both O | - |
| Q70Z53 | F10C1_HUMAN Protein FRA10AC1 OS=Homo sapiens GN=FRA10AC1 PE=1 SV=3 | 251 | S | 0.99926 | F | 0.998368 | 8.92E-04 | No Change: Both D | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 54 | D | 0.136048 | H | 0.115229 | 0.020819 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 209 | P | 0.518102 | S | 0.520205 | -0.002103 | No Change: Both D | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 228 | Y | 0.547233 | H | 0.687194 | -0.139961 | No Change: Both D | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 243 | I | 0.530421 | V | 0.593849 | -0.063428 | No Change: Both D | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 429 | S | 0.710763 | Y | 0.485548 | 0.225215 | D to O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 466 | L | 0.433722 | I | 0.33436 | 0.099362 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 590 | M | 0.73568 | T | 0.778996 | -0.043316 | No Change: Both D | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 817 | A | 0.270252 | V | 0.19611 | 0.074142 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 954 | T | 0.332886 | M | 0.297297 | 0.035589 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 1022 | G | 0.422901 | E | 0.488085 | -0.065184 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 1135 | E | 0.328178 | K | 0.314745 | 0.013433 | No Change: Both O | - |
| Q86XX4 | FRAS1_HUMAN Extracellular matrix protein FRAS1 OS=Homo sapiens GN=FRAS1 PE=2 SV=1 | 1625 | A | 0.479207 | V | 0.420635 | 0.058572 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 439 | V | 0.144473 | L | 0.134054 | 0.010419 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 499 | I | 0.153055 | V | 0.181378 | -0.028323 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 803 | S | 0.345149 | Y | 0.175312 | 0.169837 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 863 | L | 0.264716 | V | 0.261558 | 0.003158 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1202 | S | 0.553941 | R | 0.505759 | 0.048182 | No Change: Both D | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1273 | D | 0.540729 | E | 0.587588 | -0.046859 | No Change: Both D | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1502 | V | 0.184303 | M | 0.215011 | -0.030708 | No Change: Both O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1576 | N | 0.578792 | I | 0.392601 | 0.186191 | D to O | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 2143 | Q | 0.724122 | P | 0.734136 | -0.010014 | No Change: Both D | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 2174 | V | 0.682924 | G | 0.777112 | -0.094188 | No Change: Both D | - |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 649 | R | 0.35191 | W | 0.181512 | 0.170398 | No Change: Both O | Bifid nose with or without anorectal and renal anomalies (BNAR) [MIM:608980] |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1440 | G | 0.339446 | S | 0.410694 | -0.071248 | No Change: Both O | Bifid nose with or without anorectal and renal anomalies (BNAR) [MIM:608980] |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 1324 | L | 0.326268 | R | 0.445204 | -0.118936 | No Change: Both O | Manitoba oculotrichoanal syndrome (MOTA) [MIM:248450] |
| Q5H8C1 | FREM1_HUMAN FRAS1-related extracellular matrix protein 1 OS=Homo sapiens GN=FREM1 PE=1 SV=3 | 2091 | V | 0.133808 | I | 0.109246 | 0.024562 | No Change: Both O | Manitoba oculotrichoanal syndrome (MOTA) [MIM:248450] |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1972 | E | 0.420325 | K | 0.392798 | 0.027527 | No Change: Both O | Fraser syndrome (FRASS) [MIM:219000] |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 2066 | R | 0.336525 | C | 0.220276 | 0.116249 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 2153 | T | 0.448046 | S | 0.52294 | -0.074894 | O to D | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 2326 | T | 0.377063 | I | 0.264026 | 0.113037 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 770 | V | 0.237299 | M | 0.268345 | -0.031046 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 868 | L | 0.335654 | V | 0.345726 | -0.010072 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1039 | M | 0.440765 | K | 0.570565 | -0.1298 | O to D | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1070 | F | 0.183609 | S | 0.385451 | -0.201842 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1840 | R | 0.338207 | W | 0.163954 | 0.174253 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1045 | I | 0.298413 | S | 0.533498 | -0.235085 | O to D | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 1668 | R | 0.3606 | H | 0.382312 | -0.021712 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 2962 | A | 0.413728 | V | 0.349895 | 0.063833 | No Change: Both O | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 722 | R | 0.569241 | K | 0.579605 | -0.010364 | No Change: Both D | - |
| Q5SZK8 | FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens GN=FREM2 PE=1 SV=2 | 745 | S | 0.689966 | P | 0.717075 | -0.027109 | No Change: Both D | - |
| P0C091 | FREM3_HUMAN FRAS1-related extracellular matrix protein 3 OS=Homo sapiens GN=FREM3 PE=2 SV=2 | 412 | D | 0.463976 | N | 0.425251 | 0.038725 | No Change: Both O | - |
| P0C091 | FREM3_HUMAN FRAS1-related extracellular matrix protein 3 OS=Homo sapiens GN=FREM3 PE=2 SV=2 | 417 | D | 0.350546 | N | 0.316493 | 0.034053 | No Change: Both O | - |
| Q14331 | FRG1_HUMAN Protein FRG1 OS=Homo sapiens GN=FRG1 PE=1 SV=1 | 66 | K | 0.294753 | E | 0.307446 | -0.012693 | No Change: Both O | - |
| Q14331 | FRG1_HUMAN Protein FRG1 OS=Homo sapiens GN=FRG1 PE=1 SV=1 | 19 | T | 0.972103 | A | 0.959266 | 0.012837 | No Change: Both D | - |
| A6NGY1 | FRG2C_HUMAN Protein FRG2-like-2 OS=Homo sapiens GN=FRG2C PE=3 SV=1 | 12 | C | 0.91909 | R | 0.927708 | -0.008618 | No Change: Both D | - |
| A6NGY1 | FRG2C_HUMAN Protein FRG2-like-2 OS=Homo sapiens GN=FRG2C PE=3 SV=1 | 210 | L | 0.173244 | M | 0.202501 | -0.029257 | No Change: Both O | - |
| P42685 | FRK_HUMAN Tyrosine-protein kinase FRK OS=Homo sapiens GN=FRK PE=1 SV=1 | 122 | G | 0.315203 | R | 0.333725 | -0.018522 | No Change: Both O | - |
| P42685 | FRK_HUMAN Tyrosine-protein kinase FRK OS=Homo sapiens GN=FRK PE=1 SV=1 | 100 | I | 0.32747 | V | 0.373804 | -0.046334 | No Change: Both O | - |
| P42685 | FRK_HUMAN Tyrosine-protein kinase FRK OS=Homo sapiens GN=FRK PE=1 SV=1 | 133 | S | 0.501216 | L | 0.316184 | 0.185032 | D to O | - |
| Q8N878 | FRMD1_HUMAN FERM domain-containing protein 1 OS=Homo sapiens GN=FRMD1 PE=2 SV=2 | 274 | R | 0.4705 | C | 0.318668 | 0.151832 | No Change: Both O | - |
| Q8N878 | FRMD1_HUMAN FERM domain-containing protein 1 OS=Homo sapiens GN=FRMD1 PE=2 SV=2 | 456 | Q | 0.95839 | E | 0.95828 | 1.10E-04 | No Change: Both D | - |
| A2A2Y4 | FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens GN=FRMD3 PE=2 SV=1 | 485 | D | 0.842252 | Y | 0.69788 | 0.144372 | No Change: Both D | - |
| Q9P2Q2 | FRM4A_HUMAN FERM domain-containing protein 4A OS=Homo sapiens GN=FRMD4A PE=1 SV=3 | 242 | Q | 0.199717 | H | 0.199799 | -8.20E-05 | No Change: Both O | - |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 24 | G | 0.458196 | E | 0.509872 | -0.051676 | O to D | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 24 | G | 0.458196 | R | 0.45516 | 0.003036 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 142 | L | 0.443592 | R | 0.548087 | -0.104495 | O to D | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 221 | N | 0.174905 | D | 0.171062 | 0.003843 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 226 | A | 0.145659 | T | 0.176386 | -0.030727 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 231 | L | 0.279703 | V | 0.276042 | 0.003661 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 266 | A | 0.139665 | P | 0.182824 | -0.043159 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 271 | C | 0.127207 | Y | 0.112798 | 0.014409 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 281 | S | 0.585756 | L | 0.449321 | 0.136435 | D to O | - |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 301 | Y | 0.833217 | C | 0.863279 | -0.030062 | No Change: Both D | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 340 | S | 0.697975 | L | 0.529291 | 0.168684 | No Change: Both D | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 468 | R | 0.439532 | H | 0.444262 | -0.00473 | No Change: Both O | - |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 24 | G | 0.458196 | W | 0.256501 | 0.201695 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 146 | R | 0.333766 | W | 0.151516 | 0.18225 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 225 | W | 0.13768 | G | 0.313664 | -0.175984 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 229 | R | 0.236129 | C | 0.11381 | 0.122319 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 229 | R | 0.236129 | G | 0.236095 | 3.40E-05 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 261 | R | 0.226114 | G | 0.230982 | -0.004868 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 261 | R | 0.226114 | Q | 0.237246 | -0.011132 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 271 | C | 0.127207 | F | 0.117947 | 0.00926 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 275 | H | 0.179843 | P | 0.269174 | -0.089331 | No Change: Both O | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q6ZUT3 | FRMD7_HUMAN FERM domain-containing protein 7 OS=Homo sapiens GN=FRMD7 PE=1 SV=1 | 296 | G | 0.75957 | R | 0.796457 | -0.036887 | No Change: Both D | Nystagmus congenital X-linked type 1 (NYS1) [MIM:310700] |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 6 | T | 0.740237 | P | 0.755148 | -0.014911 | No Change: Both D | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 44 | A | 0.598758 | T | 0.62034 | -0.021582 | No Change: Both D | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 50 | T | 0.419243 | N | 0.442515 | -0.023272 | No Change: Both O | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 225 | A | 0.221232 | V | 0.16458 | 0.056652 | No Change: Both O | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 846 | Y | 0.554456 | D | 0.697749 | -0.143293 | No Change: Both D | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 1092 | G | 0.893561 | E | 0.921141 | -0.02758 | No Change: Both D | - |
| Q5SYB0 | FRPD1_HUMAN FERM and PDZ domain-containing protein 1 OS=Homo sapiens GN=FRMPD1 PE=1 SV=1 | 572 | G | 0.975332 | D | 0.977065 | -0.001733 | No Change: Both D | A breast cancer sample |
| Q68DX3 | FRPD2_HUMAN FERM and PDZ domain-containing protein 2 OS=Homo sapiens GN=FRMPD2 PE=1 SV=3 | 727 | R | 0.61345 | W | 0.401907 | 0.211543 | D to O | A colorectal cancer sample |
| Q68DX3 | FRPD2_HUMAN FERM and PDZ domain-containing protein 2 OS=Homo sapiens GN=FRMPD2 PE=1 SV=3 | 20 | A | 0.418297 | T | 0.442212 | -0.023915 | No Change: Both O | - |
| Q68DX3 | FRPD2_HUMAN FERM and PDZ domain-containing protein 2 OS=Homo sapiens GN=FRMPD2 PE=1 SV=3 | 534 | K | 0.217243 | E | 0.256931 | -0.039688 | No Change: Both O | - |
| Q68DX3 | FRPD2_HUMAN FERM and PDZ domain-containing protein 2 OS=Homo sapiens GN=FRMPD2 PE=1 SV=3 | 239 | T | 0.949596 | M | 0.938542 | 0.011054 | No Change: Both D | - |
| Q68DX3 | FRPD2_HUMAN FERM and PDZ domain-containing protein 2 OS=Homo sapiens GN=FRMPD2 PE=1 SV=3 | 1021 | T | 0.363527 | K | 0.423403 | -0.059876 | No Change: Both O | - |
| Q8WU20 | FRS2_HUMAN Fibroblast growth factor receptor substrate 2 OS=Homo sapiens GN=FRS2 PE=1 SV=4 | 303 | K | 0.557953 | N | 0.602733 | -0.04478 | No Change: Both D | - |
| Q8WU20 | FRS2_HUMAN Fibroblast growth factor receptor substrate 2 OS=Homo sapiens GN=FRS2 PE=1 SV=4 | 449 | N | 0.851374 | D | 0.869635 | -0.018261 | No Change: Both D | - |
| O43559 | FRS3_HUMAN Fibroblast growth factor receptor substrate 3 OS=Homo sapiens GN=FRS3 PE=1 SV=3 | 221 | P | 0.891324 | L | 0.795846 | 0.095478 | No Change: Both D | - |
| Q5TBA9 | FRY_HUMAN Protein furry homolog OS=Homo sapiens GN=FRY PE=1 SV=1 | 1968 | G | 0.930066 | S | 0.947996 | -0.01793 | No Change: Both D | - |
| O94915 | FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens GN=FRYL PE=1 SV=2 | 1878 | I | 0.314603 | V | 0.344375 | -0.029772 | No Change: Both O | - |
| Q92765 | SFRP3_HUMAN Secreted frizzled-related protein 3 OS=Homo sapiens GN=FRZB PE=1 SV=2 | 324 | R | 0.998277 | G | 0.997722 | 5.55E-04 | No Change: Both D | - |
| Q92765 | SFRP3_HUMAN Secreted frizzled-related protein 3 OS=Homo sapiens GN=FRZB PE=1 SV=2 | 200 | R | 0.216912 | W | 0.087197 | 0.129715 | No Change: Both O | - |
| O95073 | FSBP_HUMAN Fibrinogen silencer-binding protein OS=Homo sapiens GN=FSBP PE=2 SV=1 | 226 | R | 0.573126 | K | 0.600657 | -0.027531 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 262 | T | 0.926302 | R | 0.930536 | -0.004234 | No Change: Both D | A breast cancer sample |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 764 | Q | 0.65392 | K | 0.669864 | -0.015944 | No Change: Both D | A breast cancer sample |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 775 | S | 0.43147 | L | 0.286246 | 0.145224 | No Change: Both O | A breast cancer sample |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 119 | P | 0.713302 | S | 0.707626 | 0.005676 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 195 | H | 0.921586 | Q | 0.939704 | -0.018118 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 380 | L | 0.984746 | P | 0.991855 | -0.007109 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 409 | P | 0.962463 | S | 0.952526 | 0.009937 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 423 | D | 0.975136 | E | 0.984627 | -0.009491 | No Change: Both D | - |
| Q5H9T9 | FSCB_HUMAN Fibrous sheath CABYR-binding protein OS=Homo sapiens GN=FSCB PE=2 SV=3 | 642 | A | 0.999944 | T | 0.999924 | 2.00E-05 | No Change: Both D | - |
| Q9NQT6 | FSCN3_HUMAN Fascin-3 OS=Homo sapiens GN=FSCN3 PE=1 SV=1 | 24 | A | 0.05765 | S | 0.09831 | -0.04066 | No Change: Both O | - |
| Q9NQT6 | FSCN3_HUMAN Fascin-3 OS=Homo sapiens GN=FSCN3 PE=1 SV=1 | 428 | H | 0.172411 | L | 0.106268 | 0.066143 | No Change: Both O | - |
| Q9BTV5 | FSD1_HUMAN Fibronectin type III and SPRY domain-containing protein 1 OS=Homo sapiens GN=FSD1 PE=1 SV=1 | 232 | L | 0.214738 | V | 0.20466 | 0.010078 | No Change: Both O | - |
| A1L4K1 | FSD2_HUMAN Fibronectin type III and SPRY domain-containing protein 2 OS=Homo sapiens GN=FSD2 PE=2 SV=1 | 333 | K | 0.459216 | T | 0.395398 | 0.063818 | No Change: Both O | - |
| A1L4K1 | FSD2_HUMAN Fibronectin type III and SPRY domain-containing protein 2 OS=Homo sapiens GN=FSD2 PE=2 SV=1 | 720 | E | 0.12787 | K | 0.127346 | 5.24E-04 | No Change: Both O | - |
| P01225 | FSHB_HUMAN Follitropin subunit beta OS=Homo sapiens GN=FSHB PE=1 SV=2 | 20 | S | 0.066439 | I | 0.027339 | 0.0391 | No Change: Both O | - |
| P01225 | FSHB_HUMAN Follitropin subunit beta OS=Homo sapiens GN=FSHB PE=1 SV=2 | 69 | C | 0.21051 | G | 0.380475 | -0.169965 | No Change: Both O | Isolated follicle-stimulating hormone deficiency (IFSHD) [MIM:229070] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 307 | A | 0.564162 | T | 0.605681 | -0.041519 | No Change: Both D | - |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 524 | S | 0.353089 | R | 0.266246 | 0.086843 | No Change: Both O | - |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 680 | N | 0.470179 | S | 0.547042 | -0.076863 | O to D | - |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 449 | T | 0.085209 | I | 0.044651 | 0.040558 | No Change: Both O | Ovarian hyperstimulation syndrome (OHSS) [MIM:608115] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 567 | D | 0.693684 | N | 0.686943 | 0.006741 | No Change: Both D | Ovarian hyperstimulation syndrome (OHSS) [MIM:608115] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 160 | I | 0.237875 | T | 0.370007 | -0.132132 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 189 | A | 0.187829 | V | 0.142228 | 0.045601 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 419 | A | 0.069188 | T | 0.084142 | -0.014954 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 573 | R | 0.241929 | C | 0.122816 | 0.119113 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 591 | F | 0.111416 | S | 0.258849 | -0.147433 | No Change: Both O | Ovarian sex cord tumor |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 128 | S | 0.177465 | Y | 0.089146 | 0.088319 | No Change: Both O | Ovarian hyperstimulation syndrome (OHSS) [MIM:608115] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 224 | D | 0.305839 | V | 0.190811 | 0.115028 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 348 | P | 0.42537 | R | 0.361734 | 0.063636 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 449 | T | 0.085209 | A | 0.08389 | 0.001319 | No Change: Both O | Ovarian hyperstimulation syndrome (OHSS) [MIM:608115] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 519 | P | 0.198214 | T | 0.153263 | 0.044951 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 545 | I | 0.006534 | T | 0.011808 | -0.005274 | No Change: Both O | Ovarian hyperstimulation syndrome (OHSS) [MIM:608115] |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 567 | D | 0.693684 | G | 0.667005 | 0.026679 | No Change: Both D | - |
| P23945 | FSHR_HUMAN Follicle-stimulating hormone receptor OS=Homo sapiens GN=FSHR PE=1 SV=3 | 601 | L | 0.212427 | V | 0.218409 | -0.005982 | No Change: Both O | Ovarian dysgenesis type 1 (ODG1) [MIM:233300] |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 64 | N | 0.983874 | D | 0.985184 | -0.00131 | No Change: Both D | - |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 354 | R | 0.936429 | H | 0.908591 | 0.027838 | No Change: Both D | - |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 374 | E | 0.923826 | G | 0.893105 | 0.030721 | No Change: Both D | - |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 402 | C | 0.902695 | R | 0.920952 | -0.018257 | No Change: Both D | - |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 411 | L | 0.813522 | F | 0.765258 | 0.048264 | No Change: Both D | - |
| Q8NA03 | FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens GN=FSIP1 PE=2 SV=1 | 528 | G | 0.334907 | A | 0.265436 | 0.069471 | No Change: Both O | - |
| Q5CZC0 | FSIP2_HUMAN Fibrous sheath-interacting protein 2 OS=Homo sapiens GN=FSIP2 PE=1 SV=4 | 306 | M | 0.760159 | V | 0.649308 | 0.110851 | No Change: Both D | - |
| P19883 | FST_HUMAN Follistatin OS=Homo sapiens GN=FST PE=1 SV=2 | 152 | E | 0.548917 | Q | 0.519781 | 0.029136 | No Change: Both D | - |
| Q6MZW2 | FSTL4_HUMAN Follistatin-related protein 4 OS=Homo sapiens GN=FSTL4 PE=2 SV=3 | 158 | R | 0.390472 | H | 0.347921 | 0.042551 | No Change: Both O | - |
| Q6MZW2 | FSTL4_HUMAN Follistatin-related protein 4 OS=Homo sapiens GN=FSTL4 PE=2 SV=3 | 757 | T | 0.17865 | M | 0.156283 | 0.022367 | No Change: Both O | - |
| Q8N475 | FSTL5_HUMAN Follistatin-related protein 5 OS=Homo sapiens GN=FSTL5 PE=2 SV=2 | 92 | L | 0.294785 | I | 0.245776 | 0.049009 | No Change: Both O | A colorectal cancer sample |
| Q8N475 | FSTL5_HUMAN Follistatin-related protein 5 OS=Homo sapiens GN=FSTL5 PE=2 SV=2 | 711 | D | 0.199717 | Y | 0.109407 | 0.09031 | No Change: Both O | - |
| Q8N475 | FSTL5_HUMAN Follistatin-related protein 5 OS=Homo sapiens GN=FSTL5 PE=2 SV=2 | 815 | K | 0.356656 | E | 0.356991 | -3.35E-04 | No Change: Both O | - |
| O95954 | FTCD_HUMAN Formimidoyltransferase-cyclodeaminase OS=Homo sapiens GN=FTCD PE=1 SV=2 | 135 | R | 0.480658 | C | 0.303178 | 0.17748 | No Change: Both O | Glutamate formiminotransferase deficiency (FIGLU-URIA) [MIM:229100] |
| O95954 | FTCD_HUMAN Formimidoyltransferase-cyclodeaminase OS=Homo sapiens GN=FTCD PE=1 SV=2 | 299 | R | 0.23516 | P | 0.252438 | -0.017278 | No Change: Both O | Glutamate formiminotransferase deficiency (FIGLU-URIA) [MIM:229100] |
| O95954 | FTCD_HUMAN Formimidoyltransferase-cyclodeaminase OS=Homo sapiens GN=FTCD PE=1 SV=2 | 438 | A | 0.632822 | E | 0.722062 | -0.08924 | No Change: Both D | - |
| P0C7X4 | FHL19_HUMAN Putative ferritin heavy polypeptide-like 19 OS=Homo sapiens GN=FTH1P19 PE=5 SV=1 | 17 | R | 0.346466 | H | 0.310899 | 0.035567 | No Change: Both O | - |
| P0C7X4 | FHL19_HUMAN Putative ferritin heavy polypeptide-like 19 OS=Homo sapiens GN=FTH1P19 PE=5 SV=1 | 106 | A | 0.366243 | P | 0.448214 | -0.081971 | No Change: Both O | - |
| Q9BXU8 | FHL17_HUMAN Ferritin heavy polypeptide-like 17 OS=Homo sapiens GN=FTHL17 PE=2 SV=1 | 120 | Q | 0.17527 | H | 0.154114 | 0.021156 | No Change: Both O | - |
| Q9BXU8 | FHL17_HUMAN Ferritin heavy polypeptide-like 17 OS=Homo sapiens GN=FTHL17 PE=2 SV=1 | 138 | Y | 0.246743 | H | 0.379694 | -0.132951 | No Change: Both O | - |
| P02792 | FRIL_HUMAN Ferritin light chain OS=Homo sapiens GN=FTL PE=1 SV=2 | 96 | A | 0.654885 | T | 0.655005 | -1.20E-04 | No Change: Both D | Neurodegeneration with brain iron accumulation type 3 (NBIA3) [MIM:606159] |
| Q9C0B1 | FTO_HUMAN Alpha-ketoglutarate-dependent dioxygenase FTO OS=Homo sapiens GN=FTO PE=1 SV=3 | 405 | A | 0.215173 | V | 0.153511 | 0.061662 | No Change: Both O | - |
| Q9C0B1 | FTO_HUMAN Alpha-ketoglutarate-dependent dioxygenase FTO OS=Homo sapiens GN=FTO PE=1 SV=3 | 316 | R | 0.569196 | Q | 0.587741 | -0.018545 | No Change: Both D | Growth retardation developmental delay coarse facies and early death (GDFD) [MIM:612938] |
| Q8IY81 | RRMJ3_HUMAN Putative rRNA methyltransferase 3 OS=Homo sapiens GN=FTSJ3 PE=1 SV=2 | 91 | Q | 0.270296 | E | 0.308871 | -0.038575 | No Change: Both O | - |
| Q8IY81 | RRMJ3_HUMAN Putative rRNA methyltransferase 3 OS=Homo sapiens GN=FTSJ3 PE=1 SV=2 | 424 | S | 0.49479 | C | 0.322121 | 0.172669 | No Change: Both O | - |
| Q8IYT2 | FTSJ1_HUMAN FtsJ methyltransferase domain-containing protein 1 OS=Homo sapiens GN=FTSJD1 PE=2 SV=2 | 60 | L | 0.28655 | F | 0.260052 | 0.026498 | No Change: Both O | - |
| Q8IYT2 | FTSJ1_HUMAN FtsJ methyltransferase domain-containing protein 1 OS=Homo sapiens GN=FTSJD1 PE=2 SV=2 | 163 | F | 0.166147 | Y | 0.200877 | -0.03473 | No Change: Both O | - |
| Q8IYT2 | FTSJ1_HUMAN FtsJ methyltransferase domain-containing protein 1 OS=Homo sapiens GN=FTSJD1 PE=2 SV=2 | 416 | N | 0.319724 | S | 0.364329 | -0.044605 | No Change: Both O | - |
| Q8IYT2 | FTSJ1_HUMAN FtsJ methyltransferase domain-containing protein 1 OS=Homo sapiens GN=FTSJD1 PE=2 SV=2 | 608 | T | 0.308164 | K | 0.369341 | -0.061177 | No Change: Both O | - |
| Q8IYT2 | FTSJ1_HUMAN FtsJ methyltransferase domain-containing protein 1 OS=Homo sapiens GN=FTSJD1 PE=2 SV=2 | 753 | F | 0.162167 | L | 0.193716 | -0.031549 | No Change: Both O | - |
| Q96AE4 | FUBP1_HUMAN Far upstream element-binding protein 1 OS=Homo sapiens GN=FUBP1 PE=1 SV=3 | 399 | I | 0.656544 | K | 0.760736 | -0.104192 | No Change: Both D | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 65 | G | 0.036132 | D | 0.038354 | -0.002222 | No Change: Both O | Fucosidosis (FUCA1D) [MIM:230000] |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 68 | S | 0.066286 | L | 0.025341 | 0.040945 | No Change: Both O | Fucosidosis (FUCA1D) [MIM:230000] |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 286 | Q | 0.576055 | R | 0.560276 | 0.015779 | No Change: Both D | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 10 | P | 0.82166 | R | 0.8118 | 0.00986 | No Change: Both D | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 269 | C | 0.290706 | S | 0.529758 | -0.239052 | O to D | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 410 | L | 0.392032 | R | 0.493166 | -0.101134 | No Change: Both O | Fucosidosis (FUCA1D) [MIM:230000] |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 2 | R | 0.889474 | W | 0.759158 | 0.130316 | No Change: Both D | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 146 | P | 0.313015 | L | 0.172114 | 0.140901 | No Change: Both O | - |
| P04066 | FUCO_HUMAN Tissue alpha-L-fucosidase OS=Homo sapiens GN=FUCA1 PE=1 SV=4 | 260 | V | 0.266604 | I | 0.22123 | 0.045374 | No Change: Both O | - |
| Q9BTY2 | FUCO2_HUMAN Plasma alpha-L-fucosidase OS=Homo sapiens GN=FUCA2 PE=1 SV=2 | 356 | M | 0.233913 | V | 0.197617 | 0.036296 | No Change: Both O | - |
| Q9BTY2 | FUCO2_HUMAN Plasma alpha-L-fucosidase OS=Homo sapiens GN=FUCA2 PE=1 SV=2 | 371 | H | 0.288015 | Y | 0.195499 | 0.092516 | No Change: Both O | - |
| Q9BTY2 | FUCO2_HUMAN Plasma alpha-L-fucosidase OS=Homo sapiens GN=FUCA2 PE=1 SV=2 | 233 | A | 0.511557 | E | 0.600553 | -0.088996 | No Change: Both D | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 146 | V | 0.250211 | M | 0.305349 | -0.055138 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 521 | A | 0.316005 | T | 0.31107 | 0.004935 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 571 | R | 0.189524 | H | 0.159322 | 0.030202 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 701 | P | 0.383643 | L | 0.226678 | 0.156965 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 858 | A | 0.284439 | T | 0.301399 | -0.01696 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 861 | V | 0.263311 | M | 0.307005 | -0.043694 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 901 | R | 0.373141 | W | 0.173108 | 0.200033 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 939 | R | 0.222447 | Q | 0.235893 | -0.013446 | No Change: Both O | - |
| Q8N0W3 | FUK_HUMAN L-fucose kinase OS=Homo sapiens GN=FUK PE=2 SV=2 | 939 | R | 0.222447 | W | 0.091615 | 0.130832 | No Change: Both O | - |
| P09958 | FURIN_HUMAN Furin OS=Homo sapiens GN=FURIN PE=1 SV=2 | 43 | A | 0.394072 | V | 0.308411 | 0.085661 | No Change: Both O | - |
| P09958 | FURIN_HUMAN Furin OS=Homo sapiens GN=FURIN PE=1 SV=2 | 547 | W | 0.326085 | R | 0.516877 | -0.190792 | O to D | - |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 312 | K | 0.386041 | Q | 0.346461 | 0.03958 | No Change: Both O | A breast cancer sample |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 244 | R | 0.997582 | C | 0.995804 | 0.001778 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 514 | R | 0.995928 | G | 0.994838 | 0.00109 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 514 | R | 0.995928 | S | 0.994907 | 0.001021 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 515 | G | 0.996009 | C | 0.993089 | 0.00292 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 517 | H | 0.995851 | Q | 0.997435 | -0.001584 | No Change: Both D | - |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 518 | R | 0.995753 | K | 0.99465 | 0.001103 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 521 | R | 0.995478 | C | 0.989278 | 0.0062 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 521 | R | 0.995478 | G | 0.994125 | 0.001353 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 521 | R | 0.995478 | H | 0.992299 | 0.003179 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 522 | R | 0.9954 | G | 0.994011 | 0.001389 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 524 | R | 0.995247 | S | 0.994011 | 0.001236 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 524 | R | 0.995247 | T | 0.989502 | 0.005745 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 525 | P | 0.995167 | L | 0.985221 | 0.009946 | No Change: Both D | Amyotrophic lateral sclerosis type 6 (ALS6) [MIM:608030] |
| P35637 | FUS_HUMAN RNA-binding protein FUS OS=Homo sapiens GN=FUS PE=1 SV=1 | 254 | M | 0.994235 | V | 0.991693 | 0.002542 | No Change: Both D | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 154 | Y | 0.360052 | C | 0.335159 | 0.024893 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 171 | W | 0.124923 | C | 0.179345 | -0.054422 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 259 | V | 0.179675 | E | 0.327889 | -0.148214 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 315 | A | 0.054195 | V | 0.034522 | 0.019673 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 349 | W | 0.104414 | C | 0.124434 | -0.02002 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 164 | L | 0.209379 | H | 0.281812 | -0.072433 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 242 | L | 0.17927 | R | 0.296689 | -0.117419 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 148 | D | 0.253973 | Y | 0.141013 | 0.11296 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 154 | Y | 0.360052 | H | 0.482907 | -0.122855 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 241 | Y | 0.177513 | H | 0.270435 | -0.092922 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 348 | E | 0.098881 | K | 0.097004 | 0.001877 | No Change: Both O | - |
| P19526 | FUT1_HUMAN Galactoside 2-alpha-L-fucosyltransferase 1 OS=Homo sapiens GN=FUT1 PE=2 SV=1 | 12 | A | 0.024172 | V | 0.018183 | 0.005989 | No Change: Both O | - |
| Q6P4F1 | FUT10_HUMAN Alpha-(1 3)-fucosyltransferase 10 OS=Homo sapiens GN=FUT10 PE=2 SV=2 | 59 | L | 0.544764 | F | 0.519179 | 0.025585 | No Change: Both D | - |
| Q6P4F1 | FUT10_HUMAN Alpha-(1 3)-fucosyltransferase 10 OS=Homo sapiens GN=FUT10 PE=2 SV=2 | 268 | Y | 0.113082 | H | 0.176725 | -0.063643 | No Change: Both O | - |
| Q6P4F1 | FUT10_HUMAN Alpha-(1 3)-fucosyltransferase 10 OS=Homo sapiens GN=FUT10 PE=2 SV=2 | 368 | L | 0.216605 | V | 0.209098 | 0.007507 | No Change: Both O | - |
| Q6P4F1 | FUT10_HUMAN Alpha-(1 3)-fucosyltransferase 10 OS=Homo sapiens GN=FUT10 PE=2 SV=2 | 371 | R | 0.254468 | P | 0.27341 | -0.018942 | No Change: Both O | - |
| Q495W5 | FUT11_HUMAN Alpha-(1 3)-fucosyltransferase 11 OS=Homo sapiens GN=FUT11 PE=1 SV=1 | 51 | S | 0.660052 | A | 0.594966 | 0.065086 | No Change: Both D | - |
| Q10981 | FUT2_HUMAN Galactoside 2-alpha-L-fucosyltransferase 2 OS=Homo sapiens GN=FUT2 PE=2 SV=1 | 25 | I | 0.075877 | V | 0.095827 | -0.01995 | No Change: Both O | - |
| Q10981 | FUT2_HUMAN Galactoside 2-alpha-L-fucosyltransferase 2 OS=Homo sapiens GN=FUT2 PE=2 SV=1 | 138 | R | 0.351697 | C | 0.19129 | 0.160407 | No Change: Both O | - |
| Q10981 | FUT2_HUMAN Galactoside 2-alpha-L-fucosyltransferase 2 OS=Homo sapiens GN=FUT2 PE=2 SV=1 | 140 | I | 0.327269 | F | 0.337328 | -0.010059 | No Change: Both O | - |
| Q10981 | FUT2_HUMAN Galactoside 2-alpha-L-fucosyltransferase 2 OS=Homo sapiens GN=FUT2 PE=2 SV=1 | 172 | D | 0.33722 | N | 0.321065 | 0.016155 | No Change: Both O | - |
| Q10981 | FUT2_HUMAN Galactoside 2-alpha-L-fucosyltransferase 2 OS=Homo sapiens GN=FUT2 PE=2 SV=1 | 258 | G | 0.316853 | S | 0.37341 | -0.056557 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 20 | L | 0.04444 | R | 0.08198 | -0.03754 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 105 | T | 0.209096 | M | 0.195185 | 0.013911 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 170 | G | 0.120136 | S | 0.161988 | -0.041852 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 336 | D | 0.061267 | A | 0.047838 | 0.013429 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 356 | I | 0.244527 | K | 0.453276 | -0.208749 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 68 | W | 0.249246 | R | 0.412244 | -0.162998 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 102 | Q | 0.273023 | K | 0.32022 | -0.047197 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 124 | S | 0.747196 | A | 0.679422 | 0.067774 | No Change: Both D | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 162 | D | 0.437605 | N | 0.411433 | 0.026172 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 223 | G | 0.444327 | R | 0.445092 | -7.65E-04 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 270 | V | 0.093402 | M | 0.112002 | -0.0186 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 5 | G | 0.714811 | S | 0.746275 | -0.031464 | No Change: Both D | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 160 | R | 0.379073 | C | 0.234172 | 0.144901 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 325 | T | 0.268737 | M | 0.246128 | 0.022609 | No Change: Both O | - |
| P21217 | FUT3_HUMAN Galactoside 3(4)-L-fucosyltransferase OS=Homo sapiens GN=FUT3 PE=2 SV=1 | 327 | R | 0.274558 | Q | 0.267214 | 0.007344 | No Change: Both O | - |
| P22083 | FUT4_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT4 PE=1 SV=3 | 255 | I | 0.307984 | V | 0.363037 | -0.055053 | No Change: Both O | - |
| Q11128 | FUT5_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT5 PE=2 SV=1 | 187 | P | 0.302537 | L | 0.170457 | 0.13208 | No Change: Both O | - |
| Q11128 | FUT5_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT5 PE=2 SV=1 | 338 | T | 0.264673 | M | 0.240366 | 0.024307 | No Change: Both O | - |
| P51993 | FUT6_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT6 PE=1 SV=1 | 124 | P | 0.645066 | S | 0.667346 | -0.02228 | No Change: Both D | - |
| P51993 | FUT6_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT6 PE=1 SV=1 | 230 | Q | 0.642854 | K | 0.689061 | -0.046207 | No Change: Both D | - |
| P51993 | FUT6_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT6 PE=1 SV=1 | 244 | L | 0.160791 | V | 0.150828 | 0.009963 | No Change: Both O | - |
| P51993 | FUT6_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT6 PE=1 SV=1 | 247 | E | 0.198626 | K | 0.209663 | -0.011037 | No Change: Both O | - |
| P51993 | FUT6_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT6 PE=1 SV=1 | 303 | R | 0.341417 | G | 0.327015 | 0.014402 | No Change: Both O | - |
| Q9BYC5 | FUT8_HUMAN Alpha-(1 6)-fucosyltransferase OS=Homo sapiens GN=FUT8 PE=1 SV=2 | 267 | T | 0.506112 | K | 0.558209 | -0.052097 | No Change: Both D | - |
| Q9BYC5 | FUT8_HUMAN Alpha-(1 6)-fucosyltransferase OS=Homo sapiens GN=FUT8 PE=1 SV=2 | 101 | K | 0.643645 | Q | 0.616182 | 0.027463 | No Change: Both D | - |
| Q9Y231 | FUT9_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT9 PE=2 SV=2 | 237 | T | 0.098568 | A | 0.080813 | 0.017755 | No Change: Both O | - |
| Q9Y231 | FUT9_HUMAN Alpha-(1 3)-fucosyltransferase OS=Homo sapiens GN=FUT9 PE=2 SV=2 | 358 | W | 0.506574 | G | 0.774171 | -0.267597 | No Change: Both D | - |
| Q9BT04 | FUZZY_HUMAN Protein fuzzy homolog OS=Homo sapiens GN=FUZ PE=2 SV=1 | 34 | A | 0.578504 | S | 0.67268 | -0.094176 | No Change: Both D | - |
| Q9BT04 | FUZZY_HUMAN Protein fuzzy homolog OS=Homo sapiens GN=FUZ PE=2 SV=1 | 175 | G | 0.257923 | D | 0.269235 | -0.011312 | No Change: Both O | - |
| Q9BT04 | FUZZY_HUMAN Protein fuzzy homolog OS=Homo sapiens GN=FUZ PE=2 SV=1 | 400 | T | 0.753372 | I | 0.587431 | 0.165941 | No Change: Both D | - |
| Q9Y5J6 | TIM9B_HUMAN Mitochondrial import inner membrane translocase subunit Tim9 B OS=Homo sapiens GN=FXC1 PE=1 SV=1 | 90 | G | 0.582452 | S | 0.658571 | -0.076119 | No Change: Both D | - |
| Q9Y5J6 | TIM9B_HUMAN Mitochondrial import inner membrane translocase subunit Tim9 B OS=Homo sapiens GN=FXC1 PE=1 SV=1 | 66 | A | 0.181978 | S | 0.246204 | -0.064226 | No Change: Both O | - |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 122 | D | 0.334901 | Y | 0.201103 | 0.133798 | No Change: Both O | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 130 | G | 0.243662 | V | 0.15284 | 0.090822 | No Change: Both O | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 154 | I | 0.501309 | F | 0.494845 | 0.006464 | D to O | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 155 | W | 0.53754 | R | 0.712078 | -0.174538 | No Change: Both D | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 165 | R | 0.581192 | C | 0.443349 | 0.137843 | D to O | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 182 | L | 0.330156 | F | 0.276903 | 0.053253 | No Change: Both O | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 106 | L | 0.426137 | S | 0.60266 | -0.176523 | O to D | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 198 | L | 0.535639 | R | 0.631745 | -0.096106 | No Change: Both D | Friedreich ataxia (FRDA) [MIM:229300] |
| Q16595 | FRDA_HUMAN Frataxin mitochondrial OS=Homo sapiens GN=FXN PE=1 SV=2 | 202 | S | 0.539375 | C | 0.260174 | 0.279201 | D to O | - |
| P51114 | FXR1_HUMAN Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens GN=FXR1 PE=1 SV=3 | 614 | A | 0.73442 | V | 0.670568 | 0.063852 | No Change: Both D | - |
| P51114 | FXR1_HUMAN Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens GN=FXR1 PE=1 SV=3 | 429 | D | 0.992441 | N | 0.990579 | 0.001862 | No Change: Both D | - |
| P51114 | FXR1_HUMAN Fragile X mental retardation syndrome-related protein 1 OS=Homo sapiens GN=FXR1 PE=1 SV=3 | 233 | A | 0.224227 | T | 0.256297 | -0.03207 | No Change: Both O | A breast cancer sample |
| P51116 | FXR2_HUMAN Fragile X mental retardation syndrome-related protein 2 OS=Homo sapiens GN=FXR2 PE=1 SV=2 | 591 | R | 0.991357 | P | 0.990631 | 7.26E-04 | No Change: Both D | - |
| P54710 | ATNG_HUMAN Sodium/potassium-transporting ATPase subunit gamma OS=Homo sapiens GN=FXYD2 PE=1 SV=3 | 41 | G | 0.027553 | R | 0.029314 | -0.001761 | No Change: Both O | Hypomagnesemia type 2 (HOMG2) [MIM:154020] |
| Q14802 | FXYD3_HUMAN FXYD domain-containing ion transport regulator 3 OS=Homo sapiens GN=FXYD3 PE=2 SV=1 | 40 | G | 0.076837 | S | 0.095247 | -0.01841 | No Change: Both O | - |
| Q96DB9 | FXYD5_HUMAN FXYD domain-containing ion transport regulator 5 OS=Homo sapiens GN=FXYD5 PE=1 SV=2 | 35 | S | 0.764533 | A | 0.674416 | 0.090117 | No Change: Both D | - |
| Q96DB9 | FXYD5_HUMAN FXYD domain-containing ion transport regulator 5 OS=Homo sapiens GN=FXYD5 PE=1 SV=2 | 176 | R | 0.789037 | H | 0.798089 | -0.009052 | No Change: Both D | - |
| O15117 | FYB_HUMAN FYN-binding protein OS=Homo sapiens GN=FYB PE=1 SV=2 | 51 | P | 0.981272 | L | 0.961476 | 0.019796 | No Change: Both D | - |
| O15117 | FYB_HUMAN FYN-binding protein OS=Homo sapiens GN=FYB PE=1 SV=2 | 332 | K | 0.969416 | R | 0.961912 | 0.007504 | No Change: Both D | - |
| O15117 | FYB_HUMAN FYN-binding protein OS=Homo sapiens GN=FYB PE=1 SV=2 | 672 | V | 0.920306 | F | 0.916127 | 0.004179 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 250 | R | 0.962047 | Q | 0.963987 | -0.00194 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 282 | R | 0.85503 | H | 0.797184 | 0.057846 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 321 | G | 0.49845 | A | 0.492819 | 0.005631 | No Change: Both O | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 381 | T | 0.83062 | M | 0.835172 | -0.004552 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 679 | A | 0.844675 | V | 0.777138 | 0.067537 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 1001 | N | 0.733454 | D | 0.750533 | -0.017079 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 447 | R | 0.88753 | C | 0.818953 | 0.068577 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 994 | E | 0.831422 | K | 0.821686 | 0.009736 | No Change: Both D | - |
| Q9BQS8 | FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=FYCO1 PE=1 SV=3 | 1376 | L | 0.189525 | P | 0.34626 | -0.156735 | No Change: Both O | Cataract congenital autosomal recessive type 2 (CATC2) [MIM:610019] |
| P06241 | FYN_HUMAN Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN PE=1 SV=3 | 445 | I | 0.11939 | F | 0.1263 | -0.00691 | No Change: Both O | - |
| P06241 | FYN_HUMAN Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN PE=1 SV=3 | 243 | V | 0.076432 | L | 0.080114 | -0.003682 | No Change: Both O | A lung squamous cell carcinoma sample |
| P06241 | FYN_HUMAN Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN PE=1 SV=3 | 410 | G | 0.071151 | R | 0.071623 | -4.72E-04 | No Change: Both O | A metastatic melanoma sample |
| P06241 | FYN_HUMAN Tyrosine-protein kinase Fyn OS=Homo sapiens GN=FYN PE=1 SV=3 | 506 | D | 0.494232 | E | 0.541464 | -0.047232 | O to D | - |
| Q96QD9 | UIF_HUMAN UAP56-interacting factor OS=Homo sapiens GN=FYTTD1 PE=1 SV=3 | 87 | R | 0.745858 | H | 0.654379 | 0.091479 | No Change: Both D | - |
| Q9UP38 | FZD1_HUMAN Frizzled-1 OS=Homo sapiens GN=FZD1 PE=1 SV=2 | 343 | V | 0.087408 | M | 0.115225 | -0.027817 | No Change: Both O | - |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 436 | K | 0.091881 | T | 0.063131 | 0.02875 | No Change: Both O | A colorectal cancer sample |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 105 | M | 0.094372 | V | 0.074959 | 0.019413 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 157 | M | 0.810461 | V | 0.744411 | 0.06605 | No Change: Both D | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 33 | P | 0.287468 | S | 0.295511 | -0.008043 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 36 | G | 0.458623 | D | 0.474495 | -0.015872 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 40 | E | 0.633245 | Q | 0.591297 | 0.041948 | No Change: Both D | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 69 | H | 0.335367 | Y | 0.234668 | 0.100699 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 105 | M | 0.094372 | T | 0.11554 | -0.021168 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 114 | I | 0.186344 | T | 0.289576 | -0.103232 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 168 | P | 0.759009 | S | 0.745389 | 0.01362 | No Change: Both D | - |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 181 | C | 0.574674 | R | 0.678896 | -0.104222 | No Change: Both D | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 203 | K | 0.092371 | N | 0.079882 | 0.012489 | No Change: Both O | - |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 204 | C | 0.102694 | R | 0.201589 | -0.098895 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 204 | C | 0.102694 | Y | 0.130136 | -0.027442 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 223 | M | 0.028759 | K | 0.05354 | -0.024781 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 256 | I | 0.076243 | V | 0.081174 | -0.004931 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 335 | W | 0.217109 | C | 0.243428 | -0.026319 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 342 | M | 0.41915 | V | 0.346567 | 0.072583 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 370 | A | 0.140961 | G | 0.190294 | -0.049333 | No Change: Both O | - |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 417 | R | 0.237893 | Q | 0.26843 | -0.030537 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 445 | T | 0.037933 | P | 0.048781 | -0.010848 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 488 | G | 0.063954 | D | 0.067308 | -0.003354 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 497 | S | 0.121953 | F | 0.043007 | 0.078946 | No Change: Both O | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q9ULV1 | FZD4_HUMAN Frizzled-4 OS=Homo sapiens GN=FZD4 PE=1 SV=2 | 525 | G | 0.698515 | R | 0.707673 | -0.009158 | No Change: Both D | Vitreoretinopathy exudative type 1 (EVR1) [MIM:133780] |
| Q13467 | FZD5_HUMAN Frizzled-5 OS=Homo sapiens GN=FZD5 PE=2 SV=2 | 216 | P | 0.218948 | L | 0.105284 | 0.113664 | No Change: Both O | - |
| O60353 | FZD6_HUMAN Frizzled-6 OS=Homo sapiens GN=FZD6 PE=1 SV=2 | 33 | M | 0.147549 | V | 0.109912 | 0.037637 | No Change: Both O | - |
| O60353 | FZD6_HUMAN Frizzled-6 OS=Homo sapiens GN=FZD6 PE=1 SV=2 | 345 | M | 0.191145 | L | 0.152525 | 0.03862 | No Change: Both O | - |
| O60353 | FZD6_HUMAN Frizzled-6 OS=Homo sapiens GN=FZD6 PE=1 SV=2 | 664 | A | 0.926643 | E | 0.951759 | -0.025116 | No Change: Both D | - |
| O60353 | FZD6_HUMAN Frizzled-6 OS=Homo sapiens GN=FZD6 PE=1 SV=2 | 511 | R | 0.532143 | C | 0.371735 | 0.160408 | D to O | Nail disorder non-syndromic congenital type 10 (NDNC10) [MIM:614157] |
| O75084 | FZD7_HUMAN Frizzled-7 OS=Homo sapiens GN=FZD7 PE=2 SV=2 | 24 | G | 0.228016 | S | 0.271877 | -0.043861 | No Change: Both O | - |
| O75084 | FZD7_HUMAN Frizzled-7 OS=Homo sapiens GN=FZD7 PE=2 SV=2 | 196 | G | 0.853068 | E | 0.846885 | 0.006183 | No Change: Both D | - |
| O75084 | FZD7_HUMAN Frizzled-7 OS=Homo sapiens GN=FZD7 PE=2 SV=2 | 487 | A | 0.020655 | V | 0.014076 | 0.006579 | No Change: Both O | - |
| O75084 | FZD7_HUMAN Frizzled-7 OS=Homo sapiens GN=FZD7 PE=2 SV=2 | 24 | G | 0.228016 | D | 0.230181 | -0.002165 | No Change: Both O | - |
| Q7L622 | G2E3_HUMAN G2/M phase-specific E3 ubiquitin-protein ligase OS=Homo sapiens GN=G2E3 PE=1 SV=1 | 232 | R | 0.397721 | H | 0.342599 | 0.055122 | No Change: Both O | - |
| Q9UN86 | G3BP2_HUMAN Ras GTPase-activating protein-binding protein 2 OS=Homo sapiens GN=G3BP2 PE=1 SV=2 | 434 | P | 0.993627 | L | 0.98725 | 0.006377 | No Change: Both D | A breast cancer sample |
| O95866 | G6B_HUMAN Protein G6b OS=Homo sapiens GN=G6B PE=1 SV=1 | 175 | R | 0.567913 | G | 0.544419 | 0.023494 | No Change: Both D | - |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 38 | D | 0.050508 | V | 0.025495 | 0.025013 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 77 | W | 0.016224 | R | 0.044182 | -0.027958 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 83 | R | 0.020471 | C | 0.008922 | 0.011549 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 83 | R | 0.020471 | H | 0.020703 | -2.32E-04 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 83 | R | 0.020471 | I | 0.010299 | 0.010172 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 110 | E | 0.492397 | K | 0.500417 | -0.00802 | O to D | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 124 | A | 0.284278 | T | 0.316144 | -0.031866 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 166 | V | 0.02665 | G | 0.048517 | -0.021867 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 184 | G | 0.161118 | E | 0.190206 | -0.029088 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 188 | G | 0.166728 | R | 0.148373 | 0.018355 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 211 | L | 0.034408 | P | 0.067694 | -0.033286 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 222 | G | 0.021922 | R | 0.019389 | 0.002533 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 266 | G | 0.160154 | V | 0.082162 | 0.077992 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 270 | G | 0.146209 | V | 0.074001 | 0.072208 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 295 | R | 0.142452 | C | 0.070625 | 0.071827 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 338 | V | 0.143634 | F | 0.114769 | 0.028865 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 341 | I | 0.118521 | N | 0.229638 | -0.111117 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 20 | Q | 0.315606 | R | 0.273494 | 0.042112 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 54 | Q | 0.044226 | P | 0.051379 | -0.007153 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 81 | G | 0.017276 | R | 0.017146 | 1.30E-04 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 108 | T | 0.295178 | I | 0.18388 | 0.111298 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 156 | W | 0.005971 | L | 0.009313 | -0.003342 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 188 | G | 0.166728 | D | 0.174491 | -0.007763 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 116 | P | 0.813487 | L | 0.687362 | 0.126125 | No Change: Both D | A breast cancer sample |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 5 | M | 0.703979 | R | 0.735192 | -0.031213 | No Change: Both D | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 16 | T | 0.20175 | A | 0.179033 | 0.022717 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 16 | T | 0.20175 | R | 0.213367 | -0.011617 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 63 | W | 0.018782 | R | 0.048445 | -0.029663 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 65 | A | 0.012272 | P | 0.018139 | -0.005867 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 68 | G | 0.014215 | R | 0.013297 | 9.18E-04 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 76 | K | 0.015081 | N | 0.013261 | 0.00182 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 111 | T | 0.601659 | I | 0.457066 | 0.144593 | D to O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 113 | P | 0.750548 | L | 0.592671 | 0.157877 | No Change: Both D | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 119 | H | 0.653087 | L | 0.54889 | 0.104197 | No Change: Both D | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 122 | G | 0.422732 | D | 0.421204 | 0.001528 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 166 | V | 0.02665 | A | 0.039716 | -0.013066 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 170 | R | 0.054242 | Q | 0.061855 | -0.007613 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 177 | F | 0.118168 | C | 0.110862 | 0.007306 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 178 | P | 0.139828 | S | 0.16174 | -0.021912 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 179 | H | 0.162434 | P | 0.18678 | -0.024346 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 184 | G | 0.161118 | V | 0.093639 | 0.067479 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 188 | G | 0.166728 | S | 0.207378 | -0.04065 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 209 | Y | 0.075032 | C | 0.056495 | 0.018537 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 236 | W | 0.070745 | R | 0.17981 | -0.109065 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 241 | A | 0.159359 | T | 0.191301 | -0.031942 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 257 | P | 0.164617 | L | 0.091215 | 0.073402 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 264 | N | 0.200593 | K | 0.246606 | -0.046013 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 265 | L | 0.190803 | P | 0.310115 | -0.119312 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 270 | G | 0.146209 | R | 0.129893 | 0.016316 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 270 | G | 0.146209 | W | 0.051845 | 0.094364 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 298 | S | 0.128576 | P | 0.111837 | 0.016739 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 322 | F | 0.065846 | L | 0.077908 | -0.012062 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 345 | L | 0.097988 | R | 0.147918 | -0.04993 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 178 | P | 0.139828 | A | 0.109838 | 0.02999 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| P35575 | G6PC_HUMAN Glucose-6-phosphatase OS=Homo sapiens GN=G6PC PE=1 SV=2 | 255 | T | 0.16584 | I | 0.09182 | 0.07402 | No Change: Both O | Glycogen storage disease type 1A (GSD1A) [MIM:232200] |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 171 | I | 0.072243 | V | 0.084691 | -0.012448 | No Change: Both O | - |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 207 | Y | 0.173443 | S | 0.35792 | -0.184477 | No Change: Both O | - |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 219 | V | 0.011314 | L | 0.012668 | -0.001354 | No Change: Both O | - |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 324 | S | 0.091471 | P | 0.076378 | 0.015093 | No Change: Both O | - |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 340 | P | 0.093343 | L | 0.044365 | 0.048978 | No Change: Both O | - |
| Q9NQR9 | G6PC2_HUMAN Glucose-6-phosphatase 2 OS=Homo sapiens GN=G6PC2 PE=1 SV=1 | 342 | S | 0.124954 | C | 0.045356 | 0.079598 | No Change: Both O | - |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 216 | T | 0.028622 | I | 0.014191 | 0.014431 | No Change: Both O | - |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 185 | L | 0.091763 | P | 0.186972 | -0.095209 | No Change: Both O | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 253 | R | 0.580671 | H | 0.585184 | -0.004513 | No Change: Both D | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 262 | G | 0.229786 | R | 0.211749 | 0.018037 | No Change: Both O | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 116 | M | 0.419171 | K | 0.456315 | -0.037144 | No Change: Both O | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 116 | M | 0.419171 | V | 0.333766 | 0.085405 | No Change: Both O | Dursun syndrome (DURSS) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 189 | R | 0.247229 | Q | 0.251123 | -0.003894 | No Change: Both O | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| Q9BUM1 | G6PC3_HUMAN Glucose-6-phosphatase 3 OS=Homo sapiens GN=G6PC3 PE=1 SV=2 | 260 | G | 0.305109 | R | 0.284716 | 0.020393 | No Change: Both O | Neutropenia severe congenital autosomal recessive type 4 (SCN4) [MIM:612541] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 12 | V | 0.131596 | L | 0.142269 | -0.010673 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 32 | H | 0.187115 | R | 0.173493 | 0.013622 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 44 | A | 0.448352 | G | 0.517772 | -0.06942 | O to D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 48 | I | 0.149533 | T | 0.241971 | -0.092438 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 58 | D | 0.049299 | N | 0.048705 | 5.94E-04 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 68 | V | 0.108476 | M | 0.141291 | -0.032815 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 70 | Y | 0.124376 | H | 0.197755 | -0.073379 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 75 | L | 0.196568 | P | 0.333943 | -0.137375 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 81 | R | 0.415345 | H | 0.408546 | 0.006799 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 81 | R | 0.415345 | C | 0.237664 | 0.177681 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 106 | S | 0.257244 | C | 0.119673 | 0.137571 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 126 | N | 0.463385 | D | 0.462366 | 0.001019 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 128 | L | 0.486136 | P | 0.630862 | -0.144726 | O to D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 131 | G | 0.394464 | V | 0.263745 | 0.130719 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 156 | E | 0.304479 | K | 0.312496 | -0.008017 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 163 | G | 0.121677 | S | 0.16703 | -0.045353 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 163 | G | 0.121677 | D | 0.139293 | -0.017616 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 165 | N | 0.106432 | D | 0.114736 | -0.008304 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 166 | R | 0.098671 | H | 0.093986 | 0.004685 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 176 | D | 0.538534 | G | 0.511501 | 0.027033 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 181 | D | 0.669036 | V | 0.532603 | 0.136433 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 182 | R | 0.62964 | W | 0.454966 | 0.174674 | D to O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 188 | S | 0.44843 | F | 0.227117 | 0.221313 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 198 | R | 0.170216 | C | 0.080302 | 0.089914 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 198 | R | 0.170216 | P | 0.185328 | -0.015112 | No Change: Both O | Chronic non-spherocytic hemolytic anemia (CNSHA) [MIM:305900] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 212 | M | 0.08976 | V | 0.0691 | 0.02066 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 213 | V | 0.077694 | L | 0.079046 | -0.001352 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 216 | F | 0.052531 | L | 0.061723 | -0.009192 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 227 | R | 0.063815 | Q | 0.067292 | -0.003477 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 227 | R | 0.063815 | L | 0.035177 | 0.028638 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 257 | R | 0.113751 | G | 0.130533 | -0.016782 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 274 | E | 0.390702 | K | 0.405751 | -0.015049 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 278 | S | 0.699103 | F | 0.466063 | 0.23304 | D to O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 279 | T | 0.749419 | S | 0.807748 | -0.058329 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 282 | D | 0.728631 | H | 0.695086 | 0.033545 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 285 | R | 0.628487 | H | 0.636838 | -0.008351 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 291 | V | 0.326328 | M | 0.377563 | -0.051235 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 317 | E | 0.640847 | K | 0.639278 | 0.001569 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 323 | L | 0.49547 | P | 0.651621 | -0.156151 | O to D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 335 | A | 0.264662 | T | 0.294081 | -0.029419 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 342 | L | 0.077988 | F | 0.07428 | 0.003708 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 353 | P | 0.067199 | S | 0.075249 | -0.00805 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 363 | N | 0.404232 | K | 0.470035 | -0.065803 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 385 | C | 0.21253 | R | 0.365142 | -0.152612 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 386 | K | 0.231611 | E | 0.243231 | -0.01162 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 387 | R | 0.252357 | H | 0.245129 | 0.007228 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 387 | R | 0.252357 | C | 0.165528 | 0.086829 | No Change: Both O | Chronic non-spherocytic hemolytic anemia (CNSHA) [MIM:305900] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 393 | R | 0.228872 | H | 0.20788 | 0.020992 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 394 | V | 0.233957 | L | 0.230735 | 0.003222 | No Change: Both O | Chronic non-spherocytic hemolytic anemia (CNSHA) [MIM:305900] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 396 | P | 0.257162 | L | 0.145635 | 0.111527 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 398 | E | 0.299886 | K | 0.312413 | -0.012527 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 410 | G | 0.531178 | C | 0.372237 | 0.158941 | D to O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 410 | G | 0.531178 | D | 0.561447 | -0.030269 | No Change: Both D | Chronic non-spherocytic hemolytic anemia (CNSHA) [MIM:305900] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 416 | E | 0.540972 | K | 0.529067 | 0.011905 | No Change: Both D | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 439 | R | 0.086775 | P | 0.108462 | -0.021687 | No Change: Both O | Chronic non-spherocytic hemolytic anemia (CNSHA) [MIM:305900] |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 440 | L | 0.068625 | F | 0.0596 | 0.009025 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 447 | G | 0.100376 | R | 0.104437 | -0.004061 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 449 | Q | 0.148538 | H | 0.14746 | 0.001078 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 454 | R | 0.368324 | C | 0.199318 | 0.169006 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 454 | R | 0.368324 | H | 0.371651 | -0.003327 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 459 | R | 0.240441 | L | 0.149103 | 0.091338 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 459 | R | 0.240441 | P | 0.257884 | -0.017443 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 463 | R | 0.108459 | H | 0.101717 | 0.006742 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 488 | G | 0.491105 | V | 0.330938 | 0.160167 | No Change: Both O | - |
| P11413 | G6PD_HUMAN Glucose-6-phosphate 1-dehydrogenase OS=Homo sapiens GN=G6PD PE=1 SV=4 | 322 | Y | 0.529804 | H | 0.648282 | -0.118478 | No Change: Both D | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 91 | D | 0.821189 | N | 0.803461 | 0.017728 | No Change: Both D | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 199 | H | 0.604361 | R | 0.634385 | -0.030024 | No Change: Both D | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 223 | R | 0.193974 | H | 0.167403 | 0.026571 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 299 | L | 0.273911 | R | 0.367711 | -0.0938 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 318 | M | 0.237453 | T | 0.275617 | -0.038164 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 402 | W | 0.192635 | R | 0.395142 | -0.202507 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 478 | G | 0.251328 | R | 0.225266 | 0.026062 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 481 | W | 0.20247 | R | 0.38497 | -0.1825 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 519 | M | 0.32737 | T | 0.336942 | -0.009572 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 519 | M | 0.32737 | V | 0.252372 | 0.074998 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 521 | E | 0.389701 | K | 0.366056 | 0.023645 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 529 | S | 0.588802 | V | 0.383139 | 0.205663 | D to O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 545 | P | 0.333441 | L | 0.184109 | 0.149332 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 566 | S | 0.37674 | P | 0.32652 | 0.05022 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 576 | G | 0.215708 | A | 0.189784 | 0.025924 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 576 | G | 0.215708 | S | 0.268972 | -0.053264 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 643 | G | 0.083939 | R | 0.071324 | 0.012615 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 645 | D | 0.090153 | E | 0.10157 | -0.011417 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 645 | D | 0.090153 | H | 0.075815 | 0.014338 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 645 | D | 0.090153 | N | 0.087986 | 0.002167 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 647 | C | 0.11123 | W | 0.094586 | 0.016644 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 648 | G | 0.124675 | S | 0.150116 | -0.025441 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 672 | R | 0.258892 | Q | 0.279414 | -0.020522 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 672 | R | 0.258892 | W | 0.11626 | 0.142632 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 689 | E | 0.67503 | K | 0.667576 | 0.007454 | No Change: Both D | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 725 | R | 0.182944 | W | 0.076862 | 0.106082 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 746 | W | 0.072 | C | 0.083646 | -0.011646 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 768 | P | 0.098455 | R | 0.078864 | 0.019591 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 780 | V | 0.309095 | I | 0.269944 | 0.039151 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 816 | V | 0.208375 | I | 0.214785 | -0.00641 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 927 | T | 0.404596 | I | 0.247733 | 0.156863 | No Change: Both O | - |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 949 | V | 0.262768 | D | 0.476372 | -0.213604 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 600 | R | 0.333758 | H | 0.332642 | 0.001116 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 615 | G | 0.195937 | R | 0.179686 | 0.016251 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 103 | C | 0.60763 | G | 0.644414 | -0.036784 | No Change: Both D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 219 | G | 0.267854 | R | 0.298785 | -0.030931 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 285 | P | 0.335831 | R | 0.299809 | 0.036022 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 292 | Y | 0.332544 | C | 0.272839 | 0.059705 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 293 | G | 0.289098 | R | 0.262702 | 0.026396 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 308 | H | 0.296418 | P | 0.328499 | -0.032081 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 309 | G | 0.273685 | R | 0.242264 | 0.031421 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 312 | L | 0.226425 | R | 0.330193 | -0.103768 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 355 | L | 0.136378 | P | 0.273729 | -0.137351 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 374 | C | 0.055731 | R | 0.126127 | -0.070396 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 405 | L | 0.272586 | P | 0.428092 | -0.155506 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 455 | Y | 0.601487 | F | 0.56808 | 0.033407 | No Change: Both D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 549 | G | 0.245251 | R | 0.223407 | 0.021844 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 552 | L | 0.194314 | P | 0.345631 | -0.151317 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 575 | Y | 0.217227 | S | 0.372224 | -0.154997 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 579 | E | 0.262425 | K | 0.261729 | 6.96E-04 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 600 | R | 0.333758 | C | 0.171846 | 0.161912 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 607 | G | 0.418048 | D | 0.425782 | -0.007734 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 880 | A | 0.085452 | D | 0.117994 | -0.032542 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 208 | L | 0.555123 | P | 0.696907 | -0.141784 | No Change: Both D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 224 | R | 0.203473 | W | 0.078044 | 0.125429 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 237 | A | 0.089971 | V | 0.066279 | 0.023692 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 262 | E | 0.287196 | K | 0.284494 | 0.002702 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 324 | P | 0.355928 | L | 0.211504 | 0.144424 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 330 | W | 0.354182 | G | 0.607299 | -0.253117 | O to D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 361 | P | 0.093187 | L | 0.043655 | 0.049532 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 377 | G | 0.129893 | R | 0.128859 | 0.001034 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 404 | D | 0.258286 | N | 0.234663 | 0.023623 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 408 | M | 0.332103 | V | 0.275844 | 0.056259 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 437 | R | 0.344418 | C | 0.198644 | 0.145774 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 445 | A | 0.471621 | P | 0.572336 | -0.100715 | O to D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 489 | D | 0.346891 | N | 0.348356 | -0.001465 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 612 | H | 0.235629 | Q | 0.238765 | -0.003136 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 901 | L | 0.295058 | Q | 0.444622 | -0.149564 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 457 | P | 0.572798 | L | 0.413422 | 0.159376 | D to O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 191 | Y | 0.506369 | C | 0.510422 | -0.004053 | No Change: Both D | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 308 | H | 0.296418 | L | 0.207737 | 0.088681 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 375 | R | 0.072128 | L | 0.044112 | 0.028016 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 401 | Q | 0.173893 | R | 0.16796 | 0.005933 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 522 | P | 0.438591 | A | 0.342104 | 0.096487 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 585 | R | 0.290065 | M | 0.2247 | 0.065365 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 599 | S | 0.330222 | Y | 0.160185 | 0.170037 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 619 | S | 0.22779 | R | 0.163141 | 0.064649 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 638 | G | 0.06768 | W | 0.022355 | 0.045325 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 660 | R | 0.08859 | H | 0.088189 | 4.01E-04 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 672 | R | 0.258892 | T | 0.243562 | 0.01533 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| P10253 | LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens GN=GAA PE=1 SV=4 | 702 | R | 0.209666 | C | 0.116016 | 0.09365 | No Change: Both O | Glycogen storage disease type 2 (GSD2) [MIM:232300] |
| Q13480 | GAB1_HUMAN GRB2-associated-binding protein 1 OS=Homo sapiens GN=GAB1 PE=1 SV=2 | 311 | P | 0.63987 | L | 0.447317 | 0.192553 | D to O | - |
| Q13480 | GAB1_HUMAN GRB2-associated-binding protein 1 OS=Homo sapiens GN=GAB1 PE=1 SV=2 | 83 | Y | 0.19335 | C | 0.15944 | 0.03391 | No Change: Both O | A breast cancer sample |
| Q13480 | GAB1_HUMAN GRB2-associated-binding protein 1 OS=Homo sapiens GN=GAB1 PE=1 SV=2 | 387 | T | 0.846581 | N | 0.850078 | -0.003497 | No Change: Both D | A breast cancer sample |
| Q13480 | GAB1_HUMAN GRB2-associated-binding protein 1 OS=Homo sapiens GN=GAB1 PE=1 SV=2 | 377 | T | 0.877035 | I | 0.818805 | 0.05823 | No Change: Both D | - |
| Q9UQC2 | GAB2_HUMAN GRB2-associated-binding protein 2 OS=Homo sapiens GN=GAB2 PE=1 SV=1 | 344 | P | 0.812513 | L | 0.712503 | 0.10001 | No Change: Both D | - |
| Q9UQC2 | GAB2_HUMAN GRB2-associated-binding protein 2 OS=Homo sapiens GN=GAB2 PE=1 SV=1 | 320 | P | 0.317892 | L | 0.182468 | 0.135424 | No Change: Both O | - |
| Q8WWW8 | GAB3_HUMAN GRB2-associated-binding protein 3 OS=Homo sapiens GN=GAB3 PE=2 SV=1 | 237 | P | 0.786792 | S | 0.797411 | -0.010619 | No Change: Both D | - |
| Q2WGN9 | GAB4_HUMAN GRB2-associated-binding protein 4 OS=Homo sapiens GN=GAB4 PE=2 SV=1 | 273 | L | 0.639747 | P | 0.734482 | -0.094735 | No Change: Both D | - |
| P60520 | GBRL2_HUMAN Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Homo sapiens GN=GABARAPL2 PE=1 SV=1 | 51 | V | 0.216885 | A | 0.279023 | -0.062138 | No Change: Both O | - |
| Q9UBS5 | GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens GN=GABBR1 PE=1 SV=1 | 20 | A | 0.662756 | V | 0.588943 | 0.073813 | No Change: Both D | - |
| Q9UBS5 | GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens GN=GABBR1 PE=1 SV=1 | 489 | G | 0.63994 | S | 0.658485 | -0.018545 | No Change: Both D | - |
| Q9UBS5 | GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens GN=GABBR1 PE=1 SV=1 | 645 | F | 0.084421 | L | 0.108146 | -0.023725 | No Change: Both O | - |
| O75899 | GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens GN=GABBR2 PE=1 SV=1 | 628 | Y | 0.639499 | F | 0.598494 | 0.041005 | No Change: Both D | - |
| O75899 | GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens GN=GABBR2 PE=1 SV=1 | 869 | T | 0.675875 | A | 0.613118 | 0.062757 | No Change: Both D | - |
| O75899 | GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens GN=GABBR2 PE=1 SV=1 | 163 | L | 0.363854 | P | 0.554504 | -0.19065 | O to D | - |
| Q06546 | GABPA_HUMAN GA-binding protein alpha chain OS=Homo sapiens GN=GABPA PE=1 SV=1 | 291 | A | 0.789871 | V | 0.742991 | 0.04688 | No Change: Both D | - |
| Q06546 | GABPA_HUMAN GA-binding protein alpha chain OS=Homo sapiens GN=GABPA PE=1 SV=1 | 345 | E | 0.308625 | K | 0.308148 | 4.77E-04 | No Change: Both O | - |
| Q06547 | GABP1_HUMAN GA-binding protein subunit beta-1 OS=Homo sapiens GN=GABPB1 PE=1 SV=2 | 31 | P | 0.166557 | A | 0.131726 | 0.034831 | No Change: Both O | A colorectal cancer sample |
| Q8TAK5 | GABP2_HUMAN GA-binding protein subunit beta-2 OS=Homo sapiens GN=GABPB2 PE=2 SV=1 | 62 | V | 0.354076 | I | 0.304026 | 0.05005 | No Change: Both O | - |
| P14867 | GBRA1_HUMAN Gamma-aminobutyric acid receptor subunit alpha-1 OS=Homo sapiens GN=GABRA1 PE=1 SV=3 | 322 | A | 0.00879 | D | 0.012159 | -0.003369 | No Change: Both O | Juvenile myoclonic epilepsy type 5 (EJM5) [MIM:611136] |
| P48169 | GBRA4_HUMAN Gamma-aminobutyric acid receptor subunit alpha-4 OS=Homo sapiens GN=GABRA4 PE=1 SV=2 | 516 | S | 0.680514 | R | 0.639858 | 0.040656 | No Change: Both D | A breast cancer sample |
| P48169 | GBRA4_HUMAN Gamma-aminobutyric acid receptor subunit alpha-4 OS=Homo sapiens GN=GABRA4 PE=1 SV=2 | 19 | A | 0.083909 | T | 0.081728 | 0.002181 | No Change: Both O | - |
| P48169 | GBRA4_HUMAN Gamma-aminobutyric acid receptor subunit alpha-4 OS=Homo sapiens GN=GABRA4 PE=1 SV=2 | 26 | L | 0.048282 | M | 0.057397 | -0.009115 | No Change: Both O | - |
| Q16445 | GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens GN=GABRA6 PE=2 SV=2 | 180 | P | 0.26555 | H | 0.232523 | 0.033027 | No Change: Both O | A colorectal cancer sample |
| Q16445 | GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens GN=GABRA6 PE=2 SV=2 | 187 | T | 0.193222 | M | 0.16901 | 0.024212 | No Change: Both O | - |
| Q16445 | GBRA6_HUMAN Gamma-aminobutyric acid receptor subunit alpha-6 OS=Homo sapiens GN=GABRA6 PE=2 SV=2 | 404 | P | 0.633477 | S | 0.640969 | -0.007492 | No Change: Both D | - |
| P18505 | GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 OS=Homo sapiens GN=GABRB1 PE=1 SV=2 | 421 | H | 0.663077 | Q | 0.72936 | -0.066283 | No Change: Both D | - |
| P18505 | GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 OS=Homo sapiens GN=GABRB1 PE=1 SV=2 | 429 | I | 0.63555 | N | 0.732388 | -0.096838 | No Change: Both D | - |
| P28472 | GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 OS=Homo sapiens GN=GABRB3 PE=1 SV=1 | 32 | G | 0.490951 | R | 0.475749 | 0.015202 | No Change: Both O | Childhood absence epilepsy type 5 (ECA5) [MIM:612269] |
| P28472 | GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 OS=Homo sapiens GN=GABRB3 PE=1 SV=1 | 173 | Q | 0.331205 | L | 0.218174 | 0.113031 | No Change: Both O | - |
| P28472 | GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 OS=Homo sapiens GN=GABRB3 PE=1 SV=1 | 217 | R | 0.201161 | H | 0.204166 | -0.003005 | No Change: Both O | - |
| O14764 | GBRD_HUMAN Gamma-aminobutyric acid receptor subunit delta OS=Homo sapiens GN=GABRD PE=1 SV=2 | 177 | E | 0.394629 | A | 0.270402 | 0.124227 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 5 (GEFS+5) [MIM:613060] |
| O14764 | GBRD_HUMAN Gamma-aminobutyric acid receptor subunit delta OS=Homo sapiens GN=GABRD PE=1 SV=2 | 220 | R | 0.161854 | C | 0.078246 | 0.083608 | No Change: Both O | - |
| O14764 | GBRD_HUMAN Gamma-aminobutyric acid receptor subunit delta OS=Homo sapiens GN=GABRD PE=1 SV=2 | 220 | R | 0.161854 | H | 0.163135 | -0.001281 | No Change: Both O | - |
| P78334 | GBRE_HUMAN Gamma-aminobutyric acid receptor subunit epsilon OS=Homo sapiens GN=GABRE PE=2 SV=2 | 102 | S | 0.274415 | A | 0.169811 | 0.104604 | No Change: Both O | - |
| Q8N1C3 | GBRG1_HUMAN Gamma-aminobutyric acid receptor subunit gamma-1 OS=Homo sapiens GN=GABRG1 PE=2 SV=2 | 403 | G | 0.327485 | E | 0.385417 | -0.057932 | No Change: Both O | - |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 82 | R | 0.370499 | Q | 0.390294 | -0.019795 | No Change: Both O | Childhood absence epilepsy type 2 (ECA2) [MIM:607681] |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 82 | R | 0.370499 | Q | 0.390294 | -0.019795 | No Change: Both O | Familial febrile convulsions type 8 (FEB8) [MIM:611277] |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 328 | K | 0.392432 | M | 0.258062 | 0.13437 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 3 (GEFS+3) [MIM:611277] |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 177 | R | 0.078517 | G | 0.080492 | -0.001975 | No Change: Both O | Familial febrile convulsions type 8 (FEB8) [MIM:611277] |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 357 | H | 0.162643 | R | 0.188903 | -0.02626 | No Change: Both O | - |
| P18507 | GBRG2_HUMAN Gamma-aminobutyric acid receptor subunit gamma-2 OS=Homo sapiens GN=GABRG2 PE=1 SV=2 | 79 | N | 0.386189 | S | 0.417581 | -0.031392 | No Change: Both O | - |
| Q99928 | GBRG3_HUMAN Gamma-aminobutyric acid receptor subunit gamma-3 OS=Homo sapiens GN=GABRG3 PE=2 SV=2 | 352 | T | 0.761495 | A | 0.721995 | 0.0395 | No Change: Both D | - |
| O00591 | GBRP_HUMAN Gamma-aminobutyric acid receptor subunit pi OS=Homo sapiens GN=GABRP PE=1 SV=1 | 391 | F | 0.400264 | L | 0.405309 | -0.005045 | No Change: Both O | - |
| O00591 | GBRP_HUMAN Gamma-aminobutyric acid receptor subunit pi OS=Homo sapiens GN=GABRP PE=1 SV=1 | 416 | H | 0.348757 | R | 0.345782 | 0.002975 | No Change: Both O | A breast cancer sample |
| Q9UN88 | GBRT_HUMAN Gamma-aminobutyric acid receptor subunit theta OS=Homo sapiens GN=GABRQ PE=2 SV=2 | 15 | L | 0.018807 | I | 0.015936 | 0.002871 | No Change: Both O | - |
| Q9UN88 | GBRT_HUMAN Gamma-aminobutyric acid receptor subunit theta OS=Homo sapiens GN=GABRQ PE=2 SV=2 | 478 | F | 0.508358 | I | 0.499326 | 0.009032 | D to O | - |
| P24046 | GBRR1_HUMAN Gamma-aminobutyric acid receptor subunit rho-1 OS=Homo sapiens GN=GABRR1 PE=2 SV=2 | 27 | H | 0.408417 | R | 0.421841 | -0.013424 | No Change: Both O | - |
| P24046 | GBRR1_HUMAN Gamma-aminobutyric acid receptor subunit rho-1 OS=Homo sapiens GN=GABRR1 PE=2 SV=2 | 26 | M | 0.352737 | V | 0.308505 | 0.044232 | No Change: Both O | - |
| Q99259 | DCE1_HUMAN Glutamate decarboxylase 1 OS=Homo sapiens GN=GAD1 PE=1 SV=1 | 474 | V | 0.212357 | G | 0.365101 | -0.152744 | No Change: Both O | - |
| Q99259 | DCE1_HUMAN Glutamate decarboxylase 1 OS=Homo sapiens GN=GAD1 PE=1 SV=1 | 532 | R | 0.630639 | Q | 0.635179 | -0.00454 | No Change: Both D | - |
| Q99259 | DCE1_HUMAN Glutamate decarboxylase 1 OS=Homo sapiens GN=GAD1 PE=1 SV=1 | 565 | F | 0.210539 | L | 0.220785 | -0.010246 | No Change: Both O | - |
| Q99259 | DCE1_HUMAN Glutamate decarboxylase 1 OS=Homo sapiens GN=GAD1 PE=1 SV=1 | 228 | I | 0.163333 | L | 0.193325 | -0.029992 | No Change: Both O | - |
| Q99259 | DCE1_HUMAN Glutamate decarboxylase 1 OS=Homo sapiens GN=GAD1 PE=1 SV=1 | 12 | S | 0.92366 | C | 0.889392 | 0.034268 | No Change: Both D | Cerebral palsy spastic quadriplegic type 1 (CPSQ1) [MIM:603513] |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 12 | G | 0.76531 | R | 0.749393 | 0.015917 | No Change: Both D | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 124 | K | 0.175819 | N | 0.147232 | 0.028587 | No Change: Both O | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 286 | K | 0.501311 | R | 0.471061 | 0.03025 | D to O | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 375 | R | 0.40983 | Q | 0.428582 | -0.018752 | No Change: Both O | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 153 | P | 0.408704 | Q | 0.41311 | -0.004406 | No Change: Both O | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 232 | G | 0.375117 | E | 0.410479 | -0.035362 | No Change: Both O | - |
| Q05329 | DCE2_HUMAN Glutamate decarboxylase 2 OS=Homo sapiens GN=GAD2 PE=1 SV=1 | 326 | G | 0.206161 | A | 0.177432 | 0.028729 | No Change: Both O | - |
| O95257 | GA45G_HUMAN Growth arrest and DNA damage-inducible protein GADD45 gamma OS=Homo sapiens GN=GADD45G PE=1 SV=1 | 112 | G | 0.530767 | S | 0.55377 | -0.023003 | No Change: Both D | - |
| A6NER3 | GG12J_HUMAN G antigen 12J OS=Homo sapiens GN=GAGE12J PE=2 SV=1 | 9 | Y | 0.878751 | C | 0.889041 | -0.01029 | No Change: Both D | - |
| A6NER3 | GG12J_HUMAN G antigen 12J OS=Homo sapiens GN=GAGE12J PE=2 SV=1 | 13 | R | 0.909173 | S | 0.90978 | -6.07E-04 | No Change: Both D | - |
| A6NER3 | GG12J_HUMAN G antigen 12J OS=Homo sapiens GN=GAGE12J PE=2 SV=1 | 16 | P | 0.92153 | R | 0.909044 | 0.012486 | No Change: Both D | - |
| A6NER3 | GG12J_HUMAN G antigen 12J OS=Homo sapiens GN=GAGE12J PE=2 SV=1 | 28 | R | 0.954673 | Q | 0.953624 | 0.001049 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 144 | S | 0.287098 | L | 0.160882 | 0.126216 | No Change: Both O | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 580 | V | 0.172825 | M | 0.230448 | -0.057623 | No Change: Both O | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 787 | D | 0.975673 | Y | 0.95085 | 0.024823 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 877 | Q | 0.75712 | R | 0.714689 | 0.042431 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 962 | G | 0.95747 | D | 0.962724 | -0.005254 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1051 | T | 0.85149 | M | 0.825877 | 0.025613 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1120 | Q | 0.986179 | H | 0.979443 | 0.006736 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1137 | P | 0.955172 | L | 0.897668 | 0.057504 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1168 | S | 0.797419 | N | 0.76754 | 0.029879 | No Change: Both D | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1265 | K | 0.419885 | R | 0.36072 | 0.059165 | No Change: Both O | - |
| O14976 | GAK_HUMAN Cyclin-G-associated kinase OS=Homo sapiens GN=GAK PE=1 SV=2 | 1297 | D | 0.226425 | N | 0.235626 | -0.009201 | No Change: Both O | - |
| P22466 | GALA_HUMAN Galanin peptides OS=Homo sapiens GN=GAL PE=1 SV=3 | 16 | A | 0.417241 | V | 0.252955 | 0.164286 | No Change: Both O | - |
| Q99999 | G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens GN=GAL3ST1 PE=1 SV=1 | 29 | V | 0.156677 | M | 0.207611 | -0.050934 | No Change: Both O | - |
| Q9H3Q3 | G3ST2_HUMAN Galactose-3-O-sulfotransferase 2 OS=Homo sapiens GN=GAL3ST2 PE=1 SV=2 | 4 | M | 0.752219 | L | 0.691074 | 0.061145 | No Change: Both D | - |
| Q96A11 | G3ST3_HUMAN Galactose-3-O-sulfotransferase 3 OS=Homo sapiens GN=GAL3ST3 PE=1 SV=1 | 221 | A | 0.412443 | D | 0.49729 | -0.084847 | No Change: Both O | - |
| Q96A11 | G3ST3_HUMAN Galactose-3-O-sulfotransferase 3 OS=Homo sapiens GN=GAL3ST3 PE=1 SV=1 | 410 | E | 0.901914 | A | 0.883086 | 0.018828 | No Change: Both D | - |
| Q96RP7 | G3ST4_HUMAN Galactose-3-O-sulfotransferase 4 OS=Homo sapiens GN=GAL3ST4 PE=1 SV=1 | 353 | R | 0.537101 | Q | 0.553906 | -0.016805 | No Change: Both D | - |
| Q96RP7 | G3ST4_HUMAN Galactose-3-O-sulfotransferase 4 OS=Homo sapiens GN=GAL3ST4 PE=1 SV=1 | 467 | A | 0.846591 | V | 0.814141 | 0.03245 | No Change: Both D | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 111 | G | 0.822618 | D | 0.828744 | -0.006126 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 111 | G | 0.822618 | S | 0.839062 | -0.016444 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 112 | T | 0.798733 | A | 0.77731 | 0.021423 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 117 | M | 0.471025 | L | 0.420942 | 0.050083 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 187 | D | 0.150374 | V | 0.067683 | 0.082691 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 194 | G | 0.091351 | A | 0.071911 | 0.01944 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 248 | D | 0.097178 | N | 0.086445 | 0.010733 | No Change: Both O | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 250 | I | 0.146048 | T | 0.254135 | -0.108087 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 263 | A | 0.674313 | T | 0.699937 | -0.025624 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 284 | G | 0.235745 | S | 0.279097 | -0.043352 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 286 | G | 0.153117 | D | 0.165268 | -0.012151 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 295 | N | 0.15561 | T | 0.12889 | 0.02672 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 303 | S | 0.102233 | F | 0.038456 | 0.063777 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 318 | P | 0.192729 | A | 0.144487 | 0.048242 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 396 | R | 0.211738 | W | 0.092913 | 0.118825 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 400 | P | 0.08591 | L | 0.040216 | 0.045694 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 468 | T | 0.551212 | S | 0.612846 | -0.061634 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 514 | F | 0.172107 | S | 0.317661 | -0.145554 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 529 | T | 0.269114 | M | 0.229576 | 0.039538 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 531 | R | 0.273269 | C | 0.1369 | 0.136369 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 544 | D | 0.255635 | N | 0.256228 | -5.93E-04 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 562 | I | 0.061107 | T | 0.119916 | -0.058809 | No Change: Both O | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 566 | V | 0.11946 | G | 0.214425 | -0.094965 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 567 | Y | 0.149608 | S | 0.294194 | -0.144586 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 592 | A | 0.064624 | S | 0.11147 | -0.046846 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 599 | I | 0.029787 | S | 0.083188 | -0.053401 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 641 | A | 0.299731 | T | 0.3459 | -0.046169 | No Change: Both O | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 645 | L | 0.369759 | R | 0.498644 | -0.128885 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 59 | G | 0.402294 | R | 0.373194 | 0.0291 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 68 | S | 0.361453 | F | 0.164712 | 0.196741 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 79 | R | 0.236281 | H | 0.239559 | -0.003278 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 82 | I | 0.167975 | M | 0.236125 | -0.06815 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 184 | R | 0.124265 | C | 0.057512 | 0.066753 | No Change: Both O | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 278 | T | 0.550681 | I | 0.393775 | 0.156906 | D to O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 305 | I | 0.084905 | V | 0.102004 | -0.017099 | No Change: Both O | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 314 | Y | 0.135962 | C | 0.103262 | 0.0327 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 335 | Y | 0.249927 | C | 0.206842 | 0.043085 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 426 | W | 0.12808 | G | 0.29546 | -0.16738 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 531 | R | 0.273269 | H | 0.285725 | -0.012456 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 553 | G | 0.141751 | R | 0.13395 | 0.007801 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 634 | L | 0.115096 | S | 0.242161 | -0.127065 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 668 | T | 0.163988 | R | 0.173427 | -0.009439 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 21 | A | 0.582329 | P | 0.624277 | -0.041948 | No Change: Both D | - |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 41 | G | 0.258099 | S | 0.293262 | -0.035163 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 130 | E | 0.069444 | K | 0.069573 | -1.29E-04 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 318 | P | 0.192729 | R | 0.175671 | 0.017058 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 323 | G | 0.168488 | R | 0.159796 | 0.008692 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 384 | I | 0.272018 | T | 0.412486 | -0.140468 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 396 | R | 0.211738 | L | 0.137208 | 0.07453 | No Change: Both O | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| P54803 | GALC_HUMAN Galactocerebrosidase OS=Homo sapiens GN=GALC PE=1 SV=2 | 490 | Y | 0.647047 | N | 0.764762 | -0.117715 | No Change: Both D | Leukodystrophy globoid cell (GLD) [MIM:245200] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 34 | N | 0.126898 | S | 0.143831 | -0.016933 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 90 | G | 0.151522 | E | 0.184965 | -0.033443 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 103 | D | 0.242176 | G | 0.228595 | 0.013581 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 180 | A | 0.060434 | V | 0.042976 | 0.017458 | No Change: Both O | - |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 183 | L | 0.058969 | P | 0.120766 | -0.061797 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 257 | K | 0.28149 | R | 0.225015 | 0.056475 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 313 | L | 0.287546 | M | 0.329195 | -0.041649 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 319 | G | 0.252211 | E | 0.306863 | -0.054652 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 94 | V | 0.37444 | M | 0.42219 | -0.04775 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 25 | A | 0.126124 | V | 0.100109 | 0.026015 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 40 | R | 0.404189 | C | 0.251127 | 0.153062 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 69 | D | 0.268033 | E | 0.302519 | -0.034486 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 165 | E | 0.16366 | K | 0.166645 | -0.002985 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 169 | R | 0.109103 | W | 0.044539 | 0.064564 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 239 | R | 0.274542 | W | 0.126138 | 0.148404 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 302 | G | 0.281531 | D | 0.317488 | -0.035957 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| Q14376 | GALE_HUMAN UDP-glucose 4-epimerase OS=Homo sapiens GN=GALE PE=1 SV=2 | 335 | R | 0.181769 | H | 0.162884 | 0.018885 | No Change: Both O | Epimerase-deficiency galactosemia (EDG) [MIM:230350] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 32 | V | 0.429184 | M | 0.486678 | -0.057494 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 28 | P | 0.555707 | T | 0.489825 | 0.065882 | D to O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 198 | A | 0.195498 | V | 0.14386 | 0.051638 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 36 | G | 0.325871 | R | 0.333133 | -0.007262 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 44 | H | 0.293838 | Y | 0.217453 | 0.076385 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 68 | R | 0.48724 | C | 0.341238 | 0.146002 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 184 | I | 0.217967 | M | 0.327217 | -0.10925 | No Change: Both O | - |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 239 | R | 0.662718 | Q | 0.650501 | 0.012217 | No Change: Both D | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 274 | G | 0.670283 | D | 0.695644 | -0.025361 | No Change: Both D | - |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 288 | T | 0.504503 | M | 0.522334 | -0.017831 | No Change: Both D | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 338 | V | 0.287502 | A | 0.364094 | -0.076592 | No Change: Both O | - |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 346 | G | 0.404315 | S | 0.433562 | -0.029247 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 349 | G | 0.286316 | S | 0.313993 | -0.027677 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| P51570 | GALK1_HUMAN Galactokinase OS=Homo sapiens GN=GALK1 PE=1 SV=1 | 384 | A | 0.245424 | P | 0.295251 | -0.049827 | No Change: Both O | Galactosemia II (GALCT2) [MIM:230200] |
| Q01415 | GALK2_HUMAN N-acetylgalactosamine kinase OS=Homo sapiens GN=GALK2 PE=1 SV=1 | 182 | I | 0.442336 | V | 0.463011 | -0.020675 | No Change: Both O | - |
| Q96C23 | GALM_HUMAN Aldose 1-epimerase OS=Homo sapiens GN=GALM PE=1 SV=1 | 190 | N | 0.429388 | Y | 0.299495 | 0.129893 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 47 | G | 0.37277 | R | 0.364101 | 0.008669 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 60 | D | 0.508181 | N | 0.513094 | -0.004913 | No Change: Both D | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 67 | L | 0.289593 | M | 0.356241 | -0.066648 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 77 | P | 0.439563 | R | 0.400545 | 0.039018 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 80 | S | 0.452483 | L | 0.325595 | 0.126888 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 90 | R | 0.24903 | W | 0.096153 | 0.152877 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 94 | R | 0.247267 | C | 0.132641 | 0.114626 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 94 | R | 0.247267 | G | 0.251892 | -0.004625 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 96 | G | 0.262858 | C | 0.154838 | 0.10802 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 96 | G | 0.262858 | V | 0.154699 | 0.108159 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 97 | F | 0.273772 | V | 0.295936 | -0.022164 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 111 | Q | 0.337096 | R | 0.330847 | 0.006249 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 113 | I | 0.342377 | F | 0.326459 | 0.015918 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 125 | P | 0.380427 | L | 0.242209 | 0.138218 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 135 | S | 0.210109 | R | 0.166551 | 0.043558 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 138 | V | 0.228336 | A | 0.294165 | -0.065829 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 139 | G | 0.221669 | S | 0.262468 | -0.040799 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 141 | W | 0.228575 | R | 0.439134 | -0.210559 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 151 | P | 0.436516 | L | 0.28145 | 0.155066 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 151 | P | 0.436516 | S | 0.4514 | -0.014884 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 155 | G | 0.326091 | R | 0.306176 | 0.019915 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 156 | F | 0.327024 | C | 0.299031 | 0.027993 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 156 | F | 0.327024 | S | 0.540895 | -0.213871 | O to D | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 166 | H | 0.264836 | Q | 0.278601 | -0.013765 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 168 | G | 0.368101 | R | 0.35831 | 0.009791 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 178 | I | 0.265814 | V | 0.308648 | -0.042834 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 179 | P | 0.197037 | H | 0.160767 | 0.03627 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 179 | P | 0.197037 | L | 0.093333 | 0.103704 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 185 | E | 0.140062 | G | 0.113457 | 0.026605 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 200 | T | 0.35095 | M | 0.291039 | 0.059911 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 204 | N | 0.267917 | K | 0.314839 | -0.046922 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 230 | W | 0.066481 | G | 0.171139 | -0.104658 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 231 | A | 0.06916 | G | 0.081647 | -0.012487 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 247 | G | 0.469687 | D | 0.480905 | -0.011218 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 257 | A | 0.458372 | T | 0.495455 | -0.037083 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 259 | R | 0.413589 | Q | 0.422402 | -0.008813 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 284 | F | 0.154156 | V | 0.17031 | -0.016154 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 287 | S | 0.212007 | L | 0.104829 | 0.107178 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 290 | G | 0.283133 | S | 0.349247 | -0.066114 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 291 | A | 0.308956 | D | 0.377466 | -0.06851 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 291 | A | 0.308956 | T | 0.332165 | -0.023209 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 295 | S | 0.528912 | F | 0.288489 | 0.240423 | D to O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 301 | G | 0.613436 | C | 0.4159 | 0.197536 | D to O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 309 | G | 0.335597 | R | 0.30211 | 0.033487 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 312 | T | 0.376148 | S | 0.444568 | -0.06842 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 318 | M | 0.373975 | R | 0.443826 | -0.069851 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 343 | M | 0.251699 | R | 0.30628 | -0.054581 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 344 | D | 0.226198 | E | 0.24292 | -0.016722 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 344 | D | 0.226198 | N | 0.211039 | 0.015159 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 346 | F | 0.193877 | L | 0.253435 | -0.059558 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 351 | A | 0.254575 | V | 0.179012 | 0.075563 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 361 | R | 0.444853 | G | 0.470018 | -0.025165 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 376 | R | 0.199204 | Q | 0.210014 | -0.01081 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 386 | R | 0.131037 | C | 0.05957 | 0.071467 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 391 | M | 0.233421 | V | 0.185 | 0.048421 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 393 | A | 0.330719 | S | 0.427789 | -0.09707 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 395 | L | 0.339243 | P | 0.500187 | -0.160944 | O to D | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 395 | L | 0.339243 | V | 0.326611 | 0.012632 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 407 | N | 0.132679 | H | 0.1197 | 0.012979 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 409 | W | 0.161222 | S | 0.391202 | -0.22998 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 450 | E | 0.479218 | V | 0.306551 | 0.172667 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 459 | A | 0.421912 | V | 0.328233 | 0.093679 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 487 | N | 0.24746 | S | 0.27635 | -0.02889 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 488 | V | 0.235326 | M | 0.300845 | -0.065519 | No Change: Both O | - |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 494 | M | 0.180458 | V | 0.157337 | 0.023121 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 15 | L | 0.046685 | M | 0.066206 | -0.019521 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 23 | G | 0.578379 | R | 0.546074 | 0.032305 | No Change: Both D | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 36 | L | 0.177407 | P | 0.30719 | -0.129783 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 41 | M | 0.23205 | L | 0.185693 | 0.046357 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 42 | G | 0.259515 | E | 0.289671 | -0.030156 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 53 | S | 0.535748 | F | 0.38692 | 0.148828 | D to O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 61 | R | 0.455842 | W | 0.248043 | 0.207799 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 69 | F | 0.269191 | V | 0.262687 | 0.006504 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 79 | C | 0.460817 | Y | 0.47994 | -0.019123 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 94 | R | 0.247267 | L | 0.158111 | 0.089156 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 107 | A | 0.390202 | T | 0.418051 | -0.027849 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 116 | G | 0.391275 | S | 0.450031 | -0.058756 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 141 | W | 0.228575 | C | 0.269223 | -0.040648 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 150 | H | 0.457771 | Y | 0.321305 | 0.136466 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 155 | G | 0.326091 | E | 0.377431 | -0.05134 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 162 | S | 0.270982 | F | 0.129729 | 0.141253 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 164 | N | 0.229784 | T | 0.193377 | 0.036407 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 167 | F | 0.311329 | V | 0.33145 | -0.020121 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 171 | D | 0.483275 | A | 0.414249 | 0.069026 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 179 | P | 0.197037 | S | 0.205425 | -0.008388 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 203 | A | 0.281589 | V | 0.212526 | 0.069063 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 233 | D | 0.091313 | N | 0.085037 | 0.006276 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 239 | V | 0.290688 | F | 0.265079 | 0.025609 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 253 | R | 0.469445 | W | 0.228792 | 0.240653 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 260 | E | 0.383585 | D | 0.382254 | 0.001331 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 307 | L | 0.355102 | P | 0.549622 | -0.19452 | O to D | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 310 | K | 0.347034 | N | 0.327992 | 0.019042 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 325 | W | 0.160033 | C | 0.200282 | -0.040249 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 340 | G | 0.288817 | D | 0.315602 | -0.026785 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 341 | S | 0.276885 | R | 0.213097 | 0.063788 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 345 | L | 0.212979 | P | 0.334287 | -0.121308 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 352 | L | 0.303645 | P | 0.462327 | -0.158682 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 357 | P | 0.466811 | L | 0.315518 | 0.151293 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 369 | L | 0.206208 | P | 0.338113 | -0.131905 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 380 | R | 0.16257 | S | 0.192537 | -0.029967 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 380 | R | 0.16257 | T | 0.144514 | 0.018056 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 386 | R | 0.131037 | H | 0.123694 | 0.007343 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 388 | D | 0.147487 | N | 0.1361 | 0.011387 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 392 | A | 0.29363 | V | 0.208473 | 0.085157 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 398 | H | 0.241011 | D | 0.259555 | -0.018544 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 401 | H | 0.155325 | Y | 0.087416 | 0.067909 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 452 | F | 0.453805 | I | 0.436827 | 0.016978 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 470 | S | 0.362786 | P | 0.327862 | 0.034924 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 484 | P | 0.273839 | S | 0.270738 | 0.003101 | No Change: Both O | Mucopolysaccharidosis type 4A (MPS4A) [MIM:253000] |
| P34059 | GALNS_HUMAN N-acetylgalactosamine-6-sulfatase OS=Homo sapiens GN=GALNS PE=1 SV=1 | 510 | P | 0.558499 | T | 0.459615 | 0.098884 | D to O | A colorectal cancer sample |
| Q10472 | GALT1_HUMAN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GALNT1 PE=1 SV=1 | 414 | Y | 0.092763 | D | 0.170818 | -0.078055 | No Change: Both O | - |
| Q8NCW6 | GLT11_HUMAN Polypeptide N-acetylgalactosaminyltransferase 11 OS=Homo sapiens GN=GALNT11 PE=2 SV=2 | 151 | P | 0.195479 | S | 0.209878 | -0.014399 | No Change: Both O | - |
| Q8NCW6 | GLT11_HUMAN Polypeptide N-acetylgalactosaminyltransferase 11 OS=Homo sapiens GN=GALNT11 PE=2 SV=2 | 197 | D | 0.584988 | Y | 0.411166 | 0.173822 | D to O | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 3 | G | 0.830246 | E | 0.858941 | -0.028695 | No Change: Both D | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 46 | G | 0.929262 | R | 0.937902 | -0.00864 | No Change: Both D | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 119 | E | 0.358606 | V | 0.182331 | 0.176275 | No Change: Both O | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 261 | D | 0.039196 | N | 0.03663 | 0.002566 | No Change: Both O | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 272 | G | 0.503753 | R | 0.456539 | 0.047214 | D to O | - |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 297 | R | 0.483596 | W | 0.249965 | 0.233631 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 303 | D | 0.403483 | N | 0.389095 | 0.014388 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 341 | E | 0.131415 | D | 0.109365 | 0.02205 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 373 | R | 0.53343 | H | 0.540807 | -0.007377 | No Change: Both D | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 382 | R | 0.228469 | H | 0.220732 | 0.007737 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 479 | C | 0.073731 | F | 0.079132 | -0.005401 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 491 | T | 0.375638 | M | 0.32741 | 0.048228 | No Change: Both O | Colorectal cancer type 1 (CRCS1) [MIM:608812] |
| Q8IXK2 | GLT12_HUMAN Polypeptide N-acetylgalactosaminyltransferase 12 OS=Homo sapiens GN=GALNT12 PE=1 SV=3 | 552 | R | 0.682867 | K | 0.727264 | -0.044397 | No Change: Both D | - |
| Q8IUC8 | GLT13_HUMAN Polypeptide N-acetylgalactosaminyltransferase 13 OS=Homo sapiens GN=GALNT13 PE=2 SV=2 | 59 | E | 0.641926 | D | 0.621264 | 0.020662 | No Change: Both D | - |
| Q96FL9 | GLT14_HUMAN Polypeptide N-acetylgalactosaminyltransferase 14 OS=Homo sapiens GN=GALNT14 PE=2 SV=1 | 469 | Q | 0.127907 | K | 0.138491 | -0.010584 | No Change: Both O | - |
| Q10471 | GALT2_HUMAN Polypeptide N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=GALNT2 PE=1 SV=1 | 554 | V | 0.328786 | M | 0.385972 | -0.057186 | No Change: Both O | - |
| Q10471 | GALT2_HUMAN Polypeptide N-acetylgalactosaminyltransferase 2 OS=Homo sapiens GN=GALNT2 PE=1 SV=1 | 245 | R | 0.392052 | H | 0.373569 | 0.018483 | No Change: Both O | - |
| Q8N4A0 | GALT4_HUMAN Polypeptide N-acetylgalactosaminyltransferase 4 OS=Homo sapiens GN=GALNT4 PE=1 SV=2 | 270 | I | 0.174213 | T | 0.27907 | -0.104857 | No Change: Both O | - |
| Q8N4A0 | GALT4_HUMAN Polypeptide N-acetylgalactosaminyltransferase 4 OS=Homo sapiens GN=GALNT4 PE=1 SV=2 | 506 | V | 0.357079 | I | 0.313577 | 0.043502 | No Change: Both O | - |
| Q8N4A0 | GALT4_HUMAN Polypeptide N-acetylgalactosaminyltransferase 4 OS=Homo sapiens GN=GALNT4 PE=1 SV=2 | 51 | D | 0.68256 | G | 0.666613 | 0.015947 | No Change: Both D | - |
| Q7Z7M9 | GALT5_HUMAN Polypeptide N-acetylgalactosaminyltransferase 5 OS=Homo sapiens GN=GALNT5 PE=1 SV=1 | 77 | P | 0.613587 | L | 0.480969 | 0.132618 | D to O | - |
| Q7Z7M9 | GALT5_HUMAN Polypeptide N-acetylgalactosaminyltransferase 5 OS=Homo sapiens GN=GALNT5 PE=1 SV=1 | 489 | Q | 0.295461 | H | 0.294411 | 0.00105 | No Change: Both O | - |
| Q7Z7M9 | GALT5_HUMAN Polypeptide N-acetylgalactosaminyltransferase 5 OS=Homo sapiens GN=GALNT5 PE=1 SV=1 | 507 | E | 0.058498 | D | 0.055914 | 0.002584 | No Change: Both O | A breast cancer sample |
| Q7Z7M9 | GALT5_HUMAN Polypeptide N-acetylgalactosaminyltransferase 5 OS=Homo sapiens GN=GALNT5 PE=1 SV=1 | 692 | L | 0.253555 | F | 0.22328 | 0.030275 | No Change: Both O | A breast cancer sample |
| Q8NCL4 | GALT6_HUMAN Polypeptide N-acetylgalactosaminyltransferase 6 OS=Homo sapiens GN=GALNT6 PE=2 SV=2 | 423 | V | 0.299902 | I | 0.275178 | 0.024724 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 53 | Y | 0.257858 | D | 0.410377 | -0.152519 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 53 | Y | 0.257858 | N | 0.415007 | -0.157149 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 267 | E | 0.295922 | G | 0.261942 | 0.03398 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 312 | F | 0.140168 | S | 0.308481 | -0.168313 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 337 | A | 0.045692 | V | 0.028785 | 0.016907 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 438 | D | 0.232251 | G | 0.208077 | 0.024174 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 515 | V | 0.369338 | F | 0.327317 | 0.042021 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 611 | V | 0.140718 | M | 0.174894 | -0.034176 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 234 | E | 0.34999 | K | 0.367641 | -0.017651 | No Change: Both O | - |
| Q9NY28 | GALT8_HUMAN Probable polypeptide N-acetylgalactosaminyltransferase 8 OS=Homo sapiens GN=GALNT8 PE=2 SV=1 | 630 | D | 0.412283 | G | 0.404982 | 0.007301 | No Change: Both O | - |
| Q8N428 | GLTL1_HUMAN Putative polypeptide N-acetylgalactosaminyltransferase-like protein 1 OS=Homo sapiens GN=GALNTL1 PE=2 SV=2 | 201 | V | 0.255958 | M | 0.29132 | -0.035362 | No Change: Both O | - |
| Q8N428 | GLTL1_HUMAN Putative polypeptide N-acetylgalactosaminyltransferase-like protein 1 OS=Homo sapiens GN=GALNTL1 PE=2 SV=2 | 497 | P | 0.604177 | S | 0.625484 | -0.021307 | No Change: Both D | - |
| Q8N3T1 | GLTL2_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like protein 2 OS=Homo sapiens GN=GALNTL2 PE=2 SV=2 | 510 | H | 0.429463 | Y | 0.319312 | 0.110151 | No Change: Both O | - |
| Q8N3T1 | GLTL2_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like protein 2 OS=Homo sapiens GN=GALNTL2 PE=2 SV=2 | 68 | V | 0.531511 | G | 0.677354 | -0.145843 | No Change: Both D | - |
| Q8N3T1 | GLTL2_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like protein 2 OS=Homo sapiens GN=GALNTL2 PE=2 SV=2 | 151 | P | 0.877146 | L | 0.805466 | 0.07168 | No Change: Both D | - |
| Q8N3T1 | GLTL2_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like protein 2 OS=Homo sapiens GN=GALNTL2 PE=2 SV=2 | 324 | P | 0.28383 | A | 0.220184 | 0.063646 | No Change: Both O | - |
| Q8N3T1 | GLTL2_HUMAN Polypeptide N-acetylgalactosaminyltransferase-like protein 2 OS=Homo sapiens GN=GALNTL2 PE=2 SV=2 | 432 | A | 0.497046 | T | 0.532478 | -0.035432 | O to D | - |
| Q7Z4T8 | GLTL5_HUMAN Putative polypeptide N-acetylgalactosaminyltransferase-like protein 5 OS=Homo sapiens GN=GALNTL5 PE=2 SV=3 | 124 | C | 0.373481 | R | 0.57628 | -0.202799 | O to D | - |
| Q9UBC7 | GALP_HUMAN Galanin-like peptide OS=Homo sapiens GN=GALP PE=2 SV=1 | 72 | I | 0.24567 | M | 0.349364 | -0.103694 | No Change: Both O | - |
| P47211 | GALR1_HUMAN Galanin receptor type 1 OS=Homo sapiens GN=GALR1 PE=2 SV=3 | 15 | W | 0.74542 | C | 0.776344 | -0.030924 | No Change: Both D | - |
| P47211 | GALR1_HUMAN Galanin receptor type 1 OS=Homo sapiens GN=GALR1 PE=2 SV=3 | 334 | S | 0.837511 | N | 0.809159 | 0.028352 | No Change: Both D | - |
| P47211 | GALR1_HUMAN Galanin receptor type 1 OS=Homo sapiens GN=GALR1 PE=2 SV=3 | 342 | P | 0.891133 | L | 0.781728 | 0.109405 | No Change: Both D | - |
| O60755 | GALR3_HUMAN Galanin receptor type 3 OS=Homo sapiens GN=GALR3 PE=2 SV=1 | 342 | R | 0.992691 | G | 0.992139 | 5.52E-04 | No Change: Both D | - |
| O60755 | GALR3_HUMAN Galanin receptor type 3 OS=Homo sapiens GN=GALR3 PE=2 SV=1 | 349 | Q | 0.991993 | R | 0.994459 | -0.002466 | No Change: Both D | - |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 28 | D | 0.490234 | Y | 0.354386 | 0.135848 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 32 | I | 0.397263 | N | 0.553436 | -0.156173 | O to D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 38 | Q | 0.285187 | P | 0.299983 | -0.014796 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 44 | V | 0.214165 | L | 0.224597 | -0.010432 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 44 | V | 0.214165 | M | 0.280104 | -0.065939 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 51 | R | 0.435683 | L | 0.310508 | 0.125175 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 55 | G | 0.437145 | C | 0.314199 | 0.122946 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 62 | L | 0.439651 | M | 0.493572 | -0.053921 | No Change: Both O | - |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 67 | R | 0.442952 | C | 0.289989 | 0.152963 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 74 | L | 0.389643 | P | 0.573653 | -0.18401 | O to D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 81 | A | 0.500851 | T | 0.52519 | -0.024339 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 97 | N | 0.6254 | S | 0.670166 | -0.044766 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 98 | D | 0.618101 | N | 0.592814 | 0.025287 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 113 | D | 0.742684 | N | 0.71365 | 0.029034 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 114 | H | 0.715085 | L | 0.652519 | 0.062566 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 117 | F | 0.608707 | S | 0.760581 | -0.151874 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 118 | Q | 0.567448 | H | 0.555134 | 0.012314 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 123 | R | 0.354549 | G | 0.36626 | -0.011711 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 123 | R | 0.354549 | Q | 0.39232 | -0.037771 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 125 | V | 0.276684 | A | 0.348503 | -0.071819 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 127 | K | 0.239353 | E | 0.2298 | 0.009553 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 130 | C | 0.202044 | Y | 0.146201 | 0.055843 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 132 | H | 0.154735 | Y | 0.091303 | 0.063432 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 135 | S | 0.156995 | L | 0.082419 | 0.074576 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 138 | T | 0.206785 | M | 0.192223 | 0.014562 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 139 | L | 0.193394 | P | 0.333825 | -0.140431 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 142 | M | 0.185515 | K | 0.292139 | -0.106624 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 142 | M | 0.185515 | V | 0.158206 | 0.027309 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 143 | S | 0.197944 | L | 0.094812 | 0.103132 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 148 | R | 0.153827 | G | 0.162072 | -0.008245 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 148 | R | 0.153827 | Q | 0.16588 | -0.012053 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 148 | R | 0.153827 | W | 0.067634 | 0.086193 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 150 | V | 0.130515 | L | 0.118973 | 0.011542 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 151 | V | 0.137349 | A | 0.189925 | -0.052576 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 154 | W | 0.152928 | G | 0.335977 | -0.183049 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 171 | F | 0.14601 | S | 0.315695 | -0.169685 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 179 | G | 0.481103 | D | 0.488928 | -0.007825 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 183 | P | 0.40256 | T | 0.336895 | 0.065665 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 184 | H | 0.376068 | Q | 0.400766 | -0.024698 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 188 | Q | 0.305212 | R | 0.282573 | 0.022639 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 192 | S | 0.280714 | N | 0.228176 | 0.052538 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 194 | F | 0.332222 | L | 0.373723 | -0.041501 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 195 | L | 0.359855 | P | 0.558851 | -0.198996 | O to D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 198 | I | 0.545107 | M | 0.668397 | -0.12329 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 198 | I | 0.545107 | T | 0.645283 | -0.100176 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 199 | A | 0.597452 | T | 0.585639 | 0.011813 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 201 | R | 0.662787 | H | 0.642658 | 0.020129 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 203 | E | 0.706143 | K | 0.692156 | 0.013987 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 209 | Y | 0.770383 | C | 0.791371 | -0.020988 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 209 | Y | 0.770383 | S | 0.873263 | -0.10288 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 212 | Q | 0.703349 | H | 0.670865 | 0.032484 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 217 | L | 0.580065 | P | 0.726246 | -0.146181 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 226 | L | 0.462877 | P | 0.589412 | -0.126535 | O to D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 231 | R | 0.373363 | H | 0.363104 | 0.010259 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 249 | W | 0.068405 | R | 0.172112 | -0.103707 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 251 | Y | 0.0906 | C | 0.096969 | -0.006369 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 251 | Y | 0.0906 | S | 0.204328 | -0.113728 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 258 | R | 0.275448 | C | 0.13476 | 0.140688 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 259 | R | 0.296665 | W | 0.122198 | 0.174467 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 262 | R | 0.401372 | P | 0.441179 | -0.039807 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 282 | L | 0.301536 | V | 0.267222 | 0.034314 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 285 | K | 0.276011 | N | 0.236743 | 0.039268 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 289 | L | 0.280096 | R | 0.382528 | -0.102432 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 291 | E | 0.264394 | K | 0.276074 | -0.01168 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 308 | E | 0.607048 | K | 0.60266 | 0.004388 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 314 | N | 0.275058 | D | 0.275382 | -3.24E-04 | No Change: Both O | - |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 317 | Q | 0.162027 | H | 0.168946 | -0.006919 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 317 | Q | 0.162027 | R | 0.150792 | 0.011235 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 319 | H | 0.147559 | Q | 0.15355 | -0.005991 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 320 | A | 0.157147 | T | 0.17381 | -0.016663 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 323 | Y | 0.225494 | D | 0.341691 | -0.116197 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 323 | Y | 0.225494 | H | 0.33483 | -0.109336 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 324 | P | 0.259794 | S | 0.285299 | -0.025505 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 325 | P | 0.270556 | L | 0.157318 | 0.113238 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 328 | R | 0.24774 | H | 0.247138 | 6.02E-04 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 329 | S | 0.23091 | F | 0.109055 | 0.121855 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 330 | A | 0.209788 | V | 0.166829 | 0.042959 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 333 | R | 0.197721 | G | 0.194467 | 0.003254 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 333 | R | 0.197721 | Q | 0.200728 | -0.003007 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 333 | R | 0.197721 | W | 0.081947 | 0.115774 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 334 | K | 0.182576 | R | 0.176039 | 0.006537 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 336 | M | 0.167212 | L | 0.129049 | 0.038163 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 344 | Q | 0.334917 | K | 0.351748 | -0.016831 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 350 | T | 0.586587 | A | 0.591038 | -0.004451 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 45 | S | 0.208178 | L | 0.124407 | 0.083771 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 129 | M | 0.191379 | T | 0.200921 | -0.009542 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 167 | W | 0.082839 | R | 0.19113 | -0.108291 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 204 | R | 0.73215 | P | 0.756751 | -0.024601 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 272 | R | 0.558224 | G | 0.566479 | -0.008255 | No Change: Both D | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 294 | F | 0.245607 | Y | 0.278047 | -0.03244 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 51 | R | 0.435683 | Q | 0.460491 | -0.024808 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 135 | S | 0.156995 | W | 0.054126 | 0.102869 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 229 | K | 0.429452 | N | 0.394266 | 0.035186 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| P07902 | GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens GN=GALT PE=1 SV=3 | 252 | Q | 0.114957 | H | 0.110335 | 0.004622 | No Change: Both O | Galactosemia (GALCT) [MIM:230400] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 209 | T | 0.249891 | M | 0.228803 | 0.021088 | No Change: Both O | - |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 20 | W | 0.403477 | S | 0.654618 | -0.251141 | O to D | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 50 | M | 0.223 | L | 0.175352 | 0.047648 | No Change: Both O | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 51 | H | 0.248388 | P | 0.303262 | -0.054874 | No Change: Both O | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 54 | A | 0.382911 | P | 0.440542 | -0.057631 | No Change: Both O | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 169 | C | 0.076608 | Y | 0.103123 | -0.026515 | No Change: Both O | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q14353 | GAMT_HUMAN Guanidinoacetate N-methyltransferase OS=Homo sapiens GN=GAMT PE=1 SV=1 | 197 | L | 0.241043 | P | 0.400413 | -0.15937 | No Change: Both O | Guanidinoacetate methyltransferase deficiency (GAMT deficiency) [MIM:612736] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 486 | E | 0.523334 | K | 0.521757 | 0.001577 | No Change: Both D | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 15 | R | 0.554388 | S | 0.608434 | -0.054046 | No Change: Both D | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 52 | S | 0.196948 | G | 0.159315 | 0.037633 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 79 | S | 0.153326 | L | 0.073744 | 0.079582 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 82 | V | 0.093167 | F | 0.077802 | 0.015365 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 138 | R | 0.065474 | H | 0.071766 | -0.006292 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 269 | R | 0.397784 | Q | 0.406969 | -0.009185 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 309 | L | 0.158518 | R | 0.245652 | -0.087134 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 545 | R | 0.353703 | C | 0.187016 | 0.166687 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 570 | C | 0.177377 | Y | 0.197271 | -0.019894 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 423 | I | 0.391685 | T | 0.527608 | -0.135923 | O to D | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 86 | I | 0.086384 | F | 0.084181 | 0.002203 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 368 | G | 0.17671 | R | 0.171854 | 0.004856 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 51 | A | 0.204659 | P | 0.276585 | -0.071926 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 89 | Y | 0.077166 | C | 0.065402 | 0.011764 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 195 | V | 0.086747 | F | 0.073492 | 0.013255 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 315 | P | 0.260761 | L | 0.155391 | 0.10537 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 474 | G | 0.187643 | R | 0.183273 | 0.00437 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q9H2C0 | GAN_HUMAN Gigaxonin OS=Homo sapiens GN=GAN PE=1 SV=1 | 545 | R | 0.353703 | H | 0.342474 | 0.011229 | No Change: Both O | Giant axonal neuropathy (GAN) [MIM:256850] |
| Q14697 | GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANAB PE=1 SV=3 | 173 | R | 0.459589 | Q | 0.455591 | 0.003998 | No Change: Both O | - |
| Q14697 | GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANAB PE=1 SV=3 | 154 | R | 0.154594 | W | 0.050384 | 0.10421 | No Change: Both O | - |
| Q14697 | GANAB_HUMAN Neutral alpha-glucosidase AB OS=Homo sapiens GN=GANAB PE=1 SV=3 | 309 | R | 0.181101 | C | 0.088716 | 0.092385 | No Change: Both O | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 11 | L | 0.514231 | V | 0.549628 | -0.035397 | No Change: Both D | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 44 | Q | 0.372938 | R | 0.352271 | 0.020667 | No Change: Both O | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 153 | I | 0.203659 | M | 0.262692 | -0.059033 | No Change: Both O | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 443 | D | 0.405817 | E | 0.406253 | -4.36E-04 | No Change: Both O | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 845 | F | 0.290216 | S | 0.504912 | -0.214696 | O to D | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 848 | Q | 0.344285 | R | 0.347684 | -0.003399 | No Change: Both O | - |
| Q8TET4 | GANC_HUMAN Neutral alpha-glucosidase C OS=Homo sapiens GN=GANC PE=2 SV=3 | 166 | I | 0.294837 | V | 0.326201 | -0.031364 | No Change: Both O | - |
| P17677 | NEUM_HUMAN Neuromodulin OS=Homo sapiens GN=GAP43 PE=1 SV=1 | 59 | V | 0.911581 | I | 0.913169 | -0.001588 | No Change: Both D | - |
| P17677 | NEUM_HUMAN Neuromodulin OS=Homo sapiens GN=GAP43 PE=1 SV=1 | 162 | K | 0.995426 | E | 0.995668 | -2.42E-04 | No Change: Both D | - |
| P04406 | G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 | 22 | A | 0.209382 | G | 0.262301 | -0.052919 | No Change: Both O | - |
| P04406 | G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 | 251 | K | 0.366532 | N | 0.307931 | 0.058601 | No Change: Both O | - |
| O14556 | G3PT_HUMAN Glyceraldehyde-3-phosphate dehydrogenase testis-specific OS=Homo sapiens GN=GAPDHS PE=1 SV=2 | 110 | D | 0.181151 | N | 0.169587 | 0.011564 | No Change: Both O | - |
| Q8N292 | GAPT_HUMAN Protein GAPT OS=Homo sapiens GN=GAPT PE=1 SV=1 | 83 | A | 0.621968 | T | 0.663943 | -0.041975 | No Change: Both D | - |
| Q5VVW2 | GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens GN=GARNL3 PE=1 SV=2 | 108 | H | 0.149319 | R | 0.147604 | 0.001715 | No Change: Both O | - |
| Q5VVW2 | GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens GN=GARNL3 PE=1 SV=2 | 752 | A | 0.040235 | S | 0.06286 | -0.022625 | No Change: Both O | - |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 125 | E | 0.474506 | G | 0.418201 | 0.056305 | No Change: Both O | Charcot-Marie-Tooth disease type 2D (CMT2D) [MIM:601472] |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 183 | L | 0.184745 | P | 0.321044 | -0.136299 | No Change: Both O | Distal spinal muscular neuropathy type 5 (HMN5) [MIM:600794] |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 294 | G | 0.423721 | R | 0.410297 | 0.013424 | No Change: Both O | Charcot-Marie-Tooth disease type 2D (CMT2D) [MIM:601472] |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 580 | G | 0.148163 | R | 0.140847 | 0.007316 | No Change: Both O | Distal spinal muscular neuropathy type 5 (HMN5) [MIM:600794] |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 42 | P | 0.934228 | A | 0.911299 | 0.022929 | No Change: Both D | - |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 268 | T | 0.480113 | I | 0.365465 | 0.114648 | No Change: Both O | - |
| P41250 | SYG_HUMAN Glycine--tRNA ligase OS=Homo sapiens GN=GARS PE=1 SV=3 | 388 | R | 0.625273 | Q | 0.64843 | -0.023157 | No Change: Both D | - |
| P22102 | PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens GN=GART PE=1 SV=1 | 21 | L | 0.357091 | F | 0.315543 | 0.041548 | No Change: Both O | - |
| P22102 | PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens GN=GART PE=1 SV=1 | 421 | V | 0.134538 | I | 0.132314 | 0.002224 | No Change: Both O | - |
| P22102 | PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens GN=GART PE=1 SV=1 | 752 | D | 0.422936 | G | 0.400733 | 0.022203 | No Change: Both O | - |
| P22102 | PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens GN=GART PE=1 SV=1 | 510 | D | 0.26423 | G | 0.240507 | 0.023723 | No Change: Both O | - |
| P22102 | PUR2_HUMAN Trifunctional purine biosynthetic protein adenosine-3 OS=Homo sapiens GN=GART PE=1 SV=1 | 641 | P | 0.647483 | A | 0.582995 | 0.064488 | No Change: Both D | - |
| Q99501 | GA2L1_HUMAN GAS2-like protein 1 OS=Homo sapiens GN=GAS2L1 PE=1 SV=2 | 490 | S | 0.982759 | G | 0.975441 | 0.007318 | No Change: Both D | - |
| Q8NHY3 | GA2L2_HUMAN GAS2-like protein 2 OS=Homo sapiens GN=GAS2L2 PE=2 SV=1 | 540 | A | 0.665037 | T | 0.701779 | -0.036742 | No Change: Both D | - |
| Q8NHY3 | GA2L2_HUMAN GAS2-like protein 2 OS=Homo sapiens GN=GAS2L2 PE=2 SV=1 | 654 | A | 0.56845 | V | 0.486033 | 0.082417 | D to O | - |
| Q8NHY3 | GA2L2_HUMAN GAS2-like protein 2 OS=Homo sapiens GN=GAS2L2 PE=2 SV=1 | 164 | A | 0.327628 | V | 0.290592 | 0.037036 | No Change: Both O | - |
| Q8NHY3 | GA2L2_HUMAN GAS2-like protein 2 OS=Homo sapiens GN=GAS2L2 PE=2 SV=1 | 829 | R | 0.896081 | W | 0.811367 | 0.084714 | No Change: Both D | - |
| Q86XJ1 | GA2L3_HUMAN GAS2-like protein 3 OS=Homo sapiens GN=GAS2L3 PE=1 SV=1 | 461 | L | 0.813439 | S | 0.888989 | -0.07555 | No Change: Both D | - |
| Q86XJ1 | GA2L3_HUMAN GAS2-like protein 3 OS=Homo sapiens GN=GAS2L3 PE=1 SV=1 | 500 | P | 0.94606 | T | 0.921552 | 0.024508 | No Change: Both D | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 41 | F | 0.754772 | L | 0.79345 | -0.038678 | No Change: Both D | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 231 | S | 0.676308 | Y | 0.495867 | 0.180441 | D to O | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 390 | V | 0.076083 | M | 0.100753 | -0.02467 | No Change: Both O | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 543 | G | 0.393638 | R | 0.391872 | 0.001766 | No Change: Both O | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 623 | S | 0.391824 | L | 0.247344 | 0.14448 | No Change: Both O | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 655 | E | 0.435211 | K | 0.38766 | 0.047551 | No Change: Both O | - |
| Q14393 | GAS6_HUMAN Growth arrest-specific protein 6 OS=Homo sapiens GN=GAS6 PE=1 SV=2 | 659 | R | 0.325202 | Q | 0.324457 | 7.45E-04 | No Change: Both O | - |
| O95995 | GAS8_HUMAN Growth arrest-specific protein 8 OS=Homo sapiens GN=GAS8 PE=1 SV=1 | 199 | E | 0.886351 | K | 0.884972 | 0.001379 | No Change: Both D | - |
| O95995 | GAS8_HUMAN Growth arrest-specific protein 8 OS=Homo sapiens GN=GAS8 PE=1 SV=1 | 259 | R | 0.795142 | Q | 0.803451 | -0.008309 | No Change: Both D | - |
| P01350 | GAST_HUMAN Gastrin OS=Homo sapiens GN=GAST PE=1 SV=1 | 3 | R | 0.299886 | P | 0.331813 | -0.031927 | No Change: Both O | - |
| P15976 | GATA1_HUMAN Erythroid transcription factor OS=Homo sapiens GN=GATA1 PE=1 SV=1 | 205 | V | 0.451567 | M | 0.572904 | -0.121337 | O to D | X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367] |
| P15976 | GATA1_HUMAN Erythroid transcription factor OS=Homo sapiens GN=GATA1 PE=1 SV=1 | 208 | G | 0.363844 | S | 0.405059 | -0.041215 | No Change: Both O | X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367] |
| P15976 | GATA1_HUMAN Erythroid transcription factor OS=Homo sapiens GN=GATA1 PE=1 SV=1 | 218 | D | 0.341855 | G | 0.368 | -0.026145 | No Change: Both O | X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367] |
| P15976 | GATA1_HUMAN Erythroid transcription factor OS=Homo sapiens GN=GATA1 PE=1 SV=1 | 216 | R | 0.368406 | Q | 0.335353 | 0.033053 | No Change: Both O | X-linked thrombocytopenia with beta-thalassemia (XLTT) [MIM:314050] |
| P15976 | GATA1_HUMAN Erythroid transcription factor OS=Homo sapiens GN=GATA1 PE=1 SV=1 | 218 | D | 0.341855 | Y | 0.259193 | 0.082662 | No Change: Both O | X-linked dyserythropoietic anemia and thrombocytopenia (XDAT) [MIM:300367] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 164 | A | 0.970557 | T | 0.973973 | -0.003416 | No Change: Both D | - |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 235 | T | 0.719982 | N | 0.690979 | 0.029003 | No Change: Both D | - |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 254 | P | 0.650168 | L | 0.476446 | 0.173722 | D to O | Dendritic cell monocyte lymphocyte B and natural killer lymphocyte deficiency (DCML) [MIM:614172] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 354 | T | 0.446373 | M | 0.388004 | 0.058369 | No Change: Both O | Dendritic cell monocyte lymphocyte B and natural killer lymphocyte deficiency (DCML) [MIM:614172] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 354 | T | 0.446373 | M | 0.388004 | 0.058369 | No Change: Both O | Myelodysplastic syndrome (MDS) [MIM:614286] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 398 | R | 0.851941 | W | 0.725973 | 0.125968 | No Change: Both D | Dendritic cell monocyte lymphocyte B and natural killer lymphocyte deficiency (DCML) [MIM:614172] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 361 | R | 0.405562 | P | 0.428188 | -0.022626 | No Change: Both O | Lymphedema primary with myelodysplasia (LMPM) [MIM:614038] |
| P23769 | GATA2_HUMAN Endothelial transcription factor GATA-2 OS=Homo sapiens GN=GATA2 PE=1 SV=3 | 373 | C | 0.256886 | R | 0.332461 | -0.075575 | No Change: Both O | Lymphedema primary with myelodysplasia (LMPM) [MIM:614038] |
| P23771 | GATA3_HUMAN Trans-acting T-cell-specific transcription factor GATA-3 OS=Homo sapiens GN=GATA3 PE=1 SV=1 | 274 | W | 0.447547 | R | 0.663319 | -0.215772 | O to D | Hypoparathyroidism with sensorineural deafness and renal dysplasia (HDR) [MIM:146255] |
| P23771 | GATA3_HUMAN Trans-acting T-cell-specific transcription factor GATA-3 OS=Homo sapiens GN=GATA3 PE=1 SV=1 | 242 | G | 0.9116 | S | 0.932269 | -0.020669 | No Change: Both D | - |
| P23771 | GATA3_HUMAN Trans-acting T-cell-specific transcription factor GATA-3 OS=Homo sapiens GN=GATA3 PE=1 SV=1 | 366 | R | 0.82597 | L | 0.753808 | 0.072162 | No Change: Both D | A breast cancer sample |
| P43694 | GATA4_HUMAN Transcription factor GATA-4 OS=Homo sapiens GN=GATA4 PE=1 SV=2 | 296 | G | 0.304782 | S | 0.32166 | -0.016878 | No Change: Both O | Atrial septal defect type 2 (ASD2) [MIM:607941] |
| P43694 | GATA4_HUMAN Transcription factor GATA-4 OS=Homo sapiens GN=GATA4 PE=1 SV=2 | 52 | S | 0.863757 | F | 0.764465 | 0.099292 | No Change: Both D | Atrial septal defect type 2 (ASD2) [MIM:607941] |
| P43694 | GATA4_HUMAN Transcription factor GATA-4 OS=Homo sapiens GN=GATA4 PE=1 SV=2 | 377 | S | 0.932234 | G | 0.907793 | 0.024441 | No Change: Both D | - |
| Q8WUU5 | GATD1_HUMAN GATA zinc finger domain-containing protein 1 OS=Homo sapiens GN=GATAD1 PE=1 SV=1 | 54 | G | 0.978658 | S | 0.979597 | -9.39E-04 | No Change: Both D | - |
| Q86YP4 | P66A_HUMAN Transcriptional repressor p66-alpha OS=Homo sapiens GN=GATAD2A PE=1 SV=1 | 17 | R | 0.950209 | Q | 0.943492 | 0.006717 | No Change: Both D | - |
| Q86YP4 | P66A_HUMAN Transcriptional repressor p66-alpha OS=Homo sapiens GN=GATAD2A PE=1 SV=1 | 296 | N | 0.564973 | S | 0.613591 | -0.048618 | No Change: Both D | - |
| O43716 | GATC_HUMAN Glutamyl-tRNA(Gln) amidotransferase subunit C mitochondrial OS=Homo sapiens GN=GATC PE=1 SV=1 | 3 | S | 0.333572 | L | 0.158814 | 0.174758 | No Change: Both O | - |
| P50440 | GATM_HUMAN Glycine amidinotransferase mitochondrial OS=Homo sapiens GN=GATM PE=1 SV=1 | 110 | Q | 0.354824 | H | 0.34351 | 0.011314 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 54 | V | 0.121206 | L | 0.116963 | 0.004243 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 76 | F | 0.488546 | V | 0.494556 | -0.00601 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 82 | T | 0.72677 | I | 0.608866 | 0.117904 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 85 | G | 0.72647 | E | 0.760491 | -0.034021 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 87 | R | 0.703986 | W | 0.47985 | 0.224136 | D to O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 118 | K | 0.464186 | N | 0.406695 | 0.057491 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 152 | G | 0.254724 | E | 0.307127 | -0.052403 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 158 | I | 0.100008 | T | 0.163117 | -0.063109 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 159 | R | 0.092768 | Q | 0.100714 | -0.007946 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 159 | R | 0.092768 | W | 0.036518 | 0.05625 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 161 | P | 0.093737 | S | 0.113569 | -0.019832 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 173 | T | 0.241948 | P | 0.283205 | -0.041257 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 179 | D | 0.433374 | H | 0.392138 | 0.041236 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 196 | K | 0.379671 | Q | 0.340405 | 0.039266 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 209 | R | 0.340471 | P | 0.399149 | -0.058678 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 215 | A | 0.327341 | D | 0.396376 | -0.069035 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 217 | P | 0.323249 | S | 0.34277 | -0.019521 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 221 | P | 0.3133 | T | 0.269929 | 0.043371 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 223 | W | 0.300759 | R | 0.506049 | -0.20529 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 227 | N | 0.405476 | S | 0.452436 | -0.04696 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 227 | N | 0.405476 | K | 0.45666 | -0.051184 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 230 | V | 0.51906 | G | 0.676346 | -0.157286 | No Change: Both D | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 234 | G | 0.69352 | E | 0.707874 | -0.014354 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 235 | S | 0.658347 | P | 0.64366 | 0.014687 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 241 | G | 0.485043 | R | 0.453662 | 0.031381 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 251 | Y | 0.039653 | H | 0.068139 | -0.028486 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 252 | F | 0.043532 | I | 0.040819 | 0.002713 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 255 | F | 0.083287 | Y | 0.100342 | -0.017055 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 276 | S | 0.581001 | P | 0.548856 | 0.032145 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 296 | R | 0.314838 | Q | 0.334405 | -0.019567 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 305 | P | 0.407206 | R | 0.3863 | 0.020906 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 324 | R | 0.183611 | C | 0.088041 | 0.09557 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 328 | P | 0.086516 | L | 0.046116 | 0.0404 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 342 | K | 0.25834 | I | 0.114798 | 0.143542 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 348 | A | 0.042866 | V | 0.030027 | 0.012839 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 351 | W | 0.029375 | C | 0.035542 | -0.006167 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 352 | Y | 0.032897 | H | 0.062751 | -0.029854 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 354 | D | 0.051304 | H | 0.046845 | 0.004459 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 357 | A | 0.130244 | D | 0.177955 | -0.047711 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 362 | T | 0.41407 | I | 0.251319 | 0.162751 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 363 | L | 0.429775 | P | 0.616038 | -0.186263 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 364 | G | 0.412434 | R | 0.414234 | -0.0018 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 365 | E | 0.397735 | K | 0.41511 | -0.017375 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 381 | C | 0.167503 | G | 0.338581 | -0.171078 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 398 | R | 0.443215 | Q | 0.471255 | -0.02804 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 403 | S | 0.276384 | T | 0.20489 | 0.071494 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 408 | T | 0.145171 | M | 0.123619 | 0.021552 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 409 | N | 0.110164 | S | 0.143161 | -0.032997 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 416 | G | 0.037022 | S | 0.047531 | -0.010509 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 417 | W | 0.04807 | G | 0.127317 | -0.079247 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 419 | D | 0.069524 | A | 0.050463 | 0.019061 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 419 | D | 0.069524 | N | 0.07097 | -0.001446 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 428 | G | 0.386472 | E | 0.447278 | -0.060806 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 430 | P | 0.363631 | L | 0.208638 | 0.154993 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 431 | N | 0.310261 | I | 0.144355 | 0.165906 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 433 | V | 0.232175 | L | 0.220279 | 0.011896 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 435 | N | 0.159647 | T | 0.128141 | 0.031506 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 438 | D | 0.105928 | N | 0.101619 | 0.004309 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 448 | D | 0.208541 | H | 0.16872 | 0.039821 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 448 | D | 0.208541 | V | 0.105392 | 0.103149 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 451 | Y | 0.230084 | H | 0.334333 | -0.104249 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 454 | P | 0.217457 | R | 0.189578 | 0.027879 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 456 | F | 0.180281 | V | 0.187428 | -0.007147 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 457 | Y | 0.147653 | C | 0.113981 | 0.033672 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 464 | K | 0.337378 | E | 0.35472 | -0.017342 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 483 | L | 0.41999 | R | 0.519515 | -0.099525 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 483 | L | 0.41999 | P | 0.557173 | -0.137183 | O to D | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 483 | L | 0.41999 | P | 0.557173 | -0.137183 | O to D | Gaucher disease type 2 (GD2) [MIM:230900] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 485 | A | 0.369991 | P | 0.450442 | -0.080451 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 495 | A | 0.276047 | P | 0.366737 | -0.09069 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 502 | R | 0.36757 | C | 0.21319 | 0.15438 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 509 | L | 0.428856 | P | 0.610811 | -0.181955 | O to D | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 517 | G | 0.164075 | S | 0.207531 | -0.043456 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 535 | R | 0.727053 | C | 0.484278 | 0.242775 | D to O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 535 | R | 0.727053 | H | 0.752383 | -0.02533 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 80 | E | 0.691638 | K | 0.679631 | 0.012007 | No Change: Both D | Gaucher disease type 2 (GD2) [MIM:230900] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 146 | S | 0.27869 | L | 0.13973 | 0.13896 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 170 | R | 0.179362 | C | 0.097472 | 0.08189 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 170 | R | 0.179362 | C | 0.097472 | 0.08189 | No Change: Both O | Gaucher disease type 2 (GD2) [MIM:230900] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 170 | R | 0.179362 | L | 0.108026 | 0.071336 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 198 | P | 0.258211 | L | 0.152799 | 0.105412 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 229 | A | 0.472092 | E | 0.595119 | -0.123027 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 234 | G | 0.69352 | W | 0.44749 | 0.24603 | D to O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 294 | H | 0.287864 | Q | 0.323332 | -0.035468 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 298 | F | 0.29716 | L | 0.334883 | -0.037723 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 324 | R | 0.183611 | H | 0.191192 | -0.007581 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 343 | Y | 0.222496 | C | 0.180153 | 0.042343 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 350 | H | 0.03013 | R | 0.027629 | 0.002501 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 380 | A | 0.168242 | T | 0.183621 | -0.015379 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 405 | S | 0.205309 | N | 0.174105 | 0.031204 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 432 | W | 0.271053 | R | 0.519766 | -0.248713 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 437 | V | 0.104728 | F | 0.089488 | 0.01524 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 501 | N | 0.333019 | K | 0.393167 | -0.060148 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 513 | D | 0.235495 | Y | 0.120056 | 0.115439 | No Change: Both O | Gaucher disease type 2 (GD2) [MIM:230900] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 200 | I | 0.18129 | S | 0.369077 | -0.187787 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 228 | G | 0.42223 | V | 0.274502 | 0.147728 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 241 | G | 0.485043 | E | 0.517944 | -0.032901 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 244 | Y | 0.195791 | C | 0.156762 | 0.039029 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 304 | G | 0.339237 | D | 0.38887 | -0.049633 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 310 | S | 0.473532 | N | 0.454951 | 0.018581 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 391 | V | 0.241067 | L | 0.250201 | -0.009134 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 392 | R | 0.249833 | G | 0.269688 | -0.019855 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 405 | S | 0.205309 | G | 0.164525 | 0.040784 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 414 | V | 0.03023 | L | 0.031045 | -8.15E-04 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 426 | P | 0.366354 | L | 0.215574 | 0.15078 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 437 | V | 0.104728 | L | 0.094862 | 0.009866 | No Change: Both O | Gaucher disease type 3 (GD3) [MIM:231000] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 440 | P | 0.117647 | L | 0.055803 | 0.061844 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 441 | I | 0.119337 | T | 0.210271 | -0.090934 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 450 | F | 0.221441 | I | 0.226294 | -0.004853 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 452 | K | 0.251863 | Q | 0.213973 | 0.03789 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 530 | T | 0.2171 | I | 0.129529 | 0.087571 | No Change: Both O | Gaucher disease type 3 (GD3) [MIM:231000] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 87 | R | 0.703986 | Q | 0.696298 | 0.007688 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 161 | P | 0.093737 | L | 0.045158 | 0.048579 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 162 | M | 0.103629 | V | 0.083955 | 0.019674 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 166 | D | 0.150078 | V | 0.081253 | 0.068825 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 200 | I | 0.18129 | N | 0.317362 | -0.136072 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 213 | L | 0.31724 | F | 0.26251 | 0.05473 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 224 | L | 0.320098 | F | 0.288681 | 0.031417 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 232 | G | 0.628412 | E | 0.647221 | -0.018809 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 237 | K | 0.675221 | E | 0.663411 | 0.01181 | No Change: Both D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 303 | L | 0.295891 | I | 0.2643 | 0.031591 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 388 | E | 0.239618 | K | 0.250741 | -0.011123 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 392 | R | 0.249833 | W | 0.113683 | 0.13615 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 402 | Y | 0.29603 | C | 0.244272 | 0.051758 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 410 | L | 0.084085 | V | 0.087139 | -0.003054 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 419 | D | 0.069524 | H | 0.06137 | 0.008154 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 421 | N | 0.122447 | K | 0.136184 | -0.013737 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 429 | G | 0.379926 | R | 0.364884 | 0.015042 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 436 | F | 0.123394 | S | 0.309756 | -0.186362 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 455 | M | 0.204174 | V | 0.161045 | 0.043129 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 500 | L | 0.291412 | P | 0.457393 | -0.165981 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 502 | R | 0.36757 | P | 0.424934 | -0.057364 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 55 | C | 0.103699 | S | 0.219688 | -0.115989 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 63 | D | 0.317794 | N | 0.303479 | 0.014315 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 92 | M | 0.627703 | T | 0.654482 | -0.026779 | No Change: Both D | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 129 | A | 0.201856 | T | 0.215454 | -0.013598 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 156 | N | 0.128436 | D | 0.13759 | -0.009154 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 158 | I | 0.100008 | S | 0.233221 | -0.133213 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 173 | T | 0.241948 | I | 0.138857 | 0.103091 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 175 | A | 0.326138 | E | 0.432006 | -0.105868 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 198 | P | 0.258211 | T | 0.217761 | 0.04045 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 201 | H | 0.173348 | P | 0.2438 | -0.070452 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 209 | R | 0.340471 | C | 0.202374 | 0.138097 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 221 | P | 0.3133 | L | 0.178817 | 0.134483 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 229 | A | 0.472092 | T | 0.527291 | -0.055199 | O to D | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 230 | V | 0.51906 | E | 0.699492 | -0.180432 | No Change: Both D | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 270 | T | 0.252163 | R | 0.264345 | -0.012182 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 290 | F | 0.219605 | L | 0.24184 | -0.022235 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 310 | S | 0.473532 | G | 0.432707 | 0.040825 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 368 | R | 0.277468 | H | 0.297851 | -0.020383 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 400 | M | 0.400391 | I | 0.315615 | 0.084776 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 438 | D | 0.105928 | Y | 0.048961 | 0.056967 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 441 | I | 0.119337 | F | 0.11693 | 0.002407 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 460 | G | 0.157707 | D | 0.173822 | -0.016115 | No Change: Both O | Gaucher disease type 1 (GD1) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 490 | H | 0.320309 | R | 0.337452 | -0.017143 | No Change: Both O | Gaucher disease (GD) [MIM:230800] |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 46 | K | 0.359185 | E | 0.357352 | 0.001833 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 482 | D | 0.43119 | N | 0.414704 | 0.016486 | No Change: Both O | - |
| P04062 | GLCM_HUMAN Glucosylceramidase OS=Homo sapiens GN=GBA PE=1 SV=3 | 497 | V | 0.25856 | L | 0.251291 | 0.007269 | No Change: Both O | - |
| Q9H227 | GBA3_HUMAN Cytosolic beta-glucosidase OS=Homo sapiens GN=GBA3 PE=1 SV=2 | 106 | D | 0.18498 | N | 0.176395 | 0.008585 | No Change: Both O | - |
| Q9H227 | GBA3_HUMAN Cytosolic beta-glucosidase OS=Homo sapiens GN=GBA3 PE=1 SV=2 | 213 | R | 0.511671 | P | 0.540423 | -0.028752 | No Change: Both D | - |
| Q9H227 | GBA3_HUMAN Cytosolic beta-glucosidase OS=Homo sapiens GN=GBA3 PE=1 SV=2 | 354 | C | 0.032096 | R | 0.070041 | -0.037945 | No Change: Both O | - |
| Q9H227 | GBA3_HUMAN Cytosolic beta-glucosidase OS=Homo sapiens GN=GBA3 PE=1 SV=2 | 172 | M | 0.183053 | I | 0.118687 | 0.064366 | No Change: Both O | - |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 190 | R | 0.784066 | G | 0.780449 | 0.003617 | No Change: Both D | - |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 224 | L | 0.110639 | P | 0.218741 | -0.108102 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 257 | F | 0.248407 | L | 0.255607 | -0.0072 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 329 | Y | 0.094549 | S | 0.22177 | -0.127221 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 515 | R | 0.186326 | C | 0.090178 | 0.096148 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 515 | R | 0.186326 | H | 0.195757 | -0.009431 | No Change: Both O | Adult polyglucosan body disease (APBD) [MIM:263570] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 524 | R | 0.15979 | Q | 0.178347 | -0.018557 | No Change: Both O | Adult polyglucosan body disease (APBD) [MIM:263570] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 524 | R | 0.15979 | Q | 0.178347 | -0.018557 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 545 | H | 0.289231 | R | 0.295356 | -0.006125 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 628 | H | 0.208823 | R | 0.206654 | 0.002169 | No Change: Both O | Glycogen storage disease type 4 (GSD4) [MIM:232500] |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 265 | T | 0.592978 | S | 0.684811 | -0.091833 | No Change: Both D | - |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 334 | I | 0.067793 | V | 0.075849 | -0.008056 | No Change: Both O | - |
| Q04446 | GLGB_HUMAN 1 4-alpha-glucan-branching enzyme OS=Homo sapiens GN=GBE1 PE=1 SV=3 | 507 | T | 0.176003 | A | 0.143717 | 0.032286 | No Change: Both O | - |
| Q92538 | GBF1_HUMAN Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Homo sapiens GN=GBF1 PE=1 SV=2 | 1693 | G | 0.46479 | S | 0.508393 | -0.043603 | O to D | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 20 | L | 0.059826 | F | 0.047804 | 0.012022 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 21 | S | 0.051494 | G | 0.040067 | 0.011427 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 79 | L | 0.302461 | P | 0.46144 | -0.158979 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 163 | R | 0.355129 | W | 0.17527 | 0.179859 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 200 | D | 0.10912 | N | 0.095293 | 0.013827 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 238 | Q | 0.403774 | P | 0.429006 | -0.025232 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 248 | T | 0.333968 | I | 0.207438 | 0.12653 | No Change: Both O | - |
| Q8N5D6 | GBGT1_HUMAN Globoside alpha-1 3-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens GN=GBGT1 PE=1 SV=2 | 291 | I | 0.215438 | F | 0.20974 | 0.005698 | No Change: Both O | - |
| P32455 | GBP1_HUMAN Interferon-induced guanylate-binding protein 1 OS=Homo sapiens GN=GBP1 PE=1 SV=2 | 349 | T | 0.453142 | S | 0.528802 | -0.07566 | O to D | - |
| P32455 | GBP1_HUMAN Interferon-induced guanylate-binding protein 1 OS=Homo sapiens GN=GBP1 PE=1 SV=2 | 78 | I | 0.14414 | V | 0.177645 | -0.033505 | No Change: Both O | - |
| P32455 | GBP1_HUMAN Interferon-induced guanylate-binding protein 1 OS=Homo sapiens GN=GBP1 PE=1 SV=2 | 166 | E | 0.667278 | D | 0.653352 | 0.013926 | No Change: Both D | - |
| P32455 | GBP1_HUMAN Interferon-induced guanylate-binding protein 1 OS=Homo sapiens GN=GBP1 PE=1 SV=2 | 409 | A | 0.371907 | G | 0.397029 | -0.025122 | No Change: Both O | - |
| P32456 | GBP2_HUMAN Interferon-induced guanylate-binding protein 2 OS=Homo sapiens GN=GBP2 PE=2 SV=3 | 281 | S | 0.459039 | P | 0.432676 | 0.026363 | No Change: Both O | - |
| P32456 | GBP2_HUMAN Interferon-induced guanylate-binding protein 2 OS=Homo sapiens GN=GBP2 PE=2 SV=3 | 285 | P | 0.401809 | A | 0.30369 | 0.098119 | No Change: Both O | - |
| P32456 | GBP2_HUMAN Interferon-induced guanylate-binding protein 2 OS=Homo sapiens GN=GBP2 PE=2 SV=3 | 303 | S | 0.23077 | G | 0.190558 | 0.040212 | No Change: Both O | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 469 | V | 0.676454 | M | 0.738396 | -0.061942 | No Change: Both D | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 491 | C | 0.873273 | R | 0.898009 | -0.024736 | No Change: Both D | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 558 | V | 0.968689 | A | 0.979292 | -0.010603 | No Change: Both D | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 221 | R | 0.315777 | Q | 0.328774 | -0.012997 | No Change: Both O | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 225 | R | 0.359274 | W | 0.151373 | 0.207901 | No Change: Both O | - |
| Q9H0R5 | GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens GN=GBP3 PE=2 SV=3 | 347 | T | 0.395056 | S | 0.484169 | -0.089113 | No Change: Both O | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 125 | K | 0.540409 | E | 0.540255 | 1.54E-04 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 379 | I | 0.283383 | V | 0.336803 | -0.05342 | No Change: Both O | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 541 | Y | 0.990915 | N | 0.995194 | -0.004279 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 549 | L | 0.988554 | M | 0.991644 | -0.00309 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 551 | E | 0.988534 | K | 0.987556 | 9.78E-04 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 551 | E | 0.988534 | G | 0.978547 | 0.009987 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 542 | M | 0.990116 | I | 0.979905 | 0.010211 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 545 | M | 0.989329 | I | 0.978472 | 0.010857 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 545 | M | 0.989329 | L | 0.986139 | 0.00319 | No Change: Both D | - |
| Q96PP9 | GBP4_HUMAN Guanylate-binding protein 4 OS=Homo sapiens GN=GBP4 PE=1 SV=2 | 546 | E | 0.989031 | K | 0.988036 | 9.95E-04 | No Change: Both D | - |
| Q96PP8 | GBP5_HUMAN Guanylate-binding protein 5 OS=Homo sapiens GN=GBP5 PE=2 SV=1 | 35 | T | 0.092062 | M | 0.076094 | 0.015968 | No Change: Both O | - |
| Q96PP8 | GBP5_HUMAN Guanylate-binding protein 5 OS=Homo sapiens GN=GBP5 PE=2 SV=1 | 4 | E | 0.695872 | Q | 0.66723 | 0.028642 | No Change: Both D | - |
| Q6ZN66 | GBP6_HUMAN Guanylate-binding protein 6 OS=Homo sapiens GN=GBP6 PE=2 SV=1 | 278 | T | 0.308827 | I | 0.188238 | 0.120589 | No Change: Both O | - |
| Q6ZN66 | GBP6_HUMAN Guanylate-binding protein 6 OS=Homo sapiens GN=GBP6 PE=2 SV=1 | 331 | A | 0.451986 | S | 0.538732 | -0.086746 | O to D | - |
| Q6ZN66 | GBP6_HUMAN Guanylate-binding protein 6 OS=Homo sapiens GN=GBP6 PE=2 SV=1 | 344 | L | 0.438387 | F | 0.383746 | 0.054641 | No Change: Both O | - |
| Q6ZN66 | GBP6_HUMAN Guanylate-binding protein 6 OS=Homo sapiens GN=GBP6 PE=2 SV=1 | 355 | M | 0.369161 | V | 0.269107 | 0.100054 | No Change: Both O | - |
| Q6ZN66 | GBP6_HUMAN Guanylate-binding protein 6 OS=Homo sapiens GN=GBP6 PE=2 SV=1 | 520 | D | 0.991467 | V | 0.986978 | 0.004489 | No Change: Both D | - |
| Q8N8V2 | GBP7_HUMAN Guanylate-binding protein 7 OS=Homo sapiens GN=GBP7 PE=2 SV=2 | 14 | T | 0.362421 | I | 0.215867 | 0.146554 | No Change: Both O | - |
| Q8N8V2 | GBP7_HUMAN Guanylate-binding protein 7 OS=Homo sapiens GN=GBP7 PE=2 SV=2 | 618 | G | 0.220242 | R | 0.214165 | 0.006077 | No Change: Both O | - |
| Q14549 | GBX1_HUMAN Homeobox protein GBX-1 OS=Homo sapiens GN=GBX1 PE=2 SV=2 | 194 | A | 0.989996 | T | 0.989595 | 4.01E-04 | No Change: Both D | - |
| P02774 | VTDB_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1 | 432 | D | 0.753904 | E | 0.785453 | -0.031549 | No Change: Both D | - |
| P02774 | VTDB_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1 | 436 | K | 0.744573 | T | 0.672138 | 0.072435 | No Change: Both D | - |
| P02774 | VTDB_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1 | 445 | R | 0.662437 | C | 0.6117 | 0.050737 | No Change: Both D | - |
| P02774 | VTDB_HUMAN Vitamin D-binding protein OS=Homo sapiens GN=GC PE=1 SV=1 | 445 | R | 0.662437 | H | 0.61599 | 0.046447 | No Change: Both D | - |
| P28676 | GRAN_HUMAN Grancalcin OS=Homo sapiens GN=GCA PE=1 SV=2 | 80 | S | 0.328639 | A | 0.223656 | 0.104983 | No Change: Both O | - |
| O75600 | KBL_HUMAN 2-amino-3-ketobutyrate coenzyme A ligase mitochondrial OS=Homo sapiens GN=GCAT PE=2 SV=1 | 39 | R | 0.382161 | C | 0.220828 | 0.161333 | No Change: Both O | - |
| O75600 | KBL_HUMAN 2-amino-3-ketobutyrate coenzyme A ligase mitochondrial OS=Homo sapiens GN=GCAT PE=2 SV=1 | 100 | S | 0.173991 | N | 0.137952 | 0.036039 | No Change: Both O | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 87 | C | 0.78379 | W | 0.721411 | 0.062379 | No Change: Both D | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 86 | R | 0.759269 | W | 0.590877 | 0.168392 | No Change: Both D | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 122 | A | 0.981605 | V | 0.975283 | 0.006322 | No Change: Both D | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 262 | Q | 0.955216 | R | 0.954792 | 4.24E-04 | No Change: Both D | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 274 | A | 0.917203 | T | 0.92398 | -0.006777 | No Change: Both D | - |
| Q96CN9 | GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=GCC1 PE=1 SV=1 | 618 | R | 0.885053 | C | 0.82022 | 0.064833 | No Change: Both D | - |
| Q8IWJ2 | GCC2_HUMAN GRIP and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=GCC2 PE=1 SV=4 | 1298 | R | 0.758844 | G | 0.687339 | 0.071505 | No Change: Both D | - |
| Q8IWJ2 | GCC2_HUMAN GRIP and coiled-coil domain-containing protein 2 OS=Homo sapiens GN=GCC2 PE=1 SV=4 | 1134 | Q | 0.972011 | E | 0.971403 | 6.08E-04 | No Change: Both D | - |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 88 | R | 0.232117 | C | 0.112262 | 0.119855 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 94 | R | 0.293826 | L | 0.180588 | 0.113238 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 101 | G | 0.330093 | R | 0.307424 | 0.022669 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 115 | C | 0.224861 | Y | 0.278073 | -0.053212 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 122 | A | 0.187331 | V | 0.139376 | 0.047955 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 128 | R | 0.289886 | G | 0.297332 | -0.007446 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 138 | R | 0.545891 | G | 0.554709 | -0.008818 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 139 | S | 0.562911 | L | 0.352095 | 0.210816 | D to O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 148 | V | 0.309808 | I | 0.278062 | 0.031746 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 161 | R | 0.536032 | Q | 0.581618 | -0.045586 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 178 | G | 0.474327 | R | 0.47077 | 0.003557 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 179 | L | 0.565569 | R | 0.657072 | -0.091503 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 191 | M | 0.787211 | T | 0.812734 | -0.025523 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 195 | A | 0.76806 | T | 0.800407 | -0.032347 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 227 | R | 0.042564 | P | 0.047773 | -0.005209 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 236 | F | 0.137226 | L | 0.167812 | -0.030586 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 257 | R | 0.348405 | Q | 0.358266 | -0.009861 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 257 | R | 0.348405 | W | 0.16571 | 0.182695 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 266 | M | 0.261599 | V | 0.203406 | 0.058193 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 278 | P | 0.523306 | S | 0.560097 | -0.036791 | No Change: Both D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 283 | L | 0.431855 | P | 0.595759 | -0.163904 | O to D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 293 | A | 0.098671 | T | 0.104186 | -0.005515 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 294 | R | 0.075755 | W | 0.031317 | 0.044438 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 295 | Y | 0.069155 | H | 0.117444 | -0.048289 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 298 | A | 0.075111 | T | 0.077563 | -0.002452 | No Change: Both O | - |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 298 | A | 0.075111 | V | 0.050944 | 0.024167 | No Change: Both O | - |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 305 | S | 0.119847 | L | 0.056989 | 0.062858 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 308 | C | 0.12393 | S | 0.311156 | -0.187226 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 309 | L | 0.127475 | W | 0.084822 | 0.042653 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 313 | R | 0.165218 | W | 0.063526 | 0.101692 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 333 | Q | 0.299865 | E | 0.325693 | -0.025828 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 349 | A | 0.1681 | T | 0.18845 | -0.02035 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 354 | G | 0.338835 | R | 0.364139 | -0.025304 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 354 | G | 0.338835 | S | 0.382169 | -0.043334 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 355 | R | 0.389581 | C | 0.290017 | 0.099564 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 355 | R | 0.389581 | H | 0.376855 | 0.012726 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 365 | E | 0.482421 | K | 0.521016 | -0.038595 | O to D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 375 | C | 0.352448 | R | 0.525137 | -0.172689 | O to D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 382 | A | 0.330743 | T | 0.323893 | 0.00685 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 383 | R | 0.321911 | C | 0.18878 | 0.133131 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 383 | R | 0.321911 | H | 0.296069 | 0.025842 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 386 | R | 0.355703 | Q | 0.36969 | -0.013987 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 390 | G | 0.42737 | R | 0.415891 | 0.011479 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 390 | G | 0.42737 | A | 0.371046 | 0.056324 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 392 | N | 0.449521 | D | 0.487369 | -0.037848 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 400 | V | 0.221338 | M | 0.290955 | -0.069617 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 402 | R | 0.179819 | W | 0.074731 | 0.105088 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 402 | R | 0.179819 | Q | 0.192738 | -0.012919 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 403 | H | 0.191728 | R | 0.191134 | 5.94E-04 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 406 | N | 0.237183 | K | 0.258311 | -0.021128 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 407 | L | 0.270906 | P | 0.433439 | -0.162533 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 414 | E | 0.364662 | K | 0.350619 | 0.014043 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 416 | T | 0.314173 | I | 0.196778 | 0.117395 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 421 | A | 0.144445 | T | 0.168141 | -0.023696 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 421 | A | 0.144445 | V | 0.097595 | 0.04685 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 429 | T | 0.119323 | M | 0.092377 | 0.026946 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 433 | A | 0.463605 | E | 0.552991 | -0.089386 | O to D | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| Q92947 | GCDH_HUMAN Glutaryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=GCDH PE=1 SV=1 | 263 | M | 0.252968 | V | 0.187161 | 0.065807 | No Change: Both O | Glutaric aciduria type 1 (GA1) [MIM:231670] |
| P16383 | GCFC2_HUMAN GC-rich sequence DNA-binding factor 2 OS=Homo sapiens GN=GCFC2 PE=1 SV=2 | 32 | P | 0.993779 | A | 0.990783 | 0.002996 | No Change: Both D | - |
| P16383 | GCFC2_HUMAN GC-rich sequence DNA-binding factor 2 OS=Homo sapiens GN=GCFC2 PE=1 SV=2 | 249 | N | 0.597062 | S | 0.670089 | -0.073027 | No Change: Both D | - |
| P16383 | GCFC2_HUMAN GC-rich sequence DNA-binding factor 2 OS=Homo sapiens GN=GCFC2 PE=1 SV=2 | 316 | Q | 0.569544 | E | 0.612206 | -0.042662 | No Change: Both D | - |
| P16383 | GCFC2_HUMAN GC-rich sequence DNA-binding factor 2 OS=Homo sapiens GN=GCFC2 PE=1 SV=2 | 594 | T | 0.572288 | A | 0.528768 | 0.04352 | No Change: Both D | - |
| P16383 | GCFC2_HUMAN GC-rich sequence DNA-binding factor 2 OS=Homo sapiens GN=GCFC2 PE=1 SV=2 | 724 | E | 0.203776 | D | 0.178973 | 0.024803 | No Change: Both O | - |
| P01275 | GLUC_HUMAN Glucagon OS=Homo sapiens GN=GCG PE=1 SV=3 | 115 | A | 0.270356 | V | 0.205765 | 0.064591 | No Change: Both O | - |
| P47871 | GLR_HUMAN Glucagon receptor OS=Homo sapiens GN=GCGR PE=1 SV=1 | 40 | G | 0.211879 | S | 0.267148 | -0.055269 | No Change: Both O | - |
| P47871 | GLR_HUMAN Glucagon receptor OS=Homo sapiens GN=GCGR PE=1 SV=1 | 114 | P | 0.568615 | A | 0.462128 | 0.106487 | D to O | - |
| P47871 | GLR_HUMAN Glucagon receptor OS=Homo sapiens GN=GCGR PE=1 SV=1 | 303 | F | 0.030092 | C | 0.027123 | 0.002969 | No Change: Both O | - |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 15 | G | 0.995017 | D | 0.9943 | 7.17E-04 | No Change: Both D | - |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 23 | P | 0.997684 | L | 0.992978 | 0.004706 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 79 | L | 0.58447 | P | 0.71382 | -0.12935 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 88 | R | 0.535096 | P | 0.574245 | -0.039149 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 88 | R | 0.535096 | W | 0.365537 | 0.169559 | D to O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 102 | M | 0.211707 | K | 0.337337 | -0.12563 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 134 | D | 0.214344 | V | 0.110792 | 0.103552 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 141 | C | 0.154563 | W | 0.132009 | 0.022554 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 144 | H | 0.140387 | P | 0.16142 | -0.021033 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 153 | H | 0.125273 | P | 0.155066 | -0.029793 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 178 | R | 0.249678 | S | 0.304519 | -0.054841 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 184 | R | 0.336106 | H | 0.321359 | 0.014747 | No Change: Both O | GTP cyclohydrolase 1 deficiency (GCH1D) [MIM:233910] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 186 | T | 0.266738 | K | 0.350771 | -0.084033 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 201 | G | 0.225914 | E | 0.27747 | -0.051556 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 203 | G | 0.226491 | R | 0.232967 | -0.006476 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 211 | M | 0.219097 | I | 0.123437 | 0.09566 | No Change: Both O | GTP cyclohydrolase 1 deficiency (GCH1D) [MIM:233910] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 224 | K | 0.59618 | R | 0.561928 | 0.034252 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 224 | K | 0.59618 | R | 0.561928 | 0.034252 | No Change: Both D | GTP cyclohydrolase 1 deficiency (GCH1D) [MIM:233910] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 234 | F | 0.506888 | S | 0.73293 | -0.226042 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 71 | L | 0.765581 | Q | 0.823474 | -0.057893 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 74 | A | 0.666761 | V | 0.534945 | 0.131816 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 83 | G | 0.620019 | A | 0.595786 | 0.024233 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 90 | G | 0.442596 | V | 0.309726 | 0.13287 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 102 | M | 0.211707 | R | 0.276479 | -0.064772 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 108 | G | 0.2902 | D | 0.327403 | -0.037203 | No Change: Both O | GTP cyclohydrolase 1 deficiency (GCH1D) [MIM:233910] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 115 | D | 0.221593 | N | 0.206274 | 0.015319 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 135 | I | 0.199147 | K | 0.409276 | -0.210129 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 141 | C | 0.154563 | R | 0.287557 | -0.132994 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 163 | L | 0.229953 | R | 0.337689 | -0.107736 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 176 | S | 0.177379 | T | 0.128319 | 0.04906 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 180 | Q | 0.291779 | R | 0.280389 | 0.01139 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 191 | V | 0.160892 | I | 0.152 | 0.008892 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 199 | P | 0.22232 | L | 0.13443 | 0.08789 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 211 | M | 0.219097 | V | 0.16507 | 0.054027 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 213 | M | 0.253695 | V | 0.190931 | 0.062764 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 221 | M | 0.586103 | T | 0.610453 | -0.02435 | No Change: Both D | GTP cyclohydrolase 1 deficiency (GCH1D) [MIM:233910] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 241 | R | 0.618938 | W | 0.328583 | 0.290355 | D to O | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 249 | R | 0.700339 | S | 0.71839 | -0.018051 | No Change: Both D | Dystonia type 5 (DYT5) [MIM:128230] |
| P30793 | GCH1_HUMAN GTP cyclohydrolase 1 OS=Homo sapiens GN=GCH1 PE=1 SV=1 | 106 | T | 0.279041 | I | 0.168786 | 0.110255 | No Change: Both O | Dystonia type 5 (DYT5) [MIM:128230] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 4 | D | 0.916137 | N | 0.888614 | 0.027523 | No Change: Both D | - |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 70 | E | 0.545819 | K | 0.527631 | 0.018188 | No Change: Both D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 80 | G | 0.258223 | A | 0.19023 | 0.067993 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 80 | G | 0.258223 | S | 0.307674 | -0.049451 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 107 | M | 0.414919 | T | 0.475197 | -0.060278 | No Change: Both O | - |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 131 | S | 0.234329 | P | 0.218687 | 0.015642 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 175 | G | 0.537895 | R | 0.499044 | 0.038851 | D to O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 182 | V | 0.242083 | M | 0.283183 | -0.0411 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 188 | A | 0.266616 | T | 0.295744 | -0.029128 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 203 | V | 0.19539 | A | 0.254702 | -0.059312 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 221 | E | 0.217417 | K | 0.187506 | 0.029911 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 226 | V | 0.200865 | M | 0.280019 | -0.079154 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 227 | G | 0.159976 | C | 0.117367 | 0.042609 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 228 | T | 0.156032 | M | 0.165345 | -0.009313 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 256 | E | 0.303186 | K | 0.248191 | 0.054995 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 257 | W | 0.31788 | R | 0.561221 | -0.243341 | O to D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 261 | G | 0.383261 | R | 0.370288 | 0.012973 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 279 | E | 0.590612 | Q | 0.548833 | 0.041779 | No Change: Both D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 299 | G | 0.16587 | R | 0.159797 | 0.006073 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 300 | E | 0.136854 | Q | 0.113982 | 0.022872 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 300 | E | 0.136854 | K | 0.143478 | -0.006624 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 309 | L | 0.117529 | P | 0.183203 | -0.065674 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 414 | K | 0.366277 | E | 0.379164 | -0.012887 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 455 | V | 0.362579 | M | 0.484803 | -0.122224 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 3 (HHF3) [MIM:602485] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 11 | A | 0.926825 | T | 0.910214 | 0.016611 | No Change: Both D | - |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 36 | R | 0.883295 | W | 0.715165 | 0.16813 | No Change: Both D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 53 | A | 0.724647 | S | 0.824788 | -0.100141 | No Change: Both D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 108 | Y | 0.427824 | H | 0.567663 | -0.139839 | O to D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 137 | H | 0.560098 | R | 0.536838 | 0.02326 | No Change: Both D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 150 | F | 0.169326 | S | 0.34977 | -0.180444 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 168 | T | 0.174928 | P | 0.215344 | -0.040416 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 209 | T | 0.116704 | M | 0.10368 | 0.013024 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 210 | M | 0.12153 | T | 0.151573 | -0.030043 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 213 | C | 0.132291 | R | 0.233314 | -0.101023 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 259 | A | 0.332026 | T | 0.37826 | -0.046234 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 261 | G | 0.383261 | E | 0.446258 | -0.062997 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 336 | S | 0.438467 | L | 0.254132 | 0.184335 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 367 | V | 0.36588 | M | 0.448041 | -0.082161 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 382 | C | 0.461088 | Y | 0.401821 | 0.059267 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 384 | A | 0.418919 | T | 0.444612 | -0.025693 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 392 | R | 0.503988 | C | 0.357348 | 0.14664 | D to O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 164 | L | 0.140347 | P | 0.234572 | -0.094225 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 210 | M | 0.12153 | K | 0.18531 | -0.06378 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 110 | I | 0.477818 | T | 0.614295 | -0.136477 | O to D | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 119 | A | 0.287179 | D | 0.375077 | -0.087898 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 385 | G | 0.389324 | V | 0.275059 | 0.114265 | No Change: Both O | Maturity-onset diabetes of the young type 2 (MODY2) [MIM:125851] |
| P35557 | HXK4_HUMAN Glucokinase OS=Homo sapiens GN=GCK PE=1 SV=1 | 342 | T | 0.547434 | P | 0.570459 | -0.023025 | No Change: Both D | - |
| Q14397 | GCKR_HUMAN Glucokinase regulatory protein OS=Homo sapiens GN=GCKR PE=1 SV=6 | 446 | P | 0.283487 | L | 0.15994 | 0.123547 | No Change: Both O | - |
| Q14397 | GCKR_HUMAN Glucokinase regulatory protein OS=Homo sapiens GN=GCKR PE=1 SV=6 | 77 | E | 0.315053 | G | 0.265689 | 0.049364 | No Change: Both O | - |
| Q14397 | GCKR_HUMAN Glucokinase regulatory protein OS=Homo sapiens GN=GCKR PE=1 SV=6 | 256 | G | 0.712442 | S | 0.743954 | -0.031512 | No Change: Both D | - |
| Q14397 | GCKR_HUMAN Glucokinase regulatory protein OS=Homo sapiens GN=GCKR PE=1 SV=6 | 540 | R | 0.197953 | Q | 0.211486 | -0.013533 | No Change: Both O | - |
| P48506 | GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens GN=GCLC PE=1 SV=2 | 370 | H | 0.133318 | L | 0.082553 | 0.050765 | No Change: Both O | Hemolytic anemia (HAGGSD) [MIM:230450] |
| P48506 | GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens GN=GCLC PE=1 SV=2 | 55 | L | 0.208023 | S | 0.397815 | -0.189792 | No Change: Both O | - |
| P48506 | GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens GN=GCLC PE=1 SV=2 | 158 | P | 0.525454 | L | 0.354172 | 0.171282 | D to O | Hemolytic anemia (HAGGSD) [MIM:230450] |
| P48506 | GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens GN=GCLC PE=1 SV=2 | 462 | P | 0.165922 | S | 0.199273 | -0.033351 | No Change: Both O | - |
| P48506 | GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens GN=GCLC PE=1 SV=2 | 127 | R | 0.674281 | C | 0.542993 | 0.131288 | No Change: Both D | Hemolytic anemia (HAGGSD) [MIM:230450] |
| P48507 | GSH0_HUMAN Glutamate--cysteine ligase regulatory subunit OS=Homo sapiens GN=GCLM PE=1 SV=1 | 209 | I | 0.357085 | M | 0.482327 | -0.125242 | No Change: Both O | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 53 | D | 0.533779 | N | 0.520944 | 0.012835 | No Change: Both D | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 117 | A | 0.543028 | V | 0.456956 | 0.086072 | D to O | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 203 | G | 0.908348 | S | 0.943885 | -0.035537 | No Change: Both D | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 227 | I | 0.741487 | V | 0.759276 | -0.017789 | No Change: Both D | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 47 | R | 0.137338 | L | 0.078692 | 0.058646 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 63 | G | 0.367518 | S | 0.445141 | -0.077623 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 110 | R | 0.548362 | W | 0.300515 | 0.247847 | D to O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 282 | Y | 0.67999 | D | 0.770862 | -0.090872 | No Change: Both D | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 382 | V | 0.550952 | M | 0.642713 | -0.091761 | No Change: Both D | - |
| O75603 | GCM2_HUMAN Chorion-specific transcription factor GCMb OS=Homo sapiens GN=GCM2 PE=1 SV=1 | 502 | N | 0.584944 | H | 0.567939 | 0.017005 | No Change: Both D | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| Q92616 | GCN1L_HUMAN Translational activator GCN1 OS=Homo sapiens GN=GCN1L1 PE=1 SV=6 | 2155 | Y | 0.137066 | D | 0.253111 | -0.116045 | No Change: Both O | - |
| Q02742 | GCNT1_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase OS=Homo sapiens GN=GCNT1 PE=2 SV=2 | 152 | I | 0.109614 | V | 0.132114 | -0.0225 | No Change: Both O | - |
| Q02742 | GCNT1_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase OS=Homo sapiens GN=GCNT1 PE=2 SV=2 | 158 | S | 0.531009 | C | 0.268292 | 0.262717 | D to O | - |
| Q06430 | GNT2B_HUMAN N-acetyllactosaminide beta-1 6-N-acetylglucosaminyl-transferase isoform B OS=Homo sapiens GN=GCNT2 PE=2 SV=1 | 85 | P | 0.476017 | R | 0.429094 | 0.046923 | No Change: Both O | - |
| Q9P109 | GCNT4_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=GCNT4 PE=2 SV=1 | 321 | V | 0.08109 | I | 0.075943 | 0.005147 | No Change: Both O | - |
| Q9P109 | GCNT4_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=GCNT4 PE=2 SV=1 | 439 | P | 0.3413 | S | 0.380362 | -0.039062 | No Change: Both O | - |
| Q9P109 | GCNT4_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 4 OS=Homo sapiens GN=GCNT4 PE=2 SV=1 | 321 | V | 0.08109 | L | 0.07905 | 0.00204 | No Change: Both O | - |
| Q5T4J0 | GCNT6_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 6 OS=Homo sapiens GN=GCNT6 PE=2 SV=2 | 316 | P | 0.140711 | L | 0.071132 | 0.069579 | No Change: Both O | - |
| Q6ZNI0 | GCNT7_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 7 OS=Homo sapiens GN=GCNT7 PE=2 SV=2 | 425 | N | 0.632497 | H | 0.642626 | -0.010129 | No Change: Both D | - |
| Q6ZNI0 | GCNT7_HUMAN Beta-1 3-galactosyl-O-glycosyl-glycoprotein beta-1 6-N-acetylglucosaminyltransferase 7 OS=Homo sapiens GN=GCNT7 PE=2 SV=2 | 352 | D | 0.494334 | E | 0.537352 | -0.043018 | O to D | - |
| P0CAP1 | GCOM1_HUMAN GRINL1A complex locus protein 1 OS=Homo sapiens GN=GCOM1 PE=1 SV=1 | 277 | A | 0.897237 | V | 0.836481 | 0.060756 | No Change: Both D | - |
| Q9BZD3 | GCOM2_HUMAN Putative GRINL1B complex locus protein 2 OS=Homo sapiens GN=GCOM2 PE=5 SV=2 | 176 | R | 0.932807 | H | 0.928428 | 0.004379 | No Change: Both D | An acute myeloid leukemia sample |
| P23434 | GCSH_HUMAN Glycine cleavage system H protein mitochondrial OS=Homo sapiens GN=GCSH PE=1 SV=2 | 21 | S | 0.695039 | L | 0.578123 | 0.116916 | No Change: Both D | - |
| P23434 | GCSH_HUMAN Glycine cleavage system H protein mitochondrial OS=Homo sapiens GN=GCSH PE=1 SV=2 | 73 | N | 0.216183 | S | 0.260882 | -0.044699 | No Change: Both O | - |
| Q8TB36 | GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens GN=GDAP1 PE=1 SV=3 | 120 | R | 0.364802 | Q | 0.379447 | -0.014645 | No Change: Both O | Charcot-Marie-Tooth disease type 4A (CMT4A) [MIM:214400] |
| Q8TB36 | GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens GN=GDAP1 PE=1 SV=3 | 161 | R | 0.423413 | H | 0.39905 | 0.024363 | No Change: Both O | Charcot-Marie-Tooth disease type 4A (CMT4A) [MIM:214400] |
| Q8TB36 | GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens GN=GDAP1 PE=1 SV=3 | 282 | R | 0.282338 | C | 0.141388 | 0.14095 | No Change: Both O | Charcot-Marie-Tooth disease type 4A (CMT4A) [MIM:214400] |
| Q8TB36 | GDAP1_HUMAN Ganglioside-induced differentiation-associated protein 1 OS=Homo sapiens GN=GDAP1 PE=1 SV=3 | 310 | R | 0.267628 | Q | 0.272089 | -0.004461 | No Change: Both O | Charcot-Marie-Tooth disease axonal recessive with vocal cord paresis (CMT2RV) [MIM:607706] |
| Q96MZ0 | GD1L1_HUMAN Ganglioside-induced differentiation-associated protein 1-like 1 OS=Homo sapiens GN=GDAP1L1 PE=2 SV=2 | 141 | R | 0.228824 | W | 0.092784 | 0.13604 | No Change: Both O | A colorectal cancer sample |
| Q9NXN4 | GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 OS=Homo sapiens GN=GDAP2 PE=2 SV=1 | 95 | P | 0.39254 | R | 0.354586 | 0.037954 | No Change: Both O | - |
| Q9NXN4 | GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 OS=Homo sapiens GN=GDAP2 PE=2 SV=1 | 106 | G | 0.424555 | S | 0.459733 | -0.035178 | No Change: Both O | - |
| Q9NXN4 | GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 OS=Homo sapiens GN=GDAP2 PE=2 SV=1 | 312 | Q | 0.607721 | P | 0.582855 | 0.024866 | No Change: Both D | - |
| Q9NXN4 | GDAP2_HUMAN Ganglioside-induced differentiation-associated protein 2 OS=Homo sapiens GN=GDAP2 PE=2 SV=1 | 489 | T | 0.603197 | A | 0.596075 | 0.007122 | No Change: Both D | - |
| Q9NZC3 | GDE1_HUMAN Glycerophosphodiester phosphodiesterase 1 OS=Homo sapiens GN=GDE1 PE=1 SV=1 | 218 | R | 0.324365 | Q | 0.343284 | -0.018919 | No Change: Both O | - |
| Q9NZC3 | GDE1_HUMAN Glycerophosphodiester phosphodiesterase 1 OS=Homo sapiens GN=GDE1 PE=1 SV=1 | 328 | E | 0.804699 | K | 0.786826 | 0.017873 | No Change: Both D | - |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 118 | A | 0.622954 | V | 0.567732 | 0.055222 | No Change: Both D | - |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 68 | R | 0.83853 | H | 0.780127 | 0.058403 | No Change: Both D | - |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 162 | G | 0.739658 | D | 0.739632 | 2.60E-05 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 262 | G | 0.553751 | S | 0.57597 | -0.022219 | No Change: Both D | - |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 267 | C | 0.35133 | Y | 0.397861 | -0.046531 | No Change: Both O | Conotruncal heart malformations (CTHM) [MIM:217095] |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 309 | S | 0.601466 | P | 0.585839 | 0.015627 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 312 | P | 0.610306 | T | 0.555585 | 0.054721 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P27539 | GDF1_HUMAN Embryonic growth/differentiation factor 1 OS=Homo sapiens GN=GDF1 PE=1 SV=2 | 318 | A | 0.403339 | T | 0.36228 | 0.041059 | No Change: Both O | Transposition of the great arteries dextro-looped type 3 (DTGA3) [MIM:613854] |
| Q99988 | GDF15_HUMAN Growth/differentiation factor 15 OS=Homo sapiens GN=GDF15 PE=1 SV=3 | 48 | S | 0.841852 | T | 0.774554 | 0.067298 | No Change: Both D | - |
| Q99988 | GDF15_HUMAN Growth/differentiation factor 15 OS=Homo sapiens GN=GDF15 PE=1 SV=3 | 9 | V | 0.398873 | L | 0.423552 | -0.024679 | No Change: Both O | - |
| Q99988 | GDF15_HUMAN Growth/differentiation factor 15 OS=Homo sapiens GN=GDF15 PE=1 SV=3 | 202 | H | 0.759483 | D | 0.791158 | -0.031675 | No Change: Both D | - |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 328 | V | 0.156662 | L | 0.161573 | -0.004911 | No Change: Both O | - |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 213 | G | 0.490554 | R | 0.500532 | -0.009978 | O to D | - |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 195 | R | 0.351984 | Q | 0.37048 | -0.018496 | No Change: Both O | Microphthalmia isolated type 7 (MCOP7) [MIM:613704] |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 266 | R | 0.116555 | C | 0.063606 | 0.052949 | No Change: Both O | Klippel-Feil syndrome type 3 (KFS3) [MIM:613702] |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 266 | R | 0.116555 | C | 0.063606 | 0.052949 | No Change: Both O | Microphthalmia isolated with coloboma type 6 (MCOPCB6) [MIM:613703] |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 274 | R | 0.086642 | W | 0.035673 | 0.050969 | No Change: Both O | Microphthalmia isolated with coloboma type 6 (MCOPCB6) [MIM:613703] |
| Q9NR23 | GDF3_HUMAN Growth/differentiation factor 3 OS=Homo sapiens GN=GDF3 PE=1 SV=3 | 305 | L | 0.342602 | P | 0.509904 | -0.167302 | O to D | Microphthalmia isolated type 7 (MCOP7) [MIM:613704] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 400 | C | 0.48016 | Y | 0.520327 | -0.040167 | O to D | Acromesomelic chondrodysplasia Grebe type (AMDG) [MIM:200700] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 441 | L | 0.460617 | P | 0.595356 | -0.134739 | O to D | Brachydactyly type A2 (BDA2) [MIM:112600] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 441 | L | 0.460617 | P | 0.595356 | -0.134739 | O to D | Du Pan syndrome (DPS) [MIM:228900] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 276 | S | 0.579414 | A | 0.485905 | 0.093509 | D to O | - |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 438 | R | 0.354166 | L | 0.269538 | 0.084628 | No Change: Both O | Multiple synostoses syndrome type 2 (SYNS2) [MIM:610017] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 438 | R | 0.354166 | L | 0.269538 | 0.084628 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 163 | R | 0.92688 | G | 0.914758 | 0.012122 | No Change: Both D | - |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 173 | M | 0.67899 | V | 0.628295 | 0.050695 | No Change: Both D | Brachydactyly type C (BDC) [MIM:113100] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 439 | S | 0.401152 | T | 0.342891 | 0.058261 | No Change: Both O | Du Pan syndrome (DPS) [MIM:228900] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 440 | H | 0.421538 | L | 0.320701 | 0.100837 | No Change: Both O | Du Pan syndrome (DPS) [MIM:228900] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 475 | S | 0.18199 | N | 0.153147 | 0.028843 | No Change: Both O | Multiple synostoses syndrome type 2 (SYNS2) [MIM:610017] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 491 | E | 0.256689 | K | 0.255794 | 8.95E-04 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 380 | R | 0.745017 | Q | 0.733838 | 0.011179 | No Change: Both D | Brachydactyly type A2 (BDA2) [MIM:112600] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 373 | L | 0.604692 | R | 0.732379 | -0.127687 | No Change: Both D | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 378 | R | 0.71359 | Q | 0.700235 | 0.013355 | No Change: Both D | Du Pan syndrome (DPS) [MIM:228900] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 436 | P | 0.280892 | T | 0.232213 | 0.048679 | No Change: Both O | Du Pan syndrome (DPS) [MIM:228900] |
| P43026 | GDF5_HUMAN Growth/differentiation factor 5 OS=Homo sapiens GN=GDF5 PE=1 SV=3 | 399 | R | 0.555586 | C | 0.379123 | 0.176463 | D to O | Brachydactyly type A1 (BDA1) [MIM:112500] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 110 | K | 0.257091 | E | 0.274601 | -0.01751 | No Change: Both O | - |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 249 | A | 0.882213 | E | 0.905189 | -0.022976 | No Change: Both D | Klippel-Feil syndrome type 1 (KFS1) [MIM:118100] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 249 | A | 0.882213 | E | 0.905189 | -0.022976 | No Change: Both D | Microphthalmia isolated type 4 (MCOP4) [MIM:613094] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 289 | L | 0.72853 | P | 0.8261 | -0.09757 | No Change: Both D | Klippel-Feil syndrome type 1 (KFS1) [MIM:118100] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 42 | G | 0.936619 | V | 0.907848 | 0.028771 | No Change: Both D | Klippel-Feil syndrome type 1 (KFS1) [MIM:118100] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 119 | Q | 0.501722 | R | 0.487323 | 0.014399 | D to O | Microphthalmia isolated type 4 (MCOP4) [MIM:613094] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 216 | D | 0.119979 | G | 0.113291 | 0.006688 | No Change: Both O | Microphthalmia isolated type 4 (MCOP4) [MIM:613094] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 253 | Q | 0.931056 | L | 0.892029 | 0.039027 | No Change: Both D | Microphthalmia isolated type 4 (MCOP4) [MIM:613094] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 327 | P | 0.984711 | H | 0.976173 | 0.008538 | No Change: Both D | Microphthalmia isolated type 4 (MCOP4) [MIM:613094] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 424 | K | 0.250628 | R | 0.208402 | 0.042226 | No Change: Both O | Klippel-Feil syndrome type 1 (KFS1) [MIM:118100] |
| Q6KF10 | GDF6_HUMAN Growth/differentiation factor 6 OS=Homo sapiens GN=GDF6 PE=1 SV=1 | 199 | A | 0.395735 | T | 0.415801 | -0.020066 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 67 | K | 0.227363 | E | 0.23296 | -0.005597 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 186 | S | 0.736651 | Y | 0.581348 | 0.155303 | No Change: Both D | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 216 | V | 0.127917 | M | 0.174253 | -0.046336 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 57 | D | 0.446523 | Y | 0.284713 | 0.16181 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 103 | P | 0.513565 | S | 0.534022 | -0.020457 | No Change: Both D | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 121 | T | 0.30998 | I | 0.18244 | 0.12754 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 146 | R | 0.130823 | C | 0.064096 | 0.066727 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 238 | T | 0.216044 | A | 0.194221 | 0.021823 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 374 | P | 0.115998 | L | 0.053235 | 0.062763 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 428 | S | 0.303064 | T | 0.228828 | 0.074236 | No Change: Both O | - |
| O60383 | GDF9_HUMAN Growth/differentiation factor 9 OS=Homo sapiens GN=GDF9 PE=1 SV=1 | 454 | R | 0.678243 | C | 0.475896 | 0.202347 | D to O | - |
| P31150 | GDIA_HUMAN Rab GDP dissociation inhibitor alpha OS=Homo sapiens GN=GDI1 PE=1 SV=2 | 92 | L | 0.094672 | P | 0.168273 | -0.073601 | No Change: Both O | Mental retardation X-linked type 41 (MRX41) [MIM:300849] |
| P31150 | GDIA_HUMAN Rab GDP dissociation inhibitor alpha OS=Homo sapiens GN=GDI1 PE=1 SV=2 | 423 | R | 0.311842 | P | 0.325739 | -0.013897 | No Change: Both O | Mental retardation X-linked type 41 (MRX41) [MIM:300849] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 21 | P | 0.471556 | S | 0.468951 | 0.002605 | No Change: Both O | Hirschsprung disease type 3 (HSCR3) [MIM:613711] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 93 | R | 0.900358 | W | 0.737505 | 0.162853 | No Change: Both D | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 93 | R | 0.900358 | W | 0.737505 | 0.162853 | No Change: Both D | Hirschsprung disease type 3 (HSCR3) [MIM:613711] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 150 | D | 0.341863 | N | 0.317088 | 0.024775 | No Change: Both O | Hirschsprung disease type 3 (HSCR3) [MIM:613711] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 154 | T | 0.336849 | S | 0.420979 | -0.08413 | No Change: Both O | Hirschsprung disease type 3 (HSCR3) [MIM:613711] |
| P39905 | GDNF_HUMAN Glial cell line-derived neurotrophic factor OS=Homo sapiens GN=GDNF PE=1 SV=1 | 211 | I | 0.763725 | M | 0.841217 | -0.077492 | No Change: Both D | Hirschsprung disease type 3 (HSCR3) [MIM:613711] |
| Q6W3E5 | GDPD4_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 4 OS=Homo sapiens GN=GDPD4 PE=2 SV=1 | 220 | K | 0.529054 | R | 0.49811 | 0.030944 | D to O | - |
| Q6W3E5 | GDPD4_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 4 OS=Homo sapiens GN=GDPD4 PE=2 SV=1 | 383 | H | 0.224376 | Y | 0.13953 | 0.084846 | No Change: Both O | - |
| Q6W3E5 | GDPD4_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 4 OS=Homo sapiens GN=GDPD4 PE=2 SV=1 | 390 | I | 0.218668 | V | 0.257371 | -0.038703 | No Change: Both O | - |
| Q6W3E5 | GDPD4_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 4 OS=Homo sapiens GN=GDPD4 PE=2 SV=1 | 396 | N | 0.235435 | K | 0.268303 | -0.032868 | No Change: Both O | - |
| Q8WTR4 | GDPD5_HUMAN Glycerophosphodiester phosphodiesterase domain-containing protein 5 OS=Homo sapiens GN=GDPD5 PE=2 SV=2 | 480 | A | 0.668779 | T | 0.702929 | -0.03415 | No Change: Both D | - |
| P55040 | GEM_HUMAN GTP-binding protein GEM OS=Homo sapiens GN=GEM PE=1 SV=1 | 43 | R | 0.872743 | G | 0.84156 | 0.031183 | No Change: Both D | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 1033 | R | 0.530982 | C | 0.380338 | 0.150644 | D to O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 684 | R | 0.178076 | Q | 0.205113 | -0.027037 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 579 | A | 0.105405 | G | 0.130683 | -0.025278 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 182 | F | 0.462577 | L | 0.50221 | -0.039633 | O to D | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 502 | I | 0.141916 | V | 0.171977 | -0.030061 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 739 | I | 0.111728 | T | 0.191783 | -0.080055 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 749 | P | 0.23157 | L | 0.127178 | 0.104392 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 782 | F | 0.196168 | L | 0.212056 | -0.015888 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 824 | V | 0.122321 | F | 0.108411 | 0.01391 | No Change: Both O | - |
| P57678 | GEMI4_HUMAN Gem-associated protein 4 OS=Homo sapiens GN=GEMIN4 PE=1 SV=2 | 913 | V | 0.078472 | I | 0.06808 | 0.010392 | No Change: Both O | - |
| Q8TEQ6 | GEMI5_HUMAN Gem-associated protein 5 OS=Homo sapiens GN=GEMIN5 PE=1 SV=3 | 682 | R | 0.140234 | Q | 0.138315 | 0.001919 | No Change: Both O | - |
| Q8TEQ6 | GEMI5_HUMAN Gem-associated protein 5 OS=Homo sapiens GN=GEMIN5 PE=1 SV=3 | 1155 | P | 0.353046 | S | 0.3904 | -0.037354 | No Change: Both O | - |
| Q8WXD5 | GEMI6_HUMAN Gem-associated protein 6 OS=Homo sapiens GN=GEMIN6 PE=1 SV=1 | 140 | G | 0.501761 | D | 0.529898 | -0.028137 | No Change: Both D | - |
| Q9NWZ8 | GEMI8_HUMAN Gem-associated protein 8 OS=Homo sapiens GN=GEMIN8 PE=1 SV=1 | 195 | E | 0.772653 | V | 0.639701 | 0.132952 | No Change: Both D | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 92 | S | 0.737131 | T | 0.65975 | 0.077381 | No Change: Both D | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 143 | N | 0.179422 | S | 0.211112 | -0.03169 | No Change: Both O | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 203 | I | 0.060977 | V | 0.073151 | -0.012174 | No Change: Both O | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 275 | R | 0.86311 | L | 0.802256 | 0.060854 | No Change: Both D | A breast cancer sample |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 310 | S | 0.601409 | N | 0.601623 | -2.14E-04 | No Change: Both D | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 680 | T | 0.337947 | I | 0.236448 | 0.101499 | No Change: Both O | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 898 | R | 0.930359 | C | 0.902822 | 0.027537 | No Change: Both D | - |
| Q17RS7 | GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens GN=GEN1 PE=1 SV=2 | 766 | C | 0.485594 | R | 0.642525 | -0.156931 | O to D | - |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 47 | P | 0.804329 | L | 0.699216 | 0.105113 | No Change: Both D | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 76 | L | 0.52824 | F | 0.51683 | 0.01141 | No Change: Both D | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 77 | N | 0.514543 | Y | 0.36798 | 0.146563 | D to O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 79 | R | 0.462552 | C | 0.307198 | 0.155354 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 79 | R | 0.462552 | H | 0.372284 | 0.090268 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 88 | R | 0.424658 | C | 0.27762 | 0.147038 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 88 | R | 0.424658 | S | 0.449944 | -0.025286 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 239 | R | 0.44332 | C | 0.298372 | 0.144948 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 239 | R | 0.44332 | H | 0.421838 | 0.021482 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 244 | A | 0.523077 | V | 0.421088 | 0.101989 | D to O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 258 | R | 0.527422 | P | 0.518682 | 0.00874 | No Change: Both D | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 362 | E | 0.151977 | D | 0.135974 | 0.016003 | No Change: Both O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 416 | R | 0.706627 | W | 0.436389 | 0.270238 | D to O | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 78 | D | 0.484143 | E | 0.57186 | -0.087717 | O to D | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 223 | E | 0.535032 | Q | 0.509821 | 0.025211 | No Change: Both D | Alexander disease (ALEXD) [MIM:203450] |
| P14136 | GFAP_HUMAN Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 | 295 | D | 0.861479 | N | 0.860499 | 9.80E-04 | No Change: Both D | - |
| P55789 | ALR_HUMAN FAD-linked sulfhydryl oxidase ALR OS=Homo sapiens GN=GFER PE=1 SV=2 | 166 | F | 0.288518 | L | 0.325897 | -0.037379 | No Change: Both O | - |
| P55789 | ALR_HUMAN FAD-linked sulfhydryl oxidase ALR OS=Homo sapiens GN=GFER PE=1 SV=2 | 194 | R | 0.460172 | H | 0.419771 | 0.040401 | No Change: Both O | Mitochondrial progressive myopathy with congenital cataract hearing loss and developmental delay (MPMCHD) [MIM:613076] |
| Q99684 | GFI1_HUMAN Zinc finger protein Gfi-1 OS=Homo sapiens GN=GFI1 PE=1 SV=2 | 382 | N | 0.656879 | S | 0.747893 | -0.091014 | No Change: Both D | Neutropenia severe congenital autosomal dominant type 2 (SCN2) [MIM:613107] |
| Q99684 | GFI1_HUMAN Zinc finger protein Gfi-1 OS=Homo sapiens GN=GFI1 PE=1 SV=2 | 403 | K | 0.585119 | R | 0.561158 | 0.023961 | No Change: Both D | Dominant nonimmune chronic idiopathic neutropenia of adults (NI-CINA) [MIM:607847] |
| Q99684 | GFI1_HUMAN Zinc finger protein Gfi-1 OS=Homo sapiens GN=GFI1 PE=1 SV=2 | 36 | S | 0.941971 | N | 0.926004 | 0.015967 | No Change: Both D | - |
| Q5VTD9 | GFI1B_HUMAN Zinc finger protein Gfi-1b OS=Homo sapiens GN=GFI1B PE=1 SV=1 | 231 | R | 0.658154 | H | 0.642573 | 0.015581 | No Change: Both D | A colorectal cancer sample |
| Q96RP9 | EFGM_HUMAN Elongation factor G mitochondrial OS=Homo sapiens GN=GFM1 PE=1 SV=2 | 174 | N | 0.239593 | S | 0.259933 | -0.02034 | No Change: Both O | Combined oxidative phosphorylation deficiency type 1 (COXPD1) [MIM:609060] |
| Q96RP9 | EFGM_HUMAN Elongation factor G mitochondrial OS=Homo sapiens GN=GFM1 PE=1 SV=2 | 215 | V | 0.143353 | I | 0.142135 | 0.001218 | No Change: Both O | - |
| Q96RP9 | EFGM_HUMAN Elongation factor G mitochondrial OS=Homo sapiens GN=GFM1 PE=1 SV=2 | 496 | M | 0.305155 | R | 0.35905 | -0.053895 | No Change: Both O | Combined oxidative phosphorylation deficiency type 1 (COXPD1) [MIM:609060] |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 64 | N | 0.315225 | S | 0.37092 | -0.055695 | No Change: Both O | - |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 300 | S | 0.334322 | C | 0.179514 | 0.154808 | No Change: Both O | - |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 774 | R | 0.725256 | Q | 0.746391 | -0.021135 | No Change: Both D | - |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 425 | P | 0.276002 | H | 0.265284 | 0.010718 | No Change: Both O | - |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 594 | E | 0.407425 | G | 0.328105 | 0.07932 | No Change: Both O | - |
| Q969S9 | RRF2M_HUMAN Ribosome-releasing factor 2 mitochondrial OS=Homo sapiens GN=GFM2 PE=1 SV=1 | 735 | E | 0.094889 | G | 0.082415 | 0.012474 | No Change: Both O | - |
| Q3B7J2 | GFOD2_HUMAN Glucose-fructose oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=GFOD2 PE=2 SV=1 | 231 | G | 0.139259 | V | 0.07744 | 0.061819 | No Change: Both O | - |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 15 | T | 0.310226 | A | 0.273389 | 0.036837 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 15 | T | 0.310226 | M | 0.25428 | 0.055946 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 43 | D | 0.451445 | V | 0.304571 | 0.146874 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 111 | R | 0.777656 | C | 0.673578 | 0.104078 | No Change: Both D | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 121 | I | 0.179608 | T | 0.274845 | -0.095237 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 199 | V | 0.481422 | F | 0.455076 | 0.026346 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 366 | D | 0.230371 | Y | 0.123307 | 0.107064 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 403 | R | 0.29357 | H | 0.311593 | -0.018023 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 452 | R | 0.194326 | H | 0.177607 | 0.016719 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 509 | M | 0.091196 | T | 0.092722 | -0.001526 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 510 | M | 0.13073 | T | 0.132766 | -0.002036 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 514 | R | 0.386588 | W | 0.192551 | 0.194037 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| Q06210 | GFPT1_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Homo sapiens GN=GFPT1 PE=1 SV=3 | 530 | R | 0.29937 | W | 0.121557 | 0.177813 | No Change: Both O | Limb-girdle myasthenia with tubular aggregates (LGMTA) [MIM:610542] |
| O94808 | GFPT2_HUMAN Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2 OS=Homo sapiens GN=GFPT2 PE=1 SV=3 | 471 | I | 0.378665 | V | 0.41475 | -0.036085 | No Change: Both O | - |
| P56159 | GFRA1_HUMAN GDNF family receptor alpha-1 OS=Homo sapiens GN=GFRA1 PE=2 SV=2 | 85 | Y | 0.610483 | N | 0.758783 | -0.1483 | No Change: Both D | - |
| P56159 | GFRA1_HUMAN GDNF family receptor alpha-1 OS=Homo sapiens GN=GFRA1 PE=2 SV=2 | 366 | T | 0.481308 | A | 0.436631 | 0.044677 | No Change: Both O | - |
| P56159 | GFRA1_HUMAN GDNF family receptor alpha-1 OS=Homo sapiens GN=GFRA1 PE=2 SV=2 | 371 | L | 0.529029 | R | 0.651095 | -0.122066 | No Change: Both D | - |
| O00451 | GFRA2_HUMAN GDNF family receptor alpha-2 OS=Homo sapiens GN=GFRA2 PE=2 SV=2 | 462 | L | 0.659931 | Q | 0.715244 | -0.055313 | No Change: Both D | - |
| Q6UXV0 | GFRAL_HUMAN GDNF family receptor alpha-like OS=Homo sapiens GN=GFRAL PE=2 SV=2 | 195 | D | 0.399003 | H | 0.343474 | 0.055529 | No Change: Both O | A breast cancer sample |
| Q6UXV0 | GFRAL_HUMAN GDNF family receptor alpha-like OS=Homo sapiens GN=GFRAL PE=2 SV=2 | 33 | R | 0.288393 | C | 0.196001 | 0.092392 | No Change: Both O | - |
| Q6UXV0 | GFRAL_HUMAN GDNF family receptor alpha-like OS=Homo sapiens GN=GFRAL PE=2 SV=2 | 387 | S | 0.662962 | P | 0.643503 | 0.019459 | No Change: Both D | - |
| Q9UJY5 | GGA1_HUMAN ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1 PE=1 SV=1 | 239 | G | 0.725411 | S | 0.766317 | -0.040906 | No Change: Both D | A breast cancer sample |
| Q9UJY5 | GGA1_HUMAN ADP-ribosylation factor-binding protein GGA1 OS=Homo sapiens GN=GGA1 PE=1 SV=1 | 484 | P | 0.978531 | A | 0.96345 | 0.015081 | No Change: Both D | A breast cancer sample |
| Q9UJY4 | GGA2_HUMAN ADP-ribosylation factor-binding protein GGA2 OS=Homo sapiens GN=GGA2 PE=1 SV=3 | 424 | A | 0.835704 | P | 0.894834 | -0.05913 | No Change: Both D | - |
| Q9NZ52 | GGA3_HUMAN ADP-ribosylation factor-binding protein GGA3 OS=Homo sapiens GN=GGA3 PE=1 SV=1 | 574 | P | 0.918518 | L | 0.873253 | 0.045265 | No Change: Both D | A breast cancer sample |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 325 | R | 0.595208 | Q | 0.605935 | -0.010727 | No Change: Both D | - |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 394 | L | 0.14582 | R | 0.239777 | -0.093957 | No Change: Both O | Combined deficiency of vitamin K-dependent clotting factors type 1 (VKCFD1) [MIM:277450] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 501 | W | 0.171639 | S | 0.41861 | -0.246971 | No Change: Both O | Combined deficiency of vitamin K-dependent clotting factors type 1 (VKCFD1) [MIM:277450] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 485 | R | 0.172657 | P | 0.19924 | -0.026583 | No Change: Both O | Combined deficiency of vitamin K-dependent clotting factors type 1 (VKCFD1) [MIM:277450] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 299 | F | 0.118371 | S | 0.28045 | -0.162079 | No Change: Both O | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 476 | R | 0.16193 | C | 0.074812 | 0.087118 | No Change: Both O | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 476 | R | 0.16193 | H | 0.153132 | 0.008798 | No Change: Both O | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 493 | W | 0.159678 | S | 0.407314 | -0.247636 | No Change: Both O | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842] |
| P38435 | VKGC_HUMAN Vitamin K-dependent gamma-carboxylase OS=Homo sapiens GN=GGCX PE=1 SV=2 | 558 | G | 0.272512 | R | 0.263763 | 0.008749 | No Change: Both O | Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency (PXEL-MCFD) [MIM:610842] |
| Q92820 | GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo sapiens GN=GGH PE=1 SV=2 | 6 | C | 0.282877 | R | 0.395991 | -0.113114 | No Change: Both O | - |
| Q92820 | GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo sapiens GN=GGH PE=1 SV=2 | 31 | A | 0.553044 | T | 0.600398 | -0.047354 | No Change: Both D | - |
| Q92820 | GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo sapiens GN=GGH PE=1 SV=2 | 151 | T | 0.14859 | I | 0.076879 | 0.071711 | No Change: Both O | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 272 | V | 0.133338 | A | 0.178473 | -0.045135 | No Change: Both O | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 52 | K | 0.435923 | E | 0.417059 | 0.018864 | No Change: Both O | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 177 | A | 0.325886 | V | 0.258726 | 0.06716 | No Change: Both O | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 51 | S | 0.441521 | L | 0.260552 | 0.180969 | No Change: Both O | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 419 | N | 0.548244 | D | 0.559766 | -0.011522 | No Change: Both D | - |
| P19440 | GGT1_HUMAN Gamma-glutamyltranspeptidase 1 OS=Homo sapiens GN=GGT1 PE=1 SV=2 | 435 | V | 0.752011 | A | 0.791024 | -0.039013 | No Change: Both D | - |
| P36269 | GGT5_HUMAN Gamma-glutamyltransferase 5 OS=Homo sapiens GN=GGT5 PE=1 SV=2 | 475 | I | 0.555594 | V | 0.577995 | -0.022401 | No Change: Both D | - |
| P36269 | GGT5_HUMAN Gamma-glutamyltransferase 5 OS=Homo sapiens GN=GGT5 PE=1 SV=2 | 11 | L | 0.096941 | I | 0.075459 | 0.021482 | No Change: Both O | - |
| P36269 | GGT5_HUMAN Gamma-glutamyltransferase 5 OS=Homo sapiens GN=GGT5 PE=1 SV=2 | 330 | K | 0.286208 | R | 0.263229 | 0.022979 | No Change: Both O | - |
| P36269 | GGT5_HUMAN Gamma-glutamyltransferase 5 OS=Homo sapiens GN=GGT5 PE=1 SV=2 | 332 | Q | 0.316747 | H | 0.298376 | 0.018371 | No Change: Both O | - |
| Q6P531 | GGT6_HUMAN Gamma-glutamyltransferase 6 OS=Homo sapiens GN=GGT6 PE=2 SV=2 | 40 | R | 0.694363 | W | 0.490917 | 0.203446 | D to O | - |
| Q6P531 | GGT6_HUMAN Gamma-glutamyltransferase 6 OS=Homo sapiens GN=GGT6 PE=2 SV=2 | 58 | A | 0.238286 | V | 0.186008 | 0.052278 | No Change: Both O | - |
| Q14390 | GGTL2_HUMAN Gamma-glutamyltransferase light chain 2 OS=Homo sapiens GN=GGTLC2 PE=2 SV=4 | 70 | E | 0.417582 | G | 0.361312 | 0.05627 | No Change: Both O | - |
| Q14390 | GGTL2_HUMAN Gamma-glutamyltransferase light chain 2 OS=Homo sapiens GN=GGTLC2 PE=2 SV=4 | 75 | D | 0.564585 | N | 0.5582 | 0.006385 | No Change: Both D | - |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 3 | T | 0.769258 | A | 0.775003 | -0.005745 | No Change: Both D | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 105 | S | 0.262899 | C | 0.154044 | 0.108855 | No Change: Both O | - |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 136 | V | 0.33519 | I | 0.297924 | 0.037266 | No Change: Both O | - |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 16 | L | 0.051883 | P | 0.108035 | -0.056152 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 37 | D | 0.237083 | N | 0.237098 | -1.50E-05 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 42 | R | 0.260923 | C | 0.129022 | 0.131901 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 53 | T | 0.285333 | I | 0.187033 | 0.0983 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 67 | K | 0.593555 | R | 0.568849 | 0.024706 | No Change: Both D | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 73 | N | 0.675686 | D | 0.689756 | -0.01407 | No Change: Both D | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 97 | S | 0.69866 | F | 0.53343 | 0.16523 | No Change: Both D | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 100 | E | 0.482999 | K | 0.472805 | 0.010194 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 103 | R | 0.318841 | C | 0.228982 | 0.089859 | No Change: Both O | Kowarski syndrome (KWKS) [MIM:262650] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 117 | Q | 0.122371 | L | 0.072905 | 0.049466 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 134 | S | 0.365933 | C | 0.15337 | 0.212563 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 134 | S | 0.365933 | R | 0.283612 | 0.082321 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 138 | D | 0.315914 | G | 0.280945 | 0.034969 | No Change: Both O | Kowarski syndrome (KWKS) [MIM:262650] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 201 | T | 0.158829 | A | 0.141056 | 0.017773 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 209 | R | 0.188558 | H | 0.179229 | 0.009329 | No Change: Both O | Growth hormone deficiency isolated type 2 (IGHD2) [MIM:173100] |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 79 | C | 0.690598 | S | 0.850695 | -0.160097 | No Change: Both D | - |
| P01241 | SOMA_HUMAN Somatotropin OS=Homo sapiens GN=GH1 PE=1 SV=2 | 205 | I | 0.092243 | M | 0.15435 | -0.062107 | No Change: Both O | - |
| P01242 | SOM2_HUMAN Growth hormone variant OS=Homo sapiens GN=GH2 PE=1 SV=3 | 90 | R | 0.762638 | W | 0.58203 | 0.180608 | No Change: Both D | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 62 | E | 0.640275 | K | 0.640018 | 2.57E-04 | No Change: Both D | Idiopathic short stature autosomal (ISSA) [MIM:604271] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 89 | R | 0.23584 | K | 0.268462 | -0.032622 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 114 | F | 0.285766 | S | 0.506419 | -0.220653 | O to D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 143 | V | 0.261531 | A | 0.321365 | -0.059834 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 162 | V | 0.090901 | D | 0.187848 | -0.096947 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 170 | D | 0.131268 | H | 0.118513 | 0.012755 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 179 | R | 0.283438 | C | 0.143213 | 0.140225 | No Change: Both O | Idiopathic short stature autosomal (ISSA) [MIM:604271] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 179 | R | 0.283438 | C | 0.143213 | 0.140225 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 229 | R | 0.535595 | G | 0.521937 | 0.013658 | No Change: Both D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 242 | E | 0.419716 | D | 0.374579 | 0.045137 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 179 | R | 0.283438 | H | 0.273696 | 0.009742 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 229 | R | 0.535595 | H | 0.508403 | 0.027192 | No Change: Both D | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 440 | C | 0.850037 | F | 0.796842 | 0.053195 | No Change: Both D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 495 | P | 0.478355 | T | 0.40854 | 0.069815 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 544 | I | 0.252929 | L | 0.266978 | -0.014049 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 579 | P | 0.657306 | T | 0.630318 | 0.026988 | No Change: Both D | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 56 | C | 0.743172 | S | 0.859272 | -0.1161 | No Change: Both D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 58 | S | 0.714163 | L | 0.533621 | 0.180542 | No Change: Both D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 68 | W | 0.487855 | R | 0.689738 | -0.201883 | O to D | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 149 | P | 0.29312 | Q | 0.272809 | 0.020311 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 162 | V | 0.090901 | I | 0.085557 | 0.005344 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 171 | I | 0.146419 | T | 0.248697 | -0.102278 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 172 | Q | 0.160245 | P | 0.181226 | -0.020981 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 173 | V | 0.187594 | G | 0.312576 | -0.124982 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 226 | Y | 0.49837 | C | 0.470606 | 0.027764 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 244 | S | 0.287421 | I | 0.119036 | 0.168385 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 262 | D | 0.09321 | N | 0.086924 | 0.006286 | No Change: Both O | Laron syndrome (LARS) [MIM:262500] |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 162 | V | 0.090901 | F | 0.0791 | 0.011801 | No Change: Both O | - |
| P10912 | GHR_HUMAN Growth hormone receptor OS=Homo sapiens GN=GHR PE=1 SV=1 | 465 | E | 0.820897 | K | 0.813046 | 0.007851 | No Change: Both D | - |
| P01286 | SLIB_HUMAN Somatoliberin OS=Homo sapiens GN=GHRH PE=1 SV=1 | 75 | L | 0.805966 | F | 0.749623 | 0.056343 | No Change: Both D | - |
| P01286 | SLIB_HUMAN Somatoliberin OS=Homo sapiens GN=GHRH PE=1 SV=1 | 32 | Y | 0.201225 | C | 0.195314 | 0.005911 | No Change: Both O | - |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 144 | L | 0.030019 | H | 0.056795 | -0.026776 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 176 | A | 0.07948 | V | 0.054063 | 0.025417 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 222 | A | 0.045903 | E | 0.075584 | -0.029681 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 242 | F | 0.085237 | C | 0.082126 | 0.003111 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 329 | K | 0.186384 | E | 0.188643 | -0.002259 | No Change: Both O | Growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781] |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 57 | A | 0.22323 | T | 0.269011 | -0.045781 | No Change: Both O | - |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 121 | E | 0.454349 | D | 0.397889 | 0.05646 | No Change: Both O | - |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 225 | V | 0.038943 | I | 0.032959 | 0.005984 | No Change: Both O | - |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 422 | M | 0.743438 | T | 0.792661 | -0.049223 | No Change: Both D | - |
| Q02643 | GHRHR_HUMAN Growth hormone-releasing hormone receptor OS=Homo sapiens GN=GHRHR PE=1 SV=2 | 45 | A | 0.501203 | T | 0.535512 | -0.034309 | No Change: Both D | A colorectal cancer sample |
| Q9UBU3 | GHRL_HUMAN Appetite-regulating hormone OS=Homo sapiens GN=GHRL PE=1 SV=1 | 90 | Q | 0.364303 | L | 0.251664 | 0.112639 | No Change: Both O | - |
| Q9UBU3 | GHRL_HUMAN Appetite-regulating hormone OS=Homo sapiens GN=GHRL PE=1 SV=1 | 72 | L | 0.501282 | M | 0.540151 | -0.038869 | No Change: Both D | - |
| Q92847 | GHSR_HUMAN Growth hormone secretagogue receptor type 1 OS=Homo sapiens GN=GHSR PE=1 SV=1 | 204 | A | 0.23156 | E | 0.35813 | -0.12657 | No Change: Both O | Idiopathic short stature autosomal (ISSA) [MIM:604271] |
| Q92847 | GHSR_HUMAN Growth hormone secretagogue receptor type 1 OS=Homo sapiens GN=GHSR PE=1 SV=1 | 5 | T | 0.675214 | I | 0.610133 | 0.065081 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 566 | H | 0.816538 | R | 0.846191 | -0.029653 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 656 | H | 0.254872 | R | 0.264003 | -0.009131 | No Change: Both O | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 113 | S | 0.853116 | P | 0.854113 | -9.97E-04 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 238 | K | 0.601222 | N | 0.568527 | 0.032695 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 261 | S | 0.811833 | G | 0.77066 | 0.041173 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 535 | D | 0.900123 | A | 0.874364 | 0.025759 | No Change: Both D | - |
| Q7Z5L2 | GIDRP_HUMAN Growth inhibition and differentiation-related protein 88 OS=Homo sapiens GN=GIDRP88 PE=2 SV=2 | 546 | P | 0.951795 | S | 0.96146 | -0.009665 | No Change: Both D | - |
| P27352 | IF_HUMAN Gastric intrinsic factor OS=Homo sapiens GN=GIF PE=1 SV=2 | 23 | Q | 0.728458 | R | 0.714402 | 0.014056 | No Change: Both D | Hereditary intrinsic factor deficiency (IFD) [MIM:261000] |
| P27352 | IF_HUMAN Gastric intrinsic factor OS=Homo sapiens GN=GIF PE=1 SV=2 | 46 | S | 0.503802 | L | 0.345609 | 0.158193 | D to O | Hereditary intrinsic factor deficiency (IFD) [MIM:261000] |
| P27352 | IF_HUMAN Gastric intrinsic factor OS=Homo sapiens GN=GIF PE=1 SV=2 | 255 | N | 0.407029 | S | 0.454678 | -0.047649 | No Change: Both O | - |
| P27352 | IF_HUMAN Gastric intrinsic factor OS=Homo sapiens GN=GIF PE=1 SV=2 | 65 | G | 0.18987 | R | 0.182477 | 0.007393 | No Change: Both O | - |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 56 | N | 0.512408 | S | 0.59824 | -0.085832 | No Change: Both D | - |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 112 | T | 0.847583 | A | 0.839205 | 0.008378 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 278 | I | 0.921772 | V | 0.935621 | -0.013849 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 335 | S | 0.981462 | T | 0.971971 | 0.009491 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 457 | N | 0.949103 | T | 0.959005 | -0.009902 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 460 | P | 0.943156 | T | 0.917867 | 0.025289 | No Change: Both D | - |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 606 | D | 0.788897 | E | 0.827967 | -0.03907 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 1171 | H | 0.251756 | R | 0.272224 | -0.020468 | No Change: Both O | - |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 1242 | V | 0.955734 | I | 0.941851 | 0.013883 | No Change: Both D | Parkinson disease type 11 (PARK11) [MIM:607688] |
| Q6Y7W6 | PERQ2_HUMAN PERQ amino acid-rich with GYF domain-containing protein 2 OS=Homo sapiens GN=GIGYF2 PE=1 SV=1 | 423 | P | 0.9327 | L | 0.884767 | 0.047933 | No Change: Both D | - |
| Q8WWP7 | GIMA1_HUMAN GTPase IMAP family member 1 OS=Homo sapiens GN=GIMAP1 PE=1 SV=1 | 166 | V | 0.452425 | E | 0.605591 | -0.153166 | O to D | A breast cancer sample |
| Q8WWP7 | GIMA1_HUMAN GTPase IMAP family member 1 OS=Homo sapiens GN=GIMAP1 PE=1 SV=1 | 254 | R | 0.291278 | S | 0.31285 | -0.021572 | No Change: Both O | - |
| Q9UG22 | GIMA2_HUMAN GTPase IMAP family member 2 OS=Homo sapiens GN=GIMAP2 PE=1 SV=2 | 161 | H | 0.557697 | R | 0.551955 | 0.005742 | No Change: Both D | - |
| Q9UG22 | GIMA2_HUMAN GTPase IMAP family member 2 OS=Homo sapiens GN=GIMAP2 PE=1 SV=2 | 74 | V | 0.155079 | F | 0.15277 | 0.002309 | No Change: Both O | - |
| Q9UG22 | GIMA2_HUMAN GTPase IMAP family member 2 OS=Homo sapiens GN=GIMAP2 PE=1 SV=2 | 152 | N | 0.521986 | S | 0.573011 | -0.051025 | No Change: Both D | - |
| Q9NUV9 | GIMA4_HUMAN GTPase IMAP family member 4 OS=Homo sapiens GN=GIMAP4 PE=1 SV=1 | 128 | E | 0.536418 | D | 0.496858 | 0.03956 | D to O | - |
| Q6P9H5 | GIMA6_HUMAN GTPase IMAP family member 6 OS=Homo sapiens GN=GIMAP6 PE=2 SV=1 | 170 | G | 0.475289 | D | 0.511722 | -0.036433 | O to D | - |
| Q6P9H5 | GIMA6_HUMAN GTPase IMAP family member 6 OS=Homo sapiens GN=GIMAP6 PE=2 SV=1 | 171 | G | 0.477538 | S | 0.537473 | -0.059935 | O to D | - |
| Q6P9H5 | GIMA6_HUMAN GTPase IMAP family member 6 OS=Homo sapiens GN=GIMAP6 PE=2 SV=1 | 237 | Q | 0.513228 | R | 0.481142 | 0.032086 | D to O | - |
| Q6P9H5 | GIMA6_HUMAN GTPase IMAP family member 6 OS=Homo sapiens GN=GIMAP6 PE=2 SV=1 | 65 | V | 0.693271 | I | 0.691444 | 0.001827 | No Change: Both D | - |
| Q8NHV1 | GIMA7_HUMAN GTPase IMAP family member 7 OS=Homo sapiens GN=GIMAP7 PE=2 SV=1 | 83 | R | 0.207739 | C | 0.128258 | 0.079481 | No Change: Both O | - |
| Q8ND71 | GIMA8_HUMAN GTPase IMAP family member 8 OS=Homo sapiens GN=GIMAP8 PE=1 SV=2 | 301 | I | 0.450246 | T | 0.570061 | -0.119815 | O to D | - |
| Q9NXP7 | GIN1_HUMAN Gypsy retrotransposon integrase-like protein 1 OS=Homo sapiens GN=GIN1 PE=2 SV=3 | 22 | G | 0.471907 | C | 0.308011 | 0.163896 | No Change: Both O | - |
| Q9NXP7 | GIN1_HUMAN Gypsy retrotransposon integrase-like protein 1 OS=Homo sapiens GN=GIN1 PE=2 SV=3 | 239 | T | 0.766861 | M | 0.726448 | 0.040413 | No Change: Both D | - |
| Q14691 | PSF1_HUMAN DNA replication complex GINS protein PSF1 OS=Homo sapiens GN=GINS1 PE=1 SV=1 | 97 | V | 0.148948 | I | 0.132156 | 0.016792 | No Change: Both O | - |
| P09681 | GIP_HUMAN Gastric inhibitory polypeptide OS=Homo sapiens GN=GIP PE=1 SV=1 | 103 | S | 0.787392 | G | 0.747527 | 0.039865 | No Change: Both D | - |
| P09681 | GIP_HUMAN Gastric inhibitory polypeptide OS=Homo sapiens GN=GIP PE=1 SV=1 | 146 | N | 0.682434 | S | 0.764507 | -0.082073 | No Change: Both D | - |
| Q8TF65 | GIPC2_HUMAN PDZ domain-containing protein GIPC2 OS=Homo sapiens GN=GIPC2 PE=1 SV=1 | 61 | S | 0.331853 | F | 0.160916 | 0.170937 | No Change: Both O | - |
| Q8TF65 | GIPC2_HUMAN PDZ domain-containing protein GIPC2 OS=Homo sapiens GN=GIPC2 PE=1 SV=1 | 206 | L | 0.811019 | P | 0.877125 | -0.066106 | No Change: Both D | - |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 46 | G | 0.51827 | R | 0.542684 | -0.024414 | No Change: Both D | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 88 | M | 0.443246 | I | 0.346765 | 0.096481 | No Change: Both O | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 94 | G | 0.217594 | D | 0.237056 | -0.019462 | No Change: Both O | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 189 | R | 0.390695 | C | 0.26528 | 0.125415 | No Change: Both O | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 221 | T | 0.857104 | I | 0.772167 | 0.084937 | No Change: Both D | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 256 | G | 0.678701 | D | 0.742137 | -0.063436 | No Change: Both D | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| Q8TF64 | GIPC3_HUMAN PDZ domain-containing protein GIPC3 OS=Homo sapiens GN=GIPC3 PE=1 SV=1 | 262 | L | 0.623971 | R | 0.724111 | -0.10014 | No Change: Both D | Deafness autosomal recessive type 15 (DFNB15) [MIM:601869] |
| P48546 | GIPR_HUMAN Gastric inhibitory polypeptide receptor OS=Homo sapiens GN=GIPR PE=1 SV=1 | 207 | A | 0.113722 | V | 0.071133 | 0.042589 | No Change: Both O | - |
| P48546 | GIPR_HUMAN Gastric inhibitory polypeptide receptor OS=Homo sapiens GN=GIPR PE=1 SV=1 | 262 | L | 0.042953 | V | 0.039392 | 0.003561 | No Change: Both O | - |
| P48546 | GIPR_HUMAN Gastric inhibitory polypeptide receptor OS=Homo sapiens GN=GIPR PE=1 SV=1 | 354 | E | 0.120952 | Q | 0.099593 | 0.021359 | No Change: Both O | - |
| P48546 | GIPR_HUMAN Gastric inhibitory polypeptide receptor OS=Homo sapiens GN=GIPR PE=1 SV=1 | 136 | R | 0.099716 | W | 0.03547 | 0.064246 | No Change: Both O | - |
| Q14161 | GIT2_HUMAN ARF GTPase-activating protein GIT2 OS=Homo sapiens GN=GIT2 PE=1 SV=2 | 387 | N | 0.904743 | S | 0.922165 | -0.017422 | No Change: Both D | - |
| Q14161 | GIT2_HUMAN ARF GTPase-activating protein GIT2 OS=Homo sapiens GN=GIT2 PE=1 SV=2 | 338 | N | 0.305769 | S | 0.356482 | -0.050713 | No Change: Both O | - |
| Q14161 | GIT2_HUMAN ARF GTPase-activating protein GIT2 OS=Homo sapiens GN=GIT2 PE=1 SV=2 | 552 | A | 0.929827 | V | 0.906152 | 0.023675 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 124 | D | 0.354742 | E | 0.401946 | -0.047204 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 148 | R | 0.410207 | Q | 0.414813 | -0.004606 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 168 | A | 0.016287 | T | 0.018785 | -0.002498 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 185 | Y | 0.155867 | H | 0.246374 | -0.090507 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 202 | R | 0.228555 | C | 0.122193 | 0.106362 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 204 | T | 0.192361 | M | 0.150744 | 0.041617 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 239 | R | 0.621088 | W | 0.395583 | 0.225505 | D to O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 283 | P | 0.80002 | L | 0.657762 | 0.142258 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 290 | T | 0.783202 | N | 0.831719 | -0.048517 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 17 | Y | 0.297595 | S | 0.518747 | -0.221152 | O to D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 18 | S | 0.282577 | P | 0.253353 | 0.029224 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 21 | G | 0.240073 | R | 0.215227 | 0.024846 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 22 | G | 0.205537 | E | 0.235961 | -0.030424 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 23 | K | 0.152517 | T | 0.117532 | 0.034985 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 40 | A | 0.129622 | V | 0.092918 | 0.036704 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 49 | Q | 0.418839 | K | 0.465046 | -0.046207 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 76 | R | 0.038411 | S | 0.056861 | -0.01845 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 90 | L | 0.041454 | V | 0.042567 | -0.001113 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 98 | Y | 0.08172 | C | 0.064474 | 0.017246 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 102 | K | 0.498446 | N | 0.448645 | 0.049801 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 130 | I | 0.35317 | T | 0.457347 | -0.104177 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 134 | K | 0.374399 | E | 0.37172 | 0.002679 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 138 | G | 0.428717 | R | 0.400172 | 0.028545 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 202 | R | 0.228555 | H | 0.237495 | -0.00894 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 216 | V | 0.023099 | L | 0.023609 | -5.10E-04 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 253 | A | 0.60209 | V | 0.512279 | 0.089811 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 362 | R | 0.943884 | Q | 0.946222 | -0.002338 | No Change: Both D | Atrioventricular septal defect type 3 (AVSD3) [MIM:600309] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 362 | R | 0.943884 | Q | 0.946222 | -0.002338 | No Change: Both D | Hypoplastic left heart syndrome (HLHS) [MIM:241550] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 376 | R | 0.979453 | Q | 0.977733 | 0.00172 | No Change: Both D | Atrioventricular septal defect type 3 (AVSD3) [MIM:600309] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 376 | R | 0.979453 | Q | 0.977733 | 0.00172 | No Change: Both D | Hypoplastic left heart syndrome (HLHS) [MIM:241550] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 27 | S | 0.025217 | P | 0.021415 | 0.003802 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 31 | I | 0.009544 | M | 0.014232 | -0.004688 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 69 | S | 0.232111 | Y | 0.108309 | 0.123802 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 113 | L | 0.64688 | P | 0.749212 | -0.102332 | No Change: Both D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 134 | K | 0.374399 | N | 0.307146 | 0.067253 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 143 | G | 0.571089 | S | 0.602865 | -0.031776 | No Change: Both D | Syndactyly type 3 (SDTY3) [MIM:186100] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 2 | G | 0.849341 | V | 0.698155 | 0.151186 | No Change: Both D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 7 | L | 0.401194 | V | 0.388676 | 0.012518 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 11 | L | 0.296962 | P | 0.455985 | -0.159023 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 41 | V | 0.193758 | L | 0.209431 | -0.015673 | No Change: Both O | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 49 | Q | 0.418839 | P | 0.432065 | -0.013226 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 59 | P | 0.301181 | H | 0.267268 | 0.033913 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 76 | R | 0.038411 | H | 0.04201 | -0.003599 | No Change: Both O | Hallermann-Streiff syndrome (HSS) [MIM:234100] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 95 | H | 0.03546 | R | 0.037732 | -0.002272 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 96 | V | 0.041383 | A | 0.059295 | -0.017912 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 96 | V | 0.041383 | E | 0.096694 | -0.055311 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 96 | V | 0.041383 | M | 0.05568 | -0.014297 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 106 | L | 0.819653 | P | 0.863819 | -0.044166 | No Change: Both D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 110 | E | 0.804946 | D | 0.784522 | 0.020424 | No Change: Both D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 147 | M | 0.481357 | T | 0.546393 | -0.065036 | O to D | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 154 | T | 0.062716 | A | 0.054734 | 0.007982 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 154 | T | 0.062716 | N | 0.074772 | -0.012056 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 194 | H | 0.228078 | P | 0.281853 | -0.053775 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 201 | S | 0.220315 | F | 0.093129 | 0.127186 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 220 | S | 0.04629 | Y | 0.017616 | 0.028674 | No Change: Both O | Autosomal dominant oculodentodigital dysplasia (ODDD) [MIM:164200] |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 251 | S | 0.615546 | T | 0.533837 | 0.081709 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 253 | A | 0.60209 | P | 0.661872 | -0.059782 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 326 | T | 0.80001 | A | 0.827713 | -0.027703 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 352 | E | 0.855516 | G | 0.852339 | 0.003177 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 364 | S | 0.956495 | P | 0.956779 | -2.84E-04 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 365 | S | 0.960156 | N | 0.94367 | 0.016486 | No Change: Both D | - |
| P17302 | CXA1_HUMAN Gap junction alpha-1 protein OS=Homo sapiens GN=GJA1 PE=1 SV=2 | 373 | S | 0.978798 | G | 0.96534 | 0.013458 | No Change: Both D | - |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 63 | N | 0.192601 | S | 0.218239 | -0.025638 | No Change: Both O | Cataract zonular pulverulent cataract type 3 (CZP3) [MIM:601885] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 299 | L | 0.337369 | M | 0.383882 | -0.046513 | No Change: Both O | - |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 187 | P | 0.098373 | L | 0.04343 | 0.054943 | No Change: Both O | Cataract zonular pulverulent cataract type 3 (CZP3) [MIM:601885] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 11 | L | 0.335132 | S | 0.540436 | -0.205304 | O to D | - |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 32 | F | 0.008443 | L | 0.010231 | -0.001788 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 59 | P | 0.317844 | L | 0.174297 | 0.143547 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 76 | R | 0.035688 | H | 0.037215 | -0.001527 | No Change: Both O | Cataract zonular pulverulent cataract type 3 (CZP3) [MIM:601885] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 45 | W | 0.408062 | S | 0.71639 | -0.308328 | O to D | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 2 | G | 0.776982 | D | 0.805048 | -0.028066 | No Change: Both D | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 3 | D | 0.710244 | Y | 0.507681 | 0.202563 | No Change: Both D | Cataract zonular pulverulent cataract type 3 (CZP3) [MIM:601885] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 28 | V | 0.007547 | M | 0.009323 | -0.001776 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 33 | R | 0.010943 | L | 0.00675 | 0.004193 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 44 | V | 0.375187 | M | 0.438219 | -0.063032 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 47 | D | 0.445404 | N | 0.408549 | 0.036855 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 76 | R | 0.035688 | G | 0.036045 | -3.57E-04 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 87 | T | 0.061854 | M | 0.049108 | 0.012746 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 187 | P | 0.098373 | S | 0.107098 | -0.008725 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q9Y6H8 | CXA3_HUMAN Gap junction alpha-3 protein OS=Homo sapiens GN=GJA3 PE=1 SV=4 | 188 | N | 0.10078 | T | 0.090877 | 0.009903 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P35212 | CXA4_HUMAN Gap junction alpha-4 protein OS=Homo sapiens GN=GJA4 PE=1 SV=3 | 71 | P | 0.082609 | S | 0.099939 | -0.01733 | No Change: Both O | - |
| P35212 | CXA4_HUMAN Gap junction alpha-4 protein OS=Homo sapiens GN=GJA4 PE=1 SV=3 | 128 | A | 0.590207 | V | 0.513134 | 0.077073 | No Change: Both D | - |
| P35212 | CXA4_HUMAN Gap junction alpha-4 protein OS=Homo sapiens GN=GJA4 PE=1 SV=3 | 130 | V | 0.576254 | I | 0.5525 | 0.023754 | No Change: Both D | - |
| P35212 | CXA4_HUMAN Gap junction alpha-4 protein OS=Homo sapiens GN=GJA4 PE=1 SV=3 | 319 | P | 0.992934 | S | 0.992598 | 3.36E-04 | No Change: Both D | - |
| P36382 | CXA5_HUMAN Gap junction alpha-5 protein OS=Homo sapiens GN=GJA5 PE=1 SV=3 | 88 | P | 0.129937 | S | 0.158746 | -0.028809 | No Change: Both O | Familial atrial standstill (FAS) [MIM:108770] |
| P36382 | CXA5_HUMAN Gap junction alpha-5 protein OS=Homo sapiens GN=GJA5 PE=1 SV=3 | 96 | A | 0.271368 | S | 0.39101 | -0.119642 | No Change: Both O | Familial atrial standstill (FAS) [MIM:108770] |
| P36382 | CXA5_HUMAN Gap junction alpha-5 protein OS=Homo sapiens GN=GJA5 PE=1 SV=3 | 85 | V | 0.053618 | I | 0.047336 | 0.006282 | No Change: Both O | Familial atrial fibrillation type 11 (ATFB11) [MIM:614049] |
| P36382 | CXA5_HUMAN Gap junction alpha-5 protein OS=Homo sapiens GN=GJA5 PE=1 SV=3 | 221 | L | 0.138774 | I | 0.107595 | 0.031179 | No Change: Both O | Familial atrial fibrillation type 11 (ATFB11) [MIM:614049] |
| P36382 | CXA5_HUMAN Gap junction alpha-5 protein OS=Homo sapiens GN=GJA5 PE=1 SV=3 | 229 | L | 0.107645 | M | 0.13028 | -0.022635 | No Change: Both O | Familial atrial fibrillation type 11 (ATFB11) [MIM:614049] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 88 | P | 0.125651 | S | 0.154151 | -0.0285 | No Change: Both O | Cataract zonular pulverulent type 1 (CZP1) [MIM:116200] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 64 | V | 0.184777 | G | 0.319126 | -0.134349 | No Change: Both O | Cataract zonular pulverulent type 1 (CZP1) [MIM:116200] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 23 | R | 0.056227 | T | 0.058093 | -0.001866 | No Change: Both O | - |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 44 | V | 0.171782 | E | 0.357796 | -0.186014 | No Change: Both O | Cataract-microcornea syndrome (CAMIS) [MIM:116150] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 48 | E | 0.260599 | K | 0.247139 | 0.01346 | No Change: Both O | Cataract zonular pulverulent type 1 (CZP1) [MIM:116200] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 198 | R | 0.199474 | Q | 0.215669 | -0.016195 | No Change: Both O | Cataract-microcornea syndrome (CAMIS) [MIM:116150] |
| P48165 | CXA8_HUMAN Gap junction alpha-8 protein OS=Homo sapiens GN=GJA8 PE=1 SV=3 | 247 | I | 0.656151 | M | 0.718387 | -0.062236 | No Change: Both D | Cataract zonular pulverulent type 1 (CZP1) [MIM:116200] |
| P57773 | CXA9_HUMAN Gap junction alpha-9 protein OS=Homo sapiens GN=GJA9 PE=2 SV=2 | 497 | V | 0.359831 | I | 0.31615 | 0.043681 | No Change: Both O | - |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 3 | W | 0.614309 | R | 0.833775 | -0.219466 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 3 | W | 0.614309 | S | 0.886035 | -0.271726 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 7 | Y | 0.200701 | C | 0.162762 | 0.037939 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 8 | T | 0.15443 | P | 0.177908 | -0.023478 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 11 | S | 0.269848 | G | 0.228708 | 0.04114 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 12 | G | 0.315522 | S | 0.382322 | -0.0668 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 13 | V | 0.371011 | L | 0.395553 | -0.024542 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 13 | V | 0.371011 | M | 0.444808 | -0.073797 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 14 | N | 0.362482 | K | 0.410724 | -0.048242 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 15 | R | 0.342838 | Q | 0.354747 | -0.011909 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 15 | R | 0.342838 | W | 0.154082 | 0.188756 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 16 | H | 0.344536 | P | 0.384777 | -0.040241 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 20 | I | 0.174295 | S | 0.391694 | -0.217399 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 21 | G | 0.128908 | D | 0.141466 | -0.012558 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 22 | R | 0.085888 | G | 0.092086 | -0.006198 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 22 | R | 0.085888 | P | 0.096065 | -0.010177 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 22 | R | 0.085888 | Q | 0.088507 | -0.002619 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 23 | V | 0.057269 | A | 0.081578 | -0.024309 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 25 | L | 0.02008 | F | 0.019226 | 8.54E-04 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 26 | S | 0.013695 | L | 0.005647 | 0.008048 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 28 | I | 0.008759 | T | 0.015704 | -0.006945 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 29 | F | 0.007597 | L | 0.008868 | -0.001271 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 30 | I | 0.007725 | N | 0.016563 | -0.008838 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 34 | M | 0.013624 | T | 0.01706 | -0.003436 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 34 | M | 0.013624 | V | 0.01144 | 0.002184 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 35 | V | 0.015061 | M | 0.01968 | -0.004619 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 38 | V | 0.047109 | M | 0.060159 | -0.01305 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 39 | A | 0.078107 | P | 0.103723 | -0.025616 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 39 | A | 0.078107 | V | 0.057954 | 0.020153 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 40 | A | 0.12428 | V | 0.093823 | 0.030457 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 41 | E | 0.190434 | K | 0.188955 | 0.001479 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 43 | V | 0.31869 | M | 0.365128 | -0.046438 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 44 | W | 0.370219 | L | 0.468563 | -0.098344 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 49 | S | 0.333842 | Y | 0.164544 | 0.169298 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 50 | S | 0.281821 | P | 0.24536 | 0.036461 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 53 | C | 0.190649 | S | 0.441968 | -0.251319 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 56 | L | 0.176657 | F | 0.167468 | 0.009189 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 58 | P | 0.157396 | R | 0.134629 | 0.022767 | No Change: Both O | - |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 59 | G | 0.147858 | C | 0.074242 | 0.073616 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 60 | C | 0.13774 | F | 0.139622 | -0.001882 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 63 | V | 0.105826 | I | 0.092858 | 0.012968 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 64 | C | 0.095918 | S | 0.253189 | -0.157271 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 65 | Y | 0.093426 | C | 0.082315 | 0.011111 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 75 | R | 0.061465 | P | 0.078655 | -0.01719 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 75 | R | 0.061465 | Q | 0.073414 | -0.011949 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 75 | R | 0.061465 | W | 0.025614 | 0.035851 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 77 | W | 0.064836 | S | 0.217491 | -0.152655 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 80 | Q | 0.073501 | R | 0.071993 | 0.001508 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 81 | L | 0.067959 | F | 0.052819 | 0.01514 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 83 | L | 0.066701 | P | 0.127934 | -0.061233 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 84 | V | 0.074484 | I | 0.06624 | 0.008244 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 85 | S | 0.090242 | C | 0.030522 | 0.05972 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 85 | S | 0.090242 | F | 0.031857 | 0.058385 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 86 | T | 0.100024 | A | 0.097133 | 0.002891 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 86 | T | 0.100024 | N | 0.117948 | -0.017924 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 86 | T | 0.100024 | S | 0.15184 | -0.051816 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 87 | P | 0.108246 | A | 0.082661 | 0.025585 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 87 | P | 0.108246 | L | 0.058852 | 0.049394 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 87 | P | 0.108246 | S | 0.130222 | -0.021976 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 89 | L | 0.131847 | P | 0.243834 | -0.111987 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 90 | L | 0.146468 | H | 0.2408 | -0.094332 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 93 | M | 0.199066 | V | 0.168158 | 0.030908 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 94 | H | 0.213471 | Q | 0.228629 | -0.015158 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 94 | H | 0.213471 | Y | 0.119447 | 0.094024 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 95 | V | 0.236574 | M | 0.296503 | -0.059929 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 100 | H | 0.489679 | Y | 0.350104 | 0.139575 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 102 | E | 0.57195 | G | 0.518365 | 0.053585 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 103 | K | 0.59893 | E | 0.604686 | -0.005756 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 107 | R | 0.54408 | W | 0.312044 | 0.232036 | D to O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 124 | K | 0.41578 | N | 0.357298 | 0.058482 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 128 | S | 0.123432 | P | 0.109635 | 0.013797 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 133 | W | 0.025853 | C | 0.028698 | -0.002845 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 133 | W | 0.025853 | R | 0.063938 | -0.038085 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 135 | Y | 0.015408 | C | 0.012024 | 0.003384 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 139 | V | 0.012276 | M | 0.014963 | -0.002687 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 141 | F | 0.016651 | L | 0.019444 | -0.002793 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 142 | R | 0.019309 | E | 0.02882 | -0.009511 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 142 | R | 0.019309 | W | 0.007103 | 0.012206 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 149 | F | 0.013639 | I | 0.012139 | 0.0015 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 156 | L | 0.028463 | F | 0.024918 | 0.003545 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 156 | L | 0.028463 | R | 0.049905 | -0.021442 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 157 | Y | 0.034014 | C | 0.02364 | 0.010374 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 158 | P | 0.040425 | A | 0.029292 | 0.011133 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 158 | P | 0.040425 | R | 0.035864 | 0.004561 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 158 | P | 0.040425 | S | 0.046058 | -0.005633 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 159 | G | 0.045229 | S | 0.058023 | -0.012794 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 160 | Y | 0.046688 | H | 0.074474 | -0.027786 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 161 | A | 0.047944 | P | 0.07583 | -0.027886 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 164 | R | 0.05915 | Q | 0.064816 | -0.005666 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 164 | R | 0.05915 | W | 0.022127 | 0.037023 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 172 | P | 0.096747 | L | 0.043975 | 0.052772 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 172 | P | 0.096747 | S | 0.102072 | -0.005325 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 173 | C | 0.105971 | R | 0.200222 | -0.094251 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 175 | N | 0.122721 | D | 0.143493 | -0.020772 | No Change: Both O | - |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 178 | D | 0.158555 | Y | 0.081182 | 0.077373 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 179 | C | 0.179523 | R | 0.336581 | -0.157058 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 180 | F | 0.208015 | L | 0.231522 | -0.023507 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 181 | V | 0.230082 | M | 0.271418 | -0.041336 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 182 | S | 0.266497 | T | 0.216949 | 0.049548 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 183 | R | 0.314853 | C | 0.178556 | 0.136297 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 183 | R | 0.314853 | H | 0.318456 | -0.003603 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 183 | R | 0.314853 | S | 0.405977 | -0.091124 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 184 | P | 0.326725 | R | 0.302471 | 0.024254 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 186 | E | 0.336787 | K | 0.353465 | -0.016678 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 187 | K | 0.301403 | E | 0.317328 | -0.015925 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 189 | V | 0.200635 | G | 0.30262 | -0.101985 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 189 | V | 0.200635 | I | 0.165865 | 0.03477 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 193 | F | 0.056954 | C | 0.051127 | 0.005827 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 194 | M | 0.041997 | V | 0.03464 | 0.007357 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 198 | S | 0.029851 | F | 0.011583 | 0.018268 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 199 | G | 0.032187 | R | 0.034582 | -0.002395 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 201 | C | 0.031235 | R | 0.063396 | -0.032161 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 203 | I | 0.03352 | N | 0.06818 | -0.03466 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 204 | L | 0.031512 | F | 0.027852 | 0.00366 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 205 | N | 0.028279 | S | 0.037523 | -0.009244 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 208 | E | 0.029624 | K | 0.031608 | -0.001984 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 215 | R | 0.073855 | W | 0.022939 | 0.050916 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 219 | R | 0.311076 | C | 0.177032 | 0.134044 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 219 | R | 0.311076 | H | 0.284135 | 0.026941 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 220 | R | 0.435238 | G | 0.419508 | 0.01573 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 230 | R | 0.799438 | C | 0.734798 | 0.06464 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 230 | R | 0.799438 | L | 0.75418 | 0.045258 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 235 | F | 0.752625 | C | 0.787493 | -0.034868 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 238 | R | 0.760496 | H | 0.722152 | 0.038344 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 55 | T | 0.183426 | I | 0.107254 | 0.076172 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 120 | V | 0.645423 | E | 0.807862 | -0.162439 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 65 | Y | 0.093426 | H | 0.161512 | -0.068086 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 136 | V | 0.012336 | A | 0.016521 | -0.004185 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 168 | C | 0.080958 | R | 0.168179 | -0.087221 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 8 | T | 0.15443 | I | 0.076441 | 0.077989 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 9 | L | 0.19234 | W | 0.134824 | 0.057516 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 24 | W | 0.033761 | C | 0.040098 | -0.006337 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 25 | L | 0.02008 | P | 0.043687 | -0.023607 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 26 | S | 0.013695 | W | 0.00382 | 0.009875 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 28 | I | 0.008759 | N | 0.01906 | -0.010301 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 30 | I | 0.007725 | T | 0.013784 | -0.006059 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 34 | M | 0.013624 | I | 0.009669 | 0.003955 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 34 | M | 0.013624 | K | 0.025111 | -0.011487 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 37 | V | 0.031629 | M | 0.040675 | -0.009046 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 40 | A | 0.12428 | T | 0.13141 | -0.00713 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 49 | S | 0.333842 | P | 0.290014 | 0.043828 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 55 | T | 0.183426 | A | 0.162372 | 0.021054 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 55 | T | 0.183426 | R | 0.193956 | -0.01053 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 57 | Q | 0.169733 | H | 0.159293 | 0.01044 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 59 | G | 0.147858 | R | 0.139808 | 0.00805 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 64 | C | 0.095918 | F | 0.102885 | -0.006967 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 69 | F | 0.080469 | L | 0.088345 | -0.007876 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 70 | P | 0.0778 | A | 0.053971 | 0.023829 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 90 | L | 0.146468 | V | 0.150482 | -0.004014 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 91 | V | 0.17275 | M | 0.219159 | -0.046409 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 94 | H | 0.213471 | D | 0.226486 | -0.013015 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 104 | K | 0.603476 | T | 0.499859 | 0.103617 | D to O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 108 | L | 0.531196 | P | 0.688232 | -0.157036 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 125 | V | 0.323429 | D | 0.476985 | -0.153556 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 126 | H | 0.235011 | Y | 0.141043 | 0.093968 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 127 | I | 0.171288 | M | 0.244792 | -0.073504 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 127 | I | 0.171288 | S | 0.389491 | -0.218203 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 130 | T | 0.076274 | I | 0.040614 | 0.03566 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 131 | L | 0.050119 | P | 0.105143 | -0.055024 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 138 | S | 0.010598 | N | 0.008634 | 0.001964 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 142 | R | 0.019309 | Q | 0.021264 | -0.001955 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 146 | E | 0.022391 | K | 0.022374 | 1.70E-05 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 147 | A | 0.020634 | D | 0.031009 | -0.010375 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 149 | F | 0.013639 | V | 0.015779 | -0.00214 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 151 | Y | 0.011926 | S | 0.026313 | -0.014387 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 153 | F | 0.014001 | S | 0.037715 | -0.023714 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 159 | G | 0.045229 | D | 0.051557 | -0.006328 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 168 | C | 0.080958 | Y | 0.10276 | -0.021802 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 172 | P | 0.096747 | A | 0.061951 | 0.034796 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 172 | P | 0.096747 | R | 0.078161 | 0.018586 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 177 | V | 0.153573 | A | 0.197242 | -0.043669 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 177 | V | 0.153573 | E | 0.300752 | -0.147179 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 180 | F | 0.208015 | S | 0.450708 | -0.242693 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 181 | V | 0.230082 | A | 0.288344 | -0.058262 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 184 | P | 0.326725 | L | 0.175616 | 0.151109 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 191 | T | 0.102875 | A | 0.089886 | 0.012989 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 192 | V | 0.072946 | F | 0.065212 | 0.007734 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 193 | F | 0.056954 | L | 0.064681 | -0.007727 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 201 | C | 0.031235 | Y | 0.035556 | -0.004321 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 204 | L | 0.031512 | V | 0.034502 | -0.00299 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 205 | N | 0.028279 | I | 0.014682 | 0.013597 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 208 | E | 0.029624 | G | 0.025573 | 0.004051 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 211 | Y | 0.046117 | H | 0.082151 | -0.036034 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 213 | I | 0.050224 | V | 0.057656 | -0.007432 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 215 | R | 0.073855 | Q | 0.069329 | 0.004526 | No Change: Both O | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 239 | L | 0.749774 | I | 0.728254 | 0.02152 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 264 | R | 0.756554 | C | 0.63932 | 0.117234 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P08034 | CXB1_HUMAN Gap junction beta-1 protein OS=Homo sapiens GN=GJB1 PE=1 SV=1 | 280 | C | 0.884267 | G | 0.905468 | -0.021201 | No Change: Both D | Charcot-Marie-Tooth disease X-linked type 1 (CMTX1) [MIM:302800] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 27 | V | 0.008874 | I | 0.008699 | 1.75E-04 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 34 | M | 0.010303 | T | 0.013267 | -0.002964 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 37 | V | 0.023595 | I | 0.020521 | 0.003074 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 75 | R | 0.040059 | W | 0.016409 | 0.02365 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 75 | R | 0.040059 | W | 0.016409 | 0.02365 | No Change: Both O | Palmoplantar keratoderma with deafness (PPKDFN) [MIM:148350] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 77 | W | 0.027798 | R | 0.077763 | -0.049965 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 83 | F | 0.035906 | L | 0.046619 | -0.010713 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 84 | V | 0.045586 | L | 0.048781 | -0.003195 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 95 | V | 0.187963 | M | 0.238279 | -0.050316 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 113 | S | 0.543156 | R | 0.479702 | 0.063454 | D to O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 160 | G | 0.112957 | S | 0.151035 | -0.038078 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 44 | W | 0.246575 | C | 0.28404 | -0.037465 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 66 | D | 0.087087 | H | 0.079899 | 0.007188 | No Change: Both O | Palmoplantar keratoderma with deafness (PPKDFN) [MIM:148350] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 66 | D | 0.087087 | H | 0.079899 | 0.007188 | No Change: Both O | Vohwinkel syndrome (VS) [MIM:124500] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 59 | G | 0.169131 | A | 0.132112 | 0.037019 | No Change: Both O | Palmoplantar keratoderma with deafness (PPKDFN) [MIM:148350] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 114 | E | 0.570648 | G | 0.501669 | 0.068979 | No Change: Both D | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 153 | V | 0.020496 | I | 0.016646 | 0.00385 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 169 | C | 0.102369 | Y | 0.11993 | -0.017561 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 184 | R | 0.313338 | W | 0.14376 | 0.169578 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 203 | I | 0.022207 | T | 0.042486 | -0.020279 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 12 | G | 0.397474 | R | 0.361582 | 0.035892 | No Change: Both O | Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 17 | S | 0.443438 | F | 0.204593 | 0.238845 | No Change: Both O | Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 45 | G | 0.267358 | E | 0.34532 | -0.077962 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 50 | D | 0.160699 | N | 0.150658 | 0.010041 | No Change: Both O | Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 50 | D | 0.160699 | N | 0.150658 | 0.010041 | No Change: Both O | Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 71 | I | 0.0655 | T | 0.114703 | -0.049203 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 86 | T | 0.073069 | R | 0.078368 | -0.005299 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 123 | T | 0.443501 | N | 0.485082 | -0.041581 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 143 | R | 0.042283 | W | 0.015865 | 0.026418 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 191 | F | 0.123593 | L | 0.130029 | -0.006436 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 50 | D | 0.160699 | Y | 0.077106 | 0.083593 | No Change: Both O | Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 75 | R | 0.040059 | Q | 0.047052 | -0.006993 | No Change: Both O | Palmoplantar keratoderma with deafness (PPKDFN) [MIM:148350] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 90 | L | 0.094422 | P | 0.186715 | -0.092293 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 111 | I | 0.558675 | T | 0.679018 | -0.120343 | No Change: Both D | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 127 | R | 0.236011 | H | 0.235679 | 3.32E-04 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 143 | R | 0.042283 | Q | 0.046416 | -0.004133 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 159 | D | 0.097109 | V | 0.050785 | 0.046324 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 165 | R | 0.11427 | W | 0.047527 | 0.066743 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 184 | R | 0.313338 | P | 0.372774 | -0.059436 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 202 | C | 0.021387 | F | 0.022909 | -0.001522 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 32 | R | 0.00677 | L | 0.004065 | 0.002705 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 32 | R | 0.00677 | H | 0.006843 | -7.30E-05 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 79 | L | 0.029057 | P | 0.060376 | -0.031319 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 80 | Q | 0.03052 | K | 0.038233 | -0.007713 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 93 | M | 0.135902 | I | 0.090471 | 0.045431 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 129 | E | 0.152274 | K | 0.162008 | -0.009734 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 167 | V | 0.101315 | M | 0.141801 | -0.040486 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 178 | V | 0.127636 | A | 0.173123 | -0.045487 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 184 | R | 0.313338 | Q | 0.334133 | -0.020795 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 197 | A | 0.021454 | S | 0.039108 | -0.017654 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 203 | I | 0.022207 | K | 0.0571 | -0.034893 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 214 | L | 0.03504 | P | 0.068429 | -0.033389 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 44 | W | 0.246575 | S | 0.549514 | -0.302939 | O to D | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 54 | N | 0.129003 | K | 0.155995 | -0.026992 | No Change: Both O | Bart-Pumphrey syndrome (BPS) [MIM:149200] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 59 | G | 0.169131 | S | 0.208417 | -0.039286 | No Change: Both O | Bart-Pumphrey syndrome (BPS) [MIM:149200] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 179 | D | 0.138281 | N | 0.138653 | -3.72E-04 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 168 | K | 0.106546 | R | 0.085529 | 0.021017 | No Change: Both O | - |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 46 | D | 0.268701 | E | 0.300575 | -0.031874 | No Change: Both O | Deafness autosomal dominant type 3A (DFNA3A) [MIM:601544] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 73 | H | 0.056329 | R | 0.056542 | -2.13E-04 | No Change: Both O | Palmoplantar keratoderma with deafness (PPKDFN) [MIM:148350] |
| P29033 | CXB2_HUMAN Gap junction beta-2 protein OS=Homo sapiens GN=GJB2 PE=1 SV=3 | 84 | V | 0.045586 | M | 0.059188 | -0.013602 | No Change: Both O | Deafness autosomal recessive type 1A (DFNB1A) [MIM:220290] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 12 | G | 0.28874 | D | 0.313314 | -0.024574 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 12 | G | 0.28874 | R | 0.271633 | 0.017107 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 86 | C | 0.027154 | S | 0.084359 | -0.057205 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 183 | E | 0.258102 | K | 0.278299 | -0.020197 | No Change: Both O | Deafness autosomal dominant type 2B (DFNA2B) [MIM:612644] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 32 | R | 0.013185 | W | 0.004842 | 0.008343 | No Change: Both O | - |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 42 | R | 0.152435 | P | 0.178071 | -0.025636 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 137 | F | 0.014823 | L | 0.017508 | -0.002685 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 141 | I | 0.014256 | V | 0.01495 | -6.94E-04 | No Change: Both O | Deafness autosomal dominant type 2B (DFNA2B) [MIM:612644] |
| O75712 | CXB3_HUMAN Gap junction beta-3 protein OS=Homo sapiens GN=GJB3 PE=1 SV=1 | 200 | V | 0.016611 | I | 0.014714 | 0.001897 | No Change: Both O | - |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 137 | F | 0.05294 | L | 0.065754 | -0.012814 | No Change: Both O | Erythrokeratodermia variabilis (EKV) [MIM:133200] |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 103 | R | 0.839623 | C | 0.701507 | 0.138116 | No Change: Both D | - |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 124 | R | 0.28417 | Q | 0.303731 | -0.019561 | No Change: Both O | - |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 160 | R | 0.172032 | C | 0.088602 | 0.08343 | No Change: Both O | - |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 169 | C | 0.207994 | W | 0.164909 | 0.043085 | No Change: Both O | - |
| Q9NTQ9 | CXB4_HUMAN Gap junction beta-4 protein OS=Homo sapiens GN=GJB4 PE=1 SV=1 | 204 | E | 0.048409 | A | 0.029547 | 0.018862 | No Change: Both O | - |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 5 | T | 0.401254 | M | 0.348842 | 0.052412 | No Change: Both O | Deafness autosomal dominant type 3B (DFNA3B) [MIM:612643] |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 11 | G | 0.322097 | R | 0.291261 | 0.030836 | No Change: Both O | Ectodermal dysplasia type 2 (ED2) [MIM:129500] |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 88 | A | 0.084514 | V | 0.060093 | 0.024421 | No Change: Both O | Ectodermal dysplasia type 2 (ED2) [MIM:129500] |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 37 | V | 0.024768 | E | 0.056693 | -0.031925 | No Change: Both O | Ectodermal dysplasia type 2 (ED2) [MIM:129500] |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 139 | S | 0.03874 | G | 0.028213 | 0.010527 | No Change: Both O | - |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 199 | S | 0.035704 | T | 0.024181 | 0.011523 | No Change: Both O | - |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 159 | N | 0.029615 | S | 0.036131 | -0.006516 | No Change: Both O | - |
| O95452 | CXB6_HUMAN Gap junction beta-6 protein OS=Homo sapiens GN=GJB6 PE=1 SV=2 | 59 | G | 0.161652 | R | 0.151675 | 0.009977 | No Change: Both O | - |
| Q6PEY0 | CXB7_HUMAN Gap junction beta-7 protein OS=Homo sapiens GN=GJB7 PE=2 SV=1 | 20 | T | 0.100095 | I | 0.054231 | 0.045864 | No Change: Both O | - |
| Q6PEY0 | CXB7_HUMAN Gap junction beta-7 protein OS=Homo sapiens GN=GJB7 PE=2 SV=1 | 206 | F | 0.020945 | L | 0.026088 | -0.005143 | No Change: Both O | - |
| Q6PEY0 | CXB7_HUMAN Gap junction beta-7 protein OS=Homo sapiens GN=GJB7 PE=2 SV=1 | 177 | T | 0.115853 | M | 0.089046 | 0.026807 | No Change: Both O | - |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 90 | P | 0.120487 | S | 0.144056 | -0.023569 | No Change: Both O | Leukodystrophy hypomyelinating type 2 (HLD2) [MIM:608804] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 272 | Y | 0.02301 | D | 0.058553 | -0.035543 | No Change: Both O | Leukodystrophy hypomyelinating type 2 (HLD2) [MIM:608804] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 286 | M | 0.218369 | T | 0.230325 | -0.011956 | No Change: Both O | Leukodystrophy hypomyelinating type 2 (HLD2) [MIM:608804] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 36 | I | 0.024786 | M | 0.038957 | -0.014171 | No Change: Both O | Spastic paraplegia autosomal recessive type 44 (SPG44) [MIM:613206] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 19 | H | 0.26861 | P | 0.287812 | -0.019202 | No Change: Both O | - |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 48 | S | 0.396056 | L | 0.20526 | 0.190796 | No Change: Both O | Lymphedema hereditary type 1C (LMPH1C) [MIM:613480] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 125 | R | 0.988533 | Q | 0.985437 | 0.003096 | No Change: Both D | - |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 149 | G | 0.99666 | S | 0.99625 | 4.10E-04 | No Change: Both D | - |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 260 | R | 0.252862 | C | 0.141706 | 0.111156 | No Change: Both O | Lymphedema hereditary type 1C (LMPH1C) [MIM:613480] |
| Q5T442 | CXG2_HUMAN Gap junction gamma-2 protein OS=Homo sapiens GN=GJC2 PE=1 SV=1 | 316 | P | 0.964392 | L | 0.925459 | 0.038933 | No Change: Both D | - |
| Q96KN9 | CXD4_HUMAN Gap junction delta-4 protein OS=Homo sapiens GN=GJD4 PE=2 SV=1 | 269 | R | 0.993221 | H | 0.991093 | 0.002128 | No Change: Both D | A colorectal cancer sample |
| Q96KN9 | CXD4_HUMAN Gap junction delta-4 protein OS=Homo sapiens GN=GJD4 PE=2 SV=1 | 271 | G | 0.992411 | R | 0.993262 | -8.51E-04 | No Change: Both D | A colorectal cancer sample |
| Q96KN9 | CXD4_HUMAN Gap junction delta-4 protein OS=Homo sapiens GN=GJD4 PE=2 SV=1 | 90 | A | 0.075639 | V | 0.06028 | 0.015359 | No Change: Both O | - |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 185 | S | 0.078159 | N | 0.064234 | 0.013925 | No Change: Both O | - |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 232 | N | 0.397222 | H | 0.377839 | 0.019383 | No Change: Both O | - |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 382 | A | 0.143709 | T | 0.158762 | -0.015053 | No Change: Both O | - |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 446 | D | 0.103047 | V | 0.058103 | 0.044944 | No Change: Both O | GK deficiency (GKD) [MIM:307030] |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 509 | W | 0.426457 | R | 0.61192 | -0.185463 | O to D | GK deficiency (GKD) [MIM:307030] |
| P32189 | GLPK_HUMAN Glycerol kinase OS=Homo sapiens GN=GK PE=1 SV=3 | 294 | N | 0.076321 | D | 0.083906 | -0.007585 | No Change: Both O | GK deficiency (GKD) [MIM:307030] |
| Q9NS71 | GKN1_HUMAN Gastrokine-1 OS=Homo sapiens GN=GKN1 PE=2 SV=3 | 118 | K | 0.781785 | T | 0.69996 | 0.081825 | No Change: Both D | A breast cancer sample |
| Q86XP6 | GKN2_HUMAN Gastrokine-2 OS=Homo sapiens GN=GKN2 PE=1 SV=2 | 113 | S | 0.229943 | N | 0.198259 | 0.031684 | No Change: Both O | - |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 32 | L | 0.3221 | P | 0.455377 | -0.133277 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 34 | N | 0.402679 | S | 0.452292 | -0.049613 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 35 | G | 0.401997 | R | 0.385903 | 0.016094 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 40 | P | 0.216374 | S | 0.238676 | -0.022302 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 49 | R | 0.083586 | L | 0.054114 | 0.029472 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 52 | C | 0.121087 | R | 0.205171 | -0.084084 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 52 | C | 0.121087 | S | 0.239335 | -0.118248 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 56 | C | 0.320109 | F | 0.314791 | 0.005318 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 56 | C | 0.320109 | G | 0.452508 | -0.132399 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 59 | E | 0.484196 | K | 0.468053 | 0.016143 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 66 | E | 0.395447 | Q | 0.325465 | 0.069982 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 72 | M | 0.295095 | V | 0.217881 | 0.077214 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 85 | G | 0.268187 | D | 0.32241 | -0.054223 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 89 | L | 0.17713 | R | 0.273105 | -0.095975 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 100 | R | 0.453664 | K | 0.486083 | -0.032419 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 112 | R | 0.452859 | C | 0.267307 | 0.185552 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 112 | R | 0.452859 | H | 0.454769 | -0.00191 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 128 | G | 0.255572 | E | 0.280969 | -0.025397 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 131 | L | 0.23676 | P | 0.363569 | -0.126809 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 142 | C | 0.268035 | Y | 0.331065 | -0.06303 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 143 | A | 0.268541 | P | 0.36314 | -0.094599 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 144 | G | 0.256439 | V | 0.141596 | 0.114843 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 146 | P | 0.215003 | S | 0.253672 | -0.038669 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 156 | A | 0.146889 | T | 0.165192 | -0.018303 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 156 | A | 0.146889 | V | 0.101348 | 0.045541 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 162 | W | 0.090168 | R | 0.211447 | -0.121279 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 165 | D | 0.074244 | V | 0.033809 | 0.040435 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 166 | L | 0.073168 | V | 0.073597 | -4.29E-04 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 172 | C | 0.090389 | Y | 0.113055 | -0.022666 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 202 | C | 0.061979 | W | 0.056825 | 0.005154 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 205 | P | 0.04158 | T | 0.030149 | 0.011431 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 215 | N | 0.260211 | S | 0.295594 | -0.035383 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 219 | I | 0.237733 | N | 0.445928 | -0.208195 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 224 | N | 0.079267 | D | 0.082849 | -0.003582 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 227 | R | 0.102674 | Q | 0.114304 | -0.01163 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 231 | D | 0.222379 | N | 0.207434 | 0.014945 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 244 | D | 0.168617 | N | 0.167816 | 8.01E-04 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 264 | D | 0.323918 | V | 0.181712 | 0.142206 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 266 | D | 0.241981 | V | 0.131839 | 0.110142 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 269 | V | 0.105178 | A | 0.146608 | -0.04143 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 272 | N | 0.094821 | K | 0.106051 | -0.01123 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 279 | Q | 0.174303 | E | 0.190578 | -0.016275 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 284 | M | 0.088341 | T | 0.104828 | -0.016487 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 288 | A | 0.062362 | D | 0.080607 | -0.018245 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 296 | M | 0.23998 | V | 0.183937 | 0.056043 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 297 | S | 0.296053 | F | 0.137157 | 0.158896 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 298 | N | 0.329147 | K | 0.371019 | -0.041872 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 301 | R | 0.372022 | Q | 0.410971 | -0.038949 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 313 | D | 0.325168 | Y | 0.172983 | 0.152185 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 316 | V | 0.251193 | E | 0.440301 | -0.189108 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 327 | Q | 0.497815 | K | 0.527826 | -0.030011 | O to D | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 328 | G | 0.486655 | R | 0.469887 | 0.016768 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 328 | G | 0.486655 | A | 0.413501 | 0.073154 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 342 | R | 0.168857 | Q | 0.18488 | -0.016023 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 356 | R | 0.265282 | W | 0.124521 | 0.140761 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 358 | E | 0.402588 | K | 0.402996 | -4.08E-04 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 361 | G | 0.4142 | R | 0.404298 | 0.009902 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 396 | F | 0.166204 | Y | 0.203273 | -0.037069 | No Change: Both O | - |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 20 | A | 0.031269 | P | 0.045357 | -0.014088 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 31 | A | 0.264511 | V | 0.192408 | 0.072103 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 40 | P | 0.216374 | L | 0.123686 | 0.092688 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 42 | M | 0.159042 | V | 0.11872 | 0.040322 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 46 | H | 0.089397 | R | 0.116614 | -0.027217 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 46 | H | 0.089397 | Y | 0.050439 | 0.038958 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 47 | W | 0.077459 | G | 0.178688 | -0.101229 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 49 | R | 0.083586 | P | 0.097846 | -0.01426 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 49 | R | 0.083586 | S | 0.100076 | -0.01649 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 56 | C | 0.320109 | Y | 0.329409 | -0.0093 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 86 | Y | 0.242989 | C | 0.32439 | -0.081401 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 89 | L | 0.17713 | P | 0.308138 | -0.131008 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 91 | I | 0.129104 | T | 0.186026 | -0.056922 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 92 | D | 0.114897 | H | 0.077329 | 0.037568 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 92 | D | 0.114897 | Y | 0.052217 | 0.06268 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 93 | D | 0.098744 | G | 0.080605 | 0.018139 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 94 | C | 0.100028 | S | 0.212498 | -0.11247 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 94 | C | 0.100028 | Y | 0.101724 | -0.001696 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 95 | W | 0.131042 | S | 0.348034 | -0.216992 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 97 | A | 0.247484 | V | 0.186675 | 0.060809 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 100 | R | 0.453664 | T | 0.424591 | 0.029073 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 113 | F | 0.418943 | L | 0.46822 | -0.049277 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 113 | F | 0.418943 | S | 0.63532 | -0.216377 | O to D | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 134 | Y | 0.174211 | S | 0.336804 | -0.162593 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 138 | G | 0.19848 | R | 0.173894 | 0.024586 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 142 | C | 0.268035 | R | 0.451248 | -0.183213 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 143 | A | 0.268541 | T | 0.307164 | -0.038623 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 148 | S | 0.192763 | N | 0.167661 | 0.025102 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 148 | S | 0.192763 | R | 0.149414 | 0.043349 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 162 | W | 0.090168 | C | 0.108006 | -0.017838 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 163 | G | 0.08662 | V | 0.047964 | 0.038656 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 170 | D | 0.09059 | V | 0.040391 | 0.050199 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 172 | C | 0.090389 | R | 0.173258 | -0.082869 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 183 | G | 0.441897 | D | 0.493012 | -0.051115 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 187 | M | 0.35111 | V | 0.285774 | 0.065336 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 202 | C | 0.061979 | Y | 0.08603 | -0.024051 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 216 | Y | 0.278805 | D | 0.425933 | -0.147128 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 223 | C | 0.104714 | G | 0.214033 | -0.109319 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 224 | N | 0.079267 | S | 0.08869 | -0.009423 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 226 | W | 0.102795 | R | 0.248986 | -0.146191 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 230 | A | 0.202996 | T | 0.226011 | -0.023015 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 235 | S | 0.381307 | C | 0.159019 | 0.222288 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 236 | W | 0.39797 | C | 0.431602 | -0.033632 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 236 | W | 0.39797 | L | 0.492164 | -0.094194 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 242 | I | 0.242534 | N | 0.402258 | -0.159724 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 244 | D | 0.168617 | H | 0.143458 | 0.025159 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 258 | G | 0.294582 | R | 0.273032 | 0.02155 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 259 | P | 0.33251 | L | 0.178394 | 0.154116 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 259 | P | 0.33251 | R | 0.289835 | 0.042675 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 260 | G | 0.355985 | A | 0.291062 | 0.064923 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 261 | G | 0.350698 | D | 0.381657 | -0.030959 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 263 | N | 0.350432 | S | 0.392221 | -0.041789 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 265 | P | 0.280443 | R | 0.236337 | 0.044106 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 266 | D | 0.241981 | N | 0.232203 | 0.009778 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 267 | M | 0.185571 | I | 0.13821 | 0.047361 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 279 | Q | 0.174303 | H | 0.148958 | 0.025345 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 280 | Q | 0.163686 | H | 0.140238 | 0.023448 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 287 | W | 0.065237 | C | 0.080323 | -0.015086 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 287 | W | 0.065237 | G | 0.159256 | -0.094019 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 289 | I | 0.060626 | F | 0.064245 | -0.003619 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 296 | M | 0.23998 | I | 0.175099 | 0.064881 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 298 | N | 0.329147 | H | 0.324132 | 0.005015 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 298 | N | 0.329147 | S | 0.392576 | -0.063429 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 320 | N | 0.302185 | K | 0.362282 | -0.060097 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 320 | N | 0.302185 | Y | 0.184402 | 0.117783 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 321 | Q | 0.331431 | E | 0.35274 | -0.021309 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 340 | W | 0.232915 | R | 0.447359 | -0.214444 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 341 | E | 0.206063 | K | 0.194365 | 0.011698 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 363 | R | 0.341215 | H | 0.338906 | 0.002309 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 373 | G | 0.217728 | D | 0.228332 | -0.010604 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 373 | G | 0.217728 | S | 0.264132 | -0.046404 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 377 | A | 0.137672 | D | 0.177403 | -0.039731 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 378 | C | 0.102271 | Y | 0.119091 | -0.01682 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 409 | P | 0.362659 | A | 0.279138 | 0.083521 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 409 | P | 0.362659 | T | 0.334555 | 0.028104 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 65 | S | 0.409006 | T | 0.305805 | 0.103201 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 266 | D | 0.241981 | H | 0.203106 | 0.038875 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 272 | N | 0.094821 | S | 0.113621 | -0.0188 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 410 | T | 0.332459 | A | 0.285173 | 0.047286 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 42 | M | 0.159042 | L | 0.130509 | 0.028533 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 43 | G | 0.134319 | R | 0.137478 | -0.003159 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 46 | H | 0.089397 | P | 0.127706 | -0.038309 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 93 | D | 0.098744 | N | 0.075884 | 0.02286 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 112 | R | 0.452859 | S | 0.501862 | -0.049003 | O to D | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 120 | L | 0.261294 | V | 0.271953 | -0.010659 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 135 | A | 0.165296 | V | 0.12432 | 0.040976 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 171 | G | 0.08792 | D | 0.106855 | -0.018935 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 201 | S | 0.07599 | F | 0.025398 | 0.050592 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 219 | I | 0.237733 | T | 0.395037 | -0.157304 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 234 | D | 0.343815 | E | 0.348604 | -0.004789 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 264 | D | 0.323918 | Y | 0.172991 | 0.150927 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 276 | S | 0.149283 | G | 0.132655 | 0.016628 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 285 | A | 0.081396 | P | 0.110219 | -0.028823 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 300 | L | 0.367487 | F | 0.337963 | 0.029524 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 328 | G | 0.486655 | V | 0.337183 | 0.149472 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 338 | E | 0.25993 | K | 0.246049 | 0.013881 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 356 | R | 0.265282 | Q | 0.284724 | -0.019442 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 358 | E | 0.402588 | A | 0.301579 | 0.101009 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 360 | G | 0.427633 | C | 0.226605 | 0.201028 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P06280 | AGAL_HUMAN Alpha-galactosidase A OS=Homo sapiens GN=GLA PE=1 SV=1 | 414 | L | 0.250888 | S | 0.421058 | -0.17017 | No Change: Both O | Fabry disease (FD) [MIM:301500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 49 | R | 0.287502 | C | 0.161752 | 0.12575 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 51 | I | 0.308384 | T | 0.426984 | -0.1186 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 123 | G | 0.062136 | R | 0.062368 | -2.32E-04 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 201 | R | 0.102109 | C | 0.04721 | 0.054899 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 201 | R | 0.102109 | C | 0.04721 | 0.054899 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 273 | W | 0.121956 | L | 0.168704 | -0.046748 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 316 | Y | 0.160212 | C | 0.127357 | 0.032855 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 457 | R | 0.216706 | Q | 0.242134 | -0.025428 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 482 | R | 0.185146 | H | 0.188587 | -0.003441 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 482 | R | 0.185146 | H | 0.188587 | -0.003441 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 509 | W | 0.093349 | C | 0.112132 | -0.018783 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 10 | P | 0.043405 | L | 0.020178 | 0.023227 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 59 | R | 0.205505 | H | 0.206367 | -8.62E-04 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 82 | T | 0.078942 | M | 0.066102 | 0.01284 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 83 | Y | 0.074444 | H | 0.133849 | -0.059405 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 121 | R | 0.061631 | S | 0.082166 | -0.020535 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 208 | R | 0.262051 | C | 0.124339 | 0.137712 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 240 | V | 0.218657 | M | 0.273324 | -0.054667 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 482 | R | 0.185146 | C | 0.091475 | 0.093671 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 491 | D | 0.164183 | N | 0.168311 | -0.004128 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 521 | R | 0.379666 | C | 0.221522 | 0.158144 | No Change: Both O | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 532 | S | 0.663743 | G | 0.64949 | 0.014253 | No Change: Both D | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 578 | K | 0.103459 | R | 0.078217 | 0.025242 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 590 | R | 0.121174 | H | 0.11435 | 0.006824 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 591 | Y | 0.144825 | C | 0.117821 | 0.027004 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 591 | Y | 0.144825 | N | 0.26471 | -0.119885 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 632 | E | 0.334515 | G | 0.279931 | 0.054584 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 148 | R | 0.455407 | S | 0.555959 | -0.100552 | O to D | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 201 | R | 0.102109 | H | 0.10069 | 0.001419 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 214 | D | 0.263875 | Y | 0.132415 | 0.13146 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 216 | V | 0.230286 | A | 0.296141 | -0.065855 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 263 | P | 0.414452 | S | 0.442267 | -0.027815 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 266 | N | 0.239994 | S | 0.29156 | -0.051566 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 270 | Y | 0.1103 | D | 0.219546 | -0.109246 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 281 | H | 0.423224 | Y | 0.278311 | 0.144913 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 281 | H | 0.423224 | Y | 0.278311 | 0.144913 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 332 | D | 0.530875 | N | 0.494003 | 0.036872 | D to O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 408 | Q | 0.112198 | P | 0.124445 | -0.012247 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 438 | G | 0.426224 | E | 0.482 | -0.055776 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 438 | G | 0.426224 | E | 0.482 | -0.055776 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 484 | N | 0.160514 | K | 0.177568 | -0.017054 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 494 | G | 0.187706 | C | 0.086087 | 0.101619 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 500 | T | 0.269575 | A | 0.234174 | 0.035401 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 579 | G | 0.103263 | D | 0.106714 | -0.003451 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 579 | G | 0.103263 | D | 0.106714 | -0.003451 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 59 | R | 0.205505 | C | 0.095126 | 0.110379 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 68 | R | 0.169781 | W | 0.070295 | 0.099486 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 151 | D | 0.441184 | Y | 0.283879 | 0.157305 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 239 | T | 0.188 | M | 0.143504 | 0.044496 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 436 | L | 0.5831 | F | 0.536234 | 0.046866 | No Change: Both D | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 134 | G | 0.116868 | V | 0.059037 | 0.057831 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 155 | L | 0.262045 | R | 0.379095 | -0.11705 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 155 | L | 0.262045 | R | 0.379095 | -0.11705 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 162 | L | 0.089117 | S | 0.176857 | -0.08774 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 434 | S | 0.635299 | L | 0.433693 | 0.201606 | D to O | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 491 | D | 0.164183 | Y | 0.091006 | 0.073177 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 549 | P | 0.250059 | L | 0.143529 | 0.10653 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 554 | G | 0.176077 | E | 0.205925 | -0.029848 | No Change: Both O | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 590 | R | 0.121174 | C | 0.054086 | 0.067088 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 595 | R | 0.193984 | W | 0.081454 | 0.11253 | No Change: Both O | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 272 | G | 0.101554 | D | 0.115151 | -0.013597 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 109 | R | 0.120379 | W | 0.047596 | 0.072783 | No Change: Both O | - |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 49 | R | 0.287502 | H | 0.294796 | -0.007294 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 68 | R | 0.169781 | Q | 0.173643 | -0.003862 | No Change: Both O | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 73 | K | 0.242575 | E | 0.226578 | 0.015997 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 83 | Y | 0.074444 | C | 0.058898 | 0.015546 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 132 | M | 0.110306 | T | 0.131506 | -0.0212 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 136 | P | 0.144002 | S | 0.165566 | -0.021564 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 148 | R | 0.455407 | C | 0.279222 | 0.176185 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 149 | S | 0.441904 | F | 0.21487 | 0.227034 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 151 | D | 0.441184 | V | 0.271409 | 0.169775 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 173 | L | 0.285273 | P | 0.469695 | -0.184422 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 184 | Q | 0.277037 | R | 0.255448 | 0.021589 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 190 | G | 0.185749 | D | 0.217754 | -0.032005 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 198 | D | 0.054913 | Y | 0.026335 | 0.028578 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 199 | Y | 0.059639 | C | 0.049766 | 0.009873 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 255 | Q | 0.352518 | H | 0.338646 | 0.013872 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 264 | L | 0.337226 | S | 0.538714 | -0.201488 | O to D | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 318 | N | 0.245619 | H | 0.210862 | 0.034757 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 329 | T | 0.56326 | I | 0.408584 | 0.154676 | D to O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 332 | D | 0.530875 | E | 0.549926 | -0.019051 | No Change: Both D | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 333 | Y | 0.554935 | H | 0.66433 | -0.109395 | No Change: Both D | GM1-gangliosidosis type 2 (GM1G2) [MIM:230600] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 346 | K | 0.267707 | N | 0.239727 | 0.02798 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 347 | Y | 0.233658 | C | 0.223433 | 0.010225 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 397 | P | 0.260061 | A | 0.183327 | 0.076734 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 420 | T | 0.142178 | K | 0.181448 | -0.03927 | No Change: Both O | GM1-gangliosidosis type 3 (GM1G3) [MIM:230650] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 420 | T | 0.142178 | P | 0.180203 | -0.038025 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 422 | L | 0.238666 | R | 0.340026 | -0.10136 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 441 | D | 0.269424 | N | 0.261776 | 0.007648 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 442 | R | 0.240818 | Q | 0.257731 | -0.016913 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 444 | Y | 0.188898 | C | 0.170443 | 0.018455 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 494 | G | 0.187706 | S | 0.23963 | -0.051924 | No Change: Both O | Mucopolysaccharidosis type 4B (MPS4B) [MIM:253010] |
| P16278 | BGAL_HUMAN Beta-galactosidase OS=Homo sapiens GN=GLB1 PE=1 SV=2 | 597 | P | 0.185597 | S | 0.192338 | -0.006741 | No Change: Both O | GM1-gangliosidosis type 1 (GM1G1) [MIM:230500] |
| Q8NCI6 | GLBL3_HUMAN Beta-galactosidase-1-like protein 3 OS=Homo sapiens GN=GLB1L3 PE=2 SV=3 | 163 | R | 0.081363 | P | 0.096181 | -0.014818 | No Change: Both O | - |
| Q8NCI6 | GLBL3_HUMAN Beta-galactosidase-1-like protein 3 OS=Homo sapiens GN=GLB1L3 PE=2 SV=3 | 474 | V | 0.239075 | M | 0.283992 | -0.044917 | No Change: Both O | - |
| O94923 | GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens GN=GLCE PE=1 SV=3 | 65 | M | 0.848581 | V | 0.826866 | 0.021715 | No Change: Both D | - |
| O94923 | GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens GN=GLCE PE=1 SV=3 | 597 | V | 0.298017 | I | 0.27115 | 0.026867 | No Change: Both O | - |
| P23378 | GCSP_HUMAN Glycine dehydrogenase [decarboxylating] mitochondrial OS=Homo sapiens GN=GLDC PE=1 SV=2 | 564 | S | 0.56766 | I | 0.323914 | 0.243746 | D to O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P23378 | GCSP_HUMAN Glycine dehydrogenase [decarboxylating] mitochondrial OS=Homo sapiens GN=GLDC PE=1 SV=2 | 283 | A | 0.439765 | P | 0.50969 | -0.069925 | O to D | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| P23378 | GCSP_HUMAN Glycine dehydrogenase [decarboxylating] mitochondrial OS=Homo sapiens GN=GLDC PE=1 SV=2 | 329 | P | 0.248486 | T | 0.190539 | 0.057947 | No Change: Both O | - |
| P23378 | GCSP_HUMAN Glycine dehydrogenase [decarboxylating] mitochondrial OS=Homo sapiens GN=GLDC PE=1 SV=2 | 515 | R | 0.394661 | S | 0.483171 | -0.08851 | No Change: Both O | Non-ketotic hyperglycinemia (NKH) [MIM:605899] |
| Q6ZMI3 | GLDN_HUMAN Gliomedin OS=Homo sapiens GN=GLDN PE=2 SV=1 | 141 | S | 0.840175 | N | 0.818985 | 0.02119 | No Change: Both D | - |
| Q6ZMI3 | GLDN_HUMAN Gliomedin OS=Homo sapiens GN=GLDN PE=2 SV=1 | 265 | S | 0.934316 | N | 0.927884 | 0.006432 | No Change: Both D | - |
| Q6ZMI3 | GLDN_HUMAN Gliomedin OS=Homo sapiens GN=GLDN PE=2 SV=1 | 351 | D | 0.495148 | N | 0.490562 | 0.004586 | No Change: Both O | - |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 130 | G | 0.523185 | D | 0.513724 | 0.009461 | No Change: Both D | - |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 243 | I | 0.881511 | V | 0.894746 | -0.013235 | No Change: Both D | - |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 590 | R | 0.43853 | Q | 0.466309 | -0.027779 | No Change: Both O | - |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 569 | R | 0.280231 | H | 0.267635 | 0.012596 | No Change: Both O | Lethal congenital contracture syndrome type 1 (LCCS1) [MIM:253310] |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 617 | V | 0.200688 | M | 0.26621 | -0.065522 | No Change: Both O | Lethal arthrogryposis with anterior horn cell disease (LAAHD) [MIM:611890] |
| Q53GS7 | GLE1_HUMAN Nucleoporin GLE1 OS=Homo sapiens GN=GLE1 PE=1 SV=2 | 684 | I | 0.325319 | T | 0.471768 | -0.146449 | No Change: Both O | Lethal arthrogryposis with anterior horn cell disease (LAAHD) [MIM:611890] |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 884 | D | 0.736442 | A | 0.684894 | 0.051548 | No Change: Both D | - |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 933 | G | 0.873838 | D | 0.86675 | 0.007088 | No Change: Both D | - |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 1100 | E | 0.843879 | Q | 0.815612 | 0.028267 | No Change: Both D | - |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 210 | P | 0.901017 | A | 0.829168 | 0.071849 | No Change: Both D | A breast cancer sample |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 514 | T | 0.74217 | I | 0.631126 | 0.111044 | No Change: Both D | A breast cancer sample |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 817 | E | 0.759564 | Q | 0.775643 | -0.016079 | No Change: Both D | A breast cancer sample |
| P08151 | GLI1_HUMAN Zinc finger protein GLI1 OS=Homo sapiens GN=GLI1 PE=1 SV=1 | 1012 | G | 0.834054 | V | 0.753481 | 0.080573 | No Change: Both D | - |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 479 | R | 0.343831 | G | 0.320547 | 0.023284 | No Change: Both O | Holoprosencephaly type 9 (HPE9) [MIM:610829] |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 932 | P | 0.950313 | S | 0.939347 | 0.010966 | No Change: Both D | Holoprosencephaly type 9 (HPE9) [MIM:610829] |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 1444 | M | 0.6778 | I | 0.550387 | 0.127413 | No Change: Both D | Holoprosencephaly type 9 (HPE9) [MIM:610829] |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 1554 | P | 0.82901 | L | 0.734818 | 0.094192 | No Change: Both D | Holoprosencephaly type 9 (HPE9) [MIM:610829] |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 449 | D | 0.479859 | H | 0.460452 | 0.019407 | No Change: Both O | - |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 579 | S | 0.714817 | I | 0.553145 | 0.161672 | No Change: Both D | - |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 625 | P | 0.927385 | S | 0.932516 | -0.005131 | No Change: Both D | - |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 1156 | A | 0.628209 | S | 0.728782 | -0.100573 | No Change: Both D | - |
| P10070 | GLI2_HUMAN Zinc finger protein GLI2 OS=Homo sapiens GN=GLI2 PE=1 SV=4 | 1306 | D | 0.879046 | N | 0.876456 | 0.00259 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 727 | G | 0.915109 | R | 0.905066 | 0.010043 | No Change: Both D | Polydactyly postaxial type A1 (PAPA1) [MIM:174200] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 727 | G | 0.915109 | R | 0.905066 | 0.010043 | No Change: Both D | Polydactyly postaxial type B polydactyly (PAPB) [MIM:174200] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 440 | D | 0.981839 | E | 0.983941 | -0.002102 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 515 | C | 0.147415 | G | 0.215288 | -0.067873 | No Change: Both O | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 520 | C | 0.209146 | Y | 0.197385 | 0.011761 | No Change: Both O | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 707 | P | 0.98502 | S | 0.986256 | -0.001236 | No Change: Both D | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 808 | I | 0.640718 | M | 0.754475 | -0.113757 | No Change: Both D | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 1537 | R | 0.900695 | C | 0.852777 | 0.047918 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 625 | R | 0.798423 | W | 0.630046 | 0.168377 | No Change: Both D | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 934 | A | 0.853457 | P | 0.897172 | -0.043715 | No Change: Both D | Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700] |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 183 | T | 0.931538 | A | 0.931804 | -2.66E-04 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 998 | P | 0.89873 | L | 0.820906 | 0.077824 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 1336 | G | 0.783037 | E | 0.774872 | 0.008165 | No Change: Both D | - |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 169 | P | 0.90301 | L | 0.826411 | 0.076599 | No Change: Both D | A colorectal cancer sample |
| P10071 | GLI3_HUMAN Transcriptional activator GLI3 OS=Homo sapiens GN=GLI3 PE=1 SV=6 | 1304 | S | 0.782844 | P | 0.789761 | -0.006917 | No Change: Both D | A colorectal cancer sample |
| P10075 | GLI4_HUMAN Zinc finger protein GLI4 OS=Homo sapiens GN=GLI4 PE=1 SV=2 | 180 | A | 0.748831 | T | 0.735807 | 0.013024 | No Change: Both D | - |
| P48060 | GLIP1_HUMAN Glioma pathogenesis-related protein 1 OS=Homo sapiens GN=GLIPR1 PE=1 SV=3 | 211 | R | 0.369068 | Q | 0.389196 | -0.020128 | No Change: Both O | - |
| P48060 | GLIP1_HUMAN Glioma pathogenesis-related protein 1 OS=Homo sapiens GN=GLIPR1 PE=1 SV=3 | 163 | D | 0.319204 | E | 0.346914 | -0.02771 | No Change: Both O | - |
| Q8NBF1 | GLIS1_HUMAN Zinc finger protein GLIS1 OS=Homo sapiens GN=GLIS1 PE=2 SV=2 | 157 | F | 0.901214 | L | 0.916086 | -0.014872 | No Change: Both D | - |
| Q8NBF1 | GLIS1_HUMAN Zinc finger protein GLIS1 OS=Homo sapiens GN=GLIS1 PE=2 SV=2 | 110 | T | 0.892654 | A | 0.875795 | 0.016859 | No Change: Both D | - |
| Q8NBF1 | GLIS1_HUMAN Zinc finger protein GLIS1 OS=Homo sapiens GN=GLIS1 PE=2 SV=2 | 187 | A | 0.420784 | G | 0.480229 | -0.059445 | No Change: Both O | - |
| Q9BZE0 | GLIS2_HUMAN Zinc finger protein GLIS2 OS=Homo sapiens GN=GLIS2 PE=1 SV=2 | 492 | T | 0.713545 | A | 0.710403 | 0.003142 | No Change: Both D | - |
| Q8NEA6 | GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens GN=GLIS3 PE=2 SV=5 | 301 | P | 0.994483 | Q | 0.991293 | 0.00319 | No Change: Both D | - |
| Q8NEA6 | GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens GN=GLIS3 PE=2 SV=5 | 269 | S | 0.732449 | P | 0.757985 | -0.025536 | No Change: Both D | - |
| Q8NEA6 | GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens GN=GLIS3 PE=2 SV=5 | 578 | P | 0.972874 | L | 0.941644 | 0.03123 | No Change: Both D | - |
| Q92990 | GLMN_HUMAN Glomulin OS=Homo sapiens GN=GLMN PE=1 SV=2 | 336 | L | 0.42834 | S | 0.616414 | -0.188074 | O to D | - |
| Q04760 | LGUL_HUMAN Lactoylglutathione lyase OS=Homo sapiens GN=GLO1 PE=1 SV=4 | 111 | E | 0.685927 | A | 0.623478 | 0.062449 | No Change: Both D | - |
| Q04760 | LGUL_HUMAN Lactoylglutathione lyase OS=Homo sapiens GN=GLO1 PE=1 SV=4 | 19 | C | 0.78808 | Y | 0.724119 | 0.063961 | No Change: Both D | - |
| Q9HC38 | GLOD4_HUMAN Glyoxalase domain-containing protein 4 OS=Homo sapiens GN=GLOD4 PE=1 SV=1 | 282 | M | 0.658727 | I | 0.584821 | 0.073906 | No Change: Both D | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 260 | L | 0.062804 | F | 0.054345 | 0.008459 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 7 | P | 0.590958 | L | 0.425658 | 0.1653 | D to O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 20 | R | 0.481681 | K | 0.489631 | -0.00795 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 44 | R | 0.448871 | H | 0.371205 | 0.077666 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 131 | R | 0.886702 | Q | 0.888173 | -0.001471 | No Change: Both D | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 168 | G | 0.082132 | S | 0.111299 | -0.029167 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 316 | A | 0.014654 | T | 0.016942 | -0.002288 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 333 | S | 0.073555 | C | 0.026768 | 0.046787 | No Change: Both O | - |
| P43220 | GLP1R_HUMAN Glucagon-like peptide 1 receptor OS=Homo sapiens GN=GLP1R PE=1 SV=2 | 421 | R | 0.270533 | Q | 0.275829 | -0.005296 | No Change: Both O | - |
| O95838 | GLP2R_HUMAN Glucagon-like peptide 2 receptor OS=Homo sapiens GN=GLP2R PE=1 SV=1 | 22 | H | 0.642846 | L | 0.609576 | 0.03327 | No Change: Both D | - |
| O95838 | GLP2R_HUMAN Glucagon-like peptide 2 receptor OS=Homo sapiens GN=GLP2R PE=1 SV=1 | 470 | D | 0.294306 | N | 0.279202 | 0.015104 | No Change: Both O | - |
| O95838 | GLP2R_HUMAN Glucagon-like peptide 2 receptor OS=Homo sapiens GN=GLP2R PE=1 SV=1 | 523 | R | 0.776371 | H | 0.749358 | 0.027013 | No Change: Both D | - |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 272 | I | 0.050765 | N | 0.113066 | -0.062301 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 294 | Q | 0.714023 | H | 0.703872 | 0.010151 | No Change: Both D | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 299 | R | 0.788829 | L | 0.695302 | 0.093527 | No Change: Both D | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 299 | R | 0.788829 | Q | 0.813345 | -0.024516 | No Change: Both D | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 304 | K | 0.477559 | E | 0.461225 | 0.016334 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 307 | Y | 0.186944 | C | 0.155687 | 0.031257 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 278 | P | 0.178622 | T | 0.150877 | 0.027745 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 280 | R | 0.192174 | H | 0.193565 | -0.001391 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P23415 | GLRA1_HUMAN Glycine receptor subunit alpha-1 OS=Homo sapiens GN=GLRA1 PE=1 SV=2 | 428 | R | 0.230922 | H | 0.218365 | 0.012557 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P48167 | GLRB_HUMAN Glycine receptor subunit beta OS=Homo sapiens GN=GLRB PE=1 SV=1 | 251 | G | 0.153785 | D | 0.161732 | -0.007947 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P35754 | GLRX1_HUMAN Glutaredoxin-1 OS=Homo sapiens GN=GLRX PE=1 SV=2 | 47 | D | 0.157217 | Y | 0.080346 | 0.076871 | No Change: Both O | - |
| Q9NS18 | GLRX2_HUMAN Glutaredoxin-2 mitochondrial OS=Homo sapiens GN=GLRX2 PE=1 SV=1 | 95 | K | 0.171429 | E | 0.184255 | -0.012826 | No Change: Both O | - |
| O76003 | GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=GLRX3 PE=1 SV=2 | 21 | Q | 0.406176 | H | 0.386524 | 0.019652 | No Change: Both O | - |
| O76003 | GLRX3_HUMAN Glutaredoxin-3 OS=Homo sapiens GN=GLRX3 PE=1 SV=2 | 123 | P | 0.696814 | S | 0.724593 | -0.027779 | No Change: Both D | - |
| Q86SX6 | GLRX5_HUMAN Glutaredoxin-related protein 5 mitochondrial OS=Homo sapiens GN=GLRX5 PE=1 SV=2 | 146 | A | 0.525685 | T | 0.566224 | -0.040539 | No Change: Both D | - |
| O94925 | GLSK_HUMAN Glutaminase kidney isoform mitochondrial OS=Homo sapiens GN=GLS PE=1 SV=1 | 254 | A | 0.195001 | P | 0.275866 | -0.080865 | No Change: Both O | - |
| Q9UI32 | GLSL_HUMAN Glutaminase liver isoform mitochondrial OS=Homo sapiens GN=GLS2 PE=1 SV=2 | 581 | L | 0.595354 | P | 0.72394 | -0.128586 | No Change: Both D | - |
| Q8IYK4 | GT252_HUMAN Procollagen galactosyltransferase 2 OS=Homo sapiens GN=GLT25D2 PE=1 SV=1 | 475 | V | 0.608706 | I | 0.582896 | 0.02581 | No Change: Both D | A breast cancer sample |
| Q7Z4J2 | GL6D1_HUMAN Glycosyltransferase 6 domain-containing protein 1 OS=Homo sapiens GN=GLT6D1 PE=2 SV=1 | 195 | H | 0.029138 | R | 0.03182 | -0.002682 | No Change: Both O | - |
| Q7Z4J2 | GL6D1_HUMAN Glycosyltransferase 6 domain-containing protein 1 OS=Homo sapiens GN=GLT6D1 PE=2 SV=1 | 219 | P | 0.16659 | S | 0.189314 | -0.022724 | No Change: Both O | - |
| Q7Z4J2 | GL6D1_HUMAN Glycosyltransferase 6 domain-containing protein 1 OS=Homo sapiens GN=GLT6D1 PE=2 SV=1 | 282 | A | 0.250315 | E | 0.33169 | -0.081375 | No Change: Both O | - |
| Q68CQ7 | GL8D1_HUMAN Glycosyltransferase 8 domain-containing protein 1 OS=Homo sapiens GN=GLT8D1 PE=1 SV=2 | 210 | R | 0.251866 | H | 0.25542 | -0.003554 | No Change: Both O | - |
| Q9H1C3 | GL8D2_HUMAN Glycosyltransferase 8 domain-containing protein 2 OS=Homo sapiens GN=GLT8D2 PE=2 SV=1 | 37 | A | 0.838901 | T | 0.858771 | -0.01987 | No Change: Both D | - |
| Q9NZM4 | GSCR1_HUMAN Glioma tumor suppressor candidate region gene 1 protein OS=Homo sapiens GN=GLTSCR1 PE=1 SV=2 | 1044 | T | 0.903059 | A | 0.913687 | -0.010628 | No Change: Both D | - |
| Q9NZM4 | GSCR1_HUMAN Glioma tumor suppressor candidate region gene 1 protein OS=Homo sapiens GN=GLTSCR1 PE=1 SV=2 | 683 | P | 0.937269 | S | 0.933543 | 0.003726 | No Change: Both D | - |
| Q9NZM5 | GSCR2_HUMAN Glioma tumor suppressor candidate region gene 2 protein OS=Homo sapiens GN=GLTSCR2 PE=1 SV=2 | 389 | Q | 0.952759 | R | 0.958102 | -0.005343 | No Change: Both D | - |
| Q9NZM5 | GSCR2_HUMAN Glioma tumor suppressor candidate region gene 2 protein OS=Homo sapiens GN=GLTSCR2 PE=1 SV=2 | 16 | S | 0.966041 | R | 0.96217 | 0.003871 | No Change: Both D | - |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 498 | S | 0.439161 | L | 0.27658 | 0.162581 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 499 | G | 0.472281 | D | 0.507722 | -0.035441 | O to D | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 499 | G | 0.472281 | S | 0.530928 | -0.058647 | O to D | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 501 | S | 0.518403 | P | 0.48496 | 0.033443 | D to O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 507 | H | 0.342078 | Y | 0.25322 | 0.088858 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 318 | R | 0.204487 | K | 0.250231 | -0.045744 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 349 | E | 0.554993 | A | 0.428584 | 0.126409 | D to O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 270 | S | 0.450547 | C | 0.217952 | 0.232595 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 274 | R | 0.325464 | C | 0.17505 | 0.150414 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 318 | R | 0.204487 | T | 0.181754 | 0.022733 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 319 | Y | 0.186961 | C | 0.156054 | 0.030907 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 322 | R | 0.128434 | C | 0.062687 | 0.065747 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P00367 | DHE3_HUMAN Glutamate dehydrogenase 1 mitochondrial OS=Homo sapiens GN=GLUD1 PE=1 SV=2 | 322 | R | 0.128434 | H | 0.131979 | -0.003545 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 6 (HHF6) [MIM:606762] |
| P49448 | DHE4_HUMAN Glutamate dehydrogenase 2 mitochondrial OS=Homo sapiens GN=GLUD2 PE=1 SV=2 | 498 | S | 0.522809 | A | 0.433008 | 0.089801 | D to O | - |
| P15104 | GLNA_HUMAN Glutamine synthetase OS=Homo sapiens GN=GLUL PE=1 SV=4 | 324 | R | 0.467595 | C | 0.312017 | 0.155578 | No Change: Both O | Congenital systemic glutamine deficiency (CSGD) [MIM:610015] |
| P15104 | GLNA_HUMAN Glutamine synthetase OS=Homo sapiens GN=GLUL PE=1 SV=4 | 341 | R | 0.517766 | C | 0.381441 | 0.136325 | D to O | Congenital systemic glutamine deficiency (CSGD) [MIM:610015] |
| Q6IB77 | GLYAT_HUMAN Glycine N-acyltransferase OS=Homo sapiens GN=GLYAT PE=1 SV=3 | 17 | S | 0.611407 | T | 0.513602 | 0.097805 | No Change: Both D | - |
| Q6IB77 | GLYAT_HUMAN Glycine N-acyltransferase OS=Homo sapiens GN=GLYAT PE=1 SV=3 | 156 | N | 0.663205 | S | 0.709585 | -0.04638 | No Change: Both D | - |
| Q8WU03 | GLYL2_HUMAN Glycine N-acyltransferase-like protein 2 OS=Homo sapiens GN=GLYATL2 PE=2 SV=1 | 82 | P | 0.384486 | S | 0.417537 | -0.033051 | No Change: Both O | - |
| Q8WU03 | GLYL2_HUMAN Glycine N-acyltransferase-like protein 2 OS=Homo sapiens GN=GLYATL2 PE=2 SV=1 | 160 | E | 0.661911 | K | 0.664223 | -0.002312 | No Change: Both D | - |
| Q8WU03 | GLYL2_HUMAN Glycine N-acyltransferase-like protein 2 OS=Homo sapiens GN=GLYATL2 PE=2 SV=1 | 168 | L | 0.393248 | I | 0.34409 | 0.049158 | No Change: Both O | - |
| Q8IVS8 | GLCTK_HUMAN Glycerate kinase OS=Homo sapiens GN=GLYCTK PE=1 SV=1 | 170 | L | 0.27917 | V | 0.235804 | 0.043366 | No Change: Both O | - |
| Q8IVS8 | GLCTK_HUMAN Glycerate kinase OS=Homo sapiens GN=GLYCTK PE=1 SV=1 | 394 | T | 0.438835 | I | 0.319568 | 0.119267 | No Change: Both O | - |
| Q8IVS8 | GLCTK_HUMAN Glycerate kinase OS=Homo sapiens GN=GLYCTK PE=1 SV=1 | 27 | R | 0.500497 | C | 0.33068 | 0.169817 | D to O | - |
| Q8IVS8 | GLCTK_HUMAN Glycerate kinase OS=Homo sapiens GN=GLYCTK PE=1 SV=1 | 493 | F | 0.106072 | C | 0.108349 | -0.002277 | No Change: Both O | D-glyceric aciduria (D-GA) [MIM:220120] |
| Q49A26 | GLYR1_HUMAN Putative oxidoreductase GLYR1 OS=Homo sapiens GN=GLYR1 PE=1 SV=3 | 103 | N | 0.961253 | D | 0.965253 | -0.004 | No Change: Both D | - |
| Q49A26 | GLYR1_HUMAN Putative oxidoreductase GLYR1 OS=Homo sapiens GN=GLYR1 PE=1 SV=3 | 459 | H | 0.320452 | Q | 0.373017 | -0.052565 | No Change: Both O | - |
| Q49A26 | GLYR1_HUMAN Putative oxidoreductase GLYR1 OS=Homo sapiens GN=GLYR1 PE=1 SV=3 | 531 | Y | 0.430445 | C | 0.390641 | 0.039804 | No Change: Both O | - |
| P17900 | SAP3_HUMAN Ganglioside GM2 activator OS=Homo sapiens GN=GM2A PE=1 SV=4 | 138 | C | 0.310704 | R | 0.418434 | -0.10773 | No Change: Both O | GM2-gangliosidosis type AB (GM2GAB) [MIM:272750] |
| P17900 | SAP3_HUMAN Ganglioside GM2 activator OS=Homo sapiens GN=GM2A PE=1 SV=4 | 169 | R | 0.330783 | P | 0.369604 | -0.038821 | No Change: Both O | GM2-gangliosidosis type AB (GM2GAB) [MIM:272750] |
| P17900 | SAP3_HUMAN Ganglioside GM2 activator OS=Homo sapiens GN=GM2A PE=1 SV=4 | 19 | A | 0.387385 | T | 0.353743 | 0.033642 | No Change: Both O | - |
| P17900 | SAP3_HUMAN Ganglioside GM2 activator OS=Homo sapiens GN=GM2A PE=1 SV=4 | 59 | I | 0.390371 | V | 0.435881 | -0.04551 | No Change: Both O | - |
| P17900 | SAP3_HUMAN Ganglioside GM2 activator OS=Homo sapiens GN=GM2A PE=1 SV=4 | 69 | M | 0.474412 | V | 0.443273 | 0.031139 | No Change: Both O | - |
| Q8NEA9 | GMCLL_HUMAN Putative germ cell-less protein-like 1-like OS=Homo sapiens GN=GMCL1P1 PE=1 SV=1 | 275 | V | 0.134002 | A | 0.171054 | -0.037052 | No Change: Both O | A colorectal cancer sample |
| Q9Y692 | GMEB1_HUMAN Glucocorticoid modulatory element-binding protein 1 OS=Homo sapiens GN=GMEB1 PE=1 SV=2 | 14 | V | 0.545677 | A | 0.580944 | -0.035267 | No Change: Both D | - |
| O60234 | GMFG_HUMAN Glia maturation factor gamma OS=Homo sapiens GN=GMFG PE=1 SV=1 | 122 | E | 0.259139 | K | 0.25923 | -9.10E-05 | No Change: Both O | - |
| O60234 | GMFG_HUMAN Glia maturation factor gamma OS=Homo sapiens GN=GMFG PE=1 SV=1 | 136 | E | 0.318191 | K | 0.315122 | 0.003069 | No Change: Both O | - |
| Q9P107 | GMIP_HUMAN GEM-interacting protein OS=Homo sapiens GN=GMIP PE=1 SV=2 | 641 | D | 0.187965 | N | 0.151698 | 0.036267 | No Change: Both O | - |
| Q99445 | GML_HUMAN Glycosyl-phosphatidylinositol-anchored molecule-like protein OS=Homo sapiens GN=GML PE=2 SV=1 | 54 | R | 0.082768 | C | 0.039743 | 0.043025 | No Change: Both O | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 18 | N | 0.943041 | T | 0.934246 | 0.008795 | No Change: Both D | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 15 | N | 0.957742 | H | 0.942551 | 0.015191 | No Change: Both D | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 48 | L | 0.87394 | F | 0.834607 | 0.039333 | No Change: Both D | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 54 | R | 0.865634 | W | 0.717699 | 0.147935 | No Change: Both D | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 60 | S | 0.839602 | P | 0.827284 | 0.012318 | No Change: Both D | - |
| O75496 | GEMI_HUMAN Geminin OS=Homo sapiens GN=GMNN PE=1 SV=1 | 203 | T | 0.873356 | M | 0.838613 | 0.034743 | No Change: Both D | - |
| Q96IJ6 | GMPPA_HUMAN Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens GN=GMPPA PE=1 SV=1 | 21 | S | 0.350031 | F | 0.205092 | 0.144939 | No Change: Both O | - |
| Q96IJ6 | GMPPA_HUMAN Mannose-1-phosphate guanyltransferase alpha OS=Homo sapiens GN=GMPPA PE=1 SV=1 | 156 | V | 0.230796 | A | 0.298617 | -0.067821 | No Change: Both O | - |
| Q9Y5P6 | GMPPB_HUMAN Mannose-1-phosphate guanyltransferase beta OS=Homo sapiens GN=GMPPB PE=1 SV=2 | 126 | H | 0.4619 | D | 0.473909 | -0.012009 | No Change: Both O | - |
| Q9Y5P6 | GMPPB_HUMAN Mannose-1-phosphate guanyltransferase beta OS=Homo sapiens GN=GMPPB PE=1 SV=2 | 184 | Q | 0.190612 | R | 0.172814 | 0.017798 | No Change: Both O | - |
| P36959 | GMPR1_HUMAN GMP reductase 1 OS=Homo sapiens GN=GMPR PE=1 SV=1 | 234 | A | 0.264009 | T | 0.267649 | -0.00364 | No Change: Both O | - |
| P36959 | GMPR1_HUMAN GMP reductase 1 OS=Homo sapiens GN=GMPR PE=1 SV=1 | 256 | F | 0.382372 | I | 0.367216 | 0.015156 | No Change: Both O | - |
| Q9P2T1 | GMPR2_HUMAN GMP reductase 2 OS=Homo sapiens GN=GMPR2 PE=1 SV=1 | 242 | G | 0.340067 | D | 0.35304 | -0.012973 | No Change: Both O | - |
| Q03113 | GNA12_HUMAN Guanine nucleotide-binding protein subunit alpha-12 OS=Homo sapiens GN=GNA12 PE=1 SV=4 | 242 | F | 0.099993 | L | 0.102902 | -0.002909 | No Change: Both O | - |
| Q03113 | GNA12_HUMAN Guanine nucleotide-binding protein subunit alpha-12 OS=Homo sapiens GN=GNA12 PE=1 SV=4 | 330 | Y | 0.24929 | H | 0.411856 | -0.162566 | No Change: Both O | - |
| Q14344 | GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-13 OS=Homo sapiens GN=GNA13 PE=1 SV=2 | 221 | V | 0.290546 | L | 0.27021 | 0.020336 | No Change: Both O | - |
| P30679 | GNA15_HUMAN Guanine nucleotide-binding protein subunit alpha-15 OS=Homo sapiens GN=GNA15 PE=2 SV=2 | 147 | Y | 0.263394 | C | 0.206673 | 0.056721 | No Change: Both O | - |
| P50148 | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit alpha OS=Homo sapiens GN=GNAQ PE=1 SV=4 | 355 | E | 0.531233 | D | 0.504555 | 0.026678 | No Change: Both D | - |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 99 | L | 0.556458 | P | 0.682118 | -0.12566 | No Change: Both D | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 165 | R | 0.294808 | C | 0.165788 | 0.12902 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | H | 0.106775 | 0.007068 | No Change: Both O | ACTH-independent macronodular adrenal hyperplasia (AIMAH) [MIM:219080] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | H | 0.106775 | 0.007068 | No Change: Both O | McCune-Albright syndrome (MAS) [MIM:174800] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | C | 0.057518 | 0.056325 | No Change: Both O | McCune-Albright syndrome (MAS) [MIM:174800] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 227 | Q | 0.516454 | R | 0.518736 | -0.002282 | No Change: Both D | - |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 385 | R | 0.162052 | H | 0.156842 | 0.00521 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 258 | R | 0.463897 | W | 0.242906 | 0.220991 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 115 | P | 0.344131 | L | 0.212117 | 0.132014 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | G | 0.117962 | -0.004119 | No Change: Both O | McCune-Albright syndrome (MAS) [MIM:174800] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | L | 0.069489 | 0.044354 | No Change: Both O | Non-MAS endocrine tumors |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.113843 | S | 0.14821 | -0.034367 | No Change: Both O | ACTH-independent macronodular adrenal hyperplasia (AIMAH) [MIM:219080] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 227 | Q | 0.516454 | H | 0.50641 | 0.010044 | No Change: Both D | - |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 231 | R | 0.368308 | H | 0.353489 | 0.014819 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 250 | S | 0.14439 | R | 0.104801 | 0.039589 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 366 | A | 0.139664 | S | 0.210798 | -0.071134 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 106 | I | 0.304073 | S | 0.487319 | -0.183246 | No Change: Both O | - |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 156 | D | 0.306036 | N | 0.290538 | 0.015498 | No Change: Both O | Pseudohypoparathyroidism type 1A (PHP1A) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 159 | V | 0.237483 | M | 0.294835 | -0.057352 | No Change: Both O | Pseudohypoparathyroidism type 1A (PHP1A) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 242 | T | 0.031104 | I | 0.018378 | 0.012726 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 246 | F | 0.065083 | S | 0.179628 | -0.114545 | No Change: Both O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 259 | E | 0.516898 | V | 0.3212 | 0.195698 | D to O | Albright hereditary osteodystrophy (AHO) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 280 | R | 0.073727 | G | 0.068577 | 0.00515 | No Change: Both O | Pseudohypoparathyroidism type 1A (PHP1A) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 280 | R | 0.073727 | K | 0.094708 | -0.020981 | No Change: Both O | Pseudohypoparathyroidism type 1A (PHP1A) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 281 | W | 0.062208 | R | 0.156459 | -0.094251 | No Change: Both O | Progressive osseous heteroplasia (POH) [MIM:166350] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 338 | K | 0.38085 | N | 0.341456 | 0.039394 | No Change: Both O | Pseudohypoparathyroidism type 1A (PHP1A) [MIM:103580] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 380 | R | 0.158874 | L | 0.083744 | 0.07513 | No Change: Both O | - |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 388 | L | 0.282184 | R | 0.409006 | -0.126822 | No Change: Both O | Pseudohypoparathyroidism type 1C (PHP1C) [MIM:612462] |
| P63092 | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms short OS=Homo sapiens GN=GNAS PE=1 SV=1 | 392 | E | 0.762056 | K | 0.756275 | 0.005781 | No Change: Both D | Pseudohypoparathyroidism type 1C (PHP1C) [MIM:612462] |
| P84996 | ALEX_HUMAN Protein ALEX OS=Homo sapiens GN=GNAS PE=1 SV=1 | 374 | P | 0.999315 | T | 0.999002 | 3.13E-04 | No Change: Both D | GNAS hyperfunction (GNASHYP) [MIM:139320] |
| P84996 | ALEX_HUMAN Protein ALEX OS=Homo sapiens GN=GNAS PE=1 SV=1 | 397 | L | 0.99932 | V | 0.999001 | 3.19E-04 | No Change: Both D | GNAS hyperfunction (GNASHYP) [MIM:139320] |
| P84996 | ALEX_HUMAN Protein ALEX OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.988146 | C | 0.977722 | 0.010424 | No Change: Both D | A colorectal cancer sample |
| P84996 | ALEX_HUMAN Protein ALEX OS=Homo sapiens GN=GNAS PE=1 SV=1 | 201 | R | 0.988146 | H | 0.984518 | 0.003628 | No Change: Both D | A colorectal cancer sample |
| Q5JWF2 | GNAS1_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens GN=GNAS PE=1 SV=2 | 436 | A | 0.999411 | D | 0.999511 | -1.00E-04 | No Change: Both D | GNAS hyperfunction (GNASHYP) [MIM:139320] |
| Q5JWF2 | GNAS1_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens GN=GNAS PE=1 SV=2 | 459 | P | 0.999257 | R | 0.998929 | 3.28E-04 | No Change: Both D | GNAS hyperfunction (GNASHYP) [MIM:139320] |
| Q5JWF2 | GNAS1_HUMAN Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas OS=Homo sapiens GN=GNAS PE=1 SV=2 | 1023 | R | 0.158874 | L | 0.083744 | 0.07513 | No Change: Both O | - |
| P11488 | GNAT1_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-1 OS=Homo sapiens GN=GNAT1 PE=1 SV=5 | 38 | G | 0.509095 | D | 0.52427 | -0.015175 | No Change: Both D | Congenital stationary night blindness autosomal dominant type 3 (CSNBAD3) [MIM:610444] |
| P19087 | GNAT2_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-2 OS=Homo sapiens GN=GNAT2 PE=1 SV=4 | 183 | G | 0.331567 | D | 0.373255 | -0.041688 | No Change: Both O | - |
| P19087 | GNAT2_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-2 OS=Homo sapiens GN=GNAT2 PE=1 SV=4 | 107 | L | 0.470376 | I | 0.433069 | 0.037307 | No Change: Both O | - |
| P19087 | GNAT2_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-2 OS=Homo sapiens GN=GNAT2 PE=1 SV=4 | 124 | V | 0.243788 | M | 0.301718 | -0.05793 | No Change: Both O | - |
| Q9BYB4 | GNB1L_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Homo sapiens GN=GNB1L PE=1 SV=2 | 239 | W | 0.12382 | G | 0.266168 | -0.142348 | No Change: Both O | - |
| Q9BYB4 | GNB1L_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Homo sapiens GN=GNB1L PE=1 SV=2 | 296 | A | 0.094764 | T | 0.098522 | -0.003758 | No Change: Both O | A breast cancer sample |
| Q9BYB4 | GNB1L_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Homo sapiens GN=GNB1L PE=1 SV=2 | 30 | E | 0.509157 | K | 0.50949 | -3.33E-04 | No Change: Both D | - |
| Q9BYB4 | GNB1L_HUMAN Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Homo sapiens GN=GNB1L PE=1 SV=2 | 37 | R | 0.453186 | H | 0.444813 | 0.008373 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 76 | D | 0.315995 | N | 0.292409 | 0.023586 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 272 | G | 0.121977 | S | 0.169963 | -0.047986 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 339 | W | 0.54505 | L | 0.652208 | -0.107158 | No Change: Both D | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 280 | L | 0.179428 | F | 0.16001 | 0.019418 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 324 | G | 0.255582 | E | 0.285177 | -0.029595 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 40 | V | 0.282226 | M | 0.33744 | -0.055214 | No Change: Both O | - |
| P16520 | GBB3_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 OS=Homo sapiens GN=GNB3 PE=1 SV=1 | 81 | V | 0.157642 | M | 0.199669 | -0.042027 | No Change: Both O | - |
| O14775 | GBB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 OS=Homo sapiens GN=GNB5 PE=1 SV=2 | 213 | A | 0.332554 | V | 0.251671 | 0.080883 | No Change: Both O | - |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 36 | P | 0.254195 | L | 0.14154 | 0.112655 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 200 | I | 0.115646 | F | 0.104591 | 0.011055 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 225 | D | 0.418303 | N | 0.40143 | 0.016873 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 246 | R | 0.12023 | Q | 0.126423 | -0.006193 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 246 | R | 0.12023 | W | 0.046587 | 0.073643 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 263 | R | 0.435725 | L | 0.286963 | 0.148762 | No Change: Both O | Sialuria (SIALURIA) [MIM:269921] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 266 | R | 0.55905 | Q | 0.561536 | -0.002486 | No Change: Both D | Sialuria (SIALURIA) [MIM:269921] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 266 | R | 0.55905 | W | 0.328993 | 0.230057 | D to O | Sialuria (SIALURIA) [MIM:269921] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 303 | C | 0.274871 | V | 0.329277 | -0.054406 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 378 | D | 0.315844 | Y | 0.180782 | 0.135062 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 378 | D | 0.315844 | Y | 0.180782 | 0.135062 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 460 | A | 0.183542 | V | 0.131351 | 0.052191 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 460 | A | 0.183542 | V | 0.131351 | 0.052191 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 524 | A | 0.325324 | V | 0.231156 | 0.094168 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 528 | F | 0.474957 | C | 0.455953 | 0.019004 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 557 | I | 0.32411 | T | 0.439074 | -0.114964 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 572 | V | 0.243877 | L | 0.263543 | -0.019666 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 572 | V | 0.243877 | L | 0.263543 | -0.019666 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 576 | G | 0.425024 | E | 0.458741 | -0.033717 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 587 | I | 0.346182 | T | 0.484097 | -0.137915 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 631 | A | 0.329831 | T | 0.330192 | -3.61E-04 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 631 | A | 0.329831 | V | 0.239997 | 0.089834 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 631 | A | 0.329831 | V | 0.239997 | 0.089834 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 675 | Y | 0.093476 | H | 0.171231 | -0.077755 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 696 | V | 0.287183 | M | 0.321111 | -0.033928 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 712 | M | 0.173442 | T | 0.223042 | -0.0496 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 27 | P | 0.147312 | S | 0.172527 | -0.025215 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 132 | H | 0.184663 | Q | 0.195503 | -0.01084 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 162 | R | 0.268577 | C | 0.169225 | 0.099352 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 171 | M | 0.330598 | V | 0.270336 | 0.060262 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 176 | D | 0.214742 | V | 0.102861 | 0.111881 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 177 | R | 0.181637 | C | 0.10501 | 0.076627 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 206 | G | 0.190863 | S | 0.250024 | -0.059161 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 216 | V | 0.193233 | A | 0.253437 | -0.060204 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 306 | R | 0.307909 | Q | 0.327637 | -0.019728 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 331 | V | 0.388205 | A | 0.469866 | -0.081661 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 472 | I | 0.22912 | T | 0.358187 | -0.129067 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 519 | N | 0.192939 | S | 0.212368 | -0.019429 | No Change: Both O | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 600 | A | 0.587778 | T | 0.590911 | -0.003133 | No Change: Both D | Inclusion body myopathy type 2 (IBM2) [MIM:600737] |
| Q9Y223 | GLCNE_HUMAN Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase OS=Homo sapiens GN=GNE PE=1 SV=1 | 630 | A | 0.266041 | T | 0.266268 | -2.27E-04 | No Change: Both O | Nonaka myopathy (NM) [MIM:605820] |
| P63211 | GBG1_HUMAN Guanine nucleotide-binding protein G(T) subunit gamma-T1 OS=Homo sapiens GN=GNGT1 PE=2 SV=2 | 50 | E | 0.782561 | K | 0.776807 | 0.005754 | No Change: Both D | - |
| O14610 | GBGT2_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 OS=Homo sapiens GN=GNGT2 PE=2 SV=1 | 11 | L | 0.786366 | F | 0.715619 | 0.070747 | No Change: Both D | - |
| Q13823 | NOG2_HUMAN Nucleolar GTP-binding protein 2 OS=Homo sapiens GN=GNL2 PE=1 SV=1 | 452 | Q | 0.221374 | H | 0.170044 | 0.05133 | No Change: Both O | - |
| Q9BVP2 | GNL3_HUMAN Guanine nucleotide-binding protein-like 3 OS=Homo sapiens GN=GNL3 PE=1 SV=2 | 39 | R | 0.980898 | Q | 0.977338 | 0.00356 | No Change: Both D | - |
| Q9BVP2 | GNL3_HUMAN Guanine nucleotide-binding protein-like 3 OS=Homo sapiens GN=GNL3 PE=1 SV=2 | 367 | V | 0.134069 | M | 0.182657 | -0.048588 | No Change: Both O | - |
| Q9NVN8 | GNL3L_HUMAN Guanine nucleotide-binding protein-like 3-like protein OS=Homo sapiens GN=GNL3L PE=1 SV=1 | 320 | R | 0.1172 | H | 0.12406 | -0.00686 | No Change: Both O | - |
| P22749 | GNLY_HUMAN Granulysin OS=Homo sapiens GN=GNLY PE=1 SV=3 | 119 | T | 0.39245 | I | 0.255036 | 0.137414 | No Change: Both O | - |
| Q14749 | GNMT_HUMAN Glycine N-methyltransferase OS=Homo sapiens GN=GNMT PE=1 SV=3 | 50 | L | 0.0773 | P | 0.141508 | -0.064208 | No Change: Both O | Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664] |
| Q14749 | GNMT_HUMAN Glycine N-methyltransferase OS=Homo sapiens GN=GNMT PE=1 SV=3 | 177 | H | 0.182549 | N | 0.193549 | -0.011 | No Change: Both O | Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664] |
| Q14749 | GNMT_HUMAN Glycine N-methyltransferase OS=Homo sapiens GN=GNMT PE=1 SV=3 | 141 | N | 0.107005 | S | 0.13808 | -0.031075 | No Change: Both O | Glycine N-methyltransferase deficiency (GNMT deficiency) [MIM:606664] |
| O15228 | GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens GN=GNPAT PE=1 SV=1 | 211 | R | 0.19468 | C | 0.089921 | 0.104759 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 2 (RCDP2) [MIM:222765] |
| O15228 | GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens GN=GNPAT PE=1 SV=1 | 211 | R | 0.19468 | H | 0.184753 | 0.009927 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 2 (RCDP2) [MIM:222765] |
| O15228 | GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens GN=GNPAT PE=1 SV=1 | 519 | D | 0.054117 | G | 0.044118 | 0.009999 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 2 (RCDP2) [MIM:222765] |
| O15228 | GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens GN=GNPAT PE=1 SV=1 | 495 | V | 0.097895 | I | 0.080261 | 0.017634 | No Change: Both O | - |
| O15228 | GNPAT_HUMAN Dihydroxyacetone phosphate acyltransferase OS=Homo sapiens GN=GNPAT PE=1 SV=1 | 586 | Y | 0.141525 | H | 0.222449 | -0.080924 | No Change: Both O | - |
| Q8TDQ7 | GNPI2_HUMAN Glucosamine-6-phosphate isomerase 2 OS=Homo sapiens GN=GNPDA2 PE=1 SV=1 | 182 | P | 0.285688 | S | 0.326091 | -0.040403 | No Change: Both O | - |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 407 | D | 0.116812 | A | 0.073523 | 0.043289 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 662 | A | 0.437149 | G | 0.467712 | -0.030563 | No Change: Both O | - |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 4 | K | 0.542623 | Q | 0.525667 | 0.016956 | No Change: Both D | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 348 | I | 0.058195 | L | 0.061224 | -0.003029 | No Change: Both O | - |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 1236 | K | 0.201571 | M | 0.114022 | 0.087549 | No Change: Both O | Mucolipidosis type II (MLII) [MIM:252500] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 190 | D | 0.551862 | V | 0.427128 | 0.124734 | D to O | - |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 374 | F | 0.266761 | L | 0.312816 | -0.046055 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 399 | S | 0.234691 | F | 0.108144 | 0.126547 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 403 | I | 0.11408 | T | 0.195689 | -0.081609 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 442 | C | 0.275089 | Y | 0.261217 | 0.013872 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 461 | C | 0.541331 | G | 0.652265 | -0.110934 | No Change: Both D | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 926 | Q | 0.536514 | P | 0.543708 | -0.007194 | No Change: Both D | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 956 | H | 0.403866 | Y | 0.276237 | 0.127629 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 1001 | L | 0.09577 | P | 0.18521 | -0.08944 | No Change: Both O | Mucolipidosis type II (MLII) [MIM:252500] |
| Q3T906 | GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens GN=GNPTAB PE=1 SV=1 | 1153 | N | 0.347243 | S | 0.364694 | -0.017451 | No Change: Both O | Mucolipidosis type III complementation group A (MLIIIA) [MIM:252600] |
| P01148 | GON1_HUMAN Progonadoliberin-1 OS=Homo sapiens GN=GNRH1 PE=1 SV=1 | 16 | W | 0.032928 | S | 0.124926 | -0.091998 | No Change: Both O | - |
| O43555 | GON2_HUMAN Progonadoliberin-2 OS=Homo sapiens GN=GNRH2 PE=1 SV=1 | 16 | A | 0.336438 | V | 0.214685 | 0.121753 | No Change: Both O | - |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 10 | N | 0.816157 | K | 0.806714 | 0.009443 | No Change: Both D | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 90 | E | 0.103935 | K | 0.107887 | -0.003952 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 106 | Q | 0.031355 | R | 0.028547 | 0.002808 | No Change: Both O | Fertile eunuch syndrome (FEUNS) [MIM:228300] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 106 | Q | 0.031355 | R | 0.028547 | 0.002808 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 129 | A | 0.073413 | D | 0.101177 | -0.027764 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 139 | R | 0.179624 | H | 0.170816 | 0.008808 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 168 | S | 0.068444 | R | 0.047517 | 0.020927 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 171 | A | 0.079696 | T | 0.088408 | -0.008712 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 217 | S | 0.012122 | R | 0.008758 | 0.003364 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 262 | R | 0.390568 | Q | 0.399248 | -0.00868 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P30968 | GNRHR_HUMAN Gonadotropin-releasing hormone receptor OS=Homo sapiens GN=GNRHR PE=1 SV=1 | 284 | Y | 0.007989 | C | 0.006149 | 0.00184 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| P15586 | GNS_HUMAN N-acetylglucosamine-6-sulfatase OS=Homo sapiens GN=GNS PE=1 SV=3 | 94 | S | 0.2622 | I | 0.114833 | 0.147367 | No Change: Both O | Mucopolysaccharidosis type 3D (MPS3D) [MIM:252940] |
| P15586 | GNS_HUMAN N-acetylglucosamine-6-sulfatase OS=Homo sapiens GN=GNS PE=1 SV=3 | 340 | K | 0.267059 | R | 0.222493 | 0.044566 | No Change: Both O | Mucopolysaccharidosis type 3D (MPS3D) [MIM:252940] |
| P15586 | GNS_HUMAN N-acetylglucosamine-6-sulfatase OS=Homo sapiens GN=GNS PE=1 SV=3 | 418 | G | 0.448576 | E | 0.502924 | -0.054348 | O to D | Mucopolysaccharidosis type 3D (MPS3D) [MIM:252940] |
| P15586 | GNS_HUMAN N-acetylglucosamine-6-sulfatase OS=Homo sapiens GN=GNS PE=1 SV=3 | 550 | H | 0.788999 | Q | 0.809812 | -0.020813 | No Change: Both D | - |
| Q92805 | GOGA1_HUMAN Golgin subfamily A member 1 OS=Homo sapiens GN=GOLGA1 PE=1 SV=3 | 220 | N | 0.966735 | S | 0.975782 | -0.009047 | No Change: Both D | - |
| Q92805 | GOGA1_HUMAN Golgin subfamily A member 1 OS=Homo sapiens GN=GOLGA1 PE=1 SV=3 | 317 | L | 0.914101 | V | 0.890764 | 0.023337 | No Change: Both D | - |
| Q92805 | GOGA1_HUMAN Golgin subfamily A member 1 OS=Homo sapiens GN=GOLGA1 PE=1 SV=3 | 425 | T | 0.850317 | M | 0.835166 | 0.015151 | No Change: Both D | - |
| Q08379 | GOGA2_HUMAN Golgin subfamily A member 2 OS=Homo sapiens GN=GOLGA2 PE=1 SV=3 | 902 | R | 0.422266 | G | 0.407625 | 0.014641 | No Change: Both O | - |
| Q9HBQ8 | GGA2B_HUMAN Putative golgin subfamily A member 2B OS=Homo sapiens GN=GOLGA2P5 PE=5 SV=1 | 110 | A | 0.961048 | V | 0.957552 | 0.003496 | No Change: Both D | - |
| Q08378 | GOGA3_HUMAN Golgin subfamily A member 3 OS=Homo sapiens GN=GOLGA3 PE=1 SV=2 | 70 | G | 0.982674 | E | 0.983629 | -9.55E-04 | No Change: Both D | - |
| Q08378 | GOGA3_HUMAN Golgin subfamily A member 3 OS=Homo sapiens GN=GOLGA3 PE=1 SV=2 | 1185 | K | 0.909246 | R | 0.896938 | 0.012308 | No Change: Both D | - |
| Q08378 | GOGA3_HUMAN Golgin subfamily A member 3 OS=Homo sapiens GN=GOLGA3 PE=1 SV=2 | 264 | P | 0.941535 | L | 0.903207 | 0.038328 | No Change: Both D | - |
| Q13439 | GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens GN=GOLGA4 PE=1 SV=1 | 1028 | Q | 0.697844 | K | 0.708694 | -0.01085 | No Change: Both D | - |
| Q13439 | GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens GN=GOLGA4 PE=1 SV=1 | 1552 | N | 0.714206 | S | 0.730244 | -0.016038 | No Change: Both D | - |
| Q13439 | GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens GN=GOLGA4 PE=1 SV=1 | 2058 | R | 0.89561 | S | 0.887675 | 0.007935 | No Change: Both D | - |
| Q8TBA6 | GOGA5_HUMAN Golgin subfamily A member 5 OS=Homo sapiens GN=GOLGA5 PE=1 SV=3 | 67 | A | 0.467126 | G | 0.489087 | -0.021961 | No Change: Both O | - |
| Q8TBA6 | GOGA5_HUMAN Golgin subfamily A member 5 OS=Homo sapiens GN=GOLGA5 PE=1 SV=3 | 486 | M | 0.9577 | V | 0.929687 | 0.028013 | No Change: Both D | - |
| Q9NYA3 | GOG6A_HUMAN Golgin subfamily A member 6A OS=Homo sapiens GN=GOLGA6A PE=1 SV=3 | 200 | W | 0.618825 | R | 0.80721 | -0.188385 | No Change: Both D | - |
| A6NDN3 | GOG6B_HUMAN Putative golgin subfamily A member 6B OS=Homo sapiens GN=GOLGA6B PE=5 SV=3 | 200 | R | 0.749691 | W | 0.531928 | 0.217763 | No Change: Both D | - |
| Q8N9W4 | GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 OS=Homo sapiens GN=GOLGA6L2 PE=2 SV=2 | 43 | R | 0.720485 | G | 0.709938 | 0.010547 | No Change: Both D | - |
| Q8N9W4 | GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 OS=Homo sapiens GN=GOLGA6L2 PE=2 SV=2 | 54 | N | 0.848412 | H | 0.817163 | 0.031249 | No Change: Both D | - |
| Q8N9W4 | GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 OS=Homo sapiens GN=GOLGA6L2 PE=2 SV=2 | 64 | E | 0.931994 | G | 0.920471 | 0.011523 | No Change: Both D | - |
| Q8N9W4 | GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 OS=Homo sapiens GN=GOLGA6L2 PE=2 SV=2 | 191 | W | 0.348806 | R | 0.559739 | -0.210933 | O to D | - |
| Q8N9W4 | GG6L2_HUMAN Golgin subfamily A member 6-like protein 2 OS=Homo sapiens GN=GOLGA6L2 PE=2 SV=2 | 235 | R | 0.916283 | P | 0.917309 | -0.001026 | No Change: Both D | - |
| A7E2F4 | GOG8A_HUMAN Golgin subfamily A member 8A OS=Homo sapiens GN=GOLGA8A PE=1 SV=3 | 480 | K | 0.57713 | N | 0.497767 | 0.079363 | D to O | - |
| A7E2F4 | GOG8A_HUMAN Golgin subfamily A member 8A OS=Homo sapiens GN=GOLGA8A PE=1 SV=3 | 530 | S | 0.869455 | N | 0.84303 | 0.026425 | No Change: Both D | - |
| A7E2F4 | GOG8A_HUMAN Golgin subfamily A member 8A OS=Homo sapiens GN=GOLGA8A PE=1 SV=3 | 541 | R | 0.856229 | Q | 0.876798 | -0.020569 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 911 | T | 0.753926 | S | 0.804997 | -0.051071 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 1212 | Y | 0.961086 | C | 0.970134 | -0.009048 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 1249 | P | 0.916844 | S | 0.924669 | -0.007825 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 1713 | C | 0.821562 | F | 0.796396 | 0.025166 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 1765 | G | 0.873567 | D | 0.902816 | -0.029249 | No Change: Both D | - |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 348 | Q | 0.869799 | H | 0.844947 | 0.024852 | No Change: Both D | A breast cancer sample |
| Q14789 | GOGB1_HUMAN Golgin subfamily B member 1 OS=Homo sapiens GN=GOLGB1 PE=1 SV=2 | 944 | A | 0.896468 | G | 0.907761 | -0.011293 | No Change: Both D | A breast cancer sample |
| O00461 | GOLI4_HUMAN Golgi integral membrane protein 4 OS=Homo sapiens GN=GOLIM4 PE=1 SV=1 | 312 | A | 0.852521 | V | 0.823503 | 0.029018 | No Change: Both D | A breast cancer sample |
| Q8NBJ4 | GOLM1_HUMAN Golgi membrane protein 1 OS=Homo sapiens GN=GOLM1 PE=1 SV=1 | 217 | H | 0.913676 | R | 0.938525 | -0.024849 | No Change: Both D | - |
| Q3T8J9 | GON4L_HUMAN GON-4-like protein OS=Homo sapiens GN=GON4L PE=1 SV=1 | 1418 | M | 0.991706 | V | 0.990716 | 9.90E-04 | No Change: Both D | - |
| Q3T8J9 | GON4L_HUMAN GON-4-like protein OS=Homo sapiens GN=GON4L PE=1 SV=1 | 150 | L | 0.910649 | F | 0.900595 | 0.010054 | No Change: Both D | - |
| Q3T8J9 | GON4L_HUMAN GON-4-like protein OS=Homo sapiens GN=GON4L PE=1 SV=1 | 416 | T | 0.953709 | A | 0.948151 | 0.005558 | No Change: Both D | - |
| Q3T8J9 | GON4L_HUMAN GON-4-like protein OS=Homo sapiens GN=GON4L PE=1 SV=1 | 1197 | S | 0.662553 | P | 0.666284 | -0.003731 | No Change: Both D | - |
| Q3T8J9 | GON4L_HUMAN GON-4-like protein OS=Homo sapiens GN=GON4L PE=1 SV=1 | 1539 | Q | 0.996461 | E | 0.997705 | -0.001244 | No Change: Both D | - |
| Q5T7V8 | GORAB_HUMAN RAB6-interacting golgin OS=Homo sapiens GN=GORAB PE=1 SV=1 | 320 | E | 0.940216 | K | 0.920137 | 0.020079 | No Change: Both D | - |
| Q9BQQ3 | GORS1_HUMAN Golgi reassembly-stacking protein 1 OS=Homo sapiens GN=GORASP1 PE=1 SV=3 | 425 | T | 0.972455 | M | 0.961694 | 0.010761 | No Change: Both D | - |
| Q9H8Y8 | GORS2_HUMAN Golgi reassembly-stacking protein 2 OS=Homo sapiens GN=GORASP2 PE=1 SV=3 | 432 | S | 0.960641 | F | 0.90088 | 0.059761 | No Change: Both D | - |
| O14653 | GOSR2_HUMAN Golgi SNAP receptor complex member 2 OS=Homo sapiens GN=GOSR2 PE=1 SV=2 | 67 | R | 0.697826 | K | 0.71091 | -0.013084 | No Change: Both D | - |
| O14653 | GOSR2_HUMAN Golgi SNAP receptor complex member 2 OS=Homo sapiens GN=GOSR2 PE=1 SV=2 | 144 | G | 0.347893 | W | 0.149375 | 0.198518 | No Change: Both O | Progressive myoclonic epilepsy type 6 (EPM6) [MIM:614018] |
| P00505 | AATM_HUMAN Aspartate aminotransferase mitochondrial OS=Homo sapiens GN=GOT2 PE=1 SV=3 | 188 | G | 0.192464 | S | 0.219863 | -0.027399 | No Change: Both O | - |
| P00505 | AATM_HUMAN Aspartate aminotransferase mitochondrial OS=Homo sapiens GN=GOT2 PE=1 SV=3 | 346 | V | 0.141213 | G | 0.227317 | -0.086104 | No Change: Both O | - |
| P00505 | AATM_HUMAN Aspartate aminotransferase mitochondrial OS=Homo sapiens GN=GOT2 PE=1 SV=3 | 428 | V | 0.803923 | A | 0.852688 | -0.048765 | No Change: Both D | - |
| P00505 | AATM_HUMAN Aspartate aminotransferase mitochondrial OS=Homo sapiens GN=GOT2 PE=1 SV=3 | 2 | A | 0.627948 | S | 0.657594 | -0.029646 | No Change: Both D | - |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 81 | C | 0.246684 | R | 0.421587 | -0.174903 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 161 | T | 0.849636 | M | 0.811628 | 0.038008 | No Change: Both D | - |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 172 | A | 0.796353 | V | 0.720997 | 0.075356 | No Change: Both D | Benign mediterranean macrothrombocytopenia (BMM) [MIM:153670] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 172 | A | 0.796353 | V | 0.720997 | 0.075356 | No Change: Both D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 225 | C | 0.032849 | S | 0.091604 | -0.058755 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 249 | G | 0.201007 | V | 0.130288 | 0.070719 | No Change: Both O | Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 255 | M | 0.385684 | V | 0.347662 | 0.038022 | No Change: Both O | Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 72 | R | 0.220669 | H | 0.207524 | 0.013145 | No Change: Both O | - |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 254 | A | 0.373116 | S | 0.498488 | -0.125372 | No Change: Both O | - |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 86 | L | 0.305095 | F | 0.239708 | 0.065387 | No Change: Both O | - |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 73 | L | 0.220144 | F | 0.173926 | 0.046218 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 145 | L | 0.532956 | P | 0.644436 | -0.11148 | No Change: Both D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P07359 | GP1BA_HUMAN Platelet glycoprotein Ib alpha chain OS=Homo sapiens GN=GP1BA PE=1 SV=1 | 249 | G | 0.201007 | S | 0.251596 | -0.050589 | No Change: Both O | Pseudo-von Willebrand disease (VWDP) [MIM:177820] |
| P13224 | GP1BB_HUMAN Platelet glycoprotein Ib beta chain OS=Homo sapiens GN=GP1BB PE=1 SV=1 | 113 | Y | 0.664328 | C | 0.747553 | -0.083225 | No Change: Both D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P13224 | GP1BB_HUMAN Platelet glycoprotein Ib beta chain OS=Homo sapiens GN=GP1BB PE=1 SV=1 | 133 | A | 0.539293 | P | 0.628114 | -0.088821 | No Change: Both D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 317 | L | 0.929532 | Q | 0.952874 | -0.023342 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 322 | N | 0.959456 | H | 0.965772 | -0.006316 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 219 | P | 0.920569 | S | 0.920535 | 3.40E-05 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 237 | E | 0.884393 | K | 0.870709 | 0.013684 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 249 | A | 0.78216 | T | 0.804023 | -0.021863 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 335 | R | 0.957513 | G | 0.951139 | 0.006374 | No Change: Both D | - |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 58 | R | 0.49754 | C | 0.378127 | 0.119413 | No Change: Both O | Bleeding disorder platelet-type 11 (BDPLT11) [MIM:614201] |
| Q9HCN6 | GPVI_HUMAN Platelet glycoprotein VI OS=Homo sapiens GN=GP6 PE=1 SV=4 | 175 | S | 0.252418 | N | 0.206174 | 0.046244 | No Change: Both O | Bleeding disorder platelet-type 11 (BDPLT11) [MIM:614201] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 37 | D | 0.168166 | G | 0.167297 | 8.69E-04 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 61 | N | 0.462318 | S | 0.513731 | -0.051413 | O to D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 7 | L | 0.083179 | P | 0.188598 | -0.105419 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 24 | C | 0.278746 | R | 0.396439 | -0.117693 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 56 | L | 0.347957 | P | 0.503926 | -0.155969 | O to D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 71 | F | 0.423696 | S | 0.658149 | -0.234453 | O to D | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 113 | C | 0.276343 | Y | 0.30292 | -0.026577 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| P14770 | GPIX_HUMAN Platelet glycoprotein IX OS=Homo sapiens GN=GP9 PE=1 SV=3 | 156 | A | 0.04131 | T | 0.041679 | -3.69E-04 | No Change: Both O | Bernard-Soulier syndrome (BSS) [MIM:231200] |
| Q99795 | GPA33_HUMAN Cell surface A33 antigen OS=Homo sapiens GN=GPA33 PE=1 SV=1 | 20 | D | 0.173844 | N | 0.159299 | 0.014545 | No Change: Both O | - |
| Q99795 | GPA33_HUMAN Cell surface A33 antigen OS=Homo sapiens GN=GPA33 PE=1 SV=1 | 165 | K | 0.699896 | N | 0.691594 | 0.008302 | No Change: Both D | - |
| Q9HCL2 | GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1 mitochondrial OS=Homo sapiens GN=GPAM PE=1 SV=3 | 4 | S | 0.703409 | Y | 0.617277 | 0.086132 | No Change: Both D | - |
| Q9HCL2 | GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1 mitochondrial OS=Homo sapiens GN=GPAM PE=1 SV=3 | 43 | I | 0.339956 | V | 0.401671 | -0.061715 | No Change: Both O | - |
| Q9HCL2 | GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1 mitochondrial OS=Homo sapiens GN=GPAM PE=1 SV=3 | 131 | E | 0.390981 | G | 0.344284 | 0.046697 | No Change: Both O | - |
| Q9HCL2 | GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1 mitochondrial OS=Homo sapiens GN=GPAM PE=1 SV=3 | 386 | I | 0.122375 | T | 0.204898 | -0.082523 | No Change: Both O | - |
| O95872 | GPAN1_HUMAN G patch domain and ankyrin repeats-containing protein 1 OS=Homo sapiens GN=GPANK1 PE=2 SV=1 | 235 | A | 0.828886 | V | 0.810286 | 0.0186 | No Change: Both D | - |
| O95872 | GPAN1_HUMAN G patch domain and ankyrin repeats-containing protein 1 OS=Homo sapiens GN=GPANK1 PE=2 SV=1 | 41 | R | 0.896278 | L | 0.868896 | 0.027382 | No Change: Both D | - |
| O95872 | GPAN1_HUMAN G patch domain and ankyrin repeats-containing protein 1 OS=Homo sapiens GN=GPANK1 PE=2 SV=1 | 112 | A | 0.707902 | V | 0.60013 | 0.107772 | No Change: Both D | - |
| O95872 | GPAN1_HUMAN G patch domain and ankyrin repeats-containing protein 1 OS=Homo sapiens GN=GPANK1 PE=2 SV=1 | 210 | S | 0.912488 | A | 0.868731 | 0.043757 | No Change: Both D | - |
| O95872 | GPAN1_HUMAN G patch domain and ankyrin repeats-containing protein 1 OS=Homo sapiens GN=GPANK1 PE=2 SV=1 | 314 | T | 0.66422 | N | 0.6376 | 0.02662 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 476 | L | 0.794586 | P | 0.866174 | -0.071588 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 724 | H | 0.920533 | R | 0.939743 | -0.01921 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 728 | L | 0.882684 | S | 0.932599 | -0.049915 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 909 | E | 0.997163 | K | 0.997061 | 1.02E-04 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 520 | L | 0.596209 | S | 0.72062 | -0.124411 | No Change: Both D | - |
| Q9BRR8 | GPTC1_HUMAN G patch domain-containing protein 1 OS=Homo sapiens GN=GPATCH1 PE=1 SV=1 | 631 | D | 0.44959 | E | 0.449105 | 4.85E-04 | No Change: Both O | - |
| Q96I76 | GPTC3_HUMAN G patch domain-containing protein 3 OS=Homo sapiens GN=GPATCH3 PE=2 SV=1 | 234 | N | 0.529668 | S | 0.617471 | -0.087803 | No Change: Both D | - |
| Q9UKJ3 | GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens GN=GPATCH8 PE=1 SV=2 | 1043 | R | 0.975422 | Q | 0.972261 | 0.003161 | No Change: Both D | - |
| Q9UKJ3 | GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens GN=GPATCH8 PE=1 SV=2 | 1161 | C | 0.964844 | W | 0.946425 | 0.018419 | No Change: Both D | - |
| Q86WP2 | GPBP1_HUMAN Vasculin OS=Homo sapiens GN=GPBP1 PE=1 SV=1 | 122 | R | 0.947391 | G | 0.939246 | 0.008145 | No Change: Both D | - |
| Q9HC44 | GPBL1_HUMAN Vasculin-like protein 1 OS=Homo sapiens GN=GPBP1L1 PE=1 SV=1 | 192 | P | 0.830959 | S | 0.826166 | 0.004793 | No Change: Both D | - |
| Q9HC44 | GPBL1_HUMAN Vasculin-like protein 1 OS=Homo sapiens GN=GPBP1L1 PE=1 SV=1 | 439 | R | 0.846975 | H | 0.808798 | 0.038177 | No Change: Both D | - |
| P35052 | GPC1_HUMAN Glypican-1 OS=Homo sapiens GN=GPC1 PE=1 SV=2 | 500 | S | 0.951359 | G | 0.934666 | 0.016693 | No Change: Both D | - |
| P35052 | GPC1_HUMAN Glypican-1 OS=Homo sapiens GN=GPC1 PE=1 SV=2 | 337 | A | 0.375286 | D | 0.439855 | -0.064569 | No Change: Both O | A breast cancer sample |
| Q8N158 | GPC2_HUMAN Glypican-2 OS=Homo sapiens GN=GPC2 PE=1 SV=1 | 200 | D | 0.687449 | N | 0.653816 | 0.033633 | No Change: Both D | A breast cancer sample |
| P51654 | GPC3_HUMAN Glypican-3 OS=Homo sapiens GN=GPC3 PE=1 SV=1 | 296 | W | 0.093174 | R | 0.227961 | -0.134787 | No Change: Both O | Simpson-Golabi-Behmel syndrome type 1 (SGBS1) [MIM:312870] |
| O75487 | GPC4_HUMAN Glypican-4 OS=Homo sapiens GN=GPC4 PE=1 SV=4 | 391 | E | 0.615638 | D | 0.611396 | 0.004242 | No Change: Both D | - |
| O75487 | GPC4_HUMAN Glypican-4 OS=Homo sapiens GN=GPC4 PE=1 SV=4 | 442 | A | 0.492302 | V | 0.427531 | 0.064771 | No Change: Both O | - |
| P78333 | GPC5_HUMAN Glypican-5 OS=Homo sapiens GN=GPC5 PE=1 SV=1 | 155 | A | 0.151917 | V | 0.119186 | 0.032731 | No Change: Both O | - |
| Q9Y625 | GPC6_HUMAN Glypican-6 OS=Homo sapiens GN=GPC6 PE=2 SV=1 | 412 | V | 0.483285 | M | 0.543746 | -0.060461 | O to D | - |
| Q9NPB8 | GPCP1_HUMAN Glycerophosphocholine phosphodiesterase GPCPD1 OS=Homo sapiens GN=GPCPD1 PE=1 SV=2 | 273 | T | 0.283333 | I | 0.186488 | 0.096845 | No Change: Both O | - |
| P21695 | GPDA_HUMAN Glycerol-3-phosphate dehydrogenase [NAD+] cytoplasmic OS=Homo sapiens GN=GPD1 PE=1 SV=4 | 54 | I | 0.349853 | V | 0.371678 | -0.021825 | No Change: Both O | - |
| P21695 | GPDA_HUMAN Glycerol-3-phosphate dehydrogenase [NAD+] cytoplasmic OS=Homo sapiens GN=GPD1 PE=1 SV=4 | 113 | A | 0.338138 | P | 0.406046 | -0.067908 | No Change: Both O | - |
| P21695 | GPDA_HUMAN Glycerol-3-phosphate dehydrogenase [NAD+] cytoplasmic OS=Homo sapiens GN=GPD1 PE=1 SV=4 | 197 | V | 0.128088 | A | 0.166781 | -0.038693 | No Change: Both O | - |
| Q8N335 | GPD1L_HUMAN Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens GN=GPD1L PE=1 SV=1 | 178 | L | 0.213949 | F | 0.184609 | 0.02934 | No Change: Both O | - |
| Q8N335 | GPD1L_HUMAN Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens GN=GPD1L PE=1 SV=1 | 83 | E | 0.431219 | K | 0.430549 | 6.70E-04 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q8N335 | GPD1L_HUMAN Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens GN=GPD1L PE=1 SV=1 | 124 | I | 0.396234 | V | 0.404645 | -0.008411 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q8N335 | GPD1L_HUMAN Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens GN=GPD1L PE=1 SV=1 | 273 | R | 0.333927 | C | 0.203099 | 0.130828 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q8N335 | GPD1L_HUMAN Glycerol-3-phosphate dehydrogenase 1-like protein OS=Homo sapiens GN=GPD1L PE=1 SV=1 | 280 | A | 0.379055 | V | 0.298671 | 0.080384 | No Change: Both O | Brugada syndrome type 2 (BRS2) [MIM:611777] |
| P43304 | GPDM_HUMAN Glycerol-3-phosphate dehydrogenase mitochondrial OS=Homo sapiens GN=GPD2 PE=1 SV=3 | 525 | R | 0.074178 | H | 0.072057 | 0.002121 | No Change: Both O | - |
| P43304 | GPDM_HUMAN Glycerol-3-phosphate dehydrogenase mitochondrial OS=Homo sapiens GN=GPD2 PE=1 SV=3 | 264 | R | 0.448671 | H | 0.43278 | 0.015891 | No Change: Both O | - |
| P43304 | GPDM_HUMAN Glycerol-3-phosphate dehydrogenase mitochondrial OS=Homo sapiens GN=GPD2 PE=1 SV=3 | 453 | K | 0.372057 | Q | 0.309219 | 0.062838 | No Change: Both O | - |
| Q99527 | GPER_HUMAN G-protein coupled estrogen receptor 1 OS=Homo sapiens GN=GPER PE=2 SV=1 | 16 | P | 0.657432 | L | 0.453897 | 0.203535 | D to O | - |
| Q9NQX3 | GEPH_HUMAN Gephyrin OS=Homo sapiens GN=GPHN PE=1 SV=1 | 10 | N | 0.289326 | Y | 0.17474 | 0.114586 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 5 | T | 0.628337 | I | 0.49187 | 0.136467 | D to O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 20 | H | 0.479349 | P | 0.542451 | -0.063102 | O to D | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 75 | R | 0.468144 | G | 0.4763 | -0.008156 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 83 | R | 0.43405 | W | 0.224503 | 0.209547 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 159 | G | 0.282033 | S | 0.321821 | -0.039788 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 101 | V | 0.246953 | M | 0.302156 | -0.055203 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 195 | T | 0.325993 | I | 0.209024 | 0.116969 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 224 | T | 0.412387 | M | 0.336694 | 0.075693 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 273 | R | 0.067495 | H | 0.068675 | -0.00118 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 278 | S | 0.11437 | L | 0.047662 | 0.066708 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 300 | A | 0.239628 | P | 0.320575 | -0.080947 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 339 | L | 0.190398 | P | 0.338165 | -0.147767 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 343 | Q | 0.198204 | R | 0.194749 | 0.003455 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 347 | R | 0.109787 | C | 0.050655 | 0.059132 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 347 | R | 0.109787 | H | 0.1188 | -0.009013 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 375 | T | 0.323859 | R | 0.33987 | -0.016011 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 389 | H | 0.27479 | R | 0.263295 | 0.011495 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 472 | R | 0.424477 | H | 0.43375 | -0.009273 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 487 | L | 0.079834 | F | 0.069003 | 0.010831 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 495 | E | 0.088121 | K | 0.094318 | -0.006197 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 517 | L | 0.262847 | V | 0.264937 | -0.00209 | No Change: Both O | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 525 | I | 0.578111 | T | 0.679022 | -0.100911 | No Change: Both D | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 539 | D | 0.553914 | N | 0.560501 | -0.006587 | No Change: Both D | Hemolytic anemia non-spherocytic due to glucose phosphate isomerase deficiency (HA-GPID) [MIM:613470] |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 208 | I | 0.237995 | T | 0.381221 | -0.143226 | No Change: Both O | - |
| P06744 | G6PI_HUMAN Glucose-6-phosphate isomerase OS=Homo sapiens GN=GPI PE=1 SV=4 | 308 | R | 0.339627 | H | 0.363005 | -0.023378 | No Change: Both O | - |
| Q8IV16 | HDBP1_HUMAN Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 OS=Homo sapiens GN=GPIHBP1 PE=1 SV=2 | 14 | C | 0.73815 | F | 0.671194 | 0.066956 | No Change: Both D | - |
| Q8IV16 | HDBP1_HUMAN Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 OS=Homo sapiens GN=GPIHBP1 PE=1 SV=2 | 56 | G | 0.926378 | R | 0.943839 | -0.017461 | No Change: Both D | - |
| Q8IV16 | HDBP1_HUMAN Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 OS=Homo sapiens GN=GPIHBP1 PE=1 SV=2 | 115 | Q | 0.611355 | P | 0.632941 | -0.021586 | No Change: Both D | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 17 | L | 0.188541 | V | 0.169076 | 0.019465 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 30 | V | 0.328931 | I | 0.313831 | 0.0151 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 275 | D | 0.46219 | E | 0.510866 | -0.048676 | O to D | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 396 | G | 0.437026 | S | 0.471732 | -0.034706 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 461 | V | 0.183495 | M | 0.213108 | -0.029613 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 694 | M | 0.35154 | V | 0.288894 | 0.062646 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 698 | T | 0.340706 | I | 0.201435 | 0.139271 | No Change: Both O | - |
| P80108 | PHLD_HUMAN Phosphatidylinositol-glycan-specific phospholipase D OS=Homo sapiens GN=GPLD1 PE=1 SV=3 | 350 | I | 0.151345 | V | 0.159507 | -0.008162 | No Change: Both O | - |
| P51674 | GPM6A_HUMAN Neuronal membrane glycoprotein M6-a OS=Homo sapiens GN=GPM6A PE=1 SV=2 | 242 | V | 0.131351 | L | 0.132708 | -0.001357 | No Change: Both O | - |
| Q9H9Y4 | GPN2_HUMAN GPN-loop GTPase 2 OS=Homo sapiens GN=GPN2 PE=2 SV=2 | 227 | Q | 0.177728 | R | 0.164732 | 0.012996 | No Change: Both O | - |
| Q9H9Y4 | GPN2_HUMAN GPN-loop GTPase 2 OS=Homo sapiens GN=GPN2 PE=2 SV=2 | 264 | R | 0.286614 | G | 0.288137 | -0.001523 | No Change: Both O | - |
| Q9UHW5 | GPN3_HUMAN GPN-loop GTPase 3 OS=Homo sapiens GN=GPN3 PE=1 SV=2 | 52 | A | 0.152917 | V | 0.117795 | 0.035122 | No Change: Both O | - |
| Q9UHW5 | GPN3_HUMAN GPN-loop GTPase 3 OS=Homo sapiens GN=GPN3 PE=1 SV=2 | 244 | V | 0.242664 | A | 0.310936 | -0.068272 | No Change: Both O | - |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 195 | S | 0.255939 | C | 0.09783 | 0.158109 | No Change: Both O | - |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 197 | N | 0.30406 | H | 0.267849 | 0.036211 | No Change: Both O | - |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 110 | A | 0.393233 | D | 0.499552 | -0.106319 | No Change: Both O | A breast cancer sample |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 531 | S | 0.642576 | I | 0.417293 | 0.225283 | D to O | A breast cancer sample |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 294 | S | 0.359541 | F | 0.176419 | 0.183122 | No Change: Both O | - |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 324 | P | 0.941293 | L | 0.903008 | 0.038285 | No Change: Both D | - |
| Q14956 | GPNMB_HUMAN Transmembrane glycoprotein NMB OS=Homo sapiens GN=GPNMB PE=1 SV=2 | 538 | S | 0.448784 | R | 0.378417 | 0.070367 | No Change: Both O | - |
| P46091 | GPR1_HUMAN G-protein coupled receptor 1 OS=Homo sapiens GN=GPR1 PE=1 SV=2 | 307 | I | 0.083323 | V | 0.095364 | -0.012041 | No Change: Both O | - |
| Q96P66 | GP101_HUMAN Probable G-protein coupled receptor 101 OS=Homo sapiens GN=GPR101 PE=2 SV=1 | 124 | V | 0.090578 | L | 0.082626 | 0.007952 | No Change: Both O | - |
| Q96P66 | GP101_HUMAN Probable G-protein coupled receptor 101 OS=Homo sapiens GN=GPR101 PE=2 SV=1 | 376 | L | 0.795035 | P | 0.887721 | -0.092686 | No Change: Both D | - |
| Q5VW38 | GP107_HUMAN Protein GPR107 OS=Homo sapiens GN=GPR107 PE=2 SV=1 | 189 | A | 0.802065 | P | 0.824585 | -0.02252 | No Change: Both D | - |
| Q9NPR9 | GP108_HUMAN Protein GPR108 OS=Homo sapiens GN=GPR108 PE=2 SV=3 | 79 | L | 0.550761 | P | 0.655921 | -0.10516 | No Change: Both D | - |
| Q9NPR9 | GP108_HUMAN Protein GPR108 OS=Homo sapiens GN=GPR108 PE=2 SV=3 | 36 | Q | 0.247114 | R | 0.247491 | -3.77E-04 | No Change: Both O | - |
| Q5T601 | GP110_HUMAN Probable G-protein coupled receptor 110 OS=Homo sapiens GN=GPR110 PE=2 SV=2 | 787 | I | 0.20647 | V | 0.229561 | -0.023091 | No Change: Both O | - |
| Q8IZF7 | GP111_HUMAN Probable G-protein coupled receptor 111 OS=Homo sapiens GN=GPR111 PE=2 SV=1 | 148 | Q | 0.213909 | R | 0.197222 | 0.016687 | No Change: Both O | - |
| Q8IZF7 | GP111_HUMAN Probable G-protein coupled receptor 111 OS=Homo sapiens GN=GPR111 PE=2 SV=1 | 467 | I | 0.028154 | V | 0.033794 | -0.00564 | No Change: Both O | - |
| Q8IZF6 | GP112_HUMAN Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 | 276 | I | 0.579206 | M | 0.663126 | -0.08392 | No Change: Both D | - |
| Q8IZF6 | GP112_HUMAN Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 | 368 | P | 0.924973 | H | 0.883634 | 0.041339 | No Change: Both D | - |
| Q8IZF6 | GP112_HUMAN Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 | 1213 | T | 0.716963 | N | 0.711768 | 0.005195 | No Change: Both D | - |
| Q8IZF6 | GP112_HUMAN Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 | 1540 | S | 0.872917 | P | 0.874302 | -0.001385 | No Change: Both D | - |
| Q8IZF6 | GP112_HUMAN Probable G-protein coupled receptor 112 OS=Homo sapiens GN=GPR112 PE=2 SV=2 | 1791 | F | 0.890605 | L | 0.907752 | -0.017147 | No Change: Both D | - |
| Q8IZF5 | GP113_HUMAN Probable G-protein coupled receptor 113 OS=Homo sapiens GN=GPR113 PE=2 SV=1 | 404 | A | 0.21457 | T | 0.240343 | -0.025773 | No Change: Both O | - |
| Q8IZF3 | GP115_HUMAN Probable G-protein coupled receptor 115 OS=Homo sapiens GN=GPR115 PE=2 SV=3 | 541 | K | 0.551476 | N | 0.505425 | 0.046051 | No Change: Both D | - |
| Q8IZF3 | GP115_HUMAN Probable G-protein coupled receptor 115 OS=Homo sapiens GN=GPR115 PE=2 SV=3 | 674 | S | 0.775468 | L | 0.679469 | 0.095999 | No Change: Both D | A breast cancer sample |
| Q8IZF3 | GP115_HUMAN Probable G-protein coupled receptor 115 OS=Homo sapiens GN=GPR115 PE=2 SV=3 | 507 | R | 0.098053 | C | 0.041468 | 0.056585 | No Change: Both O | - |
| Q8IZF2 | GP116_HUMAN Probable G-protein coupled receptor 116 OS=Homo sapiens GN=GPR116 PE=1 SV=3 | 856 | M | 0.6162 | T | 0.643514 | -0.027314 | No Change: Both D | - |
| Q8IZF2 | GP116_HUMAN Probable G-protein coupled receptor 116 OS=Homo sapiens GN=GPR116 PE=1 SV=3 | 604 | T | 0.48453 | M | 0.431912 | 0.052618 | No Change: Both O | - |
| Q8IZF2 | GP116_HUMAN Probable G-protein coupled receptor 116 OS=Homo sapiens GN=GPR116 PE=1 SV=3 | 801 | V | 0.151714 | I | 0.128036 | 0.023678 | No Change: Both O | - |
| Q8TDV5 | GP119_HUMAN Glucose-dependent insulinotropic receptor OS=Homo sapiens GN=GPR119 PE=1 SV=1 | 309 | S | 0.143148 | L | 0.066627 | 0.076521 | No Change: Both O | - |
| Q86SQ6 | GP123_HUMAN Probable G-protein coupled receptor 123 OS=Homo sapiens GN=GPR123 PE=2 SV=3 | 183 | A | 0.073373 | S | 0.112014 | -0.038641 | No Change: Both O | - |
| Q86SQ6 | GP123_HUMAN Probable G-protein coupled receptor 123 OS=Homo sapiens GN=GPR123 PE=2 SV=3 | 214 | Q | 0.750149 | L | 0.672146 | 0.078003 | No Change: Both D | - |
| Q8IWK6 | GP125_HUMAN Probable G-protein coupled receptor 125 OS=Homo sapiens GN=GPR125 PE=1 SV=2 | 1043 | V | 0.071133 | M | 0.086032 | -0.014899 | No Change: Both O | - |
| Q8IWK6 | GP125_HUMAN Probable G-protein coupled receptor 125 OS=Homo sapiens GN=GPR125 PE=1 SV=2 | 1166 | V | 0.650515 | G | 0.714461 | -0.063946 | No Change: Both D | - |
| Q86SQ4 | GP126_HUMAN G-protein coupled receptor 126 OS=Homo sapiens GN=GPR126 PE=1 SV=3 | 230 | K | 0.294332 | Q | 0.253733 | 0.040599 | No Change: Both O | - |
| Q86SQ4 | GP126_HUMAN G-protein coupled receptor 126 OS=Homo sapiens GN=GPR126 PE=1 SV=3 | 123 | S | 0.650729 | G | 0.588472 | 0.062257 | No Change: Both D | - |
| Q86SQ4 | GP126_HUMAN G-protein coupled receptor 126 OS=Homo sapiens GN=GPR126 PE=1 SV=3 | 1127 | Q | 0.139464 | R | 0.129092 | 0.010372 | No Change: Both O | - |
| Q96K78 | GP128_HUMAN Probable G-protein coupled receptor 128 OS=Homo sapiens GN=GPR128 PE=1 SV=2 | 645 | T | 0.058217 | S | 0.085499 | -0.027282 | No Change: Both O | - |
| Q96K78 | GP128_HUMAN Probable G-protein coupled receptor 128 OS=Homo sapiens GN=GPR128 PE=1 SV=2 | 756 | R | 0.621787 | H | 0.529216 | 0.092571 | No Change: Both D | - |
| Q96K78 | GP128_HUMAN Probable G-protein coupled receptor 128 OS=Homo sapiens GN=GPR128 PE=1 SV=2 | 151 | K | 0.481765 | E | 0.497765 | -0.016 | No Change: Both O | - |
| Q6QNK2 | GP133_HUMAN Probable G-protein coupled receptor 133 OS=Homo sapiens GN=GPR133 PE=2 SV=1 | 508 | V | 0.067146 | M | 0.082695 | -0.015549 | No Change: Both O | - |
| Q6QNK2 | GP133_HUMAN Probable G-protein coupled receptor 133 OS=Homo sapiens GN=GPR133 PE=2 SV=1 | 523 | S | 0.311133 | L | 0.15267 | 0.158463 | No Change: Both O | - |
| Q8IZ08 | GP135_HUMAN Probable G-protein coupled receptor 135 OS=Homo sapiens GN=GPR135 PE=2 SV=2 | 5 | Q | 0.996899 | P | 0.9979 | -0.001001 | No Change: Both D | - |
| Q8IZ08 | GP135_HUMAN Probable G-protein coupled receptor 135 OS=Homo sapiens GN=GPR135 PE=2 SV=2 | 481 | V | 0.691965 | A | 0.747253 | -0.055288 | No Change: Both D | - |
| Q8N3F9 | G137C_HUMAN Integral membrane protein GPR137C OS=Homo sapiens GN=GPR137C PE=2 SV=2 | 248 | V | 0.07269 | I | 0.058404 | 0.014286 | No Change: Both O | - |
| Q7Z601 | GP142_HUMAN Probable G-protein coupled receptor 142 OS=Homo sapiens GN=GPR142 PE=2 SV=1 | 132 | H | 0.538151 | N | 0.543489 | -0.005338 | No Change: Both D | - |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 35 | G | 0.53108 | D | 0.516151 | 0.014929 | No Change: Both D | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 84 | G | 0.07333 | D | 0.081737 | -0.008407 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 84 | G | 0.07333 | R | 0.078053 | -0.004723 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 116 | C | 0.035676 | R | 0.077505 | -0.041829 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 118 | G | 0.029425 | E | 0.038569 | -0.009144 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 133 | W | 0.003637 | R | 0.009263 | -0.005626 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 138 | A | 0.00706 | V | 0.004911 | 0.002149 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 152 | S | 0.154717 | N | 0.121331 | 0.033386 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 173 | A | 0.091823 | D | 0.123674 | -0.031851 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 232 | T | 0.511463 | K | 0.612954 | -0.101491 | No Change: Both D | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 235 | E | 0.459203 | K | 0.447537 | 0.011666 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 292 | W | 0.058788 | G | 0.161867 | -0.103079 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 5 | R | 0.563421 | C | 0.436778 | 0.126643 | D to O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 39 | L | 0.579287 | R | 0.65591 | -0.076623 | No Change: Both D | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 78 | D | 0.176396 | N | 0.168062 | 0.008334 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 78 | D | 0.176396 | V | 0.120455 | 0.055941 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 116 | C | 0.035676 | S | 0.111048 | -0.075372 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 124 | Q | 0.023008 | R | 0.020871 | 0.002137 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 229 | G | 0.372197 | V | 0.220276 | 0.151921 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 233 | E | 0.531596 | K | 0.519593 | 0.012003 | No Change: Both D | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 244 | I | 0.058493 | V | 0.066032 | -0.007539 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 261 | I | 0.044713 | N | 0.100756 | -0.056043 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 271 | E | 0.142559 | G | 0.117911 | 0.024648 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 292 | W | 0.058788 | C | 0.070008 | -0.01122 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 81 | G | 0.097373 | V | 0.061191 | 0.036182 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 89 | S | 0.051216 | F | 0.019792 | 0.031424 | No Change: Both O | Nystagmus congenital X-linked type 6 (NYS6) [MIM:300814] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 116 | C | 0.035676 | G | 0.08807 | -0.052394 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 116 | C | 0.035676 | W | 0.032803 | 0.002873 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 132 | W | 0.003494 | R | 0.008939 | -0.005445 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 134 | L | 0.00342 | P | 0.007514 | -0.004094 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 166 | T | 0.037288 | N | 0.044767 | -0.007479 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 185 | E | 0.427196 | K | 0.426829 | 3.67E-04 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 186 | R | 0.413956 | P | 0.460541 | -0.046585 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| P51810 | GP143_HUMAN G-protein coupled receptor 143 OS=Homo sapiens GN=GPR143 PE=1 SV=2 | 186 | R | 0.413956 | W | 0.192579 | 0.221377 | No Change: Both O | Albinism ocular type 1 (OA1) [MIM:300500] |
| Q8TDV2 | GP148_HUMAN Probable G-protein coupled receptor 148 OS=Homo sapiens GN=GPR148 PE=2 SV=2 | 317 | T | 0.072551 | P | 0.099412 | -0.026861 | No Change: Both O | - |
| P49685 | GPR15_HUMAN G-protein coupled receptor 15 OS=Homo sapiens GN=GPR15 PE=2 SV=1 | 37 | P | 0.049334 | S | 0.057038 | -0.007704 | No Change: Both O | - |
| P49685 | GPR15_HUMAN G-protein coupled receptor 15 OS=Homo sapiens GN=GPR15 PE=2 SV=1 | 112 | M | 0.271931 | V | 0.216934 | 0.054997 | No Change: Both O | - |
| Q8TDV0 | GP151_HUMAN Probable G-protein coupled receptor 151 OS=Homo sapiens GN=GPR151 PE=2 SV=1 | 40 | P | 0.035936 | L | 0.018412 | 0.017524 | No Change: Both O | - |
| Q8TDV0 | GP151_HUMAN Probable G-protein coupled receptor 151 OS=Homo sapiens GN=GPR151 PE=2 SV=1 | 144 | A | 0.473775 | V | 0.381884 | 0.091891 | No Change: Both O | - |
| Q8TDV0 | GP151_HUMAN Probable G-protein coupled receptor 151 OS=Homo sapiens GN=GPR151 PE=2 SV=1 | 261 | L | 0.023503 | V | 0.021859 | 0.001644 | No Change: Both O | - |
| Q8TDT2 | GP152_HUMAN Probable G-protein coupled receptor 152 OS=Homo sapiens GN=GPR152 PE=2 SV=1 | 317 | L | 0.740027 | V | 0.700453 | 0.039574 | No Change: Both D | - |
| Q6NV75 | GP153_HUMAN Probable G-protein coupled receptor 153 OS=Homo sapiens GN=GPR153 PE=2 SV=2 | 209 | R | 0.350207 | H | 0.320841 | 0.029366 | No Change: Both O | - |
| Q8NFN8 | GP156_HUMAN Probable G-protein coupled receptor 156 OS=Homo sapiens GN=GPR156 PE=2 SV=2 | 516 | E | 0.98952 | D | 0.988481 | 0.001039 | No Change: Both D | - |
| Q5T848 | GP158_HUMAN Probable G-protein coupled receptor 158 OS=Homo sapiens GN=GPR158 PE=1 SV=1 | 425 | A | 0.028888 | G | 0.034959 | -0.006071 | No Change: Both O | - |
| Q5T848 | GP158_HUMAN Probable G-protein coupled receptor 158 OS=Homo sapiens GN=GPR158 PE=1 SV=1 | 1209 | I | 0.543095 | V | 0.574797 | -0.031702 | No Change: Both D | - |
| Q16538 | GP162_HUMAN Probable G-protein coupled receptor 162 OS=Homo sapiens GN=GPR162 PE=2 SV=1 | 459 | R | 0.822405 | G | 0.816459 | 0.005946 | No Change: Both D | - |
| O14626 | GP171_HUMAN Probable G-protein coupled receptor 171 OS=Homo sapiens GN=GPR171 PE=2 SV=1 | 283 | I | 0.083116 | V | 0.100406 | -0.01729 | No Change: Both O | - |
| Q9NWF4 | RFT_HUMAN Riboflavin transporter 1 OS=Homo sapiens GN=GPR172B PE=1 SV=2 | 70 | Q | 0.137317 | R | 0.130148 | 0.007169 | No Change: Both O | - |
| Q9NWF4 | RFT_HUMAN Riboflavin transporter 1 OS=Homo sapiens GN=GPR172B PE=1 SV=2 | 271 | A | 0.633331 | V | 0.567177 | 0.066154 | No Change: Both D | - |
| Q9NWF4 | RFT_HUMAN Riboflavin transporter 1 OS=Homo sapiens GN=GPR172B PE=1 SV=2 | 296 | V | 0.31682 | M | 0.355535 | -0.038715 | No Change: Both O | - |
| Q9BXC1 | GP174_HUMAN Probable G-protein coupled receptor 174 OS=Homo sapiens GN=GPR174 PE=2 SV=1 | 162 | S | 0.713709 | P | 0.672863 | 0.040846 | No Change: Both D | - |
| Q6PRD1 | GP179_HUMAN Probable G-protein coupled receptor 179 OS=Homo sapiens GN=GPR179 PE=2 SV=2 | 1176 | Q | 0.968786 | E | 0.969291 | -5.05E-04 | No Change: Both D | - |
| Q6PRD1 | GP179_HUMAN Probable G-protein coupled receptor 179 OS=Homo sapiens GN=GPR179 PE=2 SV=2 | 1381 | C | 0.931034 | R | 0.950316 | -0.019282 | No Change: Both D | - |
| Q6PRD1 | GP179_HUMAN Probable G-protein coupled receptor 179 OS=Homo sapiens GN=GPR179 PE=2 SV=2 | 1869 | Q | 0.64864 | E | 0.6677 | -0.01906 | No Change: Both D | - |
| Q6PRD1 | GP179_HUMAN Probable G-protein coupled receptor 179 OS=Homo sapiens GN=GPR179 PE=2 SV=2 | 1150 | K | 0.920207 | E | 0.923652 | -0.003445 | No Change: Both D | - |
| Q86V85 | GP180_HUMAN Integral membrane protein GPR180 OS=Homo sapiens GN=GPR180 PE=2 SV=1 | 32 | T | 0.660403 | N | 0.683738 | -0.023335 | No Change: Both D | A breast cancer sample |
| O15218 | GP182_HUMAN G-protein coupled receptor 182 OS=Homo sapiens GN=GPR182 PE=2 SV=1 | 349 | C | 0.651658 | R | 0.708254 | -0.056596 | No Change: Both D | - |
| P32249 | GP183_HUMAN G-protein coupled receptor 183 OS=Homo sapiens GN=GPR183 PE=1 SV=3 | 338 | A | 0.863935 | V | 0.850138 | 0.013797 | No Change: Both D | An acute myeloid leukemia sample |
| Q15760 | GPR19_HUMAN Probable G-protein coupled receptor 19 OS=Homo sapiens GN=GPR19 PE=2 SV=2 | 189 | V | 0.060991 | I | 0.053443 | 0.007548 | No Change: Both O | - |
| Q99678 | GPR20_HUMAN G-protein coupled receptor 20 OS=Homo sapiens GN=GPR20 PE=1 SV=2 | 230 | H | 0.511936 | R | 0.537587 | -0.025651 | No Change: Both D | - |
| Q99678 | GPR20_HUMAN G-protein coupled receptor 20 OS=Homo sapiens GN=GPR20 PE=1 SV=2 | 260 | R | 0.090482 | C | 0.044138 | 0.046344 | No Change: Both O | - |
| Q99678 | GPR20_HUMAN G-protein coupled receptor 20 OS=Homo sapiens GN=GPR20 PE=1 SV=2 | 313 | G | 0.474423 | S | 0.517236 | -0.042813 | O to D | - |
| P46089 | GPR3_HUMAN G-protein coupled receptor 3 OS=Homo sapiens GN=GPR3 PE=1 SV=1 | 222 | R | 0.071645 | H | 0.072098 | -4.53E-04 | No Change: Both O | - |
| O00270 | GPR31_HUMAN 12-(S)-hydroxy-5 8 10 14-eicosatetraenoic acid receptor OS=Homo sapiens GN=GPR31 PE=2 SV=2 | 91 | H | 0.032505 | R | 0.034873 | -0.002368 | No Change: Both O | - |
| O75388 | GPR32_HUMAN Probable G-protein coupled receptor 32 OS=Homo sapiens GN=GPR32 PE=2 SV=1 | 327 | F | 0.322351 | L | 0.340214 | -0.017863 | No Change: Both O | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 25 | A | 0.029933 | T | 0.032743 | -0.00281 | No Change: Both O | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 29 | V | 0.023501 | I | 0.018746 | 0.004755 | No Change: Both O | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 108 | T | 0.100054 | M | 0.091728 | 0.008326 | No Change: Both O | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 125 | R | 0.586631 | S | 0.646964 | -0.060333 | No Change: Both D | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 253 | T | 0.077515 | M | 0.060504 | 0.017011 | No Change: Both O | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 294 | S | 0.664205 | R | 0.589023 | 0.075182 | No Change: Both D | - |
| Q9HC97 | GPR35_HUMAN G-protein coupled receptor 35 OS=Homo sapiens GN=GPR35 PE=2 SV=4 | 76 | V | 0.094105 | M | 0.126555 | -0.03245 | No Change: Both O | - |
| O60883 | ETBR2_HUMAN Endothelin B receptor-like protein 2 OS=Homo sapiens GN=GPR37L1 PE=1 SV=2 | 81 | P | 0.796945 | A | 0.713578 | 0.083367 | No Change: Both D | - |
| O60883 | ETBR2_HUMAN Endothelin B receptor-like protein 2 OS=Homo sapiens GN=GPR37L1 PE=1 SV=2 | 90 | G | 0.879756 | D | 0.883005 | -0.003249 | No Change: Both D | - |
| O60883 | ETBR2_HUMAN Endothelin B receptor-like protein 2 OS=Homo sapiens GN=GPR37L1 PE=1 SV=2 | 91 | K | 0.889677 | R | 0.89336 | -0.003683 | No Change: Both D | - |
| O43194 | GPR39_HUMAN G-protein coupled receptor 39 OS=Homo sapiens GN=GPR39 PE=1 SV=1 | 50 | A | 0.200818 | V | 0.157697 | 0.043121 | No Change: Both O | - |
| O43194 | GPR39_HUMAN G-protein coupled receptor 39 OS=Homo sapiens GN=GPR39 PE=1 SV=1 | 390 | R | 0.723227 | C | 0.617176 | 0.106051 | No Change: Both D | - |
| P46093 | GPR4_HUMAN G-protein coupled receptor 4 OS=Homo sapiens GN=GPR4 PE=2 SV=2 | 295 | S | 0.401937 | N | 0.382005 | 0.019932 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 45 | C | 0.085391 | R | 0.193531 | -0.10814 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 227 | V | 0.111122 | L | 0.114712 | -0.00359 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 256 | V | 0.060513 | A | 0.0804 | -0.019887 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 44 | R | 0.084657 | Q | 0.086371 | -0.001714 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 174 | W | 0.055385 | R | 0.13928 | -0.083895 | No Change: Both O | - |
| O15529 | GPR42_HUMAN G-protein coupled receptor 42 OS=Homo sapiens GN=GPR42 PE=1 SV=1 | 346 | N | 0.940671 | S | 0.966028 | -0.025357 | No Change: Both D | - |
| Q9Y5Y4 | GPR44_HUMAN Putative G-protein coupled receptor 44 OS=Homo sapiens GN=GPR44 PE=2 SV=3 | 204 | V | 0.212234 | A | 0.284588 | -0.072354 | No Change: Both O | - |
| Q9Y5Y3 | GPR45_HUMAN Probable G-protein coupled receptor 45 OS=Homo sapiens GN=GPR45 PE=2 SV=2 | 7 | S | 0.597336 | C | 0.39421 | 0.203126 | D to O | A breast cancer sample |
| Q9Y5Y3 | GPR45_HUMAN Probable G-protein coupled receptor 45 OS=Homo sapiens GN=GPR45 PE=2 SV=2 | 312 | L | 0.047897 | F | 0.039747 | 0.00815 | No Change: Both O | - |
| Q13585 | MTR1L_HUMAN Melatonin-related receptor OS=Homo sapiens GN=GPR50 PE=1 SV=3 | 532 | T | 0.975925 | A | 0.974679 | 0.001246 | No Change: Both D | - |
| Q13585 | MTR1L_HUMAN Melatonin-related receptor OS=Homo sapiens GN=GPR50 PE=1 SV=3 | 606 | I | 0.502822 | V | 0.608027 | -0.105205 | No Change: Both D | - |
| Q9Y2T6 | GPR55_HUMAN G-protein coupled receptor 55 OS=Homo sapiens GN=GPR55 PE=1 SV=2 | 195 | G | 0.052315 | V | 0.02558 | 0.026735 | No Change: Both O | - |
| Q9Y2T6 | GPR55_HUMAN G-protein coupled receptor 55 OS=Homo sapiens GN=GPR55 PE=1 SV=2 | 215 | T | 0.362038 | N | 0.406875 | -0.044837 | No Change: Both O | - |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 281 | S | 0.666336 | R | 0.652461 | 0.013875 | No Change: Both D | - |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 306 | Q | 0.470159 | H | 0.428403 | 0.041756 | No Change: Both O | - |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 38 | R | 0.611649 | W | 0.365022 | 0.246627 | D to O | Bilateral frontoparietal polymicrogyria (BFPP) [MIM:606854] |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 88 | Y | 0.111567 | C | 0.121784 | -0.010217 | No Change: Both O | Bilateral frontoparietal polymicrogyria (BFPP) [MIM:606854] |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 91 | C | 0.077946 | S | 0.174611 | -0.096665 | No Change: Both O | Bilateral frontoparietal polymicrogyria (BFPP) [MIM:606854] |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 346 | C | 0.122566 | S | 0.22129 | -0.098724 | No Change: Both O | Bilateral frontoparietal polymicrogyria (BFPP) [MIM:606854] |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 565 | R | 0.084263 | W | 0.034813 | 0.04945 | No Change: Both O | Bilateral frontoparietal polymicrogyria (BFPP) [MIM:606854] |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 493 | M | 0.080321 | T | 0.105654 | -0.025333 | No Change: Both O | - |
| Q9Y653 | GPR56_HUMAN G-protein coupled receptor 56 OS=Homo sapiens GN=GPR56 PE=1 SV=2 | 527 | P | 0.028999 | L | 0.014585 | 0.014414 | No Change: Both O | - |
| Q9BZJ7 | GPR62_HUMAN Probable G-protein coupled receptor 62 OS=Homo sapiens GN=GPR62 PE=2 SV=2 | 313 | V | 0.655959 | L | 0.698716 | -0.042757 | No Change: Both D | - |
| Q9BZJ6 | GPR63_HUMAN Probable G-protein coupled receptor 63 OS=Homo sapiens GN=GPR63 PE=2 SV=2 | 21 | V | 0.196135 | M | 0.251024 | -0.054889 | No Change: Both O | - |
| Q8IZP9 | GPR64_HUMAN G-protein coupled receptor 64 OS=Homo sapiens GN=GPR64 PE=1 SV=2 | 290 | H | 0.870688 | Q | 0.908912 | -0.038224 | No Change: Both D | - |
| Q8IZP9 | GPR64_HUMAN G-protein coupled receptor 64 OS=Homo sapiens GN=GPR64 PE=1 SV=2 | 771 | N | 0.559509 | S | 0.626286 | -0.066777 | No Change: Both D | - |
| Q8IYL9 | PSYR_HUMAN Psychosine receptor OS=Homo sapiens GN=GPR65 PE=1 SV=1 | 231 | I | 0.029519 | L | 0.035028 | -0.005509 | No Change: Both O | - |
| Q15743 | OGR1_HUMAN Ovarian cancer G-protein coupled receptor 1 OS=Homo sapiens GN=GPR68 PE=1 SV=1 | 53 | R | 0.170624 | Q | 0.196776 | -0.026152 | No Change: Both O | - |
| Q15743 | OGR1_HUMAN Ovarian cancer G-protein coupled receptor 1 OS=Homo sapiens GN=GPR68 PE=1 SV=1 | 39 | N | 0.052325 | S | 0.068213 | -0.015888 | No Change: Both O | - |
| O95800 | GPR75_HUMAN Probable G-protein coupled receptor 75 OS=Homo sapiens GN=GPR75 PE=2 SV=1 | 116 | A | 0.206545 | T | 0.232076 | -0.025531 | No Change: Both O | - |
| O95800 | GPR75_HUMAN Probable G-protein coupled receptor 75 OS=Homo sapiens GN=GPR75 PE=2 SV=1 | 160 | C | 0.110863 | G | 0.205787 | -0.094924 | No Change: Both O | - |
| O95800 | GPR75_HUMAN Probable G-protein coupled receptor 75 OS=Homo sapiens GN=GPR75 PE=2 SV=1 | 433 | L | 0.824003 | V | 0.829107 | -0.005104 | No Change: Both D | - |
| Q96P69 | GPR78_HUMAN G-protein coupled receptor 78 OS=Homo sapiens GN=GPR78 PE=1 SV=2 | 201 | R | 0.362002 | S | 0.403871 | -0.041869 | No Change: Both O | - |
| Q96P69 | GPR78_HUMAN G-protein coupled receptor 78 OS=Homo sapiens GN=GPR78 PE=1 SV=2 | 330 | A | 0.688219 | T | 0.730867 | -0.042648 | No Change: Both D | - |
| Q96P69 | GPR78_HUMAN G-protein coupled receptor 78 OS=Homo sapiens GN=GPR78 PE=1 SV=2 | 342 | R | 0.799566 | H | 0.788123 | 0.011443 | No Change: Both D | - |
| Q9NYM4 | GPR83_HUMAN Probable G-protein coupled receptor 83 OS=Homo sapiens GN=GPR83 PE=2 SV=2 | 374 | P | 0.842789 | Q | 0.823736 | 0.019053 | No Change: Both D | - |
| Q9NQS5 | GPR84_HUMAN G-protein coupled receptor 84 OS=Homo sapiens GN=GPR84 PE=2 SV=1 | 37 | G | 0.136411 | D | 0.143773 | -0.007362 | No Change: Both O | - |
| Q9BY21 | GPR87_HUMAN G-protein coupled receptor 87 OS=Homo sapiens GN=GPR87 PE=2 SV=1 | 191 | D | 0.514735 | Y | 0.311783 | 0.202952 | D to O | A colorectal cancer sample |
| Q9BY21 | GPR87_HUMAN G-protein coupled receptor 87 OS=Homo sapiens GN=GPR87 PE=2 SV=1 | 205 | T | 0.108128 | M | 0.082015 | 0.026113 | No Change: Both O | - |
| Q9GZN0 | GPR88_HUMAN Probable G-protein coupled receptor 88 OS=Homo sapiens GN=GPR88 PE=2 SV=2 | 190 | V | 0.38786 | I | 0.352942 | 0.034918 | No Change: Both O | - |
| Q9GZN0 | GPR88_HUMAN Probable G-protein coupled receptor 88 OS=Homo sapiens GN=GPR88 PE=2 SV=2 | 318 | Q | 0.071495 | H | 0.065625 | 0.00587 | No Change: Both O | - |
| Q86Y34 | GPR97_HUMAN Probable G-protein coupled receptor 97 OS=Homo sapiens GN=GPR97 PE=1 SV=1 | 430 | A | 0.076002 | T | 0.097455 | -0.021453 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 127 | L | 0.275381 | R | 0.421197 | -0.145816 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 249 | R | 0.42278 | K | 0.49018 | -0.0674 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1093 | L | 0.086883 | F | 0.078948 | 0.007935 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1927 | T | 0.314367 | M | 0.25084 | 0.063527 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1951 | V | 0.439097 | I | 0.383634 | 0.055463 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1985 | N | 0.407972 | D | 0.424519 | -0.016547 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1987 | P | 0.548818 | L | 0.371374 | 0.177444 | D to O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2004 | L | 0.133468 | F | 0.1077 | 0.025768 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2232 | Y | 0.192323 | C | 0.157158 | 0.035165 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2345 | N | 0.26882 | S | 0.294977 | -0.026157 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2379 | G | 0.328076 | A | 0.25978 | 0.068296 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2584 | N | 0.14549 | S | 0.173582 | -0.028092 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2764 | S | 0.29576 | L | 0.15732 | 0.13844 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2803 | A | 0.19584 | T | 0.202952 | -0.007112 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3217 | A | 0.32645 | V | 0.26297 | 0.06348 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3248 | G | 0.285977 | D | 0.312256 | -0.026279 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3471 | E | 0.058675 | K | 0.057745 | 9.30E-04 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 5344 | E | 0.525092 | G | 0.490715 | 0.034377 | D to O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 5437 | T | 0.485797 | A | 0.419958 | 0.065839 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 551 | V | 0.241935 | A | 0.287839 | -0.045904 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1187 | I | 0.23885 | V | 0.248446 | -0.009596 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 1916 | T | 0.284767 | I | 0.179582 | 0.105185 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 2097 | R | 0.529802 | C | 0.391783 | 0.138019 | D to O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3094 | V | 0.169341 | I | 0.138312 | 0.031029 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3347 | F | 0.111513 | L | 0.123002 | -0.011489 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3867 | E | 0.318828 | A | 0.207053 | 0.111775 | No Change: Both O | - |
| Q8WXG9 | GPR98_HUMAN G-protein coupled receptor 98 OS=Homo sapiens GN=GPR98 PE=1 SV=2 | 3868 | E | 0.290103 | A | 0.184728 | 0.105375 | No Change: Both O | - |
| Q5JY77 | GASP1_HUMAN G-protein coupled receptor-associated sorting protein 1 OS=Homo sapiens GN=GPRASP1 PE=1 SV=3 | 315 | A | 0.876477 | G | 0.887945 | -0.011468 | No Change: Both D | - |
| Q5JY77 | GASP1_HUMAN G-protein coupled receptor-associated sorting protein 1 OS=Homo sapiens GN=GPRASP1 PE=1 SV=3 | 779 | I | 0.801742 | V | 0.773743 | 0.027999 | No Change: Both D | - |
| Q5JY77 | GASP1_HUMAN G-protein coupled receptor-associated sorting protein 1 OS=Homo sapiens GN=GPRASP1 PE=1 SV=3 | 1093 | P | 0.885561 | S | 0.881858 | 0.003703 | No Change: Both D | - |
| Q96D09 | GASP2_HUMAN G-protein coupled receptor-associated sorting protein 2 OS=Homo sapiens GN=GPRASP2 PE=1 SV=1 | 173 | R | 0.499898 | S | 0.598452 | -0.098554 | O to D | - |
| Q8NFJ5 | RAI3_HUMAN Retinoic acid-induced protein 3 OS=Homo sapiens GN=GPRC5A PE=1 SV=2 | 118 | S | 0.177457 | G | 0.148457 | 0.029 | No Change: Both O | - |
| Q8NFJ5 | RAI3_HUMAN Retinoic acid-induced protein 3 OS=Homo sapiens GN=GPRC5A PE=1 SV=2 | 9 | C | 0.414738 | F | 0.43298 | -0.018242 | No Change: Both O | - |
| Q8NFJ5 | RAI3_HUMAN Retinoic acid-induced protein 3 OS=Homo sapiens GN=GPRC5A PE=1 SV=2 | 182 | T | 0.017096 | A | 0.015 | 0.002096 | No Change: Both O | - |
| Q9NZD1 | GPC5D_HUMAN G-protein coupled receptor family C group 5 member D OS=Homo sapiens GN=GPRC5D PE=2 SV=1 | 18 | A | 0.075274 | D | 0.119677 | -0.044403 | No Change: Both O | - |
| Q5T6X5 | GPC6A_HUMAN G-protein coupled receptor family C group 6 member A OS=Homo sapiens GN=GPRC6A PE=1 SV=1 | 91 | P | 0.214328 | S | 0.251182 | -0.036854 | No Change: Both O | - |
| Q5T6X5 | GPC6A_HUMAN G-protein coupled receptor family C group 6 member A OS=Homo sapiens GN=GPRC6A PE=1 SV=1 | 144 | I | 0.279066 | R | 0.429562 | -0.150496 | No Change: Both O | - |
| Q5T6X5 | GPC6A_HUMAN G-protein coupled receptor family C group 6 member A OS=Homo sapiens GN=GPRC6A PE=1 SV=1 | 599 | I | 0.023222 | T | 0.041104 | -0.017882 | No Change: Both O | - |
| Q7Z2K8 | GRIN1_HUMAN G protein-regulated inducer of neurite outgrowth 1 OS=Homo sapiens GN=GPRIN1 PE=1 SV=2 | 337 | G | 0.894886 | A | 0.872179 | 0.022707 | No Change: Both D | - |
| Q7Z2K8 | GRIN1_HUMAN G protein-regulated inducer of neurite outgrowth 1 OS=Homo sapiens GN=GPRIN1 PE=1 SV=2 | 357 | S | 0.780801 | P | 0.7948 | -0.013999 | No Change: Both D | - |
| Q7Z2K8 | GRIN1_HUMAN G protein-regulated inducer of neurite outgrowth 1 OS=Homo sapiens GN=GPRIN1 PE=1 SV=2 | 121 | P | 0.9809 | T | 0.976126 | 0.004774 | No Change: Both D | - |
| Q7Z2K8 | GRIN1_HUMAN G protein-regulated inducer of neurite outgrowth 1 OS=Homo sapiens GN=GPRIN1 PE=1 SV=2 | 300 | M | 0.973162 | V | 0.960777 | 0.012385 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 39 | L | 0.975691 | V | 0.971427 | 0.004264 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 104 | S | 0.7576 | G | 0.708979 | 0.048621 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 5 | R | 0.998356 | H | 0.997198 | 0.001158 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 40 | R | 0.975194 | H | 0.962325 | 0.012869 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 47 | V | 0.973434 | M | 0.983291 | -0.009857 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 91 | W | 0.816037 | R | 0.9051 | -0.089063 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 400 | L | 0.129584 | P | 0.213825 | -0.084241 | No Change: Both O | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 100 | T | 0.758655 | P | 0.806353 | -0.047698 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 202 | G | 0.841587 | W | 0.739124 | 0.102463 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 233 | A | 0.435374 | S | 0.478194 | -0.04282 | No Change: Both O | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 241 | V | 0.35526 | M | 0.459943 | -0.104683 | No Change: Both O | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 242 | R | 0.34871 | G | 0.35562 | -0.00691 | No Change: Both O | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 328 | S | 0.749711 | C | 0.646225 | 0.103486 | No Change: Both D | - |
| O60269 | GRIN2_HUMAN G protein-regulated inducer of neurite outgrowth 2 OS=Homo sapiens GN=GPRIN2 PE=1 SV=2 | 375 | V | 0.609985 | A | 0.646129 | -0.036144 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 39 | L | 0.804259 | V | 0.763324 | 0.040935 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 378 | A | 0.825222 | V | 0.779836 | 0.045386 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 382 | S | 0.788692 | P | 0.784247 | 0.004445 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 390 | P | 0.569786 | S | 0.586775 | -0.016989 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 446 | V | 0.701382 | A | 0.786393 | -0.085011 | No Change: Both D | - |
| Q6ZVF9 | GRIN3_HUMAN G protein-regulated inducer of neurite outgrowth 3 OS=Homo sapiens GN=GPRIN3 PE=2 SV=2 | 746 | R | 0.925451 | K | 0.925476 | -2.50E-05 | No Change: Both D | - |
| Q13227 | GPS2_HUMAN G protein pathway suppressor 2 OS=Homo sapiens GN=GPS2 PE=1 SV=3 | 306 | T | 0.86914 | A | 0.888693 | -0.019553 | No Change: Both D | - |
| P24298 | ALAT1_HUMAN Alanine aminotransferase 1 OS=Homo sapiens GN=GPT PE=1 SV=3 | 14 | H | 0.494578 | N | 0.554586 | -0.060008 | O to D | - |
| O75715 | GPX5_HUMAN Epididymal secretory glutathione peroxidase OS=Homo sapiens GN=GPX5 PE=1 SV=1 | 85 | L | 0.451795 | V | 0.429449 | 0.022346 | No Change: Both O | - |
| O75715 | GPX5_HUMAN Epididymal secretory glutathione peroxidase OS=Homo sapiens GN=GPX5 PE=1 SV=1 | 85 | L | 0.451795 | P | 0.603873 | -0.152078 | O to D | - |
| Q8TED1 | GPX8_HUMAN Probable glutathione peroxidase 8 OS=Homo sapiens GN=GPX8 PE=1 SV=2 | 182 | K | 0.29081 | R | 0.229795 | 0.061015 | No Change: Both O | - |
| Q8IYS0 | GRM1C_HUMAN GRAM domain-containing protein 1C OS=Homo sapiens GN=GRAMD1C PE=2 SV=2 | 644 | L | 0.343773 | P | 0.441736 | -0.097963 | No Change: Both O | - |
| Q6IC98 | GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens GN=GRAMD4 PE=1 SV=1 | 159 | S | 0.815536 | I | 0.673556 | 0.14198 | No Change: Both D | - |
| O75791 | GRAP2_HUMAN GRB2-related adapter protein 2 OS=Homo sapiens GN=GRAP2 PE=1 SV=1 | 319 | L | 0.194246 | F | 0.170625 | 0.023621 | No Change: Both O | - |
| Q13322 | GRB10_HUMAN Growth factor receptor-bound protein 10 OS=Homo sapiens GN=GRB10 PE=1 SV=2 | 36 | P | 0.844475 | L | 0.73424 | 0.110235 | No Change: Both D | - |
| Q13322 | GRB10_HUMAN Growth factor receptor-bound protein 10 OS=Homo sapiens GN=GRB10 PE=1 SV=2 | 558 | D | 0.460991 | H | 0.399636 | 0.061355 | No Change: Both O | - |
| Q13322 | GRB10_HUMAN Growth factor receptor-bound protein 10 OS=Homo sapiens GN=GRB10 PE=1 SV=2 | 95 | P | 0.974156 | S | 0.974524 | -3.68E-04 | No Change: Both D | - |
| Q14449 | GRB14_HUMAN Growth factor receptor-bound protein 14 OS=Homo sapiens GN=GRB14 PE=1 SV=2 | 90 | F | 0.651325 | I | 0.632042 | 0.019283 | No Change: Both D | - |
| Q14449 | GRB14_HUMAN Growth factor receptor-bound protein 14 OS=Homo sapiens GN=GRB14 PE=1 SV=2 | 507 | H | 0.404053 | Y | 0.273436 | 0.130617 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 77 | N | 0.84446 | T | 0.83976 | 0.0047 | No Change: Both D | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 122 | V | 0.32558 | A | 0.384573 | -0.058993 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 346 | V | 0.558014 | M | 0.612942 | -0.054928 | No Change: Both D | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 973 | R | 0.283724 | Q | 0.2832 | 5.24E-04 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 1463 | Y | 0.30622 | C | 0.297363 | 0.008857 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 1687 | D | 0.220358 | N | 0.21579 | 0.004568 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 1814 | L | 0.309234 | V | 0.282367 | 0.026867 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 359 | F | 0.326641 | L | 0.369622 | -0.042981 | No Change: Both O | - |
| Q4ZG55 | GREB1_HUMAN Protein GREB1 OS=Homo sapiens GN=GREB1 PE=2 SV=1 | 632 | A | 0.611833 | T | 0.628716 | -0.016883 | No Change: Both D | - |
| Q9H772 | GREM2_HUMAN Gremlin-2 OS=Homo sapiens GN=GREM2 PE=1 SV=1 | 131 | V | 0.435161 | I | 0.386501 | 0.04866 | No Change: Both O | - |
| Q9NZI5 | GRHL1_HUMAN Grainyhead-like protein 1 homolog OS=Homo sapiens GN=GRHL1 PE=1 SV=2 | 191 | N | 0.559911 | S | 0.604479 | -0.044568 | No Change: Both D | - |
| Q9NZI5 | GRHL1_HUMAN Grainyhead-like protein 1 homolog OS=Homo sapiens GN=GRHL1 PE=1 SV=2 | 397 | V | 0.223919 | I | 0.210547 | 0.013372 | No Change: Both O | - |
| Q6ISB3 | GRHL2_HUMAN Grainyhead-like protein 2 homolog OS=Homo sapiens GN=GRHL2 PE=1 SV=1 | 415 | V | 0.424033 | I | 0.467501 | -0.043468 | No Change: Both O | - |
| Q8TE85 | GRHL3_HUMAN Grainyhead-like protein 3 homolog OS=Homo sapiens GN=GRHL3 PE=1 SV=3 | 55 | D | 0.411548 | E | 0.409321 | 0.002227 | No Change: Both O | - |
| Q8TE85 | GRHL3_HUMAN Grainyhead-like protein 3 homolog OS=Homo sapiens GN=GRHL3 PE=1 SV=3 | 160 | V | 0.606955 | A | 0.695973 | -0.089018 | No Change: Both D | - |
| Q9UBQ7 | GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens GN=GRHPR PE=1 SV=1 | 170 | R | 0.221535 | Q | 0.236196 | -0.014661 | No Change: Both O | - |
| P42261 | GRIA1_HUMAN Glutamate receptor 1 OS=Homo sapiens GN=GRIA1 PE=1 SV=2 | 487 | D | 0.142668 | N | 0.133616 | 0.009052 | No Change: Both O | - |
| P42261 | GRIA1_HUMAN Glutamate receptor 1 OS=Homo sapiens GN=GRIA1 PE=1 SV=2 | 521 | P | 0.713239 | T | 0.654798 | 0.058441 | No Change: Both D | - |
| P42261 | GRIA1_HUMAN Glutamate receptor 1 OS=Homo sapiens GN=GRIA1 PE=1 SV=2 | 536 | A | 0.032943 | S | 0.059429 | -0.026486 | No Change: Both O | - |
| P42261 | GRIA1_HUMAN Glutamate receptor 1 OS=Homo sapiens GN=GRIA1 PE=1 SV=2 | 548 | I | 0.011952 | M | 0.018352 | -0.0064 | No Change: Both O | - |
| P42261 | GRIA1_HUMAN Glutamate receptor 1 OS=Homo sapiens GN=GRIA1 PE=1 SV=2 | 588 | F | 0.264658 | L | 0.267592 | -0.002934 | No Change: Both O | - |
| P42262 | GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens GN=GRIA2 PE=1 SV=3 | 607 | Q | 0.200046 | R | 0.183224 | 0.016822 | No Change: Both O | - |
| P42262 | GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens GN=GRIA2 PE=1 SV=3 | 608 | Q | 0.245812 | R | 0.22702 | 0.018792 | No Change: Both O | - |
| P42263 | GRIA3_HUMAN Glutamate receptor 3 OS=Homo sapiens GN=GRIA3 PE=1 SV=2 | 525 | F | 0.234314 | L | 0.258383 | -0.024069 | No Change: Both O | - |
| P42263 | GRIA3_HUMAN Glutamate receptor 3 OS=Homo sapiens GN=GRIA3 PE=1 SV=2 | 450 | R | 0.437122 | Q | 0.470749 | -0.033627 | No Change: Both O | Mental retardation X-linked type 94 (MRX94) [MIM:300699] |
| P42263 | GRIA3_HUMAN Glutamate receptor 3 OS=Homo sapiens GN=GRIA3 PE=1 SV=2 | 631 | R | 0.225282 | S | 0.28677 | -0.061488 | No Change: Both O | Mental retardation X-linked type 94 (MRX94) [MIM:300699] |
| P42263 | GRIA3_HUMAN Glutamate receptor 3 OS=Homo sapiens GN=GRIA3 PE=1 SV=2 | 706 | M | 0.448851 | T | 0.478259 | -0.029408 | No Change: Both O | Mental retardation X-linked type 94 (MRX94) [MIM:300699] |
| P42263 | GRIA3_HUMAN Glutamate receptor 3 OS=Homo sapiens GN=GRIA3 PE=1 SV=2 | 833 | G | 0.062428 | R | 0.05473 | 0.007698 | No Change: Both O | Mental retardation X-linked type 94 (MRX94) [MIM:300699] |
| Q9ULK0 | GRID1_HUMAN Glutamate receptor delta-1 subunit OS=Homo sapiens GN=GRID1 PE=2 SV=2 | 529 | V | 0.443179 | I | 0.405101 | 0.038078 | No Change: Both O | - |
| O43424 | GRID2_HUMAN Glutamate receptor delta-2 subunit OS=Homo sapiens GN=GRID2 PE=2 SV=2 | 209 | T | 0.194789 | N | 0.221621 | -0.026832 | No Change: Both O | A colorectal cancer sample |
| O43424 | GRID2_HUMAN Glutamate receptor delta-2 subunit OS=Homo sapiens GN=GRID2 PE=2 SV=2 | 68 | T | 0.173416 | M | 0.136562 | 0.036854 | No Change: Both O | - |
| O43424 | GRID2_HUMAN Glutamate receptor delta-2 subunit OS=Homo sapiens GN=GRID2 PE=2 SV=2 | 398 | F | 0.348809 | S | 0.546271 | -0.197462 | O to D | - |
| O43424 | GRID2_HUMAN Glutamate receptor delta-2 subunit OS=Homo sapiens GN=GRID2 PE=2 SV=2 | 490 | V | 0.182261 | I | 0.172179 | 0.010082 | No Change: Both O | - |
| A4D2P6 | GRD2I_HUMAN Delphilin OS=Homo sapiens GN=GRID2IP PE=2 SV=2 | 20 | R | 0.301651 | Q | 0.329442 | -0.027791 | No Change: Both O | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 636 | Q | 0.352882 | R | 0.319105 | 0.033777 | No Change: Both O | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 757 | I | 0.301131 | V | 0.342834 | -0.041703 | No Change: Both O | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 870 | A | 0.091571 | V | 0.065448 | 0.026123 | No Change: Both O | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 902 | L | 0.542599 | S | 0.736917 | -0.194318 | No Change: Both D | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 332 | A | 0.17645 | V | 0.126606 | 0.049844 | No Change: Both O | - |
| P39086 | GRIK1_HUMAN Glutamate receptor ionotropic kainate 1 OS=Homo sapiens GN=GRIK1 PE=1 SV=1 | 862 | R | 0.463172 | Q | 0.492886 | -0.029714 | No Change: Both O | - |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 567 | I | 0.015141 | V | 0.016964 | -0.001823 | No Change: Both O | - |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 571 | Y | 0.012826 | C | 0.01028 | 0.002546 | No Change: Both O | - |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 621 | Q | 0.352882 | R | 0.319105 | 0.033777 | No Change: Both O | - |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 187 | E | 0.238601 | Q | 0.219804 | 0.018797 | No Change: Both O | A breast cancer sample |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 867 | M | 0.48682 | I | 0.34757 | 0.13925 | No Change: Both O | - |
| Q13002 | GRIK2_HUMAN Glutamate receptor ionotropic kainate 2 OS=Homo sapiens GN=GRIK2 PE=1 SV=1 | 766 | V | 0.452941 | I | 0.437861 | 0.01508 | No Change: Both O | - |
| Q13003 | GRIK3_HUMAN Glutamate receptor ionotropic kainate 3 OS=Homo sapiens GN=GRIK3 PE=1 SV=3 | 310 | S | 0.638032 | A | 0.527584 | 0.110448 | No Change: Both D | - |
| Q13003 | GRIK3_HUMAN Glutamate receptor ionotropic kainate 3 OS=Homo sapiens GN=GRIK3 PE=1 SV=3 | 352 | R | 0.228349 | Q | 0.244046 | -0.015697 | No Change: Both O | - |
| Q13003 | GRIK3_HUMAN Glutamate receptor ionotropic kainate 3 OS=Homo sapiens GN=GRIK3 PE=1 SV=3 | 215 | R | 0.669158 | H | 0.634863 | 0.034295 | No Change: Both D | A colorectal cancer sample |
| Q13003 | GRIK3_HUMAN Glutamate receptor ionotropic kainate 3 OS=Homo sapiens GN=GRIK3 PE=1 SV=3 | 391 | D | 0.230534 | H | 0.18415 | 0.046384 | No Change: Both O | A breast cancer sample |
| Q16099 | GRIK4_HUMAN Glutamate receptor ionotropic kainate 4 OS=Homo sapiens GN=GRIK4 PE=2 SV=2 | 528 | V | 0.143912 | I | 0.137342 | 0.00657 | No Change: Both O | - |
| Q16099 | GRIK4_HUMAN Glutamate receptor ionotropic kainate 4 OS=Homo sapiens GN=GRIK4 PE=2 SV=2 | 824 | M | 0.02159 | T | 0.026468 | -0.004878 | No Change: Both O | - |
| Q16478 | GRIK5_HUMAN Glutamate receptor ionotropic kainate 5 OS=Homo sapiens GN=GRIK5 PE=2 SV=2 | 527 | V | 0.143802 | M | 0.197837 | -0.054035 | No Change: Both O | - |
| Q05586 | NMDZ1_HUMAN Glutamate [NMDA] receptor subunit zeta-1 OS=Homo sapiens GN=GRIN1 PE=1 SV=1 | 540 | I | 0.133306 | M | 0.186658 | -0.053352 | No Change: Both O | - |
| Q05586 | NMDZ1_HUMAN Glutamate [NMDA] receptor subunit zeta-1 OS=Homo sapiens GN=GRIN1 PE=1 SV=1 | 662 | E | 0.406093 | K | 0.387883 | 0.01821 | No Change: Both O | Mental retardation autosomal dominant type 8 (MRD8) [MIM:614254] |
| Q12879 | NMDE1_HUMAN Glutamate [NMDA] receptor subunit epsilon-1 OS=Homo sapiens GN=GRIN2A PE=1 SV=1 | 270 | K | 0.454483 | E | 0.471665 | -0.017182 | No Change: Both O | - |
| Q12879 | NMDE1_HUMAN Glutamate [NMDA] receptor subunit epsilon-1 OS=Homo sapiens GN=GRIN2A PE=1 SV=1 | 615 | N | 0.188547 | K | 0.209141 | -0.020594 | No Change: Both O | Epilepsy with neurodevelopmental defects (EPND) [MIM:613971] |
| Q13224 | NMDE2_HUMAN Glutamate [NMDA] receptor subunit epsilon-2 OS=Homo sapiens GN=GRIN2B PE=1 SV=3 | 407 | S | 0.371168 | N | 0.322616 | 0.048552 | No Change: Both O | - |
| Q13224 | NMDE2_HUMAN Glutamate [NMDA] receptor subunit epsilon-2 OS=Homo sapiens GN=GRIN2B PE=1 SV=3 | 682 | R | 0.501029 | C | 0.329196 | 0.171833 | D to O | Mental retardation autosomal dominant type 6 (MRD6) [MIM:613970] |
| Q14957 | NMDE3_HUMAN Glutamate [NMDA] receptor subunit epsilon-3 OS=Homo sapiens GN=GRIN2C PE=2 SV=3 | 1209 | R | 0.509631 | S | 0.547681 | -0.03805 | No Change: Both D | - |
| O15399 | NMDE4_HUMAN Glutamate [NMDA] receptor subunit epsilon-4 OS=Homo sapiens GN=GRIN2D PE=2 SV=2 | 140 | P | 0.237008 | S | 0.272128 | -0.03512 | No Change: Both O | A breast cancer sample |
| O15399 | NMDE4_HUMAN Glutamate [NMDA] receptor subunit epsilon-4 OS=Homo sapiens GN=GRIN2D PE=2 SV=2 | 286 | G | 0.798174 | R | 0.773354 | 0.02482 | No Change: Both D | A breast cancer sample |
| O15399 | NMDE4_HUMAN Glutamate [NMDA] receptor subunit epsilon-4 OS=Homo sapiens GN=GRIN2D PE=2 SV=2 | 527 | E | 0.10224 | G | 0.0899 | 0.01234 | No Change: Both O | A breast cancer sample |
| Q8TCU5 | NMD3A_HUMAN Glutamate [NMDA] receptor subunit 3A OS=Homo sapiens GN=GRIN3A PE=1 SV=2 | 362 | V | 0.504888 | M | 0.551707 | -0.046819 | No Change: Both D | - |
| Q8TCU5 | NMD3A_HUMAN Glutamate [NMDA] receptor subunit 3A OS=Homo sapiens GN=GRIN3A PE=1 SV=2 | 487 | G | 0.200558 | R | 0.183723 | 0.016835 | No Change: Both O | - |
| Q8TCU5 | NMD3A_HUMAN Glutamate [NMDA] receptor subunit 3A OS=Homo sapiens GN=GRIN3A PE=1 SV=2 | 835 | D | 0.512989 | N | 0.495353 | 0.017636 | D to O | - |
| Q8TCU5 | NMD3A_HUMAN Glutamate [NMDA] receptor subunit 3A OS=Homo sapiens GN=GRIN3A PE=1 SV=2 | 1041 | R | 0.42815 | Q | 0.445626 | -0.017476 | No Change: Both O | - |
| Q8TCU5 | NMD3A_HUMAN Glutamate [NMDA] receptor subunit 3A OS=Homo sapiens GN=GRIN3A PE=1 SV=2 | 480 | R | 0.237259 | H | 0.240375 | -0.003116 | No Change: Both O | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 157 | T | 0.143178 | M | 0.121226 | 0.021952 | No Change: Both O | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 404 | R | 0.743187 | W | 0.617748 | 0.125439 | No Change: Both D | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 414 | W | 0.509693 | R | 0.731533 | -0.22184 | No Change: Both D | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 577 | T | 0.034245 | M | 0.028687 | 0.005558 | No Change: Both O | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 845 | A | 0.302165 | T | 0.327322 | -0.025157 | No Change: Both O | - |
| O60391 | NMD3B_HUMAN Glutamate [NMDA] receptor subunit 3B OS=Homo sapiens GN=GRIN3B PE=2 SV=2 | 612 | T | 0.520066 | A | 0.488526 | 0.03154 | D to O | - |
| Q7Z429 | GRINA_HUMAN Glutamate [NMDA] receptor-associated protein 1 OS=Homo sapiens GN=GRINA PE=2 SV=1 | 107 | S | 0.997961 | N | 0.997824 | 1.37E-04 | No Change: Both D | - |
| Q9Y3R0 | GRIP1_HUMAN Glutamate receptor-interacting protein 1 OS=Homo sapiens GN=GRIP1 PE=1 SV=3 | 322 | A | 0.272995 | T | 0.30841 | -0.035415 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 380 | V | 0.057139 | D | 0.117367 | -0.060228 | No Change: Both O | Congenital stationary night blindness Oguchi type 2 (CSNBO2) [MIM:613411] |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 136 | E | 0.359616 | Q | 0.316459 | 0.043157 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 298 | T | 0.049113 | M | 0.041451 | 0.007662 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 330 | N | 0.354524 | S | 0.396036 | -0.041512 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 438 | R | 0.666874 | H | 0.627733 | 0.039141 | No Change: Both D | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 514 | C | 0.173655 | S | 0.346504 | -0.172849 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 522 | M | 0.284756 | T | 0.323696 | -0.03894 | No Change: Both O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 536 | S | 0.559851 | L | 0.389523 | 0.170328 | D to O | - |
| Q15835 | RK_HUMAN Rhodopsin kinase OS=Homo sapiens GN=GRK1 PE=1 SV=1 | 391 | P | 0.32655 | H | 0.29472 | 0.03183 | No Change: Both O | Congenital stationary night blindness Oguchi type 2 (CSNBO2) [MIM:613411] |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 247 | V | 0.121663 | I | 0.101208 | 0.020455 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 65 | R | 0.312437 | L | 0.207695 | 0.104742 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 142 | A | 0.641582 | V | 0.588273 | 0.053309 | No Change: Both D | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 486 | V | 0.095255 | A | 0.125729 | -0.030474 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 425 | L | 0.435453 | P | 0.608707 | -0.173254 | O to D | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 116 | A | 0.468308 | T | 0.47777 | -0.009462 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 383 | H | 0.356043 | Q | 0.381306 | -0.025263 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 473 | V | 0.132955 | I | 0.111683 | 0.021272 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 495 | A | 0.222931 | T | 0.246785 | -0.023854 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 95 | D | 0.53057 | H | 0.495112 | 0.035458 | D to O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 183 | T | 0.365603 | R | 0.386524 | -0.020921 | No Change: Both O | - |
| P32298 | GRK4_HUMAN G protein-coupled receptor kinase 4 OS=Homo sapiens GN=GRK4 PE=1 SV=3 | 440 | A | 0.470823 | V | 0.413915 | 0.056908 | No Change: Both O | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 41 | Q | 0.447993 | L | 0.339464 | 0.108529 | No Change: Both O | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 119 | A | 0.41115 | V | 0.38465 | 0.0265 | No Change: Both O | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 122 | G | 0.408197 | S | 0.502328 | -0.094131 | O to D | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 129 | T | 0.548886 | M | 0.525743 | 0.023143 | No Change: Both D | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 141 | L | 0.307342 | I | 0.255179 | 0.052163 | No Change: Both O | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 163 | D | 0.210701 | E | 0.235126 | -0.024425 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 304 | R | 0.324411 | H | 0.330195 | -0.005784 | No Change: Both O | - |
| P34947 | GRK5_HUMAN G protein-coupled receptor kinase 5 OS=Homo sapiens GN=GRK5 PE=1 SV=1 | 172 | Q | 0.060341 | H | 0.052594 | 0.007747 | No Change: Both O | - |
| P43250 | GRK6_HUMAN G protein-coupled receptor kinase 6 OS=Homo sapiens GN=GRK6 PE=1 SV=2 | 31 | R | 0.53271 | Q | 0.553823 | -0.021113 | No Change: Both D | A gastric adenocarcinoma sample |
| P43250 | GRK6_HUMAN G protein-coupled receptor kinase 6 OS=Homo sapiens GN=GRK6 PE=1 SV=2 | 73 | T | 0.322771 | M | 0.298669 | 0.024102 | No Change: Both O | - |
| P43250 | GRK6_HUMAN G protein-coupled receptor kinase 6 OS=Homo sapiens GN=GRK6 PE=1 SV=2 | 275 | I | 0.167421 | M | 0.255615 | -0.088194 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 81 | R | 0.215655 | H | 0.20885 | 0.006805 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 113 | C | 0.610884 | W | 0.505257 | 0.105627 | No Change: Both D | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 115 | S | 0.643015 | C | 0.533545 | 0.10947 | No Change: Both D | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 127 | S | 0.726228 | T | 0.708971 | 0.017257 | No Change: Both D | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 196 | V | 0.197103 | G | 0.330819 | -0.133716 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 196 | V | 0.197103 | M | 0.245958 | -0.048855 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 226 | R | 0.793687 | W | 0.631842 | 0.161845 | No Change: Both D | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 253 | S | 0.165638 | F | 0.070877 | 0.094761 | No Change: Both O | A metastatic melanoma sample |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 309 | E | 0.121521 | Q | 0.099117 | 0.022404 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 313 | V | 0.18978 | I | 0.176169 | 0.013611 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 443 | E | 0.792047 | G | 0.756859 | 0.035188 | No Change: Both D | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 460 | P | 0.382656 | T | 0.299246 | 0.08341 | No Change: Both O | - |
| Q8WTQ7 | GRK7_HUMAN G protein-coupled receptor kinase 7 OS=Homo sapiens GN=GRK7 PE=1 SV=1 | 461 | R | 0.398557 | C | 0.285841 | 0.112716 | No Change: Both O | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 929 | V | 0.322846 | I | 0.297554 | 0.025292 | No Change: Both O | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 34 | S | 0.543912 | Y | 0.342092 | 0.20182 | D to O | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 285 | R | 0.141697 | K | 0.169275 | -0.027578 | No Change: Both O | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 741 | E | 0.136426 | D | 0.122061 | 0.014365 | No Change: Both O | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 884 | G | 0.694001 | E | 0.698605 | -0.004604 | No Change: Both D | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 993 | S | 0.944777 | P | 0.95384 | -0.009063 | No Change: Both D | - |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 696 | R | 0.387346 | W | 0.188624 | 0.198722 | No Change: Both O | A colorectal cancer sample |
| Q13255 | GRM1_HUMAN Metabotropic glutamate receptor 1 OS=Homo sapiens GN=GRM1 PE=1 SV=3 | 593 | S | 0.097419 | P | 0.079209 | 0.01821 | No Change: Both O | - |
| Q14832 | GRM3_HUMAN Metabotropic glutamate receptor 3 OS=Homo sapiens GN=GRM3 PE=1 SV=2 | 475 | G | 0.256905 | D | 0.264458 | -0.007553 | No Change: Both O | - |
| Q14833 | GRM4_HUMAN Metabotropic glutamate receptor 4 OS=Homo sapiens GN=GRM4 PE=1 SV=1 | 797 | V | 0.007117 | I | 0.006951 | 1.66E-04 | No Change: Both O | - |
| Q14833 | GRM4_HUMAN Metabotropic glutamate receptor 4 OS=Homo sapiens GN=GRM4 PE=1 SV=1 | 169 | L | 0.075566 | F | 0.070841 | 0.004725 | No Change: Both O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 150 | G | 0.48772 | S | 0.580175 | -0.092455 | O to D | Congenital stationary night blindness type 1B (CSNB1B) [MIM:257270] |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 781 | E | 0.444877 | K | 0.444541 | 3.36E-04 | No Change: Both O | Congenital stationary night blindness type 1B (CSNB1B) [MIM:257270] |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 191 | S | 0.302734 | F | 0.133659 | 0.169075 | No Change: Both O | A breast cancer sample |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 227 | E | 0.540113 | V | 0.357197 | 0.182916 | D to O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 236 | I | 0.281009 | F | 0.290587 | -0.009578 | No Change: Both O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 712 | M | 0.08246 | V | 0.074614 | 0.007846 | No Change: Both O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 807 | A | 0.178476 | V | 0.1241 | 0.054376 | No Change: Both O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 817 | T | 0.190298 | S | 0.252572 | -0.062274 | No Change: Both O | - |
| O15303 | GRM6_HUMAN Metabotropic glutamate receptor 6 OS=Homo sapiens GN=GRM6 PE=1 SV=2 | 59 | Q | 0.492768 | P | 0.497901 | -0.005133 | No Change: Both O | - |
| Q14831 | GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens GN=GRM7 PE=1 SV=1 | 433 | Y | 0.158265 | F | 0.138409 | 0.019856 | No Change: Both O | - |
| Q14831 | GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens GN=GRM7 PE=1 SV=1 | 495 | I | 0.168071 | V | 0.187868 | -0.019797 | No Change: Both O | - |
| Q14831 | GRM7_HUMAN Metabotropic glutamate receptor 7 OS=Homo sapiens GN=GRM7 PE=1 SV=1 | 745 | G | 0.245077 | E | 0.30987 | -0.064793 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 10 | S | 0.16318 | C | 0.064492 | 0.098688 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 21 | F | 0.019173 | C | 0.01807 | 0.001103 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 392 | R | 0.495351 | Q | 0.510921 | -0.01557 | O to D | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 548 | V | 0.387362 | G | 0.519484 | -0.132122 | O to D | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 265 | I | 0.475068 | T | 0.584228 | -0.10916 | O to D | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 362 | F | 0.12555 | Y | 0.112579 | 0.012971 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 368 | G | 0.286853 | D | 0.292029 | -0.005176 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 430 | L | 0.114573 | F | 0.097322 | 0.017251 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 343 | R | 0.270594 | Q | 0.266 | 0.004594 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 768 | I | 0.135335 | N | 0.270256 | -0.134921 | No Change: Both O | - |
| O00222 | GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens GN=GRM8 PE=2 SV=2 | 902 | S | 0.873888 | I | 0.702021 | 0.171867 | No Change: Both D | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 515 | G | 0.402839 | A | 0.365974 | 0.036865 | No Change: Both O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 9 | A | 0.055911 | D | 0.074438 | -0.018527 | No Change: Both O | Ubiquitin-positive frontotemporal dementia (UP-FTD) [MIM:607485] |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 19 | R | 0.212003 | W | 0.09155 | 0.120453 | No Change: Both O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 55 | R | 0.433101 | W | 0.256061 | 0.17704 | No Change: Both O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 69 | A | 0.412388 | T | 0.440909 | -0.028521 | No Change: Both O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 120 | S | 0.741357 | Y | 0.501548 | 0.239809 | No Change: Both D | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 182 | T | 0.516934 | M | 0.470343 | 0.046591 | D to O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 221 | C | 0.887237 | S | 0.918058 | -0.030821 | No Change: Both D | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 275 | P | 0.392727 | L | 0.264186 | 0.128541 | No Change: Both O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 376 | D | 0.84599 | N | 0.823511 | 0.022479 | No Change: Both D | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 398 | S | 0.629773 | L | 0.45947 | 0.170303 | D to O | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 433 | R | 0.688265 | Q | 0.693806 | -0.005541 | No Change: Both D | - |
| P28799 | GRN_HUMAN Granulins OS=Homo sapiens GN=GRN PE=1 SV=2 | 564 | R | 0.744358 | H | 0.662173 | 0.082185 | No Change: Both D | - |
| P07492 | GRP_HUMAN Gastrin-releasing peptide OS=Homo sapiens GN=GRP PE=1 SV=2 | 4 | R | 0.660431 | S | 0.648022 | 0.012409 | No Change: Both D | - |
| Q8TAY7 | GRPP1_HUMAN Glycine/arginine-rich protein 1 OS=Homo sapiens GN=GRRP1 PE=2 SV=1 | 53 | H | 0.911603 | R | 0.929431 | -0.017828 | No Change: Both D | - |
| Q12849 | GRSF1_HUMAN G-rich sequence factor 1 OS=Homo sapiens GN=GRSF1 PE=1 SV=3 | 277 | D | 0.044296 | Y | 0.020356 | 0.02394 | No Change: Both O | - |
| Q9BQ67 | GRWD1_HUMAN Glutamate-rich WD repeat-containing protein 1 OS=Homo sapiens GN=GRWD1 PE=1 SV=1 | 319 | R | 0.261886 | Q | 0.26415 | -0.002264 | No Change: Both O | - |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 9 | E | 0.934675 | K | 0.938884 | -0.004209 | No Change: Both D | - |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 38 | P | 0.787028 | L | 0.719169 | 0.067859 | No Change: Both D | Deafness autosomal recessive type 25 (DFNB25) [MIM:613285] |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 51 | G | 0.800303 | E | 0.825204 | -0.024901 | No Change: Both D | - |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 64 | G | 0.888474 | S | 0.907169 | -0.018695 | No Change: Both D | Deafness autosomal recessive type 25 (DFNB25) [MIM:613285] |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 91 | G | 0.505518 | V | 0.39493 | 0.110588 | D to O | - |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 138 | R | 0.123006 | C | 0.062385 | 0.060621 | No Change: Both O | Deafness autosomal recessive type 25 (DFNB25) [MIM:613285] |
| A8MXD5 | GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens GN=GRXCR1 PE=1 SV=1 | 153 | F | 0.162692 | V | 0.198187 | -0.035495 | No Change: Both O | Deafness autosomal recessive type 25 (DFNB25) [MIM:613285] |
| A6NFK2 | GRCR2_HUMAN Glutaredoxin domain-containing cysteine-rich protein 2 OS=Homo sapiens GN=GRXCR2 PE=3 SV=1 | 181 | L | 0.787898 | F | 0.768389 | 0.019509 | No Change: Both D | - |
| O15499 | GSC2_HUMAN Homeobox protein goosecoid-2 OS=Homo sapiens GN=GSC2 PE=2 SV=1 | 47 | R | 0.992838 | C | 0.991159 | 0.001679 | No Change: Both D | - |
| Q96QA5 | GSDMA_HUMAN Gasdermin-A OS=Homo sapiens GN=GSDMA PE=2 SV=4 | 18 | R | 0.476989 | Q | 0.490644 | -0.013655 | No Change: Both O | - |
| Q96QA5 | GSDMA_HUMAN Gasdermin-A OS=Homo sapiens GN=GSDMA PE=2 SV=4 | 128 | V | 0.517331 | L | 0.534701 | -0.01737 | No Change: Both D | - |
| Q96QA5 | GSDMA_HUMAN Gasdermin-A OS=Homo sapiens GN=GSDMA PE=2 SV=4 | 130 | E | 0.523204 | K | 0.522795 | 4.09E-04 | No Change: Both D | - |
| Q96QA5 | GSDMA_HUMAN Gasdermin-A OS=Homo sapiens GN=GSDMA PE=2 SV=4 | 314 | T | 0.449627 | N | 0.471235 | -0.021608 | No Change: Both O | - |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 122 | E | 0.52315 | G | 0.472723 | 0.050427 | D to O | - |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 132 | T | 0.413566 | A | 0.382371 | 0.031195 | No Change: Both O | - |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 245 | D | 0.935827 | G | 0.931649 | 0.004178 | No Change: Both D | A breast cancer sample |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 299 | G | 0.47081 | R | 0.490783 | -0.019973 | No Change: Both O | - |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 306 | P | 0.633493 | S | 0.653953 | -0.02046 | No Change: Both D | - |
| Q8TAX9 | GSDMB_HUMAN Gasdermin-B OS=Homo sapiens GN=GSDMB PE=1 SV=2 | 325 | R | 0.198949 | C | 0.119013 | 0.079936 | No Change: Both O | - |
| Q9BYG8 | GSDMC_HUMAN Gasdermin-C OS=Homo sapiens GN=GSDMC PE=2 SV=3 | 23 | P | 0.394758 | S | 0.447066 | -0.052308 | No Change: Both O | - |
| Q9BYG8 | GSDMC_HUMAN Gasdermin-C OS=Homo sapiens GN=GSDMC PE=2 SV=3 | 150 | R | 0.312549 | K | 0.360882 | -0.048333 | No Change: Both O | - |
| Q9BYG8 | GSDMC_HUMAN Gasdermin-C OS=Homo sapiens GN=GSDMC PE=2 SV=3 | 475 | M | 0.344261 | T | 0.387344 | -0.043083 | No Change: Both O | - |
| Q14687 | GSE1_HUMAN Genetic suppressor element 1 OS=Homo sapiens GN=GSE1 PE=1 SV=3 | 936 | V | 0.866005 | A | 0.897497 | -0.031492 | No Change: Both D | - |
| Q14687 | GSE1_HUMAN Genetic suppressor element 1 OS=Homo sapiens GN=GSE1 PE=1 SV=3 | 1153 | R | 0.560747 | Q | 0.587306 | -0.026559 | No Change: Both D | - |
| Q14687 | GSE1_HUMAN Genetic suppressor element 1 OS=Homo sapiens GN=GSE1 PE=1 SV=3 | 627 | R | 0.923078 | W | 0.83108 | 0.091998 | No Change: Both D | A colorectal cancer sample |
| Q2KHT4 | GSG1_HUMAN Germ cell-specific gene 1 protein OS=Homo sapiens GN=GSG1 PE=2 SV=2 | 39 | F | 0.122165 | L | 0.149449 | -0.027284 | No Change: Both O | - |
| Q2KHT4 | GSG1_HUMAN Germ cell-specific gene 1 protein OS=Homo sapiens GN=GSG1 PE=2 SV=2 | 67 | G | 0.56819 | V | 0.472049 | 0.096141 | D to O | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 204 | G | 0.694431 | D | 0.723103 | -0.028672 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 328 | I | 0.913243 | T | 0.946247 | -0.033004 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 378 | V | 0.180997 | A | 0.232929 | -0.051932 | No Change: Both O | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 422 | N | 0.716739 | D | 0.713369 | 0.00337 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 76 | V | 0.996936 | E | 0.99765 | -7.14E-04 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 82 | R | 0.995152 | C | 0.990334 | 0.004818 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 145 | R | 0.971173 | H | 0.956052 | 0.015121 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 283 | G | 0.917851 | S | 0.930189 | -0.012338 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 301 | Q | 0.899172 | L | 0.832401 | 0.066771 | No Change: Both D | - |
| Q8TF76 | HASP_HUMAN Serine/threonine-protein kinase haspin OS=Homo sapiens GN=GSG2 PE=1 SV=3 | 706 | M | 0.216591 | V | 0.186022 | 0.030569 | No Change: Both O | - |
| P49840 | GSK3A_HUMAN Glycogen synthase kinase-3 alpha OS=Homo sapiens GN=GSK3A PE=1 SV=2 | 461 | L | 0.961574 | F | 0.946917 | 0.014657 | No Change: Both D | - |
| P49840 | GSK3A_HUMAN Glycogen synthase kinase-3 alpha OS=Homo sapiens GN=GSK3A PE=1 SV=2 | 109 | Q | 0.50544 | E | 0.540818 | -0.035378 | No Change: Both D | - |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 214 | D | 0.125508 | N | 0.122361 | 0.003147 | No Change: Both O | Amyloidosis type 5 (AMYL5) [MIM:105120] |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 214 | D | 0.125508 | Y | 0.059162 | 0.066346 | No Change: Both O | Amyloidosis type 5 (AMYL5) [MIM:105120] |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 129 | A | 0.191969 | T | 0.208859 | -0.01689 | No Change: Both O | - |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 668 | R | 0.349891 | L | 0.246115 | 0.103776 | No Change: Both O | - |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 22 | S | 0.813541 | L | 0.731725 | 0.081816 | No Change: Both D | A breast cancer sample |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 201 | T | 0.302251 | I | 0.182459 | 0.119792 | No Change: Both O | A breast cancer sample |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 611 | S | 0.469967 | N | 0.433453 | 0.036514 | No Change: Both O | A breast cancer sample |
| P06396 | GELS_HUMAN Gelsolin OS=Homo sapiens GN=GSN PE=1 SV=1 | 231 | N | 0.417632 | D | 0.414062 | 0.00357 | No Change: Both O | - |
| Q8IYD1 | ERF3B_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3B OS=Homo sapiens GN=GSPT2 PE=1 SV=2 | 23 | P | 0.963263 | T | 0.942908 | 0.020355 | No Change: Both D | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 314 | P | 0.265355 | H | 0.216057 | 0.049298 | No Change: Both O | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 153 | R | 0.185115 | C | 0.088664 | 0.096451 | No Change: Both O | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 232 | G | 0.250244 | S | 0.290354 | -0.04011 | No Change: Both O | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 261 | I | 0.323809 | V | 0.366948 | -0.043139 | No Change: Both O | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 297 | E | 0.525603 | D | 0.480395 | 0.045208 | D to O | - |
| P00390 | GSHR_HUMAN Glutathione reductase mitochondrial OS=Homo sapiens GN=GSR PE=1 SV=2 | 232 | G | 0.250244 | R | 0.240251 | 0.009993 | No Change: Both O | - |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 26 | A | 0.417186 | D | 0.487617 | -0.070431 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 188 | L | 0.369664 | P | 0.51885 | -0.149186 | O to D | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 219 | D | 0.340116 | A | 0.275477 | 0.064639 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 219 | D | 0.340116 | G | 0.312037 | 0.028079 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 254 | L | 0.280541 | R | 0.411472 | -0.130931 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 267 | R | 0.122971 | W | 0.046733 | 0.076238 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 270 | Y | 0.207509 | C | 0.164645 | 0.042864 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 270 | Y | 0.207509 | H | 0.279878 | -0.072369 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 283 | R | 0.246901 | C | 0.122963 | 0.123938 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 286 | L | 0.279509 | Q | 0.399876 | -0.120367 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 330 | R | 0.383412 | C | 0.251105 | 0.132307 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 464 | G | 0.237683 | V | 0.145318 | 0.092365 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 469 | D | 0.450962 | E | 0.474816 | -0.023854 | No Change: Both O | Glutathione synthetase deficiency (GSS deficiency) [MIM:266130] |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 236 | R | 0.189517 | Q | 0.187629 | 0.001888 | No Change: Both O | - |
| P48637 | GSHB_HUMAN Glutathione synthetase OS=Homo sapiens GN=GSS PE=1 SV=1 | 437 | K | 0.288721 | E | 0.290557 | -0.001836 | No Change: Both O | - |
| P08263 | GSTA1_HUMAN Glutathione S-transferase A1 OS=Homo sapiens GN=GSTA1 PE=1 SV=3 | 19 | T | 0.284639 | I | 0.17886 | 0.105779 | No Change: Both O | - |
| P08263 | GSTA1_HUMAN Glutathione S-transferase A1 OS=Homo sapiens GN=GSTA1 PE=1 SV=3 | 113 | P | 0.347359 | Q | 0.300046 | 0.047313 | No Change: Both O | - |
| P08263 | GSTA1_HUMAN Glutathione S-transferase A1 OS=Homo sapiens GN=GSTA1 PE=1 SV=3 | 117 | K | 0.528847 | Q | 0.4679 | 0.060947 | D to O | - |
| P09210 | GSTA2_HUMAN Glutathione S-transferase A2 OS=Homo sapiens GN=GSTA2 PE=1 SV=4 | 112 | S | 0.391635 | T | 0.325204 | 0.066431 | No Change: Both O | - |
| P09210 | GSTA2_HUMAN Glutathione S-transferase A2 OS=Homo sapiens GN=GSTA2 PE=1 SV=4 | 210 | E | 0.948579 | A | 0.916066 | 0.032513 | No Change: Both D | - |
| P09210 | GSTA2_HUMAN Glutathione S-transferase A2 OS=Homo sapiens GN=GSTA2 PE=1 SV=4 | 110 | P | 0.252327 | S | 0.268811 | -0.016484 | No Change: Both O | - |
| P09210 | GSTA2_HUMAN Glutathione S-transferase A2 OS=Homo sapiens GN=GSTA2 PE=1 SV=4 | 149 | V | 0.373281 | A | 0.46479 | -0.091509 | No Change: Both O | - |
| Q16772 | GSTA3_HUMAN Glutathione S-transferase A3 OS=Homo sapiens GN=GSTA3 PE=1 SV=3 | 71 | I | 0.088145 | L | 0.102077 | -0.013932 | No Change: Both O | - |
| Q16772 | GSTA3_HUMAN Glutathione S-transferase A3 OS=Homo sapiens GN=GSTA3 PE=1 SV=3 | 73 | N | 0.094771 | D | 0.09828 | -0.003509 | No Change: Both O | - |
| Q16772 | GSTA3_HUMAN Glutathione S-transferase A3 OS=Homo sapiens GN=GSTA3 PE=1 SV=3 | 36 | G | 0.377279 | E | 0.4442 | -0.066921 | No Change: Both O | - |
| Q16772 | GSTA3_HUMAN Glutathione S-transferase A3 OS=Homo sapiens GN=GSTA3 PE=1 SV=3 | 113 | R | 0.347754 | Q | 0.348592 | -8.38E-04 | No Change: Both O | - |
| Q16772 | GSTA3_HUMAN Glutathione S-transferase A3 OS=Homo sapiens GN=GSTA3 PE=1 SV=3 | 208 | A | 0.852262 | T | 0.853662 | -0.0014 | No Change: Both D | - |
| O15217 | GSTA4_HUMAN Glutathione S-transferase A4 OS=Homo sapiens GN=GSTA4 PE=1 SV=1 | 100 | L | 0.121387 | P | 0.210088 | -0.088701 | No Change: Both O | - |
| O15217 | GSTA4_HUMAN Glutathione S-transferase A4 OS=Homo sapiens GN=GSTA4 PE=1 SV=1 | 163 | T | 0.054891 | A | 0.052419 | 0.002472 | No Change: Both O | - |
| Q7RTV2 | GSTA5_HUMAN Glutathione S-transferase A5 OS=Homo sapiens GN=GSTA5 PE=2 SV=1 | 55 | V | 0.16394 | I | 0.145526 | 0.018414 | No Change: Both O | - |
| P09488 | GSTM1_HUMAN Glutathione S-transferase Mu 1 OS=Homo sapiens GN=GSTM1 PE=1 SV=3 | 173 | K | 0.176582 | N | 0.153055 | 0.023527 | No Change: Both O | - |
| P09488 | GSTM1_HUMAN Glutathione S-transferase Mu 1 OS=Homo sapiens GN=GSTM1 PE=1 SV=3 | 210 | S | 0.259853 | T | 0.165781 | 0.094072 | No Change: Both O | - |
| P28161 | GSTM2_HUMAN Glutathione S-transferase Mu 2 OS=Homo sapiens GN=GSTM2 PE=1 SV=2 | 173 | S | 0.205264 | N | 0.187585 | 0.017679 | No Change: Both O | - |
| P21266 | GSTM3_HUMAN Glutathione S-transferase Mu 3 OS=Homo sapiens GN=GSTM3 PE=1 SV=3 | 224 | V | 0.71213 | I | 0.677372 | 0.034758 | No Change: Both D | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 2 | S | 0.683348 | P | 0.660526 | 0.022822 | No Change: Both D | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 160 | A | 0.050065 | V | 0.038263 | 0.011802 | No Change: Both O | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 208 | L | 0.198319 | V | 0.202057 | -0.003738 | No Change: Both O | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 209 | Y | 0.14223 | F | 0.138944 | 0.003286 | No Change: Both O | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 211 | R | 0.126356 | K | 0.174505 | -0.048149 | No Change: Both O | - |
| Q03013 | GSTM4_HUMAN Glutathione S-transferase Mu 4 OS=Homo sapiens GN=GSTM4 PE=1 SV=3 | 212 | V | 0.167342 | M | 0.214548 | -0.047206 | No Change: Both O | - |
| P46439 | GSTM5_HUMAN Glutathione S-transferase Mu 5 OS=Homo sapiens GN=GSTM5 PE=1 SV=3 | 179 | L | 0.094993 | P | 0.177817 | -0.082824 | No Change: Both O | - |
| P46439 | GSTM5_HUMAN Glutathione S-transferase Mu 5 OS=Homo sapiens GN=GSTM5 PE=1 SV=3 | 67 | A | 0.246889 | T | 0.282865 | -0.035976 | No Change: Both O | - |
| P78417 | GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2 | 140 | A | 0.55128 | D | 0.645993 | -0.094713 | No Change: Both D | - |
| P78417 | GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2 | 208 | E | 0.404048 | K | 0.418654 | -0.014606 | No Change: Both O | - |
| P78417 | GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2 | 236 | A | 0.518306 | V | 0.447885 | 0.070421 | D to O | - |
| P78417 | GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2 | 86 | S | 0.176244 | C | 0.090865 | 0.085379 | No Change: Both O | - |
| P78417 | GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens GN=GSTO1 PE=1 SV=2 | 32 | C | 0.269858 | Y | 0.263842 | 0.006016 | No Change: Both O | - |
| Q9H4Y5 | GSTO2_HUMAN Glutathione S-transferase omega-2 OS=Homo sapiens GN=GSTO2 PE=1 SV=1 | 142 | N | 0.275843 | D | 0.281873 | -0.00603 | No Change: Both O | - |
| Q9H4Y5 | GSTO2_HUMAN Glutathione S-transferase omega-2 OS=Homo sapiens GN=GSTO2 PE=1 SV=1 | 130 | C | 0.196048 | Y | 0.17812 | 0.017928 | No Change: Both O | - |
| P09211 | GSTP1_HUMAN Glutathione S-transferase P OS=Homo sapiens GN=GSTP1 PE=1 SV=2 | 105 | I | 0.063894 | V | 0.071534 | -0.00764 | No Change: Both O | - |
| P09211 | GSTP1_HUMAN Glutathione S-transferase P OS=Homo sapiens GN=GSTP1 PE=1 SV=2 | 114 | A | 0.340843 | V | 0.274039 | 0.066804 | No Change: Both O | - |
| P09211 | GSTP1_HUMAN Glutathione S-transferase P OS=Homo sapiens GN=GSTP1 PE=1 SV=2 | 169 | G | 0.100097 | D | 0.12085 | -0.020753 | No Change: Both O | - |
| P30711 | GSTT1_HUMAN Glutathione S-transferase theta-1 OS=Homo sapiens GN=GSTT1 PE=1 SV=4 | 21 | A | 0.129418 | T | 0.137238 | -0.00782 | No Change: Both O | - |
| P30711 | GSTT1_HUMAN Glutathione S-transferase theta-1 OS=Homo sapiens GN=GSTT1 PE=1 SV=4 | 141 | D | 0.193209 | N | 0.176673 | 0.016536 | No Change: Both O | - |
| P30711 | GSTT1_HUMAN Glutathione S-transferase theta-1 OS=Homo sapiens GN=GSTT1 PE=1 SV=4 | 169 | V | 0.129655 | I | 0.122525 | 0.00713 | No Change: Both O | - |
| P30711 | GSTT1_HUMAN Glutathione S-transferase theta-1 OS=Homo sapiens GN=GSTT1 PE=1 SV=4 | 173 | E | 0.139887 | K | 0.139642 | 2.45E-04 | No Change: Both O | - |
| P0CG30 | GSTT2_HUMAN Glutathione S-transferase theta-2B OS=Homo sapiens GN=GSTT2B PE=1 SV=1 | 139 | M | 0.331244 | I | 0.243391 | 0.087853 | No Change: Both O | - |
| O43708 | MAAI_HUMAN Maleylacetoacetate isomerase OS=Homo sapiens GN=GSTZ1 PE=1 SV=3 | 32 | K | 0.150096 | E | 0.13764 | 0.012456 | No Change: Both O | - |
| O43708 | MAAI_HUMAN Maleylacetoacetate isomerase OS=Homo sapiens GN=GSTZ1 PE=1 SV=3 | 42 | R | 0.382288 | G | 0.41501 | -0.032722 | No Change: Both O | - |
| O43708 | MAAI_HUMAN Maleylacetoacetate isomerase OS=Homo sapiens GN=GSTZ1 PE=1 SV=3 | 82 | M | 0.451304 | T | 0.488345 | -0.037041 | No Change: Both O | - |
| O43708 | MAAI_HUMAN Maleylacetoacetate isomerase OS=Homo sapiens GN=GSTZ1 PE=1 SV=3 | 133 | N | 0.096488 | H | 0.083181 | 0.013307 | No Change: Both O | - |
| Q9BZM3 | GSX2_HUMAN GS homeobox 2 OS=Homo sapiens GN=GSX2 PE=2 SV=2 | 107 | G | 0.77258 | S | 0.796513 | -0.023933 | No Change: Both D | - |
| Q4AE62 | GTDC1_HUMAN Glycosyltransferase-like domain-containing protein 1 OS=Homo sapiens GN=GTDC1 PE=2 SV=1 | 137 | M | 0.320099 | I | 0.221235 | 0.098864 | No Change: Both O | - |
| P52655 | TF2AA_HUMAN Transcription initiation factor IIA subunit 1 OS=Homo sapiens GN=GTF2A1 PE=1 SV=1 | 30 | L | 0.194732 | V | 0.211214 | -0.016482 | No Change: Both O | A breast cancer sample |
| P52655 | TF2AA_HUMAN Transcription initiation factor IIA subunit 1 OS=Homo sapiens GN=GTF2A1 PE=1 SV=1 | 109 | A | 0.924246 | P | 0.941735 | -0.017489 | No Change: Both D | - |
| Q00403 | TF2B_HUMAN Transcription initiation factor IIB OS=Homo sapiens GN=GTF2B PE=1 SV=1 | 19 | P | 0.273128 | S | 0.273018 | 1.10E-04 | No Change: Both O | - |
| Q00403 | TF2B_HUMAN Transcription initiation factor IIB OS=Homo sapiens GN=GTF2B PE=1 SV=1 | 132 | R | 0.395924 | Q | 0.385284 | 0.01064 | No Change: Both O | A colorectal cancer sample |
| P29083 | T2EA_HUMAN General transcription factor IIE subunit 1 OS=Homo sapiens GN=GTF2E1 PE=1 SV=2 | 366 | P | 0.990884 | S | 0.991138 | -2.54E-04 | No Change: Both D | - |
| P29084 | T2EB_HUMAN Transcription initiation factor IIE subunit beta OS=Homo sapiens GN=GTF2E2 PE=1 SV=1 | 183 | K | 0.376284 | R | 0.31288 | 0.063404 | No Change: Both O | - |
| P29084 | T2EB_HUMAN Transcription initiation factor IIE subunit beta OS=Homo sapiens GN=GTF2E2 PE=1 SV=1 | 133 | I | 0.233132 | T | 0.333369 | -0.100237 | No Change: Both O | - |
| P35269 | T2FA_HUMAN General transcription factor IIF subunit 1 OS=Homo sapiens GN=GTF2F1 PE=1 SV=2 | 3 | A | 0.789757 | V | 0.789312 | 4.45E-04 | No Change: Both D | - |
| P32780 | TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens GN=GTF2H1 PE=1 SV=1 | 234 | R | 0.442477 | W | 0.249992 | 0.192485 | No Change: Both O | - |
| P32780 | TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens GN=GTF2H1 PE=1 SV=1 | 285 | S | 0.697869 | F | 0.448598 | 0.249271 | D to O | - |
| P32780 | TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens GN=GTF2H1 PE=1 SV=1 | 517 | L | 0.294149 | V | 0.283579 | 0.01057 | No Change: Both O | - |
| Q13888 | TF2H2_HUMAN General transcription factor IIH subunit 2 OS=Homo sapiens GN=GTF2H2 PE=1 SV=1 | 151 | I | 0.329906 | M | 0.451417 | -0.121511 | No Change: Both O | - |
| Q13888 | TF2H2_HUMAN General transcription factor IIH subunit 2 OS=Homo sapiens GN=GTF2H2 PE=1 SV=1 | 236 | V | 0.632982 | L | 0.658693 | -0.025711 | No Change: Both D | - |
| Q92759 | TF2H4_HUMAN General transcription factor IIH subunit 4 OS=Homo sapiens GN=GTF2H4 PE=2 SV=1 | 337 | R | 0.099783 | Q | 0.112445 | -0.012662 | No Change: Both O | - |
| Q6ZYL4 | TF2H5_HUMAN General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 | 21 | L | 0.125863 | P | 0.232088 | -0.106225 | No Change: Both O | Trichothiodystrophy photosensitive (TTDP) [MIM:601675] |
| P78347 | GTF2I_HUMAN General transcription factor II-I OS=Homo sapiens GN=GTF2I PE=1 SV=2 | 174 | L | 0.117574 | V | 0.10943 | 0.008144 | No Change: Both O | - |
| Q9UHL9 | GT2D1_HUMAN General transcription factor II-I repeat domain-containing protein 1 OS=Homo sapiens GN=GTF2IRD1 PE=1 SV=1 | 652 | M | 0.688157 | V | 0.655836 | 0.032321 | No Change: Both D | - |
| Q86UP8 | GTD2A_HUMAN General transcription factor II-I repeat domain-containing protein 2A OS=Homo sapiens GN=GTF2IRD2 PE=2 SV=2 | 514 | H | 0.668813 | N | 0.696137 | -0.027324 | No Change: Both D | - |
| Q92664 | TF3A_HUMAN Transcription factor IIIA OS=Homo sapiens GN=GTF3A PE=1 SV=3 | 245 | V | 0.48449 | L | 0.497159 | -0.012669 | No Change: Both O | - |
| Q12789 | TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens GN=GTF3C1 PE=1 SV=4 | 1889 | Q | 0.954561 | E | 0.959999 | -0.005438 | No Change: Both D | - |
| Q12789 | TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens GN=GTF3C1 PE=1 SV=4 | 1959 | F | 0.851767 | S | 0.905992 | -0.054225 | No Change: Both D | - |
| Q12789 | TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens GN=GTF3C1 PE=1 SV=4 | 2077 | E | 0.63005 | K | 0.605881 | 0.024169 | No Change: Both D | - |
| Q9Y5Q9 | TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens GN=GTF3C3 PE=1 SV=1 | 70 | N | 0.952848 | S | 0.964564 | -0.011716 | No Change: Both D | - |
| Q9UKN8 | TF3C4_HUMAN General transcription factor 3C polypeptide 4 OS=Homo sapiens GN=GTF3C4 PE=1 SV=2 | 243 | H | 0.47904 | R | 0.537678 | -0.058638 | O to D | - |
| Q9Y5Q8 | TF3C5_HUMAN General transcription factor 3C polypeptide 5 OS=Homo sapiens GN=GTF3C5 PE=1 SV=2 | 445 | D | 0.660357 | N | 0.622993 | 0.037364 | No Change: Both D | - |
| Q8N6N6 | GTL3B_HUMAN Protein GTLF3B OS=Homo sapiens GN=GTLF3B PE=2 SV=2 | 42 | V | 0.100404 | I | 0.083769 | 0.016635 | No Change: Both O | - |
| O00178 | GTPB1_HUMAN GTP-binding protein 1 OS=Homo sapiens GN=GTPBP1 PE=1 SV=3 | 91 | G | 0.30283 | R | 0.301738 | 0.001092 | No Change: Both O | - |
| A4D1E9 | GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens GN=GTPBP10 PE=1 SV=1 | 88 | C | 0.511685 | W | 0.437857 | 0.073828 | D to O | - |
| A4D1E9 | GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens GN=GTPBP10 PE=1 SV=1 | 110 | N | 0.429829 | S | 0.445596 | -0.015767 | No Change: Both O | - |
| A4D1E9 | GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens GN=GTPBP10 PE=1 SV=1 | 164 | L | 0.478708 | F | 0.43901 | 0.039698 | No Change: Both O | - |
| A4D1E9 | GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens GN=GTPBP10 PE=1 SV=1 | 368 | M | 0.679656 | I | 0.591917 | 0.087739 | No Change: Both D | - |
| Q969Y2 | GTPB3_HUMAN tRNA modification GTPase GTPBP3 mitochondrial OS=Homo sapiens GN=GTPBP3 PE=2 SV=2 | 250 | V | 0.469453 | A | 0.528086 | -0.058633 | O to D | - |
| Q969Y2 | GTPB3_HUMAN tRNA modification GTPase GTPBP3 mitochondrial OS=Homo sapiens GN=GTPBP3 PE=2 SV=2 | 368 | R | 0.82885 | H | 0.813585 | 0.015265 | No Change: Both D | - |
| Q9H4K7 | GTPB5_HUMAN GTP-binding protein 5 OS=Homo sapiens GN=GTPBP5 PE=2 SV=1 | 47 | G | 0.539174 | S | 0.618949 | -0.079775 | No Change: Both D | - |
| Q9H4K7 | GTPB5_HUMAN GTP-binding protein 5 OS=Homo sapiens GN=GTPBP5 PE=2 SV=1 | 93 | H | 0.568255 | R | 0.617786 | -0.049531 | No Change: Both D | - |
| Q9H4K7 | GTPB5_HUMAN GTP-binding protein 5 OS=Homo sapiens GN=GTPBP5 PE=2 SV=1 | 337 | A | 0.361147 | V | 0.279779 | 0.081368 | No Change: Both O | - |
| Q8N3Z3 | GTPB8_HUMAN GTP-binding protein 8 OS=Homo sapiens GN=GTPBP8 PE=2 SV=1 | 242 | Q | 0.161063 | H | 0.141424 | 0.019639 | No Change: Both O | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 470 | S | 0.958265 | L | 0.917802 | 0.040463 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 506 | W | 0.941003 | R | 0.978578 | -0.037575 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 181 | T | 0.977531 | A | 0.97989 | -0.002359 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 200 | A | 0.940752 | V | 0.904174 | 0.036578 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 274 | A | 0.767558 | T | 0.759518 | 0.00804 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 322 | S | 0.948681 | N | 0.927382 | 0.021299 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 463 | D | 0.950695 | E | 0.944145 | 0.00655 | No Change: Both D | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 635 | A | 0.48536 | T | 0.49319 | -0.00783 | No Change: Both O | - |
| Q9NYZ3 | GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens GN=GTSE1 PE=1 SV=3 | 303 | S | 0.885971 | N | 0.859155 | 0.026816 | No Change: Both D | - |
| Q9H1H1 | GTSFL_HUMAN Gametocyte-specific factor 1-like OS=Homo sapiens GN=GTSF1L PE=2 SV=1 | 56 | L | 0.674211 | V | 0.71171 | -0.037499 | No Change: Both D | - |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 99 | Y | 0.074799 | C | 0.057628 | 0.017171 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 50 | P | 0.505419 | L | 0.35284 | 0.152579 | D to O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 155 | E | 0.451031 | G | 0.38468 | 0.066351 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 89 | E | 0.273098 | K | 0.299317 | -0.026219 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 100 | D | 0.093227 | E | 0.095925 | -0.002698 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 114 | T | 0.078141 | I | 0.046491 | 0.03165 | No Change: Both O | - |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 151 | L | 0.45326 | F | 0.426377 | 0.026883 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| P43080 | GUC1A_HUMAN Guanylyl cyclase-activating protein 1 OS=Homo sapiens GN=GUCA1A PE=1 SV=3 | 159 | G | 0.457262 | V | 0.353094 | 0.104168 | No Change: Both O | Cone dystrophy type 3 (COD3) [MIM:602093] |
| Q9UMX6 | GUC1B_HUMAN Guanylyl cyclase-activating protein 2 OS=Homo sapiens GN=GUCA1B PE=1 SV=4 | 155 | E | 0.349502 | D | 0.339235 | 0.010267 | No Change: Both O | - |
| Q9UMX6 | GUC1B_HUMAN Guanylyl cyclase-activating protein 2 OS=Homo sapiens GN=GUCA1B PE=1 SV=4 | 157 | G | 0.417551 | R | 0.427289 | -0.009738 | No Change: Both O | Retinitis pigmentosa type 48 (RP48) [MIM:613827] |
| O95843 | GUC1C_HUMAN Guanylyl cyclase-activating protein 3 OS=Homo sapiens GN=GUCA1C PE=1 SV=3 | 72 | V | 0.123653 | I | 0.112997 | 0.010656 | No Change: Both O | - |
| O95843 | GUC1C_HUMAN Guanylyl cyclase-activating protein 3 OS=Homo sapiens GN=GUCA1C PE=1 SV=3 | 85 | M | 0.246901 | V | 0.200431 | 0.04647 | No Change: Both O | - |
| O95843 | GUC1C_HUMAN Guanylyl cyclase-activating protein 3 OS=Homo sapiens GN=GUCA1C PE=1 SV=3 | 119 | A | 0.130401 | V | 0.093318 | 0.037083 | No Change: Both O | - |
| O95843 | GUC1C_HUMAN Guanylyl cyclase-activating protein 3 OS=Homo sapiens GN=GUCA1C PE=1 SV=3 | 159 | M | 0.288159 | V | 0.230553 | 0.057606 | No Change: Both O | - |
| Q02747 | GUC2A_HUMAN Guanylin OS=Homo sapiens GN=GUCA2A PE=1 SV=2 | 7 | S | 0.095572 | F | 0.035603 | 0.059969 | No Change: Both O | - |
| Q16661 | GUC2B_HUMAN Guanylate cyclase activator 2B OS=Homo sapiens GN=GUCA2B PE=1 SV=1 | 11 | P | 0.140099 | T | 0.11249 | 0.027609 | No Change: Both O | - |
| P33402 | GCYA2_HUMAN Guanylate cyclase soluble subunit alpha-2 OS=Homo sapiens GN=GUCY1A2 PE=1 SV=1 | 681 | E | 0.717776 | V | 0.573593 | 0.144183 | No Change: Both D | A colorectal cancer sample |
| P33402 | GCYA2_HUMAN Guanylate cyclase soluble subunit alpha-2 OS=Homo sapiens GN=GUCY1A2 PE=1 SV=1 | 685 | N | 0.714744 | T | 0.734722 | -0.019978 | No Change: Both D | A colorectal cancer sample |
| Q02108 | GCYA3_HUMAN Guanylate cyclase soluble subunit alpha-3 OS=Homo sapiens GN=GUCY1A3 PE=1 SV=2 | 25 | V | 0.757769 | I | 0.765912 | -0.008143 | No Change: Both D | - |
| O75343 | GCYB2_HUMAN Guanylate cyclase soluble subunit beta-2 OS=Homo sapiens GN=GUCY1B2 PE=2 SV=2 | 316 | N | 0.551846 | H | 0.525177 | 0.026669 | No Change: Both D | - |
| O75343 | GCYB2_HUMAN Guanylate cyclase soluble subunit beta-2 OS=Homo sapiens GN=GUCY1B2 PE=2 SV=2 | 55 | Y | 0.241381 | C | 0.192938 | 0.048443 | No Change: Both O | - |
| O75343 | GCYB2_HUMAN Guanylate cyclase soluble subunit beta-2 OS=Homo sapiens GN=GUCY1B2 PE=2 SV=2 | 128 | M | 0.775716 | I | 0.682156 | 0.09356 | No Change: Both D | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 30 | C | 0.550627 | R | 0.68713 | -0.136503 | No Change: Both D | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 61 | G | 0.327168 | R | 0.322576 | 0.004592 | No Change: Both O | A metastatic melanoma sample |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 114 | R | 0.187682 | Q | 0.2023 | -0.014618 | No Change: Both O | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 464 | R | 0.533332 | L | 0.390316 | 0.143016 | D to O | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 610 | E | 0.697808 | K | 0.709703 | -0.011895 | No Change: Both D | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 859 | I | 0.308664 | V | 0.351835 | -0.043171 | No Change: Both O | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 1045 | Q | 0.651149 | R | 0.652906 | -0.001757 | No Change: Both D | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 1072 | Y | 0.710528 | C | 0.696602 | 0.013926 | No Change: Both D | - |
| P25092 | GUC2C_HUMAN Heat-stable enterotoxin receptor OS=Homo sapiens GN=GUCY2C PE=1 SV=2 | 281 | F | 0.254298 | L | 0.277482 | -0.023184 | No Change: Both O | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 52 | A | 0.232569 | S | 0.297581 | -0.065012 | No Change: Both O | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 837 | E | 0.812238 | D | 0.781898 | 0.03034 | No Change: Both D | Cone-rod dystrophy type 6 (CORD6) [MIM:601777] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 838 | R | 0.820494 | C | 0.697858 | 0.122636 | No Change: Both D | Cone-rod dystrophy type 6 (CORD6) [MIM:601777] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 362 | A | 0.314979 | S | 0.386189 | -0.07121 | No Change: Both O | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 573 | I | 0.298885 | V | 0.313461 | -0.014576 | No Change: Both O | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 565 | F | 0.250488 | S | 0.437761 | -0.187273 | No Change: Both O | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 701 | P | 0.592546 | S | 0.581065 | 0.011481 | No Change: Both D | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 782 | L | 0.367967 | H | 0.399522 | -0.031555 | No Change: Both O | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 858 | P | 0.543819 | S | 0.544424 | -6.05E-04 | No Change: Both D | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 954 | L | 0.22052 | P | 0.356152 | -0.135632 | No Change: Both O | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 838 | R | 0.820494 | H | 0.758572 | 0.061922 | No Change: Both D | Cone-rod dystrophy type 6 (CORD6) [MIM:601777] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 105 | C | 0.736837 | Y | 0.66611 | 0.070727 | No Change: Both D | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 325 | L | 0.666521 | P | 0.778283 | -0.111762 | No Change: Both D | Leber congenital amaurosis type 1 (LCA1) [MIM:204000] |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 328 | A | 0.673832 | V | 0.622005 | 0.051827 | No Change: Both D | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 431 | G | 0.581006 | D | 0.603483 | -0.022477 | No Change: Both D | A metastatic melanoma sample |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 507 | V | 0.145517 | M | 0.19837 | -0.052853 | No Change: Both O | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 693 | A | 0.488363 | E | 0.583317 | -0.094954 | O to D | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 331 | R | 0.705135 | S | 0.73811 | -0.032975 | No Change: Both D | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 602 | R | 0.20505 | W | 0.09187 | 0.11318 | No Change: Both O | - |
| Q02846 | GUC2D_HUMAN Retinal guanylyl cyclase 1 OS=Homo sapiens GN=GUCY2D PE=1 SV=2 | 722 | R | 0.410443 | W | 0.219339 | 0.191104 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 284 | L | 0.09722 | P | 0.190506 | -0.093286 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 296 | R | 0.34527 | Q | 0.347214 | -0.001944 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 308 | Y | 0.217256 | C | 0.186404 | 0.030852 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 380 | Q | 0.486752 | H | 0.466407 | 0.020345 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 628 | R | 0.221102 | Q | 0.237078 | -0.015976 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 10 | R | 0.045184 | P | 0.049347 | -0.004163 | No Change: Both O | A breast cancer sample |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 40 | S | 0.0399 | C | 0.013345 | 0.026555 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 160 | I | 0.340575 | N | 0.568928 | -0.228353 | O to D | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 230 | R | 0.584822 | W | 0.393006 | 0.191816 | D to O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 305 | R | 0.373516 | Q | 0.378865 | -0.005349 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 434 | G | 0.247945 | R | 0.235913 | 0.012032 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 568 | G | 0.080577 | D | 0.097248 | -0.016671 | No Change: Both O | A glioblastoma multiforme sample |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 677 | V | 0.174446 | L | 0.174589 | -1.43E-04 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 794 | E | 0.485384 | K | 0.487979 | -0.002595 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 1010 | A | 0.491757 | V | 0.426794 | 0.064963 | No Change: Both O | - |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 1052 | K | 0.63084 | R | 0.58818 | 0.04266 | No Change: Both D | A lung adenocarcinoma sample |
| P51841 | GUC2F_HUMAN Retinal guanylyl cyclase 2 OS=Homo sapiens GN=GUCY2F PE=2 SV=2 | 1055 | E | 0.509059 | D | 0.449686 | 0.059373 | D to O | A lung squamous cell carcinoma sample |
| Q8N442 | GUF1_HUMAN Translation factor GUF1 mitochondrial OS=Homo sapiens GN=GUF1 PE=1 SV=1 | 58 | L | 0.470885 | P | 0.569776 | -0.098891 | O to D | - |
| Q8N442 | GUF1_HUMAN Translation factor GUF1 mitochondrial OS=Homo sapiens GN=GUF1 PE=1 SV=1 | 329 | T | 0.301095 | I | 0.198044 | 0.103051 | No Change: Both O | - |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 216 | R | 0.134282 | W | 0.054033 | 0.080249 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 354 | A | 0.589098 | V | 0.515739 | 0.073359 | No Change: Both D | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 382 | R | 0.257013 | C | 0.132753 | 0.12426 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 611 | R | 0.47952 | W | 0.250389 | 0.229131 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 619 | A | 0.318071 | V | 0.243773 | 0.074298 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 627 | W | 0.179697 | C | 0.269983 | -0.090286 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 649 | L | 0.774267 | P | 0.829452 | -0.055185 | No Change: Both D | - |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 38 | C | 0.604729 | G | 0.711309 | -0.10658 | No Change: Both D | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 52 | S | 0.609274 | F | 0.451921 | 0.157353 | D to O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 136 | G | 0.12652 | R | 0.113715 | 0.012805 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 148 | P | 0.280793 | S | 0.321592 | -0.040799 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 150 | E | 0.249874 | K | 0.240027 | 0.009847 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 152 | D | 0.193301 | N | 0.193786 | -4.85E-04 | No Change: Both O | - |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 176 | L | 0.350253 | F | 0.304202 | 0.046051 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 320 | Y | 0.159356 | C | 0.130284 | 0.029072 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 320 | Y | 0.159356 | S | 0.323476 | -0.16412 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 350 | K | 0.485049 | N | 0.449058 | 0.035991 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 351 | H | 0.55386 | Y | 0.419103 | 0.134757 | D to O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 374 | R | 0.054259 | C | 0.023557 | 0.030702 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 382 | R | 0.257013 | H | 0.270644 | -0.013631 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 408 | P | 0.107992 | S | 0.116071 | -0.008079 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 415 | P | 0.128676 | L | 0.067301 | 0.061375 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 435 | R | 0.508123 | P | 0.536041 | -0.027918 | No Change: Both D | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 477 | R | 0.568391 | W | 0.354279 | 0.214112 | D to O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 495 | Y | 0.126903 | C | 0.104607 | 0.022296 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 508 | Y | 0.152133 | C | 0.11177 | 0.040363 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 572 | G | 0.354052 | D | 0.397681 | -0.043629 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 577 | R | 0.371455 | L | 0.270347 | 0.101108 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 606 | K | 0.408627 | N | 0.369798 | 0.038829 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 626 | Y | 0.173496 | H | 0.259662 | -0.086166 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 376 | L | 0.091668 | F | 0.080323 | 0.011345 | No Change: Both O | - |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 30 | P | 0.55689 | S | 0.582214 | -0.025324 | No Change: Both D | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 152 | D | 0.193301 | G | 0.187434 | 0.005867 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 243 | L | 0.341013 | P | 0.502579 | -0.161566 | O to D | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 339 | N | 0.187497 | S | 0.230742 | -0.043245 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 362 | D | 0.124766 | N | 0.108882 | 0.015884 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 364 | P | 0.092737 | L | 0.048911 | 0.043826 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 540 | E | 0.348201 | K | 0.34636 | 0.001841 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P08236 | BGLR_HUMAN Beta-glucuronidase OS=Homo sapiens GN=GUSB PE=1 SV=2 | 607 | G | 0.400932 | A | 0.329442 | 0.07149 | No Change: Both O | Mucopolysaccharidosis type 7 (MPS7) [MIM:253220] |
| P46976 | GLYG_HUMAN Glycogenin-1 OS=Homo sapiens GN=GYG1 PE=1 SV=4 | 83 | T | 0.19369 | M | 0.158683 | 0.035007 | No Change: Both O | Glycogen storage disease type 15 (GSD15) [MIM:613507] |
| O15488 | GLYG2_HUMAN Glycogenin-2 OS=Homo sapiens GN=GYG2 PE=1 SV=2 | 270 | A | 0.778311 | V | 0.753728 | 0.024583 | No Change: Both D | - |
| O15488 | GLYG2_HUMAN Glycogenin-2 OS=Homo sapiens GN=GYG2 PE=1 SV=2 | 313 | H | 0.524779 | R | 0.533624 | -0.008845 | No Change: Both D | - |
| O15488 | GLYG2_HUMAN Glycogenin-2 OS=Homo sapiens GN=GYG2 PE=1 SV=2 | 373 | R | 0.901028 | C | 0.884143 | 0.016885 | No Change: Both D | - |
| O15488 | GLYG2_HUMAN Glycogenin-2 OS=Homo sapiens GN=GYG2 PE=1 SV=2 | 7 | H | 0.868393 | Y | 0.748997 | 0.119396 | No Change: Both D | - |
| O15488 | GLYG2_HUMAN Glycogenin-2 OS=Homo sapiens GN=GYG2 PE=1 SV=2 | 194 | G | 0.573519 | R | 0.53587 | 0.037649 | No Change: Both D | - |
| Q8N3Y3 | LARG2_HUMAN Glycosyltransferase-like protein LARGE2 OS=Homo sapiens GN=GYLTL1B PE=2 SV=2 | 677 | R | 0.500631 | C | 0.34147 | 0.159161 | D to O | - |
| Q8N3Y3 | LARG2_HUMAN Glycosyltransferase-like protein LARGE2 OS=Homo sapiens GN=GYLTL1B PE=2 SV=2 | 37 | E | 0.835488 | K | 0.811812 | 0.023676 | No Change: Both D | - |
| Q8N3Y3 | LARG2_HUMAN Glycosyltransferase-like protein LARGE2 OS=Homo sapiens GN=GYLTL1B PE=2 SV=2 | 546 | R | 0.393675 | W | 0.185316 | 0.208359 | No Change: Both O | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 20 | S | 0.560476 | L | 0.368471 | 0.192005 | D to O | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 24 | G | 0.698334 | E | 0.740238 | -0.041904 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 13 | E | 0.248459 | A | 0.212452 | 0.036007 | No Change: Both O | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 23 | T | 0.662684 | N | 0.65934 | 0.003344 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 24 | G | 0.698334 | D | 0.715757 | -0.017423 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 46 | D | 0.868808 | E | 0.881521 | -0.012713 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 47 | T | 0.865738 | K | 0.869448 | -0.00371 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 47 | T | 0.865738 | M | 0.836391 | 0.029347 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 50 | R | 0.84418 | W | 0.694749 | 0.149431 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 66 | S | 0.608677 | Y | 0.403641 | 0.205036 | D to O | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 73 | P | 0.655904 | S | 0.668957 | -0.013053 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 76 | E | 0.671872 | K | 0.646409 | 0.025463 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 77 | T | 0.688023 | I | 0.587834 | 0.100189 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 78 | G | 0.672799 | R | 0.68163 | -0.008831 | No Change: Both D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 82 | Q | 0.49044 | K | 0.537909 | -0.047469 | O to D | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 84 | A | 0.386613 | P | 0.489964 | -0.103351 | No Change: Both O | - |
| P02724 | GLPA_HUMAN Glycophorin-A OS=Homo sapiens GN=GYPA PE=1 SV=2 | 13 | E | 0.248459 | G | 0.238083 | 0.010376 | No Change: Both O | - |
| P06028 | GLPB_HUMAN Glycophorin-B OS=Homo sapiens GN=GYPB PE=1 SV=2 | 48 | T | 0.577107 | M | 0.516913 | 0.060194 | No Change: Both D | - |
| P06028 | GLPB_HUMAN Glycophorin-B OS=Homo sapiens GN=GYPB PE=1 SV=2 | 84 | T | 0.085728 | S | 0.127234 | -0.041506 | No Change: Both O | - |
| P06028 | GLPB_HUMAN Glycophorin-B OS=Homo sapiens GN=GYPB PE=1 SV=2 | 22 | T | 0.486625 | S | 0.567323 | -0.080698 | O to D | - |
| P06028 | GLPB_HUMAN Glycophorin-B OS=Homo sapiens GN=GYPB PE=1 SV=2 | 54 | R | 0.167176 | H | 0.179556 | -0.01238 | No Change: Both O | - |
| P06028 | GLPB_HUMAN Glycophorin-B OS=Homo sapiens GN=GYPB PE=1 SV=2 | 58 | P | 0.07615 | R | 0.064254 | 0.011896 | No Change: Both O | - |
| P04921 | GLPC_HUMAN Glycophorin-C OS=Homo sapiens GN=GYPC PE=1 SV=1 | 8 | N | 0.937224 | S | 0.967559 | -0.030335 | No Change: Both D | - |
| P04921 | GLPC_HUMAN Glycophorin-C OS=Homo sapiens GN=GYPC PE=1 SV=1 | 14 | L | 0.923808 | F | 0.902806 | 0.021002 | No Change: Both D | - |
| P04921 | GLPC_HUMAN Glycophorin-C OS=Homo sapiens GN=GYPC PE=1 SV=1 | 23 | A | 0.94751 | S | 0.965892 | -0.018382 | No Change: Both D | - |
| P04921 | GLPC_HUMAN Glycophorin-C OS=Homo sapiens GN=GYPC PE=1 SV=1 | 124 | K | 0.700217 | E | 0.730745 | -0.030528 | No Change: Both D | - |
| P15421 | GLPE_HUMAN Glycophorin-E OS=Homo sapiens GN=GYPE PE=2 SV=2 | 78 | R | 0.296949 | P | 0.371865 | -0.074916 | No Change: Both O | - |
| P15421 | GLPE_HUMAN Glycophorin-E OS=Homo sapiens GN=GYPE PE=2 SV=2 | 13 | G | 0.237124 | E | 0.246796 | -0.009672 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 464 | G | 0.246176 | S | 0.356803 | -0.110627 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 130 | K | 0.1417 | E | 0.15512 | -0.01342 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 283 | N | 0.372511 | S | 0.411986 | -0.039475 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 359 | E | 0.226664 | G | 0.200405 | 0.026259 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 416 | M | 0.48779 | V | 0.408481 | 0.079309 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 619 | E | 0.440705 | Q | 0.39475 | 0.045955 | No Change: Both O | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 691 | P | 0.974852 | A | 0.96673 | 0.008122 | No Change: Both D | - |
| P13807 | GYS1_HUMAN Glycogen [starch] synthase muscle OS=Homo sapiens GN=GYS1 PE=1 SV=2 | 108 | I | 0.058119 | M | 0.090273 | -0.032154 | No Change: Both O | - |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 39 | N | 0.139332 | S | 0.167132 | -0.0278 | No Change: Both O | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 339 | A | 0.340673 | P | 0.427326 | -0.086653 | No Change: Both O | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 446 | H | 0.557079 | D | 0.654109 | -0.09703 | No Change: Both D | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 479 | P | 0.282799 | Q | 0.254501 | 0.028298 | No Change: Both O | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 483 | S | 0.470884 | P | 0.444153 | 0.026731 | No Change: Both O | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 491 | M | 0.348196 | R | 0.418394 | -0.070198 | No Change: Both O | Glycogen storage disease type 0 (GSD0) [MIM:240600] |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 193 | A | 0.183112 | T | 0.201277 | -0.018165 | No Change: Both O | - |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 415 | D | 0.324357 | E | 0.336105 | -0.011748 | No Change: Both O | - |
| P54840 | GYS2_HUMAN Glycogen [starch] synthase liver OS=Homo sapiens GN=GYS2 PE=1 SV=2 | 363 | M | 0.069427 | V | 0.052204 | 0.017223 | No Change: Both O | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 275 | Q | 0.938663 | P | 0.940533 | -0.00187 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 190 | N | 0.970727 | S | 0.98243 | -0.011703 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 318 | K | 0.851254 | N | 0.820771 | 0.030483 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 667 | D | 0.714863 | N | 0.694855 | 0.020008 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 275 | Q | 0.938663 | L | 0.89808 | 0.040583 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 275 | Q | 0.938663 | R | 0.934547 | 0.004116 | No Change: Both D | - |
| Q9H116 | GZF1_HUMAN GDNF-inducible zinc finger protein 1 OS=Homo sapiens GN=GZF1 PE=1 SV=1 | 97 | A | 0.188285 | V | 0.15735 | 0.030935 | No Change: Both O | - |
| P12544 | GRAA_HUMAN Granzyme A OS=Homo sapiens GN=GZMA PE=1 SV=2 | 121 | M | 0.297816 | T | 0.332763 | -0.034947 | No Change: Both O | - |
| P10144 | GRAB_HUMAN Granzyme B OS=Homo sapiens GN=GZMB PE=1 SV=2 | 55 | R | 0.08094 | Q | 0.085113 | -0.004173 | No Change: Both O | - |
| P10144 | GRAB_HUMAN Granzyme B OS=Homo sapiens GN=GZMB PE=1 SV=2 | 247 | Y | 0.679873 | H | 0.713052 | -0.033179 | No Change: Both D | - |
| P10144 | GRAB_HUMAN Granzyme B OS=Homo sapiens GN=GZMB PE=1 SV=2 | 94 | P | 0.441714 | A | 0.331124 | 0.11059 | No Change: Both O | - |
| P20718 | GRAH_HUMAN Granzyme H OS=Homo sapiens GN=GZMH PE=2 SV=1 | 84 | R | 0.513195 | Q | 0.55263 | -0.039435 | No Change: Both D | - |
| P51124 | GRAM_HUMAN Granzyme M OS=Homo sapiens GN=GZMM PE=1 SV=2 | 221 | R | 0.264078 | G | 0.264832 | -7.54E-04 | No Change: Both O | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 84 | R | 0.551174 | G | 0.526033 | 0.025141 | No Change: Both D | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 108 | L | 0.626482 | P | 0.750822 | -0.12434 | No Change: Both D | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 136 | R | 0.900573 | S | 0.894562 | 0.006011 | No Change: Both D | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 174 | R | 0.996008 | Q | 0.994619 | 0.001389 | No Change: Both D | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 237 | S | 0.998086 | F | 0.995624 | 0.002462 | No Change: Both D | - |
| Q75WM6 | H1FNT_HUMAN Testis-specific H1 histone OS=Homo sapiens GN=H1FNT PE=2 SV=3 | 195 | R | 0.995547 | Q | 0.994054 | 0.001493 | No Change: Both D | - |
| Q8IZA3 | H1FOO_HUMAN Histone H1oo OS=Homo sapiens GN=H1FOO PE=2 SV=1 | 296 | N | 0.982724 | S | 0.988353 | -0.005629 | No Change: Both D | - |
| Q71UI9 | H2AV_HUMAN Histone H2A.V OS=Homo sapiens GN=H2AFV PE=1 SV=3 | 125 | Q | 0.77716 | R | 0.769314 | 0.007846 | No Change: Both D | - |
| P0C1H6 | H2BFM_HUMAN Histone H2B type F-M OS=Homo sapiens GN=H2BFM PE=2 SV=1 | 22 | R | 0.236347 | H | 0.200738 | 0.035609 | No Change: Both O | - |
| Q7Z2G1 | H2BWT_HUMAN Histone H2B type W-T OS=Homo sapiens GN=H2BFWT PE=1 SV=2 | 87 | R | 0.359408 | W | 0.161268 | 0.19814 | No Change: Both O | - |
| Q7Z2G1 | H2BWT_HUMAN Histone H2B type W-T OS=Homo sapiens GN=H2BFWT PE=1 SV=2 | 123 | R | 0.479731 | H | 0.44727 | 0.032461 | No Change: Both O | - |
| O95479 | G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens GN=H6PD PE=1 SV=2 | 453 | R | 0.528767 | Q | 0.535412 | -0.006645 | No Change: Both D | - |
| O95479 | G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens GN=H6PD PE=1 SV=2 | 151 | D | 0.245027 | A | 0.197688 | 0.047339 | No Change: Both O | - |
| O95479 | G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens GN=H6PD PE=1 SV=2 | 218 | R | 0.283323 | Q | 0.306384 | -0.023061 | No Change: Both O | - |
| O95479 | G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens GN=H6PD PE=1 SV=2 | 484 | N | 0.070089 | D | 0.070283 | -1.94E-04 | No Change: Both O | - |
| O95479 | G6PE_HUMAN GDH/6PGL endoplasmic bifunctional protein OS=Homo sapiens GN=H6PD PE=1 SV=2 | 554 | P | 0.452518 | L | 0.326479 | 0.126039 | No Change: Both O | - |
| P46952 | 3HAO_HUMAN 3-hydroxyanthranilate 3 4-dioxygenase OS=Homo sapiens GN=HAAO PE=1 SV=2 | 37 | I | 0.211763 | V | 0.253657 | -0.041894 | No Change: Both O | - |
| P46952 | 3HAO_HUMAN 3-hydroxyanthranilate 3 4-dioxygenase OS=Homo sapiens GN=HAAO PE=1 SV=2 | 42 | T | 0.379122 | S | 0.43312 | -0.053998 | No Change: Both O | - |
| Q14520 | HABP2_HUMAN Hyaluronan-binding protein 2 OS=Homo sapiens GN=HABP2 PE=1 SV=1 | 90 | V | 0.552324 | I | 0.512122 | 0.040202 | No Change: Both D | - |
| Q14520 | HABP2_HUMAN Hyaluronan-binding protein 2 OS=Homo sapiens GN=HABP2 PE=1 SV=1 | 393 | E | 0.375368 | Q | 0.331898 | 0.04347 | No Change: Both O | - |
| Q14520 | HABP2_HUMAN Hyaluronan-binding protein 2 OS=Homo sapiens GN=HABP2 PE=1 SV=1 | 534 | G | 0.232115 | E | 0.270823 | -0.038708 | No Change: Both O | - |
| Q8IYU2 | HACE1_HUMAN E3 ubiquitin-protein ligase HACE1 OS=Homo sapiens GN=HACE1 PE=1 SV=2 | 17 | R | 0.815336 | H | 0.738489 | 0.076847 | No Change: Both D | - |
| Q8IYU2 | HACE1_HUMAN E3 ubiquitin-protein ligase HACE1 OS=Homo sapiens GN=HACE1 PE=1 SV=2 | 374 | I | 0.092455 | T | 0.170024 | -0.077569 | No Change: Both O | - |
| Q16836 | HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase mitochondrial OS=Homo sapiens GN=HADH PE=1 SV=3 | 40 | A | 0.253155 | T | 0.264563 | -0.011408 | No Change: Both O | 3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) [MIM:231530] |
| Q16836 | HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase mitochondrial OS=Homo sapiens GN=HADH PE=1 SV=3 | 57 | D | 0.263878 | E | 0.29276 | -0.028882 | No Change: Both O | 3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) [MIM:231530] |
| Q16836 | HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase mitochondrial OS=Homo sapiens GN=HADH PE=1 SV=3 | 258 | P | 0.216475 | L | 0.118985 | 0.09749 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 4 (HHF4) [MIM:609975] |
| Q16836 | HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase mitochondrial OS=Homo sapiens GN=HADH PE=1 SV=3 | 86 | L | 0.630722 | P | 0.718388 | -0.087666 | No Change: Both D | - |
| Q16836 | HCDH_HUMAN Hydroxyacyl-coenzyme A dehydrogenase mitochondrial OS=Homo sapiens GN=HADH PE=1 SV=3 | 152 | Q | 0.439353 | H | 0.424372 | 0.014981 | No Change: Both O | - |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 510 | E | 0.260913 | Q | 0.229728 | 0.031185 | No Change: Both O | Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD deficiency) [MIM:609016] |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 510 | E | 0.260913 | Q | 0.229728 | 0.031185 | No Change: Both O | Maternal acute fatty liver of pregnancy (AFLP) [MIM:609016] |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 282 | V | 0.328344 | D | 0.440452 | -0.112108 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 305 | I | 0.179098 | N | 0.271988 | -0.09289 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 342 | L | 0.213334 | P | 0.332583 | -0.119249 | No Change: Both O | Long-chain 3-hydroxyl-CoA dehydrogenase deficiency (LCHAD deficiency) [MIM:609016] |
| P40939 | ECHA_HUMAN Trifunctional enzyme subunit alpha mitochondrial OS=Homo sapiens GN=HADHA PE=1 SV=2 | 358 | Q | 0.492982 | K | 0.547384 | -0.054402 | O to D | - |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 61 | R | 0.194566 | H | 0.178127 | 0.016439 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 247 | R | 0.553844 | H | 0.540728 | 0.013116 | No Change: Both D | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 263 | D | 0.429057 | G | 0.386923 | 0.042134 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 444 | R | 0.389281 | K | 0.452501 | -0.06322 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 59 | G | 0.173878 | D | 0.209568 | -0.03569 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 61 | R | 0.194566 | C | 0.102235 | 0.092331 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 117 | R | 0.405566 | G | 0.44309 | -0.037524 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 121 | L | 0.365423 | P | 0.529767 | -0.164344 | O to D | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 133 | T | 0.273885 | P | 0.312702 | -0.038817 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 242 | D | 0.61239 | G | 0.574896 | 0.037494 | No Change: Both D | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 280 | G | 0.575978 | D | 0.616394 | -0.040416 | No Change: Both D | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 294 | P | 0.360237 | L | 0.214617 | 0.14562 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 294 | P | 0.360237 | R | 0.300665 | 0.059572 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 301 | G | 0.307115 | S | 0.382649 | -0.075534 | No Change: Both O | Trifunctional protein deficiency (TFP deficiency) [MIM:609015] |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 209 | P | 0.406302 | S | 0.443659 | -0.037357 | No Change: Both O | - |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 119 | A | 0.368365 | V | 0.282936 | 0.085429 | No Change: Both O | A breast cancer sample |
| P55084 | ECHB_HUMAN Trifunctional enzyme subunit beta mitochondrial OS=Homo sapiens GN=HADHB PE=1 SV=3 | 277 | K | 0.594052 | R | 0.546615 | 0.047437 | No Change: Both D | - |
| P42357 | HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens GN=HAL PE=1 SV=1 | 439 | V | 0.541466 | I | 0.503032 | 0.038434 | No Change: Both D | - |
| P42357 | HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens GN=HAL PE=1 SV=1 | 206 | R | 0.317966 | T | 0.280345 | 0.037621 | No Change: Both O | Histidinemia (HISTID) [MIM:235800] |
| P42357 | HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens GN=HAL PE=1 SV=1 | 208 | R | 0.206828 | L | 0.13367 | 0.073158 | No Change: Both O | Histidinemia (HISTID) [MIM:235800] |
| P42357 | HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens GN=HAL PE=1 SV=1 | 259 | P | 0.390092 | L | 0.256246 | 0.133846 | No Change: Both O | Histidinemia (HISTID) [MIM:235800] |
| P42357 | HUTH_HUMAN Histidine ammonia-lyase OS=Homo sapiens GN=HAL PE=1 SV=1 | 322 | R | 0.338121 | P | 0.357978 | -0.019857 | No Change: Both O | Histidinemia (HISTID) [MIM:235800] |
| P81172 | HEPC_HUMAN Hepcidin OS=Homo sapiens GN=HAMP PE=1 SV=2 | 71 | G | 0.742492 | D | 0.767569 | -0.025077 | No Change: Both D | Hemochromatosis type 2B (HFE2B) [MIM:613313] |
| P81172 | HEPC_HUMAN Hepcidin OS=Homo sapiens GN=HAMP PE=1 SV=2 | 59 | R | 0.723354 | G | 0.669167 | 0.054187 | No Change: Both D | Hemochromatosis type 2B (HFE2B) [MIM:613313] |
| P81172 | HEPC_HUMAN Hepcidin OS=Homo sapiens GN=HAMP PE=1 SV=2 | 70 | C | 0.735196 | R | 0.781976 | -0.04678 | No Change: Both D | Hemochromatosis type 2B (HFE2B) [MIM:613313] |
| P81172 | HEPC_HUMAN Hepcidin OS=Homo sapiens GN=HAMP PE=1 SV=2 | 78 | C | 0.826941 | Y | 0.659424 | 0.167517 | No Change: Both D | Hemochromatosis type 2B (HFE2B) [MIM:613313] |
| Q9NYQ3 | HAOX2_HUMAN Hydroxyacid oxidase 2 OS=Homo sapiens GN=HAO2 PE=2 SV=1 | 15 | E | 0.597237 | K | 0.611197 | -0.01396 | No Change: Both D | - |
| Q9NYQ3 | HAOX2_HUMAN Hydroxyacid oxidase 2 OS=Homo sapiens GN=HAO2 PE=2 SV=1 | 221 | L | 0.112637 | M | 0.135875 | -0.023238 | No Change: Both O | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 4 | K | 0.97893 | R | 0.986077 | -0.007147 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 58 | S | 0.980392 | T | 0.974447 | 0.005945 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 357 | S | 0.840465 | L | 0.767021 | 0.073444 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 437 | R | 0.673658 | W | 0.509969 | 0.163689 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 441 | M | 0.547052 | T | 0.528584 | 0.018468 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 483 | F | 0.550189 | L | 0.615089 | -0.0649 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 488 | A | 0.586559 | V | 0.554898 | 0.031661 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 408 | L | 0.855657 | F | 0.808574 | 0.047083 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 493 | T | 0.549402 | M | 0.539017 | 0.010385 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 557 | A | 0.787873 | V | 0.738522 | 0.049351 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 656 | G | 0.591316 | R | 0.626759 | -0.035443 | No Change: Both D | - |
| P54257 | HAP1_HUMAN Huntingtin-associated protein 1 OS=Homo sapiens GN=HAP1 PE=1 SV=3 | 560 | F | 0.817879 | L | 0.830727 | -0.012848 | No Change: Both D | - |
| P10915 | HPLN1_HUMAN Hyaluronan and proteoglycan link protein 1 OS=Homo sapiens GN=HAPLN1 PE=2 SV=2 | 333 | R | 0.205718 | H | 0.192743 | 0.012975 | No Change: Both O | A colorectal cancer sample |
| P10915 | HPLN1_HUMAN Hyaluronan and proteoglycan link protein 1 OS=Homo sapiens GN=HAPLN1 PE=2 SV=2 | 281 | N | 0.193382 | S | 0.22707 | -0.033688 | No Change: Both O | - |
| P12081 | SYHC_HUMAN Histidine--tRNA ligase cytoplasmic OS=Homo sapiens GN=HARS PE=1 SV=2 | 399 | A | 0.460388 | V | 0.414322 | 0.046066 | No Change: Both O | - |
| Q92839 | HAS1_HUMAN Hyaluronan synthase 1 OS=Homo sapiens GN=HAS1 PE=1 SV=2 | 14 | C | 0.313057 | R | 0.499766 | -0.186709 | No Change: Both O | - |
| O00219 | HAS3_HUMAN Hyaluronan synthase 3 OS=Homo sapiens GN=HAS3 PE=1 SV=3 | 173 | R | 0.42685 | H | 0.398905 | 0.027945 | No Change: Both O | - |
| O14929 | HAT1_HUMAN Histone acetyltransferase type B catalytic subunit OS=Homo sapiens GN=HAT1 PE=1 SV=1 | 317 | A | 0.386608 | P | 0.451937 | -0.065329 | No Change: Both O | A colorectal cancer sample |
| Q9NVX0 | HAUS2_HUMAN HAUS augmin-like complex subunit 2 OS=Homo sapiens GN=HAUS2 PE=1 SV=1 | 76 | T | 0.343959 | P | 0.399106 | -0.055147 | No Change: Both O | - |
| Q68CZ6 | HAUS3_HUMAN HAUS augmin-like complex subunit 3 OS=Homo sapiens GN=HAUS3 PE=1 SV=1 | 586 | I | 0.342328 | T | 0.486795 | -0.144467 | No Change: Both O | - |
| O94927 | HAUS5_HUMAN HAUS augmin-like complex subunit 5 OS=Homo sapiens GN=HAUS5 PE=1 SV=2 | 213 | P | 0.649321 | L | 0.517834 | 0.131487 | No Change: Both D | - |
| O94927 | HAUS5_HUMAN HAUS augmin-like complex subunit 5 OS=Homo sapiens GN=HAUS5 PE=1 SV=2 | 277 | A | 0.844573 | D | 0.890925 | -0.046352 | No Change: Both D | - |
| Q7Z4H7 | HAUS6_HUMAN HAUS augmin-like complex subunit 6 OS=Homo sapiens GN=HAUS6 PE=1 SV=2 | 674 | H | 0.670522 | Q | 0.72044 | -0.049918 | No Change: Both D | - |
| Q7Z4H7 | HAUS6_HUMAN HAUS augmin-like complex subunit 6 OS=Homo sapiens GN=HAUS6 PE=1 SV=2 | 761 | S | 0.606027 | I | 0.388554 | 0.217473 | D to O | - |
| Q7Z4H7 | HAUS6_HUMAN HAUS augmin-like complex subunit 6 OS=Homo sapiens GN=HAUS6 PE=1 SV=2 | 552 | S | 0.758529 | T | 0.669901 | 0.088628 | No Change: Both D | - |
| Q9BT25 | HAUS8_HUMAN HAUS augmin-like complex subunit 8 OS=Homo sapiens GN=HAUS8 PE=1 SV=3 | 83 | G | 0.904084 | R | 0.893987 | 0.010097 | No Change: Both D | - |
| Q96D42 | HAVR1_HUMAN Hepatitis A virus cellular receptor 1 OS=Homo sapiens GN=HAVCR1 PE=1 SV=2 | 51 | S | 0.144393 | L | 0.062525 | 0.081868 | No Change: Both O | - |
| Q8TDQ0 | HAVR2_HUMAN Hepatitis A virus cellular receptor 2 OS=Homo sapiens GN=HAVCR2 PE=1 SV=3 | 140 | R | 0.559312 | L | 0.432424 | 0.126888 | D to O | - |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 49 | P | 0.967166 | S | 0.965651 | 0.001515 | No Change: Both D | - |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 141 | F | 0.829419 | L | 0.856416 | -0.026997 | No Change: Both D | Neutropenia severe congenital autosomal recessive type 3 (SCN3) [MIM:610738] |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 151 | S | 0.868442 | G | 0.837135 | 0.031307 | No Change: Both D | - |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 278 | S | 0.741998 | P | 0.76495 | -0.022952 | No Change: Both D | - |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 130 | L | 0.883245 | R | 0.923413 | -0.040168 | No Change: Both D | Neutropenia severe congenital autosomal recessive type 3 (SCN3) [MIM:610738] |
| O00165 | HAX1_HUMAN HCLS1-associated protein X-1 OS=Homo sapiens GN=HAX1 PE=1 SV=2 | 172 | V | 0.887299 | I | 0.862869 | 0.02443 | No Change: Both D | Neutropenia severe congenital autosomal recessive type 3 (SCN3) [MIM:610738] |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 2 | V | 0.767132 | E | 0.727625 | 0.039507 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 3 | L | 0.729552 | R | 0.700264 | 0.029288 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 6 | A | 0.645649 | D | 0.701814 | -0.056165 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 6 | A | 0.645649 | P | 0.687426 | -0.041777 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 7 | D | 0.593774 | A | 0.535835 | 0.057939 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 7 | D | 0.593774 | G | 0.56873 | 0.025044 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 7 | D | 0.593774 | N | 0.589737 | 0.004037 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 7 | D | 0.593774 | V | 0.460164 | 0.13361 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 7 | D | 0.593774 | Y | 0.445441 | 0.148333 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 8 | K | 0.525689 | E | 0.509458 | 0.016231 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 12 | K | 0.363527 | E | 0.342532 | 0.020995 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 13 | A | 0.354655 | D | 0.427993 | -0.073338 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 15 | W | 0.343221 | R | 0.542856 | -0.199635 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 16 | G | 0.336724 | R | 0.305549 | 0.031175 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 17 | K | 0.345895 | M | 0.217951 | 0.127944 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 17 | K | 0.345895 | N | 0.298505 | 0.04739 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 19 | G | 0.357919 | D | 0.359611 | -0.001692 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 19 | G | 0.357919 | R | 0.319881 | 0.038038 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 20 | A | 0.35485 | D | 0.410746 | -0.055896 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 20 | A | 0.35485 | E | 0.454643 | -0.099793 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 21 | H | 0.392926 | Q | 0.412881 | -0.019955 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 21 | H | 0.392926 | R | 0.391648 | 0.001278 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 22 | A | 0.419042 | D | 0.47311 | -0.054068 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 22 | A | 0.419042 | P | 0.467729 | -0.048687 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 23 | G | 0.433544 | D | 0.433282 | 2.62E-04 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 24 | E | 0.464624 | G | 0.424583 | 0.040041 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 24 | E | 0.464624 | K | 0.451939 | 0.012685 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 25 | Y | 0.48428 | H | 0.589422 | -0.105142 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 27 | A | 0.444648 | E | 0.537503 | -0.092855 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 28 | E | 0.398919 | D | 0.355202 | 0.043717 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 28 | E | 0.398919 | G | 0.352818 | 0.046101 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 28 | E | 0.398919 | V | 0.21785 | 0.181069 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 31 | E | 0.253892 | K | 0.240725 | 0.013167 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 32 | R | 0.222836 | S | 0.289898 | -0.067062 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 35 | L | 0.195526 | R | 0.291195 | -0.095669 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 38 | P | 0.25134 | R | 0.222528 | 0.028812 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 41 | K | 0.308141 | M | 0.209568 | 0.098573 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 42 | T | 0.296309 | S | 0.367153 | -0.070844 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 44 | F | 0.33226 | L | 0.358069 | -0.025809 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 45 | P | 0.345701 | L | 0.202567 | 0.143134 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 45 | P | 0.345701 | R | 0.297823 | 0.047878 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 46 | H | 0.348848 | Q | 0.353652 | -0.004804 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 46 | H | 0.348848 | R | 0.33122 | 0.017628 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 48 | D | 0.358858 | A | 0.297913 | 0.060945 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 48 | D | 0.358858 | G | 0.351109 | 0.007749 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 48 | D | 0.358858 | H | 0.349282 | 0.009576 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 48 | D | 0.358858 | Y | 0.231055 | 0.127803 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 49 | L | 0.373556 | R | 0.481464 | -0.107908 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 50 | S | 0.42452 | R | 0.351238 | 0.073282 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 51 | H | 0.481533 | R | 0.458808 | 0.022725 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 52 | G | 0.523854 | D | 0.545373 | -0.021519 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 52 | G | 0.523854 | R | 0.500319 | 0.023535 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 54 | A | 0.631185 | D | 0.685324 | -0.054139 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 55 | Q | 0.647246 | R | 0.628809 | 0.018437 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 57 | K | 0.636036 | R | 0.58279 | 0.053246 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 57 | K | 0.636036 | T | 0.578157 | 0.057879 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 58 | G | 0.620841 | R | 0.593511 | 0.02733 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 59 | H | 0.614005 | Y | 0.520958 | 0.093047 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 60 | G | 0.588505 | D | 0.605799 | -0.017294 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 60 | G | 0.588505 | V | 0.489481 | 0.099024 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 61 | K | 0.539221 | N | 0.497597 | 0.041624 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 62 | K | 0.52416 | N | 0.479792 | 0.044368 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 62 | K | 0.52416 | T | 0.451524 | 0.072636 | D to O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 63 | V | 0.506067 | M | 0.557722 | -0.051655 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 64 | A | 0.491328 | D | 0.561826 | -0.070498 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 65 | D | 0.45041 | Y | 0.284002 | 0.166408 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 69 | N | 0.356768 | K | 0.424041 | -0.067273 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 72 | A | 0.341384 | E | 0.405563 | -0.064179 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 72 | A | 0.341384 | V | 0.261086 | 0.080298 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 73 | H | 0.380992 | R | 0.376602 | 0.00439 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 75 | D | 0.43355 | A | 0.370618 | 0.062932 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 75 | D | 0.43355 | G | 0.377681 | 0.055869 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 75 | D | 0.43355 | N | 0.414481 | 0.019069 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 76 | D | 0.454214 | A | 0.387892 | 0.066322 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 76 | D | 0.454214 | H | 0.417246 | 0.036968 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 77 | M | 0.497665 | K | 0.602377 | -0.104712 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 77 | M | 0.497665 | T | 0.5381 | -0.040435 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 78 | P | 0.49267 | R | 0.456918 | 0.035752 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 79 | N | 0.484465 | H | 0.485158 | -6.93E-04 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 79 | N | 0.484465 | K | 0.52863 | -0.044165 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 81 | L | 0.508167 | R | 0.598222 | -0.090055 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 82 | S | 0.495837 | C | 0.267755 | 0.228082 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 83 | A | 0.496808 | D | 0.574 | -0.077192 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 85 | S | 0.477695 | R | 0.408693 | 0.069002 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 86 | D | 0.447972 | V | 0.297019 | 0.150953 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 86 | D | 0.447972 | Y | 0.282145 | 0.165827 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 87 | L | 0.435834 | R | 0.542333 | -0.106499 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 88 | H | 0.415221 | N | 0.424275 | -0.009054 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 88 | H | 0.415221 | R | 0.414128 | 0.001093 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 89 | A | 0.392937 | S | 0.50398 | -0.111043 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 91 | K | 0.370104 | M | 0.268743 | 0.101361 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 92 | L | 0.340726 | P | 0.487622 | -0.146896 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 93 | R | 0.331491 | Q | 0.348048 | -0.016557 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 95 | D | 0.308754 | Y | 0.172102 | 0.136652 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 96 | P | 0.286455 | A | 0.227086 | 0.059369 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 96 | P | 0.286455 | T | 0.237703 | 0.048752 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 98 | N | 0.241657 | K | 0.294251 | -0.052594 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 100 | K | 0.168873 | E | 0.161556 | 0.007317 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 103 | S | 0.118434 | R | 0.093186 | 0.025248 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 104 | H | 0.117842 | R | 0.120221 | -0.002379 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 110 | L | 0.140868 | R | 0.19132 | -0.050452 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 111 | A | 0.140832 | D | 0.175032 | -0.0342 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 113 | H | 0.175345 | D | 0.199174 | -0.023829 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 114 | L | 0.22519 | H | 0.321315 | -0.096125 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 115 | P | 0.278336 | L | 0.166816 | 0.11152 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 115 | P | 0.278336 | R | 0.23424 | 0.044096 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 115 | P | 0.278336 | S | 0.28917 | -0.010834 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 116 | A | 0.337761 | D | 0.384752 | -0.046991 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 117 | E | 0.374734 | A | 0.304371 | 0.070363 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 121 | A | 0.304933 | E | 0.40054 | -0.095607 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 122 | V | 0.274614 | M | 0.334365 | -0.059751 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 123 | H | 0.25956 | Q | 0.270613 | -0.011053 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 126 | L | 0.343145 | P | 0.506029 | -0.162884 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 127 | D | 0.361554 | V | 0.228623 | 0.132931 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 127 | D | 0.361554 | Y | 0.212312 | 0.149242 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 128 | K | 0.357227 | N | 0.310473 | 0.046754 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 130 | L | 0.324551 | P | 0.476247 | -0.151696 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 131 | A | 0.293463 | P | 0.372259 | -0.078796 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 131 | A | 0.293463 | D | 0.380255 | -0.086792 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 132 | S | 0.283492 | P | 0.242643 | 0.040849 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 134 | S | 0.294229 | R | 0.221918 | 0.072311 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 136 | V | 0.437968 | E | 0.580871 | -0.142903 | O to D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 137 | L | 0.54136 | M | 0.581295 | -0.039935 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 137 | L | 0.54136 | P | 0.633111 | -0.091751 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 139 | S | 0.689553 | P | 0.651403 | 0.03815 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 140 | K | 0.757461 | E | 0.771044 | -0.013583 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 140 | K | 0.757461 | T | 0.765979 | -0.008518 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 141 | Y | 0.744027 | H | 0.726746 | 0.017281 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 142 | R | 0.760635 | C | 0.745979 | 0.014656 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 142 | R | 0.760635 | L | 0.773769 | -0.013134 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 142 | R | 0.760635 | H | 0.779832 | -0.019197 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 142 | R | 0.760635 | P | 0.727694 | 0.032941 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 80 | A | 0.500573 | G | 0.518309 | -0.017736 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 11 | V | 0.378605 | F | 0.331992 | 0.046613 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 93 | R | 0.331491 | W | 0.163893 | 0.167598 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 32 | R | 0.222836 | K | 0.278389 | -0.055553 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 27 | A | 0.444648 | V | 0.351327 | 0.093321 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 59 | H | 0.614005 | Q | 0.62434 | -0.010335 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 95 | D | 0.308754 | A | 0.252994 | 0.05576 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 104 | H | 0.117842 | Y | 0.05656 | 0.061282 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 126 | L | 0.343145 | R | 0.453618 | -0.110473 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 127 | D | 0.361554 | G | 0.331826 | 0.029728 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 137 | L | 0.54136 | R | 0.626442 | -0.085082 | No Change: Both D | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 10 | N | 0.4074 | T | 0.385771 | 0.021629 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 14 | A | 0.349147 | P | 0.412223 | -0.063076 | No Change: Both O | - |
| P69905 | HBA_HUMAN Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 | 92 | L | 0.340726 | F | 0.298592 | 0.042134 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 2 | V | 0.853256 | A | 0.8541 | -8.44E-04 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 3 | H | 0.848912 | L | 0.769105 | 0.079807 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 3 | H | 0.848912 | Q | 0.830194 | 0.018718 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 3 | H | 0.848912 | R | 0.797372 | 0.05154 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 3 | H | 0.848912 | Y | 0.788477 | 0.060435 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 6 | P | 0.80517 | R | 0.775011 | 0.030159 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 7 | E | 0.72363 | A | 0.641481 | 0.082149 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 7 | E | 0.72363 | V | 0.562416 | 0.161214 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 7 | E | 0.72363 | K | 0.719446 | 0.004184 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 7 | E | 0.72363 | Q | 0.682478 | 0.041152 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 8 | E | 0.682219 | G | 0.622288 | 0.059931 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 8 | E | 0.682219 | K | 0.680227 | 0.001992 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 9 | K | 0.586645 | E | 0.604192 | -0.017547 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 9 | K | 0.586645 | Q | 0.53914 | 0.047505 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 9 | K | 0.586645 | T | 0.523523 | 0.063122 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 10 | S | 0.479499 | C | 0.246162 | 0.233337 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 11 | A | 0.383798 | D | 0.453493 | -0.069695 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 12 | V | 0.306966 | D | 0.466065 | -0.159099 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 12 | V | 0.306966 | I | 0.271732 | 0.035234 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 14 | A | 0.181256 | D | 0.240003 | -0.058747 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 15 | L | 0.157015 | P | 0.295854 | -0.138839 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 15 | L | 0.157015 | R | 0.255132 | -0.098117 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 16 | W | 0.147451 | G | 0.35434 | -0.206889 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 16 | W | 0.147451 | R | 0.322295 | -0.174844 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 17 | G | 0.156153 | D | 0.180022 | -0.023869 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 17 | G | 0.156153 | R | 0.143351 | 0.012802 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 18 | K | 0.18529 | E | 0.196389 | -0.011099 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 18 | K | 0.18529 | N | 0.165765 | 0.019525 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 18 | K | 0.18529 | Q | 0.152515 | 0.032775 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 19 | V | 0.210185 | M | 0.246204 | -0.036019 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 20 | N | 0.231406 | D | 0.259091 | -0.027685 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 20 | N | 0.231406 | K | 0.285869 | -0.054463 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 20 | N | 0.231406 | S | 0.270519 | -0.039113 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 21 | V | 0.270429 | M | 0.31217 | -0.041741 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 22 | D | 0.329129 | G | 0.331963 | -0.002834 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 22 | D | 0.329129 | N | 0.330258 | -0.001129 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 22 | D | 0.329129 | H | 0.298296 | 0.030833 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 22 | D | 0.329129 | Y | 0.19526 | 0.133869 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 23 | E | 0.352058 | A | 0.252909 | 0.099149 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 23 | E | 0.352058 | G | 0.31423 | 0.037828 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 23 | E | 0.352058 | K | 0.354561 | -0.002503 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 23 | E | 0.352058 | Q | 0.292036 | 0.060022 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 23 | E | 0.352058 | V | 0.195667 | 0.156391 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 24 | V | 0.372319 | D | 0.524242 | -0.151923 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 24 | V | 0.372319 | F | 0.314748 | 0.057571 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 24 | V | 0.372319 | G | 0.5122 | -0.139881 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 25 | G | 0.386801 | D | 0.406293 | -0.019492 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 25 | G | 0.386801 | R | 0.363252 | 0.023549 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 25 | G | 0.386801 | V | 0.252764 | 0.134037 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 26 | G | 0.361764 | D | 0.381107 | -0.019343 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 26 | G | 0.361764 | R | 0.339951 | 0.021813 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 27 | E | 0.298501 | K | 0.287515 | 0.010986 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 27 | E | 0.298501 | V | 0.157287 | 0.141214 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 28 | A | 0.252482 | D | 0.34103 | -0.088548 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 28 | A | 0.252482 | S | 0.352858 | -0.100376 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 28 | A | 0.252482 | V | 0.209262 | 0.04322 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 29 | L | 0.194928 | P | 0.304298 | -0.10937 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 30 | G | 0.139287 | D | 0.147203 | -0.007916 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 31 | R | 0.105022 | S | 0.135113 | -0.030091 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 32 | L | 0.076659 | P | 0.143859 | -0.0672 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 33 | L | 0.050713 | R | 0.087179 | -0.036466 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 33 | L | 0.050713 | V | 0.051621 | -9.08E-04 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 35 | V | 0.042415 | F | 0.036634 | 0.005781 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 36 | Y | 0.045212 | F | 0.04916 | -0.003948 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 37 | P | 0.045326 | R | 0.041264 | 0.004062 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 37 | P | 0.045326 | S | 0.051324 | -0.005998 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 37 | P | 0.045326 | T | 0.037242 | 0.008084 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 38 | W | 0.051478 | G | 0.13856 | -0.087082 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 38 | W | 0.051478 | S | 0.169516 | -0.118038 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 38 | W | 0.051478 | R | 0.13886 | -0.087382 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 39 | T | 0.06495 | N | 0.07634 | -0.01139 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 40 | Q | 0.071957 | E | 0.095395 | -0.023438 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 40 | Q | 0.071957 | K | 0.089053 | -0.017096 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 40 | Q | 0.071957 | R | 0.07252 | -5.63E-04 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 42 | F | 0.133263 | Y | 0.147747 | -0.014484 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 43 | F | 0.169629 | L | 0.182013 | -0.012384 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 44 | E | 0.228035 | Q | 0.206384 | 0.021651 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 45 | S | 0.290724 | C | 0.117417 | 0.173307 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 46 | F | 0.330724 | S | 0.544422 | -0.213698 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 47 | G | 0.333557 | E | 0.397915 | -0.064358 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 48 | D | 0.373812 | A | 0.293207 | 0.080605 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 48 | D | 0.373812 | G | 0.34847 | 0.025342 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 48 | D | 0.373812 | Y | 0.217383 | 0.156429 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 49 | L | 0.407795 | P | 0.581328 | -0.173533 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 50 | S | 0.422897 | F | 0.22223 | 0.200667 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 51 | T | 0.438054 | K | 0.516044 | -0.07799 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 52 | P | 0.463218 | R | 0.413224 | 0.049994 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 53 | D | 0.462439 | A | 0.372957 | 0.089482 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 53 | D | 0.462439 | H | 0.409278 | 0.053161 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 55 | V | 0.459181 | D | 0.612973 | -0.153792 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 56 | M | 0.501775 | K | 0.632013 | -0.130238 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 57 | G | 0.548256 | R | 0.526756 | 0.0215 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 58 | N | 0.604315 | K | 0.659924 | -0.055609 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 59 | P | 0.636433 | R | 0.590956 | 0.045477 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 60 | K | 0.616579 | E | 0.597493 | 0.019086 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 61 | V | 0.620132 | A | 0.681823 | -0.061691 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 62 | K | 0.617071 | E | 0.591315 | 0.025756 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 62 | K | 0.617071 | M | 0.474907 | 0.142164 | D to O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 62 | K | 0.617071 | N | 0.568173 | 0.048898 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 63 | A | 0.577782 | D | 0.643646 | -0.065864 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 63 | A | 0.577782 | P | 0.653281 | -0.075499 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 64 | H | 0.571636 | Y | 0.440335 | 0.131301 | D to O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 66 | K | 0.504121 | M | 0.359349 | 0.144772 | D to O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 66 | K | 0.504121 | N | 0.446065 | 0.058056 | D to O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 66 | K | 0.504121 | Q | 0.43175 | 0.072371 | D to O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 67 | K | 0.460216 | T | 0.362679 | 0.097537 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 68 | V | 0.44823 | A | 0.53867 | -0.09044 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 68 | V | 0.44823 | M | 0.508034 | -0.059804 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 69 | L | 0.419881 | H | 0.539826 | -0.119945 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 69 | L | 0.419881 | P | 0.561087 | -0.141206 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 70 | G | 0.387314 | D | 0.413894 | -0.02658 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 70 | G | 0.387314 | R | 0.35262 | 0.034694 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 70 | G | 0.387314 | S | 0.436237 | -0.048923 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 71 | A | 0.374586 | D | 0.454985 | -0.080399 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 72 | F | 0.367166 | S | 0.563105 | -0.195939 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 74 | D | 0.341522 | G | 0.322228 | 0.019294 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 74 | D | 0.341522 | V | 0.210931 | 0.130591 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 74 | D | 0.341522 | Y | 0.178672 | 0.16285 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 75 | G | 0.341918 | R | 0.314339 | 0.027579 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 75 | G | 0.341918 | V | 0.22895 | 0.112968 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 76 | L | 0.329763 | P | 0.461628 | -0.131865 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 76 | L | 0.329763 | R | 0.409014 | -0.079251 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 77 | A | 0.319879 | D | 0.40597 | -0.086091 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 78 | H | 0.335456 | D | 0.393227 | -0.057771 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 78 | H | 0.335456 | R | 0.33016 | 0.005296 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 78 | H | 0.335456 | Y | 0.214841 | 0.120615 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 79 | L | 0.346872 | R | 0.42482 | -0.077948 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 80 | D | 0.338037 | Y | 0.183056 | 0.154981 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 81 | N | 0.344579 | K | 0.405428 | -0.060849 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 82 | L | 0.365579 | R | 0.450322 | -0.084743 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 83 | K | 0.355069 | M | 0.240252 | 0.114817 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 84 | G | 0.329776 | R | 0.313344 | 0.016432 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 85 | T | 0.313312 | I | 0.181098 | 0.132214 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 87 | A | 0.252777 | D | 0.34341 | -0.090633 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 88 | T | 0.24385 | I | 0.13353 | 0.11032 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 88 | T | 0.24385 | K | 0.318179 | -0.074329 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 88 | T | 0.24385 | P | 0.280655 | -0.036805 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 89 | L | 0.253069 | P | 0.387045 | -0.133976 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 89 | L | 0.253069 | R | 0.344619 | -0.09155 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 90 | S | 0.254168 | N | 0.22425 | 0.029918 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 90 | S | 0.254168 | R | 0.203175 | 0.050993 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 91 | E | 0.255747 | D | 0.251269 | 0.004478 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 91 | E | 0.255747 | K | 0.272079 | -0.016332 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 92 | L | 0.267905 | P | 0.398108 | -0.130203 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 92 | L | 0.267905 | R | 0.357877 | -0.089972 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 93 | H | 0.29473 | D | 0.330403 | -0.035673 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 93 | H | 0.29473 | N | 0.297007 | -0.002277 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 93 | H | 0.29473 | P | 0.3194 | -0.02467 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 93 | H | 0.29473 | Q | 0.291598 | 0.003132 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 94 | C | 0.307032 | R | 0.470171 | -0.163139 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 95 | D | 0.324127 | G | 0.284385 | 0.039742 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 95 | D | 0.324127 | H | 0.295835 | 0.028292 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 95 | D | 0.324127 | N | 0.300856 | 0.023271 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 96 | K | 0.337188 | M | 0.228136 | 0.109052 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 96 | K | 0.337188 | N | 0.30954 | 0.027648 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 97 | L | 0.34331 | P | 0.495644 | -0.152334 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 97 | L | 0.34331 | V | 0.341251 | 0.002059 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 98 | H | 0.338659 | L | 0.228069 | 0.11059 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 98 | H | 0.338659 | P | 0.370347 | -0.031688 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 98 | H | 0.338659 | Q | 0.336106 | 0.002553 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 98 | H | 0.338659 | Y | 0.215399 | 0.12326 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 99 | V | 0.314665 | G | 0.449788 | -0.135123 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 100 | D | 0.322824 | E | 0.34793 | -0.025106 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 101 | P | 0.326645 | L | 0.205266 | 0.121379 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 101 | P | 0.326645 | R | 0.307184 | 0.019461 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 102 | E | 0.303621 | D | 0.297854 | 0.005767 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 102 | E | 0.303621 | G | 0.266577 | 0.037044 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 102 | E | 0.303621 | K | 0.31565 | -0.012029 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 102 | E | 0.303621 | Q | 0.259713 | 0.043908 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 103 | N | 0.267446 | S | 0.292316 | -0.02487 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 103 | N | 0.267446 | Y | 0.15453 | 0.112916 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 104 | F | 0.234893 | L | 0.276748 | -0.041855 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 105 | R | 0.167242 | S | 0.212528 | -0.045286 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 105 | R | 0.167242 | T | 0.159226 | 0.008016 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 108 | G | 0.061561 | R | 0.063151 | -0.00159 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 109 | N | 0.053797 | K | 0.062245 | -0.008448 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 110 | V | 0.047671 | M | 0.057304 | -0.009633 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 111 | L | 0.042696 | P | 0.081848 | -0.039152 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 112 | V | 0.040954 | A | 0.057659 | -0.016705 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 113 | C | 0.044244 | R | 0.093808 | -0.049564 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 113 | C | 0.044244 | Y | 0.052943 | -0.008699 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 116 | A | 0.062588 | D | 0.090218 | -0.02763 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 116 | A | 0.062588 | P | 0.09275 | -0.030162 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 117 | H | 0.091502 | Q | 0.091543 | -4.10E-05 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 118 | H | 0.128606 | P | 0.148476 | -0.01987 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 118 | H | 0.128606 | R | 0.119439 | 0.009167 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 120 | G | 0.283169 | A | 0.250138 | 0.033031 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 121 | K | 0.36688 | E | 0.382962 | -0.016082 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 121 | K | 0.36688 | I | 0.1827 | 0.18418 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 121 | K | 0.36688 | Q | 0.333968 | 0.032912 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 122 | E | 0.429013 | A | 0.335542 | 0.093471 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 122 | E | 0.429013 | G | 0.390615 | 0.038398 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 122 | E | 0.429013 | Q | 0.393566 | 0.035447 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 122 | E | 0.429013 | K | 0.44341 | -0.014397 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 122 | E | 0.429013 | V | 0.256675 | 0.172338 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 124 | T | 0.449669 | I | 0.302351 | 0.147318 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 125 | P | 0.413236 | R | 0.360055 | 0.053181 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 125 | P | 0.413236 | Q | 0.398676 | 0.01456 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 125 | P | 0.413236 | S | 0.431572 | -0.018336 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 127 | V | 0.321055 | A | 0.418474 | -0.097419 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 127 | V | 0.321055 | G | 0.468217 | -0.147162 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 127 | V | 0.321055 | E | 0.53129 | -0.210235 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 128 | Q | 0.283517 | E | 0.326443 | -0.042926 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 128 | Q | 0.283517 | K | 0.33282 | -0.049303 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 129 | A | 0.268487 | D | 0.332725 | -0.064238 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 130 | A | 0.264085 | P | 0.345483 | -0.081398 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 130 | A | 0.264085 | V | 0.200523 | 0.063562 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 131 | Y | 0.260937 | D | 0.42389 | -0.162953 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 131 | Y | 0.260937 | S | 0.452247 | -0.19131 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 132 | Q | 0.254807 | E | 0.283534 | -0.028727 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 132 | Q | 0.254807 | K | 0.299597 | -0.04479 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 132 | Q | 0.254807 | P | 0.273252 | -0.018445 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 132 | Q | 0.254807 | R | 0.222914 | 0.031893 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 133 | K | 0.244015 | N | 0.215273 | 0.028742 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 133 | K | 0.244015 | Q | 0.222313 | 0.021702 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 134 | V | 0.228586 | L | 0.211138 | 0.017448 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 135 | V | 0.212088 | E | 0.373733 | -0.161645 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 136 | A | 0.19944 | E | 0.26971 | -0.07027 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 136 | A | 0.19944 | P | 0.24559 | -0.04615 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 137 | G | 0.199457 | D | 0.221759 | -0.022302 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 139 | A | 0.259162 | P | 0.313002 | -0.05384 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 140 | N | 0.326328 | D | 0.342689 | -0.016361 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 140 | N | 0.326328 | K | 0.387531 | -0.061203 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 140 | N | 0.326328 | Y | 0.21451 | 0.111818 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 141 | A | 0.429968 | D | 0.492653 | -0.062685 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 141 | A | 0.429968 | T | 0.434009 | -0.004041 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 141 | A | 0.429968 | V | 0.346183 | 0.083785 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 142 | L | 0.540253 | R | 0.648497 | -0.108244 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 143 | A | 0.646323 | D | 0.700626 | -0.054303 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 144 | H | 0.736915 | D | 0.750473 | -0.013558 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 144 | H | 0.736915 | Q | 0.717574 | 0.019341 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 144 | H | 0.736915 | P | 0.717947 | 0.018968 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 144 | H | 0.736915 | R | 0.722671 | 0.014244 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 145 | K | 0.790386 | E | 0.809536 | -0.01915 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 146 | Y | 0.777561 | C | 0.730566 | 0.046995 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 146 | Y | 0.777561 | H | 0.742076 | 0.035485 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 147 | H | 0.81408 | D | 0.824011 | -0.009931 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 147 | H | 0.81408 | L | 0.793672 | 0.020408 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 147 | H | 0.81408 | P | 0.761215 | 0.052865 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 147 | H | 0.81408 | Q | 0.781255 | 0.032825 | No Change: Both D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 115 | L | 0.049055 | M | 0.060279 | -0.011224 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 115 | L | 0.049055 | P | 0.096202 | -0.047147 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 82 | L | 0.365579 | H | 0.475251 | -0.109672 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 83 | K | 0.355069 | N | 0.326009 | 0.02906 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 140 | N | 0.326328 | S | 0.369745 | -0.043417 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 11 | A | 0.383798 | V | 0.305919 | 0.077879 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 35 | V | 0.042415 | D | 0.079756 | -0.037341 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 35 | V | 0.042415 | L | 0.043728 | -0.001313 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 84 | G | 0.329776 | D | 0.370826 | -0.04105 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 113 | C | 0.044244 | F | 0.049428 | -0.005184 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 117 | H | 0.091502 | L | 0.053322 | 0.03818 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 118 | H | 0.128606 | Y | 0.072589 | 0.056017 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 29 | L | 0.194928 | Q | 0.287924 | -0.092996 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 43 | F | 0.169629 | S | 0.343864 | -0.174235 | No Change: Both O | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 68 | V | 0.44823 | D | 0.600455 | -0.152225 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 68 | V | 0.44823 | G | 0.587014 | -0.138784 | O to D | - |
| P68871 | HBB_HUMAN Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 | 82 | L | 0.365579 | V | 0.342272 | 0.023307 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 2 | V | 0.856743 | A | 0.860533 | -0.00379 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 3 | H | 0.848375 | R | 0.800476 | 0.047899 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 13 | N | 0.209655 | K | 0.256391 | -0.046736 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 17 | G | 0.148433 | R | 0.135769 | 0.012664 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 21 | V | 0.197663 | E | 0.368597 | -0.170934 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 23 | A | 0.255314 | E | 0.353786 | -0.098472 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 25 | G | 0.291664 | D | 0.30861 | -0.016946 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 26 | G | 0.287578 | D | 0.306561 | -0.018983 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 27 | E | 0.245187 | D | 0.236795 | 0.008392 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 28 | A | 0.213715 | S | 0.294013 | -0.080298 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 44 | E | 0.259069 | G | 0.230741 | 0.028328 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 44 | E | 0.259069 | K | 0.259436 | -3.67E-04 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 48 | D | 0.467705 | V | 0.292734 | 0.174971 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 52 | P | 0.572434 | R | 0.518713 | 0.053721 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 70 | G | 0.419651 | R | 0.386237 | 0.033414 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 76 | L | 0.368265 | V | 0.345127 | 0.023138 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 91 | E | 0.3569 | V | 0.19503 | 0.16187 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 99 | V | 0.313972 | M | 0.371015 | -0.057043 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 100 | D | 0.32142 | N | 0.308771 | 0.012649 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 117 | R | 0.091999 | C | 0.04934 | 0.042659 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 117 | R | 0.091999 | H | 0.092721 | -7.22E-04 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 118 | N | 0.125472 | D | 0.132447 | -0.006975 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 122 | E | 0.37942 | V | 0.201861 | 0.177559 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 126 | Q | 0.371601 | E | 0.417059 | -0.045458 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 137 | G | 0.200067 | D | 0.222298 | -0.022231 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 142 | L | 0.542008 | P | 0.672472 | -0.130464 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 143 | A | 0.647323 | D | 0.701327 | -0.054004 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 94 | C | 0.358167 | G | 0.534964 | -0.176797 | O to D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 147 | H | 0.809298 | R | 0.743251 | 0.066047 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 5 | T | 0.804065 | I | 0.683171 | 0.120894 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 5 | T | 0.804065 | S | 0.83915 | -0.035085 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 3 | H | 0.848375 | L | 0.760229 | 0.088146 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 11 | A | 0.333957 | D | 0.406203 | -0.072246 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 12 | V | 0.27345 | G | 0.419402 | -0.145952 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 37 | P | 0.044874 | H | 0.035554 | 0.00932 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 58 | N | 0.623361 | K | 0.673125 | -0.049764 | No Change: Both D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 71 | A | 0.412175 | G | 0.472401 | -0.060226 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 86 | F | 0.409212 | S | 0.626708 | -0.217496 | O to D | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 88 | Q | 0.368118 | K | 0.433418 | -0.0653 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 89 | L | 0.376481 | V | 0.354424 | 0.022057 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 105 | R | 0.168731 | S | 0.21433 | -0.045599 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 134 | V | 0.243293 | A | 0.329475 | -0.086182 | No Change: Both O | - |
| P02042 | HBD_HUMAN Hemoglobin subunit delta OS=Homo sapiens GN=HBD PE=1 SV=2 | 141 | A | 0.431137 | V | 0.346874 | 0.084263 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 3 | H | 0.851735 | Q | 0.826996 | 0.024739 | No Change: Both D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 6 | E | 0.808733 | K | 0.804322 | 0.004411 | No Change: Both D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 7 | E | 0.723941 | G | 0.683853 | 0.040088 | No Change: Both D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 7 | E | 0.723941 | Q | 0.678717 | 0.045224 | No Change: Both D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 13 | T | 0.206943 | R | 0.203415 | 0.003528 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 23 | D | 0.449226 | G | 0.449463 | -2.37E-04 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 26 | G | 0.44844 | R | 0.425404 | 0.023036 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 37 | P | 0.042573 | R | 0.039565 | 0.003008 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 38 | W | 0.047881 | G | 0.131097 | -0.083216 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 40 | Q | 0.066234 | R | 0.066573 | -3.39E-04 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 41 | R | 0.082622 | K | 0.109235 | -0.026613 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 44 | D | 0.226628 | N | 0.226904 | -2.76E-04 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 54 | A | 0.465698 | D | 0.533007 | -0.067309 | O to D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 62 | K | 0.602111 | E | 0.575792 | 0.026319 | No Change: Both D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 73 | G | 0.385063 | R | 0.362147 | 0.022916 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 74 | D | 0.374869 | N | 0.337603 | 0.037266 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 74 | D | 0.374869 | H | 0.334778 | 0.040091 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 76 | I | 0.394428 | T | 0.552858 | -0.15843 | O to D | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 80 | D | 0.373282 | N | 0.334285 | 0.038997 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 81 | D | 0.362651 | Y | 0.197288 | 0.165363 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 81 | D | 0.362651 | N | 0.324565 | 0.038086 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 98 | H | 0.349787 | R | 0.330103 | 0.019684 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 122 | E | 0.299869 | K | 0.298997 | 8.72E-04 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 129 | A | 0.321892 | T | 0.367677 | -0.045785 | No Change: Both O | - |
| P69891 | HBG1_HUMAN Hemoglobin subunit gamma-1 OS=Homo sapiens GN=HBG1 PE=1 SV=2 | 135 | V | 0.27916 | M | 0.339891 | -0.060731 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 2 | G | 0.849982 | C | 0.81152 | 0.038462 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 6 | E | 0.808733 | G | 0.780015 | 0.028718 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 8 | D | 0.655933 | N | 0.640723 | 0.01521 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 16 | W | 0.163986 | R | 0.347591 | -0.183605 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 17 | G | 0.179497 | R | 0.164402 | 0.015095 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 22 | E | 0.433177 | K | 0.432942 | 2.35E-04 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 22 | E | 0.433177 | Q | 0.366955 | 0.066222 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 23 | D | 0.449226 | V | 0.304482 | 0.144744 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 26 | G | 0.44844 | E | 0.501618 | -0.053178 | O to D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 27 | E | 0.371945 | K | 0.359282 | 0.012663 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 35 | V | 0.043536 | I | 0.035062 | 0.008474 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 41 | R | 0.082622 | G | 0.092729 | -0.010107 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 42 | F | 0.127482 | S | 0.274671 | -0.147189 | No Change: Both O | Cyanosis transient neonatal (TNCY) [MIM:613977] |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 45 | S | 0.313295 | R | 0.249996 | 0.063299 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 56 | M | 0.528819 | R | 0.583463 | -0.054644 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 60 | K | 0.59692 | E | 0.58088 | 0.01604 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 60 | K | 0.59692 | Q | 0.530349 | 0.066571 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 64 | H | 0.585459 | Y | 0.452572 | 0.132887 | D to O | Cyanosis transient neonatal (TNCY) [MIM:613977] |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 66 | K | 0.54124 | N | 0.482259 | 0.058981 | D to O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 67 | K | 0.488358 | R | 0.398168 | 0.09019 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 67 | K | 0.488358 | Q | 0.419749 | 0.068609 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 78 | H | 0.394869 | R | 0.384597 | 0.010272 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 93 | H | 0.303866 | Y | 0.187276 | 0.11659 | No Change: Both O | Cyanosis transient neonatal (TNCY) [MIM:613977] |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 95 | D | 0.331678 | N | 0.306687 | 0.024991 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 102 | E | 0.352583 | K | 0.373081 | -0.020498 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 105 | K | 0.233726 | N | 0.213816 | 0.01991 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 118 | H | 0.098928 | R | 0.097309 | 0.001619 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 121 | K | 0.26372 | Q | 0.234533 | 0.029187 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 126 | E | 0.365145 | A | 0.253871 | 0.111274 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 131 | W | 0.306763 | G | 0.5608 | -0.254037 | O to D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 147 | H | 0.907455 | Y | 0.911832 | -0.004377 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 119 | F | 0.138292 | L | 0.15531 | -0.017018 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 9 | K | 0.545061 | E | 0.563164 | -0.018103 | No Change: Both D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 9 | K | 0.545061 | Q | 0.496872 | 0.048189 | D to O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 13 | T | 0.206943 | R | 0.203415 | 0.003528 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 18 | K | 0.228567 | N | 0.206297 | 0.02227 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 20 | N | 0.313368 | K | 0.370898 | -0.05753 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 23 | D | 0.449226 | G | 0.449463 | -2.37E-04 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 41 | R | 0.082622 | K | 0.109235 | -0.026613 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 73 | G | 0.385063 | R | 0.362147 | 0.022916 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 76 | I | 0.394428 | T | 0.552858 | -0.15843 | O to D | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 81 | D | 0.362651 | N | 0.324565 | 0.038086 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 122 | E | 0.299932 | K | 0.299053 | 8.79E-04 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 64 | H | 0.585459 | L | 0.466109 | 0.11935 | D to O | Cyanosis transient neonatal (TNCY) [MIM:613977] |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 21 | V | 0.356566 | A | 0.442356 | -0.08579 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 39 | T | 0.060489 | P | 0.08214 | -0.021651 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 76 | I | 0.394428 | V | 0.440694 | -0.046266 | No Change: Both O | - |
| P69892 | HBG2_HUMAN Hemoglobin subunit gamma-2 OS=Homo sapiens GN=HBG2 PE=1 SV=2 | 68 | V | 0.46595 | M | 0.527194 | -0.061244 | O to D | Cyanosis transient neonatal (TNCY) [MIM:613977] |
| Q9Y450 | HBS1L_HUMAN HBS1-like protein OS=Homo sapiens GN=HBS1L PE=1 SV=1 | 440 | G | 0.362701 | S | 0.426199 | -0.063498 | No Change: Both O | - |
| Q9BXC0 | HCAR1_HUMAN Hydroxycarboxylic acid receptor 1 OS=Homo sapiens GN=HCAR1 PE=1 SV=1 | 43 | H | 0.067914 | Q | 0.07176 | -0.003846 | No Change: Both O | - |
| Q9BXC0 | HCAR1_HUMAN Hydroxycarboxylic acid receptor 1 OS=Homo sapiens GN=HCAR1 PE=1 SV=1 | 253 | D | 0.518128 | E | 0.548873 | -0.030745 | No Change: Both D | - |
| Q9BXC0 | HCAR1_HUMAN Hydroxycarboxylic acid receptor 1 OS=Homo sapiens GN=HCAR1 PE=1 SV=1 | 253 | D | 0.518128 | H | 0.496411 | 0.021717 | D to O | - |
| Q8TDS4 | HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 OS=Homo sapiens GN=HCAR2 PE=1 SV=1 | 311 | R | 0.381648 | C | 0.293361 | 0.088287 | No Change: Both O | - |
| Q8TDS4 | HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 OS=Homo sapiens GN=HCAR2 PE=1 SV=1 | 317 | M | 0.617626 | I | 0.522639 | 0.094987 | No Change: Both D | - |
| Q8TDS4 | HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 OS=Homo sapiens GN=HCAR2 PE=1 SV=1 | 187 | Q | 0.084401 | R | 0.077455 | 0.006946 | No Change: Both O | - |
| Q8TDS4 | HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 OS=Homo sapiens GN=HCAR2 PE=1 SV=1 | 198 | F | 0.027542 | L | 0.032264 | -0.004722 | No Change: Both O | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 173 | P | 0.164267 | T | 0.131776 | 0.032491 | No Change: Both O | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 198 | L | 0.031557 | F | 0.02681 | 0.004747 | No Change: Both O | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 253 | R | 0.02222 | H | 0.022144 | 7.60E-05 | No Change: Both O | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 317 | M | 0.617626 | I | 0.522639 | 0.094987 | No Change: Both D | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 346 | M | 0.892008 | I | 0.829706 | 0.062302 | No Change: Both D | - |
| P49019 | HCAR3_HUMAN Hydroxycarboxylic acid receptor 3 OS=Homo sapiens GN=HCAR3 PE=1 SV=2 | 350 | G | 0.895676 | S | 0.920814 | -0.025138 | No Change: Both D | - |
| P53701 | CCHL_HUMAN Cytochrome c-type heme lyase OS=Homo sapiens GN=HCCS PE=1 SV=1 | 217 | R | 0.088792 | C | 0.040226 | 0.048566 | No Change: Both O | Microphthalmia syndromic type 7 (MCOPS7) [MIM:309801] |
| P51610 | HCFC1_HUMAN Host cell factor 1 OS=Homo sapiens GN=HCFC1 PE=1 SV=2 | 1164 | S | 0.874608 | P | 0.864407 | 0.010201 | No Change: Both D | - |
| P51610 | HCFC1_HUMAN Host cell factor 1 OS=Homo sapiens GN=HCFC1 PE=1 SV=2 | 2004 | S | 0.746294 | I | 0.667913 | 0.078381 | No Change: Both D | - |
| Q9NWW0 | HPIP_HUMAN Host cell factor C1 regulator 1 OS=Homo sapiens GN=HCFC1R1 PE=1 SV=1 | 92 | P | 0.719071 | Q | 0.637444 | 0.081627 | No Change: Both D | - |
| Q9Y5Z7 | HCFC2_HUMAN Host cell factor 2 OS=Homo sapiens GN=HCFC2 PE=1 SV=1 | 268 | G | 0.579844 | A | 0.536999 | 0.042845 | No Change: Both D | - |
| Q9Y5Z7 | HCFC2_HUMAN Host cell factor 2 OS=Homo sapiens GN=HCFC2 PE=1 SV=1 | 46 | A | 0.350449 | S | 0.460372 | -0.109923 | No Change: Both O | - |
| P08631 | HCK_HUMAN Tyrosine-protein kinase HCK OS=Homo sapiens GN=HCK PE=1 SV=5 | 502 | P | 0.516399 | Q | 0.492691 | 0.023708 | D to O | - |
| P08631 | HCK_HUMAN Tyrosine-protein kinase HCK OS=Homo sapiens GN=HCK PE=1 SV=5 | 44 | A | 0.800059 | T | 0.849809 | -0.04975 | No Change: Both D | - |
| P08631 | HCK_HUMAN Tyrosine-protein kinase HCK OS=Homo sapiens GN=HCK PE=1 SV=5 | 105 | M | 0.355395 | L | 0.306586 | 0.048809 | No Change: Both O | - |
| P08631 | HCK_HUMAN Tyrosine-protein kinase HCK OS=Homo sapiens GN=HCK PE=1 SV=5 | 399 | D | 0.073631 | G | 0.068983 | 0.004648 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P14317 | HCLS1_HUMAN Hematopoietic lineage cell-specific protein OS=Homo sapiens GN=HCLS1 PE=1 SV=3 | 235 | T | 0.891269 | A | 0.88558 | 0.005689 | No Change: Both D | - |
| P14317 | HCLS1_HUMAN Hematopoietic lineage cell-specific protein OS=Homo sapiens GN=HCLS1 PE=1 SV=3 | 361 | E | 0.997659 | K | 0.996306 | 0.001353 | No Change: Both D | - |
| P14317 | HCLS1_HUMAN Hematopoietic lineage cell-specific protein OS=Homo sapiens GN=HCLS1 PE=1 SV=3 | 436 | V | 0.237169 | L | 0.232458 | 0.004711 | No Change: Both O | - |
| O60741 | HCN1_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 OS=Homo sapiens GN=HCN1 PE=2 SV=3 | 42 | P | 0.924772 | S | 0.920458 | 0.004314 | No Change: Both D | - |
| Q9UL51 | HCN2_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 OS=Homo sapiens GN=HCN2 PE=1 SV=3 | 527 | R | 0.304789 | Q | 0.319626 | -0.014837 | No Change: Both O | - |
| Q9P1Z3 | HCN3_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 OS=Homo sapiens GN=HCN3 PE=2 SV=2 | 630 | P | 0.652808 | L | 0.517566 | 0.135242 | No Change: Both D | - |
| Q9Y3Q4 | HCN4_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Homo sapiens GN=HCN4 PE=1 SV=1 | 553 | D | 0.564419 | N | 0.514212 | 0.050207 | No Change: Both D | - |
| Q9Y3Q4 | HCN4_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Homo sapiens GN=HCN4 PE=1 SV=1 | 672 | S | 0.399285 | R | 0.366392 | 0.032893 | No Change: Both O | Sick sinus syndrome type 2 (SSS2) [MIM:163800] |
| Q9Y3Q4 | HCN4_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Homo sapiens GN=HCN4 PE=1 SV=1 | 485 | A | 0.236147 | V | 0.186914 | 0.049233 | No Change: Both O | Sick sinus syndrome type 2 (SSS2) [MIM:163800] |
| Q6MZN7 | HCP5_HUMAN HLA class I histocompatibility antigen protein P5 OS=Homo sapiens GN=HCP5 PE=2 SV=1 | 32 | W | 0.473258 | R | 0.656999 | -0.183741 | O to D | - |
| Q6MZN7 | HCP5_HUMAN HLA class I histocompatibility antigen protein P5 OS=Homo sapiens GN=HCP5 PE=2 SV=1 | 82 | W | 0.775319 | C | 0.846596 | -0.071277 | No Change: Both D | - |
| Q6MZN7 | HCP5_HUMAN HLA class I histocompatibility antigen protein P5 OS=Homo sapiens GN=HCP5 PE=2 SV=1 | 93 | G | 0.700261 | E | 0.70517 | -0.004909 | No Change: Both D | - |
| Q6MZN7 | HCP5_HUMAN HLA class I histocompatibility antigen protein P5 OS=Homo sapiens GN=HCP5 PE=2 SV=1 | 112 | V | 0.472645 | G | 0.621926 | -0.149281 | O to D | - |
| Q6MZN7 | HCP5_HUMAN HLA class I histocompatibility antigen protein P5 OS=Homo sapiens GN=HCP5 PE=2 SV=1 | 123 | H | 0.547045 | R | 0.558507 | -0.011462 | No Change: Both D | - |
| O43612 | OREX_HUMAN Orexin OS=Homo sapiens GN=HCRT PE=1 SV=1 | 16 | L | 0.226689 | R | 0.2747 | -0.048011 | No Change: Both O | Narcolepsy type 1 (NRCLP1) [MIM:161400] |
| O43613 | OX1R_HUMAN Orexin receptor type 1 OS=Homo sapiens GN=HCRTR1 PE=1 SV=2 | 408 | I | 0.847537 | V | 0.874498 | -0.026961 | No Change: Both D | - |
| O43613 | OX1R_HUMAN Orexin receptor type 1 OS=Homo sapiens GN=HCRTR1 PE=1 SV=2 | 279 | R | 0.614102 | Q | 0.624198 | -0.010096 | No Change: Both D | - |
| O43613 | OX1R_HUMAN Orexin receptor type 1 OS=Homo sapiens GN=HCRTR1 PE=1 SV=2 | 167 | G | 0.088089 | S | 0.113964 | -0.025875 | No Change: Both O | - |
| O43613 | OX1R_HUMAN Orexin receptor type 1 OS=Homo sapiens GN=HCRTR1 PE=1 SV=2 | 281 | R | 0.473261 | H | 0.413414 | 0.059847 | No Change: Both O | - |
| O43614 | OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens GN=HCRTR2 PE=2 SV=2 | 10 | P | 0.868228 | S | 0.874426 | -0.006198 | No Change: Both D | - |
| O43614 | OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens GN=HCRTR2 PE=2 SV=2 | 11 | P | 0.866226 | T | 0.822922 | 0.043304 | No Change: Both D | - |
| O43614 | OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens GN=HCRTR2 PE=2 SV=2 | 293 | I | 0.492758 | V | 0.51698 | -0.024222 | O to D | - |
| O43614 | OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens GN=HCRTR2 PE=2 SV=2 | 308 | I | 0.02962 | V | 0.035474 | -0.005854 | No Change: Both O | - |
| Q969S8 | HDA10_HUMAN Histone deacetylase 10 OS=Homo sapiens GN=HDAC10 PE=1 SV=1 | 584 | G | 0.539261 | C | 0.312679 | 0.226582 | D to O | - |
| Q969S8 | HDA10_HUMAN Histone deacetylase 10 OS=Homo sapiens GN=HDAC10 PE=1 SV=1 | 429 | V | 0.601658 | I | 0.582478 | 0.01918 | No Change: Both D | - |
| Q92769 | HDAC2_HUMAN Histone deacetylase 2 OS=Homo sapiens GN=HDAC2 PE=1 SV=2 | 230 | R | 0.311013 | C | 0.176892 | 0.134121 | No Change: Both O | - |
| Q92769 | HDAC2_HUMAN Histone deacetylase 2 OS=Homo sapiens GN=HDAC2 PE=1 SV=2 | 315 | Y | 0.066975 | H | 0.115124 | -0.048149 | No Change: Both O | - |
| O15379 | HDAC3_HUMAN Histone deacetylase 3 OS=Homo sapiens GN=HDAC3 PE=1 SV=2 | 411 | N | 0.919808 | S | 0.933069 | -0.013261 | No Change: Both D | - |
| P56524 | HDAC4_HUMAN Histone deacetylase 4 OS=Homo sapiens GN=HDAC4 PE=1 SV=3 | 727 | P | 0.412827 | R | 0.399397 | 0.01343 | No Change: Both O | A breast cancer sample |
| Q9UQL6 | HDAC5_HUMAN Histone deacetylase 5 OS=Homo sapiens GN=HDAC5 PE=1 SV=2 | 137 | R | 0.997945 | Q | 0.9984 | -4.55E-04 | No Change: Both D | - |
| Q9UQL6 | HDAC5_HUMAN Histone deacetylase 5 OS=Homo sapiens GN=HDAC5 PE=1 SV=2 | 565 | G | 0.989598 | A | 0.98739 | 0.002208 | No Change: Both D | - |
| Q9UBN7 | HDAC6_HUMAN Histone deacetylase 6 OS=Homo sapiens GN=HDAC6 PE=1 SV=2 | 994 | T | 0.938105 | I | 0.880532 | 0.057573 | No Change: Both D | - |
| Q8WUI4 | HDAC7_HUMAN Histone deacetylase 7 OS=Homo sapiens GN=HDAC7 PE=1 SV=2 | 43 | V | 0.907246 | M | 0.944809 | -0.037563 | No Change: Both D | A breast cancer sample |
| Q9UKV0 | HDAC9_HUMAN Histone deacetylase 9 OS=Homo sapiens GN=HDAC9 PE=1 SV=2 | 921 | P | 0.432005 | T | 0.381644 | 0.050361 | No Change: Both O | - |
| P19113 | DCHS_HUMAN Histidine decarboxylase OS=Homo sapiens GN=HDC PE=2 SV=2 | 644 | E | 0.629754 | D | 0.607241 | 0.022513 | No Change: Both D | - |
| P19113 | DCHS_HUMAN Histidine decarboxylase OS=Homo sapiens GN=HDC PE=2 SV=2 | 49 | E | 0.677937 | V | 0.561638 | 0.116299 | No Change: Both D | A colorectal cancer sample |
| P19113 | DCHS_HUMAN Histidine decarboxylase OS=Homo sapiens GN=HDC PE=2 SV=2 | 285 | E | 0.094718 | K | 0.099129 | -0.004411 | No Change: Both O | A colorectal cancer sample |
| P19113 | DCHS_HUMAN Histidine decarboxylase OS=Homo sapiens GN=HDC PE=2 SV=2 | 31 | T | 0.608625 | M | 0.601087 | 0.007538 | No Change: Both D | - |
| P19113 | DCHS_HUMAN Histidine decarboxylase OS=Homo sapiens GN=HDC PE=2 SV=2 | 553 | F | 0.523626 | L | 0.575129 | -0.051503 | No Change: Both D | - |
| Q7Z4H3 | HDDC2_HUMAN HD domain-containing protein 2 OS=Homo sapiens GN=HDDC2 PE=1 SV=1 | 64 | R | 0.389846 | C | 0.23308 | 0.156766 | No Change: Both O | - |
| P51858 | HDGF_HUMAN Hepatoma-derived growth factor OS=Homo sapiens GN=HDGF PE=1 SV=1 | 201 | P | 0.997791 | L | 0.995772 | 0.002019 | No Change: Both D | - |
| Q5TGJ6 | HDGL1_HUMAN Hepatoma-derived growth factor-like protein 1 OS=Homo sapiens GN=HDGFL1 PE=2 SV=1 | 87 | T | 0.687605 | M | 0.696044 | -0.008439 | No Change: Both D | - |
| Q08623 | HDHD1_HUMAN Pseudouridine-5'-monophosphatase OS=Homo sapiens GN=HDHD1 PE=1 SV=3 | 165 | P | 0.518589 | A | 0.423049 | 0.09554 | D to O | - |
| Q08623 | HDHD1_HUMAN Pseudouridine-5'-monophosphatase OS=Homo sapiens GN=HDHD1 PE=1 SV=3 | 88 | T | 0.319225 | M | 0.306429 | 0.012796 | No Change: Both O | - |
| Q9H0R4 | HDHD2_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Homo sapiens GN=HDHD2 PE=1 SV=1 | 85 | R | 0.493687 | Q | 0.493832 | -1.45E-04 | No Change: Both O | - |
| Q9BSH5 | HDHD3_HUMAN Haloacid dehalogenase-like hydrolase domain-containing protein 3 OS=Homo sapiens GN=HDHD3 PE=1 SV=1 | 146 | G | 0.270434 | E | 0.31206 | -0.041626 | No Change: Both O | - |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 418 | N | 0.467578 | S | 0.498061 | -0.030483 | No Change: Both O | - |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 1264 | W | 0.913675 | L | 0.948449 | -0.034774 | No Change: Both D | - |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 568 | K | 0.356324 | N | 0.305019 | 0.051305 | No Change: Both O | A breast cancer sample |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 939 | D | 0.893062 | V | 0.828586 | 0.064476 | No Change: Both D | A breast cancer sample |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 61 | S | 0.523808 | A | 0.467719 | 0.056089 | D to O | - |
| Q00341 | VIGLN_HUMAN Vigilin OS=Homo sapiens GN=HDLBP PE=1 SV=2 | 229 | V | 0.362657 | I | 0.332457 | 0.0302 | No Change: Both O | - |
| Q7Z353 | HDX_HUMAN Highly divergent homeobox OS=Homo sapiens GN=HDX PE=1 SV=1 | 193 | A | 0.576167 | T | 0.597081 | -0.020914 | No Change: Both D | - |
| Q7Z353 | HDX_HUMAN Highly divergent homeobox OS=Homo sapiens GN=HDX PE=1 SV=1 | 397 | F | 0.831306 | S | 0.916311 | -0.085005 | No Change: Both D | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1694 | N | 0.148887 | S | 0.166153 | -0.017266 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1854 | V | 0.425838 | A | 0.510113 | -0.084275 | O to D | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1967 | N | 0.261581 | D | 0.279537 | -0.017956 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 2017 | E | 0.370632 | G | 0.305844 | 0.064788 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 348 | H | 0.158597 | R | 0.146042 | 0.012555 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 607 | M | 0.065429 | V | 0.052648 | 0.012781 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 957 | D | 0.075899 | G | 0.066505 | 0.009394 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1433 | Y | 0.262569 | C | 0.216561 | 0.046008 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1559 | S | 0.161731 | N | 0.130239 | 0.031492 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 1654 | R | 0.466884 | H | 0.468091 | -0.001207 | No Change: Both O | - |
| Q9H583 | HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens GN=HEATR1 PE=1 SV=3 | 2077 | S | 0.524885 | L | 0.32467 | 0.200215 | D to O | - |
| Q86Y56 | HEAT2_HUMAN HEAT repeat-containing protein 2 OS=Homo sapiens GN=HEATR2 PE=1 SV=4 | 632 | V | 0.159491 | A | 0.223546 | -0.064055 | No Change: Both O | - |
| Q86Y56 | HEAT2_HUMAN HEAT repeat-containing protein 2 OS=Homo sapiens GN=HEATR2 PE=1 SV=4 | 560 | R | 0.241572 | C | 0.140041 | 0.101531 | No Change: Both O | - |
| Q86Y56 | HEAT2_HUMAN HEAT repeat-containing protein 2 OS=Homo sapiens GN=HEATR2 PE=1 SV=4 | 743 | R | 0.197438 | K | 0.253594 | -0.056156 | No Change: Both O | - |
| Q7Z4Q2 | HEAT3_HUMAN HEAT repeat-containing protein 3 OS=Homo sapiens GN=HEATR3 PE=1 SV=2 | 302 | R | 0.698319 | S | 0.744127 | -0.045808 | No Change: Both D | - |
| Q86WZ0 | HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens GN=HEATR4 PE=1 SV=2 | 634 | L | 0.115659 | H | 0.187325 | -0.071666 | No Change: Both O | - |
| Q86WZ0 | HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens GN=HEATR4 PE=1 SV=2 | 643 | W | 0.113127 | G | 0.264575 | -0.151448 | No Change: Both O | - |
| Q86WZ0 | HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens GN=HEATR4 PE=1 SV=2 | 660 | V | 0.185481 | A | 0.254457 | -0.068976 | No Change: Both O | - |
| Q9P2D3 | HTR5B_HUMAN HEAT repeat-containing protein 5B OS=Homo sapiens GN=HEATR5B PE=1 SV=2 | 1601 | S | 0.318494 | P | 0.308317 | 0.010177 | No Change: Both O | - |
| Q6AI08 | HEAT6_HUMAN HEAT repeat-containing protein 6 OS=Homo sapiens GN=HEATR6 PE=1 SV=1 | 71 | A | 0.5292 | V | 0.481019 | 0.048181 | D to O | - |
| Q6AI08 | HEAT6_HUMAN HEAT repeat-containing protein 6 OS=Homo sapiens GN=HEATR6 PE=1 SV=1 | 1006 | S | 0.210904 | L | 0.098599 | 0.112305 | No Change: Both O | - |
| Q8NDA8 | HTR7A_HUMAN HEAT repeat-containing protein 7A OS=Homo sapiens GN=HEATR7A PE=1 SV=3 | 38 | A | 0.42097 | V | 0.337655 | 0.083315 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 41 | D | 0.766112 | A | 0.721881 | 0.044231 | No Change: Both D | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 301 | H | 0.194095 | Y | 0.114555 | 0.07954 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 359 | G | 0.161004 | E | 0.200383 | -0.039379 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 519 | K | 0.446004 | N | 0.410378 | 0.035626 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1008 | R | 0.077524 | W | 0.029266 | 0.048258 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1071 | Q | 0.681686 | E | 0.710352 | -0.028666 | No Change: Both D | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1105 | S | 0.151702 | I | 0.060975 | 0.090727 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1137 | F | 0.031084 | S | 0.084917 | -0.053833 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1171 | R | 0.171814 | C | 0.087861 | 0.083953 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1214 | V | 0.299173 | M | 0.391419 | -0.092246 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1402 | V | 0.200705 | M | 0.265058 | -0.064353 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1405 | M | 0.198666 | V | 0.171898 | 0.026768 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1442 | A | 0.526885 | T | 0.480778 | 0.046107 | D to O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1486 | T | 0.372811 | A | 0.367773 | 0.005038 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1569 | M | 0.184004 | V | 0.126866 | 0.057138 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1578 | F | 0.157688 | L | 0.166157 | -0.008469 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1594 | A | 0.721897 | T | 0.75594 | -0.034043 | No Change: Both D | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1601 | V | 0.303243 | I | 0.27737 | 0.025873 | No Change: Both O | - |
| A6NES4 | HTRB1_HUMAN HEAT repeat-containing protein 7B1 OS=Homo sapiens GN=HEATR7B1 PE=4 SV=3 | 1675 | P | 0.544209 | L | 0.397288 | 0.146921 | D to O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 11 | M | 0.364965 | V | 0.278004 | 0.086961 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 191 | W | 0.012305 | R | 0.03132 | -0.019015 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 263 | L | 0.06261 | I | 0.054069 | 0.008541 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 468 | E | 0.188743 | V | 0.081365 | 0.107378 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 496 | V | 0.39919 | I | 0.362978 | 0.036212 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 526 | R | 0.379475 | H | 0.380808 | -0.001333 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 617 | K | 0.195775 | N | 0.160115 | 0.03566 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 648 | D | 0.467583 | V | 0.307607 | 0.159976 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 781 | M | 0.13736 | V | 0.097039 | 0.040321 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 918 | N | 0.278046 | K | 0.322582 | -0.044536 | No Change: Both O | - |
| Q7Z745 | HTRB2_HUMAN HEAT repeat-containing protein 7B2 OS=Homo sapiens GN=HEATR7B2 PE=2 SV=3 | 1179 | L | 0.276194 | P | 0.425495 | -0.149301 | No Change: Both O | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 182 | H | 0.633488 | R | 0.675214 | -0.041726 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 290 | V | 0.673181 | M | 0.73815 | -0.064969 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 306 | Y | 0.710104 | D | 0.804515 | -0.094411 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 312 | S | 0.808081 | F | 0.608474 | 0.199607 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 316 | E | 0.850854 | G | 0.847411 | 0.003443 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 352 | T | 0.860894 | M | 0.840812 | 0.020082 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 183 | S | 0.640654 | Y | 0.379134 | 0.26152 | D to O | A breast cancer sample |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 455 | K | 0.833117 | R | 0.798164 | 0.034953 | No Change: Both D | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 509 | V | 0.272729 | A | 0.325317 | -0.052588 | No Change: Both O | - |
| Q68CQ1 | HEAT8_HUMAN HEAT repeat-containing protein 8 OS=Homo sapiens GN=HEATR8 PE=2 SV=4 | 618 | H | 0.173934 | R | 0.185082 | -0.011148 | No Change: Both O | - |
| Q9NRV9 | HEBP1_HUMAN Heme-binding protein 1 OS=Homo sapiens GN=HEBP1 PE=1 SV=1 | 183 | E | 0.267915 | D | 0.246973 | 0.020942 | No Change: Both O | - |
| Q9Y5Z4 | HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens GN=HEBP2 PE=1 SV=1 | 140 | R | 0.359187 | Q | 0.379567 | -0.02038 | No Change: Both O | - |
| Q9Y5Z4 | HEBP2_HUMAN Heme-binding protein 2 OS=Homo sapiens GN=HEBP2 PE=1 SV=1 | 191 | E | 0.222948 | A | 0.135149 | 0.087799 | No Change: Both O | - |
| Q9ULT8 | HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens GN=HECTD1 PE=1 SV=3 | 656 | Q | 0.685195 | H | 0.662385 | 0.02281 | No Change: Both D | - |
| Q5U5R9 | HECD2_HUMAN Probable E3 ubiquitin-protein ligase HECTD2 OS=Homo sapiens GN=HECTD2 PE=2 SV=2 | 19 | P | 0.948069 | A | 0.92215 | 0.025919 | No Change: Both D | - |
| Q9ULI3 | HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3 | 602 | F | 0.880924 | S | 0.944582 | -0.063658 | No Change: Both D | - |
| Q9ULI3 | HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3 | 980 | V | 0.905781 | L | 0.898727 | 0.007054 | No Change: Both D | - |
| Q9ULI3 | HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3 | 1039 | M | 0.451834 | T | 0.5221 | -0.070266 | O to D | - |
| Q9ULI3 | HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3 | 145 | Q | 0.714495 | R | 0.686907 | 0.027588 | No Change: Both D | - |
| Q9ULI3 | HEG1_HUMAN Protein HEG homolog 1 OS=Homo sapiens GN=HEG1 PE=1 SV=3 | 305 | S | 0.92794 | P | 0.914626 | 0.013314 | No Change: Both D | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 172 | E | 0.777738 | K | 0.782406 | -0.004668 | No Change: Both D | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 191 | L | 0.678221 | P | 0.78789 | -0.109669 | No Change: Both D | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 267 | L | 0.094658 | F | 0.07841 | 0.016248 | No Change: Both O | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 966 | P | 0.984563 | L | 0.969248 | 0.015315 | No Change: Both D | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 980 | T | 0.969857 | I | 0.943431 | 0.026426 | No Change: Both D | - |
| Q8NG08 | HELB_HUMAN DNA helicase B OS=Homo sapiens GN=HELB PE=1 SV=2 | 575 | T | 0.439533 | A | 0.383158 | 0.056375 | No Change: Both O | - |
| Q9NRZ9 | HELLS_HUMAN Lymphoid-specific helicase OS=Homo sapiens GN=HELLS PE=1 SV=1 | 616 | H | 0.352674 | R | 0.379439 | -0.026765 | No Change: Both O | - |
| Q8TDG4 | HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens GN=HELQ PE=1 SV=2 | 565 | D | 0.327568 | N | 0.300629 | 0.026939 | No Change: Both O | A breast cancer sample |
| Q8TDG4 | HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens GN=HELQ PE=1 SV=2 | 235 | L | 0.926039 | P | 0.954258 | -0.028219 | No Change: Both D | - |
| Q8TDG4 | HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens GN=HELQ PE=1 SV=2 | 585 | P | 0.290741 | S | 0.311256 | -0.020515 | No Change: Both O | - |
| Q8TDG4 | HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens GN=HELQ PE=1 SV=2 | 1094 | V | 0.731363 | M | 0.801468 | -0.070105 | No Change: Both D | - |
| Q8TDG4 | HELQ_HUMAN Helicase POLQ-like OS=Homo sapiens GN=HELQ PE=1 SV=2 | 35 | V | 0.771857 | E | 0.869244 | -0.097387 | No Change: Both D | - |
| A6NFD8 | HELT_HUMAN Hairy and enhancer of split-related protein HELT OS=Homo sapiens GN=HELT PE=2 SV=1 | 147 | L | 0.15914 | V | 0.153709 | 0.005431 | No Change: Both O | - |
| P42694 | HELZ_HUMAN Probable helicase with zinc finger domain OS=Homo sapiens GN=HELZ PE=1 SV=2 | 48 | C | 0.196247 | R | 0.349159 | -0.152912 | No Change: Both O | - |
| P42694 | HELZ_HUMAN Probable helicase with zinc finger domain OS=Homo sapiens GN=HELZ PE=1 SV=2 | 74 | V | 0.254604 | M | 0.307863 | -0.053259 | No Change: Both O | - |
| P42694 | HELZ_HUMAN Probable helicase with zinc finger domain OS=Homo sapiens GN=HELZ PE=1 SV=2 | 1530 | A | 0.848541 | V | 0.803773 | 0.044768 | No Change: Both D | - |
| Q9Y5R4 | HEMK1_HUMAN HemK methyltransferase family member 1 OS=Homo sapiens GN=HEMK1 PE=2 SV=1 | 192 | R | 0.401779 | Q | 0.41614 | -0.014361 | No Change: Both O | - |
| Q9Y5R4 | HEMK1_HUMAN HemK methyltransferase family member 1 OS=Homo sapiens GN=HEMK1 PE=2 SV=1 | 200 | H | 0.42387 | Q | 0.466036 | -0.042166 | No Change: Both O | - |
| Q5T8I9 | HENMT_HUMAN Small RNA 2'-O-methyltransferase OS=Homo sapiens GN=HENMT1 PE=2 SV=1 | 129 | T | 0.038548 | A | 0.033175 | 0.005373 | No Change: Both O | - |
| Q5T8I9 | HENMT_HUMAN Small RNA 2'-O-methyltransferase OS=Homo sapiens GN=HENMT1 PE=2 SV=1 | 230 | R | 0.308172 | Q | 0.343382 | -0.03521 | No Change: Both O | - |
| Q5T8I9 | HENMT_HUMAN Small RNA 2'-O-methyltransferase OS=Homo sapiens GN=HENMT1 PE=2 SV=1 | 361 | M | 0.318747 | I | 0.231561 | 0.087186 | No Change: Both O | - |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 218 | M | 0.260467 | V | 0.210332 | 0.050135 | No Change: Both O | - |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 23 | L | 0.040335 | H | 0.055556 | -0.015221 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 89 | G | 0.273605 | D | 0.31179 | -0.038185 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B) [MIM:613926] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 89 | G | 0.273605 | S | 0.326515 | -0.05291 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B) [MIM:613926] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 92 | R | 0.287611 | Q | 0.283461 | 0.00415 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 92 | R | 0.287611 | W | 0.12073 | 0.166881 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B) [MIM:613926] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 98 | R | 0.284135 | C | 0.140866 | 0.143269 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 128 | D | 0.368451 | N | 0.334634 | 0.033817 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B) [MIM:613926] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 148 | P | 0.269043 | S | 0.296638 | -0.027595 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 196 | S | 0.458602 | Y | 0.258365 | 0.200237 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 211 | D | 0.362898 | N | 0.323936 | 0.038962 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A) [MIM:613925] |
| Q14CZ8 | HECAM_HUMAN Hepatocyte cell adhesion molecule OS=Homo sapiens GN=HEPACAM PE=1 SV=1 | 288 | R | 0.901524 | C | 0.863682 | 0.037842 | No Change: Both D | Leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B) [MIM:613926] |
| A8MVW5 | HECA2_HUMAN HEPACAM family member 2 OS=Homo sapiens GN=HEPACAM2 PE=1 SV=1 | 31 | G | 0.180877 | R | 0.162234 | 0.018643 | No Change: Both O | A breast cancer sample |
| A8MVW5 | HECA2_HUMAN HEPACAM family member 2 OS=Homo sapiens GN=HEPACAM2 PE=1 SV=1 | 86 | K | 0.340737 | T | 0.262871 | 0.077866 | No Change: Both O | - |
| A8MVW5 | HECA2_HUMAN HEPACAM family member 2 OS=Homo sapiens GN=HEPACAM2 PE=1 SV=1 | 114 | F | 0.24405 | L | 0.290763 | -0.046713 | No Change: Both O | - |
| Q9BQS7 | HEPH_HUMAN Hephaestin OS=Homo sapiens GN=HEPH PE=2 SV=3 | 595 | A | 0.403976 | T | 0.407533 | -0.003557 | No Change: Both O | - |
| Q6MZM0 | HPHL1_HUMAN Hephaestin-like protein 1 OS=Homo sapiens GN=HEPHL1 PE=2 SV=2 | 251 | N | 0.419568 | D | 0.448343 | -0.028775 | No Change: Both O | - |
| Q6MZM0 | HPHL1_HUMAN Hephaestin-like protein 1 OS=Homo sapiens GN=HEPHL1 PE=2 SV=2 | 381 | R | 0.233691 | C | 0.119349 | 0.114342 | No Change: Both O | - |
| Q6WQI6 | HEPN1_HUMAN Putative cancer susceptibility gene HEPN1 protein OS=Homo sapiens GN=HEPN1 PE=5 SV=2 | 37 | W | 0.433619 | R | 0.668465 | -0.234846 | O to D | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1088 | L | 0.231305 | F | 0.160386 | 0.070919 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1278 | L | 0.311027 | F | 0.262431 | 0.048596 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1411 | G | 0.928004 | V | 0.893419 | 0.034585 | No Change: Both D | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1447 | H | 0.214185 | N | 0.257971 | -0.043786 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1572 | S | 0.407047 | A | 0.26902 | 0.138027 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1696 | G | 0.746174 | A | 0.700889 | 0.045285 | No Change: Both D | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 1995 | T | 0.371002 | A | 0.404579 | -0.033577 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 2220 | I | 0.098957 | V | 0.101929 | -0.002972 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 2816 | A | 0.829535 | T | 0.834301 | -0.004766 | No Change: Both D | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 3152 | S | 0.603296 | F | 0.425938 | 0.177358 | D to O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 3517 | G | 0.207935 | R | 0.185178 | 0.022757 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 3722 | E | 0.39345 | D | 0.359945 | 0.033505 | No Change: Both O | - |
| Q15751 | HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens GN=HERC1 PE=1 SV=2 | 4394 | I | 0.236559 | V | 0.290385 | -0.053826 | No Change: Both O | - |
| Q9BVR0 | HRC23_HUMAN Putative HERC2-like protein 3 OS=Homo sapiens GN=HERC2P3 PE=5 SV=2 | 759 | L | 0.086918 | P | 0.157366 | -0.070448 | No Change: Both O | - |
| Q9BVR0 | HRC23_HUMAN Putative HERC2-like protein 3 OS=Homo sapiens GN=HERC2P3 PE=5 SV=2 | 1119 | R | 0.48181 | I | 0.3102 | 0.17161 | No Change: Both O | - |
| Q15034 | HERC3_HUMAN Probable E3 ubiquitin-protein ligase HERC3 OS=Homo sapiens GN=HERC3 PE=1 SV=1 | 946 | E | 0.363627 | Q | 0.293893 | 0.069734 | No Change: Both O | - |
| Q9UII4 | HERC5_HUMAN E3 ISG15--protein ligase HERC5 OS=Homo sapiens GN=HERC5 PE=1 SV=2 | 301 | A | 0.071606 | T | 0.087225 | -0.015619 | No Change: Both O | - |
| Q8IVU3 | HERC6_HUMAN Probable E3 ubiquitin-protein ligase HERC6 OS=Homo sapiens GN=HERC6 PE=2 SV=2 | 123 | M | 0.218897 | T | 0.279342 | -0.060445 | No Change: Both O | - |
| Q8IVU3 | HERC6_HUMAN Probable E3 ubiquitin-protein ligase HERC6 OS=Homo sapiens GN=HERC6 PE=2 SV=2 | 199 | C | 0.350776 | R | 0.479814 | -0.129038 | No Change: Both O | - |
| Q8IVU3 | HERC6_HUMAN Probable E3 ubiquitin-protein ligase HERC6 OS=Homo sapiens GN=HERC6 PE=2 SV=2 | 343 | F | 0.158442 | L | 0.173302 | -0.01486 | No Change: Both O | - |
| Q8IVU3 | HERC6_HUMAN Probable E3 ubiquitin-protein ligase HERC6 OS=Homo sapiens GN=HERC6 PE=2 SV=2 | 614 | T | 0.403198 | I | 0.291924 | 0.111274 | No Change: Both O | - |
| Q15011 | HERP1_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein OS=Homo sapiens GN=HERPUD1 PE=1 SV=1 | 50 | R | 0.636328 | H | 0.601639 | 0.034689 | No Change: Both D | - |
| Q9BSE4 | HERP2_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein OS=Homo sapiens GN=HERPUD2 PE=1 SV=2 | 108 | A | 0.994213 | T | 0.99541 | -0.001197 | No Change: Both D | - |
| Q9BSE4 | HERP2_HUMAN Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein OS=Homo sapiens GN=HERPUD2 PE=1 SV=2 | 200 | H | 0.388017 | L | 0.362657 | 0.02536 | No Change: Both O | - |
| Q9Y543 | HES2_HUMAN Transcription factor HES-2 OS=Homo sapiens GN=HES2 PE=2 SV=1 | 139 | P | 0.970772 | S | 0.970527 | 2.45E-04 | No Change: Both D | - |
| Q96HZ4 | HES6_HUMAN Transcription cofactor HES-6 OS=Homo sapiens GN=HES6 PE=1 SV=1 | 218 | R | 0.343491 | Q | 0.358198 | -0.014707 | No Change: Both O | - |
| Q9BYE0 | HES7_HUMAN Transcription factor HES-7 OS=Homo sapiens GN=HES7 PE=1 SV=2 | 25 | R | 0.945109 | W | 0.840746 | 0.104363 | No Change: Both D | Spondylocostal dysostosis type 4 (SCDO4) [MIM:613686] |
| Q9BYE0 | HES7_HUMAN Transcription factor HES-7 OS=Homo sapiens GN=HES7 PE=1 SV=2 | 58 | I | 0.598858 | V | 0.660006 | -0.061148 | No Change: Both D | Spondylocostal dysostosis type 4 (SCDO4) [MIM:613686] |
| Q9BYE0 | HES7_HUMAN Transcription factor HES-7 OS=Homo sapiens GN=HES7 PE=1 SV=2 | 186 | D | 0.98421 | Y | 0.973805 | 0.010405 | No Change: Both D | Spondylocostal dysostosis type 4 (SCDO4) [MIM:613686] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 160 | R | 0.449865 | C | 0.27795 | 0.171915 | No Change: Both O | Septooptic dysplasia (SOD) [MIM:182230] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 125 | N | 0.12673 | S | 0.135189 | -0.008459 | No Change: Both O | - |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 6 | Q | 0.834039 | H | 0.788386 | 0.045653 | No Change: Both D | Pituitary hormone deficiency combined type 5 (CPHD5) [MIM:182230] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 26 | I | 0.568683 | T | 0.676601 | -0.107918 | No Change: Both D | Pituitary hormone deficiency combined type 5 (CPHD5) [MIM:182230] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 149 | E | 0.299537 | K | 0.299691 | -1.54E-04 | No Change: Both O | Growth hormone deficiency with pituitary anomalies (GHDPA) [MIM:182230] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 170 | S | 0.679388 | L | 0.528198 | 0.15119 | No Change: Both D | Septooptic dysplasia (SOD) [MIM:182230] |
| Q9UBX0 | HESX1_HUMAN Homeobox expressed in ES cells 1 OS=Homo sapiens GN=HESX1 PE=1 SV=1 | 181 | T | 0.741799 | A | 0.754149 | -0.01235 | No Change: Both D | Growth hormone deficiency with pituitary anomalies (GHDPA) [MIM:182230] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 25 | P | 0.141145 | S | 0.152138 | -0.010993 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 39 | L | 0.178895 | R | 0.295452 | -0.116557 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 127 | L | 0.090787 | R | 0.139594 | -0.048807 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 166 | R | 0.314239 | G | 0.327139 | -0.0129 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 170 | R | 0.297745 | Q | 0.298247 | -5.02E-04 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 170 | R | 0.297745 | W | 0.127967 | 0.169778 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 178 | R | 0.327773 | C | 0.174982 | 0.152791 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 178 | R | 0.327773 | H | 0.341588 | -0.013815 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 178 | R | 0.327773 | L | 0.231361 | 0.096412 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 180 | Y | 0.31632 | H | 0.459791 | -0.143471 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 192 | V | 0.123952 | L | 0.135432 | -0.01148 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 196 | N | 0.123354 | S | 0.138195 | -0.014841 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 197 | K | 0.123143 | T | 0.091985 | 0.031158 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 200 | V | 0.079795 | M | 0.104117 | -0.024322 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 204 | H | 0.101103 | R | 0.093705 | 0.007398 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 210 | S | 0.396607 | F | 0.192932 | 0.203675 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 211 | F | 0.393393 | S | 0.615317 | -0.221924 | O to D | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 247 | R | 0.112532 | W | 0.040523 | 0.072009 | No Change: Both O | - |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 249 | R | 0.100203 | W | 0.035615 | 0.064588 | No Change: Both O | - |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 250 | G | 0.098047 | D | 0.113194 | -0.015147 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 250 | G | 0.098047 | S | 0.122932 | -0.024885 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 252 | R | 0.11318 | H | 0.103913 | 0.009267 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 258 | D | 0.291095 | H | 0.273358 | 0.017737 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 269 | G | 0.338447 | S | 0.384806 | -0.046359 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 279 | S | 0.58663 | P | 0.579353 | 0.007277 | No Change: Both D | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 301 | M | 0.264785 | R | 0.305031 | -0.040246 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 335 | I | 0.35284 | F | 0.374403 | -0.021563 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 391 | V | 0.090521 | M | 0.114877 | -0.024356 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 399 | N | 0.178281 | D | 0.201936 | -0.023655 | No Change: Both O | - |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 420 | W | 0.085217 | C | 0.100166 | -0.014949 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 436 | I | 0.061157 | V | 0.075751 | -0.014594 | No Change: Both O | - |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 454 | G | 0.125854 | S | 0.144689 | -0.018835 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 455 | G | 0.105902 | R | 0.08914 | 0.016762 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 458 | C | 0.0794 | Y | 0.105721 | -0.026321 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 474 | W | 0.163322 | C | 0.191203 | -0.027881 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 482 | E | 0.216537 | K | 0.22748 | -0.010943 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 484 | L | 0.254319 | Q | 0.37816 | -0.123841 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 485 | W | 0.266592 | R | 0.486401 | -0.219809 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 499 | R | 0.198114 | C | 0.105035 | 0.093079 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 499 | R | 0.198114 | H | 0.194758 | 0.003356 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 504 | R | 0.197059 | C | 0.101756 | 0.095303 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 504 | R | 0.197059 | H | 0.18392 | 0.013139 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 252 | R | 0.11318 | L | 0.0653 | 0.04788 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 295 | N | 0.478324 | S | 0.531175 | -0.052851 | O to D | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 127 | L | 0.090787 | F | 0.071723 | 0.019064 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 226 | S | 0.434136 | F | 0.21762 | 0.216516 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 269 | G | 0.338447 | D | 0.337996 | 4.51E-04 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 314 | D | 0.159616 | V | 0.087239 | 0.072377 | No Change: Both O | GM2-gangliosidosis type 1 (GM2G1) [MIM:272800] |
| P06865 | HEXA_HUMAN Beta-hexosaminidase subunit alpha OS=Homo sapiens GN=HEXA PE=1 SV=2 | 293 | S | 0.527612 | I | 0.289093 | 0.238519 | D to O | - |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 62 | S | 0.393477 | L | 0.252762 | 0.140715 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 121 | K | 0.476275 | R | 0.406165 | 0.07011 | No Change: Both O | - |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 207 | I | 0.321165 | V | 0.340787 | -0.019622 | No Change: Both O | - |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 309 | C | 0.316717 | Y | 0.355432 | -0.038715 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 417 | P | 0.209282 | L | 0.114879 | 0.094403 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 456 | Y | 0.107281 | S | 0.209419 | -0.102138 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 505 | R | 0.268295 | Q | 0.261232 | 0.007063 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 534 | C | 0.29064 | Y | 0.307431 | -0.016791 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 255 | S | 0.635868 | R | 0.538636 | 0.097232 | No Change: Both D | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 504 | P | 0.262056 | S | 0.285987 | -0.023931 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| P07686 | HEXB_HUMAN Beta-hexosaminidase subunit beta OS=Homo sapiens GN=HEXB PE=1 SV=3 | 543 | A | 0.204291 | T | 0.210752 | -0.006461 | No Change: Both O | GM2-gangliosidosis type 2 (GM2G2) [MIM:268800] |
| Q8WVB3 | HEXDC_HUMAN Hexosaminidase D OS=Homo sapiens GN=HEXDC PE=2 SV=3 | 145 | I | 0.147174 | V | 0.177687 | -0.030513 | No Change: Both O | - |
| Q8WVB3 | HEXDC_HUMAN Hexosaminidase D OS=Homo sapiens GN=HEXDC PE=2 SV=3 | 232 | H | 0.189518 | Y | 0.125646 | 0.063872 | No Change: Both O | - |
| Q9UBP5 | HEY2_HUMAN Hairy/enhancer-of-split related with YRPW motif protein 2 OS=Homo sapiens GN=HEY2 PE=1 SV=1 | 96 | T | 0.229216 | A | 0.220866 | 0.00835 | No Change: Both O | - |
| Q9UBP5 | HEY2_HUMAN Hairy/enhancer-of-split related with YRPW motif protein 2 OS=Homo sapiens GN=HEY2 PE=1 SV=1 | 98 | D | 0.23674 | A | 0.19588 | 0.04086 | No Change: Both O | - |
| Q9UBP5 | HEY2_HUMAN Hairy/enhancer-of-split related with YRPW motif protein 2 OS=Homo sapiens GN=HEY2 PE=1 SV=1 | 100 | L | 0.288723 | S | 0.446517 | -0.157794 | No Change: Both O | - |
| Q9UBP5 | HEY2_HUMAN Hairy/enhancer-of-split related with YRPW motif protein 2 OS=Homo sapiens GN=HEY2 PE=1 SV=1 | 140 | V | 0.531735 | M | 0.580426 | -0.048691 | No Change: Both D | - |
| Q9NQ87 | HEYL_HUMAN Hairy/enhancer-of-split related with YRPW motif-like protein OS=Homo sapiens GN=HEYL PE=2 SV=2 | 47 | H | 0.927118 | R | 0.955482 | -0.028364 | No Change: Both D | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 63 | H | 0.313254 | D | 0.366239 | -0.052985 | No Change: Both O | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 65 | S | 0.426453 | C | 0.226756 | 0.199697 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 282 | C | 0.369418 | Y | 0.429222 | -0.059804 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 53 | V | 0.11573 | M | 0.152261 | -0.036531 | No Change: Both O | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 59 | V | 0.136783 | M | 0.172277 | -0.035494 | No Change: Both O | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 127 | Q | 0.453916 | H | 0.430667 | 0.023249 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 330 | R | 0.18047 | M | 0.134384 | 0.046086 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 93 | G | 0.280921 | R | 0.296864 | -0.015943 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 105 | I | 0.215391 | T | 0.345918 | -0.130527 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 277 | E | 0.460863 | K | 0.43756 | 0.023303 | No Change: Both O | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 217 | T | 0.406416 | I | 0.25375 | 0.152666 | No Change: Both O | - |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 283 | Q | 0.357504 | P | 0.378019 | -0.020515 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 6 | R | 0.570616 | S | 0.595159 | -0.024543 | No Change: Both D | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 43 | G | 0.329219 | D | 0.354142 | -0.024923 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 66 | R | 0.47263 | C | 0.296822 | 0.175808 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 176 | A | 0.503375 | V | 0.388047 | 0.115328 | D to O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 224 | R | 0.187127 | G | 0.177415 | 0.009712 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 295 | V | 0.135966 | A | 0.18784 | -0.051874 | No Change: Both O | Hemochromatosis (HFE) [MIM:235200] |
| Q30201 | HFE_HUMAN Hereditary hemochromatosis protein OS=Homo sapiens GN=HFE PE=1 SV=1 | 224 | R | 0.187127 | Q | 0.194657 | -0.00753 | No Change: Both O | - |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 80 | C | 0.735295 | R | 0.800453 | -0.065158 | No Change: Both D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 85 | S | 0.547075 | P | 0.507318 | 0.039757 | No Change: Both D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 99 | G | 0.422216 | R | 0.461553 | -0.039337 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 101 | L | 0.394571 | P | 0.515902 | -0.121331 | O to D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 168 | A | 0.440873 | D | 0.540226 | -0.099353 | O to D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 170 | F | 0.436722 | S | 0.610269 | -0.173547 | O to D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 172 | D | 0.490145 | E | 0.505567 | -0.015422 | O to D | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 191 | W | 0.111324 | C | 0.175938 | -0.064614 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 205 | S | 0.324565 | R | 0.24844 | 0.076125 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 222 | I | 0.129711 | N | 0.252079 | -0.122368 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 250 | G | 0.477595 | V | 0.328956 | 0.148639 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 288 | R | 0.165348 | W | 0.069922 | 0.095426 | No Change: Both O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 320 | G | 0.500274 | V | 0.386176 | 0.114098 | D to O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 321 | C | 0.53092 | W | 0.393281 | 0.137639 | D to O | Hemochromatosis type 2A (HFE2A) [MIM:602390] |
| Q6ZVN8 | RGMC_HUMAN Hemojuvelin OS=Homo sapiens GN=HFE2 PE=1 SV=1 | 310 | A | 0.333768 | G | 0.370321 | -0.036553 | No Change: Both O | - |
| A2PYH4 | HFM1_HUMAN Probable ATP-dependent DNA helicase HFM1 OS=Homo sapiens GN=HFM1 PE=1 SV=2 | 115 | S | 0.332748 | P | 0.314721 | 0.018027 | No Change: Both O | - |
| A2PYH4 | HFM1_HUMAN Probable ATP-dependent DNA helicase HFM1 OS=Homo sapiens GN=HFM1 PE=1 SV=2 | 117 | I | 0.311874 | V | 0.339797 | -0.027923 | No Change: Both O | - |
| A2PYH4 | HFM1_HUMAN Probable ATP-dependent DNA helicase HFM1 OS=Homo sapiens GN=HFM1 PE=1 SV=2 | 939 | I | 0.190093 | V | 0.205244 | -0.015151 | No Change: Both O | - |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 42 | E | 0.541472 | A | 0.481419 | 0.060053 | D to O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 60 | W | 0.245674 | G | 0.448785 | -0.203111 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 62 | Y | 0.215998 | C | 0.235754 | -0.019756 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 97 | W | 0.363493 | G | 0.560755 | -0.197262 | O to D | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 122 | A | 0.322214 | D | 0.416563 | -0.094349 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 153 | D | 0.159914 | G | 0.144727 | 0.015187 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 161 | G | 0.119624 | R | 0.110241 | 0.009383 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 189 | S | 0.186157 | I | 0.080549 | 0.105608 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 216 | I | 0.360819 | T | 0.521375 | -0.160556 | O to D | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 225 | R | 0.176943 | H | 0.178788 | -0.001845 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 227 | F | 0.094415 | S | 0.220297 | -0.125882 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 230 | P | 0.052769 | S | 0.056174 | -0.003405 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 230 | P | 0.052769 | T | 0.038486 | 0.014283 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 291 | D | 0.254747 | E | 0.264729 | -0.009982 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 300 | V | 0.19648 | G | 0.310476 | -0.113996 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 368 | M | 0.67467 | V | 0.61807 | 0.0566 | No Change: Both D | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 330 | R | 0.297252 | S | 0.34896 | -0.051708 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 371 | H | 0.640932 | R | 0.644141 | -0.003209 | No Change: Both D | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 25 | L | 0.811846 | P | 0.900201 | -0.088355 | No Change: Both D | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 168 | E | 0.102063 | K | 0.109614 | -0.007551 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 270 | G | 0.129731 | R | 0.122978 | 0.006753 | No Change: Both O | Alkaptonuria (AKU) [MIM:203500] |
| Q93099 | HGD_HUMAN Homogentisate 1 2-dioxygenase OS=Homo sapiens GN=HGD PE=1 SV=2 | 80 | Q | 0.434117 | H | 0.422171 | 0.011946 | No Change: Both O | - |
| P14210 | HGF_HUMAN Hepatocyte growth factor OS=Homo sapiens GN=HGF PE=1 SV=2 | 153 | S | 0.480673 | I | 0.271603 | 0.20907 | No Change: Both O | - |
| P14210 | HGF_HUMAN Hepatocyte growth factor OS=Homo sapiens GN=HGF PE=1 SV=2 | 304 | E | 0.35587 | K | 0.331017 | 0.024853 | No Change: Both O | - |
| P14210 | HGF_HUMAN Hepatocyte growth factor OS=Homo sapiens GN=HGF PE=1 SV=2 | 330 | D | 0.400437 | Y | 0.274489 | 0.125948 | No Change: Both O | - |
| Q04756 | HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 | 509 | R | 0.444732 | H | 0.428741 | 0.015991 | No Change: Both O | - |
| Q04756 | HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 | 644 | R | 0.239536 | Q | 0.230256 | 0.00928 | No Change: Both O | - |
| Q04756 | HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 | 225 | V | 0.398948 | M | 0.462114 | -0.063166 | No Change: Both O | - |
| Q04756 | HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 | 231 | F | 0.208159 | L | 0.239764 | -0.031605 | No Change: Both O | - |
| Q04756 | HGFA_HUMAN Hepatocyte growth factor activator OS=Homo sapiens GN=HGFAC PE=1 SV=1 | 218 | A | 0.424908 | S | 0.523018 | -0.09811 | O to D | - |
| O14964 | HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens GN=HGS PE=1 SV=1 | 400 | E | 0.874051 | D | 0.83805 | 0.036001 | No Change: Both D | - |
| O14964 | HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens GN=HGS PE=1 SV=1 | 7 | T | 0.591268 | S | 0.662776 | -0.071508 | No Change: Both D | - |
| O14964 | HGS_HUMAN Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Homo sapiens GN=HGS PE=1 SV=1 | 733 | A | 0.983534 | S | 0.988895 | -0.005361 | No Change: Both D | - |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 311 | P | 0.013974 | L | 0.006845 | 0.007129 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 372 | R | 0.17276 | C | 0.079659 | 0.093101 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 452 | G | 0.391834 | S | 0.418339 | -0.026505 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 499 | E | 0.30566 | K | 0.294064 | 0.011596 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 510 | M | 0.052325 | K | 0.096198 | -0.043873 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 569 | S | 0.168958 | L | 0.073099 | 0.095859 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 590 | D | 0.083501 | V | 0.044617 | 0.038884 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 599 | P | 0.124192 | L | 0.058595 | 0.065597 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 104 | C | 0.030835 | F | 0.029783 | 0.001052 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 165 | L | 0.151032 | P | 0.255459 | -0.104427 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 265 | P | 0.368503 | Q | 0.329244 | 0.039259 | No Change: Both O | - |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 280 | I | 0.018139 | R | 0.03828 | -0.020141 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 290 | G | 0.141695 | R | 0.121968 | 0.019727 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 301 | N | 0.116535 | K | 0.150977 | -0.034442 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 372 | R | 0.17276 | H | 0.168638 | 0.004122 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 431 | W | 0.029131 | C | 0.039606 | -0.010475 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 509 | V | 0.057395 | L | 0.05891 | -0.001515 | No Change: Both O | - |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 514 | G | 0.064587 | E | 0.07692 | -0.012333 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 517 | A | 0.083482 | E | 0.128031 | -0.044549 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 546 | S | 0.051363 | F | 0.017289 | 0.034074 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 551 | K | 0.32864 | Q | 0.282461 | 0.046179 | No Change: Both O | - |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 567 | S | 0.157076 | C | 0.050996 | 0.10608 | No Change: Both O | Mucopolysaccharidosis type 3C (MPS3C) [MIM:252930] |
| Q68CP4 | HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens GN=HGSNAT PE=1 SV=2 | 643 | A | 0.05188 | T | 0.060689 | -0.008809 | No Change: Both O | - |
| Q5VTY9 | HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens GN=HHAT PE=1 SV=1 | 182 | S | 0.058353 | N | 0.044595 | 0.013758 | No Change: Both O | - |
| Q5VTY9 | HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens GN=HHAT PE=1 SV=1 | 448 | G | 0.187205 | E | 0.224944 | -0.037739 | No Change: Both O | A melanoma cell line |
| Q5VTY9 | HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens GN=HHAT PE=1 SV=1 | 450 | N | 0.244424 | S | 0.274395 | -0.029971 | No Change: Both O | A lung cancer cell line |
| Q5VTY9 | HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens GN=HHAT PE=1 SV=1 | 165 | E | 0.203547 | G | 0.157659 | 0.045888 | No Change: Both O | - |
| Q5VTY9 | HHAT_HUMAN Protein-cysteine N-palmitoyltransferase HHAT OS=Homo sapiens GN=HHAT PE=1 SV=1 | 188 | C | 0.105772 | R | 0.213571 | -0.107799 | No Change: Both O | - |
| Q9HCP6 | HHATL_HUMAN Protein-cysteine N-palmitoyltransferase HHAT-like protein OS=Homo sapiens GN=HHATL PE=2 SV=1 | 403 | M | 0.079388 | V | 0.059336 | 0.020052 | No Change: Both O | - |
| Q96QV1 | HHIP_HUMAN Hedgehog-interacting protein OS=Homo sapiens GN=HHIP PE=1 SV=3 | 341 | V | 0.128361 | I | 0.103389 | 0.024972 | No Change: Both O | - |
| Q96JK4 | HIPL1_HUMAN HHIP-like protein 1 OS=Homo sapiens GN=HHIPL1 PE=2 SV=2 | 692 | V | 0.198071 | A | 0.240722 | -0.042651 | No Change: Both O | - |
| Q6UWX4 | HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens GN=HHIPL2 PE=2 SV=1 | 241 | V | 0.040135 | M | 0.047795 | -0.00766 | No Change: Both O | - |
| Q6UWX4 | HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens GN=HHIPL2 PE=2 SV=1 | 391 | H | 0.565317 | D | 0.604128 | -0.038811 | No Change: Both D | - |
| Q6UWX4 | HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens GN=HHIPL2 PE=2 SV=1 | 394 | R | 0.652375 | Q | 0.651236 | 0.001139 | No Change: Both D | - |
| Q6UWX4 | HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens GN=HHIPL2 PE=2 SV=1 | 434 | R | 0.464366 | L | 0.303336 | 0.16103 | No Change: Both O | - |
| Q9UM44 | HHLA2_HUMAN HERV-H LTR-associating protein 2 OS=Homo sapiens GN=HHLA2 PE=2 SV=1 | 30 | I | 0.026111 | T | 0.045921 | -0.01981 | No Change: Both O | - |
| Q9UM44 | HHLA2_HUMAN HERV-H LTR-associating protein 2 OS=Homo sapiens GN=HHLA2 PE=2 SV=1 | 344 | N | 0.369372 | K | 0.429977 | -0.060605 | No Change: Both O | - |
| Q9UM44 | HHLA2_HUMAN HERV-H LTR-associating protein 2 OS=Homo sapiens GN=HHLA2 PE=2 SV=1 | 364 | S | 0.073127 | R | 0.070123 | 0.003004 | No Change: Both O | - |
| Q5SR56 | HIAL1_HUMAN Hippocampus abundant transcript-like protein 1 OS=Homo sapiens GN=HIATL1 PE=2 SV=3 | 406 | V | 0.078202 | L | 0.085707 | -0.007505 | No Change: Both O | - |
| Q6NVY1 | HIBCH_HUMAN 3-hydroxyisobutyryl-CoA hydrolase mitochondrial OS=Homo sapiens GN=HIBCH PE=1 SV=2 | 46 | T | 0.18729 | A | 0.156787 | 0.030503 | No Change: Both O | - |
| Q6NVY1 | HIBCH_HUMAN 3-hydroxyisobutyryl-CoA hydrolase mitochondrial OS=Homo sapiens GN=HIBCH PE=1 SV=2 | 122 | Y | 0.166533 | C | 0.142122 | 0.024411 | No Change: Both O | HIBCH deficiency (HIBCHD) [MIM:250620] |
| Q14526 | HIC1_HUMAN Hypermethylated in cancer 1 protein OS=Homo sapiens GN=HIC1 PE=1 SV=5 | 725 | R | 0.554141 | G | 0.551684 | 0.002457 | No Change: Both D | - |
| Q16665 | HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens GN=HIF1A PE=1 SV=1 | 796 | T | 0.419601 | A | 0.410263 | 0.009338 | No Change: Both O | - |
| Q16665 | HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens GN=HIF1A PE=1 SV=1 | 582 | P | 0.953271 | S | 0.956405 | -0.003134 | No Change: Both D | - |
| Q16665 | HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens GN=HIF1A PE=1 SV=1 | 588 | A | 0.969984 | T | 0.973558 | -0.003574 | No Change: Both D | - |
| Q9NWT6 | HIF1N_HUMAN Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens GN=HIF1AN PE=1 SV=2 | 41 | P | 0.808278 | A | 0.720324 | 0.087954 | No Change: Both D | - |
| Q9Y2N7 | HIF3A_HUMAN Hypoxia-inducible factor 3-alpha OS=Homo sapiens GN=HIF3A PE=1 SV=2 | 343 | Q | 0.376141 | R | 0.354289 | 0.021852 | No Change: Both O | - |
| Q9Y2N7 | HIF3A_HUMAN Hypoxia-inducible factor 3-alpha OS=Homo sapiens GN=HIF3A PE=1 SV=2 | 463 | F | 0.507595 | L | 0.588259 | -0.080664 | No Change: Both D | - |
| Q9P298 | HIG1B_HUMAN HIG1 domain family member 1B OS=Homo sapiens GN=HIGD1B PE=2 SV=1 | 86 | S | 0.206863 | N | 0.179054 | 0.027809 | No Change: Both O | - |
| Q9P298 | HIG1B_HUMAN HIG1 domain family member 1B OS=Homo sapiens GN=HIGD1B PE=2 SV=1 | 87 | D | 0.248797 | N | 0.228501 | 0.020296 | No Change: Both O | - |
| Q9BQA5 | HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens GN=HINFP PE=1 SV=2 | 493 | A | 0.903744 | V | 0.88958 | 0.014164 | No Change: Both D | - |
| Q9BQA5 | HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens GN=HINFP PE=1 SV=2 | 4 | P | 0.727976 | S | 0.723246 | 0.00473 | No Change: Both D | - |
| Q9BQA5 | HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens GN=HINFP PE=1 SV=2 | 78 | S | 0.328923 | C | 0.226033 | 0.10289 | No Change: Both O | - |
| Q9BQA5 | HINFP_HUMAN Histone H4 transcription factor OS=Homo sapiens GN=HINFP PE=1 SV=2 | 352 | K | 0.332928 | R | 0.30707 | 0.025858 | No Change: Both O | - |
| Q9NQE9 | HINT3_HUMAN Histidine triad nucleotide-binding protein 3 OS=Homo sapiens GN=HINT3 PE=1 SV=1 | 36 | G | 0.759142 | A | 0.746462 | 0.01268 | No Change: Both D | - |
| O00291 | HIP1_HUMAN Huntingtin-interacting protein 1 OS=Homo sapiens GN=HIP1 PE=1 SV=5 | 263 | M | 0.383079 | K | 0.527264 | -0.144185 | O to D | - |
| O75146 | HIP1R_HUMAN Huntingtin-interacting protein 1-related protein OS=Homo sapiens GN=HIP1R PE=1 SV=2 | 782 | V | 0.54864 | M | 0.640444 | -0.091804 | No Change: Both D | - |
| O75146 | HIP1R_HUMAN Huntingtin-interacting protein 1-related protein OS=Homo sapiens GN=HIP1R PE=1 SV=2 | 404 | K | 0.918905 | Q | 0.922742 | -0.003837 | No Change: Both D | - |
| O75146 | HIP1R_HUMAN Huntingtin-interacting protein 1-related protein OS=Homo sapiens GN=HIP1R PE=1 SV=2 | 516 | K | 0.98247 | Q | 0.981141 | 0.001329 | No Change: Both D | - |
| O75146 | HIP1R_HUMAN Huntingtin-interacting protein 1-related protein OS=Homo sapiens GN=HIP1R PE=1 SV=2 | 943 | N | 0.683536 | S | 0.742626 | -0.05909 | No Change: Both D | - |
| Q86Z02 | HIPK1_HUMAN Homeodomain-interacting protein kinase 1 OS=Homo sapiens GN=HIPK1 PE=1 SV=1 | 310 | G | 0.22757 | C | 0.12126 | 0.10631 | No Change: Both O | - |
| Q86Z02 | HIPK1_HUMAN Homeodomain-interacting protein kinase 1 OS=Homo sapiens GN=HIPK1 PE=1 SV=1 | 1165 | L | 0.643006 | V | 0.658199 | -0.015193 | No Change: Both D | - |
| Q86Z02 | HIPK1_HUMAN Homeodomain-interacting protein kinase 1 OS=Homo sapiens GN=HIPK1 PE=1 SV=1 | 6 | Q | 0.885775 | R | 0.854631 | 0.031144 | No Change: Both D | - |
| Q9H2X6 | HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens GN=HIPK2 PE=1 SV=2 | 792 | R | 0.826518 | Q | 0.85557 | -0.029052 | No Change: Both D | - |
| Q9H2X6 | HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens GN=HIPK2 PE=1 SV=2 | 1027 | R | 0.970311 | Q | 0.975314 | -0.005003 | No Change: Both D | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 142 | Q | 0.421636 | R | 0.404089 | 0.017547 | No Change: Both O | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 170 | G | 0.5394 | E | 0.574595 | -0.035195 | No Change: Both D | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 191 | C | 0.198189 | R | 0.325161 | -0.126972 | No Change: Both O | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 500 | S | 0.237737 | N | 0.209027 | 0.02871 | No Change: Both O | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 729 | P | 0.386978 | L | 0.241208 | 0.14577 | No Change: Both O | - |
| Q9H422 | HIPK3_HUMAN Homeodomain-interacting protein kinase 3 OS=Homo sapiens GN=HIPK3 PE=1 SV=1 | 474 | V | 0.280181 | I | 0.245901 | 0.03428 | No Change: Both O | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 302 | R | 0.362593 | Q | 0.359519 | 0.003074 | No Change: Both O | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 106 | A | 0.394118 | T | 0.413048 | -0.01893 | No Change: Both O | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 171 | V | 0.280084 | M | 0.32604 | -0.045956 | No Change: Both O | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 381 | T | 0.531958 | M | 0.501752 | 0.030206 | No Change: Both D | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 386 | A | 0.4973 | T | 0.530489 | -0.033189 | O to D | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 406 | S | 0.692958 | R | 0.651945 | 0.041013 | No Change: Both D | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 421 | G | 0.539174 | S | 0.595082 | -0.055908 | No Change: Both D | - |
| Q8NE63 | HIPK4_HUMAN Homeodomain-interacting protein kinase 4 OS=Homo sapiens GN=HIPK4 PE=2 SV=1 | 481 | R | 0.615307 | C | 0.469297 | 0.14601 | D to O | - |
| Q9BW71 | HIRP3_HUMAN HIRA-interacting protein 3 OS=Homo sapiens GN=HIRIP3 PE=1 SV=3 | 521 | G | 0.829368 | W | 0.72516 | 0.104208 | No Change: Both D | - |
| Q9BW71 | HIRP3_HUMAN HIRA-interacting protein 3 OS=Homo sapiens GN=HIRIP3 PE=1 SV=3 | 496 | A | 0.577038 | V | 0.482566 | 0.094472 | D to O | - |
| Q02539 | H11_HUMAN Histone H1.1 OS=Homo sapiens GN=HIST1H1A PE=1 SV=3 | 99 | T | 0.722481 | I | 0.616216 | 0.106265 | No Change: Both D | - |
| Q02539 | H11_HUMAN Histone H1.1 OS=Homo sapiens GN=HIST1H1A PE=1 SV=3 | 115 | S | 0.945286 | F | 0.89463 | 0.050656 | No Change: Both D | - |
| Q02539 | H11_HUMAN Histone H1.1 OS=Homo sapiens GN=HIST1H1A PE=1 SV=3 | 140 | K | 0.996668 | R | 0.99482 | 0.001848 | No Change: Both D | - |
| P16401 | H15_HUMAN Histone H1.5 OS=Homo sapiens GN=HIST1H1B PE=1 SV=3 | 86 | G | 0.593116 | D | 0.592573 | 5.43E-04 | No Change: Both D | A colorectal cancer sample |
| P16401 | H15_HUMAN Histone H1.5 OS=Homo sapiens GN=HIST1H1B PE=1 SV=3 | 144 | K | 0.999566 | R | 0.99928 | 2.86E-04 | No Change: Both D | - |
| P16401 | H15_HUMAN Histone H1.5 OS=Homo sapiens GN=HIST1H1B PE=1 SV=3 | 211 | A | 0.999968 | T | 0.999959 | 9.00E-06 | No Change: Both D | - |
| P16403 | H12_HUMAN Histone H1.2 OS=Homo sapiens GN=HIST1H1C PE=1 SV=2 | 18 | A | 0.99453 | V | 0.991533 | 0.002997 | No Change: Both D | - |
| P16403 | H12_HUMAN Histone H1.2 OS=Homo sapiens GN=HIST1H1C PE=1 SV=2 | 113 | S | 0.964493 | A | 0.954208 | 0.010285 | No Change: Both D | - |
| P16403 | H12_HUMAN Histone H1.2 OS=Homo sapiens GN=HIST1H1C PE=1 SV=2 | 124 | G | 0.993507 | A | 0.992966 | 5.41E-04 | No Change: Both D | - |
| P16402 | H13_HUMAN Histone H1.3 OS=Homo sapiens GN=HIST1H1D PE=1 SV=2 | 75 | E | 0.550118 | K | 0.606946 | -0.056828 | No Change: Both D | - |
| P10412 | H14_HUMAN Histone H1.4 OS=Homo sapiens GN=HIST1H1E PE=1 SV=2 | 128 | A | 0.998131 | V | 0.996737 | 0.001394 | No Change: Both D | A colorectal cancer sample |
| P10412 | H14_HUMAN Histone H1.4 OS=Homo sapiens GN=HIST1H1E PE=1 SV=2 | 152 | K | 0.999871 | R | 0.999786 | 8.50E-05 | No Change: Both D | - |
| P22492 | H1T_HUMAN Histone H1t OS=Homo sapiens GN=HIST1H1T PE=1 SV=4 | 14 | V | 0.90372 | L | 0.909791 | -0.006071 | No Change: Both D | - |
| P22492 | H1T_HUMAN Histone H1t OS=Homo sapiens GN=HIST1H1T PE=1 SV=4 | 52 | L | 0.485634 | F | 0.411081 | 0.074553 | No Change: Both O | - |
| P22492 | H1T_HUMAN Histone H1t OS=Homo sapiens GN=HIST1H1T PE=1 SV=4 | 178 | Q | 0.989136 | K | 0.990652 | -0.001516 | No Change: Both D | - |
| P62807 | H2B1C_HUMAN Histone H2B type 1-C/E/F/G/I OS=Homo sapiens GN=HIST1H2BC PE=1 SV=4 | 27 | G | 0.941018 | S | 0.956521 | -0.015503 | No Change: Both D | - |
| Q99880 | H2B1L_HUMAN Histone H2B type 1-L OS=Homo sapiens GN=HIST1H2BL PE=1 SV=3 | 4 | L | 0.99712 | P | 0.999089 | -0.001969 | No Change: Both D | - |
| Q99879 | H2B1M_HUMAN Histone H2B type 1-M OS=Homo sapiens GN=HIST1H2BM PE=1 SV=3 | 110 | H | 0.530209 | Y | 0.420556 | 0.109653 | D to O | A colorectal cancer sample |
| P62805 | H4_HUMAN Histone H4 OS=Homo sapiens GN=HIST1H4A PE=1 SV=2 | 64 | E | 0.088121 | Q | 0.070704 | 0.017417 | No Change: Both O | A breast cancer sample |
| Q8IUE6 | H2A2B_HUMAN Histone H2A type 2-B OS=Homo sapiens GN=HIST2H2AB PE=1 SV=3 | 53 | A | 0.085017 | T | 0.088588 | -0.003571 | No Change: Both O | A breast cancer sample |
| Q71DI3 | H32_HUMAN Histone H3.2 OS=Homo sapiens GN=HIST2H3A PE=1 SV=3 | 91 | M | 0.380777 | T | 0.432454 | -0.051677 | No Change: Both O | - |
| Q71DI3 | H32_HUMAN Histone H3.2 OS=Homo sapiens GN=HIST2H3A PE=1 SV=3 | 128 | A | 0.311575 | V | 0.228895 | 0.08268 | No Change: Both O | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 187 | T | 0.781979 | M | 0.760578 | 0.021401 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 362 | P | 0.950428 | L | 0.917067 | 0.033361 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 716 | T | 0.9315 | A | 0.92288 | 0.00862 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 828 | V | 0.704435 | I | 0.698779 | 0.005656 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 873 | T | 0.388753 | A | 0.372161 | 0.016592 | No Change: Both O | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 1074 | N | 0.707587 | S | 0.740425 | -0.032838 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 1170 | K | 0.864217 | N | 0.851099 | 0.013118 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 1520 | A | 0.826461 | G | 0.844545 | -0.018084 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 1609 | M | 0.759106 | I | 0.691827 | 0.067279 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 1915 | Q | 0.743738 | R | 0.692836 | 0.050902 | No Change: Both D | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 2444 | T | 0.546553 | M | 0.477386 | 0.069167 | D to O | - |
| P15822 | ZEP1_HUMAN Zinc finger protein 40 OS=Homo sapiens GN=HIVEP1 PE=1 SV=3 | 2692 | A | 0.921956 | G | 0.927367 | -0.005411 | No Change: Both D | - |
| P31629 | ZEP2_HUMAN Transcription factor HIVEP2 OS=Homo sapiens GN=HIVEP2 PE=1 SV=2 | 46 | R | 0.842433 | Q | 0.87391 | -0.031477 | No Change: Both D | - |
| P31629 | ZEP2_HUMAN Transcription factor HIVEP2 OS=Homo sapiens GN=HIVEP2 PE=1 SV=2 | 1041 | A | 0.887627 | V | 0.868338 | 0.019289 | No Change: Both D | - |
| P31629 | ZEP2_HUMAN Transcription factor HIVEP2 OS=Homo sapiens GN=HIVEP2 PE=1 SV=2 | 1293 | L | 0.863712 | I | 0.818857 | 0.044855 | No Change: Both D | - |
| P31629 | ZEP2_HUMAN Transcription factor HIVEP2 OS=Homo sapiens GN=HIVEP2 PE=1 SV=2 | 1538 | L | 0.998089 | P | 0.99899 | -9.01E-04 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 35 | V | 0.947838 | I | 0.943208 | 0.00463 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 484 | V | 0.848339 | M | 0.864536 | -0.016197 | No Change: Both D | A colorectal cancer sample |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 575 | H | 0.742943 | R | 0.750459 | -0.007516 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 1087 | Q | 0.993541 | H | 0.99228 | 0.001261 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 2023 | A | 0.916019 | P | 0.946251 | -0.030232 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 2109 | D | 0.917987 | A | 0.922538 | -0.004551 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 2272 | G | 0.942271 | R | 0.947632 | -0.005361 | No Change: Both D | - |
| Q5T1R4 | ZEP3_HUMAN Transcription factor HIVEP3 OS=Homo sapiens GN=HIVEP3 PE=1 SV=1 | 2339 | T | 0.990941 | A | 0.991115 | -1.74E-04 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 4 | T | 0.857951 | A | 0.872917 | -0.014966 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 548 | S | 0.894848 | T | 0.863376 | 0.031472 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 549 | S | 0.88728 | C | 0.804488 | 0.082792 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 568 | E | 0.765016 | D | 0.760764 | 0.004252 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 691 | S | 0.936951 | F | 0.885846 | 0.051105 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 76 | E | 0.621663 | K | 0.613933 | 0.00773 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 199 | R | 0.949393 | G | 0.940723 | 0.00867 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 295 | S | 0.798115 | C | 0.681966 | 0.116149 | No Change: Both D | - |
| Q8NCD3 | HJURP_HUMAN Holliday junction recognition protein OS=Homo sapiens GN=HJURP PE=1 SV=2 | 723 | E | 0.978757 | G | 0.972466 | 0.006291 | No Change: Both D | - |
| P19367 | HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=HK1 PE=1 SV=3 | 529 | L | 0.277782 | S | 0.416374 | -0.138592 | No Change: Both O | Hexokinase deficiency (HK deficiency) [MIM:235700] |
| P19367 | HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=HK1 PE=1 SV=3 | 680 | T | 0.286093 | S | 0.344042 | -0.057949 | No Change: Both O | Hexokinase deficiency (HK deficiency) [MIM:235700] |
| P19367 | HXK1_HUMAN Hexokinase-1 OS=Homo sapiens GN=HK1 PE=1 SV=3 | 776 | L | 0.382418 | M | 0.445815 | -0.063397 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 142 | Q | 0.373128 | H | 0.356085 | 0.017043 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 148 | L | 0.340106 | F | 0.320518 | 0.019588 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 314 | A | 0.269927 | V | 0.246344 | 0.023583 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 353 | R | 0.446046 | C | 0.307343 | 0.138703 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 497 | R | 0.753683 | Q | 0.746718 | 0.006965 | No Change: Both D | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 775 | R | 0.427435 | Q | 0.420329 | 0.007106 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 844 | R | 0.29445 | K | 0.337397 | -0.042947 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 274 | R | 0.489887 | C | 0.367614 | 0.122273 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 314 | A | 0.269927 | P | 0.391643 | -0.121716 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 331 | T | 0.457655 | I | 0.32206 | 0.135595 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 387 | A | 0.245896 | S | 0.340848 | -0.094952 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 801 | R | 0.095898 | Q | 0.111583 | -0.015685 | No Change: Both O | - |
| P52789 | HXK2_HUMAN Hexokinase-2 OS=Homo sapiens GN=HK2 PE=1 SV=2 | 881 | D | 0.393634 | N | 0.362551 | 0.031083 | No Change: Both O | - |
| P52790 | HXK3_HUMAN Hexokinase-3 OS=Homo sapiens GN=HK3 PE=1 SV=2 | 281 | G | 0.38129 | R | 0.352008 | 0.029282 | No Change: Both O | - |
| P52790 | HXK3_HUMAN Hexokinase-3 OS=Homo sapiens GN=HK3 PE=1 SV=2 | 480 | R | 0.353974 | W | 0.153416 | 0.200558 | No Change: Both O | A colorectal cancer sample |
| P52790 | HXK3_HUMAN Hexokinase-3 OS=Homo sapiens GN=HK3 PE=1 SV=2 | 499 | A | 0.498283 | V | 0.388769 | 0.109514 | No Change: Both O | A breast cancer sample |
| Q2TB90 | HKDC1_HUMAN Putative hexokinase HKDC1 OS=Homo sapiens GN=HKDC1 PE=2 SV=3 | 54 | D | 0.574563 | G | 0.559002 | 0.015561 | No Change: Both D | - |
| Q2TB90 | HKDC1_HUMAN Putative hexokinase HKDC1 OS=Homo sapiens GN=HKDC1 PE=2 SV=3 | 124 | T | 0.209619 | I | 0.136324 | 0.073295 | No Change: Both O | - |
| Q2TB90 | HKDC1_HUMAN Putative hexokinase HKDC1 OS=Homo sapiens GN=HKDC1 PE=2 SV=3 | 204 | L | 0.169906 | P | 0.286266 | -0.11636 | No Change: Both O | - |
| Q2TB90 | HKDC1_HUMAN Putative hexokinase HKDC1 OS=Homo sapiens GN=HKDC1 PE=2 SV=3 | 721 | W | 0.20058 | R | 0.402238 | -0.201658 | No Change: Both O | - |
| Q2TB90 | HKDC1_HUMAN Putative hexokinase HKDC1 OS=Homo sapiens GN=HKDC1 PE=2 SV=3 | 917 | N | 0.790572 | K | 0.790125 | 4.47E-04 | No Change: Both D | - |
| P10072 | HKR1_HUMAN Krueppel-related zinc finger protein 1 OS=Homo sapiens GN=HKR1 PE=2 SV=4 | 448 | R | 0.31284 | H | 0.302077 | 0.010763 | No Change: Both O | - |
| P10072 | HKR1_HUMAN Krueppel-related zinc finger protein 1 OS=Homo sapiens GN=HKR1 PE=2 SV=4 | 513 | S | 0.82005 | I | 0.652871 | 0.167179 | No Change: Both D | - |
| P10072 | HKR1_HUMAN Krueppel-related zinc finger protein 1 OS=Homo sapiens GN=HKR1 PE=2 SV=4 | 628 | T | 0.82275 | I | 0.783239 | 0.039511 | No Change: Both D | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 36 | V | 0.4775 | M | 0.548346 | -0.070846 | O to D | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 121 | M | 0.250476 | R | 0.295075 | -0.044599 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 129 | S | 0.33609 | P | 0.307433 | 0.028657 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 138 | R | 0.354977 | H | 0.33472 | 0.020257 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 140 | D | 0.357967 | Y | 0.231224 | 0.126743 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 94 | Q | 0.572946 | H | 0.533938 | 0.039008 | No Change: Both D | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 97 | T | 0.513905 | I | 0.372127 | 0.141778 | D to O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 98 | D | 0.498262 | H | 0.441919 | 0.056343 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 138 | R | 0.354977 | E | 0.392309 | -0.037332 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 140 | D | 0.357967 | H | 0.304846 | 0.053121 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 140 | D | 0.357967 | V | 0.207369 | 0.150598 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 175 | H | 0.257707 | L | 0.158987 | 0.09872 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 180 | W | 0.183506 | L | 0.247453 | -0.063947 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 180 | W | 0.183506 | Q | 0.359662 | -0.176156 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 89 | R | 0.515544 | G | 0.486597 | 0.028947 | D to O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 101 | D | 0.41439 | N | 0.388835 | 0.025555 | No Change: Both O | - |
| P01891 | 1A68_HUMAN HLA class I histocompatibility antigen A-68 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=4 | 133 | F | 0.325111 | L | 0.372572 | -0.047461 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 33 | F | 0.369512 | Y | 0.408621 | -0.039109 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 54 | D | 0.333677 | N | 0.263664 | 0.070013 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 67 | Q | 0.610461 | R | 0.623291 | -0.01283 | No Change: Both D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 90 | K | 0.554776 | N | 0.509092 | 0.045684 | No Change: Both D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 97 | T | 0.479651 | I | 0.334587 | 0.145064 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 119 | V | 0.383172 | L | 0.376011 | 0.007161 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 121 | R | 0.315541 | M | 0.272571 | 0.04297 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 123 | Y | 0.248035 | C | 0.221528 | 0.026507 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 123 | Y | 0.248035 | F | 0.215977 | 0.032058 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 131 | W | 0.145356 | G | 0.344978 | -0.199622 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 162 | M | 0.412062 | K | 0.563071 | -0.151009 | O to D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 173 | A | 0.414709 | T | 0.436465 | -0.021756 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 176 | V | 0.279394 | E | 0.480732 | -0.201338 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 180 | L | 0.247453 | W | 0.183506 | 0.063947 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 180 | L | 0.247453 | Q | 0.359662 | -0.112209 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 187 | T | 0.147257 | E | 0.200129 | -0.052872 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 260 | A | 0.460329 | E | 0.57775 | -0.117421 | O to D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 65 | A | 0.595552 | G | 0.617524 | -0.021972 | No Change: Both D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 94 | H | 0.557097 | Q | 0.576964 | -0.019867 | No Change: Both D | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 98 | H | 0.465552 | D | 0.498146 | -0.032594 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 190 | E | 0.145288 | D | 0.117589 | 0.027699 | No Change: Both O | - |
| P01892 | 1A02_HUMAN HLA class I histocompatibility antigen A-2 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 191 | W | 0.149829 | G | 0.310212 | -0.160383 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 176 | E | 0.438585 | V | 0.244 | 0.194585 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 180 | L | 0.325328 | Q | 0.435429 | -0.110101 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 185 | D | 0.178675 | E | 0.221456 | -0.042781 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 199 | G | 0.497734 | R | 0.531446 | -0.033712 | O to D | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 186 | G | 0.161264 | A | 0.163906 | -0.002642 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 89 | R | 0.56137 | G | 0.544736 | 0.016634 | No Change: Both D | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 94 | Q | 0.590635 | H | 0.55034 | 0.040295 | No Change: Both D | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 101 | D | 0.40884 | N | 0.380778 | 0.028062 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 121 | I | 0.172533 | M | 0.247665 | -0.075132 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 129 | S | 0.300926 | P | 0.275258 | 0.025668 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 131 | G | 0.341788 | W | 0.144878 | 0.19691 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 133 | F | 0.320707 | L | 0.364334 | -0.043627 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 151 | N | 0.237449 | K | 0.290908 | -0.053459 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 166 | I | 0.325872 | T | 0.486874 | -0.161002 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 169 | R | 0.450096 | H | 0.471367 | -0.021271 | No Change: Both O | - |
| P04439 | 1A03_HUMAN HLA class I histocompatibility antigen A-3 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 205 | R | 0.670226 | H | 0.684045 | -0.013819 | No Change: Both D | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 5 | A | 0.417446 | G | 0.453457 | -0.036011 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 27 | H | 0.396006 | Q | 0.432355 | -0.036349 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 86 | E | 0.597573 | G | 0.53701 | 0.060563 | No Change: Both D | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 89 | G | 0.582116 | R | 0.611542 | -0.029426 | No Change: Both D | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 180 | Q | 0.365176 | W | 0.184724 | 0.180452 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 206 | T | 0.700204 | A | 0.66216 | 0.038044 | No Change: Both D | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 119 | L | 0.312404 | V | 0.317217 | -0.004813 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 121 | M | 0.230428 | R | 0.269361 | -0.038933 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 123 | F | 0.213945 | Y | 0.243049 | -0.029104 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 131 | G | 0.344155 | W | 0.141658 | 0.202497 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 180 | Q | 0.365176 | L | 0.253473 | 0.111703 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 187 | T | 0.287832 | R | 0.326667 | -0.038835 | No Change: Both O | - |
| P05534 | 1A24_HUMAN HLA class I histocompatibility antigen A-24 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 205 | R | 0.686068 | H | 0.69608 | -0.010012 | No Change: Both D | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 175 | R | 0.268325 | H | 0.245885 | 0.02244 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 180 | L | 0.247169 | Q | 0.368262 | -0.121093 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 101 | S | 0.466476 | N | 0.419235 | 0.047241 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 121 | M | 0.231472 | I | 0.160091 | 0.071381 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 129 | P | 0.333313 | S | 0.362526 | -0.029213 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 133 | L | 0.332672 | F | 0.289121 | 0.043551 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 138 | Q | 0.394543 | R | 0.382135 | 0.012408 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 168 | Q | 0.314628 | K | 0.356036 | -0.041408 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 176 | V | 0.271168 | E | 0.473505 | -0.202337 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 185 | E | 0.168185 | D | 0.135659 | 0.032526 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 89 | R | 0.569754 | G | 0.536579 | 0.033175 | No Change: Both D | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 151 | N | 0.237968 | K | 0.291575 | -0.053607 | No Change: Both O | - |
| P10314 | 1A32_HUMAN HLA class I histocompatibility antigen A-32 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 166 | I | 0.283116 | T | 0.444843 | -0.161727 | No Change: Both O | - |
| P10316 | 1A69_HUMAN HLA class I histocompatibility antigen A-69 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 89 | R | 0.529041 | G | 0.497226 | 0.031815 | D to O | - |
| P10316 | 1A69_HUMAN HLA class I histocompatibility antigen A-69 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 94 | Q | 0.585659 | H | 0.53901 | 0.046649 | No Change: Both D | - |
| P10316 | 1A69_HUMAN HLA class I histocompatibility antigen A-69 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 101 | D | 0.423481 | N | 0.396748 | 0.026733 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 43 | E | 0.450211 | K | 0.450619 | -4.08E-04 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 133 | F | 0.293452 | L | 0.336496 | -0.043044 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 168 | K | 0.405274 | E | 0.410124 | -0.00485 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 175 | H | 0.447234 | R | 0.488683 | -0.041449 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 176 | A | 0.463475 | E | 0.554699 | -0.091224 | O to D | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 187 | R | 0.280356 | T | 0.243465 | 0.036891 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 345 | T | 0.782471 | S | 0.835096 | -0.052625 | No Change: Both D | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 89 | R | 0.580178 | G | 0.560357 | 0.019821 | No Change: Both D | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 94 | Q | 0.603563 | H | 0.557589 | 0.045974 | No Change: Both D | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 101 | D | 0.426389 | N | 0.39506 | 0.031329 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 131 | G | 0.314818 | W | 0.129635 | 0.185183 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 151 | N | 0.237166 | K | 0.290968 | -0.053802 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 166 | I | 0.331151 | T | 0.492437 | -0.161286 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 169 | R | 0.440096 | H | 0.454979 | -0.014883 | No Change: Both O | - |
| P13746 | 1A11_HUMAN HLA class I histocompatibility antigen A-11 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 205 | R | 0.665651 | H | 0.67723 | -0.011579 | No Change: Both D | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 21 | H | 0.315997 | Q | 0.320147 | -0.00415 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 80 | R | 0.581161 | G | 0.539503 | 0.041658 | No Change: Both D | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 94 | Q | 0.60408 | H | 0.560029 | 0.044051 | No Change: Both D | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 176 | W | 0.221941 | R | 0.423619 | -0.201678 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 180 | L | 0.209849 | W | 0.158959 | 0.05089 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 33 | S | 0.630052 | Y | 0.431314 | 0.198738 | D to O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 55 | T | 0.462398 | A | 0.469293 | -0.006895 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 86 | Q | 0.63193 | E | 0.657055 | -0.025125 | No Change: Both D | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 89 | R | 0.600197 | G | 0.565918 | 0.034279 | No Change: Both D | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 101 | D | 0.41735 | N | 0.389108 | 0.028242 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 121 | I | 0.168478 | M | 0.24112 | -0.072642 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 129 | S | 0.298509 | P | 0.27307 | 0.025439 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 131 | G | 0.339399 | W | 0.14246 | 0.196939 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 133 | F | 0.333404 | L | 0.376497 | -0.043093 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 151 | N | 0.231917 | K | 0.27973 | -0.047813 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 166 | I | 0.283077 | T | 0.447215 | -0.164138 | No Change: Both O | - |
| P16188 | 1A30_HUMAN HLA class I histocompatibility antigen A-30 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=2 | 205 | R | 0.689898 | H | 0.704992 | -0.015094 | No Change: Both D | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 121 | M | 0.237974 | I | 0.166712 | 0.071262 | No Change: Both O | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 138 | Q | 0.367907 | R | 0.355278 | 0.012629 | No Change: Both O | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 90 | N | 0.486113 | K | 0.533897 | -0.047784 | O to D | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 114 | A | 0.538381 | D | 0.592484 | -0.054103 | No Change: Both D | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 151 | N | 0.234223 | K | 0.285552 | -0.051329 | No Change: Both O | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 166 | I | 0.282549 | T | 0.443793 | -0.161244 | No Change: Both O | - |
| P16189 | 1A31_HUMAN HLA class I histocompatibility antigen A-31 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 205 | R | 0.671594 | H | 0.687977 | -0.016383 | No Change: Both D | - |
| P16190 | 1A33_HUMAN HLA class I histocompatibility antigen A-33 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=3 | 41 | R | 0.584273 | S | 0.626548 | -0.042275 | No Change: Both D | - |
| P16190 | 1A33_HUMAN HLA class I histocompatibility antigen A-33 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=3 | 195 | H | 0.37484 | Y | 0.257858 | 0.116982 | No Change: Both O | - |
| P16190 | 1A33_HUMAN HLA class I histocompatibility antigen A-33 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=3 | 358 | M | 0.943712 | V | 0.928136 | 0.015576 | No Change: Both D | - |
| P16190 | 1A33_HUMAN HLA class I histocompatibility antigen A-33 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=3 | 151 | N | 0.234223 | K | 0.285552 | -0.051329 | No Change: Both O | - |
| P16190 | 1A33_HUMAN HLA class I histocompatibility antigen A-33 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=3 | 166 | I | 0.28294 | T | 0.44421 | -0.16127 | No Change: Both O | - |
| P18462 | 1A25_HUMAN HLA class I histocompatibility antigen A-25 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 94 | H | 0.603929 | Q | 0.653698 | -0.049769 | No Change: Both D | - |
| P18462 | 1A25_HUMAN HLA class I histocompatibility antigen A-25 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 33 | Y | 0.408621 | F | 0.369512 | 0.039109 | No Change: Both O | - |
| P18462 | 1A25_HUMAN HLA class I histocompatibility antigen A-25 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 151 | N | 0.235273 | K | 0.286796 | -0.051523 | No Change: Both O | - |
| P18462 | 1A25_HUMAN HLA class I histocompatibility antigen A-25 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 166 | I | 0.296044 | T | 0.463094 | -0.16705 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 33 | F | 0.370494 | S | 0.607654 | -0.23716 | O to D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 41 | R | 0.551551 | S | 0.595902 | -0.044351 | No Change: Both D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 80 | G | 0.538114 | R | 0.573612 | -0.035498 | No Change: Both D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 91 | M | 0.633669 | V | 0.548711 | 0.084958 | No Change: Both D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 100 | A | 0.520084 | E | 0.607738 | -0.087654 | No Change: Both D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 114 | D | 0.534374 | A | 0.48208 | 0.052294 | D to O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 121 | I | 0.18225 | M | 0.265727 | -0.083477 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 180 | R | 0.323229 | L | 0.217365 | 0.105864 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 182 | V | 0.294571 | A | 0.37245 | -0.077879 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 89 | R | 0.624275 | G | 0.605354 | 0.018921 | No Change: Both D | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 131 | G | 0.316985 | W | 0.12983 | 0.187155 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 133 | F | 0.292962 | L | 0.335778 | -0.042816 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 151 | N | 0.229313 | K | 0.277504 | -0.048191 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 166 | I | 0.289089 | T | 0.442698 | -0.153609 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 169 | R | 0.349343 | H | 0.36807 | -0.018727 | No Change: Both O | - |
| P30443 | 1A01_HUMAN HLA class I histocompatibility antigen A-1 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 205 | R | 0.679595 | H | 0.688631 | -0.009036 | No Change: Both D | - |
| P30447 | 1A23_HUMAN HLA class I histocompatibility antigen A-23 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 31 | Y | 0.526167 | C | 0.4811 | 0.045067 | D to O | - |
| P30447 | 1A23_HUMAN HLA class I histocompatibility antigen A-23 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 151 | K | 0.27308 | N | 0.227823 | 0.045257 | No Change: Both O | - |
| P30447 | 1A23_HUMAN HLA class I histocompatibility antigen A-23 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 180 | L | 0.284536 | W | 0.20778 | 0.076756 | No Change: Both O | - |
| P30447 | 1A23_HUMAN HLA class I histocompatibility antigen A-23 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 205 | R | 0.687838 | H | 0.699156 | -0.011318 | No Change: Both D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 187 | R | 0.171864 | L | 0.098795 | 0.073069 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 140 | D | 0.356627 | N | 0.323522 | 0.033105 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 306 | I | 0.249683 | V | 0.268922 | -0.019239 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 60 | F | 0.464736 | L | 0.441341 | 0.023395 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 90 | N | 0.538467 | K | 0.558358 | -0.019891 | No Change: Both D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 100 | A | 0.49196 | E | 0.575876 | -0.083916 | O to D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 176 | E | 0.400167 | V | 0.21189 | 0.188277 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 180 | W | 0.305163 | Q | 0.505651 | -0.200488 | O to D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 89 | R | 0.514935 | G | 0.484262 | 0.030673 | D to O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 94 | H | 0.570733 | Q | 0.621825 | -0.051092 | No Change: Both D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 101 | N | 0.470627 | D | 0.495381 | -0.024754 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 129 | P | 0.31586 | S | 0.346268 | -0.030408 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 131 | G | 0.315602 | W | 0.129789 | 0.185813 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 133 | F | 0.292285 | L | 0.338484 | -0.046199 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 151 | N | 0.235273 | K | 0.286796 | -0.051523 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 166 | I | 0.296044 | T | 0.463094 | -0.16705 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 169 | R | 0.422017 | H | 0.441245 | -0.019228 | No Change: Both O | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 180 | W | 0.305163 | R | 0.502445 | -0.197282 | O to D | - |
| P30450 | 1A26_HUMAN HLA class I histocompatibility antigen A-26 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 185 | E | 0.185661 | D | 0.147489 | 0.038172 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 3 | I | 0.646381 | V | 0.692209 | -0.045828 | No Change: Both D | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 90 | K | 0.590504 | N | 0.564666 | 0.025838 | No Change: Both D | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 121 | R | 0.308462 | I | 0.182386 | 0.126076 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 129 | P | 0.319317 | S | 0.350084 | -0.030767 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 138 | Q | 0.362837 | R | 0.350548 | 0.012289 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 180 | W | 0.290611 | L | 0.367625 | -0.077014 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 312 | L | 0.039636 | I | 0.035099 | 0.004537 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 101 | D | 0.454961 | N | 0.420799 | 0.034162 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 151 | N | 0.235273 | K | 0.286796 | -0.051523 | No Change: Both O | - |
| P30453 | 1A34_HUMAN HLA class I histocompatibility antigen A-34 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 166 | I | 0.295675 | T | 0.46337 | -0.167695 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 182 | V | 0.231895 | A | 0.299913 | -0.068018 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 185 | E | 0.179981 | D | 0.147492 | 0.032489 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 89 | R | 0.624275 | G | 0.605354 | 0.018921 | No Change: Both D | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 131 | G | 0.316985 | W | 0.12983 | 0.187155 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 133 | F | 0.292962 | L | 0.335778 | -0.042816 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 151 | N | 0.229313 | K | 0.277504 | -0.048191 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 166 | I | 0.294104 | T | 0.455295 | -0.161191 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 169 | R | 0.359641 | H | 0.380045 | -0.020404 | No Change: Both O | - |
| P30455 | 1A36_HUMAN HLA class I histocompatibility antigen A-36 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 205 | R | 0.676468 | H | 0.690614 | -0.014146 | No Change: Both D | - |
| P30456 | 1A43_HUMAN HLA class I histocompatibility antigen A-43 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 151 | N | 0.235273 | K | 0.286796 | -0.051523 | No Change: Both O | - |
| P30456 | 1A43_HUMAN HLA class I histocompatibility antigen A-43 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 166 | I | 0.296044 | T | 0.463094 | -0.16705 | No Change: Both O | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 28 | S | 0.292677 | W | 0.098754 | 0.193923 | No Change: Both O | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 114 | D | 0.573863 | A | 0.515553 | 0.05831 | No Change: Both D | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 187 | R | 0.171864 | E | 0.202108 | -0.030244 | No Change: Both O | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 89 | R | 0.53928 | G | 0.506039 | 0.033241 | No Change: Both D | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 101 | D | 0.448995 | N | 0.420317 | 0.028678 | No Change: Both O | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 151 | N | 0.235273 | K | 0.286796 | -0.051523 | No Change: Both O | - |
| P30457 | 1A66_HUMAN HLA class I histocompatibility antigen A-66 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 166 | I | 0.296044 | T | 0.463094 | -0.16705 | No Change: Both O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 23 | R | 0.533273 | W | 0.308732 | 0.224541 | D to O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 86 | Q | 0.521728 | G | 0.493364 | 0.028364 | D to O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 90 | N | 0.533516 | K | 0.579129 | -0.045613 | No Change: Both D | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 97 | T | 0.492124 | A | 0.466395 | 0.025729 | No Change: Both O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 103 | G | 0.327685 | A | 0.265084 | 0.062601 | No Change: Both O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 89 | R | 0.516642 | G | 0.505088 | 0.011554 | No Change: Both D | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 151 | N | 0.237968 | K | 0.291575 | -0.053607 | No Change: Both O | - |
| P30459 | 1A74_HUMAN HLA class I histocompatibility antigen A-74 alpha chain OS=Homo sapiens GN=HLA-A PE=1 SV=1 | 166 | I | 0.283116 | T | 0.444843 | -0.161727 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 126 | H | 0.215684 | D | 0.257901 | -0.042217 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 90 | N | 0.471332 | H | 0.4346 | 0.036732 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 129 | S | 0.317689 | P | 0.291167 | 0.026522 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 131 | G | 0.358669 | W | 0.153692 | 0.204977 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 133 | F | 0.335615 | L | 0.378792 | -0.043177 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 151 | N | 0.233183 | K | 0.283031 | -0.049848 | No Change: Both O | - |
| P30512 | 1A29_HUMAN HLA class I histocompatibility antigen A-29 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=2 | 166 | I | 0.282193 | T | 0.442808 | -0.160615 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 121 | I | 0.191188 | M | 0.274193 | -0.083005 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 129 | S | 0.300354 | P | 0.274299 | 0.026055 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 131 | G | 0.34481 | W | 0.145998 | 0.198812 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 133 | F | 0.320923 | L | 0.365331 | -0.044408 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 151 | N | 0.244983 | K | 0.303256 | -0.058273 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 166 | I | 0.342502 | T | 0.504429 | -0.161927 | O to D | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 169 | R | 0.442751 | H | 0.410576 | 0.032175 | No Change: Both O | - |
| Q09160 | 1A80_HUMAN HLA class I histocompatibility antigen A-80 alpha chain OS=Homo sapiens GN=HLA-A PE=2 SV=1 | 205 | R | 0.674101 | H | 0.679739 | -0.005638 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 121 | S | 0.391139 | R | 0.327601 | 0.063538 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 138 | D | 0.38333 | N | 0.346045 | 0.037285 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 180 | R | 0.585193 | D | 0.565012 | 0.020181 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | L | 0.261244 | 0.167169 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 65 | A | 0.7028 | T | 0.717642 | -0.014842 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 87 | N | 0.517904 | D | 0.560546 | -0.042642 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 97 | T | 0.576235 | A | 0.566013 | 0.010222 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 101 | S | 0.568988 | N | 0.545861 | 0.023127 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 137 | H | 0.398394 | Y | 0.300933 | 0.097461 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 155 | R | 0.289687 | S | 0.341514 | -0.051827 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 195 | Y | 0.411218 | H | 0.544844 | -0.133626 | O to D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 87 | N | 0.517904 | K | 0.562034 | -0.04413 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 98 | D | 0.591096 | Y | 0.463861 | 0.127235 | D to O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | A | 0.328513 | 0.0999 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | G | 0.335699 | 0.092714 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | K | 0.402185 | 0.026228 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | Q | 0.376611 | 0.051802 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 187 | E | 0.428413 | V | 0.236759 | 0.191654 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 138 | D | 0.38333 | H | 0.342781 | 0.040549 | No Change: Both O | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P01889 | 1B07_HUMAN HLA class I histocompatibility antigen B-7 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=3 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 83 | Y | 0.590545 | H | 0.669092 | -0.078547 | No Change: Both D | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 101 | D | 0.488678 | N | 0.458588 | 0.03009 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 101 | D | 0.488678 | S | 0.497593 | -0.008915 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 104 | T | 0.328003 | N | 0.35931 | -0.031307 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 121 | N | 0.314558 | S | 0.372698 | -0.05814 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 138 | H | 0.363315 | D | 0.425286 | -0.061971 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 140 | D | 0.358635 | H | 0.326452 | 0.032183 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 140 | D | 0.358635 | Y | 0.233985 | 0.12465 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 155 | S | 0.328341 | R | 0.259091 | 0.06925 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 176 | V | 0.284958 | E | 0.498462 | -0.213504 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 235 | A | 0.171874 | G | 0.193025 | -0.021151 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 65 | A | 0.637233 | T | 0.656694 | -0.019461 | No Change: Both D | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P03989 | 1B27_HUMAN HLA class I histocompatibility antigen B-27 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P10319 | 1B58_HUMAN HLA class I histocompatibility antigen B-58 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 86 | G | 0.5748 | E | 0.64964 | -0.07484 | No Change: Both D | - |
| P10319 | 1B58_HUMAN HLA class I histocompatibility antigen B-58 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 121 | R | 0.204872 | W | 0.080082 | 0.12479 | No Change: Both O | - |
| P10319 | 1B58_HUMAN HLA class I histocompatibility antigen B-58 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 171 | W | 0.323999 | L | 0.408774 | -0.084775 | No Change: Both O | - |
| P10319 | 1B58_HUMAN HLA class I histocompatibility antigen B-58 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 176 | V | 0.269636 | A | 0.375361 | -0.105725 | No Change: Both O | - |
| P10319 | 1B58_HUMAN HLA class I histocompatibility antigen B-58 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 187 | L | 0.114592 | T | 0.16282 | -0.048228 | No Change: Both O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 104 | T | 0.365286 | N | 0.383584 | -0.018298 | No Change: Both O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 195 | Y | 0.257536 | H | 0.373613 | -0.116077 | No Change: Both O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 35 | S | 0.580855 | A | 0.439467 | 0.141388 | D to O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 36 | V | 0.598592 | M | 0.661651 | -0.063059 | No Change: Both D | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.699891 | T | 0.730708 | -0.030817 | No Change: Both D | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.377959 | A | 0.277842 | 0.100117 | No Change: Both O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.377959 | P | 0.381635 | -0.003676 | No Change: Both O | - |
| P18463 | 1B37_HUMAN HLA class I histocompatibility antigen B-37 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.377959 | T | 0.312779 | 0.06518 | No Change: Both O | - |
| P18464 | 1B51_HUMAN HLA class I histocompatibility antigen B-51 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 176 | E | 0.477853 | V | 0.272644 | 0.205209 | No Change: Both O | - |
| P18464 | 1B51_HUMAN HLA class I histocompatibility antigen B-51 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.381982 | D | 0.481742 | -0.09976 | No Change: Both O | - |
| P18464 | 1B51_HUMAN HLA class I histocompatibility antigen B-51 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 191 | W | 0.272105 | G | 0.473204 | -0.201099 | No Change: Both O | - |
| P18464 | 1B51_HUMAN HLA class I histocompatibility antigen B-51 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 195 | H | 0.386476 | Y | 0.267884 | 0.118592 | No Change: Both O | - |
| P18464 | 1B51_HUMAN HLA class I histocompatibility antigen B-51 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | S | 0.328693 | R | 0.264509 | 0.064184 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 138 | D | 0.549602 | N | 0.51372 | 0.035882 | No Change: Both D | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | S | 0.506665 | Y | 0.361432 | 0.145233 | D to O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.225541 | R | 0.331492 | -0.105951 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | V | 0.11533 | R | 0.18963 | -0.0743 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | V | 0.233775 | L | 0.236289 | -0.002514 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.543332 | Y | 0.433762 | 0.10957 | D to O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P18465 | 1B57_HUMAN HLA class I histocompatibility antigen B-57 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.526101 | D | 0.552275 | -0.026174 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 91 | F | 0.598833 | S | 0.764549 | -0.165716 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.597398 | N | 0.580915 | 0.016483 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 119 | L | 0.470481 | W | 0.38262 | 0.087861 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | S | 0.386814 | R | 0.319819 | 0.066995 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | S | 0.386814 | T | 0.308491 | 0.078323 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 138 | N | 0.346045 | D | 0.38333 | -0.037285 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 176 | V | 0.364334 | E | 0.565485 | -0.201151 | O to D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | D | 0.358327 | L | 0.249039 | 0.109288 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | D | 0.358327 | R | 0.36517 | -0.006843 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | Y | 0.312403 | D | 0.439418 | -0.127015 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.476432 | T | 0.530048 | -0.053616 | O to D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.145723 | L | 0.177743 | -0.03202 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.159085 | V | 0.139688 | 0.019397 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.711596 | T | 0.728899 | -0.017303 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.603203 | A | 0.549365 | 0.053838 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.362087 | Y | 0.267608 | 0.094479 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.256856 | S | 0.324034 | -0.067178 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.526101 | K | 0.55312 | -0.027019 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.6214 | Y | 0.492516 | 0.128884 | D to O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.427275 | A | 0.333885 | 0.09339 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.427275 | P | 0.435659 | -0.008384 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.427275 | T | 0.360378 | 0.066897 | No Change: Both O | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30460 | 1B08_HUMAN HLA class I histocompatibility antigen B-8 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 121 | T | 0.232085 | R | 0.240396 | -0.008311 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 183 | Y | 0.200816 | C | 0.215768 | -0.014952 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 138 | N | 0.338381 | D | 0.375284 | -0.036903 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 140 | L | 0.307458 | S | 0.453882 | -0.146424 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 169 | L | 0.225065 | R | 0.353877 | -0.128812 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 187 | E | 0.188416 | L | 0.092155 | 0.096261 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30461 | 1B13_HUMAN HLA class I histocompatibility antigen B-13 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.424066 | R | 0.553872 | -0.129806 | O to D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.706763 | T | 0.725523 | -0.01876 | No Change: Both D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.544464 | D | 0.570442 | -0.025978 | No Change: Both D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.594695 | A | 0.542684 | 0.052011 | No Change: Both D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.29063 | T | 0.273034 | 0.017596 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.544464 | K | 0.570924 | -0.02646 | No Change: Both D | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.612601 | Y | 0.483084 | 0.129517 | D to O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| P30462 | 1B14_HUMAN HLA class I histocompatibility antigen B-14 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 48 | A | 0.232296 | S | 0.318001 | -0.085705 | No Change: Both O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 87 | E | 0.614087 | N | 0.55574 | 0.058347 | No Change: Both D | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 91 | S | 0.669271 | C | 0.516436 | 0.152835 | No Change: Both D | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 91 | S | 0.669271 | Y | 0.52346 | 0.145811 | No Change: Both D | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 119 | L | 0.433121 | W | 0.330991 | 0.10213 | No Change: Both O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 121 | R | 0.36542 | T | 0.343172 | 0.022248 | No Change: Both O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 137 | H | 0.526822 | Y | 0.426756 | 0.100066 | D to O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 180 | W | 0.280725 | L | 0.362027 | -0.081302 | No Change: Both O | - |
| P30464 | 1B15_HUMAN HLA class I histocompatibility antigen B-15 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=2 | 274 | P | 0.415603 | L | 0.280737 | 0.134866 | No Change: Both O | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | Y | 0.620956 | D | 0.732466 | -0.11151 | No Change: Both D | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | R | 0.365058 | N | 0.364191 | 8.67E-04 | No Change: Both O | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.612333 | E | 0.669422 | -0.057089 | No Change: Both D | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 91 | S | 0.681609 | F | 0.492016 | 0.189593 | D to O | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.268975 | R | 0.391345 | -0.12237 | No Change: Both O | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | T | 0.211885 | E | 0.280801 | -0.068916 | No Change: Both O | - |
| P30466 | 1B18_HUMAN HLA class I histocompatibility antigen B-18 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 195 | H | 0.350141 | Y | 0.238646 | 0.111495 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.552601 | E | 0.615121 | -0.06252 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 91 | C | 0.645509 | S | 0.76266 | -0.117151 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 91 | C | 0.645509 | Y | 0.635649 | 0.00986 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.64895 | Y | 0.521565 | 0.127385 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 119 | L | 0.404344 | W | 0.31564 | 0.088704 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 121 | R | 0.322958 | S | 0.386976 | -0.064018 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 121 | R | 0.322958 | T | 0.310798 | 0.01216 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 122 | M | 0.302374 | T | 0.359066 | -0.056692 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 123 | Y | 0.296374 | S | 0.476739 | -0.180365 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 138 | N | 0.296111 | D | 0.331559 | -0.035448 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 140 | F | 0.264134 | S | 0.440427 | -0.176293 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 168 | Q | 0.349206 | R | 0.333356 | 0.01585 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 180 | L | 0.266779 | R | 0.387771 | -0.120992 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 33 | Y | 0.411346 | D | 0.55373 | -0.142384 | O to D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.706763 | T | 0.725523 | -0.01876 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.552601 | D | 0.578784 | -0.026183 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 97 | T | 0.638215 | A | 0.582552 | 0.055663 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 329 | A | 0.29063 | T | 0.273034 | 0.017596 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.552601 | K | 0.579222 | -0.026621 | No Change: Both D | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| P30475 | 1B39_HUMAN HLA class I histocompatibility antigen B-39 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 119 | W | 0.314151 | L | 0.404018 | -0.089867 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | R | 0.236746 | S | 0.29795 | -0.061204 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | V | 0.281754 | L | 0.303042 | -0.021288 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 138 | N | 0.347592 | D | 0.384701 | -0.037109 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 104 | N | 0.469567 | K | 0.493546 | -0.023979 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.217505 | L | 0.261467 | -0.043962 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.191377 | V | 0.167453 | 0.023924 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.256951 | S | 0.323971 | -0.06702 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30479 | 1B41_HUMAN HLA class I histocompatibility antigen B-41 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 33 | Y | 0.411346 | H | 0.542736 | -0.13139 | O to D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.7028 | T | 0.717642 | -0.014842 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517904 | D | 0.560546 | -0.042642 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.576235 | A | 0.566013 | 0.010222 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.568988 | N | 0.545861 | 0.023127 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.362087 | Y | 0.267608 | 0.094479 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.256856 | S | 0.324034 | -0.067178 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517904 | K | 0.562034 | -0.04413 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.591096 | Y | 0.463861 | 0.127235 | D to O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30480 | 1B42_HUMAN HLA class I histocompatibility antigen B-42 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | T | 0.607394 | A | 0.587458 | 0.019936 | No Change: Both D | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 85 | D | 0.615782 | E | 0.681786 | -0.066004 | No Change: Both D | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | E | 0.630734 | N | 0.575147 | 0.055587 | No Change: Both D | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | N | 0.451649 | S | 0.487409 | -0.03576 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | D | 0.413791 | Y | 0.273999 | 0.139792 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | D | 0.37253 | L | 0.272448 | 0.100082 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | D | 0.37253 | R | 0.390388 | -0.017858 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | L | 0.272468 | T | 0.359694 | -0.087226 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30481 | 1B44_HUMAN HLA class I histocompatibility antigen B-44 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30483 | 1B45_HUMAN HLA class I histocompatibility antigen B-45 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 139 | Q | 0.233489 | R | 0.235545 | -0.002056 | No Change: Both O | - |
| P30483 | 1B45_HUMAN HLA class I histocompatibility antigen B-45 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 191 | S | 0.315414 | W | 0.135277 | 0.180137 | No Change: Both O | - |
| P30483 | 1B45_HUMAN HLA class I histocompatibility antigen B-45 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 9 | V | 0.217505 | L | 0.261467 | -0.043962 | No Change: Both O | - |
| P30483 | 1B45_HUMAN HLA class I histocompatibility antigen B-45 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 17 | L | 0.191377 | V | 0.167453 | 0.023924 | No Change: Both O | - |
| P30484 | 1B46_HUMAN HLA class I histocompatibility antigen B-46 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.566606 | G | 0.54448 | 0.022126 | No Change: Both D | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 101 | D | 0.460679 | S | 0.493497 | -0.032818 | No Change: Both O | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 104 | T | 0.319457 | N | 0.342187 | -0.02273 | No Change: Both O | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 306 | V | 0.310784 | I | 0.283818 | 0.026966 | No Change: Both O | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 329 | A | 0.237709 | T | 0.221842 | 0.015867 | No Change: Both O | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 349 | C | 0.820673 | S | 0.906041 | -0.085368 | No Change: Both D | - |
| P30485 | 1B47_HUMAN HLA class I histocompatibility antigen B-47 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 349 | C | 0.820673 | Y | 0.809413 | 0.01126 | No Change: Both D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | S | 0.387105 | R | 0.323464 | 0.063641 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.742416 | T | 0.761416 | -0.019 | No Change: Both D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.586689 | N | 0.555287 | 0.031402 | No Change: Both D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.359522 | Y | 0.266744 | 0.092778 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.264715 | S | 0.332134 | -0.067419 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 195 | Y | 0.313653 | H | 0.440361 | -0.126708 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | A | 0.180749 | 0.078665 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | G | 0.192613 | 0.066801 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | K | 0.241154 | 0.01826 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | Q | 0.217751 | 0.041663 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | V | 0.125301 | 0.134113 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| P30486 | 1B48_HUMAN HLA class I histocompatibility antigen B-48 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 48 | T | 0.236176 | A | 0.206173 | 0.030003 | No Change: Both O | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 56 | L | 0.307345 | Q | 0.469127 | -0.161782 | No Change: Both O | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 65 | T | 0.61083 | A | 0.590745 | 0.020085 | No Change: Both D | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 69 | K | 0.65643 | T | 0.65784 | -0.00141 | No Change: Both D | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 104 | I | 0.219001 | T | 0.366591 | -0.14759 | No Change: Both O | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 9 | V | 0.217505 | L | 0.261467 | -0.043962 | No Change: Both O | - |
| P30487 | 1B49_HUMAN HLA class I histocompatibility antigen B-49 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=2 | 17 | L | 0.191377 | V | 0.167453 | 0.023924 | No Change: Both O | - |
| P30488 | 1B50_HUMAN HLA class I histocompatibility antigen B-50 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 127 | L | 0.299613 | V | 0.279644 | 0.019969 | No Change: Both O | - |
| P30488 | 1B50_HUMAN HLA class I histocompatibility antigen B-50 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 191 | W | 0.167713 | S | 0.363015 | -0.195302 | No Change: Both O | - |
| P30488 | 1B50_HUMAN HLA class I histocompatibility antigen B-50 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 9 | V | 0.217505 | L | 0.261467 | -0.043962 | No Change: Both O | - |
| P30488 | 1B50_HUMAN HLA class I histocompatibility antigen B-50 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 17 | L | 0.191377 | V | 0.167453 | 0.023924 | No Change: Both O | - |
| P30490 | 1B52_HUMAN HLA class I histocompatibility antigen B-52 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 176 | E | 0.477853 | V | 0.272644 | 0.205209 | No Change: Both O | - |
| P30490 | 1B52_HUMAN HLA class I histocompatibility antigen B-52 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 195 | H | 0.386476 | Y | 0.267884 | 0.118592 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | N | 0.281966 | D | 0.283306 | -0.00134 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | N | 0.281966 | S | 0.3059 | -0.023934 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 118 | I | 0.295032 | T | 0.407875 | -0.112843 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 123 | Y | 0.196296 | S | 0.367642 | -0.171346 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | L | 0.307058 | V | 0.284876 | 0.022182 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | S | 0.488938 | F | 0.300867 | 0.188071 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 176 | V | 0.269636 | E | 0.473469 | -0.203833 | No Change: Both O | - |
| P30491 | 1B53_HUMAN HLA class I histocompatibility antigen B-53 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 195 | Y | 0.224815 | H | 0.33214 | -0.107325 | No Change: Both O | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 33 | Y | 0.360898 | H | 0.493622 | -0.132724 | No Change: Both O | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.465121 | D | 0.509502 | -0.044381 | O to D | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 97 | T | 0.540311 | A | 0.529586 | 0.010725 | No Change: Both D | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 101 | S | 0.536841 | N | 0.516713 | 0.020128 | No Change: Both D | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.465121 | K | 0.511931 | -0.04681 | O to D | - |
| P30492 | 1B54_HUMAN HLA class I histocompatibility antigen B-54 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.561794 | Y | 0.435224 | 0.12657 | D to O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 82 | E | 0.563778 | A | 0.455038 | 0.10874 | D to O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.542948 | N | 0.522831 | 0.020117 | No Change: Both D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 176 | E | 0.481612 | V | 0.275077 | 0.206535 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 119 | W | 0.318403 | L | 0.417633 | -0.09923 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | T | 0.242454 | R | 0.257195 | -0.014741 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | T | 0.242454 | S | 0.314639 | -0.072185 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | L | 0.287632 | V | 0.264548 | 0.023084 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | L | 0.302518 | Y | 0.310956 | -0.008438 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | S | 0.330836 | R | 0.275592 | 0.055244 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.400857 | R | 0.5288 | -0.127943 | O to D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | T | 0.236805 | E | 0.311233 | -0.074428 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | T | 0.236805 | L | 0.173664 | 0.063141 | No Change: Both O | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.67751 | T | 0.687918 | -0.010408 | No Change: Both D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.510203 | D | 0.552545 | -0.042342 | No Change: Both D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.550576 | A | 0.539155 | 0.011421 | No Change: Both D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.510203 | K | 0.554092 | -0.043889 | No Change: Both D | - |
| P30493 | 1B55_HUMAN HLA class I histocompatibility antigen B-55 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.566848 | Y | 0.44444 | 0.122408 | D to O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 69 | E | 0.702902 | T | 0.645887 | 0.057015 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 101 | S | 0.542948 | N | 0.522831 | 0.020117 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 119 | W | 0.318403 | L | 0.417633 | -0.09923 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 121 | T | 0.242454 | R | 0.257195 | -0.014741 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 127 | L | 0.287632 | V | 0.264548 | 0.023084 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 140 | L | 0.302518 | Y | 0.310956 | -0.008438 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 176 | V | 0.269636 | E | 0.473469 | -0.203833 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 195 | Y | 0.214094 | H | 0.317465 | -0.103371 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 138 | N | 0.340409 | D | 0.377654 | -0.037245 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 140 | L | 0.302518 | S | 0.440072 | -0.137554 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 180 | L | 0.225541 | W | 0.161492 | 0.064049 | No Change: Both O | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.67751 | T | 0.687918 | -0.010408 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.510203 | D | 0.552545 | -0.042342 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 97 | T | 0.550576 | A | 0.539155 | 0.011421 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.510203 | K | 0.554092 | -0.043889 | No Change: Both D | - |
| P30495 | 1B56_HUMAN HLA class I histocompatibility antigen B-56 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.566848 | Y | 0.44444 | 0.122408 | D to O | - |
| P30498 | 1B78_HUMAN HLA class I histocompatibility antigen B-78 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.601859 | Y | 0.473137 | 0.128722 | D to O | - |
| P30498 | 1B78_HUMAN HLA class I histocompatibility antigen B-78 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 91 | F | 0.555865 | C | 0.601423 | -0.045558 | No Change: Both D | - |
| P30498 | 1B78_HUMAN HLA class I histocompatibility antigen B-78 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 97 | T | 0.578911 | A | 0.527267 | 0.051644 | No Change: Both D | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 40 | G | 0.574679 | V | 0.421765 | 0.152914 | D to O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | A | 0.245801 | S | 0.333721 | -0.08792 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 69 | T | 0.646463 | E | 0.702725 | -0.056262 | No Change: Both D | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.414808 | E | 0.476474 | -0.061666 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 91 | F | 0.451946 | S | 0.644817 | -0.192871 | O to D | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | Y | 0.469777 | D | 0.596496 | -0.126719 | O to D | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 107 | G | 0.416355 | D | 0.437622 | -0.021267 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | R | 0.221277 | S | 0.276442 | -0.055165 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | L | 0.326508 | V | 0.294443 | 0.032065 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 133 | L | 0.484363 | F | 0.430751 | 0.053612 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 138 | D | 0.538454 | N | 0.501772 | 0.036682 | No Change: Both D | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | S | 0.490277 | F | 0.301517 | 0.18876 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | S | 0.490277 | Y | 0.352862 | 0.137415 | No Change: Both O | - |
| P30685 | 1B35_HUMAN HLA class I histocompatibility antigen B-35 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.225541 | R | 0.331492 | -0.105951 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | L | 0.082662 | V | 0.076838 | 0.005824 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | V | 0.066392 | L | 0.081972 | -0.01558 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | E | 0.671668 | N | 0.615848 | 0.05582 | No Change: Both D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 91 | S | 0.71862 | F | 0.538577 | 0.180043 | No Change: Both D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 119 | L | 0.468909 | W | 0.380393 | 0.088516 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | S | 0.387105 | R | 0.323464 | 0.063641 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 121 | S | 0.387105 | T | 0.310022 | 0.077083 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 127 | V | 0.330386 | L | 0.363368 | -0.032982 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 138 | N | 0.346045 | D | 0.38333 | -0.037285 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | Y | 0.312403 | N | 0.420846 | -0.108443 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 140 | Y | 0.312403 | S | 0.441165 | -0.128762 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 167 | T | 0.347805 | S | 0.413445 | -0.06564 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 171 | W | 0.324886 | L | 0.409063 | -0.084177 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 176 | V | 0.287365 | E | 0.500411 | -0.213046 | O to D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.221044 | L | 0.112375 | 0.108669 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 204 | Q | 0.599151 | E | 0.653074 | -0.053923 | No Change: Both D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 180 | L | 0.289163 | R | 0.416354 | -0.127191 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.362087 | Y | 0.267608 | 0.094479 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.584423 | N | 0.553034 | 0.031389 | No Change: Both D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.255748 | S | 0.327665 | -0.071917 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| Q04826 | 1B40_HUMAN HLA class I histocompatibility antigen B-40 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 186 | D | 0.333828 | G | 0.276474 | 0.057354 | No Change: Both O | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.698627 | T | 0.712506 | -0.013879 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.517761 | D | 0.560399 | -0.042638 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 97 | T | 0.572959 | A | 0.562942 | 0.010017 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 101 | S | 0.568738 | N | 0.548263 | 0.020475 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.517761 | K | 0.561887 | -0.044126 | No Change: Both D | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | D | 0.587366 | Y | 0.46206 | 0.125306 | D to O | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.35 | A | 0.261717 | 0.088283 | No Change: Both O | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.35 | P | 0.355826 | -0.005826 | No Change: Both O | - |
| Q29718 | 1B82_HUMAN HLA class I histocompatibility antigen B-82 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.35 | T | 0.286613 | 0.063387 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 69 | E | 0.721165 | G | 0.66731 | 0.053855 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 76 | I | 0.589616 | V | 0.614618 | -0.025002 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517761 | E | 0.596681 | -0.07892 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 90 | I | 0.549917 | K | 0.717873 | -0.167956 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 93 | A | 0.578466 | R | 0.649821 | -0.071355 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.574377 | A | 0.564243 | 0.010134 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 100 | E | 0.577855 | V | 0.391785 | 0.18607 | D to O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.7028 | T | 0.717642 | -0.014842 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517761 | D | 0.560399 | -0.042638 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.567357 | N | 0.546554 | 0.020803 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.29063 | T | 0.273034 | 0.017596 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517761 | K | 0.561887 | -0.044126 | No Change: Both D | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.588838 | Y | 0.462912 | 0.125926 | D to O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| Q29836 | 1B67_HUMAN HLA class I histocompatibility antigen B-67 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| Q29940 | 1B59_HUMAN HLA class I histocompatibility antigen B-59 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.674339 | T | 0.687624 | -0.013285 | No Change: Both D | - |
| Q29940 | 1B59_HUMAN HLA class I histocompatibility antigen B-59 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.37103 | D | 0.390524 | -0.019494 | No Change: Both O | - |
| Q29940 | 1B59_HUMAN HLA class I histocompatibility antigen B-59 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.37103 | K | 0.405067 | -0.034037 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.491951 | T | 0.550065 | -0.058114 | O to D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.049704 | L | 0.053144 | -0.00344 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 35 | S | 0.463794 | A | 0.324714 | 0.13908 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 36 | V | 0.496503 | M | 0.571545 | -0.075042 | O to D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.7028 | T | 0.717642 | -0.014842 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517904 | D | 0.560546 | -0.042642 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 97 | T | 0.576235 | A | 0.566013 | 0.010222 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 101 | S | 0.568988 | N | 0.545861 | 0.023127 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 137 | H | 0.359522 | Y | 0.266744 | 0.092778 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.264715 | S | 0.332134 | -0.067419 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 195 | Y | 0.313653 | H | 0.440361 | -0.126708 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 329 | A | 0.245867 | T | 0.230379 | 0.015488 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.517904 | K | 0.562034 | -0.04413 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 98 | D | 0.591096 | Y | 0.463861 | 0.127235 | D to O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | A | 0.180749 | 0.078665 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | G | 0.192613 | 0.066801 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | K | 0.241154 | 0.01826 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | Q | 0.217751 | 0.041663 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 187 | E | 0.259414 | V | 0.125301 | 0.134113 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.359077 | A | 0.262409 | 0.096668 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.359077 | P | 0.361721 | -0.002644 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 48 | S | 0.359077 | T | 0.291627 | 0.06745 | No Change: Both O | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | S | 0.908116 | -0.082936 | No Change: Both D | - |
| Q31610 | 1B81_HUMAN HLA class I histocompatibility antigen B-81 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 349 | C | 0.82518 | Y | 0.813131 | 0.012049 | No Change: Both D | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 4 | M | 0.473357 | T | 0.526335 | -0.052978 | O to D | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 9 | V | 0.141543 | L | 0.166621 | -0.025078 | No Change: Both O | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 17 | L | 0.154094 | V | 0.137553 | 0.016541 | No Change: Both O | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 65 | A | 0.686077 | T | 0.705831 | -0.019754 | No Change: Both D | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.365582 | D | 0.409666 | -0.044084 | No Change: Both O | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 155 | R | 0.253991 | S | 0.326051 | -0.07206 | No Change: Both O | - |
| Q31612 | 1B73_HUMAN HLA class I histocompatibility antigen B-73 alpha chain OS=Homo sapiens GN=HLA-B PE=1 SV=1 | 87 | N | 0.365582 | K | 0.423592 | -0.05801 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 35 | S | 0.455295 | A | 0.320816 | 0.134479 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 69 | E | 0.719416 | T | 0.66395 | 0.055466 | No Change: Both D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 82 | E | 0.482516 | G | 0.39621 | 0.086306 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.391251 | E | 0.4544 | -0.063149 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 91 | C | 0.454275 | F | 0.417753 | 0.036522 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 91 | C | 0.454275 | S | 0.587398 | -0.133123 | O to D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 98 | Y | 0.366379 | D | 0.508018 | -0.141639 | O to D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 101 | N | 0.309651 | S | 0.334063 | -0.024412 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 104 | I | 0.198893 | T | 0.341249 | -0.142356 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 187 | T | 0.182572 | M | 0.137596 | 0.044976 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 4 | M | 0.482063 | T | 0.537442 | -0.055379 | O to D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 9 | V | 0.127646 | L | 0.146251 | -0.018605 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 17 | L | 0.141267 | V | 0.126865 | 0.014402 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 36 | V | 0.483566 | M | 0.555861 | -0.072295 | O to D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 65 | A | 0.700128 | T | 0.719385 | -0.019257 | No Change: Both D | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.391251 | D | 0.4107 | -0.019449 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 306 | V | 0.310642 | I | 0.283637 | 0.027005 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 329 | A | 0.29063 | T | 0.273034 | 0.017596 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 87 | N | 0.391251 | K | 0.425048 | -0.033797 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | A | 0.263376 | 0.097094 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | P | 0.363018 | -0.002548 | No Change: Both O | - |
| Q95365 | 1B38_HUMAN HLA class I histocompatibility antigen B-38 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 | 48 | S | 0.36047 | T | 0.292584 | 0.067886 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 115 | G | 0.41561 | R | 0.426331 | -0.010721 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 118 | I | 0.294474 | T | 0.402089 | -0.107615 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 101 | S | 0.442789 | N | 0.415262 | 0.027527 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 104 | N | 0.368234 | K | 0.403635 | -0.035401 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 119 | I | 0.250312 | L | 0.268357 | -0.018045 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 140 | Y | 0.274995 | S | 0.414018 | -0.139023 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 90 | K | 0.673887 | N | 0.641284 | 0.032603 | No Change: Both D | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 121 | R | 0.190471 | S | 0.24647 | -0.055999 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 127 | V | 0.280759 | L | 0.299006 | -0.018247 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 138 | D | 0.292314 | V | 0.146702 | 0.145612 | No Change: Both O | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 73 | A | 0.688426 | E | 0.771789 | -0.083363 | No Change: Both D | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 76 | V | 0.635929 | M | 0.691063 | -0.055134 | No Change: Both D | - |
| P04222 | 1C03_HUMAN HLA class I histocompatibility antigen Cw-3 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 272 | V | 0.331633 | M | 0.364234 | -0.032601 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 90 | K | 0.724488 | N | 0.696908 | 0.02758 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 101 | S | 0.610743 | N | 0.577677 | 0.033066 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 104 | N | 0.547178 | K | 0.590541 | -0.043363 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 119 | L | 0.666974 | F | 0.604217 | 0.062757 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 123 | S | 0.599994 | Y | 0.406219 | 0.193775 | D to O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 140 | S | 0.457448 | F | 0.260592 | 0.196856 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 180 | L | 0.417022 | D | 0.508512 | -0.09149 | O to D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 201 | E | 0.571538 | K | 0.56254 | 0.008998 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 331 | M | 0.344715 | K | 0.415928 | -0.071213 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 348 | A | 0.823595 | V | 0.746667 | 0.076928 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 363 | T | 0.965144 | A | 0.972631 | -0.007487 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 171 | L | 0.500501 | W | 0.411042 | 0.089459 | D to O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 187 | T | 0.293038 | L | 0.225316 | 0.067722 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 43 | E | 0.504963 | K | 0.501245 | 0.003718 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 73 | A | 0.733286 | E | 0.80921 | -0.075924 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 76 | V | 0.65972 | M | 0.71357 | -0.05385 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 97 | A | 0.668869 | T | 0.695613 | -0.026744 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 137 | Y | 0.468059 | H | 0.561467 | -0.093408 | O to D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 182 | A | 0.370445 | V | 0.265677 | 0.104768 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 272 | V | 0.393195 | M | 0.462199 | -0.069004 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 328 | V | 0.212096 | I | 0.179008 | 0.033088 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 330 | A | 0.335025 | V | 0.285593 | 0.049432 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 331 | M | 0.344715 | V | 0.289047 | 0.055668 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 10 | L | 0.141993 | I | 0.09856 | 0.043433 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 123 | S | 0.599994 | C | 0.429487 | 0.170507 | D to O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 123 | S | 0.599994 | F | 0.352363 | 0.247631 | D to O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 48 | S | 0.354617 | A | 0.265047 | 0.08957 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 48 | S | 0.354617 | P | 0.360499 | -0.005882 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 48 | S | 0.354617 | T | 0.290348 | 0.064269 | No Change: Both O | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 208 | P | 0.699447 | H | 0.693881 | 0.005566 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 208 | P | 0.699447 | R | 0.680793 | 0.018654 | No Change: Both D | - |
| P10321 | 1C07_HUMAN HLA class I histocompatibility antigen Cw-7 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=3 | 350 | C | 0.868478 | S | 0.929494 | -0.061016 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 5 | E | 0.543968 | A | 0.426828 | 0.11714 | D to O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 92 | N | 0.649167 | K | 0.674917 | -0.02575 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 138 | D | 0.290394 | N | 0.256336 | 0.034058 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 140 | Y | 0.272362 | F | 0.222753 | 0.049609 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 140 | Y | 0.272362 | S | 0.405662 | -0.1333 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 179 | E | 0.600835 | Q | 0.55249 | 0.048345 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 180 | R | 0.588214 | W | 0.381197 | 0.207017 | D to O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 202 | S | 0.618705 | T | 0.58726 | 0.031445 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 243 | W | 0.282566 | R | 0.457204 | -0.174638 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 272 | M | 0.364234 | V | 0.331633 | 0.032601 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 328 | V | 0.18478 | M | 0.218846 | -0.034066 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 364 | S | 0.990289 | C | 0.981735 | 0.008554 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 43 | E | 0.525615 | K | 0.528038 | -0.002423 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 73 | A | 0.717402 | E | 0.79951 | -0.082108 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 76 | V | 0.647993 | M | 0.703307 | -0.055314 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 90 | K | 0.661893 | N | 0.680789 | -0.018896 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 201 | E | 0.60855 | K | 0.600803 | 0.007747 | No Change: Both D | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.318027 | A | 0.226723 | 0.091304 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.318027 | P | 0.319045 | -0.001018 | No Change: Both O | - |
| P30499 | 1C01_HUMAN HLA class I histocompatibility antigen Cw-1 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.318027 | T | 0.253827 | 0.0642 | No Change: Both O | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 5 | E | 0.550989 | A | 0.430464 | 0.120525 | D to O | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 10 | I | 0.118046 | L | 0.172708 | -0.054662 | No Change: Both O | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 92 | N | 0.685662 | K | 0.715703 | -0.030041 | No Change: Both D | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 179 | E | 0.461424 | Q | 0.398375 | 0.063049 | No Change: Both O | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 202 | K | 0.648712 | T | 0.596613 | 0.052099 | No Change: Both D | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 364 | S | 0.990289 | C | 0.981735 | 0.008554 | No Change: Both D | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 137 | Y | 0.434288 | H | 0.532635 | -0.098347 | O to D | - |
| P30501 | 1C02_HUMAN HLA class I histocompatibility antigen Cw-2 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 272 | V | 0.381016 | M | 0.411569 | -0.030553 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 33 | S | 0.445864 | Y | 0.244974 | 0.20089 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 35 | S | 0.437307 | A | 0.297141 | 0.140166 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 38 | W | 0.450096 | R | 0.655022 | -0.204926 | O to D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 40 | G | 0.451859 | S | 0.513379 | -0.06152 | O to D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 45 | R | 0.285277 | H | 0.248891 | 0.036386 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 52 | V | 0.352384 | L | 0.298774 | 0.05361 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 73 | E | 0.784218 | A | 0.703404 | 0.080814 | No Change: Both D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 180 | R | 0.542985 | L | 0.410773 | 0.132212 | D to O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 327 | M | 0.243814 | V | 0.209366 | 0.034448 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 76 | V | 0.737532 | M | 0.781701 | -0.044169 | No Change: Both D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 90 | K | 0.738162 | N | 0.706084 | 0.032078 | No Change: Both D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 97 | A | 0.625347 | T | 0.658101 | -0.032754 | No Change: Both D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 182 | A | 0.48626 | V | 0.378346 | 0.107914 | No Change: Both O | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 201 | E | 0.575062 | K | 0.567018 | 0.008044 | No Change: Both D | - |
| P30504 | 1C04_HUMAN HLA class I histocompatibility antigen Cw-4 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 272 | V | 0.317573 | M | 0.350282 | -0.032709 | No Change: Both O | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 162 | T | 0.327381 | K | 0.392879 | -0.065498 | No Change: Both O | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 176 | T | 0.39131 | E | 0.482104 | -0.090794 | No Change: Both O | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 180 | L | 0.348262 | R | 0.480905 | -0.132643 | No Change: Both O | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 199 | G | 0.487191 | R | 0.524067 | -0.036876 | O to D | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 73 | A | 0.713203 | E | 0.790847 | -0.077644 | No Change: Both D | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 76 | V | 0.641999 | M | 0.697886 | -0.055887 | No Change: Both D | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 90 | K | 0.711521 | N | 0.683613 | 0.027908 | No Change: Both D | - |
| P30505 | 1C08_HUMAN HLA class I histocompatibility antigen Cw-8 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 272 | V | 0.361903 | M | 0.392655 | -0.030752 | No Change: Both O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 90 | K | 0.698406 | N | 0.670052 | 0.028354 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 97 | A | 0.602228 | T | 0.622486 | -0.020258 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 101 | S | 0.512038 | G | 0.471095 | 0.040943 | D to O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 101 | S | 0.512038 | N | 0.482128 | 0.02991 | D to O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 104 | N | 0.435686 | K | 0.476777 | -0.041091 | No Change: Both O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 121 | R | 0.365448 | W | 0.160759 | 0.204689 | No Change: Both O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 144 | G | 0.418245 | V | 0.280059 | 0.138186 | No Change: Both O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 180 | W | 0.326877 | R | 0.542985 | -0.216108 | O to D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 208 | H | 0.712047 | P | 0.718897 | -0.00685 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 363 | A | 0.979755 | T | 0.973661 | 0.006094 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 73 | A | 0.714621 | E | 0.790779 | -0.076158 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 76 | V | 0.642592 | M | 0.698333 | -0.055741 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 137 | Y | 0.434837 | H | 0.533268 | -0.098431 | O to D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 182 | A | 0.271977 | V | 0.187916 | 0.084061 | No Change: Both O | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 201 | E | 0.572404 | K | 0.568768 | 0.003636 | No Change: Both D | - |
| P30508 | 1C12_HUMAN HLA class I histocompatibility antigen Cw-12 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 272 | V | 0.381016 | M | 0.411569 | -0.030553 | No Change: Both O | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 45 | R | 0.398 | H | 0.349367 | 0.048633 | No Change: Both O | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 97 | T | 0.555735 | A | 0.537227 | 0.018508 | No Change: Both D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 101 | S | 0.435785 | N | 0.408833 | 0.026952 | No Change: Both O | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 73 | A | 0.715257 | E | 0.792431 | -0.077174 | No Change: Both D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 76 | V | 0.644398 | M | 0.699895 | -0.055497 | No Change: Both D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 90 | K | 0.681583 | N | 0.654221 | 0.027362 | No Change: Both D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 137 | Y | 0.430144 | H | 0.536428 | -0.106284 | O to D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 182 | A | 0.48626 | V | 0.378346 | 0.107914 | No Change: Both O | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 201 | E | 0.575062 | K | 0.567018 | 0.008044 | No Change: Both D | - |
| P30510 | 1C14_HUMAN HLA class I histocompatibility antigen Cw-14 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=2 | 272 | V | 0.331633 | M | 0.364234 | -0.032601 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 40 | G | 0.52956 | S | 0.575384 | -0.045824 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 45 | H | 0.311537 | R | 0.338501 | -0.026964 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 90 | N | 0.635777 | K | 0.675237 | -0.03946 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 97 | T | 0.530711 | A | 0.517156 | 0.013555 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 137 | H | 0.401085 | Y | 0.295749 | 0.105336 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 140 | L | 0.347429 | F | 0.302235 | 0.045194 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 140 | L | 0.347429 | S | 0.489736 | -0.142307 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 73 | A | 0.670661 | E | 0.761693 | -0.091032 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 76 | V | 0.619595 | M | 0.677347 | -0.057752 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 182 | A | 0.35118 | V | 0.254284 | 0.096896 | No Change: Both O | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 201 | E | 0.572704 | K | 0.567259 | 0.005445 | No Change: Both D | - |
| Q07000 | 1C15_HUMAN HLA class I histocompatibility antigen Cw-15 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 272 | V | 0.381016 | M | 0.411569 | -0.030553 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 319 | V | 0.057763 | A | 0.07706 | -0.019297 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 43 | E | 0.504963 | K | 0.501245 | 0.003718 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 73 | A | 0.724654 | E | 0.805806 | -0.081152 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 76 | V | 0.658853 | M | 0.713325 | -0.054472 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 90 | K | 0.71181 | N | 0.676086 | 0.035724 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 97 | A | 0.601106 | T | 0.629738 | -0.028632 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 182 | A | 0.48626 | V | 0.378346 | 0.107914 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 201 | E | 0.575062 | K | 0.567018 | 0.008044 | No Change: Both D | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 272 | V | 0.317573 | M | 0.350282 | -0.032709 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 10 | L | 0.141993 | I | 0.09856 | 0.043433 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.354617 | A | 0.265047 | 0.08957 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.354617 | P | 0.360499 | -0.005882 | No Change: Both O | - |
| Q29865 | 1C18_HUMAN HLA class I histocompatibility antigen Cw-18 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 48 | S | 0.354617 | T | 0.290348 | 0.064269 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 101 | S | 0.447749 | N | 0.420186 | 0.027563 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 104 | N | 0.373864 | K | 0.409429 | -0.035565 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 153 | H | 0.271417 | D | 0.357481 | -0.086064 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 157 | C | 0.356365 | W | 0.299001 | 0.057364 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 180 | Q | 0.490936 | W | 0.276181 | 0.214755 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 73 | A | 0.715257 | E | 0.792431 | -0.077174 | No Change: Both D | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 76 | V | 0.644398 | M | 0.699895 | -0.055497 | No Change: Both D | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 90 | K | 0.685282 | N | 0.657826 | 0.027456 | No Change: Both D | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 137 | Y | 0.42354 | H | 0.526326 | -0.102786 | O to D | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 182 | A | 0.444688 | V | 0.336775 | 0.107913 | No Change: Both O | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 201 | E | 0.575764 | K | 0.57207 | 0.003694 | No Change: Both D | - |
| Q29960 | 1C16_HUMAN HLA class I histocompatibility antigen Cw-16 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 272 | V | 0.381016 | M | 0.411569 | -0.030553 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 33 | D | 0.391436 | Y | 0.252137 | 0.139299 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 180 | W | 0.326877 | L | 0.410773 | -0.083896 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 43 | E | 0.503338 | K | 0.500524 | 0.002814 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 73 | A | 0.724654 | E | 0.805806 | -0.081152 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 76 | V | 0.658853 | M | 0.713325 | -0.054472 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 90 | K | 0.689741 | N | 0.654716 | 0.035025 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 97 | A | 0.546709 | T | 0.573205 | -0.026496 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 137 | Y | 0.427957 | H | 0.530563 | -0.102606 | O to D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 182 | A | 0.271977 | V | 0.187916 | 0.084061 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 201 | E | 0.572404 | K | 0.568768 | 0.003636 | No Change: Both D | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 272 | V | 0.381016 | M | 0.411569 | -0.030553 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 48 | S | 0.353762 | A | 0.264641 | 0.089121 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 48 | S | 0.353762 | P | 0.359619 | -0.005857 | No Change: Both O | - |
| Q29963 | 1C06_HUMAN HLA class I histocompatibility antigen Cw-6 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=2 | 48 | S | 0.353762 | T | 0.289667 | 0.064095 | No Change: Both O | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 10 | L | 0.112655 | I | 0.086431 | 0.026224 | No Change: Both O | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 24 | A | 0.214728 | T | 0.239899 | -0.025171 | No Change: Both O | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 73 | A | 0.707501 | E | 0.788488 | -0.080987 | No Change: Both D | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 76 | V | 0.643453 | M | 0.699405 | -0.055952 | No Change: Both D | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 90 | K | 0.683872 | N | 0.645888 | 0.037984 | No Change: Both D | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 97 | A | 0.558511 | T | 0.579116 | -0.020605 | No Change: Both D | - |
| Q95604 | 1C17_HUMAN HLA class I histocompatibility antigen Cw-17 alpha chain OS=Homo sapiens GN=HLA-C PE=1 SV=1 | 272 | V | 0.37805 | M | 0.408929 | -0.030879 | No Change: Both O | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 138 | N | 0.212659 | D | 0.244398 | -0.031739 | No Change: Both O | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 140 | F | 0.202151 | S | 0.378156 | -0.176005 | No Change: Both O | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 201 | K | 0.567018 | E | 0.575062 | -0.008044 | No Change: Both D | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 218 | V | 0.640754 | I | 0.60269 | 0.038064 | No Change: Both D | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 223 | A | 0.259488 | V | 0.213719 | 0.045769 | No Change: Both O | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 73 | A | 0.706044 | E | 0.78847 | -0.082426 | No Change: Both D | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 76 | V | 0.642738 | M | 0.698828 | -0.05609 | No Change: Both D | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 90 | K | 0.712641 | N | 0.676636 | 0.036005 | No Change: Both D | - |
| Q9TNN7 | 1C05_HUMAN HLA class I histocompatibility antigen Cw-5 alpha chain OS=Homo sapiens GN=HLA-C PE=2 SV=1 | 272 | V | 0.361903 | M | 0.392655 | -0.030752 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 162 | H | 0.246373 | Q | 0.246869 | -4.96E-04 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 163 | D | 0.263936 | H | 0.252081 | 0.011855 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 166 | V | 0.314314 | I | 0.273124 | 0.04119 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 181 | G | 0.218718 | A | 0.1888 | 0.029918 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 210 | R | 0.110465 | C | 0.054058 | 0.056407 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 210 | R | 0.110465 | H | 0.12021 | -0.009745 | No Change: Both O | - |
| P28067 | DMA_HUMAN HLA class II histocompatibility antigen DM alpha chain OS=Homo sapiens GN=HLA-DMA PE=1 SV=1 | 235 | V | 0.043557 | M | 0.053444 | -0.009887 | No Change: Both O | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 45 | S | 0.091621 | F | 0.039629 | 0.051992 | No Change: Both O | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 162 | A | 0.732718 | E | 0.795942 | -0.063224 | No Change: Both D | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 162 | A | 0.732718 | V | 0.661146 | 0.071572 | No Change: Both D | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 197 | I | 0.18178 | T | 0.29301 | -0.11123 | No Change: Both O | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 28 | T | 0.201366 | A | 0.1913 | 0.010066 | No Change: Both O | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 49 | D | 0.095969 | V | 0.042965 | 0.053004 | No Change: Both O | - |
| P28068 | DMB_HUMAN HLA class II histocompatibility antigen DM beta chain OS=Homo sapiens GN=HLA-DMB PE=1 SV=1 | 71 | S | 0.210178 | N | 0.193355 | 0.016823 | No Change: Both O | - |
| P06340 | DOA_HUMAN HLA class II histocompatibility antigen DO alpha chain OS=Homo sapiens GN=HLA-DOA PE=2 SV=1 | 99 | L | 0.285301 | V | 0.286381 | -0.00108 | No Change: Both O | - |
| P06340 | DOA_HUMAN HLA class II histocompatibility antigen DO alpha chain OS=Homo sapiens GN=HLA-DOA PE=2 SV=1 | 105 | R | 0.488169 | C | 0.294251 | 0.193918 | No Change: Both O | - |
| P13765 | DOB_HUMAN HLA class II histocompatibility antigen DO beta chain OS=Homo sapiens GN=HLA-DOB PE=2 SV=1 | 18 | R | 0.303957 | Q | 0.331077 | -0.02712 | No Change: Both O | - |
| P13765 | DOB_HUMAN HLA class II histocompatibility antigen DO beta chain OS=Homo sapiens GN=HLA-DOB PE=2 SV=1 | 244 | V | 0.032093 | I | 0.028708 | 0.003385 | No Change: Both O | - |
| P13765 | DOB_HUMAN HLA class II histocompatibility antigen DO beta chain OS=Homo sapiens GN=HLA-DOB PE=2 SV=1 | 234 | L | 0.019759 | F | 0.016576 | 0.003183 | No Change: Both O | - |
| P13765 | DOB_HUMAN HLA class II histocompatibility antigen DO beta chain OS=Homo sapiens GN=HLA-DOB PE=2 SV=1 | 210 | V | 0.446839 | I | 0.385263 | 0.061576 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 42 | A | 0.259423 | T | 0.2923 | -0.032877 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 42 | A | 0.259423 | V | 0.19598 | 0.063443 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 62 | M | 0.260956 | L | 0.210644 | 0.050312 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 81 | Q | 0.278383 | R | 0.251545 | 0.026838 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 97 | L | 0.205128 | S | 0.337106 | -0.131978 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 114 | T | 0.677308 | A | 0.64981 | 0.027498 | No Change: Both D | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 142 | K | 0.105156 | R | 0.083232 | 0.021924 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 191 | F | 0.197006 | V | 0.228869 | -0.031863 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 42 | A | 0.259423 | M | 0.229752 | 0.029671 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 49 | P | 0.328523 | T | 0.30067 | 0.027853 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 54 | M | 0.406269 | T | 0.467174 | -0.060905 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 59 | E | 0.339459 | D | 0.315928 | 0.023531 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 62 | M | 0.260956 | K | 0.380768 | -0.119812 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 74 | W | 0.212083 | C | 0.24985 | -0.037767 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 82 | A | 0.305405 | T | 0.319049 | -0.013644 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 100 | N | 0.253127 | D | 0.235712 | 0.017415 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 103 | T | 0.366673 | I | 0.249154 | 0.117519 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 104 | L | 0.413201 | A | 0.476218 | -0.063017 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 127 | P | 0.497982 | A | 0.387733 | 0.110249 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 158 | L | 0.174329 | P | 0.296982 | -0.122653 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 221 | T | 0.341048 | A | 0.302062 | 0.038986 | No Change: Both O | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 259 | T | 0.928909 | P | 0.918725 | 0.010184 | No Change: Both D | - |
| P20036 | DPA1_HUMAN HLA class II histocompatibility antigen DP alpha 1 chain OS=Homo sapiens GN=HLA-DPA1 PE=1 SV=1 | 62 | M | 0.260956 | Q | 0.326698 | -0.065742 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 38 | F | 0.236953 | Y | 0.281297 | -0.044344 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 40 | G | 0.201189 | V | 0.116448 | 0.084741 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 62 | E | 0.286256 | Q | 0.236371 | 0.049885 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 64 | F | 0.334221 | Y | 0.370152 | -0.035931 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 65 | A | 0.333534 | V | 0.268881 | 0.064653 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 85 | A | 0.310268 | E | 0.41417 | -0.103902 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 86 | E | 0.29964 | D | 0.273637 | 0.026003 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 98 | K | 0.475322 | E | 0.493973 | -0.018651 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 98 | K | 0.475322 | R | 0.455959 | 0.019363 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 105 | M | 0.440839 | V | 0.378017 | 0.062822 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 105 | M | 0.440839 | I | 0.333282 | 0.107557 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 114 | G | 0.503086 | E | 0.570869 | -0.067783 | No Change: Both D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 115 | P | 0.506891 | A | 0.386867 | 0.120024 | D to O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 116 | M | 0.507417 | V | 0.442661 | 0.064756 | D to O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 207 | L | 0.45876 | M | 0.530785 | -0.072025 | O to D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 244 | I | 0.097753 | T | 0.161516 | -0.063763 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 223 | R | 0.700744 | Q | 0.722858 | -0.022114 | No Change: Both D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 234 | V | 0.076097 | M | 0.104875 | -0.028778 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 84 | A | 0.326716 | D | 0.393483 | -0.066767 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 84 | A | 0.326716 | V | 0.248295 | 0.078421 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 94 | I | 0.425709 | F | 0.438653 | -0.012944 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 94 | I | 0.425709 | L | 0.48447 | -0.058761 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 16 | T | 0.119414 | M | 0.106934 | 0.01248 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 24 | T | 0.115755 | I | 0.055536 | 0.060219 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 30 | R | 0.321872 | P | 0.37786 | -0.055988 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 31 | A | 0.327154 | L | 0.266493 | 0.060661 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 32 | T | 0.341042 | P | 0.403231 | -0.062189 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 33 | P | 0.357757 | A | 0.297737 | 0.06002 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 37 | L | 0.279816 | V | 0.281128 | -0.001312 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 38 | F | 0.236953 | H | 0.379232 | -0.142279 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 38 | F | 0.236953 | D | 0.412623 | -0.17567 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 38 | F | 0.236953 | L | 0.271972 | -0.035019 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 40 | G | 0.201189 | L | 0.124478 | 0.076711 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 41 | R | 0.199305 | L | 0.126512 | 0.072793 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 44 | C | 0.193693 | G | 0.378184 | -0.184491 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 46 | A | 0.188328 | P | 0.255327 | -0.066999 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 46 | A | 0.188328 | T | 0.223512 | -0.035184 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 57 | Y | 0.208781 | D | 0.327 | -0.118219 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 61 | R | 0.280647 | P | 0.285758 | -0.005111 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 64 | F | 0.334221 | L | 0.344696 | -0.010475 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 68 | D | 0.381155 | Y | 0.23311 | 0.148045 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 72 | G | 0.327994 | W | 0.157101 | 0.170893 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 84 | A | 0.326716 | E | 0.436379 | -0.109663 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 86 | E | 0.29964 | V | 0.149763 | 0.149877 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 89 | N | 0.321781 | H | 0.301361 | 0.02042 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 93 | D | 0.393762 | H | 0.355607 | 0.038155 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 94 | I | 0.425709 | N | 0.587166 | -0.161457 | O to D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 99 | R | 0.453497 | W | 0.252663 | 0.200834 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 101 | V | 0.435134 | L | 0.454876 | -0.019742 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 102 | P | 0.439905 | L | 0.297173 | 0.142732 | No Change: Both O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 113 | G | 0.52263 | N | 0.550055 | -0.027425 | No Change: Both D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 113 | G | 0.52263 | V | 0.407434 | 0.115196 | D to O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 113 | G | 0.52263 | D | 0.548 | -0.02537 | No Change: Both D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 120 | R | 0.51986 | H | 0.478198 | 0.041662 | D to O | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 125 | R | 0.596928 | K | 0.625801 | -0.028873 | No Change: Both D | - |
| P04440 | DPB1_HUMAN HLA class II histocompatibility antigen DP beta 1 chain OS=Homo sapiens GN=HLA-DPB1 PE=1 SV=1 | 199 | T | 0.29168 | I | 0.163433 | 0.128247 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 57 | Q | 0.338562 | E | 0.410337 | -0.071775 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 8 | M | 0.157058 | L | 0.128353 | 0.028705 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 11 | A | 0.122379 | T | 0.138965 | -0.016586 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 41 | S | 0.468486 | F | 0.222662 | 0.245824 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 48 | Y | 0.606426 | F | 0.567422 | 0.039004 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 49 | T | 0.601656 | S | 0.690611 | -0.088955 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 70 | C | 0.048506 | Y | 0.06007 | -0.011564 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 73 | V | 0.04369 | L | 0.044724 | -0.001034 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 73 | V | 0.04369 | D | 0.089589 | -0.045899 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 78 | R | 0.126797 | S | 0.155366 | -0.028569 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 86 | T | 0.102605 | R | 0.112533 | -0.009928 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 88 | I | 0.12326 | M | 0.182052 | -0.058792 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 91 | L | 0.179686 | V | 0.175633 | 0.004053 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 229 | V | 0.068223 | M | 0.081018 | -0.012795 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 237 | F | 0.043892 | L | 0.058837 | -0.014945 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 240 | R | 0.106594 | Q | 0.106318 | 2.76E-04 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 17 | V | 0.183552 | M | 0.250297 | -0.066745 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 18 | M | 0.201946 | T | 0.260243 | -0.058297 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 25 | D | 0.373179 | G | 0.350705 | 0.022474 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 64 | R | 0.132706 | K | 0.184765 | -0.052059 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 102 | S | 0.59659 | Y | 0.413235 | 0.183355 | D to O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 129 | I | 0.083988 | T | 0.146072 | -0.062084 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 151 | H | 0.415512 | Q | 0.427999 | -0.012487 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 209 | A | 0.534776 | T | 0.582303 | -0.047527 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 221 | A | 0.085065 | T | 0.106186 | -0.021121 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 24 | E | 0.403215 | K | 0.402489 | 7.26E-04 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 34 | Y | 0.206781 | C | 0.158109 | 0.048672 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 44 | P | 0.577902 | L | 0.409232 | 0.16867 | D to O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 63 | G | 0.154154 | E | 0.201861 | -0.047707 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 67 | T | 0.092206 | A | 0.080476 | 0.01173 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 68 | V | 0.073733 | A | 0.095012 | -0.021279 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 70 | C | 0.048506 | K | 0.142248 | -0.093742 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 70 | C | 0.048506 | Q | 0.116962 | -0.068456 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 70 | C | 0.048506 | R | 0.112615 | -0.064109 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 71 | L | 0.040502 | W | 0.02721 | 0.013292 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 73 | V | 0.04369 | E | 0.098647 | -0.054957 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 74 | L | 0.047713 | F | 0.043439 | 0.004274 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 75 | R | 0.058754 | H | 0.054429 | 0.004325 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 75 | R | 0.058754 | S | 0.072521 | -0.013767 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 76 | Q | 0.078092 | K | 0.088661 | -0.010569 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 76 | Q | 0.078092 | R | 0.074692 | 0.0034 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 77 | F | 0.103469 | L | 0.116665 | -0.013196 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 81 | P | 0.153648 | R | 0.141186 | 0.012462 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 83 | F | 0.117387 | G | 0.20184 | -0.084453 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 91 | L | 0.179686 | A | 0.23342 | -0.053734 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 91 | L | 0.179686 | T | 0.256271 | -0.076585 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 97 | S | 0.454113 | I | 0.246676 | 0.207437 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 98 | L | 0.519822 | M | 0.561068 | -0.041246 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 98 | L | 0.519822 | V | 0.509515 | 0.010307 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 101 | R | 0.591474 | C | 0.448472 | 0.143002 | D to O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 124 | L | 0.252567 | V | 0.259692 | -0.007125 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 152 | S | 0.510131 | A | 0.376007 | 0.134124 | D to O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 160 | T | 0.694253 | I | 0.550089 | 0.144164 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 161 | S | 0.672265 | R | 0.594007 | 0.078258 | No Change: Both D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 161 | S | 0.672265 | I | 0.429573 | 0.242692 | D to O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 175 | Y | 0.226015 | H | 0.355166 | -0.129151 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 178 | L | 0.30072 | F | 0.272953 | 0.027767 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 182 | A | 0.439389 | D | 0.543077 | -0.103688 | O to D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 182 | A | 0.439389 | S | 0.581153 | -0.141764 | O to D | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 183 | E | 0.454834 | D | 0.430611 | 0.024223 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 185 | S | 0.44954 | I | 0.256578 | 0.192962 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 197 | K | 0.340026 | E | 0.34648 | -0.006454 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 197 | K | 0.340026 | Q | 0.27525 | 0.064776 | No Change: Both O | - |
| P01909 | DQA1_HUMAN HLA class II histocompatibility antigen DQ alpha 1 chain OS=Homo sapiens GN=HLA-DQA1 PE=1 SV=1 | 230 | G | 0.061153 | C | 0.024897 | 0.036256 | No Change: Both O | - |
| P01906 | DQA2_HUMAN HLA class II histocompatibility antigen DQ alpha 2 chain OS=Homo sapiens GN=HLA-DQA2 PE=2 SV=2 | 227 | V | 0.079172 | A | 0.108404 | -0.029232 | No Change: Both O | - |
| P01906 | DQA2_HUMAN HLA class II histocompatibility antigen DQ alpha 2 chain OS=Homo sapiens GN=HLA-DQA2 PE=2 SV=2 | 247 | G | 0.492605 | D | 0.506287 | -0.013682 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 6 | A | 0.443806 | S | 0.526248 | -0.082442 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 148 | V | 0.125887 | I | 0.106217 | 0.01967 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 194 | E | 0.172821 | D | 0.163944 | 0.008877 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 197 | P | 0.277926 | L | 0.175371 | 0.102555 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 45 | A | 0.07 | G | 0.090009 | -0.020009 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 46 | M | 0.071429 | L | 0.051287 | 0.020142 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 256 | Q | 0.6555 | R | 0.652557 | 0.002943 | No Change: Both D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 12 | G | 0.257526 | D | 0.267485 | -0.009959 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 15 | A | 0.202071 | V | 0.141231 | 0.06084 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 23 | A | 0.164816 | S | 0.245787 | -0.080971 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 24 | M | 0.185121 | I | 0.115354 | 0.069767 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 27 | T | 0.325594 | A | 0.316408 | 0.009186 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 27 | T | 0.325594 | S | 0.414272 | -0.088678 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 28 | P | 0.413458 | L | 0.275997 | 0.137461 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 28 | P | 0.413458 | S | 0.457212 | -0.043754 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 29 | V | 0.499669 | L | 0.520667 | -0.020998 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 35 | S | 0.588891 | P | 0.57214 | 0.016751 | No Change: Both D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 41 | Y | 0.143532 | F | 0.135279 | 0.008253 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 41 | Y | 0.143532 | L | 0.137146 | 0.006386 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 43 | F | 0.087048 | L | 0.08929 | -0.002242 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 55 | R | 0.231479 | L | 0.132634 | 0.098845 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 58 | Y | 0.163977 | G | 0.245193 | -0.081216 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 58 | Y | 0.163977 | L | 0.145341 | 0.018636 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 59 | V | 0.163574 | L | 0.150233 | 0.013341 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 60 | T | 0.154122 | S | 0.196975 | -0.042853 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 62 | Y | 0.164968 | H | 0.227072 | -0.062104 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 62 | Y | 0.164968 | S | 0.281279 | -0.116311 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 69 | Y | 0.371211 | D | 0.540231 | -0.16902 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 69 | Y | 0.371211 | I | 0.325434 | 0.045777 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 70 | A | 0.36058 | T | 0.392726 | -0.032146 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 70 | A | 0.36058 | V | 0.293909 | 0.066671 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 77 | E | 0.259025 | G | 0.210365 | 0.04866 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 78 | V | 0.244603 | E | 0.40732 | -0.162717 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 79 | Y | 0.24481 | F | 0.227096 | 0.017714 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 81 | A | 0.240687 | V | 0.198584 | 0.042103 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 84 | P | 0.301328 | L | 0.167301 | 0.134027 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 85 | L | 0.335117 | Q | 0.47898 | -0.143863 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 87 | P | 0.385402 | L | 0.227582 | 0.15782 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 87 | P | 0.385402 | Q | 0.3473 | 0.038102 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 87 | P | 0.385402 | R | 0.338492 | 0.04691 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 88 | P | 0.413353 | L | 0.250423 | 0.16293 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 89 | D | 0.447358 | A | 0.380798 | 0.06656 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 89 | D | 0.447358 | S | 0.486809 | -0.039451 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 89 | D | 0.447358 | V | 0.292246 | 0.155112 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 92 | Y | 0.413046 | N | 0.562452 | -0.149406 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 94 | N | 0.393753 | K | 0.447072 | -0.053319 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 95 | S | 0.411348 | R | 0.404114 | 0.007234 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 98 | E | 0.440047 | D | 0.399521 | 0.040526 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 99 | V | 0.458944 | D | 0.589128 | -0.130184 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 99 | V | 0.458944 | I | 0.415129 | 0.043815 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 102 | R | 0.452405 | E | 0.503738 | -0.051333 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 102 | R | 0.452405 | G | 0.417113 | 0.035292 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 103 | T | 0.455721 | A | 0.422138 | 0.033583 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 103 | T | 0.455721 | D | 0.497211 | -0.04149 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 103 | T | 0.455721 | K | 0.508805 | -0.053084 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 106 | E | 0.434124 | A | 0.320016 | 0.114108 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 106 | E | 0.434124 | S | 0.409984 | 0.02414 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 107 | L | 0.444895 | V | 0.443816 | 0.001079 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 109 | T | 0.43393 | R | 0.47439 | -0.04046 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 116 | Q | 0.449574 | E | 0.501899 | -0.052325 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 117 | L | 0.480517 | V | 0.462321 | 0.018196 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 118 | E | 0.464857 | A | 0.342444 | 0.122413 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 118 | E | 0.464857 | G | 0.355011 | 0.109846 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 119 | L | 0.453763 | F | 0.372595 | 0.081168 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 119 | L | 0.453763 | Y | 0.421853 | 0.03191 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 121 | T | 0.471342 | G | 0.429118 | 0.042224 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 122 | T | 0.456067 | I | 0.280386 | 0.175681 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 157 | A | 0.088404 | G | 0.111862 | -0.023458 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 157 | A | 0.088404 | S | 0.146126 | -0.057722 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 158 | Q | 0.089352 | H | 0.08209 | 0.007262 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 162 | R | 0.118219 | Q | 0.1309 | -0.012681 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 165 | R | 0.264877 | W | 0.124982 | 0.139895 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 165 | R | 0.264877 | Q | 0.28487 | -0.019993 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 167 | D | 0.412819 | G | 0.399476 | 0.013343 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 168 | Q | 0.473225 | E | 0.54563 | -0.072405 | O to D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 172 | T | 0.491823 | A | 0.438043 | 0.05378 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 199 | H | 0.323746 | R | 0.310062 | 0.013684 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 202 | V | 0.351936 | I | 0.306435 | 0.045501 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 214 | N | 0.373615 | S | 0.437991 | -0.064376 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 217 | T | 0.293453 | I | 0.18536 | 0.108093 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 218 | V | 0.289214 | A | 0.390105 | -0.100891 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 229 | S | 0.72152 | N | 0.668606 | 0.052914 | No Change: Both D | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 235 | I | 0.212772 | V | 0.244675 | -0.031903 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 252 | H | 0.208678 | R | 0.209877 | -0.001199 | No Change: Both O | - |
| P01920 | DQB1_HUMAN HLA class II histocompatibility antigen DQ beta 1 chain OS=Homo sapiens GN=HLA-DQB1 PE=1 SV=2 | 253 | H | 0.301996 | Q | 0.30974 | -0.007744 | No Change: Both O | - |
| P01903 | DRA_HUMAN HLA class II histocompatibility antigen DR alpha chain OS=Homo sapiens GN=HLA-DRA PE=1 SV=1 | 242 | V | 0.270928 | L | 0.270454 | 4.74E-04 | No Change: Both O | - |
| P01903 | DRA_HUMAN HLA class II histocompatibility antigen DR alpha chain OS=Homo sapiens GN=HLA-DRA PE=1 SV=1 | 16 | V | 0.0383 | L | 0.040625 | -0.002325 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 59 | Y | 0.233711 | H | 0.320408 | -0.086697 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 96 | I | 0.333447 | F | 0.332825 | 6.22E-04 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 115 | V | 0.232493 | G | 0.342953 | -0.11046 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 5 | K | 0.525831 | R | 0.519519 | 0.006312 | No Change: Both D | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 55 | F | 0.200788 | Y | 0.196784 | 0.004004 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 106 | T | 0.183594 | N | 0.220837 | -0.037243 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 164 | G | 0.302507 | S | 0.341932 | -0.039425 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 169 | A | 0.516579 | T | 0.553939 | -0.03736 | No Change: Both D | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 236 | V | 0.093991 | M | 0.125133 | -0.031142 | No Change: Both O | - |
| P01911 | 2B1F_HUMAN HLA class II histocompatibility antigen DRB1-15 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| P01912 | 2B13_HUMAN HLA class II histocompatibility antigen DRB1-3 chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 55 | Y | 0.268043 | F | 0.279967 | -0.011924 | No Change: Both O | - |
| P01912 | 2B13_HUMAN HLA class II histocompatibility antigen DRB1-3 chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 106 | N | 0.31737 | T | 0.275013 | 0.042357 | No Change: Both O | - |
| P01912 | 2B13_HUMAN HLA class II histocompatibility antigen DRB1-3 chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 164 | G | 0.42553 | S | 0.468926 | -0.043396 | No Change: Both O | - |
| P01912 | 2B13_HUMAN HLA class II histocompatibility antigen DRB1-3 chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 169 | T | 0.555143 | A | 0.519386 | 0.035757 | No Change: Both D | - |
| P01912 | 2B13_HUMAN HLA class II histocompatibility antigen DRB1-3 chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 236 | V | 0.097936 | M | 0.131202 | -0.033266 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 96 | L | 0.395858 | I | 0.354794 | 0.041064 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 99 | Q | 0.359329 | D | 0.381226 | -0.021897 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 100 | R | 0.336966 | E | 0.38259 | -0.045624 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 106 | T | 0.223548 | N | 0.260275 | -0.036727 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 114 | V | 0.31303 | A | 0.362248 | -0.049218 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 115 | G | 0.341802 | V | 0.238751 | 0.103051 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 253 | Q | 0.347257 | E | 0.386087 | -0.03883 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 39 | Q | 0.074687 | E | 0.098856 | -0.024169 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 74 | G | 0.385786 | R | 0.407467 | -0.021681 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 100 | R | 0.336966 | A | 0.302934 | 0.034032 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 13 | T | 0.191952 | A | 0.163758 | 0.028194 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 29 | A | 0.349377 | S | 0.458198 | -0.108821 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 33 | R | 0.192967 | K | 0.232218 | -0.039251 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 33 | R | 0.192967 | Q | 0.204091 | -0.011124 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 66 | S | 0.462009 | Y | 0.27469 | 0.187319 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 76 | Y | 0.356031 | F | 0.339683 | 0.016348 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 89 | Y | 0.372291 | S | 0.56342 | -0.191129 | O to D | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 99 | Q | 0.359329 | E | 0.398113 | -0.038784 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 99 | Q | 0.359329 | H | 0.333339 | 0.02599 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 102 | A | 0.257309 | G | 0.291583 | -0.034274 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 103 | A | 0.245782 | E | 0.343503 | -0.097721 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 107 | Y | 0.215467 | H | 0.304664 | -0.089197 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 164 | G | 0.406635 | D | 0.420992 | -0.014357 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 169 | A | 0.509391 | T | 0.544999 | -0.035608 | No Change: Both D | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 171 | V | 0.38934 | M | 0.438479 | -0.049139 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 178 | Q | 0.187419 | H | 0.169056 | 0.018363 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 195 | R | 0.332155 | Q | 0.359978 | -0.027823 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 210 | T | 0.479916 | I | 0.30669 | 0.173226 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 236 | V | 0.093991 | M | 0.125133 | -0.031142 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 5 | K | 0.48615 | R | 0.468033 | 0.018117 | No Change: Both O | - |
| P04229 | 2B11_HUMAN HLA class II histocompatibility antigen DRB1-1 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | D | 0.389679 | S | 0.42703 | -0.037351 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | L | 0.445768 | I | 0.403722 | 0.042046 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 99 | Q | 0.416092 | D | 0.439201 | -0.023109 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | K | 0.388359 | E | 0.389703 | -0.001344 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | K | 0.388359 | R | 0.339299 | 0.04906 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | A | 0.254767 | E | 0.354849 | -0.100082 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | G | 0.334585 | V | 0.223785 | 0.1108 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 5 | K | 0.390562 | R | 0.355535 | 0.035027 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 236 | V | 0.096686 | M | 0.130285 | -0.033599 | No Change: Both O | - |
| P13760 | 2B14_HUMAN HLA class II histocompatibility antigen DRB1-4 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 58 | R | 0.146467 | S | 0.176105 | -0.029638 | No Change: Both O | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 106 | T | 0.3007 | N | 0.34528 | -0.04458 | No Change: Both O | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 107 | V | 0.279422 | Y | 0.267134 | 0.012288 | No Change: Both O | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 5 | K | 0.459146 | R | 0.421816 | 0.03733 | No Change: Both O | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 236 | V | 0.095025 | M | 0.128636 | -0.033611 | No Change: Both O | - |
| P13761 | 2B17_HUMAN HLA class II histocompatibility antigen DRB1-7 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| P20039 | 2B1B_HUMAN HLA class II histocompatibility antigen DRB1-11 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | R | 0.338101 | E | 0.384295 | -0.046194 | No Change: Both O | - |
| P20039 | 2B1B_HUMAN HLA class II histocompatibility antigen DRB1-11 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | G | 0.337713 | V | 0.234238 | 0.103475 | No Change: Both O | - |
| P20039 | 2B1B_HUMAN HLA class II histocompatibility antigen DRB1-11 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 55 | F | 0.178327 | Y | 0.184738 | -0.006411 | No Change: Both O | - |
| P20039 | 2B1B_HUMAN HLA class II histocompatibility antigen DRB1-11 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 236 | V | 0.097936 | M | 0.131202 | -0.033266 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 42 | R | 0.209361 | K | 0.254786 | -0.045425 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 43 | E | 0.196982 | K | 0.20184 | -0.004858 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 56 | L | 0.175791 | P | 0.31468 | -0.138889 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | S | 0.49269 | N | 0.451492 | 0.041198 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 76 | Y | 0.360676 | F | 0.352847 | 0.007829 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | F | 0.369341 | I | 0.368413 | 9.28E-04 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | F | 0.369341 | L | 0.409673 | -0.040332 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 101 | R | 0.296191 | A | 0.26082 | 0.035371 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | A | 0.247666 | L | 0.184943 | 0.062723 | No Change: Both O | - |
| Q29974 | 2B1G_HUMAN HLA class II histocompatibility antigen DRB1-16 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| Q30134 | 2B18_HUMAN HLA class II histocompatibility antigen DRB1-8 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 86 | S | 0.42265 | D | 0.386098 | 0.036552 | No Change: Both O | - |
| Q30134 | 2B18_HUMAN HLA class II histocompatibility antigen DRB1-8 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 96 | F | 0.359254 | I | 0.361681 | -0.002427 | No Change: Both O | - |
| Q30134 | 2B18_HUMAN HLA class II histocompatibility antigen DRB1-8 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 115 | G | 0.337629 | V | 0.230116 | 0.107513 | No Change: Both O | - |
| Q30134 | 2B18_HUMAN HLA class II histocompatibility antigen DRB1-8 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 236 | V | 0.099411 | M | 0.132779 | -0.033368 | No Change: Both O | - |
| Q30134 | 2B18_HUMAN HLA class II histocompatibility antigen DRB1-8 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| Q30167 | 2B1A_HUMAN HLA class II histocompatibility antigen DRB1-10 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 236 | V | 0.097113 | M | 0.131938 | -0.034825 | No Change: Both O | - |
| Q30167 | 2B1A_HUMAN HLA class II histocompatibility antigen DRB1-10 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=2 | 262 | T | 0.854121 | R | 0.84519 | 0.008931 | No Change: Both D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 39 | Y | 0.380066 | L | 0.401331 | -0.021265 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 40 | S | 0.370242 | L | 0.203484 | 0.166758 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 41 | T | 0.336964 | K | 0.398504 | -0.06154 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 42 | S | 0.320111 | G | 0.262703 | 0.057408 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 45 | H | 0.302805 | Y | 0.212358 | 0.090447 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 45 | H | 0.302805 | Q | 0.327497 | -0.024692 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 54 | R | 0.283131 | L | 0.17064 | 0.112491 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 55 | F | 0.279967 | Y | 0.268043 | 0.011924 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 56 | L | 0.288036 | Q | 0.431334 | -0.143298 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 57 | D | 0.300366 | E | 0.346526 | -0.04616 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 61 | H | 0.346654 | Y | 0.259629 | 0.087025 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | N | 0.557539 | Y | 0.411233 | 0.146306 | D to O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | N | 0.557539 | F | 0.39171 | 0.165829 | D to O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | N | 0.557539 | S | 0.594789 | -0.03725 | No Change: Both D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | N | 0.557539 | D | 0.579266 | -0.021727 | No Change: Both D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | N | 0.557539 | I | 0.361229 | 0.19631 | D to O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 67 | V | 0.528999 | L | 0.514377 | 0.014622 | No Change: Both D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 76 | F | 0.340582 | Y | 0.353086 | -0.012504 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 77 | R | 0.322057 | L | 0.207954 | 0.114103 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 77 | R | 0.322057 | W | 0.142706 | 0.179351 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 79 | V | 0.338972 | L | 0.340756 | -0.001784 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | D | 0.385922 | S | 0.420882 | -0.03496 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | D | 0.385922 | V | 0.240233 | 0.145689 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | D | 0.385922 | A | 0.318672 | 0.06725 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 89 | Y | 0.344833 | S | 0.536448 | -0.191615 | O to D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 89 | Y | 0.344833 | H | 0.463024 | -0.118191 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | I | 0.406022 | F | 0.404089 | 0.001933 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | I | 0.406022 | L | 0.445332 | -0.03931 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 97 | L | 0.420354 | R | 0.523567 | -0.103213 | O to D | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 99 | D | 0.404857 | Q | 0.380753 | 0.024104 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | E | 0.38495 | R | 0.331203 | 0.053747 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | E | 0.38495 | K | 0.382385 | 0.002565 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | E | 0.38495 | A | 0.300202 | 0.084748 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | A | 0.265606 | L | 0.1981 | 0.067506 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | A | 0.265606 | E | 0.3717 | -0.106094 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 106 | T | 0.207627 | N | 0.248291 | -0.040664 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 113 | G | 0.172387 | R | 0.193188 | -0.020801 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 114 | V | 0.209816 | A | 0.250879 | -0.041063 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | V | 0.230757 | G | 0.341526 | -0.110769 | No Change: Both O | - |
| Q5Y7A7 | 2B1D_HUMAN HLA class II histocompatibility antigen DRB1-13 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | V | 0.230757 | D | 0.351182 | -0.120425 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 5 | R | 0.4062 | K | 0.438064 | -0.031864 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 13 | A | 0.174727 | T | 0.227383 | -0.052656 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 14 | V | 0.164125 | A | 0.221246 | -0.057121 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 14 | V | 0.164125 | I | 0.113196 | 0.050929 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 54 | R | 0.342171 | L | 0.230562 | 0.111609 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 55 | L | 0.362175 | F | 0.345629 | 0.016546 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | L | 0.487952 | F | 0.465407 | 0.022545 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 67 | L | 0.429096 | V | 0.425884 | 0.003212 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 76 | F | 0.357639 | L | 0.391771 | -0.034132 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | V | 0.393892 | D | 0.538313 | -0.144421 | O to D | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 87 | A | 0.383181 | E | 0.493095 | -0.109914 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 88 | E | 0.387243 | Q | 0.349117 | 0.038126 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 89 | S | 0.407897 | Y | 0.223314 | 0.184583 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | I | 0.453485 | F | 0.451748 | 0.001737 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | I | 0.453485 | L | 0.490535 | -0.03705 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 98 | E | 0.377522 | G | 0.33365 | 0.043872 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 114 | A | 0.251391 | V | 0.21187 | 0.039521 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | V | 0.272815 | G | 0.391459 | -0.118644 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 125 | H | 0.364185 | E | 0.42749 | -0.063305 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 169 | T | 0.555143 | A | 0.519386 | 0.035757 | No Change: Both D | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 178 | H | 0.175422 | Q | 0.196355 | -0.020933 | No Change: Both O | - |
| Q95IE3 | 2B1C_HUMAN HLA class II histocompatibility antigen DRB1-12 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 262 | R | 0.836507 | T | 0.842783 | -0.006276 | No Change: Both D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 39 | Y | 0.379737 | Q | 0.523548 | -0.143811 | O to D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 39 | Y | 0.379737 | L | 0.398719 | -0.018982 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 40 | S | 0.369193 | R | 0.314093 | 0.0551 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 40 | S | 0.369193 | V | 0.189066 | 0.180127 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 40 | S | 0.369193 | P | 0.341557 | 0.027636 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 41 | T | 0.334137 | K | 0.398994 | -0.064857 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 42 | S | 0.315334 | H | 0.255775 | 0.059559 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 42 | S | 0.315334 | G | 0.258544 | 0.05679 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 45 | H | 0.294384 | Y | 0.205075 | 0.089309 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 45 | H | 0.294384 | Q | 0.31686 | -0.022476 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 54 | R | 0.237448 | Q | 0.222857 | 0.014591 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 55 | F | 0.232795 | Y | 0.233323 | -5.28E-04 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 56 | L | 0.238975 | M | 0.293455 | -0.05448 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 57 | D | 0.240985 | E | 0.284211 | -0.043226 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 59 | Y | 0.251261 | H | 0.371935 | -0.120674 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 61 | H | 0.250885 | Y | 0.176131 | 0.074754 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | F | 0.383936 | Y | 0.404525 | -0.020589 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 66 | F | 0.383936 | N | 0.54327 | -0.159334 | O to D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 67 | V | 0.355818 | L | 0.343394 | 0.012424 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 74 | G | 0.333757 | R | 0.364507 | -0.03075 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 76 | Y | 0.347137 | F | 0.35085 | -0.003713 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 80 | T | 0.367723 | R | 0.426774 | -0.059051 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | A | 0.433528 | D | 0.49857 | -0.065042 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | A | 0.433528 | S | 0.530748 | -0.09722 | O to D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | A | 0.433528 | T | 0.456754 | -0.023226 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 86 | A | 0.433528 | V | 0.348621 | 0.084907 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 87 | A | 0.413291 | E | 0.511297 | -0.098006 | O to D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 89 | H | 0.437602 | Y | 0.319431 | 0.118171 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 89 | H | 0.437602 | S | 0.517142 | -0.07954 | O to D | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | L | 0.491887 | F | 0.448191 | 0.043696 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 96 | L | 0.491887 | I | 0.450158 | 0.041729 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 99 | R | 0.411623 | Q | 0.416576 | -0.004953 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 99 | R | 0.411623 | D | 0.438545 | -0.026922 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | R | 0.402984 | K | 0.438423 | -0.035439 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | R | 0.402984 | E | 0.45053 | -0.047546 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 100 | R | 0.402984 | A | 0.354128 | 0.048856 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 102 | A | 0.362373 | S | 0.47144 | -0.109067 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 102 | A | 0.362373 | G | 0.415896 | -0.053523 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | E | 0.359054 | A | 0.259913 | 0.099141 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | E | 0.359054 | L | 0.197409 | 0.161645 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 103 | E | 0.359054 | R | 0.318281 | 0.040773 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 106 | T | 0.290595 | N | 0.331336 | -0.040741 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 106 | T | 0.290595 | A | 0.275407 | 0.015188 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 110 | H | 0.199356 | Y | 0.137698 | 0.061658 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 114 | V | 0.22797 | A | 0.266497 | -0.038527 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | V | 0.242632 | G | 0.347606 | -0.104974 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 115 | V | 0.242632 | M | 0.274052 | -0.03142 | No Change: Both O | - |
| Q9GIY3 | 2B1E_HUMAN HLA class II histocompatibility antigen DRB1-14 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 141 | Y | 0.177742 | H | 0.283062 | -0.10532 | No Change: Both O | - |
| Q9TQE0 | 2B19_HUMAN HLA class II histocompatibility antigen DRB1-9 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 5 | K | 0.471203 | R | 0.432144 | 0.039059 | No Change: Both O | - |
| Q9TQE0 | 2B19_HUMAN HLA class II histocompatibility antigen DRB1-9 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 236 | V | 0.095025 | M | 0.128636 | -0.033611 | No Change: Both O | - |
| Q9TQE0 | 2B19_HUMAN HLA class II histocompatibility antigen DRB1-9 beta chain OS=Homo sapiens GN=HLA-DRB1 PE=1 SV=1 | 262 | T | 0.842783 | R | 0.836507 | 0.006276 | No Change: Both D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 40 | R | 0.383779 | C | 0.230883 | 0.152896 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 102 | G | 0.407452 | A | 0.353407 | 0.054045 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 114 | V | 0.325051 | A | 0.370482 | -0.045431 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 236 | V | 0.089098 | M | 0.118022 | -0.028924 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 37 | L | 0.377811 | S | 0.561774 | -0.183963 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 38 | E | 0.383997 | Q | 0.321416 | 0.062581 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 39 | L | 0.384844 | Y | 0.369149 | 0.015695 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 40 | R | 0.383779 | L | 0.26382 | 0.119959 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 40 | R | 0.383779 | S | 0.437912 | -0.054133 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 41 | K | 0.351034 | T | 0.300072 | 0.050962 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 55 | Y | 0.247128 | L | 0.266686 | -0.019558 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 55 | Y | 0.247128 | F | 0.258224 | -0.011096 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 57 | D | 0.251253 | E | 0.294833 | -0.04358 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 57 | D | 0.251253 | N | 0.247512 | 0.003741 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 58 | R | 0.242745 | I | 0.110664 | 0.132081 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 59 | Y | 0.255753 | H | 0.361973 | -0.10622 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 66 | F | 0.366486 | S | 0.555027 | -0.188541 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 66 | F | 0.366486 | L | 0.387811 | -0.021325 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 66 | F | 0.366486 | N | 0.519641 | -0.153155 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 66 | F | 0.366486 | Y | 0.387373 | -0.020887 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 67 | L | 0.33687 | A | 0.409848 | -0.072978 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 67 | L | 0.33687 | V | 0.349239 | -0.012369 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 68 | R | 0.319742 | S | 0.378621 | -0.058879 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 80 | T | 0.34132 | R | 0.403147 | -0.061827 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 84 | R | 0.356787 | L | 0.243428 | 0.113359 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 86 | V | 0.395391 | A | 0.476208 | -0.080817 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 86 | V | 0.395391 | S | 0.574549 | -0.179158 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 86 | V | 0.395391 | D | 0.538155 | -0.142764 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 87 | A | 0.396013 | E | 0.514052 | -0.118039 | O to D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 89 | S | 0.437933 | H | 0.357056 | 0.080877 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 89 | S | 0.437933 | Y | 0.247835 | 0.190098 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 96 | L | 0.539593 | F | 0.498105 | 0.041488 | D to O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 96 | L | 0.539593 | I | 0.50011 | 0.039483 | No Change: Both D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 103 | R | 0.390455 | Q | 0.402737 | -0.012282 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 106 | N | 0.338596 | T | 0.295446 | 0.04315 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 113 | G | 0.285128 | R | 0.304628 | -0.0195 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 115 | G | 0.347878 | A | 0.283783 | 0.064095 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 115 | G | 0.347878 | V | 0.244496 | 0.103382 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 169 | A | 0.509391 | T | 0.544999 | -0.035608 | No Change: Both D | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 178 | Q | 0.1866 | H | 0.168525 | 0.018075 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 193 | V | 0.29142 | F | 0.249951 | 0.041469 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 212 | A | 0.347583 | P | 0.448804 | -0.101221 | No Change: Both O | - |
| P79483 | DRB3_HUMAN HLA class II histocompatibility antigen DR beta 3 chain OS=Homo sapiens GN=HLA-DRB3 PE=1 SV=1 | 218 | R | 0.472124 | S | 0.55381 | -0.081686 | O to D | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 105 | D | 0.260791 | G | 0.240055 | 0.020736 | No Change: Both O | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 106 | T | 0.231226 | N | 0.265889 | -0.034663 | No Change: Both O | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 110 | Y | 0.159271 | H | 0.209635 | -0.050364 | No Change: Both O | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 113 | G | 0.16224 | R | 0.212073 | -0.049833 | No Change: Both O | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 141 | H | 0.268152 | Y | 0.167599 | 0.100553 | No Change: Both O | - |
| P13762 | DRB4_HUMAN HLA class II histocompatibility antigen DR beta 4 chain OS=Homo sapiens GN=HLA-DRB4 PE=1 SV=2 | 164 | G | 0.408262 | S | 0.453435 | -0.045173 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 28 | L | 0.358341 | S | 0.547323 | -0.188982 | O to D | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 154 | G | 0.155307 | A | 0.114847 | 0.04046 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 20 | M | 0.153928 | T | 0.190913 | -0.036985 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 33 | R | 0.371004 | Q | 0.397237 | -0.026233 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 41 | K | 0.279401 | T | 0.223463 | 0.055938 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 62 | N | 0.382633 | H | 0.380822 | 0.001811 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 106 | T | 0.222624 | N | 0.260733 | -0.038109 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 14 | K | 0.240629 | M | 0.173705 | 0.066924 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 14 | K | 0.240629 | Q | 0.199742 | 0.040887 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 14 | K | 0.240629 | V | 0.120103 | 0.120526 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 35 | R | 0.333544 | C | 0.181996 | 0.151548 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 57 | H | 0.221165 | Q | 0.264216 | -0.043051 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 59 | D | 0.261784 | G | 0.225746 | 0.036038 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 59 | D | 0.261784 | H | 0.227444 | 0.03434 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 66 | D | 0.483359 | N | 0.460339 | 0.02302 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 66 | D | 0.483359 | Y | 0.326471 | 0.156888 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 67 | L | 0.458552 | V | 0.473733 | -0.015181 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 87 | A | 0.363615 | E | 0.47337 | -0.109755 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 89 | Y | 0.35169 | S | 0.534467 | -0.182777 | O to D | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 96 | F | 0.369779 | L | 0.409345 | -0.039566 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 96 | F | 0.369779 | I | 0.36868 | 0.001099 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | E | 0.361883 | -0.016629 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | G | 0.305346 | 0.039908 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | H | 0.297606 | 0.047648 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | N | 0.320061 | 0.025193 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | Q | 0.323602 | 0.021652 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 99 | D | 0.345254 | R | 0.319189 | 0.026065 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 100 | R | 0.329435 | A | 0.29659 | 0.032845 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 100 | R | 0.329435 | G | 0.322007 | 0.007428 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 100 | R | 0.329435 | T | 0.311361 | 0.018074 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 103 | A | 0.247253 | E | 0.344913 | -0.09766 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 103 | A | 0.247253 | L | 0.183782 | 0.063471 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 107 | Y | 0.20888 | V | 0.216121 | -0.007241 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 114 | V | 0.309749 | A | 0.365518 | -0.055769 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 115 | G | 0.340718 | V | 0.230942 | 0.109776 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 164 | S | 0.454604 | G | 0.409309 | 0.045295 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 186 | T | 0.092246 | I | 0.044473 | 0.047773 | No Change: Both O | - |
| Q30154 | DRB5_HUMAN HLA class II histocompatibility antigen DR beta 5 chain OS=Homo sapiens GN=HLA-DRB5 PE=1 SV=1 | 232 | V | 0.25804 | I | 0.219392 | 0.038648 | No Change: Both O | - |
| P13747 | HLAE_HUMAN HLA class I histocompatibility antigen alpha chain E OS=Homo sapiens GN=HLA-E PE=1 SV=3 | 104 | G | 0.279766 | R | 0.298408 | -0.018642 | No Change: Both O | - |
| P13747 | HLAE_HUMAN HLA class I histocompatibility antigen alpha chain E OS=Homo sapiens GN=HLA-E PE=1 SV=3 | 128 | R | 0.329265 | G | 0.345287 | -0.016022 | No Change: Both O | - |
| P13747 | HLAE_HUMAN HLA class I histocompatibility antigen alpha chain E OS=Homo sapiens GN=HLA-E PE=1 SV=3 | 178 | R | 0.49859 | G | 0.491369 | 0.007221 | No Change: Both O | - |
| P13747 | HLAE_HUMAN HLA class I histocompatibility antigen alpha chain E OS=Homo sapiens GN=HLA-E PE=1 SV=3 | 98 | N | 0.193756 | K | 0.202047 | -0.008291 | No Change: Both O | - |
| P30511 | HLAF_HUMAN HLA class I histocompatibility antigen alpha chain F OS=Homo sapiens GN=HLA-F PE=2 SV=3 | 272 | P | 0.442984 | S | 0.397134 | 0.04585 | No Change: Both O | - |
| P30511 | HLAF_HUMAN HLA class I histocompatibility antigen alpha chain F OS=Homo sapiens GN=HLA-F PE=2 SV=3 | 13 | A | 0.244233 | V | 0.150742 | 0.093491 | No Change: Both O | - |
| P30511 | HLAF_HUMAN HLA class I histocompatibility antigen alpha chain F OS=Homo sapiens GN=HLA-F PE=2 SV=3 | 71 | P | 0.561667 | Q | 0.542376 | 0.019291 | No Change: Both D | - |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 237 | L | 0.215538 | P | 0.348629 | -0.133091 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 333 | V | 0.195657 | E | 0.358389 | -0.162732 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 462 | T | 0.295331 | I | 0.193501 | 0.10183 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 550 | V | 0.206361 | M | 0.251111 | -0.04475 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 571 | D | 0.13687 | N | 0.129151 | 0.007719 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 581 | G | 0.169262 | S | 0.211527 | -0.042265 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 508 | R | 0.483563 | W | 0.313776 | 0.169787 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 216 | L | 0.0345 | R | 0.060441 | -0.025941 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 511 | N | 0.318316 | K | 0.37031 | -0.051994 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 582 | G | 0.172409 | R | 0.15223 | 0.020179 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 42 | E | 0.917819 | D | 0.908296 | 0.009523 | No Change: Both D | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 183 | R | 0.183983 | P | 0.199846 | -0.015863 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 360 | R | 0.280353 | S | 0.338222 | -0.057869 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 363 | V | 0.201856 | D | 0.338261 | -0.136405 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 456 | Y | 0.259991 | C | 0.22196 | 0.038031 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 470 | L | 0.09975 | S | 0.198075 | -0.098325 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 518 | G | 0.10384 | E | 0.121389 | -0.017549 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 547 | V | 0.143072 | G | 0.220474 | -0.077402 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 615 | D | 0.123891 | Y | 0.065668 | 0.058223 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 634 | D | 0.129311 | N | 0.121706 | 0.007605 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 634 | D | 0.129311 | Y | 0.071402 | 0.057909 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| P50747 | BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens GN=HLCS PE=1 SV=1 | 715 | D | 0.307053 | G | 0.283008 | 0.024045 | No Change: Both O | Holocarboxylase synthetase deficiency (HLCS deficiency) [MIM:253270] |
| Q16534 | HLF_HUMAN Hepatic leukemia factor OS=Homo sapiens GN=HLF PE=2 SV=1 | 253 | I | 0.794772 | F | 0.801103 | -0.006331 | No Change: Both D | - |
| Q14527 | HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens GN=HLTF PE=1 SV=2 | 819 | R | 0.900048 | H | 0.892686 | 0.007362 | No Change: Both D | - |
| Q14527 | HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens GN=HLTF PE=1 SV=2 | 311 | N | 0.130213 | S | 0.145215 | -0.015002 | No Change: Both O | - |
| Q14527 | HLTF_HUMAN Helicase-like transcription factor OS=Homo sapiens GN=HLTF PE=1 SV=2 | 362 | E | 0.961137 | Q | 0.956867 | 0.00427 | No Change: Both D | - |
| Q14774 | HLX_HUMAN H2.0-like homeobox protein OS=Homo sapiens GN=HLX PE=1 SV=3 | 116 | S | 0.970688 | P | 0.974505 | -0.003817 | No Change: Both D | - |
| Q14774 | HLX_HUMAN H2.0-like homeobox protein OS=Homo sapiens GN=HLX PE=1 SV=3 | 356 | P | 0.993223 | L | 0.986698 | 0.006525 | No Change: Both D | - |
| Q14774 | HLX_HUMAN H2.0-like homeobox protein OS=Homo sapiens GN=HLX PE=1 SV=3 | 387 | A | 0.963607 | G | 0.965415 | -0.001808 | No Change: Both D | - |
| Q8TCT9 | HM13_HUMAN Minor histocompatibility antigen H13 OS=Homo sapiens GN=HM13 PE=1 SV=1 | 259 | A | 0.173769 | P | 0.221223 | -0.047454 | No Change: Both O | - |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 22 | R | 0.462156 | C | 0.283903 | 0.178253 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 26 | R | 0.444386 | H | 0.389137 | 0.055249 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 31 | A | 0.419143 | T | 0.460171 | -0.041028 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 34 | Q | 0.345654 | K | 0.381053 | -0.035399 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 55 | A | 0.195129 | S | 0.292691 | -0.097562 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 93 | V | 0.272928 | F | 0.236989 | 0.035939 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 98 | K | 0.319006 | R | 0.26371 | 0.055296 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 111 | G | 0.167635 | R | 0.172809 | -0.005174 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 116 | R | 0.287211 | Q | 0.298169 | -0.010958 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 116 | R | 0.287211 | W | 0.147186 | 0.140025 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 119 | P | 0.33419 | L | 0.201377 | 0.132813 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 149 | R | 0.542677 | L | 0.412335 | 0.130342 | D to O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 149 | R | 0.542677 | Q | 0.549726 | -0.007049 | No Change: Both D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 167 | R | 0.459244 | Q | 0.453443 | 0.005801 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 167 | R | 0.459244 | W | 0.213147 | 0.246097 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 173 | R | 0.448402 | Q | 0.45534 | -0.006938 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 173 | R | 0.448402 | W | 0.224637 | 0.223765 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 177 | L | 0.508775 | R | 0.603076 | -0.094301 | No Change: Both D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 195 | R | 0.208749 | C | 0.101682 | 0.107067 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 201 | R | 0.229782 | W | 0.104047 | 0.125735 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 222 | V | 0.300085 | M | 0.340931 | -0.040846 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 223 | E | 0.316554 | K | 0.332778 | -0.016224 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 225 | R | 0.334164 | G | 0.370715 | -0.036551 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 238 | L | 0.170911 | R | 0.24885 | -0.077939 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 245 | L | 0.139365 | R | 0.223206 | -0.083841 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 247 | C | 0.117285 | F | 0.128179 | -0.010894 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 247 | C | 0.117285 | R | 0.243135 | -0.12585 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 250 | E | 0.123289 | A | 0.079807 | 0.043482 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 250 | E | 0.123289 | K | 0.115086 | 0.008203 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 252 | A | 0.125461 | T | 0.134944 | -0.009483 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 252 | A | 0.125461 | V | 0.08352 | 0.041941 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 256 | H | 0.195207 | N | 0.212679 | -0.017472 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 269 | T | 0.237031 | I | 0.138728 | 0.098303 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 274 | G | 0.337622 | R | 0.307566 | 0.030056 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 278 | L | 0.150664 | P | 0.258792 | -0.108128 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 280 | G | 0.177147 | R | 0.1562 | 0.020947 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 24 | G | 0.427784 | S | 0.515103 | -0.087319 | O to D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 26 | R | 0.444386 | C | 0.268159 | 0.176227 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 28 | S | 0.456731 | N | 0.406777 | 0.049954 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 31 | A | 0.419143 | P | 0.48915 | -0.070007 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 34 | Q | 0.345654 | P | 0.353444 | -0.00779 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 35 | T | 0.323015 | M | 0.283506 | 0.039509 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 42 | L | 0.285617 | S | 0.45633 | -0.170713 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 61 | D | 0.416437 | N | 0.381643 | 0.034794 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 85 | L | 0.492646 | R | 0.569908 | -0.077262 | O to D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 90 | V | 0.427195 | G | 0.513435 | -0.08624 | O to D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 124 | V | 0.266607 | D | 0.401796 | -0.135189 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 178 | D | 0.488111 | N | 0.492431 | -0.00432 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 202 | V | 0.239667 | L | 0.2527 | -0.013033 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 209 | E | 0.215638 | K | 0.20315 | 0.012488 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 216 | G | 0.187884 | D | 0.19254 | -0.004656 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 217 | Q | 0.191479 | H | 0.179636 | 0.011843 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 217 | Q | 0.191479 | L | 0.113053 | 0.078426 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 219 | A | 0.223336 | D | 0.282941 | -0.059605 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 250 | E | 0.123289 | Q | 0.096152 | 0.027137 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 250 | E | 0.123289 | V | 0.050829 | 0.07246 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 256 | H | 0.195207 | Y | 0.121107 | 0.0741 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 267 | V | 0.221487 | M | 0.272683 | -0.051196 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 270 | A | 0.265921 | D | 0.343096 | -0.077175 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 270 | A | 0.265921 | G | 0.318347 | -0.052426 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 335 | G | 0.332998 | D | 0.366259 | -0.033261 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 335 | G | 0.332998 | S | 0.394873 | -0.061875 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 18 | M | 0.612401 | I | 0.511547 | 0.100854 | No Change: Both D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 34 | Q | 0.345654 | R | 0.338213 | 0.007441 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 61 | D | 0.416437 | Y | 0.255694 | 0.160743 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 78 | T | 0.52294 | P | 0.567565 | -0.044625 | No Change: Both D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 80 | E | 0.527714 | G | 0.453119 | 0.074595 | D to O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 81 | L | 0.527649 | P | 0.633619 | -0.10597 | No Change: Both D | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 86 | E | 0.508939 | V | 0.326033 | 0.182906 | D to O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 92 | L | 0.315865 | P | 0.451933 | -0.136068 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 96 | S | 0.276835 | F | 0.132441 | 0.144394 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 99 | D | 0.32962 | G | 0.306398 | 0.023222 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 99 | D | 0.32962 | H | 0.307741 | 0.021879 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 99 | D | 0.32962 | N | 0.311436 | 0.018184 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 113 | I | 0.214472 | T | 0.333265 | -0.118793 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 122 | A | 0.303282 | G | 0.357446 | -0.054164 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 212 | M | 0.198439 | V | 0.161254 | 0.037185 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 225 | R | 0.334164 | Q | 0.374941 | -0.040777 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 236 | G | 0.145009 | S | 0.175894 | -0.030885 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 244 | L | 0.158881 | P | 0.274965 | -0.116084 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 254 | L | 0.151639 | P | 0.266266 | -0.114627 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 260 | G | 0.262098 | D | 0.271621 | -0.009523 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 261 | C | 0.27199 | Y | 0.324667 | -0.052677 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| P08397 | HEM3_HUMAN Porphobilinogen deaminase OS=Homo sapiens GN=HMBS PE=1 SV=2 | 343 | L | 0.314052 | P | 0.445491 | -0.131439 | No Change: Both O | Acute intermittent porphyria (AIP) [MIM:176000] |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 1624 | A | 0.347958 | V | 0.273154 | 0.074804 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 2327 | M | 0.322959 | I | 0.258109 | 0.06485 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 2418 | I | 0.187553 | T | 0.291912 | -0.104359 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 2893 | E | 0.400641 | G | 0.351567 | 0.049074 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 4084 | H | 0.245041 | Y | 0.1682 | 0.076841 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 4720 | A | 0.658432 | T | 0.686172 | -0.02774 | No Change: Both D | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 5087 | D | 0.5885 | V | 0.493452 | 0.095048 | D to O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 5345 | Q | 0.45668 | R | 0.434852 | 0.021828 | No Change: Both O | Age-related macular degeneration type 1 (ARMD1) [MIM:603075] |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 1056 | T | 0.302429 | A | 0.279907 | 0.022522 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 1184 | V | 0.359933 | F | 0.294569 | 0.065364 | No Change: Both O | - |
| Q96RW7 | HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens GN=HMCN1 PE=1 SV=2 | 4437 | Q | 0.393919 | R | 0.390086 | 0.003833 | No Change: Both O | - |
| P09429 | HMGB1_HUMAN High mobility group protein B1 OS=Homo sapiens GN=HMGB1 PE=1 SV=3 | 11 | G | 0.88627 | R | 0.90651 | -0.02024 | No Change: Both D | Gastric-carcinoma cell line |
| P09429 | HMGB1_HUMAN High mobility group protein B1 OS=Homo sapiens GN=HMGB1 PE=1 SV=3 | 149 | A | 0.835839 | E | 0.869487 | -0.033648 | No Change: Both D | Gastric-carcinoma cell line |
| P09429 | HMGB1_HUMAN High mobility group protein B1 OS=Homo sapiens GN=HMGB1 PE=1 SV=3 | 156 | E | 0.910183 | Q | 0.899618 | 0.010565 | No Change: Both D | - |
| P09429 | HMGB1_HUMAN High mobility group protein B1 OS=Homo sapiens GN=HMGB1 PE=1 SV=3 | 190 | D | 0.999473 | G | 0.999362 | 1.11E-04 | No Change: Both D | Gastric-carcinoma cell line |
| O15347 | HMGB3_HUMAN High mobility group protein B3 OS=Homo sapiens GN=HMGB3 PE=1 SV=4 | 51 | T | 0.91969 | A | 0.92254 | -0.00285 | No Change: Both D | - |
| O15347 | HMGB3_HUMAN High mobility group protein B3 OS=Homo sapiens GN=HMGB3 PE=1 SV=4 | 56 | E | 0.946205 | Q | 0.927019 | 0.019186 | No Change: Both D | - |
| Q8WW32 | HMGB4_HUMAN High mobility group protein B4 OS=Homo sapiens GN=HMGB4 PE=2 SV=1 | 59 | K | 0.767152 | R | 0.736945 | 0.030207 | No Change: Both D | - |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 41 | R | 0.455116 | Q | 0.477933 | -0.022817 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 42 | D | 0.470415 | E | 0.526142 | -0.055727 | O to D | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 42 | D | 0.470415 | G | 0.472087 | -0.001672 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 42 | D | 0.470415 | H | 0.424428 | 0.045987 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 70 | V | 0.313471 | L | 0.320347 | -0.006876 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 233 | H | 0.125205 | R | 0.116935 | 0.00827 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 279 | E | 0.266984 | K | 0.258747 | 0.008237 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 37 | E | 0.425887 | K | 0.457853 | -0.031966 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 48 | K | 0.482601 | N | 0.45745 | 0.025151 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 75 | S | 0.246091 | R | 0.179879 | 0.066212 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 142 | S | 0.317369 | F | 0.149033 | 0.168336 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 174 | C | 0.177802 | Y | 0.207137 | -0.029335 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 192 | F | 0.22561 | S | 0.445932 | -0.220322 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 200 | I | 0.175005 | F | 0.169932 | 0.005073 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 201 | S | 0.188996 | Y | 0.093088 | 0.095908 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 203 | G | 0.220518 | E | 0.255879 | -0.035361 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 204 | D | 0.230225 | N | 0.215732 | 0.014493 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 263 | L | 0.309281 | P | 0.48991 | -0.180629 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P35914 | HMGCL_HUMAN Hydroxymethylglutaryl-CoA lyase mitochondrial OS=Homo sapiens GN=HMGCL PE=1 SV=2 | 165 | R | 0.193807 | Q | 0.216375 | -0.022568 | No Change: Both O | 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (HMGCLD) [MIM:246450] |
| P04035 | HMDH_HUMAN 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Homo sapiens GN=HMGCR PE=1 SV=1 | 638 | I | 0.269683 | V | 0.275774 | -0.006091 | No Change: Both O | - |
| P54868 | HMCS2_HUMAN Hydroxymethylglutaryl-CoA synthase mitochondrial OS=Homo sapiens GN=HMGCS2 PE=1 SV=1 | 174 | F | 0.201142 | L | 0.231319 | -0.030177 | No Change: Both O | HMG-CoA synthase deficiency (HMGCS deficiency) [MIM:605911] |
| P54868 | HMCS2_HUMAN Hydroxymethylglutaryl-CoA synthase mitochondrial OS=Homo sapiens GN=HMGCS2 PE=1 SV=1 | 54 | V | 0.145695 | M | 0.1795 | -0.033805 | No Change: Both O | HMG-CoA synthase deficiency (HMGCS deficiency) [MIM:605911] |
| P54868 | HMCS2_HUMAN Hydroxymethylglutaryl-CoA synthase mitochondrial OS=Homo sapiens GN=HMGCS2 PE=1 SV=1 | 167 | Y | 0.236195 | C | 0.218583 | 0.017612 | No Change: Both O | HMG-CoA synthase deficiency (HMGCS deficiency) [MIM:605911] |
| P54868 | HMCS2_HUMAN Hydroxymethylglutaryl-CoA synthase mitochondrial OS=Homo sapiens GN=HMGCS2 PE=1 SV=1 | 212 | G | 0.333478 | R | 0.310574 | 0.022904 | No Change: Both O | HMG-CoA synthase deficiency (HMGCS deficiency) [MIM:605911] |
| P54868 | HMCS2_HUMAN Hydroxymethylglutaryl-CoA synthase mitochondrial OS=Homo sapiens GN=HMGCS2 PE=1 SV=1 | 500 | R | 0.589293 | H | 0.588903 | 3.90E-04 | No Change: Both D | HMG-CoA synthase deficiency (HMGCS deficiency) [MIM:605911] |
| P05204 | HMGN2_HUMAN Non-histone chromosomal protein HMG-17 OS=Homo sapiens GN=HMGN2 PE=1 SV=3 | 7 | E | 0.996804 | K | 0.997708 | -9.04E-04 | No Change: Both D | - |
| Q86SG4 | DPCA2_HUMAN Putative Dresden prostate carcinoma protein 2 OS=Homo sapiens GN=HMGN2P46 PE=5 SV=1 | 91 | C | 0.945317 | R | 0.96187 | -0.016553 | No Change: Both D | - |
| Q9UGU5 | HMGX4_HUMAN HMG domain-containing protein 4 OS=Homo sapiens GN=HMGXB4 PE=2 SV=2 | 165 | G | 0.935885 | V | 0.91075 | 0.025135 | No Change: Both D | - |
| Q92619 | HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2 | 139 | R | 0.318913 | H | 0.284676 | 0.034237 | No Change: Both O | - |
| Q92619 | HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2 | 259 | E | 0.782917 | D | 0.772285 | 0.010632 | No Change: Both D | - |
| Q92619 | HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2 | 439 | S | 0.877785 | G | 0.864645 | 0.01314 | No Change: Both D | - |
| Q92619 | HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2 | 515 | M | 0.354032 | I | 0.239304 | 0.114728 | No Change: Both O | - |
| Q92619 | HMHA1_HUMAN Minor histocompatibility protein HA-1 OS=Homo sapiens GN=HMHA1 PE=1 SV=2 | 886 | A | 0.728989 | P | 0.77476 | -0.045771 | No Change: Both D | - |
| O97980 | HMHB1_HUMAN Minor histocompatibility protein HB-1 OS=Homo sapiens GN=HMHB1 PE=1 SV=1 | 16 | H | 0.645905 | Y | 0.52203 | 0.123875 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 368 | V | 0.965139 | A | 0.972975 | -0.007836 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 92 | R | 0.88092 | C | 0.812957 | 0.067963 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 332 | R | 0.974699 | H | 0.971797 | 0.002902 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 484 | A | 0.789574 | V | 0.723742 | 0.065832 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 305 | N | 0.91025 | K | 0.918065 | -0.007815 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 320 | N | 0.949383 | K | 0.954931 | -0.005548 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 557 | D | 0.92802 | H | 0.902044 | 0.025976 | No Change: Both D | - |
| O75330 | HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens GN=HMMR PE=1 SV=2 | 595 | L | 0.298842 | I | 0.243842 | 0.055 | No Change: Both O | - |
| P09601 | HMOX1_HUMAN Heme oxygenase 1 OS=Homo sapiens GN=HMOX1 PE=1 SV=1 | 7 | D | 0.958188 | H | 0.952082 | 0.006106 | No Change: Both D | - |
| P09601 | HMOX1_HUMAN Heme oxygenase 1 OS=Homo sapiens GN=HMOX1 PE=1 SV=1 | 106 | P | 0.16653 | L | 0.077777 | 0.088753 | No Change: Both O | - |
| P30519 | HMOX2_HUMAN Heme oxygenase 2 OS=Homo sapiens GN=HMOX2 PE=1 SV=2 | 137 | R | 0.200477 | Q | 0.232832 | -0.032355 | No Change: Both O | - |
| P30519 | HMOX2_HUMAN Heme oxygenase 2 OS=Homo sapiens GN=HMOX2 PE=1 SV=2 | 146 | P | 0.350664 | L | 0.222791 | 0.127873 | No Change: Both O | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 122 | Y | 0.345466 | C | 0.362412 | -0.016946 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 142 | S | 0.582029 | F | 0.361499 | 0.22053 | D to O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 159 | R | 0.358735 | Q | 0.390265 | -0.03153 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 272 | R | 0.393171 | H | 0.371897 | 0.021274 | No Change: Both O | Diabetes mellitus insulin-dependent type 20 (IDDM20) [MIM:612520] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 272 | R | 0.393171 | H | 0.371897 | 0.021274 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 447 | P | 0.700815 | L | 0.561749 | 0.139066 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 583 | R | 0.928953 | G | 0.932557 | -0.003604 | No Change: Both D | Diabetes mellitus insulin-dependent type 20 (IDDM20) [MIM:612520] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 27 | I | 0.663673 | L | 0.769728 | -0.106055 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 487 | S | 0.872911 | N | 0.818854 | 0.054057 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 12 | L | 0.532926 | H | 0.551234 | -0.018308 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 31 | G | 0.70465 | D | 0.679694 | 0.024956 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 48 | E | 0.909443 | K | 0.89808 | 0.011363 | No Change: Both D | Diabetes mellitus insulin-dependent type 20 (IDDM20) [MIM:612520] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 98 | A | 0.625366 | V | 0.564446 | 0.06092 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 107 | L | 0.332876 | R | 0.442993 | -0.110117 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 117 | K | 0.291095 | E | 0.300931 | -0.009836 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 128 | I | 0.404974 | N | 0.574095 | -0.169121 | O to D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 129 | P | 0.423609 | T | 0.389758 | 0.033851 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 131 | R | 0.426539 | Q | 0.473825 | -0.047286 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 131 | R | 0.426539 | W | 0.245413 | 0.181126 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 133 | V | 0.415601 | M | 0.47634 | -0.060739 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 143 | H | 0.607946 | Y | 0.476615 | 0.131331 | D to O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 158 | K | 0.425526 | N | 0.375568 | 0.049958 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 159 | R | 0.358735 | W | 0.201923 | 0.156812 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 161 | A | 0.237566 | T | 0.280367 | -0.042801 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 191 | G | 0.667041 | D | 0.678744 | -0.011703 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 203 | R | 0.676342 | C | 0.518448 | 0.157894 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 205 | K | 0.686676 | Q | 0.687078 | -4.02E-04 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 229 | R | 0.823018 | Q | 0.830995 | -0.007977 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 241 | C | 0.491375 | G | 0.60422 | -0.112845 | O to D | Diabetes mellitus insulin-dependent type 20 (IDDM20) [MIM:612520] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 241 | C | 0.491375 | G | 0.60422 | -0.112845 | O to D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 254 | L | 0.473856 | M | 0.503361 | -0.029505 | O to D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 259 | V | 0.235213 | D | 0.33581 | -0.100597 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 260 | T | 0.197035 | M | 0.17976 | 0.017275 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 263 | R | 0.153983 | C | 0.091871 | 0.062112 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 271 | R | 0.355317 | W | 0.204664 | 0.150653 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 272 | R | 0.393171 | C | 0.269589 | 0.123582 | No Change: Both O | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 319 | G | 0.96081 | S | 0.97069 | -0.00988 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 415 | G | 0.682935 | R | 0.642748 | 0.040187 | No Change: Both D | Diabetes mellitus insulin-dependent type 20 (IDDM20) [MIM:612520] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 514 | H | 0.419794 | R | 0.408076 | 0.011718 | No Change: Both O | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 519 | P | 0.409232 | L | 0.277138 | 0.132094 | No Change: Both O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 537 | T | 0.655928 | R | 0.607131 | 0.048797 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 574 | G | 0.920387 | S | 0.950926 | -0.030539 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 583 | R | 0.928953 | Q | 0.949258 | -0.020305 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 594 | S | 0.899146 | I | 0.753838 | 0.145308 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 619 | E | 0.875526 | K | 0.882435 | -0.006909 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 620 | T | 0.87683 | I | 0.811655 | 0.065175 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 20 | G | 0.663107 | R | 0.642986 | 0.020121 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 203 | R | 0.676342 | H | 0.608078 | 0.068264 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 432 | S | 0.53361 | C | 0.337507 | 0.196103 | D to O | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 618 | I | 0.881756 | M | 0.931547 | -0.049791 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 127 | N | 0.396327 | Y | 0.278091 | 0.118236 | No Change: Both O | A hepatocellular carcinoma sample |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 165 | W | 0.201943 | C | 0.293161 | -0.091218 | No Change: Both O | A hepatocellular carcinoma sample |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 206 | W | 0.663233 | C | 0.763964 | -0.100731 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 206 | W | 0.663233 | L | 0.767272 | -0.104039 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 237 | N | 0.571646 | S | 0.619209 | -0.047563 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 244 | R | 0.557245 | G | 0.537345 | 0.0199 | No Change: Both D | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 250 | Q | 0.536707 | P | 0.540726 | -0.004019 | No Change: Both D | A hepatocellular carcinoma sample |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 268 | F | 0.227137 | C | 0.250446 | -0.023309 | No Change: Both O | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 273 | K | 0.412129 | E | 0.430821 | -0.018692 | No Change: Both O | - |
| P20823 | HNF1A_HUMAN Hepatocyte nuclear factor 1-alpha OS=Homo sapiens GN=HNF1A PE=1 SV=2 | 200 | R | 0.699121 | W | 0.515437 | 0.183684 | No Change: Both D | Maturity-onset diabetes of the young type 3 (MODY3) [MIM:600496] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 492 | G | 0.969012 | S | 0.981485 | -0.012473 | No Change: Both D | - |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 465 | S | 0.803356 | R | 0.733815 | 0.069541 | No Change: Both D | Non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 36 | S | 0.665474 | F | 0.480476 | 0.184998 | D to O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 61 | V | 0.77747 | G | 0.863791 | -0.086321 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 76 | G | 0.810955 | C | 0.744592 | 0.066363 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 110 | V | 0.635332 | G | 0.733037 | -0.097705 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 112 | R | 0.57072 | P | 0.602948 | -0.032228 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 136 | Q | 0.416314 | E | 0.420782 | -0.004468 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 148 | S | 0.517063 | L | 0.353581 | 0.163482 | D to O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 148 | S | 0.517063 | W | 0.25393 | 0.263133 | D to O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 151 | S | 0.580603 | P | 0.550252 | 0.030351 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 153 | H | 0.626943 | N | 0.637498 | -0.010555 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 156 | K | 0.623567 | E | 0.613696 | 0.009871 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 164 | K | 0.407749 | Q | 0.383751 | 0.023998 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 165 | R | 0.349576 | H | 0.328717 | 0.020859 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 235 | R | 0.749523 | Q | 0.762479 | -0.012956 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 241 | A | 0.730141 | T | 0.730201 | -6.00E-05 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 260 | E | 0.789056 | D | 0.750133 | 0.038923 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 276 | R | 0.532313 | G | 0.518917 | 0.013396 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 276 | R | 0.532313 | Q | 0.53753 | -0.005217 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 285 | G | 0.474658 | D | 0.470887 | 0.003771 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 295 | R | 0.141502 | C | 0.082256 | 0.059246 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 295 | R | 0.141502 | H | 0.114906 | 0.026596 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 295 | R | 0.141502 | P | 0.144923 | -0.003421 | No Change: Both O | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P35680 | HNF1B_HUMAN Hepatocyte nuclear factor 1-beta OS=Homo sapiens GN=HNF1B PE=1 SV=1 | 370 | G | 0.884309 | S | 0.920673 | -0.036364 | No Change: Both D | Renal cysts and diabetes syndrome (RCAD) [MIM:137920] |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 136 | R | 0.804541 | W | 0.580971 | 0.22357 | No Change: Both D | Maturity-onset diabetes of the young type 1 (MODY1) [MIM:125850] |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 139 | T | 0.809572 | I | 0.755842 | 0.05373 | No Change: Both D | - |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 402 | V | 0.661488 | I | 0.647602 | 0.013886 | No Change: Both D | Maturity-onset diabetes of the young type 1 (MODY1) [MIM:125850] |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 264 | V | 0.220465 | M | 0.291475 | -0.07101 | No Change: Both O | - |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 285 | E | 0.215806 | Q | 0.192979 | 0.022827 | No Change: Both O | Maturity-onset diabetes of the young type 1 (MODY1) [MIM:125850] |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 445 | P | 0.876941 | S | 0.866701 | 0.01024 | No Change: Both D | - |
| P41235 | HNF4A_HUMAN Hepatocyte nuclear factor 4-alpha OS=Homo sapiens GN=HNF4A PE=1 SV=3 | 453 | V | 0.72634 | I | 0.731079 | -0.004739 | No Change: Both D | - |
| Q14541 | HNF4G_HUMAN Hepatocyte nuclear factor 4-gamma OS=Homo sapiens GN=HNF4G PE=1 SV=3 | 190 | M | 0.232139 | I | 0.161148 | 0.070991 | No Change: Both O | - |
| P50135 | HNMT_HUMAN Histamine N-methyltransferase OS=Homo sapiens GN=HNMT PE=1 SV=1 | 105 | T | 0.463694 | I | 0.348194 | 0.1155 | No Change: Both O | - |
| P09651 | ROA1_HUMAN Heterogeneous nuclear ribonucleoprotein A1 OS=Homo sapiens GN=HNRNPA1 PE=1 SV=5 | 73 | N | 0.551651 | S | 0.60896 | -0.057309 | No Change: Both D | - |
| Q32P51 | RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens GN=HNRNPA1L2 PE=2 SV=2 | 215 | N | 0.991743 | D | 0.992005 | -2.62E-04 | No Change: Both D | - |
| P07910 | HNRPC_HUMAN Heterogeneous nuclear ribonucleoproteins C1/C2 OS=Homo sapiens GN=HNRNPC PE=1 SV=4 | 167 | R | 0.976623 | Q | 0.974024 | 0.002599 | No Change: Both D | - |
| O60812 | HNRCL_HUMAN Heterogeneous nuclear ribonucleoprotein C-like 1 OS=Homo sapiens GN=HNRNPCL1 PE=1 SV=1 | 258 | V | 0.987539 | D | 0.994055 | -0.006516 | No Change: Both D | - |
| O60812 | HNRCL_HUMAN Heterogeneous nuclear ribonucleoprotein C-like 1 OS=Homo sapiens GN=HNRNPCL1 PE=1 SV=1 | 208 | Q | 0.979636 | H | 0.968015 | 0.011621 | No Change: Both D | - |
| O60812 | HNRCL_HUMAN Heterogeneous nuclear ribonucleoprotein C-like 1 OS=Homo sapiens GN=HNRNPCL1 PE=1 SV=1 | 81 | D | 0.250334 | V | 0.156691 | 0.093643 | No Change: Both O | - |
| P52597 | HNRPF_HUMAN Heterogeneous nuclear ribonucleoprotein F OS=Homo sapiens GN=HNRNPF PE=1 SV=3 | 87 | K | 0.399197 | R | 0.370929 | 0.028268 | No Change: Both O | - |
| P31942 | HNRH3_HUMAN Heterogeneous nuclear ribonucleoprotein H3 OS=Homo sapiens GN=HNRNPH3 PE=1 SV=2 | 163 | N | 0.936673 | S | 0.940033 | -0.00336 | No Change: Both D | - |
| P31942 | HNRH3_HUMAN Heterogeneous nuclear ribonucleoprotein H3 OS=Homo sapiens GN=HNRNPH3 PE=1 SV=2 | 284 | G | 0.908869 | A | 0.854232 | 0.054637 | No Change: Both D | - |
| Q00839 | HNRPU_HUMAN Heterogeneous nuclear ribonucleoprotein U OS=Homo sapiens GN=HNRNPU PE=1 SV=6 | 712 | F | 0.99286 | L | 0.991247 | 0.001613 | No Change: Both D | - |
| Q9BUJ2 | HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens GN=HNRNPUL1 PE=1 SV=2 | 91 | G | 0.793198 | C | 0.728771 | 0.064427 | No Change: Both D | - |
| Q86XE5 | HOGA1_HUMAN Probable 4-hydroxy-2-oxoglutarate aldolase mitochondrial OS=Homo sapiens GN=HOGA1 PE=1 SV=1 | 257 | C | 0.07599 | G | 0.151269 | -0.075279 | No Change: Both O | Hyperoxaluria primary type 3 (HP3) [MIM:613616] |
| Q86XE5 | HOGA1_HUMAN Probable 4-hydroxy-2-oxoglutarate aldolase mitochondrial OS=Homo sapiens GN=HOGA1 PE=1 SV=1 | 287 | G | 0.17326 | V | 0.097164 | 0.076096 | No Change: Both O | Hyperoxaluria primary type 3 (HP3) [MIM:613616] |
| Q9NSB8 | HOME2_HUMAN Homer protein homolog 2 OS=Homo sapiens GN=HOMER2 PE=1 SV=1 | 219 | R | 0.799722 | H | 0.719417 | 0.080305 | No Change: Both D | - |
| Q9NSB8 | HOME2_HUMAN Homer protein homolog 2 OS=Homo sapiens GN=HOMER2 PE=1 SV=1 | 239 | I | 0.972647 | S | 0.984643 | -0.011996 | No Change: Both D | - |
| Q9NSC5 | HOME3_HUMAN Homer protein homolog 3 OS=Homo sapiens GN=HOMER3 PE=1 SV=2 | 342 | S | 0.829079 | R | 0.842755 | -0.013676 | No Change: Both D | - |
| Q8IX15 | HOMEZ_HUMAN Homeobox and leucine zipper protein Homez OS=Homo sapiens GN=HOMEZ PE=1 SV=2 | 278 | A | 0.969699 | T | 0.972412 | -0.002713 | No Change: Both D | - |
| Q9UJC3 | HOOK1_HUMAN Protein Hook homolog 1 OS=Homo sapiens GN=HOOK1 PE=1 SV=2 | 433 | S | 0.758346 | L | 0.658623 | 0.099723 | No Change: Both D | A breast cancer sample |
| Q96ED9 | HOOK2_HUMAN Protein Hook homolog 2 OS=Homo sapiens GN=HOOK2 PE=1 SV=3 | 10 | G | 0.129371 | R | 0.128945 | 4.26E-04 | No Change: Both O | - |
| Q96ED9 | HOOK2_HUMAN Protein Hook homolog 2 OS=Homo sapiens GN=HOOK2 PE=1 SV=3 | 488 | H | 0.973485 | Q | 0.980967 | -0.007482 | No Change: Both D | - |
| Q86VS8 | HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens GN=HOOK3 PE=1 SV=2 | 221 | Q | 0.811042 | R | 0.797981 | 0.013061 | No Change: Both D | A breast cancer sample |
| Q86VS8 | HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens GN=HOOK3 PE=1 SV=2 | 670 | Y | 0.341682 | S | 0.539758 | -0.198076 | O to D | - |
| Q86X24 | HORM1_HUMAN HORMA domain-containing protein 1 OS=Homo sapiens GN=HORMAD1 PE=2 SV=1 | 267 | T | 0.90797 | I | 0.870879 | 0.037091 | No Change: Both D | - |
| Q8N7B1 | HORM2_HUMAN HORMA domain-containing protein 2 OS=Homo sapiens GN=HORMAD2 PE=2 SV=2 | 2 | A | 0.692697 | T | 0.709383 | -0.016686 | No Change: Both D | - |
| Q8N7B1 | HORM2_HUMAN HORMA domain-containing protein 2 OS=Homo sapiens GN=HORMAD2 PE=2 SV=2 | 20 | V | 0.500838 | L | 0.512861 | -0.012023 | No Change: Both D | - |
| P49639 | HXA1_HUMAN Homeobox protein Hox-A1 OS=Homo sapiens GN=HOXA1 PE=1 SV=2 | 73 | H | 0.84193 | R | 0.831779 | 0.010151 | No Change: Both D | - |
| P49639 | HXA1_HUMAN Homeobox protein Hox-A1 OS=Homo sapiens GN=HOXA1 PE=1 SV=2 | 189 | E | 0.815939 | A | 0.769887 | 0.046052 | No Change: Both D | - |
| P31271 | HXA13_HUMAN Homeobox protein Hox-A13 OS=Homo sapiens GN=HOXA13 PE=1 SV=3 | 371 | Q | 0.507961 | L | 0.356616 | 0.151345 | D to O | Guttmacher syndrome (GUTTS) [MIM:176305] |
| P31271 | HXA13_HUMAN Homeobox protein Hox-A13 OS=Homo sapiens GN=HOXA13 PE=1 SV=3 | 372 | N | 0.589246 | H | 0.488071 | 0.101175 | D to O | Hand-foot-genital syndrome (HFGS) [MIM:140000] |
| O43364 | HXA2_HUMAN Homeobox protein Hox-A2 OS=Homo sapiens GN=HOXA2 PE=1 SV=1 | 196 | M | 0.670927 | L | 0.646814 | 0.024113 | No Change: Both D | - |
| O43364 | HXA2_HUMAN Homeobox protein Hox-A2 OS=Homo sapiens GN=HOXA2 PE=1 SV=1 | 186 | Q | 0.342483 | K | 0.36867 | -0.026187 | No Change: Both O | Microtia hearing impairment and cleft palate (MHICP) [MIM:612290] |
| O43365 | HXA3_HUMAN Homeobox protein Hox-A3 OS=Homo sapiens GN=HOXA3 PE=2 SV=1 | 42 | D | 0.72017 | N | 0.738829 | -0.018659 | No Change: Both D | A breast cancer sample |
| O43365 | HXA3_HUMAN Homeobox protein Hox-A3 OS=Homo sapiens GN=HOXA3 PE=2 SV=1 | 131 | A | 0.992123 | T | 0.992373 | -2.50E-04 | No Change: Both D | A breast cancer sample |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 70 | T | 0.928655 | P | 0.950851 | -0.022196 | No Change: Both D | - |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 140 | L | 0.987309 | P | 0.993675 | -0.006366 | No Change: Both D | - |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 178 | L | 0.634551 | F | 0.562474 | 0.072077 | No Change: Both D | - |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 251 | T | 0.194603 | P | 0.229193 | -0.03459 | No Change: Both O | - |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 317 | P | 0.997486 | S | 0.997317 | 1.69E-04 | No Change: Both D | - |
| Q00056 | HXA4_HUMAN Homeobox protein Hox-A4 OS=Homo sapiens GN=HOXA4 PE=1 SV=3 | 37 | G | 0.950502 | D | 0.946637 | 0.003865 | No Change: Both D | A breast cancer sample |
| P31268 | HXA7_HUMAN Homeobox protein Hox-A7 OS=Homo sapiens GN=HOXA7 PE=2 SV=3 | 18 | A | 0.427371 | T | 0.444081 | -0.01671 | No Change: Both O | - |
| P14653 | HXB1_HUMAN Homeobox protein Hox-B1 OS=Homo sapiens GN=HOXB1 PE=1 SV=2 | 71 | T | 0.955732 | N | 0.963873 | -0.008141 | No Change: Both D | - |
| P14653 | HXB1_HUMAN Homeobox protein Hox-B1 OS=Homo sapiens GN=HOXB1 PE=1 SV=2 | 103 | Q | 0.898477 | H | 0.874378 | 0.024099 | No Change: Both D | - |
| P14653 | HXB1_HUMAN Homeobox protein Hox-B1 OS=Homo sapiens GN=HOXB1 PE=1 SV=2 | 265 | E | 0.919103 | G | 0.896758 | 0.022345 | No Change: Both D | - |
| Q92826 | HXB13_HUMAN Homeobox protein Hox-B13 OS=Homo sapiens GN=HOXB13 PE=1 SV=2 | 41 | T | 0.638796 | M | 0.638854 | -5.80E-05 | No Change: Both D | - |
| P14651 | HXB3_HUMAN Homeobox protein Hox-B3 OS=Homo sapiens GN=HOXB3 PE=1 SV=2 | 82 | P | 0.99199 | T | 0.986166 | 0.005824 | No Change: Both D | - |
| P09629 | HXB7_HUMAN Homeobox protein Hox-B7 OS=Homo sapiens GN=HOXB7 PE=1 SV=4 | 9 | T | 0.419948 | A | 0.417431 | 0.002517 | No Change: Both O | - |
| O43248 | HXC11_HUMAN Homeobox protein Hox-C11 OS=Homo sapiens GN=HOXC11 PE=2 SV=1 | 130 | P | 0.727163 | S | 0.73953 | -0.012367 | No Change: Both D | - |
| O43248 | HXC11_HUMAN Homeobox protein Hox-C11 OS=Homo sapiens GN=HOXC11 PE=2 SV=1 | 222 | A | 0.923778 | V | 0.90136 | 0.022418 | No Change: Both D | - |
| P31276 | HXC13_HUMAN Homeobox protein Hox-C13 OS=Homo sapiens GN=HOXC13 PE=1 SV=3 | 50 | S | 0.981928 | I | 0.955459 | 0.026469 | No Change: Both D | - |
| P09017 | HXC4_HUMAN Homeobox protein Hox-C4 OS=Homo sapiens GN=HOXC4 PE=2 SV=2 | 158 | R | 0.654648 | L | 0.565452 | 0.089196 | No Change: Both D | - |
| P09017 | HXC4_HUMAN Homeobox protein Hox-C4 OS=Homo sapiens GN=HOXC4 PE=2 SV=2 | 178 | N | 0.35252 | S | 0.404368 | -0.051848 | No Change: Both O | - |
| P31274 | HXC9_HUMAN Homeobox protein Hox-C9 OS=Homo sapiens GN=HOXC9 PE=2 SV=3 | 87 | G | 0.444638 | S | 0.501975 | -0.057337 | O to D | A colorectal cancer sample |
| Q9GZZ0 | HXD1_HUMAN Homeobox protein Hox-D1 OS=Homo sapiens GN=HOXD1 PE=1 SV=1 | 296 | A | 0.459479 | T | 0.504089 | -0.04461 | O to D | - |
| P28358 | HXD10_HUMAN Homeobox protein Hox-D10 OS=Homo sapiens GN=HOXD10 PE=1 SV=2 | 319 | M | 0.609618 | K | 0.69522 | -0.085602 | No Change: Both D | Congenital vertical talus (CVT) [MIM:192950] |
| P31277 | HXD11_HUMAN Homeobox protein Hox-D11 OS=Homo sapiens GN=HOXD11 PE=2 SV=3 | 245 | G | 0.993096 | D | 0.992556 | 5.40E-04 | No Change: Both D | - |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 316 | S | 0.422944 | C | 0.239793 | 0.183151 | No Change: Both O | Brachydactyly type D (BDD) [MIM:113200] |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 316 | S | 0.422944 | C | 0.239793 | 0.183151 | No Change: Both O | Brachydactyly type E (BDE1) [MIM:113300] |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 322 | I | 0.329216 | L | 0.34854 | -0.019324 | No Change: Both O | Brachydactyly type E (BDE1) [MIM:113300] |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 252 | S | 0.522518 | A | 0.38917 | 0.133348 | D to O | - |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 306 | R | 0.52107 | W | 0.298086 | 0.222984 | D to O | Synpolydactyly 1 (SPD1) [MIM:186000] |
| P35453 | HXD13_HUMAN Homeobox protein Hox-D13 OS=Homo sapiens GN=HOXD13 PE=1 SV=3 | 325 | Q | 0.337552 | R | 0.373791 | -0.036239 | No Change: Both O | Syndactyly type 5 (SDTY5) [MIM:186300] |
| P31249 | HXD3_HUMAN Homeobox protein Hox-D3 OS=Homo sapiens GN=HOXD3 PE=2 SV=3 | 129 | S | 0.998803 | C | 0.99788 | 9.23E-04 | No Change: Both D | - |
| P00738 | HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=1 | 129 | N | 0.277682 | D | 0.280704 | -0.003022 | No Change: Both O | - |
| P00738 | HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=1 | 130 | E | 0.29159 | K | 0.308856 | -0.017266 | No Change: Both O | - |
| P00738 | HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=1 | 397 | D | 0.161949 | H | 0.138715 | 0.023234 | No Change: Both O | - |
| P00738 | HPT_HUMAN Haptoglobin OS=Homo sapiens GN=HP PE=1 SV=1 | 247 | I | 0.177205 | T | 0.275944 | -0.098739 | No Change: Both O | Anhaptoglobinemia (AHP) [MIM:614081] |
| P84074 | HPCA_HUMAN Neuron-specific calcium-binding protein hippocalcin OS=Homo sapiens GN=HPCA PE=1 SV=2 | 21 | E | 0.57421 | D | 0.534565 | 0.039645 | No Change: Both D | - |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 33 | A | 0.236723 | T | 0.240937 | -0.004214 | No Change: Both O | - |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 160 | Y | 0.229896 | C | 0.199936 | 0.02996 | No Change: Both O | Tyrosinemia type 3 (TYRO3) [MIM:276710] |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 267 | I | 0.206212 | F | 0.195307 | 0.010905 | No Change: Both O | - |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 268 | A | 0.210444 | V | 0.157293 | 0.053151 | No Change: Both O | Tyrosinemia type 3 (TYRO3) [MIM:276710] |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 335 | I | 0.11697 | M | 0.170118 | -0.053148 | No Change: Both O | Tyrosinemia type 3 (TYRO3) [MIM:276710] |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 340 | V | 0.263235 | L | 0.281974 | -0.018739 | No Change: Both O | - |
| P32754 | HPPD_HUMAN 4-hydroxyphenylpyruvate dioxygenase OS=Homo sapiens GN=HPD PE=1 SV=2 | 113 | R | 0.450259 | Q | 0.463008 | -0.012749 | No Change: Both O | - |
| P15428 | PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD+] OS=Homo sapiens GN=HPGD PE=1 SV=1 | 217 | Y | 0.131922 | C | 0.10633 | 0.025592 | No Change: Both O | - |
| P15428 | PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD+] OS=Homo sapiens GN=HPGD PE=1 SV=1 | 140 | A | 0.233656 | P | 0.309461 | -0.075805 | No Change: Both O | Cranioosteoarthropathy (COA) [MIM:259100] |
| P15428 | PGDH_HUMAN 15-hydroxyprostaglandin dehydrogenase [NAD+] OS=Homo sapiens GN=HPGD PE=1 SV=1 | 193 | S | 0.441928 | P | 0.414032 | 0.027896 | No Change: Both O | Isolated congenital nail clubbing (ICNC) [MIM:119900] |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 339 | H | 0.138662 | D | 0.162098 | -0.023436 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 27 | T | 0.47623 | M | 0.420343 | 0.055887 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 42 | N | 0.302028 | H | 0.297785 | 0.004243 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 58 | R | 0.190071 | K | 0.234633 | -0.044562 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 203 | R | 0.127066 | K | 0.179693 | -0.052627 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 283 | V | 0.176725 | A | 0.231373 | -0.054648 | No Change: Both O | - |
| P00739 | HPTR_HUMAN Haptoglobin-related protein OS=Homo sapiens GN=HPR PE=1 SV=2 | 156 | A | 0.544351 | V | 0.440256 | 0.104095 | D to O | - |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 7 | G | 0.587026 | D | 0.626944 | -0.039918 | No Change: Both D | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 8 | V | 0.508105 | G | 0.641724 | -0.133619 | No Change: Both D | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 16 | G | 0.318242 | D | 0.369117 | -0.050875 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 16 | G | 0.318242 | S | 0.380796 | -0.062554 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 20 | D | 0.143387 | V | 0.06561 | 0.077777 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 23 | C | 0.083471 | W | 0.064926 | 0.018545 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 41 | L | 0.138965 | P | 0.261459 | -0.122494 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 42 | I | 0.181671 | F | 0.179404 | 0.002267 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 42 | I | 0.181671 | T | 0.291931 | -0.11026 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 45 | R | 0.336019 | K | 0.383628 | -0.047609 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 48 | R | 0.378373 | H | 0.36309 | 0.015283 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 50 | A | 0.42481 | V | 0.354252 | 0.070558 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 50 | A | 0.42481 | P | 0.51433 | -0.08952 | O to D | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 51 | R | 0.46842 | G | 0.474785 | -0.006365 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 51 | R | 0.46842 | P | 0.488827 | -0.020407 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 52 | D | 0.524888 | G | 0.504891 | 0.019997 | No Change: Both D | - |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 53 | V | 0.540582 | A | 0.640108 | -0.099526 | No Change: Both D | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 53 | V | 0.540582 | M | 0.627512 | -0.08693 | No Change: Both D | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 54 | M | 0.544074 | L | 0.467221 | 0.076853 | D to O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 57 | M | 0.4329 | T | 0.468078 | -0.035178 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 58 | G | 0.348829 | R | 0.330575 | 0.018254 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 61 | H | 0.127551 | R | 0.119163 | 0.008388 | No Change: Both O | - |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 70 | G | 0.07252 | E | 0.086332 | -0.013812 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 71 | G | 0.081722 | R | 0.07274 | 0.008982 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 74 | F | 0.080875 | L | 0.09542 | -0.014545 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 78 | L | 0.080319 | V | 0.074474 | 0.005845 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 80 | D | 0.087745 | V | 0.039012 | 0.048733 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 104 | S | 0.213989 | R | 0.169337 | 0.044652 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 110 | S | 0.407613 | L | 0.22626 | 0.181353 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 130 | V | 0.174482 | D | 0.306333 | -0.131851 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 131 | L | 0.145907 | S | 0.274612 | -0.128705 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 132 | I | 0.146774 | M | 0.203211 | -0.056437 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 132 | I | 0.146774 | T | 0.245757 | -0.098983 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 135 | D | 0.166281 | G | 0.148244 | 0.018037 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 143 | M | 0.30257 | K | 0.430752 | -0.128182 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 161 | A | 0.243286 | S | 0.373074 | -0.129788 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 162 | S | 0.243979 | R | 0.204992 | 0.038987 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 168 | T | 0.415548 | I | 0.276427 | 0.139121 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 176 | P | 0.309849 | L | 0.16115 | 0.148699 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 177 | D | 0.269227 | V | 0.155672 | 0.113555 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 177 | D | 0.269227 | Y | 0.155843 | 0.113384 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 188 | V | 0.08293 | A | 0.115871 | -0.032941 | No Change: Both O | - |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 183 | I | 0.161198 | T | 0.271338 | -0.11014 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 194 | D | 0.10519 | E | 0.118424 | -0.013234 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 194 | D | 0.10519 | N | 0.100091 | 0.005099 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 195 | Y | 0.142669 | C | 0.10575 | 0.036919 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 199 | F | 0.159629 | V | 0.189269 | -0.02964 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 201 | D | 0.111921 | G | 0.094452 | 0.017469 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 201 | D | 0.111921 | N | 0.110002 | 0.001919 | No Change: Both O | Gout HPRT-related (GOUT-HPRT) [MIM:300323] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 201 | D | 0.111921 | Y | 0.058001 | 0.05392 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 204 | H | 0.083073 | D | 0.105381 | -0.022308 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 204 | H | 0.083073 | R | 0.088251 | -0.005178 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| P00492 | HPRT_HUMAN Hypoxanthine-guanine phosphoribosyltransferase OS=Homo sapiens GN=HPRT1 PE=1 SV=2 | 206 | C | 0.100319 | Y | 0.127495 | -0.027176 | No Change: Both O | Lesch-Nyhan syndrome (LNS) [MIM:300322] |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 283 | G | 0.957198 | W | 0.925444 | 0.031754 | No Change: Both D | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 491 | P | 0.48937 | R | 0.458623 | 0.030747 | No Change: Both O | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 603 | Q | 0.140185 | R | 0.127148 | 0.013037 | No Change: Both O | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 630 | V | 0.271953 | I | 0.243471 | 0.028482 | No Change: Both O | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 100 | E | 0.702563 | D | 0.685741 | 0.016822 | No Change: Both D | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 186 | A | 0.18121 | V | 0.136554 | 0.044656 | No Change: Both O | - |
| Q92902 | HPS1_HUMAN Hermansky-Pudlak syndrome 1 protein OS=Homo sapiens GN=HPS1 PE=1 SV=2 | 480 | A | 0.155519 | T | 0.173999 | -0.01848 | No Change: Both O | - |
| Q969F9 | HPS3_HUMAN Hermansky-Pudlak syndrome 3 protein OS=Homo sapiens GN=HPS3 PE=1 SV=1 | 397 | R | 0.171094 | W | 0.065079 | 0.106015 | No Change: Both O | Hermansky-Pudlak syndrome type 3 (HPS3) [MIM:614072] |
| Q969F9 | HPS3_HUMAN Hermansky-Pudlak syndrome 3 protein OS=Homo sapiens GN=HPS3 PE=1 SV=1 | 397 | R | 0.171094 | Q | 0.191329 | -0.020235 | No Change: Both O | A colorectal cancer sample |
| Q969F9 | HPS3_HUMAN Hermansky-Pudlak syndrome 3 protein OS=Homo sapiens GN=HPS3 PE=1 SV=1 | 275 | E | 0.550619 | K | 0.544397 | 0.006222 | No Change: Both D | - |
| Q9NQG7 | HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein OS=Homo sapiens GN=HPS4 PE=1 SV=2 | 625 | Q | 0.398425 | H | 0.353634 | 0.044791 | No Change: Both O | - |
| Q9NQG7 | HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein OS=Homo sapiens GN=HPS4 PE=1 SV=2 | 443 | L | 0.979864 | V | 0.972152 | 0.007712 | No Change: Both D | - |
| Q9NQG7 | HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein OS=Homo sapiens GN=HPS4 PE=1 SV=2 | 606 | H | 0.321002 | Y | 0.237117 | 0.083885 | No Change: Both O | - |
| Q9NQG7 | HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein OS=Homo sapiens GN=HPS4 PE=1 SV=2 | 229 | E | 0.735637 | G | 0.701717 | 0.03392 | No Change: Both D | - |
| Q9NQG7 | HPS4_HUMAN Hermansky-Pudlak syndrome 4 protein OS=Homo sapiens GN=HPS4 PE=1 SV=2 | 552 | V | 0.119366 | M | 0.154936 | -0.03557 | No Change: Both O | - |
| Q9UPZ3 | HPS5_HUMAN Hermansky-Pudlak syndrome 5 protein OS=Homo sapiens GN=HPS5 PE=1 SV=2 | 417 | L | 0.506414 | M | 0.513548 | -0.007134 | No Change: Both D | - |
| Q9UPZ3 | HPS5_HUMAN Hermansky-Pudlak syndrome 5 protein OS=Homo sapiens GN=HPS5 PE=1 SV=2 | 624 | L | 0.629012 | R | 0.685511 | -0.056499 | No Change: Both D | Hermansky-Pudlak syndrome type 5 (HPS5) [MIM:614074] |
| Q9UPZ3 | HPS5_HUMAN Hermansky-Pudlak syndrome 5 protein OS=Homo sapiens GN=HPS5 PE=1 SV=2 | 1098 | T | 0.258216 | I | 0.175047 | 0.083169 | No Change: Both O | Hermansky-Pudlak syndrome type 5 (HPS5) [MIM:614074] |
| Q9Y251 | HPSE_HUMAN Heparanase OS=Homo sapiens GN=HPSE PE=1 SV=2 | 260 | N | 0.418106 | S | 0.4855 | -0.067394 | No Change: Both O | Some hepatocellular carcinoma |
| Q8WWQ2 | HPSE2_HUMAN Heparanase-2 OS=Homo sapiens GN=HPSE2 PE=2 SV=3 | 579 | Y | 0.090767 | F | 0.089716 | 0.001051 | No Change: Both O | - |
| Q8WWQ2 | HPSE2_HUMAN Heparanase-2 OS=Homo sapiens GN=HPSE2 PE=2 SV=3 | 315 | A | 0.102199 | T | 0.114952 | -0.012753 | No Change: Both O | - |
| P02790 | HEMO_HUMAN Hemopexin OS=Homo sapiens GN=HPX PE=1 SV=2 | 83 | R | 0.343343 | W | 0.174802 | 0.168541 | No Change: Both O | - |
| P02790 | HEMO_HUMAN Hemopexin OS=Homo sapiens GN=HPX PE=1 SV=2 | 52 | D | 0.429228 | N | 0.383433 | 0.045795 | No Change: Both O | - |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 620 | R | 0.520868 | Q | 0.478222 | 0.042646 | D to O | - |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 1022 | T | 0.226613 | A | 0.225181 | 0.001432 | No Change: Both O | Alopecia universalis congenita (ALUNC) [MIM:203655] |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 1136 | V | 0.500109 | D | 0.596921 | -0.096812 | No Change: Both D | Alopecia universalis congenita (ALUNC) [MIM:203655] |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 1012 | D | 0.074064 | N | 0.070603 | 0.003461 | No Change: Both O | Alopecia universalis congenita (ALUNC) [MIM:203655] |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 337 | G | 0.980954 | D | 0.975188 | 0.005766 | No Change: Both D | - |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 924 | P | 0.612215 | L | 0.467294 | 0.144921 | D to O | - |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 633 | R | 0.676085 | Q | 0.669228 | 0.006857 | No Change: Both D | A colorectal cancer sample |
| O43593 | HAIR_HUMAN Protein hairless OS=Homo sapiens GN=HR PE=1 SV=5 | 526 | L | 0.966637 | P | 0.980252 | -0.013615 | No Change: Both D | - |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | V | 0.175551 | 0.114682 | No Change: Both O | Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | V | 0.175551 | 0.114682 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | S | 0.333493 | -0.04326 | No Change: Both O | Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | S | 0.333493 | -0.04326 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | S | 0.333493 | -0.04326 | No Change: Both O | Oral squamous cell carcinoma (OSCC) |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 61 | Q | 0.473317 | L | 0.351509 | 0.121808 | No Change: Both O | Melanoma |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | A | 0.232773 | 0.05746 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 13 | G | 0.319217 | C | 0.146913 | 0.172304 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 13 | G | 0.319217 | D | 0.319804 | -5.87E-04 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | C | 0.129552 | 0.160681 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 12 | G | 0.290233 | E | 0.320167 | -0.029934 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 22 | Q | 0.130915 | K | 0.156413 | -0.025498 | No Change: Both O | Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 58 | T | 0.277061 | I | 0.177774 | 0.099287 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 61 | Q | 0.473317 | K | 0.50784 | -0.034523 | O to D | Follicular thyroid carcinoma samples |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 63 | E | 0.545875 | K | 0.530832 | 0.015043 | No Change: Both D | Congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 117 | K | 0.230745 | R | 0.209476 | 0.021269 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 146 | A | 0.390492 | T | 0.428942 | -0.03845 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| P01112 | RASH_HUMAN GTPase HRas OS=Homo sapiens GN=HRAS PE=1 SV=1 | 146 | A | 0.390492 | V | 0.339069 | 0.051423 | No Change: Both O | Faciocutaneoskeletal syndrome (FCSS) [MIM:218040] |
| Q96KN8 | HRSL5_HUMAN HRAS-like suppressor 5 OS=Homo sapiens GN=HRASLS5 PE=2 SV=2 | 93 | A | 0.82689 | P | 0.885865 | -0.058975 | No Change: Both D | - |
| Q96KN8 | HRSL5_HUMAN HRAS-like suppressor 5 OS=Homo sapiens GN=HRASLS5 PE=2 SV=2 | 31 | S | 0.963328 | G | 0.952738 | 0.01059 | No Change: Both D | - |
| Q96KN8 | HRSL5_HUMAN HRAS-like suppressor 5 OS=Homo sapiens GN=HRASLS5 PE=2 SV=2 | 214 | Q | 0.297855 | R | 0.293419 | 0.004436 | No Change: Both O | - |
| Q96KN8 | HRSL5_HUMAN HRAS-like suppressor 5 OS=Homo sapiens GN=HRASLS5 PE=2 SV=2 | 258 | A | 0.479752 | V | 0.37998 | 0.099772 | No Change: Both O | - |
| P23327 | SRCH_HUMAN Sarcoplasmic reticulum histidine-rich calcium-binding protein OS=Homo sapiens GN=HRC PE=2 SV=1 | 96 | S | 0.884602 | A | 0.813979 | 0.070623 | No Change: Both D | - |
| P23327 | SRCH_HUMAN Sarcoplasmic reticulum histidine-rich calcium-binding protein OS=Homo sapiens GN=HRC PE=2 SV=1 | 43 | S | 0.669483 | N | 0.643952 | 0.025531 | No Change: Both D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 204 | P | 0.41536 | S | 0.433501 | -0.018141 | No Change: Both O | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 118 | D | 0.486914 | G | 0.434973 | 0.051941 | No Change: Both O | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 340 | H | 0.9736 | R | 0.972431 | 0.001169 | No Change: Both D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 180 | I | 0.434146 | T | 0.595319 | -0.161173 | O to D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 436 | G | 0.982682 | R | 0.984895 | -0.002213 | No Change: Both D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 448 | R | 0.923028 | C | 0.895626 | 0.027402 | No Change: Both D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 493 | N | 0.953878 | I | 0.914283 | 0.039595 | No Change: Both D | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 79 | S | 0.318146 | L | 0.161437 | 0.156709 | No Change: Both O | - |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 103 | G | 0.396047 | E | 0.525128 | -0.129081 | O to D | Thrombophilia due to histidine-rich glycoprotein deficiency (THR-HRG) [MIM:613116] |
| P04196 | HRG_HUMAN Histidine-rich glycoprotein OS=Homo sapiens GN=HRG PE=1 SV=1 | 241 | C | 0.177862 | R | 0.298824 | -0.120962 | No Change: Both O | Thrombophilia due to histidine-rich glycoprotein deficiency (THR-HRG) [MIM:613116] |
| P35367 | HRH1_HUMAN Histamine H1 receptor OS=Homo sapiens GN=HRH1 PE=1 SV=1 | 270 | G | 0.959104 | E | 0.966987 | -0.007883 | No Change: Both D | - |
| P35367 | HRH1_HUMAN Histamine H1 receptor OS=Homo sapiens GN=HRH1 PE=1 SV=1 | 385 | D | 0.498975 | E | 0.528269 | -0.029294 | O to D | A colorectal cancer sample |
| P35367 | HRH1_HUMAN Histamine H1 receptor OS=Homo sapiens GN=HRH1 PE=1 SV=1 | 19 | K | 0.617435 | N | 0.588739 | 0.028696 | No Change: Both D | - |
| P25021 | HRH2_HUMAN Histamine H2 receptor OS=Homo sapiens GN=HRH2 PE=2 SV=1 | 217 | N | 0.365188 | D | 0.398423 | -0.033235 | No Change: Both O | - |
| P25021 | HRH2_HUMAN Histamine H2 receptor OS=Homo sapiens GN=HRH2 PE=2 SV=1 | 231 | K | 0.364661 | R | 0.302225 | 0.062436 | No Change: Both O | - |
| P25021 | HRH2_HUMAN Histamine H2 receptor OS=Homo sapiens GN=HRH2 PE=2 SV=1 | 268 | V | 0.122493 | M | 0.148892 | -0.026399 | No Change: Both O | - |
| Q9Y5N1 | HRH3_HUMAN Histamine H3 receptor OS=Homo sapiens GN=HRH3 PE=1 SV=2 | 280 | A | 0.763704 | V | 0.711258 | 0.052446 | No Change: Both D | - |
| Q9H3N8 | HRH4_HUMAN Histamine H4 receptor OS=Homo sapiens GN=HRH4 PE=1 SV=2 | 138 | A | 0.010306 | V | 0.007507 | 0.002799 | No Change: Both O | - |
| Q9H3N8 | HRH4_HUMAN Histamine H4 receptor OS=Homo sapiens GN=HRH4 PE=1 SV=2 | 206 | H | 0.35028 | R | 0.357759 | -0.007479 | No Change: Both O | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 85 | R | 0.172359 | H | 0.168146 | 0.004213 | No Change: Both O | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 167 | G | 0.956403 | D | 0.958637 | -0.002234 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 473 | E | 0.997871 | G | 0.997997 | -1.26E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 492 | G | 0.999643 | R | 0.999634 | 9.00E-06 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 664 | R | 0.998964 | Q | 0.999082 | -1.18E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 799 | S | 0.998749 | T | 0.99797 | 7.79E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 273 | H | 0.999847 | Q | 0.999875 | -2.80E-05 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 2435 | S | 0.999418 | G | 0.999244 | 1.74E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 2461 | G | 0.99899 | S | 0.999232 | -2.42E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 122 | R | 0.983755 | W | 0.965857 | 0.017898 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 376 | Q | 0.999805 | R | 0.999738 | 6.70E-05 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 427 | G | 0.999711 | D | 0.999606 | 1.05E-04 | No Change: Both D | - |
| Q86YZ3 | HORN_HUMAN Hornerin OS=Homo sapiens GN=HRNR PE=1 SV=2 | 517 | Y | 0.99974 | C | 0.999815 | -7.50E-05 | No Change: Both D | - |
| Q53T59 | H1BP3_HUMAN HCLS1-binding protein 3 OS=Homo sapiens GN=HS1BP3 PE=1 SV=1 | 260 | V | 0.896342 | M | 0.916 | -0.019658 | No Change: Both D | - |
| Q53T59 | H1BP3_HUMAN HCLS1-binding protein 3 OS=Homo sapiens GN=HS1BP3 PE=1 SV=1 | 273 | G | 0.856777 | R | 0.852305 | 0.004472 | No Change: Both D | - |
| Q53T59 | H1BP3_HUMAN HCLS1-binding protein 3 OS=Homo sapiens GN=HS1BP3 PE=1 SV=1 | 348 | P | 0.970997 | R | 0.960859 | 0.010138 | No Change: Both D | - |
| Q53T59 | H1BP3_HUMAN HCLS1-binding protein 3 OS=Homo sapiens GN=HS1BP3 PE=1 SV=1 | 388 | A | 0.695588 | T | 0.702103 | -0.006515 | No Change: Both D | - |
| O14792 | HS3S1_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Homo sapiens GN=HS3ST1 PE=1 SV=1 | 22 | P | 0.678282 | T | 0.582977 | 0.095305 | No Change: Both D | - |
| O14792 | HS3S1_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 1 OS=Homo sapiens GN=HS3ST1 PE=1 SV=1 | 295 | K | 0.379065 | R | 0.318086 | 0.060979 | No Change: Both O | - |
| Q9Y278 | HS3S2_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 2 OS=Homo sapiens GN=HS3ST2 PE=1 SV=1 | 339 | P | 0.336898 | A | 0.2563 | 0.080598 | No Change: Both O | - |
| Q8IZT8 | HS3S5_HUMAN Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Homo sapiens GN=HS3ST5 PE=1 SV=1 | 247 | I | 0.082125 | N | 0.165285 | -0.08316 | No Change: Both O | - |
| Q96MM7 | H6ST2_HUMAN Heparan-sulfate 6-O-sulfotransferase 2 OS=Homo sapiens GN=HS6ST2 PE=2 SV=2 | 127 | K | 0.256213 | N | 0.220632 | 0.035581 | No Change: Both O | - |
| Q8IZP7 | H6ST3_HUMAN Heparan-sulfate 6-O-sulfotransferase 3 OS=Homo sapiens GN=HS6ST3 PE=2 SV=3 | 265 | K | 0.338657 | R | 0.302674 | 0.035983 | No Change: Both O | - |
| Q8IWL3 | HSC20_HUMAN Iron-sulfur cluster co-chaperone protein HscB mitochondrial OS=Homo sapiens GN=HSCB PE=1 SV=3 | 73 | Y | 0.495219 | C | 0.585218 | -0.089999 | O to D | - |
| Q8IWL3 | HSC20_HUMAN Iron-sulfur cluster co-chaperone protein HscB mitochondrial OS=Homo sapiens GN=HSCB PE=1 SV=3 | 163 | I | 0.313142 | M | 0.411997 | -0.098855 | No Change: Both O | - |
| P28845 | DHI1_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 1 OS=Homo sapiens GN=HSD11B1 PE=1 SV=3 | 148 | V | 0.047472 | E | 0.102558 | -0.055086 | No Change: Both O | A breast cancer sample |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 208 | R | 0.331386 | C | 0.192407 | 0.138979 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 213 | R | 0.403443 | C | 0.231021 | 0.172422 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 179 | L | 0.33061 | R | 0.458543 | -0.127933 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 180 | S | 0.284586 | F | 0.134652 | 0.149934 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 186 | R | 0.156539 | C | 0.086432 | 0.070107 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 208 | R | 0.331386 | H | 0.303556 | 0.02783 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 227 | P | 0.280229 | L | 0.152881 | 0.127348 | No Change: Both O | - |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 237 | A | 0.243045 | V | 0.176438 | 0.066607 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 244 | D | 0.088025 | N | 0.081472 | 0.006553 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 250 | L | 0.074631 | R | 0.116952 | -0.042321 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 279 | R | 0.340465 | C | 0.18454 | 0.155925 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 328 | A | 0.203316 | V | 0.141434 | 0.061882 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 338 | Y | 0.426841 | H | 0.543304 | -0.116463 | O to D | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 147 | R | 0.276318 | H | 0.279261 | -0.002943 | No Change: Both O | - |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 223 | D | 0.386546 | N | 0.370557 | 0.015989 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P80365 | DHI2_HUMAN Corticosteroid 11-beta-dehydrogenase isozyme 2 OS=Homo sapiens GN=HSD11B2 PE=1 SV=2 | 337 | R | 0.413291 | C | 0.220761 | 0.19253 | No Change: Both O | Apparent mineralocorticoid excess (AME) [MIM:218030] |
| P14061 | DHB1_HUMAN Estradiol 17-beta-dehydrogenase 1 OS=Homo sapiens GN=HSD17B1 PE=1 SV=3 | 238 | A | 0.347231 | V | 0.273826 | 0.073405 | No Change: Both O | - |
| P14061 | DHB1_HUMAN Estradiol 17-beta-dehydrogenase 1 OS=Homo sapiens GN=HSD17B1 PE=1 SV=3 | 313 | G | 0.981474 | S | 0.97781 | 0.003664 | No Change: Both D | - |
| Q99714 | HCD2_HUMAN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens GN=HSD17B10 PE=1 SV=3 | 122 | L | 0.105223 | V | 0.109398 | -0.004175 | No Change: Both O | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency) [MIM:300438] |
| Q99714 | HCD2_HUMAN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens GN=HSD17B10 PE=1 SV=3 | 130 | R | 0.108721 | C | 0.053086 | 0.055635 | No Change: Both O | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency) [MIM:300438] |
| Q99714 | HCD2_HUMAN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Homo sapiens GN=HSD17B10 PE=1 SV=3 | 247 | N | 0.161649 | S | 0.176527 | -0.014878 | No Change: Both O | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (MHBD deficiency) [MIM:300438] |
| Q53GQ0 | DHB12_HUMAN Estradiol 17-beta-dehydrogenase 12 OS=Homo sapiens GN=HSD17B12 PE=1 SV=2 | 280 | S | 0.16083 | L | 0.074125 | 0.086705 | No Change: Both O | - |
| Q9BPX1 | DHB14_HUMAN 17-beta-hydroxysteroid dehydrogenase 14 OS=Homo sapiens GN=HSD17B14 PE=1 SV=1 | 31 | N | 0.150852 | D | 0.1701 | -0.019248 | No Change: Both O | - |
| Q9BPX1 | DHB14_HUMAN 17-beta-hydroxysteroid dehydrogenase 14 OS=Homo sapiens GN=HSD17B14 PE=1 SV=1 | 130 | R | 0.265237 | W | 0.122047 | 0.14319 | No Change: Both O | - |
| P37059 | DHB2_HUMAN Estradiol 17-beta-dehydrogenase 2 OS=Homo sapiens GN=HSD17B2 PE=1 SV=1 | 121 | A | 0.633947 | T | 0.664976 | -0.031029 | No Change: Both D | - |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 80 | R | 0.159406 | Q | 0.167657 | -0.008251 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 80 | R | 0.159406 | W | 0.06322 | 0.096186 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 203 | A | 0.224048 | V | 0.16074 | 0.063308 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 232 | S | 0.222783 | L | 0.112695 | 0.110088 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 235 | M | 0.26415 | V | 0.225179 | 0.038971 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 31 | V | 0.023713 | I | 0.018747 | 0.004966 | No Change: Both O | - |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 289 | G | 0.071386 | S | 0.097318 | -0.025932 | No Change: Both O | - |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 56 | A | 0.25163 | T | 0.274281 | -0.022651 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 65 | S | 0.278375 | L | 0.142699 | 0.135676 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 130 | N | 0.100562 | S | 0.110719 | -0.010157 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 176 | Q | 0.469306 | P | 0.487689 | -0.018383 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 205 | V | 0.179289 | E | 0.345693 | -0.166404 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 208 | F | 0.165815 | I | 0.155455 | 0.01036 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 268 | C | 0.110091 | Y | 0.128724 | -0.018633 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 282 | P | 0.046085 | L | 0.02284 | 0.023245 | No Change: Both O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 215 | E | 0.508201 | D | 0.456706 | 0.051495 | D to O | Male pseudohermaphrodism with gynecomastia (MPH) [MIM:264300] |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 289 | G | 0.071386 | C | 0.030051 | 0.041335 | No Change: Both O | - |
| P37058 | DHB3_HUMAN Testosterone 17-beta-dehydrogenase 3 OS=Homo sapiens GN=HSD17B3 PE=1 SV=2 | 289 | G | 0.071386 | R | 0.07202 | -6.34E-04 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 106 | R | 0.309238 | H | 0.292138 | 0.0171 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 511 | W | 0.236764 | R | 0.443737 | -0.206973 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 559 | I | 0.290018 | V | 0.339147 | -0.049129 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 292 | T | 0.668437 | S | 0.753716 | -0.085279 | No Change: Both D | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 16 | G | 0.225656 | S | 0.246504 | -0.020848 | No Change: Both O | D-bifunctional protein deficiency (DBPD) [MIM:261515] |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 90 | F | 0.138354 | L | 0.163767 | -0.025413 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 140 | K | 0.461258 | N | 0.395896 | 0.065362 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 427 | A | 0.16791 | V | 0.124098 | 0.043812 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 491 | A | 0.456137 | T | 0.507199 | -0.051062 | O to D | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 606 | A | 0.416021 | S | 0.52213 | -0.106109 | O to D | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 687 | T | 0.272775 | I | 0.172876 | 0.099899 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 728 | M | 0.269309 | V | 0.187527 | 0.081782 | No Change: Both O | - |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 106 | R | 0.309238 | P | 0.326721 | -0.017483 | No Change: Both O | D-bifunctional protein deficiency (DBPD) [MIM:261515] |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 217 | Y | 0.153753 | C | 0.137782 | 0.015971 | No Change: Both O | Perrault syndrome (PRS) [MIM:233400] |
| P51659 | DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens GN=HSD17B4 PE=1 SV=3 | 457 | N | 0.098432 | Y | 0.053196 | 0.045236 | No Change: Both O | D-bifunctional protein deficiency (DBPD) [MIM:261515] |
| Q92506 | DHB8_HUMAN Estradiol 17-beta-dehydrogenase 8 OS=Homo sapiens GN=HSD17B8 PE=1 SV=2 | 158 | V | 0.282977 | L | 0.263132 | 0.019845 | No Change: Both O | A breast cancer sample |
| Q92506 | DHB8_HUMAN Estradiol 17-beta-dehydrogenase 8 OS=Homo sapiens GN=HSD17B8 PE=1 SV=2 | 190 | H | 0.286595 | R | 0.31449 | -0.027895 | No Change: Both O | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 367 | T | 0.754995 | N | 0.753757 | 0.001238 | No Change: Both D | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 79 | I | 0.055551 | V | 0.064139 | -0.008588 | No Change: Both O | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 286 | F | 0.140995 | L | 0.174557 | -0.033562 | No Change: Both O | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 54 | T | 0.467804 | I | 0.334008 | 0.133796 | No Change: Both O | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 71 | R | 0.15212 | I | 0.084018 | 0.068102 | No Change: Both O | - |
| P14060 | 3BHS1_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 OS=Homo sapiens GN=HSD3B1 PE=1 SV=2 | 90 | G | 0.092016 | S | 0.121862 | -0.029846 | No Change: Both O | - |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 142 | E | 0.630243 | K | 0.610523 | 0.01972 | No Change: Both D | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 205 | L | 0.470496 | P | 0.63373 | -0.163234 | O to D | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 245 | A | 0.644013 | P | 0.716471 | -0.072458 | No Change: Both D | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 253 | Y | 0.21889 | N | 0.340779 | -0.121889 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 254 | Y | 0.270652 | D | 0.435136 | -0.164484 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 259 | T | 0.540238 | R | 0.551558 | -0.01132 | No Change: Both D | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 10 | A | 0.1553 | E | 0.241318 | -0.086018 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 10 | A | 0.1553 | V | 0.120705 | 0.034595 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 15 | G | 0.185893 | D | 0.184048 | 0.001845 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 82 | A | 0.032063 | T | 0.04004 | -0.007977 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 100 | N | 0.307152 | S | 0.348516 | -0.041364 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 108 | L | 0.122168 | W | 0.078029 | 0.044139 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 129 | G | 0.442486 | R | 0.431911 | 0.010575 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 155 | P | 0.443961 | L | 0.270832 | 0.173129 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 167 | A | 0.199629 | V | 0.140275 | 0.059354 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 173 | L | 0.265045 | R | 0.347581 | -0.082536 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 186 | P | 0.114152 | L | 0.060209 | 0.053943 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 213 | S | 0.391923 | G | 0.334961 | 0.056962 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 216 | K | 0.349202 | E | 0.351157 | -0.001955 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 222 | P | 0.166789 | H | 0.14755 | 0.019239 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 222 | P | 0.166789 | Q | 0.155714 | 0.011075 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 236 | L | 0.120733 | S | 0.221559 | -0.100826 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 259 | T | 0.540238 | M | 0.495297 | 0.044941 | D to O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 294 | G | 0.013824 | V | 0.007899 | 0.005925 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 94 | E | 0.291943 | Q | 0.248115 | 0.043828 | No Change: Both O | - |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 222 | P | 0.166789 | T | 0.146447 | 0.020342 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 74 | D | 0.128125 | N | 0.119276 | 0.008849 | No Change: Both O | - |
| P26439 | 3BHS2_HUMAN 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 OS=Homo sapiens GN=HSD3B2 PE=1 SV=2 | 341 | P | 0.250301 | L | 0.159205 | 0.091096 | No Change: Both O | Adrenal hyperplasia type 2 (AH2) [MIM:201810] |
| Q9H2F3 | 3BHS7_HUMAN 3 beta-hydroxysteroid dehydrogenase type 7 OS=Homo sapiens GN=HSD3B7 PE=1 SV=2 | 250 | T | 0.294699 | A | 0.284519 | 0.01018 | No Change: Both O | - |
| Q9H2F3 | 3BHS7_HUMAN 3 beta-hydroxysteroid dehydrogenase type 7 OS=Homo sapiens GN=HSD3B7 PE=1 SV=2 | 347 | L | 0.268758 | P | 0.442494 | -0.173736 | No Change: Both O | - |
| Q9H2F3 | 3BHS7_HUMAN 3 beta-hydroxysteroid dehydrogenase type 7 OS=Homo sapiens GN=HSD3B7 PE=1 SV=2 | 19 | G | 0.125426 | S | 0.140125 | -0.014699 | No Change: Both O | Congenital bile acid synthesis defect type 1 (CBAS1) [MIM:607765] |
| Q9H2F3 | 3BHS7_HUMAN 3 beta-hydroxysteroid dehydrogenase type 7 OS=Homo sapiens GN=HSD3B7 PE=1 SV=2 | 147 | E | 0.551542 | K | 0.538633 | 0.012909 | No Change: Both D | Congenital bile acid synthesis defect type 1 (CBAS1) [MIM:607765] |
| Q6ZVN6 | YO003_HUMAN Uncharacterized protein HSD47 OS=Homo sapiens GN=HSD47 PE=4 SV=2 | 53 | S | 0.853318 | I | 0.728395 | 0.124923 | No Change: Both D | - |
| Q3SXM5 | HSDL1_HUMAN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Homo sapiens GN=HSDL1 PE=1 SV=3 | 248 | P | 0.062914 | S | 0.078038 | -0.015124 | No Change: Both O | - |
| Q3SXM5 | HSDL1_HUMAN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Homo sapiens GN=HSDL1 PE=1 SV=3 | 327 | S | 0.826843 | C | 0.549585 | 0.277258 | No Change: Both D | - |
| Q9ULV5 | HSF4_HUMAN Heat shock factor protein 4 OS=Homo sapiens GN=HSF4 PE=1 SV=2 | 19 | A | 0.383913 | D | 0.45004 | -0.066127 | No Change: Both O | Cataract zonular HSF4-related (CZ-HSF4) [MIM:116800] |
| Q9ULV5 | HSF4_HUMAN Heat shock factor protein 4 OS=Homo sapiens GN=HSF4 PE=1 SV=2 | 86 | I | 0.299502 | V | 0.366548 | -0.067046 | No Change: Both O | Cataract zonular HSF4-related (CZ-HSF4) [MIM:116800] |
| Q9ULV5 | HSF4_HUMAN Heat shock factor protein 4 OS=Homo sapiens GN=HSF4 PE=1 SV=2 | 114 | L | 0.761438 | P | 0.855138 | -0.0937 | No Change: Both D | Cataract zonular HSF4-related (CZ-HSF4) [MIM:116800] |
| Q9ULV5 | HSF4_HUMAN Heat shock factor protein 4 OS=Homo sapiens GN=HSF4 PE=1 SV=2 | 119 | R | 0.773245 | C | 0.622909 | 0.150336 | No Change: Both D | Cataract Marner type (CAM) [MIM:116800] |
| Q9ULV5 | HSF4_HUMAN Heat shock factor protein 4 OS=Homo sapiens GN=HSF4 PE=1 SV=2 | 73 | R | 0.219697 | H | 0.217326 | 0.002371 | No Change: Both O | Cataract zonular HSF4-related (CZ-HSF4) [MIM:116800] |
| Q4G112 | HSF5_HUMAN Heat shock factor protein 5 OS=Homo sapiens GN=HSF5 PE=2 SV=2 | 329 | N | 0.659599 | T | 0.645537 | 0.014062 | No Change: Both D | - |
| Q4G112 | HSF5_HUMAN Heat shock factor protein 5 OS=Homo sapiens GN=HSF5 PE=2 SV=2 | 473 | S | 0.61316 | N | 0.569846 | 0.043314 | No Change: Both D | - |
| Q14568 | HS902_HUMAN Putative heat shock protein HSP 90-alpha A2 OS=Homo sapiens GN=HSP90AA2 PE=1 SV=2 | 235 | T | 0.964452 | A | 0.954537 | 0.009915 | No Change: Both D | - |
| Q14568 | HS902_HUMAN Putative heat shock protein HSP 90-alpha A2 OS=Homo sapiens GN=HSP90AA2 PE=1 SV=2 | 312 | C | 0.27459 | Y | 0.333929 | -0.059339 | No Change: Both O | - |
| P08238 | HS90B_HUMAN Heat shock protein HSP 90-beta OS=Homo sapiens GN=HSP90AB1 PE=1 SV=4 | 349 | K | 0.618655 | E | 0.60854 | 0.010115 | No Change: Both D | - |
| Q96MM6 | HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens GN=HSPA12B PE=1 SV=2 | 23 | V | 0.973847 | L | 0.978003 | -0.004156 | No Change: Both D | - |
| Q96MM6 | HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens GN=HSPA12B PE=1 SV=2 | 270 | R | 0.810836 | H | 0.769454 | 0.041382 | No Change: Both D | - |
| Q0VDF9 | HSP7E_HUMAN Heat shock 70 kDa protein 14 OS=Homo sapiens GN=HSPA14 PE=1 SV=1 | 85 | A | 0.375581 | V | 0.320018 | 0.055563 | No Change: Both O | A breast cancer sample |
| P08107 | HSP71_HUMAN Heat shock 70 kDa protein 1A/1B OS=Homo sapiens GN=HSPA1A PE=1 SV=5 | 110 | E | 0.470325 | D | 0.435077 | 0.035248 | No Change: Both O | - |
| P08107 | HSP71_HUMAN Heat shock 70 kDa protein 1A/1B OS=Homo sapiens GN=HSPA1A PE=1 SV=5 | 499 | N | 0.639462 | S | 0.667403 | -0.027941 | No Change: Both D | - |
| P08107 | HSP71_HUMAN Heat shock 70 kDa protein 1A/1B OS=Homo sapiens GN=HSPA1A PE=1 SV=5 | 95 | I | 0.297168 | V | 0.350282 | -0.053114 | No Change: Both O | - |
| P08107 | HSP71_HUMAN Heat shock 70 kDa protein 1A/1B OS=Homo sapiens GN=HSPA1A PE=1 SV=5 | 467 | A | 0.454167 | V | 0.390609 | 0.063558 | No Change: Both O | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 493 | T | 0.469345 | M | 0.40945 | 0.059895 | No Change: Both O | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 8 | A | 0.231414 | P | 0.28578 | -0.054366 | No Change: Both O | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 268 | A | 0.593298 | T | 0.631983 | -0.038685 | No Change: Both D | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 294 | D | 0.236656 | G | 0.210878 | 0.025778 | No Change: Both O | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 479 | T | 0.219673 | M | 0.182555 | 0.037118 | No Change: Both O | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 558 | E | 0.681405 | A | 0.586746 | 0.094659 | No Change: Both D | - |
| P34931 | HS71L_HUMAN Heat shock 70 kDa protein 1-like OS=Homo sapiens GN=HSPA1L PE=1 SV=2 | 602 | E | 0.440935 | K | 0.446402 | -0.005467 | No Change: Both O | - |
| P54652 | HSP72_HUMAN Heat shock-related 70 kDa protein 2 OS=Homo sapiens GN=HSPA2 PE=1 SV=1 | 191 | C | 0.448149 | S | 0.670157 | -0.222008 | O to D | - |
| P54652 | HSP72_HUMAN Heat shock-related 70 kDa protein 2 OS=Homo sapiens GN=HSPA2 PE=1 SV=1 | 496 | K | 0.570779 | E | 0.56394 | 0.006839 | No Change: Both D | - |
| O95757 | HS74L_HUMAN Heat shock 70 kDa protein 4L OS=Homo sapiens GN=HSPA4L PE=1 SV=3 | 211 | L | 0.069958 | S | 0.169762 | -0.099804 | No Change: Both O | - |
| O95757 | HS74L_HUMAN Heat shock 70 kDa protein 4L OS=Homo sapiens GN=HSPA4L PE=1 SV=3 | 216 | N | 0.134816 | T | 0.118135 | 0.016681 | No Change: Both O | - |
| O95757 | HS74L_HUMAN Heat shock 70 kDa protein 4L OS=Homo sapiens GN=HSPA4L PE=1 SV=3 | 601 | I | 0.485342 | T | 0.599502 | -0.11416 | O to D | - |
| P11021 | GRP78_HUMAN 78 kDa glucose-regulated protein OS=Homo sapiens GN=HSPA5 PE=1 SV=2 | 543 | N | 0.812784 | H | 0.752331 | 0.060453 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 198 | L | 0.14543 | F | 0.130175 | 0.015255 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 562 | D | 0.777279 | E | 0.806452 | -0.029173 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 150 | A | 0.165564 | T | 0.184599 | -0.019035 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 153 | N | 0.327168 | S | 0.379547 | -0.052379 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 154 | D | 0.4067 | N | 0.398898 | 0.007802 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 170 | N | 0.090001 | K | 0.103577 | -0.013576 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 173 | R | 0.108117 | P | 0.134134 | -0.026017 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 178 | P | 0.190527 | A | 0.157061 | 0.033466 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 194 | E | 0.312713 | K | 0.312372 | 3.41E-04 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 260 | R | 0.767398 | H | 0.711848 | 0.05555 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 464 | S | 0.349256 | I | 0.187047 | 0.162209 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 471 | R | 0.405268 | H | 0.406549 | -0.001281 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 528 | K | 0.807386 | E | 0.825682 | -0.018296 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 572 | M | 0.792064 | V | 0.761589 | 0.030475 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 577 | R | 0.708795 | Q | 0.714834 | -0.006039 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 626 | T | 0.80687 | A | 0.788468 | 0.018402 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 336 | V | 0.188175 | F | 0.161117 | 0.027058 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 528 | K | 0.807386 | R | 0.798341 | 0.009045 | No Change: Both D | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 65 | P | 0.363911 | T | 0.337365 | 0.026546 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 95 | R | 0.292746 | Q | 0.303863 | -0.011117 | No Change: Both O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 159 | A | 0.5919 | V | 0.497098 | 0.094802 | D to O | - |
| P17066 | HSP76_HUMAN Heat shock 70 kDa protein 6 OS=Homo sapiens GN=HSPA6 PE=1 SV=2 | 297 | T | 0.349702 | K | 0.372393 | -0.022691 | No Change: Both O | - |
| P11142 | HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1 | 32 | D | 0.435827 | Y | 0.290271 | 0.145556 | No Change: Both O | - |
| P11142 | HSP7C_HUMAN Heat shock cognate 71 kDa protein OS=Homo sapiens GN=HSPA8 PE=1 SV=1 | 459 | F | 0.274839 | L | 0.327516 | -0.052677 | No Change: Both O | - |
| P38646 | GRP75_HUMAN Stress-70 protein mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 | 74 | Q | 0.445004 | R | 0.438125 | 0.006879 | No Change: Both O | - |
| P38646 | GRP75_HUMAN Stress-70 protein mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 | 184 | H | 0.310835 | Y | 0.22378 | 0.087055 | No Change: Both O | - |
| P38646 | GRP75_HUMAN Stress-70 protein mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 | 127 | R | 0.369054 | G | 0.367614 | 0.00144 | No Change: Both O | - |
| P38646 | GRP75_HUMAN Stress-70 protein mitochondrial OS=Homo sapiens GN=HSPA9 PE=1 SV=2 | 225 | A | 0.192321 | G | 0.225928 | -0.033607 | No Change: Both O | - |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 127 | R | 0.656168 | W | 0.554683 | 0.101485 | No Change: Both D | Distal hereditary motor neuronopathy type 2B (HMN2B) [MIM:608634] |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 135 | S | 0.438142 | F | 0.2744 | 0.163742 | No Change: Both O | Charcot-Marie-Tooth disease type 2F (CMT2F) [MIM:606595] |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 135 | S | 0.438142 | F | 0.2744 | 0.163742 | No Change: Both O | Distal hereditary motor neuronopathy type 2B (HMN2B) [MIM:608634] |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 136 | R | 0.469598 | W | 0.240658 | 0.22894 | No Change: Both O | Charcot-Marie-Tooth disease type 2F (CMT2F) [MIM:606595] |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 151 | T | 0.728965 | I | 0.609494 | 0.119471 | No Change: Both D | Distal hereditary motor neuronopathy type 2B (HMN2B) [MIM:608634] |
| P04792 | HSPB1_HUMAN Heat shock protein beta-1 OS=Homo sapiens GN=HSPB1 PE=1 SV=2 | 182 | P | 0.708331 | L | 0.552915 | 0.155416 | No Change: Both D | Distal hereditary motor neuronopathy type 2B (HMN2B) [MIM:608634] |
| Q16082 | HSPB2_HUMAN Heat shock protein beta-2 OS=Homo sapiens GN=HSPB2 PE=1 SV=2 | 111 | G | 0.343529 | S | 0.422021 | -0.078492 | No Change: Both O | - |
| Q12988 | HSPB3_HUMAN Heat shock protein beta-3 OS=Homo sapiens GN=HSPB3 PE=1 SV=2 | 67 | G | 0.612449 | S | 0.665704 | -0.053255 | No Change: Both D | - |
| Q12988 | HSPB3_HUMAN Heat shock protein beta-3 OS=Homo sapiens GN=HSPB3 PE=1 SV=2 | 7 | R | 0.119451 | S | 0.154753 | -0.035302 | No Change: Both O | Distal hereditary motor neuronopathy type 2C (HMN2C) [MIM:613376] |
| Q9UJY1 | HSPB8_HUMAN Heat shock protein beta-8 OS=Homo sapiens GN=HSPB8 PE=1 SV=1 | 141 | K | 0.429884 | E | 0.426499 | 0.003385 | No Change: Both O | Distal hereditary motor neuronopathy type 2A (HMN2A) [MIM:158590] |
| Q9UJY1 | HSPB8_HUMAN Heat shock protein beta-8 OS=Homo sapiens GN=HSPB8 PE=1 SV=1 | 141 | K | 0.429884 | N | 0.367866 | 0.062018 | No Change: Both O | Charcot-Marie-Tooth disease type 2L (CMT2L) [MIM:608673] |
| Q9UJY1 | HSPB8_HUMAN Heat shock protein beta-8 OS=Homo sapiens GN=HSPB8 PE=1 SV=1 | 141 | K | 0.429884 | N | 0.367866 | 0.062018 | No Change: Both O | Distal hereditary motor neuronopathy type 2A (HMN2A) [MIM:158590] |
| Q9UJY1 | HSPB8_HUMAN Heat shock protein beta-8 OS=Homo sapiens GN=HSPB8 PE=1 SV=1 | 67 | G | 0.787371 | S | 0.820725 | -0.033354 | No Change: Both D | A glioblastoma multiforme sample |
| Q9UJY1 | HSPB8_HUMAN Heat shock protein beta-8 OS=Homo sapiens GN=HSPB8 PE=1 SV=1 | 78 | R | 0.728891 | M | 0.671829 | 0.057062 | No Change: Both D | - |
| Q9BQS6 | HSPB9_HUMAN Heat shock protein beta-9 OS=Homo sapiens GN=HSPB9 PE=1 SV=1 | 2 | Q | 0.838908 | P | 0.880931 | -0.042023 | No Change: Both D | - |
| Q96EW2 | HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens GN=HSPBAP1 PE=1 SV=1 | 64 | S | 0.227894 | A | 0.160194 | 0.0677 | No Change: Both O | - |
| P10809 | CH60_HUMAN 60 kDa heat shock protein mitochondrial OS=Homo sapiens GN=HSPD1 PE=1 SV=2 | 98 | V | 0.351556 | I | 0.32257 | 0.028986 | No Change: Both O | Spastic paraplegia autosomal dominant type 13 (SPG13) [MIM:605280] |
| P10809 | CH60_HUMAN 60 kDa heat shock protein mitochondrial OS=Homo sapiens GN=HSPD1 PE=1 SV=2 | 29 | D | 0.350392 | G | 0.327316 | 0.023076 | No Change: Both O | Leukodystrophy hypomyelinating type 4 (HLD4) [MIM:612233] |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1532 | C | 0.48161 | Y | 0.422609 | 0.059001 | No Change: Both O | Schwartz-Jampel syndrome (SJS1) [MIM:255800] |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 68 | D | 0.709638 | E | 0.703351 | 0.006287 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 638 | M | 0.276836 | V | 0.227806 | 0.04903 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 765 | N | 0.566377 | S | 0.620905 | -0.054528 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1186 | R | 0.966035 | Q | 0.972495 | -0.00646 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1503 | A | 0.495935 | V | 0.415394 | 0.080541 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1758 | R | 0.526962 | Q | 0.548059 | -0.021097 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1919 | R | 0.344915 | C | 0.253798 | 0.091117 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1967 | V | 0.537244 | I | 0.47121 | 0.066034 | D to O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 2980 | L | 0.505214 | H | 0.61126 | -0.106046 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 2981 | V | 0.533171 | I | 0.469521 | 0.06365 | D to O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 2995 | S | 0.771903 | G | 0.726187 | 0.045716 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 3168 | A | 0.348885 | T | 0.374261 | -0.025376 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 3256 | H | 0.334711 | Y | 0.222462 | 0.112249 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 3530 | R | 0.356376 | W | 0.175413 | 0.180963 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 3632 | R | 0.439109 | Q | 0.462636 | -0.023527 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 3640 | V | 0.273983 | I | 0.224668 | 0.049315 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 4331 | S | 0.341297 | N | 0.313177 | 0.02812 | No Change: Both O | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 303 | L | 0.907999 | H | 0.924454 | -0.016455 | No Change: Both D | - |
| P98160 | PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens GN=HSPG2 PE=1 SV=4 | 1323 | L | 0.277596 | V | 0.247878 | 0.029718 | No Change: Both O | - |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 106 | R | 0.231864 | S | 0.269481 | -0.037617 | No Change: Both O | A hepatocellular carcinoma sample |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 108 | D | 0.232988 | Y | 0.125415 | 0.107573 | No Change: Both O | A hepatocellular carcinoma sample |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 116 | A | 0.380072 | T | 0.382581 | -0.002509 | No Change: Both O | A hepatocellular carcinoma sample |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 134 | G | 0.658765 | V | 0.573788 | 0.084977 | No Change: Both D | A hepatocellular carcinoma sample |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 144 | L | 0.284486 | I | 0.214563 | 0.069923 | No Change: Both O | A hepatocellular carcinoma sample |
| Q9BUP3 | HTAI2_HUMAN Oxidoreductase HTATIP2 OS=Homo sapiens GN=HTATIP2 PE=1 SV=2 | 197 | S | 0.411149 | R | 0.337573 | 0.073576 | No Change: Both O | - |
| O43719 | HTSF1_HUMAN HIV Tat-specific factor 1 OS=Homo sapiens GN=HTATSF1 PE=1 SV=1 | 478 | G | 0.998738 | A | 0.998211 | 5.27E-04 | No Change: Both D | - |
| O43719 | HTSF1_HUMAN HIV Tat-specific factor 1 OS=Homo sapiens GN=HTATSF1 PE=1 SV=1 | 526 | N | 0.998535 | T | 0.998445 | 9.00E-05 | No Change: Both D | - |
| O43719 | HTSF1_HUMAN HIV Tat-specific factor 1 OS=Homo sapiens GN=HTATSF1 PE=1 SV=1 | 678 | D | 0.998098 | G | 0.997363 | 7.35E-04 | No Change: Both D | - |
| P15516 | HIS3_HUMAN Histatin-3 OS=Homo sapiens GN=HTN3 PE=1 SV=2 | 41 | R | 0.769024 | Q | 0.731649 | 0.037375 | No Change: Both D | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 16 | P | 0.760357 | L | 0.611559 | 0.148798 | No Change: Both D | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 22 | G | 0.653182 | S | 0.692653 | -0.039471 | No Change: Both D | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 28 | I | 0.47283 | V | 0.52456 | -0.05173 | O to D | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 184 | P | 0.693262 | L | 0.499674 | 0.193588 | D to O | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 220 | R | 0.094441 | L | 0.050663 | 0.043778 | No Change: Both O | - |
| P08908 | 5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 | 273 | G | 0.555052 | D | 0.552458 | 0.002594 | No Change: Both D | - |
| P28222 | 5HT1B_HUMAN 5-hydroxytryptamine receptor 1B OS=Homo sapiens GN=HTR1B PE=1 SV=1 | 124 | F | 0.037398 | C | 0.038413 | -0.001015 | No Change: Both O | - |
| P28222 | 5HT1B_HUMAN 5-hydroxytryptamine receptor 1B OS=Homo sapiens GN=HTR1B PE=1 SV=1 | 219 | F | 0.033684 | L | 0.040536 | -0.006852 | No Change: Both O | - |
| P28222 | 5HT1B_HUMAN 5-hydroxytryptamine receptor 1B OS=Homo sapiens GN=HTR1B PE=1 SV=1 | 367 | I | 0.139554 | V | 0.14567 | -0.006116 | No Change: Both O | - |
| P28222 | 5HT1B_HUMAN 5-hydroxytryptamine receptor 1B OS=Homo sapiens GN=HTR1B PE=1 SV=1 | 374 | E | 0.415271 | K | 0.435343 | -0.020072 | No Change: Both O | - |
| P28221 | 5HT1D_HUMAN 5-hydroxytryptamine receptor 1D OS=Homo sapiens GN=HTR1D PE=2 SV=1 | 265 | S | 0.773575 | L | 0.663416 | 0.110159 | No Change: Both D | - |
| P28566 | 5HT1E_HUMAN 5-hydroxytryptamine receptor 1E OS=Homo sapiens GN=HTR1E PE=2 SV=1 | 262 | S | 0.653312 | F | 0.505332 | 0.14798 | No Change: Both D | - |
| P28566 | 5HT1E_HUMAN 5-hydroxytryptamine receptor 1E OS=Homo sapiens GN=HTR1E PE=2 SV=1 | 208 | A | 0.195833 | T | 0.20673 | -0.010897 | No Change: Both O | - |
| P28223 | 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A OS=Homo sapiens GN=HTR2A PE=1 SV=2 | 25 | T | 0.769254 | N | 0.799314 | -0.03006 | No Change: Both D | - |
| P28223 | 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A OS=Homo sapiens GN=HTR2A PE=1 SV=2 | 452 | H | 0.931112 | Y | 0.895007 | 0.036105 | No Change: Both D | - |
| P28223 | 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A OS=Homo sapiens GN=HTR2A PE=1 SV=2 | 197 | I | 0.031154 | V | 0.035261 | -0.004107 | No Change: Both O | - |
| P28223 | 5HT2A_HUMAN 5-hydroxytryptamine receptor 2A OS=Homo sapiens GN=HTR2A PE=1 SV=2 | 447 | A | 0.90761 | V | 0.88527 | 0.02234 | No Change: Both D | - |
| P41595 | 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B OS=Homo sapiens GN=HTR2B PE=1 SV=1 | 421 | M | 0.553651 | V | 0.452651 | 0.101 | D to O | - |
| P41595 | 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B OS=Homo sapiens GN=HTR2B PE=1 SV=1 | 45 | Q | 0.588536 | E | 0.643894 | -0.055358 | No Change: Both D | - |
| P41595 | 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B OS=Homo sapiens GN=HTR2B PE=1 SV=1 | 173 | F | 0.082953 | L | 0.094939 | -0.011986 | No Change: Both O | - |
| P41595 | 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B OS=Homo sapiens GN=HTR2B PE=1 SV=1 | 388 | R | 0.150276 | W | 0.055857 | 0.094419 | No Change: Both O | - |
| P28335 | 5HT2C_HUMAN 5-hydroxytryptamine receptor 2C OS=Homo sapiens GN=HTR2C PE=1 SV=1 | 23 | C | 0.051027 | S | 0.157402 | -0.106375 | No Change: Both O | - |
| P28335 | 5HT2C_HUMAN 5-hydroxytryptamine receptor 2C OS=Homo sapiens GN=HTR2C PE=1 SV=1 | 156 | I | 0.207629 | V | 0.231561 | -0.023932 | No Change: Both O | - |
| P28335 | 5HT2C_HUMAN 5-hydroxytryptamine receptor 2C OS=Homo sapiens GN=HTR2C PE=1 SV=1 | 158 | N | 0.308623 | S | 0.363438 | -0.054815 | No Change: Both O | - |
| P28335 | 5HT2C_HUMAN 5-hydroxytryptamine receptor 2C OS=Homo sapiens GN=HTR2C PE=1 SV=1 | 160 | I | 0.418976 | V | 0.451152 | -0.032176 | No Change: Both O | - |
| P46098 | 5HT3A_HUMAN 5-hydroxytryptamine receptor 3A OS=Homo sapiens GN=HTR3A PE=1 SV=1 | 33 | A | 0.450992 | T | 0.50856 | -0.057568 | O to D | - |
| P46098 | 5HT3A_HUMAN 5-hydroxytryptamine receptor 3A OS=Homo sapiens GN=HTR3A PE=1 SV=1 | 253 | S | 0.049073 | N | 0.037464 | 0.011609 | No Change: Both O | - |
| P46098 | 5HT3A_HUMAN 5-hydroxytryptamine receptor 3A OS=Homo sapiens GN=HTR3A PE=1 SV=1 | 344 | R | 0.091602 | H | 0.085746 | 0.005856 | No Change: Both O | - |
| P46098 | 5HT3A_HUMAN 5-hydroxytryptamine receptor 3A OS=Homo sapiens GN=HTR3A PE=1 SV=1 | 391 | P | 0.969529 | R | 0.963883 | 0.005646 | No Change: Both D | - |
| P46098 | 5HT3A_HUMAN 5-hydroxytryptamine receptor 3A OS=Homo sapiens GN=HTR3A PE=1 SV=1 | 409 | R | 0.913585 | Q | 0.911186 | 0.002399 | No Change: Both D | - |
| O95264 | 5HT3B_HUMAN 5-hydroxytryptamine receptor 3B OS=Homo sapiens GN=HTR3B PE=1 SV=1 | 129 | Y | 0.174632 | S | 0.311602 | -0.13697 | No Change: Both O | - |
| O95264 | 5HT3B_HUMAN 5-hydroxytryptamine receptor 3B OS=Homo sapiens GN=HTR3B PE=1 SV=1 | 143 | I | 0.421678 | T | 0.588192 | -0.166514 | O to D | - |
| O95264 | 5HT3B_HUMAN 5-hydroxytryptamine receptor 3B OS=Homo sapiens GN=HTR3B PE=1 SV=1 | 156 | S | 0.126081 | R | 0.088566 | 0.037515 | No Change: Both O | - |
| O95264 | 5HT3B_HUMAN 5-hydroxytryptamine receptor 3B OS=Homo sapiens GN=HTR3B PE=1 SV=1 | 183 | V | 0.214189 | I | 0.188773 | 0.025416 | No Change: Both O | - |
| Q8WXA8 | 5HT3C_HUMAN 5-hydroxytryptamine receptor 3C OS=Homo sapiens GN=HTR3C PE=1 SV=2 | 163 | N | 0.050895 | K | 0.062792 | -0.011897 | No Change: Both O | - |
| Q8WXA8 | 5HT3C_HUMAN 5-hydroxytryptamine receptor 3C OS=Homo sapiens GN=HTR3C PE=1 SV=2 | 405 | G | 0.572101 | A | 0.509121 | 0.06298 | No Change: Both D | - |
| Q8WXA8 | 5HT3C_HUMAN 5-hydroxytryptamine receptor 3C OS=Homo sapiens GN=HTR3C PE=1 SV=2 | 128 | V | 0.122602 | M | 0.158835 | -0.036233 | No Change: Both O | A colorectal cancer sample |
| Q70Z44 | 5HT3D_HUMAN 5-hydroxytryptamine receptor 3D OS=Homo sapiens GN=HTR3D PE=1 SV=3 | 171 | A | 0.696753 | G | 0.722259 | -0.025506 | No Change: Both D | - |
| Q70Z44 | 5HT3D_HUMAN 5-hydroxytryptamine receptor 3D OS=Homo sapiens GN=HTR3D PE=1 SV=3 | 225 | R | 0.208219 | H | 0.20312 | 0.005099 | No Change: Both O | - |
| Q70Z44 | 5HT3D_HUMAN 5-hydroxytryptamine receptor 3D OS=Homo sapiens GN=HTR3D PE=1 SV=3 | 435 | R | 0.040088 | H | 0.04234 | -0.002252 | No Change: Both O | - |
| A5X5Y0 | 5HT3E_HUMAN 5-hydroxytryptamine receptor 3E OS=Homo sapiens GN=HTR3E PE=1 SV=1 | 71 | A | 0.124848 | T | 0.139043 | -0.014195 | No Change: Both O | - |
| A5X5Y0 | 5HT3E_HUMAN 5-hydroxytryptamine receptor 3E OS=Homo sapiens GN=HTR3E PE=1 SV=1 | 430 | A | 0.122042 | T | 0.129609 | -0.007567 | No Change: Both O | - |
| Q13639 | 5HT4R_HUMAN 5-hydroxytryptamine receptor 4 OS=Homo sapiens GN=HTR4 PE=1 SV=2 | 372 | C | 0.652084 | Y | 0.56388 | 0.088204 | No Change: Both D | - |
| P47898 | 5HT5A_HUMAN 5-hydroxytryptamine receptor 5A OS=Homo sapiens GN=HTR5A PE=1 SV=1 | 262 | R | 0.323202 | C | 0.200376 | 0.122826 | No Change: Both O | A colorectal cancer sample |
| P34969 | 5HT7R_HUMAN 5-hydroxytryptamine receptor 7 OS=Homo sapiens GN=HTR7 PE=1 SV=2 | 92 | T | 0.03935 | K | 0.052752 | -0.013402 | No Change: Both O | - |
| P34969 | 5HT7R_HUMAN 5-hydroxytryptamine receptor 7 OS=Homo sapiens GN=HTR7 PE=1 SV=2 | 279 | P | 0.445291 | L | 0.253707 | 0.191584 | No Change: Both O | - |
| P34969 | 5HT7R_HUMAN 5-hydroxytryptamine receptor 7 OS=Homo sapiens GN=HTR7 PE=1 SV=2 | 448 | P | 0.438362 | Q | 0.389484 | 0.048878 | No Change: Both O | - |
| Q92743 | HTRA1_HUMAN Serine protease HTRA1 OS=Homo sapiens GN=HTRA1 PE=1 SV=1 | 252 | A | 0.248797 | T | 0.259757 | -0.01096 | No Change: Both O | Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) [MIM:600142] |
| Q92743 | HTRA1_HUMAN Serine protease HTRA1 OS=Homo sapiens GN=HTRA1 PE=1 SV=1 | 297 | V | 0.425476 | M | 0.480463 | -0.054987 | No Change: Both O | Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) [MIM:600142] |
| O43464 | HTRA2_HUMAN Serine protease HTRA2 mitochondrial OS=Homo sapiens GN=HTRA2 PE=1 SV=2 | 141 | A | 0.761692 | S | 0.805803 | -0.044111 | No Change: Both D | - |
| O43464 | HTRA2_HUMAN Serine protease HTRA2 mitochondrial OS=Homo sapiens GN=HTRA2 PE=1 SV=2 | 399 | G | 0.286875 | S | 0.33637 | -0.049495 | No Change: Both O | Parkinson disease type 13 (PARK13) [MIM:610297] |
| O43464 | HTRA2_HUMAN Serine protease HTRA2 mitochondrial OS=Homo sapiens GN=HTRA2 PE=1 SV=2 | 72 | L | 0.786612 | P | 0.871952 | -0.08534 | No Change: Both D | - |
| O43464 | HTRA2_HUMAN Serine protease HTRA2 mitochondrial OS=Homo sapiens GN=HTRA2 PE=1 SV=2 | 404 | R | 0.421982 | W | 0.217072 | 0.20491 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1382 | E | 0.601808 | A | 0.499756 | 0.102052 | D to O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 893 | G | 0.455065 | R | 0.441103 | 0.013962 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1064 | V | 0.277007 | I | 0.261428 | 0.015579 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1091 | I | 0.270659 | M | 0.379102 | -0.108443 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1173 | T | 0.711336 | A | 0.73651 | -0.025174 | No Change: Both D | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1260 | T | 0.495918 | M | 0.433126 | 0.062792 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1385 | N | 0.525007 | H | 0.49848 | 0.026527 | D to O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 1720 | T | 0.741623 | N | 0.750509 | -0.008886 | No Change: Both D | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 2113 | D | 0.323605 | Y | 0.192294 | 0.131311 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 2309 | Y | 0.020026 | H | 0.041367 | -0.021341 | No Change: Both O | - |
| P42858 | HD_HUMAN Huntingtin OS=Homo sapiens GN=HTT PE=1 SV=2 | 2786 | V | 0.090836 | I | 0.071074 | 0.019762 | No Change: Both O | - |
| P57058 | HUNK_HUMAN Hormonally up-regulated neu tumor-associated kinase OS=Homo sapiens GN=HUNK PE=1 SV=1 | 157 | R | 0.700964 | W | 0.516875 | 0.184089 | No Change: Both D | - |
| P57058 | HUNK_HUMAN Hormonally up-regulated neu tumor-associated kinase OS=Homo sapiens GN=HUNK PE=1 SV=1 | 591 | R | 0.899799 | C | 0.833261 | 0.066538 | No Change: Both D | - |
| P57058 | HUNK_HUMAN Hormonally up-regulated neu tumor-associated kinase OS=Homo sapiens GN=HUNK PE=1 SV=1 | 625 | E | 0.961315 | K | 0.961114 | 2.01E-04 | No Change: Both D | - |
| P57058 | HUNK_HUMAN Hormonally up-regulated neu tumor-associated kinase OS=Homo sapiens GN=HUNK PE=1 SV=1 | 648 | M | 0.965799 | T | 0.960499 | 0.0053 | No Change: Both D | - |
| O60921 | HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens GN=HUS1 PE=1 SV=1 | 147 | Q | 0.433877 | K | 0.521628 | -0.087751 | O to D | - |
| O60921 | HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens GN=HUS1 PE=1 SV=1 | 221 | D | 0.683782 | E | 0.699472 | -0.01569 | No Change: Both D | - |
| O60921 | HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens GN=HUS1 PE=1 SV=1 | 126 | S | 0.553082 | G | 0.47822 | 0.074862 | D to O | - |
| Q8NHY5 | HUS1B_HUMAN Checkpoint protein HUS1B OS=Homo sapiens GN=HUS1B PE=1 SV=2 | 268 | D | 0.150577 | Y | 0.080855 | 0.069722 | No Change: Both O | - |
| Q8NHY5 | HUS1B_HUMAN Checkpoint protein HUS1B OS=Homo sapiens GN=HUS1B PE=1 SV=2 | 130 | H | 0.568891 | Q | 0.612717 | -0.043826 | No Change: Both D | - |
| Q8NHY5 | HUS1B_HUMAN Checkpoint protein HUS1B OS=Homo sapiens GN=HUS1B PE=1 SV=2 | 201 | Q | 0.262508 | R | 0.256732 | 0.005776 | No Change: Both O | - |
| Q7Z6Z7 | HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3 | 2981 | R | 0.689962 | H | 0.597143 | 0.092819 | No Change: Both D | - |
| Q7Z6Z7 | HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3 | 4013 | R | 0.628512 | W | 0.393277 | 0.235235 | D to O | - |
| Q7Z6Z7 | HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3 | 4187 | R | 0.242924 | C | 0.137975 | 0.104949 | No Change: Both O | - |
| Q7Z6Z7 | HUWE1_HUMAN E3 ubiquitin-protein ligase HUWE1 OS=Homo sapiens GN=HUWE1 PE=1 SV=3 | 483 | N | 0.683641 | S | 0.721772 | -0.038131 | No Change: Both D | - |
| Q12794 | HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens GN=HYAL1 PE=1 SV=2 | 268 | E | 0.215201 | K | 0.214898 | 3.03E-04 | No Change: Both O | Mucopolysaccharidosis type 9 (MPS9) [MIM:601492] |
| Q12891 | HYAL2_HUMAN Hyaluronidase-2 OS=Homo sapiens GN=HYAL2 PE=1 SV=4 | 18 | S | 0.10276 | A | 0.084903 | 0.017857 | No Change: Both O | - |
| Q12891 | HYAL2_HUMAN Hyaluronidase-2 OS=Homo sapiens GN=HYAL2 PE=1 SV=4 | 418 | I | 0.208201 | L | 0.261984 | -0.053783 | No Change: Both O | - |
| O43820 | HYAL3_HUMAN Hyaluronidase-3 OS=Homo sapiens GN=HYAL3 PE=2 SV=1 | 113 | H | 0.232694 | Y | 0.147645 | 0.085049 | No Change: Both O | - |
| Q2M3T9 | HYAL4_HUMAN Hyaluronidase-4 OS=Homo sapiens GN=HYAL4 PE=2 SV=2 | 346 | A | 0.302186 | S | 0.400192 | -0.098006 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 451 | R | 0.365874 | P | 0.407354 | -0.04148 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 584 | T | 0.110714 | N | 0.134563 | -0.023849 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 690 | T | 0.037748 | A | 0.036712 | 0.001036 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 724 | N | 0.35935 | D | 0.401389 | -0.042039 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1718 | V | 0.115107 | M | 0.150609 | -0.035502 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1892 | R | 0.686762 | H | 0.641268 | 0.045494 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1952 | R | 0.837128 | Q | 0.835229 | 0.001899 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2099 | V | 0.658688 | M | 0.702428 | -0.04374 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2276 | Q | 0.783788 | R | 0.777693 | 0.006095 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2306 | E | 0.964299 | G | 0.947368 | 0.016931 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2445 | N | 0.848677 | I | 0.797869 | 0.050808 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2502 | L | 0.965992 | S | 0.972401 | -0.006409 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2558 | G | 0.883607 | E | 0.907889 | -0.024282 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2589 | K | 0.640763 | R | 0.57224 | 0.068523 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2932 | P | 0.457622 | L | 0.297547 | 0.160075 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2937 | E | 0.543343 | K | 0.504844 | 0.038499 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2939 | R | 0.460284 | K | 0.487487 | -0.027203 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2994 | E | 0.343215 | G | 0.297747 | 0.045468 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3116 | T | 0.580643 | R | 0.573067 | 0.007576 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3269 | Y | 0.217073 | D | 0.360311 | -0.143238 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3811 | R | 0.224397 | H | 0.223403 | 9.94E-04 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3899 | V | 0.513608 | M | 0.583617 | -0.070009 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4026 | A | 0.192548 | T | 0.224798 | -0.03225 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4088 | K | 0.470186 | R | 0.405072 | 0.065114 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4270 | H | 0.301874 | Y | 0.200432 | 0.101442 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4520 | G | 0.081878 | S | 0.113772 | -0.031894 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4606 | N | 0.135016 | K | 0.182255 | -0.047239 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1077 | I | 0.303037 | V | 0.305628 | -0.002591 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1228 | V | 0.629076 | L | 0.630618 | -0.001542 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 1534 | I | 0.337958 | V | 0.372491 | -0.034533 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2087 | R | 0.249102 | C | 0.159868 | 0.089234 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2242 | Q | 0.168564 | R | 0.155432 | 0.013132 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2298 | R | 0.970652 | G | 0.965178 | 0.005474 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2530 | K | 0.998855 | E | 0.999034 | -1.79E-04 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2570 | D | 0.626783 | N | 0.539104 | 0.087679 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2694 | I | 0.745525 | S | 0.836977 | -0.091452 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3291 | A | 0.159964 | P | 0.209887 | -0.049923 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3316 | L | 0.087481 | P | 0.169076 | -0.081595 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3739 | A | 0.286234 | T | 0.348922 | -0.062688 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3742 | V | 0.380953 | I | 0.356099 | 0.024854 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3840 | V | 0.38363 | L | 0.379616 | 0.004014 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 3869 | M | 0.866131 | R | 0.863751 | 0.00238 | No Change: Both D | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4005 | T | 0.276076 | A | 0.231847 | 0.044229 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4160 | E | 0.320631 | Q | 0.292092 | 0.028539 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4363 | S | 0.38469 | C | 0.191434 | 0.193256 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4412 | K | 0.351248 | E | 0.335806 | 0.015442 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4552 | M | 0.226452 | L | 0.17674 | 0.049712 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 4869 | R | 0.32846 | Q | 0.364338 | -0.035878 | No Change: Both O | - |
| Q4G0P3 | HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens GN=HYDIN PE=1 SV=3 | 2455 | P | 0.588293 | Q | 0.578849 | 0.009444 | No Change: Both D | - |
| Q5T013 | HYI_HUMAN Putative hydroxypyruvate isomerase OS=Homo sapiens GN=HYI PE=2 SV=2 | 239 | D | 0.292751 | N | 0.279693 | 0.013058 | No Change: Both O | - |
| Q96M11 | HYLS1_HUMAN Hydrolethalus syndrome protein 1 OS=Homo sapiens GN=HYLS1 PE=1 SV=1 | 31 | C | 0.268489 | R | 0.422989 | -0.1545 | No Change: Both O | - |
| Q96M11 | HYLS1_HUMAN Hydrolethalus syndrome protein 1 OS=Homo sapiens GN=HYLS1 PE=1 SV=1 | 211 | D | 0.471318 | G | 0.450358 | 0.02096 | No Change: Both O | Hydrolethalus syndrome type 1 (HLS1) [MIM:236680] |
| Q9NX55 | HYPK_HUMAN Huntingtin-interacting protein K OS=Homo sapiens GN=HYPK PE=1 SV=2 | 105 | S | 0.655947 | P | 0.623503 | 0.032444 | No Change: Both D | - |
| P10997 | IAPP_HUMAN Islet amyloid polypeptide OS=Homo sapiens GN=IAPP PE=1 SV=1 | 53 | S | 0.330866 | G | 0.273153 | 0.057713 | No Change: Both O | - |
| P41252 | SYIC_HUMAN Isoleucine--tRNA ligase cytoplasmic OS=Homo sapiens GN=IARS PE=1 SV=2 | 769 | M | 0.102367 | I | 0.064529 | 0.037838 | No Change: Both O | - |
| P41252 | SYIC_HUMAN Isoleucine--tRNA ligase cytoplasmic OS=Homo sapiens GN=IARS PE=1 SV=2 | 1182 | K | 0.328607 | E | 0.357674 | -0.029067 | No Change: Both O | - |
| P41252 | SYIC_HUMAN Isoleucine--tRNA ligase cytoplasmic OS=Homo sapiens GN=IARS PE=1 SV=2 | 684 | T | 0.431606 | M | 0.371649 | 0.059957 | No Change: Both O | - |
| Q9NSE4 | SYIM_HUMAN Isoleucine--tRNA ligase mitochondrial OS=Homo sapiens GN=IARS2 PE=1 SV=2 | 522 | I | 0.079286 | V | 0.098055 | -0.018769 | No Change: Both O | - |
| Q9NSE4 | SYIM_HUMAN Isoleucine--tRNA ligase mitochondrial OS=Homo sapiens GN=IARS2 PE=1 SV=2 | 14 | A | 0.739161 | V | 0.600443 | 0.138718 | No Change: Both D | - |
| Q5T440 | CAF17_HUMAN Putative transferase CAF17 mitochondrial OS=Homo sapiens GN=IBA57 PE=1 SV=1 | 211 | G | 0.318463 | S | 0.329301 | -0.010838 | No Change: Both O | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 256 | T | 0.823338 | A | 0.773731 | 0.049607 | No Change: Both D | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 268 | A | 0.76738 | V | 0.737571 | 0.029809 | No Change: Both D | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 195 | G | 0.996398 | E | 0.997078 | -6.80E-04 | No Change: Both D | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 213 | D | 0.99029 | G | 0.991966 | -0.001676 | No Change: Both D | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 219 | R | 0.988698 | G | 0.990007 | -0.001309 | No Change: Both D | - |
| P21815 | SIAL_HUMAN Bone sialoprotein 2 OS=Homo sapiens GN=IBSP PE=1 SV=4 | 270 | E | 0.738131 | D | 0.692287 | 0.045844 | No Change: Both D | - |
| Q9P2D0 | IBTK_HUMAN Inhibitor of Bruton tyrosine kinase OS=Homo sapiens GN=IBTK PE=1 SV=3 | 1065 | V | 0.510313 | I | 0.483555 | 0.026758 | D to O | - |
| Q9P2D0 | IBTK_HUMAN Inhibitor of Bruton tyrosine kinase OS=Homo sapiens GN=IBTK PE=1 SV=3 | 1185 | A | 0.751099 | V | 0.706888 | 0.044211 | No Change: Both D | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 56 | K | 0.625077 | M | 0.501379 | 0.123698 | No Change: Both D | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 241 | G | 0.207369 | R | 0.212426 | -0.005057 | No Change: Both O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 469 | K | 0.368283 | E | 0.384274 | -0.015991 | No Change: Both O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 155 | K | 0.640702 | N | 0.603479 | 0.037223 | No Change: Both D | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 315 | V | 0.255586 | M | 0.294941 | -0.039355 | No Change: Both O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 352 | P | 0.523778 | L | 0.354508 | 0.16927 | D to O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 397 | R | 0.383243 | Q | 0.385534 | -0.002291 | No Change: Both O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 478 | R | 0.102367 | W | 0.039876 | 0.062491 | No Change: Both O | - |
| P05362 | ICAM1_HUMAN Intercellular adhesion molecule 1 OS=Homo sapiens GN=ICAM1 PE=1 SV=2 | 34 | S | 0.64186 | C | 0.479949 | 0.161911 | D to O | - |
| P13598 | ICAM2_HUMAN Intercellular adhesion molecule 2 OS=Homo sapiens GN=ICAM2 PE=1 SV=2 | 37 | A | 0.555345 | T | 0.599668 | -0.044323 | No Change: Both D | - |
| P13598 | ICAM2_HUMAN Intercellular adhesion molecule 2 OS=Homo sapiens GN=ICAM2 PE=1 SV=2 | 199 | R | 0.281665 | H | 0.296236 | -0.014571 | No Change: Both O | - |
| P13598 | ICAM2_HUMAN Intercellular adhesion molecule 2 OS=Homo sapiens GN=ICAM2 PE=1 SV=2 | 256 | R | 0.450032 | Q | 0.479858 | -0.029826 | No Change: Both O | - |
| P32942 | ICAM3_HUMAN Intercellular adhesion molecule 3 OS=Homo sapiens GN=ICAM3 PE=1 SV=2 | 525 | S | 0.599712 | T | 0.537153 | 0.062559 | No Change: Both D | - |
| P32942 | ICAM3_HUMAN Intercellular adhesion molecule 3 OS=Homo sapiens GN=ICAM3 PE=1 SV=2 | 63 | I | 0.580309 | V | 0.620129 | -0.03982 | No Change: Both D | - |
| P32942 | ICAM3_HUMAN Intercellular adhesion molecule 3 OS=Homo sapiens GN=ICAM3 PE=1 SV=2 | 143 | D | 0.560192 | G | 0.575377 | -0.015185 | No Change: Both D | - |
| P32942 | ICAM3_HUMAN Intercellular adhesion molecule 3 OS=Homo sapiens GN=ICAM3 PE=1 SV=2 | 115 | R | 0.252544 | G | 0.244546 | 0.007998 | No Change: Both O | - |
| Q14773 | ICAM4_HUMAN Intercellular adhesion molecule 4 OS=Homo sapiens GN=ICAM4 PE=2 SV=1 | 100 | Q | 0.200411 | R | 0.208049 | -0.007638 | No Change: Both O | - |
| Q14773 | ICAM4_HUMAN Intercellular adhesion molecule 4 OS=Homo sapiens GN=ICAM4 PE=2 SV=1 | 208 | V | 0.060879 | L | 0.063851 | -0.002972 | No Change: Both O | - |
| Q9UMF0 | ICAM5_HUMAN Intercellular adhesion molecule 5 OS=Homo sapiens GN=ICAM5 PE=1 SV=3 | 140 | L | 0.383766 | V | 0.368966 | 0.0148 | No Change: Both O | A breast cancer sample |
| Q9UMF0 | ICAM5_HUMAN Intercellular adhesion molecule 5 OS=Homo sapiens GN=ICAM5 PE=1 SV=3 | 188 | R | 0.521924 | W | 0.26432 | 0.257604 | D to O | A breast cancer sample |
| Q9UMF0 | ICAM5_HUMAN Intercellular adhesion molecule 5 OS=Homo sapiens GN=ICAM5 PE=1 SV=3 | 488 | E | 0.203684 | Q | 0.171543 | 0.032141 | No Change: Both O | A breast cancer sample |
| Q9UMF0 | ICAM5_HUMAN Intercellular adhesion molecule 5 OS=Homo sapiens GN=ICAM5 PE=1 SV=3 | 301 | V | 0.303856 | I | 0.256553 | 0.047303 | No Change: Both O | - |
| Q9UMF0 | ICAM5_HUMAN Intercellular adhesion molecule 5 OS=Homo sapiens GN=ICAM5 PE=1 SV=3 | 348 | A | 0.366492 | T | 0.39378 | -0.027288 | No Change: Both O | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 115 | F | 0.111267 | Y | 0.125489 | -0.014222 | No Change: Both O | A renal clear cell carcinoma sample |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 320 | V | 0.968697 | I | 0.973528 | -0.004831 | No Change: Both D | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 471 | T | 0.805368 | K | 0.825386 | -0.020018 | No Change: Both D | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 476 | R | 0.752975 | Q | 0.762073 | -0.009098 | No Change: Both D | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 615 | A | 0.861512 | T | 0.874892 | -0.01338 | No Change: Both D | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 98 | P | 0.352922 | L | 0.212939 | 0.139983 | No Change: Both O | - |
| Q9UPZ9 | ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | 272 | R | 0.546803 | Q | 0.571645 | -0.024842 | No Change: Both D | Endocrine-cerebroosteodysplasia (ECO) [MIM:612651] |
| O75144 | ICOSL_HUMAN ICOS ligand OS=Homo sapiens GN=ICOSLG PE=1 SV=2 | 128 | V | 0.240409 | I | 0.182452 | 0.057957 | No Change: Both O | - |
| Q14197 | ICT1_HUMAN Peptidyl-tRNA hydrolase ICT1 mitochondrial OS=Homo sapiens GN=ICT1 PE=1 SV=1 | 8 | R | 0.402559 | P | 0.429494 | -0.026935 | No Change: Both O | - |
| Q14197 | ICT1_HUMAN Peptidyl-tRNA hydrolase ICT1 mitochondrial OS=Homo sapiens GN=ICT1 PE=1 SV=1 | 77 | L | 0.317858 | F | 0.275673 | 0.042185 | No Change: Both O | - |
| Q14197 | ICT1_HUMAN Peptidyl-tRNA hydrolase ICT1 mitochondrial OS=Homo sapiens GN=ICT1 PE=1 SV=1 | 122 | T | 0.314766 | M | 0.272563 | 0.042203 | No Change: Both O | - |
| P41134 | ID1_HUMAN DNA-binding protein inhibitor ID-1 OS=Homo sapiens GN=ID1 PE=1 SV=3 | 63 | N | 0.181652 | D | 0.202017 | -0.020365 | No Change: Both O | - |
| Q02535 | ID3_HUMAN DNA-binding protein inhibitor ID-3 OS=Homo sapiens GN=ID3 PE=1 SV=2 | 105 | T | 0.358135 | A | 0.329864 | 0.028271 | No Change: Both O | - |
| Q02535 | ID3_HUMAN DNA-binding protein inhibitor ID-3 OS=Homo sapiens GN=ID3 PE=1 SV=2 | 111 | S | 0.448379 | A | 0.343489 | 0.10489 | No Change: Both O | - |
| P14735 | IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens GN=IDE PE=1 SV=4 | 612 | E | 0.254153 | K | 0.242272 | 0.011881 | No Change: Both O | - |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 132 | R | 0.138889 | C | 0.06364 | 0.075249 | No Change: Both O | Colorectal cancer |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 178 | V | 0.393309 | I | 0.359749 | 0.03356 | No Change: Both O | - |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 132 | R | 0.138889 | G | 0.153384 | -0.014495 | No Change: Both O | A glioma sample |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 132 | R | 0.138889 | H | 0.145304 | -0.006415 | No Change: Both O | A glioma sample |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 132 | R | 0.138889 | L | 0.078084 | 0.060805 | No Change: Both O | A glioma sample |
| O75874 | IDHC_HUMAN Isocitrate dehydrogenase [NADP] cytoplasmic OS=Homo sapiens GN=IDH1 PE=1 SV=2 | 132 | R | 0.138889 | S | 0.173669 | -0.03478 | No Change: Both O | A glioma sample |
| P48735 | IDHP_HUMAN Isocitrate dehydrogenase [NADP] mitochondrial OS=Homo sapiens GN=IDH2 PE=1 SV=2 | 140 | R | 0.25226 | G | 0.27429 | -0.02203 | No Change: Both O | D-2-hydroxyglutaric aciduria type 2 (D2HGA2) [MIM:613657] |
| P48735 | IDHP_HUMAN Isocitrate dehydrogenase [NADP] mitochondrial OS=Homo sapiens GN=IDH2 PE=1 SV=2 | 140 | R | 0.25226 | Q | 0.256482 | -0.004222 | No Change: Both O | D-2-hydroxyglutaric aciduria type 2 (D2HGA2) [MIM:613657] |
| O43837 | IDH3B_HUMAN Isocitrate dehydrogenase [NAD] subunit beta mitochondrial OS=Homo sapiens GN=IDH3B PE=1 SV=2 | 3 | A | 0.570321 | V | 0.50614 | 0.064181 | No Change: Both D | - |
| O43837 | IDH3B_HUMAN Isocitrate dehydrogenase [NAD] subunit beta mitochondrial OS=Homo sapiens GN=IDH3B PE=1 SV=2 | 166 | Q | 0.400753 | H | 0.387208 | 0.013545 | No Change: Both O | - |
| O43837 | IDH3B_HUMAN Isocitrate dehydrogenase [NAD] subunit beta mitochondrial OS=Homo sapiens GN=IDH3B PE=1 SV=2 | 132 | L | 0.279231 | P | 0.409028 | -0.129797 | No Change: Both O | Retinitis pigmentosa type 46 (RP46) [MIM:612572] |
| O43837 | IDH3B_HUMAN Isocitrate dehydrogenase [NAD] subunit beta mitochondrial OS=Homo sapiens GN=IDH3B PE=1 SV=2 | 360 | T | 0.433553 | A | 0.392862 | 0.040691 | No Change: Both O | - |
| P14902 | I23O1_HUMAN Indoleamine 2 3-dioxygenase 1 OS=Homo sapiens GN=IDO1 PE=1 SV=1 | 4 | A | 0.709593 | T | 0.717497 | -0.007904 | No Change: Both D | - |
| Q6ZQW0 | I23O2_HUMAN Indoleamine 2 3-dioxygenase 2 OS=Homo sapiens GN=IDO2 PE=1 SV=3 | 235 | R | 0.03865 | W | 0.015389 | 0.023261 | No Change: Both O | - |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 45 | D | 0.095266 | N | 0.085659 | 0.009607 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 48 | R | 0.154928 | P | 0.190886 | -0.035958 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 54 | Y | 0.280731 | D | 0.452677 | -0.171946 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 63 | N | 0.44664 | D | 0.482384 | -0.035744 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 68 | A | 0.348279 | E | 0.453971 | -0.105692 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 79 | A | 0.198802 | E | 0.25298 | -0.054178 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 85 | A | 0.238968 | T | 0.251959 | -0.012991 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 86 | P | 0.235661 | L | 0.131595 | 0.104066 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 86 | P | 0.235661 | Q | 0.236719 | -0.001058 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 86 | P | 0.235661 | R | 0.220738 | 0.014923 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 87 | S | 0.243167 | N | 0.197855 | 0.045312 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 88 | R | 0.258292 | C | 0.146934 | 0.111358 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 88 | R | 0.258292 | H | 0.244973 | 0.013319 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 88 | R | 0.258292 | L | 0.165808 | 0.092484 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 88 | R | 0.258292 | P | 0.296686 | -0.038394 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 92 | L | 0.389781 | P | 0.560127 | -0.170346 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 94 | G | 0.46593 | D | 0.511398 | -0.045468 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 102 | L | 0.289378 | R | 0.433583 | -0.144205 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 108 | Y | 0.119494 | C | 0.092339 | 0.027155 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 115 | N | 0.17632 | Y | 0.107665 | 0.068655 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 118 | T | 0.219458 | I | 0.13759 | 0.081868 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 120 | P | 0.231384 | H | 0.212661 | 0.018723 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 120 | P | 0.231384 | R | 0.20308 | 0.028304 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 125 | E | 0.292646 | V | 0.160204 | 0.132442 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 132 | S | 0.268966 | W | 0.093711 | 0.175255 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 134 | G | 0.321058 | R | 0.29883 | 0.022228 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 135 | K | 0.339458 | N | 0.31217 | 0.027288 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 135 | K | 0.339458 | R | 0.28242 | 0.057038 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 143 | S | 0.640812 | F | 0.483504 | 0.157308 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 159 | H | 0.722367 | P | 0.783594 | -0.061227 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 160 | P | 0.735133 | R | 0.680236 | 0.054897 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 184 | C | 0.429412 | F | 0.354783 | 0.074629 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 184 | C | 0.429412 | W | 0.28633 | 0.143082 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 196 | L | 0.620191 | S | 0.726575 | -0.106384 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 198 | D | 0.640448 | G | 0.624481 | 0.015967 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 221 | L | 0.231634 | P | 0.398958 | -0.167324 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 224 | G | 0.241929 | E | 0.324001 | -0.082072 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 225 | Y | 0.231955 | D | 0.356598 | -0.124643 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 227 | K | 0.272973 | Q | 0.248372 | 0.024601 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 228 | P | 0.28278 | L | 0.157322 | 0.125458 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 229 | H | 0.301972 | Y | 0.217166 | 0.084806 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 252 | D | 0.494288 | N | 0.475787 | 0.018501 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 266 | P | 0.234387 | H | 0.154833 | 0.079554 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 266 | P | 0.234387 | R | 0.192539 | 0.041848 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 269 | D | 0.271352 | V | 0.161276 | 0.110076 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 293 | Q | 0.271057 | H | 0.241681 | 0.029376 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 333 | S | 0.188389 | L | 0.083591 | 0.104798 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 337 | W | 0.295041 | R | 0.51136 | -0.216319 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 340 | G | 0.373985 | D | 0.39393 | -0.019945 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 345 | W | 0.317689 | C | 0.346425 | -0.028736 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 346 | A | 0.302744 | D | 0.389542 | -0.086798 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 346 | A | 0.302744 | V | 0.228039 | 0.074705 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 347 | K | 0.325456 | I | 0.143236 | 0.18222 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 347 | K | 0.325456 | T | 0.253398 | 0.072058 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 348 | Y | 0.308761 | H | 0.456625 | -0.147864 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 349 | S | 0.291937 | I | 0.12571 | 0.166227 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 358 | P | 0.05871 | R | 0.047683 | 0.011027 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 403 | L | 0.342551 | R | 0.444277 | -0.101726 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 422 | C | 0.37075 | G | 0.496743 | -0.125993 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 432 | C | 0.347784 | Y | 0.346277 | 0.001507 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 434 | E | 0.396729 | K | 0.396061 | 6.68E-04 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 468 | R | 0.568819 | G | 0.551529 | 0.01729 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 468 | R | 0.568819 | L | 0.438171 | 0.130648 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 468 | R | 0.568819 | Q | 0.593493 | -0.024674 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 468 | R | 0.568819 | W | 0.346042 | 0.222777 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 469 | P | 0.593071 | H | 0.501895 | 0.091176 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 478 | D | 0.613274 | G | 0.576684 | 0.03659 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 478 | D | 0.613274 | Y | 0.462086 | 0.151188 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 485 | I | 0.419779 | K | 0.616714 | -0.196935 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 485 | I | 0.419779 | R | 0.551908 | -0.132129 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 502 | W | 0.047007 | C | 0.055759 | -0.008752 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 502 | W | 0.047007 | S | 0.155299 | -0.108292 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 521 | E | 0.200637 | V | 0.096636 | 0.104001 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 523 | Y | 0.209152 | C | 0.174185 | 0.034967 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 341 | E | 0.396104 | K | 0.392227 | 0.003877 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 342 | H | 0.372572 | Y | 0.253883 | 0.118689 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 491 | S | 0.141272 | F | 0.053674 | 0.087598 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 71 | S | 0.261192 | R | 0.206889 | 0.054303 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 82 | A | 0.230659 | E | 0.302982 | -0.072323 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 264 | Y | 0.245978 | N | 0.400422 | -0.154444 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 334 | D | 0.208762 | G | 0.204162 | 0.0046 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 465 | Q | 0.530526 | P | 0.601478 | -0.070952 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 41 | L | 0.055619 | P | 0.104774 | -0.049155 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 71 | S | 0.261192 | N | 0.226716 | 0.034476 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 73 | L | 0.2635 | F | 0.241646 | 0.021854 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 82 | A | 0.230659 | V | 0.167008 | 0.063651 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 85 | A | 0.238968 | S | 0.336926 | -0.097958 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 88 | R | 0.258292 | G | 0.262656 | -0.004364 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 89 | V | 0.263619 | F | 0.248647 | 0.014972 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 95 | R | 0.484172 | G | 0.492414 | -0.008242 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 95 | R | 0.484172 | T | 0.473211 | 0.010961 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 108 | Y | 0.119494 | S | 0.245574 | -0.12608 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 117 | S | 0.195368 | Y | 0.102416 | 0.092952 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 121 | Q | 0.244088 | H | 0.234535 | 0.009553 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 121 | Q | 0.244088 | R | 0.227154 | 0.016934 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 138 | H | 0.460024 | D | 0.491834 | -0.03181 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 140 | G | 0.530253 | V | 0.433666 | 0.096587 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 148 | D | 0.711571 | H | 0.702373 | 0.009198 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 181 | N | 0.377299 | I | 0.230771 | 0.146528 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 182 | L | 0.373469 | P | 0.551433 | -0.177964 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 205 | A | 0.48835 | P | 0.594712 | -0.106362 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 227 | K | 0.272973 | M | 0.199192 | 0.073781 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 228 | P | 0.28278 | T | 0.216476 | 0.066304 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 229 | H | 0.301972 | R | 0.314211 | -0.012239 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 231 | P | 0.337943 | L | 0.197229 | 0.140714 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 259 | L | 0.447841 | P | 0.622674 | -0.174833 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 265 | N | 0.264343 | I | 0.164582 | 0.099761 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 299 | S | 0.255071 | I | 0.108386 | 0.146685 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 308 | D | 0.246603 | E | 0.269153 | -0.02255 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 308 | D | 0.246603 | N | 0.232646 | 0.013957 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 309 | T | 0.235796 | A | 0.22444 | 0.011356 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 313 | R | 0.21603 | C | 0.10874 | 0.10729 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 314 | L | 0.221276 | P | 0.348297 | -0.127021 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 334 | D | 0.208762 | N | 0.198313 | 0.010449 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 335 | H | 0.251044 | R | 0.238751 | 0.012293 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 336 | G | 0.261622 | E | 0.312532 | -0.05091 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 336 | G | 0.261622 | R | 0.231965 | 0.029657 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 339 | L | 0.364402 | R | 0.507014 | -0.142612 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 347 | K | 0.325456 | Q | 0.279013 | 0.046443 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 410 | L | 0.277117 | P | 0.435112 | -0.157995 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 422 | C | 0.37075 | R | 0.51362 | -0.14287 | O to D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 467 | P | 0.53279 | L | 0.335046 | 0.197744 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 480 | P | 0.562706 | L | 0.40798 | 0.154726 | D to O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 480 | P | 0.562706 | Q | 0.55014 | 0.012566 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 480 | P | 0.562706 | R | 0.521213 | 0.041493 | No Change: Both D | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 490 | Y | 0.140266 | S | 0.289122 | -0.148856 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P22304 | IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens GN=IDS PE=1 SV=1 | 521 | E | 0.200637 | K | 0.200071 | 5.66E-04 | No Change: Both O | Mucopolysaccharidosis type 2 (MPS2) [MIM:309900] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 33 | H | 0.434829 | Q | 0.450669 | -0.01584 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 51 | G | 0.221473 | D | 0.255864 | -0.034391 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 75 | A | 0.127331 | T | 0.134899 | -0.007568 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 82 | H | 0.268746 | P | 0.30828 | -0.039534 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 89 | R | 0.157251 | Q | 0.170424 | -0.013173 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 89 | R | 0.157251 | W | 0.066148 | 0.091103 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 105 | R | 0.562633 | Q | 0.567488 | -0.004855 | No Change: Both D | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 116 | G | 0.186028 | R | 0.190303 | -0.004275 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 218 | L | 0.581853 | P | 0.727574 | -0.145721 | No Change: Both D | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 279 | V | 0.270866 | A | 0.34686 | -0.075994 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 315 | D | 0.151057 | Y | 0.082779 | 0.068278 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 327 | A | 0.123531 | P | 0.15963 | -0.036099 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 327 | A | 0.123531 | P | 0.15963 | -0.036099 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 349 | D | 0.341863 | N | 0.359453 | -0.01759 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 361 | A | 0.433086 | T | 0.475098 | -0.042012 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 366 | T | 0.321315 | P | 0.386692 | -0.065377 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 380 | Q | 0.360155 | R | 0.363076 | -0.002921 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 383 | R | 0.311262 | H | 0.314611 | -0.003349 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 388 | T | 0.15946 | R | 0.18162 | -0.02216 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 409 | G | 0.351231 | R | 0.340774 | 0.010457 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 454 | V | 0.378005 | I | 0.328347 | 0.049658 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 489 | R | 0.487977 | P | 0.516757 | -0.02878 | O to D | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 490 | L | 0.48934 | P | 0.643608 | -0.154268 | O to D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 490 | L | 0.48934 | P | 0.643608 | -0.154268 | O to D | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 492 | R | 0.508258 | P | 0.539903 | -0.031645 | No Change: Both D | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 496 | P | 0.536154 | L | 0.372144 | 0.16401 | D to O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 504 | M | 0.751822 | T | 0.778129 | -0.026307 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 533 | P | 0.770793 | R | 0.74904 | 0.021753 | No Change: Both D | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 533 | P | 0.770793 | R | 0.74904 | 0.021753 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 626 | W | 0.528498 | R | 0.722855 | -0.194357 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 300 | A | 0.313554 | T | 0.349772 | -0.036218 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 346 | L | 0.248419 | R | 0.346722 | -0.098303 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 619 | R | 0.396756 | G | 0.377474 | 0.019282 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 79 | A | 0.151901 | V | 0.111796 | 0.040105 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 82 | H | 0.268746 | Q | 0.292006 | -0.02326 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 133 | M | 0.4291 | I | 0.331646 | 0.097454 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 182 | E | 0.52856 | K | 0.517161 | 0.011399 | No Change: Both D | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 208 | G | 0.414767 | D | 0.45284 | -0.038073 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 238 | L | 0.326034 | Q | 0.400944 | -0.07491 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 260 | S | 0.275043 | F | 0.119917 | 0.155126 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 349 | D | 0.341863 | Y | 0.226769 | 0.115094 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 350 | N | 0.361731 | I | 0.191687 | 0.170044 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 363 | R | 0.407856 | C | 0.240406 | 0.16745 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 423 | S | 0.417025 | R | 0.369848 | 0.047177 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 423 | S | 0.417025 | R | 0.369848 | 0.047177 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 602 | F | 0.298697 | I | 0.275171 | 0.023526 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 628 | R | 0.55728 | P | 0.609595 | -0.052315 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 76 | Y | 0.1304 | C | 0.107205 | 0.023195 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 84 | G | 0.319729 | R | 0.313527 | 0.006202 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 103 | T | 0.588914 | P | 0.617424 | -0.02851 | No Change: Both D | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 178 | E | 0.357075 | K | 0.357044 | 3.10E-05 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 188 | F | 0.575021 | L | 0.602418 | -0.027397 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 219 | G | 0.61287 | E | 0.634884 | -0.022014 | No Change: Both D | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 265 | G | 0.565832 | R | 0.57393 | -0.008098 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 276 | E | 0.428833 | K | 0.428842 | -9.00E-06 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 276 | E | 0.428833 | K | 0.428842 | -9.00E-06 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 306 | W | 0.186632 | L | 0.258161 | -0.071529 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 348 | N | 0.306312 | K | 0.320281 | -0.013969 | No Change: Both O | Mucopolysaccharidosis type 1S (MPS1S) [MIM:607016] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 385 | P | 0.249769 | R | 0.222024 | 0.027745 | No Change: Both O | Mucopolysaccharidosis type 1H (MPS1H) [MIM:607014] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 396 | L | 0.187609 | P | 0.293296 | -0.105687 | No Change: Both O | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 436 | A | 0.208159 | P | 0.272719 | -0.06456 | No Change: Both O | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 449 | H | 0.547851 | N | 0.570982 | -0.023131 | No Change: Both D | - |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 496 | P | 0.536154 | R | 0.512917 | 0.023237 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 535 | L | 0.716671 | F | 0.615087 | 0.101584 | No Change: Both D | Mucopolysaccharidosis type 1H/S (MPS1H/S) [MIM:607015] |
| P35475 | IDUA_HUMAN Alpha-L-iduronidase OS=Homo sapiens GN=IDUA PE=1 SV=2 | 591 | A | 0.524191 | T | 0.565814 | -0.041623 | No Change: Both D | - |
| Q9BTL4 | IER2_HUMAN Immediate early response gene 2 protein OS=Homo sapiens GN=IER2 PE=2 SV=1 | 133 | A | 0.984566 | V | 0.979273 | 0.005293 | No Change: Both D | - |
| P46695 | IEX1_HUMAN Radiation-inducible immediate-early gene IEX-1 OS=Homo sapiens GN=IER3 PE=1 SV=4 | 127 | A | 0.705373 | P | 0.779428 | -0.074055 | No Change: Both D | - |
| Q9Y5U9 | IR3IP_HUMAN Immediate early response 3-interacting protein 1 OS=Homo sapiens GN=IER3IP1 PE=1 SV=1 | 21 | V | 0.081445 | G | 0.135188 | -0.053743 | No Change: Both O | Microcephaly epilepsy and diabetes syndrome (MEDS) [MIM:614231] |
| Q9Y5U9 | IR3IP_HUMAN Immediate early response 3-interacting protein 1 OS=Homo sapiens GN=IER3IP1 PE=1 SV=1 | 78 | L | 0.069881 | P | 0.141282 | -0.071401 | No Change: Both O | Microcephaly epilepsy and diabetes syndrome (MEDS) [MIM:614231] |
| Q5VY09 | IER5_HUMAN Immediate early response gene 5 protein OS=Homo sapiens GN=IER5 PE=2 SV=3 | 92 | R | 0.993783 | H | 0.991018 | 0.002765 | No Change: Both D | - |
| Q5VY09 | IER5_HUMAN Immediate early response gene 5 protein OS=Homo sapiens GN=IER5 PE=2 SV=3 | 168 | V | 0.882785 | I | 0.852612 | 0.030173 | No Change: Both D | - |
| Q5VY09 | IER5_HUMAN Immediate early response gene 5 protein OS=Homo sapiens GN=IER5 PE=2 SV=3 | 194 | R | 0.982218 | G | 0.98066 | 0.001558 | No Change: Both D | - |
| Q5VY09 | IER5_HUMAN Immediate early response gene 5 protein OS=Homo sapiens GN=IER5 PE=2 SV=3 | 202 | Q | 0.994511 | R | 0.995748 | -0.001237 | No Change: Both D | - |
| Q5VY09 | IER5_HUMAN Immediate early response gene 5 protein OS=Homo sapiens GN=IER5 PE=2 SV=3 | 285 | P | 0.922362 | S | 0.93455 | -0.012188 | No Change: Both D | - |
| Q5T953 | IER5L_HUMAN Immediate early response gene 5-like protein OS=Homo sapiens GN=IER5L PE=2 SV=1 | 105 | P | 0.913517 | S | 0.901281 | 0.012236 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 103 | D | 0.978185 | H | 0.972295 | 0.00589 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 179 | S | 0.973956 | T | 0.968725 | 0.005231 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 202 | K | 0.690232 | E | 0.683898 | 0.006334 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 409 | R | 0.973988 | S | 0.978828 | -0.00484 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 413 | Y | 0.97712 | N | 0.988511 | -0.011391 | No Change: Both D | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 723 | T | 0.20965 | S | 0.251512 | -0.041862 | No Change: Both O | - |
| Q16666 | IF16_HUMAN Gamma-interferon-inducible protein 16 OS=Homo sapiens GN=IFI16 PE=1 SV=3 | 779 | T | 0.789675 | S | 0.847522 | -0.057847 | No Change: Both D | - |
| P40305 | IFI27_HUMAN Interferon alpha-inducible protein 27 mitochondrial OS=Homo sapiens GN=IFI27 PE=1 SV=3 | 106 | S | 0.156711 | F | 0.06039 | 0.096321 | No Change: Both O | - |
| Q96BM0 | I27L1_HUMAN Interferon alpha-inducible protein 27-like protein 1 OS=Homo sapiens GN=IFI27L1 PE=2 SV=1 | 35 | G | 0.233999 | S | 0.28593 | -0.051931 | No Change: Both O | - |
| P80217 | IN35_HUMAN Interferon-induced 35 kDa protein OS=Homo sapiens GN=IFI35 PE=1 SV=5 | 126 | M | 0.589091 | V | 0.51778 | 0.071311 | No Change: Both D | - |
| Q8TCB0 | IFI44_HUMAN Interferon-induced protein 44 OS=Homo sapiens GN=IFI44 PE=2 SV=2 | 9 | W | 0.127025 | R | 0.290622 | -0.163597 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 390 | M | 0.254021 | I | 0.173325 | 0.080696 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 73 | H | 0.516766 | R | 0.502325 | 0.014441 | No Change: Both D | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 104 | A | 0.25033 | T | 0.328691 | -0.078361 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 148 | R | 0.127516 | C | 0.063418 | 0.064098 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 217 | V | 0.493701 | I | 0.469785 | 0.023916 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 235 | I | 0.305998 | T | 0.427303 | -0.121305 | No Change: Both O | - |
| Q53G44 | IF44L_HUMAN Interferon-induced protein 44-like OS=Homo sapiens GN=IFI44L PE=2 SV=3 | 296 | R | 0.594489 | C | 0.418487 | 0.176002 | D to O | - |
| Q9BYX4 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens GN=IFIH1 PE=1 SV=3 | 843 | H | 0.448166 | R | 0.442515 | 0.005651 | No Change: Both O | - |
| Q9BYX4 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens GN=IFIH1 PE=1 SV=3 | 946 | A | 0.309571 | T | 0.324198 | -0.014627 | No Change: Both O | - |
| Q9BYX4 | IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens GN=IFIH1 PE=1 SV=3 | 460 | H | 0.168947 | R | 0.184083 | -0.015136 | No Change: Both O | - |
| P09914 | IFIT1_HUMAN Interferon-induced protein with tetratricopeptide repeats 1 OS=Homo sapiens GN=IFIT1 PE=1 SV=2 | 131 | P | 0.282247 | H | 0.243596 | 0.038651 | No Change: Both O | - |
| Q5T764 | IFT1B_HUMAN Interferon-induced protein with tetratricopeptide repeats 1B OS=Homo sapiens GN=IFIT1B PE=2 SV=1 | 188 | L | 0.183021 | P | 0.308163 | -0.125142 | No Change: Both O | - |
| P09913 | IFIT2_HUMAN Interferon-induced protein with tetratricopeptide repeats 2 OS=Homo sapiens GN=IFIT2 PE=1 SV=1 | 352 | D | 0.372545 | E | 0.405685 | -0.03314 | No Change: Both O | - |
| P09913 | IFIT2_HUMAN Interferon-induced protein with tetratricopeptide repeats 2 OS=Homo sapiens GN=IFIT2 PE=1 SV=1 | 79 | E | 0.467741 | A | 0.339119 | 0.128622 | No Change: Both O | - |
| P09913 | IFIT2_HUMAN Interferon-induced protein with tetratricopeptide repeats 2 OS=Homo sapiens GN=IFIT2 PE=1 SV=1 | 121 | K | 0.237161 | R | 0.17189 | 0.065271 | No Change: Both O | - |
| P13164 | IFM1_HUMAN Interferon-induced transmembrane protein 1 OS=Homo sapiens GN=IFITM1 PE=1 SV=3 | 13 | P | 0.506036 | A | 0.381147 | 0.124889 | D to O | - |
| Q01629 | IFM2_HUMAN Interferon-induced transmembrane protein 2 OS=Homo sapiens GN=IFITM2 PE=1 SV=2 | 41 | M | 0.53537 | T | 0.576742 | -0.041372 | No Change: Both D | - |
| Q01629 | IFM2_HUMAN Interferon-induced transmembrane protein 2 OS=Homo sapiens GN=IFITM2 PE=1 SV=2 | 121 | I | 0.008999 | V | 0.010296 | -0.001297 | No Change: Both O | - |
| Q01629 | IFM2_HUMAN Interferon-induced transmembrane protein 2 OS=Homo sapiens GN=IFITM2 PE=1 SV=2 | 33 | V | 0.518039 | A | 0.589214 | -0.071175 | No Change: Both D | - |
| Q01628 | IFM3_HUMAN Interferon-induced transmembrane protein 3 OS=Homo sapiens GN=IFITM3 PE=1 SV=2 | 3 | H | 0.767166 | Q | 0.790705 | -0.023539 | No Change: Both D | - |
| A6NNB3 | IFM5_HUMAN Interferon-induced transmembrane protein 5 OS=Homo sapiens GN=IFITM5 PE=2 SV=1 | 27 | G | 0.602121 | A | 0.569725 | 0.032396 | No Change: Both D | - |
| Q8N9Z9 | ILFT1_HUMAN Intermediate filament tail domain-containing protein 1 OS=Homo sapiens GN=IFLTD1 PE=2 SV=2 | 264 | A | 0.231433 | T | 0.24517 | -0.013737 | No Change: Both O | - |
| Q8N9Z9 | ILFT1_HUMAN Intermediate filament tail domain-containing protein 1 OS=Homo sapiens GN=IFLTD1 PE=2 SV=2 | 267 | E | 0.215733 | G | 0.168465 | 0.047268 | No Change: Both O | - |
| Q8N9Z9 | ILFT1_HUMAN Intermediate filament tail domain-containing protein 1 OS=Homo sapiens GN=IFLTD1 PE=2 SV=2 | 289 | T | 0.41872 | A | 0.378024 | 0.040696 | No Change: Both O | - |
| Q8N9Z9 | ILFT1_HUMAN Intermediate filament tail domain-containing protein 1 OS=Homo sapiens GN=IFLTD1 PE=2 SV=2 | 290 | A | 0.498852 | T | 0.556279 | -0.057427 | O to D | - |
| Q8N9Z9 | ILFT1_HUMAN Intermediate filament tail domain-containing protein 1 OS=Homo sapiens GN=IFLTD1 PE=2 SV=2 | 366 | T | 0.944772 | S | 0.954482 | -0.00971 | No Change: Both D | - |
| P01562 | IFNA1_HUMAN Interferon alpha-1/13 OS=Homo sapiens GN=IFNA1 PE=1 SV=1 | 137 | A | 0.254427 | V | 0.190468 | 0.063959 | No Change: Both O | - |
| P01562 | IFNA1_HUMAN Interferon alpha-1/13 OS=Homo sapiens GN=IFNA1 PE=1 SV=1 | 10 | V | 0.193545 | A | 0.262974 | -0.069429 | No Change: Both O | - |
| P01562 | IFNA1_HUMAN Interferon alpha-1/13 OS=Homo sapiens GN=IFNA1 PE=1 SV=1 | 163 | A | 0.16724 | G | 0.183964 | -0.016724 | No Change: Both O | - |
| P01566 | IFN10_HUMAN Interferon alpha-10 OS=Homo sapiens GN=IFNA10 PE=1 SV=1 | 42 | G | 0.222136 | A | 0.177578 | 0.044558 | No Change: Both O | - |
| P01571 | IFN17_HUMAN Interferon alpha-17 OS=Homo sapiens GN=IFNA17 PE=1 SV=2 | 184 | I | 0.551361 | R | 0.648997 | -0.097636 | No Change: Both D | - |
| P01563 | IFNA2_HUMAN Interferon alpha-2 OS=Homo sapiens GN=IFNA2 PE=1 SV=1 | 46 | K | 0.360844 | R | 0.3492 | 0.011644 | No Change: Both O | - |
| P01563 | IFNA2_HUMAN Interferon alpha-2 OS=Homo sapiens GN=IFNA2 PE=1 SV=1 | 57 | H | 0.347056 | R | 0.388957 | -0.041901 | No Change: Both O | - |
| P01563 | IFNA2_HUMAN Interferon alpha-2 OS=Homo sapiens GN=IFNA2 PE=1 SV=1 | 177 | S | 0.540493 | L | 0.352324 | 0.188169 | D to O | A breast cancer sample |
| P01563 | IFNA2_HUMAN Interferon alpha-2 OS=Homo sapiens GN=IFNA2 PE=1 SV=1 | 6 | A | 0.163056 | D | 0.201194 | -0.038138 | No Change: Both O | - |
| P01568 | IFN21_HUMAN Interferon alpha-21 OS=Homo sapiens GN=IFNA21 PE=1 SV=2 | 179 | K | 0.432676 | E | 0.447023 | -0.014347 | No Change: Both O | - |
| P01568 | IFN21_HUMAN Interferon alpha-21 OS=Homo sapiens GN=IFNA21 PE=1 SV=2 | 119 | L | 0.244878 | M | 0.286652 | -0.041774 | No Change: Both O | - |
| P05014 | IFNA4_HUMAN Interferon alpha-4 OS=Homo sapiens GN=IFNA4 PE=1 SV=2 | 74 | A | 0.416817 | T | 0.433792 | -0.016975 | No Change: Both O | - |
| P05014 | IFNA4_HUMAN Interferon alpha-4 OS=Homo sapiens GN=IFNA4 PE=1 SV=2 | 137 | E | 0.374311 | V | 0.197453 | 0.176858 | No Change: Both O | - |
| P05014 | IFNA4_HUMAN Interferon alpha-4 OS=Homo sapiens GN=IFNA4 PE=1 SV=2 | 49 | H | 0.26318 | P | 0.300761 | -0.037581 | No Change: Both O | - |
| P32881 | IFNA8_HUMAN Interferon alpha-8 OS=Homo sapiens GN=IFNA8 PE=1 SV=1 | 137 | E | 0.245566 | K | 0.240359 | 0.005207 | No Change: Both O | - |
| P17181 | INAR1_HUMAN Interferon alpha/beta receptor 1 OS=Homo sapiens GN=IFNAR1 PE=1 SV=3 | 168 | V | 0.107178 | L | 0.111861 | -0.004683 | No Change: Both O | - |
| P17181 | INAR1_HUMAN Interferon alpha/beta receptor 1 OS=Homo sapiens GN=IFNAR1 PE=1 SV=3 | 307 | V | 0.19454 | I | 0.184047 | 0.010493 | No Change: Both O | - |
| P17181 | INAR1_HUMAN Interferon alpha/beta receptor 1 OS=Homo sapiens GN=IFNAR1 PE=1 SV=3 | 359 | T | 0.454903 | M | 0.4093 | 0.045603 | No Change: Both O | - |
| P48551 | INAR2_HUMAN Interferon alpha/beta receptor 2 OS=Homo sapiens GN=IFNAR2 PE=1 SV=1 | 8 | F | 0.152124 | S | 0.329877 | -0.177753 | No Change: Both O | - |
| P48551 | INAR2_HUMAN Interferon alpha/beta receptor 2 OS=Homo sapiens GN=IFNAR2 PE=1 SV=1 | 10 | F | 0.0751 | V | 0.085152 | -0.010052 | No Change: Both O | - |
| P48551 | INAR2_HUMAN Interferon alpha/beta receptor 2 OS=Homo sapiens GN=IFNAR2 PE=1 SV=1 | 196 | I | 0.116095 | V | 0.118714 | -0.002619 | No Change: Both O | - |
| P01574 | IFNB_HUMAN Interferon beta OS=Homo sapiens GN=IFNB1 PE=1 SV=1 | 162 | C | 0.073371 | Y | 0.099785 | -0.026414 | No Change: Both O | - |
| P01574 | IFNB_HUMAN Interferon beta OS=Homo sapiens GN=IFNB1 PE=1 SV=1 | 164 | W | 0.046718 | C | 0.058821 | -0.012103 | No Change: Both O | A breast cancer sample |
| Q86WN2 | IFNE_HUMAN Interferon epsilon OS=Homo sapiens GN=IFNE PE=2 SV=1 | 46 | Q | 0.568116 | H | 0.476381 | 0.091735 | D to O | - |
| P01579 | IFNG_HUMAN Interferon gamma OS=Homo sapiens GN=IFNG PE=1 SV=1 | 29 | K | 0.372408 | Q | 0.320979 | 0.051429 | No Change: Both O | - |
| P01579 | IFNG_HUMAN Interferon gamma OS=Homo sapiens GN=IFNG PE=1 SV=1 | 160 | R | 0.850037 | Q | 0.846023 | 0.004014 | No Change: Both D | - |
| P15260 | INGR1_HUMAN Interferon gamma receptor 1 OS=Homo sapiens GN=IFNGR1 PE=1 SV=1 | 77 | C | 0.117952 | Y | 0.148629 | -0.030677 | No Change: Both O | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P15260 | INGR1_HUMAN Interferon gamma receptor 1 OS=Homo sapiens GN=IFNGR1 PE=1 SV=1 | 87 | I | 0.410493 | T | 0.528867 | -0.118374 | O to D | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P15260 | INGR1_HUMAN Interferon gamma receptor 1 OS=Homo sapiens GN=IFNGR1 PE=1 SV=1 | 61 | V | 0.170142 | I | 0.135362 | 0.03478 | No Change: Both O | - |
| P15260 | INGR1_HUMAN Interferon gamma receptor 1 OS=Homo sapiens GN=IFNGR1 PE=1 SV=1 | 335 | H | 0.777908 | P | 0.843913 | -0.066005 | No Change: Both D | - |
| P15260 | INGR1_HUMAN Interferon gamma receptor 1 OS=Homo sapiens GN=IFNGR1 PE=1 SV=1 | 467 | L | 0.326461 | P | 0.479502 | -0.153041 | No Change: Both O | - |
| P38484 | INGR2_HUMAN Interferon gamma receptor 2 OS=Homo sapiens GN=IFNGR2 PE=1 SV=2 | 64 | Q | 0.187099 | R | 0.173388 | 0.013711 | No Change: Both O | - |
| P38484 | INGR2_HUMAN Interferon gamma receptor 2 OS=Homo sapiens GN=IFNGR2 PE=1 SV=2 | 58 | T | 0.336597 | R | 0.36777 | -0.031173 | No Change: Both O | - |
| P38484 | INGR2_HUMAN Interferon gamma receptor 2 OS=Homo sapiens GN=IFNGR2 PE=1 SV=2 | 147 | E | 0.623609 | K | 0.602084 | 0.021525 | No Change: Both D | - |
| P38484 | INGR2_HUMAN Interferon gamma receptor 2 OS=Homo sapiens GN=IFNGR2 PE=1 SV=2 | 182 | K | 0.236355 | E | 0.239396 | -0.003041 | No Change: Both O | - |
| P38484 | INGR2_HUMAN Interferon gamma receptor 2 OS=Homo sapiens GN=IFNGR2 PE=1 SV=2 | 168 | T | 0.208962 | N | 0.225377 | -0.016415 | No Change: Both O | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| Q9P0W0 | IFNK_HUMAN Interferon kappa OS=Homo sapiens GN=IFNK PE=1 SV=2 | 133 | K | 0.886701 | E | 0.894004 | -0.007303 | No Change: Both D | - |
| Q9P0W0 | IFNK_HUMAN Interferon kappa OS=Homo sapiens GN=IFNK PE=1 SV=2 | 97 | I | 0.168608 | N | 0.305542 | -0.136934 | No Change: Both O | - |
| P05000 | IFNW1_HUMAN Interferon omega-1 OS=Homo sapiens GN=IFNW1 PE=1 SV=2 | 95 | R | 0.373519 | S | 0.457797 | -0.084278 | No Change: Both O | - |
| O00458 | IFRD1_HUMAN Interferon-related developmental regulator 1 OS=Homo sapiens GN=IFRD1 PE=1 SV=4 | 39 | Q | 0.838009 | K | 0.817382 | 0.020627 | No Change: Both D | - |
| Q12894 | IFRD2_HUMAN Interferon-related developmental regulator 2 OS=Homo sapiens GN=IFRD2 PE=2 SV=3 | 502 | R | 0.737713 | Q | 0.691625 | 0.046088 | No Change: Both D | - |
| Q9HBG6 | IF122_HUMAN Intraflagellar transport protein 122 homolog OS=Homo sapiens GN=IFT122 PE=1 SV=2 | 7 | W | 0.289211 | C | 0.33321 | -0.043999 | No Change: Both O | Cranioectodermal dysplasia type 1 (CED1) [MIM:218330] |
| Q9HBG6 | IF122_HUMAN Intraflagellar transport protein 122 homolog OS=Homo sapiens GN=IFT122 PE=1 SV=2 | 322 | S | 0.148637 | F | 0.056405 | 0.092232 | No Change: Both O | Cranioectodermal dysplasia type 1 (CED1) [MIM:218330] |
| Q9HBG6 | IF122_HUMAN Intraflagellar transport protein 122 homolog OS=Homo sapiens GN=IFT122 PE=1 SV=2 | 502 | V | 0.036155 | G | 0.069008 | -0.032853 | No Change: Both O | Cranioectodermal dysplasia type 1 (CED1) [MIM:218330] |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 165 | D | 0.381854 | A | 0.325697 | 0.056157 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 279 | R | 0.40371 | P | 0.423945 | -0.020235 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 280 | R | 0.369648 | Q | 0.368775 | 8.73E-04 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 398 | V | 0.149545 | I | 0.134269 | 0.015276 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 451 | A | 0.195248 | V | 0.14359 | 0.051658 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 621 | R | 0.431815 | Q | 0.453244 | -0.021429 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 670 | P | 0.716094 | S | 0.728663 | -0.012569 | No Change: Both D | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 1070 | A | 0.405161 | V | 0.315149 | 0.090012 | No Change: Both O | - |
| Q96RY7 | IF140_HUMAN Intraflagellar transport protein 140 homolog OS=Homo sapiens GN=IFT140 PE=1 SV=1 | 561 | S | 0.380638 | N | 0.297496 | 0.083142 | No Change: Both O | - |
| Q9UG01 | IF172_HUMAN Intraflagellar transport protein 172 homolog OS=Homo sapiens GN=IFT172 PE=1 SV=2 | 953 | R | 0.335329 | H | 0.332297 | 0.003032 | No Change: Both O | - |
| Q96FT9 | IFT43_HUMAN Intraflagellar transport protein 43 homolog OS=Homo sapiens GN=IFT43 PE=1 SV=3 | 85 | R | 0.609439 | H | 0.527971 | 0.081468 | No Change: Both D | - |
| Q9NQC8 | IFT46_HUMAN Intraflagellar transport protein 46 homolog OS=Homo sapiens GN=IFT46 PE=2 SV=1 | 9 | C | 0.994807 | Y | 0.991938 | 0.002869 | No Change: Both D | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 55 | I | 0.777378 | M | 0.844943 | -0.067565 | No Change: Both D | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 110 | T | 0.467156 | A | 0.40633 | 0.060826 | No Change: Both O | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 224 | F | 0.819869 | L | 0.859238 | -0.039369 | No Change: Both D | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 355 | N | 0.926221 | T | 0.928151 | -0.00193 | No Change: Both D | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 597 | T | 0.622168 | I | 0.601122 | 0.021046 | No Change: Both D | - |
| Q96LB3 | IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens GN=IFT74 PE=2 SV=1 | 85 | K | 0.670724 | R | 0.631924 | 0.0388 | No Change: Both D | - |
| Q9P2H3 | IFT80_HUMAN Intraflagellar transport protein 80 homolog OS=Homo sapiens GN=IFT80 PE=1 SV=3 | 105 | H | 0.244404 | Q | 0.259417 | -0.015013 | No Change: Both O | Asphyxiating thoracic dystrophy type 2 (ATD2) [MIM:611263] |
| Q9P2H3 | IFT80_HUMAN Intraflagellar transport protein 80 homolog OS=Homo sapiens GN=IFT80 PE=1 SV=3 | 586 | T | 0.170866 | S | 0.247552 | -0.076686 | No Change: Both O | - |
| Q9P2H3 | IFT80_HUMAN Intraflagellar transport protein 80 homolog OS=Homo sapiens GN=IFT80 PE=1 SV=3 | 701 | A | 0.121652 | P | 0.160913 | -0.039261 | No Change: Both O | Asphyxiating thoracic dystrophy type 2 (ATD2) [MIM:611263] |
| Q13099 | IFT88_HUMAN Intraflagellar transport protein 88 homolog OS=Homo sapiens GN=IFT88 PE=2 SV=2 | 383 | M | 0.566454 | I | 0.467203 | 0.099251 | D to O | - |
| Q13099 | IFT88_HUMAN Intraflagellar transport protein 88 homolog OS=Homo sapiens GN=IFT88 PE=2 SV=2 | 455 | S | 0.613452 | N | 0.574624 | 0.038828 | No Change: Both D | - |
| Q13099 | IFT88_HUMAN Intraflagellar transport protein 88 homolog OS=Homo sapiens GN=IFT88 PE=2 SV=2 | 671 | S | 0.10411 | G | 0.081525 | 0.022585 | No Change: Both O | - |
| P78318 | IGBP1_HUMAN Immunoglobulin-binding protein 1 OS=Homo sapiens GN=IGBP1 PE=1 SV=1 | 20 | R | 0.52229 | K | 0.547872 | -0.025582 | No Change: Both D | - |
| Q8IVU1 | IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens GN=IGDCC3 PE=2 SV=2 | 751 | V | 0.925057 | L | 0.946889 | -0.021832 | No Change: Both D | - |
| Q8TDY8 | IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens GN=IGDCC4 PE=2 SV=1 | 52 | A | 0.240533 | P | 0.322697 | -0.082164 | No Change: Both O | - |
| Q8TDY8 | IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens GN=IGDCC4 PE=2 SV=1 | 301 | N | 0.179771 | S | 0.207704 | -0.027933 | No Change: Both O | - |
| Q8TDY8 | IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens GN=IGDCC4 PE=2 SV=1 | 1102 | T | 0.407452 | A | 0.4046 | 0.002852 | No Change: Both O | - |
| Q8TDY8 | IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens GN=IGDCC4 PE=2 SV=1 | 1125 | C | 0.483422 | Y | 0.501174 | -0.017752 | O to D | - |
| Q8TDY8 | IGDC4_HUMAN Immunoglobulin superfamily DCC subclass member 4 OS=Homo sapiens GN=IGDCC4 PE=2 SV=1 | 803 | S | 0.320523 | C | 0.1249 | 0.195623 | No Change: Both O | - |
| P05019 | IGF1_HUMAN Insulin-like growth factor I OS=Homo sapiens GN=IGF1 PE=1 SV=1 | 187 | A | 0.990403 | D | 0.991198 | -7.95E-04 | No Change: Both D | - |
| P05019 | IGF1_HUMAN Insulin-like growth factor I OS=Homo sapiens GN=IGF1 PE=1 SV=1 | 115 | A | 0.787055 | T | 0.795329 | -0.008274 | No Change: Both D | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 388 | V | 0.18386 | M | 0.213636 | -0.029776 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 605 | R | 0.205619 | H | 0.20361 | 0.002009 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 138 | R | 0.190445 | Q | 0.189394 | 0.001051 | No Change: Both O | Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 145 | K | 0.224192 | N | 0.202394 | 0.021798 | No Change: Both O | Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 437 | R | 0.140646 | H | 0.152335 | -0.011689 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 511 | R | 0.150893 | Q | 0.144584 | 0.006309 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 739 | R | 0.717282 | Q | 0.697887 | 0.019395 | No Change: Both D | Insulin-like growth factor 1 resistance (IGF1RES) [MIM:270450] |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 808 | H | 0.358025 | R | 0.346146 | 0.011879 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 828 | A | 0.436214 | T | 0.456482 | -0.020268 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 105 | V | 0.044691 | L | 0.049583 | -0.004892 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 595 | R | 0.372814 | H | 0.394916 | -0.022102 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 857 | N | 0.447816 | S | 0.480467 | -0.032651 | No Change: Both O | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 1338 | A | 0.689097 | T | 0.678393 | 0.010704 | No Change: Both D | - |
| P08069 | IGF1R_HUMAN Insulin-like growth factor 1 receptor OS=Homo sapiens GN=IGF1R PE=1 SV=1 | 1347 | A | 0.670008 | V | 0.592835 | 0.077173 | No Change: Both D | A lung squamous cell carcinoma sample |
| P01344 | IGF2_HUMAN Insulin-like growth factor II OS=Homo sapiens GN=IGF2 PE=1 SV=1 | 120 | K | 0.430187 | N | 0.380591 | 0.049596 | No Change: Both O | - |
| P01344 | IGF2_HUMAN Insulin-like growth factor II OS=Homo sapiens GN=IGF2 PE=1 SV=1 | 173 | P | 0.872595 | Q | 0.841125 | 0.03147 | No Change: Both D | - |
| P01344 | IGF2_HUMAN Insulin-like growth factor II OS=Homo sapiens GN=IGF2 PE=1 SV=1 | 180 | K | 0.913739 | N | 0.908504 | 0.005235 | No Change: Both D | - |
| Q6U949 | IG2AS_HUMAN Putative insulin-like growth factor 2 antisense gene protein OS=Homo sapiens GN=IGF2-AS PE=2 SV=2 | 106 | S | 0.745344 | I | 0.542169 | 0.203175 | No Change: Both D | - |
| Q6U949 | IG2AS_HUMAN Putative insulin-like growth factor 2 antisense gene protein OS=Homo sapiens GN=IGF2-AS PE=2 SV=2 | 112 | P | 0.800329 | T | 0.748041 | 0.052288 | No Change: Both D | - |
| Q6U949 | IG2AS_HUMAN Putative insulin-like growth factor 2 antisense gene protein OS=Homo sapiens GN=IGF2-AS PE=2 SV=2 | 125 | F | 0.913969 | V | 0.909327 | 0.004642 | No Change: Both D | - |
| Q6U949 | IG2AS_HUMAN Putative insulin-like growth factor 2 antisense gene protein OS=Homo sapiens GN=IGF2-AS PE=2 SV=2 | 150 | T | 0.955319 | A | 0.955596 | -2.77E-04 | No Change: Both D | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 2020 | N | 0.150077 | S | 0.187513 | -0.037436 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 203 | P | 0.434203 | L | 0.313222 | 0.120981 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 252 | L | 0.425054 | V | 0.4249 | 1.54E-04 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 529 | R | 0.438287 | Q | 0.460607 | -0.02232 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 604 | G | 0.240143 | S | 0.279767 | -0.039624 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 724 | A | 0.23007 | T | 0.277978 | -0.047908 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 856 | G | 0.445927 | S | 0.502522 | -0.056595 | O to D | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1107 | T | 0.291875 | M | 0.237656 | 0.054219 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1184 | T | 0.200635 | S | 0.26904 | -0.068405 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 91 | R | 0.43177 | H | 0.461332 | -0.029562 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 231 | G | 0.432225 | D | 0.479316 | -0.047091 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 273 | D | 0.346936 | G | 0.328362 | 0.018574 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 512 | K | 0.394256 | Q | 0.364217 | 0.030039 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 817 | L | 0.183294 | V | 0.201143 | -0.017849 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1124 | V | 0.09818 | I | 0.086566 | 0.011614 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1315 | G | 0.294245 | E | 0.32317 | -0.028925 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1335 | R | 0.114728 | H | 0.10684 | 0.007888 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1619 | R | 0.477565 | G | 0.453387 | 0.024178 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1832 | R | 0.43244 | H | 0.388985 | 0.043455 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1860 | G | 0.368822 | D | 0.376942 | -0.00812 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1908 | I | 0.091164 | M | 0.132985 | -0.041821 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 2459 | A | 0.928224 | V | 0.918015 | 0.010209 | No Change: Both D | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1254 | E | 0.165759 | A | 0.119524 | 0.046235 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1395 | T | 0.346912 | S | 0.410947 | -0.064035 | No Change: Both O | - |
| P11717 | MPRI_HUMAN Cation-independent mannose-6-phosphate receptor OS=Homo sapiens GN=IGF2R PE=1 SV=3 | 1696 | Q | 0.22558 | R | 0.234667 | -0.009087 | No Change: Both O | - |
| P35858 | ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1 | 498 | P | 0.485771 | S | 0.495791 | -0.01002 | No Change: Both O | - |
| P35858 | ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1 | 548 | R | 0.247573 | W | 0.113327 | 0.134246 | No Change: Both O | - |
| P35858 | ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1 | 97 | L | 0.486274 | F | 0.436683 | 0.049591 | No Change: Both O | - |
| P35858 | ALS_HUMAN Insulin-like growth factor-binding protein complex acid labile subunit OS=Homo sapiens GN=IGFALS PE=1 SV=1 | 307 | P | 0.321574 | L | 0.212766 | 0.108808 | No Change: Both O | - |
| P08833 | IBP1_HUMAN Insulin-like growth factor-binding protein 1 OS=Homo sapiens GN=IGFBP1 PE=1 SV=1 | 253 | I | 0.213032 | M | 0.298267 | -0.085235 | No Change: Both O | - |
| P08833 | IBP1_HUMAN Insulin-like growth factor-binding protein 1 OS=Homo sapiens GN=IGFBP1 PE=1 SV=1 | 183 | V | 0.151334 | I | 0.135032 | 0.016302 | No Change: Both O | - |
| P08833 | IBP1_HUMAN Insulin-like growth factor-binding protein 1 OS=Homo sapiens GN=IGFBP1 PE=1 SV=1 | 114 | H | 0.941048 | D | 0.950837 | -0.009789 | No Change: Both D | - |
| P18065 | IBP2_HUMAN Insulin-like growth factor-binding protein 2 OS=Homo sapiens GN=IGFBP2 PE=1 SV=2 | 137 | A | 0.717392 | D | 0.770732 | -0.05334 | No Change: Both D | - |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 158 | H | 0.881481 | P | 0.904762 | -0.023281 | No Change: Both D | - |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 32 | A | 0.665575 | G | 0.681167 | -0.015592 | No Change: Both D | - |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 56 | A | 0.771389 | T | 0.760529 | 0.01086 | No Change: Both D | - |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 234 | G | 0.469139 | S | 0.529417 | -0.060278 | O to D | - |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 7 | T | 0.472375 | M | 0.47734 | -0.004965 | No Change: Both O | A colorectal cancer sample |
| P17936 | IBP3_HUMAN Insulin-like growth factor-binding protein 3 OS=Homo sapiens GN=IGFBP3 PE=1 SV=2 | 252 | R | 0.720881 | C | 0.637544 | 0.083337 | No Change: Both D | A colorectal cancer sample |
| P22692 | IBP4_HUMAN Insulin-like growth factor-binding protein 4 OS=Homo sapiens GN=IGFBP4 PE=1 SV=2 | 42 | V | 0.837434 | G | 0.897724 | -0.06029 | No Change: Both D | - |
| P24593 | IBP5_HUMAN Insulin-like growth factor-binding protein 5 OS=Homo sapiens GN=IGFBP5 PE=1 SV=1 | 138 | R | 0.883826 | W | 0.746185 | 0.137641 | No Change: Both D | - |
| P24592 | IBP6_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1 | 236 | T | 0.993162 | P | 0.996554 | -0.003392 | No Change: Both D | - |
| P24592 | IBP6_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1 | 128 | R | 0.976385 | G | 0.971308 | 0.005077 | No Change: Both D | - |
| P24592 | IBP6_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1 | 217 | R | 0.930934 | Q | 0.928094 | 0.00284 | No Change: Both D | - |
| P24592 | IBP6_HUMAN Insulin-like growth factor-binding protein 6 OS=Homo sapiens GN=IGFBP6 PE=1 SV=1 | 134 | R | 0.988392 | L | 0.976995 | 0.011397 | No Change: Both D | - |
| Q16270 | IBP7_HUMAN Insulin-like growth factor-binding protein 7 OS=Homo sapiens GN=IGFBP7 PE=1 SV=1 | 11 | L | 0.891921 | F | 0.819013 | 0.072908 | No Change: Both D | - |
| Q16270 | IBP7_HUMAN Insulin-like growth factor-binding protein 7 OS=Homo sapiens GN=IGFBP7 PE=1 SV=1 | 78 | R | 0.961688 | G | 0.962735 | -0.001047 | No Change: Both D | - |
| Q16270 | IBP7_HUMAN Insulin-like growth factor-binding protein 7 OS=Homo sapiens GN=IGFBP7 PE=1 SV=1 | 95 | K | 0.942628 | R | 0.94144 | 0.001188 | No Change: Both D | - |
| Q6UXB1 | IGFL3_HUMAN Insulin growth factor-like family member 3 OS=Homo sapiens GN=IGFL3 PE=1 SV=1 | 66 | T | 0.414907 | S | 0.484144 | -0.069237 | No Change: Both O | - |
| Q6B9Z1 | IGFL4_HUMAN Insulin growth factor-like family member 4 OS=Homo sapiens GN=IGFL4 PE=2 SV=1 | 25 | L | 0.125381 | P | 0.22321 | -0.097829 | No Change: Both O | - |
| Q6B9Z1 | IGFL4_HUMAN Insulin growth factor-like family member 4 OS=Homo sapiens GN=IGFL4 PE=2 SV=1 | 60 | R | 0.209362 | Q | 0.245265 | -0.035903 | No Change: Both O | - |
| Q9H665 | IGFR1_HUMAN IGF-like family receptor 1 OS=Homo sapiens GN=IGFLR1 PE=1 SV=1 | 189 | W | 0.113944 | R | 0.216814 | -0.10287 | No Change: Both O | - |
| Q86VF2 | IGFN1_HUMAN Immunoglobulin-like and fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=IGFN1 PE=1 SV=2 | 1056 | T | 0.422474 | M | 0.367093 | 0.055381 | No Change: Both O | - |
| Q86VF2 | IGFN1_HUMAN Immunoglobulin-like and fibronectin type III domain-containing protein 1 OS=Homo sapiens GN=IGFN1 PE=1 SV=2 | 1095 | H | 0.239836 | Y | 0.148667 | 0.091169 | No Change: Both O | - |
| P01876 | IGHA1_HUMAN Ig alpha-1 chain C region OS=Homo sapiens GN=IGHA1 PE=1 SV=2 | 176 | E | 0.496621 | D | 0.496204 | 4.17E-04 | No Change: Both O | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 93 | P | 0.882515 | S | 0.873275 | 0.00924 | No Change: Both D | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 102 | P | 0.882841 | R | 0.83816 | 0.044681 | No Change: Both D | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 279 | F | 0.2681 | Y | 0.295615 | -0.027515 | No Change: Both O | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 296 | D | 0.28724 | E | 0.306527 | -0.019287 | No Change: Both O | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 326 | V | 0.331645 | I | 0.277591 | 0.054054 | No Change: Both O | - |
| P01877 | IGHA2_HUMAN Ig alpha-2 chain C region OS=Homo sapiens GN=IGHA2 PE=1 SV=3 | 335 | V | 0.401724 | A | 0.470716 | -0.068992 | No Change: Both O | - |
| P01854 | IGHE_HUMAN Ig epsilon chain C region OS=Homo sapiens GN=IGHE PE=1 SV=1 | 359 | W | 0.178217 | L | 0.264665 | -0.086448 | No Change: Both O | - |
| P01854 | IGHE_HUMAN Ig epsilon chain C region OS=Homo sapiens GN=IGHE PE=1 SV=1 | 43 | W | 0.23457 | C | 0.304754 | -0.070184 | No Change: Both O | - |
| P01857 | IGHG1_HUMAN Ig gamma-1 chain C region OS=Homo sapiens GN=IGHG1 PE=1 SV=1 | 97 | K | 0.898076 | R | 0.85471 | 0.043366 | No Change: Both D | - |
| P01857 | IGHG1_HUMAN Ig gamma-1 chain C region OS=Homo sapiens GN=IGHG1 PE=1 SV=1 | 239 | D | 0.582389 | E | 0.622126 | -0.039737 | No Change: Both D | - |
| P01857 | IGHG1_HUMAN Ig gamma-1 chain C region OS=Homo sapiens GN=IGHG1 PE=1 SV=1 | 241 | L | 0.555013 | M | 0.577218 | -0.022205 | No Change: Both D | - |
| P01859 | IGHG2_HUMAN Ig gamma-2 chain C region OS=Homo sapiens GN=IGHG2 PE=1 SV=2 | 60 | S | 0.445143 | A | 0.319023 | 0.12612 | No Change: Both O | - |
| P01860 | IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 | 221 | P | 0.735418 | L | 0.634473 | 0.100945 | No Change: Both D | - |
| P01860 | IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 | 226 | Y | 0.503231 | F | 0.484174 | 0.019057 | D to O | - |
| P01860 | IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 | 269 | T | 0.772106 | A | 0.742834 | 0.029272 | No Change: Both D | - |
| P01860 | IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 | 314 | S | 0.535562 | N | 0.50709 | 0.028472 | No Change: Both D | - |
| P01860 | IGHG3_HUMAN Ig gamma-3 chain C region OS=Homo sapiens GN=IGHG3 PE=1 SV=2 | 366 | F | 0.488367 | Y | 0.509325 | -0.020958 | O to D | - |
| P01871 | IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 | 191 | G | 0.267891 | S | 0.34722 | -0.079329 | No Change: Both O | - |
| P01871 | IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 | 215 | V | 0.382232 | G | 0.499972 | -0.11774 | No Change: Both O | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 671 | T | 0.942548 | A | 0.936907 | 0.005641 | No Change: Both D | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 694 | R | 0.992722 | W | 0.982567 | 0.010155 | No Change: Both D | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 928 | E | 0.440314 | K | 0.419623 | 0.020691 | No Change: Both O | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 192 | L | 0.254731 | P | 0.392534 | -0.137803 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 213 | H | 0.360116 | R | 0.359327 | 7.89E-04 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 221 | T | 0.444467 | A | 0.395842 | 0.048625 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 241 | C | 0.07835 | R | 0.142313 | -0.063963 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 334 | E | 0.795406 | K | 0.78967 | 0.005736 | No Change: Both D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 361 | L | 0.463402 | P | 0.586467 | -0.123065 | O to D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 364 | L | 0.291376 | P | 0.437277 | -0.145901 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 382 | E | 0.094316 | K | 0.092697 | 0.001619 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 426 | L | 0.406051 | P | 0.530512 | -0.124461 | O to D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 514 | E | 0.521663 | K | 0.528377 | -0.006714 | No Change: Both D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 565 | D | 0.444979 | N | 0.430447 | 0.014532 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 577 | L | 0.284813 | P | 0.433995 | -0.149182 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 580 | V | 0.299791 | I | 0.26735 | 0.032441 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 583 | N | 0.406812 | I | 0.264846 | 0.141966 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 586 | G | 0.451695 | C | 0.296847 | 0.154848 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 603 | R | 0.243391 | H | 0.234528 | 0.008863 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 637 | R | 0.258111 | C | 0.143803 | 0.114308 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 879 | T | 0.788051 | K | 0.811308 | -0.023257 | No Change: Both D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 974 | D | 0.926474 | E | 0.935784 | -0.00931 | No Change: Both D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 201 | L | 0.253914 | S | 0.422121 | -0.168207 | No Change: Both O | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 275 | I | 0.46597 | V | 0.501043 | -0.035073 | O to D | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 75 | A | 0.502435 | T | 0.517823 | -0.015388 | No Change: Both D | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 557 | P | 0.450049 | A | 0.379629 | 0.07042 | No Change: Both O | - |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 17 | L | 0.489051 | P | 0.611963 | -0.122912 | O to D | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 196 | Q | 0.301317 | R | 0.282168 | 0.019149 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 216 | P | 0.519766 | L | 0.353951 | 0.165815 | D to O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 251 | L | 0.156438 | P | 0.267032 | -0.110594 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 386 | W | 0.073733 | R | 0.187271 | -0.113538 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 445 | H | 0.163809 | P | 0.187337 | -0.023528 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 472 | L | 0.312414 | P | 0.482007 | -0.169593 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 493 | T | 0.245807 | I | 0.139439 | 0.106368 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 581 | R | 0.31929 | S | 0.371958 | -0.052668 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P38935 | SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens GN=IGHMBP2 PE=1 SV=3 | 603 | R | 0.243391 | C | 0.115999 | 0.127392 | No Change: Both O | Distal hereditary motor neuronopathy type 6 (HMN6) [MIM:604320] |
| P01834 | IGKC_HUMAN Ig kappa chain C region OS=Homo sapiens GN=IGKC PE=1 SV=1 | 83 | V | 0.538657 | L | 0.547834 | -0.009177 | No Change: Both D | - |
| P01834 | IGKC_HUMAN Ig kappa chain C region OS=Homo sapiens GN=IGKC PE=1 SV=1 | 40 | W | 0.424777 | R | 0.60731 | -0.182533 | O to D | Immunoglobulin kappa light chain deficiency (IGKCD) [MIM:614102] |
| P15814 | IGLL1_HUMAN Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens GN=IGLL1 PE=1 SV=1 | 142 | P | 0.105778 | L | 0.055891 | 0.049887 | No Change: Both O | - |
| P15814 | IGLL1_HUMAN Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens GN=IGLL1 PE=1 SV=1 | 120 | P | 0.597392 | L | 0.427229 | 0.170163 | D to O | - |
| P15814 | IGLL1_HUMAN Immunoglobulin lambda-like polypeptide 1 OS=Homo sapiens GN=IGLL1 PE=1 SV=1 | 189 | R | 0.713966 | H | 0.663094 | 0.050872 | No Change: Both D | - |
| Q8N6C5 | IGSF1_HUMAN Immunoglobulin superfamily member 1 OS=Homo sapiens GN=IGSF1 PE=1 SV=3 | 381 | N | 0.229331 | H | 0.19652 | 0.032811 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 124 | T | 0.30835 | I | 0.185461 | 0.122889 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 150 | Y | 0.056482 | D | 0.114628 | -0.058146 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 571 | P | 0.156834 | S | 0.173705 | -0.016871 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 1199 | S | 0.368764 | A | 0.279067 | 0.089697 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 1370 | T | 0.95636 | I | 0.920815 | 0.035545 | No Change: Both D | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 1875 | Y | 0.191331 | H | 0.293278 | -0.101947 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 2476 | R | 0.293276 | W | 0.135914 | 0.157362 | No Change: Both O | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 2579 | H | 0.717839 | Y | 0.628592 | 0.089247 | No Change: Both D | - |
| Q6WRI0 | IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens GN=IGSF10 PE=1 SV=1 | 795 | D | 0.695625 | N | 0.69025 | 0.005375 | No Change: Both D | - |
| Q5DX21 | IGS11_HUMAN Immunoglobulin superfamily member 11 OS=Homo sapiens GN=IGSF11 PE=2 SV=3 | 39 | P | 0.235598 | T | 0.191433 | 0.044165 | No Change: Both O | - |
| Q5DX21 | IGS11_HUMAN Immunoglobulin superfamily member 11 OS=Homo sapiens GN=IGSF11 PE=2 SV=3 | 333 | E | 0.647915 | D | 0.659978 | -0.012063 | No Change: Both D | - |
| Q5DX21 | IGS11_HUMAN Immunoglobulin superfamily member 11 OS=Homo sapiens GN=IGSF11 PE=2 SV=3 | 388 | S | 0.864911 | N | 0.834493 | 0.030418 | No Change: Both D | - |
| Q96ID5 | IGS21_HUMAN Immunoglobulin superfamily member 21 OS=Homo sapiens GN=IGSF21 PE=2 SV=1 | 467 | T | 0.549916 | M | 0.499622 | 0.050294 | D to O | A colorectal cancer sample |
| Q96ID5 | IGS21_HUMAN Immunoglobulin superfamily member 21 OS=Homo sapiens GN=IGSF21 PE=2 SV=1 | 245 | R | 0.857678 | H | 0.809496 | 0.048182 | No Change: Both D | - |
| Q96ID5 | IGS21_HUMAN Immunoglobulin superfamily member 21 OS=Homo sapiens GN=IGSF21 PE=2 SV=1 | 379 | T | 0.168836 | M | 0.150764 | 0.018072 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 94 | A | 0.498271 | P | 0.588358 | -0.090087 | O to D | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 130 | L | 0.600457 | R | 0.674215 | -0.073758 | No Change: Both D | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 414 | V | 0.218681 | I | 0.200441 | 0.01824 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 472 | R | 0.465866 | Q | 0.492258 | -0.026392 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 503 | S | 0.288545 | I | 0.139514 | 0.149031 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 559 | M | 0.260307 | V | 0.220319 | 0.039988 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 677 | L | 0.292651 | F | 0.230945 | 0.061706 | No Change: Both O | - |
| Q8N9C0 | IGS22_HUMAN Immunoglobulin superfamily member 22 OS=Homo sapiens GN=IGSF22 PE=1 SV=2 | 7 | R | 0.909679 | W | 0.763079 | 0.1466 | No Change: Both D | - |
| O75054 | IGSF3_HUMAN Immunoglobulin superfamily member 3 OS=Homo sapiens GN=IGSF3 PE=1 SV=3 | 51 | S | 0.496571 | P | 0.474309 | 0.022262 | No Change: Both O | - |
| O75054 | IGSF3_HUMAN Immunoglobulin superfamily member 3 OS=Homo sapiens GN=IGSF3 PE=1 SV=3 | 1020 | D | 0.991015 | E | 0.991915 | -9.00E-04 | No Change: Both D | - |
| O75054 | IGSF3_HUMAN Immunoglobulin superfamily member 3 OS=Homo sapiens GN=IGSF3 PE=1 SV=3 | 1073 | Q | 0.387219 | R | 0.375585 | 0.011634 | No Change: Both O | - |
| Q9NSI5 | IGSF5_HUMAN Immunoglobulin superfamily member 5 OS=Homo sapiens GN=IGSF5 PE=2 SV=2 | 49 | R | 0.428736 | T | 0.403206 | 0.02553 | No Change: Both O | - |
| Q9NSI5 | IGSF5_HUMAN Immunoglobulin superfamily member 5 OS=Homo sapiens GN=IGSF5 PE=2 SV=2 | 156 | N | 0.296633 | K | 0.324626 | -0.027993 | No Change: Both O | - |
| Q9NSI5 | IGSF5_HUMAN Immunoglobulin superfamily member 5 OS=Homo sapiens GN=IGSF5 PE=2 SV=2 | 170 | R | 0.181137 | W | 0.085832 | 0.095305 | No Change: Both O | - |
| Q9NSI5 | IGSF5_HUMAN Immunoglobulin superfamily member 5 OS=Homo sapiens GN=IGSF5 PE=2 SV=2 | 350 | D | 0.995122 | E | 0.995867 | -7.45E-04 | No Change: Both D | - |
| O95976 | IGSF6_HUMAN Immunoglobulin superfamily member 6 OS=Homo sapiens GN=IGSF6 PE=2 SV=2 | 74 | Q | 0.231563 | R | 0.230216 | 0.001347 | No Change: Both O | - |
| O95976 | IGSF6_HUMAN Immunoglobulin superfamily member 6 OS=Homo sapiens GN=IGSF6 PE=2 SV=2 | 173 | F | 0.124558 | S | 0.283053 | -0.158495 | No Change: Both O | - |
| O95976 | IGSF6_HUMAN Immunoglobulin superfamily member 6 OS=Homo sapiens GN=IGSF6 PE=2 SV=2 | 186 | N | 0.777074 | K | 0.798949 | -0.021875 | No Change: Both D | - |
| Q9P2J2 | TUTLA_HUMAN Protein turtle homolog A OS=Homo sapiens GN=IGSF9 PE=1 SV=2 | 34 | G | 0.335785 | E | 0.386402 | -0.050617 | No Change: Both O | - |
| Q9P2J2 | TUTLA_HUMAN Protein turtle homolog A OS=Homo sapiens GN=IGSF9 PE=1 SV=2 | 474 | R | 0.393039 | P | 0.446407 | -0.053368 | No Change: Both O | - |
| Q9P2J2 | TUTLA_HUMAN Protein turtle homolog A OS=Homo sapiens GN=IGSF9 PE=1 SV=2 | 914 | P | 0.935368 | L | 0.884863 | 0.050505 | No Change: Both D | - |
| Q9P2J2 | TUTLA_HUMAN Protein turtle homolog A OS=Homo sapiens GN=IGSF9 PE=1 SV=2 | 1026 | S | 0.949354 | T | 0.935955 | 0.013399 | No Change: Both D | - |
| Q9P2J2 | TUTLA_HUMAN Protein turtle homolog A OS=Homo sapiens GN=IGSF9 PE=1 SV=2 | 1117 | P | 0.785086 | T | 0.741129 | 0.043957 | No Change: Both D | - |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 46 | P | 0.484793 | L | 0.310191 | 0.174602 | No Change: Both O | Acrocapitofemoral dysplasia (ACFD) [MIM:607778] |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 95 | E | 0.527266 | K | 0.528015 | -7.49E-04 | No Change: Both D | Brachydactyly type A1 (BDA1) [MIM:112500] |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 100 | D | 0.467956 | E | 0.49631 | -0.028354 | No Change: Both O | Brachydactyly type A1 (BDA1) [MIM:112500] |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 100 | D | 0.467956 | N | 0.457101 | 0.010855 | No Change: Both O | Brachydactyly type A1 (BDA1) [MIM:112500] |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 131 | E | 0.379216 | K | 0.373549 | 0.005667 | No Change: Both O | Brachydactyly type A1 (BDA1) [MIM:112500] |
| Q14623 | IHH_HUMAN Indian hedgehog protein OS=Homo sapiens GN=IHH PE=1 SV=4 | 190 | V | 0.693904 | A | 0.736935 | -0.043031 | No Change: Both D | Acrocapitofemoral dysplasia (ACFD) [MIM:607778] |
| Q70UQ0 | IKIP_HUMAN Inhibitor of nuclear factor kappa-B kinase-interacting protein OS=Homo sapiens GN=IKBIP PE=1 SV=1 | 265 | G | 0.515975 | S | 0.630837 | -0.114862 | No Change: Both D | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 696 | R | 0.302219 | P | 0.327755 | -0.025536 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 3 (HSAN3) [MIM:223900] |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 70 | R | 0.359507 | C | 0.241477 | 0.11803 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 182 | M | 0.484734 | K | 0.57318 | -0.088446 | O to D | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 312 | E | 0.606321 | K | 0.599951 | 0.00637 | No Change: Both D | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 525 | R | 0.564512 | Q | 0.576871 | -0.012359 | No Change: Both D | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 765 | G | 0.145033 | E | 0.189007 | -0.043974 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 816 | I | 0.33389 | L | 0.380372 | -0.046482 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 830 | I | 0.308759 | M | 0.411998 | -0.103239 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 848 | T | 0.480812 | N | 0.491012 | -0.0102 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 952 | K | 0.296816 | I | 0.145698 | 0.151118 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 1013 | G | 0.243354 | S | 0.293168 | -0.049814 | No Change: Both O | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 1072 | C | 0.283519 | S | 0.513553 | -0.230034 | O to D | - |
| O95163 | ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens GN=IKBKAP PE=1 SV=3 | 1158 | P | 0.831518 | L | 0.778942 | 0.052576 | No Change: Both D | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 554 | R | 0.78181 | W | 0.604051 | 0.177759 | No Change: Both D | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 360 | A | 0.453699 | S | 0.544482 | -0.090783 | O to D | Breast cancer samples |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 369 | Q | 0.3852 | R | 0.35451 | 0.03069 | No Change: Both O | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 526 | R | 0.351437 | Q | 0.371817 | -0.02038 | No Change: Both O | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 710 | A | 0.654098 | T | 0.673687 | -0.019589 | No Change: Both D | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 734 | F | 0.470656 | L | 0.559398 | -0.088742 | O to D | - |
| O14920 | IKKB_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit beta OS=Homo sapiens GN=IKBKB PE=1 SV=1 | 736 | A | 0.423946 | T | 0.474929 | -0.050983 | No Change: Both O | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 713 | P | 0.717923 | L | 0.651769 | 0.066154 | No Change: Both D | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 128 | E | 0.391129 | K | 0.395079 | -0.00395 | No Change: Both O | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 371 | A | 0.515323 | T | 0.540409 | -0.025086 | No Change: Both D | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 515 | E | 0.886166 | D | 0.85645 | 0.029716 | No Change: Both D | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 543 | I | 0.459746 | M | 0.572673 | -0.112927 | O to D | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 602 | A | 0.302966 | V | 0.253809 | 0.049157 | No Change: Both O | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 483 | T | 0.652419 | M | 0.593916 | 0.058503 | No Change: Both D | - |
| Q14164 | IKKE_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit epsilon OS=Homo sapiens GN=IKBKE PE=1 SV=1 | 660 | G | 0.833366 | E | 0.876373 | -0.043007 | No Change: Both D | - |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 407 | M | 0.743866 | V | 0.649369 | 0.094497 | No Change: Both D | Incontinentia pigmenti (IP) [MIM:308300] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 175 | R | 0.974246 | P | 0.969604 | 0.004642 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 227 | L | 0.646764 | P | 0.718398 | -0.071634 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 288 | A | 0.726415 | G | 0.697963 | 0.028452 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 311 | D | 0.711496 | N | 0.659021 | 0.052475 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 406 | D | 0.755089 | V | 0.644286 | 0.110803 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 417 | C | 0.6885 | F | 0.596754 | 0.091746 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 417 | C | 0.6885 | R | 0.699614 | -0.011114 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 57 | E | 0.884933 | K | 0.855951 | 0.028982 | No Change: Both D | Incontinentia pigmenti (IP) [MIM:308300] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 113 | D | 0.91755 | N | 0.907557 | 0.009993 | No Change: Both D | - |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 123 | R | 0.880696 | W | 0.705261 | 0.175435 | No Change: Both D | Incontinentia pigmenti (IP) [MIM:308300] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 153 | L | 0.931396 | R | 0.952408 | -0.021012 | No Change: Both D | Ectodermal dysplasia anhidrotic with immunodeficiency X-linked (EDAID) [MIM:300291] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 417 | C | 0.6885 | Y | 0.601364 | 0.087136 | No Change: Both D | Immunodeficiency NEMO-related without anhidrotic ectodermal dysplasia (NEMOID) [MIM:300584] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 173 | R | 0.970243 | G | 0.963372 | 0.006871 | No Change: Both D | Recurrent isolated invasive pneumococcal disease type 2 (IPD2) [MIM:300640] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 315 | E | 0.788827 | A | 0.735111 | 0.053716 | No Change: Both D | X-linked familial atypical micobacteriosis type 1 (AMCBX1) [MIM:300636] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 319 | R | 0.842388 | Q | 0.862123 | -0.019735 | No Change: Both D | X-linked familial atypical micobacteriosis type 1 (AMCBX1) [MIM:300636] |
| Q9Y6K9 | NEMO_HUMAN NF-kappa-B essential modulator OS=Homo sapiens GN=IKBKG PE=1 SV=2 | 323 | A | 0.870804 | P | 0.889749 | -0.018945 | No Change: Both D | Incontinentia pigmenti (IP) [MIM:308300] |
| Q9UKS7 | IKZF2_HUMAN Zinc finger protein Helios OS=Homo sapiens GN=IKZF2 PE=1 SV=2 | 93 | N | 0.761913 | S | 0.800297 | -0.038384 | No Change: Both D | - |
| Q9UKT9 | IKZF3_HUMAN Zinc finger protein Aiolos OS=Homo sapiens GN=IKZF3 PE=1 SV=2 | 277 | E | 0.418447 | Q | 0.396772 | 0.021675 | No Change: Both O | - |
| P22301 | IL10_HUMAN Interleukin-10 OS=Homo sapiens GN=IL10 PE=1 SV=1 | 15 | G | 0.333322 | R | 0.38777 | -0.054448 | No Change: Both O | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 61 | L | 0.073049 | V | 0.07344 | -3.91E-04 | No Change: Both O | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 113 | V | 0.411179 | I | 0.364972 | 0.046207 | No Change: Both O | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 159 | S | 0.326834 | G | 0.265673 | 0.061161 | No Change: Both O | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 212 | R | 0.659827 | Q | 0.681603 | -0.021776 | No Change: Both D | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 351 | R | 0.946132 | G | 0.945059 | 0.001073 | No Change: Both D | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 420 | S | 0.901032 | L | 0.829725 | 0.071307 | No Change: Both D | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 224 | I | 0.222818 | V | 0.25109 | -0.028272 | No Change: Both O | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 353 | P | 0.952059 | S | 0.951101 | 9.58E-04 | No Change: Both D | - |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 84 | T | 0.195425 | I | 0.101183 | 0.094242 | No Change: Both O | Inflammatory bowel disease type 28 (IBD28) [MIM:613148] |
| Q13651 | I10R1_HUMAN Interleukin-10 receptor subunit alpha OS=Homo sapiens GN=IL10RA PE=1 SV=2 | 141 | G | 0.176234 | R | 0.166592 | 0.009642 | No Change: Both O | Inflammatory bowel disease type 28 (IBD28) [MIM:613148] |
| Q08334 | I10R2_HUMAN Interleukin-10 receptor subunit beta OS=Homo sapiens GN=IL10RB PE=1 SV=2 | 47 | K | 0.274436 | E | 0.285584 | -0.011148 | No Change: Both O | - |
| P20809 | IL11_HUMAN Interleukin-11 OS=Homo sapiens GN=IL11 PE=1 SV=1 | 108 | V | 0.225006 | M | 0.302837 | -0.077831 | No Change: Both O | - |
| P20809 | IL11_HUMAN Interleukin-11 OS=Homo sapiens GN=IL11 PE=1 SV=1 | 112 | R | 0.362944 | H | 0.328411 | 0.034533 | No Change: Both O | - |
| Q14626 | I11RA_HUMAN Interleukin-11 receptor subunit alpha OS=Homo sapiens GN=IL11RA PE=1 SV=2 | 65 | P | 0.502483 | T | 0.427797 | 0.074686 | D to O | - |
| Q14626 | I11RA_HUMAN Interleukin-11 receptor subunit alpha OS=Homo sapiens GN=IL11RA PE=1 SV=2 | 395 | R | 0.447767 | W | 0.256766 | 0.191001 | No Change: Both O | - |
| Q14626 | I11RA_HUMAN Interleukin-11 receptor subunit alpha OS=Homo sapiens GN=IL11RA PE=1 SV=2 | 221 | P | 0.611035 | R | 0.57637 | 0.034665 | No Change: Both D | Craniosynostosis and dental anomalies (CRSDA) [MIM:614188] |
| Q14626 | I11RA_HUMAN Interleukin-11 receptor subunit alpha OS=Homo sapiens GN=IL11RA PE=1 SV=2 | 245 | S | 0.297774 | C | 0.182555 | 0.115219 | No Change: Both O | Craniosynostosis and dental anomalies (CRSDA) [MIM:614188] |
| Q14626 | I11RA_HUMAN Interleukin-11 receptor subunit alpha OS=Homo sapiens GN=IL11RA PE=1 SV=2 | 296 | R | 0.258143 | W | 0.128703 | 0.12944 | No Change: Both O | Craniosynostosis and dental anomalies (CRSDA) [MIM:614188] |
| P29460 | IL12B_HUMAN Interleukin-12 subunit beta OS=Homo sapiens GN=IL12B PE=1 SV=1 | 33 | V | 0.087616 | I | 0.069028 | 0.018588 | No Change: Both O | - |
| P29460 | IL12B_HUMAN Interleukin-12 subunit beta OS=Homo sapiens GN=IL12B PE=1 SV=1 | 298 | V | 0.398204 | F | 0.374848 | 0.023356 | No Change: Both O | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 365 | M | 0.173839 | T | 0.201067 | -0.027228 | No Change: Both O | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 378 | G | 0.397408 | R | 0.387857 | 0.009551 | No Change: Both O | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 213 | R | 0.816236 | W | 0.677489 | 0.138747 | No Change: Both D | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 3 | P | 0.581313 | Q | 0.549896 | 0.031417 | No Change: Both D | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 47 | P | 0.775951 | S | 0.793505 | -0.017554 | No Change: Both D | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 156 | R | 0.323424 | H | 0.310243 | 0.013181 | No Change: Both O | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 214 | Q | 0.832005 | R | 0.825123 | 0.006882 | No Change: Both D | - |
| P42701 | I12R1_HUMAN Interleukin-12 receptor subunit beta-1 OS=Homo sapiens GN=IL12RB1 PE=1 SV=1 | 339 | H | 0.397942 | Q | 0.401595 | -0.003653 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 185 | I | 0.243295 | V | 0.262335 | -0.01904 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 420 | G | 0.257148 | R | 0.28944 | -0.032292 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 426 | Q | 0.434138 | H | 0.412546 | 0.021592 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 465 | G | 0.430547 | D | 0.45785 | -0.027303 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 625 | A | 0.058781 | V | 0.039177 | 0.019604 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 201 | T | 0.427907 | I | 0.271878 | 0.156029 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 313 | R | 0.565084 | G | 0.578766 | -0.013682 | No Change: Both D | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 720 | H | 0.554304 | R | 0.594446 | -0.040142 | No Change: Both D | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 13 | M | 0.010233 | V | 0.007412 | 0.002821 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 149 | R | 0.304057 | Q | 0.311958 | -0.007901 | No Change: Both O | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 808 | L | 0.781046 | R | 0.808148 | -0.027102 | No Change: Both D | - |
| Q99665 | I12R2_HUMAN Interleukin-12 receptor subunit beta-2 OS=Homo sapiens GN=IL12RB2 PE=1 SV=1 | 420 | G | 0.257148 | S | 0.332177 | -0.075029 | No Change: Both O | - |
| P35225 | IL13_HUMAN Interleukin-13 OS=Homo sapiens GN=IL13 PE=1 SV=2 | 144 | R | 0.760757 | Q | 0.775348 | -0.014591 | No Change: Both D | - |
| Q14627 | I13R2_HUMAN Interleukin-13 receptor subunit alpha-2 OS=Homo sapiens GN=IL13RA2 PE=1 SV=1 | 111 | W | 0.131857 | R | 0.281442 | -0.149585 | No Change: Both O | - |
| Q13261 | I15RA_HUMAN Interleukin-15 receptor subunit alpha OS=Homo sapiens GN=IL15RA PE=1 SV=1 | 182 | N | 0.878017 | T | 0.904935 | -0.026918 | No Change: Both D | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 889 | R | 0.901048 | Q | 0.90962 | -0.008572 | No Change: Both D | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 906 | S | 0.961444 | L | 0.939025 | 0.022419 | No Change: Both D | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 1147 | N | 0.278518 | K | 0.310186 | -0.031668 | No Change: Both O | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 1027 | S | 0.960339 | T | 0.945755 | 0.014584 | No Change: Both D | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 1176 | H | 0.390378 | R | 0.422939 | -0.032561 | No Change: Both O | - |
| Q14005 | IL16_HUMAN Pro-interleukin-16 OS=Homo sapiens GN=IL16 PE=1 SV=4 | 434 | P | 0.392769 | S | 0.404329 | -0.01156 | No Change: Both O | - |
| Q9P0M4 | IL17C_HUMAN Interleukin-17C OS=Homo sapiens GN=IL17C PE=2 SV=1 | 25 | R | 0.733729 | G | 0.752534 | -0.018805 | No Change: Both D | - |
| Q96PD4 | IL17F_HUMAN Interleukin-17F OS=Homo sapiens GN=IL17F PE=1 SV=3 | 126 | E | 0.361751 | G | 0.31013 | 0.051621 | No Change: Both O | - |
| Q96PD4 | IL17F_HUMAN Interleukin-17F OS=Homo sapiens GN=IL17F PE=1 SV=3 | 155 | V | 0.124058 | I | 0.096714 | 0.027344 | No Change: Both O | - |
| Q96PD4 | IL17F_HUMAN Interleukin-17F OS=Homo sapiens GN=IL17F PE=1 SV=3 | 161 | H | 0.582635 | R | 0.520279 | 0.062356 | No Change: Both D | - |
| Q96PD4 | IL17F_HUMAN Interleukin-17F OS=Homo sapiens GN=IL17F PE=1 SV=3 | 95 | S | 0.39357 | L | 0.240693 | 0.152877 | No Change: Both O | Familial candidiasis type 6 (CANDF6) [MIM:613956] |
| Q96F46 | I17RA_HUMAN Interleukin-17 receptor A OS=Homo sapiens GN=IL17RA PE=1 SV=2 | 367 | A | 0.349922 | V | 0.25436 | 0.095562 | No Change: Both O | - |
| Q96F46 | I17RA_HUMAN Interleukin-17 receptor A OS=Homo sapiens GN=IL17RA PE=1 SV=2 | 580 | R | 0.319631 | H | 0.222495 | 0.097136 | No Change: Both O | - |
| Q96F46 | I17RA_HUMAN Interleukin-17 receptor A OS=Homo sapiens GN=IL17RA PE=1 SV=2 | 562 | P | 0.570457 | Q | 0.569247 | 0.00121 | No Change: Both D | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 278 | F | 0.36457 | L | 0.412869 | -0.048299 | No Change: Both O | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 451 | I | 0.225641 | T | 0.371409 | -0.145768 | No Change: Both O | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 458 | N | 0.285207 | S | 0.341971 | -0.056764 | No Change: Both O | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 499 | C | 0.65566 | R | 0.728139 | -0.072479 | No Change: Both D | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 177 | G | 0.272241 | S | 0.340566 | -0.068325 | No Change: Both O | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 209 | A | 0.1551 | V | 0.11392 | 0.04118 | No Change: Both O | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 232 | R | 0.474957 | Q | 0.518897 | -0.04394 | O to D | - |
| Q9NRM6 | I17RB_HUMAN Interleukin-17 receptor B OS=Homo sapiens GN=IL17RB PE=1 SV=2 | 177 | G | 0.272241 | R | 0.268541 | 0.0037 | No Change: Both O | - |
| Q8NAC3 | I17RC_HUMAN Interleukin-17 receptor C OS=Homo sapiens GN=IL17RC PE=1 SV=2 | 182 | S | 0.664692 | L | 0.481503 | 0.183189 | D to O | - |
| Q8NFM7 | I17RD_HUMAN Interleukin-17 receptor D OS=Homo sapiens GN=IL17RD PE=1 SV=3 | 255 | T | 0.516814 | M | 0.436242 | 0.080572 | D to O | - |
| Q8NFM7 | I17RD_HUMAN Interleukin-17 receptor D OS=Homo sapiens GN=IL17RD PE=1 SV=3 | 301 | V | 0.078352 | M | 0.094752 | -0.0164 | No Change: Both O | - |
| Q8NFR9 | I17RE_HUMAN Interleukin-17 receptor E OS=Homo sapiens GN=IL17RE PE=2 SV=1 | 219 | Y | 0.40304 | C | 0.361603 | 0.041437 | No Change: Both O | - |
| Q8NFR9 | I17RE_HUMAN Interleukin-17 receptor E OS=Homo sapiens GN=IL17RE PE=2 SV=1 | 402 | P | 0.265191 | S | 0.283917 | -0.018726 | No Change: Both O | - |
| Q8NFR9 | I17RE_HUMAN Interleukin-17 receptor E OS=Homo sapiens GN=IL17RE PE=2 SV=1 | 417 | S | 0.309793 | T | 0.222715 | 0.087078 | No Change: Both O | - |
| Q6ZVW7 | I17EL_HUMAN Putative interleukin-17 receptor E-like OS=Homo sapiens GN=IL17REL PE=2 SV=2 | 333 | L | 0.944538 | P | 0.974206 | -0.029668 | No Change: Both D | - |
| Q6ZVW7 | I17EL_HUMAN Putative interleukin-17 receptor E-like OS=Homo sapiens GN=IL17REL PE=2 SV=2 | 70 | G | 0.68936 | R | 0.681365 | 0.007995 | No Change: Both D | - |
| O95998 | I18BP_HUMAN Interleukin-18-binding protein OS=Homo sapiens GN=IL18BP PE=1 SV=2 | 121 | R | 0.766052 | Q | 0.769022 | -0.00297 | No Change: Both D | - |
| O95998 | I18BP_HUMAN Interleukin-18-binding protein OS=Homo sapiens GN=IL18BP PE=1 SV=2 | 91 | R | 0.107821 | H | 0.107128 | 6.93E-04 | No Change: Both O | - |
| Q13478 | IL18R_HUMAN Interleukin-18 receptor 1 OS=Homo sapiens GN=IL18R1 PE=1 SV=1 | 210 | R | 0.214832 | H | 0.217421 | -0.002589 | No Change: Both O | - |
| Q13478 | IL18R_HUMAN Interleukin-18 receptor 1 OS=Homo sapiens GN=IL18R1 PE=1 SV=1 | 232 | N | 0.253447 | K | 0.290289 | -0.036842 | No Change: Both O | - |
| Q13478 | IL18R_HUMAN Interleukin-18 receptor 1 OS=Homo sapiens GN=IL18R1 PE=1 SV=1 | 310 | S | 0.339097 | N | 0.291287 | 0.04781 | No Change: Both O | - |
| Q13478 | IL18R_HUMAN Interleukin-18 receptor 1 OS=Homo sapiens GN=IL18R1 PE=1 SV=1 | 423 | G | 0.272956 | R | 0.257753 | 0.015203 | No Change: Both O | - |
| O95256 | I18RA_HUMAN Interleukin-18 receptor accessory protein OS=Homo sapiens GN=IL18RAP PE=1 SV=1 | 350 | V | 0.556701 | I | 0.523668 | 0.033033 | No Change: Both D | - |
| Q9UHD0 | IL19_HUMAN Interleukin-19 OS=Homo sapiens GN=IL19 PE=1 SV=2 | 175 | F | 0.812303 | S | 0.897338 | -0.085035 | No Change: Both D | - |
| P01583 | IL1A_HUMAN Interleukin-1 alpha OS=Homo sapiens GN=IL1A PE=1 SV=1 | 85 | R | 0.6627 | Q | 0.666012 | -0.003312 | No Change: Both D | - |
| P01583 | IL1A_HUMAN Interleukin-1 alpha OS=Homo sapiens GN=IL1A PE=1 SV=1 | 114 | A | 0.388376 | S | 0.510829 | -0.122453 | O to D | - |
| P01583 | IL1A_HUMAN Interleukin-1 alpha OS=Homo sapiens GN=IL1A PE=1 SV=1 | 138 | D | 0.122591 | N | 0.125928 | -0.003337 | No Change: Both O | - |
| P01583 | IL1A_HUMAN Interleukin-1 alpha OS=Homo sapiens GN=IL1A PE=1 SV=1 | 125 | N | 0.116877 | D | 0.118524 | -0.001647 | No Change: Both O | - |
| P01583 | IL1A_HUMAN Interleukin-1 alpha OS=Homo sapiens GN=IL1A PE=1 SV=1 | 176 | D | 0.542372 | H | 0.516474 | 0.025898 | No Change: Both D | - |
| Q8WWZ1 | IL1FA_HUMAN Interleukin-1 family member 10 OS=Homo sapiens GN=IL1F10 PE=1 SV=1 | 44 | I | 0.091512 | T | 0.156105 | -0.064593 | No Change: Both O | - |
| Q8WWZ1 | IL1FA_HUMAN Interleukin-1 family member 10 OS=Homo sapiens GN=IL1F10 PE=1 SV=1 | 51 | A | 0.184148 | D | 0.243767 | -0.059619 | No Change: Both O | - |
| P14778 | IL1R1_HUMAN Interleukin-1 receptor type 1 OS=Homo sapiens GN=IL1R1 PE=1 SV=1 | 124 | A | 0.130631 | G | 0.154142 | -0.023511 | No Change: Both O | - |
| P14778 | IL1R1_HUMAN Interleukin-1 receptor type 1 OS=Homo sapiens GN=IL1R1 PE=1 SV=1 | 344 | T | 0.018393 | M | 0.014527 | 0.003866 | No Change: Both O | - |
| P27930 | IL1R2_HUMAN Interleukin-1 receptor type 2 OS=Homo sapiens GN=IL1R2 PE=1 SV=1 | 181 | E | 0.506491 | K | 0.528611 | -0.02212 | No Change: Both D | - |
| P27930 | IL1R2_HUMAN Interleukin-1 receptor type 2 OS=Homo sapiens GN=IL1R2 PE=1 SV=1 | 292 | E | 0.627212 | K | 0.619433 | 0.007779 | No Change: Both D | - |
| Q9NPH3 | IL1AP_HUMAN Interleukin-1 receptor accessory protein OS=Homo sapiens GN=IL1RAP PE=1 SV=2 | 473 | V | 0.166467 | M | 0.199621 | -0.033154 | No Change: Both O | - |
| Q9NZN1 | IRPL1_HUMAN Interleukin-1 receptor accessory protein-like 1 OS=Homo sapiens GN=IL1RAPL1 PE=1 SV=2 | 379 | K | 0.023252 | R | 0.015619 | 0.007633 | No Change: Both O | - |
| Q9NZN1 | IRPL1_HUMAN Interleukin-1 receptor accessory protein-like 1 OS=Homo sapiens GN=IL1RAPL1 PE=1 SV=2 | 618 | Q | 0.566684 | H | 0.565458 | 0.001226 | No Change: Both D | - |
| Q9NZN1 | IRPL1_HUMAN Interleukin-1 receptor accessory protein-like 1 OS=Homo sapiens GN=IL1RAPL1 PE=1 SV=2 | 637 | T | 0.406592 | S | 0.461105 | -0.054513 | No Change: Both O | - |
| Q9NZN1 | IRPL1_HUMAN Interleukin-1 receptor accessory protein-like 1 OS=Homo sapiens GN=IL1RAPL1 PE=1 SV=2 | 643 | I | 0.45146 | V | 0.457588 | -0.006128 | No Change: Both O | - |
| Q9NP60 | IRPL2_HUMAN X-linked interleukin-1 receptor accessory protein-like 2 OS=Homo sapiens GN=IL1RAPL2 PE=2 SV=1 | 606 | F | 0.646476 | L | 0.694773 | -0.048297 | No Change: Both D | A breast cancer sample |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 78 | A | 0.136001 | E | 0.190922 | -0.054921 | No Change: Both O | - |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 433 | A | 0.26013 | T | 0.306619 | -0.046489 | No Change: Both O | - |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 501 | Q | 0.355674 | K | 0.39149 | -0.035816 | No Change: Both O | - |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 501 | Q | 0.355674 | R | 0.313882 | 0.041792 | No Change: Both O | - |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 549 | T | 0.785648 | I | 0.728575 | 0.057073 | No Change: Both D | - |
| Q01638 | ILRL1_HUMAN Interleukin-1 receptor-like 1 OS=Homo sapiens GN=IL1RL1 PE=1 SV=4 | 551 | L | 0.826408 | S | 0.904808 | -0.0784 | No Change: Both D | - |
| Q9HB29 | ILRL2_HUMAN Interleukin-1 receptor-like 2 OS=Homo sapiens GN=IL1RL2 PE=2 SV=2 | 352 | V | 0.02462 | I | 0.020605 | 0.004015 | No Change: Both O | - |
| Q9HB29 | ILRL2_HUMAN Interleukin-1 receptor-like 2 OS=Homo sapiens GN=IL1RL2 PE=2 SV=2 | 550 | L | 0.712033 | P | 0.84164 | -0.129607 | No Change: Both D | - |
| Q9HB29 | ILRL2_HUMAN Interleukin-1 receptor-like 2 OS=Homo sapiens GN=IL1RL2 PE=2 SV=2 | 237 | I | 0.283979 | T | 0.424868 | -0.140889 | No Change: Both O | - |
| P18510 | IL1RA_HUMAN Interleukin-1 receptor antagonist protein OS=Homo sapiens GN=IL1RN PE=1 SV=1 | 124 | A | 0.471186 | T | 0.513145 | -0.041959 | O to D | - |
| Q9NYY1 | IL20_HUMAN Interleukin-20 OS=Homo sapiens GN=IL20 PE=1 SV=2 | 107 | R | 0.378324 | Q | 0.405909 | -0.027585 | No Change: Both O | - |
| Q9UHF4 | I20RA_HUMAN Interleukin-20 receptor subunit alpha OS=Homo sapiens GN=IL20RA PE=1 SV=2 | 259 | V | 0.018152 | I | 0.015537 | 0.002615 | No Change: Both O | - |
| Q9UHF4 | I20RA_HUMAN Interleukin-20 receptor subunit alpha OS=Homo sapiens GN=IL20RA PE=1 SV=2 | 382 | L | 0.744038 | F | 0.718312 | 0.025726 | No Change: Both D | - |
| Q9HBE5 | IL21R_HUMAN Interleukin-21 receptor OS=Homo sapiens GN=IL21R PE=1 SV=1 | 191 | R | 0.61415 | C | 0.46867 | 0.14548 | D to O | - |
| Q9HBE5 | IL21R_HUMAN Interleukin-21 receptor OS=Homo sapiens GN=IL21R PE=1 SV=1 | 318 | S | 0.723469 | R | 0.674355 | 0.049114 | No Change: Both D | - |
| Q9HBE5 | IL21R_HUMAN Interleukin-21 receptor OS=Homo sapiens GN=IL21R PE=1 SV=1 | 484 | G | 0.870618 | S | 0.893168 | -0.02255 | No Change: Both D | - |
| Q9GZX6 | IL22_HUMAN Interleukin-22 OS=Homo sapiens GN=IL22 PE=1 SV=1 | 158 | S | 0.560532 | G | 0.53771 | 0.022822 | No Change: Both D | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 130 | S | 0.433786 | P | 0.446161 | -0.012375 | No Change: Both O | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 205 | V | 0.056658 | I | 0.054868 | 0.00179 | No Change: Both O | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 209 | A | 0.181856 | S | 0.263761 | -0.081905 | No Change: Both O | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 222 | L | 0.209946 | P | 0.384072 | -0.174126 | No Change: Both O | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 407 | M | 0.909744 | V | 0.891712 | 0.018032 | No Change: Both D | - |
| Q8N6P7 | I22R1_HUMAN Interleukin-22 receptor subunit alpha-1 OS=Homo sapiens GN=IL22RA1 PE=1 SV=1 | 518 | R | 0.975982 | G | 0.979049 | -0.003067 | No Change: Both D | - |
| Q969J5 | I22R2_HUMAN Interleukin-22 receptor subunit alpha-2 OS=Homo sapiens GN=IL22RA2 PE=1 SV=1 | 16 | L | 0.095819 | P | 0.184462 | -0.088643 | No Change: Both O | - |
| Q969J5 | I22R2_HUMAN Interleukin-22 receptor subunit alpha-2 OS=Homo sapiens GN=IL22RA2 PE=1 SV=1 | 190 | E | 0.538739 | K | 0.54847 | -0.009731 | No Change: Both D | - |
| Q5VWK5 | IL23R_HUMAN Interleukin-23 receptor OS=Homo sapiens GN=IL23R PE=1 SV=3 | 3 | Q | 0.652309 | H | 0.625081 | 0.027228 | No Change: Both D | - |
| Q5VWK5 | IL23R_HUMAN Interleukin-23 receptor OS=Homo sapiens GN=IL23R PE=1 SV=3 | 310 | L | 0.169766 | P | 0.332514 | -0.162748 | No Change: Both O | - |
| Q5VWK5 | IL23R_HUMAN Interleukin-23 receptor OS=Homo sapiens GN=IL23R PE=1 SV=3 | 381 | R | 0.215785 | Q | 0.21274 | 0.003045 | No Change: Both O | - |
| Q5VWK5 | IL23R_HUMAN Interleukin-23 receptor OS=Homo sapiens GN=IL23R PE=1 SV=3 | 175 | T | 0.405805 | N | 0.451922 | -0.046117 | No Change: Both O | - |
| Q13007 | IL24_HUMAN Interleukin-24 OS=Homo sapiens GN=IL24 PE=1 SV=1 | 124 | Y | 0.271966 | H | 0.395863 | -0.123897 | No Change: Both O | - |
| Q13007 | IL24_HUMAN Interleukin-24 OS=Homo sapiens GN=IL24 PE=1 SV=1 | 125 | H | 0.281252 | R | 0.294389 | -0.013137 | No Change: Both O | - |
| Q13007 | IL24_HUMAN Interleukin-24 OS=Homo sapiens GN=IL24 PE=1 SV=1 | 131 | V | 0.382795 | L | 0.38117 | 0.001625 | No Change: Both O | - |
| Q8NEV9 | IL27A_HUMAN Interleukin-27 subunit alpha OS=Homo sapiens GN=IL27 PE=1 SV=2 | 59 | S | 0.487301 | A | 0.410323 | 0.076978 | No Change: Both O | - |
| Q8NEV9 | IL27A_HUMAN Interleukin-27 subunit alpha OS=Homo sapiens GN=IL27 PE=1 SV=2 | 119 | L | 0.240508 | P | 0.372712 | -0.132204 | No Change: Both O | - |
| Q8IZJ0 | IL28A_HUMAN Interleukin-28A OS=Homo sapiens GN=IL28A PE=1 SV=1 | 10 | T | 0.197122 | M | 0.192602 | 0.00452 | No Change: Both O | - |
| Q8IZJ0 | IL28A_HUMAN Interleukin-28A OS=Homo sapiens GN=IL28A PE=1 SV=1 | 112 | T | 0.423202 | A | 0.399647 | 0.023555 | No Change: Both O | - |
| Q8IZI9 | IL28B_HUMAN Interleukin-28B OS=Homo sapiens GN=IL28B PE=1 SV=2 | 28 | R | 0.304292 | H | 0.278523 | 0.025769 | No Change: Both O | - |
| Q8IZI9 | IL28B_HUMAN Interleukin-28B OS=Homo sapiens GN=IL28B PE=1 SV=2 | 70 | K | 0.641223 | R | 0.640699 | 5.24E-04 | No Change: Both D | - |
| Q8IU54 | IL29_HUMAN Interleukin-29 OS=Homo sapiens GN=IL29 PE=1 SV=1 | 188 | N | 0.217581 | D | 0.253159 | -0.035578 | No Change: Both O | - |
| P01589 | IL2RA_HUMAN Interleukin-2 receptor subunit alpha OS=Homo sapiens GN=IL2RA PE=1 SV=1 | 272 | I | 0.914346 | T | 0.877892 | 0.036454 | No Change: Both D | - |
| P14784 | IL2RB_HUMAN Interleukin-2 receptor subunit beta OS=Homo sapiens GN=IL2RB PE=1 SV=1 | 391 | D | 0.715654 | E | 0.725629 | -0.009975 | No Change: Both D | - |
| P14784 | IL2RB_HUMAN Interleukin-2 receptor subunit beta OS=Homo sapiens GN=IL2RB PE=1 SV=1 | 83 | S | 0.111882 | F | 0.03879 | 0.073092 | No Change: Both O | - |
| P14784 | IL2RB_HUMAN Interleukin-2 receptor subunit beta OS=Homo sapiens GN=IL2RB PE=1 SV=1 | 10 | L | 0.069329 | V | 0.056487 | 0.012842 | No Change: Both O | - |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 39 | D | 0.370997 | N | 0.357722 | 0.013275 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 62 | C | 0.154498 | G | 0.209834 | -0.055336 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 68 | E | 0.177694 | G | 0.116183 | 0.061511 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 68 | E | 0.177694 | K | 0.166449 | 0.011245 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 84 | N | 0.443139 | K | 0.474047 | -0.030908 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 89 | Y | 0.229001 | C | 0.233061 | -0.00406 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 105 | Y | 0.291415 | C | 0.323802 | -0.032387 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 114 | G | 0.375803 | D | 0.422945 | -0.047142 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 115 | C | 0.392633 | F | 0.406114 | -0.013481 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 115 | C | 0.392633 | R | 0.547504 | -0.154871 | O to D | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 123 | H | 0.258018 | P | 0.333057 | -0.075039 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 125 | Y | 0.177408 | N | 0.305269 | -0.127861 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 144 | Q | 0.433593 | P | 0.446118 | -0.012525 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 153 | I | 0.161078 | N | 0.341659 | -0.180581 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 156 | A | 0.253037 | V | 0.213375 | 0.039662 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 162 | L | 0.414306 | H | 0.503317 | -0.089011 | O to D | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 172 | L | 0.375848 | P | 0.517396 | -0.141548 | O to D | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 172 | L | 0.375848 | Q | 0.516432 | -0.140584 | O to D | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 182 | C | 0.12006 | R | 0.243946 | -0.123886 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 183 | L | 0.119405 | S | 0.231412 | -0.112007 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 222 | R | 0.269883 | C | 0.147168 | 0.122715 | No Change: Both O | X-linked combined immunodeficiency (XCID) [MIM:312863] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 224 | R | 0.265194 | W | 0.116316 | 0.148878 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 226 | R | 0.261149 | C | 0.156934 | 0.104215 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 226 | R | 0.261149 | H | 0.23492 | 0.026229 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 227 | F | 0.281976 | C | 0.289605 | -0.007629 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 230 | L | 0.30606 | P | 0.484516 | -0.178456 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 231 | C | 0.289636 | Y | 0.325234 | -0.035598 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 232 | G | 0.262188 | R | 0.274986 | -0.012798 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 240 | W | 0.411348 | C | 0.43332 | -0.021972 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 241 | S | 0.389194 | I | 0.186142 | 0.203052 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 270 | M | 0.117915 | R | 0.151857 | -0.033942 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 285 | R | 0.080876 | Q | 0.082439 | -0.001563 | No Change: Both O | Severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID) [MIM:300400] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 293 | L | 0.372012 | Q | 0.51622 | -0.144208 | O to D | X-linked combined immunodeficiency (XCID) [MIM:312863] |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 109 | E | 0.370364 | K | 0.368391 | 0.001973 | No Change: Both O | - |
| P31785 | IL2RG_HUMAN Cytokine receptor common subunit gamma OS=Homo sapiens GN=IL2RG PE=1 SV=1 | 44 | T | 0.353294 | S | 0.426742 | -0.073448 | No Change: Both O | - |
| P08700 | IL3_HUMAN Interleukin-3 OS=Homo sapiens GN=IL3 PE=1 SV=2 | 15 | R | 0.233792 | H | 0.213085 | 0.020707 | No Change: Both O | - |
| P08700 | IL3_HUMAN Interleukin-3 OS=Homo sapiens GN=IL3 PE=1 SV=2 | 27 | P | 0.416046 | S | 0.438165 | -0.022119 | No Change: Both O | - |
| P08700 | IL3_HUMAN Interleukin-3 OS=Homo sapiens GN=IL3 PE=1 SV=2 | 3 | R | 0.714643 | C | 0.551194 | 0.163449 | No Change: Both D | - |
| P08700 | IL3_HUMAN Interleukin-3 OS=Homo sapiens GN=IL3 PE=1 SV=2 | 60 | N | 0.502715 | S | 0.510583 | -0.007868 | No Change: Both D | - |
| Q8NI17 | IL31R_HUMAN Interleukin-31 receptor subunit alpha OS=Homo sapiens GN=IL31RA PE=1 SV=1 | 155 | D | 0.344853 | N | 0.333352 | 0.011501 | No Change: Both O | - |
| Q8NI17 | IL31R_HUMAN Interleukin-31 receptor subunit alpha OS=Homo sapiens GN=IL31RA PE=1 SV=1 | 497 | S | 0.421613 | N | 0.371077 | 0.050536 | No Change: Both O | - |
| Q8NI17 | IL31R_HUMAN Interleukin-31 receptor subunit alpha OS=Homo sapiens GN=IL31RA PE=1 SV=1 | 489 | S | 0.309228 | F | 0.141434 | 0.167794 | No Change: Both O | Amyloidosis primary localized cutaneous type 2 (PLCA2) [MIM:613955] |
| P24001 | IL32_HUMAN Interleukin-32 OS=Homo sapiens GN=IL32 PE=1 SV=3 | 152 | D | 0.244529 | N | 0.224961 | 0.019568 | No Change: Both O | - |
| O95760 | IL33_HUMAN Interleukin-33 OS=Homo sapiens GN=IL33 PE=1 SV=1 | 263 | I | 0.250628 | M | 0.344539 | -0.093911 | No Change: Both O | - |
| Q6ZMJ4 | IL34_HUMAN Interleukin-34 OS=Homo sapiens GN=IL34 PE=1 SV=1 | 123 | E | 0.203669 | Q | 0.180248 | 0.023421 | No Change: Both O | - |
| Q6ZMJ4 | IL34_HUMAN Interleukin-34 OS=Homo sapiens GN=IL34 PE=1 SV=1 | 195 | S | 0.863899 | T | 0.80212 | 0.061779 | No Change: Both D | - |
| Q9UHA7 | IL36A_HUMAN Interleukin-36 alpha OS=Homo sapiens GN=IL36A PE=1 SV=1 | 12 | Q | 0.450523 | R | 0.41764 | 0.032883 | No Change: Both O | - |
| Q9UHA7 | IL36A_HUMAN Interleukin-36 alpha OS=Homo sapiens GN=IL36A PE=1 SV=1 | 63 | I | 0.22969 | T | 0.345405 | -0.115715 | No Change: Both O | - |
| Q9UHA7 | IL36A_HUMAN Interleukin-36 alpha OS=Homo sapiens GN=IL36A PE=1 SV=1 | 134 | G | 0.202839 | R | 0.181217 | 0.021622 | No Change: Both O | - |
| Q9NZH7 | IL36B_HUMAN Interleukin-36 beta OS=Homo sapiens GN=IL36B PE=2 SV=1 | 36 | R | 0.357564 | C | 0.206581 | 0.150983 | No Change: Both O | - |
| Q9NZH8 | IL36G_HUMAN Interleukin-36 gamma OS=Homo sapiens GN=IL36G PE=1 SV=1 | 69 | Q | 0.427762 | K | 0.473722 | -0.04596 | No Change: Both O | - |
| Q9UBH0 | I36RA_HUMAN Interleukin-36 receptor antagonist protein OS=Homo sapiens GN=IL36RN PE=1 SV=1 | 47 | N | 0.193435 | S | 0.248453 | -0.055018 | No Change: Both O | - |
| Q9UBH0 | I36RA_HUMAN Interleukin-36 receptor antagonist protein OS=Homo sapiens GN=IL36RN PE=1 SV=1 | 27 | L | 0.320623 | P | 0.466275 | -0.145652 | No Change: Both O | Psoriasis generalized pustular (PSORP) [MIM:614204] |
| Q9UBH0 | I36RA_HUMAN Interleukin-36 receptor antagonist protein OS=Homo sapiens GN=IL36RN PE=1 SV=1 | 48 | R | 0.211423 | W | 0.098201 | 0.113222 | No Change: Both O | Psoriasis generalized pustular (PSORP) [MIM:614204] |
| Q9UBH0 | I36RA_HUMAN Interleukin-36 receptor antagonist protein OS=Homo sapiens GN=IL36RN PE=1 SV=1 | 113 | S | 0.343348 | L | 0.182521 | 0.160827 | No Change: Both O | Psoriasis generalized pustular (PSORP) [MIM:614204] |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 31 | G | 0.882676 | V | 0.840493 | 0.042183 | No Change: Both D | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 42 | T | 0.785695 | A | 0.750753 | 0.034942 | No Change: Both D | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 108 | P | 0.551715 | L | 0.425059 | 0.126656 | D to O | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 152 | R | 0.325168 | W | 0.153313 | 0.171855 | No Change: Both O | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 164 | W | 0.243867 | R | 0.425495 | -0.181628 | No Change: Both O | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 218 | D | 0.84305 | N | 0.846868 | -0.003818 | No Change: Both D | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 50 | P | 0.695086 | R | 0.611699 | 0.083387 | No Change: Both D | - |
| Q9NZH6 | IL37_HUMAN Interleukin-37 OS=Homo sapiens GN=IL37 PE=1 SV=1 | 54 | N | 0.681994 | S | 0.71431 | -0.032316 | No Change: Both D | - |
| P26951 | IL3RA_HUMAN Interleukin-3 receptor subunit alpha OS=Homo sapiens GN=IL3RA PE=1 SV=1 | 12 | A | 0.063369 | T | 0.089732 | -0.026363 | No Change: Both O | - |
| P26951 | IL3RA_HUMAN Interleukin-3 receptor subunit alpha OS=Homo sapiens GN=IL3RA PE=1 SV=1 | 77 | E | 0.0852 | G | 0.070737 | 0.014463 | No Change: Both O | - |
| P26951 | IL3RA_HUMAN Interleukin-3 receptor subunit alpha OS=Homo sapiens GN=IL3RA PE=1 SV=1 | 123 | S | 0.111158 | T | 0.07262 | 0.038538 | No Change: Both O | - |
| P26951 | IL3RA_HUMAN Interleukin-3 receptor subunit alpha OS=Homo sapiens GN=IL3RA PE=1 SV=1 | 323 | V | 0.007703 | L | 0.007865 | -1.62E-04 | No Change: Both O | - |
| P05112 | IL4_HUMAN Interleukin-4 OS=Homo sapiens GN=IL4 PE=1 SV=1 | 27 | C | 0.173794 | R | 0.313663 | -0.139869 | No Change: Both O | - |
| Q96RQ9 | OXLA_HUMAN L-amino-acid oxidase OS=Homo sapiens GN=IL4I1 PE=1 SV=1 | 501 | A | 0.372741 | S | 0.475371 | -0.10263 | No Change: Both O | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 75 | I | 0.395926 | V | 0.425063 | -0.029137 | No Change: Both O | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 576 | Q | 0.460411 | R | 0.424849 | 0.035562 | No Change: Both O | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 400 | E | 0.761117 | A | 0.680414 | 0.080703 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 431 | C | 0.689409 | R | 0.768648 | -0.079239 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 436 | S | 0.8239 | L | 0.735477 | 0.088423 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 503 | S | 0.831406 | P | 0.84058 | -0.009174 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 579 | V | 0.387074 | I | 0.326834 | 0.06024 | No Change: Both O | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 752 | S | 0.970136 | A | 0.956865 | 0.013271 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 786 | S | 0.980383 | P | 0.97985 | 5.33E-04 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 387 | S | 0.906797 | L | 0.836341 | 0.070456 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 675 | P | 0.987896 | S | 0.986926 | 9.70E-04 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 492 | A | 0.812017 | T | 0.837291 | -0.025274 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 492 | A | 0.812017 | V | 0.769696 | 0.042321 | No Change: Both D | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 75 | I | 0.395926 | F | 0.396779 | -8.53E-04 | No Change: Both O | - |
| P24394 | IL4RA_HUMAN Interleukin-4 receptor subunit alpha OS=Homo sapiens GN=IL4R PE=1 SV=1 | 75 | I | 0.395926 | L | 0.433422 | -0.037496 | No Change: Both O | - |
| Q01344 | IL5RA_HUMAN Interleukin-5 receptor subunit alpha OS=Homo sapiens GN=IL5RA PE=1 SV=2 | 129 | I | 0.419197 | V | 0.476811 | -0.057614 | No Change: Both O | - |
| Q01344 | IL5RA_HUMAN Interleukin-5 receptor subunit alpha OS=Homo sapiens GN=IL5RA PE=1 SV=2 | 262 | V | 0.200361 | A | 0.278391 | -0.07803 | No Change: Both O | - |
| P05231 | IL6_HUMAN Interleukin-6 OS=Homo sapiens GN=IL6 PE=1 SV=1 | 32 | P | 0.709337 | S | 0.706835 | 0.002502 | No Change: Both D | - |
| P05231 | IL6_HUMAN Interleukin-6 OS=Homo sapiens GN=IL6 PE=1 SV=1 | 162 | D | 0.601986 | V | 0.439818 | 0.162168 | D to O | - |
| P05231 | IL6_HUMAN Interleukin-6 OS=Homo sapiens GN=IL6 PE=1 SV=1 | 162 | D | 0.601986 | E | 0.605375 | -0.003389 | No Change: Both D | - |
| P08887 | IL6RA_HUMAN Interleukin-6 receptor subunit alpha OS=Homo sapiens GN=IL6R PE=1 SV=1 | 358 | D | 0.651211 | A | 0.600249 | 0.050962 | No Change: Both D | - |
| P08887 | IL6RA_HUMAN Interleukin-6 receptor subunit alpha OS=Homo sapiens GN=IL6R PE=1 SV=1 | 385 | V | 0.031342 | I | 0.029791 | 0.001551 | No Change: Both O | - |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 415 | T | 0.109667 | I | 0.061491 | 0.048176 | No Change: Both O | A colorectal cancer sample |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 8 | L | 0.043298 | V | 0.041182 | 0.002116 | No Change: Both O | - |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 148 | G | 0.51487 | R | 0.532062 | -0.017192 | No Change: Both D | - |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 397 | L | 0.171136 | V | 0.170073 | 0.001063 | No Change: Both O | - |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 454 | I | 0.095924 | T | 0.174659 | -0.078735 | No Change: Both O | - |
| P40189 | IL6RB_HUMAN Interleukin-6 receptor subunit beta OS=Homo sapiens GN=IL6ST PE=1 SV=2 | 499 | V | 0.271333 | I | 0.253299 | 0.018034 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 66 | T | 0.31313 | I | 0.186624 | 0.126506 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 113 | E | 0.319053 | D | 0.29689 | 0.022163 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 138 | I | 0.137599 | V | 0.166714 | -0.029115 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 244 | T | 0.087387 | I | 0.052471 | 0.034916 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 356 | I | 0.737151 | V | 0.785633 | -0.048482 | No Change: Both D | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 132 | P | 0.22496 | S | 0.247015 | -0.022055 | No Change: Both O | - |
| P16871 | IL7RA_HUMAN Interleukin-7 receptor subunit alpha OS=Homo sapiens GN=IL7R PE=1 SV=2 | 414 | T | 0.680027 | M | 0.625004 | 0.055023 | No Change: Both D | - |
| P15248 | IL9_HUMAN Interleukin-9 OS=Homo sapiens GN=IL9 PE=2 SV=1 | 117 | T | 0.388771 | M | 0.341668 | 0.047103 | No Change: Both O | - |
| Q01113 | IL9R_HUMAN Interleukin-9 receptor OS=Homo sapiens GN=IL9R PE=1 SV=3 | 239 | E | 0.462748 | Q | 0.416265 | 0.046483 | No Change: Both O | - |
| Q01113 | IL9R_HUMAN Interleukin-9 receptor OS=Homo sapiens GN=IL9R PE=1 SV=3 | 288 | Y | 0.096417 | C | 0.07888 | 0.017537 | No Change: Both O | - |
| Q01113 | IL9R_HUMAN Interleukin-9 receptor OS=Homo sapiens GN=IL9R PE=1 SV=3 | 63 | R | 0.129742 | K | 0.135333 | -0.005591 | No Change: Both O | - |
| Q01113 | IL9R_HUMAN Interleukin-9 receptor OS=Homo sapiens GN=IL9R PE=1 SV=3 | 331 | G | 0.195157 | R | 0.169895 | 0.025262 | No Change: Both O | - |
| Q01113 | IL9R_HUMAN Interleukin-9 receptor OS=Homo sapiens GN=IL9R PE=1 SV=3 | 365 | R | 0.678723 | H | 0.621977 | 0.056746 | No Change: Both D | - |
| Q86SU0 | ILDR1_HUMAN Immunoglobulin-like domain-containing receptor 1 OS=Homo sapiens GN=ILDR1 PE=1 SV=2 | 97 | R | 0.558088 | Q | 0.57713 | -0.019042 | No Change: Both D | Deafness autosomal recessive type 42 (DFNB42) [MIM:609646] |
| Q86SU0 | ILDR1_HUMAN Immunoglobulin-like domain-containing receptor 1 OS=Homo sapiens GN=ILDR1 PE=1 SV=2 | 453 | R | 0.999197 | Q | 0.999042 | 1.55E-04 | No Change: Both D | Deafness autosomal recessive type 42 (DFNB42) [MIM:609646] |
| Q86SU0 | ILDR1_HUMAN Immunoglobulin-like domain-containing receptor 1 OS=Homo sapiens GN=ILDR1 PE=1 SV=2 | 463 | R | 0.998024 | C | 0.996562 | 0.001462 | No Change: Both D | - |
| Q71H61 | ILDR2_HUMAN Immunoglobulin-like domain-containing receptor 2 OS=Homo sapiens GN=ILDR2 PE=2 SV=1 | 202 | V | 0.007601 | I | 0.005989 | 0.001612 | No Change: Both O | - |
| Q12906 | ILF3_HUMAN Interleukin enhancer-binding factor 3 OS=Homo sapiens GN=ILF3 PE=1 SV=3 | 50 | D | 0.820618 | H | 0.791826 | 0.028792 | No Change: Both D | - |
| Q12906 | ILF3_HUMAN Interleukin enhancer-binding factor 3 OS=Homo sapiens GN=ILF3 PE=1 SV=3 | 501 | A | 0.85587 | S | 0.882848 | -0.026978 | No Change: Both D | - |
| Q9H0C8 | ILKAP_HUMAN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Homo sapiens GN=ILKAP PE=1 SV=1 | 66 | I | 0.948345 | M | 0.97231 | -0.023965 | No Change: Both D | - |
| A1L0T0 | ILVBL_HUMAN Acetolactate synthase-like protein OS=Homo sapiens GN=ILVBL PE=1 SV=2 | 374 | N | 0.309919 | D | 0.308711 | 0.001208 | No Change: Both O | - |
| A1L0T0 | ILVBL_HUMAN Acetolactate synthase-like protein OS=Homo sapiens GN=ILVBL PE=1 SV=2 | 510 | R | 0.118481 | Q | 0.127924 | -0.009443 | No Change: Both O | - |
| Q16891 | IMMT_HUMAN Mitochondrial inner membrane protein OS=Homo sapiens GN=IMMT PE=1 SV=1 | 124 | P | 0.961981 | S | 0.964336 | -0.002355 | No Change: Both D | - |
| Q16891 | IMMT_HUMAN Mitochondrial inner membrane protein OS=Homo sapiens GN=IMMT PE=1 SV=1 | 294 | A | 0.840622 | V | 0.78252 | 0.058102 | No Change: Both D | - |
| P29218 | IMPA1_HUMAN Inositol monophosphatase 1 OS=Homo sapiens GN=IMPA1 PE=1 SV=1 | 109 | I | 0.079313 | V | 0.099228 | -0.019915 | No Change: Both O | - |
| O14732 | IMPA2_HUMAN Inositol monophosphatase 2 OS=Homo sapiens GN=IMPA2 PE=1 SV=1 | 88 | A | 0.397831 | T | 0.418174 | -0.020343 | No Change: Both O | - |
| Q9P2X3 | IMPCT_HUMAN Protein IMPACT OS=Homo sapiens GN=IMPACT PE=1 SV=2 | 125 | D | 0.762779 | E | 0.781316 | -0.018537 | No Change: Both D | - |
| Q9P2X3 | IMPCT_HUMAN Protein IMPACT OS=Homo sapiens GN=IMPACT PE=1 SV=2 | 151 | L | 0.747139 | V | 0.734041 | 0.013098 | No Change: Both D | - |
| Q9NX62 | IMPA3_HUMAN Inositol monophosphatase 3 OS=Homo sapiens GN=IMPAD1 PE=1 SV=1 | 177 | D | 0.236863 | N | 0.203715 | 0.033148 | No Change: Both O | Chondrodysplasia with joint dislocations GPAPP type (CDP-GPAPP) [MIM:614078] |
| Q9NX62 | IMPA3_HUMAN Inositol monophosphatase 3 OS=Homo sapiens GN=IMPAD1 PE=1 SV=1 | 183 | T | 0.448263 | P | 0.478523 | -0.03026 | No Change: Both O | Chondrodysplasia with joint dislocations GPAPP type (CDP-GPAPP) [MIM:614078] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 224 | R | 0.293217 | P | 0.320366 | -0.027149 | No Change: Both O | Retinitis pigmentosa type 10 (RP10) [MIM:180105] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 226 | D | 0.377237 | N | 0.351254 | 0.025983 | No Change: Both O | Retinitis pigmentosa type 10 (RP10) [MIM:180105] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 268 | V | 0.136992 | I | 0.1175 | 0.019492 | No Change: Both O | Retinitis pigmentosa type 10 (RP10) [MIM:180105] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 105 | R | 0.447309 | W | 0.252686 | 0.194623 | No Change: Both O | Leber congenital amaurosis type 11 (LCA11) [MIM:613837] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 116 | T | 0.205827 | M | 0.179868 | 0.025959 | No Change: Both O | Retinitis pigmentosa type 10 (RP10) [MIM:180105] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 198 | N | 0.409642 | K | 0.46997 | -0.060328 | No Change: Both O | Leber congenital amaurosis type 11 (LCA11) [MIM:613837] |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 285 | A | 0.110329 | T | 0.125029 | -0.0147 | No Change: Both O | - |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 324 | G | 0.178021 | D | 0.189634 | -0.011613 | No Change: Both O | - |
| P20839 | IMDH1_HUMAN Inosine-5'-monophosphate dehydrogenase 1 OS=Homo sapiens GN=IMPDH1 PE=1 SV=2 | 372 | H | 0.148235 | P | 0.1714 | -0.023165 | No Change: Both O | Retinitis pigmentosa type 10 (RP10) [MIM:180105] |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 518 | H | 0.90332 | D | 0.931831 | -0.028511 | No Change: Both D | - |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 704 | R | 0.700752 | W | 0.492563 | 0.208189 | D to O | - |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 463 | G | 0.769417 | V | 0.698776 | 0.070641 | No Change: Both D | - |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 569 | K | 0.341598 | R | 0.298721 | 0.042877 | No Change: Both O | - |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 711 | R | 0.777317 | H | 0.722033 | 0.055284 | No Change: Both D | - |
| Q17R60 | IMPG1_HUMAN Interphotoreceptor matrix proteoglycan 1 OS=Homo sapiens GN=IMPG1 PE=1 SV=2 | 761 | S | 0.710821 | N | 0.694175 | 0.016646 | No Change: Both D | - |
| Q9BZV3 | IMPG2_HUMAN Interphotoreceptor matrix proteoglycan 2 OS=Homo sapiens GN=IMPG2 PE=1 SV=3 | 344 | K | 0.338158 | N | 0.305132 | 0.033026 | No Change: Both O | - |
| Q9BZV3 | IMPG2_HUMAN Interphotoreceptor matrix proteoglycan 2 OS=Homo sapiens GN=IMPG2 PE=1 SV=3 | 674 | T | 0.824879 | I | 0.751095 | 0.073784 | No Change: Both D | - |
| Q9BZV3 | IMPG2_HUMAN Interphotoreceptor matrix proteoglycan 2 OS=Homo sapiens GN=IMPG2 PE=1 SV=3 | 1013 | P | 0.415528 | L | 0.261716 | 0.153812 | No Change: Both O | - |
| Q9BZV3 | IMPG2_HUMAN Interphotoreceptor matrix proteoglycan 2 OS=Homo sapiens GN=IMPG2 PE=1 SV=3 | 124 | F | 0.09732 | L | 0.109205 | -0.011885 | No Change: Both O | Maculopathy IMPG2-related (MACLP-IMPG2) [MIM:613581] |
| Q16352 | AINX_HUMAN Alpha-internexin OS=Homo sapiens GN=INA PE=1 SV=2 | 149 | D | 0.939605 | H | 0.931831 | 0.007774 | No Change: Both D | - |
| Q16352 | AINX_HUMAN Alpha-internexin OS=Homo sapiens GN=INA PE=1 SV=2 | 110 | E | 0.300928 | Q | 0.279352 | 0.021576 | No Change: Both O | A breast cancer sample |
| Q16352 | AINX_HUMAN Alpha-internexin OS=Homo sapiens GN=INA PE=1 SV=2 | 92 | T | 0.4557 | S | 0.520218 | -0.064518 | O to D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 744 | C | 0.226042 | R | 0.391835 | -0.165793 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 303 | G | 0.443701 | R | 0.427905 | 0.015796 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 362 | E | 0.379843 | A | 0.280536 | 0.099307 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 400 | I | 0.277475 | V | 0.30394 | -0.026465 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 599 | Q | 0.377708 | H | 0.35597 | 0.021738 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 779 | E | 0.555791 | K | 0.534072 | 0.021719 | No Change: Both D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 780 | E | 0.568217 | K | 0.544017 | 0.0242 | No Change: Both D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 870 | I | 0.816583 | M | 0.89144 | -0.074857 | No Change: Both D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 1178 | G | 0.816272 | S | 0.854 | -0.037728 | No Change: Both D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 1282 | R | 0.347421 | H | 0.319805 | 0.027616 | No Change: Both O | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 1360 | V | 0.951966 | L | 0.951235 | 7.31E-04 | No Change: Both D | - |
| Q8NI35 | INADL_HUMAN InaD-like protein OS=Homo sapiens GN=INADL PE=1 SV=3 | 1504 | A | 0.436182 | P | 0.517639 | -0.081457 | O to D | - |
| Q9NQS7 | INCE_HUMAN Inner centromere protein OS=Homo sapiens GN=INCENP PE=1 SV=3 | 2 | G | 0.805015 | V | 0.796039 | 0.008976 | No Change: Both D | - |
| Q9NQS7 | INCE_HUMAN Inner centromere protein OS=Homo sapiens GN=INCENP PE=1 SV=3 | 100 | R | 0.959118 | H | 0.935882 | 0.023236 | No Change: Both D | - |
| Q9NQS7 | INCE_HUMAN Inner centromere protein OS=Homo sapiens GN=INCENP PE=1 SV=3 | 137 | A | 0.823915 | V | 0.752932 | 0.070983 | No Change: Both D | - |
| Q9NQS7 | INCE_HUMAN Inner centromere protein OS=Homo sapiens GN=INCENP PE=1 SV=3 | 506 | M | 0.835093 | T | 0.838552 | -0.003459 | No Change: Both D | - |
| Q9NQS7 | INCE_HUMAN Inner centromere protein OS=Homo sapiens GN=INCENP PE=1 SV=3 | 644 | E | 0.998102 | D | 0.996862 | 0.00124 | No Change: Both D | - |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 1096 | P | 0.645569 | S | 0.626519 | 0.01905 | No Change: Both D | - |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 1135 | T | 0.895788 | M | 0.884818 | 0.01097 | No Change: Both D | - |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 13 | A | 0.718073 | T | 0.717233 | 8.40E-04 | No Change: Both D | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 42 | L | 0.279265 | P | 0.418014 | -0.138749 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 184 | E | 0.394482 | K | 0.397713 | -0.003231 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 186 | S | 0.462664 | P | 0.425621 | 0.037043 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 198 | L | 0.043718 | R | 0.072242 | -0.028524 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 214 | R | 0.350754 | H | 0.333852 | 0.016902 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 218 | R | 0.253813 | Q | 0.269249 | -0.015436 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 218 | R | 0.253813 | W | 0.101474 | 0.152339 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q27J81 | INF2_HUMAN Inverted formin-2 OS=Homo sapiens GN=INF2 PE=1 SV=2 | 220 | E | 0.202908 | K | 0.198076 | 0.004832 | No Change: Both O | Focal segmental glomerulosclerosis type 5 (FSGS5) [MIM:613237] |
| Q9UK53 | ING1_HUMAN Inhibitor of growth protein 1 OS=Homo sapiens GN=ING1 PE=1 SV=2 | 335 | A | 0.946853 | D | 0.953595 | -0.006742 | No Change: Both D | Head and neck squamous cell carcinomas (HNSCC) [MIM:275355] |
| Q9UK53 | ING1_HUMAN Inhibitor of growth protein 1 OS=Homo sapiens GN=ING1 PE=1 SV=2 | 358 | C | 0.26794 | S | 0.401158 | -0.133218 | No Change: Both O | Head and neck squamous cell carcinomas (HNSCC) [MIM:275355] |
| Q9UK53 | ING1_HUMAN Inhibitor of growth protein 1 OS=Homo sapiens GN=ING1 PE=1 SV=2 | 359 | N | 0.260621 | S | 0.298318 | -0.037697 | No Change: Both O | Head and neck squamous cell carcinomas (HNSCC) [MIM:275355] |
| Q9UK53 | ING1_HUMAN Inhibitor of growth protein 1 OS=Homo sapiens GN=ING1 PE=1 SV=2 | 125 | L | 0.426163 | R | 0.542187 | -0.116024 | O to D | - |
| Q9NXR8 | ING3_HUMAN Inhibitor of growth protein 3 OS=Homo sapiens GN=ING3 PE=1 SV=2 | 20 | D | 0.718931 | G | 0.613097 | 0.105834 | No Change: Both D | Head and neck squamous cell carcinomas (HNSCC) [MIM:275355] |
| P05111 | INHA_HUMAN Inhibin alpha chain OS=Homo sapiens GN=INHA PE=1 SV=1 | 257 | A | 0.609465 | T | 0.606376 | 0.003089 | No Change: Both D | - |
| P05111 | INHA_HUMAN Inhibin alpha chain OS=Homo sapiens GN=INHA PE=1 SV=1 | 227 | G | 0.935661 | R | 0.954141 | -0.01848 | No Change: Both D | - |
| P08476 | INHBA_HUMAN Inhibin beta A chain OS=Homo sapiens GN=INHBA PE=1 SV=2 | 299 | Q | 0.85119 | P | 0.858279 | -0.007089 | No Change: Both D | - |
| P55103 | INHBC_HUMAN Inhibin beta C chain OS=Homo sapiens GN=INHBC PE=1 SV=1 | 322 | R | 0.227671 | Q | 0.22413 | 0.003541 | No Change: Both O | - |
| P58166 | INHBE_HUMAN Inhibin beta E chain OS=Homo sapiens GN=INHBE PE=1 SV=1 | 62 | R | 0.726178 | T | 0.699584 | 0.026594 | No Change: Both D | A breast cancer sample |
| P58166 | INHBE_HUMAN Inhibin beta E chain OS=Homo sapiens GN=INHBE PE=1 SV=1 | 215 | Q | 0.675824 | H | 0.621107 | 0.054717 | No Change: Both D | A breast cancer sample |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 205 | M | 0.241104 | V | 0.203583 | 0.037521 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 219 | E | 0.4684 | G | 0.391366 | 0.077034 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 28 | D | 0.461999 | N | 0.444761 | 0.017238 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 246 | N | 0.409313 | S | 0.447813 | -0.0385 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 254 | F | 0.091425 | C | 0.100244 | -0.008819 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 258 | R | 0.467655 | H | 0.47552 | -0.007865 | No Change: Both O | - |
| O95050 | INMT_HUMAN Indolethylamine N-methyltransferase OS=Homo sapiens GN=INMT PE=1 SV=3 | 214 | V | 0.2589 | M | 0.306478 | -0.047578 | No Change: Both O | - |
| Q9ULG1 | INO80_HUMAN DNA helicase INO80 OS=Homo sapiens GN=INO80 PE=1 SV=2 | 882 | I | 0.430884 | V | 0.460832 | -0.029948 | No Change: Both O | - |
| Q9ULG1 | INO80_HUMAN DNA helicase INO80 OS=Homo sapiens GN=INO80 PE=1 SV=2 | 1108 | V | 0.108228 | G | 0.199772 | -0.091544 | No Change: Both O | - |
| Q9C086 | IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens GN=INO80B PE=1 SV=2 | 152 | W | 0.904651 | G | 0.960073 | -0.055422 | No Change: Both D | - |
| Q53TQ3 | IN80D_HUMAN INO80 complex subunit D OS=Homo sapiens GN=INO80D PE=1 SV=2 | 358 | A | 0.772722 | V | 0.720256 | 0.052466 | No Change: Both D | - |
| P49441 | INPP_HUMAN Inositol polyphosphate 1-phosphatase OS=Homo sapiens GN=INPP1 PE=1 SV=1 | 228 | T | 0.314934 | A | 0.273774 | 0.04116 | No Change: Both O | - |
| P49441 | INPP_HUMAN Inositol polyphosphate 1-phosphatase OS=Homo sapiens GN=INPP1 PE=1 SV=1 | 355 | V | 0.279133 | M | 0.316216 | -0.037083 | No Change: Both O | - |
| Q96PE3 | INP4A_HUMAN Type I inositol-3 4-bisphosphate 4-phosphatase OS=Homo sapiens GN=INPP4A PE=1 SV=1 | 604 | T | 0.95025 | A | 0.941233 | 0.009017 | No Change: Both D | - |
| O15327 | INP4B_HUMAN Type II inositol-3 4-bisphosphate 4-phosphatase OS=Homo sapiens GN=INPP4B PE=2 SV=4 | 311 | Y | 0.358863 | F | 0.395985 | -0.037122 | No Change: Both O | - |
| Q14642 | I5P1_HUMAN Type I inositol-1 4 5-trisphosphate 5-phosphatase OS=Homo sapiens GN=INPP5A PE=2 SV=1 | 45 | K | 0.314216 | R | 0.254874 | 0.059342 | No Change: Both O | - |
| P32019 | I5P2_HUMAN Type II inositol-1 4 5-trisphosphate 5-phosphatase OS=Homo sapiens GN=INPP5B PE=1 SV=4 | 745 | M | 0.277587 | T | 0.342157 | -0.06457 | No Change: Both O | - |
| P32019 | I5P2_HUMAN Type II inositol-1 4 5-trisphosphate 5-phosphatase OS=Homo sapiens GN=INPP5B PE=1 SV=4 | 46 | G | 0.467442 | S | 0.510577 | -0.043135 | O to D | - |
| Q92835 | SHIP1_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 1 OS=Homo sapiens GN=INPP5D PE=1 SV=2 | 685 | V | 0.114518 | E | 0.215816 | -0.101298 | No Change: Both O | - |
| Q92835 | SHIP1_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 1 OS=Homo sapiens GN=INPP5D PE=1 SV=2 | 1169 | H | 0.942172 | Y | 0.900854 | 0.041318 | No Change: Both D | - |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 201 | I | 0.878026 | M | 0.919923 | -0.041897 | No Change: Both D | - |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 378 | R | 0.029784 | C | 0.013208 | 0.016576 | No Change: Both O | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 435 | R | 0.314909 | Q | 0.324033 | -0.009124 | No Change: Both O | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 512 | R | 0.362848 | W | 0.168834 | 0.194014 | No Change: Both O | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 515 | R | 0.376597 | W | 0.175896 | 0.200701 | No Change: Both O | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 563 | R | 0.595011 | H | 0.545357 | 0.049654 | No Change: Both D | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9NRR6 | INP5E_HUMAN 72 kDa inositol polyphosphate 5-phosphatase OS=Homo sapiens GN=INPP5E PE=1 SV=2 | 580 | K | 0.568173 | E | 0.554304 | 0.013869 | No Change: Both D | Joubert syndrome type 1 (JBTS1) [MIM:213300] |
| Q9Y2H2 | SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens GN=INPP5F PE=1 SV=3 | 453 | I | 0.079461 | V | 0.09373 | -0.014269 | No Change: Both O | - |
| Q9Y2H2 | SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens GN=INPP5F PE=1 SV=3 | 997 | N | 0.99104 | D | 0.990731 | 3.09E-04 | No Change: Both D | - |
| Q15735 | PI5PA_HUMAN Phosphatidylinositol 4 5-bisphosphate 5-phosphatase A OS=Homo sapiens GN=INPP5J PE=1 SV=3 | 333 | S | 0.995469 | I | 0.989237 | 0.006232 | No Change: Both D | - |
| Q9BT40 | INP5K_HUMAN Inositol polyphosphate 5-phosphatase K OS=Homo sapiens GN=INPP5K PE=1 SV=3 | 315 | S | 0.449515 | F | 0.246667 | 0.202848 | No Change: Both O | A breast cancer sample |
| O15357 | SHIP2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 2 OS=Homo sapiens GN=INPPL1 PE=1 SV=2 | 632 | L | 0.265004 | I | 0.222842 | 0.042162 | No Change: Both O | - |
| O15357 | SHIP2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 2 OS=Homo sapiens GN=INPPL1 PE=1 SV=2 | 721 | V | 0.350872 | M | 0.396763 | -0.045891 | No Change: Both O | - |
| O15357 | SHIP2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 2 OS=Homo sapiens GN=INPPL1 PE=1 SV=2 | 982 | N | 0.935157 | S | 0.94146 | -0.006303 | No Change: Both D | - |
| O15357 | SHIP2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 2 OS=Homo sapiens GN=INPPL1 PE=1 SV=2 | 1083 | A | 0.992122 | G | 0.993358 | -0.001236 | No Change: Both D | - |
| O15357 | SHIP2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 5-phosphatase 2 OS=Homo sapiens GN=INPPL1 PE=1 SV=2 | 1114 | A | 0.824812 | G | 0.832285 | -0.007473 | No Change: Both D | - |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 34 | H | 0.13401 | D | 0.148074 | -0.014064 | No Change: Both O | Familial hyperproinsulinemia (FHPRI) [MIM:176730] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 48 | F | 0.166336 | S | 0.305547 | -0.139211 | No Change: Both O | - |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 49 | F | 0.218642 | L | 0.236217 | -0.017575 | No Change: Both O | - |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 89 | R | 0.404666 | H | 0.38276 | 0.021906 | No Change: Both O | Familial hyperproinsulinemia (FHPRI) [MIM:176730] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 89 | R | 0.404666 | L | 0.329247 | 0.075419 | No Change: Both O | Familial hyperproinsulinemia (FHPRI) [MIM:176730] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 92 | V | 0.307496 | L | 0.360752 | -0.053256 | No Change: Both O | - |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 6 | R | 0.126314 | C | 0.05628 | 0.070034 | No Change: Both O | Maturity-onset diabetes of the young type 10 (MODY10) [MIM:613370] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 6 | R | 0.126314 | H | 0.133526 | -0.007212 | No Change: Both O | Maturity-onset diabetes of the young type 10 (MODY10) [MIM:613370] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 24 | A | 0.19492 | D | 0.259833 | -0.064913 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 29 | H | 0.180161 | D | 0.198266 | -0.018105 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 32 | G | 0.150251 | R | 0.142194 | 0.008057 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 32 | G | 0.150251 | S | 0.197556 | -0.047305 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 35 | L | 0.121852 | P | 0.210884 | -0.089032 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 43 | C | 0.065626 | G | 0.145918 | -0.080292 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 46 | R | 0.109748 | Q | 0.117055 | -0.007307 | No Change: Both O | Maturity-onset diabetes of the young type 10 (MODY10) [MIM:613370] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 47 | G | 0.128204 | V | 0.072824 | 0.05538 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 48 | F | 0.166336 | C | 0.174626 | -0.00829 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 55 | R | 0.488448 | C | 0.320569 | 0.167879 | No Change: Both O | Diabetes mellitus insulin-dependent type 2 (IDDM2) [MIM:125852] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 68 | L | 0.583522 | M | 0.619438 | -0.035916 | No Change: Both D | - |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 84 | G | 0.519177 | R | 0.518001 | 0.001176 | No Change: Both D | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 89 | R | 0.404666 | C | 0.337317 | 0.067349 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 90 | G | 0.356228 | C | 0.258635 | 0.097593 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 96 | C | 0.18305 | S | 0.31799 | -0.13494 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 96 | C | 0.18305 | Y | 0.142309 | 0.040741 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 101 | S | 0.172562 | C | 0.10637 | 0.066192 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 103 | Y | 0.19975 | C | 0.280729 | -0.080979 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| P01308 | INS_HUMAN Insulin OS=Homo sapiens GN=INS PE=1 SV=1 | 108 | Y | 0.608732 | C | 0.585271 | 0.023461 | No Change: Both D | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q1MX18 | INSC_HUMAN Protein inscuteable homolog OS=Homo sapiens GN=INSC PE=1 SV=1 | 450 | Q | 0.225996 | R | 0.206077 | 0.019919 | No Change: Both O | - |
| Q1MX18 | INSC_HUMAN Protein inscuteable homolog OS=Homo sapiens GN=INSC PE=1 SV=1 | 333 | D | 0.417904 | N | 0.403495 | 0.014409 | No Change: Both O | - |
| O15503 | INSI1_HUMAN Insulin-induced gene 1 protein OS=Homo sapiens GN=INSIG1 PE=1 SV=3 | 27 | A | 0.705966 | T | 0.663849 | 0.042117 | No Change: Both D | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 24 | A | 0.402042 | G | 0.447522 | -0.04548 | No Change: Both O | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 43 | V | 0.266431 | L | 0.285717 | -0.019286 | No Change: Both O | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 49 | P | 0.382562 | S | 0.384065 | -0.001503 | No Change: Both O | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 60 | T | 0.576794 | A | 0.563982 | 0.012812 | No Change: Both D | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 93 | P | 0.713125 | L | 0.589451 | 0.123674 | No Change: Both D | Cryptorchidism (CRYPTO) [MIM:219050] |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 102 | R | 0.762113 | C | 0.669589 | 0.092524 | No Change: Both D | Cryptorchidism (CRYPTO) [MIM:219050] |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 102 | R | 0.762113 | H | 0.765376 | -0.003263 | No Change: Both D | - |
| P51460 | INSL3_HUMAN Insulin-like 3 OS=Homo sapiens GN=INSL3 PE=1 SV=2 | 110 | N | 0.607314 | K | 0.631496 | -0.024182 | No Change: Both D | Cryptorchidism (CRYPTO) [MIM:219050] |
| Q9Y5Q6 | INSL5_HUMAN Insulin-like peptide INSL5 OS=Homo sapiens GN=INSL5 PE=1 SV=2 | 50 | Q | 0.508107 | L | 0.3804 | 0.127707 | D to O | - |
| Q9Y581 | INSL6_HUMAN Insulin-like peptide INSL6 OS=Homo sapiens GN=INSL6 PE=2 SV=2 | 80 | F | 0.788543 | L | 0.793404 | -0.004861 | No Change: Both D | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 42 | N | 0.295432 | K | 0.319261 | -0.023829 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 55 | V | 0.228264 | A | 0.295315 | -0.067051 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 58 | G | 0.118301 | R | 0.121511 | -0.00321 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 113 | R | 0.079267 | P | 0.089719 | -0.010452 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 220 | P | 0.451324 | L | 0.300932 | 0.150392 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 236 | H | 0.430653 | R | 0.467716 | -0.037063 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 260 | L | 0.166587 | P | 0.317439 | -0.150852 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 393 | G | 0.221013 | R | 0.224801 | -0.003788 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 409 | F | 0.122263 | V | 0.137909 | -0.015646 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 487 | K | 0.485467 | E | 0.500078 | -0.014611 | O to D | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 489 | N | 0.497956 | S | 0.541017 | -0.043061 | O to D | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 762 | R | 0.824517 | S | 0.838816 | -0.014299 | No Change: Both D | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1012 | V | 0.21519 | M | 0.249152 | -0.033962 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1020 | R | 0.323313 | Q | 0.332426 | -0.009113 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1035 | G | 0.30015 | V | 0.180061 | 0.120089 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1075 | A | 0.257273 | D | 0.328189 | -0.070916 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1161 | A | 0.206729 | T | 0.211399 | -0.00467 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1162 | A | 0.207785 | E | 0.28128 | -0.073495 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1180 | M | 0.190753 | I | 0.143449 | 0.047304 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1191 | R | 0.396236 | Q | 0.41697 | -0.020734 | No Change: Both O | Noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1205 | P | 0.263749 | L | 0.146275 | 0.117474 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1220 | W | 0.153147 | L | 0.209229 | -0.056082 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1227 | W | 0.053177 | S | 0.177988 | -0.124811 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 146 | I | 0.420739 | M | 0.524767 | -0.104028 | O to D | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 279 | R | 0.102817 | C | 0.070234 | 0.032583 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 439 | W | 0.198134 | S | 0.463711 | -0.265577 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 86 | D | 0.030727 | G | 0.026674 | 0.004053 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 89 | L | 0.02297 | P | 0.044561 | -0.021591 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 119 | A | 0.027333 | V | 0.020495 | 0.006838 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 167 | V | 0.217693 | L | 0.227723 | -0.01003 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 280 | C | 0.090852 | Y | 0.081645 | 0.009207 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 301 | C | 0.378744 | Y | 0.394391 | -0.015647 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 350 | S | 0.453416 | L | 0.290123 | 0.163293 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 350 | S | 0.453416 | L | 0.290123 | 0.163293 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 448 | I | 0.219499 | T | 0.365674 | -0.146175 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 492 | Q | 0.501955 | K | 0.558371 | -0.056416 | No Change: Both D | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 858 | T | 0.203883 | A | 0.188054 | 0.015829 | No Change: Both O | Noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 925 | I | 0.295413 | T | 0.464901 | -0.169488 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 926 | R | 0.313484 | W | 0.136909 | 0.176575 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 937 | T | 0.305131 | M | 0.242662 | 0.062469 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 997 | P | 0.602876 | T | 0.54696 | 0.055916 | No Change: Both D | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1023 | I | 0.277512 | F | 0.283435 | -0.005923 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1055 | A | 0.418548 | V | 0.345513 | 0.073035 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1095 | K | 0.303772 | E | 0.307429 | -0.003657 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1119 | R | 0.654648 | W | 0.416341 | 0.238307 | D to O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1143 | I | 0.344006 | T | 0.46692 | -0.122914 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1158 | R | 0.210291 | Q | 0.212443 | -0.002152 | No Change: Both O | Noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1158 | R | 0.210291 | W | 0.086501 | 0.12379 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1201 | R | 0.168831 | Q | 0.181038 | -0.012207 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 5 (HHF5) [MIM:609968] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1201 | R | 0.168831 | Q | 0.181038 | -0.012207 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1201 | R | 0.168831 | W | 0.074934 | 0.093897 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1201 | R | 0.168831 | W | 0.074934 | 0.093897 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1206 | E | 0.294799 | D | 0.286763 | 0.008036 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1206 | E | 0.294799 | K | 0.310171 | -0.015372 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1361 | Y | 0.714947 | C | 0.754373 | -0.039426 | No Change: Both D | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1378 | R | 0.821531 | Q | 0.789142 | 0.032389 | No Change: Both D | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 120 | L | 0.024103 | Q | 0.044336 | -0.020233 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 279 | R | 0.102817 | H | 0.098694 | 0.004123 | No Change: Both O | Insulin-resistant diabetes mellitus with acanthosis nigricans type A (IRAN type A) [MIM:610549] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 386 | G | 0.243211 | S | 0.29547 | -0.052259 | No Change: Both O | Rabson-Mendenhall syndrome (RMS) [MIM:262190] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 458 | N | 0.140189 | D | 0.148865 | -0.008676 | No Change: Both O | Leprechaunism (LEPRCH) [MIM:246200] |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 228 | C | 0.414526 | R | 0.481528 | -0.067002 | No Change: Both O | A gastric adenocarcinoma sample |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 695 | Q | 0.911087 | R | 0.907042 | 0.004045 | No Change: Both D | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 811 | G | 0.303951 | S | 0.380926 | -0.076975 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1065 | L | 0.45712 | V | 0.466375 | -0.009255 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 1282 | T | 0.270212 | A | 0.235389 | 0.034823 | No Change: Both O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 830 | P | 0.502896 | L | 0.361716 | 0.14118 | D to O | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 2 | A | 0.76558 | G | 0.762865 | 0.002715 | No Change: Both D | - |
| P06213 | INSR_HUMAN Insulin receptor OS=Homo sapiens GN=INSR PE=1 SV=4 | 171 | Y | 0.238262 | H | 0.342925 | -0.104663 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 127 | A | 0.220905 | E | 0.312753 | -0.091848 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 161 | A | 0.276438 | V | 0.211868 | 0.06457 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 244 | R | 0.467539 | H | 0.444933 | 0.022606 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 246 | C | 0.329392 | R | 0.414841 | -0.085449 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 278 | E | 0.235677 | Q | 0.211029 | 0.024648 | No Change: Both O | A lung adenocarcinoma sample |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 554 | R | 0.44613 | C | 0.296725 | 0.149405 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 928 | P | 0.119015 | L | 0.065865 | 0.05315 | No Change: Both O | - |
| P14616 | INSRR_HUMAN Insulin receptor-related protein OS=Homo sapiens GN=INSRR PE=1 SV=2 | 1065 | G | 0.50001 | E | 0.56108 | -0.06107 | No Change: Both D | A glioblastoma multiforme sample |
| Q8N201 | INT1_HUMAN Integrator complex subunit 1 OS=Homo sapiens GN=INTS1 PE=1 SV=2 | 172 | P | 0.161785 | L | 0.08984 | 0.071945 | No Change: Both O | - |
| Q96CB8 | INT12_HUMAN Integrator complex subunit 12 OS=Homo sapiens GN=INTS12 PE=1 SV=1 | 323 | T | 0.969678 | A | 0.964823 | 0.004855 | No Change: Both D | - |
| Q9H0H0 | INT2_HUMAN Integrator complex subunit 2 OS=Homo sapiens GN=INTS2 PE=1 SV=2 | 768 | N | 0.302596 | H | 0.268681 | 0.033915 | No Change: Both O | - |
| Q9NVH2 | INT7_HUMAN Integrator complex subunit 7 OS=Homo sapiens GN=INTS7 PE=1 SV=1 | 425 | H | 0.432233 | R | 0.448689 | -0.016456 | No Change: Both O | - |
| Q9Y283 | INVS_HUMAN Inversin OS=Homo sapiens GN=INVS PE=1 SV=2 | 482 | P | 0.604874 | R | 0.573223 | 0.031651 | No Change: Both D | Nephronophthisis type 2 (NPHP2) [MIM:602088] |
| Q9Y283 | INVS_HUMAN Inversin OS=Homo sapiens GN=INVS PE=1 SV=2 | 493 | L | 0.188155 | S | 0.361935 | -0.17378 | No Change: Both O | Nephronophthisis type 2 (NPHP2) [MIM:602088] |
| Q9Y283 | INVS_HUMAN Inversin OS=Homo sapiens GN=INVS PE=1 SV=2 | 242 | S | 0.205662 | L | 0.091044 | 0.114618 | No Change: Both O | - |
| Q9Y283 | INVS_HUMAN Inversin OS=Homo sapiens GN=INVS PE=1 SV=2 | 888 | S | 0.667561 | R | 0.654129 | 0.013432 | No Change: Both D | - |
| Q96PC2 | IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens GN=IP6K3 PE=1 SV=2 | 60 | R | 0.293252 | W | 0.139429 | 0.153823 | No Change: Both O | - |
| Q96PC2 | IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens GN=IP6K3 PE=1 SV=2 | 308 | A | 0.245816 | V | 0.20628 | 0.039536 | No Change: Both O | - |
| Q96PC2 | IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens GN=IP6K3 PE=1 SV=2 | 312 | V | 0.388736 | I | 0.39173 | -0.002994 | No Change: Both O | - |
| Q96PC2 | IP6K3_HUMAN Inositol hexakisphosphate kinase 3 OS=Homo sapiens GN=IP6K3 PE=1 SV=2 | 378 | Y | 0.377176 | S | 0.543929 | -0.166753 | O to D | - |
| Q8WWN9 | ICEF1_HUMAN Interactor protein for cytohesin exchange factors 1 OS=Homo sapiens GN=IPCEF1 PE=1 SV=1 | 194 | S | 0.993173 | P | 0.992449 | 7.24E-04 | No Change: Both D | - |
| Q8NFU5 | IPMK_HUMAN Inositol polyphosphate multikinase OS=Homo sapiens GN=IPMK PE=1 SV=1 | 349 | M | 0.624454 | I | 0.53301 | 0.091444 | No Change: Both D | - |
| Q9UI26 | IPO11_HUMAN Importin-11 OS=Homo sapiens GN=IPO11 PE=1 SV=1 | 260 | N | 0.326446 | D | 0.36635 | -0.039904 | No Change: Both O | - |
| Q9UI26 | IPO11_HUMAN Importin-11 OS=Homo sapiens GN=IPO11 PE=1 SV=1 | 937 | I | 0.538883 | V | 0.598489 | -0.059606 | No Change: Both D | - |
| Q8TEX9 | IPO4_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=2 | 513 | A | 0.22309 | V | 0.146158 | 0.076932 | No Change: Both O | - |
| Q8TEX9 | IPO4_HUMAN Importin-4 OS=Homo sapiens GN=IPO4 PE=1 SV=2 | 580 | P | 0.405088 | A | 0.324727 | 0.080361 | No Change: Both O | - |
| O00410 | IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 | 286 | L | 0.224508 | I | 0.193871 | 0.030637 | No Change: Both O | - |
| O00410 | IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 | 525 | E | 0.354661 | K | 0.353636 | 0.001025 | No Change: Both O | - |
| O00410 | IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 | 549 | E | 0.306878 | K | 0.312189 | -0.005311 | No Change: Both O | - |
| O00410 | IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 | 905 | Y | 0.141717 | C | 0.10921 | 0.032507 | No Change: Both O | - |
| O00410 | IPO5_HUMAN Importin-5 OS=Homo sapiens GN=IPO5 PE=1 SV=4 | 969 | T | 0.427223 | I | 0.292003 | 0.13522 | No Change: Both O | - |
| O95373 | IPO7_HUMAN Importin-7 OS=Homo sapiens GN=IPO7 PE=1 SV=1 | 111 | T | 0.091206 | N | 0.099982 | -0.008776 | No Change: Both O | - |
| O15397 | IPO8_HUMAN Importin-8 OS=Homo sapiens GN=IPO8 PE=1 SV=2 | 6 | I | 0.328034 | F | 0.307954 | 0.02008 | No Change: Both O | - |
| O15397 | IPO8_HUMAN Importin-8 OS=Homo sapiens GN=IPO8 PE=1 SV=2 | 640 | I | 0.033499 | V | 0.037663 | -0.004164 | No Change: Both O | - |
| Q9Y573 | IPP_HUMAN Actin-binding protein IPP OS=Homo sapiens GN=IPP PE=2 SV=1 | 264 | K | 0.444394 | R | 0.36615 | 0.078244 | No Change: Both O | - |
| Q9H8X2 | IPPK_HUMAN Inositol-pentakisphosphate 2-kinase OS=Homo sapiens GN=IPPK PE=1 SV=1 | 277 | R | 0.637534 | W | 0.477821 | 0.159713 | D to O | - |
| Q9H8X2 | IPPK_HUMAN Inositol-pentakisphosphate 2-kinase OS=Homo sapiens GN=IPPK PE=1 SV=1 | 376 | L | 0.367159 | F | 0.331947 | 0.035212 | No Change: Both O | - |
| Q86XH1 | IQCA1_HUMAN IQ and AAA domain-containing protein 1 OS=Homo sapiens GN=IQCA1 PE=2 SV=1 | 452 | K | 0.941309 | R | 0.938262 | 0.003047 | No Change: Both D | - |
| Q86XH1 | IQCA1_HUMAN IQ and AAA domain-containing protein 1 OS=Homo sapiens GN=IQCA1 PE=2 SV=1 | 8 | K | 0.468625 | M | 0.390045 | 0.07858 | No Change: Both O | - |
| Q86XH1 | IQCA1_HUMAN IQ and AAA domain-containing protein 1 OS=Homo sapiens GN=IQCA1 PE=2 SV=1 | 362 | Q | 0.999046 | R | 0.998713 | 3.33E-04 | No Change: Both D | - |
| Q15051 | IQCB1_HUMAN IQ calmodulin-binding motif-containing protein 1 OS=Homo sapiens GN=IQCB1 PE=1 SV=1 | 142 | F | 0.06932 | L | 0.080936 | -0.011616 | No Change: Both O | - |
| Q15051 | IQCB1_HUMAN IQ calmodulin-binding motif-containing protein 1 OS=Homo sapiens GN=IQCB1 PE=1 SV=1 | 393 | I | 0.32411 | N | 0.471148 | -0.147038 | No Change: Both O | - |
| Q15051 | IQCB1_HUMAN IQ calmodulin-binding motif-containing protein 1 OS=Homo sapiens GN=IQCB1 PE=1 SV=1 | 435 | R | 0.445598 | C | 0.313592 | 0.132006 | No Change: Both O | - |
| Q15051 | IQCB1_HUMAN IQ calmodulin-binding motif-containing protein 1 OS=Homo sapiens GN=IQCB1 PE=1 SV=1 | 434 | C | 0.453787 | Y | 0.44937 | 0.004417 | No Change: Both O | - |
| Q4KMZ1 | IQCC_HUMAN IQ domain-containing protein C OS=Homo sapiens GN=IQCC PE=2 SV=2 | 209 | F | 0.787492 | C | 0.836551 | -0.049059 | No Change: Both D | - |
| Q4KMZ1 | IQCC_HUMAN IQ domain-containing protein C OS=Homo sapiens GN=IQCC PE=2 SV=2 | 217 | C | 0.923418 | Y | 0.911174 | 0.012244 | No Change: Both D | - |
| Q4KMZ1 | IQCC_HUMAN IQ domain-containing protein C OS=Homo sapiens GN=IQCC PE=2 SV=2 | 464 | P | 0.944591 | L | 0.877218 | 0.067373 | No Change: Both D | - |
| Q96DY2 | IQCD_HUMAN IQ domain-containing protein D OS=Homo sapiens GN=IQCD PE=2 SV=2 | 136 | L | 0.834774 | V | 0.795324 | 0.03945 | No Change: Both D | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 101 | H | 0.319275 | N | 0.364032 | -0.044757 | No Change: Both O | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 546 | A | 0.311173 | V | 0.242237 | 0.068936 | No Change: Both O | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 587 | R | 0.899143 | H | 0.88562 | 0.013523 | No Change: Both D | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 596 | T | 0.827447 | A | 0.841801 | -0.014354 | No Change: Both D | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 666 | L | 0.956627 | V | 0.953845 | 0.002782 | No Change: Both D | - |
| Q6IPM2 | IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens GN=IQCE PE=1 SV=2 | 690 | T | 0.81283 | M | 0.822815 | -0.009985 | No Change: Both D | - |
| Q8N6M8 | IQCF1_HUMAN IQ domain-containing protein F1 OS=Homo sapiens GN=IQCF1 PE=2 SV=2 | 114 | R | 0.400424 | Q | 0.418657 | -0.018233 | No Change: Both O | - |
| Q8N6M8 | IQCF1_HUMAN IQ domain-containing protein F1 OS=Homo sapiens GN=IQCF1 PE=2 SV=2 | 76 | Q | 0.138297 | K | 0.173779 | -0.035482 | No Change: Both O | - |
| Q9H095 | IQCG_HUMAN IQ domain-containing protein G OS=Homo sapiens GN=IQCG PE=2 SV=1 | 112 | A | 0.527079 | D | 0.62684 | -0.099761 | No Change: Both D | - |
| Q86VS3 | IQCH_HUMAN IQ domain-containing protein H OS=Homo sapiens GN=IQCH PE=2 SV=2 | 932 | V | 0.424048 | L | 0.409077 | 0.014971 | No Change: Both O | - |
| Q8N0W5 | IQCK_HUMAN IQ domain-containing protein K OS=Homo sapiens GN=IQCK PE=2 SV=1 | 220 | L | 0.171976 | P | 0.288477 | -0.116501 | No Change: Both O | - |
| P46940 | IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens GN=IQGAP1 PE=1 SV=1 | 256 | S | 0.429536 | A | 0.398603 | 0.030933 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 455 | V | 0.181497 | A | 0.237644 | -0.056147 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 479 | P | 0.21818 | R | 0.189845 | 0.028335 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 714 | R | 0.346546 | W | 0.160091 | 0.186455 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 894 | T | 0.154706 | I | 0.086181 | 0.068525 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 1052 | R | 0.311301 | I | 0.183606 | 0.127695 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 1184 | N | 0.46232 | S | 0.504888 | -0.042568 | O to D | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 1379 | R | 0.720016 | W | 0.488962 | 0.231054 | D to O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 532 | K | 0.452526 | E | 0.441576 | 0.01095 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 527 | D | 0.47569 | E | 0.478407 | -0.002717 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 629 | L | 0.247801 | F | 0.211714 | 0.036087 | No Change: Both O | - |
| Q13576 | IQGA2_HUMAN Ras GTPase-activating-like protein IQGAP2 OS=Homo sapiens GN=IQGAP2 PE=1 SV=4 | 724 | I | 0.216544 | V | 0.23573 | -0.019186 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 391 | R | 0.347398 | G | 0.304061 | 0.043337 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 410 | V | 0.422467 | L | 0.427695 | -0.005228 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 645 | D | 0.247824 | N | 0.253285 | -0.005461 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 663 | R | 0.540941 | C | 0.377409 | 0.163532 | D to O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 770 | H | 0.130018 | Y | 0.081661 | 0.048357 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 1061 | Q | 0.170116 | H | 0.155469 | 0.014647 | No Change: Both O | - |
| Q86VI3 | IQGA3_HUMAN Ras GTPase-activating-like protein IQGAP3 OS=Homo sapiens GN=IQGAP3 PE=1 SV=2 | 1097 | P | 0.456942 | S | 0.482351 | -0.025409 | No Change: Both O | - |
| Q6DN90 | IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens GN=IQSEC1 PE=1 SV=1 | 882 | V | 0.891057 | I | 0.878009 | 0.013048 | No Change: Both D | - |
| Q6DN90 | IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens GN=IQSEC1 PE=1 SV=1 | 640 | P | 0.096306 | S | 0.109472 | -0.013166 | No Change: Both O | - |
| Q5JU85 | IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 OS=Homo sapiens GN=IQSEC2 PE=1 SV=1 | 349 | R | 0.702677 | C | 0.567367 | 0.13531 | No Change: Both D | Mental retardation X-linked type 1 (MRX1) [MIM:309530] |
| Q5JU85 | IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 OS=Homo sapiens GN=IQSEC2 PE=1 SV=1 | 748 | R | 0.145321 | Q | 0.152228 | -0.006907 | No Change: Both O | Mental retardation X-linked type 1 (MRX1) [MIM:309530] |
| Q5JU85 | IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 OS=Homo sapiens GN=IQSEC2 PE=1 SV=1 | 791 | Q | 0.312013 | P | 0.328225 | -0.016212 | No Change: Both O | Mental retardation X-linked type 1 (MRX1) [MIM:309530] |
| Q5JU85 | IQEC2_HUMAN IQ motif and SEC7 domain-containing protein 2 OS=Homo sapiens GN=IQSEC2 PE=1 SV=1 | 853 | R | 0.076585 | W | 0.027324 | 0.049261 | No Change: Both O | Mental retardation X-linked type 1 (MRX1) [MIM:309530] |
| Q9UPP2 | IQEC3_HUMAN IQ motif and SEC7 domain-containing protein 3 OS=Homo sapiens GN=IQSEC3 PE=2 SV=3 | 558 | A | 0.993394 | G | 0.993214 | 1.80E-04 | No Change: Both D | - |
| Q8NA54 | IQUB_HUMAN IQ and ubiquitin-like domain-containing protein OS=Homo sapiens GN=IQUB PE=1 SV=2 | 126 | V | 0.629146 | M | 0.655349 | -0.026203 | No Change: Both D | - |
| Q8NA54 | IQUB_HUMAN IQ and ubiquitin-like domain-containing protein OS=Homo sapiens GN=IQUB PE=1 SV=2 | 691 | D | 0.29497 | N | 0.279761 | 0.015209 | No Change: Both O | - |
| Q8NA54 | IQUB_HUMAN IQ and ubiquitin-like domain-containing protein OS=Homo sapiens GN=IQUB PE=1 SV=2 | 735 | R | 0.434968 | P | 0.476653 | -0.041685 | No Change: Both O | - |
| Q8NA54 | IQUB_HUMAN IQ and ubiquitin-like domain-containing protein OS=Homo sapiens GN=IQUB PE=1 SV=2 | 735 | R | 0.434968 | H | 0.45923 | -0.024262 | No Change: Both O | A colorectal cancer sample |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 398 | T | 0.248469 | M | 0.208619 | 0.03985 | No Change: Both O | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 412 | V | 0.10175 | M | 0.119356 | -0.017606 | No Change: Both O | A glioblastoma multiforme sample |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 421 | Q | 0.345719 | H | 0.343479 | 0.00224 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 532 | S | 0.701045 | L | 0.543168 | 0.157877 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 619 | G | 0.893635 | S | 0.914762 | -0.021127 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 625 | T | 0.933365 | M | 0.924919 | 0.008446 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 638 | R | 0.949991 | W | 0.903057 | 0.046934 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 690 | S | 0.814122 | G | 0.769617 | 0.044505 | No Change: Both D | A lung adenocarcinoma sample |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 194 | R | 0.658272 | H | 0.633626 | 0.024646 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 196 | F | 0.570033 | S | 0.671728 | -0.101695 | No Change: Both D | - |
| P51617 | IRAK1_HUMAN Interleukin-1 receptor-associated kinase 1 OS=Homo sapiens GN=IRAK1 PE=1 SV=2 | 203 | C | 0.295225 | S | 0.407863 | -0.112638 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 47 | S | 0.475638 | Y | 0.273329 | 0.202309 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 392 | L | 0.147667 | V | 0.162025 | -0.014358 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 431 | D | 0.415119 | E | 0.425543 | -0.010424 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 439 | L | 0.506144 | V | 0.507182 | -0.001038 | No Change: Both D | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 503 | L | 0.746256 | I | 0.664435 | 0.081821 | No Change: Both D | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 574 | D | 0.639017 | H | 0.592711 | 0.046306 | No Change: Both D | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 43 | R | 0.336971 | Q | 0.364678 | -0.027707 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 99 | I | 0.356254 | V | 0.364871 | -0.008617 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 147 | R | 0.967519 | T | 0.961832 | 0.005687 | No Change: Both D | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 214 | R | 0.503131 | G | 0.531926 | -0.028795 | No Change: Both D | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 249 | S | 0.441702 | L | 0.242666 | 0.199036 | No Change: Both O | A lung adenocarcinoma sample |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 421 | P | 0.343995 | T | 0.287965 | 0.05603 | No Change: Both O | A lung adenocarcinoma sample |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 469 | D | 0.477449 | N | 0.486117 | -0.008668 | No Change: Both O | - |
| O43187 | IRAK2_HUMAN Interleukin-1 receptor-associated kinase-like 2 OS=Homo sapiens GN=IRAK2 PE=1 SV=2 | 566 | R | 0.554413 | W | 0.330992 | 0.223421 | D to O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 147 | I | 0.44856 | V | 0.462997 | -0.014437 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 270 | I | 0.055466 | V | 0.055935 | -4.69E-04 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 269 | G | 0.041627 | S | 0.052807 | -0.01118 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 22 | P | 0.183839 | L | 0.106319 | 0.07752 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 111 | P | 0.607315 | A | 0.554009 | 0.053306 | No Change: Both D | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 134 | V | 0.19733 | M | 0.22909 | -0.03176 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 400 | L | 0.442719 | V | 0.404455 | 0.038264 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 429 | R | 0.519845 | Q | 0.492384 | 0.027461 | D to O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 57 | H | 0.202568 | R | 0.223871 | -0.021303 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 84 | G | 0.222852 | S | 0.269911 | -0.047059 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 171 | I | 0.180459 | V | 0.194012 | -0.013553 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 288 | S | 0.168868 | L | 0.07059 | 0.098278 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 384 | R | 0.317462 | Q | 0.329487 | -0.012025 | No Change: Both O | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 391 | M | 0.47461 | T | 0.512109 | -0.037499 | O to D | - |
| Q9Y616 | IRAK3_HUMAN Interleukin-1 receptor-associated kinase 3 OS=Homo sapiens GN=IRAK3 PE=1 SV=2 | 482 | D | 0.85276 | N | 0.851083 | 0.001677 | No Change: Both D | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 98 | S | 0.200064 | R | 0.154305 | 0.045759 | No Change: Both O | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 390 | H | 0.468558 | R | 0.494349 | -0.025791 | No Change: Both O | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 428 | A | 0.725073 | T | 0.748946 | -0.023873 | No Change: Both D | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 5 | I | 0.680455 | V | 0.707696 | -0.027241 | No Change: Both D | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 355 | M | 0.251557 | V | 0.208637 | 0.04292 | No Change: Both O | - |
| Q9NWZ3 | IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1 | 391 | R | 0.46904 | H | 0.487571 | -0.018531 | No Change: Both O | - |
| P48200 | IREB2_HUMAN Iron-responsive element-binding protein 2 OS=Homo sapiens GN=IREB2 PE=1 SV=3 | 159 | V | 0.857398 | L | 0.873807 | -0.016409 | No Change: Both D | - |
| P48200 | IREB2_HUMAN Iron-responsive element-binding protein 2 OS=Homo sapiens GN=IREB2 PE=1 SV=3 | 580 | I | 0.072844 | T | 0.136829 | -0.063985 | No Change: Both O | - |
| P10914 | IRF1_HUMAN Interferon regulatory factor 1 OS=Homo sapiens GN=IRF1 PE=1 SV=2 | 8 | M | 0.418031 | L | 0.296967 | 0.121064 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P10914 | IRF1_HUMAN Interferon regulatory factor 1 OS=Homo sapiens GN=IRF1 PE=1 SV=2 | 11 | W | 0.3418 | R | 0.616295 | -0.274495 | O to D | Gastric cancer (GASC) [MIM:613659] |
| Q8IU81 | I2BP1_HUMAN Interferon regulatory factor 2-binding protein 1 OS=Homo sapiens GN=IRF2BP1 PE=1 SV=1 | 24 | M | 0.06822 | I | 0.040154 | 0.028066 | No Change: Both O | - |
| Q7Z5L9 | I2BP2_HUMAN Interferon regulatory factor 2-binding protein 2 OS=Homo sapiens GN=IRF2BP2 PE=1 SV=2 | 254 | A | 0.981363 | V | 0.971775 | 0.009588 | No Change: Both D | - |
| Q14653 | IRF3_HUMAN Interferon regulatory factor 3 OS=Homo sapiens GN=IRF3 PE=1 SV=1 | 96 | R | 0.714351 | Q | 0.681612 | 0.032739 | No Change: Both D | - |
| Q14653 | IRF3_HUMAN Interferon regulatory factor 3 OS=Homo sapiens GN=IRF3 PE=1 SV=1 | 377 | E | 0.193524 | K | 0.193436 | 8.80E-05 | No Change: Both O | - |
| Q14653 | IRF3_HUMAN Interferon regulatory factor 3 OS=Homo sapiens GN=IRF3 PE=1 SV=1 | 427 | S | 0.743897 | T | 0.763689 | -0.019792 | No Change: Both D | - |
| Q14653 | IRF3_HUMAN Interferon regulatory factor 3 OS=Homo sapiens GN=IRF3 PE=1 SV=1 | 107 | Y | 0.704847 | F | 0.761196 | -0.056349 | No Change: Both D | - |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 2 | A | 0.852726 | V | 0.814361 | 0.038365 | No Change: Both D | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 18 | V | 0.135422 | A | 0.18563 | -0.050208 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 18 | V | 0.135422 | M | 0.169386 | -0.033964 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 39 | P | 0.386348 | A | 0.314461 | 0.071887 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 60 | W | 0.279748 | G | 0.459786 | -0.180038 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 61 | A | 0.296021 | G | 0.318737 | -0.022716 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 66 | K | 0.418134 | T | 0.354696 | 0.063438 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 70 | G | 0.571242 | R | 0.557513 | 0.013729 | No Change: Both D | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 76 | P | 0.465639 | S | 0.467219 | -0.00158 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 82 | Q | 0.249609 | K | 0.309313 | -0.059704 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 84 | R | 0.198201 | C | 0.111771 | 0.08643 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 84 | R | 0.198201 | H | 0.184465 | 0.013736 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 88 | N | 0.290394 | H | 0.252421 | 0.037973 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 89 | K | 0.320387 | E | 0.329172 | -0.008785 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 90 | S | 0.319021 | G | 0.285333 | 0.033688 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 98 | D | 0.334348 | H | 0.288473 | 0.045875 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 250 | R | 0.349503 | Q | 0.401563 | -0.05206 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 273 | Q | 0.51182 | R | 0.483597 | 0.028223 | D to O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 274 | V | 0.522063 | I | 0.486602 | 0.035461 | D to O | - |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 294 | L | 0.250355 | P | 0.392205 | -0.14185 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 297 | V | 0.166546 | I | 0.152447 | 0.014099 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 320 | K | 0.038711 | E | 0.038777 | -6.60E-05 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 321 | V | 0.050552 | M | 0.067432 | -0.01688 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 325 | G | 0.130698 | E | 0.162469 | -0.031771 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 345 | L | 0.124863 | P | 0.221684 | -0.096821 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 347 | C | 0.090087 | F | 0.099249 | -0.009162 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 369 | F | 0.191757 | S | 0.358769 | -0.167012 | No Change: Both O | Non-syndromic orofacial cleft type 6 (OFC6) [MIM:608864] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 369 | F | 0.191757 | S | 0.358769 | -0.167012 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 374 | C | 0.069897 | W | 0.059159 | 0.010738 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 388 | K | 0.18623 | E | 0.188334 | -0.002104 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 430 | D | 0.377778 | N | 0.354699 | 0.023079 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 6 | R | 0.493612 | C | 0.316473 | 0.177139 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 16 | A | 0.120141 | V | 0.096123 | 0.024018 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 22 | L | 0.110265 | P | 0.203154 | -0.092889 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 22 | L | 0.110265 | P | 0.203154 | -0.092889 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 45 | R | 0.575053 | Q | 0.6109 | -0.035847 | No Change: Both D | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 64 | T | 0.350055 | I | 0.238626 | 0.111429 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 84 | R | 0.198201 | G | 0.198437 | -2.36E-04 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 100 | T | 0.391925 | A | 0.377059 | 0.014866 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 251 | L | 0.323708 | P | 0.501899 | -0.178191 | O to D | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 349 | E | 0.072285 | V | 0.03175 | 0.040535 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 396 | P | 0.044601 | S | 0.049235 | -0.004634 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 400 | R | 0.064876 | W | 0.023884 | 0.040992 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 339 | R | 0.30073 | I | 0.183151 | 0.117579 | No Change: Both O | Van der Woude syndrome type 1 (VWS1) [MIM:119300] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 84 | R | 0.198201 | L | 0.125761 | 0.07244 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| O14896 | IRF6_HUMAN Interferon regulatory factor 6 OS=Homo sapiens GN=IRF6 PE=1 SV=1 | 424 | S | 0.364387 | L | 0.195794 | 0.168593 | No Change: Both O | Popliteal pterygium syndrome (PPS) [MIM:119500] |
| Q92985 | IRF7_HUMAN Interferon regulatory factor 7 OS=Homo sapiens GN=IRF7 PE=1 SV=2 | 179 | K | 0.761772 | E | 0.756162 | 0.00561 | No Change: Both D | - |
| Q92985 | IRF7_HUMAN Interferon regulatory factor 7 OS=Homo sapiens GN=IRF7 PE=1 SV=2 | 412 | Q | 0.262737 | R | 0.290966 | -0.028229 | No Change: Both O | - |
| Q92985 | IRF7_HUMAN Interferon regulatory factor 7 OS=Homo sapiens GN=IRF7 PE=1 SV=2 | 204 | D | 0.639598 | N | 0.5828 | 0.056798 | No Change: Both D | - |
| Q02556 | IRF8_HUMAN Interferon regulatory factor 8 OS=Homo sapiens GN=IRF8 PE=1 SV=2 | 81 | R | 0.288879 | K | 0.351406 | -0.062527 | No Change: Both O | A breast cancer sample |
| Q02556 | IRF8_HUMAN Interferon regulatory factor 8 OS=Homo sapiens GN=IRF8 PE=1 SV=2 | 197 | A | 0.404405 | T | 0.441684 | -0.037279 | No Change: Both O | A breast cancer sample |
| Q6NXR0 | IIGP5_HUMAN Interferon-inducible GTPase 5 OS=Homo sapiens GN=IRGC PE=2 SV=1 | 135 | D | 0.102725 | N | 0.085497 | 0.017228 | No Change: Both O | - |
| A1A4Y4 | IRGM_HUMAN Immunity-related GTPase family M protein OS=Homo sapiens GN=IRGM PE=1 SV=2 | 17 | E | 0.495826 | D | 0.459771 | 0.036055 | No Change: Both O | - |
| A1A4Y4 | IRGM_HUMAN Immunity-related GTPase family M protein OS=Homo sapiens GN=IRGM PE=1 SV=2 | 94 | T | 0.34878 | K | 0.402138 | -0.053358 | No Change: Both O | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 512 | A | 0.785119 | P | 0.828024 | -0.042905 | No Change: Both D | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 971 | G | 0.835694 | R | 0.854562 | -0.018868 | No Change: Both D | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 1043 | S | 0.965308 | Y | 0.91556 | 0.049748 | No Change: Both D | The etiology of non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 1095 | C | 0.843079 | Y | 0.807115 | 0.035964 | No Change: Both D | The etiology of non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 158 | P | 0.376489 | R | 0.311177 | 0.065312 | No Change: Both O | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 209 | M | 0.101864 | T | 0.124435 | -0.022571 | No Change: Both O | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 809 | S | 0.931409 | F | 0.854435 | 0.076974 | No Change: Both D | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 892 | S | 0.902765 | G | 0.880384 | 0.022381 | No Change: Both D | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 1137 | D | 0.890999 | N | 0.902698 | -0.011699 | No Change: Both D | - |
| P35568 | IRS1_HUMAN Insulin receptor substrate 1 OS=Homo sapiens GN=IRS1 PE=1 SV=1 | 608 | T | 0.955 | R | 0.963693 | -0.008693 | No Change: Both D | - |
| Q9Y4H2 | IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sapiens GN=IRS2 PE=1 SV=2 | 1057 | G | 0.872813 | D | 0.88299 | -0.010177 | No Change: Both D | - |
| Q9Y4H2 | IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sapiens GN=IRS2 PE=1 SV=2 | 879 | G | 0.962582 | S | 0.969235 | -0.006653 | No Change: Both D | - |
| Q9Y4H2 | IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sapiens GN=IRS2 PE=1 SV=2 | 882 | G | 0.963391 | A | 0.953621 | 0.00977 | No Change: Both D | - |
| Q9Y4H2 | IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sapiens GN=IRS2 PE=1 SV=2 | 789 | H | 0.571679 | Y | 0.501509 | 0.07017 | No Change: Both D | - |
| Q9Y4H2 | IRS2_HUMAN Insulin receptor substrate 2 OS=Homo sapiens GN=IRS2 PE=1 SV=2 | 999 | V | 0.988845 | M | 0.993648 | -0.004803 | No Change: Both D | - |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 20 | A | 0.708176 | V | 0.582109 | 0.126067 | No Change: Both D | A colorectal cancer sample |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 215 | G | 0.621203 | E | 0.660929 | -0.039726 | No Change: Both D | A colorectal cancer sample |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 557 | G | 0.998876 | R | 0.998751 | 1.25E-04 | No Change: Both D | A colorectal cancer sample |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 34 | L | 0.69192 | F | 0.629277 | 0.062643 | No Change: Both D | - |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 508 | N | 0.998348 | K | 0.99811 | 2.38E-04 | No Change: Both D | - |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 879 | H | 0.992211 | D | 0.994213 | -0.002002 | No Change: Both D | - |
| O14654 | IRS4_HUMAN Insulin receptor substrate 4 OS=Homo sapiens GN=IRS4 PE=1 SV=1 | 1230 | D | 0.994033 | Y | 0.985374 | 0.008659 | No Change: Both D | - |
| P78415 | IRX3_HUMAN Iroquois-class homeodomain protein IRX-3 OS=Homo sapiens GN=IRX3 PE=2 SV=3 | 479 | Q | 0.622277 | H | 0.574024 | 0.048253 | No Change: Both D | - |
| P78415 | IRX3_HUMAN Iroquois-class homeodomain protein IRX-3 OS=Homo sapiens GN=IRX3 PE=2 SV=3 | 422 | L | 0.924812 | P | 0.960651 | -0.035839 | No Change: Both D | - |
| P78413 | IRX4_HUMAN Iroquois-class homeodomain protein IRX-4 OS=Homo sapiens GN=IRX4 PE=2 SV=2 | 119 | A | 0.512404 | T | 0.496552 | 0.015852 | D to O | - |
| Q9H1K1 | ISCU_HUMAN Iron-sulfur cluster assembly enzyme ISCU mitochondrial OS=Homo sapiens GN=ISCU PE=1 SV=2 | 12 | A | 0.750635 | V | 0.623293 | 0.127342 | No Change: Both D | - |
| P05161 | ISG15_HUMAN Ubiquitin-like protein ISG15 OS=Homo sapiens GN=ISG15 PE=1 SV=5 | 83 | S | 0.264425 | N | 0.233142 | 0.031283 | No Change: Both O | - |
| Q9H9L3 | I20L2_HUMAN Interferon-stimulated 20 kDa exonuclease-like 2 OS=Homo sapiens GN=ISG20L2 PE=1 SV=1 | 130 | N | 0.896602 | S | 0.927419 | -0.030817 | No Change: Both D | - |
| O14498 | ISLR_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein OS=Homo sapiens GN=ISLR PE=1 SV=1 | 183 | D | 0.085216 | N | 0.088713 | -0.003497 | No Change: Both O | A colorectal cancer sample |
| Q6UXK2 | ISLR2_HUMAN Immunoglobulin superfamily containing leucine-rich repeat protein 2 OS=Homo sapiens GN=ISLR2 PE=2 SV=1 | 137 | S | 0.624937 | F | 0.406403 | 0.218534 | D to O | - |
| B1AKI9 | ISM1_HUMAN Isthmin-1 OS=Homo sapiens GN=ISM1 PE=2 SV=2 | 193 | P | 0.740767 | R | 0.71825 | 0.022517 | No Change: Both D | - |
| Q6H9L7 | ISM2_HUMAN Isthmin-2 OS=Homo sapiens GN=ISM2 PE=2 SV=1 | 94 | A | 0.894677 | T | 0.91416 | -0.019483 | No Change: Both D | - |
| Q6H9L7 | ISM2_HUMAN Isthmin-2 OS=Homo sapiens GN=ISM2 PE=2 SV=1 | 133 | P | 0.958837 | A | 0.939475 | 0.019362 | No Change: Both D | - |
| Q2M1V0 | ISX_HUMAN Intestine-specific homeobox OS=Homo sapiens GN=ISX PE=2 SV=2 | 28 | S | 0.809825 | G | 0.771832 | 0.037993 | No Change: Both D | - |
| Q2M1V0 | ISX_HUMAN Intestine-specific homeobox OS=Homo sapiens GN=ISX PE=2 SV=2 | 57 | P | 0.988227 | S | 0.987959 | 2.68E-04 | No Change: Both D | - |
| Q2M1V0 | ISX_HUMAN Intestine-specific homeobox OS=Homo sapiens GN=ISX PE=2 SV=2 | 83 | R | 0.842294 | Q | 0.84208 | 2.14E-04 | No Change: Both D | - |
| Q2M1V0 | ISX_HUMAN Intestine-specific homeobox OS=Homo sapiens GN=ISX PE=2 SV=2 | 158 | A | 0.457926 | V | 0.36991 | 0.088016 | No Change: Both O | - |
| P56199 | ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens GN=ITGA1 PE=1 SV=2 | 480 | T | 0.282065 | M | 0.240893 | 0.041172 | No Change: Both O | - |
| P56199 | ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens GN=ITGA1 PE=1 SV=2 | 961 | I | 0.398175 | M | 0.482373 | -0.084198 | No Change: Both O | - |
| P56199 | ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens GN=ITGA1 PE=1 SV=2 | 1108 | E | 0.497552 | G | 0.440756 | 0.056796 | No Change: Both O | - |
| P56199 | ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens GN=ITGA1 PE=1 SV=2 | 670 | V | 0.128475 | I | 0.102213 | 0.026262 | No Change: Both O | - |
| O75578 | ITA10_HUMAN Integrin alpha-10 OS=Homo sapiens GN=ITGA10 PE=2 SV=2 | 381 | R | 0.274491 | Q | 0.302431 | -0.02794 | No Change: Both O | - |
| O75578 | ITA10_HUMAN Integrin alpha-10 OS=Homo sapiens GN=ITGA10 PE=2 SV=2 | 691 | R | 0.316451 | H | 0.314837 | 0.001614 | No Change: Both O | - |
| O75578 | ITA10_HUMAN Integrin alpha-10 OS=Homo sapiens GN=ITGA10 PE=2 SV=2 | 725 | R | 0.550765 | Q | 0.558959 | -0.008194 | No Change: Both D | - |
| O75578 | ITA10_HUMAN Integrin alpha-10 OS=Homo sapiens GN=ITGA10 PE=2 SV=2 | 668 | R | 0.390615 | W | 0.174355 | 0.21626 | No Change: Both O | - |
| O75578 | ITA10_HUMAN Integrin alpha-10 OS=Homo sapiens GN=ITGA10 PE=2 SV=2 | 702 | A | 0.19737 | T | 0.223546 | -0.026176 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 433 | V | 0.42819 | M | 0.46563 | -0.03744 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 524 | L | 0.096751 | R | 0.163413 | -0.066662 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 972 | P | 0.71289 | L | 0.601431 | 0.111459 | No Change: Both D | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 1003 | M | 0.133971 | I | 0.090913 | 0.043058 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 1093 | L | 0.210201 | V | 0.192179 | 0.018022 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 471 | M | 0.372769 | L | 0.316098 | 0.056671 | No Change: Both O | - |
| Q9UKX5 | ITA11_HUMAN Integrin alpha-11 OS=Homo sapiens GN=ITGA11 PE=1 SV=2 | 891 | Q | 0.322702 | K | 0.359825 | -0.037123 | No Change: Both O | - |
| P17301 | ITA2_HUMAN Integrin alpha-2 OS=Homo sapiens GN=ITGA2 PE=1 SV=1 | 534 | K | 0.175322 | E | 0.165937 | 0.009385 | No Change: Both O | - |
| P17301 | ITA2_HUMAN Integrin alpha-2 OS=Homo sapiens GN=ITGA2 PE=1 SV=1 | 1127 | K | 0.62352 | Q | 0.558884 | 0.064636 | No Change: Both D | - |
| P17301 | ITA2_HUMAN Integrin alpha-2 OS=Homo sapiens GN=ITGA2 PE=1 SV=1 | 927 | N | 0.261454 | S | 0.285583 | -0.024129 | No Change: Both O | - |
| P17301 | ITA2_HUMAN Integrin alpha-2 OS=Homo sapiens GN=ITGA2 PE=1 SV=1 | 691 | N | 0.372691 | K | 0.40709 | -0.034399 | No Change: Both O | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 273 | G | 0.228201 | D | 0.251183 | -0.022982 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 358 | R | 0.12584 | H | 0.108385 | 0.017455 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 449 | G | 0.32606 | D | 0.34185 | -0.01579 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 778 | Q | 0.529837 | P | 0.569162 | -0.039325 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 874 | I | 0.753687 | S | 0.861155 | -0.107468 | No Change: Both D | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 176 | P | 0.487745 | A | 0.423919 | 0.063826 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 176 | P | 0.487745 | L | 0.34877 | 0.138975 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 320 | F | 0.280787 | S | 0.537676 | -0.256889 | O to D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 355 | E | 0.264158 | K | 0.272608 | -0.00845 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 40 | T | 0.158692 | I | 0.087054 | 0.071638 | No Change: Both O | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 968 | Y | 0.272855 | N | 0.425887 | -0.153032 | No Change: Both O | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 86 | L | 0.187695 | P | 0.336795 | -0.1491 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 139 | A | 0.052414 | V | 0.038604 | 0.01381 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 161 | C | 0.272299 | W | 0.22566 | 0.046639 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 174 | Y | 0.555727 | H | 0.634896 | -0.079169 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 202 | F | 0.231661 | C | 0.232344 | -6.83E-04 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 207 | T | 0.256947 | I | 0.148548 | 0.108399 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 214 | L | 0.216229 | P | 0.375308 | -0.159079 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 222 | F | 0.084266 | L | 0.10746 | -0.023194 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 267 | G | 0.091864 | E | 0.114757 | -0.022893 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 329 | V | 0.475051 | F | 0.430588 | 0.044463 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 380 | G | 0.240599 | D | 0.246922 | -0.006323 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 405 | I | 0.28784 | T | 0.408699 | -0.120859 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 412 | G | 0.476994 | R | 0.471784 | 0.00521 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 581 | A | 0.190804 | D | 0.263805 | -0.073001 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 596 | I | 0.229739 | T | 0.367763 | -0.138024 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 705 | C | 0.298719 | R | 0.462117 | -0.163398 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 752 | L | 0.533843 | V | 0.543645 | -0.009802 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 755 | R | 0.624001 | P | 0.670385 | -0.046384 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 847 | L | 0.487053 | P | 0.656627 | -0.169574 | O to D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 943 | P | 0.072435 | L | 0.036965 | 0.03547 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 982 | V | 0.174887 | M | 0.223285 | -0.048398 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 989 | A | 0.143524 | T | 0.161578 | -0.018054 | No Change: Both O | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 1026 | R | 0.347396 | Q | 0.351455 | -0.004059 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 313 | G | 0.476282 | A | 0.420624 | 0.055658 | No Change: Both O | - |
| P08514 | ITA2B_HUMAN Integrin alpha-IIb OS=Homo sapiens GN=ITGA2B PE=1 SV=3 | 649 | V | 0.366721 | L | 0.382587 | -0.015866 | No Change: Both O | - |
| P26006 | ITA3_HUMAN Integrin alpha-3 OS=Homo sapiens GN=ITGA3 PE=1 SV=5 | 268 | I | 0.256049 | F | 0.243548 | 0.012501 | No Change: Both O | - |
| P26006 | ITA3_HUMAN Integrin alpha-3 OS=Homo sapiens GN=ITGA3 PE=1 SV=5 | 719 | A | 0.071616 | T | 0.091655 | -0.020039 | No Change: Both O | - |
| P26006 | ITA3_HUMAN Integrin alpha-3 OS=Homo sapiens GN=ITGA3 PE=1 SV=5 | 840 | G | 0.320067 | S | 0.362779 | -0.042712 | No Change: Both O | - |
| P13612 | ITA4_HUMAN Integrin alpha-4 OS=Homo sapiens GN=ITGA4 PE=1 SV=3 | 878 | R | 0.170303 | Q | 0.184818 | -0.014515 | No Change: Both O | - |
| P13612 | ITA4_HUMAN Integrin alpha-4 OS=Homo sapiens GN=ITGA4 PE=1 SV=3 | 634 | S | 0.223054 | T | 0.163809 | 0.059245 | No Change: Both O | - |
| P13612 | ITA4_HUMAN Integrin alpha-4 OS=Homo sapiens GN=ITGA4 PE=1 SV=3 | 824 | V | 0.414118 | A | 0.462457 | -0.048339 | No Change: Both O | - |
| P08648 | ITA5_HUMAN Integrin alpha-5 OS=Homo sapiens GN=ITGA5 PE=1 SV=2 | 585 | R | 0.343723 | I | 0.200752 | 0.142971 | No Change: Both O | - |
| Q13683 | ITA7_HUMAN Integrin alpha-7 OS=Homo sapiens GN=ITGA7 PE=1 SV=3 | 695 | R | 0.193072 | H | 0.156053 | 0.037019 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 216 | V | 0.201001 | L | 0.211901 | -0.0109 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 577 | S | 0.344532 | F | 0.179978 | 0.164554 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 581 | Q | 0.190795 | P | 0.190687 | 1.08E-04 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 748 | R | 0.317121 | H | 0.277051 | 0.04007 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 993 | I | 0.25128 | V | 0.278851 | -0.027571 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 994 | V | 0.187891 | A | 0.247346 | -0.059455 | No Change: Both O | - |
| P53708 | ITA8_HUMAN Integrin alpha-8 OS=Homo sapiens GN=ITGA8 PE=1 SV=3 | 567 | V | 0.161116 | L | 0.165013 | -0.003897 | No Change: Both O | - |
| Q13797 | ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens GN=ITGA9 PE=1 SV=2 | 750 | R | 0.64704 | C | 0.595804 | 0.051236 | No Change: Both D | A breast cancer sample |
| Q13797 | ITA9_HUMAN Integrin alpha-9 OS=Homo sapiens GN=ITGA9 PE=1 SV=2 | 507 | G | 0.350339 | E | 0.396559 | -0.04622 | No Change: Both O | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 360 | D | 0.488121 | E | 0.512135 | -0.024014 | O to D | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 1041 | C | 0.336169 | S | 0.552433 | -0.216264 | O to D | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 892 | Q | 0.743228 | H | 0.689609 | 0.053619 | No Change: Both D | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 950 | R | 0.72045 | W | 0.526906 | 0.193544 | No Change: Both D | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 477 | I | 0.2233 | V | 0.248563 | -0.025263 | No Change: Both O | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 482 | R | 0.389822 | Q | 0.407048 | -0.017226 | No Change: Both O | - |
| P38570 | ITAE_HUMAN Integrin alpha-E OS=Homo sapiens GN=ITGAE PE=1 SV=3 | 1019 | V | 0.187756 | A | 0.247079 | -0.059323 | No Change: Both O | - |
| P20701 | ITAL_HUMAN Integrin alpha-L OS=Homo sapiens GN=ITGAL PE=1 SV=3 | 144 | R | 0.384515 | H | 0.373454 | 0.011061 | No Change: Both O | - |
| P20701 | ITAL_HUMAN Integrin alpha-L OS=Homo sapiens GN=ITGAL PE=1 SV=3 | 214 | R | 0.524046 | W | 0.319732 | 0.204314 | D to O | - |
| P20701 | ITAL_HUMAN Integrin alpha-L OS=Homo sapiens GN=ITGAL PE=1 SV=3 | 746 | Q | 0.63486 | K | 0.651871 | -0.017011 | No Change: Both D | - |
| P20701 | ITAL_HUMAN Integrin alpha-L OS=Homo sapiens GN=ITGAL PE=1 SV=3 | 791 | R | 0.501537 | T | 0.466594 | 0.034943 | D to O | - |
| P11215 | ITAM_HUMAN Integrin alpha-M OS=Homo sapiens GN=ITGAM PE=1 SV=2 | 77 | R | 0.293436 | H | 0.267338 | 0.026098 | No Change: Both O | - |
| P11215 | ITAM_HUMAN Integrin alpha-M OS=Homo sapiens GN=ITGAM PE=1 SV=2 | 441 | M | 0.357105 | T | 0.413594 | -0.056489 | No Change: Both O | - |
| P11215 | ITAM_HUMAN Integrin alpha-M OS=Homo sapiens GN=ITGAM PE=1 SV=2 | 858 | A | 0.736489 | V | 0.687282 | 0.049207 | No Change: Both D | - |
| P11215 | ITAM_HUMAN Integrin alpha-M OS=Homo sapiens GN=ITGAM PE=1 SV=2 | 1146 | P | 0.812644 | S | 0.827747 | -0.015103 | No Change: Both D | - |
| P06756 | ITAV_HUMAN Integrin alpha-V OS=Homo sapiens GN=ITGAV PE=1 SV=2 | 405 | I | 0.1273 | V | 0.141661 | -0.014361 | No Change: Both O | - |
| P06756 | ITAV_HUMAN Integrin alpha-V OS=Homo sapiens GN=ITGAV PE=1 SV=2 | 783 | V | 0.267811 | I | 0.242144 | 0.025667 | No Change: Both O | - |
| P06756 | ITAV_HUMAN Integrin alpha-V OS=Homo sapiens GN=ITGAV PE=1 SV=2 | 548 | S | 0.571316 | A | 0.466072 | 0.105244 | D to O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 48 | W | 0.108944 | R | 0.243131 | -0.134187 | No Change: Both O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 251 | A | 0.175233 | T | 0.185057 | -0.009824 | No Change: Both O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 517 | P | 0.272862 | R | 0.253274 | 0.019588 | No Change: Both O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 547 | E | 0.60426 | K | 0.584094 | 0.020166 | No Change: Both D | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 971 | F | 0.151894 | L | 0.19702 | -0.045126 | No Change: Both O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 201 | F | 0.479244 | L | 0.472234 | 0.00701 | No Change: Both O | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 564 | I | 0.650478 | V | 0.675875 | -0.025397 | No Change: Both D | - |
| P20702 | ITAX_HUMAN Integrin alpha-X OS=Homo sapiens GN=ITGAX PE=1 SV=3 | 1012 | A | 0.353744 | V | 0.282119 | 0.071625 | No Change: Both O | - |
| Q9NPI5 | NRK2_HUMAN Nicotinamide riboside kinase 2 OS=Homo sapiens GN=ITGB1BP3 PE=1 SV=1 | 178 | E | 0.523208 | K | 0.499955 | 0.023253 | D to O | - |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 128 | D | 0.109294 | N | 0.096954 | 0.01234 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 149 | L | 0.402358 | P | 0.537204 | -0.134846 | O to D | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 169 | G | 0.280147 | R | 0.289972 | -0.009825 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 178 | P | 0.306124 | L | 0.173606 | 0.132518 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 196 | K | 0.719734 | T | 0.655944 | 0.06379 | No Change: Both D | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 284 | G | 0.311389 | S | 0.356392 | -0.045003 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 351 | N | 0.420856 | S | 0.477659 | -0.056803 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 586 | R | 0.909174 | W | 0.770201 | 0.138973 | No Change: Both D | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 593 | R | 0.928385 | C | 0.918191 | 0.010194 | No Change: Both D | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 138 | S | 0.270557 | P | 0.232695 | 0.037862 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 273 | G | 0.33766 | R | 0.300494 | 0.037166 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 354 | Q | 0.286599 | H | 0.271208 | 0.015391 | No Change: Both O | - |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 128 | D | 0.109294 | Y | 0.05816 | 0.051134 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 239 | A | 0.309045 | T | 0.312557 | -0.003512 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 300 | D | 0.424584 | V | 0.278019 | 0.146565 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05107 | ITB2_HUMAN Integrin beta-2 OS=Homo sapiens GN=ITGB2 PE=1 SV=2 | 716 | G | 0.011308 | A | 0.008532 | 0.002776 | No Change: Both O | Leukocyte adhesion deficiency type 1 (LAD1) [MIM:116920] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 59 | L | 0.567707 | P | 0.723606 | -0.155899 | No Change: Both D | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 169 | R | 0.407022 | Q | 0.434422 | -0.0274 | No Change: Both O | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 433 | P | 0.549828 | A | 0.479044 | 0.070784 | D to O | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 515 | R | 0.954009 | Q | 0.960163 | -0.006154 | No Change: Both D | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 662 | R | 0.59556 | C | 0.543847 | 0.051713 | No Change: Both D | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 145 | D | 0.180955 | Y | 0.097365 | 0.08359 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 240 | R | 0.677352 | Q | 0.690886 | -0.013534 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 240 | R | 0.677352 | W | 0.477613 | 0.199739 | D to O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 306 | H | 0.629853 | P | 0.640602 | -0.010749 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 400 | C | 0.171538 | Y | 0.187318 | -0.01578 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 586 | C | 0.652096 | F | 0.501839 | 0.150257 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 598 | G | 0.757934 | S | 0.800145 | -0.042211 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 778 | S | 0.420243 | P | 0.473489 | -0.053246 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 143 | L | 0.129577 | W | 0.083299 | 0.046278 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 188 | S | 0.273236 | L | 0.135196 | 0.13804 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 568 | C | 0.603261 | R | 0.644527 | -0.041266 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 605 | G | 0.753076 | S | 0.793213 | -0.040137 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 453 | V | 0.256816 | I | 0.239914 | 0.016902 | No Change: Both O | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 119 | R | 0.593576 | W | 0.347874 | 0.245702 | D to O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 141 | Y | 0.114148 | C | 0.0977 | 0.016448 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 145 | D | 0.180955 | N | 0.15565 | 0.025305 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 150 | M | 0.347238 | V | 0.27842 | 0.068818 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 166 | T | 0.386485 | I | 0.23379 | 0.152695 | No Change: Both O | - |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 222 | L | 0.215734 | P | 0.354566 | -0.138832 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 242 | R | 0.682377 | Q | 0.693745 | -0.011368 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 243 | D | 0.67734 | V | 0.534219 | 0.143121 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 288 | L | 0.194156 | P | 0.331494 | -0.137338 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 321 | M | 0.43067 | L | 0.378823 | 0.051847 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 330 | I | 0.190611 | N | 0.34065 | -0.150039 | No Change: Both O | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 532 | C | 0.721133 | Y | 0.624586 | 0.096547 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 586 | C | 0.652096 | R | 0.683764 | -0.031668 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 601 | C | 0.746355 | R | 0.773769 | -0.027414 | No Change: Both D | Glanzmann thrombasthenia (GT) [MIM:273800] |
| P05106 | ITB3_HUMAN Integrin beta-3 OS=Homo sapiens GN=ITGB3 PE=1 SV=2 | 66 | L | 0.699038 | R | 0.771823 | -0.072785 | No Change: Both D | - |
| Q13352 | CENPR_HUMAN Centromere protein R OS=Homo sapiens GN=ITGB3BP PE=1 SV=2 | 30 | I | 0.715701 | V | 0.735724 | -0.020023 | No Change: Both D | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 61 | C | 0.489682 | Y | 0.418512 | 0.07117 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 156 | L | 0.369673 | P | 0.500448 | -0.130775 | O to D | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 245 | C | 0.079409 | G | 0.166565 | -0.087156 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 252 | R | 0.260493 | C | 0.135221 | 0.125272 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 562 | C | 0.609199 | R | 0.66189 | -0.052691 | No Change: Both D | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 1281 | R | 0.324878 | W | 0.145755 | 0.179123 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 38 | C | 0.371232 | R | 0.517463 | -0.146231 | O to D | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 98 | R | 0.821051 | H | 0.765854 | 0.055197 | No Change: Both D | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 131 | D | 0.448605 | Y | 0.271494 | 0.177111 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 273 | G | 0.304701 | D | 0.329578 | -0.024877 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 283 | R | 0.354475 | C | 0.220733 | 0.133742 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 325 | V | 0.085719 | D | 0.16988 | -0.084161 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 336 | L | 0.30301 | P | 0.49711 | -0.1941 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 844 | R | 0.559192 | L | 0.437461 | 0.121731 | D to O | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 931 | G | 0.362644 | D | 0.402872 | -0.040228 | No Change: Both O | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 1216 | H | 0.557996 | Q | 0.6089 | -0.050904 | No Change: Both D | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 1225 | R | 0.448138 | H | 0.439342 | 0.008796 | No Change: Both O | Epidermolysis bullosa letalis with pyloric atresia (EB-PA) [MIM:226730] |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 478 | Q | 0.366699 | H | 0.267244 | 0.099455 | No Change: Both O | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 1779 | L | 0.377779 | P | 0.519653 | -0.141874 | O to D | - |
| P16144 | ITB4_HUMAN Integrin beta-4 OS=Homo sapiens GN=ITGB4 PE=1 SV=5 | 1764 | T | 0.630109 | S | 0.673642 | -0.043533 | No Change: Both D | - |
| P18084 | ITB5_HUMAN Integrin beta-5 OS=Homo sapiens GN=ITGB5 PE=1 SV=1 | 428 | L | 0.486447 | V | 0.500384 | -0.013937 | O to D | - |
| P18084 | ITB5_HUMAN Integrin beta-5 OS=Homo sapiens GN=ITGB5 PE=1 SV=1 | 431 | R | 0.571428 | Q | 0.563063 | 0.008365 | No Change: Both D | - |
| P18084 | ITB5_HUMAN Integrin beta-5 OS=Homo sapiens GN=ITGB5 PE=1 SV=1 | 477 | N | 0.584306 | S | 0.637212 | -0.052906 | No Change: Both D | - |
| P18564 | ITB6_HUMAN Integrin beta-6 OS=Homo sapiens GN=ITGB6 PE=1 SV=2 | 437 | P | 0.246597 | T | 0.193706 | 0.052891 | No Change: Both O | - |
| P26010 | ITB7_HUMAN Integrin beta-7 OS=Homo sapiens GN=ITGB7 PE=1 SV=1 | 672 | H | 0.233787 | Y | 0.14635 | 0.087437 | No Change: Both O | - |
| P26012 | ITB8_HUMAN Integrin beta-8 OS=Homo sapiens GN=ITGB8 PE=1 SV=1 | 552 | S | 0.442569 | F | 0.273848 | 0.168721 | No Change: Both O | - |
| O95965 | ITGBL_HUMAN Integrin beta-like protein 1 OS=Homo sapiens GN=ITGBL1 PE=2 SV=1 | 154 | A | 0.676342 | S | 0.789583 | -0.113241 | No Change: Both D | - |
| P19827 | ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3 | 585 | E | 0.660095 | V | 0.498045 | 0.16205 | D to O | - |
| P19827 | ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3 | 595 | Q | 0.391563 | R | 0.367086 | 0.024477 | No Change: Both O | - |
| P19827 | ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3 | 263 | S | 0.21281 | T | 0.17119 | 0.04162 | No Change: Both O | - |
| P19827 | ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3 | 695 | G | 0.214577 | C | 0.130189 | 0.084388 | No Change: Both O | - |
| P19827 | ITIH1_HUMAN Inter-alpha-trypsin inhibitor heavy chain H1 OS=Homo sapiens GN=ITIH1 PE=1 SV=3 | 844 | D | 0.47321 | E | 0.495765 | -0.022555 | No Change: Both O | - |
| P19823 | ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens GN=ITIH2 PE=1 SV=2 | 263 | N | 0.223372 | S | 0.265926 | -0.042554 | No Change: Both O | - |
| P19823 | ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens GN=ITIH2 PE=1 SV=2 | 569 | L | 0.568051 | V | 0.552624 | 0.015427 | No Change: Both D | - |
| P19823 | ITIH2_HUMAN Inter-alpha-trypsin inhibitor heavy chain H2 OS=Homo sapiens GN=ITIH2 PE=1 SV=2 | 674 | P | 0.732524 | A | 0.63837 | 0.094154 | No Change: Both D | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 315 | Q | 0.338932 | K | 0.386044 | -0.047112 | No Change: Both O | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 340 | T | 0.45457 | M | 0.405715 | 0.048855 | No Change: Both O | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 751 | T | 0.267884 | A | 0.224126 | 0.043758 | No Change: Both O | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 825 | R | 0.579916 | Q | 0.604599 | -0.024683 | No Change: Both D | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 858 | A | 0.445454 | V | 0.387829 | 0.057625 | No Change: Both O | - |
| Q06033 | ITIH3_HUMAN Inter-alpha-trypsin inhibitor heavy chain H3 OS=Homo sapiens GN=ITIH3 PE=1 SV=2 | 640 | P | 0.50456 | L | 0.346292 | 0.158268 | D to O | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 86 | I | 0.160634 | N | 0.271966 | -0.111332 | No Change: Both O | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 85 | I | 0.161445 | N | 0.268848 | -0.107403 | No Change: Both O | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 669 | Q | 0.77209 | L | 0.716916 | 0.055174 | No Change: Both D | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 698 | P | 0.821267 | T | 0.761909 | 0.059358 | No Change: Both D | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 714 | M | 0.804506 | I | 0.724484 | 0.080022 | No Change: Both D | - |
| Q14624 | ITIH4_HUMAN Inter-alpha-trypsin inhibitor heavy chain H4 OS=Homo sapiens GN=ITIH4 PE=1 SV=4 | 791 | L | 0.11071 | P | 0.226868 | -0.116158 | No Change: Both O | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 139 | E | 0.683178 | K | 0.681164 | 0.002014 | No Change: Both D | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 207 | N | 0.742105 | H | 0.720191 | 0.021914 | No Change: Both D | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 570 | T | 0.625281 | P | 0.677426 | -0.052145 | No Change: Both D | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 629 | R | 0.674417 | C | 0.539873 | 0.134544 | No Change: Both D | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 421 | N | 0.408422 | H | 0.386933 | 0.021489 | No Change: Both O | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 925 | F | 0.165859 | S | 0.346786 | -0.180927 | No Change: Both O | - |
| Q86UX2 | ITIH5_HUMAN Inter-alpha-trypsin inhibitor heavy chain H5 OS=Homo sapiens GN=ITIH5 PE=2 SV=2 | 496 | V | 0.370214 | M | 0.422832 | -0.052618 | No Change: Both O | - |
| Q6UXX5 | ITIH6_HUMAN Inter-alpha-trypsin inhibitor heavy chain H6 OS=Homo sapiens GN=ITIH6 PE=2 SV=1 | 387 | G | 0.29346 | R | 0.29336 | 1.00E-04 | No Change: Both O | - |
| Q6UXX5 | ITIH6_HUMAN Inter-alpha-trypsin inhibitor heavy chain H6 OS=Homo sapiens GN=ITIH6 PE=2 SV=1 | 561 | R | 0.041344 | C | 0.018831 | 0.022513 | No Change: Both O | - |
| Q6UXX5 | ITIH6_HUMAN Inter-alpha-trypsin inhibitor heavy chain H6 OS=Homo sapiens GN=ITIH6 PE=2 SV=1 | 1041 | W | 0.714558 | S | 0.8691 | -0.154542 | No Change: Both D | - |
| Q6UXX5 | ITIH6_HUMAN Inter-alpha-trypsin inhibitor heavy chain H6 OS=Homo sapiens GN=ITIH6 PE=2 SV=1 | 1170 | G | 0.459035 | A | 0.393671 | 0.065364 | No Change: Both O | - |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 19 | R | 0.74235 | K | 0.762441 | -0.020091 | No Change: Both D | A metastatic melanoma sample |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 23 | P | 0.636855 | L | 0.525092 | 0.111763 | No Change: Both D | A metastatic melanoma sample |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 451 | R | 0.204645 | Q | 0.220646 | -0.016001 | No Change: Both O | A gastric adenocarcinoma sample |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 581 | R | 0.27558 | W | 0.131755 | 0.143825 | No Change: Both O | - |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 587 | V | 0.157814 | I | 0.15336 | 0.004454 | No Change: Both O | - |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 193 | R | 0.341677 | Q | 0.358673 | -0.016996 | No Change: Both O | - |
| Q08881 | ITK_HUMAN Tyrosine-protein kinase ITK/TSK OS=Homo sapiens GN=ITK PE=1 SV=1 | 335 | R | 0.090006 | W | 0.03134 | 0.058666 | No Change: Both O | Lymphoproliferative syndrome EBV-associated autosomal type 1 (LPSA1) [MIM:613011] |
| Q8WWA0 | ITLN1_HUMAN Intelectin-1 OS=Homo sapiens GN=ITLN1 PE=1 SV=1 | 109 | V | 0.54571 | D | 0.67838 | -0.13267 | No Change: Both D | - |
| Q8WWA0 | ITLN1_HUMAN Intelectin-1 OS=Homo sapiens GN=ITLN1 PE=1 SV=1 | 313 | R | 0.455935 | P | 0.538868 | -0.082933 | O to D | - |
| Q8WWU7 | ITLN2_HUMAN Intelectin-2 OS=Homo sapiens GN=ITLN2 PE=2 SV=1 | 103 | R | 0.458688 | H | 0.469313 | -0.010625 | No Change: Both O | - |
| Q8WWU7 | ITLN2_HUMAN Intelectin-2 OS=Homo sapiens GN=ITLN2 PE=2 SV=1 | 171 | Q | 0.491554 | R | 0.488775 | 0.002779 | No Change: Both O | - |
| O43736 | ITM2A_HUMAN Integral membrane protein 2A OS=Homo sapiens GN=ITM2A PE=1 SV=2 | 72 | A | 0.037063 | V | 0.026032 | 0.011031 | No Change: Both O | - |
| O43736 | ITM2A_HUMAN Integral membrane protein 2A OS=Homo sapiens GN=ITM2A PE=1 SV=2 | 230 | R | 0.263611 | T | 0.225983 | 0.037628 | No Change: Both O | - |
| Q9NQX7 | ITM2C_HUMAN Integral membrane protein 2C OS=Homo sapiens GN=ITM2C PE=1 SV=1 | 53 | G | 0.631607 | S | 0.667509 | -0.035902 | No Change: Both D | - |
| Q9BY32 | ITPA_HUMAN Inosine triphosphate pyrophosphatase OS=Homo sapiens GN=ITPA PE=1 SV=2 | 32 | P | 0.133488 | T | 0.106711 | 0.026777 | No Change: Both O | Inosine triphosphate pyrophosphohydrolase deficiency (ITPAD) [MIM:613850] |
| P27987 | IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens GN=ITPKB PE=1 SV=5 | 552 | P | 0.821657 | Q | 0.797631 | 0.024026 | No Change: Both D | - |
| P27987 | IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens GN=ITPKB PE=1 SV=5 | 408 | S | 0.942738 | A | 0.914664 | 0.028074 | No Change: Both D | - |
| P27987 | IP3KB_HUMAN Inositol-trisphosphate 3-kinase B OS=Homo sapiens GN=ITPKB PE=1 SV=5 | 322 | A | 0.834726 | T | 0.85395 | -0.019224 | No Change: Both D | - |
| Q14643 | ITPR1_HUMAN Inositol 1 4 5-trisphosphate receptor type 1 OS=Homo sapiens GN=ITPR1 PE=1 SV=2 | 769 | M | 0.190836 | V | 0.146907 | 0.043929 | No Change: Both O | - |
| Q14643 | ITPR1_HUMAN Inositol 1 4 5-trisphosphate receptor type 1 OS=Homo sapiens GN=ITPR1 PE=1 SV=2 | 1430 | I | 0.064449 | V | 0.072228 | -0.007779 | No Change: Both O | - |
| Q14571 | ITPR2_HUMAN Inositol 1 4 5-trisphosphate receptor type 2 OS=Homo sapiens GN=ITPR2 PE=1 SV=2 | 453 | A | 0.303508 | V | 0.238934 | 0.064574 | No Change: Both O | - |
| Q14571 | ITPR2_HUMAN Inositol 1 4 5-trisphosphate receptor type 2 OS=Homo sapiens GN=ITPR2 PE=1 SV=2 | 1143 | E | 0.843205 | D | 0.808822 | 0.034383 | No Change: Both D | - |
| Q14571 | ITPR2_HUMAN Inositol 1 4 5-trisphosphate receptor type 2 OS=Homo sapiens GN=ITPR2 PE=1 SV=2 | 1898 | A | 0.689126 | V | 0.615528 | 0.073598 | No Change: Both D | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 667 | R | 0.254847 | Q | 0.259319 | -0.004472 | No Change: Both O | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 742 | D | 0.078849 | E | 0.086859 | -0.00801 | No Change: Both O | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 1029 | G | 0.494436 | V | 0.368639 | 0.125797 | No Change: Both O | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 1552 | L | 0.616867 | V | 0.598907 | 0.01796 | No Change: Both D | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 1850 | R | 0.826338 | Q | 0.82104 | 0.005298 | No Change: Both D | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 2398 | E | 0.20271 | Q | 0.170583 | 0.032127 | No Change: Both O | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 2436 | L | 0.532167 | V | 0.538603 | -0.006436 | No Change: Both D | - |
| Q14573 | ITPR3_HUMAN Inositol 1 4 5-trisphosphate receptor type 3 OS=Homo sapiens GN=ITPR3 PE=1 SV=2 | 374 | L | 0.453679 | W | 0.354967 | 0.098712 | No Change: Both O | - |
| Q6GPH6 | IPIL1_HUMAN Inositol 1 4 5-triphosphate receptor-interacting protein-like 1 OS=Homo sapiens GN=ITPRIPL1 PE=1 SV=1 | 280 | G | 0.315101 | R | 0.35596 | -0.040859 | No Change: Both O | - |
| Q6GPH6 | IPIL1_HUMAN Inositol 1 4 5-triphosphate receptor-interacting protein-like 1 OS=Homo sapiens GN=ITPRIPL1 PE=1 SV=1 | 428 | S | 0.205115 | C | 0.083664 | 0.121451 | No Change: Both O | - |
| Q6GPH6 | IPIL1_HUMAN Inositol 1 4 5-triphosphate receptor-interacting protein-like 1 OS=Homo sapiens GN=ITPRIPL1 PE=1 SV=1 | 463 | T | 0.163165 | M | 0.150887 | 0.012278 | No Change: Both O | - |
| Q3MIP1 | IPIL2_HUMAN Inositol 1 4 5-triphosphate receptor-interacting protein-like 2 OS=Homo sapiens GN=ITPRIPL2 PE=2 SV=1 | 237 | C | 0.172687 | S | 0.316573 | -0.143886 | No Change: Both O | - |
| Q3MIP1 | IPIL2_HUMAN Inositol 1 4 5-triphosphate receptor-interacting protein-like 2 OS=Homo sapiens GN=ITPRIPL2 PE=2 SV=1 | 522 | P | 0.868769 | S | 0.851129 | 0.01764 | No Change: Both D | - |
| Q9NZM3 | ITSN2_HUMAN Intersectin-2 OS=Homo sapiens GN=ITSN2 PE=1 SV=3 | 1287 | I | 0.175362 | T | 0.273251 | -0.097889 | No Change: Both O | - |
| Q9NZM3 | ITSN2_HUMAN Intersectin-2 OS=Homo sapiens GN=ITSN2 PE=1 SV=3 | 1534 | A | 0.322178 | T | 0.359496 | -0.037318 | No Change: Both O | - |
| Q9NZM3 | ITSN2_HUMAN Intersectin-2 OS=Homo sapiens GN=ITSN2 PE=1 SV=3 | 254 | T | 0.55884 | A | 0.527254 | 0.031586 | No Change: Both D | - |
| Q9NZM3 | ITSN2_HUMAN Intersectin-2 OS=Homo sapiens GN=ITSN2 PE=1 SV=3 | 291 | V | 0.243314 | I | 0.234942 | 0.008372 | No Change: Both O | - |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 42 | L | 0.532027 | P | 0.64981 | -0.117783 | No Change: Both D | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 199 | G | 0.14904 | V | 0.088151 | 0.060889 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 50 | R | 0.565876 | P | 0.588967 | -0.023091 | No Change: Both D | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 69 | D | 0.554349 | N | 0.561146 | -0.006797 | No Change: Both D | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 311 | A | 0.229559 | V | 0.181463 | 0.048096 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 357 | C | 0.149883 | R | 0.261068 | -0.111185 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 371 | V | 0.115133 | A | 0.177042 | -0.061909 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 392 | R | 0.156981 | C | 0.071074 | 0.085907 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P26440 | IVD_HUMAN Isovaleryl-CoA dehydrogenase mitochondrial OS=Homo sapiens GN=IVD PE=1 SV=1 | 411 | R | 0.210281 | L | 0.125692 | 0.084589 | No Change: Both O | Isovaleric acidemia (IVA) [MIM:243500] |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 113 | T | 0.997109 | A | 0.997111 | -2.00E-06 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 166 | L | 0.996294 | P | 0.997442 | -0.001148 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 174 | K | 0.998775 | E | 0.998973 | -1.98E-04 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 237 | Q | 0.999681 | E | 0.999681 | 0 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 312 | Q | 0.998607 | K | 0.998436 | 1.71E-04 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 480 | V | 0.997404 | L | 0.997876 | -4.72E-04 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 227 | E | 0.999824 | Q | 0.999826 | -2.00E-06 | No Change: Both D | - |
| P07476 | INVO_HUMAN Involucrin OS=Homo sapiens GN=IVL PE=1 SV=2 | 236 | P | 0.999696 | S | 0.999697 | -1.00E-06 | No Change: Both D | - |
| Q96ST2 | IWS1_HUMAN Protein IWS1 homolog OS=Homo sapiens GN=IWS1 PE=1 SV=2 | 390 | A | 0.997679 | V | 0.997039 | 6.40E-04 | No Change: Both D | - |
| Q96ST2 | IWS1_HUMAN Protein IWS1 homolog OS=Homo sapiens GN=IWS1 PE=1 SV=2 | 425 | V | 0.996097 | I | 0.995649 | 4.48E-04 | No Change: Both D | - |
| Q6PHW0 | IYD1_HUMAN Iodotyrosine dehalogenase 1 OS=Homo sapiens GN=IYD PE=1 SV=2 | 260 | L | 0.294866 | P | 0.463551 | -0.168685 | No Change: Both O | - |
| Q6PHW0 | IYD1_HUMAN Iodotyrosine dehalogenase 1 OS=Homo sapiens GN=IYD PE=1 SV=2 | 101 | R | 0.390243 | W | 0.171252 | 0.218991 | No Change: Both O | Thyroid dyshormonogenesis 4 (TDH4) [MIM:274800] |
| Q6PHW0 | IYD1_HUMAN Iodotyrosine dehalogenase 1 OS=Homo sapiens GN=IYD PE=1 SV=2 | 116 | I | 0.230639 | T | 0.354005 | -0.123366 | No Change: Both O | Thyroid dyshormonogenesis 4 (TDH4) [MIM:274800] |
| Q6PHW0 | IYD1_HUMAN Iodotyrosine dehalogenase 1 OS=Homo sapiens GN=IYD PE=1 SV=2 | 271 | E | 0.541606 | K | 0.577794 | -0.036188 | No Change: Both D | - |
| Q8IYV9 | IZUM1_HUMAN Izumo sperm-egg fusion protein 1 OS=Homo sapiens GN=IZUMO1 PE=1 SV=2 | 333 | A | 0.573545 | V | 0.492982 | 0.080563 | D to O | - |
| Q6UXV1 | IZUM2_HUMAN Izumo sperm-egg fusion protein 2 OS=Homo sapiens GN=IZUMO2 PE=1 SV=1 | 139 | R | 0.181029 | C | 0.116166 | 0.064863 | No Change: Both O | - |
| Q1ZYL8 | IZUM4_HUMAN Izumo sperm-egg fusion protein 4 OS=Homo sapiens GN=IZUMO4 PE=2 SV=2 | 2 | A | 0.221959 | T | 0.260925 | -0.038966 | No Change: Both O | - |
| Q1ZYL8 | IZUM4_HUMAN Izumo sperm-egg fusion protein 4 OS=Homo sapiens GN=IZUMO4 PE=2 SV=2 | 38 | F | 0.121932 | L | 0.131791 | -0.009859 | No Change: Both O | - |
| Q1ZYL8 | IZUM4_HUMAN Izumo sperm-egg fusion protein 4 OS=Homo sapiens GN=IZUMO4 PE=2 SV=2 | 137 | Y | 0.124563 | F | 0.124802 | -2.39E-04 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 37 | L | 0.408654 | S | 0.551626 | -0.142972 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 79 | L | 0.359733 | H | 0.431988 | -0.072255 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 127 | A | 0.098595 | T | 0.119056 | -0.020461 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 129 | P | 0.109146 | R | 0.095365 | 0.013781 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 152 | I | 0.59244 | T | 0.688809 | -0.096369 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 163 | P | 0.535297 | L | 0.361957 | 0.17334 | D to O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 184 | R | 0.090898 | C | 0.04762 | 0.043278 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 184 | R | 0.090898 | G | 0.096861 | -0.005963 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 184 | R | 0.090898 | H | 0.09631 | -0.005412 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 184 | R | 0.090898 | L | 0.051241 | 0.039657 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 187 | C | 0.081884 | S | 0.201469 | -0.119585 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 220 | C | 0.478559 | F | 0.426051 | 0.052508 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 229 | C | 0.531088 | G | 0.589996 | -0.058908 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 229 | C | 0.531088 | Y | 0.424305 | 0.106783 | D to O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 274 | G | 0.194787 | D | 0.207791 | -0.013004 | No Change: Both O | Tetralogy of Fallot (TOF) [MIM:187500] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 284 | C | 0.183299 | F | 0.118591 | 0.064708 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 288 | W | 0.315004 | C | 0.472768 | -0.157764 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 386 | G | 0.677392 | R | 0.640033 | 0.037359 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 438 | C | 0.154581 | F | 0.091791 | 0.06279 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 731 | C | 0.489212 | S | 0.571576 | -0.082364 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 740 | C | 0.459201 | R | 0.520402 | -0.061201 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 753 | C | 0.478359 | R | 0.540035 | -0.061676 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 31 | A | 0.39727 | V | 0.323147 | 0.074123 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 33 | G | 0.391214 | D | 0.368101 | 0.023113 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 33 | G | 0.391214 | S | 0.443546 | -0.052332 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 33 | G | 0.391214 | V | 0.278168 | 0.113046 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 39 | I | 0.404978 | S | 0.640656 | -0.235678 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 40 | L | 0.391705 | P | 0.511381 | -0.119676 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 45 | V | 0.469896 | L | 0.509596 | -0.0397 | O to D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 53 | N | 0.476747 | D | 0.469369 | 0.007378 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 65 | K | 0.624307 | M | 0.523501 | 0.100806 | No Change: Both D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 75 | F | 0.399836 | S | 0.594161 | -0.194325 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 78 | C | 0.384404 | S | 0.49407 | -0.109666 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 92 | C | 0.53327 | R | 0.639622 | -0.106352 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 92 | C | 0.53327 | Y | 0.547849 | -0.014579 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 120 | I | 0.229179 | N | 0.375126 | -0.145947 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 123 | P | 0.115219 | S | 0.128278 | -0.013059 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 155 | A | 0.609125 | P | 0.688462 | -0.079337 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 163 | P | 0.535297 | R | 0.510666 | 0.024631 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 181 | Y | 0.115852 | N | 0.209233 | -0.093381 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 187 | C | 0.081884 | Y | 0.10988 | -0.027996 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 203 | R | 0.256563 | K | 0.312761 | -0.056198 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 224 | W | 0.561666 | C | 0.735196 | -0.17353 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 234 | C | 0.467091 | Y | 0.38775 | 0.079341 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 252 | R | 0.4327 | G | 0.450868 | -0.018168 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 256 | G | 0.388425 | S | 0.407892 | -0.019467 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 269 | P | 0.24301 | L | 0.129636 | 0.113374 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 271 | C | 0.216075 | R | 0.275341 | -0.059266 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 504 | N | 0.519103 | S | 0.5312 | -0.012097 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 690 | Y | 0.45609 | D | 0.644572 | -0.188482 | O to D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 693 | C | 0.5023 | Y | 0.399551 | 0.102749 | D to O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 714 | C | 0.579697 | Y | 0.523743 | 0.055954 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 818 | R | 0.351291 | K | 0.34602 | 0.005271 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 871 | P | 0.377494 | R | 0.342085 | 0.035409 | No Change: Both O | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 889 | R | 0.317058 | Q | 0.329952 | -0.012894 | No Change: Both O | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 902 | C | 0.377339 | S | 0.515455 | -0.138116 | O to D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 908 | H | 0.621055 | Q | 0.653222 | -0.032167 | No Change: Both D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 911 | C | 0.655983 | Y | 0.595989 | 0.059994 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 913 | S | 0.633852 | R | 0.585726 | 0.048126 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 921 | L | 0.587444 | P | 0.739514 | -0.15207 | No Change: Both D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 937 | R | 0.593222 | Q | 0.652553 | -0.059331 | No Change: Both D | Alagille syndrome type 1 (ALGS1) [MIM:118450] |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 1213 | R | 0.59085 | Q | 0.610809 | -0.019959 | No Change: Both D | - |
| P78504 | JAG1_HUMAN Protein jagged-1 OS=Homo sapiens GN=JAG1 PE=1 SV=3 | 146 | V | 0.531725 | I | 0.525491 | 0.006234 | No Change: Both D | - |
| Q9Y219 | JAG2_HUMAN Protein jagged-2 OS=Homo sapiens GN=JAG2 PE=1 SV=3 | 501 | E | 0.769296 | K | 0.737181 | 0.032115 | No Change: Both D | - |
| Q9Y219 | JAG2_HUMAN Protein jagged-2 OS=Homo sapiens GN=JAG2 PE=1 SV=3 | 538 | D | 0.52256 | N | 0.483365 | 0.039195 | D to O | - |
| P23458 | JAK1_HUMAN Tyrosine-protein kinase JAK1 OS=Homo sapiens GN=JAK1 PE=1 SV=2 | 973 | N | 0.611899 | K | 0.651289 | -0.03939 | No Change: Both D | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 539 | K | 0.259943 | L | 0.146076 | 0.113867 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 607 | K | 0.417028 | N | 0.376321 | 0.040707 | No Change: Both O | Acute myelogenous leukemia (AML) [MIM:601626] |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 617 | V | 0.05484 | F | 0.044638 | 0.010202 | No Change: Both O | Acute myelogenous leukemia (AML) [MIM:601626] |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 617 | V | 0.05484 | F | 0.044638 | 0.010202 | No Change: Both O | Polycythemia vera (PV) [MIM:263300] |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 127 | G | 0.30214 | D | 0.320021 | -0.017881 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 191 | K | 0.465236 | Q | 0.432126 | 0.03311 | No Change: Both O | An ovarian serous carcinoma sample |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 346 | K | 0.44988 | R | 0.376436 | 0.073444 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 377 | A | 0.192229 | E | 0.267165 | -0.074936 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 393 | L | 0.305371 | V | 0.328871 | -0.0235 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 1063 | R | 0.351203 | H | 0.35515 | -0.003947 | No Change: Both O | - |
| O60674 | JAK2_HUMAN Tyrosine-protein kinase JAK2 OS=Homo sapiens GN=JAK2 PE=1 SV=2 | 584 | D | 0.329423 | E | 0.375105 | -0.045682 | No Change: Both O | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 100 | Y | 0.041443 | C | 0.030673 | 0.01077 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 151 | P | 0.414781 | R | 0.411042 | 0.003739 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 481 | E | 0.51142 | G | 0.479435 | 0.031985 | D to O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 582 | R | 0.204148 | W | 0.087369 | 0.116779 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 722 | V | 0.134506 | I | 0.118155 | 0.016351 | No Change: Both O | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 759 | C | 0.146629 | R | 0.263973 | -0.117344 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 910 | L | 0.226514 | S | 0.395761 | -0.169247 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 132 | P | 0.134319 | T | 0.104267 | 0.030052 | No Change: Both O | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 169 | D | 0.461844 | E | 0.529376 | -0.067532 | O to D | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 589 | G | 0.105179 | S | 0.13333 | -0.028151 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-negative (T(-)B(+)NK(-) SCID) [MIM:600802] |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 12 | P | 0.871998 | L | 0.778778 | 0.09322 | No Change: Both D | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 40 | R | 0.581697 | H | 0.580381 | 0.001316 | No Change: Both D | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 521 | L | 0.363095 | V | 0.34987 | 0.013225 | No Change: Both O | - |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 527 | L | 0.386364 | P | 0.517629 | -0.131265 | O to D | A gastric adenocarcinoma sample |
| P52333 | JAK3_HUMAN Tyrosine-protein kinase JAK3 OS=Homo sapiens GN=JAK3 PE=1 SV=2 | 688 | I | 0.151083 | F | 0.153239 | -0.002156 | No Change: Both O | - |
| Q96N16 | JKIP1_HUMAN Janus kinase and microtubule-interacting protein 1 OS=Homo sapiens GN=JAKMIP1 PE=1 SV=1 | 251 | K | 0.82102 | R | 0.804479 | 0.016541 | No Change: Both D | - |
| Q96N16 | JKIP1_HUMAN Janus kinase and microtubule-interacting protein 1 OS=Homo sapiens GN=JAKMIP1 PE=1 SV=1 | 375 | A | 0.823406 | V | 0.7853 | 0.038106 | No Change: Both D | A colorectal cancer sample |
| Q96AA8 | JKIP2_HUMAN Janus kinase and microtubule-interacting protein 2 OS=Homo sapiens GN=JAKMIP2 PE=2 SV=1 | 106 | V | 0.692017 | I | 0.676207 | 0.01581 | No Change: Both D | - |
| Q96AA8 | JKIP2_HUMAN Janus kinase and microtubule-interacting protein 2 OS=Homo sapiens GN=JAKMIP2 PE=2 SV=1 | 315 | R | 0.875244 | C | 0.808197 | 0.067047 | No Change: Both D | A colorectal cancer sample |
| Q5VZ66 | JKIP3_HUMAN Janus kinase and microtubule-interacting protein 3 OS=Homo sapiens GN=JAKMIP3 PE=2 SV=2 | 795 | R | 0.927255 | G | 0.885696 | 0.041559 | No Change: Both D | A breast cancer sample |
| Q5VZ66 | JKIP3_HUMAN Janus kinase and microtubule-interacting protein 3 OS=Homo sapiens GN=JAKMIP3 PE=2 SV=2 | 493 | M | 0.867176 | V | 0.812483 | 0.054693 | No Change: Both D | - |
| P57087 | JAM2_HUMAN Junctional adhesion molecule B OS=Homo sapiens GN=JAM2 PE=1 SV=1 | 286 | S | 0.884669 | R | 0.83766 | 0.047009 | No Change: Both D | - |
| Q8WYK2 | JDP2_HUMAN Jun dimerization protein 2 OS=Homo sapiens GN=JDP2 PE=1 SV=1 | 13 | T | 0.727499 | A | 0.678702 | 0.048797 | No Change: Both D | - |
| Q6ZMT4 | KDM7_HUMAN Lysine-specific demethylase 7 OS=Homo sapiens GN=JHDM1D PE=1 SV=2 | 392 | D | 0.291093 | Y | 0.170741 | 0.120352 | No Change: Both O | - |
| Q6ZMT4 | KDM7_HUMAN Lysine-specific demethylase 7 OS=Homo sapiens GN=JHDM1D PE=1 SV=2 | 644 | R | 0.885716 | S | 0.9074 | -0.021684 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 272 | A | 0.660117 | T | 0.679671 | -0.019554 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 394 | E | 0.992359 | D | 0.991068 | 0.001291 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 464 | S | 0.913031 | T | 0.885448 | 0.027583 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 1393 | N | 0.735689 | Y | 0.561588 | 0.174101 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 2400 | D | 0.282938 | E | 0.305664 | -0.022726 | No Change: Both O | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 2535 | E | 0.751141 | D | 0.736067 | 0.015074 | No Change: Both D | - |
| Q15652 | JHD2C_HUMAN Probable JmjC domain-containing histone demethylation protein 2C OS=Homo sapiens GN=JMJD1C PE=1 SV=2 | 591 | M | 0.668052 | V | 0.630025 | 0.038027 | No Change: Both D | - |
| Q9H9V9 | JMJD4_HUMAN JmjC domain-containing protein 4 OS=Homo sapiens GN=JMJD4 PE=2 SV=2 | 11 | A | 0.782411 | V | 0.712597 | 0.069814 | No Change: Both D | - |
| Q9H9V9 | JMJD4_HUMAN JmjC domain-containing protein 4 OS=Homo sapiens GN=JMJD4 PE=2 SV=2 | 16 | G | 0.654979 | C | 0.53937 | 0.115609 | No Change: Both D | - |
| Q9H9V9 | JMJD4_HUMAN JmjC domain-containing protein 4 OS=Homo sapiens GN=JMJD4 PE=2 SV=2 | 65 | D | 0.368946 | E | 0.389374 | -0.020428 | No Change: Both O | - |
| Q9H9V9 | JMJD4_HUMAN JmjC domain-containing protein 4 OS=Homo sapiens GN=JMJD4 PE=2 SV=2 | 461 | A | 0.86552 | V | 0.810367 | 0.055153 | No Change: Both D | - |
| Q8N371 | KDM8_HUMAN Lysine-specific demethylase 8 OS=Homo sapiens GN=JMJD5 PE=1 SV=1 | 302 | E | 0.506421 | D | 0.478753 | 0.027668 | D to O | - |
| P0C870 | JMJD7_HUMAN JmjC domain-containing protein 7 OS=Homo sapiens GN=JMJD7 PE=2 SV=1 | 28 | A | 0.193412 | G | 0.195331 | -0.001919 | No Change: Both O | - |
| Q8N9B5 | JMY_HUMAN Junction-mediating and -regulatory protein OS=Homo sapiens GN=JMY PE=1 SV=2 | 364 | M | 0.499952 | L | 0.447817 | 0.052135 | No Change: Both O | - |
| Q8N9B5 | JMY_HUMAN Junction-mediating and -regulatory protein OS=Homo sapiens GN=JMY PE=1 SV=2 | 592 | A | 0.836685 | V | 0.77649 | 0.060195 | No Change: Both D | - |
| Q8N9B5 | JMY_HUMAN Junction-mediating and -regulatory protein OS=Homo sapiens GN=JMY PE=1 SV=2 | 720 | H | 0.693588 | R | 0.745071 | -0.051483 | No Change: Both D | - |
| Q15040 | JOS1_HUMAN Josephin-1 OS=Homo sapiens GN=JOSD1 PE=1 SV=1 | 48 | S | 0.377924 | R | 0.356537 | 0.021387 | No Change: Both O | - |
| Q9HDC5 | JPH1_HUMAN Junctophilin-1 OS=Homo sapiens GN=JPH1 PE=1 SV=2 | 507 | T | 0.745943 | M | 0.756133 | -0.01019 | No Change: Both D | - |
| Q9HDC5 | JPH1_HUMAN Junctophilin-1 OS=Homo sapiens GN=JPH1 PE=1 SV=2 | 624 | D | 0.7967 | H | 0.781957 | 0.014743 | No Change: Both D | - |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 396 | A | 0.921241 | T | 0.914471 | 0.00677 | No Change: Both D | - |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 101 | S | 0.656267 | R | 0.616533 | 0.039734 | No Change: Both D | Familial hypertrophic cardiomyopathy type 17 (CMH17) [MIM:613873] |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 141 | Y | 0.434289 | H | 0.541878 | -0.107589 | O to D | Familial hypertrophic cardiomyopathy type 17 (CMH17) [MIM:613873] |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 165 | S | 0.841181 | F | 0.712747 | 0.128434 | No Change: Both D | Familial hypertrophic cardiomyopathy type 17 (CMH17) [MIM:613873] |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 436 | R | 0.764892 | C | 0.658353 | 0.106539 | No Change: Both D | - |
| Q9BR39 | JPH2_HUMAN Junctophilin-2 OS=Homo sapiens GN=JPH2 PE=1 SV=2 | 505 | G | 0.989719 | S | 0.991663 | -0.001944 | No Change: Both D | - |
| Q8WXH2 | JPH3_HUMAN Junctophilin-3 OS=Homo sapiens GN=JPH3 PE=1 SV=2 | 376 | I | 0.868561 | T | 0.904087 | -0.035526 | No Change: Both D | - |
| Q8WXH2 | JPH3_HUMAN Junctophilin-3 OS=Homo sapiens GN=JPH3 PE=1 SV=2 | 472 | P | 0.971322 | T | 0.962589 | 0.008733 | No Change: Both D | - |
| Q8WXH2 | JPH3_HUMAN Junctophilin-3 OS=Homo sapiens GN=JPH3 PE=1 SV=2 | 645 | P | 0.8712 | L | 0.798101 | 0.073099 | No Change: Both D | - |
| Q96MG2 | JSPR1_HUMAN Junctional sarcoplasmic reticulum protein 1 OS=Homo sapiens GN=JSRP1 PE=2 SV=1 | 92 | V | 0.991623 | A | 0.995207 | -0.003584 | No Change: Both D | - |
| Q96MG2 | JSPR1_HUMAN Junctional sarcoplasmic reticulum protein 1 OS=Homo sapiens GN=JSRP1 PE=2 SV=1 | 233 | R | 0.996183 | Q | 0.994613 | 0.00157 | No Change: Both D | - |
| O76095 | JTB_HUMAN Protein JTB OS=Homo sapiens GN=JTB PE=1 SV=1 | 16 | L | 0.139874 | F | 0.103622 | 0.036252 | No Change: Both O | - |
| P05412 | JUN_HUMAN Transcription factor AP-1 OS=Homo sapiens GN=JUN PE=1 SV=2 | 297 | T | 0.789386 | M | 0.802995 | -0.013609 | No Change: Both D | - |
| P17275 | JUNB_HUMAN Transcription factor jun-B OS=Homo sapiens GN=JUNB PE=1 SV=1 | 230 | L | 0.742384 | V | 0.725147 | 0.017237 | No Change: Both D | - |
| P17535 | JUND_HUMAN Transcription factor jun-D OS=Homo sapiens GN=JUND PE=1 SV=3 | 20 | G | 0.92193 | V | 0.835428 | 0.086502 | No Change: Both D | - |
| P14923 | PLAK_HUMAN Junction plakoglobin OS=Homo sapiens GN=JUP PE=1 SV=3 | 697 | M | 0.595282 | L | 0.509457 | 0.085825 | No Change: Both D | - |
| P14923 | PLAK_HUMAN Junction plakoglobin OS=Homo sapiens GN=JUP PE=1 SV=3 | 19 | T | 0.281157 | I | 0.172965 | 0.108192 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 12 (ARVD12) [MIM:611528] |
| P14923 | PLAK_HUMAN Junction plakoglobin OS=Homo sapiens GN=JUP PE=1 SV=3 | 142 | R | 0.341306 | H | 0.33751 | 0.003796 | No Change: Both O | - |
| P14923 | PLAK_HUMAN Junction plakoglobin OS=Homo sapiens GN=JUP PE=1 SV=3 | 648 | V | 0.160173 | I | 0.15547 | 0.004703 | No Change: Both O | - |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 267 | N | 0.308483 | K | 0.358529 | -0.050046 | No Change: Both O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 534 | V | 0.556421 | I | 0.510142 | 0.046279 | No Change: Both D | - |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 514 | E | 0.537705 | K | 0.569129 | -0.031424 | No Change: Both D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 163 | C | 0.688398 | Y | 0.588986 | 0.099412 | No Change: Both D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 172 | C | 0.507317 | R | 0.578658 | -0.071341 | No Change: Both D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 262 | R | 0.229986 | P | 0.24922 | -0.019234 | No Change: Both O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 304 | N | 0.582661 | S | 0.622056 | -0.039395 | No Change: Both D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 396 | S | 0.501808 | L | 0.321002 | 0.180806 | D to O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 517 | F | 0.395933 | L | 0.413454 | -0.017521 | No Change: Both O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 571 | W | 0.188725 | R | 0.361862 | -0.173137 | No Change: Both O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 666 | K | 0.961016 | M | 0.944896 | 0.01612 | No Change: Both D | - |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 668 | R | 0.968419 | H | 0.967344 | 0.001075 | No Change: Both D | - |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 134 | C | 0.451181 | G | 0.518508 | -0.067327 | O to D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 163 | C | 0.688398 | R | 0.71201 | -0.023612 | No Change: Both D | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| P23352 | KALM_HUMAN Anosmin-1 OS=Homo sapiens GN=KAL1 PE=1 SV=3 | 539 | E | 0.388057 | K | 0.415269 | -0.027212 | No Change: Both O | Kallmann syndrome type 1 (KAL1) [MIM:308700] |
| O60229 | KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | 1326 | E | 0.210761 | D | 0.186859 | 0.023902 | No Change: Both O | - |
| O60229 | KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | 1896 | S | 0.74696 | C | 0.660438 | 0.086522 | No Change: Both D | A breast cancer sample |
| O60229 | KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | 213 | R | 0.415461 | W | 0.200204 | 0.215257 | No Change: Both O | A colorectal cancer sample |
| O60229 | KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | 196 | S | 0.305022 | L | 0.180603 | 0.124419 | No Change: Both O | - |
| O60229 | KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | 1929 | R | 0.461844 | M | 0.440159 | 0.021685 | No Change: Both O | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 464 | S | 0.654744 | A | 0.586075 | 0.068669 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 206 | N | 0.772025 | K | 0.776714 | -0.004689 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 432 | E | 0.23938 | Q | 0.199148 | 0.040232 | No Change: Both O | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 210 | H | 0.770823 | Q | 0.811937 | -0.041114 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 321 | K | 0.702983 | R | 0.715507 | -0.012524 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 664 | A | 0.599293 | V | 0.533507 | 0.065786 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 667 | R | 0.654145 | H | 0.630369 | 0.023776 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 901 | N | 0.623402 | S | 0.688771 | -0.065369 | No Change: Both D | - |
| Q14678 | KANK1_HUMAN KN motif and ankyrin repeat domain-containing protein 1 OS=Homo sapiens GN=KANK1 PE=1 SV=3 | 1055 | I | 0.828566 | T | 0.87748 | -0.048914 | No Change: Both D | - |
| Q63ZY3 | KANK2_HUMAN KN motif and ankyrin repeat domain-containing protein 2 OS=Homo sapiens GN=KANK2 PE=1 SV=1 | 118 | G | 0.515004 | S | 0.548757 | -0.033753 | No Change: Both D | - |
| Q63ZY3 | KANK2_HUMAN KN motif and ankyrin repeat domain-containing protein 2 OS=Homo sapiens GN=KANK2 PE=1 SV=1 | 401 | M | 0.661097 | T | 0.673254 | -0.012157 | No Change: Both D | - |
| Q6NY19 | KANK3_HUMAN KN motif and ankyrin repeat domain-containing protein 3 OS=Homo sapiens GN=KANK3 PE=2 SV=1 | 288 | D | 0.887757 | Y | 0.785884 | 0.101873 | No Change: Both D | - |
| Q6NY19 | KANK3_HUMAN KN motif and ankyrin repeat domain-containing protein 3 OS=Homo sapiens GN=KANK3 PE=2 SV=1 | 359 | R | 0.79 | H | 0.751642 | 0.038358 | No Change: Both D | - |
| Q6NY19 | KANK3_HUMAN KN motif and ankyrin repeat domain-containing protein 3 OS=Homo sapiens GN=KANK3 PE=2 SV=1 | 485 | A | 0.988418 | T | 0.98882 | -4.02E-04 | No Change: Both D | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 822 | H | 0.378211 | R | 0.36459 | 0.013621 | No Change: Both O | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 840 | V | 0.193933 | A | 0.24774 | -0.053807 | No Change: Both O | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 935 | V | 0.38097 | L | 0.404059 | -0.023089 | No Change: Both O | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 701 | G | 0.946399 | S | 0.954899 | -0.0085 | No Change: Both D | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 768 | T | 0.645192 | A | 0.598064 | 0.047128 | No Change: Both D | - |
| Q5T7N3 | KANK4_HUMAN KN motif and ankyrin repeat domain-containing protein 4 OS=Homo sapiens GN=KANK4 PE=1 SV=1 | 987 | A | 0.558233 | V | 0.411648 | 0.146585 | D to O | - |
| Q15046 | SYK_HUMAN Lysine--tRNA ligase OS=Homo sapiens GN=KARS PE=1 SV=3 | 595 | T | 0.836299 | S | 0.84849 | -0.012191 | No Change: Both D | - |
| Q15046 | SYK_HUMAN Lysine--tRNA ligase OS=Homo sapiens GN=KARS PE=1 SV=3 | 179 | G | 0.318467 | A | 0.243051 | 0.075416 | No Change: Both O | - |
| Q15046 | SYK_HUMAN Lysine--tRNA ligase OS=Homo sapiens GN=KARS PE=1 SV=3 | 105 | L | 0.195131 | H | 0.32078 | -0.125649 | No Change: Both O | Charcot-Marie-Tooth disease recessive intermediate type B (CMTRIB) [MIM:613641] |
| Q15046 | SYK_HUMAN Lysine--tRNA ligase OS=Homo sapiens GN=KARS PE=1 SV=3 | 274 | I | 0.240457 | M | 0.33529 | -0.094833 | No Change: Both O | Charcot-Marie-Tooth disease recessive intermediate type B (CMTRIB) [MIM:613641] |
| Q92831 | KAT2B_HUMAN Histone acetyltransferase KAT2B OS=Homo sapiens GN=KAT2B PE=1 SV=3 | 386 | N | 0.662098 | S | 0.724326 | -0.062228 | No Change: Both D | - |
| Q92993 | KAT5_HUMAN Histone acetyltransferase KAT5 OS=Homo sapiens GN=KAT5 PE=1 SV=2 | 78 | P | 0.817843 | T | 0.792363 | 0.02548 | No Change: Both D | - |
| Q92794 | KAT6A_HUMAN Histone acetyltransferase KAT6A OS=Homo sapiens GN=KAT6A PE=1 SV=2 | 134 | L | 0.467904 | S | 0.630534 | -0.16263 | O to D | - |
| Q8WYB5 | KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens GN=KAT6B PE=1 SV=3 | 483 | T | 0.945338 | A | 0.932652 | 0.012686 | No Change: Both D | A breast cancer sample |
| Q8WYB5 | KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens GN=KAT6B PE=1 SV=3 | 1499 | V | 0.981124 | I | 0.975368 | 0.005756 | No Change: Both D | - |
| Q8WYB5 | KAT6B_HUMAN Histone acetyltransferase KAT6B OS=Homo sapiens GN=KAT6B PE=1 SV=3 | 1217 | A | 0.957661 | S | 0.972667 | -0.015006 | No Change: Both D | - |
| Q8IYT4 | KATL2_HUMAN Katanin p60 ATPase-containing subunit A-like 2 OS=Homo sapiens GN=KATNAL2 PE=2 SV=3 | 160 | S | 0.595473 | N | 0.572423 | 0.02305 | No Change: Both D | - |
| Q9BVA0 | KTNB1_HUMAN Katanin p80 WD40-containing subunit B1 OS=Homo sapiens GN=KATNB1 PE=1 SV=1 | 181 | M | 0.379773 | V | 0.31428 | 0.065493 | No Change: Both O | - |
| Q96I82 | KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 OS=Homo sapiens GN=KAZALD1 PE=1 SV=1 | 76 | C | 0.509532 | G | 0.532167 | -0.022635 | No Change: Both D | - |
| Q96I82 | KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 OS=Homo sapiens GN=KAZALD1 PE=1 SV=1 | 236 | G | 0.174204 | D | 0.189766 | -0.015562 | No Change: Both O | - |
| Q96I82 | KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 OS=Homo sapiens GN=KAZALD1 PE=1 SV=1 | 255 | G | 0.259904 | A | 0.220996 | 0.038908 | No Change: Both O | - |
| Q96I82 | KAZD1_HUMAN Kazal-type serine protease inhibitor domain-containing protein 1 OS=Homo sapiens GN=KAZALD1 PE=1 SV=1 | 256 | R | 0.279288 | H | 0.225751 | 0.053537 | No Change: Both O | - |
| Q674X7 | KAZRN_HUMAN Kazrin OS=Homo sapiens GN=KAZN PE=1 SV=2 | 706 | A | 0.871742 | T | 0.882652 | -0.01091 | No Change: Both D | - |
| Q674X7 | KAZRN_HUMAN Kazrin OS=Homo sapiens GN=KAZN PE=1 SV=2 | 763 | R | 0.716296 | C | 0.631501 | 0.084795 | No Change: Both D | - |
| O60662 | KBTBA_HUMAN Kelch repeat and BTB domain-containing protein 10 OS=Homo sapiens GN=KBTBD10 PE=1 SV=2 | 271 | A | 0.719584 | T | 0.728446 | -0.008862 | No Change: Both D | - |
| O60662 | KBTBA_HUMAN Kelch repeat and BTB domain-containing protein 10 OS=Homo sapiens GN=KBTBD10 PE=1 SV=2 | 481 | M | 0.320403 | V | 0.255201 | 0.065202 | No Change: Both O | - |
| Q3ZCT8 | KBTBC_HUMAN Kelch repeat and BTB domain-containing protein 12 OS=Homo sapiens GN=KBTBD12 PE=2 SV=2 | 22 | Q | 0.399603 | K | 0.470076 | -0.070473 | No Change: Both O | - |
| C9JR72 | KBTBD_HUMAN Kelch repeat and BTB domain-containing protein 13 OS=Homo sapiens GN=KBTBD13 PE=1 SV=1 | 248 | R | 0.484421 | S | 0.553568 | -0.069147 | O to D | Nemaline myopathy type 6 (NEM6) [MIM:609273] |
| C9JR72 | KBTBD_HUMAN Kelch repeat and BTB domain-containing protein 13 OS=Homo sapiens GN=KBTBD13 PE=1 SV=1 | 390 | K | 0.269596 | N | 0.244655 | 0.024941 | No Change: Both O | Nemaline myopathy type 6 (NEM6) [MIM:609273] |
| C9JR72 | KBTBD_HUMAN Kelch repeat and BTB domain-containing protein 13 OS=Homo sapiens GN=KBTBD13 PE=1 SV=1 | 408 | R | 0.073746 | C | 0.033293 | 0.040453 | No Change: Both O | Nemaline myopathy type 6 (NEM6) [MIM:609273] |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 166 | Q | 0.233751 | K | 0.260973 | -0.027222 | No Change: Both O | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 189 | E | 0.617736 | G | 0.571709 | 0.046027 | No Change: Both D | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 193 | T | 0.49006 | P | 0.532087 | -0.042027 | O to D | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 254 | P | 0.397862 | R | 0.351995 | 0.045867 | No Change: Both O | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 301 | P | 0.360405 | R | 0.297968 | 0.062437 | No Change: Both O | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 534 | L | 0.086151 | I | 0.080365 | 0.005786 | No Change: Both O | - |
| Q8IY47 | KBTB2_HUMAN Kelch repeat and BTB domain-containing protein 2 OS=Homo sapiens GN=KBTBD2 PE=2 SV=2 | 594 | S | 0.514245 | Y | 0.330664 | 0.183581 | D to O | - |
| Q8NAB2 | KBTB3_HUMAN Kelch repeat and BTB domain-containing protein 3 OS=Homo sapiens GN=KBTBD3 PE=2 SV=2 | 189 | M | 0.214497 | V | 0.175318 | 0.039179 | No Change: Both O | - |
| Q9NVX7 | KBTB4_HUMAN Kelch repeat and BTB domain-containing protein 4 OS=Homo sapiens GN=KBTBD4 PE=1 SV=3 | 330 | D | 0.375568 | N | 0.357869 | 0.017699 | No Change: Both O | - |
| Q2TBA0 | KBTB5_HUMAN Kelch repeat and BTB domain-containing protein 5 OS=Homo sapiens GN=KBTBD5 PE=2 SV=2 | 345 | N | 0.412165 | S | 0.461774 | -0.049609 | No Change: Both O | - |
| Q2TBA0 | KBTB5_HUMAN Kelch repeat and BTB domain-containing protein 5 OS=Homo sapiens GN=KBTBD5 PE=2 SV=2 | 617 | C | 0.255321 | R | 0.425901 | -0.17058 | No Change: Both O | - |
| Q8NFY9 | KBTB8_HUMAN Kelch repeat and BTB domain-containing protein 8 OS=Homo sapiens GN=KBTBD8 PE=2 SV=2 | 420 | C | 0.122829 | R | 0.229073 | -0.106244 | No Change: Both O | - |
| Q8NFY9 | KBTB8_HUMAN Kelch repeat and BTB domain-containing protein 8 OS=Homo sapiens GN=KBTBD8 PE=2 SV=2 | 198 | S | 0.333985 | C | 0.172252 | 0.161733 | No Change: Both O | A breast cancer sample |
| Q8NFY9 | KBTB8_HUMAN Kelch repeat and BTB domain-containing protein 8 OS=Homo sapiens GN=KBTBD8 PE=2 SV=2 | 405 | R | 0.592405 | K | 0.654575 | -0.06217 | No Change: Both D | A breast cancer sample |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 174 | V | 0.025579 | F | 0.019692 | 0.005887 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 177 | I | 0.013918 | R | 0.025929 | -0.012011 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 226 | T | 0.010975 | A | 0.009062 | 0.001913 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 239 | R | 0.037662 | S | 0.056493 | -0.018831 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 249 | F | 0.21369 | I | 0.209798 | 0.003892 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 404 | V | 0.06856 | I | 0.058822 | 0.009738 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 408 | V | 0.082044 | A | 0.109135 | -0.027091 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 400 | I | 0.046326 | V | 0.05569 | -0.009364 | No Change: Both O | - |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 204 | R | 0.266291 | H | 0.282623 | -0.016332 | No Change: Both O | - |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 184 | F | 0.017283 | C | 0.017657 | -3.74E-04 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 226 | T | 0.010975 | M | 0.008401 | 0.002574 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 325 | E | 0.154756 | D | 0.141036 | 0.01372 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 329 | L | 0.029318 | I | 0.024778 | 0.00454 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 342 | S | 0.068211 | I | 0.024425 | 0.043786 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 226 | T | 0.010975 | K | 0.015775 | -0.0048 | No Change: Both O | Myokymia isolated type 1 (MK1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 226 | T | 0.010975 | R | 0.011381 | -4.06E-04 | No Change: Both O | Episodic ataxia type 1 (EA1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 242 | A | 0.07884 | P | 0.120075 | -0.041235 | No Change: Both O | Myokymia isolated type 1 (MK1) [MIM:160120] |
| Q09470 | KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens GN=KCNA1 PE=1 SV=2 | 244 | P | 0.153056 | H | 0.13259 | 0.020466 | No Change: Both O | Myokymia isolated type 1 (MK1) [MIM:160120] |
| Q16322 | KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 OS=Homo sapiens GN=KCNA10 PE=1 SV=2 | 200 | R | 0.078467 | H | 0.081307 | -0.00284 | No Change: Both O | A colorectal cancer sample |
| Q16322 | KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 OS=Homo sapiens GN=KCNA10 PE=1 SV=2 | 220 | V | 0.136757 | M | 0.155202 | -0.018445 | No Change: Both O | - |
| Q16322 | KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 OS=Homo sapiens GN=KCNA10 PE=1 SV=2 | 258 | S | 0.490536 | N | 0.452707 | 0.037829 | No Change: Both O | - |
| P22460 | KCNA5_HUMAN Potassium voltage-gated channel subfamily A member 5 OS=Homo sapiens GN=KCNA5 PE=1 SV=4 | 300 | G | 0.87308 | S | 0.886277 | -0.013197 | No Change: Both D | A breast cancer sample |
| P22460 | KCNA5_HUMAN Potassium voltage-gated channel subfamily A member 5 OS=Homo sapiens GN=KCNA5 PE=1 SV=4 | 228 | P | 0.619904 | S | 0.618795 | 0.001109 | No Change: Both D | - |
| P22460 | KCNA5_HUMAN Potassium voltage-gated channel subfamily A member 5 OS=Homo sapiens GN=KCNA5 PE=1 SV=4 | 578 | R | 0.747923 | K | 0.766499 | -0.018576 | No Change: Both D | - |
| Q96RP8 | KCNA7_HUMAN Potassium voltage-gated channel subfamily A member 7 OS=Homo sapiens GN=KCNA7 PE=2 SV=1 | 189 | P | 0.681122 | R | 0.621672 | 0.05945 | No Change: Both D | - |
| Q96RP8 | KCNA7_HUMAN Potassium voltage-gated channel subfamily A member 7 OS=Homo sapiens GN=KCNA7 PE=2 SV=1 | 418 | M | 0.423282 | T | 0.435503 | -0.012221 | No Change: Both O | - |
| Q13303 | KCAB2_HUMAN Voltage-gated potassium channel subunit beta-2 OS=Homo sapiens GN=KCNAB2 PE=1 SV=2 | 88 | E | 0.171423 | K | 0.174889 | -0.003466 | No Change: Both O | - |
| Q14721 | KCNB1_HUMAN Potassium voltage-gated channel subfamily B member 1 OS=Homo sapiens GN=KCNB1 PE=1 SV=2 | 825 | P | 0.691881 | S | 0.700297 | -0.008416 | No Change: Both D | - |
| Q14721 | KCNB1_HUMAN Potassium voltage-gated channel subfamily B member 1 OS=Homo sapiens GN=KCNB1 PE=1 SV=2 | 616 | T | 0.809234 | N | 0.784007 | 0.025227 | No Change: Both D | - |
| Q14721 | KCNB1_HUMAN Potassium voltage-gated channel subfamily B member 1 OS=Homo sapiens GN=KCNB1 PE=1 SV=2 | 616 | T | 0.809234 | S | 0.846453 | -0.037219 | No Change: Both D | - |
| Q14721 | KCNB1_HUMAN Potassium voltage-gated channel subfamily B member 1 OS=Homo sapiens GN=KCNB1 PE=1 SV=2 | 857 | S | 0.779798 | N | 0.751153 | 0.028645 | No Change: Both D | - |
| Q92953 | KCNB2_HUMAN Potassium voltage-gated channel subfamily B member 2 OS=Homo sapiens GN=KCNB2 PE=2 SV=2 | 657 | E | 0.649784 | G | 0.623114 | 0.02667 | No Change: Both D | - |
| Q92953 | KCNB2_HUMAN Potassium voltage-gated channel subfamily B member 2 OS=Homo sapiens GN=KCNB2 PE=2 SV=2 | 450 | V | 0.662305 | I | 0.664067 | -0.001762 | No Change: Both D | A colorectal cancer sample |
| Q14003 | KCNC3_HUMAN Potassium voltage-gated channel subfamily C member 3 OS=Homo sapiens GN=KCNC3 PE=1 SV=3 | 420 | R | 0.029128 | H | 0.025508 | 0.00362 | No Change: Both O | Spinocerebellar ataxia type 13 (SCA13) [MIM:605259] |
| Q14003 | KCNC3_HUMAN Potassium voltage-gated channel subfamily C member 3 OS=Homo sapiens GN=KCNC3 PE=1 SV=3 | 448 | F | 0.083055 | L | 0.101549 | -0.018494 | No Change: Both O | Spinocerebellar ataxia type 13 (SCA13) [MIM:605259] |
| Q03721 | KCNC4_HUMAN Potassium voltage-gated channel subfamily C member 4 OS=Homo sapiens GN=KCNC4 PE=1 SV=2 | 520 | C | 0.983581 | Y | 0.977633 | 0.005948 | No Change: Both D | - |
| Q03721 | KCNC4_HUMAN Potassium voltage-gated channel subfamily C member 4 OS=Homo sapiens GN=KCNC4 PE=1 SV=2 | 318 | D | 0.021269 | Y | 0.009852 | 0.011417 | No Change: Both O | - |
| Q03721 | KCNC4_HUMAN Potassium voltage-gated channel subfamily C member 4 OS=Homo sapiens GN=KCNC4 PE=1 SV=2 | 516 | R | 0.986641 | Q | 0.985833 | 8.08E-04 | No Change: Both D | - |
| Q9UK17 | KCND3_HUMAN Potassium voltage-gated channel subfamily D member 3 OS=Homo sapiens GN=KCND3 PE=1 SV=3 | 94 | V | 0.059291 | M | 0.075092 | -0.015801 | No Change: Both O | A colorectal cancer sample |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 38 | S | 0.771243 | G | 0.7361 | 0.035143 | No Change: Both D | - |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 7 | T | 0.319878 | I | 0.197392 | 0.122486 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 2 (JLNS2) [MIM:612347] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 47 | V | 0.052605 | F | 0.049747 | 0.002858 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 2 (JLNS2) [MIM:612347] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 51 | L | 0.02673 | H | 0.037408 | -0.010678 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 2 (JLNS2) [MIM:612347] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 74 | S | 0.59525 | L | 0.372218 | 0.223032 | D to O | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 76 | D | 0.497217 | N | 0.499987 | -0.00277 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 2 (JLNS2) [MIM:612347] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 76 | D | 0.497217 | N | 0.499987 | -0.00277 | No Change: Both O | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 85 | D | 0.294197 | N | 0.275013 | 0.019184 | No Change: Both O | - |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 87 | W | 0.389585 | R | 0.599221 | -0.209636 | O to D | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 32 | R | 0.771646 | H | 0.767099 | 0.004547 | No Change: Both D | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 98 | R | 0.22633 | W | 0.100922 | 0.125408 | No Change: Both O | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 127 | P | 0.768473 | T | 0.772559 | -0.004086 | No Change: Both D | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 109 | V | 0.187765 | I | 0.163608 | 0.024157 | No Change: Both O | Long QT syndrome type 5 (LQT5) [MIM:613695] |
| P15382 | KCNE1_HUMAN Potassium voltage-gated channel subfamily E member 1 OS=Homo sapiens GN=KCNE1 PE=1 SV=1 | 52 | G | 0.026158 | A | 0.018801 | 0.007357 | No Change: Both O | - |
| Q9UJ90 | KCE1L_HUMAN Potassium voltage-gated channel subfamily E member 1-like protein OS=Homo sapiens GN=KCNE1L PE=2 SV=1 | 114 | E | 0.87505 | Q | 0.864977 | 0.010073 | No Change: Both D | - |
| Q9UJ90 | KCE1L_HUMAN Potassium voltage-gated channel subfamily E member 1-like protein OS=Homo sapiens GN=KCNE1L PE=2 SV=1 | 33 | P | 0.703447 | S | 0.719519 | -0.016072 | No Change: Both D | - |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 8 | T | 0.389016 | A | 0.342418 | 0.046598 | No Change: Both O | - |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 9 | Q | 0.307341 | E | 0.361342 | -0.054001 | No Change: Both O | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 54 | M | 0.013597 | T | 0.015362 | -0.001765 | No Change: Both O | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 57 | I | 0.017987 | T | 0.031829 | -0.013842 | No Change: Both O | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 65 | V | 0.023302 | M | 0.030532 | -0.00723 | No Change: Both O | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 66 | A | 0.032146 | V | 0.024858 | 0.007288 | No Change: Both O | - |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 60 | F | 0.019422 | L | 0.022437 | -0.003015 | No Change: Both O | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 77 | R | 0.851392 | W | 0.688946 | 0.162446 | No Change: Both D | Long QT syndrome type 6 (LQT6) [MIM:613693] |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 8 | T | 0.389016 | I | 0.258773 | 0.130243 | No Change: Both O | - |
| Q9Y6J6 | KCNE2_HUMAN Potassium voltage-gated channel subfamily E member 2 OS=Homo sapiens GN=KCNE2 PE=1 SV=1 | 27 | R | 0.322572 | C | 0.181856 | 0.140716 | No Change: Both O | Familial atrial fibrillation type 4 (ATFB4) [MIM:611493] |
| Q9Y6H6 | KCNE3_HUMAN Potassium voltage-gated channel subfamily E member 3 OS=Homo sapiens GN=KCNE3 PE=1 SV=1 | 83 | R | 0.585954 | H | 0.571116 | 0.014838 | No Change: Both D | - |
| Q9Y6H6 | KCNE3_HUMAN Potassium voltage-gated channel subfamily E member 3 OS=Homo sapiens GN=KCNE3 PE=1 SV=1 | 4 | T | 0.800927 | A | 0.798716 | 0.002211 | No Change: Both D | - |
| Q9Y6H6 | KCNE3_HUMAN Potassium voltage-gated channel subfamily E member 3 OS=Homo sapiens GN=KCNE3 PE=1 SV=1 | 39 | P | 0.740102 | R | 0.70905 | 0.031052 | No Change: Both D | - |
| Q9Y6H6 | KCNE3_HUMAN Potassium voltage-gated channel subfamily E member 3 OS=Homo sapiens GN=KCNE3 PE=1 SV=1 | 99 | R | 0.532599 | H | 0.567243 | -0.034644 | No Change: Both D | Brugada syndrome type 6 (BRS6) [MIM:613119] |
| Q8WWG9 | KCNE4_HUMAN Potassium voltage-gated channel subfamily E member 4 OS=Homo sapiens GN=KCNE4 PE=2 SV=3 | 145 | D | 0.983001 | E | 0.986297 | -0.003296 | No Change: Both D | - |
| Q8WWG9 | KCNE4_HUMAN Potassium voltage-gated channel subfamily E member 4 OS=Homo sapiens GN=KCNE4 PE=2 SV=3 | 47 | G | 0.042152 | S | 0.056662 | -0.01451 | No Change: Both O | - |
| Q9UIX4 | KCNG1_HUMAN Potassium voltage-gated channel subfamily G member 1 OS=Homo sapiens GN=KCNG1 PE=2 SV=1 | 304 | I | 0.058548 | M | 0.084155 | -0.025607 | No Change: Both O | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 8 | G | 0.963255 | W | 0.926637 | 0.036618 | No Change: Both D | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 206 | R | 0.339684 | W | 0.159505 | 0.180179 | No Change: Both O | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 255 | C | 0.380981 | Y | 0.44144 | -0.060459 | No Change: Both O | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 321 | E | 0.878688 | K | 0.873136 | 0.005552 | No Change: Both D | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 325 | G | 0.757234 | R | 0.748241 | 0.008993 | No Change: Both D | - |
| Q8TDN1 | KCNG4_HUMAN Potassium voltage-gated channel subfamily G member 4 OS=Homo sapiens GN=KCNG4 PE=2 SV=1 | 427 | R | 0.438221 | H | 0.443551 | -0.00533 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 470 | N | 0.037995 | D | 0.041368 | -0.003373 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 534 | R | 0.154443 | C | 0.065237 | 0.089206 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 561 | A | 0.008599 | V | 0.005204 | 0.003395 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 582 | R | 0.356015 | C | 0.198335 | 0.15768 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 593 | I | 0.522939 | R | 0.679671 | -0.156732 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 628 | G | 0.497213 | S | 0.554206 | -0.056993 | O to D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 822 | V | 0.339074 | M | 0.399288 | -0.060214 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 29 | F | 0.22914 | L | 0.244133 | -0.014993 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 33 | N | 0.128576 | T | 0.102633 | 0.025943 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 53 | G | 0.135689 | R | 0.14587 | -0.010181 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 56 | R | 0.211452 | Q | 0.226036 | -0.014584 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 66 | C | 0.199103 | G | 0.328874 | -0.129771 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 70 | H | 0.303913 | R | 0.354276 | -0.050363 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 78 | A | 0.461565 | P | 0.521491 | -0.059926 | O to D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 86 | L | 0.289315 | R | 0.417577 | -0.128262 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 176 | R | 0.662509 | W | 0.439308 | 0.223201 | D to O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 436 | T | 0.677684 | M | 0.618463 | 0.059221 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 474 | T | 0.113558 | I | 0.060944 | 0.052614 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 552 | L | 0.015175 | S | 0.034857 | -0.019682 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 558 | A | 0.011014 | P | 0.015097 | -0.004083 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 564 | L | 0.006477 | P | 0.013527 | -0.00705 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 569 | Y | 0.023943 | H | 0.044748 | -0.020805 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 572 | G | 0.144504 | R | 0.137382 | 0.007122 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 572 | G | 0.144504 | C | 0.071313 | 0.073191 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 584 | G | 0.237946 | S | 0.290011 | -0.052065 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 588 | N | 0.174157 | D | 0.199369 | -0.025212 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 601 | G | 0.656197 | S | 0.692483 | -0.036286 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 604 | G | 0.60472 | S | 0.643098 | -0.038378 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 611 | Y | 0.222084 | H | 0.301435 | -0.079351 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 612 | V | 0.169241 | L | 0.181509 | -0.012268 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 613 | T | 0.130421 | M | 0.100549 | 0.029872 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 614 | A | 0.10842 | V | 0.089767 | 0.018653 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 629 | N | 0.55706 | D | 0.552454 | 0.004606 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 629 | N | 0.55706 | K | 0.5743 | -0.01724 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 630 | V | 0.561833 | L | 0.550206 | 0.011627 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 630 | V | 0.561833 | A | 0.612318 | -0.050485 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 633 | N | 0.62103 | S | 0.656034 | -0.035004 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 640 | F | 0.164759 | L | 0.18708 | -0.022321 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 818 | S | 0.607622 | L | 0.417398 | 0.190224 | D to O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 629 | N | 0.55706 | S | 0.596576 | -0.039516 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 47 | G | 0.061272 | V | 0.035069 | 0.026203 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 72 | P | 0.398448 | Q | 0.397658 | 7.90E-04 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 312 | R | 0.636526 | C | 0.47842 | 0.158106 | D to O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 347 | P | 0.386308 | S | 0.404071 | -0.017763 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 531 | R | 0.116396 | Q | 0.113829 | 0.002567 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 585 | W | 0.207443 | C | 0.238665 | -0.031222 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 593 | I | 0.522939 | T | 0.666027 | -0.143088 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 609 | D | 0.355673 | N | 0.34761 | 0.008063 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 65 | T | 0.208418 | P | 0.274949 | -0.066531 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 451 | P | 0.060229 | L | 0.030776 | 0.029453 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 561 | A | 0.008599 | T | 0.009622 | -0.001023 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 615 | L | 0.105704 | V | 0.108446 | -0.002742 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 626 | G | 0.435594 | S | 0.502669 | -0.067075 | O to D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 627 | F | 0.473315 | L | 0.512712 | -0.039397 | O to D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 632 | P | 0.618576 | S | 0.665434 | -0.046858 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 637 | E | 0.466571 | K | 0.480631 | -0.01406 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 638 | K | 0.34178 | E | 0.357598 | -0.015818 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 645 | M | 0.033937 | L | 0.0257 | 0.008237 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 752 | R | 0.185362 | W | 0.070582 | 0.11478 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 805 | F | 0.210755 | C | 0.199929 | 0.010826 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 805 | F | 0.210755 | S | 0.432117 | -0.221362 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 823 | R | 0.260756 | W | 0.116505 | 0.144251 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 861 | N | 0.3193 | I | 0.205149 | 0.114151 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 897 | K | 0.969004 | T | 0.965322 | 0.003682 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 917 | P | 0.991088 | L | 0.983694 | 0.007394 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 922 | R | 0.993257 | W | 0.985792 | 0.007465 | No Change: Both D | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 588 | N | 0.174157 | K | 0.214383 | -0.040226 | No Change: Both O | Short QT syndrome type 1 (SQT1) [MIM:609620] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 100 | R | 0.130687 | G | 0.141714 | -0.011027 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 181 | R | 0.74068 | Q | 0.708738 | 0.031942 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 490 | A | 0.141328 | T | 0.157189 | -0.015861 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 525 | K | 0.155993 | N | 0.130934 | 0.025059 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 528 | R | 0.105763 | P | 0.113911 | -0.008148 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 696 | R | 0.380606 | C | 0.20396 | 0.176646 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 752 | R | 0.185362 | Q | 0.192643 | -0.007281 | No Change: Both O | Long QT syndrome type 2 (LQT2) [MIM:613688] |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 784 | R | 0.136468 | W | 0.052412 | 0.084056 | No Change: Both O | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 948 | R | 0.999522 | C | 0.999346 | 1.76E-04 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 1016 | P | 0.709072 | S | 0.707405 | 0.001667 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 1016 | P | 0.709072 | L | 0.570377 | 0.138695 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 1020 | P | 0.738591 | S | 0.73663 | 0.001961 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 1026 | P | 0.856322 | L | 0.751298 | 0.105024 | No Change: Both D | - |
| Q12809 | KCNH2_HUMAN Potassium voltage-gated channel subfamily H member 2 OS=Homo sapiens GN=KCNH2 PE=1 SV=1 | 1055 | R | 0.726532 | Q | 0.731876 | -0.005344 | No Change: Both D | - |
| Q9UQ05 | KCNH4_HUMAN Potassium voltage-gated channel subfamily H member 4 OS=Homo sapiens GN=KCNH4 PE=2 SV=1 | 797 | G | 0.93998 | R | 0.943919 | -0.003939 | No Change: Both D | A colorectal cancer sample |
| Q8NCM2 | KCNH5_HUMAN Potassium voltage-gated channel subfamily H member 5 OS=Homo sapiens GN=KCNH5 PE=1 SV=3 | 745 | A | 0.753962 | T | 0.808579 | -0.054617 | No Change: Both D | - |
| Q9H252 | KCNH6_HUMAN Potassium voltage-gated channel subfamily H member 6 OS=Homo sapiens GN=KCNH6 PE=1 SV=1 | 165 | G | 0.877999 | R | 0.882221 | -0.004222 | No Change: Both D | - |
| Q9H252 | KCNH6_HUMAN Potassium voltage-gated channel subfamily H member 6 OS=Homo sapiens GN=KCNH6 PE=1 SV=1 | 925 | T | 0.879173 | M | 0.878489 | 6.84E-04 | No Change: Both D | - |
| Q9NS40 | KCNH7_HUMAN Potassium voltage-gated channel subfamily H member 7 OS=Homo sapiens GN=KCNH7 PE=1 SV=2 | 958 | G | 0.802526 | A | 0.764312 | 0.038214 | No Change: Both D | - |
| Q96L42 | KCNH8_HUMAN Potassium voltage-gated channel subfamily H member 8 OS=Homo sapiens GN=KCNH8 PE=2 SV=2 | 893 | Q | 0.644832 | R | 0.620393 | 0.024439 | No Change: Both D | - |
| Q96L42 | KCNH8_HUMAN Potassium voltage-gated channel subfamily H member 8 OS=Homo sapiens GN=KCNH8 PE=2 SV=2 | 984 | E | 0.793588 | Q | 0.79022 | 0.003368 | No Change: Both D | - |
| Q9Y2W7 | CSEN_HUMAN Calsenilin OS=Homo sapiens GN=KCNIP3 PE=1 SV=1 | 170 | A | 0.099618 | S | 0.157054 | -0.057436 | No Change: Both O | A breast cancer sample |
| Q9Y2W7 | CSEN_HUMAN Calsenilin OS=Homo sapiens GN=KCNIP3 PE=1 SV=1 | 179 | D | 0.30293 | Y | 0.172252 | 0.130678 | No Change: Both O | A breast cancer sample |
| Q9Y2W7 | CSEN_HUMAN Calsenilin OS=Homo sapiens GN=KCNIP3 PE=1 SV=1 | 119 | A | 0.080204 | V | 0.053987 | 0.026217 | No Change: Both O | - |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 72 | V | 0.033684 | E | 0.07711 | -0.043426 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 74 | D | 0.054386 | Y | 0.026397 | 0.027989 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 99 | W | 0.009289 | C | 0.010771 | -0.001482 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 108 | D | 0.350815 | H | 0.331611 | 0.019204 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 110 | P | 0.512569 | L | 0.323467 | 0.189102 | D to O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 122 | V | 0.377024 | E | 0.619496 | -0.242472 | O to D | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 167 | G | 0.035924 | E | 0.045125 | -0.009201 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 198 | A | 0.3942 | T | 0.443543 | -0.049343 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 315 | V | 0.196319 | G | 0.303431 | -0.107112 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 124 | N | 0.300196 | K | 0.323369 | -0.023173 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 214 | A | 0.121983 | V | 0.10113 | 0.020853 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 219 | S | 0.232688 | R | 0.185645 | 0.047043 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 357 | M | 0.160087 | T | 0.187897 | -0.02781 | No Change: Both O | Bartter syndrome type 2 (BS2) [MIM:241200] |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 115 | S | 0.595913 | F | 0.358635 | 0.237278 | D to O | A breast cancer sample |
| P48048 | IRK1_HUMAN ATP-sensitive inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ1 PE=1 SV=1 | 6 | R | 0.573151 | W | 0.405809 | 0.167342 | D to O | - |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 271 | R | 0.497538 | H | 0.503715 | -0.006177 | O to D | - |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 271 | R | 0.497538 | C | 0.350617 | 0.146921 | No Change: Both O | - |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 65 | R | 0.044613 | P | 0.053608 | -0.008995 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 77 | G | 0.037466 | R | 0.033102 | 0.004364 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 140 | C | 0.089315 | R | 0.192005 | -0.10269 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 164 | T | 0.058748 | I | 0.032134 | 0.026614 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 167 | A | 0.171257 | V | 0.117694 | 0.053563 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| P78508 | IRK10_HUMAN ATP-sensitive inward rectifier potassium channel 10 OS=Homo sapiens GN=KCNJ10 PE=1 SV=1 | 297 | R | 0.290305 | C | 0.172679 | 0.117626 | No Change: Both O | Seizures-sensorineural deafness-ataxia-mental retardation-electrolyte imbalance (SESAME) [MIM:612780] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 147 | L | 0.01818 | P | 0.038841 | -0.020661 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 10 | E | 0.517128 | K | 0.514414 | 0.002714 | No Change: Both D | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 23 | E | 0.664511 | K | 0.653725 | 0.010786 | No Change: Both D | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 270 | L | 0.553875 | V | 0.533245 | 0.02063 | No Change: Both D | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 337 | I | 0.268866 | V | 0.316975 | -0.048109 | No Change: Both O | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 355 | L | 0.496467 | P | 0.619033 | -0.122566 | O to D | Non-insulin-dependent diabetes mellitus (NIDDM) |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 385 | S | 0.949018 | C | 0.881934 | 0.067084 | No Change: Both D | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 195 | R | 0.076477 | H | 0.072216 | 0.004261 | No Change: Both O | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 35 | F | 0.480861 | L | 0.51596 | -0.035099 | O to D | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 35 | F | 0.480861 | V | 0.531641 | -0.05078 | O to D | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 50 | R | 0.373964 | P | 0.393449 | -0.019485 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 52 | Q | 0.347652 | R | 0.335049 | 0.012603 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 53 | G | 0.303839 | R | 0.313349 | -0.00951 | No Change: Both O | Transient neonatal diabetes mellitus type 3 (TNDM3) [MIM:610582] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 53 | G | 0.303839 | S | 0.354358 | -0.050519 | No Change: Both O | Transient neonatal diabetes mellitus type 3 (TNDM3) [MIM:610582] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 59 | V | 0.108937 | G | 0.187122 | -0.078185 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 59 | V | 0.108937 | M | 0.133034 | -0.024097 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 67 | K | 0.100306 | N | 0.083392 | 0.016914 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 91 | W | 0.011854 | R | 0.029096 | -0.017242 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 170 | K | 0.172591 | N | 0.146537 | 0.026054 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 170 | K | 0.172591 | R | 0.143244 | 0.029347 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 182 | I | 0.238661 | V | 0.268787 | -0.030126 | No Change: Both O | Transient neonatal diabetes mellitus type 3 (TNDM3) [MIM:610582] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 201 | R | 0.118076 | C | 0.058247 | 0.059829 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 201 | R | 0.118076 | H | 0.108328 | 0.009748 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 254 | P | 0.032036 | L | 0.015818 | 0.016218 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 296 | I | 0.376073 | L | 0.41656 | -0.040487 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 322 | E | 0.363613 | K | 0.349921 | 0.013692 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 330 | Y | 0.386307 | C | 0.315622 | 0.070685 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 333 | F | 0.350717 | I | 0.367168 | -0.016451 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 34 | R | 0.494258 | H | 0.441833 | 0.052425 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 40 | G | 0.480732 | D | 0.512493 | -0.031761 | O to D | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 42 | C | 0.436727 | R | 0.608783 | -0.172056 | O to D | Transient neonatal diabetes mellitus type 3 (TNDM3) [MIM:610582] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 46 | H | 0.394778 | Y | 0.281088 | 0.11369 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 50 | R | 0.373964 | Q | 0.396687 | -0.022723 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 53 | G | 0.303839 | D | 0.345287 | -0.041448 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 55 | F | 0.200929 | L | 0.22437 | -0.023441 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 101 | A | 0.563614 | D | 0.640735 | -0.077121 | No Change: Both D | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 116 | S | 0.259892 | P | 0.220833 | 0.039059 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 134 | G | 0.1861 | A | 0.135025 | 0.051075 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 136 | R | 0.196411 | L | 0.119682 | 0.076729 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 148 | I | 0.0163 | S | 0.040934 | -0.024634 | No Change: Both O | - |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 164 | L | 0.028392 | P | 0.058856 | -0.030464 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 166 | C | 0.040153 | Y | 0.050406 | -0.010253 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 170 | K | 0.172591 | T | 0.13355 | 0.039041 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 201 | R | 0.118076 | L | 0.06888 | 0.049196 | No Change: Both O | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 259 | H | 0.053306 | R | 0.052511 | 7.95E-04 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 266 | P | 0.319187 | L | 0.182779 | 0.136408 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 301 | R | 0.336229 | H | 0.340768 | -0.004539 | No Change: Both O | Familial hyperinsulinemic hypoglycemia type 2 (HHF2) [MIM:601820] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 330 | Y | 0.386307 | S | 0.569988 | -0.183681 | O to D | Diabetes mellitus permanent neonatal (PNDM) [MIM:606176] |
| Q14654 | IRK11_HUMAN ATP-sensitive inward rectifier potassium channel 11 OS=Homo sapiens GN=KCNJ11 PE=1 SV=2 | 18 | A | 0.533015 | G | 0.557551 | -0.024536 | No Change: Both D | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 6 | R | 0.655071 | Q | 0.666054 | -0.010983 | No Change: Both D | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 15 | S | 0.482544 | L | 0.33079 | 0.151754 | No Change: Both O | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 156 | P | 0.088414 | L | 0.04339 | 0.045024 | No Change: Both O | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 249 | I | 0.158493 | V | 0.174051 | -0.015558 | No Change: Both O | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 100 | I | 0.004137 | V | 0.004768 | -6.31E-04 | No Change: Both O | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 118 | R | 0.579689 | Q | 0.591782 | -0.012093 | No Change: Both D | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 192 | Q | 0.427758 | H | 0.425615 | 0.002143 | No Change: Both O | - |
| Q14500 | IRK12_HUMAN ATP-sensitive inward rectifier potassium channel 12 OS=Homo sapiens GN=KCNJ12 PE=1 SV=2 | 430 | E | 0.819537 | G | 0.796481 | 0.023056 | No Change: Both D | - |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 175 | T | 0.193995 | I | 0.111935 | 0.08206 | No Change: Both O | - |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 162 | R | 0.352886 | W | 0.16107 | 0.191816 | No Change: Both O | Snowflake vitreoretinal degeneration (SVD) [MIM:193230] |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 290 | P | 0.346224 | Q | 0.344925 | 0.001299 | No Change: Both O | - |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 309 | G | 0.469739 | C | 0.353901 | 0.115838 | No Change: Both O | - |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 117 | Q | 0.219152 | R | 0.203873 | 0.015279 | No Change: Both O | Leber congenital amaurosis type 16 (LCA16) [MIM:614186] |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 162 | R | 0.352886 | Q | 0.355016 | -0.00213 | No Change: Both O | - |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 241 | L | 0.079759 | P | 0.17272 | -0.092961 | No Change: Both O | Leber congenital amaurosis type 16 (LCA16) [MIM:614186] |
| O60928 | IRK13_HUMAN Inward rectifier potassium channel 13 OS=Homo sapiens GN=KCNJ13 PE=1 SV=1 | 276 | E | 0.323983 | A | 0.236725 | 0.087258 | No Change: Both O | - |
| Q9UNX9 | IRK14_HUMAN ATP-sensitive inward rectifier potassium channel 14 OS=Homo sapiens GN=KCNJ14 PE=1 SV=1 | 289 | R | 0.345629 | C | 0.189337 | 0.156292 | No Change: Both O | - |
| Q99712 | IRK15_HUMAN ATP-sensitive inward rectifier potassium channel 15 OS=Homo sapiens GN=KCNJ15 PE=1 SV=2 | 98 | G | 0.723002 | D | 0.745288 | -0.022286 | No Change: Both D | - |
| Q99712 | IRK15_HUMAN ATP-sensitive inward rectifier potassium channel 15 OS=Homo sapiens GN=KCNJ15 PE=1 SV=2 | 30 | M | 0.726151 | L | 0.682056 | 0.044095 | No Change: Both D | - |
| Q99712 | IRK15_HUMAN ATP-sensitive inward rectifier potassium channel 15 OS=Homo sapiens GN=KCNJ15 PE=1 SV=2 | 71 | A | 0.033069 | T | 0.039726 | -0.006657 | No Change: Both O | A breast cancer sample |
| Q9NPI9 | IRK16_HUMAN Inward rectifier potassium channel 16 OS=Homo sapiens GN=KCNJ16 PE=2 SV=1 | 11 | I | 0.334972 | V | 0.320814 | 0.014158 | No Change: Both O | - |
| B7U540 | IRK18_HUMAN Inward rectifier potassium channel 18 OS=Homo sapiens GN=KCNJ18 PE=1 SV=2 | 140 | T | 0.1765 | M | 0.135964 | 0.040536 | No Change: Both O | Thyrotoxic hypokalemic periodic paralysis (TTPP2) [MIM:613239] |
| B7U540 | IRK18_HUMAN Inward rectifier potassium channel 18 OS=Homo sapiens GN=KCNJ18 PE=1 SV=2 | 205 | R | 0.136355 | H | 0.140475 | -0.00412 | No Change: Both O | Thyrotoxic hypokalemic periodic paralysis (TTPP2) [MIM:613239] |
| B7U540 | IRK18_HUMAN Inward rectifier potassium channel 18 OS=Homo sapiens GN=KCNJ18 PE=1 SV=2 | 354 | T | 0.489261 | M | 0.43869 | 0.050571 | No Change: Both O | Thyrotoxic hypokalemic periodic paralysis (TTPP2) [MIM:613239] |
| B7U540 | IRK18_HUMAN Inward rectifier potassium channel 18 OS=Homo sapiens GN=KCNJ18 PE=1 SV=2 | 366 | K | 0.468242 | R | 0.418124 | 0.050118 | No Change: Both O | Thyrotoxic hypokalemic periodic paralysis (TTPP2) [MIM:613239] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 67 | R | 0.188326 | W | 0.077602 | 0.110724 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 71 | D | 0.070453 | V | 0.033221 | 0.037232 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 186 | P | 0.745247 | L | 0.594233 | 0.151014 | No Change: Both D | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 216 | N | 0.189311 | H | 0.187539 | 0.001772 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 218 | R | 0.304992 | W | 0.14349 | 0.161502 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 300 | G | 0.134972 | V | 0.085012 | 0.04996 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 302 | V | 0.197616 | M | 0.253721 | -0.056105 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 172 | D | 0.02306 | N | 0.021382 | 0.001678 | No Change: Both O | Short QT syndrome type 3 (SQT3) [MIM:609622] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 54 | C | 0.190048 | F | 0.208102 | -0.018054 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 75 | T | 0.027424 | R | 0.030196 | -0.002772 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 93 | V | 0.004898 | I | 0.004189 | 7.09E-04 | No Change: Both O | Familial atrial fibrillation type 9 (ATFB9) [MIM:613980] |
| P63252 | IRK2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens GN=KCNJ2 PE=1 SV=1 | 305 | T | 0.313456 | P | 0.340549 | -0.027093 | No Change: Both O | Long QT syndrome type 7 (LQT7) [MIM:170390] |
| P48549 | IRK3_HUMAN G protein-activated inward rectifier potassium channel 1 OS=Homo sapiens GN=KCNJ3 PE=1 SV=1 | 40 | K | 0.900216 | R | 0.896989 | 0.003227 | No Change: Both D | - |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 282 | Q | 0.441365 | E | 0.50254 | -0.061175 | O to D | - |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 387 | G | 0.846633 | R | 0.857293 | -0.01066 | No Change: Both D | Long QT syndrome type 13 (LQT13) [MIM:613485] |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 39 | R | 0.47227 | H | 0.399273 | 0.072997 | No Change: Both O | - |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 151 | G | 0.17518 | R | 0.163216 | 0.011964 | No Change: Both O | - |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 158 | T | 0.14695 | A | 0.128448 | 0.018502 | No Change: Both O | Familial hyperaldosteronism type 3 (FH3) [MIM:613677] |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 168 | L | 0.028996 | R | 0.046629 | -0.017633 | No Change: Both O | - |
| P48544 | IRK5_HUMAN G protein-activated inward rectifier potassium channel 4 OS=Homo sapiens GN=KCNJ5 PE=1 SV=2 | 210 | M | 0.251189 | I | 0.176075 | 0.075114 | No Change: Both O | - |
| Q15842 | IRK8_HUMAN ATP-sensitive inward rectifier potassium channel 8 OS=Homo sapiens GN=KCNJ8 PE=1 SV=1 | 334 | V | 0.382934 | A | 0.43242 | -0.049486 | No Change: Both O | - |
| Q15842 | IRK8_HUMAN ATP-sensitive inward rectifier potassium channel 8 OS=Homo sapiens GN=KCNJ8 PE=1 SV=1 | 422 | S | 0.967844 | L | 0.92557 | 0.042274 | No Change: Both D | - |
| Q15842 | IRK8_HUMAN ATP-sensitive inward rectifier potassium channel 8 OS=Homo sapiens GN=KCNJ8 PE=1 SV=1 | 346 | V | 0.302581 | I | 0.260152 | 0.042429 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q92806 | IRK9_HUMAN G protein-activated inward rectifier potassium channel 3 OS=Homo sapiens GN=KCNJ9 PE=2 SV=2 | 366 | A | 0.836309 | V | 0.786148 | 0.050161 | No Change: Both D | - |
| P57789 | KCNKA_HUMAN Potassium channel subfamily K member 10 OS=Homo sapiens GN=KCNK10 PE=2 SV=1 | 512 | A | 0.879655 | T | 0.909049 | -0.029394 | No Change: Both D | - |
| P57789 | KCNKA_HUMAN Potassium channel subfamily K member 10 OS=Homo sapiens GN=KCNK10 PE=2 SV=1 | 70 | K | 0.077244 | Q | 0.065107 | 0.012137 | No Change: Both O | - |
| Q9HB14 | KCNKD_HUMAN Potassium channel subfamily K member 13 OS=Homo sapiens GN=KCNK13 PE=2 SV=2 | 389 | G | 0.382603 | A | 0.343131 | 0.039472 | No Change: Both O | - |
| Q9HB14 | KCNKD_HUMAN Potassium channel subfamily K member 13 OS=Homo sapiens GN=KCNK13 PE=2 SV=2 | 305 | G | 0.390196 | R | 0.427297 | -0.037101 | No Change: Both O | - |
| Q9H427 | KCNKF_HUMAN Potassium channel subfamily K member 15 OS=Homo sapiens GN=KCNK15 PE=1 SV=2 | 95 | G | 0.186857 | E | 0.212646 | -0.025789 | No Change: Both O | - |
| Q9H427 | KCNKF_HUMAN Potassium channel subfamily K member 15 OS=Homo sapiens GN=KCNK15 PE=1 SV=2 | 260 | P | 0.768143 | T | 0.723546 | 0.044597 | No Change: Both D | - |
| Q9H427 | KCNKF_HUMAN Potassium channel subfamily K member 15 OS=Homo sapiens GN=KCNK15 PE=1 SV=2 | 261 | P | 0.797852 | H | 0.76427 | 0.033582 | No Change: Both D | - |
| Q9H427 | KCNKF_HUMAN Potassium channel subfamily K member 15 OS=Homo sapiens GN=KCNK15 PE=1 SV=2 | 323 | P | 0.807806 | L | 0.619784 | 0.188022 | No Change: Both D | - |
| Q96T55 | KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens GN=KCNK16 PE=2 SV=1 | 301 | P | 0.868321 | H | 0.774089 | 0.094232 | No Change: Both D | - |
| Q96T55 | KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens GN=KCNK16 PE=2 SV=1 | 215 | F | 0.127581 | L | 0.15081 | -0.023229 | No Change: Both O | - |
| Q96T55 | KCNKG_HUMAN Potassium channel subfamily K member 16 OS=Homo sapiens GN=KCNK16 PE=2 SV=1 | 275 | A | 0.597298 | G | 0.651227 | -0.053929 | No Change: Both D | - |
| Q96T54 | KCNKH_HUMAN Potassium channel subfamily K member 17 OS=Homo sapiens GN=KCNK17 PE=2 SV=1 | 296 | R | 0.962425 | Q | 0.967509 | -0.005084 | No Change: Both D | - |
| Q96T54 | KCNKH_HUMAN Potassium channel subfamily K member 17 OS=Homo sapiens GN=KCNK17 PE=2 SV=1 | 21 | S | 0.113644 | G | 0.100918 | 0.012726 | No Change: Both O | - |
| Q96T54 | KCNKH_HUMAN Potassium channel subfamily K member 17 OS=Homo sapiens GN=KCNK17 PE=2 SV=1 | 253 | M | 0.008953 | L | 0.007286 | 0.001667 | No Change: Both O | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 58 | F | 0.406989 | Y | 0.430831 | -0.023842 | No Change: Both O | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 198 | A | 0.833878 | G | 0.838033 | -0.004155 | No Change: Both D | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 231 | S | 0.83351 | P | 0.836723 | -0.003213 | No Change: Both D | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 233 | A | 0.824433 | V | 0.774682 | 0.049751 | No Change: Both D | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 255 | E | 0.490235 | K | 0.45602 | 0.034215 | No Change: Both O | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 346 | V | 0.016187 | I | 0.014899 | 0.001288 | No Change: Both O | - |
| Q7Z418 | KCNKI_HUMAN Potassium channel subfamily K member 18 OS=Homo sapiens GN=KCNK18 PE=1 SV=1 | 34 | A | 0.02209 | V | 0.015946 | 0.006144 | No Change: Both O | - |
| Q9NYG8 | KCNK4_HUMAN Potassium channel subfamily K member 4 OS=Homo sapiens GN=KCNK4 PE=2 SV=2 | 328 | P | 0.99292 | L | 0.986415 | 0.006505 | No Change: Both D | - |
| O95279 | KCNK5_HUMAN Potassium channel subfamily K member 5 OS=Homo sapiens GN=KCNK5 PE=1 SV=1 | 465 | P | 0.962647 | T | 0.954354 | 0.008293 | No Change: Both D | - |
| Q9Y257 | KCNK6_HUMAN Potassium channel subfamily K member 6 OS=Homo sapiens GN=KCNK6 PE=1 SV=1 | 150 | T | 0.141166 | I | 0.076854 | 0.064312 | No Change: Both O | - |
| Q9Y257 | KCNK6_HUMAN Potassium channel subfamily K member 6 OS=Homo sapiens GN=KCNK6 PE=1 SV=1 | 259 | V | 0.262985 | M | 0.315399 | -0.052414 | No Change: Both O | - |
| Q9Y257 | KCNK6_HUMAN Potassium channel subfamily K member 6 OS=Homo sapiens GN=KCNK6 PE=1 SV=1 | 240 | V | 0.018195 | I | 0.013946 | 0.004249 | No Change: Both O | - |
| Q9NPC2 | KCNK9_HUMAN Potassium channel subfamily K member 9 OS=Homo sapiens GN=KCNK9 PE=1 SV=1 | 236 | G | 0.02944 | R | 0.027319 | 0.002121 | No Change: Both O | Birk-Barel syndrome (BIBAS) [MIM:612292] |
| Q12791 | KCMA1_HUMAN Calcium-activated potassium channel subunit alpha-1 OS=Homo sapiens GN=KCNMA1 PE=1 SV=2 | 434 | D | 0.374016 | G | 0.323336 | 0.05068 | No Change: Both O | Generalized epilepsy and paroxysmal dyskinesia (GEPD) [MIM:609446] |
| Q16558 | KCMB1_HUMAN Calcium-activated potassium channel subunit beta-1 OS=Homo sapiens GN=KCNMB1 PE=1 SV=5 | 65 | E | 0.655549 | K | 0.661094 | -0.005545 | No Change: Both D | - |
| Q16558 | KCMB1_HUMAN Calcium-activated potassium channel subunit beta-1 OS=Homo sapiens GN=KCNMB1 PE=1 SV=5 | 110 | V | 0.369793 | L | 0.361013 | 0.00878 | No Change: Both O | - |
| Q9NPA1 | KCMB3_HUMAN Calcium-activated potassium channel subunit beta-3 OS=Homo sapiens GN=KCNMB3 PE=1 SV=2 | 44 | D | 0.627743 | G | 0.590772 | 0.036971 | No Change: Both D | - |
| Q9NPA1 | KCMB3_HUMAN Calcium-activated potassium channel subunit beta-3 OS=Homo sapiens GN=KCNMB3 PE=1 SV=2 | 53 | A | 0.607672 | T | 0.613828 | -0.006156 | No Change: Both D | - |
| Q9NPA1 | KCMB3_HUMAN Calcium-activated potassium channel subunit beta-3 OS=Homo sapiens GN=KCNMB3 PE=1 SV=2 | 75 | L | 0.047235 | V | 0.04285 | 0.004385 | No Change: Both O | - |
| Q9NPA1 | KCMB3_HUMAN Calcium-activated potassium channel subunit beta-3 OS=Homo sapiens GN=KCNMB3 PE=1 SV=2 | 165 | N | 0.422982 | S | 0.457274 | -0.034292 | No Change: Both O | - |
| Q9NPA1 | KCMB3_HUMAN Calcium-activated potassium channel subunit beta-3 OS=Homo sapiens GN=KCNMB3 PE=1 SV=2 | 230 | M | 0.097117 | T | 0.127799 | -0.030682 | No Change: Both O | - |
| Q86W47 | KCMB4_HUMAN Calcium-activated potassium channel subunit beta-4 OS=Homo sapiens GN=KCNMB4 PE=1 SV=2 | 199 | V | 0.377282 | I | 0.354141 | 0.023141 | No Change: Both O | - |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 168 | G | 0.030534 | R | 0.030558 | -2.40E-05 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 174 | R | 0.064137 | C | 0.029369 | 0.034768 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 178 | A | 0.118467 | P | 0.16776 | -0.049293 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 189 | G | 0.085771 | R | 0.084341 | 0.00143 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 190 | R | 0.095295 | Q | 0.093592 | 0.001703 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 216 | G | 0.168268 | R | 0.149766 | 0.018502 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 254 | V | 0.066734 | M | 0.083009 | -0.016275 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 261 | E | 0.092765 | K | 0.092669 | 9.60E-05 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 269 | G | 0.030741 | D | 0.032479 | -0.001738 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 273 | L | 0.032456 | F | 0.028886 | 0.00357 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 300 | A | 0.088179 | T | 0.093709 | -0.00553 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 305 | W | 0.030838 | S | 0.106965 | -0.076127 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 1 (JLNS1) [MIM:220400] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 306 | G | 0.030065 | R | 0.027002 | 0.003063 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 309 | T | 0.036808 | R | 0.035559 | 0.001249 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 312 | T | 0.121317 | I | 0.064601 | 0.056716 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 313 | I | 0.175328 | M | 0.246457 | -0.071129 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 314 | G | 0.22025 | S | 0.249864 | -0.029614 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 315 | Y | 0.255402 | S | 0.44478 | -0.189378 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 317 | D | 0.310411 | N | 0.293836 | 0.016575 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 320 | P | 0.273998 | A | 0.204455 | 0.069543 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 325 | G | 0.15871 | R | 0.148042 | 0.010668 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 341 | A | 0.0779 | E | 0.107994 | -0.030094 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 341 | A | 0.0779 | V | 0.051081 | 0.026819 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 342 | L | 0.093099 | F | 0.087808 | 0.005291 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 344 | A | 0.134201 | V | 0.087384 | 0.046817 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 345 | G | 0.146543 | E | 0.164529 | -0.017986 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 366 | R | 0.446009 | P | 0.489892 | -0.043883 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 371 | A | 0.24857 | T | 0.260938 | -0.012368 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 555 | R | 0.385393 | C | 0.252811 | 0.132582 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 157 | F | 0.025307 | C | 0.023383 | 0.001924 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 184 | Y | 0.141777 | S | 0.310858 | -0.169081 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 345 | G | 0.146543 | R | 0.130438 | 0.016105 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 373 | S | 0.189026 | P | 0.191149 | -0.002123 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 392 | W | 0.4463 | R | 0.642897 | -0.196597 | O to D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 174 | R | 0.064137 | H | 0.061002 | 0.003135 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 242 | D | 0.235926 | N | 0.222338 | 0.013588 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 243 | R | 0.26432 | H | 0.263772 | 5.48E-04 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 1 (JLNS1) [MIM:220400] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 248 | W | 0.193779 | R | 0.397967 | -0.204188 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 250 | L | 0.105799 | H | 0.174868 | -0.069069 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 261 | E | 0.092765 | D | 0.082718 | 0.010047 | No Change: Both O | Jervell and Lange-Nielsen syndrome type 1 (JLNS1) [MIM:220400] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 281 | Y | 0.110703 | C | 0.084095 | 0.026608 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 315 | Y | 0.255402 | C | 0.209323 | 0.046079 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 318 | K | 0.304233 | N | 0.2548 | 0.049433 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 366 | R | 0.446009 | W | 0.22452 | 0.221489 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 533 | R | 0.45158 | W | 0.252414 | 0.199166 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 539 | R | 0.334185 | W | 0.15099 | 0.183195 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 587 | T | 0.588266 | M | 0.564713 | 0.023553 | No Change: Both D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 589 | G | 0.519866 | D | 0.569358 | -0.049492 | No Change: Both D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 591 | R | 0.459158 | H | 0.402805 | 0.056353 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 643 | G | 0.82099 | S | 0.84581 | -0.02482 | No Change: Both D | - |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 353 | L | 0.334263 | P | 0.490106 | -0.155843 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 525 | A | 0.323479 | T | 0.340841 | -0.017362 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 111 | Y | 0.195432 | C | 0.159773 | 0.035659 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 160 | E | 0.014813 | K | 0.014795 | 1.80E-05 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 178 | A | 0.118467 | T | 0.136128 | -0.017661 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 179 | G | 0.124246 | S | 0.162928 | -0.038682 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 194 | A | 0.139284 | P | 0.205374 | -0.06609 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 225 | S | 0.171521 | L | 0.075416 | 0.096105 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 266 | L | 0.045195 | P | 0.086929 | -0.041734 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 269 | G | 0.030741 | S | 0.039215 | -0.008474 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 310 | V | 0.049548 | I | 0.041428 | 0.00812 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 311 | T | 0.082799 | I | 0.043297 | 0.039502 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 349 | S | 0.188677 | W | 0.058889 | 0.129788 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 366 | R | 0.446009 | Q | 0.480781 | -0.034772 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 391 | T | 0.44269 | I | 0.348721 | 0.093969 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 448 | P | 0.698462 | R | 0.669352 | 0.02911 | No Change: Both D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 566 | S | 0.555516 | F | 0.322991 | 0.232525 | D to O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 583 | R | 0.699363 | C | 0.601275 | 0.098088 | No Change: Both D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 594 | R | 0.442442 | Q | 0.452521 | -0.010079 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 243 | R | 0.26432 | C | 0.124795 | 0.139525 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 417 | V | 0.899441 | M | 0.917958 | -0.018517 | No Change: Both D | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 140 | S | 0.027402 | G | 0.01969 | 0.007712 | No Change: Both O | Familial atrial fibrillation type 3 (ATFB3) [MIM:607554] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 307 | V | 0.028574 | L | 0.027461 | 0.001113 | No Change: Both O | Short QT syndrome type 2 (SQT2) [MIM:609621] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 362 | K | 0.620957 | R | 0.560366 | 0.060591 | No Change: Both D | - |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 393 | K | 0.417197 | N | 0.359447 | 0.05775 | No Change: Both O | - |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 277 | S | 0.039093 | L | 0.016063 | 0.02303 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| P51787 | KCNQ1_HUMAN Potassium voltage-gated channel subfamily KQT member 1 OS=Homo sapiens GN=KCNQ1 PE=1 SV=3 | 320 | P | 0.273998 | H | 0.242428 | 0.03157 | No Change: Both O | Long QT syndrome type 1 (LQT1) [MIM:192500] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 214 | R | 0.314786 | W | 0.138453 | 0.176333 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 284 | Y | 0.344233 | C | 0.274502 | 0.069731 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 306 | A | 0.080455 | T | 0.08636 | -0.005905 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 780 | N | 0.897225 | T | 0.900891 | -0.003666 | No Change: Both D | - |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 207 | R | 0.115075 | W | 0.039673 | 0.075402 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 208 | M | 0.143066 | V | 0.102297 | 0.040769 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 228 | H | 0.253634 | Q | 0.269487 | -0.015853 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 243 | L | 0.006424 | F | 0.005492 | 9.32E-04 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 247 | S | 0.015759 | W | 0.004125 | 0.011634 | No Change: Both O | Epileptic encephalopathy early infantile type 7 (EIEE7) [MIM:613720] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 333 | R | 0.593983 | Q | 0.610334 | -0.016351 | No Change: Both D | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 554 | K | 0.484467 | N | 0.434719 | 0.049748 | No Change: Both O | Benign familial neonatal seizures type 1 (BFNS1) [MIM:121200] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 554 | K | 0.484467 | N | 0.434719 | 0.049748 | No Change: Both O | Epileptic encephalopathy early infantile type 7 (EIEE7) [MIM:613720] |
| O43526 | KCNQ2_HUMAN Potassium voltage-gated channel subfamily KQT member 2 OS=Homo sapiens GN=KCNQ2 PE=1 SV=2 | 207 | R | 0.115075 | Q | 0.119191 | -0.004116 | No Change: Both O | - |
| O43525 | KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 OS=Homo sapiens GN=KCNQ3 PE=1 SV=2 | 310 | G | 0.025467 | V | 0.012818 | 0.012649 | No Change: Both O | Benign familial neonatal seizures type 2 (BFNS2) [MIM:121201] |
| O43525 | KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 OS=Homo sapiens GN=KCNQ3 PE=1 SV=2 | 309 | W | 0.024908 | R | 0.061403 | -0.036495 | No Change: Both O | Benign familial neonatal seizures type 2 (BFNS2) [MIM:121201] |
| O43525 | KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 OS=Homo sapiens GN=KCNQ3 PE=1 SV=2 | 305 | D | 0.067979 | G | 0.064261 | 0.003718 | No Change: Both O | Benign familial neonatal seizures type 2 (BFNS2) [MIM:121201] |
| O43525 | KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 OS=Homo sapiens GN=KCNQ3 PE=1 SV=2 | 468 | N | 0.625961 | S | 0.665988 | -0.040027 | No Change: Both D | - |
| O43525 | KCNQ3_HUMAN Potassium voltage-gated channel subfamily KQT member 3 OS=Homo sapiens GN=KCNQ3 PE=1 SV=2 | 414 | E | 0.458744 | G | 0.400263 | 0.058481 | No Change: Both O | - |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 285 | G | 0.332752 | S | 0.369249 | -0.036497 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 276 | W | 0.072088 | S | 0.233241 | -0.161153 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 285 | G | 0.332752 | C | 0.162345 | 0.170407 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 321 | G | 0.202463 | S | 0.240812 | -0.038349 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 274 | L | 0.118344 | H | 0.194589 | -0.076245 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 281 | L | 0.079062 | S | 0.175779 | -0.096717 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 455 | H | 0.980453 | Q | 0.98762 | -0.007167 | No Change: Both D | - |
| P56696 | KCNQ4_HUMAN Potassium voltage-gated channel subfamily KQT member 4 OS=Homo sapiens GN=KCNQ4 PE=1 SV=2 | 287 | G | 0.428122 | R | 0.393219 | 0.034903 | No Change: Both O | Deafness autosomal dominant type 2A (DFNA2A) [MIM:600101] |
| Q9NR82 | KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens GN=KCNQ5 PE=1 SV=3 | 191 | W | 0.120226 | G | 0.304998 | -0.184772 | No Change: Both O | A colorectal cancer sample |
| Q9NR82 | KCNQ5_HUMAN Potassium voltage-gated channel subfamily KQT member 5 OS=Homo sapiens GN=KCNQ5 PE=1 SV=3 | 244 | R | 0.210988 | C | 0.092941 | 0.118047 | No Change: Both O | A colorectal cancer sample |
| Q96KK3 | KCNS1_HUMAN Potassium voltage-gated channel subfamily S member 1 OS=Homo sapiens GN=KCNS1 PE=2 SV=2 | 489 | I | 0.772918 | V | 0.805391 | -0.032473 | No Change: Both D | - |
| Q96KK3 | KCNS1_HUMAN Potassium voltage-gated channel subfamily S member 1 OS=Homo sapiens GN=KCNS1 PE=2 SV=2 | 508 | Q | 0.981965 | R | 0.979457 | 0.002508 | No Change: Both D | - |
| Q9BQ31 | KCNS3_HUMAN Potassium voltage-gated channel subfamily S member 3 OS=Homo sapiens GN=KCNS3 PE=2 SV=3 | 450 | T | 0.204611 | A | 0.184123 | 0.020488 | No Change: Both O | - |
| Q9BQ31 | KCNS3_HUMAN Potassium voltage-gated channel subfamily S member 3 OS=Homo sapiens GN=KCNS3 PE=2 SV=3 | 225 | V | 0.093017 | L | 0.09072 | 0.002297 | No Change: Both O | - |
| Q6UVM3 | KCNT2_HUMAN Potassium channel subfamily T member 2 OS=Homo sapiens GN=KCNT2 PE=1 SV=1 | 33 | V | 0.316863 | I | 0.276694 | 0.040169 | No Change: Both O | A breast cancer sample |
| Q6UVM3 | KCNT2_HUMAN Potassium channel subfamily T member 2 OS=Homo sapiens GN=KCNT2 PE=1 SV=1 | 413 | C | 0.079963 | W | 0.067134 | 0.012829 | No Change: Both O | - |
| Q6UVM3 | KCNT2_HUMAN Potassium channel subfamily T member 2 OS=Homo sapiens GN=KCNT2 PE=1 SV=1 | 429 | K | 0.203292 | N | 0.171208 | 0.032084 | No Change: Both O | - |
| A8MYU2 | KCNU1_HUMAN Potassium channel subfamily U member 1 OS=Homo sapiens GN=KCNU1 PE=2 SV=2 | 768 | W | 0.023428 | R | 0.063633 | -0.040205 | No Change: Both O | - |
| A8MYU2 | KCNU1_HUMAN Potassium channel subfamily U member 1 OS=Homo sapiens GN=KCNU1 PE=2 SV=2 | 916 | N | 0.069357 | S | 0.090646 | -0.021289 | No Change: Both O | - |
| A8MYU2 | KCNU1_HUMAN Potassium channel subfamily U member 1 OS=Homo sapiens GN=KCNU1 PE=2 SV=2 | 175 | D | 0.072072 | N | 0.071662 | 4.10E-04 | No Change: Both O | - |
| Q6PIU1 | KCNV1_HUMAN Potassium voltage-gated channel subfamily V member 1 OS=Homo sapiens GN=KCNV1 PE=1 SV=2 | 22 | D | 0.7841 | G | 0.773521 | 0.010579 | No Change: Both D | - |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 126 | L | 0.574287 | Q | 0.671315 | -0.097028 | No Change: Both D | Cone dystrophy retinal type 3B (RCD3B) [MIM:610356] |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 188 | W | 0.100404 | C | 0.133853 | -0.033449 | No Change: Both O | Cone dystrophy retinal type 3B (RCD3B) [MIM:610356] |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 256 | S | 0.325583 | W | 0.117876 | 0.207707 | No Change: Both O | Cone dystrophy retinal type 3B (RCD3B) [MIM:610356] |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 259 | A | 0.369028 | V | 0.291328 | 0.0777 | No Change: Both O | Cone dystrophy retinal type 3B (RCD3B) [MIM:610356] |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 459 | G | 0.291603 | D | 0.319217 | -0.027614 | No Change: Both O | Cone dystrophy retinal type 3B (RCD3B) [MIM:610356] |
| Q8TDN2 | KCNV2_HUMAN Potassium voltage-gated channel subfamily V member 2 OS=Homo sapiens GN=KCNV2 PE=1 SV=1 | 533 | L | 0.492224 | V | 0.45179 | 0.040434 | No Change: Both O | - |
| Q6ZWJ8 | KCP_HUMAN Kielin/chordin-like protein OS=Homo sapiens GN=KCP PE=2 SV=2 | 47 | G | 0.669563 | E | 0.726637 | -0.057074 | No Change: Both D | - |
| Q6ZWJ8 | KCP_HUMAN Kielin/chordin-like protein OS=Homo sapiens GN=KCP PE=2 SV=2 | 397 | K | 0.834777 | E | 0.867356 | -0.032579 | No Change: Both D | - |
| Q6ZWJ8 | KCP_HUMAN Kielin/chordin-like protein OS=Homo sapiens GN=KCP PE=2 SV=2 | 623 | D | 0.945254 | V | 0.916776 | 0.028478 | No Change: Both D | - |
| Q6ZWJ8 | KCP_HUMAN Kielin/chordin-like protein OS=Homo sapiens GN=KCP PE=2 SV=2 | 1128 | P | 0.945372 | R | 0.936168 | 0.009204 | No Change: Both D | - |
| Q719H9 | KCTD1_HUMAN BTB/POZ domain-containing protein KCTD1 OS=Homo sapiens GN=KCTD1 PE=1 SV=1 | 107 | L | 0.189694 | W | 0.126913 | 0.062781 | No Change: Both O | - |
| Q693B1 | KCD11_HUMAN BTB/POZ domain-containing protein KCTD11 OS=Homo sapiens GN=KCTD11 PE=1 SV=1 | 22 | G | 0.394484 | S | 0.432989 | -0.038505 | No Change: Both O | - |
| Q96SI1 | KCD15_HUMAN BTB/POZ domain-containing protein KCTD15 OS=Homo sapiens GN=KCTD15 PE=1 SV=1 | 64 | G | 0.338088 | S | 0.401721 | -0.063633 | No Change: Both O | - |
| Q8N5Z5 | KCD17_HUMAN BTB/POZ domain-containing protein KCTD17 OS=Homo sapiens GN=KCTD17 PE=1 SV=3 | 51 | R | 0.441892 | G | 0.42812 | 0.013772 | No Change: Both O | - |
| Q6PI47 | KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 OS=Homo sapiens GN=KCTD18 PE=2 SV=2 | 333 | A | 0.947116 | V | 0.918243 | 0.028873 | No Change: Both D | - |
| Q6PI47 | KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 OS=Homo sapiens GN=KCTD18 PE=2 SV=2 | 336 | G | 0.93392 | C | 0.897364 | 0.036556 | No Change: Both D | - |
| Q6PI47 | KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 OS=Homo sapiens GN=KCTD18 PE=2 SV=2 | 390 | C | 0.883753 | S | 0.921027 | -0.037274 | No Change: Both D | - |
| Q6PI47 | KCD18_HUMAN BTB/POZ domain-containing protein KCTD18 OS=Homo sapiens GN=KCTD18 PE=2 SV=2 | 413 | A | 0.89798 | V | 0.844211 | 0.053769 | No Change: Both D | - |
| Q17RG1 | KCD19_HUMAN BTB/POZ domain-containing protein KCTD19 OS=Homo sapiens GN=KCTD19 PE=2 SV=1 | 750 | E | 0.763737 | K | 0.751995 | 0.011742 | No Change: Both D | - |
| Q7Z5Y7 | KCD20_HUMAN BTB/POZ domain-containing protein KCTD20 OS=Homo sapiens GN=KCTD20 PE=1 SV=1 | 171 | S | 0.18518 | T | 0.155925 | 0.029255 | No Change: Both O | - |
| Q9Y597 | KCTD3_HUMAN BTB/POZ domain-containing protein KCTD3 OS=Homo sapiens GN=KCTD3 PE=1 SV=2 | 9 | F | 0.523666 | V | 0.558919 | -0.035253 | No Change: Both D | - |
| Q6ZWB6 | KCTD8_HUMAN BTB/POZ domain-containing protein KCTD8 OS=Homo sapiens GN=KCTD8 PE=2 SV=1 | 329 | P | 0.728998 | L | 0.607254 | 0.121744 | No Change: Both D | - |
| Q6UW63 | KDEL1_HUMAN KDEL motif-containing protein 1 OS=Homo sapiens GN=KDELC1 PE=1 SV=1 | 114 | I | 0.305096 | V | 0.352154 | -0.047058 | No Change: Both O | - |
| Q7Z4H8 | KDEL2_HUMAN KDEL motif-containing protein 2 OS=Homo sapiens GN=KDELC2 PE=1 SV=2 | 319 | R | 0.612556 | L | 0.490394 | 0.122162 | D to O | - |
| O43731 | ERD23_HUMAN ER lumen protein retaining receptor 3 OS=Homo sapiens GN=KDELR3 PE=2 SV=1 | 199 | V | 0.053292 | G | 0.097263 | -0.043971 | No Change: Both O | - |
| Q9Y4C1 | KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo sapiens GN=KDM3A PE=1 SV=4 | 212 | I | 0.254541 | V | 0.295428 | -0.040887 | No Change: Both O | - |
| Q9Y4C1 | KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo sapiens GN=KDM3A PE=1 SV=4 | 194 | E | 0.350383 | K | 0.369304 | -0.018921 | No Change: Both O | - |
| Q9Y4C1 | KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo sapiens GN=KDM3A PE=1 SV=4 | 710 | V | 0.216062 | E | 0.408556 | -0.192494 | No Change: Both O | - |
| Q9Y4C1 | KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo sapiens GN=KDM3A PE=1 SV=4 | 187 | D | 0.587195 | H | 0.571349 | 0.015846 | No Change: Both D | A breast cancer sample |
| Q9Y4C1 | KDM3A_HUMAN Lysine-specific demethylase 3A OS=Homo sapiens GN=KDM3A PE=1 SV=4 | 447 | S | 0.957441 | P | 0.959857 | -0.002416 | No Change: Both D | - |
| Q7LBC6 | KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo sapiens GN=KDM3B PE=1 SV=2 | 256 | A | 0.756574 | T | 0.790589 | -0.034015 | No Change: Both D | - |
| Q7LBC6 | KDM3B_HUMAN Lysine-specific demethylase 3B OS=Homo sapiens GN=KDM3B PE=1 SV=2 | 1201 | S | 0.965712 | N | 0.955633 | 0.010079 | No Change: Both D | - |
| O75164 | KDM4A_HUMAN Lysine-specific demethylase 4A OS=Homo sapiens GN=KDM4A PE=1 SV=2 | 482 | A | 0.871444 | E | 0.912536 | -0.041092 | No Change: Both D | - |
| O75164 | KDM4A_HUMAN Lysine-specific demethylase 4A OS=Homo sapiens GN=KDM4A PE=1 SV=2 | 877 | V | 0.028524 | G | 0.048519 | -0.019995 | No Change: Both O | - |
| O94953 | KDM4B_HUMAN Lysine-specific demethylase 4B OS=Homo sapiens GN=KDM4B PE=1 SV=4 | 29 | N | 0.244139 | T | 0.239192 | 0.004947 | No Change: Both O | - |
| O94953 | KDM4B_HUMAN Lysine-specific demethylase 4B OS=Homo sapiens GN=KDM4B PE=1 SV=4 | 710 | K | 0.659812 | E | 0.66517 | -0.005358 | No Change: Both D | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 396 | D | 0.97219 | N | 0.966743 | 0.005447 | No Change: Both D | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 767 | Q | 0.515159 | E | 0.556044 | -0.040885 | No Change: Both D | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 1039 | V | 0.345597 | I | 0.305117 | 0.04048 | No Change: Both O | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 206 | E | 0.24893 | D | 0.227567 | 0.021363 | No Change: Both O | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 492 | S | 0.971905 | T | 0.956258 | 0.015647 | No Change: Both D | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 697 | N | 0.466507 | S | 0.526293 | -0.059786 | O to D | - |
| Q9H3R0 | KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens GN=KDM4C PE=1 SV=2 | 772 | K | 0.305566 | R | 0.245722 | 0.059844 | No Change: Both O | - |
| Q6B0I6 | KDM4D_HUMAN Lysine-specific demethylase 4D OS=Homo sapiens GN=KDM4D PE=1 SV=3 | 408 | R | 0.921722 | Q | 0.912397 | 0.009325 | No Change: Both D | - |
| Q6B0I6 | KDM4D_HUMAN Lysine-specific demethylase 4D OS=Homo sapiens GN=KDM4D PE=1 SV=3 | 355 | S | 0.725463 | R | 0.718567 | 0.006896 | No Change: Both D | - |
| Q6B0I6 | KDM4D_HUMAN Lysine-specific demethylase 4D OS=Homo sapiens GN=KDM4D PE=1 SV=3 | 471 | A | 0.941452 | S | 0.95386 | -0.012408 | No Change: Both D | - |
| B2RXH2 | KD4DL_HUMAN Lysine-specific demethylase 4D-like OS=Homo sapiens GN=KDM4DL PE=1 SV=1 | 26 | A | 0.271551 | T | 0.316238 | -0.044687 | No Change: Both O | - |
| B2RXH2 | KD4DL_HUMAN Lysine-specific demethylase 4D-like OS=Homo sapiens GN=KDM4DL PE=1 SV=1 | 42 | Q | 0.439408 | R | 0.401568 | 0.03784 | No Change: Both O | - |
| B2RXH2 | KD4DL_HUMAN Lysine-specific demethylase 4D-like OS=Homo sapiens GN=KDM4DL PE=1 SV=1 | 113 | Q | 0.510867 | R | 0.484437 | 0.02643 | D to O | - |
| B2RXH2 | KD4DL_HUMAN Lysine-specific demethylase 4D-like OS=Homo sapiens GN=KDM4DL PE=1 SV=1 | 258 | F | 0.188103 | S | 0.385674 | -0.197571 | No Change: Both O | - |
| P29375 | KDM5A_HUMAN Lysine-specific demethylase 5A OS=Homo sapiens GN=KDM5A PE=1 SV=3 | 865 | M | 0.748703 | T | 0.740922 | 0.007781 | No Change: Both D | - |
| P29375 | KDM5A_HUMAN Lysine-specific demethylase 5A OS=Homo sapiens GN=KDM5A PE=1 SV=3 | 1190 | P | 0.601362 | A | 0.505942 | 0.09542 | No Change: Both D | - |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 388 | A | 0.435468 | P | 0.534531 | -0.099063 | O to D | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 402 | D | 0.401898 | Y | 0.251754 | 0.150144 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 698 | E | 0.559769 | K | 0.535873 | 0.023896 | No Change: Both D | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 731 | L | 0.126393 | F | 0.098774 | 0.027619 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 87 | D | 0.086008 | G | 0.075562 | 0.010446 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 451 | S | 0.596561 | R | 0.518891 | 0.07767 | No Change: Both D | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 642 | F | 0.102616 | L | 0.125543 | -0.022927 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 750 | R | 0.229344 | W | 0.092107 | 0.137237 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 751 | Y | 0.195206 | C | 0.15883 | 0.036376 | No Change: Both O | Mental retardation syndromic X-linked JARID1C-related (MRXSJ) [MIM:300534] |
| P41229 | KDM5C_HUMAN Lysine-specific demethylase 5C OS=Homo sapiens GN=KDM5C PE=1 SV=2 | 640 | C | 0.134525 | Y | 0.173922 | -0.039397 | No Change: Both O | - |
| Q9BY66 | KDM5D_HUMAN Lysine-specific demethylase 5D OS=Homo sapiens GN=KDM5D PE=1 SV=2 | 1186 | V | 0.341636 | L | 0.352103 | -0.010467 | No Change: Both O | - |
| O15550 | KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens GN=KDM6A PE=1 SV=2 | 30 | A | 0.953049 | T | 0.94995 | 0.003099 | No Change: Both D | - |
| O15550 | KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens GN=KDM6A PE=1 SV=2 | 497 | Q | 0.661834 | H | 0.577938 | 0.083896 | No Change: Both D | - |
| O15550 | KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens GN=KDM6A PE=1 SV=2 | 726 | T | 0.851247 | K | 0.859238 | -0.007991 | No Change: Both D | - |
| O15550 | KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens GN=KDM6A PE=1 SV=2 | 1106 | L | 0.197382 | R | 0.29932 | -0.101938 | No Change: Both O | A colorectal cancer sample |
| O15550 | KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens GN=KDM6A PE=1 SV=2 | 581 | T | 0.657799 | A | 0.615109 | 0.04269 | No Change: Both D | - |
| O15054 | KDM6B_HUMAN Lysine-specific demethylase 6B OS=Homo sapiens GN=KDM6B PE=1 SV=4 | 308 | S | 0.943807 | L | 0.912518 | 0.031289 | No Change: Both D | - |
| O15054 | KDM6B_HUMAN Lysine-specific demethylase 6B OS=Homo sapiens GN=KDM6B PE=1 SV=4 | 203 | P | 0.866586 | A | 0.811327 | 0.055259 | No Change: Both D | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 472 | Q | 0.566749 | H | 0.550011 | 0.016738 | No Change: Both D | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 297 | V | 0.458066 | I | 0.447021 | 0.011045 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 275 | R | 0.60287 | L | 0.510192 | 0.092678 | No Change: Both D | A colorectal cancer sample |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 873 | G | 0.665136 | R | 0.662428 | 0.002708 | No Change: Both D | A colorectal cancer sample |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 2 | Q | 0.776634 | R | 0.740944 | 0.03569 | No Change: Both D | A lung adenocarcinoma sample |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 136 | V | 0.239866 | M | 0.280772 | -0.040906 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 248 | A | 0.144917 | G | 0.191784 | -0.046867 | No Change: Both O | A renal clear cell carcinoma sample |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 462 | L | 0.226849 | V | 0.236185 | -0.009336 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 482 | C | 0.360876 | R | 0.51972 | -0.158844 | O to D | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 539 | G | 0.324072 | R | 0.323899 | 1.73E-04 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 689 | T | 0.49692 | M | 0.453914 | 0.043006 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 814 | D | 0.491497 | N | 0.447497 | 0.044 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 1065 | A | 0.319518 | T | 0.343317 | -0.023799 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 848 | V | 0.218372 | E | 0.397897 | -0.179525 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 952 | V | 0.401421 | I | 0.380354 | 0.021067 | No Change: Both O | - |
| P35968 | VGFR2_HUMAN Vascular endothelial growth factor receptor 2 OS=Homo sapiens GN=KDR PE=1 SV=2 | 1147 | P | 0.500927 | S | 0.51845 | -0.017523 | No Change: Both D | Hemangioma capillary infantile (HCI) [MIM:602089] |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 167 | V | 0.12727 | F | 0.105562 | 0.021708 | No Change: Both O | A lung adenocarcinoma patient |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 236 | D | 0.276794 | H | 0.227876 | 0.048918 | No Change: Both O | - |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 284 | Q | 0.207603 | L | 0.121499 | 0.086104 | No Change: Both O | A lung adenocarcinoma patient |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 333 | G | 0.152969 | C | 0.066661 | 0.086308 | No Change: Both O | - |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 349 | D | 0.306143 | N | 0.300592 | 0.005551 | No Change: Both O | - |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 350 | G | 0.249062 | S | 0.311774 | -0.062712 | No Change: Both O | - |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 364 | G | 0.230258 | C | 0.12779 | 0.102468 | No Change: Both O | A lung adenocarcinoma cell line |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 430 | G | 0.347738 | C | 0.197232 | 0.150506 | No Change: Both O | A lung adenocarcinoma patient |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 23 | C | 0.676289 | Y | 0.6052 | 0.071089 | No Change: Both D | A breast cancer sample |
| Q14145 | KEAP1_HUMAN Kelch-like ECH-associated protein 1 OS=Homo sapiens GN=KEAP1 PE=1 SV=2 | 522 | A | 0.17985 | V | 0.125674 | 0.054176 | No Change: Both O | A breast cancer sample |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 180 | R | 0.180016 | P | 0.20743 | -0.027414 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 193 | T | 0.18848 | M | 0.161253 | 0.027227 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 281 | R | 0.303245 | W | 0.119476 | 0.183769 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 281 | R | 0.303245 | Q | 0.329767 | -0.026522 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 302 | V | 0.258621 | A | 0.374608 | -0.115987 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 494 | E | 0.409344 | V | 0.226687 | 0.182657 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 597 | L | 0.125336 | P | 0.226973 | -0.101637 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 248 | R | 0.122386 | Q | 0.171803 | -0.049417 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 249 | E | 0.111069 | K | 0.113133 | -0.002064 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 322 | A | 0.176323 | V | 0.133676 | 0.042647 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 382 | Q | 0.672418 | R | 0.665451 | 0.006967 | No Change: Both D | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 406 | R | 0.740324 | Q | 0.73216 | 0.008164 | No Change: Both D | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 492 | R | 0.372243 | Q | 0.423814 | -0.051571 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 548 | H | 0.161387 | R | 0.160893 | 4.94E-04 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 163 | A | 0.288072 | T | 0.314297 | -0.026225 | No Change: Both O | - |
| P23276 | KELL_HUMAN Kell blood group glycoprotein OS=Homo sapiens GN=KEL PE=1 SV=2 | 726 | S | 0.473441 | A | 0.3688 | 0.104641 | No Change: Both O | - |
| O60938 | KERA_HUMAN Keratocan OS=Homo sapiens GN=KERA PE=1 SV=1 | 215 | T | 0.390366 | K | 0.48569 | -0.095324 | No Change: Both O | The autosomal recessive cornea plana 2 (CNA2) [MIM:217300] |
| O60938 | KERA_HUMAN Keratocan OS=Homo sapiens GN=KERA PE=1 SV=1 | 247 | N | 0.424815 | S | 0.465554 | -0.040739 | No Change: Both O | The autosomal recessive cornea plana 2 (CNA2) [MIM:217300] |
| O60938 | KERA_HUMAN Keratocan OS=Homo sapiens GN=KERA PE=1 SV=1 | 235 | V | 0.134382 | G | 0.207713 | -0.073331 | No Change: Both O | - |
| Q5VWX1 | KHDR2_HUMAN KH domain-containing RNA-binding signal transduction-associated protein 2 OS=Homo sapiens GN=KHDRBS2 PE=1 SV=1 | 308 | G | 0.603889 | A | 0.590395 | 0.013494 | No Change: Both D | - |
| P50053 | KHK_HUMAN Ketohexokinase OS=Homo sapiens GN=KHK PE=1 SV=1 | 40 | G | 0.538493 | R | 0.535305 | 0.003188 | No Change: Both D | Fructosuria (FRUCT) [MIM:229800] |
| P50053 | KHK_HUMAN Ketohexokinase OS=Homo sapiens GN=KHK PE=1 SV=1 | 43 | A | 0.518842 | T | 0.56709 | -0.048248 | No Change: Both D | Fructosuria (FRUCT) [MIM:229800] |
| P50053 | KHK_HUMAN Ketohexokinase OS=Homo sapiens GN=KHK PE=1 SV=1 | 49 | V | 0.238166 | I | 0.212819 | 0.025347 | No Change: Both O | - |
| P50053 | KHK_HUMAN Ketohexokinase OS=Homo sapiens GN=KHK PE=1 SV=1 | 159 | R | 0.64614 | G | 0.635127 | 0.011013 | No Change: Both D | - |
| O15037 | KHNYN_HUMAN Protein KHNYN OS=Homo sapiens GN=KHNYN PE=1 SV=3 | 261 | K | 0.856235 | T | 0.827741 | 0.028494 | No Change: Both D | - |
| O15037 | KHNYN_HUMAN Protein KHNYN OS=Homo sapiens GN=KHNYN PE=1 SV=3 | 270 | W | 0.811439 | L | 0.84749 | -0.036051 | No Change: Both D | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 289 | R | 0.368328 | P | 0.40986 | -0.041532 | No Change: Both O | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 297 | V | 0.417978 | L | 0.445653 | -0.027675 | No Change: Both O | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 13 | S | 0.978996 | N | 0.974848 | 0.004148 | No Change: Both D | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 264 | I | 0.289093 | V | 0.322415 | -0.033322 | No Change: Both O | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 414 | T | 0.152091 | S | 0.212181 | -0.06009 | No Change: Both O | - |
| Q15397 | K0020_HUMAN Pumilio domain-containing protein KIAA0020 OS=Homo sapiens GN=KIAA0020 PE=1 SV=3 | 480 | R | 0.558508 | Q | 0.556039 | 0.002469 | No Change: Both D | - |
| Q15053 | K0040_HUMAN Uncharacterized protein KIAA0040 OS=Homo sapiens GN=KIAA0040 PE=2 SV=1 | 26 | Q | 0.805374 | K | 0.80098 | 0.004394 | No Change: Both D | - |
| Q14695 | K0087_HUMAN Uncharacterized protein KIAA0087 OS=Homo sapiens GN=KIAA0087 PE=1 SV=1 | 85 | S | 0.688604 | N | 0.659085 | 0.029519 | No Change: Both D | - |
| Q8N766 | K0090_HUMAN Uncharacterized protein KIAA0090 OS=Homo sapiens GN=KIAA0090 PE=1 SV=1 | 295 | L | 0.27982 | S | 0.45931 | -0.17949 | No Change: Both O | - |
| Q8N766 | K0090_HUMAN Uncharacterized protein KIAA0090 OS=Homo sapiens GN=KIAA0090 PE=1 SV=1 | 345 | S | 0.864447 | T | 0.832054 | 0.032393 | No Change: Both D | - |
| Q8N766 | K0090_HUMAN Uncharacterized protein KIAA0090 OS=Homo sapiens GN=KIAA0090 PE=1 SV=1 | 347 | S | 0.885917 | N | 0.858762 | 0.027155 | No Change: Both D | - |
| Q14667 | K0100_HUMAN UPF0378 protein KIAA0100 OS=Homo sapiens GN=KIAA0100 PE=1 SV=3 | 986 | H | 0.483748 | Q | 0.508281 | -0.024533 | O to D | - |
| Q14667 | K0100_HUMAN UPF0378 protein KIAA0100 OS=Homo sapiens GN=KIAA0100 PE=1 SV=3 | 1516 | V | 0.879937 | G | 0.915313 | -0.035376 | No Change: Both D | - |
| Q14667 | K0100_HUMAN UPF0378 protein KIAA0100 OS=Homo sapiens GN=KIAA0100 PE=1 SV=3 | 2060 | R | 0.580559 | G | 0.583982 | -0.003423 | No Change: Both D | - |
| Q14154 | DELE_HUMAN Death ligand signal enhancer OS=Homo sapiens GN=KIAA0141 PE=1 SV=3 | 128 | F | 0.684433 | L | 0.715066 | -0.030633 | No Change: Both D | - |
| Q14154 | DELE_HUMAN Death ligand signal enhancer OS=Homo sapiens GN=KIAA0141 PE=1 SV=3 | 247 | A | 0.188503 | T | 0.216362 | -0.027859 | No Change: Both O | - |
| Q14154 | DELE_HUMAN Death ligand signal enhancer OS=Homo sapiens GN=KIAA0141 PE=1 SV=3 | 95 | A | 0.074745 | T | 0.082271 | -0.007526 | No Change: Both O | - |
| Q14154 | DELE_HUMAN Death ligand signal enhancer OS=Homo sapiens GN=KIAA0141 PE=1 SV=3 | 468 | R | 0.837579 | C | 0.792507 | 0.045072 | No Change: Both D | - |
| Q14154 | DELE_HUMAN Death ligand signal enhancer OS=Homo sapiens GN=KIAA0141 PE=1 SV=3 | 60 | G | 0.748404 | D | 0.752213 | -0.003809 | No Change: Both D | - |
| Q12767 | K0195_HUMAN Uncharacterized protein KIAA0195 OS=Homo sapiens GN=KIAA0195 PE=1 SV=1 | 1040 | I | 0.416982 | T | 0.569426 | -0.152444 | O to D | - |
| Q12768 | STRUM_HUMAN WASH complex subunit strumpellin OS=Homo sapiens GN=KIAA0196 PE=1 SV=1 | 471 | N | 0.303243 | D | 0.305052 | -0.001809 | No Change: Both O | Spastic paraplegia autosomal dominant type 8 (SPG8) [MIM:603563] |
| Q12768 | STRUM_HUMAN WASH complex subunit strumpellin OS=Homo sapiens GN=KIAA0196 PE=1 SV=1 | 619 | L | 0.290787 | F | 0.261181 | 0.029606 | No Change: Both O | Spastic paraplegia autosomal dominant type 8 (SPG8) [MIM:603563] |
| Q12768 | STRUM_HUMAN WASH complex subunit strumpellin OS=Homo sapiens GN=KIAA0196 PE=1 SV=1 | 626 | V | 0.122898 | F | 0.100678 | 0.02222 | No Change: Both O | Spastic paraplegia autosomal dominant type 8 (SPG8) [MIM:603563] |
| Q9H714 | K226L_HUMAN Uncharacterized protein KIAA0226-like OS=Homo sapiens GN=KIAA0226L PE=1 SV=3 | 152 | G | 0.752747 | R | 0.782846 | -0.030099 | No Change: Both D | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 142 | T | 0.525321 | P | 0.645129 | -0.119808 | No Change: Both D | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 311 | A | 0.988888 | T | 0.991451 | -0.002563 | No Change: Both D | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 919 | G | 0.305661 | A | 0.240399 | 0.065262 | No Change: Both O | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 567 | G | 0.417457 | S | 0.468267 | -0.05081 | No Change: Both O | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 773 | S | 0.327378 | G | 0.283553 | 0.043825 | No Change: Both O | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 774 | V | 0.299472 | A | 0.368411 | -0.068939 | No Change: Both O | - |
| Q5VV43 | K0319_HUMAN Dyslexia-associated protein KIAA0319 OS=Homo sapiens GN=KIAA0319 PE=1 SV=1 | 1013 | Y | 0.848058 | C | 0.870953 | -0.022895 | No Change: Both D | - |
| Q8IZA0 | K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens GN=KIAA0319L PE=1 SV=2 | 243 | G | 0.792496 | D | 0.799481 | -0.006985 | No Change: Both D | - |
| Q8IZA0 | K319L_HUMAN Dyslexia-associated protein KIAA0319-like protein OS=Homo sapiens GN=KIAA0319L PE=1 SV=2 | 837 | Q | 0.422853 | H | 0.386527 | 0.036326 | No Change: Both O | - |
| O15091 | MRRP3_HUMAN Mitochondrial ribonuclease P protein 3 OS=Homo sapiens GN=KIAA0391 PE=1 SV=2 | 437 | N | 0.389342 | S | 0.451804 | -0.062462 | No Change: Both O | - |
| Q6ZU52 | K0408_HUMAN Uncharacterized protein KIAA0408 OS=Homo sapiens GN=KIAA0408 PE=1 SV=1 | 61 | S | 0.309483 | R | 0.278166 | 0.031317 | No Change: Both O | - |
| Q6ZU52 | K0408_HUMAN Uncharacterized protein KIAA0408 OS=Homo sapiens GN=KIAA0408 PE=1 SV=1 | 331 | S | 0.664819 | L | 0.512231 | 0.152588 | No Change: Both D | - |
| O43299 | K0415_HUMAN Protein KIAA0415 OS=Homo sapiens GN=KIAA0415 PE=1 SV=2 | 94 | S | 0.542078 | C | 0.340999 | 0.201079 | D to O | - |
| O75071 | K0494_HUMAN EF-hand domain-containing protein KIAA0494 OS=Homo sapiens GN=KIAA0494 PE=1 SV=1 | 337 | L | 0.791537 | P | 0.839822 | -0.048285 | No Change: Both D | - |
| O60268 | K0513_HUMAN Uncharacterized protein KIAA0513 OS=Homo sapiens GN=KIAA0513 PE=2 SV=1 | 100 | R | 0.710968 | H | 0.637479 | 0.073489 | No Change: Both D | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 522 | T | 0.402146 | M | 0.341606 | 0.06054 | No Change: Both O | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 535 | A | 0.508468 | S | 0.603236 | -0.094768 | No Change: Both D | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 885 | R | 0.986152 | Q | 0.984268 | 0.001884 | No Change: Both D | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 1267 | A | 0.518028 | T | 0.561308 | -0.04328 | No Change: Both D | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 1368 | R | 0.161625 | Q | 0.172755 | -0.01113 | No Change: Both O | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 1597 | V | 0.82828 | I | 0.826519 | 0.001761 | No Change: Both D | - |
| O60303 | K0556_HUMAN Uncharacterized protein KIAA0556 OS=Homo sapiens GN=KIAA0556 PE=1 SV=4 | 1240 | A | 0.366484 | V | 0.304112 | 0.062372 | No Change: Both O | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 165 | R | 0.22143 | H | 0.177001 | 0.044429 | No Change: Both O | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 383 | M | 0.558209 | T | 0.565774 | -0.007565 | No Change: Both D | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 408 | G | 0.328806 | R | 0.407832 | -0.079026 | No Change: Both O | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 660 | R | 0.674495 | G | 0.586607 | 0.087888 | No Change: Both D | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 1300 | E | 0.512686 | K | 0.511167 | 0.001519 | No Change: Both D | - |
| A3KMH1 | K0564_HUMAN Uncharacterized protein KIAA0564 OS=Homo sapiens GN=KIAA0564 PE=1 SV=2 | 898 | R | 0.084847 | K | 0.104046 | -0.019199 | No Change: Both O | - |
| O75153 | K0664_HUMAN Protein KIAA0664 OS=Homo sapiens GN=KIAA0664 PE=1 SV=2 | 633 | A | 0.655646 | V | 0.604358 | 0.051288 | No Change: Both D | - |
| A2RU30 | K0748_HUMAN Uncharacterized protein KIAA0748 OS=Homo sapiens GN=KIAA0748 PE=1 SV=2 | 496 | E | 0.986023 | K | 0.983378 | 0.002645 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 201 | H | 0.860996 | Q | 0.882646 | -0.02165 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 375 | E | 0.711163 | D | 0.677858 | 0.033305 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 375 | E | 0.711163 | G | 0.624635 | 0.086528 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 444 | D | 0.780893 | N | 0.724178 | 0.056715 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 466 | L | 0.40194 | P | 0.542233 | -0.140293 | O to D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 501 | V | 0.82755 | M | 0.847824 | -0.020274 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 566 | P | 0.95336 | L | 0.908974 | 0.044386 | No Change: Both D | - |
| Q2KHM9 | K0753_HUMAN Uncharacterized protein KIAA0753 OS=Homo sapiens GN=KIAA0753 PE=2 SV=3 | 896 | Q | 0.370714 | R | 0.359002 | 0.011712 | No Change: Both O | - |
| O94854 | K0754_HUMAN Uncharacterized protein KIAA0754 OS=Homo sapiens GN=KIAA0754 PE=1 SV=3 | 824 | I | 0.610881 | V | 0.640968 | -0.030087 | No Change: Both D | - |
| O94854 | K0754_HUMAN Uncharacterized protein KIAA0754 OS=Homo sapiens GN=KIAA0754 PE=1 SV=3 | 969 | T | 0.999696 | A | 0.999691 | 5.00E-06 | No Change: Both D | - |
| O94854 | K0754_HUMAN Uncharacterized protein KIAA0754 OS=Homo sapiens GN=KIAA0754 PE=1 SV=3 | 1058 | E | 0.97448 | K | 0.965426 | 0.009054 | No Change: Both D | - |
| Q8IV33 | K0825_HUMAN Uncharacterized protein KIAA0825 OS=Homo sapiens GN=KIAA0825 PE=2 SV=2 | 46 | K | 0.387117 | E | 0.399397 | -0.01228 | No Change: Both O | - |
| O94964 | K0889_HUMAN Uncharacterized protein KIAA0889 OS=Homo sapiens GN=KIAA0889 PE=1 SV=2 | 993 | Q | 0.737153 | H | 0.693422 | 0.043731 | No Change: Both D | - |
| A2VDJ0 | T131L_HUMAN Transmembrane protein 131-like OS=Homo sapiens GN=KIAA0922 PE=1 SV=2 | 604 | I | 0.136861 | V | 0.171897 | -0.035036 | No Change: Both O | - |
| A2VDJ0 | T131L_HUMAN Transmembrane protein 131-like OS=Homo sapiens GN=KIAA0922 PE=1 SV=2 | 645 | M | 0.153558 | T | 0.189792 | -0.036234 | No Change: Both O | - |
| A2VDJ0 | T131L_HUMAN Transmembrane protein 131-like OS=Homo sapiens GN=KIAA0922 PE=1 SV=2 | 1110 | S | 0.93338 | Y | 0.866979 | 0.066401 | No Change: Both D | - |
| A2VDJ0 | T131L_HUMAN Transmembrane protein 131-like OS=Homo sapiens GN=KIAA0922 PE=1 SV=2 | 1254 | N | 0.655367 | S | 0.760619 | -0.105252 | No Change: Both D | - |
| A2VDJ0 | T131L_HUMAN Transmembrane protein 131-like OS=Homo sapiens GN=KIAA0922 PE=1 SV=2 | 1392 | A | 0.749216 | P | 0.847635 | -0.098419 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 391 | C | 0.818066 | S | 0.905756 | -0.08769 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 596 | K | 0.869621 | E | 0.885169 | -0.015548 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 901 | V | 0.712605 | I | 0.674156 | 0.038449 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 1054 | T | 0.668134 | A | 0.626792 | 0.041342 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 1058 | G | 0.679867 | D | 0.690273 | -0.010406 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 1597 | Q | 0.934201 | P | 0.93266 | 0.001541 | No Change: Both D | - |
| Q9Y2F5 | K0947_HUMAN Uncharacterized protein KIAA0947 OS=Homo sapiens GN=KIAA0947 PE=1 SV=5 | 1618 | P | 0.914713 | L | 0.858586 | 0.056127 | No Change: Both D | - |
| Q5TB80 | QN1_HUMAN Protein QN1 homolog OS=Homo sapiens GN=KIAA1009 PE=1 SV=2 | 266 | C | 0.570874 | S | 0.754626 | -0.183752 | No Change: Both D | - |
| Q5TB80 | QN1_HUMAN Protein QN1 homolog OS=Homo sapiens GN=KIAA1009 PE=1 SV=2 | 272 | E | 0.663701 | Q | 0.619789 | 0.043912 | No Change: Both D | - |
| Q5TB80 | QN1_HUMAN Protein QN1 homolog OS=Homo sapiens GN=KIAA1009 PE=1 SV=2 | 342 | S | 0.824272 | C | 0.710277 | 0.113995 | No Change: Both D | - |
| Q5TB80 | QN1_HUMAN Protein QN1 homolog OS=Homo sapiens GN=KIAA1009 PE=1 SV=2 | 348 | E | 0.749352 | Q | 0.711714 | 0.037638 | No Change: Both D | - |
| Q9UPX6 | K1024_HUMAN UPF0258 protein KIAA1024 OS=Homo sapiens GN=KIAA1024 PE=2 SV=3 | 832 | I | 0.384389 | V | 0.431045 | -0.046656 | No Change: Both O | - |
| Q9UPX6 | K1024_HUMAN UPF0258 protein KIAA1024 OS=Homo sapiens GN=KIAA1024 PE=2 SV=3 | 320 | V | 0.660841 | F | 0.661219 | -3.78E-04 | No Change: Both D | - |
| Q2M389 | WASH7_HUMAN WASH complex subunit 7 OS=Homo sapiens GN=KIAA1033 PE=1 SV=2 | 323 | V | 0.014606 | L | 0.01559 | -9.84E-04 | No Change: Both O | - |
| Q2M389 | WASH7_HUMAN WASH complex subunit 7 OS=Homo sapiens GN=KIAA1033 PE=1 SV=2 | 901 | V | 0.373571 | I | 0.373929 | -3.58E-04 | No Change: Both O | - |
| Q2M389 | WASH7_HUMAN WASH complex subunit 7 OS=Homo sapiens GN=KIAA1033 PE=1 SV=2 | 599 | T | 0.131643 | S | 0.185634 | -0.053991 | No Change: Both O | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 422 | H | 0.866627 | R | 0.898881 | -0.032254 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 442 | S | 0.82525 | I | 0.70135 | 0.1239 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 522 | V | 0.822431 | L | 0.822544 | -1.13E-04 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 602 | Q | 0.895084 | R | 0.892481 | 0.002603 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 681 | D | 0.619199 | G | 0.553011 | 0.066188 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 715 | N | 0.67974 | Y | 0.572245 | 0.107495 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 826 | K | 0.976979 | E | 0.979299 | -0.00232 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 945 | N | 0.766322 | S | 0.803595 | -0.037273 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 1048 | N | 0.62782 | T | 0.59644 | 0.03138 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 1083 | F | 0.744208 | V | 0.752747 | -0.008539 | No Change: Both D | - |
| Q9UPP5 | K1107_HUMAN Uncharacterized protein KIAA1107 OS=Homo sapiens GN=KIAA1107 PE=1 SV=2 | 1158 | V | 0.934449 | I | 0.929693 | 0.004756 | No Change: Both D | - |
| Q2LD37 | K1109_HUMAN Uncharacterized protein KIAA1109 OS=Homo sapiens GN=KIAA1109 PE=1 SV=2 | 978 | I | 0.341275 | T | 0.487583 | -0.146308 | No Change: Both O | - |
| Q2LD37 | K1109_HUMAN Uncharacterized protein KIAA1109 OS=Homo sapiens GN=KIAA1109 PE=1 SV=2 | 4352 | T | 0.959235 | A | 0.949817 | 0.009418 | No Change: Both D | - |
| Q2LD37 | K1109_HUMAN Uncharacterized protein KIAA1109 OS=Homo sapiens GN=KIAA1109 PE=1 SV=2 | 4786 | T | 0.732173 | A | 0.698442 | 0.033731 | No Change: Both D | - |
| Q2LD37 | K1109_HUMAN Uncharacterized protein KIAA1109 OS=Homo sapiens GN=KIAA1109 PE=1 SV=2 | 1951 | D | 0.973031 | E | 0.970279 | 0.002752 | No Change: Both D | - |
| Q2LD37 | K1109_HUMAN Uncharacterized protein KIAA1109 OS=Homo sapiens GN=KIAA1109 PE=1 SV=2 | 2521 | S | 0.236746 | R | 0.187541 | 0.049205 | No Change: Both O | - |
| Q96AT1 | K1143_HUMAN Uncharacterized protein KIAA1143 OS=Homo sapiens GN=KIAA1143 PE=1 SV=2 | 139 | I | 0.986982 | M | 0.99263 | -0.005648 | No Change: Both D | - |
| Q6NSJ0 | K1161_HUMAN Uncharacterized family 31 glucosidase KIAA1161 OS=Homo sapiens GN=KIAA1161 PE=1 SV=2 | 4 | N | 0.913145 | I | 0.868364 | 0.044781 | No Change: Both D | - |
| Q6NSJ0 | K1161_HUMAN Uncharacterized family 31 glucosidase KIAA1161 OS=Homo sapiens GN=KIAA1161 PE=1 SV=2 | 53 | D | 0.76548 | E | 0.776951 | -0.011471 | No Change: Both D | - |
| Q6NSJ0 | K1161_HUMAN Uncharacterized family 31 glucosidase KIAA1161 OS=Homo sapiens GN=KIAA1161 PE=1 SV=2 | 199 | R | 0.368947 | S | 0.427179 | -0.058232 | No Change: Both O | - |
| Q6NSJ0 | K1161_HUMAN Uncharacterized family 31 glucosidase KIAA1161 OS=Homo sapiens GN=KIAA1161 PE=1 SV=2 | 385 | F | 0.116448 | Y | 0.121519 | -0.005071 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 187 | R | 0.155389 | C | 0.074032 | 0.081357 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 187 | R | 0.155389 | H | 0.157031 | -0.001642 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 783 | H | 0.127863 | R | 0.144695 | -0.016832 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 783 | H | 0.127863 | Y | 0.080694 | 0.047169 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 1109 | V | 0.256127 | I | 0.215684 | 0.040443 | No Change: Both O | - |
| Q8WUJ3 | K1199_HUMAN Protein KIAA1199 OS=Homo sapiens GN=KIAA1199 PE=1 SV=2 | 1169 | P | 0.286247 | A | 0.238303 | 0.047944 | No Change: Both O | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 103 | G | 0.086133 | V | 0.044293 | 0.04184 | No Change: Both O | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 419 | L | 0.324309 | F | 0.292483 | 0.031826 | No Change: Both O | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 844 | P | 0.944631 | A | 0.934105 | 0.010526 | No Change: Both D | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 852 | E | 0.914052 | A | 0.871233 | 0.042819 | No Change: Both D | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 945 | I | 0.954801 | F | 0.956416 | -0.001615 | No Change: Both D | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 1032 | R | 0.816066 | W | 0.642454 | 0.173612 | No Change: Both D | - |
| Q9ULL0 | K1210_HUMAN Uncharacterized protein KIAA1210 OS=Homo sapiens GN=KIAA1210 PE=2 SV=3 | 1616 | E | 0.942358 | G | 0.928269 | 0.014089 | No Change: Both D | - |
| Q6ZU35 | K1211_HUMAN Uncharacterized protein KIAA1211 OS=Homo sapiens GN=KIAA1211 PE=1 SV=3 | 269 | L | 0.996955 | I | 0.995325 | 0.00163 | No Change: Both D | - |
| Q6ZU35 | K1211_HUMAN Uncharacterized protein KIAA1211 OS=Homo sapiens GN=KIAA1211 PE=1 SV=3 | 655 | R | 0.983817 | P | 0.985644 | -0.001827 | No Change: Both D | - |
| Q6ZU35 | K1211_HUMAN Uncharacterized protein KIAA1211 OS=Homo sapiens GN=KIAA1211 PE=1 SV=3 | 710 | R | 0.907537 | Q | 0.908331 | -7.94E-04 | No Change: Both D | - |
| Q6ZU35 | K1211_HUMAN Uncharacterized protein KIAA1211 OS=Homo sapiens GN=KIAA1211 PE=1 SV=3 | 776 | S | 0.934004 | L | 0.90663 | 0.027374 | No Change: Both D | - |
| Q9ULI1 | K1239_HUMAN Leucine-rich repeat and WD repeat-containing protein KIAA1239 OS=Homo sapiens GN=KIAA1239 PE=2 SV=3 | 569 | L | 0.289586 | M | 0.360142 | -0.070556 | No Change: Both O | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 1010 | P | 0.91551 | L | 0.85219 | 0.06332 | No Change: Both D | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 104 | K | 0.618467 | T | 0.524025 | 0.094442 | No Change: Both D | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 221 | T | 0.7964 | I | 0.655178 | 0.141222 | No Change: Both D | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 225 | N | 0.840828 | D | 0.836004 | 0.004824 | No Change: Both D | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 718 | S | 0.944384 | P | 0.946866 | -0.002482 | No Change: Both D | - |
| Q7Z3B3 | K1267_HUMAN MLL1/MLL complex subunit KIAA1267 OS=Homo sapiens GN=KIAA1267 PE=1 SV=2 | 1085 | I | 0.925817 | T | 0.96691 | -0.041093 | No Change: Both D | - |
| Q96EK5 | KBP_HUMAN KIF1-binding protein OS=Homo sapiens GN=KIAA1279 PE=1 SV=1 | 66 | G | 0.939831 | S | 0.938083 | 0.001748 | No Change: Both D | - |
| Q9P2N6 | K1310_HUMAN Uncharacterized protein KIAA1310 OS=Homo sapiens GN=KIAA1310 PE=1 SV=2 | 707 | V | 0.956838 | I | 0.945916 | 0.010922 | No Change: Both D | - |
| Q6UXG2 | K1324_HUMAN UPF0577 protein KIAA1324 OS=Homo sapiens GN=KIAA1324 PE=2 SV=2 | 86 | I | 0.507351 | V | 0.556093 | -0.048742 | No Change: Both D | - |
| Q6UXG2 | K1324_HUMAN UPF0577 protein KIAA1324 OS=Homo sapiens GN=KIAA1324 PE=2 SV=2 | 623 | T | 0.420189 | P | 0.48789 | -0.067701 | No Change: Both O | - |
| Q6UXG2 | K1324_HUMAN UPF0577 protein KIAA1324 OS=Homo sapiens GN=KIAA1324 PE=2 SV=2 | 1009 | L | 0.921132 | P | 0.959106 | -0.037974 | No Change: Both D | - |
| Q6UXG2 | K1324_HUMAN UPF0577 protein KIAA1324 OS=Homo sapiens GN=KIAA1324 PE=2 SV=2 | 829 | S | 0.518306 | R | 0.458035 | 0.060271 | D to O | A breast cancer sample |
| A8MWY0 | K132L_HUMAN UPF0577 protein KIAA1324-like OS=Homo sapiens GN=KIAA1324L PE=2 SV=2 | 539 | N | 0.410771 | Y | 0.244988 | 0.165783 | No Change: Both O | - |
| A8MWY0 | K132L_HUMAN UPF0577 protein KIAA1324-like OS=Homo sapiens GN=KIAA1324L PE=2 SV=2 | 729 | L | 0.230582 | V | 0.231583 | -0.001001 | No Change: Both O | - |
| A8MWY0 | K132L_HUMAN UPF0577 protein KIAA1324-like OS=Homo sapiens GN=KIAA1324L PE=2 SV=2 | 767 | S | 0.569092 | R | 0.495697 | 0.073395 | D to O | - |
| Q86T90 | K1328_HUMAN Uncharacterized protein KIAA1328 OS=Homo sapiens GN=KIAA1328 PE=1 SV=2 | 383 | R | 0.904065 | C | 0.865475 | 0.03859 | No Change: Both D | - |
| Q32MH5 | K1370_HUMAN Uncharacterized protein KIAA1370 OS=Homo sapiens GN=KIAA1370 PE=2 SV=2 | 135 | Q | 0.37803 | R | 0.381592 | -0.003562 | No Change: Both O | - |
| Q32MH5 | K1370_HUMAN Uncharacterized protein KIAA1370 OS=Homo sapiens GN=KIAA1370 PE=2 SV=2 | 560 | V | 0.829474 | I | 0.837856 | -0.008382 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 178 | A | 0.695494 | T | 0.705179 | -0.009685 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 238 | G | 0.646512 | C | 0.571221 | 0.075291 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 275 | S | 0.718342 | Y | 0.525087 | 0.193255 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 281 | I | 0.629081 | T | 0.740435 | -0.111354 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 302 | A | 0.483992 | T | 0.541452 | -0.05746 | O to D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 710 | P | 0.317867 | S | 0.341046 | -0.023179 | No Change: Both O | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 1021 | M | 0.577489 | T | 0.641075 | -0.063586 | No Change: Both D | - |
| Q9P2H0 | K1377_HUMAN Uncharacterized protein KIAA1377 OS=Homo sapiens GN=KIAA1377 PE=1 SV=3 | 1077 | S | 0.577807 | N | 0.537658 | 0.040149 | No Change: Both D | - |
| Q8NCU4 | K1407_HUMAN Coiled-coil domain-containing protein KIAA1407 OS=Homo sapiens GN=KIAA1407 PE=2 SV=1 | 374 | R | 0.594601 | W | 0.374343 | 0.220258 | D to O | - |
| Q8NCU4 | K1407_HUMAN Coiled-coil domain-containing protein KIAA1407 OS=Homo sapiens GN=KIAA1407 PE=2 SV=1 | 696 | E | 0.999477 | D | 0.999135 | 3.42E-04 | No Change: Both D | - |
| Q69YN4 | VIR_HUMAN Protein virilizer homolog OS=Homo sapiens GN=KIAA1429 PE=1 SV=2 | 753 | I | 0.21655 | V | 0.249214 | -0.032664 | No Change: Both O | - |
| Q9P2B7 | K1430_HUMAN UPF0501 protein KIAA1430 OS=Homo sapiens GN=KIAA1430 PE=1 SV=2 | 238 | T | 0.967314 | A | 0.948007 | 0.019307 | No Change: Both D | - |
| Q9P2B7 | K1430_HUMAN UPF0501 protein KIAA1430 OS=Homo sapiens GN=KIAA1430 PE=1 SV=2 | 443 | L | 0.573546 | S | 0.69618 | -0.122634 | No Change: Both D | - |
| Q8N9K7 | CH079_HUMAN Uncharacterized protein KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=1 | 18 | Q | 0.918431 | H | 0.885652 | 0.032779 | No Change: Both D | - |
| Q8N9K7 | CH079_HUMAN Uncharacterized protein KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=1 | 111 | S | 0.294096 | T | 0.25202 | 0.042076 | No Change: Both O | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 219 | P | 0.605262 | T | 0.576543 | 0.028719 | No Change: Both D | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 265 | I | 0.550648 | T | 0.719983 | -0.169335 | No Change: Both D | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 337 | H | 0.665453 | L | 0.582494 | 0.082959 | No Change: Both D | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 150 | H | 0.424183 | R | 0.42223 | 0.001953 | No Change: Both O | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 207 | C | 0.829959 | G | 0.838616 | -0.008657 | No Change: Both D | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 304 | G | 0.767664 | E | 0.824734 | -0.05707 | No Change: Both D | - |
| Q9P272 | K1456_HUMAN Putative methyltransferase KIAA1456 OS=Homo sapiens GN=KIAA1456 PE=2 SV=3 | 451 | R | 0.602926 | G | 0.62411 | -0.021184 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 487 | E | 0.746055 | D | 0.759797 | -0.013742 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 494 | D | 0.720477 | N | 0.698108 | 0.022369 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 729 | E | 0.948752 | A | 0.951229 | -0.002477 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 957 | R | 0.858885 | G | 0.854427 | 0.004458 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 1002 | S | 0.979931 | T | 0.971132 | 0.008799 | No Change: Both D | - |
| Q9P266 | K1462_HUMAN Uncharacterized protein KIAA1462 OS=Homo sapiens GN=KIAA1462 PE=1 SV=3 | 1095 | A | 0.680882 | G | 0.69685 | -0.015968 | No Change: Both D | - |
| Q9P260 | K1468_HUMAN LisH domain and HEAT repeat-containing protein KIAA1468 OS=Homo sapiens GN=KIAA1468 PE=1 SV=2 | 929 | G | 0.121369 | E | 0.165563 | -0.044194 | No Change: Both O | A colorectal cancer sample |
| Q9P242 | K1486_HUMAN Uncharacterized protein KIAA1486 OS=Homo sapiens GN=KIAA1486 PE=1 SV=3 | 205 | T | 0.965319 | A | 0.953466 | 0.011853 | No Change: Both D | - |
| Q9P242 | K1486_HUMAN Uncharacterized protein KIAA1486 OS=Homo sapiens GN=KIAA1486 PE=1 SV=3 | 586 | T | 0.775146 | P | 0.821408 | -0.046262 | No Change: Both D | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 57 | P | 0.816267 | S | 0.810378 | 0.005889 | No Change: Both D | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 114 | S | 0.756961 | P | 0.722147 | 0.034814 | No Change: Both D | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 232 | M | 0.593751 | V | 0.526529 | 0.067222 | No Change: Both D | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 310 | L | 0.453662 | I | 0.393041 | 0.060621 | No Change: Both O | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 770 | P | 0.997972 | L | 0.995825 | 0.002147 | No Change: Both D | - |
| Q9P206 | K1522_HUMAN Uncharacterized protein KIAA1522 OS=Homo sapiens GN=KIAA1522 PE=1 SV=2 | 1021 | E | 0.86092 | K | 0.860697 | 2.23E-04 | No Change: Both D | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 126 | K | 0.076541 | R | 0.052955 | 0.023586 | No Change: Both O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 229 | R | 0.205456 | Q | 0.237884 | -0.032428 | No Change: Both O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 409 | T | 0.415934 | I | 0.281017 | 0.134917 | No Change: Both O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 447 | T | 0.130095 | A | 0.102327 | 0.027768 | No Change: Both O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 494 | P | 0.221934 | L | 0.123241 | 0.098693 | No Change: Both O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 572 | S | 0.619607 | A | 0.493881 | 0.125726 | D to O | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 680 | R | 0.822494 | T | 0.792288 | 0.030206 | No Change: Both D | - |
| Q8TCG1 | CIP2A_HUMAN Protein CIP2A OS=Homo sapiens GN=KIAA1524 PE=1 SV=2 | 759 | I | 0.930107 | V | 0.930171 | -6.40E-05 | No Change: Both D | - |
| Q2YD98 | K1530_HUMAN Uncharacterized protein KIAA1530 OS=Homo sapiens GN=KIAA1530 PE=1 SV=2 | 391 | R | 0.909718 | H | 0.877363 | 0.032355 | No Change: Both D | - |
| Q2YD98 | K1530_HUMAN Uncharacterized protein KIAA1530 OS=Homo sapiens GN=KIAA1530 PE=1 SV=2 | 620 | P | 0.96848 | L | 0.948596 | 0.019884 | No Change: Both D | - |
| Q9HCM3 | K1549_HUMAN UPF0606 protein KIAA1549 OS=Homo sapiens GN=KIAA1549 PE=1 SV=4 | 448 | A | 0.570768 | P | 0.653289 | -0.082521 | No Change: Both D | - |
| Q9HCM3 | K1549_HUMAN UPF0606 protein KIAA1549 OS=Homo sapiens GN=KIAA1549 PE=1 SV=4 | 851 | V | 0.615535 | G | 0.693652 | -0.078117 | No Change: Both D | - |
| Q9HCM3 | K1549_HUMAN UPF0606 protein KIAA1549 OS=Homo sapiens GN=KIAA1549 PE=1 SV=4 | 652 | P | 0.981803 | L | 0.968237 | 0.013566 | No Change: Both D | - |
| Q9HCI6 | K1586_HUMAN Uncharacterized protein KIAA1586 OS=Homo sapiens GN=KIAA1586 PE=2 SV=2 | 75 | F | 0.279875 | L | 0.306274 | -0.026399 | No Change: Both O | - |
| Q9HCI6 | K1586_HUMAN Uncharacterized protein KIAA1586 OS=Homo sapiens GN=KIAA1586 PE=2 SV=2 | 81 | V | 0.374645 | M | 0.440816 | -0.066171 | No Change: Both O | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 10 | R | 0.748034 | L | 0.59813 | 0.149904 | No Change: Both D | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 97 | H | 0.72698 | Q | 0.7981 | -0.07112 | No Change: Both D | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 172 | D | 0.414356 | E | 0.422859 | -0.008503 | No Change: Both O | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 220 | I | 0.034945 | V | 0.040405 | -0.00546 | No Change: Both O | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 233 | E | 0.426223 | D | 0.419109 | 0.007114 | No Change: Both O | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 267 | C | 0.13597 | R | 0.275084 | -0.139114 | No Change: Both O | - |
| Q6P9B6 | K1609_HUMAN TLD domain-containing protein KIAA1609 OS=Homo sapiens GN=KIAA1609 PE=1 SV=2 | 443 | S | 0.835325 | L | 0.734245 | 0.10108 | No Change: Both D | - |
| Q5VZ46 | K1614_HUMAN Uncharacterized protein KIAA1614 OS=Homo sapiens GN=KIAA1614 PE=2 SV=3 | 214 | H | 0.86298 | Y | 0.775279 | 0.087701 | No Change: Both D | - |
| Q5VZ46 | K1614_HUMAN Uncharacterized protein KIAA1614 OS=Homo sapiens GN=KIAA1614 PE=2 SV=3 | 740 | R | 0.9071 | W | 0.817501 | 0.089599 | No Change: Both D | - |
| Q5VZ46 | K1614_HUMAN Uncharacterized protein KIAA1614 OS=Homo sapiens GN=KIAA1614 PE=2 SV=3 | 801 | L | 0.930928 | F | 0.911162 | 0.019766 | No Change: Both D | - |
| Q5VZ46 | K1614_HUMAN Uncharacterized protein KIAA1614 OS=Homo sapiens GN=KIAA1614 PE=2 SV=3 | 1078 | N | 0.848316 | D | 0.856443 | -0.008127 | No Change: Both D | - |
| Q5VZ46 | K1614_HUMAN Uncharacterized protein KIAA1614 OS=Homo sapiens GN=KIAA1614 PE=2 SV=3 | 64 | L | 0.880444 | P | 0.936959 | -0.056515 | No Change: Both D | - |
| Q9HCF4 | ALO17_HUMAN Protein ALO17 OS=Homo sapiens GN=KIAA1618 PE=1 SV=2 | 61 | P | 0.953318 | L | 0.915562 | 0.037756 | No Change: Both D | - |
| Q9HCF4 | ALO17_HUMAN Protein ALO17 OS=Homo sapiens GN=KIAA1618 PE=1 SV=2 | 270 | M | 0.933699 | T | 0.940058 | -0.006359 | No Change: Both D | - |
| Q9HCF4 | ALO17_HUMAN Protein ALO17 OS=Homo sapiens GN=KIAA1618 PE=1 SV=2 | 321 | M | 0.987002 | T | 0.989219 | -0.002217 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 44 | L | 0.853725 | P | 0.910356 | -0.056631 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 235 | L | 0.524735 | V | 0.521001 | 0.003734 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 285 | S | 0.726342 | T | 0.699745 | 0.026597 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 359 | M | 0.914764 | T | 0.932551 | -0.017787 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 908 | P | 0.522982 | H | 0.449921 | 0.073061 | D to O | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 648 | Y | 0.409503 | F | 0.42441 | -0.014907 | No Change: Both O | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 823 | P | 0.852722 | R | 0.801447 | 0.051275 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 50 | A | 0.940813 | V | 0.926742 | 0.014071 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 197 | C | 0.788533 | R | 0.827659 | -0.039126 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 524 | T | 0.552726 | A | 0.534157 | 0.018569 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 610 | T | 0.767909 | P | 0.799414 | -0.031505 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 614 | A | 0.75397 | V | 0.69029 | 0.06368 | No Change: Both D | - |
| Q9H0B3 | K1683_HUMAN Uncharacterized protein KIAA1683 OS=Homo sapiens GN=KIAA1683 PE=1 SV=1 | 835 | P | 0.803568 | L | 0.668859 | 0.134709 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 80 | Q | 0.747336 | K | 0.750141 | -0.002805 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 208 | R | 0.758618 | Q | 0.735788 | 0.02283 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 499 | A | 0.727301 | E | 0.791159 | -0.063858 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 1026 | E | 0.929617 | K | 0.937635 | -0.008018 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 1270 | A | 0.737427 | G | 0.752766 | -0.015339 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 1441 | G | 0.532303 | E | 0.596741 | -0.064438 | No Change: Both D | - |
| Q9C0D2 | K1731_HUMAN Centrosomal protein KIAA1731 OS=Homo sapiens GN=KIAA1731 PE=2 SV=4 | 1459 | L | 0.441041 | R | 0.492616 | -0.051575 | No Change: Both O | - |
| Q9C0C6 | K1737_HUMAN Uncharacterized protein KIAA1737 OS=Homo sapiens GN=KIAA1737 PE=2 SV=2 | 31 | L | 0.951755 | F | 0.948137 | 0.003618 | No Change: Both D | - |
| Q9C0C6 | K1737_HUMAN Uncharacterized protein KIAA1737 OS=Homo sapiens GN=KIAA1737 PE=2 SV=2 | 203 | T | 0.983593 | A | 0.982205 | 0.001388 | No Change: Both D | - |
| Q9C0B2 | K1751_HUMAN Uncharacterized protein KIAA1751 OS=Homo sapiens GN=KIAA1751 PE=2 SV=2 | 50 | S | 0.898738 | I | 0.80011 | 0.098628 | No Change: Both D | - |
| Q9C0B2 | K1751_HUMAN Uncharacterized protein KIAA1751 OS=Homo sapiens GN=KIAA1751 PE=2 SV=2 | 363 | I | 0.972159 | V | 0.96957 | 0.002589 | No Change: Both D | - |
| Q9C0B2 | K1751_HUMAN Uncharacterized protein KIAA1751 OS=Homo sapiens GN=KIAA1751 PE=2 SV=2 | 628 | G | 0.223766 | C | 0.138467 | 0.085299 | No Change: Both O | - |
| Q5JYT7 | K1755_HUMAN Uncharacterized protein KIAA1755 OS=Homo sapiens GN=KIAA1755 PE=2 SV=2 | 339 | K | 0.889256 | N | 0.883767 | 0.005489 | No Change: Both D | - |
| Q5JYT7 | K1755_HUMAN Uncharacterized protein KIAA1755 OS=Homo sapiens GN=KIAA1755 PE=2 SV=2 | 415 | P | 0.96728 | L | 0.939758 | 0.027522 | No Change: Both D | - |
| Q5JYT7 | K1755_HUMAN Uncharacterized protein KIAA1755 OS=Homo sapiens GN=KIAA1755 PE=2 SV=2 | 633 | A | 0.352212 | V | 0.278997 | 0.073215 | No Change: Both O | - |
| Q5JYT7 | K1755_HUMAN Uncharacterized protein KIAA1755 OS=Homo sapiens GN=KIAA1755 PE=2 SV=2 | 940 | E | 0.484973 | K | 0.441129 | 0.043844 | No Change: Both O | - |
| Q5JYT7 | K1755_HUMAN Uncharacterized protein KIAA1755 OS=Homo sapiens GN=KIAA1755 PE=2 SV=2 | 1045 | R | 0.616665 | W | 0.388656 | 0.228009 | D to O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 166 | L | 0.169794 | S | 0.345523 | -0.175729 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 234 | V | 0.163547 | I | 0.155543 | 0.008004 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 523 | I | 0.056892 | V | 0.06539 | -0.008498 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 718 | T | 0.307818 | S | 0.383578 | -0.07576 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 1373 | T | 0.362525 | P | 0.454136 | -0.091611 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 1668 | K | 0.20304 | E | 0.203109 | -6.90E-05 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 721 | E | 0.325612 | K | 0.318585 | 0.007027 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 1373 | T | 0.362525 | A | 0.351075 | 0.01145 | No Change: Both O | - |
| Q5VW36 | K1797_HUMAN Uncharacterized protein KIAA1797 OS=Homo sapiens GN=KIAA1797 PE=1 SV=1 | 1373 | T | 0.362525 | S | 0.457453 | -0.094928 | No Change: Both O | - |
| A6NE52 | K1875_HUMAN WD repeat-containing protein KIAA1875 OS=Homo sapiens GN=KIAA1875 PE=2 SV=2 | 149 | R | 0.129852 | G | 0.145325 | -0.015473 | No Change: Both O | - |
| A6NE52 | K1875_HUMAN WD repeat-containing protein KIAA1875 OS=Homo sapiens GN=KIAA1875 PE=2 SV=2 | 427 | H | 0.287044 | Q | 0.356481 | -0.069437 | No Change: Both O | - |
| A6NE52 | K1875_HUMAN WD repeat-containing protein KIAA1875 OS=Homo sapiens GN=KIAA1875 PE=2 SV=2 | 537 | E | 0.33977 | G | 0.303579 | 0.036191 | No Change: Both O | - |
| Q5T5S1 | K1984_HUMAN Uncharacterized coiled-coil domain-containing protein KIAA1984 OS=Homo sapiens GN=KIAA1984 PE=2 SV=3 | 38 | M | 0.589972 | T | 0.632189 | -0.042217 | No Change: Both D | - |
| Q5T5S1 | K1984_HUMAN Uncharacterized coiled-coil domain-containing protein KIAA1984 OS=Homo sapiens GN=KIAA1984 PE=2 SV=3 | 113 | L | 0.357252 | R | 0.482649 | -0.125397 | No Change: Both O | - |
| Q5T5S1 | K1984_HUMAN Uncharacterized coiled-coil domain-containing protein KIAA1984 OS=Homo sapiens GN=KIAA1984 PE=2 SV=3 | 129 | D | 0.723799 | A | 0.639416 | 0.084383 | No Change: Both D | - |
| Q5T5S1 | K1984_HUMAN Uncharacterized coiled-coil domain-containing protein KIAA1984 OS=Homo sapiens GN=KIAA1984 PE=2 SV=3 | 342 | W | 0.366172 | R | 0.618031 | -0.251859 | O to D | - |
| Q5T5S1 | K1984_HUMAN Uncharacterized coiled-coil domain-containing protein KIAA1984 OS=Homo sapiens GN=KIAA1984 PE=2 SV=3 | 421 | N | 0.155933 | T | 0.141039 | 0.014894 | No Change: Both O | - |
| Q68DE3 | K2018_HUMAN Basic helix-loop-helix domain-containing protein KIAA2018 OS=Homo sapiens GN=KIAA2018 PE=1 SV=3 | 222 | P | 0.444785 | A | 0.341346 | 0.103439 | No Change: Both O | - |
| Q68DE3 | K2018_HUMAN Basic helix-loop-helix domain-containing protein KIAA2018 OS=Homo sapiens GN=KIAA2018 PE=1 SV=3 | 1966 | A | 0.959866 | V | 0.952446 | 0.00742 | No Change: Both D | - |
| Q68DE3 | K2018_HUMAN Basic helix-loop-helix domain-containing protein KIAA2018 OS=Homo sapiens GN=KIAA2018 PE=1 SV=3 | 907 | A | 0.988255 | E | 0.990306 | -0.002051 | No Change: Both D | - |
| Q68DE3 | K2018_HUMAN Basic helix-loop-helix domain-containing protein KIAA2018 OS=Homo sapiens GN=KIAA2018 PE=1 SV=3 | 943 | V | 0.895777 | G | 0.916315 | -0.020538 | No Change: Both D | - |
| Q68DE3 | K2018_HUMAN Basic helix-loop-helix domain-containing protein KIAA2018 OS=Homo sapiens GN=KIAA2018 PE=1 SV=3 | 2200 | V | 0.796333 | A | 0.867718 | -0.071385 | No Change: Both D | - |
| Q5QGS0 | K2022_HUMAN Uncharacterized protein KIAA2022 OS=Homo sapiens GN=KIAA2022 PE=2 SV=1 | 1112 | I | 0.389589 | T | 0.56195 | -0.172361 | O to D | - |
| Q9ULH0 | KDIS_HUMAN Kinase D-interacting substrate of 220 kDa OS=Homo sapiens GN=KIDINS220 PE=1 SV=3 | 1307 | R | 0.936853 | H | 0.933879 | 0.002974 | No Change: Both D | - |
| Q9ULH0 | KDIS_HUMAN Kinase D-interacting substrate of 220 kDa OS=Homo sapiens GN=KIDINS220 PE=1 SV=3 | 1608 | Q | 0.902132 | H | 0.903632 | -0.0015 | No Change: Both D | - |
| Q9ULH0 | KDIS_HUMAN Kinase D-interacting substrate of 220 kDa OS=Homo sapiens GN=KIDINS220 PE=1 SV=3 | 538 | I | 0.004575 | T | 0.008203 | -0.003628 | No Change: Both O | - |
| P52732 | KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sapiens GN=KIF11 PE=1 SV=2 | 1042 | L | 0.692057 | F | 0.617126 | 0.074931 | No Change: Both D | - |
| Q9H1H9 | KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens GN=KIF13A PE=1 SV=2 | 1415 | M | 0.788918 | V | 0.750846 | 0.038072 | No Change: Both D | - |
| Q9H1H9 | KI13A_HUMAN Kinesin-like protein KIF13A OS=Homo sapiens GN=KIF13A PE=1 SV=2 | 1600 | F | 0.861025 | S | 0.943194 | -0.082169 | No Change: Both D | - |
| Q9NQT8 | KI13B_HUMAN Kinesin-like protein KIF13B OS=Homo sapiens GN=KIF13B PE=1 SV=1 | 1471 | V | 0.789686 | I | 0.752849 | 0.036837 | No Change: Both D | - |
| Q15058 | KIF14_HUMAN Kinesin-like protein KIF14 OS=Homo sapiens GN=KIF14 PE=1 SV=1 | 1633 | P | 0.726276 | A | 0.634781 | 0.091495 | No Change: Both D | - |
| Q9NS87 | KIF15_HUMAN Kinesin-like protein KIF15 OS=Homo sapiens GN=KIF15 PE=1 SV=1 | 211 | A | 0.313319 | V | 0.24872 | 0.064599 | No Change: Both O | - |
| Q9NS87 | KIF15_HUMAN Kinesin-like protein KIF15 OS=Homo sapiens GN=KIF15 PE=1 SV=1 | 996 | T | 0.612104 | S | 0.669112 | -0.057008 | No Change: Both D | - |
| Q9NS87 | KIF15_HUMAN Kinesin-like protein KIF15 OS=Homo sapiens GN=KIF15 PE=1 SV=1 | 1206 | L | 0.836828 | M | 0.869567 | -0.032739 | No Change: Both D | - |
| Q9NS87 | KIF15_HUMAN Kinesin-like protein KIF15 OS=Homo sapiens GN=KIF15 PE=1 SV=1 | 1272 | E | 0.841088 | D | 0.807417 | 0.033671 | No Change: Both D | - |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 824 | R | 0.697499 | S | 0.680872 | 0.016627 | No Change: Both D | - |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 1027 | M | 0.962031 | T | 0.966135 | -0.004104 | No Change: Both D | - |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 1119 | N | 0.282344 | S | 0.379817 | -0.097473 | No Change: Both O | - |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 772 | K | 0.90865 | T | 0.870443 | 0.038207 | No Change: Both D | A breast cancer sample |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 810 | G | 0.857579 | R | 0.880869 | -0.02329 | No Change: Both D | - |
| Q96L93 | KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens GN=KIF16B PE=1 SV=2 | 999 | K | 0.970113 | N | 0.959685 | 0.010428 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 402 | V | 0.836195 | M | 0.85725 | -0.021055 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 933 | D | 0.868524 | E | 0.879814 | -0.01129 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 341 | I | 0.77942 | V | 0.758013 | 0.021407 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 675 | V | 0.817431 | I | 0.759145 | 0.058286 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 735 | V | 0.612416 | I | 0.50979 | 0.102626 | No Change: Both D | - |
| Q9P2E2 | KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens GN=KIF17 PE=1 SV=3 | 369 | S | 0.846677 | R | 0.820096 | 0.026581 | No Change: Both D | - |
| Q8NI77 | KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens GN=KIF18A PE=1 SV=2 | 735 | I | 0.570867 | V | 0.581042 | -0.010175 | No Change: Both D | - |
| Q8NI77 | KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens GN=KIF18A PE=1 SV=2 | 273 | T | 0.497671 | A | 0.478107 | 0.019564 | No Change: Both O | - |
| Q8NI77 | KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens GN=KIF18A PE=1 SV=2 | 334 | P | 0.262268 | S | 0.312544 | -0.050276 | No Change: Both O | - |
| Q86Y91 | KI18B_HUMAN Kinesin-like protein KIF18B OS=Homo sapiens GN=KIF18B PE=1 SV=3 | 527 | Q | 0.377121 | R | 0.376245 | 8.76E-04 | No Change: Both O | - |
| Q2TAC6 | KIF19_HUMAN Kinesin-like protein KIF19 OS=Homo sapiens GN=KIF19 PE=2 SV=2 | 471 | R | 0.678963 | W | 0.504771 | 0.174192 | No Change: Both D | - |
| Q2TAC6 | KIF19_HUMAN Kinesin-like protein KIF19 OS=Homo sapiens GN=KIF19 PE=2 SV=2 | 937 | L | 0.672136 | P | 0.795666 | -0.12353 | No Change: Both D | - |
| Q2TAC6 | KIF19_HUMAN Kinesin-like protein KIF19 OS=Homo sapiens GN=KIF19 PE=2 SV=2 | 807 | R | 0.864234 | H | 0.842211 | 0.022023 | No Change: Both D | - |
| Q2TAC6 | KIF19_HUMAN Kinesin-like protein KIF19 OS=Homo sapiens GN=KIF19 PE=2 SV=2 | 974 | R | 0.983979 | Q | 0.980153 | 0.003826 | No Change: Both D | - |
| Q12756 | KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens GN=KIF1A PE=1 SV=2 | 99 | T | 0.290997 | M | 0.265526 | 0.025471 | No Change: Both O | Mental retardation autosomal dominant type 9 (MRD9) [MIM:614255] |
| Q12756 | KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens GN=KIF1A PE=1 SV=2 | 255 | A | 0.712725 | V | 0.650619 | 0.062106 | No Change: Both D | Spastic paraplegia autosomal recessive type 30 (SPG30) [MIM:610357] |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 98 | Q | 0.219382 | L | 0.131133 | 0.088249 | No Change: Both O | Charcot-Marie-Tooth disease type 2A1 (CMT2A1) [MIM:118210] |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 34 | S | 0.77866 | L | 0.555766 | 0.222894 | No Change: Both D | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 692 | E | 0.937122 | V | 0.869547 | 0.067575 | No Change: Both D | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 873 | T | 0.631262 | I | 0.514838 | 0.116424 | No Change: Both D | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 1133 | Y | 0.092643 | C | 0.088152 | 0.004491 | No Change: Both O | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 1263 | P | 0.346819 | S | 0.378726 | -0.031907 | No Change: Both O | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 1527 | S | 0.939695 | N | 0.906255 | 0.03344 | No Change: Both D | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 1600 | V | 0.536422 | M | 0.582274 | -0.045852 | No Change: Both D | - |
| O60333 | KIF1B_HUMAN Kinesin-like protein KIF1B OS=Homo sapiens GN=KIF1B PE=1 SV=5 | 1674 | E | 0.398338 | K | 0.378045 | 0.020293 | No Change: Both O | - |
| O95235 | KI20A_HUMAN Kinesin-like protein KIF20A OS=Homo sapiens GN=KIF20A PE=1 SV=1 | 63 | E | 0.820715 | K | 0.817691 | 0.003024 | No Change: Both D | - |
| O95235 | KI20A_HUMAN Kinesin-like protein KIF20A OS=Homo sapiens GN=KIF20A PE=1 SV=1 | 839 | P | 0.936703 | L | 0.895556 | 0.041147 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 50 | A | 0.469955 | G | 0.481511 | -0.011556 | No Change: Both O | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 490 | E | 0.638663 | D | 0.636598 | 0.002065 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 756 | N | 0.915876 | I | 0.879645 | 0.036231 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 789 | H | 0.62337 | L | 0.567371 | 0.055999 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 1011 | D | 0.635824 | E | 0.649673 | -0.013849 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 1127 | E | 0.783672 | Q | 0.779215 | 0.004457 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 1177 | C | 0.654689 | R | 0.740187 | -0.085498 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 1219 | N | 0.867257 | S | 0.875061 | -0.007804 | No Change: Both D | - |
| Q96Q89 | KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens GN=KIF20B PE=1 SV=3 | 1789 | I | 0.734388 | V | 0.729849 | 0.004539 | No Change: Both D | - |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 356 | M | 0.395198 | T | 0.433925 | -0.038727 | No Change: Both O | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 947 | M | 0.823147 | R | 0.838692 | -0.015545 | No Change: Both D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 947 | M | 0.823147 | V | 0.750483 | 0.072664 | No Change: Both D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 954 | R | 0.914307 | Q | 0.909446 | 0.004861 | No Change: Both D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 954 | R | 0.914307 | W | 0.79256 | 0.121747 | No Change: Both D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 1010 | I | 0.45801 | T | 0.586123 | -0.128113 | O to D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q7Z4S6 | KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens GN=KIF21A PE=1 SV=2 | 947 | M | 0.823147 | T | 0.815125 | 0.008022 | No Change: Both D | Congenital fibrosis of extraocular muscles type 1 (CFEOM1) [MIM:135700] |
| Q02241 | KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens GN=KIF23 PE=1 SV=3 | 515 | F | 0.569497 | L | 0.607024 | -0.037527 | No Change: Both D | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 50 | D | 0.393342 | E | 0.401507 | -0.008165 | No Change: Both O | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 140 | M | 0.398962 | V | 0.344834 | 0.054128 | No Change: Both O | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 218 | W | 0.575 | L | 0.65245 | -0.07745 | No Change: Both D | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 1077 | T | 0.873198 | K | 0.86754 | 0.005658 | No Change: Both D | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 109 | R | 0.865877 | G | 0.857375 | 0.008502 | No Change: Both D | - |
| Q5T7B8 | KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens GN=KIF24 PE=1 SV=2 | 837 | S | 0.862736 | F | 0.73122 | 0.131516 | No Change: Both D | - |
| Q9UIL4 | KIF25_HUMAN Kinesin-like protein KIF25 OS=Homo sapiens GN=KIF25 PE=2 SV=2 | 229 | T | 0.918584 | P | 0.932539 | -0.013955 | No Change: Both D | - |
| Q9UIL4 | KIF25_HUMAN Kinesin-like protein KIF25 OS=Homo sapiens GN=KIF25 PE=2 SV=2 | 255 | A | 0.76565 | T | 0.751008 | 0.014642 | No Change: Both D | - |
| Q9UIL4 | KIF25_HUMAN Kinesin-like protein KIF25 OS=Homo sapiens GN=KIF25 PE=2 SV=2 | 28 | K | 0.413453 | M | 0.307703 | 0.10575 | No Change: Both O | - |
| Q9UIL4 | KIF25_HUMAN Kinesin-like protein KIF25 OS=Homo sapiens GN=KIF25 PE=2 SV=2 | 41 | A | 0.312887 | T | 0.32211 | -0.009223 | No Change: Both O | - |
| Q9Y6Z4 | KIAS1_HUMAN Putative uncharacterized protein KIF25-AS1 OS=Homo sapiens GN=KIF25-AS1 PE=5 SV=2 | 23 | H | 0.120756 | D | 0.142387 | -0.021631 | No Change: Both O | - |
| Q9Y6Z4 | KIAS1_HUMAN Putative uncharacterized protein KIF25-AS1 OS=Homo sapiens GN=KIF25-AS1 PE=5 SV=2 | 24 | C | 0.131708 | R | 0.243334 | -0.111626 | No Change: Both O | - |
| Q9Y6Z4 | KIAS1_HUMAN Putative uncharacterized protein KIF25-AS1 OS=Homo sapiens GN=KIF25-AS1 PE=5 SV=2 | 57 | Q | 0.691165 | E | 0.705631 | -0.014466 | No Change: Both D | - |
| Q86VH2 | KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens GN=KIF27 PE=2 SV=1 | 213 | I | 0.181069 | V | 0.193749 | -0.01268 | No Change: Both O | - |
| Q86VH2 | KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens GN=KIF27 PE=2 SV=1 | 300 | R | 0.423857 | Q | 0.395667 | 0.02819 | No Change: Both O | - |
| Q86VH2 | KIF27_HUMAN Kinesin-like protein KIF27 OS=Homo sapiens GN=KIF27 PE=2 SV=1 | 1036 | N | 0.856491 | D | 0.869375 | -0.012884 | No Change: Both D | - |
| Q8N4N8 | KIF2B_HUMAN Kinesin-like protein KIF2B OS=Homo sapiens GN=KIF2B PE=1 SV=3 | 112 | A | 0.739282 | V | 0.67372 | 0.065562 | No Change: Both D | - |
| Q8N4N8 | KIF2B_HUMAN Kinesin-like protein KIF2B OS=Homo sapiens GN=KIF2B PE=1 SV=3 | 128 | G | 0.710331 | R | 0.771739 | -0.061408 | No Change: Both D | - |
| Q8N4N8 | KIF2B_HUMAN Kinesin-like protein KIF2B OS=Homo sapiens GN=KIF2B PE=1 SV=3 | 417 | P | 0.710209 | S | 0.741566 | -0.031357 | No Change: Both D | - |
| Q8N4N8 | KIF2B_HUMAN Kinesin-like protein KIF2B OS=Homo sapiens GN=KIF2B PE=1 SV=3 | 437 | R | 0.291272 | G | 0.283063 | 0.008209 | No Change: Both O | - |
| Q8N4N8 | KIF2B_HUMAN Kinesin-like protein KIF2B OS=Homo sapiens GN=KIF2B PE=1 SV=3 | 148 | P | 0.843245 | S | 0.844039 | -7.94E-04 | No Change: Both D | - |
| Q99661 | KIF2C_HUMAN Kinesin-like protein KIF2C OS=Homo sapiens GN=KIF2C PE=1 SV=2 | 449 | I | 0.320128 | L | 0.338642 | -0.018514 | No Change: Both O | - |
| Q9Y496 | KIF3A_HUMAN Kinesin-like protein KIF3A OS=Homo sapiens GN=KIF3A PE=1 SV=4 | 172 | K | 0.535977 | I | 0.308928 | 0.227049 | D to O | - |
| O14782 | KIF3C_HUMAN Kinesin-like protein KIF3C OS=Homo sapiens GN=KIF3C PE=1 SV=3 | 370 | Q | 0.735939 | R | 0.751075 | -0.015136 | No Change: Both D | - |
| O95239 | KIF4A_HUMAN Chromosome-associated kinesin KIF4A OS=Homo sapiens GN=KIF4A PE=1 SV=3 | 422 | L | 0.701293 | W | 0.557175 | 0.144118 | No Change: Both D | - |
| O95239 | KIF4A_HUMAN Chromosome-associated kinesin KIF4A OS=Homo sapiens GN=KIF4A PE=1 SV=3 | 491 | A | 0.659895 | V | 0.580078 | 0.079817 | No Change: Both D | - |
| O95239 | KIF4A_HUMAN Chromosome-associated kinesin KIF4A OS=Homo sapiens GN=KIF4A PE=1 SV=3 | 1193 | L | 0.784201 | S | 0.871286 | -0.087085 | No Change: Both D | - |
| Q2VIQ3 | KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens GN=KIF4B PE=1 SV=2 | 494 | E | 0.790895 | Q | 0.772523 | 0.018372 | No Change: Both D | - |
| Q2VIQ3 | KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens GN=KIF4B PE=1 SV=2 | 580 | R | 0.746147 | L | 0.675506 | 0.070641 | No Change: Both D | - |
| Q2VIQ3 | KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens GN=KIF4B PE=1 SV=2 | 680 | R | 0.938223 | H | 0.903689 | 0.034534 | No Change: Both D | - |
| Q2VIQ3 | KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens GN=KIF4B PE=1 SV=2 | 684 | Y | 0.927326 | C | 0.944916 | -0.01759 | No Change: Both D | - |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 256 | N | 0.523188 | S | 0.571746 | -0.048558 | No Change: Both D | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 280 | R | 0.43603 | C | 0.294444 | 0.141586 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 361 | A | 0.889684 | V | 0.84048 | 0.049204 | No Change: Both D | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 276 | Y | 0.449707 | C | 0.400768 | 0.048939 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 253 | K | 0.529286 | N | 0.49583 | 0.033456 | D to O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 63 | Y | 0.219281 | C | 0.193918 | 0.025363 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 198 | M | 0.648419 | T | 0.668302 | -0.019883 | No Change: Both D | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 204 | R | 0.629524 | Q | 0.643124 | -0.0136 | No Change: Both D | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 251 | E | 0.524003 | K | 0.536138 | -0.012135 | No Change: Both D | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 257 | K | 0.495735 | N | 0.463258 | 0.032477 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 280 | R | 0.43603 | H | 0.423585 | 0.012445 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 280 | R | 0.43603 | L | 0.324672 | 0.111358 | No Change: Both O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q12840 | KIF5A_HUMAN Kinesin heavy chain isoform 5A OS=Homo sapiens GN=KIF5A PE=1 SV=2 | 203 | S | 0.676559 | C | 0.466862 | 0.209697 | D to O | Spastic paraplegia autosomal dominant type 10 (SPG10) [MIM:604187] |
| Q6ZMV9 | KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens GN=KIF6 PE=1 SV=3 | 719 | W | 0.697443 | R | 0.811648 | -0.114205 | No Change: Both D | - |
| Q6ZMV9 | KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens GN=KIF6 PE=1 SV=3 | 386 | A | 0.713834 | E | 0.810422 | -0.096588 | No Change: Both D | A breast cancer sample |
| Q6ZMV9 | KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens GN=KIF6 PE=1 SV=3 | 512 | R | 0.953359 | H | 0.938075 | 0.015284 | No Change: Both D | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 958 | S | 0.891946 | I | 0.802935 | 0.089011 | No Change: Both D | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 1005 | G | 0.979648 | R | 0.983709 | -0.004061 | No Change: Both D | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 52 | D | 0.309996 | N | 0.292655 | 0.017341 | No Change: Both O | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 632 | P | 0.989648 | L | 0.983724 | 0.005924 | No Change: Both D | Pallister-Hall syndrome (PHS) [MIM:146510] |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 641 | R | 0.970627 | G | 0.963066 | 0.007561 | No Change: Both D | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 702 | R | 0.523059 | Q | 0.547397 | -0.024338 | No Change: Both D | Acrocallosal syndrome (ACLS) [MIM:200990] |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 759 | L | 0.976933 | P | 0.981714 | -0.004781 | No Change: Both D | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 834 | Q | 0.989918 | R | 0.989496 | 4.22E-04 | No Change: Both D | - |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 994 | Q | 0.973295 | R | 0.97134 | 0.001955 | No Change: Both D | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 1068 | R | 0.379192 | W | 0.164255 | 0.214937 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q2M1P5 | KIF7_HUMAN Kinesin-like protein KIF7 OS=Homo sapiens GN=KIF7 PE=1 SV=2 | 1115 | H | 0.52891 | Q | 0.605739 | -0.076829 | No Change: Both D | Hydrolethalus syndrome type 2 (HLS2) [MIM:614120] |
| Q9HAQ2 | KIF9_HUMAN Kinesin-like protein KIF9 OS=Homo sapiens GN=KIF9 PE=1 SV=4 | 96 | G | 0.389749 | A | 0.324824 | 0.064925 | No Change: Both O | - |
| Q9HAQ2 | KIF9_HUMAN Kinesin-like protein KIF9 OS=Homo sapiens GN=KIF9 PE=1 SV=4 | 78 | V | 0.273499 | I | 0.228226 | 0.045273 | No Change: Both O | - |
| Q9HAQ2 | KIF9_HUMAN Kinesin-like protein KIF9 OS=Homo sapiens GN=KIF9 PE=1 SV=4 | 638 | R | 0.612605 | W | 0.422628 | 0.189977 | D to O | - |
| Q92845 | KIFA3_HUMAN Kinesin-associated protein 3 OS=Homo sapiens GN=KIFAP3 PE=1 SV=2 | 513 | S | 0.512139 | A | 0.416186 | 0.095953 | D to O | - |
| Q9BW19 | KIFC1_HUMAN Kinesin-like protein KIFC1 OS=Homo sapiens GN=KIFC1 PE=1 SV=2 | 219 | R | 0.913226 | Q | 0.927241 | -0.014015 | No Change: Both D | - |
| Q96AC6 | KIFC2_HUMAN Kinesin-like protein KIFC2 OS=Homo sapiens GN=KIFC2 PE=2 SV=1 | 67 | G | 0.929827 | E | 0.946201 | -0.016374 | No Change: Both D | - |
| Q96AC6 | KIFC2_HUMAN Kinesin-like protein KIFC2 OS=Homo sapiens GN=KIFC2 PE=2 SV=1 | 166 | S | 0.98292 | F | 0.966349 | 0.016571 | No Change: Both D | - |
| Q9BVG8 | KIFC3_HUMAN Kinesin-like protein KIFC3 OS=Homo sapiens GN=KIFC3 PE=1 SV=4 | 391 | G | 0.226725 | V | 0.147649 | 0.079076 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 5 | V | 0.30651 | F | 0.259007 | 0.047503 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 37 | P | 0.494674 | R | 0.434543 | 0.060131 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 135 | P | 0.540162 | L | 0.408609 | 0.131553 | D to O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 175 | P | 0.540048 | T | 0.480814 | 0.059234 | D to O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 184 | D | 0.400149 | N | 0.391087 | 0.009062 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 203 | H | 0.455817 | R | 0.489473 | -0.033656 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 237 | K | 0.848679 | E | 0.854684 | -0.006005 | No Change: Both D | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 266 | R | 0.06003 | C | 0.03221 | 0.02782 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 66 | F | 0.266158 | Y | 0.295871 | -0.029713 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 9 | A | 0.046104 | V | 0.035921 | 0.010183 | No Change: Both O | - |
| P43626 | KI2L1_HUMAN Killer cell immunoglobulin-like receptor 2DL1 OS=Homo sapiens GN=KIR2DL1 PE=1 SV=1 | 111 | V | 0.574566 | L | 0.570766 | 0.0038 | No Change: Both D | - |
| P43627 | KI2L2_HUMAN Killer cell immunoglobulin-like receptor 2DL2 OS=Homo sapiens GN=KIR2DL2 PE=1 SV=1 | 37 | R | 0.424973 | P | 0.482647 | -0.057674 | No Change: Both O | - |
| P43627 | KI2L2_HUMAN Killer cell immunoglobulin-like receptor 2DL2 OS=Homo sapiens GN=KIR2DL2 PE=1 SV=1 | 9 | A | 0.060021 | V | 0.047018 | 0.013003 | No Change: Both O | - |
| P43627 | KI2L2_HUMAN Killer cell immunoglobulin-like receptor 2DL2 OS=Homo sapiens GN=KIR2DL2 PE=1 SV=1 | 66 | F | 0.476346 | Y | 0.517691 | -0.041345 | O to D | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 9 | V | 0.049709 | A | 0.063285 | -0.013576 | No Change: Both O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 32 | L | 0.507213 | R | 0.630237 | -0.123024 | No Change: Both D | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 56 | Q | 0.121372 | E | 0.14789 | -0.026518 | No Change: Both O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 71 | H | 0.3519 | R | 0.330324 | 0.021576 | No Change: Both O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 318 | R | 0.712423 | H | 0.665025 | 0.047398 | No Change: Both D | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 34 | H | 0.488357 | Q | 0.497212 | -0.008855 | No Change: Both O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 229 | P | 0.844895 | L | 0.770334 | 0.074561 | No Change: Both D | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 242 | R | 0.50006 | I | 0.372807 | 0.127253 | D to O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 304 | A | 0.585894 | T | 0.661371 | -0.075477 | No Change: Both D | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 37 | P | 0.487565 | R | 0.428696 | 0.058869 | No Change: Both O | - |
| P43628 | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3 OS=Homo sapiens GN=KIR2DL3 PE=1 SV=1 | 66 | F | 0.475381 | Y | 0.517527 | -0.042146 | O to D | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 53 | Y | 0.111984 | C | 0.096409 | 0.015575 | No Change: Both O | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 87 | V | 0.253751 | L | 0.266019 | -0.012268 | No Change: Both O | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 138 | A | 0.516551 | T | 0.570194 | -0.053643 | No Change: Both D | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 209 | P | 0.778725 | A | 0.691853 | 0.086872 | No Change: Both D | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 271 | D | 0.519197 | N | 0.519397 | -2.00E-04 | No Change: Both D | - |
| Q99706 | KI2L4_HUMAN Killer cell immunoglobulin-like receptor 2DL4 OS=Homo sapiens GN=KIR2DL4 PE=1 SV=3 | 371 | N | 0.840333 | H | 0.848415 | -0.008082 | No Change: Both D | - |
| Q14954 | KI2S1_HUMAN Killer cell immunoglobulin-like receptor 2DS1 OS=Homo sapiens GN=KIR2DS1 PE=2 SV=1 | 91 | R | 0.340854 | K | 0.382455 | -0.041601 | No Change: Both O | - |
| Q14954 | KI2S1_HUMAN Killer cell immunoglobulin-like receptor 2DS1 OS=Homo sapiens GN=KIR2DS1 PE=2 SV=1 | 111 | L | 0.568326 | V | 0.571847 | -0.003521 | No Change: Both D | - |
| P43631 | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2 OS=Homo sapiens GN=KIR2DS2 PE=1 SV=2 | 237 | K | 0.80272 | E | 0.80518 | -0.00246 | No Change: Both D | - |
| P43631 | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2 OS=Homo sapiens GN=KIR2DS2 PE=1 SV=2 | 9 | A | 0.063285 | V | 0.049709 | 0.013576 | No Change: Both O | - |
| P43631 | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2 OS=Homo sapiens GN=KIR2DS2 PE=1 SV=2 | 66 | Y | 0.515661 | F | 0.474221 | 0.04144 | D to O | - |
| P43631 | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2 OS=Homo sapiens GN=KIR2DS2 PE=1 SV=2 | 254 | K | 0.103908 | N | 0.091051 | 0.012857 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 65 | K | 0.432389 | M | 0.305221 | 0.127168 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 68 | N | 0.379374 | D | 0.379648 | -2.74E-04 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 71 | H | 0.31867 | R | 0.29796 | 0.02071 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 89 | P | 0.227002 | R | 0.186531 | 0.040471 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 92 | P | 0.169282 | H | 0.133356 | 0.035926 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 93 | V | 0.157999 | D | 0.282184 | -0.124185 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 103 | S | 0.358514 | C | 0.174294 | 0.18422 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 178 | N | 0.344731 | H | 0.364402 | -0.019671 | No Change: Both O | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 205 | A | 0.454285 | S | 0.561904 | -0.107619 | O to D | - |
| P43632 | KI2S4_HUMAN Killer cell immunoglobulin-like receptor 2DS4 OS=Homo sapiens GN=KIR2DS4 PE=1 SV=2 | 254 | K | 0.101793 | N | 0.088212 | 0.013581 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 2 | S | 0.633402 | L | 0.488319 | 0.145083 | D to O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 13 | L | 0.127632 | F | 0.115535 | 0.012097 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 23 | M | 0.526951 | V | 0.480328 | 0.046623 | D to O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 68 | I | 0.132786 | V | 0.136241 | -0.003455 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 75 | I | 0.200813 | L | 0.204015 | -0.003202 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 333 | S | 0.815973 | C | 0.735455 | 0.080518 | No Change: Both D | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 259 | G | 0.639098 | R | 0.677143 | -0.038045 | No Change: Both D | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 203 | P | 0.410843 | S | 0.435831 | -0.024988 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 220 | P | 0.629389 | L | 0.472239 | 0.15715 | D to O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 362 | L | 0.038649 | R | 0.060414 | -0.021765 | No Change: Both O | - |
| P43629 | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1 OS=Homo sapiens GN=KIR3DL1 PE=1 SV=1 | 394 | E | 0.803566 | Q | 0.801147 | 0.002419 | No Change: Both D | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 40 | P | 0.44798 | A | 0.363941 | 0.084039 | No Change: Both O | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 113 | L | 0.389848 | V | 0.389435 | 4.13E-04 | No Change: Both O | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 158 | E | 0.425133 | D | 0.400014 | 0.025119 | No Change: Both O | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 166 | R | 0.504367 | H | 0.520618 | -0.016251 | No Change: Both D | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 228 | A | 0.588255 | P | 0.671683 | -0.083428 | No Change: Both D | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 252 | I | 0.354874 | T | 0.506701 | -0.151827 | O to D | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 132 | P | 0.486402 | T | 0.425197 | 0.061205 | No Change: Both O | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 397 | T | 0.701079 | M | 0.678741 | 0.022338 | No Change: Both D | - |
| P43630 | KI3L2_HUMAN Killer cell immunoglobulin-like receptor 3DL2 OS=Homo sapiens GN=KIR3DL2 PE=2 SV=1 | 439 | K | 0.790903 | Q | 0.803355 | -0.012452 | No Change: Both D | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 168 | V | 0.287572 | I | 0.263785 | 0.023787 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 348 | A | 0.147166 | P | 0.187258 | -0.040092 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 324 | V | 0.179084 | A | 0.221294 | -0.04221 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 52 | R | 0.257687 | H | 0.242661 | 0.015026 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 56 | N | 0.40948 | K | 0.462459 | -0.052979 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 77 | R | 0.232188 | W | 0.089993 | 0.142195 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 149 | R | 0.097254 | S | 0.120785 | -0.023531 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 152 | R | 0.13617 | H | 0.131366 | 0.004804 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 231 | G | 0.592419 | D | 0.59743 | -0.005011 | No Change: Both D | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 290 | N | 0.275164 | T | 0.2602 | 0.014964 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 321 | H | 0.318825 | N | 0.341634 | -0.022809 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 321 | H | 0.318825 | Y | 0.195887 | 0.122938 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 324 | V | 0.179084 | D | 0.302953 | -0.123869 | No Change: Both O | - |
| Q8N743 | KI3L3_HUMAN Killer cell immunoglobulin-like receptor 3DL3 OS=Homo sapiens GN=KIR3DL3 PE=2 SV=2 | 373 | E | 0.733112 | D | 0.728873 | 0.004239 | No Change: Both D | - |
| A8MWS1 | KI3P1_HUMAN Putative killer cell immunoglobulin-like receptor like protein KIR3DP1 OS=Homo sapiens GN=KIR3DP1 PE=2 SV=2 | 160 | K | 0.424919 | T | 0.366704 | 0.058215 | No Change: Both O | - |
| A8MWS1 | KI3P1_HUMAN Putative killer cell immunoglobulin-like receptor like protein KIR3DP1 OS=Homo sapiens GN=KIR3DP1 PE=2 SV=2 | 258 | E | 0.511499 | D | 0.481965 | 0.029534 | D to O | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 166 | R | 0.39106 | H | 0.410847 | -0.019787 | No Change: Both O | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 2 | S | 0.633402 | L | 0.488319 | 0.145083 | D to O | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 68 | V | 0.135268 | I | 0.131757 | 0.003511 | No Change: Both O | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 203 | P | 0.407706 | S | 0.437706 | -0.03 | No Change: Both O | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 220 | L | 0.474744 | P | 0.633787 | -0.159043 | O to D | - |
| Q14943 | KI3S1_HUMAN Killer cell immunoglobulin-like receptor 3DS1 OS=Homo sapiens GN=KIR3DS1 PE=2 SV=1 | 259 | G | 0.639098 | R | 0.677143 | -0.038045 | No Change: Both D | - |
| Q96J84 | KIRR1_HUMAN Kin of IRRE-like protein 1 OS=Homo sapiens GN=KIRREL PE=1 SV=2 | 78 | A | 0.328282 | T | 0.340966 | -0.012684 | No Change: Both O | - |
| Q6UWL6 | KIRR2_HUMAN Kin of IRRE-like protein 2 OS=Homo sapiens GN=KIRREL2 PE=1 SV=2 | 19 | R | 0.298602 | S | 0.331773 | -0.033171 | No Change: Both O | - |
| Q6UWL6 | KIRR2_HUMAN Kin of IRRE-like protein 2 OS=Homo sapiens GN=KIRREL2 PE=1 SV=2 | 170 | A | 0.28015 | T | 0.349687 | -0.069537 | No Change: Both O | - |
| Q6UWL6 | KIRR2_HUMAN Kin of IRRE-like protein 2 OS=Homo sapiens GN=KIRREL2 PE=1 SV=2 | 353 | V | 0.442868 | M | 0.497748 | -0.05488 | No Change: Both O | - |
| Q6UWL6 | KIRR2_HUMAN Kin of IRRE-like protein 2 OS=Homo sapiens GN=KIRREL2 PE=1 SV=2 | 556 | S | 0.895822 | N | 0.86877 | 0.027052 | No Change: Both D | - |
| Q8IZU9 | KIRR3_HUMAN Kin of IRRE-like protein 3 OS=Homo sapiens GN=KIRREL3 PE=1 SV=1 | 40 | R | 0.447393 | W | 0.230946 | 0.216447 | No Change: Both O | Mental retardation autosomal dominant type 4 (MRD4) [MIM:612581] |
| Q8IZU9 | KIRR3_HUMAN Kin of IRRE-like protein 3 OS=Homo sapiens GN=KIRREL3 PE=1 SV=1 | 336 | R | 0.328736 | Q | 0.355466 | -0.02673 | No Change: Both O | Mental retardation autosomal dominant type 4 (MRD4) [MIM:612581] |
| Q8IZU9 | KIRR3_HUMAN Kin of IRRE-like protein 3 OS=Homo sapiens GN=KIRREL3 PE=1 SV=1 | 731 | V | 0.976609 | F | 0.979184 | -0.002575 | No Change: Both D | Mental retardation autosomal dominant type 4 (MRD4) [MIM:612581] |
| Q15726 | KISS1_HUMAN Metastasis-suppressor KiSS-1 OS=Homo sapiens GN=KISS1 PE=1 SV=4 | 20 | E | 0.311709 | K | 0.308772 | 0.002937 | No Change: Both O | - |
| Q15726 | KISS1_HUMAN Metastasis-suppressor KiSS-1 OS=Homo sapiens GN=KISS1 PE=1 SV=4 | 36 | Q | 0.686878 | R | 0.674329 | 0.012549 | No Change: Both D | - |
| Q15726 | KISS1_HUMAN Metastasis-suppressor KiSS-1 OS=Homo sapiens GN=KISS1 PE=1 SV=4 | 81 | P | 0.982898 | R | 0.979009 | 0.003889 | No Change: Both D | - |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 148 | L | 0.128855 | S | 0.247363 | -0.118508 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 223 | C | 0.070574 | R | 0.130566 | -0.059992 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 297 | R | 0.377634 | L | 0.258055 | 0.119579 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 364 | L | 0.958652 | H | 0.965899 | -0.007247 | No Change: Both D | - |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 102 | L | 0.04024 | P | 0.085152 | -0.044912 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q969F8 | KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens GN=KISS1R PE=1 SV=2 | 386 | R | 0.756152 | P | 0.808118 | -0.051966 | No Change: Both D | Central precocious puberty (CEPREPU) [MIM:176400] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 583 | E | 0.325312 | K | 0.341736 | -0.016424 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 584 | F | 0.327142 | L | 0.366974 | -0.039832 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 664 | G | 0.114491 | R | 0.098569 | 0.015922 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 791 | R | 0.181778 | G | 0.181135 | 6.43E-04 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 812 | G | 0.11297 | V | 0.061965 | 0.051005 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 816 | D | 0.279914 | V | 0.144352 | 0.135562 | No Change: Both O | Mast cell leukemia |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 816 | D | 0.279914 | Y | 0.150056 | 0.129858 | No Change: Both O | Acute myeloid leukemia |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 822 | N | 0.398001 | K | 0.445034 | -0.047033 | No Change: Both O | A germ cell tumor of the testis |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 829 | A | 0.232219 | P | 0.32028 | -0.088061 | No Change: Both O | A germ cell tumor of the testis |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 550 | K | 0.208323 | I | 0.076201 | 0.132122 | No Change: Both O | Gastrointestinal stromal tumor (GIST) [MIM:606764] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 559 | V | 0.201307 | A | 0.251366 | -0.050059 | No Change: Both O | Gastrointestinal stromal tumor (GIST) [MIM:606764] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 559 | V | 0.201307 | D | 0.335841 | -0.134534 | No Change: Both O | Gastrointestinal stromal tumor (GIST) [MIM:606764] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 584 | F | 0.327142 | C | 0.302313 | 0.024829 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 601 | G | 0.269302 | R | 0.237493 | 0.031809 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 656 | L | 0.088317 | P | 0.166338 | -0.078021 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 796 | R | 0.194645 | G | 0.19894 | -0.004295 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 816 | D | 0.279914 | F | 0.131182 | 0.148732 | No Change: Both O | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 816 | D | 0.279914 | H | 0.22905 | 0.050864 | No Change: Both O | A testicular tumor |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 820 | D | 0.437862 | G | 0.408205 | 0.029657 | No Change: Both O | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 839 | E | 0.098271 | K | 0.105137 | -0.006866 | No Change: Both O | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 847 | T | 0.070431 | P | 0.08995 | -0.019519 | No Change: Both O | Piebald trait (PBT) [MIM:172800] |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 532 | V | 0.015638 | I | 0.013988 | 0.00165 | No Change: Both O | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 541 | M | 0.015671 | L | 0.011337 | 0.004334 | No Change: Both O | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 691 | C | 0.476011 | S | 0.670323 | -0.194312 | O to D | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 715 | S | 0.77906 | N | 0.737897 | 0.041163 | No Change: Both D | - |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 737 | D | 0.617877 | N | 0.576437 | 0.04144 | No Change: Both D | A colorectal adenocarcinoma sample |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 804 | R | 0.105493 | W | 0.039661 | 0.065832 | No Change: Both O | A colorectal adenocarcinoma sample |
| P10721 | KIT_HUMAN Mast/stem cell growth factor receptor Kit OS=Homo sapiens GN=KIT PE=1 SV=1 | 541 | M | 0.015671 | V | 0.011303 | 0.004368 | No Change: Both O | - |
| P21583 | SCF_HUMAN Kit ligand OS=Homo sapiens GN=KITLG PE=1 SV=1 | 54 | T | 0.141895 | A | 0.126307 | 0.015588 | No Change: Both O | - |
| P21583 | SCF_HUMAN Kit ligand OS=Homo sapiens GN=KITLG PE=1 SV=1 | 232 | F | 0.033356 | Y | 0.035482 | -0.002126 | No Change: Both O | - |
| P21583 | SCF_HUMAN Kit ligand OS=Homo sapiens GN=KITLG PE=1 SV=1 | 36 | N | 0.383261 | S | 0.405719 | -0.022458 | No Change: Both O | Familial progressive hyperpigmentation (FPH) [MIM:145250] |
| P21583 | SCF_HUMAN Kit ligand OS=Homo sapiens GN=KITLG PE=1 SV=1 | 210 | D | 0.65782 | Y | 0.543997 | 0.113823 | No Change: Both D | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 15 | P | 0.967595 | Q | 0.953816 | 0.013779 | No Change: Both D | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 45 | F | 0.523959 | V | 0.533695 | -0.009736 | No Change: Both D | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 352 | F | 0.505902 | V | 0.523015 | -0.017113 | No Change: Both D | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 370 | C | 0.157734 | S | 0.309765 | -0.152031 | No Change: Both O | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 954 | P | 0.460511 | L | 0.293287 | 0.167224 | No Change: Both O | A colorectal cancer sample |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 514 | P | 0.501997 | S | 0.50434 | -0.002343 | No Change: Both D | - |
| Q9UEF7 | KLOT_HUMAN Klotho OS=Homo sapiens GN=KL PE=1 SV=2 | 193 | H | 0.094008 | R | 0.109683 | -0.015675 | No Change: Both O | Hyperphosphatemic familial tumoral calcinosis (HFTC) [MIM:211900] |
| Q86Z14 | KLOTB_HUMAN Beta-klotho OS=Homo sapiens GN=KLB PE=1 SV=1 | 728 | R | 0.258232 | Q | 0.270591 | -0.012359 | No Change: Both O | - |
| Q86Z14 | KLOTB_HUMAN Beta-klotho OS=Homo sapiens GN=KLB PE=1 SV=1 | 747 | A | 0.420972 | V | 0.319034 | 0.101938 | No Change: Both O | - |
| Q86Z14 | KLOTB_HUMAN Beta-klotho OS=Homo sapiens GN=KLB PE=1 SV=1 | 1020 | Q | 0.27989 | K | 0.329601 | -0.049711 | No Change: Both O | - |
| Q86Z14 | KLOTB_HUMAN Beta-klotho OS=Homo sapiens GN=KLB PE=1 SV=1 | 906 | Y | 0.199281 | H | 0.28415 | -0.084869 | No Change: Both O | - |
| Q86Z14 | KLOTB_HUMAN Beta-klotho OS=Homo sapiens GN=KLB PE=1 SV=1 | 65 | P | 0.394816 | A | 0.303867 | 0.090949 | No Change: Both O | - |
| Q9H0B6 | KLC2_HUMAN Kinesin light chain 2 OS=Homo sapiens GN=KLC2 PE=1 SV=1 | 517 | P | 0.963088 | S | 0.968477 | -0.005389 | No Change: Both D | - |
| Q9NSK0 | KLC4_HUMAN Kinesin light chain 4 OS=Homo sapiens GN=KLC4 PE=1 SV=3 | 72 | R | 0.701351 | H | 0.672934 | 0.028417 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 102 | S | 0.856888 | P | 0.871746 | -0.014858 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 182 | F | 0.811412 | L | 0.853347 | -0.041935 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 299 | H | 0.653735 | Y | 0.542564 | 0.111171 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 328 | R | 0.5774 | H | 0.558017 | 0.019383 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 328 | R | 0.5774 | L | 0.441935 | 0.135465 | D to O | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 331 | R | 0.58944 | G | 0.553535 | 0.035905 | No Change: Both D | - |
| Q13351 | KLF1_HUMAN Krueppel-like factor 1 OS=Homo sapiens GN=KLF1 PE=1 SV=1 | 325 | E | 0.504845 | K | 0.515169 | -0.010324 | No Change: Both D | Congenital dyserythropoietic anemia type 4 (CDA4) [MIM:613673] |
| Q13118 | KLF10_HUMAN Krueppel-like factor 10 OS=Homo sapiens GN=KLF10 PE=1 SV=1 | 249 | S | 0.873542 | F | 0.736913 | 0.136629 | No Change: Both D | - |
| O14901 | KLF11_HUMAN Krueppel-like factor 11 OS=Homo sapiens GN=KLF11 PE=1 SV=2 | 62 | Q | 0.561847 | R | 0.569846 | -0.007999 | No Change: Both D | - |
| O14901 | KLF11_HUMAN Krueppel-like factor 11 OS=Homo sapiens GN=KLF11 PE=1 SV=2 | 220 | T | 0.664115 | M | 0.595795 | 0.06832 | No Change: Both D | Maturity-onset diabetes of the young type 7 (MODY7) [MIM:610508] |
| O14901 | KLF11_HUMAN Krueppel-like factor 11 OS=Homo sapiens GN=KLF11 PE=1 SV=2 | 347 | A | 0.746937 | S | 0.757749 | -0.010812 | No Change: Both D | Maturity-onset diabetes of the young type 7 (MODY7) [MIM:610508] |
| O14901 | KLF11_HUMAN Krueppel-like factor 11 OS=Homo sapiens GN=KLF11 PE=1 SV=2 | 378 | S | 0.373328 | F | 0.222272 | 0.151056 | No Change: Both O | - |
| Q8TD94 | KLF14_HUMAN Krueppel-like factor 14 OS=Homo sapiens GN=KLF14 PE=1 SV=1 | 173 | A | 0.963275 | P | 0.972745 | -0.00947 | No Change: Both D | - |
| Q5JT82 | KLF17_HUMAN Krueppel-like factor 17 OS=Homo sapiens GN=KLF17 PE=1 SV=1 | 156 | N | 0.823184 | S | 0.850407 | -0.027223 | No Change: Both D | - |
| Q5JT82 | KLF17_HUMAN Krueppel-like factor 17 OS=Homo sapiens GN=KLF17 PE=1 SV=1 | 35 | I | 0.875786 | N | 0.935016 | -0.05923 | No Change: Both D | - |
| Q5JT82 | KLF17_HUMAN Krueppel-like factor 17 OS=Homo sapiens GN=KLF17 PE=1 SV=1 | 57 | S | 0.788339 | T | 0.709007 | 0.079332 | No Change: Both D | - |
| Q5JT82 | KLF17_HUMAN Krueppel-like factor 17 OS=Homo sapiens GN=KLF17 PE=1 SV=1 | 80 | Q | 0.80121 | H | 0.759914 | 0.041296 | No Change: Both D | - |
| Q9Y5W3 | KLF2_HUMAN Krueppel-like factor 2 OS=Homo sapiens GN=KLF2 PE=1 SV=2 | 104 | L | 0.82608 | P | 0.896744 | -0.070664 | No Change: Both D | - |
| Q9Y5W3 | KLF2_HUMAN Krueppel-like factor 2 OS=Homo sapiens GN=KLF2 PE=1 SV=2 | 145 | R | 0.973118 | P | 0.9775 | -0.004382 | No Change: Both D | - |
| P57682 | KLF3_HUMAN Krueppel-like factor 3 OS=Homo sapiens GN=KLF3 PE=1 SV=1 | 207 | R | 0.910107 | S | 0.938123 | -0.028016 | No Change: Both D | - |
| O43474 | KLF4_HUMAN Krueppel-like factor 4 OS=Homo sapiens GN=KLF4 PE=1 SV=3 | 315 | T | 0.858655 | S | 0.885713 | -0.027058 | No Change: Both D | - |
| O43474 | KLF4_HUMAN Krueppel-like factor 4 OS=Homo sapiens GN=KLF4 PE=1 SV=3 | 321 | L | 0.872268 | F | 0.850983 | 0.021285 | No Change: Both D | - |
| Q13887 | KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens GN=KLF5 PE=1 SV=2 | 301 | P | 0.979115 | S | 0.976772 | 0.002343 | No Change: Both D | A colorectal cancer sample |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 64 | W | 0.603609 | R | 0.757497 | -0.153888 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 116 | S | 0.976741 | P | 0.973646 | 0.003095 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 123 | A | 0.976153 | D | 0.985595 | -0.009442 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 155 | S | 0.980181 | R | 0.973677 | 0.006504 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 169 | L | 0.976688 | P | 0.988554 | -0.011866 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 172 | P | 0.975469 | T | 0.964273 | 0.011196 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 180 | S | 0.965333 | L | 0.933353 | 0.03198 | No Change: Both D | - |
| Q99612 | KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens GN=KLF6 PE=1 SV=3 | 198 | R | 0.853388 | K | 0.85688 | -0.003492 | No Change: Both D | - |
| Q6PID8 | KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens GN=KLHDC10 PE=2 SV=1 | 2 | S | 0.991448 | L | 0.976919 | 0.014529 | No Change: Both D | - |
| Q6PID8 | KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens GN=KLHDC10 PE=2 SV=1 | 183 | D | 0.376638 | G | 0.370962 | 0.005676 | No Change: Both O | - |
| Q6PID8 | KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens GN=KLHDC10 PE=2 SV=1 | 274 | I | 0.162059 | V | 0.171235 | -0.009176 | No Change: Both O | - |
| Q6PID8 | KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens GN=KLHDC10 PE=2 SV=1 | 295 | E | 0.263535 | G | 0.201972 | 0.061563 | No Change: Both O | - |
| Q6PID8 | KLD10_HUMAN Kelch domain-containing protein 10 OS=Homo sapiens GN=KLHDC10 PE=2 SV=1 | 437 | L | 0.466373 | I | 0.425279 | 0.041094 | No Change: Both O | - |
| Q8TBB5 | KLDC4_HUMAN Kelch domain-containing protein 4 OS=Homo sapiens GN=KLHDC4 PE=1 SV=1 | 56 | L | 0.649123 | V | 0.632686 | 0.016437 | No Change: Both D | - |
| Q8TBB5 | KLDC4_HUMAN Kelch domain-containing protein 4 OS=Homo sapiens GN=KLHDC4 PE=1 SV=1 | 155 | L | 0.078105 | V | 0.076892 | 0.001213 | No Change: Both O | - |
| Q8TBB5 | KLDC4_HUMAN Kelch domain-containing protein 4 OS=Homo sapiens GN=KLHDC4 PE=1 SV=1 | 102 | T | 0.214076 | I | 0.115392 | 0.098684 | No Change: Both O | - |
| Q8TBB5 | KLDC4_HUMAN Kelch domain-containing protein 4 OS=Homo sapiens GN=KLHDC4 PE=1 SV=1 | 130 | G | 0.244592 | V | 0.146917 | 0.097675 | No Change: Both O | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 147 | T | 0.965936 | P | 0.977981 | -0.012045 | No Change: Both D | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 273 | H | 0.333706 | N | 0.355326 | -0.02162 | No Change: Both O | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 21 | V | 0.191786 | L | 0.198275 | -0.006489 | No Change: Both O | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 194 | R | 0.839431 | P | 0.879944 | -0.040513 | No Change: Both D | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 160 | R | 0.948158 | S | 0.960909 | -0.012751 | No Change: Both D | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 351 | T | 0.906812 | P | 0.931404 | -0.024592 | No Change: Both D | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 94 | G | 0.93876 | S | 0.951194 | -0.012434 | No Change: Both D | - |
| Q5VTJ3 | KLD7A_HUMAN Kelch domain-containing protein 7A OS=Homo sapiens GN=KLHDC7A PE=1 SV=5 | 141 | P | 0.982897 | R | 0.97881 | 0.004087 | No Change: Both D | - |
| Q8NEP7 | KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens GN=KLHDC9 PE=1 SV=2 | 171 | S | 0.395675 | R | 0.38308 | 0.012595 | No Change: Both O | - |
| Q8NEP7 | KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens GN=KLHDC9 PE=1 SV=2 | 288 | N | 0.112797 | S | 0.137624 | -0.024827 | No Change: Both O | - |
| Q8NEP7 | KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens GN=KLHDC9 PE=1 SV=2 | 282 | A | 0.243222 | T | 0.291145 | -0.047923 | No Change: Both O | - |
| Q53G59 | KLH12_HUMAN Kelch-like protein 12 OS=Homo sapiens GN=KLHL12 PE=1 SV=2 | 72 | P | 0.485952 | L | 0.341611 | 0.144341 | No Change: Both O | - |
| Q9P2N7 | KLH13_HUMAN Kelch-like protein 13 OS=Homo sapiens GN=KLHL13 PE=1 SV=3 | 223 | F | 0.17795 | I | 0.164967 | 0.012983 | No Change: Both O | - |
| Q9H0H3 | ENC2_HUMAN Ectoderm-neural cortex protein 2 OS=Homo sapiens GN=KLHL25 PE=2 SV=1 | 250 | V | 0.55206 | I | 0.525388 | 0.026672 | No Change: Both D | - |
| Q9H0H3 | ENC2_HUMAN Ectoderm-neural cortex protein 2 OS=Homo sapiens GN=KLHL25 PE=2 SV=1 | 257 | M | 0.459877 | L | 0.413207 | 0.04667 | No Change: Both O | - |
| Q53HC5 | KLH26_HUMAN Kelch-like protein 26 OS=Homo sapiens GN=KLHL26 PE=1 SV=2 | 542 | V | 0.502803 | M | 0.587064 | -0.084261 | No Change: Both D | - |
| Q9NXS3 | KLH28_HUMAN Kelch-like protein 28 OS=Homo sapiens GN=KLHL28 PE=2 SV=2 | 349 | I | 0.443086 | V | 0.502987 | -0.059901 | O to D | - |
| Q9H511 | KLH31_HUMAN Kelch-like protein 31 OS=Homo sapiens GN=KLHL31 PE=2 SV=1 | 11 | N | 0.749591 | S | 0.757209 | -0.007618 | No Change: Both D | - |
| Q9H511 | KLH31_HUMAN Kelch-like protein 31 OS=Homo sapiens GN=KLHL31 PE=2 SV=1 | 156 | V | 0.071087 | I | 0.065338 | 0.005749 | No Change: Both O | - |
| Q9H511 | KLH31_HUMAN Kelch-like protein 31 OS=Homo sapiens GN=KLHL31 PE=2 SV=1 | 508 | A | 0.139965 | T | 0.173317 | -0.033352 | No Change: Both O | - |
| Q96NJ5 | KLH32_HUMAN Kelch-like protein 32 OS=Homo sapiens GN=KLHL32 PE=2 SV=2 | 129 | N | 0.107165 | S | 0.137302 | -0.030137 | No Change: Both O | - |
| Q96NJ5 | KLH32_HUMAN Kelch-like protein 32 OS=Homo sapiens GN=KLHL32 PE=2 SV=2 | 146 | D | 0.101093 | G | 0.084878 | 0.016215 | No Change: Both O | - |
| Q96NJ5 | KLH32_HUMAN Kelch-like protein 32 OS=Homo sapiens GN=KLHL32 PE=2 SV=2 | 5 | R | 0.803751 | C | 0.737743 | 0.066008 | No Change: Both D | - |
| A6NCF5 | KLH33_HUMAN Kelch-like protein 33 OS=Homo sapiens GN=KLHL33 PE=2 SV=2 | 163 | R | 0.333074 | H | 0.249156 | 0.083918 | No Change: Both O | - |
| A6NCF5 | KLH33_HUMAN Kelch-like protein 33 OS=Homo sapiens GN=KLHL33 PE=2 SV=2 | 176 | R | 0.62792 | Q | 0.599054 | 0.028866 | No Change: Both D | - |
| A6NCF5 | KLH33_HUMAN Kelch-like protein 33 OS=Homo sapiens GN=KLHL33 PE=2 SV=2 | 345 | E | 0.313071 | G | 0.247964 | 0.065107 | No Change: Both O | - |
| A6NCF5 | KLH33_HUMAN Kelch-like protein 33 OS=Homo sapiens GN=KLHL33 PE=2 SV=2 | 516 | A | 0.242298 | T | 0.272524 | -0.030226 | No Change: Both O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 310 | G | 0.379778 | S | 0.465986 | -0.086208 | No Change: Both O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 352 | N | 0.195849 | Y | 0.121608 | 0.074241 | No Change: Both O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 394 | G | 0.534265 | R | 0.498617 | 0.035648 | D to O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 504 | C | 0.386087 | Y | 0.440592 | -0.054505 | No Change: Both O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 334 | I | 0.117871 | V | 0.137695 | -0.019824 | No Change: Both O | - |
| Q2WGJ6 | KLH38_HUMAN Kelch-like protein 38 OS=Homo sapiens GN=KLHL38 PE=2 SV=3 | 346 | R | 0.576888 | K | 0.638733 | -0.061845 | No Change: Both D | - |
| Q96PQ7 | KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens GN=KLHL5 PE=2 SV=3 | 508 | G | 0.130861 | S | 0.151798 | -0.020937 | No Change: Both O | - |
| Q96PQ7 | KLHL5_HUMAN Kelch-like protein 5 OS=Homo sapiens GN=KLHL5 PE=2 SV=3 | 10 | I | 0.023299 | L | 0.027302 | -0.004003 | No Change: Both O | - |
| Q8WZ60 | KLHL6_HUMAN Kelch-like protein 6 OS=Homo sapiens GN=KLHL6 PE=2 SV=3 | 518 | I | 0.115497 | V | 0.143834 | -0.028337 | No Change: Both O | - |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 150 | S | 0.091384 | N | 0.077663 | 0.013721 | No Change: Both O | Retinitis pigmentosa type 42 (RP42) [MIM:612943] |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 153 | A | 0.085814 | T | 0.09639 | -0.010576 | No Change: Both O | Retinitis pigmentosa type 42 (RP42) [MIM:612943] |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 153 | A | 0.085814 | V | 0.064526 | 0.021288 | No Change: Both O | Retinitis pigmentosa type 42 (RP42) [MIM:612943] |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 255 | D | 0.321644 | N | 0.321266 | 3.78E-04 | No Change: Both O | - |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 423 | H | 0.303813 | Y | 0.20027 | 0.103543 | No Change: Both O | - |
| Q8IXQ5 | KLHL7_HUMAN Kelch-like protein 7 OS=Homo sapiens GN=KLHL7 PE=1 SV=2 | 472 | K | 0.24516 | Q | 0.202099 | 0.043061 | No Change: Both O | - |
| Q9P2G9 | KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens GN=KLHL8 PE=2 SV=4 | 520 | P | 0.580335 | R | 0.558515 | 0.02182 | No Change: Both D | - |
| P06870 | KLK1_HUMAN Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 | 145 | E | 0.598017 | Q | 0.533427 | 0.06459 | No Change: Both D | - |
| P06870 | KLK1_HUMAN Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 | 186 | K | 0.420973 | E | 0.414402 | 0.006571 | No Change: Both O | - |
| P06870 | KLK1_HUMAN Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 | 77 | R | 0.142746 | H | 0.154674 | -0.011928 | No Change: Both O | - |
| P06870 | KLK1_HUMAN Kallikrein-1 OS=Homo sapiens GN=KLK1 PE=1 SV=2 | 193 | V | 0.283065 | E | 0.428577 | -0.145512 | No Change: Both O | - |
| O43240 | KLK10_HUMAN Kallikrein-10 OS=Homo sapiens GN=KLK10 PE=1 SV=3 | 50 | S | 0.500113 | A | 0.393738 | 0.106375 | D to O | - |
| O43240 | KLK10_HUMAN Kallikrein-10 OS=Homo sapiens GN=KLK10 PE=1 SV=3 | 149 | L | 0.301877 | P | 0.47365 | -0.171773 | No Change: Both O | - |
| Q9UBX7 | KLK11_HUMAN Kallikrein-11 OS=Homo sapiens GN=KLK11 PE=1 SV=2 | 49 | G | 0.205917 | E | 0.237344 | -0.031427 | No Change: Both O | - |
| Q9UBX7 | KLK11_HUMAN Kallikrein-11 OS=Homo sapiens GN=KLK11 PE=1 SV=2 | 166 | R | 0.351206 | C | 0.247578 | 0.103628 | No Change: Both O | - |
| Q9UBX7 | KLK11_HUMAN Kallikrein-11 OS=Homo sapiens GN=KLK11 PE=1 SV=2 | 32 | A | 0.329789 | T | 0.345942 | -0.016153 | No Change: Both O | - |
| Q9UKR3 | KLK13_HUMAN Kallikrein-13 OS=Homo sapiens GN=KLK13 PE=1 SV=1 | 109 | H | 0.608212 | Y | 0.492717 | 0.115495 | D to O | - |
| Q9P0G3 | KLK14_HUMAN Kallikrein-14 OS=Homo sapiens GN=KLK14 PE=1 SV=2 | 33 | Q | 0.405122 | R | 0.370697 | 0.034425 | No Change: Both O | - |
| Q9P0G3 | KLK14_HUMAN Kallikrein-14 OS=Homo sapiens GN=KLK14 PE=1 SV=2 | 45 | H | 0.35488 | Y | 0.242285 | 0.112595 | No Change: Both O | - |
| Q9P0G3 | KLK14_HUMAN Kallikrein-14 OS=Homo sapiens GN=KLK14 PE=1 SV=2 | 64 | R | 0.210172 | H | 0.189575 | 0.020597 | No Change: Both O | - |
| Q9H2R5 | KLK15_HUMAN Kallikrein-15 OS=Homo sapiens GN=KLK15 PE=2 SV=1 | 134 | P | 0.542945 | L | 0.369049 | 0.173896 | D to O | - |
| Q9H2R5 | KLK15_HUMAN Kallikrein-15 OS=Homo sapiens GN=KLK15 PE=2 SV=1 | 137 | A | 0.486086 | T | 0.521044 | -0.034958 | O to D | A breast cancer sample |
| P20151 | KLK2_HUMAN Kallikrein-2 OS=Homo sapiens GN=KLK2 PE=2 SV=1 | 18 | V | 0.135211 | L | 0.134935 | 2.76E-04 | No Change: Both O | - |
| P20151 | KLK2_HUMAN Kallikrein-2 OS=Homo sapiens GN=KLK2 PE=2 SV=1 | 250 | R | 0.118013 | W | 0.050119 | 0.067894 | No Change: Both O | - |
| P20151 | KLK2_HUMAN Kallikrein-2 OS=Homo sapiens GN=KLK2 PE=2 SV=1 | 255 | D | 0.318835 | A | 0.265138 | 0.053697 | No Change: Both O | - |
| P07288 | KLK3_HUMAN Prostate-specific antigen OS=Homo sapiens GN=KLK3 PE=1 SV=2 | 32 | E | 0.366899 | K | 0.366507 | 3.92E-04 | No Change: Both O | - |
| P07288 | KLK3_HUMAN Prostate-specific antigen OS=Homo sapiens GN=KLK3 PE=1 SV=2 | 132 | L | 0.501295 | I | 0.420567 | 0.080728 | D to O | - |
| P07288 | KLK3_HUMAN Prostate-specific antigen OS=Homo sapiens GN=KLK3 PE=1 SV=2 | 179 | I | 0.117686 | T | 0.206674 | -0.088988 | No Change: Both O | - |
| Q9Y5K2 | KLK4_HUMAN Kallikrein-4 OS=Homo sapiens GN=KLK4 PE=1 SV=2 | 22 | S | 0.258421 | A | 0.166488 | 0.091933 | No Change: Both O | - |
| Q9Y5K2 | KLK4_HUMAN Kallikrein-4 OS=Homo sapiens GN=KLK4 PE=1 SV=2 | 197 | H | 0.591665 | Q | 0.626983 | -0.035318 | No Change: Both D | - |
| Q9Y5K2 | KLK4_HUMAN Kallikrein-4 OS=Homo sapiens GN=KLK4 PE=1 SV=2 | 159 | G | 0.188111 | D | 0.191873 | -0.003762 | No Change: Both O | - |
| Q9Y337 | KLK5_HUMAN Kallikrein-5 OS=Homo sapiens GN=KLK5 PE=1 SV=2 | 55 | G | 0.862749 | R | 0.869289 | -0.00654 | No Change: Both D | - |
| Q9Y337 | KLK5_HUMAN Kallikrein-5 OS=Homo sapiens GN=KLK5 PE=1 SV=2 | 153 | N | 0.577095 | D | 0.561746 | 0.015349 | No Change: Both D | - |
| Q92876 | KLK6_HUMAN Kallikrein-6 OS=Homo sapiens GN=KLK6 PE=1 SV=1 | 78 | R | 0.654744 | W | 0.451604 | 0.20314 | D to O | - |
| O60259 | KLK8_HUMAN Kallikrein-8 OS=Homo sapiens GN=KLK8 PE=1 SV=1 | 154 | V | 0.410912 | I | 0.373877 | 0.037035 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 143 | N | 0.21889 | S | 0.248183 | -0.029293 | No Change: Both O | Prekallikrein deficiency (PKK deficiency) [MIM:612423] |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 202 | H | 0.101039 | Q | 0.111161 | -0.010122 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 208 | H | 0.10293 | P | 0.114451 | -0.011521 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 178 | A | 0.385652 | T | 0.439006 | -0.053354 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 269 | S | 0.831125 | C | 0.760721 | 0.070404 | No Change: Both D | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 311 | F | 0.159942 | V | 0.192757 | -0.032815 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 358 | T | 0.540522 | A | 0.494381 | 0.046141 | D to O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 381 | S | 0.510443 | A | 0.367986 | 0.142457 | D to O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 442 | Q | 0.080715 | P | 0.094117 | -0.013402 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 560 | R | 0.195247 | Q | 0.226721 | -0.031474 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 210 | A | 0.121582 | E | 0.18347 | -0.061888 | No Change: Both O | - |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 123 | G | 0.282702 | R | 0.292633 | -0.009931 | No Change: Both O | Prekallikrein deficiency (PKK deficiency) [MIM:612423] |
| P03952 | KLKB1_HUMAN Plasma kallikrein OS=Homo sapiens GN=KLKB1 PE=1 SV=1 | 548 | C | 0.381316 | Y | 0.445393 | -0.064077 | No Change: Both O | Prekallikrein deficiency (PKK deficiency) [MIM:612423] |
| Q12918 | KLRB1_HUMAN Killer cell lectin-like receptor subfamily B member 1 OS=Homo sapiens GN=KLRB1 PE=1 SV=1 | 168 | I | 0.210627 | T | 0.339964 | -0.129337 | No Change: Both O | - |
| P26715 | NKG2A_HUMAN NKG2-A/NKG2-B type II integral membrane protein OS=Homo sapiens GN=KLRC1 PE=1 SV=2 | 29 | N | 0.757353 | S | 0.775677 | -0.018324 | No Change: Both D | - |
| P26717 | NKG2C_HUMAN NKG2-C type II integral membrane protein OS=Homo sapiens GN=KLRC2 PE=1 SV=2 | 2 | S | 0.98275 | N | 0.972695 | 0.010055 | No Change: Both D | - |
| P26717 | NKG2C_HUMAN NKG2-C type II integral membrane protein OS=Homo sapiens GN=KLRC2 PE=1 SV=2 | 102 | S | 0.762489 | F | 0.552974 | 0.209515 | No Change: Both D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 19 | W | 0.857919 | P | 0.949886 | -0.091967 | No Change: Both D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 135 | R | 0.43752 | S | 0.503441 | -0.065921 | O to D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 2 | S | 0.940051 | N | 0.906219 | 0.033832 | No Change: Both D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 113 | H | 0.389544 | P | 0.431634 | -0.04209 | No Change: Both O | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 155 | C | 0.435223 | S | 0.663903 | -0.22868 | O to D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 19 | W | 0.857919 | R | 0.942249 | -0.08433 | No Change: Both D | - |
| Q07444 | NKG2E_HUMAN NKG2-E type II integral membrane protein OS=Homo sapiens GN=KLRC3 PE=2 SV=3 | 106 | A | 0.794327 | T | 0.80804 | -0.013713 | No Change: Both D | - |
| O43908 | NKG2F_HUMAN NKG2-F type II integral membrane protein OS=Homo sapiens GN=KLRC4 PE=2 SV=2 | 29 | I | 0.738994 | S | 0.853201 | -0.114207 | No Change: Both D | - |
| O43908 | NKG2F_HUMAN NKG2-F type II integral membrane protein OS=Homo sapiens GN=KLRC4 PE=2 SV=2 | 104 | N | 0.341716 | S | 0.380848 | -0.039132 | No Change: Both O | - |
| Q13241 | KLRD1_HUMAN Natural killer cells antigen CD94 OS=Homo sapiens GN=KLRD1 PE=1 SV=2 | 25 | S | 0.095143 | A | 0.053507 | 0.041636 | No Change: Both O | - |
| Q9NZS2 | KLRF1_HUMAN Killer cell lectin-like receptor subfamily F member 1 OS=Homo sapiens GN=KLRF1 PE=1 SV=2 | 67 | L | 0.190095 | F | 0.153627 | 0.036468 | No Change: Both O | - |
| Q96E93 | KLRG1_HUMAN Killer cell lectin-like receptor subfamily G member 1 OS=Homo sapiens GN=KLRG1 PE=1 SV=1 | 58 | W | 0.032669 | R | 0.087179 | -0.05451 | No Change: Both O | - |
| A4D1S0 | KLRG2_HUMAN Killer cell lectin-like receptor subfamily G member 2 OS=Homo sapiens GN=KLRG2 PE=1 SV=3 | 152 | K | 0.845533 | T | 0.82716 | 0.018373 | No Change: Both D | - |
| A4D1S0 | KLRG2_HUMAN Killer cell lectin-like receptor subfamily G member 2 OS=Homo sapiens GN=KLRG2 PE=1 SV=3 | 339 | G | 0.318637 | A | 0.268897 | 0.04974 | No Change: Both O | - |
| P26718 | NKG2D_HUMAN NKG2-D type II integral membrane protein OS=Homo sapiens GN=KLRK1 PE=1 SV=1 | 72 | A | 0.013076 | T | 0.013858 | -7.82E-04 | No Change: Both O | - |
| P26718 | NKG2D_HUMAN NKG2-D type II integral membrane protein OS=Homo sapiens GN=KLRK1 PE=1 SV=1 | 177 | N | 0.17823 | S | 0.22645 | -0.04822 | No Change: Both O | - |
| O15229 | KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens GN=KMO PE=1 SV=2 | 452 | R | 0.19799 | C | 0.089042 | 0.108948 | No Change: Both O | - |
| Q76NI1 | VKIND_HUMAN Protein very KIND OS=Homo sapiens GN=KNDC1 PE=2 SV=2 | 436 | E | 0.738574 | G | 0.691529 | 0.047045 | No Change: Both D | - |
| Q76NI1 | VKIND_HUMAN Protein very KIND OS=Homo sapiens GN=KNDC1 PE=2 SV=2 | 581 | G | 0.312671 | S | 0.403056 | -0.090385 | No Change: Both O | - |
| Q76NI1 | VKIND_HUMAN Protein very KIND OS=Homo sapiens GN=KNDC1 PE=2 SV=2 | 717 | L | 0.98697 | P | 0.992808 | -0.005838 | No Change: Both D | - |
| Q76NI1 | VKIND_HUMAN Protein very KIND OS=Homo sapiens GN=KNDC1 PE=2 SV=2 | 1332 | A | 0.089443 | T | 0.09795 | -0.008507 | No Change: Both O | - |
| Q76NI1 | VKIND_HUMAN Protein very KIND OS=Homo sapiens GN=KNDC1 PE=2 SV=2 | 1038 | R | 0.925676 | W | 0.815268 | 0.110408 | No Change: Both D | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 163 | G | 0.159057 | S | 0.20125 | -0.042193 | No Change: Both O | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 178 | M | 0.30524 | T | 0.35489 | -0.04965 | No Change: Both O | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 212 | L | 0.16146 | P | 0.28978 | -0.12832 | No Change: Both O | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 197 | I | 0.068867 | M | 0.100029 | -0.031162 | No Change: Both O | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 430 | D | 0.976146 | E | 0.97963 | -0.003484 | No Change: Both D | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 581 | I | 0.803114 | T | 0.856495 | -0.053381 | No Change: Both D | - |
| P01042 | KNG1_HUMAN Kininogen-1 OS=Homo sapiens GN=KNG1 PE=1 SV=2 | 642 | G | 0.635526 | A | 0.629608 | 0.005918 | No Change: Both D | - |
| P50748 | KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens GN=KNTC1 PE=1 SV=1 | 245 | K | 0.321046 | N | 0.277513 | 0.043533 | No Change: Both O | - |
| P50748 | KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens GN=KNTC1 PE=1 SV=1 | 738 | E | 0.126087 | D | 0.106458 | 0.019629 | No Change: Both O | - |
| P50748 | KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens GN=KNTC1 PE=1 SV=1 | 1506 | T | 0.282768 | M | 0.259677 | 0.023091 | No Change: Both O | - |
| P50748 | KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens GN=KNTC1 PE=1 SV=1 | 1830 | P | 0.699406 | L | 0.576434 | 0.122972 | No Change: Both D | - |
| P50748 | KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens GN=KNTC1 PE=1 SV=1 | 2021 | V | 0.117012 | G | 0.179659 | -0.062647 | No Change: Both O | - |
| P52294 | IMA1_HUMAN Importin subunit alpha-1 OS=Homo sapiens GN=KPNA1 PE=1 SV=3 | 73 | S | 0.744012 | N | 0.702642 | 0.04137 | No Change: Both D | - |
| P52292 | IMA2_HUMAN Importin subunit alpha-2 OS=Homo sapiens GN=KPNA2 PE=1 SV=1 | 165 | P | 0.126897 | R | 0.104388 | 0.022509 | No Change: Both O | - |
| P52292 | IMA2_HUMAN Importin subunit alpha-2 OS=Homo sapiens GN=KPNA2 PE=1 SV=1 | 430 | T | 0.182045 | P | 0.220936 | -0.038891 | No Change: Both O | - |
| O00505 | IMA3_HUMAN Importin subunit alpha-3 OS=Homo sapiens GN=KPNA3 PE=1 SV=2 | 291 | P | 0.141857 | S | 0.160315 | -0.018458 | No Change: Both O | - |
| O15131 | IMA5_HUMAN Importin subunit alpha-6 OS=Homo sapiens GN=KPNA5 PE=1 SV=2 | 45 | F | 0.918495 | L | 0.940334 | -0.021839 | No Change: Both D | A breast cancer sample |
| O15131 | IMA5_HUMAN Importin subunit alpha-6 OS=Homo sapiens GN=KPNA5 PE=1 SV=2 | 316 | R | 0.156785 | S | 0.216513 | -0.059728 | No Change: Both O | A breast cancer sample |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 14 | Q | 0.919575 | H | 0.851411 | 0.068164 | No Change: Both D | - |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 37 | V | 0.913315 | A | 0.926438 | -0.013123 | No Change: Both D | - |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 113 | C | 0.969491 | R | 0.967262 | 0.002229 | No Change: Both D | - |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 168 | R | 0.863463 | H | 0.810999 | 0.052464 | No Change: Both D | - |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 413 | C | 0.999061 | S | 0.999308 | -2.47E-04 | No Change: Both D | - |
| Q5T749 | KPRP_HUMAN Keratinocyte proline-rich protein OS=Homo sapiens GN=KPRP PE=1 SV=1 | 532 | P | 0.883527 | T | 0.831312 | 0.052215 | No Change: Both D | - |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | C | 0.129552 | 0.160681 | No Change: Both O | Lung carcinoma |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | V | 0.175551 | 0.114682 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | V | 0.175551 | 0.114682 | No Change: Both O | Lung carcinoma |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 61 | Q | 0.473056 | H | 0.464341 | 0.008715 | No Change: Both O | Lung carcinoma |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | D | 0.291449 | -0.001216 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | D | 0.291449 | -0.001216 | No Change: Both O | Pancreatic carcinoma |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | R | 0.252464 | 0.037769 | No Change: Both O | Lung cancer |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | S | 0.333493 | -0.04326 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | S | 0.333493 | -0.04326 | No Change: Both O | Lung carcinoma |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 13 | G | 0.319217 | D | 0.319804 | -5.87E-04 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 13 | G | 0.319217 | D | 0.319804 | -5.87E-04 | No Change: Both O | A breast carcinoma cell line |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 59 | A | 0.337569 | T | 0.371022 | -0.033453 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 59 | A | 0.337569 | T | 0.371022 | -0.033453 | No Change: Both O | Bladder cancer |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 14 | V | 0.346582 | I | 0.300866 | 0.045716 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 34 | P | 0.484871 | R | 0.450997 | 0.033874 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 58 | T | 0.277061 | I | 0.177774 | 0.099287 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 60 | G | 0.404035 | R | 0.398922 | 0.005113 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 12 | G | 0.290233 | A | 0.232773 | 0.05746 | No Change: Both O | A colorectal cancer sample |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 61 | Q | 0.473056 | R | 0.460515 | 0.012541 | No Change: Both O | A colorectal cancer sample |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 117 | K | 0.330382 | N | 0.293194 | 0.037188 | No Change: Both O | A colorectal cancer sample |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 146 | A | 0.397148 | T | 0.442144 | -0.044996 | No Change: Both O | A colorectal cancer sample |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 5 | K | 0.499047 | N | 0.458568 | 0.040479 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 22 | Q | 0.130915 | E | 0.150515 | -0.0196 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 22 | Q | 0.130915 | R | 0.112529 | 0.018386 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 34 | P | 0.484871 | L | 0.302492 | 0.182379 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 34 | P | 0.484871 | Q | 0.468298 | 0.016573 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 36 | I | 0.49351 | M | 0.601464 | -0.107954 | O to D | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 5 | K | 0.499047 | E | 0.526651 | -0.027604 | O to D | Noonan syndrome type 3 (NS3) [MIM:609942] |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 13 | G | 0.319217 | R | 0.279132 | 0.040085 | No Change: Both O | Pylocytic astrocytoma (PA) |
| P01116 | RASK_HUMAN GTPase KRas OS=Homo sapiens GN=KRAS PE=1 SV=1 | 60 | G | 0.404035 | S | 0.4666 | -0.062565 | No Change: Both O | Noonan syndrome type 3 (NS3) [MIM:609942] |
| A5PL33 | KRBA1_HUMAN Protein KRBA1 OS=Homo sapiens GN=KRBA1 PE=2 SV=2 | 320 | H | 0.758796 | R | 0.810974 | -0.052178 | No Change: Both D | - |
| Q6ZNG9 | KRBA2_HUMAN KRAB-A domain-containing protein 2 OS=Homo sapiens GN=KRBA2 PE=1 SV=1 | 435 | T | 0.610474 | M | 0.5721 | 0.038374 | No Change: Both D | - |
| Q8NCW0 | KREM2_HUMAN Kremen protein 2 OS=Homo sapiens GN=KREMEN2 PE=2 SV=1 | 408 | A | 0.834802 | P | 0.888888 | -0.054086 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 5 | T | 0.833488 | A | 0.8656 | -0.032112 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 144 | G | 0.826629 | R | 0.851377 | -0.024748 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 185 | E | 0.927798 | A | 0.898909 | 0.028889 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 272 | E | 0.975639 | K | 0.96992 | 0.005719 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 315 | S | 0.886949 | L | 0.81998 | 0.066969 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 342 | R | 0.998789 | W | 0.996176 | 0.002613 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 355 | E | 0.989952 | Q | 0.988585 | 0.001367 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 451 | L | 0.85318 | P | 0.928308 | -0.075128 | No Change: Both D | - |
| Q8N9T8 | KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens GN=KRI1 PE=1 SV=2 | 709 | S | 0.989671 | P | 0.990843 | -0.001172 | No Change: Both D | - |
| O00522 | KRIT1_HUMAN Krev interaction trapped protein 1 OS=Homo sapiens GN=KRIT1 PE=1 SV=2 | 97 | F | 0.358323 | S | 0.567291 | -0.208968 | O to D | Cerebral cavernous malformations type 1 (CCM1) [MIM:116860] |
| O00522 | KRIT1_HUMAN Krev interaction trapped protein 1 OS=Homo sapiens GN=KRIT1 PE=1 SV=2 | 569 | K | 0.635059 | E | 0.6372 | -0.002141 | No Change: Both D | Cerebral cavernous malformations type 1 (CCM1) [MIM:116860] |
| Q13601 | KRR1_HUMAN KRR1 small subunit processome component homolog OS=Homo sapiens GN=KRR1 PE=1 SV=4 | 134 | R | 0.167871 | Q | 0.189504 | -0.021633 | No Change: Both O | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 155 | V | 0.574169 | G | 0.70543 | -0.131261 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 161 | L | 0.490817 | P | 0.672336 | -0.181519 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 186 | S | 0.640883 | P | 0.61705 | 0.023833 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 188 | N | 0.597531 | S | 0.643254 | -0.045723 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 193 | S | 0.493096 | P | 0.473323 | 0.019773 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 312 | I | 0.252549 | V | 0.277108 | -0.024559 | No Change: Both O | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 330 | I | 0.496153 | T | 0.619065 | -0.122912 | O to D | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 358 | Y | 0.543979 | N | 0.691143 | -0.147164 | No Change: Both D | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 490 | E | 0.677055 | Q | 0.62674 | 0.050315 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 537 | G | 0.999532 | C | 0.99918 | 3.52E-04 | No Change: Both D | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 633 | K | 0.993143 | R | 0.9931 | 4.30E-05 | No Change: Both D | - |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 74 | K | 0.946734 | I | 0.925967 | 0.020767 | No Change: Both D | Palmoplantar keratoderma non-epidermolytic (NEPPK) [MIM:600962] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 155 | V | 0.574169 | D | 0.685817 | -0.111648 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 188 | N | 0.597531 | K | 0.642535 | -0.045004 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 188 | N | 0.597531 | T | 0.541925 | 0.055606 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 214 | L | 0.30323 | P | 0.437346 | -0.134116 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 340 | D | 0.514331 | V | 0.355119 | 0.159212 | D to O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 479 | I | 0.338506 | F | 0.349435 | -0.010929 | No Change: Both O | Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 479 | I | 0.338506 | T | 0.539002 | -0.200496 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 479 | I | 0.338506 | T | 0.539002 | -0.200496 | O to D | Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 482 | Y | 0.331309 | C | 0.38325 | -0.051941 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 486 | L | 0.53859 | P | 0.64772 | -0.10913 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P04264 | K2C1_HUMAN Keratin type II cytoskeletal 1 OS=Homo sapiens GN=KRT1 PE=1 SV=6 | 454 | A | 0.779962 | S | 0.799995 | -0.020033 | No Change: Both D | - |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 154 | N | 0.424749 | H | 0.362349 | 0.0624 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 156 | R | 0.369368 | H | 0.343244 | 0.026124 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 156 | R | 0.369368 | C | 0.227949 | 0.141419 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 156 | R | 0.369368 | P | 0.389497 | -0.020129 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 156 | R | 0.369368 | S | 0.443855 | -0.074487 | No Change: Both O | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 160 | Y | 0.347429 | D | 0.542983 | -0.195554 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 161 | L | 0.36269 | S | 0.537465 | -0.174775 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 442 | L | 0.693995 | Q | 0.796645 | -0.10265 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 126 | G | 0.948773 | S | 0.947758 | 0.001015 | No Change: Both D | - |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 150 | M | 0.522767 | R | 0.597296 | -0.074529 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 150 | M | 0.522767 | T | 0.565453 | -0.042686 | No Change: Both D | - |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 160 | Y | 0.347429 | N | 0.527907 | -0.180478 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 160 | Y | 0.347429 | S | 0.567436 | -0.220007 | O to D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 439 | K | 0.64023 | E | 0.720941 | -0.080711 | No Change: Both D | Bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 446 | I | 0.717867 | T | 0.802472 | -0.084605 | No Change: Both D | Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 422 | R | 0.703632 | E | 0.768653 | -0.065021 | No Change: Both D | Ichthyosis annular epidermolytic (AEI) [MIM:607602] |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 101 | I | 0.993984 | S | 0.997857 | -0.003873 | No Change: Both D | - |
| P13645 | K1C10_HUMAN Keratin type I cytoskeletal 10 OS=Homo sapiens GN=KRT10 PE=1 SV=6 | 487 | H | 0.999867 | Y | 0.999814 | 5.30E-05 | No Change: Both D | - |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 135 | R | 0.541784 | T | 0.519464 | 0.02232 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 143 | V | 0.532021 | L | 0.620158 | -0.088137 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 135 | R | 0.541784 | I | 0.366232 | 0.175552 | D to O | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 135 | R | 0.541784 | G | 0.533 | 0.008784 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 140 | L | 0.478818 | R | 0.606471 | -0.127653 | O to D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 429 | Y | 0.480165 | D | 0.69314 | -0.212975 | O to D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 20 | R | 0.937842 | W | 0.801732 | 0.13611 | No Change: Both D | - |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 129 | M | 0.723287 | T | 0.753631 | -0.030344 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 130 | Q | 0.693897 | P | 0.719757 | -0.02586 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 135 | R | 0.541784 | S | 0.598628 | -0.056844 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 137 | A | 0.503275 | P | 0.564865 | -0.06159 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 426 | I | 0.464322 | S | 0.674552 | -0.21023 | O to D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 429 | Y | 0.480165 | C | 0.540538 | -0.060373 | O to D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| Q99456 | K1C12_HUMAN Keratin type I cytoskeletal 12 OS=Homo sapiens GN=KRT12 PE=1 SV=1 | 15 | P | 0.956198 | S | 0.966996 | -0.010798 | No Change: Both D | - |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 119 | L | 0.323721 | P | 0.45821 | -0.134489 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 108 | M | 0.36788 | T | 0.428848 | -0.060968 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 112 | N | 0.333221 | S | 0.374772 | -0.041551 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 115 | L | 0.294309 | P | 0.439155 | -0.144846 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 111 | L | 0.337108 | P | 0.493885 | -0.156777 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 146 | A | 0.634376 | G | 0.653923 | -0.019547 | No Change: Both D | - |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 81 | F | 0.734194 | Y | 0.715555 | 0.018639 | No Change: Both D | - |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 298 | T | 0.651341 | A | 0.629512 | 0.021829 | No Change: Both D | - |
| P13646 | K1C13_HUMAN Keratin type I cytoskeletal 13 OS=Homo sapiens GN=KRT13 PE=1 SV=4 | 187 | A | 0.294182 | V | 0.212749 | 0.081433 | No Change: Both O | - |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 125 | R | 0.318849 | C | 0.178397 | 0.140452 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 125 | R | 0.318849 | H | 0.306036 | 0.012813 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 144 | E | 0.282987 | A | 0.206314 | 0.076673 | No Change: Both O | Epidermolysis bullosa simplex autosomal recessive (AREBS) [MIM:601001] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 270 | V | 0.556524 | M | 0.648613 | -0.092089 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 272 | M | 0.540633 | R | 0.571753 | -0.03112 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 384 | L | 0.640669 | P | 0.720149 | -0.07948 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 415 | Y | 0.635808 | H | 0.720806 | -0.084998 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 419 | L | 0.700818 | Q | 0.781282 | -0.080464 | No Change: Both D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 94 | A | 0.848447 | T | 0.859875 | -0.011428 | No Change: Both D | - |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 116 | K | 0.427611 | N | 0.41678 | 0.010831 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 119 | M | 0.401704 | I | 0.306132 | 0.095572 | No Change: Both O | - |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 119 | M | 0.401704 | T | 0.452012 | -0.050308 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 120 | Q | 0.40475 | R | 0.411451 | -0.006701 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 122 | L | 0.38601 | F | 0.335454 | 0.050556 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 122 | L | 0.38601 | F | 0.335454 | 0.050556 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 123 | N | 0.374444 | S | 0.420474 | -0.04603 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 125 | R | 0.318849 | S | 0.391671 | -0.072822 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 129 | Y | 0.29434 | D | 0.495769 | -0.201429 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 143 | L | 0.312567 | P | 0.448792 | -0.136225 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 247 | A | 0.563244 | D | 0.635166 | -0.071922 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 273 | D | 0.539509 | G | 0.511192 | 0.028317 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 274 | A | 0.537603 | D | 0.607372 | -0.069769 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 377 | I | 0.697631 | N | 0.793393 | -0.095762 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 388 | R | 0.620516 | C | 0.515874 | 0.104642 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 422 | E | 0.764702 | K | 0.749331 | 0.015371 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 119 | M | 0.401704 | V | 0.3613 | 0.040404 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 119 | M | 0.401704 | V | 0.3613 | 0.040404 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 123 | N | 0.374444 | K | 0.414572 | -0.040128 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 125 | R | 0.318849 | G | 0.323325 | -0.004476 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 130 | L | 0.303474 | P | 0.441429 | -0.137955 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 133 | V | 0.355168 | L | 0.381632 | -0.026464 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 133 | V | 0.355168 | L | 0.381632 | -0.026464 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 408 | L | 0.581958 | M | 0.622334 | -0.040376 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 413 | A | 0.601463 | T | 0.648654 | -0.047191 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 211 | R | 0.331833 | P | 0.343312 | -0.011479 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 272 | M | 0.540633 | T | 0.492541 | 0.048092 | D to O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 417 | R | 0.668586 | P | 0.640466 | 0.02812 | No Change: Both D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 134 | R | 0.347689 | P | 0.374262 | -0.026573 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 148 | R | 0.220173 | C | 0.108603 | 0.11157 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 388 | R | 0.620516 | H | 0.550817 | 0.069699 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 415 | Y | 0.635808 | C | 0.686062 | -0.050254 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 416 | R | 0.658453 | P | 0.62938 | 0.029073 | No Change: Both D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 133 | V | 0.355168 | A | 0.464077 | -0.108909 | No Change: Both O | - |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 215 | E | 0.352947 | K | 0.334104 | 0.018843 | No Change: Both O | - |
| P02533 | K1C14_HUMAN Keratin type I cytoskeletal 14 OS=Homo sapiens GN=KRT14 PE=1 SV=4 | 63 | C | 0.971804 | Y | 0.965792 | 0.006012 | No Change: Both D | - |
| P19012 | K1C15_HUMAN Keratin type I cytoskeletal 15 OS=Homo sapiens GN=KRT15 PE=1 SV=3 | 147 | T | 0.560328 | A | 0.523383 | 0.036945 | No Change: Both D | - |
| P19012 | K1C15_HUMAN Keratin type I cytoskeletal 15 OS=Homo sapiens GN=KRT15 PE=1 SV=3 | 416 | K | 0.476711 | R | 0.453965 | 0.022746 | No Change: Both O | - |
| P19012 | K1C15_HUMAN Keratin type I cytoskeletal 15 OS=Homo sapiens GN=KRT15 PE=1 SV=3 | 421 | A | 0.501274 | G | 0.55788 | -0.056606 | No Change: Both D | - |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 132 | L | 0.305744 | P | 0.441344 | -0.1356 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 125 | N | 0.372172 | S | 0.418124 | -0.045952 | No Change: Both O | Palmoplantar keratoderma non-epidermolytic focal (FNEPPK) [MIM:613000] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 127 | R | 0.317355 | C | 0.176382 | 0.140973 | No Change: Both O | Palmoplantar keratoderma non-epidermolytic focal (FNEPPK) [MIM:613000] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 122 | Q | 0.404666 | P | 0.423381 | -0.018715 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 127 | R | 0.317355 | P | 0.34616 | -0.028805 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 124 | L | 0.3851 | R | 0.515138 | -0.130038 | O to D | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 121 | M | 0.399745 | T | 0.452764 | -0.053019 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 128 | L | 0.312532 | Q | 0.449433 | -0.136901 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P08779 | K1C16_HUMAN Keratin type I cytoskeletal 16 OS=Homo sapiens GN=KRT16 PE=1 SV=4 | 354 | K | 0.832686 | N | 0.817485 | 0.015201 | No Change: Both D | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 92 | N | 0.415349 | D | 0.438259 | -0.02291 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 92 | N | 0.415349 | H | 0.370855 | 0.044494 | No Change: Both O | Steatocystoma multiplex (SM) [MIM:184500] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 92 | N | 0.415349 | S | 0.461143 | -0.045794 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 94 | R | 0.35047 | H | 0.332196 | 0.018274 | No Change: Both O | Steatocystoma multiplex (SM) [MIM:184500] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 98 | Y | 0.305961 | D | 0.504037 | -0.198076 | O to D | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 88 | M | 0.474489 | T | 0.52627 | -0.051781 | O to D | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 88 | M | 0.474489 | T | 0.52627 | -0.051781 | O to D | Steatocystoma multiplex (SM) [MIM:184500] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 94 | R | 0.35047 | C | 0.20629 | 0.14418 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 94 | R | 0.35047 | C | 0.20629 | 0.14418 | No Change: Both O | Steatocystoma multiplex (SM) [MIM:184500] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 94 | R | 0.35047 | P | 0.375626 | -0.025156 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 95 | L | 0.335163 | Q | 0.468014 | -0.132851 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 95 | L | 0.335163 | P | 0.465517 | -0.130354 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 99 | L | 0.314258 | P | 0.445172 | -0.130914 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 102 | V | 0.358403 | M | 0.433926 | -0.075523 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| Q04695 | K1C17_HUMAN Keratin type I cytoskeletal 17 OS=Homo sapiens GN=KRT17 PE=1 SV=2 | 109 | N | 0.456763 | D | 0.484367 | -0.027604 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| P05783 | K1C18_HUMAN Keratin type I cytoskeletal 18 OS=Homo sapiens GN=KRT18 PE=1 SV=2 | 128 | H | 0.128213 | L | 0.088251 | 0.039962 | No Change: Both O | Cirrhosis (CIRRH) [MIM:215600] |
| P05783 | K1C18_HUMAN Keratin type I cytoskeletal 18 OS=Homo sapiens GN=KRT18 PE=1 SV=2 | 103 | T | 0.702258 | A | 0.681706 | 0.020552 | No Change: Both D | Cirrhosis (CIRRH) [MIM:215600] |
| P05783 | K1C18_HUMAN Keratin type I cytoskeletal 18 OS=Homo sapiens GN=KRT18 PE=1 SV=2 | 230 | S | 0.469355 | T | 0.392855 | 0.0765 | No Change: Both O | - |
| P05783 | K1C18_HUMAN Keratin type I cytoskeletal 18 OS=Homo sapiens GN=KRT18 PE=1 SV=2 | 261 | R | 0.572296 | Q | 0.588732 | -0.016436 | No Change: Both D | Cirrhosis (CIRRH) [MIM:215600] |
| P05783 | K1C18_HUMAN Keratin type I cytoskeletal 18 OS=Homo sapiens GN=KRT18 PE=1 SV=2 | 340 | G | 0.512505 | R | 0.585066 | -0.072561 | No Change: Both D | Cirrhosis (CIRRH) [MIM:215600] |
| P08727 | K1C19_HUMAN Keratin type I cytoskeletal 19 OS=Homo sapiens GN=KRT19 PE=1 SV=4 | 60 | A | 0.769234 | G | 0.808387 | -0.039153 | No Change: Both D | - |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 181 | Q | 0.563553 | P | 0.553311 | 0.010242 | No Change: Both D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 487 | E | 0.514767 | D | 0.480742 | 0.034025 | D to O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 487 | E | 0.514767 | K | 0.504303 | 0.010464 | No Change: Both D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 186 | N | 0.470746 | Y | 0.279565 | 0.191181 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 476 | E | 0.255796 | K | 0.24806 | 0.007736 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 479 | T | 0.247904 | P | 0.281118 | -0.033214 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 182 | I | 0.55537 | N | 0.701701 | -0.146331 | No Change: Both D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 186 | N | 0.470746 | D | 0.467905 | 0.002841 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 484 | L | 0.405402 | P | 0.506558 | -0.101156 | O to D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 186 | N | 0.470746 | K | 0.517746 | -0.047 | O to D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 465 | E | 0.392481 | D | 0.373509 | 0.018972 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 465 | E | 0.392481 | K | 0.38856 | 0.003921 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 476 | E | 0.255796 | V | 0.136773 | 0.119023 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 477 | I | 0.244593 | N | 0.425422 | -0.180829 | No Change: Both O | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 488 | E | 0.541077 | K | 0.529048 | 0.012029 | No Change: Both D | Ichthyosis bullosa of Siemens (IBS) [MIM:146800] |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 101 | S | 0.995172 | G | 0.995 | 1.72E-04 | No Change: Both D | - |
| P35908 | K22E_HUMAN Keratin type II cytoskeletal 2 epidermal OS=Homo sapiens GN=KRT2 PE=1 SV=2 | 219 | G | 0.255101 | D | 0.280999 | -0.025898 | No Change: Both O | - |
| P35900 | K1C20_HUMAN Keratin type I cytoskeletal 20 OS=Homo sapiens GN=KRT20 PE=1 SV=1 | 129 | S | 0.443207 | N | 0.406704 | 0.036503 | No Change: Both O | - |
| P35900 | K1C20_HUMAN Keratin type I cytoskeletal 20 OS=Homo sapiens GN=KRT20 PE=1 SV=1 | 4 | S | 0.893385 | R | 0.881233 | 0.012152 | No Change: Both D | A colorectal cancer sample |
| P35900 | K1C20_HUMAN Keratin type I cytoskeletal 20 OS=Homo sapiens GN=KRT20 PE=1 SV=1 | 214 | G | 0.605634 | C | 0.463925 | 0.141709 | D to O | - |
| Q9C075 | K1C23_HUMAN Keratin type I cytoskeletal 23 OS=Homo sapiens GN=KRT23 PE=1 SV=2 | 303 | T | 0.572451 | A | 0.536177 | 0.036274 | No Change: Both D | - |
| Q9C075 | K1C23_HUMAN Keratin type I cytoskeletal 23 OS=Homo sapiens GN=KRT23 PE=1 SV=2 | 393 | S | 0.761143 | F | 0.552152 | 0.208991 | No Change: Both D | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 115 | A | 0.928743 | T | 0.948756 | -0.020013 | No Change: Both D | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 250 | G | 0.302402 | D | 0.388537 | -0.086135 | No Change: Both O | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 267 | M | 0.577701 | I | 0.471449 | 0.106252 | D to O | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 366 | R | 0.698306 | C | 0.623386 | 0.07492 | No Change: Both D | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 415 | C | 0.206037 | Y | 0.202502 | 0.003535 | No Change: Both O | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 418 | W | 0.198432 | R | 0.416179 | -0.217747 | No Change: Both O | - |
| Q2M2I5 | K1C24_HUMAN Keratin type I cytoskeletal 24 OS=Homo sapiens GN=KRT24 PE=1 SV=1 | 429 | K | 0.303788 | E | 0.320059 | -0.016271 | No Change: Both O | - |
| Q7Z3Z0 | K1C25_HUMAN Keratin type I cytoskeletal 25 OS=Homo sapiens GN=KRT25 PE=1 SV=1 | 54 | S | 0.91597 | L | 0.85142 | 0.06455 | No Change: Both D | - |
| Q7Z3Y9 | K1C26_HUMAN Keratin type I cytoskeletal 26 OS=Homo sapiens GN=KRT26 PE=1 SV=2 | 118 | W | 0.353328 | R | 0.586911 | -0.233583 | O to D | - |
| Q7Z3Y8 | K1C27_HUMAN Keratin type I cytoskeletal 27 OS=Homo sapiens GN=KRT27 PE=1 SV=2 | 193 | G | 0.291856 | S | 0.378015 | -0.086159 | No Change: Both O | - |
| Q7Z3Y8 | K1C27_HUMAN Keratin type I cytoskeletal 27 OS=Homo sapiens GN=KRT27 PE=1 SV=2 | 284 | A | 0.661356 | T | 0.669077 | -0.007721 | No Change: Both D | - |
| Q7Z3Y8 | K1C27_HUMAN Keratin type I cytoskeletal 27 OS=Homo sapiens GN=KRT27 PE=1 SV=2 | 52 | S | 0.889608 | T | 0.841762 | 0.047846 | No Change: Both D | - |
| Q7Z3Y8 | K1C27_HUMAN Keratin type I cytoskeletal 27 OS=Homo sapiens GN=KRT27 PE=1 SV=2 | 144 | E | 0.176243 | K | 0.187406 | -0.011163 | No Change: Both O | - |
| Q7Z3Y8 | K1C27_HUMAN Keratin type I cytoskeletal 27 OS=Homo sapiens GN=KRT27 PE=1 SV=2 | 305 | I | 0.688109 | T | 0.804989 | -0.11688 | No Change: Both D | - |
| Q7Z3Y7 | K1C28_HUMAN Keratin type I cytoskeletal 28 OS=Homo sapiens GN=KRT28 PE=1 SV=2 | 52 | G | 0.820618 | D | 0.7744 | 0.046218 | No Change: Both D | - |
| Q7Z3Y7 | K1C28_HUMAN Keratin type I cytoskeletal 28 OS=Homo sapiens GN=KRT28 PE=1 SV=2 | 286 | A | 0.64935 | T | 0.647109 | 0.002241 | No Change: Both D | - |
| Q7Z3Y7 | K1C28_HUMAN Keratin type I cytoskeletal 28 OS=Homo sapiens GN=KRT28 PE=1 SV=2 | 62 | A | 0.732329 | V | 0.66461 | 0.067719 | No Change: Both D | - |
| P12035 | K2C3_HUMAN Keratin type II cytoskeletal 3 OS=Homo sapiens GN=KRT3 PE=1 SV=3 | 509 | E | 0.559295 | K | 0.546957 | 0.012338 | No Change: Both D | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| P12035 | K2C3_HUMAN Keratin type II cytoskeletal 3 OS=Homo sapiens GN=KRT3 PE=1 SV=3 | 503 | R | 0.289858 | P | 0.308443 | -0.018585 | No Change: Both O | Meesmann corneal dystrophy (MECD) [MIM:122100] |
| P12035 | K2C3_HUMAN Keratin type II cytoskeletal 3 OS=Homo sapiens GN=KRT3 PE=1 SV=3 | 375 | R | 0.402345 | G | 0.359696 | 0.042649 | No Change: Both O | - |
| P12035 | K2C3_HUMAN Keratin type II cytoskeletal 3 OS=Homo sapiens GN=KRT3 PE=1 SV=3 | 44 | G | 0.812141 | A | 0.772515 | 0.039626 | No Change: Both D | - |
| Q15323 | K1H1_HUMAN Keratin type I cuticular Ha1 OS=Homo sapiens GN=KRT31 PE=2 SV=3 | 39 | A | 0.585255 | G | 0.619389 | -0.034134 | No Change: Both D | - |
| Q15323 | K1H1_HUMAN Keratin type I cuticular Ha1 OS=Homo sapiens GN=KRT31 PE=2 SV=3 | 82 | A | 0.726869 | V | 0.672305 | 0.054564 | No Change: Both D | - |
| Q15323 | K1H1_HUMAN Keratin type I cuticular Ha1 OS=Homo sapiens GN=KRT31 PE=2 SV=3 | 377 | A | 0.909342 | V | 0.881004 | 0.028338 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 72 | Q | 0.715549 | R | 0.711953 | 0.003596 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 171 | I | 0.266381 | T | 0.394832 | -0.128451 | No Change: Both O | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 222 | S | 0.581663 | Y | 0.378263 | 0.2034 | D to O | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 339 | T | 0.748298 | M | 0.724387 | 0.023911 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 395 | T | 0.553833 | M | 0.520883 | 0.03295 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 428 | R | 0.965552 | C | 0.958897 | 0.006655 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 151 | E | 0.360695 | D | 0.324601 | 0.036094 | No Change: Both O | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 280 | R | 0.628022 | H | 0.544172 | 0.08385 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 402 | N | 0.667682 | S | 0.700099 | -0.032417 | No Change: Both D | - |
| Q14532 | K1H2_HUMAN Keratin type I cuticular Ha2 OS=Homo sapiens GN=KRT32 PE=1 SV=3 | 427 | P | 0.965029 | T | 0.952429 | 0.0126 | No Change: Both D | - |
| O76009 | KT33A_HUMAN Keratin type I cuticular Ha3-I OS=Homo sapiens GN=KRT33A PE=2 SV=2 | 270 | A | 0.576698 | V | 0.510658 | 0.06604 | No Change: Both D | - |
| O76011 | KRT34_HUMAN Keratin type I cuticular Ha4 OS=Homo sapiens GN=KRT34 PE=2 SV=2 | 280 | I | 0.464182 | T | 0.643616 | -0.179434 | O to D | - |
| O76011 | KRT34_HUMAN Keratin type I cuticular Ha4 OS=Homo sapiens GN=KRT34 PE=2 SV=2 | 348 | H | 0.787731 | R | 0.8224 | -0.034669 | No Change: Both D | - |
| Q92764 | KRT35_HUMAN Keratin type I cuticular Ha5 OS=Homo sapiens GN=KRT35 PE=2 SV=5 | 36 | S | 0.961292 | P | 0.955578 | 0.005714 | No Change: Both D | - |
| Q92764 | KRT35_HUMAN Keratin type I cuticular Ha5 OS=Homo sapiens GN=KRT35 PE=2 SV=5 | 441 | C | 0.964153 | Y | 0.926443 | 0.03771 | No Change: Both D | - |
| Q92764 | KRT35_HUMAN Keratin type I cuticular Ha5 OS=Homo sapiens GN=KRT35 PE=2 SV=5 | 443 | P | 0.96031 | A | 0.93193 | 0.02838 | No Change: Both D | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 315 | T | 0.722247 | M | 0.704739 | 0.017508 | No Change: Both D | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 119 | A | 0.599393 | V | 0.54409 | 0.055303 | No Change: Both D | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 126 | Q | 0.237861 | R | 0.225562 | 0.012299 | No Change: Both O | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 179 | R | 0.398558 | Q | 0.415539 | -0.016981 | No Change: Both O | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 277 | R | 0.442329 | C | 0.336206 | 0.106123 | No Change: Both O | - |
| O76013 | KRT36_HUMAN Keratin type I cuticular Ha6 OS=Homo sapiens GN=KRT36 PE=1 SV=1 | 357 | N | 0.581903 | T | 0.553335 | 0.028568 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 13 | G | 0.410271 | C | 0.337468 | 0.072803 | No Change: Both O | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 39 | N | 0.323956 | S | 0.372626 | -0.04867 | No Change: Both O | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 72 | T | 0.623429 | A | 0.587402 | 0.036027 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 73 | S | 0.60767 | C | 0.458834 | 0.148836 | D to O | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 217 | A | 0.806823 | V | 0.744023 | 0.0628 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 306 | A | 0.64089 | D | 0.689319 | -0.048429 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 421 | S | 0.845535 | F | 0.691484 | 0.154051 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 422 | T | 0.873252 | M | 0.853239 | 0.020013 | No Change: Both D | - |
| O76014 | KRT37_HUMAN Keratin type I cuticular Ha7 OS=Homo sapiens GN=KRT37 PE=2 SV=3 | 434 | P | 0.973992 | S | 0.974534 | -5.42E-04 | No Change: Both D | - |
| O76015 | KRT38_HUMAN Keratin type I cuticular Ha8 OS=Homo sapiens GN=KRT38 PE=2 SV=3 | 423 | S | 0.913927 | P | 0.91937 | -0.005443 | No Change: Both D | - |
| Q6A163 | K1C39_HUMAN Keratin type I cytoskeletal 39 OS=Homo sapiens GN=KRT39 PE=1 SV=2 | 341 | T | 0.46943 | M | 0.42523 | 0.0442 | No Change: Both O | - |
| Q6A163 | K1C39_HUMAN Keratin type I cytoskeletal 39 OS=Homo sapiens GN=KRT39 PE=1 SV=2 | 383 | L | 0.383616 | M | 0.404434 | -0.020818 | No Change: Both O | - |
| Q6A163 | K1C39_HUMAN Keratin type I cytoskeletal 39 OS=Homo sapiens GN=KRT39 PE=1 SV=2 | 456 | R | 0.357148 | Q | 0.386086 | -0.028938 | No Change: Both O | - |
| P19013 | K2C4_HUMAN Keratin type II cytoskeletal 4 OS=Homo sapiens GN=KRT4 PE=1 SV=4 | 72 | A | 0.789147 | V | 0.724387 | 0.06476 | No Change: Both D | - |
| P19013 | K2C4_HUMAN Keratin type II cytoskeletal 4 OS=Homo sapiens GN=KRT4 PE=1 SV=4 | 449 | E | 0.306582 | K | 0.289386 | 0.017196 | No Change: Both O | White sponge nevus of cannon (WSN) [MIM:193900] |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 37 | T | 0.9056 | A | 0.889699 | 0.015901 | No Change: Both D | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 85 | F | 0.292434 | S | 0.490428 | -0.197994 | No Change: Both O | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 102 | S | 0.366702 | N | 0.333246 | 0.033456 | No Change: Both O | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 153 | T | 0.346094 | M | 0.318842 | 0.027252 | No Change: Both O | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 235 | R | 0.676695 | H | 0.636416 | 0.040279 | No Change: Both D | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 265 | C | 0.619658 | Y | 0.506897 | 0.112761 | No Change: Both D | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 286 | E | 0.823553 | D | 0.762425 | 0.061128 | No Change: Both D | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 303 | M | 0.834235 | T | 0.862093 | -0.027858 | No Change: Both D | - |
| Q6A162 | K1C40_HUMAN Keratin type I cytoskeletal 40 OS=Homo sapiens GN=KRT40 PE=1 SV=2 | 406 | S | 0.704607 | L | 0.497235 | 0.207372 | D to O | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 138 | G | 0.602103 | E | 0.620652 | -0.018549 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 161 | I | 0.489872 | S | 0.693692 | -0.20382 | O to D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 193 | N | 0.37848 | K | 0.44068 | -0.0622 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 193 | N | 0.37848 | K | 0.44068 | -0.0622 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 327 | M | 0.484565 | T | 0.517319 | -0.032754 | O to D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 331 | R | 0.495697 | C | 0.340485 | 0.155212 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 463 | L | 0.280545 | P | 0.390147 | -0.109602 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 475 | E | 0.421918 | G | 0.365298 | 0.05662 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 25 | P | 0.974251 | L | 0.959631 | 0.01462 | No Change: Both D | Epidermolysis bullosa simplex with mottled pigmentation (MP-EBS) [MIM:131960] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 152 | P | 0.429358 | L | 0.268855 | 0.160503 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 173 | K | 0.529149 | N | 0.496528 | 0.032621 | D to O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 175 | L | 0.459103 | F | 0.446111 | 0.012992 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 176 | N | 0.448995 | S | 0.485747 | -0.036752 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 179 | F | 0.361256 | S | 0.550584 | -0.189328 | O to D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 181 | S | 0.333544 | P | 0.342403 | -0.008859 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 323 | V | 0.494536 | A | 0.552742 | -0.058206 | O to D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 325 | L | 0.481454 | P | 0.606431 | -0.124977 | O to D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 327 | M | 0.484565 | K | 0.55701 | -0.072445 | O to D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 328 | D | 0.490712 | H | 0.430383 | 0.060329 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 328 | D | 0.490712 | V | 0.349712 | 0.141 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 329 | N | 0.486403 | K | 0.495547 | -0.009144 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 467 | I | 0.226773 | T | 0.378071 | -0.151298 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 477 | E | 0.493111 | K | 0.479616 | 0.013495 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 186 | V | 0.354247 | L | 0.384689 | -0.030442 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 404 | K | 0.665635 | E | 0.678361 | -0.012726 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 438 | A | 0.820756 | D | 0.845768 | -0.025012 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 475 | E | 0.421918 | K | 0.408614 | 0.013304 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 167 | E | 0.616743 | K | 0.609075 | 0.007668 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 170 | E | 0.605233 | K | 0.602377 | 0.002856 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 177 | N | 0.399806 | S | 0.438213 | -0.038407 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 199 | K | 0.325702 | T | 0.269904 | 0.055798 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 311 | L | 0.432236 | P | 0.564296 | -0.13206 | O to D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 324 | V | 0.487573 | D | 0.635755 | -0.148182 | O to D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 328 | D | 0.490712 | E | 0.497175 | -0.006463 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 328 | D | 0.490712 | G | 0.419835 | 0.070877 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 418 | E | 0.812242 | K | 0.811732 | 5.10E-04 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 168 | E | 0.627731 | K | 0.623163 | 0.004568 | No Change: Both D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 169 | R | 0.610967 | P | 0.619036 | -0.008069 | No Change: Both D | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 190 | E | 0.375223 | K | 0.393624 | -0.018401 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 331 | R | 0.495697 | H | 0.492515 | 0.003182 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 469 | T | 0.223059 | P | 0.266728 | -0.043669 | No Change: Both O | Epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 79 | S | 0.806987 | R | 0.779942 | 0.027045 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 197 | D | 0.339689 | E | 0.396491 | -0.056802 | No Change: Both O | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 232 | S | 0.518011 | N | 0.510752 | 0.007259 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 387 | S | 0.648056 | T | 0.61284 | 0.035216 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 528 | S | 0.993466 | G | 0.992523 | 9.43E-04 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 543 | G | 0.991931 | S | 0.993245 | -0.001314 | No Change: Both D | - |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 143 | V | 0.542933 | D | 0.662819 | -0.119886 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 158 | D | 0.449942 | V | 0.324898 | 0.125044 | No Change: Both O | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 186 | V | 0.354247 | M | 0.406943 | -0.052696 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 191 | Q | 0.383236 | P | 0.359221 | 0.024015 | No Change: Both O | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 352 | R | 0.587595 | S | 0.634311 | -0.046716 | No Change: Both D | Epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800] |
| P13647 | K2C5_HUMAN Keratin type II cytoskeletal 5 OS=Homo sapiens GN=KRT5 PE=1 SV=3 | 517 | G | 0.977663 | D | 0.968542 | 0.009121 | No Change: Both D | Epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900] |
| P02538 | K2C6A_HUMAN Keratin type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 | 174 | F | 0.340656 | V | 0.353055 | -0.012399 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P02538 | K2C6A_HUMAN Keratin type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 | 469 | L | 0.327783 | R | 0.448078 | -0.120295 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P02538 | K2C6A_HUMAN Keratin type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 | 472 | E | 0.445791 | K | 0.434703 | 0.011088 | No Change: Both O | Pachyonychia congenita type 1 (PC1) [MIM:167200] |
| P02538 | K2C6A_HUMAN Keratin type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 | 21 | N | 0.986296 | S | 0.993092 | -0.006796 | No Change: Both D | - |
| P02538 | K2C6A_HUMAN Keratin type II cytoskeletal 6A OS=Homo sapiens GN=KRT6A PE=1 SV=3 | 111 | G | 0.797133 | D | 0.744958 | 0.052175 | No Change: Both D | - |
| P04259 | K2C6B_HUMAN Keratin type II cytoskeletal 6B OS=Homo sapiens GN=KRT6B PE=1 SV=5 | 21 | N | 0.984686 | S | 0.992218 | -0.007532 | No Change: Both D | - |
| P04259 | K2C6B_HUMAN Keratin type II cytoskeletal 6B OS=Homo sapiens GN=KRT6B PE=1 SV=5 | 227 | N | 0.536768 | S | 0.542456 | -0.005688 | No Change: Both D | - |
| P04259 | K2C6B_HUMAN Keratin type II cytoskeletal 6B OS=Homo sapiens GN=KRT6B PE=1 SV=5 | 365 | I | 0.478759 | V | 0.465546 | 0.013213 | No Change: Both O | - |
| P04259 | K2C6B_HUMAN Keratin type II cytoskeletal 6B OS=Homo sapiens GN=KRT6B PE=1 SV=5 | 472 | E | 0.445791 | K | 0.434703 | 0.011088 | No Change: Both O | Pachyonychia congenita type 2 (PC2) [MIM:167210] |
| P48668 | K2C6C_HUMAN Keratin type II cytoskeletal 6C OS=Homo sapiens GN=KRT6C PE=1 SV=3 | 182 | R | 0.29864 | Q | 0.336369 | -0.037729 | No Change: Both O | - |
| P48668 | K2C6C_HUMAN Keratin type II cytoskeletal 6C OS=Homo sapiens GN=KRT6C PE=1 SV=3 | 227 | S | 0.542456 | N | 0.536768 | 0.005688 | No Change: Both D | - |
| P48668 | K2C6C_HUMAN Keratin type II cytoskeletal 6C OS=Homo sapiens GN=KRT6C PE=1 SV=3 | 481 | V | 0.423952 | I | 0.365625 | 0.058327 | No Change: Both O | - |
| P08729 | K2C7_HUMAN Keratin type II cytoskeletal 7 OS=Homo sapiens GN=KRT7 PE=1 SV=5 | 364 | G | 0.813076 | A | 0.83216 | -0.019084 | No Change: Both D | - |
| P08729 | K2C7_HUMAN Keratin type II cytoskeletal 7 OS=Homo sapiens GN=KRT7 PE=1 SV=5 | 186 | H | 0.492663 | R | 0.54571 | -0.053047 | O to D | - |
| Q3SY84 | K2C71_HUMAN Keratin type II cytoskeletal 71 OS=Homo sapiens GN=KRT71 PE=1 SV=3 | 107 | V | 0.310631 | I | 0.278601 | 0.03203 | No Change: Both O | - |
| Q3SY84 | K2C71_HUMAN Keratin type II cytoskeletal 71 OS=Homo sapiens GN=KRT71 PE=1 SV=3 | 122 | E | 0.456077 | K | 0.449762 | 0.006315 | No Change: Both O | - |
| Q3SY84 | K2C71_HUMAN Keratin type II cytoskeletal 71 OS=Homo sapiens GN=KRT71 PE=1 SV=3 | 355 | I | 0.578526 | F | 0.539783 | 0.038743 | No Change: Both D | - |
| Q3SY84 | K2C71_HUMAN Keratin type II cytoskeletal 71 OS=Homo sapiens GN=KRT71 PE=1 SV=3 | 464 | V | 0.800929 | G | 0.86804 | -0.067111 | No Change: Both D | - |
| Q3SY84 | K2C71_HUMAN Keratin type II cytoskeletal 71 OS=Homo sapiens GN=KRT71 PE=1 SV=3 | 523 | R | 0.98891 | Q | 0.985489 | 0.003421 | No Change: Both D | - |
| Q14CN4 | K2C72_HUMAN Keratin type II cytoskeletal 72 OS=Homo sapiens GN=KRT72 PE=1 SV=2 | 171 | N | 0.340595 | D | 0.340476 | 1.19E-04 | No Change: Both O | - |
| Q14CN4 | K2C72_HUMAN Keratin type II cytoskeletal 72 OS=Homo sapiens GN=KRT72 PE=1 SV=2 | 264 | Y | 0.126861 | C | 0.147685 | -0.020824 | No Change: Both O | - |
| Q14CN4 | K2C72_HUMAN Keratin type II cytoskeletal 72 OS=Homo sapiens GN=KRT72 PE=1 SV=2 | 366 | D | 0.51876 | E | 0.553475 | -0.034715 | No Change: Both D | - |
| Q14CN4 | K2C72_HUMAN Keratin type II cytoskeletal 72 OS=Homo sapiens GN=KRT72 PE=1 SV=2 | 428 | R | 0.430135 | L | 0.326217 | 0.103918 | No Change: Both O | - |
| Q14CN4 | K2C72_HUMAN Keratin type II cytoskeletal 72 OS=Homo sapiens GN=KRT72 PE=1 SV=2 | 326 | Q | 0.464347 | E | 0.493619 | -0.029272 | No Change: Both O | - |
| Q86Y46 | K2C73_HUMAN Keratin type II cytoskeletal 73 OS=Homo sapiens GN=KRT73 PE=1 SV=1 | 61 | V | 0.725848 | M | 0.803066 | -0.077218 | No Change: Both D | - |
| Q86Y46 | K2C73_HUMAN Keratin type II cytoskeletal 73 OS=Homo sapiens GN=KRT73 PE=1 SV=1 | 96 | P | 0.28198 | L | 0.151306 | 0.130674 | No Change: Both O | - |
| Q86Y46 | K2C73_HUMAN Keratin type II cytoskeletal 73 OS=Homo sapiens GN=KRT73 PE=1 SV=1 | 212 | R | 0.660676 | H | 0.573059 | 0.087617 | No Change: Both D | A colorectal cancer sample |
| Q86Y46 | K2C73_HUMAN Keratin type II cytoskeletal 73 OS=Homo sapiens GN=KRT73 PE=1 SV=1 | 248 | T | 0.362824 | M | 0.319321 | 0.043503 | No Change: Both O | A colorectal cancer sample |
| Q86Y46 | K2C73_HUMAN Keratin type II cytoskeletal 73 OS=Homo sapiens GN=KRT73 PE=1 SV=1 | 365 | E | 0.645264 | G | 0.561183 | 0.084081 | No Change: Both D | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 165 | N | 0.349911 | K | 0.409642 | -0.059731 | No Change: Both O | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 271 | E | 0.320476 | D | 0.318311 | 0.002165 | No Change: Both O | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 178 | L | 0.283177 | Q | 0.419636 | -0.136459 | No Change: Both O | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 392 | R | 0.742432 | Q | 0.759357 | -0.016925 | No Change: Both D | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 424 | E | 0.690646 | K | 0.672475 | 0.018171 | No Change: Both D | - |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 148 | N | 0.370303 | K | 0.438934 | -0.068631 | No Change: Both O | Woolly hair autosomal dominant (ADWH) [MIM:194300] |
| Q7RTS7 | K2C74_HUMAN Keratin type II cytoskeletal 74 OS=Homo sapiens GN=KRT74 PE=1 SV=2 | 482 | D | 0.928477 | N | 0.922236 | 0.006241 | No Change: Both D | Hypotrichosis type 3 (HYPT3) [MIM:613981] |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 39 | R | 0.940882 | C | 0.88953 | 0.051352 | No Change: Both D | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 91 | R | 0.84601 | G | 0.854009 | -0.007999 | No Change: Both D | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 117 | P | 0.469524 | A | 0.315488 | 0.154036 | No Change: Both O | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 161 | A | 0.281246 | T | 0.332353 | -0.051107 | No Change: Both O | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 209 | R | 0.656812 | Q | 0.662594 | -0.005782 | No Change: Both D | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 242 | E | 0.566307 | G | 0.457358 | 0.108949 | D to O | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 337 | E | 0.494205 | K | 0.47751 | 0.016695 | No Change: Both O | Loose anagen hair syndrome (LAHS) [MIM:600628] |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 367 | I | 0.66849 | V | 0.678776 | -0.010286 | No Change: Both D | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 427 | M | 0.58521 | T | 0.583656 | 0.001554 | No Change: Both D | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 432 | R | 0.4457 | C | 0.312001 | 0.133699 | No Change: Both O | - |
| O95678 | K2C75_HUMAN Keratin type II cytoskeletal 75 OS=Homo sapiens GN=KRT75 PE=1 SV=2 | 485 | S | 0.903164 | R | 0.865396 | 0.037768 | No Change: Both D | - |
| Q01546 | K22O_HUMAN Keratin type II cytoskeletal 2 oral OS=Homo sapiens GN=KRT76 PE=1 SV=2 | 283 | A | 0.566602 | T | 0.584814 | -0.018212 | No Change: Both D | - |
| Q01546 | K22O_HUMAN Keratin type II cytoskeletal 2 oral OS=Homo sapiens GN=KRT76 PE=1 SV=2 | 359 | A | 0.382517 | T | 0.39207 | -0.009553 | No Change: Both O | - |
| Q01546 | K22O_HUMAN Keratin type II cytoskeletal 2 oral OS=Homo sapiens GN=KRT76 PE=1 SV=2 | 629 | T | 0.998417 | M | 0.997896 | 5.21E-04 | No Change: Both D | - |
| Q01546 | K22O_HUMAN Keratin type II cytoskeletal 2 oral OS=Homo sapiens GN=KRT76 PE=1 SV=2 | 168 | L | 0.429676 | V | 0.429361 | 3.15E-04 | No Change: Both O | A breast cancer sample |
| Q7Z794 | K2C1B_HUMAN Keratin type II cytoskeletal 1b OS=Homo sapiens GN=KRT77 PE=1 SV=3 | 10 | A | 0.98854 | T | 0.98941 | -8.70E-04 | No Change: Both D | - |
| Q8N1N4 | K2C78_HUMAN Keratin type II cytoskeletal 78 OS=Homo sapiens GN=KRT78 PE=2 SV=2 | 25 | R | 0.996072 | H | 0.993093 | 0.002979 | No Change: Both D | - |
| Q8N1N4 | K2C78_HUMAN Keratin type II cytoskeletal 78 OS=Homo sapiens GN=KRT78 PE=2 SV=2 | 92 | L | 0.277929 | P | 0.446948 | -0.169019 | No Change: Both O | - |
| Q8N1N4 | K2C78_HUMAN Keratin type II cytoskeletal 78 OS=Homo sapiens GN=KRT78 PE=2 SV=2 | 224 | G | 0.341033 | A | 0.320863 | 0.02017 | No Change: Both O | - |
| Q8N1N4 | K2C78_HUMAN Keratin type II cytoskeletal 78 OS=Homo sapiens GN=KRT78 PE=2 SV=2 | 238 | A | 0.300956 | T | 0.332781 | -0.031825 | No Change: Both O | - |
| Q5XKE5 | K2C79_HUMAN Keratin type II cytoskeletal 79 OS=Homo sapiens GN=KRT79 PE=1 SV=2 | 81 | L | 0.452839 | S | 0.60984 | -0.157001 | O to D | - |
| Q5XKE5 | K2C79_HUMAN Keratin type II cytoskeletal 79 OS=Homo sapiens GN=KRT79 PE=1 SV=2 | 195 | F | 0.45601 | L | 0.55123 | -0.09522 | O to D | - |
| Q5XKE5 | K2C79_HUMAN Keratin type II cytoskeletal 79 OS=Homo sapiens GN=KRT79 PE=1 SV=2 | 266 | H | 0.371751 | R | 0.38536 | -0.013609 | No Change: Both O | - |
| Q5XKE5 | K2C79_HUMAN Keratin type II cytoskeletal 79 OS=Homo sapiens GN=KRT79 PE=1 SV=2 | 393 | A | 0.869848 | V | 0.798713 | 0.071135 | No Change: Both D | - |
| P05787 | K2C8_HUMAN Keratin type II cytoskeletal 8 OS=Homo sapiens GN=KRT8 PE=1 SV=7 | 53 | G | 0.681849 | V | 0.582289 | 0.09956 | No Change: Both D | Cirrhosis (CIRRH) [MIM:215600] |
| P05787 | K2C8_HUMAN Keratin type II cytoskeletal 8 OS=Homo sapiens GN=KRT8 PE=1 SV=7 | 54 | Y | 0.663116 | C | 0.682831 | -0.019715 | No Change: Both D | Cirrhosis (CIRRH) [MIM:215600] |
| P05787 | K2C8_HUMAN Keratin type II cytoskeletal 8 OS=Homo sapiens GN=KRT8 PE=1 SV=7 | 62 | G | 0.433215 | C | 0.275128 | 0.158087 | No Change: Both O | Cirrhosis (CIRRH) [MIM:215600] |
| P05787 | K2C8_HUMAN Keratin type II cytoskeletal 8 OS=Homo sapiens GN=KRT8 PE=1 SV=7 | 63 | I | 0.397201 | V | 0.453788 | -0.056587 | No Change: Both O | - |
| P05787 | K2C8_HUMAN Keratin type II cytoskeletal 8 OS=Homo sapiens GN=KRT8 PE=1 SV=7 | 401 | R | 0.722296 | W | 0.574278 | 0.148018 | No Change: Both D | - |
| Q6KB66 | K2C80_HUMAN Keratin type II cytoskeletal 80 OS=Homo sapiens GN=KRT80 PE=1 SV=2 | 238 | V | 0.31499 | I | 0.270885 | 0.044105 | No Change: Both O | - |
| Q14533 | KRT81_HUMAN Keratin type II cuticular Hb1 OS=Homo sapiens GN=KRT81 PE=1 SV=3 | 52 | G | 0.691029 | R | 0.690314 | 7.15E-04 | No Change: Both D | - |
| Q14533 | KRT81_HUMAN Keratin type II cuticular Hb1 OS=Homo sapiens GN=KRT81 PE=1 SV=3 | 248 | L | 0.215181 | R | 0.318238 | -0.103057 | No Change: Both O | - |
| Q14533 | KRT81_HUMAN Keratin type II cuticular Hb1 OS=Homo sapiens GN=KRT81 PE=1 SV=3 | 316 | R | 0.707569 | C | 0.602239 | 0.10533 | No Change: Both D | - |
| Q14533 | KRT81_HUMAN Keratin type II cuticular Hb1 OS=Homo sapiens GN=KRT81 PE=1 SV=3 | 402 | E | 0.205623 | K | 0.199954 | 0.005669 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| Q14533 | KRT81_HUMAN Keratin type II cuticular Hb1 OS=Homo sapiens GN=KRT81 PE=1 SV=3 | 413 | E | 0.492659 | K | 0.464935 | 0.027724 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| Q9NSB4 | KRT82_HUMAN Keratin type II cuticular Hb2 OS=Homo sapiens GN=KRT82 PE=1 SV=3 | 458 | T | 0.352561 | M | 0.29898 | 0.053581 | No Change: Both O | - |
| Q9NSB4 | KRT82_HUMAN Keratin type II cuticular Hb2 OS=Homo sapiens GN=KRT82 PE=1 SV=3 | 219 | E | 0.363394 | Q | 0.297792 | 0.065602 | No Change: Both O | - |
| Q9NSB4 | KRT82_HUMAN Keratin type II cuticular Hb2 OS=Homo sapiens GN=KRT82 PE=1 SV=3 | 452 | E | 0.288438 | D | 0.244125 | 0.044313 | No Change: Both O | - |
| P78385 | KRT83_HUMAN Keratin type II cuticular Hb3 OS=Homo sapiens GN=KRT83 PE=1 SV=2 | 149 | R | 0.314189 | C | 0.214502 | 0.099687 | No Change: Both O | - |
| P78385 | KRT83_HUMAN Keratin type II cuticular Hb3 OS=Homo sapiens GN=KRT83 PE=1 SV=2 | 279 | I | 0.20541 | M | 0.288181 | -0.082771 | No Change: Both O | - |
| P78385 | KRT83_HUMAN Keratin type II cuticular Hb3 OS=Homo sapiens GN=KRT83 PE=1 SV=2 | 493 | H | 0.903428 | Y | 0.862364 | 0.041064 | No Change: Both D | - |
| P78385 | KRT83_HUMAN Keratin type II cuticular Hb3 OS=Homo sapiens GN=KRT83 PE=1 SV=2 | 407 | E | 0.227146 | K | 0.216479 | 0.010667 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| Q9NSB2 | KRT84_HUMAN Keratin type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=2 | 184 | R | 0.406618 | Q | 0.457568 | -0.05095 | No Change: Both O | - |
| Q9NSB2 | KRT84_HUMAN Keratin type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=2 | 206 | I | 0.31578 | V | 0.342539 | -0.026759 | No Change: Both O | - |
| Q9NSB2 | KRT84_HUMAN Keratin type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=2 | 446 | C | 0.506222 | R | 0.620558 | -0.114336 | No Change: Both D | - |
| Q9NSB2 | KRT84_HUMAN Keratin type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=2 | 198 | S | 0.283508 | N | 0.256716 | 0.026792 | No Change: Both O | - |
| Q9NSB2 | KRT84_HUMAN Keratin type II cuticular Hb4 OS=Homo sapiens GN=KRT84 PE=1 SV=2 | 497 | G | 0.784147 | R | 0.78914 | -0.004993 | No Change: Both D | - |
| P78386 | KRT85_HUMAN Keratin type II cuticular Hb5 OS=Homo sapiens GN=KRT85 PE=1 SV=1 | 78 | R | 0.683865 | H | 0.60077 | 0.083095 | No Change: Both D | Ectodermal dysplasia pure hair-nail type (EDPHN) [MIM:602032] |
| P78386 | KRT85_HUMAN Keratin type II cuticular Hb5 OS=Homo sapiens GN=KRT85 PE=1 SV=1 | 155 | W | 0.25294 | L | 0.377324 | -0.124384 | No Change: Both O | - |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 114 | N | 0.497607 | D | 0.507207 | -0.0096 | O to D | Monilethrix (MLTRX) [MIM:158000] |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 402 | E | 0.232605 | Q | 0.201367 | 0.031238 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 402 | E | 0.232605 | K | 0.222775 | 0.00983 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 413 | E | 0.50612 | K | 0.47441 | 0.03171 | D to O | Monilethrix (MLTRX) [MIM:158000] |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 413 | E | 0.50612 | D | 0.457077 | 0.049043 | D to O | Monilethrix (MLTRX) [MIM:158000] |
| O43790 | KRT86_HUMAN Keratin type II cuticular Hb6 OS=Homo sapiens GN=KRT86 PE=1 SV=1 | 114 | N | 0.497607 | H | 0.425047 | 0.07256 | No Change: Both O | Monilethrix (MLTRX) [MIM:158000] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 161 | N | 0.572446 | K | 0.616824 | -0.044378 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 163 | R | 0.479681 | Q | 0.542881 | -0.0632 | O to D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 163 | R | 0.479681 | W | 0.282377 | 0.197304 | No Change: Both O | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 168 | L | 0.433071 | S | 0.603507 | -0.170436 | O to D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 157 | M | 0.650334 | T | 0.691704 | -0.04137 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 157 | M | 0.650334 | V | 0.59161 | 0.058724 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 160 | L | 0.610266 | V | 0.583069 | 0.027197 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 161 | N | 0.572446 | S | 0.631135 | -0.058689 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 161 | N | 0.572446 | Y | 0.427607 | 0.144839 | D to O | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 172 | Q | 0.457933 | P | 0.462013 | -0.00408 | No Change: Both O | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 160 | L | 0.610266 | F | 0.556512 | 0.053754 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 171 | V | 0.458671 | M | 0.579612 | -0.120941 | O to D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 157 | M | 0.650334 | R | 0.700292 | -0.049958 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 161 | N | 0.572446 | H | 0.530001 | 0.042445 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 161 | N | 0.572446 | I | 0.387735 | 0.184711 | D to O | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 163 | R | 0.479681 | P | 0.522639 | -0.042958 | O to D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| P35527 | K1C9_HUMAN Keratin type I cytoskeletal 9 OS=Homo sapiens GN=KRT9 PE=1 SV=3 | 458 | L | 0.613784 | F | 0.570064 | 0.04372 | No Change: Both D | Palmoplantar keratoderma epidermolytic (EPPK) [MIM:144200] |
| Q8IUG1 | KRA13_HUMAN Keratin-associated protein 1-3 OS=Homo sapiens GN=KRTAP1-3 PE=2 SV=1 | 34 | C | 0.998919 | S | 0.999187 | -2.68E-04 | No Change: Both D | - |
| Q8IUG1 | KRA13_HUMAN Keratin-associated protein 1-3 OS=Homo sapiens GN=KRTAP1-3 PE=2 SV=1 | 92 | G | 0.9481 | R | 0.948303 | -2.03E-04 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 72 | T | 0.992506 | P | 0.994172 | -0.001666 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 20 | V | 0.898782 | D | 0.939085 | -0.040303 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 158 | V | 0.988817 | M | 0.989744 | -9.27E-04 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 86 | T | 0.981372 | S | 0.987529 | -0.006157 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 126 | C | 0.99469 | S | 0.995729 | -0.001039 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 129 | Q | 0.995208 | P | 0.996012 | -8.04E-04 | No Change: Both D | - |
| P60014 | KR10A_HUMAN Keratin-associated protein 10-10 OS=Homo sapiens GN=KRTAP10-10 PE=1 SV=1 | 116 | V | 0.987216 | M | 0.987589 | -3.73E-04 | No Change: Both D | - |
| P60331 | KR101_HUMAN Keratin-associated protein 10-1 OS=Homo sapiens GN=KRTAP10-1 PE=1 SV=2 | 39 | P | 0.936439 | L | 0.89388 | 0.042559 | No Change: Both D | - |
| P60331 | KR101_HUMAN Keratin-associated protein 10-1 OS=Homo sapiens GN=KRTAP10-1 PE=1 SV=2 | 101 | V | 0.99724 | M | 0.997648 | -4.08E-04 | No Change: Both D | - |
| P60331 | KR101_HUMAN Keratin-associated protein 10-1 OS=Homo sapiens GN=KRTAP10-1 PE=1 SV=2 | 241 | R | 0.992982 | Q | 0.992759 | 2.23E-04 | No Change: Both D | - |
| P60331 | KR101_HUMAN Keratin-associated protein 10-1 OS=Homo sapiens GN=KRTAP10-1 PE=1 SV=2 | 280 | P | 0.995608 | L | 0.989647 | 0.005961 | No Change: Both D | - |
| P60412 | KR10B_HUMAN Keratin-associated protein 10-11 OS=Homo sapiens GN=KRTAP10-11 PE=1 SV=3 | 130 | S | 0.990005 | F | 0.976085 | 0.01392 | No Change: Both D | - |
| P60413 | KR10C_HUMAN Keratin-associated protein 10-12 OS=Homo sapiens GN=KRTAP10-12 PE=1 SV=1 | 146 | P | 0.994233 | Q | 0.993802 | 4.31E-04 | No Change: Both D | - |
| P60413 | KR10C_HUMAN Keratin-associated protein 10-12 OS=Homo sapiens GN=KRTAP10-12 PE=1 SV=1 | 226 | G | 0.978478 | S | 0.986839 | -0.008361 | No Change: Both D | - |
| P60368 | KR102_HUMAN Keratin-associated protein 10-2 OS=Homo sapiens GN=KRTAP10-2 PE=2 SV=1 | 15 | N | 0.866417 | D | 0.902584 | -0.036167 | No Change: Both D | - |
| P60368 | KR102_HUMAN Keratin-associated protein 10-2 OS=Homo sapiens GN=KRTAP10-2 PE=2 SV=1 | 107 | P | 0.995714 | T | 0.99345 | 0.002264 | No Change: Both D | - |
| P60368 | KR102_HUMAN Keratin-associated protein 10-2 OS=Homo sapiens GN=KRTAP10-2 PE=2 SV=1 | 117 | A | 0.995118 | P | 0.996829 | -0.001711 | No Change: Both D | - |
| P60368 | KR102_HUMAN Keratin-associated protein 10-2 OS=Homo sapiens GN=KRTAP10-2 PE=2 SV=1 | 241 | R | 0.99677 | G | 0.995625 | 0.001145 | No Change: Both D | - |
| P60368 | KR102_HUMAN Keratin-associated protein 10-2 OS=Homo sapiens GN=KRTAP10-2 PE=2 SV=1 | 177 | P | 0.996556 | L | 0.99203 | 0.004526 | No Change: Both D | - |
| P60369 | KR103_HUMAN Keratin-associated protein 10-3 OS=Homo sapiens GN=KRTAP10-3 PE=1 SV=2 | 3 | T | 0.937193 | A | 0.934928 | 0.002265 | No Change: Both D | - |
| P60369 | KR103_HUMAN Keratin-associated protein 10-3 OS=Homo sapiens GN=KRTAP10-3 PE=1 SV=2 | 170 | C | 0.987936 | Y | 0.974775 | 0.013161 | No Change: Both D | - |
| P60372 | KR104_HUMAN Keratin-associated protein 10-4 OS=Homo sapiens GN=KRTAP10-4 PE=2 SV=1 | 62 | R | 0.99443 | C | 0.995627 | -0.001197 | No Change: Both D | - |
| P60372 | KR104_HUMAN Keratin-associated protein 10-4 OS=Homo sapiens GN=KRTAP10-4 PE=2 SV=1 | 159 | I | 0.994971 | V | 0.995862 | -8.91E-04 | No Change: Both D | - |
| P60372 | KR104_HUMAN Keratin-associated protein 10-4 OS=Homo sapiens GN=KRTAP10-4 PE=2 SV=1 | 285 | G | 0.983754 | C | 0.987259 | -0.003505 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 20 | D | 0.942325 | N | 0.92155 | 0.020775 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 235 | V | 0.97357 | L | 0.976132 | -0.002562 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 183 | F | 0.967687 | C | 0.98372 | -0.016033 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 247 | Y | 0.972352 | C | 0.987185 | -0.014833 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 268 | R | 0.975316 | P | 0.97882 | -0.003504 | No Change: Both D | - |
| P60370 | KR105_HUMAN Keratin-associated protein 10-5 OS=Homo sapiens GN=KRTAP10-5 PE=2 SV=2 | 4 | C | 0.952986 | S | 0.970737 | -0.017751 | No Change: Both D | - |
| P60371 | KR106_HUMAN Keratin-associated protein 10-6 OS=Homo sapiens GN=KRTAP10-6 PE=2 SV=2 | 159 | V | 0.995893 | I | 0.995016 | 8.77E-04 | No Change: Both D | - |
| P60371 | KR106_HUMAN Keratin-associated protein 10-6 OS=Homo sapiens GN=KRTAP10-6 PE=2 SV=2 | 68 | C | 0.995163 | S | 0.99625 | -0.001087 | No Change: Both D | - |
| P60371 | KR106_HUMAN Keratin-associated protein 10-6 OS=Homo sapiens GN=KRTAP10-6 PE=2 SV=2 | 74 | P | 0.996542 | S | 0.996486 | 5.60E-05 | No Change: Both D | - |
| P60371 | KR106_HUMAN Keratin-associated protein 10-6 OS=Homo sapiens GN=KRTAP10-6 PE=2 SV=2 | 300 | P | 0.987179 | S | 0.988303 | -0.001124 | No Change: Both D | - |
| P60409 | KR107_HUMAN Keratin-associated protein 10-7 OS=Homo sapiens GN=KRTAP10-7 PE=2 SV=2 | 116 | M | 0.973301 | V | 0.971477 | 0.001824 | No Change: Both D | - |
| P60409 | KR107_HUMAN Keratin-associated protein 10-7 OS=Homo sapiens GN=KRTAP10-7 PE=2 SV=2 | 220 | Q | 0.997705 | K | 0.997272 | 4.33E-04 | No Change: Both D | - |
| P60409 | KR107_HUMAN Keratin-associated protein 10-7 OS=Homo sapiens GN=KRTAP10-7 PE=2 SV=2 | 290 | S | 0.995404 | T | 0.993233 | 0.002171 | No Change: Both D | - |
| P60409 | KR107_HUMAN Keratin-associated protein 10-7 OS=Homo sapiens GN=KRTAP10-7 PE=2 SV=2 | 325 | T | 0.991805 | A | 0.991152 | 6.53E-04 | No Change: Both D | - |
| P60409 | KR107_HUMAN Keratin-associated protein 10-7 OS=Homo sapiens GN=KRTAP10-7 PE=2 SV=2 | 129 | Y | 0.970981 | C | 0.986564 | -0.015583 | No Change: Both D | - |
| P60410 | KR108_HUMAN Keratin-associated protein 10-8 OS=Homo sapiens GN=KRTAP10-8 PE=2 SV=2 | 26 | H | 0.828241 | R | 0.876468 | -0.048227 | No Change: Both D | - |
| P60410 | KR108_HUMAN Keratin-associated protein 10-8 OS=Homo sapiens GN=KRTAP10-8 PE=2 SV=2 | 64 | S | 0.97858 | N | 0.969379 | 0.009201 | No Change: Both D | A colorectal cancer sample |
| P60410 | KR108_HUMAN Keratin-associated protein 10-8 OS=Homo sapiens GN=KRTAP10-8 PE=2 SV=2 | 159 | S | 0.975275 | F | 0.951637 | 0.023638 | No Change: Both D | A breast cancer sample |
| P60411 | KR109_HUMAN Keratin-associated protein 10-9 OS=Homo sapiens GN=KRTAP10-9 PE=1 SV=2 | 182 | Y | 0.980786 | C | 0.990372 | -0.009586 | No Change: Both D | - |
| P60411 | KR109_HUMAN Keratin-associated protein 10-9 OS=Homo sapiens GN=KRTAP10-9 PE=1 SV=2 | 257 | R | 0.979088 | C | 0.976559 | 0.002529 | No Change: Both D | - |
| Q8IUC1 | KR111_HUMAN Keratin-associated protein 11-1 OS=Homo sapiens GN=KRTAP11-1 PE=1 SV=1 | 111 | C | 0.786799 | S | 0.856274 | -0.069475 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 116 | A | 0.938068 | V | 0.930752 | 0.007316 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 143 | S | 0.950682 | P | 0.945017 | 0.005665 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 16 | A | 0.996021 | T | 0.996037 | -1.60E-05 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 16 | A | 0.996021 | V | 0.994494 | 0.001527 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 29 | S | 0.986259 | C | 0.982479 | 0.00378 | No Change: Both D | - |
| P59991 | KR122_HUMAN Keratin-associated protein 12-2 OS=Homo sapiens GN=KRTAP12-2 PE=1 SV=1 | 29 | S | 0.986259 | P | 0.98684 | -5.81E-04 | No Change: Both D | - |
| P60328 | KR123_HUMAN Keratin-associated protein 12-3 OS=Homo sapiens GN=KRTAP12-3 PE=1 SV=2 | 17 | H | 0.932809 | R | 0.944511 | -0.011702 | No Change: Both D | - |
| Q52LG2 | KR132_HUMAN Keratin-associated protein 13-2 OS=Homo sapiens GN=KRTAP13-2 PE=1 SV=1 | 26 | R | 0.771014 | C | 0.721694 | 0.04932 | No Change: Both D | - |
| Q52LG2 | KR132_HUMAN Keratin-associated protein 13-2 OS=Homo sapiens GN=KRTAP13-2 PE=1 SV=1 | 74 | S | 0.917345 | R | 0.895788 | 0.021557 | No Change: Both D | - |
| Q3LI77 | KR134_HUMAN Keratin-associated protein 13-4 OS=Homo sapiens GN=KRTAP13-4 PE=2 SV=1 | 59 | A | 0.836774 | T | 0.879294 | -0.04252 | No Change: Both D | - |
| Q3LI77 | KR134_HUMAN Keratin-associated protein 13-4 OS=Homo sapiens GN=KRTAP13-4 PE=2 SV=1 | 154 | R | 0.190092 | H | 0.163429 | 0.026663 | No Change: Both O | - |
| Q3LI76 | KR151_HUMAN Keratin-associated protein 15-1 OS=Homo sapiens GN=KRTAP15-1 PE=2 SV=2 | 43 | L | 0.474319 | M | 0.513693 | -0.039374 | O to D | - |
| Q3LHN2 | KR192_HUMAN Keratin-associated protein 19-2 OS=Homo sapiens GN=KRTAP19-2 PE=2 SV=1 | 5 | Y | 0.75349 | H | 0.807134 | -0.053644 | No Change: Both D | - |
| Q3LHN2 | KR192_HUMAN Keratin-associated protein 19-2 OS=Homo sapiens GN=KRTAP19-2 PE=2 SV=1 | 32 | G | 0.786374 | C | 0.755905 | 0.030469 | No Change: Both D | - |
| Q3LI73 | KR194_HUMAN Keratin-associated protein 19-4 OS=Homo sapiens GN=KRTAP19-4 PE=2 SV=1 | 48 | Y | 0.322776 | C | 0.33279 | -0.010014 | No Change: Both O | - |
| Q3LI54 | KR198_HUMAN Keratin-associated protein 19-8 OS=Homo sapiens GN=KRTAP19-8 PE=2 SV=1 | 61 | A | 0.57999 | T | 0.602994 | -0.023004 | No Change: Both D | - |
| Q3LI63 | KR201_HUMAN Keratin-associated protein 20-1 OS=Homo sapiens GN=KRTAP20-1 PE=2 SV=1 | 52 | S | 0.352704 | L | 0.149948 | 0.202756 | No Change: Both O | A breast cancer sample |
| Q3LI61 | KR202_HUMAN Keratin-associated protein 20-2 OS=Homo sapiens GN=KRTAP20-2 PE=2 SV=1 | 7 | Y | 0.336685 | H | 0.415511 | -0.078826 | No Change: Both O | - |
| Q3LI61 | KR202_HUMAN Keratin-associated protein 20-2 OS=Homo sapiens GN=KRTAP20-2 PE=2 SV=1 | 13 | Y | 0.348399 | C | 0.377324 | -0.028925 | No Change: Both O | - |
| Q3LI61 | KR202_HUMAN Keratin-associated protein 20-2 OS=Homo sapiens GN=KRTAP20-2 PE=2 SV=1 | 17 | V | 0.423184 | G | 0.66796 | -0.244776 | O to D | - |
| Q3LI58 | KR211_HUMAN Keratin-associated protein 21-1 OS=Homo sapiens GN=KRTAP21-1 PE=2 SV=1 | 15 | G | 0.958552 | S | 0.964234 | -0.005682 | No Change: Both D | A breast cancer sample |
| Q3MIV0 | KR221_HUMAN Keratin-associated protein 22-1 OS=Homo sapiens GN=KRTAP22-1 PE=2 SV=2 | 29 | Y | 0.131338 | C | 0.136347 | -0.005009 | No Change: Both O | - |
| Q3MIV0 | KR221_HUMAN Keratin-associated protein 22-1 OS=Homo sapiens GN=KRTAP22-1 PE=2 SV=2 | 26 | L | 0.209666 | H | 0.312667 | -0.103001 | No Change: Both O | - |
| Q3LHN0 | KR251_HUMAN Keratin-associated protein 25-1 OS=Homo sapiens GN=KRTAP25-1 PE=2 SV=1 | 40 | S | 0.316185 | P | 0.290467 | 0.025718 | No Change: Both O | - |
| Q6PEX3 | KR261_HUMAN Keratin-associated protein 26-1 OS=Homo sapiens GN=KRTAP26-1 PE=1 SV=1 | 26 | S | 0.623939 | Y | 0.398261 | 0.225678 | D to O | - |
| Q6PEX3 | KR261_HUMAN Keratin-associated protein 26-1 OS=Homo sapiens GN=KRTAP26-1 PE=1 SV=1 | 188 | P | 0.81465 | T | 0.751828 | 0.062822 | No Change: Both D | - |
| Q3LI81 | KR271_HUMAN Keratin-associated protein 27-1 OS=Homo sapiens GN=KRTAP27-1 PE=2 SV=1 | 99 | A | 0.913417 | V | 0.89629 | 0.017127 | No Change: Both D | - |
| Q9BYR7 | KRA32_HUMAN Keratin-associated protein 3-2 OS=Homo sapiens GN=KRTAP3-2 PE=1 SV=1 | 8 | S | 0.948249 | G | 0.920946 | 0.027303 | No Change: Both D | - |
| Q9BYR7 | KRA32_HUMAN Keratin-associated protein 3-2 OS=Homo sapiens GN=KRTAP3-2 PE=1 SV=1 | 27 | R | 0.774906 | C | 0.783134 | -0.008228 | No Change: Both D | - |
| Q9BYR7 | KRA32_HUMAN Keratin-associated protein 3-2 OS=Homo sapiens GN=KRTAP3-2 PE=1 SV=1 | 46 | I | 0.706738 | T | 0.802296 | -0.095558 | No Change: Both D | - |
| Q9BYQ7 | KRA41_HUMAN Keratin-associated protein 4-1 OS=Homo sapiens GN=KRTAP4-1 PE=2 SV=3 | 66 | H | 0.996636 | R | 0.997621 | -9.85E-04 | No Change: Both D | - |
| Q9BYQ7 | KRA41_HUMAN Keratin-associated protein 4-1 OS=Homo sapiens GN=KRTAP4-1 PE=2 SV=3 | 115 | S | 0.994553 | R | 0.993995 | 5.58E-04 | No Change: Both D | - |
| Q9BYQ7 | KRA41_HUMAN Keratin-associated protein 4-1 OS=Homo sapiens GN=KRTAP4-1 PE=2 SV=3 | 134 | A | 0.995859 | T | 0.997587 | -0.001728 | No Change: Both D | - |
| Q9BYR5 | KRA42_HUMAN Keratin-associated protein 4-2 OS=Homo sapiens GN=KRTAP4-2 PE=2 SV=2 | 95 | Y | 0.993092 | C | 0.996521 | -0.003429 | No Change: Both D | - |
| Q9BYR4 | KRA43_HUMAN Keratin-associated protein 4-3 OS=Homo sapiens GN=KRTAP4-3 PE=2 SV=2 | 122 | P | 0.999027 | S | 0.999077 | -5.00E-05 | No Change: Both D | - |
| Q9BYR4 | KRA43_HUMAN Keratin-associated protein 4-3 OS=Homo sapiens GN=KRTAP4-3 PE=2 SV=2 | 152 | P | 0.99708 | S | 0.997125 | -4.50E-05 | No Change: Both D | - |
| Q9BYR3 | KRA44_HUMAN Keratin-associated protein 4-4 OS=Homo sapiens GN=KRTAP4-4 PE=2 SV=1 | 25 | Y | 0.961635 | C | 0.983909 | -0.022274 | No Change: Both D | - |
| Q9BYR3 | KRA44_HUMAN Keratin-associated protein 4-4 OS=Homo sapiens GN=KRTAP4-4 PE=2 SV=1 | 35 | C | 0.987489 | S | 0.989201 | -0.001712 | No Change: Both D | - |
| Q9BYR3 | KRA44_HUMAN Keratin-associated protein 4-4 OS=Homo sapiens GN=KRTAP4-4 PE=2 SV=1 | 154 | R | 0.987641 | S | 0.98858 | -9.39E-04 | No Change: Both D | - |
| Q9BYR2 | KRA45_HUMAN Keratin-associated protein 4-5 OS=Homo sapiens GN=KRTAP4-5 PE=2 SV=3 | 6 | C | 0.990512 | R | 0.991307 | -7.95E-04 | No Change: Both D | - |
| Q9BYR2 | KRA45_HUMAN Keratin-associated protein 4-5 OS=Homo sapiens GN=KRTAP4-5 PE=2 SV=3 | 22 | R | 0.990072 | C | 0.990392 | -3.20E-04 | No Change: Both D | - |
| Q9BYR2 | KRA45_HUMAN Keratin-associated protein 4-5 OS=Homo sapiens GN=KRTAP4-5 PE=2 SV=3 | 67 | R | 0.997198 | H | 0.996484 | 7.14E-04 | No Change: Both D | - |
| Q9BYR2 | KRA45_HUMAN Keratin-associated protein 4-5 OS=Homo sapiens GN=KRTAP4-5 PE=2 SV=3 | 130 | C | 0.998392 | Y | 0.996379 | 0.002013 | No Change: Both D | - |
| Q9BYR0 | KRA47_HUMAN Keratin-associated protein 4-7 OS=Homo sapiens GN=KRTAP4-7 PE=2 SV=2 | 16 | S | 0.984317 | G | 0.976217 | 0.0081 | No Change: Both D | - |
| Q9BYR0 | KRA47_HUMAN Keratin-associated protein 4-7 OS=Homo sapiens GN=KRTAP4-7 PE=2 SV=2 | 18 | D | 0.985507 | V | 0.977107 | 0.0084 | No Change: Both D | - |
| Q9BYR0 | KRA47_HUMAN Keratin-associated protein 4-7 OS=Homo sapiens GN=KRTAP4-7 PE=2 SV=2 | 68 | T | 0.997611 | S | 0.998097 | -4.86E-04 | No Change: Both D | - |
| Q9BYR0 | KRA47_HUMAN Keratin-associated protein 4-7 OS=Homo sapiens GN=KRTAP4-7 PE=2 SV=2 | 168 | S | 0.992308 | C | 0.991185 | 0.001123 | No Change: Both D | - |
| Q6L8H2 | KRA53_HUMAN Keratin-associated protein 5-3 OS=Homo sapiens GN=KRTAP5-3 PE=2 SV=1 | 27 | G | 0.996394 | S | 0.996971 | -5.77E-04 | No Change: Both D | - |
| Q6L8H2 | KRA53_HUMAN Keratin-associated protein 5-3 OS=Homo sapiens GN=KRTAP5-3 PE=2 SV=1 | 28 | Y | 0.996173 | C | 0.998289 | -0.002116 | No Change: Both D | - |
| Q6L8H2 | KRA53_HUMAN Keratin-associated protein 5-3 OS=Homo sapiens GN=KRTAP5-3 PE=2 SV=1 | 73 | C | 0.998855 | S | 0.999092 | -2.37E-04 | No Change: Both D | - |
| Q6L8H2 | KRA53_HUMAN Keratin-associated protein 5-3 OS=Homo sapiens GN=KRTAP5-3 PE=2 SV=1 | 76 | G | 0.999081 | V | 0.998465 | 6.16E-04 | No Change: Both D | - |
| Q6L8H2 | KRA53_HUMAN Keratin-associated protein 5-3 OS=Homo sapiens GN=KRTAP5-3 PE=2 SV=1 | 83 | S | 0.998905 | C | 0.998631 | 2.74E-04 | No Change: Both D | - |
| Q6L8G9 | KRA56_HUMAN Keratin-associated protein 5-6 OS=Homo sapiens GN=KRTAP5-6 PE=2 SV=1 | 6 | C | 0.998747 | F | 0.996999 | 0.001748 | No Change: Both D | - |
| O75690 | KRA58_HUMAN Keratin-associated protein 5-8 OS=Homo sapiens GN=KRTAP5-8 PE=2 SV=2 | 28 | C | 0.996027 | R | 0.994952 | 0.001075 | No Change: Both D | - |
| P26371 | KRA59_HUMAN Keratin-associated protein 5-9 OS=Homo sapiens GN=KRTAP5-9 PE=2 SV=1 | 8 | G | 0.999321 | R | 0.999223 | 9.80E-05 | No Change: Both D | - |
| P26371 | KRA59_HUMAN Keratin-associated protein 5-9 OS=Homo sapiens GN=KRTAP5-9 PE=2 SV=1 | 40 | Y | 0.991919 | C | 0.996362 | -0.004443 | No Change: Both D | - |
| Q3LI67 | KRA63_HUMAN Keratin-associated protein 6-3 OS=Homo sapiens GN=KRTAP6-3 PE=2 SV=3 | 51 | Y | 0.740117 | S | 0.827873 | -0.087756 | No Change: Both D | - |
| Q3LI67 | KRA63_HUMAN Keratin-associated protein 6-3 OS=Homo sapiens GN=KRTAP6-3 PE=2 SV=3 | 44 | Y | 0.836082 | S | 0.88848 | -0.052398 | No Change: Both D | - |
| Q9BYQ4 | KRA92_HUMAN Keratin-associated protein 9-2 OS=Homo sapiens GN=KRTAP9-2 PE=1 SV=2 | 36 | P | 0.995959 | S | 0.995778 | 1.81E-04 | No Change: Both D | - |
| Q9BYQ4 | KRA92_HUMAN Keratin-associated protein 9-2 OS=Homo sapiens GN=KRTAP9-2 PE=1 SV=2 | 56 | C | 0.997982 | S | 0.998148 | -1.66E-04 | No Change: Both D | - |
| Q9BYQ2 | KRA94_HUMAN Keratin-associated protein 9-4 OS=Homo sapiens GN=KRTAP9-4 PE=2 SV=2 | 146 | S | 0.981905 | Y | 0.946947 | 0.034958 | No Change: Both D | - |
| A8MVA2 | KRA96_HUMAN Keratin-associated protein 9-6 OS=Homo sapiens GN=KRTAP9-6 PE=3 SV=1 | 86 | Y | 0.994773 | C | 0.997322 | -0.002549 | No Change: Both D | - |
| A8MTY7 | KRA97_HUMAN Keratin-associated protein 9-7 OS=Homo sapiens GN=KRTAP9-7 PE=3 SV=1 | 23 | T | 0.996108 | I | 0.990559 | 0.005549 | No Change: Both D | - |
| A8MTY7 | KRA97_HUMAN Keratin-associated protein 9-7 OS=Homo sapiens GN=KRTAP9-7 PE=3 SV=1 | 130 | S | 0.90553 | N | 0.879108 | 0.026422 | No Change: Both D | - |
| Q9BYP9 | KRA99_HUMAN Keratin-associated protein 9-9 OS=Homo sapiens GN=KRTAP9-9 PE=2 SV=1 | 36 | P | 0.997068 | S | 0.997009 | 5.90E-05 | No Change: Both D | - |
| Q9BYP9 | KRA99_HUMAN Keratin-associated protein 9-9 OS=Homo sapiens GN=KRTAP9-9 PE=2 SV=1 | 56 | C | 0.997082 | S | 0.997461 | -3.79E-04 | No Change: Both D | - |
| Q8N6L1 | KTAP2_HUMAN Keratinocyte-associated protein 2 OS=Homo sapiens GN=KRTCAP2 PE=1 SV=1 | 32 | G | 0.38375 | V | 0.252937 | 0.130813 | No Change: Both O | - |
| Q8IVT5 | KSR1_HUMAN Kinase suppressor of Ras 1 OS=Homo sapiens GN=KSR1 PE=1 SV=2 | 225 | S | 0.947821 | P | 0.946455 | 0.001366 | No Change: Both D | - |
| Q8IVT5 | KSR1_HUMAN Kinase suppressor of Ras 1 OS=Homo sapiens GN=KSR1 PE=1 SV=2 | 357 | V | 0.276832 | A | 0.302155 | -0.025323 | No Change: Both O | - |
| Q8IVT5 | KSR1_HUMAN Kinase suppressor of Ras 1 OS=Homo sapiens GN=KSR1 PE=1 SV=2 | 661 | Q | 0.380163 | H | 0.380519 | -3.56E-04 | No Change: Both O | - |
| Q6VAB6 | KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens GN=KSR2 PE=1 SV=2 | 676 | R | 0.253525 | S | 0.305594 | -0.052069 | No Change: Both O | A lung adenocarcinoma sample |
| Q96EK9 | KTI12_HUMAN Protein KTI12 homolog OS=Homo sapiens GN=KTI12 PE=1 SV=1 | 191 | D | 0.874294 | E | 0.899177 | -0.024883 | No Change: Both D | - |
| Q86UP2 | KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1 PE=1 SV=1 | 282 | V | 0.706216 | M | 0.778072 | -0.071856 | No Change: Both D | - |
| Q86UP2 | KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1 PE=1 SV=1 | 226 | P | 0.445208 | R | 0.38763 | 0.057578 | No Change: Both O | A breast cancer sample |
| Q86UP2 | KTN1_HUMAN Kinectin OS=Homo sapiens GN=KTN1 PE=1 SV=1 | 1316 | T | 0.905705 | P | 0.913757 | -0.008052 | No Change: Both D | A breast cancer sample |
| Q16719 | KYNU_HUMAN Kynureninase OS=Homo sapiens GN=KYNU PE=1 SV=1 | 412 | K | 0.332753 | E | 0.345627 | -0.012874 | No Change: Both O | - |
| Q16719 | KYNU_HUMAN Kynureninase OS=Homo sapiens GN=KYNU PE=1 SV=1 | 188 | R | 0.558026 | Q | 0.55948 | -0.001454 | No Change: Both D | - |
| Q16719 | KYNU_HUMAN Kynureninase OS=Homo sapiens GN=KYNU PE=1 SV=1 | 198 | T | 0.524097 | A | 0.495223 | 0.028874 | D to O | - |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 9 | W | 0.022693 | S | 0.092581 | -0.069888 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 121 | G | 0.388442 | S | 0.456986 | -0.068544 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 179 | I | 0.301309 | S | 0.48837 | -0.187061 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 179 | I | 0.301309 | S | 0.48837 | -0.187061 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 179 | I | 0.301309 | S | 0.48837 | -0.187061 | No Change: Both O | Spastic paraplegia X-linked type 1 (SPG1) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 184 | R | 0.443691 | Q | 0.487437 | -0.043746 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 194 | Y | 0.154915 | C | 0.126206 | 0.028709 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 210 | H | 0.20344 | Q | 0.199862 | 0.003578 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 219 | I | 0.300675 | T | 0.425551 | -0.124876 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 240 | P | 0.38841 | L | 0.241009 | 0.147401 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 240 | P | 0.38841 | L | 0.241009 | 0.147401 | No Change: Both O | Partial agenesis of the corpus callosum (ACCPX) [MIM:304100] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 264 | C | 0.155316 | Y | 0.156314 | -9.98E-04 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 309 | E | 0.441038 | K | 0.422456 | 0.018582 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 335 | W | 0.208649 | R | 0.380512 | -0.171863 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 335 | W | 0.208649 | R | 0.380512 | -0.171863 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 370 | G | 0.216806 | R | 0.243886 | -0.02708 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 370 | G | 0.216806 | R | 0.243886 | -0.02708 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 370 | G | 0.216806 | R | 0.243886 | -0.02708 | No Change: Both O | Spastic paraplegia X-linked type 1 (SPG1) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 386 | R | 0.206188 | C | 0.108268 | 0.09792 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 452 | G | 0.116616 | R | 0.110336 | 0.00628 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 473 | R | 0.201818 | C | 0.103408 | 0.09841 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 473 | R | 0.201818 | C | 0.103408 | 0.09841 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 598 | D | 0.381228 | N | 0.362216 | 0.019012 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 632 | R | 0.387518 | P | 0.450194 | -0.062676 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 691 | A | 0.307781 | D | 0.36819 | -0.060409 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 698 | G | 0.633333 | R | 0.645413 | -0.01208 | No Change: Both D | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 698 | G | 0.633333 | R | 0.645413 | -0.01208 | No Change: Both D | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 768 | V | 0.21025 | F | 0.188109 | 0.022141 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 784 | Y | 0.278578 | C | 0.283241 | -0.004663 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 935 | L | 0.34674 | P | 0.501873 | -0.155133 | O to D | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 941 | P | 0.337272 | L | 0.211031 | 0.126241 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 941 | P | 0.337272 | L | 0.211031 | 0.126241 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 1070 | Y | 0.525048 | C | 0.446814 | 0.078234 | D to O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 1194 | S | 0.851095 | L | 0.747616 | 0.103479 | No Change: Both D | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 1194 | S | 0.851095 | L | 0.747616 | 0.103479 | No Change: Both D | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 1224 | S | 0.684121 | L | 0.496328 | 0.187793 | D to O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 752 | V | 0.260981 | M | 0.309849 | -0.048868 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 415 | A | 0.077517 | P | 0.102305 | -0.024788 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 674 | S | 0.466987 | C | 0.276608 | 0.190379 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 770 | D | 0.219893 | N | 0.226109 | -0.006216 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 30 | H | 0.50846 | N | 0.512086 | -0.003626 | No Change: Both D | - |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 184 | R | 0.443691 | W | 0.239499 | 0.204192 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 202 | D | 0.357194 | Y | 0.223647 | 0.133547 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 268 | G | 0.178916 | D | 0.192387 | -0.013471 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 335 | W | 0.208649 | C | 0.267772 | -0.059123 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 408 | N | 0.286829 | I | 0.14603 | 0.140799 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 421 | V | 0.037939 | D | 0.074624 | -0.036685 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 426 | A | 0.119259 | D | 0.165178 | -0.045919 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 482 | L | 0.182863 | P | 0.314831 | -0.131968 | No Change: Both O | Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome (MASA) [MIM:303350] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 497 | C | 0.126898 | Y | 0.152269 | -0.025371 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 542 | S | 0.525344 | P | 0.517151 | 0.008193 | No Change: Both D | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 655 | K | 0.543373 | E | 0.557387 | -0.014014 | No Change: Both D | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 691 | A | 0.307781 | T | 0.379247 | -0.071466 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 739 | R | 0.18776 | W | 0.0997 | 0.08806 | No Change: Both O | - |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 741 | M | 0.183218 | T | 0.204248 | -0.02103 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 751 | R | 0.235949 | P | 0.274175 | -0.038226 | No Change: Both O | Hydrocephalus due to stenosis of the aqueduct of Sylvius (HSAS) [MIM:307000] |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 768 | V | 0.21025 | I | 0.184497 | 0.025753 | No Change: Both O | - |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 1239 | G | 0.835944 | E | 0.854571 | -0.018627 | No Change: Both D | - |
| P32004 | L1CAM_HUMAN Neural cell adhesion molecule L1 OS=Homo sapiens GN=L1CAM PE=1 SV=2 | 958 | L | 0.438348 | V | 0.423314 | 0.015034 | No Change: Both O | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 27 | R | 0.569495 | S | 0.620937 | -0.051442 | No Change: Both D | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 246 | V | 0.264844 | A | 0.333438 | -0.068594 | No Change: Both O | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 309 | V | 0.745871 | M | 0.785451 | -0.03958 | No Change: Both D | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 329 | K | 0.682394 | N | 0.620562 | 0.061832 | No Change: Both D | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 549 | P | 0.857706 | T | 0.841053 | 0.016653 | No Change: Both D | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 613 | T | 0.942447 | I | 0.916621 | 0.025826 | No Change: Both D | - |
| Q5T7N2 | LITD1_HUMAN LINE-1 type transposase domain-containing protein 1 OS=Homo sapiens GN=L1TD1 PE=1 SV=1 | 860 | L | 0.567637 | V | 0.547214 | 0.020423 | No Change: Both D | - |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 18 | L | 0.684881 | R | 0.796776 | -0.111895 | No Change: Both D | - |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 55 | G | 0.244861 | D | 0.246913 | -0.002052 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 57 | G | 0.215259 | R | 0.219926 | -0.004667 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 81 | K | 0.49564 | E | 0.506939 | -0.011299 | O to D | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 98 | H | 0.341033 | R | 0.322867 | 0.018166 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 98 | H | 0.341033 | Y | 0.236855 | 0.104178 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 176 | E | 0.480187 | D | 0.457602 | 0.022585 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 178 | Y | 0.28805 | F | 0.260512 | 0.027538 | No Change: Both O | - |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 302 | P | 0.208249 | L | 0.104223 | 0.104026 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 434 | H | 0.250054 | P | 0.315775 | -0.065721 | No Change: Both O | L-2-hydroxyglutaric aciduria (L2HGA) [MIM:236792] |
| Q9H9P8 | L2HDH_HUMAN L-2-hydroxyglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=L2HGDH PE=1 SV=3 | 33 | R | 0.728421 | S | 0.767921 | -0.0395 | No Change: Both D | - |
| Q9Y468 | LMBL1_HUMAN Lethal(3)malignant brain tumor-like protein 1 OS=Homo sapiens GN=L3MBTL1 PE=1 SV=3 | 49 | S | 0.885603 | T | 0.860751 | 0.024852 | No Change: Both D | - |
| Q9Y468 | LMBL1_HUMAN Lethal(3)malignant brain tumor-like protein 1 OS=Homo sapiens GN=L3MBTL1 PE=1 SV=3 | 479 | I | 0.29955 | M | 0.377238 | -0.077688 | No Change: Both O | - |
| Q969R5 | LMBL2_HUMAN Lethal(3)malignant brain tumor-like protein 2 OS=Homo sapiens GN=L3MBTL2 PE=1 SV=1 | 300 | R | 0.215092 | W | 0.089621 | 0.125471 | No Change: Both O | - |
| Q969R5 | LMBL2_HUMAN Lethal(3)malignant brain tumor-like protein 2 OS=Homo sapiens GN=L3MBTL2 PE=1 SV=1 | 7 | I | 0.989621 | V | 0.990705 | -0.001084 | No Change: Both D | - |
| Q969R5 | LMBL2_HUMAN Lethal(3)malignant brain tumor-like protein 2 OS=Homo sapiens GN=L3MBTL2 PE=1 SV=1 | 337 | V | 0.496749 | A | 0.553518 | -0.056769 | O to D | - |
| Q96JM7 | LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens GN=L3MBTL3 PE=1 SV=2 | 183 | T | 0.991125 | N | 0.992945 | -0.00182 | No Change: Both D | - |
| Q8NA19 | LMBL4_HUMAN Lethal(3)malignant brain tumor-like protein 4 OS=Homo sapiens GN=L3MBTL4 PE=2 SV=2 | 489 | G | 0.294547 | S | 0.367146 | -0.072599 | No Change: Both O | - |
| Q8NA19 | LMBL4_HUMAN Lethal(3)malignant brain tumor-like protein 4 OS=Homo sapiens GN=L3MBTL4 PE=2 SV=2 | 618 | G | 0.706194 | D | 0.719532 | -0.013338 | No Change: Both D | - |
| Q8IV20 | LACC1_HUMAN Laccase domain-containing protein 1 OS=Homo sapiens GN=LACC1 PE=1 SV=1 | 254 | I | 0.277074 | V | 0.289234 | -0.01216 | No Change: Both O | - |
| P83111 | LACTB_HUMAN Serine beta-lactamase-like protein LACTB mitochondrial OS=Homo sapiens GN=LACTB PE=1 SV=2 | 469 | R | 0.309493 | K | 0.381069 | -0.071576 | No Change: Both O | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 56 | A | 0.984787 | S | 0.989709 | -0.004922 | No Change: Both D | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 155 | A | 0.974312 | P | 0.985696 | -0.011384 | No Change: Both D | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 243 | L | 0.936392 | P | 0.957633 | -0.021241 | No Change: Both D | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 279 | P | 0.975431 | Q | 0.968559 | 0.006872 | No Change: Both D | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 323 | K | 0.93596 | E | 0.933321 | 0.002639 | No Change: Both D | - |
| O00515 | LAD1_HUMAN Ladinin-1 OS=Homo sapiens GN=LAD1 PE=1 SV=2 | 503 | T | 0.944958 | S | 0.964012 | -0.019054 | No Change: Both D | - |
| P18627 | LAG3_HUMAN Lymphocyte activation gene 3 protein OS=Homo sapiens GN=LAG3 PE=1 SV=5 | 455 | I | 0.036615 | T | 0.075988 | -0.039373 | No Change: Both O | - |
| Q6GTX8 | LAIR1_HUMAN Leukocyte-associated immunoglobulin-like receptor 1 OS=Homo sapiens GN=LAIR1 PE=1 SV=1 | 63 | E | 0.682724 | D | 0.660944 | 0.02178 | No Change: Both D | - |
| Q6ISS4 | LAIR2_HUMAN Leukocyte-associated immunoglobulin-like receptor 2 OS=Homo sapiens GN=LAIR2 PE=2 SV=1 | 78 | G | 0.473342 | S | 0.548381 | -0.075039 | O to D | - |
| Q6ISS4 | LAIR2_HUMAN Leukocyte-associated immunoglobulin-like receptor 2 OS=Homo sapiens GN=LAIR2 PE=2 SV=1 | 87 | H | 0.485732 | R | 0.509685 | -0.023953 | O to D | - |
| Q6ISS4 | LAIR2_HUMAN Leukocyte-associated immunoglobulin-like receptor 2 OS=Homo sapiens GN=LAIR2 PE=2 SV=1 | 115 | F | 0.524263 | Y | 0.553246 | -0.028983 | No Change: Both D | - |
| P00709 | LALBA_HUMAN Alpha-lactalbumin OS=Homo sapiens GN=LALBA PE=1 SV=1 | 46 | I | 0.077635 | V | 0.083446 | -0.005811 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 349 | L | 0.492847 | S | 0.598209 | -0.105362 | O to D | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 559 | V | 0.223791 | I | 0.20351 | 0.020281 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1577 | S | 0.123293 | A | 0.08174 | 0.041553 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1591 | L | 0.213098 | V | 0.209408 | 0.00369 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1632 | K | 0.680144 | E | 0.681154 | -0.00101 | No Change: Both D | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1682 | D | 0.639907 | V | 0.437018 | 0.202889 | D to O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 2076 | I | 0.266445 | T | 0.414771 | -0.148326 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 2611 | T | 0.324103 | A | 0.272057 | 0.052046 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 674 | N | 0.236117 | T | 0.200109 | 0.036008 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1340 | M | 0.519838 | V | 0.464743 | 0.055095 | D to O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 1876 | A | 0.362851 | T | 0.367385 | -0.004534 | No Change: Both O | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 2002 | K | 0.508335 | E | 0.502035 | 0.0063 | No Change: Both D | - |
| P25391 | LAMA1_HUMAN Laminin subunit alpha-1 OS=Homo sapiens GN=LAMA1 PE=1 SV=2 | 2511 | L | 0.282731 | M | 0.326254 | -0.043523 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 545 | L | 0.201086 | Q | 0.330047 | -0.128961 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 619 | R | 0.389264 | H | 0.386923 | 0.002341 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 919 | R | 0.515278 | L | 0.384775 | 0.130503 | D to O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 2586 | Y | 0.316643 | H | 0.412862 | -0.096219 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 2614 | E | 0.340552 | K | 0.344263 | -0.003711 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 527 | C | 0.313113 | Y | 0.362208 | -0.049095 | No Change: Both O | Merosin-deficient congenital muscular dystrophy type 1A (MDC1A) [MIM:607855] |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 862 | C | 0.808367 | R | 0.82617 | -0.017803 | No Change: Both D | Merosin-deficient congenital muscular dystrophy type 1A (MDC1A) [MIM:607855] |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 2564 | L | 0.443166 | P | 0.630836 | -0.18767 | O to D | Merosin-deficient congenital muscular dystrophy type 1A (MDC1A) [MIM:607855] |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 1160 | P | 0.354291 | A | 0.288818 | 0.065473 | No Change: Both O | A breast cancer sample |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 96 | R | 0.70702 | S | 0.759107 | -0.052087 | No Change: Both D | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 240 | Y | 0.232078 | H | 0.370944 | -0.138866 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 644 | H | 0.515752 | D | 0.540794 | -0.025042 | No Change: Both D | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 1138 | V | 0.625075 | M | 0.677897 | -0.052822 | No Change: Both D | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 1205 | T | 0.30779 | A | 0.273458 | 0.034332 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 1561 | K | 0.377979 | Q | 0.325463 | 0.052516 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 1945 | A | 0.679523 | T | 0.681257 | -0.001734 | No Change: Both D | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 2587 | A | 0.283177 | V | 0.212211 | 0.070966 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 2636 | T | 0.248927 | A | 0.202219 | 0.046708 | No Change: Both O | - |
| P24043 | LAMA2_HUMAN Laminin subunit alpha-2 OS=Homo sapiens GN=LAMA2 PE=1 SV=4 | 3029 | T | 0.304204 | A | 0.291734 | 0.01247 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 2702 | T | 0.129128 | A | 0.114093 | 0.015035 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 2815 | N | 0.255152 | K | 0.296727 | -0.041575 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 796 | T | 0.366834 | N | 0.406376 | -0.039542 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 1206 | V | 0.080235 | A | 0.105101 | -0.024866 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 1208 | P | 0.111295 | T | 0.088116 | 0.023179 | No Change: Both O | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 1774 | F | 0.6927 | L | 0.685773 | 0.006927 | No Change: Both D | - |
| Q16787 | LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens GN=LAMA3 PE=1 SV=2 | 2834 | S | 0.730925 | G | 0.683993 | 0.046932 | No Change: Both D | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 498 | Y | 0.64087 | H | 0.71382 | -0.07295 | No Change: Both D | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 1117 | G | 0.311488 | S | 0.361075 | -0.049587 | No Change: Both O | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 1119 | P | 0.354047 | R | 0.312565 | 0.041482 | No Change: Both O | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 94 | G | 0.466592 | S | 0.52106 | -0.054468 | O to D | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 154 | R | 0.340641 | W | 0.144728 | 0.195913 | No Change: Both O | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 492 | L | 0.546891 | H | 0.576965 | -0.030074 | No Change: Both D | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 1549 | N | 0.369192 | S | 0.428287 | -0.059095 | No Change: Both O | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 1815 | V | 0.329318 | I | 0.300989 | 0.028329 | No Change: Both O | - |
| Q16363 | LAMA4_HUMAN Laminin subunit alpha-4 OS=Homo sapiens GN=LAMA4 PE=1 SV=4 | 283 | A | 0.192206 | E | 0.2678 | -0.075594 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 889 | V | 0.298714 | M | 0.375086 | -0.076372 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1258 | M | 0.946782 | T | 0.957639 | -0.010857 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1367 | K | 0.103385 | E | 0.105206 | -0.001821 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1434 | G | 0.398542 | A | 0.363695 | 0.034847 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1667 | R | 0.627834 | W | 0.417957 | 0.209877 | D to O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1717 | H | 0.51862 | Y | 0.418232 | 0.100388 | D to O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1807 | F | 0.198203 | S | 0.417596 | -0.219393 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1900 | V | 0.821236 | M | 0.843823 | -0.022587 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1908 | A | 0.817826 | T | 0.827798 | -0.009972 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 2036 | H | 0.712515 | R | 0.747195 | -0.03468 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 2053 | R | 0.866105 | H | 0.847408 | 0.018697 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 2062 | D | 0.899982 | N | 0.875326 | 0.024656 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 2226 | R | 0.809885 | H | 0.784508 | 0.025377 | No Change: Both D | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 3079 | R | 0.413476 | W | 0.19619 | 0.217286 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 401 | T | 0.429824 | A | 0.365689 | 0.064135 | No Change: Both O | - |
| O15230 | LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens GN=LAMA5 PE=1 SV=8 | 1671 | T | 0.610775 | M | 0.606779 | 0.003996 | No Change: Both D | - |
| P07942 | LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=2 | 670 | V | 0.345528 | A | 0.33273 | 0.012798 | No Change: Both O | - |
| P07942 | LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=2 | 1022 | Q | 0.279373 | R | 0.264499 | 0.014874 | No Change: Both O | - |
| P07942 | LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=2 | 860 | G | 0.441928 | S | 0.474799 | -0.032871 | No Change: Both O | - |
| P07942 | LAMB1_HUMAN Laminin subunit beta-1 OS=Homo sapiens GN=LAMB1 PE=1 SV=2 | 379 | P | 0.494349 | S | 0.477358 | 0.016991 | No Change: Both O | - |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 246 | R | 0.197277 | Q | 0.198556 | -0.001279 | No Change: Both O | Pierson syndrome (PIERSS) [MIM:609049] |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 246 | R | 0.197277 | W | 0.074731 | 0.122546 | No Change: Both O | Pierson syndrome (PIERSS) [MIM:609049] |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 321 | C | 0.37169 | R | 0.441733 | -0.070043 | No Change: Both O | Pierson syndrome (PIERSS) [MIM:609049] |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 987 | E | 0.818676 | K | 0.794149 | 0.024527 | No Change: Both D | - |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 1380 | N | 0.728246 | K | 0.755502 | -0.027256 | No Change: Both D | Pierson syndrome (PIERSS) [MIM:609049] |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 1393 | L | 0.5515 | F | 0.502639 | 0.048861 | No Change: Both D | Pierson syndrome (PIERSS) [MIM:609049] |
| P55268 | LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens GN=LAMB2 PE=1 SV=2 | 147 | H | 0.090881 | R | 0.085647 | 0.005234 | No Change: Both O | Nephrotic syndrome type 5 with or without ocular abnormalities (NPHS5) [MIM:614199] |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 210 | E | 0.43968 | K | 0.438137 | 0.001543 | No Change: Both O | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 679 | P | 0.768676 | L | 0.66451 | 0.104166 | No Change: Both D | Epidermolysis bullosa junctional Herlitz type (H-JEB) [MIM:226700] |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 438 | S | 0.566849 | T | 0.512686 | 0.054163 | No Change: Both D | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 690 | N | 0.703709 | S | 0.794722 | -0.091013 | No Change: Both D | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 852 | M | 0.852589 | L | 0.821858 | 0.030731 | No Change: Both D | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 988 | R | 0.687908 | W | 0.437617 | 0.250291 | D to O | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 450 | R | 0.506557 | C | 0.454009 | 0.052548 | D to O | A colorectal cancer sample |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 181 | N | 0.692018 | D | 0.700049 | -0.008031 | No Change: Both D | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 199 | G | 0.364521 | A | 0.330848 | 0.033673 | No Change: Both O | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 207 | K | 0.430858 | Q | 0.449814 | -0.018956 | No Change: Both O | Generalized atrophic benign epidermolysis bullosa (GABEB) [MIM:226650] |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 292 | R | 0.625321 | L | 0.455538 | 0.169783 | D to O | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 527 | V | 0.660014 | M | 0.767626 | -0.107612 | No Change: Both D | - |
| Q13751 | LAMB3_HUMAN Laminin subunit beta-3 OS=Homo sapiens GN=LAMB3 PE=1 SV=1 | 926 | A | 0.235704 | D | 0.304965 | -0.069261 | No Change: Both O | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 44 | M | 0.36414 | T | 0.425187 | -0.061047 | No Change: Both O | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 234 | H | 0.176442 | Y | 0.10799 | 0.068452 | No Change: Both O | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 591 | V | 0.377756 | F | 0.344787 | 0.032969 | No Change: Both O | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 866 | N | 0.65168 | S | 0.702775 | -0.051095 | No Change: Both D | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 1350 | T | 0.58991 | N | 0.610973 | -0.021063 | No Change: Both D | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 1510 | H | 0.219687 | Y | 0.13635 | 0.083337 | No Change: Both O | - |
| A4D0S4 | LAMB4_HUMAN Laminin subunit beta-4 OS=Homo sapiens GN=LAMB4 PE=2 SV=1 | 1612 | R | 0.836866 | S | 0.859152 | -0.022286 | No Change: Both D | - |
| P11047 | LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3 | 458 | I | 0.765184 | V | 0.784035 | -0.018851 | No Change: Both D | - |
| P11047 | LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3 | 888 | L | 0.552465 | P | 0.73012 | -0.177655 | No Change: Both D | - |
| P11047 | LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3 | 1121 | R | 0.695976 | Q | 0.706059 | -0.010083 | No Change: Both D | - |
| P11047 | LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3 | 1116 | R | 0.714076 | H | 0.64144 | 0.072636 | No Change: Both D | A colorectal cancer sample |
| P11047 | LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens GN=LAMC1 PE=1 SV=3 | 731 | E | 0.728932 | K | 0.692453 | 0.036479 | No Change: Both D | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 733 | S | 0.553957 | T | 0.493418 | 0.060539 | D to O | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 247 | D | 0.287601 | E | 0.280466 | 0.007135 | No Change: Both O | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 111 | A | 0.785965 | P | 0.849633 | -0.063668 | No Change: Both D | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 115 | R | 0.747769 | Q | 0.735318 | 0.012451 | No Change: Both D | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 124 | T | 0.703665 | M | 0.70355 | 1.15E-04 | No Change: Both D | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 136 | D | 0.71802 | V | 0.551707 | 0.166313 | No Change: Both D | - |
| Q13753 | LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens GN=LAMC2 PE=1 SV=2 | 608 | S | 0.396572 | I | 0.232363 | 0.164209 | No Change: Both O | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 522 | P | 0.682641 | S | 0.697214 | -0.014573 | No Change: Both D | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 544 | E | 0.635647 | G | 0.582198 | 0.053449 | No Change: Both D | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 770 | R | 0.785971 | G | 0.783138 | 0.002833 | No Change: Both D | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 1082 | S | 0.487162 | G | 0.474623 | 0.012539 | No Change: Both O | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 1264 | R | 0.651628 | W | 0.46844 | 0.183188 | D to O | - |
| Q9Y6N6 | LAMC3_HUMAN Laminin subunit gamma-3 OS=Homo sapiens GN=LAMC3 PE=1 SV=3 | 350 | G | 0.838123 | R | 0.861675 | -0.023552 | No Change: Both D | Cortical malformations occipital (OCCM) [MIM:614115] |
| P11279 | LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens GN=LAMP1 PE=1 SV=3 | 309 | I | 0.214702 | T | 0.34225 | -0.127548 | No Change: Both O | - |
| P13473 | LAMP2_HUMAN Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens GN=LAMP2 PE=1 SV=2 | 256 | P | 0.5233 | H | 0.508768 | 0.014532 | No Change: Both D | - |
| P13473 | LAMP2_HUMAN Lysosome-associated membrane glycoprotein 2 OS=Homo sapiens GN=LAMP2 PE=1 SV=2 | 321 | W | 0.273472 | R | 0.479124 | -0.205652 | No Change: Both O | Danon disease (DAND) [MIM:300257] |
| Q9UQV4 | LAMP3_HUMAN Lysosome-associated membrane glycoprotein 3 OS=Homo sapiens GN=LAMP3 PE=1 SV=3 | 318 | I | 0.291473 | V | 0.322957 | -0.031484 | No Change: Both O | - |
| Q9UQV4 | LAMP3_HUMAN Lysosome-associated membrane glycoprotein 3 OS=Homo sapiens GN=LAMP3 PE=1 SV=3 | 32 | E | 0.588939 | G | 0.574143 | 0.014796 | No Change: Both D | - |
| Q9UJQ1 | LAMP5_HUMAN Lysosome-associated membrane glycoprotein 5 OS=Homo sapiens GN=LAMP5 PE=1 SV=1 | 12 | D | 0.232193 | G | 0.22584 | 0.006353 | No Change: Both O | - |
| Q9UJQ1 | LAMP5_HUMAN Lysosome-associated membrane glycoprotein 5 OS=Homo sapiens GN=LAMP5 PE=1 SV=1 | 81 | I | 0.148502 | V | 0.170595 | -0.022093 | No Change: Both O | - |
| Q9UJQ1 | LAMP5_HUMAN Lysosome-associated membrane glycoprotein 5 OS=Homo sapiens GN=LAMP5 PE=1 SV=1 | 103 | Q | 0.395652 | E | 0.444503 | -0.048851 | No Change: Both O | - |
| Q9UJQ1 | LAMP5_HUMAN Lysosome-associated membrane glycoprotein 5 OS=Homo sapiens GN=LAMP5 PE=1 SV=1 | 158 | S | 0.592957 | G | 0.544673 | 0.048284 | No Change: Both D | - |
| Q6IAA8 | LTOR1_HUMAN Ragulator complex protein LAMTOR1 OS=Homo sapiens GN=LAMTOR1 PE=1 SV=2 | 73 | S | 0.591971 | L | 0.425197 | 0.166774 | D to O | - |
| Q9NS86 | LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens GN=LANCL2 PE=1 SV=1 | 74 | I | 0.248514 | V | 0.225015 | 0.023499 | No Change: Both O | - |
| Q9NS86 | LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens GN=LANCL2 PE=1 SV=1 | 56 | T | 0.573678 | P | 0.631103 | -0.057425 | No Change: Both D | - |
| Q13571 | LAPM5_HUMAN Lysosomal-associated transmembrane protein 5 OS=Homo sapiens GN=LAPTM5 PE=1 SV=1 | 226 | R | 0.704761 | K | 0.738567 | -0.033806 | No Change: Both D | - |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 68 | R | 0.975605 | G | 0.965142 | 0.010463 | No Change: Both D | - |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 68 | R | 0.975605 | P | 0.974629 | 9.76E-04 | No Change: Both D | - |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 665 | R | 0.224783 | H | 0.208719 | 0.016064 | No Change: Both O | - |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 509 | E | 0.310057 | K | 0.309942 | 1.15E-04 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B6 (MDDGB6) [MIM:608840] |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 331 | S | 0.343401 | F | 0.152048 | 0.191353 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A6 (MDDGA6) [MIM:613154] |
| O95461 | LARGE_HUMAN Glycosyltransferase-like protein LARGE1 OS=Homo sapiens GN=LARGE PE=1 SV=1 | 495 | W | 0.141946 | R | 0.297589 | -0.155643 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A6 (MDDGA6) [MIM:613154] |
| Q659C4 | LAR1B_HUMAN La-related protein 1B OS=Homo sapiens GN=LARP1B PE=1 SV=2 | 462 | P | 0.651714 | R | 0.635969 | 0.015745 | No Change: Both D | - |
| Q659C4 | LAR1B_HUMAN La-related protein 1B OS=Homo sapiens GN=LARP1B PE=1 SV=2 | 660 | R | 0.895332 | H | 0.879678 | 0.015654 | No Change: Both D | - |
| Q71RC2 | LARP4_HUMAN La-related protein 4 OS=Homo sapiens GN=LARP4 PE=1 SV=3 | 351 | F | 0.770187 | L | 0.750055 | 0.020132 | No Change: Both D | - |
| Q71RC2 | LARP4_HUMAN La-related protein 4 OS=Homo sapiens GN=LARP4 PE=1 SV=3 | 502 | N | 0.692702 | T | 0.670832 | 0.02187 | No Change: Both D | - |
| Q9P2J5 | SYLC_HUMAN Leucine--tRNA ligase cytoplasmic OS=Homo sapiens GN=LARS PE=1 SV=2 | 1088 | R | 0.468598 | K | 0.524812 | -0.056214 | O to D | - |
| Q15031 | SYLM_HUMAN Probable leucine--tRNA ligase mitochondrial OS=Homo sapiens GN=LARS2 PE=1 SV=2 | 727 | K | 0.464521 | N | 0.417747 | 0.046774 | No Change: Both O | - |
| Q15031 | SYLM_HUMAN Probable leucine--tRNA ligase mitochondrial OS=Homo sapiens GN=LARS2 PE=1 SV=2 | 831 | E | 0.309082 | D | 0.288095 | 0.020987 | No Change: Both O | - |
| Q9Y4W2 | LAS1L_HUMAN Protein LAS1 homolog OS=Homo sapiens GN=LAS1L PE=1 SV=2 | 170 | R | 0.113362 | C | 0.056449 | 0.056913 | No Change: Both O | A colorectal cancer sample |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 96 | R | 0.778834 | W | 0.647061 | 0.131773 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 204 | S | 0.870996 | G | 0.837785 | 0.033211 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 237 | P | 0.987354 | Q | 0.985157 | 0.002197 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 370 | R | 0.8358 | W | 0.703042 | 0.132758 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 531 | P | 0.852503 | S | 0.832517 | 0.019986 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 641 | F | 0.770241 | L | 0.770584 | -3.43E-04 | No Change: Both D | - |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 669 | M | 0.835928 | I | 0.720266 | 0.115662 | No Change: Both D | A lung adenocarcinoma sample |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 806 | R | 0.085039 | P | 0.107359 | -0.02232 | No Change: Both O | A lung large cell carcinoma sample |
| O95835 | LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens GN=LATS1 PE=1 SV=1 | 1000 | G | 0.574657 | S | 0.625524 | -0.050867 | No Change: Both D | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 324 | A | 0.83953 | V | 0.79769 | 0.04184 | No Change: Both D | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 40 | G | 0.919384 | E | 0.925536 | -0.006152 | No Change: Both D | A lung adenocarcinoma sample |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 91 | S | 0.52355 | L | 0.390183 | 0.133367 | D to O | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 799 | I | 0.196783 | V | 0.203281 | -0.006498 | No Change: Both O | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 1014 | A | 0.784989 | G | 0.796845 | -0.011856 | No Change: Both D | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 1025 | L | 0.645702 | P | 0.80169 | -0.155988 | No Change: Both D | - |
| Q9NRM7 | LATS2_HUMAN Serine/threonine-protein kinase LATS2 OS=Homo sapiens GN=LATS2 PE=1 SV=2 | 363 | G | 0.630596 | S | 0.724957 | -0.094361 | No Change: Both D | - |
| Q6UX15 | LAYN_HUMAN Layilin OS=Homo sapiens GN=LAYN PE=2 SV=1 | 66 | E | 0.517021 | K | 0.50792 | 0.009101 | No Change: Both D | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 9 | P | 0.231388 | L | 0.129857 | 0.101531 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 125 | L | 0.478242 | I | 0.459855 | 0.018387 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 166 | V | 0.488126 | M | 0.558899 | -0.070773 | O to D | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 242 | M | 0.228143 | I | 0.15084 | 0.077303 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 283 | D | 0.078097 | G | 0.069054 | 0.009043 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 294 | H | 0.22184 | R | 0.219035 | 0.002805 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 333 | P | 0.415049 | L | 0.264473 | 0.150576 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 339 | L | 0.510597 | F | 0.468234 | 0.042363 | D to O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 436 | F | 0.09509 | L | 0.110212 | -0.015122 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 445 | A | 0.324883 | T | 0.356667 | -0.031784 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 111 | R | 0.463646 | Q | 0.479303 | -0.015657 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 147 | E | 0.655749 | K | 0.662675 | -0.006926 | No Change: Both D | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 364 | I | 0.278964 | T | 0.433381 | -0.154417 | No Change: Both O | - |
| P18428 | LBP_HUMAN Lipopolysaccharide-binding protein OS=Homo sapiens GN=LBP PE=1 SV=3 | 157 | S | 0.605272 | C | 0.374164 | 0.231108 | D to O | - |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 119 | P | 0.561162 | L | 0.429208 | 0.131954 | D to O | Pelger-Huet anomaly (PHA) [MIM:169400] |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 569 | P | 0.019739 | R | 0.015769 | 0.00397 | No Change: Both O | Pelger-Huet anomaly (PHA) [MIM:169400] |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 311 | T | 0.151968 | A | 0.136321 | 0.015647 | No Change: Both O | - |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 154 | S | 0.820404 | N | 0.784541 | 0.035863 | No Change: Both D | - |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 169 | R | 0.736406 | C | 0.593433 | 0.142973 | No Change: Both D | - |
| Q14739 | LBR_HUMAN Lamin-B receptor OS=Homo sapiens GN=LBR PE=1 SV=2 | 372 | R | 0.145316 | C | 0.065438 | 0.079878 | No Change: Both O | Reynolds syndrome (REYNS) [MIM:613471] |
| Q6XYB7 | LBX2_HUMAN Transcription factor LBX2 OS=Homo sapiens GN=LBX2 PE=2 SV=1 | 158 | S | 0.587244 | F | 0.389297 | 0.197947 | D to O | - |
| Q86VQ0 | LCA5_HUMAN Lebercilin OS=Homo sapiens GN=LCA5 PE=1 SV=2 | 24 | L | 0.916733 | S | 0.963717 | -0.046984 | No Change: Both D | - |
| Q86VQ0 | LCA5_HUMAN Lebercilin OS=Homo sapiens GN=LCA5 PE=1 SV=2 | 26 | D | 0.930196 | A | 0.918375 | 0.011821 | No Change: Both D | - |
| Q86VQ0 | LCA5_HUMAN Lebercilin OS=Homo sapiens GN=LCA5 PE=1 SV=2 | 66 | R | 0.966181 | Q | 0.964971 | 0.00121 | No Change: Both D | - |
| Q86VQ0 | LCA5_HUMAN Lebercilin OS=Homo sapiens GN=LCA5 PE=1 SV=2 | 546 | A | 0.846288 | P | 0.895375 | -0.049087 | No Change: Both D | - |
| Q86VQ0 | LCA5_HUMAN Lebercilin OS=Homo sapiens GN=LCA5 PE=1 SV=2 | 656 | G | 0.884277 | D | 0.906219 | -0.021942 | No Change: Both D | - |
| O95447 | LCA5L_HUMAN Lebercilin-like protein OS=Homo sapiens GN=LCA5L PE=2 SV=1 | 17 | G | 0.365825 | S | 0.465096 | -0.099271 | No Change: Both O | - |
| O95447 | LCA5L_HUMAN Lebercilin-like protein OS=Homo sapiens GN=LCA5L PE=2 SV=1 | 547 | G | 0.837814 | S | 0.866221 | -0.028407 | No Change: Both D | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 34 | P | 0.275409 | L | 0.162255 | 0.113154 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 54 | G | 0.105532 | S | 0.125744 | -0.020212 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 57 | G | 0.169927 | R | 0.155229 | 0.014698 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 117 | A | 0.439291 | T | 0.472007 | -0.032716 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 147 | T | 0.12101 | I | 0.06556 | 0.05545 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 159 | R | 0.326972 | W | 0.150031 | 0.176941 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 164 | R | 0.25901 | H | 0.244459 | 0.014551 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 171 | R | 0.335809 | W | 0.16741 | 0.168399 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 180 | Y | 0.462682 | N | 0.587435 | -0.124753 | O to D | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 182 | R | 0.350796 | C | 0.195566 | 0.15523 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 233 | L | 0.140557 | P | 0.274246 | -0.133689 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 252 | N | 0.416786 | K | 0.479025 | -0.062239 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 276 | M | 0.328688 | K | 0.421279 | -0.092591 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 317 | M | 0.071981 | I | 0.046506 | 0.025475 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 345 | T | 0.215886 | M | 0.170347 | 0.045539 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 371 | T | 0.474092 | M | 0.414171 | 0.059921 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 232 | S | 0.113199 | T | 0.076037 | 0.037162 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 29 | N | 0.109054 | I | 0.050753 | 0.058301 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 34 | P | 0.275409 | Q | 0.241577 | 0.033832 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 37 | T | 0.52385 | M | 0.475584 | 0.048266 | D to O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 70 | V | 0.11339 | E | 0.234186 | -0.120796 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 95 | G | 0.037633 | R | 0.036205 | 0.001428 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 115 | S | 0.486746 | P | 0.446268 | 0.040478 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 123 | R | 0.250551 | C | 0.129062 | 0.121489 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 159 | R | 0.326972 | Q | 0.333574 | -0.006602 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 164 | R | 0.25901 | C | 0.12991 | 0.1291 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 165 | A | 0.237025 | T | 0.263186 | -0.026161 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 205 | S | 0.089318 | N | 0.074264 | 0.015054 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 242 | K | 0.242901 | N | 0.207665 | 0.035236 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 268 | R | 0.500674 | H | 0.488913 | 0.011761 | D to O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 298 | T | 0.320648 | A | 0.282634 | 0.038014 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 298 | T | 0.320648 | A | 0.282634 | 0.038014 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 298 | T | 0.320648 | I | 0.19114 | 0.129508 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 331 | P | 0.175372 | S | 0.184573 | -0.009201 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 333 | V | 0.12847 | M | 0.15566 | -0.02719 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 396 | L | 0.25272 | R | 0.346779 | -0.094059 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 406 | F | 0.191989 | V | 0.227097 | -0.035108 | No Change: Both O | Lecithin-cholesterol acyltransferase deficiency (LCATD) [MIM:245900] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 99 | W | 0.044503 | S | 0.150143 | -0.10564 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 246 | V | 0.239975 | F | 0.239117 | 8.58E-04 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 268 | R | 0.500674 | C | 0.365195 | 0.135479 | D to O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 322 | R | 0.137388 | C | 0.066004 | 0.071384 | No Change: Both O | - |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 338 | L | 0.060769 | F | 0.049544 | 0.011225 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| P04180 | LCAT_HUMAN Phosphatidylcholine-sterol acyltransferase OS=Homo sapiens GN=LCAT PE=1 SV=1 | 347 | R | 0.238263 | C | 0.123324 | 0.114939 | No Change: Both O | Fish-eye disease (FED) [MIM:136120] |
| Q5T751 | LCE1C_HUMAN Late cornified envelope protein 1C OS=Homo sapiens GN=LCE1C PE=2 SV=1 | 16 | C | 0.999969 | Y | 0.999925 | 4.40E-05 | No Change: Both D | - |
| Q5T752 | LCE1D_HUMAN Late cornified envelope protein 1D OS=Homo sapiens GN=LCE1D PE=2 SV=1 | 59 | N | 0.999157 | S | 0.999532 | -3.75E-04 | No Change: Both D | - |
| Q5T752 | LCE1D_HUMAN Late cornified envelope protein 1D OS=Homo sapiens GN=LCE1D PE=2 SV=1 | 78 | R | 0.99891 | H | 0.99871 | 2.00E-04 | No Change: Both D | - |
| Q5T753 | LCE1E_HUMAN Late cornified envelope protein 1E OS=Homo sapiens GN=LCE1E PE=2 SV=1 | 59 | S | 0.999702 | G | 0.99962 | 8.20E-05 | No Change: Both D | - |
| Q5T753 | LCE1E_HUMAN Late cornified envelope protein 1E OS=Homo sapiens GN=LCE1E PE=2 SV=1 | 111 | G | 0.999464 | S | 0.999606 | -1.42E-04 | No Change: Both D | - |
| Q5TA79 | LCE2A_HUMAN Late cornified envelope protein 2A OS=Homo sapiens GN=LCE2A PE=2 SV=1 | 20 | C | 0.999963 | Y | 0.999919 | 4.40E-05 | No Change: Both D | - |
| O14633 | LCE2B_HUMAN Late cornified envelope protein 2B OS=Homo sapiens GN=LCE2B PE=2 SV=1 | 51 | I | 0.98951 | S | 0.996139 | -0.006629 | No Change: Both D | - |
| O14633 | LCE2B_HUMAN Late cornified envelope protein 2B OS=Homo sapiens GN=LCE2B PE=2 SV=1 | 83 | R | 0.984964 | Q | 0.983079 | 0.001885 | No Change: Both D | - |
| Q5TA82 | LCE2D_HUMAN Late cornified envelope protein 2D OS=Homo sapiens GN=LCE2D PE=2 SV=1 | 92 | C | 0.991964 | Y | 0.982897 | 0.009067 | No Change: Both D | - |
| Q5TA76 | LCE3A_HUMAN Late cornified envelope protein 3A OS=Homo sapiens GN=LCE3A PE=2 SV=1 | 59 | R | 0.998907 | C | 0.998679 | 2.28E-04 | No Change: Both D | - |
| Q9BYE3 | LCE3D_HUMAN Late cornified envelope protein 3D OS=Homo sapiens GN=LCE3D PE=2 SV=1 | 43 | G | 0.990307 | V | 0.98311 | 0.007197 | No Change: Both D | - |
| Q9BYE3 | LCE3D_HUMAN Late cornified envelope protein 3D OS=Homo sapiens GN=LCE3D PE=2 SV=1 | 81 | G | 0.996794 | V | 0.992232 | 0.004562 | No Change: Both D | - |
| Q5TA78 | LCE4A_HUMAN Late cornified envelope protein 4A OS=Homo sapiens GN=LCE4A PE=2 SV=1 | 95 | G | 0.998104 | V | 0.994704 | 0.0034 | No Change: Both D | - |
| Q5TCM9 | LCE5A_HUMAN Late cornified envelope protein 5A OS=Homo sapiens GN=LCE5A PE=2 SV=1 | 40 | C | 0.999695 | Y | 0.99935 | 3.45E-04 | No Change: Both D | - |
| P06239 | LCK_HUMAN Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK PE=1 SV=6 | 28 | V | 0.214099 | L | 0.229992 | -0.015893 | No Change: Both O | Leukemia |
| P06239 | LCK_HUMAN Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK PE=1 SV=6 | 353 | A | 0.212413 | V | 0.142783 | 0.06963 | No Change: Both O | Leukemia |
| P06239 | LCK_HUMAN Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK PE=1 SV=6 | 447 | P | 0.409212 | L | 0.233724 | 0.175488 | No Change: Both O | Leukemia |
| P06239 | LCK_HUMAN Tyrosine-protein kinase Lck OS=Homo sapiens GN=LCK PE=1 SV=6 | 201 | G | 0.206278 | S | 0.252153 | -0.045875 | No Change: Both O | - |
| Q6UWP7 | LCLT1_HUMAN Lysocardiolipin acyltransferase 1 OS=Homo sapiens GN=LCLAT1 PE=1 SV=1 | 290 | I | 0.358315 | V | 0.395007 | -0.036692 | No Change: Both O | - |
| O60294 | LCMT2_HUMAN Leucine carboxyl methyltransferase 2 OS=Homo sapiens GN=LCMT2 PE=1 SV=3 | 141 | R | 0.52369 | S | 0.575205 | -0.051515 | No Change: Both D | - |
| O60294 | LCMT2_HUMAN Leucine carboxyl methyltransferase 2 OS=Homo sapiens GN=LCMT2 PE=1 SV=3 | 67 | V | 0.097355 | L | 0.098591 | -0.001236 | No Change: Both O | - |
| O60294 | LCMT2_HUMAN Leucine carboxyl methyltransferase 2 OS=Homo sapiens GN=LCMT2 PE=1 SV=3 | 149 | C | 0.350339 | Y | 0.308838 | 0.041501 | No Change: Both O | - |
| O60294 | LCMT2_HUMAN Leucine carboxyl methyltransferase 2 OS=Homo sapiens GN=LCMT2 PE=1 SV=3 | 518 | T | 0.054852 | A | 0.051624 | 0.003228 | No Change: Both O | - |
| Q6UWW0 | LCN15_HUMAN Lipocalin-15 OS=Homo sapiens GN=LCN15 PE=1 SV=1 | 152 | S | 0.46273 | A | 0.355207 | 0.107523 | No Change: Both O | - |
| Q6UWW0 | LCN15_HUMAN Lipocalin-15 OS=Homo sapiens GN=LCN15 PE=1 SV=1 | 164 | K | 0.67655 | E | 0.665712 | 0.010838 | No Change: Both D | - |
| Q8WX39 | LCN9_HUMAN Epididymal-specific lipocalin-9 OS=Homo sapiens GN=LCN9 PE=2 SV=3 | 65 | H | 0.244023 | Y | 0.152506 | 0.091517 | No Change: Both O | - |
| Q8WX39 | LCN9_HUMAN Epididymal-specific lipocalin-9 OS=Homo sapiens GN=LCN9 PE=2 SV=3 | 90 | C | 0.213459 | F | 0.218989 | -0.00553 | No Change: Both O | - |
| Q6ZST4 | LCNL1_HUMAN Lipocalin-like 1 protein OS=Homo sapiens GN=LCNL1 PE=2 SV=2 | 68 | A | 0.271832 | T | 0.280939 | -0.009107 | No Change: Both O | - |
| P13796 | PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1 PE=1 SV=6 | 24 | D | 0.364773 | E | 0.386526 | -0.021753 | No Change: Both O | - |
| P13796 | PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1 PE=1 SV=6 | 533 | K | 0.665513 | E | 0.666028 | -5.15E-04 | No Change: Both D | - |
| P13796 | PLSL_HUMAN Plastin-2 OS=Homo sapiens GN=LCP1 PE=1 SV=6 | 544 | P | 0.696866 | A | 0.627784 | 0.069082 | No Change: Both D | - |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 219 | V | 0.189315 | I | 0.167787 | 0.021528 | No Change: Both O | - |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 268 | Q | 0.460235 | H | 0.406593 | 0.053642 | No Change: Both O | Congenital lactase deficiency (COLACD) [MIM:223000] |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 362 | I | 0.503302 | V | 0.521793 | -0.018491 | No Change: Both D | - |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 1363 | G | 0.314819 | S | 0.368061 | -0.053242 | No Change: Both O | Congenital lactase deficiency (COLACD) [MIM:223000] |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 1639 | N | 0.328665 | S | 0.349216 | -0.020551 | No Change: Both O | - |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 190 | S | 0.708244 | L | 0.528875 | 0.179369 | No Change: Both D | - |
| P09848 | LPH_HUMAN Lactase-phlorizin hydrolase OS=Homo sapiens GN=LCT PE=1 SV=3 | 1593 | V | 0.289951 | M | 0.348803 | -0.058852 | No Change: Both O | - |
| Q6UWM7 | LCTL_HUMAN Lactase-like protein OS=Homo sapiens GN=LCTL PE=1 SV=2 | 240 | A | 0.324308 | T | 0.347941 | -0.023633 | No Change: Both O | - |
| Q6UWM7 | LCTL_HUMAN Lactase-like protein OS=Homo sapiens GN=LCTL PE=1 SV=2 | 212 | T | 0.634526 | M | 0.600728 | 0.033798 | No Change: Both D | - |
| Q86U70 | LDB1_HUMAN LIM domain-binding protein 1 OS=Homo sapiens GN=LDB1 PE=1 SV=2 | 299 | R | 0.984887 | Q | 0.984943 | -5.60E-05 | No Change: Both D | A colorectal cancer sample |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 55 | V | 0.349003 | I | 0.333586 | 0.015417 | No Change: Both O | - |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 189 | S | 0.843173 | L | 0.776428 | 0.066745 | No Change: Both D | Cardiomyopathy dilated type 1C (CMD1C) [MIM:601493] |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 206 | T | 0.585697 | I | 0.513682 | 0.072015 | No Change: Both D | Cardiomyopathy dilated type 1C (CMD1C) [MIM:601493] |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 345 | I | 0.996615 | M | 0.997864 | -0.001249 | No Change: Both D | Cardiomyopathy dilated type 1C (CMD1C) [MIM:601493] |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 635 | V | 0.045975 | I | 0.040931 | 0.005044 | No Change: Both O | - |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 673 | D | 0.215105 | N | 0.194024 | 0.021081 | No Change: Both O | Cardiomyopathy dilated type 1C (CMD1C) [MIM:601493] |
| O75112 | LDB3_HUMAN LIM domain-binding protein 3 OS=Homo sapiens GN=LDB3 PE=1 SV=2 | 101 | P | 0.889494 | L | 0.802941 | 0.086553 | No Change: Both D | - |
| P00338 | LDHA_HUMAN L-lactate dehydrogenase A chain OS=Homo sapiens GN=LDHA PE=1 SV=2 | 222 | K | 0.662976 | E | 0.66329 | -3.14E-04 | No Change: Both D | - |
| P00338 | LDHA_HUMAN L-lactate dehydrogenase A chain OS=Homo sapiens GN=LDHA PE=1 SV=2 | 315 | R | 0.71295 | C | 0.564042 | 0.148908 | No Change: Both D | - |
| P00338 | LDHA_HUMAN L-lactate dehydrogenase A chain OS=Homo sapiens GN=LDHA PE=1 SV=2 | 161 | S | 0.276977 | R | 0.221354 | 0.055623 | No Change: Both O | - |
| Q9BYZ2 | LDH6B_HUMAN L-lactate dehydrogenase A-like 6B OS=Homo sapiens GN=LDHAL6B PE=1 SV=3 | 14 | V | 0.449792 | M | 0.490802 | -0.04101 | No Change: Both O | - |
| Q9BYZ2 | LDH6B_HUMAN L-lactate dehydrogenase A-like 6B OS=Homo sapiens GN=LDHAL6B PE=1 SV=3 | 30 | P | 0.148954 | L | 0.07942 | 0.069534 | No Change: Both O | - |
| Q9BYZ2 | LDH6B_HUMAN L-lactate dehydrogenase A-like 6B OS=Homo sapiens GN=LDHAL6B PE=1 SV=3 | 326 | I | 0.166579 | T | 0.275509 | -0.10893 | No Change: Both O | - |
| Q9BYZ2 | LDH6B_HUMAN L-lactate dehydrogenase A-like 6B OS=Homo sapiens GN=LDHAL6B PE=1 SV=3 | 259 | P | 0.276674 | S | 0.313982 | -0.037308 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 7 | K | 0.503889 | E | 0.513751 | -0.009862 | No Change: Both D | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 35 | A | 0.117883 | E | 0.168153 | -0.05027 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 129 | S | 0.087346 | R | 0.064184 | 0.023162 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 171 | F | 0.158053 | V | 0.178628 | -0.020575 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 172 | R | 0.135704 | H | 0.128694 | 0.00701 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 175 | M | 0.192615 | L | 0.161875 | 0.03074 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 322 | D | 0.409917 | V | 0.222342 | 0.187575 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 69 | G | 0.313454 | E | 0.371707 | -0.058253 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 107 | R | 0.570657 | W | 0.332435 | 0.238222 | D to O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 172 | R | 0.135704 | P | 0.149429 | -0.013725 | No Change: Both O | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 325 | W | 0.412986 | R | 0.702245 | -0.289259 | O to D | - |
| P07195 | LDHB_HUMAN L-lactate dehydrogenase B chain OS=Homo sapiens GN=LDHB PE=1 SV=2 | 175 | M | 0.192615 | V | 0.15069 | 0.041925 | No Change: Both O | - |
| P07864 | LDHC_HUMAN L-lactate dehydrogenase C chain OS=Homo sapiens GN=LDHC PE=2 SV=4 | 285 | E | 0.175306 | Q | 0.13791 | 0.037396 | No Change: Both O | - |
| Q86WU2 | LDHD_HUMAN Probable D-lactate dehydrogenase mitochondrial OS=Homo sapiens GN=LDHD PE=1 SV=1 | 233 | R | 0.469134 | K | 0.540261 | -0.071127 | O to D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 27 | C | 0.363832 | W | 0.317412 | 0.04642 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 52 | C | 0.760613 | Y | 0.678013 | 0.0826 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 78 | R | 0.707985 | C | 0.690598 | 0.017387 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 87 | W | 0.718717 | G | 0.855479 | -0.136762 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 89 | C | 0.728606 | Y | 0.583797 | 0.144809 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 90 | D | 0.737424 | G | 0.713371 | 0.024053 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 90 | D | 0.737424 | N | 0.707805 | 0.029619 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 90 | D | 0.737424 | Y | 0.545677 | 0.191747 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 92 | Q | 0.733272 | E | 0.734986 | -0.001714 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 95 | C | 0.816232 | G | 0.82819 | -0.011958 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 101 | E | 0.885728 | K | 0.894069 | -0.008341 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 109 | C | 0.895494 | R | 0.915094 | -0.0196 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 116 | C | 0.858303 | R | 0.885605 | -0.027302 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 140 | E | 0.742851 | K | 0.745634 | -0.002783 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 155 | C | 0.72202 | G | 0.7216 | 4.20E-04 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 160 | C | 0.59223 | Y | 0.451649 | 0.140581 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 168 | D | 0.659824 | H | 0.546377 | 0.113447 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 168 | D | 0.659824 | N | 0.621717 | 0.038107 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 168 | D | 0.659824 | Y | 0.468235 | 0.191589 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 173 | C | 0.675908 | R | 0.721395 | -0.045487 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 173 | C | 0.675908 | W | 0.584223 | 0.091685 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 175 | D | 0.687661 | N | 0.652925 | 0.034736 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 177 | S | 0.673844 | L | 0.526672 | 0.147172 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 197 | C | 0.600263 | F | 0.540319 | 0.059944 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 197 | C | 0.600263 | Y | 0.499923 | 0.10034 | D to O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 197 | C | 0.600263 | R | 0.637242 | -0.036979 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 221 | D | 0.800672 | G | 0.775422 | 0.02525 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 221 | D | 0.800672 | Y | 0.642421 | 0.158251 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 224 | D | 0.834819 | N | 0.809477 | 0.025342 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 224 | D | 0.834819 | G | 0.812551 | 0.022268 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 224 | D | 0.834819 | V | 0.735008 | 0.099811 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 226 | S | 0.836082 | P | 0.833587 | 0.002495 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 227 | D | 0.830657 | E | 0.837834 | -0.007177 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 228 | E | 0.825428 | Q | 0.797058 | 0.02837 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 228 | E | 0.825428 | K | 0.820065 | 0.005363 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 231 | C | 0.795014 | G | 0.811775 | -0.016761 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 240 | E | 0.801989 | K | 0.794329 | 0.00766 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 248 | C | 0.741515 | F | 0.659519 | 0.081996 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 248 | C | 0.741515 | Y | 0.643991 | 0.097524 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 256 | D | 0.682109 | G | 0.642061 | 0.040048 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 266 | D | 0.565304 | E | 0.581216 | -0.015912 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 270 | C | 0.420345 | Y | 0.317279 | 0.103066 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 276 | C | 0.368318 | Y | 0.28043 | 0.087888 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 277 | E | 0.408865 | K | 0.421271 | -0.012406 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 286 | S | 0.422181 | R | 0.400388 | 0.021793 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 301 | D | 0.443556 | A | 0.338522 | 0.105034 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 302 | C | 0.462147 | Y | 0.355473 | 0.106674 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 302 | C | 0.462147 | W | 0.3303 | 0.131847 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 304 | D | 0.495607 | N | 0.47522 | 0.020387 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 304 | D | 0.495607 | E | 0.515374 | -0.019767 | O to D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 306 | S | 0.534278 | L | 0.372745 | 0.161533 | D to O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 313 | C | 0.525256 | Y | 0.436096 | 0.08916 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 318 | C | 0.458274 | Y | 0.441639 | 0.016635 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 318 | C | 0.458274 | F | 0.410032 | 0.048242 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 327 | H | 0.330718 | Y | 0.255035 | 0.075683 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 329 | C | 0.325629 | Y | 0.259718 | 0.065911 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 335 | G | 0.304232 | S | 0.345565 | -0.041333 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 338 | C | 0.30103 | S | 0.352006 | -0.050976 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 342 | D | 0.300198 | E | 0.317675 | -0.017477 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 342 | D | 0.300198 | N | 0.27381 | 0.026388 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 343 | G | 0.297483 | S | 0.33514 | -0.037657 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 350 | R | 0.385145 | P | 0.428675 | -0.04353 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 352 | C | 0.436547 | Y | 0.364005 | 0.072542 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 354 | D | 0.504634 | G | 0.453109 | 0.051525 | D to O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 354 | D | 0.504634 | V | 0.335107 | 0.169527 | D to O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 357 | E | 0.568829 | K | 0.543518 | 0.025311 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 364 | C | 0.47682 | R | 0.543178 | -0.066358 | O to D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 368 | C | 0.398007 | R | 0.454802 | -0.056795 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 379 | C | 0.352492 | R | 0.456903 | -0.104411 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 399 | A | 0.062856 | D | 0.084348 | -0.021492 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 401 | L | 0.064985 | H | 0.118466 | -0.053481 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 408 | E | 0.311166 | K | 0.325823 | -0.014657 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 414 | L | 0.522015 | R | 0.655235 | -0.13322 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 416 | R | 0.500542 | Q | 0.513189 | -0.012647 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 416 | R | 0.500542 | W | 0.275839 | 0.224703 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 423 | I | 0.256584 | T | 0.41373 | -0.157146 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 429 | V | 0.160176 | M | 0.19278 | -0.032604 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 431 | A | 0.195746 | T | 0.221852 | -0.026106 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 433 | D | 0.249325 | H | 0.218882 | 0.030443 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 434 | T | 0.225653 | K | 0.274625 | -0.048972 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 441 | I | 0.193799 | N | 0.352844 | -0.159045 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 441 | I | 0.193799 | M | 0.276098 | -0.082299 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 443 | W | 0.198663 | C | 0.258611 | -0.059948 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 478 | G | 0.201254 | R | 0.200395 | 8.59E-04 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 482 | D | 0.090427 | H | 0.07479 | 0.015637 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 483 | W | 0.07133 | R | 0.163977 | -0.092647 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 485 | H | 0.058906 | R | 0.062572 | -0.003666 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 523 | V | 0.244816 | M | 0.285377 | -0.040561 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 526 | P | 0.111239 | S | 0.120521 | -0.009282 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 546 | G | 0.427831 | D | 0.45037 | -0.022539 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 549 | G | 0.247038 | D | 0.266285 | -0.019247 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 564 | N | 0.137109 | H | 0.11786 | 0.019249 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 564 | N | 0.137109 | S | 0.156592 | -0.019483 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 565 | G | 0.135426 | V | 0.074082 | 0.061344 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 579 | D | 0.267142 | N | 0.252795 | 0.014347 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 592 | G | 0.517328 | E | 0.562854 | -0.045526 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 599 | L | 0.553904 | S | 0.721421 | -0.167517 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 633 | R | 0.26986 | C | 0.142986 | 0.126874 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 649 | P | 0.345652 | L | 0.217721 | 0.127931 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 667 | C | 0.239956 | Y | 0.263604 | -0.023648 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 677 | C | 0.227528 | R | 0.329974 | -0.102446 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 682 | L | 0.205813 | P | 0.363804 | -0.157991 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 685 | P | 0.358744 | L | 0.213816 | 0.144928 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 700 | D | 0.376758 | E | 0.410182 | -0.033424 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 726 | T | 0.806078 | I | 0.657073 | 0.149005 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 792 | I | 0.086654 | F | 0.081459 | 0.005195 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 797 | V | 0.011939 | M | 0.014756 | -0.002817 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 827 | V | 0.379189 | I | 0.355917 | 0.023272 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 828 | Y | 0.429631 | C | 0.370489 | 0.059142 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 844 | G | 0.480622 | D | 0.531897 | -0.051275 | O to D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 50 | A | 0.701228 | S | 0.806608 | -0.10538 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 56 | S | 0.797496 | P | 0.757362 | 0.040134 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 175 | D | 0.687661 | Y | 0.510382 | 0.177279 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 221 | D | 0.800672 | N | 0.766182 | 0.03449 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 288 | E | 0.404132 | K | 0.414025 | -0.009893 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 356 | D | 0.549476 | Y | 0.353141 | 0.196335 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 366 | Q | 0.437012 | R | 0.397322 | 0.03969 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 379 | C | 0.352492 | Y | 0.360621 | -0.008129 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 401 | L | 0.064985 | V | 0.069777 | -0.004792 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 432 | L | 0.229262 | V | 0.242945 | -0.013683 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 608 | P | 0.210043 | S | 0.243662 | -0.033619 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 403 | F | 0.092163 | L | 0.104376 | -0.012213 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 568 | L | 0.117431 | V | 0.108213 | 0.009218 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 714 | E | 0.638263 | K | 0.626414 | 0.011849 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 2 | G | 0.642526 | R | 0.606137 | 0.036389 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 468 | V | 0.35919 | I | 0.334554 | 0.024636 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 814 | R | 0.093 | Q | 0.101356 | -0.008356 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 46 | C | 0.539156 | S | 0.633918 | -0.094762 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 172 | D | 0.667191 | H | 0.571618 | 0.095573 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 184 | C | 0.444717 | Y | 0.355887 | 0.08883 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 253 | R | 0.706222 | W | 0.479133 | 0.227089 | D to O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 261 | C | 0.628183 | F | 0.557649 | 0.070534 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 406 | R | 0.196833 | Q | 0.19819 | -0.001357 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 699 | P | 0.371218 | L | 0.232075 | 0.139143 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 391 | A | 0.307213 | T | 0.327277 | -0.020064 | No Change: Both O | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 105 | P | 0.896868 | S | 0.900088 | -0.00322 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 134 | C | 0.797815 | F | 0.739148 | 0.058667 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 134 | C | 0.797815 | W | 0.656309 | 0.141506 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 222 | C | 0.815196 | Y | 0.714428 | 0.100768 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 254 | Q | 0.696576 | P | 0.726416 | -0.02984 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 276 | C | 0.368318 | R | 0.434802 | -0.066484 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 318 | C | 0.458274 | R | 0.576372 | -0.118098 | O to D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 358 | C | 0.57763 | Y | 0.530486 | 0.047144 | No Change: Both D | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 370 | N | 0.357661 | T | 0.378577 | -0.020916 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 415 | D | 0.512392 | G | 0.486422 | 0.02597 | D to O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 451 | I | 0.242085 | T | 0.387449 | -0.145364 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 479 | L | 0.176679 | P | 0.320797 | -0.144118 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 579 | D | 0.267142 | Y | 0.157771 | 0.109371 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 826 | P | 0.349631 | S | 0.394969 | -0.045338 | No Change: Both O | Familial hypercholesterolemia (FH) [MIM:143890] |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 139 | D | 0.755404 | H | 0.674903 | 0.080501 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 201 | E | 0.604838 | K | 0.570801 | 0.034037 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 255 | C | 0.683251 | S | 0.753851 | -0.0706 | No Change: Both D | - |
| P01130 | LDLR_HUMAN Low-density lipoprotein receptor OS=Homo sapiens GN=LDLR PE=1 SV=1 | 471 | R | 0.343378 | G | 0.367579 | -0.024201 | No Change: Both O | - |
| Q5SZI1 | LRAD2_HUMAN Low-density lipoprotein receptor class A domain-containing protein 2 OS=Homo sapiens GN=LDLRAD2 PE=2 SV=1 | 134 | N | 0.54358 | T | 0.552073 | -0.008493 | No Change: Both D | - |
| Q5SW96 | ARH_HUMAN Low density lipoprotein receptor adapter protein 1 OS=Homo sapiens GN=LDLRAP1 PE=1 SV=3 | 202 | S | 0.674124 | H | 0.553544 | 0.12058 | No Change: Both D | Autosomal recessive hypercholesterolemia (ARH) [MIM:603813] |
| Q5SW96 | ARH_HUMAN Low density lipoprotein receptor adapter protein 1 OS=Homo sapiens GN=LDLRAP1 PE=1 SV=3 | 202 | S | 0.674124 | P | 0.667961 | 0.006163 | No Change: Both D | - |
| O75829 | LECT1_HUMAN Leukocyte cell-derived chemotaxin 1 OS=Homo sapiens GN=LECT1 PE=2 SV=1 | 175 | V | 0.139875 | I | 0.121 | 0.018875 | No Change: Both O | - |
| O75829 | LECT1_HUMAN Leukocyte cell-derived chemotaxin 1 OS=Homo sapiens GN=LECT1 PE=2 SV=1 | 116 | F | 0.227901 | L | 0.23822 | -0.010319 | No Change: Both O | - |
| O14960 | LECT2_HUMAN Leukocyte cell-derived chemotaxin-2 OS=Homo sapiens GN=LECT2 PE=1 SV=2 | 58 | I | 0.313879 | V | 0.351372 | -0.037493 | No Change: Both O | - |
| Q9UJU2 | LEF1_HUMAN Lymphoid enhancer-binding factor 1 OS=Homo sapiens GN=LEF1 PE=1 SV=1 | 113 | G | 0.916258 | R | 0.915965 | 2.93E-04 | No Change: Both D | A colorectal cancer sample |
| O75610 | LFTY1_HUMAN Left-right determination factor 1 OS=Homo sapiens GN=LEFTY1 PE=2 SV=1 | 322 | D | 0.395446 | A | 0.371399 | 0.024047 | No Change: Both O | - |
| O75610 | LFTY1_HUMAN Left-right determination factor 1 OS=Homo sapiens GN=LEFTY1 PE=2 SV=1 | 57 | V | 0.224618 | M | 0.285023 | -0.060405 | No Change: Both O | - |
| O00292 | LFTY2_HUMAN Left-right determination factor 2 OS=Homo sapiens GN=LEFTY2 PE=1 SV=2 | 342 | S | 0.627016 | N | 0.567449 | 0.059567 | No Change: Both D | Left-right axis malformations (LRAM) [MIM:601877] |
| O00292 | LFTY2_HUMAN Left-right determination factor 2 OS=Homo sapiens GN=LEFTY2 PE=1 SV=2 | 92 | S | 0.514901 | L | 0.350063 | 0.164838 | D to O | - |
| O00292 | LFTY2_HUMAN Left-right determination factor 2 OS=Homo sapiens GN=LEFTY2 PE=1 SV=2 | 286 | P | 0.11829 | L | 0.059924 | 0.058366 | No Change: Both O | - |
| Q6ZMV7 | LEKR1_HUMAN Leucine- glutamate- and lysine-rich protein 1 OS=Homo sapiens GN=LEKR1 PE=2 SV=2 | 356 | I | 0.925107 | V | 0.935947 | -0.01084 | No Change: Both D | - |
| Q68G75 | LEMD1_HUMAN LEM domain-containing protein 1 OS=Homo sapiens GN=LEMD1 PE=2 SV=2 | 25 | P | 0.562787 | S | 0.560441 | 0.002346 | No Change: Both D | - |
| Q9Y2U8 | MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens GN=LEMD3 PE=1 SV=2 | 260 | D | 0.93201 | Y | 0.884358 | 0.047652 | No Change: Both D | - |
| Q96BZ8 | LENG1_HUMAN Leukocyte receptor cluster member 1 OS=Homo sapiens GN=LENG1 PE=1 SV=1 | 97 | E | 0.896771 | K | 0.889304 | 0.007467 | No Change: Both D | - |
| Q96PV6 | LENG8_HUMAN Leukocyte receptor cluster member 8 OS=Homo sapiens GN=LENG8 PE=1 SV=2 | 242 | R | 0.880364 | P | 0.902989 | -0.022625 | No Change: Both D | - |
| Q96PV6 | LENG8_HUMAN Leukocyte receptor cluster member 8 OS=Homo sapiens GN=LENG8 PE=1 SV=2 | 520 | I | 0.221426 | V | 0.255681 | -0.034255 | No Change: Both O | - |
| Q96B70 | LENG9_HUMAN Leukocyte receptor cluster member 9 OS=Homo sapiens GN=LENG9 PE=2 SV=2 | 153 | H | 0.114762 | R | 0.143821 | -0.029059 | No Change: Both O | - |
| Q96B70 | LENG9_HUMAN Leukocyte receptor cluster member 9 OS=Homo sapiens GN=LENG9 PE=2 SV=2 | 499 | R | 0.641253 | P | 0.659358 | -0.018105 | No Change: Both D | - |
| P41159 | LEP_HUMAN Leptin OS=Homo sapiens GN=LEP PE=1 SV=1 | 94 | V | 0.357321 | M | 0.441027 | -0.083706 | No Change: Both O | - |
| P41159 | LEP_HUMAN Leptin OS=Homo sapiens GN=LEP PE=1 SV=1 | 105 | R | 0.247996 | W | 0.112369 | 0.135627 | No Change: Both O | - |
| P41159 | LEP_HUMAN Leptin OS=Homo sapiens GN=LEP PE=1 SV=1 | 110 | V | 0.122494 | M | 0.160583 | -0.038089 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 109 | K | 0.309979 | R | 0.257736 | 0.052243 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 204 | K | 0.253406 | R | 0.201251 | 0.052155 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 223 | Q | 0.29946 | R | 0.264169 | 0.035291 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 656 | K | 0.547257 | N | 0.509067 | 0.03819 | No Change: Both D | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 675 | S | 0.188844 | T | 0.129145 | 0.059699 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 503 | I | 0.046252 | V | 0.043193 | 0.003059 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 124 | D | 0.079525 | G | 0.070109 | 0.009416 | No Change: Both O | - |
| P48357 | LEPR_HUMAN Leptin receptor OS=Homo sapiens GN=LEPR PE=1 SV=2 | 699 | T | 0.207301 | M | 0.160629 | 0.046672 | No Change: Both O | - |
| Q32P28 | P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens GN=LEPRE1 PE=1 SV=2 | 349 | G | 0.394299 | R | 0.396445 | -0.002146 | No Change: Both O | - |
| Q32P28 | P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens GN=LEPRE1 PE=1 SV=2 | 506 | P | 0.593495 | R | 0.576511 | 0.016984 | No Change: Both D | - |
| Q32P28 | P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens GN=LEPRE1 PE=1 SV=2 | 549 | M | 0.224203 | I | 0.166259 | 0.057944 | No Change: Both O | - |
| Q32P28 | P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens GN=LEPRE1 PE=1 SV=2 | 644 | Q | 0.331929 | K | 0.368115 | -0.036186 | No Change: Both O | - |
| Q8IVL5 | P3H2_HUMAN Prolyl 3-hydroxylase 2 OS=Homo sapiens GN=LEPREL1 PE=1 SV=1 | 613 | D | 0.248111 | N | 0.23265 | 0.015461 | No Change: Both O | A breast cancer sample |
| Q8IVL5 | P3H2_HUMAN Prolyl 3-hydroxylase 2 OS=Homo sapiens GN=LEPREL1 PE=1 SV=1 | 508 | G | 0.439502 | V | 0.328295 | 0.111207 | No Change: Both O | Myopia high with cataract and vitreoretinal degeneration (MCVD) [MIM:614292] |
| Q8IVL6 | P3H3_HUMAN Prolyl 3-hydroxylase 3 OS=Homo sapiens GN=LEPREL2 PE=2 SV=1 | 301 | T | 0.467161 | A | 0.440569 | 0.026592 | No Change: Both O | - |
| Q8IVL6 | P3H3_HUMAN Prolyl 3-hydroxylase 3 OS=Homo sapiens GN=LEPREL2 PE=2 SV=1 | 304 | R | 0.504218 | C | 0.346458 | 0.15776 | D to O | - |
| Q8IVL6 | P3H3_HUMAN Prolyl 3-hydroxylase 3 OS=Homo sapiens GN=LEPREL2 PE=2 SV=1 | 385 | G | 0.369793 | E | 0.436758 | -0.066965 | No Change: Both O | - |
| Q8IVL6 | P3H3_HUMAN Prolyl 3-hydroxylase 3 OS=Homo sapiens GN=LEPREL2 PE=2 SV=1 | 685 | I | 0.735543 | T | 0.786836 | -0.051293 | No Change: Both D | - |
| Q8IVL6 | P3H3_HUMAN Prolyl 3-hydroxylase 3 OS=Homo sapiens GN=LEPREL2 PE=2 SV=1 | 705 | M | 0.998114 | T | 0.998252 | -1.38E-04 | No Change: Both D | - |
| Q92791 | SC65_HUMAN Synaptonemal complex protein SC65 OS=Homo sapiens GN=LEPREL4 PE=1 SV=1 | 186 | Q | 0.136606 | R | 0.127286 | 0.00932 | No Change: Both O | - |
| Q6P1Q0 | LTMD1_HUMAN LETM1 domain-containing protein 1 OS=Homo sapiens GN=LETMD1 PE=1 SV=1 | 84 | V | 0.029741 | I | 0.027903 | 0.001838 | No Change: Both O | - |
| Q8NES3 | LFNG_HUMAN Beta-1 3-N-acetylglucosaminyltransferase lunatic fringe OS=Homo sapiens GN=LFNG PE=1 SV=2 | 188 | F | 0.190513 | L | 0.207605 | -0.017092 | No Change: Both O | Spondylocostal dysostosis type 3 (SCDO3) [MIM:609813] |
| Q8NES3 | LFNG_HUMAN Beta-1 3-N-acetylglucosaminyltransferase lunatic fringe OS=Homo sapiens GN=LFNG PE=1 SV=2 | 38 | G | 0.940716 | R | 0.951376 | -0.01066 | No Change: Both D | - |
| Q8NES3 | LFNG_HUMAN Beta-1 3-N-acetylglucosaminyltransferase lunatic fringe OS=Homo sapiens GN=LFNG PE=1 SV=2 | 346 | V | 0.362504 | M | 0.410396 | -0.047892 | No Change: Both O | - |
| Q8TCE9 | PPL13_HUMAN Placental protein 13-like OS=Homo sapiens GN=LGALS14 PE=2 SV=2 | 67 | C | 0.046167 | R | 0.103418 | -0.057251 | No Change: Both O | - |
| Q8TCE9 | PPL13_HUMAN Placental protein 13-like OS=Homo sapiens GN=LGALS14 PE=2 SV=2 | 127 | F | 0.126535 | L | 0.156612 | -0.030077 | No Change: Both O | - |
| A8MUM7 | LEG16_HUMAN Galectin-16 OS=Homo sapiens GN=LGALS16 PE=2 SV=1 | 97 | L | 0.064078 | H | 0.107893 | -0.043815 | No Change: Both O | - |
| P05162 | LEG2_HUMAN Galectin-2 OS=Homo sapiens GN=LGALS2 PE=1 SV=3 | 132 | E | 0.774157 | Q | 0.79086 | -0.016703 | No Change: Both D | A breast cancer sample |
| P05162 | LEG2_HUMAN Galectin-2 OS=Homo sapiens GN=LGALS2 PE=1 SV=3 | 119 | V | 0.502072 | I | 0.463136 | 0.038936 | D to O | - |
| P17931 | LEG3_HUMAN Galectin-3 OS=Homo sapiens GN=LGALS3 PE=1 SV=5 | 64 | P | 0.997425 | H | 0.994778 | 0.002647 | No Change: Both D | - |
| P17931 | LEG3_HUMAN Galectin-3 OS=Homo sapiens GN=LGALS3 PE=1 SV=5 | 98 | T | 0.92554 | P | 0.949295 | -0.023755 | No Change: Both D | - |
| P17931 | LEG3_HUMAN Galectin-3 OS=Homo sapiens GN=LGALS3 PE=1 SV=5 | 183 | R | 0.492394 | K | 0.532329 | -0.039935 | O to D | - |
| P56470 | LEG4_HUMAN Galectin-4 OS=Homo sapiens GN=LGALS4 PE=1 SV=1 | 16 | T | 0.419341 | M | 0.369382 | 0.049959 | No Change: Both O | - |
| O00214 | LEG8_HUMAN Galectin-8 OS=Homo sapiens GN=LGALS8 PE=1 SV=4 | 36 | R | 0.20032 | C | 0.100098 | 0.100222 | No Change: Both O | - |
| O00214 | LEG8_HUMAN Galectin-8 OS=Homo sapiens GN=LGALS8 PE=1 SV=4 | 19 | F | 0.091234 | Y | 0.108388 | -0.017154 | No Change: Both O | - |
| O00214 | LEG8_HUMAN Galectin-8 OS=Homo sapiens GN=LGALS8 PE=1 SV=4 | 56 | M | 0.631979 | V | 0.58964 | 0.042339 | No Change: Both D | - |
| O00214 | LEG8_HUMAN Galectin-8 OS=Homo sapiens GN=LGALS8 PE=1 SV=4 | 184 | R | 0.641558 | S | 0.672802 | -0.031244 | No Change: Both D | - |
| O00182 | LEG9_HUMAN Galectin-9 OS=Homo sapiens GN=LGALS9 PE=1 SV=2 | 5 | G | 0.732185 | S | 0.770304 | -0.038119 | No Change: Both D | - |
| Q6DKI2 | LEG9C_HUMAN Galectin-9C OS=Homo sapiens GN=LGALS9C PE=2 SV=2 | 126 | V | 0.127727 | M | 0.151615 | -0.023888 | No Change: Both O | - |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 26 | L | 0.24967 | R | 0.336563 | -0.086893 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 46 | C | 0.328768 | R | 0.431053 | -0.102285 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 383 | E | 0.185044 | A | 0.113263 | 0.071781 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 318 | F | 0.205367 | C | 0.182847 | 0.02252 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 42 | C | 0.519192 | G | 0.599234 | -0.080042 | No Change: Both D | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 473 | S | 0.51396 | L | 0.290096 | 0.223864 | D to O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 42 | C | 0.519192 | R | 0.610581 | -0.091389 | No Change: Both D | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 110 | A | 0.177386 | D | 0.260713 | -0.083327 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 122 | I | 0.18112 | K | 0.356616 | -0.175496 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 123 | E | 0.23671 | K | 0.236533 | 1.77E-04 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 136 | R | 0.364584 | W | 0.173682 | 0.190902 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 145 | S | 0.283906 | R | 0.22251 | 0.061396 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 154 | L | 0.323884 | P | 0.458384 | -0.1345 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 200 | C | 0.293004 | R | 0.45516 | -0.162156 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 232 | L | 0.444904 | P | 0.572962 | -0.128058 | O to D | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 298 | I | 0.03974 | T | 0.078229 | -0.038489 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| O95970 | LGI1_HUMAN Leucine-rich glioma-inactivated protein 1 OS=Homo sapiens GN=LGI1 PE=1 SV=1 | 432 | V | 0.249836 | E | 0.433368 | -0.183532 | No Change: Both O | Lateral temporal lobe epilepsy autosomal dominant (ADLTE) [MIM:600512] |
| Q8N0V4 | LGI2_HUMAN Leucine-rich repeat LGI family member 2 OS=Homo sapiens GN=LGI2 PE=1 SV=1 | 444 | R | 0.215299 | Q | 0.218701 | -0.003402 | No Change: Both O | - |
| Q8N0V4 | LGI2_HUMAN Leucine-rich repeat LGI family member 2 OS=Homo sapiens GN=LGI2 PE=1 SV=1 | 452 | Q | 0.216704 | R | 0.205748 | 0.010956 | No Change: Both O | - |
| Q8N145 | LGI3_HUMAN Leucine-rich repeat LGI family member 3 OS=Homo sapiens GN=LGI3 PE=2 SV=1 | 524 | A | 0.208366 | T | 0.214053 | -0.005687 | No Change: Both O | - |
| Q99538 | LGMN_HUMAN Legumain OS=Homo sapiens GN=LGMN PE=1 SV=1 | 18 | V | 0.270419 | I | 0.25775 | 0.012669 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 215 | S | 0.421452 | G | 0.360067 | 0.061385 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 233 | N | 0.301893 | S | 0.320378 | -0.018485 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 480 | A | 0.250848 | V | 0.190302 | 0.060546 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 684 | R | 0.255436 | G | 0.284158 | -0.028722 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 709 | T | 0.088541 | M | 0.067229 | 0.021312 | No Change: Both O | - |
| Q9BXB1 | LGR4_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 4 OS=Homo sapiens GN=LGR4 PE=2 SV=2 | 844 | D | 0.190317 | G | 0.176198 | 0.014119 | No Change: Both O | - |
| O75473 | LGR5_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 5 OS=Homo sapiens GN=LGR5 PE=2 SV=1 | 383 | H | 0.243207 | R | 0.256158 | -0.012951 | No Change: Both O | - |
| O75473 | LGR5_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 5 OS=Homo sapiens GN=LGR5 PE=2 SV=1 | 666 | V | 0.335324 | A | 0.446647 | -0.111323 | No Change: Both O | - |
| Q9HBX8 | LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 OS=Homo sapiens GN=LGR6 PE=1 SV=3 | 516 | A | 0.764201 | S | 0.827672 | -0.063471 | No Change: Both D | - |
| Q9HBX8 | LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 OS=Homo sapiens GN=LGR6 PE=1 SV=3 | 725 | G | 0.532654 | C | 0.336415 | 0.196239 | D to O | A colorectal cancer sample |
| Q9HBX8 | LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 OS=Homo sapiens GN=LGR6 PE=1 SV=3 | 928 | P | 0.850205 | H | 0.80575 | 0.044455 | No Change: Both D | A colorectal cancer sample |
| Q9HBX8 | LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 OS=Homo sapiens GN=LGR6 PE=1 SV=3 | 267 | N | 0.308374 | K | 0.345343 | -0.036969 | No Change: Both O | - |
| Q9HBX8 | LGR6_HUMAN Leucine-rich repeat-containing G-protein coupled receptor 6 OS=Homo sapiens GN=LGR6 PE=1 SV=3 | 592 | V | 0.260403 | A | 0.334751 | -0.074348 | No Change: Both O | - |
| Q5TDP6 | LGSN_HUMAN Lengsin OS=Homo sapiens GN=LGSN PE=1 SV=1 | 26 | N | 0.926493 | Y | 0.867645 | 0.058848 | No Change: Both D | - |
| Q5TDP6 | LGSN_HUMAN Lengsin OS=Homo sapiens GN=LGSN PE=1 SV=1 | 46 | G | 0.884914 | E | 0.923668 | -0.038754 | No Change: Both D | - |
| Q5TDP6 | LGSN_HUMAN Lengsin OS=Homo sapiens GN=LGSN PE=1 SV=1 | 137 | N | 0.376043 | H | 0.329691 | 0.046352 | No Change: Both O | - |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 74 | Q | 0.165449 | R | 0.172065 | -0.006616 | No Change: Both O | Hypogonadism LHB-related (HGON-LHB) [MIM:152780] |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 28 | W | 0.146048 | R | 0.325707 | -0.179659 | No Change: Both O | - |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 35 | I | 0.106587 | T | 0.175454 | -0.068867 | No Change: Both O | - |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 18 | A | 0.29092 | T | 0.302277 | -0.011357 | No Change: Both O | - |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 122 | G | 0.884191 | S | 0.912295 | -0.028104 | No Change: Both D | - |
| P01229 | LSHB_HUMAN Lutropin subunit beta OS=Homo sapiens GN=LHB PE=1 SV=3 | 15 | M | 0.172 | I | 0.108325 | 0.063675 | No Change: Both O | - |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 284 | N | 0.488773 | S | 0.544793 | -0.05602 | O to D | - |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 306 | S | 0.595361 | N | 0.550372 | 0.044989 | No Change: Both D | - |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 354 | E | 0.224478 | K | 0.217857 | 0.006621 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 373 | A | 0.024433 | V | 0.017671 | 0.006762 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 398 | M | 0.045766 | T | 0.060664 | -0.014898 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 568 | A | 0.390343 | V | 0.296017 | 0.094326 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 571 | M | 0.16254 | I | 0.122729 | 0.039811 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 572 | A | 0.11666 | V | 0.077777 | 0.038883 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 577 | T | 0.048623 | I | 0.026357 | 0.022266 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 578 | D | 0.048696 | G | 0.039848 | 0.008848 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 593 | A | 0.085858 | P | 0.12035 | -0.034492 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 616 | S | 0.071783 | Y | 0.033286 | 0.038497 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 625 | I | 0.056311 | K | 0.156773 | -0.100462 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 131 | C | 0.105307 | R | 0.220767 | -0.11546 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 343 | C | 0.445948 | S | 0.675386 | -0.229438 | O to D | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 457 | L | 0.083263 | R | 0.137842 | -0.054579 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 542 | I | 0.003612 | L | 0.003804 | -1.92E-04 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 543 | C | 0.004206 | R | 0.008828 | -0.004622 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 564 | D | 0.625437 | G | 0.598987 | 0.02645 | No Change: Both D | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 575 | I | 0.050028 | L | 0.054938 | -0.00491 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 578 | D | 0.048696 | E | 0.054135 | -0.005439 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 578 | D | 0.048696 | H | 0.038035 | 0.010661 | No Change: Both O | Leydig cell tumor |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 578 | D | 0.048696 | Y | 0.021975 | 0.026721 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 581 | C | 0.050592 | R | 0.101541 | -0.050949 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 564 | D | 0.625437 | N | 0.62553 | -9.30E-05 | No Change: Both D | A breast cancer sample |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 291 | N | 0.663579 | S | 0.706304 | -0.042725 | No Change: Both D | - |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 312 | N | 0.556389 | S | 0.611115 | -0.054726 | No Change: Both D | - |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 144 | V | 0.389194 | F | 0.362875 | 0.026319 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 152 | I | 0.175838 | T | 0.272399 | -0.096561 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 368 | L | 0.00824 | P | 0.016448 | -0.008208 | No Change: Both O | Familial male precocious puberty (FMPP) [MIM:176410] |
| P22888 | LSHR_HUMAN Lutropin-choriogonadotropic hormone receptor OS=Homo sapiens GN=LHCGR PE=1 SV=4 | 502 | L | 0.106268 | P | 0.208153 | -0.101885 | No Change: Both O | Luteinizing hormone resistance (LHR) [MIM:238320] |
| Q6ZUX7 | LHPL2_HUMAN Lipoma HMGIC fusion partner-like 2 protein OS=Homo sapiens GN=LHFPL2 PE=2 SV=2 | 102 | I | 0.026102 | V | 0.031037 | -0.004935 | No Change: Both O | - |
| Q8TAF8 | TMHS_HUMAN Tetraspan membrane protein of hair cell stereocilia OS=Homo sapiens GN=LHFPL5 PE=1 SV=1 | 127 | Y | 0.028153 | C | 0.024179 | 0.003974 | No Change: Both O | Deafness autosomal recessive type 67 (DFNB67) [MIM:610265] |
| Q8TAF8 | TMHS_HUMAN Tetraspan membrane protein of hair cell stereocilia OS=Homo sapiens GN=LHFPL5 PE=1 SV=1 | 165 | T | 0.478732 | M | 0.421825 | 0.056907 | No Change: Both O | Deafness autosomal recessive type 67 (DFNB67) [MIM:610265] |
| Q8TAF8 | TMHS_HUMAN Tetraspan membrane protein of hair cell stereocilia OS=Homo sapiens GN=LHFPL5 PE=1 SV=1 | 176 | R | 0.025425 | L | 0.015356 | 0.010069 | No Change: Both O | Deafness autosomal recessive type 67 (DFNB67) [MIM:610265] |
| Q9H008 | LHPP_HUMAN Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Homo sapiens GN=LHPP PE=1 SV=2 | 94 | Q | 0.233221 | R | 0.217226 | 0.015995 | No Change: Both O | - |
| Q9UBR4 | LHX3_HUMAN LIM/homeobox protein Lhx3 OS=Homo sapiens GN=LHX3 PE=1 SV=2 | 111 | Y | 0.054607 | C | 0.056782 | -0.002175 | No Change: Both O | Pituitary hormone deficiency combined type 3 (CPHD3) [MIM:221750] |
| Q9UBR4 | LHX3_HUMAN LIM/homeobox protein Lhx3 OS=Homo sapiens GN=LHX3 PE=1 SV=2 | 210 | A | 0.674731 | V | 0.645735 | 0.028996 | No Change: Both D | Pituitary hormone deficiency combined type 3 (CPHD3) [MIM:221750] |
| Q969G2 | LHX4_HUMAN LIM/homeobox protein Lhx4 OS=Homo sapiens GN=LHX4 PE=1 SV=2 | 328 | N | 0.482346 | S | 0.563144 | -0.080798 | O to D | - |
| Q969G2 | LHX4_HUMAN LIM/homeobox protein Lhx4 OS=Homo sapiens GN=LHX4 PE=1 SV=2 | 84 | R | 0.252724 | C | 0.1827 | 0.070024 | No Change: Both O | Pituitary hormone deficiency combined type 4 (CPHD4) [MIM:262700] |
| Q969G2 | LHX4_HUMAN LIM/homeobox protein Lhx4 OS=Homo sapiens GN=LHX4 PE=1 SV=2 | 190 | L | 0.621732 | R | 0.716762 | -0.09503 | No Change: Both D | Pituitary hormone deficiency combined type 4 (CPHD4) [MIM:262700] |
| Q969G2 | LHX4_HUMAN LIM/homeobox protein Lhx4 OS=Homo sapiens GN=LHX4 PE=1 SV=2 | 210 | A | 0.623578 | P | 0.675844 | -0.052266 | No Change: Both D | Pituitary hormone deficiency combined type 4 (CPHD4) [MIM:262700] |
| Q969G2 | LHX4_HUMAN LIM/homeobox protein Lhx4 OS=Homo sapiens GN=LHX4 PE=1 SV=2 | 389 | P | 0.876034 | T | 0.817021 | 0.059013 | No Change: Both D | Pituitary hormone deficiency combined type 4 (CPHD4) [MIM:262700] |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 633 | I | 0.34725 | M | 0.459464 | -0.112214 | No Change: Both O | - |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 279 | S | 0.20293 | P | 0.176048 | 0.026882 | No Change: Both O | Stueve-Wiedemann syndrome (SWS) [MIM:601559] |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 116 | H | 0.437349 | Y | 0.329168 | 0.108181 | No Change: Both O | - |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 578 | D | 0.751072 | N | 0.75271 | -0.001638 | No Change: Both D | - |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 785 | V | 0.504634 | I | 0.500129 | 0.004505 | No Change: Both D | - |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 1068 | F | 0.852613 | L | 0.849151 | 0.003462 | No Change: Both D | A colorectal cancer sample |
| P42702 | LIFR_HUMAN Leukemia inhibitory factor receptor OS=Homo sapiens GN=LIFR PE=1 SV=1 | 664 | S | 0.284299 | L | 0.140748 | 0.143551 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 566 | E | 0.238724 | K | 0.236659 | 0.002065 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 771 | R | 0.491592 | W | 0.260743 | 0.230849 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 249 | G | 0.97211 | E | 0.978313 | -0.006203 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 267 | N | 0.717249 | S | 0.727992 | -0.010743 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 409 | R | 0.33713 | H | 0.288672 | 0.048458 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 480 | M | 0.568592 | V | 0.502398 | 0.066194 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 614 | T | 0.243018 | I | 0.162402 | 0.080616 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 24 | A | 0.9897 | V | 0.985195 | 0.004505 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 62 | R | 0.954156 | W | 0.899714 | 0.054442 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 349 | V | 0.375351 | M | 0.415712 | -0.040361 | No Change: Both O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 369 | V | 0.679098 | I | 0.607442 | 0.071656 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 677 | R | 0.523368 | L | 0.388863 | 0.134505 | D to O | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 52 | P | 0.958295 | L | 0.928653 | 0.029642 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 72 | D | 0.96825 | G | 0.968192 | 5.80E-05 | No Change: Both D | - |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 152 | K | 0.998615 | E | 0.998804 | -1.89E-04 | No Change: Both D | A colorectal cancer sample |
| P18858 | DNLI1_HUMAN DNA ligase 1 OS=Homo sapiens GN=LIG1 PE=1 SV=1 | 612 | S | 0.269061 | L | 0.144592 | 0.124469 | No Change: Both O | A colorectal cancer sample |
| P49916 | DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=LIG3 PE=1 SV=2 | 867 | R | 0.995134 | H | 0.99442 | 7.14E-04 | No Change: Both D | - |
| P49916 | DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=LIG3 PE=1 SV=2 | 224 | R | 0.936536 | W | 0.884818 | 0.051718 | No Change: Both D | - |
| P49916 | DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=LIG3 PE=1 SV=2 | 986 | P | 0.674521 | S | 0.708865 | -0.034344 | No Change: Both D | - |
| P49916 | DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=LIG3 PE=1 SV=2 | 898 | K | 0.96843 | T | 0.959461 | 0.008969 | No Change: Both D | - |
| P49916 | DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens GN=LIG3 PE=1 SV=2 | 717 | D | 0.170554 | N | 0.156972 | 0.013582 | No Change: Both O | A colorectal cancer sample |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 278 | R | 0.579773 | H | 0.599934 | -0.020161 | No Change: Both D | LIG4 syndrome (LIG4S) [MIM:606593] |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 469 | G | 0.155062 | E | 0.17227 | -0.017208 | No Change: Both O | LIG4 syndrome (LIG4S) [MIM:606593] |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 539 | L | 0.392106 | F | 0.364855 | 0.027251 | No Change: Both O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 658 | I | 0.207298 | V | 0.230996 | -0.023698 | No Change: Both O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 857 | A | 0.193733 | T | 0.204247 | -0.010514 | No Change: Both O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 231 | P | 0.400634 | S | 0.456067 | -0.055433 | No Change: Both O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 3 | A | 0.730924 | V | 0.715176 | 0.015748 | No Change: Both D | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 62 | D | 0.374409 | H | 0.348824 | 0.025585 | No Change: Both O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 9 | T | 0.624107 | I | 0.471043 | 0.153064 | D to O | - |
| P49917 | DNLI4_HUMAN DNA ligase 4 OS=Homo sapiens GN=LIG4 PE=1 SV=2 | 461 | E | 0.172532 | G | 0.149339 | 0.023193 | No Change: Both O | - |
| O75019 | LIRA1_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 1 OS=Homo sapiens GN=LILRA1 PE=2 SV=1 | 153 | S | 0.124283 | G | 0.097699 | 0.026584 | No Change: Both O | - |
| O75019 | LIRA1_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 1 OS=Homo sapiens GN=LILRA1 PE=2 SV=1 | 220 | L | 0.322669 | P | 0.490096 | -0.167427 | No Change: Both O | - |
| O75019 | LIRA1_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 1 OS=Homo sapiens GN=LILRA1 PE=2 SV=1 | 12 | R | 0.101104 | G | 0.100213 | 8.91E-04 | No Change: Both O | - |
| Q8N149 | LIRA2_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 2 OS=Homo sapiens GN=LILRA2 PE=1 SV=2 | 25 | H | 0.417343 | L | 0.306617 | 0.110726 | No Change: Both O | - |
| Q8N149 | LIRA2_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 2 OS=Homo sapiens GN=LILRA2 PE=1 SV=2 | 25 | H | 0.417343 | N | 0.415378 | 0.001965 | No Change: Both O | - |
| Q8N149 | LIRA2_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 2 OS=Homo sapiens GN=LILRA2 PE=1 SV=2 | 331 | V | 0.450626 | G | 0.557384 | -0.106758 | O to D | - |
| Q8N149 | LIRA2_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 2 OS=Homo sapiens GN=LILRA2 PE=1 SV=2 | 361 | G | 0.614654 | A | 0.57742 | 0.037234 | No Change: Both D | - |
| Q8N149 | LIRA2_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 2 OS=Homo sapiens GN=LILRA2 PE=1 SV=2 | 381 | R | 0.536371 | C | 0.400762 | 0.135609 | D to O | - |
| Q8N6C8 | LIRA3_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 3 OS=Homo sapiens GN=LILRA3 PE=1 SV=3 | 3 | P | 0.420336 | S | 0.458913 | -0.038577 | No Change: Both O | - |
| Q8N6C8 | LIRA3_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 3 OS=Homo sapiens GN=LILRA3 PE=1 SV=3 | 107 | L | 0.662527 | R | 0.713332 | -0.050805 | No Change: Both D | - |
| Q8N6C8 | LIRA3_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 3 OS=Homo sapiens GN=LILRA3 PE=1 SV=3 | 301 | Y | 0.392276 | H | 0.474981 | -0.082705 | No Change: Both O | - |
| Q8N6C8 | LIRA3_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 3 OS=Homo sapiens GN=LILRA3 PE=1 SV=3 | 307 | W | 0.543098 | C | 0.593868 | -0.05077 | No Change: Both D | - |
| P59901 | LIRA4_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 4 OS=Homo sapiens GN=LILRA4 PE=1 SV=2 | 27 | P | 0.280964 | L | 0.153676 | 0.127288 | No Change: Both O | - |
| P59901 | LIRA4_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 4 OS=Homo sapiens GN=LILRA4 PE=1 SV=2 | 155 | I | 0.320758 | V | 0.353138 | -0.03238 | No Change: Both O | - |
| Q6PI73 | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 6 OS=Homo sapiens GN=LILRA6 PE=2 SV=2 | 69 | L | 0.79273 | W | 0.72582 | 0.06691 | No Change: Both D | - |
| Q6PI73 | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 6 OS=Homo sapiens GN=LILRA6 PE=2 SV=2 | 149 | G | 0.363228 | R | 0.361255 | 0.001973 | No Change: Both O | - |
| Q6PI73 | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 6 OS=Homo sapiens GN=LILRA6 PE=2 SV=2 | 288 | P | 0.586275 | R | 0.545249 | 0.041026 | No Change: Both D | - |
| Q6PI73 | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A member 6 OS=Homo sapiens GN=LILRA6 PE=2 SV=2 | 400 | Y | 0.636387 | H | 0.717215 | -0.080828 | No Change: Both D | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 68 | L | 0.174319 | P | 0.31566 | -0.141341 | No Change: Both O | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 142 | I | 0.301103 | T | 0.432844 | -0.131741 | No Change: Both O | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 155 | S | 0.489375 | I | 0.281163 | 0.208212 | No Change: Both O | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 620 | L | 0.872483 | F | 0.836996 | 0.035487 | No Change: Both D | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 93 | A | 0.168236 | T | 0.201505 | -0.033269 | No Change: Both O | - |
| Q8NHL6 | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 1 OS=Homo sapiens GN=LILRB1 PE=1 SV=1 | 301 | H | 0.315917 | Y | 0.240861 | 0.075056 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 20 | H | 0.408875 | R | 0.43931 | -0.030435 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 161 | E | 0.644113 | D | 0.566821 | 0.077292 | No Change: Both D | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 300 | H | 0.408844 | Y | 0.338996 | 0.069848 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 306 | C | 0.617127 | W | 0.598586 | 0.018541 | No Change: Both D | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 235 | V | 0.556397 | M | 0.588939 | -0.032542 | No Change: Both D | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 324 | T | 0.259732 | R | 0.277272 | -0.01754 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 326 | F | 0.301565 | S | 0.552797 | -0.251232 | O to D | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 349 | R | 0.083555 | G | 0.086444 | -0.002889 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 322 | R | 0.213342 | H | 0.203494 | 0.009848 | No Change: Both O | - |
| Q8N423 | LIRB2_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 2 OS=Homo sapiens GN=LILRB2 PE=1 SV=4 | 403 | D | 0.652167 | N | 0.670939 | -0.018772 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 21 | V | 0.467405 | M | 0.549477 | -0.082072 | O to D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 59 | R | 0.667612 | Q | 0.69998 | -0.032368 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 69 | L | 0.800929 | W | 0.742393 | 0.058536 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 90 | E | 0.628819 | Q | 0.569165 | 0.059654 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 122 | S | 0.571384 | N | 0.487174 | 0.08421 | D to O | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 205 | W | 0.177363 | Q | 0.350908 | -0.173545 | No Change: Both O | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 400 | Y | 0.67824 | R | 0.762978 | -0.084738 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 400 | Y | 0.67824 | H | 0.757766 | -0.079526 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 400 | Y | 0.67824 | F | 0.655033 | 0.023207 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 405 | H | 0.791233 | Y | 0.734487 | 0.056746 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 539 | Q | 0.923905 | H | 0.910859 | 0.013046 | No Change: Both D | - |
| O75022 | LIRB3_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 3 OS=Homo sapiens GN=LILRB3 PE=1 SV=3 | 574 | V | 0.915566 | A | 0.939404 | -0.023838 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 223 | D | 0.915148 | G | 0.91106 | 0.004088 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 362 | K | 0.92025 | E | 0.925478 | -0.005228 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 5 | F | 0.332584 | L | 0.460451 | -0.127867 | No Change: Both O | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 18 | R | 0.446346 | S | 0.536596 | -0.09025 | O to D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 330 | C | 0.835738 | Y | 0.798771 | 0.036967 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 335 | N | 0.816453 | D | 0.846166 | -0.029713 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 414 | Q | 0.861719 | R | 0.850223 | 0.011496 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 362 | K | 0.92025 | T | 0.908578 | 0.011672 | No Change: Both D | - |
| Q8NHJ6 | LIRB4_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 4 OS=Homo sapiens GN=LILRB4 PE=1 SV=3 | 20 | H | 0.523235 | D | 0.561332 | -0.038097 | No Change: Both D | - |
| O75023 | LIRB5_HUMAN Leukocyte immunoglobulin-like receptor subfamily B member 5 OS=Homo sapiens GN=LILRB5 PE=1 SV=1 | 247 | D | 0.173314 | G | 0.166491 | 0.006823 | No Change: Both O | - |
| Q9UPQ0 | LIMC1_HUMAN LIM and calponin homology domains-containing protein 1 OS=Homo sapiens GN=LIMCH1 PE=1 SV=4 | 759 | M | 0.869335 | T | 0.875008 | -0.005673 | No Change: Both D | - |
| Q9UGP4 | LIMD1_HUMAN LIM domain-containing protein 1 OS=Homo sapiens GN=LIMD1 PE=1 SV=1 | 415 | G | 0.93745 | R | 0.939721 | -0.002271 | No Change: Both D | - |
| Q9UGP4 | LIMD1_HUMAN LIM domain-containing protein 1 OS=Homo sapiens GN=LIMD1 PE=1 SV=1 | 36 | G | 0.552347 | D | 0.580709 | -0.028362 | No Change: Both D | - |
| Q9H400 | LIME1_HUMAN Lck-interacting transmembrane adapter 1 OS=Homo sapiens GN=LIME1 PE=1 SV=1 | 211 | P | 0.804532 | L | 0.701589 | 0.102943 | No Change: Both D | - |
| P53667 | LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | 190 | G | 0.862782 | A | 0.815687 | 0.047095 | No Change: Both D | - |
| P53667 | LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | 247 | S | 0.470732 | N | 0.43898 | 0.031752 | No Change: Both O | - |
| P53667 | LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | 422 | R | 0.288191 | Q | 0.31349 | -0.025299 | No Change: Both O | - |
| P53667 | LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | 580 | F | 0.321956 | Y | 0.29438 | 0.027576 | No Change: Both O | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 35 | G | 0.159032 | S | 0.211682 | -0.05265 | No Change: Both O | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 45 | D | 0.204878 | N | 0.204245 | 6.33E-04 | No Change: Both O | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 213 | R | 0.436618 | C | 0.279644 | 0.156974 | No Change: Both O | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 296 | P | 0.990868 | R | 0.99032 | 5.48E-04 | No Change: Both D | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 418 | R | 0.268348 | C | 0.139249 | 0.129099 | No Change: Both O | - |
| P53671 | LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | 381 | R | 0.313645 | H | 0.33202 | -0.018375 | No Change: Both O | - |
| Q96GY3 | LIN37_HUMAN Protein lin-37 homolog OS=Homo sapiens GN=LIN37 PE=1 SV=1 | 172 | P | 0.989244 | S | 0.987627 | 0.001617 | No Change: Both D | - |
| Q96GY3 | LIN37_HUMAN Protein lin-37 homolog OS=Homo sapiens GN=LIN37 PE=1 SV=1 | 16 | A | 0.714597 | V | 0.661326 | 0.053271 | No Change: Both D | - |
| Q6XXX2 | CU024_HUMAN Putative uncharacterized protein encoded by LINC00114 OS=Homo sapiens GN=LINC00114 PE=5 SV=1 | 21 | S | 0.719526 | T | 0.660546 | 0.05898 | No Change: Both D | - |
| Q6XXX2 | CU024_HUMAN Putative uncharacterized protein encoded by LINC00114 OS=Homo sapiens GN=LINC00114 PE=5 SV=1 | 39 | N | 0.830198 | K | 0.850174 | -0.019976 | No Change: Both D | - |
| Q6XXX2 | CU024_HUMAN Putative uncharacterized protein encoded by LINC00114 OS=Homo sapiens GN=LINC00114 PE=5 SV=1 | 52 | A | 0.958469 | S | 0.971272 | -0.012803 | No Change: Both D | - |
| Q6XXX2 | CU024_HUMAN Putative uncharacterized protein encoded by LINC00114 OS=Homo sapiens GN=LINC00114 PE=5 SV=1 | 104 | M | 0.459484 | R | 0.504157 | -0.044673 | O to D | - |
| Q52M62 | YG053_HUMAN Putative uncharacterized protein encoded by LINC00174 OS=Homo sapiens GN=LINC00174 PE=5 SV=3 | 18 | T | 0.629238 | A | 0.643833 | -0.014595 | No Change: Both D | - |
| Q52M62 | YG053_HUMAN Putative uncharacterized protein encoded by LINC00174 OS=Homo sapiens GN=LINC00174 PE=5 SV=3 | 18 | T | 0.629238 | M | 0.62798 | 0.001258 | No Change: Both D | - |
| Q52M62 | YG053_HUMAN Putative uncharacterized protein encoded by LINC00174 OS=Homo sapiens GN=LINC00174 PE=5 SV=3 | 126 | S | 0.898597 | P | 0.911389 | -0.012792 | No Change: Both D | - |
| Q52M62 | YG053_HUMAN Putative uncharacterized protein encoded by LINC00174 OS=Homo sapiens GN=LINC00174 PE=5 SV=3 | 157 | P | 0.993497 | S | 0.992474 | 0.001023 | No Change: Both D | - |
| Q52M62 | YG053_HUMAN Putative uncharacterized protein encoded by LINC00174 OS=Homo sapiens GN=LINC00174 PE=5 SV=3 | 206 | F | 0.964143 | L | 0.97654 | -0.012397 | No Change: Both D | - |
| P0C7V0 | CF217_HUMAN Putative uncharacterized protein encoded by LINC00271 OS=Homo sapiens GN=LINC00271 PE=5 SV=1 | 112 | A | 0.981307 | E | 0.979471 | 0.001836 | No Change: Both D | - |
| Q3SY05 | CA157_HUMAN Putative uncharacterized protein encoded by LINC00303 OS=Homo sapiens GN=LINC00303 PE=5 SV=2 | 98 | V | 0.792152 | A | 0.849383 | -0.057231 | No Change: Both D | - |
| P59092 | CU094_HUMAN Putative uncharacterized protein encoded by LINC00314 OS=Homo sapiens GN=LINC00314 PE=5 SV=1 | 49 | C | 0.019968 | Y | 0.027573 | -0.007605 | No Change: Both O | - |
| Q6ZN03 | CU136_HUMAN Uncharacterized protein encoded by LINC00322 OS=Homo sapiens GN=LINC00322 PE=1 SV=1 | 116 | L | 0.721708 | F | 0.668569 | 0.053139 | No Change: Both D | - |
| Q6ZN03 | CU136_HUMAN Uncharacterized protein encoded by LINC00322 OS=Homo sapiens GN=LINC00322 PE=1 SV=1 | 149 | A | 0.813424 | T | 0.828334 | -0.01491 | No Change: Both D | - |
| Q8NAT9 | NC324_HUMAN Putative uncharacterized protein encoded by LINC00324 OS=Homo sapiens GN=LINC00324 PE=5 SV=2 | 32 | R | 0.834607 | M | 0.789504 | 0.045103 | No Change: Both D | - |
| Q6ZUF6 | NC336_HUMAN Putative uncharacterized protein encoded by LINC00336 OS=Homo sapiens GN=LINC00336 PE=2 SV=1 | 13 | S | 0.39954 | R | 0.417056 | -0.017516 | No Change: Both O | - |
| Q6ZUF6 | NC336_HUMAN Putative uncharacterized protein encoded by LINC00336 OS=Homo sapiens GN=LINC00336 PE=2 SV=1 | 73 | L | 0.993387 | P | 0.997127 | -0.00374 | No Change: Both D | - |
| Q6ZUF6 | NC336_HUMAN Putative uncharacterized protein encoded by LINC00336 OS=Homo sapiens GN=LINC00336 PE=2 SV=1 | 84 | P | 0.989148 | S | 0.988561 | 5.87E-04 | No Change: Both D | - |
| Q8IVM7 | CM029_HUMAN Putative uncharacterized protein encoded by LINC00346 OS=Homo sapiens GN=LINC00346 PE=5 SV=1 | 154 | R | 0.889996 | Q | 0.886037 | 0.003959 | No Change: Both D | - |
| Q8N8I6 | CQ055_HUMAN Putative uncharacterized protein LINC00482 OS=Homo sapiens GN=LINC00482 PE=2 SV=1 | 50 | V | 0.751273 | L | 0.742392 | 0.008881 | No Change: Both D | - |
| Q8N8I6 | CQ055_HUMAN Putative uncharacterized protein LINC00482 OS=Homo sapiens GN=LINC00482 PE=2 SV=1 | 119 | R | 0.60428 | C | 0.44045 | 0.16383 | D to O | - |
| Q8N0U6 | CF218_HUMAN Putative uncharacterized protein encoded by LINC00518 OS=Homo sapiens GN=LINC00518 PE=2 SV=1 | 106 | Y | 0.056633 | C | 0.080934 | -0.024301 | No Change: Both O | - |
| Q96FE5 | LIGO1_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 OS=Homo sapiens GN=LINGO1 PE=1 SV=2 | 183 | S | 0.166743 | F | 0.06414 | 0.102603 | No Change: Both O | - |
| Q7L985 | LIGO2_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 OS=Homo sapiens GN=LINGO2 PE=1 SV=1 | 507 | R | 0.261833 | H | 0.22109 | 0.040743 | No Change: Both O | - |
| P0C6S8 | LIGO3_HUMAN Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 OS=Homo sapiens GN=LINGO3 PE=2 SV=1 | 426 | R | 0.356674 | H | 0.284236 | 0.072438 | No Change: Both O | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 29 | I | 0.14659 | V | 0.172115 | -0.025525 | No Change: Both O | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 331 | A | 0.270271 | V | 0.202322 | 0.067949 | No Change: Both O | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 406 | V | 0.459389 | M | 0.515093 | -0.055704 | O to D | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 472 | S | 0.523942 | T | 0.462164 | 0.061778 | D to O | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 541 | I | 0.080756 | V | 0.091628 | -0.010872 | No Change: Both O | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 641 | E | 0.939255 | D | 0.941306 | -0.002051 | No Change: Both D | - |
| Q8NG48 | LINES_HUMAN Protein Lines homolog OS=Homo sapiens GN=LINS PE=2 SV=2 | 680 | R | 0.595715 | S | 0.667804 | -0.072089 | No Change: Both D | - |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 16 | T | 0.101831 | P | 0.125899 | -0.024068 | No Change: Both O | - |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 129 | H | 0.637304 | P | 0.654664 | -0.01736 | No Change: Both D | Cholesteryl ester storage disease (CESD) [MIM:278000] |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 129 | H | 0.637304 | R | 0.640836 | -0.003532 | No Change: Both D | Cholesteryl ester storage disease (CESD) [MIM:278000] |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 200 | L | 0.087836 | P | 0.187305 | -0.099469 | No Change: Both O | Cholesteryl ester storage disease (CESD) [MIM:278000] |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 200 | L | 0.087836 | P | 0.187305 | -0.099469 | No Change: Both O | Wolman disease (WOD) [MIM:278000] |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 23 | G | 0.697369 | R | 0.662602 | 0.034767 | No Change: Both D | - |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 29 | V | 0.528167 | L | 0.535558 | -0.007391 | No Change: Both D | - |
| P38571 | LICH_HUMAN Lysosomal acid lipase/cholesteryl ester hydrolase OS=Homo sapiens GN=LIPA PE=1 SV=2 | 228 | F | 0.285227 | S | 0.500094 | -0.214867 | O to D | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 95 | V | 0.069234 | M | 0.08781 | -0.018576 | No Change: Both O | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 215 | N | 0.354947 | S | 0.409241 | -0.054294 | No Change: Both O | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 289 | S | 0.206436 | F | 0.084843 | 0.121593 | No Change: Both O | Hepatic lipase deficiency (HL deficiency) [MIM:614025] |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 405 | T | 0.069028 | M | 0.053044 | 0.015984 | No Change: Both O | Hepatic lipase deficiency (HL deficiency) [MIM:614025] |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 440 | S | 0.349872 | N | 0.293932 | 0.05594 | No Change: Both O | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 342 | V | 0.277208 | I | 0.251604 | 0.025604 | No Change: Both O | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 356 | F | 0.196048 | L | 0.197295 | -0.001247 | No Change: Both O | - |
| P11150 | LIPC_HUMAN Hepatic triacylglycerol lipase OS=Homo sapiens GN=LIPC PE=1 SV=3 | 409 | D | 0.071681 | A | 0.045198 | 0.026483 | No Change: Both O | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 100 | Y | 0.957712 | H | 0.971135 | -0.013423 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 127 | Q | 0.960656 | H | 0.94332 | 0.017336 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 146 | P | 0.995764 | S | 0.99479 | 9.74E-04 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 177 | S | 0.996006 | T | 0.995397 | 6.09E-04 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 194 | A | 0.900346 | V | 0.883846 | 0.0165 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 217 | R | 0.687979 | Q | 0.749889 | -0.06191 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 497 | K | 0.477661 | N | 0.45564 | 0.022021 | No Change: Both O | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 499 | N | 0.536448 | H | 0.536456 | -8.00E-06 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 938 | R | 0.697755 | S | 0.727146 | -0.029391 | No Change: Both D | - |
| Q05469 | LIPS_HUMAN Hormone-sensitive lipase OS=Homo sapiens GN=LIPE PE=1 SV=4 | 146 | P | 0.995764 | Q | 0.995315 | 4.49E-04 | No Change: Both D | A breast cancer sample |
| P07098 | LIPG_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens GN=LIPF PE=1 SV=1 | 161 | T | 0.355576 | A | 0.322559 | 0.033017 | No Change: Both O | - |
| P07098 | LIPG_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens GN=LIPF PE=1 SV=1 | 224 | F | 0.070072 | I | 0.068116 | 0.001956 | No Change: Both O | - |
| P07098 | LIPG_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens GN=LIPF PE=1 SV=1 | 348 | P | 0.384005 | T | 0.321297 | 0.062708 | No Change: Both O | - |
| Q9Y5X9 | LIPE_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1 | 96 | G | 0.102942 | S | 0.130326 | -0.027384 | No Change: Both O | - |
| Q9Y5X9 | LIPE_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1 | 111 | T | 0.459765 | I | 0.300867 | 0.158898 | No Change: Both O | - |
| Q9Y5X9 | LIPE_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1 | 312 | R | 0.648351 | H | 0.550245 | 0.098106 | No Change: Both D | - |
| Q9Y5X9 | LIPE_HUMAN Endothelial lipase OS=Homo sapiens GN=LIPG PE=1 SV=1 | 26 | G | 0.511743 | S | 0.550811 | -0.039068 | No Change: Both D | - |
| Q8WWY8 | LIPH_HUMAN Lipase member H OS=Homo sapiens GN=LIPH PE=1 SV=1 | 108 | W | 0.109776 | R | 0.256612 | -0.146836 | No Change: Both O | Hypotrichosis type 7 (HYPT7) [MIM:604379] |
| Q8WWY8 | LIPH_HUMAN Lipase member H OS=Homo sapiens GN=LIPH PE=1 SV=1 | 108 | W | 0.109776 | R | 0.256612 | -0.146836 | No Change: Both O | Woolly hair autosomal recessive type 2 (ARWH2) [MIM:604379] |
| Q6XZB0 | LIPI_HUMAN Lipase member I OS=Homo sapiens GN=LIPI PE=1 SV=2 | 55 | C | 0.263673 | Y | 0.316786 | -0.053113 | No Change: Both O | - |
| Q6XZB0 | LIPI_HUMAN Lipase member I OS=Homo sapiens GN=LIPI PE=1 SV=2 | 364 | G | 0.213259 | E | 0.283586 | -0.070327 | No Change: Both O | - |
| Q6XZB0 | LIPI_HUMAN Lipase member I OS=Homo sapiens GN=LIPI PE=1 SV=2 | 431 | E | 0.428404 | K | 0.450862 | -0.022458 | No Change: Both O | - |
| Q6XZB0 | LIPI_HUMAN Lipase member I OS=Homo sapiens GN=LIPI PE=1 SV=2 | 444 | D | 0.426377 | E | 0.524303 | -0.097926 | O to D | - |
| Q5W064 | LIPJ_HUMAN Lipase member J OS=Homo sapiens GN=LIPJ PE=2 SV=3 | 210 | I | 0.285405 | V | 0.30464 | -0.019235 | No Change: Both O | - |
| Q5VXJ0 | LIPK_HUMAN Lipase member K OS=Homo sapiens GN=LIPK PE=2 SV=2 | 331 | M | 0.204764 | I | 0.155706 | 0.049058 | No Change: Both O | - |
| Q5VXJ0 | LIPK_HUMAN Lipase member K OS=Homo sapiens GN=LIPK PE=2 SV=2 | 391 | I | 0.086577 | T | 0.145995 | -0.059418 | No Change: Both O | - |
| Q5VYY2 | LIPM_HUMAN Lipase member M OS=Homo sapiens GN=LIPM PE=2 SV=2 | 418 | R | 0.574026 | W | 0.321114 | 0.252912 | D to O | - |
| Q5VYY2 | LIPM_HUMAN Lipase member M OS=Homo sapiens GN=LIPM PE=2 SV=2 | 274 | L | 0.062076 | S | 0.139405 | -0.077329 | No Change: Both O | - |
| Q5VXI9 | LIPN_HUMAN Lipase member N OS=Homo sapiens GN=LIPN PE=2 SV=2 | 244 | T | 0.330733 | N | 0.369286 | -0.038553 | No Change: Both O | - |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 23 | Y | 0.971288 | H | 0.975291 | -0.004003 | No Change: Both D | One EMPD primary tumor |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 49 | T | 0.913441 | M | 0.90712 | 0.006321 | No Change: Both D | Charcot-Marie-Tooth disease type 1C (CMT1C) [MIM:601098] |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 92 | I | 0.138889 | V | 0.149947 | -0.011058 | No Change: Both O | - |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 112 | G | 0.15505 | S | 0.204872 | -0.049822 | No Change: Both O | Charcot-Marie-Tooth disease type 1C (CMT1C) [MIM:601098] |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 115 | T | 0.102775 | N | 0.130228 | -0.027453 | No Change: Both O | Charcot-Marie-Tooth disease type 1C (CMT1C) [MIM:601098] |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 116 | W | 0.092365 | G | 0.238578 | -0.146213 | No Change: Both O | Charcot-Marie-Tooth disease type 1C (CMT1C) [MIM:601098] |
| Q99732 | LITAF_HUMAN Lipopolysaccharide-induced tumor necrosis factor-alpha factor OS=Homo sapiens GN=LITAF PE=1 SV=2 | 122 | L | 0.040353 | V | 0.035382 | 0.004971 | No Change: Both O | Charcot-Marie-Tooth disease type 1C (CMT1C) [MIM:601098] |
| Q8N485 | LIX1_HUMAN Protein limb expression 1 homolog OS=Homo sapiens GN=LIX1 PE=2 SV=2 | 3 | R | 0.832216 | I | 0.792227 | 0.039989 | No Change: Both D | - |
| Q15334 | L2GL1_HUMAN Lethal(2) giant larvae protein homolog 1 OS=Homo sapiens GN=LLGL1 PE=1 SV=3 | 148 | S | 0.177382 | G | 0.146661 | 0.030721 | No Change: Both O | - |
| Q15334 | L2GL1_HUMAN Lethal(2) giant larvae protein homolog 1 OS=Homo sapiens GN=LLGL1 PE=1 SV=3 | 550 | Q | 0.260395 | H | 0.246794 | 0.013601 | No Change: Both O | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 748 | R | 0.252789 | H | 0.230787 | 0.022002 | No Change: Both O | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 1001 | G | 0.682914 | S | 0.730572 | -0.047658 | No Change: Both D | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 45 | R | 0.216252 | H | 0.210768 | 0.005484 | No Change: Both O | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 479 | F | 0.624806 | L | 0.646828 | -0.022022 | No Change: Both D | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 488 | P | 0.465612 | L | 0.292942 | 0.17267 | No Change: Both O | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 490 | L | 0.4238 | P | 0.621661 | -0.197861 | O to D | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 759 | P | 0.672324 | S | 0.688731 | -0.016407 | No Change: Both D | - |
| Q6P1M3 | L2GL2_HUMAN Lethal(2) giant larvae protein homolog 2 OS=Homo sapiens GN=LLGL2 PE=1 SV=2 | 790 | P | 0.600675 | L | 0.454956 | 0.145719 | D to O | - |
| P49257 | LMAN1_HUMAN Protein ERGIC-53 OS=Homo sapiens GN=LMAN1 PE=1 SV=2 | 14 | R | 0.451966 | Q | 0.394004 | 0.057962 | No Change: Both O | - |
| P49257 | LMAN1_HUMAN Protein ERGIC-53 OS=Homo sapiens GN=LMAN1 PE=1 SV=2 | 39 | V | 0.387689 | A | 0.475388 | -0.087699 | No Change: Both O | - |
| P49257 | LMAN1_HUMAN Protein ERGIC-53 OS=Homo sapiens GN=LMAN1 PE=1 SV=2 | 410 | M | 0.63934 | L | 0.574259 | 0.065081 | No Change: Both D | - |
| P49257 | LMAN1_HUMAN Protein ERGIC-53 OS=Homo sapiens GN=LMAN1 PE=1 SV=2 | 355 | I | 0.454937 | T | 0.569953 | -0.115016 | O to D | - |
| Q9HAT1 | LMA1L_HUMAN Protein ERGIC-53-like OS=Homo sapiens GN=LMAN1L PE=2 SV=2 | 105 | R | 0.403964 | Q | 0.419946 | -0.015982 | No Change: Both O | - |
| Q9HAT1 | LMA1L_HUMAN Protein ERGIC-53-like OS=Homo sapiens GN=LMAN1L PE=2 SV=2 | 517 | R | 0.896447 | S | 0.908872 | -0.012425 | No Change: Both D | - |
| Q8WVP7 | LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens GN=LMBR1 PE=2 SV=1 | 228 | T | 0.192593 | A | 0.170885 | 0.021708 | No Change: Both O | - |
| Q9NUN5 | LMBD1_HUMAN Probable lysosomal cobalamin transporter OS=Homo sapiens GN=LMBRD1 PE=1 SV=1 | 144 | T | 0.055586 | A | 0.048375 | 0.007211 | No Change: Both O | - |
| Q9NUN5 | LMBD1_HUMAN Probable lysosomal cobalamin transporter OS=Homo sapiens GN=LMBRD1 PE=1 SV=1 | 395 | I | 0.009753 | V | 0.010159 | -4.06E-04 | No Change: Both O | - |
| Q9NUN5 | LMBD1_HUMAN Probable lysosomal cobalamin transporter OS=Homo sapiens GN=LMBRD1 PE=1 SV=1 | 469 | D | 0.540986 | E | 0.562941 | -0.021955 | No Change: Both D | - |
| Q96S06 | LMF1_HUMAN Lipase maturation factor 1 OS=Homo sapiens GN=LMF1 PE=1 SV=1 | 203 | S | 0.231879 | P | 0.222497 | 0.009382 | No Change: Both O | - |
| Q96S06 | LMF1_HUMAN Lipase maturation factor 1 OS=Homo sapiens GN=LMF1 PE=1 SV=1 | 562 | P | 0.560307 | R | 0.521595 | 0.038712 | No Change: Both D | - |
| Q96S06 | LMF1_HUMAN Lipase maturation factor 1 OS=Homo sapiens GN=LMF1 PE=1 SV=1 | 164 | V | 0.072534 | A | 0.095035 | -0.022501 | No Change: Both O | - |
| Q96S06 | LMF1_HUMAN Lipase maturation factor 1 OS=Homo sapiens GN=LMF1 PE=1 SV=1 | 364 | R | 0.339917 | Q | 0.32671 | 0.013207 | No Change: Both O | - |
| Q9BU23 | LMF2_HUMAN Lipase maturation factor 2 OS=Homo sapiens GN=LMF2 PE=1 SV=2 | 68 | P | 0.326179 | L | 0.20986 | 0.116319 | No Change: Both O | A breast cancer sample |
| Q9BU23 | LMF2_HUMAN Lipase maturation factor 2 OS=Homo sapiens GN=LMF2 PE=1 SV=2 | 479 | T | 0.248302 | M | 0.232108 | 0.016194 | No Change: Both O | - |
| Q96KR4 | LMLN_HUMAN Leishmanolysin-like peptidase OS=Homo sapiens GN=LMLN PE=2 SV=2 | 106 | E | 0.506164 | D | 0.477174 | 0.02899 | D to O | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 45 | Y | 0.550182 | C | 0.627366 | -0.077184 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 50 | R | 0.492787 | P | 0.472369 | 0.020418 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 50 | R | 0.492787 | P | 0.472369 | 0.020418 | No Change: Both O | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 63 | I | 0.534894 | S | 0.734322 | -0.199428 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 85 | L | 0.693627 | R | 0.788834 | -0.095207 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 195 | N | 0.817143 | K | 0.859533 | -0.04239 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 203 | E | 0.807752 | G | 0.724758 | 0.082994 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 222 | H | 0.812519 | Y | 0.757786 | 0.054733 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 249 | R | 0.83612 | Q | 0.849405 | -0.013285 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 294 | Q | 0.832185 | P | 0.801664 | 0.030521 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 336 | R | 0.975772 | Q | 0.975052 | 7.20E-04 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 343 | R | 0.958503 | Q | 0.958315 | 1.88E-04 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 358 | E | 0.855916 | K | 0.83993 | 0.015986 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 358 | E | 0.855916 | K | 0.83993 | 0.015986 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 371 | M | 0.774338 | K | 0.810679 | -0.036341 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 386 | R | 0.867472 | K | 0.868894 | -0.001422 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 453 | R | 0.684838 | W | 0.452743 | 0.232095 | D to O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 465 | G | 0.558311 | D | 0.60075 | -0.042439 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 469 | I | 0.4931 | T | 0.637561 | -0.144461 | O to D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 482 | R | 0.228264 | L | 0.157123 | 0.071141 | No Change: Both O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 482 | R | 0.228264 | Q | 0.244106 | -0.015842 | No Change: Both O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 482 | R | 0.228264 | W | 0.103889 | 0.124375 | No Change: Both O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 486 | K | 0.248793 | N | 0.20715 | 0.041643 | No Change: Both O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 527 | R | 0.238542 | P | 0.268005 | -0.029463 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 527 | R | 0.238542 | P | 0.268005 | -0.029463 | No Change: Both O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 528 | T | 0.270324 | K | 0.318882 | -0.048558 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 530 | L | 0.321156 | P | 0.43006 | -0.108904 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 582 | R | 0.77443 | H | 0.757373 | 0.017057 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 377 | R | 0.795691 | H | 0.753524 | 0.042167 | No Change: Both D | Limb-girdle muscular dystrophy type 1B (LGMD1B) [MIM:159001] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 133 | R | 0.777409 | L | 0.718269 | 0.05914 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 57 | A | 0.551977 | P | 0.606891 | -0.054914 | No Change: Both D | Cardiomyopathy dilated with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 133 | R | 0.777409 | P | 0.760933 | 0.016476 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 140 | L | 0.771443 | R | 0.832214 | -0.060771 | No Change: Both D | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 145 | E | 0.794146 | K | 0.792115 | 0.002031 | No Change: Both D | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 161 | E | 0.791807 | K | 0.785748 | 0.006059 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 298 | R | 0.86004 | C | 0.784693 | 0.075347 | No Change: Both D | Charcot-Marie-Tooth disease type 2B1 (CMT2B1) [MIM:605588] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 471 | R | 0.490642 | C | 0.318873 | 0.171769 | No Change: Both O | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 527 | R | 0.238542 | C | 0.143079 | 0.095463 | No Change: Both O | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 608 | G | 0.926029 | S | 0.942546 | -0.016517 | No Change: Both D | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 527 | R | 0.238542 | H | 0.233518 | 0.005024 | No Change: Both O | Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 60 | R | 0.533482 | G | 0.491082 | 0.0424 | D to O | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 60 | R | 0.533482 | G | 0.491082 | 0.0424 | D to O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 143 | S | 0.779412 | F | 0.603589 | 0.175823 | No Change: Both D | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 529 | A | 0.291988 | V | 0.237037 | 0.054951 | No Change: Both O | Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 542 | K | 0.382867 | N | 0.356417 | 0.02645 | No Change: Both O | Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 10 | T | 0.980664 | I | 0.964446 | 0.016218 | No Change: Both D | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 25 | R | 0.83756 | G | 0.792786 | 0.044774 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 25 | R | 0.83756 | P | 0.844041 | -0.006481 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 28 | R | 0.789054 | W | 0.589398 | 0.199656 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 33 | E | 0.744321 | D | 0.729711 | 0.01461 | No Change: Both D | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 33 | E | 0.744321 | G | 0.681118 | 0.063203 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 35 | L | 0.719001 | V | 0.691623 | 0.027378 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 43 | A | 0.554428 | T | 0.607194 | -0.052766 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 50 | R | 0.492787 | S | 0.513588 | -0.020801 | O to D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 62 | R | 0.513579 | G | 0.479971 | 0.033608 | D to O | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 63 | I | 0.534894 | N | 0.682793 | -0.147899 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 65 | E | 0.585937 | G | 0.506744 | 0.079193 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 89 | R | 0.725679 | L | 0.631707 | 0.093972 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 97 | K | 0.775113 | E | 0.787584 | -0.012471 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 140 | L | 0.771443 | P | 0.813032 | -0.041589 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 143 | S | 0.779412 | P | 0.74448 | 0.034932 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 150 | T | 0.790398 | P | 0.80432 | -0.013922 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 190 | R | 0.780909 | Q | 0.791918 | -0.011009 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 190 | R | 0.780909 | W | 0.538857 | 0.242052 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 192 | D | 0.789717 | G | 0.748027 | 0.04169 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 203 | E | 0.807752 | K | 0.799072 | 0.00868 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 215 | L | 0.819178 | P | 0.857745 | -0.038567 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 222 | H | 0.812519 | P | 0.845054 | -0.032535 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 230 | D | 0.799363 | N | 0.790217 | 0.009146 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 232 | G | 0.806346 | E | 0.883012 | -0.076666 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 248 | L | 0.829657 | P | 0.871412 | -0.041755 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 260 | K | 0.850761 | N | 0.825322 | 0.025439 | No Change: Both D | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 267 | Y | 0.822609 | C | 0.837768 | -0.015159 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 317 | E | 0.952982 | K | 0.953236 | -2.54E-04 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 349 | R | 0.919871 | L | 0.879782 | 0.040089 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 377 | R | 0.795691 | L | 0.733346 | 0.062345 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 377 | R | 0.795691 | L | 0.733346 | 0.062345 | No Change: Both D | Limb-girdle muscular dystrophy type 1B (LGMD1B) [MIM:159001] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 399 | R | 0.982356 | C | 0.970989 | 0.011367 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 435 | R | 0.922328 | C | 0.878921 | 0.043407 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 446 | D | 0.821089 | V | 0.7706 | 0.050489 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 456 | N | 0.701981 | I | 0.557134 | 0.144847 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 456 | N | 0.701981 | K | 0.729292 | -0.027311 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 481 | Y | 0.234803 | H | 0.343443 | -0.10864 | No Change: Both O | Limb-girdle muscular dystrophy type 1B (LGMD1B) [MIM:159001] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 520 | W | 0.166487 | S | 0.401652 | -0.235165 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 528 | T | 0.270324 | R | 0.284699 | -0.014375 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 541 | R | 0.413931 | C | 0.266208 | 0.147723 | No Change: Both O | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 541 | R | 0.413931 | H | 0.388486 | 0.025445 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 541 | R | 0.413931 | S | 0.476417 | -0.062486 | No Change: Both O | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 541 | R | 0.413931 | S | 0.476417 | -0.062486 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 573 | S | 0.836607 | L | 0.742231 | 0.094376 | No Change: Both D | Cardiomyopathy dilated type 1A (CMD1A) [MIM:115200] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 573 | S | 0.836607 | L | 0.742231 | 0.094376 | No Change: Both D | Familial partial lipodystrophy type 2 (FPLD2) [MIM:151660] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 573 | S | 0.836607 | L | 0.742231 | 0.094376 | No Change: Both D | Mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 578 | E | 0.811851 | V | 0.717617 | 0.094234 | No Change: Both D | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 624 | R | 0.924849 | H | 0.892808 | 0.032041 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 644 | R | 0.807292 | C | 0.73394 | 0.073352 | No Change: Both D | - |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 39 | N | 0.632573 | S | 0.695684 | -0.063111 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 39 | N | 0.632573 | S | 0.695684 | -0.063111 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 249 | R | 0.83612 | W | 0.646603 | 0.189517 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 249 | R | 0.83612 | W | 0.646603 | 0.189517 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 302 | L | 0.89591 | P | 0.916131 | -0.020221 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 380 | L | 0.823473 | S | 0.868478 | -0.045005 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 453 | R | 0.684838 | P | 0.681278 | 0.00356 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 455 | R | 0.701183 | P | 0.699048 | 0.002135 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 456 | N | 0.701981 | D | 0.715636 | -0.013655 | No Change: Both D | Muscular dystrophy congenital LMNA-related (MDCL) [MIM:613205] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 59 | L | 0.530876 | R | 0.664605 | -0.133729 | No Change: Both D | Cardiomyopathy dilated with hypergonadotropic hypogonadism (CMDHH) [MIM:212112] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 189 | R | 0.78139 | P | 0.759498 | 0.021892 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 206 | F | 0.815983 | L | 0.861646 | -0.045663 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 268 | S | 0.831739 | P | 0.799781 | 0.031958 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 271 | L | 0.810668 | P | 0.857145 | -0.046477 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 295 | S | 0.83545 | P | 0.792821 | 0.042629 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 303 | S | 0.896608 | P | 0.867145 | 0.029463 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 361 | E | 0.805096 | K | 0.78596 | 0.019136 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 449 | G | 0.774908 | D | 0.803521 | -0.028613 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 454 | L | 0.683654 | P | 0.800615 | -0.116961 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 461 | D | 0.694648 | Y | 0.565637 | 0.129011 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 467 | W | 0.507018 | R | 0.715204 | -0.208186 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 541 | R | 0.413931 | P | 0.425065 | -0.011134 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P02545 | LMNA_HUMAN Prelamin-A/C OS=Homo sapiens GN=LMNA PE=1 SV=1 | 602 | G | 0.901517 | S | 0.921725 | -0.020208 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350] |
| P20700 | LMNB1_HUMAN Lamin-B1 OS=Homo sapiens GN=LMNB1 PE=1 SV=2 | 501 | A | 0.166845 | V | 0.11817 | 0.048675 | No Change: Both O | - |
| Q03252 | LMNB2_HUMAN Lamin-B2 OS=Homo sapiens GN=LMNB2 PE=1 SV=3 | 215 | R | 0.949472 | Q | 0.945126 | 0.004346 | No Change: Both D | Partial acquired lipodystrophy (APLD) [MIM:608709] |
| Q03252 | LMNB2_HUMAN Lamin-B2 OS=Homo sapiens GN=LMNB2 PE=1 SV=3 | 407 | A | 0.990311 | T | 0.992741 | -0.00243 | No Change: Both D | Partial acquired lipodystrophy (APLD) [MIM:608709] |
| Q03252 | LMNB2_HUMAN Lamin-B2 OS=Homo sapiens GN=LMNB2 PE=1 SV=3 | 216 | R | 0.947854 | W | 0.851239 | 0.096615 | No Change: Both D | A colorectal cancer sample |
| Q8WWI1 | LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens GN=LMO7 PE=1 SV=3 | 354 | T | 0.527016 | A | 0.493348 | 0.033668 | D to O | A colorectal cancer sample |
| Q8WWI1 | LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens GN=LMO7 PE=1 SV=3 | 785 | L | 0.98003 | M | 0.987021 | -0.006991 | No Change: Both D | A colorectal cancer sample |
| Q8WWI1 | LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens GN=LMO7 PE=1 SV=3 | 1547 | P | 0.939334 | Q | 0.930807 | 0.008527 | No Change: Both D | - |
| P29536 | LMOD1_HUMAN Leiomodin-1 OS=Homo sapiens GN=LMOD1 PE=1 SV=3 | 295 | T | 0.995546 | M | 0.994515 | 0.001031 | No Change: Both D | - |
| Q0VAK6 | LMOD3_HUMAN Leiomodin-3 OS=Homo sapiens GN=LMOD3 PE=2 SV=1 | 560 | A | 0.820094 | V | 0.822373 | -0.002279 | No Change: Both D | - |
| Q0VAK6 | LMOD3_HUMAN Leiomodin-3 OS=Homo sapiens GN=LMOD3 PE=2 SV=1 | 438 | K | 0.936389 | M | 0.933633 | 0.002756 | No Change: Both D | - |
| Q0VAK6 | LMOD3_HUMAN Leiomodin-3 OS=Homo sapiens GN=LMOD3 PE=2 SV=1 | 263 | I | 0.646238 | T | 0.735249 | -0.089011 | No Change: Both D | - |
| Q0VAK6 | LMOD3_HUMAN Leiomodin-3 OS=Homo sapiens GN=LMOD3 PE=2 SV=1 | 83 | R | 0.58418 | H | 0.545345 | 0.038835 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 30 | P | 0.643493 | A | 0.582218 | 0.061275 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 780 | L | 0.716189 | M | 0.757596 | -0.041407 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 1061 | D | 0.881753 | N | 0.868602 | 0.013151 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 484 | D | 0.493802 | H | 0.472066 | 0.021736 | No Change: Both O | A lung large cell carcinoma sample |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 595 | V | 0.926712 | I | 0.916856 | 0.009856 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 624 | V | 0.888682 | M | 0.914495 | -0.025813 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 693 | I | 0.688135 | T | 0.776309 | -0.088174 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 849 | V | 0.683684 | F | 0.632532 | 0.051152 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 862 | A | 0.666094 | T | 0.730245 | -0.064151 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 916 | S | 0.784071 | R | 0.751043 | 0.033028 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 1220 | D | 0.758541 | N | 0.737655 | 0.020886 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 1341 | A | 0.652379 | G | 0.661763 | -0.009384 | No Change: Both D | - |
| Q8IWU2 | LMTK2_HUMAN Serine/threonine-protein kinase LMTK2 OS=Homo sapiens GN=LMTK2 PE=1 SV=2 | 1401 | S | 0.922111 | N | 0.894168 | 0.027943 | No Change: Both D | - |
| Q96Q04 | LMTK3_HUMAN Serine/threonine-protein kinase LMTK3 OS=Homo sapiens GN=LMTK3 PE=2 SV=2 | 929 | L | 0.69941 | V | 0.698755 | 6.55E-04 | No Change: Both D | - |
| Q96Q04 | LMTK3_HUMAN Serine/threonine-protein kinase LMTK3 OS=Homo sapiens GN=LMTK3 PE=2 SV=2 | 900 | V | 0.905594 | L | 0.912749 | -0.007155 | No Change: Both D | - |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 95 | C | 0.236945 | F | 0.238664 | -0.001719 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 142 | C | 0.754868 | W | 0.6231 | 0.131768 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 200 | R | 0.965003 | Q | 0.962254 | 0.002749 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 213 | A | 0.790046 | P | 0.834594 | -0.044548 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 218 | S | 0.718685 | P | 0.711138 | 0.007547 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 226 | R | 0.585369 | P | 0.590446 | -0.005077 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 230 | A | 0.526798 | V | 0.470384 | 0.056414 | D to O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 246 | N | 0.673679 | K | 0.743027 | -0.069348 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 54 | H | 0.375 | N | 0.419177 | -0.044177 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 58 | L | 0.264784 | W | 0.200549 | 0.064235 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 60 | C | 0.222355 | F | 0.185794 | 0.036561 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 60 | C | 0.222355 | W | 0.148951 | 0.073404 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 80 | C | 0.289099 | W | 0.208367 | 0.080732 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 95 | C | 0.236945 | Y | 0.258006 | -0.021061 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 114 | H | 0.054607 | Y | 0.041061 | 0.013546 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 117 | C | 0.054898 | Y | 0.033331 | 0.021567 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 243 | W | 0.606824 | C | 0.726058 | -0.119234 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 36 | C | 0.404196 | R | 0.506077 | -0.101881 | O to D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 36 | C | 0.404196 | S | 0.539256 | -0.13506 | O to D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 54 | H | 0.375 | Q | 0.450153 | -0.075153 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 54 | H | 0.375 | Y | 0.271474 | 0.103526 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 57 | C | 0.310016 | R | 0.414684 | -0.104668 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 60 | C | 0.222355 | G | 0.294476 | -0.072121 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 60 | C | 0.222355 | Y | 0.195879 | 0.026476 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 63 | C | 0.259847 | R | 0.347 | -0.087153 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 83 | D | 0.253356 | G | 0.221215 | 0.032141 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 120 | C | 0.123212 | S | 0.138364 | -0.015152 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 123 | C | 0.151307 | F | 0.116538 | 0.034769 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 123 | C | 0.151307 | Y | 0.109921 | 0.041386 | No Change: Both O | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 229 | L | 0.531348 | P | 0.668164 | -0.136816 | No Change: Both D | Nail-patella syndrome (NPS) [MIM:161200] |
| O60663 | LMX1B_HUMAN LIM homeobox transcription factor 1-beta OS=Homo sapiens GN=LMX1B PE=1 SV=2 | 52 | S | 0.393245 | F | 0.203158 | 0.190087 | No Change: Both O | - |
| Q9UIQ6 | LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3 | 763 | A | 0.391834 | T | 0.431989 | -0.040155 | No Change: Both O | - |
| Q9UIQ6 | LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3 | 86 | S | 0.790008 | P | 0.764166 | 0.025842 | No Change: Both D | - |
| Q9UIQ6 | LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3 | 963 | I | 0.156623 | V | 0.177072 | -0.020449 | No Change: Both O | - |
| Q9UIQ6 | LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3 | 594 | N | 0.318932 | I | 0.159254 | 0.159678 | No Change: Both O | - |
| Q9UIQ6 | LCAP_HUMAN Leucyl-cystinyl aminopeptidase OS=Homo sapiens GN=LNPEP PE=1 SV=3 | 913 | S | 0.329976 | T | 0.248116 | 0.08186 | No Change: Both O | - |
| Q8N448 | LNX2_HUMAN Ligand of Numb protein X 2 OS=Homo sapiens GN=LNX2 PE=1 SV=1 | 198 | S | 0.774987 | P | 0.778182 | -0.003195 | No Change: Both D | - |
| Q969J3 | L12R1_HUMAN Loss of heterozygosity 12 chromosomal region 1 protein OS=Homo sapiens GN=LOH12CR1 PE=1 SV=1 | 41 | S | 0.609313 | C | 0.435725 | 0.173588 | D to O | - |
| Q969J3 | L12R1_HUMAN Loss of heterozygosity 12 chromosomal region 1 protein OS=Homo sapiens GN=LOH12CR1 PE=1 SV=1 | 191 | D | 0.912359 | N | 0.904383 | 0.007976 | No Change: Both D | - |
| P36776 | LONM_HUMAN Lon protease homolog mitochondrial OS=Homo sapiens GN=LONP1 PE=1 SV=2 | 87 | E | 0.951646 | D | 0.942364 | 0.009282 | No Change: Both D | - |
| P36776 | LONM_HUMAN Lon protease homolog mitochondrial OS=Homo sapiens GN=LONP1 PE=1 SV=2 | 241 | R | 0.989846 | Q | 0.987354 | 0.002492 | No Change: Both D | - |
| Q17RB8 | LONF1_HUMAN LON peptidase N-terminal domain and RING finger protein 1 OS=Homo sapiens GN=LONRF1 PE=2 SV=2 | 265 | I | 0.201826 | L | 0.242646 | -0.04082 | No Change: Both O | - |
| Q1L5Z9 | LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens GN=LONRF2 PE=2 SV=3 | 183 | L | 0.628877 | P | 0.749243 | -0.120366 | No Change: Both D | - |
| Q1L5Z9 | LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens GN=LONRF2 PE=2 SV=3 | 562 | R | 0.182497 | W | 0.062041 | 0.120456 | No Change: Both O | A colorectal cancer sample |
| Q1L5Z9 | LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens GN=LONRF2 PE=2 SV=3 | 426 | L | 0.854708 | P | 0.911688 | -0.05698 | No Change: Both D | - |
| Q496Y0 | LONF3_HUMAN LON peptidase N-terminal domain and RING finger protein 3 OS=Homo sapiens GN=LONRF3 PE=1 SV=1 | 122 | A | 0.880293 | G | 0.882326 | -0.002033 | No Change: Both D | A breast cancer sample |
| P23490 | LORI_HUMAN Loricrin OS=Homo sapiens GN=LOR PE=1 SV=2 | 29 | S | 0.993476 | G | 0.99347 | 6.00E-06 | No Change: Both D | - |
| P23490 | LORI_HUMAN Loricrin OS=Homo sapiens GN=LOR PE=1 SV=2 | 285 | S | 0.990719 | F | 0.976252 | 0.014467 | No Change: Both D | - |
| P28300 | LYOX_HUMAN Protein-lysine 6-oxidase OS=Homo sapiens GN=LOX PE=1 SV=2 | 158 | R | 0.791704 | Q | 0.778305 | 0.013399 | No Change: Both D | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 85 | V | 0.470693 | I | 0.406901 | 0.063792 | No Change: Both O | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 348 | G | 0.594177 | C | 0.440892 | 0.153285 | D to O | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 354 | G | 0.412386 | C | 0.266975 | 0.145411 | No Change: Both O | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 398 | D | 0.548361 | G | 0.520442 | 0.027919 | No Change: Both D | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 547 | V | 0.304651 | M | 0.350894 | -0.046243 | No Change: Both O | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 1105 | T | 0.459532 | M | 0.435913 | 0.023619 | No Change: Both O | - |
| Q8IVV2 | LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens GN=LOXHD1 PE=2 SV=3 | 1345 | E | 0.260876 | G | 0.231922 | 0.028954 | No Change: Both O | - |
| Q08397 | LOXL1_HUMAN Lysyl oxidase homolog 1 OS=Homo sapiens GN=LOXL1 PE=2 SV=2 | 153 | G | 0.91972 | D | 0.921866 | -0.002146 | No Change: Both D | - |
| Q08397 | LOXL1_HUMAN Lysyl oxidase homolog 1 OS=Homo sapiens GN=LOXL1 PE=2 SV=2 | 141 | R | 0.794094 | L | 0.649449 | 0.144645 | No Change: Both D | - |
| Q9Y4K0 | LOXL2_HUMAN Lysyl oxidase homolog 2 OS=Homo sapiens GN=LOXL2 PE=1 SV=1 | 570 | M | 0.358569 | L | 0.27876 | 0.079809 | No Change: Both O | - |
| Q9Y4K0 | LOXL2_HUMAN Lysyl oxidase homolog 2 OS=Homo sapiens GN=LOXL2 PE=1 SV=1 | 308 | S | 0.591224 | R | 0.558452 | 0.032772 | No Change: Both D | - |
| Q9Y4K0 | LOXL2_HUMAN Lysyl oxidase homolog 2 OS=Homo sapiens GN=LOXL2 PE=1 SV=1 | 359 | S | 0.128405 | W | 0.038053 | 0.090352 | No Change: Both O | - |
| P58215 | LOXL3_HUMAN Lysyl oxidase homolog 3 OS=Homo sapiens GN=LOXL3 PE=2 SV=1 | 615 | I | 0.24707 | F | 0.249617 | -0.002547 | No Change: Both O | - |
| Q96JB6 | LOXL4_HUMAN Lysyl oxidase homolog 4 OS=Homo sapiens GN=LOXL4 PE=1 SV=1 | 154 | R | 0.554198 | Q | 0.553456 | 7.42E-04 | No Change: Both D | - |
| Q96JB6 | LOXL4_HUMAN Lysyl oxidase homolog 4 OS=Homo sapiens GN=LOXL4 PE=1 SV=1 | 405 | D | 0.541636 | A | 0.505618 | 0.036018 | No Change: Both D | - |
| Q96JB6 | LOXL4_HUMAN Lysyl oxidase homolog 4 OS=Homo sapiens GN=LOXL4 PE=1 SV=1 | 372 | P | 0.354146 | T | 0.297872 | 0.056274 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4193 | W | 0.220226 | R | 0.430134 | -0.209908 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 3498 | R | 0.263908 | Q | 0.260527 | 0.003381 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 3866 | L | 0.614679 | V | 0.624193 | -0.009514 | No Change: Both D | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 3880 | L | 0.873772 | V | 0.880902 | -0.00713 | No Change: Both D | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 3907 | T | 0.659985 | P | 0.689562 | -0.029577 | No Change: Both D | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 3929 | R | 0.280115 | Q | 0.270006 | 0.010109 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4106 | M | 0.75923 | T | 0.809524 | -0.050294 | No Change: Both D | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4187 | M | 0.231881 | T | 0.276628 | -0.044747 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4330 | G | 0.325176 | A | 0.265707 | 0.059469 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4399 | I | 0.363327 | M | 0.448913 | -0.085586 | No Change: Both O | - |
| P08519 | APOA_HUMAN Apolipoprotein(a) OS=Homo sapiens GN=LPA PE=1 SV=1 | 4524 | R | 0.301359 | C | 0.175477 | 0.125882 | No Change: Both O | - |
| Q16609 | LPAL2_HUMAN Putative apolipoprotein(a)-like protein 2 OS=Homo sapiens GN=LPAL2 PE=5 SV=1 | 91 | T | 0.211319 | M | 0.165122 | 0.046197 | No Change: Both O | - |
| Q92633 | LPAR1_HUMAN Lysophosphatidic acid receptor 1 OS=Homo sapiens GN=LPAR1 PE=1 SV=3 | 77 | N | 0.052576 | S | 0.063817 | -0.011241 | No Change: Both O | - |
| Q9UBY5 | LPAR3_HUMAN Lysophosphatidic acid receptor 3 OS=Homo sapiens GN=LPAR3 PE=2 SV=1 | 231 | R | 0.71073 | Q | 0.71119 | -4.60E-04 | No Change: Both D | - |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 137 | C | 0.049558 | W | 0.043699 | 0.005859 | No Change: Both O | - |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 33 | I | 0.02615 | V | 0.032108 | -0.005958 | No Change: Both O | - |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 63 | D | 0.056596 | V | 0.02774 | 0.028856 | No Change: Both O | Woolly hair autosomal recessive type 1 with or without hypotrichosis (ARWH1) [MIM:278150] |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 188 | I | 0.016334 | F | 0.016247 | 8.70E-05 | No Change: Both O | Woolly hair autosomal recessive type 1 with or without hypotrichosis (ARWH1) [MIM:278150] |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 189 | E | 0.015103 | K | 0.015282 | -1.79E-04 | No Change: Both O | Woolly hair autosomal recessive type 1 with or without hypotrichosis (ARWH1) [MIM:278150] |
| P43657 | LPAR6_HUMAN Lysophosphatidic acid receptor 6 OS=Homo sapiens GN=LPAR6 PE=1 SV=3 | 307 | W | 0.402853 | C | 0.439975 | -0.037122 | No Change: Both O | - |
| Q7L5N7 | PCAT2_HUMAN Lysophosphatidylcholine acyltransferase 2 OS=Homo sapiens GN=LPCAT2 PE=1 SV=1 | 163 | M | 0.353703 | I | 0.277418 | 0.076285 | No Change: Both O | - |
| Q6P1A2 | MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens GN=LPCAT3 PE=1 SV=1 | 63 | F | 0.075366 | L | 0.090487 | -0.015121 | No Change: Both O | - |
| Q6P1A2 | MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens GN=LPCAT3 PE=1 SV=1 | 217 | I | 0.209106 | T | 0.321918 | -0.112812 | No Change: Both O | - |
| O94910 | LPHN1_HUMAN Latrophilin-1 OS=Homo sapiens GN=LPHN1 PE=1 SV=1 | 595 | E | 0.535153 | Q | 0.493614 | 0.041539 | D to O | - |
| Q9HAR2 | LPHN3_HUMAN Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 | 465 | R | 0.977742 | Q | 0.975088 | 0.002654 | No Change: Both D | - |
| Q9HAR2 | LPHN3_HUMAN Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 | 247 | A | 0.348513 | S | 0.468115 | -0.119602 | No Change: Both O | - |
| Q9HAR2 | LPHN3_HUMAN Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 | 770 | T | 0.195511 | M | 0.169493 | 0.026018 | No Change: Both O | - |
| Q9HAR2 | LPHN3_HUMAN Latrophilin-3 OS=Homo sapiens GN=LPHN3 PE=1 SV=2 | 915 | L | 0.038356 | V | 0.036497 | 0.001859 | No Change: Both O | - |
| Q14693 | LPIN1_HUMAN Phosphatidate phosphatase LPIN1 OS=Homo sapiens GN=LPIN1 PE=2 SV=2 | 610 | P | 0.894012 | S | 0.899984 | -0.005972 | No Change: Both D | - |
| Q14693 | LPIN1_HUMAN Phosphatidate phosphatase LPIN1 OS=Homo sapiens GN=LPIN1 PE=2 SV=2 | 56 | G | 0.326744 | E | 0.376432 | -0.049688 | No Change: Both O | A colorectal cancer sample |
| Q14693 | LPIN1_HUMAN Phosphatidate phosphatase LPIN1 OS=Homo sapiens GN=LPIN1 PE=2 SV=2 | 637 | S | 0.630087 | T | 0.562121 | 0.067966 | No Change: Both D | - |
| Q92539 | LPIN2_HUMAN Phosphatidate phosphatase LPIN2 OS=Homo sapiens GN=LPIN2 PE=1 SV=1 | 734 | S | 0.082194 | L | 0.036558 | 0.045636 | No Change: Both O | Majeed syndrome (MAJEEDS) [MIM:609628] |
| Q9BQK8 | LPIN3_HUMAN Phosphatidate phosphatase LPIN3 OS=Homo sapiens GN=LPIN3 PE=1 SV=3 | 679 | Q | 0.167132 | H | 0.16641 | 7.22E-04 | No Change: Both O | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 102 | R | 0.386206 | S | 0.479084 | -0.092878 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 113 | W | 0.108844 | G | 0.266964 | -0.15812 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 113 | W | 0.108844 | R | 0.268693 | -0.159849 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 163 | H | 0.318769 | R | 0.311286 | 0.007483 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 169 | G | 0.403016 | E | 0.434423 | -0.031407 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 181 | G | 0.345604 | S | 0.388026 | -0.042422 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 183 | D | 0.365944 | G | 0.359632 | 0.006312 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 183 | D | 0.365944 | N | 0.370596 | -0.004652 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 184 | P | 0.370069 | R | 0.327202 | 0.042867 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 185 | A | 0.408764 | T | 0.442588 | -0.033824 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 199 | S | 0.555227 | C | 0.370248 | 0.184979 | D to O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 203 | A | 0.469645 | T | 0.504995 | -0.03535 | O to D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 207 | D | 0.288531 | E | 0.281196 | 0.007335 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 210 | H | 0.269209 | Q | 0.311749 | -0.04254 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 215 | G | 0.496657 | E | 0.51629 | -0.019633 | O to D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 220 | S | 0.522426 | R | 0.473751 | 0.048675 | D to O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 221 | I | 0.530263 | T | 0.630419 | -0.100156 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 222 | G | 0.507318 | E | 0.523082 | -0.015764 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 231 | D | 0.262629 | E | 0.284971 | -0.022342 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 232 | I | 0.27682 | S | 0.484519 | -0.207699 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 234 | P | 0.318027 | L | 0.167196 | 0.150831 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 243 | C | 0.219105 | S | 0.382428 | -0.163323 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 270 | R | 0.297343 | H | 0.304063 | -0.00672 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 271 | S | 0.278647 | T | 0.189411 | 0.089236 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 277 | D | 0.335126 | N | 0.337698 | -0.002572 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 278 | S | 0.373928 | C | 0.219547 | 0.154381 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 286 | S | 0.678184 | G | 0.611019 | 0.067165 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 286 | S | 0.678184 | R | 0.638049 | 0.040135 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 318 | N | 0.495226 | S | 0.542246 | -0.04702 | O to D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 328 | M | 0.595583 | T | 0.614228 | -0.018645 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 330 | L | 0.58506 | P | 0.696163 | -0.111103 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 361 | A | 0.375915 | T | 0.433004 | -0.057089 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 392 | L | 0.096412 | V | 0.104872 | -0.00846 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 437 | E | 0.409243 | K | 0.441875 | -0.032632 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 437 | E | 0.409243 | V | 0.258223 | 0.15102 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 36 | D | 0.294822 | N | 0.253658 | 0.041164 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 288 | A | 0.678317 | T | 0.684121 | -0.005804 | No Change: Both D | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 370 | V | 0.292617 | M | 0.355257 | -0.06264 | No Change: Both O | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 379 | T | 0.3789 | A | 0.338979 | 0.039921 | No Change: Both O | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 427 | A | 0.189853 | T | 0.206549 | -0.016696 | No Change: Both O | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 71 | H | 0.402849 | Q | 0.402594 | 2.55E-04 | No Change: Both O | - |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 70 | N | 0.378602 | S | 0.451089 | -0.072487 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 96 | V | 0.116957 | L | 0.118873 | -0.001916 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 98 | A | 0.191951 | T | 0.201602 | -0.009651 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 128 | T | 0.29602 | A | 0.283609 | 0.012411 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 132 | G | 0.176283 | R | 0.167959 | 0.008324 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 181 | G | 0.345604 | V | 0.222974 | 0.12263 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 183 | D | 0.365944 | H | 0.324886 | 0.041058 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 186 | G | 0.432951 | E | 0.489093 | -0.056142 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 190 | E | 0.496235 | G | 0.459737 | 0.036498 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 201 | D | 0.540714 | V | 0.397069 | 0.143645 | D to O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 208 | V | 0.274658 | I | 0.249218 | 0.02544 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 210 | H | 0.269209 | D | 0.352442 | -0.083233 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 215 | G | 0.496657 | R | 0.49595 | 7.07E-04 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 225 | K | 0.376943 | R | 0.35593 | 0.021013 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 227 | V | 0.295863 | A | 0.353596 | -0.057733 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 252 | I | 0.169249 | T | 0.26152 | -0.092271 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 266 | C | 0.330791 | W | 0.292576 | 0.038215 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 270 | R | 0.297343 | C | 0.205449 | 0.091894 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 279 | L | 0.430982 | R | 0.539198 | -0.108216 | O to D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 279 | L | 0.430982 | V | 0.399031 | 0.031951 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 289 | Y | 0.67226 | H | 0.772181 | -0.099921 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 297 | F | 0.73731 | L | 0.784511 | -0.047201 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 303 | L | 0.585692 | F | 0.551301 | 0.034391 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 305 | C | 0.659372 | R | 0.739145 | -0.079773 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 310 | C | 0.682007 | Y | 0.619668 | 0.062339 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 313 | L | 0.587441 | P | 0.714112 | -0.126671 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 325 | S | 0.59939 | R | 0.563641 | 0.035749 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 328 | M | 0.595583 | R | 0.640785 | -0.045202 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 330 | L | 0.58506 | F | 0.57567 | 0.00939 | No Change: Both D | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 365 | S | 0.216428 | F | 0.09516 | 0.121268 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 445 | C | 0.341625 | Y | 0.326411 | 0.015214 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P06858 | LIPL_HUMAN Lipoprotein lipase OS=Homo sapiens GN=LPL PE=1 SV=1 | 448 | E | 0.439479 | K | 0.493285 | -0.053806 | No Change: Both O | Lipoprotein lipase deficiency (LPL deficiency) [MIM:238600] |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 105 | T | 0.544809 | I | 0.375761 | 0.169048 | D to O | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 244 | A | 0.479938 | T | 0.509237 | -0.029299 | O to D | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 414 | R | 0.227397 | Q | 0.257276 | -0.029879 | No Change: Both O | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 421 | V | 0.034664 | M | 0.049265 | -0.014601 | No Change: Both O | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 514 | R | 0.297526 | Q | 0.304393 | -0.006867 | No Change: Both O | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 614 | I | 0.080088 | T | 0.129632 | -0.049544 | No Change: Both O | - |
| P22079 | PERL_HUMAN Lactoperoxidase OS=Homo sapiens GN=LPO PE=1 SV=2 | 700 | D | 0.233352 | N | 0.203332 | 0.03002 | No Change: Both O | - |
| Q93052 | LPP_HUMAN Lipoma-preferred partner OS=Homo sapiens GN=LPP PE=1 SV=1 | 346 | Y | 0.896348 | H | 0.922274 | -0.025926 | No Change: Both D | - |
| Q93052 | LPP_HUMAN Lipoma-preferred partner OS=Homo sapiens GN=LPP PE=1 SV=1 | 146 | T | 0.966468 | A | 0.960014 | 0.006454 | No Change: Both D | - |
| Q93052 | LPP_HUMAN Lipoma-preferred partner OS=Homo sapiens GN=LPP PE=1 SV=1 | 259 | S | 0.929074 | P | 0.940826 | -0.011752 | No Change: Both D | - |
| Q96GM1 | LPPR2_HUMAN Lipid phosphate phosphatase-related protein type 2 OS=Homo sapiens GN=LPPR2 PE=2 SV=1 | 155 | T | 0.35386 | M | 0.298466 | 0.055394 | No Change: Both O | A colorectal cancer sample |
| Q6T4P5 | LPPR3_HUMAN Lipid phosphate phosphatase-related protein type 3 OS=Homo sapiens GN=LPPR3 PE=2 SV=1 | 193 | I | 0.234168 | T | 0.357712 | -0.123544 | No Change: Both O | - |
| Q6T4P5 | LPPR3_HUMAN Lipid phosphate phosphatase-related protein type 3 OS=Homo sapiens GN=LPPR3 PE=2 SV=1 | 690 | A | 0.853138 | V | 0.760536 | 0.092602 | No Change: Both D | - |
| Q7Z2D5 | LPPR4_HUMAN Lipid phosphate phosphatase-related protein type 4 OS=Homo sapiens GN=LPPR4 PE=1 SV=1 | 2 | Q | 0.92637 | K | 0.927509 | -0.001139 | No Change: Both D | - |
| Q7Z2D5 | LPPR4_HUMAN Lipid phosphate phosphatase-related protein type 4 OS=Homo sapiens GN=LPPR4 PE=1 SV=1 | 32 | A | 0.837333 | V | 0.779976 | 0.057357 | No Change: Both D | - |
| O60711 | LPXN_HUMAN Leupaxin OS=Homo sapiens GN=LPXN PE=1 SV=1 | 148 | P | 0.343108 | T | 0.291076 | 0.052032 | No Change: Both O | - |
| O95237 | LRAT_HUMAN Lecithin retinol acyltransferase OS=Homo sapiens GN=LRAT PE=1 SV=2 | 175 | S | 0.471936 | R | 0.394568 | 0.077368 | No Change: Both O | Leber congenital amaurosis type 14 (LCA14) [MIM:613341] |
| O95237 | LRAT_HUMAN Lecithin retinol acyltransferase OS=Homo sapiens GN=LRAT PE=1 SV=2 | 173 | P | 0.348694 | L | 0.186024 | 0.16267 | No Change: Both O | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2809 | S | 0.197162 | L | 0.10179 | 0.095372 | No Change: Both O | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2038 | Q | 0.667537 | H | 0.613543 | 0.053994 | No Change: Both D | A breast cancer sample |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2274 | G | 0.39327 | R | 0.408347 | -0.015077 | No Change: Both O | A breast cancer sample |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2701 | T | 0.122885 | K | 0.156058 | -0.033173 | No Change: Both O | A breast cancer sample |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 1090 | A | 0.958884 | G | 0.960779 | -0.001895 | No Change: Both D | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 1230 | G | 0.644612 | D | 0.7042 | -0.059588 | No Change: Both D | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 1677 | N | 0.58994 | S | 0.633528 | -0.043588 | No Change: Both D | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 1997 | R | 0.481901 | C | 0.289462 | 0.192439 | No Change: Both O | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2704 | A | 0.094187 | T | 0.105319 | -0.011132 | No Change: Both O | - |
| P50851 | LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens GN=LRBA PE=1 SV=4 | 2713 | L | 0.294793 | F | 0.245369 | 0.049424 | No Change: Both O | - |
| Q9Y2L9 | LRCH1_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Homo sapiens GN=LRCH1 PE=1 SV=3 | 234 | S | 0.147456 | P | 0.139165 | 0.008291 | No Change: Both O | - |
| Q9Y2L9 | LRCH1_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Homo sapiens GN=LRCH1 PE=1 SV=3 | 486 | A | 0.481878 | S | 0.592118 | -0.11024 | O to D | - |
| Q96II8 | LRCH3_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 3 OS=Homo sapiens GN=LRCH3 PE=1 SV=2 | 522 | P | 0.822562 | L | 0.72119 | 0.101372 | No Change: Both D | - |
| O75427 | LRCH4_HUMAN Leucine-rich repeat and calponin homology domain-containing protein 4 OS=Homo sapiens GN=LRCH4 PE=1 SV=2 | 642 | V | 0.384841 | M | 0.438905 | -0.054064 | No Change: Both O | - |
| Q9ULH4 | LRFN2_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 2 OS=Homo sapiens GN=LRFN2 PE=1 SV=2 | 770 | D | 0.387665 | N | 0.392717 | -0.005052 | No Change: Both O | - |
| Q9BTN0 | LRFN3_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 3 OS=Homo sapiens GN=LRFN3 PE=1 SV=1 | 14 | A | 0.968234 | V | 0.94106 | 0.027174 | No Change: Both D | - |
| Q6PJG9 | LRFN4_HUMAN Leucine-rich repeat and fibronectin type-III domain-containing protein 4 OS=Homo sapiens GN=LRFN4 PE=1 SV=1 | 340 | V | 0.348692 | A | 0.453191 | -0.104499 | No Change: Both O | - |
| P02750 | A2GL_HUMAN Leucine-rich alpha-2-glycoprotein OS=Homo sapiens GN=LRG1 PE=1 SV=2 | 133 | P | 0.354681 | S | 0.368352 | -0.013671 | No Change: Both O | - |
| P02750 | A2GL_HUMAN Leucine-rich alpha-2-glycoprotein OS=Homo sapiens GN=LRG1 PE=1 SV=2 | 64 | G | 0.327832 | S | 0.388907 | -0.061075 | No Change: Both O | - |
| Q96M69 | LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein OS=Homo sapiens GN=LRGUK PE=1 SV=1 | 302 | D | 0.330512 | Y | 0.181748 | 0.148764 | No Change: Both O | - |
| Q96M69 | LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein OS=Homo sapiens GN=LRGUK PE=1 SV=1 | 661 | A | 0.640693 | V | 0.592015 | 0.048678 | No Change: Both D | - |
| Q5T3J3 | LRIF1_HUMAN Ligand-dependent nuclear receptor-interacting factor 1 OS=Homo sapiens GN=LRIF1 PE=1 SV=1 | 599 | S | 0.579863 | P | 0.542465 | 0.037398 | No Change: Both D | - |
| Q5T3J3 | LRIF1_HUMAN Ligand-dependent nuclear receptor-interacting factor 1 OS=Homo sapiens GN=LRIF1 PE=1 SV=1 | 641 | I | 0.793411 | M | 0.839933 | -0.046522 | No Change: Both D | - |
| Q5T3J3 | LRIF1_HUMAN Ligand-dependent nuclear receptor-interacting factor 1 OS=Homo sapiens GN=LRIF1 PE=1 SV=1 | 438 | A | 0.936533 | T | 0.944004 | -0.007471 | No Change: Both D | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 615 | M | 0.299912 | V | 0.237614 | 0.062298 | No Change: Both O | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 926 | G | 0.680289 | S | 0.721934 | -0.041645 | No Change: Both D | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 957 | A | 0.950096 | T | 0.952236 | -0.00214 | No Change: Both D | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 1031 | P | 0.699463 | R | 0.666113 | 0.03335 | No Change: Both D | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 1053 | Q | 0.732089 | P | 0.774045 | -0.041956 | No Change: Both D | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 24 | L | 0.429983 | V | 0.365453 | 0.06453 | No Change: Both O | - |
| Q96JA1 | LRIG1_HUMAN Leucine-rich repeats and immunoglobulin-like domains protein 1 OS=Homo sapiens GN=LRIG1 PE=1 SV=2 | 993 | G | 0.829662 | A | 0.819347 | 0.010315 | No Change: Both D | - |
| Q9P2V4 | LRIT1_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRIT1 PE=1 SV=1 | 591 | S | 0.678103 | G | 0.610937 | 0.067166 | No Change: Both D | - |
| Q9P2V4 | LRIT1_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRIT1 PE=1 SV=1 | 154 | L | 0.218369 | M | 0.252053 | -0.033684 | No Change: Both O | - |
| Q9P2V4 | LRIT1_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRIT1 PE=1 SV=1 | 258 | P | 0.467538 | Q | 0.440808 | 0.02673 | No Change: Both O | - |
| Q9P2V4 | LRIT1_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRIT1 PE=1 SV=1 | 389 | P | 0.444116 | T | 0.373891 | 0.070225 | No Change: Both O | - |
| A6NDA9 | LRIT2_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRIT2 PE=2 SV=1 | 28 | C | 0.205819 | Y | 0.218362 | -0.012543 | No Change: Both O | - |
| A6NDA9 | LRIT2_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRIT2 PE=2 SV=1 | 179 | K | 0.194709 | N | 0.17382 | 0.020889 | No Change: Both O | - |
| A6NDA9 | LRIT2_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRIT2 PE=2 SV=1 | 220 | L | 0.064055 | F | 0.054874 | 0.009181 | No Change: Both O | - |
| A6NDA9 | LRIT2_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRIT2 PE=2 SV=1 | 496 | V | 0.211102 | A | 0.278808 | -0.067706 | No Change: Both O | - |
| A6NDA9 | LRIT2_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRIT2 PE=2 SV=1 | 510 | T | 0.747712 | P | 0.827685 | -0.079973 | No Change: Both D | - |
| Q3SXY7 | LRIT3_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 3 OS=Homo sapiens GN=LRIT3 PE=2 SV=2 | 291 | M | 0.343975 | L | 0.297261 | 0.046714 | No Change: Both O | - |
| Q3SXY7 | LRIT3_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 3 OS=Homo sapiens GN=LRIT3 PE=2 SV=2 | 441 | A | 0.53421 | T | 0.591625 | -0.057415 | No Change: Both D | - |
| Q3SXY7 | LRIT3_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 3 OS=Homo sapiens GN=LRIT3 PE=2 SV=2 | 458 | T | 0.230893 | M | 0.190369 | 0.040524 | No Change: Both O | - |
| Q3SXY7 | LRIT3_HUMAN Leucine-rich repeat immunoglobulin-like domain and transmembrane domain-containing protein 3 OS=Homo sapiens GN=LRIT3 PE=2 SV=2 | 130 | S | 0.286463 | N | 0.233872 | 0.052591 | No Change: Both O | - |
| Q12912 | LRMP_HUMAN Lymphoid-restricted membrane protein OS=Homo sapiens GN=LRMP PE=1 SV=3 | 94 | T | 0.888671 | A | 0.854933 | 0.033738 | No Change: Both D | - |
| Q12912 | LRMP_HUMAN Lymphoid-restricted membrane protein OS=Homo sapiens GN=LRMP PE=1 SV=3 | 197 | L | 0.699319 | V | 0.712167 | -0.012848 | No Change: Both D | - |
| Q12912 | LRMP_HUMAN Lymphoid-restricted membrane protein OS=Homo sapiens GN=LRMP PE=1 SV=3 | 241 | L | 0.732123 | W | 0.631692 | 0.100431 | No Change: Both D | - |
| Q12912 | LRMP_HUMAN Lymphoid-restricted membrane protein OS=Homo sapiens GN=LRMP PE=1 SV=3 | 253 | C | 0.663272 | S | 0.78041 | -0.117138 | No Change: Both D | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 217 | A | 0.316577 | V | 0.248654 | 0.067923 | No Change: Both O | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 166 | N | 0.345706 | D | 0.392328 | -0.046622 | No Change: Both O | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 2059 | V | 0.22609 | L | 0.231422 | -0.005332 | No Change: Both O | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 869 | E | 0.626258 | K | 0.620708 | 0.00555 | No Change: Both D | A colorectal cancer sample |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 3760 | R | 0.86841 | H | 0.839975 | 0.028435 | No Change: Both D | A colorectal cancer sample |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 2080 | D | 0.483652 | N | 0.465606 | 0.018046 | No Change: Both O | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 2900 | Q | 0.897824 | P | 0.904651 | -0.006827 | No Change: Both D | - |
| Q07954 | LRP1_HUMAN Prolow-density lipoprotein receptor-related protein 1 OS=Homo sapiens GN=LRP1 PE=1 SV=2 | 4536 | E | 0.772839 | G | 0.737229 | 0.03561 | No Change: Both D | - |
| Q7Z4F1 | LRP10_HUMAN Low-density lipoprotein receptor-related protein 10 OS=Homo sapiens GN=LRP10 PE=1 SV=2 | 48 | R | 0.530199 | W | 0.307866 | 0.222333 | D to O | - |
| Q7Z4F1 | LRP10_HUMAN Low-density lipoprotein receptor-related protein 10 OS=Homo sapiens GN=LRP10 PE=1 SV=2 | 139 | M | 0.096524 | V | 0.071843 | 0.024681 | No Change: Both O | - |
| Q86VZ4 | LRP11_HUMAN Low-density lipoprotein receptor-related protein 11 OS=Homo sapiens GN=LRP11 PE=2 SV=2 | 92 | P | 0.841965 | R | 0.822334 | 0.019631 | No Change: Both D | - |
| Q86VZ4 | LRP11_HUMAN Low-density lipoprotein receptor-related protein 11 OS=Homo sapiens GN=LRP11 PE=2 SV=2 | 351 | R | 0.54252 | H | 0.525231 | 0.017289 | No Change: Both D | - |
| Q86VZ4 | LRP11_HUMAN Low-density lipoprotein receptor-related protein 11 OS=Homo sapiens GN=LRP11 PE=2 SV=2 | 281 | T | 0.426713 | M | 0.359749 | 0.066964 | No Change: Both O | - |
| Q86VZ4 | LRP11_HUMAN Low-density lipoprotein receptor-related protein 11 OS=Homo sapiens GN=LRP11 PE=2 SV=2 | 442 | G | 0.772353 | R | 0.75652 | 0.015833 | No Change: Both D | - |
| Q9Y561 | LRP12_HUMAN Low-density lipoprotein receptor-related protein 12 OS=Homo sapiens GN=LRP12 PE=1 SV=1 | 694 | S | 0.887404 | G | 0.862685 | 0.024719 | No Change: Both D | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 3157 | R | 0.280536 | C | 0.159787 | 0.120749 | No Change: Both O | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 48 | Q | 0.629422 | R | 0.618741 | 0.010681 | No Change: Both D | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 3140 | Q | 0.205522 | R | 0.199096 | 0.006426 | No Change: Both O | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 3458 | E | 0.764366 | K | 0.777625 | -0.013259 | No Change: Both D | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 3734 | Q | 0.72663 | K | 0.745802 | -0.019172 | No Change: Both D | - |
| Q9NZR2 | LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens GN=LRP1B PE=1 SV=2 | 4264 | V | 0.441133 | L | 0.447187 | -0.006054 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 1287 | A | 0.324041 | P | 0.466528 | -0.142487 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 2872 | A | 0.770381 | T | 0.823105 | -0.052724 | No Change: Both D | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 4094 | K | 0.274184 | E | 0.274909 | -7.25E-04 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 4210 | I | 0.462248 | L | 0.49275 | -0.030502 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 2065 | I | 0.178674 | T | 0.28302 | -0.104346 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 3305 | R | 0.358162 | H | 0.368786 | -0.010624 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 1279 | D | 0.442399 | A | 0.354017 | 0.088382 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 2012 | R | 0.437339 | K | 0.468433 | -0.031094 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 2632 | N | 0.334151 | D | 0.341555 | -0.007404 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 4272 | M | 0.276596 | V | 0.236222 | 0.040374 | No Change: Both O | A colorectal cancer sample |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 83 | N | 0.780226 | S | 0.840405 | -0.060179 | No Change: Both D | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 669 | G | 0.362163 | D | 0.392042 | -0.029879 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 909 | H | 0.447594 | R | 0.45864 | -0.011046 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 1083 | H | 0.538056 | Q | 0.553734 | -0.015678 | No Change: Both D | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 2522 | Y | 0.0474 | H | 0.080306 | -0.032906 | No Change: Both O | Donnai-Barrow syndrome (DBS) [MIM:222448] |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 3011 | R | 0.44147 | M | 0.348812 | 0.092658 | No Change: Both O | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 259 | G | 0.870069 | R | 0.874182 | -0.004113 | No Change: Both D | - |
| P98164 | LRP2_HUMAN Low-density lipoprotein receptor-related protein 2 OS=Homo sapiens GN=LRP2 PE=1 SV=3 | 103 | C | 0.976815 | R | 0.979 | -0.002185 | No Change: Both D | - |
| O75074 | LRP3_HUMAN Low-density lipoprotein receptor-related protein 3 OS=Homo sapiens GN=LRP3 PE=2 SV=2 | 708 | V | 0.979666 | A | 0.984749 | -0.005083 | No Change: Both D | - |
| O75074 | LRP3_HUMAN Low-density lipoprotein receptor-related protein 3 OS=Homo sapiens GN=LRP3 PE=2 SV=2 | 213 | P | 0.948107 | L | 0.897313 | 0.050794 | No Change: Both D | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1086 | I | 0.218912 | V | 0.247717 | -0.028805 | No Change: Both O | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1554 | S | 0.251579 | G | 0.200923 | 0.050656 | No Change: Both O | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1646 | R | 0.803027 | Q | 0.781446 | 0.021581 | No Change: Both D | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 314 | L | 0.632154 | S | 0.748901 | -0.116747 | No Change: Both D | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1203 | A | 0.338425 | V | 0.279719 | 0.058706 | No Change: Both O | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1238 | A | 0.524014 | T | 0.547479 | -0.023465 | No Change: Both D | - |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 137 | D | 0.88599 | N | 0.867965 | 0.018025 | No Change: Both D | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 160 | C | 0.873495 | Y | 0.807008 | 0.066487 | No Change: Both D | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 449 | D | 0.13794 | N | 0.138653 | -7.13E-04 | No Change: Both O | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 461 | T | 0.278672 | P | 0.342771 | -0.064099 | No Change: Both O | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 473 | L | 0.222884 | F | 0.198741 | 0.024143 | No Change: Both O | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 529 | D | 0.297745 | N | 0.271419 | 0.026326 | No Change: Both O | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1017 | C | 0.752309 | R | 0.808294 | -0.055985 | No Change: Both D | Cenani-Lenz syndactyly syndrome (CLSS) [MIM:212780] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1170 | R | 0.155131 | W | 0.067094 | 0.088037 | No Change: Both O | Sclerosteosis type 2 (SOST2) [MIM:614305] |
| O75096 | LRP4_HUMAN Low-density lipoprotein receptor-related protein 4 OS=Homo sapiens GN=LRP4 PE=1 SV=4 | 1186 | W | 0.169713 | S | 0.382713 | -0.213 | No Change: Both O | Sclerosteosis type 2 (SOST2) [MIM:614305] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 173 | T | 0.330962 | M | 0.283267 | 0.047695 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1168 | Y | 0.086713 | H | 0.160661 | -0.073948 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1361 | C | 0.662744 | G | 0.702886 | -0.040142 | No Change: Both D | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 570 | R | 0.483055 | Q | 0.493979 | -0.010924 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 752 | R | 0.104216 | G | 0.108547 | -0.004331 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1367 | E | 0.587841 | K | 0.594959 | -0.007118 | No Change: Both D | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1525 | A | 0.758007 | V | 0.681855 | 0.076152 | No Change: Both D | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 89 | Q | 0.379827 | R | 0.344019 | 0.035808 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 111 | D | 0.188136 | Y | 0.094247 | 0.093889 | No Change: Both O | Osteopetrosis autosomal dominant type 1 (OPTA1) [MIM:607634] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 171 | G | 0.227457 | R | 0.22627 | 0.001187 | No Change: Both O | Osteopetrosis autosomal dominant type 1 (OPTA1) [MIM:607634] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 171 | G | 0.227457 | V | 0.128561 | 0.098896 | No Change: Both O | High bone mass trait (HBM) [MIM:601884] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 214 | A | 0.143856 | T | 0.150743 | -0.006887 | No Change: Both O | Endosteal hyperostosis Worth type (WENHY) [MIM:144750] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 214 | A | 0.143856 | V | 0.094113 | 0.049743 | No Change: Both O | Endosteal hyperostosis Worth type (WENHY) [MIM:144750] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 242 | A | 0.251904 | T | 0.298597 | -0.046693 | No Change: Both O | Endosteal hyperostosis Worth type (WENHY) [MIM:144750] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 242 | A | 0.251904 | T | 0.298597 | -0.046693 | No Change: Both O | Osteopetrosis autosomal dominant type 1 (OPTA1) [MIM:607634] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 242 | A | 0.251904 | T | 0.298597 | -0.046693 | No Change: Both O | Van Buchem disease type 2 (VBCH2) [MIM:607636] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 253 | T | 0.141584 | I | 0.073899 | 0.067685 | No Change: Both O | Osteopetrosis autosomal dominant type 1 (OPTA1) [MIM:607634] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 494 | R | 0.337449 | Q | 0.358047 | -0.020598 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 570 | R | 0.483055 | W | 0.249372 | 0.233683 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 667 | V | 0.303106 | M | 0.357208 | -0.054102 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1330 | A | 0.793472 | V | 0.728476 | 0.064996 | No Change: Both D | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1204 | V | 0.365066 | L | 0.369954 | -0.004888 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 282 | M | 0.272814 | V | 0.227307 | 0.045507 | No Change: Both O | High bone mass trait (HBM) [MIM:601884] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 29 | A | 0.319793 | T | 0.309373 | 0.01042 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 97 | A | 0.243136 | V | 0.186554 | 0.056582 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 145 | L | 0.133782 | F | 0.117411 | 0.016371 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 154 | R | 0.281325 | M | 0.231587 | 0.049738 | No Change: Both O | High bone mass trait (HBM) [MIM:601884] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 203 | D | 0.18459 | N | 0.184558 | 3.20E-05 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 244 | T | 0.224401 | M | 0.176225 | 0.048176 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 307 | S | 0.406783 | F | 0.220375 | 0.186408 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 348 | R | 0.222989 | W | 0.081994 | 0.140995 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 353 | R | 0.362501 | Q | 0.353788 | 0.008713 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 356 | S | 0.395341 | L | 0.238307 | 0.157034 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 390 | T | 0.145634 | K | 0.196378 | -0.050744 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 400 | A | 0.266816 | E | 0.365299 | -0.098483 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 404 | G | 0.377893 | R | 0.368316 | 0.009577 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 409 | T | 0.312 | A | 0.284324 | 0.027676 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 434 | D | 0.188701 | N | 0.177197 | 0.011504 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 441 | E | 0.386735 | K | 0.387405 | -6.70E-04 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 444 | R | 0.377117 | C | 0.201176 | 0.175941 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 455 | S | 0.454458 | L | 0.263718 | 0.19074 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 460 | E | 0.450733 | K | 0.437495 | 0.013238 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 478 | W | 0.144342 | R | 0.281302 | -0.13696 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 504 | W | 0.181774 | C | 0.211145 | -0.029371 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 511 | D | 0.20272 | A | 0.157443 | 0.045277 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 520 | G | 0.259769 | V | 0.150618 | 0.109151 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 522 | A | 0.271889 | T | 0.315317 | -0.043428 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 531 | N | 0.306893 | I | 0.168259 | 0.138634 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 535 | T | 0.350451 | M | 0.288146 | 0.062305 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 550 | G | 0.067301 | R | 0.060673 | 0.006628 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 610 | G | 0.311339 | R | 0.301505 | 0.009834 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 610 | G | 0.311339 | R | 0.301505 | 0.009834 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 617 | F | 0.124825 | C | 0.140423 | -0.015598 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 683 | D | 0.303654 | N | 0.293635 | 0.010019 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 733 | Y | 0.12369 | H | 0.201204 | -0.077514 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 798 | T | 0.161607 | A | 0.138357 | 0.02325 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 805 | R | 0.254651 | W | 0.111838 | 0.142813 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1036 | R | 0.092778 | Q | 0.100243 | -0.007465 | No Change: Both O | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1099 | D | 0.403434 | Y | 0.243048 | 0.160386 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1113 | R | 0.07315 | C | 0.034707 | 0.038443 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1121 | N | 0.088168 | D | 0.103733 | -0.015565 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1253 | C | 0.327012 | F | 0.286886 | 0.040126 | No Change: Both O | Vitreoretinopathy exudative type 4 (EVR4) [MIM:601813] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1401 | G | 0.032486 | D | 0.033994 | -0.001508 | No Change: Both O | Osteoporosis-pseudoglioma syndrome (OPPG) [MIM:259770] |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1537 | A | 0.548422 | T | 0.601045 | -0.052623 | No Change: Both D | - |
| O75197 | LRP5_HUMAN Low-density lipoprotein receptor-related protein 5 OS=Homo sapiens GN=LRP5 PE=1 SV=2 | 1540 | T | 0.586157 | M | 0.562839 | 0.023318 | No Change: Both D | - |
| A4QPB2 | LRP5L_HUMAN Low-density lipoprotein receptor-related protein 5-like protein OS=Homo sapiens GN=LRP5L PE=2 SV=2 | 61 | T | 0.340568 | M | 0.276094 | 0.064474 | No Change: Both O | - |
| O75581 | LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens GN=LRP6 PE=1 SV=2 | 1062 | V | 0.346889 | I | 0.296157 | 0.050732 | No Change: Both O | - |
| O75581 | LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens GN=LRP6 PE=1 SV=2 | 483 | V | 0.200365 | I | 0.163622 | 0.036743 | No Change: Both O | - |
| O75581 | LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens GN=LRP6 PE=1 SV=2 | 817 | S | 0.473045 | C | 0.210703 | 0.262342 | No Change: Both O | - |
| O75581 | LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens GN=LRP6 PE=1 SV=2 | 611 | R | 0.102253 | C | 0.06051 | 0.041743 | No Change: Both O | Autosomal dominant coronary artery disease type 2 (ADCAD2) [MIM:610947] |
| O75581 | LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens GN=LRP6 PE=1 SV=2 | 1401 | R | 0.348195 | H | 0.337964 | 0.010231 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 46 | D | 0.682999 | E | 0.696955 | -0.013956 | No Change: Both D | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 952 | R | 0.809378 | Q | 0.824045 | -0.014667 | No Change: Both D | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 453 | V | 0.110635 | M | 0.139212 | -0.028577 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 466 | W | 0.041146 | C | 0.059593 | -0.018447 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 607 | Q | 0.373456 | R | 0.354187 | 0.019269 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 611 | I | 0.536242 | L | 0.588584 | -0.052342 | No Change: Both D | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 653 | S | 0.261645 | T | 0.196802 | 0.064843 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 25 | Q | 0.483474 | R | 0.453502 | 0.029972 | No Change: Both O | - |
| Q14114 | LRP8_HUMAN Low-density lipoprotein receptor-related protein 8 OS=Homo sapiens GN=LRP8 PE=1 SV=4 | 736 | R | 0.843418 | Q | 0.844658 | -0.00124 | No Change: Both D | - |
| P30533 | AMRP_HUMAN Alpha-2-macroglobulin receptor-associated protein OS=Homo sapiens GN=LRPAP1 PE=1 SV=1 | 311 | V | 0.794555 | M | 0.828682 | -0.034127 | No Change: Both D | - |
| P30533 | AMRP_HUMAN Alpha-2-macroglobulin receptor-associated protein OS=Homo sapiens GN=LRPAP1 PE=1 SV=1 | 114 | N | 0.383391 | S | 0.408909 | -0.025518 | No Change: Both O | - |
| P42704 | LPPRC_HUMAN Leucine-rich PPR motif-containing protein mitochondrial OS=Homo sapiens GN=LRPPRC PE=1 SV=3 | 354 | A | 0.105622 | V | 0.078071 | 0.027551 | No Change: Both O | Leigh syndrome French-Canadian type (LSFC) [MIM:220111] |
| P42704 | LPPRC_HUMAN Leucine-rich PPR motif-containing protein mitochondrial OS=Homo sapiens GN=LRPPRC PE=1 SV=3 | 478 | T | 0.224233 | A | 0.193508 | 0.030725 | No Change: Both O | - |
| Q96L50 | LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens GN=LRR1 PE=1 SV=2 | 96 | I | 0.374679 | N | 0.528254 | -0.153575 | O to D | - |
| Q96L50 | LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens GN=LRR1 PE=1 SV=2 | 229 | R | 0.603415 | W | 0.408267 | 0.195148 | D to O | - |
| Q9BTT6 | LRRC1_HUMAN Leucine-rich repeat-containing protein 1 OS=Homo sapiens GN=LRRC1 PE=1 SV=1 | 193 | I | 0.276089 | V | 0.276687 | -5.98E-04 | No Change: Both O | - |
| Q15048 | LRC14_HUMAN Leucine-rich repeat-containing protein 14 OS=Homo sapiens GN=LRRC14 PE=2 SV=1 | 437 | G | 0.234266 | D | 0.279573 | -0.045307 | No Change: Both O | - |
| Q8TF66 | LRC15_HUMAN Leucine-rich repeat-containing protein 15 OS=Homo sapiens GN=LRRC15 PE=1 SV=2 | 264 | V | 0.512452 | I | 0.541127 | -0.028675 | No Change: Both D | - |
| Q8TF66 | LRC15_HUMAN Leucine-rich repeat-containing protein 15 OS=Homo sapiens GN=LRRC15 PE=1 SV=2 | 286 | P | 0.428901 | L | 0.283478 | 0.145423 | No Change: Both O | - |
| Q5VZK9 | LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16A PE=1 SV=1 | 77 | V | 0.200147 | I | 0.181864 | 0.018283 | No Change: Both O | - |
| Q5VZK9 | LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16A PE=1 SV=1 | 545 | P | 0.661844 | L | 0.578067 | 0.083777 | No Change: Both D | - |
| Q5VZK9 | LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16A PE=1 SV=1 | 639 | A | 0.381754 | G | 0.397092 | -0.015338 | No Change: Both O | - |
| Q5VZK9 | LR16A_HUMAN Leucine-rich repeat-containing protein 16A OS=Homo sapiens GN=LRRC16A PE=1 SV=1 | 1117 | N | 0.950525 | S | 0.962354 | -0.011829 | No Change: Both D | - |
| Q8ND23 | LR16B_HUMAN Leucine-rich repeat-containing protein 16B OS=Homo sapiens GN=LRRC16B PE=2 SV=2 | 1022 | L | 0.882945 | M | 0.901743 | -0.018798 | No Change: Both D | - |
| Q8N6Y2 | LRC17_HUMAN Leucine-rich repeat-containing protein 17 OS=Homo sapiens GN=LRRC17 PE=2 SV=1 | 95 | T | 0.384224 | I | 0.2788 | 0.105424 | No Change: Both O | - |
| Q8N6Y2 | LRC17_HUMAN Leucine-rich repeat-containing protein 17 OS=Homo sapiens GN=LRRC17 PE=2 SV=1 | 119 | K | 0.55145 | E | 0.563192 | -0.011742 | No Change: Both D | - |
| Q8N6Y2 | LRC17_HUMAN Leucine-rich repeat-containing protein 17 OS=Homo sapiens GN=LRRC17 PE=2 SV=1 | 187 | G | 0.570315 | A | 0.567876 | 0.002439 | No Change: Both D | - |
| Q8N456 | LRC18_HUMAN Leucine-rich repeat-containing protein 18 OS=Homo sapiens GN=LRRC18 PE=2 SV=2 | 7 | G | 0.766837 | V | 0.696925 | 0.069912 | No Change: Both D | - |
| Q8N456 | LRC18_HUMAN Leucine-rich repeat-containing protein 18 OS=Homo sapiens GN=LRRC18 PE=2 SV=2 | 31 | R | 0.53126 | H | 0.475112 | 0.056148 | D to O | - |
| Q9BYS8 | LRRC2_HUMAN Leucine-rich repeat-containing protein 2 OS=Homo sapiens GN=LRRC2 PE=2 SV=2 | 32 | V | 0.624513 | A | 0.695486 | -0.070973 | No Change: Both D | - |
| Q9BYS8 | LRRC2_HUMAN Leucine-rich repeat-containing protein 2 OS=Homo sapiens GN=LRRC2 PE=2 SV=2 | 83 | T | 0.518468 | A | 0.467497 | 0.050971 | D to O | - |
| Q9BYS8 | LRRC2_HUMAN Leucine-rich repeat-containing protein 2 OS=Homo sapiens GN=LRRC2 PE=2 SV=2 | 145 | A | 0.064006 | E | 0.105254 | -0.041248 | No Change: Both O | - |
| Q53EV4 | LRC23_HUMAN Leucine-rich repeat-containing protein 23 OS=Homo sapiens GN=LRRC23 PE=2 SV=2 | 65 | N | 0.267412 | H | 0.266009 | 0.001403 | No Change: Both O | - |
| Q53EV4 | LRC23_HUMAN Leucine-rich repeat-containing protein 23 OS=Homo sapiens GN=LRRC23 PE=2 SV=2 | 124 | R | 0.410765 | L | 0.289998 | 0.120767 | No Change: Both O | - |
| Q53EV4 | LRC23_HUMAN Leucine-rich repeat-containing protein 23 OS=Homo sapiens GN=LRRC23 PE=2 SV=2 | 317 | V | 0.942379 | E | 0.972864 | -0.030485 | No Change: Both D | - |
| Q8N386 | LRC25_HUMAN Leucine-rich repeat-containing protein 25 OS=Homo sapiens GN=LRRC25 PE=2 SV=2 | 294 | P | 0.515426 | S | 0.55675 | -0.041324 | No Change: Both D | - |
| Q8N386 | LRC25_HUMAN Leucine-rich repeat-containing protein 25 OS=Homo sapiens GN=LRRC25 PE=2 SV=2 | 234 | P | 0.810799 | T | 0.731498 | 0.079301 | No Change: Both D | - |
| Q9C0I9 | LRC27_HUMAN Leucine-rich repeat-containing protein 27 OS=Homo sapiens GN=LRRC27 PE=2 SV=2 | 195 | R | 0.808519 | C | 0.698652 | 0.109867 | No Change: Both D | - |
| Q86X40 | LRC28_HUMAN Leucine-rich repeat-containing protein 28 OS=Homo sapiens GN=LRRC28 PE=2 SV=1 | 168 | R | 0.126627 | H | 0.114653 | 0.011974 | No Change: Both O | - |
| Q8WV35 | LRC29_HUMAN Leucine-rich repeat-containing protein 29 OS=Homo sapiens GN=LRRC29 PE=2 SV=1 | 75 | R | 0.717642 | Q | 0.758551 | -0.040909 | No Change: Both D | - |
| Q8WV35 | LRC29_HUMAN Leucine-rich repeat-containing protein 29 OS=Homo sapiens GN=LRRC29 PE=2 SV=1 | 117 | G | 0.278303 | S | 0.351654 | -0.073351 | No Change: Both O | - |
| Q6UY01 | LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens GN=LRRC31 PE=2 SV=1 | 322 | L | 0.328415 | F | 0.264114 | 0.064301 | No Change: Both O | - |
| Q6UY01 | LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens GN=LRRC31 PE=2 SV=1 | 324 | A | 0.392588 | E | 0.491475 | -0.098887 | No Change: Both O | - |
| Q6UY01 | LRC31_HUMAN Leucine-rich repeat-containing protein 31 OS=Homo sapiens GN=LRRC31 PE=2 SV=1 | 378 | L | 0.2668 | F | 0.237743 | 0.029057 | No Change: Both O | - |
| Q14392 | LRC32_HUMAN Leucine-rich repeat-containing protein 32 OS=Homo sapiens GN=LRRC32 PE=1 SV=1 | 223 | L | 0.285875 | V | 0.248268 | 0.037607 | No Change: Both O | - |
| Q14392 | LRC32_HUMAN Leucine-rich repeat-containing protein 32 OS=Homo sapiens GN=LRRC32 PE=1 SV=1 | 311 | G | 0.72761 | A | 0.711552 | 0.016058 | No Change: Both D | - |
| Q8IZ02 | LRC34_HUMAN Leucine-rich repeat-containing protein 34 OS=Homo sapiens GN=LRRC34 PE=2 SV=2 | 241 | L | 0.149175 | I | 0.129369 | 0.019806 | No Change: Both O | - |
| Q8IZ02 | LRC34_HUMAN Leucine-rich repeat-containing protein 34 OS=Homo sapiens GN=LRRC34 PE=2 SV=2 | 36 | P | 0.717439 | L | 0.629904 | 0.087535 | No Change: Both D | - |
| Q8IZ02 | LRC34_HUMAN Leucine-rich repeat-containing protein 34 OS=Homo sapiens GN=LRRC34 PE=2 SV=2 | 360 | M | 0.146713 | I | 0.106517 | 0.040196 | No Change: Both O | - |
| Q1X8D7 | LRC36_HUMAN Leucine-rich repeat-containing protein 36 OS=Homo sapiens GN=LRRC36 PE=2 SV=2 | 222 | R | 0.818712 | P | 0.84061 | -0.021898 | No Change: Both D | - |
| Q1X8D7 | LRC36_HUMAN Leucine-rich repeat-containing protein 36 OS=Homo sapiens GN=LRRC36 PE=2 SV=2 | 509 | G | 0.616829 | S | 0.676463 | -0.059634 | No Change: Both D | - |
| Q1X8D7 | LRC36_HUMAN Leucine-rich repeat-containing protein 36 OS=Homo sapiens GN=LRRC36 PE=2 SV=2 | 744 | S | 0.50011 | G | 0.415423 | 0.084687 | D to O | - |
| O60309 | L37A3_HUMAN Leucine-rich repeat-containing protein 37A3 OS=Homo sapiens GN=LRRC37A3 PE=2 SV=2 | 1215 | K | 0.90859 | E | 0.9125 | -0.00391 | No Change: Both D | - |
| O60309 | L37A3_HUMAN Leucine-rich repeat-containing protein 37A3 OS=Homo sapiens GN=LRRC37A3 PE=2 SV=2 | 1590 | G | 0.025067 | A | 0.020372 | 0.004695 | No Change: Both O | - |
| Q5VT99 | LRC38_HUMAN Leucine-rich repeat-containing protein 38 OS=Homo sapiens GN=LRRC38 PE=2 SV=1 | 276 | L | 0.120917 | F | 0.113011 | 0.007906 | No Change: Both O | - |
| Q5VT99 | LRC38_HUMAN Leucine-rich repeat-containing protein 38 OS=Homo sapiens GN=LRRC38 PE=2 SV=1 | 292 | K | 0.846238 | E | 0.855805 | -0.009567 | No Change: Both D | - |
| Q96DD0 | LRC39_HUMAN Leucine-rich repeat-containing protein 39 OS=Homo sapiens GN=LRRC39 PE=2 SV=1 | 121 | I | 0.380916 | L | 0.408703 | -0.027787 | No Change: Both O | - |
| Q9HBW1 | LRRC4_HUMAN Leucine-rich repeat-containing protein 4 OS=Homo sapiens GN=LRRC4 PE=1 SV=2 | 579 | T | 0.540293 | A | 0.532785 | 0.007508 | No Change: Both D | A colorectal cancer sample |
| Q9H9A6 | LRC40_HUMAN Leucine-rich repeat-containing protein 40 OS=Homo sapiens GN=LRRC40 PE=1 SV=1 | 53 | Q | 0.178139 | P | 0.199409 | -0.02127 | No Change: Both O | - |
| Q9H9A6 | LRC40_HUMAN Leucine-rich repeat-containing protein 40 OS=Homo sapiens GN=LRRC40 PE=1 SV=1 | 500 | I | 0.186527 | V | 0.220996 | -0.034469 | No Change: Both O | - |
| Q15345 | LRC41_HUMAN Leucine-rich repeat-containing protein 41 OS=Homo sapiens GN=LRRC41 PE=1 SV=3 | 609 | V | 0.495181 | I | 0.481585 | 0.013596 | No Change: Both O | - |
| Q8N309 | LRC43_HUMAN Leucine-rich repeat-containing protein 43 OS=Homo sapiens GN=LRRC43 PE=2 SV=2 | 256 | Q | 0.15448 | K | 0.182217 | -0.027737 | No Change: Both O | - |
| Q8N1G4 | LRC47_HUMAN Leucine-rich repeat-containing protein 47 OS=Homo sapiens GN=LRRC47 PE=1 SV=1 | 193 | E | 0.536258 | D | 0.530573 | 0.005685 | No Change: Both D | A colorectal cancer sample |
| Q8N1G4 | LRC47_HUMAN Leucine-rich repeat-containing protein 47 OS=Homo sapiens GN=LRRC47 PE=1 SV=1 | 545 | P | 0.664901 | L | 0.54 | 0.124901 | No Change: Both D | - |
| Q8N1G4 | LRC47_HUMAN Leucine-rich repeat-containing protein 47 OS=Homo sapiens GN=LRRC47 PE=1 SV=1 | 581 | V | 0.723151 | I | 0.711764 | 0.011387 | No Change: Both D | - |
| Q9H069 | LRC48_HUMAN Leucine-rich repeat-containing protein 48 OS=Homo sapiens GN=LRRC48 PE=2 SV=2 | 191 | R | 0.283158 | W | 0.1242 | 0.158958 | No Change: Both O | - |
| Q9H069 | LRC48_HUMAN Leucine-rich repeat-containing protein 48 OS=Homo sapiens GN=LRRC48 PE=2 SV=2 | 159 | R | 0.19171 | Q | 0.186839 | 0.004871 | No Change: Both O | - |
| Q9H069 | LRC48_HUMAN Leucine-rich repeat-containing protein 48 OS=Homo sapiens GN=LRRC48 PE=2 SV=2 | 364 | A | 0.251563 | V | 0.192206 | 0.059357 | No Change: Both O | - |
| Q8N7C0 | LRC52_HUMAN Leucine-rich repeat-containing protein 52 OS=Homo sapiens GN=LRRC52 PE=2 SV=2 | 209 | D | 0.461275 | E | 0.476603 | -0.015328 | No Change: Both O | - |
| Q8IYG6 | LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens GN=LRRC56 PE=2 SV=1 | 507 | R | 0.829096 | G | 0.815615 | 0.013481 | No Change: Both D | - |
| Q8IYG6 | LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens GN=LRRC56 PE=2 SV=1 | 523 | D | 0.978823 | H | 0.976247 | 0.002576 | No Change: Both D | - |
| Q8IYG6 | LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens GN=LRRC56 PE=2 SV=1 | 12 | R | 0.926698 | Q | 0.913186 | 0.013512 | No Change: Both D | - |
| Q8IYG6 | LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens GN=LRRC56 PE=2 SV=1 | 300 | R | 0.75007 | H | 0.699539 | 0.050531 | No Change: Both D | - |
| Q8IYG6 | LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens GN=LRRC56 PE=2 SV=1 | 467 | R | 0.960278 | Q | 0.954966 | 0.005312 | No Change: Both D | - |
| Q86X45 | TILB_HUMAN Protein TILB homolog OS=Homo sapiens GN=LRRC6 PE=2 SV=3 | 232 | T | 0.798266 | I | 0.69745 | 0.100816 | No Change: Both D | - |
| Q86X45 | TILB_HUMAN Protein TILB homolog OS=Homo sapiens GN=LRRC6 PE=2 SV=3 | 466 | I | 0.981994 | T | 0.989598 | -0.007604 | No Change: Both D | - |
| Q9BV99 | LRC61_HUMAN Leucine-rich repeat-containing protein 61 OS=Homo sapiens GN=LRRC61 PE=2 SV=1 | 143 | N | 0.221338 | S | 0.261498 | -0.04016 | No Change: Both O | - |
| Q05C16 | LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens GN=LRRC63 PE=2 SV=2 | 137 | M | 0.697685 | V | 0.62235 | 0.075335 | No Change: Both D | - |
| Q05C16 | LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens GN=LRRC63 PE=2 SV=2 | 206 | M | 0.823237 | V | 0.773971 | 0.049266 | No Change: Both D | - |
| Q05C16 | LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens GN=LRRC63 PE=2 SV=2 | 281 | K | 0.771316 | R | 0.747735 | 0.023581 | No Change: Both D | - |
| Q05C16 | LRC63_HUMAN Leucine-rich repeat-containing protein 63 OS=Homo sapiens GN=LRRC63 PE=2 SV=2 | 282 | T | 0.754444 | A | 0.712964 | 0.04148 | No Change: Both D | - |
| Q68CR7 | LRC66_HUMAN Leucine-rich repeat-containing protein 66 OS=Homo sapiens GN=LRRC66 PE=2 SV=1 | 342 | G | 0.952122 | A | 0.945817 | 0.006305 | No Change: Both D | - |
| Q6ZNQ3 | LRC69_HUMAN Leucine-rich repeat-containing protein 69 OS=Homo sapiens GN=LRRC69 PE=2 SV=2 | 64 | T | 0.456645 | I | 0.293757 | 0.162888 | No Change: Both O | - |
| Q96NW7 | LRRC7_HUMAN Leucine-rich repeat-containing protein 7 OS=Homo sapiens GN=LRRC7 PE=1 SV=1 | 235 | L | 0.191425 | M | 0.245249 | -0.053824 | No Change: Both O | A breast cancer sample |
| Q96NW7 | LRRC7_HUMAN Leucine-rich repeat-containing protein 7 OS=Homo sapiens GN=LRRC7 PE=1 SV=1 | 1054 | H | 0.69352 | Y | 0.644047 | 0.049473 | No Change: Both D | - |
| Q8N4P6 | LRC71_HUMAN Leucine-rich repeat-containing protein 71 OS=Homo sapiens GN=LRRC71 PE=2 SV=1 | 483 | R | 0.169478 | H | 0.167852 | 0.001626 | No Change: Both O | - |
| Q8N4P6 | LRC71_HUMAN Leucine-rich repeat-containing protein 71 OS=Homo sapiens GN=LRRC71 PE=2 SV=1 | 503 | S | 0.647442 | A | 0.540735 | 0.106707 | No Change: Both D | - |
| Q8N4P6 | LRC71_HUMAN Leucine-rich repeat-containing protein 71 OS=Homo sapiens GN=LRRC71 PE=2 SV=1 | 533 | A | 0.171191 | T | 0.147923 | 0.023268 | No Change: Both O | - |
| Q6P9F7 | LRC8B_HUMAN Leucine-rich repeat-containing protein 8B OS=Homo sapiens GN=LRRC8B PE=2 SV=2 | 419 | Q | 0.405151 | K | 0.468211 | -0.06306 | No Change: Both O | - |
| Q6P9F7 | LRC8B_HUMAN Leucine-rich repeat-containing protein 8B OS=Homo sapiens GN=LRRC8B PE=2 SV=2 | 288 | D | 0.12902 | N | 0.11223 | 0.01679 | No Change: Both O | - |
| Q6P9F7 | LRC8B_HUMAN Leucine-rich repeat-containing protein 8B OS=Homo sapiens GN=LRRC8B PE=2 SV=2 | 469 | R | 0.266764 | H | 0.281734 | -0.01497 | No Change: Both O | - |
| Q6P9F7 | LRC8B_HUMAN Leucine-rich repeat-containing protein 8B OS=Homo sapiens GN=LRRC8B PE=2 SV=2 | 689 | N | 0.137872 | S | 0.172218 | -0.034346 | No Change: Both O | - |
| Q8TDW0 | LRC8C_HUMAN Leucine-rich repeat-containing protein 8C OS=Homo sapiens GN=LRRC8C PE=1 SV=2 | 205 | D | 0.901301 | G | 0.890563 | 0.010738 | No Change: Both D | - |
| Q8TDW0 | LRC8C_HUMAN Leucine-rich repeat-containing protein 8C OS=Homo sapiens GN=LRRC8C PE=1 SV=2 | 468 | N | 0.318412 | S | 0.376356 | -0.057944 | No Change: Both O | - |
| Q8TDW0 | LRC8C_HUMAN Leucine-rich repeat-containing protein 8C OS=Homo sapiens GN=LRRC8C PE=1 SV=2 | 800 | M | 0.721849 | I | 0.719354 | 0.002495 | No Change: Both D | - |
| Q7L1W4 | LRC8D_HUMAN Leucine-rich repeat-containing protein 8D OS=Homo sapiens GN=LRRC8D PE=1 SV=1 | 371 | S | 0.017703 | Y | 0.007378 | 0.010325 | No Change: Both O | - |
| Q6NSJ5 | LRC8E_HUMAN Leucine-rich repeat-containing protein 8E OS=Homo sapiens GN=LRRC8E PE=2 SV=2 | 433 | V | 0.316349 | I | 0.283061 | 0.033288 | No Change: Both O | - |
| Q6NSJ5 | LRC8E_HUMAN Leucine-rich repeat-containing protein 8E OS=Homo sapiens GN=LRRC8E PE=2 SV=2 | 181 | E | 0.660581 | G | 0.629546 | 0.031035 | No Change: Both D | - |
| Q6NSJ5 | LRC8E_HUMAN Leucine-rich repeat-containing protein 8E OS=Homo sapiens GN=LRRC8E PE=2 SV=2 | 190 | M | 0.807549 | T | 0.847151 | -0.039602 | No Change: Both D | - |
| Q6NSJ5 | LRC8E_HUMAN Leucine-rich repeat-containing protein 8E OS=Homo sapiens GN=LRRC8E PE=2 SV=2 | 160 | P | 0.220094 | L | 0.121717 | 0.098377 | No Change: Both O | - |
| Q9C099 | LRCC1_HUMAN Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=LRRCC1 PE=2 SV=2 | 69 | H | 0.25575 | Q | 0.281945 | -0.026195 | No Change: Both O | - |
| Q9C099 | LRCC1_HUMAN Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=LRRCC1 PE=2 SV=2 | 210 | T | 0.395459 | A | 0.362906 | 0.032553 | No Change: Both O | - |
| Q9C099 | LRCC1_HUMAN Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=LRRCC1 PE=2 SV=2 | 613 | K | 0.849914 | N | 0.795856 | 0.054058 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 275 | Q | 0.626482 | R | 0.631572 | -0.00509 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 418 | N | 0.656659 | S | 0.693892 | -0.037233 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 609 | E | 0.943853 | K | 0.943102 | 7.51E-04 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 645 | P | 0.886031 | L | 0.815306 | 0.070725 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 779 | R | 0.96457 | G | 0.96006 | 0.00451 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 783 | H | 0.971932 | D | 0.98023 | -0.008298 | No Change: Both D | - |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 68 | S | 0.994381 | C | 0.989619 | 0.004762 | No Change: Both D | A breast cancer sample |
| Q32MZ4 | LRRF1_HUMAN Leucine-rich repeat flightless-interacting protein 1 OS=Homo sapiens GN=LRRFIP1 PE=1 SV=2 | 633 | K | 0.943951 | E | 0.946973 | -0.003022 | No Change: Both D | - |
| Q9Y608 | LRRF2_HUMAN Leucine-rich repeat flightless-interacting protein 2 OS=Homo sapiens GN=LRRFIP2 PE=1 SV=1 | 143 | K | 0.941095 | E | 0.925451 | 0.015644 | No Change: Both D | - |
| Q96JM4 | LRIQ1_HUMAN Leucine-rich repeat and IQ domain-containing protein 1 OS=Homo sapiens GN=LRRIQ1 PE=2 SV=3 | 29 | I | 0.977555 | N | 0.983811 | -0.006256 | No Change: Both D | - |
| Q96JM4 | LRIQ1_HUMAN Leucine-rich repeat and IQ domain-containing protein 1 OS=Homo sapiens GN=LRRIQ1 PE=2 SV=3 | 83 | C | 0.234519 | Y | 0.280507 | -0.045988 | No Change: Both O | - |
| Q96JM4 | LRIQ1_HUMAN Leucine-rich repeat and IQ domain-containing protein 1 OS=Homo sapiens GN=LRRIQ1 PE=2 SV=3 | 912 | A | 0.23091 | T | 0.262351 | -0.031441 | No Change: Both O | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 35 | F | 0.150368 | C | 0.136837 | 0.013531 | No Change: Both O | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 129 | M | 0.055728 | I | 0.038427 | 0.017301 | No Change: Both O | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 156 | H | 0.208306 | Y | 0.11906 | 0.089246 | No Change: Both O | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 255 | A | 0.09723 | T | 0.119003 | -0.021773 | No Change: Both O | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 398 | I | 0.520591 | V | 0.500122 | 0.020469 | No Change: Both D | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 434 | E | 0.663366 | K | 0.670921 | -0.007555 | No Change: Both D | - |
| A6PVS8 | LRIQ3_HUMAN Leucine-rich repeat and IQ domain-containing protein 3 OS=Homo sapiens GN=LRRIQ3 PE=2 SV=1 | 483 | L | 0.514883 | F | 0.483818 | 0.031065 | D to O | - |
| A6NIV6 | LRIQ4_HUMAN Leucine-rich repeat and IQ domain-containing protein 4 OS=Homo sapiens GN=LRRIQ4 PE=2 SV=2 | 159 | K | 0.295967 | E | 0.293242 | 0.002725 | No Change: Both O | - |
| Q38SD2 | LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens GN=LRRK1 PE=1 SV=3 | 1803 | A | 0.712525 | T | 0.731083 | -0.018558 | No Change: Both D | - |
| Q38SD2 | LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens GN=LRRK1 PE=1 SV=3 | 1824 | L | 0.545729 | F | 0.485608 | 0.060121 | D to O | - |
| Q38SD2 | LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens GN=LRRK1 PE=1 SV=3 | 1847 | S | 0.940398 | N | 0.910061 | 0.030337 | No Change: Both D | - |
| Q38SD2 | LRRK1_HUMAN Leucine-rich repeat serine/threonine-protein kinase 1 OS=Homo sapiens GN=LRRK1 PE=1 SV=3 | 1927 | D | 0.131943 | G | 0.128834 | 0.003109 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 50 | R | 0.334403 | H | 0.339565 | -0.005162 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 119 | L | 0.118141 | P | 0.204906 | -0.086765 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 551 | N | 0.095586 | K | 0.113331 | -0.017745 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 723 | I | 0.230815 | V | 0.276147 | -0.045332 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 793 | R | 0.120073 | M | 0.086383 | 0.03369 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 930 | Q | 0.589249 | R | 0.602137 | -0.012888 | No Change: Both D | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 944 | D | 0.74588 | Y | 0.609598 | 0.136282 | No Change: Both D | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1067 | R | 0.354885 | Q | 0.369767 | -0.014882 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1096 | S | 0.274734 | C | 0.132796 | 0.141938 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1122 | I | 0.314639 | V | 0.321947 | -0.007308 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1228 | S | 0.218444 | T | 0.143787 | 0.074657 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1262 | P | 0.381562 | A | 0.280269 | 0.101293 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1371 | I | 0.265454 | V | 0.29846 | -0.033006 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1398 | R | 0.281701 | H | 0.297125 | -0.015424 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1441 | R | 0.304034 | C | 0.175888 | 0.128146 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1441 | R | 0.304034 | G | 0.316847 | -0.012813 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1441 | R | 0.304034 | H | 0.310688 | -0.006654 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1514 | R | 0.163424 | Q | 0.189562 | -0.026138 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1542 | P | 0.292215 | S | 0.300756 | -0.008541 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1598 | V | 0.062798 | E | 0.153273 | -0.090475 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1628 | R | 0.433019 | P | 0.47352 | -0.040501 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1646 | M | 0.374204 | T | 0.390821 | -0.016617 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1647 | S | 0.328823 | T | 0.236256 | 0.092567 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1699 | Y | 0.149474 | C | 0.168577 | -0.019103 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1869 | M | 0.301463 | T | 0.341153 | -0.03969 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1941 | R | 0.251565 | H | 0.220216 | 0.031349 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2012 | I | 0.101115 | T | 0.169363 | -0.068248 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2019 | G | 0.067731 | S | 0.084758 | -0.017027 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2020 | I | 0.059431 | T | 0.103711 | -0.04428 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2081 | N | 0.341278 | D | 0.377115 | -0.035837 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2119 | P | 0.565254 | L | 0.461722 | 0.103532 | D to O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2261 | N | 0.415468 | I | 0.271211 | 0.144257 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2356 | T | 0.101604 | I | 0.056161 | 0.045443 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2385 | G | 0.102492 | R | 0.106829 | -0.004337 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2397 | M | 0.387997 | T | 0.422918 | -0.034921 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 419 | A | 0.406596 | V | 0.326371 | 0.080225 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 755 | P | 0.675361 | L | 0.598608 | 0.076753 | No Change: Both D | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1550 | R | 0.229684 | Q | 0.242333 | -0.012649 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1723 | R | 0.502943 | P | 0.53179 | -0.028847 | No Change: Both D | An ovarian serous carcinoma sample |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1375 | D | 0.213131 | E | 0.208078 | 0.005053 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 228 | C | 0.061588 | S | 0.173315 | -0.111727 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 712 | M | 0.243371 | V | 0.1824 | 0.060971 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 716 | A | 0.283079 | V | 0.228999 | 0.05408 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 871 | K | 0.595963 | E | 0.637227 | -0.041264 | No Change: Both D | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1728 | R | 0.411368 | H | 0.384347 | 0.027021 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1728 | R | 0.411368 | L | 0.27242 | 0.138948 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1870 | L | 0.341902 | F | 0.302804 | 0.039098 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2141 | T | 0.074371 | M | 0.062848 | 0.011523 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2143 | R | 0.069862 | H | 0.061879 | 0.007983 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2395 | E | 0.216502 | K | 0.224259 | -0.007757 | No Change: Both O | - |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 2466 | L | 0.25224 | H | 0.351909 | -0.099669 | No Change: Both O | Parkinson disease type 8 (PARK8) [MIM:607060] |
| Q5S007 | LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens GN=LRRK2 PE=1 SV=2 | 1359 | K | 0.692308 | I | 0.501618 | 0.19069 | No Change: Both D | - |
| Q6UXK5 | LRRN1_HUMAN Leucine-rich repeat neuronal protein 1 OS=Homo sapiens GN=LRRN1 PE=1 SV=1 | 395 | L | 0.209942 | V | 0.209203 | 7.39E-04 | No Change: Both O | - |
| Q6UXK5 | LRRN1_HUMAN Leucine-rich repeat neuronal protein 1 OS=Homo sapiens GN=LRRN1 PE=1 SV=1 | 702 | T | 0.754155 | P | 0.782715 | -0.02856 | No Change: Both D | - |
| O75325 | LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens GN=LRRN2 PE=2 SV=2 | 7 | P | 0.085035 | L | 0.042016 | 0.043019 | No Change: Both O | - |
| O75325 | LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens GN=LRRN2 PE=2 SV=2 | 518 | L | 0.268919 | V | 0.277082 | -0.008163 | No Change: Both O | - |
| O75325 | LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens GN=LRRN2 PE=2 SV=2 | 19 | A | 0.151508 | T | 0.161081 | -0.009573 | No Change: Both O | - |
| O75325 | LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens GN=LRRN2 PE=2 SV=2 | 659 | V | 0.663706 | A | 0.713191 | -0.049485 | No Change: Both D | - |
| O75325 | LRRN2_HUMAN Leucine-rich repeat neuronal protein 2 OS=Homo sapiens GN=LRRN2 PE=2 SV=2 | 692 | P | 0.705044 | S | 0.693112 | 0.011932 | No Change: Both D | - |
| Q9H3W5 | LRRN3_HUMAN Leucine-rich repeat neuronal protein 3 OS=Homo sapiens GN=LRRN3 PE=2 SV=1 | 24 | D | 0.258766 | G | 0.223885 | 0.034881 | No Change: Both O | - |
| Q8WUT4 | LRRN4_HUMAN Leucine-rich repeat neuronal protein 4 OS=Homo sapiens GN=LRRN4 PE=1 SV=3 | 138 | P | 0.467131 | L | 0.31282 | 0.154311 | No Change: Both O | - |
| Q8WUT4 | LRRN4_HUMAN Leucine-rich repeat neuronal protein 4 OS=Homo sapiens GN=LRRN4 PE=1 SV=3 | 141 | T | 0.541286 | A | 0.562551 | -0.021265 | No Change: Both D | - |
| Q86UE6 | LRRT1_HUMAN Leucine-rich repeat transmembrane neuronal protein 1 OS=Homo sapiens GN=LRRTM1 PE=2 SV=2 | 330 | N | 0.128094 | S | 0.150963 | -0.022869 | No Change: Both O | - |
| Q6UWE0 | LRSM1_HUMAN E3 ubiquitin-protein ligase LRSAM1 OS=Homo sapiens GN=LRSAM1 PE=1 SV=1 | 318 | N | 0.978629 | D | 0.979344 | -7.15E-04 | No Change: Both D | - |
| Q9HBL6 | LRTM1_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRTM1 PE=1 SV=1 | 43 | E | 0.527689 | K | 0.536524 | -0.008835 | No Change: Both D | - |
| Q9HBL6 | LRTM1_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 1 OS=Homo sapiens GN=LRTM1 PE=1 SV=1 | 117 | L | 0.624814 | V | 0.555969 | 0.068845 | No Change: Both D | - |
| Q8N967 | LRTM2_HUMAN Leucine-rich repeat and transmembrane domain-containing protein 2 OS=Homo sapiens GN=LRTM2 PE=2 SV=1 | 161 | D | 0.548055 | N | 0.536319 | 0.011736 | No Change: Both D | - |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 16 | L | 0.363131 | P | 0.552313 | -0.189182 | O to D | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 158 | R | 0.340933 | H | 0.317121 | 0.023812 | No Change: Both O | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 208 | R | 0.222507 | Q | 0.244917 | -0.02241 | No Change: Both O | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 81 | R | 0.227729 | Q | 0.230426 | -0.002697 | No Change: Both O | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 105 | W | 0.261452 | R | 0.468241 | -0.206789 | No Change: Both O | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q8WZ04 | TOMT_HUMAN Transmembrane O-methyltransferase OS=Homo sapiens GN=LRTOMT PE=1 SV=3 | 110 | E | 0.331932 | K | 0.335123 | -0.003191 | No Change: Both O | Deafness autosomal recessive type 63 (DFNB63) [MIM:611451] |
| Q9H089 | LSG1_HUMAN Large subunit GTPase 1 homolog OS=Homo sapiens GN=LSG1 PE=1 SV=2 | 92 | L | 0.444 | P | 0.593923 | -0.149923 | O to D | - |
| Q9H089 | LSG1_HUMAN Large subunit GTPase 1 homolog OS=Homo sapiens GN=LSG1 PE=1 SV=2 | 267 | K | 0.830236 | E | 0.854493 | -0.024257 | No Change: Both D | - |
| Q3MHD2 | LSM12_HUMAN Protein LSM12 homolog OS=Homo sapiens GN=LSM12 PE=1 SV=2 | 77 | P | 0.597175 | R | 0.559401 | 0.037774 | No Change: Both D | - |
| Q3MHD2 | LSM12_HUMAN Protein LSM12 homolog OS=Homo sapiens GN=LSM12 PE=1 SV=2 | 173 | V | 0.727474 | L | 0.729668 | -0.002194 | No Change: Both D | - |
| Q8ND56 | LS14A_HUMAN Protein LSM14 homolog A OS=Homo sapiens GN=LSM14A PE=1 SV=3 | 448 | R | 0.944512 | Q | 0.914444 | 0.030068 | No Change: Both D | - |
| Q8ND56 | LS14A_HUMAN Protein LSM14 homolog A OS=Homo sapiens GN=LSM14A PE=1 SV=3 | 238 | R | 0.972474 | Q | 0.971739 | 7.35E-04 | No Change: Both D | - |
| P33241 | LSP1_HUMAN Lymphocyte-specific protein 1 OS=Homo sapiens GN=LSP1 PE=1 SV=1 | 100 | A | 0.988826 | T | 0.987663 | 0.001163 | No Change: Both D | - |
| P33241 | LSP1_HUMAN Lymphocyte-specific protein 1 OS=Homo sapiens GN=LSP1 PE=1 SV=1 | 229 | Q | 0.574541 | K | 0.589179 | -0.014638 | No Change: Both D | - |
| P33241 | LSP1_HUMAN Lymphocyte-specific protein 1 OS=Homo sapiens GN=LSP1 PE=1 SV=1 | 108 | Q | 0.986057 | L | 0.976419 | 0.009638 | No Change: Both D | - |
| Q86X29 | LSR_HUMAN Lipolysis-stimulated lipoprotein receptor OS=Homo sapiens GN=LSR PE=1 SV=4 | 363 | S | 0.868695 | N | 0.822989 | 0.045706 | No Change: Both D | - |
| P48449 | ERG7_HUMAN Lanosterol synthase OS=Homo sapiens GN=LSS PE=1 SV=1 | 642 | L | 0.490038 | V | 0.482855 | 0.007183 | No Change: Both O | - |
| P48449 | ERG7_HUMAN Lanosterol synthase OS=Homo sapiens GN=LSS PE=1 SV=1 | 175 | R | 0.314011 | Q | 0.319054 | -0.005043 | No Change: Both O | - |
| P48449 | ERG7_HUMAN Lanosterol synthase OS=Homo sapiens GN=LSS PE=1 SV=1 | 310 | H | 0.60486 | R | 0.594056 | 0.010804 | No Change: Both D | - |
| P48449 | ERG7_HUMAN Lanosterol synthase OS=Homo sapiens GN=LSS PE=1 SV=1 | 614 | R | 0.22446 | W | 0.096339 | 0.128121 | No Change: Both O | - |
| P48449 | ERG7_HUMAN Lanosterol synthase OS=Homo sapiens GN=LSS PE=1 SV=1 | 688 | P | 0.381799 | L | 0.220649 | 0.16115 | No Change: Both O | - |
| P01374 | TNFB_HUMAN Lymphotoxin-alpha OS=Homo sapiens GN=LTA PE=1 SV=2 | 60 | T | 0.657257 | N | 0.667001 | -0.009744 | No Change: Both D | - |
| P01374 | TNFB_HUMAN Lymphotoxin-alpha OS=Homo sapiens GN=LTA PE=1 SV=2 | 125 | T | 0.583246 | P | 0.630503 | -0.047257 | No Change: Both D | - |
| P01374 | TNFB_HUMAN Lymphotoxin-alpha OS=Homo sapiens GN=LTA PE=1 SV=2 | 13 | C | 0.254213 | R | 0.425878 | -0.171665 | No Change: Both O | - |
| P01374 | TNFB_HUMAN Lymphotoxin-alpha OS=Homo sapiens GN=LTA PE=1 SV=2 | 51 | H | 0.736185 | P | 0.777537 | -0.041352 | No Change: Both D | - |
| P09960 | LKHA4_HUMAN Leukotriene A-4 hydrolase OS=Homo sapiens GN=LTA4H PE=1 SV=2 | 131 | Y | 0.379471 | H | 0.526975 | -0.147504 | O to D | - |
| Q06643 | TNFC_HUMAN Lymphotoxin-beta OS=Homo sapiens GN=LTB PE=1 SV=1 | 70 | G | 0.791823 | E | 0.825856 | -0.034033 | No Change: Both D | - |
| Q06643 | TNFC_HUMAN Lymphotoxin-beta OS=Homo sapiens GN=LTB PE=1 SV=1 | 111 | A | 0.444195 | P | 0.536687 | -0.092492 | O to D | - |
| Q06643 | TNFC_HUMAN Lymphotoxin-beta OS=Homo sapiens GN=LTB PE=1 SV=1 | 84 | S | 0.812433 | R | 0.789554 | 0.022879 | No Change: Both D | - |
| Q06643 | TNFC_HUMAN Lymphotoxin-beta OS=Homo sapiens GN=LTB PE=1 SV=1 | 87 | L | 0.765088 | F | 0.730558 | 0.03453 | No Change: Both D | - |
| Q06643 | TNFC_HUMAN Lymphotoxin-beta OS=Homo sapiens GN=LTB PE=1 SV=1 | 122 | A | 0.476176 | D | 0.542806 | -0.06663 | O to D | - |
| Q15722 | LT4R1_HUMAN Leukotriene B4 receptor 1 OS=Homo sapiens GN=LTB4R PE=1 SV=2 | 346 | L | 0.97608 | F | 0.96153 | 0.01455 | No Change: Both D | - |
| Q14767 | LTBP2_HUMAN Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens GN=LTBP2 PE=1 SV=3 | 319 | P | 0.876131 | Q | 0.86309 | 0.013041 | No Change: Both D | - |
| Q14767 | LTBP2_HUMAN Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens GN=LTBP2 PE=1 SV=3 | 37 | R | 0.511126 | M | 0.427761 | 0.083365 | D to O | - |
| Q14767 | LTBP2_HUMAN Latent-transforming growth factor beta-binding protein 2 OS=Homo sapiens GN=LTBP2 PE=1 SV=3 | 591 | P | 0.311618 | S | 0.29171 | 0.019908 | No Change: Both O | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 194 | V | 0.602925 | I | 0.537111 | 0.065814 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 635 | R | 0.717187 | G | 0.70224 | 0.014947 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 679 | P | 0.650199 | A | 0.554201 | 0.095998 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 787 | T | 0.836818 | A | 0.827495 | 0.009323 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 820 | T | 0.882029 | A | 0.871625 | 0.010404 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 1141 | T | 0.966411 | M | 0.966671 | -2.60E-04 | No Change: Both D | - |
| Q8N2S1 | LTBP4_HUMAN Latent-transforming growth factor beta-binding protein 4 OS=Homo sapiens GN=LTBP4 PE=1 SV=2 | 311 | C | 0.357705 | G | 0.432366 | -0.074661 | No Change: Both O | Urban-Rifkin-Davis syndrome (URDS) [MIM:613177] |
| P36941 | TNR3_HUMAN Tumor necrosis factor receptor superfamily member 3 OS=Homo sapiens GN=LTBR PE=1 SV=1 | 274 | V | 0.706767 | I | 0.683074 | 0.023693 | No Change: Both D | - |
| Q16873 | LTC4S_HUMAN Leukotriene C4 synthase OS=Homo sapiens GN=LTC4S PE=1 SV=1 | 142 | R | 0.1772 | Q | 0.158987 | 0.018213 | No Change: Both O | - |
| P02788 | TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6 | 29 | A | 0.238102 | T | 0.259788 | -0.021686 | No Change: Both O | - |
| P02788 | TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6 | 47 | K | 0.511185 | R | 0.510202 | 9.83E-04 | No Change: Both D | - |
| P02788 | TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6 | 148 | I | 0.144496 | T | 0.26059 | -0.116094 | No Change: Both O | - |
| P02788 | TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6 | 422 | G | 0.212406 | C | 0.154969 | 0.057437 | No Change: Both O | - |
| P02788 | TRFL_HUMAN Lactotransferrin OS=Homo sapiens GN=LTF PE=1 SV=6 | 579 | E | 0.450131 | D | 0.453781 | -0.00365 | No Change: Both O | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 42 | R | 0.952027 | Q | 0.952429 | -4.02E-04 | No Change: Both D | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 384 | C | 0.280359 | R | 0.391103 | -0.110744 | No Change: Both O | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 535 | D | 0.451116 | N | 0.4331 | 0.018016 | No Change: Both O | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 569 | R | 0.131859 | S | 0.171012 | -0.039153 | No Change: Both O | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 673 | R | 0.27237 | Q | 0.263565 | 0.008805 | No Change: Both O | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 745 | P | 0.601755 | S | 0.592591 | 0.009164 | No Change: Both D | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 838 | P | 0.942016 | S | 0.941354 | 6.62E-04 | No Change: Both D | - |
| P29376 | LTK_HUMAN Leukocyte tyrosine kinase receptor OS=Homo sapiens GN=LTK PE=1 SV=3 | 763 | E | 0.416273 | K | 0.384124 | 0.032149 | No Change: Both O | - |
| O94822 | LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens GN=LTN1 PE=1 SV=6 | 403 | L | 0.648283 | S | 0.734801 | -0.086518 | No Change: Both D | - |
| O94822 | LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens GN=LTN1 PE=1 SV=6 | 500 | A | 0.284507 | V | 0.237026 | 0.047481 | No Change: Both O | - |
| O94822 | LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens GN=LTN1 PE=1 SV=6 | 565 | G | 0.828238 | C | 0.783383 | 0.044855 | No Change: Both D | - |
| O94822 | LTN1_HUMAN E3 ubiquitin-protein ligase listerin OS=Homo sapiens GN=LTN1 PE=1 SV=6 | 761 | V | 0.788023 | I | 0.762846 | 0.025177 | No Change: Both D | - |
| Q9Y383 | LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens GN=LUC7L2 PE=1 SV=2 | 361 | D | 0.999419 | E | 0.999393 | 2.60E-05 | No Change: Both D | - |
| P51884 | LUM_HUMAN Lumican OS=Homo sapiens GN=LUM PE=1 SV=2 | 199 | L | 0.261272 | P | 0.402136 | -0.140864 | No Change: Both O | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 458 | G | 0.970607 | S | 0.979853 | -0.009246 | No Change: Both D | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 461 | Q | 0.975065 | K | 0.977595 | -0.00253 | No Change: Both D | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 868 | D | 0.704938 | N | 0.664028 | 0.04091 | No Change: Both D | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 317 | S | 0.958961 | A | 0.933388 | 0.025573 | No Change: Both D | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 491 | T | 0.944215 | I | 0.893629 | 0.050586 | No Change: Both D | - |
| Q86V48 | LUZP1_HUMAN Leucine zipper protein 1 OS=Homo sapiens GN=LUZP1 PE=1 SV=2 | 1034 | S | 0.472899 | N | 0.426244 | 0.046655 | No Change: Both O | - |
| Q86TE4 | LUZP2_HUMAN Leucine zipper protein 2 OS=Homo sapiens GN=LUZP2 PE=2 SV=2 | 308 | E | 0.984082 | Q | 0.98233 | 0.001752 | No Change: Both D | - |
| Q9P127 | LUZP4_HUMAN Leucine zipper protein 4 OS=Homo sapiens GN=LUZP4 PE=2 SV=1 | 14 | P | 0.753824 | S | 0.767532 | -0.013708 | No Change: Both D | - |
| Q9P127 | LUZP4_HUMAN Leucine zipper protein 4 OS=Homo sapiens GN=LUZP4 PE=2 SV=1 | 306 | T | 0.855274 | A | 0.807143 | 0.048131 | No Change: Both D | - |
| Q9BS40 | LXN_HUMAN Latexin OS=Homo sapiens GN=LXN PE=1 SV=2 | 53 | H | 0.256772 | R | 0.262025 | -0.005253 | No Change: Both O | - |
| Q9BS40 | LXN_HUMAN Latexin OS=Homo sapiens GN=LXN PE=1 SV=2 | 134 | T | 0.162495 | M | 0.144579 | 0.017916 | No Change: Both O | - |
| Q14210 | LY6D_HUMAN Lymphocyte antigen 6D OS=Homo sapiens GN=LY6D PE=1 SV=1 | 10 | A | 0.219359 | T | 0.243967 | -0.024608 | No Change: Both O | - |
| Q8NDX9 | LY65B_HUMAN Lymphocyte antigen 6 complex locus protein G5b OS=Homo sapiens GN=LY6G5B PE=1 SV=1 | 102 | D | 0.338184 | N | 0.339017 | -8.33E-04 | No Change: Both O | - |
| Q8NDX9 | LY65B_HUMAN Lymphocyte antigen 6 complex locus protein G5b OS=Homo sapiens GN=LY6G5B PE=1 SV=1 | 131 | S | 0.505411 | Y | 0.319196 | 0.186215 | D to O | - |
| Q8NDX9 | LY65B_HUMAN Lymphocyte antigen 6 complex locus protein G5b OS=Homo sapiens GN=LY6G5B PE=1 SV=1 | 176 | R | 0.187887 | C | 0.102154 | 0.085733 | No Change: Both O | - |
| O95867 | LY66C_HUMAN Lymphocyte antigen 6 complex locus protein G6c OS=Homo sapiens GN=LY6G6C PE=1 SV=1 | 63 | L | 0.213645 | M | 0.2738 | -0.060155 | No Change: Both O | - |
| O95868 | LY66D_HUMAN Lymphocyte antigen 6 complex locus protein G6d OS=Homo sapiens GN=LY6G6D PE=1 SV=1 | 9 | L | 0.214547 | V | 0.188053 | 0.026494 | No Change: Both O | - |
| O95868 | LY66D_HUMAN Lymphocyte antigen 6 complex locus protein G6d OS=Homo sapiens GN=LY6G6D PE=1 SV=1 | 34 | S | 0.735754 | T | 0.676459 | 0.059295 | No Change: Both D | - |
| Q5SQ64 | LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens GN=LY6G6F PE=1 SV=2 | 34 | P | 0.437219 | Q | 0.391196 | 0.046023 | No Change: Both O | - |
| Q5SQ64 | LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens GN=LY6G6F PE=1 SV=2 | 39 | P | 0.590571 | S | 0.609306 | -0.018735 | No Change: Both D | - |
| Q5SQ64 | LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens GN=LY6G6F PE=1 SV=2 | 107 | A | 0.088476 | T | 0.093796 | -0.00532 | No Change: Both O | - |
| Q5SQ64 | LY66F_HUMAN Lymphocyte antigen 6 complex locus protein G6f OS=Homo sapiens GN=LY6G6F PE=1 SV=2 | 167 | R | 0.479689 | K | 0.476814 | 0.002875 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 692 | D | 0.427668 | N | 0.41149 | 0.016178 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 268 | E | 0.417604 | D | 0.368966 | 0.048638 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 486 | K | 0.632556 | M | 0.506304 | 0.126252 | No Change: Both D | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 807 | D | 0.439122 | E | 0.448772 | -0.00965 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 884 | D | 0.235475 | A | 0.158727 | 0.076748 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 1202 | T | 0.10675 | S | 0.140374 | -0.033624 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 1321 | K | 0.150632 | N | 0.129317 | 0.021315 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 1347 | K | 0.394412 | R | 0.317329 | 0.077083 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 1391 | Y | 0.433763 | H | 0.54956 | -0.115797 | O to D | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 20 | W | 0.028122 | R | 0.090223 | -0.062101 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 666 | V | 0.293107 | A | 0.367795 | -0.074688 | No Change: Both O | - |
| O60449 | LY75_HUMAN Lymphocyte antigen 75 OS=Homo sapiens GN=LY75 PE=1 SV=3 | 1393 | T | 0.350798 | I | 0.20203 | 0.148768 | No Change: Both O | - |
| O95711 | LY86_HUMAN Lymphocyte antigen 86 OS=Homo sapiens GN=LY86 PE=1 SV=1 | 160 | M | 0.601178 | V | 0.52783 | 0.073348 | No Change: Both D | - |
| O95711 | LY86_HUMAN Lymphocyte antigen 86 OS=Homo sapiens GN=LY86 PE=1 SV=1 | 93 | S | 0.372292 | P | 0.327353 | 0.044939 | No Change: Both O | - |
| O95711 | LY86_HUMAN Lymphocyte antigen 86 OS=Homo sapiens GN=LY86 PE=1 SV=1 | 121 | Y | 0.257389 | C | 0.223543 | 0.033846 | No Change: Both O | - |
| Q9HBG7 | LY9_HUMAN T-lymphocyte surface antigen Ly-9 OS=Homo sapiens GN=LY9 PE=1 SV=3 | 602 | M | 0.324315 | V | 0.303395 | 0.02092 | No Change: Both O | - |
| Q9Y6Y9 | LY96_HUMAN Lymphocyte antigen 96 OS=Homo sapiens GN=LY96 PE=1 SV=2 | 157 | P | 0.645051 | S | 0.682755 | -0.037704 | No Change: Both D | - |
| Q9Y6Y9 | LY96_HUMAN Lymphocyte antigen 96 OS=Homo sapiens GN=LY96 PE=1 SV=2 | 56 | R | 0.297892 | G | 0.329036 | -0.031144 | No Change: Both O | - |
| Q9NX58 | LYAR_HUMAN Cell growth-regulating nucleolar protein OS=Homo sapiens GN=LYAR PE=1 SV=2 | 151 | D | 0.776535 | Y | 0.651538 | 0.124997 | No Change: Both D | - |
| Q9NX58 | LYAR_HUMAN Cell growth-regulating nucleolar protein OS=Homo sapiens GN=LYAR PE=1 SV=2 | 265 | H | 0.994448 | R | 0.995794 | -0.001346 | No Change: Both D | - |
| P07948 | LYN_HUMAN Tyrosine-protein kinase Lyn OS=Homo sapiens GN=LYN PE=1 SV=3 | 385 | D | 0.091547 | Y | 0.045046 | 0.046501 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q6UXB3 | LYPD2_HUMAN Ly6/PLAUR domain-containing protein 2 OS=Homo sapiens GN=LYPD2 PE=2 SV=1 | 5 | R | 0.441504 | Q | 0.43696 | 0.004544 | No Change: Both O | - |
| Q6UXB3 | LYPD2_HUMAN Ly6/PLAUR domain-containing protein 2 OS=Homo sapiens GN=LYPD2 PE=2 SV=1 | 7 | A | 0.237923 | V | 0.166375 | 0.071548 | No Change: Both O | - |
| Q6UWN0 | LYPD4_HUMAN Ly6/PLAUR domain-containing protein 4 OS=Homo sapiens GN=LYPD4 PE=2 SV=2 | 184 | T | 0.081489 | S | 0.107799 | -0.02631 | No Change: Both O | - |
| Q6UWN5 | LYPD5_HUMAN Ly6/PLAUR domain-containing protein 5 OS=Homo sapiens GN=LYPD5 PE=1 SV=2 | 47 | P | 0.309902 | A | 0.236881 | 0.073021 | No Change: Both O | - |
| Q6UWN5 | LYPD5_HUMAN Ly6/PLAUR domain-containing protein 5 OS=Homo sapiens GN=LYPD5 PE=1 SV=2 | 90 | A | 0.591167 | P | 0.657868 | -0.066701 | No Change: Both D | - |
| Q6UWN5 | LYPD5_HUMAN Ly6/PLAUR domain-containing protein 5 OS=Homo sapiens GN=LYPD5 PE=1 SV=2 | 167 | N | 0.409764 | S | 0.464371 | -0.054607 | No Change: Both O | - |
| O75608 | LYPA1_HUMAN Acyl-protein thioesterase 1 OS=Homo sapiens GN=LYPLA1 PE=1 SV=1 | 153 | P | 0.355581 | S | 0.377097 | -0.021516 | No Change: Both O | - |
| Q5VWZ2 | LYPL1_HUMAN Lysophospholipase-like protein 1 OS=Homo sapiens GN=LYPLAL1 PE=1 SV=3 | 131 | I | 0.120177 | M | 0.192701 | -0.072524 | No Change: Both O | - |
| Q5VWZ2 | LYPL1_HUMAN Lysophospholipase-like protein 1 OS=Homo sapiens GN=LYPLAL1 PE=1 SV=3 | 197 | L | 0.467418 | V | 0.470722 | -0.003304 | No Change: Both O | - |
| Q9NU23 | LYRM2_HUMAN LYR motif-containing protein 2 OS=Homo sapiens GN=LYRM2 PE=1 SV=1 | 46 | K | 0.491525 | E | 0.502067 | -0.010542 | O to D | - |
| Q9NU23 | LYRM2_HUMAN LYR motif-containing protein 2 OS=Homo sapiens GN=LYRM2 PE=1 SV=1 | 34 | R | 0.392852 | W | 0.186074 | 0.206778 | No Change: Both O | - |
| Q9NU23 | LYRM2_HUMAN LYR motif-containing protein 2 OS=Homo sapiens GN=LYRM2 PE=1 SV=1 | 60 | T | 0.729076 | P | 0.74125 | -0.012174 | No Change: Both D | - |
| Q9HD34 | LYRM4_HUMAN LYR motif-containing protein 4 OS=Homo sapiens GN=LYRM4 PE=1 SV=1 | 11 | S | 0.487803 | A | 0.380049 | 0.107754 | No Change: Both O | - |
| Q8IV50 | LYSM2_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Homo sapiens GN=LYSMD2 PE=1 SV=1 | 107 | I | 0.096639 | V | 0.101332 | -0.004693 | No Change: Both O | - |
| Q8IV50 | LYSM2_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Homo sapiens GN=LYSMD2 PE=1 SV=1 | 164 | S | 0.96836 | F | 0.940789 | 0.027571 | No Change: Both D | - |
| Q5XG99 | LYSM4_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 4 OS=Homo sapiens GN=LYSMD4 PE=2 SV=2 | 157 | A | 0.596184 | V | 0.509837 | 0.086347 | No Change: Both D | - |
| Q5XG99 | LYSM4_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 4 OS=Homo sapiens GN=LYSMD4 PE=2 SV=2 | 161 | A | 0.528358 | V | 0.432629 | 0.095729 | D to O | - |
| Q5XG99 | LYSM4_HUMAN LysM and putative peptidoglycan-binding domain-containing protein 4 OS=Homo sapiens GN=LYSMD4 PE=2 SV=2 | 180 | A | 0.321589 | G | 0.361699 | -0.04011 | No Change: Both O | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 1563 | R | 0.083346 | H | 0.087993 | -0.004647 | No Change: Both O | Chediak-Higashi syndrome (CHS) [MIM:214500] |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 1999 | V | 0.198308 | D | 0.339582 | -0.141274 | No Change: Both O | Chediak-Higashi syndrome (CHS) [MIM:214500] |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 123 | H | 0.84198 | R | 0.877683 | -0.035703 | No Change: Both D | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 192 | L | 0.766358 | V | 0.70086 | 0.065498 | No Change: Both D | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 702 | E | 0.274976 | G | 0.213621 | 0.061355 | No Change: Both O | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 1017 | S | 0.777581 | N | 0.764389 | 0.013192 | No Change: Both D | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 1949 | Q | 0.25837 | H | 0.245259 | 0.013111 | No Change: Both O | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 2598 | F | 0.693033 | Y | 0.68205 | 0.010983 | No Change: Both D | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 2804 | G | 0.560602 | D | 0.565847 | -0.005245 | No Change: Both D | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 2936 | V | 0.108225 | I | 0.10669 | 0.001535 | No Change: Both O | - |
| Q99698 | LYST_HUMAN Lysosomal-trafficking regulator OS=Homo sapiens GN=LYST PE=1 SV=3 | 2116 | T | 0.692537 | M | 0.658993 | 0.033544 | No Change: Both D | - |
| Q9Y5Y7 | LYVE1_HUMAN Lymphatic vessel endothelial hyaluronic acid receptor 1 OS=Homo sapiens GN=LYVE1 PE=1 SV=2 | 116 | W | 0.071257 | R | 0.182454 | -0.111197 | No Change: Both O | - |
| Q9Y5Y7 | LYVE1_HUMAN Lymphatic vessel endothelial hyaluronic acid receptor 1 OS=Homo sapiens GN=LYVE1 PE=1 SV=2 | 214 | T | 0.694325 | I | 0.565746 | 0.128579 | No Change: Both D | - |
| Q9Y5Y7 | LYVE1_HUMAN Lymphatic vessel endothelial hyaluronic acid receptor 1 OS=Homo sapiens GN=LYVE1 PE=1 SV=2 | 315 | V | 0.992233 | M | 0.994487 | -0.002254 | No Change: Both D | - |
| P61626 | LYSC_HUMAN Lysozyme C OS=Homo sapiens GN=LYZ PE=1 SV=1 | 74 | I | 0.199406 | T | 0.317452 | -0.118046 | No Change: Both O | Amyloidosis type 8 (AMYL8) [MIM:105200] |
| P61626 | LYSC_HUMAN Lysozyme C OS=Homo sapiens GN=LYZ PE=1 SV=1 | 85 | D | 0.294822 | H | 0.265391 | 0.029431 | No Change: Both O | Amyloidosis type 8 (AMYL8) [MIM:105200] |
| P61626 | LYSC_HUMAN Lysozyme C OS=Homo sapiens GN=LYZ PE=1 SV=1 | 88 | T | 0.342928 | N | 0.402393 | -0.059465 | No Change: Both O | - |
| Q6UWQ5 | LYZL1_HUMAN Lysozyme-like protein 1 OS=Homo sapiens GN=LYZL1 PE=2 SV=2 | 62 | Q | 0.376768 | P | 0.39841 | -0.021642 | No Change: Both O | - |
| Q7Z4W2 | LYZL2_HUMAN Lysozyme-like protein 2 OS=Homo sapiens GN=LYZL2 PE=2 SV=2 | 144 | D | 0.646054 | G | 0.626609 | 0.019445 | No Change: Both D | - |
| O75951 | LYZL6_HUMAN Lysozyme-like protein 6 OS=Homo sapiens GN=LYZL6 PE=2 SV=1 | 139 | F | 0.058907 | S | 0.162284 | -0.103377 | No Change: Both O | - |
| Q8WZA0 | LZIC_HUMAN Protein LZIC OS=Homo sapiens GN=LZIC PE=1 SV=1 | 104 | G | 0.506878 | D | 0.549267 | -0.042389 | No Change: Both D | - |
| Q9NQ48 | LZTL1_HUMAN Leucine zipper transcription factor-like protein 1 OS=Homo sapiens GN=LZTFL1 PE=1 SV=1 | 152 | K | 0.773463 | E | 0.78211 | -0.008647 | No Change: Both D | - |
| Q9NQ48 | LZTL1_HUMAN Leucine zipper transcription factor-like protein 1 OS=Homo sapiens GN=LZTFL1 PE=1 SV=1 | 246 | D | 0.804981 | N | 0.821179 | -0.016198 | No Change: Both D | - |
| Q9NQ48 | LZTL1_HUMAN Leucine zipper transcription factor-like protein 1 OS=Homo sapiens GN=LZTFL1 PE=1 SV=1 | 251 | Q | 0.793183 | R | 0.774955 | 0.018228 | No Change: Both D | - |
| Q9Y250 | LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 OS=Homo sapiens GN=LZTS1 PE=1 SV=3 | 29 | S | 0.879595 | P | 0.83665 | 0.042945 | No Change: Both D | - |
| Q9Y250 | LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 OS=Homo sapiens GN=LZTS1 PE=1 SV=3 | 119 | K | 0.806881 | E | 0.815712 | -0.008831 | No Change: Both D | - |
| Q9Y250 | LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 OS=Homo sapiens GN=LZTS1 PE=1 SV=3 | 475 | L | 0.87974 | V | 0.858838 | 0.020902 | No Change: Both D | - |
| Q9Y250 | LZTS1_HUMAN Leucine zipper putative tumor suppressor 1 OS=Homo sapiens GN=LZTS1 PE=1 SV=3 | 50 | S | 0.877961 | F | 0.788451 | 0.08951 | No Change: Both D | - |
| Q9BRK4 | LZTS2_HUMAN Leucine zipper putative tumor suppressor 2 OS=Homo sapiens GN=LZTS2 PE=1 SV=2 | 299 | R | 0.995241 | W | 0.98813 | 0.007111 | No Change: Both D | - |
| Q9BRK4 | LZTS2_HUMAN Leucine zipper putative tumor suppressor 2 OS=Homo sapiens GN=LZTS2 PE=1 SV=2 | 121 | R | 0.818813 | H | 0.796869 | 0.021944 | No Change: Both D | A colorectal cancer sample |
| Q9BRK4 | LZTS2_HUMAN Leucine zipper putative tumor suppressor 2 OS=Homo sapiens GN=LZTS2 PE=1 SV=2 | 291 | G | 0.995748 | R | 0.995985 | -2.37E-04 | No Change: Both D | A breast cancer sample |
| Q13394 | MB211_HUMAN Protein mab-21-like 1 OS=Homo sapiens GN=MAB21L1 PE=2 SV=1 | 70 | S | 0.261243 | P | 0.251981 | 0.009262 | No Change: Both O | - |
| Q6ZN28 | MACC1_HUMAN Metastasis-associated in colon cancer protein 1 OS=Homo sapiens GN=MACC1 PE=1 SV=2 | 31 | L | 0.488882 | V | 0.454818 | 0.034064 | No Change: Both O | - |
| Q6ZN28 | MACC1_HUMAN Metastasis-associated in colon cancer protein 1 OS=Homo sapiens GN=MACC1 PE=1 SV=2 | 50 | P | 0.245011 | L | 0.143553 | 0.101458 | No Change: Both O | - |
| Q6ZN28 | MACC1_HUMAN Metastasis-associated in colon cancer protein 1 OS=Homo sapiens GN=MACC1 PE=1 SV=2 | 515 | S | 0.650744 | L | 0.517908 | 0.132836 | No Change: Both D | - |
| Q6ZN28 | MACC1_HUMAN Metastasis-associated in colon cancer protein 1 OS=Homo sapiens GN=MACC1 PE=1 SV=2 | 728 | E | 0.117062 | A | 0.078305 | 0.038757 | No Change: Both O | - |
| Q6ZN28 | MACC1_HUMAN Metastasis-associated in colon cancer protein 1 OS=Homo sapiens GN=MACC1 PE=1 SV=2 | 804 | R | 0.332167 | T | 0.31718 | 0.014987 | No Change: Both O | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 39 | I | 0.416311 | V | 0.41237 | 0.003941 | No Change: Both O | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 498 | T | 0.895698 | I | 0.823319 | 0.072379 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 916 | A | 0.502533 | G | 0.553054 | -0.050521 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 1743 | K | 0.841252 | T | 0.830762 | 0.01049 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 2792 | M | 0.77085 | V | 0.719859 | 0.050991 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 4745 | K | 0.425669 | R | 0.384844 | 0.040825 | No Change: Both O | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 4852 | A | 0.769241 | T | 0.78584 | -0.016599 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 5296 | T | 0.394865 | I | 0.238192 | 0.156673 | No Change: Both O | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 5399 | I | 0.056224 | V | 0.061369 | -0.005145 | No Change: Both O | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 1625 | K | 0.746953 | N | 0.681418 | 0.065535 | No Change: Both D | - |
| Q96PK2 | MACF4_HUMAN Microtubule-actin cross-linking factor 1 isoform 4 OS=Homo sapiens GN=MACF1 PE=1 SV=2 | 5172 | S | 0.558638 | T | 0.544059 | 0.014579 | No Change: Both D | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 302 | E | 0.492269 | V | 0.353085 | 0.139184 | No Change: Both O | A breast cancer sample |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6462 | E | 0.306898 | Q | 0.283926 | 0.022972 | No Change: Both O | A breast cancer sample |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 4357 | M | 0.77085 | V | 0.719859 | 0.050991 | No Change: Both D | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6201 | K | 0.425669 | R | 0.384844 | 0.040825 | No Change: Both O | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6308 | A | 0.769241 | T | 0.78584 | -0.016599 | No Change: Both D | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6628 | S | 0.558638 | T | 0.544059 | 0.014579 | No Change: Both D | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6752 | T | 0.394865 | I | 0.238192 | 0.156673 | No Change: Both O | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 6855 | I | 0.056224 | V | 0.061369 | -0.005145 | No Change: Both O | - |
| Q9UPN3 | MACF1_HUMAN Microtubule-actin cross-linking factor 1 isoforms 1/2/3/5 OS=Homo sapiens GN=MACF1 PE=1 SV=4 | 7093 | G | 0.291264 | E | 0.325794 | -0.03453 | No Change: Both O | A breast cancer sample |
| A1Z1Q3 | MACD2_HUMAN MACRO domain-containing protein 2 OS=Homo sapiens GN=MACROD2 PE=1 SV=1 | 58 | T | 0.844847 | I | 0.773669 | 0.071178 | No Change: Both D | - |
| A1Z1Q3 | MACD2_HUMAN MACRO domain-containing protein 2 OS=Homo sapiens GN=MACROD2 PE=1 SV=1 | 335 | T | 0.950052 | M | 0.943355 | 0.006697 | No Change: Both D | - |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 29 | S | 0.716669 | L | 0.574219 | 0.14245 | No Change: Both D | A lymphoid cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 59 | R | 0.930821 | C | 0.882747 | 0.048074 | No Change: Both D | A prostate cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 160 | N | 0.717716 | S | 0.78423 | -0.066514 | No Change: Both D | - |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 299 | T | 0.845486 | A | 0.825644 | 0.019842 | No Change: Both D | Lung cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 360 | R | 0.887367 | Q | 0.891994 | -0.004627 | No Change: Both D | A prostate cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 500 | T | 0.96843 | M | 0.976092 | -0.007662 | No Change: Both D | - |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 511 | E | 0.970801 | K | 0.965808 | 0.004993 | No Change: Both D | - |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 516 | E | 0.955648 | K | 0.94887 | 0.006778 | No Change: Both D | A breast cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 556 | R | 0.777889 | C | 0.664262 | 0.113627 | No Change: Both D | A prostate cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 556 | R | 0.777889 | H | 0.734154 | 0.043735 | No Change: Both D | One individual with lung cancer |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 558 | R | 0.792506 | H | 0.751297 | 0.041209 | No Change: Both D | A cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 569 | E | 0.777674 | K | 0.743412 | 0.034262 | No Change: Both D | A breast cancer cell line |
| Q9Y6D9 | MD1L1_HUMAN Mitotic spindle assembly checkpoint protein MAD1 OS=Homo sapiens GN=MAD1L1 PE=1 SV=2 | 572 | R | 0.745827 | H | 0.678391 | 0.067436 | No Change: Both D | A cancer cell line |
| Q13477 | MADCA_HUMAN Mucosal addressin cell adhesion molecule 1 OS=Homo sapiens GN=MADCAM1 PE=1 SV=2 | 300 | P | 0.911912 | H | 0.869164 | 0.042748 | No Change: Both D | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 696 | P | 0.994511 | T | 0.992534 | 0.001977 | No Change: Both D | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 751 | V | 0.793854 | M | 0.82667 | -0.032816 | No Change: Both D | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 968 | R | 0.402287 | G | 0.379139 | 0.023148 | No Change: Both O | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 1040 | L | 0.143465 | F | 0.12529 | 0.018175 | No Change: Both O | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 765 | R | 0.797711 | Q | 0.789423 | 0.008288 | No Change: Both D | - |
| Q8WXG6 | MADD_HUMAN MAP kinase-activating death domain protein OS=Homo sapiens GN=MADD PE=1 SV=2 | 1518 | L | 0.199728 | P | 0.343318 | -0.14359 | No Change: Both O | - |
| Q7L5Y9 | MAEA_HUMAN Macrophage erythroblast attacher OS=Homo sapiens GN=MAEA PE=1 SV=1 | 34 | R | 0.353054 | C | 0.217198 | 0.135856 | No Change: Both O | - |
| Q96JY0 | MAEL_HUMAN Protein maelstrom homolog OS=Homo sapiens GN=MAEL PE=1 SV=1 | 41 | S | 0.278064 | A | 0.228881 | 0.049183 | No Change: Both O | - |
| O75444 | MAF_HUMAN Transcription factor Maf OS=Homo sapiens GN=MAF PE=1 SV=2 | 288 | R | 0.745518 | P | 0.702906 | 0.042612 | No Change: Both D | Cataract pulverulent juvenile-onset MAF-related (CAPJOM) [MIM:610202] |
| O75444 | MAF_HUMAN Transcription factor Maf OS=Homo sapiens GN=MAF PE=1 SV=2 | 297 | K | 0.773277 | R | 0.769798 | 0.003479 | No Change: Both D | Cataract congenital cerulean type 4 (CCA4) [MIM:610202] |
| Q9H063 | MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog OS=Homo sapiens GN=MAF1 PE=1 SV=2 | 236 | G | 0.978043 | R | 0.980927 | -0.002884 | No Change: Both D | - |
| P20916 | MAG_HUMAN Myelin-associated glycoprotein OS=Homo sapiens GN=MAG PE=1 SV=1 | 202 | L | 0.105802 | M | 0.125516 | -0.019714 | No Change: Both O | - |
| P43355 | MAGA1_HUMAN Melanoma-associated antigen 1 OS=Homo sapiens GN=MAGEA1 PE=1 SV=1 | 32 | T | 0.845448 | A | 0.846107 | -6.59E-04 | No Change: Both D | - |
| P43355 | MAGA1_HUMAN Melanoma-associated antigen 1 OS=Homo sapiens GN=MAGEA1 PE=1 SV=1 | 72 | R | 0.952637 | Q | 0.95511 | -0.002473 | No Change: Both D | - |
| P43355 | MAGA1_HUMAN Melanoma-associated antigen 1 OS=Homo sapiens GN=MAGEA1 PE=1 SV=1 | 278 | K | 0.138229 | T | 0.105488 | 0.032741 | No Change: Both O | A breast cancer sample |
| P43355 | MAGA1_HUMAN Melanoma-associated antigen 1 OS=Homo sapiens GN=MAGEA1 PE=1 SV=1 | 63 | A | 0.962672 | T | 0.970401 | -0.007729 | No Change: Both D | - |
| P43363 | MAGAA_HUMAN Melanoma-associated antigen 10 OS=Homo sapiens GN=MAGEA10 PE=2 SV=2 | 166 | R | 0.211185 | K | 0.267957 | -0.056772 | No Change: Both O | - |
| P43363 | MAGAA_HUMAN Melanoma-associated antigen 10 OS=Homo sapiens GN=MAGEA10 PE=2 SV=2 | 234 | V | 0.018437 | I | 0.018207 | 2.30E-04 | No Change: Both O | - |
| P43364 | MAGAB_HUMAN Melanoma-associated antigen 11 OS=Homo sapiens GN=MAGEA11 PE=1 SV=2 | 191 | S | 0.983168 | R | 0.97379 | 0.009378 | No Change: Both D | - |
| P43365 | MAGAC_HUMAN Melanoma-associated antigen 12 OS=Homo sapiens GN=MAGEA12 PE=2 SV=2 | 57 | E | 0.935292 | D | 0.919744 | 0.015548 | No Change: Both D | - |
| P43358 | MAGA4_HUMAN Melanoma-associated antigen 4 OS=Homo sapiens GN=MAGEA4 PE=1 SV=2 | 173 | A | 0.410192 | T | 0.465704 | -0.055512 | No Change: Both O | - |
| P43358 | MAGA4_HUMAN Melanoma-associated antigen 4 OS=Homo sapiens GN=MAGEA4 PE=1 SV=2 | 153 | G | 0.192541 | D | 0.209381 | -0.01684 | No Change: Both O | A breast cancer sample |
| P43359 | MAGA5_HUMAN Melanoma-associated antigen 5 OS=Homo sapiens GN=MAGEA5 PE=2 SV=1 | 29 | Q | 0.888534 | H | 0.847977 | 0.040557 | No Change: Both D | - |
| P43360 | MAGA6_HUMAN Melanoma-associated antigen 6 OS=Homo sapiens GN=MAGEA6 PE=2 SV=1 | 152 | S | 0.212483 | I | 0.083277 | 0.129206 | No Change: Both O | - |
| P43361 | MAGA8_HUMAN Melanoma-associated antigen 8 OS=Homo sapiens GN=MAGEA8 PE=2 SV=2 | 121 | R | 0.259095 | H | 0.218802 | 0.040293 | No Change: Both O | - |
| P43361 | MAGA8_HUMAN Melanoma-associated antigen 8 OS=Homo sapiens GN=MAGEA8 PE=2 SV=2 | 306 | S | 0.428193 | F | 0.203568 | 0.224625 | No Change: Both O | - |
| P43362 | MAGA9_HUMAN Melanoma-associated antigen 9 OS=Homo sapiens GN=MAGEA9 PE=2 SV=1 | 31 | P | 0.991571 | H | 0.988177 | 0.003394 | No Change: Both D | - |
| P43366 | MAGB1_HUMAN Melanoma-associated antigen B1 OS=Homo sapiens GN=MAGEB1 PE=1 SV=2 | 267 | R | 0.327098 | C | 0.189741 | 0.137357 | No Change: Both O | - |
| Q96LZ2 | MAGBA_HUMAN Melanoma-associated antigen B10 OS=Homo sapiens GN=MAGEB10 PE=2 SV=4 | 65 | R | 0.907003 | Q | 0.917653 | -0.01065 | No Change: Both D | - |
| Q96LZ2 | MAGBA_HUMAN Melanoma-associated antigen B10 OS=Homo sapiens GN=MAGEB10 PE=2 SV=4 | 50 | F | 0.81709 | S | 0.927 | -0.10991 | No Change: Both D | - |
| A2A368 | MAGBG_HUMAN Melanoma-associated antigen B16 OS=Homo sapiens GN=MAGEB16 PE=4 SV=2 | 38 | L | 0.88754 | F | 0.861911 | 0.025629 | No Change: Both D | - |
| A2A368 | MAGBG_HUMAN Melanoma-associated antigen B16 OS=Homo sapiens GN=MAGEB16 PE=4 SV=2 | 128 | C | 0.327864 | Y | 0.31388 | 0.013984 | No Change: Both O | - |
| A2A368 | MAGBG_HUMAN Melanoma-associated antigen B16 OS=Homo sapiens GN=MAGEB16 PE=4 SV=2 | 161 | H | 0.225794 | R | 0.23642 | -0.010626 | No Change: Both O | - |
| A2A368 | MAGBG_HUMAN Melanoma-associated antigen B16 OS=Homo sapiens GN=MAGEB16 PE=4 SV=2 | 248 | M | 0.148015 | V | 0.117986 | 0.030029 | No Change: Both O | - |
| A2A368 | MAGBG_HUMAN Melanoma-associated antigen B16 OS=Homo sapiens GN=MAGEB16 PE=4 SV=2 | 248 | M | 0.148015 | K | 0.252038 | -0.104023 | No Change: Both O | - |
| Q96M61 | MAGBI_HUMAN Melanoma-associated antigen B18 OS=Homo sapiens GN=MAGEB18 PE=1 SV=2 | 40 | P | 0.742733 | S | 0.732415 | 0.010318 | No Change: Both D | - |
| O15479 | MAGB2_HUMAN Melanoma-associated antigen B2 OS=Homo sapiens GN=MAGEB2 PE=1 SV=3 | 61 | E | 0.98737 | K | 0.98765 | -2.80E-04 | No Change: Both D | - |
| O15479 | MAGB2_HUMAN Melanoma-associated antigen B2 OS=Homo sapiens GN=MAGEB2 PE=1 SV=3 | 318 | G | 0.83738 | R | 0.832741 | 0.004639 | No Change: Both D | - |
| O15480 | MAGB3_HUMAN Melanoma-associated antigen B3 OS=Homo sapiens GN=MAGEB3 PE=2 SV=2 | 107 | R | 0.69981 | H | 0.673163 | 0.026647 | No Change: Both D | - |
| O15480 | MAGB3_HUMAN Melanoma-associated antigen B3 OS=Homo sapiens GN=MAGEB3 PE=2 SV=2 | 112 | I | 0.598629 | T | 0.725562 | -0.126933 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 25 | C | 0.998224 | Y | 0.997485 | 7.39E-04 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 151 | T | 0.962864 | I | 0.951424 | 0.01144 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 257 | Q | 0.957416 | H | 0.933391 | 0.024025 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 276 | F | 0.95865 | S | 0.978835 | -0.020185 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 327 | H | 0.972388 | Q | 0.98255 | -0.010162 | No Change: Both D | - |
| O60732 | MAGC1_HUMAN Melanoma-associated antigen C1 OS=Homo sapiens GN=MAGEC1 PE=1 SV=3 | 709 | H | 0.992727 | Y | 0.987468 | 0.005259 | No Change: Both D | - |
| Q9UBF1 | MAGC2_HUMAN Melanoma-associated antigen C2 OS=Homo sapiens GN=MAGEC2 PE=1 SV=1 | 6 | G | 0.815944 | C | 0.785467 | 0.030477 | No Change: Both D | A breast cancer sample |
| Q8TD91 | MAGC3_HUMAN Melanoma-associated antigen C3 OS=Homo sapiens GN=MAGEC3 PE=1 SV=1 | 165 | L | 0.51637 | M | 0.555522 | -0.039152 | No Change: Both D | - |
| Q8TD91 | MAGC3_HUMAN Melanoma-associated antigen C3 OS=Homo sapiens GN=MAGEC3 PE=1 SV=1 | 307 | A | 0.109652 | T | 0.110386 | -7.34E-04 | No Change: Both O | - |
| Q8TD91 | MAGC3_HUMAN Melanoma-associated antigen C3 OS=Homo sapiens GN=MAGEC3 PE=1 SV=1 | 328 | A | 0.583267 | T | 0.585714 | -0.002447 | No Change: Both D | - |
| Q8TD91 | MAGC3_HUMAN Melanoma-associated antigen C3 OS=Homo sapiens GN=MAGEC3 PE=1 SV=1 | 155 | S | 0.519572 | P | 0.533315 | -0.013743 | No Change: Both D | - |
| Q9Y5V3 | MAGD1_HUMAN Melanoma-associated antigen D1 OS=Homo sapiens GN=MAGED1 PE=1 SV=3 | 238 | L | 0.874045 | M | 0.899126 | -0.025081 | No Change: Both D | - |
| Q9UNF1 | MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens GN=MAGED2 PE=1 SV=2 | 266 | Q | 0.917743 | R | 0.919199 | -0.001456 | No Change: Both D | - |
| Q9UNF1 | MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens GN=MAGED2 PE=1 SV=2 | 458 | K | 0.302122 | Q | 0.254012 | 0.04811 | No Change: Both O | A breast cancer sample |
| Q9UNF1 | MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens GN=MAGED2 PE=1 SV=2 | 187 | E | 0.969795 | D | 0.970929 | -0.001134 | No Change: Both D | - |
| Q9HCI5 | MAGE1_HUMAN Melanoma-associated antigen E1 OS=Homo sapiens GN=MAGEE1 PE=2 SV=2 | 640 | Y | 0.123463 | F | 0.104622 | 0.018841 | No Change: Both O | A breast cancer sample |
| Q9HCI5 | MAGE1_HUMAN Melanoma-associated antigen E1 OS=Homo sapiens GN=MAGEE1 PE=2 SV=2 | 664 | T | 0.427685 | N | 0.44922 | -0.021535 | No Change: Both O | A breast cancer sample |
| Q9HCI5 | MAGE1_HUMAN Melanoma-associated antigen E1 OS=Homo sapiens GN=MAGEE1 PE=2 SV=2 | 339 | E | 0.996162 | D | 0.994662 | 0.0015 | No Change: Both D | - |
| Q8TD90 | MAGE2_HUMAN Melanoma-associated antigen E2 OS=Homo sapiens GN=MAGEE2 PE=2 SV=1 | 291 | G | 0.680411 | C | 0.58055 | 0.099861 | No Change: Both D | - |
| Q9HAY2 | MAGF1_HUMAN Melanoma-associated antigen F1 OS=Homo sapiens GN=MAGEF1 PE=2 SV=2 | 93 | K | 0.57078 | R | 0.520433 | 0.050347 | No Change: Both D | - |
| Q9H6Y5 | MAGIX_HUMAN PDZ domain-containing protein MAGIX OS=Homo sapiens GN=MAGIX PE=1 SV=3 | 53 | R | 0.626052 | H | 0.50635 | 0.119702 | No Change: Both D | - |
| Q9H6Y5 | MAGIX_HUMAN PDZ domain-containing protein MAGIX OS=Homo sapiens GN=MAGIX PE=1 SV=3 | 112 | H | 0.686702 | R | 0.688333 | -0.001631 | No Change: Both D | - |
| Q9H6Y5 | MAGIX_HUMAN PDZ domain-containing protein MAGIX OS=Homo sapiens GN=MAGIX PE=1 SV=3 | 173 | V | 0.222393 | L | 0.23046 | -0.008067 | No Change: Both O | - |
| Q9H6Y5 | MAGIX_HUMAN PDZ domain-containing protein MAGIX OS=Homo sapiens GN=MAGIX PE=1 SV=3 | 323 | F | 0.750015 | L | 0.810405 | -0.06039 | No Change: Both D | - |
| Q96A72 | MGN2_HUMAN Protein mago nashi homolog 2 OS=Homo sapiens GN=MAGOHB PE=1 SV=1 | 119 | E | 0.412758 | K | 0.428143 | -0.015385 | No Change: Both O | A breast cancer sample |
| Q9H0U3 | MAGT1_HUMAN Magnesium transporter protein 1 OS=Homo sapiens GN=MAGT1 PE=1 SV=1 | 311 | V | 0.01308 | G | 0.025841 | -0.012761 | No Change: Both O | Mental retardation X-linked type 95 (MRX95) [MIM:300716] |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 189 | I | 0.071567 | V | 0.088006 | -0.016439 | No Change: Both O | - |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 272 | R | 0.539361 | P | 0.603776 | -0.064415 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 384 | N | 0.772805 | S | 0.811355 | -0.03855 | No Change: Both D | - |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 520 | P | 0.341804 | S | 0.365202 | -0.023398 | No Change: Both O | - |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 550 | F | 0.341807 | L | 0.387782 | -0.045975 | No Change: Both O | - |
| P20794 | MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=2 SV=2 | 329 | D | 0.981391 | E | 0.984173 | -0.002782 | No Change: Both D | - |
| Q9BXY0 | MAK16_HUMAN Protein MAK16 homolog OS=Homo sapiens GN=MAK16 PE=1 SV=2 | 277 | Q | 0.870504 | R | 0.881082 | -0.010578 | No Change: Both D | - |
| Q969L2 | MAL2_HUMAN Protein MAL2 OS=Homo sapiens GN=MAL2 PE=1 SV=1 | 92 | A | 0.102823 | T | 0.109458 | -0.006635 | No Change: Both O | - |
| Q9UDY8 | MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens GN=MALT1 PE=1 SV=1 | 641 | I | 0.467338 | V | 0.503327 | -0.035989 | O to D | - |
| Q7Z304 | MAMC2_HUMAN MAM domain-containing protein 2 OS=Homo sapiens GN=MAMDC2 PE=2 SV=3 | 294 | S | 0.245347 | N | 0.219735 | 0.025612 | No Change: Both O | - |
| Q7Z304 | MAMC2_HUMAN MAM domain-containing protein 2 OS=Homo sapiens GN=MAMDC2 PE=2 SV=3 | 646 | V | 0.221388 | A | 0.306294 | -0.084906 | No Change: Both O | - |
| Q6UXC1 | AEGP_HUMAN Apical endosomal glycoprotein OS=Homo sapiens GN=MAMDC4 PE=1 SV=2 | 987 | W | 0.287126 | G | 0.482799 | -0.195673 | No Change: Both O | - |
| Q6UXC1 | AEGP_HUMAN Apical endosomal glycoprotein OS=Homo sapiens GN=MAMDC4 PE=1 SV=2 | 244 | P | 0.658106 | T | 0.581914 | 0.076192 | No Change: Both D | A breast cancer sample |
| Q6UXC1 | AEGP_HUMAN Apical endosomal glycoprotein OS=Homo sapiens GN=MAMDC4 PE=1 SV=2 | 1174 | R | 0.211073 | W | 0.092615 | 0.118458 | No Change: Both O | A breast cancer sample |
| Q92585 | MAML1_HUMAN Mastermind-like protein 1 OS=Homo sapiens GN=MAML1 PE=1 SV=3 | 1007 | S | 0.62037 | N | 0.533599 | 0.086771 | No Change: Both D | - |
| Q92585 | MAML1_HUMAN Mastermind-like protein 1 OS=Homo sapiens GN=MAML1 PE=1 SV=3 | 583 | S | 0.957532 | N | 0.947574 | 0.009958 | No Change: Both D | - |
| Q8IZL2 | MAML2_HUMAN Mastermind-like protein 2 OS=Homo sapiens GN=MAML2 PE=1 SV=2 | 896 | P | 0.944693 | T | 0.931388 | 0.013305 | No Change: Both D | - |
| Q13495 | MAMD1_HUMAN Mastermind-like domain-containing protein 1 OS=Homo sapiens GN=MAMLD1 PE=1 SV=2 | 662 | N | 0.819892 | S | 0.870464 | -0.050572 | No Change: Both D | - |
| Q13495 | MAMD1_HUMAN Mastermind-like domain-containing protein 1 OS=Homo sapiens GN=MAMLD1 PE=1 SV=2 | 359 | P | 0.997801 | S | 0.997655 | 1.46E-04 | No Change: Both D | - |
| Q13495 | MAMD1_HUMAN Mastermind-like domain-containing protein 1 OS=Homo sapiens GN=MAMLD1 PE=1 SV=2 | 580 | Q | 0.993529 | R | 0.991983 | 0.001546 | No Change: Both D | - |
| P33908 | MA1A1_HUMAN Mannosyl-oligosaccharide 1 2-alpha-mannosidase IA OS=Homo sapiens GN=MAN1A1 PE=1 SV=3 | 651 | R | 0.799564 | G | 0.810434 | -0.01087 | No Change: Both D | - |
| Q9UKM7 | MA1B1_HUMAN Endoplasmic reticulum mannosyl-oligosaccharide 1 2-alpha-mannosidase OS=Homo sapiens GN=MAN1B1 PE=1 SV=2 | 59 | N | 0.540626 | S | 0.596945 | -0.056319 | No Change: Both D | - |
| Q9UKM7 | MA1B1_HUMAN Endoplasmic reticulum mannosyl-oligosaccharide 1 2-alpha-mannosidase OS=Homo sapiens GN=MAN1B1 PE=1 SV=2 | 334 | R | 0.111186 | C | 0.054782 | 0.056404 | No Change: Both O | Mental retardation autosomal recessive type 15 (MRT15) [MIM:614202] |
| Q9UKM7 | MA1B1_HUMAN Endoplasmic reticulum mannosyl-oligosaccharide 1 2-alpha-mannosidase OS=Homo sapiens GN=MAN1B1 PE=1 SV=2 | 397 | E | 0.358077 | K | 0.34912 | 0.008957 | No Change: Both O | Mental retardation autosomal recessive type 15 (MRT15) [MIM:614202] |
| P49641 | MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens GN=MAN2A2 PE=2 SV=3 | 412 | Q | 0.407597 | R | 0.398138 | 0.009459 | No Change: Both O | - |
| P49641 | MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens GN=MAN2A2 PE=2 SV=3 | 665 | S | 0.400525 | F | 0.207427 | 0.193098 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 72 | H | 0.307466 | L | 0.196234 | 0.111232 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 278 | L | 0.355573 | V | 0.367219 | -0.011646 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 312 | T | 0.352307 | I | 0.204072 | 0.148235 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 337 | R | 0.127312 | Q | 0.15113 | -0.023818 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 355 | T | 0.106672 | P | 0.141555 | -0.034883 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 356 | P | 0.080173 | R | 0.067699 | 0.012474 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 402 | E | 0.339008 | K | 0.352841 | -0.013833 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 413 | N | 0.087801 | S | 0.103283 | -0.015482 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 714 | W | 0.249864 | R | 0.469676 | -0.219812 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 750 | R | 0.531601 | W | 0.300777 | 0.230824 | D to O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 809 | L | 0.635806 | P | 0.735212 | -0.099406 | No Change: Both D | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 200 | H | 0.407811 | L | 0.284534 | 0.123277 | No Change: Both O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 453 | S | 0.567321 | Y | 0.42033 | 0.146991 | D to O | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 801 | G | 0.746211 | D | 0.758743 | -0.012532 | No Change: Both D | Lysosomal alpha-mannosidosis (AM) [MIM:248500] |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 250 | A | 0.376546 | S | 0.484109 | -0.107563 | No Change: Both O | - |
| O00754 | MA2B1_HUMAN Lysosomal alpha-mannosidase OS=Homo sapiens GN=MAN2B1 PE=1 SV=3 | 481 | A | 0.16752 | S | 0.246454 | -0.078934 | No Change: Both O | - |
| Q9Y2E5 | MA2B2_HUMAN Epididymis-specific alpha-mannosidase OS=Homo sapiens GN=MAN2B2 PE=1 SV=4 | 243 | Q | 0.52194 | P | 0.568263 | -0.046323 | No Change: Both D | - |
| Q9Y2E5 | MA2B2_HUMAN Epididymis-specific alpha-mannosidase OS=Homo sapiens GN=MAN2B2 PE=1 SV=4 | 320 | V | 0.206981 | M | 0.245742 | -0.038761 | No Change: Both O | - |
| Q9Y2E5 | MA2B2_HUMAN Epididymis-specific alpha-mannosidase OS=Homo sapiens GN=MAN2B2 PE=1 SV=4 | 446 | M | 0.424181 | V | 0.320985 | 0.103196 | No Change: Both O | - |
| Q9Y2E5 | MA2B2_HUMAN Epididymis-specific alpha-mannosidase OS=Homo sapiens GN=MAN2B2 PE=1 SV=4 | 541 | N | 0.370493 | S | 0.446295 | -0.075802 | No Change: Both O | - |
| Q9Y2E5 | MA2B2_HUMAN Epididymis-specific alpha-mannosidase OS=Homo sapiens GN=MAN2B2 PE=1 SV=4 | 365 | R | 0.433747 | C | 0.266611 | 0.167136 | No Change: Both O | - |
| Q9NTJ4 | MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens GN=MAN2C1 PE=1 SV=1 | 960 | V | 0.63859 | I | 0.570375 | 0.068215 | No Change: Both D | - |
| Q9NTJ4 | MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens GN=MAN2C1 PE=1 SV=1 | 950 | V | 0.621715 | M | 0.657948 | -0.036233 | No Change: Both D | - |
| Q9NTJ4 | MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens GN=MAN2C1 PE=1 SV=1 | 975 | R | 0.303171 | K | 0.335647 | -0.032476 | No Change: Both O | - |
| Q9NTJ4 | MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens GN=MAN2C1 PE=1 SV=1 | 818 | R | 0.374531 | H | 0.361625 | 0.012906 | No Change: Both O | - |
| O00462 | MANBA_HUMAN Beta-mannosidase OS=Homo sapiens GN=MANBA PE=1 SV=3 | 253 | V | 0.146066 | I | 0.130825 | 0.015241 | No Change: Both O | - |
| O00462 | MANBA_HUMAN Beta-mannosidase OS=Homo sapiens GN=MANBA PE=1 SV=3 | 701 | T | 0.172863 | M | 0.14312 | 0.029743 | No Change: Both O | - |
| O00462 | MANBA_HUMAN Beta-mannosidase OS=Homo sapiens GN=MANBA PE=1 SV=3 | 253 | V | 0.146066 | L | 0.142083 | 0.003983 | No Change: Both O | - |
| Q5SRI9 | MANEA_HUMAN Glycoprotein endo-alpha-1 2-mannosidase OS=Homo sapiens GN=MANEA PE=1 SV=1 | 331 | Y | 0.44108 | C | 0.373912 | 0.067168 | No Change: Both O | A breast cancer sample |
| Q9H8J5 | MANS1_HUMAN MANSC domain-containing protein 1 OS=Homo sapiens GN=MANSC1 PE=2 SV=1 | 55 | V | 0.539329 | I | 0.549833 | -0.010504 | No Change: Both D | - |
| Q9H8J5 | MANS1_HUMAN MANSC domain-containing protein 1 OS=Homo sapiens GN=MANSC1 PE=2 SV=1 | 375 | N | 0.575219 | Y | 0.461468 | 0.113751 | D to O | - |
| Q9H8J5 | MANS1_HUMAN MANSC domain-containing protein 1 OS=Homo sapiens GN=MANSC1 PE=2 SV=1 | 165 | D | 0.559135 | N | 0.489443 | 0.069692 | D to O | - |
| Q9H8J5 | MANS1_HUMAN MANSC domain-containing protein 1 OS=Homo sapiens GN=MANSC1 PE=2 SV=1 | 141 | L | 0.570345 | V | 0.536948 | 0.033397 | No Change: Both D | - |
| P21397 | AOFA_HUMAN Amine oxidase [flavin-containing] A OS=Homo sapiens GN=MAOA PE=1 SV=1 | 314 | F | 0.205437 | V | 0.226185 | -0.020748 | No Change: Both O | - |
| P21397 | AOFA_HUMAN Amine oxidase [flavin-containing] A OS=Homo sapiens GN=MAOA PE=1 SV=1 | 520 | K | 0.162202 | R | 0.124784 | 0.037418 | No Change: Both O | - |
| P21397 | AOFA_HUMAN Amine oxidase [flavin-containing] A OS=Homo sapiens GN=MAOA PE=1 SV=1 | 15 | D | 0.099986 | E | 0.115613 | -0.015627 | No Change: Both O | A breast cancer sample |
| P21397 | AOFA_HUMAN Amine oxidase [flavin-containing] A OS=Homo sapiens GN=MAOA PE=1 SV=1 | 188 | E | 0.273977 | K | 0.259704 | 0.014273 | No Change: Both O | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 72 | F | 0.183825 | L | 0.218768 | -0.034943 | No Change: Both O | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 335 | A | 0.967726 | S | 0.975939 | -0.008213 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 336 | K | 0.969752 | T | 0.961684 | 0.008068 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 353 | A | 0.994779 | S | 0.995882 | -0.001103 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 357 | A | 0.996716 | S | 0.997382 | -6.66E-04 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 364 | K | 0.998629 | Q | 0.997934 | 6.95E-04 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 485 | K | 0.851828 | Q | 0.815756 | 0.036072 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 830 | T | 0.692832 | A | 0.666976 | 0.025856 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1078 | N | 0.682436 | S | 0.727188 | -0.044752 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1102 | I | 0.414192 | T | 0.520889 | -0.106697 | O to D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1185 | R | 0.939648 | H | 0.941654 | -0.002006 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1245 | D | 0.883823 | N | 0.885057 | -0.001234 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1461 | D | 0.99698 | N | 0.995421 | 0.001559 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1553 | Q | 0.936747 | H | 0.910009 | 0.026738 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1605 | K | 0.984236 | N | 0.974948 | 0.009288 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1650 | W | 0.909067 | C | 0.928474 | -0.019407 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1690 | A | 0.414612 | S | 0.509334 | -0.094722 | O to D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1827 | P | 0.952339 | A | 0.920235 | 0.032104 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1881 | A | 0.73064 | P | 0.782308 | -0.051668 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1912 | A | 0.940685 | V | 0.92507 | 0.015615 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 1938 | S | 0.994955 | R | 0.994266 | 6.89E-04 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2056 | S | 0.988329 | R | 0.985893 | 0.002436 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2214 | H | 0.878242 | Y | 0.854175 | 0.024067 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2327 | D | 0.860454 | V | 0.758099 | 0.102355 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2461 | I | 0.944764 | T | 0.97014 | -0.025376 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2405 | T | 0.970648 | I | 0.95682 | 0.013828 | No Change: Both D | - |
| P78559 | MAP1A_HUMAN Microtubule-associated protein 1A OS=Homo sapiens GN=MAP1A PE=1 SV=6 | 2465 | D | 0.943337 | N | 0.934014 | 0.009323 | No Change: Both D | - |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 594 | I | 0.99711 | V | 0.998118 | -0.001008 | No Change: Both D | - |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 869 | E | 0.913139 | G | 0.863404 | 0.049735 | No Change: Both D | - |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 1296 | P | 0.867791 | L | 0.771048 | 0.096743 | No Change: Both D | - |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 326 | R | 0.429927 | Q | 0.474263 | -0.044336 | No Change: Both O | A colorectal cancer sample |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 574 | V | 0.995974 | M | 0.996682 | -7.08E-04 | No Change: Both D | A colorectal cancer sample |
| P46821 | MAP1B_HUMAN Microtubule-associated protein 1B OS=Homo sapiens GN=MAP1B PE=1 SV=2 | 1917 | S | 0.925126 | R | 0.910957 | 0.014169 | No Change: Both D | - |
| Q66K74 | MAP1S_HUMAN Microtubule-associated protein 1S OS=Homo sapiens GN=MAP1S PE=1 SV=2 | 411 | S | 0.126661 | C | 0.065349 | 0.061312 | No Change: Both O | - |
| Q66K74 | MAP1S_HUMAN Microtubule-associated protein 1S OS=Homo sapiens GN=MAP1S PE=1 SV=2 | 538 | P | 0.992062 | Q | 0.990357 | 0.001705 | No Change: Both D | - |
| Q66K74 | MAP1S_HUMAN Microtubule-associated protein 1S OS=Homo sapiens GN=MAP1S PE=1 SV=2 | 372 | L | 0.442127 | V | 0.422669 | 0.019458 | No Change: Both O | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 82 | A | 0.678331 | G | 0.701773 | -0.023442 | No Change: Both D | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 423 | R | 0.82284 | K | 0.866113 | -0.043273 | No Change: Both D | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 277 | E | 0.702147 | D | 0.689275 | 0.012872 | No Change: Both D | A colorectal cancer sample |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 705 | P | 0.501394 | L | 0.390488 | 0.110906 | D to O | A colorectal cancer sample |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 179 | E | 0.99197 | G | 0.987531 | 0.004439 | No Change: Both D | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 976 | H | 0.874074 | L | 0.853539 | 0.020535 | No Change: Both D | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 991 | G | 0.696671 | R | 0.678093 | 0.018578 | No Change: Both D | - |
| P11137 | MAP2_HUMAN Microtubule-associated protein 2 OS=Homo sapiens GN=MAP2 PE=1 SV=4 | 1099 | M | 0.919086 | V | 0.895117 | 0.023969 | No Change: Both D | - |
| Q02750 | MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2 | 53 | F | 0.768932 | S | 0.869891 | -0.100959 | No Change: Both D | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| Q02750 | MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2 | 130 | Y | 0.08183 | C | 0.06229 | 0.01954 | No Change: Both O | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P36507 | MP2K2_HUMAN Dual specificity mitogen-activated protein kinase kinase 2 OS=Homo sapiens GN=MAP2K2 PE=1 SV=1 | 57 | F | 0.726383 | C | 0.740277 | -0.013894 | No Change: Both D | Cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150] |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 175 | R | 0.191281 | W | 0.080934 | 0.110347 | No Change: Both O | Colon cancer |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 215 | L | 0.158722 | V | 0.174631 | -0.015909 | No Change: Both O | Colon cancer |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 26 | R | 0.978821 | T | 0.975338 | 0.003483 | No Change: Both D | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 40 | P | 0.847025 | T | 0.815776 | 0.031249 | No Change: Both D | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 68 | S | 0.258201 | P | 0.237956 | 0.020245 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 84 | A | 0.347033 | T | 0.383597 | -0.036564 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 90 | M | 0.265359 | I | 0.203676 | 0.061683 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 94 | R | 0.237819 | L | 0.135146 | 0.102673 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 96 | R | 0.28727 | W | 0.122727 | 0.164543 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 293 | R | 0.585964 | H | 0.540869 | 0.045095 | No Change: Both D | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 339 | V | 0.224773 | M | 0.346632 | -0.121859 | No Change: Both O | - |
| P46734 | MP2K3_HUMAN Dual specificity mitogen-activated protein kinase kinase 3 OS=Homo sapiens GN=MAP2K3 PE=1 SV=2 | 55 | R | 0.346675 | T | 0.332351 | 0.014324 | No Change: Both O | - |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 142 | Q | 0.614624 | L | 0.49875 | 0.115874 | D to O | A lung squamous cell carcinoma sample |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 154 | R | 0.228634 | W | 0.100399 | 0.128235 | No Change: Both O | A colorectal adenocarcinoma sample |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 234 | N | 0.388181 | I | 0.238196 | 0.149985 | No Change: Both O | An ovarian serous carcinoma sample |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 251 | S | 0.233816 | N | 0.191115 | 0.042701 | No Change: Both O | A metastatic melanoma sample |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 279 | A | 0.583201 | T | 0.597317 | -0.014116 | No Change: Both D | A colorectal adenocarcinoma sample |
| P45985 | MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens GN=MAP2K4 PE=1 SV=1 | 16 | S | 0.99457 | R | 0.993063 | 0.001507 | No Change: Both D | - |
| Q13163 | MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2 | 118 | H | 0.653392 | R | 0.705867 | -0.052475 | No Change: Both D | - |
| Q13163 | MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2 | 427 | A | 0.27335 | V | 0.233118 | 0.040232 | No Change: Both O | - |
| Q13163 | MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2 | 428 | A | 0.281716 | T | 0.25855 | 0.023166 | No Change: Both O | - |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 259 | L | 0.170613 | F | 0.154878 | 0.015735 | No Change: Both O | - |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 118 | N | 0.407989 | S | 0.437067 | -0.029078 | No Change: Both O | - |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 138 | R | 0.251403 | C | 0.151338 | 0.100065 | No Change: Both O | - |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 162 | R | 0.42937 | C | 0.284229 | 0.145141 | No Change: Both O | A colorectal adenocarcinoma sample |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 162 | R | 0.42937 | H | 0.430293 | -9.23E-04 | No Change: Both O | A colorectal adenocarcinoma sample |
| O14733 | MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens GN=MAP2K7 PE=1 SV=2 | 195 | A | 0.088812 | T | 0.109978 | -0.021166 | No Change: Both O | - |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 92 | S | 0.979573 | N | 0.966892 | 0.012681 | No Change: Both D | - |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 443 | C | 0.846296 | S | 0.872177 | -0.025881 | No Change: Both D | - |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 806 | D | 0.414814 | N | 0.41945 | -0.004636 | No Change: Both O | - |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 906 | V | 0.68065 | I | 0.650071 | 0.030579 | No Change: Both D | - |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 189 | L | 0.785038 | P | 0.87219 | -0.087152 | No Change: Both D | 46 XY sex reversal type 6 (SRXY6) [MIM:613762] |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 189 | L | 0.785038 | R | 0.865941 | -0.080903 | No Change: Both D | 46 XY sex reversal type 6 (SRXY6) [MIM:613762] |
| Q13233 | M3K1_HUMAN Mitogen-activated protein kinase kinase kinase 1 OS=Homo sapiens GN=MAP3K1 PE=1 SV=4 | 616 | G | 0.970156 | R | 0.965313 | 0.004843 | No Change: Both D | 46 XY sex reversal type 6 (SRXY6) [MIM:613762] |
| Q02779 | M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | 107 | G | 0.16189 | E | 0.196178 | -0.034288 | No Change: Both O | A metastatic melanoma sample |
| Q02779 | M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | 168 | P | 0.13092 | Q | 0.111139 | 0.019781 | No Change: Both O | - |
| Q16584 | M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 252 | P | 0.34711 | H | 0.32119 | 0.02592 | No Change: Both O | - |
| Q16584 | M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 151 | D | 0.683876 | V | 0.515464 | 0.168412 | No Change: Both D | - |
| Q16584 | M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | 282 | A | 0.359098 | G | 0.406458 | -0.04736 | No Change: Both O | - |
| Q12852 | M3K12_HUMAN Mitogen-activated protein kinase kinase kinase 12 OS=Homo sapiens GN=MAP3K12 PE=1 SV=2 | 409 | E | 0.71132 | K | 0.682542 | 0.028778 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| Q12852 | M3K12_HUMAN Mitogen-activated protein kinase kinase kinase 12 OS=Homo sapiens GN=MAP3K12 PE=1 SV=2 | 628 | G | 0.988826 | R | 0.989754 | -9.28E-04 | No Change: Both D | - |
| Q12852 | M3K12_HUMAN Mitogen-activated protein kinase kinase kinase 12 OS=Homo sapiens GN=MAP3K12 PE=1 SV=2 | 640 | G | 0.998752 | S | 0.998972 | -2.20E-04 | No Change: Both D | - |
| O43283 | M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | 915 | R | 0.59667 | H | 0.54079 | 0.05588 | No Change: Both D | - |
| O43283 | M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | 517 | R | 0.735354 | G | 0.697054 | 0.0383 | No Change: Both D | - |
| O43283 | M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | 712 | E | 0.782954 | K | 0.799474 | -0.01652 | No Change: Both D | - |
| O43283 | M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | 746 | P | 0.84083 | L | 0.726007 | 0.114823 | No Change: Both D | A metastatic melanoma sample |
| O43283 | M3K13_HUMAN Mitogen-activated protein kinase kinase kinase 13 OS=Homo sapiens GN=MAP3K13 PE=1 SV=1 | 44 | E | 0.779651 | K | 0.771782 | 0.007869 | No Change: Both D | - |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 140 | S | 0.923455 | N | 0.905332 | 0.018123 | No Change: Both D | - |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 514 | G | 0.319309 | K | 0.384285 | -0.064976 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 764 | T | 0.962529 | A | 0.966209 | -0.00368 | No Change: Both D | - |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 852 | T | 0.476179 | I | 0.336106 | 0.140073 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 928 | P | 0.176461 | H | 0.150291 | 0.02617 | No Change: Both O | - |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 255 | T | 0.754819 | M | 0.753667 | 0.001152 | No Change: Both D | - |
| Q99558 | M3K14_HUMAN Mitogen-activated protein kinase kinase kinase 14 OS=Homo sapiens GN=MAP3K14 PE=1 SV=2 | 674 | H | 0.85522 | Y | 0.81194 | 0.04328 | No Change: Both D | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 192 | A | 0.050517 | T | 0.060861 | -0.010344 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 199 | S | 0.333695 | N | 0.285099 | 0.048596 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 226 | D | 0.065421 | H | 0.052593 | 0.012828 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 255 | R | 0.52739 | S | 0.574158 | -0.046768 | No Change: Both D | A lung squamous cell carcinoma sample |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 456 | S | 0.177545 | G | 0.144752 | 0.032793 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 494 | R | 0.119543 | C | 0.054956 | 0.064587 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 562 | S | 0.408455 | L | 0.24008 | 0.168375 | No Change: Both O | A lung adenocarcinoma sample |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 677 | R | 0.209746 | Q | 0.224155 | -0.014409 | No Change: Both O | A metastatic melanoma sample |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 838 | G | 0.088999 | S | 0.112714 | -0.023715 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 993 | S | 0.814725 | L | 0.71097 | 0.103755 | No Change: Both D | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 1029 | N | 0.425059 | H | 0.384972 | 0.040087 | No Change: Both O | - |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 1247 | W | 0.147098 | R | 0.345455 | -0.198357 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q6ZN16 | M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | 1251 | Q | 0.191766 | E | 0.235927 | -0.044161 | No Change: Both O | - |
| Q9Y2U5 | M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | 110 | I | 0.281458 | V | 0.306314 | -0.024856 | No Change: Both O | - |
| Q9Y2U5 | M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | 112 | M | 0.26279 | I | 0.209024 | 0.053766 | No Change: Both O | A lung large cell carcinoma sample |
| Q9Y2U5 | M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | 140 | D | 0.489445 | G | 0.46217 | 0.027275 | No Change: Both O | - |
| Q99759 | M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | 325 | A | 0.566413 | G | 0.633233 | -0.06682 | No Change: Both D | - |
| Q99759 | M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | 435 | A | 0.26086 | G | 0.325873 | -0.065013 | No Change: Both O | - |
| Q99759 | M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | 281 | V | 0.560424 | M | 0.608543 | -0.048119 | No Change: Both D | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 294 | I | 0.12051 | T | 0.207131 | -0.086621 | No Change: Both O | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 335 | V | 0.47779 | I | 0.460509 | 0.017281 | No Change: Both O | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 566 | R | 0.411704 | H | 0.371481 | 0.040223 | No Change: Both O | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 584 | Q | 0.635411 | H | 0.582921 | 0.05249 | No Change: Both D | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 906 | H | 0.442164 | P | 0.483897 | -0.041733 | No Change: Both O | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 1413 | E | 0.210689 | Q | 0.159657 | 0.051032 | No Change: Both O | An ovarian serous carcinoma sample |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 1492 | A | 0.487749 | V | 0.432171 | 0.055578 | No Change: Both O | - |
| Q9Y6R4 | M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens GN=MAP3K4 PE=1 SV=2 | 157 | R | 0.65312 | H | 0.584753 | 0.068367 | No Change: Both D | - |
| Q99683 | M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 1006 | G | 0.662311 | R | 0.698352 | -0.036041 | No Change: Both D | - |
| Q99683 | M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 1214 | I | 0.857182 | T | 0.924572 | -0.06739 | No Change: Both D | - |
| Q99683 | M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 1250 | I | 0.689321 | V | 0.738553 | -0.049232 | No Change: Both D | - |
| Q99683 | M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 1314 | T | 0.365314 | I | 0.22003 | 0.145284 | No Change: Both O | - |
| Q99683 | M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | 1315 | D | 0.306723 | N | 0.290879 | 0.015844 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 455 | T | 0.23755 | I | 0.142388 | 0.095162 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 622 | N | 0.313256 | K | 0.344552 | -0.031296 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 969 | S | 0.984942 | N | 0.975874 | 0.009068 | No Change: Both D | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 869 | P | 0.645081 | T | 0.558611 | 0.08647 | No Change: Both D | A breast cancer sample |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 499 | R | 0.517563 | C | 0.338756 | 0.178807 | D to O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 544 | R | 0.410967 | W | 0.228102 | 0.182865 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 668 | R | 0.334734 | G | 0.333077 | 0.001657 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 673 | R | 0.306938 | L | 0.182756 | 0.124182 | No Change: Both O | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 925 | S | 0.998521 | L | 0.997173 | 0.001348 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 968 | T | 0.985512 | I | 0.976067 | 0.009445 | No Change: Both D | An ovarian endometrioid cancer sample |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 1061 | A | 0.549767 | T | 0.547744 | 0.002023 | No Change: Both D | - |
| O95382 | M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | 1233 | G | 0.266452 | A | 0.218126 | 0.048326 | No Change: Both O | - |
| P41279 | M3K8_HUMAN Mitogen-activated protein kinase kinase kinase 8 OS=Homo sapiens GN=MAP3K8 PE=1 SV=2 | 214 | S | 0.558948 | F | 0.306508 | 0.25244 | D to O | - |
| P80192 | M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | 246 | A | 0.047859 | V | 0.03372 | 0.014139 | No Change: Both O | A metastatic melanoma sample |
| P80192 | M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | 467 | R | 0.941514 | C | 0.902041 | 0.039473 | No Change: Both D | A gastric adenocarcinoma sample |
| P80192 | M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | 497 | R | 0.820551 | Q | 0.814892 | 0.005659 | No Change: Both D | - |
| P80192 | M3K9_HUMAN Mitogen-activated protein kinase kinase kinase 9 OS=Homo sapiens GN=MAP3K9 PE=1 SV=3 | 646 | Y | 0.705299 | C | 0.761762 | -0.056463 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 427 | S | 0.676001 | Y | 0.430134 | 0.245867 | D to O | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 441 | E | 0.68876 | Q | 0.619841 | 0.068919 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 23 | R | 0.341413 | Q | 0.356715 | -0.015302 | No Change: Both O | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 366 | P | 0.958616 | L | 0.930738 | 0.027878 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 367 | S | 0.966268 | P | 0.972168 | -0.0059 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 409 | D | 0.668148 | G | 0.611004 | 0.057144 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 628 | V | 0.759472 | I | 0.750472 | 0.009 | No Change: Both D | - |
| P27816 | MAP4_HUMAN Microtubule-associated protein 4 OS=Homo sapiens GN=MAP4 PE=1 SV=3 | 994 | I | 0.814614 | V | 0.83728 | -0.022666 | No Change: Both D | - |
| Q92918 | M4K1_HUMAN Mitogen-activated protein kinase kinase kinase kinase 1 OS=Homo sapiens GN=MAP4K1 PE=1 SV=1 | 312 | P | 0.915599 | T | 0.868729 | 0.04687 | No Change: Both D | - |
| Q92918 | M4K1_HUMAN Mitogen-activated protein kinase kinase kinase kinase 1 OS=Homo sapiens GN=MAP4K1 PE=1 SV=1 | 351 | P | 0.943607 | S | 0.941428 | 0.002179 | No Change: Both D | - |
| Q92918 | M4K1_HUMAN Mitogen-activated protein kinase kinase kinase kinase 1 OS=Homo sapiens GN=MAP4K1 PE=1 SV=1 | 361 | P | 0.97529 | L | 0.9544 | 0.02089 | No Change: Both D | - |
| Q92918 | M4K1_HUMAN Mitogen-activated protein kinase kinase kinase kinase 1 OS=Homo sapiens GN=MAP4K1 PE=1 SV=1 | 737 | S | 0.63446 | F | 0.416564 | 0.217896 | D to O | A metastatic melanoma sample |
| Q92918 | M4K1_HUMAN Mitogen-activated protein kinase kinase kinase kinase 1 OS=Homo sapiens GN=MAP4K1 PE=1 SV=1 | 811 | N | 0.668694 | S | 0.753116 | -0.084422 | No Change: Both D | - |
| Q8IVH8 | M4K3_HUMAN Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens GN=MAP4K3 PE=1 SV=1 | 200 | V | 0.027182 | L | 0.030617 | -0.003435 | No Change: Both O | - |
| Q8IVH8 | M4K3_HUMAN Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens GN=MAP4K3 PE=1 SV=1 | 424 | H | 0.943715 | Q | 0.948088 | -0.004373 | No Change: Both D | - |
| Q8IVH8 | M4K3_HUMAN Mitogen-activated protein kinase kinase kinase kinase 3 OS=Homo sapiens GN=MAP4K3 PE=1 SV=1 | 669 | T | 0.234211 | S | 0.317429 | -0.083218 | No Change: Both O | A lung squamous cell carcinoma sample |
| O95819 | M4K4_HUMAN Mitogen-activated protein kinase kinase kinase kinase 4 OS=Homo sapiens GN=MAP4K4 PE=1 SV=2 | 712 | S | 0.99057 | T | 0.985227 | 0.005343 | No Change: Both D | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 334 | A | 0.804546 | T | 0.823743 | -0.019197 | No Change: Both D | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 407 | P | 0.972154 | L | 0.944312 | 0.027842 | No Change: Both D | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 446 | I | 0.909839 | V | 0.910006 | -1.67E-04 | No Change: Both D | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 473 | N | 0.856389 | K | 0.881888 | -0.025499 | No Change: Both D | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 552 | R | 0.084345 | Q | 0.098475 | -0.01413 | No Change: Both O | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 633 | T | 0.15051 | M | 0.124154 | 0.026356 | No Change: Both O | - |
| Q9Y4K4 | M4K5_HUMAN Mitogen-activated protein kinase kinase kinase kinase 5 OS=Homo sapiens GN=MAP4K5 PE=1 SV=1 | 41 | H | 0.29046 | Y | 0.198297 | 0.092163 | No Change: Both O | - |
| Q96JE9 | MAP6_HUMAN Microtubule-associated protein 6 OS=Homo sapiens GN=MAP6 PE=1 SV=2 | 247 | I | 0.769169 | M | 0.841665 | -0.072496 | No Change: Both D | - |
| Q14244 | MAP7_HUMAN Ensconsin OS=Homo sapiens GN=MAP7 PE=1 SV=1 | 558 | R | 0.999785 | W | 0.99937 | 4.15E-04 | No Change: Both D | - |
| Q14244 | MAP7_HUMAN Ensconsin OS=Homo sapiens GN=MAP7 PE=1 SV=1 | 361 | V | 0.986781 | I | 0.984459 | 0.002322 | No Change: Both D | - |
| Q14244 | MAP7_HUMAN Ensconsin OS=Homo sapiens GN=MAP7 PE=1 SV=1 | 526 | R | 0.99958 | P | 0.999428 | 1.52E-04 | No Change: Both D | - |
| Q3KQU3 | MA7D1_HUMAN MAP7 domain-containing protein 1 OS=Homo sapiens GN=MAP7D1 PE=1 SV=1 | 104 | R | 0.99932 | W | 0.998209 | 0.001111 | No Change: Both D | - |
| Q3KQU3 | MA7D1_HUMAN MAP7 domain-containing protein 1 OS=Homo sapiens GN=MAP7D1 PE=1 SV=1 | 531 | R | 0.999305 | S | 0.999395 | -9.00E-05 | No Change: Both D | - |
| Q96T17 | MA7D2_HUMAN MAP7 domain-containing protein 2 OS=Homo sapiens GN=MAP7D2 PE=1 SV=2 | 182 | N | 0.855157 | S | 0.901617 | -0.04646 | No Change: Both D | - |
| Q96T17 | MA7D2_HUMAN MAP7 domain-containing protein 2 OS=Homo sapiens GN=MAP7D2 PE=1 SV=2 | 32 | A | 0.893325 | P | 0.928974 | -0.035649 | No Change: Both D | A breast cancer sample |
| Q8IWC1 | MA7D3_HUMAN MAP7 domain-containing protein 3 OS=Homo sapiens GN=MAP7D3 PE=1 SV=2 | 502 | E | 0.826344 | A | 0.788575 | 0.037769 | No Change: Both D | - |
| Q8IWC1 | MA7D3_HUMAN MAP7 domain-containing protein 3 OS=Homo sapiens GN=MAP7D3 PE=1 SV=2 | 628 | Q | 0.983423 | R | 0.98258 | 8.43E-04 | No Change: Both D | - |
| Q49MG5 | MAP9_HUMAN Microtubule-associated protein 9 OS=Homo sapiens GN=MAP9 PE=1 SV=3 | 177 | R | 0.985653 | W | 0.964853 | 0.0208 | No Change: Both D | - |
| Q49MG5 | MAP9_HUMAN Microtubule-associated protein 9 OS=Homo sapiens GN=MAP9 PE=1 SV=3 | 146 | M | 0.962544 | V | 0.948388 | 0.014156 | No Change: Both D | - |
| Q49MG5 | MAP9_HUMAN Microtubule-associated protein 9 OS=Homo sapiens GN=MAP9 PE=1 SV=3 | 499 | K | 0.992334 | R | 0.990439 | 0.001895 | No Change: Both D | - |
| Q49MG5 | MAP9_HUMAN Microtubule-associated protein 9 OS=Homo sapiens GN=MAP9 PE=1 SV=3 | 601 | N | 0.98285 | D | 0.984256 | -0.001406 | No Change: Both D | - |
| Q15759 | MK11_HUMAN Mitogen-activated protein kinase 11 OS=Homo sapiens GN=MAPK11 PE=1 SV=2 | 275 | R | 0.302265 | H | 0.283938 | 0.018327 | No Change: Both O | - |
| Q15759 | MK11_HUMAN Mitogen-activated protein kinase 11 OS=Homo sapiens GN=MAPK11 PE=1 SV=2 | 221 | A | 0.254454 | V | 0.180843 | 0.073611 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P53778 | MK12_HUMAN Mitogen-activated protein kinase 12 OS=Homo sapiens GN=MAPK12 PE=1 SV=3 | 244 | T | 0.413993 | M | 0.404507 | 0.009486 | No Change: Both O | - |
| P53778 | MK12_HUMAN Mitogen-activated protein kinase 12 OS=Homo sapiens GN=MAPK12 PE=1 SV=3 | 103 | T | 0.189787 | M | 0.169508 | 0.020279 | No Change: Both O | - |
| P53778 | MK12_HUMAN Mitogen-activated protein kinase 12 OS=Homo sapiens GN=MAPK12 PE=1 SV=3 | 230 | D | 0.456407 | N | 0.423178 | 0.033229 | No Change: Both O | - |
| O15264 | MK13_HUMAN Mitogen-activated protein kinase 13 OS=Homo sapiens GN=MAPK13 PE=1 SV=1 | 41 | S | 0.372297 | L | 0.189295 | 0.183002 | No Change: Both O | - |
| O15264 | MK13_HUMAN Mitogen-activated protein kinase 13 OS=Homo sapiens GN=MAPK13 PE=1 SV=1 | 282 | A | 0.677133 | V | 0.570261 | 0.106872 | No Change: Both D | - |
| O15264 | MK13_HUMAN Mitogen-activated protein kinase 13 OS=Homo sapiens GN=MAPK13 PE=1 SV=1 | 300 | A | 0.745852 | T | 0.762183 | -0.016331 | No Change: Both D | - |
| Q16539 | MK14_HUMAN Mitogen-activated protein kinase 14 OS=Homo sapiens GN=MAPK14 PE=1 SV=3 | 51 | A | 0.289691 | V | 0.241811 | 0.04788 | No Change: Both O | A gastric adenocarcinoma sample |
| Q16539 | MK14_HUMAN Mitogen-activated protein kinase 14 OS=Homo sapiens GN=MAPK14 PE=1 SV=3 | 322 | P | 0.578912 | R | 0.539812 | 0.0391 | No Change: Both D | A lung adenocarcinoma sample |
| Q16539 | MK14_HUMAN Mitogen-activated protein kinase 14 OS=Homo sapiens GN=MAPK14 PE=1 SV=3 | 343 | D | 0.52927 | G | 0.398526 | 0.130744 | D to O | - |
| Q8TD08 | MK15_HUMAN Mitogen-activated protein kinase 15 OS=Homo sapiens GN=MAPK15 PE=1 SV=1 | 221 | T | 0.440414 | K | 0.480048 | -0.039634 | No Change: Both O | - |
| Q8TD08 | MK15_HUMAN Mitogen-activated protein kinase 15 OS=Homo sapiens GN=MAPK15 PE=1 SV=1 | 505 | S | 0.719937 | P | 0.720813 | -8.76E-04 | No Change: Both D | - |
| P27361 | MK03_HUMAN Mitogen-activated protein kinase 3 OS=Homo sapiens GN=MAPK3 PE=1 SV=4 | 323 | E | 0.352339 | K | 0.339331 | 0.013008 | No Change: Both O | - |
| P31152 | MK04_HUMAN Mitogen-activated protein kinase 4 OS=Homo sapiens GN=MAPK4 PE=1 SV=2 | 38 | V | 0.245499 | M | 0.285976 | -0.040477 | No Change: Both O | - |
| P31152 | MK04_HUMAN Mitogen-activated protein kinase 4 OS=Homo sapiens GN=MAPK4 PE=1 SV=2 | 371 | R | 0.886266 | P | 0.897119 | -0.010853 | No Change: Both D | - |
| Q16659 | MK06_HUMAN Mitogen-activated protein kinase 6 OS=Homo sapiens GN=MAPK6 PE=1 SV=1 | 290 | L | 0.239964 | V | 0.207023 | 0.032941 | No Change: Both O | - |
| Q13164 | MK07_HUMAN Mitogen-activated protein kinase 7 OS=Homo sapiens GN=MAPK7 PE=1 SV=2 | 550 | G | 0.934293 | A | 0.930488 | 0.003805 | No Change: Both D | - |
| Q13164 | MK07_HUMAN Mitogen-activated protein kinase 7 OS=Homo sapiens GN=MAPK7 PE=1 SV=2 | 535 | R | 0.994562 | H | 0.990994 | 0.003568 | No Change: Both D | - |
| P45983 | MK08_HUMAN Mitogen-activated protein kinase 8 OS=Homo sapiens GN=MAPK8 PE=1 SV=2 | 171 | G | 0.132949 | S | 0.161895 | -0.028946 | No Change: Both O | A renal clear cell carcinoma sample |
| P45983 | MK08_HUMAN Mitogen-activated protein kinase 8 OS=Homo sapiens GN=MAPK8 PE=1 SV=2 | 177 | G | 0.306811 | R | 0.296864 | 0.009947 | No Change: Both O | A glioblastoma multiforme sample |
| P45983 | MK08_HUMAN Mitogen-activated protein kinase 8 OS=Homo sapiens GN=MAPK8 PE=1 SV=2 | 365 | E | 0.529771 | K | 0.519595 | 0.010176 | No Change: Both D | - |
| Q9UQF2 | JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens GN=MAPK8IP1 PE=1 SV=1 | 59 | S | 0.648581 | N | 0.558327 | 0.090254 | No Change: Both D | Non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| Q9UQF2 | JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens GN=MAPK8IP1 PE=1 SV=1 | 322 | A | 0.978607 | V | 0.968335 | 0.010272 | No Change: Both D | - |
| Q9UQF2 | JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens GN=MAPK8IP1 PE=1 SV=1 | 353 | R | 0.967617 | Q | 0.961756 | 0.005861 | No Change: Both D | - |
| Q13387 | JIP2_HUMAN C-Jun-amino-terminal kinase-interacting protein 2 OS=Homo sapiens GN=MAPK8IP2 PE=2 SV=2 | 743 | P | 0.549998 | L | 0.41177 | 0.138228 | D to O | - |
| Q9UPT6 | JIP3_HUMAN C-Jun-amino-terminal kinase-interacting protein 3 OS=Homo sapiens GN=MAPK8IP3 PE=1 SV=3 | 753 | T | 0.953067 | A | 0.947147 | 0.00592 | No Change: Both D | - |
| P45984 | MK09_HUMAN Mitogen-activated protein kinase 9 OS=Homo sapiens GN=MAPK9 PE=1 SV=2 | 268 | G | 0.416385 | A | 0.38586 | 0.030525 | No Change: Both O | - |
| P45984 | MK09_HUMAN Mitogen-activated protein kinase 9 OS=Homo sapiens GN=MAPK9 PE=1 SV=2 | 13 | V | 0.354104 | M | 0.428653 | -0.074549 | No Change: Both O | A colorectal adenocarcinoma sample |
| P45984 | MK09_HUMAN Mitogen-activated protein kinase 9 OS=Homo sapiens GN=MAPK9 PE=1 SV=2 | 56 | K | 0.308014 | N | 0.273321 | 0.034693 | No Change: Both O | A head & Neck squamous cell carcinoma sample |
| P45984 | MK09_HUMAN Mitogen-activated protein kinase 9 OS=Homo sapiens GN=MAPK9 PE=1 SV=2 | 246 | A | 0.427872 | T | 0.471881 | -0.044009 | No Change: Both O | - |
| P45984 | MK09_HUMAN Mitogen-activated protein kinase 9 OS=Homo sapiens GN=MAPK9 PE=1 SV=2 | 366 | R | 0.632393 | I | 0.515604 | 0.116789 | No Change: Both D | - |
| P49137 | MAPK2_HUMAN MAP kinase-activated protein kinase 2 OS=Homo sapiens GN=MAPKAPK2 PE=1 SV=1 | 173 | A | 0.274075 | G | 0.335648 | -0.061573 | No Change: Both O | - |
| P49137 | MAPK2_HUMAN MAP kinase-activated protein kinase 2 OS=Homo sapiens GN=MAPKAPK2 PE=1 SV=1 | 361 | A | 0.586525 | S | 0.677798 | -0.091273 | No Change: Both D | - |
| Q16644 | MAPK3_HUMAN MAP kinase-activated protein kinase 3 OS=Homo sapiens GN=MAPKAPK3 PE=1 SV=1 | 28 | P | 0.839463 | S | 0.821385 | 0.018078 | No Change: Both D | A glioblastoma multiforme sample |
| Q16644 | MAPK3_HUMAN MAP kinase-activated protein kinase 3 OS=Homo sapiens GN=MAPKAPK3 PE=1 SV=1 | 105 | E | 0.162951 | A | 0.104451 | 0.0585 | No Change: Both O | - |
| Q16644 | MAPK3_HUMAN MAP kinase-activated protein kinase 3 OS=Homo sapiens GN=MAPKAPK3 PE=1 SV=1 | 276 | D | 0.428146 | Y | 0.290131 | 0.138015 | No Change: Both O | - |
| Q8IW41 | MAPK5_HUMAN MAP kinase-activated protein kinase 5 OS=Homo sapiens GN=MAPKAPK5 PE=1 SV=2 | 67 | M | 0.205254 | I | 0.140054 | 0.0652 | No Change: Both O | - |
| Q8IW41 | MAPK5_HUMAN MAP kinase-activated protein kinase 5 OS=Homo sapiens GN=MAPKAPK5 PE=1 SV=2 | 282 | R | 0.410653 | K | 0.482919 | -0.072266 | No Change: Both O | - |
| O60336 | MABP1_HUMAN Mitogen-activated protein kinase-binding protein 1 OS=Homo sapiens GN=MAPKBP1 PE=2 SV=4 | 204 | Y | 0.179693 | S | 0.341786 | -0.162093 | No Change: Both O | - |
| O60336 | MABP1_HUMAN Mitogen-activated protein kinase-binding protein 1 OS=Homo sapiens GN=MAPKBP1 PE=2 SV=4 | 313 | L | 0.352091 | V | 0.333137 | 0.018954 | No Change: Both O | - |
| O60336 | MABP1_HUMAN Mitogen-activated protein kinase-binding protein 1 OS=Homo sapiens GN=MAPKBP1 PE=2 SV=4 | 1240 | R | 0.915556 | P | 0.930551 | -0.014995 | No Change: Both D | - |
| Q15555 | MARE2_HUMAN Microtubule-associated protein RP/EB family member 2 OS=Homo sapiens GN=MAPRE2 PE=1 SV=1 | 162 | Y | 0.40728 | C | 0.375443 | 0.031837 | No Change: Both O | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 285 | D | 0.748442 | N | 0.716773 | 0.031669 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 289 | V | 0.725497 | A | 0.772576 | -0.047079 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 441 | Y | 0.978236 | H | 0.985331 | -0.007095 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 447 | S | 0.96892 | P | 0.969252 | -3.32E-04 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 574 | K | 0.851302 | T | 0.805896 | 0.045406 | No Change: Both D | Pick disease of the brain (PIDB) [MIM:172700] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 589 | G | 0.787867 | V | 0.706693 | 0.081174 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 596 | N | 0.748983 | K | 0.794191 | -0.045208 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 618 | P | 0.641858 | L | 0.493611 | 0.148247 | D to O | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 618 | P | 0.641858 | S | 0.675006 | -0.033148 | No Change: Both D | Corticobasal degeneration (CBD) |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 618 | P | 0.641858 | S | 0.675006 | -0.033148 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 622 | S | 0.572345 | N | 0.518395 | 0.05395 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 654 | V | 0.687599 | M | 0.715557 | -0.027958 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 706 | G | 0.508843 | R | 0.521545 | -0.012702 | No Change: Both D | Pick disease of the brain (PIDB) [MIM:172700] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 723 | R | 0.701836 | W | 0.53171 | 0.170126 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 5 | R | 0.756878 | H | 0.737508 | 0.01937 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 5 | R | 0.756878 | L | 0.669937 | 0.086941 | No Change: Both D | Progressive supranuclear palsy type 1 (PSNP1) [MIM:601104] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 583 | L | 0.833139 | V | 0.831373 | 0.001766 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 613 | N | 0.714703 | H | 0.700133 | 0.01457 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 637 | S | 0.59268 | F | 0.362272 | 0.230408 | D to O | Pick disease of the brain (PIDB) [MIM:172700] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 659 | E | 0.662103 | V | 0.544791 | 0.117312 | No Change: Both D | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 669 | S | 0.559179 | L | 0.38441 | 0.174769 | D to O | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 686 | K | 0.622397 | I | 0.467598 | 0.154799 | D to O | Pick disease of the brain (PIDB) [MIM:172700] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 620 | G | 0.614509 | V | 0.512529 | 0.10198 | No Change: Both D | Progressive supranuclear palsy type 1 (PSNP1) [MIM:601104] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 634 | K | 0.587638 | M | 0.452956 | 0.134682 | D to O | Frontotemporal dementia (FTD) [MIM:600274] |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 370 | R | 0.983108 | W | 0.958188 | 0.02492 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 17 | T | 0.740643 | M | 0.77578 | -0.035137 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 30 | T | 0.884358 | A | 0.869077 | 0.015281 | No Change: Both D | - |
| P10636 | TAU_HUMAN Microtubule-associated protein tau OS=Homo sapiens GN=MAPT PE=1 SV=5 | 617 | V | 0.660993 | I | 0.637674 | 0.023319 | No Change: Both D | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 165 | T | 0.196639 | A | 0.181278 | 0.015361 | No Change: Both O | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 187 | M | 0.582162 | K | 0.654286 | -0.072124 | No Change: Both D | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 246 | C | 0.110039 | S | 0.276156 | -0.166117 | No Change: Both O | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 268 | M | 0.13428 | I | 0.093238 | 0.041042 | No Change: Both O | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 96 | V | 0.08704 | L | 0.092663 | -0.005623 | No Change: Both O | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 15 | L | 0.166738 | H | 0.224818 | -0.05808 | No Change: Both O | - |
| Q5VT66 | MOSC1_HUMAN MOSC domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MARC1 PE=1 SV=1 | 247 | D | 0.127875 | H | 0.101099 | 0.026776 | No Change: Both O | - |
| Q969Z3 | MOSC2_HUMAN MOSC domain-containing protein 2 mitochondrial OS=Homo sapiens GN=MARC2 PE=1 SV=1 | 244 | G | 0.146201 | S | 0.18876 | -0.042559 | No Change: Both O | - |
| Q969Z3 | MOSC2_HUMAN MOSC domain-containing protein 2 mitochondrial OS=Homo sapiens GN=MARC2 PE=1 SV=1 | 3 | A | 0.828674 | S | 0.852652 | -0.023978 | No Change: Both D | - |
| Q8NA82 | MARHA_HUMAN Probable E3 ubiquitin-protein ligase MARCH10 OS=Homo sapiens GN=MARCH10 PE=1 SV=3 | 241 | G | 0.926665 | E | 0.93727 | -0.010605 | No Change: Both D | - |
| Q8NA82 | MARHA_HUMAN Probable E3 ubiquitin-protein ligase MARCH10 OS=Homo sapiens GN=MARCH10 PE=1 SV=3 | 319 | F | 0.92277 | S | 0.961296 | -0.038526 | No Change: Both D | - |
| Q8NA82 | MARHA_HUMAN Probable E3 ubiquitin-protein ligase MARCH10 OS=Homo sapiens GN=MARCH10 PE=1 SV=3 | 742 | E | 0.573635 | K | 0.573976 | -3.41E-04 | No Change: Both D | - |
| Q9P0N8 | MARH2_HUMAN E3 ubiquitin-protein ligase MARCH2 OS=Homo sapiens GN=MARCH2 PE=1 SV=1 | 54 | A | 0.333469 | T | 0.393048 | -0.059579 | No Change: Both O | - |
| Q9P0N8 | MARH2_HUMAN E3 ubiquitin-protein ligase MARCH2 OS=Homo sapiens GN=MARCH2 PE=1 SV=1 | 219 | R | 0.540036 | P | 0.581614 | -0.041578 | No Change: Both D | - |
| Q86UD3 | MARH3_HUMAN E3 ubiquitin-protein ligase MARCH3 OS=Homo sapiens GN=MARCH3 PE=2 SV=1 | 68 | R | 0.47172 | Q | 0.491897 | -0.020177 | No Change: Both O | - |
| O60337 | MARH6_HUMAN E3 ubiquitin-protein ligase MARCH6 OS=Homo sapiens GN=MARCH6 PE=1 SV=2 | 622 | P | 0.343358 | L | 0.186685 | 0.156673 | No Change: Both O | - |
| Q9H992 | MARH7_HUMAN E3 ubiquitin-protein ligase MARCH7 OS=Homo sapiens GN=MARCH7 PE=1 SV=1 | 100 | T | 0.904628 | S | 0.92816 | -0.023532 | No Change: Both D | - |
| Q9H992 | MARH7_HUMAN E3 ubiquitin-protein ligase MARCH7 OS=Homo sapiens GN=MARCH7 PE=1 SV=1 | 193 | T | 0.923571 | I | 0.863555 | 0.060016 | No Change: Both D | - |
| Q9H992 | MARH7_HUMAN E3 ubiquitin-protein ligase MARCH7 OS=Homo sapiens GN=MARCH7 PE=1 SV=1 | 379 | G | 0.976063 | S | 0.983807 | -0.007744 | No Change: Both D | - |
| Q5T0T0 | MARH8_HUMAN E3 ubiquitin-protein ligase MARCH8 OS=Homo sapiens GN=MARCH8 PE=1 SV=1 | 92 | P | 0.583616 | S | 0.602232 | -0.018616 | No Change: Both D | - |
| Q5T0T0 | MARH8_HUMAN E3 ubiquitin-protein ligase MARCH8 OS=Homo sapiens GN=MARCH8 PE=1 SV=1 | 266 | Y | 0.58703 | H | 0.734797 | -0.147767 | No Change: Both D | - |
| Q86YJ5 | MARH9_HUMAN E3 ubiquitin-protein ligase MARCH9 OS=Homo sapiens GN=MARCH9 PE=1 SV=2 | 257 | Q | 0.131268 | H | 0.109539 | 0.021729 | No Change: Both O | - |
| Q86YJ5 | MARH9_HUMAN E3 ubiquitin-protein ligase MARCH9 OS=Homo sapiens GN=MARCH9 PE=1 SV=2 | 307 | T | 0.863876 | P | 0.895467 | -0.031591 | No Change: Both D | - |
| P29966 | MARCS_HUMAN Myristoylated alanine-rich C-kinase substrate OS=Homo sapiens GN=MARCKS PE=1 SV=4 | 250 | P | 0.998054 | L | 0.99532 | 0.002734 | No Change: Both D | - |
| P29966 | MARCS_HUMAN Myristoylated alanine-rich C-kinase substrate OS=Homo sapiens GN=MARCKS PE=1 SV=4 | 274 | A | 0.998426 | V | 0.997413 | 0.001013 | No Change: Both D | - |
| Q9UEW3 | MARCO_HUMAN Macrophage receptor MARCO OS=Homo sapiens GN=MARCO PE=1 SV=1 | 282 | F | 0.987295 | S | 0.992862 | -0.005567 | No Change: Both D | - |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 645 | R | 0.792328 | G | 0.773105 | 0.019223 | No Change: Both D | - |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 233 | Y | 0.454635 | C | 0.399643 | 0.054992 | No Change: Both O | A gastric adenocarcinoma sample |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 355 | N | 0.24348 | T | 0.217972 | 0.025508 | No Change: Both O | An ovarian serous carcinoma sample |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 530 | V | 0.857806 | M | 0.891865 | -0.034059 | No Change: Both D | - |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 578 | P | 0.883278 | L | 0.786202 | 0.097076 | No Change: Both D | - |
| Q9P0L2 | MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | 691 | E | 0.993676 | G | 0.991779 | 0.001897 | No Change: Both D | - |
| P27448 | MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens GN=MARK3 PE=1 SV=4 | 429 | V | 0.87704 | A | 0.906443 | -0.029403 | No Change: Both D | - |
| P27448 | MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens GN=MARK3 PE=1 SV=4 | 443 | S | 0.908175 | G | 0.877902 | 0.030273 | No Change: Both D | - |
| Q96L34 | MARK4_HUMAN MAP/microtubule affinity-regulating kinase 4 OS=Homo sapiens GN=MARK4 PE=1 SV=1 | 377 | R | 0.708379 | Q | 0.68722 | 0.021159 | No Change: Both D | - |
| Q96L34 | MARK4_HUMAN MAP/microtubule affinity-regulating kinase 4 OS=Homo sapiens GN=MARK4 PE=1 SV=1 | 418 | R | 0.99071 | C | 0.98663 | 0.00408 | No Change: Both D | A colorectal adenocarcinoma sample |
| P56192 | SYMC_HUMAN Methionine--tRNA ligase cytoplasmic OS=Homo sapiens GN=MARS PE=1 SV=2 | 683 | A | 0.200769 | D | 0.294236 | -0.093467 | No Change: Both O | - |
| Q8N4S9 | MALD2_HUMAN MARVEL domain-containing protein 2 OS=Homo sapiens GN=MARVELD2 PE=1 SV=2 | 33 | T | 0.926009 | I | 0.877979 | 0.04803 | No Change: Both D | - |
| Q96A59 | MALD3_HUMAN MARVEL domain-containing protein 3 OS=Homo sapiens GN=MARVELD3 PE=2 SV=3 | 60 | E | 0.99993 | K | 0.999922 | 8.00E-06 | No Change: Both D | - |
| P35410 | MAS1L_HUMAN Mas-related G-protein coupled receptor MRG OS=Homo sapiens GN=MAS1L PE=2 SV=1 | 288 | D | 0.118214 | E | 0.132268 | -0.014054 | No Change: Both O | - |
| P48740 | MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens GN=MASP1 PE=1 SV=3 | 21 | T | 0.437836 | I | 0.286764 | 0.151072 | No Change: Both O | - |
| P48740 | MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens GN=MASP1 PE=1 SV=3 | 568 | V | 0.07716 | A | 0.106357 | -0.029197 | No Change: Both O | - |
| P48740 | MASP1_HUMAN Mannan-binding lectin serine protease 1 OS=Homo sapiens GN=MASP1 PE=1 SV=3 | 679 | G | 0.302274 | R | 0.291471 | 0.010803 | No Change: Both O | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 99 | R | 0.652513 | Q | 0.672228 | -0.019715 | No Change: Both D | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 118 | R | 0.457585 | C | 0.353684 | 0.103901 | No Change: Both O | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 120 | D | 0.47233 | G | 0.437433 | 0.034897 | No Change: Both O | MASP2 deficiency (MASPD) [MIM:613791] |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 126 | P | 0.465035 | L | 0.331542 | 0.133493 | No Change: Both O | MASP2 deficiency (MASPD) [MIM:613791] |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 155 | H | 0.359677 | R | 0.334029 | 0.025648 | No Change: Both O | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 371 | D | 0.547422 | Y | 0.373573 | 0.173849 | D to O | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 377 | V | 0.380034 | A | 0.444748 | -0.064714 | No Change: Both O | - |
| O00187 | MASP2_HUMAN Mannan-binding lectin serine protease 2 OS=Homo sapiens GN=MASP2 PE=1 SV=4 | 439 | R | 0.32447 | H | 0.301629 | 0.022841 | No Change: Both O | - |
| Q9Y2H9 | MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | 269 | A | 0.193536 | T | 0.22728 | -0.033744 | No Change: Both O | A metastatic melanoma sample |
| Q9Y2H9 | MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | 1240 | H | 0.988288 | Y | 0.979047 | 0.009241 | No Change: Both D | An ovarian serous carcinoma sample |
| Q9Y2H9 | MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | 1292 | P | 0.750011 | S | 0.774334 | -0.024323 | No Change: Both D | - |
| Q9Y2H9 | MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | 1048 | A | 0.376874 | S | 0.499971 | -0.123097 | No Change: Both O | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 69 | L | 0.604786 | F | 0.578078 | 0.026708 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 275 | K | 0.925793 | E | 0.938458 | -0.012665 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 388 | D | 0.3305 | E | 0.372999 | -0.042499 | No Change: Both O | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 655 | G | 0.248417 | A | 0.187398 | 0.061019 | No Change: Both O | A breast mucinous carcinoma sample |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 659 | I | 0.256514 | M | 0.363542 | -0.107028 | No Change: Both O | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 991 | R | 0.956284 | L | 0.933303 | 0.022981 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1197 | K | 0.680496 | R | 0.65002 | 0.030476 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1221 | D | 0.98237 | E | 0.986388 | -0.004018 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1246 | R | 0.987198 | L | 0.981341 | 0.005857 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1304 | V | 0.996669 | M | 0.997263 | -5.94E-04 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1463 | A | 0.879372 | T | 0.877415 | 0.001957 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1468 | G | 0.877341 | A | 0.864449 | 0.012892 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1551 | D | 0.967596 | G | 0.968416 | -8.20E-04 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1673 | K | 0.850688 | R | 0.846716 | 0.003972 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1703 | G | 0.950765 | E | 0.963204 | -0.012439 | No Change: Both D | - |
| Q6P0Q8 | MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | 1608 | T | 0.863262 | I | 0.801767 | 0.061495 | No Change: Both D | - |
| O60307 | MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | 883 | G | 0.989345 | S | 0.991662 | -0.002317 | No Change: Both D | - |
| O60307 | MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | 203 | R | 0.209782 | Q | 0.225596 | -0.015814 | No Change: Both O | - |
| O60307 | MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | 861 | G | 0.982878 | S | 0.986712 | -0.003834 | No Change: Both D | - |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 923 | Q | 0.893671 | R | 0.901927 | -0.008256 | No Change: Both D | - |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 1957 | R | 0.977404 | W | 0.945304 | 0.0321 | No Change: Both D | - |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 2201 | P | 0.9989 | L | 0.99765 | 0.00125 | No Change: Both D | - |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 2293 | S | 0.944445 | C | 0.911764 | 0.032681 | No Change: Both D | - |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 2470 | E | 0.977545 | D | 0.973616 | 0.003929 | No Change: Both D | A lung squamous cell carcinoma sample |
| O15021 | MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | 77 | A | 0.926826 | P | 0.95121 | -0.024384 | No Change: Both D | - |
| Q96GX5 | GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | 167 | E | 0.368055 | D | 0.367358 | 6.97E-04 | No Change: Both O | Thrombocytopenia type 2 (THC2) [MIM:188000] |
| Q96GX5 | GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | 620 | P | 0.890553 | A | 0.83427 | 0.056283 | No Change: Both D | - |
| Q96GX5 | GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | 337 | T | 0.604064 | K | 0.691291 | -0.087227 | No Change: Both D | - |
| Q96GX5 | GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | 610 | V | 0.916302 | I | 0.915874 | 4.28E-04 | No Change: Both D | - |
| Q96GX5 | GWL_HUMAN Serine/threonine-protein kinase greatwall OS=Homo sapiens GN=MASTL PE=1 SV=1 | 606 | D | 0.926941 | Y | 0.850422 | 0.076519 | No Change: Both D | - |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 55 | A | 0.249483 | D | 0.323463 | -0.07398 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 199 | R | 0.084241 | C | 0.039769 | 0.044472 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 264 | R | 0.256626 | H | 0.261279 | -0.004653 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 305 | L | 0.160231 | P | 0.279262 | -0.119031 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 322 | I | 0.131367 | M | 0.185053 | -0.053686 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 356 | R | 0.189481 | Q | 0.194477 | -0.004996 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 357 | P | 0.174954 | L | 0.094215 | 0.080739 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 378 | G | 0.165475 | S | 0.203835 | -0.03836 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 119 | Q | 0.253107 | H | 0.231777 | 0.02133 | No Change: Both O | - |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 38 | S | 0.297296 | N | 0.251496 | 0.0458 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 264 | R | 0.256626 | C | 0.142158 | 0.114468 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 336 | G | 0.390691 | R | 0.386078 | 0.004613 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q00266 | METK1_HUMAN S-adenosylmethionine synthase isoform type-1 OS=Homo sapiens GN=MAT1A PE=1 SV=2 | 344 | E | 0.483532 | A | 0.352486 | 0.131046 | No Change: Both O | Methionine adenosyltransferase deficiency (MATD) [MIM:250850] |
| Q9NZL9 | MAT2B_HUMAN Methionine adenosyltransferase 2 subunit beta OS=Homo sapiens GN=MAT2B PE=1 SV=1 | 293 | A | 0.461845 | T | 0.490579 | -0.028734 | No Change: Both O | - |
| P42679 | MATK_HUMAN Megakaryocyte-associated tyrosine-protein kinase OS=Homo sapiens GN=MATK PE=1 SV=1 | 354 | A | 0.232446 | T | 0.234403 | -0.001957 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P42679 | MATK_HUMAN Megakaryocyte-associated tyrosine-protein kinase OS=Homo sapiens GN=MATK PE=1 SV=1 | 496 | A | 0.980659 | T | 0.979768 | 8.91E-04 | No Change: Both D | - |
| P42679 | MATK_HUMAN Megakaryocyte-associated tyrosine-protein kinase OS=Homo sapiens GN=MATK PE=1 SV=1 | 503 | R | 0.985584 | Q | 0.985536 | 4.80E-05 | No Change: Both D | A colorectal adenocarcinoma sample |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 356 | K | 0.447463 | E | 0.447618 | -1.55E-04 | No Change: Both O | - |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 14 | G | 0.189959 | A | 0.176025 | 0.013934 | No Change: Both O | - |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 187 | T | 0.1419 | M | 0.119595 | 0.022305 | No Change: Both O | - |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 599 | A | 0.481375 | T | 0.538819 | -0.057444 | O to D | - |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 855 | T | 0.745324 | M | 0.706548 | 0.038776 | No Change: Both D | - |
| O00339 | MATN2_HUMAN Matrilin-2 OS=Homo sapiens GN=MATN2 PE=1 SV=4 | 932 | V | 0.80037 | I | 0.813974 | -0.013604 | No Change: Both D | - |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 121 | R | 0.19222 | W | 0.085112 | 0.107108 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 194 | V | 0.266512 | D | 0.418919 | -0.152407 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 303 | T | 0.480017 | M | 0.430081 | 0.049936 | No Change: Both O | - |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 11 | P | 0.875253 | S | 0.832196 | 0.043057 | No Change: Both D | - |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 120 | T | 0.200419 | M | 0.166634 | 0.033785 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 128 | A | 0.133774 | P | 0.173865 | -0.040091 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 134 | E | 0.193643 | K | 0.209779 | -0.016136 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 192 | I | 0.243636 | N | 0.392066 | -0.14843 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 219 | A | 0.176266 | D | 0.236964 | -0.060698 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 252 | E | 0.289355 | K | 0.28706 | 0.002295 | No Change: Both O | - |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 304 | C | 0.446363 | S | 0.570022 | -0.123659 | O to D | Spondyloepimetaphyseal dysplasia MATN3-related (SEMD-MATN3) [MIM:608728] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 105 | F | 0.153595 | S | 0.333901 | -0.180306 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 70 | R | 0.865431 | H | 0.81766 | 0.047771 | No Change: Both D | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 195 | T | 0.315467 | K | 0.39303 | -0.077563 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 218 | Y | 0.191524 | N | 0.320491 | -0.128967 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 173 | A | 0.414706 | D | 0.46868 | -0.053974 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 209 | R | 0.40187 | P | 0.434395 | -0.032525 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 231 | K | 0.502362 | N | 0.468244 | 0.034118 | D to O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O15232 | MATN3_HUMAN Matrilin-3 OS=Homo sapiens GN=MATN3 PE=1 SV=2 | 245 | V | 0.122512 | M | 0.148672 | -0.02616 | No Change: Both O | Multiple epiphyseal dysplasia type 5 (EDM5) [MIM:607078] |
| O95460 | MATN4_HUMAN Matrilin-4 OS=Homo sapiens GN=MATN4 PE=1 SV=3 | 13 | L | 0.061565 | F | 0.042616 | 0.018949 | No Change: Both O | - |
| O95460 | MATN4_HUMAN Matrilin-4 OS=Homo sapiens GN=MATN4 PE=1 SV=3 | 164 | R | 0.409225 | S | 0.408947 | 2.78E-04 | No Change: Both O | - |
| P43243 | MATR3_HUMAN Matrin-3 OS=Homo sapiens GN=MATR3 PE=1 SV=2 | 85 | S | 0.891818 | C | 0.782972 | 0.108846 | No Change: Both D | Myopathy distal type 2 (MPD2) [MIM:606070] |
| Q7Z434 | MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2 | 409 | S | 0.896241 | F | 0.802474 | 0.093767 | No Change: Both D | - |
| Q7Z434 | MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2 | 79 | C | 0.112673 | F | 0.116877 | -0.004204 | No Change: Both O | - |
| Q7Z434 | MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2 | 93 | Q | 0.601641 | E | 0.619477 | -0.017836 | No Change: Both D | - |
| Q7Z434 | MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2 | 198 | Q | 0.970589 | K | 0.964687 | 0.005902 | No Change: Both D | - |
| Q7Z434 | MAVS_HUMAN Mitochondrial antiviral-signaling protein OS=Homo sapiens GN=MAVS PE=1 SV=2 | 79 | C | 0.112673 | S | 0.237643 | -0.12497 | No Change: Both O | - |
| P02144 | MYG_HUMAN Myoglobin OS=Homo sapiens GN=MB PE=1 SV=2 | 55 | E | 0.827545 | K | 0.835386 | -0.007841 | No Change: Both D | - |
| P02144 | MYG_HUMAN Myoglobin OS=Homo sapiens GN=MB PE=1 SV=2 | 134 | K | 0.371906 | N | 0.332227 | 0.039679 | No Change: Both O | - |
| P02144 | MYG_HUMAN Myoglobin OS=Homo sapiens GN=MB PE=1 SV=2 | 140 | R | 0.399555 | Q | 0.444084 | -0.044529 | No Change: Both O | - |
| P02144 | MYG_HUMAN Myoglobin OS=Homo sapiens GN=MB PE=1 SV=2 | 140 | R | 0.399555 | W | 0.1927 | 0.206855 | No Change: Both O | - |
| Q8N884 | M21D1_HUMAN Protein MB21D1 OS=Homo sapiens GN=MB21D1 PE=1 SV=2 | 261 | P | 0.568422 | H | 0.516143 | 0.052279 | No Change: Both D | - |
| Q8N884 | M21D1_HUMAN Protein MB21D1 OS=Homo sapiens GN=MB21D1 PE=1 SV=2 | 35 | T | 0.986749 | N | 0.987661 | -9.12E-04 | No Change: Both D | - |
| Q9UIS9 | MBD1_HUMAN Methyl-CpG-binding domain protein 1 OS=Homo sapiens GN=MBD1 PE=1 SV=2 | 401 | P | 0.935323 | A | 0.903196 | 0.032127 | No Change: Both D | - |
| Q8WWY6 | MB3L1_HUMAN Methyl-CpG-binding domain protein 3-like 1 OS=Homo sapiens GN=MBD3L1 PE=2 SV=2 | 190 | R | 0.850182 | C | 0.772952 | 0.07723 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 273 | A | 0.867688 | S | 0.907453 | -0.039765 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 342 | S | 0.807176 | P | 0.765929 | 0.041247 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 346 | E | 0.799383 | K | 0.792366 | 0.007017 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 568 | D | 0.247716 | H | 0.228855 | 0.018861 | No Change: Both O | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 273 | A | 0.867688 | T | 0.874569 | -0.006881 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 358 | I | 0.695083 | T | 0.798009 | -0.102926 | No Change: Both D | - |
| O95243 | MBD4_HUMAN Methyl-CpG-binding domain protein 4 OS=Homo sapiens GN=MBD4 PE=1 SV=1 | 61 | C | 0.707092 | R | 0.786079 | -0.078987 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 144 | T | 0.853612 | I | 0.773139 | 0.080473 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 461 | R | 0.975575 | H | 0.971061 | 0.004514 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 654 | D | 0.942382 | E | 0.942895 | -5.13E-04 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 655 | A | 0.948058 | T | 0.954874 | -0.006816 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 677 | S | 0.969535 | N | 0.950851 | 0.018684 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 857 | A | 0.597731 | T | 0.636345 | -0.038614 | No Change: Both D | - |
| Q9P267 | MBD5_HUMAN Methyl-CpG-binding domain protein 5 OS=Homo sapiens GN=MBD5 PE=1 SV=3 | 1048 | T | 0.797783 | I | 0.676209 | 0.121574 | No Change: Both D | - |
| Q9NS73 | MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens GN=MBIP PE=1 SV=2 | 7 | L | 0.842213 | H | 0.860521 | -0.018308 | No Change: Both D | - |
| Q9NS73 | MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens GN=MBIP PE=1 SV=2 | 22 | R | 0.556851 | S | 0.592931 | -0.03608 | No Change: Both D | - |
| P11226 | MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2 | 54 | G | 0.919748 | D | 0.920107 | -3.59E-04 | No Change: Both D | - |
| P11226 | MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2 | 57 | G | 0.941107 | E | 0.942859 | -0.001752 | No Change: Both D | - |
| P11226 | MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2 | 52 | R | 0.895989 | C | 0.892104 | 0.003885 | No Change: Both D | - |
| P11226 | MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2 | 24 | T | 0.434342 | A | 0.409492 | 0.02485 | No Change: Both O | - |
| P11226 | MBL2_HUMAN Mannose-binding protein C OS=Homo sapiens GN=MBL2 PE=1 SV=2 | 214 | N | 0.675976 | Y | 0.578606 | 0.09737 | No Change: Both D | - |
| A4D2B0 | MBLC1_HUMAN Metallo-beta-lactamase domain-containing protein 1 OS=Homo sapiens GN=MBLAC1 PE=2 SV=1 | 79 | P | 0.656388 | H | 0.56452 | 0.091868 | No Change: Both D | - |
| A4D2B0 | MBLC1_HUMAN Metallo-beta-lactamase domain-containing protein 1 OS=Homo sapiens GN=MBLAC1 PE=2 SV=1 | 114 | H | 0.4516 | N | 0.455454 | -0.003854 | No Change: Both O | - |
| Q68D91 | MBLC2_HUMAN Metallo-beta-lactamase domain-containing protein 2 OS=Homo sapiens GN=MBLAC2 PE=1 SV=3 | 128 | T | 0.494923 | A | 0.473213 | 0.02171 | No Change: Both O | - |
| Q6ZNC8 | MBOA1_HUMAN Lysophospholipid acyltransferase 1 OS=Homo sapiens GN=MBOAT1 PE=2 SV=1 | 450 | I | 0.183271 | V | 0.222177 | -0.038906 | No Change: Both O | - |
| Q6ZWT7 | MBOA2_HUMAN Lysophospholipid acyltransferase 2 OS=Homo sapiens GN=MBOAT2 PE=2 SV=2 | 501 | T | 0.90531 | A | 0.885152 | 0.020158 | No Change: Both D | - |
| Q96T53 | MBOA4_HUMAN Ghrelin O-acyltransferase OS=Homo sapiens GN=MBOAT4 PE=1 SV=2 | 231 | G | 0.23702 | E | 0.27717 | -0.04015 | No Change: Both O | - |
| Q96T53 | MBOA4_HUMAN Ghrelin O-acyltransferase OS=Homo sapiens GN=MBOAT4 PE=1 SV=2 | 46 | T | 0.110568 | A | 0.107391 | 0.003177 | No Change: Both O | - |
| Q96N66 | MBOA7_HUMAN Lysophospholipid acyltransferase 7 OS=Homo sapiens GN=MBOAT7 PE=1 SV=2 | 261 | F | 0.140108 | L | 0.151171 | -0.011063 | No Change: Both O | - |
| Q96N66 | MBOA7_HUMAN Lysophospholipid acyltransferase 7 OS=Homo sapiens GN=MBOAT7 PE=1 SV=2 | 415 | V | 0.04049 | L | 0.045401 | -0.004911 | No Change: Both O | - |
| Q14703 | MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens GN=MBTPS1 PE=1 SV=1 | 6 | I | 0.063843 | T | 0.125558 | -0.061715 | No Change: Both O | - |
| Q14703 | MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens GN=MBTPS1 PE=1 SV=1 | 90 | R | 0.508469 | G | 0.48819 | 0.020279 | D to O | - |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 87 | M | 0.077779 | I | 0.047525 | 0.030254 | No Change: Both O | Ichthyosis follicularis-atrichia-photophobia syndrome (IFAPS) [MIM:308205] |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 226 | W | 0.01401 | L | 0.023079 | -0.009069 | No Change: Both O | Ichthyosis follicularis-atrichia-photophobia syndrome (IFAPS) [MIM:308205] |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 227 | H | 0.013903 | L | 0.008274 | 0.005629 | No Change: Both O | Ichthyosis follicularis-atrichia-photophobia syndrome (IFAPS) [MIM:308205] |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 429 | R | 0.108777 | H | 0.110198 | -0.001421 | No Change: Both O | Ichthyosis follicularis-atrichia-photophobia syndrome (IFAPS) [MIM:308205] |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 475 | F | 0.090788 | S | 0.246784 | -0.155996 | No Change: Both O | Ichthyosis follicularis-atrichia-photophobia syndrome (IFAPS) [MIM:308205] |
| O43462 | MBTP2_HUMAN Membrane-bound transcription factor site-2 protease OS=Homo sapiens GN=MBTPS2 PE=1 SV=1 | 508 | N | 0.081015 | S | 0.103486 | -0.022471 | No Change: Both O | Keratosis follicularis spinulosa decalvans X-linked (KFSDX) [MIM:308800] |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 84 | D | 0.103625 | E | 0.115655 | -0.01203 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 92 | V | 0.225889 | M | 0.260887 | -0.034998 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 151 | R | 0.054605 | C | 0.023756 | 0.030849 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 160 | R | 0.248657 | W | 0.098011 | 0.150646 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 294 | D | 0.03891 | H | 0.034595 | 0.004315 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 67 | R | 0.35155 | Q | 0.372737 | -0.021187 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 163 | R | 0.141183 | Q | 0.140002 | 0.001181 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 40 | I | 0.185207 | T | 0.305006 | -0.119799 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 60 | V | 0.104983 | L | 0.103827 | 0.001156 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 122 | V | 0.129248 | M | 0.165837 | -0.036589 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 155 | I | 0.147021 | T | 0.263972 | -0.116951 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 156 | V | 0.187005 | L | 0.197254 | -0.010249 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 196 | F | 0.007283 | L | 0.009013 | -0.00173 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 162 | R | 0.190863 | P | 0.21482 | -0.023957 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 89 | G | 0.323394 | R | 0.308314 | 0.01508 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 95 | T | 0.12634 | M | 0.103325 | 0.023015 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 104 | G | 0.104414 | S | 0.131736 | -0.027322 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 120 | I | 0.102313 | T | 0.186134 | -0.083821 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 157 | T | 0.223125 | I | 0.132477 | 0.090648 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 159 | P | 0.273586 | T | 0.23847 | 0.035116 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 166 | A | 0.094426 | G | 0.107861 | -0.013435 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 171 | A | 0.04038 | S | 0.066861 | -0.026481 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 192 | L | 0.007712 | M | 0.009779 | -0.002067 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 38 | V | 0.203484 | M | 0.254428 | -0.050944 | No Change: Both O | Cutaneous malignant melanoma type 5 (CMM5) [MIM:613099] |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 41 | S | 0.189547 | F | 0.075798 | 0.113749 | No Change: Both O | Cutaneous malignant melanoma type 5 (CMM5) [MIM:613099] |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 51 | V | 0.110231 | A | 0.150268 | -0.040037 | No Change: Both O | Cutaneous malignant melanoma type 5 (CMM5) [MIM:613099] |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 93 | L | 0.177945 | R | 0.26163 | -0.083685 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 128 | M | 0.142971 | T | 0.184859 | -0.041888 | No Change: Both O | Cutaneous malignant melanoma type 5 (CMM5) [MIM:613099] |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 142 | R | 0.042423 | H | 0.042091 | 3.32E-04 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 281 | N | 0.021276 | S | 0.024007 | -0.002731 | No Change: Both O | - |
| Q01726 | MSHR_HUMAN Melanocyte-stimulating hormone receptor OS=Homo sapiens GN=MC1R PE=1 SV=2 | 289 | C | 0.013786 | R | 0.031137 | -0.017351 | No Change: Both O | Cutaneous malignant melanoma type 5 (CMM5) [MIM:613099] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 27 | P | 0.118934 | R | 0.101059 | 0.017875 | No Change: Both O | - |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 74 | S | 0.159504 | I | 0.061554 | 0.09795 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 120 | S | 0.122079 | R | 0.084 | 0.038079 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 128 | R | 0.077071 | C | 0.034329 | 0.042742 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 146 | R | 0.117964 | H | 0.116313 | 0.001651 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 103 | D | 0.334621 | N | 0.298067 | 0.036554 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 137 | R | 0.088256 | W | 0.032047 | 0.056209 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 107 | D | 0.132992 | N | 0.113159 | 0.019833 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 251 | C | 0.093626 | F | 0.09768 | -0.004054 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 254 | Y | 0.054861 | C | 0.044714 | 0.010147 | No Change: Both O | Glucocorticoid deficiency type 1 (GCCD1) [MIM:202200] |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 278 | F | 0.145114 | C | 0.12761 | 0.017504 | No Change: Both O | - |
| Q01718 | ACTHR_HUMAN Adrenocorticotropic hormone receptor OS=Homo sapiens GN=MC2R PE=1 SV=1 | 137 | R | 0.088256 | P | 0.099372 | -0.011116 | No Change: Both O | - |
| P41968 | MC3R_HUMAN Melanocortin receptor 3 OS=Homo sapiens GN=MC3R PE=1 SV=2 | 6 | T | 0.447082 | K | 0.522915 | -0.075833 | O to D | - |
| P41968 | MC3R_HUMAN Melanocortin receptor 3 OS=Homo sapiens GN=MC3R PE=1 SV=2 | 81 | V | 0.10467 | I | 0.093543 | 0.011127 | No Change: Both O | - |
| P41968 | MC3R_HUMAN Melanocortin receptor 3 OS=Homo sapiens GN=MC3R PE=1 SV=2 | 183 | I | 0.036918 | N | 0.082683 | -0.045765 | No Change: Both O | - |
| P41968 | MC3R_HUMAN Melanocortin receptor 3 OS=Homo sapiens GN=MC3R PE=1 SV=2 | 335 | I | 0.063243 | S | 0.168913 | -0.10567 | No Change: Both O | - |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 30 | S | 0.756721 | R | 0.705656 | 0.051065 | No Change: Both D | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 37 | D | 0.47856 | V | 0.316089 | 0.162471 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 78 | P | 0.13648 | L | 0.071283 | 0.065197 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 103 | V | 0.223692 | I | 0.210439 | 0.013253 | No Change: Both O | - |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 112 | T | 0.462738 | M | 0.395965 | 0.066773 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 165 | R | 0.085362 | W | 0.032628 | 0.052734 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 251 | I | 0.011265 | L | 0.013003 | -0.001738 | No Change: Both O | - |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 252 | G | 0.00769 | S | 0.009694 | -0.002004 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 317 | I | 0.045087 | T | 0.085404 | -0.040317 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 274 | N | 0.0789 | S | 0.10329 | -0.02439 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 11 | T | 0.624327 | A | 0.568652 | 0.055675 | No Change: Both D | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 36 | S | 0.548935 | Y | 0.361042 | 0.187893 | D to O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 50 | V | 0.098272 | M | 0.115876 | -0.017604 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 58 | S | 0.04609 | C | 0.015057 | 0.031033 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 62 | N | 0.041442 | S | 0.054187 | -0.012745 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 97 | N | 0.38591 | D | 0.412873 | -0.026963 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 102 | I | 0.253712 | S | 0.471883 | -0.218171 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 102 | I | 0.253712 | T | 0.393667 | -0.139955 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 106 | L | 0.210154 | P | 0.339286 | -0.129132 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 125 | I | 0.152487 | K | 0.312057 | -0.15957 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 127 | S | 0.149041 | L | 0.062848 | 0.086193 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 165 | R | 0.085362 | Q | 0.095026 | -0.009664 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 170 | I | 0.017232 | V | 0.019576 | -0.002344 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 175 | A | 0.01648 | T | 0.019043 | -0.002563 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 181 | G | 0.024593 | D | 0.029342 | -0.004749 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 219 | A | 0.078879 | V | 0.056713 | 0.022166 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 226 | I | 0.14185 | T | 0.240529 | -0.098679 | No Change: Both O | - |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 253 | V | 0.00581 | I | 0.005029 | 7.81E-04 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 271 | C | 0.057036 | R | 0.11573 | -0.058694 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 271 | C | 0.057036 | Y | 0.074486 | -0.01745 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 316 | I | 0.068988 | S | 0.165008 | -0.09602 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P32245 | MC4R_HUMAN Melanocortin receptor 4 OS=Homo sapiens GN=MC4R PE=1 SV=2 | 325 | L | 0.213422 | F | 0.179997 | 0.033425 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P33032 | MC5R_HUMAN Melanocortin receptor 5 OS=Homo sapiens GN=MC5R PE=1 SV=3 | 209 | F | 0.049691 | L | 0.064095 | -0.014404 | No Change: Both O | - |
| P43121 | MUC18_HUMAN Cell surface glycoprotein MUC18 OS=Homo sapiens GN=MCAM PE=1 SV=2 | 89 | E | 0.72004 | G | 0.678481 | 0.041559 | No Change: Both D | - |
| Q9H1U9 | MCAR1_HUMAN Mitochondrial carrier triple repeat protein 1 OS=Homo sapiens GN=MCART1 PE=2 SV=1 | 205 | T | 0.591471 | M | 0.511909 | 0.079562 | No Change: Both D | A breast cancer sample |
| Q3SY17 | MCAR2_HUMAN Mitochondrial carrier triple repeat protein 2 OS=Homo sapiens GN=MCART2 PE=1 SV=2 | 239 | L | 0.283124 | I | 0.273738 | 0.009386 | No Change: Both O | - |
| Q8IVS2 | FABD_HUMAN Malonyl-CoA-acyl carrier protein transacylase mitochondrial OS=Homo sapiens GN=MCAT PE=1 SV=2 | 303 | A | 0.435895 | G | 0.506132 | -0.070237 | O to D | - |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 267 | R | 0.93873 | L | 0.898956 | 0.039774 | No Change: Both D | A colorectal cancer sample |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 486 | P | 0.725862 | L | 0.659338 | 0.066524 | No Change: Both D | A colorectal cancer sample |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 490 | S | 0.697329 | L | 0.595088 | 0.102241 | No Change: Both D | A colorectal cancer sample |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 506 | R | 0.546159 | Q | 0.556529 | -0.01037 | No Change: Both D | Colorectal cancer samples |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 698 | A | 0.937876 | V | 0.899004 | 0.038872 | No Change: Both D | Colorectal cancer samples |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 751 | S | 0.737552 | C | 0.588521 | 0.149031 | No Change: Both D | - |
| P23508 | CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens GN=MCC PE=1 SV=2 | 190 | K | 0.446657 | R | 0.396638 | 0.050019 | No Change: Both O | - |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 289 | A | 0.547407 | V | 0.457483 | 0.089924 | D to O | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 325 | M | 0.203575 | R | 0.244783 | -0.041208 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 385 | R | 0.304924 | S | 0.373551 | -0.068627 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 437 | L | 0.072345 | P | 0.155216 | -0.082871 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 464 | H | 0.078719 | P | 0.092299 | -0.01358 | No Change: Both O | - |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 532 | D | 0.533964 | H | 0.502775 | 0.031189 | No Change: Both D | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 535 | S | 0.658732 | F | 0.482463 | 0.176269 | D to O | Methylcrotonoyl-CoA carboxylase deficiency type 1 (MCC1 deficiency) [MIM:210200] |
| Q96RQ3 | MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha mitochondrial OS=Homo sapiens GN=MCCC1 PE=1 SV=3 | 560 | N | 0.375472 | T | 0.342 | 0.033472 | No Change: Both O | - |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 99 | E | 0.301171 | Q | 0.275858 | 0.025313 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 155 | R | 0.352872 | Q | 0.396929 | -0.044057 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 167 | C | 0.067287 | R | 0.148233 | -0.080946 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 173 | S | 0.152983 | L | 0.076125 | 0.076858 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 193 | R | 0.224072 | C | 0.106436 | 0.117636 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 218 | A | 0.233582 | T | 0.252874 | -0.019292 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 268 | R | 0.470674 | T | 0.455226 | 0.015448 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 310 | P | 0.537742 | R | 0.476391 | 0.061351 | D to O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 339 | V | 0.170097 | M | 0.203658 | -0.033561 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 437 | I | 0.094482 | V | 0.106522 | -0.01204 | No Change: Both O | Methylcrotonoyl-CoA carboxylase deficiency type 2 (MCC2 deficiency) [MIM:210210] |
| Q9HCC0 | MCCB_HUMAN Methylcrotonoyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=MCCC2 PE=1 SV=1 | 478 | A | 0.308871 | G | 0.354381 | -0.04551 | No Change: Both O | - |
| P59942 | MCCD1_HUMAN Mitochondrial coiled-coil domain protein 1 OS=Homo sapiens GN=MCCD1 PE=2 SV=3 | 42 | E | 0.931302 | K | 0.931979 | -6.77E-04 | No Change: Both D | - |
| P59942 | MCCD1_HUMAN Mitochondrial coiled-coil domain protein 1 OS=Homo sapiens GN=MCCD1 PE=2 SV=3 | 45 | S | 0.95265 | N | 0.941273 | 0.011377 | No Change: Both D | - |
| P59942 | MCCD1_HUMAN Mitochondrial coiled-coil domain protein 1 OS=Homo sapiens GN=MCCD1 PE=2 SV=3 | 53 | T | 0.960038 | M | 0.960103 | -6.50E-05 | No Change: Both D | - |
| Q96PE7 | MCEE_HUMAN Methylmalonyl-CoA epimerase mitochondrial OS=Homo sapiens GN=MCEE PE=1 SV=1 | 104 | R | 0.37367 | L | 0.280551 | 0.093119 | No Change: Both O | - |
| Q96PE7 | MCEE_HUMAN Methylmalonyl-CoA epimerase mitochondrial OS=Homo sapiens GN=MCEE PE=1 SV=1 | 76 | A | 0.435398 | V | 0.362484 | 0.072914 | No Change: Both O | - |
| Q8IX19 | MCEM1_HUMAN Mast cell-expressed membrane protein 1 OS=Homo sapiens GN=MCEMP1 PE=1 SV=1 | 167 | I | 0.473658 | V | 0.490821 | -0.017163 | No Change: Both O | - |
| Q8IX19 | MCEM1_HUMAN Mast cell-expressed membrane protein 1 OS=Homo sapiens GN=MCEMP1 PE=1 SV=1 | 175 | L | 0.531701 | V | 0.525855 | 0.005846 | No Change: Both D | - |
| Q8IX19 | MCEM1_HUMAN Mast cell-expressed membrane protein 1 OS=Homo sapiens GN=MCEMP1 PE=1 SV=1 | 129 | V | 0.405741 | I | 0.363566 | 0.042175 | No Change: Both O | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 159 | T | 0.232011 | M | 0.2053 | 0.026711 | No Change: Both O | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 254 | L | 0.804947 | P | 0.864016 | -0.059069 | No Change: Both D | A colorectal cancer sample |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 277 | N | 0.652178 | S | 0.681 | -0.028822 | No Change: Both D | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 359 | I | 0.594939 | L | 0.655325 | -0.060386 | No Change: Both D | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 378 | Q | 0.436942 | L | 0.310152 | 0.12679 | No Change: Both O | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 589 | F | 0.937889 | S | 0.968131 | -0.030242 | No Change: Both D | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 622 | R | 0.47012 | H | 0.405297 | 0.064823 | No Change: Both O | A colorectal cancer sample |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 772 | F | 0.640968 | L | 0.699602 | -0.058634 | No Change: Both D | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 902 | T | 0.512026 | A | 0.462114 | 0.049912 | D to O | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 1015 | M | 0.95689 | T | 0.958073 | -0.001183 | No Change: Both D | - |
| Q86YR7 | MF2L2_HUMAN Probable guanine nucleotide exchange factor MCF2L2 OS=Homo sapiens GN=MCF2L2 PE=2 SV=3 | 1039 | L | 0.968875 | F | 0.968 | 8.75E-04 | No Change: Both D | A breast cancer sample |
| Q8NI22 | MCFD2_HUMAN Multiple coagulation factor deficiency protein 2 OS=Homo sapiens GN=MCFD2 PE=1 SV=1 | 129 | D | 0.536311 | E | 0.525814 | 0.010497 | No Change: Both D | Factor V and factor VIII combined deficiency type 2 (F5F8D2) [MIM:613625] |
| Q8NI22 | MCFD2_HUMAN Multiple coagulation factor deficiency protein 2 OS=Homo sapiens GN=MCFD2 PE=1 SV=1 | 136 | I | 0.302837 | T | 0.426256 | -0.123419 | No Change: Both O | Factor V and factor VIII combined deficiency type 2 (F5F8D2) [MIM:613625] |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 32 | N | 0.721088 | D | 0.767404 | -0.046316 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 25 | T | 0.781172 | M | 0.80793 | -0.026758 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 28 | D | 0.779367 | V | 0.718881 | 0.060486 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 34 | G | 0.716649 | R | 0.721385 | -0.004736 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 210 | R | 0.114197 | H | 0.121441 | -0.007244 | No Change: Both O | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 250 | Y | 0.028053 | H | 0.049686 | -0.021633 | No Change: Both O | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 305 | T | 0.397328 | M | 0.358341 | 0.038987 | No Change: Both O | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 317 | R | 0.503393 | Q | 0.513669 | -0.010276 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 377 | P | 0.037882 | S | 0.046222 | -0.00834 | No Change: Both O | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 411 | T | 0.731161 | M | 0.689501 | 0.04166 | No Change: Both D | - |
| Q99705 | MCHR1_HUMAN Melanin-concentrating hormone receptor 1 OS=Homo sapiens GN=MCHR1 PE=1 SV=2 | 103 | G | 0.547162 | R | 0.543291 | 0.003871 | No Change: Both D | - |
| Q969V1 | MCHR2_HUMAN Melanin-concentrating hormone receptor 2 OS=Homo sapiens GN=MCHR2 PE=1 SV=1 | 63 | R | 0.31167 | K | 0.390107 | -0.078437 | No Change: Both O | - |
| Q969V1 | MCHR2_HUMAN Melanin-concentrating hormone receptor 2 OS=Homo sapiens GN=MCHR2 PE=1 SV=1 | 152 | R | 0.092755 | Q | 0.092373 | 3.82E-04 | No Change: Both O | - |
| Q07820 | MCL1_HUMAN Induced myeloid leukemia cell differentiation protein Mcl-1 OS=Homo sapiens GN=MCL1 PE=1 SV=3 | 173 | E | 0.909097 | D | 0.891745 | 0.017352 | No Change: Both D | - |
| Q07820 | MCL1_HUMAN Induced myeloid leukemia cell differentiation protein Mcl-1 OS=Homo sapiens GN=MCL1 PE=1 SV=3 | 227 | A | 0.452261 | V | 0.410489 | 0.041772 | No Change: Both O | - |
| Q07820 | MCL1_HUMAN Induced myeloid leukemia cell differentiation protein Mcl-1 OS=Homo sapiens GN=MCL1 PE=1 SV=3 | 231 | M | 0.307637 | L | 0.262675 | 0.044962 | No Change: Both O | - |
| Q7L590 | MCM10_HUMAN Protein MCM10 homolog OS=Homo sapiens GN=MCM10 PE=1 SV=2 | 134 | K | 0.962544 | R | 0.959906 | 0.002638 | No Change: Both D | - |
| Q7L590 | MCM10_HUMAN Protein MCM10 homolog OS=Homo sapiens GN=MCM10 PE=1 SV=2 | 541 | T | 0.716438 | S | 0.787067 | -0.070629 | No Change: Both D | - |
| Q7L590 | MCM10_HUMAN Protein MCM10 homolog OS=Homo sapiens GN=MCM10 PE=1 SV=2 | 669 | K | 0.764314 | R | 0.722325 | 0.041989 | No Change: Both D | - |
| Q7L590 | MCM10_HUMAN Protein MCM10 homolog OS=Homo sapiens GN=MCM10 PE=1 SV=2 | 195 | A | 0.982812 | P | 0.988854 | -0.006042 | No Change: Both D | - |
| Q7L590 | MCM10_HUMAN Protein MCM10 homolog OS=Homo sapiens GN=MCM10 PE=1 SV=2 | 418 | A | 0.412753 | V | 0.344306 | 0.068447 | No Change: Both O | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 396 | A | 0.311798 | T | 0.32137 | -0.009572 | No Change: Both O | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 667 | V | 0.24547 | M | 0.290381 | -0.044911 | No Change: Both O | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 727 | A | 0.345299 | T | 0.359038 | -0.013739 | No Change: Both O | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 68 | D | 0.962046 | E | 0.968501 | -0.006455 | No Change: Both D | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 135 | L | 0.986711 | F | 0.982461 | 0.00425 | No Change: Both D | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 166 | E | 0.886937 | Q | 0.850769 | 0.036168 | No Change: Both D | - |
| P49736 | MCM2_HUMAN DNA replication licensing factor MCM2 OS=Homo sapiens GN=MCM2 PE=1 SV=4 | 501 | G | 0.398644 | R | 0.376863 | 0.021781 | No Change: Both O | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 105 | S | 0.517749 | G | 0.469577 | 0.048172 | D to O | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 280 | D | 0.613306 | V | 0.433085 | 0.180221 | D to O | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 287 | F | 0.673694 | L | 0.688071 | -0.014377 | No Change: Both D | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 777 | E | 0.727362 | K | 0.70899 | 0.018372 | No Change: Both D | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 590 | I | 0.519884 | L | 0.547555 | -0.027671 | No Change: Both D | - |
| P25205 | MCM3_HUMAN DNA replication licensing factor MCM3 OS=Homo sapiens GN=MCM3 PE=1 SV=3 | 774 | R | 0.678346 | W | 0.509073 | 0.169273 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 102 | S | 0.929008 | L | 0.862434 | 0.066574 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 288 | M | 0.931528 | V | 0.923287 | 0.008241 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 333 | R | 0.827592 | L | 0.747372 | 0.08022 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 413 | P | 0.955519 | L | 0.929754 | 0.025765 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1051 | P | 0.984715 | L | 0.972869 | 0.011846 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1062 | V | 0.960854 | M | 0.970089 | -0.009235 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1314 | R | 0.359701 | W | 0.163561 | 0.19614 | No Change: Both O | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1449 | D | 0.411813 | E | 0.441542 | -0.029729 | No Change: Both O | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1576 | V | 0.181079 | I | 0.179326 | 0.001753 | No Change: Both O | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1795 | A | 0.336265 | T | 0.380016 | -0.043751 | No Change: Both O | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1870 | L | 0.804269 | R | 0.853152 | -0.048883 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1941 | A | 0.82797 | V | 0.8067 | 0.02127 | No Change: Both D | - |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 409 | L | 0.972706 | V | 0.971743 | 9.63E-04 | No Change: Both D | A colorectal cancer sample |
| O60318 | MCM3A_HUMAN 80 kDa MCM3-associated protein OS=Homo sapiens GN=MCM3AP PE=1 SV=2 | 1831 | R | 0.441729 | C | 0.320583 | 0.121146 | No Change: Both O | - |
| P33991 | MCM4_HUMAN DNA replication licensing factor MCM4 OS=Homo sapiens GN=MCM4 PE=1 SV=5 | 460 | E | 0.473084 | G | 0.392773 | 0.080311 | No Change: Both O | - |
| P33991 | MCM4_HUMAN DNA replication licensing factor MCM4 OS=Homo sapiens GN=MCM4 PE=1 SV=5 | 650 | L | 0.118665 | M | 0.132474 | -0.013809 | No Change: Both O | - |
| P33992 | MCM5_HUMAN DNA replication licensing factor MCM5 OS=Homo sapiens GN=MCM5 PE=1 SV=5 | 136 | S | 0.807235 | T | 0.725689 | 0.081546 | No Change: Both D | - |
| P33992 | MCM5_HUMAN DNA replication licensing factor MCM5 OS=Homo sapiens GN=MCM5 PE=1 SV=5 | 180 | T | 0.369912 | S | 0.432273 | -0.062361 | No Change: Both O | - |
| P33992 | MCM5_HUMAN DNA replication licensing factor MCM5 OS=Homo sapiens GN=MCM5 PE=1 SV=5 | 258 | V | 0.167846 | I | 0.143299 | 0.024547 | No Change: Both O | - |
| Q14566 | MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens GN=MCM6 PE=1 SV=1 | 35 | E | 0.376443 | V | 0.193848 | 0.182595 | No Change: Both O | - |
| Q14566 | MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens GN=MCM6 PE=1 SV=1 | 806 | E | 0.727389 | K | 0.707743 | 0.019646 | No Change: Both D | - |
| P33993 | MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1 SV=4 | 144 | N | 0.568274 | S | 0.635254 | -0.06698 | No Change: Both D | - |
| P33993 | MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1 SV=4 | 473 | G | 0.194041 | S | 0.256306 | -0.062265 | No Change: Both O | - |
| P33993 | MCM7_HUMAN DNA replication licensing factor MCM7 OS=Homo sapiens GN=MCM7 PE=1 SV=4 | 114 | R | 0.735657 | Q | 0.737256 | -0.001599 | No Change: Both D | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 63 | Q | 0.718768 | K | 0.728928 | -0.01016 | No Change: Both D | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 101 | K | 0.169629 | N | 0.130101 | 0.039528 | No Change: Both O | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 183 | N | 0.592972 | S | 0.637159 | -0.044187 | No Change: Both D | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 341 | E | 0.638764 | K | 0.639007 | -2.43E-04 | No Change: Both D | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 365 | S | 0.747037 | N | 0.716829 | 0.030208 | No Change: Both D | - |
| Q9UJA3 | MCM8_HUMAN DNA replication licensing factor MCM8 OS=Homo sapiens GN=MCM8 PE=1 SV=2 | 785 | N | 0.283423 | S | 0.316662 | -0.033239 | No Change: Both O | - |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 106 | L | 0.094472 | P | 0.167602 | -0.07313 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 232 | T | 0.131262 | P | 0.153917 | -0.022655 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 362 | D | 0.104267 | Y | 0.052232 | 0.052035 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 446 | V | 0.017686 | L | 0.017749 | -6.30E-05 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 447 | L | 0.027575 | P | 0.062989 | -0.035414 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 465 | F | 0.117641 | L | 0.145134 | -0.027493 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 331 | V | 0.081741 | L | 0.088636 | -0.006895 | No Change: Both O | A breast cancer sample |
| Q9GZU1 | MCLN1_HUMAN Mucolipin-1 OS=Homo sapiens GN=MCOLN1 PE=1 SV=1 | 403 | R | 0.015822 | C | 0.006866 | 0.008956 | No Change: Both O | Mucolipidosis type IV (MLIV) [MIM:252650] |
| Q8IZK6 | MCLN2_HUMAN Mucolipin-2 OS=Homo sapiens GN=MCOLN2 PE=2 SV=2 | 365 | M | 0.283659 | V | 0.224872 | 0.058787 | No Change: Both O | - |
| Q8IZK6 | MCLN2_HUMAN Mucolipin-2 OS=Homo sapiens GN=MCOLN2 PE=2 SV=2 | 370 | K | 0.343396 | Q | 0.273374 | 0.070022 | No Change: Both O | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 27 | T | 0.415736 | R | 0.405865 | 0.009871 | No Change: Both O | Microcephaly primary type 1 (MCPH1) [MIM:251200] |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 171 | R | 0.632862 | S | 0.668565 | -0.035703 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 212 | A | 0.754003 | T | 0.784045 | -0.030042 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 264 | I | 0.557402 | V | 0.566175 | -0.008773 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 288 | P | 0.765571 | H | 0.734418 | 0.031153 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 304 | R | 0.593793 | I | 0.486994 | 0.106799 | D to O | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 314 | D | 0.6201 | H | 0.599238 | 0.020862 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 392 | D | 0.76502 | G | 0.74681 | 0.01821 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 580 | S | 0.895789 | G | 0.867409 | 0.02838 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 602 | L | 0.794445 | F | 0.793585 | 8.60E-04 | No Change: Both D | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 682 | T | 0.284681 | N | 0.301495 | -0.016814 | No Change: Both O | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 761 | V | 0.377526 | A | 0.45547 | -0.077944 | No Change: Both O | - |
| Q8NEM0 | MCPH1_HUMAN Microcephalin OS=Homo sapiens GN=MCPH1 PE=1 SV=3 | 828 | P | 0.304047 | S | 0.346808 | -0.042761 | No Change: Both O | - |
| Q96EZ8 | MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens GN=MCRS1 PE=1 SV=1 | 441 | V | 0.028686 | I | 0.026698 | 0.001988 | No Change: Both O | A colorectal cancer sample |
| Q6DN14 | MCTP1_HUMAN Multiple C2 and transmembrane domain-containing protein 1 OS=Homo sapiens GN=MCTP1 PE=2 SV=2 | 612 | R | 0.352435 | K | 0.412129 | -0.059694 | No Change: Both O | - |
| Q6DN12 | MCTP2_HUMAN Multiple C2 and transmembrane domain-containing protein 2 OS=Homo sapiens GN=MCTP2 PE=1 SV=3 | 877 | A | 0.873428 | T | 0.866556 | 0.006872 | No Change: Both D | - |
| Q9ULC4 | MCTS1_HUMAN Malignant T cell-amplified sequence 1 OS=Homo sapiens GN=MCTS1 PE=1 SV=1 | 106 | L | 0.104411 | H | 0.177436 | -0.073025 | No Change: Both O | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 251 | E | 0.870334 | K | 0.863948 | 0.006386 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 268 | R | 0.763183 | K | 0.789115 | -0.025932 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 371 | E | 0.730293 | K | 0.737916 | -0.007623 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 586 | S | 0.564826 | A | 0.481592 | 0.083234 | D to O | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1509 | E | 0.986855 | D | 0.985242 | 0.001613 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1540 | S | 0.989599 | P | 0.990602 | -0.001003 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 536 | I | 0.437464 | M | 0.506115 | -0.068651 | O to D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1545 | Q | 0.987728 | R | 0.989076 | -0.001348 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 179 | R | 0.90507 | C | 0.843633 | 0.061437 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 386 | P | 0.841297 | L | 0.745396 | 0.095901 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 917 | R | 0.925052 | S | 0.926346 | -0.001294 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1100 | P | 0.981824 | A | 0.970664 | 0.01116 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1112 | S | 0.990665 | F | 0.982863 | 0.007802 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1180 | S | 0.992838 | P | 0.993134 | -2.96E-04 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1745 | P | 0.874549 | R | 0.854812 | 0.019737 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1791 | V | 0.890439 | E | 0.942277 | -0.051838 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1855 | D | 0.990751 | E | 0.992823 | -0.002072 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1883 | R | 0.804481 | Q | 0.791871 | 0.01261 | No Change: Both D | - |
| Q14676 | MDC1_HUMAN Mediator of DNA damage checkpoint protein 1 OS=Homo sapiens GN=MDC1 PE=1 SV=3 | 1904 | R | 0.395747 | Q | 0.371979 | 0.023768 | No Change: Both O | - |
| Q8NFP4 | MDGA1_HUMAN MAM domain-containing glycosylphosphatidylinositol anchor protein 1 OS=Homo sapiens GN=MDGA1 PE=1 SV=1 | 61 | L | 0.154571 | P | 0.278206 | -0.123635 | No Change: Both O | - |
| Q7Z553 | MDGA2_HUMAN MAM domain-containing glycosylphosphatidylinositol anchor protein 2 OS=Homo sapiens GN=MDGA2 PE=2 SV=2 | 608 | V | 0.197966 | F | 0.178615 | 0.019351 | No Change: Both O | - |
| Q5I0G3 | MDH1B_HUMAN Putative malate dehydrogenase 1B OS=Homo sapiens GN=MDH1B PE=2 SV=1 | 510 | E | 0.787468 | D | 0.713196 | 0.074272 | No Change: Both D | - |
| Q5I0G3 | MDH1B_HUMAN Putative malate dehydrogenase 1B OS=Homo sapiens GN=MDH1B PE=2 SV=1 | 515 | T | 0.864947 | A | 0.825533 | 0.039414 | No Change: Both D | - |
| Q5I0G3 | MDH1B_HUMAN Putative malate dehydrogenase 1B OS=Homo sapiens GN=MDH1B PE=2 SV=1 | 48 | L | 0.160618 | I | 0.143042 | 0.017576 | No Change: Both O | - |
| P40926 | MDHM_HUMAN Malate dehydrogenase mitochondrial OS=Homo sapiens GN=MDH2 PE=1 SV=3 | 9 | A | 0.775393 | V | 0.665228 | 0.110165 | No Change: Both D | - |
| Q8TC05 | MDM1_HUMAN Nuclear protein MDM1 OS=Homo sapiens GN=MDM1 PE=1 SV=2 | 103 | T | 0.974253 | I | 0.958028 | 0.016225 | No Change: Both D | - |
| Q8TC05 | MDM1_HUMAN Nuclear protein MDM1 OS=Homo sapiens GN=MDM1 PE=1 SV=2 | 383 | V | 0.74082 | I | 0.739509 | 0.001311 | No Change: Both D | - |
| Q8TC05 | MDM1_HUMAN Nuclear protein MDM1 OS=Homo sapiens GN=MDM1 PE=1 SV=2 | 489 | R | 0.989409 | H | 0.985186 | 0.004223 | No Change: Both D | - |
| Q8TC05 | MDM1_HUMAN Nuclear protein MDM1 OS=Homo sapiens GN=MDM1 PE=1 SV=2 | 552 | P | 0.898997 | L | 0.830653 | 0.068344 | No Change: Both D | - |
| O15151 | MDM4_HUMAN Protein Mdm4 OS=Homo sapiens GN=MDM4 PE=1 SV=2 | 175 | I | 0.585382 | T | 0.686698 | -0.101316 | No Change: Both D | - |
| O15151 | MDM4_HUMAN Protein Mdm4 OS=Homo sapiens GN=MDM4 PE=1 SV=2 | 406 | T | 0.855134 | I | 0.817697 | 0.037437 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 440 | F | 0.091456 | V | 0.100547 | -0.009091 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 1559 | S | 0.207898 | N | 0.179209 | 0.028689 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 4044 | A | 0.640206 | S | 0.705951 | -0.065745 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 660 | I | 0.229035 | V | 0.29078 | -0.061745 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 1044 | A | 0.122695 | V | 0.101973 | 0.020722 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 1929 | H | 0.301499 | D | 0.355832 | -0.054333 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 2972 | H | 0.180783 | P | 0.224383 | -0.0436 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 3004 | E | 0.515455 | K | 0.511563 | 0.003892 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 3423 | H | 0.561713 | Y | 0.417358 | 0.144355 | D to O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 3794 | A | 0.466312 | G | 0.500296 | -0.033984 | O to D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 3986 | R | 0.758552 | L | 0.678082 | 0.08047 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 4167 | A | 0.450171 | T | 0.493354 | -0.043183 | No Change: Both O | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 4720 | I | 0.989594 | T | 0.992427 | -0.002833 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 4783 | D | 0.99576 | E | 0.996174 | -4.14E-04 | No Change: Both D | - |
| Q9NU22 | MDN1_HUMAN Midasin OS=Homo sapiens GN=MDN1 PE=1 SV=2 | 5251 | N | 0.908825 | K | 0.927154 | -0.018329 | No Change: Both D | - |
| P23368 | MAOM_HUMAN NAD-dependent malic enzyme mitochondrial OS=Homo sapiens GN=ME2 PE=1 SV=1 | 114 | P | 0.106791 | L | 0.051869 | 0.054922 | No Change: Both O | - |
| P23368 | MAOM_HUMAN NAD-dependent malic enzyme mitochondrial OS=Homo sapiens GN=ME2 PE=1 SV=1 | 450 | G | 0.413538 | E | 0.445031 | -0.031493 | No Change: Both O | - |
| Q16798 | MAON_HUMAN NADP-dependent malic enzyme mitochondrial OS=Homo sapiens GN=ME3 PE=2 SV=2 | 85 | S | 0.123791 | G | 0.101959 | 0.021832 | No Change: Both O | - |
| Q16798 | MAON_HUMAN NADP-dependent malic enzyme mitochondrial OS=Homo sapiens GN=ME3 PE=2 SV=2 | 324 | K | 0.356398 | N | 0.318637 | 0.037761 | No Change: Both O | - |
| Q16626 | MEA1_HUMAN Male-enhanced antigen 1 OS=Homo sapiens GN=MEA1 PE=1 SV=2 | 183 | A | 0.746555 | D | 0.759181 | -0.012626 | No Change: Both D | - |
| Q03112 | EVI1_HUMAN MDS1 and EVI1 complex locus protein EVI1 OS=Homo sapiens GN=MECOM PE=1 SV=2 | 107 | Q | 0.503852 | R | 0.495997 | 0.007855 | D to O | - |
| Q13465 | MDS1_HUMAN MDS1 and EVI1 complex locus protein MDS1 OS=Homo sapiens GN=MECOM PE=2 SV=1 | 120 | P | 0.49755 | S | 0.539273 | -0.041723 | O to D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 106 | R | 0.642162 | W | 0.453951 | 0.188211 | D to O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 133 | R | 0.272142 | C | 0.154944 | 0.117198 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 155 | F | 0.641903 | S | 0.718851 | -0.076948 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 158 | T | 0.730321 | M | 0.703254 | 0.027067 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 101 | P | 0.707873 | R | 0.691163 | 0.01671 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 124 | L | 0.202419 | F | 0.186795 | 0.015624 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 134 | S | 0.251313 | C | 0.113573 | 0.13774 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 140 | A | 0.213552 | V | 0.185088 | 0.028464 | No Change: Both O | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 152 | P | 0.563695 | R | 0.54756 | 0.016135 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 201 | A | 0.960304 | V | 0.957101 | 0.003203 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 306 | R | 0.868787 | C | 0.794711 | 0.074076 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 397 | E | 0.999688 | K | 0.999649 | 3.90E-05 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 100 | L | 0.727176 | V | 0.71478 | 0.012396 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 428 | G | 0.950343 | S | 0.959372 | -0.009029 | No Change: Both D | Encephalopathy neonatal severe due to MECP2 mutations (ENS-MECP2) [MIM:300673] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 137 | E | 0.202636 | G | 0.180761 | 0.021875 | No Change: Both O | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 10 | E | 0.929592 | Q | 0.931533 | -0.001941 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 86 | S | 0.930403 | C | 0.879485 | 0.050918 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 97 | D | 0.775986 | Y | 0.665725 | 0.110261 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 101 | P | 0.707873 | H | 0.599688 | 0.108185 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 101 | P | 0.707873 | L | 0.570301 | 0.137572 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 101 | P | 0.707873 | T | 0.64886 | 0.059013 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 106 | R | 0.642162 | Q | 0.637224 | 0.004938 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 111 | R | 0.649133 | G | 0.645961 | 0.003172 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 128 | Q | 0.268977 | P | 0.300861 | -0.031884 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 133 | R | 0.272142 | H | 0.270987 | 0.001155 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 135 | K | 0.240131 | E | 0.240587 | -4.56E-04 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 156 | D | 0.674815 | G | 0.657016 | 0.017799 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 167 | R | 0.92334 | W | 0.862236 | 0.061104 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 181 | A | 0.996796 | V | 0.996442 | 3.54E-04 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 196 | T | 0.974989 | S | 0.979298 | -0.004309 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 197 | T | 0.972043 | M | 0.970155 | 0.001888 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 203 | T | 0.954158 | M | 0.951844 | 0.002314 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 210 | K | 0.917057 | I | 0.82006 | 0.096997 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 225 | P | 0.838474 | R | 0.814859 | 0.023615 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 228 | T | 0.846567 | S | 0.872147 | -0.02558 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 229 | S | 0.84784 | L | 0.768491 | 0.079349 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 232 | G | 0.856639 | A | 0.833939 | 0.0227 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 251 | P | 0.909991 | L | 0.820905 | 0.089086 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 284 | K | 0.939458 | E | 0.935986 | 0.003472 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 287 | A | 0.933744 | P | 0.946791 | -0.013047 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 291 | S | 0.922189 | A | 0.898933 | 0.023256 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 302 | P | 0.861166 | A | 0.812716 | 0.04845 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 302 | P | 0.861166 | H | 0.800167 | 0.060999 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 302 | P | 0.861166 | L | 0.782826 | 0.07834 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 302 | P | 0.861166 | R | 0.85971 | 0.001456 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 305 | K | 0.868045 | R | 0.845332 | 0.022713 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 306 | R | 0.868787 | H | 0.822382 | 0.046405 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 322 | P | 0.902811 | A | 0.844528 | 0.058283 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 322 | P | 0.902811 | L | 0.860482 | 0.042329 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 344 | R | 0.994213 | W | 0.987797 | 0.006416 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 359 | S | 0.999584 | P | 0.999586 | -2.00E-06 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 376 | P | 0.999705 | S | 0.999681 | 2.40E-05 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 388 | P | 0.999798 | S | 0.999767 | 3.10E-05 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 394 | E | 0.999761 | K | 0.999732 | 2.90E-05 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 399 | P | 0.999615 | L | 0.999232 | 3.83E-04 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 402 | P | 0.999394 | L | 0.998833 | 5.61E-04 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 412 | V | 0.992265 | I | 0.990563 | 0.001702 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 439 | A | 0.916831 | T | 0.920803 | -0.003972 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 444 | A | 0.911241 | T | 0.91542 | -0.004179 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 453 | R | 0.915321 | Q | 0.907647 | 0.007674 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 480 | P | 0.987393 | S | 0.9876 | -2.07E-04 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 97 | D | 0.775986 | E | 0.778556 | -0.00257 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 100 | L | 0.727176 | R | 0.818053 | -0.090877 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 101 | P | 0.707873 | S | 0.700043 | 0.00783 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 120 | Y | 0.336564 | D | 0.48268 | -0.146116 | No Change: Both O | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 155 | F | 0.641903 | I | 0.621529 | 0.020374 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 158 | T | 0.730321 | A | 0.707237 | 0.023084 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 161 | G | 0.816394 | V | 0.778402 | 0.037992 | No Change: Both D | Rett syndrome (RTT) [MIM:312750] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 388 | P | 0.999798 | L | 0.999584 | 2.14E-04 | No Change: Both D | - |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 225 | P | 0.838474 | L | 0.742576 | 0.095898 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| P51608 | MECP2_HUMAN Methyl-CpG-binding protein 2 OS=Homo sapiens GN=MECP2 PE=1 SV=1 | 322 | P | 0.902811 | S | 0.910557 | -0.007746 | No Change: Both D | Mental retardation syndromic X-linked type 13 (MRXS13) [MIM:300055] |
| Q9BV79 | MECR_HUMAN Trans-2-enoyl-CoA reductase mitochondrial OS=Homo sapiens GN=MECR PE=1 SV=2 | 96 | F | 0.184846 | L | 0.228059 | -0.043213 | No Change: Both O | - |
| Q9BV79 | MECR_HUMAN Trans-2-enoyl-CoA reductase mitochondrial OS=Homo sapiens GN=MECR PE=1 SV=2 | 227 | R | 0.534527 | K | 0.581289 | -0.046762 | No Change: Both D | - |
| Q9BV79 | MECR_HUMAN Trans-2-enoyl-CoA reductase mitochondrial OS=Homo sapiens GN=MECR PE=1 SV=2 | 258 | R | 0.395563 | L | 0.286411 | 0.109152 | No Change: Both O | - |
| Q15648 | MED1_HUMAN Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens GN=MED1 PE=1 SV=4 | 1240 | S | 0.999753 | G | 0.999658 | 9.50E-05 | No Change: Both D | - |
| Q15648 | MED1_HUMAN Mediator of RNA polymerase II transcription subunit 1 OS=Homo sapiens GN=MED1 PE=1 SV=4 | 753 | P | 0.95802 | T | 0.941888 | 0.016132 | No Change: Both D | - |
| Q93074 | MED12_HUMAN Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens GN=MED12 PE=1 SV=4 | 961 | R | 0.736546 | W | 0.572182 | 0.164364 | No Change: Both D | Opitz-Kaveggia syndrome (OKS) [MIM:305450] |
| Q93074 | MED12_HUMAN Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens GN=MED12 PE=1 SV=4 | 1007 | N | 0.330264 | S | 0.372363 | -0.042099 | No Change: Both O | Lujan-Fryns syndrome (LUJFRYS) [MIM:309520] |
| Q93074 | MED12_HUMAN Mediator of RNA polymerase II transcription subunit 12 OS=Homo sapiens GN=MED12 PE=1 SV=4 | 1392 | Q | 0.879555 | R | 0.853814 | 0.025741 | No Change: Both D | - |
| Q86YW9 | MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens GN=MED12L PE=1 SV=2 | 401 | Q | 0.502488 | P | 0.561788 | -0.0593 | No Change: Both D | - |
| Q86YW9 | MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens GN=MED12L PE=1 SV=2 | 464 | E | 0.197172 | K | 0.196119 | 0.001053 | No Change: Both O | - |
| Q86YW9 | MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens GN=MED12L PE=1 SV=2 | 903 | Q | 0.169851 | H | 0.148698 | 0.021153 | No Change: Both O | - |
| Q86YW9 | MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens GN=MED12L PE=1 SV=2 | 1210 | R | 0.396831 | Q | 0.392061 | 0.00477 | No Change: Both O | - |
| Q86YW9 | MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens GN=MED12L PE=1 SV=2 | 1698 | R | 0.184643 | Q | 0.18857 | -0.003927 | No Change: Both O | - |
| Q9UHV7 | MED13_HUMAN Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens GN=MED13 PE=1 SV=3 | 1370 | A | 0.092088 | P | 0.140209 | -0.048121 | No Change: Both O | - |
| Q9UHV7 | MED13_HUMAN Mediator of RNA polymerase II transcription subunit 13 OS=Homo sapiens GN=MED13 PE=1 SV=3 | 1385 | A | 0.308622 | P | 0.374972 | -0.06635 | No Change: Both O | - |
| Q71F56 | MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens GN=MED13L PE=1 SV=1 | 251 | E | 0.728404 | G | 0.707254 | 0.02115 | No Change: Both D | Transposition of the great arteries dextro-looped type 1 (DTGA1) [MIM:608808] |
| Q71F56 | MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens GN=MED13L PE=1 SV=1 | 1872 | R | 0.476195 | H | 0.466362 | 0.009833 | No Change: Both O | Transposition of the great arteries dextro-looped type 1 (DTGA1) [MIM:608808] |
| Q71F56 | MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens GN=MED13L PE=1 SV=1 | 2023 | D | 0.642784 | G | 0.586088 | 0.056696 | No Change: Both D | Transposition of the great arteries dextro-looped type 1 (DTGA1) [MIM:608808] |
| O60244 | MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens GN=MED14 PE=1 SV=2 | 1325 | F | 0.198811 | L | 0.234674 | -0.035863 | No Change: Both O | A breast cancer sample |
| Q9Y2X0 | MED16_HUMAN Mediator of RNA polymerase II transcription subunit 16 OS=Homo sapiens GN=MED16 PE=1 SV=2 | 770 | L | 0.741946 | F | 0.682104 | 0.059842 | No Change: Both D | - |
| Q9Y2X0 | MED16_HUMAN Mediator of RNA polymerase II transcription subunit 16 OS=Homo sapiens GN=MED16 PE=1 SV=2 | 874 | E | 0.979763 | K | 0.97692 | 0.002843 | No Change: Both D | - |
| Q9NVC6 | MED17_HUMAN Mediator of RNA polymerase II transcription subunit 17 OS=Homo sapiens GN=MED17 PE=1 SV=2 | 357 | F | 0.691731 | L | 0.725718 | -0.033987 | No Change: Both D | - |
| Q9NVC6 | MED17_HUMAN Mediator of RNA polymerase II transcription subunit 17 OS=Homo sapiens GN=MED17 PE=1 SV=2 | 69 | E | 0.878691 | D | 0.869067 | 0.009624 | No Change: Both D | - |
| Q9NVC6 | MED17_HUMAN Mediator of RNA polymerase II transcription subunit 17 OS=Homo sapiens GN=MED17 PE=1 SV=2 | 371 | L | 0.315604 | P | 0.456556 | -0.140952 | No Change: Both O | Microcephaly postnatal progressive with seizures and brain atrophy (MCPHSBA) [MIM:613668] |
| Q9ULK4 | MED23_HUMAN Mediator of RNA polymerase II transcription subunit 23 OS=Homo sapiens GN=MED23 PE=1 SV=2 | 617 | P | 0.34392 | Q | 0.345619 | -0.001699 | No Change: Both O | Mental retardation autosomal recessive type 18 (MRT18) [MIM:614249] |
| O75448 | MED24_HUMAN Mediator of RNA polymerase II transcription subunit 24 OS=Homo sapiens GN=MED24 PE=1 SV=1 | 204 | A | 0.333282 | T | 0.369079 | -0.035797 | No Change: Both O | - |
| Q71SY5 | MED25_HUMAN Mediator of RNA polymerase II transcription subunit 25 OS=Homo sapiens GN=MED25 PE=1 SV=2 | 335 | A | 0.998366 | V | 0.997746 | 6.20E-04 | No Change: Both D | Charcot-Marie-Tooth disease type 2B2 (CMT2B2) [MIM:605589] |
| Q02078 | MEF2A_HUMAN Myocyte-specific enhancer factor 2A OS=Homo sapiens GN=MEF2A PE=1 SV=1 | 263 | N | 0.963674 | S | 0.969814 | -0.00614 | No Change: Both D | - |
| Q02078 | MEF2A_HUMAN Myocyte-specific enhancer factor 2A OS=Homo sapiens GN=MEF2A PE=1 SV=1 | 279 | P | 0.968005 | L | 0.943557 | 0.024448 | No Change: Both D | - |
| Q02078 | MEF2A_HUMAN Myocyte-specific enhancer factor 2A OS=Homo sapiens GN=MEF2A PE=1 SV=1 | 283 | G | 0.964663 | D | 0.969122 | -0.004459 | No Change: Both D | - |
| Q14814 | MEF2D_HUMAN Myocyte-specific enhancer factor 2D OS=Homo sapiens GN=MEF2D PE=1 SV=1 | 434 | P | 0.865653 | S | 0.861975 | 0.003678 | No Change: Both D | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 148 | E | 0.975478 | Q | 0.973585 | 0.001893 | No Change: Both D | Familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 148 | E | 0.975478 | Q | 0.973585 | 0.001893 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 167 | E | 0.988601 | D | 0.987058 | 0.001543 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 202 | R | 0.91309 | Q | 0.910294 | 0.002796 | No Change: Both D | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 267 | T | 0.890696 | I | 0.831162 | 0.059534 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 369 | P | 0.953121 | S | 0.951663 | 0.001458 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 408 | R | 0.683788 | Q | 0.710186 | -0.026398 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 479 | F | 0.18578 | L | 0.20719 | -0.02141 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 681 | T | 0.532259 | I | 0.39613 | 0.136129 | D to O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 694 | M | 0.204777 | I | 0.143711 | 0.061066 | No Change: Both O | Familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 694 | M | 0.204777 | I | 0.143711 | 0.061066 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 694 | M | 0.204777 | V | 0.164132 | 0.040645 | No Change: Both O | Familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 694 | M | 0.204777 | V | 0.164132 | 0.040645 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 695 | K | 0.289356 | R | 0.240947 | 0.048409 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 726 | V | 0.105621 | A | 0.133988 | -0.028367 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 744 | A | 0.229112 | S | 0.343817 | -0.114705 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 761 | R | 0.640934 | H | 0.635985 | 0.004949 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 110 | L | 0.933409 | P | 0.958638 | -0.025229 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 138 | G | 0.971838 | A | 0.966218 | 0.00562 | No Change: Both D | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 230 | E | 0.656657 | K | 0.65082 | 0.005837 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 591 | I | 0.216328 | T | 0.33103 | -0.114702 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 653 | R | 0.222803 | H | 0.214883 | 0.00792 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 675 | S | 0.465291 | N | 0.430498 | 0.034793 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 680 | M | 0.563424 | L | 0.524851 | 0.038573 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 440 | Q | 0.917418 | E | 0.924713 | -0.007295 | No Change: Both D | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 42 | R | 0.628599 | W | 0.405621 | 0.222978 | D to O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 108 | S | 0.917251 | R | 0.905589 | 0.011662 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 148 | E | 0.975478 | V | 0.947207 | 0.028271 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 163 | E | 0.988471 | A | 0.986005 | 0.002466 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 177 | T | 0.983994 | I | 0.976295 | 0.007699 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 319 | E | 0.944417 | K | 0.935705 | 0.008712 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 474 | E | 0.236989 | K | 0.226573 | 0.010416 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 478 | H | 0.193328 | Y | 0.13462 | 0.058708 | No Change: Both O | Familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 585 | F | 0.303331 | L | 0.347576 | -0.044245 | No Change: Both O | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 632 | G | 0.416039 | S | 0.476656 | -0.060617 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 640 | I | 0.107035 | M | 0.148788 | -0.041753 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 641 | I | 0.102656 | F | 0.106008 | -0.003352 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 646 | P | 0.233491 | L | 0.136363 | 0.097128 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 649 | L | 0.260904 | P | 0.405428 | -0.144524 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 656 | E | 0.208852 | A | 0.136037 | 0.072815 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 661 | D | 0.140304 | N | 0.131861 | 0.008443 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 678 | G | 0.609764 | E | 0.645484 | -0.03572 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 680 | M | 0.563424 | I | 0.495489 | 0.067935 | D to O | Familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 680 | M | 0.563424 | I | 0.495489 | 0.067935 | D to O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 688 | Y | 0.162928 | C | 0.175761 | -0.012833 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 694 | M | 0.204777 | L | 0.151562 | 0.053215 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 695 | K | 0.289356 | M | 0.214683 | 0.074673 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 702 | S | 0.525078 | C | 0.292915 | 0.232163 | D to O | - |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 704 | V | 0.436943 | I | 0.415373 | 0.02157 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 705 | P | 0.393049 | S | 0.424137 | -0.031088 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 720 | I | 0.139582 | M | 0.19709 | -0.057508 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 743 | F | 0.216773 | L | 0.226662 | -0.009889 | No Change: Both O | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 758 | P | 0.552807 | S | 0.565343 | -0.012536 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 780 | P | 0.84281 | T | 0.799887 | 0.042923 | No Change: Both D | Familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100] |
| O15553 | MEFV_HUMAN Pyrin OS=Homo sapiens GN=MEFV PE=1 SV=1 | 33 | V | 0.607015 | L | 0.624663 | -0.017648 | No Change: Both D | - |
| Q96KG7 | MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens GN=MEGF10 PE=1 SV=1 | 206 | V | 0.811594 | I | 0.803123 | 0.008471 | No Change: Both D | - |
| Q96KG7 | MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens GN=MEGF10 PE=1 SV=1 | 1072 | R | 0.623703 | K | 0.629154 | -0.005451 | No Change: Both D | - |
| Q96KG7 | MEG10_HUMAN Multiple epidermal growth factor-like domains protein 10 OS=Homo sapiens GN=MEGF10 PE=1 SV=1 | 897 | P | 0.262045 | L | 0.13033 | 0.131715 | No Change: Both O | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 242 | H | 0.737377 | R | 0.747263 | -0.009886 | No Change: Both D | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 95 | S | 0.39227 | N | 0.305186 | 0.087084 | No Change: Both O | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 317 | H | 0.874024 | R | 0.886184 | -0.01216 | No Change: Both D | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 474 | L | 0.756468 | P | 0.85282 | -0.096352 | No Change: Both D | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 861 | L | 0.008191 | F | 0.006577 | 0.001614 | No Change: Both O | - |
| A6BM72 | MEG11_HUMAN Multiple epidermal growth factor-like domains protein 11 OS=Homo sapiens GN=MEGF11 PE=2 SV=3 | 988 | I | 0.600567 | T | 0.715924 | -0.115357 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 131 | S | 0.68911 | G | 0.655188 | 0.033922 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 916 | R | 0.80137 | L | 0.690188 | 0.111182 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 1137 | G | 0.770397 | A | 0.752064 | 0.018333 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 115 | M | 0.344119 | T | 0.381392 | -0.037273 | No Change: Both O | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 313 | A | 0.17379 | V | 0.126891 | 0.046899 | No Change: Both O | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 688 | L | 0.552739 | P | 0.73422 | -0.181481 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 587 | P | 0.88232 | L | 0.761266 | 0.121054 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 1287 | R | 0.826132 | H | 0.785417 | 0.040715 | No Change: Both D | - |
| O75095 | MEGF6_HUMAN Multiple epidermal growth factor-like domains protein 6 OS=Homo sapiens GN=MEGF6 PE=2 SV=4 | 1536 | G | 0.99333 | S | 0.995238 | -0.001908 | No Change: Both D | - |
| Q5TIA1 | MEI1_HUMAN Meiosis inhibitor protein 1 OS=Homo sapiens GN=MEI1 PE=2 SV=2 | 657 | E | 0.695625 | Q | 0.664824 | 0.030801 | No Change: Both D | - |
| Q5TIA1 | MEI1_HUMAN Meiosis inhibitor protein 1 OS=Homo sapiens GN=MEI1 PE=2 SV=2 | 853 | S | 0.209601 | T | 0.155884 | 0.053717 | No Change: Both O | - |
| Q5TIA1 | MEI1_HUMAN Meiosis inhibitor protein 1 OS=Homo sapiens GN=MEI1 PE=2 SV=2 | 1049 | K | 0.506641 | E | 0.480947 | 0.025694 | D to O | - |
| Q5JSS6 | MEIG1_HUMAN Meiosis expressed gene 1 protein homolog OS=Homo sapiens GN=MEIG1 PE=2 SV=1 | 9 | K | 0.744573 | T | 0.689931 | 0.054642 | No Change: Both D | - |
| O00470 | MEIS1_HUMAN Homeobox protein Meis1 OS=Homo sapiens GN=MEIS1 PE=1 SV=1 | 272 | R | 0.779882 | H | 0.767246 | 0.012636 | No Change: Both D | - |
| Q14680 | MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | 56 | T | 0.365447 | M | 0.316982 | 0.048465 | No Change: Both O | - |
| Q14680 | MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | 219 | K | 0.215243 | R | 0.163793 | 0.05145 | No Change: Both O | - |
| Q14680 | MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | 333 | R | 0.354252 | K | 0.419739 | -0.065487 | No Change: Both O | - |
| Q14680 | MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | 348 | T | 0.423976 | I | 0.279699 | 0.144277 | No Change: Both O | - |
| Q14680 | MELK_HUMAN Maternal embryonic leucine zipper kinase OS=Homo sapiens GN=MELK PE=1 SV=3 | 460 | T | 0.810305 | M | 0.776061 | 0.034244 | No Change: Both D | An ovarian mucinous carcinoma sample |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 12 | P | 0.186144 | L | 0.106059 | 0.080085 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 22 | L | 0.117192 | R | 0.198507 | -0.081315 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 26 | E | 0.293883 | K | 0.273113 | 0.02077 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 39 | L | 0.074508 | W | 0.040559 | 0.033949 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 42 | G | 0.096288 | D | 0.120969 | -0.024681 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 45 | E | 0.09158 | G | 0.07304 | 0.01854 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 139 | H | 0.249749 | D | 0.292505 | -0.042756 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 139 | H | 0.249749 | Y | 0.173524 | 0.076225 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 135 | K | 0.414739 | I | 0.226139 | 0.1886 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 144 | F | 0.123076 | V | 0.132164 | -0.009088 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 165 | A | 0.110278 | P | 0.141719 | -0.031441 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 169 | A | 0.076985 | D | 0.103092 | -0.026107 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 176 | R | 0.170457 | Q | 0.197621 | -0.027164 | No Change: Both O | - |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 177 | D | 0.189923 | Y | 0.097439 | 0.092484 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 181 | A | 0.246208 | P | 0.300425 | -0.054217 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 184 | E | 0.217281 | D | 0.213342 | 0.003939 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 188 | W | 0.138145 | S | 0.355167 | -0.217022 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 189 | V | 0.137453 | E | 0.273491 | -0.136038 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 228 | L | 0.165198 | P | 0.278424 | -0.113226 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 247 | A | 0.066308 | V | 0.046981 | 0.019327 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 260 | E | 0.366999 | K | 0.37402 | -0.007021 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 269 | L | 0.07595 | P | 0.132905 | -0.056955 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 272 | L | 0.077916 | P | 0.137585 | -0.059669 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 289 | A | 0.395753 | E | 0.5288 | -0.133047 | O to D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 291 | L | 0.516988 | P | 0.661667 | -0.144679 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 314 | A | 0.391856 | P | 0.458579 | -0.066723 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 319 | R | 0.29746 | P | 0.345436 | -0.047976 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 342 | A | 0.26645 | D | 0.340093 | -0.073643 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 346 | W | 0.171975 | R | 0.366973 | -0.194998 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 349 | T | 0.14428 | R | 0.147675 | -0.003395 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 364 | E | 0.315156 | K | 0.305144 | 0.010012 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 373 | A | 0.177064 | D | 0.240639 | -0.063575 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 423 | D | 0.113637 | N | 0.096555 | 0.017082 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 441 | W | 0.065246 | R | 0.16213 | -0.096884 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 452 | F | 0.366463 | S | 0.540093 | -0.17363 | O to D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 546 | T | 0.947313 | A | 0.943258 | 0.004055 | No Change: Both D | - |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 560 | S | 0.826597 | N | 0.786064 | 0.040533 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 161 | G | 0.299543 | D | 0.324636 | -0.025093 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 246 | C | 0.053259 | R | 0.114889 | -0.06163 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 45 | E | 0.09158 | K | 0.078188 | 0.013392 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 98 | R | 0.146603 | L | 0.088314 | 0.058289 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 110 | G | 0.604266 | E | 0.654962 | -0.050696 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 139 | H | 0.249749 | P | 0.27843 | -0.028681 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 139 | H | 0.249749 | R | 0.26417 | -0.014421 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 158 | D | 0.455442 | V | 0.312698 | 0.142744 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 158 | D | 0.455442 | V | 0.312698 | 0.142744 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 159 | S | 0.424148 | I | 0.197827 | 0.226321 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 160 | S | 0.388018 | F | 0.190945 | 0.197073 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 165 | A | 0.110278 | T | 0.113203 | -0.002925 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 167 | V | 0.090784 | F | 0.077359 | 0.013425 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 170 | C | 0.086335 | R | 0.182714 | -0.096379 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 173 | L | 0.127797 | P | 0.227103 | -0.099306 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 184 | E | 0.217281 | K | 0.21413 | 0.003151 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 184 | E | 0.217281 | Q | 0.186074 | 0.031207 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 186 | H | 0.167368 | R | 0.161282 | 0.006086 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 188 | W | 0.138145 | R | 0.288767 | -0.150622 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 220 | V | 0.238778 | M | 0.284497 | -0.045719 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 230 | G | 0.17982 | R | 0.188566 | -0.008746 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 234 | R | 0.233185 | L | 0.143756 | 0.089429 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 245 | V | 0.050813 | F | 0.044114 | 0.006699 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 246 | C | 0.053259 | F | 0.060691 | -0.007432 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 246 | C | 0.053259 | Y | 0.066858 | -0.013599 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 258 | S | 0.402566 | P | 0.367248 | 0.035318 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 258 | S | 0.402566 | W | 0.151391 | 0.251175 | No Change: Both O | Parathyroid tumor |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 264 | L | 0.191343 | R | 0.264769 | -0.073426 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 265 | Q | 0.152309 | P | 0.151446 | 8.63E-04 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 279 | E | 0.269732 | A | 0.192746 | 0.076986 | No Change: Both O | Parathyroid tumor |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 282 | P | 0.295488 | H | 0.261702 | 0.033786 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 286 | G | 0.31269 | R | 0.330437 | -0.017747 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 289 | A | 0.395753 | P | 0.506111 | -0.110358 | O to D | Parathyroid tumor |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 310 | G | 0.322103 | D | 0.357653 | -0.03555 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 316 | T | 0.371342 | P | 0.425899 | -0.054557 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 322 | H | 0.210273 | R | 0.220075 | -0.009802 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 322 | H | 0.210273 | Y | 0.151478 | 0.058795 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 325 | P | 0.118761 | L | 0.061899 | 0.056862 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 325 | P | 0.118761 | R | 0.107139 | 0.011622 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 330 | A | 0.099309 | P | 0.150023 | -0.050714 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 342 | A | 0.26645 | P | 0.324201 | -0.057751 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 347 | A | 0.148756 | P | 0.189242 | -0.040486 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 353 | I | 0.131429 | N | 0.274752 | -0.143323 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 358 | Y | 0.197595 | D | 0.344062 | -0.146467 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 360 | R | 0.299932 | W | 0.149144 | 0.150788 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 362 | D | 0.38532 | H | 0.340455 | 0.044865 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 377 | I | 0.292345 | M | 0.366065 | -0.07372 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 378 | P | 0.319816 | S | 0.339747 | -0.019931 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 390 | A | 0.728052 | V | 0.65757 | 0.070482 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 416 | A | 0.17501 | P | 0.248726 | -0.073716 | No Change: Both O | Familial isolated hyperparathyroidism (FIHP) [MIM:145000] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 416 | A | 0.17501 | P | 0.248726 | -0.073716 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 419 | L | 0.137119 | P | 0.231086 | -0.093967 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 420 | R | 0.118262 | P | 0.152174 | -0.033912 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 423 | D | 0.113637 | H | 0.099929 | 0.013708 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 426 | C | 0.166449 | Y | 0.198059 | -0.03161 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 428 | W | 0.252543 | S | 0.439985 | -0.187442 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 432 | S | 0.387604 | R | 0.32117 | 0.066434 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 441 | W | 0.065246 | C | 0.083464 | -0.018218 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 449 | L | 0.210738 | P | 0.334962 | -0.124224 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 532 | R | 0.98109 | C | 0.973368 | 0.007722 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 545 | P | 0.951289 | S | 0.946602 | 0.004687 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 549 | P | 0.934137 | S | 0.928525 | 0.005612 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 557 | T | 0.82229 | S | 0.86131 | -0.03902 | No Change: Both D | - |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 560 | S | 0.826597 | R | 0.776804 | 0.049793 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 220 | V | 0.238778 | F | 0.203903 | 0.034875 | No Change: Both O | - |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 147 | I | 0.123091 | F | 0.131329 | -0.008238 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 157 | L | 0.487897 | W | 0.422606 | 0.065291 | No Change: Both O | Parathyroid tumors |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 418 | L | 0.149814 | R | 0.217703 | -0.067889 | No Change: Both O | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| O00255 | MEN1_HUMAN Menin OS=Homo sapiens GN=MEN1 PE=1 SV=4 | 476 | W | 0.952384 | C | 0.965334 | -0.01295 | No Change: Both D | Familial multiple endocrine neoplasia type I (MEN1) [MIM:131100] |
| P50221 | MEOX1_HUMAN Homeobox protein MOX-1 OS=Homo sapiens GN=MEOX1 PE=2 SV=1 | 27 | S | 0.741093 | L | 0.627004 | 0.114089 | No Change: Both D | - |
| P50222 | MEOX2_HUMAN Homeobox protein MOX-2 OS=Homo sapiens GN=MEOX2 PE=1 SV=2 | 287 | I | 0.818685 | L | 0.850893 | -0.032208 | No Change: Both D | - |
| Q16819 | MEP1A_HUMAN Meprin A subunit alpha OS=Homo sapiens GN=MEP1A PE=1 SV=2 | 469 | V | 0.258774 | L | 0.27671 | -0.017936 | No Change: Both O | - |
| Q16819 | MEP1A_HUMAN Meprin A subunit alpha OS=Homo sapiens GN=MEP1A PE=1 SV=2 | 634 | M | 0.940397 | V | 0.930858 | 0.009539 | No Change: Both D | - |
| Q16819 | MEP1A_HUMAN Meprin A subunit alpha OS=Homo sapiens GN=MEP1A PE=1 SV=2 | 476 | R | 0.539188 | G | 0.559041 | -0.019853 | No Change: Both D | - |
| Q16819 | MEP1A_HUMAN Meprin A subunit alpha OS=Homo sapiens GN=MEP1A PE=1 SV=2 | 726 | T | 0.090068 | M | 0.07548 | 0.014588 | No Change: Both O | - |
| Q16819 | MEP1A_HUMAN Meprin A subunit alpha OS=Homo sapiens GN=MEP1A PE=1 SV=2 | 606 | T | 0.656424 | S | 0.693752 | -0.037328 | No Change: Both D | - |
| Q16820 | MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens GN=MEP1B PE=1 SV=3 | 326 | V | 0.274927 | M | 0.322129 | -0.047202 | No Change: Both O | - |
| Q16820 | MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens GN=MEP1B PE=1 SV=3 | 695 | P | 0.75666 | L | 0.641446 | 0.115214 | No Change: Both D | - |
| Q9NQ76 | MEPE_HUMAN Matrix extracellular phosphoglycoprotein OS=Homo sapiens GN=MEPE PE=1 SV=1 | 330 | V | 0.663555 | I | 0.640807 | 0.022748 | No Change: Both D | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 865 | R | 0.319264 | W | 0.153574 | 0.16569 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 20 | R | 0.383421 | S | 0.372025 | 0.011396 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 118 | S | 0.152981 | N | 0.131975 | 0.021006 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 282 | A | 0.383207 | T | 0.429243 | -0.046036 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 293 | R | 0.531375 | H | 0.553113 | -0.021738 | No Change: Both D | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 466 | R | 0.249868 | K | 0.29398 | -0.044112 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 498 | N | 0.502911 | S | 0.554998 | -0.052087 | No Change: Both D | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 518 | I | 0.012366 | V | 0.012561 | -1.95E-04 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 540 | E | 0.50973 | K | 0.493986 | 0.015744 | D to O | Retinitis pigmentosa type 38 (RP38) [MIM:613862] |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 661 | S | 0.365549 | C | 0.162816 | 0.202733 | No Change: Both O | Retinitis pigmentosa type 38 (RP38) [MIM:613862] |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 871 | I | 0.253991 | T | 0.404359 | -0.150368 | No Change: Both O | Retinitis pigmentosa type 38 (RP38) [MIM:613862] |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 871 | I | 0.253991 | V | 0.313404 | -0.059413 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 870 | V | 0.259827 | I | 0.233987 | 0.02584 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 185 | V | 0.289522 | M | 0.356694 | -0.067172 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 289 | E | 0.597288 | K | 0.60342 | -0.006132 | No Change: Both D | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 446 | A | 0.507734 | G | 0.581602 | -0.073868 | No Change: Both D | A renal clear cell carcinoma sample |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 452 | V | 0.232339 | L | 0.214297 | 0.018042 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 662 | Q | 0.386245 | E | 0.442411 | -0.056166 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 708 | A | 0.081824 | S | 0.136153 | -0.054329 | No Change: Both O | A head & Neck squamous cell carcinoma sample |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 823 | E | 0.483201 | Q | 0.438537 | 0.044664 | No Change: Both O | - |
| Q12866 | MERTK_HUMAN Tyrosine-protein kinase Mer OS=Homo sapiens GN=MERTK PE=1 SV=2 | 329 | N | 0.3881 | S | 0.448369 | -0.060269 | No Change: Both O | - |
| Q9BRJ9 | MESP1_HUMAN Mesoderm posterior protein 1 OS=Homo sapiens GN=MESP1 PE=2 SV=1 | 53 | A | 0.992418 | P | 0.995243 | -0.002825 | No Change: Both D | - |
| Q0VG99 | MESP2_HUMAN Mesoderm posterior protein 2 OS=Homo sapiens GN=MESP2 PE=1 SV=2 | 66 | A | 0.994935 | G | 0.995007 | -7.20E-05 | No Change: Both D | - |
| Q0VG99 | MESP2_HUMAN Mesoderm posterior protein 2 OS=Homo sapiens GN=MESP2 PE=1 SV=2 | 125 | L | 0.278374 | V | 0.227088 | 0.051286 | No Change: Both O | - |
| Q0VG99 | MESP2_HUMAN Mesoderm posterior protein 2 OS=Homo sapiens GN=MESP2 PE=1 SV=2 | 224 | S | 0.803761 | F | 0.646245 | 0.157516 | No Change: Both D | - |
| Q0VG99 | MESP2_HUMAN Mesoderm posterior protein 2 OS=Homo sapiens GN=MESP2 PE=1 SV=2 | 138 | V | 0.381911 | M | 0.476765 | -0.094854 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 320 | A | 0.18548 | V | 0.134394 | 0.051086 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1131 | M | 0.227841 | T | 0.285243 | -0.057402 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1188 | V | 0.17186 | L | 0.185156 | -0.013296 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1195 | L | 0.348879 | V | 0.367011 | -0.018132 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1220 | V | 0.173745 | I | 0.141892 | 0.031853 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1228 | D | 0.25007 | N | 0.2207 | 0.02937 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1228 | D | 0.25007 | H | 0.205372 | 0.044698 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1230 | Y | 0.349115 | C | 0.280318 | 0.068797 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1230 | Y | 0.349115 | H | 0.451616 | -0.102501 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1250 | M | 0.170963 | T | 0.213166 | -0.042203 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 238 | L | 0.241783 | S | 0.445164 | -0.203381 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 316 | I | 0.152305 | M | 0.224376 | -0.072071 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 375 | N | 0.195482 | S | 0.205182 | -0.0097 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 773 | P | 0.290237 | L | 0.167572 | 0.122665 | No Change: Both O | Gastric cancer |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 970 | R | 0.299118 | C | 0.157508 | 0.14161 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 991 | P | 0.711642 | S | 0.740824 | -0.029182 | No Change: Both D | Gastric cancer |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 992 | T | 0.729895 | I | 0.598392 | 0.131503 | No Change: Both D | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1092 | V | 0.10262 | I | 0.090434 | 0.012186 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1094 | H | 0.129396 | L | 0.076422 | 0.052974 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1094 | H | 0.129396 | R | 0.124286 | 0.00511 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1094 | H | 0.129396 | Y | 0.077344 | 0.052052 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1106 | H | 0.271719 | D | 0.327961 | -0.056242 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1173 | T | 0.417306 | I | 0.27673 | 0.140576 | No Change: Both O | Hepatocellular carcinoma (HCC) [MIM:114550] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1230 | Y | 0.349115 | D | 0.498643 | -0.149528 | No Change: Both O | Renal cell carcinoma papillary (RCCP) [MIM:605074] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1244 | K | 0.351048 | R | 0.265881 | 0.085167 | No Change: Both O | Hepatocellular carcinoma (HCC) [MIM:114550] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1250 | M | 0.170963 | I | 0.114443 | 0.05652 | No Change: Both O | Hepatocellular carcinoma (HCC) [MIM:114550] |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 143 | R | 0.362605 | Q | 0.383162 | -0.020557 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 156 | S | 0.402716 | L | 0.21813 | 0.184586 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 168 | E | 0.547512 | D | 0.521718 | 0.025794 | No Change: Both D | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 150 | H | 0.444528 | Y | 0.297532 | 0.146996 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 385 | C | 0.162403 | Y | 0.177053 | -0.01465 | No Change: Both O | - |
| P08581 | MET_HUMAN Hepatocyte growth factor receptor OS=Homo sapiens GN=MET PE=1 SV=4 | 1294 | V | 0.059654 | I | 0.052869 | 0.006785 | No Change: Both O | - |
| Q6UB28 | AMP1D_HUMAN Methionine aminopeptidase 1D mitochondrial OS=Homo sapiens GN=METAP1D PE=1 SV=1 | 14 | G | 0.521216 | V | 0.417616 | 0.1036 | D to O | - |
| Q5JPI9 | MTL10_HUMAN Methyltransferase-like protein 10 OS=Homo sapiens GN=METTL10 PE=1 SV=2 | 67 | R | 0.203232 | Q | 0.217096 | -0.013864 | No Change: Both O | - |
| Q5VVY1 | NTM1B_HUMAN Alpha N-terminal protein methyltransferase 1B OS=Homo sapiens GN=METTL11B PE=2 SV=2 | 150 | S | 0.200908 | P | 0.1795 | 0.021408 | No Change: Both O | - |
| Q5VVY1 | NTM1B_HUMAN Alpha N-terminal protein methyltransferase 1B OS=Homo sapiens GN=METTL11B PE=2 SV=2 | 72 | A | 0.145568 | G | 0.175438 | -0.02987 | No Change: Both O | - |
| Q5VVY1 | NTM1B_HUMAN Alpha N-terminal protein methyltransferase 1B OS=Homo sapiens GN=METTL11B PE=2 SV=2 | 247 | S | 0.253685 | R | 0.207555 | 0.04613 | No Change: Both O | - |
| A8MUP2 | MTL12_HUMAN Methyltransferase-like protein 12 mitochondrial OS=Homo sapiens GN=METTL12 PE=2 SV=1 | 125 | G | 0.598466 | S | 0.642787 | -0.044321 | No Change: Both D | - |
| Q8N6R0 | MTL13_HUMAN Methyltransferase-like protein 13 OS=Homo sapiens GN=METTL13 PE=1 SV=1 | 105 | M | 0.540268 | V | 0.424764 | 0.115504 | D to O | - |
| Q8N6R0 | MTL13_HUMAN Methyltransferase-like protein 13 OS=Homo sapiens GN=METTL13 PE=1 SV=1 | 359 | M | 0.383956 | I | 0.27092 | 0.113036 | No Change: Both O | - |
| Q8N6R0 | MTL13_HUMAN Methyltransferase-like protein 13 OS=Homo sapiens GN=METTL13 PE=1 SV=1 | 16 | Y | 0.19173 | C | 0.158657 | 0.033073 | No Change: Both O | - |
| A6NJ78 | MET15_HUMAN Probable methyltransferase-like protein 15 OS=Homo sapiens GN=METTL15 PE=2 SV=1 | 31 | N | 0.198581 | K | 0.226624 | -0.028043 | No Change: Both O | - |
| A6NJ78 | MET15_HUMAN Probable methyltransferase-like protein 15 OS=Homo sapiens GN=METTL15 PE=2 SV=1 | 149 | A | 0.337493 | T | 0.34373 | -0.006237 | No Change: Both O | - |
| A6NJ78 | MET15_HUMAN Probable methyltransferase-like protein 15 OS=Homo sapiens GN=METTL15 PE=2 SV=1 | 267 | I | 0.23495 | F | 0.247395 | -0.012445 | No Change: Both O | - |
| Q86W50 | MET16_HUMAN Methyltransferase-like protein 16 OS=Homo sapiens GN=METTL16 PE=1 SV=2 | 479 | S | 0.972992 | N | 0.964677 | 0.008315 | No Change: Both D | - |
| Q9H7H0 | MET17_HUMAN Methyltransferase-like protein 17 mitochondrial OS=Homo sapiens GN=METTL17 PE=1 SV=1 | 289 | G | 0.111603 | A | 0.091708 | 0.019895 | No Change: Both O | - |
| Q9H7H0 | MET17_HUMAN Methyltransferase-like protein 17 mitochondrial OS=Homo sapiens GN=METTL17 PE=1 SV=1 | 346 | A | 0.400112 | P | 0.535061 | -0.134949 | O to D | - |
| O95568 | MET18_HUMAN Histidine protein methyltransferase 1 homolog OS=Homo sapiens GN=METTL18 PE=1 SV=1 | 10 | E | 0.348356 | D | 0.320385 | 0.027971 | No Change: Both O | - |
| O95568 | MET18_HUMAN Histidine protein methyltransferase 1 homolog OS=Homo sapiens GN=METTL18 PE=1 SV=1 | 325 | A | 0.212327 | V | 0.157358 | 0.054969 | No Change: Both O | - |
| O95568 | MET18_HUMAN Histidine protein methyltransferase 1 homolog OS=Homo sapiens GN=METTL18 PE=1 SV=1 | 360 | K | 0.116368 | M | 0.060292 | 0.056076 | No Change: Both O | - |
| O95568 | MET18_HUMAN Histidine protein methyltransferase 1 homolog OS=Homo sapiens GN=METTL18 PE=1 SV=1 | 309 | F | 0.203921 | L | 0.251793 | -0.047872 | No Change: Both O | - |
| O95568 | MET18_HUMAN Histidine protein methyltransferase 1 homolog OS=Homo sapiens GN=METTL18 PE=1 SV=1 | 318 | R | 0.329448 | H | 0.329409 | 3.90E-05 | No Change: Both O | - |
| Q8IYL2 | TRM44_HUMAN Probable tRNA (uracil-O(2)-)-methyltransferase OS=Homo sapiens GN=METTL19 PE=2 SV=2 | 352 | R | 0.527758 | G | 0.515838 | 0.01192 | No Change: Both D | - |
| Q8IYL2 | TRM44_HUMAN Probable tRNA (uracil-O(2)-)-methyltransferase OS=Homo sapiens GN=METTL19 PE=2 SV=2 | 300 | M | 0.428704 | L | 0.375732 | 0.052972 | No Change: Both O | - |
| Q8IYL2 | TRM44_HUMAN Probable tRNA (uracil-O(2)-)-methyltransferase OS=Homo sapiens GN=METTL19 PE=2 SV=2 | 455 | I | 0.093948 | V | 0.107459 | -0.013511 | No Change: Both O | - |
| Q8IYL2 | TRM44_HUMAN Probable tRNA (uracil-O(2)-)-methyltransferase OS=Homo sapiens GN=METTL19 PE=2 SV=2 | 641 | G | 0.658632 | A | 0.608239 | 0.050393 | No Change: Both D | - |
| Q8WXB1 | MT21A_HUMAN Methyltransferase-like protein 21A OS=Homo sapiens GN=METTL21A PE=2 SV=2 | 192 | T | 0.215545 | I | 0.131106 | 0.084439 | No Change: Both O | - |
| Q96AZ1 | MT21B_HUMAN Methyltransferase-like protein 21B OS=Homo sapiens GN=METTL21B PE=2 SV=1 | 28 | S | 0.43028 | L | 0.248828 | 0.181452 | No Change: Both O | - |
| Q5VZV1 | MT21C_HUMAN Methyltransferase-like protein 21C OS=Homo sapiens GN=METTL21C PE=2 SV=1 | 46 | N | 0.671464 | S | 0.731786 | -0.060322 | No Change: Both D | - |
| Q5VZV1 | MT21C_HUMAN Methyltransferase-like protein 21C OS=Homo sapiens GN=METTL21C PE=2 SV=1 | 15 | G | 0.911911 | R | 0.919611 | -0.0077 | No Change: Both D | - |
| Q9H867 | MT21D_HUMAN Methyltransferase-like protein 21D OS=Homo sapiens GN=METTL21D PE=2 SV=2 | 63 | A | 0.574806 | D | 0.64805 | -0.073244 | No Change: Both D | - |
| Q9BUU2 | MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens GN=METTL22 PE=2 SV=2 | 59 | W | 0.540874 | S | 0.703492 | -0.162618 | No Change: Both D | - |
| Q9BUU2 | MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens GN=METTL22 PE=2 SV=2 | 219 | A | 0.223228 | T | 0.243386 | -0.020158 | No Change: Both O | - |
| Q9BUU2 | MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens GN=METTL22 PE=2 SV=2 | 366 | A | 0.270329 | T | 0.281877 | -0.011548 | No Change: Both O | - |
| Q9BUU2 | MET22_HUMAN Methyltransferase-like protein 22 OS=Homo sapiens GN=METTL22 PE=2 SV=2 | 375 | E | 0.223764 | K | 0.220545 | 0.003219 | No Change: Both O | - |
| Q86XA0 | MET23_HUMAN Methyltransferase-like protein 23 OS=Homo sapiens GN=METTL23 PE=2 SV=3 | 141 | L | 0.149738 | V | 0.144297 | 0.005441 | No Change: Both O | - |
| Q6P1Q9 | MTL2B_HUMAN Methyltransferase-like protein 2B OS=Homo sapiens GN=METTL2B PE=1 SV=3 | 124 | C | 0.630274 | R | 0.707684 | -0.07741 | No Change: Both D | - |
| Q6P1Q9 | MTL2B_HUMAN Methyltransferase-like protein 2B OS=Homo sapiens GN=METTL2B PE=1 SV=3 | 129 | N | 0.760164 | H | 0.736072 | 0.024092 | No Change: Both D | - |
| Q6P1Q9 | MTL2B_HUMAN Methyltransferase-like protein 2B OS=Homo sapiens GN=METTL2B PE=1 SV=3 | 169 | E | 0.315142 | K | 0.307959 | 0.007183 | No Change: Both O | - |
| Q6P1Q9 | MTL2B_HUMAN Methyltransferase-like protein 2B OS=Homo sapiens GN=METTL2B PE=1 SV=3 | 266 | V | 0.118686 | I | 0.103108 | 0.015578 | No Change: Both O | - |
| Q6P1Q9 | MTL2B_HUMAN Methyltransferase-like protein 2B OS=Homo sapiens GN=METTL2B PE=1 SV=3 | 68 | V | 0.348659 | I | 0.323026 | 0.025633 | No Change: Both O | - |
| Q8N3J2 | METL4_HUMAN Methyltransferase-like protein 4 OS=Homo sapiens GN=METTL4 PE=2 SV=3 | 163 | L | 0.234279 | F | 0.193752 | 0.040527 | No Change: Both O | - |
| Q8N3J2 | METL4_HUMAN Methyltransferase-like protein 4 OS=Homo sapiens GN=METTL4 PE=2 SV=3 | 310 | Q | 0.273 | K | 0.306037 | -0.033037 | No Change: Both O | - |
| Q8N3J2 | METL4_HUMAN Methyltransferase-like protein 4 OS=Homo sapiens GN=METTL4 PE=2 SV=3 | 468 | V | 0.607064 | L | 0.585787 | 0.021277 | No Change: Both D | - |
| Q8N3J2 | METL4_HUMAN Methyltransferase-like protein 4 OS=Homo sapiens GN=METTL4 PE=2 SV=3 | 230 | E | 0.462242 | D | 0.427035 | 0.035207 | No Change: Both O | - |
| Q8N3J2 | METL4_HUMAN Methyltransferase-like protein 4 OS=Homo sapiens GN=METTL4 PE=2 SV=3 | 42 | S | 0.434889 | F | 0.239745 | 0.195144 | No Change: Both O | - |
| Q9NRN9 | METL5_HUMAN Methyltransferase-like protein 5 OS=Homo sapiens GN=METTL5 PE=1 SV=1 | 202 | V | 0.237024 | G | 0.355463 | -0.118439 | No Change: Both O | - |
| Q9H8H3 | MET7A_HUMAN Methyltransferase-like protein 7A OS=Homo sapiens GN=METTL7A PE=1 SV=1 | 134 | A | 0.417393 | T | 0.441312 | -0.023919 | No Change: Both O | - |
| Q5U5Q3 | MEX3C_HUMAN RNA-binding protein MEX3C OS=Homo sapiens GN=MEX3C PE=1 SV=3 | 412 | T | 0.407509 | P | 0.449668 | -0.042159 | No Change: Both O | - |
| Q13361 | MFAP5_HUMAN Microfibrillar-associated protein 5 OS=Homo sapiens GN=MFAP5 PE=1 SV=1 | 61 | V | 0.562133 | D | 0.714432 | -0.152299 | No Change: Both D | A breast cancer sample |
| Q9GZY8 | MFF_HUMAN Mitochondrial fission factor OS=Homo sapiens GN=MFF PE=1 SV=1 | 29 | E | 0.732972 | K | 0.701152 | 0.03182 | No Change: Both D | A colorectal cancer sample |
| Q9GZY8 | MFF_HUMAN Mitochondrial fission factor OS=Homo sapiens GN=MFF PE=1 SV=1 | 7 | S | 0.906189 | C | 0.8212 | 0.084989 | No Change: Both D | - |
| Q9GZY8 | MFF_HUMAN Mitochondrial fission factor OS=Homo sapiens GN=MFF PE=1 SV=1 | 7 | S | 0.906189 | I | 0.801263 | 0.104926 | No Change: Both D | - |
| Q08431 | MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MFGE8 PE=1 SV=2 | 76 | M | 0.393638 | L | 0.338717 | 0.054921 | No Change: Both O | - |
| Q08431 | MFGM_HUMAN Lactadherin OS=Homo sapiens GN=MFGE8 PE=1 SV=2 | 3 | R | 0.679013 | S | 0.697518 | -0.018505 | No Change: Both D | - |
| Q9Y4C4 | MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 OS=Homo sapiens GN=MFHAS1 PE=1 SV=2 | 163 | L | 0.44734 | V | 0.401385 | 0.045955 | No Change: Both O | - |
| Q9Y4C4 | MFHA1_HUMAN Malignant fibrous histiocytoma-amplified sequence 1 OS=Homo sapiens GN=MFHAS1 PE=1 SV=2 | 892 | L | 0.086456 | P | 0.179047 | -0.092591 | No Change: Both O | - |
| P08582 | TRFM_HUMAN Melanotransferrin OS=Homo sapiens GN=MFI2 PE=1 SV=2 | 294 | R | 0.135464 | W | 0.050807 | 0.084657 | No Change: Both O | - |
| P08582 | TRFM_HUMAN Melanotransferrin OS=Homo sapiens GN=MFI2 PE=1 SV=2 | 559 | A | 0.12165 | T | 0.132251 | -0.010601 | No Change: Both O | - |
| Q8IWA4 | MFN1_HUMAN Mitofusin-1 OS=Homo sapiens GN=MFN1 PE=1 SV=2 | 523 | P | 0.092448 | R | 0.077859 | 0.014589 | No Change: Both O | - |
| Q8IWA4 | MFN1_HUMAN Mitofusin-1 OS=Homo sapiens GN=MFN1 PE=1 SV=2 | 415 | D | 0.210449 | H | 0.169559 | 0.04089 | No Change: Both O | A colorectal cancer sample |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 69 | V | 0.457023 | F | 0.408259 | 0.048764 | No Change: Both O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 76 | L | 0.322187 | P | 0.479398 | -0.157211 | No Change: Both O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 94 | R | 0.21038 | Q | 0.209532 | 8.48E-04 | No Change: Both O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 251 | P | 0.320161 | A | 0.249635 | 0.070526 | No Change: Both O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 280 | R | 0.325733 | H | 0.308662 | 0.017071 | No Change: Both O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 740 | W | 0.280004 | S | 0.596207 | -0.316203 | O to D | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 357 | K | 0.551017 | N | 0.493918 | 0.057099 | D to O | Charcot-Marie-Tooth disease type 2A2 (CMT2A2) [MIM:609260] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 94 | R | 0.21038 | W | 0.084398 | 0.125982 | No Change: Both O | Charcot-Marie-Tooth disease type 6 (CMT6) [MIM:601152] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 206 | T | 0.307953 | I | 0.19799 | 0.109963 | No Change: Both O | Charcot-Marie-Tooth disease type 6 (CMT6) [MIM:601152] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 276 | Q | 0.498764 | R | 0.521488 | -0.022724 | O to D | Charcot-Marie-Tooth disease type 6 (CMT6) [MIM:601152] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 361 | H | 0.479715 | Y | 0.354661 | 0.125054 | No Change: Both O | Charcot-Marie-Tooth disease type 6 (CMT6) [MIM:601152] |
| O95140 | MFN2_HUMAN Mitofusin-2 OS=Homo sapiens GN=MFN2 PE=1 SV=3 | 364 | R | 0.480345 | W | 0.247312 | 0.233033 | No Change: Both O | Charcot-Marie-Tooth disease type 6 (CMT6) [MIM:601152] |
| O00587 | MFNG_HUMAN Beta-1 3-N-acetylglucosaminyltransferase manic fringe OS=Homo sapiens GN=MFNG PE=1 SV=2 | 302 | R | 0.379623 | C | 0.242373 | 0.13725 | No Change: Both O | - |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 54 | R | 0.614358 | G | 0.591853 | 0.022505 | No Change: Both D | - |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 119 | I | 0.976499 | V | 0.977696 | -0.001197 | No Change: Both D | - |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 136 | V | 0.975172 | M | 0.983135 | -0.007963 | No Change: Both D | - |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 182 | I | 0.182968 | T | 0.280557 | -0.097589 | No Change: Both O | Nanophthalmos 2 (NNO2) [MIM:609549] |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 449 | G | 0.677809 | S | 0.72606 | -0.048251 | No Change: Both D | - |
| Q9BY79 | MFRP_HUMAN Membrane frizzled-related protein OS=Homo sapiens GN=MFRP PE=1 SV=1 | 514 | Q | 0.144574 | H | 0.13572 | 0.008854 | No Change: Both O | - |
| Q9H3U5 | MFSD1_HUMAN Major facilitator superfamily domain-containing protein 1 OS=Homo sapiens GN=MFSD1 PE=2 SV=2 | 24 | P | 0.798736 | S | 0.781183 | 0.017553 | No Change: Both D | - |
| Q9H3U5 | MFSD1_HUMAN Major facilitator superfamily domain-containing protein 1 OS=Homo sapiens GN=MFSD1 PE=2 SV=2 | 168 | K | 0.187226 | E | 0.187322 | -9.60E-05 | No Change: Both O | - |
| Q9H3U5 | MFSD1_HUMAN Major facilitator superfamily domain-containing protein 1 OS=Homo sapiens GN=MFSD1 PE=2 SV=2 | 220 | I | 0.039684 | V | 0.039998 | -3.14E-04 | No Change: Both O | - |
| Q9H3U5 | MFSD1_HUMAN Major facilitator superfamily domain-containing protein 1 OS=Homo sapiens GN=MFSD1 PE=2 SV=2 | 271 | I | 0.001827 | T | 0.003302 | -0.001475 | No Change: Both O | - |
| O43934 | MFS11_HUMAN UNC93-like protein MFSD11 OS=Homo sapiens GN=MFSD11 PE=2 SV=2 | 428 | S | 0.044809 | F | 0.017776 | 0.027033 | No Change: Both O | - |
| Q6NUT3 | MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens GN=MFSD12 PE=2 SV=2 | 182 | Y | 0.034169 | H | 0.062073 | -0.027904 | No Change: Both O | - |
| Q6NUT3 | MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens GN=MFSD12 PE=2 SV=2 | 243 | R | 0.756013 | H | 0.757076 | -0.001063 | No Change: Both D | - |
| Q6NUT3 | MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens GN=MFSD12 PE=2 SV=2 | 476 | R | 0.728956 | C | 0.597775 | 0.131181 | No Change: Both D | - |
| Q6NUT3 | MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens GN=MFSD12 PE=2 SV=2 | 203 | I | 0.560047 | V | 0.589695 | -0.029648 | No Change: Both D | - |
| Q6NUT3 | MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens GN=MFSD12 PE=2 SV=2 | 395 | G | 0.375388 | S | 0.43881 | -0.063422 | No Change: Both O | - |
| Q96ES6 | MFSD3_HUMAN Major facilitator superfamily domain-containing protein 3 OS=Homo sapiens GN=MFSD3 PE=2 SV=1 | 292 | G | 0.109217 | R | 0.10921 | 7.00E-06 | No Change: Both O | - |
| Q8N468 | MFSD4_HUMAN Major facilitator superfamily domain-containing protein 4 OS=Homo sapiens GN=MFSD4 PE=2 SV=3 | 228 | L | 0.030552 | I | 0.026112 | 0.00444 | No Change: Both O | - |
| Q8N468 | MFSD4_HUMAN Major facilitator superfamily domain-containing protein 4 OS=Homo sapiens GN=MFSD4 PE=2 SV=3 | 314 | G | 0.043694 | A | 0.036282 | 0.007412 | No Change: Both O | - |
| Q6ZSS7 | MFSD6_HUMAN Major facilitator superfamily domain-containing protein 6 OS=Homo sapiens GN=MFSD6 PE=1 SV=2 | 205 | R | 0.782432 | G | 0.725709 | 0.056723 | No Change: Both D | - |
| Q8IWD5 | MFS6L_HUMAN Major facilitator superfamily domain-containing protein 6-like OS=Homo sapiens GN=MFSD6L PE=2 SV=2 | 486 | R | 0.45939 | H | 0.447077 | 0.012313 | No Change: Both O | - |
| Q6UXD7 | MFSD7_HUMAN Major facilitator superfamily domain-containing protein 7 OS=Homo sapiens GN=MFSD7 PE=2 SV=1 | 170 | S | 0.296187 | P | 0.28469 | 0.011497 | No Change: Both O | - |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 109 | V | 0.121218 | G | 0.200602 | -0.079384 | No Change: Both O | - |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 310 | G | 0.056269 | D | 0.061684 | -0.005415 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 385 | G | 0.106158 | R | 0.097461 | 0.008697 | No Change: Both O | - |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 423 | A | 0.069779 | V | 0.04897 | 0.020809 | No Change: Both O | - |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 429 | G | 0.058738 | D | 0.06216 | -0.003422 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 52 | G | 0.179717 | R | 0.169906 | 0.009811 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 121 | Y | 0.052867 | C | 0.041718 | 0.011149 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 139 | R | 0.085529 | H | 0.087486 | -0.001957 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 157 | A | 0.354477 | P | 0.417765 | -0.063288 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 294 | T | 0.101302 | K | 0.130963 | -0.029661 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 447 | P | 0.407408 | L | 0.2432 | 0.164208 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 465 | R | 0.315553 | W | 0.146082 | 0.169471 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 160 | T | 0.592839 | I | 0.420496 | 0.172343 | D to O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 160 | T | 0.592839 | N | 0.61023 | -0.017391 | No Change: Both D | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 458 | T | 0.224953 | K | 0.300387 | -0.075434 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 465 | R | 0.315553 | Q | 0.339885 | -0.024332 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NHS3 | MFSD8_HUMAN Major facilitator superfamily domain-containing protein 8 OS=Homo sapiens GN=MFSD8 PE=1 SV=1 | 470 | M | 0.110732 | V | 0.089783 | 0.020949 | No Change: Both O | Neuronal ceroid lipofuscinosis type 7 (CLN7) [MIM:610951] |
| Q8NBP5 | MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens GN=MFSD9 PE=2 SV=2 | 129 | A | 0.052397 | S | 0.079941 | -0.027544 | No Change: Both O | - |
| Q8NBP5 | MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens GN=MFSD9 PE=2 SV=2 | 288 | I | 0.027376 | T | 0.053302 | -0.025926 | No Change: Both O | - |
| Q8NBP5 | MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens GN=MFSD9 PE=2 SV=2 | 59 | G | 0.063055 | A | 0.04626 | 0.016795 | No Change: Both O | A breast cancer sample |
| Q8NBP5 | MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens GN=MFSD9 PE=2 SV=2 | 84 | V | 0.26481 | A | 0.343521 | -0.078711 | No Change: Both O | A breast cancer sample |
| Q8NBP5 | MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens GN=MFSD9 PE=2 SV=2 | 376 | A | 0.245273 | T | 0.278061 | -0.032788 | No Change: Both O | - |
| Q8IWI9 | MGAP_HUMAN MAX gene-associated protein OS=Homo sapiens GN=MGA PE=1 SV=2 | 338 | T | 0.541315 | A | 0.523014 | 0.018301 | No Change: Both D | - |
| Q8IWI9 | MGAP_HUMAN MAX gene-associated protein OS=Homo sapiens GN=MGA PE=1 SV=2 | 716 | S | 0.497511 | T | 0.418291 | 0.07922 | No Change: Both O | - |
| Q8IWI9 | MGAP_HUMAN MAX gene-associated protein OS=Homo sapiens GN=MGA PE=1 SV=2 | 1270 | C | 0.996321 | R | 0.997033 | -7.12E-04 | No Change: Both D | - |
| Q8IWI9 | MGAP_HUMAN MAX gene-associated protein OS=Homo sapiens GN=MGA PE=1 SV=2 | 1523 | P | 0.725502 | A | 0.654232 | 0.07127 | No Change: Both D | - |
| O43451 | MGA_HUMAN Maltase-glucoamylase intestinal OS=Homo sapiens GN=MGAM PE=1 SV=5 | 404 | Q | 0.35548 | H | 0.334696 | 0.020784 | No Change: Both O | - |
| O43451 | MGA_HUMAN Maltase-glucoamylase intestinal OS=Homo sapiens GN=MGAM PE=1 SV=5 | 542 | S | 0.480117 | L | 0.267348 | 0.212769 | No Change: Both O | - |
| O43451 | MGA_HUMAN Maltase-glucoamylase intestinal OS=Homo sapiens GN=MGAM PE=1 SV=5 | 858 | N | 0.372309 | D | 0.406242 | -0.033933 | No Change: Both O | - |
| O43451 | MGA_HUMAN Maltase-glucoamylase intestinal OS=Homo sapiens GN=MGAM PE=1 SV=5 | 1638 | L | 0.162716 | I | 0.13548 | 0.027236 | No Change: Both O | - |
| P26572 | MGAT1_HUMAN Alpha-1 3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens GN=MGAT1 PE=2 SV=2 | 223 | R | 0.084098 | Q | 0.091591 | -0.007493 | No Change: Both O | - |
| P26572 | MGAT1_HUMAN Alpha-1 3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens GN=MGAT1 PE=2 SV=2 | 435 | L | 0.231534 | P | 0.38751 | -0.155976 | No Change: Both O | - |
| Q10469 | MGAT2_HUMAN Alpha-1 6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens GN=MGAT2 PE=1 SV=1 | 262 | H | 0.188882 | R | 0.181297 | 0.007585 | No Change: Both O | Congenital disorder of glycosylation type 2A (CDG2A) [MIM:212066] |
| Q10469 | MGAT2_HUMAN Alpha-1 6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens GN=MGAT2 PE=1 SV=1 | 290 | S | 0.242305 | F | 0.097705 | 0.1446 | No Change: Both O | Congenital disorder of glycosylation type 2A (CDG2A) [MIM:212066] |
| Q10469 | MGAT2_HUMAN Alpha-1 6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Homo sapiens GN=MGAT2 PE=1 SV=1 | 318 | N | 0.415525 | D | 0.425891 | -0.010366 | No Change: Both O | Congenital disorder of glycosylation type 2A (CDG2A) [MIM:212066] |
| Q9UQ53 | MGT4B_HUMAN Alpha-1 3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Homo sapiens GN=MGAT4B PE=1 SV=1 | 491 | L | 0.483814 | F | 0.455197 | 0.028617 | No Change: Both O | - |
| Q9UQ53 | MGT4B_HUMAN Alpha-1 3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Homo sapiens GN=MGAT4B PE=1 SV=1 | 257 | Q | 0.127389 | H | 0.115419 | 0.01197 | No Change: Both O | - |
| Q9UBM8 | MGT4C_HUMAN Alpha-1 3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens GN=MGAT4C PE=2 SV=2 | 428 | T | 0.293199 | S | 0.394244 | -0.101045 | No Change: Both O | - |
| Q3V5L5 | MGT5B_HUMAN Alpha-1 6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B OS=Homo sapiens GN=MGAT5B PE=2 SV=2 | 70 | V | 0.696819 | I | 0.665853 | 0.030966 | No Change: Both D | - |
| O60502 | NCOAT_HUMAN Bifunctional protein NCOAT OS=Homo sapiens GN=MGEA5 PE=1 SV=2 | 46 | G | 0.774809 | E | 0.784208 | -0.009399 | No Change: Both D | - |
| O60502 | NCOAT_HUMAN Bifunctional protein NCOAT OS=Homo sapiens GN=MGEA5 PE=1 SV=2 | 602 | E | 0.612319 | K | 0.611801 | 5.18E-04 | No Change: Both D | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 30 | E | 0.588047 | K | 0.58833 | -2.83E-04 | No Change: Both D | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 84 | L | 0.252595 | F | 0.246584 | 0.006011 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 143 | I | 0.109394 | V | 0.133185 | -0.023791 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 160 | G | 0.299369 | R | 0.275543 | 0.023826 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 166 | E | 0.251131 | D | 0.213233 | 0.037898 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 178 | K | 0.676485 | R | 0.662516 | 0.013969 | No Change: Both D | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 65 | W | 0.13074 | C | 0.228951 | -0.098211 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 58 | P | 0.272249 | S | 0.269272 | 0.002977 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 53 | L | 0.377671 | F | 0.335137 | 0.042534 | No Change: Both O | - |
| P16455 | MGMT_HUMAN Methylated-DNA--protein-cysteine methyltransferase OS=Homo sapiens GN=MGMT PE=1 SV=1 | 112 | I | 0.128437 | V | 0.161415 | -0.032978 | No Change: Both O | - |
| P08493 | MGP_HUMAN Matrix Gla protein OS=Homo sapiens GN=MGP PE=1 SV=2 | 53 | K | 0.608115 | E | 0.650114 | -0.041999 | No Change: Both D | - |
| P08493 | MGP_HUMAN Matrix Gla protein OS=Homo sapiens GN=MGP PE=1 SV=2 | 102 | T | 0.767091 | A | 0.753648 | 0.013443 | No Change: Both D | - |
| Q99735 | MGST2_HUMAN Microsomal glutathione S-transferase 2 OS=Homo sapiens GN=MGST2 PE=1 SV=1 | 101 | A | 0.363998 | V | 0.265543 | 0.098455 | No Change: Both O | - |
| O14880 | MGST3_HUMAN Microsomal glutathione S-transferase 3 OS=Homo sapiens GN=MGST3 PE=1 SV=1 | 15 | G | 0.071456 | C | 0.029198 | 0.042258 | No Change: Both O | - |
| O14880 | MGST3_HUMAN Microsomal glutathione S-transferase 3 OS=Homo sapiens GN=MGST3 PE=1 SV=1 | 48 | P | 0.478212 | S | 0.518755 | -0.040543 | O to D | - |
| Q96PC5 | MIA2_HUMAN Melanoma inhibitory activity protein 2 OS=Homo sapiens GN=MIA2 PE=2 SV=3 | 437 | D | 0.86142 | H | 0.816478 | 0.044942 | No Change: Both D | A breast cancer sample |
| Q5JRA6 | MIA3_HUMAN Melanoma inhibitory activity protein 3 OS=Homo sapiens GN=MIA3 PE=1 SV=1 | 482 | K | 0.869746 | E | 0.879388 | -0.009642 | No Change: Both D | - |
| Q5JRA6 | MIA3_HUMAN Melanoma inhibitory activity protein 3 OS=Homo sapiens GN=MIA3 PE=1 SV=1 | 605 | K | 0.65001 | R | 0.644186 | 0.005824 | No Change: Both D | - |
| Q5JRA6 | MIA3_HUMAN Melanoma inhibitory activity protein 3 OS=Homo sapiens GN=MIA3 PE=1 SV=1 | 881 | E | 0.950958 | G | 0.935796 | 0.015162 | No Change: Both D | - |
| Q5JRA6 | MIA3_HUMAN Melanoma inhibitory activity protein 3 OS=Homo sapiens GN=MIA3 PE=1 SV=1 | 1659 | G | 0.97685 | C | 0.968957 | 0.007893 | No Change: Both D | - |
| Q5JRA6 | MIA3_HUMAN Melanoma inhibitory activity protein 3 OS=Homo sapiens GN=MIA3 PE=1 SV=1 | 1723 | K | 0.982107 | E | 0.985615 | -0.003508 | No Change: Both D | - |
| Q96AX9 | MIB2_HUMAN E3 ubiquitin-protein ligase MIB2 OS=Homo sapiens GN=MIB2 PE=1 SV=3 | 15 | F | 0.976679 | L | 0.983163 | -0.006484 | No Change: Both D | - |
| Q96AX9 | MIB2_HUMAN E3 ubiquitin-protein ligase MIB2 OS=Homo sapiens GN=MIB2 PE=1 SV=3 | 45 | M | 0.98803 | T | 0.987524 | 5.06E-04 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 29 | R | 0.255855 | P | 0.305755 | -0.0499 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 37 | W | 0.216221 | G | 0.431901 | -0.21568 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 47 | T | 0.296746 | A | 0.273905 | 0.022841 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 49 | V | 0.267185 | G | 0.405572 | -0.138387 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 59 | C | 0.301662 | Y | 0.300278 | 0.001384 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 114 | Q | 0.381005 | R | 0.38029 | 7.15E-04 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 128 | R | 0.60873 | K | 0.625374 | -0.016644 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 137 | G | 0.34964 | R | 0.394761 | -0.045121 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 145 | L | 0.411319 | V | 0.381018 | 0.030301 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 147 | T | 0.493295 | S | 0.560428 | -0.067133 | O to D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 148 | K | 0.521272 | E | 0.557893 | -0.036621 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 152 | M | 0.545884 | V | 0.468167 | 0.077717 | D to O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 165 | V | 0.29379 | I | 0.271082 | 0.022708 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 174 | M | 0.532608 | V | 0.470281 | 0.062327 | D to O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 179 | H | 0.501952 | L | 0.389576 | 0.112376 | D to O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 196 | K | 0.266788 | E | 0.284506 | -0.017718 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 198 | G | 0.284629 | S | 0.361873 | -0.077244 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 199 | V | 0.264463 | I | 0.215321 | 0.049142 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 204 | T | 0.267131 | R | 0.300055 | -0.032924 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 229 | G | 0.090603 | S | 0.124932 | -0.034329 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 231 | Y | 0.088716 | C | 0.107682 | -0.018966 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 233 | W | 0.089558 | R | 0.208747 | -0.119189 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 236 | T | 0.089845 | I | 0.050624 | 0.039221 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 238 | S | 0.113343 | T | 0.08188 | 0.031463 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 244 | V | 0.461726 | L | 0.479964 | -0.018238 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 274 | Q | 0.233301 | R | 0.221668 | 0.011633 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 279 | R | 0.308011 | S | 0.369575 | -0.061564 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 291 | S | 0.799738 | G | 0.771881 | 0.027857 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 294 | P | 0.745737 | A | 0.65925 | 0.086487 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 328 | V | 0.020284 | I | 0.018962 | 0.001322 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 329 | R | 0.038946 | C | 0.020412 | 0.018534 | No Change: Both O | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 356 | T | 0.655822 | M | 0.627051 | 0.028771 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 373 | D | 0.756807 | A | 0.678206 | 0.078601 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 377 | T | 0.834486 | A | 0.806609 | 0.027877 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 383 | A | 0.872503 | T | 0.903875 | -0.031372 | No Change: Both D | - |
| Q29983 | MICA_HUMAN MHC class I polypeptide-related sequence A OS=Homo sapiens GN=MICA PE=1 SV=1 | 253 | W | 0.434122 | S | 0.699304 | -0.265182 | O to D | - |
| Q8TDZ2 | MICA1_HUMAN NEDD9-interacting protein with calponin homology and LIM domains OS=Homo sapiens GN=MICAL1 PE=1 SV=2 | 758 | A | 0.856274 | E | 0.895809 | -0.039535 | No Change: Both D | - |
| Q8TDZ2 | MICA1_HUMAN NEDD9-interacting protein with calponin homology and LIM domains OS=Homo sapiens GN=MICAL1 PE=1 SV=2 | 309 | L | 0.134854 | M | 0.158762 | -0.023908 | No Change: Both O | A breast cancer sample |
| Q8TDZ2 | MICA1_HUMAN NEDD9-interacting protein with calponin homology and LIM domains OS=Homo sapiens GN=MICAL1 PE=1 SV=2 | 12 | A | 0.593508 | T | 0.621569 | -0.028061 | No Change: Both D | - |
| Q8TDZ2 | MICA1_HUMAN NEDD9-interacting protein with calponin homology and LIM domains OS=Homo sapiens GN=MICAL1 PE=1 SV=2 | 153 | D | 0.161938 | A | 0.11386 | 0.048078 | No Change: Both O | - |
| Q8TDZ2 | MICA1_HUMAN NEDD9-interacting protein with calponin homology and LIM domains OS=Homo sapiens GN=MICAL1 PE=1 SV=2 | 758 | A | 0.856274 | T | 0.880436 | -0.024162 | No Change: Both D | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 1089 | R | 0.870052 | Q | 0.876715 | -0.006663 | No Change: Both D | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 220 | I | 0.192884 | V | 0.205047 | -0.012163 | No Change: Both O | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 1106 | L | 0.556926 | P | 0.715899 | -0.158973 | No Change: Both D | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 145 | F | 0.244622 | L | 0.275745 | -0.031123 | No Change: Both O | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 687 | D | 0.96389 | E | 0.968578 | -0.004688 | No Change: Both D | - |
| O94851 | MICA2_HUMAN Protein MICAL-2 OS=Homo sapiens GN=MICAL2 PE=1 SV=1 | 1110 | P | 0.535619 | S | 0.539569 | -0.00395 | No Change: Both D | - |
| Q7RTP6 | MICA3_HUMAN Protein MICAL-3 OS=Homo sapiens GN=MICAL3 PE=1 SV=2 | 750 | M | 0.5934 | L | 0.545046 | 0.048354 | No Change: Both D | - |
| Q7RTP6 | MICA3_HUMAN Protein MICAL-3 OS=Homo sapiens GN=MICAL3 PE=1 SV=2 | 11 | P | 0.413797 | A | 0.353746 | 0.060051 | No Change: Both O | - |
| Q7RTP6 | MICA3_HUMAN Protein MICAL-3 OS=Homo sapiens GN=MICAL3 PE=1 SV=2 | 745 | R | 0.526663 | Q | 0.556488 | -0.029825 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 70 | V | 0.757603 | I | 0.750201 | 0.007402 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 93 | Y | 0.570273 | S | 0.737978 | -0.167705 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 305 | A | 0.873517 | T | 0.883809 | -0.010292 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 313 | S | 0.926662 | G | 0.90179 | 0.024872 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 369 | D | 0.877116 | E | 0.896139 | -0.019023 | No Change: Both D | - |
| Q6ZW33 | MICLK_HUMAN MICAL C-terminal-like protein OS=Homo sapiens GN=MICALCL PE=2 SV=3 | 471 | T | 0.998157 | P | 0.998822 | -6.65E-04 | No Change: Both D | - |
| Q8N3F8 | MILK1_HUMAN MICAL-like protein 1 OS=Homo sapiens GN=MICALL1 PE=1 SV=2 | 519 | A | 0.992254 | S | 0.994698 | -0.002444 | No Change: Both D | - |
| Q8N3F8 | MILK1_HUMAN MICAL-like protein 1 OS=Homo sapiens GN=MICALL1 PE=1 SV=2 | 583 | P | 0.982278 | L | 0.965911 | 0.016367 | No Change: Both D | - |
| Q8N3F8 | MILK1_HUMAN MICAL-like protein 1 OS=Homo sapiens GN=MICALL1 PE=1 SV=2 | 817 | E | 0.935743 | K | 0.932985 | 0.002758 | No Change: Both D | A breast cancer sample |
| Q8N3F8 | MILK1_HUMAN MICAL-like protein 1 OS=Homo sapiens GN=MICALL1 PE=1 SV=2 | 685 | H | 0.582053 | R | 0.629454 | -0.047401 | No Change: Both D | - |
| Q8IY33 | MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens GN=MICALL2 PE=1 SV=1 | 480 | A | 0.985848 | P | 0.990184 | -0.004336 | No Change: Both D | - |
| Q8IY33 | MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens GN=MICALL2 PE=1 SV=1 | 519 | P | 0.990251 | L | 0.982473 | 0.007778 | No Change: Both D | - |
| Q8IY33 | MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens GN=MICALL2 PE=1 SV=1 | 711 | L | 0.905286 | V | 0.901777 | 0.003509 | No Change: Both D | - |
| Q8IY33 | MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens GN=MICALL2 PE=1 SV=1 | 623 | K | 0.928848 | R | 0.938142 | -0.009294 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 39 | E | 0.4946 | G | 0.461245 | 0.033355 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 68 | P | 0.639147 | H | 0.587153 | 0.051994 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 75 | D | 0.500816 | N | 0.442446 | 0.05837 | D to O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 80 | K | 0.586059 | E | 0.604154 | -0.018095 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 88 | D | 0.678898 | G | 0.648863 | 0.030035 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 105 | D | 0.650589 | G | 0.638608 | 0.011981 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 121 | I | 0.516426 | M | 0.583979 | -0.067553 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 136 | D | 0.403923 | N | 0.396748 | 0.007175 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 212 | T | 0.335187 | I | 0.208293 | 0.126894 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 215 | E | 0.404877 | K | 0.38577 | 0.019107 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 279 | R | 0.379085 | K | 0.408832 | -0.029747 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 291 | G | 0.717544 | S | 0.740089 | -0.022545 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 300 | V | 0.409812 | A | 0.468147 | -0.058335 | No Change: Both O | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 383 | A | 0.862928 | T | 0.880865 | -0.017937 | No Change: Both D | - |
| Q29980 | MICB_HUMAN MHC class I polypeptide-related sequence B OS=Homo sapiens GN=MICB PE=1 SV=1 | 136 | D | 0.403923 | H | 0.380608 | 0.023315 | No Change: Both O | - |
| O15344 | TRI18_HUMAN Midline-1 OS=Homo sapiens GN=MID1 PE=1 SV=1 | 266 | C | 0.356511 | R | 0.497361 | -0.14085 | No Change: Both O | Opitz syndrome type I (OS-I) [MIM:300000] |
| O15344 | TRI18_HUMAN Midline-1 OS=Homo sapiens GN=MID1 PE=1 SV=1 | 536 | I | 0.18973 | T | 0.295025 | -0.105295 | No Change: Both O | Opitz syndrome type I (OS-I) [MIM:300000] |
| O15344 | TRI18_HUMAN Midline-1 OS=Homo sapiens GN=MID1 PE=1 SV=1 | 626 | L | 0.064263 | P | 0.12582 | -0.061557 | No Change: Both O | Opitz syndrome type I (OS-I) [MIM:300000] |
| O15344 | TRI18_HUMAN Midline-1 OS=Homo sapiens GN=MID1 PE=1 SV=1 | 295 | L | 0.505373 | P | 0.613904 | -0.108531 | No Change: Both D | Opitz syndrome type I (OS-I) [MIM:300000] |
| Q9UJV3 | TRIM1_HUMAN Probable E3 ubiquitin-protein ligase MID2 OS=Homo sapiens GN=MID2 PE=1 SV=3 | 378 | A | 0.224013 | D | 0.295498 | -0.071485 | No Change: Both O | - |
| Q8N344 | MIER2_HUMAN Mesoderm induction early response protein 2 OS=Homo sapiens GN=MIER2 PE=2 SV=2 | 68 | D | 0.799973 | N | 0.787289 | 0.012684 | No Change: Both D | - |
| Q8N344 | MIER2_HUMAN Mesoderm induction early response protein 2 OS=Homo sapiens GN=MIER2 PE=2 SV=2 | 104 | D | 0.737487 | N | 0.706481 | 0.031006 | No Change: Both D | - |
| Q8N344 | MIER2_HUMAN Mesoderm induction early response protein 2 OS=Homo sapiens GN=MIER2 PE=2 SV=2 | 464 | P | 0.85613 | S | 0.844981 | 0.011149 | No Change: Both D | - |
| Q8N344 | MIER2_HUMAN Mesoderm induction early response protein 2 OS=Homo sapiens GN=MIER2 PE=2 SV=2 | 485 | S | 0.49987 | G | 0.425947 | 0.073923 | No Change: Both O | - |
| Q7Z3K6 | MIER3_HUMAN Mesoderm induction early response protein 3 OS=Homo sapiens GN=MIER3 PE=1 SV=2 | 126 | D | 0.942612 | G | 0.922639 | 0.019973 | No Change: Both D | - |
| Q7Z3K6 | MIER3_HUMAN Mesoderm induction early response protein 3 OS=Homo sapiens GN=MIER3 PE=1 SV=2 | 414 | N | 0.436906 | K | 0.433536 | 0.00337 | No Change: Both O | - |
| Q7Z3K6 | MIER3_HUMAN Mesoderm induction early response protein 3 OS=Homo sapiens GN=MIER3 PE=1 SV=2 | 432 | N | 0.497923 | D | 0.508624 | -0.010701 | O to D | - |
| Q7Z3K6 | MIER3_HUMAN Mesoderm induction early response protein 3 OS=Homo sapiens GN=MIER3 PE=1 SV=2 | 530 | N | 0.489077 | S | 0.548232 | -0.059155 | O to D | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 99 | K | 0.934966 | N | 0.927771 | 0.007195 | No Change: Both D | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 142 | P | 0.956295 | S | 0.95648 | -1.85E-04 | No Change: Both D | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 167 | K | 0.533298 | E | 0.552841 | -0.019543 | No Change: Both D | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 247 | R | 0.671857 | W | 0.417856 | 0.254001 | D to O | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 288 | S | 0.509777 | L | 0.375938 | 0.133839 | D to O | - |
| Q5JXC2 | MIIP_HUMAN Migration and invasion-inhibitory protein OS=Homo sapiens GN=MIIP PE=1 SV=3 | 381 | P | 0.992033 | S | 0.990212 | 0.001821 | No Change: Both D | - |
| Q8IUF8 | MINA_HUMAN MYC-induced nuclear antigen OS=Homo sapiens GN=MINA PE=1 SV=1 | 386 | A | 0.580642 | T | 0.612018 | -0.031376 | No Change: Both D | - |
| Q8IUF8 | MINA_HUMAN MYC-induced nuclear antigen OS=Homo sapiens GN=MINA PE=1 SV=1 | 17 | A | 0.968232 | P | 0.979492 | -0.01126 | No Change: Both D | - |
| Q8IUF8 | MINA_HUMAN MYC-induced nuclear antigen OS=Homo sapiens GN=MINA PE=1 SV=1 | 201 | P | 0.192062 | L | 0.1019 | 0.090162 | No Change: Both O | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 514 | A | 0.841422 | T | 0.845003 | -0.003581 | No Change: Both D | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 1200 | I | 0.218864 | V | 0.243751 | -0.024887 | No Change: Both O | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 771 | V | 0.959731 | A | 0.966616 | -0.006885 | No Change: Both D | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 775 | P | 0.963859 | L | 0.937074 | 0.026785 | No Change: Both D | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 863 | V | 0.929577 | I | 0.915706 | 0.013871 | No Change: Both D | - |
| Q8N4C8 | MINK1_HUMAN Misshapen-like kinase 1 OS=Homo sapiens GN=MINK1 PE=1 SV=2 | 1010 | E | 0.661821 | V | 0.473317 | 0.188504 | D to O | A gastric adenocarcinoma sample |
| Q9UNW1 | MINP1_HUMAN Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens GN=MINPP1 PE=1 SV=1 | 41 | S | 0.616874 | L | 0.460915 | 0.155959 | D to O | A follicular thyroid carcinoma |
| Q9UNW1 | MINP1_HUMAN Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens GN=MINPP1 PE=1 SV=1 | 270 | Q | 0.181827 | R | 0.168194 | 0.013633 | No Change: Both O | - |
| P30301 | MIP_HUMAN Lens fiber major intrinsic protein OS=Homo sapiens GN=MIP PE=1 SV=1 | 134 | E | 0.092372 | G | 0.07791 | 0.014462 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| P30301 | MIP_HUMAN Lens fiber major intrinsic protein OS=Homo sapiens GN=MIP PE=1 SV=1 | 138 | T | 0.023053 | R | 0.022686 | 3.67E-04 | No Change: Both O | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q99797 | MIPEP_HUMAN Mitochondrial intermediate peptidase OS=Homo sapiens GN=MIPEP PE=1 SV=2 | 137 | A | 0.57194 | V | 0.461059 | 0.110881 | D to O | - |
| Q99797 | MIPEP_HUMAN Mitochondrial intermediate peptidase OS=Homo sapiens GN=MIPEP PE=1 SV=2 | 340 | R | 0.480787 | Q | 0.492159 | -0.011372 | No Change: Both O | - |
| Q99797 | MIPEP_HUMAN Mitochondrial intermediate peptidase OS=Homo sapiens GN=MIPEP PE=1 SV=2 | 453 | R | 0.281546 | H | 0.283131 | -0.001585 | No Change: Both O | - |
| Q99797 | MIPEP_HUMAN Mitochondrial intermediate peptidase OS=Homo sapiens GN=MIPEP PE=1 SV=2 | 488 | S | 0.683018 | G | 0.609399 | 0.073619 | No Change: Both D | - |
| Q8TD10 | MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens GN=MIPOL1 PE=2 SV=1 | 141 | Q | 0.945802 | L | 0.915015 | 0.030787 | No Change: Both D | - |
| Q8N6C7 | PGSF1_HUMAN Putative uncharacterized protein encoded by MIR7-3HG OS=Homo sapiens GN=MIR7-3HG PE=5 SV=1 | 73 | R | 0.66388 | S | 0.706489 | -0.042609 | No Change: Both D | - |
| Q8N6C7 | PGSF1_HUMAN Putative uncharacterized protein encoded by MIR7-3HG OS=Homo sapiens GN=MIR7-3HG PE=5 SV=1 | 91 | H | 0.558294 | Q | 0.559822 | -0.001528 | No Change: Both D | - |
| Q9H081 | MIS12_HUMAN Protein MIS12 homolog OS=Homo sapiens GN=MIS12 PE=1 SV=1 | 21 | M | 0.039421 | V | 0.028728 | 0.010693 | No Change: Both O | - |
| Q6P0N0 | M18BP_HUMAN Mis18-binding protein 1 OS=Homo sapiens GN=MIS18BP1 PE=1 SV=1 | 164 | C | 0.861558 | R | 0.905396 | -0.043838 | No Change: Both D | - |
| Q6P0N0 | M18BP_HUMAN Mis18-binding protein 1 OS=Homo sapiens GN=MIS18BP1 PE=1 SV=1 | 347 | P | 0.489338 | R | 0.456651 | 0.032687 | No Change: Both O | - |
| Q6P0N0 | M18BP_HUMAN Mis18-binding protein 1 OS=Homo sapiens GN=MIS18BP1 PE=1 SV=1 | 583 | E | 0.804689 | D | 0.805215 | -5.26E-04 | No Change: Both D | - |
| Q6P0N0 | M18BP_HUMAN Mis18-binding protein 1 OS=Homo sapiens GN=MIS18BP1 PE=1 SV=1 | 851 | E | 0.637626 | Q | 0.600341 | 0.037285 | No Change: Both D | - |
| O75030 | MITF_HUMAN Microphthalmia-associated transcription factor OS=Homo sapiens GN=MITF PE=1 SV=2 | 310 | R | 0.797024 | K | 0.803184 | -0.00616 | No Change: Both D | Waardenburg syndrome type 2A (WS2A) [MIM:193510] |
| O75030 | MITF_HUMAN Microphthalmia-associated transcription factor OS=Homo sapiens GN=MITF PE=1 SV=2 | 317 | N | 0.787729 | K | 0.813458 | -0.025729 | No Change: Both D | Tietz syndrome (TIETZS) [MIM:103500] |
| O75030 | MITF_HUMAN Microphthalmia-associated transcription factor OS=Homo sapiens GN=MITF PE=1 SV=2 | 357 | S | 0.449939 | P | 0.472058 | -0.022119 | No Change: Both O | Waardenburg syndrome type 2A (WS2A) [MIM:193510] |
| O75030 | MITF_HUMAN Microphthalmia-associated transcription factor OS=Homo sapiens GN=MITF PE=1 SV=2 | 385 | N | 0.674856 | D | 0.681319 | -0.006463 | No Change: Both D | Waardenburg syndrome type 2A (WS2A) [MIM:193510] |
| O75030 | MITF_HUMAN Microphthalmia-associated transcription factor OS=Homo sapiens GN=MITF PE=1 SV=2 | 405 | S | 0.386731 | P | 0.382263 | 0.004468 | No Change: Both O | Waardenburg syndrome type 2A (WS2A) [MIM:193510] |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 3150 | T | 0.963952 | S | 0.97615 | -0.012198 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 3217 | K | 0.950208 | E | 0.94776 | 0.002448 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1403 | E | 0.944383 | V | 0.910783 | 0.0336 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1247 | T | 0.818053 | I | 0.728295 | 0.089758 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 631 | I | 0.835263 | L | 0.845383 | -0.01012 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 854 | L | 0.936285 | V | 0.93909 | -0.002805 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1042 | G | 0.696599 | S | 0.736822 | -0.040223 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2337 | T | 0.96326 | N | 0.951973 | 0.011287 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2608 | P | 0.981189 | L | 0.966063 | 0.015126 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2720 | T | 0.829287 | P | 0.851492 | -0.022205 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2868 | T | 0.911566 | S | 0.915124 | -0.003558 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 104 | N | 0.72443 | S | 0.759372 | -0.034942 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 238 | W | 0.647179 | R | 0.820999 | -0.17382 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 497 | E | 0.668147 | D | 0.651219 | 0.016928 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 574 | Q | 0.953966 | P | 0.961982 | -0.008016 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 872 | A | 0.954537 | V | 0.955022 | -4.85E-04 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1120 | T | 0.967624 | S | 0.972874 | -0.00525 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1470 | L | 0.862719 | W | 0.788096 | 0.074623 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1559 | V | 0.465352 | M | 0.588381 | -0.123029 | O to D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1622 | P | 0.939414 | L | 0.902916 | 0.036498 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1849 | T | 0.942057 | A | 0.925062 | 0.016995 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1876 | R | 0.946461 | Q | 0.946516 | -5.50E-05 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2101 | I | 0.973615 | T | 0.988119 | -0.014504 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2363 | N | 0.948271 | S | 0.964417 | -0.016146 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2649 | R | 0.967037 | H | 0.961876 | 0.005161 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2760 | D | 0.962818 | G | 0.959787 | 0.003031 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2786 | R | 0.94758 | Q | 0.94324 | 0.00434 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2793 | S | 0.929537 | N | 0.89785 | 0.031687 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2845 | R | 0.949817 | H | 0.930506 | 0.019311 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2904 | Q | 0.92726 | R | 0.928154 | -8.94E-04 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 3097 | N | 0.835027 | D | 0.826052 | 0.008975 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 832 | R | 0.817709 | W | 0.612906 | 0.204803 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 1951 | L | 0.807581 | I | 0.754928 | 0.052653 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 3102 | E | 0.813481 | G | 0.741664 | 0.071817 | No Change: Both D | - |
| P46013 | KI67_HUMAN Antigen KI-67 OS=Homo sapiens GN=MKI67 PE=1 SV=2 | 2607 | R | 0.982852 | H | 0.977024 | 0.005828 | No Change: Both D | - |
| Q9BYG3 | MK67I_HUMAN MKI67 FHA domain-interacting nucleolar phosphoprotein OS=Homo sapiens GN=MKI67IP PE=1 SV=1 | 144 | P | 0.636802 | Q | 0.608199 | 0.028603 | No Change: Both D | - |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 37 | Y | 0.361181 | C | 0.432081 | -0.0709 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 37 | Y | 0.361181 | C | 0.432081 | -0.0709 | No Change: Both O | McKusick-Kaufman syndrome (MKKS) [MIM:236700] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 49 | G | 0.240061 | V | 0.142143 | 0.097918 | No Change: Both O | - |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 84 | H | 0.369992 | Y | 0.258919 | 0.111073 | No Change: Both O | McKusick-Kaufman syndrome (MKKS) [MIM:236700] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 242 | A | 0.128869 | S | 0.207829 | -0.07896 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 242 | A | 0.128869 | S | 0.207829 | -0.07896 | No Change: Both O | McKusick-Kaufman syndrome (MKKS) [MIM:236700] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 517 | R | 0.364227 | C | 0.231975 | 0.132252 | No Change: Both O | - |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 532 | G | 0.456401 | V | 0.335307 | 0.121094 | No Change: Both O | - |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 52 | G | 0.237923 | D | 0.238535 | -6.12E-04 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 57 | T | 0.355608 | A | 0.328655 | 0.026953 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 277 | L | 0.163806 | P | 0.264316 | -0.10051 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 499 | C | 0.1979 | S | 0.392987 | -0.195087 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 32 | I | 0.424018 | M | 0.537515 | -0.113497 | O to D | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 236 | S | 0.297188 | P | 0.286543 | 0.010645 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 286 | D | 0.166019 | A | 0.108915 | 0.057104 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 511 | S | 0.359275 | A | 0.242675 | 0.1166 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 518 | R | 0.384753 | H | 0.348277 | 0.036476 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 155 | R | 0.101318 | L | 0.065576 | 0.035742 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 339 | I | 0.370792 | V | 0.394954 | -0.024162 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 345 | G | 0.320687 | E | 0.361833 | -0.041146 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 181 | A | 0.051637 | P | 0.076875 | -0.025238 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 237 | T | 0.266234 | A | 0.254166 | 0.012068 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 237 | T | 0.266234 | P | 0.320912 | -0.054678 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 325 | T | 0.43946 | P | 0.486053 | -0.046593 | No Change: Both O | - |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 460 | S | 0.504451 | P | 0.455399 | 0.049052 | D to O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 492 | D | 0.130961 | N | 0.129396 | 0.001565 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 41 | G | 0.424147 | R | 0.423256 | 8.91E-04 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 99 | C | 0.019148 | R | 0.037496 | -0.018348 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 299 | P | 0.199675 | L | 0.117005 | 0.08267 | No Change: Both O | Bardet-Biedl syndrome type 6 (BBS6) [MIM:209900] |
| Q9NPJ1 | MKKS_HUMAN McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin OS=Homo sapiens GN=MKKS PE=1 SV=1 | 488 | A | 0.173243 | T | 0.185634 | -0.012391 | No Change: Both O | - |
| Q969V6 | MKL1_HUMAN MKL/myocardin-like protein 1 OS=Homo sapiens GN=MKL1 PE=1 SV=1 | 648 | S | 0.754084 | G | 0.732023 | 0.022061 | No Change: Both D | - |
| Q9ULH7 | MKL2_HUMAN MKL/myocardin-like protein 2 OS=Homo sapiens GN=MKL2 PE=1 SV=3 | 390 | D | 0.940842 | G | 0.934252 | 0.00659 | No Change: Both D | - |
| Q9UL63 | MKLN1_HUMAN Muskelin OS=Homo sapiens GN=MKLN1 PE=1 SV=2 | 469 | C | 0.123777 | G | 0.251103 | -0.127326 | No Change: Both O | - |
| Q9BUB5 | MKNK1_HUMAN MAP kinase-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=MKNK1 PE=1 SV=1 | 49 | K | 0.484954 | Q | 0.431558 | 0.053396 | No Change: Both O | - |
| Q9BUB5 | MKNK1_HUMAN MAP kinase-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=MKNK1 PE=1 SV=1 | 158 | L | 0.18587 | V | 0.18887 | -0.003 | No Change: Both O | - |
| Q9BUB5 | MKNK1_HUMAN MAP kinase-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=MKNK1 PE=1 SV=1 | 308 | D | 0.175927 | N | 0.155228 | 0.020699 | No Change: Both O | - |
| Q9BUB5 | MKNK1_HUMAN MAP kinase-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=MKNK1 PE=1 SV=1 | 446 | R | 0.952479 | Q | 0.946059 | 0.00642 | No Change: Both D | - |
| Q9HBH9 | MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=MKNK2 PE=1 SV=3 | 73 | D | 0.710583 | N | 0.670384 | 0.040199 | No Change: Both D | - |
| Q9HBH9 | MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=MKNK2 PE=1 SV=3 | 10 | Q | 0.671752 | K | 0.702782 | -0.03103 | No Change: Both D | - |
| Q9HBH9 | MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=MKNK2 PE=1 SV=3 | 428 | R | 0.831686 | Q | 0.846034 | -0.014348 | No Change: Both D | - |
| Q9UHC7 | MKRN1_HUMAN E3 ubiquitin-protein ligase makorin-1 OS=Homo sapiens GN=MKRN1 PE=1 SV=3 | 243 | V | 0.208618 | L | 0.227977 | -0.019359 | No Change: Both O | - |
| Q9UHC7 | MKRN1_HUMAN E3 ubiquitin-protein ligase makorin-1 OS=Homo sapiens GN=MKRN1 PE=1 SV=3 | 439 | V | 0.552727 | A | 0.626062 | -0.073335 | No Change: Both D | - |
| Q9H000 | MKRN2_HUMAN Probable E3 ubiquitin-protein ligase makorin-2 OS=Homo sapiens GN=MKRN2 PE=1 SV=2 | 388 | R | 0.565429 | Q | 0.545338 | 0.020091 | No Change: Both D | - |
| Q13064 | MKRN3_HUMAN Probable E3 ubiquitin-protein ligase makorin-3 OS=Homo sapiens GN=MKRN3 PE=1 SV=1 | 145 | T | 0.928532 | M | 0.924312 | 0.00422 | No Change: Both D | A colorectal cancer sample |
| Q13064 | MKRN3_HUMAN Probable E3 ubiquitin-protein ligase makorin-3 OS=Homo sapiens GN=MKRN3 PE=1 SV=1 | 239 | S | 0.268512 | T | 0.197902 | 0.07061 | No Change: Both O | A colorectal cancer sample |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 39 | L | 0.274163 | F | 0.252264 | 0.021899 | No Change: Both O | - |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 123 | R | 0.491962 | Q | 0.491298 | 6.64E-04 | No Change: Both O | - |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 166 | R | 0.699245 | W | 0.475117 | 0.224128 | D to O | Meckel syndrome type 1 (MKS1) [MIM:249000] |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 286 | D | 0.411806 | G | 0.395645 | 0.016161 | No Change: Both O | - |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 450 | I | 0.189146 | T | 0.312227 | -0.123081 | No Change: Both O | - |
| Q9NXB0 | MKS1_HUMAN Meckel syndrome type 1 protein OS=Homo sapiens GN=MKS1 PE=1 SV=2 | 492 | C | 0.604352 | W | 0.493215 | 0.111137 | D to O | Bardet-Biedl syndrome type 13 (BBS13) [MIM:209900] |
| Q8IYA7 | MKX_HUMAN Homeobox protein Mohawk OS=Homo sapiens GN=MKX PE=2 SV=2 | 40 | R | 0.833098 | H | 0.801178 | 0.03192 | No Change: Both D | - |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 93 | S | 0.173749 | L | 0.068648 | 0.105101 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 118 | T | 0.052 | R | 0.049766 | 0.002234 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 212 | G | 0.073704 | R | 0.063192 | 0.010512 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 280 | S | 0.126464 | L | 0.054155 | 0.072309 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 309 | L | 0.016619 | M | 0.019164 | -0.002545 | No Change: Both O | - |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 59 | G | 0.08156 | E | 0.096802 | -0.015242 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 92 | P | 0.169714 | S | 0.20957 | -0.039856 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 141 | N | 0.107387 | K | 0.117395 | -0.010008 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 141 | N | 0.107387 | S | 0.123238 | -0.015851 | No Change: Both O | Leukoencephalopathy megalencephalic with subcortical cysts type 1 (MLC1) [MIM:604004] |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 171 | C | 0.830879 | F | 0.831416 | -5.37E-04 | No Change: Both D | - |
| Q15049 | MLC1_HUMAN Membrane protein MLC1 OS=Homo sapiens GN=MLC1 PE=1 SV=5 | 344 | N | 0.557471 | S | 0.617535 | -0.060064 | No Change: Both D | - |
| P58340 | MLF1_HUMAN Myeloid leukemia factor 1 OS=Homo sapiens GN=MLF1 PE=1 SV=1 | 226 | P | 0.892257 | T | 0.86465 | 0.027607 | No Change: Both D | - |
| Q71F23 | CENPU_HUMAN Centromere protein U OS=Homo sapiens GN=MLF1IP PE=1 SV=1 | 16 | G | 0.972892 | S | 0.980325 | -0.007433 | No Change: Both D | - |
| Q71F23 | CENPU_HUMAN Centromere protein U OS=Homo sapiens GN=MLF1IP PE=1 SV=1 | 157 | I | 0.975432 | T | 0.984526 | -0.009094 | No Change: Both D | - |
| Q71F23 | CENPU_HUMAN Centromere protein U OS=Homo sapiens GN=MLF1IP PE=1 SV=1 | 214 | I | 0.954831 | M | 0.96423 | -0.009399 | No Change: Both D | - |
| Q71F23 | CENPU_HUMAN Centromere protein U OS=Homo sapiens GN=MLF1IP PE=1 SV=1 | 16 | G | 0.972892 | R | 0.980612 | -0.00772 | No Change: Both D | - |
| Q71F23 | CENPU_HUMAN Centromere protein U OS=Homo sapiens GN=MLF1IP PE=1 SV=1 | 279 | A | 0.151617 | T | 0.171481 | -0.019864 | No Change: Both O | - |
| Q15773 | MLF2_HUMAN Myeloid leukemia factor 2 OS=Homo sapiens GN=MLF2 PE=1 SV=1 | 80 | F | 0.756288 | C | 0.772284 | -0.015996 | No Change: Both D | A colorectal cancer sample |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 28 | P | 0.302546 | L | 0.169792 | 0.132754 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 35 | M | 0.280957 | R | 0.34301 | -0.062053 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 44 | S | 0.275437 | F | 0.116107 | 0.15933 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 62 | Q | 0.324711 | K | 0.364472 | -0.039761 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 64 | N | 0.351439 | S | 0.409057 | -0.057618 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 67 | G | 0.397915 | R | 0.39452 | 0.003395 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 68 | I | 0.39968 | N | 0.547479 | -0.147799 | O to D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 69 | R | 0.401397 | K | 0.476812 | -0.075415 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 77 | C | 0.166938 | R | 0.321025 | -0.154087 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 93 | S | 0.277842 | G | 0.228981 | 0.048861 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 107 | I | 0.29194 | R | 0.423205 | -0.131265 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 117 | T | 0.402184 | M | 0.336636 | 0.065548 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 117 | T | 0.402184 | R | 0.394808 | 0.007376 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 185 | V | 0.227247 | G | 0.3448 | -0.117553 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 193 | S | 0.423761 | P | 0.380791 | 0.04297 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 217 | R | 0.262886 | C | 0.143578 | 0.119308 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 219 | I | 0.225477 | V | 0.254496 | -0.029019 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 226 | R | 0.193434 | L | 0.125262 | 0.068172 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 326 | V | 0.485077 | A | 0.543708 | -0.058631 | O to D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 384 | V | 0.843751 | D | 0.901774 | -0.058023 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 492 | A | 0.76178 | T | 0.798382 | -0.036602 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 506 | V | 0.375896 | A | 0.437155 | -0.061259 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 542 | Q | 0.186188 | L | 0.102124 | 0.084064 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 574 | L | 0.144099 | P | 0.259447 | -0.115348 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 578 | E | 0.262338 | G | 0.227769 | 0.034569 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 582 | L | 0.230704 | V | 0.212003 | 0.018701 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 618 | K | 0.356029 | A | 0.257634 | 0.098395 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 618 | K | 0.356029 | T | 0.262675 | 0.093354 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 659 | R | 0.050007 | P | 0.068457 | -0.01845 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 681 | A | 0.326503 | T | 0.372617 | -0.046114 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 718 | H | 0.108275 | Y | 0.068227 | 0.040048 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 729 | L | 0.356666 | V | 0.345822 | 0.010844 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 54 | G | 0.248483 | E | 0.30126 | -0.052777 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 67 | G | 0.397915 | W | 0.191124 | 0.206791 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 77 | C | 0.166938 | Y | 0.187852 | -0.020914 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 80 | F | 0.20298 | V | 0.225231 | -0.022251 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 84 | K | 0.407995 | E | 0.431498 | -0.023503 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 111 | A | 0.269067 | V | 0.207116 | 0.061951 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 128 | A | 0.42194 | P | 0.495388 | -0.073448 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 182 | R | 0.179456 | G | 0.200904 | -0.021448 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 213 | V | 0.347748 | M | 0.40166 | -0.053912 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 244 | G | 0.234935 | D | 0.260145 | -0.02521 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 244 | G | 0.234935 | V | 0.141235 | 0.0937 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 265 | R | 0.143296 | H | 0.148615 | -0.005319 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 268 | E | 0.348632 | G | 0.292162 | 0.05647 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 295 | S | 0.204343 | T | 0.149231 | 0.055112 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 325 | R | 0.484434 | Q | 0.53209 | -0.047656 | O to D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 329 | H | 0.465612 | P | 0.520167 | -0.054555 | O to D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 406 | S | 0.839665 | N | 0.770987 | 0.068678 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 441 | A | 0.925417 | T | 0.931598 | -0.006181 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 549 | L | 0.286055 | P | 0.438158 | -0.152103 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 551 | N | 0.308007 | T | 0.294654 | 0.013353 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 565 | I | 0.025292 | F | 0.027286 | -0.001994 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 588 | L | 0.220292 | P | 0.379082 | -0.15879 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 603 | P | 0.587452 | R | 0.54903 | 0.038422 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 607 | L | 0.441963 | H | 0.489701 | -0.047738 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 607 | L | 0.441963 | H | 0.489701 | -0.047738 | No Change: Both O | Lobular carcinoma in situ (LCIS) |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 622 | L | 0.275221 | H | 0.340704 | -0.065483 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 648 | P | 0.151573 | L | 0.078018 | 0.073555 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 659 | R | 0.050007 | L | 0.033309 | 0.016698 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 662 | T | 0.110215 | P | 0.145811 | -0.035596 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 687 | R | 0.357507 | W | 0.196722 | 0.160785 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 689 | Q | 0.445441 | R | 0.440191 | 0.00525 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 716 | V | 0.106827 | M | 0.131778 | -0.024951 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 751 | K | 0.2561 | R | 0.218124 | 0.037976 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 755 | R | 0.582431 | W | 0.27209 | 0.310341 | D to O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 32 | I | 0.304033 | V | 0.321292 | -0.017259 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 586 | A | 0.200462 | P | 0.274136 | -0.073674 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 217 | R | 0.262886 | G | 0.28246 | -0.019574 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 18 | R | 0.182378 | C | 0.090084 | 0.092294 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 101 | G | 0.330699 | D | 0.342512 | -0.011813 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 132 | D | 0.603468 | H | 0.571308 | 0.03216 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 182 | R | 0.179456 | K | 0.232927 | -0.053471 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 379 | Y | 0.887222 | C | 0.914111 | -0.026889 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 559 | L | 0.145115 | R | 0.214437 | -0.069322 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 648 | P | 0.151573 | S | 0.151827 | -2.54E-04 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 22 | G | 0.242135 | A | 0.217811 | 0.024324 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 67 | G | 0.397915 | E | 0.450279 | -0.052364 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 309 | P | 0.508524 | S | 0.534962 | -0.026438 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 19 | I | 0.175243 | F | 0.165517 | 0.009726 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 21 | A | 0.213539 | V | 0.160895 | 0.052644 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 25 | I | 0.279815 | F | 0.262014 | 0.017801 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 29 | A | 0.315943 | S | 0.408682 | -0.092739 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 35 | M | 0.280957 | K | 0.409958 | -0.129001 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 35 | M | 0.280957 | N | 0.374899 | -0.093942 | No Change: Both O | Mismatch repair cancer syndrome (MMRCS) [MIM:276300] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 38 | N | 0.279555 | H | 0.250463 | 0.029092 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 41 | D | 0.300636 | G | 0.28055 | 0.020086 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 63 | D | 0.333061 | E | 0.359705 | -0.026644 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 102 | E | 0.31931 | K | 0.321131 | -0.001821 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 106 | S | 0.30172 | R | 0.24634 | 0.05538 | No Change: Both O | Gastric cancer |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 109 | H | 0.261561 | Q | 0.265796 | -0.004235 | No Change: Both O | Gastric cancer |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 155 | L | 0.144855 | R | 0.244043 | -0.099188 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 185 | V | 0.227247 | L | 0.212927 | 0.01432 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 234 | E | 0.220225 | G | 0.177363 | 0.042862 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 247 | S | 0.2976 | P | 0.259859 | 0.037741 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 260 | L | 0.022949 | R | 0.040576 | -0.017627 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 264 | H | 0.093035 | Y | 0.055023 | 0.038012 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 282 | A | 0.165943 | G | 0.191157 | -0.025214 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 292 | L | 0.161596 | P | 0.287435 | -0.125839 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 304 | D | 0.469831 | V | 0.334864 | 0.134967 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 321 | S | 0.46628 | I | 0.258105 | 0.208175 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 338 | N | 0.573893 | S | 0.665038 | -0.091145 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 385 | R | 0.847061 | C | 0.788302 | 0.058759 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 385 | R | 0.847061 | P | 0.867714 | -0.020653 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 443 | K | 0.934766 | Q | 0.937853 | -0.003087 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 472 | R | 0.983339 | I | 0.966694 | 0.016645 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 474 | R | 0.977228 | Q | 0.969554 | 0.007674 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 485 | D | 0.883116 | E | 0.896207 | -0.013091 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 485 | D | 0.883116 | H | 0.86062 | 0.022496 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 542 | Q | 0.186188 | P | 0.193491 | -0.007303 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 550 | L | 0.300376 | P | 0.457733 | -0.157357 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 589 | A | 0.267886 | D | 0.354818 | -0.086932 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 601 | D | 0.684526 | G | 0.701086 | -0.01656 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 618 | K | 0.356029 | R | 0.273111 | 0.082918 | No Change: Both O | Colorectal cancer |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 623 | A | 0.2345 | P | 0.307502 | -0.073002 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 631 | D | 0.35138 | A | 0.271451 | 0.079929 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 635 | N | 0.289343 | K | 0.327193 | -0.03785 | No Change: Both O | Gastric cancer |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 636 | L | 0.238518 | P | 0.383594 | -0.145076 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 640 | P | 0.103692 | S | 0.111927 | -0.008235 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 646 | Y | 0.155609 | C | 0.137248 | 0.018361 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 654 | P | 0.085832 | L | 0.042371 | 0.043461 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 655 | I | 0.066957 | V | 0.07369 | -0.006733 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 659 | R | 0.050007 | Q | 0.053535 | -0.003528 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 724 | L | 0.207489 | M | 0.247723 | -0.040234 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 2 (HNPCC2) [MIM:609310] |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 749 | L | 0.157204 | P | 0.2832 | -0.125996 | No Change: Both O | Colorectal cancer |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 41 | D | 0.300636 | H | 0.262189 | 0.038447 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 98 | G | 0.268434 | S | 0.329492 | -0.061058 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 101 | G | 0.330699 | S | 0.391564 | -0.060865 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 116 | T | 0.379484 | K | 0.438637 | -0.059153 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 126 | Y | 0.414644 | N | 0.547205 | -0.132561 | O to D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 215 | N | 0.278938 | S | 0.322914 | -0.043976 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 216 | I | 0.280564 | S | 0.509409 | -0.228845 | O to D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 260 | L | 0.022949 | F | 0.020264 | 0.002685 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 265 | R | 0.143296 | C | 0.068347 | 0.074949 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 320 | E | 0.477543 | D | 0.418129 | 0.059414 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 474 | R | 0.977228 | W | 0.940226 | 0.037002 | No Change: Both D | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 539 | A | 0.149687 | D | 0.197403 | -0.047716 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 585 | L | 0.184326 | R | 0.265433 | -0.081107 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 619 | A | 0.338023 | P | 0.410914 | -0.072891 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 640 | P | 0.103692 | L | 0.055483 | 0.048209 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 656 | F | 0.060674 | S | 0.152629 | -0.091955 | No Change: Both O | - |
| P40692 | MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens GN=MLH1 PE=1 SV=1 | 666 | W | 0.346171 | R | 0.549867 | -0.203696 | O to D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 494 | H | 0.877853 | R | 0.872687 | 0.005166 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 24 | Q | 0.241237 | E | 0.298825 | -0.057588 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 499 | N | 0.817873 | S | 0.870875 | -0.053002 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 624 | E | 0.698018 | Q | 0.675022 | 0.022996 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 647 | R | 0.762894 | C | 0.67331 | 0.089584 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 817 | S | 0.886919 | G | 0.819315 | 0.067604 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 981 | G | 0.612685 | S | 0.702494 | -0.089809 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1007 | N | 0.753729 | S | 0.807336 | -0.053607 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1394 | A | 0.473161 | T | 0.4785 | -0.005339 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1451 | E | 0.918735 | K | 0.927324 | -0.008589 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 7 (HNPCC7) [MIM:604395] |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 93 | R | 0.20843 | G | 0.215355 | -0.006925 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 120 | F | 0.334971 | S | 0.558947 | -0.223976 | O to D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 231 | K | 0.382853 | Q | 0.321571 | 0.061282 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 420 | V | 0.778791 | I | 0.761105 | 0.017686 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 492 | L | 0.89896 | V | 0.8797 | 0.01926 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 600 | R | 0.413826 | Q | 0.412329 | 0.001497 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 606 | T | 0.488727 | P | 0.497198 | -0.008471 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 720 | Y | 0.5528 | C | 0.617923 | -0.065123 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 723 | V | 0.599236 | I | 0.609164 | -0.009928 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 741 | V | 0.651329 | F | 0.66281 | -0.011481 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 797 | R | 0.741074 | H | 0.740928 | 1.46E-04 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 844 | P | 0.954224 | L | 0.92646 | 0.027764 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 845 | S | 0.954501 | G | 0.921711 | 0.03279 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 942 | T | 0.845445 | I | 0.759587 | 0.085858 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 966 | S | 0.667471 | P | 0.657689 | 0.009782 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1073 | D | 0.269018 | N | 0.249784 | 0.019234 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1105 | D | 0.353226 | E | 0.360918 | -0.007692 | No Change: Both O | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1163 | G | 0.551877 | D | 0.589 | -0.037123 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 1319 | G | 0.577917 | R | 0.600806 | -0.022889 | No Change: Both D | - |
| Q9UHC1 | MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens GN=MLH3 PE=1 SV=3 | 826 | N | 0.91239 | D | 0.928643 | -0.016253 | No Change: Both D | - |
| Q5VWP3 | MLIP_HUMAN Muscular LMNA-interacting protein OS=Homo sapiens GN=MLIP PE=1 SV=3 | 159 | V | 0.667938 | I | 0.645604 | 0.022334 | No Change: Both D | - |
| Q5VWP3 | MLIP_HUMAN Muscular LMNA-interacting protein OS=Homo sapiens GN=MLIP PE=1 SV=3 | 320 | S | 0.884605 | T | 0.856991 | 0.027614 | No Change: Both D | - |
| Q5VWP3 | MLIP_HUMAN Muscular LMNA-interacting protein OS=Homo sapiens GN=MLIP PE=1 SV=3 | 6 | R | 0.890116 | H | 0.862899 | 0.027217 | No Change: Both D | - |
| Q5VWP3 | MLIP_HUMAN Muscular LMNA-interacting protein OS=Homo sapiens GN=MLIP PE=1 SV=3 | 376 | P | 0.766249 | S | 0.755193 | 0.011056 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 420 | D | 0.651195 | N | 0.596035 | 0.05516 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 563 | E | 0.778565 | D | 0.766105 | 0.01246 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 597 | S | 0.634634 | F | 0.444468 | 0.190166 | D to O | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 728 | V | 0.418783 | I | 0.375617 | 0.043166 | No Change: Both O | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 741 | E | 0.625531 | D | 0.584888 | 0.040643 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 784 | C | 0.990033 | G | 0.991926 | -0.001893 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 892 | R | 0.87832 | W | 0.748474 | 0.129846 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 900 | T | 0.878863 | I | 0.815705 | 0.063158 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 977 | R | 0.646413 | C | 0.567751 | 0.078662 | No Change: Both D | - |
| Q5TCX8 | M3KL4_HUMAN Mitogen-activated protein kinase kinase kinase MLK4 OS=Homo sapiens GN=MLK4 PE=1 SV=1 | 982 | P | 0.605347 | L | 0.442715 | 0.162632 | D to O | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 52 | S | 0.681927 | T | 0.634752 | 0.047175 | No Change: Both D | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 100 | D | 0.312199 | E | 0.326618 | -0.014419 | No Change: Both O | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 132 | S | 0.764865 | P | 0.756066 | 0.008799 | No Change: Both D | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 146 | R | 0.863309 | Q | 0.868749 | -0.00544 | No Change: Both D | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 169 | M | 0.866724 | L | 0.836307 | 0.030417 | No Change: Both D | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 291 | L | 0.24031 | P | 0.378602 | -0.138292 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 364 | T | 0.679366 | M | 0.648688 | 0.030678 | No Change: Both D | - |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 398 | F | 0.049213 | I | 0.054559 | -0.005346 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8NB16 | MLKL_HUMAN Mixed lineage kinase domain-like protein OS=Homo sapiens GN=MLKL PE=1 SV=1 | 421 | R | 0.336264 | H | 0.319387 | 0.016877 | No Change: Both O | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 30 | A | 0.973242 | G | 0.979516 | -0.006274 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 53 | A | 0.995626 | V | 0.993822 | 0.001804 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 502 | E | 0.993835 | K | 0.991123 | 0.002712 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 2319 | S | 0.83139 | T | 0.787997 | 0.043393 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 2354 | P | 0.755117 | R | 0.731208 | 0.023909 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 2387 | Q | 0.953447 | R | 0.954031 | -5.84E-04 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 3714 | V | 0.169699 | I | 0.153735 | 0.015964 | No Change: Both O | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 3773 | S | 0.740761 | A | 0.691814 | 0.048947 | No Change: Both D | - |
| Q03164 | MLL1_HUMAN Histone-lysine N-methyltransferase MLL OS=Homo sapiens GN=MLL PE=1 SV=5 | 1975 | Q | 0.205795 | P | 0.224182 | -0.018387 | No Change: Both O | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5224 | R | 0.16748 | H | 0.151251 | 0.016229 | No Change: Both O | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 476 | A | 0.999878 | T | 0.999877 | 1.00E-06 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5109 | C | 0.261269 | F | 0.2416 | 0.019669 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5179 | R | 0.146075 | H | 0.148024 | -0.001949 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5214 | R | 0.097812 | H | 0.092958 | 0.004854 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5340 | R | 0.470807 | L | 0.363563 | 0.107244 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5464 | T | 0.262909 | M | 0.213499 | 0.04941 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 692 | P | 0.999977 | T | 0.999962 | 1.50E-05 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 813 | P | 0.998741 | L | 0.997756 | 9.85E-04 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 2382 | P | 0.995139 | S | 0.994095 | 0.001044 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 2460 | R | 0.990561 | C | 0.984581 | 0.00598 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 2557 | P | 0.937981 | L | 0.868527 | 0.069454 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 3398 | M | 0.865927 | V | 0.791812 | 0.074115 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 3419 | D | 0.416459 | G | 0.355596 | 0.060863 | No Change: Both O | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 4357 | R | 0.942094 | S | 0.956685 | -0.014591 | No Change: Both D | - |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5210 | Y | 0.12897 | C | 0.098199 | 0.030771 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| O14686 | MLL2_HUMAN Histone-lysine N-methyltransferase MLL2 OS=Homo sapiens GN=MLL2 PE=1 SV=2 | 5428 | G | 0.092846 | D | 0.104122 | -0.011276 | No Change: Both O | Kabuki syndrome (KABS) [MIM:147920] |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 823 | I | 0.675899 | T | 0.781018 | -0.105119 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 823 | I | 0.675899 | N | 0.776755 | -0.100856 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 347 | C | 0.286651 | G | 0.444433 | -0.157782 | No Change: Both O | A colorectal cancer sample |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 400 | D | 0.598893 | N | 0.578724 | 0.020169 | No Change: Both D | A colorectal cancer sample |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 478 | L | 0.496442 | W | 0.392518 | 0.103924 | No Change: Both O | A colorectal cancer sample |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 3698 | T | 0.871937 | S | 0.895679 | -0.023742 | No Change: Both D | A colorectal cancer sample |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 526 | R | 0.545069 | P | 0.616494 | -0.071425 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 1836 | S | 0.984167 | N | 0.978531 | 0.005636 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 2008 | T | 0.796663 | A | 0.787123 | 0.00954 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 2412 | P | 0.935928 | T | 0.899749 | 0.036179 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 2600 | P | 0.946367 | A | 0.906476 | 0.039891 | No Change: Both D | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 291 | L | 0.123453 | F | 0.128168 | -0.004715 | No Change: Both O | - |
| Q8NEZ4 | MLL3_HUMAN Histone-lysine N-methyltransferase MLL3 OS=Homo sapiens GN=MLL3 PE=1 SV=3 | 316 | T | 0.254967 | S | 0.336474 | -0.081507 | No Change: Both O | - |
| Q8IZD2 | MLL5_HUMAN Histone-lysine N-methyltransferase MLL5 OS=Homo sapiens GN=MLL5 PE=1 SV=1 | 1424 | S | 0.985301 | P | 0.985641 | -3.40E-04 | No Change: Both D | - |
| P55198 | AF17_HUMAN Protein AF-17 OS=Homo sapiens GN=MLLT6 PE=1 SV=2 | 198 | A | 0.949584 | T | 0.960374 | -0.01079 | No Change: Both D | - |
| P12872 | MOTI_HUMAN Promotilin OS=Homo sapiens GN=MLN PE=1 SV=1 | 15 | V | 0.104258 | A | 0.151098 | -0.04684 | No Change: Both O | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 139 | R | 0.383942 | W | 0.189 | 0.194942 | No Change: Both O | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 153 | L | 0.814013 | P | 0.860538 | -0.046525 | No Change: Both D | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 163 | D | 0.955893 | N | 0.939742 | 0.016151 | No Change: Both D | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 172 | G | 0.969378 | D | 0.97442 | -0.005042 | No Change: Both D | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 347 | H | 0.25514 | R | 0.277887 | -0.022747 | No Change: Both O | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 374 | V | 0.500787 | A | 0.56887 | -0.068083 | No Change: Both D | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 35 | R | 0.885957 | W | 0.723319 | 0.162638 | No Change: Both D | Griscelli syndrome type 3 (GS3) [MIM:609227] |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 289 | T | 0.474309 | I | 0.376421 | 0.097888 | No Change: Both O | - |
| Q9BV36 | MELPH_HUMAN Melanophilin OS=Homo sapiens GN=MLPH PE=1 SV=1 | 451 | P | 0.926732 | S | 0.923331 | 0.003401 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 531 | S | 0.536944 | L | 0.310084 | 0.22686 | D to O | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 267 | T | 0.635358 | M | 0.649204 | -0.013846 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 281 | A | 0.604931 | T | 0.647015 | -0.042084 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 281 | A | 0.604931 | V | 0.505365 | 0.099566 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 580 | R | 0.738521 | W | 0.565447 | 0.173074 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 740 | P | 0.879686 | T | 0.834069 | 0.045617 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 773 | Y | 0.92092 | H | 0.959347 | -0.038427 | No Change: Both D | - |
| Q9NYL2 | MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | 784 | K | 0.940801 | T | 0.921116 | 0.019685 | No Change: Both D | - |
| Q9UH92 | MLX_HUMAN Max-like protein X OS=Homo sapiens GN=MLX PE=1 SV=2 | 223 | Q | 0.581312 | R | 0.54482 | 0.036492 | No Change: Both D | - |
| Q9HAP2 | MLXIP_HUMAN MLX-interacting protein OS=Homo sapiens GN=MLXIP PE=1 SV=2 | 396 | E | 0.882685 | G | 0.852951 | 0.029734 | No Change: Both D | - |
| Q9HAP2 | MLXIP_HUMAN MLX-interacting protein OS=Homo sapiens GN=MLXIP PE=1 SV=2 | 539 | V | 0.886639 | L | 0.892507 | -0.005868 | No Change: Both D | - |
| Q9NP71 | MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens GN=MLXIPL PE=1 SV=1 | 241 | Q | 0.562474 | H | 0.477973 | 0.084501 | D to O | - |
| Q9NP71 | MLXPL_HUMAN Carbohydrate-responsive element-binding protein OS=Homo sapiens GN=MLXIPL PE=1 SV=1 | 244 | D | 0.480315 | E | 0.502874 | -0.022559 | O to D | - |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 207 | Y | 0.583866 | C | 0.633455 | -0.049589 | No Change: Both D | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 363 | Q | 0.304102 | H | 0.263819 | 0.040283 | No Change: Both O | - |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 89 | L | 0.238895 | P | 0.323062 | -0.084167 | No Change: Both O | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 145 | R | 0.404886 | Q | 0.426394 | -0.021508 | No Change: Both O | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 218 | G | 0.557983 | E | 0.589801 | -0.031818 | No Change: Both D | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 359 | R | 0.505746 | Q | 0.528467 | -0.022721 | No Change: Both D | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q8IVH4 | MMAA_HUMAN Methylmalonic aciduria type A protein mitochondrial OS=Homo sapiens GN=MMAA PE=1 SV=1 | 359 | R | 0.505746 | G | 0.507898 | -0.002152 | No Change: Both D | Methylmalonic aciduria type cblA (MMAA) [MIM:251100] |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 19 | R | 0.626102 | Q | 0.586358 | 0.039744 | No Change: Both D | - |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 135 | A | 0.468353 | T | 0.489049 | -0.020696 | No Change: Both O | Methylmalonic aciduria type cblB (MMAB) [MIM:251110] |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 186 | R | 0.11366 | W | 0.038839 | 0.074821 | No Change: Both O | - |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 191 | R | 0.213816 | W | 0.080625 | 0.133191 | No Change: Both O | Methylmalonic aciduria type cblB (MMAB) [MIM:251110] |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 193 | E | 0.240063 | K | 0.242855 | -0.002792 | No Change: Both O | Methylmalonic aciduria type cblB (MMAB) [MIM:251110] |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 239 | M | 0.62292 | K | 0.72581 | -0.10289 | No Change: Both D | - |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 96 | I | 0.319902 | T | 0.4923 | -0.172398 | No Change: Both O | Methylmalonic aciduria type cblB (MMAB) [MIM:251110] |
| Q96EY8 | MMAB_HUMAN Cob(I)yrinic acid a c-diamide adenosyltransferase mitochondrial OS=Homo sapiens GN=MMAB PE=1 SV=1 | 19 | R | 0.626102 | H | 0.485551 | 0.140551 | D to O | - |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 27 | Q | 0.05315 | R | 0.047754 | 0.005396 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 116 | L | 0.366272 | P | 0.525322 | -0.15905 | O to D | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 122 | H | 0.207313 | R | 0.208501 | -0.001188 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 130 | Y | 0.251253 | H | 0.352195 | -0.100942 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 147 | G | 0.161825 | A | 0.119688 | 0.042137 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 147 | G | 0.161825 | D | 0.170198 | -0.008373 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 156 | G | 0.065107 | D | 0.06822 | -0.003113 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 157 | W | 0.060609 | C | 0.08582 | -0.025211 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 161 | R | 0.069858 | G | 0.067673 | 0.002185 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 161 | R | 0.069858 | Q | 0.063991 | 0.005867 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 189 | R | 0.173569 | S | 0.196948 | -0.023379 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 193 | L | 0.128551 | P | 0.238831 | -0.11028 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 206 | R | 0.208111 | P | 0.233752 | -0.025641 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 206 | R | 0.208111 | W | 0.093159 | 0.114952 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblC (MMACHC) [MIM:277400] |
| Q9Y4U1 | MMAC_HUMAN Methylmalonic aciduria and homocystinuria type C protein OS=Homo sapiens GN=MMACHC PE=1 SV=3 | 271 | S | 0.997477 | G | 0.996181 | 0.001296 | No Change: Both D | - |
| Q9H3L0 | MMAD_HUMAN Methylmalonic aciduria and homocystinuria type D protein mitochondrial OS=Homo sapiens GN=MMADHC PE=1 SV=2 | 182 | T | 0.426531 | N | 0.44574 | -0.019209 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblD (MMADHC) [MIM:277410] |
| Q9H3L0 | MMAD_HUMAN Methylmalonic aciduria and homocystinuria type D protein mitochondrial OS=Homo sapiens GN=MMADHC PE=1 SV=2 | 249 | Y | 0.348772 | C | 0.294703 | 0.054069 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblD (MMADHC) [MIM:277410] |
| Q9H3L0 | MMAD_HUMAN Methylmalonic aciduria and homocystinuria type D protein mitochondrial OS=Homo sapiens GN=MMADHC PE=1 SV=2 | 259 | L | 0.125579 | P | 0.228269 | -0.10269 | No Change: Both O | Methylmalonic aciduria and homocystinuria type cblD (MMADHC) [MIM:277410] |
| Q495T6 | MMEL1_HUMAN Membrane metallo-endopeptidase-like 1 OS=Homo sapiens GN=MMEL1 PE=1 SV=2 | 518 | M | 0.57267 | T | 0.565879 | 0.006791 | No Change: Both D | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 29 | Q | 0.453651 | P | 0.452877 | 7.74E-04 | No Change: Both O | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 252 | D | 0.37933 | G | 0.347347 | 0.031983 | No Change: Both O | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 191 | I | 0.574528 | V | 0.602603 | -0.028075 | No Change: Both D | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 405 | R | 0.531762 | Q | 0.542665 | -0.010903 | No Change: Both D | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 406 | S | 0.572037 | T | 0.491734 | 0.080303 | D to O | - |
| P03956 | MMP1_HUMAN Interstitial collagenase OS=Homo sapiens GN=MMP1 PE=1 SV=3 | 262 | R | 0.399313 | S | 0.486493 | -0.08718 | No Change: Both O | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 4 | L | 0.245164 | V | 0.238707 | 0.006457 | No Change: Both O | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 53 | R | 0.5051 | K | 0.574032 | -0.068932 | No Change: Both D | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 65 | G | 0.325051 | R | 0.345623 | -0.020572 | No Change: Both O | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 226 | F | 0.372114 | L | 0.428001 | -0.055887 | No Change: Both O | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 282 | G | 0.766557 | E | 0.801422 | -0.034865 | No Change: Both D | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 440 | L | 0.11401 | F | 0.126917 | -0.012907 | No Change: Both O | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 475 | H | 0.708684 | L | 0.527957 | 0.180727 | No Change: Both D | - |
| P09238 | MMP10_HUMAN Stromelysin-2 OS=Homo sapiens GN=MMP10 PE=1 SV=1 | 142 | E | 0.186726 | Q | 0.143302 | 0.043424 | No Change: Both O | A breast cancer sample |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 38 | A | 0.951495 | V | 0.914615 | 0.03688 | No Change: Both D | - |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 44 | E | 0.968532 | K | 0.967024 | 0.001508 | No Change: Both D | - |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 61 | P | 0.990207 | L | 0.98069 | 0.009517 | No Change: Both D | - |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 86 | S | 0.810787 | P | 0.819211 | -0.008424 | No Change: Both D | - |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 182 | F | 0.266548 | S | 0.467394 | -0.200846 | No Change: Both O | - |
| P24347 | MMP11_HUMAN Stromelysin-3 OS=Homo sapiens GN=MMP11 PE=1 SV=3 | 166 | D | 0.286574 | N | 0.255241 | 0.031333 | No Change: Both O | A colorectal cancer sample |
| P39900 | MMP12_HUMAN Macrophage metalloelastase OS=Homo sapiens GN=MMP12 PE=1 SV=1 | 357 | N | 0.225184 | S | 0.261934 | -0.03675 | No Change: Both O | - |
| P39900 | MMP12_HUMAN Macrophage metalloelastase OS=Homo sapiens GN=MMP12 PE=1 SV=1 | 469 | G | 0.713731 | R | 0.685225 | 0.028506 | No Change: Both D | - |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 2 | H | 0.690335 | L | 0.581518 | 0.108817 | No Change: Both D | - |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 390 | D | 0.342613 | G | 0.334334 | 0.008279 | No Change: Both O | - |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 75 | F | 0.278783 | S | 0.501652 | -0.222869 | O to D | Spondyloepimetaphyseal dysplasia Missouri type (SEMD-MO) [MIM:602111] |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 74 | F | 0.297009 | S | 0.519093 | -0.222084 | O to D | Metaphyseal anadysplasia type 1 (MANDP1) [MIM:602111] |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 91 | M | 0.413428 | T | 0.457089 | -0.043661 | No Change: Both O | Metaphyseal anadysplasia type 1 (MANDP1) [MIM:602111] |
| P45452 | MMP13_HUMAN Collagenase 3 OS=Homo sapiens GN=MMP13 PE=1 SV=1 | 232 | H | 0.623798 | N | 0.618451 | 0.005347 | No Change: Both D | Metaphyseal anadysplasia type 1 (MANDP1) [MIM:602111] |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 4 | A | 0.946509 | T | 0.952575 | -0.006066 | No Change: Both D | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 6 | R | 0.938403 | K | 0.926571 | 0.011832 | No Change: Both D | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 8 | P | 0.905334 | S | 0.900419 | 0.004915 | No Change: Both D | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 233 | I | 0.137378 | V | 0.169388 | -0.03201 | No Change: Both O | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 273 | D | 0.449235 | N | 0.418914 | 0.030321 | No Change: Both O | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 302 | R | 0.919687 | W | 0.832444 | 0.087243 | No Change: Both D | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 355 | M | 0.184318 | I | 0.127013 | 0.057305 | No Change: Both O | - |
| P50281 | MMP14_HUMAN Matrix metalloproteinase-14 OS=Homo sapiens GN=MMP14 PE=1 SV=3 | 431 | R | 0.220111 | H | 0.211956 | 0.008155 | No Change: Both O | - |
| P51511 | MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sapiens GN=MMP15 PE=1 SV=1 | 609 | G | 0.581836 | R | 0.567873 | 0.013963 | No Change: Both D | - |
| P51511 | MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sapiens GN=MMP15 PE=1 SV=1 | 200 | L | 0.121121 | P | 0.234697 | -0.113576 | No Change: Both O | - |
| P51511 | MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sapiens GN=MMP15 PE=1 SV=1 | 350 | P | 0.985892 | L | 0.971993 | 0.013899 | No Change: Both D | - |
| P51511 | MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sapiens GN=MMP15 PE=1 SV=1 | 596 | D | 0.865029 | G | 0.856734 | 0.008295 | No Change: Both D | - |
| P51511 | MMP15_HUMAN Matrix metalloproteinase-15 OS=Homo sapiens GN=MMP15 PE=1 SV=1 | 622 | R | 0.20936 | W | 0.089628 | 0.119732 | No Change: Both O | - |
| Q99542 | MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens GN=MMP19 PE=1 SV=1 | 103 | R | 0.266279 | C | 0.162126 | 0.104153 | No Change: Both O | - |
| Q99542 | MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens GN=MMP19 PE=1 SV=1 | 488 | P | 0.826441 | T | 0.815208 | 0.011233 | No Change: Both D | - |
| Q99542 | MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens GN=MMP19 PE=1 SV=1 | 491 | T | 0.80098 | M | 0.737127 | 0.063853 | No Change: Both D | - |
| Q99542 | MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens GN=MMP19 PE=1 SV=1 | 245 | P | 0.371671 | S | 0.380549 | -0.008878 | No Change: Both O | - |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 447 | A | 0.35036 | V | 0.280048 | 0.070312 | No Change: Both O | - |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 621 | V | 0.288004 | L | 0.290807 | -0.002803 | No Change: Both O | - |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 101 | R | 0.509153 | H | 0.459218 | 0.049935 | D to O | Torg-Winchester syndrome (TWS) [MIM:259600] |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 210 | D | 0.445963 | Y | 0.266729 | 0.179234 | No Change: Both O | - |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 404 | E | 0.235564 | K | 0.228851 | 0.006713 | No Change: Both O | Torg-Winchester syndrome (TWS) [MIM:259600] |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 228 | A | 0.272871 | T | 0.29766 | -0.024789 | No Change: Both O | A colorectal cancer sample |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 498 | T | 0.279866 | M | 0.238954 | 0.040912 | No Change: Both O | A colorectal cancer sample |
| P08253 | MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens GN=MMP2 PE=1 SV=2 | 644 | S | 0.494691 | I | 0.252017 | 0.242674 | No Change: Both O | A colorectal cancer sample |
| O60882 | MMP20_HUMAN Matrix metalloproteinase-20 OS=Homo sapiens GN=MMP20 PE=1 SV=3 | 18 | K | 0.136856 | T | 0.103875 | 0.032981 | No Change: Both O | - |
| O60882 | MMP20_HUMAN Matrix metalloproteinase-20 OS=Homo sapiens GN=MMP20 PE=1 SV=3 | 139 | D | 0.538504 | N | 0.528905 | 0.009599 | No Change: Both D | - |
| O60882 | MMP20_HUMAN Matrix metalloproteinase-20 OS=Homo sapiens GN=MMP20 PE=1 SV=3 | 169 | I | 0.357286 | L | 0.372274 | -0.014988 | No Change: Both O | - |
| O60882 | MMP20_HUMAN Matrix metalloproteinase-20 OS=Homo sapiens GN=MMP20 PE=1 SV=3 | 275 | V | 0.389223 | A | 0.479358 | -0.090135 | No Change: Both O | - |
| O60882 | MMP20_HUMAN Matrix metalloproteinase-20 OS=Homo sapiens GN=MMP20 PE=1 SV=3 | 281 | T | 0.585853 | N | 0.604371 | -0.018518 | No Change: Both D | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 191 | V | 0.413973 | A | 0.497693 | -0.08372 | No Change: Both O | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 95 | A | 0.771633 | E | 0.80578 | -0.034147 | No Change: Both D | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 115 | P | 0.933945 | Q | 0.92114 | 0.012805 | No Change: Both D | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 349 | E | 0.276568 | G | 0.233139 | 0.043429 | No Change: Both O | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 454 | A | 0.294156 | V | 0.227874 | 0.066282 | No Change: Both O | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 263 | D | 0.567491 | E | 0.576855 | -0.009364 | No Change: Both D | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 311 | A | 0.296615 | T | 0.326774 | -0.030159 | No Change: Both O | - |
| Q8N119 | MMP21_HUMAN Matrix metalloproteinase-21 OS=Homo sapiens GN=MMP21 PE=2 SV=2 | 360 | R | 0.048602 | H | 0.046643 | 0.001959 | No Change: Both O | - |
| O75900 | MMP23_HUMAN Matrix metalloproteinase-23 OS=Homo sapiens GN=MMP23A PE=1 SV=2 | 91 | F | 0.385198 | L | 0.438679 | -0.053481 | No Change: Both O | - |
| Q9Y5R2 | MMP24_HUMAN Matrix metalloproteinase-24 OS=Homo sapiens GN=MMP24 PE=1 SV=1 | 564 | R | 0.183542 | H | 0.14825 | 0.035292 | No Change: Both O | - |
| Q9NRE1 | MMP26_HUMAN Matrix metalloproteinase-26 OS=Homo sapiens GN=MMP26 PE=2 SV=2 | 43 | K | 0.429865 | E | 0.433934 | -0.004069 | No Change: Both O | - |
| Q9NRE1 | MMP26_HUMAN Matrix metalloproteinase-26 OS=Homo sapiens GN=MMP26 PE=2 SV=2 | 260 | I | 0.895353 | M | 0.895035 | 3.18E-04 | No Change: Both D | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 22 | R | 0.35404 | W | 0.173161 | 0.180879 | No Change: Both O | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 24 | T | 0.482282 | M | 0.454708 | 0.027574 | No Change: Both O | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 30 | M | 0.536629 | V | 0.469209 | 0.06742 | D to O | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 266 | E | 0.69835 | V | 0.559389 | 0.138961 | No Change: Both D | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 304 | W | 0.039383 | L | 0.061402 | -0.022019 | No Change: Both O | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 447 | D | 0.41145 | N | 0.415189 | -0.003739 | No Change: Both O | - |
| Q9H306 | MMP27_HUMAN Matrix metalloproteinase-27 OS=Homo sapiens GN=MMP27 PE=2 SV=2 | 477 | I | 0.596641 | V | 0.624941 | -0.0283 | No Change: Both D | - |
| P08254 | MMP3_HUMAN Stromelysin-1 OS=Homo sapiens GN=MMP3 PE=1 SV=2 | 45 | K | 0.388842 | E | 0.375146 | 0.013696 | No Change: Both O | - |
| P09237 | MMP7_HUMAN Matrilysin OS=Homo sapiens GN=MMP7 PE=1 SV=1 | 77 | R | 0.224117 | H | 0.199007 | 0.02511 | No Change: Both O | - |
| P09237 | MMP7_HUMAN Matrilysin OS=Homo sapiens GN=MMP7 PE=1 SV=1 | 137 | G | 0.210857 | D | 0.234008 | -0.023151 | No Change: Both O | - |
| P09237 | MMP7_HUMAN Matrilysin OS=Homo sapiens GN=MMP7 PE=1 SV=1 | 241 | P | 0.613369 | L | 0.475299 | 0.13807 | D to O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 87 | K | 0.663479 | E | 0.664 | -5.21E-04 | No Change: Both D | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 3 | S | 0.535934 | C | 0.320675 | 0.215259 | D to O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 32 | T | 0.557185 | I | 0.414481 | 0.142704 | D to O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 154 | G | 0.254391 | E | 0.317033 | -0.062642 | No Change: Both O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 193 | D | 0.457803 | V | 0.28319 | 0.174613 | No Change: Both O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 246 | N | 0.439179 | Y | 0.337037 | 0.102142 | No Change: Both O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 436 | V | 0.16732 | A | 0.231235 | -0.063915 | No Change: Both O | - |
| P22894 | MMP8_HUMAN Neutrophil collagenase OS=Homo sapiens GN=MMP8 PE=1 SV=1 | 460 | K | 0.231871 | T | 0.175873 | 0.055998 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 20 | A | 0.161481 | V | 0.118402 | 0.043079 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 82 | E | 0.680102 | K | 0.679091 | 0.001011 | No Change: Both D | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 279 | Q | 0.530827 | R | 0.532143 | -0.001316 | No Change: Both D | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 668 | R | 0.211674 | Q | 0.234159 | -0.022485 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 127 | N | 0.170341 | K | 0.193921 | -0.02358 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 574 | R | 0.378381 | P | 0.403709 | -0.025328 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 239 | R | 0.244915 | H | 0.243542 | 0.001373 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 571 | F | 0.420175 | V | 0.44516 | -0.024985 | No Change: Both O | - |
| P14780 | MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens GN=MMP9 PE=1 SV=3 | 38 | N | 0.364287 | S | 0.411802 | -0.047515 | No Change: Both O | - |
| Q13201 | MMRN1_HUMAN Multimerin-1 OS=Homo sapiens GN=MMRN1 PE=1 SV=3 | 58 | T | 0.859722 | A | 0.83875 | 0.020972 | No Change: Both D | - |
| Q13201 | MMRN1_HUMAN Multimerin-1 OS=Homo sapiens GN=MMRN1 PE=1 SV=3 | 805 | T | 0.189004 | A | 0.178131 | 0.010873 | No Change: Both O | - |
| Q13201 | MMRN1_HUMAN Multimerin-1 OS=Homo sapiens GN=MMRN1 PE=1 SV=3 | 883 | G | 0.387475 | D | 0.420382 | -0.032907 | No Change: Both O | - |
| Q13201 | MMRN1_HUMAN Multimerin-1 OS=Homo sapiens GN=MMRN1 PE=1 SV=3 | 964 | T | 0.172699 | R | 0.178257 | -0.005558 | No Change: Both O | - |
| Q9H8L6 | MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2 | 49 | G | 0.592561 | S | 0.623168 | -0.030607 | No Change: Both D | - |
| Q9H8L6 | MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2 | 731 | H | 0.464588 | D | 0.475694 | -0.011106 | No Change: Both O | - |
| Q9H8L6 | MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2 | 448 | V | 0.549257 | M | 0.64374 | -0.094483 | No Change: Both D | A colorectal cancer sample |
| Q9H8L6 | MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2 | 831 | S | 0.308275 | R | 0.228842 | 0.079433 | No Change: Both O | - |
| Q9H8L6 | MMRN2_HUMAN Multimerin-2 OS=Homo sapiens GN=MMRN2 PE=1 SV=2 | 910 | V | 0.388318 | L | 0.401531 | -0.013213 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 68 | A | 0.290922 | G | 0.331972 | -0.04105 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 98 | R | 0.246083 | W | 0.109259 | 0.136824 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 197 | V | 0.071362 | I | 0.063803 | 0.007559 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 306 | R | 0.189121 | H | 0.17373 | 0.015391 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 365 | M | 0.293811 | V | 0.251983 | 0.041828 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 409 | Q | 0.634576 | P | 0.628294 | 0.006282 | No Change: Both D | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 434 | Q | 0.534404 | E | 0.566503 | -0.032099 | No Change: Both D | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 526 | V | 0.361494 | I | 0.303747 | 0.057747 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 558 | A | 0.281147 | V | 0.226069 | 0.055078 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 790 | G | 0.45866 | D | 0.473938 | -0.015278 | No Change: Both O | - |
| Q96T76 | MMS19_HUMAN MMS19 nucleotide excision repair protein homolog OS=Homo sapiens GN=MMS19 PE=1 SV=2 | 983 | R | 0.282925 | H | 0.25947 | 0.023455 | No Change: Both O | - |
| Q6ZRQ5 | MMS22_HUMAN Protein MMS22-like OS=Homo sapiens GN=MMS22L PE=1 SV=3 | 419 | N | 0.034574 | D | 0.040144 | -0.00557 | No Change: Both O | - |
| Q6ZRQ5 | MMS22_HUMAN Protein MMS22-like OS=Homo sapiens GN=MMS22L PE=1 SV=3 | 564 | T | 0.120833 | M | 0.098901 | 0.021932 | No Change: Both O | - |
| Q6ZRQ5 | MMS22_HUMAN Protein MMS22-like OS=Homo sapiens GN=MMS22L PE=1 SV=3 | 875 | V | 0.300466 | A | 0.393114 | -0.092648 | No Change: Both O | - |
| Q6ZRQ5 | MMS22_HUMAN Protein MMS22-like OS=Homo sapiens GN=MMS22L PE=1 SV=3 | 1015 | P | 0.296973 | L | 0.180482 | 0.116491 | No Change: Both O | - |
| Q10571 | MN1_HUMAN Probable tumor suppressor protein MN1 OS=Homo sapiens GN=MN1 PE=1 SV=3 | 382 | Q | 0.972417 | H | 0.963997 | 0.00842 | No Change: Both D | - |
| P51948 | MAT1_HUMAN CDK-activating kinase assembly factor MAT1 OS=Homo sapiens GN=MNAT1 PE=1 SV=1 | 282 | D | 0.550538 | A | 0.494255 | 0.056283 | D to O | - |
| P41218 | MNDA_HUMAN Myeloid cell nuclear differentiation antigen OS=Homo sapiens GN=MNDA PE=1 SV=1 | 286 | V | 0.511387 | L | 0.492327 | 0.01906 | D to O | - |
| P41218 | MNDA_HUMAN Myeloid cell nuclear differentiation antigen OS=Homo sapiens GN=MNDA PE=1 SV=1 | 357 | H | 0.30964 | Y | 0.21262 | 0.09702 | No Change: Both O | - |
| P41218 | MNDA_HUMAN Myeloid cell nuclear differentiation antigen OS=Homo sapiens GN=MNDA PE=1 SV=1 | 156 | S | 0.993368 | R | 0.991981 | 0.001387 | No Change: Both D | - |
| Q8NEH6 | MNS1_HUMAN Meiosis-specific nuclear structural protein 1 OS=Homo sapiens GN=MNS1 PE=2 SV=2 | 10 | C | 0.7696 | Y | 0.724242 | 0.045358 | No Change: Both D | - |
| Q8NEH6 | MNS1_HUMAN Meiosis-specific nuclear structural protein 1 OS=Homo sapiens GN=MNS1 PE=2 SV=2 | 55 | Q | 0.839792 | P | 0.803531 | 0.036261 | No Change: Both D | - |
| Q8NEH6 | MNS1_HUMAN Meiosis-specific nuclear structural protein 1 OS=Homo sapiens GN=MNS1 PE=2 SV=2 | 216 | I | 0.892802 | T | 0.907476 | -0.014674 | No Change: Both D | - |
| Q8NEH6 | MNS1_HUMAN Meiosis-specific nuclear structural protein 1 OS=Homo sapiens GN=MNS1 PE=2 SV=2 | 244 | Y | 0.889766 | H | 0.915372 | -0.025606 | No Change: Both D | - |
| Q8NEH6 | MNS1_HUMAN Meiosis-specific nuclear structural protein 1 OS=Homo sapiens GN=MNS1 PE=2 SV=2 | 426 | E | 0.840493 | G | 0.780687 | 0.059806 | No Change: Both D | - |
| Q99583 | MNT_HUMAN Max-binding protein MNT OS=Homo sapiens GN=MNT PE=1 SV=1 | 109 | A | 0.990735 | T | 0.990434 | 3.01E-04 | No Change: Both D | - |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 245 | R | 0.565324 | G | 0.519359 | 0.045965 | No Change: Both D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 245 | R | 0.565324 | H | 0.495806 | 0.069518 | D to O | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 246 | T | 0.552278 | S | 0.635715 | -0.083437 | No Change: Both D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 288 | W | 0.490802 | G | 0.62025 | -0.129448 | O to D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 288 | W | 0.490802 | L | 0.576243 | -0.085441 | O to D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 290 | Q | 0.542898 | P | 0.536495 | 0.006403 | No Change: Both D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 292 | R | 0.627913 | W | 0.446751 | 0.181162 | D to O | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 293 | R | 0.679047 | Q | 0.687032 | -0.007985 | No Change: Both D | Currarino syndrome (CURRAS) [MIM:176450] |
| P50219 | MNX1_HUMAN Motor neuron and pancreas homeobox protein 1 OS=Homo sapiens GN=MNX1 PE=1 SV=3 | 293 | R | 0.679047 | W | 0.507704 | 0.171343 | No Change: Both D | Currarino syndrome (CURRAS) [MIM:176450] |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 57 | A | 0.340179 | P | 0.413536 | -0.073357 | No Change: Both O | Xanthinuria type 2 (XU2) [MIM:603592] |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 120 | S | 0.172281 | N | 0.145753 | 0.026528 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 170 | T | 0.294043 | I | 0.191525 | 0.102518 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 184 | S | 0.691964 | G | 0.632885 | 0.059079 | No Change: Both D | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 225 | H | 0.472108 | R | 0.481576 | -0.009468 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 294 | T | 0.34136 | I | 0.201618 | 0.139742 | No Change: Both O | Xanthinuria type 2 (XU2) [MIM:603592] |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 358 | V | 0.139574 | M | 0.178419 | -0.038845 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 495 | D | 0.516649 | N | 0.490177 | 0.026472 | D to O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 541 | V | 0.669358 | L | 0.653963 | 0.015395 | No Change: Both D | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 703 | H | 0.406681 | N | 0.456812 | -0.050131 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 867 | V | 0.416651 | A | 0.469713 | -0.053062 | No Change: Both O | - |
| Q96EN8 | MOCOS_HUMAN Molybdenum cofactor sulfurase OS=Homo sapiens GN=MOCOS PE=1 SV=2 | 776 | R | 0.221934 | C | 0.120648 | 0.101286 | No Change: Both O | Xanthinuria type 2 (XU2) [MIM:603592] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 73 | R | 0.279879 | W | 0.116082 | 0.163797 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 126 | G | 0.309779 | D | 0.334515 | -0.024736 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 127 | G | 0.312363 | D | 0.338799 | -0.026436 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 319 | R | 0.172217 | Q | 0.17246 | -2.43E-04 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 324 | G | 0.159972 | E | 0.193985 | -0.034013 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 67 | R | 0.395796 | W | 0.197952 | 0.197844 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 80 | C | 0.203193 | G | 0.300563 | -0.09737 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 84 | C | 0.144124 | F | 0.127429 | 0.016695 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 123 | R | 0.300415 | W | 0.137166 | 0.163249 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 324 | G | 0.159972 | R | 0.170014 | -0.010042 | No Change: Both O | Molybdenum cofactor deficiency type A (MOCOD type A) [MIM:252150] |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 390 | P | 0.471141 | H | 0.373068 | 0.098073 | No Change: Both O | - |
| Q9NZB8 | MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens GN=MOCS1 PE=1 SV=3 | 452 | R | 0.816303 | L | 0.744378 | 0.071925 | No Change: Both D | - |
| O96007 | MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 168 | E | 0.38738 | K | 0.393529 | -0.006149 | No Change: Both O | Molybdenum cofactor deficiency type B (MOCOD type B) [MIM:252150] |
| O96007 | MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 50 | T | 0.46334 | A | 0.457419 | 0.005921 | No Change: Both O | - |
| O96007 | MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 77 | T | 0.218551 | A | 0.191532 | 0.027019 | No Change: Both O | - |
| O96007 | MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 123 | H | 0.0842 | Y | 0.045228 | 0.038972 | No Change: Both O | - |
| O96007 | MOC2B_HUMAN Molybdopterin synthase catalytic subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 187 | N | 0.710992 | S | 0.736035 | -0.025043 | No Change: Both D | - |
| O96033 | MOC2A_HUMAN Molybdopterin synthase sulfur carrier subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 51 | V | 0.190454 | A | 0.263536 | -0.073082 | No Change: Both O | - |
| O96033 | MOC2A_HUMAN Molybdopterin synthase sulfur carrier subunit OS=Homo sapiens GN=MOCS2 PE=1 SV=1 | 7 | V | 0.094225 | F | 0.079162 | 0.015063 | No Change: Both O | Molybdenum cofactor deficiency type B (MOCOD type B) [MIM:252150] |
| O95396 | MOCS3_HUMAN Adenylyltransferase and sulfurtransferase MOCS3 OS=Homo sapiens GN=MOCS3 PE=1 SV=1 | 429 | S | 0.336114 | A | 0.240375 | 0.095739 | No Change: Both O | - |
| Q16653 | MOG_HUMAN Myelin-oligodendrocyte glycoprotein OS=Homo sapiens GN=MOG PE=1 SV=2 | 171 | V | 0.016533 | L | 0.018196 | -0.001663 | No Change: Both O | - |
| Q16653 | MOG_HUMAN Myelin-oligodendrocyte glycoprotein OS=Homo sapiens GN=MOG PE=1 SV=2 | 174 | I | 0.012798 | V | 0.014913 | -0.002115 | No Change: Both O | - |
| Q16653 | MOG_HUMAN Myelin-oligodendrocyte glycoprotein OS=Homo sapiens GN=MOG PE=1 SV=2 | 133 | S | 0.354921 | C | 0.164291 | 0.19063 | No Change: Both O | Narcolepsy type 7 (NRCLP7) [MIM:614250] |
| Q96PD6 | MOGT1_HUMAN 2-acylglycerol O-acyltransferase 1 OS=Homo sapiens GN=MOGAT1 PE=2 SV=2 | 163 | S | 0.50238 | P | 0.442426 | 0.059954 | D to O | - |
| Q96PD6 | MOGT1_HUMAN 2-acylglycerol O-acyltransferase 1 OS=Homo sapiens GN=MOGAT1 PE=2 SV=2 | 13 | A | 0.144464 | T | 0.162449 | -0.017985 | No Change: Both O | - |
| Q3SYC2 | MOGT2_HUMAN 2-acylglycerol O-acyltransferase 2 OS=Homo sapiens GN=MOGAT2 PE=1 SV=2 | 9 | M | 0.117324 | V | 0.090246 | 0.027078 | No Change: Both O | - |
| Q3SYC2 | MOGT2_HUMAN 2-acylglycerol O-acyltransferase 2 OS=Homo sapiens GN=MOGAT2 PE=1 SV=2 | 313 | C | 0.16763 | Y | 0.185784 | -0.018154 | No Change: Both O | - |
| Q3SYC2 | MOGT2_HUMAN 2-acylglycerol O-acyltransferase 2 OS=Homo sapiens GN=MOGAT2 PE=1 SV=2 | 196 | P | 0.339579 | H | 0.308338 | 0.031241 | No Change: Both O | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 486 | R | 0.214191 | T | 0.197979 | 0.016212 | No Change: Both O | Type IIb congenital disorder of glycosylation (CDGIIb) [MIM:606056] |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 652 | F | 0.284149 | L | 0.327896 | -0.043747 | No Change: Both O | Type IIb congenital disorder of glycosylation (CDGIIb) [MIM:606056] |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 236 | E | 0.424972 | Q | 0.377469 | 0.047503 | No Change: Both O | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 239 | D | 0.358826 | N | 0.338131 | 0.020695 | No Change: Both O | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 222 | G | 0.293732 | R | 0.276897 | 0.016835 | No Change: Both O | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 293 | P | 0.668112 | S | 0.655777 | 0.012335 | No Change: Both D | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 495 | R | 0.380441 | P | 0.422706 | -0.042265 | No Change: Both O | - |
| Q13724 | MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens GN=MOGS PE=1 SV=5 | 785 | G | 0.419628 | S | 0.471753 | -0.052125 | No Change: Both O | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 398 | Q | 0.92324 | R | 0.924369 | -0.001129 | No Change: Both D | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 38 | R | 0.444757 | H | 0.420148 | 0.024609 | No Change: Both O | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 86 | D | 0.083595 | N | 0.083971 | -3.76E-04 | No Change: Both O | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 230 | K | 0.392222 | R | 0.330943 | 0.061279 | No Change: Both O | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 248 | P | 0.336089 | S | 0.364997 | -0.028908 | No Change: Both O | - |
| Q9UQ07 | MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens GN=MOK PE=2 SV=1 | 272 | E | 0.417204 | D | 0.418247 | -0.001043 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q7Z3U7 | MON2_HUMAN Protein MON2 homolog OS=Homo sapiens GN=MON2 PE=1 SV=2 | 548 | A | 0.36876 | T | 0.389432 | -0.020672 | No Change: Both O | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 153 | T | 0.38691 | P | 0.455962 | -0.069052 | No Change: Both O | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 322 | K | 0.802607 | M | 0.71843 | 0.084177 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 470 | F | 0.36425 | I | 0.367176 | -0.002926 | No Change: Both O | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 478 | M | 0.148894 | V | 0.116007 | 0.032887 | No Change: Both O | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 649 | M | 0.906798 | I | 0.868697 | 0.038101 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 767 | S | 0.730711 | N | 0.681259 | 0.049452 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 836 | H | 0.795985 | Y | 0.755286 | 0.040699 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 982 | S | 0.806307 | C | 0.772151 | 0.034156 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 982 | S | 0.806307 | W | 0.709595 | 0.096712 | No Change: Both D | - |
| Q86VD1 | MORC1_HUMAN MORC family CW-type zinc finger protein 1 OS=Homo sapiens GN=MORC1 PE=2 SV=2 | 462 | D | 0.37368 | E | 0.404567 | -0.030887 | No Change: Both O | - |
| Q8TE76 | MORC4_HUMAN MORC family CW-type zinc finger protein 4 OS=Homo sapiens GN=MORC4 PE=1 SV=2 | 473 | T | 0.737563 | I | 0.663834 | 0.073729 | No Change: Both D | - |
| Q8TE76 | MORC4_HUMAN MORC family CW-type zinc finger protein 4 OS=Homo sapiens GN=MORC4 PE=1 SV=2 | 653 | R | 0.757608 | C | 0.644773 | 0.112835 | No Change: Both D | - |
| Q5T089 | MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens GN=MORN1 PE=2 SV=2 | 330 | H | 0.801288 | Y | 0.675728 | 0.12556 | No Change: Both D | - |
| Q5T089 | MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens GN=MORN1 PE=2 SV=2 | 124 | L | 0.463684 | V | 0.501531 | -0.037847 | O to D | - |
| Q502X0 | MORN2_HUMAN MORN repeat-containing protein 2 OS=Homo sapiens GN=MORN2 PE=1 SV=2 | 48 | E | 0.597517 | K | 0.571303 | 0.026214 | No Change: Both D | - |
| P00540 | MOS_HUMAN Proto-oncogene serine/threonine-protein kinase mos OS=Homo sapiens GN=MOS PE=2 SV=1 | 96 | R | 0.433957 | L | 0.303952 | 0.130005 | No Change: Both O | - |
| P00540 | MOS_HUMAN Proto-oncogene serine/threonine-protein kinase mos OS=Homo sapiens GN=MOS PE=2 SV=1 | 105 | A | 0.211993 | S | 0.30304 | -0.091047 | No Change: Both O | - |
| P00540 | MOS_HUMAN Proto-oncogene serine/threonine-protein kinase mos OS=Homo sapiens GN=MOS PE=2 SV=1 | 123 | A | 0.333424 | T | 0.363248 | -0.029824 | No Change: Both O | A lung adenocarcinoma sample |
| P00540 | MOS_HUMAN Proto-oncogene serine/threonine-protein kinase mos OS=Homo sapiens GN=MOS PE=2 SV=1 | 300 | S | 0.31075 | P | 0.289521 | 0.021229 | No Change: Both O | - |
| Q9UJG1 | MSPD1_HUMAN Motile sperm domain-containing protein 1 OS=Homo sapiens GN=MOSPD1 PE=2 SV=1 | 63 | V | 0.189867 | I | 0.151576 | 0.038291 | No Change: Both O | A breast cancer sample |
| Q8NHP6 | MSPD2_HUMAN Motile sperm domain-containing protein 2 OS=Homo sapiens GN=MOSPD2 PE=1 SV=1 | 240 | S | 0.540933 | N | 0.493169 | 0.047764 | D to O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 454 | I | 0.360963 | L | 0.397881 | -0.036918 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 650 | V | 0.087209 | I | 0.075102 | 0.012107 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 820 | Q | 0.318313 | R | 0.319276 | -9.63E-04 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 1179 | A | 0.324256 | E | 0.424173 | -0.099917 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 182 | R | 0.271671 | C | 0.157006 | 0.114665 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 57 | M | 0.201832 | L | 0.148719 | 0.053113 | No Change: Both O | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 683 | S | 0.821818 | G | 0.79718 | 0.024638 | No Change: Both D | - |
| Q9BXT6 | M10L1_HUMAN Putative helicase Mov10l1 OS=Homo sapiens GN=MOV10L1 PE=1 SV=1 | 18 | T | 0.436863 | S | 0.496109 | -0.059246 | No Change: Both O | - |
| Q6UVY6 | MOXD1_HUMAN DBH-like monooxygenase protein 1 OS=Homo sapiens GN=MOXD1 PE=2 SV=1 | 488 | E | 0.14099 | Q | 0.125794 | 0.015196 | No Change: Both O | - |
| Q6UVY6 | MOXD1_HUMAN DBH-like monooxygenase protein 1 OS=Homo sapiens GN=MOXD1 PE=2 SV=1 | 539 | K | 0.26696 | E | 0.258143 | 0.008817 | No Change: Both O | - |
| P56378 | 68MP_HUMAN 6.8 kDa mitochondrial proteolipid OS=Homo sapiens GN=MP68 PE=1 SV=1 | 9 | I | 0.1012 | V | 0.102904 | -0.001704 | No Change: Both O | - |
| O75352 | MPU1_HUMAN Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens GN=MPDU1 PE=1 SV=2 | 73 | G | 0.527515 | E | 0.585755 | -0.05824 | No Change: Both D | Congenital disorder of glycosylation type 1F (CDG1F) [MIM:609180] |
| O75352 | MPU1_HUMAN Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens GN=MPDU1 PE=1 SV=2 | 74 | L | 0.488612 | S | 0.674859 | -0.186247 | O to D | Congenital disorder of glycosylation type 1F (CDG1F) [MIM:609180] |
| O75352 | MPU1_HUMAN Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens GN=MPDU1 PE=1 SV=2 | 119 | L | 0.022836 | P | 0.049546 | -0.02671 | No Change: Both O | Congenital disorder of glycosylation type 1F (CDG1F) [MIM:609180] |
| O75352 | MPU1_HUMAN Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens GN=MPDU1 PE=1 SV=2 | 225 | G | 0.076732 | S | 0.107424 | -0.030692 | No Change: Both O | - |
| O75352 | MPU1_HUMAN Mannose-P-dolichol utilization defect 1 protein OS=Homo sapiens GN=MPDU1 PE=1 SV=2 | 229 | A | 0.040797 | T | 0.042386 | -0.001589 | No Change: Both O | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 92 | S | 0.428132 | L | 0.262087 | 0.166045 | No Change: Both O | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 351 | L | 0.727183 | F | 0.678573 | 0.04861 | No Change: Both D | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 702 | E | 0.435535 | K | 0.435431 | 1.04E-04 | No Change: Both O | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 702 | E | 0.435535 | V | 0.256693 | 0.178842 | No Change: Both O | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 1604 | T | 0.959611 | A | 0.954373 | 0.005238 | No Change: Both D | - |
| O75970 | MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens GN=MPDZ PE=1 SV=2 | 1663 | G | 0.3136 | R | 0.29774 | 0.01586 | No Change: Both O | - |
| Q2M385 | MPEG1_HUMAN Macrophage-expressed gene 1 protein OS=Homo sapiens GN=MPEG1 PE=2 SV=1 | 467 | A | 0.167253 | T | 0.174419 | -0.007166 | No Change: Both O | - |
| Q2M385 | MPEG1_HUMAN Macrophage-expressed gene 1 protein OS=Homo sapiens GN=MPEG1 PE=2 SV=1 | 552 | P | 0.499768 | L | 0.339536 | 0.160232 | No Change: Both O | - |
| Q2M385 | MPEG1_HUMAN Macrophage-expressed gene 1 protein OS=Homo sapiens GN=MPEG1 PE=2 SV=1 | 694 | Q | 0.472952 | R | 0.454082 | 0.01887 | No Change: Both O | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 64 | P | 0.845225 | L | 0.757788 | 0.087437 | No Change: Both D | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 71 | Y | 0.703577 | H | 0.766699 | -0.063122 | No Change: Both D | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 120 | R | 0.444735 | C | 0.282638 | 0.162097 | No Change: Both O | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 141 | R | 0.750094 | Q | 0.758295 | -0.008201 | No Change: Both D | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 258 | A | 0.342075 | V | 0.268368 | 0.073707 | No Change: Both O | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 298 | A | 0.83582 | S | 0.794889 | 0.040931 | No Change: Both D | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 22 | K | 0.989968 | Q | 0.990155 | -1.87E-04 | No Change: Both D | - |
| P29372 | 3MG_HUMAN DNA-3-methyladenine glycosylase OS=Homo sapiens GN=MPG PE=1 SV=3 | 93 | Q | 0.237065 | R | 0.25524 | -0.018175 | No Change: Both O | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 634 | E | 0.908934 | K | 0.930181 | -0.021247 | No Change: Both D | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 425 | L | 0.384557 | M | 0.448518 | -0.063961 | No Change: Both O | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 229 | E | 0.984903 | D | 0.983345 | 0.001558 | No Change: Both D | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 69 | E | 0.217286 | A | 0.130907 | 0.086379 | No Change: Both O | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 115 | R | 0.964359 | H | 0.959973 | 0.004386 | No Change: Both D | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 140 | D | 0.995522 | N | 0.994527 | 9.95E-04 | No Change: Both D | - |
| O00566 | MPP10_HUMAN U3 small nucleolar ribonucleoprotein protein MPP10 OS=Homo sapiens GN=MPHOSPH10 PE=1 SV=2 | 639 | A | 0.92145 | T | 0.928187 | -0.006737 | No Change: Both D | - |
| Q99547 | MPH6_HUMAN M-phase phosphoprotein 6 OS=Homo sapiens GN=MPHOSPH6 PE=1 SV=2 | 58 | I | 0.50121 | V | 0.491898 | 0.009312 | D to O | - |
| Q99550 | MPP9_HUMAN M-phase phosphoprotein 9 OS=Homo sapiens GN=MPHOSPH9 PE=1 SV=3 | 125 | G | 0.523181 | S | 0.602484 | -0.079303 | No Change: Both D | - |
| Q99550 | MPP9_HUMAN M-phase phosphoprotein 9 OS=Homo sapiens GN=MPHOSPH9 PE=1 SV=3 | 926 | A | 0.657056 | D | 0.721188 | -0.064132 | No Change: Both D | - |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 102 | S | 0.239592 | L | 0.137601 | 0.101991 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 138 | M | 0.392404 | T | 0.439206 | -0.046802 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 219 | R | 0.28857 | Q | 0.345304 | -0.056734 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 140 | I | 0.276511 | T | 0.40501 | -0.128499 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 51 | M | 0.282298 | T | 0.326734 | -0.044436 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 129 | Y | 0.630957 | C | 0.627657 | 0.0033 | No Change: Both D | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 131 | D | 0.663793 | N | 0.668468 | -0.004675 | No Change: Both D | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 152 | R | 0.124255 | Q | 0.152253 | -0.027998 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 250 | G | 0.065842 | S | 0.077046 | -0.011204 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 255 | Y | 0.014779 | C | 0.014209 | 5.70E-04 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 295 | R | 0.262157 | H | 0.259857 | 0.0023 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 398 | I | 0.178452 | T | 0.295172 | -0.11672 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P34949 | MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens GN=MPI PE=1 SV=2 | 418 | R | 0.051768 | H | 0.053406 | -0.001638 | No Change: Both O | Congenital disorder of glycosylation type 1B (CDG1B) [MIM:602579] |
| P40238 | TPOR_HUMAN Thrombopoietin receptor OS=Homo sapiens GN=MPL PE=1 SV=1 | 58 | A | 0.493312 | V | 0.386901 | 0.106411 | No Change: Both O | - |
| P40238 | TPOR_HUMAN Thrombopoietin receptor OS=Homo sapiens GN=MPL PE=1 SV=1 | 168 | E | 0.368114 | K | 0.352395 | 0.015719 | No Change: Both O | - |
| P40238 | TPOR_HUMAN Thrombopoietin receptor OS=Homo sapiens GN=MPL PE=1 SV=1 | 39 | K | 0.460127 | N | 0.425543 | 0.034584 | No Change: Both O | - |
| P40238 | TPOR_HUMAN Thrombopoietin receptor OS=Homo sapiens GN=MPL PE=1 SV=1 | 114 | V | 0.107222 | M | 0.131307 | -0.024085 | No Change: Both O | - |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 717 | I | 0.373723 | V | 0.410046 | -0.036323 | No Change: Both O | - |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 173 | Y | 0.36423 | C | 0.367656 | -0.003426 | No Change: Both O | Myeloperoxidase deficiency (MPOD) [MIM:254600] |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 251 | M | 0.235808 | T | 0.263759 | -0.027951 | No Change: Both O | Myeloperoxidase deficiency (MPOD) [MIM:254600] |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 569 | R | 0.293816 | W | 0.119731 | 0.174085 | No Change: Both O | Myeloperoxidase deficiency (MPOD) [MIM:254600] |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 53 | V | 0.496608 | F | 0.433406 | 0.063202 | No Change: Both O | - |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 604 | R | 0.131607 | C | 0.070713 | 0.060894 | No Change: Both O | - |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 683 | E | 0.205821 | Q | 0.176243 | 0.029578 | No Change: Both O | - |
| P05164 | PERM_HUMAN Myeloperoxidase OS=Homo sapiens GN=MPO PE=1 SV=1 | 447 | R | 0.256621 | Q | 0.277771 | -0.02115 | No Change: Both O | A colorectal cancer sample |
| Q00013 | EM55_HUMAN 55 kDa erythrocyte membrane protein OS=Homo sapiens GN=MPP1 PE=1 SV=2 | 448 | E | 0.414997 | Q | 0.377235 | 0.037762 | No Change: Both O | - |
| Q13368 | MPP3_HUMAN MAGUK p55 subfamily member 3 OS=Homo sapiens GN=MPP3 PE=1 SV=2 | 585 | R | 0.607724 | G | 0.642362 | -0.034638 | No Change: Both D | - |
| Q96JB8 | MPP4_HUMAN MAGUK p55 subfamily member 4 OS=Homo sapiens GN=MPP4 PE=1 SV=2 | 44 | G | 0.113074 | S | 0.143061 | -0.029987 | No Change: Both O | - |
| Q96JB8 | MPP4_HUMAN MAGUK p55 subfamily member 4 OS=Homo sapiens GN=MPP4 PE=1 SV=2 | 562 | V | 0.363067 | I | 0.343929 | 0.019138 | No Change: Both O | - |
| Q5T2T1 | MPP7_HUMAN MAGUK p55 subfamily member 7 OS=Homo sapiens GN=MPP7 PE=1 SV=1 | 322 | K | 0.904899 | R | 0.893379 | 0.01152 | No Change: Both D | - |
| Q53F39 | MPPE1_HUMAN Metallophosphoesterase 1 OS=Homo sapiens GN=MPPE1 PE=1 SV=2 | 138 | R | 0.321864 | Q | 0.34425 | -0.022386 | No Change: Both O | - |
| Q53F39 | MPPE1_HUMAN Metallophosphoesterase 1 OS=Homo sapiens GN=MPPE1 PE=1 SV=2 | 197 | V | 0.16366 | M | 0.205673 | -0.042013 | No Change: Both O | - |
| Q53F39 | MPPE1_HUMAN Metallophosphoesterase 1 OS=Homo sapiens GN=MPPE1 PE=1 SV=2 | 268 | A | 0.626956 | P | 0.685612 | -0.058656 | No Change: Both D | - |
| Q53F39 | MPPE1_HUMAN Metallophosphoesterase 1 OS=Homo sapiens GN=MPPE1 PE=1 SV=2 | 336 | M | 0.354097 | L | 0.284886 | 0.069211 | No Change: Both O | - |
| Q15777 | MPPD2_HUMAN Metallophosphoesterase MPPED2 OS=Homo sapiens GN=MPPED2 PE=2 SV=1 | 67 | H | 0.4054 | R | 0.426341 | -0.020941 | No Change: Both O | - |
| Q6WCQ1 | MPRIP_HUMAN Myosin phosphatase Rho-interacting protein OS=Homo sapiens GN=MPRIP PE=1 SV=3 | 327 | P | 0.907794 | Q | 0.898147 | 0.009647 | No Change: Both D | - |
| P39210 | MPV17_HUMAN Protein Mpv17 OS=Homo sapiens GN=MPV17 PE=1 SV=1 | 50 | R | 0.460076 | Q | 0.485545 | -0.025469 | No Change: Both O | Mitochondrial DNA depletion syndrome type 6 (MTDPS6) [MIM:256810] |
| P39210 | MPV17_HUMAN Protein Mpv17 OS=Homo sapiens GN=MPV17 PE=1 SV=1 | 50 | R | 0.460076 | W | 0.235987 | 0.224089 | No Change: Both O | Mitochondrial DNA depletion syndrome type 6 (MTDPS6) [MIM:256810] |
| P39210 | MPV17_HUMAN Protein Mpv17 OS=Homo sapiens GN=MPV17 PE=1 SV=1 | 166 | N | 0.041956 | K | 0.053251 | -0.011295 | No Change: Both O | Mitochondrial DNA depletion syndrome type 6 (MTDPS6) [MIM:256810] |
| Q567V2 | M17L2_HUMAN Mpv17-like protein 2 OS=Homo sapiens GN=MPV17L2 PE=1 SV=2 | 72 | M | 0.127131 | V | 0.097274 | 0.029857 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 30 | I | 0.138756 | M | 0.202579 | -0.063823 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 32 | V | 0.14929 | F | 0.122332 | 0.026958 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 34 | T | 0.193368 | I | 0.121702 | 0.071666 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 44 | S | 0.327228 | F | 0.145189 | 0.182039 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 44 | S | 0.327228 | F | 0.145189 | 0.182039 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 54 | S | 0.212207 | C | 0.077998 | 0.134209 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 54 | S | 0.212207 | P | 0.173066 | 0.039141 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 58 | V | 0.274842 | F | 0.26423 | 0.010612 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 63 | S | 0.168141 | C | 0.05808 | 0.110061 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 63 | S | 0.168141 | F | 0.065838 | 0.102303 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 68 | Y | 0.265818 | C | 0.222322 | 0.043496 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 78 | S | 0.213846 | L | 0.09799 | 0.115856 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 81 | H | 0.146484 | R | 0.1551 | -0.008616 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 82 | Y | 0.165007 | C | 0.130177 | 0.03483 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 82 | Y | 0.165007 | C | 0.130177 | 0.03483 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 90 | D | 0.284891 | E | 0.330175 | -0.045284 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 93 | G | 0.225782 | E | 0.283515 | -0.057733 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 96 | K | 0.185815 | E | 0.201857 | -0.016042 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 98 | R | 0.185377 | C | 0.090145 | 0.095232 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 98 | R | 0.185377 | H | 0.183658 | 0.001719 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 98 | R | 0.185377 | P | 0.216645 | -0.031268 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 98 | R | 0.185377 | S | 0.232137 | -0.04676 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 99 | I | 0.170972 | T | 0.295273 | -0.124301 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 101 | W | 0.148942 | C | 0.165277 | -0.016335 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 112 | I | 0.178977 | T | 0.272483 | -0.093506 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 114 | I | 0.174664 | T | 0.265075 | -0.090411 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 116 | N | 0.240839 | H | 0.224288 | 0.016551 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 122 | N | 0.326978 | S | 0.367794 | -0.040816 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 124 | T | 0.306035 | M | 0.250546 | 0.055489 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 124 | T | 0.306035 | M | 0.250546 | 0.055489 | No Change: Both O | Charcot-Marie-Tooth disease type 2J (CMT2J) [MIM:607736] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 127 | C | 0.303688 | Y | 0.362948 | -0.05926 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 128 | D | 0.325417 | E | 0.333026 | -0.007609 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 128 | D | 0.325417 | N | 0.311458 | 0.013959 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 130 | K | 0.353106 | R | 0.279855 | 0.073251 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 130 | K | 0.353106 | R | 0.279855 | 0.073251 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 132 | P | 0.434137 | L | 0.24966 | 0.184477 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 134 | D | 0.457521 | E | 0.473065 | -0.015544 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 134 | D | 0.457521 | N | 0.444252 | 0.013269 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 135 | I | 0.476971 | L | 0.51401 | -0.037039 | O to D | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 135 | I | 0.476971 | L | 0.51401 | -0.037039 | O to D | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 135 | I | 0.476971 | T | 0.646597 | -0.169626 | O to D | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 137 | G | 0.42572 | S | 0.505285 | -0.079565 | O to D | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 143 | T | 0.137911 | M | 0.105157 | 0.032754 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 163 | G | 0.065409 | R | 0.054294 | 0.011115 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 167 | G | 0.033248 | A | 0.023925 | 0.009323 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 167 | G | 0.033248 | A | 0.023925 | 0.009323 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 167 | G | 0.033248 | R | 0.027896 | 0.005352 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 244 | R | 0.954437 | L | 0.933114 | 0.021323 | No Change: Both D | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 35 | D | 0.217673 | Y | 0.130811 | 0.086862 | No Change: Both O | Charcot-Marie-Tooth disease dominant intermediate type D (CMTDID) [MIM:607791] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 62 | I | 0.190145 | F | 0.202216 | -0.012071 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 75 | D | 0.342145 | V | 0.193369 | 0.148776 | No Change: Both O | Charcot-Marie-Tooth disease type 2J (CMT2J) [MIM:607736] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 89 | I | 0.305483 | N | 0.497053 | -0.19157 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 92 | V | 0.270446 | M | 0.332004 | -0.061558 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 103 | G | 0.196721 | E | 0.238192 | -0.041471 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 123 | G | 0.319344 | C | 0.185876 | 0.133468 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 123 | G | 0.319344 | C | 0.185876 | 0.133468 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 131 | N | 0.396957 | K | 0.460045 | -0.063088 | No Change: Both O | Roussy-Levy syndrome (ROULS) [MIM:180800] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 136 | V | 0.45908 | E | 0.650147 | -0.191067 | O to D | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 162 | I | 0.071968 | M | 0.110199 | -0.038231 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 118 | D | 0.287187 | N | 0.276489 | 0.010698 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 236 | K | 0.930681 | E | 0.920234 | 0.010447 | No Change: Both D | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 51 | S | 0.12851 | F | 0.046218 | 0.082292 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 60 | D | 0.251334 | H | 0.207084 | 0.04425 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 62 | I | 0.190145 | M | 0.26697 | -0.076825 | No Change: Both O | Charcot-Marie-Tooth disease type 2I (CMT2I) [MIM:607677] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 65 | T | 0.158103 | I | 0.094025 | 0.064078 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 97 | E | 0.183634 | V | 0.085395 | 0.098239 | No Change: Both O | Charcot-Marie-Tooth disease type 2J (CMT2J) [MIM:607736] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 110 | G | 0.253299 | D | 0.28739 | -0.034091 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 113 | V | 0.166521 | I | 0.160902 | 0.005619 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 124 | T | 0.306035 | K | 0.381117 | -0.075082 | No Change: Both O | Congenital hypomyelination neuropathy (CHN) [MIM:605253] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 134 | D | 0.457521 | G | 0.431209 | 0.026312 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 138 | K | 0.367485 | N | 0.32847 | 0.039015 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 139 | T | 0.313943 | N | 0.341634 | -0.027691 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 140 | S | 0.248312 | T | 0.201412 | 0.0469 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 145 | Y | 0.13542 | S | 0.290362 | -0.154942 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 146 | V | 0.147531 | F | 0.126356 | 0.021175 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 170 | L | 0.014729 | R | 0.023376 | -0.008647 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 61 | D | 0.208801 | G | 0.176765 | 0.032036 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 65 | T | 0.158103 | A | 0.140517 | 0.017586 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 78 | S | 0.213846 | W | 0.069113 | 0.144733 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 81 | H | 0.146484 | Y | 0.097917 | 0.048567 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 109 | D | 0.273938 | N | 0.253455 | 0.020483 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 113 | V | 0.166521 | F | 0.148941 | 0.01758 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 119 | Y | 0.302958 | C | 0.266445 | 0.036513 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 221 | A | 0.871708 | T | 0.881604 | -0.009896 | No Change: Both D | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 39 | H | 0.373881 | P | 0.408947 | -0.035066 | No Change: Both O | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 56 | E | 0.270533 | K | 0.267937 | 0.002596 | No Change: Both O | - |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 224 | D | 0.879692 | Y | 0.806202 | 0.07349 | No Change: Both D | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| P25189 | MYP0_HUMAN Myelin protein P0 OS=Homo sapiens GN=MPZ PE=1 SV=1 | 227 | R | 0.895933 | S | 0.90899 | -0.013057 | No Change: Both D | Charcot-Marie-Tooth disease type 1B (CMT1B) [MIM:118200] |
| Q6UWV2 | MPZL3_HUMAN Myelin protein zero-like protein 3 OS=Homo sapiens GN=MPZL3 PE=1 SV=1 | 155 | M | 0.258499 | V | 0.220442 | 0.038057 | No Change: Both O | - |
| Q6UWV2 | MPZL3_HUMAN Myelin protein zero-like protein 3 OS=Homo sapiens GN=MPZL3 PE=1 SV=1 | 228 | D | 0.757548 | V | 0.601107 | 0.156441 | No Change: Both D | - |
| Q6UWV2 | MPZL3_HUMAN Myelin protein zero-like protein 3 OS=Homo sapiens GN=MPZL3 PE=1 SV=1 | 168 | V | 0.072829 | G | 0.111148 | -0.038319 | No Change: Both O | - |
| Q6UWV2 | MPZL3_HUMAN Myelin protein zero-like protein 3 OS=Homo sapiens GN=MPZL3 PE=1 SV=1 | 172 | V | 0.102956 | M | 0.135832 | -0.032876 | No Change: Both O | - |
| Q95460 | HMR1_HUMAN Major histocompatibility complex class I-related gene protein OS=Homo sapiens GN=MR1 PE=1 SV=1 | 39 | H | 0.273334 | R | 0.280541 | -0.007207 | No Change: Both O | - |
| Q95460 | HMR1_HUMAN Major histocompatibility complex class I-related gene protein OS=Homo sapiens GN=MR1 PE=1 SV=1 | 63 | R | 0.545484 | Q | 0.560859 | -0.015375 | No Change: Both D | - |
| Q95460 | HMR1_HUMAN Major histocompatibility complex class I-related gene protein OS=Homo sapiens GN=MR1 PE=1 SV=1 | 77 | A | 0.312841 | V | 0.226046 | 0.086795 | No Change: Both O | - |
| P22897 | MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens GN=MRC1 PE=1 SV=1 | 167 | T | 0.156495 | I | 0.084894 | 0.071601 | No Change: Both O | - |
| P22897 | MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens GN=MRC1 PE=1 SV=1 | 396 | G | 0.526588 | S | 0.583784 | -0.057196 | No Change: Both D | - |
| P22897 | MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens GN=MRC1 PE=1 SV=1 | 399 | T | 0.408509 | A | 0.357455 | 0.051054 | No Change: Both O | - |
| P22897 | MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens GN=MRC1 PE=1 SV=1 | 407 | L | 0.205931 | F | 0.187432 | 0.018499 | No Change: Both O | - |
| Q9UBG0 | MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens GN=MRC2 PE=1 SV=2 | 43 | V | 0.192687 | I | 0.178893 | 0.013794 | No Change: Both O | - |
| Q9UBG0 | MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens GN=MRC2 PE=1 SV=2 | 1156 | R | 0.277728 | H | 0.286101 | -0.008373 | No Change: Both O | - |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 117 | N | 0.182379 | S | 0.21122 | -0.028841 | No Change: Both O | Ataxia telangiectasia-like disorder (ATLD) [MIM:604391] |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 104 | S | 0.170091 | C | 0.058776 | 0.111315 | No Change: Both O | Cancer |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 157 | M | 0.375472 | V | 0.335539 | 0.039933 | No Change: Both O | - |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 503 | R | 0.895953 | H | 0.8594 | 0.036553 | No Change: Both D | Cancer |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 572 | R | 0.977287 | Q | 0.974646 | 0.002641 | No Change: Both D | Cancer |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 468 | D | 0.650663 | G | 0.609552 | 0.041111 | No Change: Both D | - |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 698 | M | 0.983766 | V | 0.976696 | 0.00707 | No Change: Both D | - |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 305 | R | 0.143781 | W | 0.055411 | 0.08837 | No Change: Both O | Ovarian cancer |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 237 | F | 0.055074 | C | 0.04997 | 0.005104 | No Change: Both O | A breast cancer sample |
| P49959 | MRE11_HUMAN Double-strand break repair protein MRE11A OS=Homo sapiens GN=MRE11A PE=1 SV=3 | 302 | H | 0.206806 | Y | 0.116404 | 0.090402 | No Change: Both O | A breast cancer sample |
| Q8N565 | MREG_HUMAN Melanoregulin OS=Homo sapiens GN=MREG PE=1 SV=1 | 15 | G | 0.205815 | R | 0.262967 | -0.057152 | No Change: Both O | - |
| Q9Y2G1 | MRF_HUMAN Myelin gene regulatory factor OS=Homo sapiens GN=MRF PE=1 SV=3 | 723 | A | 0.890702 | T | 0.897605 | -0.006903 | No Change: Both D | - |
| Q86SM8 | MRGRE_HUMAN Mas-related G-protein coupled receptor member E OS=Homo sapiens GN=MRGPRE PE=2 SV=2 | 15 | G | 0.506364 | S | 0.541697 | -0.035333 | No Change: Both D | - |
| Q86SM8 | MRGRE_HUMAN Mas-related G-protein coupled receptor member E OS=Homo sapiens GN=MRGPRE PE=2 SV=2 | 159 | G | 0.099871 | S | 0.128124 | -0.028253 | No Change: Both O | - |
| Q96AM1 | MRGRF_HUMAN Mas-related G-protein coupled receptor member F OS=Homo sapiens GN=MRGPRF PE=2 SV=1 | 16 | K | 0.590242 | R | 0.585227 | 0.005015 | No Change: Both D | - |
| Q96LB2 | MRGX1_HUMAN Mas-related G-protein coupled receptor member X1 OS=Homo sapiens GN=MRGPRX1 PE=1 SV=1 | 36 | I | 0.047752 | V | 0.061909 | -0.014157 | No Change: Both O | - |
| Q96LB1 | MRGX2_HUMAN Mas-related G-protein coupled receptor member X2 OS=Homo sapiens GN=MRGPRX2 PE=2 SV=1 | 62 | N | 0.141929 | S | 0.181507 | -0.039578 | No Change: Both O | - |
| Q96LB1 | MRGX2_HUMAN Mas-related G-protein coupled receptor member X2 OS=Homo sapiens GN=MRGPRX2 PE=2 SV=1 | 16 | N | 0.498101 | H | 0.453826 | 0.044275 | No Change: Both O | - |
| Q96LB1 | MRGX2_HUMAN Mas-related G-protein coupled receptor member X2 OS=Homo sapiens GN=MRGPRX2 PE=2 SV=1 | 78 | F | 0.014549 | L | 0.017026 | -0.002477 | No Change: Both O | - |
| Q96LB1 | MRGX2_HUMAN Mas-related G-protein coupled receptor member X2 OS=Homo sapiens GN=MRGPRX2 PE=2 SV=1 | 43 | V | 0.022171 | I | 0.019079 | 0.003092 | No Change: Both O | - |
| Q96LB0 | MRGX3_HUMAN Mas-related G-protein coupled receptor member X3 OS=Homo sapiens GN=MRGPRX3 PE=2 SV=2 | 169 | N | 0.129412 | D | 0.147831 | -0.018419 | No Change: Both O | - |
| Q96LB0 | MRGX3_HUMAN Mas-related G-protein coupled receptor member X3 OS=Homo sapiens GN=MRGPRX3 PE=2 SV=2 | 82 | C | 0.078826 | R | 0.172921 | -0.094095 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 8 | F | 0.348974 | L | 0.398941 | -0.049967 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 25 | N | 0.259473 | K | 0.29771 | -0.038237 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 54 | Y | 0.06804 | C | 0.053658 | 0.014382 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 83 | L | 0.056797 | S | 0.130193 | -0.073396 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 182 | A | 0.011992 | V | 0.00901 | 0.002982 | No Change: Both O | - |
| Q96LA9 | MRGX4_HUMAN Mas-related G-protein coupled receptor member X4 OS=Homo sapiens GN=MRGPRX4 PE=2 SV=2 | 245 | N | 0.072383 | S | 0.087433 | -0.01505 | No Change: Both O | - |
| Q9BWK5 | MRI_HUMAN Modulator of retrovirus infection homolog OS=Homo sapiens GN=MRI PE=2 SV=2 | 82 | P | 0.685574 | L | 0.577864 | 0.10771 | No Change: Both D | A colorectal cancer sample |
| Q9BV20 | MTNA_HUMAN Methylthioribose-1-phosphate isomerase OS=Homo sapiens GN=MRI1 PE=1 SV=1 | 235 | M | 0.342018 | V | 0.286361 | 0.055657 | No Change: Both O | - |
| Q9BV20 | MTNA_HUMAN Methylthioribose-1-phosphate isomerase OS=Homo sapiens GN=MRI1 PE=1 SV=1 | 319 | G | 0.108658 | A | 0.088901 | 0.019757 | No Change: Both O | - |
| Q6IN84 | MRM1_HUMAN rRNA methyltransferase 1 mitochondrial OS=Homo sapiens GN=MRM1 PE=1 SV=1 | 98 | P | 0.570275 | S | 0.544004 | 0.026271 | No Change: Both D | - |
| Q9BYG7 | MSTRO_HUMAN Protein maestro OS=Homo sapiens GN=MRO PE=2 SV=2 | 39 | R | 0.5525 | S | 0.586659 | -0.034159 | No Change: Both D | - |
| Q9BYG7 | MSTRO_HUMAN Protein maestro OS=Homo sapiens GN=MRO PE=2 SV=2 | 134 | T | 0.10696 | A | 0.084876 | 0.022084 | No Change: Both O | - |
| Q9BYD6 | RM01_HUMAN 39S ribosomal protein L1 mitochondrial OS=Homo sapiens GN=MRPL1 PE=1 SV=2 | 47 | T | 0.771715 | K | 0.81751 | -0.045795 | No Change: Both D | - |
| Q9BYD6 | RM01_HUMAN 39S ribosomal protein L1 mitochondrial OS=Homo sapiens GN=MRPL1 PE=1 SV=2 | 177 | F | 0.349657 | S | 0.583822 | -0.234165 | O to D | - |
| Q7Z7H8 | RM10_HUMAN 39S ribosomal protein L10 mitochondrial OS=Homo sapiens GN=MRPL10 PE=1 SV=3 | 125 | V | 0.188087 | I | 0.166977 | 0.02111 | No Change: Both O | - |
| P52815 | RM12_HUMAN 39S ribosomal protein L12 mitochondrial OS=Homo sapiens GN=MRPL12 PE=1 SV=2 | 105 | S | 0.41491 | P | 0.420335 | -0.005425 | No Change: Both O | - |
| Q9NX20 | RM16_HUMAN 39S ribosomal protein L16 mitochondrial OS=Homo sapiens GN=MRPL16 PE=1 SV=1 | 29 | G | 0.416483 | S | 0.555582 | -0.139099 | O to D | - |
| Q9NX20 | RM16_HUMAN 39S ribosomal protein L16 mitochondrial OS=Homo sapiens GN=MRPL16 PE=1 SV=1 | 199 | R | 0.753388 | Q | 0.755221 | -0.001833 | No Change: Both D | - |
| Q9NX20 | RM16_HUMAN 39S ribosomal protein L16 mitochondrial OS=Homo sapiens GN=MRPL16 PE=1 SV=1 | 207 | R | 0.709567 | C | 0.595641 | 0.113926 | No Change: Both D | - |
| Q9H0U6 | RM18_HUMAN 39S ribosomal protein L18 mitochondrial OS=Homo sapiens GN=MRPL18 PE=1 SV=1 | 6 | R | 0.367487 | Q | 0.303458 | 0.064029 | No Change: Both O | - |
| Q5T653 | RM02_HUMAN 39S ribosomal protein L2 mitochondrial OS=Homo sapiens GN=MRPL2 PE=1 SV=2 | 300 | S | 0.873584 | F | 0.710229 | 0.163355 | No Change: Both D | - |
| Q9NWU5 | RM22_HUMAN 39S ribosomal protein L22 mitochondrial OS=Homo sapiens GN=MRPL22 PE=1 SV=1 | 154 | G | 0.273159 | S | 0.295013 | -0.021854 | No Change: Both O | - |
| Q16540 | RM23_HUMAN 39S ribosomal protein L23 mitochondrial OS=Homo sapiens GN=MRPL23 PE=1 SV=1 | 11 | R | 0.150264 | Q | 0.159919 | -0.009655 | No Change: Both O | - |
| Q16540 | RM23_HUMAN 39S ribosomal protein L23 mitochondrial OS=Homo sapiens GN=MRPL23 PE=1 SV=1 | 32 | G | 0.255254 | S | 0.300465 | -0.045211 | No Change: Both O | - |
| Q16540 | RM23_HUMAN 39S ribosomal protein L23 mitochondrial OS=Homo sapiens GN=MRPL23 PE=1 SV=1 | 34 | A | 0.365068 | V | 0.318006 | 0.047062 | No Change: Both O | - |
| Q16540 | RM23_HUMAN 39S ribosomal protein L23 mitochondrial OS=Homo sapiens GN=MRPL23 PE=1 SV=1 | 81 | D | 0.723383 | N | 0.72929 | -0.005907 | No Change: Both D | - |
| Q16540 | RM23_HUMAN 39S ribosomal protein L23 mitochondrial OS=Homo sapiens GN=MRPL23 PE=1 SV=1 | 122 | A | 0.794885 | T | 0.804559 | -0.009674 | No Change: Both D | - |
| Q9P0M9 | RM27_HUMAN 39S ribosomal protein L27 mitochondrial OS=Homo sapiens GN=MRPL27 PE=1 SV=1 | 24 | T | 0.75716 | A | 0.741786 | 0.015374 | No Change: Both D | - |
| Q13084 | RM28_HUMAN 39S ribosomal protein L28 mitochondrial OS=Homo sapiens GN=MRPL28 PE=1 SV=4 | 160 | D | 0.42192 | E | 0.435219 | -0.013299 | No Change: Both O | - |
| Q13084 | RM28_HUMAN 39S ribosomal protein L28 mitochondrial OS=Homo sapiens GN=MRPL28 PE=1 SV=4 | 27 | H | 0.372524 | Y | 0.269755 | 0.102769 | No Change: Both O | - |
| Q13084 | RM28_HUMAN 39S ribosomal protein L28 mitochondrial OS=Homo sapiens GN=MRPL28 PE=1 SV=4 | 230 | Y | 0.269593 | C | 0.345358 | -0.075765 | No Change: Both O | - |
| P09001 | RM03_HUMAN 39S ribosomal protein L3 mitochondrial OS=Homo sapiens GN=MRPL3 PE=1 SV=1 | 261 | M | 0.467475 | T | 0.506869 | -0.039394 | O to D | - |
| P09001 | RM03_HUMAN 39S ribosomal protein L3 mitochondrial OS=Homo sapiens GN=MRPL3 PE=1 SV=1 | 317 | P | 0.522743 | R | 0.405573 | 0.11717 | D to O | - |
| Q8TCC3 | RM30_HUMAN 39S ribosomal protein L30 mitochondrial OS=Homo sapiens GN=MRPL30 PE=1 SV=1 | 130 | A | 0.563272 | T | 0.608621 | -0.045349 | No Change: Both D | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 19 | P | 0.24593 | S | 0.305659 | -0.059729 | No Change: Both O | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 80 | A | 0.3371 | P | 0.471205 | -0.134105 | No Change: Both O | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 81 | P | 0.301791 | L | 0.194695 | 0.107096 | No Change: Both O | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 24 | A | 0.220008 | T | 0.252705 | -0.032697 | No Change: Both O | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 29 | R | 0.287179 | H | 0.259511 | 0.027668 | No Change: Both O | - |
| Q9NZE8 | RM35_HUMAN 39S ribosomal protein L35 mitochondrial OS=Homo sapiens GN=MRPL35 PE=2 SV=3 | 180 | Y | 0.407224 | C | 0.36636 | 0.040864 | No Change: Both O | - |
| Q9BZE1 | RM37_HUMAN 39S ribosomal protein L37 mitochondrial OS=Homo sapiens GN=MRPL37 PE=1 SV=2 | 322 | L | 0.146297 | V | 0.132661 | 0.013636 | No Change: Both O | - |
| Q9BZE1 | RM37_HUMAN 39S ribosomal protein L37 mitochondrial OS=Homo sapiens GN=MRPL37 PE=1 SV=2 | 366 | C | 0.328623 | S | 0.59344 | -0.264817 | O to D | - |
| Q96DV4 | RM38_HUMAN 39S ribosomal protein L38 mitochondrial OS=Homo sapiens GN=MRPL38 PE=1 SV=2 | 371 | D | 0.712426 | H | 0.696916 | 0.01551 | No Change: Both D | - |
| Q96DV4 | RM38_HUMAN 39S ribosomal protein L38 mitochondrial OS=Homo sapiens GN=MRPL38 PE=1 SV=2 | 99 | R | 0.697523 | W | 0.454451 | 0.243072 | D to O | - |
| Q9NYK5 | RM39_HUMAN 39S ribosomal protein L39 mitochondrial OS=Homo sapiens GN=MRPL39 PE=1 SV=3 | 31 | S | 0.436293 | P | 0.410941 | 0.025352 | No Change: Both O | - |
| Q9NQ50 | RM40_HUMAN 39S ribosomal protein L40 mitochondrial OS=Homo sapiens GN=MRPL40 PE=1 SV=1 | 129 | R | 0.844818 | H | 0.786257 | 0.058561 | No Change: Both D | - |
| Q9NQ50 | RM40_HUMAN 39S ribosomal protein L40 mitochondrial OS=Homo sapiens GN=MRPL40 PE=1 SV=1 | 11 | L | 0.398727 | P | 0.570247 | -0.17152 | O to D | - |
| Q9H9J2 | RM44_HUMAN 39S ribosomal protein L44 mitochondrial OS=Homo sapiens GN=MRPL44 PE=1 SV=1 | 138 | T | 0.328881 | I | 0.194588 | 0.134293 | No Change: Both O | - |
| Q9BRJ2 | RM45_HUMAN 39S ribosomal protein L45 mitochondrial OS=Homo sapiens GN=MRPL45 PE=1 SV=2 | 298 | G | 0.969205 | V | 0.953674 | 0.015531 | No Change: Both D | - |
| Q9H2W6 | RM46_HUMAN 39S ribosomal protein L46 mitochondrial OS=Homo sapiens GN=MRPL46 PE=1 SV=1 | 106 | H | 0.847652 | Y | 0.778135 | 0.069517 | No Change: Both D | - |
| Q9HD33 | RM47_HUMAN 39S ribosomal protein L47 mitochondrial OS=Homo sapiens GN=MRPL47 PE=1 SV=2 | 10 | C | 0.360768 | G | 0.483594 | -0.122826 | No Change: Both O | - |
| Q9HD33 | RM47_HUMAN 39S ribosomal protein L47 mitochondrial OS=Homo sapiens GN=MRPL47 PE=1 SV=2 | 213 | R | 0.569948 | H | 0.535345 | 0.034603 | No Change: Both D | - |
| Q96GC5 | RM48_HUMAN 39S ribosomal protein L48 mitochondrial OS=Homo sapiens GN=MRPL48 PE=1 SV=2 | 6 | E | 0.435474 | G | 0.409011 | 0.026463 | No Change: Both O | - |
| Q13405 | RM49_HUMAN 39S ribosomal protein L49 mitochondrial OS=Homo sapiens GN=MRPL49 PE=1 SV=1 | 9 | T | 0.365937 | A | 0.324692 | 0.041245 | No Change: Both O | - |
| Q8N5N7 | RM50_HUMAN 39S ribosomal protein L50 mitochondrial OS=Homo sapiens GN=MRPL50 PE=1 SV=2 | 127 | L | 0.109424 | F | 0.101802 | 0.007622 | No Change: Both O | - |
| Q4U2R6 | RM51_HUMAN 39S ribosomal protein L51 mitochondrial OS=Homo sapiens GN=MRPL51 PE=1 SV=1 | 102 | M | 0.345523 | I | 0.238587 | 0.106936 | No Change: Both O | - |
| Q86TS9 | RM52_HUMAN 39S ribosomal protein L52 mitochondrial OS=Homo sapiens GN=MRPL52 PE=2 SV=2 | 5 | G | 0.366635 | V | 0.238488 | 0.128147 | No Change: Both O | - |
| Q86TS9 | RM52_HUMAN 39S ribosomal protein L52 mitochondrial OS=Homo sapiens GN=MRPL52 PE=2 SV=2 | 19 | V | 0.109744 | A | 0.164747 | -0.055003 | No Change: Both O | - |
| Q86TS9 | RM52_HUMAN 39S ribosomal protein L52 mitochondrial OS=Homo sapiens GN=MRPL52 PE=2 SV=2 | 104 | K | 0.942973 | R | 0.9418 | 0.001173 | No Change: Both D | - |
| Q96EL3 | RM53_HUMAN 39S ribosomal protein L53 mitochondrial OS=Homo sapiens GN=MRPL53 PE=1 SV=1 | 4 | A | 0.581909 | S | 0.64639 | -0.064481 | No Change: Both D | - |
| Q7Z7F7 | RM55_HUMAN 39S ribosomal protein L55 mitochondrial OS=Homo sapiens GN=MRPL55 PE=1 SV=1 | 24 | R | 0.62713 | C | 0.425165 | 0.201965 | D to O | - |
| Q7Z7F7 | RM55_HUMAN 39S ribosomal protein L55 mitochondrial OS=Homo sapiens GN=MRPL55 PE=1 SV=1 | 42 | R | 0.499779 | H | 0.467047 | 0.032732 | No Change: Both O | - |
| Q9BYD2 | RM09_HUMAN 39S ribosomal protein L9 mitochondrial OS=Homo sapiens GN=MRPL9 PE=1 SV=2 | 67 | E | 0.479244 | G | 0.455109 | 0.024135 | No Change: Both O | - |
| Q9BYD2 | RM09_HUMAN 39S ribosomal protein L9 mitochondrial OS=Homo sapiens GN=MRPL9 PE=1 SV=2 | 210 | E | 0.504596 | A | 0.369704 | 0.134892 | D to O | - |
| P82912 | RT11_HUMAN 28S ribosomal protein S11 mitochondrial OS=Homo sapiens GN=MRPS11 PE=1 SV=2 | 10 | R | 0.317585 | W | 0.126739 | 0.190846 | No Change: Both O | - |
| P82912 | RT11_HUMAN 28S ribosomal protein S11 mitochondrial OS=Homo sapiens GN=MRPS11 PE=1 SV=2 | 51 | Q | 0.669088 | H | 0.640581 | 0.028507 | No Change: Both D | - |
| O15235 | RT12_HUMAN 28S ribosomal protein S12 mitochondrial OS=Homo sapiens GN=MRPS12 PE=1 SV=1 | 8 | H | 0.344939 | R | 0.371283 | -0.026344 | No Change: Both O | - |
| Q9Y3D3 | RT16_HUMAN 28S ribosomal protein S16 mitochondrial OS=Homo sapiens GN=MRPS16 PE=1 SV=1 | 12 | Y | 0.175674 | H | 0.291086 | -0.115412 | No Change: Both O | - |
| Q9Y676 | RT18B_HUMAN 28S ribosomal protein S18b mitochondrial OS=Homo sapiens GN=MRPS18B PE=1 SV=1 | 230 | P | 0.977356 | A | 0.957409 | 0.019947 | No Change: Both D | - |
| Q9Y399 | RT02_HUMAN 28S ribosomal protein S2 mitochondrial OS=Homo sapiens GN=MRPS2 PE=1 SV=1 | 294 | H | 0.944593 | R | 0.954068 | -0.009475 | No Change: Both D | - |
| Q9Y399 | RT02_HUMAN 28S ribosomal protein S2 mitochondrial OS=Homo sapiens GN=MRPS2 PE=1 SV=1 | 112 | D | 0.208378 | G | 0.183816 | 0.024562 | No Change: Both O | - |
| Q9Y399 | RT02_HUMAN 28S ribosomal protein S2 mitochondrial OS=Homo sapiens GN=MRPS2 PE=1 SV=1 | 158 | M | 0.198458 | V | 0.15491 | 0.043548 | No Change: Both O | - |
| P82921 | RT21_HUMAN 28S ribosomal protein S21 mitochondrial OS=Homo sapiens GN=MRPS21 PE=1 SV=2 | 51 | R | 0.741757 | Q | 0.714793 | 0.026964 | No Change: Both D | - |
| P82921 | RT21_HUMAN 28S ribosomal protein S21 mitochondrial OS=Homo sapiens GN=MRPS21 PE=1 SV=2 | 50 | R | 0.738664 | C | 0.626539 | 0.112125 | No Change: Both D | - |
| P82650 | RT22_HUMAN 28S ribosomal protein S22 mitochondrial OS=Homo sapiens GN=MRPS22 PE=1 SV=1 | 170 | R | 0.271093 | H | 0.260587 | 0.010506 | No Change: Both O | Combined oxidative phosphorylation deficiency type 5 (COXPD5) [MIM:611719] |
| Q96EL2 | RT24_HUMAN 28S ribosomal protein S24 mitochondrial OS=Homo sapiens GN=MRPS24 PE=1 SV=1 | 97 | W | 0.053566 | R | 0.14335 | -0.089784 | No Change: Both O | - |
| Q92552 | RT27_HUMAN 28S ribosomal protein S27 mitochondrial OS=Homo sapiens GN=MRPS27 PE=1 SV=3 | 284 | G | 0.397786 | D | 0.458931 | -0.061145 | No Change: Both O | - |
| Q9Y2Q9 | RT28_HUMAN 28S ribosomal protein S28 mitochondrial OS=Homo sapiens GN=MRPS28 PE=1 SV=1 | 103 | R | 0.068633 | W | 0.024729 | 0.043904 | No Change: Both O | - |
| Q9NP92 | RT30_HUMAN 28S ribosomal protein S30 mitochondrial OS=Homo sapiens GN=MRPS30 PE=1 SV=2 | 33 | C | 0.544438 | S | 0.692767 | -0.148329 | No Change: Both D | - |
| Q9NP92 | RT30_HUMAN 28S ribosomal protein S30 mitochondrial OS=Homo sapiens GN=MRPS30 PE=1 SV=2 | 102 | A | 0.186377 | V | 0.147615 | 0.038762 | No Change: Both O | - |
| Q92665 | RT31_HUMAN 28S ribosomal protein S31 mitochondrial OS=Homo sapiens GN=MRPS31 PE=1 SV=3 | 241 | T | 0.663996 | M | 0.654685 | 0.009311 | No Change: Both D | - |
| Q92665 | RT31_HUMAN 28S ribosomal protein S31 mitochondrial OS=Homo sapiens GN=MRPS31 PE=1 SV=3 | 279 | D | 0.294243 | N | 0.277993 | 0.01625 | No Change: Both O | - |
| P82930 | RT34_HUMAN 28S ribosomal protein S34 mitochondrial OS=Homo sapiens GN=MRPS34 PE=1 SV=2 | 33 | L | 0.58092 | I | 0.499519 | 0.081401 | D to O | - |
| P82673 | RT35_HUMAN 28S ribosomal protein S35 mitochondrial OS=Homo sapiens GN=MRPS35 PE=1 SV=1 | 6 | L | 0.624005 | I | 0.503878 | 0.120127 | No Change: Both D | - |
| Q9Y2R9 | RT07_HUMAN 28S ribosomal protein S7 mitochondrial OS=Homo sapiens GN=MRPS7 PE=1 SV=2 | 2 | A | 0.760737 | V | 0.735898 | 0.024839 | No Change: Both D | - |
| P82933 | RT09_HUMAN 28S ribosomal protein S9 mitochondrial OS=Homo sapiens GN=MRPS9 PE=1 SV=2 | 13 | S | 0.112754 | L | 0.051143 | 0.061611 | No Change: Both O | - |
| Q96E11 | RRFM_HUMAN Ribosome-recycling factor mitochondrial OS=Homo sapiens GN=MRRF PE=1 SV=1 | 216 | M | 0.915434 | V | 0.890668 | 0.024766 | No Change: Both D | - |
| Q9HD23 | MRS2_HUMAN Magnesium transporter MRS2 homolog mitochondrial OS=Homo sapiens GN=MRS2 PE=2 SV=1 | 35 | P | 0.58098 | S | 0.566581 | 0.014399 | No Change: Both D | - |
| Q9HD23 | MRS2_HUMAN Magnesium transporter MRS2 homolog mitochondrial OS=Homo sapiens GN=MRS2 PE=2 SV=1 | 412 | P | 0.709764 | S | 0.717556 | -0.007792 | No Change: Both D | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 11 | I | 0.268343 | V | 0.28082 | -0.012477 | No Change: Both O | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 28 | A | 0.608418 | T | 0.606371 | 0.002047 | No Change: Both D | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 70 | A | 0.943811 | T | 0.949778 | -0.005967 | No Change: Both D | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 186 | P | 0.994864 | S | 0.995238 | -3.74E-04 | No Change: Both D | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 270 | Q | 0.858584 | H | 0.805228 | 0.053356 | No Change: Both D | - |
| Q9Y6F6 | MRVI1_HUMAN Protein MRVI1 OS=Homo sapiens GN=MRVI1 PE=1 SV=2 | 334 | Q | 0.977367 | H | 0.968383 | 0.008984 | No Change: Both D | - |
| Q96PG2 | M4A10_HUMAN Membrane-spanning 4-domains subfamily A member 10 OS=Homo sapiens GN=MS4A10 PE=2 SV=3 | 219 | P | 0.652533 | L | 0.48483 | 0.167703 | D to O | - |
| Q9NXJ0 | M4A12_HUMAN Membrane-spanning 4-domains subfamily A member 12 OS=Homo sapiens GN=MS4A12 PE=2 SV=2 | 10 | A | 0.926102 | D | 0.933036 | -0.006934 | No Change: Both D | - |
| Q5J8X5 | M4A13_HUMAN Membrane-spanning 4-domains subfamily A member 13 OS=Homo sapiens GN=MS4A13 PE=2 SV=2 | 58 | P | 0.287295 | L | 0.162897 | 0.124398 | No Change: Both O | - |
| Q5J8X5 | M4A13_HUMAN Membrane-spanning 4-domains subfamily A member 13 OS=Homo sapiens GN=MS4A13 PE=2 SV=2 | 3 | G | 0.284216 | D | 0.322001 | -0.037785 | No Change: Both O | - |
| Q5J8X5 | M4A13_HUMAN Membrane-spanning 4-domains subfamily A member 13 OS=Homo sapiens GN=MS4A13 PE=2 SV=2 | 7 | I | 0.01685 | V | 0.01788 | -0.00103 | No Change: Both O | - |
| Q96JA4 | M4A14_HUMAN Membrane-spanning 4-domains subfamily A member 14 OS=Homo sapiens GN=MS4A14 PE=2 SV=2 | 177 | N | 0.709352 | Y | 0.566687 | 0.142665 | No Change: Both D | - |
| Q96JA4 | M4A14_HUMAN Membrane-spanning 4-domains subfamily A member 14 OS=Homo sapiens GN=MS4A14 PE=2 SV=2 | 584 | G | 0.99804 | R | 0.997877 | 1.63E-04 | No Change: Both D | - |
| Q8N5U1 | M4A15_HUMAN Membrane-spanning 4-domains subfamily A member 15 OS=Homo sapiens GN=MS4A15 PE=2 SV=2 | 20 | S | 0.799665 | G | 0.759098 | 0.040567 | No Change: Both D | - |
| Q8N5U1 | M4A15_HUMAN Membrane-spanning 4-domains subfamily A member 15 OS=Homo sapiens GN=MS4A15 PE=2 SV=2 | 47 | L | 0.900222 | R | 0.933449 | -0.033227 | No Change: Both D | - |
| Q01362 | FCERB_HUMAN High affinity immunoglobulin epsilon receptor subunit beta OS=Homo sapiens GN=MS4A2 PE=2 SV=1 | 237 | E | 0.705931 | G | 0.652355 | 0.053576 | No Change: Both D | - |
| Q01362 | FCERB_HUMAN High affinity immunoglobulin epsilon receptor subunit beta OS=Homo sapiens GN=MS4A2 PE=2 SV=1 | 143 | T | 0.228855 | M | 0.18121 | 0.047645 | No Change: Both O | - |
| Q01362 | FCERB_HUMAN High affinity immunoglobulin epsilon receptor subunit beta OS=Homo sapiens GN=MS4A2 PE=2 SV=1 | 211 | N | 0.61461 | K | 0.650986 | -0.036376 | No Change: Both D | - |
| Q96JQ5 | M4A4A_HUMAN Membrane-spanning 4-domains subfamily A member 4A OS=Homo sapiens GN=MS4A4A PE=2 SV=1 | 178 | M | 0.296358 | V | 0.223784 | 0.072574 | No Change: Both O | - |
| Q96JQ5 | M4A4A_HUMAN Membrane-spanning 4-domains subfamily A member 4A OS=Homo sapiens GN=MS4A4A PE=2 SV=1 | 52 | K | 0.272228 | E | 0.269501 | 0.002727 | No Change: Both O | - |
| Q96JQ5 | M4A4A_HUMAN Membrane-spanning 4-domains subfamily A member 4A OS=Homo sapiens GN=MS4A4A PE=2 SV=1 | 191 | L | 0.037679 | I | 0.029806 | 0.007873 | No Change: Both O | - |
| Q9H3V2 | MS4A5_HUMAN Membrane-spanning 4-domains subfamily A member 5 OS=Homo sapiens GN=MS4A5 PE=2 SV=1 | 123 | L | 0.101438 | R | 0.171539 | -0.070101 | No Change: Both O | A colorectal cancer sample |
| Q9H2W1 | M4A6A_HUMAN Membrane-spanning 4-domains subfamily A member 6A OS=Homo sapiens GN=MS4A6A PE=2 SV=1 | 183 | A | 0.260135 | S | 0.372096 | -0.111961 | No Change: Both O | - |
| Q9H2W1 | M4A6A_HUMAN Membrane-spanning 4-domains subfamily A member 6A OS=Homo sapiens GN=MS4A6A PE=2 SV=1 | 185 | T | 0.188102 | S | 0.26033 | -0.072228 | No Change: Both O | - |
| Q96DS6 | M4A6E_HUMAN Membrane-spanning 4-domains subfamily A member 6E OS=Homo sapiens GN=MS4A6E PE=2 SV=1 | 47 | V | 0.359623 | F | 0.314011 | 0.045612 | No Change: Both O | - |
| Q96DS6 | M4A6E_HUMAN Membrane-spanning 4-domains subfamily A member 6E OS=Homo sapiens GN=MS4A6E PE=2 SV=1 | 6 | I | 0.828878 | V | 0.816044 | 0.012834 | No Change: Both D | - |
| Q96DS6 | M4A6E_HUMAN Membrane-spanning 4-domains subfamily A member 6E OS=Homo sapiens GN=MS4A6E PE=2 SV=1 | 10 | T | 0.790899 | A | 0.743368 | 0.047531 | No Change: Both D | - |
| Q9GZW8 | MS4A7_HUMAN Membrane-spanning 4-domains subfamily A member 7 OS=Homo sapiens GN=MS4A7 PE=1 SV=1 | 34 | E | 0.496294 | K | 0.497248 | -9.54E-04 | No Change: Both O | - |
| Q9GZW8 | MS4A7_HUMAN Membrane-spanning 4-domains subfamily A member 7 OS=Homo sapiens GN=MS4A7 PE=1 SV=1 | 112 | P | 0.673521 | H | 0.647981 | 0.02554 | No Change: Both D | - |
| Q9GZW8 | MS4A7_HUMAN Membrane-spanning 4-domains subfamily A member 7 OS=Homo sapiens GN=MS4A7 PE=1 SV=1 | 157 | S | 0.488746 | F | 0.228527 | 0.260219 | No Change: Both O | - |
| Q9BY19 | M4A8B_HUMAN Membrane-spanning 4-domains subfamily A member 8B OS=Homo sapiens GN=MS4A8B PE=2 SV=1 | 95 | V | 0.096744 | L | 0.098587 | -0.001843 | No Change: Both O | - |
| A6NI15 | MSGN1_HUMAN Mesogenin-1 OS=Homo sapiens GN=MSGN1 PE=2 SV=1 | 80 | E | 0.780659 | D | 0.766134 | 0.014525 | No Change: Both D | - |
| A6NI15 | MSGN1_HUMAN Mesogenin-1 OS=Homo sapiens GN=MSGN1 PE=2 SV=1 | 104 | H | 0.590227 | Y | 0.526994 | 0.063233 | No Change: Both D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 46 | H | 0.306953 | Q | 0.323002 | -0.016049 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 96 | R | 0.109299 | H | 0.092697 | 0.016602 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 139 | N | 0.323491 | S | 0.372206 | -0.048715 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 145 | I | 0.330455 | M | 0.455599 | -0.125144 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 167 | D | 0.223631 | H | 0.188288 | 0.035343 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 305 | A | 0.116374 | T | 0.124787 | -0.008413 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 322 | G | 0.577668 | D | 0.597723 | -0.020055 | No Change: Both D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 390 | L | 0.463183 | F | 0.42941 | 0.033773 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 524 | R | 0.128941 | P | 0.143856 | -0.014915 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 562 | E | 0.706911 | V | 0.534508 | 0.172403 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 622 | P | 0.211193 | L | 0.10642 | 0.104773 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 639 | H | 0.161142 | Y | 0.09728 | 0.063862 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 641 | C | 0.182569 | G | 0.337678 | -0.155109 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 674 | G | 0.553068 | S | 0.596958 | -0.04389 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 697 | C | 0.142643 | F | 0.150713 | -0.00807 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 770 | I | 0.088329 | V | 0.092205 | -0.003876 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 834 | A | 0.208708 | T | 0.216923 | -0.008215 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 905 | T | 0.546752 | R | 0.559518 | -0.012766 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 692 | G | 0.037209 | R | 0.035078 | 0.002131 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 697 | C | 0.142643 | R | 0.248863 | -0.10622 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 161 | V | 0.329385 | D | 0.484743 | -0.155358 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 199 | C | 0.304212 | R | 0.442701 | -0.138489 | No Change: Both O | Glioma |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 216 | I | 0.280645 | V | 0.274237 | 0.006408 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 323 | S | 0.549277 | C | 0.322063 | 0.227214 | D to O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 419 | Q | 0.298675 | K | 0.340827 | -0.042152 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 506 | D | 0.467266 | Y | 0.304419 | 0.162847 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 554 | S | 0.62293 | R | 0.560241 | 0.062689 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 596 | N | 0.225542 | S | 0.261143 | -0.035601 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 636 | A | 0.208542 | P | 0.262246 | -0.053704 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 688 | M | 0.033922 | I | 0.023768 | 0.010154 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 8 | T | 0.572464 | M | 0.585139 | -0.012675 | No Change: Both D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 845 | K | 0.326236 | E | 0.336668 | -0.010432 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 43 | Y | 0.262194 | C | 0.23616 | 0.026034 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 127 | N | 0.39221 | S | 0.453362 | -0.061152 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 163 | V | 0.282155 | G | 0.422993 | -0.140838 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 660 | D | 0.357002 | G | 0.313325 | 0.043677 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 106 | R | 0.551499 | K | 0.614227 | -0.062728 | No Change: Both D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 670 | P | 0.423992 | L | 0.259994 | 0.163998 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 779 | M | 0.060137 | I | 0.041727 | 0.01841 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 807 | T | 0.414788 | S | 0.473076 | -0.058288 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 835 | N | 0.19632 | H | 0.196821 | -5.01E-04 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 911 | L | 0.444866 | R | 0.564061 | -0.119195 | O to D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 13 | S | 0.431012 | I | 0.218636 | 0.212376 | No Change: Both O | Colorectal cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 17 | V | 0.268913 | F | 0.271068 | -0.002155 | No Change: Both O | Gastric cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 33 | T | 0.351482 | P | 0.397092 | -0.04561 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 40 | G | 0.265268 | S | 0.299758 | -0.03449 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 44 | T | 0.270491 | M | 0.234455 | 0.036036 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 45 | A | 0.286187 | V | 0.206315 | 0.079872 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 93 | L | 0.096537 | F | 0.083865 | 0.012672 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 98 | Y | 0.139083 | C | 0.121386 | 0.017697 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 102 | V | 0.289566 | I | 0.247204 | 0.042362 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 110 | K | 0.631444 | T | 0.571341 | 0.060103 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 162 | G | 0.311932 | R | 0.298481 | 0.013451 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 163 | V | 0.282155 | D | 0.440826 | -0.158671 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 164 | G | 0.257406 | R | 0.24715 | 0.010256 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 169 | I | 0.208572 | V | 0.253816 | -0.045244 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 173 | L | 0.184627 | P | 0.320756 | -0.136129 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 175 | L | 0.195986 | P | 0.33907 | -0.143084 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 187 | L | 0.22876 | P | 0.36682 | -0.13806 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 203 | G | 0.436774 | R | 0.409914 | 0.02686 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 246 | K | 0.564469 | Q | 0.525511 | 0.038958 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 272 | A | 0.24982 | V | 0.205299 | 0.044521 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 283 | D | 0.412868 | Y | 0.243411 | 0.169457 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 323 | S | 0.549277 | Y | 0.361929 | 0.187348 | D to O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 333 | C | 0.399394 | Y | 0.430358 | -0.030964 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 335 | T | 0.423794 | I | 0.294566 | 0.129228 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 336 | P | 0.426892 | S | 0.452292 | -0.0254 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 342 | V | 0.276101 | I | 0.264592 | 0.011509 | No Change: Both O | Colorectal cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 349 | P | 0.372103 | L | 0.262278 | 0.109825 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 359 | R | 0.440115 | S | 0.423508 | 0.016607 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 393 | K | 0.501563 | M | 0.367845 | 0.133718 | D to O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 492 | M | 0.588224 | V | 0.492377 | 0.095847 | D to O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 552 | T | 0.592666 | P | 0.602578 | -0.009912 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 564 | T | 0.674873 | A | 0.637268 | 0.037605 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 583 | N | 0.235339 | S | 0.285316 | -0.049977 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 600 | A | 0.15513 | V | 0.115774 | 0.039356 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 603 | D | 0.148472 | N | 0.137437 | 0.011035 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 619 | Y | 0.213816 | C | 0.181713 | 0.032103 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 629 | Q | 0.296177 | R | 0.296117 | 6.00E-05 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 639 | H | 0.161142 | R | 0.172692 | -0.01155 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 647 | E | 0.157049 | K | 0.147877 | 0.009172 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 656 | Y | 0.211237 | H | 0.314419 | -0.103182 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 671 | N | 0.454086 | Y | 0.317839 | 0.136247 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 679 | I | 0.261004 | T | 0.408204 | -0.1472 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 714 | A | 0.297335 | V | 0.237705 | 0.05963 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 723 | S | 0.330601 | F | 0.157452 | 0.173149 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 729 | M | 0.325001 | V | 0.255339 | 0.069662 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 732 | T | 0.361193 | I | 0.231646 | 0.129547 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 749 | E | 0.278134 | K | 0.282594 | -0.00446 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 813 | M | 0.199339 | V | 0.166651 | 0.032688 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 824 | Q | 0.212026 | E | 0.246815 | -0.034789 | No Change: Both O | Gastric cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 839 | H | 0.189375 | R | 0.189454 | -7.90E-05 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 853 | E | 0.357045 | A | 0.252641 | 0.104404 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 868 | P | 0.466139 | A | 0.405524 | 0.060615 | No Change: Both O | Gastric cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 870 | A | 0.488375 | G | 0.531813 | -0.043438 | O to D | Gastric cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 873 | C | 0.55414 | G | 0.650229 | -0.096089 | No Change: Both D | Gastric cancer |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 886 | E | 0.481818 | G | 0.386879 | 0.094939 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 923 | V | 0.344679 | E | 0.551029 | -0.20635 | O to D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 931 | K | 0.546166 | T | 0.518758 | 0.027408 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 2 | A | 0.646485 | T | 0.658015 | -0.01153 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 162 | G | 0.311932 | A | 0.247514 | 0.064418 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 198 | E | 0.285827 | G | 0.254258 | 0.031569 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 1 (HNPCC1) [MIM:120435] |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 331 | N | 0.367226 | D | 0.381824 | -0.014598 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 470 | V | 0.591181 | E | 0.766688 | -0.175507 | No Change: Both D | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 610 | H | 0.264983 | N | 0.298444 | -0.033461 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 638 | R | 0.174929 | G | 0.181836 | -0.006907 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 645 | Q | 0.192979 | E | 0.244907 | -0.051928 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 696 | P | 0.10875 | L | 0.052978 | 0.055772 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 748 | D | 0.254778 | Y | 0.13393 | 0.120848 | No Change: Both O | - |
| P43246 | MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens GN=MSH2 PE=1 SV=1 | 839 | H | 0.189375 | Q | 0.216528 | -0.027153 | No Change: Both O | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 709 | F | 0.362349 | L | 0.41114 | -0.048791 | No Change: Both O | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 949 | Q | 0.36156 | R | 0.3441 | 0.01746 | No Change: Both O | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 1045 | A | 0.562344 | T | 0.579656 | -0.017312 | No Change: Both D | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 1054 | T | 0.05324 | A | 0.046523 | 0.006717 | No Change: Both O | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 79 | I | 0.964577 | V | 0.967646 | -0.003069 | No Change: Both D | - |
| P20585 | MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens GN=MSH3 PE=1 SV=4 | 789 | Y | 0.217506 | F | 0.20213 | 0.015376 | No Change: Both O | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 60 | A | 0.976143 | V | 0.967752 | 0.008391 | No Change: Both D | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 90 | A | 0.79999 | T | 0.812491 | -0.012501 | No Change: Both D | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 97 | A | 0.766842 | T | 0.786417 | -0.019575 | No Change: Both D | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 162 | E | 0.260604 | K | 0.257109 | 0.003495 | No Change: Both O | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 589 | Y | 0.142869 | C | 0.134097 | 0.008772 | No Change: Both O | - |
| O15457 | MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens GN=MSH4 PE=2 SV=2 | 914 | S | 0.566165 | N | 0.528987 | 0.037178 | No Change: Both D | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 29 | P | 0.960424 | S | 0.957363 | 0.003061 | No Change: Both D | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 85 | L | 0.484247 | F | 0.429032 | 0.055215 | No Change: Both O | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 202 | Y | 0.224074 | C | 0.18416 | 0.039914 | No Change: Both O | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 206 | V | 0.111706 | F | 0.097724 | 0.013982 | No Change: Both O | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 351 | R | 0.28583 | G | 0.295543 | -0.009713 | No Change: Both O | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 377 | L | 0.188427 | F | 0.171208 | 0.017219 | No Change: Both O | - |
| O43196 | MSH5_HUMAN MutS protein homolog 5 OS=Homo sapiens GN=MSH5 PE=1 SV=1 | 786 | P | 0.645405 | S | 0.647238 | -0.001833 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 39 | G | 0.988997 | E | 0.989683 | -6.86E-04 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1213 | D | 0.27592 | V | 0.168462 | 0.107458 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1260 | V | 0.253786 | I | 0.21129 | 0.042496 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 144 | S | 0.421144 | I | 0.211953 | 0.209191 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 220 | E | 0.985534 | D | 0.982153 | 0.003381 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 285 | S | 0.973111 | I | 0.94177 | 0.031341 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 396 | L | 0.310429 | V | 0.312164 | -0.001735 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 566 | G | 0.139202 | R | 0.133946 | 0.005256 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 698 | Q | 0.151967 | E | 0.195448 | -0.043481 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 800 | V | 0.18177 | L | 0.183721 | -0.001951 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 803 | D | 0.279552 | G | 0.239213 | 0.040339 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 850 | Y | 0.419752 | C | 0.365219 | 0.054533 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 878 | V | 0.255518 | A | 0.337002 | -0.081484 | No Change: Both O | Colorectal/endometrial cancer |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 976 | R | 0.219787 | H | 0.170956 | 0.048831 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1087 | P | 0.436078 | T | 0.369133 | 0.066945 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 886 | I | 0.296878 | V | 0.330128 | -0.03325 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 623 | P | 0.37376 | A | 0.301605 | 0.072155 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 13 | K | 0.934872 | T | 0.917991 | 0.016881 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 25 | A | 0.960629 | V | 0.926195 | 0.034434 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 65 | S | 0.954111 | L | 0.928649 | 0.025462 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 468 | R | 0.23161 | H | 0.235695 | -0.004085 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 503 | S | 0.448949 | C | 0.321389 | 0.12756 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 538 | Y | 0.525789 | S | 0.713571 | -0.187782 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 580 | S | 0.305254 | L | 0.156352 | 0.148902 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1232 | V | 0.212356 | L | 0.210921 | 0.001435 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1234 | E | 0.222914 | Q | 0.176409 | 0.046505 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1321 | R | 0.601789 | G | 0.582876 | 0.018913 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 221 | E | 0.986496 | D | 0.983244 | 0.003252 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 492 | M | 0.603033 | V | 0.519676 | 0.083357 | No Change: Both D | Hereditary non-polyposis colorectal cancer type 5 (HNPCC5) [MIM:614350] |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 20 | A | 0.950652 | V | 0.905178 | 0.045474 | No Change: Both D | Colorectal/endometrial cancer |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 54 | G | 0.986256 | A | 0.986006 | 2.50E-04 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 99 | K | 0.121319 | N | 0.103071 | 0.018248 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 128 | R | 0.281861 | L | 0.174933 | 0.106928 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 295 | K | 0.967869 | R | 0.965683 | 0.002186 | No Change: Both D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 340 | F | 0.83562 | S | 0.917136 | -0.081516 | No Change: Both D | Breast cancer |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 449 | L | 0.097956 | P | 0.181228 | -0.083272 | No Change: Both O | Colorectal/endometrial cancer |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 509 | V | 0.308912 | A | 0.365315 | -0.056403 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 522 | Q | 0.360126 | R | 0.406529 | -0.046403 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 619 | E | 0.497969 | D | 0.458992 | 0.038977 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 623 | P | 0.37376 | L | 0.274594 | 0.099166 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 685 | G | 0.136016 | A | 0.113625 | 0.022391 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 725 | I | 0.277358 | M | 0.370609 | -0.093251 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 728 | K | 0.17904 | T | 0.148747 | 0.030293 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 772 | R | 0.170196 | Q | 0.194764 | -0.024568 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 772 | R | 0.170196 | W | 0.076217 | 0.093979 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 5 (HNPCC5) [MIM:614350] |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 787 | A | 0.120261 | V | 0.07992 | 0.040341 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 800 | V | 0.18177 | A | 0.236427 | -0.054657 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 854 | K | 0.353876 | M | 0.238989 | 0.114887 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 901 | R | 0.4555 | H | 0.459646 | -0.004146 | No Change: Both O | Colorectal/endometrial cancer |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1021 | A | 0.431394 | D | 0.511502 | -0.080108 | O to D | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1031 | D | 0.266353 | V | 0.148261 | 0.118092 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1076 | R | 0.198634 | C | 0.111619 | 0.087015 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1095 | R | 0.426099 | H | 0.415352 | 0.010747 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1100 | T | 0.311572 | M | 0.273494 | 0.038078 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1158 | C | 0.101227 | R | 0.18366 | -0.082433 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1163 | E | 0.114112 | V | 0.06131 | 0.052802 | No Change: Both O | Hereditary non-polyposis colorectal cancer type 5 (HNPCC5) [MIM:614350] |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1193 | E | 0.347047 | K | 0.319574 | 0.027473 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1219 | T | 0.335466 | I | 0.195992 | 0.139474 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1248 | H | 0.219156 | D | 0.243441 | -0.024285 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1284 | T | 0.126763 | M | 0.102518 | 0.024245 | No Change: Both O | - |
| P52701 | MSH6_HUMAN DNA mismatch repair protein Msh6 OS=Homo sapiens GN=MSH6 PE=1 SV=2 | 1354 | L | 0.290069 | Q | 0.394235 | -0.104166 | No Change: Both O | - |
| O43347 | MSI1H_HUMAN RNA-binding protein Musashi homolog 1 OS=Homo sapiens GN=MSI1 PE=1 SV=1 | 160 | E | 0.313886 | Q | 0.2558 | 0.058086 | No Change: Both O | A breast cancer sample |
| Q8N5Y2 | MS3L1_HUMAN Male-specific lethal 3 homolog OS=Homo sapiens GN=MSL3 PE=1 SV=1 | 199 | K | 0.194344 | Q | 0.163902 | 0.030442 | No Change: Both O | - |
| Q8N5Y2 | MS3L1_HUMAN Male-specific lethal 3 homolog OS=Homo sapiens GN=MSL3 PE=1 SV=1 | 251 | V | 0.294659 | I | 0.266743 | 0.027916 | No Change: Both O | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 47 | N | 0.975543 | D | 0.977036 | -0.001493 | No Change: Both D | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 99 | L | 0.766966 | I | 0.747395 | 0.019571 | No Change: Both D | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 145 | S | 0.26595 | N | 0.228631 | 0.037319 | No Change: Both O | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 147 | A | 0.344457 | D | 0.384475 | -0.040018 | No Change: Both O | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 257 | P | 0.994734 | S | 0.994957 | -2.23E-04 | No Change: Both D | - |
| P0C860 | MS3L2_HUMAN Putative male-specific lethal-3 protein-like 2 OS=Homo sapiens GN=MSL3P1 PE=5 SV=1 | 316 | K | 0.931836 | E | 0.932985 | -0.001149 | No Change: Both D | - |
| Q13421 | MSLN_HUMAN Mesothelin OS=Homo sapiens GN=MSLN PE=1 SV=2 | 72 | A | 0.4485 | V | 0.382241 | 0.066259 | No Change: Both O | - |
| Q13421 | MSLN_HUMAN Mesothelin OS=Homo sapiens GN=MSLN PE=1 SV=2 | 309 | R | 0.540254 | P | 0.566272 | -0.026018 | No Change: Both D | - |
| Q13421 | MSLN_HUMAN Mesothelin OS=Homo sapiens GN=MSLN PE=1 SV=2 | 601 | M | 0.322411 | V | 0.277088 | 0.045323 | No Change: Both O | - |
| Q13421 | MSLN_HUMAN Mesothelin OS=Homo sapiens GN=MSLN PE=1 SV=2 | 497 | G | 0.245136 | E | 0.293395 | -0.048259 | No Change: Both O | - |
| Q96KJ4 | MSLNL_HUMAN Mesothelin-like protein OS=Homo sapiens GN=MSLNL PE=2 SV=3 | 139 | A | 0.238954 | T | 0.247137 | -0.008183 | No Change: Both O | - |
| Q96KJ4 | MSLNL_HUMAN Mesothelin-like protein OS=Homo sapiens GN=MSLNL PE=2 SV=3 | 463 | D | 0.374103 | V | 0.21847 | 0.155633 | No Change: Both O | - |
| Q96KJ4 | MSLNL_HUMAN Mesothelin-like protein OS=Homo sapiens GN=MSLNL PE=2 SV=3 | 597 | S | 0.913768 | G | 0.894544 | 0.019224 | No Change: Both D | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 17 | L | 0.028076 | S | 0.072148 | -0.044072 | No Change: Both O | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 25 | I | 0.163388 | M | 0.226666 | -0.063278 | No Change: Both O | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 52 | W | 0.520655 | R | 0.718689 | -0.198034 | No Change: Both D | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 53 | Q | 0.504013 | R | 0.509134 | -0.005121 | No Change: Both D | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 80 | D | 0.47598 | A | 0.351137 | 0.124843 | No Change: Both O | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 87 | I | 0.422369 | T | 0.56181 | -0.139441 | O to D | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 91 | E | 0.388987 | G | 0.301283 | 0.087704 | No Change: Both O | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 92 | D | 0.370433 | G | 0.308716 | 0.061717 | No Change: Both O | - |
| P08118 | MSMB_HUMAN Beta-microseminoprotein OS=Homo sapiens GN=MSMB PE=1 SV=1 | 98 | V | 0.474418 | L | 0.434241 | 0.040177 | No Change: Both O | - |
| Q15800 | MSMO1_HUMAN Methylsterol monooxygenase 1 OS=Homo sapiens GN=MSMO1 PE=1 SV=1 | 124 | N | 0.0812 | S | 0.097923 | -0.016723 | No Change: Both O | - |
| Q1L6U9 | MSMP_HUMAN Prostate-associated microseminoprotein OS=Homo sapiens GN=MSMP PE=1 SV=1 | 116 | G | 0.852478 | V | 0.786959 | 0.065519 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 23 | F | 0.821568 | C | 0.854751 | -0.033183 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 275 | P | 0.835581 | A | 0.750823 | 0.084758 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 269 | T | 0.650263 | I | 0.563111 | 0.087152 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 36 | P | 0.765058 | A | 0.71758 | 0.047478 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 41 | S | 0.769369 | Y | 0.649287 | 0.120082 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 113 | V | 0.769244 | A | 0.830968 | -0.061724 | No Change: Both D | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 174 | D | 0.470086 | Y | 0.320548 | 0.149538 | No Change: Both O | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 254 | L | 0.390897 | V | 0.369155 | 0.021742 | No Change: Both O | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 369 | G | 0.173799 | S | 0.2087 | -0.034901 | No Change: Both O | - |
| P21757 | MSRE_HUMAN Macrophage scavenger receptor types I and II OS=Homo sapiens GN=MSR1 PE=1 SV=1 | 441 | H | 0.506856 | R | 0.532969 | -0.026113 | No Change: Both D | - |
| Q9Y3D2 | MSRB2_HUMAN Methionine-R-sulfoxide reductase B2 mitochondrial OS=Homo sapiens GN=MSRB2 PE=2 SV=2 | 46 | E | 0.721718 | G | 0.690433 | 0.031285 | No Change: Both D | - |
| Q8IXL7 | MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens GN=MSRB3 PE=1 SV=2 | 89 | C | 0.131124 | G | 0.205816 | -0.074692 | No Change: Both O | Deafness autosomal recessive type 74 (DFNB74) [MIM:613718] |
| P26927 | HGFL_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=2 | 13 | C | 0.137108 | Y | 0.150871 | -0.013763 | No Change: Both O | - |
| P26927 | HGFL_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=2 | 212 | C | 0.537947 | F | 0.514536 | 0.023411 | No Change: Both D | - |
| P26927 | HGFL_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=2 | 676 | E | 0.036163 | K | 0.036075 | 8.80E-05 | No Change: Both O | - |
| P26927 | HGFL_HUMAN Hepatocyte growth factor-like protein OS=Homo sapiens GN=MST1 PE=1 SV=2 | 551 | S | 0.55974 | G | 0.535194 | 0.024546 | No Change: Both D | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 322 | R | 0.350204 | Q | 0.373313 | -0.023109 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 1335 | R | 0.139 | G | 0.143269 | -0.004269 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 434 | S | 0.33723 | L | 0.192592 | 0.144638 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 440 | N | 0.187198 | S | 0.233014 | -0.045816 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 75 | R | 0.118333 | S | 0.148047 | -0.029714 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 95 | P | 0.631497 | T | 0.578595 | 0.052902 | No Change: Both D | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 185 | R | 0.304086 | C | 0.217333 | 0.086753 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 356 | G | 0.583257 | D | 0.586608 | -0.003351 | No Change: Both D | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 465 | G | 0.266405 | D | 0.2947 | -0.028295 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 504 | R | 0.397825 | C | 0.230959 | 0.166866 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 523 | Q | 0.260026 | R | 0.245268 | 0.014758 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 613 | Q | 0.758116 | P | 0.804324 | -0.046208 | No Change: Both D | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 900 | V | 0.246676 | M | 0.281269 | -0.034593 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 1304 | R | 0.364146 | G | 0.370164 | -0.006018 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 1360 | Y | 0.37188 | C | 0.368136 | 0.003744 | No Change: Both O | - |
| Q04912 | RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens GN=MST1R PE=1 SV=2 | 1195 | S | 0.242067 | G | 0.20528 | 0.036787 | No Change: Both O | - |
| Q9P289 | MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2 | 9 | Q | 0.42402 | R | 0.386406 | 0.037614 | No Change: Both O | - |
| Q9P289 | MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2 | 36 | G | 0.345125 | W | 0.154016 | 0.191109 | No Change: Both O | A gastric adenocarcinoma sample |
| Q9P289 | MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2 | 45 | R | 0.299504 | C | 0.188518 | 0.110986 | No Change: Both O | - |
| O14793 | GDF8_HUMAN Growth/differentiation factor 8 OS=Homo sapiens GN=MSTN PE=1 SV=1 | 55 | A | 0.523052 | T | 0.566608 | -0.043556 | No Change: Both D | - |
| O14793 | GDF8_HUMAN Growth/differentiation factor 8 OS=Homo sapiens GN=MSTN PE=1 SV=1 | 153 | K | 0.082512 | R | 0.058824 | 0.023688 | No Change: Both O | - |
| O14793 | GDF8_HUMAN Growth/differentiation factor 8 OS=Homo sapiens GN=MSTN PE=1 SV=1 | 348 | I | 0.245847 | T | 0.389406 | -0.143559 | No Change: Both O | - |
| O14793 | GDF8_HUMAN Growth/differentiation factor 8 OS=Homo sapiens GN=MSTN PE=1 SV=1 | 371 | R | 0.406229 | G | 0.431692 | -0.025463 | No Change: Both O | - |
| Q9BUK6 | MSTO1_HUMAN Protein misato homolog 1 OS=Homo sapiens GN=MSTO1 PE=1 SV=1 | 324 | T | 0.189256 | I | 0.111372 | 0.077884 | No Change: Both O | - |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 196 | R | 0.649257 | P | 0.634994 | 0.014263 | No Change: Both D | Tooth agenesis selective type 1 (STHAG1) [MIM:106600] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 61 | M | 0.858735 | K | 0.896926 | -0.038191 | No Change: Both D | Tooth agenesis selective type 1 (STHAG1) [MIM:106600] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 78 | E | 0.923418 | V | 0.883677 | 0.039741 | No Change: Both D | Non-syndromic orofacial cleft type 5 (OFC5) [MIM:608874] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 91 | G | 0.950574 | D | 0.948856 | 0.001718 | No Change: Both D | Non-syndromic orofacial cleft type 5 (OFC5) [MIM:608874] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 114 | V | 0.895276 | G | 0.931633 | -0.036357 | No Change: Both D | Non-syndromic orofacial cleft type 5 (OFC5) [MIM:608874] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 116 | G | 0.892231 | E | 0.909528 | -0.017297 | No Change: Both D | Non-syndromic orofacial cleft type 5 (OFC5) [MIM:608874] |
| P28360 | MSX1_HUMAN Homeobox protein MSX-1 OS=Homo sapiens GN=MSX1 PE=1 SV=2 | 151 | R | 0.981861 | S | 0.982645 | -7.84E-04 | No Change: Both D | Non-syndromic orofacial cleft type 5 (OFC5) [MIM:608874] |
| P35548 | MSX2_HUMAN Homeobox protein MSX-2 OS=Homo sapiens GN=MSX2 PE=1 SV=3 | 148 | P | 0.888246 | H | 0.852033 | 0.036213 | No Change: Both D | Craniosynostosis type 2 (CRS2) [MIM:604757] |
| P35548 | MSX2_HUMAN Homeobox protein MSX-2 OS=Homo sapiens GN=MSX2 PE=1 SV=3 | 172 | R | 0.614977 | H | 0.537587 | 0.07739 | No Change: Both D | Parietal foramina 1 (PFM1) [MIM:168500] |
| P35548 | MSX2_HUMAN Homeobox protein MSX-2 OS=Homo sapiens GN=MSX2 PE=1 SV=3 | 154 | L | 0.815452 | P | 0.872857 | -0.057405 | No Change: Both D | Parietal foramina 1 (PFM1) [MIM:168500] |
| P35548 | MSX2_HUMAN Homeobox protein MSX-2 OS=Homo sapiens GN=MSX2 PE=1 SV=3 | 129 | M | 0.918034 | T | 0.928607 | -0.010573 | No Change: Both D | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 59 | T | 0.568566 | A | 0.512656 | 0.05591 | No Change: Both D | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 156 | L | 0.09315 | R | 0.14906 | -0.05591 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 156 | L | 0.09315 | R | 0.14906 | -0.05591 | No Change: Both O | Neurogenic muscle weakness ataxia and retinitis pigmentosa (NARP) [MIM:551500] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 156 | L | 0.09315 | P | 0.175796 | -0.082646 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 192 | I | 0.023295 | T | 0.044822 | -0.021527 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 213 | V | 0.021008 | I | 0.017809 | 0.003199 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 217 | L | 0.039609 | P | 0.076378 | -0.036769 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 217 | L | 0.039609 | P | 0.076378 | -0.036769 | No Change: Both O | Mitochondrial infantile bilateral striatal necrosis (MIBSN) [MIM:500003] |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 33 | T | 0.18322 | S | 0.257657 | -0.074437 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 61 | H | 0.560282 | Y | 0.434103 | 0.126179 | D to O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 90 | H | 0.317872 | Y | 0.211235 | 0.106637 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 112 | T | 0.063279 | A | 0.058619 | 0.00466 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 155 | A | 0.094271 | T | 0.1069 | -0.012629 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 177 | A | 0.263911 | T | 0.297155 | -0.033244 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 219 | S | 0.102847 | G | 0.081059 | 0.021788 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 7 | A | 0.249326 | T | 0.268564 | -0.019238 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 11 | A | 0.081483 | T | 0.091458 | -0.009975 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 14 | I | 0.084042 | V | 0.093206 | -0.009164 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 16 | G | 0.071286 | S | 0.095347 | -0.024061 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 37 | L | 0.179842 | P | 0.310633 | -0.130791 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 53 | T | 0.35178 | I | 0.217477 | 0.134303 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 60 | M | 0.580961 | T | 0.630048 | -0.049087 | No Change: Both D | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 80 | A | 0.050635 | T | 0.07252 | -0.021885 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 117 | F | 0.155285 | L | 0.179741 | -0.024456 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 121 | I | 0.292574 | V | 0.320296 | -0.027722 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 133 | T | 0.36302 | A | 0.327838 | 0.035182 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 178 | T | 0.242422 | A | 0.221969 | 0.020453 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 182 | S | 0.30333 | L | 0.148492 | 0.154838 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 192 | I | 0.023295 | V | 0.023654 | -3.59E-04 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 193 | F | 0.018079 | L | 0.024101 | -0.006022 | No Change: Both O | - |
| P00846 | ATP6_HUMAN ATP synthase subunit a OS=Homo sapiens GN=MT-ATP6 PE=1 SV=1 | 204 | I | 0.026657 | T | 0.050498 | -0.023841 | No Change: Both O | - |
| P03928 | ATP8_HUMAN ATP synthase protein 8 OS=Homo sapiens GN=MT-ATP8 PE=1 SV=1 | 17 | L | 0.437911 | P | 0.610502 | -0.172591 | O to D | - |
| P03928 | ATP8_HUMAN ATP synthase protein 8 OS=Homo sapiens GN=MT-ATP8 PE=1 SV=1 | 21 | F | 0.458836 | S | 0.644951 | -0.186115 | O to D | - |
| P03928 | ATP8_HUMAN ATP synthase protein 8 OS=Homo sapiens GN=MT-ATP8 PE=1 SV=1 | 28 | M | 0.554322 | T | 0.565919 | -0.011597 | No Change: Both D | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 273 | M | 0.088726 | T | 0.0976 | -0.008874 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 280 | I | 0.035025 | T | 0.063758 | -0.028733 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 10 | T | 0.208002 | A | 0.183009 | 0.024993 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 94 | F | 0.337585 | C | 0.320843 | 0.016742 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 155 | V | 0.190362 | L | 0.207946 | -0.017584 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 224 | G | 0.383438 | A | 0.313792 | 0.069646 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 305 | F | 0.170223 | L | 0.190266 | -0.020043 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 235 | F | 0.028406 | S | 0.07276 | -0.044354 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 415 | T | 0.038357 | A | 0.033626 | 0.004731 | No Change: Both O | - |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 142 | S | 0.366054 | F | 0.164381 | 0.201673 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 196 | L | 0.046119 | I | 0.036534 | 0.009585 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 125 | G | 0.213658 | D | 0.216647 | -0.002989 | No Change: Both O | Colorectal cancer (CRC) [MIM:114500] |
| P00395 | COX1_HUMAN Cytochrome c oxidase subunit 1 OS=Homo sapiens GN=MT-CO1 PE=1 SV=1 | 458 | S | 0.170161 | P | 0.136691 | 0.03347 | No Change: Both O | Colorectal cancer (CRC) [MIM:114500] |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 142 | V | 0.129879 | M | 0.15738 | -0.027501 | No Change: Both O | Colorectal cancer |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 123 | L | 0.11606 | P | 0.224687 | -0.108627 | No Change: Both O | - |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 187 | T | 0.278951 | M | 0.215219 | 0.063732 | No Change: Both O | - |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 11 | D | 0.42071 | A | 0.349003 | 0.071707 | No Change: Both O | - |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 30 | I | 0.013884 | V | 0.014644 | -7.60E-04 | No Change: Both O | - |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 148 | A | 0.165654 | T | 0.194261 | -0.028607 | No Change: Both O | - |
| P00403 | COX2_HUMAN Cytochrome c oxidase subunit 2 OS=Homo sapiens GN=MT-CO2 PE=1 SV=1 | 29 | M | 0.019372 | K | 0.035181 | -0.015809 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 78 | G | 0.360881 | S | 0.392901 | -0.03202 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 200 | A | 0.129425 | T | 0.159934 | -0.030509 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 251 | F | 0.005107 | L | 0.006191 | -0.001084 | No Change: Both O | - |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 3 | H | 0.6987 | R | 0.673681 | 0.025019 | No Change: Both D | - |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 35 | F | 0.106217 | S | 0.258369 | -0.152152 | No Change: Both O | - |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 91 | V | 0.030994 | I | 0.029664 | 0.00133 | No Change: Both O | - |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 177 | Q | 0.159265 | R | 0.147149 | 0.012116 | No Change: Both O | - |
| P00414 | COX3_HUMAN Cytochrome c oxidase subunit 3 OS=Homo sapiens GN=MT-CO3 PE=1 SV=2 | 254 | V | 0.009779 | I | 0.008553 | 0.001226 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 171 | D | 0.270128 | N | 0.255272 | 0.014856 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 339 | G | 0.081613 | E | 0.096351 | -0.014738 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 356 | V | 0.038993 | M | 0.04882 | -0.009827 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 80 | R | 0.050425 | H | 0.054521 | -0.004096 | No Change: Both O | Colorectal cancer |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 276 | F | 0.01842 | L | 0.022339 | -0.003919 | No Change: Both O | Colorectal cancer |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 7 | I | 0.535932 | T | 0.652882 | -0.11695 | No Change: Both D | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 87 | A | 0.082777 | P | 0.111844 | -0.029067 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 191 | A | 0.034294 | T | 0.038641 | -0.004347 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 194 | T | 0.046604 | A | 0.044512 | 0.002092 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 229 | A | 0.101587 | T | 0.132594 | -0.031007 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 8 | N | 0.461143 | S | 0.502248 | -0.041105 | O to D | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 18 | F | 0.223587 | L | 0.269896 | -0.046309 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 34 | G | 0.055261 | S | 0.073036 | -0.017775 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 39 | A | 0.03463 | V | 0.023303 | 0.011327 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 78 | I | 0.039838 | T | 0.073632 | -0.033794 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 122 | A | 0.040701 | T | 0.046824 | -0.006123 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 123 | T | 0.046887 | A | 0.042606 | 0.004281 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 151 | S | 0.0845 | P | 0.079947 | 0.004553 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 153 | I | 0.090489 | T | 0.167664 | -0.077175 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 164 | I | 0.048724 | V | 0.06105 | -0.012326 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 166 | G | 0.075143 | E | 0.089855 | -0.014712 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 236 | L | 0.099265 | I | 0.072034 | 0.027231 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 251 | G | 0.432682 | D | 0.492425 | -0.059743 | No Change: Both O | Cardiomyopathy infantile histiocytoid (CMIH) [MIM:500000] |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 255 | N | 0.446252 | H | 0.404367 | 0.041885 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 278 | Y | 0.025332 | C | 0.018973 | 0.006359 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 290 | G | 0.171043 | D | 0.179039 | -0.007996 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 306 | I | 0.143706 | T | 0.223625 | -0.079919 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 316 | M | 0.580124 | T | 0.610966 | -0.030842 | No Change: Both D | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 329 | A | 0.028701 | T | 0.031964 | -0.003263 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 330 | A | 0.024897 | T | 0.028136 | -0.003239 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 334 | I | 0.023482 | V | 0.025719 | -0.002237 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 353 | V | 0.062606 | M | 0.078019 | -0.015413 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 360 | T | 0.026082 | A | 0.022011 | 0.004071 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 368 | T | 0.089036 | I | 0.050406 | 0.03863 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 39 | A | 0.03463 | T | 0.04251 | -0.00788 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 78 | I | 0.039838 | V | 0.045909 | -0.006071 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 260 | N | 0.475945 | D | 0.486667 | -0.010722 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 35 | S | 0.039829 | P | 0.034006 | 0.005823 | No Change: Both O | - |
| P00156 | CYB_HUMAN Cytochrome b OS=Homo sapiens GN=MT-CYB PE=1 SV=1 | 251 | G | 0.432682 | S | 0.510098 | -0.077416 | O to D | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 4 | A | 0.458912 | T | 0.491032 | -0.03212 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 30 | Y | 0.197248 | H | 0.298647 | -0.101399 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 31 | M | 0.198942 | T | 0.240387 | -0.041445 | No Change: Both O | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 31 | M | 0.198942 | V | 0.16002 | 0.038922 | No Change: Both O | Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 52 | A | 0.226148 | T | 0.254723 | -0.028575 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 277 | Y | 0.067664 | C | 0.049626 | 0.018038 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 285 | L | 0.081992 | P | 0.160631 | -0.078639 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 304 | Y | 0.041177 | H | 0.072431 | -0.031254 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 205 | S | 0.511968 | P | 0.470257 | 0.041711 | D to O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 255 | Y | 0.166347 | C | 0.124873 | 0.041474 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 288 | L | 0.054454 | P | 0.106814 | -0.05236 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 87 | T | 0.112639 | A | 0.100305 | 0.012334 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 168 | T | 0.161351 | A | 0.130648 | 0.030703 | No Change: Both O | - |
| P03886 | NU1M_HUMAN NADH-ubiquinone oxidoreductase chain 1 OS=Homo sapiens GN=MT-ND1 PE=1 SV=1 | 30 | Y | 0.197248 | C | 0.164987 | 0.032261 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 150 | N | 0.23265 | D | 0.24457 | -0.01192 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 259 | G | 0.156643 | S | 0.189931 | -0.033288 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 331 | A | 0.168446 | T | 0.270413 | -0.101967 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 331 | A | 0.168446 | S | 0.304846 | -0.1364 | No Change: Both O | Alzheimer disease mitochondrial (AD-MT) [MIM:502500] |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 42 | P | 0.108196 | L | 0.055139 | 0.053057 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 57 | I | 0.233548 | T | 0.392312 | -0.158764 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 63 | Q | 0.133839 | R | 0.125552 | 0.008287 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 119 | T | 0.275317 | A | 0.234217 | 0.0411 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 148 | S | 0.258248 | P | 0.230143 | 0.028105 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 150 | N | 0.23265 | S | 0.300549 | -0.067899 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 159 | I | 0.108313 | T | 0.192278 | -0.083965 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 185 | T | 0.141697 | A | 0.135571 | 0.006126 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 43 | V | 0.150066 | I | 0.141261 | 0.008805 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 69 | I | 0.101719 | V | 0.099422 | 0.002297 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 88 | N | 0.485954 | S | 0.536347 | -0.050393 | O to D | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 237 | L | 0.162575 | M | 0.178825 | -0.01625 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 265 | A | 0.087351 | T | 0.112732 | -0.025381 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 265 | A | 0.087351 | V | 0.059794 | 0.027557 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 278 | I | 0.130584 | T | 0.227515 | -0.096931 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 325 | F | 0.305991 | L | 0.354482 | -0.048491 | No Change: Both O | - |
| P03891 | NU2M_HUMAN NADH-ubiquinone oxidoreductase chain 2 OS=Homo sapiens GN=MT-ND2 PE=1 SV=2 | 333 | T | 0.178883 | A | 0.131535 | 0.047348 | No Change: Both O | - |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 10 | N | 0.029332 | D | 0.030715 | -0.001383 | No Change: Both O | - |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 114 | T | 0.822971 | A | 0.794169 | 0.028802 | No Change: Both D | - |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 53 | M | 0.118644 | V | 0.097129 | 0.021515 | No Change: Both O | - |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 45 | S | 0.423297 | P | 0.408727 | 0.01457 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 47 | A | 0.418355 | T | 0.457499 | -0.039144 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 47 | A | 0.418355 | T | 0.457499 | -0.039144 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03897 | NU3M_HUMAN NADH-ubiquinone oxidoreductase chain 3 OS=Homo sapiens GN=MT-ND3 PE=1 SV=1 | 34 | S | 0.512278 | P | 0.499123 | 0.013155 | D to O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 109 | T | 0.086933 | A | 0.073179 | 0.013754 | No Change: Both O | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 340 | R | 0.330346 | H | 0.334187 | -0.003841 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 313 | V | 0.053297 | I | 0.051095 | 0.002202 | No Change: Both O | Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 79 | A | 0.535195 | P | 0.692037 | -0.156842 | No Change: Both D | - |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 109 | T | 0.086933 | P | 0.100395 | -0.013462 | No Change: Both O | - |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 132 | I | 0.063201 | T | 0.120315 | -0.057114 | No Change: Both O | - |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 294 | M | 0.137186 | T | 0.176495 | -0.039309 | No Change: Both O | - |
| P03905 | NU4M_HUMAN NADH-ubiquinone oxidoreductase chain 4 OS=Homo sapiens GN=MT-ND4 PE=1 SV=1 | 420 | T | 0.321257 | A | 0.274438 | 0.046819 | No Change: Both O | - |
| P03901 | NU4LM_HUMAN NADH-ubiquinone oxidoreductase chain 4L OS=Homo sapiens GN=MT-ND4L PE=1 SV=1 | 65 | V | 0.032098 | A | 0.049707 | -0.017609 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03901 | NU4LM_HUMAN NADH-ubiquinone oxidoreductase chain 4L OS=Homo sapiens GN=MT-ND4L PE=1 SV=1 | 32 | C | 0.232382 | R | 0.403353 | -0.170971 | No Change: Both O | Colorectal cancer |
| P03901 | NU4LM_HUMAN NADH-ubiquinone oxidoreductase chain 4L OS=Homo sapiens GN=MT-ND4L PE=1 SV=1 | 36 | M | 0.110638 | I | 0.068321 | 0.042317 | No Change: Both O | - |
| P03901 | NU4LM_HUMAN NADH-ubiquinone oxidoreductase chain 4L OS=Homo sapiens GN=MT-ND4L PE=1 SV=1 | 57 | N | 0.104089 | S | 0.126913 | -0.022824 | No Change: Both O | - |
| P03901 | NU4LM_HUMAN NADH-ubiquinone oxidoreductase chain 4L OS=Homo sapiens GN=MT-ND4L PE=1 SV=1 | 61 | I | 0.038049 | T | 0.068158 | -0.030109 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 458 | A | 0.277073 | T | 0.313839 | -0.036766 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 465 | G | 0.15652 | E | 0.185782 | -0.029262 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 475 | A | 0.428913 | T | 0.482604 | -0.053691 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 17 | P | 0.408815 | S | 0.411439 | -0.002624 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 95 | F | 0.021815 | S | 0.062291 | -0.040476 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 99 | S | 0.030652 | P | 0.025787 | 0.004865 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 146 | G | 0.052823 | D | 0.054569 | -0.001746 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 160 | A | 0.067676 | V | 0.041471 | 0.026205 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 165 | N | 0.212975 | S | 0.252453 | -0.039478 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 304 | F | 0.267184 | S | 0.530106 | -0.262922 | O to D | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 331 | T | 0.047339 | A | 0.046135 | 0.001204 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 503 | D | 0.12177 | G | 0.115785 | 0.005985 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 211 | T | 0.306911 | P | 0.402353 | -0.095442 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 257 | I | 0.04498 | V | 0.052889 | -0.007909 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 314 | M | 0.141604 | V | 0.108564 | 0.03304 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 124 | F | 0.00808 | L | 0.009917 | -0.001837 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 124 | F | 0.00808 | L | 0.009917 | -0.001837 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 145 | E | 0.052504 | G | 0.045733 | 0.006771 | No Change: Both O | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 171 | A | 0.097424 | V | 0.060503 | 0.036921 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 236 | A | 0.504457 | T | 0.543756 | -0.039299 | No Change: Both D | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 237 | M | 0.518162 | L | 0.477174 | 0.040988 | D to O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 250 | S | 0.255732 | C | 0.100345 | 0.155387 | No Change: Both O | - |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 393 | D | 0.242273 | N | 0.239015 | 0.003258 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 393 | D | 0.242273 | N | 0.239015 | 0.003258 | No Change: Both O | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 253 | V | 0.11554 | A | 0.162157 | -0.046617 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03915 | NU5M_HUMAN NADH-ubiquinone oxidoreductase chain 5 OS=Homo sapiens GN=MT-ND5 PE=1 SV=2 | 447 | N | 0.523907 | S | 0.534626 | -0.010719 | No Change: Both D | - |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 64 | M | 0.046099 | V | 0.034873 | 0.011226 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 72 | A | 0.152237 | V | 0.107229 | 0.045008 | No Change: Both O | Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 72 | A | 0.152237 | V | 0.107229 | 0.045008 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 26 | I | 0.335116 | M | 0.420491 | -0.085375 | No Change: Both O | Leber hereditary optic neuropathy with dystonia (LDYT) [MIM:500001] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 36 | G | 0.035714 | S | 0.044437 | -0.008723 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 59 | Y | 0.028897 | C | 0.022369 | 0.006528 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 64 | M | 0.046099 | I | 0.028515 | 0.017584 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 165 | Y | 0.014695 | C | 0.011458 | 0.003237 | No Change: Both O | - |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 31 | V | 0.07775 | A | 0.100529 | -0.022779 | No Change: Both O | - |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 33 | I | 0.050146 | V | 0.062507 | -0.012361 | No Change: Both O | - |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 58 | I | 0.02672 | V | 0.034241 | -0.007521 | No Change: Both O | - |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 60 | L | 0.030216 | S | 0.068487 | -0.038271 | No Change: Both O | Leber hereditary optic neuropathy (LHON) [MIM:535000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 74 | A | 0.222516 | V | 0.153506 | 0.06901 | No Change: Both O | Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000] |
| P03923 | NU6M_HUMAN NADH-ubiquinone oxidoreductase chain 6 OS=Homo sapiens GN=MT-ND6 PE=1 SV=2 | 63 | M | 0.040045 | V | 0.030439 | 0.009606 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P04731 | MT1A_HUMAN Metallothionein-1A OS=Homo sapiens GN=MT1A PE=1 SV=2 | 51 | K | 0.994361 | R | 0.991284 | 0.003077 | No Change: Both D | - |
| P04731 | MT1A_HUMAN Metallothionein-1A OS=Homo sapiens GN=MT1A PE=1 SV=2 | 27 | T | 0.996736 | N | 0.996489 | 2.47E-04 | No Change: Both D | - |
| Q8N339 | MT1M_HUMAN Metallothionein-1M OS=Homo sapiens GN=MT1M PE=2 SV=2 | 20 | T | 0.986119 | K | 0.98906 | -0.002941 | No Change: Both D | - |
| P02795 | MT2_HUMAN Metallothionein-2 OS=Homo sapiens GN=MT2A PE=1 SV=1 | 42 | A | 0.988846 | V | 0.98377 | 0.005076 | No Change: Both D | - |
| P47944 | MT4_HUMAN Metallothionein-4 OS=Homo sapiens GN=MT4 PE=2 SV=2 | 30 | Y | 0.911209 | C | 0.957859 | -0.04665 | No Change: Both D | - |
| P47944 | MT4_HUMAN Metallothionein-4 OS=Homo sapiens GN=MT4 PE=2 SV=2 | 31 | W | 0.914253 | R | 0.962832 | -0.048579 | No Change: Both D | - |
| P47944 | MT4_HUMAN Metallothionein-4 OS=Homo sapiens GN=MT4 PE=2 SV=2 | 48 | G | 0.970934 | D | 0.971927 | -9.93E-04 | No Change: Both D | - |
| Q13330 | MTA1_HUMAN Metastasis-associated protein MTA1 OS=Homo sapiens GN=MTA1 PE=1 SV=2 | 372 | V | 0.598575 | I | 0.559622 | 0.038953 | No Change: Both D | - |
| Q13330 | MTA1_HUMAN Metastasis-associated protein MTA1 OS=Homo sapiens GN=MTA1 PE=1 SV=2 | 612 | A | 0.754135 | T | 0.767673 | -0.013538 | No Change: Both D | - |
| Q13126 | MTAP_HUMAN S-methyl-5'-thioadenosine phosphorylase OS=Homo sapiens GN=MTAP PE=1 SV=2 | 56 | V | 0.100979 | I | 0.087155 | 0.013824 | No Change: Both O | - |
| Q9Y6C9 | MTCH2_HUMAN Mitochondrial carrier homolog 2 OS=Homo sapiens GN=MTCH2 PE=1 SV=1 | 68 | R | 0.304485 | S | 0.370377 | -0.065892 | No Change: Both O | - |
| Q9Y6C9 | MTCH2_HUMAN Mitochondrial carrier homolog 2 OS=Homo sapiens GN=MTCH2 PE=1 SV=1 | 290 | P | 0.128052 | A | 0.088562 | 0.03949 | No Change: Both O | - |
| Q86UE4 | LYRIC_HUMAN Protein LYRIC OS=Homo sapiens GN=MTDH PE=1 SV=2 | 317 | T | 0.89926 | A | 0.897782 | 0.001478 | No Change: Both D | - |
| Q99551 | MTERF_HUMAN Transcription termination factor mitochondrial OS=Homo sapiens GN=MTERF PE=1 SV=1 | 294 | A | 0.364925 | T | 0.379893 | -0.014968 | No Change: Both O | - |
| Q99551 | MTERF_HUMAN Transcription termination factor mitochondrial OS=Homo sapiens GN=MTERF PE=1 SV=1 | 231 | A | 0.275046 | T | 0.296529 | -0.021483 | No Change: Both O | - |
| Q96E29 | MTER1_HUMAN mTERF domain-containing protein 1 mitochondrial OS=Homo sapiens GN=MTERFD1 PE=1 SV=2 | 396 | E | 0.156078 | G | 0.112194 | 0.043884 | No Change: Both O | - |
| Q7Z6M4 | MTER2_HUMAN mTERF domain-containing protein 2 OS=Homo sapiens GN=MTERFD2 PE=1 SV=3 | 45 | T | 0.454815 | A | 0.416827 | 0.037988 | No Change: Both O | - |
| Q7Z6M4 | MTER2_HUMAN mTERF domain-containing protein 2 OS=Homo sapiens GN=MTERFD2 PE=1 SV=3 | 189 | M | 0.188501 | T | 0.231231 | -0.04273 | No Change: Both O | - |
| Q7Z6M4 | MTER2_HUMAN mTERF domain-containing protein 2 OS=Homo sapiens GN=MTERFD2 PE=1 SV=3 | 339 | L | 0.997655 | V | 0.997528 | 1.27E-04 | No Change: Both D | - |
| Q7Z6M4 | MTER2_HUMAN mTERF domain-containing protein 2 OS=Homo sapiens GN=MTERFD2 PE=1 SV=3 | 347 | D | 0.999626 | E | 0.999645 | -1.90E-05 | No Change: Both D | - |
| Q7Z6M4 | MTER2_HUMAN mTERF domain-containing protein 2 OS=Homo sapiens GN=MTERFD2 PE=1 SV=3 | 378 | D | 0.999995 | E | 0.999995 | 0 | No Change: Both D | - |
| Q49AM1 | MTER3_HUMAN mTERF domain-containing protein 3 mitochondrial OS=Homo sapiens GN=MTERFD3 PE=1 SV=2 | 14 | L | 0.731999 | V | 0.650337 | 0.081662 | No Change: Both D | - |
| Q49AM1 | MTER3_HUMAN mTERF domain-containing protein 3 mitochondrial OS=Homo sapiens GN=MTERFD3 PE=1 SV=2 | 81 | A | 0.194436 | G | 0.24073 | -0.046294 | No Change: Both O | - |
| Q49AM1 | MTER3_HUMAN mTERF domain-containing protein 3 mitochondrial OS=Homo sapiens GN=MTERFD3 PE=1 SV=2 | 31 | A | 0.489433 | V | 0.465545 | 0.023888 | No Change: Both O | - |
| Q49AM1 | MTER3_HUMAN mTERF domain-containing protein 3 mitochondrial OS=Homo sapiens GN=MTERFD3 PE=1 SV=2 | 198 | V | 0.40804 | I | 0.379526 | 0.028514 | No Change: Both O | - |
| Q9Y483 | MTF2_HUMAN Metal-response element-binding transcription factor 2 OS=Homo sapiens GN=MTF2 PE=1 SV=2 | 140 | C | 0.267548 | S | 0.465725 | -0.198177 | No Change: Both O | - |
| Q96DP5 | FMT_HUMAN Methionyl-tRNA formyltransferase mitochondrial OS=Homo sapiens GN=MTFMT PE=2 SV=2 | 5 | V | 0.676438 | A | 0.77956 | -0.103122 | No Change: Both D | - |
| Q9BT17 | MTG1_HUMAN Mitochondrial GTPase 1 OS=Homo sapiens GN=MTG1 PE=1 SV=2 | 293 | I | 0.237615 | V | 0.265712 | -0.028097 | No Change: Both O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 293 | R | 0.426447 | H | 0.426731 | -2.84E-04 | No Change: Both O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 653 | R | 0.156927 | Q | 0.16893 | -0.012003 | No Change: Both O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 134 | R | 0.338918 | K | 0.373742 | -0.034824 | No Change: Both O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 761 | T | 0.400125 | M | 0.337443 | 0.062682 | No Change: Both O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 769 | L | 0.532305 | F | 0.478945 | 0.05336 | D to O | - |
| P11586 | C1TC_HUMAN C-1-tetrahydrofolate synthase cytoplasmic OS=Homo sapiens GN=MTHFD1 PE=1 SV=3 | 162 | P | 0.256245 | L | 0.144114 | 0.112131 | No Change: Both O | - |
| Q6UB35 | C1TM_HUMAN Monofunctional C1-tetrahydrofolate synthase mitochondrial OS=Homo sapiens GN=MTHFD1L PE=1 SV=1 | 444 | L | 0.156057 | R | 0.232941 | -0.076884 | No Change: Both O | A colorectal cancer sample |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 52 | R | 0.82916 | Q | 0.787125 | 0.042035 | No Change: Both D | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 157 | R | 0.232022 | Q | 0.257588 | -0.025566 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 227 | T | 0.063478 | M | 0.051245 | 0.012233 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 251 | P | 0.069493 | L | 0.029285 | 0.040208 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 325 | R | 0.283071 | C | 0.152939 | 0.130132 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 335 | R | 0.283338 | C | 0.163533 | 0.119805 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 357 | R | 0.638627 | C | 0.491008 | 0.147619 | D to O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 222 | A | 0.167506 | V | 0.121813 | 0.045693 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 428 | E | 0.518766 | A | 0.375789 | 0.142977 | D to O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 51 | R | 0.845248 | P | 0.845281 | -3.30E-05 | No Change: Both D | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 323 | L | 0.218283 | P | 0.357272 | -0.138989 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 324 | N | 0.265555 | S | 0.304675 | -0.03912 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 339 | W | 0.360293 | G | 0.581116 | -0.220823 | O to D | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 377 | R | 0.275694 | C | 0.142765 | 0.132929 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 387 | G | 0.456977 | D | 0.48162 | -0.024643 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 572 | P | 0.198879 | L | 0.093712 | 0.105167 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 586 | E | 0.063188 | K | 0.065176 | -0.001988 | No Change: Both O | Methylenetetrahydrofolate reductase deficiency (MTHFRD) [MIM:236250] |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 68 | R | 0.365399 | Q | 0.347285 | 0.018114 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 429 | E | 0.461133 | A | 0.319455 | 0.141678 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 422 | G | 0.51261 | R | 0.509249 | 0.003361 | No Change: Both D | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 519 | R | 0.34027 | C | 0.194234 | 0.146036 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 594 | R | 0.081447 | Q | 0.088527 | -0.00708 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 653 | T | 0.76893 | M | 0.754819 | 0.014111 | No Change: Both D | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 519 | R | 0.34027 | H | 0.351028 | -0.010758 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 566 | G | 0.117796 | E | 0.148379 | -0.030583 | No Change: Both O | - |
| P42898 | MTHR_HUMAN Methylenetetrahydrofolate reductase OS=Homo sapiens GN=MTHFR PE=1 SV=3 | 470 | E | 0.431987 | A | 0.32424 | 0.107747 | No Change: Both O | - |
| P49914 | MTHFS_HUMAN 5-formyltetrahydrofolate cyclo-ligase OS=Homo sapiens GN=MTHFS PE=1 SV=2 | 202 | T | 0.871962 | A | 0.853592 | 0.01837 | No Change: Both D | - |
| Q2M296 | MTHSD_HUMAN Methenyltetrahydrofolate synthase domain-containing protein OS=Homo sapiens GN=MTHFSD PE=1 SV=2 | 45 | L | 0.125356 | V | 0.124228 | 0.001128 | No Change: Both O | - |
| Q2M296 | MTHSD_HUMAN Methenyltetrahydrofolate synthase domain-containing protein OS=Homo sapiens GN=MTHFSD PE=1 SV=2 | 296 | S | 0.909907 | C | 0.860643 | 0.049264 | No Change: Both D | - |
| Q2M296 | MTHSD_HUMAN Methenyltetrahydrofolate synthase domain-containing protein OS=Homo sapiens GN=MTHFSD PE=1 SV=2 | 315 | G | 0.585034 | R | 0.614483 | -0.029449 | No Change: Both D | - |
| P46199 | IF2M_HUMAN Translation initiation factor IF-2 mitochondrial OS=Homo sapiens GN=MTIF2 PE=1 SV=2 | 556 | V | 0.329473 | I | 0.275129 | 0.054344 | No Change: Both O | - |
| P46199 | IF2M_HUMAN Translation initiation factor IF-2 mitochondrial OS=Homo sapiens GN=MTIF2 PE=1 SV=2 | 59 | T | 0.181853 | N | 0.187101 | -0.005248 | No Change: Both O | - |
| Q9H2K0 | IF3M_HUMAN Translation initiation factor IF-3 mitochondrial OS=Homo sapiens GN=MTIF3 PE=1 SV=4 | 68 | T | 0.773223 | I | 0.708819 | 0.064404 | No Change: Both D | - |
| Q9H2K0 | IF3M_HUMAN Translation initiation factor IF-3 mitochondrial OS=Homo sapiens GN=MTIF3 PE=1 SV=4 | 243 | F | 0.499555 | L | 0.542621 | -0.043066 | O to D | - |
| Q9Y4I5 | MTL5_HUMAN Tesmin OS=Homo sapiens GN=MTL5 PE=1 SV=2 | 223 | C | 0.353484 | R | 0.473069 | -0.119585 | No Change: Both O | - |
| Q9Y4I5 | MTL5_HUMAN Tesmin OS=Homo sapiens GN=MTL5 PE=1 SV=2 | 260 | V | 0.220824 | A | 0.302529 | -0.081705 | No Change: Both O | - |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 69 | R | 0.100546 | C | 0.043766 | 0.05678 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 70 | L | 0.113927 | F | 0.091728 | 0.022199 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 87 | L | 0.152532 | P | 0.263553 | -0.111021 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 184 | R | 0.085785 | G | 0.093321 | -0.007536 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 189 | N | 0.049706 | S | 0.059204 | -0.009498 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 198 | Y | 0.069843 | N | 0.120887 | -0.051044 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 205 | P | 0.180374 | L | 0.097068 | 0.083306 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 229 | S | 0.194682 | P | 0.195687 | -0.001005 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 241 | R | 0.202865 | C | 0.122012 | 0.080853 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 241 | R | 0.202865 | L | 0.12481 | 0.078055 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 317 | M | 0.305891 | R | 0.375887 | -0.069996 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 376 | S | 0.245975 | N | 0.196467 | 0.049508 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 378 | G | 0.281892 | R | 0.285517 | -0.003625 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 397 | Y | 0.15029 | C | 0.126223 | 0.024067 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 402 | G | 0.151698 | A | 0.118522 | 0.033176 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 404 | E | 0.122787 | K | 0.118929 | 0.003858 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 406 | L | 0.099541 | P | 0.184311 | -0.08477 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 421 | R | 0.538101 | Q | 0.557762 | -0.019661 | No Change: Both D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 431 | D | 0.614485 | N | 0.599924 | 0.014561 | No Change: Both D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 433 | D | 0.481482 | N | 0.462485 | 0.018997 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 469 | H | 0.031006 | P | 0.03797 | -0.006964 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 499 | W | 0.225774 | R | 0.471213 | -0.245439 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 179 | P | 0.335139 | S | 0.365004 | -0.029865 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 225 | I | 0.209458 | T | 0.327019 | -0.117561 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 264 | I | 0.357738 | S | 0.558206 | -0.200468 | O to D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 510 | K | 0.555773 | N | 0.517854 | 0.037919 | No Change: Both D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 49 | V | 0.099921 | F | 0.091848 | 0.008073 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 68 | Y | 0.092293 | D | 0.16444 | -0.072147 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 69 | R | 0.100546 | P | 0.109208 | -0.008662 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 69 | R | 0.100546 | S | 0.130513 | -0.029967 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 157 | E | 0.234946 | K | 0.235498 | -5.52E-04 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 180 | N | 0.267312 | K | 0.304095 | -0.036783 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 184 | R | 0.085785 | L | 0.0503 | 0.035485 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 186 | T | 0.059125 | I | 0.033667 | 0.025458 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 197 | T | 0.066533 | I | 0.035789 | 0.030744 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 199 | P | 0.065913 | S | 0.069281 | -0.003368 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 202 | L | 0.090533 | S | 0.193404 | -0.102871 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 226 | P | 0.206091 | T | 0.163405 | 0.042686 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 227 | V | 0.202748 | M | 0.253026 | -0.050278 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 228 | L | 0.195541 | P | 0.359406 | -0.163865 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 230 | W | 0.171169 | C | 0.239817 | -0.068648 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 232 | H | 0.199045 | R | 0.251366 | -0.052321 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 279 | A | 0.264712 | G | 0.298922 | -0.03421 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 346 | W | 0.241113 | C | 0.275765 | -0.034652 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 346 | W | 0.241113 | S | 0.502435 | -0.261322 | O to D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 364 | V | 0.596093 | G | 0.663318 | -0.067225 | No Change: Both D | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 374 | H | 0.273186 | D | 0.332589 | -0.059403 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 378 | G | 0.281892 | E | 0.331393 | -0.049501 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 389 | A | 0.185912 | D | 0.252705 | -0.066793 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 391 | L | 0.144105 | P | 0.238553 | -0.094448 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 402 | G | 0.151698 | R | 0.153236 | -0.001538 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 402 | G | 0.151698 | V | 0.089974 | 0.061724 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 411 | W | 0.133032 | C | 0.158086 | -0.025054 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 444 | C | 0.03455 | Y | 0.041045 | -0.006495 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 470 | L | 0.033593 | P | 0.06567 | -0.032077 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q13496 | MTM1_HUMAN Myotubularin OS=Homo sapiens GN=MTM1 PE=1 SV=2 | 481 | N | 0.180301 | Y | 0.103534 | 0.076767 | No Change: Both O | Centronuclear myopathy X-linked (XCNM) [MIM:310400] |
| Q9NXD2 | MTMRA_HUMAN Myotubularin-related protein 10 OS=Homo sapiens GN=MTMR10 PE=1 SV=3 | 648 | R | 0.222917 | H | 0.243559 | -0.020642 | No Change: Both O | - |
| A4FU01 | MTMRB_HUMAN Myotubularin-related protein 11 OS=Homo sapiens GN=MTMR11 PE=2 SV=2 | 159 | M | 0.240586 | V | 0.208492 | 0.032094 | No Change: Both O | - |
| A4FU01 | MTMRB_HUMAN Myotubularin-related protein 11 OS=Homo sapiens GN=MTMR11 PE=2 SV=2 | 531 | Q | 0.411904 | P | 0.442753 | -0.030849 | No Change: Both O | - |
| Q8NCE2 | MTMRE_HUMAN Myotubularin-related protein 14 OS=Homo sapiens GN=MTMR14 PE=1 SV=2 | 336 | R | 0.10798 | Q | 0.115828 | -0.007848 | No Change: Both O | - |
| Q8NCE2 | MTMRE_HUMAN Myotubularin-related protein 14 OS=Homo sapiens GN=MTMR14 PE=1 SV=2 | 462 | Y | 0.550861 | C | 0.619481 | -0.06862 | No Change: Both D | - |
| Q13614 | MTMR2_HUMAN Myotubularin-related protein 2 OS=Homo sapiens GN=MTMR2 PE=1 SV=4 | 3 | K | 0.995007 | T | 0.994103 | 9.04E-04 | No Change: Both D | - |
| Q13614 | MTMR2_HUMAN Myotubularin-related protein 2 OS=Homo sapiens GN=MTMR2 PE=1 SV=4 | 545 | N | 0.203804 | S | 0.251056 | -0.047252 | No Change: Both O | - |
| Q13614 | MTMR2_HUMAN Myotubularin-related protein 2 OS=Homo sapiens GN=MTMR2 PE=1 SV=4 | 283 | R | 0.468985 | W | 0.25814 | 0.210845 | No Change: Both O | Charcot-Marie-Tooth disease type 4B1 (CMT4B1) [MIM:601382] |
| Q13615 | MTMR3_HUMAN Myotubularin-related protein 3 OS=Homo sapiens GN=MTMR3 PE=1 SV=3 | 221 | V | 0.152193 | L | 0.150514 | 0.001679 | No Change: Both O | A breast cancer sample |
| Q9NYA4 | MTMR4_HUMAN Myotubularin-related protein 4 OS=Homo sapiens GN=MTMR4 PE=2 SV=2 | 170 | L | 0.136548 | V | 0.142873 | -0.006325 | No Change: Both O | - |
| Q9NYA4 | MTMR4_HUMAN Myotubularin-related protein 4 OS=Homo sapiens GN=MTMR4 PE=2 SV=2 | 280 | S | 0.757436 | G | 0.708217 | 0.049219 | No Change: Both D | - |
| Q9NYA4 | MTMR4_HUMAN Myotubularin-related protein 4 OS=Homo sapiens GN=MTMR4 PE=2 SV=2 | 297 | V | 0.578311 | G | 0.683801 | -0.10549 | No Change: Both D | - |
| Q9Y217 | MTMR6_HUMAN Myotubularin-related protein 6 OS=Homo sapiens GN=MTMR6 PE=1 SV=3 | 319 | I | 0.069622 | V | 0.080356 | -0.010734 | No Change: Both O | - |
| Q9Y217 | MTMR6_HUMAN Myotubularin-related protein 6 OS=Homo sapiens GN=MTMR6 PE=1 SV=3 | 131 | A | 0.222335 | T | 0.239648 | -0.017313 | No Change: Both O | - |
| Q9Y216 | MTMR7_HUMAN Myotubularin-related protein 7 OS=Homo sapiens GN=MTMR7 PE=1 SV=3 | 559 | Q | 0.935174 | H | 0.919377 | 0.015797 | No Change: Both D | - |
| Q9Y216 | MTMR7_HUMAN Myotubularin-related protein 7 OS=Homo sapiens GN=MTMR7 PE=1 SV=3 | 44 | P | 0.502931 | A | 0.413352 | 0.089579 | D to O | - |
| Q96EF0 | MTMR8_HUMAN Myotubularin-related protein 8 OS=Homo sapiens GN=MTMR8 PE=1 SV=1 | 127 | W | 0.423478 | R | 0.650875 | -0.227397 | O to D | A breast cancer sample |
| Q96EF0 | MTMR8_HUMAN Myotubularin-related protein 8 OS=Homo sapiens GN=MTMR8 PE=1 SV=1 | 454 | E | 0.328812 | K | 0.332336 | -0.003524 | No Change: Both O | A breast cancer sample |
| P48039 | MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens GN=MTNR1A PE=2 SV=1 | 54 | R | 0.252854 | W | 0.109026 | 0.143828 | No Change: Both O | - |
| P48039 | MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens GN=MTNR1A PE=2 SV=1 | 157 | A | 0.033847 | V | 0.02288 | 0.010967 | No Change: Both O | - |
| P48039 | MTR1A_HUMAN Melatonin receptor type 1A OS=Homo sapiens GN=MTNR1A PE=2 SV=1 | 212 | I | 0.008932 | T | 0.016148 | -0.007216 | No Change: Both O | - |
| P49286 | MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens GN=MTNR1B PE=2 SV=1 | 24 | G | 0.6916 | E | 0.709846 | -0.018246 | No Change: Both D | - |
| P49286 | MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens GN=MTNR1B PE=2 SV=1 | 66 | L | 0.158067 | F | 0.127123 | 0.030944 | No Change: Both O | - |
| P49286 | MTR1B_HUMAN Melatonin receptor type 1B OS=Homo sapiens GN=MTNR1B PE=2 SV=1 | 231 | R | 0.352834 | H | 0.338461 | 0.014373 | No Change: Both O | - |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 8 | A | 0.777885 | S | 0.839933 | -0.062048 | No Change: Both D | A lung large cell carcinoma sample |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 135 | M | 0.214692 | T | 0.261013 | -0.046321 | No Change: Both O | A metastatic melanoma sample |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 1083 | M | 0.289366 | V | 0.232437 | 0.056929 | No Change: Both O | - |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 1134 | A | 0.502816 | V | 0.412609 | 0.090207 | D to O | - |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 1178 | S | 0.273189 | F | 0.116367 | 0.156822 | No Change: Both O | - |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 2011 | M | 0.252223 | V | 0.202584 | 0.049639 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 2215 | S | 0.499775 | Y | 0.297688 | 0.202087 | No Change: Both O | A colorectal adenocarcinoma sample |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 2476 | P | 0.539193 | L | 0.38546 | 0.153733 | D to O | A glioblastoma multiforme sample |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 2220 | L | 0.348269 | F | 0.307833 | 0.040436 | No Change: Both O | - |
| P42345 | MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens GN=MTOR PE=1 SV=1 | 2406 | V | 0.330995 | A | 0.388139 | -0.057144 | No Change: Both O | - |
| Q9NVV4 | PAPD1_HUMAN Poly(A) RNA polymerase mitochondrial OS=Homo sapiens GN=MTPAP PE=1 SV=1 | 162 | R | 0.85321 | C | 0.771558 | 0.081652 | No Change: Both D | - |
| Q9NVV4 | PAPD1_HUMAN Poly(A) RNA polymerase mitochondrial OS=Homo sapiens GN=MTPAP PE=1 SV=1 | 221 | Y | 0.079528 | H | 0.129554 | -0.050026 | No Change: Both O | - |
| Q9NVV4 | PAPD1_HUMAN Poly(A) RNA polymerase mitochondrial OS=Homo sapiens GN=MTPAP PE=1 SV=1 | 419 | C | 0.212341 | R | 0.322903 | -0.110562 | No Change: Both O | - |
| Q9NVV4 | PAPD1_HUMAN Poly(A) RNA polymerase mitochondrial OS=Homo sapiens GN=MTPAP PE=1 SV=1 | 546 | S | 0.820543 | N | 0.796967 | 0.023576 | No Change: Both D | - |
| Q9NVV4 | PAPD1_HUMAN Poly(A) RNA polymerase mitochondrial OS=Homo sapiens GN=MTPAP PE=1 SV=1 | 478 | N | 0.555822 | D | 0.560945 | -0.005123 | No Change: Both D | Spastic ataxia autosomal recessive type 4 (SPAX4) [MIM:613672] |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 61 | R | 0.505084 | K | 0.578938 | -0.073854 | No Change: Both D | - |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 255 | C | 0.140345 | Y | 0.159116 | -0.018771 | No Change: Both O | - |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 919 | D | 0.629447 | G | 0.564181 | 0.065266 | No Change: Both D | - |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 920 | H | 0.636266 | D | 0.713683 | -0.077417 | No Change: Both D | Methylcobalamin deficiency type G (cblG) [MIM:250940] |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 1173 | P | 0.499723 | L | 0.329577 | 0.170146 | No Change: Both O | Methylcobalamin deficiency type G (cblG) [MIM:250940] |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 52 | R | 0.588351 | Q | 0.615016 | -0.026665 | No Change: Both D | - |
| Q99707 | METH_HUMAN Methionine synthase OS=Homo sapiens GN=MTR PE=1 SV=2 | 314 | D | 0.171011 | N | 0.158617 | 0.012394 | No Change: Both O | - |
| O75570 | RF1M_HUMAN Peptide chain release factor 1 mitochondrial OS=Homo sapiens GN=MTRF1 PE=1 SV=2 | 2 | N | 0.442898 | S | 0.48537 | -0.042472 | No Change: Both O | - |
| O75570 | RF1M_HUMAN Peptide chain release factor 1 mitochondrial OS=Homo sapiens GN=MTRF1 PE=1 SV=2 | 324 | L | 0.181898 | V | 0.195546 | -0.013648 | No Change: Both O | - |
| O75570 | RF1M_HUMAN Peptide chain release factor 1 mitochondrial OS=Homo sapiens GN=MTRF1 PE=1 SV=2 | 407 | I | 0.181175 | V | 0.200937 | -0.019762 | No Change: Both O | - |
| Q9UGC7 | RF1ML_HUMAN Peptide chain release factor 1-like mitochondrial OS=Homo sapiens GN=MTRF1L PE=1 SV=1 | 38 | T | 0.738968 | A | 0.733972 | 0.004996 | No Change: Both D | - |
| Q9UGC7 | RF1ML_HUMAN Peptide chain release factor 1-like mitochondrial OS=Homo sapiens GN=MTRF1L PE=1 SV=1 | 76 | R | 0.829009 | Q | 0.810295 | 0.018714 | No Change: Both D | - |
| Q9UGC7 | RF1ML_HUMAN Peptide chain release factor 1-like mitochondrial OS=Homo sapiens GN=MTRF1L PE=1 SV=1 | 177 | L | 0.483518 | F | 0.446938 | 0.03658 | No Change: Both O | - |
| Q9UGC7 | RF1ML_HUMAN Peptide chain release factor 1-like mitochondrial OS=Homo sapiens GN=MTRF1L PE=1 SV=1 | 214 | V | 0.570874 | I | 0.53449 | 0.036384 | No Change: Both D | - |
| P0CJ72 | HMN5_HUMAN Humanin-like protein 5 OS=Homo sapiens GN=MTRNR2L5 PE=2 SV=1 | 13 | T | 0.454027 | I | 0.271344 | 0.182683 | No Change: Both O | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 49 | I | 0.2489 | M | 0.317541 | -0.068641 | No Change: Both O | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 83 | V | 0.252434 | M | 0.284305 | -0.031871 | No Change: Both O | Methylcobalamin deficiency type E (cblE) [MIM:236270] |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 156 | A | 0.294759 | T | 0.336625 | -0.041866 | No Change: Both O | Methylcobalamin deficiency type E (cblE) [MIM:236270] |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 360 | L | 0.528206 | V | 0.504176 | 0.02403 | No Change: Both D | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 432 | C | 0.487855 | R | 0.638341 | -0.150486 | O to D | Methylcobalamin deficiency type E (cblE) [MIM:236270] |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 514 | G | 0.114028 | R | 0.10981 | 0.004218 | No Change: Both O | Methylcobalamin deficiency type E (cblE) [MIM:236270] |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 622 | H | 0.224319 | Y | 0.134252 | 0.090067 | No Change: Both O | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 581 | G | 0.147923 | R | 0.149072 | -0.001149 | No Change: Both O | Methylcobalamin deficiency type E (cblE) [MIM:236270] |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 202 | S | 0.701361 | L | 0.561465 | 0.139896 | No Change: Both D | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 284 | S | 0.725085 | T | 0.655888 | 0.069197 | No Change: Both D | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 377 | K | 0.609328 | R | 0.546128 | 0.0632 | No Change: Both D | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 442 | R | 0.358976 | C | 0.263409 | 0.095567 | No Change: Both O | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 477 | P | 0.584613 | R | 0.53235 | 0.052263 | No Change: Both D | - |
| Q9UBK8 | MTRR_HUMAN Methionine synthase reductase OS=Homo sapiens GN=MTRR PE=1 SV=3 | 542 | A | 0.638078 | V | 0.557655 | 0.080423 | No Change: Both D | - |
| O43312 | MTSS1_HUMAN Metastasis suppressor protein 1 OS=Homo sapiens GN=MTSS1 PE=1 SV=2 | 305 | N | 0.972338 | I | 0.96258 | 0.009758 | No Change: Both D | - |
| O43312 | MTSS1_HUMAN Metastasis suppressor protein 1 OS=Homo sapiens GN=MTSS1 PE=1 SV=2 | 725 | T | 0.920902 | A | 0.911534 | 0.009368 | No Change: Both D | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 297 | H | 0.281395 | Q | 0.321525 | -0.04013 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 384 | D | 0.362806 | A | 0.268853 | 0.093953 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 540 | R | 0.324683 | H | 0.336672 | -0.011989 | No Change: Both O | Abetalipoproteinemia (ABL) [MIM:200100] |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 590 | S | 0.261109 | I | 0.12032 | 0.140789 | No Change: Both O | Abetalipoproteinemia (ABL) [MIM:200100] |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 746 | G | 0.417888 | E | 0.485841 | -0.067953 | No Change: Both O | Abetalipoproteinemia (ABL) [MIM:200100] |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 95 | Q | 0.645922 | H | 0.589859 | 0.056063 | No Change: Both D | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 128 | I | 0.187713 | T | 0.298706 | -0.110993 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 244 | Q | 0.174984 | E | 0.205962 | -0.030978 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 780 | N | 0.37125 | Y | 0.25152 | 0.11973 | No Change: Both O | Abetalipoproteinemia (ABL) [MIM:200100] |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 354 | E | 0.39073 | Q | 0.354763 | 0.035967 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 168 | V | 0.495174 | I | 0.475152 | 0.020022 | No Change: Both O | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 98 | E | 0.689679 | D | 0.663505 | 0.026174 | No Change: Both D | - |
| P55157 | MTP_HUMAN Microsomal triglyceride transfer protein large subunit OS=Homo sapiens GN=MTTP PE=1 SV=1 | 166 | N | 0.57895 | S | 0.625516 | -0.046566 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 75 | Q | 0.3154 | K | 0.359881 | -0.044481 | No Change: Both O | Hepatocellular carcinoma (HCC) [MIM:114550] |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 148 | C | 0.150754 | R | 0.256412 | -0.105658 | No Change: Both O | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 186 | T | 0.664099 | S | 0.714022 | -0.049923 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 425 | T | 0.53671 | M | 0.513634 | 0.023076 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 453 | K | 0.842555 | T | 0.807626 | 0.034929 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 563 | A | 0.773557 | S | 0.828979 | -0.055422 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 575 | H | 0.613454 | R | 0.650118 | -0.036664 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 873 | N | 0.731784 | H | 0.697472 | 0.034312 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 911 | K | 0.558297 | T | 0.502116 | 0.056181 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 1063 | K | 0.921963 | T | 0.889765 | 0.032198 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 1105 | E | 0.982551 | Q | 0.979969 | 0.002582 | No Change: Both D | - |
| Q9ULD2 | MTUS1_HUMAN Microtubule-associated tumor suppressor 1 OS=Homo sapiens GN=MTUS1 PE=1 SV=2 | 1201 | Q | 0.849543 | R | 0.844426 | 0.005117 | No Change: Both D | Hepatocellular carcinoma (HCC) [MIM:114550] |
| Q5JR59 | MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens GN=MTUS2 PE=1 SV=3 | 955 | P | 0.96437 | H | 0.947577 | 0.016793 | No Change: Both D | - |
| Q5JR59 | MTUS2_HUMAN Microtubule-associated tumor suppressor candidate 2 OS=Homo sapiens GN=MTUS2 PE=1 SV=3 | 1071 | L | 0.835141 | Q | 0.883023 | -0.047882 | No Change: Both D | - |
| Q13505 | MTX1_HUMAN Metaxin-1 OS=Homo sapiens GN=MTX1 PE=1 SV=2 | 63 | T | 0.946571 | S | 0.955967 | -0.009396 | No Change: Both D | - |
| Q5HYI7 | MTX3_HUMAN Metaxin-3 OS=Homo sapiens GN=MTX3 PE=1 SV=2 | 238 | S | 0.136969 | R | 0.105885 | 0.031084 | No Change: Both O | - |
| P15941 | MUC1_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=3 | 1117 | V | 0.310488 | M | 0.358263 | -0.047775 | No Change: Both O | - |
| P15941 | MUC1_HUMAN Mucin-1 OS=Homo sapiens GN=MUC1 PE=1 SV=3 | 1142 | S | 0.413427 | N | 0.343706 | 0.069721 | No Change: Both O | - |
| Q9UKN1 | MUC12_HUMAN Mucin-12 OS=Homo sapiens GN=MUC12 PE=1 SV=2 | 4775 | T | 0.997442 | R | 0.997415 | 2.70E-05 | No Change: Both D | - |
| Q9H3R2 | MUC13_HUMAN Mucin-13 OS=Homo sapiens GN=MUC13 PE=1 SV=2 | 18 | A | 0.483077 | V | 0.412322 | 0.070755 | No Change: Both O | - |
| Q9H3R2 | MUC13_HUMAN Mucin-13 OS=Homo sapiens GN=MUC13 PE=1 SV=2 | 363 | S | 0.807272 | G | 0.759494 | 0.047778 | No Change: Both D | - |
| Q9H3R2 | MUC13_HUMAN Mucin-13 OS=Homo sapiens GN=MUC13 PE=1 SV=2 | 502 | R | 0.867656 | S | 0.887593 | -0.019937 | No Change: Both D | - |
| Q9H3R2 | MUC13_HUMAN Mucin-13 OS=Homo sapiens GN=MUC13 PE=1 SV=2 | 99 | I | 0.969963 | T | 0.98059 | -0.010627 | No Change: Both D | - |
| Q8N387 | MUC15_HUMAN Mucin-15 OS=Homo sapiens GN=MUC15 PE=2 SV=2 | 184 | I | 0.763991 | T | 0.866468 | -0.102477 | No Change: Both D | - |
| Q8N387 | MUC15_HUMAN Mucin-15 OS=Homo sapiens GN=MUC15 PE=2 SV=2 | 202 | T | 0.785128 | I | 0.667494 | 0.117634 | No Change: Both D | - |
| Q8N387 | MUC15_HUMAN Mucin-15 OS=Homo sapiens GN=MUC15 PE=2 SV=2 | 19 | S | 0.461541 | W | 0.193717 | 0.267824 | No Change: Both O | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 227 | K | 0.958991 | Q | 0.959674 | -6.83E-04 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 272 | G | 0.970906 | E | 0.975395 | -0.004489 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 942 | R | 0.994383 | S | 0.996506 | -0.002123 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 982 | T | 0.991622 | M | 0.98792 | 0.003702 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1130 | I | 0.989108 | T | 0.994917 | -0.005809 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1242 | S | 0.996199 | T | 0.995465 | 7.34E-04 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1246 | T | 0.996675 | N | 0.995162 | 0.001513 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1246 | T | 0.996675 | S | 0.99728 | -6.05E-04 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1249 | P | 0.996956 | A | 0.995463 | 0.001493 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1348 | L | 0.89669 | P | 0.942447 | -0.045757 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1375 | C | 0.98718 | R | 0.989412 | -0.002232 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 4334 | D | 0.34981 | N | 0.326221 | 0.023589 | No Change: Both O | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 4482 | R | 0.539932 | Q | 0.563084 | -0.023152 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 427 | A | 0.978958 | T | 0.983496 | -0.004538 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 571 | P | 0.991639 | L | 0.984658 | 0.006981 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 925 | P | 0.996722 | R | 0.995669 | 0.001053 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 1480 | V | 0.983262 | A | 0.986121 | -0.002859 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 2096 | A | 0.985918 | T | 0.988729 | -0.002811 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 2159 | R | 0.974532 | G | 0.969044 | 0.005488 | No Change: Both D | - |
| Q685J3 | MUC17_HUMAN Mucin-17 OS=Homo sapiens GN=MUC17 PE=1 SV=2 | 3299 | S | 0.995891 | N | 0.992779 | 0.003112 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 58 | L | 0.096411 | P | 0.203749 | -0.107338 | No Change: Both O | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 116 | V | 0.295008 | M | 0.333099 | -0.038091 | No Change: Both O | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 832 | G | 0.404499 | S | 0.469653 | -0.065154 | No Change: Both O | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 1619 | S | 0.999997 | R | 0.999996 | 1.00E-06 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 1689 | P | 0.999991 | L | 0.999976 | 1.50E-05 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 2154 | I | 0.99993 | T | 0.999968 | -3.80E-05 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 2524 | T | 0.999931 | P | 0.999938 | -7.00E-06 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 2524 | T | 0.999931 | S | 0.999902 | 2.90E-05 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 2653 | Q | 0.999935 | L | 0.999882 | 5.30E-05 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 2653 | Q | 0.999935 | P | 0.999954 | -1.90E-05 | No Change: Both D | - |
| Q02817 | MUC2_HUMAN Mucin-2 OS=Homo sapiens GN=MUC2 PE=1 SV=2 | 1768 | P | 0.97505 | H | 0.958782 | 0.016268 | No Change: Both D | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 3 | C | 0.308793 | S | 0.576077 | -0.267284 | O to D | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 18 | V | 0.157069 | G | 0.256433 | -0.099364 | No Change: Both O | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 442 | T | 0.806066 | I | 0.729263 | 0.076803 | No Change: Both D | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 590 | P | 0.955985 | L | 0.915337 | 0.040648 | No Change: Both D | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 666 | R | 0.610847 | W | 0.363313 | 0.247534 | D to O | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 671 | S | 0.631166 | C | 0.462415 | 0.168751 | D to O | - |
| Q8N307 | MUC20_HUMAN Mucin-20 OS=Homo sapiens GN=MUC20 PE=1 SV=3 | 514 | G | 0.881206 | R | 0.895734 | -0.014528 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 139 | D | 0.999867 | E | 0.999885 | -1.80E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 161 | E | 0.999879 | G | 0.999856 | 2.30E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 244 | E | 0.9997 | D | 0.999603 | 9.70E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 253 | G | 0.999535 | S | 0.999682 | -1.47E-04 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 285 | V | 0.998922 | A | 0.999246 | -3.24E-04 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 289 | E | 0.999011 | D | 0.998737 | 2.74E-04 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 313 | N | 0.999643 | S | 0.999736 | -9.30E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 315 | A | 0.999706 | V | 0.999537 | 1.69E-04 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 319 | D | 0.999795 | E | 0.999846 | -5.10E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 323 | T | 0.999817 | P | 0.999787 | 3.00E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 328 | S | 0.999843 | N | 0.999789 | 5.40E-05 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 98 | V | 0.983394 | A | 0.986601 | -0.003207 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 282 | I | 0.998867 | T | 0.999499 | -6.32E-04 | No Change: Both D | - |
| Q5SSG8 | MUC21_HUMAN Mucin-21 OS=Homo sapiens GN=MUC21 PE=1 SV=2 | 282 | I | 0.998867 | V | 0.999157 | -2.90E-04 | No Change: Both D | - |
| E2RYF6 | MUC22_HUMAN Mucin-22 OS=Homo sapiens GN=MUC22 PE=1 SV=1 | 1712 | N | 0.441153 | D | 0.473321 | -0.032168 | No Change: Both O | - |
| Q9H195 | MUC3B_HUMAN Mucin-3B (Fragment) OS=Homo sapiens GN=MUC3B PE=2 SV=1 | 698 | A | 0.819821 | V | 0.776512 | 0.043309 | No Change: Both D | - |
| Q9H195 | MUC3B_HUMAN Mucin-3B (Fragment) OS=Homo sapiens GN=MUC3B PE=2 SV=1 | 877 | H | 0.345421 | Y | 0.221328 | 0.124093 | No Change: Both O | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 37 | G | 0.63902 | D | 0.658658 | -0.019638 | No Change: Both D | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 161 | T | 0.979391 | A | 0.972156 | 0.007235 | No Change: Both D | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 585 | S | 0.843192 | A | 0.777609 | 0.065583 | No Change: Both D | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 721 | A | 0.941684 | T | 0.949757 | -0.008073 | No Change: Both D | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 1205 | A | 0.084455 | T | 0.095352 | -0.010897 | No Change: Both O | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 1578 | A | 0.349153 | S | 0.452555 | -0.103402 | No Change: Both O | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 41 | A | 0.743811 | P | 0.807756 | -0.063945 | No Change: Both D | - |
| Q99102 | MUC4_HUMAN Mucin-4 OS=Homo sapiens GN=MUC4 PE=1 SV=4 | 1081 | G | 0.298408 | D | 0.316827 | -0.018419 | No Change: Both O | - |
| P98088 | MUC5A_HUMAN Mucin-5AC (Fragments) OS=Homo sapiens GN=MUC5AC PE=1 SV=3 | 4897 | L | 0.674063 | P | 0.812527 | -0.138464 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 5196 | S | 0.132349 | T | 0.103647 | 0.028702 | No Change: Both O | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 51 | R | 0.795403 | W | 0.634144 | 0.161259 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 1360 | T | 0.417651 | M | 0.378562 | 0.039089 | No Change: Both O | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 1401 | R | 0.603695 | H | 0.535558 | 0.068137 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2027 | A | 0.992545 | T | 0.994336 | -0.001791 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2559 | T | 0.987209 | M | 0.983579 | 0.00363 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 34 | E | 0.672517 | G | 0.641426 | 0.031091 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 1805 | G | 0.430399 | S | 0.466833 | -0.036434 | No Change: Both O | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 1889 | P | 0.76681 | L | 0.670207 | 0.096603 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2025 | A | 0.992647 | T | 0.994434 | -0.001787 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2194 | M | 0.962361 | T | 0.9738 | -0.011439 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2238 | L | 0.946625 | P | 0.969376 | -0.022751 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 2425 | M | 0.753638 | T | 0.77833 | -0.024692 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 3072 | F | 0.972009 | S | 0.986099 | -0.01409 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 3284 | T | 0.994706 | A | 0.992627 | 0.002079 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 3468 | R | 0.938534 | P | 0.954949 | -0.016415 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 3816 | T | 0.990261 | M | 0.987556 | 0.002705 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4404 | A | 0.980623 | G | 0.981361 | -7.38E-04 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4440 | P | 0.987685 | L | 0.977747 | 0.009938 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4706 | T | 0.996675 | P | 0.997071 | -3.96E-04 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4712 | T | 0.996263 | M | 0.994378 | 0.001885 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4867 | A | 0.902819 | T | 0.923721 | -0.020902 | No Change: Both D | - |
| Q9HC84 | MUC5B_HUMAN Mucin-5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 | 4882 | T | 0.964213 | A | 0.955784 | 0.008429 | No Change: Both D | - |
| Q6W4X9 | MUC6_HUMAN Mucin-6 OS=Homo sapiens GN=MUC6 PE=1 SV=3 | 1578 | P | 0.998676 | S | 0.998616 | 6.00E-05 | No Change: Both D | - |
| Q6W4X9 | MUC6_HUMAN Mucin-6 OS=Homo sapiens GN=MUC6 PE=1 SV=3 | 1794 | P | 0.993426 | T | 0.992619 | 8.07E-04 | No Change: Both D | - |
| Q8TAX7 | MUC7_HUMAN Mucin-7 OS=Homo sapiens GN=MUC7 PE=1 SV=2 | 80 | N | 0.987389 | K | 0.989829 | -0.00244 | No Change: Both D | - |
| Q9H0R1 | MUDEN_HUMAN MHD domain-containing death-inducing protein OS=Homo sapiens GN=MUDENG PE=2 SV=2 | 226 | G | 0.334002 | R | 0.317053 | 0.016949 | No Change: Both O | - |
| Q9H0R1 | MUDEN_HUMAN MHD domain-containing death-inducing protein OS=Homo sapiens GN=MUDENG PE=2 SV=2 | 379 | E | 0.278792 | D | 0.241041 | 0.037751 | No Change: Both O | - |
| Q2TAK8 | MUM1_HUMAN PWWP domain-containing protein MUM1 OS=Homo sapiens GN=MUM1 PE=1 SV=3 | 219 | G | 0.790172 | R | 0.800283 | -0.010111 | No Change: Both D | - |
| Q2TAK8 | MUM1_HUMAN PWWP domain-containing protein MUM1 OS=Homo sapiens GN=MUM1 PE=1 SV=3 | 551 | G | 0.812553 | A | 0.787812 | 0.024741 | No Change: Both D | - |
| Q5H9M0 | MUML1_HUMAN PWWP domain-containing protein MUM1L1 OS=Homo sapiens GN=MUM1L1 PE=2 SV=1 | 95 | G | 0.596849 | D | 0.631645 | -0.034796 | No Change: Both D | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 189 | L | 0.578729 | F | 0.479777 | 0.098952 | D to O | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 37 | R | 0.609736 | H | 0.504887 | 0.104849 | No Change: Both D | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 481 | Q | 0.273427 | H | 0.234974 | 0.038453 | No Change: Both O | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 180 | R | 0.621196 | P | 0.659581 | -0.038385 | No Change: Both D | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 350 | R | 0.410605 | W | 0.175279 | 0.235326 | No Change: Both O | - |
| Q96NY9 | MUS81_HUMAN Crossover junction endonuclease MUS81 OS=Homo sapiens GN=MUS81 PE=1 SV=3 | 115 | S | 0.816033 | F | 0.687365 | 0.128668 | No Change: Both D | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 413 | M | 0.284724 | I | 0.202683 | 0.082041 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 790 | V | 0.019006 | M | 0.023319 | -0.004313 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 829 | V | 0.165537 | L | 0.182667 | -0.01713 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 27 | A | 0.442087 | G | 0.508267 | -0.06618 | O to D | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 100 | T | 0.142089 | M | 0.119008 | 0.023081 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 107 | G | 0.3534 | E | 0.393551 | -0.040151 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 159 | S | 0.532159 | G | 0.468982 | 0.063177 | D to O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 222 | N | 0.360212 | S | 0.428039 | -0.067827 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 629 | L | 0.301131 | F | 0.293459 | 0.007672 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 644 | V | 0.074376 | A | 0.105572 | -0.031196 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 664 | N | 0.320777 | S | 0.389407 | -0.06863 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 696 | P | 0.698638 | L | 0.565707 | 0.132931 | No Change: Both D | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 782 | E | 0.220796 | D | 0.212505 | 0.008291 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 819 | N | 0.13718 | S | 0.166265 | -0.029085 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 858 | R | 0.304277 | H | 0.284408 | 0.019869 | No Change: Both O | - |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 605 | M | 0.206547 | I | 0.120056 | 0.086491 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| O15146 | MUSK_HUMAN Muscle skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | 727 | A | 0.175289 | V | 0.137568 | 0.037721 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 93 | R | 0.439746 | H | 0.408303 | 0.031443 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 105 | W | 0.168554 | R | 0.379259 | -0.210705 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 191 | A | 0.176972 | E | 0.254049 | -0.077077 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 228 | R | 0.136026 | Q | 0.159835 | -0.023809 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 231 | Y | 0.206666 | N | 0.347077 | -0.140411 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 312 | G | 0.046639 | V | 0.022363 | 0.024276 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 368 | V | 0.184347 | D | 0.312939 | -0.128592 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 369 | R | 0.163406 | H | 0.165205 | -0.001799 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 377 | A | 0.171046 | E | 0.244908 | -0.073862 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 532 | R | 0.410449 | H | 0.327661 | 0.082788 | No Change: Both O | - |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 623 | G | 0.526075 | R | 0.532085 | -0.00601 | No Change: Both D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 626 | G | 0.538993 | C | 0.378594 | 0.160399 | D to O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 630 | G | 0.45063 | E | 0.466905 | -0.016275 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 633 | V | 0.330336 | G | 0.460114 | -0.129778 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 648 | G | 0.184673 | D | 0.213512 | -0.028839 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 669 | V | 0.215424 | E | 0.36711 | -0.151686 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 671 | I | 0.270206 | V | 0.321629 | -0.051423 | No Change: Both O | - |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 678 | H | 0.272917 | R | 0.269969 | 0.002948 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 685 | L | 0.331679 | R | 0.441286 | -0.109607 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 694 | R | 0.209157 | W | 0.08854 | 0.120617 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 703 | G | 0.095925 | R | 0.086526 | 0.009399 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 717 | G | 0.138841 | V | 0.084228 | 0.054613 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 94 | G | 0.428303 | V | 0.313753 | 0.11455 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 108 | R | 0.13604 | H | 0.114241 | 0.021799 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 137 | A | 0.241523 | V | 0.176577 | 0.064946 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 148 | S | 0.622035 | L | 0.47784 | 0.144195 | D to O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 156 | D | 0.406891 | N | 0.389036 | 0.017855 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 158 | G | 0.289695 | V | 0.191664 | 0.098031 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 174 | F | 0.176083 | S | 0.367249 | -0.191166 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 203 | G | 0.328798 | R | 0.303183 | 0.025615 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 215 | G | 0.351154 | S | 0.393301 | -0.042147 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 218 | Q | 0.262891 | H | 0.245505 | 0.017386 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 219 | N | 0.237935 | Y | 0.136449 | 0.101486 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 262 | S | 0.386489 | N | 0.334633 | 0.051856 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 293 | Q | 0.26317 | P | 0.280642 | -0.017472 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 328 | L | 0.132086 | F | 0.111165 | 0.020921 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 499 | A | 0.418301 | T | 0.428574 | -0.010273 | No Change: Both O | - |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 535 | A | 0.376635 | P | 0.393495 | -0.01686 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 587 | Y | 0.484612 | C | 0.534418 | -0.049806 | O to D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 615 | P | 0.486573 | T | 0.442972 | 0.043601 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 621 | K | 0.470856 | N | 0.410159 | 0.060697 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 624 | Q | 0.539229 | R | 0.562575 | -0.023346 | No Change: Both D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 627 | H | 0.552727 | R | 0.581607 | -0.02888 | No Change: Both D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 637 | G | 0.215584 | E | 0.235646 | -0.020062 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 638 | F | 0.211279 | I | 0.202779 | 0.0085 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 640 | D | 0.198099 | Y | 0.083394 | 0.114705 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 642 | G | 0.176184 | R | 0.172422 | 0.003762 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 700 | M | 0.081422 | K | 0.138244 | -0.056822 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 69 | I | 0.521032 | V | 0.514016 | 0.007016 | No Change: Both D | - |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 109 | Q | 0.145739 | R | 0.153265 | -0.007526 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 324 | A | 0.208922 | T | 0.21527 | -0.006348 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 328 | L | 0.132086 | P | 0.236646 | -0.10456 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 616 | R | 0.455924 | C | 0.268455 | 0.187469 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 617 | L | 0.425737 | R | 0.593874 | -0.168137 | O to D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 86 | P | 0.535934 | L | 0.352176 | 0.183758 | D to O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 87 | G | 0.526406 | E | 0.596644 | -0.070238 | No Change: Both D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 94 | G | 0.428303 | R | 0.453617 | -0.025314 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 95 | P | 0.422044 | R | 0.378175 | 0.043869 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 108 | R | 0.13604 | C | 0.066268 | 0.069772 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 108 | R | 0.13604 | G | 0.136188 | -1.48E-04 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 145 | G | 0.45129 | S | 0.512818 | -0.061528 | O to D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 186 | M | 0.324729 | V | 0.26907 | 0.055659 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 189 | N | 0.25854 | K | 0.298553 | -0.040013 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 197 | A | 0.085133 | E | 0.145477 | -0.060344 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 215 | G | 0.351154 | C | 0.20096 | 0.150194 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 230 | T | 0.172426 | I | 0.109326 | 0.0631 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 265 | H | 0.397631 | Y | 0.297456 | 0.100175 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 281 | L | 0.179577 | S | 0.325302 | -0.145725 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 291 | G | 0.339343 | E | 0.393567 | -0.054224 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 305 | L | 0.067402 | S | 0.161973 | -0.094571 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 306 | S | 0.054728 | F | 0.021921 | 0.032807 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 316 | Y | 0.097875 | C | 0.082458 | 0.015417 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 347 | L | 0.307269 | R | 0.418268 | -0.110999 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 350 | H | 0.220207 | Y | 0.13766 | 0.082547 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 369 | R | 0.163406 | C | 0.085161 | 0.078245 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 370 | T | 0.149644 | P | 0.189207 | -0.039563 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 383 | Q | 0.400689 | H | 0.406842 | -0.006153 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 383 | Q | 0.400689 | P | 0.419738 | -0.019049 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 386 | H | 0.44275 | N | 0.469324 | -0.026574 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 388 | N | 0.45373 | H | 0.457632 | -0.003902 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 426 | G | 0.230429 | R | 0.2082 | 0.022229 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 427 | G | 0.200233 | D | 0.218888 | -0.018655 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 518 | L | 0.671739 | P | 0.737782 | -0.066043 | No Change: Both D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 560 | C | 0.239793 | Y | 0.253007 | -0.013214 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 566 | T | 0.241126 | R | 0.264794 | -0.023668 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 573 | F | 0.382461 | S | 0.553129 | -0.170668 | O to D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 615 | P | 0.486573 | R | 0.51154 | -0.024967 | O to D | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 637 | G | 0.215584 | R | 0.225118 | -0.009534 | No Change: Both O | Methylmalonic aciduria type mut (MMAM) [MIM:251000] |
| P22033 | MUTA_HUMAN Methylmalonyl-CoA mutase mitochondrial OS=Homo sapiens GN=MUT PE=1 SV=4 | 598 | T | 0.590367 | A | 0.607936 | -0.017569 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 22 | V | 0.784058 | M | 0.860448 | -0.07639 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 176 | Y | 0.219249 | C | 0.195785 | 0.023464 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 335 | Q | 0.735858 | H | 0.689159 | 0.046699 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 393 | G | 0.332522 | D | 0.312059 | 0.020463 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 500 | G | 0.724674 | E | 0.750746 | -0.026072 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 526 | L | 0.769767 | M | 0.842076 | -0.072309 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 531 | R | 0.702996 | Q | 0.730381 | -0.027385 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 125 | Y | 0.132402 | H | 0.204234 | -0.071832 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 128 | W | 0.101529 | R | 0.244705 | -0.143176 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 179 | R | 0.385555 | H | 0.355347 | 0.030208 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 238 | R | 0.104385 | W | 0.036942 | 0.067443 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 402 | P | 0.246457 | S | 0.253222 | -0.006765 | No Change: Both O | Gastric cancer (GASC) [MIM:613659] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 411 | Q | 0.508148 | R | 0.487463 | 0.020685 | D to O | Gastric cancer (GASC) [MIM:613659] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 512 | S | 0.910601 | F | 0.803473 | 0.107128 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 370 | A | 0.635407 | V | 0.575455 | 0.059952 | No Change: Both D | - |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 179 | R | 0.385555 | C | 0.22236 | 0.163195 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| Q9UIF7 | MUTYH_HUMAN A/G-specific adenine DNA glycosylase OS=Homo sapiens GN=MUTYH PE=1 SV=1 | 182 | R | 0.495218 | W | 0.271056 | 0.224162 | No Change: Both O | Familial adenomatous polyposis type 2 (FAP2) [MIM:608456] |
| P53602 | MVD1_HUMAN Diphosphomevalonate decarboxylase OS=Homo sapiens GN=MVD PE=1 SV=1 | 278 | N | 0.082102 | H | 0.077433 | 0.004669 | No Change: Both O | - |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 20 | H | 0.296124 | P | 0.310856 | -0.014732 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 20 | H | 0.296124 | P | 0.310856 | -0.014732 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 167 | P | 0.396943 | L | 0.238327 | 0.158616 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 268 | I | 0.175795 | T | 0.278939 | -0.103144 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 268 | I | 0.175795 | T | 0.278939 | -0.103144 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 301 | N | 0.30708 | T | 0.259672 | 0.047408 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 334 | A | 0.548356 | T | 0.593743 | -0.045387 | No Change: Both D | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 377 | V | 0.488222 | I | 0.484516 | 0.003706 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 310 | V | 0.343533 | M | 0.409656 | -0.066123 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 310 | V | 0.343533 | M | 0.409656 | -0.066123 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 20 | H | 0.296124 | N | 0.293623 | 0.002501 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 39 | L | 0.241775 | P | 0.383145 | -0.14137 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 52 | S | 0.354732 | N | 0.329256 | 0.025476 | No Change: Both O | - |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 135 | S | 0.168679 | L | 0.079837 | 0.088842 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 148 | A | 0.28412 | T | 0.285449 | -0.001329 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 150 | S | 0.192652 | L | 0.094394 | 0.098258 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 202 | G | 0.548283 | R | 0.52003 | 0.028253 | No Change: Both D | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 215 | R | 0.232062 | Q | 0.259894 | -0.027832 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 243 | T | 0.360312 | I | 0.221891 | 0.138421 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 264 | L | 0.134102 | F | 0.11102 | 0.023082 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 265 | L | 0.146332 | P | 0.262024 | -0.115692 | No Change: Both O | Mevalonic aciduria (MEVA) [MIM:610377] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 309 | G | 0.389002 | S | 0.439313 | -0.050311 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 326 | G | 0.396783 | R | 0.396658 | 1.25E-04 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 20 | H | 0.296124 | Q | 0.289414 | 0.00671 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 132 | V | 0.112181 | I | 0.097994 | 0.014187 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 171 | G | 0.329055 | R | 0.333088 | -0.004033 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 211 | G | 0.217197 | E | 0.24295 | -0.025753 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 250 | V | 0.204931 | I | 0.178974 | 0.025957 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 265 | L | 0.146332 | R | 0.220186 | -0.073854 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 335 | G | 0.523665 | S | 0.549967 | -0.026302 | No Change: Both D | - |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 356 | T | 0.565255 | M | 0.503984 | 0.061271 | No Change: Both D | - |
| Q03426 | KIME_HUMAN Mevalonate kinase OS=Homo sapiens GN=MVK PE=1 SV=1 | 376 | G | 0.484701 | V | 0.364811 | 0.11989 | No Change: Both O | Hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) [MIM:260920] |
| Q14764 | MVP_HUMAN Major vault protein OS=Homo sapiens GN=MVP PE=1 SV=4 | 635 | V | 0.594258 | I | 0.517483 | 0.076775 | No Change: Both D | - |
| Q14764 | MVP_HUMAN Major vault protein OS=Homo sapiens GN=MVP PE=1 SV=4 | 651 | R | 0.713669 | Q | 0.735949 | -0.02228 | No Change: Both D | - |
| P20591 | MX1_HUMAN Interferon-induced GTP-binding protein Mx1 OS=Homo sapiens GN=MX1 PE=1 SV=4 | 381 | A | 0.188042 | V | 0.151148 | 0.036894 | No Change: Both O | - |
| P20591 | MX1_HUMAN Interferon-induced GTP-binding protein Mx1 OS=Homo sapiens GN=MX1 PE=1 SV=4 | 611 | Q | 0.365103 | H | 0.306636 | 0.058467 | No Change: Both O | - |
| P20591 | MX1_HUMAN Interferon-induced GTP-binding protein Mx1 OS=Homo sapiens GN=MX1 PE=1 SV=4 | 379 | V | 0.185503 | I | 0.187597 | -0.002094 | No Change: Both O | - |
| Q9BW11 | MAD3_HUMAN Max dimerization protein 3 OS=Homo sapiens GN=MXD3 PE=2 SV=1 | 114 | Q | 0.91788 | H | 0.891582 | 0.026298 | No Change: Both D | - |
| P50539 | MXI1_HUMAN Max-interacting protein 1 OS=Homo sapiens GN=MXI1 PE=1 SV=2 | 152 | E | 0.925504 | A | 0.866369 | 0.059135 | No Change: Both D | Prostate cancer (PC) [MIM:176807] |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 2531 | L | 0.160057 | V | 0.148436 | 0.011621 | No Change: Both O | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 764 | V | 0.694539 | L | 0.700989 | -0.00645 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 1484 | T | 0.898895 | A | 0.882068 | 0.016827 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 1665 | P | 0.853032 | S | 0.848484 | 0.004548 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 824 | I | 0.961576 | V | 0.97079 | -0.009214 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 1128 | A | 0.960317 | V | 0.953092 | 0.007225 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 1394 | G | 0.774553 | D | 0.788218 | -0.013665 | No Change: Both D | - |
| Q9NR99 | MXRA5_HUMAN Matrix-remodeling-associated protein 5 OS=Homo sapiens GN=MXRA5 PE=2 SV=3 | 2000 | G | 0.345099 | S | 0.413528 | -0.068429 | No Change: Both O | - |
| P10242 | MYB_HUMAN Transcriptional activator Myb OS=Homo sapiens GN=MYB PE=1 SV=2 | 336 | T | 0.719188 | I | 0.615068 | 0.10412 | No Change: Both D | - |
| P10242 | MYB_HUMAN Transcriptional activator Myb OS=Homo sapiens GN=MYB PE=1 SV=2 | 422 | T | 0.62862 | N | 0.628202 | 4.18E-04 | No Change: Both D | - |
| Q9BQG0 | MBB1A_HUMAN Myb-binding protein 1A OS=Homo sapiens GN=MYBBP1A PE=1 SV=2 | 8 | Q | 0.91015 | E | 0.917681 | -0.007531 | No Change: Both D | - |
| Q9BQG0 | MBB1A_HUMAN Myb-binding protein 1A OS=Homo sapiens GN=MYBBP1A PE=1 SV=2 | 680 | H | 0.169652 | Y | 0.095023 | 0.074629 | No Change: Both O | - |
| Q9BQG0 | MBB1A_HUMAN Myb-binding protein 1A OS=Homo sapiens GN=MYBBP1A PE=1 SV=2 | 958 | H | 0.739387 | P | 0.780815 | -0.041428 | No Change: Both D | - |
| Q9BQG0 | MBB1A_HUMAN Myb-binding protein 1A OS=Homo sapiens GN=MYBBP1A PE=1 SV=2 | 1208 | M | 0.993033 | L | 0.990047 | 0.002986 | No Change: Both D | - |
| P10244 | MYBB_HUMAN Myb-related protein B OS=Homo sapiens GN=MYBL2 PE=1 SV=1 | 427 | S | 0.872011 | G | 0.813728 | 0.058283 | No Change: Both D | - |
| P10244 | MYBB_HUMAN Myb-related protein B OS=Homo sapiens GN=MYBL2 PE=1 SV=1 | 341 | N | 0.81496 | S | 0.861667 | -0.046707 | No Change: Both D | - |
| P10244 | MYBB_HUMAN Myb-related protein B OS=Homo sapiens GN=MYBL2 PE=1 SV=1 | 595 | V | 0.871292 | M | 0.912611 | -0.041319 | No Change: Both D | - |
| P10244 | MYBB_HUMAN Myb-related protein B OS=Homo sapiens GN=MYBL2 PE=1 SV=1 | 624 | I | 0.842608 | M | 0.899282 | -0.056674 | No Change: Both D | - |
| Q00872 | MYPC1_HUMAN Myosin-binding protein C slow-type OS=Homo sapiens GN=MYBPC1 PE=1 SV=2 | 481 | H | 0.370278 | Q | 0.373732 | -0.003454 | No Change: Both O | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 52 | G | 0.93537 | S | 0.949197 | -0.013827 | No Change: Both D | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 624 | V | 0.307694 | I | 0.277772 | 0.029922 | No Change: Both O | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 1089 | R | 0.420634 | H | 0.42819 | -0.007556 | No Change: Both O | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 282 | D | 0.256853 | N | 0.235241 | 0.021612 | No Change: Both O | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 514 | G | 0.220358 | S | 0.278868 | -0.05851 | No Change: Both O | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 29 | E | 0.999145 | K | 0.999123 | 2.20E-05 | No Change: Both D | - |
| Q14324 | MYPC2_HUMAN Myosin-binding protein C fast-type OS=Homo sapiens GN=MYBPC2 PE=1 SV=2 | 341 | V | 0.177221 | I | 0.148551 | 0.02867 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 541 | E | 0.323333 | Q | 0.283282 | 0.040051 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 653 | R | 0.207128 | H | 0.210897 | -0.003769 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 754 | N | 0.469057 | K | 0.525799 | -0.056742 | O to D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 257 | H | 0.314909 | P | 0.367049 | -0.05214 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 258 | E | 0.335692 | K | 0.339869 | -0.004177 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 278 | G | 0.671385 | E | 0.692293 | -0.020908 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 279 | G | 0.698367 | A | 0.658605 | 0.039762 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 326 | R | 0.453127 | Q | 0.454142 | -0.001015 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 352 | L | 0.588585 | P | 0.696771 | -0.108186 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 501 | R | 0.487772 | W | 0.284865 | 0.202907 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 810 | K | 0.505544 | R | 0.439144 | 0.0664 | D to O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 832 | A | 0.374665 | V | 0.31228 | 0.062385 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 895 | V | 0.433572 | M | 0.482431 | -0.048859 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1193 | A | 0.097647 | T | 0.109974 | -0.012327 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1254 | A | 0.164119 | T | 0.192371 | -0.028252 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 158 | V | 0.546436 | M | 0.609799 | -0.063363 | No Change: Both D | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 236 | S | 0.279086 | G | 0.235011 | 0.044075 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 189 | V | 0.166326 | I | 0.132817 | 0.033509 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 281 | R | 0.741716 | Q | 0.707501 | 0.034215 | No Change: Both D | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 382 | R | 0.313229 | W | 0.153104 | 0.160125 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 383 | L | 0.304815 | V | 0.304573 | 2.42E-04 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 521 | A | 0.257631 | T | 0.272281 | -0.01465 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 997 | Q | 0.612344 | E | 0.618209 | -0.005865 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1047 | R | 0.26696 | C | 0.148032 | 0.118928 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 450 | E | 0.300096 | Q | 0.256963 | 0.043133 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 494 | R | 0.406702 | Q | 0.416716 | -0.010014 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 501 | R | 0.487772 | Q | 0.500196 | -0.012424 | O to D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 5 | G | 0.980638 | R | 0.984832 | -0.004194 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 59 | T | 0.467074 | A | 0.438192 | 0.028882 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 161 | P | 0.469583 | S | 0.462472 | 0.007111 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 219 | V | 0.207367 | L | 0.222447 | -0.01508 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 228 | D | 0.218533 | N | 0.204459 | 0.014074 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 237 | Y | 0.291098 | S | 0.498161 | -0.207063 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 256 | V | 0.287836 | I | 0.266115 | 0.021721 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 282 | R | 0.757247 | W | 0.561428 | 0.195819 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 415 | G | 0.243352 | S | 0.300817 | -0.057465 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 457 | R | 0.27395 | H | 0.255979 | 0.017971 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 489 | G | 0.342327 | R | 0.360397 | -0.01807 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 506 | G | 0.457667 | R | 0.467761 | -0.010094 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 522 | G | 0.245394 | W | 0.100282 | 0.145112 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 544 | L | 0.312734 | M | 0.35765 | -0.044916 | No Change: Both O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 565 | C | 0.292445 | R | 0.462483 | -0.170038 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 603 | D | 0.349104 | V | 0.200627 | 0.148477 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 604 | D | 0.380108 | N | 0.339044 | 0.041064 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 607 | P | 0.415276 | L | 0.269503 | 0.145773 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 667 | R | 0.281789 | H | 0.255782 | 0.026007 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 667 | R | 0.281789 | P | 0.342266 | -0.060477 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 732 | R | 0.586837 | C | 0.467267 | 0.11957 | D to O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 769 | D | 0.375455 | N | 0.350022 | 0.025433 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 791 | W | 0.298872 | R | 0.508237 | -0.209365 | O to D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 809 | R | 0.450205 | H | 0.449334 | 8.71E-04 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 819 | R | 0.10058 | Q | 0.104925 | -0.004345 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 832 | A | 0.374665 | T | 0.406102 | -0.031437 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 833 | R | 0.352645 | T | 0.324439 | 0.028206 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 833 | R | 0.352645 | W | 0.167693 | 0.184952 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 872 | P | 0.698 | H | 0.615951 | 0.082049 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 947 | N | 0.379855 | T | 0.397407 | -0.017552 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 997 | Q | 0.612344 | R | 0.600328 | 0.012016 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1001 | R | 0.538625 | Q | 0.577203 | -0.038578 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1001 | R | 0.538625 | W | 0.322183 | 0.216442 | D to O | - |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1002 | P | 0.545444 | Q | 0.521326 | 0.024118 | No Change: Both D | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1112 | F | 0.152581 | I | 0.152246 | 3.35E-04 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1114 | V | 0.137557 | I | 0.120381 | 0.017176 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1130 | I | 0.061088 | T | 0.107647 | -0.046559 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 263 | G | 0.418148 | R | 0.419899 | -0.001751 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 273 | R | 0.538711 | H | 0.491575 | 0.047136 | D to O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 416 | A | 0.236911 | S | 0.349894 | -0.112983 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 668 | L | 0.316243 | H | 0.375354 | -0.059111 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 758 | E | 0.4668 | D | 0.459441 | 0.007359 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 494 | R | 0.406702 | G | 0.420833 | -0.014131 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1027 | T | 0.234614 | S | 0.290634 | -0.05602 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q14896 | MYPC3_HUMAN Myosin-binding protein C cardiac-type OS=Homo sapiens GN=MYBPC3 PE=1 SV=3 | 1247 | G | 0.148011 | R | 0.163812 | -0.015801 | No Change: Both O | Familial hypertrophic cardiomyopathy type 4 (CMH4) [MIM:115197] |
| Q13203 | MYBPH_HUMAN Myosin-binding protein H OS=Homo sapiens GN=MYBPH PE=2 SV=4 | 48 | Q | 0.995862 | H | 0.993771 | 0.002091 | No Change: Both D | - |
| Q13203 | MYBPH_HUMAN Myosin-binding protein H OS=Homo sapiens GN=MYBPH PE=2 SV=4 | 49 | A | 0.995612 | G | 0.994636 | 9.76E-04 | No Change: Both D | - |
| Q13203 | MYBPH_HUMAN Myosin-binding protein H OS=Homo sapiens GN=MYBPH PE=2 SV=4 | 114 | A | 0.314594 | G | 0.377345 | -0.062751 | No Change: Both O | - |
| A2RUH7 | MBPHL_HUMAN Myosin-binding protein H-like OS=Homo sapiens GN=MYBPHL PE=2 SV=2 | 269 | D | 0.228571 | N | 0.21959 | 0.008981 | No Change: Both O | - |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 11 | N | 0.41535 | S | 0.457298 | -0.041948 | No Change: Both O | - |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 160 | G | 0.766992 | C | 0.727667 | 0.039325 | No Change: Both D | - |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 170 | V | 0.664499 | I | 0.631987 | 0.032512 | No Change: Both D | - |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 322 | A | 0.755383 | V | 0.716075 | 0.039308 | No Change: Both D | - |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 39 | E | 0.868884 | D | 0.857735 | 0.011149 | No Change: Both D | A Burkitt lymphoma symple |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 57 | P | 0.814665 | S | 0.809549 | 0.005116 | No Change: Both D | A Burkitt lymphoma sample |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 59 | P | 0.826929 | A | 0.737183 | 0.089746 | No Change: Both D | A Burkitt lymphoma sample |
| P01106 | MYC_HUMAN Myc proto-oncogene protein OS=Homo sapiens GN=MYC PE=1 SV=1 | 86 | N | 0.685956 | T | 0.703059 | -0.017103 | No Change: Both D | A Burkitt lymphoma sample |
| O75592 | MYCB2_HUMAN Probable E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens GN=MYCBP2 PE=1 SV=3 | 2588 | V | 0.426241 | M | 0.46174 | -0.035499 | No Change: Both O | - |
| O75592 | MYCB2_HUMAN Probable E3 ubiquitin-protein ligase MYCBP2 OS=Homo sapiens GN=MYCBP2 PE=1 SV=3 | 1881 | A | 0.538485 | S | 0.652744 | -0.114259 | No Change: Both D | - |
| Q8TBZ2 | MYBPP_HUMAN MYCBP-associated protein OS=Homo sapiens GN=MYCBPAP PE=1 SV=2 | 387 | A | 0.633549 | T | 0.671636 | -0.038087 | No Change: Both D | - |
| Q8TBZ2 | MYBPP_HUMAN MYCBP-associated protein OS=Homo sapiens GN=MYCBPAP PE=1 SV=2 | 688 | R | 0.921415 | W | 0.841793 | 0.079622 | No Change: Both D | - |
| Q8TBZ2 | MYBPP_HUMAN MYCBP-associated protein OS=Homo sapiens GN=MYCBPAP PE=1 SV=2 | 910 | S | 0.429614 | R | 0.370112 | 0.059502 | No Change: Both O | - |
| P12524 | MYCL1_HUMAN Protein L-Myc-1 OS=Homo sapiens GN=MYCL1 PE=1 SV=2 | 362 | T | 0.732938 | S | 0.765381 | -0.032443 | No Change: Both D | - |
| P04198 | MYCN_HUMAN N-myc proto-oncogene protein OS=Homo sapiens GN=MYCN PE=1 SV=2 | 393 | R | 0.823463 | H | 0.795297 | 0.028166 | No Change: Both D | Feingold syndrome type 1 (FGLDS1) [MIM:164280] |
| P04198 | MYCN_HUMAN N-myc proto-oncogene protein OS=Homo sapiens GN=MYCN PE=1 SV=2 | 393 | R | 0.823463 | S | 0.824414 | -9.51E-04 | No Change: Both D | Feingold syndrome type 1 (FGLDS1) [MIM:164280] |
| P04198 | MYCN_HUMAN N-myc proto-oncogene protein OS=Homo sapiens GN=MYCN PE=1 SV=2 | 394 | R | 0.810303 | H | 0.781386 | 0.028917 | No Change: Both D | Feingold syndrome type 1 (FGLDS1) [MIM:164280] |
| Q8N699 | MYCT1_HUMAN Myc target protein 1 OS=Homo sapiens GN=MYCT1 PE=2 SV=1 | 119 | G | 0.839833 | S | 0.887173 | -0.04734 | No Change: Both D | - |
| Q8N699 | MYCT1_HUMAN Myc target protein 1 OS=Homo sapiens GN=MYCT1 PE=2 SV=1 | 127 | R | 0.854471 | G | 0.825416 | 0.029055 | No Change: Both D | - |
| Q99836 | MYD88_HUMAN Myeloid differentiation primary response protein MyD88 OS=Homo sapiens GN=MYD88 PE=1 SV=1 | 93 | L | 0.395625 | P | 0.523488 | -0.127863 | O to D | MYD88 deficiency (MYD88D) [MIM:612260] |
| Q99836 | MYD88_HUMAN Myeloid differentiation primary response protein MyD88 OS=Homo sapiens GN=MYD88 PE=1 SV=1 | 196 | R | 0.187654 | C | 0.104352 | 0.083302 | No Change: Both O | MYD88 deficiency (MYD88D) [MIM:612260] |
| Q9P2K5 | MYEF2_HUMAN Myelin expression factor 2 OS=Homo sapiens GN=MYEF2 PE=1 SV=3 | 91 | A | 0.787632 | T | 0.784262 | 0.00337 | No Change: Both D | - |
| Q9P2K5 | MYEF2_HUMAN Myelin expression factor 2 OS=Homo sapiens GN=MYEF2 PE=1 SV=3 | 465 | S | 0.951365 | G | 0.943246 | 0.008119 | No Change: Both D | - |
| Q9P2K5 | MYEF2_HUMAN Myelin expression factor 2 OS=Homo sapiens GN=MYEF2 PE=1 SV=3 | 426 | Q | 0.676676 | R | 0.73267 | -0.055994 | No Change: Both D | - |
| Q96EZ4 | MYEOV_HUMAN Myeloma-overexpressed gene protein OS=Homo sapiens GN=MYEOV PE=2 SV=2 | 159 | V | 0.546023 | A | 0.607512 | -0.061489 | No Change: Both D | - |
| Q96EZ4 | MYEOV_HUMAN Myeloma-overexpressed gene protein OS=Homo sapiens GN=MYEOV PE=2 SV=2 | 198 | R | 0.271164 | Q | 0.246667 | 0.024497 | No Change: Both O | - |
| Q96EZ4 | MYEOV_HUMAN Myeloma-overexpressed gene protein OS=Homo sapiens GN=MYEOV PE=2 SV=2 | 271 | G | 0.290803 | R | 0.306768 | -0.015965 | No Change: Both O | - |
| Q96EZ4 | MYEOV_HUMAN Myeloma-overexpressed gene protein OS=Homo sapiens GN=MYEOV PE=2 SV=2 | 284 | P | 0.676288 | T | 0.619847 | 0.056441 | No Change: Both D | - |
| P23409 | MYF6_HUMAN Myogenic factor 6 OS=Homo sapiens GN=MYF6 PE=1 SV=1 | 90 | A | 0.839692 | D | 0.855332 | -0.01564 | No Change: Both D | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P23409 | MYF6_HUMAN Myogenic factor 6 OS=Homo sapiens GN=MYF6 PE=1 SV=1 | 112 | A | 0.782552 | S | 0.818386 | -0.035834 | No Change: Both D | Centronuclear myopathy autosomal dominant (ADCNM) [MIM:160150] |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1341 | R | 0.905269 | C | 0.873643 | 0.031626 | No Change: Both D | - |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1539 | Q | 0.944148 | H | 0.927221 | 0.016927 | No Change: Both D | - |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1716 | R | 0.766924 | C | 0.678337 | 0.088587 | No Change: Both D | - |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1306 | S | 0.842534 | L | 0.75988 | 0.082654 | No Change: Both D | A breast cancer sample |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1445 | A | 0.557768 | T | 0.56694 | -0.009172 | No Change: Both D | A breast cancer sample |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1598 | V | 0.793753 | M | 0.872462 | -0.078709 | No Change: Both D | A breast cancer sample |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 640 | G | 0.820337 | S | 0.834319 | -0.013982 | No Change: Both D | - |
| P12882 | MYH1_HUMAN Myosin-1 OS=Homo sapiens GN=MYH1 PE=1 SV=3 | 1566 | Q | 0.825461 | K | 0.840226 | -0.014765 | No Change: Both D | - |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1234 | A | 0.903905 | T | 0.905956 | -0.002051 | No Change: Both D | - |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1289 | V | 0.695399 | A | 0.749449 | -0.05405 | No Change: Both D | - |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1310 | V | 0.751167 | M | 0.807905 | -0.056738 | No Change: Both D | - |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1758 | R | 0.97444 | Q | 0.976525 | -0.002085 | No Change: Both D | Familial aortic aneurysm thoracic type 4 (AAT4) [MIM:132900] |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1104 | A | 0.85473 | T | 0.826505 | 0.028225 | No Change: Both D | - |
| P35749 | MYH11_HUMAN Myosin-11 OS=Homo sapiens GN=MYH11 PE=1 SV=3 | 1508 | M | 0.947579 | V | 0.927494 | 0.020085 | No Change: Both D | - |
| Q9UKX3 | MYH13_HUMAN Myosin-13 OS=Homo sapiens GN=MYH13 PE=1 SV=2 | 1071 | M | 0.974595 | V | 0.955643 | 0.018952 | No Change: Both D | - |
| Q9UKX3 | MYH13_HUMAN Myosin-13 OS=Homo sapiens GN=MYH13 PE=1 SV=2 | 701 | G | 0.122924 | R | 0.119948 | 0.002976 | No Change: Both O | - |
| Q9UKX3 | MYH13_HUMAN Myosin-13 OS=Homo sapiens GN=MYH13 PE=1 SV=2 | 1076 | D | 0.968235 | E | 0.973231 | -0.004996 | No Change: Both D | - |
| Q9UKX3 | MYH13_HUMAN Myosin-13 OS=Homo sapiens GN=MYH13 PE=1 SV=2 | 1294 | R | 0.894305 | Q | 0.912917 | -0.018612 | No Change: Both D | - |
| Q9UKX3 | MYH13_HUMAN Myosin-13 OS=Homo sapiens GN=MYH13 PE=1 SV=2 | 1862 | H | 0.673184 | R | 0.730956 | -0.057772 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 266 | I | 0.143752 | V | 0.158391 | -0.014639 | No Change: Both O | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 376 | G | 0.165539 | C | 0.101708 | 0.063831 | No Change: Both O | Deafness autosomal dominant type 4 (DFNA4) [MIM:600652] |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 726 | R | 0.162718 | S | 0.156185 | 0.006533 | No Change: Both O | Deafness autosomal dominant type 4 (DFNA4) [MIM:600652] |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 976 | L | 0.941423 | F | 0.925562 | 0.015861 | No Change: Both D | Deafness autosomal dominant type 4 (DFNA4) [MIM:600652] |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 1559 | N | 0.711276 | S | 0.775678 | -0.064402 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 120 | S | 0.256243 | L | 0.138624 | 0.117619 | No Change: Both O | Deafness autosomal dominant type 4 (DFNA4) [MIM:600652] |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 334 | P | 0.733376 | A | 0.660033 | 0.073343 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 1209 | A | 0.920479 | E | 0.948399 | -0.02792 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 1540 | V | 0.832719 | I | 0.78983 | 0.042889 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 933 | R | 0.966274 | L | 0.949956 | 0.016318 | No Change: Both D | - |
| Q7Z406 | MYH14_HUMAN Myosin-14 OS=Homo sapiens GN=MYH14 PE=1 SV=2 | 1154 | A | 0.97044 | V | 0.956754 | 0.013686 | No Change: Both D | - |
| Q9Y2K3 | MYH15_HUMAN Myosin-15 OS=Homo sapiens GN=MYH15 PE=1 SV=5 | 454 | R | 0.068895 | Q | 0.069397 | -5.02E-04 | No Change: Both O | - |
| Q9Y2K3 | MYH15_HUMAN Myosin-15 OS=Homo sapiens GN=MYH15 PE=1 SV=5 | 504 | H | 0.056044 | Y | 0.033064 | 0.02298 | No Change: Both O | - |
| Q9Y2K3 | MYH15_HUMAN Myosin-15 OS=Homo sapiens GN=MYH15 PE=1 SV=5 | 949 | T | 0.900879 | I | 0.864281 | 0.036598 | No Change: Both D | - |
| Q9Y2K3 | MYH15_HUMAN Myosin-15 OS=Homo sapiens GN=MYH15 PE=1 SV=5 | 1125 | T | 0.916959 | A | 0.905756 | 0.011203 | No Change: Both D | - |
| Q9Y2K3 | MYH15_HUMAN Myosin-15 OS=Homo sapiens GN=MYH15 PE=1 SV=5 | 1467 | D | 0.873284 | N | 0.840685 | 0.032599 | No Change: Both D | - |
| Q9UKX2 | MYH2_HUMAN Myosin-2 OS=Homo sapiens GN=MYH2 PE=1 SV=1 | 706 | E | 0.111345 | K | 0.115588 | -0.004243 | No Change: Both O | Inclusion body myopathy type 3 (IBM3) [MIM:605637] |
| Q9UKX2 | MYH2_HUMAN Myosin-2 OS=Homo sapiens GN=MYH2 PE=1 SV=1 | 970 | V | 0.915293 | I | 0.914667 | 6.26E-04 | No Change: Both D | - |
| Q9UKX2 | MYH2_HUMAN Myosin-2 OS=Homo sapiens GN=MYH2 PE=1 SV=1 | 1061 | L | 0.952929 | V | 0.936503 | 0.016426 | No Change: Both D | - |
| Q9UKX2 | MYH2_HUMAN Myosin-2 OS=Homo sapiens GN=MYH2 PE=1 SV=1 | 1927 | R | 0.809671 | Q | 0.806902 | 0.002769 | No Change: Both D | - |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1137 | R | 0.96289 | C | 0.936881 | 0.026009 | No Change: Both D | - |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1192 | A | 0.658923 | T | 0.650163 | 0.00876 | No Change: Both D | - |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 178 | T | 0.404583 | I | 0.286223 | 0.11836 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 178 | T | 0.404583 | I | 0.286223 | 0.11836 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 261 | S | 0.355459 | F | 0.171847 | 0.183612 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 292 | S | 0.272704 | C | 0.110678 | 0.162026 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 375 | E | 0.707063 | K | 0.704272 | 0.002791 | No Change: Both D | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 498 | E | 0.441585 | G | 0.376285 | 0.0653 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 517 | D | 0.064933 | Y | 0.027409 | 0.037524 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 583 | Y | 0.143833 | S | 0.286821 | -0.142988 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 672 | R | 0.183656 | C | 0.113325 | 0.070331 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 672 | R | 0.183656 | H | 0.178949 | 0.004707 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 769 | G | 0.164933 | V | 0.095594 | 0.069339 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 825 | V | 0.125421 | D | 0.218621 | -0.0932 | No Change: Both O | Distal arthrogryposis type 2A (DA2A) [MIM:193700] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 838 | K | 0.373368 | E | 0.36513 | 0.008238 | No Change: Both O | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1622 | D | 0.674057 | A | 0.648244 | 0.025813 | No Change: Both D | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1637 | A | 0.674482 | V | 0.595555 | 0.078927 | No Change: Both D | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1003 | A | 0.881437 | V | 0.837931 | 0.043506 | No Change: Both D | - |
| P11055 | MYH3_HUMAN Myosin-3 OS=Homo sapiens GN=MYH3 PE=1 SV=3 | 1313 | T | 0.953755 | I | 0.920891 | 0.032864 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 883 | T | 0.935784 | M | 0.943161 | -0.007377 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1911 | K | 0.862797 | E | 0.872112 | -0.009315 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 594 | A | 0.122398 | T | 0.140992 | -0.018594 | No Change: Both O | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1106 | I | 0.939586 | M | 0.955519 | -0.015933 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1117 | A | 0.956968 | D | 0.962692 | -0.005724 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1209 | E | 0.83816 | K | 0.836406 | 0.001754 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1802 | D | 0.894153 | G | 0.881371 | 0.012782 | No Change: Both D | - |
| Q9Y623 | MYH4_HUMAN Myosin-4 OS=Homo sapiens GN=MYH4 PE=1 SV=2 | 1862 | R | 0.777349 | C | 0.66701 | 0.110339 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 88 | E | 0.37128 | Q | 0.330534 | 0.040746 | No Change: Both O | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 783 | L | 0.446415 | M | 0.527434 | -0.081019 | O to D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1101 | V | 0.946642 | A | 0.966205 | -0.019563 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1737 | T | 0.902805 | S | 0.930057 | -0.027252 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 795 | R | 0.388782 | Q | 0.411136 | -0.022354 | No Change: Both O | Familial hypertrophic cardiomyopathy type 14 (CMH14) [MIM:613251] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 820 | I | 0.034813 | N | 0.075133 | -0.04032 | No Change: Both O | Atrial septal defect type 3 (ASD3) [MIM:614089] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1593 | Q | 0.871052 | L | 0.801034 | 0.070018 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 56 | G | 0.583864 | R | 0.613953 | -0.030089 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 275 | I | 0.152588 | N | 0.306505 | -0.153917 | No Change: Both O | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 830 | P | 0.077113 | L | 0.040705 | 0.036408 | No Change: Both O | Cardiomyopathy dilated type 1EE (CMD1EE) [MIM:613252] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1004 | A | 0.847196 | S | 0.868743 | -0.021547 | No Change: Both D | Cardiomyopathy dilated type 1EE (CMD1EE) [MIM:613252] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1065 | Q | 0.939522 | H | 0.911345 | 0.028177 | No Change: Both D | Familial hypertrophic cardiomyopathy type 14 (CMH14) [MIM:613251] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1130 | A | 0.966138 | T | 0.967181 | -0.001043 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1295 | E | 0.864298 | Q | 0.859688 | 0.00461 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1457 | E | 0.755756 | K | 0.757658 | -0.001902 | No Change: Both D | Cardiomyopathy dilated type 1EE (CMD1EE) [MIM:613252] |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 1502 | R | 0.869161 | Q | 0.888392 | -0.019231 | No Change: Both D | - |
| P13533 | MYH6_HUMAN Myosin-6 OS=Homo sapiens GN=MYH6 PE=1 SV=5 | 721 | R | 0.149346 | W | 0.052757 | 0.096589 | No Change: Both O | Sick sinus syndrome type 3 (SSS3) [MIM:614090] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 26 | A | 0.684839 | V | 0.617856 | 0.066983 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 59 | V | 0.678408 | I | 0.635792 | 0.042616 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 143 | R | 0.518388 | Q | 0.522252 | -0.003864 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 249 | R | 0.151336 | Q | 0.154134 | -0.002798 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 256 | G | 0.316816 | E | 0.357373 | -0.040557 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 263 | I | 0.282987 | T | 0.440751 | -0.157764 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 349 | M | 0.492498 | T | 0.511929 | -0.019431 | O to D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 403 | R | 0.227981 | L | 0.158032 | 0.069949 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 403 | R | 0.227981 | Q | 0.246219 | -0.018238 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 403 | R | 0.227981 | W | 0.102337 | 0.125644 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 453 | R | 0.249937 | C | 0.134804 | 0.115133 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 513 | F | 0.08525 | C | 0.093181 | -0.007931 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 584 | G | 0.058342 | R | 0.054334 | 0.004008 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 587 | D | 0.045831 | V | 0.023304 | 0.022527 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 602 | N | 0.390199 | S | 0.420929 | -0.03073 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 606 | V | 0.249396 | M | 0.295361 | -0.045965 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 615 | K | 0.339075 | N | 0.290362 | 0.048713 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 716 | G | 0.167079 | R | 0.18163 | -0.014551 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 719 | R | 0.163511 | W | 0.057081 | 0.10643 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 723 | R | 0.169744 | C | 0.082082 | 0.087662 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 731 | P | 0.286274 | L | 0.160428 | 0.125846 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 736 | I | 0.412519 | M | 0.49091 | -0.078391 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 741 | G | 0.567888 | R | 0.563565 | 0.004323 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 741 | G | 0.567888 | W | 0.335896 | 0.231992 | D to O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 778 | D | 0.472184 | G | 0.462274 | 0.00991 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 797 | A | 0.28839 | T | 0.308358 | -0.019968 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 870 | R | 0.977532 | H | 0.967615 | 0.009917 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 908 | L | 0.883925 | V | 0.869401 | 0.014524 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 924 | E | 0.962528 | K | 0.959808 | 0.00272 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 930 | E | 0.968175 | K | 0.965788 | 0.002387 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 935 | E | 0.962436 | K | 0.960775 | 0.001661 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 949 | E | 0.95054 | K | 0.9495 | 0.00104 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 743 | E | 0.600467 | D | 0.593331 | 0.007136 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 107 | D | 0.155421 | E | 0.174383 | -0.018962 | No Change: Both O | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 223 | A | 0.322851 | T | 0.336654 | -0.013803 | No Change: Both O | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 532 | S | 0.288604 | P | 0.308217 | -0.019613 | No Change: Both O | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 642 | S | 0.659235 | L | 0.519024 | 0.140211 | No Change: Both D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 719 | R | 0.163511 | Q | 0.166768 | -0.003257 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 728 | A | 0.233194 | V | 0.159859 | 0.073335 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 764 | F | 0.159547 | L | 0.180721 | -0.021174 | No Change: Both O | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1124 | A | 0.976423 | S | 0.981589 | -0.005166 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1845 | R | 0.89494 | W | 0.748658 | 0.146282 | No Change: Both D | Myopathy myosin storage (MYOMS) [MIM:608358] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1845 | R | 0.89494 | W | 0.748658 | 0.146282 | No Change: Both D | Scapuloperoneal myopathy MYH7-related (SPMM) [MIM:181430] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 39 | V | 0.60781 | M | 0.643779 | -0.035969 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 188 | T | 0.283835 | N | 0.307018 | -0.023183 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 204 | R | 0.549181 | H | 0.556579 | -0.007398 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 232 | N | 0.41834 | S | 0.44666 | -0.02832 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 355 | A | 0.423575 | T | 0.460121 | -0.036546 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 428 | A | 0.160622 | V | 0.111516 | 0.049106 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 443 | I | 0.126024 | T | 0.240271 | -0.114247 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 479 | N | 0.137226 | S | 0.155614 | -0.018388 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 483 | E | 0.272974 | K | 0.284482 | -0.011508 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 659 | M | 0.51495 | I | 0.428394 | 0.086556 | D to O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 663 | R | 0.467225 | H | 0.463668 | 0.003557 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 663 | R | 0.467225 | S | 0.515982 | -0.048757 | O to D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 671 | R | 0.23843 | C | 0.158297 | 0.080133 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 733 | G | 0.354974 | E | 0.417517 | -0.062543 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 768 | G | 0.14274 | R | 0.146083 | -0.003343 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 778 | D | 0.472184 | E | 0.524098 | -0.051914 | O to D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 787 | R | 0.288384 | H | 0.261744 | 0.02664 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 852 | M | 0.860708 | T | 0.850261 | 0.010447 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 869 | R | 0.978029 | G | 0.967981 | 0.010048 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1135 | L | 0.961315 | R | 0.975919 | -0.014604 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1218 | E | 0.832412 | Q | 0.820137 | 0.012275 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1377 | T | 0.835078 | M | 0.803725 | 0.031353 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1379 | A | 0.847038 | T | 0.858972 | -0.011934 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1382 | R | 0.852859 | W | 0.717946 | 0.134913 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1692 | V | 0.832287 | M | 0.855664 | -0.023377 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1777 | A | 0.938971 | T | 0.944331 | -0.00536 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 124 | T | 0.044713 | I | 0.022361 | 0.022352 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 162 | Y | 0.22581 | C | 0.1894 | 0.03641 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 187 | N | 0.346126 | K | 0.40025 | -0.054124 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 190 | R | 0.180511 | T | 0.182923 | -0.002412 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 222 | Q | 0.308434 | K | 0.341256 | -0.032822 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 244 | F | 0.388656 | L | 0.397607 | -0.008951 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 320 | V | 0.380275 | M | 0.444392 | -0.064117 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 390 | L | 0.379378 | V | 0.34947 | 0.029908 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 406 | V | 0.338953 | M | 0.377957 | -0.039004 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 499 | E | 0.514893 | K | 0.510323 | 0.00457 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 595 | Q | 0.239092 | R | 0.22348 | 0.015612 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 601 | L | 0.43772 | V | 0.446755 | -0.009035 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 694 | R | 0.155989 | C | 0.087831 | 0.068158 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 696 | N | 0.150189 | S | 0.171731 | -0.021542 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 712 | R | 0.161461 | L | 0.092462 | 0.068999 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 723 | R | 0.169744 | G | 0.162152 | 0.007592 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 782 | S | 0.356121 | N | 0.310137 | 0.045984 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 846 | E | 0.734077 | Q | 0.705966 | 0.028111 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 869 | R | 0.978029 | C | 0.964908 | 0.013121 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 870 | R | 0.977532 | C | 0.96477 | 0.012762 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 877 | M | 0.95884 | K | 0.972309 | -0.013469 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1491 | S | 0.911706 | C | 0.855745 | 0.055961 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1555 | E | 0.929094 | K | 0.921029 | 0.008065 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1776 | S | 0.943969 | G | 0.93324 | 0.010729 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1500 | R | 0.876309 | P | 0.880017 | -0.003708 | No Change: Both D | Myopathy distal type 1 (MPD1) [MIM:160500] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1663 | A | 0.639591 | P | 0.666492 | -0.026901 | No Change: Both D | Myopathy distal type 1 (MPD1) [MIM:160500] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1706 | L | 0.873848 | P | 0.900543 | -0.026695 | No Change: Both D | Myopathy distal type 1 (MPD1) [MIM:160500] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 3 | D | 0.764604 | A | 0.777436 | -0.012832 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 143 | R | 0.518388 | W | 0.295343 | 0.223045 | D to O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 411 | V | 0.448898 | I | 0.387432 | 0.061466 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 430 | A | 0.149161 | E | 0.221919 | -0.072758 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 466 | E | 0.085451 | Q | 0.06864 | 0.016811 | No Change: Both O | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 517 | L | 0.098225 | M | 0.148218 | -0.049993 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 584 | G | 0.058342 | S | 0.076473 | -0.018131 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 694 | R | 0.155989 | H | 0.153858 | 0.002131 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 734 | Q | 0.383531 | E | 0.449265 | -0.065734 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 736 | I | 0.412519 | T | 0.524979 | -0.11246 | O to D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 796 | L | 0.291216 | F | 0.252205 | 0.039011 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 824 | V | 0.085647 | I | 0.083556 | 0.002091 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 905 | C | 0.900601 | F | 0.876203 | 0.024398 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 924 | E | 0.962528 | Q | 0.953845 | 0.008683 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 928 | D | 0.968404 | N | 0.967909 | 4.95E-04 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 515 | M | 0.080559 | V | 0.049145 | 0.031414 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 858 | R | 0.940554 | C | 0.90744 | 0.033114 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 115 | Y | 0.055164 | H | 0.087011 | -0.031847 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 143 | R | 0.518388 | G | 0.534704 | -0.016316 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 146 | K | 0.732911 | N | 0.686869 | 0.046042 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 148 | S | 0.743537 | I | 0.546995 | 0.196542 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 186 | V | 0.406155 | L | 0.389242 | 0.016913 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 196 | A | 0.120954 | T | 0.136706 | -0.015752 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 201 | I | 0.274753 | T | 0.372873 | -0.09812 | No Change: Both O | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 207 | K | 0.618632 | Q | 0.620391 | -0.001759 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 211 | P | 0.656001 | L | 0.619402 | 0.036599 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 227 | L | 0.369523 | V | 0.370864 | -0.001341 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 263 | I | 0.282987 | M | 0.376648 | -0.093661 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 312 | F | 0.203738 | C | 0.193937 | 0.009801 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 328 | E | 0.460087 | G | 0.392836 | 0.067251 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 351 | K | 0.43642 | E | 0.446634 | -0.010214 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 383 | K | 0.605156 | N | 0.57166 | 0.033496 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 385 | A | 0.496406 | V | 0.39399 | 0.102416 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 404 | V | 0.244311 | L | 0.243676 | 6.35E-04 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 404 | V | 0.244311 | M | 0.283605 | -0.039294 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 407 | G | 0.380316 | V | 0.261563 | 0.118753 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 412 | T | 0.432797 | N | 0.500821 | -0.068024 | O to D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 425 | G | 0.121581 | R | 0.11732 | 0.004261 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 435 | M | 0.075293 | T | 0.091379 | -0.016086 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 440 | V | 0.068901 | M | 0.100137 | -0.031236 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 441 | T | 0.078637 | M | 0.064176 | 0.014461 | No Change: Both O | Myopathy distal type 1 (MPD1) [MIM:160500] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 450 | K | 0.435544 | E | 0.453764 | -0.01822 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 450 | K | 0.435544 | T | 0.368537 | 0.067007 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 453 | R | 0.249937 | H | 0.25415 | -0.004213 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 500 | E | 0.532584 | A | 0.399301 | 0.133283 | D to O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 501 | Y | 0.501376 | C | 0.44252 | 0.058856 | D to O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 511 | I | 0.087286 | F | 0.092759 | -0.005473 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 511 | I | 0.087286 | T | 0.145737 | -0.058451 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 515 | M | 0.080559 | R | 0.085954 | -0.005395 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 550 | A | 0.442133 | V | 0.326903 | 0.11523 | No Change: Both O | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 571 | G | 0.599781 | R | 0.602592 | -0.002811 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 576 | H | 0.329824 | R | 0.315164 | 0.01466 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 615 | K | 0.339075 | Q | 0.29652 | 0.042555 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 663 | R | 0.467225 | C | 0.348639 | 0.118586 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 698 | V | 0.141919 | A | 0.183795 | -0.041876 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 734 | Q | 0.383531 | P | 0.424444 | -0.040913 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 742 | A | 0.603157 | E | 0.706336 | -0.103179 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 763 | V | 0.170511 | G | 0.292961 | -0.12245 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 774 | E | 0.39704 | V | 0.212197 | 0.184843 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 778 | D | 0.472184 | V | 0.320007 | 0.152177 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 822 | M | 0.063658 | L | 0.045111 | 0.018547 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 822 | M | 0.063658 | T | 0.066391 | -0.002733 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 823 | G | 0.075021 | E | 0.103403 | -0.028382 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 858 | R | 0.940554 | H | 0.920493 | 0.020061 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 869 | R | 0.978029 | H | 0.968351 | 0.009678 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 882 | Q | 0.930996 | E | 0.936719 | -0.005723 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 894 | E | 0.909122 | G | 0.851392 | 0.05773 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 901 | A | 0.908239 | G | 0.89322 | 0.015019 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 906 | D | 0.894351 | G | 0.846823 | 0.047528 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 921 | E | 0.950936 | K | 0.947852 | 0.003084 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 927 | E | 0.967462 | K | 0.965012 | 0.00245 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 931 | E | 0.967002 | K | 0.964592 | 0.00241 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 953 | D | 0.935558 | H | 0.91696 | 0.018598 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1019 | T | 0.902868 | N | 0.907068 | -0.0042 | No Change: Both D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1057 | G | 0.942003 | D | 0.960039 | -0.018036 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1057 | G | 0.942003 | S | 0.958305 | -0.016302 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1193 | R | 0.798315 | S | 0.803652 | -0.005337 | No Change: Both D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1327 | N | 0.738888 | K | 0.814072 | -0.075184 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1356 | E | 0.748574 | K | 0.731765 | 0.016809 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1420 | R | 0.736636 | W | 0.531837 | 0.204799 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1426 | E | 0.594875 | K | 0.589317 | 0.005558 | No Change: Both D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1454 | A | 0.733836 | T | 0.715801 | 0.018035 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1459 | K | 0.864914 | N | 0.835026 | 0.029888 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1475 | R | 0.950706 | C | 0.925728 | 0.024978 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1513 | T | 0.876035 | S | 0.906913 | -0.030878 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1519 | S | 0.900804 | C | 0.834664 | 0.06614 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1634 | R | 0.78677 | C | 0.691331 | 0.095439 | No Change: Both D | Cardiomyopathy dilated type 1S (CMD1S) [MIM:613426] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1712 | R | 0.857816 | W | 0.70202 | 0.155796 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1753 | E | 0.929806 | K | 0.928562 | 0.001244 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1768 | E | 0.949564 | K | 0.948793 | 7.71E-04 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1854 | T | 0.856323 | M | 0.853606 | 0.002717 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1883 | E | 0.852563 | K | 0.852715 | -1.52E-04 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1901 | H | 0.819197 | L | 0.806955 | 0.012242 | No Change: Both D | Myopathy myosin storage (MYOMS) [MIM:608358] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1919 | K | 0.776862 | N | 0.739578 | 0.037284 | No Change: Both D | - |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1929 | T | 0.812622 | M | 0.817431 | -0.004809 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 763 | V | 0.170511 | M | 0.234973 | -0.064462 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 787 | R | 0.288384 | C | 0.14238 | 0.146004 | No Change: Both O | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| P12883 | MYH7_HUMAN Myosin-7 OS=Homo sapiens GN=MYH7 PE=1 SV=5 | 1414 | L | 0.806074 | M | 0.839273 | -0.033199 | No Change: Both D | Familial hypertrophic cardiomyopathy type 1 (CMH1) [MIM:192600] |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 28 | P | 0.267257 | T | 0.240277 | 0.02698 | No Change: Both O | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 459 | F | 0.054725 | Y | 0.058452 | -0.003727 | No Change: Both O | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 738 | P | 0.428063 | S | 0.455584 | -0.027521 | No Change: Both O | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 1510 | K | 0.84946 | N | 0.833576 | 0.015884 | No Change: Both D | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 1539 | A | 0.956179 | V | 0.937788 | 0.018391 | No Change: Both D | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 1656 | Q | 0.959068 | R | 0.955656 | 0.003412 | No Change: Both D | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 1875 | V | 0.822185 | E | 0.902712 | -0.080527 | No Change: Both D | - |
| A7E2Y1 | MYH7B_HUMAN Myosin-7B OS=Homo sapiens GN=MYH7B PE=2 SV=3 | 965 | K | 0.9402 | E | 0.940913 | -7.13E-04 | No Change: Both D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 674 | R | 0.193032 | Q | 0.193865 | -8.33E-04 | No Change: Both O | Carney complex variant (CACOV) [MIM:608837] |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 674 | R | 0.193032 | Q | 0.193865 | -8.33E-04 | No Change: Both O | Distal arthrogryposis type (DA7) [MIM:158300] |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 924 | E | 0.943868 | G | 0.900039 | 0.043829 | No Change: Both D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 1261 | E | 0.900325 | G | 0.856332 | 0.043993 | No Change: Both D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 1692 | W | 0.632313 | R | 0.838055 | -0.205742 | No Change: Both D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 326 | I | 0.45364 | T | 0.567908 | -0.114268 | O to D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 636 | A | 0.856942 | V | 0.813338 | 0.043604 | No Change: Both D | - |
| P13535 | MYH8_HUMAN Myosin-8 OS=Homo sapiens GN=MYH8 PE=1 SV=3 | 1229 | M | 0.945527 | T | 0.94573 | -2.03E-04 | No Change: Both D | - |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 93 | N | 0.257724 | K | 0.29114 | -0.033416 | No Change: Both O | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | C | 0.070738 | 0.056045 | No Change: Both O | Alport syndrome with macrothrombocytopenia (APSM) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | C | 0.070738 | 0.056045 | No Change: Both O | Epstein syndrome (EPS) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | C | 0.070738 | 0.056045 | No Change: Both O | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | C | 0.070738 | 0.056045 | No Change: Both O | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | C | 0.070738 | 0.056045 | No Change: Both O | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 705 | R | 0.141823 | H | 0.119957 | 0.021866 | No Change: Both O | Deafness autosomal dominant type 17 (DFNA17) [MIM:603622] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1155 | T | 0.952699 | I | 0.920867 | 0.031832 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1155 | T | 0.952699 | I | 0.920867 | 0.031832 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1165 | R | 0.946692 | C | 0.917067 | 0.029625 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1165 | R | 0.946692 | C | 0.917067 | 0.029625 | No Change: Both D | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | H | 0.770269 | 0.047218 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | H | 0.770269 | 0.047218 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1841 | E | 0.92149 | K | 0.925143 | -0.003653 | No Change: Both D | Epstein syndrome (EPS) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1841 | E | 0.92149 | K | 0.925143 | -0.003653 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1841 | E | 0.92149 | K | 0.925143 | -0.003653 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1841 | E | 0.92149 | K | 0.925143 | -0.003653 | No Change: Both D | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 95 | A | 0.270408 | T | 0.307666 | -0.037258 | No Change: Both O | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 96 | S | 0.251333 | L | 0.134885 | 0.116448 | No Change: Both O | Epstein syndrome (EPS) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 373 | K | 0.377812 | N | 0.357331 | 0.020481 | No Change: Both O | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 373 | K | 0.377812 | N | 0.357331 | 0.020481 | No Change: Both O | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | H | 0.108077 | 0.018706 | No Change: Both O | Alport syndrome with macrothrombocytopenia (APSM) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 702 | R | 0.126783 | H | 0.108077 | 0.018706 | No Change: Both O | Epstein syndrome (EPS) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1114 | S | 0.973554 | P | 0.967035 | 0.006519 | No Change: Both D | Alport syndrome with macrothrombocytopenia (APSM) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1165 | R | 0.946692 | L | 0.927195 | 0.019497 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1165 | R | 0.946692 | L | 0.927195 | 0.019497 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1165 | R | 0.946692 | L | 0.927195 | 0.019497 | No Change: Both D | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1400 | R | 0.874828 | W | 0.730704 | 0.144124 | No Change: Both D | - |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | N | 0.775037 | 0.04245 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | N | 0.775037 | 0.04245 | No Change: Both D | Macrothrombocytopenia with progressive sensorineural deafness (MPSD) [MIM:600208] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | N | 0.775037 | 0.04245 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | N | 0.775037 | 0.04245 | No Change: Both D | Sebastian syndrome (SBS) [MIM:605249] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1424 | D | 0.817487 | Y | 0.66842 | 0.149067 | No Change: Both D | May-Hegglin anomaly (MHA) [MIM:155100] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1626 | I | 0.903747 | V | 0.904396 | -6.49E-04 | No Change: Both D | - |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 1816 | I | 0.806626 | V | 0.823491 | -0.016865 | No Change: Both D | Epstein syndrome (EPS) [MIM:153650] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 810 | K | 0.250997 | N | 0.224408 | 0.026589 | No Change: Both O | A breast cancer sample |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 910 | K | 0.967734 | Q | 0.970013 | -0.002279 | No Change: Both D | Fechtner syndrome (FTNS) [MIM:153640] |
| P35579 | MYH9_HUMAN Myosin-9 OS=Homo sapiens GN=MYH9 PE=1 SV=4 | 967 | V | 0.972704 | E | 0.989082 | -0.016378 | No Change: Both D | - |
| Q9BUA6 | MYL10_HUMAN Myosin regulatory light chain 10 OS=Homo sapiens GN=MYL10 PE=2 SV=2 | 46 | M | 0.692258 | T | 0.7015 | -0.009242 | No Change: Both D | - |
| O14950 | ML12B_HUMAN Myosin regulatory light chain 12B OS=Homo sapiens GN=MYL12B PE=1 SV=2 | 141 | E | 0.448968 | G | 0.374065 | 0.074903 | No Change: Both O | - |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 13 | A | 0.755505 | T | 0.765365 | -0.00986 | No Change: Both D | Familial hypertrophic cardiomyopathy with mid-left ventricular chamber type 2 (MVC2) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 18 | F | 0.650751 | L | 0.597447 | 0.053304 | No Change: Both D | Familial hypertrophic cardiomyopathy type 10 (CMH10) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 22 | E | 0.585187 | K | 0.603503 | -0.018316 | No Change: Both D | Familial hypertrophic cardiomyopathy type 10 (CMH10) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 22 | E | 0.585187 | K | 0.603503 | -0.018316 | No Change: Both D | Familial hypertrophic cardiomyopathy with mid-left ventricular chamber type 2 (MVC2) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 58 | R | 0.271058 | Q | 0.271647 | -5.89E-04 | No Change: Both O | Familial hypertrophic cardiomyopathy type 10 (CMH10) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 95 | P | 0.472842 | A | 0.420649 | 0.052193 | No Change: Both O | Familial hypertrophic cardiomyopathy with mid-left ventricular chamber type 2 (MVC2) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 166 | D | 0.899557 | V | 0.939199 | -0.039642 | No Change: Both D | Familial hypertrophic cardiomyopathy type 10 (CMH10) [MIM:608758] |
| P10916 | MLRV_HUMAN Myosin regulatory light chain 2 ventricular/cardiac muscle isoform OS=Homo sapiens GN=MYL2 PE=1 SV=3 | 57 | G | 0.252981 | R | 0.280283 | -0.027302 | No Change: Both O | - |
| P08590 | MYL3_HUMAN Myosin light chain 3 OS=Homo sapiens GN=MYL3 PE=1 SV=3 | 149 | M | 0.399526 | V | 0.35405 | 0.045476 | No Change: Both O | Familial hypertrophic cardiomyopathy with mid-left ventricular chamber type 1 (MVC1) [MIM:608751] |
| P08590 | MYL3_HUMAN Myosin light chain 3 OS=Homo sapiens GN=MYL3 PE=1 SV=3 | 154 | R | 0.314562 | H | 0.295948 | 0.018614 | No Change: Both O | Familial hypertrophic cardiomyopathy with mid-left ventricular chamber type 1 (MVC1) [MIM:608751] |
| P08590 | MYL3_HUMAN Myosin light chain 3 OS=Homo sapiens GN=MYL3 PE=1 SV=3 | 56 | E | 0.532357 | G | 0.449134 | 0.083223 | D to O | Familial hypertrophic cardiomyopathy type 8 (CMH8) [MIM:608751] |
| P08590 | MYL3_HUMAN Myosin light chain 3 OS=Homo sapiens GN=MYL3 PE=1 SV=3 | 143 | E | 0.457687 | K | 0.456764 | 9.23E-04 | No Change: Both O | Familial hypertrophic cardiomyopathy type 8 (CMH8) [MIM:608751] |
| P12829 | MYL4_HUMAN Myosin light chain 4 OS=Homo sapiens GN=MYL4 PE=1 SV=3 | 186 | N | 0.133729 | Y | 0.070836 | 0.062893 | No Change: Both O | - |
| Q02045 | MYL5_HUMAN Myosin light chain 5 OS=Homo sapiens GN=MYL5 PE=2 SV=1 | 88 | F | 0.251137 | S | 0.406659 | -0.155522 | No Change: Both O | - |
| P60660 | MYL6_HUMAN Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 | 103 | T | 0.386793 | P | 0.422125 | -0.035332 | No Change: Both O | - |
| P60660 | MYL6_HUMAN Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 | 85 | T | 0.467169 | I | 0.332661 | 0.134508 | No Change: Both O | - |
| Q8WY64 | MYLIP_HUMAN E3 ubiquitin-protein ligase MYLIP OS=Homo sapiens GN=MYLIP PE=1 SV=2 | 342 | N | 0.740886 | S | 0.772146 | -0.03126 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 861 | L | 0.78291 | P | 0.873403 | -0.090493 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 914 | D | 0.781826 | E | 0.799896 | -0.01807 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 261 | V | 0.634089 | A | 0.702773 | -0.068684 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 276 | T | 0.836132 | A | 0.829206 | 0.006926 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 378 | R | 0.967542 | H | 0.948683 | 0.018859 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 405 | M | 0.908109 | V | 0.894343 | 0.013766 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 443 | P | 0.378454 | S | 0.381882 | -0.003428 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 607 | R | 0.718648 | G | 0.716725 | 0.001923 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 652 | P | 0.421065 | A | 0.299572 | 0.121493 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 656 | W | 0.292175 | C | 0.39494 | -0.102765 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 692 | T | 0.28425 | M | 0.229 | 0.05525 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 701 | A | 0.308455 | T | 0.343852 | -0.035397 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 709 | V | 0.295735 | M | 0.334922 | -0.039187 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1527 | A | 0.175954 | V | 0.13451 | 0.041444 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1588 | P | 0.243505 | L | 0.14452 | 0.098985 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 21 | P | 0.712864 | H | 0.660027 | 0.052837 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 336 | P | 0.965749 | L | 0.938258 | 0.027491 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 845 | R | 0.856193 | C | 0.795943 | 0.06025 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 877 | V | 0.784909 | M | 0.811692 | -0.026783 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 128 | A | 0.437487 | V | 0.388908 | 0.048579 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 133 | Q | 0.451837 | H | 0.386978 | 0.064859 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 160 | P | 0.403134 | R | 0.365019 | 0.038115 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1085 | T | 0.862472 | A | 0.855205 | 0.007267 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1213 | V | 0.976115 | M | 0.983618 | -0.007503 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1399 | E | 0.27909 | K | 0.284785 | -0.005695 | No Change: Both O | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1754 | A | 0.812428 | T | 0.823433 | -0.011005 | No Change: Both D | - |
| Q15746 | MYLK_HUMAN Myosin light chain kinase smooth muscle OS=Homo sapiens GN=MYLK PE=1 SV=4 | 1759 | S | 0.832345 | P | 0.80441 | 0.027935 | No Change: Both D | Familial aortic aneurysm thoracic type 7 (AAT7) [MIM:613780] |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 87 | A | 0.993487 | V | 0.989832 | 0.003655 | No Change: Both D | Familial hypertrophic cardiomyopathy (CMH) [MIM:192600] |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 95 | A | 0.992789 | E | 0.994324 | -0.001535 | No Change: Both D | Familial hypertrophic cardiomyopathy (CMH) [MIM:192600] |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 117 | A | 0.989331 | V | 0.984548 | 0.004783 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 142 | G | 0.940042 | V | 0.910252 | 0.02979 | No Change: Both D | - |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 144 | P | 0.93582 | A | 0.915476 | 0.020344 | No Change: Both D | - |
| Q9H1R3 | MYLK2_HUMAN Myosin light chain kinase 2 skeletal/cardiac muscle OS=Homo sapiens GN=MYLK2 PE=1 SV=3 | 324 | K | 0.515362 | N | 0.4538 | 0.061562 | D to O | - |
| Q32MK0 | MYLK3_HUMAN Putative myosin light chain kinase 3 OS=Homo sapiens GN=MYLK3 PE=2 SV=3 | 390 | G | 0.993643 | R | 0.993886 | -2.43E-04 | No Change: Both D | A colorectal cancer sample |
| Q32MK0 | MYLK3_HUMAN Putative myosin light chain kinase 3 OS=Homo sapiens GN=MYLK3 PE=2 SV=3 | 70 | S | 0.695878 | T | 0.64754 | 0.048338 | No Change: Both D | - |
| Q32MK0 | MYLK3_HUMAN Putative myosin light chain kinase 3 OS=Homo sapiens GN=MYLK3 PE=2 SV=3 | 180 | V | 0.951865 | L | 0.954311 | -0.002446 | No Change: Both D | - |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 30 | E | 0.61536 | Q | 0.574703 | 0.040657 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 50 | G | 0.784663 | R | 0.819087 | -0.034424 | No Change: Both D | - |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 78 | A | 0.43322 | S | 0.533501 | -0.100281 | O to D | A breast infiltrating ductal carcinoma sample |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 126 | T | 0.434046 | M | 0.389882 | 0.044164 | No Change: Both O | - |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 217 | H | 0.164095 | L | 0.094006 | 0.070089 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 318 | C | 0.095468 | Y | 0.103792 | -0.008324 | No Change: Both O | - |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 373 | Q | 0.81679 | R | 0.829984 | -0.013194 | No Change: Both D | - |
| Q86YV6 | MYLK4_HUMAN Myosin light chain kinase family member 4 OS=Homo sapiens GN=MYLK4 PE=1 SV=2 | 39 | E | 0.671494 | A | 0.547043 | 0.124451 | No Change: Both D | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 32 | V | 0.084461 | I | 0.072185 | 0.012276 | No Change: Both O | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 273 | E | 0.544066 | D | 0.49589 | 0.048176 | D to O | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 324 | R | 0.467463 | W | 0.262577 | 0.204886 | No Change: Both O | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 700 | R | 0.318039 | Q | 0.339151 | -0.021112 | No Change: Both O | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 1663 | S | 0.479395 | T | 0.419709 | 0.059686 | No Change: Both O | - |
| Q9HD67 | MYO10_HUMAN Unconventionnal myosin-X OS=Homo sapiens GN=MYO10 PE=1 SV=3 | 148 | H | 0.108506 | Y | 0.066295 | 0.042211 | No Change: Both O | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2111 | N | 0.116734 | Y | 0.062863 | 0.053871 | No Change: Both O | Deafness autosomal recessive type 3 (DFNB3) [MIM:600316] |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2113 | I | 0.090989 | F | 0.091226 | -2.37E-04 | No Change: Both O | Deafness autosomal recessive type 3 (DFNB3) [MIM:600316] |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 1977 | C | 0.17782 | R | 0.332044 | -0.154224 | No Change: Both O | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2018 | G | 0.335891 | R | 0.350089 | -0.014198 | No Change: Both O | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2205 | T | 0.542641 | I | 0.369406 | 0.173235 | D to O | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2490 | A | 0.956957 | T | 0.957118 | -1.61E-04 | No Change: Both D | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2682 | Y | 0.174228 | F | 0.167577 | 0.006651 | No Change: Both O | - |
| Q9UKN7 | MYO15_HUMAN Myosin-XV OS=Homo sapiens GN=MYO15A PE=1 SV=2 | 2716 | Q | 0.130829 | H | 0.12048 | 0.010349 | No Change: Both O | Deafness autosomal recessive type 3 (DFNB3) [MIM:600316] |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 385 | M | 0.94175 | T | 0.93868 | 0.00307 | No Change: Both D | - |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 831 | P | 0.526427 | A | 0.45777 | 0.068657 | D to O | - |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 181 | D | 0.289595 | E | 0.312335 | -0.02274 | No Change: Both O | - |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 339 | V | 0.544057 | I | 0.559943 | -0.015886 | No Change: Both D | - |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 1171 | I | 0.333237 | M | 0.416479 | -0.083242 | No Change: Both O | - |
| Q9Y6X6 | MYO16_HUMAN Myosin-XVI OS=Homo sapiens GN=MYO16 PE=1 SV=3 | 1168 | L | 0.231348 | H | 0.332254 | -0.100906 | No Change: Both O | - |
| Q92614 | MY18A_HUMAN Myosin-XVIIIa OS=Homo sapiens GN=MYO18A PE=1 SV=3 | 958 | A | 0.576638 | V | 0.474281 | 0.102357 | D to O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 234 | G | 0.908854 | V | 0.861859 | 0.046995 | No Change: Both D | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 347 | K | 0.929873 | N | 0.905113 | 0.02476 | No Change: Both D | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 379 | R | 0.960579 | Q | 0.965387 | -0.004808 | No Change: Both D | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 389 | W | 0.969754 | C | 0.981388 | -0.011634 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 590 | T | 0.284799 | M | 0.25012 | 0.034679 | No Change: Both O | A lung large cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 661 | R | 0.377478 | W | 0.191316 | 0.186162 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 835 | A | 0.139575 | G | 0.171697 | -0.032122 | No Change: Both O | A lung squamous cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1095 | R | 0.134551 | L | 0.089979 | 0.044572 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1195 | R | 0.504387 | Q | 0.5057 | -0.001313 | No Change: Both D | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1238 | P | 0.453833 | Q | 0.420928 | 0.032905 | No Change: Both O | A lung large cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1238 | P | 0.453833 | T | 0.372408 | 0.081425 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1708 | E | 0.915747 | K | 0.913766 | 0.001981 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1715 | E | 0.956137 | D | 0.939184 | 0.016953 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1970 | A | 0.231613 | E | 0.348275 | -0.116662 | No Change: Both O | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2295 | G | 0.69706 | C | 0.590264 | 0.106796 | No Change: Both D | A lung small cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2347 | Q | 0.930621 | R | 0.941285 | -0.010664 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2381 | R | 0.899756 | H | 0.863279 | 0.036477 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2554 | D | 0.918902 | E | 0.923214 | -0.004312 | No Change: Both D | A lung large cell carcinoma sample |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 44 | G | 0.859252 | E | 0.893405 | -0.034153 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 177 | P | 0.977011 | L | 0.956014 | 0.020997 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 547 | W | 0.193363 | C | 0.258767 | -0.065404 | No Change: Both O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 925 | S | 0.164004 | L | 0.076634 | 0.08737 | No Change: Both O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1037 | W | 0.163366 | S | 0.428207 | -0.264841 | No Change: Both O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1119 | H | 0.547292 | Q | 0.597138 | -0.049846 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1390 | S | 0.151698 | F | 0.061611 | 0.090087 | No Change: Both O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1399 | I | 0.381261 | V | 0.413501 | -0.03224 | No Change: Both O | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 1444 | S | 0.688781 | T | 0.637521 | 0.05126 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2294 | A | 0.693658 | D | 0.733942 | -0.040284 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2395 | G | 0.742622 | A | 0.725495 | 0.017127 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2513 | G | 0.979106 | S | 0.986506 | -0.0074 | No Change: Both D | - |
| Q8IUG5 | MY18B_HUMAN Myosin-XVIIIb OS=Homo sapiens GN=MYO18B PE=1 SV=1 | 2532 | R | 0.967343 | Q | 0.95801 | 0.009333 | No Change: Both D | - |
| Q96H55 | MYO19_HUMAN Myosin-XIX OS=Homo sapiens GN=MYO19 PE=2 SV=2 | 176 | N | 0.339499 | S | 0.379483 | -0.039984 | No Change: Both O | - |
| Q96H55 | MYO19_HUMAN Myosin-XIX OS=Homo sapiens GN=MYO19 PE=2 SV=2 | 203 | Q | 0.313278 | H | 0.231448 | 0.08183 | No Change: Both O | - |
| Q96H55 | MYO19_HUMAN Myosin-XIX OS=Homo sapiens GN=MYO19 PE=2 SV=2 | 475 | L | 0.286086 | I | 0.267143 | 0.018943 | No Change: Both O | - |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 306 | V | 0.51938 | M | 0.603592 | -0.084212 | No Change: Both D | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 385 | E | 0.143117 | D | 0.130241 | 0.012876 | No Change: Both O | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 662 | G | 0.5334 | E | 0.587312 | -0.053912 | No Change: Both D | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 674 | G | 0.330799 | D | 0.338432 | -0.007633 | No Change: Both O | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 797 | S | 0.414997 | F | 0.203112 | 0.211885 | No Change: Both O | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 910 | S | 0.50696 | P | 0.475469 | 0.031491 | D to O | Deafness autosomal dominant type 48 (DFNA48) [MIM:607841] |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 600 | F | 0.542349 | L | 0.578242 | -0.035893 | No Change: Both D | - |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 426 | P | 0.22005 | L | 0.120477 | 0.099573 | No Change: Both O | - |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 506 | C | 0.046925 | S | 0.130539 | -0.083614 | No Change: Both O | - |
| Q9UBC5 | MYO1A_HUMAN Myosin-Ia OS=Homo sapiens GN=MYO1A PE=1 SV=1 | 996 | T | 0.27163 | I | 0.14468 | 0.12695 | No Change: Both O | - |
| O43795 | MYO1B_HUMAN Myosin-Ib OS=Homo sapiens GN=MYO1B PE=2 SV=3 | 969 | E | 0.426888 | K | 0.453265 | -0.026377 | No Change: Both O | A melanoma patient |
| O43795 | MYO1B_HUMAN Myosin-Ib OS=Homo sapiens GN=MYO1B PE=2 SV=3 | 385 | V | 0.099848 | G | 0.173739 | -0.073891 | No Change: Both O | A colorectal cancer sample |
| O43795 | MYO1B_HUMAN Myosin-Ib OS=Homo sapiens GN=MYO1B PE=2 SV=3 | 385 | V | 0.099848 | I | 0.086423 | 0.013425 | No Change: Both O | A colorectal cancer sample |
| O00159 | MYO1C_HUMAN Myosin-Ic OS=Homo sapiens GN=MYO1C PE=1 SV=4 | 795 | V | 0.134823 | I | 0.133126 | 0.001697 | No Change: Both O | - |
| O00159 | MYO1C_HUMAN Myosin-Ic OS=Homo sapiens GN=MYO1C PE=1 SV=4 | 826 | Q | 0.429852 | R | 0.446046 | -0.016194 | No Change: Both O | - |
| O94832 | MYO1D_HUMAN Myosin-Id OS=Homo sapiens GN=MYO1D PE=1 SV=2 | 765 | P | 0.46753 | S | 0.486949 | -0.019419 | No Change: Both O | - |
| O94832 | MYO1D_HUMAN Myosin-Id OS=Homo sapiens GN=MYO1D PE=1 SV=2 | 771 | R | 0.291826 | H | 0.271981 | 0.019845 | No Change: Both O | - |
| Q12965 | MYO1E_HUMAN Myosin-Ie OS=Homo sapiens GN=MYO1E PE=1 SV=2 | 159 | A | 0.398185 | P | 0.468403 | -0.070218 | No Change: Both O | Focal segmental glomerulosclerosis type 6 (FSGS6) [MIM:614131] |
| Q12965 | MYO1E_HUMAN Myosin-Ie OS=Homo sapiens GN=MYO1E PE=1 SV=2 | 185 | D | 0.661644 | G | 0.67867 | -0.017026 | No Change: Both D | - |
| Q12965 | MYO1E_HUMAN Myosin-Ie OS=Homo sapiens GN=MYO1E PE=1 SV=2 | 221 | A | 0.594887 | V | 0.498888 | 0.095999 | D to O | - |
| Q12965 | MYO1E_HUMAN Myosin-Ie OS=Homo sapiens GN=MYO1E PE=1 SV=2 | 795 | G | 0.306762 | R | 0.337616 | -0.030854 | No Change: Both O | - |
| Q12965 | MYO1E_HUMAN Myosin-Ie OS=Homo sapiens GN=MYO1E PE=1 SV=2 | 1049 | P | 0.908182 | H | 0.865023 | 0.043159 | No Change: Both D | - |
| O00160 | MYO1F_HUMAN Myosin-If OS=Homo sapiens GN=MYO1F PE=1 SV=3 | 960 | P | 0.987621 | L | 0.97494 | 0.012681 | No Change: Both D | - |
| B0I1T2 | MYO1G_HUMAN Myosin-Ig OS=Homo sapiens GN=MYO1G PE=1 SV=2 | 49 | V | 0.189087 | M | 0.219188 | -0.030101 | No Change: Both O | - |
| B0I1T2 | MYO1G_HUMAN Myosin-Ig OS=Homo sapiens GN=MYO1G PE=1 SV=2 | 489 | M | 0.394536 | T | 0.452923 | -0.058387 | No Change: Both O | - |
| B0I1T2 | MYO1G_HUMAN Myosin-Ig OS=Homo sapiens GN=MYO1G PE=1 SV=2 | 861 | Q | 0.438012 | R | 0.431221 | 0.006791 | No Change: Both O | - |
| B0I1T2 | MYO1G_HUMAN Myosin-Ig OS=Homo sapiens GN=MYO1G PE=1 SV=2 | 798 | R | 0.143892 | Q | 0.153925 | -0.010033 | No Change: Both O | - |
| Q8N1T3 | MYO1H_HUMAN Myosin-Ih OS=Homo sapiens GN=MYO1H PE=2 SV=2 | 37 | S | 0.224604 | R | 0.189186 | 0.035418 | No Change: Both O | - |
| Q8N1T3 | MYO1H_HUMAN Myosin-Ih OS=Homo sapiens GN=MYO1H PE=2 SV=2 | 705 | H | 0.243936 | Y | 0.170145 | 0.073791 | No Change: Both O | - |
| Q8N1T3 | MYO1H_HUMAN Myosin-Ih OS=Homo sapiens GN=MYO1H PE=2 SV=2 | 1011 | L | 0.289847 | P | 0.433695 | -0.143848 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 204 | D | 0.252994 | N | 0.223166 | 0.029828 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 956 | S | 0.546144 | N | 0.524619 | 0.021525 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1313 | R | 0.851665 | S | 0.868022 | -0.016357 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1284 | T | 0.75527 | S | 0.802817 | -0.047547 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 178 | T | 0.606587 | I | 0.448815 | 0.157772 | D to O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 319 | R | 0.639498 | H | 0.639148 | 3.50E-04 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 348 | I | 0.297054 | V | 0.342924 | -0.04587 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 369 | V | 0.048276 | I | 0.043711 | 0.004565 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 525 | N | 0.154716 | K | 0.191682 | -0.036966 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 833 | A | 0.190245 | S | 0.282115 | -0.09187 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 956 | S | 0.546144 | R | 0.507238 | 0.038906 | No Change: Both D | An ovarian serous carcinoma sample |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1032 | A | 0.181771 | T | 0.205945 | -0.024174 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1045 | V | 0.14005 | M | 0.183318 | -0.043268 | No Change: Both O | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1137 | V | 0.762135 | M | 0.809899 | -0.047764 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1195 | V | 0.832718 | A | 0.831811 | 9.07E-04 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1287 | P | 0.736719 | T | 0.700178 | 0.036541 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1347 | D | 0.819675 | H | 0.807923 | 0.011752 | No Change: Both D | A renal clear cell carcinoma sample |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1417 | T | 0.771896 | I | 0.715291 | 0.056605 | No Change: Both D | - |
| Q8NEV4 | MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens GN=MYO3A PE=1 SV=2 | 1488 | K | 0.843506 | E | 0.841756 | 0.00175 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 275 | I | 0.207955 | V | 0.219732 | -0.011777 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 309 | K | 0.47244 | E | 0.440654 | 0.031786 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 406 | A | 0.579368 | T | 0.603461 | -0.024093 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 770 | V | 0.336707 | I | 0.307405 | 0.029302 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 798 | E | 0.461189 | K | 0.445736 | 0.015453 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 1082 | R | 0.538461 | K | 0.586752 | -0.048291 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 21 | P | 0.455951 | S | 0.484788 | -0.028837 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 185 | R | 0.528989 | H | 0.519383 | 0.009606 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 267 | N | 0.229711 | S | 0.278075 | -0.048364 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 316 | H | 0.637718 | L | 0.538374 | 0.099344 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 352 | E | 0.243404 | Q | 0.191042 | 0.052362 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 388 | N | 0.211399 | S | 0.251649 | -0.04025 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 638 | Q | 0.419306 | P | 0.45071 | -0.031404 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 773 | E | 0.366894 | G | 0.307869 | 0.059025 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 918 | R | 0.420094 | Q | 0.431651 | -0.011557 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 969 | S | 0.377439 | C | 0.176762 | 0.200677 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 990 | R | 0.336508 | C | 0.177222 | 0.159286 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 1092 | I | 0.434137 | V | 0.451461 | -0.017324 | No Change: Both O | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 1137 | V | 0.938593 | I | 0.924797 | 0.013796 | No Change: Both D | - |
| Q8WXR4 | MYO3B_HUMAN Myosin-IIIb OS=Homo sapiens GN=MYO3B PE=2 SV=4 | 1165 | R | 0.949009 | C | 0.925798 | 0.023211 | No Change: Both D | - |
| Q9Y4I1 | MYO5A_HUMAN Myosin-Va OS=Homo sapiens GN=MYO5A PE=1 SV=2 | 1246 | R | 0.59695 | C | 0.468629 | 0.128321 | D to O | - |
| Q9Y4I1 | MYO5A_HUMAN Myosin-Va OS=Homo sapiens GN=MYO5A PE=1 SV=2 | 627 | M | 0.841358 | T | 0.854255 | -0.012897 | No Change: Both D | - |
| Q9Y4I1 | MYO5A_HUMAN Myosin-Va OS=Homo sapiens GN=MYO5A PE=1 SV=2 | 1673 | S | 0.259566 | L | 0.124199 | 0.135367 | No Change: Both O | - |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 108 | V | 0.030304 | G | 0.057647 | -0.027343 | No Change: Both O | Diarrhea type 2 (DIAR2) [MIM:251850] |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 219 | R | 0.448782 | H | 0.442477 | 0.006305 | No Change: Both O | Diarrhea type 2 (DIAR2) [MIM:251850] |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 656 | R | 0.215221 | C | 0.135522 | 0.079699 | No Change: Both O | Diarrhea type 2 (DIAR2) [MIM:251850] |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 10 | C | 0.114664 | G | 0.220669 | -0.106005 | No Change: Both O | - |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 307 | K | 0.482513 | N | 0.438547 | 0.043966 | No Change: Both O | - |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 918 | R | 0.550123 | H | 0.514191 | 0.035932 | No Change: Both D | - |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 942 | K | 0.719369 | R | 0.677477 | 0.041892 | No Change: Both D | - |
| Q9ULV0 | MYO5B_HUMAN Myosin-Vb OS=Homo sapiens GN=MYO5B PE=1 SV=3 | 126 | T | 0.227558 | A | 0.204793 | 0.022765 | No Change: Both O | - |
| Q9NQX4 | MYO5C_HUMAN Myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 SV=2 | 522 | L | 0.252903 | P | 0.399158 | -0.146255 | No Change: Both O | - |
| Q9NQX4 | MYO5C_HUMAN Myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 SV=2 | 634 | L | 0.209343 | S | 0.363162 | -0.153819 | No Change: Both O | - |
| Q9NQX4 | MYO5C_HUMAN Myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 SV=2 | 1075 | E | 0.717671 | K | 0.714525 | 0.003146 | No Change: Both D | - |
| Q9NQX4 | MYO5C_HUMAN Myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 SV=2 | 1396 | P | 0.077669 | L | 0.037899 | 0.03977 | No Change: Both O | - |
| Q9NQX4 | MYO5C_HUMAN Myosin-Vc OS=Homo sapiens GN=MYO5C PE=1 SV=2 | 172 | R | 0.364292 | C | 0.227504 | 0.136788 | No Change: Both O | - |
| Q9UM54 | MYO6_HUMAN Myosin-VI OS=Homo sapiens GN=MYO6 PE=1 SV=4 | 442 | C | 0.184328 | Y | 0.231623 | -0.047295 | No Change: Both O | Deafness autosomal dominant type 22 (DFNA22) [MIM:606346] |
| Q9UM54 | MYO6_HUMAN Myosin-VI OS=Homo sapiens GN=MYO6 PE=1 SV=4 | 216 | E | 0.420644 | V | 0.26374 | 0.156904 | No Change: Both O | Deafness autosomal recessive type 37 (DFNB37) [MIM:607821] |
| Q9UM54 | MYO6_HUMAN Myosin-VI OS=Homo sapiens GN=MYO6 PE=1 SV=4 | 246 | H | 0.137505 | R | 0.158368 | -0.020863 | No Change: Both O | Deafness sensorineural with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 16 | L | 0.147257 | S | 0.273825 | -0.126568 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 25 | G | 0.09617 | R | 0.089134 | 0.007036 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 205 | I | 0.537533 | V | 0.571416 | -0.033883 | No Change: Both D | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 212 | R | 0.444783 | C | 0.266253 | 0.17853 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 212 | R | 0.444783 | H | 0.44434 | 4.43E-04 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 214 | G | 0.360856 | R | 0.366849 | -0.005993 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 241 | R | 0.247787 | S | 0.298288 | -0.050501 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 244 | R | 0.2755 | P | 0.28626 | -0.01076 | No Change: Both O | Deafness autosomal recessive type 2 (DFNB2) [MIM:600060] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 302 | R | 0.256776 | H | 0.259502 | -0.002726 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 397 | A | 0.134941 | D | 0.194629 | -0.059688 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 450 | E | 0.119941 | Q | 0.105045 | 0.014896 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 503 | P | 0.368702 | L | 0.255631 | 0.113071 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 597 | V | 0.31634 | I | 0.327577 | -0.011237 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 599 | M | 0.406145 | I | 0.322729 | 0.083416 | No Change: Both O | Deafness autosomal recessive type 2 (DFNB2) [MIM:600060] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 651 | L | 0.110131 | P | 0.208793 | -0.098662 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 826 | A | 0.164194 | T | 0.15666 | 0.007534 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 955 | G | 0.774889 | S | 0.797474 | -0.022585 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1087 | L | 0.685873 | P | 0.798144 | -0.112271 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1170 | E | 0.145113 | K | 0.151946 | -0.006833 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1240 | R | 0.448028 | Q | 0.463639 | -0.015611 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1288 | A | 0.262113 | P | 0.317789 | -0.055676 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1343 | R | 0.14352 | S | 0.168646 | -0.025126 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1602 | R | 0.273524 | Q | 0.273464 | 6.00E-05 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1628 | A | 0.212201 | S | 0.319635 | -0.107434 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1666 | C | 0.276737 | S | 0.417875 | -0.141138 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1719 | Y | 0.503774 | C | 0.501761 | 0.002013 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1954 | I | 0.187274 | L | 0.197854 | -0.01058 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1992 | F | 0.060348 | I | 0.05676 | 0.003588 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 2137 | G | 0.130696 | E | 0.164904 | -0.034208 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 2163 | G | 0.33664 | S | 0.410472 | -0.073832 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 26 | A | 0.098327 | E | 0.165014 | -0.066687 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 67 | V | 0.413915 | M | 0.487933 | -0.074018 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 90 | R | 0.089618 | P | 0.09653 | -0.006912 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 134 | I | 0.16085 | N | 0.282082 | -0.121232 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 165 | T | 0.693136 | M | 0.646505 | 0.046631 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 241 | R | 0.247787 | C | 0.14023 | 0.107557 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 457 | A | 0.137223 | V | 0.098903 | 0.03832 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 519 | G | 0.647694 | D | 0.715561 | -0.067867 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 756 | R | 0.176201 | W | 0.067541 | 0.10866 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 968 | E | 0.887594 | D | 0.877746 | 0.009848 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1743 | R | 0.594729 | W | 0.370921 | 0.223808 | D to O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1858 | L | 0.333295 | P | 0.483035 | -0.14974 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1883 | R | 0.526514 | Q | 0.533546 | -0.007032 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1887 | P | 0.389893 | L | 0.245941 | 0.143952 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 2187 | G | 0.317391 | D | 0.35817 | -0.040779 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 133 | H | 0.192241 | D | 0.22869 | -0.036449 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 163 | G | 0.742473 | R | 0.716612 | 0.025861 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 164 | K | 0.736093 | R | 0.68231 | 0.053783 | No Change: Both D | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 198 | A | 0.216226 | T | 0.239098 | -0.022872 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 204 | T | 0.453277 | A | 0.44311 | 0.010167 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 458 | N | 0.132723 | I | 0.06096 | 0.071763 | No Change: Both O | Deafness autosomal dominant type 11 (DFNA11) [MIM:601317] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 722 | G | 0.254169 | R | 0.24577 | 0.008399 | No Change: Both O | Deafness autosomal dominant type 11 (DFNA11) [MIM:601317] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 853 | R | 0.323458 | C | 0.189389 | 0.134069 | No Change: Both O | Deafness autosomal dominant type 11 (DFNA11) [MIM:601317] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1327 | E | 0.409674 | K | 0.408862 | 8.12E-04 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1566 | T | 0.467598 | M | 0.383064 | 0.084534 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1666 | C | 0.276737 | G | 0.391813 | -0.115076 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1740 | G | 0.620269 | S | 0.717764 | -0.097495 | No Change: Both D | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 1873 | R | 0.241754 | W | 0.089923 | 0.151831 | No Change: Both O | Usher syndrome type 1B (USH1B) [MIM:276900] |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 2142 | D | 0.338552 | N | 0.313226 | 0.025326 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 602 | E | 0.5887 | K | 0.610116 | -0.021416 | No Change: Both D | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 679 | V | 0.11223 | I | 0.098187 | 0.014043 | No Change: Both O | - |
| Q13402 | MYO7A_HUMAN Myosin-VIIa OS=Homo sapiens GN=MYO7A PE=1 SV=1 | 193 | T | 0.178434 | I | 0.108836 | 0.069598 | No Change: Both O | Leber congenital amaurosis (LCA) |
| Q6PIF6 | MYO7B_HUMAN Myosin-VIIb OS=Homo sapiens GN=MYO7B PE=2 SV=2 | 21 | G | 0.391656 | S | 0.433395 | -0.041739 | No Change: Both O | - |
| Q6PIF6 | MYO7B_HUMAN Myosin-VIIb OS=Homo sapiens GN=MYO7B PE=2 SV=2 | 1264 | R | 0.379249 | Q | 0.410576 | -0.031327 | No Change: Both O | - |
| Q6PIF6 | MYO7B_HUMAN Myosin-VIIb OS=Homo sapiens GN=MYO7B PE=2 SV=2 | 1647 | E | 0.19354 | D | 0.175027 | 0.018513 | No Change: Both O | - |
| Q6PIF6 | MYO7B_HUMAN Myosin-VIIb OS=Homo sapiens GN=MYO7B PE=2 SV=2 | 2105 | Q | 0.69533 | R | 0.683701 | 0.011629 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 37 | R | 0.361672 | K | 0.436862 | -0.07519 | No Change: Both O | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 85 | R | 0.158422 | Q | 0.168074 | -0.009652 | No Change: Both O | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 161 | T | 0.471452 | I | 0.34041 | 0.131042 | No Change: Both O | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 168 | N | 0.377861 | D | 0.378796 | -9.35E-04 | No Change: Both O | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 211 | L | 0.386611 | P | 0.566593 | -0.179982 | O to D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 946 | R | 0.327956 | Q | 0.346081 | -0.018125 | No Change: Both O | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1193 | G | 0.531501 | E | 0.581123 | -0.049622 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1362 | S | 0.960616 | P | 0.957121 | 0.003495 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1476 | P | 0.700353 | R | 0.700529 | -1.76E-04 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1795 | H | 0.632439 | Y | 0.535952 | 0.096487 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1805 | H | 0.775377 | Q | 0.806286 | -0.030909 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 1834 | R | 0.877487 | C | 0.825857 | 0.05163 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 2390 | I | 0.973447 | V | 0.971804 | 0.001643 | No Change: Both D | - |
| B2RTY4 | MYO9A_HUMAN Myosin-IXa OS=Homo sapiens GN=MYO9A PE=1 SV=2 | 825 | A | 0.585717 | V | 0.47178 | 0.113937 | D to O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 246 | G | 0.35706 | R | 0.358108 | -0.001048 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 337 | Q | 0.311037 | R | 0.311971 | -9.34E-04 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 364 | G | 0.389184 | V | 0.230728 | 0.158456 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 367 | G | 0.296119 | R | 0.259979 | 0.03614 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 370 | P | 0.276576 | L | 0.147933 | 0.128643 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 426 | V | 0.160918 | F | 0.15207 | 0.008848 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 437 | Y | 0.104007 | H | 0.15662 | -0.052613 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 477 | I | 0.345901 | S | 0.590375 | -0.244474 | O to D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 480 | N | 0.322534 | K | 0.384558 | -0.062024 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 499 | I | 0.456305 | F | 0.457802 | -0.001497 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 53 | V | 0.59193 | A | 0.677451 | -0.085521 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 433 | C | 0.040988 | R | 0.083889 | -0.042901 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 4 | F | 0.227526 | S | 0.484669 | -0.257143 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 9 | C | 0.098689 | S | 0.231658 | -0.132969 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 12 | G | 0.191059 | R | 0.20281 | -0.011751 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 19 | Q | 0.094295 | H | 0.083235 | 0.01106 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 73 | N | 0.83108 | S | 0.88384 | -0.05276 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 76 | R | 0.845253 | K | 0.84287 | 0.002383 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 82 | R | 0.876374 | C | 0.827427 | 0.048947 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 82 | R | 0.876374 | H | 0.856632 | 0.019742 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 189 | R | 0.822309 | Q | 0.821707 | 6.02E-04 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 203 | S | 0.645075 | F | 0.474484 | 0.170591 | D to O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 286 | W | 0.238821 | R | 0.460568 | -0.221747 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 293 | T | 0.192633 | K | 0.235274 | -0.042641 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 329 | V | 0.252582 | M | 0.294598 | -0.042016 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 352 | E | 0.421264 | K | 0.417568 | 0.003696 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 353 | T | 0.482181 | I | 0.333312 | 0.148869 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 361 | P | 0.573715 | S | 0.599547 | -0.025832 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 377 | T | 0.143989 | M | 0.118642 | 0.025347 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 380 | D | 0.163417 | A | 0.115087 | 0.04833 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 380 | D | 0.163417 | G | 0.147515 | 0.015902 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 393 | S | 0.139066 | R | 0.10476 | 0.034306 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 398 | K | 0.327054 | R | 0.253647 | 0.073407 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 402 | V | 0.267218 | I | 0.252779 | 0.014439 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 422 | R | 0.327914 | C | 0.186978 | 0.140936 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 422 | R | 0.327914 | H | 0.333313 | -0.005399 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 423 | K | 0.315013 | E | 0.331938 | -0.016925 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 425 | S | 0.203867 | P | 0.184181 | 0.019686 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 445 | A | 0.430351 | V | 0.349679 | 0.080672 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 465 | I | 0.255145 | M | 0.332391 | -0.077246 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 470 | R | 0.340482 | C | 0.197662 | 0.14282 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 473 | Y | 0.340767 | C | 0.274323 | 0.066444 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 477 | I | 0.345901 | N | 0.547667 | -0.201766 | O to D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 481 | P | 0.295939 | L | 0.180429 | 0.11551 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 481 | P | 0.295939 | T | 0.2497 | 0.046239 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 495 | V | 0.10991 | I | 0.112505 | -0.002595 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 500 | K | 0.582784 | R | 0.518107 | 0.064677 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 502 | S | 0.739289 | P | 0.720925 | 0.018364 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 208 | D | 0.524676 | E | 0.593612 | -0.068936 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 16 | P | 0.174181 | L | 0.093925 | 0.080256 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 17 | A | 0.146294 | S | 0.21722 | -0.070926 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 25 | C | 0.029165 | R | 0.05375 | -0.024585 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 48 | Q | 0.404689 | H | 0.339782 | 0.064907 | No Change: Both O | Primary congenital glaucoma type 3A (GLC3A) [MIM:231300] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 48 | Q | 0.404689 | H | 0.339782 | 0.064907 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 57 | N | 0.779243 | D | 0.791534 | -0.012291 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 57 | N | 0.779243 | S | 0.82577 | -0.046527 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 77 | D | 0.849466 | E | 0.866227 | -0.016761 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 95 | L | 0.879304 | P | 0.911101 | -0.031797 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 126 | R | 0.958295 | W | 0.880137 | 0.078158 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 158 | R | 0.971772 | Q | 0.970413 | 0.001359 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 215 | L | 0.558916 | P | 0.682752 | -0.123836 | No Change: Both D | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 244 | G | 0.412511 | V | 0.289123 | 0.123388 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 245 | C | 0.371993 | Y | 0.381985 | -0.009992 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 251 | V | 0.22863 | A | 0.277803 | -0.049173 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 252 | G | 0.223346 | R | 0.229769 | -0.006423 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 261 | E | 0.312907 | K | 0.316259 | -0.003352 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 272 | R | 0.321461 | G | 0.34612 | -0.024659 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 274 | P | 0.434289 | R | 0.387501 | 0.046788 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 300 | E | 0.129819 | K | 0.131891 | -0.002072 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 323 | E | 0.36661 | K | 0.371626 | -0.005016 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 337 | Q | 0.311037 | E | 0.371336 | -0.060299 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 341 | S | 0.268101 | P | 0.240522 | 0.027579 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 342 | R | 0.243863 | K | 0.278616 | -0.034753 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 345 | I | 0.250266 | M | 0.34088 | -0.090614 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 360 | I | 0.620686 | N | 0.767538 | -0.146852 | No Change: Both D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 363 | A | 0.462878 | T | 0.48595 | -0.023072 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 369 | F | 0.289175 | L | 0.314777 | -0.025602 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 377 | T | 0.143989 | K | 0.198209 | -0.05422 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 380 | D | 0.163417 | H | 0.129166 | 0.034251 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 380 | D | 0.163417 | N | 0.140137 | 0.02328 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 393 | S | 0.139066 | N | 0.116703 | 0.022363 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 399 | G | 0.334454 | V | 0.221673 | 0.112781 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 414 | E | 0.446561 | K | 0.42491 | 0.021651 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 427 | A | 0.129655 | T | 0.144935 | -0.01528 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 434 | G | 0.046223 | S | 0.068589 | -0.022366 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 438 | T | 0.155141 | I | 0.085295 | 0.069846 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 448 | T | 0.347581 | P | 0.378832 | -0.031251 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 450 | N | 0.278295 | D | 0.314767 | -0.036472 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 470 | R | 0.340482 | H | 0.34575 | -0.005268 | No Change: Both O | - |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 471 | Y | 0.337338 | C | 0.27142 | 0.065918 | No Change: Both O | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| Q99972 | MYOC_HUMAN Myocilin OS=Homo sapiens GN=MYOC PE=1 SV=2 | 499 | I | 0.456305 | S | 0.609379 | -0.153074 | O to D | Primary open angle glaucoma type 1A (GLC1A) [MIM:137750] |
| P15172 | MYOD1_HUMAN Myoblast determination protein 1 OS=Homo sapiens GN=MYOD1 PE=1 SV=3 | 262 | E | 0.920267 | K | 0.90723 | 0.013037 | No Change: Both D | A breast cancer sample |
| P15172 | MYOD1_HUMAN Myoblast determination protein 1 OS=Homo sapiens GN=MYOD1 PE=1 SV=3 | 309 | A | 0.943584 | V | 0.91166 | 0.031924 | No Change: Both D | A breast cancer sample |
| Q9NZM1 | MYOF_HUMAN Myoferlin OS=Homo sapiens GN=MYOF PE=1 SV=1 | 1198 | Y | 0.244922 | F | 0.239113 | 0.005809 | No Change: Both O | - |
| Q9NZM1 | MYOF_HUMAN Myoferlin OS=Homo sapiens GN=MYOF PE=1 SV=1 | 1399 | R | 0.20645 | C | 0.121934 | 0.084516 | No Change: Both O | - |
| Q9NZM1 | MYOF_HUMAN Myoferlin OS=Homo sapiens GN=MYOF PE=1 SV=1 | 1783 | R | 0.384635 | Q | 0.392351 | -0.007716 | No Change: Both O | - |
| Q9NZM1 | MYOF_HUMAN Myoferlin OS=Homo sapiens GN=MYOF PE=1 SV=1 | 1136 | V | 0.042591 | I | 0.03789 | 0.004701 | No Change: Both O | - |
| Q9NZM1 | MYOF_HUMAN Myoferlin OS=Homo sapiens GN=MYOF PE=1 SV=1 | 1701 | G | 0.487319 | A | 0.41361 | 0.073709 | No Change: Both O | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 22 | V | 0.649931 | L | 0.655466 | -0.005535 | No Change: Both D | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 181 | S | 0.928517 | P | 0.911527 | 0.01699 | No Change: Both D | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 215 | T | 0.997893 | M | 0.997355 | 5.38E-04 | No Change: Both D | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 341 | G | 0.248103 | A | 0.203936 | 0.044167 | No Change: Both O | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 600 | E | 0.483046 | V | 0.318993 | 0.164053 | No Change: Both O | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 960 | I | 0.353508 | T | 0.46485 | -0.111342 | No Change: Both O | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 1408 | D | 0.263699 | N | 0.223349 | 0.04035 | No Change: Both O | - |
| P52179 | MYOM1_HUMAN Myomesin-1 OS=Homo sapiens GN=MYOM1 PE=1 SV=2 | 1453 | M | 0.21079 | T | 0.229499 | -0.018709 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 776 | T | 0.274319 | M | 0.225472 | 0.048847 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 1022 | L | 0.23683 | F | 0.214212 | 0.022618 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 81 | E | 0.827024 | K | 0.810855 | 0.016169 | No Change: Both D | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 182 | T | 0.113159 | M | 0.088689 | 0.02447 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 321 | V | 0.239425 | L | 0.264513 | -0.025088 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 363 | V | 0.399819 | I | 0.36851 | 0.031309 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 601 | S | 0.56565 | Y | 0.354634 | 0.211016 | D to O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 701 | V | 0.495873 | I | 0.463684 | 0.032189 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 1284 | E | 0.381025 | D | 0.343298 | 0.037727 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 869 | N | 0.298452 | S | 0.334733 | -0.036281 | No Change: Both O | - |
| P54296 | MYOM2_HUMAN Myomesin-2 OS=Homo sapiens GN=MYOM2 PE=2 SV=2 | 1168 | V | 0.202319 | A | 0.253361 | -0.051042 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 266 | T | 0.426078 | M | 0.378382 | 0.047696 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 344 | M | 0.390362 | T | 0.443678 | -0.053316 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 435 | Q | 0.29763 | R | 0.307354 | -0.009724 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 528 | D | 0.563181 | G | 0.556475 | 0.006706 | No Change: Both D | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 662 | G | 0.355586 | R | 0.360854 | -0.005268 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 775 | R | 0.182163 | Q | 0.182611 | -4.48E-04 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 853 | P | 0.497662 | S | 0.510365 | -0.012703 | O to D | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 892 | D | 0.539539 | A | 0.449608 | 0.089931 | D to O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 1041 | F | 0.219215 | L | 0.249474 | -0.030259 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 1066 | I | 0.231993 | T | 0.341544 | -0.109551 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 1124 | R | 0.47553 | Q | 0.494885 | -0.019355 | No Change: Both O | - |
| Q5VTT5 | MYOM3_HUMAN Myomesin-3 OS=Homo sapiens GN=MYOM3 PE=2 SV=1 | 258 | D | 0.394194 | H | 0.342659 | 0.051535 | No Change: Both O | - |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 55 | S | 0.966027 | F | 0.931475 | 0.034552 | No Change: Both D | Limb-girdle muscular dystrophy type 1A (LGMD1A) [MIM:159000] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 55 | S | 0.966027 | F | 0.931475 | 0.034552 | No Change: Both D | Myopathy myofibrillar type 3 (MFM3) [MIM:609200] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 57 | T | 0.963148 | I | 0.943379 | 0.019769 | No Change: Both D | Limb-girdle muscular dystrophy type 1A (LGMD1A) [MIM:159000] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 60 | S | 0.959174 | C | 0.918943 | 0.040231 | No Change: Both D | Myopathy myofibrillar type 3 (MFM3) [MIM:609200] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 60 | S | 0.959174 | F | 0.910564 | 0.04861 | No Change: Both D | Myopathy myofibrillar type 3 (MFM3) [MIM:609200] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 95 | S | 0.908913 | I | 0.821556 | 0.087357 | No Change: Both D | Myopathy myofibrillar type 3 (MFM3) [MIM:609200] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 39 | S | 0.982381 | F | 0.9614 | 0.020981 | No Change: Both D | Spheroid body myopathy (SBM) [MIM:182920] |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 74 | K | 0.931287 | Q | 0.947865 | -0.016578 | No Change: Both D | - |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 33 | S | 0.981172 | I | 0.96029 | 0.020882 | No Change: Both D | A colorectal cancer sample |
| Q9UBF9 | MYOTI_HUMAN Myotilin OS=Homo sapiens GN=MYOT PE=1 SV=2 | 50 | Q | 0.974171 | R | 0.972056 | 0.002115 | No Change: Both D | - |
| Q9NPC6 | MYOZ2_HUMAN Myozenin-2 OS=Homo sapiens GN=MYOZ2 PE=1 SV=1 | 48 | S | 0.5284 | P | 0.495957 | 0.032443 | D to O | Familial hypertrophic cardiomyopathy type 16 (CMH16) [MIM:613838] |
| Q9NPC6 | MYOZ2_HUMAN Myozenin-2 OS=Homo sapiens GN=MYOZ2 PE=1 SV=1 | 246 | I | 0.57352 | M | 0.652656 | -0.079136 | No Change: Both D | Familial hypertrophic cardiomyopathy type 16 (CMH16) [MIM:613838] |
| Q8TDC0 | MYOZ3_HUMAN Myozenin-3 OS=Homo sapiens GN=MYOZ3 PE=1 SV=2 | 209 | T | 0.77319 | N | 0.787162 | -0.013972 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 691 | S | 0.946142 | N | 0.934903 | 0.011239 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 707 | S | 0.944716 | N | 0.929446 | 0.01527 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 803 | S | 0.956006 | R | 0.946952 | 0.009054 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 393 | V | 0.882392 | A | 0.908634 | -0.026242 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 628 | F | 0.911131 | L | 0.910239 | 8.92E-04 | No Change: Both D | - |
| Q86TC9 | MYPN_HUMAN Myopalladin OS=Homo sapiens GN=MYPN PE=1 SV=2 | 1135 | P | 0.295751 | T | 0.266272 | 0.029479 | No Change: Both O | - |
| Q8NFW9 | MYRIP_HUMAN Rab effector MyRIP OS=Homo sapiens GN=MYRIP PE=1 SV=2 | 673 | P | 0.674232 | S | 0.678118 | -0.003886 | No Change: Both D | - |
| Q8NFW9 | MYRIP_HUMAN Rab effector MyRIP OS=Homo sapiens GN=MYRIP PE=1 SV=2 | 312 | A | 0.898626 | T | 0.904604 | -0.005978 | No Change: Both D | - |
| Q8NFW9 | MYRIP_HUMAN Rab effector MyRIP OS=Homo sapiens GN=MYRIP PE=1 SV=2 | 365 | P | 0.625118 | L | 0.466686 | 0.158432 | D to O | - |
| Q5VVJ2 | MYSM1_HUMAN Histone H2A deubiquitinase MYSM1 OS=Homo sapiens GN=MYSM1 PE=1 SV=1 | 200 | C | 0.56364 | S | 0.707962 | -0.144322 | No Change: Both D | - |
| Q5VVJ2 | MYSM1_HUMAN Histone H2A deubiquitinase MYSM1 OS=Homo sapiens GN=MYSM1 PE=1 SV=1 | 264 | T | 0.890136 | A | 0.871497 | 0.018639 | No Change: Both D | - |
| Q5VVJ2 | MYSM1_HUMAN Histone H2A deubiquitinase MYSM1 OS=Homo sapiens GN=MYSM1 PE=1 SV=1 | 825 | E | 0.75755 | K | 0.746664 | 0.010886 | No Change: Both D | - |
| P28698 | MZF1_HUMAN Myeloid zinc finger 1 OS=Homo sapiens GN=MZF1 PE=1 SV=3 | 331 | I | 0.822677 | V | 0.861737 | -0.03906 | No Change: Both D | - |
| P28698 | MZF1_HUMAN Myeloid zinc finger 1 OS=Homo sapiens GN=MZF1 PE=1 SV=3 | 51 | R | 0.670883 | H | 0.551486 | 0.119397 | No Change: Both D | - |
| P28698 | MZF1_HUMAN Myeloid zinc finger 1 OS=Homo sapiens GN=MZF1 PE=1 SV=3 | 103 | R | 0.792504 | H | 0.719509 | 0.072995 | No Change: Both D | - |
| P28698 | MZF1_HUMAN Myeloid zinc finger 1 OS=Homo sapiens GN=MZF1 PE=1 SV=3 | 130 | R | 0.844388 | Q | 0.849547 | -0.005159 | No Change: Both D | - |
| P28698 | MZF1_HUMAN Myeloid zinc finger 1 OS=Homo sapiens GN=MZF1 PE=1 SV=3 | 441 | R | 0.781894 | P | 0.794204 | -0.01231 | No Change: Both D | - |
| Q08AG7 | MZT1_HUMAN Mitotic-spindle organizing protein 1 OS=Homo sapiens GN=MZT1 PE=1 SV=2 | 5 | S | 0.834042 | G | 0.822866 | 0.011176 | No Change: Both D | - |
| Q6NZ67 | MZT2B_HUMAN Mitotic-spindle organizing protein 2B OS=Homo sapiens GN=MZT2B PE=1 SV=1 | 118 | A | 0.963225 | V | 0.946821 | 0.016404 | No Change: Both D | - |
| Q6NZ67 | MZT2B_HUMAN Mitotic-spindle organizing protein 2B OS=Homo sapiens GN=MZT2B PE=1 SV=1 | 155 | R | 0.998951 | Q | 0.998818 | 1.33E-04 | No Change: Both D | - |
| Q86UW6 | N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens GN=N4BP2 PE=1 SV=2 | 283 | P | 0.79876 | A | 0.745353 | 0.053407 | No Change: Both D | A breast cancer sample |
| Q86UW6 | N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens GN=N4BP2 PE=1 SV=2 | 101 | S | 0.854736 | I | 0.75012 | 0.104616 | No Change: Both D | - |
| Q86UW6 | N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens GN=N4BP2 PE=1 SV=2 | 196 | M | 0.918144 | V | 0.884743 | 0.033401 | No Change: Both D | - |
| Q86UW6 | N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens GN=N4BP2 PE=1 SV=2 | 611 | D | 0.903507 | N | 0.885473 | 0.018034 | No Change: Both D | - |
| Q86UW6 | N4BP2_HUMAN NEDD4-binding protein 2 OS=Homo sapiens GN=N4BP2 PE=1 SV=2 | 1587 | T | 0.862849 | A | 0.839842 | 0.023007 | No Change: Both D | - |
| Q92802 | N42L2_HUMAN NEDD4-binding protein 2-like 2 OS=Homo sapiens GN=N4BP2L2 PE=1 SV=1 | 272 | Y | 0.261166 | H | 0.324558 | -0.063392 | No Change: Both O | - |
| Q9Y5N5 | HEMK2_HUMAN HemK methyltransferase family member 2 OS=Homo sapiens GN=N6AMT1 PE=1 SV=3 | 34 | N | 0.160497 | D | 0.183289 | -0.022792 | No Change: Both O | - |
| Q9Y5N5 | HEMK2_HUMAN HemK methyltransferase family member 2 OS=Homo sapiens GN=N6AMT1 PE=1 SV=3 | 146 | K | 0.472111 | R | 0.422749 | 0.049362 | No Change: Both O | - |
| Q9Y5N5 | HEMK2_HUMAN HemK methyltransferase family member 2 OS=Homo sapiens GN=N6AMT1 PE=1 SV=3 | 166 | K | 0.183706 | R | 0.14234 | 0.041366 | No Change: Both O | - |
| Q8WVE0 | N6MT2_HUMAN N(6)-adenine-specific DNA methyltransferase 2 OS=Homo sapiens GN=N6AMT2 PE=1 SV=1 | 193 | T | 0.266215 | N | 0.312512 | -0.046297 | No Change: Both O | - |
| P41227 | NAA10_HUMAN N-alpha-acetyltransferase 10 OS=Homo sapiens GN=NAA10 PE=1 SV=1 | 37 | S | 0.120467 | P | 0.108828 | 0.011639 | No Change: Both O | N-terminal acetyltransferase deficiency (NATD) [MIM:300855] |
| Q9BSU3 | NAA11_HUMAN N-alpha-acetyltransferase 11 OS=Homo sapiens GN=NAA11 PE=1 SV=3 | 6 | A | 0.710243 | T | 0.730254 | -0.020011 | No Change: Both D | - |
| Q9BSU3 | NAA11_HUMAN N-alpha-acetyltransferase 11 OS=Homo sapiens GN=NAA11 PE=1 SV=3 | 19 | L | 0.154936 | F | 0.115684 | 0.039252 | No Change: Both O | - |
| Q6N069 | NAA16_HUMAN N-alpha-acetyltransferase 16 NatA auxiliary subunit OS=Homo sapiens GN=NAA16 PE=1 SV=2 | 344 | E | 0.185863 | G | 0.139022 | 0.046841 | No Change: Both O | - |
| Q14CX7 | NAA25_HUMAN N-alpha-acetyltransferase 25 NatB auxiliary subunit OS=Homo sapiens GN=NAA25 PE=1 SV=1 | 876 | K | 0.792916 | R | 0.766668 | 0.026248 | No Change: Both D | - |
| Q14CX7 | NAA25_HUMAN N-alpha-acetyltransferase 25 NatB auxiliary subunit OS=Homo sapiens GN=NAA25 PE=1 SV=1 | 789 | S | 0.429559 | R | 0.368096 | 0.061463 | No Change: Both O | A breast cancer sample |
| Q14CX7 | NAA25_HUMAN N-alpha-acetyltransferase 25 NatB auxiliary subunit OS=Homo sapiens GN=NAA25 PE=1 SV=1 | 426 | L | 0.160465 | F | 0.127585 | 0.03288 | No Change: Both O | - |
| Q14CX7 | NAA25_HUMAN N-alpha-acetyltransferase 25 NatB auxiliary subunit OS=Homo sapiens GN=NAA25 PE=1 SV=1 | 915 | L | 0.183971 | I | 0.159453 | 0.024518 | No Change: Both O | - |
| Q9H7X0 | NAA60_HUMAN N-alpha-acetyltransferase 60 OS=Homo sapiens GN=NAA60 PE=2 SV=1 | 218 | H | 0.203295 | Q | 0.226887 | -0.023592 | No Change: Both O | - |
| Q02083 | NAAA_HUMAN N-acylethanolamine-hydrolyzing acid amidase OS=Homo sapiens GN=NAAA PE=1 SV=3 | 151 | V | 0.139566 | I | 0.115073 | 0.024493 | No Change: Both O | - |
| Q02083 | NAAA_HUMAN N-acylethanolamine-hydrolyzing acid amidase OS=Homo sapiens GN=NAAA PE=1 SV=3 | 107 | N | 0.092374 | K | 0.110559 | -0.018185 | No Change: Both O | - |
| Q02083 | NAAA_HUMAN N-acylethanolamine-hydrolyzing acid amidase OS=Homo sapiens GN=NAAA PE=1 SV=3 | 334 | F | 0.110102 | L | 0.126935 | -0.016833 | No Change: Both O | - |
| Q9Y3Q0 | NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens GN=NAALAD2 PE=1 SV=1 | 101 | V | 0.160841 | I | 0.133215 | 0.027626 | No Change: Both O | - |
| Q9Y3Q0 | NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens GN=NAALAD2 PE=1 SV=1 | 446 | I | 0.503418 | V | 0.527612 | -0.024194 | No Change: Both D | - |
| Q9UQQ1 | NALDL_HUMAN N-acetylated-alpha-linked acidic dipeptidase-like protein OS=Homo sapiens GN=NAALADL1 PE=2 SV=2 | 2 | Q | 0.663657 | H | 0.655114 | 0.008543 | No Change: Both D | - |
| Q9UQQ1 | NALDL_HUMAN N-acetylated-alpha-linked acidic dipeptidase-like protein OS=Homo sapiens GN=NAALADL1 PE=2 SV=2 | 398 | K | 0.326948 | T | 0.265906 | 0.061042 | No Change: Both O | - |
| Q9UQQ1 | NALDL_HUMAN N-acetylated-alpha-linked acidic dipeptidase-like protein OS=Homo sapiens GN=NAALADL1 PE=2 SV=2 | 611 | L | 0.381301 | V | 0.352829 | 0.028472 | No Change: Both O | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 68 | G | 0.693636 | S | 0.744458 | -0.050822 | No Change: Both D | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 128 | I | 0.023723 | M | 0.03462 | -0.010897 | No Change: Both O | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 194 | M | 0.609914 | T | 0.652354 | -0.04244 | No Change: Both D | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 385 | P | 0.69385 | S | 0.704385 | -0.010535 | No Change: Both D | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 622 | P | 0.485166 | R | 0.456011 | 0.029155 | No Change: Both O | - |
| Q58DX5 | NADL2_HUMAN Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 OS=Homo sapiens GN=NAALADL2 PE=1 SV=3 | 677 | L | 0.541369 | S | 0.657673 | -0.116304 | No Change: Both D | - |
| Q9H009 | NACA2_HUMAN Nascent polypeptide-associated complex subunit alpha-2 OS=Homo sapiens GN=NACA2 PE=1 SV=1 | 64 | V | 0.786865 | I | 0.773723 | 0.013142 | No Change: Both D | - |
| O15069 | NACAD_HUMAN NAC-alpha domain-containing protein 1 OS=Homo sapiens GN=NACAD PE=2 SV=3 | 438 | D | 0.69189 | E | 0.733456 | -0.041566 | No Change: Both D | - |
| O15069 | NACAD_HUMAN NAC-alpha domain-containing protein 1 OS=Homo sapiens GN=NACAD PE=2 SV=3 | 498 | V | 0.839584 | A | 0.870264 | -0.03068 | No Change: Both D | - |
| O15069 | NACAD_HUMAN NAC-alpha domain-containing protein 1 OS=Homo sapiens GN=NACAD PE=2 SV=3 | 591 | K | 0.858693 | E | 0.862998 | -0.004305 | No Change: Both D | - |
| O15069 | NACAD_HUMAN NAC-alpha domain-containing protein 1 OS=Homo sapiens GN=NACAD PE=2 SV=3 | 1105 | D | 0.944786 | E | 0.962559 | -0.017773 | No Change: Both D | - |
| O15069 | NACAD_HUMAN NAC-alpha domain-containing protein 1 OS=Homo sapiens GN=NACAD PE=2 SV=3 | 1152 | C | 0.975169 | F | 0.964201 | 0.010968 | No Change: Both D | - |
| O95544 | NADK_HUMAN NAD kinase OS=Homo sapiens GN=NADK PE=1 SV=1 | 262 | N | 0.639366 | K | 0.656455 | -0.017089 | No Change: Both D | - |
| Q6IA69 | NADE_HUMAN Glutamine-dependent NAD(+) synthetase OS=Homo sapiens GN=NADSYN1 PE=1 SV=3 | 74 | V | 0.19831 | L | 0.196526 | 0.001784 | No Change: Both O | - |
| Q6IA69 | NADE_HUMAN Glutamine-dependent NAD(+) synthetase OS=Homo sapiens GN=NADSYN1 PE=1 SV=3 | 297 | P | 0.516448 | L | 0.343444 | 0.173004 | D to O | - |
| Q6IA69 | NADE_HUMAN Glutamine-dependent NAD(+) synthetase OS=Homo sapiens GN=NADSYN1 PE=1 SV=3 | 591 | M | 0.582606 | I | 0.466459 | 0.116147 | D to O | - |
| Q6IA69 | NADE_HUMAN Glutamine-dependent NAD(+) synthetase OS=Homo sapiens GN=NADSYN1 PE=1 SV=3 | 704 | G | 0.923692 | S | 0.916542 | 0.00715 | No Change: Both D | - |
| Q6IA69 | NADE_HUMAN Glutamine-dependent NAD(+) synthetase OS=Homo sapiens GN=NADSYN1 PE=1 SV=3 | 204 | Q | 0.473704 | H | 0.475769 | -0.002065 | No Change: Both O | - |
| Q13564 | ULA1_HUMAN NEDD8-activating enzyme E1 regulatory subunit OS=Homo sapiens GN=NAE1 PE=1 SV=1 | 101 | S | 0.64438 | F | 0.421356 | 0.223024 | D to O | - |
| Q96HR8 | NAF1_HUMAN H/ACA ribonucleoprotein complex non-core subunit NAF1 OS=Homo sapiens GN=NAF1 PE=1 SV=2 | 43 | P | 0.950578 | S | 0.944503 | 0.006075 | No Change: Both D | - |
| Q96HR8 | NAF1_HUMAN H/ACA ribonucleoprotein complex non-core subunit NAF1 OS=Homo sapiens GN=NAF1 PE=1 SV=2 | 162 | I | 0.914411 | V | 0.918097 | -0.003686 | No Change: Both D | - |
| P17050 | NAGAB_HUMAN Alpha-N-acetylgalactosaminidase OS=Homo sapiens GN=NAGA PE=1 SV=2 | 160 | S | 0.347507 | C | 0.186812 | 0.160695 | No Change: Both O | Schindler disease (SCHIND) [MIM:609241] |
| P17050 | NAGAB_HUMAN Alpha-N-acetylgalactosaminidase OS=Homo sapiens GN=NAGA PE=1 SV=2 | 325 | E | 0.28088 | K | 0.289388 | -0.008508 | No Change: Both O | Schindler disease (SCHIND) [MIM:609241] |
| P17050 | NAGAB_HUMAN Alpha-N-acetylgalactosaminidase OS=Homo sapiens GN=NAGA PE=1 SV=2 | 329 | R | 0.258605 | W | 0.116279 | 0.142326 | No Change: Both O | Kanzaki disease (KANZD) [MIM:609242] |
| P17050 | NAGAB_HUMAN Alpha-N-acetylgalactosaminidase OS=Homo sapiens GN=NAGA PE=1 SV=2 | 329 | R | 0.258605 | Q | 0.272211 | -0.013606 | No Change: Both O | Kanzaki disease (KANZD) [MIM:609242] |
| Q9UJ70 | NAGK_HUMAN N-acetyl-D-glucosamine kinase OS=Homo sapiens GN=NAGK PE=1 SV=4 | 38 | W | 0.155812 | R | 0.335553 | -0.179741 | No Change: Both O | - |
| Q9UJ70 | NAGK_HUMAN N-acetyl-D-glucosamine kinase OS=Homo sapiens GN=NAGK PE=1 SV=4 | 60 | A | 0.464493 | V | 0.398987 | 0.065506 | No Change: Both O | - |
| Q5TF39 | NAGT1_HUMAN Sodium-dependent glucose transporter 1 OS=Homo sapiens GN=NAGLT1 PE=2 SV=1 | 93 | S | 0.054999 | P | 0.044921 | 0.010078 | No Change: Both O | - |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 92 | Y | 0.158597 | H | 0.264962 | -0.106365 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 115 | P | 0.435121 | S | 0.441046 | -0.005925 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 140 | Y | 0.04924 | C | 0.040309 | 0.008931 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 153 | E | 0.100528 | K | 0.093882 | 0.006646 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 358 | P | 0.176996 | L | 0.088684 | 0.088312 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 643 | R | 0.246117 | H | 0.24914 | -0.003023 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 664 | A | 0.17182 | V | 0.120563 | 0.051257 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 674 | R | 0.057935 | H | 0.054446 | 0.003489 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 682 | L | 0.099383 | R | 0.163712 | -0.064329 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 79 | G | 0.46368 | C | 0.285184 | 0.178496 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 100 | H | 0.144912 | R | 0.199773 | -0.054861 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 243 | P | 0.224924 | L | 0.115575 | 0.109349 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 277 | C | 0.122961 | F | 0.13153 | -0.008569 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 280 | L | 0.140602 | P | 0.269497 | -0.128895 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 292 | G | 0.074559 | R | 0.077396 | -0.002837 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 452 | E | 0.2978 | K | 0.27957 | 0.01823 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 482 | R | 0.326292 | W | 0.152346 | 0.173946 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 561 | L | 0.211042 | R | 0.316213 | -0.105171 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 565 | R | 0.240187 | Q | 0.262219 | -0.022032 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 705 | E | 0.186743 | K | 0.205385 | -0.018642 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 737 | R | 0.102355 | G | 0.115354 | -0.012999 | No Change: Both O | - |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 48 | F | 0.562312 | L | 0.644609 | -0.082297 | No Change: Both D | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 314 | F | 0.44844 | L | 0.476673 | -0.028233 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 521 | P | 0.497399 | L | 0.342766 | 0.154633 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 565 | R | 0.240187 | P | 0.263991 | -0.023804 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 565 | R | 0.240187 | W | 0.098472 | 0.141715 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 643 | R | 0.246117 | C | 0.132011 | 0.114106 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 35 | L | 0.426278 | F | 0.367782 | 0.058496 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 38 | R | 0.443965 | W | 0.203166 | 0.240799 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 48 | F | 0.562312 | C | 0.612315 | -0.050003 | No Change: Both D | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 69 | G | 0.478854 | S | 0.51935 | -0.040496 | O to D | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 77 | V | 0.477511 | G | 0.615179 | -0.137668 | O to D | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 79 | G | 0.46368 | S | 0.507684 | -0.044004 | O to D | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 82 | G | 0.427216 | D | 0.430171 | -0.002955 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 130 | R | 0.232056 | C | 0.116702 | 0.115354 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 154 | I | 0.10289 | R | 0.210871 | -0.107981 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 156 | W | 0.086395 | C | 0.095817 | -0.009422 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 227 | H | 0.181033 | P | 0.204675 | -0.023642 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 234 | R | 0.318616 | C | 0.170608 | 0.148008 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 241 | V | 0.220293 | M | 0.286919 | -0.066626 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 242 | L | 0.226847 | P | 0.403233 | -0.176386 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 246 | A | 0.234617 | P | 0.316741 | -0.082124 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 248 | H | 0.248384 | R | 0.255413 | -0.007029 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 268 | W | 0.220205 | R | 0.411912 | -0.191707 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 309 | Y | 0.244753 | C | 0.216625 | 0.028128 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 334 | V | 0.257326 | F | 0.226349 | 0.030977 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 335 | Y | 0.267396 | C | 0.229352 | 0.038044 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 410 | F | 0.15918 | S | 0.308169 | -0.148989 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 412 | G | 0.253622 | E | 0.279209 | -0.025587 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 414 | H | 0.29812 | R | 0.283703 | 0.014417 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 437 | T | 0.369386 | I | 0.225407 | 0.143979 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 446 | E | 0.504616 | K | 0.489052 | 0.015564 | D to O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 455 | Y | 0.172332 | C | 0.15485 | 0.017482 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 474 | W | 0.110345 | G | 0.260524 | -0.150179 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 482 | R | 0.326292 | Q | 0.332439 | -0.006147 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 501 | V | 0.137569 | G | 0.241727 | -0.104158 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 516 | P | 0.557742 | L | 0.397591 | 0.160151 | D to O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 520 | R | 0.546255 | W | 0.315076 | 0.231179 | D to O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 534 | S | 0.161412 | Y | 0.070543 | 0.090869 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 560 | L | 0.206511 | P | 0.3399 | -0.133389 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 591 | L | 0.285304 | P | 0.416974 | -0.13167 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 612 | S | 0.334972 | G | 0.270961 | 0.064011 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 617 | L | 0.228246 | F | 0.193476 | 0.03477 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 649 | W | 0.166424 | C | 0.193705 | -0.027281 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 650 | G | 0.16267 | E | 0.19989 | -0.03722 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 658 | Y | 0.231624 | F | 0.199259 | 0.032365 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 674 | R | 0.057935 | C | 0.024045 | 0.03389 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| P54802 | ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGLU PE=1 SV=2 | 676 | R | 0.053541 | P | 0.06377 | -0.010229 | No Change: Both O | Mucopolysaccharidosis type 3B (MPS3B) [MIM:252920] |
| Q9UK23 | NAGPA_HUMAN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Homo sapiens GN=NAGPA PE=2 SV=2 | 465 | T | 0.141986 | I | 0.08202 | 0.059966 | No Change: Both O | - |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 200 | C | 0.243138 | R | 0.369271 | -0.126133 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 279 | A | 0.316088 | P | 0.382136 | -0.066048 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 410 | S | 0.345513 | P | 0.323294 | 0.022219 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 430 | L | 0.141234 | P | 0.250242 | -0.109008 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 484 | W | 0.229658 | R | 0.44518 | -0.215522 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q8N159 | NAGS_HUMAN N-acetylglutamate synthase mitochondrial OS=Homo sapiens GN=NAGS PE=1 SV=1 | 518 | A | 0.432137 | T | 0.458341 | -0.026204 | No Change: Both O | N-acetylglutamate synthase deficiency (NAGSD) [MIM:237310] |
| Q13075 | BIRC1_HUMAN Baculoviral IAP repeat-containing protein 1 OS=Homo sapiens GN=NAIP PE=1 SV=3 | 535 | V | 0.131445 | M | 0.177582 | -0.046137 | No Change: Both O | - |
| P43490 | NAMPT_HUMAN Nicotinamide phosphoribosyltransferase OS=Homo sapiens GN=NAMPT PE=1 SV=1 | 176 | L | 0.218156 | S | 0.403015 | -0.184859 | No Change: Both O | A colorectal cancer sample |
| Q9H9S0 | NANOG_HUMAN Homeobox protein NANOG OS=Homo sapiens GN=NANOG PE=1 SV=2 | 82 | K | 0.973983 | N | 0.963 | 0.010983 | No Change: Both D | - |
| P60321 | NANO2_HUMAN Nanos homolog 2 OS=Homo sapiens GN=NANOS2 PE=1 SV=1 | 68 | H | 0.41026 | Q | 0.429201 | -0.018941 | No Change: Both O | - |
| Q9NR45 | SIAS_HUMAN Sialic acid synthase OS=Homo sapiens GN=NANS PE=1 SV=2 | 68 | E | 0.588042 | D | 0.543636 | 0.044406 | No Change: Both D | - |
| Q99457 | NP1L3_HUMAN Nucleosome assembly protein 1-like 3 OS=Homo sapiens GN=NAP1L3 PE=2 SV=2 | 224 | P | 0.998363 | A | 0.997565 | 7.98E-04 | No Change: Both D | - |
| Q96NT1 | NP1L5_HUMAN Nucleosome assembly protein 1-like 5 OS=Homo sapiens GN=NAP1L5 PE=2 SV=1 | 154 | E | 0.99931 | Q | 0.998879 | 4.31E-04 | No Change: Both D | - |
| Q9H115 | SNAB_HUMAN Beta-soluble NSF attachment protein OS=Homo sapiens GN=NAPB PE=1 SV=2 | 61 | A | 0.332797 | T | 0.32815 | 0.004647 | No Change: Both O | - |
| Q6IQ20 | NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens GN=NAPEPLD PE=1 SV=2 | 389 | D | 0.758769 | N | 0.749066 | 0.009703 | No Change: Both D | - |
| Q6IQ20 | NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens GN=NAPEPLD PE=1 SV=2 | 152 | S | 0.535526 | A | 0.417206 | 0.11832 | D to O | - |
| Q99747 | SNAG_HUMAN Gamma-soluble NSF attachment protein OS=Homo sapiens GN=NAPG PE=1 SV=1 | 281 | K | 0.683237 | N | 0.631709 | 0.051528 | No Change: Both D | - |
| Q99747 | SNAG_HUMAN Gamma-soluble NSF attachment protein OS=Homo sapiens GN=NAPG PE=1 SV=1 | 92 | P | 0.550182 | S | 0.560054 | -0.009872 | No Change: Both D | - |
| Q6XQN6 | PNCB_HUMAN Nicotinate phosphoribosyltransferase OS=Homo sapiens GN=NAPRT1 PE=1 SV=2 | 57 | A | 0.218443 | V | 0.145954 | 0.072489 | No Change: Both O | - |
| O96009 | NAPSA_HUMAN Napsin-A OS=Homo sapiens GN=NAPSA PE=1 SV=1 | 310 | A | 0.075168 | T | 0.082965 | -0.007797 | No Change: Both O | - |
| O96009 | NAPSA_HUMAN Napsin-A OS=Homo sapiens GN=NAPSA PE=1 SV=1 | 40 | I | 0.351342 | T | 0.467121 | -0.115779 | No Change: Both O | - |
| Q9H6Q4 | NARFL_HUMAN Cytosolic Fe-S cluster assembly factor NARFL OS=Homo sapiens GN=NARFL PE=1 SV=1 | 38 | V | 0.435346 | M | 0.492049 | -0.056703 | No Change: Both O | - |
| Q9H6Q4 | NARFL_HUMAN Cytosolic Fe-S cluster assembly factor NARFL OS=Homo sapiens GN=NARFL PE=1 SV=1 | 444 | H | 0.177963 | R | 0.187307 | -0.009344 | No Change: Both O | - |
| Q96I59 | SYNM_HUMAN Probable asparagine--tRNA ligase mitochondrial OS=Homo sapiens GN=NARS2 PE=1 SV=3 | 87 | N | 0.682247 | T | 0.627147 | 0.0551 | No Change: Both D | - |
| P49321 | NASP_HUMAN Nuclear autoantigenic sperm protein OS=Homo sapiens GN=NASP PE=1 SV=2 | 620 | V | 0.428644 | G | 0.53098 | -0.102336 | O to D | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 64 | R | 0.166224 | W | 0.064474 | 0.10175 | No Change: Both O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 149 | V | 0.135499 | I | 0.112525 | 0.022974 | No Change: Both O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 187 | R | 0.394736 | Q | 0.411317 | -0.016581 | No Change: Both O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 205 | M | 0.509037 | V | 0.437686 | 0.071351 | D to O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 214 | S | 0.613436 | A | 0.460938 | 0.152498 | D to O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 251 | D | 0.308371 | V | 0.166925 | 0.141446 | No Change: Both O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 261 | E | 0.547595 | K | 0.542658 | 0.004937 | No Change: Both D | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 263 | I | 0.519577 | V | 0.55356 | -0.033983 | No Change: Both D | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 117 | R | 0.124134 | T | 0.124611 | -4.77E-04 | No Change: Both O | - |
| P18440 | ARY1_HUMAN Arylamine N-acetyltransferase 1 OS=Homo sapiens GN=NAT1 PE=1 SV=2 | 207 | T | 0.528919 | I | 0.357732 | 0.171187 | D to O | - |
| Q9H0A0 | NAT10_HUMAN N-acetyltransferase 10 OS=Homo sapiens GN=NAT10 PE=1 SV=2 | 461 | Y | 0.386148 | H | 0.479697 | -0.093549 | No Change: Both O | - |
| Q9H0A0 | NAT10_HUMAN N-acetyltransferase 10 OS=Homo sapiens GN=NAT10 PE=1 SV=2 | 983 | A | 0.747812 | T | 0.739513 | 0.008299 | No Change: Both D | - |
| Q8N8M0 | NAT16_HUMAN Putative N-acetyltransferase 16 OS=Homo sapiens GN=NAT16 PE=2 SV=2 | 63 | F | 0.403144 | S | 0.534299 | -0.131155 | O to D | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 64 | R | 0.147558 | Q | 0.15584 | -0.008282 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 114 | I | 0.106632 | T | 0.188751 | -0.082119 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 197 | R | 0.455768 | Q | 0.514119 | -0.058351 | O to D | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 268 | K | 0.276096 | R | 0.214687 | 0.061409 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 286 | G | 0.621127 | E | 0.613879 | 0.007248 | No Change: Both D | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 64 | R | 0.147558 | W | 0.056795 | 0.090763 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 145 | Q | 0.206812 | P | 0.226194 | -0.019382 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 282 | K | 0.555359 | T | 0.495075 | 0.060284 | D to O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 24 | L | 0.289267 | I | 0.256944 | 0.032323 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 228 | P | 0.198745 | L | 0.114441 | 0.084304 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 122 | D | 0.511524 | N | 0.501261 | 0.010263 | No Change: Both D | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 137 | L | 0.341353 | F | 0.296305 | 0.045048 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 193 | T | 0.323947 | M | 0.283999 | 0.039948 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 208 | Y | 0.520879 | H | 0.636494 | -0.115615 | No Change: Both D | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 135 | L | 0.381745 | V | 0.366966 | 0.014779 | No Change: Both O | - |
| P11245 | ARY2_HUMAN Arylamine N-acetyltransferase 2 OS=Homo sapiens GN=NAT2 PE=1 SV=1 | 280 | V | 0.476924 | M | 0.541803 | -0.064879 | O to D | - |
| Q93015 | NAT6_HUMAN N-acetyltransferase 6 OS=Homo sapiens GN=NAT6 PE=2 SV=2 | 145 | R | 0.252841 | S | 0.259942 | -0.007101 | No Change: Both O | Non-small cell lung cancer cell lines |
| Q93015 | NAT6_HUMAN N-acetyltransferase 6 OS=Homo sapiens GN=NAT6 PE=2 SV=2 | 207 | T | 0.541566 | S | 0.580411 | -0.038845 | No Change: Both D | Non-small cell lung cancer cell lines |
| Q9UHE5 | NAT8_HUMAN Probable N-acetyltransferase 8 OS=Homo sapiens GN=NAT8 PE=2 SV=2 | 143 | F | 0.233964 | S | 0.412359 | -0.178395 | No Change: Both O | - |
| Q9UHE5 | NAT8_HUMAN Probable N-acetyltransferase 8 OS=Homo sapiens GN=NAT8 PE=2 SV=2 | 104 | E | 0.281877 | K | 0.290974 | -0.009097 | No Change: Both O | - |
| Q9BTE0 | NAT9_HUMAN N-acetyltransferase 9 OS=Homo sapiens GN=NAT9 PE=2 SV=1 | 56 | C | 0.400122 | R | 0.493037 | -0.092915 | No Change: Both O | - |
| Q8NEY1 | NAV1_HUMAN Neuron navigator 1 OS=Homo sapiens GN=NAV1 PE=1 SV=2 | 937 | Q | 0.940274 | H | 0.916246 | 0.024028 | No Change: Both D | - |
| Q8NEY1 | NAV1_HUMAN Neuron navigator 1 OS=Homo sapiens GN=NAV1 PE=1 SV=2 | 1273 | S | 0.971159 | L | 0.944289 | 0.02687 | No Change: Both D | - |
| Q8NEY1 | NAV1_HUMAN Neuron navigator 1 OS=Homo sapiens GN=NAV1 PE=1 SV=2 | 1290 | H | 0.939342 | D | 0.941577 | -0.002235 | No Change: Both D | - |
| Q8NEY1 | NAV1_HUMAN Neuron navigator 1 OS=Homo sapiens GN=NAV1 PE=1 SV=2 | 1527 | V | 0.277212 | I | 0.244912 | 0.0323 | No Change: Both O | - |
| Q8IVL1 | NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens GN=NAV2 PE=1 SV=3 | 109 | R | 0.393866 | K | 0.469817 | -0.075951 | No Change: Both O | - |
| Q8IVL1 | NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens GN=NAV2 PE=1 SV=3 | 491 | Q | 0.871661 | H | 0.845108 | 0.026553 | No Change: Both D | - |
| Q8IVL1 | NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens GN=NAV2 PE=1 SV=3 | 1041 | E | 0.964477 | D | 0.970219 | -0.005742 | No Change: Both D | - |
| Q8IVL1 | NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens GN=NAV2 PE=1 SV=3 | 1077 | P | 0.893972 | A | 0.856686 | 0.037286 | No Change: Both D | - |
| Q8IVL1 | NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens GN=NAV2 PE=1 SV=3 | 2374 | V | 0.170142 | I | 0.155755 | 0.014387 | No Change: Both O | - |
| Q8IVL0 | NAV3_HUMAN Neuron navigator 3 OS=Homo sapiens GN=NAV3 PE=1 SV=3 | 45 | T | 0.894376 | A | 0.871049 | 0.023327 | No Change: Both D | - |
| Q8IVL0 | NAV3_HUMAN Neuron navigator 3 OS=Homo sapiens GN=NAV3 PE=1 SV=3 | 210 | S | 0.952107 | W | 0.863767 | 0.08834 | No Change: Both D | - |
| Q8IVL0 | NAV3_HUMAN Neuron navigator 3 OS=Homo sapiens GN=NAV3 PE=1 SV=3 | 2200 | E | 0.310727 | K | 0.304557 | 0.00617 | No Change: Both O | - |
| A2RRP1 | NBAS_HUMAN Neuroblastoma-amplified sequence OS=Homo sapiens GN=NBAS PE=1 SV=2 | 243 | I | 0.290399 | V | 0.302983 | -0.012584 | No Change: Both O | - |
| A2RRP1 | NBAS_HUMAN Neuroblastoma-amplified sequence OS=Homo sapiens GN=NBAS PE=1 SV=2 | 655 | K | 0.962631 | R | 0.954189 | 0.008442 | No Change: Both D | - |
| A2RRP1 | NBAS_HUMAN Neuroblastoma-amplified sequence OS=Homo sapiens GN=NBAS PE=1 SV=2 | 1004 | R | 0.216286 | Q | 0.258921 | -0.042635 | No Change: Both O | - |
| A2RRP1 | NBAS_HUMAN Neuroblastoma-amplified sequence OS=Homo sapiens GN=NBAS PE=1 SV=2 | 1178 | S | 0.287822 | N | 0.245361 | 0.042461 | No Change: Both O | - |
| A2RRP1 | NBAS_HUMAN Neuroblastoma-amplified sequence OS=Homo sapiens GN=NBAS PE=1 SV=2 | 2074 | A | 0.387885 | T | 0.379256 | 0.008629 | No Change: Both O | - |
| Q8NFP9 | NBEA_HUMAN Neurobeachin OS=Homo sapiens GN=NBEA PE=1 SV=3 | 569 | A | 0.151626 | P | 0.207577 | -0.055951 | No Change: Both O | - |
| Q8NFP9 | NBEA_HUMAN Neurobeachin OS=Homo sapiens GN=NBEA PE=1 SV=3 | 2501 | I | 0.065013 | V | 0.069712 | -0.004699 | No Change: Both O | - |
| Q6ZNJ1 | NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2 | 447 | R | 0.541674 | H | 0.526501 | 0.015173 | No Change: Both D | - |
| Q6ZNJ1 | NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2 | 511 | R | 0.450221 | G | 0.42887 | 0.021351 | No Change: Both O | - |
| Q6ZNJ1 | NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2 | 1877 | A | 0.843347 | G | 0.844662 | -0.001315 | No Change: Both D | - |
| Q6ZNJ1 | NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2 | 2054 | S | 0.715922 | F | 0.517531 | 0.198391 | No Change: Both D | - |
| Q6ZNJ1 | NBEL2_HUMAN Neurobeachin-like protein 2 OS=Homo sapiens GN=NBEAL2 PE=1 SV=2 | 2747 | E | 0.895266 | K | 0.886902 | 0.008364 | No Change: Both D | - |
| P0C6P0 | BCL8_HUMAN Putative protein BCL8 OS=Homo sapiens GN=NBEAP1 PE=5 SV=1 | 33 | V | 0.253448 | A | 0.332446 | -0.078998 | No Change: Both O | - |
| P0C6P0 | BCL8_HUMAN Putative protein BCL8 OS=Homo sapiens GN=NBEAP1 PE=5 SV=1 | 54 | T | 0.111746 | I | 0.065287 | 0.046459 | No Change: Both O | - |
| P0C6P0 | BCL8_HUMAN Putative protein BCL8 OS=Homo sapiens GN=NBEAP1 PE=5 SV=1 | 81 | C | 0.054314 | R | 0.125141 | -0.070827 | No Change: Both O | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 93 | S | 0.479238 | L | 0.289802 | 0.189436 | No Change: Both O | Some childhood acute lymphoblastic leukemia patients |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 95 | D | 0.390043 | N | 0.380261 | 0.009782 | No Change: Both O | Some childhood acute lymphoblastic leukemia patients |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 105 | K | 0.181587 | N | 0.153497 | 0.02809 | No Change: Both O | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 150 | L | 0.10763 | F | 0.096072 | 0.011558 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 171 | I | 0.125948 | V | 0.139314 | -0.013366 | No Change: Both O | Some childhood acute lymphoblastic leukemia patients |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 185 | E | 0.585938 | Q | 0.555838 | 0.0301 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 210 | V | 0.686201 | F | 0.716845 | -0.030644 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 215 | R | 0.623297 | W | 0.428365 | 0.194932 | D to O | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 216 | Q | 0.606674 | K | 0.637091 | -0.030417 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 266 | P | 0.129901 | L | 0.06854 | 0.061361 | No Change: Both O | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 497 | T | 0.906525 | A | 0.886952 | 0.019573 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 574 | L | 0.84714 | I | 0.837517 | 0.009623 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 142 | N | 0.195638 | S | 0.215304 | -0.019666 | No Change: Both O | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 408 | K | 0.909366 | E | 0.903412 | 0.005954 | No Change: Both D | - |
| O60934 | NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 | 679 | Y | 0.479263 | H | 0.594348 | -0.115085 | O to D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 20 | I | 0.474175 | M | 0.594931 | -0.120756 | O to D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 31 | N | 0.641325 | K | 0.685832 | -0.044507 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 510 | A | 0.567616 | T | 0.611089 | -0.043473 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 591 | C | 0.49986 | G | 0.467201 | 0.032659 | No Change: Both O | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 612 | V | 0.560946 | M | 0.626033 | -0.065087 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 663 | R | 0.909097 | C | 0.849443 | 0.059654 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 712 | H | 0.915136 | D | 0.944266 | -0.02913 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 726 | K | 0.95269 | E | 0.957486 | -0.004796 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 734 | Q | 0.963693 | P | 0.968562 | -0.004869 | No Change: Both D | - |
| Q3BBV0 | NBPF1_HUMAN Neuroblastoma breakpoint family member 1 OS=Homo sapiens GN=NBPF1 PE=2 SV=1 | 850 | Q | 0.501665 | K | 0.497845 | 0.00382 | D to O | - |
| Q5TI25 | NBPFE_HUMAN Neuroblastoma breakpoint family member 14 OS=Homo sapiens GN=NBPF14 PE=2 SV=2 | 243 | S | 0.536251 | G | 0.468017 | 0.068234 | D to O | - |
| Q5TI25 | NBPFE_HUMAN Neuroblastoma breakpoint family member 14 OS=Homo sapiens GN=NBPF14 PE=2 SV=2 | 571 | R | 0.357464 | C | 0.300339 | 0.057125 | No Change: Both O | - |
| Q8N660 | NBPFF_HUMAN Neuroblastoma breakpoint family member 15 OS=Homo sapiens GN=NBPF15 PE=2 SV=2 | 615 | P | 0.477669 | Q | 0.454011 | 0.023658 | No Change: Both O | - |
| Q9H094 | NBPF3_HUMAN Neuroblastoma breakpoint family member 3 OS=Homo sapiens GN=NBPF3 PE=2 SV=1 | 114 | Y | 0.373756 | C | 0.391878 | -0.018122 | No Change: Both O | - |
| Q9H094 | NBPF3_HUMAN Neuroblastoma breakpoint family member 3 OS=Homo sapiens GN=NBPF3 PE=2 SV=1 | 459 | L | 0.818991 | V | 0.772993 | 0.045998 | No Change: Both D | - |
| Q9H094 | NBPF3_HUMAN Neuroblastoma breakpoint family member 3 OS=Homo sapiens GN=NBPF3 PE=2 SV=1 | 444 | D | 0.605295 | E | 0.625207 | -0.019912 | No Change: Both D | - |
| Q9H094 | NBPF3_HUMAN Neuroblastoma breakpoint family member 3 OS=Homo sapiens GN=NBPF3 PE=2 SV=1 | 198 | R | 0.904727 | Q | 0.913591 | -0.008864 | No Change: Both D | - |
| P0C2Y1 | NBPF7_HUMAN Putative neuroblastoma breakpoint family member 7 OS=Homo sapiens GN=NBPF7 PE=5 SV=1 | 170 | E | 0.747388 | D | 0.745573 | 0.001815 | No Change: Both D | - |
| Q14596 | NBR1_HUMAN Next to BRCA1 gene 1 protein OS=Homo sapiens GN=NBR1 PE=1 SV=3 | 923 | H | 0.117838 | R | 0.118005 | -1.67E-04 | No Change: Both O | - |
| O15453 | NBR2_HUMAN Next to BRCA1 gene 2 protein OS=Homo sapiens GN=NBR2 PE=2 SV=1 | 102 | Q | 0.121391 | E | 0.154366 | -0.032975 | No Change: Both O | - |
| P13591 | NCAM1_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=3 | 260 | D | 0.79489 | N | 0.753213 | 0.041677 | No Change: Both D | - |
| P13591 | NCAM1_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=3 | 679 | E | 0.157381 | D | 0.14018 | 0.017201 | No Change: Both O | - |
| P13591 | NCAM1_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=3 | 834 | T | 0.994192 | M | 0.992187 | 0.002005 | No Change: Both D | - |
| P13591 | NCAM1_HUMAN Neural cell adhesion molecule 1 OS=Homo sapiens GN=NCAM1 PE=1 SV=3 | 7 | L | 0.128991 | F | 0.113499 | 0.015492 | No Change: Both O | - |
| O15394 | NCAM2_HUMAN Neural cell adhesion molecule 2 OS=Homo sapiens GN=NCAM2 PE=1 SV=2 | 347 | D | 0.528166 | N | 0.489044 | 0.039122 | D to O | - |
| O15394 | NCAM2_HUMAN Neural cell adhesion molecule 2 OS=Homo sapiens GN=NCAM2 PE=1 SV=2 | 350 | L | 0.553905 | P | 0.674473 | -0.120568 | No Change: Both D | - |
| O14594 | NCAN_HUMAN Neurocan core protein OS=Homo sapiens GN=NCAN PE=2 SV=3 | 1254 | A | 0.257654 | V | 0.203553 | 0.054101 | No Change: Both O | - |
| O14594 | NCAN_HUMAN Neurocan core protein OS=Homo sapiens GN=NCAN PE=2 SV=3 | 92 | P | 0.420528 | S | 0.424038 | -0.00351 | No Change: Both O | - |
| O14594 | NCAN_HUMAN Neurocan core protein OS=Homo sapiens GN=NCAN PE=2 SV=3 | 70 | A | 0.548238 | T | 0.561892 | -0.013654 | No Change: Both D | - |
| Q15021 | CND1_HUMAN Condensin complex subunit 1 OS=Homo sapiens GN=NCAPD2 PE=1 SV=3 | 83 | Q | 0.15836 | E | 0.193517 | -0.035157 | No Change: Both O | - |
| Q15021 | CND1_HUMAN Condensin complex subunit 1 OS=Homo sapiens GN=NCAPD2 PE=1 SV=3 | 797 | V | 0.202066 | M | 0.254447 | -0.052381 | No Change: Both O | - |
| Q15021 | CND1_HUMAN Condensin complex subunit 1 OS=Homo sapiens GN=NCAPD2 PE=1 SV=3 | 580 | K | 0.770494 | R | 0.765069 | 0.005425 | No Change: Both D | - |
| Q15021 | CND1_HUMAN Condensin complex subunit 1 OS=Homo sapiens GN=NCAPD2 PE=1 SV=3 | 1321 | T | 0.899563 | S | 0.925249 | -0.025686 | No Change: Both D | - |
| P42695 | CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens GN=NCAPD3 PE=1 SV=2 | 622 | R | 0.085132 | Q | 0.102177 | -0.017045 | No Change: Both O | - |
| P42695 | CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens GN=NCAPD3 PE=1 SV=2 | 907 | P | 0.84872 | T | 0.806118 | 0.042602 | No Change: Both D | - |
| P42695 | CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens GN=NCAPD3 PE=1 SV=2 | 1034 | S | 0.23137 | R | 0.169746 | 0.061624 | No Change: Both O | - |
| Q9BPX3 | CND3_HUMAN Condensin complex subunit 3 OS=Homo sapiens GN=NCAPG PE=1 SV=1 | 265 | M | 0.41739 | T | 0.434627 | -0.017237 | No Change: Both O | A colorectal cancer sample |
| Q9BPX3 | CND3_HUMAN Condensin complex subunit 3 OS=Homo sapiens GN=NCAPG PE=1 SV=1 | 64 | A | 0.254877 | P | 0.319951 | -0.065074 | No Change: Both O | - |
| Q9BPX3 | CND3_HUMAN Condensin complex subunit 3 OS=Homo sapiens GN=NCAPG PE=1 SV=1 | 581 | M | 0.303778 | I | 0.23924 | 0.064538 | No Change: Both O | - |
| Q86XI2 | CNDG2_HUMAN Condensin-2 complex subunit G2 OS=Homo sapiens GN=NCAPG2 PE=1 SV=1 | 794 | T | 0.705267 | M | 0.670169 | 0.035098 | No Change: Both D | - |
| Q86XI2 | CNDG2_HUMAN Condensin-2 complex subunit G2 OS=Homo sapiens GN=NCAPG2 PE=1 SV=1 | 867 | E | 0.434044 | D | 0.412855 | 0.021189 | No Change: Both O | - |
| Q15003 | CND2_HUMAN Condensin complex subunit 2 OS=Homo sapiens GN=NCAPH PE=1 SV=3 | 539 | V | 0.502757 | A | 0.579377 | -0.07662 | No Change: Both D | - |
| Q9UBB6 | NCDN_HUMAN Neurochondrin OS=Homo sapiens GN=NCDN PE=1 SV=1 | 392 | V | 0.22244 | E | 0.377653 | -0.155213 | No Change: Both O | A colorectal cancer sample |
| Q9UBB6 | NCDN_HUMAN Neurochondrin OS=Homo sapiens GN=NCDN PE=1 SV=1 | 392 | V | 0.22244 | L | 0.214514 | 0.007926 | No Change: Both O | A colorectal cancer sample |
| Q6PIU2 | NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens GN=NCEH1 PE=1 SV=3 | 19 | V | 0.049207 | F | 0.039629 | 0.009578 | No Change: Both O | - |
| Q6PIU2 | NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens GN=NCEH1 PE=1 SV=3 | 71 | K | 0.366067 | Q | 0.312252 | 0.053815 | No Change: Both O | - |
| Q6PIU2 | NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens GN=NCEH1 PE=1 SV=3 | 343 | L | 0.098029 | M | 0.11794 | -0.019911 | No Change: Both O | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 42 | R | 0.134697 | Q | 0.138993 | -0.004296 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 1 (CGD1) [MIM:233700] |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 160 | T | 0.277362 | S | 0.316074 | -0.038712 | No Change: Both O | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 166 | N | 0.406361 | D | 0.427553 | -0.021192 | No Change: Both O | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 262 | G | 0.045947 | S | 0.057546 | -0.011599 | No Change: Both O | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 308 | A | 0.961664 | V | 0.948787 | 0.012877 | No Change: Both D | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 90 | R | 0.541331 | H | 0.533482 | 0.007849 | No Change: Both D | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 258 | K | 0.065481 | E | 0.07096 | -0.005479 | No Change: Both O | - |
| P14598 | NCF1_HUMAN Neutrophil cytosol factor 1 OS=Homo sapiens GN=NCF1 PE=1 SV=3 | 99 | G | 0.226396 | S | 0.28055 | -0.054154 | No Change: Both O | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 78 | G | 0.105378 | E | 0.13922 | -0.033842 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 395 | R | 0.652853 | W | 0.426564 | 0.226289 | D to O | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 77 | R | 0.100398 | Q | 0.118684 | -0.018286 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 128 | A | 0.059583 | V | 0.039136 | 0.020447 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 181 | K | 0.210556 | R | 0.179155 | 0.031401 | No Change: Both O | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 328 | R | 0.988594 | K | 0.992048 | -0.003454 | No Change: Both D | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 279 | T | 0.170165 | M | 0.164023 | 0.006142 | No Change: Both O | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 297 | V | 0.490583 | A | 0.534768 | -0.044185 | O to D | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 389 | H | 0.641912 | Q | 0.706563 | -0.064651 | No Change: Both D | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 419 | N | 0.220232 | I | 0.103144 | 0.117088 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 42 | N | 0.053902 | S | 0.069648 | -0.015746 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 44 | G | 0.034261 | C | 0.01919 | 0.015071 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 44 | G | 0.034261 | R | 0.037251 | -0.00299 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 79 | M | 0.110554 | V | 0.08677 | 0.023784 | No Change: Both O | - |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 93 | D | 0.277155 | E | 0.304917 | -0.027762 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 102 | R | 0.149399 | P | 0.175455 | -0.026056 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 108 | D | 0.122134 | V | 0.058315 | 0.063819 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 137 | W | 0.686118 | R | 0.795386 | -0.109268 | No Change: Both D | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 140 | A | 0.621537 | D | 0.653499 | -0.031962 | No Change: Both D | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 169 | Q | 0.23772 | E | 0.282988 | -0.045268 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 184 | R | 0.293473 | P | 0.332989 | -0.039516 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 202 | A | 0.373952 | V | 0.322921 | 0.051031 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 2 (CGD2) [MIM:233710] |
| P19878 | NCF2_HUMAN Neutrophil cytosol factor 2 OS=Homo sapiens GN=NCF2 PE=1 SV=2 | 369 | G | 0.576816 | R | 0.657437 | -0.080621 | No Change: Both D | - |
| Q15080 | NCF4_HUMAN Neutrophil cytosol factor 4 OS=Homo sapiens GN=NCF4 PE=1 SV=2 | 147 | L | 0.594106 | I | 0.54526 | 0.048846 | No Change: Both D | - |
| Q15080 | NCF4_HUMAN Neutrophil cytosol factor 4 OS=Homo sapiens GN=NCF4 PE=1 SV=2 | 153 | R | 0.714261 | H | 0.639918 | 0.074343 | No Change: Both D | - |
| Q15080 | NCF4_HUMAN Neutrophil cytosol factor 4 OS=Homo sapiens GN=NCF4 PE=1 SV=2 | 105 | R | 0.217333 | Q | 0.244736 | -0.027403 | No Change: Both O | Chronic granulomatous disease autosomal recessive cytochrome-b-positive type 3 (CGD3) [MIM:613960] |
| P16333 | NCK1_HUMAN Cytoplasmic protein NCK1 OS=Homo sapiens GN=NCK1 PE=1 SV=1 | 180 | A | 0.316019 | V | 0.261363 | 0.054656 | No Change: Both O | - |
| P55160 | NCKPL_HUMAN Nck-associated protein 1-like OS=Homo sapiens GN=NCKAP1L PE=1 SV=3 | 402 | S | 0.402127 | L | 0.226418 | 0.175709 | No Change: Both O | - |
| P55160 | NCKPL_HUMAN Nck-associated protein 1-like OS=Homo sapiens GN=NCKAP1L PE=1 SV=3 | 391 | T | 0.653113 | A | 0.607719 | 0.045394 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 600 | S | 0.872804 | T | 0.836604 | 0.0362 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 937 | V | 0.993415 | I | 0.991641 | 0.001774 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 977 | I | 0.880461 | T | 0.924171 | -0.04371 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 1093 | N | 0.985316 | Y | 0.975248 | 0.010068 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 1260 | P | 0.970257 | Q | 0.960453 | 0.009804 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 1403 | V | 0.889902 | A | 0.917718 | -0.027816 | No Change: Both D | - |
| O14513 | NCKP5_HUMAN Nck-associated protein 5 OS=Homo sapiens GN=NCKAP5 PE=2 SV=2 | 250 | R | 0.520495 | Q | 0.54809 | -0.027595 | No Change: Both D | - |
| Q9NZQ3 | SPN90_HUMAN NCK-interacting protein with SH3 domain OS=Homo sapiens GN=NCKIPSD PE=1 SV=1 | 324 | T | 0.342548 | S | 0.415606 | -0.073058 | No Change: Both O | - |
| Q9NZQ3 | SPN90_HUMAN NCK-interacting protein with SH3 domain OS=Homo sapiens GN=NCKIPSD PE=1 SV=1 | 660 | Y | 0.258175 | S | 0.440795 | -0.18262 | No Change: Both O | - |
| P19338 | NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL PE=1 SV=3 | 68 | P | 0.973301 | L | 0.941022 | 0.032279 | No Change: Both D | - |
| P19338 | NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL PE=1 SV=3 | 122 | P | 0.983392 | L | 0.967558 | 0.015834 | No Change: Both D | - |
| P19338 | NUCL_HUMAN Nucleolin OS=Homo sapiens GN=NCL PE=1 SV=3 | 174 | A | 0.999889 | V | 0.999799 | 9.00E-05 | No Change: Both D | - |
| Q969V3 | NCLN_HUMAN Nicalin OS=Homo sapiens GN=NCLN PE=1 SV=2 | 551 | K | 0.131932 | R | 0.10235 | 0.029582 | No Change: Both O | - |
| Q969V3 | NCLN_HUMAN Nicalin OS=Homo sapiens GN=NCLN PE=1 SV=2 | 214 | E | 0.336494 | D | 0.322159 | 0.014335 | No Change: Both O | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 457 | Q | 0.956803 | K | 0.943605 | 0.013198 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 466 | N | 0.950117 | K | 0.938856 | 0.011261 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 474 | S | 0.931104 | P | 0.928529 | 0.002575 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 591 | I | 0.941144 | T | 0.9495 | -0.008356 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 685 | E | 0.940069 | A | 0.917257 | 0.022812 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 794 | P | 0.94569 | A | 0.914176 | 0.031514 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 999 | S | 0.954185 | F | 0.913598 | 0.040587 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 1154 | M | 0.977057 | T | 0.975041 | 0.002016 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 1272 | P | 0.926596 | S | 0.924269 | 0.002327 | No Change: Both D | - |
| Q15788 | NCOA1_HUMAN Nuclear receptor coactivator 1 OS=Homo sapiens GN=NCOA1 PE=1 SV=3 | 1238 | V | 0.8482 | I | 0.843234 | 0.004966 | No Change: Both D | - |
| Q15596 | NCOA2_HUMAN Nuclear receptor coactivator 2 OS=Homo sapiens GN=NCOA2 PE=1 SV=2 | 1282 | M | 0.963584 | I | 0.936371 | 0.027213 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 460 | G | 0.978801 | R | 0.978385 | 4.16E-04 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 559 | P | 0.950445 | S | 0.95365 | -0.003205 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 586 | Q | 0.959708 | H | 0.949056 | 0.010652 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 218 | R | 0.725012 | C | 0.655867 | 0.069145 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 369 | L | 0.503107 | F | 0.522158 | -0.019051 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 777 | S | 0.978595 | A | 0.961488 | 0.017107 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 220 | R | 0.680662 | I | 0.519393 | 0.161269 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 556 | I | 0.937353 | V | 0.948864 | -0.011511 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 1247 | M | 0.99641 | K | 0.995382 | 0.001028 | No Change: Both D | - |
| Q9Y6Q9 | NCOA3_HUMAN Nuclear receptor coactivator 3 OS=Homo sapiens GN=NCOA3 PE=1 SV=1 | 1247 | M | 0.99641 | L | 0.994851 | 0.001559 | No Change: Both D | - |
| Q13772 | NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens GN=NCOA4 PE=1 SV=1 | 94 | S | 0.260455 | L | 0.162307 | 0.098148 | No Change: Both O | - |
| Q13772 | NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens GN=NCOA4 PE=1 SV=1 | 154 | F | 0.244986 | L | 0.290278 | -0.045292 | No Change: Both O | - |
| Q13772 | NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens GN=NCOA4 PE=1 SV=1 | 350 | C | 0.471853 | R | 0.550263 | -0.07841 | O to D | - |
| Q13772 | NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens GN=NCOA4 PE=1 SV=1 | 561 | L | 0.403731 | P | 0.563571 | -0.15984 | O to D | - |
| Q13772 | NCOA4_HUMAN Nuclear receptor coactivator 4 OS=Homo sapiens GN=NCOA4 PE=1 SV=1 | 474 | P | 0.649528 | R | 0.61487 | 0.034658 | No Change: Both D | - |
| Q9HCD5 | NCOA5_HUMAN Nuclear receptor coactivator 5 OS=Homo sapiens GN=NCOA5 PE=1 SV=2 | 326 | E | 0.801678 | G | 0.768625 | 0.033053 | No Change: Both D | - |
| Q14686 | NCOA6_HUMAN Nuclear receptor coactivator 6 OS=Homo sapiens GN=NCOA6 PE=1 SV=3 | 512 | P | 0.969363 | L | 0.942729 | 0.026634 | No Change: Both D | - |
| Q14686 | NCOA6_HUMAN Nuclear receptor coactivator 6 OS=Homo sapiens GN=NCOA6 PE=1 SV=3 | 955 | N | 0.970902 | S | 0.974809 | -0.003907 | No Change: Both D | - |
| Q14686 | NCOA6_HUMAN Nuclear receptor coactivator 6 OS=Homo sapiens GN=NCOA6 PE=1 SV=3 | 1995 | I | 0.861711 | V | 0.881294 | -0.019583 | No Change: Both D | - |
| Q14686 | NCOA6_HUMAN Nuclear receptor coactivator 6 OS=Homo sapiens GN=NCOA6 PE=1 SV=3 | 1060 | P | 0.992514 | S | 0.991891 | 6.23E-04 | No Change: Both D | A breast cancer sample |
| Q14686 | NCOA6_HUMAN Nuclear receptor coactivator 6 OS=Homo sapiens GN=NCOA6 PE=1 SV=3 | 1191 | S | 0.98219 | R | 0.977478 | 0.004712 | No Change: Both D | A breast cancer sample |
| Q8NI08 | NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens GN=NCOA7 PE=1 SV=2 | 399 | S | 0.95492 | A | 0.930453 | 0.024467 | No Change: Both D | - |
| Q8NI08 | NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens GN=NCOA7 PE=1 SV=2 | 942 | D | 0.591552 | E | 0.621623 | -0.030071 | No Change: Both D | - |
| Q8NI08 | NCOA7_HUMAN Nuclear receptor coactivator 7 OS=Homo sapiens GN=NCOA7 PE=1 SV=2 | 533 | G | 0.706203 | R | 0.710538 | -0.004335 | No Change: Both D | - |
| Q9Y618 | NCOR2_HUMAN Nuclear receptor corepressor 2 OS=Homo sapiens GN=NCOR2 PE=1 SV=2 | 1707 | A | 0.583982 | T | 0.599068 | -0.015086 | No Change: Both D | - |
| Q9Y618 | NCOR2_HUMAN Nuclear receptor corepressor 2 OS=Homo sapiens GN=NCOR2 PE=1 SV=2 | 781 | G | 0.999022 | E | 0.999144 | -1.22E-04 | No Change: Both D | - |
| Q9Y618 | NCOR2_HUMAN Nuclear receptor corepressor 2 OS=Homo sapiens GN=NCOR2 PE=1 SV=2 | 2012 | P | 0.983294 | S | 0.981233 | 0.002061 | No Change: Both D | - |
| O76036 | NCTR1_HUMAN Natural cytotoxicity triggering receptor 1 OS=Homo sapiens GN=NCR1 PE=1 SV=1 | 82 | K | 0.24333 | Q | 0.19632 | 0.04701 | No Change: Both O | - |
| O76036 | NCTR1_HUMAN Natural cytotoxicity triggering receptor 1 OS=Homo sapiens GN=NCR1 PE=1 SV=1 | 87 | D | 0.276913 | Y | 0.165466 | 0.111447 | No Change: Both O | A colorectal cancer sample |
| O95944 | NCTR2_HUMAN Natural cytotoxicity triggering receptor 2 OS=Homo sapiens GN=NCR2 PE=1 SV=2 | 75 | M | 0.362627 | V | 0.316876 | 0.045751 | No Change: Both O | - |
| O95944 | NCTR2_HUMAN Natural cytotoxicity triggering receptor 2 OS=Homo sapiens GN=NCR2 PE=1 SV=2 | 139 | S | 0.785174 | P | 0.777457 | 0.007717 | No Change: Both D | - |
| O95944 | NCTR2_HUMAN Natural cytotoxicity triggering receptor 2 OS=Homo sapiens GN=NCR2 PE=1 SV=2 | 218 | I | 0.017785 | K | 0.055244 | -0.037459 | No Change: Both O | - |
| O95944 | NCTR2_HUMAN Natural cytotoxicity triggering receptor 2 OS=Homo sapiens GN=NCR2 PE=1 SV=2 | 223 | M | 0.110985 | V | 0.078501 | 0.032484 | No Change: Both O | - |
| O14931 | NCTR3_HUMAN Natural cytotoxicity triggering receptor 3 OS=Homo sapiens GN=NCR3 PE=1 SV=1 | 103 | A | 0.201169 | T | 0.222876 | -0.021707 | No Change: Both O | - |
| O14931 | NCTR3_HUMAN Natural cytotoxicity triggering receptor 3 OS=Homo sapiens GN=NCR3 PE=1 SV=1 | 174 | R | 0.407066 | S | 0.455902 | -0.048836 | No Change: Both O | - |
| Q92542 | NICA_HUMAN Nicastrin OS=Homo sapiens GN=NCSTN PE=1 SV=2 | 75 | V | 0.285078 | I | 0.253121 | 0.031957 | No Change: Both O | - |
| Q92542 | NICA_HUMAN Nicastrin OS=Homo sapiens GN=NCSTN PE=1 SV=2 | 77 | E | 0.328233 | D | 0.300128 | 0.028105 | No Change: Both O | - |
| O14777 | NDC80_HUMAN Kinetochore protein NDC80 homolog OS=Homo sapiens GN=NDC80 PE=1 SV=1 | 66 | S | 0.860198 | A | 0.772612 | 0.087586 | No Change: Both D | - |
| O14777 | NDC80_HUMAN Kinetochore protein NDC80 homolog OS=Homo sapiens GN=NDC80 PE=1 SV=1 | 348 | E | 0.550321 | D | 0.501927 | 0.048394 | No Change: Both D | - |
| O14777 | NDC80_HUMAN Kinetochore protein NDC80 homolog OS=Homo sapiens GN=NDC80 PE=1 SV=1 | 605 | A | 0.602865 | P | 0.662027 | -0.059162 | No Change: Both D | - |
| Q9NV92 | NFIP2_HUMAN NEDD4 family-interacting protein 2 OS=Homo sapiens GN=NDFIP2 PE=1 SV=2 | 136 | A | 0.958685 | V | 0.947219 | 0.011466 | No Change: Both D | - |
| Q9NV92 | NFIP2_HUMAN NEDD4 family-interacting protein 2 OS=Homo sapiens GN=NDFIP2 PE=1 SV=2 | 124 | P | 0.946988 | S | 0.945855 | 0.001133 | No Change: Both D | - |
| Q99608 | NECD_HUMAN Necdin OS=Homo sapiens GN=NDN PE=2 SV=1 | 318 | V | 0.927178 | A | 0.96243 | -0.035252 | No Change: Both D | - |
| Q9UHB4 | NDOR1_HUMAN NADPH-dependent diflavin oxidoreductase 1 OS=Homo sapiens GN=NDOR1 PE=1 SV=1 | 522 | V | 0.486187 | I | 0.435162 | 0.051025 | No Change: Both O | - |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 13 | L | 0.461974 | R | 0.602355 | -0.140381 | O to D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 39 | C | 0.618957 | R | 0.74504 | -0.126083 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 41 | R | 0.616686 | K | 0.639529 | -0.022843 | No Change: Both D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 42 | H | 0.581489 | R | 0.623088 | -0.041599 | No Change: Both D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 44 | Y | 0.613391 | C | 0.689762 | -0.076371 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 58 | K | 0.560361 | N | 0.473527 | 0.086834 | D to O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 58 | K | 0.560361 | N | 0.473527 | 0.086834 | D to O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 60 | V | 0.46866 | E | 0.641604 | -0.172944 | O to D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 61 | L | 0.521693 | F | 0.48199 | 0.039703 | D to O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 61 | L | 0.521693 | P | 0.67277 | -0.151077 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 63 | A | 0.590845 | D | 0.659637 | -0.068792 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 65 | C | 0.601454 | Y | 0.515297 | 0.086157 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 69 | C | 0.690514 | S | 0.78741 | -0.096896 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 65 | C | 0.601454 | W | 0.424424 | 0.17703 | D to O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 74 | R | 0.749142 | C | 0.706774 | 0.042368 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 75 | S | 0.763169 | C | 0.673985 | 0.089184 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 90 | R | 0.741753 | P | 0.762133 | -0.02038 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 96 | C | 0.695694 | Y | 0.616764 | 0.07893 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 101 | S | 0.698696 | F | 0.503615 | 0.195081 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 104 | K | 0.651182 | Q | 0.633068 | 0.018114 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 120 | Y | 0.468183 | C | 0.625814 | -0.157631 | O to D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | G | 0.365459 | 0.074404 | No Change: Both O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | Q | 0.380063 | 0.0598 | No Change: Both O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | Q | 0.380063 | 0.0598 | No Change: Both O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | W | 0.157451 | 0.282412 | No Change: Both O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | W | 0.157451 | 0.282412 | No Change: Both O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 123 | I | 0.371208 | N | 0.599217 | -0.228009 | O to D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 124 | L | 0.355669 | F | 0.26288 | 0.092789 | No Change: Both O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 96 | C | 0.695694 | W | 0.530168 | 0.165526 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 16 | L | 0.384923 | P | 0.535748 | -0.150825 | O to D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 75 | S | 0.763169 | P | 0.74721 | 0.015959 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 105 | A | 0.617745 | T | 0.680454 | -0.062709 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 110 | C | 0.518156 | G | 0.579486 | -0.06133 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 23 | D | 0.686671 | E | 0.654424 | 0.032247 | No Change: Both D | - |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 18 | I | 0.431584 | K | 0.67488 | -0.243296 | O to D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 38 | R | 0.643957 | C | 0.523455 | 0.120502 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 38 | R | 0.643957 | C | 0.523455 | 0.120502 | No Change: Both D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 41 | R | 0.616686 | S | 0.675252 | -0.058566 | No Change: Both D | - |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 43 | H | 0.583506 | Q | 0.588897 | -0.005391 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 43 | H | 0.583506 | R | 0.62628 | -0.042774 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 45 | V | 0.625595 | E | 0.762176 | -0.136581 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 45 | V | 0.625595 | M | 0.739604 | -0.114009 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 54 | K | 0.614334 | N | 0.534056 | 0.080278 | No Change: Both D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 55 | C | 0.584471 | R | 0.677195 | -0.092724 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 61 | L | 0.521693 | I | 0.469912 | 0.051781 | D to O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 67 | G | 0.646714 | E | 0.740424 | -0.09371 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 67 | G | 0.646714 | R | 0.733213 | -0.086499 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 89 | F | 0.79043 | L | 0.824449 | -0.034019 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 90 | R | 0.741753 | C | 0.676458 | 0.065295 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 92 | S | 0.734242 | P | 0.725543 | 0.008699 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 95 | C | 0.684528 | F | 0.620111 | 0.064417 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 95 | C | 0.684528 | R | 0.771668 | -0.08714 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 97 | R | 0.69378 | P | 0.714435 | -0.020655 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 98 | P | 0.710303 | L | 0.592808 | 0.117495 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 103 | L | 0.681962 | V | 0.631448 | 0.050514 | No Change: Both D | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 104 | K | 0.651182 | N | 0.58531 | 0.065872 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 108 | L | 0.491916 | P | 0.637181 | -0.145265 | O to D | - |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 110 | C | 0.518156 | R | 0.628963 | -0.110807 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 112 | G | 0.519132 | E | 0.577754 | -0.058622 | No Change: Both D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 115 | R | 0.501191 | L | 0.360873 | 0.140318 | D to O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 118 | A | 0.451811 | D | 0.49134 | -0.039529 | No Change: Both O | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 121 | R | 0.439863 | L | 0.294291 | 0.145572 | No Change: Both O | Vitreoretinopathy exudative type 2 (EVR2) [MIM:305390] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 126 | C | 0.389577 | S | 0.525427 | -0.13585 | O to D | Norrie disease (ND) [MIM:310600] |
| Q00604 | NDP_HUMAN Norrin OS=Homo sapiens GN=NDP PE=1 SV=1 | 128 | C | 0.470635 | R | 0.576785 | -0.10615 | O to D | Norrie disease (ND) [MIM:310600] |
| Q92597 | NDRG1_HUMAN Protein NDRG1 OS=Homo sapiens GN=NDRG1 PE=1 SV=1 | 67 | M | 0.259602 | V | 0.209395 | 0.050207 | No Change: Both O | - |
| Q92597 | NDRG1_HUMAN Protein NDRG1 OS=Homo sapiens GN=NDRG1 PE=1 SV=1 | 111 | M | 0.367852 | L | 0.28503 | 0.082822 | No Change: Both O | - |
| Q9UN36 | NDRG2_HUMAN Protein NDRG2 OS=Homo sapiens GN=NDRG2 PE=1 SV=2 | 48 | G | 0.373071 | V | 0.274738 | 0.098333 | No Change: Both O | - |
| Q9UN36 | NDRG2_HUMAN Protein NDRG2 OS=Homo sapiens GN=NDRG2 PE=1 SV=2 | 45 | T | 0.536541 | S | 0.599881 | -0.06334 | No Change: Both D | - |
| O95803 | NDST3_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 OS=Homo sapiens GN=NDST3 PE=2 SV=1 | 264 | H | 0.21302 | Q | 0.225814 | -0.012794 | No Change: Both O | A colorectal cancer sample |
| Q9H3R1 | NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens GN=NDST4 PE=2 SV=1 | 12 | R | 0.075165 | Q | 0.074641 | 5.24E-04 | No Change: Both O | - |
| O15239 | NDUA1_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 OS=Homo sapiens GN=NDUFA1 PE=1 SV=1 | 32 | G | 0.579562 | R | 0.568987 | 0.010575 | No Change: Both D | - |
| O15239 | NDUA1_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 OS=Homo sapiens GN=NDUFA1 PE=1 SV=1 | 8 | G | 0.103692 | R | 0.091079 | 0.012613 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O15239 | NDUA1_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 OS=Homo sapiens GN=NDUFA1 PE=1 SV=1 | 37 | R | 0.507678 | S | 0.576049 | -0.068371 | No Change: Both D | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O15239 | NDUA1_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 OS=Homo sapiens GN=NDUFA1 PE=1 SV=1 | 53 | R | 0.43013 | C | 0.234928 | 0.195202 | No Change: Both O | A colorectal cancer sample |
| O95299 | NDUAA_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 mitochondrial OS=Homo sapiens GN=NDUFA10 PE=1 SV=1 | 2 | A | 0.645267 | G | 0.658457 | -0.01319 | No Change: Both D | - |
| Q9UI09 | NDUAC_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Homo sapiens GN=NDUFA12 PE=1 SV=1 | 104 | T | 0.343491 | A | 0.296202 | 0.047289 | No Change: Both O | - |
| Q9P0J0 | NDUAD_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Homo sapiens GN=NDUFA13 PE=1 SV=3 | 5 | K | 0.849953 | N | 0.814017 | 0.035936 | No Change: Both D | A Hurthle cell variant of papillary carcinoma sample |
| Q9P0J0 | NDUAD_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Homo sapiens GN=NDUFA13 PE=1 SV=3 | 115 | R | 0.11565 | P | 0.148825 | -0.033175 | No Change: Both O | A Hurthle cell variant of papillary carcinoma sample |
| O43678 | NDUA2_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Homo sapiens GN=NDUFA2 PE=1 SV=3 | 50 | D | 0.266062 | N | 0.263144 | 0.002918 | No Change: Both O | A breast cancer sample |
| O95167 | NDUA3_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 OS=Homo sapiens GN=NDUFA3 PE=1 SV=1 | 62 | N | 0.742285 | D | 0.769314 | -0.027029 | No Change: Both D | A breast cancer sample |
| P56556 | NDUA6_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Homo sapiens GN=NDUFA6 PE=1 SV=3 | 35 | A | 0.561948 | V | 0.498421 | 0.063527 | D to O | - |
| O95182 | NDUA7_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 OS=Homo sapiens GN=NDUFA7 PE=1 SV=3 | 66 | P | 0.780097 | A | 0.7003 | 0.079797 | No Change: Both D | - |
| P51970 | NDUA8_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 OS=Homo sapiens GN=NDUFA8 PE=1 SV=3 | 140 | N | 0.849286 | H | 0.85744 | -0.008154 | No Change: Both D | A breast cancer sample |
| Q9Y375 | CIA30_HUMAN Complex I intermediate-associated protein 30 mitochondrial OS=Homo sapiens GN=NDUFAF1 PE=1 SV=2 | 9 | R | 0.132609 | H | 0.132393 | 2.16E-04 | No Change: Both O | - |
| Q9Y375 | CIA30_HUMAN Complex I intermediate-associated protein 30 mitochondrial OS=Homo sapiens GN=NDUFAF1 PE=1 SV=2 | 31 | R | 0.321991 | L | 0.23767 | 0.084321 | No Change: Both O | - |
| Q9Y375 | CIA30_HUMAN Complex I intermediate-associated protein 30 mitochondrial OS=Homo sapiens GN=NDUFAF1 PE=1 SV=2 | 176 | E | 0.659037 | K | 0.650712 | 0.008325 | No Change: Both D | - |
| Q9Y375 | CIA30_HUMAN Complex I intermediate-associated protein 30 mitochondrial OS=Homo sapiens GN=NDUFAF1 PE=1 SV=2 | 314 | A | 0.608548 | G | 0.643458 | -0.03491 | No Change: Both D | - |
| Q9BU61 | NDUF3_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Homo sapiens GN=NDUFAF3 PE=1 SV=1 | 77 | G | 0.151969 | R | 0.144154 | 0.007815 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q9BU61 | NDUF3_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 OS=Homo sapiens GN=NDUFAF3 PE=1 SV=1 | 122 | R | 0.460258 | P | 0.475303 | -0.015045 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q9P032 | NDUF4_HUMAN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 OS=Homo sapiens GN=NDUFAF4 PE=1 SV=1 | 65 | L | 0.441362 | P | 0.591299 | -0.149937 | O to D | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O43674 | NDUB5_HUMAN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5 mitochondrial OS=Homo sapiens GN=NDUFB5 PE=1 SV=1 | 133 | Y | 0.326509 | H | 0.431594 | -0.105085 | No Change: Both O | - |
| P17568 | NDUB7_HUMAN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Homo sapiens GN=NDUFB7 PE=1 SV=4 | 106 | R | 0.867706 | G | 0.822655 | 0.045051 | No Change: Both D | - |
| Q9Y6M9 | NDUB9_HUMAN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Homo sapiens GN=NDUFB9 PE=1 SV=3 | 146 | P | 0.852981 | S | 0.821741 | 0.03124 | No Change: Both D | - |
| O95298 | NDUC2_HUMAN NADH dehydrogenase [ubiquinone] 1 subunit C2 OS=Homo sapiens GN=NDUFC2 PE=1 SV=1 | 46 | L | 0.163236 | V | 0.154042 | 0.009194 | No Change: Both O | - |
| P28331 | NDUS1_HUMAN NADH-ubiquinone oxidoreductase 75 kDa subunit mitochondrial OS=Homo sapiens GN=NDUFS1 PE=1 SV=3 | 649 | V | 0.487944 | F | 0.43443 | 0.053514 | No Change: Both O | - |
| P28331 | NDUS1_HUMAN NADH-ubiquinone oxidoreductase 75 kDa subunit mitochondrial OS=Homo sapiens GN=NDUFS1 PE=1 SV=3 | 241 | R | 0.31455 | W | 0.156613 | 0.157937 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P28331 | NDUS1_HUMAN NADH-ubiquinone oxidoreductase 75 kDa subunit mitochondrial OS=Homo sapiens GN=NDUFS1 PE=1 SV=3 | 252 | D | 0.383119 | G | 0.355363 | 0.027756 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P28331 | NDUS1_HUMAN NADH-ubiquinone oxidoreductase 75 kDa subunit mitochondrial OS=Homo sapiens GN=NDUFS1 PE=1 SV=3 | 241 | R | 0.31455 | Q | 0.311222 | 0.003328 | No Change: Both O | - |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 228 | R | 0.343492 | Q | 0.368172 | -0.02468 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 229 | P | 0.328014 | Q | 0.322827 | 0.005187 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 413 | S | 0.375094 | P | 0.347108 | 0.027986 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 20 | P | 0.37851 | T | 0.272428 | 0.106082 | No Change: Both O | - |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 229 | P | 0.328014 | A | 0.270394 | 0.05762 | No Change: Both O | - |
| O75306 | NDUS2_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 mitochondrial OS=Homo sapiens GN=NDUFS2 PE=1 SV=2 | 352 | P | 0.523988 | A | 0.422212 | 0.101776 | D to O | - |
| O75489 | NDUS3_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 mitochondrial OS=Homo sapiens GN=NDUFS3 PE=1 SV=1 | 249 | P | 0.733055 | Q | 0.6907 | 0.042355 | No Change: Both D | - |
| O43181 | NDUS4_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 4 mitochondrial OS=Homo sapiens GN=NDUFS4 PE=1 SV=1 | 174 | T | 0.882525 | P | 0.91137 | -0.028845 | No Change: Both D | - |
| O43920 | NDUS5_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Homo sapiens GN=NDUFS5 PE=1 SV=3 | 96 | P | 0.91698 | S | 0.888769 | 0.028211 | No Change: Both D | - |
| O75251 | NDUS7_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7 mitochondrial OS=Homo sapiens GN=NDUFS7 PE=1 SV=3 | 122 | V | 0.262958 | M | 0.354564 | -0.091606 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| O75251 | NDUS7_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7 mitochondrial OS=Homo sapiens GN=NDUFS7 PE=1 SV=3 | 23 | P | 0.609533 | L | 0.459056 | 0.150477 | D to O | - |
| O00217 | NDUS8_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 8 mitochondrial OS=Homo sapiens GN=NDUFS8 PE=1 SV=1 | 79 | P | 0.271356 | L | 0.162182 | 0.109174 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| O00217 | NDUS8_HUMAN NADH dehydrogenase [ubiquinone] iron-sulfur protein 8 mitochondrial OS=Homo sapiens GN=NDUFS8 PE=1 SV=1 | 102 | R | 0.623154 | H | 0.5761 | 0.047054 | No Change: Both D | Leigh syndrome (LS) [MIM:256000] |
| P49821 | NDUV1_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 1 mitochondrial OS=Homo sapiens GN=NDUFV1 PE=1 SV=4 | 341 | A | 0.143423 | V | 0.103945 | 0.039478 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P49821 | NDUV1_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 1 mitochondrial OS=Homo sapiens GN=NDUFV1 PE=1 SV=4 | 423 | T | 0.172734 | M | 0.150287 | 0.022447 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P49821 | NDUV1_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 1 mitochondrial OS=Homo sapiens GN=NDUFV1 PE=1 SV=4 | 76 | I | 0.219152 | V | 0.207654 | 0.011498 | No Change: Both O | - |
| P49821 | NDUV1_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 1 mitochondrial OS=Homo sapiens GN=NDUFV1 PE=1 SV=4 | 277 | N | 0.38105 | Y | 0.227444 | 0.153606 | No Change: Both O | - |
| P49821 | NDUV1_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 1 mitochondrial OS=Homo sapiens GN=NDUFV1 PE=1 SV=4 | 214 | E | 0.411375 | K | 0.403999 | 0.007376 | No Change: Both O | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| P19404 | NDUV2_HUMAN NADH dehydrogenase [ubiquinone] flavoprotein 2 mitochondrial OS=Homo sapiens GN=NDUFV2 PE=1 SV=2 | 29 | V | 0.399926 | A | 0.475479 | -0.075553 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 5934 | G | 0.747985 | E | 0.788279 | -0.040294 | No Change: Both D | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 5030 | D | 0.569998 | V | 0.421778 | 0.14822 | D to O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 146 | T | 0.389482 | A | 0.381505 | 0.007977 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 191 | E | 0.418815 | Q | 0.400136 | 0.018679 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1027 | K | 0.326572 | N | 0.293536 | 0.033036 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1301 | Y | 0.086395 | H | 0.132059 | -0.045664 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1469 | E | 0.578044 | D | 0.577137 | 9.07E-04 | No Change: Both D | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1479 | V | 0.520183 | I | 0.465212 | 0.054971 | D to O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1491 | V | 0.407629 | M | 0.506011 | -0.098382 | O to D | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 1969 | Y | 0.541303 | H | 0.646541 | -0.105238 | No Change: Both D | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 2613 | K | 0.166818 | N | 0.129338 | 0.03748 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 2773 | R | 0.36872 | Q | 0.360113 | 0.008607 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 2912 | S | 0.119129 | P | 0.100025 | 0.019104 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 2952 | V | 0.380894 | G | 0.470922 | -0.090028 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 3360 | W | 0.116416 | C | 0.152734 | -0.036318 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 3887 | S | 0.391959 | T | 0.307939 | 0.08402 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 4271 | P | 0.283535 | L | 0.161479 | 0.122056 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 4337 | N | 0.361896 | S | 0.407821 | -0.045925 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 4401 | R | 0.3635 | T | 0.34807 | 0.01543 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 5463 | R | 0.477135 | P | 0.526958 | -0.049823 | O to D | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 6131 | T | 0.451111 | I | 0.338518 | 0.112593 | No Change: Both O | - |
| P20929 | NEBU_HUMAN Nebulin OS=Homo sapiens GN=NEB PE=1 SV=4 | 6546 | I | 0.921554 | V | 0.933641 | -0.012087 | No Change: Both D | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 187 | Q | 0.408271 | H | 0.363407 | 0.044864 | No Change: Both O | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 351 | M | 0.803565 | V | 0.772217 | 0.031348 | No Change: Both D | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 654 | N | 0.796242 | K | 0.826066 | -0.029824 | No Change: Both D | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 728 | T | 0.566748 | A | 0.521228 | 0.04552 | No Change: Both D | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 219 | A | 0.582649 | D | 0.640248 | -0.057599 | No Change: Both D | - |
| O76041 | NEBL_HUMAN Nebulette OS=Homo sapiens GN=NEBL PE=2 SV=1 | 378 | D | 0.761792 | H | 0.72237 | 0.039422 | No Change: Both D | - |
| Q7Z6G3 | NECA2_HUMAN N-terminal EF-hand calcium-binding protein 2 OS=Homo sapiens GN=NECAB2 PE=1 SV=1 | 233 | G | 0.859688 | S | 0.895345 | -0.035657 | No Change: Both D | - |
| Q7Z6G3 | NECA2_HUMAN N-terminal EF-hand calcium-binding protein 2 OS=Homo sapiens GN=NECAB2 PE=1 SV=1 | 235 | T | 0.85311 | S | 0.884765 | -0.031655 | No Change: Both D | - |
| Q7Z6G3 | NECA2_HUMAN N-terminal EF-hand calcium-binding protein 2 OS=Homo sapiens GN=NECAB2 PE=1 SV=1 | 308 | Q | 0.263764 | H | 0.24794 | 0.015824 | No Change: Both O | - |
| Q7Z6G3 | NECA2_HUMAN N-terminal EF-hand calcium-binding protein 2 OS=Homo sapiens GN=NECAB2 PE=1 SV=1 | 353 | L | 0.276612 | V | 0.272762 | 0.00385 | No Change: Both O | - |
| Q96P71 | NECA3_HUMAN N-terminal EF-hand calcium-binding protein 3 OS=Homo sapiens GN=NECAB3 PE=1 SV=2 | 254 | P | 0.793992 | L | 0.691353 | 0.102639 | No Change: Both D | - |
| Q8NC96 | NECP1_HUMAN Adaptin ear-binding coat-associated protein 1 OS=Homo sapiens GN=NECAP1 PE=1 SV=2 | 224 | D | 0.876705 | N | 0.863176 | 0.013529 | No Change: Both D | - |
| Q9NVZ3 | NECP2_HUMAN Adaptin ear-binding coat-associated protein 2 OS=Homo sapiens GN=NECAP2 PE=1 SV=1 | 149 | D | 0.667428 | A | 0.608659 | 0.058769 | No Change: Both D | - |
| P46934 | NEDD4_HUMAN E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens GN=NEDD4 PE=1 SV=4 | 627 | Y | 0.564115 | H | 0.673235 | -0.10912 | No Change: Both D | A breast cancer sample |
| P46934 | NEDD4_HUMAN E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens GN=NEDD4 PE=1 SV=4 | 679 | R | 0.9157 | Q | 0.917417 | -0.001717 | No Change: Both D | - |
| P46934 | NEDD4_HUMAN E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens GN=NEDD4 PE=1 SV=4 | 698 | N | 0.765759 | S | 0.804924 | -0.039165 | No Change: Both D | - |
| P46934 | NEDD4_HUMAN E3 ubiquitin-protein ligase NEDD4 OS=Homo sapiens GN=NEDD4 PE=1 SV=4 | 33 | M | 0.38207 | V | 0.310428 | 0.071642 | No Change: Both O | - |
| Q96PU5 | NED4L_HUMAN E3 ubiquitin-protein ligase NEDD4-like OS=Homo sapiens GN=NEDD4L PE=1 SV=2 | 355 | P | 0.935773 | L | 0.877823 | 0.05795 | No Change: Both D | - |
| Q96PU5 | NED4L_HUMAN E3 ubiquitin-protein ligase NEDD4-like OS=Homo sapiens GN=NEDD4L PE=1 SV=2 | 497 | S | 0.703994 | R | 0.693495 | 0.010499 | No Change: Both D | - |
| Q14511 | CASL_HUMAN Enhancer of filamentation 1 OS=Homo sapiens GN=NEDD9 PE=1 SV=1 | 577 | T | 0.792464 | M | 0.803025 | -0.010561 | No Change: Both D | - |
| Q14511 | CASL_HUMAN Enhancer of filamentation 1 OS=Homo sapiens GN=NEDD9 PE=1 SV=1 | 178 | D | 0.538783 | N | 0.48642 | 0.052363 | D to O | - |
| Q14511 | CASL_HUMAN Enhancer of filamentation 1 OS=Homo sapiens GN=NEDD9 PE=1 SV=1 | 304 | P | 0.857229 | L | 0.757411 | 0.099818 | No Change: Both D | - |
| P12036 | NFH_HUMAN Neurofilament heavy polypeptide OS=Homo sapiens GN=NEFH PE=1 SV=4 | 811 | E | 0.999355 | A | 0.999069 | 2.86E-04 | No Change: Both D | - |
| P12036 | NFH_HUMAN Neurofilament heavy polypeptide OS=Homo sapiens GN=NEFH PE=1 SV=4 | 575 | P | 0.999952 | S | 0.99995 | 2.00E-06 | No Change: Both D | - |
| P12036 | NFH_HUMAN Neurofilament heavy polypeptide OS=Homo sapiens GN=NEFH PE=1 SV=4 | 615 | P | 0.999857 | L | 0.999655 | 2.02E-04 | No Change: Both D | - |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 332 | Q | 0.858304 | P | 0.836617 | 0.021687 | No Change: Both D | Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 7 | E | 0.842362 | K | 0.850235 | -0.007873 | No Change: Both D | - |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 8 | P | 0.837384 | L | 0.659166 | 0.178218 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 8 | P | 0.837384 | Q | 0.789172 | 0.048212 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 8 | P | 0.837384 | R | 0.84384 | -0.006456 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 8 | P | 0.837384 | R | 0.84384 | -0.006456 | No Change: Both D | Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 22 | P | 0.850088 | S | 0.876473 | -0.026385 | No Change: Both D | Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 90 | E | 0.632989 | K | 0.637758 | -0.004769 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 98 | N | 0.506969 | S | 0.566969 | -0.06 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 468 | D | 0.986988 | N | 0.986187 | 8.01E-04 | No Change: Both D | - |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 336 | L | 0.865174 | P | 0.888953 | -0.023779 | No Change: Both D | Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684] |
| P07196 | NFL_HUMAN Neurofilament light polypeptide OS=Homo sapiens GN=NEFL PE=1 SV=3 | 396 | E | 0.546474 | K | 0.53841 | 0.008064 | No Change: Both D | Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734] |
| P07197 | NFM_HUMAN Neurofilament medium polypeptide OS=Homo sapiens GN=NEFM PE=1 SV=3 | 725 | P | 0.998088 | Q | 0.997341 | 7.47E-04 | No Change: Both D | - |
| P07197 | NFM_HUMAN Neurofilament medium polypeptide OS=Homo sapiens GN=NEFM PE=1 SV=3 | 439 | P | 0.735029 | T | 0.68872 | 0.046309 | No Change: Both D | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 82 | S | 0.537341 | C | 0.390147 | 0.147194 | D to O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 83 | G | 0.511833 | D | 0.495074 | 0.016759 | D to O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 136 | C | 0.23504 | R | 0.398408 | -0.163368 | No Change: Both O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 182 | I | 0.110816 | M | 0.148365 | -0.037549 | No Change: Both O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 252 | D | 0.499324 | N | 0.484048 | 0.015276 | No Change: Both O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 242 | K | 0.582507 | R | 0.535234 | 0.047273 | No Change: Both D | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 159 | R | 0.192889 | Q | 0.205006 | -0.012117 | No Change: Both O | - |
| Q96FI4 | NEIL1_HUMAN Endonuclease 8-like 1 OS=Homo sapiens GN=NEIL1 PE=1 SV=3 | 181 | E | 0.119913 | K | 0.123025 | -0.003112 | No Change: Both O | - |
| Q969S2 | NEIL2_HUMAN Endonuclease 8-like 2 OS=Homo sapiens GN=NEIL2 PE=1 SV=3 | 70 | T | 0.956008 | S | 0.96696 | -0.010952 | No Change: Both D | - |
| Q969S2 | NEIL2_HUMAN Endonuclease 8-like 2 OS=Homo sapiens GN=NEIL2 PE=1 SV=3 | 103 | R | 0.923948 | Q | 0.926543 | -0.002595 | No Change: Both D | - |
| Q969S2 | NEIL2_HUMAN Endonuclease 8-like 2 OS=Homo sapiens GN=NEIL2 PE=1 SV=3 | 103 | R | 0.923948 | W | 0.852113 | 0.071835 | No Change: Both D | - |
| Q969S2 | NEIL2_HUMAN Endonuclease 8-like 2 OS=Homo sapiens GN=NEIL2 PE=1 SV=3 | 257 | R | 0.417101 | L | 0.297864 | 0.119237 | No Change: Both O | - |
| Q969S2 | NEIL2_HUMAN Endonuclease 8-like 2 OS=Homo sapiens GN=NEIL2 PE=1 SV=3 | 304 | P | 0.686119 | T | 0.61691 | 0.069209 | No Change: Both D | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 117 | P | 0.321678 | R | 0.287447 | 0.034231 | No Change: Both O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 443 | P | 0.936916 | L | 0.883961 | 0.052955 | No Change: Both D | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 520 | G | 0.375163 | R | 0.393653 | -0.01849 | No Change: Both O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 38 | R | 0.538982 | C | 0.353283 | 0.185699 | D to O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 76 | V | 0.247672 | M | 0.294385 | -0.046713 | No Change: Both O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 172 | Q | 0.615263 | H | 0.590603 | 0.02466 | No Change: Both D | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 286 | H | 0.382445 | R | 0.399928 | -0.017483 | No Change: Both O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 346 | I | 0.497218 | V | 0.551122 | -0.053904 | O to D | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 471 | Q | 0.931918 | H | 0.921643 | 0.010275 | No Change: Both D | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 547 | A | 0.10274 | S | 0.160015 | -0.057275 | No Change: Both O | - |
| Q8TAT5 | NEIL3_HUMAN Endonuclease 8-like 3 OS=Homo sapiens GN=NEIL3 PE=1 SV=3 | 556 | H | 0.351644 | R | 0.37423 | -0.022586 | No Change: Both O | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 10 | I | 0.361926 | F | 0.374661 | -0.012735 | No Change: Both O | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 25 | E | 0.48325 | K | 0.493991 | -0.010741 | No Change: Both O | A lung large cell carcinoma sample |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 76 | L | 0.192546 | V | 0.204276 | -0.01173 | No Change: Both O | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 294 | A | 0.769656 | P | 0.833685 | -0.064029 | No Change: Both D | A lung adenocarcinoma sample |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 355 | R | 0.963989 | G | 0.952725 | 0.011264 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 463 | A | 0.556539 | V | 0.468778 | 0.087761 | D to O | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 745 | K | 0.823208 | N | 0.795076 | 0.028132 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 598 | A | 0.964217 | T | 0.956355 | 0.007862 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 883 | Q | 0.921278 | E | 0.939665 | -0.018387 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 1180 | D | 0.605858 | N | 0.600887 | 0.004971 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 724 | E | 0.90983 | G | 0.873794 | 0.036036 | No Change: Both D | - |
| Q96PY6 | NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens GN=NEK1 PE=1 SV=2 | 717 | N | 0.892891 | K | 0.906285 | -0.013394 | No Change: Both D | - |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 50 | F | 0.552438 | L | 0.627216 | -0.074778 | No Change: Both D | - |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 66 | A | 0.599737 | V | 0.500882 | 0.098855 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 67 | G | 0.592045 | S | 0.655348 | -0.063303 | No Change: Both D | - |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 379 | E | 0.599076 | K | 0.559194 | 0.039882 | No Change: Both D | A metastatic melanoma sample |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 513 | L | 0.296206 | S | 0.47327 | -0.177064 | No Change: Both O | - |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 659 | N | 0.344122 | S | 0.367759 | -0.023637 | No Change: Both O | - |
| Q6ZWH5 | NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens GN=NEK10 PE=2 SV=2 | 701 | L | 0.433317 | V | 0.444086 | -0.010769 | No Change: Both O | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 562 | V | 0.554661 | A | 0.647625 | -0.092964 | No Change: Both D | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 108 | T | 0.07487 | M | 0.063147 | 0.011723 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 123 | Y | 0.47159 | C | 0.412319 | 0.059271 | No Change: Both O | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 213 | S | 0.312858 | L | 0.169643 | 0.143215 | No Change: Both O | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 263 | I | 0.511827 | V | 0.520319 | -0.008492 | No Change: Both D | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 451 | E | 0.782509 | K | 0.722346 | 0.060163 | No Change: Both D | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 488 | E | 0.878033 | V | 0.746281 | 0.131752 | No Change: Both D | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 492 | E | 0.916419 | K | 0.887719 | 0.0287 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 548 | M | 0.630081 | T | 0.647582 | -0.017501 | No Change: Both D | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 606 | E | 0.328211 | K | 0.314371 | 0.01384 | No Change: Both O | - |
| Q8NG66 | NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens GN=NEK11 PE=1 SV=2 | 617 | D | 0.235144 | N | 0.212141 | 0.023003 | No Change: Both O | A colorectal adenocarcinoma sample |
| P51955 | NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens GN=NEK2 PE=1 SV=1 | 354 | N | 0.771601 | S | 0.803972 | -0.032371 | No Change: Both D | - |
| P51955 | NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens GN=NEK2 PE=1 SV=1 | 410 | C | 0.913483 | Y | 0.897169 | 0.016314 | No Change: Both D | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 23 | H | 0.467485 | L | 0.402748 | 0.064737 | No Change: Both O | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 60 | P | 0.283912 | R | 0.255129 | 0.028783 | No Change: Both O | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 122 | R | 0.439762 | H | 0.458731 | -0.018969 | No Change: Both O | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 170 | P | 0.179563 | L | 0.084295 | 0.095268 | No Change: Both O | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 259 | R | 0.192308 | G | 0.17142 | 0.020888 | No Change: Both O | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 305 | E | 0.841428 | D | 0.80664 | 0.034788 | No Change: Both D | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 461 | D | 0.825993 | N | 0.779679 | 0.046314 | No Change: Both D | - |
| P51956 | NEK3_HUMAN Serine/threonine-protein kinase Nek3 OS=Homo sapiens GN=NEK3 PE=1 SV=2 | 477 | E | 0.901981 | K | 0.884163 | 0.017818 | No Change: Both D | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 225 | P | 0.539003 | A | 0.446308 | 0.092695 | D to O | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 239 | R | 0.651938 | G | 0.58228 | 0.069658 | No Change: Both D | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 250 | P | 0.809502 | L | 0.714971 | 0.094531 | No Change: Both D | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 357 | T | 0.549971 | I | 0.429499 | 0.120472 | D to O | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 456 | Q | 0.85904 | E | 0.869687 | -0.010647 | No Change: Both D | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 567 | F | 0.754453 | L | 0.760037 | -0.005584 | No Change: Both D | - |
| P51957 | NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens GN=NEK4 PE=1 SV=2 | 777 | R | 0.28918 | K | 0.33114 | -0.04196 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q6P3R8 | NEK5_HUMAN Serine/threonine-protein kinase Nek5 OS=Homo sapiens GN=NEK5 PE=1 SV=1 | 290 | R | 0.510556 | H | 0.506345 | 0.004211 | No Change: Both D | - |
| Q6P3R8 | NEK5_HUMAN Serine/threonine-protein kinase Nek5 OS=Homo sapiens GN=NEK5 PE=1 SV=1 | 531 | C | 0.34032 | R | 0.46364 | -0.12332 | No Change: Both O | - |
| Q6P3R8 | NEK5_HUMAN Serine/threonine-protein kinase Nek5 OS=Homo sapiens GN=NEK5 PE=1 SV=1 | 255 | K | 0.375852 | Q | 0.359746 | 0.016106 | No Change: Both O | - |
| Q8TDX7 | NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens GN=NEK7 PE=1 SV=1 | 35 | R | 0.279879 | G | 0.284752 | -0.004873 | No Change: Both O | - |
| Q8TDX7 | NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens GN=NEK7 PE=1 SV=1 | 275 | I | 0.421805 | M | 0.577317 | -0.155512 | O to D | An ovarian serous carcinoma sample |
| Q86SG6 | NEK8_HUMAN Serine/threonine-protein kinase Nek8 OS=Homo sapiens GN=NEK8 PE=1 SV=1 | 330 | L | 0.270156 | F | 0.209071 | 0.061085 | No Change: Both O | Nephronophthisis type 9 (NPHP9) [MIM:613824] |
| Q86SG6 | NEK8_HUMAN Serine/threonine-protein kinase Nek8 OS=Homo sapiens GN=NEK8 PE=1 SV=1 | 425 | H | 0.467158 | Y | 0.33627 | 0.130888 | No Change: Both O | Nephronophthisis type 9 (NPHP9) [MIM:613824] |
| Q86SG6 | NEK8_HUMAN Serine/threonine-protein kinase Nek8 OS=Homo sapiens GN=NEK8 PE=1 SV=1 | 497 | A | 0.591714 | P | 0.706445 | -0.114731 | No Change: Both D | Nephronophthisis type 9 (NPHP9) [MIM:613824] |
| Q8TD19 | NEK9_HUMAN Serine/threonine-protein kinase Nek9 OS=Homo sapiens GN=NEK9 PE=1 SV=2 | 429 | R | 0.278843 | H | 0.276468 | 0.002375 | No Change: Both O | - |
| Q8TD19 | NEK9_HUMAN Serine/threonine-protein kinase Nek9 OS=Homo sapiens GN=NEK9 PE=1 SV=2 | 828 | P | 0.894753 | T | 0.846803 | 0.04795 | No Change: Both D | - |
| Q8TD19 | NEK9_HUMAN Serine/threonine-protein kinase Nek9 OS=Homo sapiens GN=NEK9 PE=1 SV=2 | 870 | P | 0.836051 | S | 0.828091 | 0.00796 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q6X4W1 | NELF_HUMAN Nasal embryonic luteinizing hormone-releasing hormone factor OS=Homo sapiens GN=NELF PE=1 SV=1 | 480 | T | 0.165177 | A | 0.133928 | 0.031249 | No Change: Both O | Idiopathic hypogonadotropic hypogonadism (IHH) [MIM:146110] |
| Q6X4W1 | NELF_HUMAN Nasal embryonic luteinizing hormone-releasing hormone factor OS=Homo sapiens GN=NELF PE=1 SV=1 | 511 | L | 0.072381 | V | 0.065272 | 0.007109 | No Change: Both O | - |
| Q92832 | NELL1_HUMAN Protein kinase C-binding protein NELL1 OS=Homo sapiens GN=NELL1 PE=2 SV=4 | 354 | R | 0.367664 | W | 0.160349 | 0.207315 | No Change: Both O | - |
| Q92832 | NELL1_HUMAN Protein kinase C-binding protein NELL1 OS=Homo sapiens GN=NELL1 PE=2 SV=4 | 553 | C | 0.50932 | F | 0.450805 | 0.058515 | D to O | A colorectal cancer sample |
| Q92832 | NELL1_HUMAN Protein kinase C-binding protein NELL1 OS=Homo sapiens GN=NELL1 PE=2 SV=4 | 82 | R | 0.244948 | Q | 0.276679 | -0.031731 | No Change: Both O | - |
| Q92832 | NELL1_HUMAN Protein kinase C-binding protein NELL1 OS=Homo sapiens GN=NELL1 PE=2 SV=4 | 211 | F | 0.114294 | V | 0.122514 | -0.00822 | No Change: Both O | - |
| Q92832 | NELL1_HUMAN Protein kinase C-binding protein NELL1 OS=Homo sapiens GN=NELL1 PE=2 SV=4 | 287 | V | 0.531274 | I | 0.470049 | 0.061225 | D to O | - |
| Q99435 | NELL2_HUMAN Protein kinase C-binding protein NELL2 OS=Homo sapiens GN=NELL2 PE=1 SV=1 | 5 | V | 0.412519 | I | 0.38578 | 0.026739 | No Change: Both O | - |
| Q99435 | NELL2_HUMAN Protein kinase C-binding protein NELL2 OS=Homo sapiens GN=NELL2 PE=1 SV=1 | 347 | N | 0.494658 | D | 0.516395 | -0.021737 | O to D | - |
| Q99435 | NELL2_HUMAN Protein kinase C-binding protein NELL2 OS=Homo sapiens GN=NELL2 PE=1 SV=1 | 631 | P | 0.398042 | L | 0.26679 | 0.131252 | No Change: Both O | - |
| O60524 | NEMF_HUMAN Nuclear export mediator factor NEMF OS=Homo sapiens GN=NEMF PE=1 SV=4 | 257 | S | 0.572564 | C | 0.35863 | 0.213934 | D to O | - |
| Q92859 | NEO1_HUMAN Neogenin OS=Homo sapiens GN=NEO1 PE=1 SV=2 | 534 | P | 0.64927 | L | 0.473791 | 0.175479 | D to O | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 815 | V | 0.930539 | I | 0.928091 | 0.002448 | No Change: Both D | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 1016 | S | 0.922585 | N | 0.91459 | 0.007995 | No Change: Both D | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 1101 | P | 0.967809 | L | 0.942744 | 0.025065 | No Change: Both D | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 1133 | R | 0.951651 | S | 0.955794 | -0.004143 | No Change: Both D | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 1275 | P | 0.995375 | L | 0.990795 | 0.00458 | No Change: Both D | - |
| P48681 | NEST_HUMAN Nestin OS=Homo sapiens GN=NES PE=1 SV=2 | 130 | V | 0.833383 | A | 0.879462 | -0.046079 | No Change: Both D | - |
| Q7Z628 | ARHG8_HUMAN Neuroepithelial cell-transforming gene 1 protein OS=Homo sapiens GN=NET1 PE=1 SV=1 | 202 | D | 0.417651 | N | 0.366387 | 0.051264 | No Change: Both O | A breast cancer sample |
| Q7Z628 | ARHG8_HUMAN Neuroepithelial cell-transforming gene 1 protein OS=Homo sapiens GN=NET1 PE=1 SV=1 | 417 | T | 0.433738 | I | 0.289721 | 0.144017 | No Change: Both O | - |
| Q8TDF5 | NETO1_HUMAN Neuropilin and tolloid-like protein 1 OS=Homo sapiens GN=NETO1 PE=2 SV=2 | 481 | S | 0.498979 | N | 0.451883 | 0.047096 | No Change: Both O | - |
| Q8TDF5 | NETO1_HUMAN Neuropilin and tolloid-like protein 1 OS=Homo sapiens GN=NETO1 PE=2 SV=2 | 487 | A | 0.491808 | G | 0.49261 | -8.02E-04 | No Change: Both O | - |
| Q8NC67 | NETO2_HUMAN Neuropilin and tolloid-like protein 2 OS=Homo sapiens GN=NETO2 PE=1 SV=1 | 456 | S | 0.866203 | T | 0.82362 | 0.042583 | No Change: Both D | - |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 54 | V | 0.172878 | M | 0.216489 | -0.043611 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 68 | G | 0.175008 | V | 0.102179 | 0.072829 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 91 | L | 0.29227 | R | 0.42896 | -0.13669 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 182 | S | 0.426578 | G | 0.367573 | 0.059005 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 217 | V | 0.221064 | M | 0.272682 | -0.051618 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 219 | G | 0.209095 | A | 0.151879 | 0.057216 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 227 | G | 0.237543 | R | 0.245521 | -0.007978 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 231 | L | 0.199711 | H | 0.286091 | -0.08638 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 240 | W | 0.44044 | R | 0.613117 | -0.172677 | O to D | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 243 | G | 0.414377 | R | 0.397459 | 0.016918 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 260 | F | 0.640444 | Y | 0.674311 | -0.033867 | No Change: Both D | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 270 | L | 0.423738 | P | 0.633196 | -0.209458 | O to D | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 270 | L | 0.423738 | F | 0.406336 | 0.017402 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 294 | R | 0.121041 | S | 0.147096 | -0.026055 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 298 | A | 0.209721 | V | 0.167141 | 0.04258 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 328 | G | 0.214078 | S | 0.27483 | -0.060752 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 335 | P | 0.300948 | Q | 0.268399 | 0.032549 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 363 | L | 0.353271 | P | 0.535266 | -0.181995 | O to D | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 370 | Y | 0.516628 | C | 0.4734 | 0.043228 | D to O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 80 | P | 0.156122 | L | 0.080325 | 0.075797 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 316 | P | 0.208625 | S | 0.21593 | -0.007305 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 225 | R | 0.25143 | P | 0.278534 | -0.027104 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 341 | R | 0.247155 | G | 0.245236 | 0.001919 | No Change: Both O | Sialidosis (SIALIDOSIS) [MIM:256550] |
| Q99519 | NEUR1_HUMAN Sialidase-1 OS=Homo sapiens GN=NEU1 PE=1 SV=1 | 88 | G | 0.272743 | A | 0.248268 | 0.024475 | No Change: Both O | - |
| Q9Y3R4 | NEUR2_HUMAN Sialidase-2 OS=Homo sapiens GN=NEU2 PE=1 SV=2 | 11 | S | 0.434142 | R | 0.358752 | 0.07539 | No Change: Both O | - |
| Q9Y3R4 | NEUR2_HUMAN Sialidase-2 OS=Homo sapiens GN=NEU2 PE=1 SV=2 | 41 | R | 0.586926 | Q | 0.611532 | -0.024606 | No Change: Both D | - |
| Q9Y3R4 | NEUR2_HUMAN Sialidase-2 OS=Homo sapiens GN=NEU2 PE=1 SV=2 | 145 | A | 0.351878 | T | 0.378748 | -0.02687 | No Change: Both O | - |
| Q9Y3R4 | NEUR2_HUMAN Sialidase-2 OS=Homo sapiens GN=NEU2 PE=1 SV=2 | 168 | H | 0.296899 | N | 0.300319 | -0.00342 | No Change: Both O | - |
| Q9Y3R4 | NEUR2_HUMAN Sialidase-2 OS=Homo sapiens GN=NEU2 PE=1 SV=2 | 182 | R | 0.202808 | Q | 0.218877 | -0.016069 | No Change: Both O | - |
| Q9UQ49 | NEUR3_HUMAN Sialidase-3 OS=Homo sapiens GN=NEU3 PE=1 SV=1 | 15 | R | 0.426531 | Q | 0.447235 | -0.020704 | No Change: Both O | - |
| Q9BR09 | NEUL2_HUMAN Neuralized-like protein 2 OS=Homo sapiens GN=NEURL2 PE=2 SV=1 | 211 | E | 0.434005 | K | 0.427182 | 0.006823 | No Change: Both O | - |
| Q96JN8 | NEUL4_HUMAN Neuralized-like protein 4 OS=Homo sapiens GN=NEURL4 PE=1 SV=2 | 1019 | Q | 0.638271 | H | 0.569744 | 0.068527 | No Change: Both D | - |
| Q13562 | NDF1_HUMAN Neurogenic differentiation factor 1 OS=Homo sapiens GN=NEUROD1 PE=1 SV=3 | 111 | R | 0.758633 | L | 0.687402 | 0.071231 | No Change: Both D | Maturity-onset diabetes of the young type 6 (MODY6) [MIM:606394] |
| Q13562 | NDF1_HUMAN Neurogenic differentiation factor 1 OS=Homo sapiens GN=NEUROD1 PE=1 SV=3 | 45 | T | 0.992619 | A | 0.992298 | 3.21E-04 | No Change: Both D | - |
| Q13562 | NDF1_HUMAN Neurogenic differentiation factor 1 OS=Homo sapiens GN=NEUROD1 PE=1 SV=3 | 197 | P | 0.696186 | H | 0.607933 | 0.088253 | No Change: Both D | - |
| Q9HD90 | NDF4_HUMAN Neurogenic differentiation factor 4 OS=Homo sapiens GN=NEUROD4 PE=2 SV=2 | 68 | K | 0.996308 | T | 0.994906 | 0.001402 | No Change: Both D | - |
| Q9Y4Z2 | NGN3_HUMAN Neurogenin-3 OS=Homo sapiens GN=NEUROG3 PE=1 SV=2 | 93 | R | 0.87796 | L | 0.833488 | 0.044472 | No Change: Both D | Diarrhea type 4 (DIAR4) [MIM:610370] |
| Q9Y4Z2 | NGN3_HUMAN Neurogenin-3 OS=Homo sapiens GN=NEUROG3 PE=1 SV=2 | 107 | R | 0.353615 | S | 0.383372 | -0.029757 | No Change: Both O | Diarrhea type 4 (DIAR4) [MIM:610370] |
| Q9Y4Z2 | NGN3_HUMAN Neurogenin-3 OS=Homo sapiens GN=NEUROG3 PE=1 SV=2 | 199 | F | 0.572354 | S | 0.80092 | -0.228566 | No Change: Both D | - |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 245 | G | 0.955771 | R | 0.969891 | -0.01412 | No Change: Both D | - |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 335 | R | 0.976511 | K | 0.97684 | -3.29E-04 | No Change: Both D | - |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 611 | P | 0.355295 | T | 0.308478 | 0.046817 | No Change: Both O | Cardiomyopathy dilated type 1CC (CMD1CC) [MIM:613122] |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 652 | Y | 0.334769 | C | 0.331202 | 0.003567 | No Change: Both O | Cardiomyopathy dilated type 1CC (CMD1CC) [MIM:613122] |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 131 | Q | 0.98753 | E | 0.989631 | -0.002101 | No Change: Both D | Familial hypertrophic cardiomyopathy type 20 (CMH20) [MIM:613876] |
| Q0ZGT2 | NEXN_HUMAN Nexilin OS=Homo sapiens GN=NEXN PE=1 SV=1 | 279 | R | 0.971017 | C | 0.953372 | 0.017645 | No Change: Both D | Familial hypertrophic cardiomyopathy type 20 (CMH20) [MIM:613876] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 629 | G | 0.095711 | R | 0.101448 | -0.005737 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 844 | L | 0.136254 | R | 0.204045 | -0.067791 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 898 | L | 0.282647 | P | 0.403011 | -0.120364 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1035 | M | 0.303656 | R | 0.361033 | -0.057377 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1440 | K | 0.345343 | R | 0.294757 | 0.050586 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1444 | K | 0.298126 | E | 0.290245 | 0.007881 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1444 | K | 0.298126 | E | 0.290245 | 0.007881 | No Change: Both O | Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1611 | R | 0.095606 | W | 0.035048 | 0.060558 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1952 | W | 0.072649 | R | 0.190966 | -0.118317 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1953 | L | 0.072107 | P | 0.141062 | -0.068955 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2164 | L | 0.135454 | M | 0.151497 | -0.016043 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2192 | Y | 0.614344 | N | 0.708253 | -0.093909 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2631 | T | 0.243185 | A | 0.208987 | 0.034198 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1446 | L | 0.280223 | P | 0.423332 | -0.143109 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 117 | I | 0.165428 | S | 0.35364 | -0.188212 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 338 | D | 0.119059 | G | 0.105746 | 0.013313 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 508 | L | 0.324395 | P | 0.475728 | -0.151333 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 844 | L | 0.136254 | F | 0.114708 | 0.021546 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1166 | G | 0.329507 | D | 0.351982 | -0.022475 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1204 | R | 0.218348 | W | 0.084345 | 0.134003 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1276 | R | 0.346358 | P | 0.388003 | -0.041645 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1412 | R | 0.21553 | S | 0.255496 | -0.039966 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1440 | K | 0.345343 | Q | 0.295176 | 0.050167 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1489 | S | 0.5381 | G | 0.462529 | 0.075571 | D to O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 74 | A | 0.316467 | D | 0.384135 | -0.067668 | No Change: Both O | Mismatch repair deficient cancer cells |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 93 | C | 0.246458 | Y | 0.281339 | -0.034881 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 176 | D | 0.1866 | E | 0.203359 | -0.016759 | No Change: Both O | Mismatch repair deficient cancer cells |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 604 | L | 0.041093 | V | 0.03366 | 0.007433 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 712 | H | 0.097774 | R | 0.105372 | -0.007598 | No Change: Both O | Mismatch repair deficient cancer cells |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1276 | R | 0.346358 | Q | 0.385015 | -0.038657 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2088 | L | 0.132096 | P | 0.230387 | -0.098291 | No Change: Both O | Familial spinal neurofibromatosis (FSNF) [MIM:162210] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 82 | S | 0.100779 | F | 0.039554 | 0.061225 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 157 | I | 0.237202 | N | 0.430941 | -0.193739 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 216 | L | 0.107201 | P | 0.189393 | -0.082192 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 357 | L | 0.289248 | P | 0.454891 | -0.165643 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 491 | Y | 0.376864 | C | 0.428251 | -0.051387 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 549 | L | 0.195277 | P | 0.315983 | -0.120706 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 578 | L | 0.053696 | R | 0.090299 | -0.036603 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 581 | I | 0.122438 | T | 0.223449 | -0.101011 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 583 | K | 0.174582 | R | 0.125613 | 0.048969 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 665 | S | 0.784188 | F | 0.667052 | 0.117136 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 695 | L | 0.055498 | P | 0.109978 | -0.05448 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 763 | L | 0.227623 | P | 0.377516 | -0.149893 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 765 | R | 0.278227 | H | 0.271365 | 0.006862 | No Change: Both O | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 777 | W | 0.458655 | S | 0.598192 | -0.139537 | O to D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 780 | T | 0.429613 | K | 0.486042 | -0.056429 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 781 | H | 0.417845 | P | 0.465833 | -0.047988 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 784 | W | 0.378132 | C | 0.425618 | -0.047486 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 784 | W | 0.378132 | R | 0.565878 | -0.187746 | O to D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 847 | L | 0.172167 | P | 0.269844 | -0.097677 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 848 | G | 0.162654 | E | 0.178645 | -0.015991 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 920 | L | 0.208857 | P | 0.329767 | -0.12091 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 968 | M | 0.223708 | R | 0.259565 | -0.035857 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1147 | L | 0.31392 | P | 0.400949 | -0.087029 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1156 | N | 0.410949 | S | 0.452167 | -0.041218 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1193 | F | 0.332773 | C | 0.319654 | 0.013119 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1204 | R | 0.218348 | G | 0.210208 | 0.00814 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1250 | R | 0.09889 | P | 0.114897 | -0.016007 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1444 | K | 0.298126 | N | 0.253078 | 0.045048 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1444 | K | 0.298126 | R | 0.246229 | 0.051897 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1605 | I | 0.15362 | V | 0.183623 | -0.030003 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1785 | A | 0.114159 | S | 0.191242 | -0.077083 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2001 | G | 0.11918 | R | 0.105629 | 0.013551 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2012 | D | 0.146677 | N | 0.125767 | 0.02091 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2221 | P | 0.09506 | A | 0.07002 | 0.02504 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2357 | E | 0.404384 | K | 0.404826 | -4.42E-04 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2507 | T | 0.761583 | I | 0.621471 | 0.140112 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 80 | Y | 0.150957 | C | 0.134111 | 0.016846 | No Change: Both O | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 678 | P | 0.396859 | L | 0.251611 | 0.145248 | No Change: Both O | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1422 | Y | 0.238039 | H | 0.352 | -0.113961 | No Change: Both O | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2511 | V | 0.831296 | L | 0.86985 | -0.038554 | No Change: Both D | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 31 | H | 0.729775 | R | 0.715317 | 0.014458 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 145 | L | 0.242518 | P | 0.363925 | -0.121407 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 186 | D | 0.093816 | V | 0.049406 | 0.04441 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 194 | L | 0.29115 | R | 0.41717 | -0.12602 | No Change: Both O | Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 324 | C | 0.106401 | R | 0.19742 | -0.091019 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 337 | E | 0.136138 | V | 0.063634 | 0.072504 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 489 | Y | 0.40446 | C | 0.434129 | -0.029669 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 532 | L | 0.323815 | P | 0.495946 | -0.172131 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 574 | S | 0.101711 | R | 0.070879 | 0.030832 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 844 | L | 0.136254 | P | 0.219052 | -0.082798 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 873 | R | 0.796037 | C | 0.718045 | 0.077992 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1073 | M | 0.439023 | V | 0.381154 | 0.057869 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1196 | L | 0.295154 | R | 0.405912 | -0.110758 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1243 | L | 0.080642 | P | 0.144741 | -0.064099 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1276 | R | 0.346358 | G | 0.379407 | -0.033049 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1430 | K | 0.581958 | E | 0.584175 | -0.002217 | No Change: Both D | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1451 | N | 0.197578 | T | 0.182872 | 0.014706 | No Change: Both O | Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1453 | V | 0.227617 | L | 0.256034 | -0.028417 | No Change: Both O | Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1187 | L | 0.231244 | I | 0.203589 | 0.027655 | No Change: Both O | A colorectal cancer sample |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1951 | P | 0.076503 | L | 0.042951 | 0.033552 | No Change: Both O | A colorectal cancer sample |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 2745 | G | 0.467462 | R | 0.478192 | -0.01073 | No Change: Both O | A breast cancer sample |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 80 | Y | 0.150957 | S | 0.30432 | -0.153363 | No Change: Both O | - |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 1411 | L | 0.20023 | F | 0.210957 | -0.010727 | No Change: Both O | Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321] |
| P21359 | NF1_HUMAN Neurofibromin OS=Homo sapiens GN=NF1 PE=1 SV=2 | 160 | R | 0.281145 | T | 0.272347 | 0.008798 | No Change: Both O | Neurofibromatosis type 1 (NF1) [MIM:162200] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 46 | L | 0.137539 | R | 0.217983 | -0.080444 | No Change: Both O | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 62 | F | 0.047697 | S | 0.112045 | -0.064348 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 79 | K | 0.398716 | E | 0.374222 | 0.024494 | No Change: Both O | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 106 | E | 0.425064 | G | 0.365877 | 0.059187 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 117 | L | 0.10771 | I | 0.092507 | 0.015203 | No Change: Both O | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 219 | V | 0.079923 | M | 0.117782 | -0.037859 | No Change: Both O | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 220 | N | 0.088125 | Y | 0.048788 | 0.039337 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 273 | I | 0.438036 | F | 0.443509 | -0.005473 | No Change: Both O | Breast ductal carcinoma |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 339 | L | 0.997798 | F | 0.997271 | 5.27E-04 | No Change: Both D | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 352 | T | 0.996182 | M | 0.996826 | -6.44E-04 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 360 | L | 0.986089 | P | 0.988779 | -0.00269 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 364 | K | 0.981807 | I | 0.967706 | 0.014101 | No Change: Both D | Melanoma |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 418 | R | 0.963943 | C | 0.940963 | 0.02298 | No Change: Both D | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 535 | L | 0.884971 | P | 0.911413 | -0.026442 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 538 | Q | 0.89634 | P | 0.888573 | 0.007767 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 234 | L | 0.185766 | R | 0.268999 | -0.083233 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 351 | R | 0.996495 | H | 0.994148 | 0.002347 | No Change: Both D | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 463 | E | 0.966759 | K | 0.966516 | 2.43E-04 | No Change: Both D | A breast cancer sample |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 77 | M | 0.299363 | V | 0.260235 | 0.039128 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 141 | L | 0.181148 | P | 0.317075 | -0.135927 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 197 | G | 0.51797 | C | 0.343067 | 0.174903 | D to O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 413 | K | 0.960445 | E | 0.965133 | -0.004688 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 533 | K | 0.881885 | T | 0.84023 | 0.041655 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 539 | L | 0.888207 | H | 0.90887 | -0.020663 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 579 | K | 0.664893 | M | 0.526419 | 0.138474 | No Change: Both D | Neurofibromatosis 2 (NF2) [MIM:101000] |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 344 | Q | 0.997641 | H | 0.996304 | 0.001337 | No Change: Both D | - |
| P35240 | MERL_HUMAN Merlin OS=Homo sapiens GN=NF2 PE=1 SV=1 | 133 | C | 0.199843 | R | 0.342148 | -0.142305 | No Change: Both O | Neurofibromatosis 2 (NF2) [MIM:101000] |
| Q8NET5 | NFAM1_HUMAN NFAT activation molecule 1 OS=Homo sapiens GN=NFAM1 PE=1 SV=1 | 137 | H | 0.352059 | Y | 0.241553 | 0.110506 | No Change: Both O | - |
| Q8NET5 | NFAM1_HUMAN NFAT activation molecule 1 OS=Homo sapiens GN=NFAM1 PE=1 SV=1 | 187 | N | 0.537009 | K | 0.614475 | -0.077466 | No Change: Both D | - |
| O94856 | NFASC_HUMAN Neurofascin OS=Homo sapiens GN=NFASC PE=1 SV=4 | 159 | T | 0.553698 | M | 0.568865 | -0.015167 | No Change: Both D | - |
| O95644 | NFAC1_HUMAN Nuclear factor of activated T-cells cytoplasmic 1 OS=Homo sapiens GN=NFATC1 PE=1 SV=3 | 315 | A | 0.411594 | T | 0.46224 | -0.050646 | No Change: Both O | A colorectal cancer sample |
| O95644 | NFAC1_HUMAN Nuclear factor of activated T-cells cytoplasmic 1 OS=Homo sapiens GN=NFATC1 PE=1 SV=3 | 68 | P | 0.784274 | T | 0.726443 | 0.057831 | No Change: Both D | - |
| O95644 | NFAC1_HUMAN Nuclear factor of activated T-cells cytoplasmic 1 OS=Homo sapiens GN=NFATC1 PE=1 SV=3 | 751 | C | 0.860882 | G | 0.888214 | -0.027332 | No Change: Both D | - |
| Q13469 | NFAC2_HUMAN Nuclear factor of activated T-cells cytoplasmic 2 OS=Homo sapiens GN=NFATC2 PE=1 SV=2 | 446 | H | 0.306256 | R | 0.297177 | 0.009079 | No Change: Both O | - |
| Q8NCF5 | NF2IP_HUMAN NFATC2-interacting protein OS=Homo sapiens GN=NFATC2IP PE=1 SV=1 | 33 | R | 0.918866 | W | 0.83151 | 0.087356 | No Change: Both D | - |
| Q12968 | NFAC3_HUMAN Nuclear factor of activated T-cells cytoplasmic 3 OS=Homo sapiens GN=NFATC3 PE=1 SV=1 | 75 | S | 0.847793 | L | 0.751471 | 0.096322 | No Change: Both D | - |
| Q12968 | NFAC3_HUMAN Nuclear factor of activated T-cells cytoplasmic 3 OS=Homo sapiens GN=NFATC3 PE=1 SV=1 | 94 | E | 0.876536 | A | 0.794838 | 0.081698 | No Change: Both D | - |
| Q12968 | NFAC3_HUMAN Nuclear factor of activated T-cells cytoplasmic 3 OS=Homo sapiens GN=NFATC3 PE=1 SV=1 | 100 | L | 0.855301 | S | 0.923123 | -0.067822 | No Change: Both D | - |
| Q12968 | NFAC3_HUMAN Nuclear factor of activated T-cells cytoplasmic 3 OS=Homo sapiens GN=NFATC3 PE=1 SV=1 | 136 | P | 0.891401 | L | 0.827906 | 0.063495 | No Change: Both D | - |
| Q12968 | NFAC3_HUMAN Nuclear factor of activated T-cells cytoplasmic 3 OS=Homo sapiens GN=NFATC3 PE=1 SV=1 | 382 | P | 0.813381 | S | 0.821374 | -0.007993 | No Change: Both D | - |
| Q14934 | NFAC4_HUMAN Nuclear factor of activated T-cells cytoplasmic 4 OS=Homo sapiens GN=NFATC4 PE=1 SV=2 | 160 | G | 0.944465 | A | 0.933726 | 0.010739 | No Change: Both D | - |
| Q14934 | NFAC4_HUMAN Nuclear factor of activated T-cells cytoplasmic 4 OS=Homo sapiens GN=NFATC4 PE=1 SV=2 | 246 | S | 0.982794 | N | 0.972027 | 0.010767 | No Change: Both D | - |
| Q14934 | NFAC4_HUMAN Nuclear factor of activated T-cells cytoplasmic 4 OS=Homo sapiens GN=NFATC4 PE=1 SV=2 | 800 | S | 0.980679 | P | 0.98283 | -0.002151 | No Change: Both D | - |
| Q14494 | NF2L1_HUMAN Nuclear factor erythroid 2-related factor 1 OS=Homo sapiens GN=NFE2L1 PE=1 SV=1 | 63 | D | 0.316819 | H | 0.303751 | 0.013068 | No Change: Both O | - |
| Q16236 | NF2L2_HUMAN Nuclear factor erythroid 2-related factor 2 OS=Homo sapiens GN=NFE2L2 PE=1 SV=3 | 99 | S | 0.654234 | P | 0.62052 | 0.033714 | No Change: Both D | - |
| Q16236 | NF2L2_HUMAN Nuclear factor erythroid 2-related factor 2 OS=Homo sapiens GN=NFE2L2 PE=1 SV=3 | 43 | R | 0.796511 | Q | 0.804968 | -0.008457 | No Change: Both D | - |
| Q16236 | NF2L2_HUMAN Nuclear factor erythroid 2-related factor 2 OS=Homo sapiens GN=NFE2L2 PE=1 SV=3 | 268 | V | 0.61302 | M | 0.676213 | -0.063193 | No Change: Both D | - |
| Q9Y4A8 | NF2L3_HUMAN Nuclear factor erythroid 2-related factor 3 OS=Homo sapiens GN=NFE2L3 PE=1 SV=1 | 441 | V | 0.774848 | E | 0.871063 | -0.096215 | No Change: Both D | - |
| Q86UQ8 | NFE4_HUMAN Transcription factor NF-E4 OS=Homo sapiens GN=NFE4 PE=1 SV=1 | 45 | A | 0.689151 | D | 0.726707 | -0.037556 | No Change: Both D | - |
| Q86UQ8 | NFE4_HUMAN Transcription factor NF-E4 OS=Homo sapiens GN=NFE4 PE=1 SV=1 | 116 | Q | 0.837617 | R | 0.802185 | 0.035432 | No Change: Both D | - |
| P08651 | NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens GN=NFIC PE=1 SV=2 | 417 | A | 0.857707 | S | 0.897461 | -0.039754 | No Change: Both D | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 489 | T | 0.597068 | I | 0.454035 | 0.143033 | D to O | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 506 | M | 0.329385 | V | 0.2706 | 0.058785 | No Change: Both O | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 566 | T | 0.230807 | I | 0.14569 | 0.085117 | No Change: Both O | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 578 | R | 0.251475 | K | 0.314196 | -0.062721 | No Change: Both O | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 711 | H | 0.370592 | Q | 0.37778 | -0.007188 | No Change: Both O | - |
| P19838 | NFKB1_HUMAN Nuclear factor NF-kappa-B p105 subunit OS=Homo sapiens GN=NFKB1 PE=1 SV=2 | 901 | A | 0.771468 | T | 0.795391 | -0.023923 | No Change: Both D | - |
| Q00653 | NFKB2_HUMAN Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens GN=NFKB2 PE=1 SV=4 | 14 | E | 0.267398 | K | 0.274678 | -0.00728 | No Change: Both O | - |
| Q00653 | NFKB2_HUMAN Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens GN=NFKB2 PE=1 SV=4 | 351 | G | 0.813462 | R | 0.808859 | 0.004603 | No Change: Both D | - |
| Q00653 | NFKB2_HUMAN Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens GN=NFKB2 PE=1 SV=4 | 452 | G | 0.535244 | R | 0.600672 | -0.065428 | No Change: Both D | - |
| Q00653 | NFKB2_HUMAN Nuclear factor NF-kappa-B p100 subunit OS=Homo sapiens GN=NFKB2 PE=1 SV=4 | 392 | A | 0.903516 | G | 0.923116 | -0.0196 | No Change: Both D | - |
| P25963 | IKBA_HUMAN NF-kappa-B inhibitor alpha OS=Homo sapiens GN=NFKBIA PE=1 SV=1 | 32 | S | 0.933839 | I | 0.862775 | 0.071064 | No Change: Both D | Ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant (ADEDAID) [MIM:612132] |
| Q15653 | IKBB_HUMAN NF-kappa-B inhibitor beta OS=Homo sapiens GN=NFKBIB PE=1 SV=2 | 339 | R | 0.980427 | W | 0.946126 | 0.034301 | No Change: Both D | - |
| Q8NI38 | IKBD_HUMAN NF-kappa-B inhibitor delta OS=Homo sapiens GN=NFKBID PE=2 SV=1 | 29 | V | 0.644079 | A | 0.724188 | -0.080109 | No Change: Both D | - |
| O00221 | IKBE_HUMAN NF-kappa-B inhibitor epsilon OS=Homo sapiens GN=NFKBIE PE=1 SV=3 | 95 | H | 0.953265 | Q | 0.96116 | -0.007895 | No Change: Both D | - |
| O00221 | IKBE_HUMAN NF-kappa-B inhibitor epsilon OS=Homo sapiens GN=NFKBIE PE=1 SV=3 | 194 | V | 0.976453 | A | 0.98474 | -0.008287 | No Change: Both D | - |
| Q9UBC1 | IKBL1_HUMAN NF-kappa-B inhibitor-like protein 1 OS=Homo sapiens GN=NFKBIL1 PE=1 SV=1 | 224 | C | 0.992817 | R | 0.995131 | -0.002314 | No Change: Both D | - |
| Q9BYH8 | IKBZ_HUMAN NF-kappa-B inhibitor zeta OS=Homo sapiens GN=NFKBIZ PE=1 SV=1 | 307 | T | 0.869481 | S | 0.903368 | -0.033887 | No Change: Both D | - |
| Q9UMS0 | NFU1_HUMAN NFU1 iron-sulfur cluster scaffold homolog mitochondrial OS=Homo sapiens GN=NFU1 PE=1 SV=2 | 25 | M | 0.186434 | K | 0.288583 | -0.102149 | No Change: Both O | - |
| Q9UMS0 | NFU1_HUMAN NFU1 iron-sulfur cluster scaffold homolog mitochondrial OS=Homo sapiens GN=NFU1 PE=1 SV=2 | 208 | G | 0.326052 | C | 0.201018 | 0.125034 | No Change: Both O | Multiple mitochondrial dysfunctions syndrome type 1 (MMDS1) [MIM:605711] |
| Q12986 | NFX1_HUMAN Transcriptional repressor NF-X1 OS=Homo sapiens GN=NFX1 PE=1 SV=2 | 731 | H | 0.460119 | Y | 0.316007 | 0.144112 | No Change: Both O | - |
| Q12986 | NFX1_HUMAN Transcriptional repressor NF-X1 OS=Homo sapiens GN=NFX1 PE=1 SV=2 | 760 | P | 0.563054 | S | 0.53801 | 0.025044 | No Change: Both D | - |
| Q12986 | NFX1_HUMAN Transcriptional repressor NF-X1 OS=Homo sapiens GN=NFX1 PE=1 SV=2 | 1086 | P | 0.879881 | Q | 0.859997 | 0.019884 | No Change: Both D | - |
| Q6ZNB6 | NFXL1_HUMAN NF-X1-type zinc finger protein NFXL1 OS=Homo sapiens GN=NFXL1 PE=1 SV=2 | 246 | P | 0.603175 | L | 0.431858 | 0.171317 | D to O | - |
| Q13952 | NFYC_HUMAN Nuclear transcription factor Y subunit gamma OS=Homo sapiens GN=NFYC PE=1 SV=3 | 165 | Q | 0.966749 | H | 0.941543 | 0.025206 | No Change: Both D | A breast cancer sample |
| Q13952 | NFYC_HUMAN Nuclear transcription factor Y subunit gamma OS=Homo sapiens GN=NFYC PE=1 SV=3 | 297 | T | 0.91746 | I | 0.863149 | 0.054311 | No Change: Both D | - |
| Q8NEJ9 | NGDN_HUMAN Neuroguidin OS=Homo sapiens GN=NGDN PE=1 SV=1 | 15 | V | 0.328046 | L | 0.358603 | -0.030557 | No Change: Both O | - |
| Q8NEJ9 | NGDN_HUMAN Neuroguidin OS=Homo sapiens GN=NGDN PE=1 SV=1 | 308 | K | 0.959983 | I | 0.918354 | 0.041629 | No Change: Both D | - |
| Q8N5V2 | NGEF_HUMAN Ephexin-1 OS=Homo sapiens GN=NGEF PE=2 SV=2 | 78 | R | 0.917306 | G | 0.890011 | 0.027295 | No Change: Both D | - |
| Q8N5V2 | NGEF_HUMAN Ephexin-1 OS=Homo sapiens GN=NGEF PE=2 SV=2 | 111 | M | 0.866074 | T | 0.869569 | -0.003495 | No Change: Both D | - |
| P01138 | NGF_HUMAN Beta-nerve growth factor OS=Homo sapiens GN=NGF PE=1 SV=3 | 35 | A | 0.372532 | V | 0.280176 | 0.092356 | No Change: Both O | - |
| P01138 | NGF_HUMAN Beta-nerve growth factor OS=Homo sapiens GN=NGF PE=1 SV=3 | 72 | V | 0.672414 | M | 0.715151 | -0.042737 | No Change: Both D | - |
| P01138 | NGF_HUMAN Beta-nerve growth factor OS=Homo sapiens GN=NGF PE=1 SV=3 | 80 | R | 0.728609 | Q | 0.706412 | 0.022197 | No Change: Both D | - |
| P01138 | NGF_HUMAN Beta-nerve growth factor OS=Homo sapiens GN=NGF PE=1 SV=3 | 221 | R | 0.077875 | W | 0.029404 | 0.048471 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 5 (HSAN5) [MIM:608654] |
| P08138 | TNR16_HUMAN Tumor necrosis factor receptor superfamily member 16 OS=Homo sapiens GN=NGFR PE=1 SV=1 | 205 | S | 0.964091 | L | 0.930893 | 0.033198 | No Change: Both D | - |
| Q96IV0 | NGLY1_HUMAN Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Homo sapiens GN=NGLY1 PE=1 SV=1 | 581 | V | 0.337502 | I | 0.309415 | 0.028087 | No Change: Both O | - |
| Q96IV0 | NGLY1_HUMAN Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Homo sapiens GN=NGLY1 PE=1 SV=1 | 591 | Q | 0.42141 | R | 0.421357 | 5.30E-05 | No Change: Both O | - |
| Q9NPE2 | NGRN_HUMAN Neugrin OS=Homo sapiens GN=NGRN PE=2 SV=2 | 174 | L | 0.852136 | F | 0.801972 | 0.050164 | No Change: Both D | - |
| Q9NPE2 | NGRN_HUMAN Neugrin OS=Homo sapiens GN=NGRN PE=2 SV=2 | 267 | D | 0.746999 | G | 0.741208 | 0.005791 | No Change: Both D | - |
| Q9H9Q4 | NHEJ1_HUMAN Non-homologous end-joining factor 1 OS=Homo sapiens GN=NHEJ1 PE=1 SV=1 | 57 | R | 0.54692 | G | 0.550409 | -0.003489 | No Change: Both D | Severe combined immunodeficiency due to NHEJ1 deficiency (NHEJ1-SCID) [MIM:611291] |
| Q9H9Q4 | NHEJ1_HUMAN Non-homologous end-joining factor 1 OS=Homo sapiens GN=NHEJ1 PE=1 SV=1 | 123 | C | 0.060034 | R | 0.120918 | -0.060884 | No Change: Both O | Severe combined immunodeficiency due to NHEJ1 deficiency (NHEJ1-SCID) [MIM:611291] |
| Q9H9Q4 | NHEJ1_HUMAN Non-homologous end-joining factor 1 OS=Homo sapiens GN=NHEJ1 PE=1 SV=1 | 14 | A | 0.075313 | T | 0.077961 | -0.002648 | No Change: Both O | - |
| Q9H9Q4 | NHEJ1_HUMAN Non-homologous end-joining factor 1 OS=Homo sapiens GN=NHEJ1 PE=1 SV=1 | 89 | H | 0.518291 | R | 0.525773 | -0.007482 | No Change: Both D | - |
| Q9H9Q4 | NHEJ1_HUMAN Non-homologous end-joining factor 1 OS=Homo sapiens GN=NHEJ1 PE=1 SV=1 | 256 | Q | 0.912076 | L | 0.855553 | 0.056523 | No Change: Both D | - |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 26 | C | 0.366945 | S | 0.493108 | -0.126163 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 33 | F | 0.434558 | S | 0.605484 | -0.170926 | O to D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 69 | P | 0.284537 | A | 0.218568 | 0.065969 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 87 | L | 0.420318 | P | 0.557488 | -0.13717 | O to D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 111 | P | 0.555415 | L | 0.404079 | 0.151336 | D to O | - |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 146 | D | 0.292207 | N | 0.272021 | 0.020186 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 302 | Q | 0.318976 | P | 0.321562 | -0.002586 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 22 | S | 0.483295 | R | 0.471729 | 0.011566 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 67 | E | 0.293441 | Q | 0.276346 | 0.017095 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 68 | C | 0.298065 | Y | 0.210082 | 0.087983 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 126 | L | 0.237936 | P | 0.38928 | -0.151344 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 153 | I | 0.406933 | M | 0.511634 | -0.104701 | O to D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 160 | C | 0.358186 | R | 0.532615 | -0.174429 | O to D | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 198 | I | 0.221299 | N | 0.384645 | -0.163346 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 219 | W | 0.235639 | R | 0.4297 | -0.194061 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 233 | D | 0.325465 | A | 0.26323 | 0.062235 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 245 | D | 0.191351 | N | 0.169086 | 0.022265 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 253 | R | 0.32643 | K | 0.372796 | -0.046366 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 264 | P | 0.174439 | H | 0.164341 | 0.010098 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 279 | L | 0.141299 | P | 0.246379 | -0.10508 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q6VVB1 | NHLC1_HUMAN E3 ubiquitin-protein ligase NHLRC1 OS=Homo sapiens GN=NHLRC1 PE=1 SV=2 | 308 | D | 0.199702 | A | 0.147007 | 0.052695 | No Change: Both O | Progressive myoclonic epilepsy type 2 (EPM2) [MIM:254780] |
| Q8NBF2 | NHLC2_HUMAN NHL repeat-containing protein 2 OS=Homo sapiens GN=NHLRC2 PE=1 SV=1 | 314 | V | 0.274564 | I | 0.25407 | 0.020494 | No Change: Both O | - |
| Q5JS37 | NHLC3_HUMAN NHL repeat-containing protein 3 OS=Homo sapiens GN=NHLRC3 PE=2 SV=1 | 221 | L | 0.286618 | R | 0.438899 | -0.152281 | No Change: Both O | - |
| Q9NX24 | NHP2_HUMAN H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens GN=NHP2 PE=1 SV=1 | 118 | A | 0.489785 | T | 0.51285 | -0.023065 | O to D | - |
| Q9NX24 | NHP2_HUMAN H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens GN=NHP2 PE=1 SV=1 | 126 | V | 0.245553 | M | 0.318583 | -0.07303 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 2 (DKCB2) [MIM:613987] |
| Q9NX24 | NHP2_HUMAN H/ACA ribonucleoprotein complex subunit 2 OS=Homo sapiens GN=NHP2 PE=1 SV=1 | 139 | Y | 0.524409 | H | 0.629009 | -0.1046 | No Change: Both D | Dyskeratosis congenita autosomal recessive type 2 (DKCB2) [MIM:613987] |
| P55769 | NH2L1_HUMAN NHP2-like protein 1 OS=Homo sapiens GN=NHP2L1 PE=1 SV=3 | 19 | T | 0.36974 | N | 0.405454 | -0.035714 | No Change: Both O | - |
| Q6T4R5 | NHS_HUMAN Nance-Horan syndrome protein OS=Homo sapiens GN=NHS PE=1 SV=1 | 1319 | F | 0.646772 | L | 0.627297 | 0.019475 | No Change: Both D | - |
| Q6T4R5 | NHS_HUMAN Nance-Horan syndrome protein OS=Homo sapiens GN=NHS PE=1 SV=1 | 1535 | S | 0.959552 | T | 0.94685 | 0.012702 | No Change: Both D | - |
| Q6T4R5 | NHS_HUMAN Nance-Horan syndrome protein OS=Homo sapiens GN=NHS PE=1 SV=1 | 844 | A | 0.982263 | T | 0.983974 | -0.001711 | No Change: Both D | A breast cancer sample |
| Q6T4R5 | NHS_HUMAN Nance-Horan syndrome protein OS=Homo sapiens GN=NHS PE=1 SV=1 | 1510 | S | 0.889052 | T | 0.852387 | 0.036665 | No Change: Both D | - |
| Q5SYE7 | NHSL1_HUMAN NHS-like protein 1 OS=Homo sapiens GN=NHSL1 PE=1 SV=2 | 1085 | V | 0.881294 | M | 0.916633 | -0.035339 | No Change: Both D | - |
| Q5SYE7 | NHSL1_HUMAN NHS-like protein 1 OS=Homo sapiens GN=NHSL1 PE=1 SV=2 | 1585 | G | 0.964423 | S | 0.968759 | -0.004336 | No Change: Both D | - |
| Q5HYW2 | NHSL2_HUMAN NHS-like protein 2 OS=Homo sapiens GN=NHSL2 PE=2 SV=1 | 535 | T | 0.935182 | I | 0.902242 | 0.03294 | No Change: Both D | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 669 | Q | 0.361373 | R | 0.359758 | 0.001615 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 246 | V | 0.582824 | I | 0.569606 | 0.013218 | No Change: Both D | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 1036 | F | 0.13687 | S | 0.310032 | -0.173162 | No Change: Both O | A colorectal cancer sample |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 31 | R | 0.364517 | L | 0.283967 | 0.08055 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 302 | R | 0.415789 | H | 0.369548 | 0.046241 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 335 | R | 0.8069 | H | 0.745339 | 0.061561 | No Change: Both D | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 387 | R | 0.519502 | H | 0.513099 | 0.006403 | No Change: Both D | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 970 | K | 0.39963 | E | 0.398063 | 0.001567 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 1163 | L | 0.142157 | V | 0.147636 | -0.005479 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 1226 | T | 0.408905 | I | 0.241241 | 0.167664 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 60 | S | 0.314904 | R | 0.273604 | 0.0413 | No Change: Both O | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 807 | Q | 0.743282 | H | 0.689265 | 0.054017 | No Change: Both D | - |
| P14543 | NID1_HUMAN Nidogen-1 OS=Homo sapiens GN=NID1 PE=1 SV=3 | 1246 | Q | 0.683148 | R | 0.720514 | -0.037366 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 1238 | P | 0.140366 | S | 0.148616 | -0.00825 | No Change: Both O | A breast cancer sample |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 313 | D | 0.650762 | G | 0.600323 | 0.050439 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 354 | P | 0.900238 | H | 0.871105 | 0.029133 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 529 | P | 0.521842 | S | 0.542584 | -0.020742 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 726 | V | 0.193871 | M | 0.229632 | -0.035761 | No Change: Both O | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 775 | R | 0.717107 | Q | 0.733048 | -0.015941 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 830 | R | 0.41069 | Q | 0.371753 | 0.038937 | No Change: Both O | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 866 | R | 0.569782 | Q | 0.610444 | -0.040662 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 22 | P | 0.261601 | Q | 0.204384 | 0.057217 | No Change: Both O | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 453 | G | 0.637666 | D | 0.65087 | -0.013204 | No Change: Both D | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 656 | S | 0.220065 | P | 0.206493 | 0.013572 | No Change: Both O | - |
| Q14112 | NID2_HUMAN Nidogen-2 OS=Homo sapiens GN=NID2 PE=1 SV=3 | 760 | G | 0.694387 | V | 0.59522 | 0.099167 | No Change: Both D | - |
| Q9GZT8 | NIF3L_HUMAN NIF3-like protein 1 OS=Homo sapiens GN=NIF3L1 PE=1 SV=2 | 324 | T | 0.597588 | I | 0.466821 | 0.130767 | D to O | - |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 21 | R | 0.528244 | W | 0.323015 | 0.205229 | D to O | - |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 64 | E | 0.436825 | Q | 0.413925 | 0.0229 | No Change: Both O | - |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 260 | L | 0.012765 | I | 0.010546 | 0.002219 | No Change: Both O | - |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 320 | M | 0.195975 | I | 0.136642 | 0.059333 | No Change: Both O | - |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 333 | P | 0.485771 | S | 0.462744 | 0.023027 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q8IY84 | NIM1_HUMAN Serine/threonine-protein kinase NIM1 OS=Homo sapiens GN=NIM1 PE=1 SV=1 | 411 | P | 0.655851 | T | 0.590131 | 0.06572 | No Change: Both D | A lung large cell carcinoma sample |
| Q8N4C6 | NIN_HUMAN Ninein OS=Homo sapiens GN=NIN PE=1 SV=4 | 1111 | P | 0.597528 | A | 0.527132 | 0.070396 | No Change: Both D | - |
| Q8N4C6 | NIN_HUMAN Ninein OS=Homo sapiens GN=NIN PE=1 SV=4 | 1320 | G | 0.342763 | E | 0.451678 | -0.108915 | No Change: Both O | - |
| Q8N4C6 | NIN_HUMAN Ninein OS=Homo sapiens GN=NIN PE=1 SV=4 | 1837 | S | 0.603189 | T | 0.540968 | 0.062221 | No Change: Both D | - |
| Q8N4C6 | NIN_HUMAN Ninein OS=Homo sapiens GN=NIN PE=1 SV=4 | 1125 | Q | 0.691221 | P | 0.676479 | 0.014742 | No Change: Both D | - |
| Q8N4C6 | NIN_HUMAN Ninein OS=Homo sapiens GN=NIN PE=1 SV=4 | 1934 | Q | 0.910943 | E | 0.91833 | -0.007387 | No Change: Both D | - |
| Q92982 | NINJ1_HUMAN Ninjurin-1 OS=Homo sapiens GN=NINJ1 PE=1 SV=2 | 110 | A | 0.50368 | D | 0.610731 | -0.107051 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 969 | R | 0.962189 | G | 0.951413 | 0.010776 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 1366 | R | 0.672784 | H | 0.570801 | 0.101983 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 79 | G | 0.668994 | V | 0.568105 | 0.100889 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 191 | S | 0.85516 | R | 0.814416 | 0.040744 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 276 | R | 0.656449 | W | 0.500808 | 0.155641 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 296 | T | 0.679378 | A | 0.626639 | 0.052739 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 973 | E | 0.964917 | K | 0.952173 | 0.012744 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 1077 | D | 0.733872 | N | 0.711274 | 0.022598 | No Change: Both D | - |
| Q9Y2I6 | NINL_HUMAN Ninein-like protein OS=Homo sapiens GN=NINL PE=1 SV=2 | 1276 | R | 0.939982 | C | 0.8846 | 0.055382 | No Change: Both D | - |
| Q9Y221 | NIP7_HUMAN 60S ribosome subunit biogenesis protein NIP7 homolog OS=Homo sapiens GN=NIP7 PE=1 SV=1 | 171 | E | 0.340327 | Q | 0.28703 | 0.053297 | No Change: Both O | A breast cancer sample |
| Q7RTP0 | NIPA1_HUMAN Magnesium transporter NIPA1 OS=Homo sapiens GN=NIPA1 PE=1 SV=1 | 45 | T | 0.253867 | R | 0.273947 | -0.02008 | No Change: Both O | Spastic paraplegia autosomal dominant type 6 (SPG6) [MIM:600363] |
| Q7RTP0 | NIPA1_HUMAN Magnesium transporter NIPA1 OS=Homo sapiens GN=NIPA1 PE=1 SV=1 | 106 | G | 0.141054 | R | 0.122951 | 0.018103 | No Change: Both O | Spastic paraplegia autosomal dominant type 6 (SPG6) [MIM:600363] |
| Q6NVV3 | NIPA3_HUMAN Magnesium transporter NIPA3 OS=Homo sapiens GN=NIPAL1 PE=2 SV=1 | 324 | I | 0.035088 | V | 0.044761 | -0.009673 | No Change: Both O | - |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 142 | G | 0.278801 | V | 0.178102 | 0.100699 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 176 | A | 0.169791 | D | 0.214078 | -0.044287 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 208 | S | 0.136109 | F | 0.048134 | 0.087975 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 237 | H | 0.360977 | N | 0.382006 | -0.021029 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 297 | G | 0.046397 | R | 0.042544 | 0.003853 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q0D2K0 | NIPA4_HUMAN Magnesium transporter NIPA4 OS=Homo sapiens GN=NIPAL4 PE=1 SV=3 | 230 | G | 0.074323 | R | 0.068918 | 0.005405 | No Change: Both O | Ichthyosis congenital autosomal recessive ichthyin-related (ARCII) [MIM:612281] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 135 | S | 0.978714 | N | 0.971936 | 0.006778 | No Change: Both D | - |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1311 | C | 0.209303 | R | 0.35544 | -0.146137 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1348 | L | 0.239513 | R | 0.337281 | -0.097768 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2430 | Y | 0.044926 | C | 0.038902 | 0.006024 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 674 | N | 0.992373 | S | 0.993064 | -6.91E-04 | No Change: Both D | - |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1206 | I | 0.592998 | V | 0.561164 | 0.031834 | No Change: Both D | - |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1246 | A | 0.608093 | G | 0.659215 | -0.051122 | No Change: Both D | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1312 | L | 0.174229 | P | 0.314583 | -0.140354 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1789 | R | 0.203217 | L | 0.131885 | 0.071332 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1803 | D | 0.199558 | V | 0.113786 | 0.085772 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1856 | R | 0.119393 | T | 0.117198 | 0.002195 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2298 | R | 0.234837 | C | 0.121993 | 0.112844 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2298 | R | 0.234837 | H | 0.255054 | -0.020217 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2312 | G | 0.116236 | R | 0.110392 | 0.005844 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2381 | G | 0.45431 | A | 0.408851 | 0.045459 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2390 | A | 0.511904 | T | 0.535729 | -0.023825 | No Change: Both D | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2440 | Y | 0.175432 | H | 0.271818 | -0.096386 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 1647 | E | 0.593485 | K | 0.592119 | 0.001366 | No Change: Both D | A breast cancer sample |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 261 | S | 0.924675 | A | 0.89 | 0.034675 | No Change: Both D | - |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 384 | N | 0.82069 | S | 0.845589 | -0.024899 | No Change: Both D | - |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2081 | G | 0.08136 | A | 0.062767 | 0.018593 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2090 | S | 0.066442 | I | 0.023217 | 0.043225 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q6KC79 | NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens GN=NIPBL PE=1 SV=2 | 2150 | L | 0.09648 | P | 0.170409 | -0.073929 | No Change: Both O | Cornelia de Lange syndrome type 1 (CDLS1) [MIM:122470] |
| Q9BPW8 | NIPS1_HUMAN Protein NipSnap homolog 1 OS=Homo sapiens GN=NIPSNAP1 PE=1 SV=1 | 245 | E | 0.634898 | K | 0.636053 | -0.001155 | No Change: Both D | - |
| Q9UFN0 | NPS3A_HUMAN Protein NipSnap homolog 3A OS=Homo sapiens GN=NIPSNAP3A PE=1 SV=2 | 100 | R | 0.493364 | Q | 0.497866 | -0.004502 | No Change: Both O | - |
| Q9BS92 | NPS3B_HUMAN Protein NipSnap homolog 3B OS=Homo sapiens GN=NIPSNAP3B PE=2 SV=1 | 94 | A | 0.194789 | P | 0.245742 | -0.050953 | No Change: Both O | - |
| Q9BS92 | NPS3B_HUMAN Protein NipSnap homolog 3B OS=Homo sapiens GN=NIPSNAP3B PE=2 SV=1 | 154 | K | 0.276729 | E | 0.28787 | -0.011141 | No Change: Both O | - |
| Q9BS92 | NPS3B_HUMAN Protein NipSnap homolog 3B OS=Homo sapiens GN=NIPSNAP3B PE=2 SV=1 | 159 | A | 0.267131 | G | 0.335514 | -0.068383 | No Change: Both O | - |
| Q9Y2I1 | NISCH_HUMAN Nischarin OS=Homo sapiens GN=NISCH PE=1 SV=3 | 299 | V | 0.58719 | I | 0.571154 | 0.016036 | No Change: Both D | - |
| Q9Y2I1 | NISCH_HUMAN Nischarin OS=Homo sapiens GN=NISCH PE=1 SV=3 | 1056 | A | 0.993432 | V | 0.989624 | 0.003808 | No Change: Both D | - |
| Q9NQR4 | NIT2_HUMAN Omega-amidase NIT2 OS=Homo sapiens GN=NIT2 PE=1 SV=1 | 231 | V | 0.24689 | A | 0.328897 | -0.082007 | No Change: Both O | - |
| Q8N8D7 | NKAI3_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3 OS=Homo sapiens GN=NKAIN3 PE=2 SV=1 | 140 | V | 0.038136 | I | 0.032181 | 0.005955 | No Change: Both O | - |
| Q8IVV8 | NKAI4_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 OS=Homo sapiens GN=NKAIN4 PE=2 SV=2 | 91 | K | 0.34303 | Q | 0.293997 | 0.049033 | No Change: Both O | - |
| Q8IVV8 | NKAI4_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 OS=Homo sapiens GN=NKAIN4 PE=2 SV=2 | 131 | A | 0.403052 | D | 0.464004 | -0.060952 | No Change: Both O | - |
| Q8IVV8 | NKAI4_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 OS=Homo sapiens GN=NKAIN4 PE=2 SV=2 | 151 | C | 0.063392 | G | 0.135235 | -0.071843 | No Change: Both O | - |
| Q8IVV8 | NKAI4_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 OS=Homo sapiens GN=NKAIN4 PE=2 SV=2 | 173 | E | 0.431343 | D | 0.405205 | 0.026138 | No Change: Both O | - |
| Q8N5F7 | NKAP_HUMAN NF-kappa-B-activating protein OS=Homo sapiens GN=NKAP PE=1 SV=1 | 115 | P | 0.892313 | H | 0.824675 | 0.067638 | No Change: Both D | - |
| Q5M9Q1 | NKAPL_HUMAN NKAP-like protein OS=Homo sapiens GN=NKAPL PE=1 SV=3 | 96 | Y | 0.746934 | C | 0.771876 | -0.024942 | No Change: Both D | - |
| Q5M9Q1 | NKAPL_HUMAN NKAP-like protein OS=Homo sapiens GN=NKAPL PE=1 SV=3 | 152 | T | 0.956409 | N | 0.953508 | 0.002901 | No Change: Both D | - |
| Q5M9Q1 | NKAPL_HUMAN NKAP-like protein OS=Homo sapiens GN=NKAPL PE=1 SV=3 | 162 | H | 0.98875 | Y | 0.980754 | 0.007996 | No Change: Both D | - |
| Q5M9Q1 | NKAPL_HUMAN NKAP-like protein OS=Homo sapiens GN=NKAPL PE=1 SV=3 | 398 | E | 0.971165 | G | 0.949604 | 0.021561 | No Change: Both D | - |
| Q969F2 | NKD2_HUMAN Protein naked cuticle homolog 2 OS=Homo sapiens GN=NKD2 PE=1 SV=1 | 257 | T | 0.621379 | K | 0.657234 | -0.035855 | No Change: Both D | - |
| Q17RQ9 | NKPD1_HUMAN NTPase KAP family P-loop domain-containing protein 1 OS=Homo sapiens GN=NKPD1 PE=2 SV=1 | 118 | V | 0.064888 | L | 0.076429 | -0.011541 | No Change: Both O | - |
| P30414 | NKTR_HUMAN NK-tumor recognition protein OS=Homo sapiens GN=NKTR PE=1 SV=2 | 861 | L | 0.986763 | V | 0.982974 | 0.003789 | No Change: Both D | - |
| P30414 | NKTR_HUMAN NK-tumor recognition protein OS=Homo sapiens GN=NKTR PE=1 SV=2 | 935 | S | 0.972864 | L | 0.945995 | 0.026869 | No Change: Both D | - |
| P30414 | NKTR_HUMAN NK-tumor recognition protein OS=Homo sapiens GN=NKTR PE=1 SV=2 | 271 | V | 0.984544 | G | 0.985455 | -9.11E-04 | No Change: Both D | - |
| P30414 | NKTR_HUMAN NK-tumor recognition protein OS=Homo sapiens GN=NKTR PE=1 SV=2 | 1182 | M | 0.878817 | T | 0.877913 | 9.04E-04 | No Change: Both D | - |
| P43699 | NKX21_HUMAN Homeobox protein Nkx-2.1 OS=Homo sapiens GN=NKX2-1 PE=1 SV=1 | 208 | W | 0.367781 | L | 0.493413 | -0.125632 | No Change: Both O | Benign hereditary chorea (BHC) [MIM:118700] |
| P43699 | NKX21_HUMAN Homeobox protein Nkx-2.1 OS=Homo sapiens GN=NKX2-1 PE=1 SV=1 | 213 | R | 0.476875 | S | 0.506453 | -0.029578 | O to D | Benign hereditary chorea (BHC) [MIM:118700] |
| P43699 | NKX21_HUMAN Homeobox protein Nkx-2.1 OS=Homo sapiens GN=NKX2-1 PE=1 SV=1 | 205 | V | 0.346948 | F | 0.388769 | -0.041821 | No Change: Both O | Choreoathetosis hypothyroidism and neonatal respiratory distress (CHNRD) [MIM:610978] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 178 | T | 0.358925 | M | 0.308676 | 0.050249 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 25 | R | 0.61725 | C | 0.524791 | 0.092459 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 25 | R | 0.61725 | C | 0.524791 | 0.092459 | No Change: Both D | Congenital hypothyroidism non-goitrous type 5 (CHNG5) [MIM:225250] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 25 | R | 0.61725 | C | 0.524791 | 0.092459 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 188 | N | 0.516661 | K | 0.621219 | -0.104558 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 189 | R | 0.517027 | G | 0.429858 | 0.087169 | D to O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 191 | Y | 0.548479 | C | 0.634874 | -0.086395 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 7 | L | 0.644318 | P | 0.791619 | -0.147301 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 15 | K | 0.584126 | I | 0.427314 | 0.156812 | D to O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 19 | N | 0.570424 | S | 0.692881 | -0.122457 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 21 | E | 0.581474 | Q | 0.593496 | -0.012022 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 21 | E | 0.581474 | Q | 0.593496 | -0.012022 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 22 | Q | 0.58711 | P | 0.618585 | -0.031475 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 45 | S | 0.716466 | P | 0.727333 | -0.010867 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 51 | F | 0.85234 | L | 0.892369 | -0.040029 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 63 | A | 0.918093 | V | 0.850253 | 0.06784 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 69 | L | 0.930257 | P | 0.964214 | -0.033957 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 77 | P | 0.953335 | L | 0.912029 | 0.041306 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 114 | C | 0.9417 | R | 0.963471 | -0.021771 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 114 | C | 0.9417 | S | 0.962685 | -0.020985 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 118 | K | 0.929523 | R | 0.92731 | 0.002213 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 124 | K | 0.934217 | R | 0.936166 | -0.001949 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 126 | E | 0.937365 | V | 0.891387 | 0.045978 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 127 | A | 0.936905 | E | 0.9532 | -0.016295 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 133 | P | 0.931593 | S | 0.92834 | 0.003253 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 135 | A | 0.927841 | T | 0.925249 | 0.002592 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 142 | R | 0.89231 | C | 0.818907 | 0.073403 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 144 | L | 0.861048 | P | 0.91863 | -0.057582 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 183 | K | 0.454715 | E | 0.439022 | 0.015693 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 187 | Q | 0.508472 | H | 0.385019 | 0.123453 | D to O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 190 | R | 0.512262 | C | 0.397989 | 0.114273 | D to O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 192 | K | 0.569537 | R | 0.559925 | 0.009612 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 192 | K | 0.569537 | T | 0.506457 | 0.06308 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 194 | K | 0.632536 | R | 0.626405 | 0.006131 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 205 | V | 0.700652 | E | 0.818962 | -0.11831 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 216 | R | 0.779927 | C | 0.686777 | 0.09315 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 216 | R | 0.779927 | C | 0.686777 | 0.09315 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 219 | A | 0.720404 | V | 0.675402 | 0.045002 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 219 | A | 0.720404 | V | 0.675402 | 0.045002 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 226 | D | 0.587469 | N | 0.565194 | 0.022275 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 248 | Y | 0.442947 | H | 0.48933 | -0.046383 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 275 | P | 0.734597 | T | 0.654507 | 0.08009 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 279 | S | 0.794601 | F | 0.659775 | 0.134826 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 279 | S | 0.794601 | P | 0.814389 | -0.019788 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 281 | A | 0.796621 | V | 0.725814 | 0.070807 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 286 | A | 0.730026 | V | 0.650153 | 0.079873 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 294 | N | 0.430705 | H | 0.348754 | 0.081951 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 299 | D | 0.401653 | G | 0.434732 | -0.033079 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 305 | S | 0.497102 | G | 0.458747 | 0.038355 | No Change: Both O | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 320 | G | 0.495774 | S | 0.57159 | -0.075816 | O to D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 322 | R | 0.642013 | Q | 0.668539 | -0.026526 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 323 | A | 0.65194 | T | 0.70493 | -0.05299 | No Change: Both D | Atrial septal defect with atrioventricular conduction defects (ASD-AVCD) [MIM:108900] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 119 | A | 0.928725 | S | 0.937095 | -0.00837 | No Change: Both D | Congenital hypothyroidism non-goitrous type 5 (CHNG5) [MIM:225250] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 161 | R | 0.638373 | P | 0.641561 | -0.003188 | No Change: Both D | Congenital hypothyroidism non-goitrous type 5 (CHNG5) [MIM:225250] |
| P52952 | NKX25_HUMAN Homeobox protein Nkx-2.5 OS=Homo sapiens GN=NKX2-5 PE=1 SV=1 | 16 | D | 0.564764 | A | 0.578046 | -0.013282 | No Change: Both D | - |
| A6NCS4 | NKX26_HUMAN Homeobox protein Nkx-2.6 OS=Homo sapiens GN=NKX2-6 PE=1 SV=1 | 151 | F | 0.691495 | L | 0.730198 | -0.038703 | No Change: Both D | Conotruncal heart malformations (CTHM) [MIM:217095] |
| O15522 | NKX28_HUMAN Homeobox protein Nkx-2.8 OS=Homo sapiens GN=NKX2-8 PE=2 SV=2 | 16 | D | 0.820323 | A | 0.789148 | 0.031175 | No Change: Both D | - |
| Q99801 | NKX31_HUMAN Homeobox protein Nkx-3.1 OS=Homo sapiens GN=NKX3-1 PE=1 SV=2 | 52 | R | 0.993457 | C | 0.988862 | 0.004595 | No Change: Both D | - |
| Q9C056 | NKX62_HUMAN Homeobox protein Nkx-6.2 OS=Homo sapiens GN=NKX6-2 PE=2 SV=2 | 209 | V | 0.66808 | A | 0.74419 | -0.07611 | No Change: Both D | - |
| Q9NVX2 | NLE1_HUMAN Notchless protein homolog 1 OS=Homo sapiens GN=NLE1 PE=1 SV=4 | 319 | Q | 0.611298 | K | 0.619455 | -0.008157 | No Change: Both D | A breast cancer sample |
| Q9NVX2 | NLE1_HUMAN Notchless protein homolog 1 OS=Homo sapiens GN=NLE1 PE=1 SV=4 | 406 | Y | 0.291151 | H | 0.402059 | -0.110908 | No Change: Both O | - |
| Q9NVX2 | NLE1_HUMAN Notchless protein homolog 1 OS=Homo sapiens GN=NLE1 PE=1 SV=4 | 434 | S | 0.609352 | N | 0.533905 | 0.075447 | No Change: Both D | - |
| Q9NVX2 | NLE1_HUMAN Notchless protein homolog 1 OS=Homo sapiens GN=NLE1 PE=1 SV=4 | 6 | P | 0.609149 | A | 0.587409 | 0.02174 | No Change: Both D | - |
| Q9NVX2 | NLE1_HUMAN Notchless protein homolog 1 OS=Homo sapiens GN=NLE1 PE=1 SV=4 | 169 | R | 0.480638 | K | 0.545484 | -0.064846 | O to D | - |
| Q9NZ94 | NLGN3_HUMAN Neuroligin-3 OS=Homo sapiens GN=NLGN3 PE=1 SV=2 | 451 | R | 0.342042 | C | 0.204927 | 0.137115 | No Change: Both O | Autism X-linked type 1 (AUTSX1) [MIM:300425] |
| Q9NZ94 | NLGN3_HUMAN Neuroligin-3 OS=Homo sapiens GN=NLGN3 PE=1 SV=2 | 451 | R | 0.342042 | C | 0.204927 | 0.137115 | No Change: Both O | X-linked Asperger syndrome 1 (ASPGX1) [MIM:300494] |
| Q8N0W4 | NLGNX_HUMAN Neuroligin-4 X-linked OS=Homo sapiens GN=NLGN4X PE=1 SV=1 | 214 | G | 0.400232 | S | 0.450623 | -0.050391 | No Change: Both O | A colorectal cancer sample |
| Q9UBE8 | NLK_HUMAN Serine/threonine-protein kinase NLK OS=Homo sapiens GN=NLK PE=1 SV=2 | 177 | V | 0.137405 | A | 0.171622 | -0.034217 | No Change: Both O | - |
| Q9UBE8 | NLK_HUMAN Serine/threonine-protein kinase NLK OS=Homo sapiens GN=NLK PE=1 SV=2 | 343 | A | 0.241834 | T | 0.267949 | -0.026115 | No Change: Both O | A glioblastoma multiforme sample |
| Q9BYT8 | NEUL_HUMAN Neurolysin mitochondrial OS=Homo sapiens GN=NLN PE=1 SV=1 | 704 | P | 0.774038 | S | 0.772755 | 0.001283 | No Change: Both D | - |
| Q9BYT8 | NEUL_HUMAN Neurolysin mitochondrial OS=Homo sapiens GN=NLN PE=1 SV=1 | 323 | S | 0.44712 | G | 0.396665 | 0.050455 | No Change: Both O | - |
| Q9BYT8 | NEUL_HUMAN Neurolysin mitochondrial OS=Homo sapiens GN=NLN PE=1 SV=1 | 372 | K | 0.435928 | R | 0.365032 | 0.070896 | No Change: Both O | - |
| Q9BYT8 | NEUL_HUMAN Neurolysin mitochondrial OS=Homo sapiens GN=NLN PE=1 SV=1 | 417 | S | 0.208072 | G | 0.169495 | 0.038577 | No Change: Both O | - |
| Q9BYT8 | NEUL_HUMAN Neurolysin mitochondrial OS=Homo sapiens GN=NLN PE=1 SV=1 | 79 | G | 0.162362 | S | 0.189102 | -0.02674 | No Change: Both O | - |
| Q7RTR2 | NLRC3_HUMAN Protein NLRC3 OS=Homo sapiens GN=NLRC3 PE=2 SV=2 | 567 | V | 0.153656 | M | 0.202722 | -0.049066 | No Change: Both O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 210 | S | 0.293753 | L | 0.163724 | 0.130029 | No Change: Both O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 453 | P | 0.577719 | L | 0.429433 | 0.148286 | D to O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 500 | C | 0.191961 | R | 0.315243 | -0.123282 | No Change: Both O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 833 | S | 0.880009 | N | 0.837821 | 0.042188 | No Change: Both D | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 1105 | Q | 0.513739 | K | 0.576319 | -0.06258 | No Change: Both D | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 1455 | V | 0.385723 | A | 0.486095 | -0.100372 | No Change: Both O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 1466 | Q | 0.499514 | R | 0.468492 | 0.031022 | No Change: Both O | - |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 361 | M | 0.234447 | I | 0.135246 | 0.099201 | No Change: Both O | A breast cancer sample |
| Q86WI3 | NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens GN=NLRC5 PE=1 SV=3 | 907 | N | 0.420001 | D | 0.435729 | -0.015728 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1366 | R | 0.299819 | C | 0.173742 | 0.126077 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 404 | R | 0.22059 | Q | 0.232891 | -0.012301 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 246 | T | 0.77956 | S | 0.817801 | -0.038241 | No Change: Both D | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1059 | V | 0.440311 | M | 0.478022 | -0.037711 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 155 | L | 0.837377 | H | 0.854323 | -0.016946 | No Change: Both D | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 878 | T | 0.317014 | M | 0.268619 | 0.048395 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1069 | H | 0.629079 | Y | 0.527764 | 0.101315 | No Change: Both D | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1119 | M | 0.068193 | V | 0.057042 | 0.011151 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1184 | M | 0.268158 | V | 0.215453 | 0.052705 | No Change: Both O | - |
| Q9C000 | NALP1_HUMAN NACHT LRR and PYD domains-containing protein 1 OS=Homo sapiens GN=NLRP1 PE=1 SV=1 | 1241 | V | 0.245644 | L | 0.243881 | 0.001763 | No Change: Both O | - |
| P59045 | NAL11_HUMAN NACHT LRR and PYD domains-containing protein 11 OS=Homo sapiens GN=NLRP11 PE=2 SV=2 | 438 | P | 0.355855 | L | 0.223159 | 0.132696 | No Change: Both O | - |
| P59045 | NAL11_HUMAN NACHT LRR and PYD domains-containing protein 11 OS=Homo sapiens GN=NLRP11 PE=2 SV=2 | 188 | A | 0.232914 | S | 0.347797 | -0.114883 | No Change: Both O | - |
| P59045 | NAL11_HUMAN NACHT LRR and PYD domains-containing protein 11 OS=Homo sapiens GN=NLRP11 PE=2 SV=2 | 233 | N | 0.174583 | D | 0.19275 | -0.018167 | No Change: Both O | - |
| P59046 | NAL12_HUMAN NACHT LRR and PYD domains-containing protein 12 OS=Homo sapiens GN=NLRP12 PE=1 SV=2 | 39 | G | 0.434315 | V | 0.285574 | 0.148741 | No Change: Both O | - |
| P59046 | NAL12_HUMAN NACHT LRR and PYD domains-containing protein 12 OS=Homo sapiens GN=NLRP12 PE=1 SV=2 | 402 | F | 0.016194 | L | 0.019093 | -0.002899 | No Change: Both O | - |
| Q86W25 | NAL13_HUMAN NACHT LRR and PYD domains-containing protein 13 OS=Homo sapiens GN=NLRP13 PE=1 SV=2 | 247 | Q | 0.156483 | R | 0.147245 | 0.009238 | No Change: Both O | - |
| Q86W25 | NAL13_HUMAN NACHT LRR and PYD domains-containing protein 13 OS=Homo sapiens GN=NLRP13 PE=1 SV=2 | 781 | N | 0.293258 | S | 0.335906 | -0.042648 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 808 | E | 0.14956 | K | 0.151299 | -0.001739 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 48 | N | 0.515821 | T | 0.498914 | 0.016907 | D to O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 55 | R | 0.504247 | E | 0.557957 | -0.05371 | No Change: Both D | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 86 | D | 0.323104 | V | 0.19481 | 0.128294 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 92 | K | 0.402513 | R | 0.351489 | 0.051024 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 98 | S | 0.403371 | L | 0.254973 | 0.148398 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 375 | A | 0.060059 | T | 0.076289 | -0.01623 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 397 | T | 0.158362 | I | 0.076482 | 0.08188 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 441 | V | 0.048373 | M | 0.071909 | -0.023536 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 522 | D | 0.560958 | Q | 0.574537 | -0.013579 | No Change: Both D | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 951 | S | 0.142501 | T | 0.103941 | 0.03856 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 954 | L | 0.242342 | S | 0.395592 | -0.15325 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 1010 | L | 0.130066 | F | 0.101192 | 0.028874 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 1019 | M | 0.228977 | I | 0.174864 | 0.054113 | No Change: Both O | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 779 | S | 0.134706 | C | 0.069154 | 0.065552 | No Change: Both O | A breast cancer sample |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 21 | E | 0.533245 | K | 0.519203 | 0.014042 | No Change: Both D | - |
| Q86W24 | NAL14_HUMAN NACHT LRR and PYD domains-containing protein 14 OS=Homo sapiens GN=NLRP14 PE=2 SV=1 | 511 | L | 0.514562 | F | 0.477726 | 0.036836 | D to O | - |
| Q9NX02 | NALP2_HUMAN NACHT LRR and PYD domains-containing protein 2 OS=Homo sapiens GN=NLRP2 PE=1 SV=1 | 1052 | A | 0.674391 | E | 0.786814 | -0.112423 | No Change: Both D | - |
| Q9NX02 | NALP2_HUMAN NACHT LRR and PYD domains-containing protein 2 OS=Homo sapiens GN=NLRP2 PE=1 SV=1 | 364 | R | 0.346952 | K | 0.355758 | -0.008806 | No Change: Both O | - |
| Q9NX02 | NALP2_HUMAN NACHT LRR and PYD domains-containing protein 2 OS=Homo sapiens GN=NLRP2 PE=1 SV=1 | 221 | T | 0.355814 | M | 0.303216 | 0.052598 | No Change: Both O | - |
| Q9NX02 | NALP2_HUMAN NACHT LRR and PYD domains-containing protein 2 OS=Homo sapiens GN=NLRP2 PE=1 SV=1 | 302 | E | 0.147333 | Q | 0.117105 | 0.030228 | No Change: Both O | - |
| Q9NX02 | NALP2_HUMAN NACHT LRR and PYD domains-containing protein 2 OS=Homo sapiens GN=NLRP2 PE=1 SV=1 | 884 | G | 0.179674 | R | 0.160532 | 0.019142 | No Change: Both O | - |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 200 | V | 0.60385 | M | 0.690459 | -0.086609 | No Change: Both D | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 200 | V | 0.60385 | M | 0.690459 | -0.086609 | No Change: Both D | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 354 | A | 0.282974 | V | 0.228343 | 0.054631 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 441 | A | 0.173423 | V | 0.133487 | 0.039936 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 629 | E | 0.14735 | G | 0.100039 | 0.047311 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 262 | R | 0.078995 | W | 0.02934 | 0.049655 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 262 | R | 0.078995 | W | 0.02934 | 0.049655 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 305 | D | 0.257816 | N | 0.225109 | 0.032707 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 305 | D | 0.257816 | N | 0.225109 | 0.032707 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 311 | F | 0.296532 | S | 0.462884 | -0.166352 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 571 | G | 0.118849 | R | 0.11427 | 0.004579 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 575 | F | 0.026078 | S | 0.061566 | -0.035488 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 307 | L | 0.322269 | P | 0.44372 | -0.121451 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 307 | L | 0.322269 | P | 0.44372 | -0.121451 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 350 | T | 0.256046 | M | 0.213147 | 0.042899 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 350 | T | 0.256046 | M | 0.213147 | 0.042899 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 360 | H | 0.374514 | R | 0.37551 | -9.96E-04 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 438 | T | 0.412288 | N | 0.423964 | -0.011676 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 441 | A | 0.173423 | T | 0.212476 | -0.039053 | No Change: Both O | Muckle-Wells syndrome (MWS) [MIM:191900] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 664 | M | 0.311608 | T | 0.320282 | -0.008674 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 861 | Y | 0.293729 | C | 0.290836 | 0.002893 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 525 | F | 0.098624 | C | 0.087115 | 0.011509 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 174 | I | 0.708414 | T | 0.804275 | -0.095861 | No Change: Both D | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 262 | R | 0.078995 | L | 0.046893 | 0.032102 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 262 | R | 0.078995 | P | 0.089484 | -0.010489 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 266 | L | 0.215461 | H | 0.324104 | -0.108643 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 305 | D | 0.257816 | G | 0.235462 | 0.022354 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 308 | Q | 0.333041 | L | 0.237548 | 0.095493 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 355 | L | 0.308046 | P | 0.453945 | -0.145899 | No Change: Both O | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 356 | E | 0.337166 | D | 0.319639 | 0.017527 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 407 | T | 0.027808 | P | 0.038437 | -0.010629 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 438 | T | 0.412288 | I | 0.262242 | 0.150046 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 490 | R | 0.460343 | K | 0.551053 | -0.09071 | O to D | Familial cold autoinflammatory syndrome type 1 (FCAS1) [MIM:120100] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 525 | F | 0.098624 | L | 0.099247 | -6.23E-04 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 572 | Y | 0.086399 | C | 0.075082 | 0.011317 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 634 | L | 0.105957 | F | 0.093473 | 0.012484 | No Change: Both O | Chronic infantile neurologic cutaneous and articular syndrome (CINCA) [MIM:607115] |
| Q96P20 | NALP3_HUMAN NACHT LRR and PYD domains-containing protein 3 OS=Homo sapiens GN=NLRP3 PE=1 SV=3 | 705 | Q | 0.649054 | K | 0.701576 | -0.052522 | No Change: Both D | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 925 | Q | 0.328155 | L | 0.221646 | 0.106509 | No Change: Both O | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 144 | A | 0.557928 | T | 0.58525 | -0.027322 | No Change: Both D | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 383 | E | 0.489995 | D | 0.450989 | 0.039006 | No Change: Both O | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 390 | P | 0.659257 | Q | 0.657395 | 0.001862 | No Change: Both D | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 774 | L | 0.112876 | M | 0.134583 | -0.021707 | No Change: Both O | - |
| Q96MN2 | NALP4_HUMAN NACHT LRR and PYD domains-containing protein 4 OS=Homo sapiens GN=NLRP4 PE=2 SV=3 | 708 | R | 0.436047 | H | 0.424572 | 0.011475 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 459 | M | 0.267189 | I | 0.206823 | 0.060366 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 584 | H | 0.066927 | P | 0.077007 | -0.01008 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 761 | R | 0.132915 | L | 0.083556 | 0.049359 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 912 | M | 0.376349 | T | 0.439963 | -0.063614 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 1097 | A | 0.38742 | T | 0.400114 | -0.012694 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 1108 | S | 0.331021 | C | 0.227456 | 0.103565 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 1181 | V | 0.162203 | I | 0.140737 | 0.021466 | No Change: Both O | - |
| P59047 | NALP5_HUMAN NACHT LRR and PYD domains-containing protein 5 OS=Homo sapiens GN=NLRP5 PE=2 SV=2 | 1195 | R | 0.489494 | Q | 0.514885 | -0.025391 | O to D | - |
| P59044 | NALP6_HUMAN NACHT LRR and PYD domains-containing protein 6 OS=Homo sapiens GN=NLRP6 PE=2 SV=2 | 163 | M | 0.929781 | L | 0.921625 | 0.008156 | No Change: Both D | - |
| P59044 | NALP6_HUMAN NACHT LRR and PYD domains-containing protein 6 OS=Homo sapiens GN=NLRP6 PE=2 SV=2 | 361 | Y | 0.40805 | F | 0.405821 | 0.002229 | No Change: Both O | - |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 319 | V | 0.203325 | I | 0.183329 | 0.019996 | No Change: Both O | - |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 693 | R | 0.308396 | P | 0.332955 | -0.024559 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 693 | R | 0.308396 | W | 0.140575 | 0.167821 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 913 | N | 0.154847 | S | 0.182497 | -0.02765 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 971 | T | 0.465744 | A | 0.447626 | 0.018118 | No Change: Both O | - |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 398 | L | 0.155022 | R | 0.242248 | -0.087226 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 651 | P | 0.10378 | S | 0.120329 | -0.016549 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 693 | R | 0.308396 | Q | 0.323907 | -0.015511 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 716 | P | 0.282125 | A | 0.225122 | 0.057003 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 721 | R | 0.099856 | W | 0.040007 | 0.059849 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 761 | C | 0.182374 | Y | 0.230357 | -0.047983 | No Change: Both O | Hydatidiform mole recurrent type 1 (HYDM1) [MIM:231090] |
| Q8WX94 | NALP7_HUMAN NACHT LRR and PYD domains-containing protein 7 OS=Homo sapiens GN=NLRP7 PE=1 SV=1 | 487 | G | 0.711804 | E | 0.722083 | -0.010279 | No Change: Both D | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 25 | P | 0.77865 | L | 0.638388 | 0.140262 | No Change: Both D | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 116 | V | 0.073414 | L | 0.069296 | 0.004118 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 234 | A | 0.097107 | T | 0.101661 | -0.004554 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 268 | Q | 0.455724 | R | 0.412802 | 0.042922 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 367 | Q | 0.159688 | E | 0.204845 | -0.045157 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 782 | V | 0.14599 | A | 0.194091 | -0.048101 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 937 | K | 0.379856 | R | 0.30481 | 0.075046 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 126 | P | 0.264531 | R | 0.23347 | 0.031061 | No Change: Both O | A breast cancer sample |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 375 | E | 0.494769 | V | 0.292655 | 0.202114 | No Change: Both O | A breast cancer sample |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 1045 | Q | 0.787646 | L | 0.716991 | 0.070655 | No Change: Both D | A colorectal cancer sample |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 543 | A | 0.402187 | V | 0.325736 | 0.076451 | No Change: Both O | - |
| Q86W28 | NALP8_HUMAN NACHT LRR and PYD domains-containing protein 8 OS=Homo sapiens GN=NLRP8 PE=2 SV=2 | 651 | R | 0.086836 | W | 0.033633 | 0.053203 | No Change: Both O | - |
| Q7RTR0 | NALP9_HUMAN NACHT LRR and PYD domains-containing protein 9 OS=Homo sapiens GN=NLRP9 PE=2 SV=1 | 425 | G | 0.392362 | D | 0.399152 | -0.00679 | No Change: Both O | A breast cancer sample |
| Q86UT6 | NLRX1_HUMAN NLR family member X1 OS=Homo sapiens GN=NLRX1 PE=1 SV=1 | 63 | P | 0.849013 | S | 0.847503 | 0.00151 | No Change: Both D | - |
| Q86UT6 | NLRX1_HUMAN NLR family member X1 OS=Homo sapiens GN=NLRX1 PE=1 SV=1 | 125 | R | 0.79862 | L | 0.732002 | 0.066618 | No Change: Both D | - |
| Q86UT6 | NLRX1_HUMAN NLR family member X1 OS=Homo sapiens GN=NLRX1 PE=1 SV=1 | 793 | A | 0.254747 | E | 0.333368 | -0.078621 | No Change: Both O | - |
| Q86UT6 | NLRX1_HUMAN NLR family member X1 OS=Homo sapiens GN=NLRX1 PE=1 SV=1 | 843 | A | 0.359677 | S | 0.434002 | -0.074325 | No Change: Both O | - |
| P08949 | NMB_HUMAN Neuromedin-B OS=Homo sapiens GN=NMB PE=1 SV=4 | 73 | P | 0.763026 | T | 0.70946 | 0.053566 | No Change: Both D | - |
| P28336 | NMBR_HUMAN Neuromedin-B receptor OS=Homo sapiens GN=NMBR PE=2 SV=2 | 390 | L | 0.851252 | M | 0.904349 | -0.053097 | No Change: Both D | - |
| Q96D46 | NMD3_HUMAN 60S ribosomal export protein NMD3 OS=Homo sapiens GN=NMD3 PE=1 SV=1 | 6 | E | 0.73202 | K | 0.720755 | 0.011265 | No Change: Both D | - |
| P15531 | NDKA_HUMAN Nucleoside diphosphate kinase A OS=Homo sapiens GN=NME1 PE=1 SV=1 | 120 | S | 0.575672 | G | 0.524251 | 0.051421 | No Change: Both D | - |
| Q13287 | NMI_HUMAN N-myc-interactor OS=Homo sapiens GN=NMI PE=1 SV=2 | 16 | S | 0.899122 | L | 0.858728 | 0.040394 | No Change: Both D | - |
| Q9HBL8 | NMRL1_HUMAN NmrA-like family domain-containing protein 1 OS=Homo sapiens GN=NMRAL1 PE=1 SV=1 | 23 | T | 0.361264 | I | 0.210467 | 0.150797 | No Change: Both O | - |
| Q9HBL8 | NMRL1_HUMAN NmrA-like family domain-containing protein 1 OS=Homo sapiens GN=NMRAL1 PE=1 SV=1 | 252 | P | 0.349569 | L | 0.22453 | 0.125039 | No Change: Both O | - |
| Q5H8A3 | NMS_HUMAN Neuromedin-S OS=Homo sapiens GN=NMS PE=2 SV=1 | 6 | P | 0.354652 | S | 0.357128 | -0.002476 | No Change: Both O | - |
| P30419 | NMT1_HUMAN Glycylpeptide N-tetradecanoyltransferase 1 OS=Homo sapiens GN=NMT1 PE=1 SV=2 | 61 | Q | 0.994111 | K | 0.995523 | -0.001412 | No Change: Both D | - |
| P48645 | NMU_HUMAN Neuromedin-U OS=Homo sapiens GN=NMU PE=2 SV=1 | 79 | E | 0.509381 | G | 0.415327 | 0.094054 | D to O | - |
| P48645 | NMU_HUMAN Neuromedin-U OS=Homo sapiens GN=NMU PE=2 SV=1 | 148 | F | 0.656996 | L | 0.659232 | -0.002236 | No Change: Both D | - |
| Q9GZQ4 | NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens GN=NMUR2 PE=2 SV=2 | 298 | S | 0.29861 | T | 0.20609 | 0.09252 | No Change: Both O | - |
| Q9GZQ4 | NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens GN=NMUR2 PE=2 SV=2 | 315 | F | 0.090372 | L | 0.103609 | -0.013237 | No Change: Both O | - |
| Q9GZQ4 | NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens GN=NMUR2 PE=2 SV=2 | 388 | M | 0.679201 | V | 0.59885 | 0.080351 | No Change: Both D | - |
| Q9GZQ4 | NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens GN=NMUR2 PE=2 SV=2 | 395 | A | 0.756575 | T | 0.782637 | -0.026062 | No Change: Both D | - |
| Q9GZQ4 | NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens GN=NMUR2 PE=2 SV=2 | 383 | P | 0.599013 | L | 0.434148 | 0.164865 | D to O | - |
| Q9H6W3 | NO66_HUMAN Lysine-specific demethylase NO66 OS=Homo sapiens GN=NO66 PE=1 SV=2 | 218 | F | 0.216654 | S | 0.42145 | -0.204796 | No Change: Both O | - |
| Q9H6W3 | NO66_HUMAN Lysine-specific demethylase NO66 OS=Homo sapiens GN=NO66 PE=1 SV=2 | 239 | Q | 0.262321 | H | 0.249382 | 0.012939 | No Change: Both O | - |
| Q9H6W3 | NO66_HUMAN Lysine-specific demethylase NO66 OS=Homo sapiens GN=NO66 PE=1 SV=2 | 17 | K | 0.986814 | R | 0.988401 | -0.001587 | No Change: Both D | - |
| Q9H6W3 | NO66_HUMAN Lysine-specific demethylase NO66 OS=Homo sapiens GN=NO66 PE=1 SV=2 | 364 | V | 0.330193 | A | 0.392149 | -0.061956 | No Change: Both O | - |
| Q8NC60 | NOA1_HUMAN Nitric oxide-associated protein 1 OS=Homo sapiens GN=NOA1 PE=1 SV=2 | 153 | A | 0.393086 | S | 0.477131 | -0.084045 | No Change: Both O | - |
| Q8NC60 | NOA1_HUMAN Nitric oxide-associated protein 1 OS=Homo sapiens GN=NOA1 PE=1 SV=2 | 450 | K | 0.414993 | R | 0.383898 | 0.031095 | No Change: Both O | - |
| Q8NC60 | NOA1_HUMAN Nitric oxide-associated protein 1 OS=Homo sapiens GN=NOA1 PE=1 SV=2 | 579 | Q | 0.425611 | R | 0.419368 | 0.006243 | No Change: Both O | A breast cancer sample |
| Q9ULX3 | NOB1_HUMAN RNA-binding protein NOB1 OS=Homo sapiens GN=NOB1 PE=1 SV=1 | 231 | R | 0.197066 | Q | 0.225594 | -0.028528 | No Change: Both O | - |
| Q9ULX3 | NOB1_HUMAN RNA-binding protein NOB1 OS=Homo sapiens GN=NOB1 PE=1 SV=1 | 366 | Y | 0.249762 | F | 0.303403 | -0.053641 | No Change: Both O | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 355 | R | 0.377493 | H | 0.295363 | 0.08213 | No Change: Both O | Premature ovarian failure type 5 (POF5) [MIM:611548] |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 360 | R | 0.588269 | Q | 0.588783 | -5.14E-04 | No Change: Both D | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 452 | D | 0.874386 | N | 0.842581 | 0.031805 | No Change: Both D | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 482 | G | 0.779026 | S | 0.820477 | -0.041451 | No Change: Both D | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 517 | F | 0.97674 | L | 0.97891 | -0.00217 | No Change: Both D | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 117 | R | 0.949426 | W | 0.889507 | 0.059919 | No Change: Both D | - |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 91 | G | 0.837343 | W | 0.699815 | 0.137528 | No Change: Both D | Premature ovarian failure type 5 (POF5) [MIM:611548] |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 342 | S | 0.367749 | T | 0.310499 | 0.05725 | No Change: Both O | Premature ovarian failure type 5 (POF5) [MIM:611548] |
| O60393 | NOBOX_HUMAN Homeobox protein NOBOX OS=Homo sapiens GN=NOBOX PE=1 SV=4 | 350 | V | 0.21887 | L | 0.23204 | -0.01317 | No Change: Both O | Premature ovarian failure type 5 (POF5) [MIM:611548] |
| Q9Y3T9 | NOC2L_HUMAN Nucleolar complex protein 2 homolog OS=Homo sapiens GN=NOC2L PE=1 SV=4 | 271 | A | 0.130581 | V | 0.095365 | 0.035216 | No Change: Both O | - |
| Q9Y3T9 | NOC2L_HUMAN Nucleolar complex protein 2 homolog OS=Homo sapiens GN=NOC2L PE=1 SV=4 | 300 | I | 0.073839 | V | 0.094248 | -0.020409 | No Change: Both O | - |
| Q9Y3T9 | NOC2L_HUMAN Nucleolar complex protein 2 homolog OS=Homo sapiens GN=NOC2L PE=1 SV=4 | 556 | S | 0.126563 | L | 0.060918 | 0.065645 | No Change: Both O | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 194 | P | 0.943549 | L | 0.925019 | 0.01853 | No Change: Both D | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 472 | E | 0.934566 | A | 0.905569 | 0.028997 | No Change: Both D | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 444 | P | 0.888072 | R | 0.893067 | -0.004995 | No Change: Both D | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 504 | R | 0.095666 | I | 0.05052 | 0.045146 | No Change: Both O | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 655 | T | 0.197752 | S | 0.245484 | -0.047732 | No Change: Both O | - |
| Q8WTT2 | NOC3L_HUMAN Nucleolar complex protein 3 homolog OS=Homo sapiens GN=NOC3L PE=1 SV=1 | 695 | A | 0.174065 | T | 0.189023 | -0.014958 | No Change: Both O | - |
| Q9Y239 | NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 | 266 | E | 0.312471 | K | 0.29212 | 0.020351 | No Change: Both O | - |
| Q9Y239 | NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 | 372 | D | 0.399008 | N | 0.39569 | 0.003318 | No Change: Both O | - |
| Q9Y239 | NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 | 447 | R | 0.604633 | H | 0.596661 | 0.007972 | No Change: Both D | - |
| Q9Y239 | NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 | 605 | R | 0.301999 | W | 0.136235 | 0.165764 | No Change: Both O | - |
| Q9Y239 | NOD1_HUMAN Nucleotide-binding oligomerization domain-containing protein 1 OS=Homo sapiens GN=NOD1 PE=1 SV=1 | 610 | A | 0.32866 | T | 0.3266 | 0.00206 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 140 | A | 0.463857 | T | 0.476685 | -0.012828 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 157 | W | 0.144673 | R | 0.333561 | -0.188888 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 189 | T | 0.209238 | M | 0.177394 | 0.031844 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 235 | R | 0.387618 | C | 0.222527 | 0.165091 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 248 | L | 0.140998 | R | 0.212184 | -0.071186 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 268 | P | 0.583542 | S | 0.603183 | -0.019641 | No Change: Both D | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 289 | N | 0.48835 | S | 0.552457 | -0.064107 | O to D | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 291 | D | 0.439884 | N | 0.417037 | 0.022847 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 294 | T | 0.33372 | S | 0.400408 | -0.066688 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 301 | A | 0.486902 | V | 0.431406 | 0.055496 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 311 | R | 0.146134 | W | 0.066483 | 0.079651 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 334 | R | 0.087175 | Q | 0.104746 | -0.017571 | No Change: Both O | Blau syndrome (BS) [MIM:186580] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 334 | R | 0.087175 | W | 0.033633 | 0.053542 | No Change: Both O | Blau syndrome (BS) [MIM:186580] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 348 | L | 0.080378 | V | 0.077279 | 0.003099 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 352 | H | 0.051402 | R | 0.061416 | -0.010014 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 373 | R | 0.244946 | C | 0.159177 | 0.085769 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 414 | N | 0.256741 | S | 0.28156 | -0.024819 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 431 | S | 0.211352 | L | 0.101895 | 0.109457 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 432 | A | 0.182654 | V | 0.132504 | 0.05015 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 441 | E | 0.21063 | K | 0.220902 | -0.010272 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 469 | L | 0.201381 | F | 0.166626 | 0.034755 | No Change: Both O | Blau syndrome (BS) [MIM:186580] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 612 | A | 0.025548 | T | 0.02689 | -0.001342 | No Change: Both O | Sarcoidosis early-onset (EOS) [MIM:609464] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 612 | A | 0.025548 | V | 0.015656 | 0.009892 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 684 | R | 0.224553 | W | 0.105243 | 0.11931 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 702 | R | 0.359048 | W | 0.171675 | 0.187373 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 703 | R | 0.300091 | C | 0.202394 | 0.097697 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 713 | R | 0.265246 | C | 0.166259 | 0.098987 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 725 | A | 0.585398 | G | 0.611391 | -0.025993 | No Change: Both D | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 755 | A | 0.508854 | V | 0.406905 | 0.101949 | D to O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 758 | A | 0.45751 | V | 0.360803 | 0.096707 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 778 | E | 0.137029 | K | 0.138037 | -0.001008 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 793 | V | 0.206781 | M | 0.25329 | -0.046509 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 843 | E | 0.150383 | K | 0.158489 | -0.008106 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 853 | N | 0.261376 | S | 0.284894 | -0.023518 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 863 | M | 0.233867 | V | 0.185121 | 0.048746 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 885 | A | 0.17275 | T | 0.187092 | -0.014342 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 908 | G | 0.145132 | R | 0.135671 | 0.009461 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 918 | A | 0.444859 | D | 0.528514 | -0.083655 | O to D | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 924 | G | 0.382255 | D | 0.421714 | -0.039459 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 955 | V | 0.242866 | I | 0.2142 | 0.028666 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 382 | D | 0.300125 | E | 0.310754 | -0.010629 | No Change: Both O | Sarcoidosis early-onset (EOS) [MIM:609464] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 383 | E | 0.323479 | K | 0.326086 | -0.002607 | No Change: Both O | Blau syndrome (BS) [MIM:186580] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 496 | H | 0.211289 | L | 0.143052 | 0.068237 | No Change: Both O | Sarcoidosis early-onset (EOS) [MIM:609464] |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 790 | R | 0.142714 | Q | 0.157847 | -0.015133 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 81 | L | 0.356807 | V | 0.329909 | 0.026898 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 471 | R | 0.173166 | C | 0.082687 | 0.090479 | No Change: Both O | - |
| Q9HC29 | NOD2_HUMAN Nucleotide-binding oligomerization domain-containing protein 2 OS=Homo sapiens GN=NOD2 PE=1 SV=1 | 605 | T | 0.028012 | N | 0.032721 | -0.004709 | No Change: Both O | Blau syndrome (BS) [MIM:186580] |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 183 | R | 0.57016 | Q | 0.582663 | -0.012503 | No Change: Both D | Visceral heterotaxy autosomal type 5 (HTX5) [MIM:270100] |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 279 | E | 0.41367 | K | 0.389331 | 0.024339 | No Change: Both O | A colorectal cancer sample |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 165 | H | 0.463852 | R | 0.51355 | -0.049698 | O to D | - |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 203 | E | 0.660369 | K | 0.630315 | 0.030054 | No Change: Both D | Visceral heterotaxy autosomal type 5 (HTX5) [MIM:270100] |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 260 | G | 0.031269 | R | 0.031488 | -2.19E-04 | No Change: Both O | Visceral heterotaxy autosomal type 5 (HTX5) [MIM:270100] |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 275 | R | 0.262185 | C | 0.150149 | 0.112036 | No Change: Both O | Visceral heterotaxy autosomal type 5 (HTX5) [MIM:270100] |
| Q96S42 | NODAL_HUMAN Nodal homolog OS=Homo sapiens GN=NODAL PE=1 SV=2 | 284 | V | 0.631647 | F | 0.616528 | 0.015119 | No Change: Both D | Visceral heterotaxy autosomal type 5 (HTX5) [MIM:270100] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 35 | P | 0.42955 | R | 0.386867 | 0.042683 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 35 | P | 0.42955 | R | 0.386867 | 0.042683 | No Change: Both O | Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 189 | G | 0.534741 | C | 0.3918 | 0.142941 | D to O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 217 | W | 0.283934 | G | 0.50622 | -0.222286 | O to D | Multiple synostoses syndrome type 1 (SYNS1) [MIM:186500] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 220 | I | 0.229311 | N | 0.306221 | -0.07691 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 222 | Y | 0.296266 | C | 0.500127 | -0.203861 | O to D | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 222 | Y | 0.296266 | C | 0.500127 | -0.203861 | O to D | Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 222 | Y | 0.296266 | D | 0.466962 | -0.170696 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 223 | P | 0.297191 | L | 0.133726 | 0.163465 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 35 | P | 0.42955 | S | 0.451203 | -0.021653 | No Change: Both O | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 35 | P | 0.42955 | S | 0.451203 | -0.021653 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 184 | C | 0.470702 | Y | 0.476601 | -0.005899 | No Change: Both O | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 204 | R | 0.360759 | L | 0.236263 | 0.124496 | No Change: Both O | Tarsal-carpal coalition syndrome (TCC) [MIM:186570] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 35 | P | 0.42955 | A | 0.341224 | 0.088326 | No Change: Both O | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 36 | A | 0.471747 | P | 0.580731 | -0.108984 | O to D | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 48 | E | 0.373208 | K | 0.377879 | -0.004671 | No Change: Both O | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 167 | R | 0.120395 | G | 0.117678 | 0.002717 | No Change: Both O | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 187 | P | 0.490432 | S | 0.533661 | -0.043229 | O to D | Brachydactyly type B2 (BDB2) [MIM:611377] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 205 | W | 0.348259 | C | 0.501172 | -0.152913 | O to D | Symphalangism proximal syndrome (SYM1) [MIM:185800] |
| Q13253 | NOGG_HUMAN Noggin OS=Homo sapiens GN=NOG PE=1 SV=1 | 232 | C | 0.693154 | W | 0.627619 | 0.065535 | No Change: Both D | Multiple synostoses syndrome type 1 (SYNS1) [MIM:186500] |
| Q9BSC4 | NOL10_HUMAN Nucleolar protein 10 OS=Homo sapiens GN=NOL10 PE=1 SV=1 | 635 | D | 0.840514 | N | 0.839995 | 5.19E-04 | No Change: Both D | - |
| Q9H8H0 | NOL11_HUMAN Nucleolar protein 11 OS=Homo sapiens GN=NOL11 PE=1 SV=1 | 115 | V | 0.171876 | A | 0.220276 | -0.0484 | No Change: Both O | - |
| Q9H6R4 | NOL6_HUMAN Nucleolar protein 6 OS=Homo sapiens GN=NOL6 PE=1 SV=2 | 52 | P | 0.851576 | S | 0.8471 | 0.004476 | No Change: Both D | - |
| Q9H6R4 | NOL6_HUMAN Nucleolar protein 6 OS=Homo sapiens GN=NOL6 PE=1 SV=2 | 723 | R | 0.528309 | W | 0.289939 | 0.23837 | D to O | - |
| Q76FK4 | NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens GN=NOL8 PE=1 SV=1 | 748 | V | 0.945996 | L | 0.954369 | -0.008373 | No Change: Both D | - |
| Q76FK4 | NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens GN=NOL8 PE=1 SV=1 | 841 | D | 0.974764 | E | 0.974708 | 5.60E-05 | No Change: Both D | - |
| Q76FK4 | NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens GN=NOL8 PE=1 SV=1 | 988 | E | 0.809514 | D | 0.777983 | 0.031531 | No Change: Both D | - |
| Q76FK4 | NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens GN=NOL8 PE=1 SV=1 | 1021 | G | 0.848094 | S | 0.88111 | -0.033016 | No Change: Both D | - |
| Q76FK4 | NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens GN=NOL8 PE=1 SV=1 | 470 | G | 0.833494 | E | 0.864664 | -0.03117 | No Change: Both D | - |
| Q5SY16 | NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens GN=NOL9 PE=1 SV=1 | 10 | R | 0.767951 | W | 0.503141 | 0.26481 | No Change: Both D | - |
| Q5SY16 | NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens GN=NOL9 PE=1 SV=1 | 50 | W | 0.794804 | R | 0.908836 | -0.114032 | No Change: Both D | - |
| Q5SY16 | NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens GN=NOL9 PE=1 SV=1 | 58 | S | 0.817604 | A | 0.779994 | 0.03761 | No Change: Both D | - |
| Q5SY16 | NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens GN=NOL9 PE=1 SV=1 | 420 | I | 0.058989 | V | 0.064956 | -0.005967 | No Change: Both O | - |
| Q14978 | NOLC1_HUMAN Nucleolar and coiled-body phosphoprotein 1 OS=Homo sapiens GN=NOLC1 PE=1 SV=2 | 412 | G | 0.984057 | V | 0.978618 | 0.005439 | No Change: Both D | - |
| Q14978 | NOLC1_HUMAN Nucleolar and coiled-body phosphoprotein 1 OS=Homo sapiens GN=NOLC1 PE=1 SV=2 | 456 | S | 0.995183 | P | 0.994928 | 2.55E-04 | No Change: Both D | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 122 | H | 0.994691 | P | 0.996592 | -0.001901 | No Change: Both D | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 779 | R | 0.277733 | H | 0.236629 | 0.041104 | No Change: Both O | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 804 | V | 0.246634 | L | 0.264878 | -0.018244 | No Change: Both O | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 812 | V | 0.279109 | M | 0.329834 | -0.050725 | No Change: Both O | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 723 | M | 0.120201 | V | 0.091138 | 0.029063 | No Change: Both O | - |
| Q5C9Z4 | NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens GN=NOM1 PE=1 SV=1 | 24 | R | 0.96881 | G | 0.964966 | 0.003844 | No Change: Both D | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 1081 | E | 0.36424 | K | 0.386258 | -0.022018 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 404 | I | 0.119815 | V | 0.133236 | -0.013421 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 458 | K | 0.377529 | N | 0.300411 | 0.077118 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 490 | N | 0.297927 | D | 0.340038 | -0.042111 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 1141 | I | 0.12014 | F | 0.121002 | -8.62E-04 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 1195 | R | 0.495404 | G | 0.492776 | 0.002628 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 493 | M | 0.229751 | V | 0.183372 | 0.046379 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 580 | M | 0.400158 | V | 0.358351 | 0.041807 | No Change: Both O | - |
| Q15155 | NOMO1_HUMAN Nodal modulator 1 OS=Homo sapiens GN=NOMO1 PE=1 SV=5 | 583 | V | 0.32564 | A | 0.414482 | -0.088842 | No Change: Both O | - |
| Q5JPE7 | NOMO2_HUMAN Nodal modulator 2 OS=Homo sapiens GN=NOMO2 PE=1 SV=1 | 580 | V | 0.358351 | M | 0.400158 | -0.041807 | No Change: Both O | - |
| Q5JPE7 | NOMO2_HUMAN Nodal modulator 2 OS=Homo sapiens GN=NOMO2 PE=1 SV=1 | 490 | D | 0.284327 | N | 0.24723 | 0.037097 | No Change: Both O | - |
| Q5JPE7 | NOMO2_HUMAN Nodal modulator 2 OS=Homo sapiens GN=NOMO2 PE=1 SV=1 | 493 | V | 0.218772 | M | 0.271923 | -0.053151 | No Change: Both O | - |
| Q5JPE7 | NOMO2_HUMAN Nodal modulator 2 OS=Homo sapiens GN=NOMO2 PE=1 SV=1 | 726 | N | 0.944229 | K | 0.951638 | -0.007409 | No Change: Both D | - |
| Q9NPE3 | NOP10_HUMAN H/ACA ribonucleoprotein complex subunit 3 OS=Homo sapiens GN=NOP10 PE=1 SV=1 | 34 | R | 0.606295 | W | 0.383398 | 0.222897 | D to O | Dyskeratosis congenita autosomal recessive type 1 (DKCB1) [MIM:224230] |
| P78316 | NOP14_HUMAN Nucleolar protein 14 OS=Homo sapiens GN=NOP14 PE=1 SV=3 | 380 | L | 0.995392 | S | 0.997516 | -0.002124 | No Change: Both D | - |
| P78316 | NOP14_HUMAN Nucleolar protein 14 OS=Homo sapiens GN=NOP14 PE=1 SV=3 | 716 | Q | 0.269123 | R | 0.244116 | 0.025007 | No Change: Both O | - |
| P46087 | NOP2_HUMAN Putative ribosomal RNA methyltransferase NOP2 OS=Homo sapiens GN=NOP2 PE=1 SV=2 | 73 | L | 0.962508 | S | 0.978264 | -0.015756 | No Change: Both D | - |
| O00567 | NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens GN=NOP56 PE=1 SV=4 | 576 | V | 0.998374 | A | 0.998822 | -4.48E-04 | No Change: Both D | - |
| O00567 | NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens GN=NOP56 PE=1 SV=4 | 121 | I | 0.126095 | V | 0.147056 | -0.020961 | No Change: Both O | - |
| O00567 | NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens GN=NOP56 PE=1 SV=4 | 475 | M | 0.998606 | T | 0.998695 | -8.90E-05 | No Change: Both D | - |
| Q9Y2X3 | NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens GN=NOP58 PE=1 SV=1 | 387 | N | 0.599935 | T | 0.617032 | -0.017097 | No Change: Both D | - |
| Q9Y2X3 | NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens GN=NOP58 PE=1 SV=1 | 389 | A | 0.593868 | P | 0.620221 | -0.026353 | No Change: Both D | - |
| Q9Y2X3 | NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens GN=NOP58 PE=1 SV=1 | 400 | D | 0.653499 | A | 0.609085 | 0.044414 | No Change: Both D | - |
| Q9Y2X3 | NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens GN=NOP58 PE=1 SV=1 | 508 | T | 0.998051 | P | 0.998582 | -5.31E-04 | No Change: Both D | - |
| P29475 | NOS1_HUMAN Nitric oxide synthase brain OS=Homo sapiens GN=NOS1 PE=1 SV=2 | 228 | P | 0.731175 | S | 0.742095 | -0.01092 | No Change: Both D | - |
| P29475 | NOS1_HUMAN Nitric oxide synthase brain OS=Homo sapiens GN=NOS1 PE=1 SV=2 | 394 | D | 0.480808 | A | 0.394105 | 0.086703 | No Change: Both O | - |
| P29475 | NOS1_HUMAN Nitric oxide synthase brain OS=Homo sapiens GN=NOS1 PE=1 SV=2 | 725 | N | 0.528873 | D | 0.537463 | -0.00859 | No Change: Both D | - |
| P29475 | NOS1_HUMAN Nitric oxide synthase brain OS=Homo sapiens GN=NOS1 PE=1 SV=2 | 864 | G | 0.87242 | D | 0.888101 | -0.015681 | No Change: Both D | - |
| P29475 | NOS1_HUMAN Nitric oxide synthase brain OS=Homo sapiens GN=NOS1 PE=1 SV=2 | 1064 | Q | 0.321149 | R | 0.32256 | -0.001411 | No Change: Both O | - |
| P35228 | NOS2_HUMAN Nitric oxide synthase inducible OS=Homo sapiens GN=NOS2 PE=1 SV=2 | 608 | S | 0.457236 | L | 0.310673 | 0.146563 | No Change: Both O | - |
| P35228 | NOS2_HUMAN Nitric oxide synthase inducible OS=Homo sapiens GN=NOS2 PE=1 SV=2 | 221 | R | 0.372303 | W | 0.186866 | 0.185437 | No Change: Both O | - |
| P35228 | NOS2_HUMAN Nitric oxide synthase inducible OS=Homo sapiens GN=NOS2 PE=1 SV=2 | 747 | T | 0.66194 | A | 0.636636 | 0.025304 | No Change: Both D | - |
| P35228 | NOS2_HUMAN Nitric oxide synthase inducible OS=Homo sapiens GN=NOS2 PE=1 SV=2 | 1009 | R | 0.320893 | C | 0.187327 | 0.133566 | No Change: Both O | - |
| P35228 | NOS2_HUMAN Nitric oxide synthase inducible OS=Homo sapiens GN=NOS2 PE=1 SV=2 | 679 | A | 0.152735 | S | 0.218441 | -0.065706 | No Change: Both O | A breast cancer sample |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 298 | E | 0.552207 | D | 0.522677 | 0.02953 | No Change: Both D | - |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 112 | R | 0.878484 | Q | 0.88427 | -0.005786 | No Change: Both D | - |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 827 | V | 0.888499 | M | 0.898964 | -0.010465 | No Change: Both D | - |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 885 | R | 0.873064 | M | 0.829019 | 0.044045 | No Change: Both D | - |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 982 | Q | 0.318402 | L | 0.218248 | 0.100154 | No Change: Both O | - |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 474 | R | 0.221745 | C | 0.118492 | 0.103253 | No Change: Both O | A colorectal cancer sample |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 602 | R | 0.855442 | Q | 0.859544 | -0.004102 | No Change: Both D | A colorectal cancer sample |
| P29474 | NOS3_HUMAN Nitric oxide synthase endothelial OS=Homo sapiens GN=NOS3 PE=1 SV=3 | 665 | R | 0.181015 | H | 0.157544 | 0.023471 | No Change: Both O | - |
| Q9Y314 | NOSIP_HUMAN Nitric oxide synthase-interacting protein OS=Homo sapiens GN=NOSIP PE=1 SV=1 | 168 | T | 0.885282 | M | 0.878823 | 0.006459 | No Change: Both D | - |
| Q8IVI9 | NOSTN_HUMAN Nostrin OS=Homo sapiens GN=NOSTRIN PE=1 SV=2 | 473 | G | 0.284625 | E | 0.332558 | -0.047933 | No Change: Both O | - |
| P46531 | NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4 | 300 | Q | 0.431658 | R | 0.394174 | 0.037484 | No Change: Both O | - |
| P46531 | NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4 | 1671 | V | 0.442114 | I | 0.413893 | 0.028221 | No Change: Both O | - |
| P46531 | NOTC1_HUMAN Neurogenic locus notch homolog protein 1 OS=Homo sapiens GN=NOTCH1 PE=1 SV=4 | 879 | R | 0.378388 | W | 0.187673 | 0.190715 | No Change: Both O | - |
| Q04721 | NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens GN=NOTCH2 PE=1 SV=3 | 444 | C | 0.445808 | Y | 0.335046 | 0.110762 | No Change: Both O | Alagille syndrome type 2 (ALGS2) [MIM:610205] |
| Q04721 | NOTC2_HUMAN Neurogenic locus notch homolog protein 2 OS=Homo sapiens GN=NOTCH2 PE=1 SV=3 | 1667 | V | 0.45676 | F | 0.39711 | 0.05965 | No Change: Both O | - |
| Q7Z3S9 | NT2NL_HUMAN Notch homolog 2 N-terminal-like protein OS=Homo sapiens GN=NOTCH2NL PE=1 SV=1 | 67 | S | 0.451128 | P | 0.43789 | 0.013238 | No Change: Both O | - |
| Q7Z3S9 | NT2NL_HUMAN Notch homolog 2 N-terminal-like protein OS=Homo sapiens GN=NOTCH2NL PE=1 SV=1 | 158 | T | 0.460196 | I | 0.310642 | 0.149554 | No Change: Both O | - |
| Q7Z3S9 | NT2NL_HUMAN Notch homolog 2 N-terminal-like protein OS=Homo sapiens GN=NOTCH2NL PE=1 SV=1 | 196 | T | 0.476204 | S | 0.525698 | -0.049494 | O to D | - |
| Q7Z3S9 | NT2NL_HUMAN Notch homolog 2 N-terminal-like protein OS=Homo sapiens GN=NOTCH2NL PE=1 SV=1 | 226 | E | 0.668239 | Q | 0.580825 | 0.087414 | No Change: Both D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 49 | C | 0.887757 | Y | 0.811709 | 0.076048 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 71 | W | 0.787699 | C | 0.893708 | -0.106009 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 90 | R | 0.797771 | C | 0.769595 | 0.028176 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 110 | R | 0.918375 | C | 0.905162 | 0.013213 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 133 | R | 0.947517 | C | 0.939862 | 0.007655 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 141 | R | 0.928523 | C | 0.917472 | 0.011051 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 146 | C | 0.902349 | R | 0.922418 | -0.020069 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 153 | R | 0.900176 | C | 0.877219 | 0.022957 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 169 | R | 0.79625 | C | 0.760493 | 0.035757 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 170 | H | 0.802955 | R | 0.86676 | -0.063805 | No Change: Both D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 171 | G | 0.805324 | C | 0.788166 | 0.017158 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 182 | R | 0.82674 | C | 0.811354 | 0.015386 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 185 | C | 0.826717 | R | 0.848764 | -0.022047 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 212 | C | 0.756712 | S | 0.793492 | -0.03678 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 222 | C | 0.587897 | G | 0.616514 | -0.028617 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 224 | C | 0.573045 | Y | 0.450008 | 0.123037 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 258 | Y | 0.507375 | C | 0.67564 | -0.168265 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 496 | P | 0.756266 | L | 0.610276 | 0.14599 | No Change: Both D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 542 | C | 0.649419 | Y | 0.533491 | 0.115928 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 558 | R | 0.612707 | C | 0.574258 | 0.038449 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 578 | R | 0.652186 | C | 0.60346 | 0.048726 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 728 | R | 0.828262 | C | 0.803516 | 0.024746 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 985 | R | 0.520281 | C | 0.495968 | 0.024313 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1006 | R | 0.407607 | C | 0.343382 | 0.064225 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1031 | R | 0.369061 | C | 0.305378 | 0.063683 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1133 | H | 0.459665 | Q | 0.556182 | -0.096517 | O to D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1183 | V | 0.464568 | M | 0.519457 | -0.054889 | O to D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1231 | R | 0.683975 | C | 0.654985 | 0.02899 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1261 | C | 0.940159 | R | 0.950155 | -0.009996 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 2223 | A | 0.940434 | V | 0.922397 | 0.018037 | No Change: Both D | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 43 | C | 0.921228 | G | 0.92978 | -0.008552 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 49 | C | 0.887757 | F | 0.820719 | 0.067038 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 54 | R | 0.828822 | C | 0.791895 | 0.036927 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 60 | S | 0.849902 | C | 0.827495 | 0.022407 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 65 | C | 0.847404 | S | 0.872543 | -0.025139 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 67 | C | 0.819982 | Y | 0.698211 | 0.121771 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 76 | C | 0.763756 | R | 0.800999 | -0.037243 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 76 | C | 0.763756 | W | 0.633977 | 0.129779 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 87 | C | 0.792504 | R | 0.827614 | -0.03511 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 87 | C | 0.792504 | Y | 0.674722 | 0.117782 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 93 | C | 0.794941 | F | 0.721016 | 0.073925 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 93 | C | 0.794941 | Y | 0.677557 | 0.117384 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 106 | C | 0.884587 | W | 0.776522 | 0.108065 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 108 | C | 0.903525 | W | 0.80735 | 0.096175 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 108 | C | 0.903525 | Y | 0.829219 | 0.074306 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 117 | C | 0.929093 | F | 0.906042 | 0.023051 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 118 | S | 0.935227 | C | 0.912044 | 0.023183 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 123 | C | 0.940558 | F | 0.917266 | 0.023292 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 123 | C | 0.940558 | Y | 0.898271 | 0.042287 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 128 | C | 0.946497 | Y | 0.909399 | 0.037098 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 134 | C | 0.943498 | W | 0.881562 | 0.061936 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 142 | F | 0.924183 | C | 0.955492 | -0.031309 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 144 | C | 0.918662 | F | 0.881307 | 0.037355 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 144 | C | 0.918662 | S | 0.937729 | -0.019067 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 144 | C | 0.918662 | Y | 0.872956 | 0.045706 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 145 | S | 0.913121 | C | 0.892989 | 0.020132 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 149 | G | 0.905128 | C | 0.897416 | 0.007712 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 150 | Y | 0.911584 | C | 0.953521 | -0.041937 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 155 | C | 0.891374 | S | 0.915967 | -0.024593 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 162 | C | 0.857205 | S | 0.888235 | -0.03103 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 174 | C | 0.826163 | F | 0.758604 | 0.067559 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 174 | C | 0.826163 | R | 0.852262 | -0.026099 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 174 | C | 0.826163 | Y | 0.747676 | 0.078487 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 180 | S | 0.818064 | C | 0.801591 | 0.016473 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 183 | C | 0.828853 | F | 0.760599 | 0.068254 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 183 | C | 0.828853 | R | 0.851014 | -0.022161 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 183 | C | 0.828853 | S | 0.853022 | -0.024169 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 185 | C | 0.826717 | G | 0.837567 | -0.01085 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 189 | Y | 0.816097 | C | 0.895553 | -0.079456 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 194 | C | 0.814602 | F | 0.737478 | 0.077124 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 194 | C | 0.814602 | R | 0.840142 | -0.02554 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 194 | C | 0.814602 | S | 0.847816 | -0.033214 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 194 | C | 0.814602 | Y | 0.740166 | 0.074436 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 201 | C | 0.819135 | Y | 0.745729 | 0.073406 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 206 | C | 0.799559 | Y | 0.722685 | 0.076874 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 207 | R | 0.786667 | C | 0.762915 | 0.023752 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 213 | R | 0.737307 | K | 0.714597 | 0.02271 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 222 | C | 0.587897 | Y | 0.465686 | 0.122211 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 233 | C | 0.552771 | S | 0.588298 | -0.035527 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 233 | C | 0.552771 | Y | 0.44631 | 0.106461 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 240 | C | 0.466411 | S | 0.550026 | -0.083615 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 245 | C | 0.415599 | R | 0.494907 | -0.079308 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 251 | C | 0.486043 | R | 0.524336 | -0.038293 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 260 | C | 0.528164 | Y | 0.408703 | 0.119461 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 319 | A | 0.142206 | C | 0.107813 | 0.034393 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 332 | R | 0.163023 | C | 0.117915 | 0.045108 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 335 | S | 0.114927 | C | 0.062957 | 0.05197 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 337 | Y | 0.121333 | C | 0.202552 | -0.081219 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 379 | C | 0.472261 | S | 0.549065 | -0.076804 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 395 | C | 0.468465 | R | 0.548924 | -0.080459 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 420 | G | 0.467318 | C | 0.43075 | 0.036568 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 421 | R | 0.47297 | C | 0.415626 | 0.057344 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 428 | C | 0.523983 | S | 0.628541 | -0.104558 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 428 | C | 0.523983 | Y | 0.467432 | 0.056551 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 440 | C | 0.352125 | G | 0.461027 | -0.108902 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 440 | C | 0.352125 | R | 0.465716 | -0.113591 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 446 | C | 0.279369 | S | 0.379377 | -0.100008 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 449 | R | 0.228471 | C | 0.199186 | 0.029285 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 455 | C | 0.146168 | R | 0.178792 | -0.032624 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 484 | C | 0.520893 | F | 0.456964 | 0.063929 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 484 | C | 0.520893 | Y | 0.432035 | 0.088858 | D to O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 495 | C | 0.707885 | Y | 0.591084 | 0.116801 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 511 | C | 0.694044 | R | 0.739437 | -0.045393 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 544 | R | 0.632666 | C | 0.590473 | 0.042193 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 549 | C | 0.676636 | Y | 0.595177 | 0.081459 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 607 | R | 0.417242 | C | 0.384777 | 0.032465 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 775 | C | 0.933366 | S | 0.949308 | -0.015942 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 953 | G | 0.535646 | C | 0.519556 | 0.01609 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 984 | F | 0.473257 | C | 0.587513 | -0.114256 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1015 | C | 0.46327 | R | 0.539108 | -0.075838 | O to D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1020 | A | 0.336551 | P | 0.47531 | -0.138759 | No Change: Both O | - |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1021 | Y | 0.294669 | C | 0.456055 | -0.161386 | No Change: Both O | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1063 | D | 0.678779 | C | 0.636643 | 0.042136 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1261 | C | 0.940159 | Y | 0.895267 | 0.044892 | No Change: Both D | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [MIM:125310] |
| Q9UM47 | NOTC3_HUMAN Neurogenic locus notch homolog protein 3 OS=Homo sapiens GN=NOTCH3 PE=1 SV=2 | 1515 | L | 0.134111 | P | 0.233377 | -0.099266 | No Change: Both O | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 117 | K | 0.912591 | Q | 0.91785 | -0.005259 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 272 | D | 0.614017 | G | 0.593856 | 0.020161 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 317 | E | 0.737528 | Q | 0.713795 | 0.023733 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 320 | T | 0.750447 | A | 0.694197 | 0.05625 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 851 | K | 0.748389 | R | 0.769733 | -0.021344 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 204 | P | 0.781479 | L | 0.632142 | 0.149337 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 206 | P | 0.810797 | L | 0.680714 | 0.130083 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 244 | S | 0.864546 | L | 0.797667 | 0.066879 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 534 | G | 0.397711 | S | 0.450467 | -0.052756 | No Change: Both O | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 809 | S | 0.901311 | I | 0.792837 | 0.108474 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 942 | G | 0.781168 | R | 0.786089 | -0.004921 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 1346 | R | 0.646946 | P | 0.668633 | -0.021687 | No Change: Both D | - |
| Q99466 | NOTC4_HUMAN Neurogenic locus notch homolog protein 4 OS=Homo sapiens GN=NOTCH4 PE=1 SV=2 | 284 | Q | 0.588471 | H | 0.538154 | 0.050317 | No Change: Both D | - |
| A8MTQ0 | NOTO_HUMAN Homeobox protein notochord OS=Homo sapiens GN=NOTO PE=2 SV=2 | 5 | R | 0.999981 | T | 0.999968 | 1.30E-05 | No Change: Both D | - |
| A8MTQ0 | NOTO_HUMAN Homeobox protein notochord OS=Homo sapiens GN=NOTO PE=2 SV=2 | 164 | N | 0.467779 | K | 0.550668 | -0.082889 | O to D | - |
| P48745 | NOV_HUMAN Protein NOV homolog OS=Homo sapiens GN=NOV PE=1 SV=1 | 42 | R | 0.828496 | Q | 0.840884 | -0.012388 | No Change: Both D | - |
| P48745 | NOV_HUMAN Protein NOV homolog OS=Homo sapiens GN=NOV PE=1 SV=1 | 233 | R | 0.824484 | H | 0.757788 | 0.066696 | No Change: Both D | - |
| Q9Y5S8 | NOX1_HUMAN NADPH oxidase 1 OS=Homo sapiens GN=NOX1 PE=1 SV=2 | 315 | R | 0.423659 | H | 0.429437 | -0.005778 | No Change: Both O | - |
| Q9Y5S8 | NOX1_HUMAN NADPH oxidase 1 OS=Homo sapiens GN=NOX1 PE=1 SV=2 | 378 | R | 0.34646 | K | 0.419904 | -0.073444 | No Change: Both O | - |
| Q9Y5S8 | NOX1_HUMAN NADPH oxidase 1 OS=Homo sapiens GN=NOX1 PE=1 SV=2 | 360 | D | 0.176786 | N | 0.173848 | 0.002938 | No Change: Both O | - |
| Q9HBY0 | NOX3_HUMAN NADPH oxidase 3 OS=Homo sapiens GN=NOX3 PE=1 SV=1 | 171 | T | 0.192895 | K | 0.220697 | -0.027802 | No Change: Both O | - |
| Q9NPH5 | NOX4_HUMAN NADPH oxidase 4 OS=Homo sapiens GN=NOX4 PE=1 SV=2 | 315 | M | 0.368989 | I | 0.28459 | 0.084399 | No Change: Both O | - |
| Q96PH1 | NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens GN=NOX5 PE=1 SV=1 | 576 | R | 0.362138 | H | 0.361415 | 7.23E-04 | No Change: Both O | - |
| Q96PH1 | NOX5_HUMAN NADPH oxidase 5 OS=Homo sapiens GN=NOX5 PE=1 SV=1 | 759 | R | 0.28082 | G | 0.31126 | -0.03044 | No Change: Both O | - |
| Q86UR1 | NOXA1_HUMAN NADPH oxidase activator 1 OS=Homo sapiens GN=NOXA1 PE=1 SV=1 | 286 | P | 0.953291 | L | 0.906584 | 0.046707 | No Change: Both D | - |
| Q8IXT1 | NOXIN_HUMAN Nitric oxide-inducible gene protein OS=Homo sapiens GN=NOXIN PE=2 SV=2 | 217 | I | 0.825848 | T | 0.901091 | -0.075243 | No Change: Both D | - |
| Q8IXT1 | NOXIN_HUMAN Nitric oxide-inducible gene protein OS=Homo sapiens GN=NOXIN PE=2 SV=2 | 460 | R | 0.577954 | S | 0.633311 | -0.055357 | No Change: Both D | - |
| Q8IXT1 | NOXIN_HUMAN Nitric oxide-inducible gene protein OS=Homo sapiens GN=NOXIN PE=2 SV=2 | 757 | D | 0.91516 | N | 0.915409 | -2.49E-04 | No Change: Both D | - |
| Q8IXT1 | NOXIN_HUMAN Nitric oxide-inducible gene protein OS=Homo sapiens GN=NOXIN PE=2 SV=2 | 795 | P | 0.278317 | R | 0.259377 | 0.01894 | No Change: Both O | - |
| Q8IXT1 | NOXIN_HUMAN Nitric oxide-inducible gene protein OS=Homo sapiens GN=NOXIN PE=2 SV=2 | 842 | V | 0.650772 | I | 0.641246 | 0.009526 | No Change: Both D | - |
| Q99743 | NPAS2_HUMAN Neuronal PAS domain-containing protein 2 OS=Homo sapiens GN=NPAS2 PE=2 SV=3 | 394 | T | 0.921652 | A | 0.923556 | -0.001904 | No Change: Both D | - |
| Q99743 | NPAS2_HUMAN Neuronal PAS domain-containing protein 2 OS=Homo sapiens GN=NPAS2 PE=2 SV=3 | 471 | S | 0.974551 | L | 0.957789 | 0.016762 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 295 | I | 0.79715 | L | 0.815617 | -0.018467 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 399 | L | 0.770293 | M | 0.793634 | -0.023341 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 447 | V | 0.469031 | M | 0.563611 | -0.09458 | O to D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 483 | I | 0.761702 | L | 0.784653 | -0.022951 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 540 | L | 0.901987 | F | 0.887453 | 0.014534 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 575 | V | 0.880623 | I | 0.877805 | 0.002818 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 608 | V | 0.810991 | A | 0.80766 | 0.003331 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 621 | V | 0.842998 | I | 0.825552 | 0.017446 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 967 | Q | 0.673411 | E | 0.632232 | 0.041179 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 973 | L | 0.659606 | V | 0.681145 | -0.021539 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 987 | V | 0.817997 | A | 0.846063 | -0.028066 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 999 | N | 0.723721 | K | 0.770028 | -0.046307 | No Change: Both D | - |
| Q14207 | NPAT_HUMAN Protein NPAT OS=Homo sapiens GN=NPAT PE=1 SV=3 | 1191 | Q | 0.9287 | R | 0.923389 | 0.005311 | No Change: Both D | - |
| P48145 | NPBW1_HUMAN Neuropeptides B/W receptor type 1 OS=Homo sapiens GN=NPBWR1 PE=1 SV=2 | 19 | P | 0.793669 | Q | 0.731828 | 0.061841 | No Change: Both D | A breast cancer sample |
| P48145 | NPBW1_HUMAN Neuropeptides B/W receptor type 1 OS=Homo sapiens GN=NPBWR1 PE=1 SV=2 | 135 | Y | 0.109126 | F | 0.094079 | 0.015047 | No Change: Both O | - |
| P48145 | NPBW1_HUMAN Neuropeptides B/W receptor type 1 OS=Homo sapiens GN=NPBWR1 PE=1 SV=2 | 319 | R | 0.172787 | C | 0.083841 | 0.088946 | No Change: Both O | - |
| P48146 | NPBW2_HUMAN Neuropeptides B/W receptor type 2 OS=Homo sapiens GN=NPBWR2 PE=1 SV=2 | 206 | Q | 0.125266 | R | 0.119418 | 0.005848 | No Change: Both O | - |
| P48146 | NPBW2_HUMAN Neuropeptides B/W receptor type 2 OS=Homo sapiens GN=NPBWR2 PE=1 SV=2 | 92 | G | 0.058772 | R | 0.055095 | 0.003677 | No Change: Both O | A colorectal cancer sample |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 177 | C | 0.23839 | G | 0.407372 | -0.168982 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 215 | H | 0.462928 | R | 0.480696 | -0.017768 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 237 | P | 0.756345 | S | 0.741879 | 0.014466 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 333 | G | 0.137054 | D | 0.159346 | -0.022292 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 472 | L | 0.159592 | P | 0.290698 | -0.131106 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 473 | S | 0.166019 | P | 0.162389 | 0.00363 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 510 | H | 0.062096 | P | 0.068323 | -0.006227 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 518 | R | 0.125291 | Q | 0.135278 | -0.009987 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 642 | M | 0.232451 | I | 0.167096 | 0.065355 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 757 | V | 0.151561 | A | 0.214196 | -0.062635 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 858 | I | 0.254907 | V | 0.298283 | -0.043376 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 889 | V | 0.190952 | M | 0.242787 | -0.051835 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 928 | Q | 0.163805 | P | 0.163424 | 3.81E-04 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 934 | R | 0.172243 | Q | 0.196981 | -0.024738 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 940 | S | 0.153102 | L | 0.064435 | 0.088667 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 948 | D | 0.139661 | N | 0.119376 | 0.020285 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 954 | S | 0.210132 | L | 0.092693 | 0.117439 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 956 | C | 0.223696 | Y | 0.233621 | -0.009925 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 992 | G | 0.66747 | W | 0.440899 | 0.226571 | D to O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1007 | P | 0.570775 | A | 0.487497 | 0.083278 | D to O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1036 | T | 0.204438 | M | 0.166591 | 0.037847 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1061 | I | 0.250211 | T | 0.414844 | -0.164633 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1088 | Y | 0.033979 | C | 0.023725 | 0.010254 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1156 | N | 0.098371 | S | 0.124201 | -0.02583 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1167 | F | 0.146601 | L | 0.161153 | -0.014552 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1186 | R | 0.647363 | H | 0.64852 | -0.001157 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1213 | L | 0.055608 | F | 0.053423 | 0.002185 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1213 | L | 0.055608 | V | 0.061246 | -0.005638 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1220 | I | 0.06069 | T | 0.10672 | -0.04603 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1266 | R | 0.684059 | Q | 0.690934 | -0.006875 | No Change: Both D | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 177 | C | 0.23839 | Y | 0.262585 | -0.024195 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 378 | V | 0.269868 | A | 0.340515 | -0.070647 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 950 | V | 0.183721 | M | 0.225387 | -0.041666 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 958 | R | 0.22858 | Q | 0.257209 | -0.028629 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 978 | R | 0.480206 | C | 0.411749 | 0.068457 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 992 | G | 0.66747 | R | 0.688661 | -0.021191 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1035 | A | 0.228401 | V | 0.18027 | 0.048131 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 63 | C | 0.150017 | R | 0.226749 | -0.076732 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 74 | C | 0.192466 | Y | 0.142303 | 0.050163 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 92 | Q | 0.317053 | R | 0.296125 | 0.020928 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 113 | C | 0.320158 | R | 0.42153 | -0.101372 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 137 | T | 0.499973 | M | 0.440892 | 0.059081 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 151 | S | 0.210919 | G | 0.181018 | 0.029901 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 166 | P | 0.600773 | S | 0.638726 | -0.037953 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 222 | N | 0.651967 | S | 0.684762 | -0.032795 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 231 | V | 0.789769 | G | 0.833385 | -0.043616 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 242 | D | 0.606725 | H | 0.527953 | 0.078772 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 242 | D | 0.606725 | N | 0.571485 | 0.03524 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 247 | C | 0.562134 | Y | 0.509817 | 0.052317 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 248 | G | 0.593975 | V | 0.506815 | 0.08716 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 272 | M | 0.013193 | R | 0.015839 | -0.002646 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 273 | W | 0.011664 | S | 0.043095 | -0.031431 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 372 | R | 0.107229 | W | 0.041809 | 0.06542 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 380 | L | 0.383558 | F | 0.351808 | 0.03175 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 381 | W | 0.417978 | C | 0.456596 | -0.038618 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 388 | A | 0.578178 | P | 0.642881 | -0.064703 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 389 | R | 0.593713 | C | 0.405352 | 0.188361 | D to O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 401 | P | 0.185837 | T | 0.156772 | 0.029065 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 404 | R | 0.178906 | P | 0.218715 | -0.039809 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 404 | R | 0.178906 | Q | 0.198873 | -0.019967 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 404 | R | 0.178906 | W | 0.070889 | 0.108017 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 433 | P | 0.27948 | L | 0.152183 | 0.127297 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 434 | P | 0.238942 | L | 0.126437 | 0.112505 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 434 | P | 0.238942 | S | 0.245673 | -0.006731 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 451 | E | 0.159059 | K | 0.154496 | 0.004563 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 474 | P | 0.188574 | L | 0.10019 | 0.088384 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 479 | C | 0.147864 | Y | 0.19224 | -0.044376 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 509 | Y | 0.072499 | S | 0.146567 | -0.074068 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 511 | T | 0.051378 | M | 0.041393 | 0.009985 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 512 | H | 0.052155 | R | 0.051421 | 7.34E-04 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 518 | R | 0.125291 | W | 0.05027 | 0.075021 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 521 | A | 0.25272 | S | 0.358291 | -0.105571 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 537 | F | 0.138897 | L | 0.159864 | -0.020967 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 543 | P | 0.064214 | L | 0.030805 | 0.033409 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 574 | T | 0.484371 | K | 0.587318 | -0.102947 | O to D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 576 | K | 0.45718 | R | 0.403807 | 0.053373 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 605 | A | 0.376677 | V | 0.294968 | 0.081709 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 612 | E | 0.789707 | D | 0.771628 | 0.018079 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 615 | R | 0.730119 | C | 0.575684 | 0.154435 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 615 | R | 0.730119 | L | 0.638028 | 0.092091 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 631 | M | 0.02206 | R | 0.029708 | -0.007648 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 640 | G | 0.164031 | R | 0.167301 | -0.00327 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 652 | S | 0.281834 | W | 0.087228 | 0.194606 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 660 | G | 0.078938 | S | 0.104295 | -0.025357 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 664 | V | 0.059586 | M | 0.07424 | -0.014654 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 666 | S | 0.069 | N | 0.051389 | 0.017611 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 670 | C | 0.090787 | W | 0.07687 | 0.013917 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 673 | G | 0.088229 | V | 0.048584 | 0.039645 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 684 | L | 0.025096 | F | 0.020546 | 0.00455 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 691 | P | 0.017507 | L | 0.008811 | 0.008696 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 695 | L | 0.021707 | V | 0.023257 | -0.00155 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 700 | D | 0.033529 | N | 0.03327 | 2.59E-04 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 703 | F | 0.034571 | S | 0.095096 | -0.060525 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 724 | L | 0.34866 | P | 0.50791 | -0.15925 | O to D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 727 | V | 0.272947 | F | 0.241153 | 0.031794 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 734 | S | 0.351911 | I | 0.145888 | 0.206023 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 742 | E | 0.247699 | K | 0.242227 | 0.005472 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 745 | A | 0.142869 | E | 0.217666 | -0.074797 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 754 | M | 0.151054 | K | 0.246989 | -0.095935 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 763 | F | 0.06831 | L | 0.077806 | -0.009496 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 767 | A | 0.028394 | V | 0.019411 | 0.008983 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 775 | Q | 0.014653 | P | 0.01606 | -0.001407 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 789 | R | 0.450989 | C | 0.263252 | 0.187737 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 789 | R | 0.450989 | G | 0.467617 | -0.016628 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 825 | Y | 0.199756 | C | 0.164604 | 0.035152 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 849 | S | 0.061998 | I | 0.022387 | 0.039611 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 862 | Q | 0.492462 | L | 0.352096 | 0.140366 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 865 | S | 0.607775 | L | 0.385722 | 0.222053 | D to O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 871 | Y | 0.405135 | C | 0.33429 | 0.070845 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 873 | V | 0.309577 | A | 0.391409 | -0.081832 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 874 | D | 0.272886 | V | 0.14367 | 0.129216 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 888 | P | 0.177451 | S | 0.190708 | -0.013257 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 890 | Y | 0.184334 | C | 0.168688 | 0.015646 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 899 | Y | 0.606901 | D | 0.717341 | -0.11044 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 910 | G | 0.313776 | S | 0.357342 | -0.043566 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 917 | D | 0.282361 | Y | 0.157047 | 0.125314 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 926 | A | 0.170163 | T | 0.186531 | -0.016368 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 927 | A | 0.169012 | V | 0.121039 | 0.047973 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 929 | L | 0.17076 | P | 0.295299 | -0.124539 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 942 | W | 0.12898 | C | 0.154288 | -0.025308 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 943 | I | 0.125388 | M | 0.175156 | -0.049768 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 944 | D | 0.11745 | N | 0.100704 | 0.016746 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 945 | D | 0.127939 | N | 0.109726 | 0.018213 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 948 | D | 0.139661 | H | 0.105142 | 0.034519 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 948 | D | 0.139661 | Y | 0.067156 | 0.072505 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 958 | R | 0.22858 | L | 0.136301 | 0.092279 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 959 | V | 0.248888 | E | 0.402226 | -0.153338 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 961 | N | 0.259786 | S | 0.310664 | -0.050878 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 968 | N | 0.305061 | S | 0.365485 | -0.060424 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 971 | V | 0.28613 | G | 0.373937 | -0.087807 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 976 | C | 0.342248 | R | 0.459486 | -0.117238 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 986 | G | 0.729864 | S | 0.758764 | -0.0289 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 992 | G | 0.66747 | A | 0.618313 | 0.049157 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 996 | M | 0.454484 | R | 0.518712 | -0.064228 | O to D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1004 | S | 0.488404 | L | 0.354757 | 0.133647 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1012 | G | 0.653058 | D | 0.660258 | -0.0072 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1015 | G | 0.588321 | V | 0.441932 | 0.146389 | D to O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1016 | H | 0.510291 | R | 0.506077 | 0.004214 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1023 | V | 0.268553 | G | 0.428641 | -0.160088 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1034 | G | 0.222785 | R | 0.208518 | 0.014267 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1036 | T | 0.204438 | K | 0.249337 | -0.044899 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1049 | A | 0.226759 | V | 0.165143 | 0.061616 | No Change: Both O | - |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1054 | A | 0.263761 | T | 0.278334 | -0.014573 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1059 | R | 0.233808 | Q | 0.251398 | -0.01759 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1062 | A | 0.261253 | V | 0.191033 | 0.07022 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1066 | T | 0.338827 | N | 0.385182 | -0.046355 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1087 | F | 0.030883 | L | 0.035033 | -0.00415 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1089 | E | 0.036279 | K | 0.036254 | 2.50E-05 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1094 | I | 0.05939 | T | 0.112008 | -0.052618 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1097 | D | 0.077638 | N | 0.072022 | 0.005616 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1137 | N | 0.024035 | I | 0.010668 | 0.013367 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1140 | G | 0.016582 | V | 0.008958 | 0.007624 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1142 | M | 0.016838 | T | 0.019375 | -0.002537 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1150 | N | 0.061531 | K | 0.070056 | -0.008525 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1156 | N | 0.098371 | I | 0.043427 | 0.054944 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1165 | V | 0.153357 | M | 0.20135 | -0.047993 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1168 | C | 0.137778 | Y | 0.152691 | -0.014913 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1174 | A | 0.237527 | V | 0.19078 | 0.046747 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1189 | E | 0.571672 | G | 0.529738 | 0.041934 | No Change: Both D | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1205 | T | 0.144758 | K | 0.197495 | -0.052737 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1205 | T | 0.144758 | R | 0.144679 | 7.90E-05 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1212 | V | 0.051279 | L | 0.051428 | -1.49E-04 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1216 | A | 0.067726 | V | 0.047756 | 0.01997 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1224 | F | 0.026303 | L | 0.028577 | -0.002274 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1236 | G | 0.07427 | E | 0.087636 | -0.013366 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1240 | G | 0.061361 | R | 0.053802 | 0.007559 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| O15118 | NPC1_HUMAN Niemann-Pick C1 protein OS=Homo sapiens GN=NPC1 PE=1 SV=2 | 1249 | S | 0.087606 | G | 0.069522 | 0.018084 | No Change: Both O | Niemann-Pick disease type C1 (NPC1) [MIM:257220] |
| Q9UHC9 | NPCL1_HUMAN Niemann-Pick C1-like protein 1 OS=Homo sapiens GN=NPC1L1 PE=1 SV=1 | 55 | V | 0.384544 | L | 0.426203 | -0.041659 | No Change: Both O | - |
| Q9UHC9 | NPCL1_HUMAN Niemann-Pick C1-like protein 1 OS=Homo sapiens GN=NPC1L1 PE=1 SV=1 | 1233 | I | 0.378589 | N | 0.56179 | -0.183201 | O to D | - |
| Q9UHC9 | NPCL1_HUMAN Niemann-Pick C1-like protein 1 OS=Homo sapiens GN=NPC1L1 PE=1 SV=1 | 510 | M | 0.366971 | I | 0.271289 | 0.095682 | No Change: Both O | - |
| Q9UHC9 | NPCL1_HUMAN Niemann-Pick C1-like protein 1 OS=Homo sapiens GN=NPC1L1 PE=1 SV=1 | 1308 | E | 0.525753 | K | 0.518665 | 0.007088 | No Change: Both D | - |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 86 | P | 0.399749 | L | 0.223359 | 0.17639 | No Change: Both O | - |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 39 | V | 0.502831 | M | 0.534417 | -0.031586 | No Change: Both D | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 67 | S | 0.59271 | P | 0.579057 | 0.013653 | No Change: Both D | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 30 | V | 0.303847 | M | 0.345114 | -0.041267 | No Change: Both O | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 47 | C | 0.652092 | F | 0.606156 | 0.045936 | No Change: Both D | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 93 | C | 0.511094 | F | 0.473099 | 0.037995 | D to O | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 99 | C | 0.381497 | R | 0.508773 | -0.127276 | O to D | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| P61916 | NPC2_HUMAN Epididymal secretory protein E1 OS=Homo sapiens GN=NPC2 PE=1 SV=1 | 120 | P | 0.357426 | S | 0.384917 | -0.027491 | No Change: Both O | Niemann-Pick disease type C2 (NPDC2) [MIM:607625] |
| Q8NDH3 | PEPL1_HUMAN Probable aminopeptidase NPEPL1 OS=Homo sapiens GN=NPEPL1 PE=1 SV=3 | 303 | K | 0.255655 | R | 0.205406 | 0.050249 | No Change: Both O | - |
| Q8NDH3 | PEPL1_HUMAN Probable aminopeptidase NPEPL1 OS=Homo sapiens GN=NPEPL1 PE=1 SV=3 | 513 | L | 0.762395 | V | 0.759939 | 0.002456 | No Change: Both D | - |
| O15130 | NPFF_HUMAN FMRFamide-related peptides OS=Homo sapiens GN=NPFF PE=2 SV=1 | 88 | W | 0.667839 | R | 0.825721 | -0.157882 | No Change: Both D | - |
| Q9GZQ6 | NPFF1_HUMAN Neuropeptide FF receptor 1 OS=Homo sapiens GN=NPFFR1 PE=1 SV=1 | 145 | I | 0.071606 | L | 0.082514 | -0.010908 | No Change: Both O | - |
| O15259 | NPHP1_HUMAN Nephrocystin-1 OS=Homo sapiens GN=NPHP1 PE=1 SV=1 | 342 | G | 0.446112 | R | 0.459454 | -0.013342 | No Change: Both O | Nephronophthisis type 1 (NPHP1) [MIM:256100] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 360 | S | 0.189151 | T | 0.132527 | 0.056624 | No Change: Both O | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 386 | N | 0.501307 | S | 0.553604 | -0.052297 | No Change: Both D | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 397 | R | 0.385373 | H | 0.370322 | 0.015051 | No Change: Both O | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 1141 | L | 0.514649 | P | 0.656115 | -0.141466 | No Change: Both D | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 1221 | A | 0.191465 | V | 0.143595 | 0.04787 | No Change: Both O | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 1252 | S | 0.400394 | R | 0.357399 | 0.042995 | No Change: Both O | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 1314 | S | 0.812595 | T | 0.751266 | 0.061329 | No Change: Both D | Nephronophthisis type 3 (NPHP3) [MIM:604387] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 973 | R | 0.467301 | Q | 0.485494 | -0.018193 | No Change: Both O | Renal-hepatic-pancreatic dysplasia (RHPD) [MIM:208540] |
| Q7Z494 | NPHP3_HUMAN Nephrocystin-3 OS=Homo sapiens GN=NPHP3 PE=1 SV=1 | 1305 | R | 0.839842 | C | 0.77174 | 0.068102 | No Change: Both D | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 991 | F | 0.123038 | S | 0.249151 | -0.126113 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 754 | G | 0.142976 | R | 0.131696 | 0.01128 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 848 | R | 0.739729 | W | 0.509716 | 0.230013 | No Change: Both D | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 3 | D | 0.584054 | Y | 0.437988 | 0.146066 | D to O | Senior-Loken syndrome type 4 (SLSN4) [MIM:606996] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 29 | T | 0.204438 | M | 0.175975 | 0.028463 | No Change: Both O | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 91 | F | 0.241589 | L | 0.266697 | -0.025108 | No Change: Both O | Senior-Loken syndrome type 4 (SLSN4) [MIM:606996] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 342 | R | 0.404478 | C | 0.258248 | 0.14623 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 469 | R | 0.986577 | W | 0.966651 | 0.019926 | No Change: Both D | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 544 | A | 0.807558 | G | 0.810568 | -0.00301 | No Change: Both D | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 618 | E | 0.763751 | K | 0.750815 | 0.012936 | No Change: Both D | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 627 | T | 0.685794 | M | 0.672379 | 0.013415 | No Change: Both D | Senior-Loken syndrome type 4 (SLSN4) [MIM:606996] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 654 | A | 0.224828 | G | 0.25437 | -0.029542 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 735 | R | 0.256388 | W | 0.115434 | 0.140954 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 740 | R | 0.078981 | H | 0.071599 | 0.007382 | No Change: Both O | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 765 | V | 0.213439 | I | 0.201019 | 0.01242 | No Change: Both O | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 766 | Q | 0.252426 | R | 0.239311 | 0.013115 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 776 | P | 0.521633 | R | 0.504901 | 0.016732 | No Change: Both D | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 782 | H | 0.435246 | Q | 0.471244 | -0.035998 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 946 | T | 0.529701 | A | 0.516267 | 0.013434 | No Change: Both D | Senior-Loken syndrome type 4 (SLSN4) [MIM:606996] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 961 | R | 0.470585 | H | 0.454215 | 0.01637 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 1098 | A | 0.572197 | T | 0.589268 | -0.017071 | No Change: Both D | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 1192 | R | 0.369171 | W | 0.187134 | 0.182037 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 1225 | T | 0.153899 | M | 0.115565 | 0.038334 | No Change: Both O | Senior-Loken syndrome type 4 (SLSN4) [MIM:606996] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 1284 | R | 0.364879 | C | 0.229566 | 0.135313 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 1287 | Q | 0.359965 | E | 0.392569 | -0.032604 | No Change: Both O | Nephronophthisis type 4 (NPHP4) [MIM:606966] |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 939 | L | 0.67984 | Q | 0.774903 | -0.095063 | No Change: Both D | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 959 | R | 0.361666 | Q | 0.371424 | -0.009758 | No Change: Both O | - |
| O75161 | NPHP4_HUMAN Nephrocystin-4 OS=Homo sapiens GN=NPHP4 PE=1 SV=2 | 160 | R | 0.428908 | L | 0.3144 | 0.114508 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 64 | W | 0.290443 | S | 0.576103 | -0.28566 | O to D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 117 | E | 0.532719 | K | 0.502359 | 0.03036 | No Change: Both D | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 171 | I | 0.279074 | N | 0.416891 | -0.137817 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 173 | I | 0.20419 | N | 0.344769 | -0.140579 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 270 | G | 0.268209 | C | 0.175425 | 0.092784 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 350 | S | 0.452033 | P | 0.410348 | 0.041685 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 366 | S | 0.498506 | R | 0.436279 | 0.062227 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 367 | R | 0.430659 | C | 0.277962 | 0.152697 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 368 | P | 0.351134 | S | 0.401852 | -0.050718 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 376 | L | 0.059977 | V | 0.053182 | 0.006795 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 408 | R | 0.363063 | Q | 0.361345 | 0.001718 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 447 | E | 0.359539 | K | 0.36588 | -0.006341 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 465 | C | 0.14777 | Y | 0.1427 | 0.00507 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 528 | C | 0.463643 | F | 0.48249 | -0.018847 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 610 | L | 0.636408 | Q | 0.752027 | -0.115619 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 623 | C | 0.492142 | F | 0.493519 | -0.001377 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 724 | S | 0.496911 | C | 0.300238 | 0.196673 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 743 | R | 0.25622 | C | 0.13696 | 0.11926 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 802 | R | 0.389386 | W | 0.185069 | 0.204317 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 802 | R | 0.389386 | P | 0.420541 | -0.031155 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 806 | A | 0.340993 | D | 0.395801 | -0.054808 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 819 | D | 0.18777 | V | 0.116944 | 0.070826 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 831 | R | 0.157187 | C | 0.081869 | 0.075318 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 1077 | N | 0.322681 | S | 0.421587 | -0.098906 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 1140 | R | 0.886583 | C | 0.81736 | 0.069223 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 233 | T | 0.251424 | A | 0.265247 | -0.013823 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 392 | L | 0.45724 | P | 0.592093 | -0.134853 | O to D | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 991 | V | 0.250671 | L | 0.233482 | 0.017189 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 96 | L | 0.470882 | V | 0.432888 | 0.037994 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 107 | A | 0.472386 | T | 0.476694 | -0.004308 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 107 | A | 0.472386 | V | 0.403397 | 0.068989 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 167 | P | 0.427869 | L | 0.262346 | 0.165523 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 256 | R | 0.407929 | W | 0.222141 | 0.185788 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 264 | P | 0.274632 | R | 0.245756 | 0.028876 | No Change: Both O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 265 | C | 0.26884 | R | 0.435052 | -0.166212 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 299 | R | 0.299055 | C | 0.198484 | 0.100571 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 340 | P | 0.29792 | H | 0.233399 | 0.064521 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 347 | G | 0.32811 | E | 0.396517 | -0.068407 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 368 | P | 0.351134 | L | 0.24109 | 0.110044 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 379 | R | 0.095671 | W | 0.037821 | 0.05785 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 407 | R | 0.34982 | W | 0.160282 | 0.189538 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 412 | G | 0.330899 | C | 0.212601 | 0.118298 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 417 | C | 0.218763 | F | 0.245735 | -0.026972 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 460 | R | 0.168586 | Q | 0.17082 | -0.002234 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 519 | P | 0.572805 | S | 0.61307 | -0.040265 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 558 | R | 0.423987 | C | 0.331242 | 0.092745 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 569 | S | 0.460788 | R | 0.400678 | 0.06011 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 572 | S | 0.567187 | N | 0.529511 | 0.037676 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 575 | P | 0.602611 | Q | 0.531296 | 0.071315 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 586 | R | 0.720054 | G | 0.701665 | 0.018389 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 587 | L | 0.720945 | R | 0.813705 | -0.09276 | No Change: Both D | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 617 | H | 0.624774 | R | 0.683814 | -0.05904 | No Change: Both D | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 673 | N | 0.444908 | K | 0.466183 | -0.021275 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 681 | W | 0.166054 | C | 0.208507 | -0.042453 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 709 | V | 0.168743 | G | 0.299385 | -0.130642 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 725 | E | 0.534479 | D | 0.497617 | 0.036862 | D to O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 739 | A | 0.168314 | V | 0.123282 | 0.045032 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 822 | V | 0.230681 | M | 0.269957 | -0.039276 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 832 | L | 0.15924 | P | 0.28989 | -0.13065 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 834 | V | 0.177991 | F | 0.154102 | 0.023889 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 851 | A | 0.547844 | V | 0.467184 | 0.08066 | D to O | - |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 910 | S | 0.207274 | P | 0.181269 | 0.026005 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| O60500 | NPHN_HUMAN Nephrin OS=Homo sapiens GN=NPHS1 PE=1 SV=1 | 976 | R | 0.101589 | S | 0.122789 | -0.0212 | No Change: Both O | Nephrotic syndrome type 1 (NPHS1) [MIM:256300] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 20 | P | 0.998929 | L | 0.997776 | 0.001153 | No Change: Both D | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 92 | G | 0.84959 | C | 0.76575 | 0.08384 | No Change: Both D | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 138 | R | 0.062338 | Q | 0.063366 | -0.001028 | No Change: Both O | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 160 | D | 0.06919 | G | 0.05809 | 0.0111 | No Change: Both O | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 180 | V | 0.148134 | M | 0.206314 | -0.05818 | No Change: Both O | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9NP85 | PODO_HUMAN Podocin OS=Homo sapiens GN=NPHS2 PE=1 SV=1 | 291 | R | 0.671746 | W | 0.395269 | 0.276477 | D to O | Nephrotic syndrome type 2 (NPHS2) [MIM:600995] |
| Q9UND3 | NPIP_HUMAN Nuclear pore complex-interacting protein OS=Homo sapiens GN=NPIP PE=2 SV=3 | 93 | R | 0.673653 | C | 0.512337 | 0.161316 | No Change: Both D | - |
| O75607 | NPM3_HUMAN Nucleoplasmin-3 OS=Homo sapiens GN=NPM3 PE=1 SV=3 | 16 | S | 0.588847 | N | 0.513241 | 0.075606 | No Change: Both D | - |
| O75607 | NPM3_HUMAN Nucleoplasmin-3 OS=Homo sapiens GN=NPM3 PE=1 SV=3 | 80 | N | 0.281952 | I | 0.148169 | 0.133783 | No Change: Both O | - |
| Q6UXI9 | NPNT_HUMAN Nephronectin OS=Homo sapiens GN=NPNT PE=2 SV=3 | 159 | Q | 0.592632 | H | 0.497358 | 0.095274 | D to O | - |
| Q6UXI9 | NPNT_HUMAN Nephronectin OS=Homo sapiens GN=NPNT PE=2 SV=3 | 234 | I | 0.191807 | V | 0.206034 | -0.014227 | No Change: Both O | - |
| Q6UXI9 | NPNT_HUMAN Nephronectin OS=Homo sapiens GN=NPNT PE=2 SV=3 | 473 | G | 0.251904 | S | 0.301635 | -0.049731 | No Change: Both O | - |
| Q6UXI9 | NPNT_HUMAN Nephronectin OS=Homo sapiens GN=NPNT PE=2 SV=3 | 476 | M | 0.258112 | T | 0.297397 | -0.039285 | No Change: Both O | - |
| P01160 | ANF_HUMAN Natriuretic peptides A OS=Homo sapiens GN=NPPA PE=1 SV=1 | 32 | V | 0.3592 | M | 0.460626 | -0.101426 | No Change: Both O | - |
| P16860 | ANFB_HUMAN Natriuretic peptides B OS=Homo sapiens GN=NPPB PE=1 SV=1 | 25 | R | 0.692678 | L | 0.627315 | 0.065363 | No Change: Both D | - |
| P16860 | ANFB_HUMAN Natriuretic peptides B OS=Homo sapiens GN=NPPB PE=1 SV=1 | 47 | R | 0.9006 | H | 0.896064 | 0.004536 | No Change: Both D | - |
| P16860 | ANFB_HUMAN Natriuretic peptides B OS=Homo sapiens GN=NPPB PE=1 SV=1 | 93 | M | 0.530277 | L | 0.461991 | 0.068286 | D to O | - |
| P23582 | ANFC_HUMAN C-type natriuretic peptide OS=Homo sapiens GN=NPPC PE=1 SV=1 | 82 | R | 0.607322 | Q | 0.577256 | 0.030066 | No Change: Both D | - |
| P16066 | ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | 182 | A | 0.136064 | V | 0.091427 | 0.044637 | No Change: Both O | - |
| P16066 | ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | 270 | F | 0.056649 | C | 0.058319 | -0.00167 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| P16066 | ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | 755 | V | 0.465681 | M | 0.542548 | -0.076867 | O to D | - |
| P16066 | ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | 939 | R | 0.261476 | Q | 0.2626 | -0.001124 | No Change: Both O | - |
| P16066 | ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens GN=NPR1 PE=1 SV=1 | 967 | E | 0.486212 | K | 0.484686 | 0.001526 | No Change: Both O | - |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 771 | Q | 0.315392 | E | 0.362363 | -0.046971 | No Change: Both O | - |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 32 | P | 0.177286 | T | 0.147156 | 0.03013 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 115 | W | 0.135303 | G | 0.307082 | -0.171779 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 176 | D | 0.423131 | E | 0.429601 | -0.00647 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 297 | T | 0.433465 | M | 0.379866 | 0.053599 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 338 | Y | 0.029064 | C | 0.027605 | 0.001459 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 409 | A | 0.44012 | T | 0.445877 | -0.005757 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 413 | G | 0.307347 | E | 0.358023 | -0.050676 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 708 | Y | 0.121639 | C | 0.10116 | 0.020479 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 776 | R | 0.429837 | W | 0.25656 | 0.173277 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 957 | R | 0.285411 | C | 0.146859 | 0.138552 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 959 | G | 0.189168 | A | 0.147313 | 0.041855 | No Change: Both O | Acromesomelic dysplasia Maroteaux type (AMDM) [MIM:602875] |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 232 | M | 0.096604 | I | 0.069412 | 0.027192 | No Change: Both O | - |
| P20594 | ANPRB_HUMAN Atrial natriuretic peptide receptor 2 OS=Homo sapiens GN=NPR2 PE=1 SV=1 | 882 | V | 0.219427 | I | 0.184238 | 0.035189 | No Change: Both O | - |
| P0C0P6 | NPS_HUMAN Neuropeptide S OS=Homo sapiens GN=NPS PE=1 SV=1 | 14 | S | 0.075765 | L | 0.032606 | 0.043159 | No Change: Both O | - |
| P0C0P6 | NPS_HUMAN Neuropeptide S OS=Homo sapiens GN=NPS PE=1 SV=1 | 75 | V | 0.677018 | L | 0.69921 | -0.022192 | No Change: Both D | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 107 | N | 0.067225 | I | 0.03041 | 0.036815 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 241 | S | 0.217027 | R | 0.170759 | 0.046268 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 344 | Q | 0.749828 | R | 0.754742 | -0.004914 | No Change: Both D | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 122 | R | 0.041014 | Q | 0.044293 | -0.003279 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 143 | S | 0.154496 | G | 0.114128 | 0.040368 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 197 | C | 0.072657 | F | 0.077534 | -0.004877 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 212 | T | 0.026635 | I | 0.013481 | 0.013154 | No Change: Both O | - |
| Q6W5P4 | NPSR1_HUMAN Neuropeptide S receptor OS=Homo sapiens GN=NPSR1 PE=2 SV=1 | 315 | I | 0.106902 | T | 0.173347 | -0.066445 | No Change: Both O | - |
| Q9HCQ7 | RFRP_HUMAN FMRFamide-related peptides OS=Homo sapiens GN=NPVF PE=1 SV=2 | 32 | I | 0.245247 | M | 0.32131 | -0.076063 | No Change: Both O | - |
| Q9HCQ7 | RFRP_HUMAN FMRFamide-related peptides OS=Homo sapiens GN=NPVF PE=1 SV=2 | 42 | D | 0.702227 | G | 0.696625 | 0.005602 | No Change: Both D | - |
| Q9HCQ7 | RFRP_HUMAN FMRFamide-related peptides OS=Homo sapiens GN=NPVF PE=1 SV=2 | 121 | V | 0.693365 | M | 0.765322 | -0.071957 | No Change: Both D | - |
| Q8N729 | NPW_HUMAN Neuropeptide W OS=Homo sapiens GN=NPW PE=1 SV=2 | 149 | D | 0.86527 | A | 0.852751 | 0.012519 | No Change: Both D | - |
| P01303 | NPY_HUMAN Pro-neuropeptide Y OS=Homo sapiens GN=NPY PE=1 SV=1 | 7 | L | 0.470224 | P | 0.539358 | -0.069134 | O to D | - |
| P01303 | NPY_HUMAN Pro-neuropeptide Y OS=Homo sapiens GN=NPY PE=1 SV=1 | 22 | L | 0.211475 | M | 0.252624 | -0.041149 | No Change: Both O | - |
| P25929 | NPY1R_HUMAN Neuropeptide Y receptor type 1 OS=Homo sapiens GN=NPY1R PE=1 SV=1 | 374 | K | 0.738136 | T | 0.654721 | 0.083415 | No Change: Both D | - |
| P15559 | NQO1_HUMAN NAD(P)H dehydrogenase [quinone] 1 OS=Homo sapiens GN=NQO1 PE=1 SV=1 | 187 | P | 0.187842 | S | 0.224108 | -0.036266 | No Change: Both O | - |
| P15559 | NQO1_HUMAN NAD(P)H dehydrogenase [quinone] 1 OS=Homo sapiens GN=NQO1 PE=1 SV=1 | 139 | R | 0.508805 | W | 0.278678 | 0.230127 | D to O | - |
| P15559 | NQO1_HUMAN NAD(P)H dehydrogenase [quinone] 1 OS=Homo sapiens GN=NQO1 PE=1 SV=1 | 269 | Q | 0.667487 | H | 0.670497 | -0.00301 | No Change: Both D | - |
| P16083 | NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens GN=NQO2 PE=1 SV=5 | 16 | K | 0.586154 | R | 0.514 | 0.072154 | No Change: Both D | - |
| P16083 | NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens GN=NQO2 PE=1 SV=5 | 29 | E | 0.329241 | G | 0.296563 | 0.032678 | No Change: Both O | - |
| P16083 | NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens GN=NQO2 PE=1 SV=5 | 47 | L | 0.343389 | F | 0.300658 | 0.042731 | No Change: Both O | - |
| P16083 | NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens GN=NQO2 PE=1 SV=5 | 58 | G | 0.393967 | D | 0.436656 | -0.042689 | No Change: Both O | - |
| P16083 | NQO2_HUMAN Ribosyldihydronicotinamide dehydrogenase [quinone] OS=Homo sapiens GN=NQO2 PE=1 SV=5 | 184 | V | 0.08274 | A | 0.126993 | -0.044253 | No Change: Both O | - |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 267 | R | 0.085817 | P | 0.107895 | -0.022078 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 287 | V | 0.05588 | G | 0.089191 | -0.033311 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 300 | A | 0.241952 | V | 0.188769 | 0.053183 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 377 | E | 0.258495 | K | 0.277128 | -0.018633 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 382 | K | 0.144125 | N | 0.120969 | 0.023156 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 385 | V | 0.124595 | G | 0.219269 | -0.094674 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 425 | R | 0.40685 | G | 0.434796 | -0.027946 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 440 | N | 0.041991 | I | 0.019192 | 0.022799 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 380 | Y | 0.177813 | D | 0.291537 | -0.113724 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 381 | L | 0.163502 | H | 0.252567 | -0.089065 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 439 | I | 0.041948 | S | 0.104522 | -0.062574 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 295 | L | 0.082963 | P | 0.147261 | -0.064298 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 300 | A | 0.241952 | P | 0.323619 | -0.081667 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 425 | R | 0.40685 | T | 0.404737 | 0.002113 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 466 | L | 0.446568 | R | 0.576565 | -0.129997 | O to D | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 278 | L | 0.087659 | P | 0.167258 | -0.079599 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 291 | W | 0.046771 | C | 0.076557 | -0.029786 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| P51843 | NR0B1_HUMAN Nuclear receptor subfamily 0 group B member 1 OS=Homo sapiens GN=NR0B1 PE=1 SV=2 | 297 | L | 0.142932 | P | 0.231763 | -0.088831 | No Change: Both O | X-linked adrenal hypoplasia congenital (XL-AHC) [MIM:300200] |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 57 | R | 0.505451 | W | 0.295179 | 0.210272 | D to O | - |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 189 | G | 0.414856 | E | 0.479917 | -0.065061 | No Change: Both O | - |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 195 | A | 0.16775 | S | 0.251422 | -0.083672 | No Change: Both O | - |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 213 | R | 0.179022 | C | 0.090177 | 0.088845 | No Change: Both O | - |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 216 | R | 0.199265 | H | 0.188573 | 0.010692 | No Change: Both O | - |
| Q15466 | NR0B2_HUMAN Nuclear receptor subfamily 0 group B member 2 OS=Homo sapiens GN=NR0B2 PE=1 SV=2 | 171 | G | 0.09797 | A | 0.083101 | 0.014869 | No Change: Both O | - |
| Q14995 | NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens GN=NR1D2 PE=1 SV=3 | 21 | P | 0.98058 | H | 0.978995 | 0.001585 | No Change: Both D | - |
| Q14995 | NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens GN=NR1D2 PE=1 SV=3 | 282 | Q | 0.875322 | K | 0.873691 | 0.001631 | No Change: Both D | - |
| Q14995 | NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens GN=NR1D2 PE=1 SV=3 | 288 | P | 0.888653 | R | 0.881214 | 0.007439 | No Change: Both D | - |
| Q14995 | NR1D2_HUMAN Nuclear receptor subfamily 1 group D member 2 OS=Homo sapiens GN=NR1D2 PE=1 SV=3 | 386 | L | 0.375335 | M | 0.450944 | -0.075609 | No Change: Both O | - |
| P55055 | NR1H2_HUMAN Oxysterols receptor LXR-beta OS=Homo sapiens GN=NR1H2 PE=1 SV=2 | 2 | S | 0.998741 | F | 0.99579 | 0.002951 | No Change: Both D | - |
| Q13133 | NR1H3_HUMAN Oxysterols receptor LXR-alpha OS=Homo sapiens GN=NR1H3 PE=1 SV=2 | 52 | G | 0.85602 | V | 0.790963 | 0.065057 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 27 | P | 0.683485 | S | 0.697308 | -0.013823 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 36 | G | 0.428942 | R | 0.423782 | 0.00516 | No Change: Both O | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 122 | R | 0.911144 | Q | 0.907135 | 0.004009 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 98 | R | 0.897103 | C | 0.865686 | 0.031417 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 148 | R | 0.634586 | Q | 0.648664 | -0.014078 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 381 | R | 0.32549 | W | 0.159798 | 0.165692 | No Change: Both O | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 403 | I | 0.395599 | V | 0.425674 | -0.030075 | No Change: Both O | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 18 | E | 0.587578 | K | 0.57521 | 0.012368 | No Change: Both D | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 370 | A | 0.148436 | T | 0.17737 | -0.028934 | No Change: Both O | - |
| O75469 | NR1I2_HUMAN Nuclear receptor subfamily 1 group I member 2 OS=Homo sapiens GN=NR1I2 PE=1 SV=1 | 12 | A | 0.535607 | T | 0.598974 | -0.063367 | No Change: Both D | - |
| Q14994 | NR1I3_HUMAN Nuclear receptor subfamily 1 group I member 3 OS=Homo sapiens GN=NR1I3 PE=1 SV=2 | 133 | V | 0.294009 | G | 0.426354 | -0.132345 | No Change: Both O | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 76 | R | 0.264469 | Q | 0.25218 | 0.012289 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 76 | R | 0.264469 | W | 0.098672 | 0.165797 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 97 | R | 0.578975 | H | 0.520944 | 0.058031 | No Change: Both D | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 104 | R | 0.613857 | W | 0.349092 | 0.264765 | D to O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 121 | E | 0.89734 | K | 0.901878 | -0.004538 | No Change: Both D | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 140 | E | 0.966854 | G | 0.957138 | 0.009716 | No Change: Both D | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 163 | M | 0.861088 | T | 0.865061 | -0.003973 | No Change: Both D | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 232 | V | 0.127321 | I | 0.116409 | 0.010912 | No Change: Both O | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 234 | W | 0.134503 | S | 0.339185 | -0.204682 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 302 | V | 0.429016 | I | 0.415783 | 0.013233 | No Change: Both O | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 309 | R | 0.32573 | G | 0.288406 | 0.037324 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 311 | R | 0.286531 | Q | 0.282572 | 0.003959 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 385 | R | 0.145975 | P | 0.164731 | -0.018756 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 407 | M | 0.565165 | K | 0.653327 | -0.088162 | No Change: Both D | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 88 | G | 0.249347 | V | 0.164574 | 0.084773 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 256 | A | 0.11845 | E | 0.195092 | -0.076642 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 263 | L | 0.091891 | P | 0.16768 | -0.075789 | No Change: Both O | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 336 | L | 0.608075 | P | 0.701362 | -0.093287 | No Change: Both D | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 353 | L | 0.720189 | V | 0.713694 | 0.006495 | No Change: Both D | Enhanced S cone syndrome (ESCS) [MIM:268100] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 56 | G | 0.53491 | R | 0.532897 | 0.002013 | No Change: Both D | Retinitis pigmentosa type 37 (RP37) [MIM:611131] |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 44 | S | 0.604516 | L | 0.422432 | 0.182084 | D to O | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 104 | R | 0.613857 | Q | 0.633112 | -0.019255 | No Change: Both D | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 287 | G | 0.632141 | S | 0.682651 | -0.05051 | No Change: Both D | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 324 | K | 0.228342 | R | 0.21412 | 0.014222 | No Change: Both O | - |
| Q9Y5X4 | NR2E3_HUMAN Photoreceptor-specific nuclear receptor OS=Homo sapiens GN=NR2E3 PE=1 SV=1 | 334 | R | 0.546202 | G | 0.542053 | 0.004149 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 363 | N | 0.459372 | S | 0.507645 | -0.048273 | O to D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 641 | D | 0.175129 | V | 0.095197 | 0.079932 | No Change: Both O | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 729 | V | 0.222178 | I | 0.189036 | 0.033142 | No Change: Both O | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 753 | L | 0.194544 | F | 0.185685 | 0.008859 | No Change: Both O | Two glucocorticoid resistant leukemia cell lines lacking the normal allele |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 477 | R | 0.398927 | H | 0.313895 | 0.085032 | No Change: Both O | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 679 | G | 0.56204 | S | 0.6203 | -0.05826 | No Change: Both D | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 23 | R | 0.671804 | K | 0.696226 | -0.024422 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 65 | F | 0.782121 | V | 0.829613 | -0.047492 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 29 | F | 0.654472 | L | 0.722701 | -0.068229 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 112 | L | 0.713823 | F | 0.675552 | 0.038271 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 233 | D | 0.79584 | N | 0.780313 | 0.015527 | No Change: Both D | - |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 421 | C | 0.701591 | Y | 0.645206 | 0.056385 | No Change: Both D | A glucocorticoid resistant leukemia cell line |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 559 | I | 0.178277 | N | 0.349846 | -0.171569 | No Change: Both O | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 747 | I | 0.282675 | M | 0.38872 | -0.106045 | No Change: Both O | Glucocorticoid resistance (GCRES) [MIM:138040] |
| P04150 | GCR_HUMAN Glucocorticoid receptor OS=Homo sapiens GN=NR3C1 PE=1 SV=1 | 571 | V | 0.105965 | A | 0.153557 | -0.047592 | No Change: Both O | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 180 | I | 0.765047 | V | 0.797607 | -0.03256 | No Change: Both D | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 444 | N | 0.76875 | T | 0.765034 | 0.003716 | No Change: Both D | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 537 | R | 0.624984 | Q | 0.645135 | -0.020151 | No Change: Both D | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 554 | N | 0.476321 | S | 0.582145 | -0.105824 | O to D | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 241 | A | 0.950265 | V | 0.938695 | 0.01157 | No Change: Both D | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 810 | S | 0.091808 | L | 0.03722 | 0.054588 | No Change: Both O | Early-onset hypertension with severe exacerbation in pregnancy (EOHSEP) [MIM:605115] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 924 | L | 0.192143 | P | 0.306301 | -0.114158 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 826 | F | 0.195213 | Y | 0.223938 | -0.028725 | No Change: Both O | - |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 633 | G | 0.218558 | R | 0.223133 | -0.004575 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 645 | C | 0.187612 | S | 0.327238 | -0.139626 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 659 | R | 0.501856 | S | 0.489222 | 0.012634 | D to O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 759 | P | 0.673243 | S | 0.694454 | -0.021211 | No Change: Both D | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 769 | L | 0.295851 | P | 0.437016 | -0.141165 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 770 | N | 0.274473 | K | 0.316172 | -0.041699 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 776 | Q | 0.188938 | R | 0.177188 | 0.01175 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 805 | S | 0.051405 | P | 0.041177 | 0.010228 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 815 | S | 0.257459 | R | 0.200154 | 0.057305 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 818 | S | 0.379757 | L | 0.196095 | 0.183662 | No Change: Both O | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 972 | E | 0.577827 | G | 0.54774 | 0.030087 | No Change: Both D | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 979 | L | 0.564549 | P | 0.669166 | -0.104617 | No Change: Both D | Autosomal dominant pseudohypoaldosteronism type I (AD-PHA1) [MIM:177735] |
| P08235 | MCR_HUMAN Mineralocorticoid receptor OS=Homo sapiens GN=NR3C2 PE=1 SV=1 | 7 | H | 0.680491 | Q | 0.773279 | -0.092788 | No Change: Both D | A colorectal cancer sample |
| P22736 | NR4A1_HUMAN Nuclear receptor subfamily 4 group A member 1 OS=Homo sapiens GN=NR4A1 PE=1 SV=1 | 26 | L | 0.880282 | V | 0.847078 | 0.033204 | No Change: Both D | - |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 35 | G | 0.32115 | E | 0.380891 | -0.059741 | No Change: Both O | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 92 | R | 0.765628 | Q | 0.748765 | 0.016863 | No Change: Both D | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 255 | R | 0.664817 | L | 0.595734 | 0.069083 | No Change: Both D | Adrenocortical insufficiency without ovarian defect (ACIWOD) [MIM:184757] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 33 | C | 0.280129 | S | 0.421053 | -0.140924 | No Change: Both O | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 84 | R | 0.71915 | H | 0.606836 | 0.112314 | No Change: Both D | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 146 | G | 0.973699 | A | 0.970951 | 0.002748 | No Change: Both D | - |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 123 | G | 0.925059 | A | 0.916042 | 0.009017 | No Change: Both D | Premature ovarian failure type 7 (POF7) [MIM:612964] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 123 | G | 0.925059 | A | 0.916042 | 0.009017 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 129 | P | 0.954289 | L | 0.910732 | 0.043557 | No Change: Both D | Premature ovarian failure type 7 (POF7) [MIM:612964] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 129 | P | 0.954289 | L | 0.910732 | 0.043557 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 293 | D | 0.197886 | N | 0.192506 | 0.00538 | No Change: Both O | Premature ovarian failure type 7 (POF7) [MIM:612964] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 15 | V | 0.216347 | M | 0.281745 | -0.065398 | No Change: Both O | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 78 | M | 0.63119 | I | 0.494507 | 0.136683 | D to O | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 91 | G | 0.757202 | S | 0.749285 | 0.007917 | No Change: Both D | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 437 | L | 0.365939 | Q | 0.50991 | -0.143971 | O to D | 46 XY sex reversal type 3 (SRXY3) [MIM:612965] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 131 | P | 0.958299 | L | 0.919917 | 0.038382 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 191 | R | 0.738352 | C | 0.689215 | 0.049137 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 212 | G | 0.829777 | S | 0.855909 | -0.026132 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q13285 | STF1_HUMAN Steroidogenic factor 1 OS=Homo sapiens GN=NR5A1 PE=1 SV=2 | 238 | D | 0.634305 | N | 0.5963 | 0.038005 | No Change: Both D | Spermatogenic failure type 8 (SPGF8) [MIM:613957] |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 208 | V | 0.479345 | A | 0.548 | -0.068655 | O to D | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 249 | Y | 0.339774 | C | 0.339299 | 4.75E-04 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 344 | A | 0.484997 | T | 0.48205 | 0.002947 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 360 | Q | 0.432661 | R | 0.392148 | 0.040513 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1531 | L | 0.22011 | P | 0.375768 | -0.155658 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 132 | A | 0.291295 | S | 0.343951 | -0.052656 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 186 | Q | 0.528888 | E | 0.548628 | -0.01974 | No Change: Both D | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 282 | A | 0.469785 | T | 0.47558 | -0.005795 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 490 | S | 0.470628 | L | 0.301115 | 0.169513 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 519 | N | 0.446956 | I | 0.285349 | 0.161607 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 674 | A | 0.365335 | V | 0.273599 | 0.091736 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 884 | R | 0.386622 | C | 0.252569 | 0.134053 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1112 | A | 0.43584 | V | 0.35861 | 0.07723 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 484 | D | 0.508629 | N | 0.493743 | 0.014886 | D to O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 647 | A | 0.452865 | S | 0.548633 | -0.095768 | O to D | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1183 | I | 0.143093 | V | 0.159636 | -0.016543 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1566 | R | 0.412591 | C | 0.249724 | 0.162867 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1569 | D | 0.469004 | N | 0.428209 | 0.040795 | No Change: Both O | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1643 | A | 0.666642 | S | 0.743484 | -0.076842 | No Change: Both D | - |
| Q86VF7 | NRAP_HUMAN Nebulin-related-anchoring protein OS=Homo sapiens GN=NRAP PE=2 SV=2 | 1022 | M | 0.283161 | V | 0.232829 | 0.050332 | No Change: Both O | - |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 13 | G | 0.319217 | R | 0.279132 | 0.040085 | No Change: Both O | Colorectal cancer |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 61 | Q | 0.481298 | K | 0.517849 | -0.036551 | O to D | - |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 61 | Q | 0.481298 | R | 0.468348 | 0.01295 | No Change: Both O | Lung carcinoma cell |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 12 | G | 0.290233 | C | 0.129552 | 0.160681 | No Change: Both O | Leukemia |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 13 | G | 0.319217 | D | 0.319804 | -5.87E-04 | No Change: Both O | - |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 50 | T | 0.10366 | I | 0.059967 | 0.043693 | No Change: Both O | Noonan syndrome type 6 (NS6) [MIM:613224] |
| P01111 | RASN_HUMAN GTPase NRas OS=Homo sapiens GN=NRAS PE=1 SV=1 | 60 | G | 0.400722 | E | 0.466015 | -0.065293 | No Change: Both O | Noonan syndrome type 6 (NS6) [MIM:613224] |
| Q9UHY1 | NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens GN=NRBP1 PE=1 SV=1 | 365 | V | 0.316678 | I | 0.30831 | 0.008368 | No Change: Both O | - |
| Q9UHY1 | NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens GN=NRBP1 PE=1 SV=1 | 432 | P | 0.901524 | L | 0.82613 | 0.075394 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q9UHY1 | NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens GN=NRBP1 PE=1 SV=1 | 460 | H | 0.445339 | R | 0.466764 | -0.021425 | No Change: Both O | - |
| Q92823 | NRCAM_HUMAN Neuronal cell adhesion molecule OS=Homo sapiens GN=NRCAM PE=1 SV=3 | 1093 | H | 0.283909 | P | 0.331426 | -0.047517 | No Change: Both O | A breast cancer sample |
| Q92823 | NRCAM_HUMAN Neuronal cell adhesion molecule OS=Homo sapiens GN=NRCAM PE=1 SV=3 | 1116 | G | 0.313439 | V | 0.198787 | 0.114652 | No Change: Both O | A breast cancer sample |
| Q92823 | NRCAM_HUMAN Neuronal cell adhesion molecule OS=Homo sapiens GN=NRCAM PE=1 SV=3 | 545 | P | 0.207249 | A | 0.1486 | 0.058649 | No Change: Both O | - |
| O43847 | NRDC_HUMAN Nardilysin OS=Homo sapiens GN=NRD1 PE=1 SV=2 | 831 | Y | 0.222049 | S | 0.421854 | -0.199805 | No Change: Both O | - |
| Q02297 | NRG1_HUMAN Pro-neuregulin-1 membrane-bound isoform OS=Homo sapiens GN=NRG1 PE=1 SV=3 | 38 | R | 0.969567 | Q | 0.969742 | -1.75E-04 | No Change: Both D | - |
| Q02297 | NRG1_HUMAN Pro-neuregulin-1 membrane-bound isoform OS=Homo sapiens GN=NRG1 PE=1 SV=3 | 463 | M | 0.985392 | K | 0.985378 | 1.40E-05 | No Change: Both D | - |
| Q02297 | NRG1_HUMAN Pro-neuregulin-1 membrane-bound isoform OS=Homo sapiens GN=NRG1 PE=1 SV=3 | 289 | M | 0.767328 | T | 0.756252 | 0.011076 | No Change: Both D | - |
| P56975 | NRG3_HUMAN Pro-neuregulin-3 membrane-bound isoform OS=Homo sapiens GN=NRG3 PE=1 SV=1 | 472 | S | 0.972354 | R | 0.968385 | 0.003969 | No Change: Both D | - |
| P56975 | NRG3_HUMAN Pro-neuregulin-3 membrane-bound isoform OS=Homo sapiens GN=NRG3 PE=1 SV=1 | 552 | K | 0.488421 | N | 0.446824 | 0.041597 | No Change: Both O | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 221 | H | 0.62923 | R | 0.666917 | -0.037687 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 441 | I | 0.842327 | V | 0.868438 | -0.026111 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 448 | R | 0.849269 | G | 0.837586 | 0.011683 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 803 | S | 0.876409 | L | 0.787718 | 0.088691 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 1079 | V | 0.600867 | F | 0.580302 | 0.020565 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 315 | Y | 0.83755 | F | 0.847597 | -0.010047 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 37 | V | 0.680132 | I | 0.671216 | 0.008916 | No Change: Both D | - |
| P48552 | NRIP1_HUMAN Nuclear receptor-interacting protein 1 OS=Homo sapiens GN=NRIP1 PE=1 SV=2 | 567 | N | 0.784531 | S | 0.831183 | -0.046652 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 358 | V | 0.518487 | M | 0.606277 | -0.08779 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 993 | A | 0.804621 | E | 0.857319 | -0.052698 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 355 | Q | 0.542335 | H | 0.516723 | 0.025612 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 424 | S | 0.889231 | C | 0.841274 | 0.047957 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 426 | P | 0.909131 | A | 0.881013 | 0.028118 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 579 | E | 0.811539 | G | 0.749284 | 0.062255 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 679 | E | 0.940349 | G | 0.919149 | 0.0212 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 880 | I | 0.306974 | L | 0.345401 | -0.038427 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 971 | D | 0.85359 | G | 0.800844 | 0.052746 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 1106 | P | 0.925801 | S | 0.927011 | -0.00121 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 1121 | A | 0.967251 | P | 0.976481 | -0.00923 | No Change: Both D | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 1276 | H | 0.18033 | L | 0.154122 | 0.026208 | No Change: Both O | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 1471 | G | 0.068947 | A | 0.055342 | 0.013605 | No Change: Both O | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 1472 | M | 0.070723 | L | 0.053599 | 0.017124 | No Change: Both O | - |
| Q7Z2Y5 | NRK_HUMAN Nik-related protein kinase OS=Homo sapiens GN=NRK PE=2 SV=2 | 727 | R | 0.957217 | H | 0.937625 | 0.019592 | No Change: Both D | - |
| P54845 | NRL_HUMAN Neural retina-specific leucine zipper protein OS=Homo sapiens GN=NRL PE=1 SV=1 | 50 | S | 0.910686 | T | 0.89653 | 0.014156 | No Change: Both D | Retinitis pigmentosa type 27 (RP27) [MIM:613750] |
| P54845 | NRL_HUMAN Neural retina-specific leucine zipper protein OS=Homo sapiens GN=NRL PE=1 SV=1 | 160 | L | 0.864196 | P | 0.890517 | -0.026321 | No Change: Both D | Retinal degeneration autosomal recessive clumped pigment type (RDCP) [MIM:162080] |
| O14786 | NRP1_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=3 | 179 | V | 0.233748 | A | 0.247845 | -0.014097 | No Change: Both O | - |
| O14786 | NRP1_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=3 | 561 | F | 0.263138 | L | 0.297472 | -0.034334 | No Change: Both O | - |
| O14786 | NRP1_HUMAN Neuropilin-1 OS=Homo sapiens GN=NRP1 PE=1 SV=3 | 733 | V | 0.365298 | I | 0.31629 | 0.049008 | No Change: Both O | - |
| O60462 | NRP2_HUMAN Neuropilin-2 OS=Homo sapiens GN=NRP2 PE=1 SV=2 | 123 | R | 0.198897 | K | 0.23211 | -0.033213 | No Change: Both O | - |
| O60462 | NRP2_HUMAN Neuropilin-2 OS=Homo sapiens GN=NRP2 PE=1 SV=2 | 602 | E | 0.683549 | K | 0.676486 | 0.007063 | No Change: Both D | - |
| Q8IZ57 | NRSN1_HUMAN Neurensin-1 OS=Homo sapiens GN=NRSN1 PE=2 SV=1 | 41 | I | 0.141414 | V | 0.158502 | -0.017088 | No Change: Both O | - |
| Q8IZ57 | NRSN1_HUMAN Neurensin-1 OS=Homo sapiens GN=NRSN1 PE=2 SV=1 | 104 | H | 0.159339 | Y | 0.094704 | 0.064635 | No Change: Both O | - |
| Q9GZP1 | NRSN2_HUMAN Neurensin-2 OS=Homo sapiens GN=NRSN2 PE=2 SV=1 | 41 | L | 0.466169 | V | 0.462259 | 0.00391 | No Change: Both O | - |
| Q9GZP1 | NRSN2_HUMAN Neurensin-2 OS=Homo sapiens GN=NRSN2 PE=2 SV=1 | 65 | S | 0.25325 | C | 0.143916 | 0.109334 | No Change: Both O | - |
| Q9GZP1 | NRSN2_HUMAN Neurensin-2 OS=Homo sapiens GN=NRSN2 PE=2 SV=1 | 160 | E | 0.549598 | Q | 0.496496 | 0.053102 | D to O | - |
| Q99748 | NRTN_HUMAN Neurturin OS=Homo sapiens GN=NRTN PE=1 SV=1 | 96 | A | 0.924064 | S | 0.938956 | -0.014892 | No Change: Both D | - |
| Q9ULB1 | NRX1A_HUMAN Neurexin-1-alpha OS=Homo sapiens GN=NRXN1 PE=2 SV=1 | 400 | Y | 0.357204 | N | 0.467983 | -0.110779 | No Change: Both O | - |
| Q9P2S2 | NRX2A_HUMAN Neurexin-2-alpha OS=Homo sapiens GN=NRXN2 PE=2 SV=1 | 81 | L | 0.181732 | Q | 0.234637 | -0.052905 | No Change: Both O | - |
| O95478 | NSA2_HUMAN Ribosome biogenesis protein NSA2 homolog OS=Homo sapiens GN=NSA2 PE=1 SV=1 | 11 | R | 0.837421 | C | 0.733889 | 0.103532 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 614 | V | 0.678583 | L | 0.713543 | -0.03496 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 691 | A | 0.521071 | T | 0.566045 | -0.044974 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 726 | S | 0.775963 | P | 0.76695 | 0.009013 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1036 | A | 0.866161 | P | 0.89771 | -0.031549 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1091 | L | 0.830936 | I | 0.804772 | 0.026164 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1616 | H | 0.187884 | L | 0.126242 | 0.061642 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1637 | L | 0.086856 | P | 0.185337 | -0.098481 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1674 | C | 0.164431 | W | 0.111175 | 0.053256 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1687 | I | 0.209797 | N | 0.365326 | -0.155529 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1792 | G | 0.218392 | V | 0.135957 | 0.082435 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1925 | C | 0.26977 | R | 0.38403 | -0.11426 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1955 | G | 0.259487 | D | 0.278089 | -0.018602 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1984 | R | 0.288142 | Q | 0.300704 | -0.012562 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 1997 | Y | 0.123734 | C | 0.11131 | 0.012424 | No Change: Both O | Weaver syndrome (WES) [MIM:277590] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2005 | R | 0.287217 | Q | 0.304406 | -0.017189 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2017 | R | 0.213232 | Q | 0.235261 | -0.022029 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2017 | R | 0.213232 | W | 0.093093 | 0.120139 | No Change: Both O | Sotos syndrome (SOTOSS) [MIM:117550] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2143 | H | 0.29057 | Q | 0.349931 | -0.059361 | No Change: Both O | Weaver syndrome (WES) [MIM:277590] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2183 | C | 0.595696 | S | 0.702657 | -0.106961 | No Change: Both D | Weaver syndrome (WES) [MIM:277590] |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2250 | M | 0.96161 | I | 0.927907 | 0.033703 | No Change: Both D | - |
| Q96L73 | NSD1_HUMAN Histone-lysine N-methyltransferase H3 lysine-36 and H4 lysine-20 specific OS=Homo sapiens GN=NSD1 PE=1 SV=1 | 2261 | M | 0.956095 | T | 0.958343 | -0.002248 | No Change: Both D | - |
| Q15738 | NSDHL_HUMAN Sterol-4-alpha-carboxylate 3-dehydrogenase decarboxylating OS=Homo sapiens GN=NSDHL PE=1 SV=2 | 105 | A | 0.464453 | V | 0.411454 | 0.052999 | No Change: Both O | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050] |
| Q15738 | NSDHL_HUMAN Sterol-4-alpha-carboxylate 3-dehydrogenase decarboxylating OS=Homo sapiens GN=NSDHL PE=1 SV=2 | 205 | G | 0.35118 | S | 0.384827 | -0.033647 | No Change: Both O | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050] |
| Q15738 | NSDHL_HUMAN Sterol-4-alpha-carboxylate 3-dehydrogenase decarboxylating OS=Homo sapiens GN=NSDHL PE=1 SV=2 | 182 | A | 0.243616 | P | 0.317714 | -0.074098 | No Change: Both O | Congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) [MIM:308050] |
| P46459 | NSF_HUMAN Vesicle-fusing ATPase OS=Homo sapiens GN=NSF PE=1 SV=3 | 476 | T | 0.335512 | M | 0.316256 | 0.019256 | No Change: Both O | - |
| Q9UNZ2 | NSF1C_HUMAN NSFL1 cofactor p47 OS=Homo sapiens GN=NSFL1C PE=1 SV=2 | 290 | D | 0.71048 | N | 0.711518 | -0.001038 | No Change: Both D | - |
| Q96IY1 | NSL1_HUMAN Kinetochore-associated protein NSL1 homolog OS=Homo sapiens GN=NSL1 PE=1 SV=3 | 254 | M | 0.869274 | V | 0.838246 | 0.031028 | No Change: Both D | - |
| Q96IY1 | NSL1_HUMAN Kinetochore-associated protein NSL1 homolog OS=Homo sapiens GN=NSL1 PE=1 SV=3 | 4 | S | 0.649419 | F | 0.503493 | 0.145926 | No Change: Both D | - |
| Q92636 | FAN_HUMAN Protein FAN OS=Homo sapiens GN=NSMAF PE=1 SV=2 | 626 | Y | 0.372851 | C | 0.378482 | -0.005631 | No Change: Both O | - |
| Q92636 | FAN_HUMAN Protein FAN OS=Homo sapiens GN=NSMAF PE=1 SV=2 | 850 | R | 0.296539 | T | 0.301076 | -0.004537 | No Change: Both O | - |
| Q8WV22 | NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens GN=NSMCE1 PE=1 SV=5 | 38 | T | 0.189237 | R | 0.214664 | -0.025427 | No Change: Both O | - |
| Q8WV22 | NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens GN=NSMCE1 PE=1 SV=5 | 47 | N | 0.396268 | S | 0.44296 | -0.046692 | No Change: Both O | - |
| Q96MF7 | NSE2_HUMAN E3 SUMO-protein ligase NSE2 OS=Homo sapiens GN=NSMCE2 PE=1 SV=2 | 27 | L | 0.685576 | F | 0.674121 | 0.011455 | No Change: Both D | A breast cancer sample |
| Q96MF7 | NSE2_HUMAN E3 SUMO-protein ligase NSE2 OS=Homo sapiens GN=NSMCE2 PE=1 SV=2 | 66 | V | 0.373537 | A | 0.447322 | -0.073785 | No Change: Both O | - |
| Q9NXX6 | NSE4A_HUMAN Non-structural maintenance of chromosomes element 4 homolog A OS=Homo sapiens GN=NSMCE4A PE=1 SV=2 | 72 | S | 0.850692 | T | 0.809674 | 0.041018 | No Change: Both D | - |
| Q9H0G5 | NSRP1_HUMAN Nuclear speckle splicing regulatory protein 1 OS=Homo sapiens GN=NSRP1 PE=1 SV=1 | 86 | K | 0.749437 | T | 0.691019 | 0.058418 | No Change: Both D | - |
| Q08J23 | NSUN2_HUMAN tRNA (cytosine(34)-C(5))-methyltransferase OS=Homo sapiens GN=NSUN2 PE=1 SV=2 | 627 | V | 0.215653 | I | 0.196366 | 0.019287 | No Change: Both O | - |
| Q9H649 | NSUN3_HUMAN Putative methyltransferase NSUN3 OS=Homo sapiens GN=NSUN3 PE=2 SV=1 | 295 | A | 0.235533 | V | 0.176638 | 0.058895 | No Change: Both O | - |
| Q96CB9 | NSUN4_HUMAN Putative methyltransferase NSUN4 OS=Homo sapiens GN=NSUN4 PE=1 SV=2 | 51 | T | 0.139712 | A | 0.129077 | 0.010635 | No Change: Both O | - |
| Q96CB9 | NSUN4_HUMAN Putative methyltransferase NSUN4 OS=Homo sapiens GN=NSUN4 PE=1 SV=2 | 128 | N | 0.27688 | K | 0.300779 | -0.023899 | No Change: Both O | - |
| Q96CB9 | NSUN4_HUMAN Putative methyltransferase NSUN4 OS=Homo sapiens GN=NSUN4 PE=1 SV=2 | 325 | I | 0.135144 | T | 0.234832 | -0.099688 | No Change: Both O | - |
| Q96CB9 | NSUN4_HUMAN Putative methyltransferase NSUN4 OS=Homo sapiens GN=NSUN4 PE=1 SV=2 | 365 | I | 0.116322 | V | 0.145103 | -0.028781 | No Change: Both O | - |
| Q96P11 | NSUN5_HUMAN Putative methyltransferase NSUN5 OS=Homo sapiens GN=NSUN5 PE=1 SV=2 | 183 | P | 0.22605 | S | 0.22547 | 5.80E-04 | No Change: Both O | - |
| Q63ZY6 | NSN5C_HUMAN Putative methyltransferase NSUN5C OS=Homo sapiens GN=NSUN5P2 PE=5 SV=2 | 47 | W | 0.44475 | S | 0.731608 | -0.286858 | O to D | - |
| Q63ZY6 | NSN5C_HUMAN Putative methyltransferase NSUN5C OS=Homo sapiens GN=NSUN5P2 PE=5 SV=2 | 90 | A | 0.058449 | V | 0.038495 | 0.019954 | No Change: Both O | - |
| Q63ZY6 | NSN5C_HUMAN Putative methyltransferase NSUN5C OS=Homo sapiens GN=NSUN5P2 PE=5 SV=2 | 272 | C | 0.941837 | R | 0.955673 | -0.013836 | No Change: Both D | - |
| Q63ZY6 | NSN5C_HUMAN Putative methyltransferase NSUN5C OS=Homo sapiens GN=NSUN5P2 PE=5 SV=2 | 303 | K | 0.629802 | R | 0.625739 | 0.004063 | No Change: Both D | - |
| Q8NE18 | NSUN7_HUMAN Putative methyltransferase NSUN7 OS=Homo sapiens GN=NSUN7 PE=2 SV=4 | 308 | S | 0.21013 | A | 0.126273 | 0.083857 | No Change: Both O | - |
| Q8NE18 | NSUN7_HUMAN Putative methyltransferase NSUN7 OS=Homo sapiens GN=NSUN7 PE=2 SV=4 | 622 | T | 0.83452 | A | 0.828388 | 0.006132 | No Change: Both D | - |
| Q8TCD5 | NT5C_HUMAN 5'(3')-deoxyribonucleotidase cytosolic type OS=Homo sapiens GN=NT5C PE=1 SV=2 | 68 | P | 0.197274 | L | 0.107371 | 0.089903 | No Change: Both O | - |
| P49902 | 5NTC_HUMAN Cytosolic purine 5'-nucleotidase OS=Homo sapiens GN=NT5C2 PE=1 SV=1 | 3 | T | 0.806345 | A | 0.830308 | -0.023963 | No Change: Both D | - |
| P49902 | 5NTC_HUMAN Cytosolic purine 5'-nucleotidase OS=Homo sapiens GN=NT5C2 PE=1 SV=1 | 136 | Q | 0.539379 | R | 0.529772 | 0.009607 | No Change: Both D | - |
| Q9H0P0 | 5NT3_HUMAN Cytosolic 5'-nucleotidase 3 OS=Homo sapiens GN=NT5C3 PE=1 SV=3 | 137 | D | 0.159184 | V | 0.092272 | 0.066912 | No Change: Both O | P5N deficiency (P5ND) [MIM:266120] |
| Q9H0P0 | 5NT3_HUMAN Cytosolic 5'-nucleotidase 3 OS=Homo sapiens GN=NT5C3 PE=1 SV=3 | 181 | L | 0.341192 | P | 0.517381 | -0.176189 | O to D | P5N deficiency (P5ND) [MIM:266120] |
| Q9H0P0 | 5NT3_HUMAN Cytosolic 5'-nucleotidase 3 OS=Homo sapiens GN=NT5C3 PE=1 SV=3 | 229 | N | 0.244809 | S | 0.286397 | -0.041588 | No Change: Both O | P5N deficiency (P5ND) [MIM:266120] |
| Q9H0P0 | 5NT3_HUMAN Cytosolic 5'-nucleotidase 3 OS=Homo sapiens GN=NT5C3 PE=1 SV=3 | 280 | G | 0.401782 | R | 0.379759 | 0.022023 | No Change: Both O | P5N deficiency (P5ND) [MIM:266120] |
| Q969T7 | 5NT3L_HUMAN Cytosolic 5'-nucleotidase III-like protein OS=Homo sapiens GN=NT5C3L PE=1 SV=3 | 201 | A | 0.603417 | V | 0.533773 | 0.069644 | No Change: Both D | - |
| Q969T7 | 5NT3L_HUMAN Cytosolic 5'-nucleotidase III-like protein OS=Homo sapiens GN=NT5C3L PE=1 SV=3 | 205 | S | 0.472904 | C | 0.246625 | 0.226279 | No Change: Both O | - |
| Q9H857 | NT5D2_HUMAN 5'-nucleotidase domain-containing protein 2 OS=Homo sapiens GN=NT5DC2 PE=1 SV=1 | 91 | S | 0.220693 | R | 0.182179 | 0.038514 | No Change: Both O | - |
| Q86UY8 | NT5D3_HUMAN 5'-nucleotidase domain-containing protein 3 OS=Homo sapiens GN=NT5DC3 PE=2 SV=1 | 266 | A | 0.138286 | E | 0.216064 | -0.077778 | No Change: Both O | - |
| P21589 | 5NTD_HUMAN 5'-nucleotidase OS=Homo sapiens GN=NT5E PE=1 SV=1 | 376 | T | 0.284876 | A | 0.26952 | 0.015356 | No Change: Both O | - |
| P21589 | 5NTD_HUMAN 5'-nucleotidase OS=Homo sapiens GN=NT5E PE=1 SV=1 | 379 | M | 0.256129 | T | 0.27963 | -0.023501 | No Change: Both O | - |
| P21589 | 5NTD_HUMAN 5'-nucleotidase OS=Homo sapiens GN=NT5E PE=1 SV=1 | 358 | C | 0.204319 | Y | 0.218058 | -0.013739 | No Change: Both O | Calcification of joints and arteries (CALJA) [MIM:211800] |
| Q96AB6 | NTAN1_HUMAN Protein N-terminal asparagine amidohydrolase OS=Homo sapiens GN=NTAN1 PE=1 SV=3 | 283 | H | 0.536386 | N | 0.547984 | -0.011598 | No Change: Both D | - |
| Q96AB6 | NTAN1_HUMAN Protein N-terminal asparagine amidohydrolase OS=Homo sapiens GN=NTAN1 PE=1 SV=3 | 287 | S | 0.457818 | P | 0.455021 | 0.002797 | No Change: Both O | - |
| P20783 | NTF3_HUMAN Neurotrophin-3 OS=Homo sapiens GN=NTF3 PE=1 SV=1 | 76 | G | 0.810932 | E | 0.855494 | -0.044562 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 7 | C | 0.907413 | Y | 0.860213 | 0.0472 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 84 | E | 0.85552 | K | 0.829135 | 0.026385 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 88 | A | 0.791029 | V | 0.733497 | 0.057532 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 89 | S | 0.777973 | N | 0.721506 | 0.056467 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 90 | R | 0.759305 | C | 0.647986 | 0.111319 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 90 | R | 0.759305 | H | 0.672492 | 0.086813 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 114 | R | 0.451311 | G | 0.433071 | 0.01824 | No Change: Both O | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 133 | R | 0.452982 | H | 0.366298 | 0.086684 | No Change: Both O | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 140 | R | 0.480487 | C | 0.373908 | 0.106579 | No Change: Both O | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 206 | R | 0.534734 | Q | 0.544411 | -0.009677 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 206 | R | 0.534734 | W | 0.329891 | 0.204843 | D to O | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 207 | T | 0.614045 | I | 0.513374 | 0.100671 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 207 | T | 0.614045 | S | 0.659312 | -0.045267 | No Change: Both D | - |
| P34130 | NTF4_HUMAN Neurotrophin-4 OS=Homo sapiens GN=NTF4 PE=1 SV=1 | 209 | R | 0.778404 | G | 0.815149 | -0.036745 | No Change: Both D | - |
| P78549 | NTHL1_HUMAN Endonuclease III-like protein 1 OS=Homo sapiens GN=NTHL1 PE=1 SV=2 | 21 | R | 0.986748 | W | 0.957661 | 0.029087 | No Change: Both D | - |
| P78549 | NTHL1_HUMAN Endonuclease III-like protein 1 OS=Homo sapiens GN=NTHL1 PE=1 SV=2 | 33 | R | 0.99086 | K | 0.988521 | 0.002339 | No Change: Both D | - |
| P78549 | NTHL1_HUMAN Endonuclease III-like protein 1 OS=Homo sapiens GN=NTHL1 PE=1 SV=2 | 176 | I | 0.07856 | T | 0.150456 | -0.071896 | No Change: Both O | - |
| P78549 | NTHL1_HUMAN Endonuclease III-like protein 1 OS=Homo sapiens GN=NTHL1 PE=1 SV=2 | 239 | D | 0.237501 | Y | 0.132864 | 0.104637 | No Change: Both O | - |
| P78549 | NTHL1_HUMAN Endonuclease III-like protein 1 OS=Homo sapiens GN=NTHL1 PE=1 SV=2 | 234 | S | 0.164012 | L | 0.079608 | 0.084404 | No Change: Both O | - |
| O95631 | NET1_HUMAN Netrin-1 OS=Homo sapiens GN=NTN1 PE=1 SV=2 | 351 | R | 0.319886 | H | 0.275655 | 0.044231 | No Change: Both O | - |
| O95631 | NET1_HUMAN Netrin-1 OS=Homo sapiens GN=NTN1 PE=1 SV=2 | 489 | K | 0.410281 | E | 0.374469 | 0.035812 | No Change: Both O | - |
| O00634 | NET3_HUMAN Netrin-3 OS=Homo sapiens GN=NTN3 PE=2 SV=1 | 425 | P | 0.913132 | S | 0.905749 | 0.007383 | No Change: Both D | - |
| Q9HB63 | NET4_HUMAN Netrin-4 OS=Homo sapiens GN=NTN4 PE=2 SV=2 | 205 | Y | 0.49335 | H | 0.557762 | -0.064412 | O to D | - |
| Q96CW9 | NTNG2_HUMAN Netrin-G2 OS=Homo sapiens GN=NTNG2 PE=1 SV=2 | 346 | T | 0.419743 | A | 0.418103 | 0.00164 | No Change: Both O | - |
| Q9BSD7 | NTPCR_HUMAN Cancer-related nucleoside-triphosphatase OS=Homo sapiens GN=NTPCR PE=1 SV=1 | 106 | G | 0.349499 | E | 0.388576 | -0.039077 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 577 | G | 0.112465 | R | 0.12999 | -0.017525 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 85 | R | 0.42926 | S | 0.477012 | -0.047752 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 93 | L | 0.26079 | P | 0.378624 | -0.117834 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 213 | L | 0.173818 | P | 0.293302 | -0.119484 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 522 | G | 0.165271 | R | 0.145356 | 0.019915 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 587 | M | 0.128162 | V | 0.096081 | 0.032081 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 604 | H | 0.435231 | Y | 0.312345 | 0.122886 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 613 | G | 0.477893 | V | 0.330287 | 0.147606 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 649 | R | 0.157202 | W | 0.059404 | 0.097798 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 654 | R | 0.169779 | C | 0.081686 | 0.088093 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 674 | D | 0.334798 | Y | 0.190912 | 0.143886 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 695 | P | 0.203411 | L | 0.10385 | 0.099561 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 714 | G | 0.040105 | S | 0.056169 | -0.016064 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 780 | R | 0.322315 | P | 0.367055 | -0.04474 | No Change: Both O | Congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800] |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 780 | R | 0.322315 | Q | 0.357165 | -0.03485 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 80 | Q | 0.398323 | R | 0.379366 | 0.018957 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 107 | A | 0.187631 | V | 0.141218 | 0.046413 | No Change: Both O | An ovarian serous carcinoma sample |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 237 | T | 0.486234 | M | 0.442376 | 0.043858 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 238 | V | 0.502725 | G | 0.633647 | -0.130922 | No Change: Both D | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 260 | R | 0.300088 | G | 0.304833 | -0.004745 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 444 | R | 0.262444 | Q | 0.265474 | -0.00303 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 452 | R | 0.264924 | C | 0.140526 | 0.124398 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 566 | M | 0.259216 | T | 0.30385 | -0.044634 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 790 | V | 0.273593 | I | 0.231869 | 0.041724 | No Change: Both O | - |
| P04629 | NTRK1_HUMAN High affinity nerve growth factor receptor OS=Homo sapiens GN=NTRK1 PE=1 SV=4 | 18 | G | 0.370774 | E | 0.348521 | 0.022253 | No Change: Both O | - |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 338 | N | 0.295263 | Y | 0.190092 | 0.105171 | No Change: Both O | - |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 309 | G | 0.305142 | R | 0.292633 | 0.012509 | No Change: Both O | - |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 138 | L | 0.288868 | F | 0.257029 | 0.031839 | No Change: Both O | A lung adenocarcinoma sample |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 697 | M | 0.287358 | I | 0.218571 | 0.068787 | No Change: Both O | A lung carcinoma sample |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 699 | R | 0.357949 | G | 0.393162 | -0.035213 | No Change: Both O | A lung carcinoma sample |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 718 | R | 0.220346 | C | 0.109759 | 0.110587 | No Change: Both O | A lung carcinoma sample |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 545 | G | 0.327096 | V | 0.201177 | 0.125919 | No Change: Both O | - |
| Q16620 | NTRK2_HUMAN BDNF/NT-3 growth factors receptor OS=Homo sapiens GN=NTRK2 PE=1 SV=1 | 783 | Y | 0.188022 | C | 0.222799 | -0.034777 | No Change: Both O | Obesity hyperphagia and developmental delay (OHPDD) [MIM:613886] |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 149 | T | 0.214984 | R | 0.250744 | -0.03576 | No Change: Both O | A gastric adenocarcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 306 | R | 0.245607 | C | 0.133173 | 0.112434 | No Change: Both O | - |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 307 | V | 0.301778 | L | 0.300035 | 0.001743 | No Change: Both O | A lung adenocarcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 336 | L | 0.329842 | Q | 0.465336 | -0.135494 | No Change: Both O | A lung adenocarcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 677 | H | 0.225232 | Y | 0.134209 | 0.091023 | No Change: Both O | A lung adenocarcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 678 | R | 0.230421 | Q | 0.247442 | -0.017021 | No Change: Both O | - |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 664 | A | 0.239181 | S | 0.345157 | -0.105976 | No Change: Both O | A lung carcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 736 | W | 0.239013 | C | 0.274758 | -0.035745 | No Change: Both O | A lung carcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 745 | R | 0.334467 | P | 0.392219 | -0.057752 | No Change: Both O | A lung carcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 766 | Y | 0.054765 | F | 0.052072 | 0.002693 | No Change: Both O | A lung carcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 735 | R | 0.220265 | F | 0.117867 | 0.102398 | No Change: Both O | A lung large cell carcinoma sample |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 768 | K | 0.104598 | R | 0.080547 | 0.024051 | No Change: Both O | - |
| Q16288 | NTRK3_HUMAN NT-3 growth factor receptor OS=Homo sapiens GN=NTRK3 PE=1 SV=2 | 781 | E | 0.147008 | K | 0.138024 | 0.008984 | No Change: Both O | - |
| P30989 | NTR1_HUMAN Neurotensin receptor type 1 OS=Homo sapiens GN=NTSR1 PE=1 SV=2 | 304 | V | 0.094476 | I | 0.076779 | 0.017697 | No Change: Both O | - |
| P30989 | NTR1_HUMAN Neurotensin receptor type 1 OS=Homo sapiens GN=NTSR1 PE=1 SV=2 | 275 | Q | 0.393 | H | 0.359251 | 0.033749 | No Change: Both O | - |
| P30989 | NTR1_HUMAN Neurotensin receptor type 1 OS=Homo sapiens GN=NTSR1 PE=1 SV=2 | 72 | A | 0.028429 | V | 0.02115 | 0.007279 | No Change: Both O | - |
| O95665 | NTR2_HUMAN Neurotensin receptor type 2 OS=Homo sapiens GN=NTSR2 PE=2 SV=2 | 54 | A | 0.252697 | V | 0.182331 | 0.070366 | No Change: Both O | - |
| O95665 | NTR2_HUMAN Neurotensin receptor type 2 OS=Homo sapiens GN=NTSR2 PE=2 SV=2 | 282 | R | 0.385469 | K | 0.453142 | -0.067673 | No Change: Both O | - |
| O60285 | NUAK1_HUMAN NUAK family SNF1-like kinase 1 OS=Homo sapiens GN=NUAK1 PE=1 SV=1 | 543 | P | 0.889213 | R | 0.868434 | 0.020779 | No Change: Both D | - |
| O60285 | NUAK1_HUMAN NUAK family SNF1-like kinase 1 OS=Homo sapiens GN=NUAK1 PE=1 SV=1 | 419 | G | 0.632212 | D | 0.633094 | -8.82E-04 | No Change: Both D | - |
| Q9H093 | NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | 309 | T | 0.211176 | S | 0.275875 | -0.064699 | No Change: Both O | - |
| Q9H093 | NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | 341 | R | 0.679108 | L | 0.573492 | 0.105616 | No Change: Both D | - |
| Q9H093 | NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | 503 | K | 0.511393 | R | 0.46477 | 0.046623 | D to O | An ovarian Endometrioid carcinoma sample |
| Q9H093 | NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | 516 | A | 0.633163 | V | 0.514669 | 0.118494 | No Change: Both D | - |
| Q9H093 | NUAK2_HUMAN NUAK family SNF1-like kinase 2 OS=Homo sapiens GN=NUAK2 PE=1 SV=1 | 541 | G | 0.942519 | E | 0.958389 | -0.01587 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| Q9Y5A7 | NUB1_HUMAN NEDD8 ultimate buster 1 OS=Homo sapiens GN=NUB1 PE=1 SV=2 | 13 | Q | 0.318476 | R | 0.30339 | 0.015086 | No Change: Both O | - |
| P53384 | NUBP1_HUMAN Cytosolic Fe-S cluster assembly factor NUBP1 OS=Homo sapiens GN=NUBP1 PE=1 SV=2 | 39 | P | 0.651036 | A | 0.60878 | 0.042256 | No Change: Both D | - |
| Q9Y5Y2 | NUBP2_HUMAN Cytosolic Fe-S cluster assembly factor NUBP2 OS=Homo sapiens GN=NUBP2 PE=1 SV=1 | 250 | P | 0.329446 | S | 0.345145 | -0.015699 | No Change: Both O | - |
| Q9Y5Y2 | NUBP2_HUMAN Cytosolic Fe-S cluster assembly factor NUBP2 OS=Homo sapiens GN=NUBP2 PE=1 SV=1 | 266 | T | 0.419711 | M | 0.372352 | 0.047359 | No Change: Both O | - |
| Q9Y5Y2 | NUBP2_HUMAN Cytosolic Fe-S cluster assembly factor NUBP2 OS=Homo sapiens GN=NUBP2 PE=1 SV=1 | 200 | T | 0.297323 | A | 0.242522 | 0.054801 | No Change: Both O | - |
| Q8TB37 | NUBPL_HUMAN Iron-sulfur protein NUBPL OS=Homo sapiens GN=NUBPL PE=1 SV=3 | 198 | N | 0.267226 | T | 0.25261 | 0.014616 | No Change: Both O | - |
| Q8TB37 | NUBPL_HUMAN Iron-sulfur protein NUBPL OS=Homo sapiens GN=NUBPL PE=1 SV=3 | 56 | G | 0.74201 | R | 0.759095 | -0.017085 | No Change: Both D | Mitochondrial complex I deficiency (MT-C1D) [MIM:252010] |
| Q02818 | NUCB1_HUMAN Nucleobindin-1 OS=Homo sapiens GN=NUCB1 PE=1 SV=4 | 399 | R | 0.983842 | Q | 0.988379 | -0.004537 | No Change: Both D | - |
| Q02818 | NUCB1_HUMAN Nucleobindin-1 OS=Homo sapiens GN=NUCB1 PE=1 SV=4 | 338 | M | 0.672297 | V | 0.623033 | 0.049264 | No Change: Both D | - |
| P80303 | NUCB2_HUMAN Nucleobindin-2 OS=Homo sapiens GN=NUCB2 PE=1 SV=2 | 338 | Q | 0.779205 | E | 0.814122 | -0.034917 | No Change: Both D | - |
| Q9H1E3 | NUCKS_HUMAN Nuclear ubiquitous casein and cyclin-dependent kinases substrate OS=Homo sapiens GN=NUCKS1 PE=1 SV=1 | 119 | E | 0.995076 | G | 0.992651 | 0.002425 | No Change: Both D | - |
| Q9H1E3 | NUCKS_HUMAN Nuclear ubiquitous casein and cyclin-dependent kinases substrate OS=Homo sapiens GN=NUCKS1 PE=1 SV=1 | 137 | L | 0.996935 | P | 0.998505 | -0.00157 | No Change: Both D | - |
| Q96RS6 | NUDC1_HUMAN NudC domain-containing protein 1 OS=Homo sapiens GN=NUDCD1 PE=1 SV=2 | 252 | L | 0.165457 | F | 0.150409 | 0.015048 | No Change: Both O | - |
| Q96RS6 | NUDC1_HUMAN NudC domain-containing protein 1 OS=Homo sapiens GN=NUDCD1 PE=1 SV=2 | 269 | I | 0.607252 | V | 0.613672 | -0.00642 | No Change: Both D | - |
| Q96RS6 | NUDC1_HUMAN NudC domain-containing protein 1 OS=Homo sapiens GN=NUDCD1 PE=1 SV=2 | 394 | N | 0.857532 | H | 0.843662 | 0.01387 | No Change: Both D | - |
| Q96RS6 | NUDC1_HUMAN NudC domain-containing protein 1 OS=Homo sapiens GN=NUDCD1 PE=1 SV=2 | 426 | N | 0.354607 | S | 0.399082 | -0.044475 | No Change: Both O | - |
| Q8IVD9 | NUDC3_HUMAN NudC domain-containing protein 3 OS=Homo sapiens GN=NUDCD3 PE=1 SV=3 | 235 | R | 0.545096 | C | 0.401069 | 0.144027 | D to O | - |
| Q8IVD9 | NUDC3_HUMAN NudC domain-containing protein 3 OS=Homo sapiens GN=NUDCD3 PE=1 SV=3 | 3 | T | 0.914989 | P | 0.925418 | -0.010429 | No Change: Both D | - |
| P36639 | 8ODP_HUMAN 7 8-dihydro-8-oxoguanine triphosphatase OS=Homo sapiens GN=NUDT1 PE=1 SV=3 | 124 | V | 0.144025 | M | 0.189149 | -0.045124 | No Change: Both O | - |
| Q96G61 | NUD11_HUMAN Diphosphoinositol polyphosphate phosphohydrolase 3-beta OS=Homo sapiens GN=NUDT11 PE=1 SV=1 | 39 | S | 0.575572 | N | 0.478667 | 0.096905 | D to O | - |
| Q9BQG2 | NUD12_HUMAN Peroxisomal NADH pyrophosphatase NUDT12 OS=Homo sapiens GN=NUDT12 PE=1 SV=1 | 129 | K | 0.653216 | E | 0.655239 | -0.002023 | No Change: Both D | - |
| Q9BQG2 | NUD12_HUMAN Peroxisomal NADH pyrophosphatase NUDT12 OS=Homo sapiens GN=NUDT12 PE=1 SV=1 | 235 | I | 0.197018 | V | 0.208056 | -0.011038 | No Change: Both O | - |
| Q86X67 | NUD13_HUMAN Nucleoside diphosphate-linked moiety X motif 13 OS=Homo sapiens GN=NUDT13 PE=2 SV=3 | 81 | G | 0.308703 | D | 0.34019 | -0.031487 | No Change: Both O | - |
| Q86X67 | NUD13_HUMAN Nucleoside diphosphate-linked moiety X motif 13 OS=Homo sapiens GN=NUDT13 PE=2 SV=3 | 273 | M | 0.161936 | V | 0.130591 | 0.031345 | No Change: Both O | - |
| A8MXV4 | NUD19_HUMAN Nucleoside diphosphate-linked moiety X motif 19 mitochondrial OS=Homo sapiens GN=NUDT19 PE=1 SV=1 | 43 | R | 0.679728 | Q | 0.673997 | 0.005731 | No Change: Both D | - |
| Q9BRQ3 | NUD22_HUMAN Nucleoside diphosphate-linked moiety X motif 22 OS=Homo sapiens GN=NUDT22 PE=2 SV=3 | 36 | G | 0.574732 | C | 0.447832 | 0.1269 | D to O | - |
| Q9BRQ3 | NUD22_HUMAN Nucleoside diphosphate-linked moiety X motif 22 OS=Homo sapiens GN=NUDT22 PE=2 SV=3 | 260 | Q | 0.224002 | R | 0.209854 | 0.014148 | No Change: Both O | - |
| Q9BRQ3 | NUD22_HUMAN Nucleoside diphosphate-linked moiety X motif 22 OS=Homo sapiens GN=NUDT22 PE=2 SV=3 | 263 | L | 0.215101 | P | 0.339514 | -0.124413 | No Change: Both O | - |
| Q9BRQ3 | NUD22_HUMAN Nucleoside diphosphate-linked moiety X motif 22 OS=Homo sapiens GN=NUDT22 PE=2 SV=3 | 129 | T | 0.193079 | R | 0.225605 | -0.032526 | No Change: Both O | - |
| Q9UKK9 | NUDT5_HUMAN ADP-sugar pyrophosphatase OS=Homo sapiens GN=NUDT5 PE=1 SV=1 | 123 | I | 0.418662 | T | 0.55006 | -0.131398 | O to D | - |
| P53370 | NUDT6_HUMAN Nucleoside diphosphate-linked moiety X motif 6 OS=Homo sapiens GN=NUDT6 PE=1 SV=2 | 209 | R | 0.414282 | Q | 0.442315 | -0.028033 | No Change: Both O | - |
| P53370 | NUDT6_HUMAN Nucleoside diphosphate-linked moiety X motif 6 OS=Homo sapiens GN=NUDT6 PE=1 SV=2 | 114 | C | 0.222242 | R | 0.371862 | -0.14962 | No Change: Both O | - |
| P0C024 | NUDT7_HUMAN Peroxisomal coenzyme A diphosphatase NUDT7 OS=Homo sapiens GN=NUDT7 PE=2 SV=1 | 100 | R | 0.408492 | H | 0.411593 | -0.003101 | No Change: Both O | - |
| P0C024 | NUDT7_HUMAN Peroxisomal coenzyme A diphosphatase NUDT7 OS=Homo sapiens GN=NUDT7 PE=2 SV=1 | 181 | E | 0.440623 | G | 0.382585 | 0.058038 | No Change: Both O | - |
| Q9BZD4 | NUF2_HUMAN Kinetochore protein Nuf2 OS=Homo sapiens GN=NUF2 PE=1 SV=2 | 229 | S | 0.887179 | L | 0.823264 | 0.063915 | No Change: Both D | - |
| Q9BZD4 | NUF2_HUMAN Kinetochore protein Nuf2 OS=Homo sapiens GN=NUF2 PE=1 SV=2 | 239 | S | 0.909453 | R | 0.887977 | 0.021476 | No Change: Both D | - |
| Q9UHK0 | NUFP1_HUMAN Nuclear fragile X mental retardation-interacting protein 1 OS=Homo sapiens GN=NUFIP1 PE=1 SV=2 | 36 | S | 0.910251 | R | 0.895639 | 0.014612 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 242 | K | 0.886668 | R | 0.886866 | -1.98E-04 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 794 | A | 0.869076 | G | 0.852002 | 0.017074 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 1153 | E | 0.989808 | D | 0.987186 | 0.002622 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 1825 | V | 0.796602 | M | 0.86206 | -0.065458 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 1836 | Y | 0.890084 | H | 0.923347 | -0.033263 | No Change: Both D | - |
| Q14980 | NUMA1_HUMAN Nuclear mitotic apparatus protein 1 OS=Homo sapiens GN=NUMA1 PE=1 SV=2 | 2049 | A | 0.915136 | T | 0.920206 | -0.00507 | No Change: Both D | - |
| P49757 | NUMB_HUMAN Protein numb homolog OS=Homo sapiens GN=NUMB PE=1 SV=2 | 387 | V | 0.422562 | I | 0.367985 | 0.054577 | No Change: Both O | - |
| P49757 | NUMB_HUMAN Protein numb homolog OS=Homo sapiens GN=NUMB PE=1 SV=2 | 595 | G | 0.542555 | D | 0.58333 | -0.040775 | No Change: Both D | - |
| Q8WUM0 | NU133_HUMAN Nuclear pore complex protein Nup133 OS=Homo sapiens GN=NUP133 PE=1 SV=2 | 106 | T | 0.218345 | P | 0.260556 | -0.042211 | No Change: Both O | - |
| Q8WUM0 | NU133_HUMAN Nuclear pore complex protein Nup133 OS=Homo sapiens GN=NUP133 PE=1 SV=2 | 294 | I | 0.61776 | V | 0.627571 | -0.009811 | No Change: Both D | - |
| Q8WUM0 | NU133_HUMAN Nuclear pore complex protein Nup133 OS=Homo sapiens GN=NUP133 PE=1 SV=2 | 406 | Q | 0.107115 | R | 0.08462 | 0.022495 | No Change: Both O | - |
| Q8WUM0 | NU133_HUMAN Nuclear pore complex protein Nup133 OS=Homo sapiens GN=NUP133 PE=1 SV=2 | 326 | G | 0.314009 | V | 0.196401 | 0.117608 | No Change: Both O | A breast cancer sample |
| Q8WUM0 | NU133_HUMAN Nuclear pore complex protein Nup133 OS=Homo sapiens GN=NUP133 PE=1 SV=2 | 448 | G | 0.273171 | R | 0.244182 | 0.028989 | No Change: Both O | A breast cancer sample |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 90 | D | 0.812584 | N | 0.804528 | 0.008056 | No Change: Both D | - |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 248 | I | 0.744353 | V | 0.769737 | -0.025384 | No Change: Both D | - |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 402 | N | 0.770239 | K | 0.79563 | -0.025391 | No Change: Both D | - |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 821 | P | 0.96524 | L | 0.930437 | 0.034803 | No Change: Both D | - |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 827 | A | 0.974055 | T | 0.978917 | -0.004862 | No Change: Both D | - |
| P49790 | NU153_HUMAN Nuclear pore complex protein Nup153 OS=Homo sapiens GN=NUP153 PE=1 SV=2 | 1388 | T | 0.991365 | A | 0.989434 | 0.001931 | No Change: Both D | - |
| Q12769 | NU160_HUMAN Nuclear pore complex protein Nup160 OS=Homo sapiens GN=NUP160 PE=1 SV=3 | 40 | A | 0.697497 | T | 0.696448 | 0.001049 | No Change: Both D | - |
| Q12769 | NU160_HUMAN Nuclear pore complex protein Nup160 OS=Homo sapiens GN=NUP160 PE=1 SV=3 | 351 | T | 0.179138 | A | 0.169593 | 0.009545 | No Change: Both O | - |
| Q5SRE5 | NU188_HUMAN Nucleoporin NUP188 homolog OS=Homo sapiens GN=NUP188 PE=1 SV=1 | 1419 | A | 0.140745 | V | 0.111037 | 0.029708 | No Change: Both O | - |
| Q5SRE5 | NU188_HUMAN Nucleoporin NUP188 homolog OS=Homo sapiens GN=NUP188 PE=1 SV=1 | 1587 | N | 0.1045 | K | 0.12405 | -0.01955 | No Change: Both O | - |
| Q92621 | NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens GN=NUP205 PE=1 SV=3 | 33 | P | 0.25194 | S | 0.272933 | -0.020993 | No Change: Both O | - |
| Q92621 | NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens GN=NUP205 PE=1 SV=3 | 1356 | E | 0.473151 | Q | 0.452245 | 0.020906 | No Change: Both O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 786 | R | 0.567873 | L | 0.448258 | 0.119615 | D to O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 1752 | L | 0.260635 | S | 0.427004 | -0.166369 | No Change: Both O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 1787 | V | 0.195001 | M | 0.222911 | -0.02791 | No Change: Both O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 297 | A | 0.635538 | T | 0.655235 | -0.019697 | No Change: Both D | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 608 | I | 0.469695 | V | 0.528527 | -0.058832 | O to D | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 755 | A | 0.565733 | V | 0.526812 | 0.038921 | No Change: Both D | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 821 | P | 0.533255 | A | 0.427488 | 0.105767 | D to O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 944 | A | 0.210202 | P | 0.284003 | -0.073801 | No Change: Both O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 1096 | M | 0.386844 | I | 0.304307 | 0.082537 | No Change: Both O | - |
| Q8TEM1 | PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens GN=NUP210 PE=1 SV=3 | 1430 | D | 0.232745 | E | 0.239351 | -0.006606 | No Change: Both O | - |
| Q5VU65 | P210L_HUMAN Nuclear pore membrane glycoprotein 210-like OS=Homo sapiens GN=NUP210L PE=2 SV=1 | 1491 | V | 0.072283 | I | 0.069475 | 0.002808 | No Change: Both O | - |
| P35658 | NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens GN=NUP214 PE=1 SV=2 | 424 | G | 0.874696 | A | 0.845537 | 0.029159 | No Change: Both D | A breast cancer sample |
| P35658 | NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens GN=NUP214 PE=1 SV=2 | 1378 | P | 0.964383 | L | 0.931144 | 0.033239 | No Change: Both D | A breast cancer sample |
| P35658 | NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens GN=NUP214 PE=1 SV=2 | 1392 | A | 0.967447 | V | 0.959816 | 0.007631 | No Change: Both D | A breast cancer sample |
| P35658 | NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens GN=NUP214 PE=1 SV=2 | 574 | P | 0.955871 | S | 0.955772 | 9.90E-05 | No Change: Both D | - |
| P35658 | NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens GN=NUP214 PE=1 SV=2 | 1592 | G | 0.917751 | A | 0.926161 | -0.00841 | No Change: Both D | - |
| P37198 | NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens GN=NUP62 PE=1 SV=3 | 233 | A | 0.931674 | S | 0.94852 | -0.016846 | No Change: Both D | - |
| P37198 | NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens GN=NUP62 PE=1 SV=3 | 139 | G | 0.926091 | S | 0.943593 | -0.017502 | No Change: Both D | - |
| P37198 | NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens GN=NUP62 PE=1 SV=3 | 283 | S | 0.974219 | T | 0.971394 | 0.002825 | No Change: Both D | - |
| P37198 | NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens GN=NUP62 PE=1 SV=3 | 391 | Q | 0.664849 | P | 0.651147 | 0.013702 | No Change: Both D | Infantile striatonigral degeneration (SNDI) [MIM:271930] |
| Q9H1M0 | N62CL_HUMAN Nucleoporin-62 C-terminal-like protein OS=Homo sapiens GN=NUP62CL PE=2 SV=3 | 177 | I | 0.668548 | T | 0.791646 | -0.123098 | No Change: Both D | - |
| Q9H1M0 | N62CL_HUMAN Nucleoporin-62 C-terminal-like protein OS=Homo sapiens GN=NUP62CL PE=2 SV=3 | 54 | F | 0.324902 | L | 0.372504 | -0.047602 | No Change: Both O | - |
| Q99567 | NUP88_HUMAN Nuclear pore complex protein Nup88 OS=Homo sapiens GN=NUP88 PE=1 SV=2 | 289 | N | 0.441361 | S | 0.508133 | -0.066772 | O to D | - |
| Q8N1F7 | NUP93_HUMAN Nuclear pore complex protein Nup93 OS=Homo sapiens GN=NUP93 PE=1 SV=2 | 509 | S | 0.684172 | R | 0.61106 | 0.073112 | No Change: Both D | - |
| P52948 | NUP98_HUMAN Nuclear pore complex protein Nup98-Nup96 OS=Homo sapiens GN=NUP98 PE=1 SV=4 | 1669 | G | 0.209239 | V | 0.119074 | 0.090165 | No Change: Both O | A breast cancer sample |
| Q9BVL2 | NUPL1_HUMAN Nucleoporin p58/p45 OS=Homo sapiens GN=NUPL1 PE=1 SV=1 | 34 | A | 0.937768 | T | 0.951128 | -0.01336 | No Change: Both D | - |
| Q9BVL2 | NUPL1_HUMAN Nucleoporin p58/p45 OS=Homo sapiens GN=NUPL1 PE=1 SV=1 | 166 | S | 0.93537 | P | 0.921983 | 0.013387 | No Change: Both D | - |
| O15504 | NUPL2_HUMAN Nucleoporin-like protein 2 OS=Homo sapiens GN=NUPL2 PE=1 SV=1 | 391 | D | 0.593217 | N | 0.583744 | 0.009473 | No Change: Both D | - |
| O15504 | NUPL2_HUMAN Nucleoporin-like protein 2 OS=Homo sapiens GN=NUPL2 PE=1 SV=1 | 392 | K | 0.582722 | N | 0.539312 | 0.04341 | No Change: Both D | - |
| Q96E22 | NGBR_HUMAN Nogo-B receptor OS=Homo sapiens GN=NUS1 PE=2 SV=1 | 175 | N | 0.621738 | Y | 0.5086 | 0.113138 | No Change: Both D | - |
| Q96E22 | NGBR_HUMAN Nogo-B receptor OS=Homo sapiens GN=NUS1 PE=2 SV=1 | 179 | D | 0.529478 | E | 0.530169 | -6.91E-04 | No Change: Both D | - |
| Q96E22 | NGBR_HUMAN Nogo-B receptor OS=Homo sapiens GN=NUS1 PE=2 SV=1 | 216 | K | 0.580116 | R | 0.546036 | 0.03408 | No Change: Both D | - |
| Q96E22 | NGBR_HUMAN Nogo-B receptor OS=Homo sapiens GN=NUS1 PE=2 SV=1 | 219 | T | 0.610515 | K | 0.675724 | -0.065209 | No Change: Both D | - |
| Q9BXS6 | NUSAP_HUMAN Nucleolar and spindle-associated protein 1 OS=Homo sapiens GN=NUSAP1 PE=1 SV=1 | 33 | T | 0.561298 | A | 0.592891 | -0.031593 | No Change: Both D | - |
| Q9BXS6 | NUSAP_HUMAN Nucleolar and spindle-associated protein 1 OS=Homo sapiens GN=NUSAP1 PE=1 SV=1 | 33 | T | 0.561298 | N | 0.628896 | -0.067598 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 22 | P | 0.998785 | L | 0.997346 | 0.001439 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 781 | T | 0.574138 | M | 0.521084 | 0.053054 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 785 | V | 0.541659 | E | 0.689573 | -0.147914 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 973 | T | 0.91662 | N | 0.909249 | 0.007371 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 985 | P | 0.938528 | R | 0.940041 | -0.001513 | No Change: Both D | - |
| Q86Y26 | NUT_HUMAN Protein NUT OS=Homo sapiens GN=NUT PE=1 SV=2 | 1113 | R | 0.948159 | H | 0.925768 | 0.022391 | No Change: Both D | - |
| O15381 | NVL_HUMAN Nuclear valosin-containing protein-like OS=Homo sapiens GN=NVL PE=1 SV=1 | 359 | C | 0.143164 | G | 0.215235 | -0.072071 | No Change: Both O | - |
| O15381 | NVL_HUMAN Nuclear valosin-containing protein-like OS=Homo sapiens GN=NVL PE=1 SV=1 | 295 | V | 0.30128 | I | 0.254201 | 0.047079 | No Change: Both O | - |
| O15381 | NVL_HUMAN Nuclear valosin-containing protein-like OS=Homo sapiens GN=NVL PE=1 SV=1 | 404 | V | 0.171968 | I | 0.154197 | 0.017771 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 174 | S | 0.469589 | G | 0.389172 | 0.080417 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 211 | L | 0.237457 | F | 0.190109 | 0.047348 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 218 | A | 0.350324 | T | 0.359948 | -0.009624 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 900 | Q | 0.263114 | E | 0.327298 | -0.064184 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 926 | N | 0.491262 | I | 0.318122 | 0.17314 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 935 | H | 0.137757 | R | 0.136376 | 0.001381 | No Change: Both O | - |
| Q149M9 | NWD1_HUMAN NACHT and WD repeat domain-containing protein 1 OS=Homo sapiens GN=NWD1 PE=2 SV=3 | 1541 | D | 0.797601 | V | 0.722714 | 0.074887 | No Change: Both D | - |
| Q9H4D5 | NXF3_HUMAN Nuclear RNA export factor 3 OS=Homo sapiens GN=NXF3 PE=1 SV=1 | 186 | N | 0.171964 | I | 0.090162 | 0.081802 | No Change: Both O | - |
| Q5VZ03 | NXNL2_HUMAN Nucleoredoxin-like protein 2 OS=Homo sapiens GN=NXNL2 PE=2 SV=1 | 76 | S | 0.540091 | C | 0.30888 | 0.231211 | D to O | - |
| Q9P2P1 | NYNRI_HUMAN Protein NYNRIN OS=Homo sapiens GN=NYNRIN PE=1 SV=3 | 457 | T | 0.817118 | M | 0.814991 | 0.002127 | No Change: Both D | - |
| Q9P2P1 | NYNRI_HUMAN Protein NYNRIN OS=Homo sapiens GN=NYNRIN PE=1 SV=3 | 659 | A | 0.995035 | V | 0.993161 | 0.001874 | No Change: Both D | - |
| Q9P2P1 | NYNRI_HUMAN Protein NYNRIN OS=Homo sapiens GN=NYNRIN PE=1 SV=3 | 978 | A | 0.863086 | T | 0.884612 | -0.021526 | No Change: Both D | - |
| Q9P2P1 | NYNRI_HUMAN Protein NYNRIN OS=Homo sapiens GN=NYNRIN PE=1 SV=3 | 997 | E | 0.990686 | K | 0.988617 | 0.002069 | No Change: Both D | - |
| Q9P2P1 | NYNRI_HUMAN Protein NYNRIN OS=Homo sapiens GN=NYNRIN PE=1 SV=3 | 1551 | I | 0.229457 | V | 0.257613 | -0.028156 | No Change: Both O | - |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 31 | C | 0.269455 | S | 0.398209 | -0.128754 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 143 | A | 0.335808 | P | 0.420888 | -0.08508 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 151 | P | 0.383392 | L | 0.269316 | 0.114076 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 175 | P | 0.305025 | R | 0.31117 | -0.006145 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 184 | L | 0.448094 | P | 0.568802 | -0.120708 | O to D | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 187 | A | 0.477848 | K | 0.503978 | -0.02613 | O to D | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 213 | L | 0.470213 | Q | 0.598904 | -0.128691 | O to D | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 216 | N | 0.438131 | S | 0.515917 | -0.077786 | O to D | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 232 | L | 0.190903 | P | 0.278448 | -0.087545 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 264 | N | 0.313097 | K | 0.33488 | -0.021783 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 285 | L | 0.11596 | P | 0.193953 | -0.077993 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 298 | F | 0.250888 | S | 0.494213 | -0.243325 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 307 | L | 0.200512 | P | 0.32382 | -0.123308 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 312 | N | 0.159345 | S | 0.176941 | -0.017596 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 347 | L | 0.109044 | P | 0.198056 | -0.089012 | No Change: Both O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 370 | G | 0.550669 | V | 0.445007 | 0.105662 | D to O | Congenital stationary night blindness type 1A (CSNB1A) [MIM:310500] |
| Q9GZU5 | NYX_HUMAN Nyctalopin OS=Homo sapiens GN=NYX PE=1 SV=1 | 406 | A | 0.9169 | G | 0.924622 | -0.007722 | No Change: Both D | - |
| Q86UD1 | OAF_HUMAN Out at first protein homolog OS=Homo sapiens GN=OAF PE=2 SV=1 | 210 | H | 0.387719 | R | 0.452067 | -0.064348 | No Change: Both O | - |
| Q86UD1 | OAF_HUMAN Out at first protein homolog OS=Homo sapiens GN=OAF PE=2 SV=1 | 217 | R | 0.188653 | H | 0.161112 | 0.027541 | No Change: Both O | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 162 | G | 0.388135 | S | 0.412373 | -0.024238 | No Change: Both O | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 354 | D | 0.761096 | G | 0.748686 | 0.01241 | No Change: Both D | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 361 | R | 0.518562 | T | 0.505206 | 0.013356 | No Change: Both D | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 31 | N | 0.073879 | D | 0.087813 | -0.013934 | No Change: Both O | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 127 | G | 0.317806 | R | 0.351877 | -0.034071 | No Change: Both O | - |
| P00973 | OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens GN=OAS1 PE=1 SV=4 | 352 | A | 0.656997 | T | 0.668918 | -0.011921 | No Change: Both D | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 65 | R | 0.629425 | W | 0.474909 | 0.154516 | D to O | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 381 | S | 0.907356 | R | 0.885504 | 0.021852 | No Change: Both D | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 869 | R | 0.381181 | H | 0.356949 | 0.024232 | No Change: Both O | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 18 | R | 0.550568 | K | 0.548316 | 0.002252 | No Change: Both D | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 18 | R | 0.550568 | M | 0.451229 | 0.099339 | D to O | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 18 | R | 0.550568 | T | 0.453457 | 0.097111 | D to O | - |
| Q9Y6K5 | OAS3_HUMAN 2'-5'-oligoadenylate synthase 3 OS=Homo sapiens GN=OAS3 PE=1 SV=3 | 378 | R | 0.892366 | K | 0.920367 | -0.028001 | No Change: Both D | - |
| Q15646 | OASL_HUMAN 59 kDa 2'-5'-oligoadenylate synthase-like protein OS=Homo sapiens GN=OASL PE=1 SV=2 | 341 | N | 0.403698 | I | 0.224956 | 0.178742 | No Change: Both O | - |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 54 | N | 0.316722 | K | 0.370085 | -0.053363 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 55 | Y | 0.292769 | H | 0.420149 | -0.12738 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 89 | N | 0.448628 | K | 0.505327 | -0.056699 | O to D | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 93 | C | 0.280565 | F | 0.296563 | -0.015998 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 154 | R | 0.158624 | L | 0.099127 | 0.059497 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 180 | R | 0.215406 | T | 0.218754 | -0.003348 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 226 | A | 0.178479 | V | 0.135933 | 0.042546 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 241 | P | 0.25095 | L | 0.136695 | 0.114255 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 245 | Y | 0.193878 | C | 0.172691 | 0.021187 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 250 | R | 0.180755 | P | 0.206595 | -0.02584 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 267 | T | 0.199489 | I | 0.113499 | 0.08599 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 270 | A | 0.172668 | P | 0.222366 | -0.049698 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 271 | R | 0.163292 | K | 0.19976 | -0.036468 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 319 | H | 0.580637 | Y | 0.485714 | 0.094923 | D to O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 332 | V | 0.100657 | M | 0.133804 | -0.033147 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 353 | G | 0.207637 | D | 0.242509 | -0.034872 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 375 | G | 0.157077 | A | 0.129586 | 0.027491 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 394 | C | 0.063127 | R | 0.139713 | -0.076586 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 402 | L | 0.336644 | P | 0.480248 | -0.143604 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 417 | P | 0.132798 | L | 0.064518 | 0.06828 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 437 | L | 0.545155 | F | 0.528197 | 0.016958 | No Change: Both D | - |
| P04181 | OAT_HUMAN Ornithine aminotransferase mitochondrial OS=Homo sapiens GN=OAT PE=1 SV=1 | 90 | Q | 0.42108 | E | 0.473699 | -0.052619 | No Change: Both O | Hyperornithinemia with gyrate atrophy of choroid and retina (HOGA) [MIM:258870] |
| P54368 | OAZ1_HUMAN Ornithine decarboxylase antizyme 1 OS=Homo sapiens GN=OAZ1 PE=1 SV=3 | 32 | R | 0.833756 | L | 0.772829 | 0.060927 | No Change: Both D | - |
| P54368 | OAZ1_HUMAN Ornithine decarboxylase antizyme 1 OS=Homo sapiens GN=OAZ1 PE=1 SV=3 | 44 | G | 0.955454 | D | 0.956389 | -9.35E-04 | No Change: Both D | - |
| P54368 | OAZ1_HUMAN Ornithine decarboxylase antizyme 1 OS=Homo sapiens GN=OAZ1 PE=1 SV=3 | 50 | S | 0.966268 | F | 0.914309 | 0.051959 | No Change: Both D | - |
| P54368 | OAZ1_HUMAN Ornithine decarboxylase antizyme 1 OS=Homo sapiens GN=OAZ1 PE=1 SV=3 | 53 | S | 0.961218 | F | 0.896888 | 0.06433 | No Change: Both D | - |
| P54368 | OAZ1_HUMAN Ornithine decarboxylase antizyme 1 OS=Homo sapiens GN=OAZ1 PE=1 SV=3 | 147 | A | 0.496568 | V | 0.412814 | 0.083754 | No Change: Both O | - |
| O95190 | OAZ2_HUMAN Ornithine decarboxylase antizyme 2 OS=Homo sapiens GN=OAZ2 PE=2 SV=1 | 70 | P | 0.413913 | L | 0.270607 | 0.143306 | No Change: Both O | - |
| Q9H668 | STN1_HUMAN CST complex subunit STN1 OS=Homo sapiens GN=OBFC1 PE=1 SV=2 | 151 | T | 0.238321 | A | 0.213864 | 0.024457 | No Change: Both O | - |
| Q9H668 | STN1_HUMAN CST complex subunit STN1 OS=Homo sapiens GN=OBFC1 PE=1 SV=2 | 248 | S | 0.56895 | C | 0.33685 | 0.2321 | D to O | - |
| Q96AH0 | SOSB2_HUMAN SOSS complex subunit B2 OS=Homo sapiens GN=OBFC2A PE=1 SV=1 | 154 | T | 0.878941 | S | 0.905163 | -0.026222 | No Change: Both D | - |
| Q9NY56 | OBP2A_HUMAN Odorant-binding protein 2a OS=Homo sapiens GN=OBP2A PE=1 SV=1 | 61 | N | 0.404058 | K | 0.504766 | -0.100708 | O to D | - |
| Q9NY56 | OBP2A_HUMAN Odorant-binding protein 2a OS=Homo sapiens GN=OBP2A PE=1 SV=1 | 159 | M | 0.277798 | T | 0.334766 | -0.056968 | No Change: Both O | - |
| Q9NY56 | OBP2A_HUMAN Odorant-binding protein 2a OS=Homo sapiens GN=OBP2A PE=1 SV=1 | 130 | G | 0.399813 | A | 0.32993 | 0.069883 | No Change: Both O | - |
| Q9NY56 | OBP2A_HUMAN Odorant-binding protein 2a OS=Homo sapiens GN=OBP2A PE=1 SV=1 | 133 | P | 0.452828 | S | 0.478627 | -0.025799 | No Change: Both O | - |
| Q9NPH6 | OBP2B_HUMAN Odorant-binding protein 2b OS=Homo sapiens GN=OBP2B PE=2 SV=1 | 167 | V | 0.685692 | I | 0.680896 | 0.004796 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 51 | A | 0.331089 | T | 0.337814 | -0.006725 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4534 | R | 0.510747 | H | 0.513115 | -0.002368 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 502 | Q | 0.497632 | R | 0.457078 | 0.040554 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1508 | V | 0.433425 | D | 0.526664 | -0.093239 | O to D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3300 | A | 0.475842 | T | 0.5036 | -0.027758 | O to D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4381 | H | 0.448076 | R | 0.435777 | 0.012299 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4450 | C | 0.101222 | R | 0.197369 | -0.096147 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1136 | A | 0.452544 | V | 0.373053 | 0.079491 | No Change: Both O | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1792 | R | 0.200464 | H | 0.197511 | 0.002953 | No Change: Both O | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1930 | V | 0.108604 | M | 0.129289 | -0.020685 | No Change: Both O | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2090 | E | 0.618418 | K | 0.580808 | 0.03761 | No Change: Both D | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2314 | S | 0.334104 | F | 0.158906 | 0.175198 | No Change: Both O | A breast cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3983 | R | 0.39822 | Q | 0.418899 | -0.020679 | No Change: Both O | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4558 | R | 0.273572 | H | 0.268032 | 0.00554 | No Change: Both O | A colorectal cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4810 | R | 0.911258 | Q | 0.896824 | 0.014434 | No Change: Both D | A breast cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 5071 | A | 0.303861 | T | 0.331452 | -0.027591 | No Change: Both O | A breast cancer sample |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 804 | G | 0.288313 | S | 0.349203 | -0.06089 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1027 | K | 0.522044 | R | 0.466932 | 0.055112 | D to O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1086 | A | 0.628073 | S | 0.697559 | -0.069486 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1090 | A | 0.541361 | T | 0.545088 | -0.003727 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1091 | S | 0.507483 | T | 0.412344 | 0.095139 | D to O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1101 | A | 0.515609 | P | 0.551399 | -0.03579 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1121 | G | 0.65181 | R | 0.660661 | -0.008851 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1133 | L | 0.35488 | V | 0.360889 | -0.006009 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1156 | H | 0.264687 | Q | 0.29892 | -0.034233 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1248 | Q | 0.253104 | H | 0.229117 | 0.023987 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1532 | A | 0.671766 | V | 0.600236 | 0.07153 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1566 | T | 0.599181 | M | 0.569639 | 0.029542 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 1601 | A | 0.514436 | T | 0.505622 | 0.008814 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3389 | A | 0.517001 | V | 0.423187 | 0.093814 | D to O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3426 | D | 0.262835 | E | 0.307858 | -0.045023 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3834 | R | 0.531152 | G | 0.534484 | -0.003332 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4823 | A | 0.91562 | S | 0.940112 | -0.024492 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 5598 | R | 0.639852 | Q | 0.651525 | -0.011673 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 6473 | E | 0.398739 | Q | 0.344617 | 0.054122 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 908 | A | 0.567967 | T | 0.580098 | -0.012131 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2106 | D | 0.489821 | E | 0.500406 | -0.010585 | O to D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2116 | F | 0.419377 | L | 0.498739 | -0.079362 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2529 | R | 0.251055 | Q | 0.257977 | -0.006922 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2720 | V | 0.333261 | M | 0.388133 | -0.054872 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 2812 | R | 0.275575 | W | 0.120751 | 0.154824 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3372 | E | 0.542119 | D | 0.479701 | 0.062418 | D to O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 3373 | S | 0.556103 | C | 0.428317 | 0.127786 | D to O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4039 | G | 0.370068 | R | 0.37322 | -0.003152 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4642 | S | 0.637721 | C | 0.504629 | 0.133092 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4662 | R | 0.383588 | C | 0.244907 | 0.138681 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4666 | G | 0.439136 | S | 0.479443 | -0.040307 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4962 | D | 0.196719 | G | 0.181033 | 0.015686 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 5269 | L | 0.489537 | V | 0.482862 | 0.006675 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 5575 | R | 0.985446 | H | 0.982079 | 0.003367 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 5891 | Q | 0.29097 | E | 0.342324 | -0.051354 | No Change: Both O | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 7172 | A | 0.69109 | V | 0.609638 | 0.081452 | No Change: Both D | - |
| Q5VST9 | OBSCN_HUMAN Obscurin OS=Homo sapiens GN=OBSCN PE=1 SV=3 | 4516 | R | 0.378579 | W | 0.175463 | 0.203116 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 27 | G | 0.706371 | R | 0.73358 | -0.027209 | No Change: Both D | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 86 | S | 0.928399 | R | 0.912264 | 0.016135 | No Change: Both D | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 112 | C | 0.475933 | F | 0.451076 | 0.024857 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 257 | A | 0.319098 | D | 0.3937 | -0.074602 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 305 | R | 0.410352 | W | 0.198266 | 0.212086 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 368 | A | 0.134294 | V | 0.089677 | 0.044617 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 385 | F | 0.053483 | I | 0.055387 | -0.001904 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 395 | M | 0.021724 | L | 0.016679 | 0.005045 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 404 | T | 0.067573 | M | 0.055184 | 0.012389 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 419 | R | 0.134208 | Q | 0.133498 | 7.10E-04 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 419 | R | 0.134208 | W | 0.051583 | 0.082625 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 440 | L | 0.105065 | H | 0.166567 | -0.061502 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 443 | V | 0.110479 | I | 0.09275 | 0.017729 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 446 | M | 0.084373 | V | 0.069376 | 0.014997 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 473 | I | 0.056894 | S | 0.134755 | -0.077861 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 489 | N | 0.245759 | D | 0.263785 | -0.018026 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 549 | H | 0.233128 | Q | 0.236983 | -0.003855 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 592 | T | 0.316139 | I | 0.216136 | 0.100003 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 614 | K | 0.534006 | N | 0.481315 | 0.052691 | D to O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 615 | H | 0.471591 | R | 0.486626 | -0.015035 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 652 | W | 0.033328 | R | 0.08579 | -0.052462 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 679 | W | 0.033103 | R | 0.093283 | -0.06018 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 722 | I | 0.078825 | T | 0.13219 | -0.053365 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 724 | A | 0.02969 | P | 0.042174 | -0.012484 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 736 | S | 0.135338 | L | 0.059454 | 0.075884 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 743 | P | 0.152804 | L | 0.079252 | 0.073552 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 787 | A | 0.187211 | V | 0.138481 | 0.04873 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 440 | L | 0.105065 | F | 0.090337 | 0.014728 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 481 | A | 0.282739 | T | 0.309465 | -0.026726 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 10 | R | 0.63033 | W | 0.353302 | 0.277028 | D to O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 198 | P | 0.147429 | L | 0.081514 | 0.065915 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 211 | P | 0.248298 | L | 0.151469 | 0.096829 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 290 | R | 0.507164 | G | 0.46328 | 0.043884 | D to O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 334 | A | 0.10844 | V | 0.076593 | 0.031847 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 350 | V | 0.041375 | M | 0.058051 | -0.016676 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 370 | I | 0.209509 | T | 0.351278 | -0.141769 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 387 | T | 0.040259 | M | 0.03388 | 0.006379 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 394 | M | 0.022215 | I | 0.014346 | 0.007869 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 614 | K | 0.534006 | E | 0.535864 | -0.001858 | No Change: Both D | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 617 | I | 0.352534 | L | 0.39162 | -0.039086 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 678 | E | 0.033544 | K | 0.031993 | 0.001551 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 679 | W | 0.033103 | C | 0.039501 | -0.006398 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 688 | L | 0.023367 | F | 0.020294 | 0.003073 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 720 | R | 0.16019 | C | 0.077869 | 0.082321 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 795 | G | 0.173242 | R | 0.151293 | 0.021949 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 799 | Q | 0.235756 | H | 0.235364 | 3.92E-04 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 241 | P | 0.604259 | R | 0.591749 | 0.01251 | No Change: Both D | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 266 | R | 0.409893 | W | 0.219771 | 0.190122 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 336 | A | 0.065605 | V | 0.045132 | 0.020473 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 519 | V | 0.005478 | A | 0.007657 | -0.002179 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 560 | R | 0.382868 | H | 0.36938 | 0.013488 | No Change: Both O | - |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 773 | A | 0.079478 | T | 0.081573 | -0.002095 | No Change: Both O | A breast cancer sample |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 476 | N | 0.110015 | D | 0.117824 | -0.007809 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 775 | G | 0.090662 | R | 0.076107 | 0.014555 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q04671 | P_HUMAN P protein OS=Homo sapiens GN=OCA2 PE=1 SV=2 | 827 | Y | 0.027082 | H | 0.051832 | -0.02475 | No Change: Both O | Albinism oculocutaneous type 2 (OCA2) [MIM:203200] |
| Q9H607 | OCEL1_HUMAN Occludin/ELL domain-containing protein 1 OS=Homo sapiens GN=OCEL1 PE=2 SV=1 | 42 | R | 0.994833 | L | 0.990862 | 0.003971 | No Change: Both D | - |
| Q9H607 | OCEL1_HUMAN Occludin/ELL domain-containing protein 1 OS=Homo sapiens GN=OCEL1 PE=2 SV=1 | 109 | A | 0.888034 | G | 0.898886 | -0.010852 | No Change: Both D | - |
| Q56VL3 | OCAD2_HUMAN OCIA domain-containing protein 2 OS=Homo sapiens GN=OCIAD2 PE=1 SV=1 | 44 | R | 0.422019 | Q | 0.448525 | -0.026506 | No Change: Both O | - |
| Q16625 | OCLN_HUMAN Occludin OS=Homo sapiens GN=OCLN PE=1 SV=1 | 219 | F | 0.095559 | S | 0.239777 | -0.144218 | No Change: Both O | Band-like calcification with simplified gyration and polymicrogyria (BLCPMG) [MIM:251290] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 337 | R | 0.158324 | P | 0.170723 | -0.012399 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 357 | G | 0.313778 | E | 0.336963 | -0.023185 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 372 | V | 0.124449 | G | 0.204986 | -0.080537 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 375 | H | 0.132706 | Y | 0.073772 | 0.058934 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 421 | G | 0.04434 | E | 0.063116 | -0.018776 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 424 | N | 0.053135 | D | 0.060791 | -0.007656 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 451 | D | 0.284931 | G | 0.243775 | 0.041156 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 463 | F | 0.335391 | S | 0.494979 | -0.159588 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 498 | C | 0.062404 | Y | 0.058287 | 0.004117 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 500 | R | 0.053493 | G | 0.049274 | 0.004219 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 500 | R | 0.053493 | Q | 0.050163 | 0.00333 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 508 | V | 0.231718 | D | 0.377417 | -0.145699 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 513 | Y | 0.395523 | C | 0.342601 | 0.052922 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 522 | S | 0.698656 | R | 0.63684 | 0.061816 | No Change: Both D | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 524 | H | 0.645129 | Q | 0.644128 | 0.001001 | No Change: Both D | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 524 | H | 0.645129 | R | 0.623625 | 0.021504 | No Change: Both D | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 533 | I | 0.140301 | S | 0.325596 | -0.185295 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 768 | I | 0.207296 | N | 0.357305 | -0.150009 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 797 | A | 0.091776 | P | 0.140717 | -0.048941 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 318 | R | 0.08379 | C | 0.039964 | 0.043826 | No Change: Both O | Dent disease type 2 (DD2) [MIM:300555] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 318 | R | 0.08379 | C | 0.039964 | 0.043826 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 479 | Y | 0.393221 | C | 0.340339 | 0.052882 | No Change: Both O | Dent disease type 2 (DD2) [MIM:300555] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 526 | P | 0.488803 | L | 0.339468 | 0.149335 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 242 | F | 0.048636 | S | 0.109107 | -0.060471 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 274 | I | 0.094465 | T | 0.162157 | -0.067692 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 277 | Q | 0.128794 | R | 0.116456 | 0.012338 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 337 | R | 0.158324 | C | 0.077352 | 0.080972 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 354 | N | 0.545617 | H | 0.525436 | 0.020181 | No Change: Both D | Dent disease type 2 (DD2) [MIM:300555] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 361 | R | 0.118444 | I | 0.060456 | 0.057988 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 373 | N | 0.137032 | Y | 0.070903 | 0.066129 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 374 | S | 0.138198 | F | 0.057745 | 0.080453 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 414 | H | 0.079471 | R | 0.082456 | -0.002985 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 451 | D | 0.284931 | N | 0.277533 | 0.007398 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 457 | R | 0.356039 | G | 0.350344 | 0.005695 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 468 | E | 0.264028 | G | 0.218706 | 0.045322 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 468 | E | 0.264028 | K | 0.28188 | -0.017852 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 493 | R | 0.188777 | W | 0.08251 | 0.106267 | No Change: Both O | Dent disease type 2 (DD2) [MIM:300555] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 495 | P | 0.114497 | L | 0.058404 | 0.056093 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 499 | D | 0.055934 | H | 0.042477 | 0.013457 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 503 | W | 0.062037 | R | 0.159547 | -0.09751 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 591 | N | 0.456311 | K | 0.500967 | -0.044656 | O to D | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 799 | P | 0.093446 | L | 0.046765 | 0.046681 | No Change: Both O | Dent disease type 2 (DD2) [MIM:300555] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 801 | P | 0.106041 | L | 0.054088 | 0.051953 | No Change: Both O | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| Q01968 | OCRL_HUMAN Inositol polyphosphate 5-phosphatase OCRL-1 OS=Homo sapiens GN=OCRL PE=1 SV=3 | 891 | L | 0.408155 | R | 0.565809 | -0.157654 | O to D | Lowe oculocerebrorenal syndrome (OCRL) [MIM:309000] |
| A1E959 | ODAM_HUMAN Odontogenic ameloblast-associated protein OS=Homo sapiens GN=ODAM PE=1 SV=1 | 222 | I | 0.40635 | T | 0.515534 | -0.109184 | O to D | - |
| A1E959 | ODAM_HUMAN Odontogenic ameloblast-associated protein OS=Homo sapiens GN=ODAM PE=1 SV=1 | 269 | E | 0.94329 | D | 0.939994 | 0.003296 | No Change: Both D | A colorectal cancer sample |
| Q14990 | ODFP1_HUMAN Outer dense fiber protein 1 OS=Homo sapiens GN=ODF1 PE=2 SV=2 | 216 | S | 0.993161 | N | 0.990655 | 0.002506 | No Change: Both D | - |
| Q14990 | ODFP1_HUMAN Outer dense fiber protein 1 OS=Homo sapiens GN=ODF1 PE=2 SV=2 | 243 | F | 0.957828 | L | 0.968536 | -0.010708 | No Change: Both D | - |
| Q5BJF6 | ODFP2_HUMAN Outer dense fiber protein 2 OS=Homo sapiens GN=ODF2 PE=1 SV=1 | 710 | T | 0.78322 | S | 0.824698 | -0.041478 | No Change: Both D | - |
| Q9ULJ1 | ODF2L_HUMAN Outer dense fiber protein 2-like OS=Homo sapiens GN=ODF2L PE=2 SV=2 | 177 | R | 0.554361 | H | 0.539965 | 0.014396 | No Change: Both D | - |
| Q9ULJ1 | ODF2L_HUMAN Outer dense fiber protein 2-like OS=Homo sapiens GN=ODF2L PE=2 SV=2 | 350 | K | 0.433077 | R | 0.388416 | 0.044661 | No Change: Both O | - |
| Q8IXM7 | OD3L1_HUMAN Outer dense fiber protein 3-like protein 1 OS=Homo sapiens GN=ODF3L1 PE=2 SV=1 | 41 | P | 0.534247 | L | 0.363491 | 0.170756 | D to O | - |
| Q3SX64 | OD3L2_HUMAN Outer dense fiber protein 3-like protein 2 OS=Homo sapiens GN=ODF3L2 PE=1 SV=2 | 135 | V | 0.88266 | A | 0.912042 | -0.029382 | No Change: Both D | - |
| Q2M2E3 | ODFP4_HUMAN Outer dense fiber protein 4 OS=Homo sapiens GN=ODF4 PE=1 SV=2 | 34 | W | 0.952837 | R | 0.982596 | -0.029759 | No Change: Both D | - |
| Q2M2E3 | ODFP4_HUMAN Outer dense fiber protein 4 OS=Homo sapiens GN=ODF4 PE=1 SV=2 | 98 | V | 0.022501 | M | 0.02814 | -0.005639 | No Change: Both O | - |
| Q2M2E3 | ODFP4_HUMAN Outer dense fiber protein 4 OS=Homo sapiens GN=ODF4 PE=1 SV=2 | 139 | Y | 0.310391 | C | 0.275603 | 0.034788 | No Change: Both O | - |
| Q5SWX8 | ODR4_HUMAN Protein odr-4 homolog OS=Homo sapiens GN=ODR4 PE=2 SV=1 | 251 | S | 0.519079 | C | 0.327086 | 0.191993 | D to O | - |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 342 | L | 0.020901 | F | 0.017673 | 0.003228 | No Change: Both O | A breast cancer sample |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 1216 | V | 0.130793 | I | 0.11725 | 0.013543 | No Change: Both O | A breast cancer sample |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 1482 | F | 0.393117 | V | 0.438272 | -0.045155 | No Change: Both O | A colorectal cancer sample |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 2235 | Q | 0.404374 | H | 0.399291 | 0.005083 | No Change: Both O | A breast cancer sample |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 2396 | L | 0.237055 | F | 0.202558 | 0.034497 | No Change: Both O | A colorectal cancer sample |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 40 | Y | 0.952925 | H | 0.966413 | -0.013488 | No Change: Both D | - |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 371 | M | 0.671886 | T | 0.711514 | -0.039628 | No Change: Both D | - |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 632 | M | 0.416514 | V | 0.349511 | 0.067003 | No Change: Both O | - |
| Q9UKZ4 | TEN1_HUMAN Teneurin-1 OS=Homo sapiens GN=ODZ1 PE=1 SV=2 | 641 | K | 0.498411 | E | 0.55374 | -0.055329 | O to D | - |
| Q9NT68 | TEN2_HUMAN Teneurin-2 OS=Homo sapiens GN=ODZ2 PE=1 SV=3 | 1719 | V | 0.434766 | F | 0.383808 | 0.050958 | No Change: Both O | - |
| Q9NT68 | TEN2_HUMAN Teneurin-2 OS=Homo sapiens GN=ODZ2 PE=1 SV=3 | 728 | N | 0.462308 | S | 0.557147 | -0.094839 | O to D | - |
| Q9P273 | TEN3_HUMAN Teneurin-3 OS=Homo sapiens GN=ODZ3 PE=2 SV=3 | 385 | S | 0.539092 | C | 0.357324 | 0.181768 | D to O | - |
| Q6N022 | TEN4_HUMAN Teneurin-4 OS=Homo sapiens GN=ODZ4 PE=2 SV=2 | 396 | V | 0.603921 | I | 0.575823 | 0.028098 | No Change: Both D | - |
| Q6N022 | TEN4_HUMAN Teneurin-4 OS=Homo sapiens GN=ODZ4 PE=2 SV=2 | 506 | E | 0.657932 | Q | 0.639456 | 0.018476 | No Change: Both D | - |
| Q6N022 | TEN4_HUMAN Teneurin-4 OS=Homo sapiens GN=ODZ4 PE=2 SV=2 | 14 | R | 0.987197 | Q | 0.98133 | 0.005867 | No Change: Both D | - |
| Q8IZS5 | OFCC1_HUMAN Orofacial cleft 1 candidate gene 1 protein OS=Homo sapiens GN=OFCC1 PE=2 SV=1 | 21 | S | 0.949798 | L | 0.914181 | 0.035617 | No Change: Both D | - |
| Q8IZS5 | OFCC1_HUMAN Orofacial cleft 1 candidate gene 1 protein OS=Homo sapiens GN=OFCC1 PE=2 SV=1 | 123 | R | 0.728461 | Q | 0.720153 | 0.008308 | No Change: Both D | - |
| Q8IZS5 | OFCC1_HUMAN Orofacial cleft 1 candidate gene 1 protein OS=Homo sapiens GN=OFCC1 PE=2 SV=1 | 145 | T | 0.960629 | I | 0.937371 | 0.023258 | No Change: Both D | - |
| O75665 | OFD1_HUMAN Oral-facial-digital syndrome 1 protein OS=Homo sapiens GN=OFD1 PE=1 SV=1 | 435 | S | 0.854994 | R | 0.817317 | 0.037677 | No Change: Both D | Oral-facial-digital syndrome type 1 (OFD1) [MIM:311200] |
| O75665 | OFD1_HUMAN Oral-facial-digital syndrome 1 protein OS=Homo sapiens GN=OFD1 PE=1 SV=1 | 74 | S | 0.397046 | F | 0.182314 | 0.214732 | No Change: Both O | Oral-facial-digital syndrome type 1 (OFD1) [MIM:311200] |
| O75665 | OFD1_HUMAN Oral-facial-digital syndrome 1 protein OS=Homo sapiens GN=OFD1 PE=1 SV=1 | 79 | A | 0.280053 | T | 0.2901 | -0.010047 | No Change: Both O | Oral-facial-digital syndrome type 1 (OFD1) [MIM:311200] |
| O75665 | OFD1_HUMAN Oral-facial-digital syndrome 1 protein OS=Homo sapiens GN=OFD1 PE=1 SV=1 | 138 | G | 0.509923 | S | 0.596322 | -0.086399 | No Change: Both D | Oral-facial-digital syndrome type 1 (OFD1) [MIM:311200] |
| Q02218 | ODO1_HUMAN 2-oxoglutarate dehydrogenase mitochondrial OS=Homo sapiens GN=OGDH PE=1 SV=3 | 1018 | V | 0.361105 | I | 0.337596 | 0.023509 | No Change: Both O | - |
| Q9ULD0 | OGDHL_HUMAN 2-oxoglutarate dehydrogenase-like mitochondrial OS=Homo sapiens GN=OGDHL PE=1 SV=3 | 511 | P | 0.290184 | L | 0.162254 | 0.12793 | No Change: Both O | - |
| Q9ULD0 | OGDHL_HUMAN 2-oxoglutarate dehydrogenase-like mitochondrial OS=Homo sapiens GN=OGDHL PE=1 SV=3 | 573 | D | 0.178877 | N | 0.163487 | 0.01539 | No Change: Both O | - |
| Q9ULD0 | OGDHL_HUMAN 2-oxoglutarate dehydrogenase-like mitochondrial OS=Homo sapiens GN=OGDHL PE=1 SV=3 | 623 | S | 0.254626 | C | 0.102903 | 0.151723 | No Change: Both O | - |
| Q9ULD0 | OGDHL_HUMAN 2-oxoglutarate dehydrogenase-like mitochondrial OS=Homo sapiens GN=OGDHL PE=1 SV=3 | 637 | T | 0.248924 | M | 0.214096 | 0.034828 | No Change: Both O | - |
| Q9ULD0 | OGDHL_HUMAN 2-oxoglutarate dehydrogenase-like mitochondrial OS=Homo sapiens GN=OGDHL PE=1 SV=3 | 725 | N | 0.149332 | S | 0.186646 | -0.037314 | No Change: Both O | - |
| Q8N543 | OGFD1_HUMAN 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1 OS=Homo sapiens GN=OGFOD1 PE=1 SV=1 | 173 | P | 0.122874 | S | 0.137175 | -0.014301 | No Change: Both O | - |
| Q9NZT2 | OGFR_HUMAN Opioid growth factor receptor OS=Homo sapiens GN=OGFR PE=1 SV=3 | 577 | S | 0.999856 | T | 0.999819 | 3.70E-05 | No Change: Both D | - |
| Q9NZT2 | OGFR_HUMAN Opioid growth factor receptor OS=Homo sapiens GN=OGFR PE=1 SV=3 | 545 | R | 0.999844 | S | 0.999884 | -4.00E-05 | No Change: Both D | - |
| Q5TC84 | OGRL1_HUMAN Opioid growth factor receptor-like protein 1 OS=Homo sapiens GN=OGFRL1 PE=2 SV=1 | 47 | S | 0.999538 | P | 0.999617 | -7.90E-05 | No Change: Both D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 46 | R | 0.470299 | Q | 0.490649 | -0.02035 | No Change: Both O | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 154 | R | 0.227905 | H | 0.222241 | 0.005664 | No Change: Both O | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 326 | S | 0.654374 | C | 0.486385 | 0.167989 | D to O | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 229 | R | 0.460842 | Q | 0.50515 | -0.044308 | O to D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 320 | S | 0.452836 | T | 0.369652 | 0.083184 | No Change: Both O | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 288 | A | 0.788653 | V | 0.758417 | 0.030236 | No Change: Both D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 322 | D | 0.513993 | N | 0.523612 | -0.009619 | No Change: Both D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 12 | G | 0.744806 | E | 0.796492 | -0.051686 | No Change: Both D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 85 | A | 0.755654 | S | 0.809727 | -0.054073 | No Change: Both D | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 131 | R | 0.180505 | Q | 0.201932 | -0.021427 | No Change: Both O | - |
| O15527 | OGG1_HUMAN N-glycosylase/DNA lyase OS=Homo sapiens GN=OGG1 PE=1 SV=2 | 232 | S | 0.634084 | T | 0.547229 | 0.086855 | No Change: Both D | - |
| O15294 | OGT1_HUMAN UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Homo sapiens GN=OGT PE=1 SV=3 | 538 | L | 0.34088 | P | 0.500971 | -0.160091 | O to D | - |
| Q8WWZ8 | OIT3_HUMAN Oncoprotein-induced transcript 3 protein OS=Homo sapiens GN=OIT3 PE=1 SV=2 | 237 | S | 0.768838 | P | 0.747442 | 0.021396 | No Change: Both D | - |
| Q9NTK5 | OLA1_HUMAN Obg-like ATPase 1 OS=Homo sapiens GN=OLA1 PE=1 SV=2 | 168 | E | 0.456102 | Q | 0.404527 | 0.051575 | No Change: Both O | A breast cancer sample |
| O95897 | NOE2_HUMAN Noelin-2 OS=Homo sapiens GN=OLFM2 PE=2 SV=2 | 106 | R | 0.657268 | Q | 0.643744 | 0.013524 | No Change: Both D | - |
| O95897 | NOE2_HUMAN Noelin-2 OS=Homo sapiens GN=OLFM2 PE=2 SV=2 | 86 | T | 0.651103 | M | 0.685377 | -0.034274 | No Change: Both D | A colorectal cancer sample |
| O95897 | NOE2_HUMAN Noelin-2 OS=Homo sapiens GN=OLFM2 PE=2 SV=2 | 127 | T | 0.616104 | M | 0.616952 | -8.48E-04 | No Change: Both D | - |
| Q6UX06 | OLFM4_HUMAN Olfactomedin-4 OS=Homo sapiens GN=OLFM4 PE=1 SV=1 | 36 | S | 0.935269 | P | 0.936788 | -0.001519 | No Change: Both D | - |
| Q6UWY5 | OLFL1_HUMAN Olfactomedin-like protein 1 OS=Homo sapiens GN=OLFML1 PE=1 SV=2 | 113 | E | 0.644789 | V | 0.433558 | 0.211231 | D to O | - |
| Q6UWY5 | OLFL1_HUMAN Olfactomedin-like protein 1 OS=Homo sapiens GN=OLFML1 PE=1 SV=2 | 259 | A | 0.267688 | T | 0.300507 | -0.032819 | No Change: Both O | - |
| Q68BL7 | OLM2A_HUMAN Olfactomedin-like protein 2A OS=Homo sapiens GN=OLFML2A PE=2 SV=1 | 309 | T | 0.441775 | A | 0.423238 | 0.018537 | No Change: Both O | - |
| Q68BL7 | OLM2A_HUMAN Olfactomedin-like protein 2A OS=Homo sapiens GN=OLFML2A PE=2 SV=1 | 425 | R | 0.35813 | Q | 0.361964 | -0.003834 | No Change: Both O | - |
| Q68BL8 | OLM2B_HUMAN Olfactomedin-like protein 2B OS=Homo sapiens GN=OLFML2B PE=2 SV=2 | 10 | Y | 0.015485 | C | 0.014598 | 8.87E-04 | No Change: Both O | - |
| Q68BL8 | OLM2B_HUMAN Olfactomedin-like protein 2B OS=Homo sapiens GN=OLFML2B PE=2 SV=2 | 470 | W | 0.794502 | R | 0.914023 | -0.119521 | No Change: Both D | - |
| P78380 | OLR1_HUMAN Oxidized low-density lipoprotein receptor 1 OS=Homo sapiens GN=OLR1 PE=1 SV=1 | 167 | K | 0.587658 | N | 0.549488 | 0.03817 | No Change: Both D | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 67 | N | 0.156302 | K | 0.178158 | -0.021856 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 117 | P | 0.282889 | L | 0.167132 | 0.115757 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 211 | F | 0.034494 | C | 0.029486 | 0.005008 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 329 | I | 0.197767 | L | 0.243758 | -0.045991 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 226 | L | 0.281553 | V | 0.258728 | 0.022825 | No Change: Both O | A colorectal cancer sample |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 69 | H | 0.153827 | Y | 0.100136 | 0.053691 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 272 | E | 0.117633 | G | 0.09564 | 0.021993 | No Change: Both O | - |
| Q96E52 | OMA1_HUMAN Metalloendopeptidase OMA1 mitochondrial OS=Homo sapiens GN=OMA1 PE=2 SV=1 | 365 | D | 0.057879 | Y | 0.027369 | 0.03051 | No Change: Both O | - |
| Q99983 | OMD_HUMAN Osteomodulin OS=Homo sapiens GN=OMD PE=1 SV=1 | 200 | D | 0.193543 | G | 0.158896 | 0.034647 | No Change: Both O | - |
| Q99983 | OMD_HUMAN Osteomodulin OS=Homo sapiens GN=OMD PE=1 SV=1 | 212 | E | 0.381736 | G | 0.324609 | 0.057127 | No Change: Both O | - |
| Q99983 | OMD_HUMAN Osteomodulin OS=Homo sapiens GN=OMD PE=1 SV=1 | 221 | S | 0.601135 | N | 0.559584 | 0.041551 | No Change: Both D | - |
| Q99983 | OMD_HUMAN Osteomodulin OS=Homo sapiens GN=OMD PE=1 SV=1 | 282 | I | 0.162766 | T | 0.256991 | -0.094225 | No Change: Both O | - |
| Q99983 | OMD_HUMAN Osteomodulin OS=Homo sapiens GN=OMD PE=1 SV=1 | 353 | C | 0.043814 | W | 0.035141 | 0.008673 | No Change: Both O | - |
| P23515 | OMGP_HUMAN Oligodendrocyte-myelin glycoprotein OS=Homo sapiens GN=OMG PE=1 SV=2 | 21 | G | 0.028236 | D | 0.033613 | -0.005377 | No Change: Both O | - |
| P23515 | OMGP_HUMAN Oligodendrocyte-myelin glycoprotein OS=Homo sapiens GN=OMG PE=1 SV=2 | 435 | V | 0.083184 | A | 0.114463 | -0.031279 | No Change: Both O | - |
| P47874 | OMP_HUMAN Olfactory marker protein OS=Homo sapiens GN=OMP PE=2 SV=2 | 26 | R | 0.896473 | W | 0.740342 | 0.156131 | No Change: Both D | - |
| P47874 | OMP_HUMAN Olfactory marker protein OS=Homo sapiens GN=OMP PE=2 SV=2 | 36 | G | 0.886457 | R | 0.912206 | -0.025749 | No Change: Both D | - |
| Q9UBC0 | HNF6_HUMAN Hepatocyte nuclear factor 6 OS=Homo sapiens GN=ONECUT1 PE=2 SV=1 | 75 | P | 0.93416 | A | 0.907158 | 0.027002 | No Change: Both D | - |
| A6NGQ2 | OOEP_HUMAN Oocyte-expressed protein homolog OS=Homo sapiens GN=OOEP PE=2 SV=3 | 18 | A | 0.790127 | T | 0.809266 | -0.019139 | No Change: Both D | - |
| A6NGQ2 | OOEP_HUMAN Oocyte-expressed protein homolog OS=Homo sapiens GN=OOEP PE=2 SV=3 | 92 | V | 0.149254 | A | 0.188745 | -0.039491 | No Change: Both O | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 290 | R | 0.237813 | Q | 0.27279 | -0.034977 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 300 | G | 0.464849 | E | 0.502552 | -0.037703 | O to D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 445 | R | 0.407622 | H | 0.414923 | -0.007301 | No Change: Both O | Dominant optic atrophy plus syndrome (DOA+) [MIM:125250] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 445 | R | 0.407622 | H | 0.414923 | -0.007301 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 158 | S | 0.506065 | N | 0.445393 | 0.060672 | D to O | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 167 | P | 0.412009 | L | 0.275049 | 0.13696 | No Change: Both O | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 192 | A | 0.809963 | V | 0.763659 | 0.046304 | No Change: Both D | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 396 | L | 0.188557 | R | 0.283493 | -0.094936 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 503 | T | 0.320117 | K | 0.401926 | -0.081809 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 571 | R | 0.393219 | H | 0.343343 | 0.049876 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 545 | S | 0.263233 | R | 0.223084 | 0.040149 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 939 | L | 0.655689 | P | 0.734893 | -0.079204 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 8 | A | 0.19296 | S | 0.294545 | -0.101585 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 80 | Y | 0.372393 | C | 0.348925 | 0.023468 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 95 | T | 0.110622 | M | 0.09066 | 0.019962 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 102 | Y | 0.076017 | C | 0.062214 | 0.013803 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 270 | E | 0.274436 | K | 0.304439 | -0.030003 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 272 | L | 0.284652 | P | 0.410139 | -0.125487 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 273 | D | 0.282001 | A | 0.198519 | 0.083482 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 290 | R | 0.237813 | W | 0.103697 | 0.134116 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 310 | Q | 0.249577 | R | 0.26173 | -0.012153 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 357 | A | 0.524004 | T | 0.56687 | -0.042866 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 382 | I | 0.412521 | M | 0.532596 | -0.120075 | O to D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 384 | L | 0.421604 | F | 0.367828 | 0.053776 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 396 | L | 0.188557 | P | 0.331029 | -0.142472 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 430 | N | 0.144014 | D | 0.155482 | -0.011468 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 438 | D | 0.179829 | V | 0.096232 | 0.083597 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 449 | T | 0.299703 | R | 0.326104 | -0.026401 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 468 | K | 0.141938 | E | 0.145117 | -0.003179 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 470 | D | 0.225913 | G | 0.205718 | 0.020195 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 487 | E | 0.233475 | K | 0.248998 | -0.015523 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 505 | K | 0.464543 | N | 0.449567 | 0.014976 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 550 | D | 0.204159 | N | 0.213307 | -0.009148 | No Change: Both O | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 551 | C | 0.193877 | Y | 0.164059 | 0.029818 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 574 | L | 0.398395 | P | 0.550746 | -0.152351 | O to D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 582 | Y | 0.469176 | C | 0.491425 | -0.022249 | No Change: Both O | Dominant optic atrophy plus syndrome (DOA+) [MIM:125250] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 590 | R | 0.522795 | Q | 0.51472 | 0.008075 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 590 | R | 0.522795 | W | 0.28783 | 0.234965 | D to O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 593 | L | 0.509449 | P | 0.627934 | -0.118485 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 646 | S | 0.463166 | L | 0.269733 | 0.193433 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 728 | N | 0.406594 | K | 0.461812 | -0.055218 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 768 | G | 0.238179 | D | 0.292163 | -0.053984 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 781 | R | 0.318011 | W | 0.170795 | 0.147216 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 785 | Q | 0.468777 | R | 0.461162 | 0.007615 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 823 | S | 0.512363 | Y | 0.331971 | 0.180392 | D to O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 841 | Y | 0.11804 | C | 0.098233 | 0.019807 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 882 | R | 0.027419 | L | 0.014977 | 0.012442 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 887 | L | 0.083463 | P | 0.148919 | -0.065456 | No Change: Both O | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 907 | E | 0.576662 | G | 0.490498 | 0.086164 | D to O | - |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 932 | R | 0.656587 | C | 0.529904 | 0.126683 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| O60313 | OPA1_HUMAN Dynamin-like 120 kDa protein mitochondrial OS=Homo sapiens GN=OPA1 PE=1 SV=3 | 949 | L | 0.629533 | P | 0.718178 | -0.088645 | No Change: Both D | Optic atrophy type 1 (OPA1) [MIM:165500] |
| Q9NX94 | OPA1L_HUMAN Outcome predictor in acute leukemia 1 OS=Homo sapiens GN=OPA1L PE=2 SV=2 | 302 | S | 0.934177 | P | 0.940046 | -0.005869 | No Change: Both D | - |
| Q9NX94 | OPA1L_HUMAN Outcome predictor in acute leukemia 1 OS=Homo sapiens GN=OPA1L PE=2 SV=2 | 320 | A | 0.976391 | S | 0.985286 | -0.008895 | No Change: Both D | - |
| Q9H6K4 | OPA3_HUMAN Optic atrophy 3 protein OS=Homo sapiens GN=OPA3 PE=1 SV=1 | 93 | G | 0.048623 | S | 0.050997 | -0.002374 | No Change: Both O | Optic atrophy type 3 (OPA3) [MIM:165300] |
| Q9H6K4 | OPA3_HUMAN Optic atrophy 3 protein OS=Homo sapiens GN=OPA3 PE=1 SV=1 | 105 | Q | 0.389338 | E | 0.425837 | -0.036499 | No Change: Both O | Optic atrophy type 3 (OPA3) [MIM:165300] |
| Q14982 | OPCM_HUMAN Opioid-binding protein/cell adhesion molecule OS=Homo sapiens GN=OPCML PE=1 SV=1 | 95 | P | 0.143493 | R | 0.123962 | 0.019531 | No Change: Both O | Ovarian cancer (OC) [MIM:167000] |
| O60890 | OPHN1_HUMAN Oligophrenin-1 OS=Homo sapiens GN=OPHN1 PE=1 SV=1 | 45 | A | 0.264284 | T | 0.282467 | -0.018183 | No Change: Both O | - |
| O60890 | OPHN1_HUMAN Oligophrenin-1 OS=Homo sapiens GN=OPHN1 PE=1 SV=1 | 301 | T | 0.627812 | M | 0.590708 | 0.037104 | No Change: Both D | - |
| O60890 | OPHN1_HUMAN Oligophrenin-1 OS=Homo sapiens GN=OPHN1 PE=1 SV=1 | 693 | M | 0.912431 | I | 0.890222 | 0.022209 | No Change: Both D | - |
| O60890 | OPHN1_HUMAN Oligophrenin-1 OS=Homo sapiens GN=OPHN1 PE=1 SV=1 | 39 | V | 0.29336 | I | 0.302817 | -0.009457 | No Change: Both O | - |
| O14841 | OPLA_HUMAN 5-oxoprolinase OS=Homo sapiens GN=OPLAH PE=1 SV=3 | 284 | S | 0.600804 | R | 0.515844 | 0.08496 | No Change: Both D | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 180 | S | 0.026001 | A | 0.015829 | 0.010172 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 203 | C | 0.450884 | R | 0.635147 | -0.184263 | O to D | Blue cone monochromacy (BCM) [MIM:303700] |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 307 | P | 0.182193 | L | 0.092527 | 0.089666 | No Change: Both O | Blue cone monochromacy (BCM) [MIM:303700] |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 65 | T | 0.040334 | I | 0.020525 | 0.019809 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 111 | I | 0.182869 | V | 0.210327 | -0.027458 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 116 | S | 0.138383 | Y | 0.060929 | 0.077454 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 153 | L | 0.020418 | M | 0.027231 | -0.006813 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 174 | A | 0.019171 | V | 0.012637 | 0.006534 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 230 | I | 0.010348 | T | 0.019104 | -0.008756 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 298 | A | 0.213763 | P | 0.283857 | -0.070094 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 309 | Y | 0.187742 | F | 0.168092 | 0.01965 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 274 | I | 0.013244 | V | 0.018651 | -0.005407 | No Change: Both O | - |
| P04000 | OPSR_HUMAN Long-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1LW PE=1 SV=1 | 338 | G | 0.259675 | E | 0.304726 | -0.045051 | No Change: Both O | Partial colorblindness protan series (CBP) [MIM:303900] |
| P04001 | OPSG_HUMAN Medium-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1MW PE=1 SV=1 | 203 | C | 0.448928 | R | 0.631509 | -0.182581 | O to D | Blue cone monochromacy (BCM) [MIM:303700] |
| P04001 | OPSG_HUMAN Medium-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1MW PE=1 SV=1 | 203 | C | 0.448928 | R | 0.631509 | -0.182581 | O to D | Partial colorblindness deutan series (CBD) [MIM:303800] |
| P04001 | OPSG_HUMAN Medium-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1MW PE=1 SV=1 | 94 | N | 0.041652 | K | 0.046966 | -0.005314 | No Change: Both O | Partial colorblindness deutan series (CBD) [MIM:303800] |
| P04001 | OPSG_HUMAN Medium-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1MW PE=1 SV=1 | 177 | W | 0.011344 | R | 0.027829 | -0.016485 | No Change: Both O | Cone dystrophy type 5 (COD5) [MIM:303700] |
| P04001 | OPSG_HUMAN Medium-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1MW PE=1 SV=1 | 330 | R | 0.079405 | Q | 0.08839 | -0.008985 | No Change: Both O | Partial colorblindness deutan series (CBD) [MIM:303800] |
| P03999 | OPSB_HUMAN Short-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1SW PE=1 SV=1 | 79 | G | 0.032032 | R | 0.027951 | 0.004081 | No Change: Both O | Tritan color blindness (CBT) [MIM:190900] |
| P03999 | OPSB_HUMAN Short-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1SW PE=1 SV=1 | 214 | S | 0.019407 | P | 0.017163 | 0.002244 | No Change: Both O | Tritan color blindness (CBT) [MIM:190900] |
| P03999 | OPSB_HUMAN Short-wave-sensitive opsin 1 OS=Homo sapiens GN=OPN1SW PE=1 SV=1 | 264 | P | 0.035904 | S | 0.043249 | -0.007345 | No Change: Both O | Tritan color blindness (CBT) [MIM:190900] |
| Q9H1Y3 | OPN3_HUMAN Opsin-3 OS=Homo sapiens GN=OPN3 PE=1 SV=1 | 167 | A | 0.033699 | V | 0.02064 | 0.013059 | No Change: Both O | - |
| Q9H1Y3 | OPN3_HUMAN Opsin-3 OS=Homo sapiens GN=OPN3 PE=1 SV=1 | 183 | V | 0.060771 | I | 0.054611 | 0.00616 | No Change: Both O | - |
| Q9UHM6 | OPN4_HUMAN Melanopsin OS=Homo sapiens GN=OPN4 PE=1 SV=1 | 394 | T | 0.833422 | I | 0.742017 | 0.091405 | No Change: Both D | - |
| Q9UHM6 | OPN4_HUMAN Melanopsin OS=Homo sapiens GN=OPN4 PE=1 SV=1 | 10 | P | 0.996361 | L | 0.989693 | 0.006668 | No Change: Both D | - |
| Q9UHM6 | OPN4_HUMAN Melanopsin OS=Homo sapiens GN=OPN4 PE=1 SV=1 | 444 | G | 0.638901 | D | 0.642376 | -0.003475 | No Change: Both D | - |
| P41143 | OPRD_HUMAN Delta-type opioid receptor OS=Homo sapiens GN=OPRD1 PE=1 SV=4 | 27 | C | 0.91514 | F | 0.902267 | 0.012873 | No Change: Both D | - |
| P41145 | OPRK_HUMAN Kappa-type opioid receptor OS=Homo sapiens GN=OPRK1 PE=1 SV=2 | 374 | D | 0.580847 | N | 0.565615 | 0.015232 | No Change: Both D | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 40 | N | 0.880245 | D | 0.892078 | -0.011833 | No Change: Both D | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 6 | A | 0.948224 | V | 0.915229 | 0.032995 | No Change: Both D | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 147 | S | 0.037158 | C | 0.012855 | 0.024303 | No Change: Both O | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 260 | R | 0.125355 | H | 0.119606 | 0.005749 | No Change: Both O | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 152 | N | 0.060662 | D | 0.070279 | -0.009617 | No Change: Both O | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 265 | R | 0.438457 | C | 0.246858 | 0.191599 | No Change: Both O | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 274 | D | 0.795894 | N | 0.794747 | 0.001147 | No Change: Both D | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 63 | G | 0.578177 | V | 0.434144 | 0.144033 | D to O | - |
| P35372 | OPRM_HUMAN Mu-type opioid receptor OS=Homo sapiens GN=OPRM1 PE=1 SV=2 | 66 | S | 0.444392 | F | 0.211202 | 0.23319 | No Change: Both O | - |
| Q9UBM4 | OPT_HUMAN Opticin OS=Homo sapiens GN=OPTC PE=1 SV=1 | 182 | I | 0.370413 | T | 0.504594 | -0.134181 | O to D | - |
| Q9UBM4 | OPT_HUMAN Opticin OS=Homo sapiens GN=OPTC PE=1 SV=1 | 229 | R | 0.218545 | C | 0.108578 | 0.109967 | No Change: Both O | - |
| Q9UBM4 | OPT_HUMAN Opticin OS=Homo sapiens GN=OPTC PE=1 SV=1 | 325 | R | 0.152011 | W | 0.045744 | 0.106267 | No Change: Both O | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 26 | H | 0.937736 | D | 0.944442 | -0.006706 | No Change: Both D | Primary open angle glaucoma type 1E (GLC1E) [MIM:137760] |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 50 | E | 0.864326 | K | 0.860758 | 0.003568 | No Change: Both D | Primary open angle glaucoma type 1E (GLC1E) [MIM:137760] |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 98 | M | 0.957541 | K | 0.972849 | -0.015308 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 103 | E | 0.973718 | D | 0.961235 | 0.012483 | No Change: Both D | Primary open angle glaucoma type 1E (GLC1E) [MIM:137760] |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 201 | P | 0.80937 | S | 0.830177 | -0.020807 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 213 | K | 0.672213 | H | 0.625374 | 0.046839 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 216 | S | 0.648455 | R | 0.617244 | 0.031211 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 322 | K | 0.849331 | E | 0.852162 | -0.002831 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 357 | T | 0.88464 | P | 0.911552 | -0.026912 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 486 | H | 0.658664 | R | 0.690253 | -0.031589 | No Change: Both D | Primary open angle glaucoma type 1E (GLC1E) [MIM:137760] |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 545 | R | 0.52999 | Q | 0.545841 | -0.015851 | No Change: Both D | Primary open angle glaucoma type 1E (GLC1E) [MIM:137760] |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 308 | S | 0.821402 | P | 0.810373 | 0.011029 | No Change: Both D | - |
| Q96CV9 | OPTN_HUMAN Optineurin OS=Homo sapiens GN=OPTN PE=1 SV=2 | 478 | E | 0.53714 | G | 0.418461 | 0.118679 | D to O | Amyotrophic lateral sclerosis type 12 (ALS12) [MIM:613435] |
| Q9H208 | O10A2_HUMAN Olfactory receptor 10A2 OS=Homo sapiens GN=OR10A2 PE=2 SV=2 | 207 | H | 0.042266 | R | 0.04185 | 4.16E-04 | No Change: Both O | - |
| Q9H208 | O10A2_HUMAN Olfactory receptor 10A2 OS=Homo sapiens GN=OR10A2 PE=2 SV=2 | 240 | I | 0.164654 | T | 0.284782 | -0.120128 | No Change: Both O | - |
| Q9H208 | O10A2_HUMAN Olfactory receptor 10A2 OS=Homo sapiens GN=OR10A2 PE=2 SV=2 | 258 | K | 0.704405 | T | 0.658211 | 0.046194 | No Change: Both D | - |
| Q9H208 | O10A2_HUMAN Olfactory receptor 10A2 OS=Homo sapiens GN=OR10A2 PE=2 SV=2 | 134 | A | 0.17306 | T | 0.183266 | -0.010206 | No Change: Both O | - |
| Q9H208 | O10A2_HUMAN Olfactory receptor 10A2 OS=Homo sapiens GN=OR10A2 PE=2 SV=2 | 43 | H | 0.192786 | R | 0.194908 | -0.002122 | No Change: Both O | - |
| P58181 | O10A3_HUMAN Olfactory receptor 10A3 OS=Homo sapiens GN=OR10A3 PE=2 SV=1 | 20 | F | 0.162837 | V | 0.180758 | -0.017921 | No Change: Both O | - |
| Q9H209 | O10A4_HUMAN Olfactory receptor 10A4 OS=Homo sapiens GN=OR10A4 PE=2 SV=2 | 262 | R | 0.471284 | Q | 0.515885 | -0.044601 | O to D | - |
| Q9H209 | O10A4_HUMAN Olfactory receptor 10A4 OS=Homo sapiens GN=OR10A4 PE=2 SV=2 | 221 | R | 0.053535 | H | 0.05157 | 0.001965 | No Change: Both O | - |
| Q9H209 | O10A4_HUMAN Olfactory receptor 10A4 OS=Homo sapiens GN=OR10A4 PE=2 SV=2 | 246 | L | 0.132147 | F | 0.119059 | 0.013088 | No Change: Both O | - |
| Q9H209 | O10A4_HUMAN Olfactory receptor 10A4 OS=Homo sapiens GN=OR10A4 PE=2 SV=2 | 206 | L | 0.021313 | P | 0.044074 | -0.022761 | No Change: Both O | - |
| Q9H207 | O10A5_HUMAN Olfactory receptor 10A5 OS=Homo sapiens GN=OR10A5 PE=2 SV=1 | 41 | K | 0.091714 | M | 0.052234 | 0.03948 | No Change: Both O | - |
| Q8NH74 | O10A6_HUMAN Olfactory receptor 10A6 OS=Homo sapiens GN=OR10A6 PE=2 SV=1 | 117 | A | 0.068205 | V | 0.041981 | 0.026224 | No Change: Both O | - |
| Q8NH74 | O10A6_HUMAN Olfactory receptor 10A6 OS=Homo sapiens GN=OR10A6 PE=2 SV=1 | 140 | V | 0.086602 | G | 0.165995 | -0.079393 | No Change: Both O | - |
| Q8NH74 | O10A6_HUMAN Olfactory receptor 10A6 OS=Homo sapiens GN=OR10A6 PE=2 SV=1 | 287 | L | 0.180154 | P | 0.292525 | -0.112371 | No Change: Both O | - |
| Q8NGE5 | O10A7_HUMAN Olfactory receptor 10A7 OS=Homo sapiens GN=OR10A7 PE=2 SV=1 | 96 | G | 0.071008 | S | 0.0907 | -0.019692 | No Change: Both O | - |
| Q8NGE0 | O10AD_HUMAN Olfactory receptor 10AD1 OS=Homo sapiens GN=OR10AD1 PE=2 SV=1 | 279 | Y | 0.092908 | H | 0.152352 | -0.059444 | No Change: Both O | - |
| Q8NGE0 | O10AD_HUMAN Olfactory receptor 10AD1 OS=Homo sapiens GN=OR10AD1 PE=2 SV=1 | 8 | V | 0.14841 | A | 0.195177 | -0.046767 | No Change: Both O | - |
| Q8NGE0 | O10AD_HUMAN Olfactory receptor 10AD1 OS=Homo sapiens GN=OR10AD1 PE=2 SV=1 | 166 | R | 0.263709 | Q | 0.262083 | 0.001626 | No Change: Both O | - |
| Q8NGE0 | O10AD_HUMAN Olfactory receptor 10AD1 OS=Homo sapiens GN=OR10AD1 PE=2 SV=1 | 275 | F | 0.356244 | V | 0.379124 | -0.02288 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 57 | P | 0.172532 | S | 0.207135 | -0.034603 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 60 | F | 0.090051 | L | 0.106867 | -0.016816 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 89 | R | 0.488781 | S | 0.564313 | -0.075532 | O to D | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 100 | M | 0.033048 | V | 0.024075 | 0.008973 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 121 | R | 0.100489 | C | 0.04972 | 0.050769 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 138 | R | 0.095541 | W | 0.036067 | 0.059474 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 160 | P | 0.093483 | S | 0.106802 | -0.013319 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 161 | F | 0.091265 | L | 0.10461 | -0.013345 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 174 | P | 0.108045 | Q | 0.098616 | 0.009429 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 246 | M | 0.098555 | V | 0.079763 | 0.018792 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 255 | L | 0.031332 | I | 0.02861 | 0.002722 | No Change: Both O | - |
| Q96KK4 | O10C1_HUMAN Olfactory receptor 10C1 OS=Homo sapiens GN=OR10C1 PE=2 SV=3 | 310 | M | 0.736556 | R | 0.732544 | 0.004012 | No Change: Both D | - |
| Q8NGC3 | O10G2_HUMAN Olfactory receptor 10G2 OS=Homo sapiens GN=OR10G2 PE=2 SV=1 | 67 | L | 0.034688 | F | 0.028465 | 0.006223 | No Change: Both O | - |
| Q8NGC3 | O10G2_HUMAN Olfactory receptor 10G2 OS=Homo sapiens GN=OR10G2 PE=2 SV=1 | 85 | R | 0.121204 | L | 0.076727 | 0.044477 | No Change: Both O | - |
| Q8NGC3 | O10G2_HUMAN Olfactory receptor 10G2 OS=Homo sapiens GN=OR10G2 PE=2 SV=1 | 187 | R | 0.026058 | P | 0.029076 | -0.003018 | No Change: Both O | - |
| Q8NGC3 | O10G2_HUMAN Olfactory receptor 10G2 OS=Homo sapiens GN=OR10G2 PE=2 SV=1 | 209 | R | 0.061536 | G | 0.065328 | -0.003792 | No Change: Both O | - |
| Q8NGC4 | O10G3_HUMAN Olfactory receptor 10G3 OS=Homo sapiens GN=OR10G3 PE=2 SV=1 | 73 | S | 0.206757 | G | 0.154279 | 0.052478 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 195 | V | 0.075094 | E | 0.156372 | -0.081278 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 235 | R | 0.463229 | G | 0.47051 | -0.007281 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 24 | L | 0.070518 | P | 0.138475 | -0.067957 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 134 | M | 0.431629 | V | 0.345144 | 0.086485 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 181 | P | 0.107801 | S | 0.113584 | -0.005783 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 226 | R | 0.166491 | Q | 0.164311 | 0.00218 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 295 | K | 0.495278 | Q | 0.414241 | 0.081037 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 101 | Y | 0.043679 | C | 0.037782 | 0.005897 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 146 | G | 0.197656 | C | 0.096056 | 0.1016 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 146 | G | 0.197656 | R | 0.184398 | 0.013258 | No Change: Both O | - |
| Q8NGN3 | O10G4_HUMAN Olfactory receptor 10G4 OS=Homo sapiens GN=OR10G4 PE=2 SV=1 | 146 | G | 0.197656 | S | 0.247054 | -0.049398 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 5 | T | 0.478222 | S | 0.560882 | -0.08266 | O to D | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 136 | T | 0.248226 | S | 0.324679 | -0.076453 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 13 | T | 0.137728 | M | 0.104888 | 0.03284 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 18 | A | 0.338357 | V | 0.242939 | 0.095418 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 20 | G | 0.353634 | A | 0.296004 | 0.05763 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 28 | I | 0.018897 | V | 0.024623 | -0.005726 | No Change: Both O | - |
| Q8NGN6 | O10G7_HUMAN Olfactory receptor 10G7 OS=Homo sapiens GN=OR10G7 PE=2 SV=1 | 90 | T | 0.44339 | A | 0.411921 | 0.031469 | No Change: Both O | - |
| Q8NGN4 | O10G9_HUMAN Olfactory receptor 10G9 OS=Homo sapiens GN=OR10G9 PE=2 SV=1 | 136 | S | 0.398601 | T | 0.309776 | 0.088825 | No Change: Both O | - |
| Q8NGN4 | O10G9_HUMAN Olfactory receptor 10G9 OS=Homo sapiens GN=OR10G9 PE=2 SV=1 | 172 | Q | 0.199192 | R | 0.173665 | 0.025527 | No Change: Both O | - |
| Q8NGN4 | O10G9_HUMAN Olfactory receptor 10G9 OS=Homo sapiens GN=OR10G9 PE=2 SV=1 | 134 | M | 0.430567 | V | 0.344188 | 0.086379 | No Change: Both O | - |
| Q8NGN4 | O10G9_HUMAN Olfactory receptor 10G9 OS=Homo sapiens GN=OR10G9 PE=2 SV=1 | 228 | H | 0.348864 | R | 0.357016 | -0.008152 | No Change: Both O | - |
| Q9Y4A9 | O10H1_HUMAN Olfactory receptor 10H1 OS=Homo sapiens GN=OR10H1 PE=2 SV=1 | 16 | G | 0.058538 | R | 0.055736 | 0.002802 | No Change: Both O | - |
| Q9Y4A9 | O10H1_HUMAN Olfactory receptor 10H1 OS=Homo sapiens GN=OR10H1 PE=2 SV=1 | 65 | A | 0.041785 | V | 0.030852 | 0.010933 | No Change: Both O | - |
| Q9Y4A9 | O10H1_HUMAN Olfactory receptor 10H1 OS=Homo sapiens GN=OR10H1 PE=2 SV=1 | 175 | H | 0.220697 | Q | 0.213685 | 0.007012 | No Change: Both O | - |
| O60403 | O10H2_HUMAN Olfactory receptor 10H2 OS=Homo sapiens GN=OR10H2 PE=2 SV=1 | 171 | S | 0.162539 | F | 0.069769 | 0.09277 | No Change: Both O | - |
| O60403 | O10H2_HUMAN Olfactory receptor 10H2 OS=Homo sapiens GN=OR10H2 PE=2 SV=1 | 40 | L | 0.034093 | Q | 0.059372 | -0.025279 | No Change: Both O | - |
| O60404 | O10H3_HUMAN Olfactory receptor 10H3 OS=Homo sapiens GN=OR10H3 PE=2 SV=1 | 224 | V | 0.018625 | M | 0.023431 | -0.004806 | No Change: Both O | - |
| O60404 | O10H3_HUMAN Olfactory receptor 10H3 OS=Homo sapiens GN=OR10H3 PE=2 SV=1 | 293 | S | 0.223883 | N | 0.196526 | 0.027357 | No Change: Both O | - |
| O60404 | O10H3_HUMAN Olfactory receptor 10H3 OS=Homo sapiens GN=OR10H3 PE=2 SV=1 | 7 | R | 0.411498 | S | 0.499157 | -0.087659 | No Change: Both O | - |
| O60404 | O10H3_HUMAN Olfactory receptor 10H3 OS=Homo sapiens GN=OR10H3 PE=2 SV=1 | 14 | L | 0.168521 | I | 0.163553 | 0.004968 | No Change: Both O | - |
| O60404 | O10H3_HUMAN Olfactory receptor 10H3 OS=Homo sapiens GN=OR10H3 PE=2 SV=1 | 54 | R | 0.113356 | H | 0.115195 | -0.001839 | No Change: Both O | - |
| Q8NGA5 | O10H4_HUMAN Olfactory receptor 10H4 OS=Homo sapiens GN=OR10H4 PE=2 SV=1 | 100 | N | 0.069246 | K | 0.083448 | -0.014202 | No Change: Both O | - |
| Q8NGA5 | O10H4_HUMAN Olfactory receptor 10H4 OS=Homo sapiens GN=OR10H4 PE=2 SV=1 | 144 | H | 0.082504 | R | 0.087187 | -0.004683 | No Change: Both O | - |
| Q8NGA5 | O10H4_HUMAN Olfactory receptor 10H4 OS=Homo sapiens GN=OR10H4 PE=2 SV=1 | 281 | T | 0.107053 | A | 0.091492 | 0.015561 | No Change: Both O | - |
| P30954 | O10J1_HUMAN Olfactory receptor 10J1 OS=Homo sapiens GN=OR10J1 PE=2 SV=2 | 62 | M | 0.096186 | I | 0.068025 | 0.028161 | No Change: Both O | - |
| P30954 | O10J1_HUMAN Olfactory receptor 10J1 OS=Homo sapiens GN=OR10J1 PE=2 SV=2 | 112 | M | 0.03993 | I | 0.02632 | 0.01361 | No Change: Both O | - |
| P30954 | O10J1_HUMAN Olfactory receptor 10J1 OS=Homo sapiens GN=OR10J1 PE=2 SV=2 | 103 | I | 0.310209 | M | 0.422482 | -0.112273 | No Change: Both O | - |
| Q5JRS4 | O10J3_HUMAN Olfactory receptor 10J3 OS=Homo sapiens GN=OR10J3 PE=2 SV=1 | 235 | Q | 0.590017 | R | 0.567347 | 0.02267 | No Change: Both D | - |
| Q8NHC4 | O10J5_HUMAN Olfactory receptor 10J5 OS=Homo sapiens GN=OR10J5 PE=2 SV=1 | 233 | R | 0.529536 | W | 0.298431 | 0.231105 | D to O | - |
| Q6IF99 | O10K2_HUMAN Olfactory receptor 10K2 OS=Homo sapiens GN=OR10K2 PE=2 SV=1 | 208 | A | 0.014166 | T | 0.017646 | -0.00348 | No Change: Both O | - |
| Q8NGE3 | O10P1_HUMAN Olfactory receptor 10P1 OS=Homo sapiens GN=OR10P1 PE=2 SV=1 | 88 | P | 0.538292 | L | 0.35183 | 0.186462 | D to O | - |
| Q8NGE3 | O10P1_HUMAN Olfactory receptor 10P1 OS=Homo sapiens GN=OR10P1 PE=2 SV=1 | 200 | V | 0.254443 | M | 0.313297 | -0.058854 | No Change: Both O | - |
| Q8NGQ4 | O10Q1_HUMAN Olfactory receptor 10Q1 OS=Homo sapiens GN=OR10Q1 PE=2 SV=1 | 12 | E | 0.371836 | D | 0.326678 | 0.045158 | No Change: Both O | - |
| Q8NGQ4 | O10Q1_HUMAN Olfactory receptor 10Q1 OS=Homo sapiens GN=OR10Q1 PE=2 SV=1 | 191 | R | 0.06704 | C | 0.031645 | 0.035395 | No Change: Both O | - |
| Q8NGX6 | O10R2_HUMAN Olfactory receptor 10R2 OS=Homo sapiens GN=OR10R2 PE=2 SV=3 | 191 | A | 0.194052 | T | 0.217913 | -0.023861 | No Change: Both O | - |
| Q8NGX6 | O10R2_HUMAN Olfactory receptor 10R2 OS=Homo sapiens GN=OR10R2 PE=2 SV=3 | 216 | E | 0.056798 | G | 0.045642 | 0.011156 | No Change: Both O | - |
| Q8NGX6 | O10R2_HUMAN Olfactory receptor 10R2 OS=Homo sapiens GN=OR10R2 PE=2 SV=3 | 239 | L | 0.008518 | F | 0.00716 | 0.001358 | No Change: Both O | - |
| Q8NGN2 | O10S1_HUMAN Olfactory receptor 10S1 OS=Homo sapiens GN=OR10S1 PE=2 SV=2 | 63 | G | 0.312916 | S | 0.387729 | -0.074813 | No Change: Both O | - |
| Q8NGN2 | O10S1_HUMAN Olfactory receptor 10S1 OS=Homo sapiens GN=OR10S1 PE=2 SV=2 | 93 | K | 0.183037 | R | 0.140024 | 0.043013 | No Change: Both O | - |
| Q8NGN2 | O10S1_HUMAN Olfactory receptor 10S1 OS=Homo sapiens GN=OR10S1 PE=2 SV=2 | 112 | A | 0.042483 | V | 0.031952 | 0.010531 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 16 | V | 0.082692 | A | 0.110913 | -0.028221 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 65 | F | 0.056816 | L | 0.065151 | -0.008335 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 78 | I | 0.027555 | V | 0.032743 | -0.005188 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 137 | I | 0.102558 | M | 0.143715 | -0.041157 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 155 | F | 0.063457 | L | 0.074208 | -0.010751 | No Change: Both O | - |
| Q8NGX3 | O10T2_HUMAN Olfactory receptor 10T2 OS=Homo sapiens GN=OR10T2 PE=2 SV=1 | 312 | K | 0.686839 | N | 0.673403 | 0.013436 | No Change: Both D | - |
| Q8NGI7 | O10V1_HUMAN Olfactory receptor 10V1 OS=Homo sapiens GN=OR10V1 PE=2 SV=3 | 123 | Q | 0.034373 | R | 0.031703 | 0.00267 | No Change: Both O | - |
| Q8NGI7 | O10V1_HUMAN Olfactory receptor 10V1 OS=Homo sapiens GN=OR10V1 PE=2 SV=3 | 117 | V | 0.024788 | A | 0.036422 | -0.011634 | No Change: Both O | - |
| Q8NGF6 | O10W1_HUMAN Olfactory receptor 10W1 OS=Homo sapiens GN=OR10W1 PE=2 SV=1 | 263 | R | 0.301767 | Q | 0.331194 | -0.029427 | No Change: Both O | - |
| Q8NGY0 | O10X1_HUMAN Olfactory receptor 10X1 OS=Homo sapiens GN=OR10X1 PE=2 SV=2 | 60 | I | 0.040242 | T | 0.078993 | -0.038751 | No Change: Both O | - |
| Q8NGY0 | O10X1_HUMAN Olfactory receptor 10X1 OS=Homo sapiens GN=OR10X1 PE=2 SV=2 | 81 | A | 0.155572 | S | 0.261559 | -0.105987 | No Change: Both O | - |
| Q8NGY0 | O10X1_HUMAN Olfactory receptor 10X1 OS=Homo sapiens GN=OR10X1 PE=2 SV=2 | 172 | S | 0.087707 | P | 0.076084 | 0.011623 | No Change: Both O | - |
| Q8NGY0 | O10X1_HUMAN Olfactory receptor 10X1 OS=Homo sapiens GN=OR10X1 PE=2 SV=2 | 180 | F | 0.107155 | L | 0.123477 | -0.016322 | No Change: Both O | - |
| Q8NGY1 | O10Z1_HUMAN Olfactory receptor 10Z1 OS=Homo sapiens GN=OR10Z1 PE=2 SV=1 | 294 | N | 0.186632 | T | 0.164708 | 0.021924 | No Change: Both O | - |
| Q9GZK7 | O11A1_HUMAN Olfactory receptor 11A1 OS=Homo sapiens GN=OR11A1 PE=2 SV=1 | 165 | A | 0.047346 | T | 0.050538 | -0.003192 | No Change: Both O | - |
| Q9GZK7 | O11A1_HUMAN Olfactory receptor 11A1 OS=Homo sapiens GN=OR11A1 PE=2 SV=1 | 121 | Y | 0.040168 | C | 0.031139 | 0.009029 | No Change: Both O | - |
| Q8NGC1 | O11G2_HUMAN Olfactory receptor 11G2 OS=Homo sapiens GN=OR11G2 PE=2 SV=2 | 99 | I | 0.062672 | N | 0.149266 | -0.086594 | No Change: Both O | - |
| Q8NGC1 | O11G2_HUMAN Olfactory receptor 11G2 OS=Homo sapiens GN=OR11G2 PE=2 SV=2 | 116 | V | 0.174886 | I | 0.149613 | 0.025273 | No Change: Both O | - |
| Q8NGC9 | O11H4_HUMAN Olfactory receptor 11H4 OS=Homo sapiens GN=OR11H4 PE=2 SV=1 | 301 | T | 0.137198 | S | 0.184538 | -0.04734 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 32 | L | 0.097862 | V | 0.101448 | -0.003586 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 7 | S | 0.09382 | Y | 0.035451 | 0.058369 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 107 | I | 0.206702 | T | 0.336102 | -0.1294 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 146 | R | 0.093892 | H | 0.095425 | -0.001533 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 195 | L | 0.098264 | F | 0.086046 | 0.012218 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 236 | Y | 0.065664 | H | 0.111332 | -0.045668 | No Change: Both O | - |
| Q8NGC7 | O11H6_HUMAN Olfactory receptor 11H6 OS=Homo sapiens GN=OR11H6 PE=2 SV=1 | 259 | C | 0.277802 | R | 0.457215 | -0.179413 | No Change: Both O | - |
| Q8NGX0 | O11L1_HUMAN Olfactory receptor 11L1 OS=Homo sapiens GN=OR11L1 PE=2 SV=1 | 117 | F | 0.030138 | L | 0.035877 | -0.005739 | No Change: Both O | - |
| Q8NGX0 | O11L1_HUMAN Olfactory receptor 11L1 OS=Homo sapiens GN=OR11L1 PE=2 SV=1 | 108 | G | 0.022664 | S | 0.029295 | -0.006631 | No Change: Both O | - |
| Q8NGX0 | O11L1_HUMAN Olfactory receptor 11L1 OS=Homo sapiens GN=OR11L1 PE=2 SV=1 | 142 | A | 0.049397 | T | 0.057667 | -0.00827 | No Change: Both O | - |
| Q8NGX0 | O11L1_HUMAN Olfactory receptor 11L1 OS=Homo sapiens GN=OR11L1 PE=2 SV=1 | 171 | R | 0.156444 | P | 0.174138 | -0.017694 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 47 | V | 0.119153 | F | 0.09762 | 0.021533 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 56 | L | 0.102538 | P | 0.199918 | -0.09738 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 113 | F | 0.140873 | L | 0.161391 | -0.020518 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 120 | L | 0.05282 | R | 0.091097 | -0.038277 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 121 | S | 0.057869 | C | 0.020338 | 0.037531 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 132 | V | 0.077595 | G | 0.138933 | -0.061338 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 159 | V | 0.191645 | I | 0.168938 | 0.022707 | No Change: Both O | - |
| P58182 | O12D2_HUMAN Olfactory receptor 12D2 OS=Homo sapiens GN=OR12D2 PE=2 SV=2 | 104 | S | 0.384228 | F | 0.184413 | 0.199815 | No Change: Both O | - |
| Q9UGF7 | O12D3_HUMAN Olfactory receptor 12D3 OS=Homo sapiens GN=OR12D3 PE=2 SV=1 | 97 | T | 0.044206 | I | 0.02457 | 0.019636 | No Change: Both O | - |
| Q9UGF7 | O12D3_HUMAN Olfactory receptor 12D3 OS=Homo sapiens GN=OR12D3 PE=2 SV=1 | 250 | F | 0.026409 | L | 0.029703 | -0.003294 | No Change: Both O | A breast cancer sample |
| Q9UGF7 | O12D3_HUMAN Olfactory receptor 12D3 OS=Homo sapiens GN=OR12D3 PE=2 SV=1 | 277 | Y | 0.091489 | H | 0.15282 | -0.061331 | No Change: Both O | - |
| Q8NGS9 | O13C2_HUMAN Olfactory receptor 13C2 OS=Homo sapiens GN=OR13C2 PE=2 SV=1 | 160 | S | 0.140956 | T | 0.093123 | 0.047833 | No Change: Both O | - |
| Q8NGS9 | O13C2_HUMAN Olfactory receptor 13C2 OS=Homo sapiens GN=OR13C2 PE=2 SV=1 | 301 | K | 0.410847 | E | 0.407977 | 0.00287 | No Change: Both O | - |
| Q8NGS6 | O13C3_HUMAN Olfactory receptor 13C3 OS=Homo sapiens GN=OR13C3 PE=2 SV=2 | 293 | K | 0.434683 | T | 0.3355 | 0.099183 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 189 | C | 0.101393 | Y | 0.127331 | -0.025938 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 258 | M | 0.15503 | T | 0.178968 | -0.023938 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 282 | I | 0.041811 | V | 0.046455 | -0.004644 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 290 | M | 0.182246 | T | 0.190135 | -0.007889 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 32 | F | 0.003223 | L | 0.003808 | -5.85E-04 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 18 | S | 0.3043 | F | 0.139192 | 0.165108 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 195 | N | 0.118561 | S | 0.151319 | -0.032758 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 69 | L | 0.060481 | M | 0.074731 | -0.01425 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 86 | L | 0.378607 | V | 0.378302 | 3.05E-04 | No Change: Both O | - |
| Q8NGS8 | O13C5_HUMAN Olfactory receptor 13C5 OS=Homo sapiens GN=OR13C5 PE=2 SV=1 | 117 | V | 0.04093 | M | 0.054958 | -0.014028 | No Change: Both O | - |
| Q8NGS7 | O13C8_HUMAN Olfactory receptor 13C8 OS=Homo sapiens GN=OR13C8 PE=2 SV=1 | 19 | A | 0.200864 | D | 0.271921 | -0.071057 | No Change: Both O | - |
| Q8NGT0 | O13C9_HUMAN Olfactory receptor 13C9 OS=Homo sapiens GN=OR13C9 PE=2 SV=1 | 24 | E | 0.116076 | D | 0.104417 | 0.011659 | No Change: Both O | - |
| Q8NGT0 | O13C9_HUMAN Olfactory receptor 13C9 OS=Homo sapiens GN=OR13C9 PE=2 SV=1 | 91 | T | 0.35852 | S | 0.469189 | -0.110669 | No Change: Both O | - |
| Q8NGT0 | O13C9_HUMAN Olfactory receptor 13C9 OS=Homo sapiens GN=OR13C9 PE=2 SV=1 | 197 | F | 0.095257 | L | 0.117687 | -0.02243 | No Change: Both O | - |
| Q8NGV5 | O13D1_HUMAN Olfactory receptor 13D1 OS=Homo sapiens GN=OR13D1 PE=2 SV=3 | 21 | F | 0.078828 | L | 0.100027 | -0.021199 | No Change: Both O | - |
| Q8NGV5 | O13D1_HUMAN Olfactory receptor 13D1 OS=Homo sapiens GN=OR13D1 PE=2 SV=3 | 64 | L | 0.00437 | V | 0.003759 | 6.11E-04 | No Change: Both O | - |
| Q8NGV5 | O13D1_HUMAN Olfactory receptor 13D1 OS=Homo sapiens GN=OR13D1 PE=2 SV=3 | 191 | Q | 0.097181 | H | 0.089525 | 0.007656 | No Change: Both O | - |
| Q8NGV5 | O13D1_HUMAN Olfactory receptor 13D1 OS=Homo sapiens GN=OR13D1 PE=2 SV=3 | 277 | S | 0.080576 | L | 0.032788 | 0.047788 | No Change: Both O | - |
| Q8NGV5 | O13D1_HUMAN Olfactory receptor 13D1 OS=Homo sapiens GN=OR13D1 PE=2 SV=3 | 113 | M | 0.216714 | V | 0.157629 | 0.059085 | No Change: Both O | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 101 | M | 0.191731 | V | 0.139622 | 0.052109 | No Change: Both O | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 18 | F | 0.030905 | S | 0.077509 | -0.046604 | No Change: Both O | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 94 | F | 0.274056 | S | 0.509877 | -0.235821 | O to D | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 254 | T | 0.103709 | M | 0.09369 | 0.010019 | No Change: Both O | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 134 | V | 0.110207 | I | 0.101417 | 0.00879 | No Change: Both O | - |
| Q8NGS4 | O13F1_HUMAN Olfactory receptor 13F1 OS=Homo sapiens GN=OR13F1 PE=2 SV=1 | 270 | I | 0.378391 | T | 0.516722 | -0.138331 | O to D | - |
| Q8NGZ3 | O13G1_HUMAN Olfactory receptor 13G1 OS=Homo sapiens GN=OR13G1 PE=2 SV=1 | 132 | I | 0.185377 | V | 0.214941 | -0.029564 | No Change: Both O | - |
| Q8NGZ3 | O13G1_HUMAN Olfactory receptor 13G1 OS=Homo sapiens GN=OR13G1 PE=2 SV=1 | 46 | K | 0.082082 | I | 0.033215 | 0.048867 | No Change: Both O | - |
| Q8NGZ3 | O13G1_HUMAN Olfactory receptor 13G1 OS=Homo sapiens GN=OR13G1 PE=2 SV=1 | 146 | M | 0.061195 | L | 0.045932 | 0.015263 | No Change: Both O | - |
| Q8NGZ3 | O13G1_HUMAN Olfactory receptor 13G1 OS=Homo sapiens GN=OR13G1 PE=2 SV=1 | 224 | R | 0.054741 | C | 0.02297 | 0.031771 | No Change: Both O | - |
| Q8NG92 | O13H1_HUMAN Olfactory receptor 13H1 OS=Homo sapiens GN=OR13H1 PE=2 SV=1 | 266 | Y | 0.711855 | S | 0.797781 | -0.085926 | No Change: Both D | - |
| Q8NGT2 | O13J1_HUMAN Olfactory receptor 13J1 OS=Homo sapiens GN=OR13J1 PE=2 SV=1 | 133 | H | 0.106005 | R | 0.108917 | -0.002912 | No Change: Both O | - |
| Q8NHC5 | O14AG_HUMAN Olfactory receptor 14A16 OS=Homo sapiens GN=OR14A16 PE=2 SV=1 | 238 | I | 0.136515 | T | 0.234121 | -0.097606 | No Change: Both O | - |
| Q8NHC7 | O14CZ_HUMAN Olfactory receptor 14C36 OS=Homo sapiens GN=OR14C36 PE=2 SV=1 | 141 | Q | 0.087653 | R | 0.086245 | 0.001408 | No Change: Both O | - |
| Q8NHC7 | O14CZ_HUMAN Olfactory receptor 14C36 OS=Homo sapiens GN=OR14C36 PE=2 SV=1 | 225 | G | 0.177678 | R | 0.171805 | 0.005873 | No Change: Both O | - |
| Q8NHC7 | O14CZ_HUMAN Olfactory receptor 14C36 OS=Homo sapiens GN=OR14C36 PE=2 SV=1 | 231 | D | 0.415467 | Y | 0.254056 | 0.161411 | No Change: Both O | - |
| A6ND48 | O14I1_HUMAN Olfactory receptor 14I1 OS=Homo sapiens GN=OR14I1 PE=2 SV=1 | 36 | V | 0.012884 | A | 0.019182 | -0.006298 | No Change: Both O | - |
| A6ND48 | O14I1_HUMAN Olfactory receptor 14I1 OS=Homo sapiens GN=OR14I1 PE=2 SV=1 | 50 | D | 0.137403 | N | 0.128069 | 0.009334 | No Change: Both O | - |
| A6ND48 | O14I1_HUMAN Olfactory receptor 14I1 OS=Homo sapiens GN=OR14I1 PE=2 SV=1 | 170 | S | 0.210105 | N | 0.167726 | 0.042379 | No Change: Both O | - |
| A6ND48 | O14I1_HUMAN Olfactory receptor 14I1 OS=Homo sapiens GN=OR14I1 PE=2 SV=1 | 84 | L | 0.649672 | M | 0.707642 | -0.05797 | No Change: Both D | - |
| A6ND48 | O14I1_HUMAN Olfactory receptor 14I1 OS=Homo sapiens GN=OR14I1 PE=2 SV=1 | 216 | Y | 0.036206 | C | 0.035138 | 0.001068 | No Change: Both O | - |
| Q9UGF5 | O14J1_HUMAN Olfactory receptor 14J1 OS=Homo sapiens GN=OR14J1 PE=2 SV=1 | 7 | M | 0.398863 | T | 0.445805 | -0.046942 | No Change: Both O | - |
| Q9UGF5 | O14J1_HUMAN Olfactory receptor 14J1 OS=Homo sapiens GN=OR14J1 PE=2 SV=1 | 278 | V | 0.10534 | M | 0.135733 | -0.030393 | No Change: Both O | - |
| Q9P1Q5 | OR1A1_HUMAN Olfactory receptor 1A1 OS=Homo sapiens GN=OR1A1 PE=2 SV=2 | 285 | P | 0.140797 | S | 0.155149 | -0.014352 | No Change: Both O | - |
| Q9P1Q5 | OR1A1_HUMAN Olfactory receptor 1A1 OS=Homo sapiens GN=OR1A1 PE=2 SV=2 | 233 | V | 0.365483 | M | 0.421109 | -0.055626 | No Change: Both O | - |
| Q9P1Q5 | OR1A1_HUMAN Olfactory receptor 1A1 OS=Homo sapiens GN=OR1A1 PE=2 SV=2 | 128 | R | 0.222463 | H | 0.228026 | -0.005563 | No Change: Both O | - |
| Q9Y585 | OR1A2_HUMAN Olfactory receptor 1A2 OS=Homo sapiens GN=OR1A2 PE=2 SV=1 | 256 | G | 0.146787 | C | 0.063711 | 0.083076 | No Change: Both O | - |
| Q9Y585 | OR1A2_HUMAN Olfactory receptor 1A2 OS=Homo sapiens GN=OR1A2 PE=2 SV=1 | 260 | R | 0.29447 | C | 0.155183 | 0.139287 | No Change: Both O | - |
| Q9Y585 | OR1A2_HUMAN Olfactory receptor 1A2 OS=Homo sapiens GN=OR1A2 PE=2 SV=1 | 293 | W | 0.1524 | C | 0.186065 | -0.033665 | No Change: Both O | - |
| Q9Y585 | OR1A2_HUMAN Olfactory receptor 1A2 OS=Homo sapiens GN=OR1A2 PE=2 SV=1 | 244 | L | 0.052334 | F | 0.047219 | 0.005115 | No Change: Both O | - |
| Q8NGR6 | OR1B1_HUMAN Olfactory receptor 1B1 OS=Homo sapiens GN=OR1B1 PE=2 SV=2 | 149 | L | 0.028177 | S | 0.068071 | -0.039894 | No Change: Both O | - |
| Q8NGR6 | OR1B1_HUMAN Olfactory receptor 1B1 OS=Homo sapiens GN=OR1B1 PE=2 SV=2 | 230 | A | 0.10895 | T | 0.112888 | -0.003938 | No Change: Both O | - |
| Q8NGR6 | OR1B1_HUMAN Olfactory receptor 1B1 OS=Homo sapiens GN=OR1B1 PE=2 SV=2 | 263 | C | 0.02294 | W | 0.016671 | 0.006269 | No Change: Both O | - |
| Q8NGR6 | OR1B1_HUMAN Olfactory receptor 1B1 OS=Homo sapiens GN=OR1B1 PE=2 SV=2 | 314 | V | 0.351575 | G | 0.47371 | -0.122135 | No Change: Both O | - |
| Q15619 | OR1C1_HUMAN Olfactory receptor 1C1 OS=Homo sapiens GN=OR1C1 PE=1 SV=4 | 209 | T | 0.035264 | M | 0.028301 | 0.006963 | No Change: Both O | - |
| P34982 | OR1D2_HUMAN Olfactory receptor 1D2 OS=Homo sapiens GN=OR1D2 PE=1 SV=2 | 25 | R | 0.236136 | Q | 0.269808 | -0.033672 | No Change: Both O | - |
| P34982 | OR1D2_HUMAN Olfactory receptor 1D2 OS=Homo sapiens GN=OR1D2 PE=1 SV=2 | 31 | F | 0.020051 | Y | 0.021538 | -0.001487 | No Change: Both O | - |
| P34982 | OR1D2_HUMAN Olfactory receptor 1D2 OS=Homo sapiens GN=OR1D2 PE=1 SV=2 | 240 | T | 0.302794 | I | 0.180597 | 0.122197 | No Change: Both O | - |
| P34982 | OR1D2_HUMAN Olfactory receptor 1D2 OS=Homo sapiens GN=OR1D2 PE=1 SV=2 | 214 | V | 0.010231 | M | 0.012939 | -0.002708 | No Change: Both O | - |
| P30953 | OR1E1_HUMAN Olfactory receptor 1E1 OS=Homo sapiens GN=OR1E1 PE=2 SV=1 | 143 | A | 0.033116 | T | 0.035489 | -0.002373 | No Change: Both O | - |
| P30953 | OR1E1_HUMAN Olfactory receptor 1E1 OS=Homo sapiens GN=OR1E1 PE=2 SV=1 | 129 | P | 0.032879 | L | 0.015745 | 0.017134 | No Change: Both O | - |
| P30953 | OR1E1_HUMAN Olfactory receptor 1E1 OS=Homo sapiens GN=OR1E1 PE=2 SV=1 | 262 | S | 0.285368 | P | 0.240223 | 0.045145 | No Change: Both O | - |
| P47887 | OR1E2_HUMAN Olfactory receptor 1E2 OS=Homo sapiens GN=OR1E2 PE=2 SV=2 | 27 | C | 0.07387 | R | 0.149388 | -0.075518 | No Change: Both O | - |
| P47887 | OR1E2_HUMAN Olfactory receptor 1E2 OS=Homo sapiens GN=OR1E2 PE=2 SV=2 | 168 | H | 0.107187 | D | 0.119545 | -0.012358 | No Change: Both O | A colorectal cancer sample |
| O43749 | OR1F1_HUMAN Olfactory receptor 1F1 OS=Homo sapiens GN=OR1F1 PE=2 SV=1 | 75 | F | 0.068062 | S | 0.173204 | -0.105142 | No Change: Both O | - |
| O43749 | OR1F1_HUMAN Olfactory receptor 1F1 OS=Homo sapiens GN=OR1F1 PE=2 SV=1 | 126 | V | 0.089039 | M | 0.112409 | -0.02337 | No Change: Both O | - |
| P47890 | OR1G1_HUMAN Olfactory receptor 1G1 OS=Homo sapiens GN=OR1G1 PE=2 SV=2 | 88 | Q | 0.325148 | H | 0.287449 | 0.037699 | No Change: Both O | - |
| O60431 | OR1I1_HUMAN Olfactory receptor 1I1 OS=Homo sapiens GN=OR1I1 PE=2 SV=1 | 139 | P | 0.050174 | R | 0.04301 | 0.007164 | No Change: Both O | - |
| O60431 | OR1I1_HUMAN Olfactory receptor 1I1 OS=Homo sapiens GN=OR1I1 PE=2 SV=1 | 211 | F | 0.090397 | L | 0.111002 | -0.020605 | No Change: Both O | - |
| O60431 | OR1I1_HUMAN Olfactory receptor 1I1 OS=Homo sapiens GN=OR1I1 PE=2 SV=1 | 252 | Y | 0.093497 | S | 0.213878 | -0.120381 | No Change: Both O | - |
| O60431 | OR1I1_HUMAN Olfactory receptor 1I1 OS=Homo sapiens GN=OR1I1 PE=2 SV=1 | 292 | I | 0.219208 | T | 0.303025 | -0.083817 | No Change: Both O | - |
| O60431 | OR1I1_HUMAN Olfactory receptor 1I1 OS=Homo sapiens GN=OR1I1 PE=2 SV=1 | 50 | I | 0.117703 | F | 0.105808 | 0.011895 | No Change: Both O | - |
| Q8NGS3 | OR1J1_HUMAN Olfactory receptor 1J1 OS=Homo sapiens GN=OR1J1 PE=2 SV=1 | 318 | N | 0.599077 | S | 0.620251 | -0.021174 | No Change: Both D | - |
| Q8NGS2 | OR1J2_HUMAN Olfactory receptor 1J2 OS=Homo sapiens GN=OR1J2 PE=2 SV=1 | 165 | R | 0.125405 | Q | 0.136243 | -0.010838 | No Change: Both O | - |
| Q8NGS2 | OR1J2_HUMAN Olfactory receptor 1J2 OS=Homo sapiens GN=OR1J2 PE=2 SV=1 | 119 | A | 0.099428 | T | 0.114883 | -0.015455 | No Change: Both O | - |
| Q8NGR3 | OR1K1_HUMAN Olfactory receptor 1K1 OS=Homo sapiens GN=OR1K1 PE=1 SV=1 | 271 | W | 0.399978 | R | 0.647532 | -0.247554 | O to D | - |
| Q8NH94 | OR1L1_HUMAN Olfactory receptor 1L1 OS=Homo sapiens GN=OR1L1 PE=2 SV=3 | 145 | S | 0.304023 | G | 0.239128 | 0.064895 | No Change: Both O | - |
| Q8NH94 | OR1L1_HUMAN Olfactory receptor 1L1 OS=Homo sapiens GN=OR1L1 PE=2 SV=3 | 149 | T | 0.073799 | A | 0.064135 | 0.009664 | No Change: Both O | - |
| Q8NH94 | OR1L1_HUMAN Olfactory receptor 1L1 OS=Homo sapiens GN=OR1L1 PE=2 SV=3 | 308 | L | 0.104694 | V | 0.098014 | 0.00668 | No Change: Both O | - |
| Q8NH94 | OR1L1_HUMAN Olfactory receptor 1L1 OS=Homo sapiens GN=OR1L1 PE=2 SV=3 | 349 | G | 0.555007 | R | 0.564646 | -0.009639 | No Change: Both D | - |
| Q8NH93 | OR1L3_HUMAN Olfactory receptor 1L3 OS=Homo sapiens GN=OR1L3 PE=2 SV=1 | 106 | V | 0.025437 | A | 0.038795 | -0.013358 | No Change: Both O | - |
| Q8NH93 | OR1L3_HUMAN Olfactory receptor 1L3 OS=Homo sapiens GN=OR1L3 PE=2 SV=1 | 121 | N | 0.044831 | D | 0.046258 | -0.001427 | No Change: Both O | - |
| Q8NH93 | OR1L3_HUMAN Olfactory receptor 1L3 OS=Homo sapiens GN=OR1L3 PE=2 SV=1 | 54 | R | 0.339703 | G | 0.355052 | -0.015349 | No Change: Both O | - |
| Q8NGR5 | OR1L4_HUMAN Olfactory receptor 1L4 OS=Homo sapiens GN=OR1L4 PE=2 SV=1 | 234 | G | 0.29063 | R | 0.284267 | 0.006363 | No Change: Both O | - |
| Q8NGR5 | OR1L4_HUMAN Olfactory receptor 1L4 OS=Homo sapiens GN=OR1L4 PE=2 SV=1 | 310 | Y | 0.753439 | H | 0.789748 | -0.036309 | No Change: Both D | - |
| Q8NGR2 | OR1L6_HUMAN Olfactory receptor 1L6 OS=Homo sapiens GN=OR1L6 PE=2 SV=2 | 59 | Q | 0.463229 | K | 0.509411 | -0.046182 | O to D | - |
| Q8NGR2 | OR1L6_HUMAN Olfactory receptor 1L6 OS=Homo sapiens GN=OR1L6 PE=2 SV=2 | 186 | C | 0.270725 | Y | 0.312119 | -0.041394 | No Change: Both O | - |
| Q8NGR2 | OR1L6_HUMAN Olfactory receptor 1L6 OS=Homo sapiens GN=OR1L6 PE=2 SV=2 | 251 | I | 0.01153 | T | 0.022424 | -0.010894 | No Change: Both O | - |
| Q8NGR2 | OR1L6_HUMAN Olfactory receptor 1L6 OS=Homo sapiens GN=OR1L6 PE=2 SV=2 | 259 | M | 0.036547 | I | 0.026082 | 0.010465 | No Change: Both O | - |
| Q8NGR8 | OR1L8_HUMAN Olfactory receptor 1L8 OS=Homo sapiens GN=OR1L8 PE=2 SV=1 | 27 | T | 0.224892 | P | 0.27312 | -0.048228 | No Change: Both O | - |
| Q8NGR8 | OR1L8_HUMAN Olfactory receptor 1L8 OS=Homo sapiens GN=OR1L8 PE=2 SV=1 | 211 | R | 0.018063 | P | 0.023312 | -0.005249 | No Change: Both O | - |
| Q8NGS0 | OR1N1_HUMAN Olfactory receptor 1N1 OS=Homo sapiens GN=OR1N1 PE=2 SV=1 | 18 | P | 0.588809 | S | 0.621784 | -0.032975 | No Change: Both D | - |
| Q8NGS0 | OR1N1_HUMAN Olfactory receptor 1N1 OS=Homo sapiens GN=OR1N1 PE=2 SV=1 | 190 | T | 0.280945 | N | 0.332869 | -0.051924 | No Change: Both O | A breast cancer sample |
| Q8NGS0 | OR1N1_HUMAN Olfactory receptor 1N1 OS=Homo sapiens GN=OR1N1 PE=2 SV=1 | 227 | R | 0.208978 | Q | 0.208032 | 9.46E-04 | No Change: Both O | - |
| Q8NGR9 | OR1N2_HUMAN Olfactory receptor 1N2 OS=Homo sapiens GN=OR1N2 PE=2 SV=2 | 37 | W | 0.369676 | R | 0.574296 | -0.20462 | O to D | - |
| Q8NGR9 | OR1N2_HUMAN Olfactory receptor 1N2 OS=Homo sapiens GN=OR1N2 PE=2 SV=2 | 244 | V | 0.049934 | G | 0.094793 | -0.044859 | No Change: Both O | - |
| Q8NGR9 | OR1N2_HUMAN Olfactory receptor 1N2 OS=Homo sapiens GN=OR1N2 PE=2 SV=2 | 301 | T | 0.055488 | M | 0.05024 | 0.005248 | No Change: Both O | - |
| Q8NGR9 | OR1N2_HUMAN Olfactory receptor 1N2 OS=Homo sapiens GN=OR1N2 PE=2 SV=2 | 237 | R | 0.007599 | C | 0.00332 | 0.004279 | No Change: Both O | - |
| Q15612 | OR1Q1_HUMAN Olfactory receptor 1Q1 OS=Homo sapiens GN=OR1Q1 PE=2 SV=3 | 163 | I | 0.035622 | M | 0.055022 | -0.0194 | No Change: Both O | - |
| Q15612 | OR1Q1_HUMAN Olfactory receptor 1Q1 OS=Homo sapiens GN=OR1Q1 PE=2 SV=3 | 24 | Q | 0.330257 | R | 0.309171 | 0.021086 | No Change: Both O | - |
| Q15612 | OR1Q1_HUMAN Olfactory receptor 1Q1 OS=Homo sapiens GN=OR1Q1 PE=2 SV=3 | 240 | T | 0.241439 | A | 0.205164 | 0.036275 | No Change: Both O | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 5 | S | 0.571106 | G | 0.513897 | 0.057209 | No Change: Both D | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 123 | I | 0.027295 | T | 0.052429 | -0.025134 | No Change: Both O | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 135 | H | 0.061149 | R | 0.057096 | 0.004053 | No Change: Both O | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 183 | N | 0.079406 | D | 0.079713 | -3.07E-04 | No Change: Both O | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 206 | L | 0.115569 | M | 0.136981 | -0.021412 | No Change: Both O | - |
| Q8NH92 | OR1S1_HUMAN Olfactory receptor 1S1 OS=Homo sapiens GN=OR1S1 PE=2 SV=2 | 227 | S | 0.025841 | I | 0.009179 | 0.016662 | No Change: Both O | - |
| Q8NGQ3 | OR1S2_HUMAN Olfactory receptor 1S2 OS=Homo sapiens GN=OR1S2 PE=2 SV=2 | 225 | V | 0.0091 | A | 0.012384 | -0.003284 | No Change: Both O | - |
| Q8NGQ3 | OR1S2_HUMAN Olfactory receptor 1S2 OS=Homo sapiens GN=OR1S2 PE=2 SV=2 | 225 | V | 0.0091 | I | 0.008127 | 9.73E-04 | No Change: Both O | - |
| Q8NGQ3 | OR1S2_HUMAN Olfactory receptor 1S2 OS=Homo sapiens GN=OR1S2 PE=2 SV=2 | 59 | I | 0.034878 | T | 0.06293 | -0.028052 | No Change: Both O | - |
| Q8NGT7 | O2A12_HUMAN Olfactory receptor 2A12 OS=Homo sapiens GN=OR2A12 PE=3 SV=1 | 223 | A | 0.045727 | T | 0.052487 | -0.00676 | No Change: Both O | - |
| Q96R47 | O2A14_HUMAN Olfactory receptor 2A14 OS=Homo sapiens GN=OR2A14 PE=2 SV=4 | 133 | S | 0.146719 | I | 0.052084 | 0.094635 | No Change: Both O | - |
| Q96R47 | O2A14_HUMAN Olfactory receptor 2A14 OS=Homo sapiens GN=OR2A14 PE=2 SV=4 | 164 | S | 0.056126 | R | 0.041035 | 0.015091 | No Change: Both O | - |
| Q6IF42 | OR2A2_HUMAN Olfactory receptor 2A2 OS=Homo sapiens GN=OR2A2 PE=2 SV=2 | 210 | L | 0.057397 | P | 0.115765 | -0.058368 | No Change: Both O | - |
| Q6IF42 | OR2A2_HUMAN Olfactory receptor 2A2 OS=Homo sapiens GN=OR2A2 PE=2 SV=2 | 5 | Q | 0.585313 | K | 0.624011 | -0.038698 | No Change: Both D | - |
| Q6IF42 | OR2A2_HUMAN Olfactory receptor 2A2 OS=Homo sapiens GN=OR2A2 PE=2 SV=2 | 280 | F | 0.214023 | L | 0.249976 | -0.035953 | No Change: Both O | - |
| A4D2G3 | O2A25_HUMAN Olfactory receptor 2A25 OS=Homo sapiens GN=OR2A25 PE=2 SV=2 | 75 | S | 0.076159 | N | 0.065035 | 0.011124 | No Change: Both O | - |
| A4D2G3 | O2A25_HUMAN Olfactory receptor 2A25 OS=Homo sapiens GN=OR2A25 PE=2 SV=2 | 209 | A | 0.073486 | P | 0.101396 | -0.02791 | No Change: Both O | - |
| Q96R48 | OR2A5_HUMAN Olfactory receptor 2A5 OS=Homo sapiens GN=OR2A5 PE=2 SV=2 | 126 | I | 0.090873 | V | 0.105364 | -0.014491 | No Change: Both O | - |
| Q96R48 | OR2A5_HUMAN Olfactory receptor 2A5 OS=Homo sapiens GN=OR2A5 PE=2 SV=2 | 202 | A | 0.024166 | S | 0.041332 | -0.017166 | No Change: Both O | - |
| Q96R48 | OR2A5_HUMAN Olfactory receptor 2A5 OS=Homo sapiens GN=OR2A5 PE=2 SV=2 | 255 | A | 0.094603 | T | 0.101095 | -0.006492 | No Change: Both O | - |
| Q8NHA4 | O2AE1_HUMAN Olfactory receptor 2AE1 OS=Homo sapiens GN=OR2AE1 PE=2 SV=1 | 77 | I | 0.120097 | T | 0.217556 | -0.097459 | No Change: Both O | - |
| Q8NHA4 | O2AE1_HUMAN Olfactory receptor 2AE1 OS=Homo sapiens GN=OR2AE1 PE=2 SV=1 | 267 | L | 0.262532 | V | 0.264776 | -0.002244 | No Change: Both O | - |
| Q8NHA4 | O2AE1_HUMAN Olfactory receptor 2AE1 OS=Homo sapiens GN=OR2AE1 PE=2 SV=1 | 217 | Y | 0.047546 | C | 0.038324 | 0.009222 | No Change: Both O | - |
| Q9H205 | O2AG1_HUMAN Olfactory receptor 2AG1 OS=Homo sapiens GN=OR2AG1 PE=2 SV=2 | 187 | V | 0.135765 | L | 0.147226 | -0.011461 | No Change: Both O | - |
| Q9H205 | O2AG1_HUMAN Olfactory receptor 2AG1 OS=Homo sapiens GN=OR2AG1 PE=2 SV=2 | 299 | R | 0.271462 | G | 0.268319 | 0.003143 | No Change: Both O | - |
| Q9H205 | O2AG1_HUMAN Olfactory receptor 2AG1 OS=Homo sapiens GN=OR2AG1 PE=2 SV=2 | 299 | R | 0.271462 | W | 0.109156 | 0.162306 | No Change: Both O | - |
| A6NM03 | O2AG2_HUMAN Olfactory receptor 2AG2 OS=Homo sapiens GN=OR2AG2 PE=2 SV=1 | 28 | Y | 0.122519 | C | 0.099776 | 0.022743 | No Change: Both O | - |
| A6NM03 | O2AG2_HUMAN Olfactory receptor 2AG2 OS=Homo sapiens GN=OR2AG2 PE=2 SV=1 | 54 | R | 0.12059 | P | 0.151276 | -0.030686 | No Change: Both O | - |
| A6NM03 | O2AG2_HUMAN Olfactory receptor 2AG2 OS=Homo sapiens GN=OR2AG2 PE=2 SV=1 | 87 | R | 0.226075 | L | 0.144638 | 0.081437 | No Change: Both O | - |
| A6NM03 | O2AG2_HUMAN Olfactory receptor 2AG2 OS=Homo sapiens GN=OR2AG2 PE=2 SV=1 | 299 | R | 0.27195 | G | 0.269761 | 0.002189 | No Change: Both O | - |
| Q8NG84 | O2AK2_HUMAN Olfactory receptor 2AK2 OS=Homo sapiens GN=OR2AK2 PE=2 SV=2 | 99 | S | 0.346347 | N | 0.282074 | 0.064273 | No Change: Both O | - |
| Q8NG84 | O2AK2_HUMAN Olfactory receptor 2AK2 OS=Homo sapiens GN=OR2AK2 PE=2 SV=2 | 203 | V | 0.148061 | M | 0.185581 | -0.03752 | No Change: Both O | - |
| Q5JQS5 | OR2BB_HUMAN Olfactory receptor 2B11 OS=Homo sapiens GN=OR2B11 PE=2 SV=1 | 198 | V | 0.160503 | M | 0.199658 | -0.039155 | No Change: Both O | - |
| Q5JQS5 | OR2BB_HUMAN Olfactory receptor 2B11 OS=Homo sapiens GN=OR2B11 PE=2 SV=1 | 223 | G | 0.036342 | D | 0.041313 | -0.004971 | No Change: Both O | - |
| Q5JQS5 | OR2BB_HUMAN Olfactory receptor 2B11 OS=Homo sapiens GN=OR2B11 PE=2 SV=1 | 293 | T | 0.225863 | I | 0.121292 | 0.104571 | No Change: Both O | - |
| Q5JQS5 | OR2BB_HUMAN Olfactory receptor 2B11 OS=Homo sapiens GN=OR2B11 PE=2 SV=1 | 300 | D | 0.498049 | G | 0.483683 | 0.014366 | No Change: Both O | - |
| Q5JQS5 | OR2BB_HUMAN Olfactory receptor 2B11 OS=Homo sapiens GN=OR2B11 PE=2 SV=1 | 130 | I | 0.068859 | S | 0.181329 | -0.11247 | No Change: Both O | - |
| Q9GZK3 | OR2B2_HUMAN Olfactory receptor 2B2 OS=Homo sapiens GN=OR2B2 PE=2 SV=1 | 234 | Q | 0.561026 | R | 0.542328 | 0.018698 | No Change: Both D | - |
| Q9GZK3 | OR2B2_HUMAN Olfactory receptor 2B2 OS=Homo sapiens GN=OR2B2 PE=2 SV=1 | 183 | A | 0.076281 | P | 0.118556 | -0.042275 | No Change: Both O | - |
| Q9GZK3 | OR2B2_HUMAN Olfactory receptor 2B2 OS=Homo sapiens GN=OR2B2 PE=2 SV=1 | 300 | A | 0.430465 | S | 0.539211 | -0.108746 | O to D | - |
| P58173 | OR2B6_HUMAN Olfactory receptor 2B6 OS=Homo sapiens GN=OR2B6 PE=2 SV=1 | 270 | Q | 0.749771 | R | 0.737372 | 0.012399 | No Change: Both D | - |
| P58173 | OR2B6_HUMAN Olfactory receptor 2B6 OS=Homo sapiens GN=OR2B6 PE=2 SV=1 | 117 | V | 0.053232 | I | 0.044693 | 0.008539 | No Change: Both O | - |
| O95371 | OR2C1_HUMAN Olfactory receptor 2C1 OS=Homo sapiens GN=OR2C1 PE=2 SV=3 | 16 | G | 0.232567 | S | 0.284485 | -0.051918 | No Change: Both O | - |
| O95371 | OR2C1_HUMAN Olfactory receptor 2C1 OS=Homo sapiens GN=OR2C1 PE=2 SV=3 | 149 | C | 0.037012 | W | 0.031389 | 0.005623 | No Change: Both O | - |
| O95371 | OR2C1_HUMAN Olfactory receptor 2C1 OS=Homo sapiens GN=OR2C1 PE=2 SV=3 | 229 | R | 0.384167 | H | 0.364681 | 0.019486 | No Change: Both O | - |
| Q8N628 | OR2C3_HUMAN Olfactory receptor 2C3 OS=Homo sapiens GN=OR2C3 PE=2 SV=3 | 20 | T | 0.254098 | A | 0.217185 | 0.036913 | No Change: Both O | - |
| Q8N628 | OR2C3_HUMAN Olfactory receptor 2C3 OS=Homo sapiens GN=OR2C3 PE=2 SV=3 | 68 | P | 0.098764 | S | 0.118601 | -0.019837 | No Change: Both O | - |
| Q8N628 | OR2C3_HUMAN Olfactory receptor 2C3 OS=Homo sapiens GN=OR2C3 PE=2 SV=3 | 129 | R | 0.077226 | S | 0.099876 | -0.02265 | No Change: Both O | - |
| Q8N628 | OR2C3_HUMAN Olfactory receptor 2C3 OS=Homo sapiens GN=OR2C3 PE=2 SV=3 | 289 | L | 0.124333 | V | 0.121902 | 0.002431 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 148 | S | 0.167687 | P | 0.138483 | 0.029204 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 163 | I | 0.074469 | M | 0.113326 | -0.038857 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 163 | I | 0.074469 | T | 0.148207 | -0.073738 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 202 | M | 0.025382 | T | 0.029341 | -0.003959 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 84 | H | 0.127695 | Y | 0.075158 | 0.052537 | No Change: Both O | - |
| Q9H210 | OR2D2_HUMAN Olfactory receptor 2D2 OS=Homo sapiens GN=OR2D2 PE=2 SV=4 | 220 | R | 0.035361 | G | 0.040569 | -0.005208 | No Change: Both O | - |
| Q8NGH3 | OR2D3_HUMAN Olfactory receptor 2D3 OS=Homo sapiens GN=OR2D3 PE=2 SV=2 | 82 | L | 0.068703 | I | 0.054459 | 0.014244 | No Change: Both O | - |
| Q8NGH3 | OR2D3_HUMAN Olfactory receptor 2D3 OS=Homo sapiens GN=OR2D3 PE=2 SV=2 | 155 | R | 0.045319 | W | 0.017598 | 0.027721 | No Change: Both O | - |
| Q8NGH3 | OR2D3_HUMAN Olfactory receptor 2D3 OS=Homo sapiens GN=OR2D3 PE=2 SV=2 | 165 | W | 0.132937 | S | 0.374278 | -0.241341 | No Change: Both O | - |
| Q13607 | OR2F1_HUMAN Olfactory receptor 2F1 OS=Homo sapiens GN=OR2F1 PE=2 SV=2 | 122 | R | 0.062726 | C | 0.029613 | 0.033113 | No Change: Both O | - |
| Q13607 | OR2F1_HUMAN Olfactory receptor 2F1 OS=Homo sapiens GN=OR2F1 PE=2 SV=2 | 137 | H | 0.13309 | R | 0.142719 | -0.009629 | No Change: Both O | - |
| O95006 | OR2F2_HUMAN Olfactory receptor 2F2 OS=Homo sapiens GN=OR2F2 PE=2 SV=1 | 98 | A | 0.109043 | V | 0.06933 | 0.039713 | No Change: Both O | - |
| O95006 | OR2F2_HUMAN Olfactory receptor 2F2 OS=Homo sapiens GN=OR2F2 PE=2 SV=1 | 170 | T | 0.117686 | A | 0.101162 | 0.016524 | No Change: Both O | - |
| O95006 | OR2F2_HUMAN Olfactory receptor 2F2 OS=Homo sapiens GN=OR2F2 PE=2 SV=1 | 278 | Y | 0.026823 | H | 0.047626 | -0.020803 | No Change: Both O | - |
| Q8NGZ5 | OR2G2_HUMAN Olfactory receptor 2G2 OS=Homo sapiens GN=OR2G2 PE=2 SV=1 | 24 | P | 0.166898 | A | 0.117344 | 0.049554 | No Change: Both O | - |
| Q8NGZ5 | OR2G2_HUMAN Olfactory receptor 2G2 OS=Homo sapiens GN=OR2G2 PE=2 SV=1 | 120 | V | 0.105991 | L | 0.10361 | 0.002381 | No Change: Both O | - |
| Q8NGZ5 | OR2G2_HUMAN Olfactory receptor 2G2 OS=Homo sapiens GN=OR2G2 PE=2 SV=1 | 167 | L | 0.163805 | P | 0.294539 | -0.130734 | No Change: Both O | - |
| Q8NGZ5 | OR2G2_HUMAN Olfactory receptor 2G2 OS=Homo sapiens GN=OR2G2 PE=2 SV=1 | 236 | R | 0.420198 | G | 0.427275 | -0.007077 | No Change: Both O | - |
| Q8NGZ4 | OR2G3_HUMAN Olfactory receptor 2G3 OS=Homo sapiens GN=OR2G3 PE=2 SV=1 | 258 | V | 0.058491 | M | 0.077415 | -0.018924 | No Change: Both O | - |
| Q8NGZ4 | OR2G3_HUMAN Olfactory receptor 2G3 OS=Homo sapiens GN=OR2G3 PE=2 SV=1 | 164 | L | 0.11849 | S | 0.234777 | -0.116287 | No Change: Both O | - |
| Q5TZ20 | OR2G6_HUMAN Olfactory receptor 2G6 OS=Homo sapiens GN=OR2G6 PE=2 SV=1 | 258 | M | 0.046573 | L | 0.036628 | 0.009945 | No Change: Both O | - |
| Q5TZ20 | OR2G6_HUMAN Olfactory receptor 2G6 OS=Homo sapiens GN=OR2G6 PE=2 SV=1 | 59 | M | 0.140508 | V | 0.10678 | 0.033728 | No Change: Both O | - |
| Q9GZK4 | OR2H1_HUMAN Olfactory receptor 2H1 OS=Homo sapiens GN=OR2H1 PE=2 SV=1 | 63 | D | 0.111329 | N | 0.097164 | 0.014165 | No Change: Both O | - |
| Q9GZK4 | OR2H1_HUMAN Olfactory receptor 2H1 OS=Homo sapiens GN=OR2H1 PE=2 SV=1 | 223 | V | 0.207537 | M | 0.262692 | -0.055155 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 30 | L | 0.039979 | S | 0.090886 | -0.050907 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 48 | A | 0.212702 | V | 0.157471 | 0.055231 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 220 | T | 0.036192 | A | 0.035025 | 0.001167 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 30 | L | 0.039979 | I | 0.030029 | 0.00995 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 38 | V | 0.058071 | M | 0.076786 | -0.018715 | No Change: Both O | - |
| O95918 | OR2H2_HUMAN Olfactory receptor 2H2 OS=Homo sapiens GN=OR2H2 PE=2 SV=2 | 30 | L | 0.039979 | F | 0.03293 | 0.007049 | No Change: Both O | - |
| Q9GZK6 | OR2J1_HUMAN Olfactory receptor 2J1 OS=Homo sapiens GN=OR2J1 PE=3 SV=2 | 14 | L | 0.06562 | I | 0.052015 | 0.013605 | No Change: Both O | - |
| O76002 | OR2J2_HUMAN Olfactory receptor 2J2 OS=Homo sapiens GN=OR2J2 PE=2 SV=1 | 74 | H | 0.210534 | Y | 0.128369 | 0.082165 | No Change: Both O | - |
| O76002 | OR2J2_HUMAN Olfactory receptor 2J2 OS=Homo sapiens GN=OR2J2 PE=2 SV=1 | 111 | A | 0.025523 | T | 0.027303 | -0.00178 | No Change: Both O | - |
| O76002 | OR2J2_HUMAN Olfactory receptor 2J2 OS=Homo sapiens GN=OR2J2 PE=2 SV=1 | 146 | A | 0.043885 | V | 0.029093 | 0.014792 | No Change: Both O | - |
| O76002 | OR2J2_HUMAN Olfactory receptor 2J2 OS=Homo sapiens GN=OR2J2 PE=2 SV=1 | 218 | A | 0.0383 | T | 0.04241 | -0.00411 | No Change: Both O | - |
| O76001 | OR2J3_HUMAN Olfactory receptor 2J3 OS=Homo sapiens GN=OR2J3 PE=2 SV=1 | 113 | T | 0.05653 | A | 0.049206 | 0.007324 | No Change: Both O | - |
| O76001 | OR2J3_HUMAN Olfactory receptor 2J3 OS=Homo sapiens GN=OR2J3 PE=2 SV=1 | 226 | R | 0.10909 | Q | 0.11815 | -0.00906 | No Change: Both O | - |
| O76001 | OR2J3_HUMAN Olfactory receptor 2J3 OS=Homo sapiens GN=OR2J3 PE=2 SV=1 | 228 | V | 0.150584 | I | 0.132039 | 0.018545 | No Change: Both O | - |
| O76001 | OR2J3_HUMAN Olfactory receptor 2J3 OS=Homo sapiens GN=OR2J3 PE=2 SV=1 | 261 | I | 0.073663 | M | 0.111379 | -0.037716 | No Change: Both O | - |
| Q8N349 | OR2LD_HUMAN Olfactory receptor 2L13 OS=Homo sapiens GN=OR2L13 PE=2 SV=1 | 156 | L | 0.182819 | F | 0.161638 | 0.021181 | No Change: Both O | - |
| Q8N349 | OR2LD_HUMAN Olfactory receptor 2L13 OS=Homo sapiens GN=OR2L13 PE=2 SV=1 | 265 | R | 0.536058 | H | 0.518197 | 0.017861 | No Change: Both D | - |
| Q8NH16 | OR2L2_HUMAN Olfactory receptor 2L2 OS=Homo sapiens GN=OR2L2 PE=2 SV=1 | 249 | F | 0.076634 | L | 0.087217 | -0.010583 | No Change: Both O | - |
| Q8NH16 | OR2L2_HUMAN Olfactory receptor 2L2 OS=Homo sapiens GN=OR2L2 PE=2 SV=1 | 259 | V | 0.252459 | L | 0.263766 | -0.011307 | No Change: Both O | - |
| Q8NG85 | OR2L3_HUMAN Olfactory receptor 2L3 OS=Homo sapiens GN=OR2L3 PE=2 SV=1 | 104 | S | 0.14176 | L | 0.062391 | 0.079369 | No Change: Both O | - |
| Q8NG85 | OR2L3_HUMAN Olfactory receptor 2L3 OS=Homo sapiens GN=OR2L3 PE=2 SV=1 | 39 | I | 0.035547 | T | 0.062278 | -0.026731 | No Change: Both O | - |
| Q8NG85 | OR2L3_HUMAN Olfactory receptor 2L3 OS=Homo sapiens GN=OR2L3 PE=2 SV=1 | 78 | P | 0.221729 | L | 0.125246 | 0.096483 | No Change: Both O | - |
| Q8NG85 | OR2L3_HUMAN Olfactory receptor 2L3 OS=Homo sapiens GN=OR2L3 PE=2 SV=1 | 139 | M | 0.132556 | V | 0.098389 | 0.034167 | No Change: Both O | - |
| Q8NGY9 | OR2L8_HUMAN Olfactory receptor 2L8 OS=Homo sapiens GN=OR2L8 PE=2 SV=1 | 217 | Y | 0.06853 | C | 0.056296 | 0.012234 | No Change: Both O | - |
| Q8NGY9 | OR2L8_HUMAN Olfactory receptor 2L8 OS=Homo sapiens GN=OR2L8 PE=2 SV=1 | 196 | G | 0.071215 | C | 0.030444 | 0.040771 | No Change: Both O | - |
| Q8NGY9 | OR2L8_HUMAN Olfactory receptor 2L8 OS=Homo sapiens GN=OR2L8 PE=2 SV=1 | 202 | A | 0.03588 | T | 0.045775 | -0.009895 | No Change: Both O | - |
| Q8NGY9 | OR2L8_HUMAN Olfactory receptor 2L8 OS=Homo sapiens GN=OR2L8 PE=2 SV=1 | 294 | K | 0.277446 | R | 0.238533 | 0.038913 | No Change: Both O | - |
| Q8NGY9 | OR2L8_HUMAN Olfactory receptor 2L8 OS=Homo sapiens GN=OR2L8 PE=2 SV=1 | 226 | H | 0.212624 | R | 0.219071 | -0.006447 | No Change: Both O | - |
| Q96R28 | OR2M2_HUMAN Olfactory receptor 2M2 OS=Homo sapiens GN=OR2M2 PE=2 SV=2 | 237 | A | 0.391047 | T | 0.448572 | -0.057525 | No Change: Both O | - |
| Q96R28 | OR2M2_HUMAN Olfactory receptor 2M2 OS=Homo sapiens GN=OR2M2 PE=2 SV=2 | 220 | R | 0.038385 | G | 0.041573 | -0.003188 | No Change: Both O | - |
| Q96R28 | OR2M2_HUMAN Olfactory receptor 2M2 OS=Homo sapiens GN=OR2M2 PE=2 SV=2 | 235 | C | 0.491161 | R | 0.683824 | -0.192663 | O to D | - |
| Q96R28 | OR2M2_HUMAN Olfactory receptor 2M2 OS=Homo sapiens GN=OR2M2 PE=2 SV=2 | 87 | S | 0.453876 | C | 0.207665 | 0.246211 | No Change: Both O | - |
| A3KFT3 | OR2M5_HUMAN Olfactory receptor 2M5 OS=Homo sapiens GN=OR2M5 PE=2 SV=1 | 244 | H | 0.164788 | N | 0.178367 | -0.013579 | No Change: Both O | - |
| Q8NG81 | OR2M7_HUMAN Olfactory receptor 2M7 OS=Homo sapiens GN=OR2M7 PE=2 SV=1 | 78 | V | 0.085332 | A | 0.131758 | -0.046426 | No Change: Both O | - |
| Q8NG81 | OR2M7_HUMAN Olfactory receptor 2M7 OS=Homo sapiens GN=OR2M7 PE=2 SV=1 | 178 | C | 0.058329 | F | 0.063095 | -0.004766 | No Change: Both O | - |
| Q8NG81 | OR2M7_HUMAN Olfactory receptor 2M7 OS=Homo sapiens GN=OR2M7 PE=2 SV=1 | 35 | F | 0.026793 | L | 0.030783 | -0.00399 | No Change: Both O | - |
| Q8NG81 | OR2M7_HUMAN Olfactory receptor 2M7 OS=Homo sapiens GN=OR2M7 PE=2 SV=1 | 191 | D | 0.155638 | N | 0.155237 | 4.01E-04 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 17 | R | 0.15709 | G | 0.175869 | -0.018779 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 30 | V | 0.025382 | M | 0.036484 | -0.011102 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 89 | P | 0.318002 | S | 0.366421 | -0.048419 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 123 | R | 0.063241 | H | 0.059281 | 0.00396 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 143 | M | 0.371225 | V | 0.292408 | 0.078817 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 161 | T | 0.175376 | A | 0.17188 | 0.003496 | No Change: Both O | - |
| Q9NQN1 | OR2S1_HUMAN Olfactory receptor 2S2 OS=Homo sapiens GN=OR2S2 PE=2 SV=2 | 287 | V | 0.102952 | A | 0.134053 | -0.031101 | No Change: Both O | - |
| O43869 | OR2T1_HUMAN Olfactory receptor 2T1 OS=Homo sapiens GN=OR2T1 PE=2 SV=3 | 25 | H | 0.033873 | R | 0.033356 | 5.17E-04 | No Change: Both O | - |
| Q8NH01 | O2T11_HUMAN Olfactory receptor 2T11 OS=Homo sapiens GN=OR2T11 PE=2 SV=1 | 119 | C | 0.027001 | R | 0.057554 | -0.030553 | No Change: Both O | - |
| Q8NH01 | O2T11_HUMAN Olfactory receptor 2T11 OS=Homo sapiens GN=OR2T11 PE=2 SV=1 | 309 | Q | 0.493786 | R | 0.475167 | 0.018619 | No Change: Both O | - |
| Q8NG77 | O2T12_HUMAN Olfactory receptor 2T12 OS=Homo sapiens GN=OR2T12 PE=2 SV=1 | 296 | K | 0.465413 | N | 0.423563 | 0.04185 | No Change: Both O | - |
| Q8NG77 | O2T12_HUMAN Olfactory receptor 2T12 OS=Homo sapiens GN=OR2T12 PE=2 SV=1 | 41 | A | 0.071027 | S | 0.126145 | -0.055118 | No Change: Both O | - |
| Q8NG77 | O2T12_HUMAN Olfactory receptor 2T12 OS=Homo sapiens GN=OR2T12 PE=2 SV=1 | 69 | M | 0.257033 | V | 0.200718 | 0.056315 | No Change: Both O | - |
| Q8NG77 | O2T12_HUMAN Olfactory receptor 2T12 OS=Homo sapiens GN=OR2T12 PE=2 SV=1 | 104 | T | 0.076137 | S | 0.108486 | -0.032349 | No Change: Both O | - |
| Q8NG77 | O2T12_HUMAN Olfactory receptor 2T12 OS=Homo sapiens GN=OR2T12 PE=2 SV=1 | 301 | R | 0.151173 | L | 0.096439 | 0.054734 | No Change: Both O | - |
| Q8NH04 | O2T27_HUMAN Olfactory receptor 2T27 OS=Homo sapiens GN=OR2T27 PE=2 SV=1 | 36 | L | 0.036991 | V | 0.037076 | -8.50E-05 | No Change: Both O | - |
| Q8NH04 | O2T27_HUMAN Olfactory receptor 2T27 OS=Homo sapiens GN=OR2T27 PE=2 SV=1 | 45 | K | 0.08339 | M | 0.046465 | 0.036925 | No Change: Both O | - |
| Q8NH03 | OR2T3_HUMAN Olfactory receptor 2T3 OS=Homo sapiens GN=OR2T3 PE=2 SV=2 | 204 | M | 0.03186 | T | 0.03917 | -0.00731 | No Change: Both O | - |
| Q8NG76 | O2T33_HUMAN Olfactory receptor 2T33 OS=Homo sapiens GN=OR2T33 PE=2 SV=1 | 169 | A | 0.139168 | V | 0.10073 | 0.038438 | No Change: Both O | - |
| Q8NH00 | OR2T4_HUMAN Olfactory receptor 2T4 OS=Homo sapiens GN=OR2T4 PE=2 SV=2 | 31 | N | 0.315594 | S | 0.35915 | -0.043556 | No Change: Both O | - |
| Q8NHC8 | OR2T6_HUMAN Olfactory receptor 2T6 OS=Homo sapiens GN=OR2T6 PE=2 SV=2 | 57 | T | 0.182905 | N | 0.220062 | -0.037157 | No Change: Both O | - |
| Q8NHC8 | OR2T6_HUMAN Olfactory receptor 2T6 OS=Homo sapiens GN=OR2T6 PE=2 SV=2 | 159 | L | 0.140259 | P | 0.260988 | -0.120729 | No Change: Both O | - |
| Q8NHC8 | OR2T6_HUMAN Olfactory receptor 2T6 OS=Homo sapiens GN=OR2T6 PE=2 SV=2 | 243 | S | 0.191886 | A | 0.127224 | 0.064662 | No Change: Both O | - |
| Q8NHC8 | OR2T6_HUMAN Olfactory receptor 2T6 OS=Homo sapiens GN=OR2T6 PE=2 SV=2 | 21 | N | 0.178604 | D | 0.189657 | -0.011053 | No Change: Both O | - |
| Q8NHC8 | OR2T6_HUMAN Olfactory receptor 2T6 OS=Homo sapiens GN=OR2T6 PE=2 SV=2 | 23 | C | 0.146921 | G | 0.307416 | -0.160495 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 39 | G | 0.106955 | S | 0.148115 | -0.04116 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 49 | W | 0.094936 | R | 0.230337 | -0.135401 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 179 | T | 0.072375 | A | 0.065952 | 0.006423 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 197 | M | 0.036865 | R | 0.047558 | -0.010693 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 221 | A | 0.091688 | S | 0.151922 | -0.060234 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 305 | R | 0.189729 | W | 0.067721 | 0.122008 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 69 | V | 0.201093 | M | 0.258442 | -0.057349 | No Change: Both O | - |
| A6NH00 | OR2T8_HUMAN Olfactory receptor 2T8 OS=Homo sapiens GN=OR2T8 PE=2 SV=1 | 311 | R | 0.709605 | H | 0.759528 | -0.049923 | No Change: Both D | - |
| Q96R30 | OR2V2_HUMAN Olfactory receptor 2V2 OS=Homo sapiens GN=OR2V2 PE=2 SV=3 | 34 | A | 0.026406 | V | 0.019204 | 0.007202 | No Change: Both O | - |
| Q96R30 | OR2V2_HUMAN Olfactory receptor 2V2 OS=Homo sapiens GN=OR2V2 PE=2 SV=3 | 221 | H | 0.072082 | R | 0.069346 | 0.002736 | No Change: Both O | - |
| Q9Y3N9 | OR2W1_HUMAN Olfactory receptor 2W1 OS=Homo sapiens GN=OR2W1 PE=2 SV=1 | 81 | M | 0.070997 | V | 0.056764 | 0.014233 | No Change: Both O | - |
| Q9Y3N9 | OR2W1_HUMAN Olfactory receptor 2W1 OS=Homo sapiens GN=OR2W1 PE=2 SV=1 | 296 | D | 0.498067 | N | 0.490837 | 0.00723 | No Change: Both O | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 169 | C | 0.308514 | S | 0.544136 | -0.235622 | O to D | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 179 | R | 0.259929 | C | 0.132419 | 0.12751 | No Change: Both O | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 190 | V | 0.070989 | I | 0.062696 | 0.008293 | No Change: Both O | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 196 | E | 0.093984 | D | 0.083802 | 0.010182 | No Change: Both O | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 272 | M | 0.256043 | K | 0.351086 | -0.095043 | No Change: Both O | - |
| Q7Z3T1 | OR2W3_HUMAN Olfactory receptor 2W3 OS=Homo sapiens GN=OR2W3 PE=2 SV=2 | 275 | M | 0.044981 | T | 0.052684 | -0.007703 | No Change: Both O | - |
| Q8NGV0 | OR2Y1_HUMAN Olfactory receptor 2Y1 OS=Homo sapiens GN=OR2Y1 PE=2 SV=1 | 200 | V | 0.089684 | L | 0.079738 | 0.009946 | No Change: Both O | - |
| Q8NGV0 | OR2Y1_HUMAN Olfactory receptor 2Y1 OS=Homo sapiens GN=OR2Y1 PE=2 SV=1 | 128 | R | 0.08764 | C | 0.04055 | 0.04709 | No Change: Both O | - |
| Q8NGV0 | OR2Y1_HUMAN Olfactory receptor 2Y1 OS=Homo sapiens GN=OR2Y1 PE=2 SV=1 | 154 | V | 0.111797 | M | 0.146978 | -0.035181 | No Change: Both O | - |
| Q8NG97 | OR2Z1_HUMAN Olfactory receptor 2Z1 OS=Homo sapiens GN=OR2Z1 PE=2 SV=1 | 138 | R | 0.091023 | C | 0.042046 | 0.048977 | No Change: Both O | - |
| P47881 | OR3A1_HUMAN Olfactory receptor 3A1 OS=Homo sapiens GN=OR3A1 PE=2 SV=2 | 125 | R | 0.053774 | Q | 0.055477 | -0.001703 | No Change: Both O | - |
| P47881 | OR3A1_HUMAN Olfactory receptor 3A1 OS=Homo sapiens GN=OR3A1 PE=2 SV=2 | 78 | S | 0.133449 | G | 0.104117 | 0.029332 | No Change: Both O | - |
| P47893 | OR3A2_HUMAN Olfactory receptor 3A2 OS=Homo sapiens GN=OR3A2 PE=2 SV=3 | 190 | L | 0.10728 | V | 0.10191 | 0.00537 | No Change: Both O | - |
| P47888 | OR3A3_HUMAN Olfactory receptor 3A3 OS=Homo sapiens GN=OR3A3 PE=2 SV=3 | 132 | L | 0.067788 | F | 0.053928 | 0.01386 | No Change: Both O | - |
| P47888 | OR3A3_HUMAN Olfactory receptor 3A3 OS=Homo sapiens GN=OR3A3 PE=2 SV=3 | 158 | W | 0.063092 | L | 0.103793 | -0.040701 | No Change: Both O | - |
| P47888 | OR3A3_HUMAN Olfactory receptor 3A3 OS=Homo sapiens GN=OR3A3 PE=2 SV=3 | 287 | M | 0.096512 | V | 0.077057 | 0.019455 | No Change: Both O | - |
| P47888 | OR3A3_HUMAN Olfactory receptor 3A3 OS=Homo sapiens GN=OR3A3 PE=2 SV=3 | 317 | K | 0.538206 | E | 0.547923 | -0.009717 | No Change: Both D | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 42 | I | 0.100539 | V | 0.114987 | -0.014448 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 86 | S | 0.210437 | R | 0.155629 | 0.054808 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 103 | E | 0.063748 | Q | 0.0515 | 0.012248 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 120 | I | 0.030472 | V | 0.034786 | -0.004314 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 168 | P | 0.154287 | T | 0.126766 | 0.027521 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 175 | N | 0.11287 | S | 0.128905 | -0.016035 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 181 | Y | 0.081785 | H | 0.152762 | -0.070977 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 193 | S | 0.322708 | A | 0.200237 | 0.122471 | No Change: Both O | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 237 | R | 0.665846 | K | 0.722845 | -0.056999 | No Change: Both D | - |
| P47883 | OR3A4_HUMAN Putative olfactory receptor 3A4 OS=Homo sapiens GN=OR3A4P PE=5 SV=4 | 300 | V | 0.152259 | I | 0.146892 | 0.005367 | No Change: Both O | - |
| Q8NGL6 | O4A15_HUMAN Olfactory receptor 4A15 OS=Homo sapiens GN=OR4A15 PE=2 SV=3 | 26 | P | 0.69737 | S | 0.711315 | -0.013945 | No Change: Both D | - |
| Q8NGL6 | O4A15_HUMAN Olfactory receptor 4A15 OS=Homo sapiens GN=OR4A15 PE=2 SV=3 | 287 | A | 0.082501 | V | 0.05919 | 0.023311 | No Change: Both O | - |
| Q8NH70 | O4A16_HUMAN Olfactory receptor 4A16 OS=Homo sapiens GN=OR4A16 PE=2 SV=1 | 188 | L | 0.026354 | I | 0.021465 | 0.004889 | No Change: Both O | - |
| Q8NH70 | O4A16_HUMAN Olfactory receptor 4A16 OS=Homo sapiens GN=OR4A16 PE=2 SV=1 | 303 | K | 0.214195 | M | 0.14844 | 0.065755 | No Change: Both O | - |
| Q8NH70 | O4A16_HUMAN Olfactory receptor 4A16 OS=Homo sapiens GN=OR4A16 PE=2 SV=1 | 232 | H | 0.608829 | R | 0.618682 | -0.009853 | No Change: Both D | - |
| Q6IF82 | O4A47_HUMAN Olfactory receptor 4A47 OS=Homo sapiens GN=OR4A47 PE=2 SV=2 | 82 | G | 0.208279 | D | 0.217319 | -0.00904 | No Change: Both O | - |
| Q6IF82 | O4A47_HUMAN Olfactory receptor 4A47 OS=Homo sapiens GN=OR4A47 PE=2 SV=2 | 104 | I | 0.099833 | L | 0.115032 | -0.015199 | No Change: Both O | - |
| Q6IF82 | O4A47_HUMAN Olfactory receptor 4A47 OS=Homo sapiens GN=OR4A47 PE=2 SV=2 | 145 | V | 0.023072 | M | 0.027135 | -0.004063 | No Change: Both O | - |
| Q6IF82 | O4A47_HUMAN Olfactory receptor 4A47 OS=Homo sapiens GN=OR4A47 PE=2 SV=2 | 192 | A | 0.073866 | D | 0.111282 | -0.037416 | No Change: Both O | - |
| Q8NH83 | OR4A5_HUMAN Olfactory receptor 4A5 OS=Homo sapiens GN=OR4A5 PE=2 SV=4 | 6 | N | 0.509502 | S | 0.529488 | -0.019986 | No Change: Both D | - |
| Q8NH83 | OR4A5_HUMAN Olfactory receptor 4A5 OS=Homo sapiens GN=OR4A5 PE=2 SV=4 | 23 | K | 0.186835 | N | 0.159132 | 0.027703 | No Change: Both O | - |
| Q8NH83 | OR4A5_HUMAN Olfactory receptor 4A5 OS=Homo sapiens GN=OR4A5 PE=2 SV=4 | 219 | L | 0.205141 | Q | 0.318333 | -0.113192 | No Change: Both O | - |
| Q8NGF8 | OR4B1_HUMAN Olfactory receptor 4B1 OS=Homo sapiens GN=OR4B1 PE=2 SV=1 | 63 | C | 0.058133 | Y | 0.077621 | -0.019488 | No Change: Both O | - |
| Q8NGF8 | OR4B1_HUMAN Olfactory receptor 4B1 OS=Homo sapiens GN=OR4B1 PE=2 SV=1 | 237 | T | 0.339288 | N | 0.367694 | -0.028406 | No Change: Both O | - |
| Q6IEV9 | OR4CB_HUMAN Olfactory receptor 4C11 OS=Homo sapiens GN=OR4C11 PE=2 SV=1 | 8 | P | 0.329382 | T | 0.285578 | 0.043804 | No Change: Both O | - |
| Q6IEV9 | OR4CB_HUMAN Olfactory receptor 4C11 OS=Homo sapiens GN=OR4C11 PE=2 SV=1 | 15 | L | 0.143181 | I | 0.122276 | 0.020905 | No Change: Both O | - |
| Q6IEV9 | OR4CB_HUMAN Olfactory receptor 4C11 OS=Homo sapiens GN=OR4C11 PE=2 SV=1 | 277 | T | 0.067378 | P | 0.087461 | -0.020083 | No Change: Both O | - |
| Q96R67 | OR4CC_HUMAN Olfactory receptor 4C12 OS=Homo sapiens GN=OR4C12 PE=2 SV=2 | 283 | V | 0.124022 | L | 0.12156 | 0.002462 | No Change: Both O | - |
| Q8NGL9 | OR4CG_HUMAN Olfactory receptor 4C16 OS=Homo sapiens GN=OR4C16 PE=2 SV=2 | 76 | T | 0.224152 | A | 0.191153 | 0.032999 | No Change: Both O | - |
| Q8NGL9 | OR4CG_HUMAN Olfactory receptor 4C16 OS=Homo sapiens GN=OR4C16 PE=2 SV=2 | 25 | V | 0.018269 | L | 0.018264 | 5.00E-06 | No Change: Both O | - |
| Q8NGL9 | OR4CG_HUMAN Olfactory receptor 4C16 OS=Homo sapiens GN=OR4C16 PE=2 SV=2 | 49 | T | 0.267322 | A | 0.254966 | 0.012356 | No Change: Both O | - |
| Q8NGL9 | OR4CG_HUMAN Olfactory receptor 4C16 OS=Homo sapiens GN=OR4C16 PE=2 SV=2 | 203 | A | 0.142972 | T | 0.151411 | -0.008439 | No Change: Both O | - |
| Q8NGL9 | OR4CG_HUMAN Olfactory receptor 4C16 OS=Homo sapiens GN=OR4C16 PE=2 SV=2 | 259 | L | 0.029827 | P | 0.069028 | -0.039201 | No Change: Both O | - |
| A6NHA9 | O4C46_HUMAN Olfactory receptor 4C46 OS=Homo sapiens GN=OR4C46 PE=2 SV=1 | 240 | S | 0.093314 | F | 0.032725 | 0.060589 | No Change: Both O | - |
| A6NHA9 | O4C46_HUMAN Olfactory receptor 4C46 OS=Homo sapiens GN=OR4C46 PE=2 SV=1 | 252 | C | 0.009047 | Y | 0.011881 | -0.002834 | No Change: Both O | - |
| A6NHA9 | O4C46_HUMAN Olfactory receptor 4C46 OS=Homo sapiens GN=OR4C46 PE=2 SV=1 | 288 | K | 0.261217 | R | 0.207561 | 0.053656 | No Change: Both O | - |
| Q8NH72 | OR4C6_HUMAN Olfactory receptor 4C6 OS=Homo sapiens GN=OR4C6 PE=2 SV=1 | 133 | I | 0.068876 | T | 0.129426 | -0.06055 | No Change: Both O | - |
| Q15615 | OR4D1_HUMAN Olfactory receptor 4D1 OS=Homo sapiens GN=OR4D1 PE=2 SV=3 | 54 | R | 0.087409 | Q | 0.09554 | -0.008131 | No Change: Both O | - |
| Q15615 | OR4D1_HUMAN Olfactory receptor 4D1 OS=Homo sapiens GN=OR4D1 PE=2 SV=3 | 174 | L | 0.081483 | I | 0.07438 | 0.007103 | No Change: Both O | - |
| Q8NGI4 | OR4DB_HUMAN Olfactory receptor 4D11 OS=Homo sapiens GN=OR4D11 PE=2 SV=1 | 197 | F | 0.084277 | L | 0.09903 | -0.014753 | No Change: Both O | - |
| P58180 | OR4D2_HUMAN Olfactory receptor 4D2 OS=Homo sapiens GN=OR4D2 PE=2 SV=1 | 29 | L | 0.013222 | I | 0.010473 | 0.002749 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 96 | D | 0.131428 | G | 0.113347 | 0.018081 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 151 | S | 0.175853 | T | 0.114333 | 0.06152 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 263 | M | 0.0991 | T | 0.122181 | -0.023081 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 11 | E | 0.178929 | Q | 0.142742 | 0.036187 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 102 | F | 0.03687 | S | 0.092924 | -0.056054 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 111 | D | 0.085989 | A | 0.064516 | 0.021473 | No Change: Both O | - |
| Q8NGJ1 | OR4D6_HUMAN Olfactory receptor 4D6 OS=Homo sapiens GN=OR4D6 PE=2 SV=1 | 59 | M | 0.156364 | V | 0.119151 | 0.037213 | No Change: Both O | - |
| Q8NGE8 | OR4D9_HUMAN Olfactory receptor 4D9 OS=Homo sapiens GN=OR4D9 PE=2 SV=3 | 159 | Q | 0.113493 | R | 0.104023 | 0.00947 | No Change: Both O | - |
| Q8NGC2 | OR4E2_HUMAN Olfactory receptor 4E2 OS=Homo sapiens GN=OR4E2 PE=2 SV=1 | 118 | V | 0.011813 | M | 0.015121 | -0.003308 | No Change: Both O | - |
| Q8NGC2 | OR4E2_HUMAN Olfactory receptor 4E2 OS=Homo sapiens GN=OR4E2 PE=2 SV=1 | 234 | Q | 0.718798 | R | 0.711026 | 0.007772 | No Change: Both D | - |
| Q8NGD4 | OR4K1_HUMAN Olfactory receptor 4K1 OS=Homo sapiens GN=OR4K1 PE=2 SV=1 | 89 | R | 0.143907 | H | 0.145464 | -0.001557 | No Change: Both O | - |
| Q8NGD4 | OR4K1_HUMAN Olfactory receptor 4K1 OS=Homo sapiens GN=OR4K1 PE=2 SV=1 | 138 | R | 0.071193 | Q | 0.072567 | -0.001374 | No Change: Both O | - |
| Q8NGD4 | OR4K1_HUMAN Olfactory receptor 4K1 OS=Homo sapiens GN=OR4K1 PE=2 SV=1 | 304 | R | 0.342101 | H | 0.348101 | -0.006 | No Change: Both O | - |
| Q8NH42 | OR4KD_HUMAN Olfactory receptor 4K13 OS=Homo sapiens GN=OR4K13 PE=2 SV=1 | 292 | Q | 0.262388 | K | 0.323964 | -0.061576 | No Change: Both O | - |
| Q8NGD5 | OR4KE_HUMAN Olfactory receptor 4K14 OS=Homo sapiens GN=OR4K14 PE=2 SV=1 | 119 | M | 0.082386 | V | 0.064733 | 0.017653 | No Change: Both O | - |
| Q8NGD5 | OR4KE_HUMAN Olfactory receptor 4K14 OS=Homo sapiens GN=OR4K14 PE=2 SV=1 | 145 | L | 0.020029 | R | 0.036698 | -0.016669 | No Change: Both O | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 89 | N | 0.039275 | S | 0.051528 | -0.012253 | No Change: Both O | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 112 | E | 0.158996 | V | 0.074409 | 0.084587 | No Change: Both O | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 117 | S | 0.110148 | A | 0.073584 | 0.036564 | No Change: Both O | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 255 | A | 0.749305 | E | 0.814915 | -0.06561 | No Change: Both D | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 304 | L | 0.018351 | P | 0.039834 | -0.021483 | No Change: Both O | - |
| Q8NH41 | OR4KF_HUMAN Olfactory receptor 4K15 OS=Homo sapiens GN=OR4K15 PE=2 SV=2 | 310 | I | 0.062351 | M | 0.089202 | -0.026851 | No Change: Both O | - |
| Q8NGD2 | OR4K2_HUMAN Olfactory receptor 4K2 OS=Homo sapiens GN=OR4K2 PE=2 SV=1 | 307 | N | 0.424219 | I | 0.238424 | 0.185795 | No Change: Both O | - |
| Q8NGD3 | OR4K5_HUMAN Olfactory receptor 4K5 OS=Homo sapiens GN=OR4K5 PE=2 SV=1 | 319 | R | 0.531591 | K | 0.55373 | -0.022139 | No Change: Both D | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 52 | R | 0.188064 | S | 0.260827 | -0.072763 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 2 | D | 0.943977 | N | 0.94067 | 0.003307 | No Change: Both D | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 40 | M | 0.061401 | V | 0.047117 | 0.014284 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 93 | S | 0.107259 | F | 0.039328 | 0.067931 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 101 | M | 0.037036 | K | 0.06172 | -0.024684 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 109 | G | 0.124214 | S | 0.145153 | -0.020939 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 16 | G | 0.024609 | V | 0.012168 | 0.012441 | No Change: Both O | - |
| Q8NH43 | OR4L1_HUMAN Olfactory receptor 4L1 OS=Homo sapiens GN=OR4L1 PE=2 SV=1 | 160 | I | 0.109084 | T | 0.196863 | -0.087779 | No Change: Both O | - |
| Q8NGD0 | OR4M1_HUMAN Olfactory receptor 4M1 OS=Homo sapiens GN=OR4M1 PE=2 SV=1 | 116 | T | 0.073907 | I | 0.038165 | 0.035742 | No Change: Both O | - |
| Q8NGD0 | OR4M1_HUMAN Olfactory receptor 4M1 OS=Homo sapiens GN=OR4M1 PE=2 SV=1 | 232 | G | 0.848235 | D | 0.856084 | -0.007849 | No Change: Both D | - |
| Q8NGB6 | OR4M2_HUMAN Olfactory receptor 4M2 OS=Homo sapiens GN=OR4M2 PE=2 SV=2 | 96 | G | 0.048256 | E | 0.064273 | -0.016017 | No Change: Both O | - |
| Q8NGB6 | OR4M2_HUMAN Olfactory receptor 4M2 OS=Homo sapiens GN=OR4M2 PE=2 SV=2 | 121 | D | 0.033618 | N | 0.031117 | 0.002501 | No Change: Both O | - |
| Q8NGB6 | OR4M2_HUMAN Olfactory receptor 4M2 OS=Homo sapiens GN=OR4M2 PE=2 SV=2 | 225 | F | 0.220776 | L | 0.253654 | -0.032878 | No Change: Both O | - |
| Q8NGB6 | OR4M2_HUMAN Olfactory receptor 4M2 OS=Homo sapiens GN=OR4M2 PE=2 SV=2 | 239 | M | 0.475405 | V | 0.408677 | 0.066728 | No Change: Both O | - |
| Q8NGB6 | OR4M2_HUMAN Olfactory receptor 4M2 OS=Homo sapiens GN=OR4M2 PE=2 SV=2 | 284 | R | 0.07736 | H | 0.074112 | 0.003248 | No Change: Both O | - |
| Q8NGD1 | OR4N2_HUMAN Olfactory receptor 4N2 OS=Homo sapiens GN=OR4N2 PE=2 SV=1 | 135 | V | 0.252396 | L | 0.264855 | -0.012459 | No Change: Both O | - |
| Q8NGD1 | OR4N2_HUMAN Olfactory receptor 4N2 OS=Homo sapiens GN=OR4N2 PE=2 SV=1 | 76 | I | 0.090677 | T | 0.166051 | -0.075374 | No Change: Both O | - |
| Q8NGD1 | OR4N2_HUMAN Olfactory receptor 4N2 OS=Homo sapiens GN=OR4N2 PE=2 SV=1 | 133 | P | 0.196411 | S | 0.201279 | -0.004868 | No Change: Both O | - |
| Q8N0Y3 | OR4N4_HUMAN Olfactory receptor 4N4 OS=Homo sapiens GN=OR4N4 PE=2 SV=2 | 61 | L | 0.054398 | F | 0.045494 | 0.008904 | No Change: Both O | - |
| Q8N0Y3 | OR4N4_HUMAN Olfactory receptor 4N4 OS=Homo sapiens GN=OR4N4 PE=2 SV=2 | 86 | L | 0.237595 | F | 0.21385 | 0.023745 | No Change: Both O | - |
| Q8N0Y3 | OR4N4_HUMAN Olfactory receptor 4N4 OS=Homo sapiens GN=OR4N4 PE=2 SV=2 | 239 | T | 0.26971 | M | 0.229338 | 0.040372 | No Change: Both O | - |
| Q8N0Y3 | OR4N4_HUMAN Olfactory receptor 4N4 OS=Homo sapiens GN=OR4N4 PE=2 SV=2 | 274 | F | 0.073278 | L | 0.084885 | -0.011607 | No Change: Both O | - |
| Q8IXE1 | OR4N5_HUMAN Olfactory receptor 4N5 OS=Homo sapiens GN=OR4N5 PE=2 SV=1 | 191 | N | 0.048619 | D | 0.052326 | -0.003707 | No Change: Both O | - |
| Q8IXE1 | OR4N5_HUMAN Olfactory receptor 4N5 OS=Homo sapiens GN=OR4N5 PE=2 SV=1 | 234 | S | 0.855958 | T | 0.811498 | 0.04446 | No Change: Both D | - |
| Q8IXE1 | OR4N5_HUMAN Olfactory receptor 4N5 OS=Homo sapiens GN=OR4N5 PE=2 SV=1 | 260 | C | 0.041688 | R | 0.091062 | -0.049374 | No Change: Both O | - |
| Q8IXE1 | OR4N5_HUMAN Olfactory receptor 4N5 OS=Homo sapiens GN=OR4N5 PE=2 SV=1 | 290 | R | 0.225936 | H | 0.224966 | 9.70E-04 | No Change: Both O | - |
| Q8NH05 | OR4Q3_HUMAN Olfactory receptor 4Q3 OS=Homo sapiens GN=OR4Q3 PE=2 SV=1 | 135 | T | 0.075519 | A | 0.06686 | 0.008659 | No Change: Both O | - |
| Q8NH05 | OR4Q3_HUMAN Olfactory receptor 4Q3 OS=Homo sapiens GN=OR4Q3 PE=2 SV=1 | 238 | F | 0.296392 | L | 0.328287 | -0.031895 | No Change: Both O | - |
| Q8NH73 | OR4S2_HUMAN Olfactory receptor 4S2 OS=Homo sapiens GN=OR4S2 PE=1 SV=2 | 72 | S | 0.115166 | T | 0.079322 | 0.035844 | No Change: Both O | - |
| Q8NH73 | OR4S2_HUMAN Olfactory receptor 4S2 OS=Homo sapiens GN=OR4S2 PE=1 SV=2 | 195 | V | 0.089688 | G | 0.159474 | -0.069786 | No Change: Both O | - |
| Q8NH49 | OR4X1_HUMAN Olfactory receptor 4X1 OS=Homo sapiens GN=OR4X1 PE=2 SV=1 | 165 | P | 0.051404 | L | 0.024539 | 0.026865 | No Change: Both O | - |
| Q8NH49 | OR4X1_HUMAN Olfactory receptor 4X1 OS=Homo sapiens GN=OR4X1 PE=2 SV=1 | 246 | D | 0.04261 | N | 0.039395 | 0.003215 | No Change: Both O | - |
| Q8NH49 | OR4X1_HUMAN Olfactory receptor 4X1 OS=Homo sapiens GN=OR4X1 PE=2 SV=1 | 282 | P | 0.096791 | S | 0.110703 | -0.013912 | No Change: Both O | - |
| Q8NH49 | OR4X1_HUMAN Olfactory receptor 4X1 OS=Homo sapiens GN=OR4X1 PE=2 SV=1 | 144 | R | 0.041989 | G | 0.048671 | -0.006682 | No Change: Both O | - |
| Q8NH49 | OR4X1_HUMAN Olfactory receptor 4X1 OS=Homo sapiens GN=OR4X1 PE=2 SV=1 | 196 | L | 0.052586 | Q | 0.095773 | -0.043187 | No Change: Both O | - |
| Q8NGJ7 | O51A2_HUMAN Olfactory receptor 51A2 OS=Homo sapiens GN=OR51A2 PE=2 SV=1 | 59 | G | 0.270351 | E | 0.338938 | -0.068587 | No Change: Both O | - |
| Q8NGJ7 | O51A2_HUMAN Olfactory receptor 51A2 OS=Homo sapiens GN=OR51A2 PE=2 SV=1 | 288 | M | 0.092381 | T | 0.114698 | -0.022317 | No Change: Both O | - |
| Q8NGJ7 | O51A2_HUMAN Olfactory receptor 51A2 OS=Homo sapiens GN=OR51A2 PE=2 SV=1 | 289 | K | 0.089718 | N | 0.070332 | 0.019386 | No Change: Both O | - |
| Q8NGJ7 | O51A2_HUMAN Olfactory receptor 51A2 OS=Homo sapiens GN=OR51A2 PE=2 SV=1 | 45 | G | 0.042014 | C | 0.016372 | 0.025642 | No Change: Both O | - |
| Q8NGJ6 | O51A4_HUMAN Olfactory receptor 51A4 OS=Homo sapiens GN=OR51A4 PE=2 SV=1 | 267 | R | 0.161247 | G | 0.160244 | 0.001003 | No Change: Both O | - |
| Q8NGJ6 | O51A4_HUMAN Olfactory receptor 51A4 OS=Homo sapiens GN=OR51A4 PE=2 SV=1 | 288 | T | 0.096361 | M | 0.078639 | 0.017722 | No Change: Both O | - |
| Q8NGJ6 | O51A4_HUMAN Olfactory receptor 51A4 OS=Homo sapiens GN=OR51A4 PE=2 SV=1 | 72 | D | 0.421521 | N | 0.405362 | 0.016159 | No Change: Both O | - |
| Q8NGJ6 | O51A4_HUMAN Olfactory receptor 51A4 OS=Homo sapiens GN=OR51A4 PE=2 SV=1 | 45 | G | 0.042083 | C | 0.016465 | 0.025618 | No Change: Both O | - |
| Q8NGJ6 | O51A4_HUMAN Olfactory receptor 51A4 OS=Homo sapiens GN=OR51A4 PE=2 SV=1 | 311 | R | 0.593039 | W | 0.357056 | 0.235983 | D to O | - |
| Q8NH64 | O51A7_HUMAN Olfactory receptor 51A7 OS=Homo sapiens GN=OR51A7 PE=2 SV=1 | 8 | E | 0.334625 | K | 0.347864 | -0.013239 | No Change: Both O | - |
| Q8NH64 | O51A7_HUMAN Olfactory receptor 51A7 OS=Homo sapiens GN=OR51A7 PE=2 SV=1 | 81 | M | 0.15447 | T | 0.189797 | -0.035327 | No Change: Both O | - |
| Q8NH64 | O51A7_HUMAN Olfactory receptor 51A7 OS=Homo sapiens GN=OR51A7 PE=2 SV=1 | 196 | V | 0.082779 | A | 0.124678 | -0.041899 | No Change: Both O | - |
| Q9Y5P1 | O51B2_HUMAN Olfactory receptor 51B2 OS=Homo sapiens GN=OR51B2 PE=2 SV=4 | 283 | P | 0.064239 | S | 0.070179 | -0.00594 | No Change: Both O | - |
| Q9Y5P1 | O51B2_HUMAN Olfactory receptor 51B2 OS=Homo sapiens GN=OR51B2 PE=2 SV=4 | 120 | C | 0.034455 | R | 0.081693 | -0.047238 | No Change: Both O | - |
| Q9Y5P1 | O51B2_HUMAN Olfactory receptor 51B2 OS=Homo sapiens GN=OR51B2 PE=2 SV=4 | 134 | L | 0.143634 | F | 0.118808 | 0.024826 | No Change: Both O | - |
| Q9Y5P1 | O51B2_HUMAN Olfactory receptor 51B2 OS=Homo sapiens GN=OR51B2 PE=2 SV=4 | 209 | C | 0.010385 | S | 0.03639 | -0.026005 | No Change: Both O | - |
| Q9Y5P1 | O51B2_HUMAN Olfactory receptor 51B2 OS=Homo sapiens GN=OR51B2 PE=2 SV=4 | 312 | S | 0.776869 | R | 0.776876 | -7.00E-06 | No Change: Both D | - |
| Q9Y5P0 | O51B4_HUMAN Olfactory receptor 51B4 OS=Homo sapiens GN=OR51B4 PE=2 SV=3 | 36 | V | 0.032598 | I | 0.027872 | 0.004726 | No Change: Both O | - |
| Q9Y5P0 | O51B4_HUMAN Olfactory receptor 51B4 OS=Homo sapiens GN=OR51B4 PE=2 SV=3 | 147 | M | 0.087937 | T | 0.0996 | -0.011663 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 5 | G | 0.8842 | S | 0.872029 | 0.012171 | No Change: Both D | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 102 | I | 0.121157 | T | 0.210361 | -0.089204 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 154 | V | 0.131576 | I | 0.1114 | 0.020176 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 160 | P | 0.053142 | L | 0.024332 | 0.02881 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 220 | L | 0.055537 | F | 0.045203 | 0.010334 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 78 | T | 0.088707 | K | 0.11402 | -0.025313 | No Change: Both O | - |
| Q9H339 | O51B5_HUMAN Olfactory receptor 51B5 OS=Homo sapiens GN=OR51B5 PE=2 SV=2 | 88 | R | 0.145158 | G | 0.165708 | -0.02055 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 5 | K | 0.82349 | T | 0.793883 | 0.029607 | No Change: Both D | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 40 | N | 0.071905 | S | 0.091633 | -0.019728 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 90 | I | 0.197406 | T | 0.323584 | -0.126178 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 123 | T | 0.070498 | A | 0.062415 | 0.008083 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 131 | T | 0.248605 | I | 0.142031 | 0.106574 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 145 | R | 0.12269 | G | 0.132549 | -0.009859 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 169 | S | 0.125833 | A | 0.075877 | 0.049956 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 172 | L | 0.138572 | F | 0.123011 | 0.015561 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 192 | F | 0.048802 | L | 0.061319 | -0.012517 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 254 | V | 0.010125 | L | 0.009736 | 3.89E-04 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 275 | S | 0.08032 | R | 0.059197 | 0.021123 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 125 | R | 0.104709 | H | 0.098628 | 0.006081 | No Change: Both O | - |
| Q9H340 | O51B6_HUMAN Olfactory receptor 51B6 OS=Homo sapiens GN=OR51B6 PE=2 SV=2 | 126 | S | 0.126806 | N | 0.100144 | 0.026662 | No Change: Both O | - |
| Q8NGF3 | O51D1_HUMAN Olfactory receptor 51D1 OS=Homo sapiens GN=OR51D1 PE=2 SV=1 | 89 | I | 0.26843 | V | 0.305737 | -0.037307 | No Change: Both O | - |
| Q8TCB6 | O51E1_HUMAN Olfactory receptor 51E1 OS=Homo sapiens GN=OR51E1 PE=2 SV=1 | 10 | S | 0.375036 | N | 0.339443 | 0.035593 | No Change: Both O | - |
| Q8TCB6 | O51E1_HUMAN Olfactory receptor 51E1 OS=Homo sapiens GN=OR51E1 PE=2 SV=1 | 9 | S | 0.509208 | N | 0.472527 | 0.036681 | D to O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 20 | T | 0.279052 | A | 0.233617 | 0.045435 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 73 | F | 0.065036 | S | 0.169925 | -0.104889 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 74 | R | 0.076066 | M | 0.060812 | 0.015254 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 232 | H | 0.052322 | R | 0.055771 | -0.003449 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 301 | D | 0.271228 | Y | 0.151274 | 0.119954 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 202 | R | 0.141657 | Q | 0.160278 | -0.018621 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 258 | A | 0.052991 | V | 0.037742 | 0.015249 | No Change: Both O | - |
| A6NGY5 | O51F1_HUMAN Olfactory receptor 51F1 OS=Homo sapiens GN=OR51F1 PE=2 SV=1 | 233 | S | 0.070523 | F | 0.022775 | 0.047748 | No Change: Both O | - |
| Q8NGK1 | O51G1_HUMAN Olfactory receptor 51G1 OS=Homo sapiens GN=OR51G1 PE=2 SV=1 | 125 | Y | 0.107919 | S | 0.258288 | -0.150369 | No Change: Both O | - |
| Q8NGK1 | O51G1_HUMAN Olfactory receptor 51G1 OS=Homo sapiens GN=OR51G1 PE=2 SV=1 | 114 | S | 0.649655 | L | 0.431516 | 0.218139 | D to O | - |
| Q8NGK1 | O51G1_HUMAN Olfactory receptor 51G1 OS=Homo sapiens GN=OR51G1 PE=2 SV=1 | 124 | R | 0.112967 | H | 0.115375 | -0.002408 | No Change: Both O | - |
| Q8NGK1 | O51G1_HUMAN Olfactory receptor 51G1 OS=Homo sapiens GN=OR51G1 PE=2 SV=1 | 195 | I | 0.057595 | T | 0.099384 | -0.041789 | No Change: Both O | - |
| Q8NGK1 | O51G1_HUMAN Olfactory receptor 51G1 OS=Homo sapiens GN=OR51G1 PE=2 SV=1 | 303 | Q | 0.281683 | H | 0.247198 | 0.034485 | No Change: Both O | - |
| Q8NGK0 | O51G2_HUMAN Olfactory receptor 51G2 OS=Homo sapiens GN=OR51G2 PE=2 SV=1 | 96 | E | 0.133765 | Q | 0.111704 | 0.022061 | No Change: Both O | - |
| Q8NGK0 | O51G2_HUMAN Olfactory receptor 51G2 OS=Homo sapiens GN=OR51G2 PE=2 SV=1 | 94 | A | 0.09472 | E | 0.155967 | -0.061247 | No Change: Both O | - |
| Q9H343 | O51I1_HUMAN Olfactory receptor 51I1 OS=Homo sapiens GN=OR51I1 PE=2 SV=1 | 252 | A | 0.016133 | S | 0.026828 | -0.010695 | No Change: Both O | - |
| Q9H343 | O51I1_HUMAN Olfactory receptor 51I1 OS=Homo sapiens GN=OR51I1 PE=2 SV=1 | 164 | V | 0.07423 | L | 0.075148 | -9.18E-04 | No Change: Both O | - |
| Q9H343 | O51I1_HUMAN Olfactory receptor 51I1 OS=Homo sapiens GN=OR51I1 PE=2 SV=1 | 124 | R | 0.044082 | H | 0.04404 | 4.20E-05 | No Change: Both O | - |
| Q9H344 | O51I2_HUMAN Olfactory receptor 51I2 OS=Homo sapiens GN=OR51I2 PE=2 SV=1 | 263 | R | 0.235265 | H | 0.257464 | -0.022199 | No Change: Both O | - |
| Q9H344 | O51I2_HUMAN Olfactory receptor 51I2 OS=Homo sapiens GN=OR51I2 PE=2 SV=1 | 122 | R | 0.057753 | C | 0.027553 | 0.0302 | No Change: Both O | - |
| Q9H344 | O51I2_HUMAN Olfactory receptor 51I2 OS=Homo sapiens GN=OR51I2 PE=2 SV=1 | 134 | T | 0.08669 | A | 0.07572 | 0.01097 | No Change: Both O | - |
| Q9H344 | O51I2_HUMAN Olfactory receptor 51I2 OS=Homo sapiens GN=OR51I2 PE=2 SV=1 | 151 | R | 0.146104 | P | 0.177095 | -0.030991 | No Change: Both O | - |
| Q9H342 | O51J1_HUMAN Olfactory receptor 51J1 OS=Homo sapiens GN=OR51J1 PE=2 SV=2 | 100 | C | 0.093763 | Y | 0.116862 | -0.023099 | No Change: Both O | - |
| Q8NGJ5 | O51L1_HUMAN Olfactory receptor 51L1 OS=Homo sapiens GN=OR51L1 PE=2 SV=1 | 196 | T | 0.236153 | I | 0.135724 | 0.100429 | No Change: Both O | - |
| Q8NGJ5 | O51L1_HUMAN Olfactory receptor 51L1 OS=Homo sapiens GN=OR51L1 PE=2 SV=1 | 207 | A | 0.026989 | V | 0.020638 | 0.006351 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 211 | V | 0.016895 | M | 0.021533 | -0.004638 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 146 | T | 0.064611 | I | 0.035731 | 0.02888 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 153 | C | 0.007939 | R | 0.016114 | -0.008175 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 178 | R | 0.352472 | H | 0.380639 | -0.028167 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 155 | V | 0.008006 | I | 0.00719 | 8.16E-04 | No Change: Both O | - |
| Q8NH59 | O51Q1_HUMAN Olfactory receptor 51Q1 OS=Homo sapiens GN=OR51Q1 PE=2 SV=2 | 308 | F | 0.160913 | S | 0.369338 | -0.208425 | No Change: Both O | - |
| Q8NGJ8 | O51S1_HUMAN Olfactory receptor 51S1 OS=Homo sapiens GN=OR51S1 PE=2 SV=1 | 178 | L | 0.089814 | R | 0.142755 | -0.052941 | No Change: Both O | - |
| Q8NGJ8 | O51S1_HUMAN Olfactory receptor 51S1 OS=Homo sapiens GN=OR51S1 PE=2 SV=1 | 57 | I | 0.035628 | N | 0.076496 | -0.040868 | No Change: Both O | - |
| Q8NGJ8 | O51S1_HUMAN Olfactory receptor 51S1 OS=Homo sapiens GN=OR51S1 PE=2 SV=1 | 60 | Q | 0.091113 | E | 0.111754 | -0.020641 | No Change: Both O | - |
| Q8NGJ8 | O51S1_HUMAN Olfactory receptor 51S1 OS=Homo sapiens GN=OR51S1 PE=2 SV=1 | 264 | L | 0.027622 | F | 0.022447 | 0.005175 | No Change: Both O | - |
| Q9H2C8 | O51V1_HUMAN Olfactory receptor 51V1 OS=Homo sapiens GN=OR51V1 PE=2 SV=2 | 233 | S | 0.0932 | L | 0.039196 | 0.054004 | No Change: Both O | - |
| A6NMU1 | O52A4_HUMAN Putative olfactory receptor 52A4 OS=Homo sapiens GN=OR52A4 PE=5 SV=1 | 87 | D | 0.053486 | G | 0.047222 | 0.006264 | No Change: Both O | - |
| A6NMU1 | O52A4_HUMAN Putative olfactory receptor 52A4 OS=Homo sapiens GN=OR52A4 PE=5 SV=1 | 180 | Y | 0.07917 | S | 0.161267 | -0.082097 | No Change: Both O | - |
| A6NMU1 | O52A4_HUMAN Putative olfactory receptor 52A4 OS=Homo sapiens GN=OR52A4 PE=5 SV=1 | 277 | C | 0.018062 | R | 0.040347 | -0.022285 | No Change: Both O | - |
| A6NMU1 | O52A4_HUMAN Putative olfactory receptor 52A4 OS=Homo sapiens GN=OR52A4 PE=5 SV=1 | 303 | T | 0.789898 | A | 0.785596 | 0.004302 | No Change: Both D | - |
| Q96RD2 | O52B2_HUMAN Olfactory receptor 52B2 OS=Homo sapiens GN=OR52B2 PE=2 SV=3 | 105 | F | 0.056751 | Y | 0.060803 | -0.004052 | No Change: Both O | - |
| Q8NGK2 | O52B4_HUMAN Olfactory receptor 52B4 OS=Homo sapiens GN=OR52B4 PE=2 SV=2 | 139 | T | 0.081971 | I | 0.042818 | 0.039153 | No Change: Both O | - |
| Q8NGF0 | O52B6_HUMAN Olfactory receptor 52B6 OS=Homo sapiens GN=OR52B6 PE=2 SV=3 | 57 | T | 0.040498 | A | 0.037897 | 0.002601 | No Change: Both O | - |
| Q8NGF0 | O52B6_HUMAN Olfactory receptor 52B6 OS=Homo sapiens GN=OR52B6 PE=2 SV=3 | 111 | L | 0.053579 | H | 0.086884 | -0.033305 | No Change: Both O | - |
| Q8NGF0 | O52B6_HUMAN Olfactory receptor 52B6 OS=Homo sapiens GN=OR52B6 PE=2 SV=3 | 167 | A | 0.118015 | T | 0.133947 | -0.015932 | No Change: Both O | - |
| Q8NGF0 | O52B6_HUMAN Olfactory receptor 52B6 OS=Homo sapiens GN=OR52B6 PE=2 SV=3 | 170 | H | 0.110895 | R | 0.109336 | 0.001559 | No Change: Both O | - |
| Q8NGF0 | O52B6_HUMAN Olfactory receptor 52B6 OS=Homo sapiens GN=OR52B6 PE=2 SV=3 | 288 | V | 0.124853 | I | 0.107221 | 0.017632 | No Change: Both O | - |
| Q9H346 | O52D1_HUMAN Olfactory receptor 52D1 OS=Homo sapiens GN=OR52D1 PE=2 SV=1 | 251 | I | 0.023772 | T | 0.042744 | -0.018972 | No Change: Both O | - |
| Q9H346 | O52D1_HUMAN Olfactory receptor 52D1 OS=Homo sapiens GN=OR52D1 PE=2 SV=1 | 154 | R | 0.06549 | C | 0.028386 | 0.037104 | No Change: Both O | - |
| Q9H346 | O52D1_HUMAN Olfactory receptor 52D1 OS=Homo sapiens GN=OR52D1 PE=2 SV=1 | 213 | D | 0.093502 | E | 0.104936 | -0.011434 | No Change: Both O | - |
| Q9H346 | O52D1_HUMAN Olfactory receptor 52D1 OS=Homo sapiens GN=OR52D1 PE=2 SV=1 | 221 | Y | 0.041503 | F | 0.037876 | 0.003627 | No Change: Both O | - |
| Q9H346 | O52D1_HUMAN Olfactory receptor 52D1 OS=Homo sapiens GN=OR52D1 PE=2 SV=1 | 304 | R | 0.39185 | W | 0.175917 | 0.215933 | No Change: Both O | - |
| Q8NGJ4 | O52E2_HUMAN Olfactory receptor 52E2 OS=Homo sapiens GN=OR52E2 PE=2 SV=2 | 5 | N | 0.790562 | S | 0.822265 | -0.031703 | No Change: Both D | - |
| Q8NGJ4 | O52E2_HUMAN Olfactory receptor 52E2 OS=Homo sapiens GN=OR52E2 PE=2 SV=2 | 167 | R | 0.03452 | W | 0.012458 | 0.022062 | No Change: Both O | - |
| Q8NGJ4 | O52E2_HUMAN Olfactory receptor 52E2 OS=Homo sapiens GN=OR52E2 PE=2 SV=2 | 264 | R | 0.20689 | C | 0.093878 | 0.113012 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 176 | V | 0.161393 | I | 0.151424 | 0.009969 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 184 | R | 0.228225 | M | 0.178982 | 0.049243 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 49 | F | 0.080613 | L | 0.099124 | -0.018511 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 228 | R | 0.129474 | H | 0.120915 | 0.008559 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 257 | F | 0.075935 | L | 0.079443 | -0.003508 | No Change: Both O | - |
| Q8NGH9 | O52E4_HUMAN Olfactory receptor 52E4 OS=Homo sapiens GN=OR52E4 PE=2 SV=1 | 227 | F | 0.087918 | L | 0.111101 | -0.023183 | No Change: Both O | - |
| Q8NH55 | O52E5_HUMAN Olfactory receptor 52E5 OS=Homo sapiens GN=OR52E5 PE=3 SV=1 | 165 | T | 0.048056 | I | 0.02223 | 0.025826 | No Change: Both O | - |
| Q8NH55 | O52E5_HUMAN Olfactory receptor 52E5 OS=Homo sapiens GN=OR52E5 PE=3 SV=1 | 209 | D | 0.075691 | G | 0.073439 | 0.002252 | No Change: Both O | - |
| Q8NH55 | O52E5_HUMAN Olfactory receptor 52E5 OS=Homo sapiens GN=OR52E5 PE=3 SV=1 | 234 | L | 0.242087 | P | 0.406817 | -0.16473 | No Change: Both O | - |
| Q8NH55 | O52E5_HUMAN Olfactory receptor 52E5 OS=Homo sapiens GN=OR52E5 PE=3 SV=1 | 309 | E | 0.463292 | K | 0.443193 | 0.020099 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 39 | I | 0.024886 | V | 0.030275 | -0.005389 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 48 | F | 0.036708 | L | 0.042543 | -0.005835 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 64 | C | 0.083478 | F | 0.088941 | -0.005463 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 95 | S | 0.136289 | P | 0.114228 | 0.022061 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 133 | W | 0.025817 | R | 0.069817 | -0.044 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 159 | I | 0.022803 | V | 0.029583 | -0.00678 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 170 | F | 0.055916 | Y | 0.064462 | -0.008546 | No Change: Both O | - |
| Q96RD3 | O52E6_HUMAN Olfactory receptor 52E6 OS=Homo sapiens GN=OR52E6 PE=2 SV=2 | 199 | M | 0.095106 | R | 0.124596 | -0.02949 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 47 | V | 0.008632 | I | 0.007622 | 0.00101 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 89 | A | 0.122961 | T | 0.137263 | -0.014302 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 130 | H | 0.056293 | R | 0.056871 | -5.78E-04 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 235 | G | 0.100269 | C | 0.04883 | 0.051439 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 242 | C | 0.377905 | R | 0.568806 | -0.190901 | O to D | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 283 | M | 0.045785 | T | 0.060707 | -0.014922 | No Change: Both O | - |
| Q8NGJ2 | O52H1_HUMAN Olfactory receptor 52H1 OS=Homo sapiens GN=OR52H1 PE=2 SV=3 | 45 | V | 0.006731 | A | 0.009707 | -0.002976 | No Change: Both O | - |
| Q8NGK6 | O52I1_HUMAN Olfactory receptor 52I1 OS=Homo sapiens GN=OR52I1 PE=2 SV=2 | 41 | T | 0.082237 | I | 0.044197 | 0.03804 | No Change: Both O | - |
| Q8NH67 | O52I2_HUMAN Olfactory receptor 52I2 OS=Homo sapiens GN=OR52I2 PE=2 SV=3 | 25 | L | 0.161554 | P | 0.292268 | -0.130714 | No Change: Both O | - |
| Q8NH67 | O52I2_HUMAN Olfactory receptor 52I2 OS=Homo sapiens GN=OR52I2 PE=2 SV=3 | 74 | I | 0.028037 | L | 0.031687 | -0.00365 | No Change: Both O | - |
| Q8NH67 | O52I2_HUMAN Olfactory receptor 52I2 OS=Homo sapiens GN=OR52I2 PE=2 SV=3 | 167 | T | 0.185221 | M | 0.166495 | 0.018726 | No Change: Both O | - |
| Q8NH67 | O52I2_HUMAN Olfactory receptor 52I2 OS=Homo sapiens GN=OR52I2 PE=2 SV=3 | 178 | I | 0.084657 | V | 0.08958 | -0.004923 | No Change: Both O | - |
| Q8NH67 | O52I2_HUMAN Olfactory receptor 52I2 OS=Homo sapiens GN=OR52I2 PE=2 SV=3 | 183 | I | 0.056875 | V | 0.057672 | -7.97E-04 | No Change: Both O | - |
| Q8NH60 | O52J3_HUMAN Olfactory receptor 52J3 OS=Homo sapiens GN=OR52J3 PE=2 SV=2 | 77 | T | 0.330508 | A | 0.295485 | 0.035023 | No Change: Both O | - |
| Q8NH60 | O52J3_HUMAN Olfactory receptor 52J3 OS=Homo sapiens GN=OR52J3 PE=2 SV=2 | 128 | V | 0.057559 | I | 0.046962 | 0.010597 | No Change: Both O | - |
| Q8NH60 | O52J3_HUMAN Olfactory receptor 52J3 OS=Homo sapiens GN=OR52J3 PE=2 SV=2 | 141 | Q | 0.100861 | L | 0.056935 | 0.043926 | No Change: Both O | - |
| Q8NH60 | O52J3_HUMAN Olfactory receptor 52J3 OS=Homo sapiens GN=OR52J3 PE=2 SV=2 | 226 | V | 0.082637 | I | 0.072364 | 0.010273 | No Change: Both O | - |
| Q8NGK4 | O52K1_HUMAN Olfactory receptor 52K1 OS=Homo sapiens GN=OR52K1 PE=2 SV=2 | 52 | Q | 0.081553 | R | 0.074765 | 0.006788 | No Change: Both O | - |
| Q8NGK4 | O52K1_HUMAN Olfactory receptor 52K1 OS=Homo sapiens GN=OR52K1 PE=2 SV=2 | 153 | R | 0.147928 | W | 0.059543 | 0.088385 | No Change: Both O | - |
| Q8NGK3 | O52K2_HUMAN Olfactory receptor 52K2 OS=Homo sapiens GN=OR52K2 PE=2 SV=2 | 124 | R | 0.043875 | C | 0.021187 | 0.022688 | No Change: Both O | - |
| Q8NGK3 | O52K2_HUMAN Olfactory receptor 52K2 OS=Homo sapiens GN=OR52K2 PE=2 SV=2 | 302 | R | 0.278742 | C | 0.143488 | 0.135254 | No Change: Both O | - |
| Q8NGK3 | O52K2_HUMAN Olfactory receptor 52K2 OS=Homo sapiens GN=OR52K2 PE=2 SV=2 | 236 | R | 0.288932 | H | 0.29406 | -0.005128 | No Change: Both O | - |
| Q8NGH7 | O52L1_HUMAN Olfactory receptor 52L1 OS=Homo sapiens GN=OR52L1 PE=2 SV=4 | 88 | D | 0.13579 | N | 0.126574 | 0.009216 | No Change: Both O | - |
| Q8NGH7 | O52L1_HUMAN Olfactory receptor 52L1 OS=Homo sapiens GN=OR52L1 PE=2 SV=4 | 140 | C | 0.030781 | R | 0.063586 | -0.032805 | No Change: Both O | - |
| Q8NGH7 | O52L1_HUMAN Olfactory receptor 52L1 OS=Homo sapiens GN=OR52L1 PE=2 SV=4 | 161 | C | 0.047159 | R | 0.105404 | -0.058245 | No Change: Both O | - |
| Q8NGH7 | O52L1_HUMAN Olfactory receptor 52L1 OS=Homo sapiens GN=OR52L1 PE=2 SV=4 | 183 | K | 0.031076 | T | 0.02173 | 0.009346 | No Change: Both O | - |
| Q8NGH7 | O52L1_HUMAN Olfactory receptor 52L1 OS=Homo sapiens GN=OR52L1 PE=2 SV=4 | 297 | W | 0.042948 | R | 0.109902 | -0.066954 | No Change: Both O | - |
| Q8NGK5 | O52M1_HUMAN Olfactory receptor 52M1 OS=Homo sapiens GN=OR52M1 PE=2 SV=1 | 9 | S | 0.175444 | L | 0.075627 | 0.099817 | No Change: Both O | - |
| Q8NGK5 | O52M1_HUMAN Olfactory receptor 52M1 OS=Homo sapiens GN=OR52M1 PE=2 SV=1 | 305 | S | 0.311038 | R | 0.272595 | 0.038443 | No Change: Both O | - |
| Q8NH53 | O52N1_HUMAN Olfactory receptor 52N1 OS=Homo sapiens GN=OR52N1 PE=2 SV=1 | 167 | R | 0.177162 | C | 0.091883 | 0.085279 | No Change: Both O | - |
| Q8NH53 | O52N1_HUMAN Olfactory receptor 52N1 OS=Homo sapiens GN=OR52N1 PE=2 SV=1 | 247 | F | 0.033964 | I | 0.034467 | -5.03E-04 | No Change: Both O | - |
| Q8NH53 | O52N1_HUMAN Olfactory receptor 52N1 OS=Homo sapiens GN=OR52N1 PE=2 SV=1 | 79 | T | 0.122176 | N | 0.139986 | -0.01781 | No Change: Both O | - |
| Q8NH53 | O52N1_HUMAN Olfactory receptor 52N1 OS=Homo sapiens GN=OR52N1 PE=2 SV=1 | 101 | A | 0.044022 | T | 0.049373 | -0.005351 | No Change: Both O | - |
| Q8NH53 | O52N1_HUMAN Olfactory receptor 52N1 OS=Homo sapiens GN=OR52N1 PE=2 SV=1 | 125 | C | 0.025326 | Y | 0.030417 | -0.005091 | No Change: Both O | - |
| Q8NGI0 | O52N2_HUMAN Olfactory receptor 52N2 OS=Homo sapiens GN=OR52N2 PE=2 SV=1 | 249 | S | 0.083828 | A | 0.048617 | 0.035211 | No Change: Both O | - |
| Q8NGI0 | O52N2_HUMAN Olfactory receptor 52N2 OS=Homo sapiens GN=OR52N2 PE=2 SV=1 | 264 | H | 0.089114 | R | 0.087755 | 0.001359 | No Change: Both O | - |
| Q8NGI2 | O52N4_HUMAN Olfactory receptor 52N4 OS=Homo sapiens GN=OR52N4 PE=2 SV=2 | 106 | T | 0.115208 | I | 0.05689 | 0.058318 | No Change: Both O | - |
| Q8NGI2 | O52N4_HUMAN Olfactory receptor 52N4 OS=Homo sapiens GN=OR52N4 PE=2 SV=2 | 218 | N | 0.049849 | I | 0.02363 | 0.026219 | No Change: Both O | - |
| Q8NGI2 | O52N4_HUMAN Olfactory receptor 52N4 OS=Homo sapiens GN=OR52N4 PE=2 SV=2 | 167 | L | 0.064433 | R | 0.109792 | -0.045359 | No Change: Both O | - |
| Q8NGI2 | O52N4_HUMAN Olfactory receptor 52N4 OS=Homo sapiens GN=OR52N4 PE=2 SV=2 | 209 | W | 0.008076 | G | 0.025446 | -0.01737 | No Change: Both O | - |
| Q8NH56 | O52N5_HUMAN Olfactory receptor 52N5 OS=Homo sapiens GN=OR52N5 PE=2 SV=2 | 133 | V | 0.036717 | I | 0.034095 | 0.002622 | No Change: Both O | - |
| Q8NGF1 | O52R1_HUMAN Olfactory receptor 52R1 OS=Homo sapiens GN=OR52R1 PE=2 SV=2 | 88 | F | 0.048011 | L | 0.053944 | -0.005933 | No Change: Both O | - |
| Q8NGF1 | O52R1_HUMAN Olfactory receptor 52R1 OS=Homo sapiens GN=OR52R1 PE=2 SV=2 | 129 | I | 0.028824 | T | 0.055165 | -0.026341 | No Change: Both O | - |
| Q8NGF1 | O52R1_HUMAN Olfactory receptor 52R1 OS=Homo sapiens GN=OR52R1 PE=2 SV=2 | 201 | N | 0.257233 | Y | 0.14675 | 0.110483 | No Change: Both O | - |
| Q8NGF1 | O52R1_HUMAN Olfactory receptor 52R1 OS=Homo sapiens GN=OR52R1 PE=2 SV=2 | 245 | S | 0.234077 | A | 0.152699 | 0.081378 | No Change: Both O | - |
| Q6IF63 | O52W1_HUMAN Olfactory receptor 52W1 OS=Homo sapiens GN=OR52W1 PE=2 SV=2 | 239 | H | 0.4428 | R | 0.456892 | -0.014092 | No Change: Both O | - |
| Q6IF63 | O52W1_HUMAN Olfactory receptor 52W1 OS=Homo sapiens GN=OR52W1 PE=2 SV=2 | 254 | L | 0.017636 | Q | 0.033985 | -0.016349 | No Change: Both O | - |
| Q6IF63 | O52W1_HUMAN Olfactory receptor 52W1 OS=Homo sapiens GN=OR52W1 PE=2 SV=2 | 266 | T | 0.216944 | A | 0.18571 | 0.031234 | No Change: Both O | - |
| Q8NH54 | O56A3_HUMAN Olfactory receptor 56A3 OS=Homo sapiens GN=OR56A3 PE=1 SV=2 | 51 | M | 0.062978 | T | 0.087399 | -0.024421 | No Change: Both O | - |
| Q8NGI3 | O56B1_HUMAN Olfactory receptor 56B1 OS=Homo sapiens GN=OR56B1 PE=2 SV=2 | 106 | C | 0.06505 | R | 0.138044 | -0.072994 | No Change: Both O | - |
| Q8NH76 | O56B4_HUMAN Olfactory receptor 56B4 OS=Homo sapiens GN=OR56B4 PE=2 SV=1 | 277 | P | 0.062431 | S | 0.065322 | -0.002891 | No Change: Both O | - |
| Q8NGJ0 | OR5A1_HUMAN Olfactory receptor 5A1 OS=Homo sapiens GN=OR5A1 PE=2 SV=1 | 183 | D | 0.062549 | N | 0.063215 | -6.66E-04 | No Change: Both O | - |
| Q8NGJ0 | OR5A1_HUMAN Olfactory receptor 5A1 OS=Homo sapiens GN=OR5A1 PE=2 SV=1 | 52 | I | 0.091102 | V | 0.097365 | -0.006263 | No Change: Both O | - |
| Q8NGI9 | OR5A2_HUMAN Olfactory receptor 5A2 OS=Homo sapiens GN=OR5A2 PE=2 SV=1 | 172 | P | 0.105439 | L | 0.050262 | 0.055177 | No Change: Both O | - |
| Q8NGI9 | OR5A2_HUMAN Olfactory receptor 5A2 OS=Homo sapiens GN=OR5A2 PE=2 SV=1 | 103 | F | 0.030073 | L | 0.032849 | -0.002776 | No Change: Both O | - |
| Q9NZP5 | O5AC2_HUMAN Olfactory receptor 5AC2 OS=Homo sapiens GN=OR5AC2 PE=2 SV=2 | 200 | M | 0.036865 | I | 0.026556 | 0.010309 | No Change: Both O | - |
| Q8NH90 | O5AK2_HUMAN Olfactory receptor 5AK2 OS=Homo sapiens GN=OR5AK2 PE=2 SV=1 | 4 | G | 0.885074 | V | 0.805074 | 0.08 | No Change: Both D | - |
| Q8NH90 | O5AK2_HUMAN Olfactory receptor 5AK2 OS=Homo sapiens GN=OR5AK2 PE=2 SV=1 | 92 | M | 0.13963 | I | 0.098342 | 0.041288 | No Change: Both O | - |
| Q8NH90 | O5AK2_HUMAN Olfactory receptor 5AK2 OS=Homo sapiens GN=OR5AK2 PE=2 SV=1 | 43 | S | 0.15266 | T | 0.108333 | 0.044327 | No Change: Both O | - |
| Q8NGI8 | O5AN1_HUMAN Olfactory receptor 5AN1 OS=Homo sapiens GN=OR5AN1 PE=2 SV=1 | 289 | L | 0.134047 | F | 0.110198 | 0.023849 | No Change: Both O | - |
| Q8NGF4 | O5AP2_HUMAN Olfactory receptor 5AP2 OS=Homo sapiens GN=OR5AP2 PE=2 SV=1 | 105 | A | 0.072573 | T | 0.076679 | -0.004106 | No Change: Both O | - |
| Q8NGP9 | O5AR1_HUMAN Olfactory receptor 5AR1 OS=Homo sapiens GN=OR5AR1 PE=1 SV=1 | 225 | I | 0.050106 | V | 0.056111 | -0.006005 | No Change: Both O | - |
| Q8N127 | O5AS1_HUMAN Olfactory receptor 5AS1 OS=Homo sapiens GN=OR5AS1 PE=2 SV=1 | 122 | R | 0.088937 | L | 0.053486 | 0.035451 | No Change: Both O | - |
| Q8N127 | O5AS1_HUMAN Olfactory receptor 5AS1 OS=Homo sapiens GN=OR5AS1 PE=2 SV=1 | 310 | Y | 0.168747 | C | 0.128003 | 0.040744 | No Change: Both O | - |
| Q8NGC0 | O5AU1_HUMAN Olfactory receptor 5AU1 OS=Homo sapiens GN=OR5AU1 PE=2 SV=2 | 80 | V | 0.027351 | M | 0.03984 | -0.012489 | No Change: Both O | - |
| Q8NGC0 | O5AU1_HUMAN Olfactory receptor 5AU1 OS=Homo sapiens GN=OR5AU1 PE=2 SV=2 | 117 | L | 0.195706 | F | 0.1727 | 0.023006 | No Change: Both O | - |
| Q8NGC0 | O5AU1_HUMAN Olfactory receptor 5AU1 OS=Homo sapiens GN=OR5AU1 PE=2 SV=2 | 299 | I | 0.047157 | V | 0.053948 | -0.006791 | No Change: Both O | - |
| Q8NGC0 | O5AU1_HUMAN Olfactory receptor 5AU1 OS=Homo sapiens GN=OR5AU1 PE=2 SV=2 | 194 | S | 0.162503 | L | 0.067354 | 0.095149 | No Change: Both O | - |
| Q8NGC0 | O5AU1_HUMAN Olfactory receptor 5AU1 OS=Homo sapiens GN=OR5AU1 PE=2 SV=2 | 274 | N | 0.070549 | K | 0.09141 | -0.020861 | No Change: Both O | - |
| Q96R08 | OR5BC_HUMAN Olfactory receptor 5B12 OS=Homo sapiens GN=OR5B12 PE=2 SV=2 | 141 | C | 0.0431 | R | 0.083564 | -0.040464 | No Change: Both O | - |
| Q96R08 | OR5BC_HUMAN Olfactory receptor 5B12 OS=Homo sapiens GN=OR5B12 PE=2 SV=2 | 141 | C | 0.0431 | Y | 0.051638 | -0.008538 | No Change: Both O | - |
| Q8NGF7 | OR5BH_HUMAN Olfactory receptor 5B17 OS=Homo sapiens GN=OR5B17 PE=2 SV=1 | 80 | L | 0.173612 | I | 0.151091 | 0.022521 | No Change: Both O | - |
| Q8NGF7 | OR5BH_HUMAN Olfactory receptor 5B17 OS=Homo sapiens GN=OR5B17 PE=2 SV=1 | 308 | Y | 0.501873 | C | 0.446764 | 0.055109 | D to O | - |
| Q96R09 | OR5B2_HUMAN Olfactory receptor 5B2 OS=Homo sapiens GN=OR5B2 PE=2 SV=3 | 200 | M | 0.056055 | T | 0.071863 | -0.015808 | No Change: Both O | - |
| Q96R09 | OR5B2_HUMAN Olfactory receptor 5B2 OS=Homo sapiens GN=OR5B2 PE=2 SV=3 | 208 | V | 0.009742 | A | 0.013443 | -0.003701 | No Change: Both O | - |
| A6NL26 | OR5BL_HUMAN Olfactory receptor 5B21 OS=Homo sapiens GN=OR5B21 PE=2 SV=1 | 272 | S | 0.134742 | Y | 0.063825 | 0.070917 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 30 | P | 0.012064 | L | 0.005516 | 0.006548 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 35 | I | 0.014593 | F | 0.0143 | 2.93E-04 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 49 | W | 0.019378 | R | 0.052056 | -0.032678 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 170 | N | 0.344986 | S | 0.414682 | -0.069696 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 181 | A | 0.062718 | T | 0.072099 | -0.009381 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 198 | I | 0.032437 | V | 0.038945 | -0.006508 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 247 | G | 0.036384 | A | 0.029408 | 0.006976 | No Change: Both O | - |
| Q8NH48 | OR5B3_HUMAN Olfactory receptor 5B3 OS=Homo sapiens GN=OR5B3 PE=2 SV=1 | 296 | K | 0.540866 | R | 0.466214 | 0.074652 | D to O | - |
| Q8NGL4 | OR5DD_HUMAN Olfactory receptor 5D13 OS=Homo sapiens GN=OR5D13 PE=2 SV=2 | 62 | C | 0.0636 | Y | 0.080558 | -0.016958 | No Change: Both O | - |
| Q8NGL4 | OR5DD_HUMAN Olfactory receptor 5D13 OS=Homo sapiens GN=OR5D13 PE=2 SV=2 | 124 | R | 0.062562 | H | 0.063058 | -4.96E-04 | No Change: Both O | - |
| Q8NGL4 | OR5DD_HUMAN Olfactory receptor 5D13 OS=Homo sapiens GN=OR5D13 PE=2 SV=2 | 236 | R | 0.718317 | L | 0.578492 | 0.139825 | No Change: Both D | - |
| Q8NGL3 | OR5DE_HUMAN Olfactory receptor 5D14 OS=Homo sapiens GN=OR5D14 PE=2 SV=1 | 249 | S | 0.189784 | A | 0.119745 | 0.070039 | No Change: Both O | - |
| Q8NGL3 | OR5DE_HUMAN Olfactory receptor 5D14 OS=Homo sapiens GN=OR5D14 PE=2 SV=1 | 290 | L | 0.160093 | P | 0.292815 | -0.132722 | No Change: Both O | - |
| Q8NGK9 | OR5DG_HUMAN Olfactory receptor 5D16 OS=Homo sapiens GN=OR5D16 PE=2 SV=1 | 156 | A | 0.035717 | T | 0.039827 | -0.00411 | No Change: Both O | - |
| Q8NGL1 | OR5DI_HUMAN Olfactory receptor 5D18 OS=Homo sapiens GN=OR5D18 PE=2 SV=1 | 118 | V | 0.052656 | M | 0.070285 | -0.017629 | No Change: Both O | - |
| Q8NGL1 | OR5DI_HUMAN Olfactory receptor 5D18 OS=Homo sapiens GN=OR5D18 PE=2 SV=1 | 36 | Y | 0.020038 | C | 0.015684 | 0.004354 | No Change: Both O | - |
| Q8NGL1 | OR5DI_HUMAN Olfactory receptor 5D18 OS=Homo sapiens GN=OR5D18 PE=2 SV=1 | 136 | N | 0.117995 | D | 0.1221 | -0.004105 | No Change: Both O | - |
| Q8NGL1 | OR5DI_HUMAN Olfactory receptor 5D18 OS=Homo sapiens GN=OR5D18 PE=2 SV=1 | 270 | H | 0.584324 | R | 0.593115 | -0.008791 | No Change: Both D | - |
| O95221 | OR5F1_HUMAN Olfactory receptor 5F1 OS=Homo sapiens GN=OR5F1 PE=2 SV=2 | 294 | S | 0.416363 | N | 0.36906 | 0.047303 | No Change: Both O | - |
| O95221 | OR5F1_HUMAN Olfactory receptor 5F1 OS=Homo sapiens GN=OR5F1 PE=2 SV=2 | 278 | Y | 0.051775 | H | 0.087642 | -0.035867 | No Change: Both O | - |
| O95221 | OR5F1_HUMAN Olfactory receptor 5F1 OS=Homo sapiens GN=OR5F1 PE=2 SV=2 | 192 | T | 0.366705 | A | 0.337273 | 0.029432 | No Change: Both O | - |
| A6NKK0 | OR5H1_HUMAN Olfactory receptor 5H1 OS=Homo sapiens GN=OR5H1 PE=2 SV=1 | 148 | S | 0.038511 | T | 0.026295 | 0.012216 | No Change: Both O | - |
| A6NKK0 | OR5H1_HUMAN Olfactory receptor 5H1 OS=Homo sapiens GN=OR5H1 PE=2 SV=1 | 150 | V | 0.05592 | I | 0.054158 | 0.001762 | No Change: Both O | - |
| A6NKK0 | OR5H1_HUMAN Olfactory receptor 5H1 OS=Homo sapiens GN=OR5H1 PE=2 SV=1 | 153 | I | 0.082419 | L | 0.096858 | -0.014439 | No Change: Both O | - |
| A6NKK0 | OR5H1_HUMAN Olfactory receptor 5H1 OS=Homo sapiens GN=OR5H1 PE=2 SV=1 | 181 | T | 0.139464 | I | 0.082928 | 0.056536 | No Change: Both O | - |
| A6NKK0 | OR5H1_HUMAN Olfactory receptor 5H1 OS=Homo sapiens GN=OR5H1 PE=2 SV=1 | 230 | S | 0.650418 | T | 0.558979 | 0.091439 | No Change: Both D | - |
| A6NHG9 | O5H14_HUMAN Olfactory receptor 5H14 OS=Homo sapiens GN=OR5H14 PE=2 SV=1 | 64 | G | 0.047367 | R | 0.044554 | 0.002813 | No Change: Both O | - |
| A6NHG9 | O5H14_HUMAN Olfactory receptor 5H14 OS=Homo sapiens GN=OR5H14 PE=2 SV=1 | 189 | Y | 0.237403 | C | 0.194164 | 0.043239 | No Change: Both O | - |
| A6NDH6 | O5H15_HUMAN Olfactory receptor 5H15 OS=Homo sapiens GN=OR5H15 PE=2 SV=1 | 108 | V | 0.051262 | I | 0.050029 | 0.001233 | No Change: Both O | - |
| A6NDH6 | O5H15_HUMAN Olfactory receptor 5H15 OS=Homo sapiens GN=OR5H15 PE=2 SV=1 | 148 | S | 0.028787 | T | 0.019576 | 0.009211 | No Change: Both O | - |
| A6NDH6 | O5H15_HUMAN Olfactory receptor 5H15 OS=Homo sapiens GN=OR5H15 PE=2 SV=1 | 167 | T | 0.058484 | S | 0.090006 | -0.031522 | No Change: Both O | - |
| Q8NGV7 | OR5H2_HUMAN Olfactory receptor 5H2 OS=Homo sapiens GN=OR5H2 PE=2 SV=3 | 230 | I | 0.147639 | V | 0.17864 | -0.031001 | No Change: Both O | - |
| Q8NGV7 | OR5H2_HUMAN Olfactory receptor 5H2 OS=Homo sapiens GN=OR5H2 PE=2 SV=3 | 266 | R | 0.207384 | C | 0.107971 | 0.099413 | No Change: Both O | - |
| Q8NGV7 | OR5H2_HUMAN Olfactory receptor 5H2 OS=Homo sapiens GN=OR5H2 PE=2 SV=3 | 286 | I | 0.026518 | V | 0.028386 | -0.001868 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 46 | A | 0.00826 | E | 0.014074 | -0.005814 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 145 | A | 0.030764 | P | 0.04563 | -0.014866 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 179 | S | 0.104134 | L | 0.046789 | 0.057345 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 195 | C | 0.027316 | R | 0.060438 | -0.033122 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 272 | T | 0.19002 | A | 0.176769 | 0.013251 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 285 | D | 0.750586 | N | 0.724093 | 0.026493 | No Change: Both D | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 88 | S | 0.411758 | L | 0.214282 | 0.197476 | No Change: Both O | - |
| Q8NGV6 | OR5H6_HUMAN Olfactory receptor 5H6 OS=Homo sapiens GN=OR5H6 PE=2 SV=2 | 88 | S | 0.411758 | W | 0.143062 | 0.268696 | No Change: Both O | - |
| Q13606 | OR5I1_HUMAN Olfactory receptor 5I1 OS=Homo sapiens GN=OR5I1 PE=2 SV=1 | 76 | F | 0.048706 | S | 0.136422 | -0.087716 | No Change: Both O | - |
| Q13606 | OR5I1_HUMAN Olfactory receptor 5I1 OS=Homo sapiens GN=OR5I1 PE=2 SV=1 | 6 | R | 0.485699 | G | 0.503384 | -0.017685 | O to D | - |
| Q13606 | OR5I1_HUMAN Olfactory receptor 5I1 OS=Homo sapiens GN=OR5I1 PE=2 SV=1 | 50 | L | 0.059821 | S | 0.127427 | -0.067606 | No Change: Both O | - |
| Q13606 | OR5I1_HUMAN Olfactory receptor 5I1 OS=Homo sapiens GN=OR5I1 PE=2 SV=1 | 306 | V | 0.615148 | I | 0.561421 | 0.053727 | No Change: Both D | - |
| Q8NH18 | OR5J2_HUMAN Olfactory receptor 5J2 OS=Homo sapiens GN=OR5J2 PE=2 SV=1 | 136 | M | 0.164265 | I | 0.109647 | 0.054618 | No Change: Both O | - |
| A6NET4 | OR5K3_HUMAN Olfactory receptor 5K3 OS=Homo sapiens GN=OR5K3 PE=2 SV=1 | 44 | G | 0.036549 | D | 0.038699 | -0.00215 | No Change: Both O | - |
| A6NMS3 | OR5K4_HUMAN Olfactory receptor 5K4 OS=Homo sapiens GN=OR5K4 PE=2 SV=1 | 206 | I | 0.029896 | V | 0.031019 | -0.001123 | No Change: Both O | - |
| Q8NGL2 | OR5L1_HUMAN Olfactory receptor 5L1 OS=Homo sapiens GN=OR5L1 PE=2 SV=1 | 46 | I | 0.072326 | F | 0.06744 | 0.004886 | No Change: Both O | - |
| Q8NGL2 | OR5L1_HUMAN Olfactory receptor 5L1 OS=Homo sapiens GN=OR5L1 PE=2 SV=1 | 287 | S | 0.112483 | P | 0.100736 | 0.011747 | No Change: Both O | - |
| Q8NGL2 | OR5L1_HUMAN Olfactory receptor 5L1 OS=Homo sapiens GN=OR5L1 PE=2 SV=1 | 54 | R | 0.204382 | W | 0.085499 | 0.118883 | No Change: Both O | - |
| Q8NGL0 | OR5L2_HUMAN Olfactory receptor 5L2 OS=Homo sapiens GN=OR5L2 PE=2 SV=1 | 81 | M | 0.115654 | R | 0.150567 | -0.034913 | No Change: Both O | - |
| Q8NGL0 | OR5L2_HUMAN Olfactory receptor 5L2 OS=Homo sapiens GN=OR5L2 PE=2 SV=1 | 59 | V | 0.172131 | M | 0.214752 | -0.042621 | No Change: Both O | - |
| Q8NGP8 | OR5M1_HUMAN Olfactory receptor 5M1 OS=Homo sapiens GN=OR5M1 PE=2 SV=1 | 282 | S | 0.089644 | T | 0.066597 | 0.023047 | No Change: Both O | - |
| Q6IEU7 | OR5MA_HUMAN Olfactory receptor 5M10 OS=Homo sapiens GN=OR5M10 PE=2 SV=1 | 69 | V | 0.082642 | L | 0.086791 | -0.004149 | No Change: Both O | - |
| Q6IEU7 | OR5MA_HUMAN Olfactory receptor 5M10 OS=Homo sapiens GN=OR5M10 PE=2 SV=1 | 313 | I | 0.552397 | T | 0.712697 | -0.1603 | No Change: Both D | - |
| Q96RB7 | OR5MB_HUMAN Olfactory receptor 5M11 OS=Homo sapiens GN=OR5M11 PE=2 SV=2 | 171 | S | 0.09871 | N | 0.081194 | 0.017516 | No Change: Both O | - |
| Q96RB7 | OR5MB_HUMAN Olfactory receptor 5M11 OS=Homo sapiens GN=OR5M11 PE=2 SV=2 | 280 | V | 0.046146 | L | 0.04548 | 6.66E-04 | No Change: Both O | - |
| Q8NGP4 | OR5M3_HUMAN Olfactory receptor 5M3 OS=Homo sapiens GN=OR5M3 PE=2 SV=2 | 84 | L | 0.449459 | F | 0.389759 | 0.0597 | No Change: Both O | - |
| Q8NGP4 | OR5M3_HUMAN Olfactory receptor 5M3 OS=Homo sapiens GN=OR5M3 PE=2 SV=2 | 163 | G | 0.023934 | S | 0.029261 | -0.005327 | No Change: Both O | - |
| Q8NGP3 | OR5M9_HUMAN Olfactory receptor 5M9 OS=Homo sapiens GN=OR5M9 PE=2 SV=1 | 270 | K | 0.332968 | R | 0.277021 | 0.055947 | No Change: Both O | - |
| Q8WZ92 | OR5P2_HUMAN Olfactory receptor 5P2 OS=Homo sapiens GN=OR5P2 PE=2 SV=1 | 7 | G | 0.689434 | R | 0.66645 | 0.022984 | No Change: Both D | - |
| Q8WZ92 | OR5P2_HUMAN Olfactory receptor 5P2 OS=Homo sapiens GN=OR5P2 PE=2 SV=1 | 318 | N | 0.609221 | D | 0.622058 | -0.012837 | No Change: Both D | - |
| Q8WZ94 | OR5P3_HUMAN Olfactory receptor 5P3 OS=Homo sapiens GN=OR5P3 PE=2 SV=1 | 158 | T | 0.016078 | K | 0.023959 | -0.007881 | No Change: Both O | - |
| Q8WZ94 | OR5P3_HUMAN Olfactory receptor 5P3 OS=Homo sapiens GN=OR5P3 PE=2 SV=1 | 251 | F | 0.059553 | L | 0.070446 | -0.010893 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 7 | I | 0.063147 | T | 0.117402 | -0.054255 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 122 | C | 0.047838 | R | 0.09722 | -0.049382 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 184 | F | 0.10986 | L | 0.133274 | -0.023414 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 274 | A | 0.273153 | V | 0.22916 | 0.043993 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 103 | C | 0.036516 | Y | 0.042851 | -0.006335 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 121 | D | 0.042361 | G | 0.037118 | 0.005243 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 128 | S | 0.093517 | G | 0.068205 | 0.025312 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 132 | Y | 0.214903 | H | 0.34791 | -0.133007 | No Change: Both O | - |
| Q8NH85 | OR5R1_HUMAN Olfactory receptor 5R1 OS=Homo sapiens GN=OR5R1 PE=2 SV=1 | 162 | I | 0.032128 | T | 0.069934 | -0.037806 | No Change: Both O | - |
| Q8NG75 | OR5T1_HUMAN Olfactory receptor 5T1 OS=Homo sapiens GN=OR5T1 PE=2 SV=1 | 164 | S | 0.157391 | G | 0.118302 | 0.039089 | No Change: Both O | - |
| Q8NG75 | OR5T1_HUMAN Olfactory receptor 5T1 OS=Homo sapiens GN=OR5T1 PE=2 SV=1 | 60 | P | 0.033236 | L | 0.016968 | 0.016268 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 21 | S | 0.218501 | Y | 0.096574 | 0.121927 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 64 | T | 0.0425 | I | 0.022182 | 0.020318 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 87 | V | 0.055558 | L | 0.058114 | -0.002556 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 125 | T | 0.225183 | M | 0.186846 | 0.038337 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 238 | L | 0.055324 | V | 0.054362 | 9.62E-04 | No Change: Both O | - |
| Q8NGG2 | OR5T2_HUMAN Olfactory receptor 5T2 OS=Homo sapiens GN=OR5T2 PE=2 SV=3 | 309 | H | 0.501853 | D | 0.559266 | -0.057413 | No Change: Both D | - |
| Q8NGG3 | OR5T3_HUMAN Olfactory receptor 5T3 OS=Homo sapiens GN=OR5T3 PE=2 SV=3 | 84 | W | 0.096814 | G | 0.241355 | -0.144541 | No Change: Both O | - |
| Q9UGF6 | OR5V1_HUMAN Olfactory receptor 5V1 OS=Homo sapiens GN=OR5V1 PE=2 SV=1 | 23 | L | 0.101851 | W | 0.06338 | 0.038471 | No Change: Both O | - |
| Q9UGF6 | OR5V1_HUMAN Olfactory receptor 5V1 OS=Homo sapiens GN=OR5V1 PE=2 SV=1 | 45 | I | 0.050577 | M | 0.070958 | -0.020381 | No Change: Both O | - |
| Q9UGF6 | OR5V1_HUMAN Olfactory receptor 5V1 OS=Homo sapiens GN=OR5V1 PE=2 SV=1 | 136 | L | 0.087272 | P | 0.169735 | -0.082463 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 163 | A | 0.031093 | P | 0.043736 | -0.012643 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 189 | R | 0.357898 | C | 0.198856 | 0.159042 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 39 | F | 0.047577 | L | 0.058451 | -0.010874 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 65 | H | 0.068084 | R | 0.065661 | 0.002423 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 160 | M | 0.043056 | T | 0.057553 | -0.014497 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 215 | F | 0.043599 | L | 0.053358 | -0.009759 | No Change: Both O | - |
| Q8NH69 | OR5W2_HUMAN Olfactory receptor 5W2 OS=Homo sapiens GN=OR5W2 PE=2 SV=1 | 310 | F | 0.689201 | Y | 0.736191 | -0.04699 | No Change: Both D | - |
| O95222 | OR6A2_HUMAN Olfactory receptor 6A2 OS=Homo sapiens GN=OR6A2 PE=2 SV=2 | 22 | A | 0.148065 | V | 0.104624 | 0.043441 | No Change: Both O | - |
| O95007 | OR6B1_HUMAN Olfactory receptor 6B1 OS=Homo sapiens GN=OR6B1 PE=2 SV=1 | 143 | R | 0.066475 | C | 0.032293 | 0.034182 | No Change: Both O | - |
| Q6IFH4 | OR6B2_HUMAN Olfactory receptor 6B2 OS=Homo sapiens GN=OR6B2 PE=2 SV=2 | 179 | C | 0.055051 | R | 0.117634 | -0.062583 | No Change: Both O | - |
| Q6IFH4 | OR6B2_HUMAN Olfactory receptor 6B2 OS=Homo sapiens GN=OR6B2 PE=2 SV=2 | 227 | R | 0.085979 | C | 0.040172 | 0.045807 | No Change: Both O | - |
| Q8NGW1 | OR6B3_HUMAN Olfactory receptor 6B3 OS=Homo sapiens GN=OR6B3 PE=2 SV=1 | 234 | C | 0.063381 | Y | 0.077148 | -0.013767 | No Change: Both O | - |
| Q96RD1 | OR6C1_HUMAN Olfactory receptor 6C1 OS=Homo sapiens GN=OR6C1 PE=2 SV=2 | 130 | C | 0.066599 | Y | 0.078229 | -0.01163 | No Change: Both O | - |
| Q96RD1 | OR6C1_HUMAN Olfactory receptor 6C1 OS=Homo sapiens GN=OR6C1 PE=2 SV=2 | 165 | H | 0.073477 | D | 0.086969 | -0.013492 | No Change: Both O | - |
| Q96RD1 | OR6C1_HUMAN Olfactory receptor 6C1 OS=Homo sapiens GN=OR6C1 PE=2 SV=2 | 222 | T | 0.065004 | I | 0.036841 | 0.028163 | No Change: Both O | - |
| Q96RD1 | OR6C1_HUMAN Olfactory receptor 6C1 OS=Homo sapiens GN=OR6C1 PE=2 SV=2 | 246 | V | 0.240157 | I | 0.21406 | 0.026097 | No Change: Both O | - |
| Q9NZP2 | OR6C2_HUMAN Olfactory receptor 6C2 OS=Homo sapiens GN=OR6C2 PE=2 SV=2 | 181 | P | 0.251236 | A | 0.194899 | 0.056337 | No Change: Both O | - |
| Q9NZP2 | OR6C2_HUMAN Olfactory receptor 6C2 OS=Homo sapiens GN=OR6C2 PE=2 SV=2 | 209 | L | 0.006794 | P | 0.013675 | -0.006881 | No Change: Both O | - |
| Q9NZP0 | OR6C3_HUMAN Olfactory receptor 6C3 OS=Homo sapiens GN=OR6C3 PE=2 SV=2 | 234 | A | 0.702172 | S | 0.782127 | -0.079955 | No Change: Both D | - |
| Q9NZP0 | OR6C3_HUMAN Olfactory receptor 6C3 OS=Homo sapiens GN=OR6C3 PE=2 SV=2 | 69 | S | 0.071858 | L | 0.029351 | 0.042507 | No Change: Both O | - |
| Q9NZP0 | OR6C3_HUMAN Olfactory receptor 6C3 OS=Homo sapiens GN=OR6C3 PE=2 SV=2 | 133 | M | 0.182356 | T | 0.239568 | -0.057212 | No Change: Both O | - |
| Q8NGE1 | OR6C4_HUMAN Olfactory receptor 6C4 OS=Homo sapiens GN=OR6C4 PE=2 SV=1 | 37 | I | 0.05744 | V | 0.06109 | -0.00365 | No Change: Both O | - |
| Q8NGE1 | OR6C4_HUMAN Olfactory receptor 6C4 OS=Homo sapiens GN=OR6C4 PE=2 SV=1 | 83 | M | 0.250311 | T | 0.317203 | -0.066892 | No Change: Both O | - |
| A6NF89 | OR6C6_HUMAN Olfactory receptor 6C6 OS=Homo sapiens GN=OR6C6 PE=2 SV=1 | 190 | T | 0.156755 | I | 0.085194 | 0.071561 | No Change: Both O | - |
| A6NJZ3 | O6C65_HUMAN Olfactory receptor 6C65 OS=Homo sapiens GN=OR6C65 PE=2 SV=1 | 13 | L | 0.090018 | Q | 0.158589 | -0.068571 | No Change: Both O | - |
| A6NJZ3 | O6C65_HUMAN Olfactory receptor 6C65 OS=Homo sapiens GN=OR6C65 PE=2 SV=1 | 222 | T | 0.127633 | A | 0.110268 | 0.017365 | No Change: Both O | - |
| A6NIJ9 | O6C70_HUMAN Olfactory receptor 6C70 OS=Homo sapiens GN=OR6C70 PE=2 SV=1 | 181 | L | 0.060309 | P | 0.115646 | -0.055337 | No Change: Both O | - |
| A6NIJ9 | O6C70_HUMAN Olfactory receptor 6C70 OS=Homo sapiens GN=OR6C70 PE=2 SV=1 | 233 | K | 0.761217 | N | 0.720231 | 0.040986 | No Change: Both D | - |
| A6NCV1 | O6C74_HUMAN Olfactory receptor 6C74 OS=Homo sapiens GN=OR6C74 PE=2 SV=1 | 2 | R | 0.896308 | G | 0.903808 | -0.0075 | No Change: Both D | - |
| A6NCV1 | O6C74_HUMAN Olfactory receptor 6C74 OS=Homo sapiens GN=OR6C74 PE=2 SV=1 | 61 | L | 0.062232 | F | 0.057142 | 0.00509 | No Change: Both O | - |
| A6NCV1 | O6C74_HUMAN Olfactory receptor 6C74 OS=Homo sapiens GN=OR6C74 PE=2 SV=1 | 75 | Y | 0.07372 | C | 0.058441 | 0.015279 | No Change: Both O | - |
| A6NCV1 | O6C74_HUMAN Olfactory receptor 6C74 OS=Homo sapiens GN=OR6C74 PE=2 SV=1 | 86 | G | 0.385721 | D | 0.433936 | -0.048215 | No Change: Both O | - |
| A6NCV1 | O6C74_HUMAN Olfactory receptor 6C74 OS=Homo sapiens GN=OR6C74 PE=2 SV=1 | 120 | R | 0.095809 | C | 0.046855 | 0.048954 | No Change: Both O | - |
| A6NL08 | O6C75_HUMAN Olfactory receptor 6C75 OS=Homo sapiens GN=OR6C75 PE=2 SV=1 | 141 | L | 0.044203 | F | 0.038029 | 0.006174 | No Change: Both O | - |
| A6NL08 | O6C75_HUMAN Olfactory receptor 6C75 OS=Homo sapiens GN=OR6C75 PE=2 SV=1 | 235 | A | 0.662924 | D | 0.716333 | -0.053409 | No Change: Both D | - |
| Q8NGZ6 | OR6F1_HUMAN Olfactory receptor 6F1 OS=Homo sapiens GN=OR6F1 PE=2 SV=1 | 215 | F | 0.03006 | L | 0.0375 | -0.00744 | No Change: Both O | - |
| Q8NGZ6 | OR6F1_HUMAN Olfactory receptor 6F1 OS=Homo sapiens GN=OR6F1 PE=2 SV=1 | 159 | P | 0.07492 | A | 0.057619 | 0.017301 | No Change: Both O | - |
| Q8NGZ6 | OR6F1_HUMAN Olfactory receptor 6F1 OS=Homo sapiens GN=OR6F1 PE=2 SV=1 | 13 | L | 0.17873 | P | 0.321029 | -0.142299 | No Change: Both O | - |
| Q8NGY2 | OR6K2_HUMAN Olfactory receptor 6K2 OS=Homo sapiens GN=OR6K2 PE=2 SV=1 | 6 | R | 0.691927 | Q | 0.719195 | -0.027268 | No Change: Both D | - |
| Q8NGY2 | OR6K2_HUMAN Olfactory receptor 6K2 OS=Homo sapiens GN=OR6K2 PE=2 SV=1 | 156 | L | 0.065369 | V | 0.063949 | 0.00142 | No Change: Both O | - |
| Q8NGY2 | OR6K2_HUMAN Olfactory receptor 6K2 OS=Homo sapiens GN=OR6K2 PE=2 SV=1 | 159 | I | 0.083607 | F | 0.082299 | 0.001308 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 20 | G | 0.761157 | R | 0.763912 | -0.002755 | No Change: Both D | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 244 | P | 0.357271 | S | 0.409317 | -0.052046 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 264 | P | 0.055574 | L | 0.027643 | 0.027931 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 308 | R | 0.288876 | K | 0.364057 | -0.075181 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 159 | Q | 0.177992 | H | 0.16742 | 0.010572 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 279 | D | 0.224158 | N | 0.202561 | 0.021597 | No Change: Both O | - |
| Q8NGY3 | OR6K3_HUMAN Olfactory receptor 6K3 OS=Homo sapiens GN=OR6K3 PE=2 SV=2 | 216 | V | 0.076355 | M | 0.099941 | -0.023586 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 39 | E | 0.188612 | D | 0.170732 | 0.01788 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 49 | H | 0.203282 | Y | 0.115411 | 0.087871 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 80 | G | 0.050647 | D | 0.057859 | -0.007212 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 134 | S | 0.08442 | L | 0.035985 | 0.048435 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 159 | R | 0.080631 | C | 0.038893 | 0.041738 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 197 | C | 0.147131 | R | 0.278222 | -0.131091 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 211 | P | 0.057251 | L | 0.029089 | 0.028162 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 247 | R | 0.012802 | Q | 0.014084 | -0.001282 | No Change: Both O | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 261 | H | 0.698825 | R | 0.672306 | 0.026519 | No Change: Both D | - |
| Q8NGW6 | OR6K6_HUMAN Olfactory receptor 6K6 OS=Homo sapiens GN=OR6K6 PE=2 SV=2 | 320 | K | 0.390968 | R | 0.298742 | 0.092226 | No Change: Both O | - |
| Q8NGM8 | OR6M1_HUMAN Olfactory receptor 6M1 OS=Homo sapiens GN=OR6M1 PE=2 SV=1 | 276 | T | 0.045705 | K | 0.06439 | -0.018685 | No Change: Both O | - |
| Q8NGY5 | OR6N1_HUMAN Olfactory receptor 6N1 OS=Homo sapiens GN=OR6N1 PE=2 SV=1 | 10 | A | 0.07415 | T | 0.088983 | -0.014833 | No Change: Both O | - |
| Q8NGY5 | OR6N1_HUMAN Olfactory receptor 6N1 OS=Homo sapiens GN=OR6N1 PE=2 SV=1 | 194 | I | 0.105849 | T | 0.198775 | -0.092926 | No Change: Both O | - |
| Q8NGY5 | OR6N1_HUMAN Olfactory receptor 6N1 OS=Homo sapiens GN=OR6N1 PE=2 SV=1 | 261 | Q | 0.312042 | R | 0.292409 | 0.019633 | No Change: Both O | - |
| Q8NGY5 | OR6N1_HUMAN Olfactory receptor 6N1 OS=Homo sapiens GN=OR6N1 PE=2 SV=1 | 293 | R | 0.265376 | H | 0.26602 | -6.44E-04 | No Change: Both O | - |
| Q8NGY5 | OR6N1_HUMAN Olfactory receptor 6N1 OS=Homo sapiens GN=OR6N1 PE=2 SV=1 | 245 | F | 0.05452 | L | 0.063515 | -0.008995 | No Change: Both O | - |
| Q8NGY6 | OR6N2_HUMAN Olfactory receptor 6N2 OS=Homo sapiens GN=OR6N2 PE=1 SV=1 | 204 | A | 0.012956 | V | 0.00863 | 0.004326 | No Change: Both O | - |
| Q8NGY6 | OR6N2_HUMAN Olfactory receptor 6N2 OS=Homo sapiens GN=OR6N2 PE=1 SV=1 | 250 | I | 0.01832 | V | 0.021358 | -0.003038 | No Change: Both O | - |
| Q8NGQ2 | OR6Q1_HUMAN Olfactory receptor 6Q1 OS=Homo sapiens GN=OR6Q1 PE=2 SV=2 | 316 | G | 0.712068 | A | 0.663065 | 0.049003 | No Change: Both D | - |
| Q8NGQ2 | OR6Q1_HUMAN Olfactory receptor 6Q1 OS=Homo sapiens GN=OR6Q1 PE=2 SV=2 | 172 | F | 0.092087 | I | 0.097018 | -0.004931 | No Change: Both O | - |
| Q8NH40 | OR6S1_HUMAN Olfactory receptor 6S1 OS=Homo sapiens GN=OR6S1 PE=2 SV=2 | 42 | T | 0.052964 | I | 0.02911 | 0.023854 | No Change: Both O | - |
| Q8NH40 | OR6S1_HUMAN Olfactory receptor 6S1 OS=Homo sapiens GN=OR6S1 PE=2 SV=2 | 156 | V | 0.066694 | I | 0.051389 | 0.015305 | No Change: Both O | - |
| Q8NH40 | OR6S1_HUMAN Olfactory receptor 6S1 OS=Homo sapiens GN=OR6S1 PE=2 SV=2 | 237 | R | 0.647308 | H | 0.654786 | -0.007478 | No Change: Both D | - |
| Q8NH40 | OR6S1_HUMAN Olfactory receptor 6S1 OS=Homo sapiens GN=OR6S1 PE=2 SV=2 | 296 | R | 0.17737 | C | 0.088125 | 0.089245 | No Change: Both O | - |
| Q8NGN1 | OR6T1_HUMAN Olfactory receptor 6T1 OS=Homo sapiens GN=OR6T1 PE=2 SV=1 | 23 | I | 0.07362 | T | 0.137772 | -0.064152 | No Change: Both O | - |
| Q8NGN1 | OR6T1_HUMAN Olfactory receptor 6T1 OS=Homo sapiens GN=OR6T1 PE=2 SV=1 | 64 | R | 0.044166 | W | 0.016317 | 0.027849 | No Change: Both O | - |
| Q8NGN1 | OR6T1_HUMAN Olfactory receptor 6T1 OS=Homo sapiens GN=OR6T1 PE=2 SV=1 | 251 | I | 0.041948 | V | 0.049006 | -0.007058 | No Change: Both O | - |
| Q8N148 | OR6V1_HUMAN Olfactory receptor 6V1 OS=Homo sapiens GN=OR6V1 PE=2 SV=1 | 237 | S | 0.397539 | F | 0.198738 | 0.198801 | No Change: Both O | - |
| Q8N148 | OR6V1_HUMAN Olfactory receptor 6V1 OS=Homo sapiens GN=OR6V1 PE=2 SV=1 | 269 | R | 0.277569 | K | 0.366547 | -0.088978 | No Change: Both O | - |
| Q8N148 | OR6V1_HUMAN Olfactory receptor 6V1 OS=Homo sapiens GN=OR6V1 PE=2 SV=1 | 295 | V | 0.196402 | A | 0.244524 | -0.048122 | No Change: Both O | - |
| Q8NH79 | OR6X1_HUMAN Olfactory receptor 6X1 OS=Homo sapiens GN=OR6X1 PE=2 SV=1 | 190 | T | 0.103155 | N | 0.122289 | -0.019134 | No Change: Both O | - |
| Q8NGX8 | OR6Y1_HUMAN Olfactory receptor 6Y1 OS=Homo sapiens GN=OR6Y1 PE=2 SV=1 | 104 | T | 0.050055 | I | 0.026365 | 0.02369 | No Change: Both O | - |
| O76100 | OR7AA_HUMAN Olfactory receptor 7A10 OS=Homo sapiens GN=OR7A10 PE=2 SV=1 | 183 | Q | 0.068687 | E | 0.091185 | -0.022498 | No Change: Both O | - |
| O76100 | OR7AA_HUMAN Olfactory receptor 7A10 OS=Homo sapiens GN=OR7A10 PE=2 SV=1 | 151 | M | 0.091741 | T | 0.104871 | -0.01313 | No Change: Both O | - |
| O76100 | OR7AA_HUMAN Olfactory receptor 7A10 OS=Homo sapiens GN=OR7A10 PE=2 SV=1 | 225 | I | 0.4636 | L | 0.471948 | -0.008348 | No Change: Both O | - |
| O76100 | OR7AA_HUMAN Olfactory receptor 7A10 OS=Homo sapiens GN=OR7A10 PE=2 SV=1 | 273 | A | 0.477573 | T | 0.506496 | -0.028923 | O to D | - |
| O14581 | OR7AH_HUMAN Olfactory receptor 7A17 OS=Homo sapiens GN=OR7A17 PE=2 SV=1 | 37 | V | 0.033745 | A | 0.045513 | -0.011768 | No Change: Both O | - |
| O14581 | OR7AH_HUMAN Olfactory receptor 7A17 OS=Homo sapiens GN=OR7A17 PE=2 SV=1 | 46 | I | 0.057486 | T | 0.104803 | -0.047317 | No Change: Both O | - |
| O14581 | OR7AH_HUMAN Olfactory receptor 7A17 OS=Homo sapiens GN=OR7A17 PE=2 SV=1 | 69 | A | 0.067619 | S | 0.124015 | -0.056396 | No Change: Both O | - |
| O14581 | OR7AH_HUMAN Olfactory receptor 7A17 OS=Homo sapiens GN=OR7A17 PE=2 SV=1 | 237 | A | 0.450845 | T | 0.475285 | -0.02444 | No Change: Both O | - |
| O76099 | OR7C1_HUMAN Olfactory receptor 7C1 OS=Homo sapiens GN=OR7C1 PE=2 SV=1 | 126 | V | 0.059847 | I | 0.047926 | 0.011921 | No Change: Both O | - |
| O76099 | OR7C1_HUMAN Olfactory receptor 7C1 OS=Homo sapiens GN=OR7C1 PE=2 SV=1 | 210 | S | 0.054898 | P | 0.046103 | 0.008795 | No Change: Both O | - |
| O76099 | OR7C1_HUMAN Olfactory receptor 7C1 OS=Homo sapiens GN=OR7C1 PE=2 SV=1 | 99 | S | 0.041141 | G | 0.032821 | 0.00832 | No Change: Both O | - |
| O76099 | OR7C1_HUMAN Olfactory receptor 7C1 OS=Homo sapiens GN=OR7C1 PE=2 SV=1 | 171 | E | 0.144015 | K | 0.134632 | 0.009383 | No Change: Both O | - |
| O60412 | OR7C2_HUMAN Olfactory receptor 7C2 OS=Homo sapiens GN=OR7C2 PE=2 SV=4 | 118 | T | 0.067961 | M | 0.054364 | 0.013597 | No Change: Both O | - |
| O60412 | OR7C2_HUMAN Olfactory receptor 7C2 OS=Homo sapiens GN=OR7C2 PE=2 SV=4 | 122 | R | 0.044389 | H | 0.04546 | -0.001071 | No Change: Both O | - |
| Q96RA2 | OR7D2_HUMAN Olfactory receptor 7D2 OS=Homo sapiens GN=OR7D2 PE=2 SV=2 | 197 | T | 0.090208 | M | 0.071307 | 0.018901 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 52 | D | 0.454767 | G | 0.422573 | 0.032194 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 75 | S | 0.071657 | C | 0.025409 | 0.046248 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 79 | P | 0.156553 | L | 0.084148 | 0.072405 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 84 | S | 0.296202 | N | 0.242776 | 0.053426 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 88 | R | 0.412642 | W | 0.210689 | 0.201953 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 131 | H | 0.050136 | Q | 0.050883 | -7.47E-04 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 133 | T | 0.061316 | M | 0.053215 | 0.008101 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 136 | M | 0.055406 | I | 0.038089 | 0.017317 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 139 | C | 0.03112 | R | 0.064099 | -0.032979 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 139 | C | 0.03112 | Y | 0.038841 | -0.007721 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 162 | L | 0.078599 | P | 0.142232 | -0.063633 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 279 | A | 0.262782 | D | 0.32034 | -0.057558 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 292 | L | 0.277662 | M | 0.355407 | -0.077745 | No Change: Both O | - |
| Q8NG98 | OR7D4_HUMAN Olfactory receptor 7D4 OS=Homo sapiens GN=OR7D4 PE=2 SV=1 | 17 | L | 0.325829 | F | 0.284008 | 0.041821 | No Change: Both O | - |
| Q6IFN5 | O7E24_HUMAN Olfactory receptor 7E24 OS=Homo sapiens GN=OR7E24 PE=2 SV=1 | 193 | S | 0.138481 | F | 0.055163 | 0.083318 | No Change: Both O | - |
| Q6IFN5 | O7E24_HUMAN Olfactory receptor 7E24 OS=Homo sapiens GN=OR7E24 PE=2 SV=1 | 242 | P | 0.154653 | S | 0.177833 | -0.02318 | No Change: Both O | - |
| Q8NGA0 | OR7G1_HUMAN Olfactory receptor 7G1 OS=Homo sapiens GN=OR7G1 PE=2 SV=2 | 141 | W | 0.018487 | C | 0.022407 | -0.00392 | No Change: Both O | - |
| Q8NGA0 | OR7G1_HUMAN Olfactory receptor 7G1 OS=Homo sapiens GN=OR7G1 PE=2 SV=2 | 252 | Y | 0.065898 | C | 0.058539 | 0.007359 | No Change: Both O | - |
| Q8NGA0 | OR7G1_HUMAN Olfactory receptor 7G1 OS=Homo sapiens GN=OR7G1 PE=2 SV=2 | 83 | V | 0.171845 | A | 0.234737 | -0.062892 | No Change: Both O | - |
| Q8NGA0 | OR7G1_HUMAN Olfactory receptor 7G1 OS=Homo sapiens GN=OR7G1 PE=2 SV=2 | 156 | A | 0.260495 | V | 0.206958 | 0.053537 | No Change: Both O | - |
| Q8NGA0 | OR7G1_HUMAN Olfactory receptor 7G1 OS=Homo sapiens GN=OR7G1 PE=2 SV=2 | 167 | S | 0.083142 | F | 0.03042 | 0.052722 | No Change: Both O | - |
| Q8NG99 | OR7G2_HUMAN Olfactory receptor 7G2 OS=Homo sapiens GN=OR7G2 PE=2 SV=1 | 281 | F | 0.15516 | V | 0.187471 | -0.032311 | No Change: Both O | - |
| Q8NG95 | OR7G3_HUMAN Olfactory receptor 7G3 OS=Homo sapiens GN=OR7G3 PE=2 SV=1 | 29 | M | 0.047053 | V | 0.028537 | 0.018516 | No Change: Both O | - |
| Q8NGG7 | OR8A1_HUMAN Olfactory receptor 8A1 OS=Homo sapiens GN=OR8A1 PE=2 SV=2 | 218 | S | 0.063458 | L | 0.025374 | 0.038084 | No Change: Both O | - |
| Q8NGG7 | OR8A1_HUMAN Olfactory receptor 8A1 OS=Homo sapiens GN=OR8A1 PE=2 SV=2 | 133 | T | 0.042553 | R | 0.048551 | -0.005998 | No Change: Both O | - |
| Q96RD0 | OR8B2_HUMAN Olfactory receptor 8B2 OS=Homo sapiens GN=OR8B2 PE=2 SV=3 | 27 | L | 0.073635 | F | 0.067217 | 0.006418 | No Change: Both O | - |
| Q96RD0 | OR8B2_HUMAN Olfactory receptor 8B2 OS=Homo sapiens GN=OR8B2 PE=2 SV=3 | 164 | L | 0.093811 | F | 0.082553 | 0.011258 | No Change: Both O | - |
| Q96RD0 | OR8B2_HUMAN Olfactory receptor 8B2 OS=Homo sapiens GN=OR8B2 PE=2 SV=3 | 20 | H | 0.31533 | R | 0.328114 | -0.012784 | No Change: Both O | - |
| Q96RD0 | OR8B2_HUMAN Olfactory receptor 8B2 OS=Homo sapiens GN=OR8B2 PE=2 SV=3 | 273 | S | 0.420392 | F | 0.225239 | 0.195153 | No Change: Both O | - |
| Q8NGG8 | OR8B3_HUMAN Olfactory receptor 8B3 OS=Homo sapiens GN=OR8B3 PE=2 SV=3 | 20 | H | 0.339723 | R | 0.336236 | 0.003487 | No Change: Both O | - |
| Q8NGG8 | OR8B3_HUMAN Olfactory receptor 8B3 OS=Homo sapiens GN=OR8B3 PE=2 SV=3 | 114 | M | 0.078195 | I | 0.050754 | 0.027441 | No Change: Both O | - |
| Q96RC9 | OR8B4_HUMAN Olfactory receptor 8B4 OS=Homo sapiens GN=OR8B4 PE=2 SV=2 | 131 | Y | 0.05846 | H | 0.100174 | -0.041714 | No Change: Both O | - |
| Q96RC9 | OR8B4_HUMAN Olfactory receptor 8B4 OS=Homo sapiens GN=OR8B4 PE=2 SV=2 | 22 | E | 0.380232 | G | 0.320447 | 0.059785 | No Change: Both O | - |
| Q96RC9 | OR8B4_HUMAN Olfactory receptor 8B4 OS=Homo sapiens GN=OR8B4 PE=2 SV=2 | 140 | C | 0.050692 | F | 0.059606 | -0.008914 | No Change: Both O | - |
| Q96RC9 | OR8B4_HUMAN Olfactory receptor 8B4 OS=Homo sapiens GN=OR8B4 PE=2 SV=2 | 178 | C | 0.053055 | R | 0.113421 | -0.060366 | No Change: Both O | - |
| Q8WZ84 | OR8D1_HUMAN Olfactory receptor 8D1 OS=Homo sapiens GN=OR8D1 PE=2 SV=1 | 194 | L | 0.198474 | P | 0.318578 | -0.120104 | No Change: Both O | - |
| Q8WZ84 | OR8D1_HUMAN Olfactory receptor 8D1 OS=Homo sapiens GN=OR8D1 PE=2 SV=1 | 102 | F | 0.011543 | V | 0.013623 | -0.00208 | No Change: Both O | - |
| Q8WZ84 | OR8D1_HUMAN Olfactory receptor 8D1 OS=Homo sapiens GN=OR8D1 PE=2 SV=1 | 127 | C | 0.049613 | W | 0.041667 | 0.007946 | No Change: Both O | - |
| Q9GZM6 | OR8D2_HUMAN Olfactory receptor 8D2 OS=Homo sapiens GN=OR8D2 PE=2 SV=1 | 122 | R | 0.080727 | H | 0.076802 | 0.003925 | No Change: Both O | - |
| Q9GZM6 | OR8D2_HUMAN Olfactory receptor 8D2 OS=Homo sapiens GN=OR8D2 PE=2 SV=1 | 263 | P | 0.611843 | L | 0.438003 | 0.17384 | D to O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 133 | R | 0.08044 | K | 0.100748 | -0.020308 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 200 | F | 0.022417 | L | 0.026388 | -0.003971 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 283 | L | 0.134516 | P | 0.218391 | -0.083875 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 298 | R | 0.370903 | K | 0.432507 | -0.061604 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 55 | L | 0.171384 | R | 0.27781 | -0.106426 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 92 | I | 0.238768 | V | 0.257184 | -0.018416 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 205 | F | 0.057619 | S | 0.151774 | -0.094155 | No Change: Both O | - |
| Q8NGM9 | OR8D4_HUMAN Olfactory receptor 8D4 OS=Homo sapiens GN=OR8D4 PE=2 SV=1 | 120 | C | 0.064612 | Y | 0.081445 | -0.016833 | No Change: Both O | - |
| Q15617 | OR8G1_HUMAN Olfactory receptor 8G1 OS=Homo sapiens GN=OR8G1 PE=2 SV=2 | 247 | A | 0.097484 | V | 0.072093 | 0.025391 | No Change: Both O | - |
| Q15614 | OR8G2_HUMAN Olfactory receptor 8G2 OS=Homo sapiens GN=OR8G2 PE=2 SV=2 | 30 | L | 0.013919 | P | 0.027225 | -0.013306 | No Change: Both O | - |
| Q8NGG4 | OR8H1_HUMAN Olfactory receptor 8H1 OS=Homo sapiens GN=OR8H1 PE=2 SV=1 | 22 | E | 0.392373 | V | 0.214124 | 0.178249 | No Change: Both O | - |
| Q8NGG4 | OR8H1_HUMAN Olfactory receptor 8H1 OS=Homo sapiens GN=OR8H1 PE=2 SV=1 | 2 | G | 0.925161 | S | 0.914047 | 0.011114 | No Change: Both D | - |
| Q8N162 | OR8H2_HUMAN Olfactory receptor 8H2 OS=Homo sapiens GN=OR8H2 PE=2 SV=1 | 120 | H | 0.267011 | Y | 0.1817 | 0.085311 | No Change: Both O | - |
| Q8N162 | OR8H2_HUMAN Olfactory receptor 8H2 OS=Homo sapiens GN=OR8H2 PE=2 SV=1 | 169 | Y | 0.280159 | C | 0.232326 | 0.047833 | No Change: Both O | - |
| Q8N162 | OR8H2_HUMAN Olfactory receptor 8H2 OS=Homo sapiens GN=OR8H2 PE=2 SV=1 | 284 | V | 0.04514 | M | 0.056631 | -0.011491 | No Change: Both O | - |
| Q8N146 | OR8H3_HUMAN Olfactory receptor 8H3 OS=Homo sapiens GN=OR8H3 PE=2 SV=1 | 201 | I | 0.061504 | V | 0.063643 | -0.002139 | No Change: Both O | - |
| Q8N146 | OR8H3_HUMAN Olfactory receptor 8H3 OS=Homo sapiens GN=OR8H3 PE=2 SV=1 | 137 | P | 0.086202 | S | 0.095949 | -0.009747 | No Change: Both O | - |
| Q8N146 | OR8H3_HUMAN Olfactory receptor 8H3 OS=Homo sapiens GN=OR8H3 PE=2 SV=1 | 295 | R | 0.318221 | K | 0.371954 | -0.053733 | No Change: Both O | - |
| Q8N146 | OR8H3_HUMAN Olfactory receptor 8H3 OS=Homo sapiens GN=OR8H3 PE=2 SV=1 | 47 | L | 0.044576 | I | 0.038107 | 0.006469 | No Change: Both O | - |
| Q8N0Y5 | OR8I2_HUMAN Olfactory receptor 8I2 OS=Homo sapiens GN=OR8I2 PE=2 SV=1 | 124 | I | 0.058875 | V | 0.06326 | -0.004385 | No Change: Both O | - |
| Q8N0Y5 | OR8I2_HUMAN Olfactory receptor 8I2 OS=Homo sapiens GN=OR8I2 PE=2 SV=1 | 139 | K | 0.283391 | N | 0.257363 | 0.026028 | No Change: Both O | - |
| Q8NGP2 | OR8J1_HUMAN Olfactory receptor 8J1 OS=Homo sapiens GN=OR8J1 PE=2 SV=2 | 36 | G | 0.03906 | V | 0.020369 | 0.018691 | No Change: Both O | - |
| Q8NGP2 | OR8J1_HUMAN Olfactory receptor 8J1 OS=Homo sapiens GN=OR8J1 PE=2 SV=2 | 114 | M | 0.038407 | L | 0.028941 | 0.009466 | No Change: Both O | - |
| Q8NGP2 | OR8J1_HUMAN Olfactory receptor 8J1 OS=Homo sapiens GN=OR8J1 PE=2 SV=2 | 120 | Y | 0.0507 | C | 0.038704 | 0.011996 | No Change: Both O | - |
| Q8NGG0 | OR8J3_HUMAN Olfactory receptor 8J3 OS=Homo sapiens GN=OR8J3 PE=2 SV=1 | 57 | N | 0.240266 | T | 0.212955 | 0.027311 | No Change: Both O | - |
| Q8NGG0 | OR8J3_HUMAN Olfactory receptor 8J3 OS=Homo sapiens GN=OR8J3 PE=2 SV=1 | 87 | V | 0.310238 | I | 0.281713 | 0.028525 | No Change: Both O | - |
| Q8NGG0 | OR8J3_HUMAN Olfactory receptor 8J3 OS=Homo sapiens GN=OR8J3 PE=2 SV=1 | 208 | V | 0.076346 | F | 0.066509 | 0.009837 | No Change: Both O | - |
| Q8NGG0 | OR8J3_HUMAN Olfactory receptor 8J3 OS=Homo sapiens GN=OR8J3 PE=2 SV=1 | 271 | D | 0.555191 | E | 0.5684 | -0.013209 | No Change: Both D | - |
| Q8NGG5 | OR8K1_HUMAN Olfactory receptor 8K1 OS=Homo sapiens GN=OR8K1 PE=2 SV=1 | 21 | M | 0.103947 | V | 0.082579 | 0.021368 | No Change: Both O | - |
| Q8NGG5 | OR8K1_HUMAN Olfactory receptor 8K1 OS=Homo sapiens GN=OR8K1 PE=2 SV=1 | 27 | P | 0.310371 | T | 0.25762 | 0.052751 | No Change: Both O | - |
| Q8NGG5 | OR8K1_HUMAN Olfactory receptor 8K1 OS=Homo sapiens GN=OR8K1 PE=2 SV=1 | 84 | A | 0.110924 | T | 0.135647 | -0.024723 | No Change: Both O | - |
| Q8NH51 | OR8K3_HUMAN Olfactory receptor 8K3 OS=Homo sapiens GN=OR8K3 PE=2 SV=1 | 122 | L | 0.056755 | R | 0.09506 | -0.038305 | No Change: Both O | - |
| Q8NH51 | OR8K3_HUMAN Olfactory receptor 8K3 OS=Homo sapiens GN=OR8K3 PE=2 SV=1 | 173 | V | 0.060007 | I | 0.055807 | 0.0042 | No Change: Both O | - |
| Q8NH51 | OR8K3_HUMAN Olfactory receptor 8K3 OS=Homo sapiens GN=OR8K3 PE=2 SV=1 | 275 | I | 0.069856 | M | 0.102952 | -0.033096 | No Change: Both O | - |
| Q8NH50 | OR8K5_HUMAN Olfactory receptor 8K5 OS=Homo sapiens GN=OR8K5 PE=2 SV=1 | 68 | F | 0.099869 | S | 0.255944 | -0.156075 | No Change: Both O | - |
| Q8NH09 | OR8S1_HUMAN Olfactory receptor 8S1 OS=Homo sapiens GN=OR8S1 PE=2 SV=2 | 48 | M | 0.072677 | V | 0.050091 | 0.022586 | No Change: Both O | - |
| Q8NH09 | OR8S1_HUMAN Olfactory receptor 8S1 OS=Homo sapiens GN=OR8S1 PE=2 SV=2 | 82 | L | 0.288654 | P | 0.456028 | -0.167374 | No Change: Both O | - |
| Q8NH09 | OR8S1_HUMAN Olfactory receptor 8S1 OS=Homo sapiens GN=OR8S1 PE=2 SV=2 | 128 | R | 0.086791 | C | 0.040048 | 0.046743 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 20 | H | 0.264475 | R | 0.261965 | 0.00251 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 109 | I | 0.100384 | V | 0.114258 | -0.013874 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 112 | S | 0.19245 | C | 0.062874 | 0.129576 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 165 | R | 0.090785 | C | 0.044358 | 0.046427 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 288 | L | 0.12476 | V | 0.118197 | 0.006563 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 293 | Q | 0.342829 | R | 0.326701 | 0.016128 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 137 | T | 0.039138 | S | 0.057157 | -0.018019 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 206 | M | 0.021793 | I | 0.015584 | 0.006209 | No Change: Both O | - |
| Q8NH10 | OR8U1_HUMAN Olfactory receptor 8U1 OS=Homo sapiens GN=OR8U1 PE=2 SV=1 | 206 | M | 0.021793 | T | 0.027249 | -0.005456 | No Change: Both O | - |
| Q8NGT5 | OR9A2_HUMAN Olfactory receptor 9A2 OS=Homo sapiens GN=OR9A2 PE=2 SV=1 | 53 | R | 0.125577 | H | 0.126786 | -0.001209 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 53 | C | 0.072836 | R | 0.144044 | -0.071208 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 61 | F | 0.109214 | V | 0.114185 | -0.004971 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 83 | T | 0.127341 | I | 0.07372 | 0.053621 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 112 | Y | 0.0775 | C | 0.061336 | 0.016164 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 117 | V | 0.055898 | M | 0.069951 | -0.014053 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 259 | A | 0.138878 | S | 0.236686 | -0.097808 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 169 | R | 0.10195 | C | 0.051324 | 0.050626 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 185 | E | 0.104929 | K | 0.104171 | 7.58E-04 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 231 | K | 0.50469 | Q | 0.432663 | 0.072027 | D to O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 53 | C | 0.072836 | Y | 0.090659 | -0.017823 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 62 | T | 0.097832 | I | 0.048023 | 0.049809 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 98 | C | 0.036073 | G | 0.084812 | -0.048739 | No Change: Both O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 233 | Y | 0.504357 | C | 0.454581 | 0.049776 | D to O | - |
| Q8NH87 | OR9G1_HUMAN Olfactory receptor 9G1 OS=Homo sapiens GN=OR9G1 PE=2 SV=1 | 233 | Y | 0.504357 | H | 0.63388 | -0.129523 | No Change: Both D | - |
| Q8NGQ1 | OR9G4_HUMAN Olfactory receptor 9G4 OS=Homo sapiens GN=OR9G4 PE=2 SV=2 | 43 | F | 0.025052 | S | 0.069085 | -0.044033 | No Change: Both O | - |
| Q8NGQ1 | OR9G4_HUMAN Olfactory receptor 9G4 OS=Homo sapiens GN=OR9G4 PE=2 SV=2 | 206 | N | 0.22387 | D | 0.237955 | -0.014085 | No Change: Both O | - |
| Q8NGQ1 | OR9G4_HUMAN Olfactory receptor 9G4 OS=Homo sapiens GN=OR9G4 PE=2 SV=2 | 222 | V | 0.053497 | A | 0.074522 | -0.021025 | No Change: Both O | - |
| Q8NGE7 | OR9K2_HUMAN Olfactory receptor 9K2 OS=Homo sapiens GN=OR9K2 PE=2 SV=2 | 45 | R | 0.105032 | C | 0.045519 | 0.059513 | No Change: Both O | - |
| Q8NGE7 | OR9K2_HUMAN Olfactory receptor 9K2 OS=Homo sapiens GN=OR9K2 PE=2 SV=2 | 103 | E | 0.195686 | A | 0.132919 | 0.062767 | No Change: Both O | - |
| Q8NGE7 | OR9K2_HUMAN Olfactory receptor 9K2 OS=Homo sapiens GN=OR9K2 PE=2 SV=2 | 207 | R | 0.326286 | H | 0.319296 | 0.00699 | No Change: Both O | - |
| Q8NGQ5 | OR9Q1_HUMAN Olfactory receptor 9Q1 OS=Homo sapiens GN=OR9Q1 PE=2 SV=1 | 159 | R | 0.114717 | L | 0.072402 | 0.042315 | No Change: Both O | - |
| Q8NGE9 | OR9Q2_HUMAN Olfactory receptor 9Q2 OS=Homo sapiens GN=OR9Q2 PE=2 SV=1 | 179 | C | 0.044167 | R | 0.096047 | -0.05188 | No Change: Both O | - |
| Q96D31 | CRCM1_HUMAN Calcium release-activated calcium channel protein 1 OS=Homo sapiens GN=ORAI1 PE=1 SV=2 | 91 | R | 0.601971 | W | 0.413011 | 0.18896 | D to O | Immune dysfunction with T-cell inactivation due to calcium entry defect type 1 (IDTICED1) [MIM:612782] |
| Q96D31 | CRCM1_HUMAN Calcium release-activated calcium channel protein 1 OS=Homo sapiens GN=ORAI1 PE=1 SV=2 | 218 | S | 0.792092 | G | 0.756891 | 0.035201 | No Change: Both D | - |
| Q96SN7 | ORAI2_HUMAN Protein orai-2 OS=Homo sapiens GN=ORAI2 PE=1 SV=1 | 15 | A | 0.622933 | P | 0.707731 | -0.084798 | No Change: Both D | - |
| Q8WV07 | ORAV1_HUMAN Oral cancer-overexpressed protein 1 OS=Homo sapiens GN=ORAOV1 PE=2 SV=2 | 3 | G | 0.699161 | S | 0.711775 | -0.012614 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 19 | R | 0.215291 | S | 0.259032 | -0.043741 | No Change: Both O | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 180 | Q | 0.907329 | H | 0.883014 | 0.024315 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 190 | V | 0.962541 | M | 0.971841 | -0.0093 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 372 | A | 0.856523 | V | 0.815344 | 0.041179 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 441 | R | 0.986373 | M | 0.979361 | 0.007012 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 456 | K | 0.973389 | E | 0.968676 | 0.004713 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 466 | T | 0.948542 | M | 0.941268 | 0.007274 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 469 | C | 0.933303 | Y | 0.913623 | 0.01968 | No Change: Both D | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 816 | M | 0.44043 | T | 0.468705 | -0.028275 | No Change: Both O | - |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 89 | F | 0.142235 | S | 0.246476 | -0.104241 | No Change: Both O | Meier-Gorlin syndrome type 1 (MGORS1) [MIM:224690] |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 105 | R | 0.403138 | Q | 0.425058 | -0.02192 | No Change: Both O | Meier-Gorlin syndrome type 1 (MGORS1) [MIM:224690] |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 127 | E | 0.154038 | G | 0.132792 | 0.021246 | No Change: Both O | Meier-Gorlin syndrome type 1 (MGORS1) [MIM:224690] |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 666 | R | 0.371588 | W | 0.167782 | 0.203806 | No Change: Both O | Meier-Gorlin syndrome type 1 (MGORS1) [MIM:224690] |
| Q13415 | ORC1_HUMAN Origin recognition complex subunit 1 OS=Homo sapiens GN=ORC1 PE=1 SV=2 | 720 | R | 0.303819 | Q | 0.295842 | 0.007977 | No Change: Both O | Meier-Gorlin syndrome type 1 (MGORS1) [MIM:224690] |
| Q13416 | ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens GN=ORC2 PE=1 SV=2 | 106 | M | 0.788825 | K | 0.851802 | -0.062977 | No Change: Both D | - |
| Q13416 | ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens GN=ORC2 PE=1 SV=2 | 521 | R | 0.134758 | Q | 0.16003 | -0.025272 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 94 | Q | 0.399432 | K | 0.45374 | -0.054308 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 126 | Q | 0.314897 | R | 0.295215 | 0.019682 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 217 | V | 0.240687 | I | 0.221383 | 0.019304 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 247 | I | 0.055367 | V | 0.05754 | -0.002173 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 287 | T | 0.218679 | M | 0.169939 | 0.04874 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 389 | T | 0.317027 | P | 0.371459 | -0.054432 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 588 | R | 0.395214 | C | 0.231622 | 0.163592 | No Change: Both O | - |
| Q9UBD5 | ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens GN=ORC3 PE=1 SV=1 | 626 | A | 0.101856 | T | 0.110053 | -0.008197 | No Change: Both O | - |
| O43929 | ORC4_HUMAN Origin recognition complex subunit 4 OS=Homo sapiens GN=ORC4 PE=1 SV=2 | 56 | L | 0.426371 | V | 0.413834 | 0.012537 | No Change: Both O | - |
| O43929 | ORC4_HUMAN Origin recognition complex subunit 4 OS=Homo sapiens GN=ORC4 PE=1 SV=2 | 78 | N | 0.285838 | S | 0.336391 | -0.050553 | No Change: Both O | - |
| O43929 | ORC4_HUMAN Origin recognition complex subunit 4 OS=Homo sapiens GN=ORC4 PE=1 SV=2 | 174 | Y | 0.143555 | C | 0.117648 | 0.025907 | No Change: Both O | Meier-Gorlin syndrome type 2 (MGORS2) [MIM:613800] |
| O43913 | ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens GN=ORC5 PE=1 SV=1 | 37 | G | 0.200331 | R | 0.17924 | 0.021091 | No Change: Both O | - |
| O43913 | ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens GN=ORC5 PE=1 SV=1 | 52 | K | 0.238231 | N | 0.199223 | 0.039008 | No Change: Both O | - |
| O43913 | ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens GN=ORC5 PE=1 SV=1 | 166 | R | 0.168823 | C | 0.087285 | 0.081538 | No Change: Both O | - |
| Q9Y5N6 | ORC6_HUMAN Origin recognition complex subunit 6 OS=Homo sapiens GN=ORC6 PE=1 SV=1 | 32 | R | 0.390739 | W | 0.171269 | 0.21947 | No Change: Both O | - |
| Q9Y5N6 | ORC6_HUMAN Origin recognition complex subunit 6 OS=Homo sapiens GN=ORC6 PE=1 SV=1 | 138 | P | 0.363373 | Q | 0.359843 | 0.00353 | No Change: Both O | - |
| Q9Y5N6 | ORC6_HUMAN Origin recognition complex subunit 6 OS=Homo sapiens GN=ORC6 PE=1 SV=1 | 232 | Y | 0.857907 | S | 0.938779 | -0.080872 | No Change: Both D | Meier-Gorlin syndrome type 3 (MGORS3) [MIM:613803] |
| P02763 | A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sapiens GN=ORM1 PE=1 SV=1 | 38 | Q | 0.120621 | R | 0.110943 | 0.009678 | No Change: Both O | - |
| P02763 | A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sapiens GN=ORM1 PE=1 SV=1 | 174 | V | 0.541131 | M | 0.585882 | -0.044751 | No Change: Both D | - |
| P02763 | A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sapiens GN=ORM1 PE=1 SV=1 | 167 | R | 0.342767 | C | 0.309332 | 0.033435 | No Change: Both O | - |
| P19652 | A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 | 38 | R | 0.110943 | Q | 0.120621 | -0.009678 | No Change: Both O | - |
| P19652 | A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 | 99 | V | 0.428947 | A | 0.487661 | -0.058714 | No Change: Both O | - |
| P19652 | A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 | 141 | G | 0.239812 | R | 0.23158 | 0.008232 | No Change: Both O | - |
| P19652 | A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 | 167 | C | 0.29154 | R | 0.349154 | -0.057614 | No Change: Both O | - |
| P19652 | A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens GN=ORM2 PE=1 SV=2 | 174 | M | 0.516909 | V | 0.46642 | 0.050489 | D to O | - |
| Q13438 | OS9_HUMAN Protein OS-9 OS=Homo sapiens GN=OS9 PE=1 SV=1 | 398 | R | 0.984869 | W | 0.967154 | 0.017715 | No Change: Both D | - |
| Q13438 | OS9_HUMAN Protein OS-9 OS=Homo sapiens GN=OS9 PE=1 SV=1 | 454 | S | 0.901956 | L | 0.867956 | 0.034 | No Change: Both D | - |
| P22059 | OSBP1_HUMAN Oxysterol-binding protein 1 OS=Homo sapiens GN=OSBP PE=1 SV=1 | 278 | D | 0.199899 | A | 0.181739 | 0.01816 | No Change: Both O | A colorectal cancer sample |
| Q969R2 | OSBP2_HUMAN Oxysterol-binding protein 2 OS=Homo sapiens GN=OSBP2 PE=1 SV=2 | 760 | M | 0.882959 | V | 0.849072 | 0.033887 | No Change: Both D | - |
| Q9BXB5 | OSB10_HUMAN Oxysterol-binding protein-related protein 10 OS=Homo sapiens GN=OSBPL10 PE=1 SV=2 | 254 | N | 0.532649 | D | 0.546592 | -0.013943 | No Change: Both D | - |
| Q9BXB4 | OSB11_HUMAN Oxysterol-binding protein-related protein 11 OS=Homo sapiens GN=OSBPL11 PE=1 SV=2 | 184 | S | 0.951812 | L | 0.912072 | 0.03974 | No Change: Both D | A breast cancer sample |
| Q9BXW6 | OSBL1_HUMAN Oxysterol-binding protein-related protein 1 OS=Homo sapiens GN=OSBPL1A PE=1 SV=2 | 810 | S | 0.885456 | P | 0.883381 | 0.002075 | No Change: Both D | - |
| Q9H4L5 | OSBL3_HUMAN Oxysterol-binding protein-related protein 3 OS=Homo sapiens GN=OSBPL3 PE=1 SV=1 | 354 | M | 0.440303 | V | 0.353 | 0.087303 | No Change: Both O | - |
| Q9H0X9 | OSBL5_HUMAN Oxysterol-binding protein-related protein 5 OS=Homo sapiens GN=OSBPL5 PE=1 SV=1 | 774 | A | 0.994533 | T | 0.995641 | -0.001108 | No Change: Both D | - |
| Q9H0X9 | OSBL5_HUMAN Oxysterol-binding protein-related protein 5 OS=Homo sapiens GN=OSBPL5 PE=1 SV=1 | 90 | T | 0.895441 | I | 0.807929 | 0.087512 | No Change: Both D | - |
| Q9BZF3 | OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens GN=OSBPL6 PE=1 SV=1 | 58 | P | 0.847301 | L | 0.766214 | 0.081087 | No Change: Both D | - |
| Q9BZF3 | OSBL6_HUMAN Oxysterol-binding protein-related protein 6 OS=Homo sapiens GN=OSBPL6 PE=1 SV=1 | 53 | R | 0.907344 | Q | 0.918803 | -0.011459 | No Change: Both D | - |
| Q9BZF2 | OSBL7_HUMAN Oxysterol-binding protein-related protein 7 OS=Homo sapiens GN=OSBPL7 PE=2 SV=1 | 156 | T | 0.754269 | I | 0.641584 | 0.112685 | No Change: Both D | - |
| Q9BZF2 | OSBL7_HUMAN Oxysterol-binding protein-related protein 7 OS=Homo sapiens GN=OSBPL7 PE=2 SV=1 | 148 | M | 0.614407 | I | 0.520481 | 0.093926 | No Change: Both D | - |
| Q9BZF2 | OSBL7_HUMAN Oxysterol-binding protein-related protein 7 OS=Homo sapiens GN=OSBPL7 PE=2 SV=1 | 169 | A | 0.800065 | E | 0.823934 | -0.023869 | No Change: Both D | - |
| Q8IYS5 | OSCAR_HUMAN Osteoclast-associated immunoglobulin-like receptor OS=Homo sapiens GN=OSCAR PE=2 SV=3 | 97 | I | 0.143358 | S | 0.314704 | -0.171346 | No Change: Both O | - |
| Q8IYS5 | OSCAR_HUMAN Osteoclast-associated immunoglobulin-like receptor OS=Homo sapiens GN=OSCAR PE=2 SV=3 | 229 | S | 0.932533 | Y | 0.8866 | 0.045933 | No Change: Both D | - |
| Q8WVF1 | OSCP1_HUMAN Protein OSCP1 OS=Homo sapiens GN=OSCP1 PE=1 SV=4 | 31 | P | 0.541088 | R | 0.533086 | 0.008002 | No Change: Both D | - |
| Q8WVF1 | OSCP1_HUMAN Protein OSCP1 OS=Homo sapiens GN=OSCP1 PE=1 SV=4 | 242 | K | 0.511539 | E | 0.530952 | -0.019413 | No Change: Both D | - |
| Q8WVF1 | OSCP1_HUMAN Protein OSCP1 OS=Homo sapiens GN=OSCP1 PE=1 SV=4 | 141 | T | 0.238705 | A | 0.208265 | 0.03044 | No Change: Both O | - |
| Q9H4B0 | OSGP2_HUMAN Probable tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1 OS=Homo sapiens GN=OSGEPL1 PE=2 SV=2 | 229 | A | 0.439188 | P | 0.51522 | -0.076032 | O to D | - |
| Q9UJX0 | OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens GN=OSGIN1 PE=2 SV=3 | 439 | E | 0.630838 | D | 0.603368 | 0.02747 | No Change: Both D | - |
| Q9UJX0 | OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens GN=OSGIN1 PE=2 SV=3 | 6 | P | 0.83561 | L | 0.696581 | 0.139029 | No Change: Both D | - |
| Q9UJX0 | OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens GN=OSGIN1 PE=2 SV=3 | 34 | N | 0.879997 | T | 0.894677 | -0.01468 | No Change: Both D | - |
| Q9UJX0 | OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens GN=OSGIN1 PE=2 SV=3 | 57 | M | 0.87511 | L | 0.864013 | 0.011097 | No Change: Both D | - |
| Q9UJX0 | OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens GN=OSGIN1 PE=2 SV=3 | 59 | L | 0.883876 | V | 0.877376 | 0.0065 | No Change: Both D | - |
| Q9Y236 | OSGI2_HUMAN Oxidative stress-induced growth inhibitor 2 OS=Homo sapiens GN=OSGIN2 PE=2 SV=1 | 101 | Y | 0.274197 | H | 0.391274 | -0.117077 | No Change: Both O | - |
| Q9Y236 | OSGI2_HUMAN Oxidative stress-induced growth inhibitor 2 OS=Homo sapiens GN=OSGIN2 PE=2 SV=1 | 319 | C | 0.083881 | S | 0.226233 | -0.142352 | No Change: Both O | - |
| P13725 | ONCM_HUMAN Oncostatin-M OS=Homo sapiens GN=OSM PE=1 SV=2 | 9 | T | 0.142362 | M | 0.124758 | 0.017604 | No Change: Both O | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 210 | G | 0.21612 | W | 0.089739 | 0.126381 | No Change: Both O | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 527 | E | 0.64982 | K | 0.638072 | 0.011748 | No Change: Both D | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 553 | D | 0.197044 | N | 0.180296 | 0.016748 | No Change: Both O | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 936 | P | 0.662825 | S | 0.665229 | -0.002404 | No Change: Both D | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 187 | H | 0.490257 | Q | 0.5143 | -0.024043 | O to D | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 618 | G | 0.47631 | A | 0.437083 | 0.039227 | No Change: Both O | Amyloidosis primary localized cutaneous type 1 (PLCA1) [MIM:105250] |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 691 | I | 0.438069 | T | 0.561748 | -0.123679 | O to D | Amyloidosis primary localized cutaneous type 1 (PLCA1) [MIM:105250] |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 959 | P | 0.695695 | R | 0.642989 | 0.052706 | No Change: Both D | - |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 647 | D | 0.483788 | V | 0.344644 | 0.139144 | No Change: Both O | Amyloidosis primary localized cutaneous type 1 (PLCA1) [MIM:105250] |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 694 | P | 0.448932 | L | 0.315402 | 0.13353 | No Change: Both O | Amyloidosis primary localized cutaneous type 1 (PLCA1) [MIM:105250] |
| Q99650 | OSMR_HUMAN Oncostatin-M-specific receptor subunit beta OS=Homo sapiens GN=OSMR PE=1 SV=1 | 697 | K | 0.438186 | T | 0.349005 | 0.089181 | No Change: Both O | Amyloidosis primary localized cutaneous type 1 (PLCA1) [MIM:105250] |
| Q86UW1 | OSTA_HUMAN Organic solute transporter subunit alpha OS=Homo sapiens GN=OSTA PE=2 SV=1 | 202 | V | 0.07854 | I | 0.068374 | 0.010166 | No Change: Both O | - |
| Q9NRP0 | OSTC_HUMAN Oligosaccharyltransferase complex subunit OSTC OS=Homo sapiens GN=OSTC PE=1 SV=1 | 9 | F | 0.070076 | L | 0.104581 | -0.034505 | No Change: Both O | A breast cancer sample |
| Q92882 | OSTF1_HUMAN Osteoclast-stimulating factor 1 OS=Homo sapiens GN=OSTF1 PE=1 SV=2 | 159 | L | 0.115194 | F | 0.091496 | 0.023698 | No Change: Both O | - |
| Q92882 | OSTF1_HUMAN Osteoclast-stimulating factor 1 OS=Homo sapiens GN=OSTF1 PE=1 SV=2 | 48 | N | 0.340063 | S | 0.40211 | -0.062047 | No Change: Both O | - |
| Q86WC4 | OSTM1_HUMAN Osteopetrosis-associated transmembrane protein 1 OS=Homo sapiens GN=OSTM1 PE=1 SV=1 | 52 | L | 0.660831 | F | 0.60806 | 0.052771 | No Change: Both D | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 26 | R | 0.204055 | Q | 0.219588 | -0.015533 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 39 | G | 0.344539 | C | 0.192486 | 0.152053 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 40 | R | 0.301782 | C | 0.172913 | 0.128869 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 40 | R | 0.301782 | H | 0.300551 | 0.001231 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 43 | L | 0.246409 | F | 0.216195 | 0.030214 | No Change: Both O | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 44 | T | 0.248255 | I | 0.139235 | 0.10902 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 45 | L | 0.260788 | P | 0.387525 | -0.126737 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 45 | L | 0.260788 | V | 0.241158 | 0.01963 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 46 | K | 0.264107 | R | 0.211264 | 0.052843 | No Change: Both O | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 47 | N | 0.267015 | I | 0.143102 | 0.123913 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 50 | G | 0.231 | R | 0.225047 | 0.005953 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 55 | Y | 0.11859 | D | 0.228221 | -0.109631 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 56 | M | 0.092971 | T | 0.116811 | -0.02384 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 60 | S | 0.09811 | L | 0.057715 | 0.040395 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 63 | L | 0.160729 | P | 0.254999 | -0.09427 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 79 | G | 0.323522 | E | 0.377351 | -0.053829 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 83 | G | 0.336137 | D | 0.344499 | -0.008362 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 83 | G | 0.336137 | R | 0.332964 | 0.003173 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 87 | E | 0.486565 | K | 0.507024 | -0.020459 | O to D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 88 | K | 0.525223 | N | 0.471118 | 0.054105 | D to O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 90 | S | 0.548309 | R | 0.501534 | 0.046775 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 92 | R | 0.598109 | Q | 0.59394 | 0.004169 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 93 | T | 0.593503 | A | 0.544608 | 0.048895 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 94 | R | 0.591731 | T | 0.585742 | 0.005989 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 100 | G | 0.380839 | D | 0.384389 | -0.00355 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 101 | F | 0.330388 | L | 0.382365 | -0.051977 | No Change: Both O | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 102 | A | 0.281702 | E | 0.411751 | -0.130049 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 111 | L | 0.176918 | P | 0.291837 | -0.114919 | No Change: Both O | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 117 | H | 0.218063 | L | 0.164157 | 0.053906 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 117 | H | 0.218063 | R | 0.232688 | -0.014625 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 125 | T | 0.402885 | M | 0.347939 | 0.054946 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 126 | D | 0.400775 | G | 0.384437 | 0.016338 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 129 | R | 0.410778 | H | 0.414426 | -0.003648 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 139 | L | 0.213441 | S | 0.409856 | -0.196415 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 141 | R | 0.238753 | P | 0.27077 | -0.032017 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 141 | R | 0.238753 | Q | 0.26823 | -0.029477 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 148 | L | 0.441119 | F | 0.393988 | 0.047131 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 159 | I | 0.209557 | T | 0.317199 | -0.107642 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 161 | N | 0.207102 | S | 0.261166 | -0.054064 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 162 | G | 0.201012 | R | 0.194326 | 0.006686 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 168 | H | 0.114175 | Q | 0.133399 | -0.019224 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 168 | H | 0.114175 | R | 0.113912 | 2.63E-04 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 172 | I | 0.095011 | M | 0.134083 | -0.039072 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 174 | A | 0.104317 | P | 0.160105 | -0.055788 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 175 | D | 0.11337 | V | 0.054504 | 0.058866 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 176 | Y | 0.145832 | C | 0.116347 | 0.029485 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 178 | T | 0.194124 | M | 0.163472 | 0.030652 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 180 | Q | 0.30183 | H | 0.299567 | 0.002263 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 181 | E | 0.337294 | G | 0.295073 | 0.042221 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 182 | H | 0.385139 | L | 0.280724 | 0.104415 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 183 | Y | 0.432035 | C | 0.364907 | 0.067128 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 183 | Y | 0.432035 | D | 0.583128 | -0.151093 | O to D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 188 | G | 0.308051 | R | 0.28647 | 0.021581 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 192 | S | 0.174975 | R | 0.126653 | 0.048322 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 195 | G | 0.208785 | R | 0.185798 | 0.022987 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 196 | D | 0.236383 | V | 0.124113 | 0.11227 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 196 | D | 0.236383 | Y | 0.127556 | 0.108827 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 197 | G | 0.261988 | E | 0.292226 | -0.030238 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 201 | L | 0.250747 | P | 0.406648 | -0.155901 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 202 | H | 0.235397 | Y | 0.147523 | 0.087874 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 203 | S | 0.232991 | C | 0.085444 | 0.147547 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 206 | M | 0.266267 | R | 0.301371 | -0.035104 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 207 | S | 0.31588 | R | 0.24437 | 0.07151 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 208 | A | 0.345806 | T | 0.35744 | -0.011634 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 209 | A | 0.352844 | V | 0.262412 | 0.090432 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 213 | M | 0.323852 | K | 0.438746 | -0.114894 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 216 | Q | 0.350428 | E | 0.403976 | -0.053548 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 220 | P | 0.539751 | A | 0.477273 | 0.062478 | D to O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 225 | P | 0.556784 | L | 0.424244 | 0.13254 | D to O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 225 | P | 0.556784 | R | 0.511342 | 0.045442 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 225 | P | 0.556784 | T | 0.523682 | 0.033102 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 242 | T | 0.446053 | I | 0.297649 | 0.148404 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 244 | L | 0.387176 | Q | 0.493622 | -0.106446 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 247 | T | 0.379746 | K | 0.435898 | -0.056152 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 255 | H | 0.310725 | P | 0.371432 | -0.060707 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 263 | D | 0.163612 | G | 0.163927 | -3.15E-04 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 263 | D | 0.163612 | N | 0.167361 | -0.003749 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 264 | T | 0.168785 | A | 0.143943 | 0.024842 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 264 | T | 0.168785 | I | 0.096886 | 0.071899 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 267 | S | 0.289276 | R | 0.257407 | 0.031869 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 268 | M | 0.382856 | T | 0.433661 | -0.050805 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 269 | G | 0.46938 | E | 0.523049 | -0.053669 | O to D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 270 | Q | 0.576616 | R | 0.570054 | 0.006562 | No Change: Both D | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 277 | R | 0.589517 | Q | 0.625377 | -0.03586 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 277 | R | 0.589517 | W | 0.423862 | 0.165655 | D to O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 302 | H | 0.158582 | L | 0.136627 | 0.021955 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 302 | H | 0.158582 | Q | 0.210957 | -0.052375 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 302 | H | 0.158582 | Y | 0.115994 | 0.042588 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 303 | C | 0.171192 | R | 0.298164 | -0.126972 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 303 | C | 0.171192 | Y | 0.179462 | -0.00827 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 304 | L | 0.212531 | F | 0.198792 | 0.013739 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 320 | R | 0.27655 | L | 0.185369 | 0.091181 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 330 | R | 0.237573 | G | 0.238137 | -5.64E-04 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 336 | A | 0.111041 | S | 0.196739 | -0.085698 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 337 | V | 0.101794 | L | 0.109386 | -0.007592 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 339 | V | 0.110189 | L | 0.1166 | -0.006411 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 340 | S | 0.126024 | P | 0.122597 | 0.003427 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 343 | T | 0.247123 | K | 0.325045 | -0.077922 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 345 | Y | 0.37491 | C | 0.333628 | 0.041282 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 345 | Y | 0.37491 | D | 0.541258 | -0.166348 | O to D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 354 | F | 0.8239 | C | 0.816648 | 0.007252 | No Change: Both D | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 172 | I | 0.095011 | F | 0.088988 | 0.006023 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 188 | G | 0.308051 | V | 0.180879 | 0.127172 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 197 | G | 0.261988 | R | 0.234212 | 0.027776 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 140 | A | 0.220173 | P | 0.273226 | -0.053053 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 198 | N | 0.250889 | K | 0.27173 | -0.020841 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 214 | H | 0.326416 | Y | 0.226344 | 0.100072 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 262 | T | 0.167746 | K | 0.212881 | -0.045135 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 265 | W | 0.1795 | L | 0.272829 | -0.093329 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 326 | E | 0.342289 | K | 0.339956 | 0.002333 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 160 | I | 0.212293 | S | 0.419317 | -0.207024 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 191 | L | 0.199629 | F | 0.165592 | 0.034037 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 206 | M | 0.266267 | I | 0.190119 | 0.076148 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 301 | L | 0.187649 | F | 0.185021 | 0.002628 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 305 | P | 0.291297 | H | 0.260746 | 0.030551 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 333 | T | 0.162411 | A | 0.155351 | 0.00706 | No Change: Both O | - |
| P00480 | OTC_HUMAN Ornithine carbamoyltransferase mitochondrial OS=Homo sapiens GN=OTC PE=1 SV=3 | 341 | L | 0.156636 | P | 0.291784 | -0.135148 | No Change: Both O | Ornithine carbamoyltransferase deficiency (OTCD) [MIM:311250] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 818 | R | 0.633773 | W | 0.387626 | 0.246147 | D to O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1646 | P | 0.54323 | S | 0.546928 | -0.003698 | No Change: Both D | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1680 | R | 0.35472 | H | 0.317911 | 0.036809 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 53 | A | 0.233169 | V | 0.183877 | 0.049292 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 82 | R | 0.084097 | C | 0.041086 | 0.043011 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 490 | P | 0.13156 | Q | 0.119623 | 0.011937 | No Change: Both O | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 515 | I | 0.142336 | T | 0.228899 | -0.086563 | No Change: Both O | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 515 | I | 0.142336 | T | 0.228899 | -0.086563 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 575 | V | 0.222013 | M | 0.257409 | -0.035396 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 773 | R | 0.645819 | S | 0.660608 | -0.014789 | No Change: Both D | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 794 | R | 0.903685 | H | 0.870182 | 0.033503 | No Change: Both D | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 822 | R | 0.465331 | W | 0.225883 | 0.239448 | No Change: Both O | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1011 | L | 0.063672 | P | 0.125954 | -0.062282 | No Change: Both O | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1011 | L | 0.063672 | P | 0.125954 | -0.062282 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1083 | A | 0.22087 | P | 0.276804 | -0.055934 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1157 | R | 0.251357 | Q | 0.269317 | -0.01796 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1322 | D | 0.939656 | E | 0.950617 | -0.010961 | No Change: Both D | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1625 | V | 0.522029 | M | 0.582063 | -0.060034 | No Change: Both D | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1825 | P | 0.185576 | A | 0.144419 | 0.041157 | No Change: Both O | Deafness autosomal recessive type 9 (DFNB9) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1888 | G | 0.13248 | D | 0.150947 | -0.018467 | No Change: Both O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1939 | R | 0.535052 | Q | 0.547707 | -0.012655 | No Change: Both D | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1987 | P | 0.07032 | R | 0.058828 | 0.011492 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1323 | E | 0.931098 | K | 0.924514 | 0.006584 | No Change: Both D | A breast cancer sample |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1547 | I | 0.376994 | V | 0.41977 | -0.042776 | No Change: Both O | A breast cancer sample |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 255 | Q | 0.308327 | H | 0.263148 | 0.045179 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 964 | A | 0.25472 | E | 0.321831 | -0.067111 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1138 | L | 0.069193 | P | 0.137606 | -0.068413 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1236 | R | 0.508672 | Q | 0.481922 | 0.02675 | D to O | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1688 | T | 0.498112 | K | 0.577289 | -0.079177 | O to D | - |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1795 | F | 0.040422 | C | 0.035126 | 0.005296 | No Change: Both O | Non-syndromic auditory neuropathy autosomal recessive (NSRAN) [MIM:601071] |
| Q9HC10 | OTOF_HUMAN Otoferlin OS=Homo sapiens GN=OTOF PE=1 SV=3 | 1886 | V | 0.150194 | A | 0.198134 | -0.04794 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 375 | T | 0.319388 | S | 0.401263 | -0.081875 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 659 | T | 0.42543 | M | 0.363844 | 0.061586 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 692 | S | 0.538868 | P | 0.522884 | 0.015984 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 919 | A | 0.564873 | T | 0.600831 | -0.035958 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1075 | R | 0.097099 | Q | 0.114607 | -0.017508 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1112 | A | 0.172839 | V | 0.12799 | 0.044849 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1129 | P | 0.544856 | L | 0.415053 | 0.129803 | D to O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1399 | A | 0.356306 | G | 0.412801 | -0.056495 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1646 | P | 0.974069 | L | 0.951886 | 0.022183 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1832 | A | 0.931842 | V | 0.913986 | 0.017856 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 1947 | T | 0.866842 | M | 0.846703 | 0.020139 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 2750 | R | 0.34192 | Q | 0.376225 | -0.034305 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 2909 | W | 0.103261 | S | 0.291769 | -0.188508 | No Change: Both O | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 2006 | A | 0.782958 | V | 0.710689 | 0.072269 | No Change: Both D | - |
| Q6ZRI0 | OTOG_HUMAN Otogelin OS=Homo sapiens GN=OTOG PE=2 SV=3 | 391 | A | 0.162138 | D | 0.19197 | -0.029832 | No Change: Both O | - |
| Q3ZCN5 | OTOGL_HUMAN Otogelin-like OS=Homo sapiens GN=OTOGL PE=2 SV=4 | 653 | C | 0.337999 | F | 0.30083 | 0.037169 | No Change: Both O | A breast cancer sample |
| A6NHN0 | OTOL1_HUMAN Otolin-1 OS=Homo sapiens GN=OTOL1 PE=3 SV=1 | 470 | E | 0.49001 | A | 0.371608 | 0.118402 | No Change: Both O | - |
| Q7RTM1 | OTOP1_HUMAN Otopetrin-1 OS=Homo sapiens GN=OTOP1 PE=2 SV=1 | 241 | I | 0.165623 | V | 0.192338 | -0.026715 | No Change: Both O | - |
| Q7RTM1 | OTOP1_HUMAN Otopetrin-1 OS=Homo sapiens GN=OTOP1 PE=2 SV=1 | 309 | D | 0.450245 | E | 0.478685 | -0.02844 | No Change: Both O | - |
| Q7RTM1 | OTOP1_HUMAN Otopetrin-1 OS=Homo sapiens GN=OTOP1 PE=2 SV=1 | 434 | V | 0.067015 | M | 0.089632 | -0.022617 | No Change: Both O | - |
| Q7RTM1 | OTOP1_HUMAN Otopetrin-1 OS=Homo sapiens GN=OTOP1 PE=2 SV=1 | 493 | K | 0.888531 | T | 0.862799 | 0.025732 | No Change: Both D | - |
| Q7RTM1 | OTOP1_HUMAN Otopetrin-1 OS=Homo sapiens GN=OTOP1 PE=2 SV=1 | 516 | Q | 0.908285 | H | 0.894838 | 0.013447 | No Change: Both D | - |
| Q7RTS6 | OTOP2_HUMAN Otopetrin-2 OS=Homo sapiens GN=OTOP2 PE=2 SV=3 | 392 | A | 0.143172 | V | 0.105145 | 0.038027 | No Change: Both O | A colorectal cancer sample |
| Q7RTS6 | OTOP2_HUMAN Otopetrin-2 OS=Homo sapiens GN=OTOP2 PE=2 SV=3 | 465 | G | 0.785618 | W | 0.679453 | 0.106165 | No Change: Both D | - |
| Q7RTS5 | OTOP3_HUMAN Otopetrin-3 OS=Homo sapiens GN=OTOP3 PE=1 SV=1 | 64 | R | 0.640929 | Q | 0.634367 | 0.006562 | No Change: Both D | - |
| Q7RTS5 | OTOP3_HUMAN Otopetrin-3 OS=Homo sapiens GN=OTOP3 PE=1 SV=1 | 146 | R | 0.364918 | Q | 0.380859 | -0.015941 | No Change: Both O | - |
| Q7RTS5 | OTOP3_HUMAN Otopetrin-3 OS=Homo sapiens GN=OTOP3 PE=1 SV=1 | 199 | S | 0.048122 | P | 0.04012 | 0.008002 | No Change: Both O | - |
| Q7RTS5 | OTOP3_HUMAN Otopetrin-3 OS=Homo sapiens GN=OTOP3 PE=1 SV=1 | 477 | L | 0.287743 | V | 0.278707 | 0.009036 | No Change: Both O | - |
| Q9NRC9 | OTOR_HUMAN Otoraplin OS=Homo sapiens GN=OTOR PE=1 SV=1 | 31 | L | 0.314615 | P | 0.47428 | -0.159665 | No Change: Both O | - |
| Q8NHW6 | OTOSP_HUMAN Otospiralin OS=Homo sapiens GN=OTOS PE=2 SV=1 | 7 | P | 0.432004 | L | 0.249049 | 0.182955 | No Change: Both O | - |
| Q5T2D3 | OTUD3_HUMAN OTU domain-containing protein 3 OS=Homo sapiens GN=OTUD3 PE=1 SV=1 | 321 | N | 0.906232 | S | 0.913675 | -0.007443 | No Change: Both D | - |
| Q5T2D3 | OTUD3_HUMAN OTU domain-containing protein 3 OS=Homo sapiens GN=OTUD3 PE=1 SV=1 | 333 | A | 0.972944 | T | 0.974146 | -0.001202 | No Change: Both D | - |
| Q01804 | OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens GN=OTUD4 PE=1 SV=3 | 194 | A | 0.698611 | G | 0.72074 | -0.022129 | No Change: Both D | - |
| Q01804 | OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens GN=OTUD4 PE=1 SV=3 | 216 | A | 0.870927 | T | 0.876304 | -0.005377 | No Change: Both D | - |
| Q8N6M0 | OTU6B_HUMAN OTU domain-containing protein 6B OS=Homo sapiens GN=OTUD6B PE=1 SV=1 | 283 | R | 0.171704 | Q | 0.186497 | -0.014793 | No Change: Both O | - |
| P32243 | OTX2_HUMAN Homeobox protein OTX2 OS=Homo sapiens GN=OTX2 PE=1 SV=1 | 89 | R | 0.706816 | G | 0.655265 | 0.051551 | No Change: Both D | Microphthalmia syndromic type 5 (MCOPS5) [MIM:610125] |
| P32243 | OTX2_HUMAN Homeobox protein OTX2 OS=Homo sapiens GN=OTX2 PE=1 SV=1 | 133 | P | 0.990022 | T | 0.987109 | 0.002913 | No Change: Both D | Microphthalmia syndromic type 5 (MCOPS5) [MIM:610125] |
| P32243 | OTX2_HUMAN Homeobox protein OTX2 OS=Homo sapiens GN=OTX2 PE=1 SV=1 | 134 | P | 0.989381 | A | 0.983128 | 0.006253 | No Change: Both D | Microphthalmia syndromic type 5 (MCOPS5) [MIM:610125] |
| P32243 | OTX2_HUMAN Homeobox protein OTX2 OS=Homo sapiens GN=OTX2 PE=1 SV=1 | 90 | R | 0.732057 | S | 0.725659 | 0.006398 | No Change: Both D | Microphthalmia syndromic type 5 (MCOPS5) [MIM:610125] |
| P32243 | OTX2_HUMAN Homeobox protein OTX2 OS=Homo sapiens GN=OTX2 PE=1 SV=1 | 225 | N | 0.783503 | S | 0.83436 | -0.050857 | No Change: Both D | Pituitary hormone deficiency combined type 6 (CPHD6) [MIM:613986] |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 133 | R | 0.531563 | C | 0.386753 | 0.14481 | D to O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 228 | W | 0.217303 | G | 0.449854 | -0.232551 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 330 | K | 0.549336 | E | 0.554699 | -0.005363 | No Change: Both D | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 444 | I | 0.069354 | T | 0.118625 | -0.049271 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 672 | S | 0.304052 | F | 0.125565 | 0.178487 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 754 | G | 0.425119 | R | 0.392831 | 0.032288 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 881 | P | 0.317563 | A | 0.262202 | 0.055361 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 934 | P | 0.326183 | S | 0.358204 | -0.032021 | No Change: Both O | - |
| Q7RTY7 | OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens GN=OVCH1 PE=2 SV=2 | 557 | L | 0.226357 | V | 0.22981 | -0.003453 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 19 | R | 0.239203 | Q | 0.255486 | -0.016283 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 292 | P | 0.162704 | S | 0.19048 | -0.027776 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 381 | G | 0.396812 | E | 0.465341 | -0.068529 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 410 | N | 0.360475 | T | 0.326675 | 0.0338 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 413 | R | 0.277774 | G | 0.286268 | -0.008494 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 526 | H | 0.371049 | Q | 0.388002 | -0.016953 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 539 | T | 0.15809 | I | 0.091558 | 0.066532 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 410 | N | 0.360475 | Y | 0.222303 | 0.138172 | No Change: Both O | - |
| Q7RTZ1 | OVCH2_HUMAN Ovochymase-2 OS=Homo sapiens GN=OVCH2 PE=1 SV=2 | 24 | T | 0.525485 | A | 0.514042 | 0.011443 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 676 | E | 0.893228 | Q | 0.883687 | 0.009541 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 477 | M | 0.813152 | T | 0.833499 | -0.020347 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 604 | H | 0.851927 | Q | 0.89647 | -0.044543 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 662 | L | 0.71565 | H | 0.773669 | -0.058019 | No Change: Both D | A colorectal cancer sample |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 332 | D | 0.182168 | E | 0.214722 | -0.032554 | No Change: Both O | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 479 | M | 0.818363 | V | 0.761108 | 0.057255 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 514 | Y | 0.894346 | H | 0.941834 | -0.047488 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 536 | S | 0.90676 | G | 0.883823 | 0.022937 | No Change: Both D | - |
| Q12889 | OVGP1_HUMAN Oviduct-specific glycoprotein OS=Homo sapiens GN=OVGP1 PE=2 SV=1 | 526 | P | 0.914496 | S | 0.915717 | -0.001221 | No Change: Both D | - |
| Q6IE36 | OVOS2_HUMAN Ovostatin homolog 2 OS=Homo sapiens GN=OVOS2 PE=2 SV=2 | 211 | T | 0.226832 | M | 0.179717 | 0.047115 | No Change: Both O | - |
| Q6IE36 | OVOS2_HUMAN Ovostatin homolog 2 OS=Homo sapiens GN=OVOS2 PE=2 SV=2 | 587 | L | 0.341509 | V | 0.338213 | 0.003296 | No Change: Both O | - |
| Q6IE36 | OVOS2_HUMAN Ovostatin homolog 2 OS=Homo sapiens GN=OVOS2 PE=2 SV=2 | 789 | S | 0.209518 | L | 0.092867 | 0.116651 | No Change: Both O | - |
| Q6IE36 | OVOS2_HUMAN Ovostatin homolog 2 OS=Homo sapiens GN=OVOS2 PE=2 SV=2 | 1328 | V | 0.091434 | A | 0.117238 | -0.025804 | No Change: Both O | - |
| Q15070 | OXA1L_HUMAN Mitochondrial inner membrane protein OXA1L OS=Homo sapiens GN=OXA1L PE=1 SV=3 | 44 | V | 0.164565 | A | 0.236929 | -0.072364 | No Change: Both O | - |
| Q15070 | OXA1L_HUMAN Mitochondrial inner membrane protein OXA1L OS=Homo sapiens GN=OXA1L PE=1 SV=3 | 91 | V | 0.822061 | I | 0.774396 | 0.047665 | No Change: Both D | - |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 58 | T | 0.163244 | M | 0.135918 | 0.027326 | No Change: Both O | - |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 133 | V | 0.477068 | E | 0.662665 | -0.185597 | O to D | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 456 | C | 0.317066 | F | 0.298817 | 0.018249 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 219 | G | 0.223359 | E | 0.268427 | -0.045068 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 221 | V | 0.236841 | M | 0.293196 | -0.056355 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 324 | G | 0.113794 | E | 0.133007 | -0.019213 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 215 | A | 0.185657 | V | 0.135076 | 0.050581 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 226 | S | 0.266605 | N | 0.251797 | 0.014808 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 327 | L | 0.11595 | P | 0.215919 | -0.099969 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 404 | V | 0.266755 | F | 0.239698 | 0.027057 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 405 | S | 0.266197 | P | 0.251237 | 0.01496 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| P55809 | SCOT1_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 mitochondrial OS=Homo sapiens GN=OXCT1 PE=1 SV=1 | 468 | R | 0.137532 | C | 0.085349 | 0.052183 | No Change: Both O | Succinyl-CoA-3-ketoacid-CoA transferase deficiency (SCOTD) [MIM:245050] |
| Q9BYC2 | SCOT2_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 2 mitochondrial OS=Homo sapiens GN=OXCT2 PE=2 SV=2 | 250 | E | 0.265481 | D | 0.227467 | 0.038014 | No Change: Both O | - |
| Q9BYC2 | SCOT2_HUMAN Succinyl-CoA:3-ketoacid-coenzyme A transferase 2 mitochondrial OS=Homo sapiens GN=OXCT2 PE=2 SV=2 | 285 | L | 0.565363 | R | 0.701589 | -0.136226 | No Change: Both D | - |
| Q8TDS5 | OXER1_HUMAN Oxoeicosanoid receptor 1 OS=Homo sapiens GN=OXER1 PE=2 SV=1 | 407 | L | 0.892539 | V | 0.899896 | -0.007357 | No Change: Both D | - |
| Q8TDS5 | OXER1_HUMAN Oxoeicosanoid receptor 1 OS=Homo sapiens GN=OXER1 PE=2 SV=1 | 316 | M | 0.060198 | L | 0.04432 | 0.015878 | No Change: Both O | - |
| Q96HP4 | OXND1_HUMAN Oxidoreductase NAD-binding domain-containing protein 1 OS=Homo sapiens GN=OXNAD1 PE=1 SV=1 | 59 | R | 0.644325 | Q | 0.602591 | 0.041734 | No Change: Both D | - |
| Q96HP4 | OXND1_HUMAN Oxidoreductase NAD-binding domain-containing protein 1 OS=Homo sapiens GN=OXNAD1 PE=1 SV=1 | 64 | S | 0.539269 | A | 0.4447 | 0.094569 | D to O | - |
| Q96HP4 | OXND1_HUMAN Oxidoreductase NAD-binding domain-containing protein 1 OS=Homo sapiens GN=OXNAD1 PE=1 SV=1 | 82 | R | 0.331128 | C | 0.208272 | 0.122856 | No Change: Both O | - |
| Q8N573 | OXR1_HUMAN Oxidation resistance protein 1 OS=Homo sapiens GN=OXR1 PE=1 SV=2 | 100 | E | 0.554145 | G | 0.499052 | 0.055093 | D to O | - |
| Q8N573 | OXR1_HUMAN Oxidation resistance protein 1 OS=Homo sapiens GN=OXR1 PE=1 SV=2 | 360 | Q | 0.972279 | P | 0.97317 | -8.91E-04 | No Change: Both D | - |
| Q8N573 | OXR1_HUMAN Oxidation resistance protein 1 OS=Homo sapiens GN=OXR1 PE=1 SV=2 | 516 | K | 0.935622 | R | 0.925919 | 0.009703 | No Change: Both D | - |
| Q9NWU1 | OXSM_HUMAN 3-oxoacyl-[acyl-carrier-protein] synthase mitochondrial OS=Homo sapiens GN=OXSM PE=1 SV=1 | 106 | F | 0.56605 | I | 0.567944 | -0.001894 | No Change: Both D | A breast cancer sample |
| O95747 | OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | 304 | T | 0.826189 | I | 0.748311 | 0.077878 | No Change: Both D | - |
| O95747 | OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | 425 | S | 0.836341 | T | 0.802518 | 0.033823 | No Change: Both D | - |
| O95747 | OXSR1_HUMAN Serine/threonine-protein kinase OSR1 OS=Homo sapiens GN=OXSR1 PE=1 SV=1 | 433 | P | 0.706077 | S | 0.726379 | -0.020302 | No Change: Both D | A metastatic melanoma sample |
| P30559 | OXYR_HUMAN Oxytocin receptor OS=Homo sapiens GN=OXTR PE=1 SV=2 | 16 | A | 0.916733 | S | 0.930063 | -0.01333 | No Change: Both D | - |
| P30559 | OXYR_HUMAN Oxytocin receptor OS=Homo sapiens GN=OXTR PE=1 SV=2 | 218 | A | 0.015782 | T | 0.016914 | -0.001132 | No Change: Both O | - |
| P51575 | P2RX1_HUMAN P2X purinoceptor 1 OS=Homo sapiens GN=P2RX1 PE=1 SV=1 | 396 | M | 0.832794 | V | 0.764563 | 0.068231 | No Change: Both D | - |
| P56373 | P2RX3_HUMAN P2X purinoceptor 3 OS=Homo sapiens GN=P2RX3 PE=2 SV=2 | 383 | A | 0.726761 | V | 0.689101 | 0.03766 | No Change: Both D | - |
| Q99571 | P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens GN=P2RX4 PE=1 SV=2 | 242 | S | 0.394068 | G | 0.359148 | 0.03492 | No Change: Both O | - |
| Q99571 | P2RX4_HUMAN P2X purinoceptor 4 OS=Homo sapiens GN=P2RX4 PE=1 SV=2 | 6 | A | 0.144745 | S | 0.200268 | -0.055523 | No Change: Both O | - |
| O15547 | P2RX6_HUMAN P2X purinoceptor 6 OS=Homo sapiens GN=P2RX6 PE=1 SV=2 | 242 | R | 0.06089 | H | 0.061141 | -2.51E-04 | No Change: Both O | - |
| O15547 | P2RX6_HUMAN P2X purinoceptor 6 OS=Homo sapiens GN=P2RX6 PE=1 SV=2 | 38 | V | 0.116113 | G | 0.208701 | -0.092588 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 270 | R | 0.219205 | H | 0.22018 | -9.75E-04 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 155 | Y | 0.337015 | H | 0.445357 | -0.108342 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 357 | T | 0.132807 | S | 0.19646 | -0.063653 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 460 | Q | 0.84946 | R | 0.85376 | -0.0043 | No Change: Both D | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 496 | E | 0.611201 | A | 0.497204 | 0.113997 | D to O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 25 | N | 0.169809 | S | 0.206667 | -0.036858 | No Change: Both O | A colorectal cancer sample |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 574 | R | 0.159837 | L | 0.080454 | 0.079383 | No Change: Both O | A colorectal cancer sample |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 76 | V | 0.427426 | A | 0.492678 | -0.065252 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 150 | G | 0.428607 | R | 0.454468 | -0.025861 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 270 | R | 0.219205 | C | 0.10694 | 0.112265 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 276 | R | 0.449252 | H | 0.43915 | 0.010102 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 307 | R | 0.289466 | Q | 0.306982 | -0.017516 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 348 | A | 0.02732 | T | 0.030707 | -0.003387 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 430 | P | 0.559755 | R | 0.524243 | 0.035512 | No Change: Both D | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 433 | A | 0.567522 | V | 0.526251 | 0.041271 | No Change: Both D | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 521 | H | 0.098001 | Q | 0.122533 | -0.024532 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 522 | V | 0.089034 | I | 0.073641 | 0.015393 | No Change: Both O | - |
| Q99572 | P2RX7_HUMAN P2X purinoceptor 7 OS=Homo sapiens GN=P2RX7 PE=1 SV=3 | 578 | R | 0.355881 | Q | 0.351009 | 0.004872 | No Change: Both O | - |
| O00398 | P2Y10_HUMAN Putative P2Y purinoceptor 10 OS=Homo sapiens GN=P2RY10 PE=2 SV=1 | 3 | N | 0.74595 | H | 0.775113 | -0.029163 | No Change: Both D | - |
| Q96G91 | P2Y11_HUMAN P2Y purinoceptor 11 OS=Homo sapiens GN=P2RY11 PE=2 SV=2 | 87 | A | 0.167681 | T | 0.184731 | -0.01705 | No Change: Both O | - |
| Q9H244 | P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1 | 256 | R | 0.100866 | Q | 0.112821 | -0.011955 | No Change: Both O | Bleeding disorder platelet-type 8 (BDPLT8) [MIM:609821] |
| Q9H244 | P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1 | 265 | R | 0.23841 | W | 0.100123 | 0.138287 | No Change: Both O | Bleeding disorder platelet-type 8 (BDPLT8) [MIM:609821] |
| Q9H244 | P2Y12_HUMAN P2Y purinoceptor 12 OS=Homo sapiens GN=P2RY12 PE=1 SV=1 | 330 | E | 0.914432 | G | 0.909012 | 0.00542 | No Change: Both D | - |
| Q9BPV8 | P2Y13_HUMAN P2Y purinoceptor 13 OS=Homo sapiens GN=P2RY13 PE=2 SV=3 | 179 | T | 0.238958 | M | 0.198002 | 0.040956 | No Change: Both O | - |
| Q15391 | P2Y14_HUMAN P2Y purinoceptor 14 OS=Homo sapiens GN=P2RY14 PE=1 SV=1 | 140 | L | 0.142267 | P | 0.253881 | -0.111614 | No Change: Both O | A colorectal cancer sample |
| P41231 | P2RY2_HUMAN P2Y purinoceptor 2 OS=Homo sapiens GN=P2RY2 PE=1 SV=4 | 46 | P | 0.044535 | L | 0.022047 | 0.022488 | No Change: Both O | - |
| P41231 | P2RY2_HUMAN P2Y purinoceptor 2 OS=Homo sapiens GN=P2RY2 PE=1 SV=4 | 312 | R | 0.39186 | S | 0.398867 | -0.007007 | No Change: Both O | - |
| P41231 | P2RY2_HUMAN P2Y purinoceptor 2 OS=Homo sapiens GN=P2RY2 PE=1 SV=4 | 334 | R | 0.922021 | C | 0.850235 | 0.071786 | No Change: Both D | - |
| P51582 | P2RY4_HUMAN P2Y purinoceptor 4 OS=Homo sapiens GN=P2RY4 PE=1 SV=1 | 168 | V | 0.031433 | M | 0.037659 | -0.006226 | No Change: Both O | - |
| P51582 | P2RY4_HUMAN P2Y purinoceptor 4 OS=Homo sapiens GN=P2RY4 PE=1 SV=1 | 178 | N | 0.36209 | T | 0.343782 | 0.018308 | No Change: Both O | - |
| P51582 | P2RY4_HUMAN P2Y purinoceptor 4 OS=Homo sapiens GN=P2RY4 PE=1 SV=1 | 191 | P | 0.590703 | L | 0.420212 | 0.170491 | D to O | - |
| P51582 | P2RY4_HUMAN P2Y purinoceptor 4 OS=Homo sapiens GN=P2RY4 PE=1 SV=1 | 234 | S | 0.780455 | A | 0.686763 | 0.093692 | No Change: Both D | - |
| Q7Z4N8 | P4HA3_HUMAN Prolyl 4-hydroxylase subunit alpha-3 OS=Homo sapiens GN=P4HA3 PE=1 SV=1 | 400 | D | 0.31938 | N | 0.297403 | 0.021977 | No Change: Both O | - |
| Q9BRP4 | PAAF1_HUMAN Proteasomal ATPase-associated factor 1 OS=Homo sapiens GN=PAAF1 PE=1 SV=2 | 53 | A | 0.373372 | V | 0.329715 | 0.043657 | No Change: Both O | - |
| Q9BRP4 | PAAF1_HUMAN Proteasomal ATPase-associated factor 1 OS=Homo sapiens GN=PAAF1 PE=1 SV=2 | 209 | A | 0.212668 | G | 0.249099 | -0.036431 | No Change: Both O | - |
| Q9BRP4 | PAAF1_HUMAN Proteasomal ATPase-associated factor 1 OS=Homo sapiens GN=PAAF1 PE=1 SV=2 | 139 | C | 0.060233 | S | 0.156984 | -0.096751 | No Change: Both O | - |
| Q4VXU2 | PAP1L_HUMAN Polyadenylate-binding protein 1-like OS=Homo sapiens GN=PABPC1L PE=2 SV=1 | 212 | S | 0.29596 | A | 0.192015 | 0.103945 | No Change: Both O | - |
| Q4VXU2 | PAP1L_HUMAN Polyadenylate-binding protein 1-like OS=Homo sapiens GN=PABPC1L PE=2 SV=1 | 492 | S | 0.793763 | G | 0.767646 | 0.026117 | No Change: Both D | - |
| Q13310 | PABP4_HUMAN Polyadenylate-binding protein 4 OS=Homo sapiens GN=PABPC4 PE=1 SV=1 | 382 | Y | 0.349899 | F | 0.325476 | 0.024423 | No Change: Both O | - |
| P0CB38 | PAB4L_HUMAN Polyadenylate-binding protein 4-like OS=Homo sapiens GN=PABPC4L PE=2 SV=1 | 192 | V | 0.364298 | I | 0.333098 | 0.0312 | No Change: Both O | - |
| P0CB38 | PAB4L_HUMAN Polyadenylate-binding protein 4-like OS=Homo sapiens GN=PABPC4L PE=2 SV=1 | 331 | S | 0.629935 | N | 0.562601 | 0.067334 | No Change: Both D | - |
| P0CB38 | PAB4L_HUMAN Polyadenylate-binding protein 4-like OS=Homo sapiens GN=PABPC4L PE=2 SV=1 | 370 | H | 0.618687 | P | 0.71273 | -0.094043 | No Change: Both D | - |
| Q96DU9 | PABP5_HUMAN Polyadenylate-binding protein 5 OS=Homo sapiens GN=PABPC5 PE=1 SV=1 | 314 | N | 0.632375 | S | 0.684475 | -0.0521 | No Change: Both D | - |
| Q6VY07 | PACS1_HUMAN Phosphofurin acidic cluster sorting protein 1 OS=Homo sapiens GN=PACS1 PE=1 SV=2 | 302 | F | 0.833278 | L | 0.859199 | -0.025921 | No Change: Both D | - |
| Q86VP3 | PACS2_HUMAN Phosphofurin acidic cluster sorting protein 2 OS=Homo sapiens GN=PACS2 PE=1 SV=3 | 185 | T | 0.813815 | A | 0.824668 | -0.010853 | No Change: Both D | - |
| Q86VP3 | PACS2_HUMAN Phosphofurin acidic cluster sorting protein 2 OS=Homo sapiens GN=PACS2 PE=1 SV=3 | 493 | L | 0.144617 | S | 0.277536 | -0.132919 | No Change: Both O | - |
| Q9BY11 | PACN1_HUMAN Protein kinase C and casein kinase substrate in neurons protein 1 OS=Homo sapiens GN=PACSIN1 PE=1 SV=1 | 334 | A | 0.817532 | V | 0.766772 | 0.05076 | No Change: Both D | - |
| Q9UNF0 | PACN2_HUMAN Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens GN=PACSIN2 PE=1 SV=2 | 294 | M | 0.357834 | I | 0.251557 | 0.106277 | No Change: Both O | - |
| Q9UNF0 | PACN2_HUMAN Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens GN=PACSIN2 PE=1 SV=2 | 324 | V | 0.703628 | F | 0.712507 | -0.008879 | No Change: Both D | - |
| Q9UNF0 | PACN2_HUMAN Protein kinase C and casein kinase substrate in neurons protein 2 OS=Homo sapiens GN=PACSIN2 PE=1 SV=2 | 175 | N | 0.94418 | S | 0.957423 | -0.013243 | No Change: Both D | - |
| Q9UKS6 | PACN3_HUMAN Protein kinase C and casein kinase substrate in neurons protein 3 OS=Homo sapiens GN=PACSIN3 PE=1 SV=2 | 61 | A | 0.18093 | V | 0.125277 | 0.055653 | No Change: Both O | - |
| Q9ULC6 | PADI1_HUMAN Protein-arginine deiminase type-1 OS=Homo sapiens GN=PADI1 PE=1 SV=2 | 649 | V | 0.294166 | M | 0.361168 | -0.067002 | No Change: Both O | - |
| Q9ULW8 | PADI3_HUMAN Protein-arginine deiminase type-3 OS=Homo sapiens GN=PADI3 PE=1 SV=2 | 52 | I | 0.304656 | V | 0.335264 | -0.030608 | No Change: Both O | - |
| Q9ULW8 | PADI3_HUMAN Protein-arginine deiminase type-3 OS=Homo sapiens GN=PADI3 PE=1 SV=2 | 171 | V | 0.294118 | M | 0.367073 | -0.072955 | No Change: Both O | - |
| Q9ULW8 | PADI3_HUMAN Protein-arginine deiminase type-3 OS=Homo sapiens GN=PADI3 PE=1 SV=2 | 509 | G | 0.25857 | R | 0.251592 | 0.006978 | No Change: Both O | A breast cancer sample |
| Q9ULW8 | PADI3_HUMAN Protein-arginine deiminase type-3 OS=Homo sapiens GN=PADI3 PE=1 SV=2 | 582 | A | 0.227747 | T | 0.254776 | -0.027029 | No Change: Both O | - |
| Q9ULW8 | PADI3_HUMAN Protein-arginine deiminase type-3 OS=Homo sapiens GN=PADI3 PE=1 SV=2 | 618 | R | 0.279898 | Q | 0.297102 | -0.017204 | No Change: Both O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 55 | G | 0.619281 | S | 0.68767 | -0.068389 | No Change: Both D | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 82 | V | 0.555715 | A | 0.605442 | -0.049727 | No Change: Both D | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 112 | G | 0.097627 | A | 0.083702 | 0.013925 | No Change: Both O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 275 | S | 0.364556 | F | 0.163613 | 0.200943 | No Change: Both O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 89 | D | 0.566283 | N | 0.548784 | 0.017499 | No Change: Both D | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 102 | P | 0.356133 | T | 0.311546 | 0.044587 | No Change: Both O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 131 | R | 0.520138 | T | 0.514319 | 0.005819 | No Change: Both D | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 164 | M | 0.676459 | T | 0.69942 | -0.022961 | No Change: Both D | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 8 | R | 0.36753 | H | 0.3796 | -0.01207 | No Change: Both O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 79 | T | 0.503475 | M | 0.464917 | 0.038558 | D to O | - |
| Q9UM07 | PADI4_HUMAN Protein-arginine deiminase type-4 OS=Homo sapiens GN=PADI4 PE=1 SV=2 | 260 | D | 0.205283 | N | 0.181927 | 0.023356 | No Change: Both O | - |
| P09466 | PAEP_HUMAN Glycodelin OS=Homo sapiens GN=PAEP PE=1 SV=2 | 126 | Q | 0.12073 | K | 0.136112 | -0.015382 | No Change: Both O | - |
| P09466 | PAEP_HUMAN Glycodelin OS=Homo sapiens GN=PAEP PE=1 SV=2 | 28 | L | 0.462866 | V | 0.444957 | 0.017909 | No Change: Both O | - |
| Q15004 | PAF_HUMAN PCNA-associated factor OS=Homo sapiens GN=PAF PE=1 SV=1 | 79 | E | 0.858017 | K | 0.859206 | -0.001189 | No Change: Both D | - |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 149 | H | 0.508792 | R | 0.518714 | -0.009922 | No Change: Both D | Lissencephaly type 1 (LIS1) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 169 | S | 0.23152 | P | 0.194317 | 0.037203 | No Change: Both O | Subcortical band heterotopia (SBH) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 31 | F | 0.446675 | S | 0.675823 | -0.229148 | O to D | Lissencephaly type 1 (LIS1) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 162 | G | 0.439761 | S | 0.521787 | -0.082026 | O to D | Lissencephaly type 1 (LIS1) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 317 | D | 0.513587 | H | 0.460891 | 0.052696 | D to O | Lissencephaly type 1 (LIS1) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 241 | R | 0.252236 | P | 0.280686 | -0.02845 | No Change: Both O | Subcortical band heterotopia (SBH) [MIM:607432] |
| P43034 | LIS1_HUMAN Platelet-activating factor acetylhydrolase IB subunit alpha OS=Homo sapiens GN=PAFAH1B1 PE=1 SV=2 | 277 | H | 0.433469 | P | 0.493096 | -0.059627 | No Change: Both O | Lissencephaly type 1 (LIS1) [MIM:607432] |
| Q15102 | PA1B3_HUMAN Platelet-activating factor acetylhydrolase IB subunit gamma OS=Homo sapiens GN=PAFAH1B3 PE=1 SV=1 | 214 | R | 0.243525 | G | 0.241451 | 0.002074 | No Change: Both O | - |
| O75459 | GAGB1_HUMAN G antigen family B member 1 OS=Homo sapiens GN=PAGE1 PE=1 SV=2 | 75 | L | 0.940849 | P | 0.966681 | -0.025832 | No Change: Both D | - |
| Q7Z2X7 | GGEE2_HUMAN G antigen family E member 2 OS=Homo sapiens GN=PAGE2 PE=2 SV=1 | 5 | L | 0.984716 | V | 0.985629 | -9.13E-04 | No Change: Both D | - |
| Q5JUK9 | GGED1_HUMAN Putative G antigen family D member 1 OS=Homo sapiens GN=PAGE3 PE=2 SV=1 | 35 | N | 0.939197 | D | 0.953744 | -0.014547 | No Change: Both D | - |
| Q5JUK9 | GGED1_HUMAN Putative G antigen family D member 1 OS=Homo sapiens GN=PAGE3 PE=2 SV=1 | 53 | G | 0.715883 | S | 0.745587 | -0.029704 | No Change: Both D | - |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 16 | S | 0.494511 | P | 0.468713 | 0.025798 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 39 | F | 0.168699 | L | 0.204464 | -0.035765 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 40 | S | 0.188353 | L | 0.094945 | 0.093408 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 41 | L | 0.236387 | F | 0.212733 | 0.023654 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 42 | K | 0.254066 | I | 0.12527 | 0.128796 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 46 | G | 0.229399 | S | 0.292533 | -0.063134 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 47 | A | 0.218068 | V | 0.169486 | 0.048582 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 48 | L | 0.215629 | S | 0.354333 | -0.138704 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 53 | R | 0.158873 | H | 0.153978 | 0.004895 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 55 | F | 0.2454 | L | 0.29046 | -0.04506 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 56 | E | 0.27734 | D | 0.251877 | 0.025463 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 65 | I | 0.503958 | N | 0.682239 | -0.178281 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 65 | I | 0.503958 | T | 0.652615 | -0.148657 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 67 | S | 0.566794 | P | 0.54269 | 0.024104 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 68 | R | 0.612127 | S | 0.664164 | -0.052037 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 76 | E | 0.540597 | A | 0.417292 | 0.123305 | D to O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 84 | D | 0.350021 | Y | 0.214997 | 0.135024 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 87 | S | 0.3409 | R | 0.322362 | 0.018538 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 92 | T | 0.195855 | I | 0.128859 | 0.066996 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 98 | L | 0.158135 | S | 0.275862 | -0.117727 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 104 | A | 0.281808 | D | 0.374833 | -0.093025 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 124 | T | 0.158081 | I | 0.091637 | 0.066444 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 129 | D | 0.200206 | Y | 0.108141 | 0.092065 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 143 | D | 0.418187 | G | 0.400092 | 0.018095 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 146 | H | 0.464287 | Y | 0.365272 | 0.099015 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 148 | G | 0.463707 | S | 0.510008 | -0.046301 | O to D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 151 | D | 0.469733 | H | 0.441227 | 0.028506 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 154 | Y | 0.365091 | N | 0.486912 | -0.121821 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 157 | R | 0.314473 | N | 0.309896 | 0.004577 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 158 | R | 0.311874 | Q | 0.32264 | -0.010766 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 158 | R | 0.311874 | W | 0.132613 | 0.179261 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 160 | Q | 0.292355 | P | 0.320813 | -0.028458 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 161 | F | 0.283616 | S | 0.50982 | -0.226204 | O to D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 164 | I | 0.252336 | T | 0.387326 | -0.13499 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 167 | N | 0.225872 | I | 0.131045 | 0.094827 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 170 | H | 0.282364 | R | 0.313415 | -0.031051 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 171 | G | 0.315221 | A | 0.281249 | 0.033972 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 171 | G | 0.315221 | R | 0.334011 | -0.01879 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 173 | P | 0.375068 | T | 0.308931 | 0.066137 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 174 | I | 0.421874 | T | 0.549688 | -0.127814 | O to D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 175 | P | 0.435033 | A | 0.340596 | 0.094437 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 176 | R | 0.469627 | L | 0.329625 | 0.140002 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 176 | R | 0.469627 | P | 0.518974 | -0.049347 | O to D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 177 | V | 0.487267 | L | 0.483338 | 0.003929 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 178 | E | 0.491094 | G | 0.418712 | 0.072382 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 190 | V | 0.240074 | A | 0.315182 | -0.075108 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 194 | L | 0.280235 | P | 0.431773 | -0.151538 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 201 | H | 0.202643 | R | 0.193588 | 0.009055 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 201 | H | 0.202643 | Y | 0.136214 | 0.066429 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 204 | Y | 0.127356 | C | 0.102728 | 0.024628 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 206 | Y | 0.109633 | D | 0.191668 | -0.082035 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 207 | N | 0.100965 | D | 0.108498 | -0.007533 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 207 | N | 0.100965 | S | 0.119947 | -0.018982 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 211 | P | 0.07958 | T | 0.063704 | 0.015876 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 212 | L | 0.103721 | P | 0.196931 | -0.09321 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 213 | L | 0.130159 | P | 0.241417 | -0.111258 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 217 | C | 0.14234 | G | 0.299151 | -0.156811 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 218 | G | 0.138145 | V | 0.076203 | 0.061942 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 221 | E | 0.245078 | G | 0.201678 | 0.0434 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 222 | D | 0.282984 | V | 0.154526 | 0.128458 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 224 | I | 0.378608 | M | 0.476663 | -0.098055 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 225 | P | 0.390897 | R | 0.351317 | 0.03958 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 225 | P | 0.390897 | T | 0.337793 | 0.053104 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 230 | V | 0.302316 | I | 0.284693 | 0.017623 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 231 | S | 0.247146 | P | 0.235936 | 0.01121 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 233 | F | 0.181705 | L | 0.213211 | -0.031506 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 238 | T | 0.122048 | P | 0.152522 | -0.030474 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 239 | G | 0.119508 | S | 0.150686 | -0.031178 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 241 | R | 0.125 | C | 0.061746 | 0.063254 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 241 | R | 0.125 | C | 0.061746 | 0.063254 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 241 | R | 0.125 | H | 0.11649 | 0.00851 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 241 | R | 0.125 | L | 0.074838 | 0.050162 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 242 | L | 0.140923 | F | 0.123706 | 0.017217 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 243 | R | 0.174832 | Q | 0.179753 | -0.004921 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 243 | R | 0.174832 | Q | 0.179753 | -0.004921 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 244 | P | 0.205919 | L | 0.120225 | 0.085694 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 245 | V | 0.224552 | A | 0.306304 | -0.081752 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 245 | V | 0.224552 | E | 0.398282 | -0.17373 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 245 | V | 0.224552 | L | 0.245663 | -0.021111 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 246 | A | 0.241266 | D | 0.329725 | -0.088459 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 247 | G | 0.254135 | V | 0.155399 | 0.098736 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 248 | L | 0.272327 | P | 0.4238 | -0.151473 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 249 | L | 0.274011 | F | 0.243575 | 0.030436 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 252 | R | 0.281262 | G | 0.309399 | -0.028137 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 252 | R | 0.281262 | Q | 0.2914 | -0.010138 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 252 | R | 0.281262 | W | 0.132108 | 0.149154 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 255 | L | 0.206058 | V | 0.19605 | 0.010008 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 255 | L | 0.206058 | S | 0.356947 | -0.150889 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 257 | G | 0.138552 | C | 0.066426 | 0.072126 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 259 | A | 0.096342 | T | 0.114553 | -0.018211 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 259 | A | 0.096342 | V | 0.07407 | 0.022272 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 261 | R | 0.052725 | P | 0.060892 | -0.008167 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 261 | R | 0.052725 | Q | 0.056774 | -0.004049 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 263 | F | 0.047459 | L | 0.054304 | -0.006845 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 264 | H | 0.060243 | L | 0.035546 | 0.024697 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 265 | C | 0.080234 | G | 0.170183 | -0.089949 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 269 | I | 0.228183 | L | 0.251805 | -0.023622 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 270 | R | 0.285488 | K | 0.356138 | -0.07065 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 270 | R | 0.285488 | S | 0.355634 | -0.070146 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 271 | H | 0.349706 | Y | 0.263768 | 0.085938 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 273 | S | 0.481115 | F | 0.286307 | 0.194808 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 276 | M | 0.546116 | I | 0.474453 | 0.071663 | D to O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 276 | M | 0.546116 | V | 0.488848 | 0.057268 | D to O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 277 | Y | 0.532754 | C | 0.481809 | 0.050945 | D to O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 277 | Y | 0.532754 | D | 0.629377 | -0.096623 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 278 | T | 0.527474 | A | 0.500128 | 0.027346 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 278 | T | 0.527474 | N | 0.566487 | -0.039013 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 280 | E | 0.447662 | K | 0.448126 | -4.64E-04 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 281 | P | 0.41584 | L | 0.263785 | 0.152055 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 282 | D | 0.350814 | N | 0.336018 | 0.014796 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 283 | I | 0.307667 | F | 0.309744 | -0.002077 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 283 | I | 0.307667 | N | 0.488163 | -0.180496 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 297 | R | 0.368277 | C | 0.210699 | 0.157578 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 297 | R | 0.368277 | H | 0.382754 | -0.014477 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 299 | F | 0.354464 | C | 0.318662 | 0.035802 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 300 | A | 0.336354 | S | 0.476826 | -0.140472 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 300 | A | 0.336354 | V | 0.260134 | 0.07622 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 303 | S | 0.37855 | P | 0.328317 | 0.050233 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 304 | Q | 0.37496 | R | 0.347469 | 0.027491 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 306 | I | 0.350821 | V | 0.384855 | -0.034034 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 309 | A | 0.312002 | D | 0.390847 | -0.078845 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 309 | A | 0.312002 | V | 0.226324 | 0.085678 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 310 | S | 0.313994 | F | 0.134633 | 0.179361 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 311 | L | 0.317347 | P | 0.490677 | -0.17333 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 314 | P | 0.379575 | H | 0.340472 | 0.039103 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 322 | A | 0.057382 | G | 0.07072 | -0.013338 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 322 | A | 0.057382 | T | 0.069422 | -0.01204 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 331 | F | 0.049941 | L | 0.056958 | -0.007017 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 333 | L | 0.115013 | F | 0.112554 | 0.002459 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 334 | C | 0.155409 | S | 0.352356 | -0.196947 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 337 | G | 0.323289 | V | 0.196018 | 0.127271 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 338 | D | 0.329187 | Y | 0.210056 | 0.119131 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 341 | K | 0.360284 | R | 0.294876 | 0.065408 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 341 | K | 0.360284 | T | 0.276554 | 0.08373 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 342 | A | 0.32647 | T | 0.345042 | -0.018572 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 343 | Y | 0.33085 | C | 0.295535 | 0.035315 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 345 | A | 0.297893 | S | 0.420298 | -0.122405 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 345 | A | 0.297893 | T | 0.313723 | -0.01583 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 347 | L | 0.274118 | F | 0.24502 | 0.029098 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 348 | L | 0.256634 | V | 0.238443 | 0.018191 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 349 | S | 0.240914 | L | 0.117649 | 0.123265 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 349 | S | 0.240914 | P | 0.206911 | 0.034003 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 350 | S | 0.258703 | T | 0.180378 | 0.078325 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 362 | P | 0.449157 | T | 0.378267 | 0.07089 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 366 | P | 0.44018 | H | 0.383876 | 0.056304 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 372 | T | 0.296751 | S | 0.361192 | -0.064441 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 377 | Y | 0.204688 | C | 0.185034 | 0.019654 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 380 | T | 0.16874 | M | 0.131191 | 0.037549 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 386 | Y | 0.144672 | C | 0.132037 | 0.012635 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 387 | Y | 0.142379 | H | 0.197452 | -0.055073 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 388 | V | 0.173904 | L | 0.184012 | -0.010108 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 388 | V | 0.173904 | M | 0.213711 | -0.039807 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 390 | E | 0.23257 | G | 0.177808 | 0.054762 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 394 | D | 0.478261 | A | 0.423941 | 0.05432 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 394 | D | 0.478261 | H | 0.451506 | 0.026755 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 395 | A | 0.524808 | G | 0.562997 | -0.038189 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 395 | A | 0.524808 | P | 0.562457 | -0.037649 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 403 | A | 0.244118 | V | 0.18175 | 0.062368 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 403 | A | 0.244118 | V | 0.18175 | 0.062368 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 408 | R | 0.240902 | Q | 0.242152 | -0.00125 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 408 | R | 0.240902 | W | 0.097183 | 0.143719 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 413 | R | 0.296835 | P | 0.338504 | -0.041669 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 413 | R | 0.296835 | P | 0.338504 | -0.041669 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 413 | R | 0.296835 | S | 0.355378 | -0.058543 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 414 | Y | 0.296524 | C | 0.241181 | 0.055343 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 415 | D | 0.275898 | N | 0.261057 | 0.014841 | No Change: Both O | Non-phenylketonuria hyperphenylalaninemia (Non-PKU HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 418 | T | 0.234792 | P | 0.294359 | -0.059567 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 430 | L | 0.270629 | P | 0.405259 | -0.13463 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 447 | A | 0.316274 | D | 0.400731 | -0.084457 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 20 | Q | 0.424815 | L | 0.303319 | 0.121496 | No Change: Both O | Hyperphenylalaninemia (HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 41 | L | 0.236387 | P | 0.341151 | -0.104764 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 110 | S | 0.606429 | C | 0.394763 | 0.211666 | D to O | Hyperphenylalaninemia (HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 155 | R | 0.327336 | P | 0.356411 | -0.029075 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 183 | E | 0.621328 | Q | 0.547117 | 0.074211 | No Change: Both D | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 231 | S | 0.247146 | F | 0.113172 | 0.133974 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 325 | Y | 0.023024 | C | 0.021096 | 0.001928 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 330 | E | 0.039304 | D | 0.036265 | 0.003039 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 344 | G | 0.339459 | R | 0.30803 | 0.031429 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 344 | G | 0.339459 | V | 0.201137 | 0.138322 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 410 | F | 0.25531 | S | 0.4533 | -0.19799 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 145 | D | 0.467337 | V | 0.300067 | 0.16727 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 167 | N | 0.225872 | S | 0.264006 | -0.038134 | No Change: Both O | Hyperphenylalaninemia (HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 169 | R | 0.248557 | H | 0.247046 | 0.001511 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 170 | H | 0.282364 | D | 0.32886 | -0.046496 | No Change: Both O | Hyperphenylalaninemia (HPA) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 174 | I | 0.421874 | V | 0.46831 | -0.046436 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 205 | E | 0.111973 | A | 0.072861 | 0.039112 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 240 | F | 0.120096 | S | 0.273398 | -0.153302 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 274 | K | 0.507617 | E | 0.513014 | -0.005397 | No Change: Both D | - |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 318 | I | 0.25788 | T | 0.39142 | -0.13354 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 357 | C | 0.283658 | G | 0.477573 | -0.193915 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P00439 | PH4H_HUMAN Phenylalanine-4-hydroxylase OS=Homo sapiens GN=PAH PE=1 SV=1 | 407 | P | 0.2332 | S | 0.252822 | -0.019622 | No Change: Both O | Phenylketonuria (PKU) [MIM:261600] |
| P22234 | PUR6_HUMAN Multifunctional protein ADE2 OS=Homo sapiens GN=PAICS PE=1 SV=3 | 201 | K | 0.169862 | N | 0.143691 | 0.026171 | No Change: Both O | - |
| Q13153 | PAK1_HUMAN Serine/threonine-protein kinase PAK 1 OS=Homo sapiens GN=PAK1 PE=1 SV=2 | 515 | L | 0.441513 | V | 0.4028 | 0.038713 | No Change: Both O | - |
| O75914 | PAK3_HUMAN Serine/threonine-protein kinase PAK 3 OS=Homo sapiens GN=PAK3 PE=1 SV=2 | 67 | R | 0.784487 | C | 0.737868 | 0.046619 | No Change: Both D | Mental retardation X-linked type 30 (MRX30) [MIM:300558] |
| O75914 | PAK3_HUMAN Serine/threonine-protein kinase PAK 3 OS=Homo sapiens GN=PAK3 PE=1 SV=2 | 380 | A | 0.134028 | E | 0.207622 | -0.073594 | No Change: Both O | Mental retardation X-linked type 30 (MRX30) [MIM:300558] |
| O75914 | PAK3_HUMAN Serine/threonine-protein kinase PAK 3 OS=Homo sapiens GN=PAK3 PE=1 SV=2 | 440 | T | 0.250732 | S | 0.325217 | -0.074485 | No Change: Both O | A colorectal adenocarcinoma sample |
| O96013 | PAK4_HUMAN Serine/threonine-protein kinase PAK 4 OS=Homo sapiens GN=PAK4 PE=1 SV=1 | 135 | R | 0.992765 | Q | 0.991027 | 0.001738 | No Change: Both D | - |
| O96013 | PAK4_HUMAN Serine/threonine-protein kinase PAK 4 OS=Homo sapiens GN=PAK4 PE=1 SV=1 | 139 | A | 0.993271 | T | 0.993316 | -4.50E-05 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 76 | M | 0.415898 | V | 0.365086 | 0.050812 | No Change: Both O | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 215 | H | 0.948665 | R | 0.959465 | -0.0108 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 337 | P | 0.961728 | L | 0.929547 | 0.032181 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 3 | R | 0.935877 | H | 0.923992 | 0.011885 | No Change: Both D | A colorectal cancer sample |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 184 | E | 0.898213 | K | 0.905229 | -0.007016 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 205 | G | 0.939109 | E | 0.942984 | -0.003875 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 208 | P | 0.942959 | T | 0.924778 | 0.018181 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 210 | T | 0.943596 | M | 0.945055 | -0.001459 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 376 | A | 0.41952 | V | 0.348323 | 0.071197 | No Change: Both O | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 514 | L | 0.088717 | R | 0.138331 | -0.049614 | No Change: Both O | A lung small cell carcinoma sample |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 103 | R | 0.740357 | C | 0.614891 | 0.125466 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 151 | T | 0.735811 | I | 0.596378 | 0.139433 | No Change: Both D | - |
| Q9NQU5 | PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens GN=PAK6 PE=1 SV=1 | 475 | E | 0.115223 | K | 0.11224 | 0.002983 | No Change: Both O | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 511 | S | 0.233937 | N | 0.199934 | 0.034003 | No Change: Both O | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 118 | G | 0.884154 | D | 0.893696 | -0.009542 | No Change: Both D | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 187 | P | 0.56077 | A | 0.502485 | 0.058285 | No Change: Both D | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 312 | S | 0.635749 | P | 0.644518 | -0.008769 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 335 | R | 0.660548 | P | 0.715002 | -0.054454 | No Change: Both D | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 538 | T | 0.332076 | N | 0.366966 | -0.03489 | No Change: Both O | A lung adenocarcinoma sample |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 555 | A | 0.122009 | S | 0.204258 | -0.082249 | No Change: Both O | - |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 604 | V | 0.279984 | I | 0.242877 | 0.037107 | No Change: Both O | A metastatic melanoma sample |
| Q9P286 | PAK7_HUMAN Serine/threonine-protein kinase PAK 7 OS=Homo sapiens GN=PAK7 PE=1 SV=1 | 704 | G | 0.292884 | S | 0.368388 | -0.075504 | No Change: Both O | A metastatic melanoma sample |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 309 | I | 0.627372 | V | 0.667309 | -0.039937 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 864 | P | 0.600556 | S | 0.6311 | -0.030544 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 46 | H | 0.863971 | Y | 0.816495 | 0.047476 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 219 | D | 0.794201 | G | 0.758718 | 0.035483 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 334 | Y | 0.877548 | C | 0.918045 | -0.040497 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 337 | L | 0.919955 | S | 0.950737 | -0.030782 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 414 | R | 0.375032 | Q | 0.38142 | -0.006388 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 425 | V | 0.312774 | M | 0.365358 | -0.052584 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 491 | A | 0.924087 | T | 0.936598 | -0.012511 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 515 | K | 0.84224 | R | 0.845071 | -0.002831 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 559 | Q | 0.618762 | R | 0.603331 | 0.015431 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 672 | E | 0.892988 | Q | 0.864838 | 0.02815 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 712 | A | 0.727083 | V | 0.682156 | 0.044927 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 728 | F | 0.540447 | L | 0.580908 | -0.040461 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 917 | V | 0.06281 | A | 0.088191 | -0.025381 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 932 | V | 0.039949 | M | 0.04786 | -0.007911 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 939 | L | 0.110404 | W | 0.070271 | 0.040133 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 966 | I | 0.3973 | V | 0.458256 | -0.060956 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 998 | G | 0.627243 | E | 0.68008 | -0.052837 | No Change: Both D | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1025 | A | 0.281106 | T | 0.325226 | -0.04412 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1043 | G | 0.186104 | A | 0.147939 | 0.038165 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1075 | S | 0.134714 | G | 0.102587 | 0.032127 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1105 | V | 0.088075 | A | 0.114603 | -0.026528 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1114 | Q | 0.241143 | H | 0.226169 | 0.014974 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1143 | L | 0.035853 | P | 0.069197 | -0.033344 | No Change: Both O | - |
| Q86YC2 | PALB2_HUMAN Partner and localizer of BRCA2 OS=Homo sapiens GN=PALB2 PE=1 SV=1 | 1170 | H | 0.423792 | Y | 0.29418 | 0.129612 | No Change: Both O | - |
| Q9ULE6 | PALD_HUMAN Paladin OS=Homo sapiens GN=PALD PE=1 SV=3 | 141 | S | 0.422029 | L | 0.24648 | 0.175549 | No Change: Both O | - |
| Q9ULE6 | PALD_HUMAN Paladin OS=Homo sapiens GN=PALD PE=1 SV=3 | 721 | R | 0.448558 | C | 0.288389 | 0.160169 | No Change: Both O | - |
| Q9ULE6 | PALD_HUMAN Paladin OS=Homo sapiens GN=PALD PE=1 SV=3 | 828 | G | 0.649257 | R | 0.662108 | -0.012851 | No Change: Both D | - |
| Q8WX93 | PALLD_HUMAN Palladin OS=Homo sapiens GN=PALLD PE=1 SV=3 | 224 | M | 0.958414 | I | 0.926004 | 0.03241 | No Change: Both D | - |
| Q8WX93 | PALLD_HUMAN Palladin OS=Homo sapiens GN=PALLD PE=1 SV=3 | 224 | M | 0.958414 | T | 0.947841 | 0.010573 | No Change: Both D | - |
| O75781 | PALM_HUMAN Paralemmin-1 OS=Homo sapiens GN=PALM PE=1 SV=2 | 107 | T | 0.94657 | A | 0.95183 | -0.00526 | No Change: Both D | - |
| A6NDB9 | PALM3_HUMAN Paralemmin-3 OS=Homo sapiens GN=PALM3 PE=1 SV=2 | 440 | A | 0.987384 | T | 0.989612 | -0.002228 | No Change: Both D | - |
| Q9NP74 | PALMD_HUMAN Palmdelphin OS=Homo sapiens GN=PALMD PE=1 SV=1 | 73 | H | 0.926449 | Q | 0.957153 | -0.030704 | No Change: Both D | - |
| Q9NP74 | PALMD_HUMAN Palmdelphin OS=Homo sapiens GN=PALMD PE=1 SV=1 | 229 | N | 0.523632 | S | 0.5749 | -0.051268 | No Change: Both D | - |
| Q9NP74 | PALMD_HUMAN Palmdelphin OS=Homo sapiens GN=PALMD PE=1 SV=1 | 459 | E | 0.83177 | D | 0.815191 | 0.016579 | No Change: Both D | - |
| P19021 | AMD_HUMAN Peptidyl-glycine alpha-amidating monooxygenase OS=Homo sapiens GN=PAM PE=1 SV=2 | 49 | V | 0.456979 | L | 0.463445 | -0.006466 | No Change: Both O | - |
| Q9Y3D7 | TIM16_HUMAN Mitochondrial import inner membrane translocase subunit TIM16 OS=Homo sapiens GN=PAM16 PE=1 SV=2 | 114 | Q | 0.786918 | K | 0.807702 | -0.020784 | No Change: Both D | - |
| Q6UXH9 | PAMR1_HUMAN Inactive serine protease PAMR1 OS=Homo sapiens GN=PAMR1 PE=1 SV=1 | 305 | A | 0.236377 | T | 0.283793 | -0.047416 | No Change: Both O | - |
| Q504Q3 | PAN2_HUMAN PAB-dependent poly(A)-specific ribonuclease subunit 2 OS=Homo sapiens GN=PAN2 PE=1 SV=3 | 32 | S | 0.420914 | N | 0.396289 | 0.024625 | No Change: Both O | - |
| Q504Q3 | PAN2_HUMAN PAB-dependent poly(A)-specific ribonuclease subunit 2 OS=Homo sapiens GN=PAN2 PE=1 SV=3 | 179 | I | 0.153443 | L | 0.176224 | -0.022781 | No Change: Both O | - |
| Q504Q3 | PAN2_HUMAN PAB-dependent poly(A)-specific ribonuclease subunit 2 OS=Homo sapiens GN=PAN2 PE=1 SV=3 | 1201 | A | 0.626048 | V | 0.549233 | 0.076815 | No Change: Both D | A colorectal cancer sample |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 111 | L | 0.857384 | Q | 0.88903 | -0.031646 | No Change: Both D | - |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 126 | G | 0.86111 | A | 0.838251 | 0.022859 | No Change: Both D | - |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 219 | G | 0.191986 | V | 0.138018 | 0.053968 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 234 | T | 0.597469 | A | 0.587656 | 0.009813 | No Change: Both D | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 264 | R | 0.26219 | W | 0.120207 | 0.141983 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 278 | R | 0.22135 | C | 0.119691 | 0.101659 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 282 | L | 0.171773 | V | 0.165049 | 0.006724 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 286 | R | 0.192763 | C | 0.094621 | 0.098142 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 327 | T | 0.100026 | I | 0.0575 | 0.042526 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 351 | S | 0.13782 | P | 0.118922 | 0.018898 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 355 | N | 0.200993 | S | 0.251044 | -0.050051 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 404 | N | 0.439551 | I | 0.267433 | 0.172118 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 413 | L | 0.37222 | P | 0.531041 | -0.158821 | O to D | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 471 | S | 0.34271 | N | 0.295326 | 0.047384 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 497 | I | 0.183144 | T | 0.291342 | -0.108198 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 500 | N | 0.204283 | I | 0.110229 | 0.094054 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 521 | G | 0.046877 | R | 0.047514 | -6.37E-04 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 528 | T | 0.061918 | M | 0.053369 | 0.008549 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 94 | R | 0.832689 | P | 0.839336 | -0.006647 | No Change: Both D | - |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 134 | E | 0.932532 | G | 0.933051 | -5.19E-04 | No Change: Both D | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 249 | R | 0.421125 | P | 0.457468 | -0.036343 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 278 | R | 0.22135 | L | 0.147533 | 0.073817 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 322 | E | 0.261995 | D | 0.254608 | 0.007387 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 322 | E | 0.261995 | G | 0.237587 | 0.024408 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 357 | R | 0.222929 | Q | 0.253783 | -0.030854 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 398 | A | 0.18185 | T | 0.20538 | -0.02353 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 428 | C | 0.123957 | Y | 0.117867 | 0.00609 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 447 | D | 0.468327 | N | 0.429593 | 0.038734 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 501 | I | 0.198991 | T | 0.307096 | -0.108105 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 509 | A | 0.134567 | V | 0.091375 | 0.043192 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 511 | N | 0.162308 | D | 0.158635 | 0.003673 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 532 | R | 0.049477 | W | 0.017548 | 0.031929 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 563 | L | 0.133873 | P | 0.234113 | -0.10024 | No Change: Both O | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9BZ23 | PANK2_HUMAN Pantothenate kinase 2 mitochondrial OS=Homo sapiens GN=PANK2 PE=1 SV=3 | 570 | P | 0.806237 | L | 0.628041 | 0.178196 | No Change: Both D | Neurodegeneration with brain iron accumulation type 1 (NBIA1) [MIM:234200] |
| Q9NVE7 | PANK4_HUMAN Pantothenate kinase 4 OS=Homo sapiens GN=PANK4 PE=1 SV=1 | 684 | Q | 0.406082 | R | 0.409497 | -0.003415 | No Change: Both O | - |
| Q9NVE7 | PANK4_HUMAN Pantothenate kinase 4 OS=Homo sapiens GN=PANK4 PE=1 SV=1 | 547 | A | 0.209029 | V | 0.16433 | 0.044699 | No Change: Both O | - |
| Q9NVE7 | PANK4_HUMAN Pantothenate kinase 4 OS=Homo sapiens GN=PANK4 PE=1 SV=1 | 475 | E | 0.578871 | K | 0.58198 | -0.003109 | No Change: Both D | A colorectal cancer sample |
| Q96RD7 | PANX1_HUMAN Pannexin-1 OS=Homo sapiens GN=PANX1 PE=1 SV=4 | 5 | Q | 0.386927 | H | 0.383893 | 0.003034 | No Change: Both O | - |
| Q96RD7 | PANX1_HUMAN Pannexin-1 OS=Homo sapiens GN=PANX1 PE=1 SV=4 | 272 | I | 0.026258 | V | 0.030681 | -0.004423 | No Change: Both O | - |
| Q96RD6 | PANX2_HUMAN Pannexin-2 OS=Homo sapiens GN=PANX2 PE=1 SV=2 | 147 | S | 0.198695 | F | 0.07918 | 0.119515 | No Change: Both O | A breast cancer sample |
| Q96QZ0 | PANX3_HUMAN Pannexin-3 OS=Homo sapiens GN=PANX3 PE=2 SV=1 | 95 | G | 0.755423 | R | 0.741119 | 0.014304 | No Change: Both D | - |
| Q96QZ0 | PANX3_HUMAN Pannexin-3 OS=Homo sapiens GN=PANX3 PE=2 SV=1 | 208 | T | 0.204234 | A | 0.193143 | 0.011091 | No Change: Both O | - |
| Q5XG87 | PAPD7_HUMAN DNA polymerase sigma OS=Homo sapiens GN=PAPD7 PE=1 SV=2 | 326 | N | 0.808079 | S | 0.848137 | -0.040058 | No Change: Both D | - |
| Q5XG87 | PAPD7_HUMAN DNA polymerase sigma OS=Homo sapiens GN=PAPD7 PE=1 SV=2 | 396 | G | 0.902979 | S | 0.931107 | -0.028128 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 33 | S | 0.769412 | G | 0.715615 | 0.053797 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 191 | A | 0.328112 | T | 0.356755 | -0.028643 | No Change: Both O | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 356 | N | 0.78996 | H | 0.813289 | -0.023329 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 443 | V | 0.616776 | I | 0.549158 | 0.067618 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 461 | A | 0.596231 | V | 0.536367 | 0.059864 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 628 | H | 0.981981 | R | 0.983686 | -0.001705 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 723 | Q | 0.644409 | H | 0.585483 | 0.058926 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 896 | G | 0.789273 | R | 0.788709 | 5.64E-04 | No Change: Both D | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 1192 | L | 0.235642 | V | 0.226537 | 0.009105 | No Change: Both O | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 1201 | T | 0.491011 | M | 0.452044 | 0.038967 | No Change: Both O | - |
| O95428 | PPN_HUMAN Papilin OS=Homo sapiens GN=PAPLN PE=2 SV=4 | 1260 | S | 0.23987 | T | 0.144243 | 0.095627 | No Change: Both O | - |
| Q13219 | PAPP1_HUMAN Pappalysin-1 OS=Homo sapiens GN=PAPPA PE=1 SV=3 | 944 | S | 0.249326 | R | 0.189942 | 0.059384 | No Change: Both O | - |
| Q13219 | PAPP1_HUMAN Pappalysin-1 OS=Homo sapiens GN=PAPPA PE=1 SV=3 | 1224 | S | 0.542612 | Y | 0.340516 | 0.202096 | D to O | - |
| Q13219 | PAPP1_HUMAN Pappalysin-1 OS=Homo sapiens GN=PAPPA PE=1 SV=3 | 5 | S | 0.299132 | I | 0.113448 | 0.185684 | No Change: Both O | - |
| Q13219 | PAPP1_HUMAN Pappalysin-1 OS=Homo sapiens GN=PAPPA PE=1 SV=3 | 325 | P | 0.323662 | L | 0.19405 | 0.129612 | No Change: Both O | - |
| Q9BXP8 | PAPP2_HUMAN Pappalysin-2 OS=Homo sapiens GN=PAPPA2 PE=1 SV=4 | 171 | T | 0.632349 | S | 0.67396 | -0.041611 | No Change: Both D | - |
| Q9BXP8 | PAPP2_HUMAN Pappalysin-2 OS=Homo sapiens GN=PAPPA2 PE=1 SV=4 | 1657 | P | 0.763048 | R | 0.694704 | 0.068344 | No Change: Both D | - |
| O43252 | PAPS1_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 OS=Homo sapiens GN=PAPSS1 PE=1 SV=2 | 587 | S | 0.42437 | L | 0.255523 | 0.168847 | No Change: Both O | - |
| O43252 | PAPS1_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 OS=Homo sapiens GN=PAPSS1 PE=1 SV=2 | 270 | L | 0.080443 | F | 0.067258 | 0.013185 | No Change: Both O | - |
| O95340 | PAPS2_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens GN=PAPSS2 PE=1 SV=2 | 291 | V | 0.150658 | M | 0.200228 | -0.04957 | No Change: Both O | - |
| O95340 | PAPS2_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens GN=PAPSS2 PE=1 SV=2 | 10 | E | 0.860238 | K | 0.899803 | -0.039565 | No Change: Both D | - |
| O95340 | PAPS2_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens GN=PAPSS2 PE=1 SV=2 | 281 | M | 0.129669 | L | 0.10692 | 0.022749 | No Change: Both O | - |
| O95340 | PAPS2_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens GN=PAPSS2 PE=1 SV=2 | 432 | R | 0.400263 | K | 0.448581 | -0.048318 | No Change: Both O | - |
| O95340 | PAPS2_HUMAN Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 OS=Homo sapiens GN=PAPSS2 PE=1 SV=2 | 48 | T | 0.132215 | R | 0.133555 | -0.00134 | No Change: Both O | Spondyloepimetaphyseal dysplasia Pakistani type (SEMD-PA) [MIM:612847] |
| Q9NXK6 | MPRG_HUMAN Membrane progestin receptor gamma OS=Homo sapiens GN=PAQR5 PE=1 SV=2 | 24 | I | 0.181654 | T | 0.298461 | -0.116807 | No Change: Both O | - |
| Q86WK9 | MPRA_HUMAN Membrane progestin receptor alpha OS=Homo sapiens GN=PAQR7 PE=2 SV=1 | 272 | G | 0.242903 | R | 0.213715 | 0.029188 | No Change: Both O | - |
| Q86WK9 | MPRA_HUMAN Membrane progestin receptor alpha OS=Homo sapiens GN=PAQR7 PE=2 SV=1 | 227 | V | 0.363496 | M | 0.407262 | -0.043766 | No Change: Both O | - |
| Q8TEW0 | PARD3_HUMAN Partitioning defective 3 homolog OS=Homo sapiens GN=PARD3 PE=1 SV=2 | 107 | E | 0.673445 | D | 0.630949 | 0.042496 | No Change: Both D | - |
| Q8TEW0 | PARD3_HUMAN Partitioning defective 3 homolog OS=Homo sapiens GN=PARD3 PE=1 SV=2 | 575 | D | 0.633204 | N | 0.596688 | 0.036516 | No Change: Both D | - |
| Q8TEW8 | PAR3L_HUMAN Partitioning defective 3 homolog B OS=Homo sapiens GN=PARD3B PE=1 SV=2 | 165 | L | 0.871338 | P | 0.923569 | -0.052231 | No Change: Both D | - |
| Q8TEW8 | PAR3L_HUMAN Partitioning defective 3 homolog B OS=Homo sapiens GN=PARD3B PE=1 SV=2 | 192 | R | 0.71648 | K | 0.74335 | -0.02687 | No Change: Both D | - |
| Q8TEW8 | PAR3L_HUMAN Partitioning defective 3 homolog B OS=Homo sapiens GN=PARD3B PE=1 SV=2 | 295 | Q | 0.522053 | K | 0.542351 | -0.020298 | No Change: Both D | - |
| Q8TEW8 | PAR3L_HUMAN Partitioning defective 3 homolog B OS=Homo sapiens GN=PARD3B PE=1 SV=2 | 317 | K | 0.604406 | R | 0.538687 | 0.065719 | No Change: Both D | - |
| Q9NPB6 | PAR6A_HUMAN Partitioning defective 6 homolog alpha OS=Homo sapiens GN=PARD6A PE=1 SV=1 | 286 | V | 0.974022 | I | 0.975076 | -0.001054 | No Change: Both D | - |
| Q3YEC7 | PARF_HUMAN Putative GTP-binding protein Parf OS=Homo sapiens GN=PARF PE=1 SV=2 | 382 | E | 0.952284 | Q | 0.944908 | 0.007376 | No Change: Both D | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 15 | V | 0.562323 | M | 0.604945 | -0.042622 | No Change: Both D | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 33 | R | 0.376763 | Q | 0.414899 | -0.038136 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 37 | P | 0.299357 | L | 0.185404 | 0.113953 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 42 | R | 0.138628 | P | 0.164787 | -0.026159 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 46 | A | 0.143687 | P | 0.199103 | -0.055416 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 82 | A | 0.657279 | E | 0.728873 | -0.071594 | No Change: Both D | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 82 | A | 0.657279 | E | 0.728873 | -0.071594 | No Change: Both D | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 92 | A | 0.719051 | V | 0.651077 | 0.067974 | No Change: Both D | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 100 | Q | 0.718577 | H | 0.686702 | 0.031875 | No Change: Both D | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 161 | K | 0.47717 | N | 0.438591 | 0.038579 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 161 | K | 0.47717 | N | 0.438591 | 0.038579 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 167 | S | 0.33654 | N | 0.284428 | 0.052112 | No Change: Both O | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 192 | M | 0.530836 | V | 0.475531 | 0.055305 | D to O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 211 | K | 0.346726 | N | 0.312499 | 0.034227 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 211 | K | 0.346726 | R | 0.304071 | 0.042655 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 212 | C | 0.350772 | Y | 0.33673 | 0.014042 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 240 | T | 0.123268 | M | 0.090602 | 0.032666 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 240 | T | 0.123268 | R | 0.130757 | -0.007489 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 253 | C | 0.105947 | Y | 0.119893 | -0.013946 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 256 | R | 0.062787 | C | 0.034773 | 0.028014 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 256 | R | 0.062787 | C | 0.034773 | 0.028014 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 271 | R | 0.11452 | S | 0.13871 | -0.02419 | No Change: Both O | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 275 | R | 0.260034 | W | 0.11191 | 0.148124 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 275 | R | 0.260034 | W | 0.11191 | 0.148124 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 280 | D | 0.309988 | N | 0.290679 | 0.019309 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 284 | G | 0.211391 | R | 0.199454 | 0.011937 | No Change: Both O | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 289 | C | 0.132839 | G | 0.273862 | -0.141023 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 328 | G | 0.285339 | E | 0.33581 | -0.050471 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 334 | R | 0.422283 | C | 0.333423 | 0.08886 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 339 | A | 0.60661 | S | 0.663496 | -0.056886 | No Change: Both D | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 351 | T | 0.61653 | P | 0.723787 | -0.107257 | No Change: Both D | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 366 | R | 0.41847 | W | 0.199511 | 0.218959 | No Change: Both O | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 380 | V | 0.560317 | L | 0.551498 | 0.008819 | No Change: Both D | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 394 | D | 0.71942 | N | 0.708173 | 0.011247 | No Change: Both D | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 415 | T | 0.817236 | N | 0.806336 | 0.0109 | No Change: Both D | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 415 | T | 0.817236 | N | 0.806336 | 0.0109 | No Change: Both D | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 430 | G | 0.716183 | D | 0.718225 | -0.002042 | No Change: Both D | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 431 | C | 0.679489 | F | 0.575694 | 0.103795 | No Change: Both D | Parkinson disease type 2 (PARK2) [MIM:600116] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 437 | P | 0.564792 | L | 0.378651 | 0.186141 | D to O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 441 | C | 0.401224 | R | 0.46354 | -0.062316 | No Change: Both O | Parkinson disease (PARK) [MIM:168600] |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 192 | M | 0.530836 | L | 0.493234 | 0.037602 | D to O | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 311 | Q | 0.381836 | R | 0.366062 | 0.015774 | No Change: Both O | - |
| O60260 | PRKN2_HUMAN E3 ubiquitin-protein ligase parkin OS=Homo sapiens GN=PARK2 PE=1 SV=2 | 371 | A | 0.52145 | T | 0.540652 | -0.019202 | No Change: Both D | - |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 26 | M | 0.201583 | I | 0.140471 | 0.061112 | No Change: Both O | Parkinson disease type 7 (PARK7) [MIM:606324] |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 64 | E | 0.545895 | D | 0.542055 | 0.00384 | No Change: Both D | Parkinson disease type 7 (PARK7) [MIM:606324] |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 98 | R | 0.42393 | Q | 0.461229 | -0.037299 | No Change: Both O | - |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 104 | A | 0.163769 | T | 0.168628 | -0.004859 | No Change: Both O | Parkinson disease type 7 (PARK7) [MIM:606324] |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 149 | D | 0.422757 | A | 0.34725 | 0.075507 | No Change: Both O | Parkinson disease type 7 (PARK7) [MIM:606324] |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 150 | G | 0.388584 | S | 0.442845 | -0.054261 | No Change: Both O | - |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 166 | L | 0.104097 | P | 0.199298 | -0.095201 | No Change: Both O | Parkinson disease type 7 (PARK7) [MIM:606324] |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 171 | A | 0.195547 | S | 0.257011 | -0.061464 | No Change: Both O | - |
| Q99497 | PARK7_HUMAN Protein DJ-1 OS=Homo sapiens GN=PARK7 PE=1 SV=2 | 163 | E | 0.208554 | K | 0.203445 | 0.005109 | No Change: Both O | - |
| Q9H300 | PARL_HUMAN Presenilins-associated rhomboid-like protein mitochondrial OS=Homo sapiens GN=PARL PE=1 SV=2 | 262 | V | 0.187052 | L | 0.171789 | 0.015263 | No Change: Both O | - |
| Q9H300 | PARL_HUMAN Presenilins-associated rhomboid-like protein mitochondrial OS=Homo sapiens GN=PARL PE=1 SV=2 | 137 | A | 0.183666 | G | 0.241071 | -0.057405 | No Change: Both O | - |
| Q6UWI2 | PARM1_HUMAN Prostate androgen-regulated mucin-like protein 1 OS=Homo sapiens GN=PARM1 PE=1 SV=1 | 127 | S | 0.951397 | L | 0.914586 | 0.036811 | No Change: Both D | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 188 | A | 0.628805 | T | 0.647521 | -0.018716 | No Change: Both D | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 762 | V | 0.352456 | A | 0.428354 | -0.075898 | No Change: Both O | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 334 | V | 0.454539 | I | 0.429858 | 0.024681 | No Change: Both O | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 383 | S | 0.91329 | Y | 0.806043 | 0.107247 | No Change: Both D | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 940 | K | 0.660651 | R | 0.610957 | 0.049694 | No Change: Both D | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 488 | E | 0.532874 | V | 0.380579 | 0.152295 | D to O | A breast cancer sample |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 54 | F | 0.07452 | L | 0.074271 | 2.49E-04 | No Change: Both O | - |
| P09874 | PARP1_HUMAN Poly [ADP-ribose] polymerase 1 OS=Homo sapiens GN=PARP1 PE=1 SV=4 | 377 | P | 0.947369 | S | 0.949083 | -0.001714 | No Change: Both D | - |
| Q53GL7 | PAR10_HUMAN Poly [ADP-ribose] polymerase 10 OS=Homo sapiens GN=PARP10 PE=1 SV=2 | 249 | I | 0.550153 | V | 0.623682 | -0.073529 | No Change: Both D | - |
| Q53GL7 | PAR10_HUMAN Poly [ADP-ribose] polymerase 10 OS=Homo sapiens GN=PARP10 PE=1 SV=2 | 395 | L | 0.831322 | P | 0.897807 | -0.066485 | No Change: Both D | - |
| Q53GL7 | PAR10_HUMAN Poly [ADP-ribose] polymerase 10 OS=Homo sapiens GN=PARP10 PE=1 SV=2 | 630 | V | 0.985225 | A | 0.988966 | -0.003741 | No Change: Both D | - |
| Q9H0J9 | PAR12_HUMAN Poly [ADP-ribose] polymerase 12 OS=Homo sapiens GN=PARP12 PE=1 SV=1 | 293 | V | 0.155156 | I | 0.14235 | 0.012806 | No Change: Both O | - |
| Q9H0J9 | PAR12_HUMAN Poly [ADP-ribose] polymerase 12 OS=Homo sapiens GN=PARP12 PE=1 SV=1 | 463 | V | 0.497928 | M | 0.559281 | -0.061353 | O to D | - |
| Q9H0J9 | PAR12_HUMAN Poly [ADP-ribose] polymerase 12 OS=Homo sapiens GN=PARP12 PE=1 SV=1 | 620 | A | 0.097362 | V | 0.074977 | 0.022385 | No Change: Both O | - |
| Q460N3 | PAR15_HUMAN Poly [ADP-ribose] polymerase 15 OS=Homo sapiens GN=PARP15 PE=1 SV=1 | 315 | R | 0.374187 | K | 0.432852 | -0.058665 | No Change: Both O | - |
| Q460N3 | PAR15_HUMAN Poly [ADP-ribose] polymerase 15 OS=Homo sapiens GN=PARP15 PE=1 SV=1 | 606 | G | 0.51426 | R | 0.547964 | -0.033704 | No Change: Both D | - |
| Q460N3 | PAR15_HUMAN Poly [ADP-ribose] polymerase 15 OS=Homo sapiens GN=PARP15 PE=1 SV=1 | 499 | A | 0.270493 | T | 0.318581 | -0.048088 | No Change: Both O | - |
| Q8N5Y8 | PAR16_HUMAN Poly [ADP-ribose] polymerase 16 OS=Homo sapiens GN=PARP16 PE=2 SV=2 | 280 | S | 0.723434 | P | 0.693376 | 0.030058 | No Change: Both D | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 161 | S | 0.33673 | N | 0.290439 | 0.046291 | No Change: Both O | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 168 | N | 0.343351 | S | 0.380592 | -0.037241 | No Change: Both O | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 235 | D | 0.819355 | G | 0.788509 | 0.030846 | No Change: Both D | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 285 | I | 0.333589 | V | 0.345361 | -0.011772 | No Change: Both O | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 296 | R | 0.289462 | Q | 0.307374 | -0.017912 | No Change: Both O | - |
| Q9UGN5 | PARP2_HUMAN Poly [ADP-ribose] polymerase 2 OS=Homo sapiens GN=PARP2 PE=1 SV=2 | 331 | I | 0.421566 | T | 0.541668 | -0.120102 | O to D | - |
| Q9Y6F1 | PARP3_HUMAN Poly [ADP-ribose] polymerase 3 OS=Homo sapiens GN=PARP3 PE=1 SV=3 | 100 | H | 0.072865 | R | 0.085998 | -0.013133 | No Change: Both O | - |
| Q9Y6F1 | PARP3_HUMAN Poly [ADP-ribose] polymerase 3 OS=Homo sapiens GN=PARP3 PE=1 SV=3 | 91 | S | 0.121813 | N | 0.112008 | 0.009805 | No Change: Both O | - |
| Q9Y6F1 | PARP3_HUMAN Poly [ADP-ribose] polymerase 3 OS=Homo sapiens GN=PARP3 PE=1 SV=3 | 269 | Q | 0.640912 | R | 0.626407 | 0.014505 | No Change: Both D | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 1265 | G | 0.66255 | A | 0.615606 | 0.046944 | No Change: Both D | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 1280 | G | 0.555578 | R | 0.568822 | -0.013244 | No Change: Both D | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 81 | I | 0.265373 | V | 0.272955 | -0.007582 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 122 | S | 0.80732 | N | 0.783303 | 0.024017 | No Change: Both D | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 215 | F | 0.46516 | Y | 0.491923 | -0.026763 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 792 | P | 0.187875 | L | 0.118537 | 0.069338 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 873 | S | 0.392438 | N | 0.313544 | 0.078894 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 899 | A | 0.159396 | T | 0.169709 | -0.010313 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 991 | K | 0.461363 | R | 0.439281 | 0.022082 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 1012 | V | 0.17967 | I | 0.172283 | 0.007387 | No Change: Both O | - |
| Q9UKK3 | PARP4_HUMAN Poly [ADP-ribose] polymerase 4 OS=Homo sapiens GN=PARP4 PE=1 SV=3 | 1253 | S | 0.842536 | T | 0.783699 | 0.058837 | No Change: Both D | - |
| Q8N3A8 | PARP8_HUMAN Poly [ADP-ribose] polymerase 8 OS=Homo sapiens GN=PARP8 PE=1 SV=1 | 777 | S | 0.812993 | A | 0.768579 | 0.044414 | No Change: Both D | A colorectal cancer sample |
| Q8IXQ6 | PARP9_HUMAN Poly [ADP-ribose] polymerase 9 OS=Homo sapiens GN=PARP9 PE=1 SV=2 | 21 | S | 0.255483 | L | 0.124771 | 0.130712 | No Change: Both O | - |
| Q8IXQ6 | PARP9_HUMAN Poly [ADP-ribose] polymerase 9 OS=Homo sapiens GN=PARP9 PE=1 SV=2 | 517 | I | 0.314696 | V | 0.343709 | -0.029013 | No Change: Both O | - |
| Q8IXQ6 | PARP9_HUMAN Poly [ADP-ribose] polymerase 9 OS=Homo sapiens GN=PARP9 PE=1 SV=2 | 528 | Y | 0.199748 | C | 0.191637 | 0.008111 | No Change: Both O | - |
| Q8IXQ6 | PARP9_HUMAN Poly [ADP-ribose] polymerase 9 OS=Homo sapiens GN=PARP9 PE=1 SV=2 | 651 | T | 0.583337 | A | 0.534717 | 0.04862 | No Change: Both D | - |
| Q7L3T8 | SYPM_HUMAN Probable proline--tRNA ligase mitochondrial OS=Homo sapiens GN=PARS2 PE=1 SV=1 | 235 | N | 0.084756 | S | 0.111017 | -0.026261 | No Change: Both O | - |
| Q7L3T8 | SYPM_HUMAN Probable proline--tRNA ligase mitochondrial OS=Homo sapiens GN=PARS2 PE=1 SV=1 | 28 | R | 0.449834 | S | 0.456196 | -0.006362 | No Change: Both O | - |
| Q9HBI1 | PARVB_HUMAN Beta-parvin OS=Homo sapiens GN=PARVB PE=1 SV=1 | 58 | V | 0.84873 | A | 0.880562 | -0.031832 | No Change: Both D | - |
| Q9HBI1 | PARVB_HUMAN Beta-parvin OS=Homo sapiens GN=PARVB PE=1 SV=1 | 52 | P | 0.788304 | R | 0.771855 | 0.016449 | No Change: Both D | - |
| Q8IV76 | PASD1_HUMAN PAS domain-containing protein 1 OS=Homo sapiens GN=PASD1 PE=2 SV=1 | 213 | Q | 0.738681 | E | 0.752242 | -0.013561 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 250 | V | 0.343362 | I | 0.307865 | 0.035497 | No Change: Both O | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 514 | L | 0.782315 | S | 0.86522 | -0.082905 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 694 | V | 0.523384 | M | 0.568181 | -0.044797 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 725 | G | 0.401399 | D | 0.431375 | -0.029976 | No Change: Both O | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 1210 | V | 0.335506 | M | 0.392593 | -0.057087 | No Change: Both O | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 1266 | F | 0.244439 | C | 0.271452 | -0.027013 | No Change: Both O | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 11 | E | 0.814496 | K | 0.765027 | 0.049469 | No Change: Both D | A metastatic melanoma sample |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 426 | Q | 0.603454 | R | 0.588436 | 0.015018 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 512 | T | 0.803887 | A | 0.828147 | -0.02426 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 684 | P | 0.493483 | R | 0.436635 | 0.056848 | No Change: Both O | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 796 | E | 0.648642 | K | 0.588705 | 0.059937 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 844 | P | 0.889349 | Q | 0.852494 | 0.036855 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 937 | R | 0.536562 | H | 0.541475 | -0.004913 | No Change: Both D | - |
| Q96RG2 | PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens GN=PASK PE=1 SV=3 | 1301 | P | 0.816514 | S | 0.805115 | 0.011399 | No Change: Both D | - |
| Q8WXA2 | PATE1_HUMAN Prostate and testis expressed protein 1 OS=Homo sapiens GN=PATE1 PE=2 SV=1 | 46 | V | 0.085327 | I | 0.083039 | 0.002288 | No Change: Both O | - |
| Q8WXA2 | PATE1_HUMAN Prostate and testis expressed protein 1 OS=Homo sapiens GN=PATE1 PE=2 SV=1 | 47 | Q | 0.090131 | R | 0.096315 | -0.006184 | No Change: Both O | - |
| B3GLJ2 | PATE3_HUMAN Prostate and testis expressed protein 3 OS=Homo sapiens GN=PATE3 PE=2 SV=1 | 30 | T | 0.276688 | K | 0.33155 | -0.054862 | No Change: Both O | - |
| C9JE40 | PATL2_HUMAN Protein PAT1 homolog 2 OS=Homo sapiens GN=PATL2 PE=1 SV=1 | 88 | M | 0.446138 | L | 0.388657 | 0.057481 | No Change: Both O | - |
| Q9HBE1 | PATZ1_HUMAN POZ- AT hook- and zinc finger-containing protein 1 OS=Homo sapiens GN=PATZ1 PE=1 SV=1 | 685 | E | 0.861684 | D | 0.863029 | -0.001345 | No Change: Both D | - |
| Q96IZ0 | PAWR_HUMAN PRKC apoptosis WT1 regulator protein OS=Homo sapiens GN=PAWR PE=1 SV=1 | 42 | P | 0.979771 | L | 0.960028 | 0.019743 | No Change: Both D | - |
| Q96IZ0 | PAWR_HUMAN PRKC apoptosis WT1 regulator protein OS=Homo sapiens GN=PAWR PE=1 SV=1 | 78 | P | 0.934717 | R | 0.910443 | 0.024274 | No Change: Both D | - |
| Q96IZ0 | PAWR_HUMAN PRKC apoptosis WT1 regulator protein OS=Homo sapiens GN=PAWR PE=1 SV=1 | 137 | G | 0.993448 | A | 0.992189 | 0.001259 | No Change: Both D | - |
| Q96IZ0 | PAWR_HUMAN PRKC apoptosis WT1 regulator protein OS=Homo sapiens GN=PAWR PE=1 SV=1 | 202 | E | 0.652483 | A | 0.555064 | 0.097419 | No Change: Both D | - |
| P15863 | PAX1_HUMAN Paired box protein Pax-1 OS=Homo sapiens GN=PAX1 PE=2 SV=4 | 139 | Q | 0.29545 | H | 0.292298 | 0.003152 | No Change: Both O | - |
| P15863 | PAX1_HUMAN Paired box protein Pax-1 OS=Homo sapiens GN=PAX1 PE=2 SV=4 | 439 | T | 0.935077 | R | 0.944587 | -0.00951 | No Change: Both D | - |
| P15863 | PAX1_HUMAN Paired box protein Pax-1 OS=Homo sapiens GN=PAX1 PE=2 SV=4 | 453 | P | 0.994666 | L | 0.987398 | 0.007268 | No Change: Both D | - |
| P15863 | PAX1_HUMAN Paired box protein Pax-1 OS=Homo sapiens GN=PAX1 PE=2 SV=4 | 504 | P | 0.79063 | L | 0.651704 | 0.138926 | No Change: Both D | - |
| Q02962 | PAX2_HUMAN Paired box protein Pax-2 OS=Homo sapiens GN=PAX2 PE=1 SV=4 | 76 | G | 0.3801 | S | 0.428626 | -0.048526 | No Change: Both O | Renal-coloboma syndrome (RCS) [MIM:120330] |
| Q02962 | PAX2_HUMAN Paired box protein Pax-2 OS=Homo sapiens GN=PAX2 PE=1 SV=4 | 334 | A | 0.831499 | V | 0.821865 | 0.009634 | No Change: Both D | - |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 45 | F | 0.29216 | L | 0.341107 | -0.048947 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 47 | N | 0.293635 | H | 0.271305 | 0.02233 | No Change: Both O | Waardenburg syndrome type 3 (WS3) [MIM:148820] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 47 | N | 0.293635 | K | 0.309205 | -0.01557 | No Change: Both O | Craniofacial-deafness-hand syndrome (CDHS) [MIM:122880] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 50 | P | 0.339641 | L | 0.201302 | 0.138339 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 56 | R | 0.344131 | L | 0.238095 | 0.106036 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 59 | I | 0.392478 | F | 0.373395 | 0.019083 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 59 | I | 0.392478 | N | 0.533643 | -0.141165 | O to D | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 60 | V | 0.400328 | M | 0.480416 | -0.080088 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 62 | M | 0.324449 | V | 0.285609 | 0.03884 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 81 | G | 0.263417 | A | 0.21574 | 0.047677 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 84 | S | 0.256677 | F | 0.101423 | 0.155254 | No Change: Both O | Waardenburg syndrome type 3 (WS3) [MIM:148820] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 85 | K | 0.261251 | E | 0.267143 | -0.005892 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 99 | G | 0.633149 | D | 0.625449 | 0.0077 | No Change: Both D | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 238 | F | 0.701594 | S | 0.800119 | -0.098525 | No Change: Both D | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 265 | V | 0.171236 | F | 0.166549 | 0.004687 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 271 | R | 0.258123 | G | 0.239849 | 0.018274 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 315 | T | 0.886899 | K | 0.874262 | 0.012637 | No Change: Both D | - |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 270 | R | 0.242667 | C | 0.117552 | 0.125115 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 270 | R | 0.242667 | C | 0.117552 | 0.125115 | No Change: Both O | Waardenburg syndrome type 3 (WS3) [MIM:148820] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 73 | S | 0.236832 | L | 0.118162 | 0.11867 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 391 | Q | 0.770815 | H | 0.746237 | 0.024578 | No Change: Both D | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 48 | G | 0.31973 | R | 0.323097 | -0.003367 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 78 | V | 0.310151 | M | 0.366908 | -0.056757 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 90 | Y | 0.368724 | H | 0.522315 | -0.153591 | O to D | Waardenburg syndrome type 3 (WS3) [MIM:148820] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 266 | W | 0.18068 | C | 0.221264 | -0.040584 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 271 | R | 0.258123 | C | 0.126401 | 0.131722 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 271 | R | 0.258123 | H | 0.226794 | 0.031329 | No Change: Both O | Waardenburg syndrome type 1 (WS1) [MIM:193500] |
| P23760 | PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens GN=PAX3 PE=1 SV=2 | 273 | R | 0.350693 | K | 0.389161 | -0.038468 | No Change: Both O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 39 | R | 0.231352 | Q | 0.231155 | 1.97E-04 | No Change: Both O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 45 | R | 0.215108 | W | 0.084273 | 0.130835 | No Change: Both O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 129 | R | 0.41251 | W | 0.187441 | 0.225069 | No Change: Both O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 141 | R | 0.672034 | W | 0.423276 | 0.248758 | D to O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 172 | R | 0.824776 | W | 0.626187 | 0.198589 | No Change: Both D | Maturity-onset diabetes of the young type 9 (MODY9) [MIM:612225] |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 191 | R | 0.60317 | C | 0.454028 | 0.149142 | D to O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 200 | R | 0.513288 | H | 0.452876 | 0.060412 | D to O | - |
| O43316 | PAX4_HUMAN Paired box protein Pax-4 OS=Homo sapiens GN=PAX4 PE=1 SV=1 | 200 | R | 0.513288 | S | 0.551804 | -0.038516 | No Change: Both D | - |
| Q02548 | PAX5_HUMAN Paired box protein Pax-5 OS=Homo sapiens GN=PAX5 PE=1 SV=1 | 322 | A | 0.867787 | T | 0.889969 | -0.022182 | No Change: Both D | - |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 17 | N | 0.379128 | S | 0.440299 | -0.061171 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 18 | G | 0.410522 | W | 0.183791 | 0.226731 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 26 | R | 0.466307 | G | 0.466874 | -5.67E-04 | No Change: Both O | Peters anomaly (PAN) [MIM:604229] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 29 | I | 0.428354 | V | 0.475435 | -0.047081 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 44 | R | 0.212091 | Q | 0.218393 | -0.006302 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 87 | I | 0.344217 | R | 0.520136 | -0.175919 | O to D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 128 | R | 0.377439 | C | 0.214942 | 0.162497 | No Change: Both O | Foveal hypoplasia (FOVHYP) [MIM:136520] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 178 | Q | 0.946349 | H | 0.914167 | 0.032182 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 208 | R | 0.877 | W | 0.715458 | 0.161542 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 29 | I | 0.428354 | S | 0.616241 | -0.187887 | O to D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 33 | A | 0.328233 | P | 0.419992 | -0.091759 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 42 | I | 0.26586 | S | 0.476849 | -0.210989 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 43 | S | 0.23552 | P | 0.217497 | 0.018023 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 53 | V | 0.232922 | L | 0.238253 | -0.005331 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 53 | V | 0.232922 | D | 0.342286 | -0.109364 | No Change: Both O | Peters anomaly (PAN) [MIM:604229] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 63 | T | 0.375154 | P | 0.463733 | -0.088579 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 64 | G | 0.392865 | V | 0.27133 | 0.121535 | No Change: Both O | Foveal hypoplasia (FOVHYP) [MIM:136520] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 79 | A | 0.476736 | E | 0.578358 | -0.101622 | O to D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 119 | S | 0.433508 | R | 0.367272 | 0.066236 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 126 | V | 0.374753 | D | 0.543485 | -0.168732 | O to D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 208 | R | 0.877 | Q | 0.883623 | -0.006623 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 353 | S | 0.970821 | A | 0.949501 | 0.02132 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 422 | Q | 0.853704 | R | 0.842462 | 0.011242 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 118 | P | 0.421929 | R | 0.408264 | 0.013665 | No Change: Both O | - |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 375 | P | 0.960475 | Q | 0.95405 | 0.006425 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 68 | P | 0.481105 | S | 0.51362 | -0.032515 | O to D | - |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 125 | R | 0.373103 | C | 0.2233 | 0.149803 | No Change: Both O | Foveal hypoplasia (FOVHYP) [MIM:136520] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 258 | F | 0.439443 | S | 0.609875 | -0.170432 | O to D | Coloboma of iris choroid and retina (COI) [MIM:120200] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 292 | S | 0.909062 | I | 0.804434 | 0.104628 | No Change: Both D | Bilateral optic nerve hypoplasia (BONH) [MIM:165550] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 363 | S | 0.970763 | P | 0.972065 | -0.001302 | No Change: Both D | Peters anomaly (PAN) [MIM:604229] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 378 | Q | 0.959343 | R | 0.954951 | 0.004392 | No Change: Both D | - |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 381 | M | 0.958761 | V | 0.93825 | 0.020511 | No Change: Both D | Bilateral optic nerve hypoplasia (BONH) [MIM:165550] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 391 | T | 0.931142 | A | 0.89416 | 0.036982 | No Change: Both D | Bilateral optic nerve hypoplasia (BONH) [MIM:165550] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 19 | R | 0.443173 | P | 0.492567 | -0.049394 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 46 | L | 0.227365 | R | 0.355415 | -0.12805 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 52 | C | 0.249249 | R | 0.370739 | -0.12149 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 56 | I | 0.238026 | T | 0.344167 | -0.106141 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 73 | G | 0.575416 | D | 0.581293 | -0.005877 | No Change: Both D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 87 | I | 0.344217 | K | 0.574503 | -0.230286 | O to D | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 242 | R | 0.357501 | T | 0.299888 | 0.057613 | No Change: Both O | Aniridia (AN) [MIM:106210] |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 321 | A | 0.890389 | T | 0.91822 | -0.027831 | No Change: Both D | - |
| P26367 | PAX6_HUMAN Paired box protein Pax-6 OS=Homo sapiens GN=PAX6 PE=1 SV=2 | 387 | G | 0.948022 | D | 0.948007 | 1.50E-05 | No Change: Both D | - |
| Q06710 | PAX8_HUMAN Paired box protein Pax-8 OS=Homo sapiens GN=PAX8 PE=1 SV=2 | 31 | R | 0.296789 | H | 0.261459 | 0.03533 | No Change: Both O | Congenital hypothyroidism non-goitrous type 2 (CHNG2) [MIM:218700] |
| Q06710 | PAX8_HUMAN Paired box protein Pax-8 OS=Homo sapiens GN=PAX8 PE=1 SV=2 | 40 | Q | 0.229017 | P | 0.254589 | -0.025572 | No Change: Both O | Congenital hypothyroidism non-goitrous type 2 (CHNG2) [MIM:218700] |
| Q06710 | PAX8_HUMAN Paired box protein Pax-8 OS=Homo sapiens GN=PAX8 PE=1 SV=2 | 57 | C | 0.272474 | Y | 0.278564 | -0.00609 | No Change: Both O | Congenital hypothyroidism non-goitrous type 2 (CHNG2) [MIM:218700] |
| Q06710 | PAX8_HUMAN Paired box protein Pax-8 OS=Homo sapiens GN=PAX8 PE=1 SV=2 | 62 | L | 0.248327 | R | 0.399372 | -0.151045 | No Change: Both O | Congenital hypothyroidism non-goitrous type 2 (CHNG2) [MIM:218700] |
| Q06710 | PAX8_HUMAN Paired box protein Pax-8 OS=Homo sapiens GN=PAX8 PE=1 SV=2 | 329 | F | 0.836447 | L | 0.846858 | -0.010411 | No Change: Both D | - |
| P55771 | PAX9_HUMAN Paired box protein Pax-9 OS=Homo sapiens GN=PAX9 PE=1 SV=3 | 51 | G | 0.215627 | S | 0.278794 | -0.063167 | No Change: Both O | Tooth agenesis selective type 3 (STHAG3) [MIM:604625] |
| P55771 | PAX9_HUMAN Paired box protein Pax-9 OS=Homo sapiens GN=PAX9 PE=1 SV=3 | 240 | A | 0.568377 | P | 0.657033 | -0.088656 | No Change: Both D | - |
| Q6ZW49 | PAXI1_HUMAN PAX-interacting protein 1 OS=Homo sapiens GN=PAXIP1 PE=1 SV=2 | 1013 | M | 0.656358 | V | 0.605882 | 0.050476 | No Change: Both D | - |
| Q96KB5 | TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens GN=PBK PE=1 SV=3 | 107 | N | 0.292128 | S | 0.344764 | -0.052636 | No Change: Both O | - |
| Q96KB5 | TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens GN=PBK PE=1 SV=3 | 241 | M | 0.175978 | L | 0.138615 | 0.037363 | No Change: Both O | - |
| Q96KB5 | TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens GN=PBK PE=1 SV=3 | 220 | E | 0.472927 | D | 0.440849 | 0.032078 | No Change: Both O | - |
| P30039 | PBLD_HUMAN Phenazine biosynthesis-like domain-containing protein OS=Homo sapiens GN=PBLD PE=1 SV=2 | 17 | R | 0.24103 | C | 0.134498 | 0.106532 | No Change: Both O | - |
| P30039 | PBLD_HUMAN Phenazine biosynthesis-like domain-containing protein OS=Homo sapiens GN=PBLD PE=1 SV=2 | 257 | H | 0.390109 | R | 0.396636 | -0.006527 | No Change: Both O | - |
| Q9GZY1 | PBOV1_HUMAN Prostate and breast cancer overexpressed gene 1 protein OS=Homo sapiens GN=PBOV1 PE=2 SV=1 | 73 | I | 0.439887 | T | 0.560001 | -0.120114 | O to D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 49 | V | 0.218807 | L | 0.241778 | -0.022971 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 56 | T | 0.248069 | A | 0.228813 | 0.019256 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 66 | R | 0.203042 | G | 0.201661 | 0.001381 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 90 | Q | 0.261013 | E | 0.298772 | -0.037759 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 144 | Y | 0.247859 | F | 0.257396 | -0.009537 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 160 | E | 0.819191 | A | 0.777951 | 0.04124 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 202 | R | 0.279246 | C | 0.158996 | 0.12025 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 206 | E | 0.302899 | K | 0.320554 | -0.017655 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 226 | E | 0.198322 | G | 0.163925 | 0.034397 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 228 | I | 0.20552 | V | 0.19959 | 0.00593 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 232 | T | 0.227483 | P | 0.296181 | -0.068698 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 233 | I | 0.235603 | T | 0.35532 | -0.119717 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 256 | A | 0.346079 | T | 0.363051 | -0.016972 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 340 | G | 0.600218 | A | 0.581156 | 0.019062 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 523 | M | 0.655831 | I | 0.575732 | 0.080099 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 540 | R | 0.411492 | S | 0.440809 | -0.029317 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 597 | A | 0.431676 | D | 0.522318 | -0.090642 | O to D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 621 | K | 0.75811 | E | 0.761512 | -0.003402 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 661 | K | 0.677212 | N | 0.634815 | 0.042397 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 674 | D | 0.478469 | E | 0.522148 | -0.043679 | O to D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 678 | R | 0.420266 | C | 0.291326 | 0.12894 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 893 | Y | 0.505464 | C | 0.55509 | -0.049626 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 895 | T | 0.56404 | S | 0.611154 | -0.047114 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 922 | E | 0.987727 | Q | 0.983268 | 0.004459 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 925 | K | 0.979147 | Q | 0.975518 | 0.003629 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1079 | P | 0.208352 | Y | 0.092317 | 0.116035 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1098 | A | 0.436306 | S | 0.531625 | -0.095319 | O to D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1120 | R | 0.916868 | Q | 0.916951 | -8.30E-05 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1177 | G | 0.230175 | S | 0.272127 | -0.041952 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1204 | H | 0.721527 | P | 0.719447 | 0.00208 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1287 | E | 0.403578 | Q | 0.37803 | 0.025548 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1414 | G | 0.325724 | E | 0.401792 | -0.076068 | No Change: Both O | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1503 | G | 0.970559 | C | 0.952042 | 0.018517 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1560 | Q | 0.982879 | H | 0.974498 | 0.008381 | No Change: Both D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1614 | I | 0.411271 | N | 0.559145 | -0.147874 | O to D | - |
| Q86U86 | PB1_HUMAN Protein polybromo-1 OS=Homo sapiens GN=PBRM1 PE=1 SV=1 | 1647 | R | 0.683866 | C | 0.558709 | 0.125157 | No Change: Both D | - |
| Q9BYU1 | PBX4_HUMAN Pre-B-cell leukemia transcription factor 4 OS=Homo sapiens GN=PBX4 PE=2 SV=2 | 283 | T | 0.370654 | M | 0.319196 | 0.051458 | No Change: Both O | A colorectal cancer sample |
| Q9BYU1 | PBX4_HUMAN Pre-B-cell leukemia transcription factor 4 OS=Homo sapiens GN=PBX4 PE=2 SV=2 | 169 | V | 0.613127 | I | 0.606912 | 0.006215 | No Change: Both D | - |
| Q9BYU1 | PBX4_HUMAN Pre-B-cell leukemia transcription factor 4 OS=Homo sapiens GN=PBX4 PE=2 SV=2 | 177 | M | 0.466568 | V | 0.384718 | 0.08185 | No Change: Both O | - |
| Q96AQ6 | PBIP1_HUMAN Pre-B-cell leukemia transcription factor-interacting protein 1 OS=Homo sapiens GN=PBXIP1 PE=1 SV=1 | 357 | G | 0.896408 | D | 0.900834 | -0.004426 | No Change: Both D | - |
| Q96AQ6 | PBIP1_HUMAN Pre-B-cell leukemia transcription factor-interacting protein 1 OS=Homo sapiens GN=PBXIP1 PE=1 SV=1 | 356 | G | 0.892793 | D | 0.897363 | -0.00457 | No Change: Both D | - |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 610 | A | 0.167646 | T | 0.187955 | -0.020309 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 743 | M | 0.146813 | I | 0.105591 | 0.041222 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 145 | V | 0.458742 | A | 0.520636 | -0.061894 | O to D | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 451 | R | 0.224358 | C | 0.104489 | 0.119869 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 76 | H | 0.668222 | L | 0.536451 | 0.131771 | No Change: Both D | - |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 156 | R | 0.311836 | Q | 0.315271 | -0.003435 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 270 | R | 0.33108 | W | 0.153109 | 0.177971 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 304 | Y | 0.321035 | C | 0.276139 | 0.044896 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 583 | R | 0.300846 | L | 0.201106 | 0.09974 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P11498 | PYC_HUMAN Pyruvate carboxylase mitochondrial OS=Homo sapiens GN=PC PE=1 SV=2 | 631 | R | 0.228238 | Q | 0.242415 | -0.014177 | No Change: Both O | Pyruvate carboxylase deficiency (PC deficiency) [MIM:266150] |
| P61457 | PHS_HUMAN Pterin-4-alpha-carbinolamine dehydratase OS=Homo sapiens GN=PCBD1 PE=1 SV=2 | 79 | T | 0.311876 | I | 0.190231 | 0.121645 | No Change: Both O | - |
| P61457 | PHS_HUMAN Pterin-4-alpha-carbinolamine dehydratase OS=Homo sapiens GN=PCBD1 PE=1 SV=2 | 82 | C | 0.383 | R | 0.58333 | -0.20033 | O to D | BH4-deficient hyperphenylalaninemia type D (HPABH4D) [MIM:264070] |
| P61457 | PHS_HUMAN Pterin-4-alpha-carbinolamine dehydratase OS=Homo sapiens GN=PCBD1 PE=1 SV=2 | 88 | R | 0.353768 | Q | 0.373055 | -0.019287 | No Change: Both O | BH4-deficient hyperphenylalaninemia type D (HPABH4D) [MIM:264070] |
| P61457 | PHS_HUMAN Pterin-4-alpha-carbinolamine dehydratase OS=Homo sapiens GN=PCBD1 PE=1 SV=2 | 97 | E | 0.218469 | K | 0.216271 | 0.002198 | No Change: Both O | BH4-deficient hyperphenylalaninemia type D (HPABH4D) [MIM:264070] |
| P57723 | PCBP4_HUMAN Poly(rC)-binding protein 4 OS=Homo sapiens GN=PCBP4 PE=2 SV=1 | 198 | G | 0.373347 | S | 0.434314 | -0.060967 | No Change: Both O | - |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 75 | A | 0.115074 | P | 0.153683 | -0.038609 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 77 | R | 0.105141 | W | 0.034891 | 0.07025 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 138 | A | 0.301091 | T | 0.325103 | -0.024012 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 164 | I | 0.155726 | T | 0.258253 | -0.102527 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 229 | M | 0.504817 | K | 0.598955 | -0.094138 | No Change: Both D | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 297 | Q | 0.48329 | R | 0.477665 | 0.005625 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 368 | D | 0.098055 | G | 0.0929 | 0.005155 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 373 | M | 0.135045 | K | 0.236921 | -0.101876 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 379 | G | 0.298222 | V | 0.19399 | 0.104232 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 399 | R | 0.094962 | Q | 0.101758 | -0.006796 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 423 | P | 0.432029 | L | 0.269822 | 0.162207 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 475 | I | 0.116351 | V | 0.140008 | -0.023657 | No Change: Both O | - |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 559 | W | 0.185342 | L | 0.268766 | -0.083424 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 631 | G | 0.087539 | R | 0.085395 | 0.002144 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 668 | G | 0.372228 | R | 0.392945 | -0.020717 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 197 | G | 0.28035 | E | 0.333261 | -0.052911 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 398 | C | 0.07706 | R | 0.16538 | -0.08832 | No Change: Both O | Propionic acidemia type I (PA-1) [MIM:606054] |
| P05165 | PCCA_HUMAN Propionyl-CoA carboxylase alpha chain mitochondrial OS=Homo sapiens GN=PCCA PE=1 SV=4 | 551 | V | 0.304251 | F | 0.282284 | 0.021967 | No Change: Both O | - |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 44 | R | 0.642531 | P | 0.605507 | 0.037024 | No Change: Both D | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 106 | S | 0.418065 | R | 0.380463 | 0.037602 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 131 | G | 0.373553 | R | 0.33672 | 0.036833 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 165 | R | 0.494114 | W | 0.277599 | 0.216515 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 168 | E | 0.498758 | K | 0.478359 | 0.020399 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 198 | G | 0.129121 | D | 0.132653 | -0.003532 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 410 | R | 0.165055 | W | 0.06735 | 0.097705 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 497 | A | 0.172967 | V | 0.124877 | 0.04809 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 512 | R | 0.253513 | C | 0.147253 | 0.10626 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 519 | L | 0.154781 | P | 0.303893 | -0.149112 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 17 | L | 0.525221 | M | 0.589737 | -0.064516 | No Change: Both D | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 205 | V | 0.213721 | D | 0.380037 | -0.166316 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 228 | P | 0.214067 | L | 0.123789 | 0.090278 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 428 | T | 0.213382 | I | 0.118854 | 0.094528 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 442 | M | 0.396397 | T | 0.452105 | -0.055708 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 536 | N | 0.556224 | D | 0.593633 | -0.037409 | No Change: Both D | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 67 | R | 0.466941 | S | 0.498396 | -0.031455 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 107 | V | 0.39678 | M | 0.440721 | -0.043941 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 112 | G | 0.333877 | D | 0.348592 | -0.014715 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 153 | A | 0.140716 | P | 0.194414 | -0.053698 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 165 | R | 0.494114 | Q | 0.530793 | -0.036679 | O to D | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 188 | G | 0.157802 | R | 0.157119 | 6.83E-04 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 246 | G | 0.648505 | V | 0.524528 | 0.123977 | No Change: Both D | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 430 | I | 0.202351 | L | 0.225903 | -0.023552 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 435 | Y | 0.257913 | C | 0.200719 | 0.057194 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 439 | Y | 0.384828 | C | 0.313575 | 0.071253 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 468 | A | 0.202559 | T | 0.209607 | -0.007048 | No Change: Both O | Propionic acidemia type II (PA-2) [MIM:606054] |
| P05166 | PCCB_HUMAN Propionyl-CoA carboxylase beta chain mitochondrial OS=Homo sapiens GN=PCCB PE=1 SV=3 | 287 | P | 0.648097 | S | 0.660944 | -0.012847 | No Change: Both D | - |
| Q08174 | PCDH1_HUMAN Protocadherin-1 OS=Homo sapiens GN=PCDH1 PE=1 SV=2 | 15 | L | 0.847799 | F | 0.779584 | 0.068215 | No Change: Both D | - |
| Q08174 | PCDH1_HUMAN Protocadherin-1 OS=Homo sapiens GN=PCDH1 PE=1 SV=2 | 25 | H | 0.893512 | P | 0.93061 | -0.037098 | No Change: Both D | - |
| Q08174 | PCDH1_HUMAN Protocadherin-1 OS=Homo sapiens GN=PCDH1 PE=1 SV=2 | 514 | A | 0.550448 | T | 0.589824 | -0.039376 | No Change: Both D | - |
| Q9BZA7 | PC11X_HUMAN Protocadherin-11 X-linked OS=Homo sapiens GN=PCDH11X PE=2 SV=1 | 42 | D | 0.173622 | G | 0.155127 | 0.018495 | No Change: Both O | A colorectal cancer sample |
| Q9BZA7 | PC11X_HUMAN Protocadherin-11 X-linked OS=Homo sapiens GN=PCDH11X PE=2 SV=1 | 1018 | R | 0.813077 | Q | 0.810723 | 0.002354 | No Change: Both D | - |
| Q9BZA8 | PC11Y_HUMAN Protocadherin-11 Y-linked OS=Homo sapiens GN=PCDH11Y PE=1 SV=1 | 917 | V | 0.726732 | F | 0.677395 | 0.049337 | No Change: Both D | - |
| Q9BZA8 | PC11Y_HUMAN Protocadherin-11 Y-linked OS=Homo sapiens GN=PCDH11Y PE=1 SV=1 | 1012 | N | 0.708798 | K | 0.726279 | -0.017481 | No Change: Both D | - |
| Q9BZA8 | PC11Y_HUMAN Protocadherin-11 Y-linked OS=Homo sapiens GN=PCDH11Y PE=1 SV=1 | 1320 | A | 0.736466 | T | 0.783529 | -0.047063 | No Change: Both D | - |
| Q9NPG4 | PCD12_HUMAN Protocadherin-12 OS=Homo sapiens GN=PCDH12 PE=2 SV=1 | 385 | H | 0.391833 | N | 0.408732 | -0.016899 | No Change: Both O | - |
| Q9NPG4 | PCD12_HUMAN Protocadherin-12 OS=Homo sapiens GN=PCDH12 PE=2 SV=1 | 640 | S | 0.369502 | N | 0.335742 | 0.03376 | No Change: Both O | - |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 134 | R | 0.116703 | G | 0.113326 | 0.003377 | No Change: Both O | Deafness autosomal recessive type 23 (DFNB23) [MIM:609533] |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 262 | G | 0.391217 | D | 0.461298 | -0.070081 | No Change: Both O | Deafness autosomal recessive type 23 (DFNB23) [MIM:609533] |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 1342 | Q | 0.276551 | K | 0.334649 | -0.058098 | No Change: Both O | Usher syndrome type 1F (USH1F) [MIM:602083] |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 19 | S | 0.05982 | A | 0.034798 | 0.025022 | No Change: Both O | - |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 380 | G | 0.156514 | S | 0.190316 | -0.033802 | No Change: Both O | - |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 435 | D | 0.601493 | A | 0.520633 | 0.08086 | No Change: Both D | - |
| Q96QU1 | PCD15_HUMAN Protocadherin-15 OS=Homo sapiens GN=PCDH15 PE=1 SV=2 | 929 | R | 0.287554 | Q | 0.299867 | -0.012313 | No Change: Both O | - |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 441 | V | 0.211293 | E | 0.390515 | -0.179222 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 557 | N | 0.186304 | K | 0.204046 | -0.017742 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 121 | D | 0.454755 | N | 0.445583 | 0.009172 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 199 | E | 0.566061 | Q | 0.544625 | 0.021436 | No Change: Both D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 203 | H | 0.425059 | P | 0.494289 | -0.06923 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 206 | F | 0.344175 | C | 0.355781 | -0.011606 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 276 | S | 0.159218 | P | 0.158418 | 8.00E-04 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 340 | N | 0.461054 | S | 0.500338 | -0.039284 | O to D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 377 | D | 0.535699 | H | 0.492499 | 0.0432 | D to O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 404 | T | 0.234718 | I | 0.158145 | 0.076573 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 414 | E | 0.533052 | Q | 0.509544 | 0.023508 | No Change: Both D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 543 | L | 0.479757 | P | 0.618735 | -0.138978 | O to D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 958 | R | 0.654211 | Q | 0.648102 | 0.006109 | No Change: Both D | - |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 1107 | R | 0.825041 | G | 0.806656 | 0.018385 | No Change: Both D | - |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 81 | L | 0.40335 | R | 0.528229 | -0.124879 | O to D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 146 | T | 0.576383 | R | 0.61284 | -0.036457 | No Change: Both D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 206 | F | 0.344175 | Y | 0.366995 | -0.02282 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 249 | E | 0.752742 | D | 0.743901 | 0.008841 | No Change: Both D | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 341 | D | 0.456975 | E | 0.470336 | -0.013361 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 561 | P | 0.262889 | R | 0.207213 | 0.055676 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 567 | P | 0.239217 | L | 0.124228 | 0.114989 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8TAB3 | PCD19_HUMAN Protocadherin-19 OS=Homo sapiens GN=PCDH19 PE=1 SV=3 | 618 | D | 0.402561 | N | 0.379817 | 0.022744 | No Change: Both O | Epileptic encephalopathy early infantile type 9 (EIEE9) [MIM:300088] |
| Q8N6Y1 | PCD20_HUMAN Protocadherin-20 OS=Homo sapiens GN=PCDH20 PE=2 SV=1 | 496 | V | 0.184948 | M | 0.216617 | -0.031669 | No Change: Both O | A breast cancer sample |
| O95206 | PCDH8_HUMAN Protocadherin-8 OS=Homo sapiens GN=PCDH8 PE=2 SV=2 | 7 | W | 0.354279 | R | 0.572642 | -0.218363 | O to D | - |
| O95206 | PCDH8_HUMAN Protocadherin-8 OS=Homo sapiens GN=PCDH8 PE=2 SV=2 | 39 | E | 0.471029 | A | 0.36441 | 0.106619 | No Change: Both O | - |
| O95206 | PCDH8_HUMAN Protocadherin-8 OS=Homo sapiens GN=PCDH8 PE=2 SV=2 | 743 | V | 0.34153 | A | 0.400148 | -0.058618 | No Change: Both O | - |
| O95206 | PCDH8_HUMAN Protocadherin-8 OS=Homo sapiens GN=PCDH8 PE=2 SV=2 | 956 | K | 0.520097 | N | 0.500004 | 0.020093 | No Change: Both D | A breast cancer sample |
| O95206 | PCDH8_HUMAN Protocadherin-8 OS=Homo sapiens GN=PCDH8 PE=2 SV=2 | 367 | T | 0.794682 | A | 0.80976 | -0.015078 | No Change: Both D | - |
| Q9Y5I3 | PCDA1_HUMAN Protocadherin alpha-1 OS=Homo sapiens GN=PCDHA1 PE=2 SV=1 | 449 | N | 0.433738 | H | 0.398088 | 0.03565 | No Change: Both O | - |
| Q9Y5I3 | PCDA1_HUMAN Protocadherin alpha-1 OS=Homo sapiens GN=PCDHA1 PE=2 SV=1 | 732 | Y | 0.469618 | C | 0.47384 | -0.004222 | No Change: Both O | - |
| Q9Y5I3 | PCDA1_HUMAN Protocadherin alpha-1 OS=Homo sapiens GN=PCDHA1 PE=2 SV=1 | 360 | R | 0.288125 | G | 0.29685 | -0.008725 | No Change: Both O | - |
| Q9Y5I3 | PCDA1_HUMAN Protocadherin alpha-1 OS=Homo sapiens GN=PCDHA1 PE=2 SV=1 | 759 | C | 0.890284 | F | 0.862552 | 0.027732 | No Change: Both D | - |
| Q9Y5I2 | PCDAA_HUMAN Protocadherin alpha-10 OS=Homo sapiens GN=PCDHA10 PE=2 SV=1 | 439 | S | 0.304225 | R | 0.248896 | 0.055329 | No Change: Both O | - |
| Q9Y5I2 | PCDAA_HUMAN Protocadherin alpha-10 OS=Homo sapiens GN=PCDHA10 PE=2 SV=1 | 585 | V | 0.195619 | G | 0.283908 | -0.088289 | No Change: Both O | - |
| Q9Y5I2 | PCDAA_HUMAN Protocadherin alpha-10 OS=Homo sapiens GN=PCDHA10 PE=2 SV=1 | 639 | T | 0.636589 | A | 0.615005 | 0.021584 | No Change: Both D | - |
| Q9Y5I1 | PCDAB_HUMAN Protocadherin alpha-11 OS=Homo sapiens GN=PCDHA11 PE=2 SV=1 | 199 | S | 0.691695 | Y | 0.490622 | 0.201073 | D to O | - |
| Q9Y5I1 | PCDAB_HUMAN Protocadherin alpha-11 OS=Homo sapiens GN=PCDHA11 PE=2 SV=1 | 418 | W | 0.109566 | S | 0.306517 | -0.196951 | No Change: Both O | - |
| Q9Y5H9 | PCDA2_HUMAN Protocadherin alpha-2 OS=Homo sapiens GN=PCDHA2 PE=1 SV=1 | 106 | V | 0.161917 | L | 0.150477 | 0.01144 | No Change: Both O | - |
| Q9Y5H9 | PCDA2_HUMAN Protocadherin alpha-2 OS=Homo sapiens GN=PCDHA2 PE=1 SV=1 | 764 | P | 0.884209 | L | 0.811445 | 0.072764 | No Change: Both D | - |
| Q9Y5H9 | PCDA2_HUMAN Protocadherin alpha-2 OS=Homo sapiens GN=PCDHA2 PE=1 SV=1 | 25 | E | 0.159096 | K | 0.157952 | 0.001144 | No Change: Both O | - |
| Q9Y5H8 | PCDA3_HUMAN Protocadherin alpha-3 OS=Homo sapiens GN=PCDHA3 PE=2 SV=1 | 318 | I | 0.498694 | V | 0.539755 | -0.041061 | O to D | - |
| Q9Y5H8 | PCDA3_HUMAN Protocadherin alpha-3 OS=Homo sapiens GN=PCDHA3 PE=2 SV=1 | 759 | C | 0.7914 | Y | 0.733467 | 0.057933 | No Change: Both D | - |
| Q9Y5H8 | PCDA3_HUMAN Protocadherin alpha-3 OS=Homo sapiens GN=PCDHA3 PE=2 SV=1 | 289 | I | 0.338186 | T | 0.483863 | -0.145677 | No Change: Both O | - |
| Q9Y5H8 | PCDA3_HUMAN Protocadherin alpha-3 OS=Homo sapiens GN=PCDHA3 PE=2 SV=1 | 440 | S | 0.379446 | I | 0.166947 | 0.212499 | No Change: Both O | - |
| Q9Y5H8 | PCDA3_HUMAN Protocadherin alpha-3 OS=Homo sapiens GN=PCDHA3 PE=2 SV=1 | 61 | P | 0.141799 | Q | 0.133623 | 0.008176 | No Change: Both O | - |
| Q9UN74 | PCDA4_HUMAN Protocadherin alpha-4 OS=Homo sapiens GN=PCDHA4 PE=2 SV=1 | 184 | P | 0.59941 | S | 0.613005 | -0.013595 | No Change: Both D | - |
| Q9UN74 | PCDA4_HUMAN Protocadherin alpha-4 OS=Homo sapiens GN=PCDHA4 PE=2 SV=1 | 55 | E | 0.192527 | D | 0.173519 | 0.019008 | No Change: Both O | - |
| Q9Y5H7 | PCDA5_HUMAN Protocadherin alpha-5 OS=Homo sapiens GN=PCDHA5 PE=2 SV=1 | 691 | A | 0.223186 | V | 0.170305 | 0.052881 | No Change: Both O | - |
| Q9UN73 | PCDA6_HUMAN Protocadherin alpha-6 OS=Homo sapiens GN=PCDHA6 PE=2 SV=1 | 585 | L | 0.351971 | V | 0.365762 | -0.013791 | No Change: Both O | - |
| Q9UN72 | PCDA7_HUMAN Protocadherin alpha-7 OS=Homo sapiens GN=PCDHA7 PE=2 SV=1 | 138 | R | 0.289565 | K | 0.319173 | -0.029608 | No Change: Both O | - |
| Q9UN72 | PCDA7_HUMAN Protocadherin alpha-7 OS=Homo sapiens GN=PCDHA7 PE=2 SV=1 | 663 | A | 0.507403 | G | 0.528688 | -0.021285 | No Change: Both D | - |
| Q9Y5H6 | PCDA8_HUMAN Protocadherin alpha-8 OS=Homo sapiens GN=PCDHA8 PE=2 SV=1 | 78 | S | 0.236233 | N | 0.211022 | 0.025211 | No Change: Both O | - |
| Q9Y5H6 | PCDA8_HUMAN Protocadherin alpha-8 OS=Homo sapiens GN=PCDHA8 PE=2 SV=1 | 403 | N | 0.157998 | T | 0.148927 | 0.009071 | No Change: Both O | - |
| Q9Y5H6 | PCDA8_HUMAN Protocadherin alpha-8 OS=Homo sapiens GN=PCDHA8 PE=2 SV=1 | 269 | P | 0.577549 | R | 0.558972 | 0.018577 | No Change: Both D | - |
| Q9Y5H6 | PCDA8_HUMAN Protocadherin alpha-8 OS=Homo sapiens GN=PCDHA8 PE=2 SV=1 | 579 | K | 0.557398 | E | 0.559629 | -0.002231 | No Change: Both D | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 28 | S | 0.174823 | R | 0.129082 | 0.045741 | No Change: Both O | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 138 | K | 0.318622 | R | 0.288872 | 0.02975 | No Change: Both O | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 336 | L | 0.096908 | V | 0.101191 | -0.004283 | No Change: Both O | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 430 | G | 0.433232 | R | 0.430758 | 0.002474 | No Change: Both O | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 764 | K | 0.833081 | T | 0.815636 | 0.017445 | No Change: Both D | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 764 | K | 0.833081 | Q | 0.844478 | -0.011397 | No Change: Both D | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 64 | F | 0.247043 | L | 0.298466 | -0.051423 | No Change: Both O | - |
| Q9Y5H5 | PCDA9_HUMAN Protocadherin alpha-9 OS=Homo sapiens GN=PCDHA9 PE=2 SV=1 | 501 | E | 0.626923 | Q | 0.573361 | 0.053562 | No Change: Both D | - |
| Q9H158 | PCDC1_HUMAN Protocadherin alpha-C1 OS=Homo sapiens GN=PCDHAC1 PE=2 SV=2 | 498 | L | 0.663452 | V | 0.661763 | 0.001689 | No Change: Both D | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 385 | F | 0.139483 | L | 0.157387 | -0.017904 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 390 | L | 0.113592 | F | 0.106609 | 0.006983 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 524 | A | 0.16517 | V | 0.120447 | 0.044723 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 611 | T | 0.201083 | I | 0.115214 | 0.085869 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 712 | I | 0.015564 | T | 0.026921 | -0.011357 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 719 | K | 0.252075 | I | 0.103843 | 0.148232 | No Change: Both O | - |
| Q9Y5F3 | PCDB1_HUMAN Protocadherin beta-1 OS=Homo sapiens GN=PCDHB1 PE=2 SV=2 | 778 | F | 0.728327 | L | 0.719715 | 0.008612 | No Change: Both D | - |
| Q9Y5F2 | PCDBB_HUMAN Protocadherin beta-11 OS=Homo sapiens GN=PCDHB11 PE=2 SV=1 | 4 | Q | 0.760102 | R | 0.756494 | 0.003608 | No Change: Both D | - |
| Q9Y5F2 | PCDBB_HUMAN Protocadherin beta-11 OS=Homo sapiens GN=PCDHB11 PE=2 SV=1 | 7 | R | 0.617858 | H | 0.615741 | 0.002117 | No Change: Both D | - |
| Q9Y5F2 | PCDBB_HUMAN Protocadherin beta-11 OS=Homo sapiens GN=PCDHB11 PE=2 SV=1 | 528 | D | 0.173722 | E | 0.184364 | -0.010642 | No Change: Both O | - |
| Q9Y5F1 | PCDBC_HUMAN Protocadherin beta-12 OS=Homo sapiens GN=PCDHB12 PE=2 SV=1 | 420 | T | 0.249889 | I | 0.146365 | 0.103524 | No Change: Both O | - |
| Q9Y5F1 | PCDBC_HUMAN Protocadherin beta-12 OS=Homo sapiens GN=PCDHB12 PE=2 SV=1 | 763 | K | 0.465895 | E | 0.456095 | 0.0098 | No Change: Both O | - |
| Q9Y5F0 | PCDBD_HUMAN Protocadherin beta-13 OS=Homo sapiens GN=PCDHB13 PE=2 SV=1 | 471 | R | 0.493099 | G | 0.46778 | 0.025319 | No Change: Both O | - |
| Q9Y5E8 | PCDBF_HUMAN Protocadherin beta-15 OS=Homo sapiens GN=PCDHB15 PE=1 SV=1 | 474 | S | 0.558708 | R | 0.506149 | 0.052559 | No Change: Both D | - |
| Q9Y5E8 | PCDBF_HUMAN Protocadherin beta-15 OS=Homo sapiens GN=PCDHB15 PE=1 SV=1 | 494 | R | 0.55553 | Q | 0.575956 | -0.020426 | No Change: Both D | - |
| Q9Y5E8 | PCDBF_HUMAN Protocadherin beta-15 OS=Homo sapiens GN=PCDHB15 PE=1 SV=1 | 719 | A | 0.451419 | V | 0.376656 | 0.074763 | No Change: Both O | A breast cancer sample |
| Q9Y5E8 | PCDBF_HUMAN Protocadherin beta-15 OS=Homo sapiens GN=PCDHB15 PE=1 SV=1 | 758 | G | 0.420088 | V | 0.315482 | 0.104606 | No Change: Both O | A breast cancer sample |
| Q9NRJ7 | PCDBG_HUMAN Protocadherin beta-16 OS=Homo sapiens GN=PCDHB16 PE=1 SV=3 | 525 | R | 0.326609 | Q | 0.304633 | 0.021976 | No Change: Both O | - |
| Q9NRJ7 | PCDBG_HUMAN Protocadherin beta-16 OS=Homo sapiens GN=PCDHB16 PE=1 SV=3 | 532 | S | 0.43001 | G | 0.366113 | 0.063897 | No Change: Both O | - |
| Q9NRJ7 | PCDBG_HUMAN Protocadherin beta-16 OS=Homo sapiens GN=PCDHB16 PE=1 SV=3 | 91 | D | 0.443946 | E | 0.497876 | -0.05393 | No Change: Both O | - |
| Q9NRJ7 | PCDBG_HUMAN Protocadherin beta-16 OS=Homo sapiens GN=PCDHB16 PE=1 SV=3 | 347 | V | 0.53879 | L | 0.540782 | -0.001992 | No Change: Both D | - |
| Q9NRJ7 | PCDBG_HUMAN Protocadherin beta-16 OS=Homo sapiens GN=PCDHB16 PE=1 SV=3 | 508 | A | 0.313918 | T | 0.321549 | -0.007631 | No Change: Both O | - |
| Q9Y5E7 | PCDB2_HUMAN Protocadherin beta-2 OS=Homo sapiens GN=PCDHB2 PE=1 SV=1 | 128 | V | 0.335553 | I | 0.312944 | 0.022609 | No Change: Both O | - |
| Q9Y5E7 | PCDB2_HUMAN Protocadherin beta-2 OS=Homo sapiens GN=PCDHB2 PE=1 SV=1 | 674 | L | 0.250069 | P | 0.405761 | -0.155692 | No Change: Both O | - |
| Q9Y5E7 | PCDB2_HUMAN Protocadherin beta-2 OS=Homo sapiens GN=PCDHB2 PE=1 SV=1 | 760 | G | 0.323547 | D | 0.317221 | 0.006326 | No Change: Both O | - |
| Q9Y5E6 | PCDB3_HUMAN Protocadherin beta-3 OS=Homo sapiens GN=PCDHB3 PE=2 SV=1 | 414 | R | 0.475163 | S | 0.531329 | -0.056166 | O to D | - |
| Q9Y5E6 | PCDB3_HUMAN Protocadherin beta-3 OS=Homo sapiens GN=PCDHB3 PE=2 SV=1 | 41 | K | 0.45593 | R | 0.403259 | 0.052671 | No Change: Both O | - |
| Q9Y5E6 | PCDB3_HUMAN Protocadherin beta-3 OS=Homo sapiens GN=PCDHB3 PE=2 SV=1 | 207 | E | 0.667106 | K | 0.646862 | 0.020244 | No Change: Both D | - |
| Q9Y5E5 | PCDB4_HUMAN Protocadherin beta-4 OS=Homo sapiens GN=PCDHB4 PE=2 SV=1 | 421 | A | 0.177915 | T | 0.226286 | -0.048371 | No Change: Both O | - |
| Q9Y5E5 | PCDB4_HUMAN Protocadherin beta-4 OS=Homo sapiens GN=PCDHB4 PE=2 SV=1 | 168 | K | 0.42882 | R | 0.381543 | 0.047277 | No Change: Both O | - |
| Q9Y5E5 | PCDB4_HUMAN Protocadherin beta-4 OS=Homo sapiens GN=PCDHB4 PE=2 SV=1 | 255 | P | 0.413325 | L | 0.257398 | 0.155927 | No Change: Both O | - |
| Q9Y5E5 | PCDB4_HUMAN Protocadherin beta-4 OS=Homo sapiens GN=PCDHB4 PE=2 SV=1 | 255 | P | 0.413325 | S | 0.453659 | -0.040334 | No Change: Both O | - |
| Q9Y5E5 | PCDB4_HUMAN Protocadherin beta-4 OS=Homo sapiens GN=PCDHB4 PE=2 SV=1 | 553 | T | 0.317787 | A | 0.315968 | 0.001819 | No Change: Both O | - |
| Q9Y5E4 | PCDB5_HUMAN Protocadherin beta-5 OS=Homo sapiens GN=PCDHB5 PE=1 SV=1 | 156 | I | 0.235831 | T | 0.361236 | -0.125405 | No Change: Both O | - |
| Q9Y5E4 | PCDB5_HUMAN Protocadherin beta-5 OS=Homo sapiens GN=PCDHB5 PE=1 SV=1 | 720 | S | 0.495782 | P | 0.458777 | 0.037005 | No Change: Both O | - |
| Q9Y5E3 | PCDB6_HUMAN Protocadherin beta-6 OS=Homo sapiens GN=PCDHB6 PE=1 SV=1 | 231 | V | 0.373739 | I | 0.374615 | -8.76E-04 | No Change: Both O | - |
| Q9Y5E3 | PCDB6_HUMAN Protocadherin beta-6 OS=Homo sapiens GN=PCDHB6 PE=1 SV=1 | 232 | L | 0.349509 | F | 0.311203 | 0.038306 | No Change: Both O | - |
| Q9Y5E3 | PCDB6_HUMAN Protocadherin beta-6 OS=Homo sapiens GN=PCDHB6 PE=1 SV=1 | 636 | H | 0.298026 | Q | 0.314332 | -0.016306 | No Change: Both O | - |
| Q9Y5E3 | PCDB6_HUMAN Protocadherin beta-6 OS=Homo sapiens GN=PCDHB6 PE=1 SV=1 | 747 | Y | 0.377126 | H | 0.476124 | -0.098998 | No Change: Both O | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 389 | V | 0.218678 | L | 0.214627 | 0.004051 | No Change: Both O | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 120 | E | 0.084109 | K | 0.080542 | 0.003567 | No Change: Both O | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 187 | E | 0.466629 | K | 0.461453 | 0.005176 | No Change: Both O | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 575 | P | 0.582718 | L | 0.409841 | 0.172877 | D to O | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 576 | L | 0.564442 | V | 0.563449 | 9.93E-04 | No Change: Both D | - |
| Q9Y5E2 | PCDB7_HUMAN Protocadherin beta-7 OS=Homo sapiens GN=PCDHB7 PE=2 SV=1 | 716 | R | 0.405269 | W | 0.176732 | 0.228537 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 305 | K | 0.323509 | E | 0.325575 | -0.002066 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 322 | A | 0.392185 | V | 0.31137 | 0.080815 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 767 | F | 0.291454 | L | 0.315759 | -0.024305 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 199 | K | 0.568704 | N | 0.516582 | 0.052122 | No Change: Both D | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 244 | E | 0.378605 | Q | 0.347298 | 0.031307 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 232 | E | 0.261574 | G | 0.209111 | 0.052463 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 382 | I | 0.498263 | T | 0.603817 | -0.105554 | O to D | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 639 | Q | 0.300764 | H | 0.286273 | 0.014491 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 661 | L | 0.18297 | V | 0.16814 | 0.01483 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 745 | S | 0.428839 | N | 0.386806 | 0.042033 | No Change: Both O | - |
| Q9UN66 | PCDB8_HUMAN Protocadherin beta-8 OS=Homo sapiens GN=PCDHB8 PE=2 SV=3 | 759 | G | 0.300364 | V | 0.203559 | 0.096805 | No Change: Both O | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 174 | S | 0.391055 | P | 0.350272 | 0.040783 | No Change: Both O | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 239 | A | 0.344 | V | 0.279702 | 0.064298 | No Change: Both O | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 124 | R | 0.324601 | S | 0.379596 | -0.054995 | No Change: Both O | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 185 | S | 0.428683 | G | 0.381742 | 0.046941 | No Change: Both O | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 414 | K | 0.505693 | E | 0.529102 | -0.023409 | No Change: Both D | - |
| Q9Y5E1 | PCDB9_HUMAN Protocadherin beta-9 OS=Homo sapiens GN=PCDHB9 PE=2 SV=2 | 426 | L | 0.291142 | M | 0.335672 | -0.04453 | No Change: Both O | - |
| Q9Y5H4 | PCDG1_HUMAN Protocadherin gamma-A1 OS=Homo sapiens GN=PCDHGA1 PE=2 SV=1 | 152 | V | 0.44536 | I | 0.429499 | 0.015861 | No Change: Both O | - |
| Q9Y5H4 | PCDG1_HUMAN Protocadherin gamma-A1 OS=Homo sapiens GN=PCDHGA1 PE=2 SV=1 | 282 | H | 0.259528 | Q | 0.265242 | -0.005714 | No Change: Both O | - |
| Q9Y5H3 | PCDGA_HUMAN Protocadherin gamma-A10 OS=Homo sapiens GN=PCDHGA10 PE=2 SV=1 | 89 | I | 0.431509 | V | 0.448552 | -0.017043 | No Change: Both O | - |
| Q9Y5H3 | PCDGA_HUMAN Protocadherin gamma-A10 OS=Homo sapiens GN=PCDHGA10 PE=2 SV=1 | 796 | S | 0.760639 | P | 0.770721 | -0.010082 | No Change: Both D | - |
| Q9Y5H2 | PCDGB_HUMAN Protocadherin gamma-A11 OS=Homo sapiens GN=PCDHGA11 PE=1 SV=1 | 104 | F | 0.119228 | L | 0.15094 | -0.031712 | No Change: Both O | - |
| Q9Y5H1 | PCDG2_HUMAN Protocadherin gamma-A2 OS=Homo sapiens GN=PCDHGA2 PE=2 SV=1 | 5 | Q | 0.644695 | R | 0.636118 | 0.008577 | No Change: Both D | - |
| Q9Y5H0 | PCDG3_HUMAN Protocadherin gamma-A3 OS=Homo sapiens GN=PCDHGA3 PE=2 SV=2 | 79 | P | 0.512417 | S | 0.560719 | -0.048302 | No Change: Both D | - |
| Q9Y5H0 | PCDG3_HUMAN Protocadherin gamma-A3 OS=Homo sapiens GN=PCDHGA3 PE=2 SV=2 | 154 | I | 0.296849 | L | 0.323688 | -0.026839 | No Change: Both O | - |
| Q9Y5H0 | PCDG3_HUMAN Protocadherin gamma-A3 OS=Homo sapiens GN=PCDHGA3 PE=2 SV=2 | 743 | A | 0.325804 | V | 0.26195 | 0.063854 | No Change: Both O | - |
| Q9Y5G9 | PCDG4_HUMAN Protocadherin gamma-A4 OS=Homo sapiens GN=PCDHGA4 PE=2 SV=1 | 150 | A | 0.589423 | T | 0.597724 | -0.008301 | No Change: Both D | - |
| Q9Y5G9 | PCDG4_HUMAN Protocadherin gamma-A4 OS=Homo sapiens GN=PCDHGA4 PE=2 SV=1 | 641 | R | 0.250136 | K | 0.286095 | -0.035959 | No Change: Both O | - |
| Q9Y5G9 | PCDG4_HUMAN Protocadherin gamma-A4 OS=Homo sapiens GN=PCDHGA4 PE=2 SV=1 | 683 | D | 0.728131 | H | 0.716616 | 0.011515 | No Change: Both D | - |
| Q9Y5G7 | PCDG6_HUMAN Protocadherin gamma-A6 OS=Homo sapiens GN=PCDHGA6 PE=2 SV=1 | 248 | R | 0.280698 | S | 0.352449 | -0.071751 | No Change: Both O | - |
| Q9Y5G6 | PCDG7_HUMAN Protocadherin gamma-A7 OS=Homo sapiens GN=PCDHGA7 PE=2 SV=1 | 188 | E | 0.618986 | G | 0.563001 | 0.055985 | No Change: Both D | - |
| Q9Y5G6 | PCDG7_HUMAN Protocadherin gamma-A7 OS=Homo sapiens GN=PCDHGA7 PE=2 SV=1 | 212 | L | 0.484513 | F | 0.426103 | 0.05841 | No Change: Both O | - |
| Q9Y5G6 | PCDG7_HUMAN Protocadherin gamma-A7 OS=Homo sapiens GN=PCDHGA7 PE=2 SV=1 | 239 | T | 0.323724 | M | 0.269215 | 0.054509 | No Change: Both O | - |
| Q9Y5G5 | PCDG8_HUMAN Protocadherin gamma-A8 OS=Homo sapiens GN=PCDHGA8 PE=2 SV=1 | 16 | L | 0.081016 | R | 0.150095 | -0.069079 | No Change: Both O | - |
| Q9Y5G5 | PCDG8_HUMAN Protocadherin gamma-A8 OS=Homo sapiens GN=PCDHGA8 PE=2 SV=1 | 187 | N | 0.428133 | K | 0.434685 | -0.006552 | No Change: Both O | - |
| Q9Y5G4 | PCDG9_HUMAN Protocadherin gamma-A9 OS=Homo sapiens GN=PCDHGA9 PE=2 SV=1 | 791 | L | 0.598757 | F | 0.586493 | 0.012264 | No Change: Both D | - |
| Q9Y5G2 | PCDGE_HUMAN Protocadherin gamma-B2 OS=Homo sapiens GN=PCDHGB2 PE=2 SV=1 | 26 | P | 0.100644 | R | 0.080468 | 0.020176 | No Change: Both O | - |
| Q9Y5G2 | PCDGE_HUMAN Protocadherin gamma-B2 OS=Homo sapiens GN=PCDHGB2 PE=2 SV=1 | 58 | V | 0.360066 | I | 0.319093 | 0.040973 | No Change: Both O | - |
| Q9Y5G2 | PCDGE_HUMAN Protocadherin gamma-B2 OS=Homo sapiens GN=PCDHGB2 PE=2 SV=1 | 687 | K | 0.327323 | E | 0.339238 | -0.011915 | No Change: Both O | - |
| Q9Y5G1 | PCDGF_HUMAN Protocadherin gamma-B3 OS=Homo sapiens GN=PCDHGB3 PE=2 SV=2 | 20 | F | 0.121334 | Y | 0.110694 | 0.01064 | No Change: Both O | - |
| Q9Y5G1 | PCDGF_HUMAN Protocadherin gamma-B3 OS=Homo sapiens GN=PCDHGB3 PE=2 SV=2 | 389 | N | 0.122087 | K | 0.156748 | -0.034661 | No Change: Both O | - |
| Q9Y5G1 | PCDGF_HUMAN Protocadherin gamma-B3 OS=Homo sapiens GN=PCDHGB3 PE=2 SV=2 | 28 | A | 0.266777 | V | 0.193605 | 0.073172 | No Change: Both O | - |
| Q9Y5G0 | PCDGH_HUMAN Protocadherin gamma-B5 OS=Homo sapiens GN=PCDHGB5 PE=2 SV=1 | 188 | G | 0.642167 | S | 0.715321 | -0.073154 | No Change: Both D | - |
| Q9Y5F9 | PCDGI_HUMAN Protocadherin gamma-B6 OS=Homo sapiens GN=PCDHGB6 PE=2 SV=1 | 684 | P | 0.456262 | S | 0.489755 | -0.033493 | No Change: Both O | - |
| Q9Y5F9 | PCDGI_HUMAN Protocadherin gamma-B6 OS=Homo sapiens GN=PCDHGB6 PE=2 SV=1 | 722 | A | 0.253001 | T | 0.296662 | -0.043661 | No Change: Both O | - |
| Q9Y5F9 | PCDGI_HUMAN Protocadherin gamma-B6 OS=Homo sapiens GN=PCDHGB6 PE=2 SV=1 | 775 | S | 0.426628 | A | 0.312619 | 0.114009 | No Change: Both O | - |
| Q9Y5F8 | PCDGJ_HUMAN Protocadherin gamma-B7 OS=Homo sapiens GN=PCDHGB7 PE=2 SV=1 | 405 | V | 0.374 | L | 0.395188 | -0.021188 | No Change: Both O | - |
| Q9Y5F6 | PCDGM_HUMAN Protocadherin gamma-C5 OS=Homo sapiens GN=PCDHGC5 PE=2 SV=1 | 570 | D | 0.722039 | G | 0.676855 | 0.045184 | No Change: Both D | - |
| Q9Y5F6 | PCDGM_HUMAN Protocadherin gamma-C5 OS=Homo sapiens GN=PCDHGC5 PE=2 SV=1 | 275 | G | 0.562874 | S | 0.603518 | -0.040644 | No Change: Both D | - |
| Q4G0U5 | PCDP1_HUMAN Primary ciliary dyskinesia protein 1 OS=Homo sapiens GN=PCDP1 PE=1 SV=2 | 637 | V | 0.671706 | I | 0.638395 | 0.033311 | No Change: Both D | - |
| Q4G0U5 | PCDP1_HUMAN Primary ciliary dyskinesia protein 1 OS=Homo sapiens GN=PCDP1 PE=1 SV=2 | 795 | M | 0.689174 | I | 0.579336 | 0.109838 | No Change: Both D | - |
| O94913 | PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens GN=PCF11 PE=1 SV=3 | 651 | Q | 0.723022 | H | 0.664334 | 0.058688 | No Change: Both D | - |
| O94913 | PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens GN=PCF11 PE=1 SV=3 | 1119 | H | 0.786839 | Y | 0.716597 | 0.070242 | No Change: Both D | - |
| O94913 | PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens GN=PCF11 PE=1 SV=3 | 1402 | E | 0.486051 | K | 0.473426 | 0.012625 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 267 | I | 0.163327 | V | 0.157923 | 0.005404 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 55 | R | 0.651902 | Q | 0.673695 | -0.021793 | No Change: Both D | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 60 | M | 0.536218 | T | 0.568469 | -0.032251 | No Change: Both D | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 138 | T | 0.190289 | I | 0.120215 | 0.070074 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 184 | V | 0.260571 | L | 0.256978 | 0.003593 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 276 | E | 0.484858 | K | 0.489568 | -0.00471 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 368 | V | 0.247619 | I | 0.238574 | 0.009045 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 427 | P | 0.313783 | S | 0.332914 | -0.019131 | No Change: Both O | - |
| P35558 | PCKGC_HUMAN Phosphoenolpyruvate carboxykinase cytosolic [GTP] OS=Homo sapiens GN=PCK1 PE=1 SV=3 | 586 | E | 0.426211 | D | 0.388519 | 0.037692 | No Change: Both O | - |
| Q16822 | PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP] mitochondrial OS=Homo sapiens GN=PCK2 PE=1 SV=3 | 31 | R | 0.246218 | Q | 0.264505 | -0.018287 | No Change: Both O | - |
| Q16822 | PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP] mitochondrial OS=Homo sapiens GN=PCK2 PE=1 SV=3 | 64 | D | 0.357662 | N | 0.355908 | 0.001754 | No Change: Both O | - |
| Q16822 | PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP] mitochondrial OS=Homo sapiens GN=PCK2 PE=1 SV=3 | 406 | G | 0.40006 | S | 0.449983 | -0.049923 | No Change: Both O | - |
| Q16822 | PCKGM_HUMAN Phosphoenolpyruvate carboxykinase [GTP] mitochondrial OS=Homo sapiens GN=PCK2 PE=1 SV=3 | 521 | R | 0.486281 | H | 0.494519 | -0.008238 | No Change: Both O | - |
| Q9Y6V0 | PCLO_HUMAN Protein piccolo OS=Homo sapiens GN=PCLO PE=1 SV=4 | 2602 | T | 0.844047 | P | 0.864097 | -0.02005 | No Change: Both D | - |
| Q9Y6V0 | PCLO_HUMAN Protein piccolo OS=Homo sapiens GN=PCLO PE=1 SV=4 | 2735 | A | 0.557713 | T | 0.621951 | -0.064238 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 159 | S | 0.868633 | N | 0.851483 | 0.01715 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 176 | A | 0.733829 | D | 0.777586 | -0.043757 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 597 | M | 0.7759 | V | 0.739786 | 0.036114 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 691 | A | 0.636353 | S | 0.708183 | -0.07183 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 871 | G | 0.828954 | V | 0.770134 | 0.05882 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 1251 | R | 0.947575 | H | 0.921713 | 0.025862 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 1543 | T | 0.525629 | I | 0.398406 | 0.127223 | D to O | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 600 | S | 0.797557 | P | 0.807425 | -0.009868 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 1326 | E | 0.953816 | D | 0.935597 | 0.018219 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 1701 | K | 0.369083 | N | 0.326768 | 0.042315 | No Change: Both O | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 1865 | N | 0.813436 | D | 0.813438 | -2.00E-06 | No Change: Both D | - |
| Q15154 | PCM1_HUMAN Pericentriolar material 1 protein OS=Homo sapiens GN=PCM1 PE=1 SV=4 | 159 | S | 0.868633 | R | 0.844325 | 0.024308 | No Change: Both D | - |
| P22061 | PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens GN=PCMT1 PE=1 SV=4 | 120 | V | 0.505928 | I | 0.455165 | 0.050763 | D to O | - |
| Q96MG8 | PCMD1_HUMAN Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 OS=Homo sapiens GN=PCMTD1 PE=2 SV=2 | 312 | N | 0.968381 | I | 0.953569 | 0.014812 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 539 | T | 0.590646 | I | 0.440998 | 0.149648 | D to O | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 704 | G | 0.712407 | E | 0.817991 | -0.105584 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 879 | T | 0.787616 | A | 0.812246 | -0.02463 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1038 | V | 0.734214 | A | 0.778712 | -0.044498 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1163 | R | 0.324797 | C | 0.194986 | 0.129811 | No Change: Both O | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1194 | A | 0.362721 | T | 0.379675 | -0.016954 | No Change: Both O | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1639 | I | 0.93444 | V | 0.950244 | -0.015804 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1841 | N | 0.857011 | S | 0.890431 | -0.03342 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1953 | R | 0.837462 | H | 0.799102 | 0.03836 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 1960 | R | 0.840903 | Q | 0.841972 | -0.001069 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2097 | L | 0.430076 | P | 0.580802 | -0.150726 | O to D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2125 | H | 0.647982 | P | 0.743845 | -0.095863 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2188 | M | 0.916269 | R | 0.921911 | -0.005642 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2191 | S | 0.911684 | P | 0.907066 | 0.004618 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2239 | W | 0.728008 | R | 0.845361 | -0.117353 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2274 | P | 0.786544 | L | 0.673479 | 0.113065 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2329 | P | 0.924886 | R | 0.913278 | 0.011608 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2361 | Q | 0.94011 | R | 0.944275 | -0.004165 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2549 | A | 0.824935 | T | 0.83857 | -0.013635 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2625 | R | 0.950436 | Q | 0.957453 | -0.007017 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2659 | Q | 0.98541 | H | 0.977268 | 0.008142 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2753 | R | 0.952585 | H | 0.941937 | 0.010648 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2792 | Q | 0.868893 | R | 0.84931 | 0.019583 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2903 | A | 0.977746 | T | 0.973251 | 0.004495 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 2975 | L | 0.850363 | P | 0.889568 | -0.039205 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 3091 | S | 0.950947 | G | 0.929127 | 0.02182 | No Change: Both D | - |
| O95613 | PCNT_HUMAN Pericentrin OS=Homo sapiens GN=PCNT PE=1 SV=4 | 3245 | R | 0.995557 | S | 0.995358 | 1.99E-04 | No Change: Both D | - |
| Q96RV3 | PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens GN=PCNX PE=2 SV=2 | 809 | L | 0.915566 | I | 0.899425 | 0.016141 | No Change: Both D | - |
| Q96RV3 | PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens GN=PCNX PE=2 SV=2 | 814 | L | 0.925387 | I | 0.909494 | 0.015893 | No Change: Both D | - |
| Q96RV3 | PCX1_HUMAN Pecanex-like protein 1 OS=Homo sapiens GN=PCNX PE=2 SV=2 | 594 | A | 0.854896 | T | 0.870524 | -0.015628 | No Change: Both D | - |
| A6NKB5 | PCX2_HUMAN Pecanex-like protein 2 OS=Homo sapiens GN=PCNXL2 PE=1 SV=3 | 454 | T | 0.895037 | A | 0.865996 | 0.029041 | No Change: Both D | - |
| A6NKB5 | PCX2_HUMAN Pecanex-like protein 2 OS=Homo sapiens GN=PCNXL2 PE=1 SV=3 | 117 | R | 0.976774 | K | 0.978736 | -0.001962 | No Change: Both D | - |
| A6NKB5 | PCX2_HUMAN Pecanex-like protein 2 OS=Homo sapiens GN=PCNXL2 PE=1 SV=3 | 1901 | S | 0.968569 | N | 0.963794 | 0.004775 | No Change: Both D | - |
| A6NKB5 | PCX2_HUMAN Pecanex-like protein 2 OS=Homo sapiens GN=PCNXL2 PE=1 SV=3 | 1984 | R | 0.919618 | Q | 0.923281 | -0.003663 | No Change: Both D | - |
| Q9H6A9 | PCX3_HUMAN Pecanex-like protein 3 OS=Homo sapiens GN=PCNXL3 PE=1 SV=2 | 258 | Q | 0.914449 | R | 0.919856 | -0.005407 | No Change: Both D | - |
| Q9H6A9 | PCX3_HUMAN Pecanex-like protein 3 OS=Homo sapiens GN=PCNXL3 PE=1 SV=2 | 458 | S | 0.992478 | C | 0.987585 | 0.004893 | No Change: Both D | - |
| Q9H6A9 | PCX3_HUMAN Pecanex-like protein 3 OS=Homo sapiens GN=PCNXL3 PE=1 SV=2 | 813 | K | 0.029332 | N | 0.023998 | 0.005334 | No Change: Both O | - |
| Q9H6A9 | PCX3_HUMAN Pecanex-like protein 3 OS=Homo sapiens GN=PCNXL3 PE=1 SV=2 | 564 | G | 0.937235 | S | 0.943038 | -0.005803 | No Change: Both D | - |
| Q9H6A9 | PCX3_HUMAN Pecanex-like protein 3 OS=Homo sapiens GN=PCNXL3 PE=1 SV=2 | 1822 | H | 0.268501 | Q | 0.283682 | -0.015181 | No Change: Both O | - |
| Q9UKZ9 | PCOC2_HUMAN Procollagen C-endopeptidase enhancer 2 OS=Homo sapiens GN=PCOLCE2 PE=1 SV=1 | 292 | P | 0.360108 | T | 0.32418 | 0.035928 | No Change: Both O | - |
| Q9UKZ9 | PCOC2_HUMAN Procollagen C-endopeptidase enhancer 2 OS=Homo sapiens GN=PCOLCE2 PE=1 SV=1 | 280 | V | 0.582459 | A | 0.636373 | -0.053914 | No Change: Both D | - |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 80 | R | 0.633251 | Q | 0.622839 | 0.010412 | No Change: Both D | - |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 221 | N | 0.344434 | D | 0.343443 | 9.91E-04 | No Change: Both O | - |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 665 | Q | 0.969058 | E | 0.972348 | -0.00329 | No Change: Both D | - |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 690 | S | 0.963111 | T | 0.938101 | 0.02501 | No Change: Both D | - |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 483 | G | 0.350629 | R | 0.402343 | -0.051714 | No Change: Both O | Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955] |
| P29120 | NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens GN=PCSK1 PE=1 SV=2 | 307 | S | 0.370442 | L | 0.190036 | 0.180406 | No Change: Both O | Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955] |
| Q9UHG2 | PCSK1_HUMAN ProSAAS OS=Homo sapiens GN=PCSK1N PE=1 SV=1 | 31 | A | 0.667119 | T | 0.646218 | 0.020901 | No Change: Both D | - |
| P16519 | NEC2_HUMAN Neuroendocrine convertase 2 OS=Homo sapiens GN=PCSK2 PE=2 SV=2 | 424 | D | 0.497599 | N | 0.49988 | -0.002281 | No Change: Both O | A colorectal cancer sample |
| Q6UW60 | PCSK4_HUMAN Proprotein convertase subtilisin/kexin type 4 OS=Homo sapiens GN=PCSK4 PE=2 SV=2 | 267 | T | 0.56392 | M | 0.511984 | 0.051936 | No Change: Both D | - |
| P29122 | PCSK6_HUMAN Proprotein convertase subtilisin/kexin type 6 OS=Homo sapiens GN=PCSK6 PE=1 SV=1 | 502 | C | 0.322725 | R | 0.506162 | -0.183437 | O to D | - |
| Q16549 | PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens GN=PCSK7 PE=1 SV=2 | 688 | L | 0.195872 | V | 0.202537 | -0.006665 | No Change: Both O | - |
| Q16549 | PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens GN=PCSK7 PE=1 SV=2 | 689 | S | 0.240445 | N | 0.212007 | 0.028438 | No Change: Both O | - |
| Q16549 | PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens GN=PCSK7 PE=1 SV=2 | 700 | R | 0.364912 | M | 0.298479 | 0.066433 | No Change: Both O | - |
| Q16549 | PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens GN=PCSK7 PE=1 SV=2 | 708 | H | 0.63146 | Y | 0.531064 | 0.100396 | No Change: Both D | - |
| Q16549 | PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens GN=PCSK7 PE=1 SV=2 | 711 | R | 0.747448 | Q | 0.744074 | 0.003374 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 46 | R | 0.591881 | L | 0.49601 | 0.095871 | D to O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 53 | A | 0.691456 | V | 0.628992 | 0.062464 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 127 | S | 0.218764 | R | 0.168646 | 0.050118 | No Change: Both O | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 216 | F | 0.567795 | L | 0.58529 | -0.017495 | No Change: Both D | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 670 | G | 0.575984 | E | 0.624499 | -0.048515 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 425 | N | 0.19404 | S | 0.236859 | -0.042819 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 443 | A | 0.366392 | T | 0.397961 | -0.031569 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 474 | V | 0.549691 | I | 0.504396 | 0.045295 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 553 | H | 0.482091 | R | 0.491788 | -0.009697 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 619 | Q | 0.508167 | P | 0.544156 | -0.035989 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 57 | E | 0.598908 | K | 0.573931 | 0.024977 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 237 | R | 0.545642 | W | 0.312834 | 0.232808 | D to O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 253 | L | 0.295095 | F | 0.250779 | 0.044316 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 391 | H | 0.401594 | N | 0.419426 | -0.017832 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 417 | H | 0.160769 | Q | 0.192823 | -0.032054 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 469 | R | 0.51013 | W | 0.33195 | 0.17818 | D to O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 482 | E | 0.681208 | G | 0.636451 | 0.044757 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 515 | F | 0.341492 | L | 0.384915 | -0.043423 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 554 | Q | 0.515691 | E | 0.535172 | -0.019481 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 77 | T | 0.26869 | I | 0.138224 | 0.130466 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 93 | R | 0.713142 | C | 0.546889 | 0.166253 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 106 | G | 0.213179 | R | 0.225489 | -0.01231 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 114 | V | 0.073868 | A | 0.107363 | -0.033495 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 129 | D | 0.222487 | G | 0.215016 | 0.007471 | No Change: Both O | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 157 | N | 0.211184 | K | 0.249175 | -0.037991 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 215 | R | 0.568387 | H | 0.554108 | 0.014279 | No Change: Both D | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 218 | R | 0.592099 | S | 0.627571 | -0.035472 | No Change: Both D | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 219 | Q | 0.615266 | E | 0.670487 | -0.055221 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 239 | A | 0.558759 | D | 0.609571 | -0.050812 | No Change: Both D | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 357 | R | 0.209236 | H | 0.187963 | 0.021273 | No Change: Both O | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 374 | D | 0.359905 | H | 0.304537 | 0.055368 | No Change: Both O | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 374 | D | 0.359905 | Y | 0.194655 | 0.16525 | No Change: Both O | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 452 | G | 0.181144 | D | 0.191059 | -0.009915 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 496 | R | 0.807419 | W | 0.665017 | 0.142402 | No Change: Both D | Hypercholesterolemia autosomal dominant type 3 (HCHOLA3) [MIM:603776] |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 522 | A | 0.176368 | T | 0.166826 | 0.009542 | No Change: Both O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 616 | P | 0.555828 | L | 0.379969 | 0.175859 | D to O | - |
| Q8NBP7 | PCSK9_HUMAN Proprotein convertase subtilisin/kexin type 9 OS=Homo sapiens GN=PCSK9 PE=1 SV=3 | 668 | S | 0.678716 | R | 0.632137 | 0.046579 | No Change: Both D | - |
| Q9UKL6 | PPCT_HUMAN Phosphatidylcholine transfer protein OS=Homo sapiens GN=PCTP PE=1 SV=1 | 10 | E | 0.474454 | A | 0.361425 | 0.113029 | No Change: Both O | - |
| Q9UHG3 | PCYOX_HUMAN Prenylcysteine oxidase 1 OS=Homo sapiens GN=PCYOX1 PE=1 SV=3 | 149 | S | 0.113806 | F | 0.045084 | 0.068722 | No Change: Both O | - |
| Q9UHG3 | PCYOX_HUMAN Prenylcysteine oxidase 1 OS=Homo sapiens GN=PCYOX1 PE=1 SV=3 | 414 | T | 0.225342 | S | 0.285761 | -0.060419 | No Change: Both O | - |
| Q9UHG3 | PCYOX_HUMAN Prenylcysteine oxidase 1 OS=Homo sapiens GN=PCYOX1 PE=1 SV=3 | 465 | S | 0.318647 | G | 0.266396 | 0.052251 | No Change: Both O | - |
| Q8NBM8 | PCYXL_HUMAN Prenylcysteine oxidase-like OS=Homo sapiens GN=PCYOX1L PE=1 SV=2 | 5 | A | 0.717831 | P | 0.76746 | -0.049629 | No Change: Both D | - |
| Q8NBM8 | PCYXL_HUMAN Prenylcysteine oxidase-like OS=Homo sapiens GN=PCYOX1L PE=1 SV=2 | 390 | E | 0.458037 | D | 0.439169 | 0.018868 | No Change: Both O | - |
| Q8NBM8 | PCYXL_HUMAN Prenylcysteine oxidase-like OS=Homo sapiens GN=PCYOX1L PE=1 SV=2 | 316 | A | 0.324213 | T | 0.372568 | -0.048355 | No Change: Both O | - |
| Q15116 | PDCD1_HUMAN Programmed cell death protein 1 OS=Homo sapiens GN=PDCD1 PE=1 SV=3 | 215 | A | 0.453267 | V | 0.409948 | 0.043319 | No Change: Both O | - |
| Q9BUL8 | PDC10_HUMAN Programmed cell death protein 10 OS=Homo sapiens GN=PDCD10 PE=1 SV=1 | 102 | D | 0.64999 | A | 0.587521 | 0.062469 | No Change: Both D | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 1871 | D | 0.788737 | A | 0.78405 | 0.004687 | No Change: Both D | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 623 | A | 0.85536 | S | 0.895396 | -0.040036 | No Change: Both D | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 1216 | L | 0.415947 | F | 0.354408 | 0.061539 | No Change: Both O | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 397 | S | 0.351222 | N | 0.30064 | 0.050582 | No Change: Both O | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 780 | A | 0.345683 | S | 0.448184 | -0.102501 | No Change: Both O | - |
| Q14690 | RRP5_HUMAN Protein RRP5 homolog OS=Homo sapiens GN=PDCD11 PE=1 SV=3 | 1453 | P | 0.999539 | S | 0.999524 | 1.50E-05 | No Change: Both D | - |
| Q9BQ51 | PD1L2_HUMAN Programmed cell death 1 ligand 2 OS=Homo sapiens GN=PDCD1LG2 PE=1 SV=2 | 229 | F | 0.006229 | S | 0.015913 | -0.009684 | No Change: Both O | - |
| Q9BQ51 | PD1L2_HUMAN Programmed cell death 1 ligand 2 OS=Homo sapiens GN=PDCD1LG2 PE=1 SV=2 | 58 | S | 0.328115 | T | 0.272349 | 0.055766 | No Change: Both O | - |
| Q9BQ51 | PD1L2_HUMAN Programmed cell death 1 ligand 2 OS=Homo sapiens GN=PDCD1LG2 PE=1 SV=2 | 241 | I | 0.039497 | T | 0.072119 | -0.032622 | No Change: Both O | - |
| Q53EL6 | PDCD4_HUMAN Programmed cell death protein 4 OS=Homo sapiens GN=PDCD4 PE=1 SV=2 | 36 | I | 0.808968 | V | 0.787695 | 0.021273 | No Change: Both D | - |
| Q53EL6 | PDCD4_HUMAN Programmed cell death protein 4 OS=Homo sapiens GN=PDCD4 PE=1 SV=2 | 48 | S | 0.869422 | Y | 0.71773 | 0.151692 | No Change: Both D | - |
| Q53EL6 | PDCD4_HUMAN Programmed cell death protein 4 OS=Homo sapiens GN=PDCD4 PE=1 SV=2 | 120 | G | 0.81131 | R | 0.801971 | 0.009339 | No Change: Both D | A breast cancer sample |
| O75340 | PDCD6_HUMAN Programmed cell death protein 6 OS=Homo sapiens GN=PDCD6 PE=1 SV=1 | 123 | G | 0.287787 | C | 0.151016 | 0.136771 | No Change: Both O | A breast cancer sample |
| Q8WUM4 | PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1 | 730 | S | 0.976449 | L | 0.963132 | 0.013317 | No Change: Both D | - |
| Q8WUM4 | PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1 | 309 | A | 0.377855 | T | 0.377847 | 8.00E-06 | No Change: Both O | - |
| Q8WUM4 | PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1 | 378 | V | 0.353518 | I | 0.334852 | 0.018666 | No Change: Both O | - |
| Q8WUM4 | PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1 | 550 | N | 0.564335 | S | 0.61582 | -0.051485 | No Change: Both D | - |
| Q8WUM4 | PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens GN=PDCD6IP PE=1 SV=1 | 638 | K | 0.771508 | E | 0.776368 | -0.00486 | No Change: Both D | - |
| Q13371 | PHLP_HUMAN Phosducin-like protein OS=Homo sapiens GN=PDCL PE=1 SV=3 | 218 | K | 0.342055 | N | 0.282005 | 0.06005 | No Change: Both O | - |
| Q9Y233 | PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3' 5'-cyclic phosphodiesterase 10A OS=Homo sapiens GN=PDE10A PE=1 SV=1 | 303 | L | 0.327451 | P | 0.485573 | -0.158122 | No Change: Both O | - |
| Q9Y233 | PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3' 5'-cyclic phosphodiesterase 10A OS=Homo sapiens GN=PDE10A PE=1 SV=1 | 706 | R | 0.636917 | K | 0.692457 | -0.05554 | No Change: Both D | - |
| Q9Y233 | PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3' 5'-cyclic phosphodiesterase 10A OS=Homo sapiens GN=PDE10A PE=1 SV=1 | 707 | D | 0.678899 | N | 0.654259 | 0.02464 | No Change: Both D | - |
| Q9HCR9 | PDE11_HUMAN Dual 3' 5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Homo sapiens GN=PDE11A PE=1 SV=2 | 804 | R | 0.23955 | H | 0.24412 | -0.00457 | No Change: Both O | - |
| Q9HCR9 | PDE11_HUMAN Dual 3' 5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Homo sapiens GN=PDE11A PE=1 SV=2 | 867 | R | 0.303776 | G | 0.283382 | 0.020394 | No Change: Both O | - |
| Q6L8Q7 | PDE12_HUMAN 2' 5'-phosphodiesterase 12 OS=Homo sapiens GN=PDE12 PE=1 SV=2 | 23 | R | 0.644117 | W | 0.41127 | 0.232847 | D to O | - |
| O00408 | PDE2A_HUMAN cGMP-dependent 3' 5'-cyclic phosphodiesterase OS=Homo sapiens GN=PDE2A PE=1 SV=1 | 224 | T | 0.59005 | I | 0.481184 | 0.108866 | D to O | - |
| Q14432 | PDE3A_HUMAN cGMP-inhibited 3' 5'-cyclic phosphodiesterase A OS=Homo sapiens GN=PDE3A PE=1 SV=3 | 12 | D | 0.91311 | N | 0.880792 | 0.032318 | No Change: Both D | - |
| Q13370 | PDE3B_HUMAN cGMP-inhibited 3' 5'-cyclic phosphodiesterase B OS=Homo sapiens GN=PDE3B PE=1 SV=2 | 87 | A | 0.344063 | V | 0.260564 | 0.083499 | No Change: Both O | - |
| P27815 | PDE4A_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4A OS=Homo sapiens GN=PDE4A PE=1 SV=3 | 736 | A | 0.720864 | E | 0.790661 | -0.069797 | No Change: Both D | - |
| P27815 | PDE4A_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4A OS=Homo sapiens GN=PDE4A PE=1 SV=3 | 808 | H | 0.781114 | Y | 0.685422 | 0.095692 | No Change: Both D | - |
| Q07343 | PDE4B_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4B OS=Homo sapiens GN=PDE4B PE=1 SV=1 | 703 | S | 0.767037 | C | 0.659752 | 0.107285 | No Change: Both D | - |
| Q08493 | PDE4C_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4C OS=Homo sapiens GN=PDE4C PE=1 SV=2 | 344 | R | 0.227348 | Q | 0.242377 | -0.015029 | No Change: Both O | - |
| Q08493 | PDE4C_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4C OS=Homo sapiens GN=PDE4C PE=1 SV=2 | 131 | S | 0.770674 | L | 0.645985 | 0.124689 | No Change: Both D | - |
| Q08493 | PDE4C_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4C OS=Homo sapiens GN=PDE4C PE=1 SV=2 | 289 | R | 0.613121 | Q | 0.649023 | -0.035902 | No Change: Both D | - |
| Q08493 | PDE4C_HUMAN cAMP-specific 3' 5'-cyclic phosphodiesterase 4C OS=Homo sapiens GN=PDE4C PE=1 SV=2 | 344 | R | 0.227348 | W | 0.105094 | 0.122254 | No Change: Both O | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 13 | N | 0.527185 | S | 0.581184 | -0.053999 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 25 | R | 0.26219 | L | 0.170448 | 0.091742 | No Change: Both O | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 49 | I | 0.511975 | T | 0.628731 | -0.116756 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 167 | A | 0.672471 | T | 0.69738 | -0.024909 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 171 | R | 0.70351 | K | 0.734632 | -0.031122 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 391 | E | 0.933713 | A | 0.913281 | 0.020432 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 410 | E | 0.946561 | V | 0.878249 | 0.068312 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 482 | H | 0.6627 | R | 0.755891 | -0.093191 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 681 | R | 0.709862 | H | 0.623922 | 0.08594 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 708 | C | 0.811196 | R | 0.878784 | -0.067588 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 1013 | F | 0.896202 | I | 0.886402 | 0.0098 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 1066 | A | 0.716284 | T | 0.741322 | -0.025038 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 1359 | K | 0.511146 | E | 0.485478 | 0.025668 | D to O | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 1736 | V | 0.825863 | E | 0.899255 | -0.073392 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 1742 | A | 0.821388 | S | 0.873838 | -0.05245 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 143 | K | 0.673821 | E | 0.686597 | -0.012776 | No Change: Both D | - |
| Q5VU43 | MYOME_HUMAN Myomegalin OS=Homo sapiens GN=PDE4DIP PE=2 SV=1 | 150 | N | 0.603781 | S | 0.638862 | -0.035081 | No Change: Both D | - |
| O76074 | PDE5A_HUMAN cGMP-specific 3' 5'-cyclic phosphodiesterase OS=Homo sapiens GN=PDE5A PE=1 SV=2 | 93 | A | 0.883574 | V | 0.854675 | 0.028899 | No Change: Both D | - |
| O76074 | PDE5A_HUMAN cGMP-specific 3' 5'-cyclic phosphodiesterase OS=Homo sapiens GN=PDE5A PE=1 SV=2 | 181 | S | 0.175028 | A | 0.111628 | 0.0634 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 344 | S | 0.157022 | R | 0.119731 | 0.037291 | No Change: Both O | Retinitis pigmentosa type 43 (RP43) [MIM:613810] |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 102 | R | 0.20255 | H | 0.192467 | 0.010083 | No Change: Both O | Retinitis pigmentosa type 43 (RP43) [MIM:613810] |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 102 | R | 0.20255 | S | 0.248883 | -0.046333 | No Change: Both O | Retinitis pigmentosa type 43 (RP43) [MIM:613810] |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 216 | N | 0.050974 | S | 0.0575 | -0.006526 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 277 | V | 0.137668 | A | 0.18983 | -0.052162 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 293 | P | 0.067708 | L | 0.031497 | 0.036211 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 391 | V | 0.300031 | M | 0.363637 | -0.063606 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 569 | Q | 0.177211 | K | 0.21302 | -0.035809 | No Change: Both O | Retinitis pigmentosa type 43 (RP43) [MIM:613810] |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 573 | S | 0.131604 | P | 0.116919 | 0.014685 | No Change: Both O | Retinitis pigmentosa type 43 (RP43) [MIM:613810] |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 827 | K | 0.932958 | Q | 0.930288 | 0.00267 | No Change: Both D | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 850 | G | 0.988439 | V | 0.974068 | 0.014371 | No Change: Both D | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 145 | A | 0.302017 | T | 0.3159 | -0.013883 | No Change: Both O | - |
| P16499 | PDE6A_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha OS=Homo sapiens GN=PDE6A PE=1 SV=4 | 492 | Q | 0.44073 | H | 0.411655 | 0.029075 | No Change: Both O | - |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 557 | H | 0.183461 | Y | 0.113563 | 0.069898 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 576 | G | 0.280509 | D | 0.316075 | -0.035566 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 699 | L | 0.284557 | R | 0.410686 | -0.126129 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 74 | R | 0.240409 | C | 0.150058 | 0.090351 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 166 | E | 0.459273 | K | 0.477294 | -0.018021 | No Change: Both O | - |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 212 | Y | 0.078807 | H | 0.12799 | -0.049183 | No Change: Both O | - |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 219 | Y | 0.055201 | H | 0.093411 | -0.03821 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 228 | L | 0.185066 | H | 0.295805 | -0.110739 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 228 | L | 0.185066 | I | 0.16178 | 0.023286 | No Change: Both O | - |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 258 | H | 0.173164 | N | 0.187319 | -0.014155 | No Change: Both O | Congenital stationary night blindness autosomal dominant type 2 (CSNBAD2) [MIM:163500] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 527 | L | 0.077661 | P | 0.160817 | -0.083156 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 535 | I | 0.154485 | N | 0.305893 | -0.151408 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 552 | R | 0.240076 | Q | 0.241609 | -0.001533 | No Change: Both O | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 854 | L | 0.737413 | R | 0.869437 | -0.132024 | No Change: Both D | Retinitis pigmentosa type 40 (RP40) [MIM:613801] |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 320 | V | 0.111189 | I | 0.098832 | 0.012357 | No Change: Both O | - |
| P35913 | PDE6B_HUMAN Rod cGMP-specific 3' 5'-cyclic phosphodiesterase subunit beta OS=Homo sapiens GN=PDE6B PE=1 SV=2 | 654 | E | 0.379373 | D | 0.361616 | 0.017757 | No Change: Both O | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 157 | D | 0.737884 | E | 0.752352 | -0.014468 | No Change: Both D | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 822 | K | 0.683117 | N | 0.639806 | 0.043311 | No Change: Both D | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 834 | E | 0.920762 | G | 0.901695 | 0.019067 | No Change: Both D | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 270 | S | 0.128663 | T | 0.094708 | 0.033955 | No Change: Both O | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 699 | E | 0.508772 | A | 0.400908 | 0.107864 | D to O | - |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 29 | R | 0.299484 | W | 0.127862 | 0.171622 | No Change: Both O | Cone dystrophy type 4 (COD4) [MIM:613093] |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 323 | Y | 0.09454 | N | 0.164275 | -0.069735 | No Change: Both O | Cone dystrophy type 4 (COD4) [MIM:613093] |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 455 | M | 0.498352 | V | 0.380502 | 0.11785 | No Change: Both O | Cone dystrophy type 4 (COD4) [MIM:613093] |
| P51160 | PDE6C_HUMAN Cone cGMP-specific 3' 5'-cyclic phosphodiesterase subunit alpha' OS=Homo sapiens GN=PDE6C PE=1 SV=2 | 826 | I | 0.780432 | S | 0.866639 | -0.086207 | No Change: Both D | - |
| P18545 | CNRG_HUMAN Retinal rod rhodopsin-sensitive cGMP 3' 5'-cyclic phosphodiesterase subunit gamma OS=Homo sapiens GN=PDE6G PE=1 SV=1 | 27 | P | 0.974213 | H | 0.95196 | 0.022253 | No Change: Both D | - |
| Q13946 | PDE7A_HUMAN High affinity cAMP-specific 3' 5'-cyclic phosphodiesterase 7A OS=Homo sapiens GN=PDE7A PE=1 SV=2 | 76 | G | 0.620892 | E | 0.66375 | -0.042858 | No Change: Both D | - |
| O95263 | PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3' 5'-cyclic phosphodiesterase 8B OS=Homo sapiens GN=PDE8B PE=1 SV=2 | 305 | H | 0.410694 | P | 0.451041 | -0.040347 | No Change: Both O | Primary pigmented nodular adrenocortical disease type 3 (PPNAD3) [MIM:614190] |
| Q9HBH1 | DEFM_HUMAN Peptide deformylase mitochondrial OS=Homo sapiens GN=PDF PE=1 SV=1 | 11 | W | 0.050949 | R | 0.134611 | -0.083662 | No Change: Both O | - |
| P01127 | PDGFB_HUMAN Platelet-derived growth factor subunit B OS=Homo sapiens GN=PDGFB PE=1 SV=1 | 88 | I | 0.536943 | V | 0.532283 | 0.00466 | No Change: Both D | - |
| Q9GZP0 | PDGFD_HUMAN Platelet-derived growth factor D OS=Homo sapiens GN=PDGFD PE=1 SV=1 | 202 | D | 0.464468 | Y | 0.299712 | 0.164756 | No Change: Both O | A colorectal cancer sample |
| Q9GZP0 | PDGFD_HUMAN Platelet-derived growth factor D OS=Homo sapiens GN=PDGFD PE=1 SV=1 | 190 | I | 0.585781 | V | 0.629182 | -0.043401 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 478 | S | 0.498669 | P | 0.452708 | 0.045961 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 79 | G | 0.434696 | D | 0.466287 | -0.031591 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 426 | G | 0.582776 | D | 0.601765 | -0.018989 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 764 | R | 0.789959 | C | 0.677632 | 0.112327 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 829 | G | 0.098274 | R | 0.096968 | 0.001306 | No Change: Both O | A glioblastoma multiforme sample |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 996 | E | 0.516992 | K | 0.521017 | -0.004025 | No Change: Both D | A metastatic melanoma sample |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 1071 | D | 0.887531 | N | 0.828381 | 0.05915 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 481 | R | 0.534368 | G | 0.539504 | -0.005136 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 507 | L | 0.297125 | P | 0.42714 | -0.130015 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 561 | V | 0.186006 | D | 0.342799 | -0.156793 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 562 | I | 0.234436 | M | 0.300302 | -0.065866 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 570 | H | 0.386695 | R | 0.382784 | 0.003911 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 650 | H | 0.248368 | Q | 0.254793 | -0.006425 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 659 | N | 0.110744 | K | 0.130378 | -0.019634 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 659 | N | 0.110744 | S | 0.128571 | -0.017827 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 705 | L | 0.501336 | P | 0.635248 | -0.133912 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 748 | R | 0.603514 | G | 0.571545 | 0.031969 | No Change: Both D | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 842 | D | 0.199146 | V | 0.095953 | 0.103193 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 842 | D | 0.199146 | Y | 0.100046 | 0.0991 | No Change: Both O | - |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 849 | Y | 0.547277 | C | 0.483827 | 0.06345 | D to O | Gastrointestinal stromal tumor (GIST) [MIM:606764] |
| P16234 | PGFRA_HUMAN Platelet-derived growth factor receptor alpha OS=Homo sapiens GN=PDGFRA PE=1 SV=1 | 849 | Y | 0.547277 | S | 0.750896 | -0.203619 | No Change: Both D | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 29 | I | 0.373167 | F | 0.405143 | -0.031976 | No Change: Both O | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 180 | S | 0.360049 | F | 0.177551 | 0.182498 | No Change: Both O | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 282 | E | 0.521905 | K | 0.506785 | 0.01512 | No Change: Both D | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 485 | E | 0.646684 | K | 0.583774 | 0.06291 | No Change: Both D | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 589 | Y | 0.290616 | H | 0.405155 | -0.114539 | No Change: Both O | A gastric adenocarcinoma sample |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 718 | N | 0.580888 | Y | 0.470911 | 0.109977 | D to O | - |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 882 | T | 0.127254 | I | 0.068951 | 0.058303 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| P09619 | PGFRB_HUMAN Platelet-derived growth factor receptor beta OS=Homo sapiens GN=PDGFRB PE=1 SV=1 | 345 | P | 0.120584 | S | 0.123342 | -0.002758 | No Change: Both O | - |
| Q15198 | PGFRL_HUMAN Platelet-derived growth factor receptor-like protein OS=Homo sapiens GN=PDGFRL PE=1 SV=1 | 23 | H | 0.613867 | Y | 0.515317 | 0.09855 | No Change: Both D | Colorectal cancer (CRC) [MIM:114500] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 72 | R | 0.361433 | C | 0.213001 | 0.148432 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 113 | H | 0.220559 | D | 0.258173 | -0.037614 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 162 | G | 0.24565 | R | 0.214496 | 0.031154 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 167 | V | 0.218253 | M | 0.263863 | -0.04561 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 199 | A | 0.319587 | T | 0.342209 | -0.022622 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 205 | F | 0.233471 | L | 0.258199 | -0.024728 | No Change: Both O | X-linked Leigh syndrome (X-LS) [MIM:308930] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 210 | M | 0.057984 | V | 0.043252 | 0.014732 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 217 | P | 0.019151 | L | 0.009679 | 0.009472 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 231 | T | 0.520599 | A | 0.508251 | 0.012348 | No Change: Both D | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 258 | D | 0.11779 | A | 0.082645 | 0.035145 | No Change: Both O | X-linked Leigh syndrome (X-LS) [MIM:308930] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 263 | R | 0.102054 | G | 0.102438 | -3.84E-04 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 263 | R | 0.102054 | G | 0.102438 | -3.84E-04 | No Change: Both O | X-linked Leigh syndrome (X-LS) [MIM:308930] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 263 | R | 0.102054 | Q | 0.101072 | 9.82E-04 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 292 | H | 0.565747 | L | 0.460124 | 0.105623 | D to O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 302 | R | 0.60239 | C | 0.429122 | 0.173268 | D to O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 302 | R | 0.60239 | H | 0.563216 | 0.039174 | No Change: Both D | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 378 | R | 0.265714 | H | 0.266567 | -8.53E-04 | No Change: Both O | X-linked Leigh syndrome (X-LS) [MIM:308930] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 10 | R | 0.563343 | P | 0.566947 | -0.003604 | No Change: Both D | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 243 | Y | 0.357802 | N | 0.495255 | -0.137453 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 282 | M | 0.262651 | L | 0.220151 | 0.0425 | No Change: Both O | - |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 288 | R | 0.397493 | H | 0.40523 | -0.007737 | No Change: Both O | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 315 | D | 0.681958 | N | 0.65463 | 0.027328 | No Change: Both D | Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) [MIM:312170] |
| P08559 | ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha somatic form mitochondrial OS=Homo sapiens GN=PDHA1 PE=1 SV=3 | 333 | E | 0.675554 | D | 0.646118 | 0.029436 | No Change: Both D | - |
| P29803 | ODPAT_HUMAN Pyruvate dehydrogenase E1 component subunit alpha testis-specific form mitochondrial OS=Homo sapiens GN=PDHA2 PE=1 SV=1 | 280 | M | 0.255669 | L | 0.215187 | 0.040482 | No Change: Both O | - |
| P29803 | ODPAT_HUMAN Pyruvate dehydrogenase E1 component subunit alpha testis-specific form mitochondrial OS=Homo sapiens GN=PDHA2 PE=1 SV=1 | 376 | R | 0.363449 | G | 0.388864 | -0.025415 | No Change: Both O | - |
| P11177 | ODPB_HUMAN Pyruvate dehydrogenase E1 component subunit beta mitochondrial OS=Homo sapiens GN=PDHB PE=1 SV=3 | 31 | L | 0.170187 | V | 0.180695 | -0.010508 | No Change: Both O | - |
| P11177 | ODPB_HUMAN Pyruvate dehydrogenase E1 component subunit beta mitochondrial OS=Homo sapiens GN=PDHB PE=1 SV=3 | 344 | P | 0.246003 | S | 0.286277 | -0.040274 | No Change: Both O | Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111] |
| P11177 | ODPB_HUMAN Pyruvate dehydrogenase E1 component subunit beta mitochondrial OS=Homo sapiens GN=PDHB PE=1 SV=3 | 132 | Y | 0.287471 | C | 0.232301 | 0.05517 | No Change: Both O | Pyruvate dehydrogenase E1-beta deficiency (PDHBD) [MIM:614111] |
| O00330 | ODPX_HUMAN Pyruvate dehydrogenase protein X component mitochondrial OS=Homo sapiens GN=PDHX PE=1 SV=3 | 23 | R | 0.289648 | C | 0.144275 | 0.145373 | No Change: Both O | - |
| O00330 | ODPX_HUMAN Pyruvate dehydrogenase protein X component mitochondrial OS=Homo sapiens GN=PDHX PE=1 SV=3 | 101 | T | 0.321066 | A | 0.305192 | 0.015874 | No Change: Both O | - |
| O00330 | ODPX_HUMAN Pyruvate dehydrogenase protein X component mitochondrial OS=Homo sapiens GN=PDHX PE=1 SV=3 | 370 | D | 0.251883 | V | 0.152543 | 0.09934 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 39 | P | 0.753 | S | 0.74902 | 0.00398 | No Change: Both D | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 119 | T | 0.31447 | R | 0.345803 | -0.031333 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 185 | E | 0.286243 | K | 0.283901 | 0.002342 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 286 | T | 0.157029 | M | 0.130131 | 0.026898 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 382 | P | 0.402228 | A | 0.300048 | 0.10218 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 388 | R | 0.363247 | Q | 0.402557 | -0.03931 | No Change: Both O | - |
| Q13087 | PDIA2_HUMAN Protein disulfide-isomerase A2 OS=Homo sapiens GN=PDIA2 PE=1 SV=2 | 502 | P | 0.924755 | S | 0.914306 | 0.010449 | No Change: Both D | - |
| P30101 | PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Homo sapiens GN=PDIA3 PE=1 SV=4 | 415 | K | 0.54633 | R | 0.484559 | 0.061771 | D to O | - |
| P13667 | PDIA4_HUMAN Protein disulfide-isomerase A4 OS=Homo sapiens GN=PDIA4 PE=1 SV=2 | 173 | T | 0.525057 | M | 0.463866 | 0.061191 | D to O | - |
| Q14554 | PDIA5_HUMAN Protein disulfide-isomerase A5 OS=Homo sapiens GN=PDIA5 PE=1 SV=1 | 391 | T | 0.747484 | M | 0.734549 | 0.012935 | No Change: Both D | - |
| Q15084 | PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Homo sapiens GN=PDIA6 PE=1 SV=1 | 214 | K | 0.567767 | R | 0.472583 | 0.095184 | D to O | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 26 | A | 0.593498 | T | 0.625397 | -0.031899 | No Change: Both D | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 106 | E | 0.433504 | Q | 0.391443 | 0.042061 | No Change: Both O | A colorectal cancer sample |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 446 | D | 0.136241 | N | 0.127467 | 0.008774 | No Change: Both O | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 447 | V | 0.117487 | I | 0.116863 | 6.24E-04 | No Change: Both O | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 475 | L | 0.418929 | R | 0.53748 | -0.118551 | O to D | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 527 | R | 0.949384 | K | 0.965482 | -0.016098 | No Change: Both D | - |
| Q8N807 | PDILT_HUMAN Protein disulfide-isomerase-like protein of the testis OS=Homo sapiens GN=PDILT PE=1 SV=2 | 529 | G | 0.956802 | E | 0.97554 | -0.018738 | No Change: Both D | - |
| Q15118 | PDK1_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1 mitochondrial OS=Homo sapiens GN=PDK1 PE=1 SV=1 | 412 | N | 0.40755 | T | 0.366121 | 0.041429 | No Change: Both O | - |
| Q15118 | PDK1_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1 mitochondrial OS=Homo sapiens GN=PDK1 PE=1 SV=1 | 134 | A | 0.367687 | T | 0.393147 | -0.02546 | No Change: Both O | - |
| Q15119 | PDK2_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2 mitochondrial OS=Homo sapiens GN=PDK2 PE=1 SV=2 | 342 | G | 0.1765 | R | 0.17042 | 0.00608 | No Change: Both O | A glioblastoma multiforme sample |
| Q15120 | PDK3_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 mitochondrial OS=Homo sapiens GN=PDK3 PE=1 SV=1 | 219 | E | 0.361966 | A | 0.256742 | 0.105224 | No Change: Both O | A head & Neck squamous cell carcinoma sample |
| Q16654 | PDK4_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4 mitochondrial OS=Homo sapiens GN=PDK4 PE=1 SV=1 | 17 | A | 0.515641 | V | 0.440048 | 0.075593 | D to O | - |
| Q16654 | PDK4_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4 mitochondrial OS=Homo sapiens GN=PDK4 PE=1 SV=1 | 19 | L | 0.472908 | M | 0.552314 | -0.079406 | O to D | - |
| Q16654 | PDK4_HUMAN [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4 mitochondrial OS=Homo sapiens GN=PDK4 PE=1 SV=1 | 109 | D | 0.752416 | G | 0.726994 | 0.025422 | No Change: Both D | - |
| O00151 | PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Homo sapiens GN=PDLIM1 PE=1 SV=4 | 175 | N | 0.752725 | S | 0.797667 | -0.044942 | No Change: Both D | - |
| Q53GG5 | PDLI3_HUMAN PDZ and LIM domain protein 3 OS=Homo sapiens GN=PDLIM3 PE=2 SV=1 | 127 | V | 0.780853 | M | 0.83409 | -0.053237 | No Change: Both D | - |
| P50479 | PDLI4_HUMAN PDZ and LIM domain protein 4 OS=Homo sapiens GN=PDLIM4 PE=1 SV=2 | 118 | R | 0.983507 | G | 0.982154 | 0.001353 | No Change: Both D | - |
| P50479 | PDLI4_HUMAN PDZ and LIM domain protein 4 OS=Homo sapiens GN=PDLIM4 PE=1 SV=2 | 184 | V | 0.852339 | I | 0.809988 | 0.042351 | No Change: Both D | - |
| P50479 | PDLI4_HUMAN PDZ and LIM domain protein 4 OS=Homo sapiens GN=PDLIM4 PE=1 SV=2 | 259 | G | 0.240155 | C | 0.17897 | 0.061185 | No Change: Both O | - |
| P50479 | PDLI4_HUMAN PDZ and LIM domain protein 4 OS=Homo sapiens GN=PDLIM4 PE=1 SV=2 | 142 | R | 0.970111 | C | 0.956968 | 0.013143 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 136 | S | 0.960846 | F | 0.924216 | 0.03663 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 319 | S | 0.969835 | L | 0.935996 | 0.033839 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 345 | A | 0.823625 | T | 0.845149 | -0.021524 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 381 | T | 0.826027 | A | 0.815815 | 0.010212 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 388 | P | 0.818478 | S | 0.828791 | -0.010313 | No Change: Both D | - |
| Q96HC4 | PDLI5_HUMAN PDZ and LIM domain protein 5 OS=Homo sapiens GN=PDLIM5 PE=1 SV=5 | 492 | S | 0.154304 | N | 0.127676 | 0.026628 | No Change: Both O | - |
| Q9NR12 | PDLI7_HUMAN PDZ and LIM domain protein 7 OS=Homo sapiens GN=PDLIM7 PE=1 SV=1 | 450 | K | 0.567168 | N | 0.50668 | 0.060488 | No Change: Both D | A breast cancer sample |
| Q9NR12 | PDLI7_HUMAN PDZ and LIM domain protein 7 OS=Homo sapiens GN=PDLIM7 PE=1 SV=1 | 326 | A | 0.217773 | T | 0.228768 | -0.010995 | No Change: Both O | - |
| Q86YL7 | PDPN_HUMAN Podoplanin OS=Homo sapiens GN=PDPN PE=1 SV=3 | 105 | A | 0.845414 | G | 0.859456 | -0.014042 | No Change: Both D | - |
| Q86YL7 | PDPN_HUMAN Podoplanin OS=Homo sapiens GN=PDPN PE=1 SV=3 | 147 | A | 0.019279 | G | 0.026996 | -0.007717 | No Change: Both O | - |
| Q8NCN5 | PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit mitochondrial OS=Homo sapiens GN=PDPR PE=1 SV=2 | 109 | Y | 0.29112 | H | 0.38054 | -0.08942 | No Change: Both O | - |
| Q5T2R2 | DPS1_HUMAN Decaprenyl-diphosphate synthase subunit 1 OS=Homo sapiens GN=PDSS1 PE=1 SV=1 | 308 | D | 0.105648 | E | 0.105293 | 3.55E-04 | No Change: Both O | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| Q86YH6 | DLP1_HUMAN Decaprenyl-diphosphate synthase subunit 2 OS=Homo sapiens GN=PDSS2 PE=1 SV=2 | 3 | F | 0.644306 | L | 0.695552 | -0.051246 | No Change: Both D | - |
| Q86YH6 | DLP1_HUMAN Decaprenyl-diphosphate synthase subunit 2 OS=Homo sapiens GN=PDSS2 PE=1 SV=2 | 382 | S | 0.688436 | L | 0.520942 | 0.167494 | No Change: Both D | Coenzyme Q10 deficiency (COQ10D) [MIM:607426] |
| P52945 | PDX1_HUMAN Pancreas/duodenum homeobox protein 1 OS=Homo sapiens GN=PDX1 PE=1 SV=1 | 18 | C | 0.668677 | R | 0.748313 | -0.079636 | No Change: Both D | Maturity-onset diabetes of the young type 4 (MODY4) [MIM:606392] |
| P52945 | PDX1_HUMAN Pancreas/duodenum homeobox protein 1 OS=Homo sapiens GN=PDX1 PE=1 SV=1 | 59 | Q | 0.930544 | L | 0.913207 | 0.017337 | No Change: Both D | Maturity-onset diabetes of the young type 4 (MODY4) [MIM:606392] |
| P52945 | PDX1_HUMAN Pancreas/duodenum homeobox protein 1 OS=Homo sapiens GN=PDX1 PE=1 SV=1 | 76 | D | 0.899845 | N | 0.871689 | 0.028156 | No Change: Both D | Maturity-onset diabetes of the young type 4 (MODY4) [MIM:606392] |
| P52945 | PDX1_HUMAN Pancreas/duodenum homeobox protein 1 OS=Homo sapiens GN=PDX1 PE=1 SV=1 | 197 | R | 0.285764 | H | 0.248356 | 0.037408 | No Change: Both O | Maturity-onset diabetes of the young type 4 (MODY4) [MIM:606392] |
| Q6P996 | PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens GN=PDXDC1 PE=1 SV=2 | 301 | P | 0.311301 | L | 0.176826 | 0.134475 | No Change: Both O | - |
| Q6P474 | PDXD2_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 2 OS=Homo sapiens GN=PDXDC2P PE=5 SV=3 | 209 | M | 0.243557 | V | 0.197733 | 0.045824 | No Change: Both O | - |
| Q6P474 | PDXD2_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 2 OS=Homo sapiens GN=PDXDC2P PE=5 SV=3 | 429 | L | 0.162332 | F | 0.127819 | 0.034513 | No Change: Both O | - |
| Q6P474 | PDXD2_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 2 OS=Homo sapiens GN=PDXDC2P PE=5 SV=3 | 429 | L | 0.162332 | R | 0.240071 | -0.077739 | No Change: Both O | - |
| P01213 | PDYN_HUMAN Proenkephalin-B OS=Homo sapiens GN=PDYN PE=1 SV=1 | 138 | R | 0.861212 | S | 0.880036 | -0.018824 | No Change: Both D | Spinocerebellar ataxia type 23 (SCA23) [MIM:610245] |
| P01213 | PDYN_HUMAN Proenkephalin-B OS=Homo sapiens GN=PDYN PE=1 SV=1 | 211 | L | 0.350559 | S | 0.505668 | -0.155109 | O to D | Spinocerebellar ataxia type 23 (SCA23) [MIM:610245] |
| P01213 | PDYN_HUMAN Proenkephalin-B OS=Homo sapiens GN=PDYN PE=1 SV=1 | 212 | R | 0.335499 | W | 0.143377 | 0.192122 | No Change: Both O | Spinocerebellar ataxia type 23 (SCA23) [MIM:610245] |
| P01213 | PDYN_HUMAN Proenkephalin-B OS=Homo sapiens GN=PDYN PE=1 SV=1 | 215 | R | 0.358243 | C | 0.210719 | 0.147524 | No Change: Both O | Spinocerebellar ataxia type 23 (SCA23) [MIM:610245] |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1258 | Q | 0.982785 | K | 0.985302 | -0.002517 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1274 | T | 0.986475 | A | 0.986371 | 1.04E-04 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1343 | D | 0.878916 | E | 0.91133 | -0.032414 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1425 | T | 0.815557 | M | 0.804876 | 0.010681 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1649 | A | 0.911972 | V | 0.880716 | 0.031256 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 2247 | R | 0.903019 | Q | 0.902349 | 6.70E-04 | No Change: Both D | - |
| O15018 | PDZD2_HUMAN PDZ domain-containing protein 2 OS=Homo sapiens GN=PDZD2 PE=1 SV=4 | 1178 | E | 0.60694 | G | 0.585979 | 0.020961 | No Change: Both D | - |
| Q76G19 | PDZD4_HUMAN PDZ domain-containing protein 4 OS=Homo sapiens GN=PDZD4 PE=2 SV=1 | 39 | R | 0.827042 | C | 0.745548 | 0.081494 | No Change: Both D | A breast cancer sample |
| Q8NEN9 | PDZD8_HUMAN PDZ domain-containing protein 8 OS=Homo sapiens GN=PDZD8 PE=1 SV=1 | 806 | V | 0.579003 | A | 0.616068 | -0.037065 | No Change: Both D | - |
| Q8NEN9 | PDZD8_HUMAN PDZ domain-containing protein 8 OS=Homo sapiens GN=PDZD8 PE=1 SV=1 | 897 | R | 0.46553 | Q | 0.456482 | 0.009048 | No Change: Both O | - |
| Q9UPQ7 | PZRN3_HUMAN E3 ubiquitin-protein ligase PDZRN3 OS=Homo sapiens GN=PDZRN3 PE=1 SV=2 | 783 | A | 0.826783 | V | 0.766099 | 0.060684 | No Change: Both D | - |
| Q6ZMN7 | PZRN4_HUMAN PDZ domain-containing RING finger protein 4 OS=Homo sapiens GN=PDZRN4 PE=1 SV=3 | 429 | G | 0.485312 | S | 0.553246 | -0.067934 | O to D | - |
| Q6ZMN7 | PZRN4_HUMAN PDZ domain-containing RING finger protein 4 OS=Homo sapiens GN=PDZRN4 PE=1 SV=3 | 784 | G | 0.987251 | R | 0.990872 | -0.003621 | No Change: Both D | A colorectal cancer sample |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 213 | G | 0.55121 | R | 0.552593 | -0.001383 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 240 | V | 0.894979 | I | 0.89283 | 0.002149 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 440 | S | 0.684201 | P | 0.684908 | -7.07E-04 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 611 | H | 0.317689 | Q | 0.34872 | -0.031031 | No Change: Both O | A bladder carcinoma NOS sample |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 792 | S | 0.927412 | I | 0.85939 | 0.068022 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 836 | D | 0.992132 | E | 0.99304 | -9.08E-04 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1035 | S | 0.929335 | F | 0.853108 | 0.076227 | No Change: Both D | A metastatic melanoma sample |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1071 | R | 0.783491 | K | 0.792187 | -0.008696 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1077 | T | 0.77156 | P | 0.812287 | -0.040727 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1145 | P | 0.928792 | L | 0.862698 | 0.066094 | No Change: Both D | A metastatic melanoma sample |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1408 | P | 0.799823 | Q | 0.785943 | 0.01388 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1542 | S | 0.742706 | T | 0.706039 | 0.036667 | No Change: Both D | - |
| Q9H792 | PEAK1_HUMAN Pseudopodium-enriched atypical kinase 1 OS=Homo sapiens GN=PEAK1 PE=1 SV=4 | 1699 | R | 0.071404 | G | 0.073633 | -0.002229 | No Change: Both O | - |
| Q5VY43 | PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens GN=PEAR1 PE=1 SV=1 | 234 | S | 0.909394 | P | 0.911322 | -0.001928 | No Change: Both D | - |
| Q5VY43 | PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens GN=PEAR1 PE=1 SV=1 | 885 | R | 0.895393 | H | 0.867307 | 0.028086 | No Change: Both D | - |
| Q5VY43 | PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens GN=PEAR1 PE=1 SV=1 | 903 | N | 0.764892 | D | 0.768831 | -0.003939 | No Change: Both D | - |
| Q5VY43 | PEAR1_HUMAN Platelet endothelial aggregation receptor 1 OS=Homo sapiens GN=PEAR1 PE=1 SV=1 | 848 | N | 0.930121 | K | 0.934215 | -0.004094 | No Change: Both D | - |
| P30086 | PEBP1_HUMAN Phosphatidylethanolamine-binding protein 1 OS=Homo sapiens GN=PEBP1 PE=1 SV=3 | 9 | S | 0.527817 | N | 0.433265 | 0.094552 | D to O | - |
| Q96S96 | PEBP4_HUMAN Phosphatidylethanolamine-binding protein 4 OS=Homo sapiens GN=PEBP4 PE=1 SV=3 | 125 | K | 0.544225 | E | 0.533251 | 0.010974 | No Change: Both D | - |
| Q96S96 | PEBP4_HUMAN Phosphatidylethanolamine-binding protein 4 OS=Homo sapiens GN=PEBP4 PE=1 SV=3 | 211 | E | 0.895155 | G | 0.845668 | 0.049487 | No Change: Both D | - |
| P16284 | PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1 | 125 | L | 0.252343 | V | 0.261469 | -0.009126 | No Change: Both O | - |
| P16284 | PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1 | 304 | C | 0.500554 | Y | 0.545095 | -0.044541 | No Change: Both D | - |
| P16284 | PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1 | 563 | S | 0.639763 | I | 0.485945 | 0.153818 | D to O | - |
| P16284 | PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1 | 563 | S | 0.639763 | N | 0.615933 | 0.02383 | No Change: Both D | - |
| P16284 | PECA1_HUMAN Platelet endothelial cell adhesion molecule OS=Homo sapiens GN=PECAM1 PE=1 SV=1 | 670 | R | 0.812608 | G | 0.814549 | -0.001941 | No Change: Both D | - |
| Q9BY49 | PECR_HUMAN Peroxisomal trans-2-enoyl-CoA reductase OS=Homo sapiens GN=PECR PE=1 SV=2 | 149 | E | 0.444997 | K | 0.46278 | -0.017783 | No Change: Both O | - |
| Q9BY49 | PECR_HUMAN Peroxisomal trans-2-enoyl-CoA reductase OS=Homo sapiens GN=PECR PE=1 SV=2 | 297 | F | 0.749669 | L | 0.782498 | -0.032829 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 235 | A | 0.680681 | T | 0.699865 | -0.019184 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 839 | V | 0.753306 | L | 0.754629 | -0.001323 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 983 | D | 0.600732 | G | 0.58493 | 0.015802 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 1576 | R | 0.304744 | L | 0.203309 | 0.101435 | No Change: Both O | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 594 | R | 0.910597 | H | 0.900328 | 0.010269 | No Change: Both D | A colorectal cancer sample |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 624 | E | 0.725828 | G | 0.67426 | 0.051568 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 947 | N | 0.592102 | S | 0.666032 | -0.07393 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 1456 | A | 0.998603 | V | 0.997623 | 9.80E-04 | No Change: Both D | - |
| Q9GZU2 | PEG3_HUMAN Paternally-expressed gene 3 protein OS=Homo sapiens GN=PEG3 PE=2 SV=1 | 1576 | R | 0.304744 | H | 0.292812 | 0.011932 | No Change: Both O | - |
| Q8N2H9 | PELI3_HUMAN E3 ubiquitin-protein ligase pellino homolog 3 OS=Homo sapiens GN=PELI3 PE=1 SV=2 | 287 | V | 0.440393 | M | 0.487667 | -0.047274 | No Change: Both O | - |
| Q9BRX2 | PELO_HUMAN Protein pelota homolog OS=Homo sapiens GN=PELO PE=1 SV=2 | 221 | L | 0.084122 | M | 0.1105 | -0.026378 | No Change: Both O | - |
| Q8IZL8 | PELP1_HUMAN Proline- glutamic acid- and leucine-rich protein 1 OS=Homo sapiens GN=PELP1 PE=1 SV=2 | 1126 | T | 0.993318 | S | 0.9948 | -0.001482 | No Change: Both D | - |
| Q9UBM1 | PEMT_HUMAN Phosphatidylethanolamine N-methyltransferase OS=Homo sapiens GN=PEMT PE=1 SV=4 | 175 | V | 0.029368 | M | 0.03766 | -0.008292 | No Change: Both O | - |
| Q9UBM1 | PEMT_HUMAN Phosphatidylethanolamine N-methyltransferase OS=Homo sapiens GN=PEMT PE=1 SV=4 | 58 | V | 0.043847 | I | 0.041458 | 0.002389 | No Change: Both O | - |
| Q9UBM1 | PEMT_HUMAN Phosphatidylethanolamine N-methyltransferase OS=Homo sapiens GN=PEMT PE=1 SV=4 | 3 | R | 0.658264 | W | 0.346855 | 0.311409 | D to O | - |
| Q9UBM1 | PEMT_HUMAN Phosphatidylethanolamine N-methyltransferase OS=Homo sapiens GN=PEMT PE=1 SV=4 | 194 | G | 0.899375 | R | 0.88757 | 0.011805 | No Change: Both D | - |
| Q9UBM1 | PEMT_HUMAN Phosphatidylethanolamine N-methyltransferase OS=Homo sapiens GN=PEMT PE=1 SV=4 | 58 | V | 0.043847 | L | 0.053041 | -0.009194 | No Change: Both O | - |
| P01210 | PENK_HUMAN Proenkephalin-A OS=Homo sapiens GN=PENK PE=1 SV=1 | 247 | G | 0.810257 | D | 0.820007 | -0.00975 | No Change: Both D | - |
| P01210 | PENK_HUMAN Proenkephalin-A OS=Homo sapiens GN=PENK PE=1 SV=1 | 83 | T | 0.83451 | N | 0.842168 | -0.007658 | No Change: Both D | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 303 | R | 0.046066 | W | 0.015304 | 0.030762 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 315 | W | 0.216848 | L | 0.294103 | -0.077255 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 319 | K | 0.246999 | E | 0.246593 | 4.06E-04 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 319 | K | 0.246999 | T | 0.175 | 0.071999 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 334 | R | 0.334791 | Q | 0.351454 | -0.016663 | No Change: Both O | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 335 | P | 0.402406 | L | 0.241064 | 0.161342 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 354 | R | 0.204936 | P | 0.228294 | -0.023358 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 359 | A | 0.176467 | T | 0.192538 | -0.016071 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 367 | I | 0.199088 | T | 0.305643 | -0.106555 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 368 | V | 0.191906 | I | 0.18241 | 0.009496 | No Change: Both O | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 369 | S | 0.207494 | P | 0.188137 | 0.019357 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 369 | S | 0.207494 | Y | 0.091311 | 0.116183 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 374 | R | 0.344412 | Q | 0.36218 | -0.017768 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 381 | L | 0.424354 | P | 0.536831 | -0.112477 | O to D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 474 | W | 0.249791 | C | 0.283079 | -0.033288 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 475 | A | 0.226215 | P | 0.30844 | -0.082225 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 457 | T | 0.153851 | I | 0.084636 | 0.069215 | No Change: Both O | Mitochondrial DNA depletion syndrome type 7 (MTDPS7) [MIM:271245] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 508 | Y | 0.044831 | C | 0.035802 | 0.009029 | No Change: Both O | Mitochondrial DNA depletion syndrome type 7 (MTDPS7) [MIM:271245] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 427 | E | 0.172623 | G | 0.149073 | 0.02355 | No Change: Both O | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 348 | G | 0.335951 | R | 0.356645 | -0.020694 | No Change: Both O | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 634 | N | 0.761 | K | 0.795237 | -0.034237 | No Change: Both D | - |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 303 | R | 0.046066 | Q | 0.047007 | -9.41E-04 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 315 | W | 0.216848 | S | 0.410887 | -0.194039 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 318 | A | 0.252664 | T | 0.252354 | 3.10E-04 | No Change: Both O | Mitochondrial DNA depletion syndrome type 7 (MTDPS7) [MIM:271245] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 334 | R | 0.334791 | P | 0.378399 | -0.043608 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 357 | R | 0.184445 | P | 0.206983 | -0.022538 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 360 | L | 0.175088 | G | 0.255426 | -0.080338 | No Change: Both O | Mitochondrial DNA depletion syndrome type 7 (MTDPS7) [MIM:271245] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 362 | A | 0.16981 | P | 0.235523 | -0.065713 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 363 | W | 0.177343 | L | 0.269128 | -0.091785 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 370 | F | 0.224662 | C | 0.221985 | 0.002677 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 370 | F | 0.224662 | L | 0.266357 | -0.041695 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 426 | S | 0.20663 | N | 0.166152 | 0.040478 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 458 | Q | 0.19409 | H | 0.179224 | 0.014866 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 460 | A | 0.278557 | P | 0.352494 | -0.073937 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 474 | W | 0.249791 | S | 0.51147 | -0.261679 | O to D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 475 | A | 0.226215 | D | 0.329213 | -0.102998 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 478 | F | 0.205111 | I | 0.197745 | 0.007366 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| Q96RR1 | PEO1_HUMAN Twinkle protein mitochondrial OS=Homo sapiens GN=PEO1 PE=1 SV=1 | 479 | E | 0.167673 | K | 0.169903 | -0.00223 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 3 (PEOA3) [MIM:609286] |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 276 | D | 0.124207 | N | 0.113237 | 0.01097 | No Change: Both O | Prolidase deficiency (PD) [MIM:170100] |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 448 | G | 0.221992 | R | 0.224968 | -0.002976 | No Change: Both O | Prolidase deficiency (PD) [MIM:170100] |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 184 | R | 0.1557 | Q | 0.153179 | 0.002521 | No Change: Both O | Prolidase deficiency (PD) [MIM:170100] |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 278 | G | 0.124853 | D | 0.142115 | -0.017262 | No Change: Both O | Prolidase deficiency (PD) [MIM:170100] |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 435 | L | 0.263336 | F | 0.239621 | 0.023715 | No Change: Both O | - |
| P12955 | PEPD_HUMAN Xaa-Pro dipeptidase OS=Homo sapiens GN=PEPD PE=1 SV=3 | 388 | R | 0.549597 | H | 0.544633 | 0.004964 | No Change: Both D | - |
| O15534 | PER1_HUMAN Period circadian protein homolog 1 OS=Homo sapiens GN=PER1 PE=1 SV=2 | 696 | E | 0.837584 | Q | 0.821648 | 0.015936 | No Change: Both D | A breast cancer sample |
| O15534 | PER1_HUMAN Period circadian protein homolog 1 OS=Homo sapiens GN=PER1 PE=1 SV=2 | 985 | N | 0.949464 | S | 0.962926 | -0.013462 | No Change: Both D | A breast cancer sample |
| O15534 | PER1_HUMAN Period circadian protein homolog 1 OS=Homo sapiens GN=PER1 PE=1 SV=2 | 1060 | S | 0.992967 | L | 0.987531 | 0.005436 | No Change: Both D | A colorectal cancer sample |
| O15534 | PER1_HUMAN Period circadian protein homolog 1 OS=Homo sapiens GN=PER1 PE=1 SV=2 | 962 | A | 0.994417 | P | 0.996864 | -0.002447 | No Change: Both D | - |
| O15534 | PER1_HUMAN Period circadian protein homolog 1 OS=Homo sapiens GN=PER1 PE=1 SV=2 | 968 | R | 0.983314 | H | 0.980396 | 0.002918 | No Change: Both D | - |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 1244 | G | 0.863634 | E | 0.906864 | -0.04323 | No Change: Both D | - |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 662 | S | 0.675024 | G | 0.606631 | 0.068393 | No Change: Both D | Familial advanced sleep-phase syndrome (FASPS) [MIM:604348] |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 823 | L | 0.937422 | V | 0.940975 | -0.003553 | No Change: Both D | A breast cancer sample |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 5 | A | 0.987699 | S | 0.994732 | -0.007033 | No Change: Both D | - |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 729 | V | 0.633494 | I | 0.645431 | -0.011937 | No Change: Both D | - |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 903 | V | 0.859604 | I | 0.819541 | 0.040063 | No Change: Both D | - |
| O15055 | PER2_HUMAN Period circadian protein homolog 2 OS=Homo sapiens GN=PER2 PE=1 SV=2 | 949 | F | 0.991776 | Y | 0.98928 | 0.002496 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 856 | P | 0.666754 | A | 0.537484 | 0.12927 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 827 | L | 0.657408 | P | 0.78644 | -0.129032 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 639 | V | 0.425536 | G | 0.5214 | -0.095864 | O to D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 1028 | M | 0.997067 | T | 0.997526 | -4.59E-04 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 1149 | H | 0.697866 | R | 0.723442 | -0.025576 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 1007 | A | 0.998344 | T | 0.998641 | -2.97E-04 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 1010 | T | 0.997875 | I | 0.995639 | 0.002236 | No Change: Both D | - |
| P56645 | PER3_HUMAN Period circadian protein homolog 3 OS=Homo sapiens GN=PER3 PE=2 SV=4 | 1081 | S | 0.859562 | C | 0.773688 | 0.085874 | No Change: Both D | - |
| Q96FX8 | PERP_HUMAN p53 apoptosis effector related to PMP-22 OS=Homo sapiens GN=PERP PE=2 SV=1 | 143 | P | 0.145528 | R | 0.121834 | 0.023694 | No Change: Both O | - |
| O00541 | PESC_HUMAN Pescadillo homolog OS=Homo sapiens GN=PES1 PE=1 SV=1 | 264 | T | 0.572674 | S | 0.671531 | -0.098857 | No Change: Both D | - |
| O00541 | PESC_HUMAN Pescadillo homolog OS=Homo sapiens GN=PES1 PE=1 SV=1 | 370 | D | 0.347333 | H | 0.307587 | 0.039746 | No Change: Both O | - |
| O00541 | PESC_HUMAN Pescadillo homolog OS=Homo sapiens GN=PES1 PE=1 SV=1 | 411 | A | 0.124268 | T | 0.137313 | -0.013045 | No Change: Both O | - |
| O75879 | GATB_HUMAN Glutamyl-tRNA(Gln) amidotransferase subunit B mitochondrial OS=Homo sapiens GN=PET112 PE=1 SV=1 | 30 | A | 0.768343 | D | 0.791011 | -0.022668 | No Change: Both D | - |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 664 | L | 0.17306 | P | 0.294626 | -0.121566 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 843 | G | 0.222619 | D | 0.242716 | -0.020097 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 843 | G | 0.222619 | D | 0.242716 | -0.020097 | No Change: Both O | Infantile Refsum disease (IRD) [MIM:266510] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 696 | I | 0.317402 | M | 0.427622 | -0.11022 | No Change: Both O | - |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 640 | I | 0.3607 | R | 0.5372 | -0.1765 | O to D | - |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 590 | L | 0.342073 | R | 0.452823 | -0.11075 | No Change: Both O | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:602136] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 593 | G | 0.342894 | R | 0.340961 | 0.001933 | No Change: Both O | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:602136] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 798 | R | 0.580359 | G | 0.570202 | 0.010157 | No Change: Both D | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:602136] |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 948 | R | 0.525696 | Q | 0.528254 | -0.002558 | No Change: Both D | - |
| O43933 | PEX1_HUMAN Peroxisome biogenesis factor 1 OS=Homo sapiens GN=PEX1 PE=1 SV=1 | 1237 | A | 0.529349 | E | 0.612777 | -0.083428 | No Change: Both D | Peroxisome biogenesis disorder complementation group 1 (PBD-CG1) [MIM:602136] |
| O60683 | PEX10_HUMAN Peroxisome biogenesis factor 10 OS=Homo sapiens GN=PEX10 PE=1 SV=1 | 290 | H | 0.36178 | Q | 0.388752 | -0.026972 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| O60683 | PEX10_HUMAN Peroxisome biogenesis factor 10 OS=Homo sapiens GN=PEX10 PE=1 SV=1 | 274 | T | 0.560603 | A | 0.53877 | 0.021833 | No Change: Both D | - |
| Q96HA9 | PX11C_HUMAN Peroxisomal membrane protein 11C OS=Homo sapiens GN=PEX11G PE=1 SV=1 | 91 | C | 0.07591 | W | 0.064055 | 0.011855 | No Change: Both O | - |
| O00623 | PEX12_HUMAN Peroxisome assembly protein 12 OS=Homo sapiens GN=PEX12 PE=1 SV=1 | 320 | S | 0.082794 | F | 0.033323 | 0.049471 | No Change: Both O | - |
| O00623 | PEX12_HUMAN Peroxisome assembly protein 12 OS=Homo sapiens GN=PEX12 PE=1 SV=1 | 245 | L | 0.311595 | I | 0.266218 | 0.045377 | No Change: Both O | - |
| O00623 | PEX12_HUMAN Peroxisome assembly protein 12 OS=Homo sapiens GN=PEX12 PE=1 SV=1 | 34 | R | 0.262122 | S | 0.34189 | -0.079768 | No Change: Both O | Peroxisome biogenesis disorder complementation group 3 (PBD-CG3) [MIM:601758] |
| Q92968 | PEX13_HUMAN Peroxisomal membrane protein PEX13 OS=Homo sapiens GN=PEX13 PE=1 SV=2 | 326 | I | 0.246925 | T | 0.374736 | -0.127811 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| O75381 | PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens GN=PEX14 PE=1 SV=1 | 117 | A | 0.055359 | S | 0.08059 | -0.025231 | No Change: Both O | - |
| O75381 | PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens GN=PEX14 PE=1 SV=1 | 150 | A | 0.618354 | S | 0.727092 | -0.108738 | No Change: Both D | - |
| O75381 | PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens GN=PEX14 PE=1 SV=1 | 320 | R | 0.988097 | K | 0.989301 | -0.001204 | No Change: Both D | - |
| Q9Y5Y5 | PEX16_HUMAN Peroxisomal membrane protein PEX16 OS=Homo sapiens GN=PEX16 PE=1 SV=2 | 254 | V | 0.212374 | L | 0.224622 | -0.012248 | No Change: Both O | - |
| Q9Y5Y5 | PEX16_HUMAN Peroxisomal membrane protein PEX16 OS=Homo sapiens GN=PEX16 PE=1 SV=2 | 103 | V | 0.177868 | M | 0.228459 | -0.050591 | No Change: Both O | - |
| Q9Y5Y5 | PEX16_HUMAN Peroxisomal membrane protein PEX16 OS=Homo sapiens GN=PEX16 PE=1 SV=2 | 116 | V | 0.036429 | I | 0.030568 | 0.005861 | No Change: Both O | - |
| P28328 | PEX2_HUMAN Peroxisome biogenesis factor 2 OS=Homo sapiens GN=PEX2 PE=1 SV=2 | 55 | E | 0.145385 | K | 0.145033 | 3.52E-04 | No Change: Both O | Infantile Refsum disease (IRD) [MIM:266510] |
| P28328 | PEX2_HUMAN Peroxisome biogenesis factor 2 OS=Homo sapiens GN=PEX2 PE=1 SV=2 | 184 | C | 0.118081 | R | 0.226434 | -0.108353 | No Change: Both O | - |
| Q7Z412 | PEX26_HUMAN Peroxisome assembly protein 26 OS=Homo sapiens GN=PEX26 PE=1 SV=2 | 45 | L | 0.289364 | P | 0.414807 | -0.125443 | No Change: Both O | Infantile Refsum disease (IRD) [MIM:266510] |
| Q7Z412 | PEX26_HUMAN Peroxisome assembly protein 26 OS=Homo sapiens GN=PEX26 PE=1 SV=2 | 89 | G | 0.065918 | R | 0.069475 | -0.003557 | No Change: Both O | Zellweger syndrome (ZWS) [MIM:214100] |
| Q7Z412 | PEX26_HUMAN Peroxisome assembly protein 26 OS=Homo sapiens GN=PEX26 PE=1 SV=2 | 98 | R | 0.164523 | W | 0.073865 | 0.090658 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| Q7Z412 | PEX26_HUMAN Peroxisome assembly protein 26 OS=Homo sapiens GN=PEX26 PE=1 SV=2 | 153 | L | 0.457651 | V | 0.442139 | 0.015512 | No Change: Both O | - |
| P56589 | PEX3_HUMAN Peroxisomal biogenesis factor 3 OS=Homo sapiens GN=PEX3 PE=1 SV=1 | 138 | G | 0.050109 | E | 0.059827 | -0.009718 | No Change: Both O | Zellweger syndrome (ZWS) [MIM:214100] |
| P56589 | PEX3_HUMAN Peroxisomal biogenesis factor 3 OS=Homo sapiens GN=PEX3 PE=1 SV=1 | 82 | Q | 0.55619 | R | 0.54648 | 0.00971 | No Change: Both D | - |
| P50542 | PEX5_HUMAN Peroxisomal targeting signal 1 receptor OS=Homo sapiens GN=PEX5 PE=1 SV=3 | 526 | N | 0.124936 | K | 0.147147 | -0.022211 | No Change: Both O | Adrenoleukodystrophy neonatal (NALD) [MIM:202370] |
| P50542 | PEX5_HUMAN Peroxisomal targeting signal 1 receptor OS=Homo sapiens GN=PEX5 PE=1 SV=3 | 600 | S | 0.548072 | W | 0.284539 | 0.263533 | D to O | Infantile Refsum disease (IRD) [MIM:266510] |
| Q8IYB4 | PEX5R_HUMAN PEX5-related protein OS=Homo sapiens GN=PEX5L PE=1 SV=2 | 226 | A | 0.932741 | T | 0.936578 | -0.003837 | No Change: Both D | A colorectal cancer sample |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 812 | R | 0.706965 | Q | 0.698451 | 0.008514 | No Change: Both D | Zellweger syndrome (ZWS) [MIM:214100] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 812 | R | 0.706965 | W | 0.572034 | 0.134931 | No Change: Both D | Zellweger syndrome (ZWS) [MIM:214100] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 809 | A | 0.585503 | V | 0.52564 | 0.059863 | No Change: Both D | - |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 882 | V | 0.264524 | I | 0.244829 | 0.019695 | No Change: Both O | - |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 939 | P | 0.701259 | Q | 0.695689 | 0.00557 | No Change: Both D | - |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 79 | A | 0.518802 | P | 0.614356 | -0.095554 | No Change: Both D | - |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 274 | P | 0.240063 | L | 0.15219 | 0.087873 | No Change: Both O | Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:601498] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 601 | R | 0.39486 | Q | 0.416289 | -0.021429 | No Change: Both O | - |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 849 | N | 0.232685 | T | 0.223461 | 0.009224 | No Change: Both O | Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:601498] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 860 | R | 0.259916 | Q | 0.261232 | -0.001316 | No Change: Both O | Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:601498] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 860 | R | 0.259916 | W | 0.107266 | 0.15265 | No Change: Both O | Peroxisome biogenesis disorder complementation group 4 (PBD-CG4) [MIM:601498] |
| Q13608 | PEX6_HUMAN Peroxisome assembly factor 2 OS=Homo sapiens GN=PEX6 PE=1 SV=2 | 924 | A | 0.413923 | S | 0.515281 | -0.101358 | O to D | - |
| O00628 | PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens GN=PEX7 PE=1 SV=1 | 217 | G | 0.119654 | R | 0.114423 | 0.005231 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 1 (RCDP1) [MIM:215100] |
| O00628 | PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens GN=PEX7 PE=1 SV=1 | 218 | A | 0.115109 | V | 0.088403 | 0.026706 | No Change: Both O | Rhizomelic chondrodysplasia punctata type 1 (RCDP1) [MIM:215100] |
| O00628 | PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens GN=PEX7 PE=1 SV=1 | 14 | T | 0.511957 | P | 0.605183 | -0.093226 | No Change: Both D | Refsum disease (RD) [MIM:266500] |
| O15067 | PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens GN=PFAS PE=1 SV=4 | 19 | P | 0.72533 | S | 0.744878 | -0.019548 | No Change: Both D | - |
| O15067 | PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens GN=PFAS PE=1 SV=4 | 367 | P | 0.362333 | L | 0.208393 | 0.15394 | No Change: Both O | - |
| O15067 | PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens GN=PFAS PE=1 SV=4 | 481 | F | 0.49804 | Y | 0.518773 | -0.020733 | O to D | - |
| O15067 | PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens GN=PFAS PE=1 SV=4 | 621 | L | 0.739647 | P | 0.850063 | -0.110416 | No Change: Both D | - |
| O60925 | PFD1_HUMAN Prefoldin subunit 1 OS=Homo sapiens GN=PFDN1 PE=1 SV=2 | 67 | M | 0.259164 | R | 0.287203 | -0.028039 | No Change: Both O | - |
| Q16877 | F264_HUMAN 6-phosphofructo-2-kinase/fructose-2 6-biphosphatase 4 OS=Homo sapiens GN=PFKFB4 PE=2 SV=6 | 181 | N | 0.55405 | K | 0.579952 | -0.025902 | No Change: Both D | A breast cancer sample |
| P17858 | K6PL_HUMAN 6-phosphofructokinase liver type OS=Homo sapiens GN=PFKL PE=1 SV=6 | 81 | G | 0.165509 | A | 0.126197 | 0.039312 | No Change: Both O | - |
| P17858 | K6PL_HUMAN 6-phosphofructokinase liver type OS=Homo sapiens GN=PFKL PE=1 SV=6 | 151 | R | 0.402542 | W | 0.222113 | 0.180429 | No Change: Both O | - |
| P17858 | K6PL_HUMAN 6-phosphofructokinase liver type OS=Homo sapiens GN=PFKL PE=1 SV=6 | 237 | D | 0.459916 | V | 0.285789 | 0.174127 | No Change: Both O | - |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 39 | R | 0.084204 | L | 0.043439 | 0.040765 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 39 | R | 0.084204 | P | 0.09151 | -0.007306 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 100 | R | 0.294684 | Q | 0.285082 | 0.009602 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 209 | G | 0.092732 | D | 0.097867 | -0.005135 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 543 | D | 0.286975 | A | 0.226458 | 0.060517 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 686 | W | 0.448306 | C | 0.56094 | -0.112634 | O to D | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P08237 | K6PF_HUMAN 6-phosphofructokinase muscle type OS=Homo sapiens GN=PFKM PE=1 SV=2 | 696 | R | 0.401445 | H | 0.372035 | 0.02941 | No Change: Both O | Glycogen storage disease type 7 (GSD7) [MIM:232800] |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 28 | L | 0.536274 | F | 0.481337 | 0.054937 | D to O | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 58 | E | 0.230533 | K | 0.232746 | -0.002213 | No Change: Both O | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 92 | V | 0.216651 | L | 0.208998 | 0.007653 | No Change: Both O | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 222 | Q | 0.4897 | K | 0.543016 | -0.053316 | O to D | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 265 | A | 0.240256 | T | 0.257759 | -0.017503 | No Change: Both O | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 353 | L | 0.418 | V | 0.412079 | 0.005921 | No Change: Both O | - |
| P00790 | PEPA_HUMAN Pepsin A OS=Homo sapiens GN=PGA3 PE=1 SV=1 | 376 | D | 0.152916 | E | 0.169437 | -0.016521 | No Change: Both O | - |
| P15259 | PGAM2_HUMAN Phosphoglycerate mutase 2 OS=Homo sapiens GN=PGAM2 PE=1 SV=3 | 89 | E | 0.295146 | A | 0.198969 | 0.096177 | No Change: Both O | Glycogen storage disease type 10 (GSD10) [MIM:261670] |
| P15259 | PGAM2_HUMAN Phosphoglycerate mutase 2 OS=Homo sapiens GN=PGAM2 PE=1 SV=3 | 90 | R | 0.292597 | W | 0.132071 | 0.160526 | No Change: Both O | Glycogen storage disease type 10 (GSD10) [MIM:261670] |
| P15259 | PGAM2_HUMAN Phosphoglycerate mutase 2 OS=Homo sapiens GN=PGAM2 PE=1 SV=3 | 97 | G | 0.461016 | D | 0.463734 | -0.002718 | No Change: Both O | Glycogen storage disease type 10 (GSD10) [MIM:261670] |
| Q8N0Y7 | PGAM4_HUMAN Probable phosphoglycerate mutase 4 OS=Homo sapiens GN=PGAM4 PE=1 SV=1 | 40 | R | 0.736234 | C | 0.588374 | 0.14786 | No Change: Both D | - |
| Q8N0Y7 | PGAM4_HUMAN Probable phosphoglycerate mutase 4 OS=Homo sapiens GN=PGAM4 PE=1 SV=1 | 90 | R | 0.294526 | Q | 0.295596 | -0.00107 | No Change: Both O | - |
| Q8N0Y7 | PGAM4_HUMAN Probable phosphoglycerate mutase 4 OS=Homo sapiens GN=PGAM4 PE=1 SV=1 | 175 | I | 0.31234 | T | 0.408017 | -0.095677 | No Change: Both O | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 244 | G | 0.546624 | E | 0.667721 | -0.121097 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 248 | Q | 0.603961 | E | 0.651477 | -0.047516 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 256 | P | 0.660321 | L | 0.586749 | 0.073572 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 398 | N | 0.582842 | S | 0.650017 | -0.067175 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 592 | M | 0.711528 | I | 0.624295 | 0.087233 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 678 | I | 0.237031 | V | 0.24729 | -0.010259 | No Change: Both O | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 806 | H | 0.736102 | D | 0.724055 | 0.012047 | No Change: Both D | - |
| Q96JS3 | PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens GN=PGBD1 PE=1 SV=1 | 244 | G | 0.546624 | R | 0.631167 | -0.084543 | No Change: Both D | - |
| Q8N328 | PGBD3_HUMAN PiggyBac transposable element-derived protein 3 OS=Homo sapiens GN=PGBD3 PE=2 SV=3 | 382 | R | 0.412893 | K | 0.480761 | -0.067868 | No Change: Both O | - |
| Q8N328 | PGBD3_HUMAN PiggyBac transposable element-derived protein 3 OS=Homo sapiens GN=PGBD3 PE=2 SV=3 | 415 | D | 0.170497 | G | 0.157961 | 0.012536 | No Change: Both O | A breast cancer sample |
| Q8N328 | PGBD3_HUMAN PiggyBac transposable element-derived protein 3 OS=Homo sapiens GN=PGBD3 PE=2 SV=3 | 446 | Q | 0.4827 | E | 0.494166 | -0.011466 | No Change: Both O | - |
| Q9Y646 | PGCP_HUMAN Plasma glutamate carboxypeptidase OS=Homo sapiens GN=PGCP PE=1 SV=1 | 138 | S | 0.399117 | N | 0.339427 | 0.05969 | No Change: Both O | - |
| P52209 | 6PGD_HUMAN 6-phosphogluconate dehydrogenase decarboxylating OS=Homo sapiens GN=PGD PE=1 SV=3 | 268 | A | 0.20306 | S | 0.293664 | -0.090604 | No Change: Both O | - |
| P53609 | PGTB1_HUMAN Geranylgeranyl transferase type-1 subunit beta OS=Homo sapiens GN=PGGT1B PE=1 SV=2 | 103 | I | 0.39258 | V | 0.425476 | -0.032896 | No Change: Both O | - |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 88 | L | 0.331574 | P | 0.492779 | -0.161205 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 158 | G | 0.306417 | V | 0.225687 | 0.08073 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 164 | D | 0.24601 | V | 0.150551 | 0.095459 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 206 | R | 0.33647 | P | 0.396095 | -0.059625 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 252 | E | 0.237473 | A | 0.157103 | 0.08037 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 266 | V | 0.421025 | M | 0.513501 | -0.092476 | O to D | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 268 | D | 0.436486 | N | 0.423896 | 0.01259 | No Change: Both O | - |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 285 | D | 0.20224 | V | 0.11299 | 0.08925 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 315 | D | 0.332639 | N | 0.318454 | 0.014185 | No Change: Both O | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 316 | C | 0.383634 | R | 0.539766 | -0.156132 | O to D | Phosphoglycerate kinase 1 deficiency (PGK1D) [MIM:300653] |
| P00558 | PGK1_HUMAN Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 | 352 | T | 0.246741 | N | 0.280673 | -0.033932 | No Change: Both O | - |
| O75594 | PGRP1_HUMAN Peptidoglycan recognition protein 1 OS=Homo sapiens GN=PGLYRP1 PE=1 SV=1 | 34 | V | 0.224407 | G | 0.342671 | -0.118264 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 46 | T | 0.477558 | A | 0.465831 | 0.011727 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 99 | R | 0.443918 | Q | 0.441499 | 0.002419 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 257 | T | 0.268762 | N | 0.282197 | -0.013435 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 270 | M | 0.164371 | K | 0.252767 | -0.088396 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 476 | R | 0.381967 | W | 0.194976 | 0.186991 | No Change: Both O | - |
| Q96PD5 | PGRP2_HUMAN N-acetylmuramoyl-L-alanine amidase OS=Homo sapiens GN=PGLYRP2 PE=1 SV=1 | 394 | R | 0.30431 | Q | 0.312681 | -0.008371 | No Change: Both O | - |
| Q96LB9 | PGRP3_HUMAN Peptidoglycan recognition protein 3 OS=Homo sapiens GN=PGLYRP3 PE=1 SV=1 | 126 | G | 0.600148 | S | 0.656693 | -0.056545 | No Change: Both D | - |
| Q96LB9 | PGRP3_HUMAN Peptidoglycan recognition protein 3 OS=Homo sapiens GN=PGLYRP3 PE=1 SV=1 | 35 | A | 0.106935 | T | 0.11655 | -0.009615 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 92 | Q | 0.291077 | R | 0.271871 | 0.019206 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 192 | G | 0.416094 | V | 0.298487 | 0.117607 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 213 | V | 0.320261 | I | 0.275558 | 0.044703 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 301 | D | 0.365825 | N | 0.334494 | 0.031331 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 13 | I | 0.110049 | L | 0.135309 | -0.02526 | No Change: Both O | - |
| Q96LB8 | PGRP4_HUMAN Peptidoglycan recognition protein 4 OS=Homo sapiens GN=PGLYRP4 PE=1 SV=2 | 3 | P | 0.268706 | L | 0.127364 | 0.141342 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 68 | K | 0.156409 | M | 0.101918 | 0.054491 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 221 | R | 0.258982 | C | 0.130977 | 0.128005 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 420 | Y | 0.213233 | H | 0.333976 | -0.120743 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 501 | V | 0.216172 | I | 0.211385 | 0.004787 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 88 | I | 0.155903 | V | 0.172409 | -0.016506 | No Change: Both O | - |
| P36871 | PGM1_HUMAN Phosphoglucomutase-1 OS=Homo sapiens GN=PGM1 PE=1 SV=3 | 115 | T | 0.296595 | A | 0.290448 | 0.006147 | No Change: Both O | Glycogen storage disease type 14 (GSD14) [MIM:612934] |
| Q96G03 | PGM2_HUMAN Phosphoglucomutase-2 OS=Homo sapiens GN=PGM2 PE=1 SV=4 | 10 | G | 0.671733 | D | 0.693888 | -0.022155 | No Change: Both D | - |
| Q96G03 | PGM2_HUMAN Phosphoglucomutase-2 OS=Homo sapiens GN=PGM2 PE=1 SV=4 | 488 | E | 0.220071 | D | 0.204557 | 0.015514 | No Change: Both O | - |
| Q6PCE3 | PGM2L_HUMAN Glucose 1 6-bisphosphate synthase OS=Homo sapiens GN=PGM2L1 PE=1 SV=3 | 14 | L | 0.410674 | P | 0.565509 | -0.154835 | O to D | - |
| Q6PCE3 | PGM2L_HUMAN Glucose 1 6-bisphosphate synthase OS=Homo sapiens GN=PGM2L1 PE=1 SV=3 | 531 | V | 0.294884 | I | 0.269107 | 0.025777 | No Change: Both O | - |
| Q6PCE3 | PGM2L_HUMAN Glucose 1 6-bisphosphate synthase OS=Homo sapiens GN=PGM2L1 PE=1 SV=3 | 608 | N | 0.196179 | I | 0.099831 | 0.096348 | No Change: Both O | - |
| O95394 | AGM1_HUMAN Phosphoacetylglucosamine mutase OS=Homo sapiens GN=PGM3 PE=1 SV=1 | 466 | D | 0.517766 | N | 0.494079 | 0.023687 | D to O | - |
| A6NFU8 | PGPIL_HUMAN Pyroglutamyl-peptidase 1-like protein OS=Homo sapiens GN=PGPEP1L PE=2 SV=4 | 142 | A | 0.248443 | V | 0.183586 | 0.064857 | No Change: Both O | - |
| A6NFU8 | PGPIL_HUMAN Pyroglutamyl-peptidase 1-like protein OS=Homo sapiens GN=PGPEP1L PE=2 SV=4 | 169 | E | 0.301829 | Q | 0.265139 | 0.03669 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 625 | R | 0.310682 | I | 0.157171 | 0.153511 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 865 | S | 0.477234 | L | 0.275374 | 0.20186 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 344 | S | 0.889398 | T | 0.851325 | 0.038073 | No Change: Both D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 660 | V | 0.446973 | L | 0.451973 | -0.005 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 50 | A | 0.849548 | T | 0.873386 | -0.023838 | No Change: Both D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 120 | A | 0.945858 | V | 0.933401 | 0.012457 | No Change: Both D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 186 | P | 0.829378 | L | 0.731925 | 0.097453 | No Change: Both D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 301 | M | 0.194208 | R | 0.241611 | -0.047403 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 444 | A | 0.962585 | S | 0.972693 | -0.010108 | No Change: Both D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 529 | V | 0.465063 | L | 0.527474 | -0.062411 | O to D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 536 | Q | 0.448284 | P | 0.500879 | -0.052595 | O to D | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 651 | L | 0.291514 | V | 0.305997 | -0.014483 | No Change: Both O | - |
| P06401 | PRGR_HUMAN Progesterone receptor OS=Homo sapiens GN=PGR PE=1 SV=4 | 347 | C | 0.895931 | S | 0.938528 | -0.042597 | No Change: Both D | - |
| Q9C0D0 | PHAR1_HUMAN Phosphatase and actin regulator 1 OS=Homo sapiens GN=PHACTR1 PE=2 SV=3 | 247 | I | 0.723915 | M | 0.834131 | -0.110216 | No Change: Both D | - |
| O75167 | PHAR2_HUMAN Phosphatase and actin regulator 2 OS=Homo sapiens GN=PHACTR2 PE=1 SV=2 | 165 | P | 0.999226 | S | 0.999044 | 1.82E-04 | No Change: Both D | - |
| O75167 | PHAR2_HUMAN Phosphatase and actin regulator 2 OS=Homo sapiens GN=PHACTR2 PE=1 SV=2 | 449 | I | 0.960246 | V | 0.95872 | 0.001526 | No Change: Both D | - |
| Q96KR7 | PHAR3_HUMAN Phosphatase and actin regulator 3 OS=Homo sapiens GN=PHACTR3 PE=1 SV=1 | 154 | P | 0.977248 | L | 0.960508 | 0.01674 | No Change: Both D | - |
| Q9H814 | PHAX_HUMAN Phosphorylated adapter RNA export protein OS=Homo sapiens GN=PHAX PE=1 SV=1 | 82 | R | 0.944412 | C | 0.932546 | 0.011866 | No Change: Both D | - |
| P35232 | PHB_HUMAN Prohibitin OS=Homo sapiens GN=PHB PE=1 SV=1 | 88 | V | 0.201586 | A | 0.257455 | -0.055869 | No Change: Both O | A breast cancer sample |
| P35232 | PHB_HUMAN Prohibitin OS=Homo sapiens GN=PHB PE=1 SV=1 | 105 | R | 0.195467 | H | 0.188302 | 0.007165 | No Change: Both O | A breast cancer sample |
| P78364 | PHC1_HUMAN Polyhomeotic-like protein 1 OS=Homo sapiens GN=PHC1 PE=1 SV=3 | 693 | T | 0.933185 | A | 0.933976 | -7.91E-04 | No Change: Both D | - |
| Q8IXK0 | PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens GN=PHC2 PE=1 SV=1 | 254 | P | 0.984112 | S | 0.982151 | 0.001961 | No Change: Both D | - |
| Q8IXK0 | PHC2_HUMAN Polyhomeotic-like protein 2 OS=Homo sapiens GN=PHC2 PE=1 SV=1 | 475 | V | 0.850843 | M | 0.874737 | -0.023894 | No Change: Both D | - |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 77 | C | 0.169307 | S | 0.372546 | -0.203239 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 85 | C | 0.061044 | Y | 0.070199 | -0.009155 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 138 | L | 0.385857 | P | 0.532819 | -0.146962 | O to D | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 166 | R | 0.204919 | C | 0.100119 | 0.1048 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 252 | F | 0.142683 | S | 0.333258 | -0.190575 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 253 | M | 0.137306 | I | 0.084361 | 0.052945 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 534 | P | 0.234919 | L | 0.121489 | 0.11343 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 579 | G | 0.156812 | R | 0.135401 | 0.021411 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 579 | G | 0.156812 | V | 0.08923 | 0.067582 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 80 | F | 0.087061 | S | 0.201983 | -0.114922 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 85 | C | 0.061044 | F | 0.06818 | -0.007136 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 85 | C | 0.061044 | R | 0.128078 | -0.067034 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 141 | S | 0.36342 | P | 0.340814 | 0.022606 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 142 | C | 0.413543 | F | 0.391511 | 0.022032 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 160 | L | 0.184639 | R | 0.289262 | -0.104623 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 237 | D | 0.492008 | G | 0.449298 | 0.04271 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 317 | Y | 0.058458 | F | 0.054139 | 0.004319 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 530 | W | 0.300407 | C | 0.334317 | -0.03391 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 555 | L | 0.238222 | P | 0.413244 | -0.175022 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 567 | R | 0.270436 | P | 0.321838 | -0.051402 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 573 | A | 0.158598 | D | 0.220348 | -0.06175 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 621 | Q | 0.247335 | R | 0.261887 | -0.014552 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 651 | R | 0.328054 | P | 0.341665 | -0.013611 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 680 | N | 0.124512 | K | 0.136245 | -0.011733 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 693 | C | 0.265044 | Y | 0.309832 | -0.044788 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 720 | A | 0.483804 | T | 0.490522 | -0.006718 | No Change: Both O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 731 | F | 0.514115 | Y | 0.463623 | 0.050492 | D to O | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 733 | C | 0.523891 | S | 0.708942 | -0.185051 | No Change: Both D | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 746 | C | 0.631338 | W | 0.582603 | 0.048735 | No Change: Both D | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| P78562 | PHEX_HUMAN Phosphate-regulating neutral endopeptidase OS=Homo sapiens GN=PHEX PE=1 SV=1 | 749 | W | 0.664983 | R | 0.840184 | -0.175201 | No Change: Both D | X-linked hypophosphatemic rickets (HYP) [MIM:307800] |
| O43189 | PHF1_HUMAN PHD finger protein 1 OS=Homo sapiens GN=PHF1 PE=1 SV=3 | 304 | R | 0.762405 | K | 0.780948 | -0.018543 | No Change: Both D | - |
| O43189 | PHF1_HUMAN PHD finger protein 1 OS=Homo sapiens GN=PHF1 PE=1 SV=3 | 42 | T | 0.133156 | S | 0.177833 | -0.044677 | No Change: Both O | - |
| Q86YI8 | PHF13_HUMAN PHD finger protein 13 OS=Homo sapiens GN=PHF13 PE=1 SV=2 | 20 | K | 0.576161 | E | 0.596825 | -0.020664 | No Change: Both D | - |
| O94880 | PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens GN=PHF14 PE=1 SV=2 | 115 | K | 0.999873 | R | 0.999847 | 2.60E-05 | No Change: Both D | - |
| Q9NQC1 | JADE2_HUMAN Protein Jade-2 OS=Homo sapiens GN=PHF15 PE=1 SV=2 | 581 | R | 0.952296 | G | 0.943385 | 0.008911 | No Change: Both D | - |
| Q6IE81 | JADE1_HUMAN Protein Jade-1 OS=Homo sapiens GN=PHF17 PE=1 SV=1 | 662 | N | 0.602646 | S | 0.645862 | -0.043216 | No Change: Both D | - |
| O75151 | PHF2_HUMAN Lysine-specific demethylase PHF2 OS=Homo sapiens GN=PHF2 PE=1 SV=4 | 56 | T | 0.64426 | P | 0.696902 | -0.052642 | No Change: Both D | - |
| O75151 | PHF2_HUMAN Lysine-specific demethylase PHF2 OS=Homo sapiens GN=PHF2 PE=1 SV=4 | 1058 | S | 0.932429 | L | 0.885831 | 0.046598 | No Change: Both D | - |
| Q9BVI0 | PHF20_HUMAN PHD finger protein 20 OS=Homo sapiens GN=PHF20 PE=1 SV=2 | 605 | V | 0.876125 | M | 0.90549 | -0.029365 | No Change: Both D | - |
| Q96BD5 | PF21A_HUMAN PHD finger protein 21A OS=Homo sapiens GN=PHF21A PE=1 SV=1 | 347 | R | 0.940612 | H | 0.934949 | 0.005663 | No Change: Both D | - |
| Q96EK2 | PF21B_HUMAN PHD finger protein 21B OS=Homo sapiens GN=PHF21B PE=2 SV=1 | 127 | G | 0.889308 | S | 0.927092 | -0.037784 | No Change: Both D | - |
| Q92576 | PHF3_HUMAN PHD finger protein 3 OS=Homo sapiens GN=PHF3 PE=1 SV=3 | 1834 | H | 0.986763 | Y | 0.977108 | 0.009655 | No Change: Both D | - |
| Q92576 | PHF3_HUMAN PHD finger protein 3 OS=Homo sapiens GN=PHF3 PE=1 SV=3 | 525 | V | 0.756892 | I | 0.726948 | 0.029944 | No Change: Both D | - |
| Q8IWS0 | PHF6_HUMAN PHD finger protein 6 OS=Homo sapiens GN=PHF6 PE=1 SV=1 | 45 | C | 0.462375 | Y | 0.379279 | 0.083096 | No Change: Both O | Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900] |
| Q8IWS0 | PHF6_HUMAN PHD finger protein 6 OS=Homo sapiens GN=PHF6 PE=1 SV=1 | 99 | C | 0.225509 | F | 0.202944 | 0.022565 | No Change: Both O | Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900] |
| Q8IWS0 | PHF6_HUMAN PHD finger protein 6 OS=Homo sapiens GN=PHF6 PE=1 SV=1 | 229 | H | 0.400675 | R | 0.431255 | -0.03058 | No Change: Both O | Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900] |
| Q8IWS0 | PHF6_HUMAN PHD finger protein 6 OS=Homo sapiens GN=PHF6 PE=1 SV=1 | 234 | K | 0.379544 | E | 0.367305 | 0.012239 | No Change: Both O | Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900] |
| Q8IWS0 | PHF6_HUMAN PHD finger protein 6 OS=Homo sapiens GN=PHF6 PE=1 SV=1 | 257 | R | 0.36818 | G | 0.391099 | -0.022919 | No Change: Both O | Boerjeson-Forssman-Lehmann syndrome (BFLS) [MIM:301900] |
| Q9BWX1 | PHF7_HUMAN PHD finger protein 7 OS=Homo sapiens GN=PHF7 PE=2 SV=1 | 369 | K | 0.943241 | N | 0.926986 | 0.016255 | No Change: Both D | A breast cancer sample |
| Q9UPP1 | PHF8_HUMAN Histone lysine demethylase PHF8 OS=Homo sapiens GN=PHF8 PE=1 SV=3 | 315 | F | 0.195733 | S | 0.432267 | -0.236534 | No Change: Both O | Mental retardation syndromic X-linked Siderius type (MRXSSD) [MIM:300263] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 425 | V | 0.132158 | M | 0.159659 | -0.027501 | No Change: Both O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 135 | R | 0.535877 | W | 0.360484 | 0.175393 | D to O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 261 | V | 0.317646 | M | 0.373153 | -0.055507 | No Change: Both O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 373 | A | 0.135015 | T | 0.143445 | -0.00843 | No Change: Both O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 377 | G | 0.215793 | S | 0.274675 | -0.058882 | No Change: Both O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| O43175 | SERA_HUMAN D-3-phosphoglycerate dehydrogenase OS=Homo sapiens GN=PHGDH PE=1 SV=4 | 490 | V | 0.184693 | M | 0.253567 | -0.068874 | No Change: Both O | Phosphoglycerate dehydrogenase deficiency (PHGDH deficiency) [MIM:601815] |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 663 | V | 0.933456 | G | 0.956146 | -0.02269 | No Change: Both D | - |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 874 | T | 0.981368 | I | 0.973907 | 0.007461 | No Change: Both D | - |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 1093 | L | 0.484584 | P | 0.644523 | -0.159939 | O to D | - |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 1135 | T | 0.402928 | P | 0.472763 | -0.069835 | No Change: Both O | - |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 1445 | N | 0.969976 | T | 0.970818 | -8.42E-04 | No Change: Both D | - |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 469 | V | 0.374888 | I | 0.320972 | 0.053916 | No Change: Both O | A colorectal cancer sample |
| Q8WWQ0 | PHIP_HUMAN PH-interacting protein OS=Homo sapiens GN=PHIP PE=1 SV=2 | 1767 | R | 0.928051 | I | 0.855912 | 0.072139 | No Change: Both D | A colorectal cancer sample |
| P46020 | KPB1_HUMAN Phosphorylase b kinase regulatory subunit alpha skeletal muscle isoform OS=Homo sapiens GN=PHKA1 PE=1 SV=2 | 299 | D | 0.286463 | V | 0.158168 | 0.128295 | No Change: Both O | Glycogen storage disease type 9D (GSD9D) [MIM:300559] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 132 | H | 0.242602 | P | 0.274842 | -0.03224 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 132 | H | 0.242602 | Y | 0.152272 | 0.09033 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 186 | R | 0.437002 | C | 0.262121 | 0.174881 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 186 | R | 0.437002 | H | 0.442231 | -0.005229 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 299 | D | 0.263169 | G | 0.247391 | 0.015778 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 1114 | T | 0.608807 | I | 0.449162 | 0.159645 | D to O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 1205 | P | 0.402238 | L | 0.25692 | 0.145318 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 189 | K | 0.533538 | E | 0.553552 | -0.020014 | No Change: Both D | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 193 | G | 0.57567 | V | 0.40493 | 0.17074 | D to O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 295 | R | 0.112558 | H | 0.095618 | 0.01694 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 399 | P | 0.232241 | S | 0.251813 | -0.019572 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 1125 | E | 0.203402 | K | 0.204398 | -9.96E-04 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 1207 | G | 0.421268 | W | 0.21907 | 0.202198 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 38 | E | 0.53877 | Q | 0.499315 | 0.039455 | D to O | - |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 416 | G | 0.19857 | R | 0.177765 | 0.020805 | No Change: Both O | - |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 498 | P | 0.35581 | L | 0.226307 | 0.129503 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 869 | P | 0.517318 | R | 0.448692 | 0.068626 | D to O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 916 | R | 0.055183 | W | 0.01803 | 0.037153 | No Change: Both O | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| P46019 | KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha liver isoform OS=Homo sapiens GN=PHKA2 PE=1 SV=1 | 1113 | M | 0.63284 | I | 0.552976 | 0.079864 | No Change: Both D | Glycogen storage disease type 9A (GSD9A) [MIM:306000] |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 770 | Y | 0.34904 | C | 0.295994 | 0.053046 | No Change: Both O | - |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 118 | A | 0.333915 | P | 0.407924 | -0.074009 | No Change: Both O | Glycogen storage disease type 9B (GSD9B) [MIM:261750] |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 657 | Q | 0.178604 | K | 0.21794 | -0.039336 | No Change: Both O | - |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 820 | E | 0.514351 | V | 0.313968 | 0.200383 | D to O | - |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 867 | L | 0.257602 | V | 0.245752 | 0.01185 | No Change: Both O | A breast cancer sample |
| Q93100 | KPBB_HUMAN Phosphorylase b kinase regulatory subunit beta OS=Homo sapiens GN=PHKB PE=1 SV=3 | 877 | G | 0.046523 | R | 0.044753 | 0.00177 | No Change: Both O | A breast cancer sample |
| Q16816 | PHKG1_HUMAN Phosphorylase b kinase gamma catalytic chain skeletal muscle isoform OS=Homo sapiens GN=PHKG1 PE=2 SV=3 | 48 | V | 0.299529 | M | 0.330695 | -0.031166 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q16816 | PHKG1_HUMAN Phosphorylase b kinase gamma catalytic chain skeletal muscle isoform OS=Homo sapiens GN=PHKG1 PE=2 SV=3 | 323 | R | 0.184195 | C | 0.083337 | 0.100858 | No Change: Both O | - |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 106 | V | 0.113043 | E | 0.243903 | -0.13086 | No Change: Both O | Glycogen storage disease type 9C (GSD9C) [MIM:613027] |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 189 | G | 0.274116 | E | 0.334275 | -0.060159 | No Change: Both O | Glycogen storage disease type 9C (GSD9C) [MIM:613027] |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 157 | E | 0.373084 | K | 0.38262 | -0.009536 | No Change: Both O | Glycogen storage disease type 9C (GSD9C) [MIM:613027] |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 215 | D | 0.130506 | N | 0.122876 | 0.00763 | No Change: Both O | Glycogen storage disease type 9C (GSD9C) [MIM:613027] |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 317 | A | 0.119975 | T | 0.134514 | -0.014539 | No Change: Both O | - |
| P15735 | PHKG2_HUMAN Phosphorylase b kinase gamma catalytic chain testis/liver isoform OS=Homo sapiens GN=PHKG2 PE=1 SV=1 | 247 | E | 0.277994 | G | 0.238363 | 0.039631 | No Change: Both O | - |
| Q9Y5J5 | PHLA3_HUMAN Pleckstrin homology-like domain family A member 3 OS=Homo sapiens GN=PHLDA3 PE=1 SV=1 | 28 | R | 0.338006 | Q | 0.331524 | 0.006482 | No Change: Both O | - |
| Q86SQ0 | PHLB2_HUMAN Pleckstrin homology-like domain family B member 2 OS=Homo sapiens GN=PHLDB2 PE=1 SV=2 | 941 | P | 0.812934 | S | 0.826158 | -0.013224 | No Change: Both D | - |
| Q6NSJ2 | PHLB3_HUMAN Pleckstrin homology-like domain family B member 3 OS=Homo sapiens GN=PHLDB3 PE=2 SV=3 | 239 | Q | 0.982011 | R | 0.980995 | 0.001016 | No Change: Both D | - |
| O60346 | PHLP1_HUMAN PH domain leucine-rich repeat-containing protein phosphatase 1 OS=Homo sapiens GN=PHLPP1 PE=1 SV=3 | 1118 | S | 0.525487 | T | 0.449574 | 0.075913 | D to O | - |
| Q8TCD6 | PHOP2_HUMAN Pyridoxal phosphate phosphatase PHOSPHO2 OS=Homo sapiens GN=PHOSPHO2 PE=1 SV=1 | 206 | K | 0.516598 | E | 0.503566 | 0.013032 | No Change: Both D | - |
| O14813 | PHX2A_HUMAN Paired mesoderm homeobox protein 2A OS=Homo sapiens GN=PHOX2A PE=1 SV=2 | 72 | A | 0.610798 | V | 0.509307 | 0.101491 | No Change: Both D | Congenital fibrosis of extraocular muscles type 2 (CFEOM2) [MIM:602078] |
| O14813 | PHX2A_HUMAN Paired mesoderm homeobox protein 2A OS=Homo sapiens GN=PHOX2A PE=1 SV=2 | 256 | P | 0.718938 | Q | 0.680467 | 0.038471 | No Change: Both D | - |
| Q99453 | PHX2B_HUMAN Paired mesoderm homeobox protein 2B OS=Homo sapiens GN=PHOX2B PE=1 SV=2 | 100 | R | 0.499432 | L | 0.366055 | 0.133377 | No Change: Both O | - |
| Q99453 | PHX2B_HUMAN Paired mesoderm homeobox protein 2B OS=Homo sapiens GN=PHOX2B PE=1 SV=2 | 141 | R | 0.207903 | G | 0.167135 | 0.040768 | No Change: Both O | - |
| Q99453 | PHX2B_HUMAN Paired mesoderm homeobox protein 2B OS=Homo sapiens GN=PHOX2B PE=1 SV=2 | 141 | R | 0.207903 | Q | 0.212455 | -0.004552 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| Q99453 | PHX2B_HUMAN Paired mesoderm homeobox protein 2B OS=Homo sapiens GN=PHOX2B PE=1 SV=2 | 143 | Q | 0.199576 | R | 0.206978 | -0.007402 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| Q99453 | PHX2B_HUMAN Paired mesoderm homeobox protein 2B OS=Homo sapiens GN=PHOX2B PE=1 SV=2 | 197 | G | 0.998893 | D | 0.998944 | -5.10E-05 | No Change: Both D | - |
| Q9P1Y6 | PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens GN=PHRF1 PE=1 SV=3 | 1231 | E | 0.84836 | A | 0.812229 | 0.036131 | No Change: Both D | - |
| Q9P1Y6 | PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens GN=PHRF1 PE=1 SV=3 | 1374 | A | 0.952482 | V | 0.94303 | 0.009452 | No Change: Both D | - |
| Q9P1Y6 | PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens GN=PHRF1 PE=1 SV=3 | 1449 | V | 0.74812 | A | 0.783022 | -0.034902 | No Change: Both D | - |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 269 | N | 0.59083 | H | 0.595358 | -0.004528 | No Change: Both D | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 275 | R | 0.359132 | W | 0.182529 | 0.176603 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 29 | P | 0.514458 | S | 0.559069 | -0.044611 | No Change: Both D | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 173 | P | 0.57709 | S | 0.609902 | -0.032812 | No Change: Both D | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 176 | Q | 0.424122 | K | 0.476557 | -0.052435 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 177 | D | 0.399172 | G | 0.370295 | 0.028877 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 193 | W | 0.069731 | R | 0.176255 | -0.106524 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 197 | E | 0.150122 | Q | 0.127111 | 0.023011 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 199 | I | 0.211554 | F | 0.211224 | 3.30E-04 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 204 | G | 0.183506 | S | 0.229645 | -0.046139 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 220 | H | 0.614371 | Y | 0.498272 | 0.116099 | D to O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 245 | R | 0.326862 | Q | 0.352683 | -0.025821 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 257 | F | 0.112562 | S | 0.24495 | -0.132388 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 275 | R | 0.359132 | Q | 0.400804 | -0.041672 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 83 | N | 0.285757 | Y | 0.173132 | 0.112625 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 175 | H | 0.4631 | R | 0.456975 | 0.006125 | No Change: Both O | Refsum disease (RD) [MIM:266500] |
| O14832 | PAHX_HUMAN Phytanoyl-CoA dioxygenase peroxisomal OS=Homo sapiens GN=PHYH PE=1 SV=1 | 215 | G | 0.654432 | S | 0.68848 | -0.034048 | No Change: Both D | - |
| Q5SRE7 | PHYD1_HUMAN Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Homo sapiens GN=PHYHD1 PE=1 SV=2 | 222 | R | 0.559089 | W | 0.353265 | 0.205824 | D to O | - |
| Q92561 | PHYIP_HUMAN Phytanoyl-CoA hydroxylase-interacting protein OS=Homo sapiens GN=PHYHIP PE=1 SV=1 | 21 | R | 0.199753 | S | 0.266439 | -0.066686 | No Change: Both O | - |
| Q96FC7 | PHIPL_HUMAN Phytanoyl-CoA hydroxylase-interacting protein-like OS=Homo sapiens GN=PHYHIPL PE=2 SV=3 | 342 | V | 0.230473 | L | 0.224578 | 0.005895 | No Change: Both O | - |
| Q6UXB8 | PI16_HUMAN Peptidase inhibitor 16 OS=Homo sapiens GN=PI16 PE=1 SV=1 | 50 | T | 0.472871 | P | 0.53752 | -0.064649 | O to D | - |
| Q6UXB8 | PI16_HUMAN Peptidase inhibitor 16 OS=Homo sapiens GN=PI16 PE=1 SV=1 | 416 | L | 0.802183 | V | 0.777359 | 0.024824 | No Change: Both D | - |
| P19957 | ELAF_HUMAN Elafin OS=Homo sapiens GN=PI3 PE=1 SV=3 | 34 | T | 0.519103 | P | 0.574873 | -0.05577 | No Change: Both D | - |
| P19957 | ELAF_HUMAN Elafin OS=Homo sapiens GN=PI3 PE=1 SV=3 | 17 | T | 0.046215 | M | 0.036171 | 0.010044 | No Change: Both O | - |
| Q8TCG2 | P4K2B_HUMAN Phosphatidylinositol 4-kinase type 2-beta OS=Homo sapiens GN=PI4K2B PE=1 SV=1 | 78 | S | 0.877816 | P | 0.873737 | 0.004079 | No Change: Both D | - |
| P42356 | PI4KA_HUMAN Phosphatidylinositol 4-kinase alpha OS=Homo sapiens GN=PI4KA PE=1 SV=3 | 322 | M | 0.137317 | V | 0.095818 | 0.041499 | No Change: Both O | - |
| P42356 | PI4KA_HUMAN Phosphatidylinositol 4-kinase alpha OS=Homo sapiens GN=PI4KA PE=1 SV=3 | 1793 | V | 0.202215 | L | 0.212696 | -0.010481 | No Change: Both O | - |
| A4QPH2 | PI4P2_HUMAN Putative phosphatidylinositol 4-kinase alpha-like protein P2 OS=Homo sapiens GN=PI4KAP2 PE=5 SV=2 | 223 | E | 0.548589 | Q | 0.525625 | 0.022964 | No Change: Both D | - |
| O75928 | PIAS2_HUMAN E3 SUMO-protein ligase PIAS2 OS=Homo sapiens GN=PIAS2 PE=1 SV=3 | 207 | V | 0.206787 | A | 0.258799 | -0.052012 | No Change: Both O | - |
| Q9Y6X2 | PIAS3_HUMAN E3 SUMO-protein ligase PIAS3 OS=Homo sapiens GN=PIAS3 PE=1 SV=2 | 390 | S | 0.48732 | C | 0.404906 | 0.082414 | No Change: Both O | - |
| Q8WXW3 | PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens GN=PIBF1 PE=2 SV=2 | 167 | I | 0.349066 | V | 0.38389 | -0.034824 | No Change: Both O | - |
| Q8WXW3 | PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens GN=PIBF1 PE=2 SV=2 | 405 | R | 0.933461 | Q | 0.927478 | 0.005983 | No Change: Both D | - |
| Q8WXW3 | PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens GN=PIBF1 PE=2 SV=2 | 630 | I | 0.679362 | V | 0.702234 | -0.022872 | No Change: Both D | - |
| Q13492 | PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens GN=PICALM PE=1 SV=2 | 158 | T | 0.380396 | P | 0.412854 | -0.032458 | No Change: Both O | - |
| Q13492 | PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens GN=PICALM PE=1 SV=2 | 383 | S | 0.900524 | F | 0.820094 | 0.08043 | No Change: Both D | - |
| Q13492 | PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens GN=PICALM PE=1 SV=2 | 578 | W | 0.629454 | C | 0.684608 | -0.055154 | No Change: Both D | - |
| Q13492 | PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens GN=PICALM PE=1 SV=2 | 579 | Q | 0.626234 | E | 0.645631 | -0.019397 | No Change: Both D | - |
| Q13492 | PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens GN=PICALM PE=1 SV=2 | 641 | F | 0.793759 | L | 0.80068 | -0.006921 | No Change: Both D | - |
| Q9HB75 | PIDD_HUMAN p53-induced protein with a death domain OS=Homo sapiens GN=PIDD PE=1 SV=2 | 331 | Q | 0.333474 | R | 0.334361 | -8.87E-04 | No Change: Both O | - |
| Q9H5I5 | PIEZ2_HUMAN Piezo-type mechanosensitive ion channel component 2 OS=Homo sapiens GN=PIEZO2 PE=2 SV=2 | 2463 | V | 0.566178 | I | 0.551472 | 0.014706 | No Change: Both D | - |
| Q9H611 | PIF1_HUMAN ATP-dependent DNA helicase PIF1 OS=Homo sapiens GN=PIF1 PE=1 SV=2 | 640 | I | 0.896969 | N | 0.939544 | -0.042575 | No Change: Both D | - |
| Q8TCI5 | PIFO_HUMAN Protein pitchfork OS=Homo sapiens GN=PIFO PE=1 SV=2 | 97 | K | 0.699684 | N | 0.651457 | 0.048227 | No Change: Both D | - |
| Q8TCI5 | PIFO_HUMAN Protein pitchfork OS=Homo sapiens GN=PIFO PE=1 SV=2 | 105 | H | 0.703556 | N | 0.735805 | -0.032249 | No Change: Both D | - |
| Q8TCI5 | PIFO_HUMAN Protein pitchfork OS=Homo sapiens GN=PIFO PE=1 SV=2 | 80 | R | 0.295627 | K | 0.356685 | -0.061058 | No Change: Both O | - |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 155 | S | 0.191793 | F | 0.085189 | 0.106604 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 297 | N | 0.241173 | D | 0.268673 | -0.0275 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 40 | D | 0.103225 | H | 0.09341 | 0.009815 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 48 | G | 0.303415 | A | 0.237005 | 0.06641 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 48 | G | 0.303415 | D | 0.320958 | -0.017543 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 48 | G | 0.303415 | V | 0.188962 | 0.114453 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 128 | H | 0.519741 | R | 0.502812 | 0.016929 | No Change: Both D | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 239 | G | 0.171951 | R | 0.169811 | 0.00214 | No Change: Both O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| P37287 | PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens GN=PIGA PE=1 SV=1 | 19 | R | 0.602866 | W | 0.367063 | 0.235803 | D to O | Paroxysmal nocturnal hemoglobinuria (PNH) [MIM:300818] |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 68 | I | 0.013611 | L | 0.016793 | -0.003182 | No Change: Both O | - |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 162 | M | 0.286827 | T | 0.333435 | -0.046608 | No Change: Both O | - |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 299 | W | 0.109685 | L | 0.163588 | -0.053903 | No Change: Both O | - |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 484 | L | 0.169361 | S | 0.309346 | -0.139985 | No Change: Both O | - |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 551 | K | 0.814557 | T | 0.765486 | 0.049071 | No Change: Both D | - |
| Q92521 | PIGB_HUMAN GPI mannosyltransferase 3 OS=Homo sapiens GN=PIGB PE=2 SV=1 | 502 | S | 0.19038 | G | 0.145273 | 0.045107 | No Change: Both O | - |
| Q92535 | PIGC_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Homo sapiens GN=PIGC PE=2 SV=1 | 266 | P | 0.020691 | S | 0.02608 | -0.005389 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 458 | R | 0.393818 | H | 0.379426 | 0.014392 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 610 | C | 0.341486 | R | 0.477673 | -0.136187 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 699 | V | 0.292358 | I | 0.265689 | 0.026669 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 932 | F | 0.017994 | S | 0.056237 | -0.038243 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 55 | S | 0.626771 | Y | 0.443385 | 0.183386 | D to O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 731 | V | 0.037963 | I | 0.033932 | 0.004031 | No Change: Both O | - |
| Q5H8A4 | PIGG_HUMAN GPI ethanolamine phosphate transferase 2 OS=Homo sapiens GN=PIGG PE=1 SV=1 | 881 | I | 0.075935 | T | 0.154298 | -0.078363 | No Change: Both O | - |
| Q92643 | GPI8_HUMAN GPI-anchor transamidase OS=Homo sapiens GN=PIGK PE=1 SV=2 | 16 | T | 0.10028 | A | 0.092604 | 0.007676 | No Change: Both O | - |
| Q9H3S5 | PIGM_HUMAN GPI mannosyltransferase 1 OS=Homo sapiens GN=PIGM PE=1 SV=1 | 365 | F | 0.012496 | L | 0.016336 | -0.00384 | No Change: Both O | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 162 | K | 0.522652 | E | 0.542076 | -0.019424 | No Change: Both D | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 229 | H | 0.647236 | D | 0.688985 | -0.041749 | No Change: Both D | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 469 | L | 0.465194 | F | 0.424122 | 0.041072 | No Change: Both O | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 470 | I | 0.536339 | L | 0.573452 | -0.037113 | No Change: Both D | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 904 | F | 0.023208 | C | 0.020285 | 0.002923 | No Change: Both O | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 904 | F | 0.023208 | L | 0.027685 | -0.004477 | No Change: Both O | - |
| O95427 | PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens GN=PIGN PE=1 SV=1 | 709 | R | 0.096179 | Q | 0.11454 | -0.018361 | No Change: Both O | Multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS) [MIM:614080] |
| Q8TEQ8 | PIGO_HUMAN GPI ethanolamine phosphate transferase 3 OS=Homo sapiens GN=PIGO PE=2 SV=3 | 686 | L | 0.045092 | M | 0.0549 | -0.009808 | No Change: Both O | A colorectal cancer sample |
| P57054 | PIGP_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit P OS=Homo sapiens GN=PIGP PE=1 SV=2 | 118 | Y | 0.56644 | C | 0.506496 | 0.059944 | No Change: Both D | - |
| P57054 | PIGP_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit P OS=Homo sapiens GN=PIGP PE=1 SV=2 | 136 | R | 0.29887 | S | 0.388039 | -0.089169 | No Change: Both O | - |
| P57054 | PIGP_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit P OS=Homo sapiens GN=PIGP PE=1 SV=2 | 9 | T | 0.237775 | A | 0.206393 | 0.031382 | No Change: Both O | - |
| Q9BRB3 | PIGQ_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Homo sapiens GN=PIGQ PE=1 SV=3 | 14 | T | 0.181936 | A | 0.153349 | 0.028587 | No Change: Both O | - |
| Q9BRB3 | PIGQ_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Homo sapiens GN=PIGQ PE=1 SV=3 | 592 | C | 0.143144 | R | 0.214178 | -0.071034 | No Change: Both O | - |
| Q9BRB3 | PIGQ_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Homo sapiens GN=PIGQ PE=1 SV=3 | 668 | C | 0.873793 | R | 0.905829 | -0.032036 | No Change: Both D | - |
| Q9BRB3 | PIGQ_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Homo sapiens GN=PIGQ PE=1 SV=3 | 668 | C | 0.873793 | Y | 0.803814 | 0.069979 | No Change: Both D | - |
| P01833 | PIGR_HUMAN Polymeric immunoglobulin receptor OS=Homo sapiens GN=PIGR PE=1 SV=4 | 580 | A | 0.640126 | V | 0.555268 | 0.084858 | No Change: Both D | - |
| P01833 | PIGR_HUMAN Polymeric immunoglobulin receptor OS=Homo sapiens GN=PIGR PE=1 SV=4 | 365 | G | 0.209388 | S | 0.250461 | -0.041073 | No Change: Both O | - |
| P01833 | PIGR_HUMAN Polymeric immunoglobulin receptor OS=Homo sapiens GN=PIGR PE=1 SV=4 | 555 | T | 0.210203 | I | 0.121019 | 0.089184 | No Change: Both O | - |
| Q96S52 | PIGS_HUMAN GPI transamidase component PIG-S OS=Homo sapiens GN=PIGS PE=1 SV=3 | 159 | M | 0.374295 | I | 0.283693 | 0.090602 | No Change: Both O | A breast cancer sample |
| Q96S52 | PIGS_HUMAN GPI transamidase component PIG-S OS=Homo sapiens GN=PIGS PE=1 SV=3 | 253 | R | 0.091848 | H | 0.086653 | 0.005195 | No Change: Both O | - |
| Q969N2 | PIGT_HUMAN GPI transamidase component PIG-T OS=Homo sapiens GN=PIGT PE=1 SV=1 | 473 | A | 0.321778 | T | 0.33584 | -0.014062 | No Change: Both O | - |
| Q9NUD9 | PIGV_HUMAN GPI mannosyltransferase 2 OS=Homo sapiens GN=PIGV PE=1 SV=1 | 256 | Q | 0.041403 | K | 0.047937 | -0.006534 | No Change: Both O | Hyperphosphatasia with mental retardation (HPMR) [MIM:239300] |
| Q9NUD9 | PIGV_HUMAN GPI mannosyltransferase 2 OS=Homo sapiens GN=PIGV PE=1 SV=1 | 341 | A | 0.027601 | E | 0.042321 | -0.01472 | No Change: Both O | Hyperphosphatasia with mental retardation (HPMR) [MIM:239300] |
| Q9NUD9 | PIGV_HUMAN GPI mannosyltransferase 2 OS=Homo sapiens GN=PIGV PE=1 SV=1 | 341 | A | 0.027601 | V | 0.019016 | 0.008585 | No Change: Both O | Hyperphosphatasia with mental retardation (HPMR) [MIM:239300] |
| Q9NUD9 | PIGV_HUMAN GPI mannosyltransferase 2 OS=Homo sapiens GN=PIGV PE=1 SV=1 | 385 | H | 0.026531 | P | 0.032708 | -0.006177 | No Change: Both O | Hyperphosphatasia with mental retardation (HPMR) [MIM:239300] |
| Q8TBF5 | PIGX_HUMAN Phosphatidylinositol-glycan biosynthesis class X protein OS=Homo sapiens GN=PIGX PE=2 SV=3 | 155 | P | 0.625253 | L | 0.474002 | 0.151251 | D to O | - |
| Q8TBF5 | PIGX_HUMAN Phosphatidylinositol-glycan biosynthesis class X protein OS=Homo sapiens GN=PIGX PE=2 SV=3 | 197 | E | 0.207072 | D | 0.186091 | 0.020981 | No Change: Both O | - |
| Q86VD9 | PIGZ_HUMAN GPI mannosyltransferase 4 OS=Homo sapiens GN=PIGZ PE=2 SV=4 | 340 | R | 0.237567 | Q | 0.275694 | -0.038127 | No Change: Both O | - |
| Q86VD9 | PIGZ_HUMAN GPI mannosyltransferase 4 OS=Homo sapiens GN=PIGZ PE=2 SV=4 | 417 | V | 0.054732 | A | 0.07786 | -0.023128 | No Change: Both O | - |
| Q86VD9 | PIGZ_HUMAN GPI mannosyltransferase 4 OS=Homo sapiens GN=PIGZ PE=2 SV=4 | 487 | M | 0.275038 | I | 0.196915 | 0.078123 | No Change: Both O | - |
| Q86VD9 | PIGZ_HUMAN GPI mannosyltransferase 4 OS=Homo sapiens GN=PIGZ PE=2 SV=4 | 266 | A | 0.111596 | T | 0.121172 | -0.009576 | No Change: Both O | - |
| Q9NWS0 | PIHD1_HUMAN PIH1 domain-containing protein 1 OS=Homo sapiens GN=PIH1D1 PE=1 SV=1 | 9 | M | 0.621553 | L | 0.552534 | 0.069019 | No Change: Both D | - |
| Q9NWS0 | PIHD1_HUMAN PIH1 domain-containing protein 1 OS=Homo sapiens GN=PIH1D1 PE=1 SV=1 | 10 | G | 0.610169 | E | 0.692328 | -0.082159 | No Change: Both D | - |
| Q9NWS0 | PIHD1_HUMAN PIH1 domain-containing protein 1 OS=Homo sapiens GN=PIH1D1 PE=1 SV=1 | 224 | V | 0.347958 | I | 0.328946 | 0.019012 | No Change: Both O | - |
| Q9NWS0 | PIHD1_HUMAN PIH1 domain-containing protein 1 OS=Homo sapiens GN=PIH1D1 PE=1 SV=1 | 230 | D | 0.359199 | E | 0.388429 | -0.02923 | No Change: Both O | - |
| Q9NWS0 | PIHD1_HUMAN PIH1 domain-containing protein 1 OS=Homo sapiens GN=PIH1D1 PE=1 SV=1 | 287 | P | 0.700901 | L | 0.565909 | 0.134992 | No Change: Both D | - |
| Q8WWB5 | PIHD2_HUMAN PIH1 domain-containing protein 2 OS=Homo sapiens GN=PIH1D2 PE=2 SV=1 | 117 | A | 0.389877 | V | 0.326724 | 0.063153 | No Change: Both O | - |
| Q6ZUJ8 | BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 OS=Homo sapiens GN=PIK3AP1 PE=1 SV=2 | 21 | E | 0.172212 | K | 0.161556 | 0.010656 | No Change: Both O | - |
| Q6ZUJ8 | BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 OS=Homo sapiens GN=PIK3AP1 PE=1 SV=2 | 83 | A | 0.27084 | S | 0.36954 | -0.0987 | No Change: Both O | - |
| Q6ZUJ8 | BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 OS=Homo sapiens GN=PIK3AP1 PE=1 SV=2 | 551 | E | 0.62146 | K | 0.614081 | 0.007379 | No Change: Both D | - |
| Q6ZUJ8 | BCAP_HUMAN Phosphoinositide 3-kinase adapter protein 1 OS=Homo sapiens GN=PIK3AP1 PE=1 SV=2 | 638 | K | 0.653287 | R | 0.636939 | 0.016348 | No Change: Both D | - |
| O00443 | P3C2A_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha OS=Homo sapiens GN=PIK3C2A PE=1 SV=2 | 1415 | T | 0.460525 | A | 0.426304 | 0.034221 | No Change: Both O | - |
| O75747 | P3C2G_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma OS=Homo sapiens GN=PIK3C2G PE=1 SV=3 | 146 | P | 0.47182 | L | 0.32998 | 0.14184 | No Change: Both O | - |
| O75747 | P3C2G_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma OS=Homo sapiens GN=PIK3C2G PE=1 SV=3 | 261 | A | 0.268307 | E | 0.364588 | -0.096281 | No Change: Both O | - |
| O75747 | P3C2G_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma OS=Homo sapiens GN=PIK3C2G PE=1 SV=3 | 911 | P | 0.263878 | L | 0.142193 | 0.121685 | No Change: Both O | - |
| O75747 | P3C2G_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma OS=Homo sapiens GN=PIK3C2G PE=1 SV=3 | 1290 | V | 0.338548 | G | 0.457563 | -0.119015 | No Change: Both O | - |
| O75747 | P3C2G_HUMAN Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit gamma OS=Homo sapiens GN=PIK3C2G PE=1 SV=3 | 1442 | N | 0.54296 | T | 0.493076 | 0.049884 | D to O | - |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 38 | R | 0.106441 | H | 0.108845 | -0.002404 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 88 | R | 0.273025 | Q | 0.271005 | 0.00202 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 106 | G | 0.374869 | V | 0.303776 | 0.071093 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 343 | Y | 0.033563 | C | 0.029115 | 0.004448 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 391 | I | 0.086144 | M | 0.118214 | -0.03207 | No Change: Both O | - |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 420 | C | 0.283481 | R | 0.446868 | -0.163387 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 453 | E | 0.270888 | Q | 0.229047 | 0.041841 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 542 | E | 0.584006 | K | 0.574847 | 0.009159 | No Change: Both D | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 542 | E | 0.584006 | Q | 0.54385 | 0.040156 | No Change: Both D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 542 | E | 0.584006 | V | 0.383804 | 0.200202 | D to O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 545 | E | 0.510172 | A | 0.390751 | 0.119421 | D to O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 545 | E | 0.510172 | G | 0.434844 | 0.075328 | D to O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 545 | E | 0.510172 | K | 0.502534 | 0.007638 | No Change: Both D | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 546 | Q | 0.495572 | E | 0.548935 | -0.053363 | O to D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 546 | Q | 0.495572 | K | 0.537839 | -0.042267 | O to D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 546 | Q | 0.495572 | P | 0.52232 | -0.026748 | O to D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 546 | Q | 0.495572 | R | 0.493984 | 0.001588 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1007 | G | 0.353876 | R | 0.326214 | 0.027662 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1021 | Y | 0.128032 | C | 0.114342 | 0.01369 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1021 | Y | 0.128032 | H | 0.208184 | -0.080152 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1021 | Y | 0.128032 | N | 0.229199 | -0.101167 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1023 | R | 0.160663 | Q | 0.184636 | -0.023973 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1025 | T | 0.21005 | N | 0.227942 | -0.017892 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1035 | A | 0.400391 | V | 0.314521 | 0.08587 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1043 | M | 0.447628 | I | 0.330847 | 0.116781 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1047 | H | 0.451956 | L | 0.30061 | 0.151346 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1047 | H | 0.451956 | R | 0.427315 | 0.024641 | No Change: Both O | Keratosis seborrheic (KERSEB) [MIM:182000] |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1047 | H | 0.451956 | Y | 0.312526 | 0.13943 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1050 | G | 0.358207 | D | 0.389302 | -0.031095 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1052 | T | 0.285421 | K | 0.35657 | -0.071149 | No Change: Both O | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1065 | H | 0.654513 | L | 0.528452 | 0.126061 | No Change: Both D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 1065 | H | 0.654513 | Y | 0.524251 | 0.130262 | No Change: Both D | Cancer |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 43 | I | 0.145958 | V | 0.155142 | -0.009184 | No Change: Both O | - |
| P42336 | PK3CA_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit alpha isoform OS=Homo sapiens GN=PIK3CA PE=1 SV=2 | 332 | S | 0.071097 | R | 0.053133 | 0.017964 | No Change: Both O | - |
| P42338 | PK3CB_HUMAN Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Homo sapiens GN=PIK3CB PE=1 SV=1 | 672 | Q | 0.086353 | H | 0.086346 | 7.00E-06 | No Change: Both O | - |
| Q96FE7 | P3IP1_HUMAN Phosphoinositide-3-kinase-interacting protein 1 OS=Homo sapiens GN=PIK3IP1 PE=1 SV=2 | 251 | T | 0.786605 | S | 0.802108 | -0.015503 | No Change: Both D | - |
| P27986 | P85A_HUMAN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Homo sapiens GN=PIK3R1 PE=1 SV=2 | 326 | M | 0.557836 | I | 0.449608 | 0.108228 | D to O | - |
| P27986 | P85A_HUMAN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Homo sapiens GN=PIK3R1 PE=1 SV=2 | 409 | R | 0.31853 | Q | 0.350754 | -0.032224 | No Change: Both O | - |
| P27986 | P85A_HUMAN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Homo sapiens GN=PIK3R1 PE=1 SV=2 | 451 | E | 0.507605 | K | 0.509844 | -0.002239 | No Change: Both D | - |
| O00459 | P85B_HUMAN Phosphatidylinositol 3-kinase regulatory subunit beta OS=Homo sapiens GN=PIK3R2 PE=1 SV=2 | 234 | S | 0.690851 | R | 0.734323 | -0.043472 | No Change: Both D | - |
| O00459 | P85B_HUMAN Phosphatidylinositol 3-kinase regulatory subunit beta OS=Homo sapiens GN=PIK3R2 PE=1 SV=2 | 313 | S | 0.817745 | P | 0.836492 | -0.018747 | No Change: Both D | - |
| Q92569 | P55G_HUMAN Phosphatidylinositol 3-kinase regulatory subunit gamma OS=Homo sapiens GN=PIK3R3 PE=1 SV=2 | 283 | N | 0.82125 | K | 0.851758 | -0.030508 | No Change: Both D | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 936 | R | 0.597288 | Q | 0.653088 | -0.0558 | No Change: Both D | A breast cancer sample |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 273 | F | 0.181816 | L | 0.20431 | -0.022494 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 342 | R | 0.162105 | H | 0.154422 | 0.007683 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 347 | R | 0.150963 | W | 0.057818 | 0.093145 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 388 | T | 0.146807 | I | 0.081692 | 0.065115 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 393 | D | 0.201376 | N | 0.190037 | 0.011339 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 699 | L | 0.107127 | V | 0.103397 | 0.00373 | No Change: Both O | - |
| Q99570 | PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens GN=PIK3R4 PE=1 SV=3 | 1043 | G | 0.224086 | V | 0.131963 | 0.092123 | No Change: Both O | - |
| Q8WYR1 | PI3R5_HUMAN Phosphoinositide 3-kinase regulatory subunit 5 OS=Homo sapiens GN=PIK3R5 PE=1 SV=1 | 28 | R | 0.589522 | C | 0.433143 | 0.156379 | D to O | A colorectal cancer sample |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 1103 | K | 0.655132 | R | 0.621085 | 0.034047 | No Change: Both D | Corneal fleck dystrophy (CFD) [MIM:121850] |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 617 | M | 0.426305 | V | 0.325005 | 0.1013 | No Change: Both O | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 1033 | S | 0.672702 | A | 0.592088 | 0.080614 | No Change: Both D | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 1858 | R | 0.587144 | Q | 0.601519 | -0.014375 | No Change: Both D | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 696 | S | 0.478869 | N | 0.443531 | 0.035338 | No Change: Both O | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 932 | L | 0.470545 | S | 0.650546 | -0.180001 | O to D | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 995 | Q | 0.853248 | L | 0.776083 | 0.077165 | No Change: Both D | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 998 | T | 0.804271 | S | 0.844725 | -0.040454 | No Change: Both D | - |
| Q9Y2I7 | FYV1_HUMAN 1-phosphatidylinositol-3-phosphate 5-kinase OS=Homo sapiens GN=PIKFYVE PE=1 SV=3 | 1183 | Q | 0.902451 | K | 0.914212 | -0.011761 | No Change: Both D | - |
| Q9UKJ1 | PILRA_HUMAN Paired immunoglobulin-like type 2 receptor alpha OS=Homo sapiens GN=PILRA PE=1 SV=3 | 279 | S | 0.898822 | L | 0.835146 | 0.063676 | No Change: Both D | - |
| Q9UKJ1 | PILRA_HUMAN Paired immunoglobulin-like type 2 receptor alpha OS=Homo sapiens GN=PILRA PE=1 SV=3 | 78 | R | 0.458678 | G | 0.466348 | -0.00767 | No Change: Both O | - |
| Q9UKJ0 | PILRB_HUMAN Paired immunoglobulin-like type 2 receptor beta OS=Homo sapiens GN=PILRB PE=2 SV=1 | 63 | I | 0.05446 | T | 0.094549 | -0.040089 | No Change: Both O | - |
| Q9UKJ0 | PILRB_HUMAN Paired immunoglobulin-like type 2 receptor beta OS=Homo sapiens GN=PILRB PE=2 SV=1 | 66 | N | 0.086626 | D | 0.092852 | -0.006226 | No Change: Both O | - |
| P11309 | PIM1_HUMAN Serine/threonine-protein kinase pim-1 OS=Homo sapiens GN=PIM1 PE=1 SV=3 | 144 | Y | 0.34652 | H | 0.453424 | -0.106904 | No Change: Both O | A colorectal adenocarcinoma sample |
| P11309 | PIM1_HUMAN Serine/threonine-protein kinase pim-1 OS=Homo sapiens GN=PIM1 PE=1 SV=3 | 215 | E | 0.268885 | Q | 0.230811 | 0.038074 | No Change: Both O | - |
| P11309 | PIM1_HUMAN Serine/threonine-protein kinase pim-1 OS=Homo sapiens GN=PIM1 PE=1 SV=3 | 226 | E | 0.207617 | K | 0.190707 | 0.01691 | No Change: Both O | - |
| P11309 | PIM1_HUMAN Serine/threonine-protein kinase pim-1 OS=Homo sapiens GN=PIM1 PE=1 SV=3 | 233 | E | 0.308205 | D | 0.27002 | 0.038185 | No Change: Both O | - |
| Q9P1W9 | PIM2_HUMAN Serine/threonine-protein kinase pim-2 OS=Homo sapiens GN=PIM2 PE=1 SV=1 | 138 | G | 0.459186 | D | 0.457749 | 0.001437 | No Change: Both O | - |
| Q9P1W9 | PIM2_HUMAN Serine/threonine-protein kinase pim-2 OS=Homo sapiens GN=PIM2 PE=1 SV=1 | 280 | I | 0.658048 | V | 0.687052 | -0.029004 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 305 | P | 0.614461 | L | 0.466642 | 0.147819 | D to O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 309 | G | 0.415502 | D | 0.425953 | -0.010451 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 340 | A | 0.202582 | T | 0.222188 | -0.019606 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 521 | N | 0.221238 | T | 0.196022 | 0.025216 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 148 | L | 0.4054 | W | 0.28786 | 0.11754 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 196 | P | 0.837712 | S | 0.831254 | 0.006458 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 209 | P | 0.778098 | L | 0.652594 | 0.125504 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 215 | P | 0.652363 | L | 0.502281 | 0.150082 | No Change: Both D | A glioblastoma multiforme sample |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 339 | A | 0.223393 | T | 0.246567 | -0.023174 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 341 | M | 0.163919 | I | 0.102984 | 0.060935 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 377 | C | 0.075678 | F | 0.080786 | -0.005108 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 477 | S | 0.692441 | T | 0.598093 | 0.094348 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 67 | L | 0.49805 | F | 0.481814 | 0.016236 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 68 | R | 0.492175 | P | 0.50488 | -0.012705 | O to D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 92 | C | 0.12435 | F | 0.11867 | 0.00568 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 98 | R | 0.117455 | W | 0.043018 | 0.074437 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 111 | I | 0.37676 | S | 0.55128 | -0.17452 | O to D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 115 | Q | 0.604987 | L | 0.507854 | 0.097133 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 124 | A | 0.454673 | V | 0.363095 | 0.091578 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 145 | T | 0.538569 | M | 0.504728 | 0.033841 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 147 | R | 0.459154 | H | 0.398527 | 0.060627 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 168 | A | 0.323336 | P | 0.410051 | -0.086715 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 186 | K | 0.668001 | N | 0.6495 | 0.018501 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 196 | P | 0.837712 | L | 0.713019 | 0.124693 | No Change: Both D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 217 | A | 0.594942 | D | 0.575093 | 0.019849 | No Change: Both D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 231 | E | 0.556841 | G | 0.528788 | 0.028053 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 235 | N | 0.463077 | I | 0.337486 | 0.125591 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 240 | E | 0.403968 | K | 0.401394 | 0.002574 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 257 | T | 0.412433 | I | 0.297952 | 0.114481 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 263 | R | 0.644227 | G | 0.653863 | -0.009636 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 268 | L | 0.524304 | V | 0.527138 | -0.002834 | No Change: Both D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 271 | H | 0.335406 | Q | 0.384742 | -0.049336 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 276 | R | 0.187917 | Q | 0.180466 | 0.007451 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 279 | R | 0.178038 | H | 0.155659 | 0.022379 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 296 | P | 0.291716 | L | 0.165725 | 0.125991 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 313 | T | 0.193716 | M | 0.182883 | 0.010833 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 317 | V | 0.112062 | I | 0.092391 | 0.019671 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 318 | M | 0.117712 | L | 0.100179 | 0.017533 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 322 | P | 0.099092 | L | 0.052605 | 0.046487 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 347 | L | 0.180234 | P | 0.285928 | -0.105694 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 362 | D | 0.36156 | H | 0.327794 | 0.033766 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 383 | A | 0.022018 | T | 0.023248 | -0.00123 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 388 | C | 0.060394 | R | 0.113574 | -0.05318 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 395 | G | 0.180975 | V | 0.104963 | 0.076012 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 411 | G | 0.229316 | S | 0.265894 | -0.036578 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 417 | E | 0.411825 | G | 0.374969 | 0.036856 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 425 | P | 0.469782 | S | 0.504442 | -0.03466 | O to D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 431 | Y | 0.27455 | H | 0.402765 | -0.128215 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 442 | I | 0.04245 | T | 0.07361 | -0.03116 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 451 | N | 0.10406 | S | 0.131887 | -0.027827 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 461 | L | 0.610301 | S | 0.750378 | -0.140077 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 464 | R | 0.65131 | H | 0.675478 | -0.024168 | No Change: Both D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 476 | E | 0.674998 | K | 0.663543 | 0.011455 | No Change: Both D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 489 | L | 0.538959 | P | 0.676424 | -0.137465 | No Change: Both D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 501 | R | 0.488303 | P | 0.517618 | -0.029315 | O to D | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 525 | D | 0.173507 | N | 0.177055 | -0.003548 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 537 | A | 0.213815 | T | 0.238135 | -0.02432 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 575 | C | 0.152141 | R | 0.241016 | -0.088875 | No Change: Both O | - |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 125 | C | 0.453188 | G | 0.567688 | -0.1145 | O to D | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 280 | A | 0.184439 | T | 0.210115 | -0.025676 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 369 | L | 0.29288 | P | 0.450811 | -0.157931 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 386 | G | 0.032798 | A | 0.027072 | 0.005726 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 399 | P | 0.14171 | L | 0.076926 | 0.064784 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 407 | R | 0.217541 | Q | 0.233489 | -0.015948 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 409 | G | 0.228412 | V | 0.129409 | 0.099003 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q9BXM7 | PINK1_HUMAN Serine/threonine-protein kinase PINK1 mitochondrial OS=Homo sapiens GN=PINK1 PE=1 SV=1 | 126 | Q | 0.380354 | P | 0.391893 | -0.011539 | No Change: Both O | Parkinson disease type 6 (PARK6) [MIM:605909] |
| Q96BK5 | PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens GN=PINX1 PE=1 SV=2 | 206 | Q | 0.83364 | H | 0.790425 | 0.043215 | No Change: Both D | - |
| Q96BK5 | PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens GN=PINX1 PE=1 SV=2 | 215 | R | 0.935819 | I | 0.886972 | 0.048847 | No Change: Both D | - |
| Q96BK5 | PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens GN=PINX1 PE=1 SV=2 | 220 | T | 0.949022 | A | 0.945864 | 0.003158 | No Change: Both D | - |
| Q96BK5 | PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens GN=PINX1 PE=1 SV=2 | 254 | S | 0.96801 | C | 0.952809 | 0.015201 | No Change: Both D | - |
| Q96BK5 | PINX1_HUMAN PIN2/TERF1-interacting telomerase inhibitor 1 OS=Homo sapiens GN=PINX1 PE=1 SV=2 | 315 | E | 0.979869 | A | 0.969844 | 0.010025 | No Change: Both D | - |
| A4D1B5 | GSAP_HUMAN Gamma-secretase-activating protein OS=Homo sapiens GN=PION PE=1 SV=2 | 47 | H | 0.288938 | R | 0.301585 | -0.012647 | No Change: Both O | - |
| A4D1B5 | GSAP_HUMAN Gamma-secretase-activating protein OS=Homo sapiens GN=PION PE=1 SV=2 | 305 | G | 0.123766 | E | 0.150238 | -0.026472 | No Change: Both O | - |
| A4D1B5 | GSAP_HUMAN Gamma-secretase-activating protein OS=Homo sapiens GN=PION PE=1 SV=2 | 649 | V | 0.076773 | I | 0.073574 | 0.003199 | No Change: Both O | - |
| A4D1B5 | GSAP_HUMAN Gamma-secretase-activating protein OS=Homo sapiens GN=PION PE=1 SV=2 | 653 | W | 0.25856 | L | 0.346229 | -0.087669 | No Change: Both O | - |
| P48426 | PI42A_HUMAN Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha OS=Homo sapiens GN=PIP4K2A PE=1 SV=2 | 251 | N | 0.412764 | S | 0.427411 | -0.014647 | No Change: Both O | - |
| P48426 | PI42A_HUMAN Phosphatidylinositol-5-phosphate 4-kinase type-2 alpha OS=Homo sapiens GN=PIP4K2A PE=1 SV=2 | 7 | L | 0.77964 | I | 0.710436 | 0.069204 | No Change: Both D | - |
| Q8TBX8 | PI42C_HUMAN Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma OS=Homo sapiens GN=PIP4K2C PE=1 SV=3 | 84 | V | 0.482248 | A | 0.54946 | -0.067212 | O to D | - |
| Q8TBX8 | PI42C_HUMAN Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma OS=Homo sapiens GN=PIP4K2C PE=1 SV=3 | 241 | K | 0.623906 | R | 0.551383 | 0.072523 | No Change: Both D | - |
| Q8TBX8 | PI42C_HUMAN Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma OS=Homo sapiens GN=PIP4K2C PE=1 SV=3 | 300 | A | 0.7977 | G | 0.824943 | -0.027243 | No Change: Both D | - |
| O14986 | PI51B_HUMAN Phosphatidylinositol-4-phosphate 5-kinase type-1 beta OS=Homo sapiens GN=PIP5K1B PE=1 SV=2 | 415 | A | 0.65577 | T | 0.668191 | -0.012421 | No Change: Both D | - |
| O60331 | PI51C_HUMAN Phosphatidylinositol-4-phosphate 5-kinase type-1 gamma OS=Homo sapiens GN=PIP5K1C PE=1 SV=2 | 253 | D | 0.444564 | N | 0.435095 | 0.009469 | No Change: Both O | Lethal congenital contracture syndrome type 3 (LCCS3) [MIM:611369] |
| O00625 | PIR_HUMAN Pirin OS=Homo sapiens GN=PIR PE=1 SV=1 | 228 | V | 0.599357 | A | 0.628805 | -0.029448 | No Change: Both D | - |
| Q9BZ72 | PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens GN=PITPNM2 PE=1 SV=1 | 9 | P | 0.225736 | L | 0.114204 | 0.111532 | No Change: Both O | - |
| Q9BZ72 | PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens GN=PITPNM2 PE=1 SV=1 | 661 | L | 0.914145 | M | 0.921574 | -0.007429 | No Change: Both D | - |
| Q9BZ71 | PITM3_HUMAN Membrane-associated phosphatidylinositol transfer protein 3 OS=Homo sapiens GN=PITPNM3 PE=1 SV=2 | 80 | A | 0.619051 | T | 0.68393 | -0.064879 | No Change: Both D | - |
| Q9BZ71 | PITM3_HUMAN Membrane-associated phosphatidylinositol transfer protein 3 OS=Homo sapiens GN=PITPNM3 PE=1 SV=2 | 626 | Q | 0.445741 | H | 0.417944 | 0.027797 | No Change: Both O | Cone-rod dystrophy type 5 (CORD5) [MIM:600977] |
| Q9BZ71 | PITM3_HUMAN Membrane-associated phosphatidylinositol transfer protein 3 OS=Homo sapiens GN=PITPNM3 PE=1 SV=2 | 17 | P | 0.74585 | S | 0.73646 | 0.00939 | No Change: Both D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 8 | Q | 0.426005 | R | 0.541838 | -0.115833 | O to D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 145 | L | 0.308269 | V | 0.29154 | 0.016729 | No Change: Both O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 169 | F | 0.06401 | S | 0.141114 | -0.077104 | No Change: Both O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 328 | V | 0.592668 | I | 0.575536 | 0.017132 | No Change: Both D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 397 | V | 0.248531 | A | 0.291148 | -0.042617 | No Change: Both O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 516 | Q | 0.782886 | H | 0.735875 | 0.047011 | No Change: Both D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 621 | V | 0.075977 | I | 0.063203 | 0.012774 | No Change: Both O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 952 | I | 0.464055 | M | 0.562039 | -0.097984 | O to D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 963 | V | 0.407861 | I | 0.358788 | 0.049073 | No Change: Both O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 969 | P | 0.557494 | L | 0.416371 | 0.141123 | D to O | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 1037 | R | 0.624702 | Q | 0.671919 | -0.047217 | No Change: Both D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 554 | A | 0.696939 | D | 0.759943 | -0.063004 | No Change: Both D | - |
| Q5JRX3 | PREP_HUMAN Presequence protease mitochondrial OS=Homo sapiens GN=PITRM1 PE=1 SV=2 | 805 | R | 0.887525 | Q | 0.880279 | 0.007246 | No Change: Both D | - |
| P78337 | PITX1_HUMAN Pituitary homeobox 1 OS=Homo sapiens GN=PITX1 PE=1 SV=2 | 299 | G | 0.71528 | A | 0.663092 | 0.052188 | No Change: Both D | - |
| P78337 | PITX1_HUMAN Pituitary homeobox 1 OS=Homo sapiens GN=PITX1 PE=1 SV=2 | 130 | E | 0.255067 | K | 0.250801 | 0.004266 | No Change: Both O | Congenital clubfoot (CCF) [MIM:119800] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 130 | R | 0.273621 | W | 0.118217 | 0.155404 | No Change: Both O | Iridogoniodysgenesis type 2 (IRID2) [MIM:137600] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 100 | L | 0.736967 | Q | 0.820264 | -0.083297 | No Change: Both D | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 114 | T | 0.501804 | P | 0.533632 | -0.031828 | No Change: Both D | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 115 | R | 0.481075 | H | 0.405394 | 0.075681 | No Change: Both O | Iridogoniodysgenesis type 2 (IRID2) [MIM:137600] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 137 | R | 0.432532 | P | 0.428338 | 0.004194 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 108 | R | 0.583756 | H | 0.524996 | 0.05876 | No Change: Both D | Ring dermoid of cornea (RDC) [MIM:180550] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 129 | V | 0.295938 | L | 0.303765 | -0.007827 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 110 | P | 0.571429 | L | 0.477318 | 0.094111 | D to O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 110 | P | 0.571429 | R | 0.605788 | -0.034359 | No Change: Both D | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 134 | K | 0.344628 | E | 0.347205 | -0.002577 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 136 | R | 0.4281 | C | 0.274354 | 0.153746 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 151 | L | 0.452143 | V | 0.448853 | 0.00329 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| Q99697 | PITX2_HUMAN Pituitary homeobox 2 OS=Homo sapiens GN=PITX2 PE=1 SV=2 | 154 | N | 0.397099 | T | 0.331069 | 0.06603 | No Change: Both O | Axenfeld-Rieger syndrome type 1 (RIEG1) [MIM:180500] |
| O75364 | PITX3_HUMAN Pituitary homeobox 3 OS=Homo sapiens GN=PITX3 PE=1 SV=1 | 13 | S | 0.904696 | N | 0.840584 | 0.064112 | No Change: Both D | Cataract autosomal dominant (ADC) [MIM:604219] |
| Q96J94 | PIWL1_HUMAN Piwi-like protein 1 OS=Homo sapiens GN=PIWIL1 PE=1 SV=1 | 491 | K | 0.14673 | N | 0.132104 | 0.014626 | No Change: Both O | - |
| Q96J94 | PIWL1_HUMAN Piwi-like protein 1 OS=Homo sapiens GN=PIWIL1 PE=1 SV=1 | 527 | R | 0.289669 | K | 0.370312 | -0.080643 | No Change: Both O | - |
| Q96J94 | PIWL1_HUMAN Piwi-like protein 1 OS=Homo sapiens GN=PIWIL1 PE=1 SV=1 | 575 | L | 0.241445 | P | 0.408718 | -0.167273 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 375 | P | 0.330571 | S | 0.367716 | -0.037145 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 412 | C | 0.248723 | R | 0.382632 | -0.133909 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 418 | V | 0.313334 | M | 0.415722 | -0.102388 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 471 | V | 0.230012 | I | 0.202627 | 0.027385 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 589 | R | 0.45598 | C | 0.312858 | 0.143122 | No Change: Both O | - |
| Q7Z3Z3 | PIWL3_HUMAN Piwi-like protein 3 OS=Homo sapiens GN=PIWIL3 PE=2 SV=2 | 186 | P | 0.48173 | L | 0.365371 | 0.116359 | No Change: Both O | - |
| Q7Z3Z4 | PIWL4_HUMAN Piwi-like protein 4 OS=Homo sapiens GN=PIWIL4 PE=2 SV=2 | 327 | Q | 0.561759 | L | 0.399686 | 0.162073 | D to O | - |
| Q7Z3Z4 | PIWL4_HUMAN Piwi-like protein 4 OS=Homo sapiens GN=PIWIL4 PE=2 SV=2 | 78 | Q | 0.444074 | R | 0.482212 | -0.038138 | No Change: Both O | - |
| Q7Z3Z4 | PIWL4_HUMAN Piwi-like protein 4 OS=Homo sapiens GN=PIWIL4 PE=2 SV=2 | 167 | K | 0.523106 | R | 0.472795 | 0.050311 | D to O | - |
| Q7Z3Z4 | PIWL4_HUMAN Piwi-like protein 4 OS=Homo sapiens GN=PIWIL4 PE=2 SV=2 | 370 | A | 0.496764 | P | 0.560353 | -0.063589 | O to D | - |
| Q8NG27 | PJA1_HUMAN E3 ubiquitin-protein ligase Praja-1 OS=Homo sapiens GN=PJA1 PE=1 SV=2 | 432 | S | 0.961586 | N | 0.951492 | 0.010094 | No Change: Both D | - |
| Q8NG27 | PJA1_HUMAN E3 ubiquitin-protein ligase Praja-1 OS=Homo sapiens GN=PJA1 PE=1 SV=2 | 606 | E | 0.314054 | D | 0.270815 | 0.043239 | No Change: Both O | - |
| O43164 | PJA2_HUMAN E3 ubiquitin-protein ligase Praja-2 OS=Homo sapiens GN=PJA2 PE=1 SV=4 | 297 | Q | 0.936171 | R | 0.936815 | -6.44E-04 | No Change: Both D | - |
| O43164 | PJA2_HUMAN E3 ubiquitin-protein ligase Praja-2 OS=Homo sapiens GN=PJA2 PE=1 SV=4 | 705 | A | 0.995939 | T | 0.994744 | 0.001195 | No Change: Both D | - |
| O43164 | PJA2_HUMAN E3 ubiquitin-protein ligase Praja-2 OS=Homo sapiens GN=PJA2 PE=1 SV=4 | 176 | E | 0.734674 | G | 0.725674 | 0.009 | No Change: Both D | - |
| Q0ZLH3 | PJVK_HUMAN Pejvakin OS=Homo sapiens GN=PJVK PE=1 SV=1 | 54 | T | 0.256212 | I | 0.15131 | 0.104902 | No Change: Both O | Deafness autosomal recessive type 59 (DFNB59) [MIM:610220] |
| Q0ZLH3 | PJVK_HUMAN Pejvakin OS=Homo sapiens GN=PJVK PE=1 SV=1 | 183 | R | 0.285598 | W | 0.121835 | 0.163763 | No Change: Both O | Deafness autosomal recessive type 59 (DFNB59) [MIM:610220] |
| Q0ZLH3 | PJVK_HUMAN Pejvakin OS=Homo sapiens GN=PJVK PE=1 SV=1 | 265 | R | 0.246336 | C | 0.122813 | 0.123523 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2760 | M | 0.532981 | T | 0.52737 | 0.005611 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2763 | L | 0.518534 | V | 0.489914 | 0.02862 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2764 | M | 0.503691 | T | 0.496456 | 0.007235 | D to O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2791 | R | 0.461249 | Q | 0.469084 | -0.007835 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2826 | I | 0.067913 | T | 0.123852 | -0.055939 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3008 | V | 0.133628 | L | 0.141631 | -0.008003 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3375 | V | 0.596038 | M | 0.668391 | -0.072353 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3632 | E | 0.574788 | D | 0.564783 | 0.010005 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3678 | M | 0.024052 | T | 0.028593 | -0.004541 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4032 | G | 0.060246 | D | 0.061904 | -0.001658 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4045 | I | 0.055274 | V | 0.071079 | -0.015805 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4058 | V | 0.091065 | A | 0.128758 | -0.037693 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 324 | R | 0.353122 | L | 0.240527 | 0.112595 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 845 | L | 0.254715 | S | 0.439419 | -0.184704 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1399 | W | 0.054752 | R | 0.129509 | -0.074757 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1786 | P | 0.509421 | L | 0.37319 | 0.136231 | D to O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2993 | L | 0.438307 | P | 0.574089 | -0.135782 | O to D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3016 | Q | 0.141831 | R | 0.13511 | 0.006721 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3510 | T | 0.916251 | M | 0.902773 | 0.013478 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3511 | L | 0.906568 | V | 0.87702 | 0.029548 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3562 | S | 0.120524 | N | 0.090601 | 0.029923 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4059 | A | 0.073327 | V | 0.053241 | 0.020086 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4136 | R | 0.178948 | G | 0.151173 | 0.027775 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4154 | R | 0.774178 | C | 0.674636 | 0.099542 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4190 | S | 0.968212 | F | 0.937186 | 0.031026 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4225 | Q | 0.514692 | P | 0.513614 | 0.001078 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4276 | R | 0.977223 | W | 0.936462 | 0.040761 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 13 | L | 0.863513 | Q | 0.875918 | -0.012405 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 75 | S | 0.316933 | F | 0.14294 | 0.173993 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 139 | W | 0.187178 | C | 0.242243 | -0.055065 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1166 | G | 0.346005 | S | 0.402271 | -0.056266 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1956 | V | 0.307939 | E | 0.445272 | -0.137333 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1995 | R | 0.429743 | H | 0.409531 | 0.020212 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2250 | T | 0.230225 | M | 0.188119 | 0.042106 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2329 | R | 0.294148 | W | 0.137671 | 0.156477 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2336 | Y | 0.161358 | D | 0.277851 | -0.116493 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2379 | Y | 0.378137 | C | 0.40271 | -0.024573 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2408 | R | 0.42275 | C | 0.276028 | 0.146722 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2604 | D | 0.308764 | N | 0.294356 | 0.014408 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2674 | P | 0.302108 | S | 0.349714 | -0.047606 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2708 | T | 0.386318 | M | 0.319832 | 0.066486 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2734 | P | 0.693034 | T | 0.63998 | 0.053054 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2735 | Q | 0.700903 | L | 0.621668 | 0.079235 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2752 | A | 0.578485 | D | 0.609851 | -0.031366 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2765 | R | 0.478612 | C | 0.351473 | 0.127139 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2768 | V | 0.445391 | M | 0.56428 | -0.118889 | O to D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2771 | E | 0.497765 | K | 0.460178 | 0.037587 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2782 | V | 0.448863 | M | 0.536476 | -0.087613 | O to D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2814 | G | 0.279793 | R | 0.267773 | 0.01202 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2816 | L | 0.25498 | P | 0.394428 | -0.139448 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2858 | G | 0.303929 | S | 0.369759 | -0.06583 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2888 | R | 0.708688 | G | 0.689406 | 0.019282 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2905 | V | 0.431734 | I | 0.346904 | 0.08483 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2921 | H | 0.300602 | P | 0.374208 | -0.073606 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2966 | E | 0.760081 | D | 0.753475 | 0.006606 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3066 | F | 0.295913 | L | 0.306101 | -0.010188 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3139 | G | 0.172529 | V | 0.096937 | 0.075592 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3193 | P | 0.174283 | L | 0.095312 | 0.078971 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3512 | A | 0.900796 | V | 0.865354 | 0.035442 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3719 | R | 0.169437 | Q | 0.175756 | -0.006319 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3753 | R | 0.46424 | W | 0.22698 | 0.23726 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3815 | D | 0.236225 | N | 0.221466 | 0.014759 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3852 | L | 0.198125 | P | 0.316441 | -0.118316 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 88 | A | 0.178738 | V | 0.122138 | 0.0566 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 967 | W | 0.122673 | R | 0.283117 | -0.160444 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2392 | R | 0.301888 | P | 0.313726 | -0.011838 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2423 | S | 0.635384 | F | 0.427892 | 0.207492 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2471 | P | 0.580907 | L | 0.419211 | 0.161696 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2519 | Q | 0.165803 | L | 0.102946 | 0.062857 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2548 | E | 0.168332 | Q | 0.145121 | 0.023211 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2582 | T | 0.315011 | M | 0.255594 | 0.059417 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2638 | H | 0.653187 | R | 0.657022 | -0.003835 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2649 | T | 0.285056 | I | 0.181973 | 0.103083 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2696 | L | 0.178988 | R | 0.257873 | -0.078885 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2972 | D | 0.612958 | N | 0.614439 | -0.001481 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2985 | R | 0.586827 | G | 0.604148 | -0.017321 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3039 | R | 0.400463 | C | 0.257575 | 0.142888 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3285 | V | 0.00898 | I | 0.008557 | 4.23E-04 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3311 | H | 0.583579 | R | 0.596456 | -0.012877 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3560 | G | 0.125538 | R | 0.123123 | 0.002415 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3247 | R | 0.104536 | H | 0.091824 | 0.012712 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3382 | T | 0.460942 | M | 0.462105 | -0.001163 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2746 | R | 0.674018 | P | 0.715371 | -0.041353 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 950 | L | 0.14066 | P | 0.266547 | -0.125887 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1092 | M | 0.238251 | T | 0.285702 | -0.047451 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1114 | L | 0.340362 | R | 0.462422 | -0.12206 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1557 | R | 0.27581 | P | 0.309924 | -0.034114 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1734 | T | 0.434229 | K | 0.485468 | -0.051239 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2515 | R | 0.104673 | Q | 0.109141 | -0.004468 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2534 | S | 0.345033 | G | 0.294609 | 0.050424 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3005 | Q | 0.162018 | E | 0.191398 | -0.02938 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3023 | M | 0.217127 | V | 0.181583 | 0.035544 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 36 | P | 0.881631 | H | 0.792762 | 0.088869 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 61 | P | 0.511574 | L | 0.380554 | 0.13102 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 87 | L | 0.16887 | M | 0.186506 | -0.017636 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 99 | S | 0.447169 | I | 0.242503 | 0.204666 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 164 | Q | 0.420148 | R | 0.398002 | 0.022146 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 210 | C | 0.394241 | G | 0.486378 | -0.092137 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 381 | G | 0.569535 | C | 0.486063 | 0.083472 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 508 | C | 0.429459 | R | 0.511597 | -0.082138 | O to D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 572 | P | 0.586504 | S | 0.571239 | 0.015265 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 594 | F | 0.546135 | Y | 0.520758 | 0.025377 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 690 | V | 0.238944 | D | 0.366247 | -0.127303 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 738 | P | 0.774348 | R | 0.722119 | 0.052229 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 739 | R | 0.765558 | Q | 0.791697 | -0.026139 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 987 | Q | 0.074165 | H | 0.067206 | 0.006959 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1168 | P | 0.424295 | S | 0.461727 | -0.037432 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1242 | T | 0.187215 | M | 0.152189 | 0.035026 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1340 | R | 0.461849 | W | 0.258412 | 0.203437 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1516 | A | 0.387055 | T | 0.443935 | -0.05688 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1649 | T | 0.222397 | M | 0.176589 | 0.045808 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1667 | T | 0.18223 | P | 0.222549 | -0.040319 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1684 | S | 0.326681 | L | 0.171128 | 0.155553 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1811 | E | 0.580611 | K | 0.579513 | 0.001098 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1871 | A | 0.26111 | T | 0.276532 | -0.015422 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1926 | A | 0.373267 | V | 0.32603 | 0.047237 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1943 | V | 0.485451 | I | 0.425514 | 0.059937 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 1952 | G | 0.399609 | D | 0.422392 | -0.022783 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2083 | T | 0.630181 | I | 0.518063 | 0.112118 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2092 | Y | 0.508718 | C | 0.550209 | -0.041491 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2185 | Y | 0.256985 | D | 0.383818 | -0.126833 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2200 | R | 0.519338 | C | 0.349003 | 0.170335 | D to O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2370 | C | 0.168267 | R | 0.266953 | -0.098686 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2373 | C | 0.241772 | Y | 0.224791 | 0.016981 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2422 | T | 0.626513 | K | 0.642538 | -0.016025 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2761 | R | 0.53452 | P | 0.552437 | -0.017917 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2785 | G | 0.554088 | D | 0.574225 | -0.020137 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2802 | P | 0.363553 | L | 0.205178 | 0.158375 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2958 | S | 0.758956 | L | 0.622507 | 0.136449 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2977 | T | 0.55702 | N | 0.615379 | -0.058359 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3008 | V | 0.133628 | M | 0.166304 | -0.032676 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3057 | V | 0.226866 | M | 0.265169 | -0.038303 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3138 | V | 0.204813 | M | 0.266281 | -0.061468 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3167 | I | 0.216621 | F | 0.220207 | -0.003586 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3355 | P | 0.740181 | L | 0.652226 | 0.087955 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3435 | R | 0.54566 | Q | 0.571291 | -0.025631 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3602 | G | 0.112987 | S | 0.160407 | -0.04742 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3649 | P | 0.489316 | L | 0.324325 | 0.164991 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3682 | L | 0.024623 | P | 0.04354 | -0.018917 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3726 | W | 0.108486 | S | 0.279698 | -0.171212 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3751 | Q | 0.524363 | R | 0.526562 | -0.002199 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3954 | A | 0.225014 | P | 0.266361 | -0.041347 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4102 | G | 0.04476 | E | 0.053146 | -0.008386 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4106 | L | 0.049062 | P | 0.094335 | -0.045273 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4124 | P | 0.33391 | S | 0.347008 | -0.013098 | No Change: Both O | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4146 | V | 0.5609 | I | 0.507921 | 0.052979 | No Change: Both D | - |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4155 | F | 0.797041 | V | 0.806415 | -0.009374 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 4255 | P | 0.958811 | S | 0.963534 | -0.004723 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 97 | D | 0.395448 | G | 0.369817 | 0.025631 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 436 | C | 0.223156 | R | 0.380228 | -0.157072 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 442 | A | 0.140032 | P | 0.179229 | -0.039197 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 727 | L | 0.638943 | P | 0.792159 | -0.153216 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 727 | L | 0.638943 | R | 0.719896 | -0.080953 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2391 | G | 0.289692 | D | 0.302081 | -0.012389 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2434 | R | 0.386195 | W | 0.16387 | 0.222325 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2546 | H | 0.215071 | Y | 0.134696 | 0.080375 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2569 | S | 0.163308 | C | 0.06224 | 0.101068 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2646 | I | 0.348262 | T | 0.489876 | -0.141614 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 2889 | S | 0.719748 | R | 0.687132 | 0.032616 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3154 | L | 0.680895 | P | 0.752835 | -0.07194 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3603 | W | 0.121117 | R | 0.258649 | -0.137532 | No Change: Both O | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| P98161 | PKD1_HUMAN Polycystin-1 OS=Homo sapiens GN=PKD1 PE=1 SV=3 | 3750 | R | 0.581786 | Q | 0.595121 | -0.013335 | No Change: Both D | Polycystic kidney disease autosomal dominant type 1 (ADPKD1) [MIM:173900] |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 2410 | E | 0.717625 | K | 0.688307 | 0.029318 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 312 | V | 0.44728 | F | 0.448789 | -0.001509 | No Change: Both O | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 1053 | R | 0.948047 | P | 0.959221 | -0.011174 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 1272 | K | 0.636609 | E | 0.635835 | 7.74E-04 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 812 | D | 0.571536 | N | 0.52437 | 0.047166 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 879 | T | 0.593268 | A | 0.567413 | 0.025855 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 2685 | A | 0.222945 | T | 0.266494 | -0.043549 | No Change: Both O | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 894 | V | 0.083276 | I | 0.071645 | 0.011631 | No Change: Both O | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 2057 | R | 0.929845 | H | 0.910133 | 0.019712 | No Change: Both D | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 2603 | L | 0.108776 | F | 0.095635 | 0.013141 | No Change: Both O | - |
| Q8TDX9 | PK1L1_HUMAN Polycystic kidney disease protein 1-like 1 OS=Homo sapiens GN=PKD1L1 PE=2 SV=1 | 906 | V | 0.146155 | I | 0.124505 | 0.02165 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 20 | V | 0.458656 | A | 0.550435 | -0.091779 | O to D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 73 | W | 0.173226 | R | 0.343317 | -0.170091 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 77 | K | 0.212702 | N | 0.181489 | 0.031213 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 120 | Q | 0.401627 | L | 0.268889 | 0.132738 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 129 | G | 0.422916 | D | 0.442679 | -0.019763 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 156 | V | 0.123076 | I | 0.107299 | 0.015777 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 162 | C | 0.217144 | S | 0.434881 | -0.217737 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 169 | V | 0.1242 | M | 0.156096 | -0.031896 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 173 | L | 0.13314 | S | 0.251869 | -0.118729 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 183 | V | 0.252073 | I | 0.220301 | 0.031772 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 205 | G | 0.414546 | R | 0.419494 | -0.004948 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 221 | E | 0.393309 | G | 0.339399 | 0.05391 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 252 | R | 0.11369 | W | 0.04864 | 0.06505 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 301 | P | 0.731055 | A | 0.637409 | 0.093646 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 407 | N | 0.301612 | S | 0.370106 | -0.068494 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 416 | K | 0.517973 | Q | 0.511647 | 0.006326 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 462 | L | 0.316346 | V | 0.293685 | 0.022661 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 512 | P | 0.080354 | L | 0.041582 | 0.038772 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 636 | R | 0.491346 | H | 0.377014 | 0.114332 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 711 | L | 0.295887 | P | 0.438954 | -0.143067 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 785 | G | 0.318264 | C | 0.216456 | 0.101808 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 849 | R | 0.443081 | H | 0.450602 | -0.007521 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 863 | A | 0.290473 | V | 0.225013 | 0.06546 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 919 | L | 0.772357 | M | 0.806761 | -0.034404 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1036 | L | 0.367724 | P | 0.508204 | -0.14048 | O to D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1042 | M | 0.300158 | V | 0.253728 | 0.04643 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1048 | T | 0.263344 | A | 0.23296 | 0.030384 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1081 | G | 0.506355 | V | 0.392957 | 0.113398 | D to O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1251 | G | 0.143421 | W | 0.054817 | 0.088604 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1326 | S | 0.155971 | P | 0.133114 | 0.022857 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1335 | A | 0.207519 | D | 0.268735 | -0.061216 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1406 | T | 0.575433 | M | 0.524957 | 0.050476 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1527 | A | 0.287958 | V | 0.2226 | 0.065358 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1616 | Q | 0.183008 | R | 0.177304 | 0.005704 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1645 | M | 0.755381 | V | 0.729167 | 0.026214 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1665 | S | 0.324583 | Y | 0.151245 | 0.173338 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1701 | Q | 0.231543 | H | 0.204055 | 0.027488 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1848 | G | 0.230435 | R | 0.222942 | 0.007493 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1867 | M | 0.190725 | V | 0.159841 | 0.030884 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2036 | Q | 0.482914 | R | 0.459673 | 0.023241 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2046 | P | 0.432855 | L | 0.269388 | 0.163467 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2055 | A | 0.374408 | T | 0.372094 | 0.002314 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2119 | L | 0.105832 | I | 0.093177 | 0.012655 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2139 | S | 0.180643 | F | 0.073704 | 0.106939 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2315 | M | 0.03118 | I | 0.021294 | 0.009886 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 998 | R | 0.811438 | C | 0.715751 | 0.095687 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 999 | Q | 0.806802 | H | 0.751502 | 0.0553 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1330 | N | 0.178084 | D | 0.178484 | -4.00E-04 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1331 | I | 0.197585 | V | 0.215745 | -0.01816 | No Change: Both O | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 1739 | A | 0.785761 | V | 0.733189 | 0.052572 | No Change: Both D | - |
| Q7Z442 | PK1L2_HUMAN Polycystic kidney disease protein 1-like 2 OS=Homo sapiens GN=PKD1L2 PE=1 SV=4 | 2209 | S | 0.444422 | R | 0.38082 | 0.063602 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 120 | I | 0.26077 | F | 0.264866 | -0.004096 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 211 | S | 0.829517 | P | 0.82788 | 0.001637 | No Change: Both D | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 274 | K | 0.408854 | E | 0.423875 | -0.015021 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 429 | T | 0.553832 | S | 0.638091 | -0.084259 | No Change: Both D | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 471 | A | 0.126373 | D | 0.183917 | -0.057544 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 571 | H | 0.13179 | Q | 0.144608 | -0.012818 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 593 | V | 0.212148 | M | 0.264096 | -0.051948 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 903 | V | 0.133761 | I | 0.116254 | 0.017507 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 1176 | S | 0.220982 | R | 0.161495 | 0.059487 | No Change: Both O | - |
| Q7Z443 | PK1L3_HUMAN Polycystic kidney disease protein 1-like 3 OS=Homo sapiens GN=PKD1L3 PE=2 SV=1 | 1474 | Y | 0.009553 | C | 0.00746 | 0.002093 | No Change: Both O | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 414 | W | 0.2174 | G | 0.456037 | -0.238637 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 28 | R | 0.915365 | P | 0.927992 | -0.012627 | No Change: Both D | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 356 | A | 0.641787 | P | 0.700957 | -0.05917 | No Change: Both D | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 452 | I | 0.169338 | V | 0.205282 | -0.035944 | No Change: Both O | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 24 | P | 0.948644 | L | 0.899397 | 0.049247 | No Change: Both D | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 190 | A | 0.560674 | T | 0.598211 | -0.037537 | No Change: Both D | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 306 | R | 0.319633 | Q | 0.349014 | -0.029381 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 322 | R | 0.237107 | Q | 0.242178 | -0.005071 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 322 | R | 0.237107 | W | 0.0908 | 0.146307 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 420 | R | 0.124288 | G | 0.132668 | -0.00838 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 482 | F | 0.003051 | C | 0.00277 | 2.81E-04 | No Change: Both O | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 511 | D | 0.015739 | V | 0.007861 | 0.007878 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 632 | C | 0.081914 | R | 0.176315 | -0.094401 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 800 | M | 0.997362 | L | 0.996843 | 5.19E-04 | No Change: Both D | - |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 807 | R | 0.997972 | Q | 0.997563 | 4.09E-04 | No Change: Both D | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q13563 | PKD2_HUMAN Polycystin-2 OS=Homo sapiens GN=PKD2 PE=1 SV=3 | 384 | A | 0.188572 | P | 0.240214 | -0.051642 | No Change: Both O | Polycystic kidney disease autosomal dominant type 2 (ADPKD2) [MIM:613095] |
| Q9P0L9 | PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein OS=Homo sapiens GN=PKD2L1 PE=1 SV=1 | 393 | V | 0.013525 | I | 0.01189 | 0.001635 | No Change: Both O | - |
| Q9P0L9 | PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein OS=Homo sapiens GN=PKD2L1 PE=1 SV=1 | 681 | R | 0.688932 | L | 0.578771 | 0.110161 | No Change: Both D | - |
| Q9P0L9 | PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein OS=Homo sapiens GN=PKD2L1 PE=1 SV=1 | 278 | R | 0.607846 | Q | 0.635085 | -0.027239 | No Change: Both D | - |
| Q9P0L9 | PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein OS=Homo sapiens GN=PKD2L1 PE=1 SV=1 | 378 | R | 0.145137 | W | 0.055428 | 0.089709 | No Change: Both O | - |
| Q9P0L9 | PK2L1_HUMAN Polycystic kidney disease 2-like 1 protein OS=Homo sapiens GN=PKD2L1 PE=1 SV=1 | 788 | A | 0.927032 | D | 0.940706 | -0.013674 | No Change: Both D | - |
| Q9NZM6 | PK2L2_HUMAN Polycystic kidney disease 2-like 2 protein OS=Homo sapiens GN=PKD2L2 PE=2 SV=2 | 404 | V | 0.157967 | I | 0.13986 | 0.018107 | No Change: Both O | - |
| Q9NZM6 | PK2L2_HUMAN Polycystic kidney disease 2-like 2 protein OS=Homo sapiens GN=PKD2L2 PE=2 SV=2 | 507 | L | 0.242382 | P | 0.380699 | -0.138317 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1147 | I | 0.260299 | M | 0.338362 | -0.078063 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 669 | A | 0.62686 | G | 0.645631 | -0.018771 | No Change: Both D | A breast cancer sample |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1875 | T | 0.265053 | I | 0.162096 | 0.102957 | No Change: Both O | A breast cancer sample |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 528 | R | 0.091688 | Q | 0.100096 | -0.008408 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 914 | L | 0.1374 | P | 0.259823 | -0.122423 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 992 | T | 0.202186 | P | 0.243207 | -0.041021 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 993 | V | 0.174554 | A | 0.213395 | -0.038841 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1091 | N | 0.2125 | S | 0.255303 | -0.042803 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1411 | N | 0.411359 | D | 0.390583 | 0.020776 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1528 | I | 0.970487 | M | 0.977876 | -0.007389 | No Change: Both D | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 1729 | V | 0.015193 | I | 0.014582 | 6.11E-04 | No Change: Both O | - |
| Q9NTG1 | PKDRE_HUMAN Polycystic kidney disease and receptor for egg jelly-related protein OS=Homo sapiens GN=PKDREJ PE=2 SV=2 | 26 | V | 0.885574 | A | 0.914714 | -0.02914 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 36 | T | 0.099296 | M | 0.076149 | 0.023147 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 222 | I | 0.345964 | V | 0.400636 | -0.054672 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 253 | F | 0.166335 | L | 0.202702 | -0.036367 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 752 | T | 0.380418 | M | 0.310881 | 0.069537 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 760 | R | 0.585074 | C | 0.515493 | 0.069581 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 760 | R | 0.585074 | H | 0.53421 | 0.050864 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 852 | W | 0.128164 | R | 0.261386 | -0.133222 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1122 | G | 0.267402 | S | 0.317149 | -0.049747 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1204 | C | 0.130136 | Y | 0.15069 | -0.020554 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1249 | C | 0.126154 | W | 0.113378 | 0.012776 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1262 | A | 0.432415 | V | 0.355251 | 0.077164 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1407 | L | 0.1456 | R | 0.235673 | -0.090073 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1624 | R | 0.065466 | W | 0.024911 | 0.040555 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1664 | S | 0.377824 | F | 0.164245 | 0.213579 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1741 | V | 0.09254 | M | 0.11401 | -0.02147 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1917 | Q | 0.438199 | R | 0.435002 | 0.003197 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1995 | E | 0.481329 | G | 0.440669 | 0.04066 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2331 | I | 0.225077 | K | 0.413198 | -0.188121 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2938 | T | 0.496954 | M | 0.456334 | 0.04062 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2957 | I | 0.19964 | T | 0.307707 | -0.108067 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3018 | S | 0.31897 | F | 0.126073 | 0.192897 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3139 | D | 0.303184 | Y | 0.186822 | 0.116362 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3553 | I | 0.491241 | T | 0.632072 | -0.140831 | O to D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3960 | V | 0.579189 | I | 0.546787 | 0.032402 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 4048 | Q | 0.870956 | R | 0.848817 | 0.022139 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 17 | A | 0.090098 | V | 0.068911 | 0.021187 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 25 | I | 0.564973 | V | 0.607603 | -0.04263 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 223 | G | 0.366724 | S | 0.434116 | -0.067392 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 307 | I | 0.477362 | T | 0.619483 | -0.142121 | O to D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 326 | G | 0.487918 | V | 0.360861 | 0.127057 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 457 | E | 0.408297 | D | 0.363895 | 0.044402 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 473 | I | 0.117926 | S | 0.261866 | -0.14394 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 486 | Y | 0.210855 | H | 0.330249 | -0.119394 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 488 | R | 0.289684 | P | 0.317058 | -0.027374 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 496 | R | 0.350581 | P | 0.383272 | -0.032691 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 579 | T | 0.574176 | M | 0.516014 | 0.058162 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 656 | W | 0.341886 | C | 0.405803 | -0.063917 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 703 | D | 0.074738 | N | 0.06923 | 0.005508 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 732 | V | 0.468668 | F | 0.402792 | 0.065876 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 739 | P | 0.463347 | L | 0.315705 | 0.147642 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 757 | I | 0.500585 | L | 0.597653 | -0.097068 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 805 | P | 0.343706 | L | 0.213251 | 0.130455 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 830 | N | 0.309803 | S | 0.376214 | -0.066411 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 899 | T | 0.265204 | P | 0.30283 | -0.037626 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 997 | M | 0.136675 | K | 0.200553 | -0.063878 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1030 | A | 0.262114 | E | 0.356849 | -0.094735 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1123 | G | 0.249048 | S | 0.293727 | -0.044679 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1136 | Y | 0.155785 | C | 0.126993 | 0.028792 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1150 | A | 0.340756 | P | 0.424213 | -0.083457 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1283 | S | 0.393687 | L | 0.261191 | 0.132496 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1389 | P | 0.11566 | T | 0.084537 | 0.031123 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1472 | C | 0.277991 | Y | 0.252222 | 0.025769 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1486 | P | 0.406993 | L | 0.292116 | 0.114877 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1584 | S | 0.335982 | I | 0.143265 | 0.192717 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1709 | L | 0.252315 | F | 0.221269 | 0.031046 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1781 | T | 0.161844 | I | 0.092462 | 0.069382 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1789 | V | 0.098361 | L | 0.10388 | -0.005519 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1833 | S | 0.128792 | L | 0.066384 | 0.062408 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1838 | Y | 0.106505 | C | 0.102985 | 0.00352 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1867 | S | 0.337272 | N | 0.278851 | 0.058421 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1870 | L | 0.343165 | V | 0.330588 | 0.012577 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1942 | D | 0.492238 | G | 0.467434 | 0.024804 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1971 | G | 0.186632 | D | 0.193291 | -0.006659 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1998 | I | 0.541048 | T | 0.646988 | -0.10594 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2032 | V | 0.152697 | L | 0.156977 | -0.00428 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2134 | L | 0.165309 | P | 0.27003 | -0.104721 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2303 | I | 0.152634 | F | 0.136538 | 0.016096 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2422 | C | 0.095603 | G | 0.202379 | -0.106776 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2615 | A | 0.153921 | G | 0.19855 | -0.044629 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2641 | T | 0.273595 | A | 0.266291 | 0.007304 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2688 | C | 0.271454 | F | 0.293238 | -0.021784 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2761 | D | 0.34386 | Y | 0.189424 | 0.154436 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2772 | L | 0.135718 | P | 0.255645 | -0.119927 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2861 | S | 0.272157 | G | 0.225934 | 0.046223 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2863 | Y | 0.369645 | C | 0.297912 | 0.071733 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2869 | T | 0.277653 | K | 0.370939 | -0.093286 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2962 | D | 0.265718 | G | 0.262298 | 0.00342 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2983 | S | 0.471519 | L | 0.298304 | 0.173215 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3036 | V | 0.213693 | G | 0.348858 | -0.135165 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3072 | A | 0.067535 | V | 0.049241 | 0.018294 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3081 | I | 0.086859 | V | 0.102721 | -0.015862 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3088 | D | 0.316982 | N | 0.324875 | -0.007893 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3107 | R | 0.321386 | P | 0.347139 | -0.025753 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3124 | H | 0.437129 | Y | 0.297491 | 0.139638 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3143 | R | 0.155398 | I | 0.086507 | 0.068891 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3167 | I | 0.346846 | L | 0.381022 | -0.034176 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3175 | N | 0.092321 | D | 0.100203 | -0.007882 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3175 | N | 0.092321 | S | 0.104381 | -0.01206 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3177 | I | 0.067224 | T | 0.129543 | -0.062319 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3289 | S | 0.225422 | I | 0.090949 | 0.134473 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3293 | D | 0.153624 | V | 0.078812 | 0.074812 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3346 | C | 0.456219 | R | 0.572134 | -0.115915 | O to D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3440 | V | 0.251841 | D | 0.410816 | -0.158975 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3468 | I | 0.082063 | V | 0.092802 | -0.010739 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3471 | V | 0.103116 | G | 0.17667 | -0.073554 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3482 | R | 0.084951 | C | 0.040837 | 0.044114 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3502 | E | 0.175774 | V | 0.088867 | 0.086907 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3505 | S | 0.27238 | R | 0.210531 | 0.061849 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3529 | E | 0.304575 | Q | 0.267176 | 0.037399 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3551 | E | 0.405298 | K | 0.382229 | 0.023069 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3622 | C | 0.652975 | Y | 0.594915 | 0.05806 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3783 | P | 0.63032 | S | 0.649327 | -0.019007 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3842 | R | 0.355602 | L | 0.243487 | 0.112115 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3899 | Q | 0.850332 | R | 0.84971 | 6.22E-04 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 372 | F | 0.361398 | L | 0.384358 | -0.02296 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3052 | D | 0.377552 | Y | 0.231209 | 0.146343 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3837 | V | 0.448521 | I | 0.403826 | 0.044695 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3905 | I | 0.878358 | N | 0.924466 | -0.046108 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3913 | R | 0.905557 | H | 0.894972 | 0.010585 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 19 | R | 0.112893 | H | 0.125566 | -0.012673 | No Change: Both O | A colorectal cancer sample |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1081 | R | 0.342479 | C | 0.194579 | 0.1479 | No Change: Both O | A colorectal cancer sample |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1096 | L | 0.158867 | R | 0.268126 | -0.109259 | No Change: Both O | A colorectal cancer sample |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1806 | E | 0.569928 | K | 0.566697 | 0.003231 | No Change: Both D | A colorectal cancer sample |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 760 | R | 0.585074 | W | 0.406595 | 0.178479 | D to O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 92 | R | 0.198297 | W | 0.081156 | 0.117141 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 246 | I | 0.161269 | T | 0.265761 | -0.104492 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 255 | Y | 0.180616 | C | 0.15126 | 0.029356 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 292 | I | 0.179732 | V | 0.189469 | -0.009737 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 293 | A | 0.207111 | V | 0.166601 | 0.04051 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 466 | G | 0.406421 | E | 0.43925 | -0.032829 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 470 | G | 0.203387 | V | 0.11965 | 0.083737 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 539 | I | 0.182395 | T | 0.300528 | -0.118133 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 686 | H | 0.15153 | P | 0.194877 | -0.043347 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 723 | R | 0.607122 | C | 0.435159 | 0.171963 | D to O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 724 | P | 0.610212 | R | 0.591157 | 0.019055 | No Change: Both D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1712 | G | 0.350638 | R | 0.338816 | 0.011822 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1817 | V | 0.134602 | G | 0.211619 | -0.077017 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1875 | V | 0.328091 | G | 0.451952 | -0.123861 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 1928 | W | 0.247019 | L | 0.326018 | -0.078999 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2009 | A | 0.28291 | T | 0.3276 | -0.04469 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2106 | L | 0.377917 | R | 0.509262 | -0.131345 | O to D | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2210 | G | 0.288565 | E | 0.333678 | -0.045113 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2219 | S | 0.334493 | L | 0.200109 | 0.134384 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2224 | G | 0.280687 | R | 0.289991 | -0.009304 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2422 | C | 0.095603 | R | 0.198725 | -0.103122 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2431 | E | 0.353019 | V | 0.216266 | 0.136753 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2573 | R | 0.152574 | C | 0.086826 | 0.065748 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2661 | Y | 0.247878 | H | 0.377604 | -0.129726 | No Change: Both O | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2798 | V | 0.163955 | G | 0.247278 | -0.083323 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2803 | C | 0.069326 | R | 0.146305 | -0.076979 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 2804 | M | 0.067508 | K | 0.117399 | -0.049891 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3049 | H | 0.245399 | R | 0.242952 | 0.002447 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3207 | A | 0.295882 | T | 0.336275 | -0.040393 | No Change: Both O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3219 | V | 0.537123 | A | 0.616454 | -0.079331 | No Change: Both D | - |
| P08F94 | PKHD1_HUMAN Fibrocystin OS=Homo sapiens GN=PKHD1 PE=1 SV=1 | 3957 | R | 0.596572 | C | 0.459903 | 0.136669 | D to O | Polycystic kidney disease autosomal recessive (ARPKD) [MIM:263200] |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 373 | W | 0.239553 | C | 0.26655 | -0.026997 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 440 | Y | 0.659851 | H | 0.7413 | -0.081449 | No Change: Both D | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 923 | H | 0.340185 | R | 0.354153 | -0.013968 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 943 | Y | 0.189721 | H | 0.314188 | -0.124467 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 957 | A | 0.266883 | E | 0.344772 | -0.077889 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 1192 | T | 0.29662 | A | 0.237049 | 0.059571 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 1514 | R | 0.252695 | S | 0.324764 | -0.072069 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 1539 | T | 0.310185 | R | 0.347722 | -0.037537 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 1965 | V | 0.16068 | L | 0.142246 | 0.018434 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 3050 | H | 0.353878 | Q | 0.369414 | -0.015536 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 3080 | V | 0.055941 | I | 0.051394 | 0.004547 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 3411 | I | 0.178853 | V | 0.192227 | -0.013374 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 3607 | D | 0.248359 | E | 0.271026 | -0.022667 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 3862 | L | 0.068186 | F | 0.060841 | 0.007345 | No Change: Both O | - |
| Q86WI1 | PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens GN=PKHD1L1 PE=2 SV=2 | 4220 | V | 0.046327 | I | 0.041643 | 0.004684 | No Change: Both O | - |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 107 | M | 0.452394 | T | 0.455244 | -0.00285 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 134 | V | 0.430307 | D | 0.556818 | -0.126511 | O to D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 155 | L | 0.300252 | P | 0.483834 | -0.183582 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 172 | E | 0.576086 | Q | 0.534215 | 0.041871 | No Change: Both D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 163 | R | 0.416176 | C | 0.264557 | 0.151619 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 275 | G | 0.243978 | R | 0.251461 | -0.007483 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 281 | D | 0.129151 | N | 0.114808 | 0.014343 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 287 | F | 0.166638 | V | 0.194567 | -0.027929 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 314 | I | 0.454132 | T | 0.557234 | -0.103102 | O to D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 331 | D | 0.215824 | E | 0.244454 | -0.02863 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 332 | G | 0.214859 | S | 0.256414 | -0.041555 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 336 | A | 0.196113 | S | 0.296287 | -0.100174 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 337 | R | 0.198099 | P | 0.23161 | -0.033511 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 337 | R | 0.198099 | Q | 0.209446 | -0.011347 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 339 | D | 0.212908 | H | 0.180129 | 0.032779 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 341 | G | 0.218539 | A | 0.180805 | 0.037734 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 357 | I | 0.175008 | T | 0.265692 | -0.090684 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 359 | R | 0.207312 | C | 0.141981 | 0.065331 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 359 | R | 0.207312 | H | 0.177824 | 0.029488 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 361 | N | 0.214201 | D | 0.243319 | -0.029118 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 368 | V | 0.213827 | F | 0.182396 | 0.031431 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 384 | T | 0.59127 | M | 0.563058 | 0.028212 | No Change: Both D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 392 | A | 0.410083 | T | 0.438318 | -0.028235 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 393 | N | 0.3729 | K | 0.42866 | -0.05576 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 393 | N | 0.3729 | S | 0.438115 | -0.065215 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 408 | T | 0.367761 | I | 0.261164 | 0.106597 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 421 | Q | 0.322358 | K | 0.376046 | -0.053688 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 426 | R | 0.411786 | Q | 0.436472 | -0.024686 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 426 | R | 0.411786 | W | 0.224781 | 0.187005 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 431 | A | 0.340985 | T | 0.337774 | 0.003211 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 458 | G | 0.207375 | D | 0.241151 | -0.033776 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 459 | A | 0.180377 | V | 0.127008 | 0.053369 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 460 | V | 0.168321 | M | 0.202467 | -0.034146 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 468 | A | 0.089724 | V | 0.058098 | 0.031626 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 486 | R | 0.377192 | W | 0.171526 | 0.205666 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 490 | R | 0.261597 | W | 0.100939 | 0.160658 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 495 | A | 0.260536 | V | 0.187126 | 0.07341 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 498 | R | 0.347633 | C | 0.189277 | 0.158356 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 498 | R | 0.347633 | H | 0.329222 | 0.018411 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 510 | R | 0.107697 | Q | 0.109183 | -0.001486 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 532 | R | 0.221345 | Q | 0.238461 | -0.017116 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 532 | R | 0.221345 | W | 0.094158 | 0.127187 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 552 | V | 0.048797 | M | 0.058412 | -0.009615 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 559 | R | 0.188851 | G | 0.218667 | -0.029816 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 566 | N | 0.235389 | K | 0.266975 | -0.031586 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 37 | G | 0.446652 | E | 0.469635 | -0.022983 | No Change: Both O | Pyruvate kinase hyperactivity (PKHYP) [MIM:102900] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 80 | S | 0.366573 | P | 0.353166 | 0.013407 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 86 | R | 0.403126 | P | 0.456855 | -0.053729 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 90 | I | 0.342366 | N | 0.486687 | -0.144321 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 95 | G | 0.421654 | R | 0.456638 | -0.034984 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 111 | G | 0.375494 | R | 0.423411 | -0.047917 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 115 | A | 0.37768 | P | 0.437135 | -0.059455 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 120 | S | 0.47729 | F | 0.278444 | 0.198846 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 130 | S | 0.516679 | Y | 0.344516 | 0.172163 | D to O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 159 | G | 0.404872 | V | 0.289266 | 0.115606 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 222 | G | 0.102495 | A | 0.074066 | 0.028429 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 293 | D | 0.343087 | N | 0.326969 | 0.016118 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 263 | G | 0.469624 | R | 0.46647 | 0.003154 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 263 | G | 0.469624 | W | 0.248715 | 0.220909 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 288 | V | 0.200249 | L | 0.182976 | 0.017273 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 295 | A | 0.290735 | V | 0.227143 | 0.063592 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 310 | I | 0.426826 | N | 0.582111 | -0.155285 | O to D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 315 | E | 0.416059 | K | 0.421764 | -0.005705 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 331 | D | 0.215824 | N | 0.19134 | 0.024484 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 341 | G | 0.218539 | D | 0.24045 | -0.021911 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 342 | I | 0.214317 | F | 0.206366 | 0.007951 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 348 | K | 0.185704 | N | 0.150464 | 0.03524 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 364 | G | 0.241935 | D | 0.256691 | -0.014756 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 376 | S | 0.414715 | I | 0.238826 | 0.175889 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 387 | E | 0.576544 | G | 0.538691 | 0.037853 | No Change: Both D | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 390 | D | 0.473217 | N | 0.46141 | 0.011807 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 394 | A | 0.327427 | D | 0.404385 | -0.076958 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 394 | A | 0.327427 | V | 0.261416 | 0.066011 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 408 | T | 0.367761 | A | 0.364719 | 0.003042 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 427 | E | 0.442646 | A | 0.361253 | 0.081393 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 427 | E | 0.442646 | D | 0.39742 | 0.045226 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 477 | T | 0.247583 | A | 0.230105 | 0.017478 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 485 | S | 0.412775 | F | 0.197033 | 0.215742 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 488 | R | 0.286806 | Q | 0.292678 | -0.005872 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 495 | A | 0.260536 | T | 0.274455 | -0.013919 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 504 | R | 0.306055 | L | 0.200734 | 0.105321 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 511 | G | 0.09736 | R | 0.124886 | -0.027526 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 531 | R | 0.197278 | C | 0.094376 | 0.102902 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 153 | I | 0.261548 | T | 0.389867 | -0.128319 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 219 | I | 0.11784 | T | 0.190424 | -0.072584 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 335 | V | 0.18553 | M | 0.243177 | -0.057647 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 352 | A | 0.159992 | D | 0.203259 | -0.043267 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 385 | R | 0.60038 | W | 0.41675 | 0.18363 | D to O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 468 | A | 0.089724 | G | 0.085558 | 0.004166 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 479 | R | 0.327903 | H | 0.311059 | 0.016844 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 557 | G | 0.121567 | A | 0.087376 | 0.034191 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 569 | R | 0.370903 | Q | 0.399714 | -0.028811 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 506 | V | 0.226126 | I | 0.196857 | 0.029269 | No Change: Both O | - |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 40 | R | 0.370591 | W | 0.169454 | 0.201137 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 73 | L | 0.174279 | P | 0.288126 | -0.113847 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 154 | A | 0.265763 | T | 0.290299 | -0.024536 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 163 | R | 0.416176 | L | 0.310768 | 0.105408 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 165 | G | 0.430069 | V | 0.300871 | 0.129198 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 272 | L | 0.339581 | V | 0.358246 | -0.018665 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 320 | V | 0.400133 | L | 0.404939 | -0.004806 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 358 | G | 0.194119 | E | 0.234938 | -0.040819 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P30613 | KPYR_HUMAN Pyruvate kinase isozymes R/L OS=Homo sapiens GN=PKLR PE=1 SV=2 | 374 | L | 0.307936 | P | 0.497776 | -0.18984 | No Change: Both O | Pyruvate kinase deficiency of red cells (PKRD) [MIM:266200] |
| P14618 | KPYM_HUMAN Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM2 PE=1 SV=4 | 204 | G | 0.675761 | V | 0.574444 | 0.101317 | No Change: Both D | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 140 | R | 0.708995 | C | 0.571616 | 0.137379 | No Change: Both D | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 417 | P | 0.882371 | R | 0.825277 | 0.057094 | No Change: Both D | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 445 | V | 0.941243 | A | 0.957101 | -0.015858 | No Change: Both D | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 103 | E | 0.872224 | Q | 0.874098 | -0.001874 | No Change: Both D | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 246 | R | 0.222471 | H | 0.211474 | 0.010997 | No Change: Both O | - |
| Q99640 | PMYT1_HUMAN Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Homo sapiens GN=PKMYT1 PE=1 SV=1 | 351 | E | 0.320942 | K | 0.317417 | 0.003525 | No Change: Both O | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 901 | V | 0.723732 | I | 0.686153 | 0.037579 | No Change: Both D | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 185 | R | 0.655998 | C | 0.514643 | 0.141355 | No Change: Both D | A metastatic melanoma sample |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 197 | A | 0.720948 | E | 0.775312 | -0.054364 | No Change: Both D | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 436 | R | 0.140719 | W | 0.054847 | 0.085872 | No Change: Both O | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 520 | R | 0.215505 | Q | 0.206216 | 0.009289 | No Change: Both O | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 555 | L | 0.970323 | I | 0.968172 | 0.002151 | No Change: Both D | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 635 | R | 0.320971 | Q | 0.322579 | -0.001608 | No Change: Both O | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 718 | I | 0.104964 | V | 0.129311 | -0.024347 | No Change: Both O | - |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 873 | F | 0.529791 | L | 0.566892 | -0.037101 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q16512 | PKN1_HUMAN Serine/threonine-protein kinase N1 OS=Homo sapiens GN=PKN1 PE=1 SV=2 | 921 | A | 0.720235 | V | 0.626532 | 0.093703 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q16513 | PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens GN=PKN2 PE=1 SV=1 | 94 | E | 0.685496 | D | 0.668882 | 0.016614 | No Change: Both D | - |
| Q16513 | PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens GN=PKN2 PE=1 SV=1 | 197 | A | 0.246264 | E | 0.344087 | -0.097823 | No Change: Both O | - |
| Q16513 | PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens GN=PKN2 PE=1 SV=1 | 655 | Q | 0.179685 | R | 0.17117 | 0.008515 | No Change: Both O | - |
| Q6P5Z2 | PKN3_HUMAN Serine/threonine-protein kinase N3 OS=Homo sapiens GN=PKN3 PE=1 SV=1 | 180 | A | 0.769278 | E | 0.836422 | -0.067144 | No Change: Both D | - |
| Q6P5Z2 | PKN3_HUMAN Serine/threonine-protein kinase N3 OS=Homo sapiens GN=PKN3 PE=1 SV=1 | 404 | V | 0.207926 | L | 0.230313 | -0.022387 | No Change: Both O | - |
| P55347 | PKNX1_HUMAN Homeobox protein PKNOX1 OS=Homo sapiens GN=PKNOX1 PE=1 SV=3 | 265 | V | 0.548443 | I | 0.529561 | 0.018882 | No Change: Both D | A colorectal cancer sample |
| P55347 | PKNX1_HUMAN Homeobox protein PKNOX1 OS=Homo sapiens GN=PKNOX1 PE=1 SV=3 | 126 | R | 0.100633 | H | 0.094339 | 0.006294 | No Change: Both O | - |
| P55347 | PKNX1_HUMAN Homeobox protein PKNOX1 OS=Homo sapiens GN=PKNOX1 PE=1 SV=3 | 216 | T | 0.479883 | A | 0.42319 | 0.056693 | No Change: Both O | - |
| Q96KN3 | PKNX2_HUMAN Homeobox protein PKNOX2 OS=Homo sapiens GN=PKNOX2 PE=1 SV=2 | 110 | E | 0.403241 | K | 0.384792 | 0.018449 | No Change: Both O | - |
| Q13835 | PKP1_HUMAN Plakophilin-1 OS=Homo sapiens GN=PKP1 PE=1 SV=2 | 116 | R | 0.653992 | H | 0.622656 | 0.031336 | No Change: Both D | - |
| Q13835 | PKP1_HUMAN Plakophilin-1 OS=Homo sapiens GN=PKP1 PE=1 SV=2 | 161 | C | 0.681148 | Y | 0.635428 | 0.04572 | No Change: Both D | - |
| Q13835 | PKP1_HUMAN Plakophilin-1 OS=Homo sapiens GN=PKP1 PE=1 SV=2 | 196 | I | 0.811595 | V | 0.832389 | -0.020794 | No Change: Both D | - |
| Q13835 | PKP1_HUMAN Plakophilin-1 OS=Homo sapiens GN=PKP1 PE=1 SV=2 | 415 | G | 0.348679 | D | 0.374884 | -0.026205 | No Change: Both O | - |
| Q13835 | PKP1_HUMAN Plakophilin-1 OS=Homo sapiens GN=PKP1 PE=1 SV=2 | 463 | A | 0.227523 | V | 0.177931 | 0.049592 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 140 | S | 0.831719 | F | 0.659871 | 0.171848 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 615 | S | 0.162189 | F | 0.066312 | 0.095877 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 654 | K | 0.650299 | Q | 0.627459 | 0.02284 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 796 | C | 0.139026 | R | 0.251859 | -0.112833 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 366 | L | 0.495644 | P | 0.619534 | -0.12389 | O to D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 26 | D | 0.558416 | N | 0.543457 | 0.014959 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 58 | E | 0.75394 | D | 0.713326 | 0.040614 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 62 | Q | 0.67187 | K | 0.682721 | -0.010851 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 70 | S | 0.674835 | I | 0.469233 | 0.205602 | D to O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 137 | E | 0.823636 | K | 0.818179 | 0.005457 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 169 | S | 0.863081 | G | 0.817937 | 0.045144 | No Change: Both D | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 195 | A | 0.565706 | V | 0.503435 | 0.062271 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 276 | P | 0.56029 | S | 0.563359 | -0.003069 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 338 | T | 0.679692 | A | 0.651006 | 0.028686 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 372 | A | 0.353268 | P | 0.424896 | -0.071628 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 424 | F | 0.32321 | S | 0.51534 | -0.19213 | O to D | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 489 | G | 0.595942 | R | 0.601 | -0.005058 | No Change: Both D | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 526 | T | 0.102802 | M | 0.080676 | 0.022126 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 531 | I | 0.094721 | S | 0.224832 | -0.130111 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 587 | V | 0.112883 | I | 0.102542 | 0.010341 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 631 | Y | 0.338538 | C | 0.349991 | -0.011453 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 673 | G | 0.412794 | V | 0.317169 | 0.095625 | No Change: Both O | - |
| Q99959 | PKP2_HUMAN Plakophilin-2 OS=Homo sapiens GN=PKP2 PE=1 SV=2 | 787 | L | 0.333444 | F | 0.28203 | 0.051414 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 9 (ARVD9) [MIM:609040] |
| Q53H76 | PLA1A_HUMAN Phospholipase A1 member A OS=Homo sapiens GN=PLA1A PE=2 SV=2 | 23 | S | 0.429163 | I | 0.237962 | 0.191201 | No Change: Both O | - |
| Q53H76 | PLA1A_HUMAN Phospholipase A1 member A OS=Homo sapiens GN=PLA1A PE=2 SV=2 | 110 | R | 0.121604 | H | 0.115335 | 0.006269 | No Change: Both O | - |
| Q53H76 | PLA1A_HUMAN Phospholipase A1 member A OS=Homo sapiens GN=PLA1A PE=2 SV=2 | 284 | S | 0.121047 | N | 0.10107 | 0.019977 | No Change: Both O | - |
| P04054 | PA21B_HUMAN Phospholipase A2 OS=Homo sapiens GN=PLA2G1B PE=1 SV=3 | 16 | D | 0.353417 | A | 0.293526 | 0.059891 | No Change: Both O | - |
| P04054 | PA21B_HUMAN Phospholipase A2 OS=Homo sapiens GN=PLA2G1B PE=1 SV=3 | 89 | N | 0.470401 | T | 0.468848 | 0.001553 | No Change: Both O | - |
| P04054 | PA21B_HUMAN Phospholipase A2 OS=Homo sapiens GN=PLA2G1B PE=1 SV=3 | 89 | N | 0.470401 | K | 0.538134 | -0.067733 | O to D | - |
| P14555 | PA2GA_HUMAN Phospholipase A2 membrane associated OS=Homo sapiens GN=PLA2G2A PE=1 SV=2 | 19 | H | 0.165109 | Y | 0.096489 | 0.06862 | No Change: Both O | - |
| Q5R387 | PA2GC_HUMAN Putative inactive group IIC secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2C PE=2 SV=3 | 139 | Q | 0.797071 | R | 0.801406 | -0.004335 | No Change: Both D | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 80 | S | 0.246825 | G | 0.216729 | 0.030096 | No Change: Both O | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 65 | Q | 0.127872 | H | 0.11846 | 0.009412 | No Change: Both O | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 73 | H | 0.270119 | R | 0.276369 | -0.00625 | No Change: Both O | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 96 | H | 0.361015 | R | 0.366154 | -0.005139 | No Change: Both O | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 121 | R | 0.181047 | C | 0.116552 | 0.064495 | No Change: Both O | - |
| Q9UNK4 | PA2GD_HUMAN Group IID secretory phospholipase A2 OS=Homo sapiens GN=PLA2G2D PE=1 SV=2 | 121 | R | 0.181047 | L | 0.112978 | 0.068069 | No Change: Both O | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 157 | L | 0.437941 | V | 0.448776 | -0.010835 | No Change: Both O | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 70 | S | 0.389268 | A | 0.277204 | 0.112064 | No Change: Both O | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 116 | E | 0.609967 | Q | 0.596075 | 0.013892 | No Change: Both D | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 322 | S | 0.972427 | R | 0.971546 | 8.81E-04 | No Change: Both D | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 378 | R | 0.476575 | Q | 0.501292 | -0.024717 | O to D | - |
| Q9NZ20 | PA2G3_HUMAN Group 3 secretory phospholipase A2 OS=Homo sapiens GN=PLA2G3 PE=1 SV=2 | 307 | H | 0.995272 | Y | 0.992108 | 0.003164 | No Change: Both D | - |
| P47712 | PA24A_HUMAN Cytosolic phospholipase A2 OS=Homo sapiens GN=PLA2G4A PE=1 SV=2 | 651 | R | 0.392535 | K | 0.429583 | -0.037048 | No Change: Both O | - |
| P47712 | PA24A_HUMAN Cytosolic phospholipase A2 OS=Homo sapiens GN=PLA2G4A PE=1 SV=2 | 224 | V | 0.120769 | I | 0.112309 | 0.00846 | No Change: Both O | - |
| P47712 | PA24A_HUMAN Cytosolic phospholipase A2 OS=Homo sapiens GN=PLA2G4A PE=1 SV=2 | 103 | G | 0.294664 | R | 0.284151 | 0.010513 | No Change: Both O | - |
| P47712 | PA24A_HUMAN Cytosolic phospholipase A2 OS=Homo sapiens GN=PLA2G4A PE=1 SV=2 | 442 | H | 0.951609 | Q | 0.959033 | -0.007424 | No Change: Both D | A breast cancer sample |
| P47712 | PA24A_HUMAN Cytosolic phospholipase A2 OS=Homo sapiens GN=PLA2G4A PE=1 SV=2 | 637 | I | 0.157237 | V | 0.168937 | -0.0117 | No Change: Both O | - |
| P0C869 | PA24B_HUMAN Cytosolic phospholipase A2 beta OS=Homo sapiens GN=PLA2G4B PE=1 SV=2 | 191 | R | 0.406803 | C | 0.356511 | 0.050292 | No Change: Both O | - |
| P0C869 | PA24B_HUMAN Cytosolic phospholipase A2 beta OS=Homo sapiens GN=PLA2G4B PE=1 SV=2 | 239 | M | 0.63184 | I | 0.507835 | 0.124005 | No Change: Both D | - |
| P0C869 | PA24B_HUMAN Cytosolic phospholipase A2 beta OS=Homo sapiens GN=PLA2G4B PE=1 SV=2 | 391 | R | 0.296935 | H | 0.277639 | 0.019296 | No Change: Both O | - |
| P0C869 | PA24B_HUMAN Cytosolic phospholipase A2 beta OS=Homo sapiens GN=PLA2G4B PE=1 SV=2 | 591 | T | 0.321516 | I | 0.179013 | 0.142503 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 38 | A | 0.388775 | P | 0.458275 | -0.0695 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 143 | I | 0.151809 | V | 0.177397 | -0.025588 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 203 | S | 0.282345 | P | 0.266285 | 0.01606 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 430 | R | 0.233796 | C | 0.129557 | 0.104239 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 21 | E | 0.603598 | K | 0.608769 | -0.005171 | No Change: Both D | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 127 | A | 0.421238 | V | 0.341281 | 0.079957 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 142 | V | 0.118166 | F | 0.121925 | -0.003759 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 148 | R | 0.533735 | G | 0.545448 | -0.011713 | No Change: Both D | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 151 | P | 0.626825 | L | 0.54492 | 0.081905 | No Change: Both D | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 226 | T | 0.408855 | S | 0.486326 | -0.077471 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 360 | T | 0.160653 | P | 0.18396 | -0.023307 | No Change: Both O | - |
| Q9UP65 | PA24C_HUMAN Cytosolic phospholipase A2 gamma OS=Homo sapiens GN=PLA2G4C PE=1 SV=2 | 411 | D | 0.200691 | N | 0.175584 | 0.025107 | No Change: Both O | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 573 | R | 0.784094 | W | 0.643337 | 0.140757 | No Change: Both D | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 649 | A | 0.199217 | G | 0.208745 | -0.009528 | No Change: Both O | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 747 | R | 0.570661 | G | 0.591183 | -0.020522 | No Change: Both D | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 275 | P | 0.430646 | R | 0.397362 | 0.033284 | No Change: Both O | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 434 | S | 0.187048 | T | 0.141627 | 0.045421 | No Change: Both O | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 783 | R | 0.257993 | Q | 0.270449 | -0.012456 | No Change: Both O | - |
| Q86XP0 | PA24D_HUMAN Cytosolic phospholipase A2 delta OS=Homo sapiens GN=PLA2G4D PE=2 SV=2 | 807 | R | 0.616976 | Q | 0.616075 | 9.01E-04 | No Change: Both D | - |
| Q3MJ16 | PA24E_HUMAN Cytosolic phospholipase A2 epsilon OS=Homo sapiens GN=PLA2G4E PE=1 SV=3 | 388 | N | 0.151631 | S | 0.191869 | -0.040238 | No Change: Both O | - |
| Q3MJ16 | PA24E_HUMAN Cytosolic phospholipase A2 epsilon OS=Homo sapiens GN=PLA2G4E PE=1 SV=3 | 681 | A | 0.298398 | T | 0.342267 | -0.043869 | No Change: Both O | - |
| Q68DD2 | PA24F_HUMAN Cytosolic phospholipase A2 zeta OS=Homo sapiens GN=PLA2G4F PE=2 SV=3 | 740 | M | 0.557837 | V | 0.516432 | 0.041405 | No Change: Both D | - |
| Q68DD2 | PA24F_HUMAN Cytosolic phospholipase A2 zeta OS=Homo sapiens GN=PLA2G4F PE=2 SV=3 | 30 | G | 0.451849 | V | 0.311097 | 0.140752 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 58 | V | 0.156738 | I | 0.129012 | 0.027726 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 63 | R | 0.337711 | G | 0.343533 | -0.005822 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 70 | R | 0.297767 | Q | 0.327038 | -0.029271 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 183 | D | 0.428333 | N | 0.393348 | 0.034985 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 343 | A | 0.559524 | T | 0.578032 | -0.018508 | No Change: Both D | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 310 | V | 0.494648 | E | 0.645919 | -0.151271 | O to D | Neurodegeneration with brain iron accumulation type 2A (NBIA2A) [MIM:256600] |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 545 | K | 0.442522 | T | 0.369351 | 0.073171 | No Change: Both O | Neurodegeneration with brain iron accumulation type 2B (NBIA2B) [MIM:610217] |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 632 | R | 0.577292 | W | 0.341956 | 0.235336 | D to O | Neurodegeneration with brain iron accumulation type 2B (NBIA2B) [MIM:610217] |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 774 | S | 0.235808 | T | 0.186132 | 0.049676 | No Change: Both O | - |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 741 | R | 0.40454 | Q | 0.401658 | 0.002882 | No Change: Both O | Parkinson disease type 14 (PARK14) [MIM:612953] |
| O60733 | PA2G6_HUMAN 85 kDa calcium-independent phospholipase A2 OS=Homo sapiens GN=PLA2G6 PE=1 SV=2 | 747 | R | 0.155787 | W | 0.063973 | 0.091814 | No Change: Both O | Parkinson disease type 14 (PARK14) [MIM:612953] |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 279 | V | 0.262718 | F | 0.249669 | 0.013049 | No Change: Both O | Platelet-activating factor acetylhydrolase deficiency (PAFAD) [MIM:614278] |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 92 | R | 0.350814 | H | 0.355279 | -0.004465 | No Change: Both O | - |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 198 | I | 0.357467 | T | 0.47641 | -0.118943 | No Change: Both O | - |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 281 | Q | 0.271709 | R | 0.252886 | 0.018823 | No Change: Both O | Platelet-activating factor acetylhydrolase deficiency (PAFAD) [MIM:614278] |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 379 | V | 0.350935 | A | 0.457691 | -0.106756 | No Change: Both O | - |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 45 | L | 0.103022 | P | 0.200195 | -0.097173 | No Change: Both O | - |
| Q13093 | PAFA_HUMAN Platelet-activating factor acetylhydrolase OS=Homo sapiens GN=PLA2G7 PE=1 SV=1 | 191 | K | 0.40581 | N | 0.36428 | 0.04153 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 142 | R | 0.237388 | Q | 0.254397 | -0.017009 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 177 | P | 0.217865 | S | 0.225385 | -0.00752 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 279 | I | 0.530157 | V | 0.552236 | -0.022079 | No Change: Both D | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 292 | M | 0.167169 | V | 0.135309 | 0.03186 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 300 | H | 0.273811 | D | 0.324016 | -0.050205 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 404 | R | 0.31899 | H | 0.337572 | -0.018582 | No Change: Both O | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 1106 | G | 0.679275 | S | 0.729036 | -0.049761 | No Change: Both D | - |
| Q13018 | PLA2R_HUMAN Secretory phospholipase A2 receptor OS=Homo sapiens GN=PLA2R1 PE=1 SV=2 | 370 | A | 0.238039 | E | 0.332562 | -0.094523 | No Change: Both O | - |
| Q8NBU9 | PLAC2_HUMAN Placenta-specific protein 2 OS=Homo sapiens GN=PLAC2 PE=2 SV=2 | 105 | F | 0.544823 | L | 0.60063 | -0.055807 | No Change: Both D | - |
| A1L4L8 | PL8L1_HUMAN PLAC8-like protein 1 OS=Homo sapiens GN=PLAC8L1 PE=2 SV=1 | 11 | C | 0.2293 | S | 0.45663 | -0.22733 | No Change: Both O | - |
| Q6DJT9 | PLAG1_HUMAN Zinc finger protein PLAG1 OS=Homo sapiens GN=PLAG1 PE=1 SV=1 | 458 | P | 0.881406 | T | 0.849366 | 0.03204 | No Change: Both D | - |
| Q9UM63 | PLAL1_HUMAN Zinc finger protein PLAGL1 OS=Homo sapiens GN=PLAGL1 PE=1 SV=2 | 272 | A | 0.982917 | V | 0.975411 | 0.007506 | No Change: Both D | - |
| P00750 | TPA_HUMAN Tissue-type plasminogen activator OS=Homo sapiens GN=PLAT PE=1 SV=1 | 164 | R | 0.530588 | W | 0.302085 | 0.228503 | D to O | - |
| P00750 | TPA_HUMAN Tissue-type plasminogen activator OS=Homo sapiens GN=PLAT PE=1 SV=1 | 34 | A | 0.293301 | D | 0.365346 | -0.072045 | No Change: Both O | - |
| P00750 | TPA_HUMAN Tissue-type plasminogen activator OS=Homo sapiens GN=PLAT PE=1 SV=1 | 136 | R | 0.411348 | S | 0.48721 | -0.075862 | No Change: Both O | - |
| P00750 | TPA_HUMAN Tissue-type plasminogen activator OS=Homo sapiens GN=PLAT PE=1 SV=1 | 146 | A | 0.521048 | T | 0.555218 | -0.03417 | No Change: Both D | - |
| P00749 | UROK_HUMAN Urokinase-type plasminogen activator OS=Homo sapiens GN=PLAU PE=1 SV=2 | 141 | P | 0.388013 | L | 0.250043 | 0.13797 | No Change: Both O | - |
| P00749 | UROK_HUMAN Urokinase-type plasminogen activator OS=Homo sapiens GN=PLAU PE=1 SV=2 | 214 | I | 0.068233 | M | 0.099046 | -0.030813 | No Change: Both O | - |
| P00749 | UROK_HUMAN Urokinase-type plasminogen activator OS=Homo sapiens GN=PLAU PE=1 SV=2 | 15 | V | 0.233483 | L | 0.241999 | -0.008516 | No Change: Both O | - |
| P00749 | UROK_HUMAN Urokinase-type plasminogen activator OS=Homo sapiens GN=PLAU PE=1 SV=2 | 231 | K | 0.262518 | Q | 0.208964 | 0.053554 | No Change: Both O | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 317 | L | 0.216303 | P | 0.365826 | -0.149523 | No Change: Both O | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 55 | E | 0.499531 | G | 0.411256 | 0.088275 | No Change: Both O | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 86 | T | 0.396357 | A | 0.315101 | 0.081256 | No Change: Both O | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 105 | R | 0.544893 | Q | 0.545523 | -6.30E-04 | No Change: Both D | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 220 | K | 0.666933 | R | 0.663399 | 0.003534 | No Change: Both D | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 281 | N | 0.340718 | K | 0.376559 | -0.035841 | No Change: Both O | - |
| Q03405 | UPAR_HUMAN Urokinase plasminogen activator surface receptor OS=Homo sapiens GN=PLAUR PE=1 SV=1 | 297 | D | 0.42277 | A | 0.340908 | 0.081862 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 212 | V | 0.144459 | L | 0.143354 | 0.001105 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 708 | M | 0.402489 | V | 0.34861 | 0.053879 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 821 | G | 0.431854 | R | 0.434196 | -0.002342 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 879 | H | 0.168172 | D | 0.191245 | -0.023073 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 1318 | A | 0.170771 | V | 0.142569 | 0.028202 | No Change: Both O | - |
| Q6P1J6 | PLB1_HUMAN Phospholipase B1 membrane-associated OS=Homo sapiens GN=PLB1 PE=1 SV=3 | 987 | A | 0.213158 | V | 0.168553 | 0.044605 | No Change: Both O | - |
| Q6P4A8 | PLBL1_HUMAN Phospholipase B-like 1 OS=Homo sapiens GN=PLBD1 PE=1 SV=2 | 265 | V | 0.307866 | I | 0.294998 | 0.012868 | No Change: Both O | - |
| Q6P4A8 | PLBL1_HUMAN Phospholipase B-like 1 OS=Homo sapiens GN=PLBD1 PE=1 SV=2 | 377 | V | 0.109476 | A | 0.145075 | -0.035599 | No Change: Both O | - |
| Q6P4A8 | PLBL1_HUMAN Phospholipase B-like 1 OS=Homo sapiens GN=PLBD1 PE=1 SV=2 | 534 | P | 0.244716 | A | 0.18035 | 0.064366 | No Change: Both O | - |
| Q8NHP8 | PLBL2_HUMAN Putative phospholipase B-like 2 OS=Homo sapiens GN=PLBD2 PE=1 SV=2 | 524 | R | 0.454554 | C | 0.30094 | 0.153614 | No Change: Both O | - |
| Q8NHP8 | PLBL2_HUMAN Putative phospholipase B-like 2 OS=Homo sapiens GN=PLBD2 PE=1 SV=2 | 54 | Q | 0.648176 | P | 0.704432 | -0.056256 | No Change: Both D | - |
| Q9NQ66 | PLCB1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-1 OS=Homo sapiens GN=PLCB1 PE=1 SV=1 | 907 | A | 0.752073 | P | 0.81992 | -0.067847 | No Change: Both D | A breast cancer sample |
| Q9NQ66 | PLCB1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-1 OS=Homo sapiens GN=PLCB1 PE=1 SV=1 | 854 | E | 0.982987 | K | 0.980787 | 0.0022 | No Change: Both D | - |
| Q00722 | PLCB2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-2 OS=Homo sapiens GN=PLCB2 PE=1 SV=2 | 324 | N | 0.360469 | I | 0.197395 | 0.163074 | No Change: Both O | - |
| Q00722 | PLCB2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-2 OS=Homo sapiens GN=PLCB2 PE=1 SV=2 | 598 | R | 0.379716 | H | 0.354084 | 0.025632 | No Change: Both O | - |
| Q00722 | PLCB2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-2 OS=Homo sapiens GN=PLCB2 PE=1 SV=2 | 664 | P | 0.529996 | L | 0.361883 | 0.168113 | D to O | - |
| Q00722 | PLCB2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-2 OS=Homo sapiens GN=PLCB2 PE=1 SV=2 | 712 | G | 0.485781 | R | 0.518743 | -0.032962 | O to D | - |
| Q00722 | PLCB2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-2 OS=Homo sapiens GN=PLCB2 PE=1 SV=2 | 1095 | E | 0.885266 | G | 0.811052 | 0.074214 | No Change: Both D | - |
| Q01970 | PLCB3_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-3 OS=Homo sapiens GN=PLCB3 PE=1 SV=2 | 483 | R | 0.97444 | H | 0.966447 | 0.007993 | No Change: Both D | - |
| Q15147 | PLCB4_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens GN=PLCB4 PE=1 SV=3 | 21 | A | 0.256951 | T | 0.283872 | -0.026921 | No Change: Both O | - |
| Q15147 | PLCB4_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens GN=PLCB4 PE=1 SV=3 | 710 | G | 0.222343 | S | 0.280585 | -0.058242 | No Change: Both O | - |
| P51178 | PLCD1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens GN=PLCD1 PE=1 SV=2 | 257 | R | 0.513728 | H | 0.487801 | 0.025927 | D to O | - |
| P51178 | PLCD1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens GN=PLCD1 PE=1 SV=2 | 209 | T | 0.242353 | R | 0.272523 | -0.03017 | No Change: Both O | Nail disorder non-syndromic congenital type 3 (NDNC3) [MIM:151600] |
| P51178 | PLCD1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens GN=PLCD1 PE=1 SV=2 | 574 | I | 0.065329 | T | 0.126622 | -0.061293 | No Change: Both O | Nail disorder non-syndromic congenital type 3 (NDNC3) [MIM:151600] |
| Q8N3E9 | PLCD3_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase delta-3 OS=Homo sapiens GN=PLCD3 PE=1 SV=3 | 652 | P | 0.645435 | L | 0.510763 | 0.134672 | No Change: Both D | - |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 1484 | S | 0.174109 | L | 0.078925 | 0.095184 | No Change: Both O | Nephrotic syndrome type 3 (NPHS3) [MIM:610725] |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 469 | S | 0.46775 | T | 0.40613 | 0.06162 | No Change: Both O | - |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 548 | R | 0.15162 | L | 0.095992 | 0.055628 | No Change: Both O | - |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 1575 | R | 0.869528 | P | 0.90302 | -0.033492 | No Change: Both D | - |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 1777 | T | 0.417295 | I | 0.265855 | 0.15144 | No Change: Both O | - |
| Q9P212 | PLCE1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase epsilon-1 OS=Homo sapiens GN=PLCE1 PE=1 SV=3 | 1927 | H | 0.064931 | R | 0.060634 | 0.004297 | No Change: Both O | - |
| P19174 | PLCG1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-1 OS=Homo sapiens GN=PLCG1 PE=1 SV=1 | 813 | I | 0.161179 | T | 0.264801 | -0.103622 | No Change: Both O | - |
| P19174 | PLCG1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-1 OS=Homo sapiens GN=PLCG1 PE=1 SV=1 | 279 | S | 0.147801 | G | 0.11683 | 0.030971 | No Change: Both O | - |
| P19174 | PLCG1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-1 OS=Homo sapiens GN=PLCG1 PE=1 SV=1 | 209 | T | 0.304855 | N | 0.325832 | -0.020977 | No Change: Both O | - |
| P19174 | PLCG1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-1 OS=Homo sapiens GN=PLCG1 PE=1 SV=1 | 739 | S | 0.184043 | T | 0.130229 | 0.053814 | No Change: Both O | - |
| P16885 | PLCG2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-2 OS=Homo sapiens GN=PLCG2 PE=1 SV=4 | 244 | H | 0.12602 | R | 0.137723 | -0.011703 | No Change: Both O | - |
| P16885 | PLCG2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-2 OS=Homo sapiens GN=PLCG2 PE=1 SV=4 | 268 | R | 0.345764 | W | 0.156213 | 0.189551 | No Change: Both O | - |
| P16885 | PLCG2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-2 OS=Homo sapiens GN=PLCG2 PE=1 SV=4 | 541 | T | 0.584961 | A | 0.548477 | 0.036484 | No Change: Both D | - |
| P16885 | PLCG2_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase gamma-2 OS=Homo sapiens GN=PLCG2 PE=1 SV=4 | 883 | D | 0.583247 | Y | 0.424904 | 0.158343 | D to O | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 445 | D | 0.576565 | N | 0.550467 | 0.026098 | No Change: Both D | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 454 | P | 0.475434 | S | 0.525236 | -0.049802 | O to D | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 546 | S | 0.872244 | F | 0.745263 | 0.126981 | No Change: Both D | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 667 | V | 0.075899 | I | 0.076189 | -2.90E-04 | No Change: Both O | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 684 | W | 0.128139 | C | 0.159711 | -0.031572 | No Change: Both O | - |
| Q15111 | PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens GN=PLCL1 PE=1 SV=3 | 937 | S | 0.571493 | N | 0.518571 | 0.052922 | No Change: Both D | - |
| Q9UPR0 | PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens GN=PLCL2 PE=1 SV=2 | 211 | Q | 0.434312 | R | 0.438921 | -0.004609 | No Change: Both O | - |
| Q9UPR0 | PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens GN=PLCL2 PE=1 SV=2 | 635 | V | 0.28354 | M | 0.317339 | -0.033799 | No Change: Both O | - |
| Q9UPR0 | PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens GN=PLCL2 PE=1 SV=2 | 742 | A | 0.456677 | V | 0.400972 | 0.055705 | No Change: Both O | - |
| Q9UPR0 | PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens GN=PLCL2 PE=1 SV=2 | 809 | P | 0.400599 | H | 0.378138 | 0.022461 | No Change: Both O | - |
| Q9UPR0 | PLCL2_HUMAN Inactive phospholipase C-like protein 2 OS=Homo sapiens GN=PLCL2 PE=1 SV=2 | 890 | H | 0.758981 | R | 0.769173 | -0.010192 | No Change: Both D | - |
| Q86YW0 | PLCZ1_HUMAN 1-phosphatidylinositol-4 5-bisphosphate phosphodiesterase zeta-1 OS=Homo sapiens GN=PLCZ1 PE=2 SV=1 | 500 | S | 0.620606 | L | 0.49966 | 0.120946 | D to O | - |
| Q13393 | PLD1_HUMAN Phospholipase D1 OS=Homo sapiens GN=PLD1 PE=1 SV=1 | 622 | A | 0.608015 | S | 0.725715 | -0.1177 | No Change: Both D | - |
| Q13393 | PLD1_HUMAN Phospholipase D1 OS=Homo sapiens GN=PLD1 PE=1 SV=1 | 820 | V | 0.043418 | M | 0.053682 | -0.010264 | No Change: Both O | - |
| Q13393 | PLD1_HUMAN Phospholipase D1 OS=Homo sapiens GN=PLD1 PE=1 SV=1 | 49 | P | 0.527958 | A | 0.439524 | 0.088434 | D to O | - |
| Q13393 | PLD1_HUMAN Phospholipase D1 OS=Homo sapiens GN=PLD1 PE=1 SV=1 | 1024 | V | 0.275863 | I | 0.266725 | 0.009138 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 807 | Q | 0.298169 | E | 0.350508 | -0.052339 | No Change: Both O | A breast cancer sample |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 172 | R | 0.226294 | C | 0.128589 | 0.097705 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 577 | T | 0.460583 | I | 0.283875 | 0.176708 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 804 | A | 0.42536 | T | 0.441399 | -0.016039 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 821 | G | 0.080944 | R | 0.083499 | -0.002555 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 821 | G | 0.080944 | S | 0.099811 | -0.018867 | No Change: Both O | - |
| O14939 | PLD2_HUMAN Phospholipase D2 OS=Homo sapiens GN=PLD2 PE=1 SV=2 | 632 | E | 0.25598 | G | 0.205607 | 0.050373 | No Change: Both O | - |
| Q96BZ4 | PLD4_HUMAN Phospholipase D4 OS=Homo sapiens GN=PLD4 PE=1 SV=2 | 27 | E | 0.396104 | Q | 0.369383 | 0.026721 | No Change: Both O | - |
| Q96BZ4 | PLD4_HUMAN Phospholipase D4 OS=Homo sapiens GN=PLD4 PE=1 SV=2 | 135 | V | 0.246673 | M | 0.288134 | -0.041461 | No Change: Both O | - |
| Q96BZ4 | PLD4_HUMAN Phospholipase D4 OS=Homo sapiens GN=PLD4 PE=1 SV=2 | 16 | C | 0.367514 | R | 0.569205 | -0.201691 | O to D | - |
| Q8N2A8 | PLD6_HUMAN Mitochondrial cardiolipin hydrolase OS=Homo sapiens GN=PLD6 PE=1 SV=1 | 42 | L | 0.57283 | P | 0.710857 | -0.138027 | No Change: Both D | - |
| Q8N2A8 | PLD6_HUMAN Mitochondrial cardiolipin hydrolase OS=Homo sapiens GN=PLD6 PE=1 SV=1 | 108 | R | 0.355484 | H | 0.35938 | -0.003896 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2110 | R | 0.991116 | W | 0.975171 | 0.015945 | No Change: Both D | Epidermolysis bullosa simplex Ogna type (O-EBS) [MIM:131950] |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 641 | A | 0.350034 | V | 0.271711 | 0.078323 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2150 | R | 0.995018 | W | 0.985914 | 0.009104 | No Change: Both D | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2194 | A | 0.977332 | V | 0.967296 | 0.010036 | No Change: Both D | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2791 | S | 0.720903 | P | 0.719347 | 0.001556 | No Change: Both D | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2821 | R | 0.513898 | W | 0.286271 | 0.227627 | D to O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 2969 | R | 0.23466 | H | 0.218039 | 0.016621 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 3162 | V | 0.109312 | I | 0.093516 | 0.015796 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 3171 | A | 0.22954 | V | 0.174322 | 0.055218 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 3486 | T | 0.361394 | M | 0.31916 | 0.042234 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 3490 | G | 0.276217 | A | 0.229101 | 0.047116 | No Change: Both O | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 1321 | L | 0.784207 | V | 0.779985 | 0.004222 | No Change: Both D | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 1386 | R | 0.780732 | Q | 0.801771 | -0.021039 | No Change: Both D | - |
| Q15149 | PLEC_HUMAN Plectin OS=Homo sapiens GN=PLEC PE=1 SV=3 | 1459 | H | 0.480192 | R | 0.571 | -0.090808 | O to D | - |
| P08567 | PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 | 92 | W | 0.242053 | R | 0.491734 | -0.249681 | No Change: Both O | - |
| P08567 | PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 | 5 | R | 0.750161 | W | 0.559578 | 0.190583 | No Change: Both D | - |
| P08567 | PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 | 97 | K | 0.230805 | N | 0.163758 | 0.067047 | No Change: Both O | - |
| P08567 | PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 | 340 | R | 0.222221 | K | 0.266385 | -0.044164 | No Change: Both O | - |
| P08567 | PLEK_HUMAN Pleckstrin OS=Homo sapiens GN=PLEK PE=1 SV=3 | 108 | K | 0.481307 | Q | 0.434147 | 0.04716 | No Change: Both O | - |
| Q9NYT0 | PLEK2_HUMAN Pleckstrin-2 OS=Homo sapiens GN=PLEK2 PE=1 SV=1 | 80 | T | 0.336696 | M | 0.271614 | 0.065082 | No Change: Both O | - |
| Q9HB21 | PKHA1_HUMAN Pleckstrin homology domain-containing family A member 1 OS=Homo sapiens GN=PLEKHA1 PE=1 SV=2 | 320 | T | 0.923699 | A | 0.916096 | 0.007603 | No Change: Both D | - |
| Q9HB19 | PKHA2_HUMAN Pleckstrin homology domain-containing family A member 2 OS=Homo sapiens GN=PLEKHA2 PE=1 SV=2 | 186 | I | 0.720252 | N | 0.807553 | -0.087301 | No Change: Both D | - |
| Q9H4M7 | PKHA4_HUMAN Pleckstrin homology domain-containing family A member 4 OS=Homo sapiens GN=PLEKHA4 PE=1 SV=2 | 37 | I | 0.672036 | V | 0.692375 | -0.020339 | No Change: Both D | - |
| Q9H4M7 | PKHA4_HUMAN Pleckstrin homology domain-containing family A member 4 OS=Homo sapiens GN=PLEKHA4 PE=1 SV=2 | 597 | R | 0.978374 | Q | 0.977309 | 0.001065 | No Change: Both D | - |
| Q9H4M7 | PKHA4_HUMAN Pleckstrin homology domain-containing family A member 4 OS=Homo sapiens GN=PLEKHA4 PE=1 SV=2 | 714 | T | 0.989303 | A | 0.987035 | 0.002268 | No Change: Both D | - |
| Q9H4M7 | PKHA4_HUMAN Pleckstrin homology domain-containing family A member 4 OS=Homo sapiens GN=PLEKHA4 PE=1 SV=2 | 742 | G | 0.883651 | V | 0.835419 | 0.048232 | No Change: Both D | - |
| Q9Y2H5 | PKHA6_HUMAN Pleckstrin homology domain-containing family A member 6 OS=Homo sapiens GN=PLEKHA6 PE=1 SV=4 | 43 | V | 0.82244 | I | 0.783851 | 0.038589 | No Change: Both D | - |
| Q9Y2H5 | PKHA6_HUMAN Pleckstrin homology domain-containing family A member 6 OS=Homo sapiens GN=PLEKHA6 PE=1 SV=4 | 837 | R | 0.974007 | K | 0.972435 | 0.001572 | No Change: Both D | - |
| Q6IQ23 | PKHA7_HUMAN Pleckstrin homology domain-containing family A member 7 OS=Homo sapiens GN=PLEKHA7 PE=1 SV=2 | 241 | L | 0.313961 | I | 0.319283 | -0.005322 | No Change: Both O | - |
| Q6IQ23 | PKHA7_HUMAN Pleckstrin homology domain-containing family A member 7 OS=Homo sapiens GN=PLEKHA7 PE=1 SV=2 | 248 | A | 0.586609 | V | 0.515768 | 0.070841 | No Change: Both D | - |
| Q6IQ23 | PKHA7_HUMAN Pleckstrin homology domain-containing family A member 7 OS=Homo sapiens GN=PLEKHA7 PE=1 SV=2 | 279 | Q | 0.630415 | R | 0.624669 | 0.005746 | No Change: Both D | - |
| Q6IQ23 | PKHA7_HUMAN Pleckstrin homology domain-containing family A member 7 OS=Homo sapiens GN=PLEKHA7 PE=1 SV=2 | 693 | V | 0.526384 | I | 0.519522 | 0.006862 | No Change: Both D | - |
| Q6IQ23 | PKHA7_HUMAN Pleckstrin homology domain-containing family A member 7 OS=Homo sapiens GN=PLEKHA7 PE=1 SV=2 | 689 | S | 0.59559 | R | 0.569356 | 0.026234 | No Change: Both D | - |
| Q96JA3 | PKHA8_HUMAN Pleckstrin homology domain-containing family A member 8 OS=Homo sapiens GN=PLEKHA8 PE=1 SV=2 | 368 | V | 0.368198 | E | 0.553105 | -0.184907 | O to D | A breast cancer sample |
| Q9ULL1 | PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens GN=PLEKHG1 PE=1 SV=2 | 787 | Q | 0.58415 | R | 0.57339 | 0.01076 | No Change: Both D | - |
| Q9ULL1 | PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens GN=PLEKHG1 PE=1 SV=2 | 1071 | V | 0.741159 | A | 0.777772 | -0.036613 | No Change: Both D | - |
| Q9ULL1 | PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens GN=PLEKHG1 PE=1 SV=2 | 1321 | L | 0.855939 | S | 0.920436 | -0.064497 | No Change: Both D | - |
| Q9ULL1 | PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens GN=PLEKHG1 PE=1 SV=2 | 1377 | Q | 0.624129 | P | 0.638008 | -0.013879 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 540 | T | 0.928511 | I | 0.897412 | 0.031099 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 622 | I | 0.859854 | V | 0.859684 | 1.70E-04 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 647 | R | 0.861469 | H | 0.825718 | 0.035751 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 992 | R | 0.716407 | K | 0.743064 | -0.026657 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 1302 | A | 0.968591 | T | 0.961856 | 0.006735 | No Change: Both D | - |
| Q9H7P9 | PKHG2_HUMAN Pleckstrin homology domain-containing family G member 2 OS=Homo sapiens GN=PLEKHG2 PE=1 SV=3 | 1329 | P | 0.953465 | A | 0.933459 | 0.020006 | No Change: Both D | - |
| A1L390 | PKHG3_HUMAN Pleckstrin homology domain-containing family G member 3 OS=Homo sapiens GN=PLEKHG3 PE=1 SV=1 | 1036 | R | 0.950478 | W | 0.890334 | 0.060144 | No Change: Both D | - |
| A1L390 | PKHG3_HUMAN Pleckstrin homology domain-containing family G member 3 OS=Homo sapiens GN=PLEKHG3 PE=1 SV=1 | 1014 | R | 0.947291 | H | 0.937859 | 0.009432 | No Change: Both D | - |
| Q58EX7 | PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens GN=PLEKHG4 PE=1 SV=1 | 412 | T | 0.381881 | I | 0.240411 | 0.14147 | No Change: Both O | - |
| Q58EX7 | PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens GN=PLEKHG4 PE=1 SV=1 | 525 | D | 0.555207 | G | 0.566235 | -0.011028 | No Change: Both D | - |
| Q58EX7 | PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens GN=PLEKHG4 PE=1 SV=1 | 830 | R | 0.659521 | H | 0.676546 | -0.017025 | No Change: Both D | - |
| Q58EX7 | PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens GN=PLEKHG4 PE=1 SV=1 | 1090 | S | 0.353545 | T | 0.252031 | 0.101514 | No Change: Both O | - |
| Q58EX7 | PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens GN=PLEKHG4 PE=1 SV=1 | 1064 | R | 0.276884 | H | 0.260907 | 0.015977 | No Change: Both O | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 72 | A | 0.992008 | T | 0.993072 | -0.001064 | No Change: Both D | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 149 | G | 0.876464 | S | 0.901516 | -0.025052 | No Change: Both D | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 220 | R | 0.264044 | H | 0.231984 | 0.03206 | No Change: Both O | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 660 | A | 0.744908 | V | 0.636005 | 0.108903 | No Change: Both D | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 37 | V | 0.941761 | A | 0.965492 | -0.023731 | No Change: Both D | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 669 | T | 0.652632 | P | 0.737538 | -0.084906 | No Change: Both D | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 1076 | R | 0.324957 | Q | 0.333849 | -0.008892 | No Change: Both O | - |
| Q96PX9 | PKH4B_HUMAN Pleckstrin homology domain-containing family G member 4B OS=Homo sapiens GN=PLEKHG4B PE=2 SV=4 | 1146 | R | 0.801993 | G | 0.770397 | 0.031596 | No Change: Both D | - |
| O94827 | PKHG5_HUMAN Pleckstrin homology domain-containing family G member 5 OS=Homo sapiens GN=PLEKHG5 PE=2 SV=3 | 703 | F | 0.105869 | S | 0.261066 | -0.155197 | No Change: Both O | Distal spinal muscular atrophy autosomal recessive type 4 (DSMA4) [MIM:611067] |
| Q3KR16 | PKHG6_HUMAN Pleckstrin homology domain-containing family G member 6 OS=Homo sapiens GN=PLEKHG6 PE=1 SV=3 | 35 | A | 0.693606 | T | 0.709494 | -0.015888 | No Change: Both D | - |
| Q6ZR37 | PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens GN=PLEKHG7 PE=2 SV=1 | 99 | D | 0.1794 | G | 0.161647 | 0.017753 | No Change: Both O | - |
| Q6ZR37 | PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens GN=PLEKHG7 PE=2 SV=1 | 212 | M | 0.36247 | T | 0.419407 | -0.056937 | No Change: Both O | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 75 | N | 0.727686 | S | 0.76878 | -0.041094 | No Change: Both D | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 113 | Q | 0.900246 | L | 0.839484 | 0.060762 | No Change: Both D | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 322 | R | 0.74587 | Q | 0.750563 | -0.004693 | No Change: Both D | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 430 | T | 0.61514 | A | 0.609185 | 0.005955 | No Change: Both D | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 438 | M | 0.75399 | V | 0.687251 | 0.066739 | No Change: Both D | - |
| Q9ULM0 | PKHH1_HUMAN Pleckstrin homology domain-containing family H member 1 OS=Homo sapiens GN=PLEKHH1 PE=2 SV=2 | 735 | H | 0.364611 | R | 0.397877 | -0.033266 | No Change: Both O | - |
| Q8IVE3 | PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 OS=Homo sapiens GN=PLEKHH2 PE=2 SV=2 | 481 | P | 0.603183 | T | 0.54597 | 0.057213 | No Change: Both D | - |
| Q8IVE3 | PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 OS=Homo sapiens GN=PLEKHH2 PE=2 SV=2 | 1069 | R | 0.441086 | K | 0.501853 | -0.060767 | O to D | - |
| Q8IVE3 | PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 OS=Homo sapiens GN=PLEKHH2 PE=2 SV=2 | 1217 | N | 0.245542 | S | 0.301636 | -0.056094 | No Change: Both O | - |
| Q8IVE3 | PKHH2_HUMAN Pleckstrin homology domain-containing family H member 2 OS=Homo sapiens GN=PLEKHH2 PE=2 SV=2 | 228 | M | 0.956845 | V | 0.939448 | 0.017397 | No Change: Both D | - |
| Q7Z736 | PKHH3_HUMAN Pleckstrin homology domain-containing family H member 3 OS=Homo sapiens GN=PLEKHH3 PE=1 SV=2 | 547 | Q | 0.959866 | H | 0.950115 | 0.009751 | No Change: Both D | - |
| Q9Y4G2 | PKHM1_HUMAN Pleckstrin homology domain-containing family M member 1 OS=Homo sapiens GN=PLEKHM1 PE=1 SV=3 | 377 | R | 0.961997 | H | 0.964751 | -0.002754 | No Change: Both D | - |
| Q8IWE5 | PKHM2_HUMAN Pleckstrin homology domain-containing family M member 2 OS=Homo sapiens GN=PLEKHM2 PE=1 SV=2 | 32 | I | 0.295585 | T | 0.400781 | -0.105196 | No Change: Both O | - |
| Q494U1 | PKHN1_HUMAN Pleckstrin homology domain-containing family N member 1 OS=Homo sapiens GN=PLEKHN1 PE=1 SV=2 | 539 | R | 0.941363 | P | 0.951563 | -0.0102 | No Change: Both D | - |
| Q53GL0 | PKHO1_HUMAN Pleckstrin homology domain-containing family O member 1 OS=Homo sapiens GN=PLEKHO1 PE=1 SV=2 | 21 | P | 0.677496 | A | 0.609132 | 0.068364 | No Change: Both D | - |
| Q8TD55 | PKHO2_HUMAN Pleckstrin homology domain-containing family O member 2 OS=Homo sapiens GN=PLEKHO2 PE=1 SV=1 | 290 | P | 0.994991 | S | 0.994738 | 2.53E-04 | No Change: Both D | - |
| Q6UQ28 | PLET1_HUMAN Placenta-expressed transcript 1 protein OS=Homo sapiens GN=PLET1 PE=2 SV=2 | 142 | S | 0.277221 | P | 0.288369 | -0.011148 | No Change: Both O | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 374 | V | 0.716104 | F | 0.668476 | 0.047628 | No Change: Both D | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 591 | S | 0.24035 | P | 0.240321 | 2.90E-05 | No Change: Both O | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 620 | A | 0.116327 | T | 0.13306 | -0.016733 | No Change: Both O | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 751 | G | 0.424656 | R | 0.387788 | 0.036868 | No Change: Both O | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 46 | I | 0.503048 | R | 0.66593 | -0.162882 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 453 | K | 0.384474 | I | 0.192665 | 0.191809 | No Change: Both O | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 57 | E | 0.591567 | K | 0.575554 | 0.016013 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 133 | H | 0.887471 | Q | 0.906404 | -0.018933 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 261 | R | 0.617736 | H | 0.529893 | 0.087843 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 408 | R | 0.838745 | W | 0.720949 | 0.117796 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 472 | D | 0.55151 | N | 0.534495 | 0.017015 | No Change: Both D | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 494 | A | 0.544832 | V | 0.492818 | 0.052014 | D to O | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 523 | R | 0.526822 | W | 0.322998 | 0.203824 | D to O | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 38 | K | 0.48356 | E | 0.479628 | 0.003932 | No Change: Both O | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 147 | L | 0.862066 | P | 0.936114 | -0.074048 | No Change: Both D | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 235 | R | 0.649428 | H | 0.596845 | 0.052583 | No Change: Both D | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 532 | R | 0.458163 | H | 0.433406 | 0.024757 | No Change: Both O | Plasminogen deficiency (PLGD) [MIM:217090] |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 676 | V | 0.23367 | D | 0.386619 | -0.152949 | No Change: Both O | - |
| P00747 | PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 | 134 | R | 0.894607 | K | 0.89977 | -0.005163 | No Change: Both D | - |
| O60240 | PLIN1_HUMAN Perilipin-1 OS=Homo sapiens GN=PLIN1 PE=2 SV=2 | 194 | P | 0.764924 | A | 0.713406 | 0.051518 | No Change: Both D | - |
| O60240 | PLIN1_HUMAN Perilipin-1 OS=Homo sapiens GN=PLIN1 PE=2 SV=2 | 210 | K | 0.891736 | E | 0.885811 | 0.005925 | No Change: Both D | - |
| O60240 | PLIN1_HUMAN Perilipin-1 OS=Homo sapiens GN=PLIN1 PE=2 SV=2 | 348 | S | 0.198718 | L | 0.1137 | 0.085018 | No Change: Both O | - |
| O60240 | PLIN1_HUMAN Perilipin-1 OS=Homo sapiens GN=PLIN1 PE=2 SV=2 | 271 | A | 0.511564 | V | 0.438912 | 0.072652 | D to O | - |
| Q99541 | PLIN2_HUMAN Perilipin-2 OS=Homo sapiens GN=PLIN2 PE=1 SV=2 | 251 | S | 0.649824 | P | 0.594707 | 0.055117 | No Change: Both D | - |
| O60664 | PLIN3_HUMAN Perilipin-3 OS=Homo sapiens GN=PLIN3 PE=1 SV=3 | 56 | I | 0.381399 | V | 0.434245 | -0.052846 | No Change: Both O | - |
| O60664 | PLIN3_HUMAN Perilipin-3 OS=Homo sapiens GN=PLIN3 PE=1 SV=3 | 275 | V | 0.491069 | A | 0.575998 | -0.084929 | O to D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 1124 | A | 0.690235 | T | 0.726323 | -0.036088 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 659 | S | 0.681675 | G | 0.668444 | 0.013231 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 1134 | R | 0.710229 | C | 0.603143 | 0.107086 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 124 | V | 0.708357 | A | 0.751843 | -0.043486 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 421 | T | 0.547827 | A | 0.493968 | 0.053859 | D to O | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 761 | K | 0.754365 | N | 0.67098 | 0.083385 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 802 | M | 0.605909 | T | 0.682941 | -0.077032 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 826 | A | 0.633298 | E | 0.642717 | -0.009419 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 826 | A | 0.633298 | G | 0.665882 | -0.032584 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 826 | A | 0.633298 | V | 0.571526 | 0.061772 | No Change: Both D | - |
| Q96Q06 | PLIN4_HUMAN Perilipin-4 OS=Homo sapiens GN=PLIN4 PE=2 SV=2 | 860 | K | 0.768787 | N | 0.723445 | 0.045342 | No Change: Both D | - |
| Q00G26 | PLIN5_HUMAN Perilipin-5 OS=Homo sapiens GN=PLIN5 PE=2 SV=2 | 6 | A | 0.801149 | V | 0.7752 | 0.025949 | No Change: Both D | - |
| Q00G26 | PLIN5_HUMAN Perilipin-5 OS=Homo sapiens GN=PLIN5 PE=2 SV=2 | 255 | C | 0.517671 | R | 0.614543 | -0.096872 | No Change: Both D | - |
| Q00G26 | PLIN5_HUMAN Perilipin-5 OS=Homo sapiens GN=PLIN5 PE=2 SV=2 | 306 | R | 0.716659 | W | 0.469059 | 0.2476 | D to O | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 12 | R | 0.9317 | L | 0.901936 | 0.029764 | No Change: Both D | A lung squamous cell carcinoma sample |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 261 | L | 0.262574 | F | 0.224093 | 0.038481 | No Change: Both O | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 332 | L | 0.762955 | V | 0.731772 | 0.031183 | No Change: Both D | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 463 | L | 0.567631 | H | 0.697164 | -0.129533 | No Change: Both D | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 518 | R | 0.110596 | H | 0.109524 | 0.001072 | No Change: Both O | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 297 | N | 0.346253 | D | 0.3656 | -0.019347 | No Change: Both O | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 595 | S | 0.845681 | L | 0.738144 | 0.107537 | No Change: Both D | - |
| P53350 | PLK1_HUMAN Serine/threonine-protein kinase PLK1 OS=Homo sapiens GN=PLK1 PE=1 SV=1 | 599 | R | 0.898112 | H | 0.855114 | 0.042998 | No Change: Both D | - |
| Q2M2Z5 | KIZ_HUMAN Centrosomal protein kizuna OS=Homo sapiens GN=PLK1S1 PE=1 SV=2 | 139 | H | 0.474276 | Q | 0.530618 | -0.056342 | O to D | - |
| Q2M2Z5 | KIZ_HUMAN Centrosomal protein kizuna OS=Homo sapiens GN=PLK1S1 PE=1 SV=2 | 236 | M | 0.630283 | T | 0.688745 | -0.058462 | No Change: Both D | - |
| Q9NYY3 | PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens GN=PLK2 PE=1 SV=3 | 14 | S | 0.742821 | T | 0.747218 | -0.004397 | No Change: Both D | An ovarian Endometrioid carcinoma sample |
| Q9NYY3 | PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens GN=PLK2 PE=1 SV=3 | 92 | G | 0.249605 | S | 0.271623 | -0.022018 | No Change: Both O | A lung adenocarcinoma sample |
| Q9NYY3 | PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens GN=PLK2 PE=1 SV=3 | 436 | E | 0.731654 | K | 0.726557 | 0.005097 | No Change: Both D | - |
| Q9NYY3 | PLK2_HUMAN Serine/threonine-protein kinase PLK2 OS=Homo sapiens GN=PLK2 PE=1 SV=3 | 487 | P | 0.322537 | L | 0.199732 | 0.122805 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 61 | T | 0.58162 | S | 0.635925 | -0.054305 | No Change: Both D | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 68 | L | 0.386525 | F | 0.347356 | 0.039169 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 283 | L | 0.381686 | F | 0.323636 | 0.05805 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 483 | R | 0.194289 | C | 0.092696 | 0.101593 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 498 | S | 0.43282 | L | 0.278073 | 0.154747 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 618 | S | 0.234688 | P | 0.215443 | 0.019245 | No Change: Both O | - |
| Q9H4B4 | PLK3_HUMAN Serine/threonine-protein kinase PLK3 OS=Homo sapiens GN=PLK3 PE=1 SV=2 | 491 | D | 0.24553 | N | 0.24802 | -0.00249 | No Change: Both O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 232 | S | 0.242747 | T | 0.171463 | 0.071284 | No Change: Both O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 86 | Y | 0.085532 | C | 0.07707 | 0.008462 | No Change: Both O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 146 | R | 0.170185 | H | 0.172584 | -0.002399 | No Change: Both O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 226 | A | 0.179256 | T | 0.208075 | -0.028819 | No Change: Both O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 317 | P | 0.628417 | L | 0.475741 | 0.152676 | D to O | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 449 | N | 0.854517 | D | 0.853366 | 0.001151 | No Change: Both D | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 519 | W | 0.8302 | S | 0.938293 | -0.108093 | No Change: Both D | - |
| O00444 | PLK4_HUMAN Serine/threonine-protein kinase PLK4 OS=Homo sapiens GN=PLK4 PE=1 SV=3 | 830 | E | 0.871388 | D | 0.870235 | 0.001153 | No Change: Both D | - |
| P26678 | PPLA_HUMAN Cardiac phospholamban OS=Homo sapiens GN=PLN PE=1 SV=1 | 9 | R | 0.357214 | C | 0.188574 | 0.16864 | No Change: Both O | Cardiomyopathy dilated type 1P (CMD1P) [MIM:609909] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 612 | W | 0.130829 | C | 0.151724 | -0.020895 | No Change: Both O | Ehlers-Danlos syndrome type 6 (EDS6) [MIM:225400] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 678 | G | 0.212393 | R | 0.200961 | 0.011432 | No Change: Both O | Ehlers-Danlos syndrome type 6 (EDS6) [MIM:225400] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 99 | A | 0.147824 | T | 0.141601 | 0.006223 | No Change: Both O | - |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 446 | W | 0.083814 | G | 0.228832 | -0.145018 | No Change: Both O | Ehlers-Danlos syndrome type 6 (EDS6) [MIM:225400] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 667 | A | 0.09275 | T | 0.112018 | -0.019268 | No Change: Both O | Ehlers-Danlos syndrome type 6 (EDS6) [MIM:225400] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 706 | H | 0.46396 | R | 0.45344 | 0.01052 | No Change: Both O | Ehlers-Danlos syndrome type 6 (EDS6) [MIM:225400] |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 67 | E | 0.499979 | D | 0.481026 | 0.018953 | No Change: Both O | - |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 84 | A | 0.534956 | T | 0.546884 | -0.011928 | No Change: Both D | - |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 120 | A | 0.348006 | S | 0.461677 | -0.113671 | No Change: Both O | - |
| Q02809 | PLOD1_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 1 OS=Homo sapiens GN=PLOD1 PE=1 SV=2 | 123 | Q | 0.330394 | H | 0.291186 | 0.039208 | No Change: Both O | A breast cancer sample |
| O00469 | PLOD2_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens GN=PLOD2 PE=1 SV=2 | 598 | R | 0.677621 | H | 0.704384 | -0.026763 | No Change: Both D | Bruck syndrome type 2 (BRKS2) [MIM:609220] |
| O00469 | PLOD2_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens GN=PLOD2 PE=1 SV=2 | 601 | G | 0.620096 | V | 0.477505 | 0.142591 | D to O | Bruck syndrome type 2 (BRKS2) [MIM:609220] |
| O00469 | PLOD2_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 OS=Homo sapiens GN=PLOD2 PE=1 SV=2 | 608 | T | 0.468726 | I | 0.33347 | 0.135256 | No Change: Both O | Bruck syndrome type 2 (BRKS2) [MIM:609220] |
| O60568 | PLOD3_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 3 OS=Homo sapiens GN=PLOD3 PE=1 SV=1 | 286 | R | 0.554228 | W | 0.323355 | 0.230873 | D to O | - |
| O60568 | PLOD3_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 3 OS=Homo sapiens GN=PLOD3 PE=1 SV=1 | 151 | A | 0.208942 | V | 0.165874 | 0.043068 | No Change: Both O | - |
| O60568 | PLOD3_HUMAN Procollagen-lysine 2-oxoglutarate 5-dioxygenase 3 OS=Homo sapiens GN=PLOD3 PE=1 SV=1 | 223 | N | 0.207436 | S | 0.236801 | -0.029365 | No Change: Both O | Lysyl hydroxylase 3 deficiency (LH3 deficiency) [MIM:612394] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 15 | P | 0.102182 | L | 0.056488 | 0.045694 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 43 | T | 0.452099 | I | 0.28665 | 0.165449 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 74 | G | 0.044665 | R | 0.041278 | 0.003387 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 140 | H | 0.091482 | Y | 0.048681 | 0.042801 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 156 | T | 0.053802 | I | 0.02829 | 0.025512 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 163 | W | 0.008569 | R | 0.023504 | -0.014935 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 166 | V | 0.011585 | E | 0.026035 | -0.01445 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 182 | T | 0.052659 | P | 0.064953 | -0.012294 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 187 | I | 0.290958 | T | 0.462866 | -0.171908 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 203 | D | 0.160828 | H | 0.138889 | 0.021939 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 216 | P | 0.15251 | S | 0.16907 | -0.01656 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 217 | G | 0.170408 | S | 0.209455 | -0.039047 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 219 | V | 0.171056 | F | 0.16071 | 0.010346 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 221 | G | 0.172832 | C | 0.082191 | 0.090641 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 224 | L | 0.146451 | P | 0.263813 | -0.117362 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 237 | F | 0.056262 | S | 0.135431 | -0.079169 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 249 | A | 0.088221 | P | 0.113748 | -0.025527 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 203 | D | 0.160828 | V | 0.085196 | 0.075632 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 31 | L | 0.027619 | P | 0.0566 | -0.028981 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 32 | F | 0.035111 | L | 0.040283 | -0.005172 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 32 | F | 0.035111 | V | 0.039523 | -0.004412 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 35 | C | 0.106956 | Y | 0.124091 | -0.017135 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 39 | A | 0.282017 | T | 0.330898 | -0.048881 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 46 | L | 0.361985 | P | 0.543137 | -0.181152 | O to D | - |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 46 | L | 0.361985 | R | 0.497 | -0.135015 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 51 | F | 0.265512 | S | 0.536417 | -0.270905 | O to D | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 60 | Y | 0.10628 | C | 0.076864 | 0.029416 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 116 | T | 0.467191 | K | 0.552851 | -0.08566 | O to D | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 130 | H | 0.726663 | Y | 0.616199 | 0.110464 | No Change: Both D | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 148 | H | 0.187831 | Y | 0.112868 | 0.074963 | No Change: Both O | - |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 151 | K | 0.172172 | N | 0.138689 | 0.033483 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 166 | V | 0.011585 | G | 0.020045 | -0.00846 | No Change: Both O | - |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 169 | C | 0.015909 | R | 0.035853 | -0.019944 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 170 | S | 0.018479 | F | 0.006928 | 0.011551 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 172 | V | 0.023828 | A | 0.035459 | -0.011631 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 175 | Y | 0.026023 | C | 0.020472 | 0.005551 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 181 | W | 0.042433 | C | 0.054535 | -0.012102 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 183 | T | 0.072297 | N | 0.084702 | -0.012405 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 203 | D | 0.160828 | E | 0.177259 | -0.016431 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 203 | D | 0.160828 | G | 0.157706 | 0.003122 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 203 | D | 0.160828 | N | 0.15148 | 0.009348 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 205 | R | 0.101002 | G | 0.116582 | -0.01558 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 207 | Y | 0.075643 | C | 0.072904 | 0.002739 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 209 | V | 0.078396 | D | 0.162681 | -0.084285 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 210 | L | 0.083182 | H | 0.141312 | -0.05813 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 211 | P | 0.086393 | L | 0.040243 | 0.04615 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 212 | W | 0.089168 | R | 0.213704 | -0.124536 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 216 | P | 0.15251 | A | 0.107876 | 0.044634 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 220 | C | 0.166277 | Y | 0.200715 | -0.034438 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 224 | L | 0.146451 | I | 0.129866 | 0.016585 | No Change: Both O | - |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 226 | S | 0.130783 | P | 0.108553 | 0.02223 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 228 | C | 0.145886 | Y | 0.175157 | -0.029271 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 234 | Q | 0.115438 | P | 0.124626 | -0.009188 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 242 | A | 0.042826 | P | 0.055801 | -0.012975 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 246 | G | 0.064531 | E | 0.082359 | -0.017828 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 248 | A | 0.088223 | E | 0.12664 | -0.038417 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 253 | S | 0.067136 | F | 0.025651 | 0.041485 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 33 | C | 0.050699 | Y | 0.058474 | -0.007775 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 35 | C | 0.106956 | R | 0.197418 | -0.090462 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 50 | Y | 0.27181 | C | 0.209376 | 0.062434 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 76 | A | 0.038995 | P | 0.055737 | -0.016742 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 137 | R | 0.251165 | W | 0.116299 | 0.134866 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 162 | V | 0.008782 | E | 0.01988 | -0.011098 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 170 | S | 0.018479 | P | 0.017422 | 0.001057 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 173 | P | 0.025281 | S | 0.031101 | -0.00582 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 216 | P | 0.15251 | L | 0.075821 | 0.076689 | No Change: Both O | Spastic paraplegia X-linked type 2 (SPG2) [MIM:312920] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 225 | L | 0.137122 | P | 0.246486 | -0.109364 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 239 | L | 0.035077 | P | 0.07516 | -0.040083 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 243 | A | 0.049018 | E | 0.072206 | -0.023188 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 243 | A | 0.049018 | V | 0.031807 | 0.017211 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 246 | G | 0.064531 | A | 0.057174 | 0.007357 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| P60201 | MYPR_HUMAN Myelin proteolipid protein OS=Homo sapiens GN=PLP1 PE=1 SV=2 | 247 | A | 0.081739 | T | 0.088775 | -0.007036 | No Change: Both O | Leukodystrophy hypomyelinating type 1 (HLD1) [MIM:312080] |
| Q04941 | PLP2_HUMAN Proteolipid protein 2 OS=Homo sapiens GN=PLP2 PE=1 SV=1 | 91 | A | 0.020327 | S | 0.034204 | -0.013877 | No Change: Both O | - |
| Q14651 | PLSI_HUMAN Plastin-1 OS=Homo sapiens GN=PLS1 PE=1 SV=2 | 146 | I | 0.442083 | M | 0.56263 | -0.120547 | O to D | - |
| Q14651 | PLSI_HUMAN Plastin-1 OS=Homo sapiens GN=PLS1 PE=1 SV=2 | 216 | S | 0.416852 | L | 0.2493 | 0.167552 | No Change: Both O | - |
| P13797 | PLST_HUMAN Plastin-3 OS=Homo sapiens GN=PLS3 PE=1 SV=4 | 488 | D | 0.528903 | A | 0.435938 | 0.092965 | D to O | A breast cancer sample |
| O15162 | PLS1_HUMAN Phospholipid scramblase 1 OS=Homo sapiens GN=PLSCR1 PE=1 SV=1 | 262 | H | 0.153085 | Y | 0.092182 | 0.060903 | No Change: Both O | - |
| Q9NRY6 | PLS3_HUMAN Phospholipid scramblase 3 OS=Homo sapiens GN=PLSCR3 PE=1 SV=2 | 293 | V | 0.929404 | I | 0.933081 | -0.003677 | No Change: Both D | - |
| Q9NRQ2 | PLS4_HUMAN Phospholipid scramblase 4 OS=Homo sapiens GN=PLSCR4 PE=1 SV=2 | 34 | N | 0.97668 | S | 0.982204 | -0.005524 | No Change: Both D | - |
| Q9NRQ2 | PLS4_HUMAN Phospholipid scramblase 4 OS=Homo sapiens GN=PLSCR4 PE=1 SV=2 | 155 | I | 0.244983 | V | 0.289968 | -0.044985 | No Change: Both O | - |
| A0PG75 | PLS5_HUMAN Phospholipid scramblase family member 5 OS=Homo sapiens GN=PLSCR5 PE=2 SV=2 | 110 | R | 0.17763 | S | 0.215361 | -0.037731 | No Change: Both O | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 444 | F | 0.169696 | L | 0.198977 | -0.029281 | No Change: Both O | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 487 | T | 0.734264 | K | 0.752117 | -0.017853 | No Change: Both D | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 282 | R | 0.197104 | Q | 0.224001 | -0.026897 | No Change: Both O | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 372 | R | 0.607202 | H | 0.570324 | 0.036878 | No Change: Both D | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 380 | R | 0.504147 | W | 0.241621 | 0.262526 | D to O | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 124 | S | 0.369395 | Y | 0.190056 | 0.179339 | No Change: Both O | - |
| P55058 | PLTP_HUMAN Phospholipid transfer protein OS=Homo sapiens GN=PLTP PE=1 SV=1 | 425 | M | 0.175593 | I | 0.117446 | 0.058147 | No Change: Both O | - |
| Q8IUK5 | PLDX1_HUMAN Plexin domain-containing protein 1 OS=Homo sapiens GN=PLXDC1 PE=1 SV=2 | 462 | R | 0.214846 | H | 0.220039 | -0.005193 | No Change: Both O | - |
| Q6UX71 | PXDC2_HUMAN Plexin domain-containing protein 2 OS=Homo sapiens GN=PLXDC2 PE=1 SV=1 | 396 | V | 0.929128 | I | 0.90658 | 0.022548 | No Change: Both D | - |
| Q6UX71 | PXDC2_HUMAN Plexin domain-containing protein 2 OS=Homo sapiens GN=PLXDC2 PE=1 SV=1 | 458 | I | 0.031285 | V | 0.033296 | -0.002011 | No Change: Both O | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 5 | R | 0.677466 | Q | 0.680574 | -0.003108 | No Change: Both D | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 369 | E | 0.252832 | G | 0.21563 | 0.037202 | No Change: Both O | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 57 | Q | 0.273422 | R | 0.253547 | 0.019875 | No Change: Both O | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 267 | A | 0.388991 | T | 0.420084 | -0.031093 | No Change: Both O | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 805 | A | 0.21198 | G | 0.25556 | -0.04358 | No Change: Both O | - |
| O75051 | PLXA2_HUMAN Plexin-A2 OS=Homo sapiens GN=PLXNA2 PE=1 SV=4 | 1443 | A | 0.064093 | T | 0.075381 | -0.011288 | No Change: Both O | - |
| P51805 | PLXA3_HUMAN Plexin-A3 OS=Homo sapiens GN=PLXNA3 PE=1 SV=2 | 384 | G | 0.133792 | S | 0.153273 | -0.019481 | No Change: Both O | - |
| P51805 | PLXA3_HUMAN Plexin-A3 OS=Homo sapiens GN=PLXNA3 PE=1 SV=2 | 413 | G | 0.467754 | S | 0.546089 | -0.078335 | O to D | - |
| P51805 | PLXA3_HUMAN Plexin-A3 OS=Homo sapiens GN=PLXNA3 PE=1 SV=2 | 863 | D | 0.24503 | E | 0.293569 | -0.048539 | No Change: Both O | - |
| O43157 | PLXB1_HUMAN Plexin-B1 OS=Homo sapiens GN=PLXNB1 PE=1 SV=3 | 1891 | D | 0.938045 | V | 0.908788 | 0.029257 | No Change: Both D | A breast cancer sample |
| O43157 | PLXB1_HUMAN Plexin-B1 OS=Homo sapiens GN=PLXNB1 PE=1 SV=3 | 389 | R | 0.522692 | W | 0.33439 | 0.188302 | D to O | - |
| O43157 | PLXB1_HUMAN Plexin-B1 OS=Homo sapiens GN=PLXNB1 PE=1 SV=3 | 753 | S | 0.993437 | L | 0.986829 | 0.006608 | No Change: Both D | - |
| O15031 | PLXB2_HUMAN Plexin-B2 OS=Homo sapiens GN=PLXNB2 PE=1 SV=3 | 318 | K | 0.253193 | E | 0.251506 | 0.001687 | No Change: Both O | - |
| O15031 | PLXB2_HUMAN Plexin-B2 OS=Homo sapiens GN=PLXNB2 PE=1 SV=3 | 823 | I | 0.293571 | V | 0.293744 | -1.73E-04 | No Change: Both O | - |
| Q9ULL4 | PLXB3_HUMAN Plexin-B3 OS=Homo sapiens GN=PLXNB3 PE=1 SV=2 | 598 | V | 0.334525 | I | 0.273227 | 0.061298 | No Change: Both O | - |
| Q9ULL4 | PLXB3_HUMAN Plexin-B3 OS=Homo sapiens GN=PLXNB3 PE=1 SV=2 | 1535 | M | 0.590797 | T | 0.623007 | -0.03221 | No Change: Both D | - |
| Q9ULL4 | PLXB3_HUMAN Plexin-B3 OS=Homo sapiens GN=PLXNB3 PE=1 SV=2 | 126 | A | 0.480211 | T | 0.48967 | -0.009459 | No Change: Both O | - |
| Q9ULL4 | PLXB3_HUMAN Plexin-B3 OS=Homo sapiens GN=PLXNB3 PE=1 SV=2 | 1156 | E | 0.667834 | D | 0.655484 | 0.01235 | No Change: Both D | - |
| O60486 | PLXC1_HUMAN Plexin-C1 OS=Homo sapiens GN=PLXNC1 PE=1 SV=1 | 1499 | E | 0.755152 | K | 0.739974 | 0.015178 | No Change: Both D | - |
| Q9Y4D7 | PLXD1_HUMAN Plexin-D1 OS=Homo sapiens GN=PLXND1 PE=1 SV=3 | 870 | M | 0.445403 | V | 0.313597 | 0.131806 | No Change: Both O | - |
| Q9Y4D7 | PLXD1_HUMAN Plexin-D1 OS=Homo sapiens GN=PLXND1 PE=1 SV=3 | 617 | P | 0.352557 | S | 0.378192 | -0.025635 | No Change: Both O | - |
| Q9Y4D7 | PLXD1_HUMAN Plexin-D1 OS=Homo sapiens GN=PLXND1 PE=1 SV=3 | 1412 | L | 0.349328 | V | 0.328139 | 0.021189 | No Change: Both O | - |
| Q9Y4D7 | PLXD1_HUMAN Plexin-D1 OS=Homo sapiens GN=PLXND1 PE=1 SV=3 | 894 | H | 0.51152 | R | 0.577857 | -0.066337 | No Change: Both D | - |
| Q9Y4D7 | PLXD1_HUMAN Plexin-D1 OS=Homo sapiens GN=PLXND1 PE=1 SV=3 | 1542 | S | 0.25167 | N | 0.223008 | 0.028662 | No Change: Both O | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 33 | H | 0.780147 | Y | 0.716053 | 0.064094 | No Change: Both D | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 149 | I | 0.254671 | V | 0.269175 | -0.014504 | No Change: Both O | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 153 | R | 0.285322 | W | 0.12843 | 0.156892 | No Change: Both O | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 237 | I | 0.226753 | T | 0.324147 | -0.097394 | No Change: Both O | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 258 | S | 0.678379 | C | 0.532799 | 0.14558 | No Change: Both D | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 346 | G | 0.119961 | R | 0.12408 | -0.004119 | No Change: Both O | - |
| Q6GTS8 | P20D1_HUMAN Probable carboxypeptidase PM20D1 OS=Homo sapiens GN=PM20D1 PE=2 SV=3 | 380 | I | 0.20077 | T | 0.334996 | -0.134226 | No Change: Both O | - |
| Q8IYS1 | P20D2_HUMAN Peptidase M20 domain-containing protein 2 OS=Homo sapiens GN=PM20D2 PE=1 SV=2 | 333 | K | 0.293034 | E | 0.310697 | -0.017663 | No Change: Both O | - |
| P40967 | PMEL_HUMAN Melanocyte protein PMEL OS=Homo sapiens GN=PMEL PE=1 SV=2 | 320 | P | 0.922978 | H | 0.890609 | 0.032369 | No Change: Both D | - |
| P40967 | PMEL_HUMAN Melanocyte protein PMEL OS=Homo sapiens GN=PMEL PE=1 SV=2 | 370 | E | 0.970858 | D | 0.958104 | 0.012754 | No Change: Both D | - |
| Q969W9 | PMEPA_HUMAN Transmembrane prostate androgen-induced protein OS=Homo sapiens GN=PMEPA1 PE=1 SV=1 | 128 | E | 0.711212 | D | 0.694201 | 0.017011 | No Change: Both D | - |
| Q6P1K2 | PMF1_HUMAN Polyamine-modulated factor 1 OS=Homo sapiens GN=PMF1 PE=1 SV=2 | 75 | Q | 0.203079 | R | 0.170913 | 0.032166 | No Change: Both O | - |
| Q6P1K2 | PMF1_HUMAN Polyamine-modulated factor 1 OS=Homo sapiens GN=PMF1 PE=1 SV=2 | 137 | M | 0.311976 | I | 0.236767 | 0.075209 | No Change: Both O | - |
| Q8TBY8 | PMFBP_HUMAN Polyamine-modulated factor 1-binding protein 1 OS=Homo sapiens GN=PMFBP1 PE=2 SV=1 | 172 | A | 0.474209 | T | 0.472073 | 0.002136 | No Change: Both O | - |
| Q8TBY8 | PMFBP_HUMAN Polyamine-modulated factor 1-binding protein 1 OS=Homo sapiens GN=PMFBP1 PE=2 SV=1 | 193 | E | 0.426053 | K | 0.421262 | 0.004791 | No Change: Both O | - |
| Q8TBY8 | PMFBP_HUMAN Polyamine-modulated factor 1-binding protein 1 OS=Homo sapiens GN=PMFBP1 PE=2 SV=1 | 381 | R | 0.734645 | L | 0.677072 | 0.057573 | No Change: Both D | - |
| Q8TBY8 | PMFBP_HUMAN Polyamine-modulated factor 1-binding protein 1 OS=Homo sapiens GN=PMFBP1 PE=2 SV=1 | 650 | K | 0.987567 | T | 0.982515 | 0.005052 | No Change: Both D | - |
| Q8TBY8 | PMFBP_HUMAN Polyamine-modulated factor 1-binding protein 1 OS=Homo sapiens GN=PMFBP1 PE=2 SV=1 | 655 | T | 0.986798 | K | 0.99155 | -0.004752 | No Change: Both D | - |
| P29590 | PML_HUMAN Protein PML OS=Homo sapiens GN=PML PE=1 SV=3 | 645 | F | 0.137468 | L | 0.143791 | -0.006323 | No Change: Both O | - |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 44 | V | 0.295388 | A | 0.338469 | -0.043081 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 65 | D | 0.206472 | Y | 0.1126 | 0.093872 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 101 | N | 0.039872 | K | 0.049951 | -0.010079 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 106 | Y | 0.06791 | C | 0.061399 | 0.006511 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 108 | A | 0.131988 | V | 0.096251 | 0.035737 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 113 | P | 0.342291 | L | 0.227114 | 0.115177 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 117 | G | 0.321319 | R | 0.324224 | -0.002905 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 119 | F | 0.25994 | L | 0.285386 | -0.025446 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 123 | R | 0.220914 | Q | 0.225504 | -0.00459 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 129 | V | 0.349689 | M | 0.446125 | -0.096436 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 131 | P | 0.400557 | A | 0.313381 | 0.087176 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 132 | I | 0.442477 | T | 0.571234 | -0.128757 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 141 | R | 0.482359 | H | 0.428261 | 0.054098 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 162 | R | 0.315596 | W | 0.146548 | 0.169048 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 175 | G | 0.202627 | R | 0.17784 | 0.024787 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 188 | D | 0.163673 | G | 0.144479 | 0.019194 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 208 | G | 0.258482 | A | 0.198207 | 0.060275 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 216 | N | 0.571579 | I | 0.410661 | 0.160918 | D to O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 223 | D | 0.425282 | E | 0.454511 | -0.029229 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 229 | Y | 0.417688 | S | 0.632103 | -0.214415 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 231 | V | 0.484947 | M | 0.589527 | -0.10458 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 233 | A | 0.474607 | T | 0.54903 | -0.074423 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 237 | T | 0.343651 | M | 0.305579 | 0.038072 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 238 | R | 0.314778 | P | 0.35002 | -0.035242 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 139 | E | 0.506429 | K | 0.491851 | 0.014578 | D to O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 104 | L | 0.035307 | V | 0.031657 | 0.00365 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 37 | Q | 0.298001 | L | 0.178786 | 0.119215 | No Change: Both O | - |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 212 | M | 0.456399 | V | 0.398234 | 0.058165 | No Change: Both O | - |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 9 | C | 0.270423 | Y | 0.213748 | 0.056675 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 11 | F | 0.255641 | C | 0.340243 | -0.084602 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 15 | G | 0.254793 | E | 0.299392 | -0.044599 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 20 | P | 0.441485 | S | 0.449365 | -0.00788 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 32 | L | 0.391337 | R | 0.524384 | -0.133047 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 37 | Q | 0.298001 | H | 0.246342 | 0.051659 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 42 | G | 0.325785 | R | 0.321866 | 0.003919 | No Change: Both O | - |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 64 | Y | 0.228993 | C | 0.191708 | 0.037285 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 67 | V | 0.174152 | M | 0.202981 | -0.028829 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 69 | P | 0.171237 | S | 0.190852 | -0.019615 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 76 | Y | 0.211074 | C | 0.18274 | 0.028334 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 93 | E | 0.251217 | A | 0.177372 | 0.073845 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 103 | C | 0.034181 | F | 0.035533 | -0.001352 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 120 | I | 0.236028 | T | 0.379442 | -0.143414 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 132 | I | 0.442477 | F | 0.445975 | -0.003498 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 132 | I | 0.442477 | N | 0.6204 | -0.177923 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 141 | R | 0.482359 | C | 0.355778 | 0.126581 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 144 | F | 0.434259 | L | 0.467185 | -0.032926 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 148 | D | 0.485925 | N | 0.488292 | -0.002367 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 151 | E | 0.468537 | G | 0.400561 | 0.067976 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 153 | I | 0.404351 | T | 0.523826 | -0.119475 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 157 | F | 0.281795 | S | 0.486383 | -0.204588 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 172 | F | 0.237245 | V | 0.249231 | -0.011986 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 176 | G | 0.197116 | V | 0.110374 | 0.086742 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 177 | Q | 0.191914 | H | 0.180375 | 0.011539 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 183 | F | 0.158843 | S | 0.346853 | -0.18801 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 185 | D | 0.153896 | G | 0.135482 | 0.018414 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 192 | C | 0.127117 | G | 0.266713 | -0.139596 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 195 | H | 0.195256 | R | 0.20976 | -0.014504 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 197 | E | 0.233272 | A | 0.157603 | 0.075669 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 206 | F | 0.168688 | S | 0.325423 | -0.156735 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 214 | G | 0.532677 | S | 0.558245 | -0.025568 | No Change: Both D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 216 | N | 0.571579 | S | 0.609121 | -0.037542 | No Change: Both D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 217 | D | 0.576133 | E | 0.597383 | -0.02125 | No Change: Both D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 218 | H | 0.526542 | L | 0.405172 | 0.12137 | D to O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 223 | D | 0.425282 | N | 0.402017 | 0.023265 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 226 | T | 0.361944 | S | 0.435037 | -0.073093 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 228 | G | 0.385217 | C | 0.236589 | 0.148628 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 228 | G | 0.385217 | R | 0.405708 | -0.020491 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 237 | T | 0.343651 | R | 0.376746 | -0.033095 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 238 | R | 0.314778 | G | 0.283672 | 0.031106 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 241 | C | 0.342958 | S | 0.574504 | -0.231546 | O to D | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| O15305 | PMM2_HUMAN Phosphomannomutase 2 OS=Homo sapiens GN=PMM2 PE=1 SV=1 | 44 | V | 0.295388 | L | 0.285945 | 0.009443 | No Change: Both O | Congenital disorder of glycosylation type 1A (CDG1A) [MIM:212065] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 12 | H | 0.015878 | Q | 0.017293 | -0.001415 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 16 | L | 0.016432 | P | 0.032535 | -0.016103 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 16 | L | 0.016432 | P | 0.032535 | -0.016103 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 19 | L | 0.024454 | P | 0.048963 | -0.024509 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 69 | M | 0.078251 | K | 0.132544 | -0.054293 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 72 | S | 0.058832 | L | 0.02407 | 0.034762 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 72 | S | 0.058832 | L | 0.02407 | 0.034762 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 72 | S | 0.058832 | P | 0.046915 | 0.011917 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 72 | S | 0.058832 | W | 0.014606 | 0.044226 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 76 | S | 0.029328 | I | 0.010338 | 0.01899 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 79 | S | 0.017407 | C | 0.005374 | 0.012033 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 79 | S | 0.017407 | P | 0.01382 | 0.003587 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 80 | L | 0.015616 | P | 0.030708 | -0.015092 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 100 | G | 0.040293 | E | 0.047076 | -0.006783 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 100 | G | 0.040293 | R | 0.036635 | 0.003658 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 105 | L | 0.028381 | R | 0.048261 | -0.01988 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 105 | L | 0.028381 | R | 0.048261 | -0.01988 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 107 | G | 0.034715 | V | 0.018275 | 0.01644 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 118 | T | 0.144874 | M | 0.122956 | 0.021918 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 137 | I | 0.019579 | V | 0.024519 | -0.00494 | No Change: Both O | - |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 147 | L | 0.029704 | R | 0.04872 | -0.019016 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 150 | G | 0.033167 | C | 0.013668 | 0.019499 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 150 | G | 0.033167 | D | 0.037859 | -0.004692 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 30 | V | 0.137573 | M | 0.166742 | -0.029169 | No Change: Both O | Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 37 | D | 0.252748 | V | 0.143478 | 0.10927 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 67 | A | 0.11651 | P | 0.170817 | -0.054307 | No Change: Both O | Charcot-Marie-Tooth disease type 1E (CMT1E) [MIM:118300] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 93 | G | 0.144925 | R | 0.132872 | 0.012053 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 157 | R | 0.541216 | G | 0.551754 | -0.010538 | No Change: Both D | - |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 157 | R | 0.541216 | W | 0.284017 | 0.257199 | D to O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 22 | S | 0.028068 | F | 0.009684 | 0.018384 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 22 | S | 0.028068 | F | 0.009684 | 0.018384 | No Change: Both O | Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 23 | T | 0.030905 | R | 0.032991 | -0.002086 | No Change: Both O | Charcot-Marie-Tooth disease type 1E (CMT1E) [MIM:118300] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 28 | W | 0.121087 | R | 0.268281 | -0.147194 | No Change: Both O | Charcot-Marie-Tooth disease type 1E (CMT1E) [MIM:118300] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 65 | V | 0.195846 | F | 0.180796 | 0.01505 | No Change: Both O | Charcot-Marie-Tooth disease type 1A (CMT1A) [MIM:118220] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 67 | A | 0.11651 | T | 0.144776 | -0.028266 | No Change: Both O | Hereditary neuropathy with liability to pressure palsies (HNPP) [MIM:162500] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 71 | L | 0.07175 | P | 0.136105 | -0.064355 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 80 | L | 0.015616 | R | 0.025485 | -0.009869 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 109 | C | 0.03883 | R | 0.085435 | -0.046605 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| Q01453 | PMP22_HUMAN Peripheral myelin protein 22 OS=Homo sapiens GN=PMP22 PE=1 SV=1 | 149 | S | 0.031724 | R | 0.023822 | 0.007902 | No Change: Both O | Dejerine-Sottas syndrome (DSS) [MIM:145900] |
| O75439 | MPPB_HUMAN Mitochondrial-processing peptidase subunit beta OS=Homo sapiens GN=PMPCB PE=1 SV=2 | 396 | E | 0.470079 | D | 0.431605 | 0.038474 | No Change: Both O | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 394 | M | 0.628507 | T | 0.672479 | -0.043972 | No Change: Both D | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 501 | G | 0.780163 | R | 0.79566 | -0.015497 | No Change: Both D | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 202 | R | 0.395607 | K | 0.48653 | -0.090923 | No Change: Both O | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 632 | N | 0.880123 | S | 0.914041 | -0.033918 | No Change: Both D | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 720 | E | 0.584384 | D | 0.568294 | 0.01609 | No Change: Both D | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 793 | Y | 0.222052 | H | 0.320314 | -0.098262 | No Change: Both O | - |
| P54277 | PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens GN=PMS1 PE=1 SV=1 | 27 | E | 0.320248 | Q | 0.266806 | 0.053442 | No Change: Both O | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 20 | R | 0.595104 | Q | 0.630084 | -0.03498 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 479 | H | 0.968696 | Q | 0.975452 | -0.006756 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 485 | T | 0.97182 | K | 0.977311 | -0.005491 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 511 | T | 0.965884 | A | 0.964156 | 0.001728 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 597 | T | 0.586663 | S | 0.690176 | -0.103513 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 622 | M | 0.475495 | I | 0.382594 | 0.092901 | No Change: Both O | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 705 | E | 0.468254 | K | 0.469052 | -7.98E-04 | No Change: Both O | Mismatch repair cancer syndrome (MMRCS) [MIM:276300] |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 277 | T | 0.30942 | K | 0.366371 | -0.056951 | No Change: Both O | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 470 | P | 0.96715 | S | 0.970418 | -0.003268 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 775 | N | 0.330994 | S | 0.397261 | -0.066267 | No Change: Both O | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 541 | K | 0.934723 | E | 0.937681 | -0.002958 | No Change: Both D | - |
| P54278 | PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens GN=PMS2 PE=1 SV=2 | 46 | S | 0.401768 | I | 0.210631 | 0.191137 | No Change: Both O | Mismatch repair cancer syndrome (MMRCS) [MIM:276300] |
| Q15126 | PMVK_HUMAN Phosphomevalonate kinase OS=Homo sapiens GN=PMVK PE=1 SV=3 | 125 | V | 0.170405 | M | 0.195793 | -0.025388 | No Change: Both O | - |
| Q6P2M8 | KCC1B_HUMAN Calcium/calmodulin-dependent protein kinase type 1B OS=Homo sapiens GN=PNCK PE=2 SV=2 | 262 | Q | 0.231421 | H | 0.20581 | 0.025611 | No Change: Both O | - |
| Q8N490 | PNKD_HUMAN Probable hydrolase PNKD OS=Homo sapiens GN=PNKD PE=1 SV=2 | 7 | A | 0.545014 | V | 0.41568 | 0.129334 | D to O | Dystonia type 8 (DYT8) [MIM:118800] |
| Q8N490 | PNKD_HUMAN Probable hydrolase PNKD OS=Homo sapiens GN=PNKD PE=1 SV=2 | 9 | A | 0.563468 | V | 0.441962 | 0.121506 | D to O | Dystonia type 8 (DYT8) [MIM:118800] |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 20 | P | 0.646792 | S | 0.623862 | 0.02293 | No Change: Both D | - |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 63 | A | 0.631222 | V | 0.615117 | 0.016105 | No Change: Both D | - |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 180 | R | 0.33753 | S | 0.410025 | -0.072495 | No Change: Both O | - |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 196 | Y | 0.184759 | N | 0.302403 | -0.117644 | No Change: Both O | - |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 478 | V | 0.235265 | G | 0.358347 | -0.123082 | No Change: Both O | - |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 176 | L | 0.249142 | F | 0.227131 | 0.022011 | No Change: Both O | Microcephaly seizures and development delay (MCSZ) [MIM:613402] |
| Q96T60 | PNKP_HUMAN Bifunctional polynucleotide phosphatase/kinase OS=Homo sapiens GN=PNKP PE=1 SV=1 | 326 | E | 0.3234 | K | 0.323281 | 1.19E-04 | No Change: Both O | Microcephaly seizures and development delay (MCSZ) [MIM:613402] |
| P54315 | LIPR1_HUMAN Pancreatic lipase-related protein 1 OS=Homo sapiens GN=PNLIPRP1 PE=1 SV=1 | 461 | L | 0.421347 | P | 0.595079 | -0.173732 | O to D | - |
| P54315 | LIPR1_HUMAN Pancreatic lipase-related protein 1 OS=Homo sapiens GN=PNLIPRP1 PE=1 SV=1 | 271 | A | 0.075749 | V | 0.054282 | 0.021467 | No Change: Both O | - |
| P54315 | LIPR1_HUMAN Pancreatic lipase-related protein 1 OS=Homo sapiens GN=PNLIPRP1 PE=1 SV=1 | 414 | E | 0.152609 | D | 0.147675 | 0.004934 | No Change: Both O | - |
| P54315 | LIPR1_HUMAN Pancreatic lipase-related protein 1 OS=Homo sapiens GN=PNLIPRP1 PE=1 SV=1 | 129 | S | 0.377275 | C | 0.178809 | 0.198466 | No Change: Both O | A breast cancer sample |
| P54315 | LIPR1_HUMAN Pancreatic lipase-related protein 1 OS=Homo sapiens GN=PNLIPRP1 PE=1 SV=1 | 61 | N | 0.29506 | D | 0.285147 | 0.009913 | No Change: Both O | - |
| Q17RR3 | LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens GN=PNLIPRP3 PE=2 SV=2 | 2 | L | 0.157651 | F | 0.135555 | 0.022096 | No Change: Both O | - |
| Q17RR3 | LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens GN=PNLIPRP3 PE=2 SV=2 | 332 | F | 0.430791 | L | 0.423959 | 0.006832 | No Change: Both O | - |
| Q17RR3 | LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens GN=PNLIPRP3 PE=2 SV=2 | 450 | F | 0.288 | Y | 0.342477 | -0.054477 | No Change: Both O | - |
| Q17RR3 | LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens GN=PNLIPRP3 PE=2 SV=2 | 381 | V | 0.264526 | I | 0.226297 | 0.038229 | No Change: Both O | - |
| Q17RR3 | LIPR3_HUMAN Pancreatic lipase-related protein 3 OS=Homo sapiens GN=PNLIPRP3 PE=2 SV=2 | 382 | R | 0.280706 | G | 0.305454 | -0.024748 | No Change: Both O | - |
| Q8ND90 | PNMA1_HUMAN Paraneoplastic antigen Ma1 OS=Homo sapiens GN=PNMA1 PE=1 SV=2 | 54 | M | 0.167692 | V | 0.12115 | 0.046542 | No Change: Both O | - |
| Q8ND90 | PNMA1_HUMAN Paraneoplastic antigen Ma1 OS=Homo sapiens GN=PNMA1 PE=1 SV=2 | 215 | R | 0.268689 | P | 0.298825 | -0.030136 | No Change: Both O | - |
| Q9UL42 | PNMA2_HUMAN Paraneoplastic antigen Ma2 OS=Homo sapiens GN=PNMA2 PE=1 SV=2 | 186 | E | 0.357993 | K | 0.330898 | 0.027095 | No Change: Both O | - |
| Q9UL41 | PNMA3_HUMAN Paraneoplastic antigen Ma3 OS=Homo sapiens GN=PNMA3 PE=2 SV=2 | 382 | G | 0.930265 | S | 0.939568 | -0.009303 | No Change: Both D | - |
| Q9UL41 | PNMA3_HUMAN Paraneoplastic antigen Ma3 OS=Homo sapiens GN=PNMA3 PE=2 SV=2 | 386 | R | 0.948708 | Q | 0.941778 | 0.00693 | No Change: Both D | - |
| Q96PV4 | PNMA5_HUMAN Paraneoplastic antigen-like protein 5 OS=Homo sapiens GN=PNMA5 PE=2 SV=2 | 107 | N | 0.274353 | H | 0.244524 | 0.029829 | No Change: Both O | - |
| Q96PV4 | PNMA5_HUMAN Paraneoplastic antigen-like protein 5 OS=Homo sapiens GN=PNMA5 PE=2 SV=2 | 349 | R | 0.934035 | W | 0.858801 | 0.075234 | No Change: Both D | - |
| Q86V59 | PNML1_HUMAN PNMA-like protein 1 OS=Homo sapiens GN=PNMAL1 PE=2 SV=2 | 80 | S | 0.322223 | T | 0.263338 | 0.058885 | No Change: Both O | - |
| Q86V59 | PNML1_HUMAN PNMA-like protein 1 OS=Homo sapiens GN=PNMAL1 PE=2 SV=2 | 97 | C | 0.150642 | Y | 0.170266 | -0.019624 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 276 | W | 0.129605 | R | 0.276527 | -0.146922 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 9 | N | 0.937658 | S | 0.955794 | -0.018136 | No Change: Both D | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 98 | T | 0.210989 | A | 0.183185 | 0.027804 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 112 | R | 0.326588 | C | 0.169184 | 0.157404 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 175 | A | 0.512653 | T | 0.493819 | 0.018834 | D to O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 188 | S | 0.326224 | C | 0.188472 | 0.137752 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 211 | L | 0.158166 | H | 0.239394 | -0.081228 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 217 | L | 0.152898 | Q | 0.224086 | -0.071188 | No Change: Both O | - |
| P11086 | PNMT_HUMAN Phenylethanolamine N-methyltransferase OS=Homo sapiens GN=PNMT PE=1 SV=1 | 254 | R | 0.184932 | H | 0.180814 | 0.004118 | No Change: Both O | - |
| Q9H307 | PININ_HUMAN Pinin OS=Homo sapiens GN=PNN PE=1 SV=4 | 671 | S | 0.999479 | G | 0.999299 | 1.80E-04 | No Change: Both D | - |
| Q9H307 | PININ_HUMAN Pinin OS=Homo sapiens GN=PNN PE=1 SV=4 | 441 | S | 0.994902 | T | 0.991697 | 0.003205 | No Change: Both D | - |
| Q9NRX1 | PNO1_HUMAN RNA-binding protein PNO1 OS=Homo sapiens GN=PNO1 PE=1 SV=1 | 11 | R | 0.98182 | G | 0.977651 | 0.004169 | No Change: Both D | - |
| Q9NRX1 | PNO1_HUMAN RNA-binding protein PNO1 OS=Homo sapiens GN=PNO1 PE=1 SV=1 | 71 | G | 0.609526 | A | 0.571467 | 0.038059 | No Change: Both D | - |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 51 | G | 0.214484 | S | 0.263676 | -0.049192 | No Change: Both O | - |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 89 | E | 0.13817 | K | 0.145149 | -0.006979 | No Change: Both O | Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179] |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 128 | D | 0.156437 | G | 0.14412 | 0.012317 | No Change: Both O | Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179] |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 174 | A | 0.614736 | P | 0.699544 | -0.084808 | No Change: Both D | Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179] |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 234 | R | 0.060544 | P | 0.066988 | -0.006444 | No Change: Both O | Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179] |
| P00491 | PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens GN=PNP PE=1 SV=2 | 192 | Y | 0.341719 | C | 0.389595 | -0.047876 | No Change: Both O | Purine nucleoside phosphorylase deficiency (PNPD) [MIM:613179] |
| Q8N8W4 | PLPL1_HUMAN Patatin-like phospholipase domain-containing protein 1 OS=Homo sapiens GN=PNPLA1 PE=2 SV=3 | 423 | P | 0.995435 | H | 0.992553 | 0.002882 | No Change: Both D | - |
| Q8N8W4 | PLPL1_HUMAN Patatin-like phospholipase domain-containing protein 1 OS=Homo sapiens GN=PNPLA1 PE=2 SV=3 | 490 | T | 0.775281 | M | 0.741566 | 0.033715 | No Change: Both D | - |
| Q8N8W4 | PLPL1_HUMAN Patatin-like phospholipase domain-containing protein 1 OS=Homo sapiens GN=PNPLA1 PE=2 SV=3 | 522 | S | 0.983551 | P | 0.98313 | 4.21E-04 | No Change: Both D | - |
| Q96AD5 | PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens GN=PNPLA2 PE=1 SV=1 | 195 | P | 0.607484 | L | 0.453381 | 0.154103 | D to O | Neutral lipid storage disease with myopathy (NLSDM) [MIM:610717] |
| Q96AD5 | PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens GN=PNPLA2 PE=1 SV=1 | 219 | L | 0.19844 | F | 0.174349 | 0.024091 | No Change: Both O | - |
| Q96AD5 | PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens GN=PNPLA2 PE=1 SV=1 | 252 | N | 0.683522 | K | 0.705563 | -0.022041 | No Change: Both D | - |
| Q96AD5 | PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens GN=PNPLA2 PE=1 SV=1 | 481 | L | 0.950263 | P | 0.976277 | -0.026014 | No Change: Both D | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 99 | C | 0.122284 | G | 0.227414 | -0.10513 | No Change: Both O | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 115 | G | 0.266516 | C | 0.140691 | 0.125825 | No Change: Both O | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 434 | K | 0.824053 | E | 0.831531 | -0.007478 | No Change: Both D | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 148 | I | 0.044875 | M | 0.065176 | -0.020301 | No Change: Both O | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 216 | T | 0.113323 | P | 0.139277 | -0.025954 | No Change: Both O | - |
| Q9NST1 | PLPL3_HUMAN Patatin-like phospholipase domain-containing protein 3 OS=Homo sapiens GN=PNPLA3 PE=1 SV=2 | 453 | S | 0.567384 | I | 0.33549 | 0.231894 | D to O | - |
| P41247 | PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens GN=PNPLA4 PE=1 SV=3 | 48 | V | 0.283508 | G | 0.413293 | -0.129785 | No Change: Both O | - |
| P41247 | PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens GN=PNPLA4 PE=1 SV=3 | 134 | D | 0.333953 | G | 0.305985 | 0.027968 | No Change: Both O | - |
| P41247 | PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens GN=PNPLA4 PE=1 SV=3 | 187 | R | 0.443491 | Q | 0.475329 | -0.031838 | No Change: Both O | - |
| P41247 | PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens GN=PNPLA4 PE=1 SV=3 | 113 | V | 0.356528 | I | 0.349453 | 0.007075 | No Change: Both O | - |
| Q7Z6Z6 | PLPL5_HUMAN Patatin-like phospholipase domain-containing protein 5 OS=Homo sapiens GN=PNPLA5 PE=2 SV=1 | 140 | L | 0.069767 | F | 0.060301 | 0.009466 | No Change: Both O | - |
| Q7Z6Z6 | PLPL5_HUMAN Patatin-like phospholipase domain-containing protein 5 OS=Homo sapiens GN=PNPLA5 PE=2 SV=1 | 200 | T | 0.492023 | I | 0.362507 | 0.129516 | No Change: Both O | - |
| Q7Z6Z6 | PLPL5_HUMAN Patatin-like phospholipase domain-containing protein 5 OS=Homo sapiens GN=PNPLA5 PE=2 SV=1 | 286 | W | 0.278277 | R | 0.46054 | -0.182263 | No Change: Both O | - |
| Q8IY17 | PLPL6_HUMAN Neuropathy target esterase OS=Homo sapiens GN=PNPLA6 PE=1 SV=2 | 403 | A | 0.906406 | P | 0.943072 | -0.036666 | No Change: Both D | - |
| Q8IY17 | PLPL6_HUMAN Neuropathy target esterase OS=Homo sapiens GN=PNPLA6 PE=1 SV=2 | 1024 | K | 0.69837 | R | 0.680834 | 0.017536 | No Change: Both D | - |
| Q8IY17 | PLPL6_HUMAN Neuropathy target esterase OS=Homo sapiens GN=PNPLA6 PE=1 SV=2 | 929 | R | 0.56946 | H | 0.524527 | 0.044933 | No Change: Both D | Spastic paraplegia autosomal recessive type 39 (SPG39) [MIM:612020] |
| Q8IY17 | PLPL6_HUMAN Neuropathy target esterase OS=Homo sapiens GN=PNPLA6 PE=1 SV=2 | 1051 | M | 0.257694 | V | 0.21794 | 0.039754 | No Change: Both O | Spastic paraplegia autosomal recessive type 39 (SPG39) [MIM:612020] |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 323 | R | 0.773685 | Q | 0.786111 | -0.012426 | No Change: Both D | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 364 | Q | 0.925485 | E | 0.939167 | -0.013682 | No Change: Both D | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 368 | E | 0.932365 | D | 0.929145 | 0.00322 | No Change: Both D | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 803 | V | 0.129966 | A | 0.166801 | -0.036835 | No Change: Both O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 824 | V | 0.094816 | M | 0.123932 | -0.029116 | No Change: Both O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 908 | P | 0.617075 | L | 0.481213 | 0.135862 | D to O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 993 | L | 0.292917 | M | 0.36384 | -0.070923 | No Change: Both O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 286 | G | 0.135651 | S | 0.167395 | -0.031744 | No Change: Both O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 1050 | D | 0.172114 | N | 0.161098 | 0.011016 | No Change: Both O | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 387 | G | 0.920438 | S | 0.935424 | -0.014986 | No Change: Both D | - |
| Q6ZV29 | PLPL7_HUMAN Patatin-like phospholipase domain-containing protein 7 OS=Homo sapiens GN=PNPLA7 PE=2 SV=3 | 236 | R | 0.259626 | H | 0.260731 | -0.001105 | No Change: Both O | - |
| Q9NVS9 | PNPO_HUMAN Pyridoxine-5'-phosphate oxidase OS=Homo sapiens GN=PNPO PE=1 SV=1 | 50 | E | 0.517596 | K | 0.496782 | 0.020814 | D to O | - |
| Q9NVS9 | PNPO_HUMAN Pyridoxine-5'-phosphate oxidase OS=Homo sapiens GN=PNPO PE=1 SV=1 | 116 | R | 0.571472 | Q | 0.568553 | 0.002919 | No Change: Both D | - |
| Q9NVS9 | PNPO_HUMAN Pyridoxine-5'-phosphate oxidase OS=Homo sapiens GN=PNPO PE=1 SV=1 | 229 | R | 0.240023 | W | 0.097743 | 0.14228 | No Change: Both O | Pyridoxine-5'-phosphate oxidase deficiency (PNPO deficiency) [MIM:610090] |
| Q8TCS8 | PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1 mitochondrial OS=Homo sapiens GN=PNPT1 PE=1 SV=2 | 121 | I | 0.397352 | V | 0.407215 | -0.009863 | No Change: Both O | - |
| Q8TCS8 | PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1 mitochondrial OS=Homo sapiens GN=PNPT1 PE=1 SV=2 | 590 | N | 0.553706 | D | 0.559193 | -0.005487 | No Change: Both D | - |
| Q8TCS8 | PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1 mitochondrial OS=Homo sapiens GN=PNPT1 PE=1 SV=2 | 230 | E | 0.29278 | Q | 0.255883 | 0.036897 | No Change: Both O | - |
| Q12796 | PNRC1_HUMAN Proline-rich nuclear receptor coactivator 1 OS=Homo sapiens GN=PNRC1 PE=1 SV=1 | 252 | P | 0.862902 | L | 0.797301 | 0.065601 | No Change: Both D | - |
| Q8NBT0 | POC1A_HUMAN POC1 centriolar protein homolog A OS=Homo sapiens GN=POC1A PE=2 SV=2 | 79 | G | 0.481324 | S | 0.518959 | -0.037635 | O to D | - |
| Q8NBT0 | POC1A_HUMAN POC1 centriolar protein homolog A OS=Homo sapiens GN=POC1A PE=2 SV=2 | 348 | Q | 0.922499 | H | 0.894918 | 0.027581 | No Change: Both D | - |
| Q8NA72 | POC5_HUMAN Centrosomal protein POC5 OS=Homo sapiens GN=POC5 PE=1 SV=2 | 36 | H | 0.451491 | R | 0.502127 | -0.050636 | O to D | - |
| Q8NA72 | POC5_HUMAN Centrosomal protein POC5 OS=Homo sapiens GN=POC5 PE=1 SV=2 | 85 | I | 0.557201 | T | 0.650746 | -0.093545 | No Change: Both D | - |
| Q8NA72 | POC5_HUMAN Centrosomal protein POC5 OS=Homo sapiens GN=POC5 PE=1 SV=2 | 446 | A | 0.935226 | T | 0.936121 | -8.95E-04 | No Change: Both D | - |
| Q7Z5L7 | PODN_HUMAN Podocan OS=Homo sapiens GN=PODN PE=1 SV=2 | 444 | T | 0.525048 | M | 0.501987 | 0.023061 | No Change: Both D | - |
| Q7Z5L7 | PODN_HUMAN Podocan OS=Homo sapiens GN=PODN PE=1 SV=2 | 472 | V | 0.22522 | A | 0.32213 | -0.09691 | No Change: Both O | - |
| Q6PEZ8 | PONL1_HUMAN Podocan-like protein 1 OS=Homo sapiens GN=PODNL1 PE=2 SV=2 | 44 | R | 0.623376 | W | 0.353874 | 0.269502 | D to O | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 60 | T | 0.914466 | R | 0.893445 | 0.021021 | No Change: Both D | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 194 | S | 0.977708 | L | 0.955331 | 0.022377 | No Change: Both D | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 112 | G | 0.948606 | S | 0.95916 | -0.010554 | No Change: Both D | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 358 | V | 0.425231 | I | 0.401509 | 0.023722 | No Change: Both O | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 298 | P | 0.996879 | A | 0.995465 | 0.001414 | No Change: Both D | - |
| O00592 | PODXL_HUMAN Podocalyxin OS=Homo sapiens GN=PODXL PE=1 SV=2 | 126 | T | 0.976039 | P | 0.977934 | -0.001895 | No Change: Both D | - |
| Q9NZ53 | PDXL2_HUMAN Podocalyxin-like protein 2 OS=Homo sapiens GN=PODXL2 PE=1 SV=1 | 456 | V | 0.387154 | A | 0.424714 | -0.03756 | No Change: Both O | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 207 | P | 0.850644 | S | 0.858937 | -0.008293 | No Change: Both D | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 239 | C | 0.41648 | S | 0.605251 | -0.188771 | O to D | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 296 | E | 0.780144 | A | 0.669734 | 0.11041 | No Change: Both D | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 323 | M | 0.497165 | V | 0.397663 | 0.099502 | No Change: Both O | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 329 | R | 0.475825 | Q | 0.485104 | -0.009279 | No Change: Both O | Premature ovarian failure type 2B (POF2B) [MIM:300604] |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 349 | M | 0.738728 | L | 0.698075 | 0.040653 | No Change: Both D | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 434 | Q | 0.735465 | K | 0.742361 | -0.006896 | No Change: Both D | - |
| Q8WVV4 | POF1B_HUMAN Protein POF1B OS=Homo sapiens GN=POF1B PE=1 SV=3 | 444 | C | 0.652884 | Y | 0.608382 | 0.044502 | No Change: Both D | - |
| Q9H488 | OFUT1_HUMAN GDP-fucose protein O-fucosyltransferase 1 OS=Homo sapiens GN=POFUT1 PE=1 SV=1 | 322 | L | 0.293358 | F | 0.266296 | 0.027062 | No Change: Both O | - |
| Q9H488 | OFUT1_HUMAN GDP-fucose protein O-fucosyltransferase 1 OS=Homo sapiens GN=POFUT1 PE=1 SV=1 | 348 | D | 0.100044 | N | 0.096697 | 0.003347 | No Change: Both O | - |
| Q8NBL1 | PGLT1_HUMAN Protein O-glucosyltransferase 1 OS=Homo sapiens GN=POGLUT1 PE=1 SV=1 | 75 | K | 0.367465 | R | 0.341969 | 0.025496 | No Change: Both O | - |
| Q8NBL1 | PGLT1_HUMAN Protein O-glucosyltransferase 1 OS=Homo sapiens GN=POGLUT1 PE=1 SV=1 | 229 | P | 0.529422 | T | 0.471023 | 0.058399 | D to O | - |
| Q7Z3K3 | POGZ_HUMAN Pogo transposable element with ZNF domain OS=Homo sapiens GN=POGZ PE=1 SV=2 | 1365 | E | 0.985652 | D | 0.981436 | 0.004216 | No Change: Both D | - |
| P09884 | DPOLA_HUMAN DNA polymerase alpha catalytic subunit OS=Homo sapiens GN=POLA1 PE=1 SV=2 | 740 | Y | 0.203953 | H | 0.315681 | -0.111728 | No Change: Both O | - |
| Q14181 | DPOA2_HUMAN DNA polymerase alpha subunit B OS=Homo sapiens GN=POLA2 PE=1 SV=2 | 583 | G | 0.566998 | R | 0.589161 | -0.022163 | No Change: Both D | - |
| Q14181 | DPOA2_HUMAN DNA polymerase alpha subunit B OS=Homo sapiens GN=POLA2 PE=1 SV=2 | 588 | S | 0.351426 | N | 0.31355 | 0.037876 | No Change: Both O | - |
| P06746 | DPOLB_HUMAN DNA polymerase beta OS=Homo sapiens GN=POLB PE=1 SV=3 | 242 | P | 0.451173 | R | 0.410728 | 0.040445 | No Change: Both O | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 30 | R | 0.964823 | W | 0.924914 | 0.039909 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 19 | R | 0.967599 | H | 0.953038 | 0.014561 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 119 | R | 0.699742 | H | 0.693323 | 0.006419 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 173 | S | 0.5219 | N | 0.474288 | 0.047612 | D to O | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 177 | R | 0.596614 | H | 0.565474 | 0.03114 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 849 | R | 0.227031 | H | 0.189969 | 0.037062 | No Change: Both O | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 1086 | R | 0.556249 | Q | 0.558771 | -0.002522 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 5 | R | 0.990894 | W | 0.975741 | 0.015153 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 21 | G | 0.96306 | C | 0.943187 | 0.019873 | No Change: Both D | - |
| P28340 | DPOD1_HUMAN DNA polymerase delta catalytic subunit OS=Homo sapiens GN=POLD1 PE=1 SV=2 | 347 | P | 0.324702 | L | 0.203197 | 0.121505 | No Change: Both O | - |
| P49005 | DPOD2_HUMAN DNA polymerase delta subunit 2 OS=Homo sapiens GN=POLD2 PE=1 SV=1 | 303 | N | 0.447092 | S | 0.506405 | -0.059313 | O to D | - |
| Q15054 | DPOD3_HUMAN DNA polymerase delta subunit 3 OS=Homo sapiens GN=POLD3 PE=1 SV=2 | 194 | G | 0.926841 | V | 0.893458 | 0.033383 | No Change: Both D | - |
| Q15054 | DPOD3_HUMAN DNA polymerase delta subunit 3 OS=Homo sapiens GN=POLD3 PE=1 SV=2 | 195 | M | 0.926641 | L | 0.888967 | 0.037674 | No Change: Both D | - |
| Q9HCU8 | DPOD4_HUMAN DNA polymerase delta subunit 4 OS=Homo sapiens GN=POLD4 PE=1 SV=1 | 39 | R | 0.880054 | P | 0.894398 | -0.014344 | No Change: Both D | - |
| Q9HCU8 | DPOD4_HUMAN DNA polymerase delta subunit 4 OS=Homo sapiens GN=POLD4 PE=1 SV=1 | 59 | G | 0.363258 | R | 0.408748 | -0.04549 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 252 | A | 0.199752 | V | 0.158595 | 0.041157 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 336 | N | 0.276987 | S | 0.315656 | -0.038669 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 695 | F | 0.810473 | I | 0.786543 | 0.02393 | No Change: Both D | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1395 | Y | 0.231239 | C | 0.190263 | 0.040976 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1396 | N | 0.242051 | S | 0.28318 | -0.041129 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1399 | E | 0.278476 | Q | 0.230898 | 0.047578 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 2040 | A | 0.510579 | V | 0.432463 | 0.078116 | D to O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 2165 | R | 0.316436 | H | 0.240764 | 0.075672 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 99 | P | 0.139817 | L | 0.07089 | 0.068927 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 260 | R | 0.382044 | Q | 0.382287 | -2.43E-04 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1382 | R | 0.449073 | C | 0.262604 | 0.186469 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1577 | E | 0.343735 | A | 0.26752 | 0.076215 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1712 | A | 0.334845 | V | 0.277292 | 0.057553 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1857 | K | 0.179858 | R | 0.147574 | 0.032284 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 1935 | C | 0.541449 | Y | 0.528644 | 0.012805 | No Change: Both D | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 2140 | E | 0.449764 | K | 0.423682 | 0.026082 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 2159 | R | 0.210861 | C | 0.151094 | 0.059767 | No Change: Both O | - |
| Q07864 | DPOE1_HUMAN DNA polymerase epsilon catalytic subunit A OS=Homo sapiens GN=POLE PE=1 SV=5 | 31 | A | 0.83112 | S | 0.877577 | -0.046457 | No Change: Both D | - |
| P56282 | DPOE2_HUMAN DNA polymerase epsilon subunit 2 OS=Homo sapiens GN=POLE2 PE=1 SV=2 | 84 | H | 0.154711 | P | 0.188043 | -0.033332 | No Change: Both O | - |
| P56282 | DPOE2_HUMAN DNA polymerase epsilon subunit 2 OS=Homo sapiens GN=POLE2 PE=1 SV=2 | 456 | L | 0.078218 | V | 0.079015 | -7.97E-04 | No Change: Both O | - |
| P56282 | DPOE2_HUMAN DNA polymerase epsilon subunit 2 OS=Homo sapiens GN=POLE2 PE=1 SV=2 | 514 | P | 0.465788 | L | 0.279058 | 0.18673 | No Change: Both O | - |
| Q9NRF9 | DPOE3_HUMAN DNA polymerase epsilon subunit 3 OS=Homo sapiens GN=POLE3 PE=1 SV=1 | 83 | T | 0.761007 | A | 0.769047 | -0.00804 | No Change: Both D | - |
| Q9NRF9 | DPOE3_HUMAN DNA polymerase epsilon subunit 3 OS=Homo sapiens GN=POLE3 PE=1 SV=1 | 135 | E | 0.999853 | D | 0.99982 | 3.30E-05 | No Change: Both D | - |
| Q9NRF9 | DPOE3_HUMAN DNA polymerase epsilon subunit 3 OS=Homo sapiens GN=POLE3 PE=1 SV=1 | 126 | D | 0.99986 | A | 0.999746 | 1.14E-04 | No Change: Both D | - |
| Q9NR33 | DPOE4_HUMAN DNA polymerase epsilon subunit 4 OS=Homo sapiens GN=POLE4 PE=1 SV=2 | 17 | G | 0.985977 | V | 0.977194 | 0.008783 | No Change: Both D | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 3 | R | 0.707091 | P | 0.752912 | -0.045821 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 304 | L | 0.542075 | R | 0.651918 | -0.109843 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 467 | A | 0.38959 | T | 0.400252 | -0.010662 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 467 | A | 0.38959 | T | 0.400252 | -0.010662 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 467 | A | 0.38959 | T | 0.400252 | -0.010662 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 955 | Y | 0.19065 | C | 0.178945 | 0.011705 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 18 | P | 0.82577 | S | 0.813243 | 0.012527 | No Change: Both D | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 324 | P | 0.845986 | S | 0.855717 | -0.009731 | No Change: Both D | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 546 | R | 0.716306 | C | 0.671633 | 0.044673 | No Change: Both D | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 662 | E | 0.452865 | K | 0.468116 | -0.015251 | No Change: Both O | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1142 | R | 0.405652 | W | 0.184444 | 0.221208 | No Change: Both O | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1143 | E | 0.457412 | G | 0.37333 | 0.084082 | No Change: Both O | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1146 | R | 0.352681 | C | 0.179654 | 0.173027 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1236 | Q | 0.761916 | H | 0.730219 | 0.031697 | No Change: Both D | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 193 | R | 0.21848 | Q | 0.226916 | -0.008436 | No Change: Both O | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 227 | R | 0.219745 | W | 0.106604 | 0.113141 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4B (MTDPS4B) [MIM:613662] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 227 | R | 0.219745 | W | 0.106604 | 0.113141 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 251 | T | 0.535326 | I | 0.399519 | 0.135807 | D to O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 251 | T | 0.535326 | I | 0.399519 | 0.135807 | D to O | Mitochondrial DNA depletion syndrome type 4B (MTDPS4B) [MIM:613662] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 251 | T | 0.535326 | I | 0.399519 | 0.135807 | D to O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 309 | R | 0.577418 | L | 0.481052 | 0.096366 | D to O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 312 | W | 0.575818 | R | 0.780663 | -0.204845 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 431 | G | 0.210431 | V | 0.131978 | 0.078453 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 468 | N | 0.405731 | D | 0.470351 | -0.06462 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 497 | Q | 0.712525 | H | 0.649539 | 0.062986 | No Change: Both D | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 579 | R | 0.521793 | W | 0.334231 | 0.187562 | D to O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 587 | P | 0.489939 | L | 0.337938 | 0.152001 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 587 | P | 0.489939 | L | 0.337938 | 0.152001 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4B (MTDPS4B) [MIM:613662] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 587 | P | 0.489939 | L | 0.337938 | 0.152001 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 627 | R | 0.287449 | W | 0.131851 | 0.155598 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 748 | W | 0.194194 | S | 0.451162 | -0.256968 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 748 | W | 0.194194 | S | 0.451162 | -0.256968 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 831 | Y | 0.448598 | C | 0.377304 | 0.071294 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 831 | Y | 0.448598 | C | 0.377304 | 0.071294 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 848 | G | 0.214201 | S | 0.255645 | -0.041444 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 848 | G | 0.214201 | S | 0.255645 | -0.041444 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 848 | G | 0.214201 | S | 0.255645 | -0.041444 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4B (MTDPS4B) [MIM:613662] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 848 | G | 0.214201 | S | 0.255645 | -0.041444 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 864 | N | 0.414978 | S | 0.481867 | -0.066889 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4B (MTDPS4B) [MIM:613662] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 889 | A | 0.256644 | T | 0.295802 | -0.039158 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 923 | G | 0.441441 | D | 0.458159 | -0.016718 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 932 | H | 0.651659 | Y | 0.544023 | 0.107636 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 932 | H | 0.651659 | Y | 0.544023 | 0.107636 | No Change: Both D | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 943 | R | 0.326767 | H | 0.346878 | -0.020111 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 953 | R | 0.165349 | C | 0.087328 | 0.078021 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 957 | A | 0.229346 | S | 0.296838 | -0.067492 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1047 | R | 0.352034 | Q | 0.363266 | -0.011232 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1051 | G | 0.496459 | R | 0.51671 | -0.020251 | O to D | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1076 | G | 0.18429 | V | 0.138177 | 0.046113 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1096 | R | 0.201821 | C | 0.101859 | 0.099962 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1104 | S | 0.178664 | C | 0.0591 | 0.119564 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1105 | A | 0.16934 | T | 0.190709 | -0.021369 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1106 | V | 0.151491 | I | 0.12045 | 0.031041 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1176 | S | 0.207852 | L | 0.103668 | 0.104184 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 232 | R | 0.398179 | G | 0.3776 | 0.020579 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 232 | R | 0.398179 | H | 0.363085 | 0.035094 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 244 | L | 0.353305 | P | 0.54135 | -0.188045 | O to D | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 268 | G | 0.230369 | A | 0.203666 | 0.026703 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 308 | Q | 0.550557 | H | 0.493367 | 0.05719 | D to O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 380 | G | 0.30127 | D | 0.346153 | -0.044883 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 463 | L | 0.506144 | F | 0.445854 | 0.06029 | D to O | - |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 511 | S | 0.87802 | N | 0.856631 | 0.021389 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 517 | G | 0.905996 | V | 0.861285 | 0.044711 | No Change: Both D | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 562 | R | 0.729992 | Q | 0.743066 | -0.013074 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 574 | R | 0.591196 | W | 0.387032 | 0.204164 | D to O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 603 | M | 0.15112 | L | 0.122821 | 0.028299 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 627 | R | 0.287449 | Q | 0.292542 | -0.005093 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 648 | P | 0.144641 | R | 0.131967 | 0.012674 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 737 | G | 0.546975 | R | 0.524931 | 0.022044 | No Change: Both D | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 767 | A | 0.43046 | D | 0.537647 | -0.107187 | O to D | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 807 | R | 0.319817 | C | 0.172542 | 0.147275 | No Change: Both O | Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 807 | R | 0.319817 | P | 0.340406 | -0.020589 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 853 | R | 0.250215 | W | 0.112968 | 0.137247 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 879 | Q | 0.314807 | H | 0.298526 | 0.016281 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 885 | T | 0.250033 | S | 0.332203 | -0.08217 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 914 | T | 0.130592 | P | 0.15118 | -0.020588 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 957 | A | 0.229346 | P | 0.293395 | -0.064049 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1096 | R | 0.201821 | H | 0.204983 | -0.003162 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1110 | H | 0.086516 | Y | 0.053871 | 0.032645 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1134 | H | 0.110192 | R | 0.120045 | -0.009853 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1184 | D | 0.135638 | N | 0.119571 | 0.016067 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal recessive (PEOB) [MIM:258450] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1191 | K | 0.263026 | N | 0.222032 | 0.040994 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1136 | E | 0.151041 | K | 0.142774 | 0.008267 | No Change: Both O | Mitochondrial DNA depletion syndrome type 4A (MTDPS4A) [MIM:203700] |
| P54098 | DPOG1_HUMAN DNA polymerase subunit gamma-1 OS=Homo sapiens GN=POLG PE=1 SV=1 | 1186 | D | 0.166731 | H | 0.123977 | 0.042754 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 1 (PEOA1) [MIM:157640] |
| Q9UHN1 | DPOG2_HUMAN DNA polymerase subunit gamma-2 mitochondrial OS=Homo sapiens GN=POLG2 PE=1 SV=1 | 451 | G | 0.351129 | E | 0.44812 | -0.096991 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 4 (PEOA4) [MIM:610131] |
| Q9UHN1 | DPOG2_HUMAN DNA polymerase subunit gamma-2 mitochondrial OS=Homo sapiens GN=POLG2 PE=1 SV=1 | 169 | A | 0.202476 | T | 0.231066 | -0.02859 | No Change: Both O | - |
| Q9UHN1 | DPOG2_HUMAN DNA polymerase subunit gamma-2 mitochondrial OS=Homo sapiens GN=POLG2 PE=1 SV=1 | 416 | G | 0.179139 | A | 0.13437 | 0.044769 | No Change: Both O | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 111 | R | 0.285087 | H | 0.241334 | 0.043753 | No Change: Both O | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 122 | T | 0.298283 | P | 0.365289 | -0.067006 | No Change: Both O | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 209 | G | 0.322519 | V | 0.203548 | 0.118971 | No Change: Both O | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 263 | G | 0.292904 | V | 0.186388 | 0.106516 | No Change: Both O | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 334 | R | 0.279089 | W | 0.138172 | 0.140917 | No Change: Both O | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 361 | R | 0.523864 | S | 0.551629 | -0.027765 | No Change: Both D | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 478 | T | 0.945395 | M | 0.930228 | 0.015167 | No Change: Both D | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 535 | K | 0.979001 | E | 0.976121 | 0.00288 | No Change: Both D | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 584 | L | 0.86617 | P | 0.923752 | -0.057582 | No Change: Both D | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 589 | K | 0.881596 | T | 0.863945 | 0.017651 | No Change: Both D | Xeroderma pigmentosum variant type (XPV) [MIM:278750] |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 595 | M | 0.907262 | V | 0.88207 | 0.025192 | No Change: Both D | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 647 | M | 0.352032 | L | 0.290924 | 0.061108 | No Change: Both O | - |
| Q9Y253 | POLH_HUMAN DNA polymerase eta OS=Homo sapiens GN=POLH PE=1 SV=1 | 153 | G | 0.628505 | D | 0.643016 | -0.014511 | No Change: Both D | A breast cancer sample |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 96 | R | 0.290926 | G | 0.295982 | -0.005056 | No Change: Both O | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 261 | I | 0.345687 | M | 0.415757 | -0.07007 | No Change: Both O | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 276 | E | 0.160668 | K | 0.173641 | -0.012973 | No Change: Both O | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 474 | H | 0.900545 | R | 0.915647 | -0.015102 | No Change: Both D | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 532 | F | 0.65736 | S | 0.793285 | -0.135925 | No Change: Both D | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 560 | C | 0.649854 | R | 0.77214 | -0.122286 | No Change: Both D | - |
| Q9UNA4 | POLI_HUMAN DNA polymerase iota OS=Homo sapiens GN=POLI PE=1 SV=3 | 731 | A | 0.355418 | T | 0.365925 | -0.010507 | No Change: Both O | - |
| Q9UBT6 | POLK_HUMAN DNA polymerase kappa OS=Homo sapiens GN=POLK PE=1 SV=1 | 595 | T | 0.804915 | I | 0.717612 | 0.087303 | No Change: Both D | - |
| Q9UBT6 | POLK_HUMAN DNA polymerase kappa OS=Homo sapiens GN=POLK PE=1 SV=1 | 612 | I | 0.640017 | V | 0.657907 | -0.01789 | No Change: Both D | - |
| Q9UBT6 | POLK_HUMAN DNA polymerase kappa OS=Homo sapiens GN=POLK PE=1 SV=1 | 832 | S | 0.938581 | N | 0.923223 | 0.015358 | No Change: Both D | - |
| Q9UBT6 | POLK_HUMAN DNA polymerase kappa OS=Homo sapiens GN=POLK PE=1 SV=1 | 423 | S | 0.620954 | R | 0.572586 | 0.048368 | No Change: Both D | - |
| Q9UBT6 | POLK_HUMAN DNA polymerase kappa OS=Homo sapiens GN=POLK PE=1 SV=1 | 635 | S | 0.230457 | N | 0.204049 | 0.026408 | No Change: Both O | - |
| Q9UGP5 | DPOLL_HUMAN DNA polymerase lambda OS=Homo sapiens GN=POLL PE=1 SV=1 | 221 | T | 0.652431 | P | 0.734211 | -0.08178 | No Change: Both D | - |
| Q9UGP5 | DPOLL_HUMAN DNA polymerase lambda OS=Homo sapiens GN=POLL PE=1 SV=1 | 438 | R | 0.525581 | W | 0.314856 | 0.210725 | D to O | - |
| Q9NP87 | DPOLM_HUMAN DNA-directed DNA/RNA polymerase mu OS=Homo sapiens GN=POLM PE=1 SV=1 | 107 | E | 0.453394 | D | 0.414656 | 0.038738 | No Change: Both O | - |
| Q9NP87 | DPOLM_HUMAN DNA-directed DNA/RNA polymerase mu OS=Homo sapiens GN=POLM PE=1 SV=1 | 220 | G | 0.477957 | A | 0.395279 | 0.082678 | No Change: Both O | - |
| Q9NP87 | DPOLM_HUMAN DNA-directed DNA/RNA polymerase mu OS=Homo sapiens GN=POLM PE=1 SV=1 | 246 | V | 0.182178 | F | 0.175498 | 0.00668 | No Change: Both O | - |
| Q9NP87 | DPOLM_HUMAN DNA-directed DNA/RNA polymerase mu OS=Homo sapiens GN=POLM PE=1 SV=1 | 484 | L | 0.263212 | F | 0.238484 | 0.024728 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 121 | Q | 0.599094 | H | 0.524436 | 0.074658 | No Change: Both D | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 201 | R | 0.160626 | G | 0.171411 | -0.010785 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 310 | M | 0.080242 | L | 0.063748 | 0.016494 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 315 | P | 0.05347 | S | 0.060723 | -0.007253 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 336 | G | 0.242725 | S | 0.289109 | -0.046384 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 425 | R | 0.054057 | C | 0.02651 | 0.027547 | No Change: Both O | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 502 | S | 0.557338 | G | 0.500335 | 0.057003 | No Change: Both D | - |
| Q7Z5Q5 | DPOLN_HUMAN DNA polymerase nu OS=Homo sapiens GN=POLN PE=1 SV=2 | 711 | F | 0.260347 | L | 0.292173 | -0.031826 | No Change: Both O | - |
| O75417 | DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens GN=POLQ PE=1 SV=2 | 1056 | P | 0.918068 | L | 0.879642 | 0.038426 | No Change: Both D | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 150 | P | 0.672912 | A | 0.615901 | 0.057011 | No Change: Both D | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 349 | Q | 0.56809 | E | 0.612901 | -0.044811 | No Change: Both D | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 364 | K | 0.686153 | E | 0.705448 | -0.019295 | No Change: Both D | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 396 | S | 0.068699 | N | 0.059374 | 0.009325 | No Change: Both O | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 815 | I | 0.425256 | V | 0.457499 | -0.032243 | No Change: Both O | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 1141 | A | 0.513006 | T | 0.521747 | -0.008741 | No Change: Both D | - |
| O95602 | RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens GN=POLR1A PE=1 SV=2 | 1608 | I | 0.184696 | M | 0.243554 | -0.058858 | No Change: Both O | - |
| Q9H9Y6 | RPA2_HUMAN DNA-directed RNA polymerase I subunit RPA2 OS=Homo sapiens GN=POLR1B PE=1 SV=2 | 295 | S | 0.332882 | L | 0.190133 | 0.142749 | No Change: Both O | - |
| O15160 | RPAC1_HUMAN DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens GN=POLR1C PE=1 SV=1 | 279 | R | 0.368224 | Q | 0.359043 | 0.009181 | No Change: Both O | Treacher Collins syndrome type 3 (TCS3) [MIM:248390] |
| O15160 | RPAC1_HUMAN DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens GN=POLR1C PE=1 SV=1 | 279 | R | 0.368224 | W | 0.158102 | 0.210122 | No Change: Both O | Treacher Collins syndrome type 3 (TCS3) [MIM:248390] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 47 | E | 0.352765 | K | 0.339719 | 0.013046 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 50 | T | 0.40785 | I | 0.294029 | 0.113821 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 51 | L | 0.399544 | R | 0.48847 | -0.088926 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 52 | G | 0.383823 | E | 0.445417 | -0.061594 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 56 | R | 0.24194 | C | 0.134254 | 0.107686 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 82 | L | 0.419694 | S | 0.595081 | -0.175387 | O to D | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9Y2S0 | RPAC2_HUMAN DNA-directed RNA polymerases I and III subunit RPAC2 OS=Homo sapiens GN=POLR1D PE=1 SV=1 | 99 | G | 0.269978 | S | 0.32604 | -0.056062 | No Change: Both O | Treacher Collins syndrome type 2 (TCS2) [MIM:613717] |
| Q9GZS1 | RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens GN=POLR1E PE=1 SV=2 | 254 | D | 0.420251 | H | 0.37836 | 0.041891 | No Change: Both O | - |
| Q9GZS1 | RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens GN=POLR1E PE=1 SV=2 | 418 | V | 0.163376 | M | 0.221534 | -0.058158 | No Change: Both O | - |
| Q9GZS1 | RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens GN=POLR1E PE=1 SV=2 | 445 | R | 0.73605 | K | 0.760722 | -0.024672 | No Change: Both D | - |
| P24928 | RPB1_HUMAN DNA-directed RNA polymerase II subunit RPB1 OS=Homo sapiens GN=POLR2A PE=1 SV=2 | 292 | R | 0.530484 | C | 0.372653 | 0.157831 | D to O | - |
| P19388 | RPAB1_HUMAN DNA-directed RNA polymerases I II and III subunit RPABC1 OS=Homo sapiens GN=POLR2E PE=1 SV=4 | 44 | S | 0.745253 | F | 0.62244 | 0.122813 | No Change: Both D | - |
| P61218 | RPAB2_HUMAN DNA-directed RNA polymerases I II and III subunit RPABC2 OS=Homo sapiens GN=POLR2F PE=1 SV=1 | 60 | Y | 0.45003 | N | 0.561091 | -0.111061 | O to D | A breast cancer sample |
| Q6EEV4 | GL1AD_HUMAN DNA-directed RNA polymerase II subunit GRINL1A isoforms 4/5 OS=Homo sapiens GN=POLR2M PE=2 SV=1 | 127 | A | 0.429727 | P | 0.529441 | -0.099714 | O to D | - |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 582 | R | 0.354612 | L | 0.262872 | 0.09174 | No Change: Both O | - |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 713 | K | 0.321428 | N | 0.28129 | 0.040138 | No Change: Both O | - |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 372 | D | 0.405565 | N | 0.393185 | 0.01238 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 558 | F | 0.167251 | L | 0.191371 | -0.02412 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 636 | S | 0.388273 | Y | 0.21597 | 0.172303 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 672 | G | 0.219883 | E | 0.261796 | -0.041913 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 724 | C | 0.318036 | Y | 0.365943 | -0.047907 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 775 | N | 0.522989 | I | 0.368467 | 0.154522 | D to O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 852 | M | 0.214724 | V | 0.175173 | 0.039551 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| O14802 | RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens GN=POLR3A PE=1 SV=2 | 1005 | R | 0.319245 | C | 0.207365 | 0.11188 | No Change: Both O | Leukodystrophy hypomyelinating type 7 with or without oligodontia and/or hypogonadotropic hypogonadism (HLD7) [MIM:607694] |
| Q9NW08 | RPC2_HUMAN DNA-directed RNA polymerase III subunit RPC2 OS=Homo sapiens GN=POLR3B PE=1 SV=2 | 740 | T | 0.31333 | A | 0.307209 | 0.006121 | No Change: Both O | - |
| Q9BUI4 | RPC3_HUMAN DNA-directed RNA polymerase III subunit RPC3 OS=Homo sapiens GN=POLR3C PE=1 SV=1 | 243 | H | 0.270527 | R | 0.297676 | -0.027149 | No Change: Both O | - |
| Q9NVU0 | RPC5_HUMAN DNA-directed RNA polymerase III subunit RPC5 OS=Homo sapiens GN=POLR3E PE=1 SV=1 | 46 | S | 0.455479 | A | 0.370458 | 0.085021 | No Change: Both O | - |
| Q9Y2Y1 | RPC10_HUMAN DNA-directed RNA polymerase III subunit RPC10 OS=Homo sapiens GN=POLR3K PE=1 SV=2 | 24 | S | 0.196133 | A | 0.127809 | 0.068324 | No Change: Both O | - |
| O00411 | RPOM_HUMAN DNA-directed RNA polymerase mitochondrial OS=Homo sapiens GN=POLRMT PE=1 SV=2 | 555 | E | 0.497474 | A | 0.381054 | 0.11642 | No Change: Both O | - |
| Q96HA1 | P121A_HUMAN Nuclear envelope pore membrane protein POM 121 OS=Homo sapiens GN=POM121 PE=1 SV=2 | 1215 | A | 0.797343 | G | 0.81839 | -0.021047 | No Change: Both D | - |
| A8CG34 | P121C_HUMAN Nuclear envelope pore membrane protein POM 121C OS=Homo sapiens GN=POM121C PE=1 SV=2 | 379 | T | 0.969936 | A | 0.964386 | 0.00555 | No Change: Both D | - |
| A8CG34 | P121C_HUMAN Nuclear envelope pore membrane protein POM 121C OS=Homo sapiens GN=POM121C PE=1 SV=2 | 1165 | Q | 0.92517 | L | 0.884203 | 0.040967 | No Change: Both D | - |
| Q8N7R1 | P1L12_HUMAN POM121-like protein 12 OS=Homo sapiens GN=POM121L12 PE=2 SV=3 | 21 | P | 0.833284 | T | 0.754371 | 0.078913 | No Change: Both D | - |
| Q8N7R1 | P1L12_HUMAN POM121-like protein 12 OS=Homo sapiens GN=POM121L12 PE=2 SV=3 | 64 | Q | 0.736007 | E | 0.7148 | 0.021207 | No Change: Both D | - |
| Q8N7R1 | P1L12_HUMAN POM121-like protein 12 OS=Homo sapiens GN=POM121L12 PE=2 SV=3 | 188 | G | 0.682854 | E | 0.713475 | -0.030621 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 7 | S | 0.704446 | T | 0.551852 | 0.152594 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 9 | S | 0.627854 | L | 0.437837 | 0.190017 | D to O | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 236 | R | 0.605795 | G | 0.620867 | -0.015072 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 106 | D | 0.957724 | N | 0.953158 | 0.004566 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 214 | E | 0.705989 | G | 0.672891 | 0.033098 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 236 | R | 0.605795 | Q | 0.613243 | -0.007448 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 132 | P | 0.968998 | A | 0.95132 | 0.017678 | No Change: Both D | - |
| P01189 | COLI_HUMAN Pro-opiomelanocortin OS=Homo sapiens GN=POMC PE=1 SV=2 | 62 | P | 0.666504 | L | 0.507688 | 0.158816 | No Change: Both D | - |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 223 | E | 0.601816 | K | 0.642111 | -0.040295 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 265 | R | 0.543544 | H | 0.473021 | 0.070523 | D to O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 269 | C | 0.560268 | Y | 0.505498 | 0.05477 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 311 | R | 0.216297 | Q | 0.219018 | -0.002721 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 311 | R | 0.216297 | Q | 0.219018 | -0.002721 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B3 (MDDGB3) [MIM:613151] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 425 | W | 0.171947 | S | 0.443113 | -0.271166 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 442 | R | 0.187972 | C | 0.10094 | 0.087032 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 490 | C | 0.319741 | Y | 0.36991 | -0.050169 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 490 | C | 0.319741 | Y | 0.36991 | -0.050169 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B3 (MDDGB3) [MIM:613151] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 493 | P | 0.284257 | R | 0.273117 | 0.01114 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 550 | S | 0.448869 | N | 0.400725 | 0.048144 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 623 | M | 0.208087 | V | 0.181083 | 0.027004 | No Change: Both O | - |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 250 | E | 0.600668 | V | 0.425938 | 0.17473 | D to O | - |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 504 | V | 0.14666 | I | 0.136461 | 0.010199 | No Change: Both O | - |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 176 | T | 0.146306 | P | 0.183875 | -0.037569 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 198 | S | 0.411456 | R | 0.361851 | 0.049605 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 367 | R | 0.469152 | H | 0.49738 | -0.028228 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 427 | D | 0.283521 | H | 0.260827 | 0.022694 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A3 (MDDGA3) [MIM:253280] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 556 | D | 0.524398 | N | 0.513225 | 0.011173 | No Change: Both D | Muscular dystrophy-dystroglycanopathy limb-girdle type C3 (MDDGC3) [MIM:613157] |
| Q8WZA1 | PMGT1_HUMAN Protein O-linked-mannose beta-1 2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens GN=POMGNT1 PE=1 SV=2 | 605 | R | 0.202927 | P | 0.219488 | -0.016561 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B3 (MDDGB3) [MIM:613151] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 76 | G | 0.149052 | R | 0.124947 | 0.024105 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 428 | V | 0.345879 | D | 0.517262 | -0.171383 | O to D | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 200 | A | 0.064143 | P | 0.087651 | -0.023508 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C1 (MDDGC1) [MIM:609308] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 537 | S | 0.70189 | R | 0.676137 | 0.025753 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 537 | S | 0.70189 | R | 0.676137 | 0.025753 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B1 (MDDGB1) [MIM:613155] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 251 | Q | 0.336219 | W | 0.133917 | 0.202302 | No Change: Both O | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 251 | Q | 0.336219 | R | 0.301387 | 0.034832 | No Change: Both O | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 327 | V | 0.170355 | I | 0.13926 | 0.031095 | No Change: Both O | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 433 | D | 0.153681 | E | 0.177996 | -0.024315 | No Change: Both O | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 65 | G | 0.42424 | R | 0.392822 | 0.031418 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B1 (MDDGB1) [MIM:613155] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 105 | R | 0.102834 | C | 0.048012 | 0.054822 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 105 | R | 0.102834 | H | 0.104481 | -0.001647 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 207 | G | 0.038328 | V | 0.020871 | 0.017457 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A1 (MDDGA1) [MIM:236670] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 285 | L | 0.017714 | F | 0.015847 | 0.001867 | No Change: Both O | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 522 | R | 0.818853 | K | 0.798291 | 0.020562 | No Change: Both D | - |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 582 | W | 0.101105 | C | 0.118995 | -0.01789 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B1 (MDDGB1) [MIM:613155] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 590 | Q | 0.220266 | H | 0.222294 | -0.002028 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B1 (MDDGB1) [MIM:613155] |
| Q9Y6A1 | POMT1_HUMAN Protein O-mannosyl-transferase 1 OS=Homo sapiens GN=POMT1 PE=1 SV=3 | 669 | A | 0.044717 | T | 0.055577 | -0.01086 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B1 (MDDGB1) [MIM:613155] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 54 | A | 0.109554 | E | 0.155084 | -0.04553 | No Change: Both O | - |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 184 | T | 0.112751 | M | 0.082579 | 0.030172 | No Change: Both O | Muscular dystrophy-dystroglycanopathy limb-girdle type C2 (MDDGC2) [MIM:613158] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 198 | I | 0.02767 | N | 0.057842 | -0.030172 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 246 | G | 0.024933 | D | 0.025769 | -8.36E-04 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) [MIM:613156] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 353 | G | 0.219768 | S | 0.278351 | -0.058583 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 373 | V | 0.321072 | F | 0.291113 | 0.029959 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 413 | R | 0.419051 | P | 0.443418 | -0.024367 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 482 | G | 0.091577 | V | 0.049918 | 0.041659 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 666 | Y | 0.077527 | C | 0.057196 | 0.020331 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 666 | Y | 0.077527 | C | 0.057196 | 0.020331 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) [MIM:613156] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 717 | F | 0.073179 | S | 0.185723 | -0.112544 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) [MIM:613156] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 726 | G | 0.157246 | E | 0.181657 | -0.024411 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A2 (MDDGA2) [MIM:613150] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 726 | G | 0.157246 | E | 0.181657 | -0.024411 | No Change: Both O | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) [MIM:613156] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 748 | W | 0.547763 | R | 0.743789 | -0.196026 | No Change: Both D | Muscular dystrophy-dystroglycanopathy congenital with mental retardation type B2 (MDDGB2) [MIM:613156] |
| Q9UKY4 | POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens GN=POMT2 PE=1 SV=2 | 748 | W | 0.547763 | S | 0.785166 | -0.237403 | No Change: Both D | Muscular dystrophy-dystroglycanopathy limb-girdle type C2 (MDDGC2) [MIM:613158] |
| Q6PJE2 | POZP3_HUMAN POM121 and ZP3 fusion protein OS=Homo sapiens GN=POMZP3 PE=2 SV=4 | 176 | R | 0.742171 | H | 0.713368 | 0.028803 | No Change: Both D | - |
| P27169 | PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=3 | 55 | L | 0.428077 | M | 0.458943 | -0.030866 | No Change: Both O | - |
| P27169 | PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=3 | 192 | Q | 0.116499 | R | 0.10669 | 0.009809 | No Change: Both O | - |
| P27169 | PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=3 | 102 | I | 0.325465 | V | 0.368569 | -0.043104 | No Change: Both O | - |
| P27169 | PON1_HUMAN Serum paraoxonase/arylesterase 1 OS=Homo sapiens GN=PON1 PE=1 SV=3 | 160 | R | 0.309459 | G | 0.320721 | -0.011262 | No Change: Both O | - |
| Q15165 | PON2_HUMAN Serum paraoxonase/arylesterase 2 OS=Homo sapiens GN=PON2 PE=1 SV=3 | 148 | A | 0.444066 | G | 0.505323 | -0.061257 | O to D | - |
| Q15165 | PON2_HUMAN Serum paraoxonase/arylesterase 2 OS=Homo sapiens GN=PON2 PE=1 SV=3 | 311 | C | 0.165708 | S | 0.344328 | -0.17862 | No Change: Both O | - |
| Q15165 | PON2_HUMAN Serum paraoxonase/arylesterase 2 OS=Homo sapiens GN=PON2 PE=1 SV=3 | 172 | V | 0.21501 | L | 0.20582 | 0.00919 | No Change: Both O | - |
| Q15166 | PON3_HUMAN Serum paraoxonase/lactonase 3 OS=Homo sapiens GN=PON3 PE=1 SV=3 | 146 | E | 0.398484 | K | 0.392472 | 0.006012 | No Change: Both O | - |
| Q15166 | PON3_HUMAN Serum paraoxonase/lactonase 3 OS=Homo sapiens GN=PON3 PE=1 SV=3 | 179 | A | 0.23435 | D | 0.331503 | -0.097153 | No Change: Both O | - |
| Q99575 | POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens GN=POP1 PE=1 SV=2 | 675 | E | 0.600053 | Q | 0.57408 | 0.025973 | No Change: Both D | A breast cancer sample |
| Q99575 | POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens GN=POP1 PE=1 SV=2 | 127 | S | 0.648277 | L | 0.497311 | 0.150966 | D to O | - |
| Q99575 | POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens GN=POP1 PE=1 SV=2 | 460 | E | 0.603977 | A | 0.504679 | 0.099298 | No Change: Both D | - |
| Q99575 | POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens GN=POP1 PE=1 SV=2 | 522 | K | 0.742334 | N | 0.71383 | 0.028504 | No Change: Both D | - |
| Q99575 | POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens GN=POP1 PE=1 SV=2 | 994 | L | 0.445024 | V | 0.423032 | 0.021992 | No Change: Both O | - |
| Q9HBU9 | POPD2_HUMAN Popeye domain-containing protein 2 OS=Homo sapiens GN=POPDC2 PE=2 SV=2 | 29 | V | 0.107253 | I | 0.087827 | 0.019426 | No Change: Both O | - |
| Q9HBV1 | POPD3_HUMAN Popeye domain-containing protein 3 OS=Homo sapiens GN=POPDC3 PE=2 SV=2 | 106 | R | 0.145883 | Q | 0.161577 | -0.015694 | No Change: Both O | - |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 500 | A | 0.646518 | V | 0.565188 | 0.08133 | No Change: Both D | - |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 551 | R | 0.308625 | Q | 0.333454 | -0.024829 | No Change: Both O | - |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 178 | Y | 0.338297 | D | 0.491401 | -0.153104 | No Change: Both O | Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 284 | A | 0.277619 | P | 0.374196 | -0.096577 | No Change: Both O | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 284 | A | 0.277619 | P | 0.374196 | -0.096577 | No Change: Both O | Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 454 | R | 0.283055 | H | 0.266914 | 0.016141 | No Change: Both O | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 454 | R | 0.283055 | H | 0.266914 | 0.016141 | No Change: Both O | Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 489 | V | 0.238008 | E | 0.399399 | -0.161391 | No Change: Both O | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 566 | C | 0.206376 | Y | 0.268957 | -0.062581 | No Change: Both O | Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 575 | Y | 0.373026 | C | 0.32727 | 0.045756 | No Change: Both O | Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis (ABS1) [MIM:201750] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 605 | V | 0.334945 | F | 0.288667 | 0.046278 | No Change: Both O | Disordered steroidogenesis due to cytochrome P450 oxidoreductase deficiency (DISPORD) [MIM:613571] |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 225 | P | 0.067124 | L | 0.033016 | 0.034108 | No Change: Both O | - |
| P16435 | NCPR_HUMAN NADPH--cytochrome P450 reductase OS=Homo sapiens GN=POR PE=1 SV=2 | 252 | D | 0.174036 | N | 0.153594 | 0.020442 | No Change: Both O | - |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 60 | G | 0.199492 | R | 0.178075 | 0.021417 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 365 | R | 0.166752 | G | 0.163254 | 0.003498 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 136 | S | 0.167049 | F | 0.070013 | 0.097036 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 168 | G | 0.048607 | R | 0.042393 | 0.006214 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 228 | R | 0.608068 | C | 0.398999 | 0.209069 | D to O | - |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 258 | V | 0.121376 | E | 0.252609 | -0.131233 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 341 | H | 0.195794 | L | 0.118246 | 0.077548 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 365 | R | 0.166752 | Q | 0.166983 | -2.31E-04 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 385 | C | 0.556788 | R | 0.728873 | -0.172085 | No Change: Both D | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 439 | W | 0.261698 | R | 0.464575 | -0.202877 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 252 | H | 0.168255 | Y | 0.113919 | 0.054336 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 297 | S | 0.29732 | L | 0.152012 | 0.145308 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 331 | L | 0.097229 | R | 0.16058 | -0.063351 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 361 | E | 0.08232 | V | 0.039237 | 0.043083 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 385 | C | 0.556788 | Y | 0.599262 | -0.042474 | No Change: Both D | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q9H237 | PORCN_HUMAN Protein-cysteine N-palmitoyltransferase porcupine OS=Homo sapiens GN=PORCN PE=1 SV=2 | 374 | A | 0.118927 | P | 0.159906 | -0.040979 | No Change: Both O | Focal dermal hypoplasia (FODH) [MIM:305600] |
| Q15063 | POSTN_HUMAN Periostin OS=Homo sapiens GN=POSTN PE=1 SV=2 | 339 | T | 0.260236 | I | 0.170918 | 0.089318 | No Change: Both O | - |
| Q15063 | POSTN_HUMAN Periostin OS=Homo sapiens GN=POSTN PE=1 SV=2 | 814 | V | 0.698064 | M | 0.741333 | -0.043269 | No Change: Both D | - |
| Q9NUX5 | POTE1_HUMAN Protection of telomeres protein 1 OS=Homo sapiens GN=POT1 PE=1 SV=1 | 529 | V | 0.257118 | M | 0.309158 | -0.05204 | No Change: Both O | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 30 | H | 0.732861 | D | 0.770981 | -0.03812 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 43 | M | 0.913704 | V | 0.864509 | 0.049195 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 64 | C | 0.908131 | W | 0.8198 | 0.088331 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 68 | C | 0.89671 | R | 0.909086 | -0.012376 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 77 | T | 0.864571 | K | 0.887762 | -0.023191 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 88 | N | 0.827021 | D | 0.842842 | -0.015821 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 286 | Q | 0.328008 | E | 0.369276 | -0.041268 | No Change: Both O | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 511 | K | 0.945546 | E | 0.948832 | -0.003286 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 535 | M | 0.91089 | K | 0.929871 | -0.018981 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 568 | A | 0.754037 | V | 0.685768 | 0.068269 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 242 | A | 0.181255 | T | 0.200611 | -0.019356 | No Change: Both O | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 568 | A | 0.754037 | T | 0.801119 | -0.047082 | No Change: Both D | - |
| Q6S5H4 | POTEB_HUMAN POTE ankyrin domain family member B OS=Homo sapiens GN=POTEB PE=2 SV=1 | 524 | R | 0.939466 | H | 0.928209 | 0.011257 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 3 | T | 0.700259 | A | 0.715453 | -0.015194 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 10 | A | 0.576139 | T | 0.596361 | -0.020222 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 13 | A | 0.620242 | T | 0.636165 | -0.015923 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 28 | F | 0.665567 | C | 0.718046 | -0.052479 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 30 | H | 0.709518 | P | 0.775412 | -0.065894 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 36 | K | 0.851036 | R | 0.832906 | 0.01813 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 66 | H | 0.9111 | R | 0.922736 | -0.011636 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 72 | C | 0.870555 | Y | 0.78198 | 0.088575 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 86 | H | 0.841157 | D | 0.860142 | -0.018985 | No Change: Both D | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 166 | M | 0.579333 | I | 0.4868 | 0.092533 | D to O | - |
| B2RU33 | POTEC_HUMAN POTE ankyrin domain family member C OS=Homo sapiens GN=POTEC PE=2 SV=2 | 221 | C | 0.18336 | R | 0.28806 | -0.1047 | No Change: Both O | - |
| Q86YR6 | POTED_HUMAN POTE ankyrin domain family member D OS=Homo sapiens GN=POTED PE=2 SV=2 | 113 | G | 0.434014 | S | 0.486077 | -0.052063 | No Change: Both O | - |
| Q86YR6 | POTED_HUMAN POTE ankyrin domain family member D OS=Homo sapiens GN=POTED PE=2 SV=2 | 135 | I | 0.343161 | V | 0.37443 | -0.031269 | No Change: Both O | - |
| Q86YR6 | POTED_HUMAN POTE ankyrin domain family member D OS=Homo sapiens GN=POTED PE=2 SV=2 | 172 | E | 0.724912 | Q | 0.703999 | 0.020913 | No Change: Both D | - |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 4 | Q | 0.666115 | R | 0.657217 | 0.008898 | No Change: Both D | - |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 24 | P | 0.445973 | L | 0.293642 | 0.152331 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 143 | R | 0.227073 | Q | 0.231276 | -0.004203 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 158 | A | 0.308476 | P | 0.359607 | -0.051131 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 227 | D | 0.650845 | Y | 0.529532 | 0.121313 | No Change: Both D | - |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 271 | R | 0.732751 | W | 0.521048 | 0.211703 | No Change: Both D | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 135 | F | 0.444247 | C | 0.431394 | 0.012853 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 174 | E | 0.159511 | G | 0.126748 | 0.032763 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 239 | P | 0.74163 | S | 0.775663 | -0.034033 | No Change: Both D | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 193 | W | 0.29826 | R | 0.520122 | -0.221862 | O to D | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 19 | A | 0.482167 | V | 0.35802 | 0.124147 | No Change: Both O | - |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 172 | R | 0.157014 | Q | 0.187568 | -0.030554 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 179 | S | 0.207815 | R | 0.169354 | 0.038461 | No Change: Both O | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| P28069 | PIT1_HUMAN Pituitary-specific positive transcription factor 1 OS=Homo sapiens GN=POU1F1 PE=1 SV=1 | 230 | E | 0.617449 | K | 0.61388 | 0.003569 | No Change: Both D | Pituitary hormone deficiency combined type 1 (CPHD1) [MIM:613038] |
| Q16633 | OBF1_HUMAN POU domain class 2-associating factor 1 OS=Homo sapiens GN=POU2AF1 PE=1 SV=1 | 141 | T | 0.569903 | A | 0.523619 | 0.046284 | No Change: Both D | - |
| Q16633 | OBF1_HUMAN POU domain class 2-associating factor 1 OS=Homo sapiens GN=POU2AF1 PE=1 SV=1 | 194 | Q | 0.905451 | R | 0.877752 | 0.027699 | No Change: Both D | - |
| P14859 | PO2F1_HUMAN POU domain class 2 transcription factor 1 OS=Homo sapiens GN=POU2F1 PE=1 SV=2 | 88 | S | 0.986026 | F | 0.966172 | 0.019854 | No Change: Both D | A breast cancer sample |
| Q9UKI9 | PO2F3_HUMAN POU domain class 2 transcription factor 3 OS=Homo sapiens GN=POU2F3 PE=2 SV=3 | 152 | H | 0.957407 | R | 0.954387 | 0.00302 | No Change: Both D | - |
| Q9UKI9 | PO2F3_HUMAN POU domain class 2 transcription factor 3 OS=Homo sapiens GN=POU2F3 PE=2 SV=3 | 390 | R | 0.995737 | K | 0.996149 | -4.12E-04 | No Change: Both D | - |
| P49335 | PO3F4_HUMAN POU domain class 3 transcription factor 4 OS=Homo sapiens GN=POU3F4 PE=1 SV=2 | 312 | A | 0.498098 | V | 0.43725 | 0.060848 | No Change: Both O | Deafness X-linked type 2 (DFNX2) [MIM:304400] |
| P49335 | PO3F4_HUMAN POU domain class 3 transcription factor 4 OS=Homo sapiens GN=POU3F4 PE=1 SV=2 | 317 | L | 0.436359 | W | 0.347157 | 0.089202 | No Change: Both O | Deafness X-linked type 2 (DFNX2) [MIM:304400] |
| P49335 | PO3F4_HUMAN POU domain class 3 transcription factor 4 OS=Homo sapiens GN=POU3F4 PE=1 SV=2 | 323 | R | 0.315658 | G | 0.258167 | 0.057491 | No Change: Both O | Deafness X-linked type 2 (DFNX2) [MIM:304400] |
| P49335 | PO3F4_HUMAN POU domain class 3 transcription factor 4 OS=Homo sapiens GN=POU3F4 PE=1 SV=2 | 330 | R | 0.568993 | S | 0.588726 | -0.019733 | No Change: Both D | Deafness X-linked type 2 (DFNX2) [MIM:304400] |
| P49335 | PO3F4_HUMAN POU domain class 3 transcription factor 4 OS=Homo sapiens GN=POU3F4 PE=1 SV=2 | 334 | K | 0.715671 | E | 0.721108 | -0.005437 | No Change: Both D | Deafness X-linked type 2 (DFNX2) [MIM:304400] |
| Q12837 | PO4F2_HUMAN POU domain class 4 transcription factor 2 OS=Homo sapiens GN=POU4F2 PE=1 SV=2 | 40 | I | 0.990493 | T | 0.994528 | -0.004035 | No Change: Both D | - |
| Q15319 | PO4F3_HUMAN POU domain class 4 transcription factor 3 OS=Homo sapiens GN=POU4F3 PE=1 SV=1 | 223 | L | 0.344467 | P | 0.519362 | -0.174895 | O to D | Deafness autosomal dominant type 15 (DFNA15) [MIM:602459] |
| Q15319 | PO4F3_HUMAN POU domain class 4 transcription factor 3 OS=Homo sapiens GN=POU4F3 PE=1 SV=1 | 289 | L | 0.766641 | F | 0.762088 | 0.004553 | No Change: Both D | Deafness autosomal dominant type 15 (DFNA15) [MIM:602459] |
| Q01860 | PO5F1_HUMAN POU domain class 5 transcription factor 1 OS=Homo sapiens GN=POU5F1 PE=1 SV=1 | 322 | T | 0.825916 | A | 0.820049 | 0.005867 | No Change: Both D | - |
| Q01860 | PO5F1_HUMAN POU domain class 5 transcription factor 1 OS=Homo sapiens GN=POU5F1 PE=1 SV=1 | 357 | M | 0.833979 | L | 0.811132 | 0.022847 | No Change: Both D | - |
| Q01860 | PO5F1_HUMAN POU domain class 5 transcription factor 1 OS=Homo sapiens GN=POU5F1 PE=1 SV=1 | 226 | L | 0.576835 | F | 0.518953 | 0.057882 | No Change: Both D | - |
| Q01860 | PO5F1_HUMAN POU domain class 5 transcription factor 1 OS=Homo sapiens GN=POU5F1 PE=1 SV=1 | 351 | T | 0.766722 | I | 0.567845 | 0.198877 | No Change: Both D | - |
| P78424 | PO6F2_HUMAN POU domain class 6 transcription factor 2 OS=Homo sapiens GN=POU6F2 PE=1 SV=3 | 192 | Q | 0.999602 | H | 0.999263 | 3.39E-04 | No Change: Both D | Hereditary susceptibility to Wilms tumor 5 (WT5) [MIM:601583] |
| P78424 | PO6F2_HUMAN POU domain class 6 transcription factor 2 OS=Homo sapiens GN=POU6F2 PE=1 SV=3 | 199 | P | 0.999936 | L | 0.999896 | 4.00E-05 | No Change: Both D | - |
| P78424 | PO6F2_HUMAN POU domain class 6 transcription factor 2 OS=Homo sapiens GN=POU6F2 PE=1 SV=3 | 500 | L | 0.305249 | M | 0.340676 | -0.035427 | No Change: Both O | - |
| P78424 | PO6F2_HUMAN POU domain class 6 transcription factor 2 OS=Homo sapiens GN=POU6F2 PE=1 SV=3 | 639 | E | 0.466365 | K | 0.458102 | 0.008263 | No Change: Both O | - |
| A8MPX8 | PP2D1_HUMAN Protein phosphatase 2C-like domain-containing protein 1 OS=Homo sapiens GN=PP2D1 PE=2 SV=2 | 37 | R | 0.841103 | H | 0.797476 | 0.043627 | No Change: Both D | - |
| A8MPX8 | PP2D1_HUMAN Protein phosphatase 2C-like domain-containing protein 1 OS=Homo sapiens GN=PP2D1 PE=2 SV=2 | 123 | F | 0.306104 | L | 0.342905 | -0.036801 | No Change: Both O | - |
| A8MPX8 | PP2D1_HUMAN Protein phosphatase 2C-like domain-containing protein 1 OS=Homo sapiens GN=PP2D1 PE=2 SV=2 | 260 | A | 0.164067 | T | 0.182068 | -0.018001 | No Change: Both O | - |
| Q15181 | IPYR_HUMAN Inorganic pyrophosphatase OS=Homo sapiens GN=PPA1 PE=1 SV=2 | 57 | K | 0.377792 | N | 0.338172 | 0.03962 | No Change: Both O | A breast cancer sample |
| Q9H2U2 | IPYR2_HUMAN Inorganic pyrophosphatase 2 mitochondrial OS=Homo sapiens GN=PPA2 PE=1 SV=2 | 282 | K | 0.201284 | N | 0.172537 | 0.028747 | No Change: Both O | - |
| Q9NQ55 | SSF1_HUMAN Suppressor of SWI4 1 homolog OS=Homo sapiens GN=PPAN PE=1 SV=1 | 358 | G | 0.950689 | V | 0.927092 | 0.023597 | No Change: Both D | - |
| Q9NQ55 | SSF1_HUMAN Suppressor of SWI4 1 homolog OS=Homo sapiens GN=PPAN PE=1 SV=1 | 408 | Q | 0.893896 | R | 0.901228 | -0.007332 | No Change: Both D | - |
| O43688 | LPP2_HUMAN Lipid phosphate phosphohydrolase 2 OS=Homo sapiens GN=PPAP2C PE=1 SV=1 | 180 | A | 0.014934 | V | 0.010305 | 0.004629 | No Change: Both O | - |
| Q8IY26 | PPAC2_HUMAN Presqualene diphosphate phosphatase OS=Homo sapiens GN=PPAPDC2 PE=1 SV=3 | 140 | S | 0.201577 | W | 0.069952 | 0.131625 | No Change: Both O | - |
| Q8IY26 | PPAC2_HUMAN Presqualene diphosphate phosphatase OS=Homo sapiens GN=PPAPDC2 PE=1 SV=3 | 7 | S | 0.999339 | G | 0.999086 | 2.53E-04 | No Change: Both D | - |
| Q8IY26 | PPAC2_HUMAN Presqualene diphosphate phosphatase OS=Homo sapiens GN=PPAPDC2 PE=1 SV=3 | 8 | M | 0.999218 | T | 0.998989 | 2.29E-04 | No Change: Both D | - |
| Q8NBV4 | PPAC3_HUMAN Probable lipid phosphate phosphatase PPAPDC3 OS=Homo sapiens GN=PPAPDC3 PE=2 SV=1 | 174 | T | 0.564942 | M | 0.507161 | 0.057781 | No Change: Both D | - |
| Q8NBV4 | PPAC3_HUMAN Probable lipid phosphate phosphatase PPAPDC3 OS=Homo sapiens GN=PPAPDC3 PE=2 SV=1 | 267 | L | 0.431161 | V | 0.43513 | -0.003969 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 127 | R | 0.156686 | Q | 0.145933 | 0.010753 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 162 | L | 0.385832 | V | 0.386015 | -1.83E-04 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 227 | V | 0.26751 | A | 0.342982 | -0.075472 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 268 | A | 0.308201 | V | 0.24867 | 0.059531 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 304 | D | 0.205048 | N | 0.197174 | 0.007874 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 409 | R | 0.185935 | T | 0.174954 | 0.010981 | No Change: Both O | - |
| Q07869 | PPARA_HUMAN Peroxisome proliferator-activated receptor alpha OS=Homo sapiens GN=PPARA PE=1 SV=2 | 395 | G | 0.278856 | R | 0.256671 | 0.022185 | No Change: Both O | - |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 12 | P | 0.880787 | A | 0.813956 | 0.066831 | No Change: Both D | - |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 113 | P | 0.666624 | Q | 0.631434 | 0.03519 | No Change: Both D | Obesity (OBESITY) [MIM:601665] |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 314 | Q | 0.137929 | P | 0.137483 | 4.46E-04 | No Change: Both O | Colon cancer |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 316 | R | 0.172442 | H | 0.165379 | 0.007063 | No Change: Both O | Colon cancer |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 318 | V | 0.218409 | M | 0.259291 | -0.040882 | No Change: Both O | - |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 495 | P | 0.276694 | L | 0.178072 | 0.098622 | No Change: Both O | - |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 40 | P | 0.473659 | A | 0.338994 | 0.134665 | No Change: Both O | - |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 388 | F | 0.411443 | L | 0.436363 | -0.02492 | No Change: Both O | Familial partial lipodystrophy type 3 (FPLD3) [MIM:604367] |
| P37231 | PPARG_HUMAN Peroxisome proliferator-activated receptor gamma OS=Homo sapiens GN=PPARG PE=1 SV=3 | 425 | R | 0.238918 | C | 0.131022 | 0.107896 | No Change: Both O | Familial partial lipodystrophy type 3 (FPLD3) [MIM:604367] |
| Q9UBK2 | PRGC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-alpha OS=Homo sapiens GN=PPARGC1A PE=1 SV=1 | 482 | G | 0.729389 | S | 0.788204 | -0.058815 | No Change: Both D | - |
| Q9UBK2 | PRGC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-alpha OS=Homo sapiens GN=PPARGC1A PE=1 SV=1 | 612 | T | 0.990753 | M | 0.991387 | -6.34E-04 | No Change: Both D | - |
| Q86YN6 | PRGC2_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-beta OS=Homo sapiens GN=PPARGC1B PE=1 SV=2 | 203 | A | 0.964889 | P | 0.975301 | -0.010412 | No Change: Both D | - |
| Q86YN6 | PRGC2_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-beta OS=Homo sapiens GN=PPARGC1B PE=1 SV=2 | 265 | R | 0.941722 | Q | 0.945384 | -0.003662 | No Change: Both D | - |
| Q86YN6 | PRGC2_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-beta OS=Homo sapiens GN=PPARGC1B PE=1 SV=2 | 279 | V | 0.77161 | I | 0.764341 | 0.007269 | No Change: Both D | - |
| Q86YN6 | PRGC2_HUMAN Peroxisome proliferator-activated receptor gamma coactivator 1-beta OS=Homo sapiens GN=PPARGC1B PE=1 SV=2 | 292 | R | 0.665347 | S | 0.681834 | -0.016487 | No Change: Both D | - |
| O14829 | PPE1_HUMAN Serine/threonine-protein phosphatase with EF-hands 1 OS=Homo sapiens GN=PPEF1 PE=1 SV=1 | 367 | K | 0.376095 | T | 0.321539 | 0.054556 | No Change: Both O | - |
| O14829 | PPE1_HUMAN Serine/threonine-protein phosphatase with EF-hands 1 OS=Homo sapiens GN=PPEF1 PE=1 SV=1 | 443 | G | 0.162843 | S | 0.208253 | -0.04541 | No Change: Both O | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 120 | S | 0.378957 | R | 0.325892 | 0.053065 | No Change: Both O | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 394 | V | 0.948279 | L | 0.955511 | -0.007232 | No Change: Both D | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 412 | E | 0.94649 | K | 0.937415 | 0.009075 | No Change: Both D | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 553 | R | 0.517933 | K | 0.542674 | -0.024741 | No Change: Both D | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 575 | S | 0.631218 | C | 0.409945 | 0.221273 | D to O | - |
| O14830 | PPE2_HUMAN Serine/threonine-protein phosphatase with EF-hands 2 OS=Homo sapiens GN=PPEF2 PE=1 SV=2 | 481 | M | 0.171618 | L | 0.146704 | 0.024914 | No Change: Both O | - |
| Q13136 | LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens GN=PPFIA1 PE=1 SV=1 | 71 | V | 0.716488 | I | 0.684481 | 0.032007 | No Change: Both D | - |
| Q13136 | LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens GN=PPFIA1 PE=1 SV=1 | 1072 | L | 0.340654 | F | 0.298499 | 0.042155 | No Change: Both O | - |
| O75145 | LIPA3_HUMAN Liprin-alpha-3 OS=Homo sapiens GN=PPFIA3 PE=1 SV=3 | 563 | A | 0.949065 | S | 0.966889 | -0.017824 | No Change: Both D | - |
| Q86W92 | LIPB1_HUMAN Liprin-beta-1 OS=Homo sapiens GN=PPFIBP1 PE=1 SV=2 | 148 | V | 0.729936 | L | 0.765604 | -0.035668 | No Change: Both D | - |
| Q8ND30 | LIPB2_HUMAN Liprin-beta-2 OS=Homo sapiens GN=PPFIBP2 PE=1 SV=3 | 658 | R | 0.354467 | G | 0.346509 | 0.007958 | No Change: Both O | - |
| Q8NEY8 | PPHLN_HUMAN Periphilin-1 OS=Homo sapiens GN=PPHLN1 PE=1 SV=2 | 173 | V | 0.986525 | M | 0.98945 | -0.002925 | No Change: Both D | A breast cancer sample |
| P23284 | PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens GN=PPIB PE=1 SV=2 | 60 | V | 0.123256 | L | 0.119518 | 0.003738 | No Change: Both O | - |
| P23284 | PPIB_HUMAN Peptidyl-prolyl cis-trans isomerase B OS=Homo sapiens GN=PPIB PE=1 SV=2 | 9 | M | 0.294344 | R | 0.350328 | -0.055984 | No Change: Both O | Osteogenesis imperfecta type 9 (OI9) [MIM:259440] |
| P45877 | PPIC_HUMAN Peptidyl-prolyl cis-trans isomerase C OS=Homo sapiens GN=PPIC PE=1 SV=1 | 190 | N | 0.308552 | S | 0.356244 | -0.047692 | No Change: Both O | - |
| P45877 | PPIC_HUMAN Peptidyl-prolyl cis-trans isomerase C OS=Homo sapiens GN=PPIC PE=1 SV=1 | 86 | K | 0.381691 | R | 0.314287 | 0.067404 | No Change: Both O | - |
| P45877 | PPIC_HUMAN Peptidyl-prolyl cis-trans isomerase C OS=Homo sapiens GN=PPIC PE=1 SV=1 | 160 | H | 0.149564 | L | 0.095263 | 0.054301 | No Change: Both O | - |
| Q08752 | PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=Homo sapiens GN=PPID PE=1 SV=3 | 49 | R | 0.212882 | C | 0.122421 | 0.090461 | No Change: Both O | - |
| Q08752 | PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=Homo sapiens GN=PPID PE=1 SV=3 | 302 | L | 0.414178 | I | 0.365789 | 0.048389 | No Change: Both O | - |
| Q08752 | PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=Homo sapiens GN=PPID PE=1 SV=3 | 335 | G | 0.683376 | E | 0.745557 | -0.062181 | No Change: Both D | - |
| Q08752 | PPID_HUMAN Peptidyl-prolyl cis-trans isomerase D OS=Homo sapiens GN=PPID PE=1 SV=3 | 196 | D | 0.846964 | V | 0.741808 | 0.105156 | No Change: Both D | - |
| Q13427 | PPIG_HUMAN Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens GN=PPIG PE=1 SV=2 | 445 | D | 0.999336 | E | 0.999392 | -5.60E-05 | No Change: Both D | - |
| Q13427 | PPIG_HUMAN Peptidyl-prolyl cis-trans isomerase G OS=Homo sapiens GN=PPIG PE=1 SV=2 | 699 | N | 0.995948 | D | 0.996355 | -4.07E-04 | No Change: Both D | - |
| Q9Y3C6 | PPIL1_HUMAN Peptidyl-prolyl cis-trans isomerase-like 1 OS=Homo sapiens GN=PPIL1 PE=1 SV=1 | 36 | C | 0.342491 | S | 0.596271 | -0.25378 | O to D | - |
| Q9H2H8 | PPIL3_HUMAN Peptidyl-prolyl cis-trans isomerase-like 3 OS=Homo sapiens GN=PPIL3 PE=1 SV=1 | 146 | D | 0.259736 | E | 0.275463 | -0.015727 | No Change: Both O | - |
| Q8IXY8 | PPIL6_HUMAN Peptidyl-prolyl cis-trans isomerase-like 6 OS=Homo sapiens GN=PPIL6 PE=2 SV=1 | 110 | H | 0.077622 | R | 0.076309 | 0.001313 | No Change: Both O | - |
| O43314 | VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens GN=PPIP5K2 PE=1 SV=3 | 944 | A | 0.777545 | G | 0.792499 | -0.014954 | No Change: Both D | - |
| O43314 | VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens GN=PPIP5K2 PE=1 SV=3 | 985 | E | 0.902248 | K | 0.892734 | 0.009514 | No Change: Both D | - |
| O43314 | VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens GN=PPIP5K2 PE=1 SV=3 | 1003 | R | 0.855983 | K | 0.843113 | 0.01287 | No Change: Both D | - |
| O43314 | VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens GN=PPIP5K2 PE=1 SV=3 | 1206 | P | 0.986653 | Q | 0.979683 | 0.00697 | No Change: Both D | - |
| O43314 | VIP2_HUMAN Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Homo sapiens GN=PPIP5K2 PE=1 SV=3 | 1232 | T | 0.995535 | M | 0.993873 | 0.001662 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 520 | R | 0.664409 | Q | 0.68136 | -0.016951 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 572 | A | 0.596925 | S | 0.678912 | -0.081987 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 589 | R | 0.492917 | Q | 0.491068 | 0.001849 | No Change: Both O | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 631 | H | 0.594515 | Y | 0.433026 | 0.161489 | D to O | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 819 | R | 0.76168 | S | 0.78078 | -0.0191 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 891 | E | 0.78693 | Q | 0.760444 | 0.026486 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 1007 | A | 0.826327 | V | 0.793483 | 0.032844 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 1199 | E | 0.88296 | Q | 0.866679 | 0.016281 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 1573 | Q | 0.88904 | E | 0.902145 | -0.013105 | No Change: Both D | - |
| O60437 | PEPL_HUMAN Periplakin OS=Homo sapiens GN=PPL PE=1 SV=4 | 1754 | G | 0.702865 | R | 0.677387 | 0.025478 | No Change: Both D | - |
| Q8WY54 | PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens GN=PPM1E PE=1 SV=2 | 231 | L | 0.198092 | S | 0.356259 | -0.158167 | No Change: Both O | A breast cancer sample |
| Q8WY54 | PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens GN=PPM1E PE=1 SV=2 | 320 | R | 0.148874 | G | 0.136661 | 0.012213 | No Change: Both O | A breast cancer sample |
| P49593 | PPM1F_HUMAN Protein phosphatase 1F OS=Homo sapiens GN=PPM1F PE=1 SV=3 | 420 | L | 0.689472 | R | 0.756253 | -0.066781 | No Change: Both D | - |
| P49593 | PPM1F_HUMAN Protein phosphatase 1F OS=Homo sapiens GN=PPM1F PE=1 SV=3 | 296 | R | 0.786338 | Q | 0.791796 | -0.005458 | No Change: Both D | A colorectal cancer sample |
| P49593 | PPM1F_HUMAN Protein phosphatase 1F OS=Homo sapiens GN=PPM1F PE=1 SV=3 | 417 | Q | 0.603824 | K | 0.570937 | 0.032887 | No Change: Both D | A breast cancer sample |
| P49593 | PPM1F_HUMAN Protein phosphatase 1F OS=Homo sapiens GN=PPM1F PE=1 SV=3 | 132 | R | 0.25824 | C | 0.171153 | 0.087087 | No Change: Both O | - |
| Q5JR12 | PPM1J_HUMAN Protein phosphatase 1J OS=Homo sapiens GN=PPM1J PE=1 SV=1 | 213 | L | 0.867149 | F | 0.839849 | 0.0273 | No Change: Both D | - |
| Q5JR12 | PPM1J_HUMAN Protein phosphatase 1J OS=Homo sapiens GN=PPM1J PE=1 SV=1 | 236 | V | 0.41776 | I | 0.345775 | 0.071985 | No Change: Both O | - |
| Q8N3J5 | PPM1K_HUMAN Protein phosphatase 1K mitochondrial OS=Homo sapiens GN=PPM1K PE=1 SV=1 | 94 | N | 0.287247 | K | 0.348949 | -0.061702 | No Change: Both O | - |
| Q8N3J5 | PPM1K_HUMAN Protein phosphatase 1K mitochondrial OS=Homo sapiens GN=PPM1K PE=1 SV=1 | 321 | E | 0.569646 | K | 0.558244 | 0.011402 | No Change: Both D | - |
| Q5SGD2 | PPM1L_HUMAN Protein phosphatase 1L OS=Homo sapiens GN=PPM1L PE=1 SV=1 | 262 | A | 0.199976 | S | 0.313445 | -0.113469 | No Change: Both O | - |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 59 | R | 0.373569 | W | 0.169705 | 0.203864 | No Change: Both O | Variegate porphyria (VP) [MIM:176200] |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 152 | R | 0.520768 | C | 0.366617 | 0.154151 | D to O | Variegate porphyria (VP) [MIM:176200] |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 168 | R | 0.357142 | C | 0.259035 | 0.098107 | No Change: Both O | - |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 232 | G | 0.430298 | R | 0.460129 | -0.029831 | No Change: Both O | Variegate porphyria (VP) [MIM:176200] |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 304 | R | 0.304897 | H | 0.306995 | -0.002098 | No Change: Both O | - |
| P50336 | PPOX_HUMAN Protoporphyrinogen oxidase OS=Homo sapiens GN=PPOX PE=1 SV=1 | 256 | P | 0.319136 | R | 0.312436 | 0.0067 | No Change: Both O | - |
| P36873 | PP1G_HUMAN Serine/threonine-protein phosphatase PP1-gamma catalytic subunit OS=Homo sapiens GN=PPP1CC PE=1 SV=1 | 152 | F | 0.048057 | S | 0.117084 | -0.069027 | No Change: Both O | - |
| Q96QC0 | PP1RA_HUMAN Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Homo sapiens GN=PPP1R10 PE=1 SV=1 | 173 | R | 0.992692 | P | 0.993431 | -7.39E-04 | No Change: Both D | - |
| O14974 | MYPT1_HUMAN Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens GN=PPP1R12A PE=1 SV=1 | 116 | C | 0.113046 | W | 0.096865 | 0.016181 | No Change: Both O | - |
| O14974 | MYPT1_HUMAN Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens GN=PPP1R12A PE=1 SV=1 | 305 | T | 0.887896 | P | 0.916514 | -0.028618 | No Change: Both D | - |
| O14974 | MYPT1_HUMAN Protein phosphatase 1 regulatory subunit 12A OS=Homo sapiens GN=PPP1R12A PE=1 SV=1 | 734 | K | 0.999659 | N | 0.999525 | 1.34E-04 | No Change: Both D | - |
| O60237 | MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens GN=PPP1R12B PE=1 SV=2 | 182 | V | 0.895507 | I | 0.876023 | 0.019484 | No Change: Both D | - |
| O60237 | MYPT2_HUMAN Protein phosphatase 1 regulatory subunit 12B OS=Homo sapiens GN=PPP1R12B PE=1 SV=2 | 836 | R | 0.923989 | K | 0.922635 | 0.001354 | No Change: Both D | - |
| Q9BZL4 | PP12C_HUMAN Protein phosphatase 1 regulatory subunit 12C OS=Homo sapiens GN=PPP1R12C PE=1 SV=1 | 419 | R | 0.95122 | C | 0.921801 | 0.029419 | No Change: Both D | - |
| Q8TAE6 | PP14C_HUMAN Protein phosphatase 1 regulatory subunit 14C OS=Homo sapiens GN=PPP1R14C PE=1 SV=3 | 10 | T | 0.962094 | A | 0.96312 | -0.001026 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 31 | R | 0.266213 | H | 0.235632 | 0.030581 | No Change: Both O | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 32 | A | 0.285998 | T | 0.299559 | -0.013561 | No Change: Both O | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 199 | V | 0.956106 | A | 0.966508 | -0.010402 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 251 | R | 0.993472 | P | 0.993796 | -3.24E-04 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 277 | K | 0.992098 | E | 0.992777 | -6.79E-04 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 316 | A | 0.867195 | P | 0.905086 | -0.037891 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 381 | A | 0.973223 | V | 0.967094 | 0.006129 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 476 | R | 0.940414 | S | 0.943833 | -0.003419 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 594 | R | 0.670674 | C | 0.522431 | 0.148243 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 597 | T | 0.762849 | A | 0.781907 | -0.019058 | No Change: Both D | - |
| O75807 | PR15A_HUMAN Protein phosphatase 1 regulatory subunit 15A OS=Homo sapiens GN=PPP1R15A PE=1 SV=1 | 312 | G | 0.914995 | S | 0.931276 | -0.016281 | No Change: Both D | - |
| Q5SWA1 | PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B OS=Homo sapiens GN=PPP1R15B PE=1 SV=1 | 26 | P | 0.94849 | S | 0.944347 | 0.004143 | No Change: Both D | - |
| Q5SWA1 | PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B OS=Homo sapiens GN=PPP1R15B PE=1 SV=1 | 144 | E | 0.637814 | K | 0.644521 | -0.006707 | No Change: Both D | - |
| Q5SWA1 | PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B OS=Homo sapiens GN=PPP1R15B PE=1 SV=1 | 308 | N | 0.690751 | S | 0.738177 | -0.047426 | No Change: Both D | - |
| Q5SWA1 | PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B OS=Homo sapiens GN=PPP1R15B PE=1 SV=1 | 363 | E | 0.822615 | G | 0.783093 | 0.039522 | No Change: Both D | - |
| Q5SWA1 | PR15B_HUMAN Protein phosphatase 1 regulatory subunit 15B OS=Homo sapiens GN=PPP1R15B PE=1 SV=1 | 589 | K | 0.76512 | E | 0.777171 | -0.012051 | No Change: Both D | - |
| O96001 | PPR17_HUMAN Protein phosphatase 1 regulatory subunit 17 OS=Homo sapiens GN=PPP1R17 PE=1 SV=2 | 12 | L | 0.961492 | V | 0.940466 | 0.021026 | No Change: Both D | - |
| O96001 | PPR17_HUMAN Protein phosphatase 1 regulatory subunit 17 OS=Homo sapiens GN=PPP1R17 PE=1 SV=2 | 10 | L | 0.958421 | R | 0.975276 | -0.016855 | No Change: Both D | - |
| Q6NYC8 | PPR18_HUMAN Phostensin OS=Homo sapiens GN=PPP1R18 PE=1 SV=1 | 356 | P | 0.944853 | L | 0.905979 | 0.038874 | No Change: Both D | - |
| Q6NYC8 | PPR18_HUMAN Phostensin OS=Homo sapiens GN=PPP1R18 PE=1 SV=1 | 222 | R | 0.968315 | G | 0.960212 | 0.008103 | No Change: Both D | - |
| Q6NYC8 | PPR18_HUMAN Phostensin OS=Homo sapiens GN=PPP1R18 PE=1 SV=1 | 339 | G | 0.833728 | R | 0.855905 | -0.022177 | No Change: Both D | - |
| Q13522 | PPR1A_HUMAN Protein phosphatase 1 regulatory subunit 1A OS=Homo sapiens GN=PPP1R1A PE=1 SV=2 | 109 | E | 0.983698 | G | 0.978779 | 0.004919 | No Change: Both D | - |
| Q13522 | PPR1A_HUMAN Protein phosphatase 1 regulatory subunit 1A OS=Homo sapiens GN=PPP1R1A PE=1 SV=2 | 147 | G | 0.978466 | D | 0.980049 | -0.001583 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 98 | V | 0.637634 | A | 0.713272 | -0.075638 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 206 | K | 0.979528 | E | 0.981589 | -0.002061 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 346 | R | 0.965243 | K | 0.966445 | -0.001202 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 434 | M | 0.972367 | T | 0.979118 | -0.006751 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 520 | R | 0.916747 | H | 0.897471 | 0.019276 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 576 | G | 0.954895 | S | 0.961981 | -0.007086 | No Change: Both D | - |
| Q5T8A7 | PPR26_HUMAN Protein phosphatase 1 regulatory subunit 26 OS=Homo sapiens GN=PPP1R26 PE=1 SV=1 | 834 | N | 0.963594 | D | 0.97335 | -0.009756 | No Change: Both D | - |
| Q7Z5V6 | PPR32_HUMAN Protein phosphatase 1 regulatory subunit 32 OS=Homo sapiens GN=PPP1R32 PE=1 SV=1 | 238 | T | 0.730001 | N | 0.710647 | 0.019354 | No Change: Both D | - |
| Q7Z5V6 | PPR32_HUMAN Protein phosphatase 1 regulatory subunit 32 OS=Homo sapiens GN=PPP1R32 PE=1 SV=1 | 382 | S | 0.535924 | T | 0.464322 | 0.071602 | D to O | - |
| Q96LQ0 | PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 OS=Homo sapiens GN=PPP1R36 PE=1 SV=1 | 83 | T | 0.828553 | I | 0.72176 | 0.106793 | No Change: Both D | - |
| Q96LQ0 | PPR36_HUMAN Protein phosphatase 1 regulatory subunit 36 OS=Homo sapiens GN=PPP1R36 PE=1 SV=1 | 267 | F | 0.285227 | L | 0.292848 | -0.007621 | No Change: Both O | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 883 | R | 0.645943 | S | 0.693991 | -0.048048 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 905 | D | 0.846047 | Y | 0.712338 | 0.133709 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 931 | A | 0.814962 | E | 0.86072 | -0.045758 | No Change: Both D | Noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 45 | G | 0.927201 | S | 0.949653 | -0.022452 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 231 | C | 0.471994 | Y | 0.45934 | 0.012654 | No Change: Both O | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 451 | V | 0.61584 | M | 0.69748 | -0.08164 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 476 | N | 0.608122 | K | 0.656016 | -0.047894 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 748 | E | 0.861176 | K | 0.858029 | 0.003147 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 882 | L | 0.618136 | H | 0.670346 | -0.05221 | No Change: Both D | - |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 554 | G | 0.374654 | A | 0.337853 | 0.036801 | No Change: Both O | A breast cancer sample |
| Q16821 | PPR3A_HUMAN Protein phosphatase 1 regulatory subunit 3A OS=Homo sapiens GN=PPP1R3A PE=1 SV=3 | 627 | R | 0.398065 | K | 0.426215 | -0.02815 | No Change: Both O | - |
| Q86XI6 | PPR3B_HUMAN Protein phosphatase 1 regulatory subunit 3B OS=Homo sapiens GN=PPP1R3B PE=1 SV=1 | 48 | G | 0.747153 | E | 0.802865 | -0.055712 | No Change: Both D | - |
| Q9UQK1 | PPR3C_HUMAN Protein phosphatase 1 regulatory subunit 3C OS=Homo sapiens GN=PPP1R3C PE=1 SV=2 | 109 | A | 0.303815 | S | 0.415005 | -0.11119 | No Change: Both O | - |
| Q6ZSY5 | PPR3F_HUMAN Protein phosphatase 1 regulatory subunit 3F OS=Homo sapiens GN=PPP1R3F PE=1 SV=3 | 351 | F | 0.780837 | S | 0.882466 | -0.101629 | No Change: Both D | - |
| B7ZBB8 | PP13G_HUMAN Putative protein phosphatase 1 regulatory inhibitor subunit 3G OS=Homo sapiens GN=PPP1R3G PE=4 SV=1 | 280 | P | 0.959487 | Q | 0.952593 | 0.006894 | No Change: Both D | - |
| Q9ULJ8 | NEB1_HUMAN Neurabin-1 OS=Homo sapiens GN=PPP1R9A PE=1 SV=2 | 331 | M | 0.980482 | V | 0.974877 | 0.005605 | No Change: Both D | - |
| Q96SB3 | NEB2_HUMAN Neurabin-2 OS=Homo sapiens GN=PPP1R9B PE=1 SV=2 | 199 | A | 0.550735 | T | 0.571742 | -0.021007 | No Change: Both D | - |
| P67775 | PP2AA_HUMAN Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform OS=Homo sapiens GN=PPP2CA PE=1 SV=1 | 52 | V | 0.182 | A | 0.210001 | -0.028001 | No Change: Both O | - |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 90 | G | 0.220113 | D | 0.233265 | -0.013152 | No Change: Both O | A lung cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 8 | G | 0.725509 | R | 0.693114 | 0.032395 | No Change: Both D | A lung cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 15 | G | 0.714949 | A | 0.674294 | 0.040655 | No Change: Both D | A colorectal cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 65 | P | 0.212976 | S | 0.248834 | -0.035858 | No Change: Both O | A lung cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 101 | L | 0.150699 | P | 0.276716 | -0.126017 | No Change: Both O | A colon adenocarcinoma |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 343 | K | 0.191473 | E | 0.203772 | -0.012299 | No Change: Both O | A lung cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 365 | S | 0.165349 | P | 0.141464 | 0.023885 | No Change: Both O | A colorectal cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 448 | V | 0.174522 | A | 0.250724 | -0.076202 | No Change: Both O | A colon adenocarcinoma |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 498 | V | 0.133101 | E | 0.256227 | -0.123126 | No Change: Both O | A colorectal cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 499 | L | 0.132547 | I | 0.124004 | 0.008543 | No Change: Both O | A colorectal cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 500 | V | 0.148347 | G | 0.225703 | -0.077356 | No Change: Both O | A colorectal cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 504 | D | 0.309148 | G | 0.277568 | 0.03158 | No Change: Both O | A lung cancer patient |
| P30154 | 2AAB_HUMAN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform OS=Homo sapiens GN=PPP2R1B PE=1 SV=3 | 545 | V | 0.207399 | A | 0.277395 | -0.069996 | No Change: Both O | A colon adenocarcinoma |
| Q00005 | 2ABB_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform OS=Homo sapiens GN=PPP2R2B PE=1 SV=1 | 36 | G | 0.321055 | V | 0.222235 | 0.09882 | No Change: Both O | - |
| Q66LE6 | 2ABD_HUMAN Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform OS=Homo sapiens GN=PPP2R2D PE=1 SV=1 | 358 | G | 0.221134 | S | 0.282567 | -0.061433 | No Change: Both O | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 745 | D | 0.342454 | N | 0.32053 | 0.021924 | No Change: Both O | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 67 | D | 0.390934 | G | 0.350153 | 0.040781 | No Change: Both O | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 108 | N | 0.303524 | S | 0.349943 | -0.046419 | No Change: Both O | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 171 | A | 0.668946 | S | 0.792935 | -0.123989 | No Change: Both D | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 481 | P | 0.82632 | A | 0.746562 | 0.079758 | No Change: Both D | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 642 | S | 0.708625 | G | 0.631997 | 0.076628 | No Change: Both D | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 695 | P | 0.848648 | L | 0.760707 | 0.087941 | No Change: Both D | - |
| Q06190 | P2R3A_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha OS=Homo sapiens GN=PPP2R3A PE=1 SV=1 | 67 | D | 0.390934 | N | 0.373886 | 0.017048 | No Change: Both O | - |
| Q9Y5P8 | P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens GN=PPP2R3B PE=1 SV=2 | 163 | D | 0.375957 | E | 0.398938 | -0.022981 | No Change: Both O | - |
| Q9Y5P8 | P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens GN=PPP2R3B PE=1 SV=2 | 519 | A | 0.580036 | V | 0.495484 | 0.084552 | D to O | - |
| Q15257 | PTPA_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4 PE=1 SV=3 | 28 | K | 0.472566 | R | 0.421287 | 0.051279 | No Change: Both O | - |
| Q15257 | PTPA_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4 PE=1 SV=3 | 208 | R | 0.058407 | Q | 0.068639 | -0.010232 | No Change: Both O | - |
| Q15257 | PTPA_HUMAN Serine/threonine-protein phosphatase 2A activator OS=Homo sapiens GN=PPP2R4 PE=1 SV=3 | 357 | S | 0.883116 | L | 0.802728 | 0.080388 | No Change: Both D | - |
| Q13362 | 2A5G_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform OS=Homo sapiens GN=PPP2R5C PE=1 SV=3 | 515 | A | 0.946704 | P | 0.96392 | -0.017216 | No Change: Both D | - |
| P48454 | PP2BC_HUMAN Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform OS=Homo sapiens GN=PPP3CC PE=1 SV=3 | 501 | A | 0.960558 | V | 0.941635 | 0.018923 | No Change: Both D | - |
| Q8TF05 | PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens GN=PPP4R1 PE=1 SV=1 | 43 | E | 0.328313 | K | 0.324094 | 0.004219 | No Change: Both O | - |
| Q8TF05 | PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens GN=PPP4R1 PE=1 SV=1 | 470 | I | 0.700697 | V | 0.691929 | 0.008768 | No Change: Both D | - |
| Q8TF05 | PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens GN=PPP4R1 PE=1 SV=1 | 595 | S | 0.790897 | N | 0.752757 | 0.03814 | No Change: Both D | - |
| Q8TF05 | PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens GN=PPP4R1 PE=1 SV=1 | 593 | S | 0.756005 | N | 0.711399 | 0.044606 | No Change: Both D | - |
| Q9NY27 | PP4R2_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 2 OS=Homo sapiens GN=PPP4R2 PE=1 SV=3 | 282 | S | 0.993466 | C | 0.989325 | 0.004141 | No Change: Both D | - |
| Q9NY27 | PP4R2_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 2 OS=Homo sapiens GN=PPP4R2 PE=1 SV=3 | 174 | P | 0.952604 | L | 0.911398 | 0.041206 | No Change: Both D | - |
| O75170 | PP6R2_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 2 OS=Homo sapiens GN=PPP6R2 PE=1 SV=2 | 633 | D | 0.855126 | E | 0.856252 | -0.001126 | No Change: Both D | - |
| O75170 | PP6R2_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 2 OS=Homo sapiens GN=PPP6R2 PE=1 SV=2 | 732 | R | 0.565393 | K | 0.628816 | -0.063423 | No Change: Both D | - |
| Q5H9R7 | PP6R3_HUMAN Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Homo sapiens GN=PPP6R3 PE=1 SV=2 | 842 | A | 0.989328 | V | 0.983147 | 0.006181 | No Change: Both D | - |
| Q5VV67 | PPRC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 OS=Homo sapiens GN=PPRC1 PE=1 SV=1 | 536 | S | 0.901799 | G | 0.87497 | 0.026829 | No Change: Both D | - |
| Q5VV67 | PPRC1_HUMAN Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 OS=Homo sapiens GN=PPRC1 PE=1 SV=1 | 834 | P | 0.99439 | R | 0.991627 | 0.002763 | No Change: Both D | - |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 39 | H | 0.101054 | Q | 0.112979 | -0.011925 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 42 | G | 0.163772 | E | 0.188867 | -0.025095 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 75 | T | 0.299615 | P | 0.348555 | -0.04894 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 79 | D | 0.300964 | G | 0.289498 | 0.011466 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 109 | Y | 0.425872 | D | 0.604272 | -0.1784 | O to D | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 122 | R | 0.322449 | W | 0.13165 | 0.190799 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 134 | I | 0.376819 | T | 0.477904 | -0.101085 | No Change: Both O | - |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 177 | Q | 0.278229 | E | 0.32701 | -0.048781 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 181 | V | 0.176229 | L | 0.171277 | 0.004952 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 181 | V | 0.176229 | M | 0.207157 | -0.030928 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 219 | L | 0.327806 | Q | 0.456106 | -0.1283 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 247 | Y | 0.201495 | H | 0.299176 | -0.097681 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 250 | G | 0.310111 | V | 0.19087 | 0.119241 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 108 | G | 0.436178 | R | 0.41608 | 0.020098 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 38 | W | 0.088669 | C | 0.12049 | -0.031821 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 45 | C | 0.289099 | Y | 0.312573 | -0.023474 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 138 | S | 0.353768 | L | 0.196012 | 0.157756 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 152 | C | 0.396382 | Y | 0.431733 | -0.035351 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 187 | H | 0.198859 | R | 0.202381 | -0.003522 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 189 | P | 0.300351 | R | 0.274499 | 0.025852 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 222 | L | 0.205643 | P | 0.338915 | -0.133272 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 228 | V | 0.100607 | G | 0.163711 | -0.063104 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 296 | W | 0.125888 | R | 0.259536 | -0.133648 | No Change: Both O | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| P50897 | PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens GN=PPT1 PE=1 SV=1 | 305 | L | 0.491756 | P | 0.705833 | -0.214077 | O to D | Neuronal ceroid lipofuscinosis type 1 (CLN1) [MIM:256730] |
| Q9UMR5 | PPT2_HUMAN Lysosomal thioesterase PPT2 OS=Homo sapiens GN=PPT2 PE=1 SV=4 | 5 | C | 0.370818 | W | 0.341534 | 0.029284 | No Change: Both O | - |
| Q9UMR5 | PPT2_HUMAN Lysosomal thioesterase PPT2 OS=Homo sapiens GN=PPT2 PE=1 SV=4 | 34 | A | 0.429689 | E | 0.528292 | -0.098603 | O to D | - |
| P01298 | PAHO_HUMAN Pancreatic prohormone OS=Homo sapiens GN=PPY PE=1 SV=1 | 78 | E | 0.431286 | G | 0.376062 | 0.055224 | No Change: Both O | - |
| P50391 | NPY4R_HUMAN Neuropeptide Y receptor type 4 OS=Homo sapiens GN=PPYR1 PE=2 SV=1 | 99 | A | 0.035982 | S | 0.060464 | -0.024482 | No Change: Both O | - |
| P50391 | NPY4R_HUMAN Neuropeptide Y receptor type 4 OS=Homo sapiens GN=PPYR1 PE=2 SV=1 | 240 | R | 0.188355 | C | 0.086173 | 0.102182 | No Change: Both O | - |
| O60828 | PQBP1_HUMAN Polyglutamine-binding protein 1 OS=Homo sapiens GN=PQBP1 PE=1 SV=1 | 224 | R | 0.842404 | W | 0.717935 | 0.124469 | No Change: Both D | A colorectal cancer sample |
| Q8N2U9 | PQLC1_HUMAN PQ-loop repeat-containing protein 1 OS=Homo sapiens GN=PQLC1 PE=2 SV=1 | 175 | G | 0.064149 | A | 0.054323 | 0.009826 | No Change: Both O | A colorectal cancer sample |
| Q6ZP29 | PQLC2_HUMAN PQ-loop repeat-containing protein 2 OS=Homo sapiens GN=PQLC2 PE=2 SV=1 | 16 | S | 0.331849 | N | 0.282116 | 0.049733 | No Change: Both O | - |
| Q96KF2 | PRAC_HUMAN Small nuclear protein PRAC OS=Homo sapiens GN=PRAC PE=2 SV=1 | 4 | A | 0.690994 | V | 0.552814 | 0.13818 | No Change: Both D | - |
| O60831 | PRAF2_HUMAN PRA1 family protein 2 OS=Homo sapiens GN=PRAF2 PE=1 SV=1 | 56 | L | 0.035798 | F | 0.030105 | 0.005693 | No Change: Both O | - |
| Q96QH2 | PRAM_HUMAN PML-RARA-regulated adapter molecule 1 OS=Homo sapiens GN=PRAM1 PE=1 SV=2 | 57 | K | 0.990765 | Q | 0.98976 | 0.001005 | No Change: Both D | - |
| Q96QH2 | PRAM_HUMAN PML-RARA-regulated adapter molecule 1 OS=Homo sapiens GN=PRAM1 PE=1 SV=2 | 73 | Q | 0.991264 | P | 0.993432 | -0.002168 | No Change: Both D | - |
| Q96QH2 | PRAM_HUMAN PML-RARA-regulated adapter molecule 1 OS=Homo sapiens GN=PRAM1 PE=1 SV=2 | 76 | F | 0.993957 | V | 0.99384 | 1.17E-04 | No Change: Both D | - |
| Q96QH2 | PRAM_HUMAN PML-RARA-regulated adapter molecule 1 OS=Homo sapiens GN=PRAM1 PE=1 SV=2 | 183 | G | 0.9746 | E | 0.981311 | -0.006711 | No Change: Both D | - |
| P78395 | PRAME_HUMAN Melanoma antigen preferentially expressed in tumors OS=Homo sapiens GN=PRAME PE=1 SV=1 | 7 | W | 0.510703 | R | 0.759736 | -0.249033 | No Change: Both D | - |
| P78395 | PRAME_HUMAN Melanoma antigen preferentially expressed in tumors OS=Homo sapiens GN=PRAME PE=1 SV=1 | 218 | M | 0.179301 | V | 0.120973 | 0.058328 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 252 | Q | 0.408972 | E | 0.466938 | -0.057966 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 302 | Y | 0.190001 | C | 0.148897 | 0.041104 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 316 | Y | 0.298073 | F | 0.249472 | 0.048601 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 375 | R | 0.19244 | C | 0.111259 | 0.081181 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 204 | L | 0.135776 | M | 0.164198 | -0.028422 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 386 | R | 0.119029 | S | 0.161234 | -0.042205 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 218 | P | 0.181464 | S | 0.21455 | -0.033086 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 372 | A | 0.255332 | G | 0.292522 | -0.03719 | No Change: Both O | - |
| O95521 | PRAM1_HUMAN PRAME family member 1 OS=Homo sapiens GN=PRAMEF1 PE=2 SV=2 | 213 | R | 0.274241 | H | 0.253449 | 0.020792 | No Change: Both O | - |
| O60809 | PRA10_HUMAN PRAME family member 10 OS=Homo sapiens GN=PRAMEF10 PE=1 SV=3 | 99 | K | 0.207479 | I | 0.079742 | 0.127737 | No Change: Both O | - |
| O60809 | PRA10_HUMAN PRAME family member 10 OS=Homo sapiens GN=PRAMEF10 PE=1 SV=3 | 144 | H | 0.366474 | R | 0.390283 | -0.023809 | No Change: Both O | - |
| O60809 | PRA10_HUMAN PRAME family member 10 OS=Homo sapiens GN=PRAMEF10 PE=1 SV=3 | 306 | T | 0.240152 | A | 0.231365 | 0.008787 | No Change: Both O | - |
| O60809 | PRA10_HUMAN PRAME family member 10 OS=Homo sapiens GN=PRAMEF10 PE=1 SV=3 | 402 | G | 0.400895 | R | 0.384726 | 0.016169 | No Change: Both O | - |
| O95522 | PRA12_HUMAN PRAME family member 12 OS=Homo sapiens GN=PRAMEF12 PE=2 SV=1 | 53 | T | 0.20055 | K | 0.217158 | -0.016608 | No Change: Both O | - |
| O95522 | PRA12_HUMAN PRAME family member 12 OS=Homo sapiens GN=PRAMEF12 PE=2 SV=1 | 157 | M | 0.157128 | T | 0.186276 | -0.029148 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 67 | V | 0.136485 | G | 0.20559 | -0.069105 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 68 | S | 0.151442 | W | 0.05445 | 0.096992 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 72 | T | 0.248717 | R | 0.264256 | -0.015539 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 128 | A | 0.422658 | T | 0.447398 | -0.02474 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 141 | T | 0.59121 | M | 0.532795 | 0.058415 | No Change: Both D | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 225 | Y | 0.065385 | C | 0.053777 | 0.011608 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 233 | T | 0.119409 | N | 0.141084 | -0.021675 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 301 | T | 0.267525 | A | 0.235957 | 0.031568 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 302 | C | 0.260038 | Y | 0.292344 | -0.032306 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 304 | N | 0.238539 | Y | 0.127627 | 0.110912 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 308 | E | 0.310261 | G | 0.253075 | 0.057186 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 310 | L | 0.318539 | M | 0.34669 | -0.028151 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 316 | F | 0.246468 | Y | 0.288181 | -0.041713 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 375 | C | 0.130596 | R | 0.219023 | -0.088427 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 83 | E | 0.249678 | K | 0.25779 | -0.008112 | No Change: Both O | - |
| O60811 | PRAM2_HUMAN PRAME family member 2 OS=Homo sapiens GN=PRAMEF2 PE=2 SV=2 | 33 | R | 0.220405 | S | 0.269107 | -0.048702 | No Change: Both O | - |
| O60810 | PRAM4_HUMAN PRAME family member 4 OS=Homo sapiens GN=PRAMEF4 PE=2 SV=4 | 85 | D | 0.131448 | E | 0.142062 | -0.010614 | No Change: Both O | - |
| Q6ZN90 | PRAML_HUMAN Leucine-rich repeat-containing protein PRAME-like OS=Homo sapiens GN=PRAMEL PE=2 SV=2 | 7 | R | 0.267357 | Q | 0.285559 | -0.018202 | No Change: Both O | - |
| Q6ZN90 | PRAML_HUMAN Leucine-rich repeat-containing protein PRAME-like OS=Homo sapiens GN=PRAMEL PE=2 SV=2 | 25 | E | 0.285954 | D | 0.271713 | 0.014241 | No Change: Both O | - |
| Q6ZN90 | PRAML_HUMAN Leucine-rich repeat-containing protein PRAME-like OS=Homo sapiens GN=PRAMEL PE=2 SV=2 | 186 | A | 0.309271 | T | 0.315856 | -0.006585 | No Change: Both O | - |
| Q6ZN90 | PRAML_HUMAN Leucine-rich repeat-containing protein PRAME-like OS=Homo sapiens GN=PRAMEL PE=2 SV=2 | 291 | L | 0.072408 | F | 0.063495 | 0.008913 | No Change: Both O | - |
| Q6ZN90 | PRAML_HUMAN Leucine-rich repeat-containing protein PRAME-like OS=Homo sapiens GN=PRAMEL PE=2 SV=2 | 396 | R | 0.230429 | K | 0.285811 | -0.055382 | No Change: Both O | - |
| Q96NZ9 | PRAP1_HUMAN Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1 PE=2 SV=2 | 54 | E | 0.772306 | G | 0.721309 | 0.050997 | No Change: Both D | - |
| Q96NZ9 | PRAP1_HUMAN Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1 PE=2 SV=2 | 69 | K | 0.750162 | R | 0.722476 | 0.027686 | No Change: Both D | - |
| Q96NZ9 | PRAP1_HUMAN Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1 PE=2 SV=2 | 81 | G | 0.782086 | S | 0.783856 | -0.00177 | No Change: Both D | - |
| Q96NZ9 | PRAP1_HUMAN Proline-rich acidic protein 1 OS=Homo sapiens GN=PRAP1 PE=2 SV=2 | 101 | H | 0.823554 | R | 0.844928 | -0.021374 | No Change: Both D | - |
| P02812 | PRB2_HUMAN Basic salivary proline-rich protein 2 OS=Homo sapiens GN=PRB2 PE=1 SV=3 | 274 | S | 0.999993 | P | 0.999995 | -2.00E-06 | No Change: Both D | - |
| P02812 | PRB2_HUMAN Basic salivary proline-rich protein 2 OS=Homo sapiens GN=PRB2 PE=1 SV=3 | 233 | Q | 0.999975 | R | 0.99997 | 5.00E-06 | No Change: Both D | - |
| Q04118 | PRB3_HUMAN Basic salivary proline-rich protein 3 OS=Homo sapiens GN=PRB3 PE=1 SV=2 | 53 | P | 0.999609 | C | 0.999226 | 3.83E-04 | No Change: Both D | - |
| Q04118 | PRB3_HUMAN Basic salivary proline-rich protein 3 OS=Homo sapiens GN=PRB3 PE=1 SV=2 | 186 | P | 0.999982 | Q | 0.999978 | 4.00E-06 | No Change: Both D | - |
| P10163 | PRB4_HUMAN Basic salivary proline-rich protein 4 OS=Homo sapiens GN=PRB4 PE=1 SV=3 | 185 | R | 0.999968 | G | 0.999969 | -1.00E-06 | No Change: Both D | - |
| P10163 | PRB4_HUMAN Basic salivary proline-rich protein 4 OS=Homo sapiens GN=PRB4 PE=1 SV=3 | 186 | P | 0.999969 | R | 0.999958 | 1.10E-05 | No Change: Both D | - |
| P10163 | PRB4_HUMAN Basic salivary proline-rich protein 4 OS=Homo sapiens GN=PRB4 PE=1 SV=3 | 200 | P | 0.999977 | H | 0.999963 | 1.40E-05 | No Change: Both D | - |
| P10163 | PRB4_HUMAN Basic salivary proline-rich protein 4 OS=Homo sapiens GN=PRB4 PE=1 SV=3 | 272 | P | 0.999993 | A | 0.999986 | 7.00E-06 | No Change: Both D | - |
| O43663 | PRC1_HUMAN Protein regulator of cytokinesis 1 OS=Homo sapiens GN=PRC1 PE=1 SV=2 | 187 | A | 0.302083 | E | 0.428858 | -0.126775 | No Change: Both O | - |
| O43663 | PRC1_HUMAN Protein regulator of cytokinesis 1 OS=Homo sapiens GN=PRC1 PE=1 SV=2 | 511 | Y | 0.789677 | C | 0.846578 | -0.056901 | No Change: Both D | - |
| Q92733 | PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens GN=PRCC PE=1 SV=1 | 136 | P | 0.986321 | S | 0.982293 | 0.004028 | No Change: Both D | - |
| Q00LT1 | PRCD_HUMAN Progressive rod-cone degeneration protein OS=Homo sapiens GN=PRCD PE=1 SV=1 | 2 | C | 0.472964 | Y | 0.561018 | -0.088054 | O to D | Retinitis pigmentosa type 36 (RP36) [MIM:610599] |
| Q00LT1 | PRCD_HUMAN Progressive rod-cone degeneration protein OS=Homo sapiens GN=PRCD PE=1 SV=1 | 17 | R | 0.328594 | C | 0.218664 | 0.10993 | No Change: Both O | - |
| Q00LT1 | PRCD_HUMAN Progressive rod-cone degeneration protein OS=Homo sapiens GN=PRCD PE=1 SV=1 | 30 | V | 0.749818 | M | 0.796891 | -0.047073 | No Change: Both D | Retinitis pigmentosa type 36 (RP36) [MIM:610599] |
| P42785 | PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens GN=PRCP PE=1 SV=1 | 112 | E | 0.169673 | D | 0.152213 | 0.01746 | No Change: Both O | - |
| P42785 | PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens GN=PRCP PE=1 SV=1 | 444 | T | 0.198459 | S | 0.246847 | -0.048388 | No Change: Both O | - |
| O75626 | PRDM1_HUMAN PR domain zinc finger protein 1 OS=Homo sapiens GN=PRDM1 PE=1 SV=2 | 74 | G | 0.62219 | S | 0.653045 | -0.030855 | No Change: Both D | - |
| O75626 | PRDM1_HUMAN PR domain zinc finger protein 1 OS=Homo sapiens GN=PRDM1 PE=1 SV=2 | 203 | D | 0.063141 | E | 0.079782 | -0.016641 | No Change: Both O | - |
| Q9NQV6 | PRD10_HUMAN PR domain zinc finger protein 10 OS=Homo sapiens GN=PRDM10 PE=1 SV=2 | 573 | T | 0.604902 | A | 0.546513 | 0.058389 | No Change: Both D | - |
| Q9NQV6 | PRD10_HUMAN PR domain zinc finger protein 10 OS=Homo sapiens GN=PRDM10 PE=1 SV=2 | 22 | A | 0.512862 | T | 0.542886 | -0.030024 | No Change: Both D | - |
| Q9GZV8 | PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens GN=PRDM14 PE=2 SV=1 | 244 | K | 0.708829 | E | 0.731777 | -0.022948 | No Change: Both D | - |
| P57071 | PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens GN=PRDM15 PE=2 SV=4 | 1342 | V | 0.676713 | I | 0.629143 | 0.04757 | No Change: Both D | - |
| P57071 | PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens GN=PRDM15 PE=2 SV=4 | 1376 | T | 0.409865 | S | 0.439046 | -0.029181 | No Change: Both O | - |
| P57071 | PRD15_HUMAN PR domain zinc finger protein 15 OS=Homo sapiens GN=PRDM15 PE=2 SV=4 | 1481 | S | 0.968497 | P | 0.97318 | -0.004683 | No Change: Both D | - |
| Q9HAZ2 | PRD16_HUMAN PR domain zinc finger protein 16 OS=Homo sapiens GN=PRDM16 PE=1 SV=3 | 533 | S | 0.943079 | P | 0.952557 | -0.009478 | No Change: Both D | - |
| Q9HAZ2 | PRD16_HUMAN PR domain zinc finger protein 16 OS=Homo sapiens GN=PRDM16 PE=1 SV=3 | 633 | P | 0.987981 | L | 0.979031 | 0.00895 | No Change: Both D | - |
| Q13029 | PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens GN=PRDM2 PE=1 SV=3 | 283 | D | 0.999842 | E | 0.999867 | -2.50E-05 | No Change: Both D | - |
| Q13029 | PRDM2_HUMAN PR domain zinc finger protein 2 OS=Homo sapiens GN=PRDM2 PE=1 SV=3 | 450 | S | 0.938942 | N | 0.922635 | 0.016307 | No Change: Both D | - |
| Q9NQX1 | PRDM5_HUMAN PR domain zinc finger protein 5 OS=Homo sapiens GN=PRDM5 PE=1 SV=2 | 107 | Y | 0.129195 | C | 0.133546 | -0.004351 | No Change: Both O | Brittle cornea syndrome type 2 (BCS2) [MIM:614170] |
| Q9NQW5 | PRDM7_HUMAN Probable histone-lysine N-methyltransferase PRDM7 OS=Homo sapiens GN=PRDM7 PE=2 SV=2 | 90 | D | 0.674752 | E | 0.685934 | -0.011182 | No Change: Both D | - |
| Q9NQW5 | PRDM7_HUMAN Probable histone-lysine N-methyltransferase PRDM7 OS=Homo sapiens GN=PRDM7 PE=2 SV=2 | 131 | R | 0.935338 | K | 0.945864 | -0.010526 | No Change: Both D | - |
| Q9NQW5 | PRDM7_HUMAN Probable histone-lysine N-methyltransferase PRDM7 OS=Homo sapiens GN=PRDM7 PE=2 SV=2 | 435 | N | 0.163396 | K | 0.174432 | -0.011036 | No Change: Both O | - |
| Q9NQV7 | PRDM9_HUMAN Histone-lysine N-methyltransferase PRDM9 OS=Homo sapiens GN=PRDM9 PE=2 SV=2 | 335 | Y | 0.079737 | H | 0.138169 | -0.058432 | No Change: Both O | - |
| Q06830 | PRDX1_HUMAN Peroxiredoxin-1 OS=Homo sapiens GN=PRDX1 PE=1 SV=1 | 62 | R | 0.36097 | G | 0.37538 | -0.01441 | No Change: Both O | - |
| P32119 | PRDX2_HUMAN Peroxiredoxin-2 OS=Homo sapiens GN=PRDX2 PE=1 SV=5 | 153 | D | 0.333279 | E | 0.370149 | -0.03687 | No Change: Both O | - |
| P30048 | PRDX3_HUMAN Thioredoxin-dependent peroxide reductase mitochondrial OS=Homo sapiens GN=PRDX3 PE=1 SV=3 | 55 | S | 0.684028 | R | 0.607679 | 0.076349 | No Change: Both D | - |
| P30048 | PRDX3_HUMAN Thioredoxin-dependent peroxide reductase mitochondrial OS=Homo sapiens GN=PRDX3 PE=1 SV=3 | 218 | A | 0.160483 | T | 0.195178 | -0.034695 | No Change: Both O | - |
| P30048 | PRDX3_HUMAN Thioredoxin-dependent peroxide reductase mitochondrial OS=Homo sapiens GN=PRDX3 PE=1 SV=3 | 234 | T | 0.423025 | I | 0.287255 | 0.13577 | No Change: Both O | - |
| P30048 | PRDX3_HUMAN Thioredoxin-dependent peroxide reductase mitochondrial OS=Homo sapiens GN=PRDX3 PE=1 SV=3 | 170 | R | 0.280126 | Q | 0.31544 | -0.035314 | No Change: Both O | - |
| P30044 | PRDX5_HUMAN Peroxiredoxin-5 mitochondrial OS=Homo sapiens GN=PRDX5 PE=1 SV=4 | 33 | Y | 0.62509 | C | 0.637668 | -0.012578 | No Change: Both D | - |
| P30044 | PRDX5_HUMAN Peroxiredoxin-5 mitochondrial OS=Homo sapiens GN=PRDX5 PE=1 SV=4 | 157 | F | 0.402557 | L | 0.45789 | -0.055333 | No Change: Both O | A breast cancer sample |
| Q8N945 | PRLD2_HUMAN PRELI domain-containing protein 2 OS=Homo sapiens GN=PRELID2 PE=2 SV=1 | 99 | N | 0.46399 | S | 0.503644 | -0.039654 | O to D | - |
| P51888 | PRELP_HUMAN Prolargin OS=Homo sapiens GN=PRELP PE=1 SV=1 | 348 | N | 0.417431 | H | 0.422369 | -0.004938 | No Change: Both O | - |
| P51888 | PRELP_HUMAN Prolargin OS=Homo sapiens GN=PRELP PE=1 SV=1 | 157 | M | 0.253675 | V | 0.219394 | 0.034281 | No Change: Both O | - |
| P51888 | PRELP_HUMAN Prolargin OS=Homo sapiens GN=PRELP PE=1 SV=1 | 334 | N | 0.138594 | S | 0.158023 | -0.019429 | No Change: Both O | - |
| P51888 | PRELP_HUMAN Prolargin OS=Homo sapiens GN=PRELP PE=1 SV=1 | 33 | G | 0.991741 | R | 0.993788 | -0.002047 | No Change: Both D | - |
| P48147 | PPCE_HUMAN Prolyl endopeptidase OS=Homo sapiens GN=PREP PE=1 SV=2 | 351 | L | 0.02906 | V | 0.029507 | -4.47E-04 | No Change: Both O | - |
| P48147 | PPCE_HUMAN Prolyl endopeptidase OS=Homo sapiens GN=PREP PE=1 SV=2 | 706 | V | 0.152769 | I | 0.144148 | 0.008621 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 1240 | V | 0.330156 | I | 0.322619 | 0.007537 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 1340 | K | 0.123606 | E | 0.127557 | -0.003951 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 1559 | S | 0.43954 | T | 0.358025 | 0.081515 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 696 | R | 0.234661 | C | 0.129383 | 0.105278 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 1118 | A | 0.737499 | T | 0.759761 | -0.022262 | No Change: Both D | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 659 | V | 0.307362 | M | 0.347498 | -0.040136 | No Change: Both O | - |
| Q8TCU6 | PREX1_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 1 protein OS=Homo sapiens GN=PREX1 PE=1 SV=3 | 786 | Q | 0.38237 | H | 0.340974 | 0.041396 | No Change: Both O | - |
| Q70Z35 | PREX2_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 2 protein OS=Homo sapiens GN=PREX2 PE=2 SV=1 | 312 | D | 0.55848 | N | 0.535592 | 0.022888 | No Change: Both D | - |
| Q70Z35 | PREX2_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 2 protein OS=Homo sapiens GN=PREX2 PE=2 SV=1 | 537 | V | 0.082707 | I | 0.077304 | 0.005403 | No Change: Both O | A colorectal cancer sample |
| Q70Z35 | PREX2_HUMAN Phosphatidylinositol 3 4 5-trisphosphate-dependent Rac exchanger 2 protein OS=Homo sapiens GN=PREX2 PE=2 SV=1 | 1571 | A | 0.544401 | E | 0.587079 | -0.042678 | No Change: Both D | A colorectal cancer sample |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 183 | V | 0.220747 | G | 0.304829 | -0.084082 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 225 | R | 0.138127 | W | 0.054104 | 0.084023 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 252 | N | 0.387048 | S | 0.43056 | -0.043512 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 279 | C | 0.741142 | Y | 0.731131 | 0.010011 | No Change: Both D | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 345 | P | 0.264232 | L | 0.157113 | 0.107119 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 429 | G | 0.039058 | E | 0.046618 | -0.00756 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 50 | V | 0.446987 | M | 0.487393 | -0.040406 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 123 | R | 0.467949 | H | 0.415581 | 0.052368 | No Change: Both O | - |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 224 | I | 0.112179 | N | 0.228093 | -0.115914 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 2 (FHL2) [MIM:603553] |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 135 | V | 0.480168 | M | 0.507461 | -0.027293 | O to D | - |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 91 | A | 0.365446 | V | 0.280397 | 0.085049 | No Change: Both O | - |
| P14222 | PERF_HUMAN Perforin-1 OS=Homo sapiens GN=PRF1 PE=1 SV=1 | 4 | R | 0.396013 | H | 0.387076 | 0.008937 | No Change: Both O | - |
| P13727 | PRG2_HUMAN Bone marrow proteoglycan OS=Homo sapiens GN=PRG2 PE=1 SV=2 | 179 | R | 0.084508 | C | 0.039837 | 0.044671 | No Change: Both O | A colorectal cancer sample |
| P13727 | PRG2_HUMAN Bone marrow proteoglycan OS=Homo sapiens GN=PRG2 PE=1 SV=2 | 206 | H | 0.20992 | Y | 0.120333 | 0.089587 | No Change: Both O | - |
| Q9Y2Y8 | PRG3_HUMAN Proteoglycan 3 OS=Homo sapiens GN=PRG3 PE=1 SV=2 | 3 | C | 0.317952 | R | 0.484398 | -0.166446 | No Change: Both O | - |
| Q9Y2Y8 | PRG3_HUMAN Proteoglycan 3 OS=Homo sapiens GN=PRG3 PE=1 SV=2 | 109 | I | 0.168586 | T | 0.27024 | -0.101654 | No Change: Both O | - |
| Q92954 | PRG4_HUMAN Proteoglycan 4 OS=Homo sapiens GN=PRG4 PE=1 SV=2 | 180 | R | 0.998838 | W | 0.99719 | 0.001648 | No Change: Both D | - |
| Q92954 | PRG4_HUMAN Proteoglycan 4 OS=Homo sapiens GN=PRG4 PE=1 SV=2 | 1130 | N | 0.325277 | S | 0.341561 | -0.016284 | No Change: Both O | - |
| Q92954 | PRG4_HUMAN Proteoglycan 4 OS=Homo sapiens GN=PRG4 PE=1 SV=2 | 1272 | I | 0.326044 | T | 0.446222 | -0.120178 | No Change: Both O | - |
| Q92954 | PRG4_HUMAN Proteoglycan 4 OS=Homo sapiens GN=PRG4 PE=1 SV=2 | 1296 | T | 0.527609 | M | 0.466958 | 0.060651 | D to O | - |
| P02810 | PRPC_HUMAN Salivary acidic proline-rich phosphoprotein 1/2 OS=Homo sapiens GN=PRH1 PE=1 SV=2 | 20 | D | 0.660267 | N | 0.612595 | 0.047672 | No Change: Both D | - |
| P02810 | PRPC_HUMAN Salivary acidic proline-rich phosphoprotein 1/2 OS=Homo sapiens GN=PRH1 PE=1 SV=2 | 66 | D | 0.999084 | N | 0.998878 | 2.06E-04 | No Change: Both D | - |
| P02810 | PRPC_HUMAN Salivary acidic proline-rich phosphoprotein 1/2 OS=Homo sapiens GN=PRH1 PE=1 SV=2 | 163 | Q | 0.999997 | K | 0.999996 | 1.00E-06 | No Change: Both D | - |
| P02810 | PRPC_HUMAN Salivary acidic proline-rich phosphoprotein 1/2 OS=Homo sapiens GN=PRH1 PE=1 SV=2 | 42 | I | 0.950995 | L | 0.959026 | -0.008031 | No Change: Both D | - |
| P02810 | PRPC_HUMAN Salivary acidic proline-rich phosphoprotein 1/2 OS=Homo sapiens GN=PRH1 PE=1 SV=2 | 119 | R | 0.999994 | C | 0.999991 | 3.00E-06 | No Change: Both D | - |
| A6NGE7 | URAD_HUMAN Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Homo sapiens GN=PRHOXNB PE=5 SV=2 | 57 | Q | 0.316368 | P | 0.32173 | -0.005362 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 788 | S | 0.510425 | N | 0.456525 | 0.0539 | D to O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1123 | H | 0.558051 | R | 0.623543 | -0.065492 | No Change: Both D | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 2016 | P | 0.466704 | L | 0.302426 | 0.164278 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 2049 | Q | 0.587733 | E | 0.598327 | -0.010594 | No Change: Both D | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1152 | S | 0.520886 | L | 0.344494 | 0.176392 | D to O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1308 | V | 0.362929 | L | 0.383234 | -0.020305 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1381 | R | 0.278066 | K | 0.297403 | -0.019337 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1821 | L | 0.359277 | R | 0.469803 | -0.110526 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 1889 | T | 0.350306 | A | 0.311094 | 0.039212 | No Change: Both O | - |
| Q9BYK8 | PR285_HUMAN Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein OS=Homo sapiens GN=PRIC285 PE=1 SV=6 | 2170 | T | 0.281879 | M | 0.236951 | 0.044928 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 104 | R | 0.601621 | Q | 0.625964 | -0.024343 | No Change: Both D | Progressive myoclonic epilepsy type 1B (EPM1B) [MIM:612437] |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 746 | P | 0.433764 | S | 0.477334 | -0.04357 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 144 | R | 0.237752 | H | 0.247136 | -0.009384 | No Change: Both O | Progressive myoclonic epilepsy type 1B (EPM1B) [MIM:612437] |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 472 | Y | 0.705678 | H | 0.790245 | -0.084567 | No Change: Both D | Progressive myoclonic epilepsy type 1B (EPM1B) [MIM:612437] |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 69 | I | 0.511978 | T | 0.607998 | -0.09602 | No Change: Both D | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 81 | N | 0.647708 | H | 0.654206 | -0.006498 | No Change: Both D | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 121 | V | 0.162211 | I | 0.142217 | 0.019994 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 124 | A | 0.130716 | T | 0.133389 | -0.002673 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 275 | T | 0.207571 | M | 0.177116 | 0.030455 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 682 | R | 0.954279 | C | 0.918707 | 0.035572 | No Change: Both D | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 739 | S | 0.411903 | F | 0.22292 | 0.188983 | No Change: Both O | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 771 | D | 0.938117 | N | 0.925227 | 0.01289 | No Change: Both D | - |
| Q96MT3 | PRIC1_HUMAN Prickle-like protein 1 OS=Homo sapiens GN=PRICKLE1 PE=1 SV=2 | 799 | S | 0.915013 | C | 0.85838 | 0.056633 | No Change: Both D | - |
| Q7Z3G6 | PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens GN=PRICKLE2 PE=1 SV=2 | 148 | R | 0.20089 | H | 0.218822 | -0.017932 | No Change: Both O | Progressive myoclonic epilepsy type 5 (EPM5) [MIM:613832] |
| Q7Z3G6 | PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens GN=PRICKLE2 PE=1 SV=2 | 153 | V | 0.129803 | I | 0.109573 | 0.02023 | No Change: Both O | Progressive myoclonic epilepsy type 5 (EPM5) [MIM:613832] |
| Q7Z3G6 | PRIC2_HUMAN Prickle-like protein 2 OS=Homo sapiens GN=PRICKLE2 PE=1 SV=2 | 605 | V | 0.824802 | F | 0.836482 | -0.01168 | No Change: Both D | Progressive myoclonic epilepsy type 5 (EPM5) [MIM:613832] |
| O43900 | PRIC3_HUMAN Prickle-like protein 3 OS=Homo sapiens GN=PRICKLE3 PE=1 SV=2 | 558 | E | 0.981831 | D | 0.980956 | 8.75E-04 | No Change: Both D | A breast cancer sample |
| O43900 | PRIC3_HUMAN Prickle-like protein 3 OS=Homo sapiens GN=PRICKLE3 PE=1 SV=2 | 343 | R | 0.340659 | C | 0.277351 | 0.063308 | No Change: Both O | - |
| Q2TBC4 | PRIC4_HUMAN Prickle-like protein 4 OS=Homo sapiens GN=PRICKLE4 PE=2 SV=2 | 266 | S | 0.973651 | R | 0.970847 | 0.002804 | No Change: Both D | - |
| P49642 | PRI1_HUMAN DNA primase small subunit OS=Homo sapiens GN=PRIM1 PE=1 SV=1 | 5 | D | 0.822306 | A | 0.766893 | 0.055413 | No Change: Both D | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 265 | Q | 0.520261 | L | 0.39057 | 0.129691 | D to O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 181 | E | 0.214921 | K | 0.227398 | -0.012477 | No Change: Both O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 204 | D | 0.159738 | G | 0.153069 | 0.006669 | No Change: Both O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 259 | G | 0.640664 | S | 0.6972 | -0.056536 | No Change: Both D | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 287 | C | 0.369422 | Y | 0.406345 | -0.036923 | No Change: Both O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 435 | D | 0.202087 | G | 0.183569 | 0.018518 | No Change: Both O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 446 | Q | 0.360881 | H | 0.330513 | 0.030368 | No Change: Both O | - |
| P49643 | PRI2_HUMAN DNA primase large subunit OS=Homo sapiens GN=PRIM2 PE=1 SV=2 | 465 | P | 0.883307 | S | 0.876738 | 0.006569 | No Change: Both D | - |
| Q86XR5 | PRIMA_HUMAN Proline-rich membrane anchor 1 OS=Homo sapiens GN=PRIMA1 PE=2 SV=2 | 22 | A | 0.066431 | V | 0.057327 | 0.009104 | No Change: Both O | A colorectal cancer sample |
| Q13131 | AAPK1_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1 PE=1 SV=4 | 16 | Q | 0.642189 | R | 0.643954 | -0.001765 | No Change: Both D | A breast cancer sample |
| Q13131 | AAPK1_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-1 OS=Homo sapiens GN=PRKAA1 PE=1 SV=4 | 10 | M | 0.543365 | L | 0.483718 | 0.059647 | D to O | - |
| P54646 | AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2 | 371 | P | 0.9109 | T | 0.868145 | 0.042755 | No Change: Both D | Breast cancer samples |
| P54646 | AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2 | 523 | S | 0.878558 | G | 0.842883 | 0.035675 | No Change: Both D | A breast cancer sample |
| P54646 | AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2 | 407 | R | 0.368759 | Q | 0.40255 | -0.033791 | No Change: Both O | A gastric adenocarcinoma sample |
| P17612 | KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens GN=PRKACA PE=1 SV=2 | 41 | L | 0.371213 | V | 0.362469 | 0.008744 | No Change: Both O | - |
| P17612 | KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens GN=PRKACA PE=1 SV=2 | 46 | R | 0.33187 | Q | 0.367603 | -0.035733 | No Change: Both O | - |
| P17612 | KAPCA_HUMAN cAMP-dependent protein kinase catalytic subunit alpha OS=Homo sapiens GN=PRKACA PE=1 SV=2 | 264 | S | 0.503103 | C | 0.25752 | 0.245583 | D to O | - |
| P22694 | KAPCB_HUMAN cAMP-dependent protein kinase catalytic subunit beta OS=Homo sapiens GN=PRKACB PE=1 SV=2 | 106 | R | 0.066974 | Q | 0.073462 | -0.006488 | No Change: Both O | - |
| P22612 | KAPCG_HUMAN cAMP-dependent protein kinase catalytic subunit gamma OS=Homo sapiens GN=PRKACG PE=1 SV=3 | 268 | H | 0.464018 | D | 0.524582 | -0.060564 | O to D | - |
| P22612 | KAPCG_HUMAN cAMP-dependent protein kinase catalytic subunit gamma OS=Homo sapiens GN=PRKACG PE=1 SV=3 | 251 | I | 0.216224 | N | 0.369167 | -0.152943 | No Change: Both O | - |
| P54619 | AAKG1_HUMAN 5'-AMP-activated protein kinase subunit gamma-1 OS=Homo sapiens GN=PRKAG1 PE=1 SV=1 | 89 | T | 0.058758 | S | 0.081049 | -0.022291 | No Change: Both O | - |
| P54619 | AAKG1_HUMAN 5'-AMP-activated protein kinase subunit gamma-1 OS=Homo sapiens GN=PRKAG1 PE=1 SV=1 | 329 | K | 0.856141 | N | 0.872249 | -0.016108 | No Change: Both D | - |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 302 | R | 0.152192 | Q | 0.16518 | -0.012988 | No Change: Both O | Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome (CMH-WPWS) [MIM:600858] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 302 | R | 0.152192 | Q | 0.16518 | -0.012988 | No Change: Both O | Wolff-Parkinson-White syndrome (WPWS) [MIM:194200] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 383 | H | 0.177084 | R | 0.186571 | -0.009487 | No Change: Both O | Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome (CMH-WPWS) [MIM:600858] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 400 | T | 0.084295 | N | 0.107611 | -0.023316 | No Change: Both O | Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome (CMH-WPWS) [MIM:600858] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 488 | N | 0.276519 | I | 0.138923 | 0.137596 | No Change: Both O | Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome (CMH-WPWS) [MIM:600858] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 531 | R | 0.149002 | Q | 0.149707 | -7.05E-04 | No Change: Both O | Glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 531 | R | 0.149002 | G | 0.145899 | 0.003103 | No Change: Both O | Wolff-Parkinson-White syndrome (WPWS) [MIM:194200] |
| Q9UGJ0 | AAKG2_HUMAN 5'-AMP-activated protein kinase subunit gamma-2 OS=Homo sapiens GN=PRKAG2 PE=1 SV=1 | 6 | M | 0.984919 | L | 0.975248 | 0.009671 | No Change: Both D | - |
| Q9UGI9 | AAKG3_HUMAN 5'-AMP-activated protein kinase subunit gamma-3 OS=Homo sapiens GN=PRKAG3 PE=1 SV=3 | 71 | P | 0.978204 | A | 0.968911 | 0.009293 | No Change: Both D | - |
| Q9UGI9 | AAKG3_HUMAN 5'-AMP-activated protein kinase subunit gamma-3 OS=Homo sapiens GN=PRKAG3 PE=1 SV=3 | 153 | L | 0.644209 | V | 0.578732 | 0.065477 | No Change: Both D | - |
| Q9UGI9 | AAKG3_HUMAN 5'-AMP-activated protein kinase subunit gamma-3 OS=Homo sapiens GN=PRKAG3 PE=1 SV=3 | 340 | R | 0.231324 | W | 0.094055 | 0.137269 | No Change: Both O | - |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 9 | S | 0.780212 | N | 0.749163 | 0.031049 | No Change: Both D | Carney complex type 1 (CNC1) [MIM:160980] |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 74 | R | 0.900907 | C | 0.83064 | 0.070267 | No Change: Both D | Carney complex type 1 (CNC1) [MIM:160980] |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 146 | R | 0.554846 | S | 0.62426 | -0.069414 | No Change: Both D | Carney complex type 1 (CNC1) [MIM:160980] |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 183 | D | 0.24328 | Y | 0.134335 | 0.108945 | No Change: Both O | Carney complex type 1 (CNC1) [MIM:160980] |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 213 | A | 0.356607 | D | 0.417141 | -0.060534 | No Change: Both O | Carney complex type 1 (CNC1) [MIM:160980] |
| P10644 | KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens GN=PRKAR1A PE=1 SV=1 | 289 | G | 0.302394 | W | 0.131953 | 0.170441 | No Change: Both O | Carney complex type 1 (CNC1) [MIM:160980] |
| P31323 | KAP3_HUMAN cAMP-dependent protein kinase type II-beta regulatory subunit OS=Homo sapiens GN=PRKAR2B PE=1 SV=3 | 335 | E | 0.605337 | D | 0.549933 | 0.055404 | No Change: Both D | - |
| P17252 | KPCA_HUMAN Protein kinase C alpha type OS=Homo sapiens GN=PRKCA PE=1 SV=4 | 98 | P | 0.809672 | S | 0.817072 | -0.0074 | No Change: Both D | A colorectal adenocarcinoma sample |
| P17252 | KPCA_HUMAN Protein kinase C alpha type OS=Homo sapiens GN=PRKCA PE=1 SV=4 | 467 | D | 0.267254 | N | 0.248054 | 0.0192 | No Change: Both O | A glioblastoma multiforme sample |
| P17252 | KPCA_HUMAN Protein kinase C alpha type OS=Homo sapiens GN=PRKCA PE=1 SV=4 | 489 | M | 0.391019 | V | 0.317479 | 0.07354 | No Change: Both O | - |
| P17252 | KPCA_HUMAN Protein kinase C alpha type OS=Homo sapiens GN=PRKCA PE=1 SV=4 | 568 | V | 0.500402 | I | 0.449427 | 0.050975 | D to O | - |
| P05771 | KPCB_HUMAN Protein kinase C beta type OS=Homo sapiens GN=PRKCB PE=1 SV=4 | 144 | V | 0.196047 | M | 0.256363 | -0.060316 | No Change: Both O | A colorectal adenocarcinoma sample |
| P05771 | KPCB_HUMAN Protein kinase C beta type OS=Homo sapiens GN=PRKCB PE=1 SV=4 | 496 | V | 0.146439 | M | 0.191624 | -0.045185 | No Change: Both O | A glioblastoma multiforme sample |
| P05771 | KPCB_HUMAN Protein kinase C beta type OS=Homo sapiens GN=PRKCB PE=1 SV=4 | 588 | P | 0.600898 | H | 0.564752 | 0.036146 | No Change: Both D | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 375 | F | 0.206908 | S | 0.423887 | -0.216979 | No Change: Both O | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 593 | V | 0.396175 | M | 0.481089 | -0.084914 | No Change: Both O | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 494 | M | 0.149632 | V | 0.114861 | 0.034771 | No Change: Both O | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 348 | N | 0.169724 | S | 0.196805 | -0.027081 | No Change: Both O | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 410 | L | 0.092977 | F | 0.081193 | 0.011784 | No Change: Both O | - |
| Q05655 | KPCD_HUMAN Protein kinase C delta type OS=Homo sapiens GN=PRKCD PE=1 SV=2 | 483 | R | 0.241704 | W | 0.107341 | 0.134363 | No Change: Both O | - |
| Q969G5 | PRDBP_HUMAN Protein kinase C delta-binding protein OS=Homo sapiens GN=PRKCDBP PE=1 SV=3 | 8 | R | 0.77669 | P | 0.817141 | -0.040451 | No Change: Both D | - |
| Q969G5 | PRDBP_HUMAN Protein kinase C delta-binding protein OS=Homo sapiens GN=PRKCDBP PE=1 SV=3 | 104 | A | 0.5945 | T | 0.567971 | 0.026529 | No Change: Both D | - |
| Q969G5 | PRDBP_HUMAN Protein kinase C delta-binding protein OS=Homo sapiens GN=PRKCDBP PE=1 SV=3 | 158 | L | 0.980357 | P | 0.98873 | -0.008373 | No Change: Both D | - |
| Q969G5 | PRDBP_HUMAN Protein kinase C delta-binding protein OS=Homo sapiens GN=PRKCDBP PE=1 SV=3 | 255 | L | 0.970285 | F | 0.958614 | 0.011671 | No Change: Both D | - |
| Q02156 | KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens GN=PRKCE PE=1 SV=1 | 143 | E | 0.785795 | K | 0.772959 | 0.012836 | No Change: Both D | A colorectal cancer sample |
| Q02156 | KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens GN=PRKCE PE=1 SV=1 | 333 | A | 0.966805 | V | 0.956193 | 0.010612 | No Change: Both D | - |
| Q02156 | KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens GN=PRKCE PE=1 SV=1 | 389 | P | 0.789922 | R | 0.785209 | 0.004713 | No Change: Both D | - |
| Q02156 | KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens GN=PRKCE PE=1 SV=1 | 563 | T | 0.170786 | M | 0.125823 | 0.044963 | No Change: Both O | - |
| Q02156 | KPCE_HUMAN Protein kinase C epsilon type OS=Homo sapiens GN=PRKCE PE=1 SV=1 | 654 | A | 0.331047 | T | 0.35108 | -0.020033 | No Change: Both O | - |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 141 | R | 0.369093 | C | 0.268321 | 0.100772 | No Change: Both O | - |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 415 | H | 0.48879 | Q | 0.509232 | -0.020442 | O to D | - |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 523 | A | 0.151325 | D | 0.210845 | -0.05952 | No Change: Both O | - |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 659 | R | 0.439393 | S | 0.465102 | -0.025709 | No Change: Both O | - |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 101 | H | 0.69363 | Y | 0.584532 | 0.109098 | No Change: Both D | Spinocerebellar ataxia type 14 (SCA14) [MIM:605361] |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 119 | S | 0.369334 | P | 0.363968 | 0.005366 | No Change: Both O | Spinocerebellar ataxia type 14 (SCA14) [MIM:605361] |
| P05129 | KPCG_HUMAN Protein kinase C gamma type OS=Homo sapiens GN=PRKCG PE=1 SV=3 | 128 | G | 0.364167 | D | 0.386402 | -0.022235 | No Change: Both O | Spinocerebellar ataxia type 14 (SCA14) [MIM:605361] |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 374 | V | 0.261779 | I | 0.220882 | 0.040897 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 19 | A | 0.210489 | V | 0.168332 | 0.042157 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 65 | K | 0.632885 | R | 0.59153 | 0.041355 | No Change: Both D | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 149 | R | 0.305856 | Q | 0.316981 | -0.011125 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 359 | R | 0.221238 | Q | 0.211885 | 0.009353 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 575 | T | 0.122168 | A | 0.10927 | 0.012898 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 594 | T | 0.515375 | I | 0.338877 | 0.176498 | D to O | A colorectal adenocarcinoma sample |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 612 | P | 0.222808 | S | 0.221309 | 0.001499 | No Change: Both O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 645 | D | 0.656899 | V | 0.496028 | 0.160871 | D to O | - |
| P24723 | KPCL_HUMAN Protein kinase C eta type OS=Homo sapiens GN=PRKCH PE=1 SV=4 | 497 | D | 0.225085 | Y | 0.117718 | 0.107367 | No Change: Both O | - |
| P41743 | KPCI_HUMAN Protein kinase C iota type OS=Homo sapiens GN=PRKCI PE=1 SV=2 | 118 | P | 0.607024 | L | 0.426449 | 0.180575 | D to O | A metastatic melanoma sample |
| P41743 | KPCI_HUMAN Protein kinase C iota type OS=Homo sapiens GN=PRKCI PE=1 SV=2 | 130 | R | 0.280655 | C | 0.169261 | 0.111394 | No Change: Both O | - |
| Q04759 | KPCT_HUMAN Protein kinase C theta type OS=Homo sapiens GN=PRKCQ PE=1 SV=3 | 330 | P | 0.799429 | L | 0.647065 | 0.152364 | No Change: Both D | - |
| Q04759 | KPCT_HUMAN Protein kinase C theta type OS=Homo sapiens GN=PRKCQ PE=1 SV=3 | 240 | K | 0.274306 | N | 0.238963 | 0.035343 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q04759 | KPCT_HUMAN Protein kinase C theta type OS=Homo sapiens GN=PRKCQ PE=1 SV=3 | 306 | D | 0.4442 | V | 0.338789 | 0.105411 | No Change: Both O | - |
| Q04759 | KPCT_HUMAN Protein kinase C theta type OS=Homo sapiens GN=PRKCQ PE=1 SV=3 | 354 | D | 0.819789 | N | 0.804497 | 0.015292 | No Change: Both D | - |
| P14314 | GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSH PE=1 SV=2 | 74 | S | 0.493288 | N | 0.478062 | 0.015226 | No Change: Both O | - |
| P14314 | GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSH PE=1 SV=2 | 291 | A | 0.865126 | T | 0.874101 | -0.008975 | No Change: Both D | - |
| P14314 | GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens GN=PRKCSH PE=1 SV=2 | 338 | A | 0.999534 | G | 0.999394 | 1.40E-04 | No Change: Both D | - |
| Q05513 | KPCZ_HUMAN Protein kinase C zeta type OS=Homo sapiens GN=PRKCZ PE=1 SV=4 | 514 | S | 0.372759 | F | 0.211555 | 0.161204 | No Change: Both O | A colorectal cancer sample |
| Q05513 | KPCZ_HUMAN Protein kinase C zeta type OS=Homo sapiens GN=PRKCZ PE=1 SV=4 | 84 | R | 0.409509 | H | 0.360905 | 0.048604 | No Change: Both O | - |
| Q05513 | KPCZ_HUMAN Protein kinase C zeta type OS=Homo sapiens GN=PRKCZ PE=1 SV=4 | 519 | R | 0.249087 | C | 0.170428 | 0.078659 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q05513 | KPCZ_HUMAN Protein kinase C zeta type OS=Homo sapiens GN=PRKCZ PE=1 SV=4 | 49 | R | 0.305526 | H | 0.30564 | -1.14E-04 | No Change: Both O | - |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 152 | H | 0.162922 | Y | 0.098605 | 0.064317 | No Change: Both O | A colorectal cancer sample |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 857 | E | 0.310804 | K | 0.302263 | 0.008541 | No Change: Both O | A colorectal cancer sample |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 225 | S | 0.920703 | P | 0.914819 | 0.005884 | No Change: Both D | - |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 478 | K | 0.379839 | Q | 0.331431 | 0.048408 | No Change: Both O | - |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 585 | P | 0.188304 | S | 0.223631 | -0.035327 | No Change: Both O | A metastatic melanoma sample |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 677 | R | 0.590025 | M | 0.535546 | 0.054479 | No Change: Both D | A lung bronchoalveolar carcinoma sample |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 679 | P | 0.44523 | L | 0.310574 | 0.134656 | No Change: Both O | - |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 891 | H | 0.754493 | R | 0.767317 | -0.012824 | No Change: Both D | - |
| Q15139 | KPCD1_HUMAN Serine/threonine-protein kinase D1 OS=Homo sapiens GN=PRKD1 PE=1 SV=2 | 825 | R | 0.357863 | K | 0.435095 | -0.077232 | No Change: Both O | - |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 324 | V | 0.577186 | M | 0.676041 | -0.098855 | No Change: Both D | - |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 496 | A | 0.601685 | V | 0.497902 | 0.103783 | D to O | - |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 604 | S | 0.206368 | G | 0.177872 | 0.028496 | No Change: Both O | - |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 773 | W | 0.32827 | R | 0.506056 | -0.177786 | O to D | - |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 848 | G | 0.653124 | E | 0.694529 | -0.041405 | No Change: Both D | A lung adenocarcinoma sample |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 870 | G | 0.612759 | E | 0.659431 | -0.046672 | No Change: Both D | A gastric adenocarcinoma sample |
| Q9BZL6 | KPCD2_HUMAN Serine/threonine-protein kinase D2 OS=Homo sapiens GN=PRKD2 PE=1 SV=2 | 835 | V | 0.414914 | A | 0.520345 | -0.105431 | O to D | - |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 42 | N | 0.835118 | D | 0.825376 | 0.009742 | No Change: Both D | - |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 128 | A | 0.337066 | T | 0.388506 | -0.05144 | No Change: Both O | - |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 546 | Q | 0.712332 | R | 0.690049 | 0.022283 | No Change: Both D | - |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 716 | V | 0.178123 | M | 0.225138 | -0.047015 | No Change: Both O | A glioblastoma multiforme sample |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 225 | P | 0.835678 | S | 0.829933 | 0.005745 | No Change: Both D | - |
| O94806 | KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens GN=PRKD3 PE=1 SV=1 | 445 | L | 0.197531 | I | 0.162396 | 0.035135 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 6 | A | 0.638341 | S | 0.722977 | -0.084636 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 333 | M | 0.528384 | I | 0.424192 | 0.104192 | D to O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 605 | T | 0.330818 | S | 0.42861 | -0.097792 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 680 | I | 0.355111 | M | 0.444738 | -0.089627 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 695 | P | 0.755317 | S | 0.767291 | -0.011974 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1071 | N | 0.300366 | S | 0.355188 | -0.054822 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1314 | G | 0.284185 | V | 0.164098 | 0.120087 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1588 | D | 0.534705 | V | 0.394191 | 0.140514 | D to O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1603 | Q | 0.416256 | H | 0.38418 | 0.032076 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2095 | A | 0.682263 | V | 0.648846 | 0.033417 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2702 | K | 0.814651 | E | 0.799271 | 0.01538 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2899 | R | 0.428034 | C | 0.294365 | 0.133669 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3149 | G | 0.517996 | D | 0.544129 | -0.026133 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3201 | P | 0.714848 | S | 0.715981 | -0.001133 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3404 | G | 0.328056 | E | 0.388653 | -0.060597 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3434 | I | 0.463994 | T | 0.586472 | -0.122478 | O to D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3459 | N | 0.47483 | S | 0.520481 | -0.045651 | O to D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3562 | L | 0.376634 | M | 0.437954 | -0.06132 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3836 | P | 0.408576 | L | 0.259507 | 0.149069 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3932 | M | 0.179432 | V | 0.142527 | 0.036905 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 263 | K | 0.255526 | N | 0.218915 | 0.036611 | No Change: Both O | A lung adenocarcinoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 420 | V | 0.121811 | I | 0.095775 | 0.026036 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 500 | G | 0.725933 | S | 0.763061 | -0.037128 | No Change: Both D | A metastatic melanoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 649 | F | 0.076083 | L | 0.090832 | -0.014749 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1136 | R | 0.201674 | H | 0.195794 | 0.00588 | No Change: Both O | A colorectal adenocarcinoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1190 | L | 0.123052 | V | 0.125914 | -0.002862 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1237 | A | 0.21736 | T | 0.257378 | -0.040018 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1279 | L | 0.218193 | F | 0.185743 | 0.03245 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1447 | R | 0.329908 | M | 0.263636 | 0.066272 | No Change: Both O | A lung squamous cell carcinoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1619 | A | 0.274144 | G | 0.334347 | -0.060203 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 1680 | A | 0.193542 | V | 0.146127 | 0.047415 | No Change: Both O | A metastatic melanoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2023 | S | 0.833355 | P | 0.814662 | 0.018693 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2598 | R | 0.423819 | Q | 0.44436 | -0.020541 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2810 | S | 0.269782 | N | 0.210148 | 0.059634 | No Change: Both O | A metastatic melanoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 2941 | G | 0.135686 | A | 0.108276 | 0.02741 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3085 | E | 0.272332 | D | 0.242813 | 0.029519 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3198 | T | 0.656321 | S | 0.710464 | -0.054143 | No Change: Both D | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3584 | L | 0.291202 | F | 0.260023 | 0.031179 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3800 | L | 0.135747 | I | 0.114978 | 0.020769 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3936 | G | 0.181655 | S | 0.202837 | -0.021182 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3937 | V | 0.176732 | M | 0.23292 | -0.056188 | No Change: Both O | - |
| P78527 | PRKDC_HUMAN DNA-dependent protein kinase catalytic subunit OS=Homo sapiens GN=PRKDC PE=1 SV=3 | 3702 | P | 0.427582 | L | 0.293189 | 0.134393 | No Change: Both O | - |
| Q13976 | KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens GN=PRKG1 PE=1 SV=3 | 249 | I | 0.264295 | V | 0.274298 | -0.010003 | No Change: Both O | - |
| Q13976 | KGP1_HUMAN cGMP-dependent protein kinase 1 OS=Homo sapiens GN=PRKG1 PE=1 SV=3 | 267 | N | 0.415153 | S | 0.478196 | -0.063043 | No Change: Both O | - |
| Q13237 | KGP2_HUMAN cGMP-dependent protein kinase 2 OS=Homo sapiens GN=PRKG2 PE=1 SV=1 | 106 | H | 0.638286 | R | 0.679416 | -0.04113 | No Change: Both D | - |
| Q13237 | KGP2_HUMAN cGMP-dependent protein kinase 2 OS=Homo sapiens GN=PRKG2 PE=1 SV=1 | 716 | W | 0.307604 | R | 0.54091 | -0.233306 | O to D | A colorectal adenocarcinoma sample |
| Q13237 | KGP2_HUMAN cGMP-dependent protein kinase 2 OS=Homo sapiens GN=PRKG2 PE=1 SV=1 | 22 | T | 0.827304 | S | 0.86415 | -0.036846 | No Change: Both D | - |
| O75569 | PRKRA_HUMAN Interferon-inducible double stranded RNA-dependent protein kinase activator A OS=Homo sapiens GN=PRKRA PE=1 SV=1 | 222 | P | 0.536077 | L | 0.420685 | 0.115392 | D to O | Dystonia type 16 (DYT16) [MIM:612067] |
| Q9H875 | PKRI1_HUMAN PRKR-interacting protein 1 OS=Homo sapiens GN=PRKRIP1 PE=1 SV=1 | 7 | S | 0.980609 | A | 0.973977 | 0.006632 | No Change: Both D | - |
| Q9H875 | PKRI1_HUMAN PRKR-interacting protein 1 OS=Homo sapiens GN=PRKRIP1 PE=1 SV=1 | 106 | D | 0.881563 | Y | 0.823223 | 0.05834 | No Change: Both D | - |
| P51817 | PRKX_HUMAN cAMP-dependent protein kinase catalytic subunit PRKX OS=Homo sapiens GN=PRKX PE=1 SV=1 | 43 | V | 0.610646 | A | 0.663142 | -0.052496 | No Change: Both D | - |
| P49683 | PRLHR_HUMAN Prolactin-releasing peptide receptor OS=Homo sapiens GN=PRLHR PE=1 SV=3 | 283 | I | 0.005481 | V | 0.008026 | -0.002545 | No Change: Both O | - |
| P49683 | PRLHR_HUMAN Prolactin-releasing peptide receptor OS=Homo sapiens GN=PRLHR PE=1 SV=3 | 302 | D | 0.238604 | G | 0.19946 | 0.039144 | No Change: Both O | - |
| P16471 | PRLR_HUMAN Prolactin receptor OS=Homo sapiens GN=PRLR PE=1 SV=1 | 100 | I | 0.0987 | V | 0.119607 | -0.020907 | No Change: Both O | - |
| Q9NNZ6 | PRM3_HUMAN Protamine-3 OS=Homo sapiens GN=PRM3 PE=2 SV=1 | 100 | Q | 0.995785 | R | 0.994843 | 9.42E-04 | No Change: Both D | - |
| Q99873 | ANM1_HUMAN Protein arginine N-methyltransferase 1 OS=Homo sapiens GN=PRMT1 PE=1 SV=2 | 78 | K | 0.298898 | M | 0.183886 | 0.115012 | No Change: Both O | - |
| Q99873 | ANM1_HUMAN Protein arginine N-methyltransferase 1 OS=Homo sapiens GN=PRMT1 PE=1 SV=2 | 158 | L | 0.039128 | F | 0.034482 | 0.004646 | No Change: Both O | - |
| Q6P2P2 | ANM10_HUMAN Putative protein arginine N-methyltransferase 10 OS=Homo sapiens GN=PRMT10 PE=1 SV=1 | 483 | S | 0.395236 | G | 0.333256 | 0.06198 | No Change: Both O | - |
| Q6P2P2 | ANM10_HUMAN Putative protein arginine N-methyltransferase 10 OS=Homo sapiens GN=PRMT10 PE=1 SV=1 | 747 | C | 0.235315 | Y | 0.275621 | -0.040306 | No Change: Both O | - |
| O60678 | ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens GN=PRMT3 PE=1 SV=3 | 440 | L | 0.339552 | V | 0.33221 | 0.007342 | No Change: Both O | - |
| O60678 | ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens GN=PRMT3 PE=1 SV=3 | 508 | S | 0.745752 | N | 0.70655 | 0.039202 | No Change: Both D | - |
| O60678 | ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens GN=PRMT3 PE=1 SV=3 | 470 | S | 0.438047 | C | 0.215905 | 0.222142 | No Change: Both O | - |
| Q96LA8 | ANM6_HUMAN Protein arginine N-methyltransferase 6 OS=Homo sapiens GN=PRMT6 PE=1 SV=1 | 194 | A | 0.164631 | V | 0.109364 | 0.055267 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 26 | T | 0.352704 | P | 0.405921 | -0.053217 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 56 | P | 0.39646 | L | 0.241068 | 0.155392 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 174 | T | 0.269507 | M | 0.22213 | 0.047377 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 6 | S | 0.164717 | I | 0.059305 | 0.105412 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 22 | S | 0.182268 | P | 0.156034 | 0.026234 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 31 | H | 0.289736 | R | 0.312704 | -0.022968 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 70 | F | 0.315368 | L | 0.35899 | -0.043622 | No Change: Both O | - |
| Q9UKY0 | PRND_HUMAN Prion-like protein doppel OS=Homo sapiens GN=PRND PE=1 SV=2 | 149 | L | 0.129069 | S | 0.260293 | -0.131224 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 102 | P | 0.860346 | L | 0.78509 | 0.075256 | No Change: Both D | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 105 | P | 0.819285 | L | 0.738486 | 0.080799 | No Change: Both D | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 117 | A | 0.4799 | V | 0.381581 | 0.098319 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 129 | M | 0.342075 | V | 0.270675 | 0.0714 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 171 | N | 0.472092 | S | 0.494688 | -0.022596 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 178 | D | 0.272552 | N | 0.290698 | -0.018146 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 178 | D | 0.272552 | N | 0.290698 | -0.018146 | No Change: Both O | Fatal familial insomnia (FFI) [MIM:600072] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 178 | D | 0.272552 | N | 0.290698 | -0.018146 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 180 | V | 0.255904 | I | 0.229571 | 0.026333 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 180 | V | 0.255904 | I | 0.229571 | 0.026333 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 183 | T | 0.350649 | A | 0.255717 | 0.094932 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 198 | F | 0.665854 | S | 0.788795 | -0.122941 | No Change: Both D | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 200 | E | 0.636342 | K | 0.630108 | 0.006234 | No Change: Both D | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 200 | E | 0.636342 | K | 0.630108 | 0.006234 | No Change: Both D | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 208 | R | 0.475285 | H | 0.432832 | 0.042453 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 208 | R | 0.475285 | H | 0.432832 | 0.042453 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 210 | V | 0.420415 | I | 0.383035 | 0.03738 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 210 | V | 0.420415 | I | 0.383035 | 0.03738 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 217 | Q | 0.374471 | R | 0.354111 | 0.02036 | No Change: Both O | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 219 | E | 0.444596 | K | 0.421058 | 0.023538 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 232 | M | 0.396139 | R | 0.481951 | -0.085812 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 232 | M | 0.396139 | R | 0.481951 | -0.085812 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 187 | H | 0.438919 | R | 0.463739 | -0.02482 | No Change: Both O | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 188 | T | 0.473254 | R | 0.454594 | 0.01866 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 188 | T | 0.473254 | K | 0.522284 | -0.04903 | O to D | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 196 | E | 0.681157 | K | 0.679911 | 0.001246 | No Change: Both D | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 196 | E | 0.681157 | K | 0.679911 | 0.001246 | No Change: Both D | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 202 | D | 0.601987 | N | 0.61725 | -0.015263 | No Change: Both D | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 203 | V | 0.567377 | I | 0.520838 | 0.046539 | No Change: Both D | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 203 | V | 0.567377 | I | 0.520838 | 0.046539 | No Change: Both D | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 211 | E | 0.399819 | Q | 0.372844 | 0.026975 | No Change: Both O | Creutzfeldt-Jakob disease (CJD) [MIM:123400] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 211 | E | 0.399819 | Q | 0.372844 | 0.026975 | No Change: Both O | High quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases like: Creutzfeldt-Jakob disease (CJD) |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 212 | Q | 0.356902 | P | 0.35295 | 0.003952 | No Change: Both O | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 238 | P | 0.200712 | S | 0.231506 | -0.030794 | No Change: Both O | - |
| P04156 | PRIO_HUMAN Major prion protein OS=Homo sapiens GN=PRNP PE=1 SV=1 | 131 | G | 0.348868 | V | 0.22273 | 0.126138 | No Change: Both O | Gerstmann-Straussler disease (GSD) [MIM:137440] |
| Q86SH4 | PRNT_HUMAN Putative testis-specific prion protein OS=Homo sapiens GN=PRNT PE=5 SV=1 | 50 | T | 0.309543 | S | 0.385531 | -0.075988 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 14 | W | 0.085105 | G | 0.222711 | -0.137606 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 32 | R | 0.548416 | C | 0.385848 | 0.162568 | D to O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 38 | R | 0.450097 | W | 0.215714 | 0.234383 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 42 | R | 0.555105 | H | 0.502774 | 0.052331 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 42 | R | 0.555105 | C | 0.418831 | 0.136274 | D to O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 43 | A | 0.569261 | T | 0.587603 | -0.018342 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 49 | E | 0.726239 | D | 0.681582 | 0.044657 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 51 | R | 0.697369 | C | 0.58213 | 0.115239 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 57 | R | 0.597029 | W | 0.358067 | 0.238962 | D to O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 57 | R | 0.597029 | G | 0.544685 | 0.052344 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 57 | R | 0.597029 | Q | 0.593855 | 0.003174 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 62 | E | 0.382435 | A | 0.25959 | 0.122845 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 76 | V | 0.212716 | M | 0.263339 | -0.050623 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 89 | G | 0.191105 | C | 0.114083 | 0.077022 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 108 | H | 0.163015 | N | 0.166377 | -0.003362 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 109 | G | 0.154844 | R | 0.14366 | 0.011184 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 114 | G | 0.313041 | R | 0.305572 | 0.007469 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 118 | F | 0.323552 | L | 0.35672 | -0.033168 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 145 | G | 0.256009 | R | 0.250091 | 0.005918 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 147 | C | 0.215942 | Y | 0.207074 | 0.008868 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 149 | H | 0.160023 | P | 0.207825 | -0.047802 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 161 | S | 0.161362 | R | 0.152708 | 0.008654 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 178 | A | 0.396512 | P | 0.531239 | -0.134727 | O to D | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 183 | C | 0.540799 | R | 0.644098 | -0.103299 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 189 | R | 0.760479 | W | 0.589228 | 0.171251 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 194 | R | 0.840452 | C | 0.792622 | 0.04783 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 210 | P | 0.771349 | L | 0.67341 | 0.097939 | No Change: Both D | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 211 | R | 0.732538 | W | 0.543356 | 0.189182 | No Change: Both D | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 211 | R | 0.732538 | Q | 0.738712 | -0.006174 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 220 | R | 0.538769 | P | 0.566934 | -0.028165 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 220 | R | 0.538769 | W | 0.348382 | 0.190387 | D to O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 220 | R | 0.538769 | Q | 0.547405 | -0.008636 | No Change: Both D | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 226 | Q | 0.299312 | H | 0.273161 | 0.026151 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 243 | I | 0.055785 | T | 0.110609 | -0.054824 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 244 | H | 0.071573 | Y | 0.039958 | 0.031615 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 253 | H | 0.184702 | Q | 0.193248 | -0.008546 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 265 | L | 0.207453 | F | 0.167834 | 0.039619 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 271 | R | 0.173271 | Q | 0.173305 | -3.40E-05 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 271 | R | 0.173271 | W | 0.072176 | 0.101095 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 272 | R | 0.19591 | C | 0.090931 | 0.104979 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 289 | P | 0.384163 | L | 0.236072 | 0.148091 | No Change: Both O | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 294 | S | 0.626467 | N | 0.595806 | 0.030661 | No Change: Both D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 298 | N | 0.472743 | D | 0.502213 | -0.02947 | O to D | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 301 | A | 0.267335 | T | 0.297856 | -0.030521 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 301 | A | 0.267335 | V | 0.19263 | 0.074705 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 309 | A | 0.299292 | T | 0.332773 | -0.033481 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 312 | S | 0.235197 | L | 0.125754 | 0.109443 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 312 | S | 0.235197 | P | 0.234465 | 7.32E-04 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 321 | P | 0.225046 | L | 0.127665 | 0.097381 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 324 | G | 0.330455 | R | 0.347546 | -0.017091 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 328 | R | 0.542369 | C | 0.400343 | 0.142026 | D to O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 328 | R | 0.542369 | H | 0.5539 | -0.011531 | No Change: Both D | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 334 | G | 0.444538 | S | 0.486859 | -0.042321 | No Change: Both O | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 340 | T | 0.285998 | M | 0.230153 | 0.055845 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 343 | G | 0.323787 | D | 0.33269 | -0.008903 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 367 | V | 0.1622 | A | 0.202816 | -0.040616 | No Change: Both O | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 369 | P | 0.265112 | L | 0.143763 | 0.121349 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 385 | M | 0.225305 | I | 0.149785 | 0.07552 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 388 | A | 0.153732 | T | 0.168153 | -0.014421 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 388 | A | 0.153732 | V | 0.116389 | 0.037343 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 392 | G | 0.234856 | R | 0.223358 | 0.011498 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 394 | R | 0.379465 | W | 0.205503 | 0.173962 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 401 | D | 0.584051 | N | 0.555704 | 0.028347 | No Change: Both D | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 418 | G | 0.044839 | D | 0.045752 | -9.13E-04 | No Change: Both O | Protein C deficiency autosomal recessive (ARPROCD) [MIM:612304] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 423 | G | 0.137665 | S | 0.163593 | -0.025928 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 426 | C | 0.159408 | Y | 0.204763 | -0.045355 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 433 | G | 0.144282 | S | 0.179862 | -0.03558 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 436 | T | 0.166581 | N | 0.207598 | -0.041017 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 441 | Y | 0.12226 | H | 0.206047 | -0.083787 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 444 | W | 0.1214 | C | 0.142244 | -0.020844 | No Change: Both O | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 445 | I | 0.132391 | M | 0.183851 | -0.05146 | No Change: Both O | - |
| P04070 | PROC_HUMAN Vitamin K-dependent protein C OS=Homo sapiens GN=PROC PE=1 SV=1 | 42 | R | 0.555105 | S | 0.595376 | -0.040271 | No Change: Both D | Protein C deficiency autosomal dominant (ADPROCD) [MIM:176860] |
| Q8NCQ7 | PRCA1_HUMAN Protein PROCA1 OS=Homo sapiens GN=PROCA1 PE=2 SV=2 | 245 | D | 0.995596 | A | 0.994596 | 0.001 | No Change: Both D | - |
| Q8NCQ7 | PRCA1_HUMAN Protein PROCA1 OS=Homo sapiens GN=PROCA1 PE=2 SV=2 | 320 | E | 0.978782 | K | 0.977842 | 9.40E-04 | No Change: Both D | - |
| Q9UNN8 | EPCR_HUMAN Endothelial protein C receptor OS=Homo sapiens GN=PROCR PE=1 SV=1 | 219 | S | 0.049665 | G | 0.042833 | 0.006832 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 167 | A | 0.839414 | V | 0.779745 | 0.059669 | No Change: Both D | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 185 | R | 0.5595 | Q | 0.554641 | 0.004859 | No Change: Both D | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 185 | R | 0.5595 | W | 0.336156 | 0.223344 | D to O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 289 | L | 0.300383 | M | 0.352223 | -0.05184 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 406 | P | 0.178548 | L | 0.098939 | 0.079609 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 426 | D | 0.222604 | N | 0.207781 | 0.014823 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 427 | V | 0.213022 | M | 0.251316 | -0.038294 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 431 | R | 0.138764 | H | 0.131779 | 0.006985 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 441 | L | 0.085135 | P | 0.158269 | -0.073134 | No Change: Both O | Hyperprolinemia type 1 (HP-1) [MIM:239500] |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 453 | R | 0.406519 | C | 0.225199 | 0.18132 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 455 | A | 0.402849 | S | 0.498266 | -0.095417 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 466 | T | 0.444817 | M | 0.388259 | 0.056558 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 472 | A | 0.216486 | T | 0.240964 | -0.024478 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 521 | Q | 0.231887 | E | 0.262029 | -0.030142 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 521 | Q | 0.231887 | R | 0.203832 | 0.028055 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 275 | T | 0.285165 | N | 0.322523 | -0.037358 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 444 | G | 0.151702 | D | 0.162237 | -0.010535 | No Change: Both O | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 488 | N | 0.447708 | S | 0.489484 | -0.041776 | No Change: Both O | A breast cancer sample |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 8 | P | 0.812638 | L | 0.661404 | 0.151234 | No Change: Both D | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 19 | Q | 0.850604 | P | 0.893676 | -0.043072 | No Change: Both D | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 30 | P | 0.894658 | S | 0.882124 | 0.012534 | No Change: Both D | - |
| O43272 | PROD_HUMAN Proline dehydrogenase 1 mitochondrial OS=Homo sapiens GN=PRODH PE=1 SV=3 | 58 | A | 0.464555 | T | 0.468507 | -0.003952 | No Change: Both O | - |
| Q9UF12 | PROD2_HUMAN Probable proline dehydrogenase 2 OS=Homo sapiens GN=PRODH2 PE=2 SV=1 | 91 | P | 0.523587 | R | 0.497199 | 0.026388 | D to O | - |
| Q9UF12 | PROD2_HUMAN Probable proline dehydrogenase 2 OS=Homo sapiens GN=PRODH2 PE=2 SV=1 | 525 | R | 0.621993 | Q | 0.602716 | 0.019277 | No Change: Both D | - |
| P58294 | PROK1_HUMAN Prokineticin-1 OS=Homo sapiens GN=PROK1 PE=1 SV=1 | 67 | V | 0.707199 | I | 0.703856 | 0.003343 | No Change: Both D | - |
| Q9HC23 | PROK2_HUMAN Prokineticin-2 OS=Homo sapiens GN=PROK2 PE=1 SV=2 | 32 | G | 0.284005 | R | 0.27468 | 0.009325 | No Change: Both O | Kallmann syndrome type 4 (KAL4) [MIM:610628] |
| Q9HC23 | PROK2_HUMAN Prokineticin-2 OS=Homo sapiens GN=PROK2 PE=1 SV=2 | 73 | R | 0.679657 | C | 0.614071 | 0.065586 | No Change: Both D | Kallmann syndrome type 4 (KAL4) [MIM:610628] |
| Q8TCW9 | PKR1_HUMAN Prokineticin receptor 1 OS=Homo sapiens GN=PROKR1 PE=2 SV=1 | 40 | S | 0.394929 | G | 0.317294 | 0.077635 | No Change: Both O | - |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 85 | R | 0.282292 | C | 0.138574 | 0.143718 | No Change: Both O | - |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 85 | R | 0.282292 | H | 0.270289 | 0.012003 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 164 | R | 0.382034 | Q | 0.423777 | -0.041743 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 173 | L | 0.031155 | R | 0.053622 | -0.022467 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 178 | W | 0.010672 | S | 0.043786 | -0.033114 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 210 | Q | 0.061339 | R | 0.050783 | 0.010556 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 268 | R | 0.280758 | C | 0.143169 | 0.137589 | No Change: Both O | - |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 290 | P | 0.01332 | S | 0.015228 | -0.001908 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 323 | M | 0.137258 | I | 0.093752 | 0.043506 | No Change: Both O | Kallmann syndrome type 3 (KAL3) [MIM:244200] |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 331 | V | 0.100938 | M | 0.135026 | -0.034088 | No Change: Both O | - |
| Q8NFJ6 | PKR2_HUMAN Prokineticin receptor 2 OS=Homo sapiens GN=PROKR2 PE=1 SV=1 | 335 | T | 0.131946 | M | 0.11127 | 0.020676 | No Change: Both O | - |
| O43490 | PROM1_HUMAN Prominin-1 OS=Homo sapiens GN=PROM1 PE=1 SV=1 | 31 | A | 0.452062 | G | 0.494351 | -0.042289 | No Change: Both O | - |
| O43490 | PROM1_HUMAN Prominin-1 OS=Homo sapiens GN=PROM1 PE=1 SV=1 | 31 | A | 0.452062 | S | 0.567984 | -0.115922 | O to D | - |
| O43490 | PROM1_HUMAN Prominin-1 OS=Homo sapiens GN=PROM1 PE=1 SV=1 | 373 | R | 0.405856 | C | 0.25039 | 0.155466 | No Change: Both O | Cone-rod dystrophy type 12 (CORD12) [MIM:612657] |
| O43490 | PROM1_HUMAN Prominin-1 OS=Homo sapiens GN=PROM1 PE=1 SV=1 | 373 | R | 0.405856 | C | 0.25039 | 0.155466 | No Change: Both O | Retinal macular dystrophy type 2 (MCDR2) [MIM:608051] |
| O43490 | PROM1_HUMAN Prominin-1 OS=Homo sapiens GN=PROM1 PE=1 SV=1 | 373 | R | 0.405856 | C | 0.25039 | 0.155466 | No Change: Both O | Stargardt disease type 4 (STGD4) [MIM:603786] |
| Q8N271 | PROM2_HUMAN Prominin-2 OS=Homo sapiens GN=PROM2 PE=1 SV=1 | 508 | Q | 0.153243 | R | 0.131379 | 0.021864 | No Change: Both O | - |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 73 | R | 0.862232 | C | 0.782425 | 0.079807 | No Change: Both D | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 117 | F | 0.348591 | I | 0.350047 | -0.001456 | No Change: Both O | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 120 | R | 0.544693 | C | 0.374645 | 0.170048 | D to O | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 73 | R | 0.862232 | H | 0.833433 | 0.028799 | No Change: Both D | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 142 | A | 0.766806 | T | 0.76613 | 6.76E-04 | No Change: Both D | - |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 20 | N | 0.959393 | S | 0.973528 | -0.014135 | No Change: Both D | - |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 125 | R | 0.735314 | W | 0.561369 | 0.173945 | No Change: Both D | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 88 | F | 0.50552 | S | 0.66574 | -0.16022 | No Change: Both D | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| O75360 | PROP1_HUMAN Homeobox protein prophet of Pit-1 OS=Homo sapiens GN=PROP1 PE=1 SV=2 | 99 | R | 0.389532 | Q | 0.390406 | -8.74E-04 | No Change: Both O | Pituitary hormone deficiency combined type 2 (CPHD2) [MIM:262600] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 196 | K | 0.667361 | E | 0.639353 | 0.028008 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 258 | N | 0.256464 | S | 0.304639 | -0.048175 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 501 | S | 0.388808 | P | 0.342339 | 0.046469 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 482 | G | 0.414547 | C | 0.225303 | 0.189244 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 485 | Y | 0.417228 | C | 0.343385 | 0.073843 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 559 | I | 0.152902 | M | 0.200609 | -0.047707 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 561 | R | 0.158816 | G | 0.130621 | 0.028195 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 78 | T | 0.399563 | M | 0.366706 | 0.032857 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 545 | E | 0.605434 | G | 0.573444 | 0.03199 | No Change: Both D | A colorectal cancer sample |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 15 | L | 0.101652 | H | 0.099295 | 0.002357 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 18 | V | 0.134695 | E | 0.248705 | -0.11401 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 40 | R | 0.678384 | L | 0.585202 | 0.093182 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 41 | R | 0.683482 | H | 0.600935 | 0.082547 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 50 | K | 0.823663 | E | 0.845962 | -0.022299 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 52 | G | 0.810056 | D | 0.846341 | -0.036285 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 67 | E | 0.590263 | A | 0.465159 | 0.125104 | D to O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 68 | A | 0.594627 | D | 0.671884 | -0.077257 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 72 | F | 0.569425 | C | 0.585562 | -0.016137 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 76 | P | 0.461509 | L | 0.34001 | 0.121499 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 87 | V | 0.082304 | L | 0.095621 | -0.013317 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 88 | C | 0.08285 | Y | 0.086734 | -0.003884 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 90 | R | 0.108664 | C | 0.072621 | 0.036043 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 90 | R | 0.108664 | H | 0.084368 | 0.024296 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 95 | G | 0.218024 | E | 0.275981 | -0.057957 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 95 | G | 0.218024 | R | 0.2628 | -0.044776 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 98 | T | 0.301476 | S | 0.366722 | -0.065246 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 101 | R | 0.359764 | C | 0.229814 | 0.12995 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 111 | R | 0.304289 | S | 0.377123 | -0.072834 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 121 | C | 0.491986 | Y | 0.427774 | 0.064212 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 129 | D | 0.600156 | G | 0.566751 | 0.033405 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 144 | T | 0.656811 | N | 0.693619 | -0.036808 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 149 | W | 0.768657 | C | 0.884043 | -0.115386 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 157 | D | 0.767367 | G | 0.753061 | 0.014306 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 161 | C | 0.734884 | G | 0.773678 | -0.038794 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 166 | N | 0.744304 | Y | 0.580592 | 0.163712 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 168 | N | 0.732356 | S | 0.765436 | -0.03308 | No Change: Both D | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 175 | C | 0.718271 | F | 0.638379 | 0.079892 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 186 | C | 0.607949 | Y | 0.512175 | 0.095774 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 204 | E | 0.603932 | G | 0.567721 | 0.036211 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 233 | R | 0.546656 | K | 0.643497 | -0.096841 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 241 | C | 0.59457 | S | 0.699804 | -0.105234 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 243 | D | 0.599822 | N | 0.591417 | 0.008405 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 245 | D | 0.569175 | G | 0.53576 | 0.033415 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 247 | C | 0.506355 | G | 0.563385 | -0.05703 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 249 | E | 0.427425 | K | 0.41974 | 0.007685 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 265 | C | 0.248412 | R | 0.296288 | -0.047876 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 265 | C | 0.248412 | W | 0.14583 | 0.102582 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 266 | Y | 0.269368 | C | 0.33718 | -0.067812 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 267 | C | 0.278347 | S | 0.401273 | -0.122926 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 300 | L | 0.111352 | P | 0.190546 | -0.079194 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 324 | S | 0.311486 | P | 0.280113 | 0.031373 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 336 | G | 0.207724 | D | 0.247502 | -0.039778 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 336 | G | 0.207724 | S | 0.268233 | -0.060509 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 336 | G | 0.207724 | V | 0.125945 | 0.081779 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 339 | L | 0.223261 | P | 0.381255 | -0.157994 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 351 | L | 0.070987 | P | 0.130274 | -0.059287 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 355 | R | 0.103516 | H | 0.106797 | -0.003281 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 357 | G | 0.184406 | R | 0.175221 | 0.009185 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 364 | K | 0.559317 | E | 0.558778 | 5.39E-04 | No Change: Both D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 376 | D | 0.308814 | N | 0.318114 | -0.0093 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 381 | G | 0.179231 | D | 0.197226 | -0.017995 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 381 | G | 0.179231 | V | 0.108973 | 0.070258 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 383 | W | 0.155492 | R | 0.324754 | -0.169262 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 385 | M | 0.214564 | V | 0.18309 | 0.031474 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 390 | E | 0.389012 | K | 0.376439 | 0.012573 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 446 | L | 0.214678 | P | 0.368133 | -0.153455 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 449 | C | 0.151511 | S | 0.350184 | -0.198673 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 475 | C | 0.253001 | R | 0.416687 | -0.163686 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 495 | I | 0.212562 | V | 0.238251 | -0.025689 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 501 | S | 0.388808 | A | 0.27853 | 0.110278 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 508 | V | 0.1644 | G | 0.267301 | -0.102901 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 508 | V | 0.1644 | M | 0.196533 | -0.032133 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 515 | R | 0.342133 | C | 0.195153 | 0.14698 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 515 | R | 0.342133 | P | 0.39285 | -0.050717 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 521 | G | 0.263291 | D | 0.27283 | -0.009539 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 525 | A | 0.22484 | P | 0.307472 | -0.082632 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 526 | L | 0.220735 | S | 0.394174 | -0.173439 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 532 | T | 0.258185 | A | 0.247015 | 0.01117 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 552 | L | 0.271324 | S | 0.460376 | -0.189052 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 562 | I | 0.14221 | L | 0.172465 | -0.030255 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 568 | C | 0.381412 | Y | 0.397397 | -0.015985 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 575 | L | 0.440057 | R | 0.554493 | -0.114436 | O to D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 583 | N | 0.437472 | H | 0.397782 | 0.03969 | No Change: Both O | - |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 584 | L | 0.426657 | Q | 0.549313 | -0.122656 | O to D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 611 | M | 0.332921 | K | 0.473691 | -0.14077 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 611 | M | 0.332921 | T | 0.391781 | -0.05886 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 616 | A | 0.240512 | P | 0.301453 | -0.060941 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 622 | L | 0.248356 | R | 0.352143 | -0.103787 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 630 | T | 0.230389 | I | 0.134158 | 0.096231 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 636 | Y | 0.121507 | C | 0.108666 | 0.012841 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 638 | G | 0.109735 | D | 0.120846 | -0.011111 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 639 | C | 0.113493 | F | 0.127739 | -0.014246 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 639 | C | 0.113493 | Y | 0.146626 | -0.033133 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 640 | M | 0.116625 | T | 0.141536 | -0.024911 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 644 | I | 0.149474 | S | 0.328316 | -0.178842 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 664 | H | 0.362893 | P | 0.41183 | -0.048937 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 665 | S | 0.336281 | L | 0.15549 | 0.180791 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 666 | C | 0.336004 | R | 0.528814 | -0.19281 | O to D | Protein S deficiency (PROS1D) [MIM:612336] |
| P07225 | PROS_HUMAN Vitamin K-dependent protein S OS=Homo sapiens GN=PROS1 PE=1 SV=1 | 667 | P | 0.38656 | L | 0.238854 | 0.147706 | No Change: Both O | Protein S deficiency (PROS1D) [MIM:612336] |
| O94903 | PROSC_HUMAN Proline synthase co-transcribed bacterial homolog protein OS=Homo sapiens GN=PROSC PE=1 SV=1 | 24 | V | 0.528819 | M | 0.601546 | -0.072727 | No Change: Both D | - |
| Q86XN7 | PRSR1_HUMAN Proline and serine-rich protein 1 OS=Homo sapiens GN=PROSER1 PE=1 SV=2 | 571 | V | 0.953985 | A | 0.966866 | -0.012881 | No Change: Both D | - |
| Q86XN7 | PRSR1_HUMAN Proline and serine-rich protein 1 OS=Homo sapiens GN=PROSER1 PE=1 SV=2 | 847 | S | 0.79389 | T | 0.702535 | 0.091355 | No Change: Both D | - |
| Q92786 | PROX1_HUMAN Prospero homeobox protein 1 OS=Homo sapiens GN=PROX1 PE=1 SV=2 | 584 | H | 0.557533 | R | 0.587881 | -0.030348 | No Change: Both D | - |
| P22891 | PROZ_HUMAN Vitamin K-dependent protein Z OS=Homo sapiens GN=PROZ PE=1 SV=2 | 70 | E | 0.339188 | K | 0.304388 | 0.0348 | No Change: Both O | - |
| P22891 | PROZ_HUMAN Vitamin K-dependent protein Z OS=Homo sapiens GN=PROZ PE=1 SV=2 | 295 | R | 0.236737 | H | 0.222188 | 0.014549 | No Change: Both O | - |
| O43395 | PRPF3_HUMAN U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens GN=PRPF3 PE=1 SV=2 | 494 | T | 0.717106 | M | 0.731659 | -0.014553 | No Change: Both D | Retinitis pigmentosa type 18 (RP18) [MIM:601414] |
| O43395 | PRPF3_HUMAN U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens GN=PRPF3 PE=1 SV=2 | 493 | P | 0.709685 | S | 0.696462 | 0.013223 | No Change: Both D | Retinitis pigmentosa type 18 (RP18) [MIM:601414] |
| O43395 | PRPF3_HUMAN U4/U6 small nuclear ribonucleoprotein Prp3 OS=Homo sapiens GN=PRPF3 PE=1 SV=2 | 12 | K | 0.382649 | N | 0.309233 | 0.073416 | No Change: Both O | - |
| Q8WWY3 | PRP31_HUMAN U4/U6 small nuclear ribonucleoprotein Prp31 OS=Homo sapiens GN=PRPF31 PE=1 SV=2 | 194 | A | 0.389186 | E | 0.520959 | -0.131773 | O to D | Retinitis pigmentosa type 11 (RP11) [MIM:600138] |
| Q8WWY3 | PRP31_HUMAN U4/U6 small nuclear ribonucleoprotein Prp31 OS=Homo sapiens GN=PRPF31 PE=1 SV=2 | 216 | A | 0.167738 | P | 0.23362 | -0.065882 | No Change: Both O | Retinitis pigmentosa type 11 (RP11) [MIM:600138] |
| Q13523 | PRP4B_HUMAN Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens GN=PRPF4B PE=1 SV=3 | 658 | F | 0.517653 | L | 0.555954 | -0.038301 | No Change: Both D | A breast cancer sample |
| Q13523 | PRP4B_HUMAN Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens GN=PRPF4B PE=1 SV=3 | 83 | I | 0.976853 | V | 0.973025 | 0.003828 | No Change: Both D | - |
| Q13523 | PRP4B_HUMAN Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens GN=PRPF4B PE=1 SV=3 | 584 | I | 0.861863 | V | 0.896886 | -0.035023 | No Change: Both D | - |
| O94906 | PRP6_HUMAN Pre-mRNA-processing factor 6 OS=Homo sapiens GN=PRPF6 PE=1 SV=1 | 729 | R | 0.684021 | W | 0.496998 | 0.187023 | D to O | Retinitis pigmentosa type 60 (RP60) [MIM:613983] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 68 | K | 0.55451 | E | 0.552567 | 0.001943 | No Change: Both D | - |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 227 | R | 0.172204 | H | 0.172179 | 2.50E-05 | No Change: Both O | - |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 874 | P | 0.474961 | L | 0.357949 | 0.117012 | No Change: Both O | - |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 1293 | N | 0.202666 | H | 0.186197 | 0.016469 | No Change: Both O | - |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2301 | P | 0.403573 | T | 0.356796 | 0.046777 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2304 | F | 0.443804 | L | 0.484659 | -0.040855 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2309 | H | 0.406209 | P | 0.438582 | -0.032373 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2309 | H | 0.406209 | R | 0.395888 | 0.010321 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2310 | R | 0.35275 | G | 0.365043 | -0.012293 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2310 | R | 0.35275 | K | 0.421479 | -0.068729 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2314 | F | 0.225258 | L | 0.255903 | -0.030645 | No Change: Both O | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| Q6P2Q9 | PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens GN=PRPF8 PE=1 SV=2 | 2334 | Y | 0.893343 | N | 0.894619 | -0.001276 | No Change: Both D | Retinitis pigmentosa type 13 (RP13) [MIM:600059] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 13 | R | 0.435748 | W | 0.237352 | 0.198396 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 32 | I | 0.023237 | V | 0.026139 | -0.002902 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 45 | L | 0.295691 | F | 0.263002 | 0.032689 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 68 | G | 0.095511 | R | 0.086187 | 0.009324 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 126 | L | 0.29574 | R | 0.411828 | -0.116088 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 142 | R | 0.457671 | W | 0.240179 | 0.217492 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 153 | K | 0.26167 | R | 0.220385 | 0.041285 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 157 | D | 0.158381 | N | 0.14903 | 0.009351 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 165 | C | 0.131629 | Y | 0.129316 | 0.002313 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 167 | G | 0.129507 | D | 0.149774 | -0.020267 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 172 | R | 0.09919 | G | 0.101379 | -0.002189 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 172 | R | 0.09919 | Q | 0.106511 | -0.007321 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 172 | R | 0.09919 | W | 0.041992 | 0.057198 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 173 | D | 0.095687 | V | 0.045508 | 0.050179 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 184 | Y | 0.178864 | S | 0.368106 | -0.189242 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 185 | L | 0.234569 | P | 0.38436 | -0.149791 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 208 | G | 0.22303 | D | 0.276093 | -0.053063 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 210 | P | 0.288203 | R | 0.254235 | 0.033968 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 210 | P | 0.288203 | R | 0.254235 | 0.033968 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 210 | P | 0.288203 | S | 0.307878 | -0.019675 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 211 | F | 0.329828 | L | 0.368589 | -0.038761 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 212 | S | 0.357625 | G | 0.285374 | 0.072251 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 212 | S | 0.357625 | T | 0.259917 | 0.097708 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 213 | C | 0.381545 | R | 0.512746 | -0.131201 | O to D | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 214 | C | 0.413894 | S | 0.60708 | -0.193186 | O to D | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 216 | P | 0.473063 | L | 0.27923 | 0.193833 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 216 | P | 0.473063 | S | 0.49756 | -0.024497 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 219 | P | 0.443837 | R | 0.398965 | 0.044872 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 220 | R | 0.413163 | Q | 0.453644 | -0.040481 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 220 | R | 0.413163 | W | 0.215002 | 0.198161 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 244 | N | 0.195567 | K | 0.22537 | -0.029803 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 244 | N | 0.195567 | H | 0.190467 | 0.0051 | No Change: Both O | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 266 | G | 0.133681 | D | 0.149016 | -0.015335 | No Change: Both O | Retinitis pigmentosa type 7 (RP7) [MIM:608133] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 268 | V | 0.05221 | I | 0.045336 | 0.006874 | No Change: Both O | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 304 | E | 0.752225 | Q | 0.705702 | 0.046523 | No Change: Both D | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 305 | G | 0.72385 | D | 0.736942 | -0.013092 | No Change: Both D | Adult-onset vitelliform macular dystrophy (AVMD) [MIM:608161] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 310 | K | 0.657621 | R | 0.58881 | 0.068811 | No Change: Both D | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 313 | P | 0.695199 | L | 0.585313 | 0.109886 | No Change: Both D | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 338 | G | 0.823294 | D | 0.790394 | 0.0329 | No Change: Both D | - |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 167 | G | 0.129507 | S | 0.152084 | -0.022577 | No Change: Both O | Patterned dystrophy of retinal pigment epithelium (PDREP) [MIM:169150] |
| P23942 | PRPH2_HUMAN Peripherin-2 OS=Homo sapiens GN=PRPH2 PE=1 SV=1 | 195 | R | 0.58201 | L | 0.488077 | 0.093933 | D to O | Choroidal dystrophy central areolar type 2 (CACD2) [MIM:613105] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 114 | N | 0.229058 | S | 0.291966 | -0.062908 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 183 | D | 0.205234 | H | 0.165131 | 0.040103 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 52 | D | 0.31528 | H | 0.277842 | 0.037438 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 129 | L | 0.221031 | I | 0.21811 | 0.002921 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 190 | A | 0.169128 | V | 0.127918 | 0.04121 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 193 | H | 0.320971 | Q | 0.341547 | -0.020576 | No Change: Both O | Phosphoribosylpyrophosphate synthetase superactivity (PRPS1 superactivity) [MIM:300661] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 203 | D | 0.346092 | H | 0.300497 | 0.045595 | No Change: Both O | A breast cancer sample |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 219 | V | 0.165262 | G | 0.260172 | -0.09491 | No Change: Both O | A breast cancer sample |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 231 | H | 0.140714 | D | 0.179517 | -0.038803 | No Change: Both O | A colorectal cancer sample |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 43 | E | 0.371582 | D | 0.326926 | 0.044656 | No Change: Both O | Charcot-Marie-Tooth disease X-linked recessive type 5 (CMTX5) [MIM:311070] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 115 | M | 0.221524 | T | 0.258207 | -0.036683 | No Change: Both O | Charcot-Marie-Tooth disease X-linked recessive type 5 (CMTX5) [MIM:311070] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 133 | Q | 0.191682 | P | 0.198344 | -0.006662 | No Change: Both O | ARTS syndrome (ARTS) [MIM:301835] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 152 | L | 0.106758 | P | 0.211653 | -0.104895 | No Change: Both O | ARTS syndrome (ARTS) [MIM:301835] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 65 | D | 0.249644 | N | 0.254016 | -0.004372 | No Change: Both O | Deafness X-linked type 1 (DFNX1) [MIM:304500] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 87 | A | 0.159043 | T | 0.163443 | -0.0044 | No Change: Both O | Deafness X-linked type 1 (DFNX1) [MIM:304500] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 290 | I | 0.124617 | T | 0.196095 | -0.071478 | No Change: Both O | Deafness X-linked type 1 (DFNX1) [MIM:304500] |
| P60891 | PRPS1_HUMAN Ribose-phosphate pyrophosphokinase 1 OS=Homo sapiens GN=PRPS1 PE=1 SV=2 | 306 | G | 0.497065 | R | 0.485644 | 0.011421 | No Change: Both O | Deafness X-linked type 1 (DFNX1) [MIM:304500] |
| P21108 | PRPS3_HUMAN Ribose-phosphate pyrophosphokinase 3 OS=Homo sapiens GN=PRPS1L1 PE=1 SV=2 | 279 | E | 0.546158 | D | 0.54622 | -6.20E-05 | No Change: Both D | - |
| Q9BWN1 | PRR14_HUMAN Proline-rich protein 14 OS=Homo sapiens GN=PRR14 PE=1 SV=1 | 359 | P | 0.991479 | L | 0.981555 | 0.009924 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 455 | N | 0.712113 | S | 0.744001 | -0.031888 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 740 | L | 0.791579 | P | 0.873317 | -0.081738 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 876 | M | 0.664202 | I | 0.616389 | 0.047813 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 961 | T | 0.785508 | I | 0.697125 | 0.088383 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 963 | D | 0.802453 | N | 0.790583 | 0.01187 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 1151 | S | 0.794574 | P | 0.787265 | 0.007309 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 1221 | S | 0.972716 | L | 0.94548 | 0.027236 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 1395 | L | 0.478698 | F | 0.429177 | 0.049521 | No Change: Both O | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 1784 | V | 0.73628 | I | 0.723326 | 0.012954 | No Change: Both D | - |
| Q5THK1 | PR14L_HUMAN Protein PRR14L OS=Homo sapiens GN=PRR14L PE=1 SV=1 | 1316 | E | 0.795045 | K | 0.80122 | -0.006175 | No Change: Both D | - |
| Q8IV56 | PRR15_HUMAN Proline-rich protein 15 OS=Homo sapiens GN=PRR15 PE=2 SV=1 | 115 | P | 0.944826 | S | 0.938937 | 0.005889 | No Change: Both D | - |
| Q569H4 | PRR16_HUMAN Proline-rich protein 16 OS=Homo sapiens GN=PRR16 PE=2 SV=1 | 110 | P | 0.909457 | T | 0.880589 | 0.028868 | No Change: Both D | - |
| Q8N4B5 | PRR18_HUMAN Proline-rich protein 18 OS=Homo sapiens GN=PRR18 PE=2 SV=2 | 136 | C | 0.410903 | S | 0.554223 | -0.14332 | O to D | - |
| Q8WXC7 | PRR21_HUMAN Putative proline-rich protein 21 OS=Homo sapiens GN=PRR21 PE=5 SV=1 | 58 | G | 0.903367 | S | 0.929953 | -0.026586 | No Change: Both D | - |
| Q8WXC7 | PRR21_HUMAN Putative proline-rich protein 21 OS=Homo sapiens GN=PRR21 PE=5 SV=1 | 342 | K | 0.790446 | M | 0.770956 | 0.01949 | No Change: Both D | - |
| Q8WXC7 | PRR21_HUMAN Putative proline-rich protein 21 OS=Homo sapiens GN=PRR21 PE=5 SV=1 | 380 | S | 0.03525 | A | 0.020583 | 0.014667 | No Change: Both O | - |
| Q8IZ63 | PRR22_HUMAN Proline-rich protein 22 OS=Homo sapiens GN=PRR22 PE=2 SV=1 | 116 | P | 0.876829 | L | 0.781801 | 0.095028 | No Change: Both D | - |
| Q96S07 | PRR25_HUMAN Proline-rich protein 25 OS=Homo sapiens GN=PRR25 PE=4 SV=1 | 92 | T | 0.621731 | S | 0.670402 | -0.048671 | No Change: Both D | - |
| Q96S07 | PRR25_HUMAN Proline-rich protein 25 OS=Homo sapiens GN=PRR25 PE=4 SV=1 | 249 | P | 0.952182 | L | 0.909146 | 0.043036 | No Change: Both D | - |
| P79522 | PRR3_HUMAN Proline-rich protein 3 OS=Homo sapiens GN=PRR3 PE=2 SV=2 | 61 | G | 0.993618 | S | 0.994557 | -9.39E-04 | No Change: Both D | - |
| Q16378 | PROL4_HUMAN Proline-rich protein 4 OS=Homo sapiens GN=PRR4 PE=1 SV=3 | 96 | R | 0.995762 | Q | 0.995838 | -7.60E-05 | No Change: Both D | - |
| Q16378 | PROL4_HUMAN Proline-rich protein 4 OS=Homo sapiens GN=PRR4 PE=1 SV=3 | 120 | Q | 0.964359 | R | 0.96565 | -0.001291 | No Change: Both D | - |
| P85299 | PRR5_HUMAN Proline-rich protein 5 OS=Homo sapiens GN=PRR5 PE=1 SV=1 | 243 | V | 0.553407 | M | 0.597409 | -0.044002 | No Change: Both D | - |
| Q6MZQ0 | PRR5L_HUMAN Proline-rich protein 5-like OS=Homo sapiens GN=PRR5L PE=1 SV=2 | 41 | A | 0.593938 | T | 0.592703 | 0.001235 | No Change: Both D | - |
| Q6MZQ0 | PRR5L_HUMAN Proline-rich protein 5-like OS=Homo sapiens GN=PRR5L PE=1 SV=2 | 330 | P | 0.927744 | S | 0.925779 | 0.001965 | No Change: Both D | - |
| Q8TB68 | PRR7_HUMAN Proline-rich protein 7 OS=Homo sapiens GN=PRR7 PE=2 SV=1 | 127 | P | 0.979298 | H | 0.971461 | 0.007837 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 57 | P | 0.729272 | R | 0.687432 | 0.04184 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 106 | P | 0.996598 | L | 0.993214 | 0.003384 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 544 | T | 0.999356 | K | 0.999224 | 1.32E-04 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 694 | Q | 0.99356 | K | 0.994072 | -5.12E-04 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 742 | D | 0.90337 | E | 0.899241 | 0.004129 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1285 | G | 0.956038 | A | 0.960815 | -0.004777 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1415 | G | 0.999438 | A | 0.999152 | 2.86E-04 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1503 | L | 0.985025 | P | 0.992826 | -0.007801 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1740 | R | 0.992962 | H | 0.990566 | 0.002396 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1744 | G | 0.987996 | A | 0.982078 | 0.005918 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1775 | V | 0.665032 | M | 0.695169 | -0.030137 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1895 | L | 0.693353 | V | 0.624405 | 0.068948 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 2006 | P | 0.987948 | S | 0.985362 | 0.002586 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 2130 | P | 0.941885 | L | 0.90269 | 0.039195 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1087 | T | 0.992775 | I | 0.987825 | 0.00495 | No Change: Both D | A breast cancer sample |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1152 | R | 0.990744 | H | 0.985396 | 0.005348 | No Change: Both D | A breast cancer sample |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 82 | D | 0.936994 | V | 0.910513 | 0.026481 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 477 | R | 0.99531 | C | 0.992283 | 0.003027 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 804 | R | 0.857424 | C | 0.796121 | 0.061303 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1407 | S | 0.999012 | N | 0.998587 | 4.25E-04 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1544 | G | 0.9705 | D | 0.971473 | -9.73E-04 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1563 | R | 0.993877 | Q | 0.992767 | 0.00111 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 1774 | V | 0.679009 | M | 0.708544 | -0.029535 | No Change: Both D | - |
| P48634 | PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens GN=PRRC2A PE=1 SV=3 | 2075 | R | 0.915914 | W | 0.813527 | 0.102387 | No Change: Both D | - |
| Q5JSZ5 | PRC2B_HUMAN Protein PRRC2B OS=Homo sapiens GN=PRRC2B PE=1 SV=2 | 1630 | S | 0.570396 | T | 0.491805 | 0.078591 | D to O | - |
| Q5JSZ5 | PRC2B_HUMAN Protein PRRC2B OS=Homo sapiens GN=PRRC2B PE=1 SV=2 | 1675 | L | 0.979871 | P | 0.988952 | -0.009081 | No Change: Both D | - |
| Q5JSZ5 | PRC2B_HUMAN Protein PRRC2B OS=Homo sapiens GN=PRRC2B PE=1 SV=2 | 417 | M | 0.936701 | V | 0.924573 | 0.012128 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 235 | A | 0.612865 | T | 0.603234 | 0.009631 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 343 | N | 0.961907 | K | 0.961626 | 2.81E-04 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 468 | E | 0.994496 | G | 0.990817 | 0.003679 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 906 | A | 0.917707 | T | 0.92247 | -0.004763 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 959 | P | 0.990341 | S | 0.990038 | 3.03E-04 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 1624 | S | 0.968678 | C | 0.944201 | 0.024477 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 1771 | P | 0.997036 | S | 0.996896 | 1.40E-04 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 1868 | L | 0.97992 | R | 0.983065 | -0.003145 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 1885 | A | 0.9925 | T | 0.992599 | -9.90E-05 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 1924 | P | 0.998665 | R | 0.997698 | 9.67E-04 | No Change: Both D | - |
| Q9Y520 | PRC2C_HUMAN Protein PRRC2C OS=Homo sapiens GN=PRRC2C PE=1 SV=4 | 2717 | T | 0.868105 | A | 0.856069 | 0.012036 | No Change: Both D | - |
| O14668 | TMG1_HUMAN Transmembrane gamma-carboxyglutamic acid protein 1 OS=Homo sapiens GN=PRRG1 PE=2 SV=1 | 60 | F | 0.574428 | I | 0.545314 | 0.029114 | No Change: Both D | A breast cancer sample |
| O14669 | TMG2_HUMAN Transmembrane gamma-carboxyglutamic acid protein 2 OS=Homo sapiens GN=PRRG2 PE=2 SV=1 | 116 | G | 0.070918 | C | 0.027179 | 0.043739 | No Change: Both O | - |
| O14669 | TMG2_HUMAN Transmembrane gamma-carboxyglutamic acid protein 2 OS=Homo sapiens GN=PRRG2 PE=2 SV=1 | 22 | P | 0.665483 | S | 0.682437 | -0.016954 | No Change: Both D | - |
| Q9BZD7 | TMG3_HUMAN Transmembrane gamma-carboxyglutamic acid protein 3 OS=Homo sapiens GN=PRRG3 PE=2 SV=2 | 153 | N | 0.794032 | S | 0.858034 | -0.064002 | No Change: Both D | - |
| Q9BZD6 | TMG4_HUMAN Transmembrane gamma-carboxyglutamic acid protein 4 OS=Homo sapiens GN=PRRG4 PE=2 SV=1 | 33 | E | 0.673744 | K | 0.675174 | -0.00143 | No Change: Both D | - |
| Q9BZD6 | TMG4_HUMAN Transmembrane gamma-carboxyglutamic acid protein 4 OS=Homo sapiens GN=PRRG4 PE=2 SV=1 | 143 | C | 0.131728 | R | 0.247064 | -0.115336 | No Change: Both O | - |
| Q9BZD6 | TMG4_HUMAN Transmembrane gamma-carboxyglutamic acid protein 4 OS=Homo sapiens GN=PRRG4 PE=2 SV=1 | 176 | P | 0.785569 | Q | 0.736999 | 0.04857 | No Change: Both D | - |
| Q99946 | PRRT1_HUMAN Proline-rich transmembrane protein 1 OS=Homo sapiens GN=PRRT1 PE=2 SV=2 | 94 | A | 0.994634 | T | 0.994855 | -2.21E-04 | No Change: Both D | A breast cancer sample |
| Q5FWE3 | PRRT3_HUMAN Proline-rich transmembrane protein 3 OS=Homo sapiens GN=PRRT3 PE=1 SV=3 | 138 | Q | 0.703437 | E | 0.710799 | -0.007362 | No Change: Both D | - |
| Q5FWE3 | PRRT3_HUMAN Proline-rich transmembrane protein 3 OS=Homo sapiens GN=PRRT3 PE=1 SV=3 | 860 | L | 0.934968 | I | 0.907386 | 0.027582 | No Change: Both D | - |
| Q5FWE3 | PRRT3_HUMAN Proline-rich transmembrane protein 3 OS=Homo sapiens GN=PRRT3 PE=1 SV=3 | 213 | S | 0.908245 | P | 0.917957 | -0.009712 | No Change: Both D | - |
| Q5FWE3 | PRRT3_HUMAN Proline-rich transmembrane protein 3 OS=Homo sapiens GN=PRRT3 PE=1 SV=3 | 233 | L | 0.819376 | F | 0.821562 | -0.002186 | No Change: Both D | - |
| Q5FWE3 | PRRT3_HUMAN Proline-rich transmembrane protein 3 OS=Homo sapiens GN=PRRT3 PE=1 SV=3 | 334 | R | 0.992895 | G | 0.991657 | 0.001238 | No Change: Both D | - |
| P54821 | PRRX1_HUMAN Paired mesoderm homeobox protein 1 OS=Homo sapiens GN=PRRX1 PE=1 SV=2 | 113 | F | 0.552537 | S | 0.683596 | -0.131059 | No Change: Both D | Agnathia-otocephaly complex (AGOTC) [MIM:202650] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 29 | N | 0.339443 | I | 0.174767 | 0.164676 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 122 | R | 0.315936 | H | 0.286355 | 0.029581 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 22 | D | 0.420329 | G | 0.386108 | 0.034221 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 23 | K | 0.376669 | R | 0.307463 | 0.069206 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 104 | L | 0.338483 | P | 0.466769 | -0.128286 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 116 | R | 0.23649 | C | 0.122005 | 0.114485 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 139 | C | 0.291088 | F | 0.259295 | 0.031793 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 16 | A | 0.249166 | V | 0.175598 | 0.073568 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 29 | N | 0.339443 | T | 0.283243 | 0.0562 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 122 | R | 0.315936 | C | 0.181283 | 0.134653 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 137 | T | 0.365591 | M | 0.305085 | 0.060506 | No Change: Both O | A colorectal cancer sample |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 54 | N | 0.158578 | S | 0.200768 | -0.04219 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P07477 | TRY1_HUMAN Trypsin-1 OS=Homo sapiens GN=PRSS1 PE=1 SV=1 | 79 | E | 0.382386 | K | 0.355435 | 0.026951 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P56730 | NETR_HUMAN Neurotrypsin OS=Homo sapiens GN=PRSS12 PE=2 SV=2 | 606 | A | 0.612036 | S | 0.715583 | -0.103547 | No Change: Both D | - |
| P56730 | NETR_HUMAN Neurotrypsin OS=Homo sapiens GN=PRSS12 PE=2 SV=2 | 833 | R | 0.376853 | Q | 0.39163 | -0.014777 | No Change: Both O | - |
| Q9NQE7 | TSSP_HUMAN Thymus-specific serine protease OS=Homo sapiens GN=PRSS16 PE=2 SV=2 | 104 | S | 0.668283 | I | 0.422368 | 0.245915 | D to O | - |
| Q9NQE7 | TSSP_HUMAN Thymus-specific serine protease OS=Homo sapiens GN=PRSS16 PE=2 SV=2 | 204 | A | 0.205254 | G | 0.230761 | -0.025507 | No Change: Both O | - |
| P07478 | TRY2_HUMAN Trypsin-2 OS=Homo sapiens GN=PRSS2 PE=1 SV=1 | 117 | A | 0.363294 | V | 0.289497 | 0.073797 | No Change: Both O | - |
| Q9Y6M0 | TEST_HUMAN Testisin OS=Homo sapiens GN=PRSS21 PE=2 SV=1 | 264 | R | 0.359175 | Q | 0.360314 | -0.001139 | No Change: Both O | - |
| P35030 | TRY3_HUMAN Trypsin-3 OS=Homo sapiens GN=PRSS3 PE=1 SV=2 | 188 | T | 0.503852 | A | 0.474395 | 0.029457 | D to O | - |
| P35030 | TRY3_HUMAN Trypsin-3 OS=Homo sapiens GN=PRSS3 PE=1 SV=2 | 232 | Y | 0.373422 | C | 0.390987 | -0.017565 | No Change: Both O | - |
| P35030 | TRY3_HUMAN Trypsin-3 OS=Homo sapiens GN=PRSS3 PE=1 SV=2 | 224 | T | 0.216351 | S | 0.289543 | -0.073192 | No Change: Both O | - |
| Q8N3Z0 | PRS35_HUMAN Inactive serine protease 35 OS=Homo sapiens GN=PRSS35 PE=2 SV=2 | 224 | R | 0.987265 | Q | 0.985275 | 0.00199 | No Change: Both D | - |
| A4D1T9 | PRS37_HUMAN Probable inactive serine protease 37 OS=Homo sapiens GN=PRSS37 PE=2 SV=1 | 119 | T | 0.324824 | P | 0.390433 | -0.065609 | No Change: Both O | - |
| A1L453 | PRS38_HUMAN Serine protease 38 OS=Homo sapiens GN=PRSS38 PE=2 SV=2 | 204 | M | 0.374245 | V | 0.312847 | 0.061398 | No Change: Both O | - |
| Q7RTY9 | PRS41_HUMAN Putative serine protease 41 OS=Homo sapiens GN=PRSS41 PE=5 SV=1 | 286 | S | 0.060476 | G | 0.050278 | 0.010198 | No Change: Both O | - |
| Q7RTY5 | PRS48_HUMAN Serine protease 48 OS=Homo sapiens GN=PRSS48 PE=2 SV=2 | 53 | C | 0.158002 | Y | 0.196888 | -0.038886 | No Change: Both O | - |
| Q7RTY5 | PRS48_HUMAN Serine protease 48 OS=Homo sapiens GN=PRSS48 PE=2 SV=2 | 118 | L | 0.265239 | S | 0.44907 | -0.183831 | No Change: Both O | - |
| Q7RTY5 | PRS48_HUMAN Serine protease 48 OS=Homo sapiens GN=PRSS48 PE=2 SV=2 | 290 | R | 0.148164 | C | 0.077079 | 0.071085 | No Change: Both O | - |
| Q9UI38 | TSP50_HUMAN Probable threonine protease PRSS50 OS=Homo sapiens GN=PRSS50 PE=1 SV=1 | 75 | Q | 0.86529 | P | 0.886101 | -0.020811 | No Change: Both D | - |
| Q9UI38 | TSP50_HUMAN Probable threonine protease PRSS50 OS=Homo sapiens GN=PRSS50 PE=1 SV=1 | 98 | V | 0.684548 | I | 0.626252 | 0.058296 | No Change: Both D | - |
| Q6PEW0 | PRS54_HUMAN Inactive serine protease 54 OS=Homo sapiens GN=PRSS54 PE=2 SV=3 | 182 | S | 0.214823 | G | 0.18075 | 0.034073 | No Change: Both O | - |
| Q6PEW0 | PRS54_HUMAN Inactive serine protease 54 OS=Homo sapiens GN=PRSS54 PE=2 SV=3 | 240 | V | 0.070962 | I | 0.057069 | 0.013893 | No Change: Both O | - |
| Q6PEW0 | PRS54_HUMAN Inactive serine protease 54 OS=Homo sapiens GN=PRSS54 PE=2 SV=3 | 295 | T | 0.580345 | A | 0.548184 | 0.032161 | No Change: Both D | - |
| Q6UWB4 | PRS55_HUMAN Serine protease 55 OS=Homo sapiens GN=PRSS55 PE=2 SV=2 | 44 | P | 0.917983 | R | 0.908186 | 0.009797 | No Change: Both D | - |
| Q6UWB4 | PRS55_HUMAN Serine protease 55 OS=Homo sapiens GN=PRSS55 PE=2 SV=2 | 212 | A | 0.27986 | V | 0.225435 | 0.054425 | No Change: Both O | - |
| P0CW18 | PRS56_HUMAN Putative serine protease 56 OS=Homo sapiens GN=PRSS56 PE=5 SV=1 | 176 | R | 0.317048 | G | 0.322719 | -0.005671 | No Change: Both O | Microphthalmia isolated type 6 (MCOP6) [MIM:613517] |
| P0CW18 | PRS56_HUMAN Putative serine protease 56 OS=Homo sapiens GN=PRSS56 PE=5 SV=1 | 309 | W | 0.462772 | S | 0.680959 | -0.218187 | O to D | Microphthalmia isolated type 6 (MCOP6) [MIM:613517] |
| Q6UWY2 | PRS57_HUMAN Serine protease 57 OS=Homo sapiens GN=PRSS57 PE=2 SV=2 | 143 | P | 0.617474 | L | 0.435739 | 0.181735 | D to O | - |
| Q2VWP7 | PRTG_HUMAN Protogenin OS=Homo sapiens GN=PRTG PE=2 SV=1 | 1062 | I | 0.511687 | L | 0.53057 | -0.018883 | No Change: Both D | - |
| Q2VWP7 | PRTG_HUMAN Protogenin OS=Homo sapiens GN=PRTG PE=2 SV=1 | 236 | T | 0.383831 | A | 0.34777 | 0.036061 | No Change: Both O | - |
| Q2VWP7 | PRTG_HUMAN Protogenin OS=Homo sapiens GN=PRTG PE=2 SV=1 | 826 | V | 0.320492 | L | 0.314291 | 0.006201 | No Change: Both O | - |
| P24158 | PRTN3_HUMAN Myeloblastin OS=Homo sapiens GN=PRTN3 PE=1 SV=3 | 119 | V | 0.310189 | I | 0.278686 | 0.031503 | No Change: Both O | - |
| P24158 | PRTN3_HUMAN Myeloblastin OS=Homo sapiens GN=PRTN3 PE=1 SV=3 | 135 | A | 0.419919 | T | 0.447494 | -0.027575 | No Change: Both O | - |
| P24158 | PRTN3_HUMAN Myeloblastin OS=Homo sapiens GN=PRTN3 PE=1 SV=3 | 136 | T | 0.450835 | S | 0.570482 | -0.119647 | O to D | - |
| Q86TP1 | PRUNE_HUMAN Protein prune homolog OS=Homo sapiens GN=PRUNE PE=1 SV=2 | 397 | G | 0.943098 | S | 0.964 | -0.020902 | No Change: Both D | - |
| Q86TP1 | PRUNE_HUMAN Protein prune homolog OS=Homo sapiens GN=PRUNE PE=1 SV=2 | 397 | G | 0.943098 | R | 0.954132 | -0.011034 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 406 | A | 0.826679 | T | 0.843318 | -0.016639 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 495 | E | 0.979841 | Q | 0.972598 | 0.007243 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 882 | V | 0.73182 | A | 0.772406 | -0.040586 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 921 | I | 0.710091 | M | 0.792709 | -0.082618 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 935 | K | 0.824915 | E | 0.819721 | 0.005194 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 1083 | P | 0.824893 | R | 0.814875 | 0.010018 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 1132 | G | 0.492458 | R | 0.473687 | 0.018771 | No Change: Both O | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 1259 | E | 0.860662 | K | 0.83248 | 0.028182 | No Change: Both D | - |
| Q9BXM0 | PRAX_HUMAN Periaxin OS=Homo sapiens GN=PRX PE=1 SV=2 | 1411 | R | 0.974839 | C | 0.954874 | 0.019965 | No Change: Both D | - |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 217 | T | 0.242976 | I | 0.146676 | 0.0963 | No Change: Both O | Leukodystrophy metachromatic due to saposin-B deficiency (MLD-SAPB) [MIM:249900] |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 241 | C | 0.201327 | S | 0.437067 | -0.23574 | No Change: Both O | Leukodystrophy metachromatic due to saposin-B deficiency (MLD-SAPB) [MIM:249900] |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 388 | C | 0.188584 | F | 0.179652 | 0.008932 | No Change: Both O | Atypical Gaucher disease (AGD) [MIM:610539] |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 215 | N | 0.291802 | H | 0.274506 | 0.017296 | No Change: Both O | Leukodystrophy metachromatic due to saposin-B deficiency (MLD-SAPB) [MIM:249900] |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 215 | N | 0.291802 | K | 0.332219 | -0.040417 | No Change: Both O | Leukodystrophy metachromatic due to saposin-B deficiency (MLD-SAPB) [MIM:249900] |
| P07602 | SAP_HUMAN Proactivator polypeptide OS=Homo sapiens GN=PSAP PE=1 SV=2 | 349 | L | 0.657966 | P | 0.757875 | -0.099909 | No Change: Both D | Atypical Gaucher disease (AGD) [MIM:610539] |
| Q6NUJ1 | SAPL1_HUMAN Proactivator polypeptide-like 1 OS=Homo sapiens GN=PSAPL1 PE=2 SV=2 | 268 | A | 0.511709 | S | 0.585897 | -0.074188 | No Change: Both D | - |
| Q6NUJ1 | SAPL1_HUMAN Proactivator polypeptide-like 1 OS=Homo sapiens GN=PSAPL1 PE=2 SV=2 | 296 | V | 0.194672 | M | 0.274917 | -0.080245 | No Change: Both O | - |
| Q6NUJ1 | SAPL1_HUMAN Proactivator polypeptide-like 1 OS=Homo sapiens GN=PSAPL1 PE=2 SV=2 | 41 | A | 0.242066 | S | 0.307857 | -0.065791 | No Change: Both O | - |
| Q6NUJ1 | SAPL1_HUMAN Proactivator polypeptide-like 1 OS=Homo sapiens GN=PSAPL1 PE=2 SV=2 | 44 | G | 0.259628 | R | 0.265213 | -0.005585 | No Change: Both O | - |
| Q6NUJ1 | SAPL1_HUMAN Proactivator polypeptide-like 1 OS=Homo sapiens GN=PSAPL1 PE=2 SV=2 | 59 | A | 0.317753 | T | 0.340872 | -0.023119 | No Change: Both O | - |
| Q9Y617 | SERC_HUMAN Phosphoserine aminotransferase OS=Homo sapiens GN=PSAT1 PE=1 SV=2 | 100 | D | 0.103469 | A | 0.081281 | 0.022188 | No Change: Both O | Phosphoserine aminotransferase deficiency (PSATD) [MIM:610992] |
| Q9Y617 | SERC_HUMAN Phosphoserine aminotransferase OS=Homo sapiens GN=PSAT1 PE=1 SV=2 | 87 | P | 0.114606 | A | 0.087603 | 0.027003 | No Change: Both O | - |
| O43653 | PSCA_HUMAN Prostate stem cell antigen OS=Homo sapiens GN=PSCA PE=1 SV=1 | 39 | E | 0.243656 | K | 0.228221 | 0.015435 | No Change: Both O | - |
| Q9BQI7 | PSD2_HUMAN PH and SEC7 domain-containing protein 2 OS=Homo sapiens GN=PSD2 PE=2 SV=3 | 31 | R | 0.982876 | Q | 0.979135 | 0.003741 | No Change: Both D | - |
| Q9BQI7 | PSD2_HUMAN PH and SEC7 domain-containing protein 2 OS=Homo sapiens GN=PSD2 PE=2 SV=3 | 51 | R | 0.898794 | M | 0.88008 | 0.018714 | No Change: Both D | - |
| Q9BQI7 | PSD2_HUMAN PH and SEC7 domain-containing protein 2 OS=Homo sapiens GN=PSD2 PE=2 SV=3 | 363 | G | 0.200407 | R | 0.201864 | -0.001457 | No Change: Both O | - |
| Q9NYI0 | PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens GN=PSD3 PE=1 SV=2 | 186 | T | 0.695722 | M | 0.640959 | 0.054763 | No Change: Both D | - |
| Q9NYI0 | PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens GN=PSD3 PE=1 SV=2 | 186 | T | 0.695722 | P | 0.742921 | -0.047199 | No Change: Both D | - |
| Q9NYI0 | PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens GN=PSD3 PE=1 SV=2 | 293 | P | 0.70957 | L | 0.590082 | 0.119488 | No Change: Both D | - |
| Q8NDX1 | PSD4_HUMAN PH and SEC7 domain-containing protein 4 OS=Homo sapiens GN=PSD4 PE=1 SV=2 | 269 | G | 0.823579 | A | 0.811426 | 0.012153 | No Change: Both D | - |
| Q8NDX1 | PSD4_HUMAN PH and SEC7 domain-containing protein 4 OS=Homo sapiens GN=PSD4 PE=1 SV=2 | 83 | G | 0.776558 | R | 0.792993 | -0.016435 | No Change: Both D | - |
| Q8NDX1 | PSD4_HUMAN PH and SEC7 domain-containing protein 4 OS=Homo sapiens GN=PSD4 PE=1 SV=2 | 233 | S | 0.943121 | P | 0.943248 | -1.27E-04 | No Change: Both D | - |
| Q8NDX1 | PSD4_HUMAN PH and SEC7 domain-containing protein 4 OS=Homo sapiens GN=PSD4 PE=1 SV=2 | 637 | R | 0.381353 | Q | 0.407117 | -0.025764 | No Change: Both O | - |
| Q8NDX1 | PSD4_HUMAN PH and SEC7 domain-containing protein 4 OS=Homo sapiens GN=PSD4 PE=1 SV=2 | 658 | I | 0.355423 | V | 0.387523 | -0.0321 | No Change: Both O | - |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 79 | A | 0.172049 | V | 0.142944 | 0.029105 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 82 | V | 0.07703 | L | 0.076814 | 2.16E-04 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 96 | V | 0.037752 | F | 0.029379 | 0.008373 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 115 | Y | 0.221903 | C | 0.179339 | 0.042564 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 115 | Y | 0.221903 | H | 0.335436 | -0.113533 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 120 | E | 0.422395 | D | 0.393654 | 0.028741 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 120 | E | 0.422395 | K | 0.404387 | 0.018008 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 139 | M | 0.048632 | I | 0.034316 | 0.014316 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 139 | M | 0.048632 | T | 0.059623 | -0.010991 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 139 | M | 0.048632 | V | 0.039063 | 0.009569 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 143 | I | 0.021557 | F | 0.01912 | 0.002437 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 143 | I | 0.021557 | T | 0.040576 | -0.019019 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 146 | M | 0.015087 | I | 0.010263 | 0.004824 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 146 | M | 0.015087 | L | 0.011722 | 0.003365 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 146 | M | 0.015087 | V | 0.012217 | 0.00287 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 163 | H | 0.02081 | R | 0.0221 | -0.00129 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 163 | H | 0.02081 | Y | 0.012685 | 0.008125 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 169 | S | 0.02454 | L | 0.010238 | 0.014302 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 169 | S | 0.02454 | P | 0.019791 | 0.004749 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 171 | L | 0.021441 | P | 0.041827 | -0.020386 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 209 | G | 0.044883 | V | 0.02383 | 0.021053 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 213 | I | 0.097631 | T | 0.167657 | -0.070026 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 231 | A | 0.032582 | T | 0.034154 | -0.001572 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 231 | A | 0.032582 | V | 0.021734 | 0.010848 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 233 | M | 0.02432 | T | 0.02823 | -0.00391 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 235 | L | 0.024719 | P | 0.052114 | -0.027395 | No Change: Both O | - |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 246 | A | 0.01683 | E | 0.028783 | -0.011953 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 250 | L | 0.012082 | S | 0.030234 | -0.018152 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 260 | A | 0.049079 | V | 0.037535 | 0.011544 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 262 | L | 0.085115 | F | 0.067965 | 0.01715 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 263 | C | 0.107402 | R | 0.224803 | -0.117401 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 264 | P | 0.136095 | L | 0.069004 | 0.067091 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 267 | P | 0.187806 | S | 0.197135 | -0.009329 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 267 | P | 0.187806 | T | 0.147133 | 0.040673 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 269 | R | 0.214601 | G | 0.235918 | -0.021317 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 269 | R | 0.214601 | H | 0.214684 | -8.30E-05 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 278 | R | 0.473447 | T | 0.480567 | -0.00712 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 280 | E | 0.353072 | A | 0.255217 | 0.097855 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 280 | E | 0.353072 | G | 0.286593 | 0.066479 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 285 | A | 0.147734 | V | 0.108924 | 0.03881 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 286 | L | 0.123106 | V | 0.119599 | 0.003507 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 318 | E | 0.858144 | G | 0.821233 | 0.036911 | No Change: Both D | - |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 378 | G | 0.512332 | E | 0.550222 | -0.03789 | No Change: Both D | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 384 | G | 0.112215 | A | 0.084529 | 0.027686 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 392 | L | 0.114781 | V | 0.125448 | -0.010667 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 410 | C | 0.014123 | Y | 0.017766 | -0.003643 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 426 | A | 0.043274 | P | 0.061077 | -0.017803 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 436 | P | 0.106682 | Q | 0.091467 | 0.015215 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 436 | P | 0.106682 | S | 0.120369 | -0.013687 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 105 | F | 0.239555 | L | 0.271657 | -0.032102 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 117 | P | 0.258352 | L | 0.14476 | 0.113592 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 209 | G | 0.044883 | R | 0.038629 | 0.006254 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 233 | M | 0.02432 | L | 0.018521 | 0.005799 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 282 | L | 0.244283 | R | 0.356723 | -0.11244 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 409 | A | 0.023148 | T | 0.027007 | -0.003859 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 116 | T | 0.230913 | N | 0.245106 | -0.014193 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 135 | N | 0.120974 | D | 0.129809 | -0.008835 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 139 | M | 0.048632 | K | 0.084864 | -0.036232 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 147 | T | 0.013932 | I | 0.007833 | 0.006099 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 165 | W | 0.022224 | C | 0.027727 | -0.005503 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 173 | L | 0.016723 | W | 0.010269 | 0.006454 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 219 | L | 0.173695 | P | 0.318477 | -0.144782 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 289 | S | 0.108493 | C | 0.049407 | 0.059086 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 390 | S | 0.058612 | I | 0.021158 | 0.037454 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 405 | N | 0.190385 | S | 0.234359 | -0.043974 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 205 | F | 0.020676 | L | 0.026327 | -0.005651 | No Change: Both O | - |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 92 | C | 0.019763 | S | 0.057062 | -0.037299 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 113 | L | 0.213251 | P | 0.393517 | -0.180266 | No Change: Both O | Frontotemporal dementia (FTD) [MIM:600274] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 166 | L | 0.021142 | P | 0.041919 | -0.020777 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 174 | L | 0.016297 | M | 0.019624 | -0.003327 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 206 | G | 0.022754 | A | 0.016594 | 0.00616 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 266 | G | 0.182211 | S | 0.224022 | -0.041811 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 271 | L | 0.280374 | V | 0.281788 | -0.001414 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 431 | A | 0.157411 | E | 0.225659 | -0.068248 | No Change: Both O | Alzheimer disease type 3 (AD3) [MIM:607822] |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 315 | Y | 0.811689 | C | 0.824497 | -0.012808 | No Change: Both D | - |
| P49768 | PSN1_HUMAN Presenilin-1 OS=Homo sapiens GN=PSEN1 PE=1 SV=1 | 333 | D | 0.922792 | G | 0.91195 | 0.010842 | No Change: Both D | Cardiomyopathy dilated type 1U (CMD1U) [MIM:613694] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 62 | R | 0.756376 | H | 0.721943 | 0.034433 | No Change: Both D | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 141 | N | 0.090346 | I | 0.040343 | 0.050003 | No Change: Both O | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 239 | M | 0.024313 | V | 0.017866 | 0.006447 | No Change: Both O | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 148 | V | 0.021663 | I | 0.019024 | 0.002639 | No Change: Both O | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 122 | T | 0.234297 | P | 0.280555 | -0.046258 | No Change: Both O | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 239 | M | 0.024313 | I | 0.016021 | 0.008292 | No Change: Both O | Alzheimer disease type 4 (AD4) [MIM:606889] |
| P49810 | PSN2_HUMAN Presenilin-2 OS=Homo sapiens GN=PSEN2 PE=1 SV=1 | 130 | S | 0.515059 | L | 0.308349 | 0.20671 | D to O | Cardiomyopathy dilated type 1V (CMD1V) [MIM:613697] |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 41 | E | 0.619022 | Q | 0.558806 | 0.060216 | No Change: Both D | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 43 | T | 0.645649 | P | 0.697119 | -0.05147 | No Change: Both D | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 47 | E | 0.571079 | K | 0.577837 | -0.006758 | No Change: Both D | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 63 | T | 0.112782 | A | 0.099006 | 0.013776 | No Change: Both O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 73 | R | 0.149577 | K | 0.206973 | -0.057396 | No Change: Both O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 87 | E | 0.105493 | Q | 0.085298 | 0.020195 | No Change: Both O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 101 | A | 0.535596 | V | 0.429907 | 0.105689 | D to O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 134 | V | 0.420713 | E | 0.576028 | -0.155315 | O to D | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 197 | E | 0.474725 | K | 0.489546 | -0.014821 | No Change: Both O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 198 | T | 0.3851 | N | 0.408346 | -0.023246 | No Change: Both O | - |
| P11464 | PSG1_HUMAN Pregnancy-specific beta-1-glycoprotein 1 OS=Homo sapiens GN=PSG1 PE=2 SV=1 | 125 | I | 0.325677 | V | 0.339735 | -0.014058 | No Change: Both O | - |
| Q9UQ72 | PSG11_HUMAN Pregnancy-specific beta-1-glycoprotein 11 OS=Homo sapiens GN=PSG11 PE=2 SV=3 | 176 | A | 0.31402 | T | 0.388988 | -0.074968 | No Change: Both O | - |
| Q9UQ72 | PSG11_HUMAN Pregnancy-specific beta-1-glycoprotein 11 OS=Homo sapiens GN=PSG11 PE=2 SV=3 | 264 | N | 0.373415 | D | 0.380643 | -0.007228 | No Change: Both O | - |
| Q9UQ72 | PSG11_HUMAN Pregnancy-specific beta-1-glycoprotein 11 OS=Homo sapiens GN=PSG11 PE=2 SV=3 | 83 | V | 0.079448 | I | 0.072316 | 0.007132 | No Change: Both O | - |
| Q9UQ72 | PSG11_HUMAN Pregnancy-specific beta-1-glycoprotein 11 OS=Homo sapiens GN=PSG11 PE=2 SV=3 | 310 | E | 0.683797 | K | 0.667238 | 0.016559 | No Change: Both D | - |
| P11465 | PSG2_HUMAN Pregnancy-specific beta-1-glycoprotein 2 OS=Homo sapiens GN=PSG2 PE=2 SV=2 | 20 | V | 0.081607 | L | 0.100937 | -0.01933 | No Change: Both O | - |
| P11465 | PSG2_HUMAN Pregnancy-specific beta-1-glycoprotein 2 OS=Homo sapiens GN=PSG2 PE=2 SV=2 | 176 | T | 0.423121 | A | 0.353556 | 0.069565 | No Change: Both O | - |
| P11465 | PSG2_HUMAN Pregnancy-specific beta-1-glycoprotein 2 OS=Homo sapiens GN=PSG2 PE=2 SV=2 | 179 | Q | 0.322442 | L | 0.209253 | 0.113189 | No Change: Both O | - |
| P11465 | PSG2_HUMAN Pregnancy-specific beta-1-glycoprotein 2 OS=Homo sapiens GN=PSG2 PE=2 SV=2 | 335 | T | 0.79135 | R | 0.803352 | -0.012002 | No Change: Both D | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 30 | L | 0.095671 | P | 0.179453 | -0.083782 | No Change: Both O | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 23 | L | 0.040712 | S | 0.07876 | -0.038048 | No Change: Both O | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 198 | N | 0.413056 | T | 0.401102 | 0.011954 | No Change: Both O | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 199 | K | 0.355359 | N | 0.326176 | 0.029183 | No Change: Both O | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 30 | L | 0.095671 | S | 0.181615 | -0.085944 | No Change: Both O | - |
| Q16557 | PSG3_HUMAN Pregnancy-specific beta-1-glycoprotein 3 OS=Homo sapiens GN=PSG3 PE=2 SV=2 | 290 | I | 0.349046 | N | 0.508724 | -0.159678 | O to D | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 75 | L | 0.073076 | V | 0.076186 | -0.00311 | No Change: Both O | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 240 | S | 0.46535 | P | 0.488592 | -0.023242 | No Change: Both O | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 286 | V | 0.49566 | A | 0.554062 | -0.058402 | O to D | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 11 | Q | 0.191205 | H | 0.169179 | 0.022026 | No Change: Both O | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 177 | S | 0.226486 | R | 0.182378 | 0.044108 | No Change: Both O | - |
| Q00888 | PSG4_HUMAN Pregnancy-specific beta-1-glycoprotein 4 OS=Homo sapiens GN=PSG4 PE=2 SV=3 | 267 | K | 0.25128 | E | 0.250714 | 5.66E-04 | No Change: Both O | - |
| Q15238 | PSG5_HUMAN Pregnancy-specific beta-1-glycoprotein 5 OS=Homo sapiens GN=PSG5 PE=1 SV=3 | 154 | N | 0.525331 | K | 0.568737 | -0.043406 | No Change: Both D | - |
| Q15238 | PSG5_HUMAN Pregnancy-specific beta-1-glycoprotein 5 OS=Homo sapiens GN=PSG5 PE=1 SV=3 | 18 | L | 0.109379 | V | 0.094798 | 0.014581 | No Change: Both O | - |
| Q15238 | PSG5_HUMAN Pregnancy-specific beta-1-glycoprotein 5 OS=Homo sapiens GN=PSG5 PE=1 SV=3 | 168 | T | 0.243785 | I | 0.144958 | 0.098827 | No Change: Both O | - |
| Q15238 | PSG5_HUMAN Pregnancy-specific beta-1-glycoprotein 5 OS=Homo sapiens GN=PSG5 PE=1 SV=3 | 227 | R | 0.567144 | H | 0.530847 | 0.036297 | No Change: Both D | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 155 | L | 0.648197 | F | 0.624002 | 0.024195 | No Change: Both D | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 165 | R | 0.217048 | L | 0.142955 | 0.074093 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 167 | I | 0.274348 | T | 0.429476 | -0.155128 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 180 | L | 0.115041 | W | 0.076923 | 0.038118 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 181 | L | 0.143321 | M | 0.177712 | -0.034391 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 185 | N | 0.270691 | S | 0.298625 | -0.027934 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 191 | R | 0.425968 | S | 0.511001 | -0.085033 | O to D | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 196 | K | 0.45091 | E | 0.449399 | 0.001511 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 253 | K | 0.434165 | N | 0.411011 | 0.023154 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 257 | L | 0.263839 | S | 0.425252 | -0.161413 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 258 | A | 0.245181 | T | 0.298191 | -0.05301 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 404 | I | 0.595181 | S | 0.727782 | -0.132601 | No Change: Both D | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 85 | H | 0.101203 | D | 0.116403 | -0.0152 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 161 | M | 0.327246 | T | 0.372568 | -0.045322 | No Change: Both O | - |
| Q00889 | PSG6_HUMAN Pregnancy-specific beta-1-glycoprotein 6 OS=Homo sapiens GN=PSG6 PE=2 SV=1 | 188 | M | 0.359814 | R | 0.44408 | -0.084266 | No Change: Both O | - |
| Q13046 | PSG7_HUMAN Putative pregnancy-specific beta-1-glycoprotein 7 OS=Homo sapiens GN=PSG7 PE=5 SV=2 | 65 | H | 0.140124 | Y | 0.087573 | 0.052551 | No Change: Both O | - |
| Q9UQ74 | PSG8_HUMAN Pregnancy-specific beta-1-glycoprotein 8 OS=Homo sapiens GN=PSG8 PE=2 SV=2 | 349 | V | 0.203162 | D | 0.35844 | -0.155278 | No Change: Both O | - |
| Q9UQ74 | PSG8_HUMAN Pregnancy-specific beta-1-glycoprotein 8 OS=Homo sapiens GN=PSG8 PE=2 SV=2 | 315 | Q | 0.294513 | P | 0.320709 | -0.026196 | No Change: Both O | - |
| Q00887 | PSG9_HUMAN Pregnancy-specific beta-1-glycoprotein 9 OS=Homo sapiens GN=PSG9 PE=2 SV=2 | 325 | I | 0.153332 | T | 0.253812 | -0.10048 | No Change: Both O | - |
| Q00887 | PSG9_HUMAN Pregnancy-specific beta-1-glycoprotein 9 OS=Homo sapiens GN=PSG9 PE=2 SV=2 | 374 | Q | 0.360616 | L | 0.233984 | 0.126632 | No Change: Both O | - |
| Q00887 | PSG9_HUMAN Pregnancy-specific beta-1-glycoprotein 9 OS=Homo sapiens GN=PSG9 PE=2 SV=2 | 397 | H | 0.397423 | R | 0.405859 | -0.008436 | No Change: Both O | - |
| Q00887 | PSG9_HUMAN Pregnancy-specific beta-1-glycoprotein 9 OS=Homo sapiens GN=PSG9 PE=2 SV=2 | 176 | A | 0.10021 | T | 0.122228 | -0.022018 | No Change: Both O | - |
| Q00887 | PSG9_HUMAN Pregnancy-specific beta-1-glycoprotein 9 OS=Homo sapiens GN=PSG9 PE=2 SV=2 | 18 | L | 0.169868 | V | 0.135453 | 0.034415 | No Change: Both O | - |
| P11801 | KPSH1_HUMAN Serine/threonine-protein kinase H1 OS=Homo sapiens GN=PSKH1 PE=1 SV=4 | 301 | N | 0.478485 | S | 0.518369 | -0.039884 | O to D | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 72 | G | 0.274158 | D | 0.300541 | -0.026383 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 79 | R | 0.44766 | K | 0.489448 | -0.041788 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 114 | R | 0.288511 | Q | 0.282673 | 0.005838 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 116 | S | 0.229528 | I | 0.102853 | 0.126675 | No Change: Both O | A lung adenocarcinoma sample |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 132 | Q | 0.219046 | R | 0.208253 | 0.010793 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 148 | R | 0.184604 | Q | 0.21085 | -0.026246 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 176 | A | 0.126164 | S | 0.193177 | -0.067013 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 211 | G | 0.462052 | R | 0.425921 | 0.036131 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 212 | K | 0.500849 | I | 0.301402 | 0.199447 | D to O | A lung adenocarcinoma sample |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 225 | T | 0.190123 | A | 0.166813 | 0.02331 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 266 | S | 0.458711 | R | 0.404914 | 0.053797 | No Change: Both O | - |
| Q96QS6 | KPSH2_HUMAN Serine/threonine-protein kinase H2 OS=Homo sapiens GN=PSKH2 PE=2 SV=1 | 336 | I | 0.793258 | V | 0.798927 | -0.005669 | No Change: Both D | - |
| P25787 | PSA2_HUMAN Proteasome subunit alpha type-2 OS=Homo sapiens GN=PSMA2 PE=1 SV=2 | 110 | L | 0.234288 | V | 0.257048 | -0.02276 | No Change: Both O | A colorectal cancer sample |
| P60900 | PSA6_HUMAN Proteasome subunit alpha type-6 OS=Homo sapiens GN=PSMA6 PE=1 SV=1 | 233 | A | 0.228276 | S | 0.303088 | -0.074812 | No Change: Both O | - |
| P20618 | PSB1_HUMAN Proteasome subunit beta type-1 OS=Homo sapiens GN=PSMB1 PE=1 SV=2 | 11 | P | 0.618917 | A | 0.54109 | 0.077827 | No Change: Both D | - |
| P20618 | PSB1_HUMAN Proteasome subunit beta type-1 OS=Homo sapiens GN=PSMB1 PE=1 SV=2 | 208 | I | 0.148044 | N | 0.281574 | -0.13353 | No Change: Both O | - |
| A5LHX3 | PSB11_HUMAN Proteasome subunit beta type-11 OS=Homo sapiens GN=PSMB11 PE=2 SV=1 | 49 | G | 0.339745 | S | 0.37437 | -0.034625 | No Change: Both O | - |
| P49720 | PSB3_HUMAN Proteasome subunit beta type-3 OS=Homo sapiens GN=PSMB3 PE=1 SV=2 | 34 | M | 0.177217 | L | 0.133605 | 0.043612 | No Change: Both O | - |
| P28070 | PSB4_HUMAN Proteasome subunit beta type-4 OS=Homo sapiens GN=PSMB4 PE=1 SV=4 | 95 | M | 0.418524 | I | 0.318452 | 0.100072 | No Change: Both O | - |
| P28070 | PSB4_HUMAN Proteasome subunit beta type-4 OS=Homo sapiens GN=PSMB4 PE=1 SV=4 | 234 | I | 0.185915 | T | 0.327295 | -0.14138 | No Change: Both O | - |
| P28074 | PSB5_HUMAN Proteasome subunit beta type-5 OS=Homo sapiens GN=PSMB5 PE=1 SV=3 | 24 | R | 0.434234 | C | 0.279849 | 0.154385 | No Change: Both O | - |
| P28072 | PSB6_HUMAN Proteasome subunit beta type-6 OS=Homo sapiens GN=PSMB6 PE=1 SV=4 | 107 | P | 0.485174 | A | 0.393901 | 0.091273 | No Change: Both O | - |
| Q99436 | PSB7_HUMAN Proteasome subunit beta type-7 OS=Homo sapiens GN=PSMB7 PE=1 SV=1 | 39 | V | 0.473353 | A | 0.545971 | -0.072618 | O to D | - |
| P28062 | PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3 | 8 | G | 0.774635 | R | 0.820611 | -0.045976 | No Change: Both D | - |
| P28062 | PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3 | 74 | T | 0.25547 | S | 0.304538 | -0.049068 | No Change: Both O | - |
| P28062 | PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3 | 49 | Q | 0.637877 | K | 0.626797 | 0.01108 | No Change: Both D | - |
| P28062 | PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3 | 75 | T | 0.256325 | M | 0.217765 | 0.03856 | No Change: Both O | Nakajo syndrome (NKJO) [MIM:256040] |
| P28062 | PSB8_HUMAN Proteasome subunit beta type-8 OS=Homo sapiens GN=PSMB8 PE=1 SV=3 | 201 | G | 0.537003 | V | 0.394014 | 0.142989 | D to O | Nakajo syndrome (NKJO) [MIM:256040] |
| P28065 | PSB9_HUMAN Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 PE=1 SV=2 | 60 | R | 0.192244 | H | 0.201389 | -0.009145 | No Change: Both O | - |
| P28065 | PSB9_HUMAN Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 PE=1 SV=2 | 9 | G | 0.585625 | E | 0.610397 | -0.024772 | No Change: Both D | - |
| P28065 | PSB9_HUMAN Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 PE=1 SV=2 | 32 | V | 0.377211 | I | 0.324662 | 0.052549 | No Change: Both O | - |
| P28065 | PSB9_HUMAN Proteasome subunit beta type-9 OS=Homo sapiens GN=PSMB9 PE=1 SV=2 | 173 | R | 0.318127 | C | 0.187331 | 0.130796 | No Change: Both O | - |
| Q9P2W1 | HOP2_HUMAN Homologous-pairing protein 2 homolog OS=Homo sapiens GN=PSMC3IP PE=1 SV=1 | 163 | Y | 0.741226 | N | 0.821447 | -0.080221 | No Change: Both D | - |
| P62195 | PRS8_HUMAN 26S protease regulatory subunit 8 OS=Homo sapiens GN=PSMC5 PE=1 SV=1 | 60 | R | 0.57014 | Q | 0.591158 | -0.021018 | No Change: Both D | A colorectal cancer sample |
| P62195 | PRS8_HUMAN 26S protease regulatory subunit 8 OS=Homo sapiens GN=PSMC5 PE=1 SV=1 | 258 | R | 0.740063 | W | 0.574993 | 0.16507 | No Change: Both D | - |
| O00232 | PSD12_HUMAN 26S proteasome non-ATPase regulatory subunit 12 OS=Homo sapiens GN=PSMD12 PE=1 SV=3 | 358 | V | 0.271667 | A | 0.329584 | -0.057917 | No Change: Both O | - |
| Q9UNM6 | PSD13_HUMAN 26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens GN=PSMD13 PE=1 SV=2 | 13 | N | 0.710935 | S | 0.740853 | -0.029918 | No Change: Both D | - |
| Q9UNM6 | PSD13_HUMAN 26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens GN=PSMD13 PE=1 SV=2 | 204 | G | 0.144483 | E | 0.173475 | -0.028992 | No Change: Both O | - |
| Q9UNM6 | PSD13_HUMAN 26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens GN=PSMD13 PE=1 SV=2 | 205 | L | 0.144023 | F | 0.12537 | 0.018653 | No Change: Both O | - |
| Q9UNM6 | PSD13_HUMAN 26S proteasome non-ATPase regulatory subunit 13 OS=Homo sapiens GN=PSMD13 PE=1 SV=2 | 150 | S | 0.29239 | L | 0.142952 | 0.149438 | No Change: Both O | - |
| Q13200 | PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=1 SV=3 | 176 | A | 0.514045 | T | 0.534681 | -0.020636 | No Change: Both D | - |
| Q13200 | PSMD2_HUMAN 26S proteasome non-ATPase regulatory subunit 2 OS=Homo sapiens GN=PSMD2 PE=1 SV=3 | 313 | E | 0.542671 | D | 0.516289 | 0.026382 | No Change: Both D | - |
| Q16401 | PSMD5_HUMAN 26S proteasome non-ATPase regulatory subunit 5 OS=Homo sapiens GN=PSMD5 PE=1 SV=3 | 21 | E | 0.697054 | G | 0.578373 | 0.118681 | No Change: Both D | - |
| Q16401 | PSMD5_HUMAN 26S proteasome non-ATPase regulatory subunit 5 OS=Homo sapiens GN=PSMD5 PE=1 SV=3 | 72 | L | 0.187911 | H | 0.270893 | -0.082982 | No Change: Both O | - |
| O00233 | PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=3 | 17 | V | 0.773568 | A | 0.816109 | -0.042541 | No Change: Both D | - |
| O00233 | PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=3 | 74 | T | 0.147159 | I | 0.099644 | 0.047515 | No Change: Both O | - |
| O00233 | PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=3 | 134 | R | 0.853614 | W | 0.716682 | 0.136932 | No Change: Both D | - |
| O00233 | PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens GN=PSMD9 PE=1 SV=3 | 197 | E | 0.395818 | G | 0.36397 | 0.031848 | No Change: Both O | - |
| Q06323 | PSME1_HUMAN Proteasome activator complex subunit 1 OS=Homo sapiens GN=PSME1 PE=1 SV=1 | 55 | S | 0.809741 | N | 0.802991 | 0.00675 | No Change: Both D | - |
| Q06323 | PSME1_HUMAN Proteasome activator complex subunit 1 OS=Homo sapiens GN=PSME1 PE=1 SV=1 | 244 | T | 0.779875 | K | 0.797922 | -0.018047 | No Change: Both D | - |
| Q9UL46 | PSME2_HUMAN Proteasome activator complex subunit 2 OS=Homo sapiens GN=PSME2 PE=1 SV=4 | 89 | H | 0.682329 | P | 0.766864 | -0.084535 | No Change: Both D | - |
| Q14997 | PSME4_HUMAN Proteasome activator complex subunit 4 OS=Homo sapiens GN=PSME4 PE=1 SV=2 | 872 | I | 0.111282 | V | 0.125935 | -0.014653 | No Change: Both O | - |
| Q14997 | PSME4_HUMAN Proteasome activator complex subunit 4 OS=Homo sapiens GN=PSME4 PE=1 SV=2 | 1371 | S | 0.627282 | T | 0.545886 | 0.081396 | No Change: Both D | - |
| Q14997 | PSME4_HUMAN Proteasome activator complex subunit 4 OS=Homo sapiens GN=PSME4 PE=1 SV=2 | 1825 | T | 0.400133 | A | 0.361363 | 0.03877 | No Change: Both O | - |
| Q92530 | PSMF1_HUMAN Proteasome inhibitor PI31 subunit OS=Homo sapiens GN=PSMF1 PE=1 SV=2 | 174 | H | 0.870217 | R | 0.888355 | -0.018138 | No Change: Both D | - |
| Q92530 | PSMF1_HUMAN Proteasome inhibitor PI31 subunit OS=Homo sapiens GN=PSMF1 PE=1 SV=2 | 36 | F | 0.161741 | C | 0.152974 | 0.008767 | No Change: Both O | - |
| O95456 | PSMG1_HUMAN Proteasome assembly chaperone 1 OS=Homo sapiens GN=PSMG1 PE=1 SV=1 | 166 | I | 0.143349 | V | 0.161139 | -0.01779 | No Change: Both O | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 24 | P | 0.922913 | T | 0.902461 | 0.020452 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 34 | E | 0.844299 | Q | 0.842468 | 0.001831 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 37 | R | 0.812118 | H | 0.813472 | -0.001354 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 133 | P | 0.945889 | L | 0.896638 | 0.049251 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 34 | E | 0.844299 | K | 0.821963 | 0.022336 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 43 | P | 0.645223 | S | 0.631626 | 0.013597 | No Change: Both D | - |
| Q9UIG5 | PS1C1_HUMAN Psoriasis susceptibility 1 candidate gene 1 protein OS=Homo sapiens GN=PSORS1C1 PE=2 SV=2 | 66 | S | 0.327539 | C | 0.217078 | 0.110461 | No Change: Both O | - |
| Q9UIG4 | PS1C2_HUMAN Psoriasis susceptibility 1 candidate gene 2 protein OS=Homo sapiens GN=PSORS1C2 PE=2 SV=2 | 25 | G | 0.700696 | D | 0.696522 | 0.004174 | No Change: Both D | - |
| Q9UIG4 | PS1C2_HUMAN Psoriasis susceptibility 1 candidate gene 2 protein OS=Homo sapiens GN=PSORS1C2 PE=2 SV=2 | 84 | P | 0.997368 | L | 0.994523 | 0.002845 | No Change: Both D | - |
| Q9UIG4 | PS1C2_HUMAN Psoriasis susceptibility 1 candidate gene 2 protein OS=Homo sapiens GN=PSORS1C2 PE=2 SV=2 | 83 | L | 0.997159 | P | 0.99871 | -0.001551 | No Change: Both D | - |
| P78330 | SERB_HUMAN Phosphoserine phosphatase OS=Homo sapiens GN=PSPH PE=1 SV=2 | 32 | D | 0.283294 | N | 0.258547 | 0.024747 | No Change: Both O | Phosphoserine phosphatase deficiency (PSPHD) [MIM:614023] |
| P78330 | SERB_HUMAN Phosphoserine phosphatase OS=Homo sapiens GN=PSPH PE=1 SV=2 | 52 | M | 0.420066 | T | 0.44661 | -0.026544 | No Change: Both O | Phosphoserine phosphatase deficiency (PSPHD) [MIM:614023] |
| Q6PGN9 | PSRC1_HUMAN Proline/serine-rich coiled-coil protein 1 OS=Homo sapiens GN=PSRC1 PE=1 SV=1 | 312 | R | 0.960771 | Q | 0.953938 | 0.006833 | No Change: Both D | - |
| Q8IV42 | PSTK_HUMAN L-seryl-tRNA(Sec) kinase OS=Homo sapiens GN=PSTK PE=2 SV=2 | 206 | G | 0.778925 | R | 0.818551 | -0.039626 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 48 | Q | 0.678887 | H | 0.611223 | 0.067664 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 106 | E | 0.873526 | K | 0.864046 | 0.00948 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 146 | Q | 0.883784 | H | 0.845284 | 0.0385 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 149 | R | 0.873631 | L | 0.803226 | 0.070405 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 151 | A | 0.880508 | S | 0.910191 | -0.029683 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 155 | E | 0.888047 | D | 0.881602 | 0.006445 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 156 | Q | 0.885928 | H | 0.850787 | 0.035141 | No Change: Both D | - |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 230 | A | 0.112009 | T | 0.138756 | -0.026747 | No Change: Both O | PAPA syndrome (PAPAS) [MIM:604416] |
| O43586 | PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens GN=PSTPIP1 PE=1 SV=1 | 250 | E | 0.317966 | Q | 0.260615 | 0.057351 | No Change: Both O | PAPA syndrome (PAPAS) [MIM:604416] |
| Q9H939 | PPIP2_HUMAN Proline-serine-threonine phosphatase-interacting protein 2 OS=Homo sapiens GN=PSTPIP2 PE=1 SV=4 | 322 | N | 0.813163 | D | 0.851076 | -0.037913 | No Change: Both D | - |
| Q9H939 | PPIP2_HUMAN Proline-serine-threonine phosphatase-interacting protein 2 OS=Homo sapiens GN=PSTPIP2 PE=1 SV=4 | 322 | N | 0.813163 | S | 0.867178 | -0.054015 | No Change: Both D | - |
| P25105 | PTAFR_HUMAN Platelet-activating factor receptor OS=Homo sapiens GN=PTAFR PE=1 SV=1 | 224 | A | 0.58129 | D | 0.658314 | -0.077024 | No Change: Both D | - |
| P25105 | PTAFR_HUMAN Platelet-activating factor receptor OS=Homo sapiens GN=PTAFR PE=1 SV=1 | 338 | N | 0.631924 | S | 0.654014 | -0.02209 | No Change: Both D | - |
| O75127 | PTCD1_HUMAN Pentatricopeptide repeat-containing protein 1 OS=Homo sapiens GN=PTCD1 PE=1 SV=2 | 356 | P | 0.794636 | L | 0.673873 | 0.120763 | No Change: Both D | - |
| O75127 | PTCD1_HUMAN Pentatricopeptide repeat-containing protein 1 OS=Homo sapiens GN=PTCD1 PE=1 SV=2 | 620 | V | 0.280243 | G | 0.393429 | -0.113186 | No Change: Both O | - |
| Q96EY7 | PTCD3_HUMAN Pentatricopeptide repeat-containing protein 3 mitochondrial OS=Homo sapiens GN=PTCD3 PE=1 SV=3 | 2 | A | 0.545876 | V | 0.480511 | 0.065365 | D to O | - |
| Q96EY7 | PTCD3_HUMAN Pentatricopeptide repeat-containing protein 3 mitochondrial OS=Homo sapiens GN=PTCD3 PE=1 SV=3 | 681 | S | 0.99218 | G | 0.98685 | 0.00533 | No Change: Both D | - |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 175 | L | 0.26386 | P | 0.398269 | -0.134409 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 376 | F | 0.384621 | S | 0.622283 | -0.237662 | O to D | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1114 | R | 0.281827 | W | 0.118613 | 0.163214 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1114 | R | 0.281827 | W | 0.118613 | 0.163214 | No Change: Both O | Sporadic basal cell carcinoma (BCC) [MIM:605462] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 509 | G | 0.073491 | R | 0.064966 | 0.008525 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 509 | G | 0.073491 | V | 0.041575 | 0.031916 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 513 | D | 0.10104 | Y | 0.045371 | 0.055669 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 829 | V | 0.298368 | M | 0.36528 | -0.066912 | No Change: Both O | Squamous cell carcinoma |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1069 | G | 0.075024 | R | 0.06421 | 0.010814 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1132 | S | 0.136438 | P | 0.126974 | 0.009464 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1132 | S | 0.136438 | Y | 0.059643 | 0.076795 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1242 | E | 0.692395 | K | 0.639235 | 0.05316 | No Change: Both D | Squamous cell carcinoma |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1315 | P | 0.97553 | L | 0.950058 | 0.025472 | No Change: Both D | - |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1438 | E | 0.904216 | D | 0.885012 | 0.019204 | No Change: Both D | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1195 | T | 0.898507 | S | 0.93116 | -0.032653 | No Change: Both D | - |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 230 | T | 0.020816 | P | 0.029785 | -0.008969 | No Change: Both O | Basal cell nevus syndrome (BCNS) [MIM:109400] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1282 | P | 0.960282 | L | 0.92702 | 0.033262 | No Change: Both D | - |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 393 | A | 0.209617 | T | 0.214316 | -0.004699 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 443 | A | 0.108682 | G | 0.142169 | -0.033487 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 728 | T | 0.452117 | M | 0.400519 | 0.051598 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 751 | V | 0.068327 | G | 0.112358 | -0.044031 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 827 | S | 0.262088 | G | 0.203042 | 0.059046 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 908 | V | 0.232808 | G | 0.379128 | -0.14632 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q13635 | PTC1_HUMAN Protein patched homolog 1 OS=Homo sapiens GN=PTCH1 PE=1 SV=2 | 1052 | T | 0.027687 | M | 0.02349 | 0.004197 | No Change: Both O | Holoprosencephaly type 7 (HPE7) [MIM:610828] |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 346 | E | 0.420139 | Q | 0.393091 | 0.027048 | No Change: Both O | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 493 | E | 0.431906 | K | 0.414388 | 0.017518 | No Change: Both O | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 622 | H | 0.658407 | Y | 0.501586 | 0.156821 | No Change: Both D | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 988 | T | 0.035124 | M | 0.028048 | 0.007076 | No Change: Both O | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 1019 | V | 0.050261 | M | 0.060607 | -0.010346 | No Change: Both O | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 1121 | I | 0.498276 | M | 0.598707 | -0.100431 | O to D | - |
| Q9Y6C5 | PTC2_HUMAN Protein patched homolog 2 OS=Homo sapiens GN=PTCH2 PE=2 SV=2 | 995 | V | 0.0259 | M | 0.035409 | -0.009509 | No Change: Both O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 73 | L | 0.313253 | F | 0.283868 | 0.029385 | No Change: Both O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 173 | I | 0.158225 | V | 0.168556 | -0.010331 | No Change: Both O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 195 | V | 0.437844 | I | 0.381088 | 0.056756 | No Change: Both O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 251 | P | 0.619837 | L | 0.478396 | 0.141441 | D to O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 359 | H | 0.676556 | R | 0.690527 | -0.013971 | No Change: Both D | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 470 | A | 0.749107 | D | 0.789984 | -0.040877 | No Change: Both D | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 479 | E | 0.302982 | G | 0.248581 | 0.054401 | No Change: Both O | - |
| Q96NR3 | PTHD1_HUMAN Patched domain-containing protein 1 OS=Homo sapiens GN=PTCHD1 PE=2 SV=2 | 497 | N | 0.046138 | K | 0.060644 | -0.014506 | No Change: Both O | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 51 | L | 0.354908 | V | 0.33214 | 0.022768 | No Change: Both O | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 182 | G | 0.889401 | S | 0.912516 | -0.023115 | No Change: Both D | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 650 | A | 0.543838 | T | 0.559102 | -0.015264 | No Change: Both D | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 661 | G | 0.589155 | A | 0.538071 | 0.051084 | No Change: Both D | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 948 | R | 0.490865 | H | 0.491056 | -1.91E-04 | No Change: Both O | - |
| Q9P2K9 | PTHD2_HUMAN Patched domain-containing protein 2 OS=Homo sapiens GN=PTCHD2 PE=2 SV=2 | 39 | G | 0.716878 | R | 0.708683 | 0.008195 | No Change: Both D | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 126 | T | 0.088478 | A | 0.077041 | 0.011437 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 152 | L | 0.120424 | P | 0.220812 | -0.100388 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 224 | A | 0.373599 | G | 0.397019 | -0.02342 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 372 | R | 0.417417 | K | 0.49431 | -0.076893 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 407 | C | 0.060275 | G | 0.126117 | -0.065842 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 473 | D | 0.446486 | G | 0.397894 | 0.048592 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 521 | M | 0.014905 | T | 0.020739 | -0.005834 | No Change: Both O | - |
| Q3KNS1 | PTHD3_HUMAN Patched domain-containing protein 3 OS=Homo sapiens GN=PTCHD3 PE=1 SV=2 | 584 | M | 0.23559 | I | 0.176307 | 0.059283 | No Change: Both O | - |
| Q6ISU1 | PTCRA_HUMAN Pre T-cell antigen receptor alpha OS=Homo sapiens GN=PTCRA PE=1 SV=1 | 106 | V | 0.674566 | I | 0.662322 | 0.012244 | No Change: Both D | - |
| Q6ISU1 | PTCRA_HUMAN Pre T-cell antigen receptor alpha OS=Homo sapiens GN=PTCRA PE=1 SV=1 | 183 | A | 0.766351 | T | 0.794486 | -0.028135 | No Change: Both D | - |
| P48651 | PTSS1_HUMAN Phosphatidylserine synthase 1 OS=Homo sapiens GN=PTDSS1 PE=1 SV=1 | 423 | T | 0.589746 | N | 0.602714 | -0.012968 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 15 | R | 0.549755 | S | 0.617637 | -0.067882 | No Change: Both D | Glioma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 36 | G | 0.133483 | E | 0.170522 | -0.037039 | No Change: Both O | Glioma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 42 | L | 0.301759 | R | 0.456096 | -0.154337 | No Change: Both O | Glioma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 57 | L | 0.381776 | W | 0.304137 | 0.077639 | No Change: Both O | Glioma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 67 | I | 0.248465 | R | 0.389829 | -0.141364 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 68 | Y | 0.22096 | H | 0.325543 | -0.104583 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 68 | Y | 0.22096 | H | 0.325543 | -0.104583 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 123 | H | 0.290418 | R | 0.28082 | 0.009598 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 124 | C | 0.318913 | R | 0.502654 | -0.183741 | O to D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 129 | G | 0.349022 | E | 0.37831 | -0.029288 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 129 | G | 0.349022 | R | 0.328455 | 0.020567 | No Change: Both O | Glioblastoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 130 | R | 0.286084 | L | 0.185066 | 0.101018 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 130 | R | 0.286084 | Q | 0.304726 | -0.018642 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 134 | M | 0.07813 | L | 0.064415 | 0.013715 | No Change: Both O | Prostate cancer (PC) [MIM:176807] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 170 | S | 0.32278 | R | 0.276106 | 0.046674 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 112 | L | 0.391576 | P | 0.540896 | -0.14932 | O to D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 112 | L | 0.391576 | P | 0.540896 | -0.14932 | O to D | Lhermitte-Duclos disease (LDD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 136 | C | 0.053604 | Y | 0.068846 | -0.015242 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 35 | M | 0.116372 | R | 0.155459 | -0.039087 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 34 | A | 0.085164 | D | 0.114863 | -0.029699 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 105 | C | 0.160747 | Y | 0.17981 | -0.019063 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 135 | I | 0.061282 | V | 0.075811 | -0.014529 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 165 | G | 0.639822 | V | 0.503809 | 0.136013 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 165 | G | 0.639822 | E | 0.693143 | -0.053321 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 246 | P | 0.193477 | L | 0.09369 | 0.099787 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 246 | P | 0.193477 | L | 0.09369 | 0.099787 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 289 | K | 0.688373 | E | 0.712069 | -0.023696 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 343 | V | 0.708245 | E | 0.808913 | -0.100668 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 347 | F | 0.736549 | L | 0.748879 | -0.01233 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 47 | R | 0.242203 | G | 0.253495 | -0.011292 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 119 | V | 0.26131 | L | 0.269941 | -0.008631 | No Change: Both O | Multiple cancers |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 158 | V | 0.360611 | L | 0.363746 | -0.003135 | No Change: Both O | Multiple cancers |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 19 | D | 0.443782 | N | 0.413097 | 0.030685 | No Change: Both O | Malignant melanoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 61 | H | 0.506444 | D | 0.542472 | -0.036028 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 70 | L | 0.174077 | P | 0.302431 | -0.128354 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 121 | A | 0.246224 | G | 0.289651 | -0.043427 | No Change: Both O | Head and neck squamous cell carcinomas (HNSCC) [MIM:275355] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 124 | C | 0.318913 | S | 0.554848 | -0.235935 | O to D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 217 | V | 0.093223 | I | 0.079784 | 0.013439 | No Change: Both O | Malignant melanoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 234 | R | 0.510977 | Q | 0.514302 | -0.003325 | No Change: Both D | A patient with glioma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 290 | V | 0.679907 | L | 0.687611 | -0.007704 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 10 | S | 0.376066 | N | 0.346885 | 0.029181 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 16 | Y | 0.534728 | C | 0.474202 | 0.060526 | D to O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 20 | G | 0.364201 | E | 0.431831 | -0.06763 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 27 | Y | 0.055312 | S | 0.115728 | -0.060416 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 36 | G | 0.133483 | R | 0.130126 | 0.003357 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 61 | H | 0.506444 | R | 0.49324 | 0.013204 | D to O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 71 | C | 0.1694 | Y | 0.222089 | -0.052689 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 93 | H | 0.502584 | Y | 0.393276 | 0.109308 | D to O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 105 | C | 0.160747 | F | 0.170762 | -0.010015 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 107 | D | 0.188738 | Y | 0.089388 | 0.09935 | No Change: Both O | Bannayan-Zonana syndrome (BZS) [MIM:153480] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 112 | L | 0.391576 | R | 0.499621 | -0.108045 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 121 | A | 0.246224 | P | 0.298531 | -0.052307 | No Change: Both O | Glioblastoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 123 | H | 0.290418 | Y | 0.18168 | 0.108738 | No Change: Both O | Endometrial cancer (ENDMC) [MIM:608089] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 130 | R | 0.286084 | G | 0.323508 | -0.037424 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 133 | V | 0.103886 | I | 0.097584 | 0.006302 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 155 | Y | 0.252599 | C | 0.210372 | 0.042227 | No Change: Both O | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 165 | G | 0.639822 | R | 0.64569 | -0.005868 | No Change: Both D | Glioblastoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 167 | T | 0.504345 | P | 0.562502 | -0.058157 | No Change: Both D | Breast cancer |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 170 | S | 0.32278 | N | 0.2791 | 0.04368 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 173 | R | 0.18932 | C | 0.088533 | 0.100787 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 173 | R | 0.18932 | H | 0.180366 | 0.008954 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 173 | R | 0.18932 | P | 0.218317 | -0.028997 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 174 | Y | 0.156632 | N | 0.23789 | -0.081258 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 191 | V | 0.137173 | A | 0.200569 | -0.063396 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 227 | S | 0.472841 | F | 0.301221 | 0.17162 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 251 | G | 0.199211 | C | 0.144222 | 0.054989 | No Change: Both O | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 331 | D | 0.64407 | G | 0.574312 | 0.069758 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 341 | F | 0.690841 | V | 0.698073 | -0.007232 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 342 | K | 0.701497 | N | 0.671422 | 0.030075 | No Change: Both D | Cowden disease (CD) [MIM:158350] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 345 | L | 0.717252 | Q | 0.769352 | -0.0521 | No Change: Both D | Glioblastoma |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 348 | T | 0.770466 | I | 0.632841 | 0.137625 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 369 | V | 0.961804 | G | 0.962632 | -8.28E-04 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 401 | T | 0.940207 | I | 0.883658 | 0.056549 | No Change: Both D | - |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 93 | H | 0.502584 | R | 0.502686 | -1.02E-04 | No Change: Both D | Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 132 | G | 0.157702 | V | 0.090927 | 0.066775 | No Change: Both O | One patient with clinical findings suggesting hamartoma tumor syndrome |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 241 | F | 0.285114 | S | 0.439676 | -0.154562 | No Change: Both O | Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309] |
| P60484 | PTEN_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Homo sapiens GN=PTEN PE=1 SV=1 | 252 | D | 0.191063 | G | 0.175914 | 0.015149 | No Change: Both O | Macrocephaly/autism syndrome (MCEPHAS) [MIM:605309] |
| Q96BW5 | PTER_HUMAN Phosphotriesterase-related protein OS=Homo sapiens GN=PTER PE=1 SV=1 | 97 | E | 0.429565 | G | 0.403417 | 0.026148 | No Change: Both O | - |
| Q7RTS3 | PTF1A_HUMAN Pancreas transcription factor 1 subunit alpha OS=Homo sapiens GN=PTF1A PE=1 SV=1 | 263 | S | 0.818114 | P | 0.825394 | -0.00728 | No Change: Both D | - |
| Q13258 | PD2R_HUMAN Prostaglandin D2 receptor OS=Homo sapiens GN=PTGDR PE=2 SV=2 | 7 | R | 0.454025 | C | 0.314921 | 0.139104 | No Change: Both O | - |
| Q13258 | PD2R_HUMAN Prostaglandin D2 receptor OS=Homo sapiens GN=PTGDR PE=2 SV=2 | 301 | E | 0.808621 | A | 0.722891 | 0.08573 | No Change: Both D | - |
| Q13258 | PD2R_HUMAN Prostaglandin D2 receptor OS=Homo sapiens GN=PTGDR PE=2 SV=2 | 198 | G | 0.302145 | E | 0.359188 | -0.057043 | No Change: Both O | - |
| Q13258 | PD2R_HUMAN Prostaglandin D2 receptor OS=Homo sapiens GN=PTGDR PE=2 SV=2 | 332 | R | 0.056312 | Q | 0.050524 | 0.005788 | No Change: Both O | - |
| P41222 | PTGDS_HUMAN Prostaglandin-H2 D-isomerase OS=Homo sapiens GN=PTGDS PE=1 SV=1 | 56 | R | 0.508473 | Q | 0.519842 | -0.011369 | No Change: Both D | - |
| P34995 | PE2R1_HUMAN Prostaglandin E2 receptor EP1 subtype OS=Homo sapiens GN=PTGER1 PE=2 SV=3 | 71 | A | 0.217576 | T | 0.234544 | -0.016968 | No Change: Both O | - |
| P34995 | PE2R1_HUMAN Prostaglandin E2 receptor EP1 subtype OS=Homo sapiens GN=PTGER1 PE=2 SV=3 | 223 | T | 0.403261 | M | 0.408663 | -0.005402 | No Change: Both O | - |
| P34995 | PE2R1_HUMAN Prostaglandin E2 receptor EP1 subtype OS=Homo sapiens GN=PTGER1 PE=2 SV=3 | 256 | H | 0.995392 | R | 0.997333 | -0.001941 | No Change: Both D | - |
| P43115 | PE2R3_HUMAN Prostaglandin E2 receptor EP3 subtype OS=Homo sapiens GN=PTGER3 PE=2 SV=1 | 169 | M | 0.453416 | L | 0.380212 | 0.073204 | No Change: Both O | - |
| P43115 | PE2R3_HUMAN Prostaglandin E2 receptor EP3 subtype OS=Homo sapiens GN=PTGER3 PE=2 SV=1 | 375 | P | 0.591173 | L | 0.433947 | 0.157226 | D to O | - |
| P43115 | PE2R3_HUMAN Prostaglandin E2 receptor EP3 subtype OS=Homo sapiens GN=PTGER3 PE=2 SV=1 | 366 | N | 0.550991 | S | 0.598447 | -0.047456 | No Change: Both D | - |
| P43115 | PE2R3_HUMAN Prostaglandin E2 receptor EP3 subtype OS=Homo sapiens GN=PTGER3 PE=2 SV=1 | 319 | T | 0.73384 | M | 0.672356 | 0.061484 | No Change: Both D | - |
| Q9H7Z7 | PGES2_HUMAN Prostaglandin E synthase 2 OS=Homo sapiens GN=PTGES2 PE=1 SV=1 | 298 | R | 0.50954 | H | 0.513864 | -0.004324 | No Change: Both D | - |
| Q9P2B2 | FPRP_HUMAN Prostaglandin F2 receptor negative regulator OS=Homo sapiens GN=PTGFRN PE=1 SV=2 | 837 | V | 0.069092 | I | 0.061353 | 0.007739 | No Change: Both O | - |
| Q9P2B2 | FPRP_HUMAN Prostaglandin F2 receptor negative regulator OS=Homo sapiens GN=PTGFRN PE=1 SV=2 | 277 | S | 0.191745 | T | 0.149731 | 0.042014 | No Change: Both O | - |
| P43119 | PI2R_HUMAN Prostacyclin receptor OS=Homo sapiens GN=PTGIR PE=1 SV=1 | 25 | V | 0.137365 | M | 0.180795 | -0.04343 | No Change: Both O | - |
| P43119 | PI2R_HUMAN Prostacyclin receptor OS=Homo sapiens GN=PTGIR PE=1 SV=1 | 319 | S | 0.656959 | W | 0.409258 | 0.247701 | D to O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 38 | P | 0.163671 | L | 0.089942 | 0.073729 | No Change: Both O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 118 | S | 0.716313 | R | 0.664635 | 0.051678 | No Change: Both D | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 379 | R | 0.346391 | S | 0.369519 | -0.023128 | No Change: Both O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 154 | E | 0.482025 | A | 0.374612 | 0.107413 | No Change: Both O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 171 | F | 0.089877 | L | 0.107948 | -0.018071 | No Change: Both O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 236 | R | 0.455481 | C | 0.321692 | 0.133789 | No Change: Both O | - |
| Q16647 | PTGIS_HUMAN Prostacyclin synthase OS=Homo sapiens GN=PTGIS PE=1 SV=1 | 500 | P | 0.718879 | S | 0.746048 | -0.027169 | No Change: Both D | - |
| Q14914 | PTGR1_HUMAN Prostaglandin reductase 1 OS=Homo sapiens GN=PTGR1 PE=1 SV=2 | 27 | A | 0.455909 | S | 0.573794 | -0.117885 | O to D | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 8 | W | 0.056603 | R | 0.206118 | -0.149515 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 17 | P | 0.085105 | L | 0.040289 | 0.044816 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 359 | K | 0.147563 | R | 0.11071 | 0.036853 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 443 | I | 0.200667 | V | 0.237395 | -0.036728 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 53 | R | 0.188758 | H | 0.154476 | 0.034282 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 149 | R | 0.291986 | L | 0.209515 | 0.082471 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 237 | L | 0.310569 | M | 0.347636 | -0.037067 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 481 | V | 0.462739 | I | 0.45232 | 0.010419 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 185 | K | 0.482828 | T | 0.436196 | 0.046632 | No Change: Both O | - |
| P23219 | PGH1_HUMAN Prostaglandin G/H synthase 1 OS=Homo sapiens GN=PTGS1 PE=1 SV=2 | 341 | K | 0.089983 | R | 0.06903 | 0.020953 | No Change: Both O | - |
| P35354 | PGH2_HUMAN Prostaglandin G/H synthase 2 OS=Homo sapiens GN=PTGS2 PE=1 SV=2 | 488 | E | 0.214161 | G | 0.163218 | 0.050943 | No Change: Both O | - |
| P35354 | PGH2_HUMAN Prostaglandin G/H synthase 2 OS=Homo sapiens GN=PTGS2 PE=1 SV=2 | 511 | V | 0.236603 | A | 0.309141 | -0.072538 | No Change: Both O | - |
| P35354 | PGH2_HUMAN Prostaglandin G/H synthase 2 OS=Homo sapiens GN=PTGS2 PE=1 SV=2 | 228 | R | 0.301108 | H | 0.279602 | 0.021506 | No Change: Both O | - |
| P35354 | PGH2_HUMAN Prostaglandin G/H synthase 2 OS=Homo sapiens GN=PTGS2 PE=1 SV=2 | 428 | P | 0.531452 | A | 0.447979 | 0.083473 | D to O | - |
| P35354 | PGH2_HUMAN Prostaglandin G/H synthase 2 OS=Homo sapiens GN=PTGS2 PE=1 SV=2 | 587 | G | 0.685263 | R | 0.73726 | -0.051997 | No Change: Both D | - |
| P01270 | PTHY_HUMAN Parathyroid hormone OS=Homo sapiens GN=PTH PE=1 SV=1 | 18 | C | 0.130838 | R | 0.223392 | -0.092554 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| P01270 | PTHY_HUMAN Parathyroid hormone OS=Homo sapiens GN=PTH PE=1 SV=1 | 23 | S | 0.423317 | P | 0.385373 | 0.037944 | No Change: Both O | Familial isolated hypoparathyroidism (FIH) [MIM:146200] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 223 | H | 0.08391 | R | 0.081807 | 0.002103 | No Change: Both O | Jansen metaphyseal chondrodysplasia (JMC) [MIM:156400] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 410 | T | 0.168127 | P | 0.216871 | -0.048744 | No Change: Both O | Jansen metaphyseal chondrodysplasia (JMC) [MIM:156400] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 132 | P | 0.097112 | L | 0.043999 | 0.053113 | No Change: Both O | Chondrodysplasia Blomstrand type (BOCD) [MIM:215045] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 150 | R | 0.318873 | C | 0.174887 | 0.143986 | No Change: Both O | Enchondromatosis multiple (ENCHOM) [MIM:166000] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 458 | I | 0.008064 | R | 0.016133 | -0.008069 | No Change: Both O | Jansen metaphyseal chondrodysplasia (JMC) [MIM:156400] |
| Q03431 | PTH1R_HUMAN Parathyroid hormone/parathyroid hormone-related peptide receptor OS=Homo sapiens GN=PTH1R PE=1 SV=1 | 410 | T | 0.168127 | R | 0.186796 | -0.018669 | No Change: Both O | Jansen metaphyseal chondrodysplasia (JMC) [MIM:156400] |
| P12272 | PTHR_HUMAN Parathyroid hormone-related protein OS=Homo sapiens GN=PTHLH PE=1 SV=1 | 169 | S | 0.951559 | T | 0.936016 | 0.015543 | No Change: Both D | A breast cancer sample |
| P12272 | PTHR_HUMAN Parathyroid hormone-related protein OS=Homo sapiens GN=PTHLH PE=1 SV=1 | 44 | L | 0.57251 | P | 0.690343 | -0.117833 | No Change: Both D | Brachydactyly type E2 (BDE2) [MIM:613382] |
| P12272 | PTHR_HUMAN Parathyroid hormone-related protein OS=Homo sapiens GN=PTHLH PE=1 SV=1 | 60 | L | 0.343653 | P | 0.459309 | -0.115656 | No Change: Both O | Brachydactyly type E2 (BDE2) [MIM:613382] |
| Q05397 | FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens GN=PTK2 PE=1 SV=2 | 292 | H | 0.271193 | P | 0.327977 | -0.056784 | No Change: Both O | - |
| Q05397 | FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens GN=PTK2 PE=1 SV=2 | 292 | H | 0.271193 | Q | 0.310194 | -0.039001 | No Change: Both O | - |
| Q05397 | FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens GN=PTK2 PE=1 SV=2 | 793 | V | 0.367213 | A | 0.409024 | -0.041811 | No Change: Both O | A glioblastoma multiforme sample |
| Q05397 | FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens GN=PTK2 PE=1 SV=2 | 1030 | D | 0.314173 | E | 0.313507 | 6.66E-04 | No Change: Both O | - |
| Q05397 | FAK1_HUMAN Focal adhesion kinase 1 OS=Homo sapiens GN=PTK2 PE=1 SV=2 | 1044 | K | 0.363463 | E | 0.342352 | 0.021111 | No Change: Both O | A metastatic melanoma sample |
| Q14289 | FAK2_HUMAN Protein-tyrosine kinase 2-beta OS=Homo sapiens GN=PTK2B PE=1 SV=2 | 838 | K | 0.765332 | T | 0.721622 | 0.04371 | No Change: Both D | - |
| Q14289 | FAK2_HUMAN Protein-tyrosine kinase 2-beta OS=Homo sapiens GN=PTK2B PE=1 SV=2 | 359 | Q | 0.49361 | E | 0.524636 | -0.031026 | O to D | - |
| Q14289 | FAK2_HUMAN Protein-tyrosine kinase 2-beta OS=Homo sapiens GN=PTK2B PE=1 SV=2 | 698 | R | 0.765569 | H | 0.702224 | 0.063345 | No Change: Both D | - |
| Q14289 | FAK2_HUMAN Protein-tyrosine kinase 2-beta OS=Homo sapiens GN=PTK2B PE=1 SV=2 | 808 | L | 0.844951 | P | 0.90157 | -0.056619 | No Change: Both D | - |
| Q14289 | FAK2_HUMAN Protein-tyrosine kinase 2-beta OS=Homo sapiens GN=PTK2B PE=1 SV=2 | 970 | E | 0.574656 | K | 0.584454 | -0.009798 | No Change: Both D | - |
| Q13882 | PTK6_HUMAN Protein-tyrosine kinase 6 OS=Homo sapiens GN=PTK6 PE=1 SV=1 | 16 | L | 0.157855 | F | 0.145654 | 0.012201 | No Change: Both O | - |
| Q13882 | PTK6_HUMAN Protein-tyrosine kinase 6 OS=Homo sapiens GN=PTK6 PE=1 SV=1 | 436 | A | 0.695748 | T | 0.777099 | -0.081351 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 276 | R | 0.487156 | H | 0.446021 | 0.041135 | No Change: Both O | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 410 | T | 0.179387 | S | 0.229073 | -0.049686 | No Change: Both O | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 745 | E | 0.826108 | D | 0.781742 | 0.044366 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 766 | E | 0.862802 | Q | 0.858726 | 0.004076 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 777 | A | 0.805415 | V | 0.748764 | 0.056651 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 783 | H | 0.78271 | R | 0.808621 | -0.025911 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 933 | A | 0.21203 | V | 0.158208 | 0.053822 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 1029 | P | 0.669206 | T | 0.567796 | 0.10141 | No Change: Both D | - |
| Q13308 | PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens GN=PTK7 PE=1 SV=2 | 1038 | R | 0.568732 | Q | 0.579882 | -0.01115 | No Change: Both D | - |
| A2A3K4 | PTPC1_HUMAN Protein tyrosine phosphatase domain-containing protein 1 OS=Homo sapiens GN=PTPDC1 PE=2 SV=1 | 571 | L | 0.917854 | Q | 0.943569 | -0.025715 | No Change: Both D | - |
| B0YJ81 | HACD1_HUMAN 3-hydroxyacyl-CoA dehydratase 1 OS=Homo sapiens GN=PTPLA PE=1 SV=1 | 64 | E | 0.615907 | K | 0.60216 | 0.013747 | No Change: Both D | - |
| B0YJ81 | HACD1_HUMAN 3-hydroxyacyl-CoA dehydratase 1 OS=Homo sapiens GN=PTPLA PE=1 SV=1 | 64 | E | 0.615907 | Q | 0.574557 | 0.04135 | No Change: Both D | - |
| B0YJ81 | HACD1_HUMAN 3-hydroxyacyl-CoA dehydratase 1 OS=Homo sapiens GN=PTPLA PE=1 SV=1 | 70 | V | 0.161083 | F | 0.153894 | 0.007189 | No Change: Both O | - |
| B0YJ81 | HACD1_HUMAN 3-hydroxyacyl-CoA dehydratase 1 OS=Homo sapiens GN=PTPLA PE=1 SV=1 | 227 | H | 0.232046 | Y | 0.153588 | 0.078458 | No Change: Both O | - |
| Q9P035 | HACD3_HUMAN 3-hydroxyacyl-CoA dehydratase 3 OS=Homo sapiens GN=PTPLAD1 PE=1 SV=2 | 56 | E | 0.168039 | K | 0.166898 | 0.001141 | No Change: Both O | - |
| Q9P035 | HACD3_HUMAN 3-hydroxyacyl-CoA dehydratase 3 OS=Homo sapiens GN=PTPLAD1 PE=1 SV=2 | 269 | M | 0.03906 | L | 0.030028 | 0.009032 | No Change: Both O | - |
| Q5VWC8 | HACD4_HUMAN 3-hydroxyacyl-CoA dehydratase 4 OS=Homo sapiens GN=PTPLAD2 PE=1 SV=1 | 36 | T | 0.071126 | A | 0.057823 | 0.013303 | No Change: Both O | - |
| P18031 | PTN1_HUMAN Tyrosine-protein phosphatase non-receptor type 1 OS=Homo sapiens GN=PTPN1 PE=1 SV=1 | 381 | G | 0.717189 | S | 0.769923 | -0.052734 | No Change: Both D | - |
| P18031 | PTN1_HUMAN Tyrosine-protein phosphatase non-receptor type 1 OS=Homo sapiens GN=PTPN1 PE=1 SV=1 | 387 | P | 0.746185 | L | 0.637103 | 0.109082 | No Change: Both D | - |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 42 | T | 0.448717 | A | 0.424459 | 0.024258 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 60 | G | 0.262897 | A | 0.206796 | 0.056101 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 61 | D | 0.245432 | G | 0.229401 | 0.016031 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 61 | D | 0.245432 | N | 0.232499 | 0.012933 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 62 | Y | 0.234481 | D | 0.366907 | -0.132426 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 63 | Y | 0.224743 | C | 0.17287 | 0.051873 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 72 | A | 0.194006 | G | 0.244286 | -0.05028 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 72 | A | 0.194006 | S | 0.271448 | -0.077442 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 73 | T | 0.16265 | I | 0.089754 | 0.072896 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 76 | E | 0.137013 | D | 0.114634 | 0.022379 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 79 | Q | 0.182464 | R | 0.165558 | 0.016906 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 106 | D | 0.307285 | A | 0.253941 | 0.053344 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 139 | E | 0.753487 | D | 0.739142 | 0.014345 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 279 | Y | 0.564665 | C | 0.576937 | -0.012272 | No Change: Both D | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 279 | Y | 0.564665 | C | 0.576937 | -0.012272 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 282 | I | 0.427015 | V | 0.468543 | -0.041528 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 285 | F | 0.327836 | S | 0.528501 | -0.200665 | O to D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 285 | F | 0.327836 | L | 0.381573 | -0.053737 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 308 | N | 0.202468 | S | 0.227048 | -0.02458 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 308 | N | 0.202468 | D | 0.211458 | -0.00899 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 309 | I | 0.186834 | V | 0.196097 | -0.009263 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 472 | T | 0.078953 | M | 0.061621 | 0.017332 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 505 | R | 0.575727 | K | 0.623603 | -0.047876 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 506 | S | 0.554757 | T | 0.478042 | 0.076715 | D to O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 508 | M | 0.538659 | V | 0.492029 | 0.04663 | D to O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 60 | G | 0.262897 | V | 0.154618 | 0.108279 | No Change: Both O | - |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 61 | D | 0.245432 | V | 0.126063 | 0.119369 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 61 | D | 0.245432 | Y | 0.143344 | 0.102088 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 69 | E | 0.265223 | K | 0.270722 | -0.005499 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 71 | F | 0.228757 | K | 0.462774 | -0.234017 | No Change: Both O | Acute myeloid leukemia |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 71 | F | 0.228757 | L | 0.275151 | -0.046394 | No Change: Both O | - |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 72 | A | 0.194006 | T | 0.21643 | -0.022424 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 72 | A | 0.194006 | V | 0.13885 | 0.055156 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 76 | E | 0.137013 | A | 0.088054 | 0.048959 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 76 | E | 0.137013 | G | 0.106248 | 0.030765 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 76 | E | 0.137013 | K | 0.135686 | 0.001327 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 76 | E | 0.137013 | V | 0.059817 | 0.077196 | No Change: Both O | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 507 | G | 0.543376 | A | 0.508824 | 0.034552 | No Change: Both D | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 507 | G | 0.543376 | R | 0.560121 | -0.016745 | No Change: Both D | Juvenile myelomonocytic leukemia (JMML) [MIM:607785] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 2 | T | 0.821593 | I | 0.754808 | 0.066785 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 58 | N | 0.282549 | K | 0.337852 | -0.055303 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 69 | E | 0.265223 | Q | 0.217608 | 0.047615 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 79 | Q | 0.182464 | P | 0.19211 | -0.009646 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 256 | Q | 0.665695 | R | 0.6461 | 0.019595 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 279 | Y | 0.564665 | S | 0.709988 | -0.145323 | No Change: Both D | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 415 | T | 0.273257 | M | 0.223843 | 0.049414 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 465 | A | 0.19184 | T | 0.227368 | -0.035528 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 468 | G | 0.174313 | A | 0.135099 | 0.039214 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 502 | R | 0.490197 | L | 0.334277 | 0.15592 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 502 | R | 0.490197 | W | 0.256973 | 0.233224 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 510 | Q | 0.420394 | P | 0.408439 | 0.011955 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 510 | Q | 0.420394 | R | 0.407464 | 0.01293 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 514 | Q | 0.292812 | P | 0.271457 | 0.021355 | No Change: Both O | LEOPARD syndrome type 1 (LEOPARD1) [MIM:151100] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 564 | L | 0.871505 | F | 0.848295 | 0.02321 | No Change: Both D | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q06124 | PTN11_HUMAN Tyrosine-protein phosphatase non-receptor type 11 OS=Homo sapiens GN=PTPN11 PE=1 SV=2 | 59 | T | 0.279718 | A | 0.247206 | 0.032512 | No Change: Both O | Noonan syndrome type 1 (NS1) [MIM:163950] |
| Q05209 | PTN12_HUMAN Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens GN=PTPN12 PE=1 SV=3 | 61 | K | 0.615288 | R | 0.576649 | 0.038639 | No Change: Both D | Colon cancer |
| Q05209 | PTN12_HUMAN Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens GN=PTPN12 PE=1 SV=3 | 322 | V | 0.733708 | I | 0.740159 | -0.006451 | No Change: Both D | - |
| Q05209 | PTN12_HUMAN Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens GN=PTPN12 PE=1 SV=3 | 573 | T | 0.856999 | A | 0.796615 | 0.060384 | No Change: Both D | - |
| Q05209 | PTN12_HUMAN Tyrosine-protein phosphatase non-receptor type 12 OS=Homo sapiens GN=PTPN12 PE=1 SV=3 | 706 | E | 0.931789 | K | 0.924801 | 0.006988 | No Change: Both D | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 1419 | L | 0.247947 | P | 0.399402 | -0.151455 | No Change: Both O | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 1522 | I | 0.411405 | M | 0.476565 | -0.06516 | No Change: Both O | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 1625 | E | 0.99268 | K | 0.99242 | 2.60E-04 | No Change: Both D | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 2081 | Y | 0.5978 | D | 0.755358 | -0.157558 | No Change: Both D | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 1356 | F | 0.893641 | L | 0.894322 | -6.81E-04 | No Change: Both D | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 1744 | S | 0.954164 | P | 0.953191 | 9.73E-04 | No Change: Both D | - |
| Q12923 | PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens GN=PTPN13 PE=1 SV=2 | 2458 | I | 0.073631 | V | 0.087638 | -0.014007 | No Change: Both O | - |
| Q15678 | PTN14_HUMAN Tyrosine-protein phosphatase non-receptor type 14 OS=Homo sapiens GN=PTPN14 PE=1 SV=2 | 159 | Q | 0.295132 | E | 0.335477 | -0.040345 | No Change: Both O | A breast cancer sample |
| Q15678 | PTN14_HUMAN Tyrosine-protein phosphatase non-receptor type 14 OS=Homo sapiens GN=PTPN14 PE=1 SV=2 | 360 | H | 0.439334 | P | 0.467121 | -0.027787 | No Change: Both O | A breast cancer sample |
| Q15678 | PTN14_HUMAN Tyrosine-protein phosphatase non-receptor type 14 OS=Homo sapiens GN=PTPN14 PE=1 SV=2 | 505 | V | 0.726842 | F | 0.668598 | 0.058244 | No Change: Both D | - |
| Q99952 | PTN18_HUMAN Tyrosine-protein phosphatase non-receptor type 18 OS=Homo sapiens GN=PTPN18 PE=1 SV=2 | 193 | M | 0.363271 | V | 0.292308 | 0.070963 | No Change: Both O | - |
| Q16825 | PTN21_HUMAN Tyrosine-protein phosphatase non-receptor type 21 OS=Homo sapiens GN=PTPN21 PE=1 SV=2 | 906 | K | 0.369004 | N | 0.326972 | 0.042032 | No Change: Both O | - |
| Q16825 | PTN21_HUMAN Tyrosine-protein phosphatase non-receptor type 21 OS=Homo sapiens GN=PTPN21 PE=1 SV=2 | 385 | L | 0.47828 | F | 0.434317 | 0.043963 | No Change: Both O | - |
| Q16825 | PTN21_HUMAN Tyrosine-protein phosphatase non-receptor type 21 OS=Homo sapiens GN=PTPN21 PE=1 SV=2 | 936 | V | 0.248765 | A | 0.29503 | -0.046265 | No Change: Both O | - |
| Q9Y2R2 | PTN22_HUMAN Tyrosine-protein phosphatase non-receptor type 22 OS=Homo sapiens GN=PTPN22 PE=1 SV=2 | 620 | R | 0.687186 | W | 0.449676 | 0.23751 | D to O | - |
| Q9H3S7 | PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens GN=PTPN23 PE=1 SV=1 | 944 | A | 0.977796 | T | 0.978324 | -5.28E-04 | No Change: Both D | - |
| Q9H3S7 | PTN23_HUMAN Tyrosine-protein phosphatase non-receptor type 23 OS=Homo sapiens GN=PTPN23 PE=1 SV=1 | 1099 | P | 0.997602 | S | 0.997202 | 4.00E-04 | No Change: Both D | A lung cancer cell line |
| P26045 | PTN3_HUMAN Tyrosine-protein phosphatase non-receptor type 3 OS=Homo sapiens GN=PTPN3 PE=1 SV=2 | 77 | D | 0.589161 | N | 0.556226 | 0.032935 | No Change: Both D | - |
| P26045 | PTN3_HUMAN Tyrosine-protein phosphatase non-receptor type 3 OS=Homo sapiens GN=PTPN3 PE=1 SV=2 | 90 | A | 0.364818 | P | 0.438688 | -0.07387 | No Change: Both O | - |
| P26045 | PTN3_HUMAN Tyrosine-protein phosphatase non-receptor type 3 OS=Homo sapiens GN=PTPN3 PE=1 SV=2 | 409 | T | 0.468248 | A | 0.425802 | 0.042446 | No Change: Both O | - |
| P26045 | PTN3_HUMAN Tyrosine-protein phosphatase non-receptor type 3 OS=Homo sapiens GN=PTPN3 PE=1 SV=2 | 605 | F | 0.541513 | L | 0.562103 | -0.02059 | No Change: Both D | - |
| P26045 | PTN3_HUMAN Tyrosine-protein phosphatase non-receptor type 3 OS=Homo sapiens GN=PTPN3 PE=1 SV=2 | 763 | D | 0.462203 | N | 0.446602 | 0.015601 | No Change: Both O | - |
| P29074 | PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens GN=PTPN4 PE=1 SV=1 | 924 | T | 0.841925 | S | 0.837027 | 0.004898 | No Change: Both D | - |
| P54829 | PTN5_HUMAN Tyrosine-protein phosphatase non-receptor type 5 OS=Homo sapiens GN=PTPN5 PE=1 SV=4 | 170 | P | 0.719303 | A | 0.605322 | 0.113981 | No Change: Both D | - |
| P54829 | PTN5_HUMAN Tyrosine-protein phosphatase non-receptor type 5 OS=Homo sapiens GN=PTPN5 PE=1 SV=4 | 561 | H | 0.783464 | R | 0.759156 | 0.024308 | No Change: Both D | - |
| P18433 | PTPRA_HUMAN Receptor-type tyrosine-protein phosphatase alpha OS=Homo sapiens GN=PTPRA PE=1 SV=2 | 109 | P | 0.802967 | L | 0.682438 | 0.120529 | No Change: Both D | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 395 | V | 0.316057 | A | 0.393892 | -0.077835 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 415 | D | 0.061653 | E | 0.07031 | -0.008657 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 939 | T | 0.42037 | M | 0.370966 | 0.049404 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 1032 | T | 0.120301 | I | 0.070412 | 0.049889 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 1934 | G | 0.227529 | A | 0.193788 | 0.033741 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 94 | R | 0.099109 | K | 0.118902 | -0.019793 | No Change: Both O | - |
| P23467 | PTPRB_HUMAN Receptor-type tyrosine-protein phosphatase beta OS=Homo sapiens GN=PTPRB PE=1 SV=3 | 127 | S | 0.425651 | G | 0.344053 | 0.081598 | No Change: Both O | - |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 1283 | S | 0.983139 | R | 0.976229 | 0.00691 | No Change: Both D | - |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 228 | E | 0.516173 | A | 0.444615 | 0.071558 | D to O | A breast cancer sample |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 863 | G | 0.155021 | R | 0.139426 | 0.015595 | No Change: Both O | A breast cancer sample |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 191 | T | 0.893044 | A | 0.874772 | 0.018272 | No Change: Both D | - |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 294 | I | 0.318495 | L | 0.370918 | -0.052423 | No Change: Both O | - |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 421 | T | 0.101661 | I | 0.056939 | 0.044722 | No Change: Both O | - |
| P08575 | PTPRC_HUMAN Receptor-type tyrosine-protein phosphatase C OS=Homo sapiens GN=PTPRC PE=1 SV=2 | 568 | H | 0.402583 | Q | 0.404358 | -0.001775 | No Change: Both O | - |
| Q14761 | PTCA_HUMAN Protein tyrosine phosphatase receptor type C-associated protein OS=Homo sapiens GN=PTPRCAP PE=1 SV=1 | 128 | G | 0.959566 | E | 0.968072 | -0.008506 | No Change: Both D | - |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 447 | Q | 0.433017 | E | 0.466118 | -0.033101 | No Change: Both O | - |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 28 | R | 0.547044 | Q | 0.567726 | -0.020682 | No Change: Both D | A colorectal cancer sample |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 276 | L | 0.440851 | P | 0.560809 | -0.119958 | O to D | A colorectal cancer sample |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 901 | V | 0.393194 | A | 0.455413 | -0.062219 | No Change: Both O | A colorectal cancer sample |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 1078 | E | 0.400373 | D | 0.378247 | 0.022126 | No Change: Both O | - |
| P23468 | PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens GN=PTPRD PE=1 SV=2 | 995 | R | 0.53992 | C | 0.378657 | 0.161263 | D to O | - |
| P10586 | PTPRF_HUMAN Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens GN=PTPRF PE=1 SV=2 | 450 | Y | 0.343633 | C | 0.314632 | 0.029001 | No Change: Both O | - |
| P10586 | PTPRF_HUMAN Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens GN=PTPRF PE=1 SV=2 | 562 | D | 0.558269 | N | 0.532643 | 0.025626 | No Change: Both D | - |
| P10586 | PTPRF_HUMAN Receptor-type tyrosine-protein phosphatase F OS=Homo sapiens GN=PTPRF PE=1 SV=2 | 412 | A | 0.927493 | V | 0.908889 | 0.018604 | No Change: Both D | - |
| P23470 | PTPRG_HUMAN Receptor-type tyrosine-protein phosphatase gamma OS=Homo sapiens GN=PTPRG PE=1 SV=4 | 574 | G | 0.994273 | S | 0.995481 | -0.001208 | No Change: Both D | - |
| P23470 | PTPRG_HUMAN Receptor-type tyrosine-protein phosphatase gamma OS=Homo sapiens GN=PTPRG PE=1 SV=4 | 639 | Q | 0.97043 | R | 0.970375 | 5.50E-05 | No Change: Both D | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 348 | H | 0.416218 | Y | 0.319872 | 0.096346 | No Change: Both O | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 543 | L | 0.168832 | F | 0.12629 | 0.042542 | No Change: Both O | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 781 | K | 0.69831 | N | 0.670622 | 0.027688 | No Change: Both D | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 823 | K | 0.48138 | E | 0.491555 | -0.010175 | No Change: Both O | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 1076 | I | 0.077673 | V | 0.101401 | -0.023728 | No Change: Both O | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 232 | D | 0.696087 | N | 0.689906 | 0.006181 | No Change: Both D | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 243 | V | 0.624794 | I | 0.57772 | 0.047074 | No Change: Both D | - |
| Q9HD43 | PTPRH_HUMAN Receptor-type tyrosine-protein phosphatase H OS=Homo sapiens GN=PTPRH PE=1 SV=3 | 831 | G | 0.567014 | D | 0.616175 | -0.049161 | No Change: Both D | - |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 214 | R | 0.192108 | C | 0.097209 | 0.094899 | No Change: Both O | A colon cancer sample |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 276 | Q | 0.567947 | P | 0.606599 | -0.038652 | No Change: Both D | A colon cancer sample |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 326 | R | 0.746969 | Q | 0.768368 | -0.021399 | No Change: Both D | - |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 293 | A | 0.830451 | T | 0.860949 | -0.030498 | No Change: Both D | - |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 372 | V | 0.114382 | I | 0.101586 | 0.012796 | No Change: Both O | - |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 872 | E | 0.363129 | D | 0.360275 | 0.002854 | No Change: Both O | - |
| Q12913 | PTPRJ_HUMAN Receptor-type tyrosine-protein phosphatase eta OS=Homo sapiens GN=PTPRJ PE=1 SV=3 | 1235 | I | 0.414956 | T | 0.54854 | -0.133584 | O to D | - |
| P28827 | PTPRM_HUMAN Receptor-type tyrosine-protein phosphatase mu OS=Homo sapiens GN=PTPRM PE=1 SV=2 | 39 | S | 0.563043 | R | 0.479149 | 0.083894 | D to O | - |
| Q16849 | PTPRN_HUMAN Receptor-type tyrosine-protein phosphatase-like N OS=Homo sapiens GN=PTPRN PE=1 SV=1 | 419 | S | 0.990646 | R | 0.988939 | 0.001707 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 325 | S | 0.644442 | N | 0.574131 | 0.070311 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 343 | V | 0.749781 | M | 0.828042 | -0.078261 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 140 | S | 0.856227 | T | 0.798706 | 0.057521 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 213 | R | 0.693849 | H | 0.651088 | 0.042761 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 716 | E | 0.886742 | K | 0.879099 | 0.007643 | No Change: Both D | A colorectal cancer sample |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 208 | S | 0.692677 | P | 0.708101 | -0.015424 | No Change: Both D | - |
| Q92932 | PTPR2_HUMAN Receptor-type tyrosine-protein phosphatase N2 OS=Homo sapiens GN=PTPRN2 PE=1 SV=2 | 388 | L | 0.686579 | H | 0.736887 | -0.050308 | No Change: Both D | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 1040 | T | 0.238641 | I | 0.124555 | 0.114086 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 1098 | F | 0.23703 | L | 0.277221 | -0.040191 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 1120 | A | 0.235054 | P | 0.323199 | -0.088145 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 1244 | N | 0.160279 | D | 0.174449 | -0.01417 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 1734 | I | 0.1931 | T | 0.312565 | -0.119465 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 2121 | R | 0.066605 | K | 0.087322 | -0.020717 | No Change: Both O | - |
| Q9UMZ3 | PTPRQ_HUMAN Phosphotidylinositol phosphatase PTPRQ OS=Homo sapiens GN=PTPRQ PE=1 SV=2 | 281 | R | 0.880338 | G | 0.869501 | 0.010837 | No Change: Both D | Deafness autosomal recessive type 84 (DFNB84) [MIM:613391] |
| Q15256 | PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens GN=PTPRR PE=1 SV=2 | 314 | K | 0.617998 | R | 0.592689 | 0.025309 | No Change: Both D | - |
| Q15256 | PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens GN=PTPRR PE=1 SV=2 | 249 | Y | 0.048639 | H | 0.083656 | -0.035017 | No Change: Both O | - |
| Q15256 | PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens GN=PTPRR PE=1 SV=2 | 386 | V | 0.440802 | I | 0.408543 | 0.032259 | No Change: Both O | - |
| Q15256 | PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens GN=PTPRR PE=1 SV=2 | 439 | V | 0.399672 | I | 0.37291 | 0.026762 | No Change: Both O | - |
| Q13332 | PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS PE=1 SV=3 | 996 | T | 0.666475 | M | 0.615826 | 0.050649 | No Change: Both D | A colorectal cancer sample |
| Q13332 | PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens GN=PTPRS PE=1 SV=3 | 1457 | C | 0.129999 | R | 0.267214 | -0.137215 | No Change: Both O | - |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 74 | F | 0.37545 | S | 0.608839 | -0.233389 | O to D | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 209 | A | 0.164357 | T | 0.18713 | -0.022773 | No Change: Both O | Some colorectal cancers |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 218 | K | 0.23222 | T | 0.169599 | 0.062621 | No Change: Both O | A gastric cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 248 | F | 0.356928 | S | 0.584925 | -0.227997 | O to D | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 280 | Y | 0.344865 | H | 0.468971 | -0.124106 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 395 | I | 0.28782 | V | 0.321415 | -0.033595 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 412 | Y | 0.087553 | F | 0.077915 | 0.009638 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 453 | R | 0.289912 | C | 0.161261 | 0.128651 | No Change: Both O | A gastric cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 510 | N | 0.304578 | K | 0.335405 | -0.030827 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 605 | T | 0.583265 | M | 0.552528 | 0.030737 | No Change: Both D | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 648 | V | 0.177457 | G | 0.244588 | -0.067131 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 707 | A | 0.27579 | T | 0.301606 | -0.025816 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 707 | A | 0.27579 | V | 0.207105 | 0.068685 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 708 | L | 0.300959 | P | 0.440417 | -0.139458 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 771 | R | 0.336088 | I | 0.191394 | 0.144694 | No Change: Both O | A lung cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 905 | D | 0.589017 | G | 0.561106 | 0.027911 | No Change: Both D | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 965 | Q | 0.381553 | K | 0.431844 | -0.050291 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1096 | A | 0.074866 | P | 0.102005 | -0.027139 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1106 | N | 0.32576 | I | 0.181728 | 0.144032 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1190 | R | 0.466294 | W | 0.214124 | 0.25217 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1237 | M | 0.403814 | L | 0.350374 | 0.05344 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1247 | V | 0.292714 | M | 0.33968 | -0.046966 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1324 | R | 0.203859 | L | 0.113366 | 0.090493 | No Change: Both O | A lung cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1329 | Y | 0.274991 | F | 0.237693 | 0.037298 | No Change: Both O | A colorectal cancer |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1346 | T | 0.550249 | M | 0.507479 | 0.04277 | No Change: Both D | Some colorectal cancers |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 29 | A | 0.50977 | P | 0.577151 | -0.067381 | No Change: Both D | - |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 76 | M | 0.46238 | V | 0.401215 | 0.061165 | No Change: Both O | - |
| O14522 | PTPRT_HUMAN Receptor-type tyrosine-protein phosphatase T OS=Homo sapiens GN=PTPRT PE=1 SV=6 | 1213 | P | 0.326055 | L | 0.200198 | 0.125857 | No Change: Both O | An acute myeloid leukemia sample |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 830 | H | 0.850923 | Y | 0.805775 | 0.045148 | No Change: Both D | A colorectal cancer sample |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 835 | R | 0.880315 | W | 0.728595 | 0.15172 | No Change: Both D | A colorectal cancer sample |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 856 | R | 0.772598 | C | 0.665356 | 0.107242 | No Change: Both D | A colorectal cancer sample |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 60 | T | 0.427418 | N | 0.450543 | -0.023125 | No Change: Both O | - |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 471 | R | 0.601231 | L | 0.546507 | 0.054724 | No Change: Both D | - |
| Q92729 | PTPRU_HUMAN Receptor-type tyrosine-protein phosphatase U OS=Homo sapiens GN=PTPRU PE=1 SV=2 | 940 | N | 0.374237 | S | 0.390523 | -0.016286 | No Change: Both O | - |
| P23471 | PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens GN=PTPRZ1 PE=1 SV=4 | 3 | I | 0.46069 | S | 0.693562 | -0.232872 | O to D | - |
| P23471 | PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens GN=PTPRZ1 PE=1 SV=4 | 6 | R | 0.130844 | L | 0.075255 | 0.055589 | No Change: Both O | - |
| P23471 | PTPRZ_HUMAN Receptor-type tyrosine-protein phosphatase zeta OS=Homo sapiens GN=PTPRZ1 PE=1 SV=4 | 1433 | G | 0.982435 | D | 0.986787 | -0.004352 | No Change: Both D | - |
| Q6NZI2 | PTRF_HUMAN Polymerase I and transcript release factor OS=Homo sapiens GN=PTRF PE=1 SV=1 | 193 | E | 0.98951 | Q | 0.983193 | 0.006317 | No Change: Both D | - |
| Q6NZI2 | PTRF_HUMAN Polymerase I and transcript release factor OS=Homo sapiens GN=PTRF PE=1 SV=1 | 14 | P | 0.872931 | T | 0.7976 | 0.075331 | No Change: Both D | A breast cancer sample |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 16 | R | 0.639039 | C | 0.493821 | 0.145218 | D to O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 25 | R | 0.494364 | G | 0.475868 | 0.018496 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 25 | R | 0.494364 | Q | 0.490654 | 0.00371 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 35 | E | 0.462003 | G | 0.41369 | 0.048313 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 36 | N | 0.454757 | K | 0.504966 | -0.050209 | O to D | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 52 | N | 0.431115 | S | 0.447244 | -0.016129 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 56 | V | 0.28085 | M | 0.318228 | -0.037378 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 67 | T | 0.307236 | M | 0.298743 | 0.008493 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 70 | V | 0.220216 | D | 0.379627 | -0.159411 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 87 | P | 0.399443 | L | 0.255283 | 0.14416 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 87 | P | 0.399443 | S | 0.429222 | -0.029779 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 96 | D | 0.25775 | N | 0.237082 | 0.020668 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 100 | F | 0.167222 | V | 0.212351 | -0.045129 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 106 | T | 0.201825 | M | 0.158007 | 0.043818 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 114 | I | 0.051111 | V | 0.065922 | -0.014811 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 129 | K | 0.147633 | E | 0.14728 | 3.53E-04 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 136 | D | 0.25141 | V | 0.145265 | 0.106145 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 47 | N | 0.60734 | D | 0.5967 | 0.01064 | No Change: Both D | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 116 | D | 0.055386 | G | 0.049745 | 0.005641 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 26 | L | 0.489114 | F | 0.472479 | 0.016635 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 97 | V | 0.216626 | M | 0.272243 | -0.055617 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 99 | Y | 0.163031 | C | 0.13513 | 0.027901 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 124 | V | 0.097144 | L | 0.095817 | 0.001327 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q03393 | PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens GN=PTS PE=1 SV=1 | 136 | D | 0.25141 | G | 0.234313 | 0.017097 | No Change: Both O | BH4-deficient hyperphenylalaninemia type A (HPABH4A) [MIM:261640] |
| Q9NZH5 | PTTG2_HUMAN Securin-2 OS=Homo sapiens GN=PTTG2 PE=1 SV=2 | 44 | R | 0.419128 | P | 0.446689 | -0.027561 | No Change: Both O | - |
| P26022 | PTX3_HUMAN Pentraxin-related protein PTX3 OS=Homo sapiens GN=PTX3 PE=1 SV=3 | 39 | H | 0.560963 | Q | 0.573159 | -0.012196 | No Change: Both D | - |
| P26022 | PTX3_HUMAN Pentraxin-related protein PTX3 OS=Homo sapiens GN=PTX3 PE=1 SV=3 | 48 | A | 0.485306 | D | 0.595445 | -0.110139 | O to D | - |
| P26022 | PTX3_HUMAN Pentraxin-related protein PTX3 OS=Homo sapiens GN=PTX3 PE=1 SV=3 | 290 | A | 0.236242 | V | 0.179103 | 0.057139 | No Change: Both O | - |
| P26022 | PTX3_HUMAN Pentraxin-related protein PTX3 OS=Homo sapiens GN=PTX3 PE=1 SV=3 | 313 | E | 0.343662 | K | 0.357084 | -0.013422 | No Change: Both O | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 92 | R | 0.648361 | W | 0.406721 | 0.24164 | D to O | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 220 | R | 0.988752 | G | 0.986362 | 0.00239 | No Change: Both D | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 234 | R | 0.981434 | Q | 0.981961 | -5.27E-04 | No Change: Both D | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 281 | R | 0.241603 | K | 0.281851 | -0.040248 | No Change: Both O | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 317 | A | 0.387552 | S | 0.515686 | -0.128134 | O to D | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 2 | G | 0.767654 | E | 0.818662 | -0.051008 | No Change: Both D | - |
| Q96A99 | PTX4_HUMAN Pentraxin-4 OS=Homo sapiens GN=PTX4 PE=2 SV=2 | 444 | I | 0.246499 | V | 0.286928 | -0.040429 | No Change: Both O | - |
| Q8TB72 | PUM2_HUMAN Pumilio homolog 2 OS=Homo sapiens GN=PUM2 PE=1 SV=2 | 367 | N | 0.826116 | S | 0.840773 | -0.014657 | No Change: Both D | - |
| Q9UJV8 | PURG_HUMAN Purine-rich element-binding protein gamma OS=Homo sapiens GN=PURG PE=2 SV=1 | 316 | K | 0.445535 | T | 0.369768 | 0.075767 | No Change: Both O | A breast cancer sample |
| Q9UJV8 | PURG_HUMAN Purine-rich element-binding protein gamma OS=Homo sapiens GN=PURG PE=2 SV=1 | 26 | S | 0.867608 | G | 0.851138 | 0.01647 | No Change: Both D | - |
| Q9UJV8 | PURG_HUMAN Purine-rich element-binding protein gamma OS=Homo sapiens GN=PURG PE=2 SV=1 | 143 | E | 0.90133 | K | 0.902544 | -0.001214 | No Change: Both D | - |
| Q9UJV8 | PURG_HUMAN Purine-rich element-binding protein gamma OS=Homo sapiens GN=PURG PE=2 SV=1 | 241 | E | 0.361493 | A | 0.246075 | 0.115418 | No Change: Both O | - |
| Q9Y606 | TRUA_HUMAN tRNA pseudouridine synthase A mitochondrial OS=Homo sapiens GN=PUS1 PE=1 SV=3 | 144 | R | 0.394378 | W | 0.191829 | 0.202549 | No Change: Both O | Myopathy with lactic acidosis and sideroblastic anemia type 1 (MLASA1) [MIM:600462] |
| Q9Y606 | TRUA_HUMAN tRNA pseudouridine synthase A mitochondrial OS=Homo sapiens GN=PUS1 PE=1 SV=3 | 133 | D | 0.619752 | N | 0.617924 | 0.001828 | No Change: Both D | A breast cancer sample |
| Q3MIT2 | PUS10_HUMAN Putative tRNA pseudouridine synthase Pus10 OS=Homo sapiens GN=PUS10 PE=1 SV=1 | 484 | T | 0.248403 | I | 0.143377 | 0.105026 | No Change: Both O | A colorectal cancer sample |
| Q9BZE2 | PUS3_HUMAN tRNA pseudouridine(38/39) synthase OS=Homo sapiens GN=PUS3 PE=1 SV=3 | 3 | Y | 0.897463 | D | 0.961966 | -0.064503 | No Change: Both D | - |
| Q9BZE2 | PUS3_HUMAN tRNA pseudouridine(38/39) synthase OS=Homo sapiens GN=PUS3 PE=1 SV=3 | 46 | A | 0.70883 | S | 0.755376 | -0.046546 | No Change: Both D | - |
| Q9BZE2 | PUS3_HUMAN tRNA pseudouridine(38/39) synthase OS=Homo sapiens GN=PUS3 PE=1 SV=3 | 460 | E | 0.848973 | D | 0.825558 | 0.023415 | No Change: Both D | - |
| Q9H0K6 | PUS7L_HUMAN Pseudouridylate synthase 7 homolog-like protein OS=Homo sapiens GN=PUS7L PE=1 SV=1 | 92 | I | 0.695307 | M | 0.766649 | -0.071342 | No Change: Both D | - |
| Q9H0K6 | PUS7L_HUMAN Pseudouridylate synthase 7 homolog-like protein OS=Homo sapiens GN=PUS7L PE=1 SV=1 | 264 | K | 0.605546 | E | 0.583115 | 0.022431 | No Change: Both D | - |
| Q9H0K6 | PUS7L_HUMAN Pseudouridylate synthase 7 homolog-like protein OS=Homo sapiens GN=PUS7L PE=1 SV=1 | 343 | I | 0.268474 | V | 0.3068 | -0.038326 | No Change: Both O | - |
| Q8N0Z8 | PUSL1_HUMAN tRNA pseudouridine synthase-like 1 OS=Homo sapiens GN=PUSL1 PE=2 SV=1 | 103 | R | 0.429985 | Q | 0.386785 | 0.0432 | No Change: Both O | - |
| Q8N0Z8 | PUSL1_HUMAN tRNA pseudouridine synthase-like 1 OS=Homo sapiens GN=PUSL1 PE=2 SV=1 | 197 | R | 0.789768 | W | 0.568893 | 0.220875 | No Change: Both D | - |
| P15151 | PVR_HUMAN Poliovirus receptor OS=Homo sapiens GN=PVR PE=1 SV=2 | 67 | A | 0.425996 | T | 0.474748 | -0.048752 | No Change: Both O | - |
| P15151 | PVR_HUMAN Poliovirus receptor OS=Homo sapiens GN=PVR PE=1 SV=2 | 340 | I | 0.532439 | M | 0.60913 | -0.076691 | No Change: Both D | - |
| P15151 | PVR_HUMAN Poliovirus receptor OS=Homo sapiens GN=PVR PE=1 SV=2 | 295 | A | 0.187389 | T | 0.203747 | -0.016358 | No Change: Both O | - |
| Q6DKI7 | PVRIG_HUMAN Transmembrane protein PVRIG OS=Homo sapiens GN=PVRIG PE=2 SV=1 | 81 | N | 0.462434 | D | 0.475039 | -0.012605 | No Change: Both O | - |
| Q9NQS3 | PVRL3_HUMAN Poliovirus receptor-related protein 3 OS=Homo sapiens GN=PVRL3 PE=1 SV=1 | 432 | R | 0.185117 | L | 0.097186 | 0.087931 | No Change: Both O | - |
| Q96NY8 | PVRL4_HUMAN Poliovirus receptor-related protein 4 OS=Homo sapiens GN=PVRL4 PE=1 SV=1 | 53 | F | 0.20256 | L | 0.243923 | -0.041363 | No Change: Both O | - |
| Q96NY8 | PVRL4_HUMAN Poliovirus receptor-related protein 4 OS=Homo sapiens GN=PVRL4 PE=1 SV=1 | 185 | T | 0.829046 | M | 0.785772 | 0.043274 | No Change: Both D | Ectodermal dysplasia-syndactyly syndrome type 1 (EDSS1) [MIM:613573] |
| Q13610 | PWP1_HUMAN Periodic tryptophan protein 1 homolog OS=Homo sapiens GN=PWP1 PE=1 SV=1 | 288 | L | 0.236369 | F | 0.198474 | 0.037895 | No Change: Both O | - |
| Q15269 | PWP2_HUMAN Periodic tryptophan protein 2 homolog OS=Homo sapiens GN=PWP2 PE=1 SV=2 | 25 | D | 0.248217 | N | 0.25953 | -0.011313 | No Change: Both O | - |
| Q15269 | PWP2_HUMAN Periodic tryptophan protein 2 homolog OS=Homo sapiens GN=PWP2 PE=1 SV=2 | 551 | F | 0.245564 | I | 0.243494 | 0.00207 | No Change: Both O | - |
| Q15269 | PWP2_HUMAN Periodic tryptophan protein 2 homolog OS=Homo sapiens GN=PWP2 PE=1 SV=2 | 174 | E | 0.070892 | K | 0.070091 | 8.01E-04 | No Change: Both O | - |
| Q6NUJ5 | PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens GN=PWWP2B PE=1 SV=3 | 89 | R | 0.993981 | C | 0.991098 | 0.002883 | No Change: Both D | - |
| Q6NUJ5 | PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens GN=PWWP2B PE=1 SV=3 | 98 | R | 0.99601 | G | 0.995894 | 1.16E-04 | No Change: Both D | - |
| Q5TGL8 | PXDC1_HUMAN PX domain-containing protein 1 OS=Homo sapiens GN=PXDC1 PE=2 SV=3 | 184 | Q | 0.556596 | H | 0.535382 | 0.021214 | No Change: Both D | - |
| Q5TGL8 | PXDC1_HUMAN PX domain-containing protein 1 OS=Homo sapiens GN=PXDC1 PE=2 SV=3 | 189 | P | 0.497099 | Q | 0.489692 | 0.007407 | No Change: Both O | - |
| Q5TGL8 | PXDC1_HUMAN PX domain-containing protein 1 OS=Homo sapiens GN=PXDC1 PE=2 SV=3 | 203 | E | 0.723896 | Q | 0.686418 | 0.037478 | No Change: Both D | A breast cancer sample |
| Q92626 | PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens GN=PXDN PE=1 SV=2 | 1261 | Q | 0.315858 | R | 0.279121 | 0.036737 | No Change: Both O | - |
| Q92626 | PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens GN=PXDN PE=1 SV=2 | 1198 | R | 0.539693 | Q | 0.54857 | -0.008877 | No Change: Both D | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 343 | I | 0.320806 | T | 0.489609 | -0.168803 | No Change: Both O | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 583 | R | 0.155814 | Q | 0.163964 | -0.00815 | No Change: Both O | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 616 | D | 0.307659 | A | 0.23578 | 0.071879 | No Change: Both O | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 981 | M | 0.379994 | V | 0.316931 | 0.063063 | No Change: Both O | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 1327 | V | 0.668211 | D | 0.78251 | -0.114299 | No Change: Both D | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 1399 | R | 0.474574 | K | 0.504399 | -0.029825 | O to D | - |
| A1KZ92 | PXDNL_HUMAN Peroxidasin-like protein OS=Homo sapiens GN=PXDNL PE=2 SV=3 | 1452 | D | 0.957323 | E | 0.96486 | -0.007537 | No Change: Both D | - |
| Q7Z7A4 | PXK_HUMAN PX domain-containing protein kinase-like protein OS=Homo sapiens GN=PXK PE=1 SV=1 | 525 | A | 0.99741 | V | 0.996202 | 0.001208 | No Change: Both D | - |
| Q7Z7A4 | PXK_HUMAN PX domain-containing protein kinase-like protein OS=Homo sapiens GN=PXK PE=1 SV=1 | 535 | A | 0.951247 | V | 0.933777 | 0.01747 | No Change: Both D | - |
| Q7Z7A4 | PXK_HUMAN PX domain-containing protein kinase-like protein OS=Homo sapiens GN=PXK PE=1 SV=1 | 426 | I | 0.787298 | V | 0.766186 | 0.021112 | No Change: Both D | - |
| Q7Z7A4 | PXK_HUMAN PX domain-containing protein kinase-like protein OS=Homo sapiens GN=PXK PE=1 SV=1 | 481 | K | 0.995424 | R | 0.994986 | 4.38E-04 | No Change: Both D | - |
| Q9Y6I8 | PXMP4_HUMAN Peroxisomal membrane protein 4 OS=Homo sapiens GN=PXMP4 PE=1 SV=3 | 204 | V | 0.296033 | I | 0.281916 | 0.014117 | No Change: Both O | - |
| P49023 | PAXI_HUMAN Paxillin OS=Homo sapiens GN=PXN PE=1 SV=3 | 73 | S | 0.918313 | G | 0.885024 | 0.033289 | No Change: Both D | - |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 119 | R | 0.170722 | G | 0.157718 | 0.013004 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 119 | R | 0.170722 | H | 0.149573 | 0.021149 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 179 | A | 0.343827 | T | 0.365988 | -0.022161 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 189 | A | 0.29598 | V | 0.218532 | 0.077448 | No Change: Both O | - |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 206 | G | 0.338166 | R | 0.364662 | -0.026496 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 206 | G | 0.338166 | W | 0.141274 | 0.196892 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 251 | R | 0.239172 | H | 0.234664 | 0.004508 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 257 | A | 0.168857 | T | 0.177666 | -0.008809 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| P32322 | P5CR1_HUMAN Pyrroline-5-carboxylate reductase 1 mitochondrial OS=Homo sapiens GN=PYCR1 PE=1 SV=2 | 266 | R | 0.393687 | Q | 0.416864 | -0.023177 | No Change: Both O | Cutis laxa autosomal recessive type 2B (ARCL2B) [MIM:612940] |
| Q53H96 | P5CR3_HUMAN Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL PE=1 SV=2 | 57 | R | 0.288363 | Q | 0.327608 | -0.039245 | No Change: Both O | - |
| Q53H96 | P5CR3_HUMAN Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL PE=1 SV=2 | 105 | V | 0.297603 | M | 0.328543 | -0.03094 | No Change: Both O | - |
| Q53H96 | P5CR3_HUMAN Pyrroline-5-carboxylate reductase 3 OS=Homo sapiens GN=PYCRL PE=1 SV=2 | 150 | N | 0.467467 | K | 0.503465 | -0.035998 | O to D | - |
| Q56P42 | PYDC2_HUMAN Pyrin domain-containing protein 2 OS=Homo sapiens GN=PYDC2 PE=1 SV=1 | 81 | Q | 0.410755 | R | 0.395873 | 0.014882 | No Change: Both O | - |
| P11216 | PYGB_HUMAN Glycogen phosphorylase brain form OS=Homo sapiens GN=PYGB PE=1 SV=5 | 502 | D | 0.161526 | N | 0.161449 | 7.70E-05 | No Change: Both O | - |
| P11216 | PYGB_HUMAN Glycogen phosphorylase brain form OS=Homo sapiens GN=PYGB PE=1 SV=5 | 303 | A | 0.076052 | S | 0.117322 | -0.04127 | No Change: Both O | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 222 | V | 0.067146 | I | 0.057022 | 0.010124 | No Change: Both O | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 339 | N | 0.277852 | S | 0.316277 | -0.038425 | No Change: Both O | Glycogen storage disease type 6 (GSD6) [MIM:232700] |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 377 | N | 0.214982 | K | 0.261164 | -0.046182 | No Change: Both O | Glycogen storage disease type 6 (GSD6) [MIM:232700] |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 231 | V | 0.341167 | E | 0.533533 | -0.192366 | O to D | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 715 | R | 0.130825 | S | 0.157078 | -0.026253 | No Change: Both O | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 425 | R | 0.316471 | P | 0.345884 | -0.029413 | No Change: Both O | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 698 | V | 0.545464 | G | 0.668861 | -0.123397 | No Change: Both D | - |
| P06737 | PYGL_HUMAN Glycogen phosphorylase liver form OS=Homo sapiens GN=PYGL PE=1 SV=4 | 806 | I | 0.273874 | L | 0.312835 | -0.038961 | No Change: Both O | - |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 205 | G | 0.284253 | S | 0.339843 | -0.05559 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 397 | L | 0.153091 | P | 0.269701 | -0.11661 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 543 | K | 0.411499 | T | 0.318449 | 0.09305 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 655 | E | 0.256027 | K | 0.263362 | -0.007335 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 116 | L | 0.374327 | P | 0.497858 | -0.123531 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 194 | R | 0.41288 | W | 0.217913 | 0.194967 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 292 | L | 0.349819 | P | 0.482626 | -0.132807 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 349 | E | 0.175131 | K | 0.174528 | 6.03E-04 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 488 | T | 0.183364 | N | 0.214881 | -0.031517 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 602 | R | 0.136516 | W | 0.05369 | 0.082826 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 660 | A | 0.341419 | D | 0.422964 | -0.081545 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 666 | Q | 0.529817 | E | 0.586391 | -0.056574 | No Change: Both D | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 685 | N | 0.403926 | Y | 0.208053 | 0.195873 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 686 | G | 0.35617 | R | 0.325344 | 0.030826 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 687 | A | 0.369506 | P | 0.429643 | -0.060137 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 704 | A | 0.555957 | V | 0.48161 | 0.074347 | D to O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 798 | W | 0.195145 | R | 0.41249 | -0.217345 | No Change: Both O | Glycogen storage disease type 5 (GSD5) [MIM:232600] |
| P11217 | PYGM_HUMAN Glycogen phosphorylase muscle form OS=Homo sapiens GN=PYGM PE=1 SV=6 | 414 | R | 0.133016 | G | 0.136072 | -0.003056 | No Change: Both O | - |
| Q9Y3Y4 | PYGO1_HUMAN Pygopus homolog 1 OS=Homo sapiens GN=PYGO1 PE=1 SV=2 | 299 | P | 0.9867 | H | 0.980152 | 0.006548 | No Change: Both D | - |
| Q8N2H3 | PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=PYROXD2 PE=2 SV=2 | 428 | P | 0.426332 | S | 0.43429 | -0.007958 | No Change: Both O | - |
| Q8N2H3 | PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=PYROXD2 PE=2 SV=2 | 461 | M | 0.135279 | T | 0.17764 | -0.042361 | No Change: Both O | - |
| Q8N2H3 | PYRD2_HUMAN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 OS=Homo sapiens GN=PYROXD2 PE=2 SV=2 | 533 | A | 0.177102 | T | 0.193098 | -0.015996 | No Change: Both O | - |
| P10082 | PYY_HUMAN Peptide YY OS=Homo sapiens GN=PYY PE=1 SV=3 | 72 | T | 0.592398 | R | 0.634802 | -0.042404 | No Change: Both D | - |
| P10082 | PYY_HUMAN Peptide YY OS=Homo sapiens GN=PYY PE=1 SV=3 | 37 | R | 0.754656 | G | 0.76766 | -0.013004 | No Change: Both D | - |
| P10082 | PYY_HUMAN Peptide YY OS=Homo sapiens GN=PYY PE=1 SV=3 | 95 | D | 0.905073 | H | 0.852338 | 0.052735 | No Change: Both D | - |
| Q5JQD4 | PYY3_HUMAN Putative peptide YY-3 OS=Homo sapiens GN=PYY3 PE=5 SV=1 | 28 | T | 0.15344 | I | 0.094517 | 0.058923 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 813 | V | 0.120094 | A | 0.163194 | -0.0431 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 691 | V | 0.409128 | M | 0.455398 | -0.04627 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 1443 | I | 0.162297 | N | 0.310538 | -0.148241 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 379 | L | 0.123279 | V | 0.135171 | -0.011892 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 1128 | R | 0.081555 | H | 0.082624 | -0.001069 | No Change: Both O | A colorectal cancer sample |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 857 | N | 0.249221 | S | 0.30671 | -0.057489 | No Change: Both O | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 1205 | T | 0.456599 | P | 0.537252 | -0.080653 | O to D | - |
| P20742 | PZP_HUMAN Pregnancy zone protein OS=Homo sapiens GN=PZP PE=1 SV=4 | 1003 | T | 0.44676 | M | 0.378484 | 0.068276 | No Change: Both O | - |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 23 | G | 0.278479 | D | 0.27629 | 0.002189 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 36 | W | 0.085705 | R | 0.212625 | -0.12692 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 74 | L | 0.376103 | P | 0.481367 | -0.105264 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 108 | W | 0.117337 | G | 0.253435 | -0.136098 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 145 | P | 0.411628 | L | 0.305815 | 0.105813 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 150 | Y | 0.387259 | C | 0.436089 | -0.04883 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 151 | G | 0.387318 | S | 0.408969 | -0.021651 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 158 | H | 0.325843 | Y | 0.244179 | 0.081664 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 170 | G | 0.590171 | S | 0.624618 | -0.034447 | No Change: Both D | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 212 | F | 0.180754 | C | 0.1794 | 0.001354 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 14 | L | 0.255511 | P | 0.420974 | -0.165463 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 17 | G | 0.302305 | V | 0.18885 | 0.113455 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 51 | S | 0.363464 | T | 0.283229 | 0.080235 | No Change: Both O | - |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 17 | G | 0.302305 | R | 0.313465 | -0.01116 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 18 | G | 0.309226 | D | 0.300211 | 0.009015 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 66 | Q | 0.444092 | R | 0.407744 | 0.036348 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| P09417 | DHPR_HUMAN Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 | 149 | G | 0.390397 | R | 0.336436 | 0.053961 | No Change: Both O | BH4-deficient hyperphenylalaninemia type C (HPABH4C) [MIM:261630] |
| Q96PU8 | QKI_HUMAN Protein quaking OS=Homo sapiens GN=QKI PE=1 SV=1 | 336 | R | 0.549475 | Q | 0.5557 | -0.006225 | No Change: Both D | A colorectal cancer sample |
| Q16769 | QPCT_HUMAN Glutaminyl-peptide cyclotransferase OS=Homo sapiens GN=QPCT PE=1 SV=1 | 71 | Q | 0.324042 | R | 0.307331 | 0.016711 | No Change: Both O | - |
| Q16769 | QPCT_HUMAN Glutaminyl-peptide cyclotransferase OS=Homo sapiens GN=QPCT PE=1 SV=1 | 54 | R | 0.464112 | W | 0.282354 | 0.181758 | No Change: Both O | - |
| Q16769 | QPCT_HUMAN Glutaminyl-peptide cyclotransferase OS=Homo sapiens GN=QPCT PE=1 SV=1 | 360 | H | 0.438104 | P | 0.474469 | -0.036365 | No Change: Both O | - |
| Q9NXS2 | QPCTL_HUMAN Glutaminyl-peptide cyclotransferase-like protein OS=Homo sapiens GN=QPCTL PE=1 SV=2 | 214 | P | 0.357377 | L | 0.24726 | 0.110117 | No Change: Both O | - |
| Q15274 | NADC_HUMAN Nicotinate-nucleotide pyrophosphorylase [carboxylating] OS=Homo sapiens GN=QPRT PE=1 SV=3 | 158 | A | 0.306598 | V | 0.236279 | 0.070319 | No Change: Both O | - |
| Q15274 | NADC_HUMAN Nicotinate-nucleotide pyrophosphorylase [carboxylating] OS=Homo sapiens GN=QPRT PE=1 SV=3 | 195 | T | 0.290179 | A | 0.318782 | -0.028603 | No Change: Both O | - |
| P83859 | OX26_HUMAN Orexigenic neuropeptide QRFP OS=Homo sapiens GN=QRFP PE=2 SV=1 | 68 | L | 0.369244 | H | 0.440145 | -0.070901 | No Change: Both O | - |
| Q96P65 | QRFPR_HUMAN Pyroglutamylated RFamide peptide receptor OS=Homo sapiens GN=QRFPR PE=1 SV=2 | 61 | F | 0.025458 | V | 0.029619 | -0.004161 | No Change: Both O | - |
| Q96P65 | QRFPR_HUMAN Pyroglutamylated RFamide peptide receptor OS=Homo sapiens GN=QRFPR PE=1 SV=2 | 149 | H | 0.233821 | Q | 0.250968 | -0.017147 | No Change: Both O | - |
| Q96P65 | QRFPR_HUMAN Pyroglutamylated RFamide peptide receptor OS=Homo sapiens GN=QRFPR PE=1 SV=2 | 344 | L | 0.116135 | S | 0.241692 | -0.125557 | No Change: Both O | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 202 | L | 0.980468 | S | 0.988977 | -0.008509 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 630 | I | 0.806764 | T | 0.869426 | -0.062662 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 906 | H | 0.908912 | Y | 0.849614 | 0.059298 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 974 | H | 0.795469 | R | 0.844101 | -0.048632 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 1036 | E | 0.588839 | Q | 0.538477 | 0.050362 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 630 | I | 0.806764 | V | 0.86784 | -0.061076 | No Change: Both D | - |
| Q9H0J4 | QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens GN=QRICH2 PE=2 SV=1 | 681 | V | 0.904662 | D | 0.932204 | -0.027542 | No Change: Both D | - |
| Q9H0R6 | GATA_HUMAN Glutamyl-tRNA(Gln) amidotransferase subunit A mitochondrial OS=Homo sapiens GN=QRSL1 PE=1 SV=2 | 11 | A | 0.447743 | V | 0.353271 | 0.094472 | No Change: Both O | - |
| Q9H0R6 | GATA_HUMAN Glutamyl-tRNA(Gln) amidotransferase subunit A mitochondrial OS=Homo sapiens GN=QRSL1 PE=1 SV=2 | 263 | N | 0.414965 | S | 0.488548 | -0.073583 | No Change: Both O | - |
| Q2KHR3 | QSER1_HUMAN Glutamine and serine-rich protein 1 OS=Homo sapiens GN=QSER1 PE=1 SV=3 | 644 | Q | 0.547777 | R | 0.484317 | 0.06346 | D to O | - |
| Q2KHR3 | QSER1_HUMAN Glutamine and serine-rich protein 1 OS=Homo sapiens GN=QSER1 PE=1 SV=3 | 1018 | N | 0.928672 | S | 0.946851 | -0.018179 | No Change: Both D | - |
| Q2KHR3 | QSER1_HUMAN Glutamine and serine-rich protein 1 OS=Homo sapiens GN=QSER1 PE=1 SV=3 | 1304 | N | 0.676065 | D | 0.685912 | -0.009847 | No Change: Both D | - |
| Q2KHR3 | QSER1_HUMAN Glutamine and serine-rich protein 1 OS=Homo sapiens GN=QSER1 PE=1 SV=3 | 385 | V | 0.834924 | I | 0.800425 | 0.034499 | No Change: Both D | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 114 | N | 0.151134 | S | 0.17994 | -0.028806 | No Change: Both O | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 200 | G | 0.296713 | A | 0.239711 | 0.057002 | No Change: Both O | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 256 | R | 0.275498 | M | 0.229073 | 0.046425 | No Change: Both O | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 294 | A | 0.190035 | S | 0.276935 | -0.0869 | No Change: Both O | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 444 | H | 0.049675 | R | 0.060219 | -0.010544 | No Change: Both O | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 591 | N | 0.974304 | H | 0.973672 | 6.32E-04 | No Change: Both D | - |
| O00391 | QSOX1_HUMAN Sulfhydryl oxidase 1 OS=Homo sapiens GN=QSOX1 PE=1 SV=3 | 605 | R | 0.988456 | P | 0.991652 | -0.003196 | No Change: Both D | - |
| Q6ZRP7 | QSOX2_HUMAN Sulfhydryl oxidase 2 OS=Homo sapiens GN=QSOX2 PE=1 SV=3 | 126 | K | 0.43464 | E | 0.458699 | -0.024059 | No Change: Both O | - |
| Q9Y3T6 | R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=R3HCC1 PE=1 SV=2 | 136 | A | 0.820883 | T | 0.823522 | -0.002639 | No Change: Both D | - |
| Q9Y3T6 | R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=R3HCC1 PE=1 SV=2 | 185 | R | 0.66215 | K | 0.642288 | 0.019862 | No Change: Both D | - |
| Q9Y3T6 | R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=R3HCC1 PE=1 SV=2 | 347 | V | 0.481821 | M | 0.540213 | -0.058392 | O to D | - |
| Q9Y3T6 | R3HC1_HUMAN R3H and coiled-coil domain-containing protein 1 OS=Homo sapiens GN=R3HCC1 PE=1 SV=2 | 403 | L | 0.127079 | R | 0.19326 | -0.066181 | No Change: Both O | - |
| Q15032 | R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens GN=R3HDM1 PE=1 SV=3 | 270 | M | 0.964398 | V | 0.946635 | 0.017763 | No Change: Both D | - |
| Q15032 | R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens GN=R3HDM1 PE=1 SV=3 | 632 | Q | 0.960244 | P | 0.964278 | -0.004034 | No Change: Both D | - |
| Q9Y2K5 | R3HD2_HUMAN R3H domain-containing protein 2 OS=Homo sapiens GN=R3HDM2 PE=1 SV=3 | 35 | T | 0.976456 | A | 0.967719 | 0.008737 | No Change: Both D | - |
| Q9H3Y0 | CRSPL_HUMAN Peptidase inhibitor R3HDML OS=Homo sapiens GN=R3HDML PE=1 SV=1 | 15 | F | 0.127585 | C | 0.165676 | -0.038091 | No Change: Both O | - |
| Q9H3Y0 | CRSPL_HUMAN Peptidase inhibitor R3HDML OS=Homo sapiens GN=R3HDML PE=1 SV=1 | 68 | D | 0.254255 | N | 0.25027 | 0.003985 | No Change: Both O | - |
| Q6WKZ4 | RFIP1_HUMAN Rab11 family-interacting protein 1 OS=Homo sapiens GN=RAB11FIP1 PE=1 SV=2 | 1185 | M | 0.580687 | T | 0.59183 | -0.011143 | No Change: Both D | - |
| Q6WKZ4 | RFIP1_HUMAN Rab11 family-interacting protein 1 OS=Homo sapiens GN=RAB11FIP1 PE=1 SV=2 | 768 | A | 0.902037 | V | 0.868786 | 0.033251 | No Change: Both D | - |
| Q6WKZ4 | RFIP1_HUMAN Rab11 family-interacting protein 1 OS=Homo sapiens GN=RAB11FIP1 PE=1 SV=2 | 651 | V | 0.907591 | A | 0.927408 | -0.019817 | No Change: Both D | - |
| Q7L804 | RFIP2_HUMAN Rab11 family-interacting protein 2 OS=Homo sapiens GN=RAB11FIP2 PE=1 SV=1 | 152 | F | 0.792698 | V | 0.781093 | 0.011605 | No Change: Both D | - |
| P61106 | RAB14_HUMAN Ras-related protein Rab-14 OS=Homo sapiens GN=RAB14 PE=1 SV=4 | 4 | A | 0.701913 | T | 0.727846 | -0.025933 | No Change: Both D | - |
| Q9H0T7 | RAB17_HUMAN Ras-related protein Rab-17 OS=Homo sapiens GN=RAB17 PE=2 SV=2 | 191 | L | 0.616208 | P | 0.726928 | -0.11072 | No Change: Both D | - |
| Q9H0T7 | RAB17_HUMAN Ras-related protein Rab-17 OS=Homo sapiens GN=RAB17 PE=2 SV=2 | 19 | V | 0.509939 | A | 0.600033 | -0.090094 | No Change: Both D | - |
| Q9H0T7 | RAB17_HUMAN Ras-related protein Rab-17 OS=Homo sapiens GN=RAB17 PE=2 SV=2 | 184 | S | 0.647573 | G | 0.619959 | 0.027614 | No Change: Both D | - |
| Q9NP72 | RAB18_HUMAN Ras-related protein Rab-18 OS=Homo sapiens GN=RAB18 PE=1 SV=1 | 198 | A | 0.515251 | T | 0.572861 | -0.05761 | No Change: Both D | - |
| Q9NP72 | RAB18_HUMAN Ras-related protein Rab-18 OS=Homo sapiens GN=RAB18 PE=1 SV=1 | 113 | N | 0.16573 | S | 0.171988 | -0.006258 | No Change: Both O | - |
| Q9NP72 | RAB18_HUMAN Ras-related protein Rab-18 OS=Homo sapiens GN=RAB18 PE=1 SV=1 | 24 | L | 0.335438 | Q | 0.443186 | -0.107748 | No Change: Both O | Warburg micro syndrome type 3 (WARBM3) [MIM:614222] |
| Q9NX57 | RAB20_HUMAN Ras-related protein Rab-20 OS=Homo sapiens GN=RAB20 PE=1 SV=1 | 134 | N | 0.703626 | S | 0.759237 | -0.055611 | No Change: Both D | - |
| Q9ULC3 | RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 | 207 | G | 0.865294 | S | 0.890696 | -0.025402 | No Change: Both D | - |
| Q9ULC3 | RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 | 40 | K | 0.287424 | R | 0.21778 | 0.069644 | No Change: Both O | - |
| Q9ULC3 | RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 | 85 | C | 0.075954 | R | 0.161993 | -0.086039 | No Change: Both O | Acrocephalopolysyndactyly type 2 (ACPS2) [MIM:201000] |
| Q9ULC3 | RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 | 101 | S | 0.434696 | A | 0.311321 | 0.123375 | No Change: Both O | - |
| Q9ULC3 | RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens GN=RAB23 PE=1 SV=1 | 12 | M | 0.165317 | K | 0.260662 | -0.095345 | No Change: Both O | - |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 73 | W | 0.198238 | G | 0.433708 | -0.23547 | No Change: Both O | Griscelli syndrome type 2 (GS2) [MIM:607624] |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 130 | L | 0.171822 | P | 0.309571 | -0.137749 | No Change: Both O | Griscelli syndrome type 2 (GS2) [MIM:607624] |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 152 | A | 0.251205 | P | 0.319439 | -0.068234 | No Change: Both O | Griscelli syndrome type 2 (GS2) [MIM:607624] |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 62 | T | 0.606445 | S | 0.658756 | -0.052311 | No Change: Both D | - |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 84 | L | 0.259721 | F | 0.257026 | 0.002695 | No Change: Both O | - |
| P51159 | RB27A_HUMAN Ras-related protein Rab-27A OS=Homo sapiens GN=RAB27A PE=1 SV=3 | 85 | T | 0.238107 | P | 0.266941 | -0.028834 | No Change: Both O | - |
| O00194 | RB27B_HUMAN Ras-related protein Rab-27B OS=Homo sapiens GN=RAB27B PE=1 SV=4 | 92 | A | 0.11813 | T | 0.136951 | -0.018821 | No Change: Both O | - |
| Q8WUD1 | RAB2B_HUMAN Ras-related protein Rab-2B OS=Homo sapiens GN=RAB2B PE=1 SV=1 | 212 | N | 0.964548 | T | 0.959114 | 0.005434 | No Change: Both D | - |
| Q14088 | RB33A_HUMAN Ras-related protein Rab-33A OS=Homo sapiens GN=RAB33A PE=1 SV=2 | 102 | M | 0.429278 | T | 0.481232 | -0.051954 | No Change: Both O | - |
| Q9BZG1 | RAB34_HUMAN Ras-related protein Rab-34 OS=Homo sapiens GN=RAB34 PE=1 SV=1 | 197 | V | 0.220778 | L | 0.228175 | -0.007397 | No Change: Both O | - |
| O95755 | RAB36_HUMAN Ras-related protein Rab-36 OS=Homo sapiens GN=RAB36 PE=1 SV=2 | 308 | N | 0.723439 | D | 0.769915 | -0.046476 | No Change: Both D | - |
| O95755 | RAB36_HUMAN Ras-related protein Rab-36 OS=Homo sapiens GN=RAB36 PE=1 SV=2 | 50 | P | 0.840354 | L | 0.757956 | 0.082398 | No Change: Both D | - |
| O95755 | RAB36_HUMAN Ras-related protein Rab-36 OS=Homo sapiens GN=RAB36 PE=1 SV=2 | 320 | E | 0.942984 | K | 0.938091 | 0.004893 | No Change: Both D | - |
| Q96AX2 | RAB37_HUMAN Ras-related protein Rab-37 OS=Homo sapiens GN=RAB37 PE=1 SV=3 | 188 | A | 0.194289 | P | 0.236307 | -0.042018 | No Change: Both O | - |
| P57729 | RAB38_HUMAN Ras-related protein Rab-38 OS=Homo sapiens GN=RAB38 PE=1 SV=1 | 111 | K | 0.580259 | T | 0.490712 | 0.089547 | D to O | A colorectal cancer sample |
| O95716 | RAB3D_HUMAN Ras-related protein Rab-3D OS=Homo sapiens GN=RAB3D PE=1 SV=1 | 64 | V | 0.240042 | I | 0.214132 | 0.02591 | No Change: Both O | - |
| Q15042 | RB3GP_HUMAN Rab3 GTPase-activating protein catalytic subunit OS=Homo sapiens GN=RAB3GAP1 PE=1 SV=3 | 598 | N | 0.934525 | S | 0.949424 | -0.014899 | No Change: Both D | - |
| Q9H2M9 | RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens GN=RAB3GAP2 PE=1 SV=1 | 863 | T | 0.419843 | A | 0.39786 | 0.021983 | No Change: Both O | - |
| Q9H2M9 | RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens GN=RAB3GAP2 PE=1 SV=1 | 1092 | S | 0.500279 | T | 0.424012 | 0.076267 | D to O | - |
| Q9H2M9 | RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens GN=RAB3GAP2 PE=1 SV=1 | 1052 | G | 0.117855 | C | 0.053411 | 0.064444 | No Change: Both O | Martsolf syndrome (MARTS) [MIM:212720] |
| Q8TBN0 | R3GEF_HUMAN Guanine nucleotide exchange factor for Rab-3A OS=Homo sapiens GN=RAB3IL1 PE=1 SV=1 | 49 | Q | 0.888946 | R | 0.883902 | 0.005044 | No Change: Both D | - |
| Q8TBN0 | R3GEF_HUMAN Guanine nucleotide exchange factor for Rab-3A OS=Homo sapiens GN=RAB3IL1 PE=1 SV=1 | 323 | H | 0.578523 | Y | 0.480132 | 0.098391 | D to O | - |
| Q8WXH6 | RB40A_HUMAN Ras-related protein Rab-40A OS=Homo sapiens GN=RAB40A PE=2 SV=2 | 45 | H | 0.407402 | L | 0.308554 | 0.098848 | No Change: Both O | - |
| P51148 | RAB5C_HUMAN Ras-related protein Rab-5C OS=Homo sapiens GN=RAB5C PE=1 SV=2 | 40 | R | 0.176007 | H | 0.18474 | -0.008733 | No Change: Both O | A colorectal cancer sample |
| Q9H0N0 | RAB6C_HUMAN Ras-related protein Rab-6C OS=Homo sapiens GN=RAB6C PE=2 SV=2 | 159 | A | 0.317776 | T | 0.339257 | -0.021481 | No Change: Both O | - |
| P51149 | RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 | 129 | L | 0.299595 | F | 0.270334 | 0.029261 | No Change: Both O | Charcot-Marie-Tooth disease type 2B (CMT2B) [MIM:600882] |
| P51149 | RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 | 162 | V | 0.360964 | M | 0.427472 | -0.066508 | No Change: Both O | Charcot-Marie-Tooth disease type 2B (CMT2B) [MIM:600882] |
| P51149 | RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 | 32 | K | 0.484749 | E | 0.464979 | 0.01977 | No Change: Both O | - |
| P51149 | RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 | 157 | K | 0.389061 | N | 0.370008 | 0.019053 | No Change: Both O | Charcot-Marie-Tooth disease type 2B (CMT2B) [MIM:600882] |
| P51149 | RAB7A_HUMAN Ras-related protein Rab-7a OS=Homo sapiens GN=RAB7A PE=1 SV=1 | 161 | N | 0.370032 | T | 0.35278 | 0.017252 | No Change: Both O | Charcot-Marie-Tooth disease type 2B (CMT2B) [MIM:600882] |
| Q15276 | RABE1_HUMAN Rab GTPase-binding effector protein 1 OS=Homo sapiens GN=RABEP1 PE=1 SV=2 | 640 | E | 0.866015 | G | 0.818194 | 0.047821 | No Change: Both D | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 60 | R | 0.534489 | G | 0.567489 | -0.033 | No Change: Both D | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 67 | T | 0.402974 | P | 0.45714 | -0.054166 | No Change: Both O | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 73 | H | 0.351993 | Y | 0.230749 | 0.121244 | No Change: Both O | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 313 | D | 0.692964 | G | 0.661506 | 0.031458 | No Change: Both D | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 333 | M | 0.821993 | I | 0.765577 | 0.056416 | No Change: Both D | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 58 | P | 0.448282 | A | 0.390933 | 0.057349 | No Change: Both O | - |
| Q7Z6M1 | RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens GN=RABEPK PE=1 SV=1 | 95 | S | 0.204457 | C | 0.084073 | 0.120384 | No Change: Both O | - |
| Q5R372 | RBG1L_HUMAN Rab GTPase-activating protein 1-like OS=Homo sapiens GN=RABGAP1L PE=1 SV=1 | 277 | S | 0.702866 | G | 0.6174 | 0.085466 | No Change: Both D | - |
| Q92696 | PGTA_HUMAN Geranylgeranyl transferase type-2 subunit alpha OS=Homo sapiens GN=RABGGTA PE=1 SV=2 | 420 | T | 0.265172 | A | 0.255181 | 0.009991 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 26 | N | 0.171221 | D | 0.182232 | -0.011011 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 28 | F | 0.228651 | L | 0.255955 | -0.027304 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 59 | A | 0.294045 | T | 0.335903 | -0.041858 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 63 | D | 0.478377 | G | 0.442361 | 0.036016 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 93 | V | 0.262028 | I | 0.226572 | 0.035456 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 93 | V | 0.262028 | G | 0.376362 | -0.114334 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 108 | T | 0.229995 | I | 0.142997 | 0.086998 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 130 | K | 0.671938 | R | 0.601028 | 0.07091 | No Change: Both D | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 133 | K | 0.589544 | E | 0.581164 | 0.00838 | No Change: Both D | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 180 | P | 0.437767 | S | 0.417216 | 0.020551 | No Change: Both O | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 182 | V | 0.542335 | E | 0.685126 | -0.142791 | No Change: Both D | - |
| P63000 | RAC1_HUMAN Ras-related C3 botulinum toxin substrate 1 OS=Homo sapiens GN=RAC1 PE=1 SV=1 | 135 | T | 0.484522 | I | 0.347749 | 0.136773 | No Change: Both O | - |
| P15153 | RAC2_HUMAN Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens GN=RAC2 PE=1 SV=1 | 57 | D | 0.216373 | N | 0.204107 | 0.012266 | No Change: Both O | Neutrophil immunodeficiency syndrome (NEUID) [MIM:608203] |
| P15153 | RAC2_HUMAN Ras-related C3 botulinum toxin substrate 2 OS=Homo sapiens GN=RAC2 PE=1 SV=1 | 29 | P | 0.250577 | L | 0.123067 | 0.12751 | No Change: Both O | A breast cancer sample |
| O60671 | RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens GN=RAD1 PE=1 SV=1 | 33 | A | 0.17793 | G | 0.210636 | -0.032706 | No Change: Both O | - |
| O60671 | RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens GN=RAD1 PE=1 SV=1 | 104 | T | 0.375772 | S | 0.467629 | -0.091857 | No Change: Both O | - |
| O60671 | RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens GN=RAD1 PE=1 SV=1 | 114 | G | 0.096584 | D | 0.100852 | -0.004268 | No Change: Both O | - |
| O60671 | RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens GN=RAD1 PE=1 SV=1 | 281 | E | 0.833039 | G | 0.857683 | -0.024644 | No Change: Both D | - |
| O60671 | RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens GN=RAD1 PE=1 SV=1 | 39 | H | 0.179425 | Q | 0.182527 | -0.003102 | No Change: Both O | - |
| O75943 | RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens GN=RAD17 PE=1 SV=2 | 32 | V | 0.534438 | I | 0.499762 | 0.034676 | D to O | - |
| O75943 | RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens GN=RAD17 PE=1 SV=2 | 487 | R | 0.344455 | L | 0.232413 | 0.112042 | No Change: Both O | - |
| O75943 | RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens GN=RAD17 PE=1 SV=2 | 535 | K | 0.173207 | E | 0.168026 | 0.005181 | No Change: Both O | - |
| O75943 | RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens GN=RAD17 PE=1 SV=2 | 557 | L | 0.070901 | R | 0.108025 | -0.037124 | No Change: Both O | - |
| Q9NS91 | RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens GN=RAD18 PE=1 SV=2 | 6 | E | 0.704486 | A | 0.626471 | 0.078015 | No Change: Both D | - |
| Q9NS91 | RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens GN=RAD18 PE=1 SV=2 | 302 | R | 0.425277 | Q | 0.435585 | -0.010308 | No Change: Both O | - |
| Q9NS91 | RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens GN=RAD18 PE=1 SV=2 | 307 | I | 0.536675 | V | 0.554061 | -0.017386 | No Change: Both D | - |
| O60216 | RAD21_HUMAN Double-strand-break repair protein rad21 homolog OS=Homo sapiens GN=RAD21 PE=1 SV=2 | 481 | G | 0.986446 | R | 0.989221 | -0.002775 | No Change: Both D | - |
| Q9H4I0 | RD21L_HUMAN Double-strand-break repair protein rad21-like protein 1 OS=Homo sapiens GN=RAD21L1 PE=2 SV=3 | 90 | C | 0.120289 | R | 0.22724 | -0.106951 | No Change: Both O | - |
| Q9H4I0 | RD21L_HUMAN Double-strand-break repair protein rad21-like protein 1 OS=Homo sapiens GN=RAD21L1 PE=2 SV=3 | 152 | I | 0.540379 | L | 0.577422 | -0.037043 | No Change: Both D | - |
| Q9H4I0 | RD21L_HUMAN Double-strand-break repair protein rad21-like protein 1 OS=Homo sapiens GN=RAD21L1 PE=2 SV=3 | 423 | H | 0.805197 | P | 0.834051 | -0.028854 | No Change: Both D | - |
| P54725 | RD23A_HUMAN UV excision repair protein RAD23 homolog A OS=Homo sapiens GN=RAD23A PE=1 SV=1 | 131 | T | 0.998786 | A | 0.998656 | 1.30E-04 | No Change: Both D | - |
| P54725 | RD23A_HUMAN UV excision repair protein RAD23 homolog A OS=Homo sapiens GN=RAD23A PE=1 SV=1 | 200 | T | 0.575561 | M | 0.58502 | -0.009459 | No Change: Both D | - |
| P54725 | RD23A_HUMAN UV excision repair protein RAD23 homolog A OS=Homo sapiens GN=RAD23A PE=1 SV=1 | 179 | R | 0.430729 | Q | 0.38809 | 0.042639 | No Change: Both O | - |
| P54727 | RD23B_HUMAN UV excision repair protein RAD23 homolog B OS=Homo sapiens GN=RAD23B PE=1 SV=1 | 249 | A | 0.874626 | V | 0.831147 | 0.043479 | No Change: Both D | - |
| Q5T890 | RAD26_HUMAN Putative DNA repair and recombination protein RAD26-like OS=Homo sapiens GN=RAD26L PE=1 SV=1 | 592 | V | 0.094954 | A | 0.132416 | -0.037462 | No Change: Both O | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 616 | K | 0.901437 | E | 0.906586 | -0.005149 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 697 | V | 0.728681 | A | 0.765534 | -0.036853 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 964 | Y | 0.709229 | H | 0.783273 | -0.074044 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 973 | K | 0.787615 | M | 0.728519 | 0.059096 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 1038 | R | 0.961092 | G | 0.950605 | 0.010487 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 191 | T | 0.377085 | I | 0.254983 | 0.122102 | No Change: Both O | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 94 | I | 0.250247 | L | 0.28813 | -0.037883 | No Change: Both O | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 224 | R | 0.766413 | H | 0.716102 | 0.050311 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 127 | V | 0.674009 | I | 0.662036 | 0.011973 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 193 | R | 0.419606 | W | 0.20245 | 0.217156 | No Change: Both O | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 842 | V | 0.902154 | A | 0.917358 | -0.015204 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 315 | V | 0.852048 | L | 0.870086 | -0.018038 | No Change: Both D | - |
| Q92878 | RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens GN=RAD50 PE=1 SV=1 | 469 | G | 0.836494 | A | 0.826089 | 0.010405 | No Change: Both D | - |
| Q06609 | RAD51_HUMAN DNA repair protein RAD51 homolog 1 OS=Homo sapiens GN=RAD51 PE=1 SV=1 | 150 | R | 0.403247 | Q | 0.435818 | -0.032571 | No Change: Both O | Breast cancer (BC) [MIM:114480] |
| Q96B01 | R51A1_HUMAN RAD51-associated protein 1 OS=Homo sapiens GN=RAD51AP1 PE=1 SV=1 | 68 | K | 0.82456 | Q | 0.808876 | 0.015684 | No Change: Both D | - |
| Q09MP3 | R51A2_HUMAN RAD51-associated protein 2 OS=Homo sapiens GN=RAD51AP2 PE=1 SV=1 | 876 | V | 0.594445 | L | 0.57243 | 0.022015 | No Change: Both D | - |
| Q09MP3 | R51A2_HUMAN RAD51-associated protein 2 OS=Homo sapiens GN=RAD51AP2 PE=1 SV=1 | 976 | R | 0.285388 | H | 0.266273 | 0.019115 | No Change: Both O | - |
| Q09MP3 | R51A2_HUMAN RAD51-associated protein 2 OS=Homo sapiens GN=RAD51AP2 PE=1 SV=1 | 1037 | G | 0.553973 | D | 0.577545 | -0.023572 | No Change: Both D | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 9 | V | 0.618797 | M | 0.753509 | -0.134712 | No Change: Both D | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 82 | F | 0.368507 | C | 0.378575 | -0.010068 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 172 | L | 0.404625 | W | 0.289698 | 0.114927 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 180 | Y | 0.265915 | C | 0.285231 | -0.019316 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 243 | K | 0.39506 | R | 0.350048 | 0.045012 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 250 | S | 0.15194 | A | 0.103349 | 0.048591 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 207 | V | 0.15557 | L | 0.161612 | -0.006042 | No Change: Both O | - |
| O15315 | RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens GN=RAD51B PE=1 SV=2 | 365 | P | 0.517989 | R | 0.432548 | 0.085441 | D to O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 144 | I | 0.124136 | T | 0.214104 | -0.089968 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 249 | R | 0.190865 | C | 0.094211 | 0.096654 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 287 | T | 0.319443 | A | 0.282297 | 0.037146 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 3 | G | 0.730775 | R | 0.759335 | -0.02856 | No Change: Both D | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 125 | G | 0.284598 | V | 0.171089 | 0.113509 | No Change: Both O | Familial breast-ovarian cancer type 3 (BROVCA3) [MIM:613399] |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 126 | A | 0.283173 | T | 0.335726 | -0.052553 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 138 | L | 0.109233 | F | 0.094691 | 0.014542 | No Change: Both O | Familial breast-ovarian cancer type 3 (BROVCA3) [MIM:613399] |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 159 | D | 0.225317 | N | 0.207624 | 0.017693 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 169 | V | 0.120155 | A | 0.163172 | -0.043017 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 264 | G | 0.234247 | S | 0.302436 | -0.068189 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 264 | G | 0.234247 | V | 0.145238 | 0.089009 | No Change: Both O | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 366 | R | 0.886352 | Q | 0.886195 | 1.57E-04 | No Change: Both D | - |
| O43502 | RA51C_HUMAN DNA repair protein RAD51 homolog 3 OS=Homo sapiens GN=RAD51C PE=1 SV=1 | 258 | R | 0.31988 | H | 0.31376 | 0.00612 | No Change: Both O | Fanconi anemia complementation group O (FANCO) [MIM:613390] |
| O75771 | RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens GN=RAD51D PE=1 SV=1 | 24 | R | 0.202786 | S | 0.257342 | -0.054556 | No Change: Both O | - |
| O75771 | RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens GN=RAD51D PE=1 SV=1 | 165 | R | 0.331554 | Q | 0.363855 | -0.032301 | No Change: Both O | - |
| O75771 | RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens GN=RAD51D PE=1 SV=1 | 225 | A | 0.334546 | T | 0.35777 | -0.023224 | No Change: Both O | - |
| O75771 | RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens GN=RAD51D PE=1 SV=1 | 232 | R | 0.318682 | Q | 0.335793 | -0.017111 | No Change: Both O | - |
| O75771 | RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens GN=RAD51D PE=1 SV=1 | 233 | E | 0.343864 | G | 0.306604 | 0.03726 | No Change: Both O | - |
| P43351 | RAD52_HUMAN DNA repair protein RAD52 homolog OS=Homo sapiens GN=RAD52 PE=1 SV=1 | 70 | R | 0.095504 | W | 0.037273 | 0.058231 | No Change: Both O | - |
| P43351 | RAD52_HUMAN DNA repair protein RAD52 homolog OS=Homo sapiens GN=RAD52 PE=1 SV=1 | 221 | Q | 0.882085 | E | 0.879126 | 0.002959 | No Change: Both D | - |
| P43351 | RAD52_HUMAN DNA repair protein RAD52 homolog OS=Homo sapiens GN=RAD52 PE=1 SV=1 | 287 | S | 0.96409 | N | 0.945883 | 0.018207 | No Change: Both D | - |
| Q9Y620 | RA54B_HUMAN DNA repair and recombination protein RAD54B OS=Homo sapiens GN=RAD54B PE=1 SV=1 | 418 | D | 0.22008 | Y | 0.116887 | 0.103193 | No Change: Both O | A colon cancer sample |
| Q9Y620 | RA54B_HUMAN DNA repair and recombination protein RAD54B OS=Homo sapiens GN=RAD54B PE=1 SV=1 | 593 | N | 0.268668 | S | 0.30699 | -0.038322 | No Change: Both O | A non-Hodgkin lymphoma sample |
| Q9Y620 | RA54B_HUMAN DNA repair and recombination protein RAD54B OS=Homo sapiens GN=RAD54B PE=1 SV=1 | 30 | L | 0.722221 | V | 0.69417 | 0.028051 | No Change: Both D | - |
| Q9Y620 | RA54B_HUMAN DNA repair and recombination protein RAD54B OS=Homo sapiens GN=RAD54B PE=1 SV=1 | 97 | D | 0.651059 | H | 0.636254 | 0.014805 | No Change: Both D | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 63 | P | 0.78619 | H | 0.717205 | 0.068985 | No Change: Both D | A colon adenocarcinoma sample |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 151 | K | 0.343458 | E | 0.348615 | -0.005157 | No Change: Both O | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 325 | G | 0.270378 | R | 0.281341 | -0.010963 | No Change: Both O | A breast cancer sample |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 444 | V | 0.637613 | E | 0.767694 | -0.130081 | No Change: Both D | A non-Hodgkin lymphoma sample |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 21 | D | 0.938646 | G | 0.928846 | 0.0098 | No Change: Both D | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 74 | I | 0.547368 | M | 0.613065 | -0.065697 | No Change: Both D | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 202 | R | 0.209394 | C | 0.130813 | 0.078581 | No Change: Both O | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 380 | R | 0.546196 | Q | 0.54413 | 0.002066 | No Change: Both D | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 534 | R | 0.122433 | C | 0.065285 | 0.057148 | No Change: Both O | - |
| Q92698 | RAD54_HUMAN DNA repair and recombination protein RAD54-like OS=Homo sapiens GN=RAD54L PE=1 SV=2 | 583 | I | 0.170075 | T | 0.267882 | -0.097807 | No Change: Both O | - |
| Q9Y4B4 | ARIP4_HUMAN Helicase ARIP4 OS=Homo sapiens GN=RAD54L2 PE=1 SV=4 | 1369 | F | 0.896816 | L | 0.910727 | -0.013911 | No Change: Both D | - |
| Q99638 | RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens GN=RAD9A PE=1 SV=1 | 3 | C | 0.653302 | F | 0.678657 | -0.025355 | No Change: Both D | - |
| Q99638 | RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens GN=RAD9A PE=1 SV=1 | 100 | S | 0.270596 | A | 0.164602 | 0.105994 | No Change: Both O | - |
| Q99638 | RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens GN=RAD9A PE=1 SV=1 | 239 | H | 0.255891 | R | 0.266003 | -0.010112 | No Change: Both O | - |
| Q99638 | RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens GN=RAD9A PE=1 SV=1 | 307 | M | 0.650665 | T | 0.659378 | -0.008713 | No Change: Both D | - |
| Q99638 | RAD9A_HUMAN Cell cycle checkpoint control protein RAD9A OS=Homo sapiens GN=RAD9A PE=1 SV=1 | 71 | L | 0.156819 | Q | 0.262851 | -0.106032 | No Change: Both O | - |
| Q96JH8 | RADIL_HUMAN Ras-associating and dilute domain-containing protein OS=Homo sapiens GN=RADIL PE=1 SV=5 | 886 | S | 0.987324 | G | 0.985472 | 0.001852 | No Change: Both D | - |
| Q96JH8 | RADIL_HUMAN Ras-associating and dilute domain-containing protein OS=Homo sapiens GN=RADIL PE=1 SV=5 | 239 | D | 0.732917 | N | 0.725181 | 0.007736 | No Change: Both D | - |
| Q96JH8 | RADIL_HUMAN Ras-associating and dilute domain-containing protein OS=Homo sapiens GN=RADIL PE=1 SV=5 | 412 | H | 0.488899 | D | 0.562863 | -0.073964 | O to D | - |
| Q96JH8 | RADIL_HUMAN Ras-associating and dilute domain-containing protein OS=Homo sapiens GN=RADIL PE=1 SV=5 | 938 | L | 0.977819 | P | 0.988195 | -0.010376 | No Change: Both D | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 82 | Y | 0.214815 | N | 0.347702 | -0.132887 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 12 | R | 0.128643 | H | 0.124955 | 0.003688 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 128 | R | 0.353212 | H | 0.308439 | 0.044773 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 237 | V | 0.00804 | L | 0.008473 | -4.33E-04 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 141 | A | 0.303213 | T | 0.336884 | -0.033671 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 142 | T | 0.323905 | I | 0.201752 | 0.122153 | No Change: Both O | - |
| Q8TD07 | N2DL4_HUMAN NKG2D ligand 4 OS=Homo sapiens GN=RAET1E PE=1 SV=1 | 194 | R | 0.188239 | G | 0.189176 | -9.37E-04 | No Change: Both O | - |
| Q6H3X3 | RET1G_HUMAN Retinoic acid early transcript 1G protein OS=Homo sapiens GN=RAET1G PE=1 SV=1 | 70 | T | 0.417213 | R | 0.412403 | 0.00481 | No Change: Both O | - |
| Q5VY80 | RET1L_HUMAN Retinoic acid early transcript 1L protein OS=Homo sapiens GN=RAET1L PE=2 SV=1 | 26 | R | 0.449648 | G | 0.460271 | -0.010623 | No Change: Both O | - |
| Q5VY80 | RET1L_HUMAN Retinoic acid early transcript 1L protein OS=Homo sapiens GN=RAET1L PE=2 SV=1 | 85 | M | 0.174279 | T | 0.222726 | -0.048447 | No Change: Both O | - |
| Q5VY80 | RET1L_HUMAN Retinoic acid early transcript 1L protein OS=Homo sapiens GN=RAET1L PE=2 SV=1 | 106 | L | 0.224455 | R | 0.303895 | -0.07944 | No Change: Both O | - |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 308 | P | 0.969056 | L | 0.93822 | 0.030836 | No Change: Both D | - |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 256 | R | 0.962341 | S | 0.970386 | -0.008045 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 257 | S | 0.962503 | L | 0.925372 | 0.037131 | No Change: Both D | LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 257 | S | 0.962503 | L | 0.925372 | 0.037131 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 259 | S | 0.958213 | F | 0.902009 | 0.056204 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 260 | T | 0.957195 | I | 0.925206 | 0.031989 | No Change: Both D | - |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 260 | T | 0.957195 | R | 0.961647 | -0.004452 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 261 | P | 0.956858 | A | 0.935313 | 0.021545 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 261 | P | 0.956858 | L | 0.923958 | 0.0329 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 261 | P | 0.956858 | S | 0.962871 | -0.006013 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 263 | V | 0.953459 | A | 0.961681 | -0.008222 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 486 | D | 0.187935 | G | 0.186373 | 0.001562 | No Change: Both O | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 486 | D | 0.187935 | N | 0.176935 | 0.011 | No Change: Both O | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 491 | T | 0.240229 | I | 0.149215 | 0.091014 | No Change: Both O | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 491 | T | 0.240229 | R | 0.264436 | -0.024207 | No Change: Both O | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 612 | S | 0.629417 | T | 0.52403 | 0.105387 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 613 | L | 0.656472 | V | 0.612626 | 0.043846 | No Change: Both D | LEOPARD syndrome type 2 (LEOPARD2) [MIM:611554] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 613 | L | 0.656472 | V | 0.612626 | 0.043846 | No Change: Both D | Noonan syndrome type 5 (NS5) [MIM:611553] |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 259 | S | 0.958213 | A | 0.92766 | 0.030553 | No Change: Both D | An ovarian serous carcinoma sample |
| P04049 | RAF1_HUMAN RAF proto-oncogene serine/threonine-protein kinase OS=Homo sapiens GN=RAF1 PE=1 SV=1 | 335 | Q | 0.648489 | H | 0.59787 | 0.050619 | No Change: Both D | A lung adenocarcinoma sample |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 156 | A | 0.09668 | V | 0.073046 | 0.023634 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 244 | R | 0.885466 | G | 0.839419 | 0.046047 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 249 | H | 0.885777 | R | 0.916945 | -0.031168 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 624 | R | 0.291206 | H | 0.300262 | -0.009056 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 722 | E | 0.416554 | K | 0.396957 | 0.019597 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 396 | R | 0.633919 | C | 0.472619 | 0.1613 | D to O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 396 | R | 0.633919 | H | 0.611916 | 0.022003 | No Change: Both D | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 429 | D | 0.470492 | G | 0.455705 | 0.014787 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 561 | R | 0.299631 | H | 0.246239 | 0.053392 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 561 | R | 0.299631 | C | 0.176738 | 0.122893 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 737 | R | 0.203956 | H | 0.204996 | -0.00104 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 737 | R | 0.203956 | H | 0.204996 | -0.00104 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 820 | K | 0.481812 | R | 0.415371 | 0.066441 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 885 | L | 0.452881 | R | 0.58066 | -0.127779 | O to D | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 912 | Y | 0.350172 | C | 0.366122 | -0.01595 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 302 | D | 0.211263 | E | 0.247916 | -0.036653 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 880 | E | 0.575956 | K | 0.557365 | 0.018591 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 328 | C | 0.186833 | Y | 0.19411 | -0.007277 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 396 | R | 0.633919 | L | 0.518531 | 0.115388 | No Change: Both D | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 401 | S | 0.596408 | P | 0.595079 | 0.001329 | No Change: Both D | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 410 | R | 0.577127 | Q | 0.583164 | -0.006037 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 433 | V | 0.290288 | M | 0.383004 | -0.092716 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 435 | M | 0.220633 | V | 0.174866 | 0.045767 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 444 | A | 0.329284 | V | 0.249142 | 0.080142 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 474 | R | 0.057085 | H | 0.053593 | 0.003492 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 507 | R | 0.258986 | W | 0.122233 | 0.136753 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 522 | W | 0.31252 | C | 0.351007 | -0.038487 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 559 | R | 0.336791 | S | 0.401736 | -0.064945 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 624 | R | 0.291206 | C | 0.224697 | 0.066509 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 669 | E | 0.598309 | G | 0.498601 | 0.099708 | D to O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 753 | H | 0.502392 | L | 0.385987 | 0.116405 | D to O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 841 | R | 0.583932 | W | 0.361854 | 0.222078 | D to O | Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion severe cytomegalovirus infection and autoimmunity (T-CMVA) [MIM:609889] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 855 | N | 0.556808 | I | 0.421291 | 0.135517 | D to O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 975 | R | 0.411777 | Q | 0.415445 | -0.003668 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 981 | Q | 0.478199 | P | 0.495822 | -0.017623 | No Change: Both O | Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion severe cytomegalovirus infection and autoimmunity (T-CMVA) [MIM:609889] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 169 | S | 0.32288 | L | 0.170688 | 0.152192 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 247 | R | 0.898758 | H | 0.873576 | 0.025182 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 449 | R | 0.577265 | K | 0.616507 | -0.039242 | No Change: Both D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 525 | P | 0.482368 | S | 0.51734 | -0.034972 | O to D | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 887 | D | 0.460409 | N | 0.439907 | 0.020502 | No Change: Both O | - |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 314 | R | 0.050959 | W | 0.014621 | 0.036338 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 778 | R | 0.513694 | Q | 0.518261 | -0.004567 | No Change: Both D | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P15918 | RAG1_HUMAN V(D)J recombination-activating protein 1 OS=Homo sapiens GN=RAG1 PE=1 SV=2 | 975 | R | 0.411777 | W | 0.189797 | 0.22198 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 229 | R | 0.320903 | Q | 0.32574 | -0.004837 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 478 | C | 0.280941 | Y | 0.341293 | -0.060352 | No Change: Both O | Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) [MIM:601457] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 41 | C | 0.293641 | W | 0.27334 | 0.020301 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 285 | M | 0.171017 | R | 0.220713 | -0.049696 | No Change: Both O | Omenn syndrome (OS) [MIM:603554] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 77 | T | 0.239253 | N | 0.250128 | -0.010875 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 293 | E | 0.29143 | G | 0.229441 | 0.061989 | No Change: Both O | - |
| P55895 | RAG2_HUMAN V(D)J recombination-activating protein 2 OS=Homo sapiens GN=RAG2 PE=1 SV=1 | 451 | G | 0.241164 | A | 0.195787 | 0.045377 | No Change: Both O | Combined cellular and humoral immune defects with granulomas (CHIDG) [MIM:233650] |
| Q7Z5J4 | RAI1_HUMAN Retinoic acid-induced protein 1 OS=Homo sapiens GN=RAI1 PE=1 SV=2 | 165 | P | 0.792736 | T | 0.737901 | 0.054835 | No Change: Both D | - |
| Q7Z5J4 | RAI1_HUMAN Retinoic acid-induced protein 1 OS=Homo sapiens GN=RAI1 PE=1 SV=2 | 90 | G | 0.740134 | A | 0.715367 | 0.024767 | No Change: Both D | - |
| Q7Z5J4 | RAI1_HUMAN Retinoic acid-induced protein 1 OS=Homo sapiens GN=RAI1 PE=1 SV=2 | 939 | Q | 0.735095 | P | 0.789989 | -0.054894 | No Change: Both D | - |
| Q9P0K7 | RAI14_HUMAN Ankycorbin OS=Homo sapiens GN=RAI14 PE=1 SV=2 | 44 | A | 0.743901 | T | 0.755072 | -0.011171 | No Change: Both D | - |
| Q9P0K7 | RAI14_HUMAN Ankycorbin OS=Homo sapiens GN=RAI14 PE=1 SV=2 | 45 | S | 0.754944 | N | 0.712082 | 0.042862 | No Change: Both D | - |
| Q9P0K7 | RAI14_HUMAN Ankycorbin OS=Homo sapiens GN=RAI14 PE=1 SV=2 | 499 | V | 0.797814 | L | 0.810579 | -0.012765 | No Change: Both D | - |
| Q9P0K7 | RAI14_HUMAN Ankycorbin OS=Homo sapiens GN=RAI14 PE=1 SV=2 | 870 | A | 0.969509 | S | 0.979901 | -0.010392 | No Change: Both D | - |
| Q9Y5P3 | RAI2_HUMAN Retinoic acid-induced protein 2 OS=Homo sapiens GN=RAI2 PE=1 SV=2 | 252 | M | 0.963701 | V | 0.960237 | 0.003464 | No Change: Both D | - |
| Q9Y5P3 | RAI2_HUMAN Retinoic acid-induced protein 2 OS=Homo sapiens GN=RAI2 PE=1 SV=2 | 342 | A | 0.570248 | P | 0.660104 | -0.089856 | No Change: Both D | - |
| Q15311 | RBP1_HUMAN RalA-binding protein 1 OS=Homo sapiens GN=RALBP1 PE=1 SV=3 | 617 | A | 0.971653 | V | 0.963109 | 0.008544 | No Change: Both D | - |
| Q6GYQ0 | RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens GN=RALGAPA1 PE=1 SV=1 | 931 | T | 0.792814 | A | 0.769222 | 0.023592 | No Change: Both D | - |
| Q2PPJ7 | RGPA2_HUMAN Ral GTPase-activating protein subunit alpha-2 OS=Homo sapiens GN=RALGAPA2 PE=1 SV=2 | 492 | S | 0.570809 | N | 0.523474 | 0.047335 | No Change: Both D | - |
| Q12967 | GNDS_HUMAN Ral guanine nucleotide dissociation stimulator OS=Homo sapiens GN=RALGDS PE=1 SV=2 | 496 | R | 0.391927 | L | 0.287583 | 0.104344 | No Change: Both O | A colorectal cancer sample |
| Q5JS13 | RGPS1_HUMAN Ras-specific guanine nucleotide-releasing factor RalGPS1 OS=Homo sapiens GN=RALGPS1 PE=1 SV=1 | 290 | S | 0.820927 | N | 0.773528 | 0.047399 | No Change: Both D | - |
| Q86X27 | RGPS2_HUMAN Ras-specific guanine nucleotide-releasing factor RalGPS2 OS=Homo sapiens GN=RALGPS2 PE=1 SV=1 | 225 | N | 0.611844 | S | 0.644171 | -0.032327 | No Change: Both D | - |
| Q9UKM9 | RALY_HUMAN RNA-binding protein Raly OS=Homo sapiens GN=RALY PE=1 SV=1 | 215 | Q | 0.87514 | R | 0.86324 | 0.0119 | No Change: Both D | - |
| Q9UKM9 | RALY_HUMAN RNA-binding protein Raly OS=Homo sapiens GN=RALY PE=1 SV=1 | 251 | G | 0.997693 | S | 0.997875 | -1.82E-04 | No Change: Both D | - |
| Q9UKM9 | RALY_HUMAN RNA-binding protein Raly OS=Homo sapiens GN=RALY PE=1 SV=1 | 139 | V | 0.514082 | M | 0.549395 | -0.035313 | No Change: Both D | - |
| O60896 | RAMP3_HUMAN Receptor activity-modifying protein 3 OS=Homo sapiens GN=RAMP3 PE=2 SV=1 | 56 | W | 0.041591 | R | 0.096693 | -0.055102 | No Change: Both O | - |
| O60896 | RAMP3_HUMAN Receptor activity-modifying protein 3 OS=Homo sapiens GN=RAMP3 PE=2 SV=1 | 26 | G | 0.47231 | D | 0.466447 | 0.005863 | No Change: Both O | - |
| O60896 | RAMP3_HUMAN Receptor activity-modifying protein 3 OS=Homo sapiens GN=RAMP3 PE=2 SV=1 | 33 | M | 0.353296 | L | 0.31009 | 0.043206 | No Change: Both O | - |
| P62826 | RAN_HUMAN GTP-binding nuclear protein Ran OS=Homo sapiens GN=RAN PE=1 SV=3 | 95 | R | 0.173067 | I | 0.093587 | 0.07948 | No Change: Both O | - |
| P43487 | RANG_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens GN=RANBP1 PE=1 SV=1 | 16 | E | 0.960666 | D | 0.958799 | 0.001867 | No Change: Both D | A breast cancer sample |
| P43487 | RANG_HUMAN Ran-specific GTPase-activating protein OS=Homo sapiens GN=RANBP1 PE=1 SV=1 | 145 | A | 0.522182 | V | 0.42614 | 0.096042 | D to O | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 1892 | P | 0.876031 | A | 0.822656 | 0.053375 | No Change: Both D | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 784 | R | 0.940473 | K | 0.949765 | -0.009292 | No Change: Both D | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 548 | V | 0.263246 | L | 0.266652 | -0.003406 | No Change: Both O | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 580 | E | 0.114756 | K | 0.12222 | -0.007464 | No Change: Both O | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 581 | C | 0.157285 | Y | 0.190649 | -0.033364 | No Change: Both O | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 1870 | P | 0.88577 | L | 0.794254 | 0.091516 | No Change: Both D | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 725 | S | 0.605988 | G | 0.4836 | 0.122388 | D to O | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 1892 | P | 0.876031 | R | 0.834544 | 0.041487 | No Change: Both D | - |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 585 | T | 0.377378 | M | 0.329086 | 0.048292 | No Change: Both O | Encephalopathy acute infection-induced type 3 (IIAE3) [MIM:608033] |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 653 | T | 0.109953 | I | 0.066087 | 0.043866 | No Change: Both O | Encephalopathy acute infection-induced type 3 (IIAE3) [MIM:608033] |
| P49792 | RBP2_HUMAN E3 SUMO-protein ligase RanBP2 OS=Homo sapiens GN=RANBP2 PE=1 SV=2 | 656 | I | 0.090142 | V | 0.102354 | -0.012212 | No Change: Both O | Encephalopathy acute infection-induced type 3 (IIAE3) [MIM:608033] |
| Q9H6Z4 | RANB3_HUMAN Ran-binding protein 3 OS=Homo sapiens GN=RANBP3 PE=1 SV=1 | 314 | A | 0.763484 | V | 0.717914 | 0.04557 | No Change: Both D | - |
| Q86VV4 | RNB3L_HUMAN Ran-binding protein 3-like OS=Homo sapiens GN=RANBP3L PE=2 SV=2 | 70 | T | 0.583961 | R | 0.616904 | -0.032943 | No Change: Both D | - |
| Q86VV4 | RNB3L_HUMAN Ran-binding protein 3-like OS=Homo sapiens GN=RANBP3L PE=2 SV=2 | 111 | A | 0.609832 | D | 0.652413 | -0.042581 | No Change: Both D | - |
| Q86VV4 | RNB3L_HUMAN Ran-binding protein 3-like OS=Homo sapiens GN=RANBP3L PE=2 SV=2 | 271 | A | 0.630479 | V | 0.555006 | 0.075473 | No Change: Both D | - |
| P46060 | RAGP1_HUMAN Ran GTPase-activating protein 1 OS=Homo sapiens GN=RANGAP1 PE=1 SV=1 | 133 | E | 0.29861 | Q | 0.274454 | 0.024156 | No Change: Both O | - |
| P47736 | RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens GN=RAP1GAP PE=1 SV=2 | 257 | C | 0.187704 | R | 0.319757 | -0.132053 | No Change: Both O | A breast cancer sample |
| P47736 | RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens GN=RAP1GAP PE=1 SV=2 | 609 | Y | 0.877977 | C | 0.90748 | -0.029503 | No Change: Both D | A breast cancer sample |
| P47736 | RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens GN=RAP1GAP PE=1 SV=2 | 107 | A | 0.166084 | T | 0.174365 | -0.008281 | No Change: Both O | - |
| Q684P5 | RPGP2_HUMAN Rap1 GTPase-activating protein 2 OS=Homo sapiens GN=RAP1GAP2 PE=1 SV=2 | 202 | L | 0.330215 | M | 0.373869 | -0.043654 | No Change: Both O | - |
| P52306 | GDS1_HUMAN Rap1 GTPase-GDP dissociation stimulator 1 OS=Homo sapiens GN=RAP1GDS1 PE=1 SV=3 | 314 | K | 0.471317 | E | 0.475656 | -0.004339 | No Change: Both O | - |
| O95398 | RPGF3_HUMAN Rap guanine nucleotide exchange factor 3 OS=Homo sapiens GN=RAPGEF3 PE=1 SV=6 | 16 | A | 0.227797 | P | 0.325468 | -0.097671 | No Change: Both O | - |
| O95398 | RPGF3_HUMAN Rap guanine nucleotide exchange factor 3 OS=Homo sapiens GN=RAPGEF3 PE=1 SV=6 | 193 | R | 0.750264 | G | 0.7467 | 0.003564 | No Change: Both D | - |
| O95398 | RPGF3_HUMAN Rap guanine nucleotide exchange factor 3 OS=Homo sapiens GN=RAPGEF3 PE=1 SV=6 | 374 | G | 0.755965 | S | 0.784907 | -0.028942 | No Change: Both D | - |
| O95398 | RPGF3_HUMAN Rap guanine nucleotide exchange factor 3 OS=Homo sapiens GN=RAPGEF3 PE=1 SV=6 | 517 | C | 0.658583 | Y | 0.580111 | 0.078472 | No Change: Both D | - |
| Q8TEU7 | RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens GN=RAPGEF6 PE=1 SV=2 | 570 | S | 0.63189 | A | 0.564035 | 0.067855 | No Change: Both D | - |
| Q8TEU7 | RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens GN=RAPGEF6 PE=1 SV=2 | 594 | A | 0.148748 | P | 0.202051 | -0.053303 | No Change: Both O | - |
| Q8TEU7 | RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens GN=RAPGEF6 PE=1 SV=2 | 1353 | I | 0.568215 | V | 0.561115 | 0.0071 | No Change: Both D | - |
| Q8TEU7 | RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens GN=RAPGEF6 PE=1 SV=2 | 1559 | V | 0.648219 | E | 0.731195 | -0.082976 | No Change: Both D | - |
| Q8TEU7 | RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens GN=RAPGEF6 PE=1 SV=2 | 1452 | Q | 0.860109 | R | 0.87339 | -0.013281 | No Change: Both D | - |
| Q70E73 | RAPH1_HUMAN Ras-associated and pleckstrin homology domains-containing protein 1 OS=Homo sapiens GN=RAPH1 PE=1 SV=3 | 891 | A | 0.995377 | S | 0.996646 | -0.001269 | No Change: Both D | A breast cancer sample |
| Q70E73 | RAPH1_HUMAN Ras-associated and pleckstrin homology domains-containing protein 1 OS=Homo sapiens GN=RAPH1 PE=1 SV=3 | 1228 | T | 0.871182 | A | 0.869231 | 0.001951 | No Change: Both D | A breast cancer sample |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 14 | L | 0.662348 | P | 0.752018 | -0.08967 | No Change: Both D | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 88 | N | 0.256552 | K | 0.291624 | -0.035072 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 8 | Q | 0.828709 | K | 0.827048 | 0.001661 | No Change: Both D | - |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 45 | V | 0.091078 | M | 0.126236 | -0.035158 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 139 | F | 0.213197 | S | 0.405812 | -0.192615 | No Change: Both O | Fetal akinesia deformation sequence (FADS) [MIM:208150] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 162 | E | 0.143405 | K | 0.143663 | -2.58E-04 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 164 | R | 0.085829 | C | 0.051803 | 0.034026 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 189 | A | 0.133811 | V | 0.093715 | 0.040096 | No Change: Both O | Fetal akinesia deformation sequence (FADS) [MIM:208150] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 283 | L | 0.219405 | P | 0.339959 | -0.120554 | No Change: Both O | Congenital myasthenic syndrome with acetylcholine receptor deficiency (CMS-ACHRD) [MIM:608931] |
| Q13702 | RAPSN_HUMAN 43 kDa receptor-associated protein of the synapse OS=Homo sapiens GN=RAPSN PE=1 SV=4 | 81 | F | 0.240668 | L | 0.290012 | -0.049344 | No Change: Both O | - |
| P10826 | RARB_HUMAN Retinoic acid receptor beta OS=Homo sapiens GN=RARB PE=1 SV=2 | 90 | V | 0.609806 | I | 0.577123 | 0.032683 | No Change: Both D | A colorectal cancer sample |
| P13631 | RARG_HUMAN Retinoic acid receptor gamma OS=Homo sapiens GN=RARG PE=1 SV=1 | 430 | G | 0.981286 | S | 0.985782 | -0.004496 | No Change: Both D | A breast cancer sample |
| P13631 | RARG_HUMAN Retinoic acid receptor gamma OS=Homo sapiens GN=RARG PE=1 SV=1 | 427 | S | 0.974879 | L | 0.957382 | 0.017497 | No Change: Both D | - |
| P49788 | TIG1_HUMAN Retinoic acid receptor responder protein 1 OS=Homo sapiens GN=RARRES1 PE=2 SV=2 | 158 | D | 0.545198 | V | 0.391247 | 0.153951 | D to O | - |
| P49788 | TIG1_HUMAN Retinoic acid receptor responder protein 1 OS=Homo sapiens GN=RARRES1 PE=2 SV=2 | 42 | D | 0.933667 | G | 0.927696 | 0.005971 | No Change: Both D | - |
| Q9UL19 | TIG3_HUMAN Retinoic acid receptor responder protein 3 OS=Homo sapiens GN=RARRES3 PE=1 SV=1 | 69 | V | 0.345974 | L | 0.334518 | 0.011456 | No Change: Both O | - |
| Q9UL19 | TIG3_HUMAN Retinoic acid receptor responder protein 3 OS=Homo sapiens GN=RARRES3 PE=1 SV=1 | 162 | A | 0.830445 | V | 0.818473 | 0.011972 | No Change: Both D | - |
| P54136 | SYRC_HUMAN Arginine--tRNA ligase cytoplasmic OS=Homo sapiens GN=RARS PE=1 SV=2 | 3 | V | 0.699669 | I | 0.666552 | 0.033117 | No Change: Both D | - |
| P54136 | SYRC_HUMAN Arginine--tRNA ligase cytoplasmic OS=Homo sapiens GN=RARS PE=1 SV=2 | 397 | F | 0.280429 | Y | 0.32174 | -0.041311 | No Change: Both O | - |
| P54136 | SYRC_HUMAN Arginine--tRNA ligase cytoplasmic OS=Homo sapiens GN=RARS PE=1 SV=2 | 135 | R | 0.557925 | G | 0.570369 | -0.012444 | No Change: Both D | - |
| Q5T160 | SYRM_HUMAN Probable arginine--tRNA ligase mitochondrial OS=Homo sapiens GN=RARS2 PE=1 SV=1 | 291 | K | 0.325669 | R | 0.256203 | 0.069466 | No Change: Both O | - |
| Q5T160 | SYRM_HUMAN Probable arginine--tRNA ligase mitochondrial OS=Homo sapiens GN=RARS2 PE=1 SV=1 | 331 | I | 0.281049 | V | 0.308552 | -0.027503 | No Change: Both O | - |
| Q5T160 | SYRM_HUMAN Probable arginine--tRNA ligase mitochondrial OS=Homo sapiens GN=RARS2 PE=1 SV=1 | 367 | D | 0.106602 | G | 0.100931 | 0.005671 | No Change: Both O | - |
| P20936 | RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens GN=RASA1 PE=1 SV=1 | 398 | R | 0.249653 | L | 0.146346 | 0.103307 | No Change: Both O | Basal cell carcinomas |
| P20936 | RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens GN=RASA1 PE=1 SV=1 | 400 | K | 0.252781 | E | 0.27054 | -0.017759 | No Change: Both O | Basal cell carcinomas |
| P20936 | RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens GN=RASA1 PE=1 SV=1 | 401 | I | 0.237332 | V | 0.245428 | -0.008096 | No Change: Both O | Basal cell carcinomas |
| P20936 | RASA1_HUMAN Ras GTPase-activating protein 1 OS=Homo sapiens GN=RASA1 PE=1 SV=1 | 540 | C | 0.094627 | Y | 0.115299 | -0.020672 | No Change: Both O | Capillary malformation-arteriovenous malformation (CMAVM) [MIM:608354] |
| O43374 | RASL2_HUMAN Ras GTPase-activating protein 4 OS=Homo sapiens GN=RASA4 PE=2 SV=2 | 352 | M | 0.625429 | V | 0.576675 | 0.048754 | No Change: Both D | - |
| O43374 | RASL2_HUMAN Ras GTPase-activating protein 4 OS=Homo sapiens GN=RASA4 PE=2 SV=2 | 432 | R | 0.50905 | P | 0.514731 | -0.005681 | No Change: Both D | - |
| O43374 | RASL2_HUMAN Ras GTPase-activating protein 4 OS=Homo sapiens GN=RASA4 PE=2 SV=2 | 731 | Y | 0.132732 | C | 0.156591 | -0.023859 | No Change: Both O | - |
| O95294 | RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens GN=RASAL1 PE=1 SV=3 | 11 | V | 0.589838 | L | 0.57835 | 0.011488 | No Change: Both D | - |
| O95294 | RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens GN=RASAL1 PE=1 SV=3 | 58 | T | 0.15094 | M | 0.12444 | 0.0265 | No Change: Both O | - |
| O95294 | RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens GN=RASAL1 PE=1 SV=3 | 321 | R | 0.221292 | H | 0.169893 | 0.051399 | No Change: Both O | - |
| Q9UJF2 | NGAP_HUMAN Ras GTPase-activating protein nGAP OS=Homo sapiens GN=RASAL2 PE=1 SV=2 | 165 | R | 0.438393 | W | 0.242193 | 0.1962 | No Change: Both O | A colorectal cancer sample |
| Q9UJF2 | NGAP_HUMAN Ras GTPase-activating protein nGAP OS=Homo sapiens GN=RASAL2 PE=1 SV=2 | 379 | E | 0.30318 | D | 0.264992 | 0.038188 | No Change: Both O | A breast cancer sample |
| Q86YV0 | RASL3_HUMAN RAS protein activator like-3 OS=Homo sapiens GN=RASAL3 PE=1 SV=2 | 251 | L | 0.300861 | V | 0.27857 | 0.022291 | No Change: Both O | - |
| Q86YV0 | RASL3_HUMAN RAS protein activator like-3 OS=Homo sapiens GN=RASAL3 PE=1 SV=2 | 594 | R | 0.573024 | C | 0.383963 | 0.189061 | D to O | - |
| Q86YV0 | RASL3_HUMAN RAS protein activator like-3 OS=Homo sapiens GN=RASAL3 PE=1 SV=2 | 825 | P | 0.995522 | T | 0.993057 | 0.002465 | No Change: Both D | - |
| Q8IZ41 | RASEF_HUMAN Ras and EF-hand domain-containing protein OS=Homo sapiens GN=RASEF PE=1 SV=1 | 262 | R | 0.84041 | C | 0.764483 | 0.075927 | No Change: Both D | - |
| O14827 | RGRF2_HUMAN Ras-specific guanine nucleotide-releasing factor 2 OS=Homo sapiens GN=RASGRF2 PE=1 SV=2 | 114 | R | 0.577172 | H | 0.587163 | -0.009991 | No Change: Both D | A colorectal cancer sample |
| O14827 | RGRF2_HUMAN Ras-specific guanine nucleotide-releasing factor 2 OS=Homo sapiens GN=RASGRF2 PE=1 SV=2 | 538 | D | 0.747884 | N | 0.742124 | 0.00576 | No Change: Both D | A breast cancer sample |
| O14827 | RGRF2_HUMAN Ras-specific guanine nucleotide-releasing factor 2 OS=Homo sapiens GN=RASGRF2 PE=1 SV=2 | 713 | L | 0.650006 | W | 0.5564 | 0.093606 | No Change: Both D | - |
| O14827 | RGRF2_HUMAN Ras-specific guanine nucleotide-releasing factor 2 OS=Homo sapiens GN=RASGRF2 PE=1 SV=2 | 1216 | D | 0.222479 | E | 0.235877 | -0.013398 | No Change: Both O | A breast cancer sample |
| Q7LDG7 | GRP2_HUMAN RAS guanyl-releasing protein 2 OS=Homo sapiens GN=RASGRP2 PE=1 SV=1 | 493 | G | 0.397849 | A | 0.31624 | 0.081609 | No Change: Both O | - |
| Q8IV61 | GRP3_HUMAN Ras guanyl-releasing protein 3 OS=Homo sapiens GN=RASGRP3 PE=2 SV=1 | 393 | T | 0.803906 | A | 0.766383 | 0.037523 | No Change: Both D | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 18 | I | 0.953933 | T | 0.971413 | -0.01748 | No Change: Both D | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 120 | Q | 0.100517 | L | 0.055635 | 0.044882 | No Change: Both O | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 145 | V | 0.210239 | A | 0.27434 | -0.064101 | No Change: Both O | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 261 | R | 0.342992 | C | 0.201741 | 0.141251 | No Change: Both O | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 335 | R | 0.259063 | G | 0.258057 | 0.001006 | No Change: Both O | - |
| Q8TDF6 | GRP4_HUMAN RAS guanyl-releasing protein 4 OS=Homo sapiens GN=RASGRP4 PE=1 SV=2 | 620 | E | 0.926673 | K | 0.908557 | 0.018116 | No Change: Both D | - |
| Q5U651 | RAIN_HUMAN Ras-interacting protein 1 OS=Homo sapiens GN=RASIP1 PE=1 SV=1 | 601 | R | 0.325111 | C | 0.213977 | 0.111134 | No Change: Both O | - |
| Q96S79 | RSLAB_HUMAN Ras-like protein family member 10B OS=Homo sapiens GN=RASL10B PE=2 SV=1 | 52 | V | 0.160649 | M | 0.202146 | -0.041497 | No Change: Both O | A breast cancer sample |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 21 | K | 0.876517 | Q | 0.882038 | -0.005521 | No Change: Both D | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 53 | R | 0.513891 | C | 0.357493 | 0.156398 | D to O | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 133 | D | 0.528656 | E | 0.581167 | -0.052511 | No Change: Both D | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 135 | S | 0.506897 | F | 0.291333 | 0.215564 | D to O | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 137 | A | 0.526704 | S | 0.638423 | -0.111719 | No Change: Both D | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 329 | Y | 0.303408 | C | 0.374323 | -0.070915 | No Change: Both O | - |
| Q9NS23 | RASF1_HUMAN Ras association domain-containing protein 1 OS=Homo sapiens GN=RASSF1 PE=1 SV=1 | 319 | H | 0.551104 | R | 0.577655 | -0.026551 | No Change: Both D | - |
| A6NK89 | RASFA_HUMAN Ras association domain-containing protein 10 OS=Homo sapiens GN=RASSF10 PE=2 SV=3 | 194 | Q | 0.990092 | H | 0.984606 | 0.005486 | No Change: Both D | - |
| P50749 | RASF2_HUMAN Ras association domain-containing protein 2 OS=Homo sapiens GN=RASSF2 PE=1 SV=1 | 144 | R | 0.944287 | H | 0.920777 | 0.02351 | No Change: Both D | A colorectal cancer sample |
| Q86WH2 | RASF3_HUMAN Ras association domain-containing protein 3 OS=Homo sapiens GN=RASSF3 PE=1 SV=1 | 232 | R | 0.648581 | H | 0.53002 | 0.118561 | No Change: Both D | - |
| Q9H2L5 | RASF4_HUMAN Ras association domain-containing protein 4 OS=Homo sapiens GN=RASSF4 PE=1 SV=2 | 10 | H | 0.706253 | Y | 0.587864 | 0.118389 | No Change: Both D | - |
| Q9H2L5 | RASF4_HUMAN Ras association domain-containing protein 4 OS=Homo sapiens GN=RASSF4 PE=1 SV=2 | 88 | R | 0.842616 | G | 0.814996 | 0.02762 | No Change: Both D | - |
| Q6ZTQ3 | RASF6_HUMAN Ras association domain-containing protein 6 OS=Homo sapiens GN=RASSF6 PE=1 SV=1 | 163 | S | 0.704982 | P | 0.690002 | 0.01498 | No Change: Both D | - |
| Q6ZTQ3 | RASF6_HUMAN Ras association domain-containing protein 6 OS=Homo sapiens GN=RASSF6 PE=1 SV=1 | 306 | A | 0.48078 | G | 0.500897 | -0.020117 | O to D | - |
| Q02833 | RASF7_HUMAN Ras association domain-containing protein 7 OS=Homo sapiens GN=RASSF7 PE=2 SV=1 | 89 | P | 0.839786 | A | 0.778717 | 0.061069 | No Change: Both D | - |
| Q02833 | RASF7_HUMAN Ras association domain-containing protein 7 OS=Homo sapiens GN=RASSF7 PE=2 SV=1 | 156 | R | 0.792016 | Q | 0.785194 | 0.006822 | No Change: Both D | - |
| O75901 | RASF9_HUMAN Ras association domain-containing protein 9 OS=Homo sapiens GN=RASSF9 PE=2 SV=2 | 285 | A | 0.575496 | T | 0.58427 | -0.008774 | No Change: Both D | - |
| Q9Y2V3 | RX_HUMAN Retinal homeobox protein Rx OS=Homo sapiens GN=RAX PE=1 SV=2 | 44 | D | 0.58857 | E | 0.612121 | -0.023551 | No Change: Both D | - |
| Q9Y2V3 | RX_HUMAN Retinal homeobox protein Rx OS=Homo sapiens GN=RAX PE=1 SV=2 | 192 | R | 0.637887 | Q | 0.640197 | -0.00231 | No Change: Both D | Microphthalmia isolated type 3 (MCOP3) [MIM:611038] |
| Q96IS3 | RAX2_HUMAN Retina and anterior neural fold homeobox protein 2 OS=Homo sapiens GN=RAX2 PE=1 SV=1 | 87 | R | 0.721677 | Q | 0.712558 | 0.009119 | No Change: Both D | Age-related macular degeneration type 6 (ARMD6) [MIM:613757] |
| Q96IS3 | RAX2_HUMAN Retina and anterior neural fold homeobox protein 2 OS=Homo sapiens GN=RAX2 PE=1 SV=1 | 137 | G | 0.836031 | R | 0.836626 | -5.95E-04 | No Change: Both D | Cone-rod dystrophy type 11 (CORD11) [MIM:610381] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 72 | E | 0.166342 | Q | 0.13327 | 0.033072 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 137 | E | 0.307187 | D | 0.301351 | 0.005836 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 185 | I | 0.490964 | T | 0.633163 | -0.142199 | O to D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 358 | R | 0.768239 | Q | 0.777387 | -0.009148 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 457 | M | 0.317413 | R | 0.377271 | -0.059858 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 549 | H | 0.389271 | Y | 0.2566 | 0.132671 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 567 | S | 0.444361 | L | 0.310193 | 0.134168 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 635 | A | 0.701682 | P | 0.755876 | -0.054194 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 654 | V | 0.163122 | E | 0.335393 | -0.172271 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 661 | R | 0.100601 | W | 0.035101 | 0.0655 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 662 | L | 0.100996 | P | 0.17478 | -0.073784 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 673 | H | 0.467099 | P | 0.500168 | -0.033069 | O to D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 685 | Q | 0.090728 | P | 0.092645 | -0.001917 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 706 | C | 0.082433 | Y | 0.104877 | -0.022444 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 712 | C | 0.095386 | R | 0.180645 | -0.085259 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 803 | N | 0.89379 | K | 0.925788 | -0.031998 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 310 | G | 0.45557 | E | 0.510702 | -0.055132 | O to D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 358 | R | 0.768239 | G | 0.71663 | 0.051609 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 447 | K | 0.230202 | Q | 0.207988 | 0.022214 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 530 | K | 0.081703 | R | 0.058029 | 0.023674 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 657 | L | 0.105103 | P | 0.180018 | -0.074915 | No Change: Both O | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 500 | R | 0.558934 | G | 0.566777 | -0.007843 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 616 | K | 0.836602 | E | 0.826289 | 0.010313 | No Change: Both D | Childhood cancer retinoblastoma (RB) [MIM:180200] |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 436 | Q | 0.21911 | K | 0.265869 | -0.046759 | No Change: Both O | - |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 525 | A | 0.064211 | G | 0.08246 | -0.018249 | No Change: Both O | - |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 746 | E | 0.350117 | G | 0.277096 | 0.073021 | No Change: Both O | - |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 133 | N | 0.157228 | H | 0.151433 | 0.005795 | No Change: Both O | - |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 569 | L | 0.465074 | F | 0.412381 | 0.052693 | No Change: Both O | - |
| P06400 | RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens GN=RB1 PE=1 SV=2 | 697 | D | 0.349907 | E | 0.382441 | -0.032534 | No Change: Both O | - |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 234 | M | 0.932257 | T | 0.939104 | -0.006847 | No Change: Both D | - |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 1514 | R | 0.13305 | C | 0.067379 | 0.065671 | No Change: Both O | A breast cancer sample |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 708 | P | 0.594768 | L | 0.439514 | 0.155254 | D to O | - |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 1216 | R | 0.930578 | K | 0.943519 | -0.012941 | No Change: Both D | - |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 1314 | N | 0.957601 | K | 0.963337 | -0.005736 | No Change: Both D | - |
| Q8TDY2 | RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens GN=RB1CC1 PE=1 SV=3 | 1424 | S | 0.857965 | F | 0.713362 | 0.144603 | No Change: Both D | - |
| Q9NYW8 | RBAK_HUMAN RB-associated KRAB zinc finger protein OS=Homo sapiens GN=RBAK PE=1 SV=1 | 229 | G | 0.309535 | E | 0.36838 | -0.058845 | No Change: Both O | - |
| Q7Z6E9 | RBBP6_HUMAN E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens GN=RBBP6 PE=1 SV=1 | 555 | V | 0.973911 | A | 0.97725 | -0.003339 | No Change: Both D | - |
| Q7Z6E9 | RBBP6_HUMAN E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens GN=RBBP6 PE=1 SV=1 | 43 | D | 0.300594 | H | 0.239726 | 0.060868 | No Change: Both O | - |
| Q7Z6E9 | RBBP6_HUMAN E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens GN=RBBP6 PE=1 SV=1 | 1208 | K | 0.978755 | I | 0.959913 | 0.018842 | No Change: Both D | - |
| Q99708 | COM1_HUMAN DNA endonuclease RBBP8 OS=Homo sapiens GN=RBBP8 PE=1 SV=2 | 387 | H | 0.659549 | Y | 0.49755 | 0.161999 | D to O | - |
| Q99708 | COM1_HUMAN DNA endonuclease RBBP8 OS=Homo sapiens GN=RBBP8 PE=1 SV=2 | 357 | K | 0.873406 | N | 0.842729 | 0.030677 | No Change: Both D | - |
| Q8N0V3 | RBFA_HUMAN Putative ribosome-binding factor A mitochondrial OS=Homo sapiens GN=RBFA PE=1 SV=3 | 122 | V | 0.305692 | M | 0.349635 | -0.043943 | No Change: Both O | - |
| Q8N0V3 | RBFA_HUMAN Putative ribosome-binding factor A mitochondrial OS=Homo sapiens GN=RBFA PE=1 SV=3 | 245 | N | 0.439035 | H | 0.445301 | -0.006266 | No Change: Both O | - |
| Q8N0V3 | RBFA_HUMAN Putative ribosome-binding factor A mitochondrial OS=Homo sapiens GN=RBFA PE=1 SV=3 | 276 | K | 0.792908 | Q | 0.780603 | 0.012305 | No Change: Both D | - |
| P28749 | RBL1_HUMAN Retinoblastoma-like protein 1 OS=Homo sapiens GN=RBL1 PE=1 SV=3 | 1035 | I | 0.674039 | M | 0.746488 | -0.072449 | No Change: Both D | - |
| Q08999 | RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens GN=RBL2 PE=1 SV=3 | 210 | Y | 0.02655 | C | 0.024342 | 0.002208 | No Change: Both O | - |
| P98175 | RBM10_HUMAN RNA-binding protein 10 OS=Homo sapiens GN=RBM10 PE=1 SV=3 | 396 | R | 0.727995 | H | 0.707985 | 0.02001 | No Change: Both D | A colorectal cancer sample |
| P57052 | RBM11_HUMAN Putative RNA-binding protein 11 OS=Homo sapiens GN=RBM11 PE=1 SV=1 | 116 | L | 0.531682 | V | 0.545769 | -0.014087 | No Change: Both D | - |
| Q9NTZ6 | RBM12_HUMAN RNA-binding protein 12 OS=Homo sapiens GN=RBM12 PE=1 SV=1 | 572 | N | 0.238062 | S | 0.266181 | -0.028119 | No Change: Both O | - |
| Q9NTZ6 | RBM12_HUMAN RNA-binding protein 12 OS=Homo sapiens GN=RBM12 PE=1 SV=1 | 921 | P | 0.347906 | L | 0.234599 | 0.113307 | No Change: Both O | - |
| Q8IXT5 | RB12B_HUMAN RNA-binding protein 12B OS=Homo sapiens GN=RBM12B PE=1 SV=2 | 250 | S | 0.807322 | F | 0.719698 | 0.087624 | No Change: Both D | - |
| Q8IXT5 | RB12B_HUMAN RNA-binding protein 12B OS=Homo sapiens GN=RBM12B PE=1 SV=2 | 605 | R | 0.999025 | C | 0.99818 | 8.45E-04 | No Change: Both D | - |
| Q8IXT5 | RB12B_HUMAN RNA-binding protein 12B OS=Homo sapiens GN=RBM12B PE=1 SV=2 | 864 | N | 0.994303 | H | 0.993969 | 3.34E-04 | No Change: Both D | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 609 | H | 0.2538 | R | 0.270036 | -0.016236 | No Change: Both O | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 623 | I | 0.143098 | T | 0.240263 | -0.097165 | No Change: Both O | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 665 | T | 0.595847 | A | 0.594767 | 0.00108 | No Change: Both D | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 921 | R | 0.443048 | Q | 0.457604 | -0.014556 | No Change: Both O | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 821 | R | 0.643696 | G | 0.592091 | 0.051605 | No Change: Both D | - |
| Q9Y4C8 | RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens GN=RBM19 PE=1 SV=3 | 602 | Q | 0.311372 | E | 0.352492 | -0.04112 | No Change: Both O | - |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 173 | P | 0.944443 | T | 0.920945 | 0.023498 | No Change: Both D | - |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 768 | W | 0.943964 | S | 0.979769 | -0.035805 | No Change: Both D | - |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 634 | R | 0.969901 | Q | 0.965989 | 0.003912 | No Change: Both D | Cardiomyopathy dilated type 1DD (CMD1DD) [MIM:613172] |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 636 | R | 0.978455 | H | 0.970772 | 0.007683 | No Change: Both D | Cardiomyopathy dilated type 1DD (CMD1DD) [MIM:613172] |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 636 | R | 0.978455 | S | 0.978999 | -5.44E-04 | No Change: Both D | Cardiomyopathy dilated type 1DD (CMD1DD) [MIM:613172] |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 637 | S | 0.981187 | G | 0.973525 | 0.007662 | No Change: Both D | Cardiomyopathy dilated type 1DD (CMD1DD) [MIM:613172] |
| Q5T481 | RBM20_HUMAN Probable RNA-binding protein 20 OS=Homo sapiens GN=RBM20 PE=1 SV=3 | 638 | P | 0.983471 | L | 0.970883 | 0.012588 | No Change: Both D | Cardiomyopathy dilated type 1DD (CMD1DD) [MIM:613172] |
| Q86U06 | RBM23_HUMAN Probable RNA-binding protein 23 OS=Homo sapiens GN=RBM23 PE=1 SV=1 | 184 | D | 0.362529 | N | 0.318759 | 0.04377 | No Change: Both O | - |
| Q86U06 | RBM23_HUMAN Probable RNA-binding protein 23 OS=Homo sapiens GN=RBM23 PE=1 SV=1 | 428 | F | 0.561405 | L | 0.638933 | -0.077528 | No Change: Both D | - |
| Q5T8P6 | RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens GN=RBM26 PE=1 SV=3 | 718 | V | 0.789795 | D | 0.858642 | -0.068847 | No Change: Both D | - |
| Q9NW13 | RBM28_HUMAN RNA-binding protein 28 OS=Homo sapiens GN=RBM28 PE=1 SV=3 | 253 | E | 0.98293 | Q | 0.980426 | 0.002504 | No Change: Both D | - |
| Q9NW13 | RBM28_HUMAN RNA-binding protein 28 OS=Homo sapiens GN=RBM28 PE=1 SV=3 | 351 | L | 0.578008 | P | 0.633683 | -0.055675 | No Change: Both D | Alopecia neurologic defects and endocrinopathy syndrome (ANES) [MIM:612079] |
| Q96EV2 | RBM33_HUMAN RNA-binding protein 33 OS=Homo sapiens GN=RBM33 PE=1 SV=3 | 574 | T | 0.993072 | A | 0.9912 | 0.001872 | No Change: Both D | - |
| Q9H0Z9 | RBM38_HUMAN RNA-binding protein 38 OS=Homo sapiens GN=RBM38 PE=1 SV=2 | 178 | A | 0.80568 | V | 0.732698 | 0.072982 | No Change: Both D | - |
| Q9H0Z9 | RBM38_HUMAN RNA-binding protein 38 OS=Homo sapiens GN=RBM38 PE=1 SV=2 | 200 | A | 0.693544 | D | 0.696998 | -0.003454 | No Change: Both D | - |
| Q9H0Z9 | RBM38_HUMAN RNA-binding protein 38 OS=Homo sapiens GN=RBM38 PE=1 SV=2 | 212 | P | 0.694979 | H | 0.55452 | 0.140459 | No Change: Both D | - |
| Q9H0Z9 | RBM38_HUMAN RNA-binding protein 38 OS=Homo sapiens GN=RBM38 PE=1 SV=2 | 226 | V | 0.676831 | L | 0.70891 | -0.032079 | No Change: Both D | - |
| Q14498 | RBM39_HUMAN RNA-binding protein 39 OS=Homo sapiens GN=RBM39 PE=1 SV=2 | 2 | A | 0.859791 | V | 0.772074 | 0.087717 | No Change: Both D | - |
| Q96IZ5 | RBM41_HUMAN RNA-binding protein 41 OS=Homo sapiens GN=RBM41 PE=1 SV=2 | 376 | H | 0.152969 | Y | 0.096301 | 0.056668 | No Change: Both O | - |
| Q6ZSC3 | RBM43_HUMAN RNA-binding protein 43 OS=Homo sapiens GN=RBM43 PE=2 SV=1 | 259 | I | 0.13935 | V | 0.151445 | -0.012095 | No Change: Both O | - |
| Q6ZP01 | RBM44_HUMAN RNA-binding protein 44 OS=Homo sapiens GN=RBM44 PE=2 SV=2 | 52 | D | 0.72204 | H | 0.628343 | 0.093697 | No Change: Both D | - |
| Q6ZP01 | RBM44_HUMAN RNA-binding protein 44 OS=Homo sapiens GN=RBM44 PE=2 SV=2 | 892 | N | 0.358774 | H | 0.31514 | 0.043634 | No Change: Both O | - |
| Q6ZP01 | RBM44_HUMAN RNA-binding protein 44 OS=Homo sapiens GN=RBM44 PE=2 SV=2 | 51 | D | 0.720006 | H | 0.624411 | 0.095595 | No Change: Both D | - |
| A0AV96 | RBM47_HUMAN RNA-binding protein 47 OS=Homo sapiens GN=RBM47 PE=1 SV=2 | 565 | M | 0.290966 | V | 0.234195 | 0.056771 | No Change: Both O | - |
| A0AV96 | RBM47_HUMAN RNA-binding protein 47 OS=Homo sapiens GN=RBM47 PE=1 SV=2 | 538 | G | 0.275892 | R | 0.288406 | -0.012514 | No Change: Both O | - |
| Q9BQ04 | RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens GN=RBM4B PE=1 SV=1 | 93 | E | 0.361129 | V | 0.193394 | 0.167735 | No Change: Both O | - |
| P52756 | RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens GN=RBM5 PE=1 SV=2 | 163 | K | 0.354052 | N | 0.309545 | 0.044507 | No Change: Both O | - |
| P78332 | RBM6_HUMAN RNA-binding protein 6 OS=Homo sapiens GN=RBM6 PE=1 SV=5 | 353 | S | 0.941276 | F | 0.9049 | 0.036376 | No Change: Both D | A non-small cell lung cancer cell line |
| P78332 | RBM6_HUMAN RNA-binding protein 6 OS=Homo sapiens GN=RBM6 PE=1 SV=5 | 721 | N | 0.181842 | T | 0.161733 | 0.020109 | No Change: Both O | - |
| Q9Y388 | RBMX2_HUMAN RNA-binding motif protein X-linked 2 OS=Homo sapiens GN=RBMX2 PE=1 SV=2 | 287 | R | 0.997856 | H | 0.996964 | 8.92E-04 | No Change: Both D | - |
| O75526 | RMXL2_HUMAN RNA-binding motif protein X-linked-like-2 OS=Homo sapiens GN=RBMXL2 PE=1 SV=3 | 15 | L | 0.257293 | F | 0.226988 | 0.030305 | No Change: Both O | - |
| O75526 | RMXL2_HUMAN RNA-binding motif protein X-linked-like-2 OS=Homo sapiens GN=RBMXL2 PE=1 SV=3 | 134 | T | 0.995182 | A | 0.995284 | -1.02E-04 | No Change: Both D | - |
| O75526 | RMXL2_HUMAN RNA-binding motif protein X-linked-like-2 OS=Homo sapiens GN=RBMXL2 PE=1 SV=3 | 308 | Y | 0.971223 | C | 0.97027 | 9.53E-04 | No Change: Both D | - |
| O75526 | RMXL2_HUMAN RNA-binding motif protein X-linked-like-2 OS=Homo sapiens GN=RBMXL2 PE=1 SV=3 | 66 | A | 0.693558 | V | 0.615797 | 0.077761 | No Change: Both D | - |
| P10745 | RET3_HUMAN Retinol-binding protein 3 OS=Homo sapiens GN=RBP3 PE=1 SV=2 | 530 | R | 0.518452 | H | 0.514369 | 0.004083 | No Change: Both D | A colorectal cancer sample |
| P10745 | RET3_HUMAN Retinol-binding protein 3 OS=Homo sapiens GN=RBP3 PE=1 SV=2 | 884 | V | 0.331256 | M | 0.412795 | -0.081539 | No Change: Both O | - |
| P02753 | RET4_HUMAN Retinol-binding protein 4 OS=Homo sapiens GN=RBP4 PE=1 SV=3 | 59 | I | 0.143455 | N | 0.293931 | -0.150476 | No Change: Both O | Retinol-binding protein deficiency (RBP deficiency) [MIM:180250] |
| P02753 | RET4_HUMAN Retinol-binding protein 4 OS=Homo sapiens GN=RBP4 PE=1 SV=3 | 93 | G | 0.192842 | D | 0.23558 | -0.042738 | No Change: Both O | Retinol-binding protein deficiency (RBP deficiency) [MIM:180250] |
| P82980 | RET5_HUMAN Retinol-binding protein 5 OS=Homo sapiens GN=RBP5 PE=1 SV=3 | 70 | E | 0.308837 | Q | 0.265711 | 0.043126 | No Change: Both O | - |
| P82980 | RET5_HUMAN Retinol-binding protein 5 OS=Homo sapiens GN=RBP5 PE=1 SV=3 | 115 | M | 0.149993 | L | 0.128518 | 0.021475 | No Change: Both O | - |
| P82980 | RET5_HUMAN Retinol-binding protein 5 OS=Homo sapiens GN=RBP5 PE=1 SV=3 | 19 | D | 0.310917 | N | 0.315331 | -0.004414 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 291 | K | 0.20801 | E | 0.208925 | -9.15E-04 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 334 | D | 0.299055 | H | 0.263781 | 0.035274 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 419 | R | 0.128272 | Q | 0.140009 | -0.011737 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 425 | P | 0.178174 | S | 0.185339 | -0.007165 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 456 | A | 0.597146 | V | 0.518601 | 0.078545 | No Change: Both D | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 296 | M | 0.202358 | K | 0.301343 | -0.098985 | No Change: Both O | - |
| Q06330 | SUH_HUMAN Recombining binding protein suppressor of hairless OS=Homo sapiens GN=RBPJ PE=1 SV=3 | 408 | I | 0.108087 | V | 0.135446 | -0.027359 | No Change: Both O | - |
| Q9UKA8 | RCAN3_HUMAN Calcipressin-3 OS=Homo sapiens GN=RCAN3 PE=1 SV=1 | 236 | T | 0.942465 | N | 0.942704 | -2.39E-04 | No Change: Both D | - |
| Q8NDN9 | RCBT1_HUMAN RCC1 and BTB domain-containing protein 1 OS=Homo sapiens GN=RCBTB1 PE=2 SV=1 | 24 | A | 0.169468 | V | 0.119354 | 0.050114 | No Change: Both O | - |
| Q8NDN9 | RCBT1_HUMAN RCC1 and BTB domain-containing protein 1 OS=Homo sapiens GN=RCBTB1 PE=2 SV=1 | 500 | T | 0.114285 | I | 0.059985 | 0.0543 | No Change: Both O | - |
| O95199 | RCBT2_HUMAN RCC1 and BTB domain-containing protein 2 OS=Homo sapiens GN=RCBTB2 PE=2 SV=1 | 263 | A | 0.109567 | T | 0.122213 | -0.012646 | No Change: Both O | - |
| O95199 | RCBT2_HUMAN RCC1 and BTB domain-containing protein 2 OS=Homo sapiens GN=RCBTB2 PE=2 SV=1 | 515 | C | 0.025669 | S | 0.066949 | -0.04128 | No Change: Both O | - |
| A6NED2 | RCCD1_HUMAN RCC1 domain-containing protein 1 OS=Homo sapiens GN=RCCD1 PE=1 SV=1 | 8 | A | 0.570727 | S | 0.682029 | -0.111302 | No Change: Both D | - |
| Q9Y256 | FACE2_HUMAN CAAX prenyl protease 2 OS=Homo sapiens GN=RCE1 PE=1 SV=1 | 326 | P | 0.735023 | A | 0.735014 | 9.00E-06 | No Change: Both D | A breast cancer sample |
| Q15293 | RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=RCN1 PE=1 SV=1 | 71 | T | 0.778272 | N | 0.784494 | -0.006222 | No Change: Both D | - |
| Q15293 | RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=RCN1 PE=1 SV=1 | 73 | D | 0.769747 | Y | 0.610874 | 0.158873 | No Change: Both D | - |
| Q15293 | RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=RCN1 PE=1 SV=1 | 74 | Q | 0.762622 | E | 0.802367 | -0.039745 | No Change: Both D | - |
| Q15293 | RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=RCN1 PE=1 SV=1 | 188 | R | 0.55867 | P | 0.594679 | -0.036009 | No Change: Both D | - |
| Q15293 | RCN1_HUMAN Reticulocalbin-1 OS=Homo sapiens GN=RCN1 PE=1 SV=1 | 117 | F | 0.121656 | L | 0.135888 | -0.014232 | No Change: Both O | A colorectal cancer sample |
| Q96D15 | RCN3_HUMAN Reticulocalbin-3 OS=Homo sapiens GN=RCN3 PE=1 SV=1 | 250 | R | 0.430874 | W | 0.217034 | 0.21384 | No Change: Both O | - |
| Q8IZ40 | RCOR2_HUMAN REST corepressor 2 OS=Homo sapiens GN=RCOR2 PE=2 SV=2 | 514 | T | 0.995647 | A | 0.995693 | -4.60E-05 | No Change: Both D | - |
| Q9P2K3 | RCOR3_HUMAN REST corepressor 3 OS=Homo sapiens GN=RCOR3 PE=1 SV=2 | 42 | K | 0.387061 | R | 0.319952 | 0.067109 | No Change: Both O | - |
| Q6JBY9 | CPZIP_HUMAN CapZ-interacting protein OS=Homo sapiens GN=RCSD1 PE=1 SV=1 | 384 | Q | 0.986771 | R | 0.981349 | 0.005422 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 47 | R | 0.706442 | C | 0.615739 | 0.090703 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 6 | W | 0.57221 | R | 0.838423 | -0.266213 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 23 | E | 0.83022 | D | 0.766976 | 0.063244 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 35 | G | 0.761746 | R | 0.812398 | -0.050652 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 57 | G | 0.330032 | V | 0.284288 | 0.045744 | No Change: Both O | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 68 | R | 0.423489 | W | 0.257782 | 0.165707 | No Change: Both O | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 130 | K | 0.812841 | M | 0.782018 | 0.030823 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 167 | R | 0.793559 | K | 0.783586 | 0.009973 | No Change: Both D | - |
| Q7Z3Z2 | RD3_HUMAN Protein RD3 OS=Homo sapiens GN=RD3 PE=2 SV=1 | 195 | D | 0.948509 | V | 0.909281 | 0.039228 | No Change: Both D | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 49 | T | 0.346276 | M | 0.289454 | 0.056822 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 51 | I | 0.460354 | N | 0.591436 | -0.131082 | O to D | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 99 | L | 0.423726 | I | 0.385211 | 0.038515 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 151 | H | 0.099155 | D | 0.106736 | -0.007581 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 151 | H | 0.099155 | N | 0.106523 | -0.007368 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 175 | S | 0.327954 | P | 0.294151 | 0.033803 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 226 | Y | 0.254437 | C | 0.213222 | 0.041215 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 230 | P | 0.245792 | A | 0.193345 | 0.052447 | No Change: Both O | Leber congenital amaurosis type 13 (LCA13) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 161 | R | 0.178784 | Q | 0.186488 | -0.007704 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 47 | A | 0.253358 | T | 0.296848 | -0.04349 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 55 | T | 0.579599 | M | 0.529128 | 0.050471 | No Change: Both D | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 65 | R | 0.19631 | Q | 0.183412 | 0.012898 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 76 | G | 0.446284 | R | 0.497055 | -0.050771 | No Change: Both O | Retinitis pigmentosa type 53 (RP53) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 101 | D | 0.441803 | N | 0.410418 | 0.031385 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 125 | N | 0.11404 | K | 0.130716 | -0.016676 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 126 | A | 0.108089 | V | 0.080916 | 0.027173 | No Change: Both O | Retinitis pigmentosa type 53 (RP53) [MIM:612712] |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 145 | G | 0.295725 | E | 0.342937 | -0.047212 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 155 | T | 0.057251 | I | 0.029379 | 0.027872 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 193 | R | 0.494549 | C | 0.330806 | 0.163743 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 206 | A | 0.130204 | D | 0.172986 | -0.042782 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 206 | A | 0.130204 | V | 0.093589 | 0.036615 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 230 | P | 0.245792 | L | 0.136124 | 0.109668 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 234 | R | 0.430879 | H | 0.448869 | -0.01799 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 239 | R | 0.266421 | W | 0.12143 | 0.144991 | No Change: Both O | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 274 | L | 0.406307 | P | 0.550069 | -0.143762 | O to D | - |
| Q96NR8 | RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens GN=RDH12 PE=1 SV=3 | 285 | C | 0.272003 | Y | 0.314552 | -0.042549 | No Change: Both O | - |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 33 | I | 0.091417 | V | 0.114085 | -0.022668 | No Change: Both O | - |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 73 | S | 0.473781 | F | 0.241738 | 0.232043 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 238 | G | 0.240786 | W | 0.0964 | 0.144386 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 35 | G | 0.10239 | S | 0.127909 | -0.025519 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 107 | G | 0.166694 | R | 0.144967 | 0.021727 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 132 | V | 0.194005 | M | 0.243187 | -0.049182 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 164 | V | 0.138462 | F | 0.116117 | 0.022345 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 177 | V | 0.175761 | G | 0.316489 | -0.140728 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 267 | C | 0.268087 | W | 0.234742 | 0.033345 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 280 | R | 0.495759 | H | 0.494763 | 9.96E-04 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 281 | Y | 0.477214 | H | 0.616591 | -0.139377 | O to D | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 294 | A | 0.127648 | P | 0.183425 | -0.055777 | No Change: Both O | Retinitis punctata albescens (RPA) [MIM:136880] |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 21 | R | 0.27102 | Q | 0.289583 | -0.018563 | No Change: Both O | - |
| Q92781 | RDH1_HUMAN 11-cis retinol dehydrogenase OS=Homo sapiens GN=RDH5 PE=1 SV=1 | 70 | R | 0.574681 | G | 0.57529 | -6.09E-04 | No Change: Both D | - |
| Q9NYR8 | RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens GN=RDH8 PE=1 SV=1 | 136 | H | 0.303399 | Q | 0.333033 | -0.029634 | No Change: Both O | - |
| Q9NYR8 | RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens GN=RDH8 PE=1 SV=1 | 202 | M | 0.299915 | T | 0.357206 | -0.057291 | No Change: Both O | - |
| Q8NG50 | RDM1_HUMAN RAD52 motif-containing protein 1 OS=Homo sapiens GN=RDM1 PE=1 SV=1 | 32 | H | 0.390543 | R | 0.369439 | 0.021104 | No Change: Both O | - |
| Q8NG50 | RDM1_HUMAN RAD52 motif-containing protein 1 OS=Homo sapiens GN=RDM1 PE=1 SV=1 | 127 | C | 0.24955 | W | 0.167693 | 0.081857 | No Change: Both O | - |
| P35241 | RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE=1 SV=1 | 328 | K | 0.996756 | E | 0.99693 | -1.74E-04 | No Change: Both D | - |
| P35241 | RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE=1 SV=1 | 490 | D | 0.989676 | N | 0.99074 | -0.001064 | No Change: Both D | - |
| P35241 | RADI_HUMAN Radixin OS=Homo sapiens GN=RDX PE=1 SV=1 | 578 | D | 0.688161 | N | 0.6915 | -0.003339 | No Change: Both D | Deafness autosomal recessive type 24 (DFNB24) [MIM:611022] |
| O95072 | REC8_HUMAN Meiotic recombination protein REC8 homolog OS=Homo sapiens GN=REC8 PE=2 SV=1 | 31 | R | 0.32454 | C | 0.160472 | 0.164068 | No Change: Both O | - |
| O95072 | REC8_HUMAN Meiotic recombination protein REC8 homolog OS=Homo sapiens GN=REC8 PE=2 SV=1 | 294 | P | 0.995197 | L | 0.990348 | 0.004849 | No Change: Both D | - |
| O95072 | REC8_HUMAN Meiotic recombination protein REC8 homolog OS=Homo sapiens GN=REC8 PE=2 SV=1 | 411 | V | 0.954938 | F | 0.942951 | 0.011987 | No Change: Both D | - |
| O95980 | RECK_HUMAN Reversion-inducing cysteine-rich protein with Kazal motifs OS=Homo sapiens GN=RECK PE=1 SV=1 | 275 | V | 0.729799 | I | 0.68086 | 0.048939 | No Change: Both D | - |
| P46063 | RECQ1_HUMAN ATP-dependent DNA helicase Q1 OS=Homo sapiens GN=RECQL PE=1 SV=3 | 487 | K | 0.406756 | T | 0.326768 | 0.079988 | No Change: Both O | - |
| P46063 | RECQ1_HUMAN ATP-dependent DNA helicase Q1 OS=Homo sapiens GN=RECQL PE=1 SV=3 | 495 | D | 0.209008 | H | 0.148238 | 0.06077 | No Change: Both O | - |
| P46063 | RECQ1_HUMAN ATP-dependent DNA helicase Q1 OS=Homo sapiens GN=RECQL PE=1 SV=3 | 102 | V | 0.172249 | I | 0.156628 | 0.015621 | No Change: Both O | - |
| P46063 | RECQ1_HUMAN ATP-dependent DNA helicase Q1 OS=Homo sapiens GN=RECQL PE=1 SV=3 | 372 | V | 0.071126 | I | 0.059749 | 0.011377 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 267 | E | 0.985923 | D | 0.97951 | 0.006413 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 355 | R | 0.418325 | Q | 0.411439 | 0.006886 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 441 | P | 0.939064 | S | 0.931466 | 0.007598 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1005 | R | 0.176604 | Q | 0.185722 | -0.009118 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 54 | Q | 0.889401 | R | 0.912324 | -0.022923 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 71 | E | 0.922898 | G | 0.90979 | 0.013108 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 92 | P | 0.926812 | S | 0.920456 | 0.006356 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 189 | G | 0.795419 | S | 0.833112 | -0.037693 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 273 | A | 0.98975 | T | 0.988255 | 0.001495 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 301 | E | 0.993947 | K | 0.992215 | 0.001732 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 522 | R | 0.310412 | C | 0.221232 | 0.08918 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 522 | R | 0.310412 | H | 0.267003 | 0.043409 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 591 | P | 0.441555 | L | 0.278109 | 0.163446 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 793 | P | 0.352823 | S | 0.374258 | -0.021435 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 799 | V | 0.37605 | M | 0.42981 | -0.05376 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 964 | P | 0.293819 | T | 0.215352 | 0.078467 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 976 | E | 0.683167 | K | 0.673835 | 0.009332 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1004 | R | 0.193253 | W | 0.084906 | 0.108347 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1021 | R | 0.429402 | Q | 0.425767 | 0.003635 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1045 | A | 0.436978 | T | 0.461958 | -0.02498 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1105 | G | 0.852612 | D | 0.869258 | -0.016646 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1105 | G | 0.852612 | S | 0.875728 | -0.023116 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1106 | R | 0.867635 | H | 0.831889 | 0.035746 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1113 | G | 0.947131 | R | 0.952652 | -0.005521 | No Change: Both D | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1148 | S | 0.401372 | F | 0.247405 | 0.153967 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 523 | S | 0.30592 | T | 0.229797 | 0.076123 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1021 | R | 0.429402 | W | 0.226419 | 0.202983 | No Change: Both O | Baller-Gerold syndrome (BGS) [MIM:218600] |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 793 | P | 0.352823 | L | 0.218768 | 0.134055 | No Change: Both O | - |
| O94761 | RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens GN=RECQL4 PE=1 SV=1 | 1043 | L | 0.434441 | P | 0.513254 | -0.078813 | O to D | - |
| O94762 | RECQ5_HUMAN ATP-dependent DNA helicase Q5 OS=Homo sapiens GN=RECQL5 PE=1 SV=2 | 480 | D | 0.818675 | G | 0.814624 | 0.004051 | No Change: Both D | - |
| O94762 | RECQ5_HUMAN ATP-dependent DNA helicase Q5 OS=Homo sapiens GN=RECQL5 PE=1 SV=2 | 628 | S | 0.849006 | N | 0.807728 | 0.041278 | No Change: Both D | - |
| Q9H902 | REEP1_HUMAN Receptor expression-enhancing protein 1 OS=Homo sapiens GN=REEP1 PE=1 SV=1 | 20 | A | 0.113334 | E | 0.166349 | -0.053015 | No Change: Both O | Spastic paraplegia autosomal dominant type 31 (SPG31) [MIM:610250] |
| Q6NUK4 | REEP3_HUMAN Receptor expression-enhancing protein 3 OS=Homo sapiens GN=REEP3 PE=2 SV=1 | 171 | Q | 0.840217 | R | 0.834728 | 0.005489 | No Change: Both D | - |
| Q96HR9 | REEP6_HUMAN Receptor expression-enhancing protein 6 OS=Homo sapiens GN=REEP6 PE=1 SV=1 | 150 | A | 0.236317 | D | 0.323577 | -0.08726 | No Change: Both O | - |
| P48304 | REG1B_HUMAN Lithostathine-1-beta OS=Homo sapiens GN=REG1B PE=1 SV=1 | 109 | R | 0.542797 | H | 0.547707 | -0.00491 | No Change: Both D | - |
| Q9BYZ8 | REG4_HUMAN Regenerating islet-derived protein 4 OS=Homo sapiens GN=REG4 PE=1 SV=1 | 135 | N | 0.562769 | H | 0.517917 | 0.044852 | No Change: Both D | - |
| Q01201 | RELB_HUMAN Transcription factor RelB OS=Homo sapiens GN=RELB PE=1 SV=2 | 396 | T | 0.344384 | M | 0.314345 | 0.030039 | No Change: Both O | - |
| Q8NC24 | RELL2_HUMAN RELT-like protein 2 OS=Homo sapiens GN=RELL2 PE=1 SV=1 | 128 | S | 0.892397 | P | 0.88967 | 0.002727 | No Change: Both D | - |
| Q8NC24 | RELL2_HUMAN RELT-like protein 2 OS=Homo sapiens GN=RELL2 PE=1 SV=1 | 133 | L | 0.896861 | I | 0.85876 | 0.038101 | No Change: Both D | - |
| Q8NC24 | RELL2_HUMAN RELT-like protein 2 OS=Homo sapiens GN=RELL2 PE=1 SV=1 | 196 | G | 0.919397 | R | 0.923486 | -0.004089 | No Change: Both D | - |
| Q8NC24 | RELL2_HUMAN RELT-like protein 2 OS=Homo sapiens GN=RELL2 PE=1 SV=1 | 283 | Q | 0.981295 | E | 0.979662 | 0.001633 | No Change: Both D | - |
| P78509 | RELN_HUMAN Reelin OS=Homo sapiens GN=RELN PE=1 SV=3 | 978 | T | 0.454973 | A | 0.445119 | 0.009854 | No Change: Both O | - |
| P78509 | RELN_HUMAN Reelin OS=Homo sapiens GN=RELN PE=1 SV=3 | 997 | L | 0.099102 | V | 0.100472 | -0.00137 | No Change: Both O | - |
| P78509 | RELN_HUMAN Reelin OS=Homo sapiens GN=RELN PE=1 SV=3 | 1703 | P | 0.169998 | R | 0.136186 | 0.033812 | No Change: Both O | - |
| Q969Z4 | TR19L_HUMAN Tumor necrosis factor receptor superfamily member 19L OS=Homo sapiens GN=RELT PE=1 SV=1 | 332 | A | 0.683502 | V | 0.628788 | 0.054714 | No Change: Both D | - |
| O75628 | REM1_HUMAN GTP-binding protein REM 1 OS=Homo sapiens GN=REM1 PE=1 SV=2 | 28 | H | 0.980198 | R | 0.985172 | -0.004974 | No Change: Both D | - |
| O75628 | REM1_HUMAN GTP-binding protein REM 1 OS=Homo sapiens GN=REM1 PE=1 SV=2 | 59 | P | 0.959761 | A | 0.939909 | 0.019852 | No Change: Both D | - |
| O75628 | REM1_HUMAN GTP-binding protein REM 1 OS=Homo sapiens GN=REM1 PE=1 SV=2 | 45 | R | 0.993299 | W | 0.985078 | 0.008221 | No Change: Both D | - |
| Q8IYK8 | REM2_HUMAN GTP-binding protein REM 2 OS=Homo sapiens GN=REM2 PE=1 SV=2 | 96 | G | 0.903917 | A | 0.898116 | 0.005801 | No Change: Both D | - |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 33 | R | 0.312232 | W | 0.14011 | 0.172122 | No Change: Both O | - |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 217 | G | 0.182866 | R | 0.175204 | 0.007662 | No Change: Both O | - |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 160 | Q | 0.206762 | K | 0.23822 | -0.031458 | No Change: Both O | - |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 230 | R | 0.546705 | K | 0.603729 | -0.057024 | No Change: Both D | Renal tubular dysgenesis (RTD) [MIM:267430] |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 104 | D | 0.252514 | N | 0.252414 | 1.00E-04 | No Change: Both O | Renal tubular dysgenesis (RTD) [MIM:267430] |
| P00797 | RENI_HUMAN Renin OS=Homo sapiens GN=REN PE=1 SV=1 | 16 | L | 0.098019 | R | 0.18239 | -0.084371 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 2 (HNFJ2) [MIM:613092] |
| P51606 | RENBP_HUMAN N-acylglucosamine 2-epimerase OS=Homo sapiens GN=RENBP PE=1 SV=2 | 169 | Q | 0.320684 | R | 0.298283 | 0.022401 | No Change: Both O | - |
| P51606 | RENBP_HUMAN N-acylglucosamine 2-epimerase OS=Homo sapiens GN=RENBP PE=1 SV=2 | 284 | D | 0.107613 | G | 0.094532 | 0.013081 | No Change: Both O | - |
| Q6BDI9 | REP15_HUMAN Rab15 effector protein OS=Homo sapiens GN=REP15 PE=1 SV=4 | 101 | N | 0.165155 | D | 0.181095 | -0.01594 | No Change: Both O | - |
| Q6BDI9 | REP15_HUMAN Rab15 effector protein OS=Homo sapiens GN=REP15 PE=1 SV=4 | 206 | E | 0.102068 | D | 0.090038 | 0.01203 | No Change: Both O | - |
| Q9BWE0 | REPI1_HUMAN Replication initiator 1 OS=Homo sapiens GN=REPIN1 PE=1 SV=1 | 14 | L | 0.967729 | P | 0.983646 | -0.015917 | No Change: Both D | - |
| Q9BWE0 | REPI1_HUMAN Replication initiator 1 OS=Homo sapiens GN=REPIN1 PE=1 SV=1 | 88 | P | 0.523978 | S | 0.452427 | 0.071551 | D to O | - |
| Q9BWE0 | REPI1_HUMAN Replication initiator 1 OS=Homo sapiens GN=REPIN1 PE=1 SV=1 | 92 | R | 0.463898 | H | 0.423566 | 0.040332 | No Change: Both O | - |
| Q9BWE0 | REPI1_HUMAN Replication initiator 1 OS=Homo sapiens GN=REPIN1 PE=1 SV=1 | 97 | A | 0.369686 | V | 0.271332 | 0.098354 | No Change: Both O | - |
| Q9BWE0 | REPI1_HUMAN Replication initiator 1 OS=Homo sapiens GN=REPIN1 PE=1 SV=1 | 49 | G | 0.794614 | R | 0.818068 | -0.023454 | No Change: Both D | - |
| Q9H628 | RERGL_HUMAN Ras-related and estrogen-regulated growth inhibitor-like protein OS=Homo sapiens GN=RERGL PE=2 SV=1 | 163 | M | 0.239365 | V | 0.167656 | 0.071709 | No Change: Both O | - |
| Q13127 | REST_HUMAN RE1-silencing transcription factor OS=Homo sapiens GN=REST PE=1 SV=3 | 626 | V | 0.99356 | I | 0.992077 | 0.001483 | No Change: Both D | - |
| Q13127 | REST_HUMAN RE1-silencing transcription factor OS=Homo sapiens GN=REST PE=1 SV=3 | 692 | E | 0.951157 | D | 0.929999 | 0.021158 | No Change: Both D | - |
| Q13127 | REST_HUMAN RE1-silencing transcription factor OS=Homo sapiens GN=REST PE=1 SV=3 | 762 | K | 0.982008 | Q | 0.982662 | -6.54E-04 | No Change: Both D | - |
| Q13127 | REST_HUMAN RE1-silencing transcription factor OS=Homo sapiens GN=REST PE=1 SV=3 | 797 | P | 0.997214 | L | 0.994322 | 0.002892 | No Change: Both D | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 32 | S | 0.081808 | L | 0.03859 | 0.043218 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 64 | P | 0.487929 | L | 0.312575 | 0.175354 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 93 | G | 0.107874 | S | 0.140684 | -0.03281 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 142 | C | 0.183789 | S | 0.285007 | -0.101218 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 231 | R | 0.418469 | H | 0.401154 | 0.017315 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 251 | E | 0.328356 | K | 0.306044 | 0.022312 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 287 | R | 0.485459 | Q | 0.467811 | 0.017648 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 330 | R | 0.215622 | Q | 0.24654 | -0.030918 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 393 | F | 0.105002 | L | 0.134589 | -0.029587 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 399 | P | 0.251041 | L | 0.139873 | 0.111168 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 475 | R | 0.342388 | Q | 0.343715 | -0.001327 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | Y | 0.400471 | 0.0938 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | Y | 0.400471 | 0.0938 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | Y | 0.400471 | 0.0938 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | W | 0.311298 | 0.182973 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | W | 0.331213 | 0.181793 | D to O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | W | 0.331213 | 0.181793 | D to O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | Y | 0.420075 | 0.092931 | D to O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | G | 0.573415 | -0.130527 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | R | 0.569512 | -0.126624 | O to D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | R | 0.569512 | -0.126624 | O to D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | R | 0.569512 | -0.126624 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | F | 0.430267 | 0.012621 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | F | 0.430267 | 0.012621 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | S | 0.619634 | -0.176746 | O to D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | S | 0.619634 | -0.176746 | O to D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | S | 0.619634 | -0.176746 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | Y | 0.431552 | 0.011336 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 618 | C | 0.442888 | Y | 0.431552 | 0.011336 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | G | 0.553856 | -0.143276 | O to D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | G | 0.553856 | -0.143276 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | R | 0.549018 | -0.138438 | O to D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | R | 0.549018 | -0.138438 | O to D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | R | 0.549018 | -0.138438 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | S | 0.601842 | -0.191262 | O to D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | S | 0.601842 | -0.191262 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | F | 0.405229 | 0.005351 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | F | 0.405229 | 0.005351 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | Y | 0.414121 | -0.003541 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 630 | C | 0.210696 | F | 0.205809 | 0.004887 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 630 | C | 0.210696 | F | 0.205809 | 0.004887 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 631 | D | 0.158082 | G | 0.130558 | 0.027524 | No Change: Both O | Thyroid carcinoma |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | G | 0.150168 | -0.071509 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | G | 0.150168 | -0.071509 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | F | 0.074775 | 0.003884 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | F | 0.074775 | 0.003884 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | Y | 0.085111 | -0.006452 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | Y | 0.085111 | -0.006452 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | Y | 0.085111 | -0.006452 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | R | 0.153283 | -0.074624 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | R | 0.153283 | -0.074624 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | R | 0.153283 | -0.074624 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | S | 0.186331 | -0.107672 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | S | 0.186331 | -0.107672 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | S | 0.186331 | -0.107672 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | W | 0.056991 | 0.021668 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | W | 0.056991 | 0.021668 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 634 | C | 0.078659 | W | 0.056991 | 0.021668 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 690 | S | 0.775585 | P | 0.767888 | 0.007697 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 691 | G | 0.773326 | S | 0.85435 | -0.081024 | No Change: Both D | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 767 | S | 0.635896 | R | 0.576989 | 0.058907 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 768 | E | 0.617835 | D | 0.593043 | 0.024792 | No Change: Both D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 804 | V | 0.106482 | L | 0.12043 | -0.013948 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 804 | V | 0.106482 | M | 0.136481 | -0.029999 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 873 | R | 0.197323 | Q | 0.197947 | -6.24E-04 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 893 | F | 0.366862 | L | 0.414496 | -0.047634 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 897 | R | 0.38726 | Q | 0.404817 | -0.017557 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 907 | K | 0.549357 | E | 0.568197 | -0.01884 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 918 | M | 0.0927 | T | 0.112902 | -0.020202 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 918 | M | 0.0927 | T | 0.112902 | -0.020202 | No Change: Both O | Multiple neoplasia type 2B (MEN2B) [MIM:162300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 918 | M | 0.0927 | T | 0.112902 | -0.020202 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 921 | E | 0.087732 | K | 0.093856 | -0.006124 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 946 | T | 0.079722 | M | 0.065163 | 0.014559 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 946 | T | 0.079722 | M | 0.065163 | 0.014559 | No Change: Both O | Multiple neoplasia type 2B (MEN2B) [MIM:162300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 972 | R | 0.653219 | G | 0.650491 | 0.002728 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 973 | P | 0.66063 | L | 0.547866 | 0.112764 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 980 | M | 0.545303 | T | 0.517417 | 0.027886 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 982 | R | 0.488722 | C | 0.399444 | 0.089278 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 600 | R | 0.649783 | Q | 0.662222 | -0.012439 | No Change: Both D | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 20 | P | 0.063039 | L | 0.035775 | 0.027264 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 77 | R | 0.304945 | C | 0.156093 | 0.148852 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 157 | C | 0.607094 | Y | 0.539259 | 0.067835 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 174 | F | 0.643795 | S | 0.789478 | -0.145683 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 180 | R | 0.644099 | P | 0.669291 | -0.025192 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 197 | C | 0.152701 | Y | 0.130279 | 0.022422 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 313 | R | 0.291101 | Q | 0.290017 | 0.001084 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 359 | N | 0.235763 | K | 0.253162 | -0.017399 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 360 | R | 0.285662 | W | 0.125278 | 0.160384 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 394 | N | 0.117156 | K | 0.135134 | -0.017978 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | G | 0.563014 | -0.068743 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 609 | C | 0.494271 | R | 0.561299 | -0.067028 | O to D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | G | 0.572961 | -0.059955 | No Change: Both D | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | R | 0.572662 | -0.059656 | No Change: Both D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 611 | C | 0.513006 | S | 0.582212 | -0.069206 | No Change: Both D | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | W | 0.322386 | 0.088194 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 620 | C | 0.41058 | W | 0.322386 | 0.088194 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 626 | Q | 0.359019 | K | 0.412891 | -0.053872 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 630 | C | 0.210696 | S | 0.403852 | -0.193156 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 630 | C | 0.210696 | Y | 0.231467 | -0.020771 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 640 | A | 0.048715 | G | 0.05033 | -0.001615 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 762 | E | 0.597506 | Q | 0.547288 | 0.050218 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 790 | L | 0.18212 | F | 0.162815 | 0.019305 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 790 | L | 0.18212 | F | 0.162815 | 0.019305 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 791 | Y | 0.180502 | F | 0.162224 | 0.018278 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 791 | Y | 0.180502 | F | 0.162224 | 0.018278 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 791 | Y | 0.180502 | F | 0.162224 | 0.018278 | No Change: Both O | Multiple neoplasia type 2A (MEN2A) [MIM:171400] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 791 | Y | 0.180502 | F | 0.162224 | 0.018278 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 813 | R | 0.36231 | Q | 0.351642 | 0.010668 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 883 | A | 0.257016 | F | 0.170686 | 0.08633 | No Change: Both O | Multiple neoplasia type 2B (MEN2B) [MIM:162300] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 891 | S | 0.42536 | A | 0.30524 | 0.12012 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 922 | S | 0.085845 | Y | 0.038669 | 0.047176 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1039 | P | 0.544445 | Q | 0.483607 | 0.060838 | D to O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1061 | L | 0.481612 | P | 0.653206 | -0.171594 | O to D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1064 | M | 0.522191 | T | 0.576814 | -0.054623 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 40 | L | 0.160304 | P | 0.294867 | -0.134563 | No Change: Both O | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 765 | S | 0.660868 | P | 0.633748 | 0.02712 | No Change: Both D | Hirschsprung disease type 1 (HSCR1) [MIM:142623] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 844 | R | 0.550591 | L | 0.466634 | 0.083957 | D to O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 639 | A | 0.046858 | G | 0.048356 | -0.001498 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 641 | A | 0.04916 | G | 0.049177 | -1.70E-05 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 922 | S | 0.085845 | F | 0.032863 | 0.052982 | No Change: Both O | Medullary thyroid carcinoma (MTC) [MIM:155240] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 67 | R | 0.323749 | H | 0.343465 | -0.019716 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 114 | R | 0.199028 | H | 0.188063 | 0.010965 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 432 | A | 0.142542 | E | 0.215547 | -0.073005 | No Change: Both O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 489 | D | 0.463838 | N | 0.450427 | 0.013411 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1039 | P | 0.544445 | L | 0.389647 | 0.154798 | D to O | Congenital central hypoventilation syndrome (CCHS) [MIM:209880] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 145 | V | 0.170335 | G | 0.27563 | -0.105295 | No Change: Both O | A colorectal cancer sample |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 593 | G | 0.60408 | E | 0.637968 | -0.033888 | No Change: Both D | A colorectal cancer sample |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 163 | R | 0.665178 | Q | 0.645422 | 0.019756 | No Change: Both D | A colorectal adenocarcinoma sample |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 278 | T | 0.481144 | N | 0.448692 | 0.032452 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 292 | V | 0.350261 | M | 0.371466 | -0.021205 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 749 | R | 0.317363 | T | 0.328796 | -0.011433 | No Change: Both O | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 826 | Y | 0.671959 | S | 0.824186 | -0.152227 | No Change: Both D | - |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1112 | F | 0.732004 | Y | 0.75425 | -0.022246 | No Change: Both D | A bladder transitional cell carcinoma sample |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 198 | P | 0.150205 | T | 0.102841 | 0.047364 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 376 | V | 0.219359 | A | 0.288334 | -0.068975 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 394 | N | 0.117156 | H | 0.114386 | 0.00277 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 778 | V | 0.284921 | I | 0.240119 | 0.044802 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 894 | G | 0.335094 | S | 0.412752 | -0.077658 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1049 | P | 0.505797 | L | 0.349326 | 0.156471 | D to O | Renal adysplasia (RADYS) [MIM:191830] |
| P07949 | RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens GN=RET PE=1 SV=3 | 1067 | P | 0.566492 | S | 0.56242 | 0.004072 | No Change: Both D | Renal adysplasia (RADYS) [MIM:191830] |
| Q9BQ08 | RETNB_HUMAN Resistin-like beta OS=Homo sapiens GN=RETNLB PE=2 SV=1 | 20 | P | 0.505322 | L | 0.357569 | 0.147753 | D to O | - |
| Q6NUM9 | RETST_HUMAN All-trans-retinol 13 14-reductase OS=Homo sapiens GN=RETSAT PE=2 SV=2 | 533 | A | 0.235225 | V | 0.1607 | 0.074525 | No Change: Both O | - |
| Q6NUM9 | RETST_HUMAN All-trans-retinol 13 14-reductase OS=Homo sapiens GN=RETSAT PE=2 SV=2 | 536 | G | 0.304372 | R | 0.297652 | 0.00672 | No Change: Both O | - |
| Q6NUM9 | RETST_HUMAN All-trans-retinol 13 14-reductase OS=Homo sapiens GN=RETSAT PE=2 SV=2 | 559 | P | 0.286383 | T | 0.240983 | 0.0454 | No Change: Both O | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 138 | V | 0.559232 | M | 0.608572 | -0.04934 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 257 | F | 0.809959 | S | 0.892161 | -0.082202 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 373 | N | 0.254947 | S | 0.300027 | -0.04508 | No Change: Both O | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 1003 | A | 0.499795 | T | 0.506475 | -0.00668 | O to D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 306 | N | 0.922249 | D | 0.915481 | 0.006768 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 656 | M | 0.507763 | V | 0.483028 | 0.024735 | D to O | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 660 | L | 0.474761 | W | 0.395578 | 0.079183 | No Change: Both O | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 700 | D | 0.481843 | N | 0.445308 | 0.036535 | No Change: Both O | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 704 | R | 0.601614 | Q | 0.588932 | 0.012682 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 902 | P | 0.763488 | S | 0.770159 | -0.006671 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 902 | P | 0.763488 | H | 0.72526 | 0.038228 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 921 | S | 0.72051 | I | 0.517095 | 0.203415 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 1060 | P | 0.915359 | T | 0.891538 | 0.023821 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 1074 | N | 0.956289 | K | 0.966437 | -0.010148 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 1091 | N | 0.876332 | T | 0.858597 | 0.017735 | No Change: Both D | - |
| Q9UBZ9 | REV1_HUMAN DNA repair protein REV1 OS=Homo sapiens GN=REV1 PE=1 SV=1 | 1102 | L | 0.873336 | P | 0.924582 | -0.051246 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 231 | Q | 0.418991 | H | 0.393727 | 0.025264 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 389 | S | 0.616754 | T | 0.552736 | 0.064018 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1540 | K | 0.888854 | E | 0.883544 | 0.00531 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 2607 | S | 0.29531 | T | 0.206871 | 0.088439 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 3064 | V | 0.305381 | I | 0.290175 | 0.015206 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 397 | Q | 0.601654 | P | 0.630991 | -0.029337 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 693 | M | 0.720278 | T | 0.760453 | -0.040175 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 962 | R | 0.797935 | Q | 0.765608 | 0.032327 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1156 | Y | 0.625942 | C | 0.700755 | -0.074813 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1224 | T | 0.932617 | I | 0.889564 | 0.043053 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1302 | S | 0.721046 | T | 0.631052 | 0.089994 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1309 | Q | 0.724044 | H | 0.687573 | 0.036471 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1339 | P | 0.484357 | T | 0.439635 | 0.044722 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1469 | Q | 0.546484 | P | 0.57088 | -0.024396 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1576 | S | 0.982319 | L | 0.967346 | 0.014973 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1713 | D | 0.701084 | N | 0.679108 | 0.021976 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1724 | S | 0.728594 | T | 0.672293 | 0.056301 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1791 | P | 0.617024 | S | 0.657568 | -0.040544 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1812 | D | 0.607448 | H | 0.577011 | 0.030437 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1923 | G | 0.418054 | R | 0.435362 | -0.017308 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1970 | R | 0.770066 | H | 0.729895 | 0.040171 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 2015 | E | 0.719976 | V | 0.589025 | 0.130951 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 2075 | I | 0.825338 | M | 0.885269 | -0.059931 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 2762 | R | 0.319539 | Q | 0.325154 | -0.005615 | No Change: Both O | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 633 | S | 0.942704 | G | 0.91263 | 0.030074 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1220 | S | 0.952743 | L | 0.92343 | 0.029313 | No Change: Both D | - |
| O60673 | DPOLZ_HUMAN DNA polymerase zeta catalytic subunit OS=Homo sapiens GN=REV3L PE=1 SV=2 | 1284 | T | 0.689713 | P | 0.777834 | -0.088121 | No Change: Both D | - |
| Q8N1G1 | REXO1_HUMAN RNA exonuclease 1 homolog OS=Homo sapiens GN=REXO1 PE=1 SV=3 | 886 | S | 0.667451 | G | 0.623029 | 0.044422 | No Change: Both D | - |
| Q8N1G1 | REXO1_HUMAN RNA exonuclease 1 homolog OS=Homo sapiens GN=REXO1 PE=1 SV=3 | 408 | V | 0.998337 | A | 0.999018 | -6.81E-04 | No Change: Both D | - |
| Q8N1G1 | REXO1_HUMAN RNA exonuclease 1 homolog OS=Homo sapiens GN=REXO1 PE=1 SV=3 | 804 | I | 0.502168 | V | 0.510859 | -0.008691 | No Change: Both D | - |
| Q8N1G1 | REXO1_HUMAN RNA exonuclease 1 homolog OS=Homo sapiens GN=REXO1 PE=1 SV=3 | 759 | S | 0.952846 | P | 0.954679 | -0.001833 | No Change: Both D | - |
| Q9GZR2 | REXO4_HUMAN RNA exonuclease 4 OS=Homo sapiens GN=REXO4 PE=1 SV=2 | 141 | R | 0.978592 | K | 0.980049 | -0.001457 | No Change: Both D | - |
| Q9GZR2 | REXO4_HUMAN RNA exonuclease 4 OS=Homo sapiens GN=REXO4 PE=1 SV=2 | 283 | T | 0.419834 | A | 0.385026 | 0.034808 | No Change: Both O | - |
| P35251 | RFC1_HUMAN Replication factor C subunit 1 OS=Homo sapiens GN=RFC1 PE=1 SV=4 | 598 | I | 0.402402 | V | 0.414484 | -0.012082 | No Change: Both O | - |
| P35251 | RFC1_HUMAN Replication factor C subunit 1 OS=Homo sapiens GN=RFC1 PE=1 SV=4 | 613 | R | 0.350687 | L | 0.272379 | 0.078308 | No Change: Both O | - |
| P35251 | RFC1_HUMAN Replication factor C subunit 1 OS=Homo sapiens GN=RFC1 PE=1 SV=4 | 692 | E | 0.451433 | D | 0.425359 | 0.026074 | No Change: Both O | - |
| P35251 | RFC1_HUMAN Replication factor C subunit 1 OS=Homo sapiens GN=RFC1 PE=1 SV=4 | 955 | Q | 0.205751 | K | 0.240458 | -0.034707 | No Change: Both O | - |
| P35251 | RFC1_HUMAN Replication factor C subunit 1 OS=Homo sapiens GN=RFC1 PE=1 SV=4 | 1146 | S | 0.999866 | L | 0.999671 | 1.95E-04 | No Change: Both D | - |
| P35250 | RFC2_HUMAN Replication factor C subunit 2 OS=Homo sapiens GN=RFC2 PE=1 SV=3 | 232 | A | 0.427761 | V | 0.334225 | 0.093536 | No Change: Both O | - |
| P40938 | RFC3_HUMAN Replication factor C subunit 3 OS=Homo sapiens GN=RFC3 PE=1 SV=2 | 16 | L | 0.336736 | V | 0.322865 | 0.013871 | No Change: Both O | - |
| P35249 | RFC4_HUMAN Replication factor C subunit 4 OS=Homo sapiens GN=RFC4 PE=1 SV=2 | 292 | V | 0.254294 | A | 0.326996 | -0.072702 | No Change: Both O | - |
| P35249 | RFC4_HUMAN Replication factor C subunit 4 OS=Homo sapiens GN=RFC4 PE=1 SV=2 | 354 | T | 0.180211 | S | 0.280083 | -0.099872 | No Change: Both O | A breast cancer sample |
| P40937 | RFC5_HUMAN Replication factor C subunit 5 OS=Homo sapiens GN=RFC5 PE=1 SV=1 | 13 | A | 0.575865 | T | 0.615005 | -0.03914 | No Change: Both D | - |
| O75677 | RFPL1_HUMAN Ret finger protein-like 1 OS=Homo sapiens GN=RFPL1 PE=2 SV=2 | 127 | M | 0.412251 | T | 0.436945 | -0.024694 | No Change: Both O | - |
| O75677 | RFPL1_HUMAN Ret finger protein-like 1 OS=Homo sapiens GN=RFPL1 PE=2 SV=2 | 94 | W | 0.631587 | R | 0.821052 | -0.189465 | No Change: Both D | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 119 | A | 0.449545 | T | 0.435601 | 0.013944 | No Change: Both O | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 141 | C | 0.664418 | Y | 0.517681 | 0.146737 | No Change: Both D | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 215 | Q | 0.568102 | H | 0.527558 | 0.040544 | No Change: Both D | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 290 | T | 0.247589 | S | 0.311849 | -0.06426 | No Change: Both O | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 324 | S | 0.450718 | G | 0.394678 | 0.05604 | No Change: Both O | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 341 | R | 0.538518 | C | 0.42496 | 0.113558 | D to O | - |
| O75678 | RFPL2_HUMAN Ret finger protein-like 2 OS=Homo sapiens GN=RFPL2 PE=2 SV=3 | 348 | V | 0.590404 | I | 0.544461 | 0.045943 | No Change: Both D | - |
| O75679 | RFPL3_HUMAN Ret finger protein-like 3 OS=Homo sapiens GN=RFPL3 PE=2 SV=2 | 83 | M | 0.595932 | T | 0.607952 | -0.01202 | No Change: Both D | - |
| O75679 | RFPL3_HUMAN Ret finger protein-like 3 OS=Homo sapiens GN=RFPL3 PE=2 SV=2 | 110 | L | 0.6647 | M | 0.725988 | -0.061288 | No Change: Both D | - |
| O75679 | RFPL3_HUMAN Ret finger protein-like 3 OS=Homo sapiens GN=RFPL3 PE=2 SV=2 | 126 | D | 0.407058 | N | 0.379894 | 0.027164 | No Change: Both O | - |
| O75679 | RFPL3_HUMAN Ret finger protein-like 3 OS=Homo sapiens GN=RFPL3 PE=2 SV=2 | 181 | Y | 0.129872 | C | 0.123662 | 0.00621 | No Change: Both O | - |
| Q6ZWI9 | RFPLB_HUMAN Ret finger protein-like 4B OS=Homo sapiens GN=RFPL4B PE=2 SV=2 | 234 | G | 0.084787 | D | 0.102521 | -0.017734 | No Change: Both O | - |
| Q96AA3 | RFT1_HUMAN Protein RFT1 homolog OS=Homo sapiens GN=RFT1 PE=1 SV=1 | 185 | A | 0.033005 | T | 0.041888 | -0.008883 | No Change: Both O | - |
| Q96AA3 | RFT1_HUMAN Protein RFT1 homolog OS=Homo sapiens GN=RFT1 PE=1 SV=1 | 67 | R | 0.195205 | C | 0.093995 | 0.10121 | No Change: Both O | Congenital disorder of glycosylation type 1N (CDG1N) [MIM:612015] |
| Q96AA3 | RFT1_HUMAN Protein RFT1 homolog OS=Homo sapiens GN=RFT1 PE=1 SV=1 | 152 | K | 0.180278 | E | 0.180354 | -7.60E-05 | No Change: Both O | Congenital disorder of glycosylation type 1N (CDG1N) [MIM:612015] |
| Q96AA3 | RFT1_HUMAN Protein RFT1 homolog OS=Homo sapiens GN=RFT1 PE=1 SV=1 | 298 | E | 0.102818 | K | 0.098078 | 0.00474 | No Change: Both O | Congenital disorder of glycosylation type 1N (CDG1N) [MIM:612015] |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 74 | I | 0.064104 | M | 0.091377 | -0.027273 | No Change: Both O | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 174 | D | 0.566881 | G | 0.557472 | 0.009409 | No Change: Both D | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 267 | P | 0.559491 | L | 0.430618 | 0.128873 | D to O | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 278 | T | 0.641776 | M | 0.600005 | 0.041771 | No Change: Both D | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 303 | I | 0.027503 | V | 0.03714 | -0.009637 | No Change: Both O | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 36 | E | 0.174991 | K | 0.164294 | 0.010697 | No Change: Both O | Brown-Vialetto-Van Laere syndrome (BVVLS) [MIM:211530] |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 132 | R | 0.151804 | W | 0.061241 | 0.090563 | No Change: Both O | Brown-Vialetto-Van Laere syndrome (BVVLS) [MIM:211530] |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 224 | F | 0.043584 | L | 0.051944 | -0.00836 | No Change: Both O | Brown-Vialetto-Van Laere syndrome (BVVLS) [MIM:211530] |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 350 | L | 0.185762 | M | 0.232063 | -0.046301 | No Change: Both O | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 411 | S | 0.059214 | R | 0.040247 | 0.018967 | No Change: Both O | - |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 413 | V | 0.074284 | A | 0.095712 | -0.021428 | No Change: Both O | Brown-Vialetto-Van Laere syndrome (BVVLS) [MIM:211530] |
| Q9NQ40 | RFT2_HUMAN Riboflavin transporter 2 OS=Homo sapiens GN=RFT2 PE=1 SV=4 | 457 | F | 0.110382 | L | 0.129726 | -0.019344 | No Change: Both O | Brown-Vialetto-Van Laere syndrome (BVVLS) [MIM:211530] |
| Q14699 | RFTN1_HUMAN Raftlin OS=Homo sapiens GN=RFTN1 PE=1 SV=4 | 248 | E | 0.982961 | K | 0.98096 | 0.002001 | No Change: Both D | - |
| Q14699 | RFTN1_HUMAN Raftlin OS=Homo sapiens GN=RFTN1 PE=1 SV=4 | 421 | V | 0.567823 | I | 0.539752 | 0.028071 | No Change: Both D | - |
| Q6PCD5 | RFWD3_HUMAN E3 ubiquitin-protein ligase RFWD3 OS=Homo sapiens GN=RFWD3 PE=1 SV=3 | 90 | T | 0.744734 | N | 0.760484 | -0.01575 | No Change: Both D | - |
| Q6PCD5 | RFWD3_HUMAN E3 ubiquitin-protein ligase RFWD3 OS=Homo sapiens GN=RFWD3 PE=1 SV=3 | 392 | R | 0.851525 | K | 0.861926 | -0.010401 | No Change: Both D | - |
| Q6PCD5 | RFWD3_HUMAN E3 ubiquitin-protein ligase RFWD3 OS=Homo sapiens GN=RFWD3 PE=1 SV=3 | 564 | I | 0.117756 | V | 0.145456 | -0.0277 | No Change: Both O | - |
| Q6PCD5 | RFWD3_HUMAN E3 ubiquitin-protein ligase RFWD3 OS=Homo sapiens GN=RFWD3 PE=1 SV=3 | 770 | I | 0.437429 | T | 0.611794 | -0.174365 | O to D | - |
| P22670 | RFX1_HUMAN MHC class II regulatory factor RFX1 OS=Homo sapiens GN=RFX1 PE=1 SV=2 | 370 | T | 0.992536 | A | 0.992219 | 3.17E-04 | No Change: Both D | - |
| P48378 | RFX2_HUMAN DNA-binding protein RFX2 OS=Homo sapiens GN=RFX2 PE=2 SV=2 | 37 | A | 0.966648 | G | 0.96535 | 0.001298 | No Change: Both D | A breast cancer sample |
| P48378 | RFX2_HUMAN DNA-binding protein RFX2 OS=Homo sapiens GN=RFX2 PE=2 SV=2 | 110 | E | 0.674761 | K | 0.654643 | 0.020118 | No Change: Both D | A breast cancer sample |
| P48378 | RFX2_HUMAN DNA-binding protein RFX2 OS=Homo sapiens GN=RFX2 PE=2 SV=2 | 86 | A | 0.323716 | T | 0.352645 | -0.028929 | No Change: Both O | - |
| P48378 | RFX2_HUMAN DNA-binding protein RFX2 OS=Homo sapiens GN=RFX2 PE=2 SV=2 | 610 | R | 0.246546 | Q | 0.276296 | -0.02975 | No Change: Both O | - |
| Q33E94 | RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens GN=RFX4 PE=1 SV=2 | 687 | S | 0.835584 | N | 0.800113 | 0.035471 | No Change: Both D | - |
| Q33E94 | RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens GN=RFX4 PE=1 SV=2 | 698 | S | 0.693599 | A | 0.597989 | 0.09561 | No Change: Both D | - |
| P48382 | RFX5_HUMAN DNA-binding protein RFX5 OS=Homo sapiens GN=RFX5 PE=1 SV=1 | 149 | R | 0.396937 | Q | 0.39001 | 0.006927 | No Change: Both O | Bare lymphocyte syndrome type 2 (BLS2) [MIM:209920] |
| P48382 | RFX5_HUMAN DNA-binding protein RFX5 OS=Homo sapiens GN=RFX5 PE=1 SV=1 | 197 | R | 0.649415 | Q | 0.629308 | 0.020107 | No Change: Both D | - |
| P48382 | RFX5_HUMAN DNA-binding protein RFX5 OS=Homo sapiens GN=RFX5 PE=1 SV=1 | 409 | P | 0.941407 | R | 0.92961 | 0.011797 | No Change: Both D | - |
| P48382 | RFX5_HUMAN DNA-binding protein RFX5 OS=Homo sapiens GN=RFX5 PE=1 SV=1 | 499 | P | 0.956081 | S | 0.959803 | -0.003722 | No Change: Both D | - |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 6 | E | 0.67874 | K | 0.682107 | -0.003367 | No Change: Both D | - |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 688 | T | 0.618165 | A | 0.585838 | 0.032327 | No Change: Both D | - |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 743 | S | 0.760136 | N | 0.695951 | 0.064185 | No Change: Both D | - |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 17 | A | 0.568325 | E | 0.669627 | -0.101302 | No Change: Both D | - |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 181 | R | 0.41927 | Q | 0.417243 | 0.002027 | No Change: Both O | The Mitchell-Riley syndrome (MIRIS) [MIM:601346] |
| Q8HWS3 | RFX6_HUMAN DNA-binding protein RFX6 OS=Homo sapiens GN=RFX6 PE=1 SV=2 | 217 | S | 0.643355 | P | 0.591823 | 0.051532 | No Change: Both D | The Mitchell-Riley syndrome (MIRIS) [MIM:601346] |
| Q2KHR2 | RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7 PE=1 SV=1 | 434 | G | 0.97163 | V | 0.962972 | 0.008658 | No Change: Both D | - |
| Q2KHR2 | RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7 PE=1 SV=1 | 677 | V | 0.720433 | L | 0.73412 | -0.013687 | No Change: Both D | - |
| Q2KHR2 | RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens GN=RFX7 PE=1 SV=1 | 1256 | L | 0.829735 | P | 0.874062 | -0.044327 | No Change: Both D | - |
| O14593 | RFXK_HUMAN DNA-binding protein RFXANK OS=Homo sapiens GN=RFXANK PE=1 SV=2 | 195 | L | 0.150872 | P | 0.279933 | -0.129061 | No Change: Both O | Bare lymphocyte syndrome type 2 (BLS2) [MIM:209920] |
| O14593 | RFXK_HUMAN DNA-binding protein RFXANK OS=Homo sapiens GN=RFXANK PE=1 SV=2 | 251 | Q | 0.189376 | E | 0.233148 | -0.043772 | No Change: Both O | - |
| O14593 | RFXK_HUMAN DNA-binding protein RFXANK OS=Homo sapiens GN=RFXANK PE=1 SV=2 | 48 | E | 0.933795 | D | 0.929968 | 0.003827 | No Change: Both D | - |
| Q7L0Y3 | MRRP1_HUMAN Mitochondrial ribonuclease P protein 1 OS=Homo sapiens GN=RG9MTD1 PE=1 SV=2 | 56 | P | 0.842738 | R | 0.817947 | 0.024791 | No Change: Both D | - |
| Q7L0Y3 | MRRP1_HUMAN Mitochondrial ribonuclease P protein 1 OS=Homo sapiens GN=RG9MTD1 PE=1 SV=2 | 164 | K | 0.690363 | N | 0.639776 | 0.050587 | No Change: Both D | - |
| Q8TBZ6 | RG9D2_HUMAN RNA (guanine-9-)-methyltransferase domain-containing protein 2 OS=Homo sapiens GN=RG9MTD2 PE=2 SV=1 | 82 | P | 0.872483 | Q | 0.885298 | -0.012815 | No Change: Both D | A breast cancer sample |
| Q8TBZ6 | RG9D2_HUMAN RNA (guanine-9-)-methyltransferase domain-containing protein 2 OS=Homo sapiens GN=RG9MTD2 PE=2 SV=1 | 133 | R | 0.290436 | Q | 0.306655 | -0.016219 | No Change: Both O | - |
| Q6PF06 | RG9D3_HUMAN RNA (guanine-9-)-methyltransferase domain-containing protein 3 OS=Homo sapiens GN=RG9MTD3 PE=2 SV=1 | 234 | V | 0.197372 | G | 0.315279 | -0.117907 | No Change: Both O | - |
| Q6PF06 | RG9D3_HUMAN RNA (guanine-9-)-methyltransferase domain-containing protein 3 OS=Homo sapiens GN=RG9MTD3 PE=2 SV=1 | 242 | V | 0.393744 | A | 0.474152 | -0.080408 | No Change: Both O | - |
| Q8NET4 | RGAG1_HUMAN Retrotransposon gag domain-containing protein 1 OS=Homo sapiens GN=RGAG1 PE=1 SV=1 | 777 | P | 0.984908 | S | 0.985561 | -6.53E-04 | No Change: Both D | - |
| Q5HYW3 | RGAG4_HUMAN Retrotransposon gag domain-containing protein 4 OS=Homo sapiens GN=RGAG4 PE=2 SV=1 | 420 | S | 0.999775 | R | 0.999794 | -1.90E-05 | No Change: Both D | - |
| Q9NZL6 | RGL1_HUMAN Ral guanine nucleotide dissociation stimulator-like 1 OS=Homo sapiens GN=RGL1 PE=1 SV=1 | 174 | Y | 0.381931 | S | 0.603846 | -0.221915 | O to D | A breast cancer sample |
| Q9NZL6 | RGL1_HUMAN Ral guanine nucleotide dissociation stimulator-like 1 OS=Homo sapiens GN=RGL1 PE=1 SV=1 | 699 | V | 0.322569 | M | 0.38127 | -0.058701 | No Change: Both O | A breast cancer sample |
| O15211 | RGL2_HUMAN Ral guanine nucleotide dissociation stimulator-like 2 OS=Homo sapiens GN=RGL2 PE=1 SV=1 | 598 | P | 0.995683 | L | 0.992534 | 0.003149 | No Change: Both D | - |
| O15211 | RGL2_HUMAN Ral guanine nucleotide dissociation stimulator-like 2 OS=Homo sapiens GN=RGL2 PE=1 SV=1 | 705 | G | 0.319142 | E | 0.399872 | -0.08073 | No Change: Both O | - |
| Q3MIN7 | RGL3_HUMAN Ral guanine nucleotide dissociation stimulator-like 3 OS=Homo sapiens GN=RGL3 PE=1 SV=2 | 162 | P | 0.657459 | H | 0.643962 | 0.013497 | No Change: Both D | - |
| Q3MIN7 | RGL3_HUMAN Ral guanine nucleotide dissociation stimulator-like 3 OS=Homo sapiens GN=RGL3 PE=1 SV=2 | 164 | A | 0.597979 | V | 0.547496 | 0.050483 | No Change: Both D | - |
| Q3MIN7 | RGL3_HUMAN Ral guanine nucleotide dissociation stimulator-like 3 OS=Homo sapiens GN=RGL3 PE=1 SV=2 | 615 | R | 0.594154 | C | 0.444997 | 0.149157 | D to O | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 24 | Q | 0.113566 | R | 0.099808 | 0.013758 | No Change: Both O | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 241 | H | 0.052398 | Y | 0.029057 | 0.023341 | No Change: Both O | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 342 | M | 0.648966 | R | 0.681999 | -0.033033 | No Change: Both D | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 378 | V | 0.611305 | A | 0.670847 | -0.059542 | No Change: Both D | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 37 | R | 0.262606 | C | 0.145912 | 0.116694 | No Change: Both O | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 216 | T | 0.667569 | M | 0.665174 | 0.002395 | No Change: Both D | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 297 | E | 0.155684 | K | 0.161718 | -0.006034 | No Change: Both O | - |
| Q8IZJ4 | RGDSR_HUMAN Ral-GDS-related protein OS=Homo sapiens GN=RGL4 PE=2 SV=1 | 358 | D | 0.559918 | V | 0.450484 | 0.109434 | D to O | - |
| Q96B86 | RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens GN=RGMA PE=1 SV=3 | 431 | A | 0.458005 | V | 0.338308 | 0.119697 | No Change: Both O | - |
| Q96B86 | RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens GN=RGMA PE=1 SV=3 | 415 | D | 0.430101 | E | 0.429711 | 3.90E-04 | No Change: Both O | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 98 | R | 0.104977 | M | 0.086082 | 0.018895 | No Change: Both O | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 225 | W | 0.413739 | R | 0.648743 | -0.235004 | O to D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 284 | P | 0.596521 | Q | 0.549004 | 0.047517 | No Change: Both D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 544 | S | 0.935226 | L | 0.883143 | 0.052083 | No Change: Both D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 585 | R | 0.900254 | K | 0.899035 | 0.001219 | No Change: Both D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 780 | H | 0.982261 | N | 0.982991 | -7.30E-04 | No Change: Both D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 1548 | P | 0.521773 | S | 0.534917 | -0.013144 | No Change: Both D | - |
| Q8N1W1 | RGNEF_HUMAN Rho-guanine nucleotide exchange factor OS=Homo sapiens GN=RGNEF PE=1 SV=3 | 1640 | H | 0.805287 | Q | 0.823613 | -0.018326 | No Change: Both D | - |
| P47804 | RGR_HUMAN RPE-retinal G protein-coupled receptor OS=Homo sapiens GN=RGR PE=1 SV=1 | 66 | S | 0.269417 | R | 0.199522 | 0.069895 | No Change: Both O | Retinitis pigmentosa type 44 (RP44) [MIM:613769] |
| P47804 | RGR_HUMAN RPE-retinal G protein-coupled receptor OS=Homo sapiens GN=RGR PE=1 SV=1 | 132 | V | 0.039215 | L | 0.039597 | -3.82E-04 | No Change: Both O | - |
| P47804 | RGR_HUMAN RPE-retinal G protein-coupled receptor OS=Homo sapiens GN=RGR PE=1 SV=1 | 152 | H | 0.152003 | N | 0.166415 | -0.014412 | No Change: Both O | - |
| P47804 | RGR_HUMAN RPE-retinal G protein-coupled receptor OS=Homo sapiens GN=RGR PE=1 SV=1 | 241 | S | 0.245119 | F | 0.094846 | 0.150273 | No Change: Both O | - |
| P47804 | RGR_HUMAN RPE-retinal G protein-coupled receptor OS=Homo sapiens GN=RGR PE=1 SV=1 | 234 | A | 0.027828 | T | 0.031116 | -0.003288 | No Change: Both O | - |
| O43665 | RGS10_HUMAN Regulator of G-protein signaling 10 OS=Homo sapiens GN=RGS10 PE=1 SV=2 | 94 | A | 0.684167 | V | 0.653523 | 0.030644 | No Change: Both D | - |
| O94810 | RGS11_HUMAN Regulator of G-protein signaling 11 OS=Homo sapiens GN=RGS11 PE=1 SV=2 | 427 | M | 0.436807 | T | 0.443897 | -0.00709 | No Change: Both O | - |
| O94810 | RGS11_HUMAN Regulator of G-protein signaling 11 OS=Homo sapiens GN=RGS11 PE=1 SV=2 | 351 | V | 0.147315 | M | 0.173546 | -0.026231 | No Change: Both O | - |
| O14924 | RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens GN=RGS12 PE=1 SV=1 | 1124 | N | 0.918587 | S | 0.936182 | -0.017595 | No Change: Both D | - |
| O14924 | RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens GN=RGS12 PE=1 SV=1 | 225 | I | 0.141255 | V | 0.155751 | -0.014496 | No Change: Both O | - |
| O14924 | RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens GN=RGS12 PE=1 SV=1 | 277 | M | 0.196063 | L | 0.150668 | 0.045395 | No Change: Both O | - |
| O14921 | RGS13_HUMAN Regulator of G-protein signaling 13 OS=Homo sapiens GN=RGS13 PE=1 SV=1 | 150 | L | 0.615712 | F | 0.589744 | 0.025968 | No Change: Both D | - |
| O15492 | RGS16_HUMAN Regulator of G-protein signaling 16 OS=Homo sapiens GN=RGS16 PE=1 SV=2 | 137 | H | 0.48394 | R | 0.508768 | -0.024828 | O to D | - |
| Q8NE09 | RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens GN=RGS22 PE=2 SV=3 | 397 | R | 0.659376 | M | 0.587138 | 0.072238 | No Change: Both D | - |
| Q8NE09 | RGS22_HUMAN Regulator of G-protein signaling 22 OS=Homo sapiens GN=RGS22 PE=2 SV=3 | 943 | H | 0.204251 | Y | 0.12596 | 0.078291 | No Change: Both O | - |
| P49796 | RGS3_HUMAN Regulator of G-protein signaling 3 OS=Homo sapiens GN=RGS3 PE=1 SV=2 | 129 | R | 0.540857 | K | 0.603845 | -0.062988 | No Change: Both D | - |
| P49796 | RGS3_HUMAN Regulator of G-protein signaling 3 OS=Homo sapiens GN=RGS3 PE=1 SV=2 | 809 | R | 0.959303 | Q | 0.970736 | -0.011433 | No Change: Both D | - |
| P49798 | RGS4_HUMAN Regulator of G-protein signaling 4 OS=Homo sapiens GN=RGS4 PE=1 SV=1 | 195 | A | 0.749565 | S | 0.833568 | -0.084003 | No Change: Both D | - |
| P49802 | RGS7_HUMAN Regulator of G-protein signaling 7 OS=Homo sapiens GN=RGS7 PE=1 SV=3 | 137 | M | 0.282533 | L | 0.244892 | 0.037641 | No Change: Both O | - |
| P49802 | RGS7_HUMAN Regulator of G-protein signaling 7 OS=Homo sapiens GN=RGS7 PE=1 SV=3 | 409 | Q | 0.627723 | H | 0.619635 | 0.008088 | No Change: Both D | - |
| Q6MZT1 | R7BP_HUMAN Regulator of G-protein signaling 7-binding protein OS=Homo sapiens GN=RGS7BP PE=2 SV=3 | 255 | I | 0.50102 | V | 0.571063 | -0.070043 | No Change: Both D | - |
| O75916 | RGS9_HUMAN Regulator of G-protein signaling 9 OS=Homo sapiens GN=RGS9 PE=1 SV=1 | 299 | W | 0.134948 | R | 0.305366 | -0.170418 | No Change: Both O | Prolonged electroretinal response suppression (PERRS) [MIM:608415] |
| O75916 | RGS9_HUMAN Regulator of G-protein signaling 9 OS=Homo sapiens GN=RGS9 PE=1 SV=1 | 258 | S | 0.514563 | L | 0.290899 | 0.223664 | D to O | - |
| Q6ZS82 | R9BP_HUMAN Regulator of G-protein signaling 9-binding protein OS=Homo sapiens GN=RGS9BP PE=2 SV=1 | 96 | A | 0.388314 | S | 0.455554 | -0.06724 | No Change: Both O | - |
| A5PLK6 | RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens GN=RGSL1 PE=2 SV=1 | 5 | E | 0.737656 | D | 0.721252 | 0.016404 | No Change: Both D | - |
| A5PLK6 | RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens GN=RGSL1 PE=2 SV=1 | 256 | W | 0.466575 | C | 0.568182 | -0.101607 | O to D | - |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 79 | S | 0.154488 | N | 0.129644 | 0.024844 | No Change: Both O | Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150] |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 270 | V | 0.239814 | I | 0.22329 | 0.016524 | No Change: Both O | Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150] |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 279 | G | 0.209793 | E | 0.235269 | -0.025476 | No Change: Both O | Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150] |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 280 | G | 0.20017 | R | 0.174938 | 0.025232 | No Change: Both O | Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150] |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 380 | G | 0.103571 | V | 0.057031 | 0.04654 | No Change: Both O | Regulator type Rh-null hemolytic anemia (RHN) [MIM:268150] |
| Q02094 | RHAG_HUMAN Ammonium transporter Rh type A OS=Homo sapiens GN=RHAG PE=1 SV=2 | 242 | N | 0.059429 | D | 0.066316 | -0.006887 | No Change: Both O | - |
| Q8TEB9 | RHBD1_HUMAN Rhomboid domain-containing protein 1 OS=Homo sapiens GN=RHBDD1 PE=2 SV=1 | 110 | A | 0.0339 | T | 0.040089 | -0.006189 | No Change: Both O | - |
| Q6NTF9 | RHBD2_HUMAN Rhomboid domain-containing protein 2 OS=Homo sapiens GN=RHBDD2 PE=2 SV=2 | 85 | R | 0.0273 | H | 0.025994 | 0.001306 | No Change: Both O | - |
| Q9Y3P4 | RHBD3_HUMAN Rhomboid domain-containing protein 3 OS=Homo sapiens GN=RHBDD3 PE=2 SV=1 | 86 | T | 0.165351 | M | 0.138707 | 0.026644 | No Change: Both O | - |
| Q9Y3P4 | RHBD3_HUMAN Rhomboid domain-containing protein 3 OS=Homo sapiens GN=RHBDD3 PE=2 SV=1 | 227 | H | 0.527118 | R | 0.599847 | -0.072729 | No Change: Both D | - |
| Q96CC6 | RHDF1_HUMAN Inactive rhomboid protein 1 OS=Homo sapiens GN=RHBDF1 PE=1 SV=2 | 265 | R | 0.666177 | W | 0.468736 | 0.197441 | D to O | - |
| Q6PJF5 | RHDF2_HUMAN Inactive rhomboid protein 2 OS=Homo sapiens GN=RHBDF2 PE=1 SV=2 | 208 | P | 0.884261 | L | 0.800834 | 0.083427 | No Change: Both D | - |
| Q6PJF5 | RHDF2_HUMAN Inactive rhomboid protein 2 OS=Homo sapiens GN=RHBDF2 PE=1 SV=2 | 249 | A | 0.459098 | T | 0.460824 | -0.001726 | No Change: Both O | - |
| Q6PJF5 | RHDF2_HUMAN Inactive rhomboid protein 2 OS=Homo sapiens GN=RHBDF2 PE=1 SV=2 | 528 | D | 0.711172 | Y | 0.498375 | 0.212797 | D to O | - |
| Q9NX52 | RHBL2_HUMAN Rhomboid-related protein 2 OS=Homo sapiens GN=RHBDL2 PE=1 SV=2 | 273 | L | 0.127881 | M | 0.156442 | -0.028561 | No Change: Both O | - |
| P58872 | RHBL3_HUMAN Rhomboid-related protein 3 OS=Homo sapiens GN=RHBDL3 PE=2 SV=1 | 255 | V | 0.06467 | M | 0.077525 | -0.012855 | No Change: Both O | - |
| Q9H310 | RHBG_HUMAN Ammonium transporter Rh type B OS=Homo sapiens GN=RHBG PE=1 SV=2 | 76 | G | 0.028516 | D | 0.030304 | -0.001788 | No Change: Both O | - |
| Q9H310 | RHBG_HUMAN Ammonium transporter Rh type B OS=Homo sapiens GN=RHBG PE=1 SV=2 | 143 | V | 0.183483 | D | 0.320758 | -0.137275 | No Change: Both O | - |
| Q9H310 | RHBG_HUMAN Ammonium transporter Rh type B OS=Homo sapiens GN=RHBG PE=1 SV=2 | 315 | G | 0.173783 | R | 0.150899 | 0.022884 | No Change: Both O | - |
| Q9H310 | RHBG_HUMAN Ammonium transporter Rh type B OS=Homo sapiens GN=RHBG PE=1 SV=2 | 339 | C | 0.26525 | R | 0.445012 | -0.179762 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 16 | W | 0.05041 | C | 0.067913 | -0.017503 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 36 | A | 0.298909 | T | 0.343776 | -0.044867 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 41 | Q | 0.5819 | R | 0.551506 | 0.030394 | No Change: Both D | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 60 | L | 0.102183 | I | 0.080341 | 0.021842 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 68 | N | 0.331868 | S | 0.405026 | -0.073158 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 103 | P | 0.219033 | S | 0.243108 | -0.024075 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 226 | P | 0.346477 | A | 0.251708 | 0.094769 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 245 | L | 0.07333 | V | 0.082274 | -0.008944 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 154 | R | 0.088196 | T | 0.091141 | -0.002945 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 233 | Q | 0.406009 | E | 0.456854 | -0.050845 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 238 | M | 0.20995 | V | 0.169955 | 0.039995 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 127 | A | 0.193003 | V | 0.142258 | 0.050745 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 128 | G | 0.171986 | D | 0.180233 | -0.008247 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 182 | T | 0.021275 | S | 0.031156 | -0.009881 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 198 | N | 0.734856 | K | 0.777722 | -0.042866 | No Change: Both D | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 323 | H | 0.133563 | P | 0.143829 | -0.010266 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 325 | I | 0.177315 | S | 0.393765 | -0.21645 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 329 | H | 0.187955 | D | 0.20295 | -0.014995 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 329 | H | 0.187955 | R | 0.171606 | 0.016349 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 330 | S | 0.171262 | Y | 0.069423 | 0.101839 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 331 | I | 0.167622 | N | 0.310204 | -0.142582 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 263 | R | 0.566448 | G | 0.587827 | -0.021379 | No Change: Both D | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 267 | M | 0.346067 | K | 0.496516 | -0.150449 | No Change: Both O | - |
| P18577 | RHCE_HUMAN Blood group Rh(CE) polypeptide OS=Homo sapiens GN=RHCE PE=1 SV=2 | 398 | V | 0.14245 | E | 0.293477 | -0.151027 | No Change: Both O | - |
| Q9UBD6 | RHCG_HUMAN Ammonium transporter Rh type C OS=Homo sapiens GN=RHCG PE=1 SV=1 | 202 | R | 0.346718 | C | 0.18454 | 0.162178 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 110 | L | 0.061752 | P | 0.124083 | -0.062331 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 218 | M | 0.034941 | I | 0.020448 | 0.014493 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 223 | F | 0.123819 | V | 0.130345 | -0.006526 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 233 | E | 0.395298 | Q | 0.343208 | 0.05209 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 238 | V | 0.188344 | M | 0.227286 | -0.038942 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 245 | V | 0.075478 | L | 0.066262 | 0.009216 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 16 | W | 0.05041 | C | 0.067913 | -0.017503 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 193 | E | 0.671724 | K | 0.675526 | -0.003802 | No Change: Both D | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 201 | T | 0.650121 | R | 0.642754 | 0.007367 | No Change: Both D | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 103 | S | 0.245366 | C | 0.087122 | 0.158244 | No Change: Both O | A breast cancer sample |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 263 | G | 0.664399 | R | 0.644443 | 0.019956 | No Change: Both D | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 306 | V | 0.169739 | I | 0.15231 | 0.017429 | No Change: Both O | - |
| Q02161 | RHD_HUMAN Blood group Rh(D) polypeptide OS=Homo sapiens GN=RHD PE=1 SV=3 | 311 | Y | 0.151179 | C | 0.134277 | 0.016902 | No Change: Both O | - |
| Q15382 | RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens GN=RHEB PE=1 SV=1 | 139 | E | 0.333838 | K | 0.325512 | 0.008326 | No Change: Both O | A colorectal cancer sample |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 4 | T | 0.713814 | K | 0.713938 | -1.24E-04 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 15 | N | 0.25793 | S | 0.3074 | -0.04947 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 17 | T | 0.288078 | M | 0.248252 | 0.039826 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 23 | P | 0.296882 | H | 0.250118 | 0.046764 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 23 | P | 0.296882 | L | 0.153403 | 0.143479 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 28 | Q | 0.198636 | H | 0.182519 | 0.016117 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 40 | L | 0.048696 | R | 0.080142 | -0.031446 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 44 | M | 0.016917 | T | 0.019715 | -0.002798 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 45 | F | 0.015314 | L | 0.018699 | -0.003385 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 46 | L | 0.013636 | R | 0.022373 | -0.008737 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 51 | G | 0.017428 | A | 0.013317 | 0.004111 | No Change: Both O | - |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 51 | G | 0.017428 | R | 0.016338 | 0.00109 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 51 | G | 0.017428 | V | 0.009576 | 0.007852 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 53 | P | 0.022892 | R | 0.019008 | 0.003884 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 58 | T | 0.040366 | R | 0.040129 | 2.37E-04 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 87 | V | 0.067284 | D | 0.142885 | -0.075601 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 89 | G | 0.105071 | D | 0.115993 | -0.010922 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 90 | G | 0.12385 | D | 0.134771 | -0.010921 | No Change: Both O | Congenital stationary night blindness autosomal dominant type 1 (CSNBAD1) [MIM:610445] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 94 | T | 0.255178 | I | 0.13368 | 0.121498 | No Change: Both O | Congenital stationary night blindness autosomal dominant type 1 (CSNBAD1) [MIM:610445] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 104 | V | 0.101776 | I | 0.088505 | 0.013271 | No Change: Both O | - |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 106 | G | 0.131766 | R | 0.11254 | 0.019226 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 106 | G | 0.131766 | W | 0.043931 | 0.087835 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 109 | G | 0.143596 | R | 0.123218 | 0.020378 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 110 | C | 0.133393 | F | 0.158332 | -0.024939 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 110 | C | 0.133393 | Y | 0.169608 | -0.036215 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 114 | G | 0.161852 | D | 0.164633 | -0.002781 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 125 | L | 0.044838 | R | 0.072335 | -0.027497 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 127 | S | 0.030479 | F | 0.010467 | 0.020012 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 131 | L | 0.021093 | P | 0.042558 | -0.021465 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 135 | R | 0.036878 | G | 0.039316 | -0.002438 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 135 | R | 0.036878 | L | 0.021935 | 0.014943 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 135 | R | 0.036878 | W | 0.013711 | 0.023167 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 140 | C | 0.104196 | S | 0.277067 | -0.172871 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 150 | E | 0.330229 | K | 0.339059 | -0.00883 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 164 | A | 0.035016 | E | 0.051774 | -0.016758 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 164 | A | 0.035016 | V | 0.022731 | 0.012285 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 167 | C | 0.071019 | R | 0.146416 | -0.075397 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 171 | P | 0.162739 | L | 0.082076 | 0.080663 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 171 | P | 0.162739 | Q | 0.141389 | 0.02135 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 171 | P | 0.162739 | S | 0.181424 | -0.018685 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 178 | Y | 0.171613 | C | 0.144558 | 0.027055 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 178 | Y | 0.171613 | N | 0.292483 | -0.12087 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 181 | E | 0.183223 | K | 0.184546 | -0.001323 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 182 | G | 0.178727 | S | 0.224575 | -0.045848 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 186 | S | 0.099266 | P | 0.092779 | 0.006487 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 188 | G | 0.092298 | E | 0.118263 | -0.025965 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 188 | G | 0.092298 | R | 0.083044 | 0.009254 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 190 | D | 0.09071 | N | 0.085598 | 0.005112 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 190 | D | 0.09071 | G | 0.085118 | 0.005592 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 190 | D | 0.09071 | Y | 0.04762 | 0.04309 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 207 | M | 0.025907 | R | 0.034198 | -0.008291 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 209 | V | 0.017619 | M | 0.023721 | -0.006102 | No Change: Both O | - |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 211 | H | 0.016457 | P | 0.021132 | -0.004675 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 211 | H | 0.016457 | R | 0.01623 | 2.27E-04 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 216 | M | 0.013905 | K | 0.024899 | -0.010994 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 220 | F | 0.009081 | C | 0.008845 | 2.36E-04 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 222 | C | 0.010509 | R | 0.021816 | -0.011307 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 267 | P | 0.011824 | L | 0.005634 | 0.00619 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 267 | P | 0.011824 | R | 0.009801 | 0.002023 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 292 | A | 0.091819 | E | 0.135719 | -0.0439 | No Change: Both O | Congenital stationary night blindness autosomal dominant type 1 (CSNBAD1) [MIM:610445] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 296 | K | 0.151487 | E | 0.151933 | -4.46E-04 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 297 | S | 0.151775 | R | 0.115963 | 0.035812 | No Change: Both O | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 342 | T | 0.77874 | M | 0.748396 | 0.030344 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 345 | V | 0.803202 | L | 0.809191 | -0.005989 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 345 | V | 0.803202 | M | 0.837199 | -0.033997 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 347 | P | 0.825503 | A | 0.813739 | 0.011764 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 347 | P | 0.825503 | L | 0.786927 | 0.038576 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 347 | P | 0.825503 | Q | 0.824939 | 5.64E-04 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 347 | P | 0.825503 | R | 0.811952 | 0.013551 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| P08100 | OPSD_HUMAN Rhodopsin OS=Homo sapiens GN=RHO PE=1 SV=1 | 347 | P | 0.825503 | S | 0.838013 | -0.01251 | No Change: Both D | Retinitis pigmentosa type 4 (RP4) [MIM:613731] |
| O94955 | RHBT3_HUMAN Rho-related BTB domain-containing protein 3 OS=Homo sapiens GN=RHOBTB3 PE=1 SV=2 | 21 | P | 0.478502 | R | 0.466823 | 0.011679 | No Change: Both O | - |
| O94955 | RHBT3_HUMAN Rho-related BTB domain-containing protein 3 OS=Homo sapiens GN=RHOBTB3 PE=1 SV=2 | 262 | N | 0.244273 | D | 0.251259 | -0.006986 | No Change: Both O | - |
| O94955 | RHBT3_HUMAN Rho-related BTB domain-containing protein 3 OS=Homo sapiens GN=RHOBTB3 PE=1 SV=2 | 20 | R | 0.494601 | Q | 0.51474 | -0.020139 | O to D | - |
| P08134 | RHOC_HUMAN Rho-related GTP-binding protein RhoC OS=Homo sapiens GN=RHOC PE=1 SV=1 | 120 | D | 0.601575 | H | 0.574889 | 0.026686 | No Change: Both D | - |
| O00212 | RHOD_HUMAN Rho-related GTP-binding protein RhoD OS=Homo sapiens GN=RHOD PE=1 SV=2 | 134 | C | 0.312959 | R | 0.46439 | -0.151431 | No Change: Both O | - |
| Q8IXI1 | MIRO2_HUMAN Mitochondrial Rho GTPase 2 OS=Homo sapiens GN=RHOT2 PE=1 SV=2 | 245 | R | 0.297798 | Q | 0.302288 | -0.00449 | No Change: Both O | - |
| Q8IXI1 | MIRO2_HUMAN Mitochondrial Rho GTPase 2 OS=Homo sapiens GN=RHOT2 PE=1 SV=2 | 425 | R | 0.301478 | C | 0.191938 | 0.10954 | No Change: Both O | - |
| Q7L0Q8 | RHOU_HUMAN Rho-related GTP-binding protein RhoU OS=Homo sapiens GN=RHOU PE=1 SV=1 | 121 | T | 0.069397 | A | 0.054755 | 0.014642 | No Change: Both O | - |
| Q8NHV9 | RHXF1_HUMAN Rhox homeobox family member 1 OS=Homo sapiens GN=RHOXF1 PE=2 SV=1 | 172 | R | 0.354836 | H | 0.342597 | 0.012239 | No Change: Both O | - |
| Q8IUC4 | RHPN2_HUMAN Rhophilin-2 OS=Homo sapiens GN=RHPN2 PE=1 SV=1 | 70 | R | 0.501781 | Q | 0.519376 | -0.017595 | No Change: Both D | - |
| Q8IUC4 | RHPN2_HUMAN Rhophilin-2 OS=Homo sapiens GN=RHPN2 PE=1 SV=1 | 342 | A | 0.104479 | P | 0.145144 | -0.040665 | No Change: Both O | - |
| Q9H4K1 | RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens GN=RIBC2 PE=2 SV=1 | 180 | R | 0.65126 | C | 0.544106 | 0.107154 | No Change: Both D | - |
| Q9H4K1 | RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens GN=RIBC2 PE=2 SV=1 | 195 | F | 0.582773 | L | 0.649055 | -0.066282 | No Change: Both D | - |
| Q9H4K1 | RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens GN=RIBC2 PE=2 SV=1 | 262 | R | 0.779891 | Q | 0.781121 | -0.00123 | No Change: Both D | - |
| Q7Z5B4 | RIC3_HUMAN Protein RIC-3 OS=Homo sapiens GN=RIC3 PE=1 SV=1 | 57 | P | 0.945155 | H | 0.931612 | 0.013543 | No Change: Both D | - |
| Q7Z5B4 | RIC3_HUMAN Protein RIC-3 OS=Homo sapiens GN=RIC3 PE=1 SV=1 | 346 | G | 0.694359 | V | 0.532225 | 0.162134 | No Change: Both D | A colorectal cancer sample |
| Q7Z5B4 | RIC3_HUMAN Protein RIC-3 OS=Homo sapiens GN=RIC3 PE=1 SV=1 | 130 | C | 0.441878 | Y | 0.513181 | -0.071303 | O to D | - |
| Q6R327 | RICTR_HUMAN Rapamycin-insensitive companion of mTOR OS=Homo sapiens GN=RICTOR PE=1 SV=1 | 837 | S | 0.305902 | F | 0.13903 | 0.166872 | No Change: Both O | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 836 | G | 0.21446 | S | 0.266674 | -0.052214 | No Change: Both O | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 1362 | V | 0.72235 | M | 0.769234 | -0.046884 | No Change: Both D | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 1686 | R | 0.688037 | G | 0.648064 | 0.039973 | No Change: Both D | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 1862 | V | 0.930698 | I | 0.925941 | 0.004757 | No Change: Both D | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 2021 | N | 0.959619 | Y | 0.91828 | 0.041339 | No Change: Both D | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 2165 | M | 0.773167 | R | 0.827787 | -0.05462 | No Change: Both D | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 2418 | L | 0.365167 | V | 0.315531 | 0.049636 | No Change: Both O | - |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 1784 | E | 0.664598 | K | 0.647258 | 0.01734 | No Change: Both D | A breast cancer sample |
| Q5UIP0 | RIF1_HUMAN Telomere-associated protein RIF1 OS=Homo sapiens GN=RIF1 PE=1 SV=2 | 1955 | D | 0.908303 | H | 0.872514 | 0.035789 | No Change: Both D | A breast cancer sample |
| Q96NA2 | RILP_HUMAN Rab-interacting lysosomal protein OS=Homo sapiens GN=RILP PE=1 SV=1 | 281 | R | 0.314448 | Q | 0.320592 | -0.006144 | No Change: Both O | - |
| Q96NA2 | RILP_HUMAN Rab-interacting lysosomal protein OS=Homo sapiens GN=RILP PE=1 SV=1 | 81 | A | 0.927756 | T | 0.911779 | 0.015977 | No Change: Both D | - |
| O15034 | RIMB2_HUMAN RIMS-binding protein 2 OS=Homo sapiens GN=RIMBP2 PE=1 SV=3 | 593 | P | 0.958025 | R | 0.944419 | 0.013606 | No Change: Both D | - |
| O15034 | RIMB2_HUMAN RIMS-binding protein 2 OS=Homo sapiens GN=RIMBP2 PE=1 SV=3 | 888 | D | 0.333 | N | 0.298893 | 0.034107 | No Change: Both O | - |
| Q9UFD9 | RIM3A_HUMAN RIMS-binding protein 3A OS=Homo sapiens GN=RIMBP3 PE=1 SV=3 | 1419 | R | 0.271982 | C | 0.152623 | 0.119359 | No Change: Both O | - |
| Q86UR5 | RIMS1_HUMAN Regulating synaptic membrane exocytosis protein 1 OS=Homo sapiens GN=RIMS1 PE=1 SV=1 | 820 | R | 0.384837 | H | 0.365214 | 0.019623 | No Change: Both O | Cone-rod dystrophy type 7 (CORD7) [MIM:603649] |
| Q8WYP3 | RIN2_HUMAN Ras and Rab interactor 2 OS=Homo sapiens GN=RIN2 PE=1 SV=1 | 197 | S | 0.557664 | T | 0.495053 | 0.062611 | D to O | - |
| Q8WYP3 | RIN2_HUMAN Ras and Rab interactor 2 OS=Homo sapiens GN=RIN2 PE=1 SV=1 | 643 | A | 0.300991 | T | 0.361846 | -0.060855 | No Change: Both O | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 111 | E | 0.47839 | K | 0.462551 | 0.015839 | No Change: Both O | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 215 | H | 0.455629 | P | 0.549562 | -0.093933 | O to D | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 425 | T | 0.99291 | M | 0.992552 | 3.58E-04 | No Change: Both D | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 613 | G | 0.375054 | A | 0.340947 | 0.034107 | No Change: Both O | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 425 | T | 0.99291 | I | 0.986019 | 0.006891 | No Change: Both D | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 215 | H | 0.455629 | L | 0.432366 | 0.023263 | No Change: Both O | - |
| Q8TB24 | RIN3_HUMAN Ras and Rab interactor 3 OS=Homo sapiens GN=RIN3 PE=1 SV=4 | 215 | H | 0.455629 | R | 0.520355 | -0.064726 | O to D | - |
| Q6ZS11 | RINL_HUMAN Ras and Rab interactor-like protein OS=Homo sapiens GN=RINL PE=2 SV=1 | 288 | P | 0.922332 | L | 0.880705 | 0.041627 | No Change: Both D | - |
| Q6NUQ1 | RINT1_HUMAN RAD50-interacting protein 1 OS=Homo sapiens GN=RINT1 PE=1 SV=1 | 668 | F | 0.042592 | S | 0.110892 | -0.0683 | No Change: Both O | - |
| Q6NUQ1 | RINT1_HUMAN RAD50-interacting protein 1 OS=Homo sapiens GN=RINT1 PE=1 SV=1 | 759 | P | 0.460001 | L | 0.307452 | 0.152549 | No Change: Both O | - |
| Q6NUQ1 | RINT1_HUMAN RAD50-interacting protein 1 OS=Homo sapiens GN=RINT1 PE=1 SV=1 | 40 | S | 0.557948 | C | 0.409667 | 0.148281 | D to O | - |
| Q9BRS2 | RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens GN=RIOK1 PE=1 SV=2 | 375 | V | 0.166036 | I | 0.133415 | 0.032621 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 144 | H | 0.457675 | Y | 0.349269 | 0.108406 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 349 | G | 0.93727 | R | 0.940162 | -0.002892 | No Change: Both D | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 397 | N | 0.844076 | S | 0.872879 | -0.028803 | No Change: Both D | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 96 | S | 0.515486 | C | 0.262731 | 0.252755 | D to O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 144 | H | 0.457675 | R | 0.464349 | -0.006674 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 155 | R | 0.193058 | H | 0.184178 | 0.00888 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 175 | V | 0.373137 | I | 0.357557 | 0.01558 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 216 | I | 0.158393 | T | 0.267596 | -0.109203 | No Change: Both O | A renal clear cell carcinoma sample |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 244 | M | 0.249247 | V | 0.194132 | 0.055115 | No Change: Both O | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 409 | E | 0.826926 | D | 0.78388 | 0.043046 | No Change: Both D | - |
| Q9BVS4 | RIOK2_HUMAN Serine/threonine-protein kinase RIO2 OS=Homo sapiens GN=RIOK2 PE=1 SV=2 | 507 | R | 0.873027 | H | 0.822885 | 0.050142 | No Change: Both D | - |
| O14730 | RIOK3_HUMAN Serine/threonine-protein kinase RIO3 OS=Homo sapiens GN=RIOK3 PE=1 SV=2 | 336 | L | 0.389684 | V | 0.389537 | 1.47E-04 | No Change: Both O | - |
| O14730 | RIOK3_HUMAN Serine/threonine-protein kinase RIO3 OS=Homo sapiens GN=RIOK3 PE=1 SV=2 | 441 | R | 0.132585 | Q | 0.140536 | -0.007951 | No Change: Both O | - |
| O14730 | RIOK3_HUMAN Serine/threonine-protein kinase RIO3 OS=Homo sapiens GN=RIOK3 PE=1 SV=2 | 447 | S | 0.218325 | L | 0.104666 | 0.113659 | No Change: Both O | - |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 234 | E | 0.124916 | K | 0.119948 | 0.004968 | No Change: Both O | - |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 64 | A | 0.565488 | V | 0.467362 | 0.098126 | D to O | A colorectal adenocarcinoma sample |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 81 | V | 0.211665 | I | 0.19189 | 0.019775 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 220 | A | 0.027725 | V | 0.019015 | 0.00871 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 404 | A | 0.902214 | S | 0.934605 | -0.032391 | No Change: Both D | - |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 443 | A | 0.753292 | V | 0.689492 | 0.0638 | No Change: Both D | - |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 569 | A | 0.494543 | V | 0.387271 | 0.107272 | No Change: Both O | - |
| Q13546 | RIPK1_HUMAN Receptor-interacting serine/threonine-protein kinase 1 OS=Homo sapiens GN=RIPK1 PE=1 SV=3 | 438 | A | 0.778521 | V | 0.719773 | 0.058748 | No Change: Both D | - |
| O43353 | RIPK2_HUMAN Receptor-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=RIPK2 PE=1 SV=2 | 259 | I | 0.389135 | T | 0.505954 | -0.116819 | O to D | - |
| O43353 | RIPK2_HUMAN Receptor-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=RIPK2 PE=1 SV=2 | 268 | L | 0.257135 | V | 0.250895 | 0.00624 | No Change: Both O | - |
| O43353 | RIPK2_HUMAN Receptor-interacting serine/threonine-protein kinase 2 OS=Homo sapiens GN=RIPK2 PE=1 SV=2 | 313 | K | 0.535404 | N | 0.472911 | 0.062493 | D to O | - |
| Q9Y572 | RIPK3_HUMAN Receptor-interacting serine/threonine-protein kinase 3 OS=Homo sapiens GN=RIPK3 PE=1 SV=2 | 300 | T | 0.603325 | M | 0.626283 | -0.022958 | No Change: Both D | - |
| Q9Y572 | RIPK3_HUMAN Receptor-interacting serine/threonine-protein kinase 3 OS=Homo sapiens GN=RIPK3 PE=1 SV=2 | 492 | P | 0.855774 | Q | 0.839428 | 0.016346 | No Change: Both D | - |
| Q9Y572 | RIPK3_HUMAN Receptor-interacting serine/threonine-protein kinase 3 OS=Homo sapiens GN=RIPK3 PE=1 SV=2 | 260 | E | 0.747583 | V | 0.576678 | 0.170905 | No Change: Both D | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 12 | A | 0.09245 | G | 0.122165 | -0.029715 | No Change: Both O | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 177 | S | 0.559774 | N | 0.497338 | 0.062436 | D to O | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 462 | I | 0.587571 | N | 0.698983 | -0.111412 | No Change: Both D | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 463 | V | 0.580255 | M | 0.655687 | -0.075432 | No Change: Both D | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 562 | N | 0.557356 | Y | 0.440579 | 0.116777 | D to O | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 669 | R | 0.081708 | H | 0.077159 | 0.004549 | No Change: Both O | - |
| P57078 | RIPK4_HUMAN Receptor-interacting serine/threonine-protein kinase 4 OS=Homo sapiens GN=RIPK4 PE=1 SV=1 | 749 | P | 0.329484 | S | 0.361551 | -0.032067 | No Change: Both O | - |
| Q96K30 | RITA_HUMAN RBPJ-interacting and tubulin-associated protein OS=Homo sapiens GN=RITA PE=1 SV=1 | 220 | T | 0.941331 | K | 0.935502 | 0.005829 | No Change: Both D | - |
| Q96K30 | RITA_HUMAN RBPJ-interacting and tubulin-associated protein OS=Homo sapiens GN=RITA PE=1 SV=1 | 113 | S | 0.772916 | W | 0.530299 | 0.242617 | No Change: Both D | - |
| P12271 | RLBP1_HUMAN Retinaldehyde-binding protein 1 OS=Homo sapiens GN=RLBP1 PE=1 SV=2 | 151 | R | 0.508875 | Q | 0.511639 | -0.002764 | No Change: Both D | Retinitis pigmentosa autosomal recessive (ARRP) [MIM:268000] |
| P12271 | RLBP1_HUMAN Retinaldehyde-binding protein 1 OS=Homo sapiens GN=RLBP1 PE=1 SV=2 | 234 | R | 0.230359 | W | 0.103615 | 0.126744 | No Change: Both O | Bothnia retinal dystrophy (BRD) [MIM:607475] |
| P12271 | RLBP1_HUMAN Retinaldehyde-binding protein 1 OS=Homo sapiens GN=RLBP1 PE=1 SV=2 | 226 | M | 0.33306 | K | 0.472034 | -0.138974 | No Change: Both O | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 668 | R | 0.36868 | K | 0.429319 | -0.060639 | No Change: Both O | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 932 | V | 0.668973 | A | 0.713686 | -0.044713 | No Change: Both D | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 957 | G | 0.42425 | D | 0.444266 | -0.020016 | No Change: Both O | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 1784 | E | 0.891903 | D | 0.884553 | 0.00735 | No Change: Both D | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 1629 | P | 0.985836 | L | 0.971629 | 0.014207 | No Change: Both D | - |
| Q13129 | RLF_HUMAN Zinc finger protein Rlf OS=Homo sapiens GN=RLF PE=1 SV=2 | 1685 | Q | 0.656088 | E | 0.685466 | -0.029378 | No Change: Both D | - |
| P04808 | REL1_HUMAN Prorelaxin H1 OS=Homo sapiens GN=RLN1 PE=2 SV=1 | 28 | K | 0.22133 | M | 0.123391 | 0.097939 | No Change: Both O | - |
| P04090 | REL2_HUMAN Prorelaxin H2 OS=Homo sapiens GN=RLN2 PE=1 SV=1 | 68 | P | 0.541033 | Q | 0.510132 | 0.030901 | No Change: Both D | - |
| P04090 | REL2_HUMAN Prorelaxin H2 OS=Homo sapiens GN=RLN2 PE=1 SV=1 | 28 | M | 0.174118 | K | 0.291256 | -0.117138 | No Change: Both O | - |
| P04090 | REL2_HUMAN Prorelaxin H2 OS=Homo sapiens GN=RLN2 PE=1 SV=1 | 12 | V | 0.023117 | F | 0.022749 | 3.68E-04 | No Change: Both O | - |
| Q9H9A7 | RMI1_HUMAN RecQ-mediated genome instability protein 1 OS=Homo sapiens GN=RMI1 PE=1 SV=3 | 100 | Y | 0.378927 | H | 0.491079 | -0.112152 | No Change: Both O | - |
| Q9H9A7 | RMI1_HUMAN RecQ-mediated genome instability protein 1 OS=Homo sapiens GN=RMI1 PE=1 SV=3 | 455 | N | 0.879823 | S | 0.896362 | -0.016539 | No Change: Both D | - |
| Q9NWS8 | RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens GN=RMND1 PE=1 SV=2 | 132 | T | 0.573591 | M | 0.531442 | 0.042149 | No Change: Both D | - |
| Q9NWS8 | RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens GN=RMND1 PE=1 SV=2 | 42 | S | 0.385456 | I | 0.207902 | 0.177554 | No Change: Both O | - |
| Q9NWS8 | RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens GN=RMND1 PE=1 SV=2 | 47 | R | 0.472169 | H | 0.440866 | 0.031303 | No Change: Both O | - |
| O94763 | RMP_HUMAN Unconventional prefoldin RPB5 interactor OS=Homo sapiens GN=RMP PE=1 SV=3 | 22 | L | 0.900437 | P | 0.948515 | -0.048078 | No Change: Both D | - |
| Q5GAN6 | RNS10_HUMAN Ribonuclease-like protein 10 OS=Homo sapiens GN=RNASE10 PE=2 SV=1 | 131 | S | 0.574323 | N | 0.530984 | 0.043339 | No Change: Both D | - |
| Q8TAA1 | RNS11_HUMAN Probable ribonuclease 11 OS=Homo sapiens GN=RNASE11 PE=2 SV=1 | 5 | P | 0.446184 | S | 0.514712 | -0.068528 | O to D | - |
| Q8TAA1 | RNS11_HUMAN Probable ribonuclease 11 OS=Homo sapiens GN=RNASE11 PE=2 SV=1 | 74 | T | 0.671804 | S | 0.748646 | -0.076842 | No Change: Both D | - |
| Q5GAN3 | RNS13_HUMAN Ribonuclease-like protein 13 OS=Homo sapiens GN=RNASE13 PE=2 SV=1 | 139 | S | 0.169846 | A | 0.113841 | 0.056005 | No Change: Both O | - |
| P10153 | RNAS2_HUMAN Non-secretory ribonuclease OS=Homo sapiens GN=RNASE2 PE=1 SV=2 | 156 | H | 0.382275 | N | 0.453318 | -0.071043 | No Change: Both O | - |
| P10153 | RNAS2_HUMAN Non-secretory ribonuclease OS=Homo sapiens GN=RNASE2 PE=1 SV=2 | 100 | H | 0.703964 | Q | 0.733008 | -0.029044 | No Change: Both D | - |
| P12724 | ECP_HUMAN Eosinophil cationic protein OS=Homo sapiens GN=RNASE3 PE=1 SV=2 | 124 | T | 0.363806 | R | 0.446633 | -0.082827 | No Change: Both O | - |
| P12724 | ECP_HUMAN Eosinophil cationic protein OS=Homo sapiens GN=RNASE3 PE=1 SV=2 | 72 | R | 0.240435 | C | 0.168344 | 0.072091 | No Change: Both O | - |
| P12724 | ECP_HUMAN Eosinophil cationic protein OS=Homo sapiens GN=RNASE3 PE=1 SV=2 | 130 | G | 0.335445 | R | 0.40686 | -0.071415 | No Change: Both O | - |
| P34096 | RNAS4_HUMAN Ribonuclease 4 OS=Homo sapiens GN=RNASE4 PE=1 SV=3 | 16 | T | 0.105474 | S | 0.149226 | -0.043752 | No Change: Both O | - |
| Q93091 | RNAS6_HUMAN Ribonuclease K6 OS=Homo sapiens GN=RNASE6 PE=1 SV=2 | 89 | R | 0.474261 | Q | 0.492583 | -0.018322 | No Change: Both O | - |
| Q9H1E1 | RNAS7_HUMAN Ribonuclease 7 OS=Homo sapiens GN=RNASE7 PE=1 SV=2 | 103 | A | 0.582294 | P | 0.680226 | -0.097932 | No Change: Both D | - |
| Q9H1E1 | RNAS7_HUMAN Ribonuclease 7 OS=Homo sapiens GN=RNASE7 PE=1 SV=2 | 116 | H | 0.740272 | Y | 0.656292 | 0.08398 | No Change: Both D | - |
| Q8TDE3 | RNAS8_HUMAN Ribonuclease 8 OS=Homo sapiens GN=RNASE8 PE=1 SV=1 | 10 | P | 0.055041 | S | 0.054877 | 1.64E-04 | No Change: Both O | - |
| P60153 | RNAS9_HUMAN Inactive ribonuclease-like protein 9 OS=Homo sapiens GN=RNASE9 PE=1 SV=1 | 204 | S | 0.689832 | P | 0.673963 | 0.015869 | No Change: Both D | - |
| P60153 | RNAS9_HUMAN Inactive ribonuclease-like protein 9 OS=Homo sapiens GN=RNASE9 PE=1 SV=1 | 148 | F | 0.12839 | S | 0.282823 | -0.154433 | No Change: Both O | - |
| O60930 | RNH1_HUMAN Ribonuclease H1 OS=Homo sapiens GN=RNASEH1 PE=1 SV=2 | 4 | L | 0.282917 | F | 0.247541 | 0.035376 | No Change: Both O | - |
| O75792 | RNH2A_HUMAN Ribonuclease H2 subunit A OS=Homo sapiens GN=RNASEH2A PE=1 SV=2 | 202 | L | 0.392322 | S | 0.558156 | -0.165834 | O to D | - |
| O75792 | RNH2A_HUMAN Ribonuclease H2 subunit A OS=Homo sapiens GN=RNASEH2A PE=1 SV=2 | 37 | G | 0.433406 | S | 0.456725 | -0.023319 | No Change: Both O | Aicardi-Goutieres syndrome type 4 (AGS4) [MIM:610333] |
| O75792 | RNH2A_HUMAN Ribonuclease H2 subunit A OS=Homo sapiens GN=RNASEH2A PE=1 SV=2 | 258 | A | 0.544372 | G | 0.58959 | -0.045218 | No Change: Both D | - |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 60 | L | 0.083638 | R | 0.130164 | -0.046526 | No Change: Both O | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 86 | H | 0.192388 | R | 0.19006 | 0.002328 | No Change: Both O | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 162 | K | 0.626978 | T | 0.543286 | 0.083692 | No Change: Both D | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 163 | T | 0.601665 | I | 0.451138 | 0.150527 | D to O | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 177 | A | 0.517773 | T | 0.568505 | -0.050732 | No Change: Both D | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 185 | V | 0.552739 | G | 0.645342 | -0.092603 | No Change: Both D | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q5TBB1 | RNH2B_HUMAN Ribonuclease H2 subunit B OS=Homo sapiens GN=RNASEH2B PE=1 SV=1 | 219 | Y | 0.554296 | H | 0.638515 | -0.084219 | No Change: Both D | Aicardi-Goutieres syndrome type 2 (AGS2) [MIM:610181] |
| Q8TDP1 | RNH2C_HUMAN Ribonuclease H2 subunit C OS=Homo sapiens GN=RNASEH2C PE=1 SV=1 | 69 | R | 0.498878 | W | 0.252014 | 0.246864 | No Change: Both O | Aicardi-Goutieres syndrome type 3 (AGS3) [MIM:610329] |
| Q8TDP1 | RNH2C_HUMAN Ribonuclease H2 subunit C OS=Homo sapiens GN=RNASEH2C PE=1 SV=1 | 143 | K | 0.36895 | I | 0.193109 | 0.175841 | No Change: Both O | Aicardi-Goutieres syndrome type 3 (AGS3) [MIM:610329] |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 462 | R | 0.353343 | Q | 0.373824 | -0.020481 | No Change: Both O | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 541 | D | 0.517782 | E | 0.552884 | -0.035102 | No Change: Both D | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 59 | G | 0.433687 | S | 0.467945 | -0.034258 | No Change: Both O | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 406 | S | 0.602878 | F | 0.342112 | 0.260766 | D to O | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 97 | I | 0.116774 | L | 0.133087 | -0.016313 | No Change: Both O | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 289 | A | 0.258852 | T | 0.28264 | -0.023788 | No Change: Both O | - |
| Q05823 | RN5A_HUMAN 2-5A-dependent ribonuclease OS=Homo sapiens GN=RNASEL PE=1 SV=2 | 592 | R | 0.186532 | H | 0.166048 | 0.020484 | No Change: Both O | - |
| O00584 | RNT2_HUMAN Ribonuclease T2 OS=Homo sapiens GN=RNASET2 PE=1 SV=2 | 236 | R | 0.61191 | W | 0.418298 | 0.193612 | D to O | - |
| O00584 | RNT2_HUMAN Ribonuclease T2 OS=Homo sapiens GN=RNASET2 PE=1 SV=2 | 184 | C | 0.267866 | R | 0.413364 | -0.145498 | No Change: Both O | Leukoencephalopathy cystic without megalencephaly (LCWM) [MIM:612951] |
| Q92730 | RND1_HUMAN Rho-related GTP-binding protein Rho6 OS=Homo sapiens GN=RND1 PE=1 SV=1 | 44 | P | 0.174092 | R | 0.140202 | 0.03389 | No Change: Both O | - |
| Q8N5U6 | RNF10_HUMAN RING finger protein 10 OS=Homo sapiens GN=RNF10 PE=1 SV=2 | 332 | L | 0.511977 | F | 0.448994 | 0.062983 | D to O | - |
| Q8N5U6 | RNF10_HUMAN RING finger protein 10 OS=Homo sapiens GN=RNF10 PE=1 SV=2 | 433 | E | 0.676256 | D | 0.641341 | 0.034915 | No Change: Both D | - |
| Q9Y3C5 | RNF11_HUMAN RING finger protein 11 OS=Homo sapiens GN=RNF11 PE=1 SV=1 | 11 | D | 0.892407 | E | 0.899199 | -0.006792 | No Change: Both D | - |
| Q6ZNA4 | RN111_HUMAN E3 ubiquitin-protein ligase Arkadia OS=Homo sapiens GN=RNF111 PE=1 SV=3 | 9 | N | 0.4239 | K | 0.560496 | -0.136596 | O to D | - |
| Q6ZNA4 | RN111_HUMAN E3 ubiquitin-protein ligase Arkadia OS=Homo sapiens GN=RNF111 PE=1 SV=3 | 718 | A | 0.982888 | T | 0.984385 | -0.001497 | No Change: Both D | - |
| Q8IZP6 | R113B_HUMAN RING finger protein 113B OS=Homo sapiens GN=RNF113B PE=1 SV=3 | 92 | V | 0.779604 | M | 0.827332 | -0.047728 | No Change: Both D | - |
| Q9Y4L5 | RN115_HUMAN E3 ubiquitin-protein ligase RNF115 OS=Homo sapiens GN=RNF115 PE=1 SV=2 | 194 | G | 0.349989 | R | 0.316856 | 0.033133 | No Change: Both O | - |
| Q5XPI4 | RN123_HUMAN E3 ubiquitin-protein ligase RNF123 OS=Homo sapiens GN=RNF123 PE=1 SV=1 | 51 | P | 0.671145 | R | 0.652443 | 0.018702 | No Change: Both D | - |
| Q5XPI4 | RN123_HUMAN E3 ubiquitin-protein ligase RNF123 OS=Homo sapiens GN=RNF123 PE=1 SV=1 | 387 | R | 0.110327 | Q | 0.117541 | -0.007214 | No Change: Both O | - |
| Q5XPI4 | RN123_HUMAN E3 ubiquitin-protein ligase RNF123 OS=Homo sapiens GN=RNF123 PE=1 SV=1 | 596 | K | 0.165528 | E | 0.165843 | -3.15E-04 | No Change: Both O | - |
| Q5XPI4 | RN123_HUMAN E3 ubiquitin-protein ligase RNF123 OS=Homo sapiens GN=RNF123 PE=1 SV=1 | 854 | R | 0.406245 | H | 0.419429 | -0.013184 | No Change: Both O | - |
| Q9BV68 | RN126_HUMAN RING finger protein 126 OS=Homo sapiens GN=RNF126 PE=1 SV=1 | 68 | V | 0.641152 | M | 0.716277 | -0.075125 | No Change: Both D | - |
| Q8IUD6 | RN135_HUMAN E3 ubiquitin-protein ligase RNF135 OS=Homo sapiens GN=RNF135 PE=1 SV=2 | 71 | H | 0.632247 | Q | 0.709 | -0.076753 | No Change: Both D | - |
| Q8IUD6 | RN135_HUMAN E3 ubiquitin-protein ligase RNF135 OS=Homo sapiens GN=RNF135 PE=1 SV=2 | 108 | S | 0.934746 | P | 0.934513 | 2.33E-04 | No Change: Both D | - |
| Q8IUD6 | RN135_HUMAN E3 ubiquitin-protein ligase RNF135 OS=Homo sapiens GN=RNF135 PE=1 SV=2 | 286 | R | 0.567373 | H | 0.544481 | 0.022892 | No Change: Both D | Macrocephaly macrosomia facial dysmorphism syndrome (MMFD) [MIM:614192] |
| Q8IUD6 | RN135_HUMAN E3 ubiquitin-protein ligase RNF135 OS=Homo sapiens GN=RNF135 PE=1 SV=2 | 115 | R | 0.912256 | K | 0.905299 | 0.006957 | No Change: Both D | - |
| Q8IUD6 | RN135_HUMAN E3 ubiquitin-protein ligase RNF135 OS=Homo sapiens GN=RNF135 PE=1 SV=2 | 415 | W | 0.073837 | C | 0.087186 | -0.013349 | No Change: Both O | - |
| Q8WVD3 | RN138_HUMAN E3 ubiquitin-protein ligase RNF138 OS=Homo sapiens GN=RNF138 PE=1 SV=1 | 81 | K | 0.495634 | R | 0.492363 | 0.003271 | No Change: Both O | - |
| P50876 | R144A_HUMAN Probable E3 ubiquitin-protein ligase RNF144A OS=Homo sapiens GN=RNF144A PE=1 SV=2 | 4 | T | 0.651248 | A | 0.642598 | 0.00865 | No Change: Both D | - |
| Q9NTX7 | RN146_HUMAN E3 ubiquitin-protein ligase RNF146 OS=Homo sapiens GN=RNF146 PE=1 SV=1 | 25 | C | 0.683714 | R | 0.738003 | -0.054289 | No Change: Both D | - |
| Q8N7C7 | RN148_HUMAN RING finger protein 148 OS=Homo sapiens GN=RNF148 PE=2 SV=2 | 221 | F | 0.58892 | L | 0.62688 | -0.03796 | No Change: Both D | - |
| Q8NC42 | RN149_HUMAN E3 ubiquitin-protein ligase RNF149 OS=Homo sapiens GN=RNF149 PE=2 SV=2 | 9 | S | 0.448133 | G | 0.427117 | 0.021016 | No Change: Both O | - |
| Q8NC42 | RN149_HUMAN E3 ubiquitin-protein ligase RNF149 OS=Homo sapiens GN=RNF149 PE=2 SV=2 | 344 | L | 0.938912 | F | 0.923035 | 0.015877 | No Change: Both D | - |
| Q8NC42 | RN149_HUMAN E3 ubiquitin-protein ligase RNF149 OS=Homo sapiens GN=RNF149 PE=2 SV=2 | 356 | D | 0.996183 | E | 0.996094 | 8.90E-05 | No Change: Both D | - |
| Q8NC42 | RN149_HUMAN E3 ubiquitin-protein ligase RNF149 OS=Homo sapiens GN=RNF149 PE=2 SV=2 | 7 | E | 0.53188 | K | 0.537918 | -0.006038 | No Change: Both D | A breast cancer sample |
| Q96PX1 | RN157_HUMAN RING finger protein 157 OS=Homo sapiens GN=RNF157 PE=1 SV=3 | 80 | P | 0.566452 | H | 0.508551 | 0.057901 | No Change: Both D | - |
| Q96PX1 | RN157_HUMAN RING finger protein 157 OS=Homo sapiens GN=RNF157 PE=1 SV=3 | 208 | G | 0.407606 | R | 0.380696 | 0.02691 | No Change: Both O | - |
| Q96PX1 | RN157_HUMAN RING finger protein 157 OS=Homo sapiens GN=RNF157 PE=1 SV=3 | 596 | E | 0.827748 | V | 0.728804 | 0.098944 | No Change: Both D | - |
| Q9H6Y7 | RN167_HUMAN E3 ubiquitin-protein ligase RNF167 OS=Homo sapiens GN=RNF167 PE=1 SV=1 | 121 | N | 0.280083 | K | 0.294521 | -0.014438 | No Change: Both O | - |
| Q8IYW5 | RN168_HUMAN E3 ubiquitin-protein ligase RNF168 OS=Homo sapiens GN=RNF168 PE=1 SV=1 | 401 | P | 0.932711 | Q | 0.929315 | 0.003396 | No Change: Both D | - |
| Q8IYW5 | RN168_HUMAN E3 ubiquitin-protein ligase RNF168 OS=Homo sapiens GN=RNF168 PE=1 SV=1 | 387 | K | 0.941591 | R | 0.934132 | 0.007459 | No Change: Both D | - |
| Q8IYW5 | RN168_HUMAN E3 ubiquitin-protein ligase RNF168 OS=Homo sapiens GN=RNF168 PE=1 SV=1 | 413 | E | 0.906146 | K | 0.90313 | 0.003016 | No Change: Both D | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 346 | K | 0.857194 | N | 0.832218 | 0.024976 | No Change: Both D | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 467 | G | 0.163554 | S | 0.222491 | -0.058937 | No Change: Both O | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 501 | S | 0.450478 | G | 0.400559 | 0.049919 | No Change: Both O | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 573 | A | 0.315065 | P | 0.447573 | -0.132508 | No Change: Both O | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 667 | H | 0.354741 | R | 0.336544 | 0.018197 | No Change: Both O | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 1110 | N | 0.659557 | K | 0.686602 | -0.027045 | No Change: Both D | - |
| Q9BXT8 | RNF17_HUMAN RING finger protein 17 OS=Homo sapiens GN=RNF17 PE=1 SV=3 | 1380 | E | 0.846571 | K | 0.834614 | 0.011957 | No Change: Both D | - |
| Q8N4F7 | RN175_HUMAN RING finger protein 175 OS=Homo sapiens GN=RNF175 PE=2 SV=2 | 159 | M | 0.021032 | V | 0.015487 | 0.005545 | No Change: Both O | - |
| Q8N4F7 | RN175_HUMAN RING finger protein 175 OS=Homo sapiens GN=RNF175 PE=2 SV=2 | 307 | L | 0.016357 | F | 0.012952 | 0.003405 | No Change: Both O | - |
| Q8N4F7 | RN175_HUMAN RING finger protein 175 OS=Homo sapiens GN=RNF175 PE=2 SV=2 | 315 | I | 0.030193 | M | 0.042627 | -0.012434 | No Change: Both O | - |
| Q8N4F7 | RN175_HUMAN RING finger protein 175 OS=Homo sapiens GN=RNF175 PE=2 SV=2 | 322 | I | 0.130786 | N | 0.241488 | -0.110702 | No Change: Both O | - |
| Q9P0P0 | RN181_HUMAN E3 ubiquitin-protein ligase RNF181 OS=Homo sapiens GN=RNF181 PE=1 SV=1 | 118 | Y | 0.526797 | H | 0.664671 | -0.137874 | No Change: Both D | - |
| Q8N6D2 | RN182_HUMAN E3 ubiquitin-protein ligase RNF182 OS=Homo sapiens GN=RNF182 PE=1 SV=1 | 43 | V | 0.067296 | A | 0.092416 | -0.02512 | No Change: Both O | A colorectal cancer sample |
| Q8N6D2 | RN182_HUMAN E3 ubiquitin-protein ligase RNF182 OS=Homo sapiens GN=RNF182 PE=1 SV=1 | 58 | P | 0.210994 | L | 0.112871 | 0.098123 | No Change: Both O | A colorectal cancer sample |
| Q96D59 | RN183_HUMAN RING finger protein 183 OS=Homo sapiens GN=RNF183 PE=2 SV=1 | 82 | T | 0.334078 | A | 0.289954 | 0.044124 | No Change: Both O | - |
| Q96D59 | RN183_HUMAN RING finger protein 183 OS=Homo sapiens GN=RNF183 PE=2 SV=1 | 114 | R | 0.499043 | Q | 0.520784 | -0.021741 | O to D | - |
| Q9NXI6 | RN186_HUMAN RING finger protein 186 OS=Homo sapiens GN=RNF186 PE=2 SV=1 | 23 | A | 0.775401 | T | 0.809104 | -0.033703 | No Change: Both D | - |
| Q9NXI6 | RN186_HUMAN RING finger protein 186 OS=Homo sapiens GN=RNF186 PE=2 SV=1 | 208 | P | 0.413682 | T | 0.369552 | 0.04413 | No Change: Both O | - |
| Q9NV58 | RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens GN=RNF19A PE=1 SV=3 | 835 | Q | 0.606541 | H | 0.602493 | 0.004048 | No Change: Both D | - |
| Q6ZRF8 | RN207_HUMAN RING finger protein 207 OS=Homo sapiens GN=RNF207 PE=1 SV=2 | 421 | A | 0.467159 | T | 0.509288 | -0.042129 | O to D | - |
| Q6ZRF8 | RN207_HUMAN RING finger protein 207 OS=Homo sapiens GN=RNF207 PE=1 SV=2 | 573 | N | 0.964925 | S | 0.970244 | -0.005319 | No Change: Both D | - |
| Q6ZRF8 | RN207_HUMAN RING finger protein 207 OS=Homo sapiens GN=RNF207 PE=1 SV=2 | 603 | G | 0.918669 | A | 0.904975 | 0.013694 | No Change: Both D | - |
| Q6ZRF8 | RN207_HUMAN RING finger protein 207 OS=Homo sapiens GN=RNF207 PE=1 SV=2 | 539 | R | 0.297155 | C | 0.174035 | 0.12312 | No Change: Both O | - |
| Q495C1 | RN212_HUMAN RING finger protein 212 OS=Homo sapiens GN=RNF212 PE=2 SV=1 | 263 | V | 0.113825 | I | 0.093734 | 0.020091 | No Change: Both O | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 407 | S | 0.270844 | N | 0.229241 | 0.041603 | No Change: Both O | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 2764 | H | 0.496322 | R | 0.529558 | -0.033236 | O to D | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 2805 | K | 0.343959 | E | 0.332565 | 0.011394 | No Change: Both O | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 3101 | V | 0.159032 | I | 0.131926 | 0.027106 | No Change: Both O | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 1911 | V | 0.114801 | L | 0.128463 | -0.013662 | No Change: Both O | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 1081 | C | 0.543075 | R | 0.619574 | -0.076499 | No Change: Both D | - |
| Q63HN8 | RN213_HUMAN RING finger protein 213 OS=Homo sapiens GN=RNF213 PE=1 SV=2 | 3257 | E | 0.29769 | A | 0.21358 | 0.08411 | No Change: Both O | - |
| Q9Y6U7 | RN215_HUMAN RING finger protein 215 OS=Homo sapiens GN=RNF215 PE=1 SV=2 | 322 | A | 0.334756 | T | 0.352893 | -0.018137 | No Change: Both O | - |
| Q8TC41 | RN217_HUMAN Probable E3 ubiquitin-protein ligase RNF217 OS=Homo sapiens GN=RNF217 PE=2 SV=3 | 89 | V | 0.169239 | I | 0.170774 | -0.001535 | No Change: Both O | - |
| Q96EP0 | RNF31_HUMAN RING finger protein 31 OS=Homo sapiens GN=RNF31 PE=1 SV=1 | 1061 | V | 0.793098 | I | 0.793755 | -6.57E-04 | No Change: Both D | - |
| Q9H0A6 | RNF32_HUMAN RING finger protein 32 OS=Homo sapiens GN=RNF32 PE=1 SV=1 | 288 | R | 0.559074 | Q | 0.574223 | -0.015149 | No Change: Both D | - |
| Q9H0A6 | RNF32_HUMAN RING finger protein 32 OS=Homo sapiens GN=RNF32 PE=1 SV=1 | 291 | H | 0.525184 | Q | 0.612653 | -0.087469 | No Change: Both D | - |
| Q9H0A6 | RNF32_HUMAN RING finger protein 32 OS=Homo sapiens GN=RNF32 PE=1 SV=1 | 307 | R | 0.645232 | C | 0.484142 | 0.16109 | D to O | - |
| Q9H0F5 | RNF38_HUMAN RING finger protein 38 OS=Homo sapiens GN=RNF38 PE=1 SV=4 | 206 | A | 0.341924 | T | 0.422694 | -0.08077 | No Change: Both O | - |
| Q9H2S5 | RNF39_HUMAN RING finger protein 39 OS=Homo sapiens GN=RNF39 PE=1 SV=2 | 203 | S | 0.817396 | P | 0.821638 | -0.004242 | No Change: Both D | - |
| Q9H2S5 | RNF39_HUMAN RING finger protein 39 OS=Homo sapiens GN=RNF39 PE=1 SV=2 | 245 | A | 0.685695 | T | 0.70947 | -0.023775 | No Change: Both D | - |
| Q9H2S5 | RNF39_HUMAN RING finger protein 39 OS=Homo sapiens GN=RNF39 PE=1 SV=2 | 268 | D | 0.665901 | N | 0.599538 | 0.066363 | No Change: Both D | - |
| Q9H2S5 | RNF39_HUMAN RING finger protein 39 OS=Homo sapiens GN=RNF39 PE=1 SV=2 | 304 | A | 0.830774 | E | 0.856252 | -0.025478 | No Change: Both D | - |
| O75150 | BRE1B_HUMAN E3 ubiquitin-protein ligase BRE1B OS=Homo sapiens GN=RNF40 PE=1 SV=4 | 463 | R | 0.385435 | H | 0.332838 | 0.052597 | No Change: Both O | - |
| O75150 | BRE1B_HUMAN E3 ubiquitin-protein ligase BRE1B OS=Homo sapiens GN=RNF40 PE=1 SV=4 | 615 | Q | 0.99369 | R | 0.99483 | -0.00114 | No Change: Both D | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 47 | I | 0.229106 | V | 0.247821 | -0.018715 | No Change: Both O | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 117 | R | 0.657883 | H | 0.587118 | 0.070765 | No Change: Both D | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 221 | R | 0.283905 | Q | 0.276783 | 0.007122 | No Change: Both O | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 231 | P | 0.666199 | L | 0.525175 | 0.141024 | No Change: Both D | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 418 | L | 0.878284 | M | 0.890752 | -0.012468 | No Change: Both D | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 686 | P | 0.556794 | R | 0.485551 | 0.071243 | D to O | - |
| Q68DV7 | RNF43_HUMAN RING finger protein 43 OS=Homo sapiens GN=RNF43 PE=1 SV=1 | 343 | R | 0.721095 | H | 0.70081 | 0.020285 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 48 | N | 0.543376 | S | 0.542722 | 6.54E-04 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 203 | V | 0.972407 | E | 0.982741 | -0.010334 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 623 | S | 0.526701 | N | 0.491203 | 0.035498 | D to O | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 102 | R | 0.828877 | K | 0.799903 | 0.028974 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 164 | I | 0.546949 | T | 0.658457 | -0.111508 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 242 | A | 0.870161 | T | 0.879219 | -0.009058 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 244 | G | 0.874656 | D | 0.84703 | 0.027626 | No Change: Both D | - |
| Q9Y252 | RNF6_HUMAN E3 ubiquitin-protein ligase RNF6 OS=Homo sapiens GN=RNF6 PE=1 SV=1 | 572 | R | 0.75023 | Q | 0.740043 | 0.010187 | No Change: Both D | - |
| O76064 | RNF8_HUMAN E3 ubiquitin-protein ligase RNF8 OS=Homo sapiens GN=RNF8 PE=1 SV=1 | 162 | A | 0.839401 | T | 0.855315 | -0.015914 | No Change: Both D | - |
| O76064 | RNF8_HUMAN E3 ubiquitin-protein ligase RNF8 OS=Homo sapiens GN=RNF8 PE=1 SV=1 | 473 | I | 0.431161 | V | 0.470774 | -0.039613 | No Change: Both O | - |
| O60942 | MCE1_HUMAN mRNA-capping enzyme OS=Homo sapiens GN=RNGTT PE=1 SV=1 | 594 | R | 0.990769 | H | 0.988804 | 0.001965 | No Change: Both D | - |
| P13489 | RINI_HUMAN Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 | 170 | P | 0.45035 | L | 0.334553 | 0.115797 | No Change: Both O | - |
| Q5VYX0 | RNLS_HUMAN Renalase OS=Homo sapiens GN=RNLS PE=1 SV=1 | 37 | E | 0.449583 | D | 0.461046 | -0.011463 | No Change: Both O | - |
| Q9HC36 | RMTL1_HUMAN RNA methyltransferase-like protein 1 OS=Homo sapiens GN=RNMTL1 PE=1 SV=2 | 8 | A | 0.274798 | S | 0.322228 | -0.04743 | No Change: Both O | - |
| Q9HC36 | RMTL1_HUMAN RNA methyltransferase-like protein 1 OS=Homo sapiens GN=RNMTL1 PE=1 SV=2 | 45 | G | 0.758598 | E | 0.801559 | -0.042961 | No Change: Both D | - |
| Q9HC36 | RMTL1_HUMAN RNA methyltransferase-like protein 1 OS=Homo sapiens GN=RNMTL1 PE=1 SV=2 | 185 | I | 0.154188 | V | 0.17287 | -0.018682 | No Change: Both O | - |
| Q9HC36 | RMTL1_HUMAN RNA methyltransferase-like protein 1 OS=Homo sapiens GN=RNMTL1 PE=1 SV=2 | 326 | E | 0.611256 | Q | 0.573305 | 0.037951 | No Change: Both D | - |
| Q9H4A4 | AMPB_HUMAN Aminopeptidase B OS=Homo sapiens GN=RNPEP PE=1 SV=2 | 579 | V | 0.176533 | I | 0.167427 | 0.009106 | No Change: Both O | - |
| Q9HAU8 | RNPL1_HUMAN Arginyl aminopeptidase-like 1 OS=Homo sapiens GN=RNPEPL1 PE=2 SV=2 | 247 | V | 0.16362 | M | 0.194687 | -0.031067 | No Change: Both O | A colorectal cancer sample |
| Q9Y6N7 | ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens GN=ROBO1 PE=1 SV=1 | 1055 | S | 0.627802 | N | 0.61472 | 0.013082 | No Change: Both D | A breast cancer sample |
| Q9Y6N7 | ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens GN=ROBO1 PE=1 SV=1 | 1533 | E | 0.933604 | D | 0.940349 | -0.006745 | No Change: Both D | A breast cancer sample |
| Q9Y6N7 | ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens GN=ROBO1 PE=1 SV=1 | 336 | V | 0.383988 | A | 0.468363 | -0.084375 | No Change: Both O | - |
| Q9Y6N7 | ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens GN=ROBO1 PE=1 SV=1 | 1091 | S | 0.796927 | N | 0.786242 | 0.010685 | No Change: Both D | - |
| Q9HCK4 | ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens GN=ROBO2 PE=1 SV=2 | 945 | I | 0.660943 | T | 0.766645 | -0.105702 | No Change: Both D | Vesicoureteral reflux type 2 (VUR2) [MIM:610878] |
| Q9HCK4 | ROBO2_HUMAN Roundabout homolog 2 OS=Homo sapiens GN=ROBO2 PE=1 SV=2 | 1236 | A | 0.888835 | T | 0.901338 | -0.012503 | No Change: Both D | Vesicoureteral reflux type 2 (VUR2) [MIM:610878] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 319 | E | 0.420624 | K | 0.392178 | 0.028446 | No Change: Both O | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 703 | R | 0.230147 | P | 0.2667 | -0.036553 | No Change: Both O | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 705 | S | 0.269234 | P | 0.276949 | -0.007715 | No Change: Both O | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 5 | L | 0.3316 | P | 0.469757 | -0.138157 | No Change: Both O | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 66 | I | 0.834843 | L | 0.877335 | -0.042492 | No Change: Both D | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 361 | G | 0.68621 | E | 0.745375 | -0.059165 | No Change: Both D | Familial horizontal gaze palsy with progressive scoliosis (HGPPS) [MIM:607313] |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 423 | V | 0.123834 | M | 0.145576 | -0.021742 | No Change: Both O | - |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 1369 | Q | 0.999975 | R | 0.999978 | -3.00E-06 | No Change: Both D | - |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 416 | R | 0.216696 | H | 0.214286 | 0.00241 | No Change: Both O | - |
| Q96MS0 | ROBO3_HUMAN Roundabout homolog 3 OS=Homo sapiens GN=ROBO3 PE=1 SV=2 | 868 | P | 0.671926 | L | 0.518931 | 0.152995 | No Change: Both D | - |
| Q8WZ75 | ROBO4_HUMAN Roundabout homolog 4 OS=Homo sapiens GN=ROBO4 PE=1 SV=1 | 103 | Q | 0.580447 | P | 0.61183 | -0.031383 | No Change: Both D | - |
| Q8WZ75 | ROBO4_HUMAN Roundabout homolog 4 OS=Homo sapiens GN=ROBO4 PE=1 SV=1 | 669 | R | 0.782129 | Q | 0.786919 | -0.00479 | No Change: Both D | - |
| Q8WZ75 | ROBO4_HUMAN Roundabout homolog 4 OS=Homo sapiens GN=ROBO4 PE=1 SV=1 | 54 | Q | 0.870972 | R | 0.857256 | 0.013716 | No Change: Both D | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 108 | S | 0.258383 | N | 0.215071 | 0.043312 | No Change: Both O | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 773 | T | 0.876243 | S | 0.902979 | -0.026736 | No Change: Both D | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 1112 | T | 0.668746 | P | 0.718597 | -0.049851 | No Change: Both D | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 1193 | P | 0.245392 | S | 0.25174 | -0.006348 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 1217 | Q | 0.543286 | E | 0.573386 | -0.0301 | No Change: Both D | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 1262 | R | 0.391238 | Q | 0.360323 | 0.030915 | No Change: Both O | - |
| Q13464 | ROCK1_HUMAN Rho-associated protein kinase 1 OS=Homo sapiens GN=ROCK1 PE=1 SV=1 | 1264 | C | 0.42016 | R | 0.53642 | -0.11626 | O to D | - |
| O75116 | ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | 431 | T | 0.758125 | N | 0.777501 | -0.019376 | No Change: Both D | - |
| O75116 | ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | 601 | D | 0.915287 | V | 0.841535 | 0.073752 | No Change: Both D | - |
| O75116 | ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | 1194 | S | 0.610885 | P | 0.594832 | 0.016053 | No Change: Both D | A metastatic melanoma sample |
| O75116 | ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens GN=ROCK2 PE=1 SV=4 | 1083 | K | 0.933626 | M | 0.919258 | 0.014368 | No Change: Both D | - |
| Q9GZN7 | ROGDI_HUMAN Protein rogdi homolog OS=Homo sapiens GN=ROGDI PE=2 SV=1 | 59 | E | 0.450756 | K | 0.457301 | -0.006545 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 60 | P | 0.188946 | T | 0.141544 | 0.047402 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 108 | T | 0.316081 | M | 0.285006 | 0.031075 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 229 | R | 0.598233 | H | 0.584341 | 0.013892 | No Change: Both D | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 265 | A | 0.310961 | T | 0.349961 | -0.039 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 271 | M | 0.134444 | T | 0.176038 | -0.041594 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 16 | R | 0.123964 | H | 0.115104 | 0.00886 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 75 | G | 0.23856 | D | 0.229505 | 0.009055 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 118 | G | 0.14502 | A | 0.114709 | 0.030311 | No Change: Both O | - |
| Q03395 | ROM1_HUMAN Rod outer segment membrane protein 1 OS=Homo sapiens GN=ROM1 PE=1 SV=2 | 242 | R | 0.547479 | Q | 0.586654 | -0.039175 | No Change: Both D | - |
| P60602 | ROMO1_HUMAN Reactive oxygen species modulator 1 OS=Homo sapiens GN=ROMO1 PE=1 SV=1 | 28 | A | 0.189017 | P | 0.24805 | -0.059033 | No Change: Both O | - |
| Q96C74 | ROP1L_HUMAN Ropporin-1-like protein OS=Homo sapiens GN=ROPN1L PE=1 SV=2 | 103 | N | 0.271239 | K | 0.351027 | -0.079788 | No Change: Both O | - |
| Q96C74 | ROP1L_HUMAN Ropporin-1-like protein OS=Homo sapiens GN=ROPN1L PE=1 SV=2 | 156 | P | 0.554749 | R | 0.508588 | 0.046161 | No Change: Both D | - |
| Q96C74 | ROP1L_HUMAN Ropporin-1-like protein OS=Homo sapiens GN=ROPN1L PE=1 SV=2 | 113 | A | 0.265943 | V | 0.200898 | 0.065045 | No Change: Both O | - |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 562 | E | 0.223129 | D | 0.215435 | 0.007694 | No Change: Both O | A breast cancer sample |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 144 | G | 0.259 | E | 0.302694 | -0.043694 | No Change: Both O | A metastatic melanoma sample |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 150 | F | 0.36339 | L | 0.381665 | -0.018275 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 301 | I | 0.35597 | V | 0.349937 | 0.006033 | No Change: Both O | A renal clear cell carcinoma sample |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 518 | T | 0.426137 | M | 0.380871 | 0.045266 | No Change: Both O | - |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 567 | R | 0.351028 | I | 0.223313 | 0.127715 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 624 | G | 0.158007 | R | 0.159832 | -0.001825 | No Change: Both O | - |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 646 | Y | 0.300289 | C | 0.235407 | 0.064882 | No Change: Both O | - |
| Q01973 | ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=2 SV=2 | 776 | S | 0.889098 | N | 0.864855 | 0.024243 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 184 | R | 0.078374 | C | 0.038687 | 0.039687 | No Change: Both O | Robinow syndrome autosomal recessive (RRS) [MIM:268310] |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 189 | R | 0.097713 | W | 0.034726 | 0.062987 | No Change: Both O | Robinow syndrome autosomal recessive (RRS) [MIM:268310] |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 366 | R | 0.520399 | W | 0.344437 | 0.175962 | D to O | Robinow syndrome autosomal recessive (RRS) [MIM:268310] |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 620 | N | 0.161975 | K | 0.202526 | -0.040551 | No Change: Both O | Robinow syndrome autosomal recessive (RRS) [MIM:268310] |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 182 | C | 0.075963 | Y | 0.092959 | -0.016996 | No Change: Both O | Robinow syndrome autosomal recessive (RRS) [MIM:268310] |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 245 | T | 0.689289 | A | 0.681553 | 0.007736 | No Change: Both D | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 819 | V | 0.768757 | I | 0.748456 | 0.020301 | No Change: Both D | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 244 | R | 0.658699 | Q | 0.646765 | 0.011934 | No Change: Both D | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 349 | H | 0.702579 | D | 0.701541 | 0.001038 | No Change: Both D | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 490 | G | 0.349087 | A | 0.308833 | 0.040254 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 530 | R | 0.302779 | Q | 0.316376 | -0.013597 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 542 | V | 0.129716 | M | 0.165802 | -0.036086 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 548 | P | 0.23229 | S | 0.267272 | -0.034982 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 557 | S | 0.232182 | L | 0.115111 | 0.117071 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 644 | D | 0.117038 | N | 0.114651 | 0.002387 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 672 | D | 0.229581 | N | 0.203026 | 0.026555 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 695 | G | 0.221821 | R | 0.201165 | 0.020656 | No Change: Both O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 738 | R | 0.531382 | C | 0.36769 | 0.163692 | D to O | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 762 | S | 0.890009 | L | 0.815791 | 0.074218 | No Change: Both D | - |
| Q01974 | ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | 935 | D | 0.843918 | E | 0.873329 | -0.029411 | No Change: Both D | - |
| P35398 | RORA_HUMAN Nuclear receptor ROR-alpha OS=Homo sapiens GN=RORA PE=1 SV=1 | 18 | P | 0.561179 | S | 0.561218 | -3.90E-05 | No Change: Both D | A colorectal cancer sample |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 145 | T | 0.337587 | P | 0.38586 | -0.048273 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 167 | R | 0.026389 | Q | 0.029449 | -0.00306 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1109 | S | 0.189076 | L | 0.085506 | 0.10357 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1439 | F | 0.360891 | S | 0.544714 | -0.183823 | O to D | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1776 | D | 0.343997 | H | 0.309276 | 0.034721 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1902 | E | 0.378953 | K | 0.372418 | 0.006535 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2039 | R | 0.191463 | H | 0.18235 | 0.009113 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2213 | D | 0.315065 | N | 0.310817 | 0.004248 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2229 | S | 0.487654 | C | 0.305245 | 0.182409 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2240 | N | 0.556152 | K | 0.5644 | -0.008248 | No Change: Both D | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 13 | N | 0.03056 | S | 0.037226 | -0.006666 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 126 | G | 0.125932 | V | 0.074418 | 0.051514 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 224 | P | 0.338696 | S | 0.333783 | 0.004913 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 338 | Y | 0.106436 | C | 0.084799 | 0.021637 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 370 | S | 0.206458 | P | 0.167831 | 0.038627 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 419 | Y | 0.124861 | H | 0.180492 | -0.055631 | No Change: Both O | A gastric adenocarcinoma sample |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 537 | I | 0.191697 | M | 0.260925 | -0.069228 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 653 | S | 0.75619 | F | 0.582898 | 0.173292 | No Change: Both D | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 865 | Q | 0.469343 | H | 0.45832 | 0.011023 | No Change: Both O | A lung large cell carcinoma sample |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1239 | Y | 0.099153 | F | 0.091185 | 0.007968 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1353 | Y | 0.111371 | S | 0.230708 | -0.119337 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1370 | C | 0.029262 | R | 0.065438 | -0.036176 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1506 | R | 0.267899 | G | 0.275356 | -0.007457 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 1999 | H | 0.356255 | N | 0.385181 | -0.028926 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2003 | K | 0.39933 | R | 0.319139 | 0.080191 | No Change: Both O | A colorectal adenocarcinoma sample |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2138 | F | 0.231886 | S | 0.480097 | -0.248211 | No Change: Both O | A gastric adenocarcinoma sample |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2203 | D | 0.513215 | N | 0.499058 | 0.014157 | D to O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2213 | D | 0.315065 | E | 0.335731 | -0.020666 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2228 | K | 0.442419 | Q | 0.430344 | 0.012075 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 790 | N | 0.17739 | S | 0.21931 | -0.04192 | No Change: Both O | - |
| P08922 | ROS1_HUMAN Proto-oncogene tyrosine-protein kinase ROS OS=Homo sapiens GN=ROS1 PE=1 SV=3 | 2328 | K | 0.589756 | R | 0.534298 | 0.055458 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 872 | R | 0.876856 | H | 0.867148 | 0.009708 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 985 | N | 0.471213 | Y | 0.297587 | 0.173626 | No Change: Both O | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1670 | A | 0.836844 | T | 0.859296 | -0.022452 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1691 | S | 0.942835 | P | 0.928056 | 0.014779 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 2033 | C | 0.254485 | Y | 0.226418 | 0.028067 | No Change: Both O | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 251 | Y | 0.673799 | C | 0.68071 | -0.006911 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 752 | T | 0.83334 | M | 0.7992 | 0.03414 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 945 | V | 0.597834 | L | 0.579975 | 0.017859 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1595 | R | 0.968041 | Q | 0.973804 | -0.005763 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 202 | D | 0.309759 | E | 0.335996 | -0.026237 | No Change: Both O | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 373 | T | 0.950617 | I | 0.919022 | 0.031595 | No Change: Both D | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 408 | I | 0.681137 | L | 0.703164 | -0.022027 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 663 | K | 0.776967 | N | 0.736536 | 0.040431 | No Change: Both D | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 669 | A | 0.846212 | T | 0.859326 | -0.013114 | No Change: Both D | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 706 | G | 0.62634 | R | 0.658502 | -0.032162 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 727 | C | 0.661667 | W | 0.527697 | 0.13397 | No Change: Both D | - |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 984 | D | 0.464708 | G | 0.445014 | 0.019694 | No Change: Both O | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1370 | K | 0.545286 | E | 0.572465 | -0.027179 | No Change: Both D | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1652 | R | 0.52761 | L | 0.415314 | 0.112296 | D to O | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| P56715 | RP1_HUMAN Oxygen-regulated protein 1 OS=Homo sapiens GN=RP1 PE=1 SV=1 | 1808 | L | 0.796662 | P | 0.870391 | -0.073729 | No Change: Both D | Retinitis pigmentosa type 1 (RP1) [MIM:180100] |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 44 | P | 0.360115 | A | 0.290448 | 0.069667 | No Change: Both O | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 56 | R | 0.288986 | C | 0.164852 | 0.124134 | No Change: Both O | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 112 | T | 0.957437 | S | 0.967618 | -0.010181 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 136 | R | 0.949288 | H | 0.922814 | 0.026474 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 487 | A | 0.949773 | V | 0.929548 | 0.020225 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 624 | A | 0.944371 | T | 0.953735 | -0.009364 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 792 | L | 0.958237 | P | 0.979836 | -0.021599 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 795 | E | 0.959139 | K | 0.955164 | 0.003975 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 860 | R | 0.995445 | W | 0.989374 | 0.006071 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1146 | R | 0.482549 | W | 0.265076 | 0.217473 | No Change: Both O | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1285 | A | 0.970346 | S | 0.978122 | -0.007776 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1319 | G | 0.996454 | A | 0.995228 | 0.001226 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1324 | E | 0.997737 | G | 0.996886 | 8.51E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1335 | G | 0.99834 | R | 0.998003 | 3.37E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1420 | G | 0.998649 | E | 0.999026 | -3.77E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1563 | A | 0.971684 | V | 0.958881 | 0.012803 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1575 | P | 0.813839 | R | 0.797281 | 0.016558 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1585 | S | 0.598686 | L | 0.444601 | 0.154085 | D to O | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1789 | A | 0.84431 | V | 0.800366 | 0.043944 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1896 | G | 0.988412 | D | 0.988595 | -1.83E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1969 | D | 0.998818 | V | 0.998406 | 4.12E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2026 | A | 0.999184 | E | 0.999454 | -2.70E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2034 | T | 0.998786 | A | 0.998946 | -1.60E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2149 | G | 0.998724 | V | 0.998246 | 4.78E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2168 | Q | 0.998417 | H | 0.997899 | 5.18E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2220 | E | 0.99889 | K | 0.998299 | 5.91E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2251 | E | 0.998962 | K | 0.998302 | 6.60E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2279 | P | 0.99919 | L | 0.998428 | 7.62E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2322 | E | 0.998837 | G | 0.998487 | 3.50E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2365 | G | 0.997259 | R | 0.997531 | -2.72E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2415 | H | 0.916524 | R | 0.932987 | -0.016463 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1547 | R | 0.995833 | S | 0.997199 | -0.001366 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 222 | H | 0.396447 | P | 0.486907 | -0.09046 | No Change: Both O | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 1340 | E | 0.998227 | G | 0.997547 | 6.80E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 2171 | E | 0.998285 | K | 0.997545 | 7.40E-04 | No Change: Both D | - |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 45 | R | 0.353698 | W | 0.152451 | 0.201247 | No Change: Both O | Occult macular dystrophy (OCMD) [MIM:613587] |
| Q8IWN7 | RP1L1_HUMAN Retinitis pigmentosa 1-like 1 protein OS=Homo sapiens GN=RP1L1 PE=1 SV=4 | 960 | W | 0.659115 | R | 0.820948 | -0.161833 | No Change: Both D | Occult macular dystrophy (OCMD) [MIM:613587] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 108 | C | 0.121615 | G | 0.181996 | -0.060381 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 118 | R | 0.156591 | H | 0.125315 | 0.031276 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 253 | L | 0.20135 | R | 0.296969 | -0.095619 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 282 | R | 0.390869 | W | 0.190435 | 0.200434 | No Change: Both O | - |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 338 | D | 0.367426 | Y | 0.220608 | 0.146818 | No Change: Both O | - |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 67 | C | 0.083063 | Y | 0.101286 | -0.018223 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 86 | C | 0.081033 | Y | 0.091679 | -0.010646 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 95 | P | 0.091626 | L | 0.050798 | 0.040828 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 118 | R | 0.156591 | L | 0.089249 | 0.067342 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 138 | E | 0.371261 | G | 0.326672 | 0.044589 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 188 | L | 0.21597 | P | 0.357365 | -0.141395 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 118 | R | 0.156591 | C | 0.09768 | 0.058911 | No Change: Both O | Retinitis pigmentosa type 2 (RP2) [MIM:312600] |
| O75695 | XRP2_HUMAN Protein XRP2 OS=Homo sapiens GN=RP2 PE=1 SV=4 | 144 | K | 0.174568 | R | 0.136642 | 0.037926 | No Change: Both O | - |
| Q8TA86 | RP9_HUMAN Retinitis pigmentosa 9 protein OS=Homo sapiens GN=RP9 PE=1 SV=2 | 137 | H | 0.395404 | L | 0.3122 | 0.083204 | No Change: Both O | Retinitis pigmentosa type 9 (RP9) [MIM:180104] |
| Q8TA86 | RP9_HUMAN Retinitis pigmentosa 9 protein OS=Homo sapiens GN=RP9 PE=1 SV=2 | 170 | D | 0.981647 | G | 0.972627 | 0.00902 | No Change: Both D | Retinitis pigmentosa type 9 (RP9) [MIM:180104] |
| Q8TA86 | RP9_HUMAN Retinitis pigmentosa 9 protein OS=Homo sapiens GN=RP9 PE=1 SV=2 | 210 | K | 0.999994 | R | 0.999991 | 3.00E-06 | No Change: Both D | - |
| P27694 | RFA1_HUMAN Replication protein A 70 kDa DNA-binding subunit OS=Homo sapiens GN=RPA1 PE=1 SV=2 | 351 | T | 0.245826 | A | 0.219239 | 0.026587 | No Change: Both O | - |
| P15927 | RFA2_HUMAN Replication protein A 32 kDa subunit OS=Homo sapiens GN=RPA2 PE=1 SV=1 | 14 | Y | 0.917866 | S | 0.967324 | -0.049458 | No Change: Both D | - |
| P15927 | RFA2_HUMAN Replication protein A 32 kDa subunit OS=Homo sapiens GN=RPA2 PE=1 SV=1 | 15 | G | 0.916625 | R | 0.901258 | 0.015367 | No Change: Both D | - |
| P15927 | RFA2_HUMAN Replication protein A 32 kDa subunit OS=Homo sapiens GN=RPA2 PE=1 SV=1 | 203 | N | 0.507181 | S | 0.523985 | -0.016804 | No Change: Both D | - |
| Q13156 | RFA4_HUMAN Replication protein A 30 kDa subunit OS=Homo sapiens GN=RPA4 PE=1 SV=2 | 33 | A | 0.562719 | T | 0.599572 | -0.036853 | No Change: Both D | - |
| Q86UA6 | RIP_HUMAN RPA-interacting protein OS=Homo sapiens GN=RPAIN PE=1 SV=1 | 103 | K | 0.698607 | N | 0.653873 | 0.044734 | No Change: Both D | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 525 | R | 0.897865 | Q | 0.874785 | 0.02308 | No Change: Both D | A colorectal cancer sample |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 165 | K | 0.763991 | M | 0.709817 | 0.054174 | No Change: Both D | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 429 | R | 0.359271 | Q | 0.382118 | -0.022847 | No Change: Both O | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 582 | R | 0.318827 | G | 0.309361 | 0.009466 | No Change: Both O | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 506 | E | 0.937418 | K | 0.930555 | 0.006863 | No Change: Both D | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 825 | Q | 0.505219 | E | 0.541582 | -0.036363 | No Change: Both D | - |
| Q9BWH6 | RPAP1_HUMAN RNA polymerase II-associated protein 1 OS=Homo sapiens GN=RPAP1 PE=1 SV=3 | 1108 | R | 0.281603 | G | 0.249388 | 0.032215 | No Change: Both O | - |
| Q9H6T3 | RPAP3_HUMAN RNA polymerase II-associated protein 3 OS=Homo sapiens GN=RPAP3 PE=1 SV=2 | 564 | D | 0.553278 | Y | 0.401801 | 0.151477 | D to O | - |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 22 | L | 0.548288 | P | 0.674237 | -0.125949 | No Change: Both D | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 40 | G | 0.106096 | S | 0.131203 | -0.025107 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 44 | R | 0.130137 | Q | 0.138563 | -0.008426 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 68 | H | 0.242778 | Y | 0.148762 | 0.094016 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 91 | R | 0.187197 | W | 0.071596 | 0.115601 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 91 | R | 0.187197 | Q | 0.185311 | 0.001886 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 132 | A | 0.161743 | T | 0.192771 | -0.031028 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 144 | Y | 0.155448 | D | 0.276256 | -0.120808 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 182 | H | 0.513826 | Y | 0.369676 | 0.14415 | D to O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 287 | V | 0.105159 | F | 0.095725 | 0.009434 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 321 | N | 0.181991 | K | 0.198355 | -0.016364 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 341 | L | 0.04128 | S | 0.090159 | -0.048879 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 363 | P | 0.546172 | T | 0.474995 | 0.071177 | D to O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 368 | Y | 0.222108 | H | 0.316431 | -0.094323 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 393 | A | 0.17169 | G | 0.200135 | -0.028445 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 417 | E | 0.275342 | Q | 0.254256 | 0.021086 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 452 | V | 0.217483 | G | 0.32266 | -0.105177 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 431 | Y | 0.199572 | C | 0.155909 | 0.043663 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 434 | A | 0.132092 | V | 0.095597 | 0.036495 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 515 | R | 0.310752 | W | 0.144823 | 0.165929 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 79 | Y | 0.209423 | H | 0.342569 | -0.133146 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 85 | R | 0.200914 | H | 0.196946 | 0.003968 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 95 | E | 0.222991 | Q | 0.180491 | 0.0425 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 102 | E | 0.100482 | K | 0.101944 | -0.001462 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 148 | E | 0.141863 | D | 0.128919 | 0.012944 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 167 | D | 0.115702 | Y | 0.062064 | 0.053638 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 182 | H | 0.513826 | N | 0.533029 | -0.019203 | No Change: Both D | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 239 | Y | 0.324259 | D | 0.472132 | -0.147873 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 294 | K | 0.430938 | T | 0.329649 | 0.101289 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 330 | C | 0.012291 | Y | 0.014946 | -0.002655 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 393 | A | 0.17169 | E | 0.254642 | -0.082952 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 435 | Y | 0.128641 | C | 0.09794 | 0.030701 | No Change: Both O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 436 | G | 0.133068 | V | 0.070235 | 0.062833 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 470 | P | 0.529216 | L | 0.370431 | 0.158785 | D to O | Leber congenital amaurosis type 2 (LCA2) [MIM:204100] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 473 | V | 0.41083 | D | 0.583 | -0.17217 | O to D | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q16518 | RPE65_HUMAN Retinoid isomerohydrolase OS=Homo sapiens GN=RPE65 PE=1 SV=3 | 528 | G | 0.396288 | V | 0.296813 | 0.099475 | No Change: Both O | Retinitis pigmentosa type 20 (RP20) [MIM:613794] |
| Q8IVN8 | RPESP_HUMAN RPE-spondin OS=Homo sapiens GN=RPESP PE=1 SV=2 | 186 | W | 0.131832 | R | 0.275002 | -0.14317 | No Change: Both O | - |
| Q8IVN8 | RPESP_HUMAN RPE-spondin OS=Homo sapiens GN=RPESP PE=1 SV=2 | 58 | F | 0.354865 | L | 0.323739 | 0.031126 | No Change: Both O | - |
| Q9H9Y2 | RPF1_HUMAN Ribosome production factor 1 OS=Homo sapiens GN=RPF1 PE=1 SV=2 | 9 | S | 0.990378 | G | 0.987979 | 0.002399 | No Change: Both D | - |
| Q9H9Y2 | RPF1_HUMAN Ribosome production factor 1 OS=Homo sapiens GN=RPF1 PE=1 SV=2 | 223 | M | 0.527754 | I | 0.459285 | 0.068469 | D to O | - |
| Q9H7B2 | RPF2_HUMAN Ribosome production factor 2 homolog OS=Homo sapiens GN=RPF2 PE=1 SV=2 | 41 | A | 0.417862 | G | 0.447288 | -0.029426 | No Change: Both O | - |
| Q9H7B2 | RPF2_HUMAN Ribosome production factor 2 homolog OS=Homo sapiens GN=RPF2 PE=1 SV=2 | 60 | G | 0.261563 | S | 0.316581 | -0.055018 | No Change: Both O | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 130 | F | 0.317978 | C | 0.305186 | 0.012792 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 235 | P | 0.413979 | S | 0.446459 | -0.03248 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 275 | G | 0.176183 | S | 0.198139 | -0.021956 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 60 | G | 0.237271 | V | 0.133963 | 0.103308 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 75 | I | 0.4925 | V | 0.542244 | -0.049744 | O to D | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 98 | H | 0.4319 | Q | 0.495585 | -0.063685 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 215 | G | 0.378024 | V | 0.243573 | 0.134451 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 250 | C | 0.167823 | R | 0.300629 | -0.132806 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 262 | A | 0.139641 | G | 0.186644 | -0.047003 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 425 | R | 0.891279 | K | 0.863493 | 0.027786 | No Change: Both D | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 431 | I | 0.832363 | V | 0.863347 | -0.030984 | No Change: Both D | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 436 | G | 0.787929 | D | 0.807055 | -0.019126 | No Change: Both D | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 566 | G | 0.682579 | E | 0.74631 | -0.063731 | No Change: Both D | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 302 | C | 0.258186 | R | 0.423866 | -0.16568 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 533 | T | 0.904411 | M | 0.899283 | 0.005128 | No Change: Both D | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 76 | S | 0.48822 | I | 0.27267 | 0.21555 | No Change: Both O | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 99 | T | 0.443905 | N | 0.471722 | -0.027817 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 289 | I | 0.444908 | V | 0.478937 | -0.034029 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 43 | G | 0.424608 | E | 0.480219 | -0.055611 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 43 | G | 0.424608 | R | 0.410315 | 0.014293 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 127 | R | 0.441119 | G | 0.475604 | -0.034485 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 173 | G | 0.426323 | R | 0.394848 | 0.031475 | No Change: Both O | Retinitis pigmentosa and sinorespiratory infections with or without deafness (RPDSI) [MIM:300455] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 173 | G | 0.426323 | R | 0.394848 | 0.031475 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 250 | C | 0.167823 | Y | 0.198566 | -0.030743 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 267 | G | 0.124499 | E | 0.14654 | -0.022041 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 302 | C | 0.258186 | Y | 0.323093 | -0.064907 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 312 | D | 0.118944 | N | 0.115154 | 0.00379 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 312 | D | 0.118944 | Y | 0.063173 | 0.055771 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 320 | G | 0.313715 | R | 0.290077 | 0.023638 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 345 | N | 0.042086 | D | 0.044338 | -0.002252 | No Change: Both O | - |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 152 | S | 0.59262 | L | 0.422363 | 0.170257 | D to O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 267 | G | 0.124499 | R | 0.10645 | 0.018049 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 285 | E | 0.401178 | G | 0.327632 | 0.073546 | No Change: Both O | Retinitis pigmentosa type 3 (RP3) [MIM:300029] |
| Q92834 | RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens GN=RPGR PE=1 SV=2 | 184 | Q | 0.208259 | H | 0.183307 | 0.024952 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 192 | K | 0.835314 | E | 0.850641 | -0.015327 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 547 | A | 0.761889 | S | 0.791479 | -0.02959 | No Change: Both D | Cone-rod dystrophy type 13 (CORD13) [MIM:608194] |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 601 | S | 0.245333 | L | 0.145503 | 0.09983 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 746 | G | 0.163594 | E | 0.203702 | -0.040108 | No Change: Both O | Leber congenital amaurosis type 6 (LCA6) [MIM:613826] |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 827 | R | 0.125949 | L | 0.071819 | 0.05413 | No Change: Both O | Cone-rod dystrophy type 13 (CORD13) [MIM:608194] |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 1033 | E | 0.380586 | Q | 0.355444 | 0.025142 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 1114 | D | 0.662474 | G | 0.6021 | 0.060374 | No Change: Both D | Leber congenital amaurosis type 6 (LCA6) [MIM:613826] |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 96 | P | 0.806695 | Q | 0.823302 | -0.016607 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 960 | A | 0.986744 | P | 0.991592 | -0.004848 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 1240 | G | 0.279537 | E | 0.35615 | -0.076613 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 32 | M | 0.787292 | L | 0.750059 | 0.037233 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 135 | S | 0.920056 | R | 0.93384 | -0.013784 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 318 | A | 0.581959 | V | 0.500254 | 0.081705 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 363 | R | 0.863849 | T | 0.847902 | 0.015947 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 585 | P | 0.545446 | S | 0.571103 | -0.025657 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 589 | Q | 0.521827 | H | 0.513347 | 0.00848 | No Change: Both D | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 598 | R | 0.250086 | Q | 0.273144 | -0.023058 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 603 | C | 0.265652 | S | 0.488161 | -0.222509 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 635 | A | 0.171105 | G | 0.191205 | -0.0201 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 638 | T | 0.250069 | I | 0.154598 | 0.095471 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 764 | A | 0.39171 | V | 0.317219 | 0.074491 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 806 | T | 0.114223 | I | 0.069166 | 0.045057 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 812 | R | 0.15215 | H | 0.134334 | 0.017816 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 814 | R | 0.193463 | L | 0.121939 | 0.071524 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 837 | A | 0.358719 | G | 0.399789 | -0.04107 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 838 | I | 0.365614 | V | 0.38247 | -0.016856 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 841 | A | 0.357867 | T | 0.386028 | -0.028161 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 852 | R | 0.185513 | Q | 0.194894 | -0.009381 | No Change: Both O | - |
| Q96KN7 | RPGR1_HUMAN X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 OS=Homo sapiens GN=RPGRIP1 PE=1 SV=2 | 883 | G | 0.490568 | D | 0.527237 | -0.036669 | O to D | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 615 | T | 0.260776 | P | 0.308174 | -0.047398 | No Change: Both O | Joubert syndrome type 7 (JBTS7) [MIM:611560] |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 677 | T | 0.193867 | I | 0.110649 | 0.083218 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 695 | A | 0.122244 | P | 0.161365 | -0.039121 | No Change: Both O | Joubert syndrome type 7 (JBTS7) [MIM:611560] |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 744 | R | 0.205605 | Q | 0.214639 | -0.009034 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 1025 | G | 0.873759 | S | 0.911134 | -0.037375 | No Change: Both D | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 1264 | D | 0.326883 | N | 0.275284 | 0.051599 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 659 | S | 0.238133 | P | 0.225867 | 0.012266 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 1183 | A | 0.431041 | G | 0.490709 | -0.059668 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 199 | S | 0.405429 | G | 0.381254 | 0.024175 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 229 | A | 0.795908 | T | 0.826214 | -0.030306 | No Change: Both D | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 447 | L | 0.818181 | S | 0.86566 | -0.047479 | No Change: Both D | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 546 | L | 0.380464 | F | 0.32909 | 0.051374 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 647 | V | 0.256255 | I | 0.216637 | 0.039618 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 937 | R | 0.476023 | L | 0.370829 | 0.105194 | No Change: Both O | - |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 1236 | R | 0.430892 | C | 0.275877 | 0.155015 | No Change: Both O | Meckel syndrome type 5 (MKS5) [MIM:611561] |
| Q68CZ1 | FTM_HUMAN Protein fantom OS=Homo sapiens GN=RPGRIP1L PE=1 SV=2 | 1264 | D | 0.326883 | Y | 0.152226 | 0.174657 | No Change: Both O | - |
| P49247 | RPIA_HUMAN Ribose-5-phosphate isomerase OS=Homo sapiens GN=RPIA PE=1 SV=3 | 135 | A | 0.124523 | V | 0.090431 | 0.034092 | No Change: Both O | Ribose 5-phosphate isomerase deficiency (RPID) [MIM:608611] |
| P27635 | RL10_HUMAN 60S ribosomal protein L10 OS=Homo sapiens GN=RPL10 PE=1 SV=4 | 202 | N | 0.261007 | S | 0.304572 | -0.043565 | No Change: Both O | - |
| P27635 | RL10_HUMAN 60S ribosomal protein L10 OS=Homo sapiens GN=RPL10 PE=1 SV=4 | 206 | L | 0.368213 | M | 0.414534 | -0.046321 | No Change: Both O | Autism X-linked type 5 (AUTSX5) [MIM:300847] |
| P27635 | RL10_HUMAN 60S ribosomal protein L10 OS=Homo sapiens GN=RPL10 PE=1 SV=4 | 213 | H | 0.758177 | Q | 0.732662 | 0.025515 | No Change: Both D | Autism X-linked type 5 (AUTSX5) [MIM:300847] |
| P62906 | RL10A_HUMAN 60S ribosomal protein L10a OS=Homo sapiens GN=RPL10A PE=1 SV=2 | 154 | T | 0.370406 | P | 0.429008 | -0.058602 | No Change: Both O | - |
| P62913 | RL11_HUMAN 60S ribosomal protein L11 OS=Homo sapiens GN=RPL11 PE=1 SV=2 | 20 | L | 0.299523 | H | 0.31164 | -0.012117 | No Change: Both O | Diamond-Blackfan anemia type 7 (DBA7) [MIM:612562] |
| P26373 | RL13_HUMAN 60S ribosomal protein L13 OS=Homo sapiens GN=RPL13 PE=1 SV=4 | 112 | A | 0.683897 | T | 0.715542 | -0.031645 | No Change: Both D | - |
| P26373 | RL13_HUMAN 60S ribosomal protein L13 OS=Homo sapiens GN=RPL13 PE=1 SV=4 | 170 | T | 0.572929 | P | 0.635215 | -0.062286 | No Change: Both D | - |
| P50914 | RL14_HUMAN 60S ribosomal protein L14 OS=Homo sapiens GN=RPL14 PE=1 SV=4 | 138 | A | 0.916418 | S | 0.926469 | -0.010051 | No Change: Both D | - |
| P46778 | RL21_HUMAN 60S ribosomal protein L21 OS=Homo sapiens GN=RPL21 PE=1 SV=2 | 15 | F | 0.497156 | S | 0.677866 | -0.18071 | O to D | - |
| P46778 | RL21_HUMAN 60S ribosomal protein L21 OS=Homo sapiens GN=RPL21 PE=1 SV=2 | 32 | R | 0.22386 | Q | 0.208306 | 0.015554 | No Change: Both O | Generalized hypotrichosis simplex (HTS) |
| Q6P5R6 | RL22L_HUMAN 60S ribosomal protein L22-like 1 OS=Homo sapiens GN=RPL22L1 PE=1 SV=2 | 97 | V | 0.35461 | F | 0.344757 | 0.009853 | No Change: Both O | - |
| P46779 | RL28_HUMAN 60S ribosomal protein L28 OS=Homo sapiens GN=RPL28 PE=1 SV=3 | 66 | R | 0.447806 | L | 0.291281 | 0.156525 | No Change: Both O | - |
| P39023 | RL3_HUMAN 60S ribosomal protein L3 OS=Homo sapiens GN=RPL3 PE=1 SV=2 | 78 | I | 0.245496 | T | 0.398353 | -0.152857 | No Change: Both O | - |
| P18077 | RL35A_HUMAN 60S ribosomal protein L35a OS=Homo sapiens GN=RPL35A PE=1 SV=2 | 33 | V | 0.195753 | I | 0.185501 | 0.010252 | No Change: Both O | Diamond-Blackfan anemia type 5 (DBA5) [MIM:612528] |
| Q9Y3U8 | RL36_HUMAN 60S ribosomal protein L36 OS=Homo sapiens GN=RPL36 PE=1 SV=3 | 67 | K | 0.530301 | E | 0.508667 | 0.021634 | No Change: Both D | - |
| Q969Q0 | RL36L_HUMAN 60S ribosomal protein L36a-like OS=Homo sapiens GN=RPL36AL PE=1 SV=3 | 66 | I | 0.549042 | V | 0.576163 | -0.027121 | No Change: Both D | - |
| P61927 | RL37_HUMAN 60S ribosomal protein L37 OS=Homo sapiens GN=RPL37 PE=1 SV=2 | 81 | G | 0.802787 | E | 0.822195 | -0.019408 | No Change: Both D | - |
| Q92901 | RL3L_HUMAN 60S ribosomal protein L3-like OS=Homo sapiens GN=RPL3L PE=1 SV=3 | 291 | P | 0.421547 | L | 0.284733 | 0.136814 | No Change: Both O | - |
| P46777 | RL5_HUMAN 60S ribosomal protein L5 OS=Homo sapiens GN=RPL5 PE=1 SV=3 | 210 | Y | 0.374001 | C | 0.354061 | 0.01994 | No Change: Both O | - |
| P46777 | RL5_HUMAN 60S ribosomal protein L5 OS=Homo sapiens GN=RPL5 PE=1 SV=3 | 140 | G | 0.197291 | S | 0.234876 | -0.037585 | No Change: Both O | Diamond-Blackfan anemia type 6 (DBA6) [MIM:612561] |
| P46777 | RL5_HUMAN 60S ribosomal protein L5 OS=Homo sapiens GN=RPL5 PE=1 SV=3 | 285 | A | 0.968779 | V | 0.953241 | 0.015538 | No Change: Both D | Diamond-Blackfan anemia type 6 (DBA6) [MIM:612561] |
| Q02878 | RL6_HUMAN 60S ribosomal protein L6 OS=Homo sapiens GN=RPL6 PE=1 SV=3 | 227 | H | 0.742573 | R | 0.779958 | -0.037385 | No Change: Both D | - |
| Q02878 | RL6_HUMAN 60S ribosomal protein L6 OS=Homo sapiens GN=RPL6 PE=1 SV=3 | 100 | K | 0.82532 | Q | 0.767865 | 0.057455 | No Change: Both D | A colorectal cancer sample |
| Q02878 | RL6_HUMAN 60S ribosomal protein L6 OS=Homo sapiens GN=RPL6 PE=1 SV=3 | 237 | K | 0.800112 | E | 0.799877 | 2.35E-04 | No Change: Both D | - |
| P62424 | RL7A_HUMAN 60S ribosomal protein L7a OS=Homo sapiens GN=RPL7A PE=1 SV=2 | 24 | A | 0.860633 | V | 0.846549 | 0.014084 | No Change: Both D | - |
| P62917 | RL8_HUMAN 60S ribosomal protein L8 OS=Homo sapiens GN=RPL8 PE=1 SV=2 | 98 | I | 0.189921 | V | 0.227109 | -0.037188 | No Change: Both O | - |
| P04844 | RPN2_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Homo sapiens GN=RPN2 PE=1 SV=3 | 597 | L | 0.058003 | F | 0.049686 | 0.008317 | No Change: Both O | - |
| Q9H633 | RPP21_HUMAN Ribonuclease P protein subunit p21 OS=Homo sapiens GN=RPP21 PE=2 SV=1 | 77 | Q | 0.835351 | H | 0.773181 | 0.06217 | No Change: Both D | - |
| Q9H633 | RPP21_HUMAN Ribonuclease P protein subunit p21 OS=Homo sapiens GN=RPP21 PE=2 SV=1 | 149 | Q | 0.968699 | K | 0.966952 | 0.001747 | No Change: Both D | - |
| P78346 | RPP30_HUMAN Ribonuclease P protein subunit p30 OS=Homo sapiens GN=RPP30 PE=1 SV=1 | 12 | G | 0.426183 | D | 0.477549 | -0.051366 | No Change: Both O | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 88 | E | 0.697831 | D | 0.681118 | 0.016713 | No Change: Both D | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 114 | A | 0.232889 | V | 0.186643 | 0.046246 | No Change: Both O | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 181 | A | 0.117289 | G | 0.134957 | -0.017668 | No Change: Both O | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 212 | I | 0.633014 | T | 0.71551 | -0.082496 | No Change: Both D | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 86 | I | 0.69981 | V | 0.718716 | -0.018906 | No Change: Both D | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 202 | S | 0.251613 | R | 0.218196 | 0.033417 | No Change: Both O | - |
| P78345 | RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens GN=RPP38 PE=1 SV=2 | 250 | R | 0.895573 | G | 0.875509 | 0.020064 | No Change: Both D | - |
| O75818 | RPP40_HUMAN Ribonuclease P protein subunit p40 OS=Homo sapiens GN=RPP40 PE=1 SV=3 | 314 | V | 0.165424 | I | 0.135077 | 0.030347 | No Change: Both O | - |
| Q96P16 | RPR1A_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 1A OS=Homo sapiens GN=RPRD1A PE=1 SV=1 | 21 | Q | 0.678591 | H | 0.64463 | 0.033961 | No Change: Both D | A breast cancer sample |
| Q5VT52 | RPRD2_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Homo sapiens GN=RPRD2 PE=1 SV=1 | 351 | M | 0.992102 | V | 0.988993 | 0.003109 | No Change: Both D | - |
| P08708 | RS17_HUMAN 40S ribosomal protein S17 OS=Homo sapiens GN=RPS17 PE=1 SV=2 | 36 | E | 0.188502 | K | 0.191595 | -0.003093 | No Change: Both O | - |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 62 | R | 0.328976 | W | 0.141713 | 0.187263 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 56 | R | 0.206265 | Q | 0.210832 | -0.004567 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 15 | V | 0.186937 | F | 0.170029 | 0.016908 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 18 | L | 0.156475 | P | 0.284904 | -0.128429 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 47 | P | 0.294731 | L | 0.182053 | 0.112678 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 52 | W | 0.164163 | R | 0.34293 | -0.178767 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 55 | T | 0.193825 | M | 0.153347 | 0.040478 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 61 | A | 0.302892 | E | 0.385636 | -0.082744 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 62 | R | 0.328976 | Q | 0.328334 | 6.42E-04 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 101 | R | 0.631211 | H | 0.562301 | 0.06891 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 120 | G | 0.804697 | R | 0.824444 | -0.019747 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 131 | L | 0.753643 | P | 0.862019 | -0.108376 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 17 | A | 0.164268 | P | 0.228911 | -0.064643 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 18 | L | 0.156475 | R | 0.254526 | -0.098051 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 59 | S | 0.260202 | F | 0.119117 | 0.141085 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 131 | L | 0.753643 | R | 0.862869 | -0.109226 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 21 | F | 0.247521 | S | 0.433672 | -0.186151 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 52 | W | 0.164163 | C | 0.191733 | -0.02757 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 57 | A | 0.217665 | P | 0.269141 | -0.051476 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 64 | L | 0.29641 | P | 0.440986 | -0.144576 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 76 | T | 0.439922 | P | 0.496964 | -0.057042 | No Change: Both O | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 127 | G | 0.784835 | E | 0.801194 | -0.016359 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| P39019 | RS19_HUMAN 40S ribosomal protein S19 OS=Homo sapiens GN=RPS19 PE=1 SV=2 | 135 | A | 0.732161 | T | 0.732716 | -5.55E-04 | No Change: Both D | Diamond-Blackfan anemia type 1 (DBA1) [MIM:105650] |
| Q86WX3 | AROS_HUMAN Active regulator of SIRT1 OS=Homo sapiens GN=RPS19BP1 PE=1 SV=1 | 124 | E | 0.787144 | A | 0.687703 | 0.099441 | No Change: Both D | - |
| P62854 | RS26_HUMAN 40S ribosomal protein S26 OS=Homo sapiens GN=RPS26 PE=1 SV=3 | 33 | D | 0.411705 | N | 0.417564 | -0.005859 | No Change: Both O | Diamond-Blackfan anemia type 10 (DBA10) [MIM:613309] |
| P62854 | RS26_HUMAN 40S ribosomal protein S26 OS=Homo sapiens GN=RPS26 PE=1 SV=3 | 115 | M | 0.999324 | T | 0.999398 | -7.40E-05 | No Change: Both D | Diamond-Blackfan anemia type 10 (DBA10) [MIM:613309] |
| P62753 | RS6_HUMAN 40S ribosomal protein S6 OS=Homo sapiens GN=RPS6 PE=1 SV=1 | 221 | K | 0.991943 | R | 0.991317 | 6.26E-04 | No Change: Both D | - |
| Q15418 | KS6A1_HUMAN Ribosomal protein S6 kinase alpha-1 OS=Homo sapiens GN=RPS6KA1 PE=1 SV=2 | 335 | K | 0.400489 | T | 0.339515 | 0.060974 | No Change: Both O | - |
| Q15349 | KS6A2_HUMAN Ribosomal protein S6 kinase alpha-2 OS=Homo sapiens GN=RPS6KA2 PE=1 SV=2 | 311 | E | 0.352189 | K | 0.350523 | 0.001666 | No Change: Both O | A metastatic melanoma sample |
| Q15349 | KS6A2_HUMAN Ribosomal protein S6 kinase alpha-2 OS=Homo sapiens GN=RPS6KA2 PE=1 SV=2 | 732 | R | 0.906233 | Q | 0.892897 | 0.013336 | No Change: Both D | A colorectal adenocarcinoma sample |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 38 | I | 0.905177 | S | 0.941304 | -0.036127 | No Change: Both D | - |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 75 | G | 0.281161 | V | 0.178894 | 0.102267 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 82 | V | 0.259444 | F | 0.244155 | 0.015289 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 114 | R | 0.437531 | W | 0.211097 | 0.226434 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 127 | H | 0.100729 | Q | 0.105136 | -0.004407 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 154 | D | 0.197201 | Y | 0.095435 | 0.101766 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 225 | A | 0.40018 | V | 0.337381 | 0.062799 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 227 | S | 0.23918 | A | 0.165439 | 0.073741 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 431 | G | 0.233906 | D | 0.258096 | -0.02419 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 729 | R | 0.53646 | Q | 0.535986 | 4.74E-04 | No Change: Both D | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 416 | I | 0.274196 | V | 0.310701 | -0.036505 | No Change: Both O | A breast cancer sample |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 483 | Y | 0.21134 | C | 0.165075 | 0.046265 | No Change: Both O | A gastric adenocarcinoma sample |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 608 | L | 0.047607 | F | 0.037301 | 0.010306 | No Change: Both O | A glioblastoma multiforme sample |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 723 | R | 0.512464 | C | 0.319013 | 0.193451 | D to O | - |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 115 | T | 0.437283 | S | 0.516577 | -0.079294 | O to D | Mental retardation X-linked type 19 (MRX19) [MIM:300844] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 189 | I | 0.159811 | K | 0.337595 | -0.177784 | No Change: Both O | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 268 | F | 0.439402 | S | 0.597639 | -0.158237 | O to D | Coffin-Lowry syndrome (CLS) [MIM:303600] |
| P51812 | KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | 383 | R | 0.287177 | W | 0.126899 | 0.160278 | No Change: Both O | Mental retardation X-linked type 19 (MRX19) [MIM:300844] |
| O75676 | KS6A4_HUMAN Ribosomal protein S6 kinase alpha-4 OS=Homo sapiens GN=RPS6KA4 PE=1 SV=1 | 236 | S | 0.302889 | L | 0.182865 | 0.120024 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| O75676 | KS6A4_HUMAN Ribosomal protein S6 kinase alpha-4 OS=Homo sapiens GN=RPS6KA4 PE=1 SV=1 | 758 | S | 0.996629 | A | 0.995774 | 8.55E-04 | No Change: Both D | - |
| O75582 | KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens GN=RPS6KA5 PE=1 SV=1 | 554 | D | 0.391609 | N | 0.384748 | 0.006861 | No Change: Both O | - |
| O75582 | KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens GN=RPS6KA5 PE=1 SV=1 | 574 | P | 0.476403 | L | 0.363816 | 0.112587 | No Change: Both O | - |
| O75582 | KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens GN=RPS6KA5 PE=1 SV=1 | 599 | Y | 0.341882 | C | 0.309831 | 0.032051 | No Change: Both O | - |
| O75582 | KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens GN=RPS6KA5 PE=1 SV=1 | 190 | H | 0.194158 | R | 0.19116 | 0.002998 | No Change: Both O | - |
| Q9UK32 | KS6A6_HUMAN Ribosomal protein S6 kinase alpha-6 OS=Homo sapiens GN=RPS6KA6 PE=1 SV=1 | 692 | D | 0.658066 | N | 0.656245 | 0.001821 | No Change: Both D | - |
| Q9UK32 | KS6A6_HUMAN Ribosomal protein S6 kinase alpha-6 OS=Homo sapiens GN=RPS6KA6 PE=1 SV=1 | 140 | Y | 0.093981 | C | 0.073913 | 0.020068 | No Change: Both O | A lung large cell carcinoma sample |
| Q9UK32 | KS6A6_HUMAN Ribosomal protein S6 kinase alpha-6 OS=Homo sapiens GN=RPS6KA6 PE=1 SV=1 | 258 | S | 0.107484 | T | 0.071086 | 0.036398 | No Change: Both O | A lung adenocarcinoma sample |
| P23443 | KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2 | 289 | G | 0.299331 | E | 0.343334 | -0.044003 | No Change: Both O | A colorectal cancer sample |
| P23443 | KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2 | 225 | M | 0.379792 | I | 0.298555 | 0.081237 | No Change: Both O | - |
| P23443 | KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2 | 272 | R | 0.209314 | C | 0.099811 | 0.109503 | No Change: Both O | - |
| P23443 | KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2 | 276 | W | 0.122176 | C | 0.132699 | -0.010523 | No Change: Both O | - |
| P23443 | KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2 | 398 | S | 0.767665 | A | 0.695589 | 0.072076 | No Change: Both D | - |
| Q9UBS0 | KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2 | 267 | P | 0.439884 | L | 0.289642 | 0.150242 | No Change: Both O | - |
| Q9UBS0 | KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2 | 368 | V | 0.74948 | M | 0.783519 | -0.034039 | No Change: Both D | - |
| Q9UBS0 | KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2 | 420 | A | 0.95228 | V | 0.949401 | 0.002879 | No Change: Both D | - |
| Q9UBS0 | KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2 | 443 | T | 0.998218 | M | 0.998106 | 1.12E-04 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 42 | P | 0.512763 | T | 0.463319 | 0.049444 | D to O | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 96 | E | 0.339933 | K | 0.31561 | 0.024323 | No Change: Both O | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 319 | P | 0.762125 | L | 0.659453 | 0.102672 | No Change: Both D | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 424 | P | 0.513278 | L | 0.418641 | 0.094637 | D to O | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 546 | A | 0.601057 | P | 0.693067 | -0.09201 | No Change: Both D | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 554 | L | 0.710005 | I | 0.685209 | 0.024796 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 575 | N | 0.912581 | S | 0.940827 | -0.028246 | No Change: Both D | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 663 | G | 0.802681 | A | 0.794641 | 0.00804 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 853 | L | 0.736497 | F | 0.714307 | 0.02219 | No Change: Both D | - |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 1003 | C | 0.225608 | Y | 0.268363 | -0.042755 | No Change: Both O | A lung adenocarcinoma sample |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 1022 | E | 0.442066 | K | 0.414091 | 0.027975 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q96S38 | KS6C1_HUMAN Ribosomal protein S6 kinase delta-1 OS=Homo sapiens GN=RPS6KC1 PE=1 SV=2 | 561 | P | 0.776679 | R | 0.749231 | 0.027448 | No Change: Both D | - |
| Q9Y6S9 | RPKL1_HUMAN Ribosomal protein S6 kinase-like 1 OS=Homo sapiens GN=RPS6KL1 PE=2 SV=1 | 21 | R | 0.645113 | Q | 0.654936 | -0.009823 | No Change: Both D | - |
| Q9Y6S9 | RPKL1_HUMAN Ribosomal protein S6 kinase-like 1 OS=Homo sapiens GN=RPS6KL1 PE=2 SV=1 | 121 | P | 0.605238 | L | 0.492244 | 0.112994 | D to O | - |
| Q9Y6S9 | RPKL1_HUMAN Ribosomal protein S6 kinase-like 1 OS=Homo sapiens GN=RPS6KL1 PE=2 SV=1 | 332 | R | 0.843734 | W | 0.711256 | 0.132478 | No Change: Both D | - |
| P62241 | RS8_HUMAN 40S ribosomal protein S8 OS=Homo sapiens GN=RPS8 PE=1 SV=2 | 110 | R | 0.23117 | G | 0.240714 | -0.009544 | No Change: Both O | - |
| P46781 | RS9_HUMAN 40S ribosomal protein S9 OS=Homo sapiens GN=RPS9 PE=1 SV=3 | 137 | V | 0.280893 | F | 0.241069 | 0.039824 | No Change: Both O | A breast cancer sample |
| P46781 | RS9_HUMAN 40S ribosomal protein S9 OS=Homo sapiens GN=RPS9 PE=1 SV=3 | 25 | L | 0.49127 | F | 0.46056 | 0.03071 | No Change: Both O | - |
| P08865 | RSSA_HUMAN 40S ribosomal protein SA OS=Homo sapiens GN=RPSA PE=1 SV=4 | 117 | R | 0.237142 | W | 0.088222 | 0.14892 | No Change: Both O | - |
| Q6XPR3 | RPTN_HUMAN Repetin OS=Homo sapiens GN=RPTN PE=1 SV=1 | 320 | S | 0.997321 | G | 0.996463 | 8.58E-04 | No Change: Both D | - |
| Q9UJJ7 | RUSD1_HUMAN RNA pseudouridylate synthase domain-containing protein 1 OS=Homo sapiens GN=RPUSD1 PE=2 SV=1 | 124 | E | 0.608552 | Q | 0.574209 | 0.034343 | No Change: Both D | - |
| Q9UJJ7 | RUSD1_HUMAN RNA pseudouridylate synthase domain-containing protein 1 OS=Homo sapiens GN=RPUSD1 PE=2 SV=1 | 247 | L | 0.755419 | P | 0.831644 | -0.076225 | No Change: Both D | - |
| Q6P087 | RUSD3_HUMAN RNA pseudouridylate synthase domain-containing protein 3 OS=Homo sapiens GN=RPUSD3 PE=2 SV=3 | 34 | D | 0.74202 | H | 0.714664 | 0.027356 | No Change: Both D | - |
| Q6P087 | RUSD3_HUMAN RNA pseudouridylate synthase domain-containing protein 3 OS=Homo sapiens GN=RPUSD3 PE=2 SV=3 | 181 | A | 0.396131 | P | 0.450519 | -0.054388 | No Change: Both O | - |
| Q6P087 | RUSD3_HUMAN RNA pseudouridylate synthase domain-containing protein 3 OS=Homo sapiens GN=RPUSD3 PE=2 SV=3 | 173 | A | 0.202162 | P | 0.269306 | -0.067144 | No Change: Both O | - |
| Q96CM3 | RUSD4_HUMAN RNA pseudouridylate synthase domain-containing protein 4 OS=Homo sapiens GN=RPUSD4 PE=2 SV=1 | 44 | Q | 0.604354 | R | 0.605846 | -0.001492 | No Change: Both D | - |
| Q96CM3 | RUSD4_HUMAN RNA pseudouridylate synthase domain-containing protein 4 OS=Homo sapiens GN=RPUSD4 PE=2 SV=1 | 58 | D | 0.864401 | G | 0.848703 | 0.015698 | No Change: Both D | - |
| Q96CM3 | RUSD4_HUMAN RNA pseudouridylate synthase domain-containing protein 4 OS=Homo sapiens GN=RPUSD4 PE=2 SV=1 | 155 | E | 0.377291 | D | 0.367812 | 0.009479 | No Change: Both O | - |
| Q96CM3 | RUSD4_HUMAN RNA pseudouridylate synthase domain-containing protein 4 OS=Homo sapiens GN=RPUSD4 PE=2 SV=1 | 209 | A | 0.608452 | V | 0.581817 | 0.026635 | No Change: Both D | - |
| Q92600 | RCD1_HUMAN Cell differentiation protein RCD1 homolog OS=Homo sapiens GN=RQCD1 PE=1 SV=1 | 143 | I | 0.123218 | T | 0.23429 | -0.111072 | No Change: Both O | - |
| P55042 | RAD_HUMAN GTP-binding protein RAD OS=Homo sapiens GN=RRAD PE=1 SV=2 | 66 | Q | 0.834285 | P | 0.869692 | -0.035407 | No Change: Both D | - |
| P62070 | RRAS2_HUMAN Ras-related protein R-Ras2 OS=Homo sapiens GN=RRAS2 PE=1 SV=1 | 72 | Q | 0.424194 | L | 0.30778 | 0.116414 | No Change: Both O | An ovarian cancer sample |
| Q9P2E9 | RRBP1_HUMAN Ribosome-binding protein 1 OS=Homo sapiens GN=RRBP1 PE=1 SV=4 | 1324 | R | 0.957558 | L | 0.941363 | 0.016195 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 195 | G | 0.826414 | R | 0.827323 | -9.09E-04 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 783 | G | 0.686784 | V | 0.535801 | 0.150983 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 1171 | D | 0.853702 | N | 0.846536 | 0.007166 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 1384 | G | 0.815081 | R | 0.796028 | 0.019053 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 1467 | L | 0.997671 | P | 0.999045 | -0.001374 | No Change: Both D | - |
| Q92766 | RREB1_HUMAN Ras-responsive element-binding protein 1 OS=Homo sapiens GN=RREB1 PE=1 SV=3 | 1499 | S | 0.984392 | Y | 0.963857 | 0.020535 | No Change: Both D | - |
| P23921 | RIR1_HUMAN Ribonucleoside-diphosphate reductase large subunit OS=Homo sapiens GN=RRM1 PE=1 SV=1 | 590 | K | 0.235016 | Q | 0.182189 | 0.052827 | No Change: Both O | - |
| P23921 | RIR1_HUMAN Ribonucleoside-diphosphate reductase large subunit OS=Homo sapiens GN=RRM1 PE=1 SV=1 | 778 | V | 0.884058 | A | 0.9281 | -0.044042 | No Change: Both D | - |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 115 | V | 0.390219 | L | 0.372995 | 0.017224 | No Change: Both O | Colorectal adenocarcinomas cell line |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 64 | W | 0.223454 | R | 0.420542 | -0.197088 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 194 | E | 0.142461 | G | 0.122519 | 0.019942 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 194 | E | 0.142461 | K | 0.140756 | 0.001705 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 224 | I | 0.41113 | S | 0.642595 | -0.231465 | O to D | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 236 | C | 0.031361 | F | 0.03303 | -0.001669 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 282 | M | 0.048501 | I | 0.032288 | 0.016213 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 317 | L | 0.359369 | V | 0.365823 | -0.006454 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8A (MTDPS8A) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 110 | R | 0.355474 | H | 0.359748 | -0.004274 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8B (MTDPS8B) [MIM:612075] |
| Q7LG56 | RIR2B_HUMAN Ribonucleoside-diphosphate reductase subunit M2 B OS=Homo sapiens GN=RRM2B PE=1 SV=1 | 121 | R | 0.110414 | H | 0.111737 | -0.001323 | No Change: Both O | Mitochondrial DNA depletion syndrome type 8B (MTDPS8B) [MIM:612075] |
| Q9NYV6 | RRN3_HUMAN RNA polymerase I-specific transcription initiation factor RRN3 OS=Homo sapiens GN=RRN3 PE=1 SV=1 | 348 | I | 0.085727 | M | 0.121284 | -0.035557 | No Change: Both O | - |
| Q96FB5 | RRNAD_HUMAN Protein RRNAD1 OS=Homo sapiens GN=RRNAD1 PE=2 SV=2 | 400 | V | 0.289741 | L | 0.291587 | -0.001846 | No Change: Both O | - |
| P56182 | RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens GN=RRP1 PE=1 SV=1 | 194 | I | 0.104824 | V | 0.113286 | -0.008462 | No Change: Both O | - |
| P56182 | RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens GN=RRP1 PE=1 SV=1 | 326 | K | 0.362946 | R | 0.339824 | 0.023122 | No Change: Both O | - |
| Q5JTH9 | RRP12_HUMAN RRP12-like protein OS=Homo sapiens GN=RRP12 PE=1 SV=2 | 1145 | G | 0.748898 | S | 0.761317 | -0.012419 | No Change: Both D | - |
| Q5JTH9 | RRP12_HUMAN RRP12-like protein OS=Homo sapiens GN=RRP12 PE=1 SV=2 | 1281 | R | 0.875554 | Q | 0.870339 | 0.005215 | No Change: Both D | - |
| Q9Y3B9 | RRP15_HUMAN RRP15-like protein OS=Homo sapiens GN=RRP15 PE=1 SV=2 | 149 | K | 0.692552 | N | 0.652575 | 0.039977 | No Change: Both D | - |
| Q9Y3B9 | RRP15_HUMAN RRP15-like protein OS=Homo sapiens GN=RRP15 PE=1 SV=2 | 230 | K | 0.883472 | R | 0.870295 | 0.013177 | No Change: Both D | - |
| Q9Y3B9 | RRP15_HUMAN RRP15-like protein OS=Homo sapiens GN=RRP15 PE=1 SV=2 | 32 | A | 0.905355 | V | 0.881891 | 0.023464 | No Change: Both D | - |
| Q96EU6 | RRP36_HUMAN Ribosomal RNA processing protein 36 homolog OS=Homo sapiens GN=RRP36 PE=1 SV=1 | 78 | A | 0.733294 | G | 0.741979 | -0.008685 | No Change: Both D | - |
| Q9Y3A4 | RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens GN=RRP7A PE=1 SV=2 | 75 | L | 0.544025 | M | 0.554788 | -0.010763 | No Change: Both D | - |
| Q9Y3A4 | RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens GN=RRP7A PE=1 SV=2 | 85 | V | 0.626355 | I | 0.551099 | 0.075256 | No Change: Both D | - |
| Q9Y3A4 | RRP7A_HUMAN Ribosomal RNA-processing protein 7 homolog A OS=Homo sapiens GN=RRP7A PE=1 SV=2 | 88 | V | 0.674107 | I | 0.600049 | 0.074058 | No Change: Both D | - |
| O43159 | RRP8_HUMAN Ribosomal RNA-processing protein 8 OS=Homo sapiens GN=RRP8 PE=1 SV=2 | 145 | A | 0.873715 | P | 0.907749 | -0.034034 | No Change: Both D | - |
| O43159 | RRP8_HUMAN Ribosomal RNA-processing protein 8 OS=Homo sapiens GN=RRP8 PE=1 SV=2 | 329 | P | 0.273858 | S | 0.299934 | -0.026076 | No Change: Both O | - |
| O43818 | U3IP2_HUMAN U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens GN=RRP9 PE=1 SV=1 | 8 | R | 0.996329 | G | 0.99583 | 4.99E-04 | No Change: Both D | A breast cancer sample |
| O43818 | U3IP2_HUMAN U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens GN=RRP9 PE=1 SV=1 | 342 | A | 0.518755 | E | 0.582096 | -0.063341 | No Change: Both D | A breast cancer sample |
| Q15050 | RRS1_HUMAN Ribosome biogenesis regulatory protein homolog OS=Homo sapiens GN=RRS1 PE=1 SV=2 | 191 | R | 0.746796 | L | 0.650422 | 0.096374 | No Change: Both D | - |
| Q15050 | RRS1_HUMAN Ribosome biogenesis regulatory protein homolog OS=Homo sapiens GN=RRS1 PE=1 SV=2 | 116 | Q | 0.604735 | H | 0.509556 | 0.095179 | No Change: Both D | - |
| Q15050 | RRS1_HUMAN Ribosome biogenesis regulatory protein homolog OS=Homo sapiens GN=RRS1 PE=1 SV=2 | 126 | K | 0.555202 | R | 0.552508 | 0.002694 | No Change: Both D | - |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 72 | E | 0.490133 | D | 0.462886 | 0.027247 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 72 | E | 0.490133 | K | 0.486051 | 0.004082 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 74 | G | 0.485254 | V | 0.357216 | 0.128038 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 96 | W | 0.199191 | R | 0.363201 | -0.16401 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 102 | R | 0.395464 | W | 0.227179 | 0.168285 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 109 | G | 0.13381 | R | 0.126371 | 0.007439 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 12 | L | 0.055128 | H | 0.068233 | -0.013105 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 13 | L | 0.063609 | P | 0.117369 | -0.05376 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 59 | C | 0.327899 | S | 0.465175 | -0.137276 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 65 | Y | 0.302349 | C | 0.373344 | -0.070995 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 70 | G | 0.455652 | A | 0.392417 | 0.063235 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 70 | G | 0.455652 | S | 0.507597 | -0.051945 | O to D | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 89 | Y | 0.22868 | C | 0.213569 | 0.015111 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 98 | A | 0.298897 | E | 0.372709 | -0.073812 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 102 | R | 0.395464 | Q | 0.42328 | -0.027816 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 103 | L | 0.362705 | R | 0.498614 | -0.135909 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 108 | F | 0.150915 | C | 0.153961 | -0.003046 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 109 | G | 0.13381 | E | 0.155312 | -0.021502 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 109 | G | 0.13381 | W | 0.053158 | 0.080652 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 110 | C | 0.122189 | Y | 0.146653 | -0.024464 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 112 | W | 0.155115 | C | 0.195078 | -0.039963 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 113 | L | 0.176915 | F | 0.17188 | 0.005035 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 127 | L | 0.177156 | P | 0.296967 | -0.119811 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 135 | G | 0.12929 | V | 0.07086 | 0.05843 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 136 | I | 0.125598 | T | 0.21577 | -0.090172 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 138 | T | 0.124469 | A | 0.109021 | 0.015448 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 140 | G | 0.146505 | E | 0.178232 | -0.031727 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 140 | G | 0.146505 | R | 0.140633 | 0.005872 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 141 | R | 0.148112 | C | 0.077813 | 0.070299 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 141 | R | 0.148112 | G | 0.169078 | -0.020966 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 141 | R | 0.148112 | H | 0.149018 | -9.06E-04 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 142 | C | 0.14575 | W | 0.13246 | 0.01329 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 143 | D | 0.167017 | V | 0.080221 | 0.086796 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 146 | E | 0.177069 | D | 0.174356 | 0.002713 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 146 | E | 0.177069 | K | 0.187994 | -0.010925 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 155 | Y | 0.264076 | C | 0.210074 | 0.054002 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 158 | D | 0.207943 | N | 0.207428 | 5.15E-04 | No Change: Both O | - |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 163 | W | 0.123442 | C | 0.153676 | -0.030234 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 178 | G | 0.489302 | D | 0.525798 | -0.036496 | O to D | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 182 | R | 0.523558 | C | 0.325421 | 0.198137 | D to O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 192 | P | 0.191847 | R | 0.170387 | 0.02146 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 192 | P | 0.191847 | S | 0.215357 | -0.02351 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 193 | P | 0.149784 | L | 0.075683 | 0.074101 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 193 | P | 0.149784 | S | 0.168573 | -0.018789 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 197 | R | 0.084829 | C | 0.035827 | 0.049002 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 197 | R | 0.084829 | H | 0.076655 | 0.008174 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 199 | I | 0.061717 | T | 0.102461 | -0.040744 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 200 | R | 0.054006 | C | 0.022883 | 0.031123 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 200 | R | 0.054006 | H | 0.051007 | 0.002999 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 203 | P | 0.04079 | L | 0.020045 | 0.020745 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 207 | H | 0.036892 | Q | 0.041869 | -0.004977 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 209 | R | 0.045776 | H | 0.044883 | 8.93E-04 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 213 | R | 0.076147 | W | 0.028138 | 0.048009 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 215 | E | 0.085645 | K | 0.083522 | 0.002123 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 215 | E | 0.085645 | Q | 0.064222 | 0.021423 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 216 | L | 0.112392 | P | 0.202608 | -0.090216 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 219 | C | 0.307833 | G | 0.469099 | -0.161266 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 219 | C | 0.307833 | R | 0.454291 | -0.146458 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 223 | C | 0.73693 | R | 0.841077 | -0.104147 | No Change: Both D | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 222 | K | 0.664301 | N | 0.633077 | 0.031224 | No Change: Both D | - |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 73 | S | 0.519417 | P | 0.516111 | 0.003306 | No Change: Both D | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 145 | D | 0.176886 | H | 0.142151 | 0.034735 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 156 | R | 0.249823 | G | 0.247888 | 0.001935 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 192 | P | 0.191847 | L | 0.100956 | 0.090891 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 209 | R | 0.045776 | C | 0.019617 | 0.026159 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| O15537 | XLRS1_HUMAN Retinoschisin OS=Homo sapiens GN=RS1 PE=1 SV=2 | 213 | R | 0.076147 | Q | 0.076874 | -7.27E-04 | No Change: Both O | Retinoschisis juvenile X-linked type 1 (XLRS1) [MIM:312700] |
| Q9HA92 | RSAD1_HUMAN Radical S-adenosyl methionine domain-containing protein 1 mitochondrial OS=Homo sapiens GN=RSAD1 PE=2 SV=2 | 119 | A | 0.432958 | T | 0.432366 | 5.92E-04 | No Change: Both O | - |
| Q9HA92 | RSAD1_HUMAN Radical S-adenosyl methionine domain-containing protein 1 mitochondrial OS=Homo sapiens GN=RSAD1 PE=2 SV=2 | 126 | L | 0.476692 | S | 0.626583 | -0.149891 | O to D | - |
| Q9HA92 | RSAD1_HUMAN Radical S-adenosyl methionine domain-containing protein 1 mitochondrial OS=Homo sapiens GN=RSAD1 PE=2 SV=2 | 354 | E | 0.212672 | Q | 0.165056 | 0.047616 | No Change: Both O | - |
| Q8WXG1 | RSAD2_HUMAN Radical S-adenosyl methionine domain-containing protein 2 OS=Homo sapiens GN=RSAD2 PE=1 SV=1 | 42 | L | 0.282928 | R | 0.373555 | -0.090627 | No Change: Both O | - |
| Q8WXG1 | RSAD2_HUMAN Radical S-adenosyl methionine domain-containing protein 2 OS=Homo sapiens GN=RSAD2 PE=1 SV=1 | 52 | V | 0.519428 | I | 0.475252 | 0.044176 | D to O | - |
| Q92681 | RSCA1_HUMAN Regulatory solute carrier protein family 1 member 1 OS=Homo sapiens GN=RSC1A1 PE=2 SV=1 | 62 | F | 0.908654 | L | 0.933817 | -0.025163 | No Change: Both D | - |
| Q92681 | RSCA1_HUMAN Regulatory solute carrier protein family 1 member 1 OS=Homo sapiens GN=RSC1A1 PE=2 SV=1 | 191 | C | 0.638908 | W | 0.532304 | 0.106604 | No Change: Both D | - |
| Q92681 | RSCA1_HUMAN Regulatory solute carrier protein family 1 member 1 OS=Homo sapiens GN=RSC1A1 PE=2 SV=1 | 271 | N | 0.47851 | S | 0.506663 | -0.028153 | O to D | - |
| Q96T23 | RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens GN=RSF1 PE=1 SV=2 | 475 | S | 0.872432 | P | 0.869218 | 0.003214 | No Change: Both D | - |
| Q96T23 | RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens GN=RSF1 PE=1 SV=2 | 304 | E | 0.979449 | D | 0.97357 | 0.005879 | No Change: Both D | - |
| Q9BU20 | RSG1_HUMAN REM2- and Rab-like small GTPase 1 OS=Homo sapiens GN=RSG1 PE=2 SV=2 | 86 | E | 0.396168 | G | 0.348792 | 0.047376 | No Change: Both O | - |
| B2RC85 | R10B2_HUMAN Radial spoke head 10 homolog B2 OS=Homo sapiens GN=RSPH10B2 PE=2 SV=2 | 836 | E | 0.626694 | K | 0.620085 | 0.006609 | No Change: Both D | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 201 | N | 0.428136 | S | 0.477529 | -0.049393 | No Change: Both O | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 213 | R | 0.668745 | Q | 0.669253 | -5.08E-04 | No Change: Both D | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 398 | R | 0.329432 | Q | 0.342267 | -0.012835 | No Change: Both O | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 439 | M | 0.135032 | T | 0.159331 | -0.024299 | No Change: Both O | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 484 | E | 0.914758 | K | 0.898219 | 0.016539 | No Change: Both D | - |
| Q86UC2 | RSPH3_HUMAN Radial spoke head protein 3 homolog OS=Homo sapiens GN=RSPH3 PE=2 SV=1 | 518 | G | 0.898413 | D | 0.910809 | -0.012396 | No Change: Both D | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 149 | T | 0.934411 | S | 0.951216 | -0.016805 | No Change: Both D | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 556 | R | 0.418182 | H | 0.436209 | -0.018027 | No Change: Both O | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 589 | L | 0.657981 | P | 0.765101 | -0.10712 | No Change: Both D | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 627 | N | 0.109556 | H | 0.099761 | 0.009795 | No Change: Both O | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 700 | A | 0.968905 | V | 0.955222 | 0.013683 | No Change: Both D | - |
| Q5TD94 | RSH4A_HUMAN Radial spoke head protein 4 homolog A OS=Homo sapiens GN=RSPH4A PE=1 SV=1 | 87 | P | 0.998476 | S | 0.998377 | 9.90E-05 | No Change: Both D | Primary ciliary dyskinesia type 11 (CILD11) [MIM:612649] |
| Q9H0K4 | RSH6A_HUMAN Radial spoke head protein 6 homolog A OS=Homo sapiens GN=RSPH6A PE=2 SV=1 | 50 | A | 0.956183 | V | 0.935742 | 0.020441 | No Change: Both D | - |
| Q9H1X1 | RSPH9_HUMAN Radial spoke head protein 9 homolog OS=Homo sapiens GN=RSPH9 PE=1 SV=1 | 261 | V | 0.211471 | I | 0.176362 | 0.035109 | No Change: Both O | - |
| Q6UXX9 | RSPO2_HUMAN R-spondin-2 OS=Homo sapiens GN=RSPO2 PE=1 SV=2 | 186 | L | 0.612715 | P | 0.740986 | -0.128271 | No Change: Both D | - |
| Q2I0M5 | RSPO4_HUMAN R-spondin-4 OS=Homo sapiens GN=RSPO4 PE=1 SV=2 | 65 | Q | 0.286796 | R | 0.298718 | -0.011922 | No Change: Both O | Nail disorder non-syndromic congenital type 4 (NDNC4) [MIM:206800] |
| Q2I0M5 | RSPO4_HUMAN R-spondin-4 OS=Homo sapiens GN=RSPO4 PE=1 SV=2 | 95 | C | 0.366973 | F | 0.309693 | 0.05728 | No Change: Both O | Nail disorder non-syndromic congenital type 4 (NDNC4) [MIM:206800] |
| Q2I0M5 | RSPO4_HUMAN R-spondin-4 OS=Homo sapiens GN=RSPO4 PE=1 SV=2 | 107 | C | 0.27607 | R | 0.340462 | -0.064392 | No Change: Both O | Nail disorder non-syndromic congenital type 4 (NDNC4) [MIM:206800] |
| Q2I0M5 | RSPO4_HUMAN R-spondin-4 OS=Homo sapiens GN=RSPO4 PE=1 SV=2 | 118 | C | 0.401177 | Y | 0.335872 | 0.065305 | No Change: Both O | Nail disorder non-syndromic congenital type 4 (NDNC4) [MIM:206800] |
| Q2I0M5 | RSPO4_HUMAN R-spondin-4 OS=Homo sapiens GN=RSPO4 PE=1 SV=2 | 106 | R | 0.276907 | Q | 0.292764 | -0.015857 | No Change: Both O | - |
| Q7L4I2 | RSRC2_HUMAN Arginine/serine-rich coiled-coil protein 2 OS=Homo sapiens GN=RSRC2 PE=1 SV=1 | 88 | H | 0.999766 | R | 0.999807 | -4.10E-05 | No Change: Both D | - |
| Q9BSG5 | RTBDN_HUMAN Retbindin OS=Homo sapiens GN=RTBDN PE=2 SV=2 | 198 | G | 0.975441 | A | 0.975113 | 3.28E-04 | No Change: Both D | - |
| Q9UHP6 | RTDR1_HUMAN Rhabdoid tumor deletion region protein 1 OS=Homo sapiens GN=RTDR1 PE=2 SV=1 | 42 | T | 0.542748 | M | 0.535188 | 0.00756 | No Change: Both D | - |
| Q9NZ71 | RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens GN=RTEL1 PE=1 SV=2 | 124 | N | 0.352132 | S | 0.398126 | -0.045994 | No Change: Both O | - |
| Q9NZ71 | RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens GN=RTEL1 PE=1 SV=2 | 1042 | Q | 0.947643 | H | 0.933816 | 0.013827 | No Change: Both D | - |
| Q8IZC4 | RTKN2_HUMAN Rhotekin-2 OS=Homo sapiens GN=RTKN2 PE=2 SV=1 | 101 | K | 0.377462 | T | 0.297788 | 0.079674 | No Change: Both O | - |
| Q8IZC4 | RTKN2_HUMAN Rhotekin-2 OS=Homo sapiens GN=RTKN2 PE=2 SV=1 | 462 | H | 0.448365 | R | 0.445649 | 0.002716 | No Change: Both O | - |
| A6NKG5 | RTL1_HUMAN Retrotransposon-like protein 1 OS=Homo sapiens GN=RTL1 PE=2 SV=2 | 849 | E | 0.217729 | Q | 0.184906 | 0.032823 | No Change: Both O | - |
| Q16799 | RTN1_HUMAN Reticulon-1 OS=Homo sapiens GN=RTN1 PE=1 SV=1 | 247 | G | 0.719187 | E | 0.797603 | -0.078416 | No Change: Both D | - |
| Q16799 | RTN1_HUMAN Reticulon-1 OS=Homo sapiens GN=RTN1 PE=1 SV=1 | 357 | I | 0.838204 | V | 0.83616 | 0.002044 | No Change: Both D | - |
| O75298 | RTN2_HUMAN Reticulon-2 OS=Homo sapiens GN=RTN2 PE=2 SV=1 | 425 | R | 0.489228 | Q | 0.508824 | -0.019596 | O to D | - |
| O95197 | RTN3_HUMAN Reticulon-3 OS=Homo sapiens GN=RTN3 PE=1 SV=2 | 6 | A | 0.993219 | E | 0.994535 | -0.001316 | No Change: Both D | - |
| O95197 | RTN3_HUMAN Reticulon-3 OS=Homo sapiens GN=RTN3 PE=1 SV=2 | 501 | D | 0.816253 | H | 0.754456 | 0.061797 | No Change: Both D | - |
| Q9NQC3 | RTN4_HUMAN Reticulon-4 OS=Homo sapiens GN=RTN4 PE=1 SV=2 | 429 | L | 0.929805 | V | 0.926544 | 0.003261 | No Change: Both D | A colorectal cancer sample |
| Q9NQC3 | RTN4_HUMAN Reticulon-4 OS=Homo sapiens GN=RTN4 PE=1 SV=2 | 357 | D | 0.788496 | V | 0.710424 | 0.078072 | No Change: Both D | - |
| Q9NQC3 | RTN4_HUMAN Reticulon-4 OS=Homo sapiens GN=RTN4 PE=1 SV=2 | 899 | E | 0.627461 | Q | 0.569154 | 0.058307 | No Change: Both D | - |
| Q9NQC3 | RTN4_HUMAN Reticulon-4 OS=Homo sapiens GN=RTN4 PE=1 SV=2 | 920 | S | 0.636014 | C | 0.481859 | 0.154155 | D to O | - |
| P59025 | RTP1_HUMAN Receptor-transporting protein 1 OS=Homo sapiens GN=RTP1 PE=2 SV=2 | 124 | R | 0.273388 | S | 0.32799 | -0.054602 | No Change: Both O | A breast cancer sample |
| P59025 | RTP1_HUMAN Receptor-transporting protein 1 OS=Homo sapiens GN=RTP1 PE=2 SV=2 | 212 | A | 0.555815 | G | 0.595118 | -0.039303 | No Change: Both D | - |
| P59025 | RTP1_HUMAN Receptor-transporting protein 1 OS=Homo sapiens GN=RTP1 PE=2 SV=2 | 229 | Q | 0.718211 | E | 0.738985 | -0.020774 | No Change: Both D | - |
| Q5QGT7 | RTP2_HUMAN Receptor-transporting protein 2 OS=Homo sapiens GN=RTP2 PE=2 SV=1 | 82 | Q | 0.363754 | R | 0.369089 | -0.005335 | No Change: Both O | - |
| Q96DX8 | RTP4_HUMAN Receptor-transporting protein 4 OS=Homo sapiens GN=RTP4 PE=2 SV=3 | 79 | T | 0.265833 | I | 0.158434 | 0.107399 | No Change: Both O | - |
| Q96DX8 | RTP4_HUMAN Receptor-transporting protein 4 OS=Homo sapiens GN=RTP4 PE=2 SV=3 | 168 | S | 0.555607 | N | 0.479647 | 0.07596 | D to O | - |
| Q86VV8 | RTTN_HUMAN Rotatin OS=Homo sapiens GN=RTTN PE=1 SV=3 | 126 | S | 0.589212 | A | 0.491197 | 0.098015 | D to O | - |
| Q86VV8 | RTTN_HUMAN Rotatin OS=Homo sapiens GN=RTTN PE=1 SV=3 | 245 | K | 0.362089 | R | 0.311462 | 0.050627 | No Change: Both O | - |
| Q86VV8 | RTTN_HUMAN Rotatin OS=Homo sapiens GN=RTTN PE=1 SV=3 | 1742 | H | 0.050205 | R | 0.046224 | 0.003981 | No Change: Both O | - |
| Q86VV8 | RTTN_HUMAN Rotatin OS=Homo sapiens GN=RTTN PE=1 SV=3 | 1761 | F | 0.066681 | S | 0.175617 | -0.108936 | No Change: Both O | - |
| Q96T51 | RUFY1_HUMAN RUN and FYVE domain-containing protein 1 OS=Homo sapiens GN=RUFY1 PE=1 SV=2 | 267 | C | 0.205763 | F | 0.213045 | -0.007282 | No Change: Both O | A breast cancer sample |
| Q96T51 | RUFY1_HUMAN RUN and FYVE domain-containing protein 1 OS=Homo sapiens GN=RUFY1 PE=1 SV=2 | 298 | H | 0.523694 | Q | 0.552985 | -0.029291 | No Change: Both D | - |
| Q8WXA3 | RUFY2_HUMAN RUN and FYVE domain-containing protein 2 OS=Homo sapiens GN=RUFY2 PE=1 SV=2 | 622 | C | 0.718097 | S | 0.789472 | -0.071375 | No Change: Both D | - |
| Q96C34 | RUND1_HUMAN RUN domain-containing protein 1 OS=Homo sapiens GN=RUNDC1 PE=1 SV=3 | 4 | V | 0.942393 | I | 0.903605 | 0.038788 | No Change: Both D | - |
| Q96C34 | RUND1_HUMAN RUN domain-containing protein 1 OS=Homo sapiens GN=RUNDC1 PE=1 SV=3 | 160 | W | 0.925158 | R | 0.975035 | -0.049877 | No Change: Both D | - |
| Q96C34 | RUND1_HUMAN RUN domain-containing protein 1 OS=Homo sapiens GN=RUNDC1 PE=1 SV=3 | 397 | L | 0.469198 | M | 0.512059 | -0.042861 | O to D | - |
| Q96C34 | RUND1_HUMAN RUN domain-containing protein 1 OS=Homo sapiens GN=RUNDC1 PE=1 SV=3 | 566 | E | 0.320155 | K | 0.331726 | -0.011571 | No Change: Both O | - |
| Q96NL0 | RUN3B_HUMAN RUN domain-containing protein 3B OS=Homo sapiens GN=RUNDC3B PE=1 SV=1 | 47 | L | 0.20471 | M | 0.246578 | -0.041868 | No Change: Both O | - |
| Q96NL0 | RUN3B_HUMAN RUN domain-containing protein 3B OS=Homo sapiens GN=RUNDC3B PE=1 SV=1 | 206 | E | 0.341381 | G | 0.317611 | 0.02377 | No Change: Both O | - |
| Q96NL0 | RUN3B_HUMAN RUN domain-containing protein 3B OS=Homo sapiens GN=RUNDC3B PE=1 SV=1 | 440 | L | 0.787681 | P | 0.855303 | -0.067622 | No Change: Both D | - |
| Q01196 | RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens GN=RUNX1 PE=1 SV=3 | 139 | R | 0.429436 | Q | 0.425202 | 0.004234 | No Change: Both O | Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399] |
| Q01196 | RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens GN=RUNX1 PE=1 SV=3 | 174 | R | 0.695195 | Q | 0.689687 | 0.005508 | No Change: Both D | Familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399] |
| Q01196 | RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens GN=RUNX1 PE=1 SV=3 | 431 | S | 0.867597 | R | 0.839572 | 0.028025 | No Change: Both D | - |
| Q01196 | RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens GN=RUNX1 PE=1 SV=3 | 433 | S | 0.863089 | R | 0.839608 | 0.023481 | No Change: Both D | - |
| Q06455 | MTG8_HUMAN Protein CBFA2T1 OS=Homo sapiens GN=RUNX1T1 PE=1 SV=2 | 386 | R | 0.495854 | W | 0.281652 | 0.214202 | No Change: Both O | A colorectal cancer sample |
| Q06455 | MTG8_HUMAN Protein CBFA2T1 OS=Homo sapiens GN=RUNX1T1 PE=1 SV=2 | 395 | R | 0.601089 | W | 0.379603 | 0.221486 | D to O | A colorectal cancer sample |
| Q06455 | MTG8_HUMAN Protein CBFA2T1 OS=Homo sapiens GN=RUNX1T1 PE=1 SV=2 | 471 | A | 0.868244 | V | 0.835532 | 0.032712 | No Change: Both D | A colorectal cancer sample |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 113 | L | 0.411524 | R | 0.53823 | -0.126706 | O to D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 118 | S | 0.3091 | R | 0.265429 | 0.043671 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 121 | F | 0.242983 | C | 0.276147 | -0.033164 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 123 | C | 0.204906 | R | 0.345779 | -0.140873 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 169 | R | 0.468435 | Q | 0.489209 | -0.020774 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 175 | M | 0.395524 | R | 0.478701 | -0.083177 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 190 | R | 0.429786 | Q | 0.425644 | 0.004142 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 190 | R | 0.429786 | W | 0.218193 | 0.211593 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 191 | S | 0.486 | N | 0.435681 | 0.050319 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 193 | R | 0.509041 | C | 0.324076 | 0.184965 | D to O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 197 | F | 0.329442 | S | 0.501078 | -0.171636 | O to D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 199 | L | 0.229119 | F | 0.241208 | -0.012089 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 200 | T | 0.205487 | A | 0.169008 | 0.036479 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 205 | T | 0.258996 | R | 0.273582 | -0.014586 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 209 | Q | 0.341916 | R | 0.369111 | -0.027195 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 225 | R | 0.703184 | Q | 0.69229 | 0.010894 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 225 | R | 0.703184 | W | 0.507838 | 0.195346 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 511 | G | 0.845573 | S | 0.903847 | -0.058274 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 53 | Q | 0.999546 | L | 0.999045 | 5.01E-04 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 118 | S | 0.3091 | N | 0.275758 | 0.033342 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 131 | R | 0.157677 | C | 0.086301 | 0.071376 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 131 | R | 0.157677 | G | 0.164239 | -0.006562 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 131 | R | 0.157677 | S | 0.2173 | -0.059623 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 136 | L | 0.137431 | P | 0.260079 | -0.122648 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 156 | V | 0.255787 | D | 0.404893 | -0.149106 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 156 | V | 0.255787 | G | 0.379738 | -0.123951 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 169 | R | 0.468435 | P | 0.497626 | -0.029191 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 175 | M | 0.395524 | K | 0.52677 | -0.131246 | O to D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 175 | M | 0.395524 | V | 0.351596 | 0.043928 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 187 | F | 0.299368 | S | 0.508823 | -0.209455 | O to D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 193 | R | 0.509041 | Q | 0.509029 | 1.20E-05 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 200 | T | 0.205487 | I | 0.115589 | 0.089898 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 201 | I | 0.193689 | K | 0.380964 | -0.187275 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 209 | Q | 0.341916 | H | 0.334447 | 0.007469 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 211 | A | 0.347016 | P | 0.453894 | -0.106878 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 218 | K | 0.471253 | E | 0.461855 | 0.009398 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 218 | K | 0.471253 | N | 0.422072 | 0.049181 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 218 | K | 0.471253 | Q | 0.453902 | 0.017351 | No Change: Both O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 220 | T | 0.544141 | I | 0.424313 | 0.119828 | D to O | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 225 | R | 0.703184 | L | 0.600333 | 0.102851 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 228 | R | 0.751476 | G | 0.719536 | 0.03194 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 233 | K | 0.838187 | R | 0.843584 | -0.005397 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 287 | D | 0.989089 | N | 0.988879 | 2.10E-04 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 362 | A | 0.844743 | V | 0.795222 | 0.049521 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 420 | T | 0.912647 | I | 0.824083 | 0.088564 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q13950 | RUNX2_HUMAN Runt-related transcription factor 2 OS=Homo sapiens GN=RUNX2 PE=1 SV=2 | 420 | T | 0.912647 | N | 0.892009 | 0.020638 | No Change: Both D | Cleidocranial dysplasia (CLCD) [MIM:119600] |
| Q9BVN2 | RUSC1_HUMAN RUN and SH3 domain-containing protein 1 OS=Homo sapiens GN=RUSC1 PE=1 SV=3 | 362 | S | 0.953078 | F | 0.917051 | 0.036027 | No Change: Both D | - |
| Q9BVN2 | RUSC1_HUMAN RUN and SH3 domain-containing protein 1 OS=Homo sapiens GN=RUSC1 PE=1 SV=3 | 493 | V | 0.187834 | A | 0.245194 | -0.05736 | No Change: Both O | - |
| Q66K80 | RUAS1_HUMAN Putative uncharacterized protein RUSC1-AS1 OS=Homo sapiens GN=RUSC1-AS1 PE=5 SV=1 | 231 | R | 0.688209 | S | 0.727706 | -0.039497 | No Change: Both D | - |
| Q8N2Y8 | RUSC2_HUMAN Iporin OS=Homo sapiens GN=RUSC2 PE=1 SV=3 | 73 | T | 0.912973 | A | 0.900246 | 0.012727 | No Change: Both D | - |
| Q8N2Y8 | RUSC2_HUMAN Iporin OS=Homo sapiens GN=RUSC2 PE=1 SV=3 | 654 | P | 0.953671 | L | 0.917644 | 0.036027 | No Change: Both D | - |
| Q9Y3V2 | RWDD3_HUMAN RWD domain-containing protein 3 OS=Homo sapiens GN=RWDD3 PE=1 SV=4 | 86 | N | 0.362184 | K | 0.415993 | -0.053809 | No Change: Both O | - |
| Q9Y3V2 | RWDD3_HUMAN RWD domain-containing protein 3 OS=Homo sapiens GN=RWDD3 PE=1 SV=4 | 47 | V | 0.15886 | A | 0.214423 | -0.055563 | No Change: Both O | - |
| Q6NW29 | RWDD4_HUMAN RWD domain-containing protein 4 OS=Homo sapiens GN=RWDD4 PE=1 SV=3 | 124 | I | 0.772405 | L | 0.765676 | 0.006729 | No Change: Both D | - |
| Q8WXD0 | RXFP2_HUMAN Relaxin receptor 2 OS=Homo sapiens GN=RXFP2 PE=1 SV=1 | 222 | T | 0.227149 | P | 0.281294 | -0.054145 | No Change: Both O | Cryptorchidism (CRYPTO) [MIM:219050] |
| Q8WXD0 | RXFP2_HUMAN Relaxin receptor 2 OS=Homo sapiens GN=RXFP2 PE=1 SV=1 | 604 | I | 0.008826 | V | 0.010228 | -0.001402 | No Change: Both O | - |
| Q8TDU9 | RL3R2_HUMAN Relaxin-3 receptor 2 OS=Homo sapiens GN=RXFP4 PE=1 SV=1 | 329 | L | 0.182915 | S | 0.302351 | -0.119436 | No Change: Both O | - |
| P19793 | RXRA_HUMAN Retinoic acid receptor RXR-alpha OS=Homo sapiens GN=RXRA PE=1 SV=1 | 261 | P | 0.614966 | L | 0.502707 | 0.112259 | No Change: Both D | - |
| P19793 | RXRA_HUMAN Retinoic acid receptor RXR-alpha OS=Homo sapiens GN=RXRA PE=1 SV=1 | 336 | S | 0.580784 | I | 0.371689 | 0.209095 | D to O | - |
| P19793 | RXRA_HUMAN Retinoic acid receptor RXR-alpha OS=Homo sapiens GN=RXRA PE=1 SV=1 | 327 | A | 0.15666 | S | 0.238317 | -0.081657 | No Change: Both O | - |
| P19793 | RXRA_HUMAN Retinoic acid receptor RXR-alpha OS=Homo sapiens GN=RXRA PE=1 SV=1 | 398 | A | 0.294734 | V | 0.220178 | 0.074556 | No Change: Both O | - |
| P34925 | RYK_HUMAN Tyrosine-protein kinase RYK OS=Homo sapiens GN=RYK PE=1 SV=2 | 96 | N | 0.169358 | S | 0.213141 | -0.043783 | No Change: Both O | - |
| P34925 | RYK_HUMAN Tyrosine-protein kinase RYK OS=Homo sapiens GN=RYK PE=1 SV=2 | 224 | R | 0.214743 | C | 0.111743 | 0.103 | No Change: Both O | - |
| P34925 | RYK_HUMAN Tyrosine-protein kinase RYK OS=Homo sapiens GN=RYK PE=1 SV=2 | 240 | V | 0.007429 | I | 0.006592 | 8.37E-04 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 35 | C | 0.18217 | R | 0.285612 | -0.103442 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 163 | R | 0.400328 | C | 0.264704 | 0.135624 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 163 | R | 0.400328 | C | 0.264704 | 0.135624 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 248 | G | 0.187669 | R | 0.188323 | -6.54E-04 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 341 | G | 0.276032 | R | 0.256416 | 0.019616 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 403 | I | 0.535643 | M | 0.668133 | -0.13249 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 403 | I | 0.535643 | M | 0.668133 | -0.13249 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 471 | R | 0.645796 | C | 0.453655 | 0.192141 | D to O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 522 | Y | 0.0583 | S | 0.14409 | -0.08579 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 522 | Y | 0.0583 | S | 0.14409 | -0.08579 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 552 | R | 0.393438 | W | 0.205866 | 0.187572 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 614 | R | 0.217476 | C | 0.123755 | 0.093721 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 614 | R | 0.217476 | C | 0.123755 | 0.093721 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 614 | R | 0.217476 | L | 0.146565 | 0.070911 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1787 | P | 0.682927 | L | 0.519018 | 0.163909 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2060 | G | 0.876926 | C | 0.857995 | 0.018931 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2163 | R | 0.156925 | C | 0.103814 | 0.053111 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2163 | R | 0.156925 | H | 0.130106 | 0.026819 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2163 | R | 0.156925 | H | 0.130106 | 0.026819 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2168 | V | 0.238648 | M | 0.34282 | -0.104172 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2168 | V | 0.238648 | M | 0.34282 | -0.104172 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2206 | T | 0.27759 | M | 0.275894 | 0.001696 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2434 | G | 0.117224 | R | 0.128773 | -0.011549 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2435 | R | 0.128578 | H | 0.132565 | -0.003987 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2435 | R | 0.128578 | H | 0.132565 | -0.003987 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 533 | R | 0.285701 | H | 0.278723 | 0.006978 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2163 | R | 0.156925 | P | 0.194607 | -0.037682 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2206 | T | 0.27759 | R | 0.308317 | -0.030727 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2435 | R | 0.128578 | L | 0.084918 | 0.04366 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2454 | R | 0.151458 | C | 0.069471 | 0.081987 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2454 | R | 0.151458 | H | 0.138617 | 0.012841 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2454 | R | 0.151458 | H | 0.138617 | 0.012841 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2458 | R | 0.119281 | C | 0.0565 | 0.062781 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2458 | R | 0.119281 | H | 0.103141 | 0.01614 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 109 | R | 0.266113 | W | 0.111039 | 0.155074 | No Change: Both O | Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 485 | M | 0.215979 | V | 0.164037 | 0.051942 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1109 | R | 0.397914 | K | 0.447329 | -0.049415 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1342 | S | 0.965852 | G | 0.965051 | 8.01E-04 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1489 | S | 0.211204 | N | 0.178288 | 0.032916 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2423 | M | 0.215092 | K | 0.262562 | -0.04747 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2423 | M | 0.215092 | K | 0.262562 | -0.04747 | No Change: Both O | Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3756 | Q | 0.787994 | E | 0.811278 | -0.023284 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 13 | L | 0.378878 | V | 0.392002 | -0.013124 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 44 | R | 0.16856 | C | 0.11745 | 0.05111 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 44 | R | 0.16856 | C | 0.11745 | 0.05111 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 160 | E | 0.675745 | G | 0.653105 | 0.02264 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 163 | R | 0.400328 | L | 0.294788 | 0.10554 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 165 | G | 0.289482 | R | 0.29629 | -0.006808 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 166 | D | 0.263002 | N | 0.225176 | 0.037826 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 177 | R | 0.4398 | C | 0.28073 | 0.15907 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 178 | Y | 0.437055 | C | 0.406715 | 0.03034 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 215 | G | 0.211607 | E | 0.251023 | -0.039416 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 227 | D | 0.219298 | V | 0.113795 | 0.105503 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 328 | R | 0.601985 | W | 0.375301 | 0.226684 | D to O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 401 | R | 0.569271 | C | 0.47319 | 0.096081 | D to O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 401 | R | 0.569271 | H | 0.555213 | 0.014058 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 401 | R | 0.569271 | S | 0.628633 | -0.059362 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 533 | R | 0.285701 | C | 0.158779 | 0.126922 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1704 | G | 0.395086 | S | 0.436142 | -0.041056 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1832 | G | 0.405405 | A | 0.347345 | 0.05806 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2101 | M | 0.610775 | K | 0.652899 | -0.042124 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2117 | V | 0.277887 | L | 0.293125 | -0.015238 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2129 | D | 0.296649 | E | 0.336384 | -0.039735 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2214 | V | 0.297308 | I | 0.251431 | 0.045877 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2280 | V | 0.260171 | I | 0.23392 | 0.026251 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2342 | N | 0.261483 | S | 0.294675 | -0.033192 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2344 | E | 0.406766 | D | 0.364355 | 0.042411 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2346 | V | 0.4971 | M | 0.525501 | -0.028401 | O to D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2348 | E | 0.494444 | G | 0.438272 | 0.056172 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2350 | A | 0.372712 | T | 0.400165 | -0.027453 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2355 | R | 0.111805 | C | 0.060634 | 0.051171 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2367 | A | 0.455149 | T | 0.46252 | -0.007371 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2421 | A | 0.273524 | P | 0.346146 | -0.072622 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2428 | A | 0.131478 | T | 0.114781 | 0.016697 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2431 | D | 0.093917 | N | 0.093865 | 5.20E-05 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2437 | A | 0.156646 | V | 0.108337 | 0.048309 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2452 | R | 0.205865 | W | 0.0794 | 0.126465 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2676 | R | 0.1393 | W | 0.062612 | 0.076688 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2787 | T | 0.467359 | S | 0.535065 | -0.067706 | O to D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3118 | A | 0.48059 | V | 0.421073 | 0.059517 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3527 | P | 0.212338 | S | 0.223356 | -0.011018 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3539 | R | 0.285043 | H | 0.28457 | 4.73E-04 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3772 | R | 0.52167 | Q | 0.550306 | -0.028636 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3916 | I | 0.02757 | M | 0.038008 | -0.010438 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4136 | R | 0.301084 | S | 0.341697 | -0.040613 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4234 | V | 0.415638 | L | 0.411751 | 0.003887 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4558 | R | 0.104486 | Q | 0.106158 | -0.001672 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4637 | T | 0.356839 | A | 0.339261 | 0.017578 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4637 | T | 0.356839 | I | 0.220806 | 0.136033 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4638 | G | 0.338503 | D | 0.367928 | -0.029425 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4650 | L | 0.051203 | P | 0.096813 | -0.04561 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4651 | H | 0.03486 | P | 0.043778 | -0.008918 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4668 | P | 0.051862 | S | 0.05832 | -0.006458 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4684 | F | 0.205236 | S | 0.416378 | -0.211142 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4724 | K | 0.327479 | Q | 0.259681 | 0.067798 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4737 | R | 0.253228 | Q | 0.249749 | 0.003479 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4737 | R | 0.253228 | W | 0.111735 | 0.141493 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4793 | L | 0.033514 | P | 0.068141 | -0.034627 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4796 | Y | 0.035256 | C | 0.025391 | 0.009865 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4814 | L | 0.055983 | F | 0.051079 | 0.004904 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4824 | L | 0.216565 | P | 0.362876 | -0.146311 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4825 | R | 0.238541 | C | 0.120255 | 0.118286 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4826 | T | 0.249994 | I | 0.140123 | 0.109871 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4838 | L | 0.307729 | V | 0.319062 | -0.011333 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4842 | V | 0.069719 | M | 0.088491 | -0.018772 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4846 | A | 0.025843 | V | 0.020469 | 0.005374 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4849 | V | 0.018577 | I | 0.013704 | 0.004873 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4849 | V | 0.018577 | I | 0.013704 | 0.004873 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4861 | R | 0.144397 | C | 0.072277 | 0.07212 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4861 | R | 0.144397 | H | 0.145424 | -0.001027 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4864 | Y | 0.425391 | C | 0.374407 | 0.050984 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4876 | K | 0.620092 | R | 0.560692 | 0.0594 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4891 | G | 0.151397 | R | 0.145774 | 0.005623 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4893 | R | 0.231896 | Q | 0.245463 | -0.013567 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4893 | R | 0.231896 | W | 0.103819 | 0.128077 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4897 | G | 0.410957 | V | 0.270678 | 0.140279 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4898 | I | 0.490504 | T | 0.605617 | -0.115113 | O to D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4899 | G | 0.575313 | E | 0.617183 | -0.04187 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4899 | G | 0.575313 | R | 0.544744 | 0.030569 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4906 | A | 0.633598 | V | 0.544534 | 0.089064 | No Change: Both D | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4914 | R | 0.057799 | G | 0.065588 | -0.007789 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4914 | R | 0.057799 | T | 0.057244 | 5.55E-04 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4938 | I | 0.06449 | M | 0.088565 | -0.024075 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4939 | D | 0.094893 | E | 0.107351 | -0.012458 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4940 | A | 0.136196 | T | 0.152692 | -0.016496 | No Change: Both O | Central core disease of muscle (CCD) [MIM:117000] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4942 | G | 0.22557 | V | 0.127975 | 0.097595 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4973 | P | 0.457049 | L | 0.317463 | 0.139586 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 291 | A | 0.244224 | T | 0.293908 | -0.049684 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2509 | V | 0.078709 | I | 0.069159 | 0.00955 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2779 | E | 0.393791 | K | 0.385655 | 0.008136 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 13 | L | 0.378878 | R | 0.529187 | -0.150309 | O to D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 226 | M | 0.208165 | K | 0.314264 | -0.106099 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 367 | R | 0.314371 | L | 0.229617 | 0.084754 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 530 | R | 0.23192 | H | 0.219611 | 0.012309 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 544 | D | 0.102832 | Y | 0.048936 | 0.053896 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1043 | R | 0.444469 | C | 0.353159 | 0.09131 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 1352 | A | 0.974948 | G | 0.977881 | -0.002933 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2321 | I | 0.181423 | V | 0.208645 | -0.027222 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2336 | R | 0.044255 | H | 0.040205 | 0.00405 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2404 | E | 0.809395 | K | 0.775038 | 0.034357 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2550 | L | 0.091471 | V | 0.083324 | 0.008147 | No Change: Both O | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2730 | D | 0.539524 | G | 0.509717 | 0.029807 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2880 | E | 0.506968 | K | 0.494035 | 0.012933 | D to O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3217 | S | 0.292935 | P | 0.299937 | -0.007002 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3290 | E | 0.6283 | K | 0.594266 | 0.034034 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3583 | E | 0.687819 | Q | 0.651517 | 0.036302 | No Change: Both D | - |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3772 | R | 0.52167 | W | 0.292561 | 0.229109 | D to O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3806 | G | 0.333798 | R | 0.301863 | 0.031935 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4501 | P | 0.999159 | L | 0.998474 | 6.85E-04 | No Change: Both D | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 4938 | I | 0.06449 | T | 0.108042 | -0.043552 | No Change: Both O | Malignant hyperthermia susceptibility type 1 (MHS1) [MIM:145600] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 402 | M | 0.556853 | T | 0.580618 | -0.023765 | No Change: Both D | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 2035 | H | 0.696106 | L | 0.672706 | 0.0234 | No Change: Both D | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3326 | N | 0.099314 | K | 0.107576 | -0.008262 | No Change: Both O | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| P21817 | RYR1_HUMAN Ryanodine receptor 1 OS=Homo sapiens GN=RYR1 PE=1 SV=3 | 3402 | C | 0.106051 | G | 0.176481 | -0.07043 | No Change: Both O | Congenital myopathy with fiber-type disproportion (CFTD) [MIM:255310] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 433 | L | 0.246819 | P | 0.369046 | -0.122227 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 433 | L | 0.246819 | P | 0.369046 | -0.122227 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 2 (ARVD2) [MIM:600996] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2246 | S | 0.412812 | L | 0.256936 | 0.155876 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2328 | P | 0.209106 | S | 0.207389 | 0.001717 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2386 | N | 0.387948 | I | 0.314317 | 0.073631 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2386 | N | 0.387948 | I | 0.314317 | 0.073631 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 2 (ARVD2) [MIM:600996] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2474 | R | 0.050163 | S | 0.067796 | -0.017633 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4104 | N | 0.263935 | K | 0.283563 | -0.019628 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4201 | Q | 0.598504 | R | 0.585321 | 0.013183 | No Change: Both D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4497 | R | 0.109129 | C | 0.047422 | 0.061707 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4653 | V | 0.303058 | F | 0.282246 | 0.020812 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2958 | Q | 0.331479 | R | 0.311255 | 0.020224 | No Change: Both O | - |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 1886 | G | 0.929341 | S | 0.928347 | 9.94E-04 | No Change: Both D | - |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2306 | V | 0.058185 | I | 0.047254 | 0.010931 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4902 | P | 0.31151 | L | 0.183753 | 0.127757 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4959 | R | 0.280328 | Q | 0.315189 | -0.034861 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 164 | P | 0.295013 | S | 0.345211 | -0.050198 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 176 | R | 0.43078 | Q | 0.445386 | -0.014606 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 176 | R | 0.43078 | Q | 0.445386 | -0.014606 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 2 (ARVD2) [MIM:600996] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 414 | R | 0.623761 | L | 0.526044 | 0.097717 | No Change: Both D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 419 | I | 0.318138 | F | 0.338378 | -0.02024 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 420 | R | 0.269818 | W | 0.096166 | 0.173652 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 507 | V | 0.168586 | I | 0.159883 | 0.008703 | No Change: Both O | - |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2311 | E | 0.347162 | D | 0.305717 | 0.041445 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2387 | A | 0.335412 | P | 0.407625 | -0.072213 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2392 | Y | 0.168682 | C | 0.232769 | -0.064087 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2403 | A | 0.184498 | T | 0.196727 | -0.012229 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2504 | T | 0.489079 | M | 0.429393 | 0.059686 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 2504 | T | 0.489079 | M | 0.429393 | 0.059686 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 2 (ARVD2) [MIM:600996] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 3778 | L | 0.385697 | F | 0.34029 | 0.045407 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 3946 | G | 0.056867 | S | 0.080149 | -0.023282 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4097 | N | 0.117232 | S | 0.133667 | -0.016435 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4146 | E | 0.302864 | K | 0.295734 | 0.00713 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4158 | T | 0.642911 | P | 0.715065 | -0.072154 | No Change: Both D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4499 | F | 0.106571 | C | 0.092975 | 0.013596 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4504 | M | 0.052295 | I | 0.031275 | 0.02102 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4510 | A | 0.016195 | T | 0.016898 | -7.03E-04 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4607 | A | 0.433825 | P | 0.529745 | -0.09592 | O to D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4671 | G | 0.511509 | R | 0.546563 | -0.035054 | No Change: Both D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4771 | V | 0.058232 | I | 0.044911 | 0.013321 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4848 | I | 0.009785 | V | 0.010577 | -7.92E-04 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4860 | A | 0.010324 | G | 0.014195 | -0.003871 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4867 | I | 0.06435 | M | 0.088351 | -0.024001 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4880 | V | 0.764577 | A | 0.819269 | -0.054692 | No Change: Both D | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4895 | N | 0.106261 | D | 0.126179 | -0.019918 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q92736 | RYR2_HUMAN Ryanodine receptor 2 OS=Homo sapiens GN=RYR2 PE=1 SV=3 | 4950 | E | 0.073347 | K | 0.070627 | 0.00272 | No Change: Both O | Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) [MIM:604772] |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 693 | Y | 0.65242 | C | 0.586164 | 0.066256 | No Change: Both D | - |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 731 | I | 0.284889 | V | 0.316785 | -0.031896 | No Change: Both O | - |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 1380 | E | 0.559274 | G | 0.529308 | 0.029966 | No Change: Both D | - |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 261 | R | 0.305574 | S | 0.353955 | -0.048381 | No Change: Both O | - |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 494 | V | 0.115113 | I | 0.101583 | 0.01353 | No Change: Both O | - |
| Q15413 | RYR3_HUMAN Ryanodine receptor 3 OS=Homo sapiens GN=RYR3 PE=1 SV=3 | 358 | I | 0.056953 | T | 0.104987 | -0.048034 | No Change: Both O | - |
| P33764 | S10A3_HUMAN Protein S100-A3 OS=Homo sapiens GN=S100A3 PE=1 SV=1 | 3 | R | 0.740662 | K | 0.736581 | 0.004081 | No Change: Both D | - |
| P33763 | S10A5_HUMAN Protein S100-A5 OS=Homo sapiens GN=S100A5 PE=1 SV=2 | 54 | D | 0.795832 | G | 0.748338 | 0.047494 | No Change: Both D | - |
| P06703 | S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN=S100A6 PE=1 SV=1 | 27 | H | 0.709521 | R | 0.705352 | 0.004169 | No Change: Both D | - |
| P06703 | S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN=S100A6 PE=1 SV=1 | 69 | N | 0.319515 | S | 0.343771 | -0.024256 | No Change: Both O | - |
| P06703 | S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN=S100A6 PE=1 SV=1 | 83 | I | 0.141572 | T | 0.230782 | -0.08921 | No Change: Both O | - |
| P06703 | S10A6_HUMAN Protein S100-A6 OS=Homo sapiens GN=S100A6 PE=1 SV=1 | 90 | G | 0.878526 | D | 0.880703 | -0.002177 | No Change: Both D | - |
| P31151 | S10A7_HUMAN Protein S100-A7 OS=Homo sapiens GN=S100A7 PE=1 SV=4 | 28 | E | 0.606955 | D | 0.609537 | -0.002582 | No Change: Both D | - |
| Q86SG5 | S1A7A_HUMAN Protein S100-A7A OS=Homo sapiens GN=S100A7A PE=2 SV=3 | 84 | A | 0.436166 | T | 0.432888 | 0.003278 | No Change: Both O | - |
| Q86SG5 | S1A7A_HUMAN Protein S100-A7A OS=Homo sapiens GN=S100A7A PE=2 SV=3 | 23 | R | 0.499175 | H | 0.505417 | -0.006242 | O to D | - |
| P06702 | S10A9_HUMAN Protein S100-A9 OS=Homo sapiens GN=S100A9 PE=1 SV=1 | 20 | H | 0.166865 | R | 0.179633 | -0.012768 | No Change: Both O | - |
| Q8WXG8 | S100Z_HUMAN Protein S100-Z OS=Homo sapiens GN=S100Z PE=1 SV=4 | 23 | E | 0.679118 | A | 0.583577 | 0.095541 | No Change: Both D | - |
| P21453 | S1PR1_HUMAN Sphingosine 1-phosphate receptor 1 OS=Homo sapiens GN=S1PR1 PE=1 SV=2 | 15 | S | 0.47264 | L | 0.267858 | 0.204782 | No Change: Both O | - |
| P21453 | S1PR1_HUMAN Sphingosine 1-phosphate receptor 1 OS=Homo sapiens GN=S1PR1 PE=1 SV=2 | 115 | A | 0.146114 | T | 0.17616 | -0.030046 | No Change: Both O | - |
| P21453 | S1PR1_HUMAN Sphingosine 1-phosphate receptor 1 OS=Homo sapiens GN=S1PR1 PE=1 SV=2 | 332 | P | 0.598263 | R | 0.588411 | 0.009852 | No Change: Both D | - |
| Q99500 | S1PR3_HUMAN Sphingosine 1-phosphate receptor 3 OS=Homo sapiens GN=S1PR3 PE=1 SV=2 | 243 | R | 0.091828 | Q | 0.0941 | -0.002272 | No Change: Both O | - |
| O95977 | S1PR4_HUMAN Sphingosine 1-phosphate receptor 4 OS=Homo sapiens GN=S1PR4 PE=1 SV=1 | 365 | R | 0.973429 | L | 0.948144 | 0.025285 | No Change: Both D | - |
| Q9H228 | S1PR5_HUMAN Sphingosine 1-phosphate receptor 5 OS=Homo sapiens GN=S1PR5 PE=2 SV=1 | 318 | L | 0.211964 | Q | 0.28891 | -0.076946 | No Change: Both O | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 15 | G | 0.189703 | S | 0.256923 | -0.06722 | No Change: Both O | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 70 | V | 0.301662 | A | 0.432098 | -0.130436 | No Change: Both O | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 75 | A | 0.310043 | V | 0.224169 | 0.085874 | No Change: Both O | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 78 | D | 0.370452 | N | 0.364416 | 0.006036 | No Change: Both O | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 89 | H | 0.445268 | R | 0.517408 | -0.07214 | O to D | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 90 | G | 0.478205 | D | 0.510414 | -0.032209 | O to D | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 102 | E | 0.606953 | K | 0.608259 | -0.001306 | No Change: Both D | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 108 | K | 0.688576 | R | 0.697111 | -0.008535 | No Change: Both D | - |
| P02735 | SAA_HUMAN Serum amyloid A protein OS=Homo sapiens GN=SAA1 PE=1 SV=2 | 86 | F | 0.413498 | L | 0.415254 | -0.001756 | No Change: Both O | - |
| P35542 | SAA4_HUMAN Serum amyloid A-4 protein OS=Homo sapiens GN=SAA4 PE=1 SV=2 | 89 | C | 0.092422 | Y | 0.103392 | -0.01097 | No Change: Both O | - |
| Q96ER3 | SAAL1_HUMAN Protein SAAL1 OS=Homo sapiens GN=SAAL1 PE=1 SV=2 | 315 | I | 0.318125 | V | 0.344149 | -0.026024 | No Change: Both O | - |
| Q96ER3 | SAAL1_HUMAN Protein SAAL1 OS=Homo sapiens GN=SAAL1 PE=1 SV=2 | 426 | S | 0.673411 | G | 0.633599 | 0.039812 | No Change: Both D | - |
| A6NKF1 | SAC31_HUMAN SAC3 domain-containing protein 1 OS=Homo sapiens GN=SAC3D1 PE=1 SV=2 | 8 | T | 0.998292 | P | 0.999231 | -9.39E-04 | No Change: Both D | - |
| A6NKF1 | SAC31_HUMAN SAC3 domain-containing protein 1 OS=Homo sapiens GN=SAC3D1 PE=1 SV=2 | 186 | L | 0.36327 | P | 0.522392 | -0.159122 | O to D | - |
| A6NKF1 | SAC31_HUMAN SAC3 domain-containing protein 1 OS=Homo sapiens GN=SAC3D1 PE=1 SV=2 | 155 | L | 0.164446 | R | 0.255165 | -0.090719 | No Change: Both O | - |
| Q9NTJ5 | SAC1_HUMAN Phosphatidylinositide phosphatase SAC1 OS=Homo sapiens GN=SACM1L PE=1 SV=2 | 434 | Y | 0.306403 | F | 0.307121 | -7.18E-04 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3369 | V | 0.173874 | A | 0.246589 | -0.072715 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1795 | M | 0.693961 | I | 0.586334 | 0.107627 | No Change: Both D | A colorectal cancer sample |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 232 | N | 0.449416 | K | 0.523201 | -0.073785 | O to D | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 694 | A | 0.246722 | T | 0.289796 | -0.043074 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 2017 | K | 0.319435 | N | 0.267427 | 0.052008 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 2958 | K | 0.212215 | R | 0.156441 | 0.055774 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3678 | P | 0.155378 | A | 0.114061 | 0.041317 | No Change: Both O | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4217 | N | 0.541973 | D | 0.566344 | -0.024371 | No Change: Both D | - |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 168 | D | 0.20582 | Y | 0.109485 | 0.096335 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 201 | T | 0.092871 | K | 0.130394 | -0.037523 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 308 | L | 0.184979 | F | 0.166653 | 0.018326 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 556 | L | 0.149725 | P | 0.270924 | -0.121199 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 802 | L | 0.170202 | P | 0.302904 | -0.132702 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 991 | C | 0.174433 | R | 0.309097 | -0.134664 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1054 | F | 0.286369 | S | 0.489399 | -0.20303 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1311 | M | 0.351593 | K | 0.503637 | -0.152044 | O to D | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1575 | R | 0.162699 | P | 0.208549 | -0.04585 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1587 | H | 0.481012 | R | 0.486386 | -0.005374 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 1946 | W | 0.157273 | R | 0.320695 | -0.163422 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 2703 | R | 0.275839 | C | 0.164129 | 0.11171 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 2798 | P | 0.354957 | Q | 0.384786 | -0.029829 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3248 | W | 0.236199 | R | 0.400572 | -0.164373 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3481 | L | 0.189193 | P | 0.313609 | -0.124416 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3636 | R | 0.26624 | Q | 0.299793 | -0.033553 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3645 | L | 0.234469 | P | 0.370909 | -0.13644 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3652 | P | 0.104061 | T | 0.074326 | 0.029735 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 3653 | F | 0.11411 | S | 0.276057 | -0.161947 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4074 | A | 0.267158 | P | 0.349448 | -0.08229 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4331 | R | 0.274608 | Q | 0.268975 | 0.005633 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4343 | E | 0.604724 | K | 0.609341 | -0.004617 | No Change: Both D | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4508 | K | 0.463114 | T | 0.391105 | 0.072009 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| Q9NZJ4 | SACS_HUMAN Sacsin OS=Homo sapiens GN=SACS PE=1 SV=2 | 4549 | N | 0.359475 | D | 0.395715 | -0.03624 | No Change: Both O | Spastic ataxia Charlevoix-Saguenay type (SACS) [MIM:270550] |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 76 | I | 0.15544 | V | 0.172554 | -0.017114 | No Change: Both O | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 84 | R | 0.090432 | C | 0.039599 | 0.050833 | No Change: Both O | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 125 | T | 0.292166 | M | 0.274759 | 0.017407 | No Change: Both O | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 364 | P | 0.656627 | L | 0.537721 | 0.118906 | No Change: Both D | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 378 | V | 0.691821 | I | 0.636854 | 0.054967 | No Change: Both D | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 384 | R | 0.746074 | C | 0.643248 | 0.102826 | No Change: Both D | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 403 | V | 0.911978 | I | 0.895471 | 0.016507 | No Change: Both D | - |
| P10523 | ARRS_HUMAN S-arrestin OS=Homo sapiens GN=SAG PE=2 SV=3 | 403 | V | 0.911978 | A | 0.938384 | -0.026406 | No Change: Both D | - |
| Q9NXZ1 | SAGE1_HUMAN Sarcoma antigen 1 OS=Homo sapiens GN=SAGE1 PE=2 SV=2 | 741 | N | 0.807266 | K | 0.798587 | 0.008679 | No Change: Both D | - |
| Q9NXZ1 | SAGE1_HUMAN Sarcoma antigen 1 OS=Homo sapiens GN=SAGE1 PE=2 SV=2 | 805 | L | 0.41853 | S | 0.639456 | -0.220926 | O to D | - |
| Q9NSC2 | SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens GN=SALL1 PE=1 SV=2 | 159 | S | 0.997538 | G | 0.996638 | 9.00E-04 | No Change: Both D | - |
| Q9NSC2 | SALL1_HUMAN Sal-like protein 1 OS=Homo sapiens GN=SALL1 PE=1 SV=2 | 1265 | G | 0.786734 | E | 0.794727 | -0.007993 | No Change: Both D | - |
| Q9Y467 | SALL2_HUMAN Sal-like protein 2 OS=Homo sapiens GN=SALL2 PE=1 SV=4 | 75 | S | 0.922865 | C | 0.894962 | 0.027903 | No Change: Both D | - |
| Q9Y467 | SALL2_HUMAN Sal-like protein 2 OS=Homo sapiens GN=SALL2 PE=1 SV=4 | 122 | P | 0.79824 | S | 0.790744 | 0.007496 | No Change: Both D | - |
| Q9Y467 | SALL2_HUMAN Sal-like protein 2 OS=Homo sapiens GN=SALL2 PE=1 SV=4 | 746 | G | 0.991079 | R | 0.989276 | 0.001803 | No Change: Both D | - |
| Q9BXA9 | SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens GN=SALL3 PE=2 SV=2 | 593 | L | 0.874414 | V | 0.867887 | 0.006527 | No Change: Both D | - |
| Q9BXA9 | SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens GN=SALL3 PE=2 SV=2 | 143 | R | 0.991261 | H | 0.987994 | 0.003267 | No Change: Both D | A colorectal cancer sample |
| Q9BXA9 | SALL3_HUMAN Sal-like protein 3 OS=Homo sapiens GN=SALL3 PE=2 SV=2 | 533 | T | 0.883877 | A | 0.866449 | 0.017428 | No Change: Both D | - |
| Q9UJQ4 | SALL4_HUMAN Sal-like protein 4 OS=Homo sapiens GN=SALL4 PE=1 SV=1 | 507 | L | 0.980453 | R | 0.984974 | -0.004521 | No Change: Both D | - |
| Q9UJQ4 | SALL4_HUMAN Sal-like protein 4 OS=Homo sapiens GN=SALL4 PE=1 SV=1 | 798 | I | 0.976458 | L | 0.980016 | -0.003558 | No Change: Both D | - |
| Q9UJQ4 | SALL4_HUMAN Sal-like protein 4 OS=Homo sapiens GN=SALL4 PE=1 SV=1 | 888 | H | 0.559081 | R | 0.5688 | -0.009719 | No Change: Both D | Duane-radial ray syndrome (DRRS) [MIM:607323] |
| Q6SPF0 | SAMD1_HUMAN Atherin OS=Homo sapiens GN=SAMD1 PE=1 SV=1 | 340 | E | 0.998053 | D | 0.997876 | 1.77E-04 | No Change: Both D | - |
| Q9P1V8 | SAM15_HUMAN Sterile alpha motif domain-containing protein 15 OS=Homo sapiens GN=SAMD15 PE=2 SV=1 | 18 | L | 0.965769 | P | 0.981807 | -0.016038 | No Change: Both D | - |
| Q9P1V8 | SAM15_HUMAN Sterile alpha motif domain-containing protein 15 OS=Homo sapiens GN=SAMD15 PE=2 SV=1 | 370 | K | 0.997689 | E | 0.997923 | -2.34E-04 | No Change: Both D | - |
| Q9P1V8 | SAM15_HUMAN Sterile alpha motif domain-containing protein 15 OS=Homo sapiens GN=SAMD15 PE=2 SV=1 | 454 | K | 0.760395 | E | 0.769085 | -0.00869 | No Change: Both D | - |
| Q9P1V8 | SAM15_HUMAN Sterile alpha motif domain-containing protein 15 OS=Homo sapiens GN=SAMD15 PE=2 SV=1 | 168 | M | 0.962251 | I | 0.933134 | 0.029117 | No Change: Both D | - |
| Q8N6K7 | SAMD3_HUMAN Sterile alpha motif domain-containing protein 3 OS=Homo sapiens GN=SAMD3 PE=2 SV=2 | 94 | E | 0.853751 | K | 0.834779 | 0.018972 | No Change: Both D | - |
| Q7Z3H4 | SAMD7_HUMAN Sterile alpha motif domain-containing protein 7 OS=Homo sapiens GN=SAMD7 PE=2 SV=1 | 220 | E | 0.87415 | D | 0.86397 | 0.01018 | No Change: Both D | - |
| Q5K651 | SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens GN=SAMD9 PE=1 SV=1 | 143 | I | 0.635099 | T | 0.732767 | -0.097668 | No Change: Both D | - |
| Q5K651 | SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens GN=SAMD9 PE=1 SV=1 | 449 | N | 0.315737 | S | 0.3544 | -0.038663 | No Change: Both O | - |
| Q5K651 | SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens GN=SAMD9 PE=1 SV=1 | 549 | V | 0.368116 | L | 0.382599 | -0.014483 | No Change: Both O | - |
| Q5K651 | SAMD9_HUMAN Sterile alpha motif domain-containing protein 9 OS=Homo sapiens GN=SAMD9 PE=1 SV=1 | 1495 | K | 0.311998 | E | 0.300985 | 0.011013 | No Change: Both O | Normophosphatemic familial tumoral calcinosis (NFTC) [MIM:610455] |
| Q8IVG5 | SAM9L_HUMAN Sterile alpha motif domain-containing protein 9-like OS=Homo sapiens GN=SAMD9L PE=1 SV=2 | 266 | V | 0.11389 | I | 0.110947 | 0.002943 | No Change: Both O | - |
| Q8IVG5 | SAM9L_HUMAN Sterile alpha motif domain-containing protein 9-like OS=Homo sapiens GN=SAMD9L PE=1 SV=2 | 289 | F | 0.176804 | S | 0.34634 | -0.169536 | No Change: Both O | - |
| Q8IVG5 | SAM9L_HUMAN Sterile alpha motif domain-containing protein 9-like OS=Homo sapiens GN=SAMD9L PE=1 SV=2 | 1137 | G | 0.176602 | A | 0.15364 | 0.022962 | No Change: Both O | - |
| Q8IVG5 | SAM9L_HUMAN Sterile alpha motif domain-containing protein 9-like OS=Homo sapiens GN=SAMD9L PE=1 SV=2 | 1516 | N | 0.430057 | T | 0.395647 | 0.03441 | No Change: Both O | - |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 123 | H | 0.26704 | P | 0.297815 | -0.030775 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 143 | R | 0.166395 | C | 0.075142 | 0.091253 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 143 | R | 0.166395 | H | 0.157824 | 0.008571 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 145 | R | 0.182892 | Q | 0.205434 | -0.022542 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 201 | I | 0.065013 | N | 0.134522 | -0.069509 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 209 | G | 0.332868 | S | 0.379285 | -0.046417 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 254 | M | 0.279652 | V | 0.236404 | 0.043248 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 369 | L | 0.501484 | S | 0.688975 | -0.187491 | No Change: Both D | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y3Z3 | SAMH1_HUMAN SAM domain and HD domain-containing protein 1 OS=Homo sapiens GN=SAMHD1 PE=1 SV=2 | 385 | M | 0.10749 | V | 0.084154 | 0.023336 | No Change: Both O | Aicardi-Goutieres syndrome type 5 (AGS5) [MIM:612952] |
| Q9Y512 | SAM50_HUMAN Sorting and assembly machinery component 50 homolog OS=Homo sapiens GN=SAMM50 PE=1 SV=3 | 345 | I | 0.436882 | V | 0.457059 | -0.020177 | No Change: Both O | - |
| Q9Y512 | SAM50_HUMAN Sorting and assembly machinery component 50 homolog OS=Homo sapiens GN=SAMM50 PE=1 SV=3 | 110 | D | 0.328698 | G | 0.304884 | 0.023814 | No Change: Both O | - |
| Q9NSI8 | SAMN1_HUMAN SAM domain-containing protein SAMSN-1 OS=Homo sapiens GN=SAMSN1 PE=1 SV=1 | 63 | G | 0.910697 | A | 0.890169 | 0.020528 | No Change: Both D | - |
| Q9Y6B6 | SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sapiens GN=SAR1B PE=1 SV=1 | 37 | G | 0.35765 | R | 0.328213 | 0.029437 | No Change: Both O | Chylomicron retention disease (CMRD) [MIM:246700] |
| Q9Y6B6 | SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sapiens GN=SAR1B PE=1 SV=1 | 137 | D | 0.404744 | N | 0.409081 | -0.004337 | No Change: Both O | Chylomicron retention disease (CMRD) [MIM:246700] |
| Q9Y6B6 | SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sapiens GN=SAR1B PE=1 SV=1 | 179 | S | 0.106861 | R | 0.08782 | 0.019041 | No Change: Both O | Chylomicron retention disease (CMRD) [MIM:246700] |
| Q9Y6B6 | SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sapiens GN=SAR1B PE=1 SV=1 | 11 | G | 0.076684 | D | 0.090903 | -0.014219 | No Change: Both O | Chylomicron retention disease (CMRD) [MIM:246700] |
| Q9Y6B6 | SAR1B_HUMAN GTP-binding protein SAR1b OS=Homo sapiens GN=SAR1B PE=1 SV=1 | 75 | D | 0.241816 | G | 0.238656 | 0.00316 | No Change: Both O | Chylomicron retention disease (CMRD) [MIM:246700] |
| Q9UL12 | SARDH_HUMAN Sarcosine dehydrogenase mitochondrial OS=Homo sapiens GN=SARDH PE=1 SV=1 | 614 | R | 0.427132 | H | 0.427695 | -5.63E-04 | No Change: Both O | - |
| Q9UL12 | SARDH_HUMAN Sarcosine dehydrogenase mitochondrial OS=Homo sapiens GN=SARDH PE=1 SV=1 | 648 | M | 0.199667 | V | 0.166644 | 0.033023 | No Change: Both O | - |
| Q9UL12 | SARDH_HUMAN Sarcosine dehydrogenase mitochondrial OS=Homo sapiens GN=SARDH PE=1 SV=1 | 22 | G | 0.886928 | C | 0.857974 | 0.028954 | No Change: Both D | - |
| Q9UL12 | SARDH_HUMAN Sarcosine dehydrogenase mitochondrial OS=Homo sapiens GN=SARDH PE=1 SV=1 | 372 | E | 0.307458 | D | 0.283134 | 0.024324 | No Change: Both O | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 87 | P | 0.972186 | S | 0.969858 | 0.002328 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 107 | T | 0.984951 | A | 0.978495 | 0.006456 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 157 | N | 0.952269 | T | 0.950659 | 0.00161 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 258 | R | 0.983556 | G | 0.980916 | 0.00264 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 434 | N | 0.987738 | S | 0.991482 | -0.003744 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 444 | S | 0.977388 | P | 0.979666 | -0.002278 | No Change: Both D | - |
| Q9BW04 | SARG_HUMAN Specifically androgen-regulated gene protein OS=Homo sapiens GN=SARG PE=1 SV=2 | 514 | F | 0.850259 | S | 0.934505 | -0.084246 | No Change: Both D | - |
| Q6SZW1 | SARM1_HUMAN Sterile alpha and TIR motif-containing protein 1 OS=Homo sapiens GN=SARM1 PE=1 SV=1 | 23 | P | 0.570711 | R | 0.54595 | 0.024761 | No Change: Both D | - |
| Q9NP81 | SYSM_HUMAN Serine--tRNA ligase mitochondrial OS=Homo sapiens GN=SARS2 PE=1 SV=1 | 35 | T | 0.728035 | A | 0.700659 | 0.027376 | No Change: Both D | - |
| Q9NP81 | SYSM_HUMAN Serine--tRNA ligase mitochondrial OS=Homo sapiens GN=SARS2 PE=1 SV=1 | 83 | S | 0.558697 | L | 0.434699 | 0.123998 | D to O | - |
| Q9NP81 | SYSM_HUMAN Serine--tRNA ligase mitochondrial OS=Homo sapiens GN=SARS2 PE=1 SV=1 | 390 | D | 0.242323 | G | 0.238494 | 0.003829 | No Change: Both O | Hyperuricemia pulmonary hypertension renal failure and alkalosis (HUPRA) [MIM:613845] |
| O43290 | SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens GN=SART1 PE=1 SV=1 | 485 | G | 0.981681 | A | 0.978851 | 0.00283 | No Change: Both D | - |
| O43290 | SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens GN=SART1 PE=1 SV=1 | 463 | S | 0.985501 | A | 0.976067 | 0.009434 | No Change: Both D | - |
| O43290 | SNUT1_HUMAN U4/U6.U5 tri-snRNP-associated protein 1 OS=Homo sapiens GN=SART1 PE=1 SV=1 | 245 | R | 0.5483 | C | 0.378322 | 0.169978 | D to O | - |
| Q15020 | SART3_HUMAN Squamous cell carcinoma antigen recognized by T-cells 3 OS=Homo sapiens GN=SART3 PE=1 SV=1 | 591 | V | 0.965146 | M | 0.974788 | -0.009642 | No Change: Both D | Disseminated superficial actinic porokeratosis type 1 (DSAP1) [MIM:175900] |
| Q15020 | SART3_HUMAN Squamous cell carcinoma antigen recognized by T-cells 3 OS=Homo sapiens GN=SART3 PE=1 SV=1 | 621 | E | 0.996216 | D | 0.995723 | 4.93E-04 | No Change: Both D | - |
| Q15020 | SART3_HUMAN Squamous cell carcinoma antigen recognized by T-cells 3 OS=Homo sapiens GN=SART3 PE=1 SV=1 | 23 | D | 0.948235 | E | 0.955418 | -0.007183 | No Change: Both D | - |
| O94885 | SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens GN=SASH1 PE=1 SV=3 | 298 | P | 0.783725 | Q | 0.723808 | 0.059917 | No Change: Both D | - |
| O94885 | SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens GN=SASH1 PE=1 SV=3 | 884 | Q | 0.917724 | R | 0.902815 | 0.014909 | No Change: Both D | - |
| Q6UVJ0 | SAS6_HUMAN Spindle assembly abnormal protein 6 homolog OS=Homo sapiens GN=SASS6 PE=1 SV=1 | 259 | A | 0.793174 | V | 0.726377 | 0.066797 | No Change: Both D | - |
| Q96F10 | SAT2_HUMAN Diamine acetyltransferase 2 OS=Homo sapiens GN=SAT2 PE=1 SV=1 | 126 | R | 0.085132 | C | 0.043043 | 0.042089 | No Change: Both O | - |
| Q9UPW6 | SATB2_HUMAN DNA-binding protein SATB2 OS=Homo sapiens GN=SATB2 PE=1 SV=2 | 263 | S | 0.689815 | P | 0.696692 | -0.006877 | No Change: Both D | - |
| Q86VE3 | SATL1_HUMAN Spermidine/spermine N(1)-acetyltransferase-like protein 1 OS=Homo sapiens GN=SATL1 PE=2 SV=3 | 92 | W | 0.901367 | R | 0.951057 | -0.04969 | No Change: Both D | - |
| Q9H4B6 | SAV1_HUMAN Protein salvador homolog 1 OS=Homo sapiens GN=SAV1 PE=1 SV=2 | 185 | A | 0.343222 | D | 0.413146 | -0.069924 | No Change: Both O | A colon cancer cell line |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 8 | N | 0.307324 | K | 0.335276 | -0.027952 | No Change: Both O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 44 | E | 0.391135 | G | 0.349392 | 0.041743 | No Change: Both O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 67 | K | 0.500944 | E | 0.496622 | 0.004322 | D to O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 87 | I | 0.344637 | S | 0.557035 | -0.212398 | O to D | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 126 | R | 0.267845 | T | 0.268904 | -0.001059 | No Change: Both O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 169 | R | 0.572701 | C | 0.410953 | 0.161748 | D to O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q9Y3A5 | SBDS_HUMAN Ribosome maturation protein SBDS OS=Homo sapiens GN=SBDS PE=1 SV=4 | 212 | I | 0.273415 | T | 0.331758 | -0.058343 | No Change: Both O | Shwachman-Diamond syndrome (SDS) [MIM:260400] |
| Q86WG5 | MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens GN=SBF2 PE=1 SV=1 | 303 | P | 0.242869 | L | 0.136998 | 0.105871 | No Change: Both O | - |
| Q86WG5 | MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens GN=SBF2 PE=1 SV=1 | 679 | E | 0.268197 | K | 0.266055 | 0.002142 | No Change: Both O | - |
| Q86WG5 | MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens GN=SBF2 PE=1 SV=1 | 1216 | Q | 0.808908 | E | 0.810518 | -0.00161 | No Change: Both D | - |
| Q52WX2 | SBK1_HUMAN Serine/threonine-protein kinase SBK1 OS=Homo sapiens GN=SBK1 PE=1 SV=1 | 92 | K | 0.473646 | E | 0.458697 | 0.014949 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q52WX2 | SBK1_HUMAN Serine/threonine-protein kinase SBK1 OS=Homo sapiens GN=SBK1 PE=1 SV=1 | 250 | N | 0.075847 | T | 0.069226 | 0.006621 | No Change: Both O | - |
| Q52WX2 | SBK1_HUMAN Serine/threonine-protein kinase SBK1 OS=Homo sapiens GN=SBK1 PE=1 SV=1 | 261 | A | 0.229364 | S | 0.321303 | -0.091939 | No Change: Both O | - |
| Q52WX2 | SBK1_HUMAN Serine/threonine-protein kinase SBK1 OS=Homo sapiens GN=SBK1 PE=1 SV=1 | 12 | R | 0.957026 | H | 0.942558 | 0.014468 | No Change: Both D | - |
| P0C263 | SBK2_HUMAN Serine/threonine-protein kinase SBK2 OS=Homo sapiens GN=SBK2 PE=3 SV=2 | 20 | E | 0.984634 | K | 0.978198 | 0.006436 | No Change: Both D | - |
| P0C263 | SBK2_HUMAN Serine/threonine-protein kinase SBK2 OS=Homo sapiens GN=SBK2 PE=3 SV=2 | 41 | A | 0.802084 | E | 0.852366 | -0.050282 | No Change: Both D | - |
| P0C263 | SBK2_HUMAN Serine/threonine-protein kinase SBK2 OS=Homo sapiens GN=SBK2 PE=3 SV=2 | 102 | G | 0.135316 | D | 0.145392 | -0.010076 | No Change: Both O | - |
| A3KN83 | SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens GN=SBNO1 PE=1 SV=1 | 634 | T | 0.382189 | S | 0.457569 | -0.07538 | No Change: Both O | A breast cancer sample |
| A3KN83 | SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens GN=SBNO1 PE=1 SV=1 | 728 | S | 0.990996 | N | 0.987546 | 0.00345 | No Change: Both D | - |
| A3KN83 | SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens GN=SBNO1 PE=1 SV=1 | 889 | E | 0.709928 | K | 0.687317 | 0.022611 | No Change: Both D | A breast cancer sample |
| A3KN83 | SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens GN=SBNO1 PE=1 SV=1 | 997 | S | 0.153921 | C | 0.060484 | 0.093437 | No Change: Both O | A breast cancer sample |
| A3KN83 | SBNO1_HUMAN Protein strawberry notch homolog 1 OS=Homo sapiens GN=SBNO1 PE=1 SV=1 | 729 | S | 0.991562 | N | 0.988343 | 0.003219 | No Change: Both D | - |
| O75845 | SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens GN=SC5DL PE=1 SV=2 | 29 | R | 0.107075 | Q | 0.124408 | -0.017333 | No Change: Both O | Lathosterolosis (LATHST) [MIM:607330] |
| O75845 | SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens GN=SC5DL PE=1 SV=2 | 211 | G | 0.187737 | D | 0.227108 | -0.039371 | No Change: Both O | Lathosterolosis (LATHST) [MIM:607330] |
| O75845 | SC5D_HUMAN Lathosterol oxidase OS=Homo sapiens GN=SC5DL PE=1 SV=2 | 46 | Y | 0.011802 | S | 0.027635 | -0.015833 | No Change: Both O | Lathosterolosis (LATHST) [MIM:607330] |
| Q9H7N4 | SFR19_HUMAN Splicing factor arginine/serine-rich 19 OS=Homo sapiens GN=SCAF1 PE=1 SV=3 | 895 | T | 0.992857 | A | 0.992581 | 2.76E-04 | No Change: Both D | - |
| Q9H7N4 | SFR19_HUMAN Splicing factor arginine/serine-rich 19 OS=Homo sapiens GN=SCAF1 PE=1 SV=3 | 1146 | M | 0.892215 | T | 0.91111 | -0.018895 | No Change: Both D | - |
| Q99590 | SCAFB_HUMAN Protein SCAF11 OS=Homo sapiens GN=SCAF11 PE=1 SV=2 | 657 | F | 0.578905 | Y | 0.548396 | 0.030509 | No Change: Both D | - |
| Q99590 | SCAFB_HUMAN Protein SCAF11 OS=Homo sapiens GN=SCAF11 PE=1 SV=2 | 1261 | V | 0.704792 | L | 0.719171 | -0.014379 | No Change: Both D | - |
| O95104 | SFR15_HUMAN Splicing factor arginine/serine-rich 15 OS=Homo sapiens GN=SCAF4 PE=1 SV=3 | 846 | S | 0.879876 | Y | 0.773565 | 0.106311 | No Change: Both D | - |
| Q9UPN6 | SCAF8_HUMAN Protein SCAF8 OS=Homo sapiens GN=SCAF8 PE=1 SV=1 | 865 | S | 0.934062 | N | 0.923504 | 0.010558 | No Change: Both D | - |
| Q8N9R8 | SCAI_HUMAN Protein SCAI OS=Homo sapiens GN=SCAI PE=1 SV=2 | 37 | A | 0.823357 | T | 0.853696 | -0.030339 | No Change: Both D | - |
| O14828 | SCAM3_HUMAN Secretory carrier-associated membrane protein 3 OS=Homo sapiens GN=SCAMP3 PE=1 SV=3 | 38 | L | 0.828642 | R | 0.886771 | -0.058129 | No Change: Both D | - |
| O14828 | SCAM3_HUMAN Secretory carrier-associated membrane protein 3 OS=Homo sapiens GN=SCAMP3 PE=1 SV=3 | 235 | V | 0.022648 | A | 0.032255 | -0.009607 | No Change: Both O | - |
| O14828 | SCAM3_HUMAN Secretory carrier-associated membrane protein 3 OS=Homo sapiens GN=SCAMP3 PE=1 SV=3 | 239 | I | 0.006097 | N | 0.015332 | -0.009235 | No Change: Both O | - |
| O14828 | SCAM3_HUMAN Secretory carrier-associated membrane protein 3 OS=Homo sapiens GN=SCAMP3 PE=1 SV=3 | 242 | V | 0.011491 | D | 0.024673 | -0.013182 | No Change: Both O | - |
| Q969E2 | SCAM4_HUMAN Secretory carrier-associated membrane protein 4 OS=Homo sapiens GN=SCAMP4 PE=2 SV=1 | 49 | A | 0.012454 | T | 0.015009 | -0.002555 | No Change: Both O | - |
| Q9GZW5 | SCND2_HUMAN Putative SCAN domain-containing protein 2 OS=Homo sapiens GN=SCAND2 PE=5 SV=2 | 185 | A | 0.991919 | T | 0.991826 | 9.30E-05 | No Change: Both D | - |
| Q9GZW5 | SCND2_HUMAN Putative SCAN domain-containing protein 2 OS=Homo sapiens GN=SCAND2 PE=5 SV=2 | 110 | P | 0.605098 | T | 0.552521 | 0.052577 | No Change: Both D | - |
| Q6R2W3 | SCND3_HUMAN SCAN domain-containing protein 3 OS=Homo sapiens GN=SCAND3 PE=2 SV=1 | 155 | M | 0.918219 | V | 0.884656 | 0.033563 | No Change: Both D | - |
| Q6R2W3 | SCND3_HUMAN SCAN domain-containing protein 3 OS=Homo sapiens GN=SCAND3 PE=2 SV=1 | 465 | Q | 0.676011 | K | 0.677356 | -0.001345 | No Change: Both D | - |
| Q12770 | SCAP_HUMAN Sterol regulatory element-binding protein cleavage-activating protein OS=Homo sapiens GN=SCAP PE=1 SV=4 | 798 | V | 0.091152 | I | 0.076517 | 0.014635 | No Change: Both O | - |
| Q9BY12 | SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens GN=SCAPER PE=1 SV=1 | 1088 | P | 0.76313 | T | 0.738963 | 0.024167 | No Change: Both D | - |
| Q9BY12 | SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens GN=SCAPER PE=1 SV=1 | 1139 | A | 0.123587 | T | 0.129183 | -0.005596 | No Change: Both O | - |
| Q9BY12 | SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens GN=SCAPER PE=1 SV=1 | 1138 | A | 0.131497 | T | 0.135861 | -0.004364 | No Change: Both O | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 130 | R | 0.615858 | Q | 0.692189 | -0.076331 | No Change: Both D | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 325 | M | 0.603611 | T | 0.630738 | -0.027127 | No Change: Both D | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 423 | R | 0.267734 | Q | 0.2634 | 0.004334 | No Change: Both O | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 428 | V | 0.234455 | I | 0.212726 | 0.021729 | No Change: Both O | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 467 | F | 0.830927 | L | 0.856879 | -0.025952 | No Change: Both D | - |
| Q6AZY7 | SCAR3_HUMAN Scavenger receptor class A member 3 OS=Homo sapiens GN=SCARA3 PE=2 SV=1 | 551 | P | 0.999466 | S | 0.999354 | 1.12E-04 | No Change: Both D | - |
| Q6ZMJ2 | SCAR5_HUMAN Scavenger receptor class A member 5 OS=Homo sapiens GN=SCARA5 PE=2 SV=1 | 316 | D | 0.928784 | H | 0.916771 | 0.012013 | No Change: Both D | - |
| Q6ZMJ2 | SCAR5_HUMAN Scavenger receptor class A member 5 OS=Homo sapiens GN=SCARA5 PE=2 SV=1 | 45 | A | 0.270612 | T | 0.311177 | -0.040565 | No Change: Both O | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 2 | G | 0.809081 | S | 0.844367 | -0.035286 | No Change: Both D | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 135 | V | 0.171012 | I | 0.159904 | 0.011108 | No Change: Both O | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 167 | G | 0.230467 | S | 0.276714 | -0.046247 | No Change: Both O | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 511 | C | 0.346149 | R | 0.496541 | -0.150392 | No Change: Both O | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 229 | S | 0.133337 | G | 0.115233 | 0.018104 | No Change: Both O | - |
| Q8WTV0 | SCRB1_HUMAN Scavenger receptor class B member 1 OS=Homo sapiens GN=SCARB1 PE=1 SV=1 | 297 | P | 0.232706 | S | 0.236976 | -0.00427 | No Change: Both O | - |
| Q14108 | SCRB2_HUMAN Lysosome membrane protein 2 OS=Homo sapiens GN=SCARB2 PE=1 SV=2 | 363 | H | 0.592956 | N | 0.613831 | -0.020875 | No Change: Both D | Progressive myoclonic epilepsy type 4 with or without renal failure (EPM4) [MIM:254900] |
| Q14108 | SCRB2_HUMAN Lysosome membrane protein 2 OS=Homo sapiens GN=SCARB2 PE=1 SV=2 | 471 | E | 0.672308 | G | 0.615615 | 0.056693 | No Change: Both D | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 425 | A | 0.356773 | V | 0.290131 | 0.066642 | No Change: Both O | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 618 | R | 0.995397 | K | 0.995261 | 1.36E-04 | No Change: Both D | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 639 | E | 0.995677 | D | 0.994216 | 0.001461 | No Change: Both D | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 662 | R | 0.875213 | W | 0.766051 | 0.109162 | No Change: Both D | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 667 | G | 0.809958 | S | 0.836448 | -0.02649 | No Change: Both D | - |
| Q14162 | SREC_HUMAN Scavenger receptor class F member 1 OS=Homo sapiens GN=SCARF1 PE=1 SV=3 | 748 | G | 0.971155 | V | 0.955768 | 0.015387 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 773 | E | 0.954979 | D | 0.944105 | 0.010874 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 774 | L | 0.954674 | V | 0.946282 | 0.008392 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 815 | A | 0.997671 | G | 0.997522 | 1.49E-04 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 833 | A | 0.99618 | G | 0.99613 | 5.00E-05 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 494 | R | 0.63375 | C | 0.532559 | 0.101191 | No Change: Both D | A breast cancer sample |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 425 | T | 0.519713 | S | 0.574163 | -0.05445 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 517 | H | 0.471559 | L | 0.422057 | 0.049502 | No Change: Both O | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 174 | P | 0.776745 | S | 0.782752 | -0.006007 | No Change: Both D | - |
| Q96GP6 | SREC2_HUMAN Scavenger receptor class F member 2 OS=Homo sapiens GN=SCARF2 PE=1 SV=3 | 258 | C | 0.80208 | Y | 0.729489 | 0.072591 | No Change: Both D | Van den Ende-Gupta syndrome (VDEGS) [MIM:600920] |
| Q8NBX0 | SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens GN=SCCPDH PE=1 SV=1 | 418 | G | 0.320272 | R | 0.34391 | -0.023638 | No Change: Both O | - |
| O00767 | ACOD_HUMAN Acyl-CoA desaturase OS=Homo sapiens GN=SCD PE=1 SV=2 | 224 | M | 0.035444 | L | 0.027211 | 0.008233 | No Change: Both O | - |
| O95171 | SCEL_HUMAN Sciellin OS=Homo sapiens GN=SCEL PE=1 SV=2 | 336 | V | 0.889064 | L | 0.891759 | -0.002695 | No Change: Both D | - |
| O95171 | SCEL_HUMAN Sciellin OS=Homo sapiens GN=SCEL PE=1 SV=2 | 386 | R | 0.696866 | K | 0.756947 | -0.060081 | No Change: Both D | - |
| O95171 | SCEL_HUMAN Sciellin OS=Homo sapiens GN=SCEL PE=1 SV=2 | 480 | K | 0.687153 | R | 0.614413 | 0.07274 | No Change: Both D | - |
| Q8WVM8 | SCFD1_HUMAN Sec1 family domain-containing protein 1 OS=Homo sapiens GN=SCFD1 PE=1 SV=4 | 63 | K | 0.309192 | R | 0.261856 | 0.047336 | No Change: Both O | - |
| Q8WU76 | SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens GN=SCFD2 PE=1 SV=2 | 512 | L | 0.338002 | S | 0.503396 | -0.165394 | O to D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 61 | Y | 0.671012 | H | 0.754164 | -0.083152 | No Change: Both D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 294 | D | 0.84371 | G | 0.824365 | 0.019345 | No Change: Both D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 421 | R | 0.606895 | G | 0.622955 | -0.01606 | No Change: Both D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 535 | D | 0.848728 | G | 0.841906 | 0.006822 | No Change: Both D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 564 | P | 0.759228 | L | 0.620869 | 0.138359 | No Change: Both D | - |
| P13521 | SCG2_HUMAN Secretogranin-2 OS=Homo sapiens GN=SCG2 PE=1 SV=2 | 196 | A | 0.686208 | V | 0.682678 | 0.00353 | No Change: Both D | - |
| Q8WXD2 | SCG3_HUMAN Secretogranin-3 OS=Homo sapiens GN=SCG3 PE=1 SV=3 | 125 | S | 0.762045 | N | 0.721888 | 0.040157 | No Change: Both D | - |
| Q8WXD2 | SCG3_HUMAN Secretogranin-3 OS=Homo sapiens GN=SCG3 PE=1 SV=3 | 233 | M | 0.647279 | V | 0.60047 | 0.046809 | No Change: Both D | - |
| P11684 | UTER_HUMAN Uteroglobin OS=Homo sapiens GN=SCGB1A1 PE=1 SV=1 | 56 | R | 0.690959 | G | 0.676669 | 0.01429 | No Change: Both D | - |
| P11684 | UTER_HUMAN Uteroglobin OS=Homo sapiens GN=SCGB1A1 PE=1 SV=1 | 68 | T | 0.695566 | A | 0.710765 | -0.015199 | No Change: Both D | - |
| Q8TD33 | SG1C1_HUMAN Secretoglobin family 1C member 1 OS=Homo sapiens GN=SCGB1C1 PE=2 SV=2 | 70 | I | 0.309301 | R | 0.464441 | -0.15514 | No Change: Both O | - |
| O95969 | SG1D2_HUMAN Secretoglobin family 1D member 2 OS=Homo sapiens GN=SCGB1D2 PE=2 SV=1 | 53 | P | 0.444229 | L | 0.291282 | 0.152947 | No Change: Both O | - |
| O95969 | SG1D2_HUMAN Secretoglobin family 1D member 2 OS=Homo sapiens GN=SCGB1D2 PE=2 SV=1 | 80 | V | 0.271844 | A | 0.350932 | -0.079088 | No Change: Both O | - |
| Q96PL1 | SG3A2_HUMAN Secretoglobin family 3A member 2 OS=Homo sapiens GN=SCGB3A2 PE=1 SV=1 | 33 | K | 0.339848 | N | 0.299486 | 0.040362 | No Change: Both O | A breast cancer sample |
| O76038 | SEGN_HUMAN Secretagogin OS=Homo sapiens GN=SCGN PE=1 SV=2 | 216 | A | 0.423652 | V | 0.380971 | 0.042681 | No Change: Both O | - |
| Q9P0W5 | SCHI1_HUMAN Schwannomin-interacting protein 1 OS=Homo sapiens GN=SCHIP1 PE=1 SV=1 | 481 | A | 0.866698 | V | 0.817072 | 0.049626 | No Change: Both D | - |
| Q9P0W5 | SCHI1_HUMAN Schwannomin-interacting protein 1 OS=Homo sapiens GN=SCHIP1 PE=1 SV=1 | 101 | E | 0.976633 | K | 0.971142 | 0.005491 | No Change: Both D | - |
| Q9Y6U3 | ADSV_HUMAN Adseverin OS=Homo sapiens GN=SCIN PE=1 SV=4 | 455 | F | 0.195627 | L | 0.241407 | -0.04578 | No Change: Both O | - |
| Q9Y6U3 | ADSV_HUMAN Adseverin OS=Homo sapiens GN=SCIN PE=1 SV=4 | 578 | L | 0.383799 | F | 0.341375 | 0.042424 | No Change: Both O | - |
| Q9Y6U3 | ADSV_HUMAN Adseverin OS=Homo sapiens GN=SCIN PE=1 SV=4 | 61 | H | 0.084292 | R | 0.083607 | 6.85E-04 | No Change: Both O | - |
| Q9Y6U3 | ADSV_HUMAN Adseverin OS=Homo sapiens GN=SCIN PE=1 SV=4 | 443 | A | 0.232987 | P | 0.290061 | -0.057074 | No Change: Both O | - |
| Q9Y6U3 | ADSV_HUMAN Adseverin OS=Homo sapiens GN=SCIN PE=1 SV=4 | 500 | K | 0.645635 | R | 0.601372 | 0.044263 | No Change: Both D | - |
| Q96NL6 | SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens GN=SCLT1 PE=1 SV=2 | 441 | S | 0.84227 | C | 0.758081 | 0.084189 | No Change: Both D | - |
| Q96I15 | SCLY_HUMAN Selenocysteine lyase OS=Homo sapiens GN=SCLY PE=1 SV=2 | 52 | K | 0.277403 | E | 0.293584 | -0.016181 | No Change: Both O | - |
| Q96I15 | SCLY_HUMAN Selenocysteine lyase OS=Homo sapiens GN=SCLY PE=1 SV=2 | 175 | A | 0.410556 | T | 0.427149 | -0.016593 | No Change: Both O | - |
| Q96I15 | SCLY_HUMAN Selenocysteine lyase OS=Homo sapiens GN=SCLY PE=1 SV=2 | 276 | F | 0.173875 | S | 0.343777 | -0.169902 | No Change: Both O | - |
| Q8N228 | SCML4_HUMAN Sex comb on midleg-like protein 4 OS=Homo sapiens GN=SCML4 PE=2 SV=2 | 126 | R | 0.578519 | Q | 0.62031 | -0.041791 | No Change: Both D | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 509 | S | 0.698482 | P | 0.688888 | 0.009594 | No Change: Both D | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 1073 | V | 0.90991 | A | 0.922944 | -0.013034 | No Change: Both D | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 1092 | L | 0.81941 | P | 0.903263 | -0.083853 | No Change: Both D | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 1713 | M | 0.016297 | V | 0.01179 | 0.004507 | No Change: Both O | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 590 | G | 0.548294 | R | 0.575326 | -0.027032 | No Change: Both D | - |
| Q9Y5Y9 | SCNAA_HUMAN Sodium channel protein type 10 subunit alpha OS=Homo sapiens GN=SCN10A PE=1 SV=2 | 916 | R | 0.156837 | W | 0.056953 | 0.099884 | No Change: Both O | - |
| Q9UI33 | SCNBA_HUMAN Sodium channel protein type 11 subunit alpha OS=Homo sapiens GN=SCN11A PE=1 SV=2 | 481 | G | 0.980277 | E | 0.984653 | -0.004376 | No Change: Both D | - |
| Q9UI33 | SCNBA_HUMAN Sodium channel protein type 11 subunit alpha OS=Homo sapiens GN=SCN11A PE=1 SV=2 | 777 | M | 0.359983 | R | 0.405344 | -0.045361 | No Change: Both O | - |
| Q9UI33 | SCNBA_HUMAN Sodium channel protein type 11 subunit alpha OS=Homo sapiens GN=SCN11A PE=1 SV=2 | 1198 | Y | 0.023409 | H | 0.041567 | -0.018158 | No Change: Both O | - |
| Q9UI33 | SCNBA_HUMAN Sodium channel protein type 11 subunit alpha OS=Homo sapiens GN=SCN11A PE=1 SV=2 | 909 | V | 0.227779 | I | 0.202798 | 0.024981 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 875 | T | 0.104747 | M | 0.091161 | 0.013586 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1648 | R | 0.12733 | H | 0.117006 | 0.010324 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1648 | R | 0.12733 | H | 0.117006 | 0.010324 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 188 | D | 0.066221 | V | 0.027478 | 0.038743 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 986 | L | 0.035454 | F | 0.028739 | 0.006715 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1067 | A | 0.533586 | T | 0.618957 | -0.085371 | No Change: Both D | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1204 | W | 0.215696 | R | 0.412452 | -0.196756 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1270 | K | 0.026382 | T | 0.018697 | 0.007685 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1353 | V | 0.004592 | L | 0.004815 | -2.23E-04 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1656 | I | 0.14615 | M | 0.206798 | -0.060648 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1489 | Q | 0.566514 | K | 0.61266 | -0.046146 | No Change: Both D | Familial hemiplegic migraine type 3 (FHM3) [MIM:609634] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 145 | M | 0.126941 | T | 0.158057 | -0.031116 | No Change: Both O | Familial febrile convulsions type 3A (FEB3A) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 78 | E | 0.437311 | D | 0.421265 | 0.016046 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 101 | R | 0.17117 | Q | 0.185566 | -0.014396 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 103 | S | 0.141919 | G | 0.111239 | 0.03068 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 112 | T | 0.105237 | I | 0.057688 | 0.047549 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 177 | G | 0.039881 | E | 0.055171 | -0.01529 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 190 | W | 0.057675 | R | 0.143088 | -0.085413 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 227 | I | 0.133821 | S | 0.312769 | -0.178948 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 252 | I | 0.043739 | N | 0.097958 | -0.054219 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 265 | G | 0.035745 | W | 0.01156 | 0.024185 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 280 | W | 0.221739 | R | 0.443597 | -0.221858 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 297 | T | 0.324746 | I | 0.214427 | 0.110319 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 343 | G | 0.517968 | D | 0.541717 | -0.023749 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 393 | R | 0.157637 | H | 0.158858 | -0.001221 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 426 | Y | 0.320031 | N | 0.457069 | -0.137038 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 542 | R | 0.877821 | Q | 0.86383 | 0.013991 | No Change: Both D | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 790 | Y | 0.356498 | C | 0.299914 | 0.056584 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 808 | T | 0.054159 | S | 0.072223 | -0.018064 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 902 | F | 0.006685 | C | 0.005814 | 8.71E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 931 | R | 0.15869 | C | 0.081985 | 0.076705 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 934 | M | 0.146875 | I | 0.098755 | 0.04812 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 939 | H | 0.05366 | Q | 0.054287 | -6.27E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 944 | V | 0.015376 | A | 0.021079 | -0.005703 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 946 | R | 0.013535 | C | 0.006543 | 0.006992 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 946 | R | 0.013535 | H | 0.014365 | -8.30E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 959 | C | 0.096569 | R | 0.191765 | -0.095196 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 960 | M | 0.102187 | V | 0.075433 | 0.026754 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 979 | G | 0.039204 | R | 0.037293 | 0.001911 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 983 | V | 0.030519 | A | 0.042847 | -0.012328 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 985 | N | 0.035215 | I | 0.014479 | 0.020736 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1011 | N | 0.418015 | I | 0.23184 | 0.186175 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1034 | I | 0.209464 | T | 0.266064 | -0.0566 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1038 | F | 0.231015 | L | 0.253375 | -0.02236 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1231 | S | 0.083942 | R | 0.057916 | 0.026026 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1233 | G | 0.112625 | R | 0.105892 | 0.006733 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1263 | F | 0.013089 | L | 0.015743 | -0.002654 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1265 | L | 0.01387 | P | 0.027563 | -0.013693 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1355 | L | 0.002654 | P | 0.005322 | -0.002668 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1326 | A | 0.291818 | P | 0.380754 | -0.088936 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1390 | V | 0.37557 | M | 0.441534 | -0.065964 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1428 | V | 0.065777 | A | 0.100766 | -0.034989 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1434 | W | 0.069237 | R | 0.170493 | -0.101256 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1450 | Q | 0.604952 | R | 0.600182 | 0.00477 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1461 | L | 0.012599 | I | 0.011205 | 0.001394 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1463 | F | 0.006236 | S | 0.017902 | -0.011666 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1611 | V | 0.010437 | F | 0.008871 | 0.001566 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1632 | P | 0.074862 | S | 0.091027 | -0.016165 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1648 | R | 0.12733 | C | 0.054042 | 0.073288 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1657 | R | 0.121947 | C | 0.056453 | 0.065494 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1661 | F | 0.063432 | S | 0.175871 | -0.112439 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1668 | P | 0.07759 | A | 0.058201 | 0.019389 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1674 | G | 0.02617 | R | 0.024654 | 0.001516 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1694 | Y | 0.154568 | C | 0.124462 | 0.030106 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1685 | A | 0.020078 | D | 0.028709 | -0.008631 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1685 | A | 0.020078 | V | 0.014072 | 0.006006 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1692 | F | 0.109451 | S | 0.267376 | -0.157925 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1709 | T | 0.183574 | I | 0.109402 | 0.074172 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1749 | G | 0.722658 | E | 0.74592 | -0.023262 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1780 | M | 0.017804 | T | 0.021731 | -0.003927 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1781 | Y | 0.020787 | C | 0.017377 | 0.00341 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1808 | F | 0.306665 | L | 0.307701 | -0.001036 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1812 | W | 0.402005 | G | 0.585446 | -0.183441 | O to D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1831 | F | 0.495801 | S | 0.669973 | -0.174172 | O to D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1852 | M | 0.201923 | T | 0.208876 | -0.006953 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1881 | E | 0.460256 | D | 0.434166 | 0.02609 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1909 | T | 0.536171 | I | 0.412571 | 0.1236 | D to O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1955 | I | 0.260681 | T | 0.369049 | -0.108368 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1957 | E | 0.289785 | G | 0.243513 | 0.046272 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 84 | Y | 0.182818 | C | 0.146081 | 0.036737 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 118 | R | 0.123173 | S | 0.162045 | -0.038872 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 226 | T | 0.129373 | M | 0.10278 | 0.026593 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 239 | A | 0.121547 | T | 0.146988 | -0.025441 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 366 | D | 0.147032 | E | 0.16219 | -0.015158 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 377 | R | 0.051737 | Q | 0.060759 | -0.009022 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 393 | R | 0.157637 | C | 0.074223 | 0.083414 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 395 | A | 0.150135 | P | 0.197451 | -0.047316 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 422 | V | 0.062734 | E | 0.141897 | -0.079163 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 626 | S | 0.833899 | G | 0.789532 | 0.044367 | No Change: Both D | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 973 | M | 0.022275 | V | 0.01635 | 0.005925 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1207 | L | 0.074205 | P | 0.150086 | -0.075881 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1238 | E | 0.163101 | D | 0.159984 | 0.003117 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1335 | V | 0.107216 | M | 0.138005 | -0.030789 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1358 | W | 0.003146 | S | 0.012994 | -0.009848 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1366 | V | 0.046951 | I | 0.044419 | 0.002532 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1366 | V | 0.046951 | I | 0.044419 | 0.002532 | No Change: Both O | Intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1462 | Y | 0.008018 | C | 0.005601 | 0.002417 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1480 | G | 0.029895 | V | 0.01655 | 0.013345 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1543 | F | 0.08387 | S | 0.179595 | -0.095725 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1596 | R | 0.040814 | C | 0.018836 | 0.021978 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1636 | R | 0.061448 | Q | 0.060748 | 7.00E-04 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1657 | R | 0.121947 | H | 0.121344 | 6.03E-04 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1928 | R | 0.249382 | G | 0.214438 | 0.034944 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 946 | R | 0.013535 | S | 0.019796 | -0.006261 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1489 | Q | 0.566514 | H | 0.5354 | 0.031114 | No Change: Both D | Familial hemiplegic migraine type 3 (FHM3) [MIM:609634] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1499 | F | 0.491588 | L | 0.491374 | 2.14E-04 | No Change: Both O | Familial hemiplegic migraine type 3 (FHM3) [MIM:609634] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1742 | D | 0.744113 | G | 0.720331 | 0.023782 | No Change: Both D | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1857 | V | 0.242545 | L | 0.269557 | -0.027012 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1866 | D | 0.088775 | Y | 0.031198 | 0.057577 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 27 | R | 0.794973 | T | 0.773635 | 0.021338 | No Change: Both D | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 63 | F | 0.666522 | L | 0.70085 | -0.034328 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 90 | F | 0.127187 | S | 0.283534 | -0.156347 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 91 | I | 0.115905 | T | 0.200754 | -0.084849 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 101 | R | 0.17117 | W | 0.070337 | 0.100833 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 124 | I | 0.081847 | N | 0.160727 | -0.07888 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 171 | I | 0.070018 | K | 0.17431 | -0.104292 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 175 | A | 0.04453 | T | 0.052586 | -0.008056 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 191 | N | 0.046266 | Y | 0.023698 | 0.022568 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 194 | D | 0.025352 | N | 0.023623 | 0.001729 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 239 | A | 0.121547 | V | 0.094181 | 0.027366 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 259 | S | 0.013393 | R | 0.00971 | 0.003683 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 388 | Y | 0.092425 | H | 0.156181 | -0.063756 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 406 | V | 0.007095 | F | 0.006476 | 6.19E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 413 | Y | 0.014462 | N | 0.031192 | -0.01673 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 604 | R | 0.944833 | H | 0.928003 | 0.01683 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 783 | L | 0.046324 | P | 0.09449 | -0.048166 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 862 | R | 0.102317 | Q | 0.101471 | 8.46E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 875 | T | 0.104747 | K | 0.161593 | -0.056846 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 939 | H | 0.05366 | Y | 0.028465 | 0.025195 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 944 | V | 0.015376 | E | 0.037455 | -0.022079 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 945 | F | 0.014499 | L | 0.016634 | -0.002135 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 950 | G | 0.022678 | E | 0.032507 | -0.009829 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 952 | W | 0.036837 | G | 0.100495 | -0.063658 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 954 | E | 0.044872 | K | 0.040912 | 0.00396 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1210 | T | 0.04102 | K | 0.061593 | -0.020573 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1260 | T | 0.025598 | P | 0.033102 | -0.007504 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1287 | L | 0.007816 | P | 0.016153 | -0.008337 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1308 | E | 0.328352 | D | 0.301129 | 0.027223 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1309 | L | 0.339905 | F | 0.288062 | 0.051843 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1367 | N | 0.058588 | K | 0.076128 | -0.01754 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1396 | C | 0.239103 | G | 0.425425 | -0.186322 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1433 | G | 0.069859 | E | 0.088907 | -0.019048 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1433 | G | 0.069859 | R | 0.065667 | 0.004192 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1450 | Q | 0.604952 | K | 0.674377 | -0.069425 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1514 | L | 0.779143 | S | 0.868471 | -0.089328 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1545 | I | 0.067152 | V | 0.073955 | -0.006803 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1586 | G | 0.028193 | E | 0.039119 | -0.010926 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1612 | V | 0.011554 | I | 0.009866 | 0.001688 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1637 | V | 0.061262 | E | 0.138396 | -0.077134 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1645 | R | 0.085696 | Q | 0.083359 | 0.002337 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1658 | T | 0.092045 | M | 0.079937 | 0.012108 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1664 | M | 0.067235 | K | 0.11167 | -0.044435 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1726 | W | 0.212343 | R | 0.375387 | -0.163044 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1756 | C | 0.589002 | G | 0.762198 | -0.173196 | No Change: Both D | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1782 | I | 0.023455 | M | 0.037085 | -0.01363 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1783 | A | 0.028112 | T | 0.031639 | -0.003527 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1795 | E | 0.736049 | K | 0.718994 | 0.017055 | No Change: Both D | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 74 | S | 0.51764 | P | 0.533403 | -0.015763 | No Change: Both D | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 162 | T | 0.09966 | P | 0.11423 | -0.01457 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 217 | T | 0.134324 | K | 0.189549 | -0.055225 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 322 | R | 0.184343 | I | 0.102494 | 0.081849 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 356 | R | 0.36544 | G | 0.405042 | -0.039602 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 358 | P | 0.399755 | T | 0.362927 | 0.036828 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 383 | F | 0.104469 | L | 0.127543 | -0.023074 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 393 | R | 0.157637 | S | 0.206383 | -0.048746 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 403 | F | 0.008393 | L | 0.009542 | -0.001149 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 812 | T | 0.049596 | R | 0.049299 | 2.97E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 846 | E | 0.122787 | K | 0.116668 | 0.006119 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 859 | R | 0.151297 | C | 0.065556 | 0.085741 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 942 | L | 0.027474 | P | 0.055966 | -0.028492 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 957 | W | 0.061921 | L | 0.084163 | -0.022242 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1174 | T | 0.813843 | S | 0.829162 | -0.015319 | No Change: Both D | Familial hemiplegic migraine type 3 (FHM3) [MIM:609634] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1231 | S | 0.083942 | T | 0.054688 | 0.029254 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1245 | R | 0.277365 | Q | 0.313359 | -0.035994 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1414 | N | 0.193631 | Y | 0.10045 | 0.093181 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1422 | Y | 0.077821 | C | 0.061824 | 0.015997 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1426 | L | 0.064961 | R | 0.103885 | -0.038924 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1451 | P | 0.602879 | L | 0.426507 | 0.176372 | D to O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1470 | G | 0.013637 | W | 0.004596 | 0.009041 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1475 | L | 0.024818 | S | 0.060475 | -0.035657 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1575 | R | 0.048563 | C | 0.021941 | 0.026622 | No Change: Both O | - |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1588 | C | 0.046699 | R | 0.104598 | -0.057899 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1608 | D | 0.010629 | Y | 0.004884 | 0.005745 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1630 | V | 0.087298 | M | 0.11162 | -0.024322 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1649 | L | 0.167381 | Q | 0.269255 | -0.101874 | No Change: Both O | Familial hemiplegic migraine type 3 (FHM3) [MIM:609634] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1658 | T | 0.092045 | R | 0.10543 | -0.013385 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1687 | F | 0.035943 | S | 0.096743 | -0.0608 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 2 (GEFS+2) [MIM:604403] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1713 | S | 0.083776 | N | 0.075983 | 0.007793 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1714 | M | 0.074598 | R | 0.095917 | -0.021319 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1716 | C | 0.065299 | R | 0.130902 | -0.065603 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1762 | G | 0.111367 | E | 0.124987 | -0.01362 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1773 | S | 0.019114 | F | 0.007132 | 0.011982 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1787 | E | 0.10528 | K | 0.097953 | 0.007327 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1783 | A | 0.028112 | V | 0.021426 | 0.006686 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 79 | D | 0.407297 | H | 0.361919 | 0.045378 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 199 | T | 0.023914 | R | 0.023089 | 8.25E-04 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1441 | A | 0.158148 | P | 0.20309 | -0.044942 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1707 | F | 0.214206 | V | 0.227542 | -0.013336 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1721 | T | 0.093189 | R | 0.0921 | 0.001089 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| P35498 | SCN1A_HUMAN Sodium channel protein type 1 subunit alpha OS=Homo sapiens GN=SCN1A PE=1 SV=2 | 1922 | I | 0.274358 | T | 0.399827 | -0.125469 | No Change: Both O | Severe myoclonic epilepsy in infancy (SMEI) [MIM:607208] |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 121 | C | 0.168983 | W | 0.146847 | 0.022136 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 1 (GEFS+1) [MIM:604233] |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 25 | D | 0.406878 | N | 0.389065 | 0.017813 | No Change: Both O | - |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 87 | E | 0.359793 | Q | 0.296725 | 0.063068 | No Change: Both O | - |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 138 | V | 0.421348 | I | 0.384813 | 0.036535 | No Change: Both O | - |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 208 | K | 0.623425 | I | 0.416503 | 0.206922 | D to O | - |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 211 | C | 0.644394 | Y | 0.632243 | 0.012151 | No Change: Both D | - |
| Q07699 | SCN1B_HUMAN Sodium channel subunit beta-1 OS=Homo sapiens GN=SCN1B PE=1 SV=1 | 213 | G | 0.672474 | D | 0.701644 | -0.02917 | No Change: Both D | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 19 | R | 0.686815 | K | 0.674355 | 0.01246 | No Change: Both D | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 188 | R | 0.063648 | W | 0.026439 | 0.037209 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 223 | R | 0.105917 | Q | 0.105711 | 2.06E-04 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 385 | F | 0.10446 | Y | 0.126729 | -0.022269 | No Change: Both O | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 524 | R | 0.988599 | Q | 0.986222 | 0.002377 | No Change: Both D | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 892 | V | 0.006391 | I | 0.005518 | 8.73E-04 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1003 | L | 0.356326 | I | 0.342272 | 0.014054 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1319 | R | 0.277603 | Q | 0.27325 | 0.004353 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1330 | L | 0.090631 | F | 0.074293 | 0.016338 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1563 | L | 0.040627 | V | 0.039694 | 9.33E-04 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1902 | R | 0.594267 | T | 0.587075 | 0.007192 | No Change: Both D | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 328 | F | 0.193652 | V | 0.204103 | -0.010451 | No Change: Both O | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 252 | M | 0.078266 | V | 0.066375 | 0.011891 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 261 | V | 0.014765 | M | 0.01943 | -0.004665 | No Change: Both O | Benign familial infantile convulsions type 3 (BFIC3) [MIM:607745] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 263 | A | 0.018828 | V | 0.014208 | 0.00462 | No Change: Both O | Epileptic encephalopathy early infantile type 11 (EIEE11) [MIM:613721] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 575 | A | 0.878384 | V | 0.819019 | 0.059365 | No Change: Both D | - |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1211 | E | 0.032192 | K | 0.031105 | 0.001087 | No Change: Both O | Epileptic encephalopathy early infantile type 11 (EIEE11) [MIM:613721] |
| Q99250 | SCN2A_HUMAN Sodium channel protein type 2 subunit alpha OS=Homo sapiens GN=SCN2A PE=1 SV=3 | 1473 | I | 0.085627 | M | 0.117664 | -0.032037 | No Change: Both O | Epileptic encephalopathy early infantile type 11 (EIEE11) [MIM:613721] |
| O60939 | SCN2B_HUMAN Sodium channel subunit beta-2 OS=Homo sapiens GN=SCN2B PE=1 SV=1 | 28 | R | 0.430104 | W | 0.233402 | 0.196702 | No Change: Both O | - |
| O60939 | SCN2B_HUMAN Sodium channel subunit beta-2 OS=Homo sapiens GN=SCN2B PE=1 SV=1 | 47 | R | 0.247219 | H | 0.244732 | 0.002487 | No Change: Both O | - |
| Q9NY46 | SCN3A_HUMAN Sodium channel protein type 3 subunit alpha OS=Homo sapiens GN=SCN3A PE=1 SV=2 | 606 | S | 0.945564 | T | 0.921988 | 0.023576 | No Change: Both D | - |
| Q9NY46 | SCN3A_HUMAN Sodium channel protein type 3 subunit alpha OS=Homo sapiens GN=SCN3A PE=1 SV=2 | 1107 | V | 0.557141 | A | 0.588832 | -0.031691 | No Change: Both D | - |
| Q9NY46 | SCN3A_HUMAN Sodium channel protein type 3 subunit alpha OS=Homo sapiens GN=SCN3A PE=1 SV=2 | 1813 | L | 0.325046 | S | 0.48914 | -0.164094 | No Change: Both O | - |
| Q9NY46 | SCN3A_HUMAN Sodium channel protein type 3 subunit alpha OS=Homo sapiens GN=SCN3A PE=1 SV=2 | 1803 | D | 0.367195 | N | 0.314409 | 0.052786 | No Change: Both O | - |
| Q9NY72 | SCN3B_HUMAN Sodium channel subunit beta-3 OS=Homo sapiens GN=SCN3B PE=1 SV=1 | 89 | Q | 0.403379 | L | 0.25163 | 0.151749 | No Change: Both O | A colorectal cancer sample |
| Q9NY72 | SCN3B_HUMAN Sodium channel subunit beta-3 OS=Homo sapiens GN=SCN3B PE=1 SV=1 | 195 | A | 0.586731 | T | 0.58819 | -0.001459 | No Change: Both D | A colorectal cancer sample |
| Q9NY72 | SCN3B_HUMAN Sodium channel subunit beta-3 OS=Homo sapiens GN=SCN3B PE=1 SV=1 | 97 | S | 0.435468 | N | 0.400544 | 0.034924 | No Change: Both O | - |
| Q9NY72 | SCN3B_HUMAN Sodium channel subunit beta-3 OS=Homo sapiens GN=SCN3B PE=1 SV=1 | 10 | L | 0.052248 | P | 0.103727 | -0.051479 | No Change: Both O | Brugada syndrome type 7 (BRS7) [MIM:613120] |
| Q9NY72 | SCN3B_HUMAN Sodium channel subunit beta-3 OS=Homo sapiens GN=SCN3B PE=1 SV=1 | 54 | V | 0.384149 | G | 0.475899 | -0.09175 | No Change: Both O | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 135 | M | 0.028813 | V | 0.020233 | 0.00858 | No Change: Both O | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 524 | S | 0.887999 | G | 0.868893 | 0.019106 | No Change: Both D | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 704 | T | 0.054844 | M | 0.044571 | 0.010273 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 704 | T | 0.054844 | M | 0.044571 | 0.010273 | No Change: Both O | Periodic paralysis hyperkalemic (HYPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 804 | S | 0.338028 | F | 0.156741 | 0.181287 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 861 | A | 0.735302 | D | 0.759943 | -0.024641 | No Change: Both D | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1156 | A | 0.097903 | T | 0.104125 | -0.006222 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1156 | A | 0.097903 | T | 0.104125 | -0.006222 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1156 | A | 0.097903 | T | 0.104125 | -0.006222 | No Change: Both O | Periodic paralysis hyperkalemic (HYPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1293 | V | 0.038466 | I | 0.037963 | 5.03E-04 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1306 | G | 0.551743 | A | 0.485925 | 0.065818 | D to O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1306 | G | 0.551743 | E | 0.588259 | -0.036516 | No Change: Both D | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1306 | G | 0.551743 | E | 0.588259 | -0.036516 | No Change: Both D | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1306 | G | 0.551743 | V | 0.408187 | 0.143556 | D to O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1306 | G | 0.551743 | V | 0.408187 | 0.143556 | D to O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1313 | T | 0.57631 | M | 0.591933 | -0.015623 | No Change: Both D | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1433 | L | 0.083404 | R | 0.132279 | -0.048875 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1433 | L | 0.083404 | R | 0.132279 | -0.048875 | No Change: Both O | Periodic paralysis hyperkalemic (HYPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1448 | R | 0.061524 | C | 0.025213 | 0.036311 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1448 | R | 0.061524 | H | 0.056598 | 0.004926 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1589 | V | 0.012452 | M | 0.017876 | -0.005424 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1592 | M | 0.013485 | V | 0.010745 | 0.00274 | No Change: Both O | Periodic paralysis hyperkalemic (HYPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1592 | M | 0.013485 | V | 0.010745 | 0.00274 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 246 | S | 0.256945 | L | 0.12396 | 0.132985 | No Change: Both O | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 445 | V | 0.035405 | M | 0.049229 | -0.013824 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 559 | N | 0.013995 | D | 0.015248 | -0.001253 | No Change: Both O | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 669 | R | 0.146033 | H | 0.135848 | 0.010185 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 672 | R | 0.101545 | G | 0.101226 | 3.19E-04 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 672 | R | 0.101545 | H | 0.093565 | 0.00798 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 672 | R | 0.101545 | S | 0.134601 | -0.033056 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1158 | P | 0.089231 | S | 0.107977 | -0.018746 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1160 | I | 0.065558 | V | 0.076573 | -0.011015 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1376 | N | 0.551428 | D | 0.590895 | -0.039467 | No Change: Both D | - |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1442 | V | 0.087742 | E | 0.191132 | -0.10339 | No Change: Both O | A congenital myasthenic syndrome SCNA4-related (CMSAR) [MIM:614198] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1152 | A | 0.081337 | D | 0.110771 | -0.029434 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 675 | R | 0.096335 | G | 0.093457 | 0.002878 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 675 | R | 0.096335 | Q | 0.096171 | 1.64E-04 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 675 | R | 0.096335 | W | 0.034777 | 0.061558 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1456 | G | 0.093311 | E | 0.113728 | -0.020417 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 141 | I | 0.022909 | V | 0.025829 | -0.00292 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 222 | R | 0.099349 | W | 0.034524 | 0.064825 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 270 | Q | 0.068044 | K | 0.082347 | -0.014303 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 452 | E | 0.42332 | K | 0.404635 | 0.018685 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 671 | F | 0.116451 | S | 0.288302 | -0.171851 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 672 | R | 0.101545 | C | 0.042452 | 0.059093 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 715 | A | 0.012541 | T | 0.014033 | -0.001492 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 781 | V | 0.022388 | I | 0.017969 | 0.004419 | No Change: Both O | Periodic paralysis hyperkalemic (HYPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 781 | V | 0.022388 | I | 0.017969 | 0.004419 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 804 | S | 0.338028 | N | 0.277287 | 0.060741 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1132 | R | 0.280899 | Q | 0.273601 | 0.007298 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1135 | R | 0.308701 | H | 0.285175 | 0.023526 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1297 | N | 0.188529 | K | 0.224914 | -0.036385 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1310 | I | 0.49493 | N | 0.623585 | -0.128655 | O to D | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1436 | L | 0.119093 | P | 0.220814 | -0.101721 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1448 | R | 0.061524 | L | 0.034158 | 0.027366 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1473 | F | 0.063579 | S | 0.175121 | -0.111542 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1476 | M | 0.067276 | I | 0.041801 | 0.025475 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1481 | A | 0.075145 | D | 0.105252 | -0.030107 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1705 | F | 0.563468 | I | 0.570391 | -0.006923 | No Change: Both D | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1129 | R | 0.307473 | Q | 0.30188 | 0.005593 | No Change: Both O | Periodic paralysis hypokalemic type 2 (HOKPP2) [MIM:613345] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 1129 | R | 0.307473 | Q | 0.30188 | 0.005593 | No Change: Both O | Periodic paralysis normokalemic (NKPP) [MIM:170500] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 225 | R | 0.09597 | W | 0.033458 | 0.062512 | No Change: Both O | Myotonia SCN4A-related (MYOSCN4A) [MIM:608390] |
| P35499 | SCN4A_HUMAN Sodium channel protein type 4 subunit alpha OS=Homo sapiens GN=SCN4A PE=1 SV=4 | 693 | I | 0.14401 | T | 0.235897 | -0.091887 | No Change: Both O | Paramyotonia congenita of von Eulenburg (PMC) [MIM:168300] |
| Q8IWT1 | SCN4B_HUMAN Sodium channel subunit beta-4 OS=Homo sapiens GN=SCN4B PE=1 SV=1 | 179 | L | 0.015866 | F | 0.011782 | 0.004084 | No Change: Both O | Long QT syndrome type 10 (LQT10) [MIM:611819] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1325 | N | 0.088693 | S | 0.110292 | -0.021599 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1623 | R | 0.058437 | Q | 0.057685 | 7.52E-04 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1644 | R | 0.119736 | H | 0.113978 | 0.005758 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1790 | D | 0.434339 | G | 0.387103 | 0.047236 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1839 | D | 0.245491 | G | 0.223625 | 0.021866 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 558 | H | 0.830475 | R | 0.857008 | -0.026533 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1304 | T | 0.286681 | M | 0.254581 | 0.0321 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1500 | K | 0.704754 | N | 0.657028 | 0.047726 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1645 | T | 0.092354 | M | 0.080475 | 0.011879 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1784 | E | 0.81195 | K | 0.798119 | 0.013831 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1784 | E | 0.81195 | K | 0.798119 | 0.013831 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1114 | D | 0.970263 | N | 0.963407 | 0.006856 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1501 | L | 0.710215 | V | 0.697545 | 0.01267 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1623 | R | 0.058437 | L | 0.032402 | 0.026035 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1787 | S | 0.729362 | N | 0.683631 | 0.045731 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1090 | P | 0.98944 | L | 0.977195 | 0.012245 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 619 | L | 0.830937 | F | 0.785315 | 0.045622 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 220 | T | 0.134257 | I | 0.070931 | 0.063326 | No Change: Both O | Sick sinus syndrome type 1 (SSS1) [MIM:608567] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 298 | G | 0.281449 | S | 0.337681 | -0.056232 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 367 | R | 0.030005 | H | 0.0298 | 2.05E-04 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 514 | G | 0.949697 | C | 0.931035 | 0.018662 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 514 | G | 0.949697 | C | 0.931035 | 0.018662 | No Change: Both D | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 735 | A | 0.135884 | V | 0.101604 | 0.03428 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 941 | S | 0.260789 | N | 0.223283 | 0.037506 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 997 | A | 0.718003 | S | 0.753841 | -0.035838 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1103 | S | 0.978995 | Y | 0.946993 | 0.032002 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1193 | R | 0.063345 | Q | 0.066212 | -0.002867 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1193 | R | 0.063345 | Q | 0.066212 | -0.002867 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1232 | R | 0.267439 | W | 0.113397 | 0.154042 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1232 | R | 0.267439 | W | 0.113397 | 0.154042 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1298 | P | 0.338502 | L | 0.204101 | 0.134401 | No Change: Both O | Sick sinus syndrome type 1 (SSS1) [MIM:608567] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1408 | G | 0.09872 | R | 0.086872 | 0.011848 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1408 | G | 0.09872 | R | 0.086872 | 0.011848 | No Change: Both O | Sick sinus syndrome type 1 (SSS1) [MIM:608567] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1512 | R | 0.539221 | W | 0.340152 | 0.199069 | D to O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1595 | D | 0.020595 | N | 0.020998 | -4.03E-04 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1620 | T | 0.058976 | M | 0.047253 | 0.011723 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1710 | S | 0.149692 | L | 0.072054 | 0.077638 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1710 | S | 0.149692 | L | 0.072054 | 0.077638 | No Change: Both O | Familial paroxysmal ventricular fibrillation type 1 (VF1) [MIM:603829] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1826 | R | 0.362996 | H | 0.366233 | -0.003237 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1924 | A | 0.506597 | T | 0.505425 | 0.001172 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1795 | Y | 0.174697 | C | 0.172644 | 0.002053 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1795 | Y | 0.174697 | H | 0.248814 | -0.074117 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 27 | R | 0.896829 | H | 0.843326 | 0.053503 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 34 | R | 0.942577 | C | 0.903549 | 0.039028 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 126 | K | 0.134446 | E | 0.13513 | -6.84E-04 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 161 | E | 0.114936 | K | 0.12251 | -0.007574 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 161 | E | 0.114936 | K | 0.12251 | -0.007574 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 187 | T | 0.037226 | I | 0.018908 | 0.018318 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 226 | A | 0.121086 | V | 0.092166 | 0.02892 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 230 | I | 0.16117 | V | 0.184522 | -0.023352 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 282 | R | 0.176944 | H | 0.179197 | -0.002253 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 294 | V | 0.463523 | M | 0.517274 | -0.053751 | O to D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 319 | G | 0.388416 | S | 0.454835 | -0.066419 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 351 | G | 0.502984 | V | 0.354066 | 0.148918 | D to O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 356 | D | 0.179334 | N | 0.16539 | 0.013944 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 367 | R | 0.030005 | C | 0.014043 | 0.015962 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 369 | M | 0.046803 | K | 0.084567 | -0.037764 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 552 | G | 0.866801 | R | 0.88954 | -0.022739 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 567 | L | 0.800288 | Q | 0.867492 | -0.067204 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 615 | G | 0.799664 | E | 0.818138 | -0.018474 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 681 | H | 0.46421 | P | 0.533296 | -0.069086 | O to D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 735 | A | 0.135884 | E | 0.215476 | -0.079592 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 752 | G | 0.12515 | R | 0.11165 | 0.0135 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 752 | G | 0.12515 | R | 0.11165 | 0.0135 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 851 | F | 0.006714 | L | 0.00793 | -0.001216 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 892 | F | 0.008554 | I | 0.008736 | -1.82E-04 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 896 | C | 0.016303 | S | 0.04947 | -0.033167 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 910 | S | 0.172946 | L | 0.077109 | 0.095837 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 965 | R | 0.220392 | C | 0.126891 | 0.093501 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1027 | R | 0.984418 | Q | 0.986104 | -0.001686 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1053 | E | 0.980718 | K | 0.974143 | 0.006575 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1053 | E | 0.980718 | K | 0.974143 | 0.006575 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1225 | E | 0.210206 | K | 0.198841 | 0.011365 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1236 | K | 0.196084 | N | 0.153892 | 0.042192 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1240 | E | 0.123922 | Q | 0.099145 | 0.024777 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1250 | F | 0.024637 | L | 0.029547 | -0.00491 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1275 | D | 0.008305 | N | 0.007533 | 7.72E-04 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1275 | D | 0.008305 | N | 0.007533 | 7.72E-04 | No Change: Both O | Cardiomyopathy dilated type 1E (CMD1E) [MIM:601154] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1275 | D | 0.008305 | N | 0.007533 | 7.72E-04 | No Change: Both O | Familial atrial standstill (FAS) [MIM:108770] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1275 | D | 0.008305 | N | 0.007533 | 7.72E-04 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1293 | F | 0.201507 | S | 0.433477 | -0.23197 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1319 | G | 0.201804 | V | 0.128149 | 0.073655 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1344 | F | 0.002833 | S | 0.008308 | -0.005475 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1382 | S | 0.433378 | I | 0.209558 | 0.22382 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1405 | V | 0.162992 | L | 0.163573 | -5.81E-04 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1406 | G | 0.138257 | R | 0.122368 | 0.015889 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1502 | G | 0.716857 | S | 0.751122 | -0.034265 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1714 | D | 0.259459 | G | 0.252147 | 0.007312 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1740 | G | 0.734375 | R | 0.717558 | 0.016817 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1743 | G | 0.476945 | E | 0.505926 | -0.028981 | O to D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1951 | V | 0.758784 | L | 0.800081 | -0.041297 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1951 | V | 0.758784 | L | 0.800081 | -0.041297 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 9 | G | 0.74539 | V | 0.615042 | 0.130348 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 225 | R | 0.110686 | Q | 0.110465 | 2.21E-04 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 512 | T | 0.956781 | I | 0.930264 | 0.026517 | No Change: Both D | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 524 | S | 0.943808 | Y | 0.861857 | 0.081951 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 639 | G | 0.943883 | R | 0.948463 | -0.00458 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1262 | G | 0.066402 | S | 0.084465 | -0.018063 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1333 | S | 0.0775 | Y | 0.03282 | 0.04468 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1333 | S | 0.0775 | Y | 0.03282 | 0.04468 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1609 | S | 0.086832 | W | 0.022593 | 0.064239 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1819 | D | 0.333614 | N | 0.301923 | 0.031691 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 618 | L | 0.821826 | F | 0.77509 | 0.046736 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1041 | D | 0.981308 | N | 0.976397 | 0.004911 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1180 | A | 0.163002 | V | 0.126169 | 0.036833 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 43 | R | 0.967688 | Q | 0.969439 | -0.001751 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 95 | V | 0.161532 | I | 0.157459 | 0.004073 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 138 | M | 0.02633 | I | 0.017116 | 0.009214 | No Change: Both O | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 212 | L | 0.201674 | P | 0.348135 | -0.146461 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 216 | S | 0.164203 | L | 0.078753 | 0.08545 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 225 | R | 0.110686 | W | 0.039217 | 0.071469 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 232 | V | 0.162053 | I | 0.151607 | 0.010446 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 325 | L | 0.390818 | R | 0.496393 | -0.105575 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 336 | P | 0.396145 | L | 0.248048 | 0.148097 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 353 | T | 0.375987 | I | 0.246388 | 0.129599 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 376 | R | 0.165137 | H | 0.158478 | 0.006659 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 406 | N | 0.022801 | K | 0.028142 | -0.005341 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 406 | N | 0.022801 | S | 0.029814 | -0.007013 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 428 | E | 0.761595 | K | 0.757105 | 0.00449 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 445 | H | 0.820161 | D | 0.850439 | -0.030278 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 461 | L | 0.887464 | V | 0.884983 | 0.002481 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 470 | N | 0.954616 | K | 0.968271 | -0.013655 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 481 | R | 0.984703 | W | 0.958463 | 0.02624 | No Change: Both D | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 532 | F | 0.889164 | C | 0.889877 | -7.13E-04 | No Change: Both D | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 572 | A | 0.831983 | D | 0.855669 | -0.023686 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 572 | A | 0.831983 | D | 0.855669 | -0.023686 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 655 | E | 0.82747 | K | 0.791439 | 0.036031 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 680 | R | 0.563002 | H | 0.57655 | -0.013548 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 814 | R | 0.100684 | Q | 0.09852 | 0.002164 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 878 | R | 0.240943 | C | 0.124421 | 0.116522 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1023 | R | 0.981956 | H | 0.975266 | 0.00669 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1084 | G | 0.994598 | S | 0.99647 | -0.001872 | No Change: Both D | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1131 | T | 0.937966 | I | 0.892941 | 0.045025 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1295 | E | 0.265886 | K | 0.280175 | -0.014289 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1308 | L | 0.302444 | F | 0.253292 | 0.049152 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1330 | A | 0.100587 | P | 0.143655 | -0.043068 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1330 | A | 0.100587 | T | 0.106992 | -0.006405 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1332 | P | 0.089622 | L | 0.046153 | 0.043469 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1432 | R | 0.48221 | G | 0.516492 | -0.034282 | O to D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1438 | P | 0.495345 | L | 0.322835 | 0.17251 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1473 | F | 0.267846 | C | 0.252714 | 0.015132 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1486 | F | 0.465224 | L | 0.492272 | -0.027048 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1494 | Y | 0.622645 | N | 0.744679 | -0.122034 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1527 | K | 0.113241 | R | 0.087628 | 0.025613 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1569 | A | 0.016381 | P | 0.023565 | -0.007184 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1620 | T | 0.058976 | K | 0.091336 | -0.03236 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1620 | T | 0.058976 | K | 0.091336 | -0.03236 | No Change: Both O | Progressive familial heart block type 1A (PFHB1A) [MIM:113900] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1626 | R | 0.062058 | P | 0.06904 | -0.006982 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1644 | R | 0.119736 | C | 0.052854 | 0.066882 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1644 | R | 0.119736 | C | 0.052854 | 0.066882 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1649 | A | 0.060233 | V | 0.038938 | 0.021295 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1652 | M | 0.070528 | R | 0.089256 | -0.018728 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1660 | I | 0.035506 | V | 0.042425 | -0.006919 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1705 | F | 0.073134 | S | 0.192132 | -0.118998 | No Change: Both O | Sudden infant death syndrome (SIDS) [MIM:272120] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1743 | G | 0.476945 | R | 0.453986 | 0.022959 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1763 | V | 0.011845 | M | 0.017095 | -0.00525 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1766 | M | 0.01334 | L | 0.010552 | 0.002788 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1768 | I | 0.018257 | V | 0.02093 | -0.002673 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1777 | V | 0.37168 | M | 0.438294 | -0.066614 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1825 | L | 0.372108 | P | 0.555538 | -0.18343 | O to D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1826 | R | 0.362996 | C | 0.209299 | 0.153697 | No Change: Both O | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1850 | C | 0.102769 | S | 0.226399 | -0.12363 | No Change: Both O | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1875 | M | 0.441563 | T | 0.452692 | -0.011129 | No Change: Both O | - |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1904 | S | 0.484463 | L | 0.327429 | 0.157034 | No Change: Both O | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1935 | G | 0.699613 | S | 0.757729 | -0.058116 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1951 | V | 0.758784 | M | 0.836768 | -0.077984 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1968 | I | 0.956155 | S | 0.981979 | -0.025824 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 2004 | F | 0.9132 | L | 0.93369 | -0.02049 | No Change: Both D | Brugada syndrome type 1 (BRS1) [MIM:601144] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 2004 | F | 0.9132 | L | 0.93369 | -0.02049 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 2006 | P | 0.906789 | A | 0.849687 | 0.057102 | No Change: Both D | Long QT syndrome type 3 (LQT3) [MIM:603830] |
| Q14524 | SCN5A_HUMAN Sodium channel protein type 5 subunit alpha OS=Homo sapiens GN=SCN5A PE=1 SV=2 | 1987 | N | 0.936289 | K | 0.942257 | -0.005968 | No Change: Both D | Familial atrial fibrillation type 10 (ATFB10) [MIM:614022] |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 407 | I | 0.634152 | V | 0.652173 | -0.018021 | No Change: Both D | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 600 | M | 0.048147 | L | 0.03944 | 0.008707 | No Change: Both O | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 1313 | A | 0.009673 | V | 0.006692 | 0.002981 | No Change: Both O | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 1516 | R | 0.251391 | K | 0.323375 | -0.071984 | No Change: Both O | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 1596 | V | 0.408136 | L | 0.392044 | 0.016092 | No Change: Both O | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 1657 | D | 0.553087 | G | 0.508687 | 0.0444 | No Change: Both D | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 41 | T | 0.688464 | N | 0.713529 | -0.025065 | No Change: Both D | - |
| Q01118 | SCN7A_HUMAN Sodium channel protein type 7 subunit alpha OS=Homo sapiens GN=SCN7A PE=2 SV=2 | 958 | M | 0.187746 | I | 0.138997 | 0.048749 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 859 | I | 0.144154 | T | 0.236255 | -0.092101 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 869 | L | 0.096063 | H | 0.146616 | -0.050553 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1161 | W | 0.124614 | R | 0.239743 | -0.115129 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1919 | D | 0.620787 | G | 0.555593 | 0.065194 | No Change: Both D | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 932 | M | 0.062197 | L | 0.04365 | 0.018547 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 241 | S | 0.25686 | T | 0.183254 | 0.073606 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1007 | R | 0.236777 | C | 0.142817 | 0.09396 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1309 | V | 0.094917 | D | 0.17389 | -0.078973 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1309 | V | 0.094917 | F | 0.080785 | 0.014132 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1310 | V | 0.081702 | F | 0.068368 | 0.013334 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1460 | F | 0.267881 | V | 0.304855 | -0.036974 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1472 | I | 0.448079 | T | 0.568384 | -0.120305 | O to D | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1473 | F | 0.481305 | V | 0.48125 | 5.50E-05 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1475 | T | 0.545277 | I | 0.469283 | 0.075994 | D to O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1638 | M | 0.067164 | K | 0.11162 | -0.044456 | No Change: Both O | Paroxysmal extreme pain disorder (PEPD) [MIM:167400] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 943 | M | 0.046373 | L | 0.03305 | 0.013323 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 10 | Q | 0.747253 | R | 0.730608 | 0.016645 | No Change: Both D | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 62 | I | 0.673282 | V | 0.679493 | -0.006211 | No Change: Both D | Familial febrile convulsions type 3B (FEB3B) [MIM:613863] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 149 | P | 0.444178 | Q | 0.405832 | 0.038346 | No Change: Both O | Familial febrile convulsions type 3B (FEB3B) [MIM:613863] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 216 | F | 0.121732 | S | 0.308286 | -0.186554 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 228 | I | 0.151079 | M | 0.203266 | -0.052187 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 395 | N | 0.019146 | K | 0.023425 | -0.004279 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 406 | E | 0.413188 | K | 0.394528 | 0.01866 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 490 | S | 0.99595 | N | 0.994316 | 0.001634 | No Change: Both D | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 519 | E | 0.931173 | K | 0.931623 | -4.50E-04 | No Change: Both D | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 641 | N | 0.329536 | Y | 0.196873 | 0.132663 | No Change: Both O | Generalized epilepsy with febrile seizures plus type 7 (GEFS+7) [MIM:613863] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 666 | K | 0.632651 | R | 0.613435 | 0.019216 | No Change: Both D | Generalized epilepsy with febrile seizures plus type 7 (GEFS+7) [MIM:613863] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 695 | I | 0.409138 | M | 0.545963 | -0.136825 | O to D | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 710 | C | 0.269645 | Y | 0.331273 | -0.061628 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 750 | I | 0.017812 | V | 0.020815 | -0.003003 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 869 | L | 0.096063 | F | 0.076811 | 0.019252 | No Change: Both O | Primary erythermalgia (PERYTHM) [MIM:133020] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 907 | R | 0.15003 | Q | 0.162496 | -0.012466 | No Change: Both O | Congenital indifference to pain autosomal recessive (CIPAR) [MIM:243000] |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1134 | L | 0.953317 | F | 0.956236 | -0.002919 | No Change: Both D | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1171 | E | 0.248331 | Q | 0.222707 | 0.025624 | No Change: Both O | - |
| Q15858 | SCN9A_HUMAN Sodium channel protein type 9 subunit alpha OS=Homo sapiens GN=SCN9A PE=1 SV=3 | 1278 | L | 0.185529 | V | 0.184388 | 0.001141 | No Change: Both O | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 493 | W | 0.376581 | R | 0.576888 | -0.200307 | O to D | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 562 | S | 0.160547 | L | 0.070187 | 0.09036 | No Change: Both O | Autosomal recessive pseudohypoaldosteronism type 1 (AR-PHA1) [MIM:264350] |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 663 | T | 0.996218 | A | 0.996213 | 5.00E-06 | No Change: Both D | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 618 | C | 0.950994 | F | 0.950133 | 8.61E-04 | No Change: Both D | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 327 | G | 0.402573 | C | 0.230721 | 0.171852 | No Change: Both O | Autosomal recessive pseudohypoaldosteronism type 1 (AR-PHA1) [MIM:264350] |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 402 | P | 0.447193 | H | 0.393794 | 0.053399 | No Change: Both O | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 61 | F | 0.127772 | L | 0.138415 | -0.010643 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 2 (BESC2) [MIM:613021] |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 114 | V | 0.176776 | I | 0.16601 | 0.010766 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 2 (BESC2) [MIM:613021] |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 181 | R | 0.754439 | W | 0.561422 | 0.193017 | No Change: Both D | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 334 | A | 0.265981 | T | 0.301722 | -0.035741 | No Change: Both O | - |
| P37088 | SCNNA_HUMAN Amiloride-sensitive sodium channel subunit alpha OS=Homo sapiens GN=SCNN1A PE=1 SV=1 | 573 | V | 0.057133 | I | 0.046182 | 0.010951 | No Change: Both O | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 37 | G | 0.393865 | S | 0.447573 | -0.053708 | No Change: Both O | Autosomal recessive pseudohypoaldosteronism type 1 (AR-PHA1) [MIM:264350] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 616 | P | 0.878031 | L | 0.776391 | 0.10164 | No Change: Both D | Liddle syndrome (LIDDS) [MIM:177200] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 616 | P | 0.878031 | S | 0.864192 | 0.013839 | No Change: Both D | Liddle syndrome (LIDDS) [MIM:177200] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 442 | G | 0.253773 | V | 0.179026 | 0.074747 | No Change: Both O | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 594 | T | 0.862406 | M | 0.833242 | 0.029164 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 336 | A | 0.33151 | P | 0.419605 | -0.088095 | No Change: Both O | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 434 | V | 0.301425 | M | 0.412533 | -0.111108 | No Change: Both O | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 589 | G | 0.790216 | S | 0.828527 | -0.038311 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 597 | R | 0.879698 | H | 0.871943 | 0.007755 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 624 | R | 0.811318 | C | 0.751827 | 0.059491 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 632 | E | 0.761284 | G | 0.722981 | 0.038303 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 563 | R | 0.529324 | Q | 0.551741 | -0.022417 | No Change: Both D | - |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 617 | P | 0.87434 | S | 0.860905 | 0.013435 | No Change: Both D | Liddle syndrome (LIDDS) [MIM:177200] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 618 | P | 0.871842 | R | 0.832307 | 0.039535 | No Change: Both D | Liddle syndrome (LIDDS) [MIM:177200] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 620 | Y | 0.863989 | H | 0.903087 | -0.039098 | No Change: Both D | Liddle syndrome (LIDDS) [MIM:177200] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 311 | A | 0.137657 | V | 0.101912 | 0.035745 | No Change: Both O | A colorectal cancer sample |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 314 | A | 0.164637 | V | 0.121564 | 0.043073 | No Change: Both O | A breast cancer sample |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 387 | L | 0.123175 | V | 0.125183 | -0.002008 | No Change: Both O | A breast cancer sample |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 82 | S | 0.221954 | C | 0.072673 | 0.149281 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 267 | P | 0.074859 | L | 0.035487 | 0.039372 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 288 | N | 0.594489 | S | 0.656707 | -0.062218 | No Change: Both D | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 294 | G | 0.212978 | S | 0.248735 | -0.035757 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 348 | V | 0.238383 | M | 0.301305 | -0.062922 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 369 | P | 0.347369 | T | 0.303676 | 0.043693 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51168 | SCNNB_HUMAN Amiloride-sensitive sodium channel subunit beta OS=Homo sapiens GN=SCNN1B PE=1 SV=2 | 539 | E | 0.035767 | K | 0.033188 | 0.002579 | No Change: Both O | Bronchiectasis with or without elevated sweat chloride type 1 (BESC1) [MIM:211400] |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 180 | R | 0.55036 | P | 0.593786 | -0.043426 | No Change: Both D | - |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 380 | E | 0.401195 | Q | 0.334365 | 0.06683 | No Change: Both O | - |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 472 | A | 0.773443 | T | 0.799224 | -0.025781 | No Change: Both D | - |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 532 | C | 0.11599 | Y | 0.140169 | -0.024179 | No Change: Both O | - |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 562 | G | 0.306978 | S | 0.377909 | -0.070931 | No Change: Both O | - |
| P51172 | SCNND_HUMAN Amiloride-sensitive sodium channel subunit delta OS=Homo sapiens GN=SCNN1D PE=1 SV=2 | 606 | G | 0.934384 | R | 0.935793 | -0.001409 | No Change: Both D | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 49 | G | 0.179549 | C | 0.082951 | 0.096598 | No Change: Both O | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 183 | G | 0.486509 | S | 0.532637 | -0.046128 | O to D | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 178 | R | 0.472898 | W | 0.250912 | 0.221986 | No Change: Both O | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 502 | A | 0.174563 | P | 0.245232 | -0.070669 | No Change: Both O | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 614 | A | 0.715717 | S | 0.774093 | -0.058376 | No Change: Both D | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 197 | E | 0.373349 | K | 0.398504 | -0.025155 | No Change: Both O | - |
| P51170 | SCNNG_HUMAN Amiloride-sensitive sodium channel subunit gamma OS=Homo sapiens GN=SCNN1G PE=1 SV=4 | 58 | G | 0.027128 | R | 0.027801 | -6.73E-04 | No Change: Both O | A colorectal cancer sample |
| O75880 | SCO1_HUMAN Protein SCO1 homolog mitochondrial OS=Homo sapiens GN=SCO1 PE=1 SV=1 | 174 | P | 0.332641 | L | 0.191491 | 0.14115 | No Change: Both O | Mitochondrial complex IV deficiency (MT-C4D) [MIM:220110] |
| O75880 | SCO1_HUMAN Protein SCO1 homolog mitochondrial OS=Homo sapiens GN=SCO1 PE=1 SV=1 | 58 | P | 0.701625 | S | 0.68882 | 0.012805 | No Change: Both D | - |
| O43819 | SCO2_HUMAN Protein SCO2 homolog mitochondrial OS=Homo sapiens GN=SCO2 PE=1 SV=3 | 140 | E | 0.291787 | K | 0.288239 | 0.003548 | No Change: Both O | Fatal infantile cardioencephalomyopathy with cytochrome c oxidase deficiency (FIC) [MIM:604377] |
| O43819 | SCO2_HUMAN Protein SCO2 homolog mitochondrial OS=Homo sapiens GN=SCO2 PE=1 SV=3 | 225 | S | 0.09359 | F | 0.035117 | 0.058473 | No Change: Both O | Fatal infantile cardioencephalomyopathy with cytochrome c oxidase deficiency (FIC) [MIM:604377] |
| O43819 | SCO2_HUMAN Protein SCO2 homolog mitochondrial OS=Homo sapiens GN=SCO2 PE=1 SV=3 | 20 | R | 0.590036 | P | 0.632585 | -0.042549 | No Change: Both D | - |
| O43819 | SCO2_HUMAN Protein SCO2 homolog mitochondrial OS=Homo sapiens GN=SCO2 PE=1 SV=3 | 171 | R | 0.498223 | W | 0.293131 | 0.205092 | No Change: Both O | Fatal infantile cardioencephalomyopathy with cytochrome c oxidase deficiency (FIC) [MIM:604377] |
| O43819 | SCO2_HUMAN Protein SCO2 homolog mitochondrial OS=Homo sapiens GN=SCO2 PE=1 SV=3 | 259 | A | 0.44695 | V | 0.359935 | 0.087015 | No Change: Both O | - |
| P22307 | NLTP_HUMAN Non-specific lipid-transfer protein OS=Homo sapiens GN=SCP2 PE=1 SV=2 | 155 | A | 0.259983 | D | 0.319737 | -0.059754 | No Change: Both O | A breast cancer sample |
| Q9HB40 | RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens GN=SCPEP1 PE=1 SV=1 | 3 | L | 0.847826 | V | 0.854061 | -0.006235 | No Change: Both D | - |
| Q9HB40 | RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens GN=SCPEP1 PE=1 SV=1 | 241 | V | 0.249232 | I | 0.206658 | 0.042574 | No Change: Both O | - |
| O75711 | SCRG1_HUMAN Scrapie-responsive protein 1 OS=Homo sapiens GN=SCRG1 PE=1 SV=1 | 42 | P | 0.398286 | L | 0.252288 | 0.145998 | No Change: Both O | - |
| Q14160 | SCRIB_HUMAN Protein scribble homolog OS=Homo sapiens GN=SCRIB PE=1 SV=4 | 422 | P | 0.817093 | L | 0.70812 | 0.108973 | No Change: Both D | - |
| Q12765 | SCRN1_HUMAN Secernin-1 OS=Homo sapiens GN=SCRN1 PE=1 SV=2 | 338 | Q | 0.863677 | R | 0.872642 | -0.008965 | No Change: Both D | - |
| Q12765 | SCRN1_HUMAN Secernin-1 OS=Homo sapiens GN=SCRN1 PE=1 SV=2 | 189 | S | 0.129034 | N | 0.09887 | 0.030164 | No Change: Both O | - |
| Q96FV2 | SCRN2_HUMAN Secernin-2 OS=Homo sapiens GN=SCRN2 PE=2 SV=3 | 103 | K | 0.392683 | R | 0.334668 | 0.058015 | No Change: Both O | - |
| Q96FV2 | SCRN2_HUMAN Secernin-2 OS=Homo sapiens GN=SCRN2 PE=2 SV=3 | 323 | M | 0.454423 | V | 0.429861 | 0.024562 | No Change: Both O | - |
| Q96FV2 | SCRN2_HUMAN Secernin-2 OS=Homo sapiens GN=SCRN2 PE=2 SV=3 | 411 | S | 0.197929 | G | 0.177143 | 0.020786 | No Change: Both O | - |
| Q96FV2 | SCRN2_HUMAN Secernin-2 OS=Homo sapiens GN=SCRN2 PE=2 SV=3 | 273 | E | 0.519548 | Q | 0.511343 | 0.008205 | No Change: Both D | - |
| Q96FV2 | SCRN2_HUMAN Secernin-2 OS=Homo sapiens GN=SCRN2 PE=2 SV=3 | 330 | Q | 0.462013 | R | 0.440901 | 0.021112 | No Change: Both O | - |
| Q0VDG4 | SCRN3_HUMAN Secernin-3 OS=Homo sapiens GN=SCRN3 PE=1 SV=1 | 179 | V | 0.355813 | A | 0.443995 | -0.088182 | No Change: Both O | - |
| Q0VDG4 | SCRN3_HUMAN Secernin-3 OS=Homo sapiens GN=SCRN3 PE=1 SV=1 | 18 | D | 0.170321 | N | 0.171599 | -0.001278 | No Change: Both O | - |
| Q9BWW7 | SCRT1_HUMAN Transcriptional repressor scratch 1 OS=Homo sapiens GN=SCRT1 PE=1 SV=1 | 133 | S | 0.904938 | A | 0.888477 | 0.016461 | No Change: Both D | - |
| P47872 | SCTR_HUMAN Secretin receptor OS=Homo sapiens GN=SCTR PE=2 SV=2 | 122 | A | 0.274672 | P | 0.408799 | -0.134127 | No Change: Both O | - |
| P47872 | SCTR_HUMAN Secretin receptor OS=Homo sapiens GN=SCTR PE=2 SV=2 | 110 | D | 0.439092 | N | 0.466313 | -0.027221 | No Change: Both O | - |
| Q8IWY4 | SCUB1_HUMAN Signal peptide CUB and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SCUBE1 PE=1 SV=3 | 398 | G | 0.595976 | R | 0.624411 | -0.028435 | No Change: Both D | - |
| Q8IWY4 | SCUB1_HUMAN Signal peptide CUB and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SCUBE1 PE=1 SV=3 | 648 | S | 0.642913 | P | 0.663132 | -0.020219 | No Change: Both D | - |
| Q9NQ36 | SCUB2_HUMAN Signal peptide CUB and EGF-like domain-containing protein 2 OS=Homo sapiens GN=SCUBE2 PE=2 SV=2 | 591 | T | 0.50575 | M | 0.479148 | 0.026602 | D to O | - |
| Q9NQ36 | SCUB2_HUMAN Signal peptide CUB and EGF-like domain-containing protein 2 OS=Homo sapiens GN=SCUBE2 PE=2 SV=2 | 712 | H | 0.358476 | Q | 0.449294 | -0.090818 | No Change: Both O | - |
| Q9NQ36 | SCUB2_HUMAN Signal peptide CUB and EGF-like domain-containing protein 2 OS=Homo sapiens GN=SCUBE2 PE=2 SV=2 | 752 | V | 0.472374 | G | 0.623282 | -0.150908 | O to D | - |
| Q9NQ36 | SCUB2_HUMAN Signal peptide CUB and EGF-like domain-containing protein 2 OS=Homo sapiens GN=SCUBE2 PE=2 SV=2 | 791 | T | 0.651529 | S | 0.686352 | -0.034823 | No Change: Both D | - |
| Q9NQ36 | SCUB2_HUMAN Signal peptide CUB and EGF-like domain-containing protein 2 OS=Homo sapiens GN=SCUBE2 PE=2 SV=2 | 843 | P | 0.285248 | R | 0.247688 | 0.03756 | No Change: Both O | - |
| Q8IX30 | SCUB3_HUMAN Signal peptide CUB and EGF-like domain-containing protein 3 OS=Homo sapiens GN=SCUBE3 PE=1 SV=1 | 410 | S | 0.856861 | L | 0.771845 | 0.085016 | No Change: Both D | - |
| Q96KG9 | NTKL_HUMAN N-terminal kinase-like protein OS=Homo sapiens GN=SCYL1 PE=1 SV=1 | 479 | P | 0.549094 | L | 0.367594 | 0.1815 | D to O | - |
| Q96KG9 | NTKL_HUMAN N-terminal kinase-like protein OS=Homo sapiens GN=SCYL1 PE=1 SV=1 | 495 | H | 0.177029 | Y | 0.11873 | 0.058299 | No Change: Both O | A metastatic melanoma sample |
| Q96KG9 | NTKL_HUMAN N-terminal kinase-like protein OS=Homo sapiens GN=SCYL1 PE=1 SV=1 | 663 | Q | 0.928321 | H | 0.896581 | 0.03174 | No Change: Both D | - |
| Q96KG9 | NTKL_HUMAN N-terminal kinase-like protein OS=Homo sapiens GN=SCYL1 PE=1 SV=1 | 755 | W | 0.900497 | S | 0.956401 | -0.055904 | No Change: Both D | - |
| Q6P3W7 | SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens GN=SCYL2 PE=1 SV=1 | 357 | P | 0.368347 | L | 0.221645 | 0.146702 | No Change: Both O | - |
| Q6P3W7 | SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens GN=SCYL2 PE=1 SV=1 | 720 | T | 0.954511 | S | 0.96212 | -0.007609 | No Change: Both D | - |
| Q6P3W7 | SCYL2_HUMAN SCY1-like protein 2 OS=Homo sapiens GN=SCYL2 PE=1 SV=1 | 863 | Q | 0.923648 | H | 0.873844 | 0.049804 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IZE3 | PACE1_HUMAN Protein-associating with the carboxyl-terminal domain of ezrin OS=Homo sapiens GN=SCYL3 PE=1 SV=3 | 597 | G | 0.823809 | A | 0.804311 | 0.019498 | No Change: Both D | - |
| Q8IZE3 | PACE1_HUMAN Protein-associating with the carboxyl-terminal domain of ezrin OS=Homo sapiens GN=SCYL3 PE=1 SV=3 | 621 | Q | 0.878063 | R | 0.865256 | 0.012807 | No Change: Both D | - |
| Q9NVU7 | SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens GN=SDAD1 PE=1 SV=3 | 258 | K | 0.96066 | Q | 0.951693 | 0.008967 | No Change: Both D | - |
| Q9NVU7 | SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens GN=SDAD1 PE=1 SV=3 | 490 | A | 0.861107 | D | 0.889543 | -0.028436 | No Change: Both D | - |
| Q9NVU7 | SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens GN=SDAD1 PE=1 SV=3 | 575 | S | 0.854802 | C | 0.757879 | 0.096923 | No Change: Both D | - |
| Q9NVU7 | SDA1_HUMAN Protein SDA1 homolog OS=Homo sapiens GN=SDAD1 PE=1 SV=3 | 660 | V | 0.976933 | I | 0.975666 | 0.001267 | No Change: Both D | - |
| P18827 | SDC1_HUMAN Syndecan-1 OS=Homo sapiens GN=SDC1 PE=1 SV=3 | 76 | T | 0.893809 | M | 0.856183 | 0.037626 | No Change: Both D | - |
| P18827 | SDC1_HUMAN Syndecan-1 OS=Homo sapiens GN=SDC1 PE=1 SV=3 | 136 | L | 0.986592 | Q | 0.991997 | -0.005405 | No Change: Both D | - |
| P34741 | SDC2_HUMAN Syndecan-2 OS=Homo sapiens GN=SDC2 PE=1 SV=2 | 59 | A | 0.883842 | T | 0.892281 | -0.008439 | No Change: Both D | - |
| P34741 | SDC2_HUMAN Syndecan-2 OS=Homo sapiens GN=SDC2 PE=1 SV=2 | 71 | S | 0.79869 | T | 0.756328 | 0.042362 | No Change: Both D | - |
| O75056 | SDC3_HUMAN Syndecan-3 OS=Homo sapiens GN=SDC3 PE=1 SV=2 | 208 | V | 0.907936 | I | 0.894843 | 0.013093 | No Change: Both D | - |
| O75056 | SDC3_HUMAN Syndecan-3 OS=Homo sapiens GN=SDC3 PE=1 SV=2 | 303 | D | 0.9389 | N | 0.929141 | 0.009759 | No Change: Both D | - |
| O75056 | SDC3_HUMAN Syndecan-3 OS=Homo sapiens GN=SDC3 PE=1 SV=2 | 329 | T | 0.903283 | I | 0.833156 | 0.070127 | No Change: Both D | - |
| P31431 | SDC4_HUMAN Syndecan-4 OS=Homo sapiens GN=SDC4 PE=1 SV=2 | 12 | F | 0.026204 | L | 0.031072 | -0.004868 | No Change: Both O | - |
| O00560 | SDCB1_HUMAN Syntenin-1 OS=Homo sapiens GN=SDCBP PE=1 SV=1 | 69 | N | 0.305488 | S | 0.356037 | -0.050549 | No Change: Both O | - |
| O00560 | SDCB1_HUMAN Syntenin-1 OS=Homo sapiens GN=SDCBP PE=1 SV=1 | 26 | P | 0.493784 | T | 0.426198 | 0.067586 | No Change: Both O | - |
| Q9H190 | SDCB2_HUMAN Syntenin-2 OS=Homo sapiens GN=SDCBP2 PE=2 SV=2 | 191 | R | 0.43706 | Q | 0.444099 | -0.007039 | No Change: Both O | A colorectal cancer sample |
| Q9H190 | SDCB2_HUMAN Syntenin-2 OS=Homo sapiens GN=SDCBP2 PE=2 SV=2 | 182 | V | 0.241359 | M | 0.287323 | -0.045964 | No Change: Both O | - |
| Q9H190 | SDCB2_HUMAN Syntenin-2 OS=Homo sapiens GN=SDCBP2 PE=2 SV=2 | 223 | R | 0.485509 | C | 0.310267 | 0.175242 | No Change: Both O | - |
| Q9H190 | SDCB2_HUMAN Syntenin-2 OS=Homo sapiens GN=SDCBP2 PE=2 SV=2 | 242 | G | 0.301172 | R | 0.272991 | 0.028181 | No Change: Both O | - |
| Q96C92 | SDCG3_HUMAN Serologically defined colon cancer antigen 3 OS=Homo sapiens GN=SDCCAG3 PE=1 SV=3 | 157 | L | 0.698647 | V | 0.641992 | 0.056655 | No Change: Both D | - |
| Q96C92 | SDCG3_HUMAN Serologically defined colon cancer antigen 3 OS=Homo sapiens GN=SDCCAG3 PE=1 SV=3 | 176 | E | 0.787077 | G | 0.752607 | 0.03447 | No Change: Both D | - |
| Q96C92 | SDCG3_HUMAN Serologically defined colon cancer antigen 3 OS=Homo sapiens GN=SDCCAG3 PE=1 SV=3 | 304 | R | 0.779552 | Q | 0.791652 | -0.0121 | No Change: Both D | - |
| Q96C92 | SDCG3_HUMAN Serologically defined colon cancer antigen 3 OS=Homo sapiens GN=SDCCAG3 PE=1 SV=3 | 379 | V | 0.37584 | M | 0.43019 | -0.05435 | No Change: Both O | - |
| Q96C92 | SDCG3_HUMAN Serologically defined colon cancer antigen 3 OS=Homo sapiens GN=SDCCAG3 PE=1 SV=3 | 428 | V | 0.751895 | I | 0.75436 | -0.002465 | No Change: Both D | - |
| Q86SQ7 | SDCG8_HUMAN Serologically defined colon cancer antigen 8 OS=Homo sapiens GN=SDCCAG8 PE=1 SV=1 | 378 | E | 0.97187 | D | 0.963598 | 0.008272 | No Change: Both D | - |
| Q99470 | SDF2_HUMAN Stromal cell-derived factor 2 OS=Homo sapiens GN=SDF2 PE=1 SV=2 | 15 | A | 0.224155 | T | 0.235609 | -0.011454 | No Change: Both O | - |
| Q9BRK5 | CAB45_HUMAN 45 kDa calcium-binding protein OS=Homo sapiens GN=SDF4 PE=1 SV=1 | 148 | A | 0.560048 | T | 0.591394 | -0.031346 | No Change: Both D | A colorectal cancer sample |
| Q9BRK5 | CAB45_HUMAN 45 kDa calcium-binding protein OS=Homo sapiens GN=SDF4 PE=1 SV=1 | 50 | N | 0.689075 | D | 0.689326 | -2.51E-04 | No Change: Both D | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 554 | R | 0.18389 | W | 0.081488 | 0.102402 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 524 | A | 0.283629 | V | 0.229086 | 0.054543 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 555 | G | 0.166562 | E | 0.207079 | -0.040517 | No Change: Both O | Cardiomyopathy dilated type 1GG (CMD1GG) [MIM:613642] |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 555 | G | 0.166562 | E | 0.207079 | -0.040517 | No Change: Both O | Mitochondrial complex II deficiency (MT-C2D) [MIM:252011] |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 33 | F | 0.263927 | V | 0.293957 | -0.03003 | No Change: Both O | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 38 | D | 0.43537 | V | 0.293282 | 0.142088 | No Change: Both O | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 240 | E | 0.145684 | Q | 0.120053 | 0.025631 | No Change: Both O | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 657 | V | 0.306532 | I | 0.292589 | 0.013943 | No Change: Both O | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 333 | V | 0.371659 | I | 0.352276 | 0.019383 | No Change: Both O | - |
| P31040 | DHSA_HUMAN Succinate dehydrogenase [ubiquinone] flavoprotein subunit mitochondrial OS=Homo sapiens GN=SDHA PE=1 SV=2 | 589 | R | 0.673016 | W | 0.554987 | 0.118029 | No Change: Both D | Paragangliomas type 5 (PGL5) [MIM:614165] |
| A6NFY7 | SDHF1_HUMAN Succinate dehydrogenase assembly factor 1 mitochondrial OS=Homo sapiens GN=SDHAF1 PE=1 SV=1 | 55 | R | 0.458124 | P | 0.452067 | 0.006057 | No Change: Both O | Mitochondrial complex II deficiency (MT-C2D) [MIM:252011] |
| A6NFY7 | SDHF1_HUMAN Succinate dehydrogenase assembly factor 1 mitochondrial OS=Homo sapiens GN=SDHAF1 PE=1 SV=1 | 57 | G | 0.477506 | R | 0.540354 | -0.062848 | O to D | Mitochondrial complex II deficiency (MT-C2D) [MIM:252011] |
| Q9NX18 | SDHF2_HUMAN Succinate dehydrogenase assembly factor 2 mitochondrial OS=Homo sapiens GN=SDHAF2 PE=1 SV=1 | 78 | G | 0.38867 | R | 0.467748 | -0.079078 | No Change: Both O | Paragangliomas type 2 (PGL2) [MIM:601650] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 197 | P | 0.114156 | R | 0.098278 | 0.015878 | No Change: Both O | Paragangliomas type 4 (PGL4) [MIM:115310] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 242 | R | 0.145459 | H | 0.127752 | 0.017707 | No Change: Both O | Paragangliomas type 4 (PGL4) [MIM:115310] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 242 | R | 0.145459 | H | 0.127752 | 0.017707 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 242 | R | 0.145459 | H | 0.127752 | 0.017707 | No Change: Both O | Familial malignant paraganglioma and pheochromocytoma |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 87 | L | 0.335899 | S | 0.542362 | -0.206463 | O to D | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 131 | P | 0.13405 | R | 0.106271 | 0.027779 | No Change: Both O | Paragangliomas type 4 (PGL4) [MIM:115310] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 46 | R | 0.220902 | G | 0.22353 | -0.002628 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 101 | C | 0.228312 | Y | 0.220618 | 0.007694 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 192 | C | 0.072116 | R | 0.112384 | -0.040268 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 196 | C | 0.101347 | Y | 0.119406 | -0.018059 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 100 | S | 0.221216 | F | 0.092838 | 0.128378 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 132 | H | 0.116562 | P | 0.160252 | -0.04369 | No Change: Both O | Paragangliomas type 4 (PGL4) [MIM:115310] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 3 | A | 0.664084 | G | 0.673269 | -0.009185 | No Change: Both D | - |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 40 | K | 0.337691 | E | 0.302244 | 0.035447 | No Change: Both O | - |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 43 | A | 0.204645 | P | 0.281268 | -0.076623 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 46 | R | 0.220902 | Q | 0.232855 | -0.011953 | No Change: Both O | Paragangliomas type 4 (PGL4) [MIM:115310] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 46 | R | 0.220902 | Q | 0.232855 | -0.011953 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 53 | G | 0.627978 | R | 0.624226 | 0.003752 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 65 | L | 0.268971 | H | 0.377108 | -0.108137 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 65 | L | 0.268971 | P | 0.420703 | -0.151732 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 127 | I | 0.298673 | N | 0.497094 | -0.198421 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 163 | S | 0.831018 | P | 0.825628 | 0.00539 | No Change: Both D | - |
| P21912 | DHSB_HUMAN Succinate dehydrogenase [ubiquinone] iron-sulfur subunit mitochondrial OS=Homo sapiens GN=SDHB PE=1 SV=3 | 230 | R | 0.492019 | C | 0.307381 | 0.184638 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 81 | P | 0.100896 | L | 0.054283 | 0.046613 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 81 | P | 0.100896 | L | 0.054283 | 0.046613 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 92 | D | 0.245956 | Y | 0.141793 | 0.104163 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 92 | D | 0.245956 | Y | 0.141793 | 0.104163 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 102 | H | 0.1538 | L | 0.093553 | 0.060247 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 12 | G | 0.115654 | S | 0.14214 | -0.026486 | No Change: Both O | - |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 50 | H | 0.468064 | R | 0.445532 | 0.022532 | No Change: Both O | - |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 114 | Y | 0.194966 | C | 0.159018 | 0.035948 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 139 | L | 0.042973 | P | 0.085872 | -0.042899 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 145 | H | 0.04356 | N | 0.052262 | -0.008702 | No Change: Both O | - |
| O14521 | DHSD_HUMAN Succinate dehydrogenase [ubiquinone] cytochrome b small subunit mitochondrial OS=Homo sapiens GN=SDHD PE=1 SV=1 | 148 | G | 0.056852 | V | 0.032536 | 0.024316 | No Change: Both O | Paragangliomas type 1 (PGL1) [MIM:168000] |
| Q7Z5N4 | SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens GN=SDK1 PE=1 SV=3 | 1016 | D | 0.448637 | N | 0.452715 | -0.004078 | No Change: Both O | - |
| Q7Z5N4 | SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens GN=SDK1 PE=1 SV=3 | 1641 | H | 0.391378 | R | 0.428647 | -0.037269 | No Change: Both O | - |
| O95810 | SDPR_HUMAN Serum deprivation-response protein OS=Homo sapiens GN=SDPR PE=1 SV=3 | 130 | E | 0.725784 | D | 0.706321 | 0.019463 | No Change: Both D | - |
| Q8N3Y7 | RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens GN=SDR16C5 PE=2 SV=2 | 62 | R | 0.081217 | W | 0.03135 | 0.049867 | No Change: Both O | - |
| Q9NRG7 | D39U1_HUMAN Epimerase family protein SDR39U1 OS=Homo sapiens GN=SDR39U1 PE=2 SV=2 | 207 | G | 0.407473 | V | 0.240424 | 0.167049 | No Change: Both O | - |
| Q9NRG7 | D39U1_HUMAN Epimerase family protein SDR39U1 OS=Homo sapiens GN=SDR39U1 PE=2 SV=2 | 258 | L | 0.284362 | F | 0.260113 | 0.024249 | No Change: Both O | - |
| Q9NRG7 | D39U1_HUMAN Epimerase family protein SDR39U1 OS=Homo sapiens GN=SDR39U1 PE=2 SV=2 | 105 | I | 0.341489 | L | 0.388895 | -0.047406 | No Change: Both O | - |
| Q9NRG7 | D39U1_HUMAN Epimerase family protein SDR39U1 OS=Homo sapiens GN=SDR39U1 PE=2 SV=2 | 296 | Q | 0.27162 | R | 0.252054 | 0.019566 | No Change: Both O | - |
| Q8WUS8 | D42E1_HUMAN Short-chain dehydrogenase/reductase family 42E member 1 OS=Homo sapiens GN=SDR42E1 PE=2 SV=2 | 10 | S | 0.607763 | T | 0.515975 | 0.091788 | No Change: Both D | - |
| Q8WUS8 | D42E1_HUMAN Short-chain dehydrogenase/reductase family 42E member 1 OS=Homo sapiens GN=SDR42E1 PE=2 SV=2 | 96 | K | 0.334758 | E | 0.356674 | -0.021916 | No Change: Both O | - |
| Q8WUS8 | D42E1_HUMAN Short-chain dehydrogenase/reductase family 42E member 1 OS=Homo sapiens GN=SDR42E1 PE=2 SV=2 | 320 | G | 0.278336 | D | 0.305081 | -0.026745 | No Change: Both O | - |
| Q9HB31 | SEBOX_HUMAN Homeobox protein SEBOX OS=Homo sapiens GN=SEBOX PE=1 SV=2 | 207 | L | 0.070236 | S | 0.166459 | -0.096223 | No Change: Both O | - |
| P55735 | SEC13_HUMAN Protein SEC13 homolog OS=Homo sapiens GN=SEC13 PE=1 SV=3 | 172 | S | 0.613083 | L | 0.427187 | 0.185896 | D to O | - |
| Q92503 | S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens GN=SEC14L1 PE=1 SV=2 | 37 | V | 0.142952 | M | 0.187407 | -0.044455 | No Change: Both O | - |
| Q92503 | S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens GN=SEC14L1 PE=1 SV=2 | 97 | A | 0.350957 | G | 0.413884 | -0.062927 | No Change: Both O | - |
| Q92503 | S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens GN=SEC14L1 PE=1 SV=2 | 98 | Y | 0.348358 | H | 0.501502 | -0.153144 | O to D | - |
| Q92503 | S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens GN=SEC14L1 PE=1 SV=2 | 188 | T | 0.891401 | P | 0.91087 | -0.019469 | No Change: Both D | - |
| O76054 | S14L2_HUMAN SEC14-like protein 2 OS=Homo sapiens GN=SEC14L2 PE=1 SV=1 | 11 | R | 0.631292 | K | 0.677631 | -0.046339 | No Change: Both D | - |
| Q9UDX4 | S14L3_HUMAN SEC14-like protein 3 OS=Homo sapiens GN=SEC14L3 PE=2 SV=1 | 335 | D | 0.452664 | E | 0.498726 | -0.046062 | No Change: Both O | - |
| Q9UDX4 | S14L3_HUMAN SEC14-like protein 3 OS=Homo sapiens GN=SEC14L3 PE=2 SV=1 | 103 | I | 0.108414 | T | 0.175342 | -0.066928 | No Change: Both O | - |
| Q9UDX4 | S14L3_HUMAN SEC14-like protein 3 OS=Homo sapiens GN=SEC14L3 PE=2 SV=1 | 214 | R | 0.276231 | H | 0.266819 | 0.009412 | No Change: Both O | - |
| Q9UDX4 | S14L3_HUMAN SEC14-like protein 3 OS=Homo sapiens GN=SEC14L3 PE=2 SV=1 | 364 | R | 0.098886 | C | 0.050278 | 0.048608 | No Change: Both O | - |
| Q9UDX3 | S14L4_HUMAN SEC14-like protein 4 OS=Homo sapiens GN=SEC14L4 PE=2 SV=1 | 3 | S | 0.842475 | G | 0.808509 | 0.033966 | No Change: Both D | - |
| Q9UDX3 | S14L4_HUMAN SEC14-like protein 4 OS=Homo sapiens GN=SEC14L4 PE=2 SV=1 | 124 | R | 0.235411 | G | 0.228602 | 0.006809 | No Change: Both O | - |
| Q9UDX3 | S14L4_HUMAN SEC14-like protein 4 OS=Homo sapiens GN=SEC14L4 PE=2 SV=1 | 200 | V | 0.093354 | M | 0.117525 | -0.024171 | No Change: Both O | - |
| Q9UDX3 | S14L4_HUMAN SEC14-like protein 4 OS=Homo sapiens GN=SEC14L4 PE=2 SV=1 | 211 | E | 0.462358 | K | 0.466943 | -0.004585 | No Change: Both O | - |
| O15027 | SC16A_HUMAN Protein transport protein Sec16A OS=Homo sapiens GN=SEC16A PE=1 SV=3 | 861 | R | 0.896869 | C | 0.850421 | 0.046448 | No Change: Both D | - |
| Q96JE7 | SC16B_HUMAN Protein transport protein Sec16B OS=Homo sapiens GN=SEC16B PE=1 SV=2 | 292 | H | 0.572905 | R | 0.564885 | 0.00802 | No Change: Both D | - |
| Q96JE7 | SC16B_HUMAN Protein transport protein Sec16B OS=Homo sapiens GN=SEC16B PE=1 SV=2 | 730 | G | 0.660321 | R | 0.642436 | 0.017885 | No Change: Both D | - |
| Q96JE7 | SC16B_HUMAN Protein transport protein Sec16B OS=Homo sapiens GN=SEC16B PE=1 SV=2 | 845 | Q | 0.915484 | H | 0.890899 | 0.024585 | No Change: Both D | - |
| Q96JE7 | SC16B_HUMAN Protein transport protein Sec16B OS=Homo sapiens GN=SEC16B PE=1 SV=2 | 864 | P | 0.990213 | A | 0.985571 | 0.004642 | No Change: Both D | - |
| Q96JE7 | SC16B_HUMAN Protein transport protein Sec16B OS=Homo sapiens GN=SEC16B PE=1 SV=2 | 873 | S | 0.995631 | N | 0.993232 | 0.002399 | No Change: Both D | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 108 | R | 0.30568 | Q | 0.328158 | -0.022478 | No Change: Both O | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 214 | W | 0.043387 | C | 0.051339 | -0.007952 | No Change: Both O | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 71 | D | 0.04374 | Y | 0.021898 | 0.021842 | No Change: Both O | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 82 | T | 0.123264 | K | 0.182771 | -0.059507 | No Change: Both O | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 130 | C | 0.199378 | R | 0.363206 | -0.163828 | No Change: Both O | - |
| O75396 | SC22B_HUMAN Vesicle-trafficking protein SEC22b OS=Homo sapiens GN=SEC22B PE=1 SV=4 | 190 | H | 0.313728 | R | 0.314685 | -9.57E-04 | No Change: Both O | - |
| Q15436 | SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens GN=SEC23A PE=1 SV=2 | 211 | L | 0.690038 | V | 0.675061 | 0.014977 | No Change: Both D | - |
| Q15436 | SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens GN=SEC23A PE=1 SV=2 | 382 | F | 0.348193 | L | 0.357541 | -0.009348 | No Change: Both O | Craniolenticulosutural dysplasia (CLSD) [MIM:607812] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 489 | H | 0.522999 | Q | 0.55057 | -0.027571 | No Change: Both D | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 433 | P | 0.355296 | L | 0.21726 | 0.138036 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 14 | R | 0.478452 | W | 0.270417 | 0.208035 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 18 | R | 0.232084 | H | 0.221947 | 0.010137 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 109 | E | 0.423626 | K | 0.405127 | 0.018499 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 239 | D | 0.494452 | G | 0.458266 | 0.036186 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 313 | R | 0.226594 | H | 0.226142 | 4.52E-04 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 318 | I | 0.377272 | T | 0.488572 | -0.1113 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 348 | D | 0.083021 | A | 0.065164 | 0.017857 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 373 | M | 0.204079 | V | 0.158844 | 0.045235 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 386 | Q | 0.248547 | R | 0.238026 | 0.010521 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 426 | V | 0.155855 | I | 0.138525 | 0.01733 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 462 | Y | 0.12829 | C | 0.125219 | 0.003071 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 497 | R | 0.348247 | C | 0.194185 | 0.154062 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 524 | A | 0.237348 | V | 0.169833 | 0.067515 | No Change: Both O | - |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 530 | R | 0.138255 | W | 0.050418 | 0.087837 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 603 | S | 0.607788 | L | 0.453524 | 0.154264 | D to O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q15437 | SC23B_HUMAN Protein transport protein Sec23B OS=Homo sapiens GN=SEC23B PE=1 SV=2 | 701 | R | 0.261837 | C | 0.148644 | 0.113193 | No Change: Both O | Congenital dyserythropoietic anemia type 2 (CDA2) [MIM:224100] |
| Q9Y6Y8 | S23IP_HUMAN SEC23-interacting protein OS=Homo sapiens GN=SEC23IP PE=1 SV=1 | 644 | K | 0.603381 | E | 0.638585 | -0.035204 | No Change: Both D | - |
| O95486 | SC24A_HUMAN Protein transport protein Sec24A OS=Homo sapiens GN=SEC24A PE=1 SV=2 | 261 | S | 0.516887 | G | 0.458721 | 0.058166 | D to O | - |
| O95486 | SC24A_HUMAN Protein transport protein Sec24A OS=Homo sapiens GN=SEC24A PE=1 SV=2 | 302 | T | 0.944297 | I | 0.890897 | 0.0534 | No Change: Both D | - |
| O95486 | SC24A_HUMAN Protein transport protein Sec24A OS=Homo sapiens GN=SEC24A PE=1 SV=2 | 396 | T | 0.373943 | M | 0.314084 | 0.059859 | No Change: Both O | - |
| O95487 | SC24B_HUMAN Protein transport protein Sec24B OS=Homo sapiens GN=SEC24B PE=1 SV=2 | 456 | A | 0.88099 | G | 0.889736 | -0.008746 | No Change: Both D | - |
| P53992 | SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens GN=SEC24C PE=1 SV=3 | 934 | L | 0.237511 | P | 0.385986 | -0.148475 | No Change: Both O | - |
| P53992 | SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens GN=SEC24C PE=1 SV=3 | 109 | P | 0.950537 | S | 0.946314 | 0.004223 | No Change: Both D | - |
| O94855 | SC24D_HUMAN Protein transport protein Sec24D OS=Homo sapiens GN=SEC24D PE=1 SV=2 | 42 | M | 0.966502 | T | 0.967441 | -9.39E-04 | No Change: Both D | - |
| O94855 | SC24D_HUMAN Protein transport protein Sec24D OS=Homo sapiens GN=SEC24D PE=1 SV=2 | 193 | P | 0.992094 | L | 0.984358 | 0.007736 | No Change: Both D | - |
| O94855 | SC24D_HUMAN Protein transport protein Sec24D OS=Homo sapiens GN=SEC24D PE=1 SV=2 | 496 | F | 0.115196 | I | 0.109371 | 0.005825 | No Change: Both O | - |
| O94979 | SC31A_HUMAN Protein transport protein Sec31A OS=Homo sapiens GN=SEC31A PE=1 SV=3 | 263 | I | 0.110987 | V | 0.119846 | -0.008859 | No Change: Both O | - |
| O94979 | SC31A_HUMAN Protein transport protein Sec31A OS=Homo sapiens GN=SEC31A PE=1 SV=3 | 841 | P | 0.898425 | L | 0.792275 | 0.10615 | No Change: Both D | - |
| O94979 | SC31A_HUMAN Protein transport protein Sec31A OS=Homo sapiens GN=SEC31A PE=1 SV=3 | 1055 | P | 0.990331 | T | 0.984144 | 0.006187 | No Change: Both D | - |
| O94979 | SC31A_HUMAN Protein transport protein Sec31A OS=Homo sapiens GN=SEC31A PE=1 SV=3 | 456 | N | 0.247021 | K | 0.312706 | -0.065685 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 89 | V | 0.374007 | A | 0.441436 | -0.067429 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 100 | Y | 0.085648 | C | 0.073704 | 0.011944 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 129 | L | 0.228303 | F | 0.199818 | 0.028485 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 332 | S | 0.166471 | A | 0.098186 | 0.068285 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 372 | P | 0.694988 | S | 0.664042 | 0.030946 | No Change: Both D | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 527 | S | 0.747264 | R | 0.683812 | 0.063452 | No Change: Both D | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 1169 | A | 0.069971 | S | 0.116291 | -0.04632 | No Change: Both O | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 433 | R | 0.502902 | Q | 0.552419 | -0.049517 | No Change: Both D | - |
| Q9NQW1 | SC31B_HUMAN Protein transport protein Sec31B OS=Homo sapiens GN=SEC31B PE=1 SV=1 | 478 | R | 0.434773 | T | 0.445793 | -0.01102 | No Change: Both O | - |
| Q9UGP8 | SEC63_HUMAN Translocation protein SEC63 homolog OS=Homo sapiens GN=SEC63 PE=1 SV=2 | 556 | V | 0.982559 | I | 0.975247 | 0.007312 | No Change: Both D | - |
| Q96T21 | SEBP2_HUMAN Selenocysteine insertion sequence-binding protein 2 OS=Homo sapiens GN=SECISBP2 PE=1 SV=2 | 540 | R | 0.932964 | Q | 0.938601 | -0.005637 | No Change: Both D | Abnormal thyroid hormone metabolism (ATHYHM) [MIM:609698] |
| Q96T21 | SEBP2_HUMAN Selenocysteine insertion sequence-binding protein 2 OS=Homo sapiens GN=SECISBP2 PE=1 SV=2 | 428 | Q | 0.897225 | E | 0.896043 | 0.001182 | No Change: Both D | - |
| Q96EE3 | SEH1_HUMAN Nucleoporin SEH1 OS=Homo sapiens GN=SEH1L PE=1 SV=3 | 342 | T | 0.959744 | N | 0.967167 | -0.007423 | No Change: Both D | - |
| Q9UBV2 | SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens GN=SEL1L PE=1 SV=3 | 162 | D | 0.606468 | G | 0.572016 | 0.034452 | No Change: Both D | - |
| Q9UBV2 | SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens GN=SEL1L PE=1 SV=3 | 714 | V | 0.01778 | I | 0.014704 | 0.003076 | No Change: Both O | - |
| Q5TEA6 | SE1L2_HUMAN Protein sel-1 homolog 2 OS=Homo sapiens GN=SEL1L2 PE=1 SV=2 | 687 | H | 0.864363 | Q | 0.85479 | 0.009573 | No Change: Both D | - |
| Q5TEA6 | SE1L2_HUMAN Protein sel-1 homolog 2 OS=Homo sapiens GN=SEL1L2 PE=1 SV=2 | 477 | G | 0.109509 | S | 0.128297 | -0.018788 | No Change: Both O | - |
| Q68CR1 | SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens GN=SEL1L3 PE=1 SV=2 | 401 | I | 0.113795 | V | 0.126597 | -0.012802 | No Change: Both O | - |
| Q68CR1 | SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens GN=SEL1L3 PE=1 SV=2 | 107 | Q | 0.12909 | R | 0.130755 | -0.001665 | No Change: Both O | - |
| Q68CR1 | SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens GN=SEL1L3 PE=1 SV=2 | 554 | I | 0.247539 | V | 0.270017 | -0.022478 | No Change: Both O | - |
| Q68CR1 | SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens GN=SEL1L3 PE=1 SV=2 | 1054 | W | 0.051006 | C | 0.060273 | -0.009267 | No Change: Both O | - |
| Q68CR1 | SE1L3_HUMAN Protein sel-1 homolog 3 OS=Homo sapiens GN=SEL1L3 PE=1 SV=2 | 1122 | P | 0.990643 | S | 0.98884 | 0.001803 | No Change: Both D | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 149 | S | 0.447043 | R | 0.370996 | 0.076047 | No Change: Both O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 130 | C | 0.404487 | W | 0.326478 | 0.078009 | No Change: Both O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 295 | E | 0.664373 | K | 0.672612 | -0.008239 | No Change: Both D | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 421 | E | 0.588701 | Q | 0.559801 | 0.0289 | No Change: Both D | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 468 | H | 0.614294 | Y | 0.493537 | 0.120757 | D to O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 575 | L | 0.149325 | F | 0.121325 | 0.028 | No Change: Both O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 21 | A | 0.316198 | S | 0.45736 | -0.141162 | No Change: Both O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 31 | M | 0.556035 | I | 0.458319 | 0.097716 | D to O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 257 | Q | 0.342905 | P | 0.410368 | -0.067463 | No Change: Both O | - |
| P16581 | LYAM2_HUMAN E-selectin OS=Homo sapiens GN=SELE PE=1 SV=1 | 550 | P | 0.453898 | S | 0.472909 | -0.019011 | No Change: Both O | - |
| P14151 | LYAM1_HUMAN L-selectin OS=Homo sapiens GN=SELL PE=1 SV=2 | 193 | F | 0.114765 | L | 0.13322 | -0.018455 | No Change: Both O | - |
| P14151 | LYAM1_HUMAN L-selectin OS=Homo sapiens GN=SELL PE=1 SV=2 | 201 | E | 0.357607 | Q | 0.320089 | 0.037518 | No Change: Both O | - |
| P14151 | LYAM1_HUMAN L-selectin OS=Homo sapiens GN=SELL PE=1 SV=2 | 213 | P | 0.469217 | S | 0.493563 | -0.024346 | No Change: Both O | - |
| P14151 | LYAM1_HUMAN L-selectin OS=Homo sapiens GN=SELL PE=1 SV=2 | 369 | N | 0.864809 | D | 0.855598 | 0.009211 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 331 | S | 0.500497 | N | 0.459722 | 0.040775 | D to O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 603 | D | 0.549822 | N | 0.566426 | -0.016604 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 640 | L | 0.638627 | V | 0.595876 | 0.042751 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 756 | T | 0.308444 | P | 0.357615 | -0.049171 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 209 | V | 0.344914 | M | 0.449599 | -0.104685 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 301 | P | 0.35559 | L | 0.216286 | 0.139304 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 365 | M | 0.190102 | V | 0.151591 | 0.038511 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 500 | S | 0.381238 | F | 0.200869 | 0.180369 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 179 | G | 0.307302 | R | 0.297227 | 0.010075 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 230 | C | 0.28646 | F | 0.268461 | 0.017999 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 274 | T | 0.442586 | I | 0.325565 | 0.117021 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 385 | S | 0.49973 | L | 0.318595 | 0.181135 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 542 | E | 0.641227 | K | 0.638679 | 0.002548 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 619 | S | 0.640785 | A | 0.536518 | 0.104267 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 631 | G | 0.704956 | V | 0.566521 | 0.138435 | No Change: Both D | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 661 | T | 0.376453 | N | 0.376448 | 5.00E-06 | No Change: Both O | - |
| P16109 | LYAM3_HUMAN P-selectin OS=Homo sapiens GN=SELP PE=1 SV=3 | 673 | N | 0.125712 | S | 0.155689 | -0.029977 | No Change: Both O | - |
| Q14242 | SELPL_HUMAN P-selectin glycoprotein ligand 1 OS=Homo sapiens GN=SELPLG PE=1 SV=1 | 62 | M | 0.904799 | I | 0.860308 | 0.044491 | No Change: Both D | - |
| Q14242 | SELPL_HUMAN P-selectin glycoprotein ligand 1 OS=Homo sapiens GN=SELPLG PE=1 SV=1 | 246 | P | 0.997365 | S | 0.997081 | 2.84E-04 | No Change: Both D | - |
| Q96BR5 | SELR1_HUMAN Sel1 repeat-containing protein 1 OS=Homo sapiens GN=SELRC1 PE=1 SV=2 | 219 | K | 0.770086 | R | 0.728224 | 0.041862 | No Change: Both D | - |
| Q14563 | SEM3A_HUMAN Semaphorin-3A OS=Homo sapiens GN=SEMA3A PE=2 SV=1 | 131 | A | 0.158811 | T | 0.181182 | -0.022371 | No Change: Both O | A breast cancer sample |
| Q14563 | SEM3A_HUMAN Semaphorin-3A OS=Homo sapiens GN=SEMA3A PE=2 SV=1 | 396 | P | 0.479568 | S | 0.493962 | -0.014394 | No Change: Both O | - |
| Q13214 | SEM3B_HUMAN Semaphorin-3B OS=Homo sapiens GN=SEMA3B PE=2 SV=1 | 348 | R | 0.178247 | C | 0.091086 | 0.087161 | No Change: Both O | A non-small cell lung cancer cell line |
| Q13214 | SEM3B_HUMAN Semaphorin-3B OS=Homo sapiens GN=SEMA3B PE=2 SV=1 | 397 | D | 0.362176 | H | 0.312107 | 0.050069 | No Change: Both O | A non-small cell lung cancer cell line |
| Q13214 | SEM3B_HUMAN Semaphorin-3B OS=Homo sapiens GN=SEMA3B PE=2 SV=1 | 415 | T | 0.275524 | I | 0.167539 | 0.107985 | No Change: Both O | A non-small cell lung cancer cell line |
| Q99985 | SEM3C_HUMAN Semaphorin-3C OS=Homo sapiens GN=SEMA3C PE=1 SV=2 | 337 | V | 0.153682 | M | 0.179629 | -0.025947 | No Change: Both O | - |
| Q99985 | SEM3C_HUMAN Semaphorin-3C OS=Homo sapiens GN=SEMA3C PE=1 SV=2 | 302 | F | 0.512699 | S | 0.679631 | -0.166932 | No Change: Both D | - |
| O95025 | SEM3D_HUMAN Semaphorin-3D OS=Homo sapiens GN=SEMA3D PE=2 SV=2 | 701 | K | 0.697477 | Q | 0.656198 | 0.041279 | No Change: Both D | - |
| Q13275 | SEM3F_HUMAN Semaphorin-3F OS=Homo sapiens GN=SEMA3F PE=2 SV=2 | 503 | L | 0.595776 | M | 0.649679 | -0.053903 | No Change: Both D | - |
| Q13275 | SEM3F_HUMAN Semaphorin-3F OS=Homo sapiens GN=SEMA3F PE=2 SV=2 | 474 | A | 0.276037 | G | 0.320658 | -0.044621 | No Change: Both O | - |
| Q9NS98 | SEM3G_HUMAN Semaphorin-3G OS=Homo sapiens GN=SEMA3G PE=1 SV=1 | 232 | I | 0.571635 | T | 0.693624 | -0.121989 | No Change: Both D | - |
| Q9NS98 | SEM3G_HUMAN Semaphorin-3G OS=Homo sapiens GN=SEMA3G PE=1 SV=1 | 180 | S | 0.535113 | N | 0.434004 | 0.101109 | D to O | - |
| Q9NS98 | SEM3G_HUMAN Semaphorin-3G OS=Homo sapiens GN=SEMA3G PE=1 SV=1 | 332 | V | 0.107182 | I | 0.085312 | 0.02187 | No Change: Both O | - |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 345 | D | 0.105447 | H | 0.091131 | 0.014316 | No Change: Both O | Cone-rod dystrophy type 10 (CORD10) [MIM:610283] |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 345 | D | 0.105447 | H | 0.091131 | 0.014316 | No Change: Both O | Retinitis pigmentosa type 35 (RP35) [MIM:610282] |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 350 | F | 0.268737 | C | 0.272991 | -0.004254 | No Change: Both O | Cone-rod dystrophy type 10 (CORD10) [MIM:610283] |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 350 | F | 0.268737 | C | 0.272991 | -0.004254 | No Change: Both O | Retinitis pigmentosa type 35 (RP35) [MIM:610282] |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 510 | R | 0.182228 | Q | 0.182465 | -2.37E-04 | No Change: Both O | - |
| Q9H3S1 | SEM4A_HUMAN Semaphorin-4A OS=Homo sapiens GN=SEMA4A PE=1 SV=2 | 713 | R | 0.412647 | Q | 0.420534 | -0.007887 | No Change: Both O | Retinitis pigmentosa type 35 (RP35) [MIM:610282] |
| Q9NPR2 | SEM4B_HUMAN Semaphorin-4B OS=Homo sapiens GN=SEMA4B PE=1 SV=3 | 792 | S | 0.937383 | A | 0.880001 | 0.057382 | No Change: Both D | - |
| Q92854 | SEM4D_HUMAN Semaphorin-4D OS=Homo sapiens GN=SEMA4D PE=1 SV=1 | 72 | A | 0.118623 | T | 0.119888 | -0.001265 | No Change: Both O | - |
| Q92854 | SEM4D_HUMAN Semaphorin-4D OS=Homo sapiens GN=SEMA4D PE=1 SV=1 | 327 | A | 0.136485 | T | 0.151733 | -0.015248 | No Change: Both O | - |
| Q13591 | SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens GN=SEMA5A PE=1 SV=3 | 246 | V | 0.260247 | L | 0.244248 | 0.015999 | No Change: Both O | - |
| Q13591 | SEM5A_HUMAN Semaphorin-5A OS=Homo sapiens GN=SEMA5A PE=1 SV=3 | 792 | S | 0.363265 | L | 0.181386 | 0.181879 | No Change: Both O | - |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 42 | G | 0.204042 | S | 0.231808 | -0.027766 | No Change: Both O | A breast cancer sample |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 220 | I | 0.336695 | T | 0.475479 | -0.138784 | No Change: Both O | - |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 223 | I | 0.29316 | M | 0.375272 | -0.082112 | No Change: Both O | A breast cancer sample |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 742 | M | 0.778101 | T | 0.792872 | -0.014771 | No Change: Both D | - |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 840 | V | 0.602624 | D | 0.732005 | -0.129381 | No Change: Both D | - |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 996 | S | 0.905931 | P | 0.901553 | 0.004378 | No Change: Both D | - |
| Q9P283 | SEM5B_HUMAN Semaphorin-5B OS=Homo sapiens GN=SEMA5B PE=2 SV=4 | 1028 | D | 0.330037 | G | 0.324308 | 0.005729 | No Change: Both O | - |
| Q9H2E6 | SEM6A_HUMAN Semaphorin-6A OS=Homo sapiens GN=SEMA6A PE=1 SV=2 | 518 | Y | 0.302159 | H | 0.411137 | -0.108978 | No Change: Both O | - |
| Q9H2E6 | SEM6A_HUMAN Semaphorin-6A OS=Homo sapiens GN=SEMA6A PE=1 SV=2 | 559 | R | 0.537398 | H | 0.530689 | 0.006709 | No Change: Both D | - |
| Q9H2E6 | SEM6A_HUMAN Semaphorin-6A OS=Homo sapiens GN=SEMA6A PE=1 SV=2 | 567 | D | 0.565953 | E | 0.582987 | -0.017034 | No Change: Both D | - |
| Q9H3T2 | SEM6C_HUMAN Semaphorin-6C OS=Homo sapiens GN=SEMA6C PE=2 SV=4 | 455 | T | 0.451445 | P | 0.514783 | -0.063338 | O to D | - |
| Q8NFY4 | SEM6D_HUMAN Semaphorin-6D OS=Homo sapiens GN=SEMA6D PE=1 SV=1 | 307 | N | 0.113501 | S | 0.139532 | -0.026031 | No Change: Both O | - |
| Q8NFY4 | SEM6D_HUMAN Semaphorin-6D OS=Homo sapiens GN=SEMA6D PE=1 SV=1 | 478 | S | 0.648172 | N | 0.631107 | 0.017065 | No Change: Both D | - |
| Q8NFY4 | SEM6D_HUMAN Semaphorin-6D OS=Homo sapiens GN=SEMA6D PE=1 SV=1 | 969 | S | 0.905463 | T | 0.874761 | 0.030702 | No Change: Both D | - |
| O75326 | SEM7A_HUMAN Semaphorin-7A OS=Homo sapiens GN=SEMA7A PE=1 SV=1 | 115 | S | 0.437717 | T | 0.361708 | 0.076009 | No Change: Both O | - |
| O75326 | SEM7A_HUMAN Semaphorin-7A OS=Homo sapiens GN=SEMA7A PE=1 SV=1 | 207 | R | 0.442199 | Q | 0.435184 | 0.007015 | No Change: Both O | - |
| O75326 | SEM7A_HUMAN Semaphorin-7A OS=Homo sapiens GN=SEMA7A PE=1 SV=1 | 207 | R | 0.442199 | W | 0.224686 | 0.217513 | No Change: Both O | - |
| O75326 | SEM7A_HUMAN Semaphorin-7A OS=Homo sapiens GN=SEMA7A PE=1 SV=1 | 460 | R | 0.229368 | H | 0.208448 | 0.02092 | No Change: Both O | - |
| O75326 | SEM7A_HUMAN Semaphorin-7A OS=Homo sapiens GN=SEMA7A PE=1 SV=1 | 461 | R | 0.234872 | C | 0.119656 | 0.115216 | No Change: Both O | - |
| P04279 | SEMG1_HUMAN Semenogelin-1 OS=Homo sapiens GN=SEMG1 PE=1 SV=2 | 79 | S | 0.810439 | T | 0.773158 | 0.037281 | No Change: Both D | - |
| P04279 | SEMG1_HUMAN Semenogelin-1 OS=Homo sapiens GN=SEMG1 PE=1 SV=2 | 372 | R | 0.732914 | L | 0.636358 | 0.096556 | No Change: Both D | - |
| P04279 | SEMG1_HUMAN Semenogelin-1 OS=Homo sapiens GN=SEMG1 PE=1 SV=2 | 58 | E | 0.893519 | G | 0.899078 | -0.005559 | No Change: Both D | - |
| P04279 | SEMG1_HUMAN Semenogelin-1 OS=Homo sapiens GN=SEMG1 PE=1 SV=2 | 108 | H | 0.881132 | R | 0.889589 | -0.008457 | No Change: Both D | - |
| Q02383 | SEMG2_HUMAN Semenogelin-2 OS=Homo sapiens GN=SEMG2 PE=1 SV=1 | 274 | S | 0.798287 | N | 0.793194 | 0.005093 | No Change: Both D | - |
| Q02383 | SEMG2_HUMAN Semenogelin-2 OS=Homo sapiens GN=SEMG2 PE=1 SV=1 | 368 | G | 0.918028 | R | 0.919844 | -0.001816 | No Change: Both D | - |
| Q02383 | SEMG2_HUMAN Semenogelin-2 OS=Homo sapiens GN=SEMG2 PE=1 SV=1 | 43 | Q | 0.919745 | K | 0.921888 | -0.002143 | No Change: Both D | - |
| Q02383 | SEMG2_HUMAN Semenogelin-2 OS=Homo sapiens GN=SEMG2 PE=1 SV=1 | 57 | T | 0.836854 | A | 0.801866 | 0.034988 | No Change: Both D | - |
| Q02383 | SEMG2_HUMAN Semenogelin-2 OS=Homo sapiens GN=SEMG2 PE=1 SV=1 | 279 | H | 0.823612 | Y | 0.751869 | 0.071743 | No Change: Both D | - |
| Q9P0U3 | SENP1_HUMAN Sentrin-specific protease 1 OS=Homo sapiens GN=SENP1 PE=1 SV=2 | 193 | I | 0.604439 | V | 0.64344 | -0.039001 | No Change: Both D | - |
| Q9P0U3 | SENP1_HUMAN Sentrin-specific protease 1 OS=Homo sapiens GN=SENP1 PE=1 SV=2 | 350 | D | 0.572287 | G | 0.52237 | 0.049917 | No Change: Both D | - |
| Q9P0U3 | SENP1_HUMAN Sentrin-specific protease 1 OS=Homo sapiens GN=SENP1 PE=1 SV=2 | 280 | A | 0.781294 | T | 0.822183 | -0.040889 | No Change: Both D | - |
| Q9HC62 | SENP2_HUMAN Sentrin-specific protease 2 OS=Homo sapiens GN=SENP2 PE=1 SV=3 | 301 | T | 0.651137 | K | 0.701076 | -0.049939 | No Change: Both D | - |
| Q9H4L4 | SENP3_HUMAN Sentrin-specific protease 3 OS=Homo sapiens GN=SENP3 PE=1 SV=2 | 515 | W | 0.197082 | R | 0.398439 | -0.201357 | No Change: Both O | - |
| Q96HI0 | SENP5_HUMAN Sentrin-specific protease 5 OS=Homo sapiens GN=SENP5 PE=1 SV=3 | 83 | N | 0.434517 | S | 0.493351 | -0.058834 | No Change: Both O | - |
| Q96HI0 | SENP5_HUMAN Sentrin-specific protease 5 OS=Homo sapiens GN=SENP5 PE=1 SV=3 | 340 | L | 0.701624 | F | 0.693334 | 0.00829 | No Change: Both D | - |
| Q9GZR1 | SENP6_HUMAN Sentrin-specific protease 6 OS=Homo sapiens GN=SENP6 PE=1 SV=2 | 1106 | Y | 0.710398 | C | 0.742447 | -0.032049 | No Change: Both D | - |
| Q9GZR1 | SENP6_HUMAN Sentrin-specific protease 6 OS=Homo sapiens GN=SENP6 PE=1 SV=2 | 121 | T | 0.659329 | M | 0.634406 | 0.024923 | No Change: Both D | - |
| Q9GZR1 | SENP6_HUMAN Sentrin-specific protease 6 OS=Homo sapiens GN=SENP6 PE=1 SV=2 | 637 | E | 0.683538 | K | 0.66532 | 0.018218 | No Change: Both D | - |
| Q9GZR1 | SENP6_HUMAN Sentrin-specific protease 6 OS=Homo sapiens GN=SENP6 PE=1 SV=2 | 717 | R | 0.40455 | P | 0.40537 | -8.20E-04 | No Change: Both O | - |
| Q9GZR1 | SENP6_HUMAN Sentrin-specific protease 6 OS=Homo sapiens GN=SENP6 PE=1 SV=2 | 820 | A | 0.903957 | V | 0.885378 | 0.018579 | No Change: Both D | - |
| Q9BQF6 | SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens GN=SENP7 PE=1 SV=4 | 79 | K | 0.623174 | Q | 0.573309 | 0.049865 | No Change: Both D | - |
| Q9BQF6 | SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens GN=SENP7 PE=1 SV=4 | 612 | Q | 0.739312 | H | 0.725009 | 0.014303 | No Change: Both D | - |
| Q96LD8 | SENP8_HUMAN Sentrin-specific protease 8 OS=Homo sapiens GN=SENP8 PE=1 SV=1 | 207 | T | 0.403231 | A | 0.363808 | 0.039423 | No Change: Both O | - |
| Q9HD40 | SPCS_HUMAN O-phosphoseryl-tRNA(Sec) selenium transferase OS=Homo sapiens GN=SEPSECS PE=1 SV=2 | 239 | A | 0.095846 | T | 0.101549 | -0.005703 | No Change: Both O | Pontocerebellar hypoplasia type 2D (PCH2D) [MIM:613811] |
| Q9HD40 | SPCS_HUMAN O-phosphoseryl-tRNA(Sec) selenium transferase OS=Homo sapiens GN=SEPSECS PE=1 SV=2 | 334 | Y | 0.532799 | C | 0.525006 | 0.007793 | No Change: Both D | Pontocerebellar hypoplasia type 2D (PCH2D) [MIM:613811] |
| Q8WYJ6 | SEPT1_HUMAN Septin-1 OS=Homo sapiens GN=SEPT1 PE=1 SV=2 | 80 | G | 0.417625 | V | 0.291916 | 0.125709 | No Change: Both O | - |
| Q9P0V9 | SEP10_HUMAN Septin-10 OS=Homo sapiens GN=SEPT10 PE=1 SV=2 | 189 | L | 0.399179 | P | 0.537133 | -0.137954 | O to D | - |
| Q8IYM1 | SEP12_HUMAN Septin-12 OS=Homo sapiens GN=SEPT12 PE=1 SV=1 | 213 | Q | 0.329786 | R | 0.33469 | -0.004904 | No Change: Both O | - |
| O43236 | SEPT4_HUMAN Septin-4 OS=Homo sapiens GN=SEPT4 PE=1 SV=1 | 311 | E | 0.480042 | V | 0.288377 | 0.191665 | No Change: Both O | - |
| Q9UHD8 | SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 | 76 | R | 0.914133 | C | 0.859394 | 0.054739 | No Change: Both D | - |
| Q9UHD8 | SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 | 145 | P | 0.820348 | L | 0.725267 | 0.095081 | No Change: Both D | - |
| Q9UHD8 | SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 | 576 | M | 0.862951 | V | 0.809046 | 0.053905 | No Change: Both D | - |
| Q9UHD8 | SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 | 106 | R | 0.814036 | W | 0.629293 | 0.184743 | No Change: Both D | Hereditary neuralgic amyotrophy (HNA) [MIM:162100] |
| Q9UHD8 | SEPT9_HUMAN Septin-9 OS=Homo sapiens GN=SEPT9 PE=1 SV=2 | 111 | S | 0.750256 | F | 0.575007 | 0.175249 | No Change: Both D | Hereditary neuralgic amyotrophy (HNA) [MIM:162100] |
| Q96JX3 | SRAC1_HUMAN Protein SERAC1 OS=Homo sapiens GN=SERAC1 PE=2 SV=1 | 543 | S | 0.218215 | T | 0.157799 | 0.060416 | No Change: Both O | - |
| P84101 | SERF2_HUMAN Small EDRK-rich factor 2 OS=Homo sapiens GN=SERF2 PE=1 SV=1 | 40 | D | 0.993445 | Y | 0.985239 | 0.008206 | No Change: Both D | - |
| Q9UGK8 | SRGEF_HUMAN Secretion-regulating guanine nucleotide exchange factor OS=Homo sapiens GN=SERGEF PE=1 SV=2 | 429 | K | 0.835013 | E | 0.841104 | -0.006091 | No Change: Both D | - |
| Q9UGK8 | SRGEF_HUMAN Secretion-regulating guanine nucleotide exchange factor OS=Homo sapiens GN=SERGEF PE=1 SV=2 | 457 | G | 0.980992 | E | 0.987033 | -0.006041 | No Change: Both D | - |
| Q9NQF3 | SERHL_HUMAN Serine hydrolase-like protein OS=Homo sapiens GN=SERHL PE=2 SV=1 | 3 | E | 0.769682 | K | 0.735464 | 0.034218 | No Change: Both D | - |
| Q9H4I8 | SEHL2_HUMAN Serine hydrolase-like protein 2 OS=Homo sapiens GN=SERHL2 PE=2 SV=1 | 46 | S | 0.243432 | N | 0.209965 | 0.033467 | No Change: Both O | - |
| Q9H4I8 | SEHL2_HUMAN Serine hydrolase-like protein 2 OS=Homo sapiens GN=SERHL2 PE=2 SV=1 | 3 | E | 0.76027 | K | 0.726386 | 0.033884 | No Change: Both D | - |
| Q9H4I8 | SEHL2_HUMAN Serine hydrolase-like protein 2 OS=Homo sapiens GN=SERHL2 PE=2 SV=1 | 306 | C | 0.223668 | R | 0.337092 | -0.113424 | No Change: Both O | - |
| Q9NRX5 | SERC1_HUMAN Serine incorporator 1 OS=Homo sapiens GN=SERINC1 PE=1 SV=1 | 199 | L | 0.072904 | V | 0.066134 | 0.00677 | No Change: Both O | - |
| Q9NRX5 | SERC1_HUMAN Serine incorporator 1 OS=Homo sapiens GN=SERINC1 PE=1 SV=1 | 216 | F | 0.014073 | V | 0.017112 | -0.003039 | No Change: Both O | - |
| Q9NRX5 | SERC1_HUMAN Serine incorporator 1 OS=Homo sapiens GN=SERINC1 PE=1 SV=1 | 225 | S | 0.381666 | G | 0.31118 | 0.070486 | No Change: Both O | - |
| Q96SA4 | SERC2_HUMAN Serine incorporator 2 OS=Homo sapiens GN=SERINC2 PE=2 SV=2 | 303 | G | 0.459877 | S | 0.511102 | -0.051225 | O to D | - |
| Q13530 | SERC3_HUMAN Serine incorporator 3 OS=Homo sapiens GN=SERINC3 PE=2 SV=2 | 437 | T | 0.372748 | A | 0.363297 | 0.009451 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 4 | S | 0.598939 | L | 0.462115 | 0.136824 | D to O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 26 | D | 0.553495 | A | 0.495352 | 0.058143 | D to O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 58 | A | 0.235724 | T | 0.261589 | -0.025865 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 63 | R | 0.291897 | C | 0.192889 | 0.099008 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 65 | L | 0.364713 | P | 0.490096 | -0.125383 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 69 | S | 0.416092 | F | 0.239583 | 0.176509 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 77 | S | 0.212374 | F | 0.088223 | 0.124151 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 84 | A | 0.141965 | T | 0.158661 | -0.016696 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 91 | G | 0.404541 | E | 0.46088 | -0.056339 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 92 | T | 0.422257 | I | 0.282922 | 0.139335 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 112 | P | 0.404231 | T | 0.375951 | 0.02828 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 116 | I | 0.432988 | N | 0.589854 | -0.156866 | O to D | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 125 | R | 0.41573 | H | 0.424094 | -0.008364 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 139 | G | 0.379048 | S | 0.439663 | -0.060615 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 172 | G | 0.418335 | R | 0.403881 | 0.014454 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 172 | G | 0.418335 | W | 0.217756 | 0.200579 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 180 | Q | 0.527634 | E | 0.583328 | -0.055694 | No Change: Both D | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 228 | E | 0.63359 | K | 0.622354 | 0.011236 | No Change: Both D | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 237 | V | 0.313311 | A | 0.364973 | -0.051662 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 247 | R | 0.221728 | C | 0.118011 | 0.103717 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 280 | D | 0.279759 | V | 0.155378 | 0.124381 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 288 | E | 0.517467 | V | 0.302268 | 0.215199 | D to O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 354 | S | 0.485507 | F | 0.277933 | 0.207574 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 360 | A | 0.306474 | T | 0.332057 | -0.025583 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 365 | D | 0.44715 | N | 0.435244 | 0.011906 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 366 | E | 0.467895 | K | 0.471061 | -0.003166 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 382 | M | 0.309968 | R | 0.320921 | -0.010953 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 386 | P | 0.426614 | H | 0.34754 | 0.079074 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 386 | P | 0.426614 | T | 0.346915 | 0.079699 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 387 | E | 0.444633 | K | 0.461271 | -0.016638 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 393 | P | 0.347366 | L | 0.193565 | 0.153801 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 400 | E | 0.420386 | D | 0.351855 | 0.068531 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 415 | P | 0.683993 | H | 0.589538 | 0.094455 | No Change: Both D | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 109 | T | 0.306146 | M | 0.263357 | 0.042789 | No Change: Both O | - |
| P01009 | A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens GN=SERPINA1 PE=1 SV=3 | 37 | T | 0.852097 | A | 0.840393 | 0.011704 | No Change: Both D | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 46 | K | 0.987877 | R | 0.988626 | -7.49E-04 | No Change: Both D | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 61 | S | 0.963603 | G | 0.948572 | 0.015031 | No Change: Both D | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 161 | T | 0.26583 | S | 0.348814 | -0.082984 | No Change: Both O | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 139 | G | 0.609594 | R | 0.615633 | -0.006039 | No Change: Both D | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 271 | G | 0.24045 | S | 0.286243 | -0.045793 | No Change: Both O | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 384 | Q | 0.226212 | P | 0.23695 | -0.010738 | No Change: Both O | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 158 | L | 0.395589 | Q | 0.513447 | -0.117858 | O to D | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 196 | R | 0.32553 | H | 0.314078 | 0.011452 | No Change: Both O | - |
| Q9UK55 | ZPI_HUMAN Protein Z-dependent protease inhibitor OS=Homo sapiens GN=SERPINA10 PE=1 SV=1 | 384 | Q | 0.226212 | R | 0.230827 | -0.004615 | No Change: Both O | - |
| Q86U17 | SPA11_HUMAN Serpin A11 OS=Homo sapiens GN=SERPINA11 PE=2 SV=2 | 406 | T | 0.083079 | S | 0.116567 | -0.033488 | No Change: Both O | - |
| Q86U17 | SPA11_HUMAN Serpin A11 OS=Homo sapiens GN=SERPINA11 PE=2 SV=2 | 230 | E | 0.531033 | A | 0.414439 | 0.116594 | D to O | - |
| Q8IW75 | SPA12_HUMAN Serpin A12 OS=Homo sapiens GN=SERPINA12 PE=2 SV=1 | 142 | Q | 0.257275 | K | 0.285294 | -0.028019 | No Change: Both O | - |
| Q8IW75 | SPA12_HUMAN Serpin A12 OS=Homo sapiens GN=SERPINA12 PE=2 SV=1 | 394 | I | 0.118702 | V | 0.129881 | -0.011179 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 9 | A | 0.235694 | T | 0.227229 | 0.008465 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 78 | L | 0.18924 | P | 0.333189 | -0.143949 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 167 | A | 0.382547 | G | 0.424683 | -0.042136 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 252 | P | 0.204877 | A | 0.14792 | 0.056957 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 401 | M | 0.07541 | V | 0.057652 | 0.017758 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 407 | D | 0.145566 | G | 0.128278 | 0.017288 | No Change: Both O | - |
| P01011 | AACT_HUMAN Alpha-1-antichymotrypsin OS=Homo sapiens GN=SERPINA3 PE=1 SV=2 | 267 | K | 0.222906 | R | 0.176845 | 0.046061 | No Change: Both O | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 55 | A | 0.401115 | V | 0.306271 | 0.094844 | No Change: Both O | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 105 | K | 0.811921 | E | 0.823942 | -0.012021 | No Change: Both D | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 44 | S | 0.529614 | G | 0.452065 | 0.077549 | D to O | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 64 | S | 0.534854 | N | 0.426076 | 0.108778 | D to O | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 94 | G | 0.674086 | V | 0.518394 | 0.155692 | No Change: Both D | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 115 | L | 0.567717 | P | 0.690453 | -0.122736 | No Change: Both D | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 217 | G | 0.605184 | R | 0.585677 | 0.019507 | No Change: Both D | - |
| P05154 | IPSP_HUMAN Plasma serine protease inhibitor OS=Homo sapiens GN=SERPINA5 PE=1 SV=3 | 121 | P | 0.542406 | A | 0.463506 | 0.0789 | D to O | - |
| P08185 | CBG_HUMAN Corticosteroid-binding globulin OS=Homo sapiens GN=SERPINA6 PE=1 SV=1 | 115 | L | 0.447299 | H | 0.548495 | -0.101196 | O to D | Corticosteroid-binding globulin deficiency (CBG deficiency) [MIM:611489] |
| P08185 | CBG_HUMAN Corticosteroid-binding globulin OS=Homo sapiens GN=SERPINA6 PE=1 SV=1 | 389 | D | 0.036853 | N | 0.034804 | 0.002049 | No Change: Both O | Corticosteroid-binding globulin deficiency (CBG deficiency) [MIM:611489] |
| P08185 | CBG_HUMAN Corticosteroid-binding globulin OS=Homo sapiens GN=SERPINA6 PE=1 SV=1 | 246 | S | 0.335737 | A | 0.224096 | 0.111641 | No Change: Both O | - |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 43 | S | 0.296486 | T | 0.22854 | 0.067946 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 116 | I | 0.112846 | N | 0.230925 | -0.118079 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 133 | A | 0.129094 | P | 0.186968 | -0.057874 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 191 | D | 0.187937 | N | 0.190177 | -0.00224 | No Change: Both O | - |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 211 | A | 0.273514 | T | 0.295059 | -0.021545 | No Change: Both O | - |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 247 | L | 0.21186 | P | 0.334952 | -0.123092 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 303 | L | 0.074056 | F | 0.068237 | 0.005819 | No Change: Both O | - |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 351 | H | 0.389449 | Y | 0.257027 | 0.132422 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| P05543 | THBG_HUMAN Thyroxine-binding globulin OS=Homo sapiens GN=SERPINA7 PE=1 SV=2 | 383 | P | 0.141211 | L | 0.070738 | 0.070473 | No Change: Both O | Thyroxine-binding globulin deficiency (TBG deficiency) [MIM:314200] |
| Q86WD7 | SPA9_HUMAN Serpin A9 OS=Homo sapiens GN=SERPINA9 PE=1 SV=3 | 24 | A | 0.421461 | V | 0.334482 | 0.086979 | No Change: Both O | - |
| Q86WD7 | SPA9_HUMAN Serpin A9 OS=Homo sapiens GN=SERPINA9 PE=1 SV=3 | 218 | P | 0.459804 | L | 0.266135 | 0.193669 | No Change: Both O | - |
| Q86WD7 | SPA9_HUMAN Serpin A9 OS=Homo sapiens GN=SERPINA9 PE=1 SV=3 | 236 | H | 0.308644 | Q | 0.332618 | -0.023974 | No Change: Both O | - |
| Q86WD7 | SPA9_HUMAN Serpin A9 OS=Homo sapiens GN=SERPINA9 PE=1 SV=3 | 292 | R | 0.476304 | I | 0.289582 | 0.186722 | No Change: Both O | - |
| Q86WD7 | SPA9_HUMAN Serpin A9 OS=Homo sapiens GN=SERPINA9 PE=1 SV=3 | 330 | V | 0.264689 | A | 0.35595 | -0.091261 | No Change: Both O | - |
| P30740 | ILEU_HUMAN Leukocyte elastase inhibitor OS=Homo sapiens GN=SERPINB1 PE=1 SV=1 | 82 | A | 0.242631 | V | 0.171356 | 0.071275 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 246 | R | 0.221105 | C | 0.116335 | 0.10477 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 41 | I | 0.134518 | M | 0.190365 | -0.055847 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 99 | I | 0.345148 | T | 0.44794 | -0.102792 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 140 | P | 0.37826 | S | 0.401288 | -0.023028 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 3 | S | 0.777252 | A | 0.726136 | 0.051116 | No Change: Both D | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 135 | G | 0.302538 | D | 0.342269 | -0.039731 | No Change: Both O | - |
| P48595 | SPB10_HUMAN Serpin B10 OS=Homo sapiens GN=SERPINB10 PE=1 SV=1 | 360 | D | 0.387496 | N | 0.372416 | 0.01508 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 148 | M | 0.352931 | T | 0.421506 | -0.068575 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 181 | I | 0.07543 | T | 0.130362 | -0.054932 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 354 | I | 0.40767 | T | 0.572886 | -0.165216 | O to D | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 51 | A | 0.480752 | E | 0.570179 | -0.089427 | O to D | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 188 | R | 0.342593 | W | 0.168767 | 0.173826 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 293 | I | 0.286553 | T | 0.433324 | -0.146771 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 303 | P | 0.242906 | S | 0.273741 | -0.030835 | No Change: Both O | - |
| Q96P15 | SPB11_HUMAN Serpin B11 OS=Homo sapiens GN=SERPINB11 PE=2 SV=1 | 181 | I | 0.07543 | A | 0.104909 | -0.029479 | No Change: Both O | - |
| Q96P63 | SPB12_HUMAN Serpin B12 OS=Homo sapiens GN=SERPINB12 PE=1 SV=1 | 227 | K | 0.271423 | E | 0.25562 | 0.015803 | No Change: Both O | - |
| Q96P63 | SPB12_HUMAN Serpin B12 OS=Homo sapiens GN=SERPINB12 PE=1 SV=1 | 289 | N | 0.66836 | T | 0.667032 | 0.001328 | No Change: Both D | - |
| Q96P63 | SPB12_HUMAN Serpin B12 OS=Homo sapiens GN=SERPINB12 PE=1 SV=1 | 338 | N | 0.384665 | S | 0.455665 | -0.071 | No Change: Both O | - |
| Q9UIV8 | SPB13_HUMAN Serpin B13 OS=Homo sapiens GN=SERPINB13 PE=2 SV=2 | 293 | G | 0.357925 | S | 0.407747 | -0.049822 | No Change: Both O | - |
| P05120 | PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | 120 | N | 0.37988 | D | 0.373905 | 0.005975 | No Change: Both O | - |
| P05120 | PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | 404 | N | 0.036856 | K | 0.052138 | -0.015282 | No Change: Both O | - |
| P05120 | PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | 413 | S | 0.717828 | C | 0.493556 | 0.224272 | D to O | - |
| P05120 | PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | 229 | R | 0.403799 | H | 0.393474 | 0.010325 | No Change: Both O | - |
| P05120 | PAI2_HUMAN Plasminogen activator inhibitor 2 OS=Homo sapiens GN=SERPINB2 PE=1 SV=2 | 374 | G | 0.573622 | A | 0.514684 | 0.058938 | No Change: Both D | - |
| P29508 | SPB3_HUMAN Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 | 351 | G | 0.440829 | A | 0.399732 | 0.041097 | No Change: Both O | - |
| P29508 | SPB3_HUMAN Serpin B3 OS=Homo sapiens GN=SERPINB3 PE=1 SV=2 | 357 | T | 0.705533 | A | 0.673675 | 0.031858 | No Change: Both D | - |
| P36952 | SPB5_HUMAN Serpin B5 OS=Homo sapiens GN=SERPINB5 PE=1 SV=2 | 319 | I | 0.166501 | V | 0.189941 | -0.02344 | No Change: Both O | - |
| P36952 | SPB5_HUMAN Serpin B5 OS=Homo sapiens GN=SERPINB5 PE=1 SV=2 | 176 | S | 0.556527 | P | 0.533024 | 0.023503 | No Change: Both D | - |
| P36952 | SPB5_HUMAN Serpin B5 OS=Homo sapiens GN=SERPINB5 PE=1 SV=2 | 187 | V | 0.480978 | L | 0.464425 | 0.016553 | No Change: Both O | - |
| P35237 | SPB6_HUMAN Serpin B6 OS=Homo sapiens GN=SERPINB6 PE=1 SV=3 | 90 | M | 0.23006 | V | 0.169443 | 0.060617 | No Change: Both O | - |
| P35237 | SPB6_HUMAN Serpin B6 OS=Homo sapiens GN=SERPINB6 PE=1 SV=3 | 153 | G | 0.406814 | S | 0.47717 | -0.070356 | No Change: Both O | - |
| O75635 | SPB7_HUMAN Serpin B7 OS=Homo sapiens GN=SERPINB7 PE=2 SV=1 | 266 | R | 0.364645 | Q | 0.370435 | -0.00579 | No Change: Both O | - |
| P50452 | SPB8_HUMAN Serpin B8 OS=Homo sapiens GN=SERPINB8 PE=1 SV=2 | 68 | R | 0.28436 | Q | 0.318045 | -0.033685 | No Change: Both O | - |
| P50452 | SPB8_HUMAN Serpin B8 OS=Homo sapiens GN=SERPINB8 PE=1 SV=2 | 158 | K | 0.129321 | N | 0.116233 | 0.013088 | No Change: Both O | - |
| P50452 | SPB8_HUMAN Serpin B8 OS=Homo sapiens GN=SERPINB8 PE=1 SV=2 | 304 | T | 0.564062 | A | 0.567736 | -0.003674 | No Change: Both D | - |
| P50452 | SPB8_HUMAN Serpin B8 OS=Homo sapiens GN=SERPINB8 PE=1 SV=2 | 359 | H | 0.164194 | R | 0.214229 | -0.050035 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 30 | V | 0.045772 | E | 0.098139 | -0.052367 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 39 | I | 0.28197 | N | 0.428889 | -0.146919 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 52 | M | 0.399273 | T | 0.426801 | -0.027528 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 56 | R | 0.61925 | C | 0.526733 | 0.092517 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 73 | P | 0.705714 | L | 0.583396 | 0.122318 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 79 | R | 0.472986 | C | 0.338144 | 0.134842 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 79 | R | 0.472986 | H | 0.41658 | 0.056406 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 79 | R | 0.472986 | S | 0.521546 | -0.04856 | O to D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 89 | R | 0.389275 | C | 0.26522 | 0.124055 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 90 | F | 0.368139 | L | 0.390518 | -0.022379 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 112 | P | 0.259074 | T | 0.243066 | 0.016008 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 131 | L | 0.211143 | F | 0.192938 | 0.018205 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 131 | L | 0.211143 | V | 0.197673 | 0.01347 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 133 | Q | 0.165751 | K | 0.194742 | -0.028991 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 148 | S | 0.429211 | P | 0.393604 | 0.035607 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 150 | Q | 0.301631 | P | 0.31486 | -0.013229 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 152 | H | 0.175932 | Y | 0.118296 | 0.057636 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 158 | L | 0.136903 | P | 0.208061 | -0.071158 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 161 | R | 0.195052 | Q | 0.198629 | -0.003577 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 190 | Y | 0.297011 | C | 0.281619 | 0.015392 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 198 | Y | 0.194736 | C | 0.194066 | 6.70E-04 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 214 | S | 0.466269 | Y | 0.29021 | 0.176059 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 219 | N | 0.352924 | K | 0.400837 | -0.047913 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 219 | N | 0.352924 | D | 0.352335 | 5.89E-04 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 269 | E | 0.475046 | K | 0.479685 | -0.004639 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 283 | M | 0.465646 | I | 0.344624 | 0.121022 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 302 | L | 0.286293 | P | 0.432894 | -0.146601 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 316 | I | 0.338645 | N | 0.451377 | -0.112732 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 334 | E | 0.476052 | K | 0.461286 | 0.014766 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 381 | S | 0.509178 | P | 0.494333 | 0.014845 | D to O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 391 | R | 0.335522 | Q | 0.35708 | -0.021558 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 414 | A | 0.615867 | T | 0.630892 | -0.015025 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 416 | A | 0.476279 | P | 0.524331 | -0.048052 | O to D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 416 | A | 0.476279 | S | 0.572867 | -0.096588 | O to D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 419 | A | 0.308273 | V | 0.233621 | 0.074652 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 424 | G | 0.277131 | D | 0.30579 | -0.028659 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 425 | R | 0.288144 | H | 0.277265 | 0.010879 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 425 | R | 0.288144 | C | 0.147253 | 0.140891 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 425 | R | 0.288144 | P | 0.331304 | -0.04316 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 426 | S | 0.299554 | L | 0.158694 | 0.14086 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 434 | F | 0.30486 | C | 0.283392 | 0.021468 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 434 | F | 0.30486 | S | 0.491505 | -0.186645 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 434 | F | 0.30486 | L | 0.332513 | -0.027653 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 436 | A | 0.213278 | T | 0.244603 | -0.031325 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 437 | N | 0.187279 | K | 0.21187 | -0.024591 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 438 | R | 0.148738 | M | 0.109429 | 0.039309 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 439 | P | 0.117284 | L | 0.059225 | 0.058059 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 439 | P | 0.117284 | T | 0.094482 | 0.022802 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 453 | I | 0.067638 | T | 0.122918 | -0.05528 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 456 | G | 0.080051 | R | 0.105324 | -0.025273 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 457 | R | 0.101317 | T | 0.096352 | 0.004965 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 459 | A | 0.248716 | D | 0.311276 | -0.06256 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 461 | P | 0.528977 | L | 0.382948 | 0.146029 | D to O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 462 | C | 0.687824 | F | 0.706758 | -0.018934 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 438 | R | 0.148738 | G | 0.13675 | 0.011988 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 95 | Y | 0.267327 | S | 0.505436 | -0.238109 | O to D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 23 | L | 0.013935 | P | 0.027658 | -0.013723 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 167 | N | 0.554162 | T | 0.516845 | 0.037317 | No Change: Both D | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 147 | T | 0.461772 | A | 0.430319 | 0.031453 | No Change: Both O | - |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 17 | Y | 0.156594 | S | 0.312923 | -0.156329 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 32 | C | 0.070063 | R | 0.127608 | -0.057545 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 95 | Y | 0.267327 | C | 0.286546 | -0.019219 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 98 | L | 0.385108 | P | 0.517749 | -0.132641 | O to D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 121 | M | 0.231367 | K | 0.335553 | -0.104186 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 127 | C | 0.254178 | R | 0.379691 | -0.125513 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 146 | K | 0.458526 | E | 0.469076 | -0.01055 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 160 | C | 0.147187 | Y | 0.165481 | -0.018294 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 178 | L | 0.337155 | H | 0.440108 | -0.102953 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 179 | F | 0.3372 | L | 0.380841 | -0.043641 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 198 | Y | 0.194736 | H | 0.270463 | -0.075727 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 214 | S | 0.466269 | F | 0.268605 | 0.197664 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 223 | S | 0.382282 | P | 0.349135 | 0.033147 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 243 | T | 0.093863 | I | 0.053405 | 0.040458 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 251 | I | 0.038689 | T | 0.079055 | -0.040366 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 257 | W | 0.237773 | R | 0.416526 | -0.178753 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 261 | F | 0.527542 | L | 0.561845 | -0.034303 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 283 | M | 0.465646 | V | 0.378398 | 0.087248 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 323 | S | 0.625518 | P | 0.669885 | -0.044367 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 397 | S | 0.274872 | P | 0.254028 | 0.020844 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 398 | D | 0.247113 | H | 0.206981 | 0.040132 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 412 | S | 0.651996 | R | 0.596176 | 0.05582 | No Change: Both D | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P01008 | ANT3_HUMAN Antithrombin-III OS=Homo sapiens GN=SERPINC1 PE=1 SV=1 | 441 | L | 0.080089 | P | 0.175364 | -0.095275 | No Change: Both O | Antithrombin III deficiency (AT3D) [MIM:613118] |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 208 | R | 0.203723 | H | 0.200657 | 0.003066 | No Change: Both O | Heparin cofactor 2 deficiency (HCF2D) [MIM:612356] |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 7 | A | 0.169819 | T | 0.189926 | -0.020107 | No Change: Both O | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 60 | H | 0.520293 | P | 0.646073 | -0.12578 | No Change: Both D | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 237 | K | 0.145505 | R | 0.110003 | 0.035502 | No Change: Both O | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 442 | T | 0.289133 | M | 0.240213 | 0.04892 | No Change: Both O | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 87 | S | 0.471238 | N | 0.419883 | 0.051355 | No Change: Both O | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 129 | L | 0.1207 | V | 0.112906 | 0.007794 | No Change: Both O | - |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 447 | E | 0.578946 | K | 0.56352 | 0.015426 | No Change: Both D | Heparin cofactor 2 deficiency (HCF2D) [MIM:612356] |
| P05546 | HEP2_HUMAN Heparin cofactor 2 OS=Homo sapiens GN=SERPIND1 PE=1 SV=3 | 462 | P | 0.216648 | L | 0.11897 | 0.097678 | No Change: Both O | Heparin cofactor 2 deficiency (HCF2D) [MIM:612356] |
| P05121 | PAI1_HUMAN Plasminogen activator inhibitor 1 OS=Homo sapiens GN=SERPINE1 PE=1 SV=1 | 15 | A | 0.059987 | T | 0.066679 | -0.006692 | No Change: Both O | - |
| P05121 | PAI1_HUMAN Plasminogen activator inhibitor 1 OS=Homo sapiens GN=SERPINE1 PE=1 SV=1 | 17 | V | 0.14025 | I | 0.114197 | 0.026053 | No Change: Both O | - |
| P05121 | PAI1_HUMAN Plasminogen activator inhibitor 1 OS=Homo sapiens GN=SERPINE1 PE=1 SV=1 | 25 | H | 0.49958 | P | 0.528341 | -0.028761 | O to D | - |
| P05121 | PAI1_HUMAN Plasminogen activator inhibitor 1 OS=Homo sapiens GN=SERPINE1 PE=1 SV=1 | 209 | R | 0.613003 | H | 0.626081 | -0.013078 | No Change: Both D | - |
| P05121 | PAI1_HUMAN Plasminogen activator inhibitor 1 OS=Homo sapiens GN=SERPINE1 PE=1 SV=1 | 255 | T | 0.191171 | N | 0.221707 | -0.030536 | No Change: Both O | - |
| P07093 | GDN_HUMAN Glia-derived nexin OS=Homo sapiens GN=SERPINE2 PE=1 SV=1 | 204 | K | 0.5382 | N | 0.502981 | 0.035219 | No Change: Both D | A breast cancer sample |
| P07093 | GDN_HUMAN Glia-derived nexin OS=Homo sapiens GN=SERPINE2 PE=1 SV=1 | 51 | I | 0.404379 | M | 0.470526 | -0.066147 | No Change: Both O | - |
| A8MV23 | SERP3_HUMAN Serpin E3 OS=Homo sapiens GN=SERPINE3 PE=2 SV=2 | 143 | D | 0.685158 | N | 0.708466 | -0.023308 | No Change: Both D | - |
| P36955 | PEDF_HUMAN Pigment epithelium-derived factor OS=Homo sapiens GN=SERPINF1 PE=1 SV=4 | 72 | T | 0.547654 | M | 0.489273 | 0.058381 | D to O | - |
| P36955 | PEDF_HUMAN Pigment epithelium-derived factor OS=Homo sapiens GN=SERPINF1 PE=1 SV=4 | 132 | P | 0.499639 | R | 0.469732 | 0.029907 | No Change: Both O | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 27 | A | 0.533679 | V | 0.497334 | 0.036345 | D to O | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 33 | R | 0.684444 | W | 0.504393 | 0.180051 | No Change: Both D | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 411 | V | 0.369978 | M | 0.459479 | -0.089501 | No Change: Both O | Alpha-2-plasmin inhibitor deficiency (APLID) [MIM:262850] |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 434 | R | 0.669825 | K | 0.678852 | -0.009027 | No Change: Both D | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 2 | A | 0.286477 | V | 0.203405 | 0.083072 | No Change: Both O | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 98 | A | 0.255947 | G | 0.263563 | -0.007616 | No Change: Both O | - |
| P08697 | A2AP_HUMAN Alpha-2-antiplasmin OS=Homo sapiens GN=SERPINF2 PE=1 SV=3 | 451 | P | 0.894872 | S | 0.889211 | 0.005661 | No Change: Both D | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 429 | G | 0.218792 | R | 0.219993 | -0.001201 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 454 | V | 0.448266 | E | 0.642044 | -0.193778 | O to D | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 456 | A | 0.441908 | E | 0.545235 | -0.103327 | O to D | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 458 | A | 0.411719 | T | 0.430411 | -0.018692 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 458 | A | 0.411719 | V | 0.32005 | 0.091669 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 465 | A | 0.140205 | V | 0.09992 | 0.040285 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 466 | R | 0.108092 | C | 0.052015 | 0.056077 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 466 | R | 0.108092 | H | 0.109036 | -9.44E-04 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 466 | R | 0.108092 | L | 0.068931 | 0.039161 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 466 | R | 0.108092 | S | 0.155441 | -0.047349 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 467 | T | 0.09446 | P | 0.119869 | -0.025409 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 473 | V | 0.071476 | M | 0.087324 | -0.015848 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 474 | Q | 0.066936 | E | 0.081869 | -0.014933 | No Change: Both O | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 477 | F | 0.043892 | S | 0.106985 | -0.063093 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 480 | V | 0.05973 | M | 0.077397 | -0.017667 | No Change: Both O | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 481 | L | 0.071234 | P | 0.148014 | -0.07678 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 481 | L | 0.071234 | R | 0.117062 | -0.045828 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 489 | P | 0.160052 | R | 0.143935 | 0.016117 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 498 | P | 0.811239 | S | 0.837563 | -0.026324 | No Change: Both D | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 308 | T | 0.575227 | S | 0.616518 | -0.041291 | No Change: Both D | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 39 | D | 0.798258 | E | 0.822427 | -0.024169 | No Change: Both D | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 56 | V | 0.645165 | A | 0.685838 | -0.040673 | No Change: Both D | - |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 345 | G | 0.383063 | R | 0.377043 | 0.00602 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 130 | C | 0.595598 | Y | 0.55893 | 0.036668 | No Change: Both D | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 394 | T | 0.4879 | P | 0.559477 | -0.071577 | O to D | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 408 | D | 0.405087 | V | 0.261133 | 0.143954 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 473 | V | 0.071476 | E | 0.158848 | -0.087372 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 493 | G | 0.226346 | E | 0.271155 | -0.044809 | No Change: Both O | Hereditary angioedema (HAE) [MIM:106100] |
| P05155 | IC1_HUMAN Plasma protease C1 inhibitor OS=Homo sapiens GN=SERPING1 PE=1 SV=2 | 498 | P | 0.811239 | R | 0.800141 | 0.011098 | No Change: Both D | Hereditary angioedema (HAE) [MIM:106100] |
| P50454 | SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SERPINH1 PE=1 SV=2 | 41 | A | 0.66151 | P | 0.704467 | -0.042957 | No Change: Both D | - |
| P50454 | SERPH_HUMAN Serpin H1 OS=Homo sapiens GN=SERPINH1 PE=1 SV=2 | 78 | L | 0.32115 | P | 0.468903 | -0.147753 | No Change: Both O | Osteogenesis imperfecta type 10 (OI10) [MIM:613848] |
| Q99574 | NEUS_HUMAN Neuroserpin OS=Homo sapiens GN=SERPINI1 PE=1 SV=1 | 49 | S | 0.228609 | P | 0.214806 | 0.013803 | No Change: Both O | Familial encephalopathy with neuroserpin inclusion bodies (FEN1B) [MIM:604218] |
| Q99574 | NEUS_HUMAN Neuroserpin OS=Homo sapiens GN=SERPINI1 PE=1 SV=1 | 52 | S | 0.239733 | R | 0.1984 | 0.041333 | No Change: Both O | Familial encephalopathy with neuroserpin inclusion bodies (FEN1B) [MIM:604218] |
| O75830 | SPI2_HUMAN Serpin I2 OS=Homo sapiens GN=SERPINI2 PE=2 SV=1 | 148 | E | 0.15762 | G | 0.118973 | 0.038647 | No Change: Both O | - |
| O75830 | SPI2_HUMAN Serpin I2 OS=Homo sapiens GN=SERPINI2 PE=2 SV=1 | 6 | L | 0.071707 | V | 0.062593 | 0.009114 | No Change: Both O | - |
| Q9UHV2 | SRTD1_HUMAN SERTA domain-containing protein 1 OS=Homo sapiens GN=SERTAD1 PE=1 SV=2 | 31 | T | 0.52602 | A | 0.575494 | -0.049474 | No Change: Both D | - |
| Q9Y6P5 | SESN1_HUMAN Sestrin-1 OS=Homo sapiens GN=SESN1 PE=1 SV=2 | 44 | L | 0.67305 | I | 0.655851 | 0.017199 | No Change: Both D | - |
| P58004 | SESN2_HUMAN Sestrin-2 OS=Homo sapiens GN=SESN2 PE=1 SV=1 | 320 | T | 0.381114 | A | 0.34445 | 0.036664 | No Change: Both O | - |
| P58005 | SESN3_HUMAN Sestrin-3 OS=Homo sapiens GN=SESN3 PE=2 SV=2 | 71 | R | 0.430002 | C | 0.265557 | 0.164445 | No Change: Both O | - |
| P58005 | SESN3_HUMAN Sestrin-3 OS=Homo sapiens GN=SESN3 PE=2 SV=2 | 227 | I | 0.141779 | T | 0.207837 | -0.066058 | No Change: Both O | - |
| Q86VW0 | SESD1_HUMAN SEC14 domain and spectrin repeat-containing protein 1 OS=Homo sapiens GN=SESTD1 PE=1 SV=2 | 49 | Y | 0.169835 | F | 0.15545 | 0.014385 | No Change: Both O | - |
| Q86VW0 | SESD1_HUMAN SEC14 domain and spectrin repeat-containing protein 1 OS=Homo sapiens GN=SESTD1 PE=1 SV=2 | 563 | V | 0.11981 | A | 0.161243 | -0.041433 | No Change: Both O | - |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 1130 | P | 0.925534 | T | 0.883409 | 0.042125 | No Change: Both D | - |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 231 | V | 0.833839 | L | 0.845298 | -0.011459 | No Change: Both D | - |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 1162 | R | 0.834979 | W | 0.6759 | 0.159079 | No Change: Both D | A colorectal cancer sample |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 1101 | V | 0.789229 | I | 0.742481 | 0.046748 | No Change: Both D | - |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 868 | D | 0.957836 | A | 0.942019 | 0.015817 | No Change: Both D | Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150] |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 868 | D | 0.957836 | N | 0.956268 | 0.001568 | No Change: Both D | Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150] |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 870 | G | 0.957568 | D | 0.966154 | -0.008586 | No Change: Both D | Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150] |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 870 | G | 0.957568 | S | 0.97277 | -0.015202 | No Change: Both D | Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150] |
| Q9Y6X0 | SETBP_HUMAN SET-binding protein OS=Homo sapiens GN=SETBP1 PE=1 SV=3 | 871 | I | 0.957487 | T | 0.975048 | -0.017561 | No Change: Both D | Schinzel-Giedion midface retraction syndrome (SGMFS) [MIM:269150] |
| O15047 | SET1A_HUMAN Histone-lysine N-methyltransferase SETD1A OS=Homo sapiens GN=SETD1A PE=1 SV=3 | 639 | D | 0.994304 | N | 0.993639 | 6.65E-04 | No Change: Both D | - |
| Q9BYW2 | SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens GN=SETD2 PE=1 SV=3 | 768 | V | 0.768643 | L | 0.755375 | 0.013268 | No Change: Both D | - |
| Q9BYW2 | SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens GN=SETD2 PE=1 SV=3 | 1868 | A | 0.937054 | D | 0.955125 | -0.018071 | No Change: Both D | - |
| Q9BYW2 | SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens GN=SETD2 PE=1 SV=3 | 1962 | P | 0.987596 | L | 0.977982 | 0.009614 | No Change: Both D | - |
| Q9BYW2 | SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens GN=SETD2 PE=1 SV=3 | 902 | E | 0.575876 | Q | 0.546862 | 0.029014 | No Change: Both D | - |
| Q86TU7 | SETD3_HUMAN Histone-lysine N-methyltransferase setd3 OS=Homo sapiens GN=SETD3 PE=1 SV=1 | 278 | N | 0.110661 | D | 0.118784 | -0.008123 | No Change: Both O | - |
| Q9NVD3 | SETD4_HUMAN SET domain-containing protein 4 OS=Homo sapiens GN=SETD4 PE=2 SV=1 | 387 | I | 0.070065 | V | 0.078767 | -0.008702 | No Change: Both O | - |
| Q9NVD3 | SETD4_HUMAN SET domain-containing protein 4 OS=Homo sapiens GN=SETD4 PE=2 SV=1 | 420 | E | 0.274096 | G | 0.189581 | 0.084515 | No Change: Both O | A colorectal cancer sample |
| Q9C0A6 | SETD5_HUMAN SET domain-containing protein 5 OS=Homo sapiens GN=SETD5 PE=1 SV=2 | 77 | R | 0.800817 | H | 0.768901 | 0.031916 | No Change: Both D | - |
| Q9C0A6 | SETD5_HUMAN SET domain-containing protein 5 OS=Homo sapiens GN=SETD5 PE=1 SV=2 | 119 | R | 0.532403 | I | 0.34721 | 0.185193 | D to O | - |
| Q9C0A6 | SETD5_HUMAN SET domain-containing protein 5 OS=Homo sapiens GN=SETD5 PE=1 SV=2 | 1137 | M | 0.989542 | V | 0.986471 | 0.003071 | No Change: Both D | - |
| Q9C0A6 | SETD5_HUMAN SET domain-containing protein 5 OS=Homo sapiens GN=SETD5 PE=1 SV=2 | 1308 | T | 0.980575 | I | 0.961732 | 0.018843 | No Change: Both D | - |
| Q8TBK2 | SETD6_HUMAN N-lysine methyltransferase SETD6 OS=Homo sapiens GN=SETD6 PE=1 SV=2 | 185 | R | 0.298401 | S | 0.375837 | -0.077436 | No Change: Both O | - |
| Q8TBK2 | SETD6_HUMAN N-lysine methyltransferase SETD6 OS=Homo sapiens GN=SETD6 PE=1 SV=2 | 206 | R | 0.25399 | G | 0.238313 | 0.015677 | No Change: Both O | - |
| Q8TBK2 | SETD6_HUMAN N-lysine methyltransferase SETD6 OS=Homo sapiens GN=SETD6 PE=1 SV=2 | 340 | D | 0.105751 | N | 0.091758 | 0.013993 | No Change: Both O | - |
| Q8TBK2 | SETD6_HUMAN N-lysine methyltransferase SETD6 OS=Homo sapiens GN=SETD6 PE=1 SV=2 | 426 | T | 0.235557 | A | 0.202409 | 0.033148 | No Change: Both O | - |
| Q8TBK2 | SETD6_HUMAN N-lysine methyltransferase SETD6 OS=Homo sapiens GN=SETD6 PE=1 SV=2 | 445 | A | 0.292785 | V | 0.234225 | 0.05856 | No Change: Both O | - |
| Q15047 | SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens GN=SETDB1 PE=1 SV=1 | 236 | N | 0.569144 | S | 0.612014 | -0.04287 | No Change: Both D | - |
| Q15047 | SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens GN=SETDB1 PE=1 SV=1 | 824 | A | 0.099523 | P | 0.139904 | -0.040381 | No Change: Both O | - |
| Q15047 | SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens GN=SETDB1 PE=1 SV=1 | 824 | A | 0.099523 | G | 0.13592 | -0.036397 | No Change: Both O | - |
| Q15047 | SETB1_HUMAN Histone-lysine N-methyltransferase SETDB1 OS=Homo sapiens GN=SETDB1 PE=1 SV=1 | 506 | P | 0.963155 | S | 0.966274 | -0.003119 | No Change: Both D | - |
| Q96T68 | SETB2_HUMAN Histone-lysine N-methyltransferase SETDB2 OS=Homo sapiens GN=SETDB2 PE=1 SV=2 | 473 | V | 0.583247 | M | 0.648449 | -0.065202 | No Change: Both D | - |
| Q96T68 | SETB2_HUMAN Histone-lysine N-methyltransferase SETDB2 OS=Homo sapiens GN=SETDB2 PE=1 SV=2 | 117 | E | 0.814461 | G | 0.728544 | 0.085917 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 3 | T | 0.44935 | I | 0.262142 | 0.187208 | No Change: Both O | Amyotrophic lateral sclerosis type 4 (ALS4) [MIM:602433] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 305 | W | 0.164581 | C | 0.187754 | -0.023173 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 332 | R | 0.499031 | W | 0.255657 | 0.243374 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 389 | L | 0.367942 | S | 0.560347 | -0.192405 | O to D | Amyotrophic lateral sclerosis type 4 (ALS4) [MIM:602433] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 413 | P | 0.030034 | L | 0.015209 | 0.014825 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 660 | A | 0.479327 | G | 0.534463 | -0.055136 | O to D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1061 | P | 0.968194 | L | 0.952118 | 0.016076 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1152 | F | 0.885771 | C | 0.921296 | -0.035525 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1192 | D | 0.953484 | E | 0.951192 | 0.002292 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1252 | G | 0.927569 | R | 0.952349 | -0.02478 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1331 | P | 0.70867 | L | 0.641294 | 0.067376 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1386 | I | 0.648133 | V | 0.694534 | -0.046401 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1756 | F | 0.110345 | S | 0.25415 | -0.143805 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1855 | T | 0.342168 | A | 0.301432 | 0.040736 | No Change: Both O | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 2136 | R | 0.698556 | H | 0.680131 | 0.018425 | No Change: Both D | Amyotrophic lateral sclerosis type 4 (ALS4) [MIM:602433] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 2213 | P | 0.384274 | L | 0.231182 | 0.153092 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 2587 | I | 0.861153 | V | 0.899117 | -0.037964 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 2612 | S | 0.958447 | G | 0.941434 | 0.017013 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 274 | M | 0.488275 | I | 0.401529 | 0.086746 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 603 | N | 0.348899 | D | 0.359898 | -0.010999 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 653 | Q | 0.626496 | K | 0.675106 | -0.04861 | No Change: Both D | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1294 | R | 0.718041 | C | 0.618113 | 0.099928 | No Change: Both D | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 2368 | P | 0.544027 | R | 0.536082 | 0.007945 | No Change: Both D | Spinocerebellar ataxia autosomal recessive type 1 (SCAR1) [MIM:606002] |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1221 | K | 0.940074 | N | 0.925379 | 0.014695 | No Change: Both D | - |
| Q7Z333 | SETX_HUMAN Probable helicase senataxin OS=Homo sapiens GN=SETX PE=1 SV=4 | 1855 | T | 0.342168 | P | 0.380033 | -0.037865 | No Change: Both O | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 300 | V | 0.50831 | M | 0.560692 | -0.052382 | No Change: Both D | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 330 | A | 0.488422 | V | 0.388123 | 0.100299 | No Change: Both O | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 546 | T | 0.614803 | A | 0.557838 | 0.056965 | No Change: Both D | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 592 | V | 0.254995 | A | 0.346135 | -0.09114 | No Change: Both O | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 736 | Y | 0.163154 | N | 0.24813 | -0.084976 | No Change: Both O | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 756 | L | 0.190897 | V | 0.192794 | -0.001897 | No Change: Both O | - |
| Q53EL9 | SEZ6_HUMAN Seizure protein 6 homolog OS=Homo sapiens GN=SEZ6 PE=1 SV=2 | 806 | M | 0.141817 | T | 0.174957 | -0.03314 | No Change: Both O | - |
| Q9BYH1 | SE6L1_HUMAN Seizure 6-like protein OS=Homo sapiens GN=SEZ6L PE=1 SV=1 | 430 | M | 0.168008 | I | 0.122812 | 0.045196 | No Change: Both O | - |
| Q9BYH1 | SE6L1_HUMAN Seizure 6-like protein OS=Homo sapiens GN=SEZ6L PE=1 SV=1 | 185 | W | 0.785083 | L | 0.862252 | -0.077169 | No Change: Both D | - |
| Q9BYH1 | SE6L1_HUMAN Seizure 6-like protein OS=Homo sapiens GN=SEZ6L PE=1 SV=1 | 52 | P | 0.968677 | L | 0.944774 | 0.023903 | No Change: Both D | - |
| Q9BYH1 | SE6L1_HUMAN Seizure 6-like protein OS=Homo sapiens GN=SEZ6L PE=1 SV=1 | 671 | Q | 0.093299 | H | 0.086498 | 0.006801 | No Change: Both O | - |
| Q6UXD5 | SE6L2_HUMAN Seizure 6-like protein 2 OS=Homo sapiens GN=SEZ6L2 PE=1 SV=2 | 74 | R | 0.856015 | P | 0.882239 | -0.026224 | No Change: Both D | - |
| Q15637 | SF01_HUMAN Splicing factor 1 OS=Homo sapiens GN=SF1 PE=1 SV=4 | 357 | S | 0.996024 | T | 0.994757 | 0.001267 | No Change: Both D | - |
| Q15459 | SF3A1_HUMAN Splicing factor 3A subunit 1 OS=Homo sapiens GN=SF3A1 PE=1 SV=1 | 511 | R | 0.659497 | W | 0.524631 | 0.134866 | No Change: Both D | A colorectal cancer sample |
| Q15393 | SF3B3_HUMAN Splicing factor 3B subunit 3 OS=Homo sapiens GN=SF3B3 PE=1 SV=4 | 908 | G | 0.043047 | R | 0.039599 | 0.003448 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 13 | H | 0.501292 | L | 0.383557 | 0.117735 | D to O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 72 | R | 0.449035 | H | 0.446806 | 0.002229 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 167 | Q | 0.402199 | H | 0.359376 | 0.042823 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 322 | Y | 0.031154 | H | 0.059963 | -0.028809 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 330 | W | 0.186127 | R | 0.329891 | -0.143764 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 549 | R | 0.274059 | Q | 0.288468 | -0.014409 | No Change: Both O | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 1087 | L | 0.932265 | P | 0.96224 | -0.029975 | No Change: Both D | - |
| A8K8P3 | SFI1_HUMAN Protein SFI1 homolog OS=Homo sapiens GN=SFI1 PE=1 SV=2 | 760 | R | 0.137785 | H | 0.103471 | 0.034314 | No Change: Both O | - |
| Q5VUG0 | SMBT2_HUMAN Scm-like with four MBT domains protein 2 OS=Homo sapiens GN=SFMBT2 PE=1 SV=1 | 675 | P | 0.917284 | R | 0.903979 | 0.013305 | No Change: Both D | - |
| P31947 | 1433S_HUMAN 14-3-3 protein sigma OS=Homo sapiens GN=SFN PE=1 SV=1 | 155 | M | 0.608645 | I | 0.511927 | 0.096718 | No Change: Both D | - |
| Q86XK3 | SFR1_HUMAN Swi5-dependent recombination DNA repair protein 1 homolog OS=Homo sapiens GN=SFR1 PE=1 SV=2 | 19 | D | 0.934473 | G | 0.924657 | 0.009816 | No Change: Both D | - |
| Q96HF1 | SFRP2_HUMAN Secreted frizzled-related protein 2 OS=Homo sapiens GN=SFRP2 PE=1 SV=2 | 45 | A | 0.252321 | V | 0.190046 | 0.062275 | No Change: Both O | - |
| Q6FHJ7 | SFRP4_HUMAN Secreted frizzled-related protein 4 OS=Homo sapiens GN=SFRP4 PE=1 SV=2 | 320 | P | 0.998562 | T | 0.998011 | 5.51E-04 | No Change: Both D | - |
| Q6FHJ7 | SFRP4_HUMAN Secreted frizzled-related protein 4 OS=Homo sapiens GN=SFRP4 PE=1 SV=2 | 340 | R | 0.999155 | K | 0.999326 | -1.71E-04 | No Change: Both D | - |
| Q5T4F7 | SFRP5_HUMAN Secreted frizzled-related protein 5 OS=Homo sapiens GN=SFRP5 PE=2 SV=3 | 7 | G | 0.63659 | A | 0.590757 | 0.045833 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 421 | L | 0.99335 | P | 0.997117 | -0.003767 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 52 | L | 0.504567 | Q | 0.615583 | -0.111016 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 122 | L | 0.666509 | F | 0.601805 | 0.064704 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 136 | L | 0.717296 | F | 0.677668 | 0.039628 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 512 | G | 0.651434 | S | 0.696605 | -0.045171 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 538 | E | 0.992256 | G | 0.990799 | 0.001457 | No Change: Both D | - |
| Q12872 | SFSWA_HUMAN Splicing factor suppressor of white-apricot homolog OS=Homo sapiens GN=SFSWAP PE=1 SV=3 | 887 | A | 0.996712 | E | 0.997238 | -5.26E-04 | No Change: Both D | - |
| Q8WV19 | SFT2A_HUMAN Vesicle transport protein SFT2A OS=Homo sapiens GN=SFT2D1 PE=1 SV=1 | 109 | I | 0.004465 | V | 0.005276 | -8.11E-04 | No Change: Both O | - |
| Q587I9 | SFT2C_HUMAN Vesicle transport protein SFT2C OS=Homo sapiens GN=SFT2D3 PE=2 SV=1 | 38 | R | 0.861103 | G | 0.853514 | 0.007589 | No Change: Both D | - |
| Q6UW10 | SFTA2_HUMAN Surfactant-associated protein 2 OS=Homo sapiens GN=SFTA2 PE=1 SV=1 | 37 | N | 0.694166 | S | 0.78588 | -0.091714 | No Change: Both D | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 9 | N | 0.052601 | T | 0.047401 | 0.0052 | No Change: Both O | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 50 | L | 0.985951 | V | 0.986916 | -9.65E-04 | No Change: Both D | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 219 | R | 0.51204 | W | 0.330453 | 0.181587 | D to O | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 223 | Q | 0.430112 | K | 0.476837 | -0.046725 | No Change: Both O | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 19 | V | 0.181416 | A | 0.239147 | -0.057731 | No Change: Both O | - |
| Q8IWL2 | SFTA1_HUMAN Pulmonary surfactant-associated protein A1 OS=Homo sapiens GN=SFTPA1 PE=1 SV=2 | 5 | P | 0.097763 | L | 0.048752 | 0.049011 | No Change: Both O | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 9 | N | 0.058931 | T | 0.054966 | 0.003965 | No Change: Both O | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 50 | V | 0.986965 | L | 0.986342 | 6.23E-04 | No Change: Both D | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 91 | A | 0.946664 | P | 0.963239 | -0.016575 | No Change: Both D | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 223 | Q | 0.430112 | K | 0.476837 | -0.046725 | No Change: Both O | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 12 | L | 0.102976 | W | 0.062172 | 0.040804 | No Change: Both O | - |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 198 | F | 0.568469 | S | 0.689725 | -0.121256 | No Change: Both D | Pulmonary fibrosis idiopathic (IPF) [MIM:178500] |
| Q8IWL1 | SFPA2_HUMAN Pulmonary surfactant-associated protein A2 OS=Homo sapiens GN=SFTPA2 PE=1 SV=1 | 231 | G | 0.233699 | V | 0.146442 | 0.087257 | No Change: Both O | Pulmonary fibrosis idiopathic (IPF) [MIM:178500] |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 131 | T | 0.357795 | I | 0.29874 | 0.059055 | No Change: Both O | - |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 228 | A | 0.122261 | R | 0.133449 | -0.011188 | No Change: Both O | - |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 228 | A | 0.122261 | I | 0.072196 | 0.050065 | No Change: Both O | - |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 176 | L | 0.891042 | F | 0.867829 | 0.023213 | No Change: Both D | - |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 272 | R | 0.186217 | H | 0.138031 | 0.048186 | No Change: Both O | - |
| P07988 | PSPB_HUMAN Pulmonary surfactant-associated protein B OS=Homo sapiens GN=SFTPB PE=1 SV=3 | 236 | R | 0.054834 | C | 0.02674 | 0.028094 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 1 (SMDP1) [MIM:265120] |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 138 | N | 0.406758 | T | 0.367528 | 0.03923 | No Change: Both O | - |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 186 | N | 0.115002 | S | 0.155126 | -0.040124 | No Change: Both O | - |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 73 | I | 0.402229 | T | 0.566526 | -0.164297 | O to D | Pulmonary surfactant metabolism dysfunction type 2 (SMDP2) [MIM:610913] |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 116 | A | 0.141974 | D | 0.186522 | -0.044548 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 2 (SMDP2) [MIM:610913] |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 167 | R | 0.757715 | Q | 0.781512 | -0.023797 | No Change: Both D | Pulmonary surfactant metabolism dysfunction type 2 (SMDP2) [MIM:610913] |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 188 | L | 0.103343 | Q | 0.171456 | -0.068113 | No Change: Both O | Pulmonary surfactant metabolism dysfunction type 2 (SMDP2) [MIM:610913] |
| P11686 | PSPC_HUMAN Pulmonary surfactant-associated protein C OS=Homo sapiens GN=SFTPC PE=1 SV=2 | 66 | E | 0.555683 | K | 0.555456 | 2.27E-04 | No Change: Both D | Pulmonary surfactant metabolism dysfunction type 2 (SMDP2) [MIM:610913] |
| P35247 | SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3 | 31 | M | 0.502489 | T | 0.53206 | -0.029571 | No Change: Both D | - |
| P35247 | SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3 | 123 | L | 0.997 | V | 0.997491 | -4.91E-04 | No Change: Both D | - |
| P35247 | SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3 | 180 | T | 0.977608 | A | 0.98234 | -0.004732 | No Change: Both D | - |
| P35247 | SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3 | 290 | S | 0.617907 | T | 0.554916 | 0.062991 | No Change: Both D | - |
| P35247 | SFTPD_HUMAN Pulmonary surfactant-associated protein D OS=Homo sapiens GN=SFTPD PE=1 SV=3 | 309 | E | 0.374634 | K | 0.385051 | -0.010417 | No Change: Both O | - |
| Q9H9B4 | SFXN1_HUMAN Sideroflexin-1 OS=Homo sapiens GN=SFXN1 PE=1 SV=4 | 26 | N | 0.168252 | S | 0.202771 | -0.034519 | No Change: Both O | - |
| Q9H9B4 | SFXN1_HUMAN Sideroflexin-1 OS=Homo sapiens GN=SFXN1 PE=1 SV=4 | 266 | P | 0.101376 | S | 0.109551 | -0.008175 | No Change: Both O | - |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 77 | R | 0.350477 | C | 0.195189 | 0.155288 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 98 | R | 0.380405 | H | 0.370135 | 0.01027 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 175 | V | 0.301607 | A | 0.382835 | -0.081228 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 284 | R | 0.382388 | C | 0.274611 | 0.107777 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 30 | P | 0.211893 | L | 0.121033 | 0.09086 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 31 | L | 0.185687 | P | 0.32727 | -0.141583 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 34 | R | 0.163776 | C | 0.082109 | 0.081667 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 34 | R | 0.163776 | H | 0.183095 | -0.019319 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 62 | Y | 0.261605 | H | 0.412508 | -0.150903 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 68 | G | 0.395177 | E | 0.438863 | -0.043686 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 74 | R | 0.311264 | W | 0.144153 | 0.167111 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 89 | L | 0.454947 | P | 0.604542 | -0.149595 | O to D | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 91 | G | 0.449796 | R | 0.442432 | 0.007364 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 93 | A | 0.431172 | V | 0.367496 | 0.063676 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 97 | D | 0.397973 | G | 0.3923 | 0.005673 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 98 | R | 0.380405 | C | 0.245397 | 0.135008 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 103 | I | 0.232584 | T | 0.38457 | -0.151986 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 124 | I | 0.380173 | T | 0.525065 | -0.144892 | O to D | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 137 | E | 0.312115 | K | 0.269646 | 0.042469 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 158 | L | 0.381446 | F | 0.336475 | 0.044971 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 196 | V | 0.373638 | I | 0.348407 | 0.025231 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 205 | P | 0.364076 | H | 0.290484 | 0.073592 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 242 | V | 0.148175 | A | 0.189798 | -0.041623 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 173 | L | 0.25532 | P | 0.404641 | -0.149321 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 228 | P | 0.315675 | Q | 0.296267 | 0.019408 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 247 | V | 0.183343 | M | 0.20704 | -0.023697 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16586 | SGCA_HUMAN Alpha-sarcoglycan OS=Homo sapiens GN=SGCA PE=1 SV=1 | 137 | E | 0.312115 | G | 0.253426 | 0.058689 | No Change: Both O | Limb-girdle muscular dystrophy type 2D (LGMD2D) [MIM:608099] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 91 | R | 0.048928 | L | 0.027853 | 0.021075 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 91 | R | 0.048928 | P | 0.06234 | -0.013412 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 100 | M | 0.540152 | K | 0.684424 | -0.144272 | No Change: Both D | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 108 | L | 0.337085 | R | 0.482104 | -0.145019 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 151 | T | 0.464078 | R | 0.462832 | 0.001246 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 11 | Q | 0.970431 | E | 0.973868 | -0.003437 | No Change: Both D | - |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 91 | R | 0.048928 | C | 0.023922 | 0.025006 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 114 | S | 0.244526 | F | 0.105546 | 0.13898 | No Change: Both O | - |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 119 | I | 0.214278 | F | 0.219419 | -0.005141 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 139 | G | 0.303507 | D | 0.317609 | -0.014102 | No Change: Both O | - |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 167 | G | 0.365299 | S | 0.45673 | -0.091431 | No Change: Both O | Limb-girdle muscular dystrophy type 2E (LGMD2E) [MIM:604286] |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 182 | T | 0.342693 | A | 0.282126 | 0.060567 | No Change: Both O | - |
| Q16585 | SGCB_HUMAN Beta-sarcoglycan OS=Homo sapiens GN=SGCB PE=1 SV=1 | 184 | Y | 0.360537 | C | 0.389472 | -0.028935 | No Change: Both O | - |
| Q92629 | SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens GN=SGCD PE=1 SV=2 | 261 | E | 0.092721 | K | 0.104031 | -0.01131 | No Change: Both O | Limb-girdle muscular dystrophy type 2F (LGMD2F) [MIM:601287] |
| Q92629 | SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens GN=SGCD PE=1 SV=2 | 96 | R | 0.390688 | Q | 0.424658 | -0.03397 | No Change: Both O | - |
| Q92629 | SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens GN=SGCD PE=1 SV=2 | 150 | S | 0.294738 | A | 0.211527 | 0.083211 | No Change: Both O | Cardiomyopathy dilated type 1L (CMD1L) [MIM:606685] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 196 | L | 0.179042 | R | 0.291729 | -0.112687 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 49 | N | 0.370259 | S | 0.411616 | -0.041357 | No Change: Both O | - |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 399 | P | 0.457403 | H | 0.392308 | 0.065095 | No Change: Both O | - |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 36 | T | 0.071196 | R | 0.069424 | 0.001772 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 60 | H | 0.087794 | P | 0.119054 | -0.03126 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 60 | H | 0.087794 | R | 0.099686 | -0.011892 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 92 | M | 0.299297 | T | 0.360387 | -0.06109 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 100 | W | 0.220238 | G | 0.428603 | -0.208365 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 112 | G | 0.365959 | R | 0.352157 | 0.013802 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 115 | Y | 0.376628 | C | 0.312949 | 0.063679 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 175 | L | 0.331576 | S | 0.530144 | -0.198568 | O to D | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 177 | S | 0.282774 | C | 0.117354 | 0.16542 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 184 | L | 0.118431 | P | 0.208913 | -0.090482 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 270 | W | 0.095896 | R | 0.25228 | -0.156384 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| O43556 | SGCE_HUMAN Epsilon-sarcoglycan OS=Homo sapiens GN=SGCE PE=1 SV=6 | 271 | C | 0.08039 | Y | 0.07566 | 0.00473 | No Change: Both O | Dystonia type 11 (DYT11) [MIM:159900] |
| Q13326 | SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens GN=SGCG PE=1 SV=4 | 116 | R | 0.62302 | H | 0.611609 | 0.011411 | No Change: Both D | - |
| Q13326 | SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens GN=SGCG PE=1 SV=4 | 283 | C | 0.340697 | Y | 0.404224 | -0.063527 | No Change: Both O | Limb-girdle muscular dystrophy type 2C (LGMD2C) [MIM:253700] |
| Q13326 | SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens GN=SGCG PE=1 SV=4 | 287 | N | 0.571085 | S | 0.604816 | -0.033731 | No Change: Both D | - |
| Q13326 | SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens GN=SGCG PE=1 SV=4 | 69 | G | 0.155724 | D | 0.166354 | -0.01063 | No Change: Both O | Limb-girdle muscular dystrophy type 2C (LGMD2C) [MIM:253700] |
| Q13326 | SGCG_HUMAN Gamma-sarcoglycan OS=Homo sapiens GN=SGCG PE=1 SV=4 | 69 | G | 0.155724 | R | 0.13648 | 0.019244 | No Change: Both O | Limb-girdle muscular dystrophy type 2C (LGMD2C) [MIM:253700] |
| Q9BQI5 | SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 OS=Homo sapiens GN=SGIP1 PE=1 SV=2 | 112 | E | 0.940819 | Q | 0.928786 | 0.012033 | No Change: Both D | - |
| Q9BQI5 | SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 OS=Homo sapiens GN=SGIP1 PE=1 SV=2 | 131 | K | 0.755748 | R | 0.701701 | 0.054047 | No Change: Both D | - |
| Q9BQI5 | SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 OS=Homo sapiens GN=SGIP1 PE=1 SV=2 | 161 | P | 0.943417 | Q | 0.921503 | 0.021914 | No Change: Both D | - |
| Q9BQI5 | SGIP1_HUMAN SH3-containing GRB2-like protein 3-interacting protein 1 OS=Homo sapiens GN=SGIP1 PE=1 SV=2 | 575 | K | 0.269385 | E | 0.268431 | 9.54E-04 | No Change: Both O | - |
| Q8NE28 | SGK71_HUMAN Protein kinase-like protein SgK071 OS=Homo sapiens GN=SGK071 PE=2 SV=4 | 473 | K | 0.522574 | E | 0.539838 | -0.017264 | No Change: Both D | - |
| Q8NE28 | SGK71_HUMAN Protein kinase-like protein SgK071 OS=Homo sapiens GN=SGK071 PE=2 SV=4 | 568 | R | 0.168642 | Q | 0.179637 | -0.010995 | No Change: Both O | - |
| Q8NE28 | SGK71_HUMAN Protein kinase-like protein SgK071 OS=Homo sapiens GN=SGK071 PE=2 SV=4 | 139 | G | 0.12062 | D | 0.15008 | -0.02946 | No Change: Both O | A glioblastoma multiforme sample |
| O00141 | SGK1_HUMAN Serine/threonine-protein kinase Sgk1 OS=Homo sapiens GN=SGK1 PE=1 SV=2 | 219 | V | 0.146588 | I | 0.138808 | 0.00778 | No Change: Both O | - |
| O00141 | SGK1_HUMAN Serine/threonine-protein kinase Sgk1 OS=Homo sapiens GN=SGK1 PE=1 SV=2 | 342 | A | 0.457062 | V | 0.391576 | 0.065486 | No Change: Both O | - |
| Q9H5K3 | SG196_HUMAN Protein kinase-like protein SgK196 OS=Homo sapiens GN=SGK196 PE=2 SV=1 | 48 | S | 0.413131 | P | 0.405152 | 0.007979 | No Change: Both O | - |
| Q9H5K3 | SG196_HUMAN Protein kinase-like protein SgK196 OS=Homo sapiens GN=SGK196 PE=2 SV=1 | 140 | Y | 0.230692 | F | 0.21935 | 0.011342 | No Change: Both O | - |
| Q9H5K3 | SG196_HUMAN Protein kinase-like protein SgK196 OS=Homo sapiens GN=SGK196 PE=2 SV=1 | 254 | V | 0.238092 | M | 0.296225 | -0.058133 | No Change: Both O | - |
| Q9H5K3 | SG196_HUMAN Protein kinase-like protein SgK196 OS=Homo sapiens GN=SGK196 PE=2 SV=1 | 301 | M | 0.247475 | T | 0.284196 | -0.036721 | No Change: Both O | - |
| Q9H5K3 | SG196_HUMAN Protein kinase-like protein SgK196 OS=Homo sapiens GN=SGK196 PE=2 SV=1 | 342 | M | 0.720154 | I | 0.509282 | 0.210872 | No Change: Both D | A lung small cell carcinoma sample |
| Q9HBY8 | SGK2_HUMAN Serine/threonine-protein kinase Sgk2 OS=Homo sapiens GN=SGK2 PE=1 SV=1 | 12 | S | 0.916103 | T | 0.904962 | 0.011141 | No Change: Both D | - |
| Q9HBY8 | SGK2_HUMAN Serine/threonine-protein kinase Sgk2 OS=Homo sapiens GN=SGK2 PE=1 SV=1 | 259 | E | 0.265356 | K | 0.249533 | 0.015823 | No Change: Both O | A lung adenocarcinoma sample |
| Q9HBY8 | SGK2_HUMAN Serine/threonine-protein kinase Sgk2 OS=Homo sapiens GN=SGK2 PE=1 SV=1 | 349 | H | 0.122774 | Y | 0.072316 | 0.050458 | No Change: Both O | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 122 | L | 0.536061 | I | 0.50119 | 0.034871 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 137 | R | 0.485403 | G | 0.493125 | -0.007722 | No Change: Both O | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 139 | V | 0.625391 | I | 0.571498 | 0.053893 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 402 | R | 0.972172 | Q | 0.974497 | -0.002325 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 567 | P | 0.997457 | L | 0.994893 | 0.002564 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 576 | S | 0.995463 | C | 0.992263 | 0.0032 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 593 | P | 0.993705 | A | 0.990416 | 0.003289 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 660 | P | 0.894242 | T | 0.894126 | 1.16E-04 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 812 | P | 0.97589 | L | 0.948679 | 0.027211 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 849 | H | 0.847863 | R | 0.85035 | -0.002487 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 1001 | S | 0.251053 | L | 0.133687 | 0.117366 | No Change: Both O | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 1039 | V | 0.524853 | M | 0.569088 | -0.044235 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 1111 | A | 0.711884 | T | 0.709654 | 0.00223 | No Change: Both D | - |
| Q86YV5 | SG223_HUMAN Tyrosine-protein kinase SgK223 OS=Homo sapiens GN=SGK223 PE=1 SV=3 | 1311 | R | 0.330603 | H | 0.287262 | 0.043341 | No Change: Both O | - |
| Q96BR1 | SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens GN=SGK3 PE=1 SV=1 | 92 | A | 0.244874 | V | 0.186587 | 0.058287 | No Change: Both O | A breast cancer sample |
| Q96BR1 | SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens GN=SGK3 PE=1 SV=1 | 355 | L | 0.066133 | P | 0.134985 | -0.068852 | No Change: Both O | - |
| Q8NHU3 | SMS2_HUMAN Phosphatidylcholine:ceramide cholinephosphotransferase 2 OS=Homo sapiens GN=SGMS2 PE=1 SV=1 | 21 | T | 0.885045 | M | 0.880172 | 0.004873 | No Change: Both D | - |
| Q5FBB7 | SGOL1_HUMAN Shugoshin-like 1 OS=Homo sapiens GN=SGOL1 PE=1 SV=1 | 171 | V | 0.640351 | A | 0.691375 | -0.051024 | No Change: Both D | - |
| Q5FBB7 | SGOL1_HUMAN Shugoshin-like 1 OS=Homo sapiens GN=SGOL1 PE=1 SV=1 | 322 | Q | 0.909111 | P | 0.922832 | -0.013721 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 9 | G | 0.537658 | D | 0.572375 | -0.034717 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 496 | I | 0.887495 | V | 0.909208 | -0.021713 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 343 | E | 0.783649 | A | 0.717581 | 0.066068 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 660 | N | 0.664735 | S | 0.710071 | -0.045336 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 1099 | I | 0.927366 | T | 0.954904 | -0.027538 | No Change: Both D | - |
| Q562F6 | SGOL2_HUMAN Shugoshin-like 2 OS=Homo sapiens GN=SGOL2 PE=1 SV=2 | 1143 | H | 0.626947 | R | 0.690092 | -0.063145 | No Change: Both D | - |
| O95470 | SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens GN=SGPL1 PE=1 SV=3 | 21 | V | 0.185242 | L | 0.199392 | -0.01415 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 40 | Y | 0.469956 | N | 0.611107 | -0.141151 | O to D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 44 | A | 0.415354 | T | 0.427741 | -0.012387 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 66 | S | 0.512497 | W | 0.209653 | 0.302844 | D to O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 74 | R | 0.644319 | C | 0.507587 | 0.136732 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 74 | R | 0.644319 | H | 0.641763 | 0.002556 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 79 | T | 0.527112 | P | 0.614391 | -0.087279 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 85 | Q | 0.498828 | R | 0.477301 | 0.021527 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 90 | G | 0.454913 | R | 0.441584 | 0.013329 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 122 | G | 0.413834 | R | 0.389287 | 0.024547 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 128 | P | 0.355882 | L | 0.194011 | 0.161871 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 131 | V | 0.243184 | M | 0.284572 | -0.041388 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 139 | T | 0.286105 | M | 0.244879 | 0.041226 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 146 | L | 0.321265 | P | 0.49339 | -0.172125 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 150 | R | 0.179972 | Q | 0.194195 | -0.014223 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 179 | D | 0.253911 | N | 0.23857 | 0.015341 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 182 | R | 0.472562 | C | 0.322321 | 0.150241 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 193 | F | 0.329627 | L | 0.336497 | -0.00687 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 206 | R | 0.384617 | P | 0.441119 | -0.056502 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 226 | V | 0.1698 | A | 0.229548 | -0.059748 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 227 | P | 0.202482 | R | 0.169837 | 0.032645 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 234 | A | 0.363794 | G | 0.389627 | -0.025833 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 235 | D | 0.349399 | V | 0.21589 | 0.133509 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 245 | R | 0.302144 | H | 0.303927 | -0.001783 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 298 | S | 0.615772 | P | 0.596563 | 0.019209 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 321 | T | 0.078032 | A | 0.064233 | 0.013799 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 354 | A | 0.250534 | P | 0.325114 | -0.07458 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 361 | V | 0.255022 | I | 0.224653 | 0.030369 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 364 | S | 0.419283 | R | 0.340479 | 0.078804 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 369 | E | 0.604364 | K | 0.600804 | 0.00356 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 377 | R | 0.528447 | C | 0.339425 | 0.189022 | D to O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 377 | R | 0.528447 | H | 0.536944 | -0.008497 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 380 | Q | 0.436894 | R | 0.445884 | -0.00899 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 386 | L | 0.250268 | R | 0.384164 | -0.133896 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 389 | N | 0.230622 | K | 0.262242 | -0.03162 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 447 | E | 0.648915 | K | 0.643948 | 0.004967 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 456 | R | 0.295176 | H | 0.282742 | 0.012434 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 394 | M | 0.230542 | I | 0.164412 | 0.06613 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 32 | D | 0.350804 | E | 0.370255 | -0.019451 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 32 | D | 0.350804 | G | 0.335637 | 0.015167 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 42 | N | 0.452266 | K | 0.46336 | -0.011094 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 84 | H | 0.494246 | Y | 0.380988 | 0.113258 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 88 | M | 0.506143 | T | 0.545154 | -0.039011 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 106 | S | 0.277197 | R | 0.219136 | 0.058061 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 150 | R | 0.179972 | W | 0.070041 | 0.109931 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 163 | L | 0.21809 | P | 0.351099 | -0.133009 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 191 | G | 0.33748 | R | 0.319492 | 0.017988 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 235 | D | 0.349399 | N | 0.342134 | 0.007265 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 251 | G | 0.226357 | A | 0.173958 | 0.052399 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 273 | D | 0.254885 | N | 0.252585 | 0.0023 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 288 | P | 0.231582 | S | 0.246054 | -0.014472 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 293 | P | 0.38741 | S | 0.414844 | -0.027434 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 293 | P | 0.38741 | T | 0.329772 | 0.057638 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 300 | E | 0.579509 | V | 0.409158 | 0.170351 | D to O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 304 | R | 0.574383 | L | 0.464184 | 0.110199 | D to O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 307 | Q | 0.384127 | P | 0.419017 | -0.03489 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 322 | I | 0.082044 | S | 0.201719 | -0.119675 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 355 | E | 0.229226 | K | 0.214376 | 0.01485 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 374 | Y | 0.599414 | H | 0.722919 | -0.123505 | No Change: Both D | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 387 | V | 0.228309 | M | 0.2985 | -0.070191 | No Change: Both O | - |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 433 | R | 0.161533 | Q | 0.156871 | 0.004662 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 433 | R | 0.161533 | W | 0.063202 | 0.098331 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 486 | V | 0.349383 | F | 0.311146 | 0.038237 | No Change: Both O | Mucopolysaccharidosis type 3A (MPS3A) [MIM:252900] |
| P51688 | SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens GN=SGSH PE=1 SV=1 | 372 | M | 0.611387 | I | 0.511378 | 0.100009 | No Change: Both D | - |
| Q2NKQ1 | SGSM1_HUMAN Small G protein signaling modulator 1 OS=Homo sapiens GN=SGSM1 PE=1 SV=2 | 802 | T | 0.967731 | P | 0.97522 | -0.007489 | No Change: Both D | - |
| Q2NKQ1 | SGSM1_HUMAN Small G protein signaling modulator 1 OS=Homo sapiens GN=SGSM1 PE=1 SV=2 | 873 | R | 0.832039 | K | 0.866776 | -0.034737 | No Change: Both D | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 63 | L | 0.34875 | M | 0.41739 | -0.06864 | No Change: Both O | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 238 | R | 0.778225 | K | 0.775206 | 0.003019 | No Change: Both D | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 244 | R | 0.616813 | S | 0.643804 | -0.026991 | No Change: Both D | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 329 | H | 0.165133 | R | 0.154974 | 0.010159 | No Change: Both O | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 374 | R | 0.624954 | Q | 0.661125 | -0.036171 | No Change: Both D | - |
| O43147 | SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens GN=SGSM2 PE=1 SV=4 | 968 | D | 0.200717 | V | 0.096328 | 0.104389 | No Change: Both O | - |
| Q96HU1 | SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens GN=SGSM3 PE=1 SV=1 | 20 | W | 0.265196 | R | 0.522492 | -0.257296 | O to D | - |
| Q96HU1 | SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens GN=SGSM3 PE=1 SV=1 | 279 | H | 0.027944 | Q | 0.030256 | -0.002312 | No Change: Both O | - |
| Q9NRF2 | SH2B1_HUMAN SH2B adapter protein 1 OS=Homo sapiens GN=SH2B1 PE=1 SV=3 | 484 | T | 0.92552 | A | 0.915019 | 0.010501 | No Change: Both D | - |
| Q9NRF2 | SH2B1_HUMAN SH2B adapter protein 1 OS=Homo sapiens GN=SH2B1 PE=1 SV=3 | 541 | V | 0.279369 | A | 0.367266 | -0.087897 | No Change: Both O | - |
| Q9UQQ2 | SH2B3_HUMAN SH2B adapter protein 3 OS=Homo sapiens GN=SH2B3 PE=2 SV=2 | 262 | W | 0.169058 | R | 0.375095 | -0.206037 | No Change: Both O | - |
| Q9UQQ2 | SH2B3_HUMAN SH2B adapter protein 3 OS=Homo sapiens GN=SH2B3 PE=2 SV=2 | 182 | F | 0.846829 | L | 0.8888 | -0.041971 | No Change: Both D | - |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 32 | R | 0.490152 | T | 0.477796 | 0.012356 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 68 | T | 0.581214 | I | 0.40786 | 0.173354 | D to O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 101 | P | 0.456854 | L | 0.296841 | 0.160013 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 55 | R | 0.248041 | L | 0.154213 | 0.093828 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 7 | Y | 0.329491 | C | 0.283492 | 0.045999 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 8 | H | 0.314255 | D | 0.355833 | -0.041578 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 16 | G | 0.537131 | D | 0.544721 | -0.00759 | No Change: Both D | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 27 | G | 0.324497 | S | 0.386011 | -0.061514 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 28 | S | 0.356826 | R | 0.287677 | 0.069149 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 31 | L | 0.470459 | P | 0.63117 | -0.160711 | O to D | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 33 | D | 0.50057 | Y | 0.339098 | 0.161472 | D to O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 42 | C | 0.041197 | W | 0.030241 | 0.010956 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 49 | G | 0.02863 | V | 0.016521 | 0.012109 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 53 | T | 0.144165 | I | 0.079757 | 0.064408 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 54 | Y | 0.208507 | C | 0.157495 | 0.051012 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 57 | S | 0.392035 | P | 0.346091 | 0.045944 | No Change: Both O | - |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 84 | I | 0.240247 | T | 0.331223 | -0.090976 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 87 | F | 0.293093 | S | 0.471453 | -0.17836 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 99 | Q | 0.340961 | P | 0.382723 | -0.041762 | No Change: Both O | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O60880 | SH21A_HUMAN SH2 domain-containing protein 1A OS=Homo sapiens GN=SH2D1A PE=1 SV=1 | 102 | V | 0.536231 | G | 0.637165 | -0.100934 | No Change: Both D | Lymphoproliferative syndrome X-linked type 1 (XLP1) [MIM:308240] |
| O14796 | SH21B_HUMAN SH2 domain-containing protein 1B OS=Homo sapiens GN=SH2D1B PE=1 SV=2 | 36 | I | 0.21166 | T | 0.340119 | -0.128459 | No Change: Both O | - |
| O14796 | SH21B_HUMAN SH2 domain-containing protein 1B OS=Homo sapiens GN=SH2D1B PE=1 SV=2 | 122 | N | 0.332065 | K | 0.364843 | -0.032778 | No Change: Both O | - |
| Q9NP31 | SH22A_HUMAN SH2 domain-containing protein 2A OS=Homo sapiens GN=SH2D2A PE=1 SV=3 | 52 | N | 0.811103 | S | 0.839871 | -0.028768 | No Change: Both D | - |
| Q9NP31 | SH22A_HUMAN SH2 domain-containing protein 2A OS=Homo sapiens GN=SH2D2A PE=1 SV=3 | 272 | R | 0.943751 | C | 0.913077 | 0.030674 | No Change: Both D | - |
| Q9BRG2 | SH23A_HUMAN SH2 domain-containing protein 3A OS=Homo sapiens GN=SH2D3A PE=1 SV=1 | 32 | N | 0.30093 | D | 0.33574 | -0.03481 | No Change: Both O | - |
| Q9BRG2 | SH23A_HUMAN SH2 domain-containing protein 3A OS=Homo sapiens GN=SH2D3A PE=1 SV=1 | 265 | E | 0.942821 | G | 0.915362 | 0.027459 | No Change: Both D | A breast cancer sample |
| Q9BRG2 | SH23A_HUMAN SH2 domain-containing protein 3A OS=Homo sapiens GN=SH2D3A PE=1 SV=1 | 223 | D | 0.96148 | G | 0.95789 | 0.00359 | No Change: Both D | - |
| Q8N5H7 | SH2D3_HUMAN SH2 domain-containing protein 3C OS=Homo sapiens GN=SH2D3C PE=1 SV=1 | 23 | L | 0.880659 | F | 0.886935 | -0.006276 | No Change: Both D | - |
| Q9H788 | SH24A_HUMAN SH2 domain-containing protein 4A OS=Homo sapiens GN=SH2D4A PE=1 SV=1 | 216 | E | 0.957292 | G | 0.92588 | 0.031412 | No Change: Both D | - |
| Q9H788 | SH24A_HUMAN SH2 domain-containing protein 4A OS=Homo sapiens GN=SH2D4A PE=1 SV=1 | 263 | G | 0.975522 | A | 0.973692 | 0.00183 | No Change: Both D | - |
| Q9H788 | SH24A_HUMAN SH2 domain-containing protein 4A OS=Homo sapiens GN=SH2D4A PE=1 SV=1 | 209 | E | 0.947924 | G | 0.91186 | 0.036064 | No Change: Both D | - |
| Q9H788 | SH24A_HUMAN SH2 domain-containing protein 4A OS=Homo sapiens GN=SH2D4A PE=1 SV=1 | 275 | S | 0.978576 | N | 0.971469 | 0.007107 | No Change: Both D | - |
| Q5SQS7 | SH24B_HUMAN SH2 domain-containing protein 4B OS=Homo sapiens GN=SH2D4B PE=2 SV=1 | 237 | H | 0.83992 | R | 0.872541 | -0.032621 | No Change: Both D | - |
| Q5SQS7 | SH24B_HUMAN SH2 domain-containing protein 4B OS=Homo sapiens GN=SH2D4B PE=2 SV=1 | 239 | S | 0.783343 | L | 0.683402 | 0.099941 | No Change: Both D | - |
| A6NKC9 | SH2D7_HUMAN SH2 domain-containing protein 7 OS=Homo sapiens GN=SH2D7 PE=4 SV=2 | 137 | M | 0.330339 | T | 0.398378 | -0.068039 | No Change: Both O | - |
| A6NKC9 | SH2D7_HUMAN SH2 domain-containing protein 7 OS=Homo sapiens GN=SH2D7 PE=4 SV=2 | 206 | R | 0.95383 | W | 0.895364 | 0.058466 | No Change: Both D | - |
| P55822 | SH3BG_HUMAN SH3 domain-binding glutamic acid-rich protein OS=Homo sapiens GN=SH3BGR PE=1 SV=3 | 188 | V | 0.989736 | A | 0.993812 | -0.004076 | No Change: Both D | - |
| P55822 | SH3BG_HUMAN SH3 domain-binding glutamic acid-rich protein OS=Homo sapiens GN=SH3BGR PE=1 SV=3 | 23 | D | 0.575015 | E | 0.588423 | -0.013408 | No Change: Both D | - |
| P55822 | SH3BG_HUMAN SH3 domain-binding glutamic acid-rich protein OS=Homo sapiens GN=SH3BGR PE=1 SV=3 | 50 | D | 0.381917 | N | 0.360723 | 0.021194 | No Change: Both O | - |
| Q9Y3L3 | 3BP1_HUMAN SH3 domain-binding protein 1 OS=Homo sapiens GN=SH3BP1 PE=1 SV=3 | 511 | P | 0.985551 | L | 0.973745 | 0.011806 | No Change: Both D | - |
| Q9Y3L3 | 3BP1_HUMAN SH3 domain-binding protein 1 OS=Homo sapiens GN=SH3BP1 PE=1 SV=3 | 656 | S | 0.987459 | F | 0.971894 | 0.015565 | No Change: Both D | - |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 415 | R | 0.984979 | P | 0.98819 | -0.003211 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 415 | R | 0.984979 | Q | 0.985691 | -7.12E-04 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 418 | P | 0.983629 | H | 0.973919 | 0.00971 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 418 | P | 0.983629 | L | 0.967763 | 0.015866 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 418 | P | 0.983629 | R | 0.980319 | 0.00331 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 420 | G | 0.983863 | E | 0.988726 | -0.004863 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| P78314 | 3BP2_HUMAN SH3 domain-binding protein 2 OS=Homo sapiens GN=SH3BP2 PE=1 SV=2 | 420 | G | 0.983863 | R | 0.98869 | -0.004827 | No Change: Both D | Cherubism (CRBM) [MIM:118400] |
| Q9P0V3 | SH3B4_HUMAN SH3 domain-binding protein 4 OS=Homo sapiens GN=SH3BP4 PE=1 SV=1 | 155 | M | 0.421343 | T | 0.453106 | -0.031763 | No Change: Both O | - |
| Q9P0V3 | SH3B4_HUMAN SH3 domain-binding protein 4 OS=Homo sapiens GN=SH3BP4 PE=1 SV=1 | 197 | A | 0.640002 | T | 0.715154 | -0.075152 | No Change: Both D | - |
| A4FU49 | SH321_HUMAN SH3 domain-containing protein 21 OS=Homo sapiens GN=SH3D21 PE=1 SV=2 | 217 | S | 0.994949 | A | 0.990691 | 0.004258 | No Change: Both D | - |
| A4FU49 | SH321_HUMAN SH3 domain-containing protein 21 OS=Homo sapiens GN=SH3D21 PE=1 SV=2 | 455 | A | 0.979377 | S | 0.985789 | -0.006412 | No Change: Both D | - |
| Q9NR46 | SHLB2_HUMAN Endophilin-B2 OS=Homo sapiens GN=SH3GLB2 PE=1 SV=1 | 305 | A | 0.947839 | V | 0.932549 | 0.01529 | No Change: Both D | - |
| Q9NR46 | SHLB2_HUMAN Endophilin-B2 OS=Homo sapiens GN=SH3GLB2 PE=1 SV=1 | 319 | P | 0.871582 | L | 0.801516 | 0.070066 | No Change: Both D | - |
| Q96B97 | SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens GN=SH3KBP1 PE=1 SV=2 | 382 | P | 0.996842 | L | 0.994032 | 0.00281 | No Change: Both D | - |
| Q5TCZ1 | SPD2A_HUMAN SH3 and PX domain-containing protein 2A OS=Homo sapiens GN=SH3PXD2A PE=1 SV=1 | 659 | K | 0.996488 | Q | 0.995694 | 7.94E-04 | No Change: Both D | - |
| Q5TCZ1 | SPD2A_HUMAN SH3 and PX domain-containing protein 2A OS=Homo sapiens GN=SH3PXD2A PE=1 SV=1 | 1035 | R | 0.938588 | Q | 0.935257 | 0.003331 | No Change: Both D | - |
| Q5TCZ1 | SPD2A_HUMAN SH3 and PX domain-containing protein 2A OS=Homo sapiens GN=SH3PXD2A PE=1 SV=1 | 1073 | L | 0.304652 | P | 0.482343 | -0.177691 | No Change: Both O | - |
| A1X283 | SPD2B_HUMAN SH3 and PX domain-containing protein 2B OS=Homo sapiens GN=SH3PXD2B PE=1 SV=3 | 101 | Y | 0.109822 | F | 0.106134 | 0.003688 | No Change: Both O | - |
| A1X283 | SPD2B_HUMAN SH3 and PX domain-containing protein 2B OS=Homo sapiens GN=SH3PXD2B PE=1 SV=3 | 43 | R | 0.250407 | W | 0.110956 | 0.139451 | No Change: Both O | Frank-Ter Haar syndrome (FTHS) [MIM:249420] |
| Q7Z6J0 | SH3R1_HUMAN E3 ubiquitin-protein ligase SH3RF1 OS=Homo sapiens GN=SH3RF1 PE=1 SV=2 | 663 | P | 0.916311 | S | 0.917944 | -0.001633 | No Change: Both D | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 267 | R | 0.810924 | C | 0.751654 | 0.05927 | No Change: Both D | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 592 | W | 0.68553 | R | 0.826605 | -0.141075 | No Change: Both D | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 687 | V | 0.737516 | I | 0.71314 | 0.024376 | No Change: Both D | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 710 | G | 0.727425 | A | 0.707646 | 0.019779 | No Change: Both D | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 16 | F | 0.229464 | S | 0.383367 | -0.153903 | No Change: Both O | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 174 | F | 0.416789 | V | 0.469739 | -0.05295 | No Change: Both O | - |
| Q8TEC5 | SH3R2_HUMAN Putative E3 ubiquitin-protein ligase SH3RF2 OS=Homo sapiens GN=SH3RF2 PE=1 SV=3 | 477 | R | 0.837848 | Q | 0.843269 | -0.005421 | No Change: Both D | - |
| Q8TE82 | S3TC1_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 1 OS=Homo sapiens GN=SH3TC1 PE=1 SV=3 | 785 | R | 0.508052 | C | 0.407541 | 0.100511 | D to O | - |
| Q8TE82 | S3TC1_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 1 OS=Homo sapiens GN=SH3TC1 PE=1 SV=3 | 291 | D | 0.55222 | N | 0.509623 | 0.042597 | No Change: Both D | - |
| Q8TE82 | S3TC1_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 1 OS=Homo sapiens GN=SH3TC1 PE=1 SV=3 | 437 | L | 0.940529 | P | 0.9701 | -0.029571 | No Change: Both D | - |
| Q8TE82 | S3TC1_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 1 OS=Homo sapiens GN=SH3TC1 PE=1 SV=3 | 719 | R | 0.140077 | H | 0.144576 | -0.004499 | No Change: Both O | A colorectal cancer sample |
| Q8TE82 | S3TC1_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 1 OS=Homo sapiens GN=SH3TC1 PE=1 SV=3 | 1130 | A | 0.306437 | T | 0.318324 | -0.011887 | No Change: Both O | A colorectal cancer sample |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 468 | A | 0.374268 | S | 0.464253 | -0.089985 | No Change: Both O | - |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 529 | R | 0.061999 | Q | 0.064485 | -0.002486 | No Change: Both O | Charcot-Marie-Tooth disease type 4C (CMT4C) [MIM:601596] |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 657 | E | 0.321439 | K | 0.29396 | 0.027479 | No Change: Both O | Charcot-Marie-Tooth disease type 4C (CMT4C) [MIM:601596] |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 658 | R | 0.335204 | C | 0.209774 | 0.12543 | No Change: Both O | Charcot-Marie-Tooth disease type 4C (CMT4C) [MIM:601596] |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 171 | G | 0.08406 | E | 0.111481 | -0.027421 | No Change: Both O | - |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 696 | H | 0.504818 | R | 0.496423 | 0.008395 | D to O | - |
| Q8TF17 | S3TC2_HUMAN SH3 domain and tetratricopeptide repeats-containing protein 2 OS=Homo sapiens GN=SH3TC2 PE=1 SV=2 | 169 | Y | 0.09512 | H | 0.170953 | -0.075833 | No Change: Both O | Mononeuropathy of the median nerve mild (MNMN) [MIM:613353] |
| Q9Y566 | SHAN1_HUMAN SH3 and multiple ankyrin repeat domains protein 1 OS=Homo sapiens GN=SHANK1 PE=1 SV=2 | 1504 | V | 0.963502 | A | 0.970734 | -0.007232 | No Change: Both D | - |
| Q9Y566 | SHAN1_HUMAN SH3 and multiple ankyrin repeat domains protein 1 OS=Homo sapiens GN=SHANK1 PE=1 SV=2 | 569 | A | 0.603669 | D | 0.614734 | -0.011065 | No Change: Both D | A colorectal cancer sample |
| Q9Y566 | SHAN1_HUMAN SH3 and multiple ankyrin repeat domains protein 1 OS=Homo sapiens GN=SHANK1 PE=1 SV=2 | 2026 | G | 0.902688 | R | 0.906233 | -0.003545 | No Change: Both D | A colorectal cancer sample |
| Q9Y566 | SHAN1_HUMAN SH3 and multiple ankyrin repeat domains protein 1 OS=Homo sapiens GN=SHANK1 PE=1 SV=2 | 6 | A | 0.998172 | V | 0.996659 | 0.001513 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 12 | R | 0.196647 | C | 0.115908 | 0.080739 | No Change: Both O | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 198 | A | 0.335812 | G | 0.367097 | -0.031285 | No Change: Both O | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 224 | A | 0.337431 | T | 0.368493 | -0.031062 | No Change: Both O | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 245 | I | 0.364961 | T | 0.52523 | -0.160269 | O to D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 300 | R | 0.10451 | C | 0.050316 | 0.054194 | No Change: Both O | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 494 | H | 0.412157 | Q | 0.442449 | -0.030292 | No Change: Both O | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 537 | R | 0.778302 | W | 0.616509 | 0.161793 | No Change: Both D | Schizophrenia type 15 (SCZD15) [MIM:613950] |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 721 | A | 0.894485 | T | 0.897754 | -0.003269 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 953 | S | 0.899034 | T | 0.84473 | 0.054304 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1011 | G | 0.875342 | V | 0.806293 | 0.069049 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1135 | P | 0.962986 | H | 0.943815 | 0.019171 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1299 | R | 0.847194 | K | 0.830569 | 0.016625 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1334 | V | 0.975042 | G | 0.982263 | -0.007221 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1556 | I | 0.91688 | V | 0.927534 | -0.010654 | No Change: Both D | - |
| Q9BYB0 | SHAN3_HUMAN SH3 and multiple ankyrin repeat domains protein 3 OS=Homo sapiens GN=SHANK3 PE=1 SV=2 | 1655 | P | 0.991475 | T | 0.984075 | 0.0074 | No Change: Both D | - |
| Q9H0F6 | SHRPN_HUMAN Sharpin OS=Homo sapiens GN=SHARPIN PE=1 SV=1 | 282 | S | 0.278181 | T | 0.205604 | 0.072577 | No Change: Both O | - |
| Q9H0F6 | SHRPN_HUMAN Sharpin OS=Homo sapiens GN=SHARPIN PE=1 SV=1 | 294 | P | 0.42208 | S | 0.418739 | 0.003341 | No Change: Both O | - |
| Q9H0F6 | SHRPN_HUMAN Sharpin OS=Homo sapiens GN=SHARPIN PE=1 SV=1 | 311 | P | 0.869922 | R | 0.847349 | 0.022573 | No Change: Both D | - |
| P04278 | SHBG_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=2 | 356 | D | 0.550279 | N | 0.545554 | 0.004725 | No Change: Both D | - |
| P04278 | SHBG_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=2 | 25 | R | 0.434442 | H | 0.379799 | 0.054643 | No Change: Both O | - |
| P04278 | SHBG_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=2 | 185 | P | 0.259132 | L | 0.15962 | 0.099512 | No Change: Both O | - |
| P04278 | SHBG_HUMAN Sex hormone-binding globulin OS=Homo sapiens GN=SHBG PE=1 SV=2 | 22 | R | 0.362742 | H | 0.30308 | 0.059662 | No Change: Both O | - |
| P29353 | SHC1_HUMAN SHC-transforming protein 1 OS=Homo sapiens GN=SHC1 PE=1 SV=4 | 205 | A | 0.673093 | V | 0.606583 | 0.06651 | No Change: Both D | - |
| P29353 | SHC1_HUMAN SHC-transforming protein 1 OS=Homo sapiens GN=SHC1 PE=1 SV=4 | 410 | M | 0.924315 | V | 0.916139 | 0.008176 | No Change: Both D | - |
| Q6S5L8 | SHC4_HUMAN SHC-transforming protein 4 OS=Homo sapiens GN=SHC4 PE=1 SV=1 | 52 | N | 0.919062 | D | 0.924943 | -0.005881 | No Change: Both D | - |
| Q6S5L8 | SHC4_HUMAN SHC-transforming protein 4 OS=Homo sapiens GN=SHC4 PE=1 SV=1 | 244 | K | 0.403592 | E | 0.367385 | 0.036207 | No Change: Both O | - |
| Q6S5L8 | SHC4_HUMAN SHC-transforming protein 4 OS=Homo sapiens GN=SHC4 PE=1 SV=1 | 400 | Q | 0.313035 | H | 0.241225 | 0.07181 | No Change: Both O | - |
| Q6S5L8 | SHC4_HUMAN SHC-transforming protein 4 OS=Homo sapiens GN=SHC4 PE=1 SV=1 | 447 | D | 0.5114 | G | 0.500923 | 0.010477 | No Change: Both D | - |
| Q8NEM2 | SHCBP_HUMAN SHC SH2 domain-binding protein 1 OS=Homo sapiens GN=SHCBP1 PE=1 SV=3 | 21 | M | 0.594116 | T | 0.57046 | 0.023656 | No Change: Both D | - |
| Q8NEM2 | SHCBP_HUMAN SHC SH2 domain-binding protein 1 OS=Homo sapiens GN=SHCBP1 PE=1 SV=3 | 60 | M | 0.603119 | R | 0.658972 | -0.055853 | No Change: Both D | - |
| Q9BZQ2 | SHP1L_HUMAN SHC SH2 domain-binding protein 1-like protein OS=Homo sapiens GN=SHCBP1L PE=1 SV=2 | 563 | V | 0.260177 | M | 0.312385 | -0.052208 | No Change: Both O | - |
| Q96IW2 | SHD_HUMAN SH2 domain-containing adapter protein D OS=Homo sapiens GN=SHD PE=2 SV=1 | 138 | G | 0.79473 | S | 0.818649 | -0.023919 | No Change: Both D | - |
| Q96IW2 | SHD_HUMAN SH2 domain-containing adapter protein D OS=Homo sapiens GN=SHD PE=2 SV=1 | 270 | N | 0.587574 | S | 0.667189 | -0.079615 | No Change: Both D | - |
| P60896 | DSS1_HUMAN 26S proteasome complex subunit DSS1 OS=Homo sapiens GN=SHFM1 PE=1 SV=1 | 17 | D | 0.862578 | G | 0.823176 | 0.039402 | No Change: Both D | - |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 31 | G | 0.629911 | R | 0.624079 | 0.005832 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 117 | W | 0.173134 | G | 0.334864 | -0.16173 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 117 | W | 0.173134 | R | 0.34244 | -0.169306 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 88 | D | 0.515055 | V | 0.336424 | 0.178631 | D to O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 100 | Q | 0.345057 | H | 0.323404 | 0.021653 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 115 | N | 0.135624 | K | 0.167082 | -0.031458 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 188 | E | 0.616798 | Q | 0.568978 | 0.04782 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 222 | D | 0.448049 | N | 0.391269 | 0.05678 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 224 | V | 0.442614 | E | 0.601819 | -0.159205 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 226 | A | 0.41648 | T | 0.43528 | -0.0188 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 236 | S | 0.189375 | R | 0.18509 | 0.004285 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 290 | G | 0.911058 | D | 0.907948 | 0.00311 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 383 | A | 0.186272 | T | 0.182865 | 0.003407 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 424 | P | 0.570112 | A | 0.542877 | 0.027235 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 436 | S | 0.080638 | L | 0.039672 | 0.040966 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 111 | I | 0.12389 | F | 0.124558 | -6.68E-04 | No Change: Both O | Solitary median maxillary central incisor (SMMCI) [MIM:147250] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 6 | R | 0.174151 | T | 0.116149 | 0.058002 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 110 | A | 0.139839 | D | 0.195437 | -0.055598 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 150 | T | 0.556481 | R | 0.579262 | -0.022781 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 271 | L | 0.324395 | P | 0.452779 | -0.128384 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 332 | V | 0.296843 | A | 0.384059 | -0.087216 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 332 | V | 0.296843 | A | 0.384059 | -0.087216 | No Change: Both O | Solitary median maxillary central incisor (SMMCI) [MIM:147250] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 347 | P | 0.292212 | Q | 0.290074 | 0.002138 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 354 | I | 0.097691 | T | 0.177926 | -0.080235 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 381 | R | 0.199567 | P | 0.226569 | -0.027002 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 27 | G | 0.461283 | A | 0.390517 | 0.070766 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 111 | I | 0.12389 | N | 0.263189 | -0.139299 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 140 | H | 0.63011 | P | 0.637855 | -0.007745 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 140 | H | 0.63011 | Q | 0.624457 | 0.005653 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 183 | C | 0.361592 | F | 0.376704 | -0.015112 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 267 | T | 0.2654 | I | 0.174902 | 0.090498 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 373 | A | 0.224151 | T | 0.22852 | -0.004369 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 17 | L | 0.142933 | P | 0.247342 | -0.104409 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 26 | P | 0.393613 | L | 0.255594 | 0.138019 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 39 | L | 0.509938 | P | 0.646852 | -0.136914 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 53 | E | 0.453326 | K | 0.484581 | -0.031255 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 83 | D | 0.46073 | V | 0.276012 | 0.184718 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 84 | I | 0.446887 | F | 0.455065 | -0.008178 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 102 | C | 0.344433 | R | 0.509275 | -0.164842 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 102 | C | 0.344433 | Y | 0.381214 | -0.036781 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 109 | L | 0.160486 | F | 0.132851 | 0.027635 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 110 | A | 0.139839 | T | 0.153121 | -0.013282 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 124 | V | 0.265411 | M | 0.314895 | -0.049484 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 136 | E | 0.787657 | K | 0.775067 | 0.01259 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 143 | G | 0.454015 | D | 0.50519 | -0.051175 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 144 | R | 0.42365 | P | 0.457786 | -0.034136 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 147 | D | 0.45388 | N | 0.410543 | 0.043337 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 150 | T | 0.556481 | K | 0.606104 | -0.049623 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 156 | S | 0.560519 | R | 0.517204 | 0.043315 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 170 | F | 0.083745 | C | 0.086277 | -0.002532 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 171 | D | 0.090555 | H | 0.079002 | 0.011553 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 183 | C | 0.361592 | R | 0.518499 | -0.156907 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 183 | C | 0.361592 | Y | 0.422445 | -0.060853 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 184 | S | 0.419533 | L | 0.218012 | 0.201521 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 196 | G | 0.505414 | E | 0.541481 | -0.036067 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 197 | G | 0.484776 | V | 0.340422 | 0.144354 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 198 | C | 0.453153 | F | 0.479541 | -0.026388 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 198 | C | 0.453153 | S | 0.687171 | -0.234018 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 218 | L | 0.502383 | P | 0.623737 | -0.121354 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 231 | G | 0.330552 | V | 0.229619 | 0.100933 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 232 | R | 0.289135 | G | 0.296175 | -0.00704 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 234 | L | 0.224906 | P | 0.342457 | -0.117551 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 236 | S | 0.189375 | N | 0.15191 | 0.037465 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 241 | F | 0.229463 | L | 0.260429 | -0.030966 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 241 | F | 0.229463 | V | 0.239717 | -0.010254 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 255 | I | 0.210808 | N | 0.356877 | -0.146069 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 275 | A | 0.468916 | E | 0.543637 | -0.074721 | O to D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 280 | S | 0.711092 | W | 0.496649 | 0.214443 | D to O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 296 | G | 0.890487 | A | 0.876762 | 0.013725 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 310 | R | 0.71343 | C | 0.600809 | 0.112621 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 321 | R | 0.524431 | S | 0.533613 | -0.009182 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 346 | A | 0.329196 | V | 0.229962 | 0.099234 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 347 | P | 0.292212 | L | 0.174521 | 0.117691 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 347 | P | 0.292212 | R | 0.258171 | 0.034041 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 362 | S | 0.058429 | L | 0.026073 | 0.032356 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 363 | C | 0.068989 | Y | 0.090699 | -0.02171 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 364 | Y | 0.080017 | C | 0.073169 | 0.006848 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 374 | H | 0.220915 | R | 0.222542 | -0.001627 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 376 | A | 0.237319 | D | 0.288242 | -0.050923 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 377 | F | 0.233398 | S | 0.42845 | -0.195052 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 382 | L | 0.202659 | P | 0.329695 | -0.127036 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 391 | A | 0.497796 | T | 0.496429 | 0.001367 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 416 | T | 0.542472 | A | 0.556045 | -0.013573 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 435 | Y | 0.089659 | N | 0.146241 | -0.056582 | No Change: Both O | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| Q15465 | SHH_HUMAN Sonic hedgehog protein OS=Homo sapiens GN=SHH PE=1 SV=1 | 456 | G | 0.594902 | R | 0.581337 | 0.013565 | No Change: Both D | Holoprosencephaly type 3 (HPE3) [MIM:142945] |
| A0PJX4 | SHSA3_HUMAN Protein shisa-3 homolog OS=Homo sapiens GN=SHISA3 PE=2 SV=1 | 13 | W | 0.029806 | C | 0.038742 | -0.008936 | No Change: Both O | - |
| Q96DD7 | SHSA4_HUMAN Protein shisa-4 OS=Homo sapiens GN=SHISA4 PE=2 SV=3 | 159 | I | 0.981941 | M | 0.988438 | -0.006497 | No Change: Both D | - |
| Q8N114 | SHSA5_HUMAN Protein shisa-5 OS=Homo sapiens GN=SHISA5 PE=2 SV=1 | 216 | G | 0.941476 | R | 0.939274 | 0.002202 | No Change: Both D | - |
| Q8TBC3 | SHKB1_HUMAN SH3KBP1-binding protein 1 OS=Homo sapiens GN=SHKBP1 PE=1 SV=2 | 507 | Q | 0.352285 | L | 0.208063 | 0.144222 | No Change: Both O | - |
| P34896 | GLYC_HUMAN Serine hydroxymethyltransferase cytosolic OS=Homo sapiens GN=SHMT1 PE=1 SV=1 | 474 | L | 0.332248 | F | 0.312762 | 0.019486 | No Change: Both O | - |
| P34896 | GLYC_HUMAN Serine hydroxymethyltransferase cytosolic OS=Homo sapiens GN=SHMT1 PE=1 SV=1 | 340 | E | 0.236806 | Q | 0.186909 | 0.049897 | No Change: Both O | - |
| Q9UQ13 | SHOC2_HUMAN Leucine-rich repeat protein SHOC-2 OS=Homo sapiens GN=SHOC2 PE=1 SV=2 | 2 | S | 0.998883 | G | 0.998263 | 6.20E-04 | No Change: Both D | Noonan syndrome-like disorder with loose anagen hair (NSLH) [MIM:607721] |
| O15266 | SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens GN=SHOX PE=1 SV=1 | 173 | R | 0.599694 | C | 0.466371 | 0.133323 | D to O | Leri-Weill dyschondrosteosis (LWD) [MIM:127300] |
| O15266 | SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens GN=SHOX PE=1 SV=1 | 132 | L | 0.720446 | V | 0.670933 | 0.049513 | No Change: Both D | Leri-Weill dyschondrosteosis (LWD) [MIM:127300] |
| O15266 | SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens GN=SHOX PE=1 SV=1 | 153 | R | 0.524116 | L | 0.405945 | 0.118171 | D to O | Leri-Weill dyschondrosteosis (LWD) [MIM:127300] |
| O15266 | SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens GN=SHOX PE=1 SV=1 | 168 | R | 0.296335 | W | 0.129727 | 0.166608 | No Change: Both O | Langer mesomelic dysplasia (LMD) [MIM:249700] |
| Q9UHJ6 | SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens GN=SHPK PE=1 SV=3 | 215 | E | 0.448649 | K | 0.450427 | -0.001778 | No Change: Both O | - |
| Q9UHJ6 | SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens GN=SHPK PE=1 SV=3 | 421 | D | 0.229691 | E | 0.262379 | -0.032688 | No Change: Both O | - |
| Q9UHJ6 | SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens GN=SHPK PE=1 SV=3 | 434 | L | 0.534792 | M | 0.598901 | -0.064109 | No Change: Both D | - |
| Q149N8 | SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens GN=SHPRH PE=1 SV=2 | 438 | Q | 0.46063 | R | 0.457188 | 0.003442 | No Change: Both O | An ovarian cancer cell line |
| Q149N8 | SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens GN=SHPRH PE=1 SV=2 | 460 | S | 0.267261 | F | 0.115807 | 0.151454 | No Change: Both O | A melanoma cell line |
| Q149N8 | SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens GN=SHPRH PE=1 SV=2 | 1028 | N | 0.149426 | Y | 0.096266 | 0.05316 | No Change: Both O | A melanoma cell line |
| Q149N8 | SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens GN=SHPRH PE=1 SV=2 | 1222 | V | 0.469093 | D | 0.56741 | -0.098317 | O to D | - |
| Q6PI26 | SHQ1_HUMAN Protein SHQ1 homolog OS=Homo sapiens GN=SHQ1 PE=1 SV=2 | 140 | S | 0.547512 | I | 0.341899 | 0.205613 | D to O | - |
| Q6PI26 | SHQ1_HUMAN Protein SHQ1 homolog OS=Homo sapiens GN=SHQ1 PE=1 SV=2 | 489 | S | 0.867404 | N | 0.829699 | 0.037705 | No Change: Both D | - |
| Q2M3G4 | SHRM1_HUMAN Protein Shroom1 OS=Homo sapiens GN=SHROOM1 PE=1 SV=1 | 180 | P | 0.982914 | L | 0.968841 | 0.014073 | No Change: Both D | - |
| Q13796 | SHRM2_HUMAN Protein Shroom2 OS=Homo sapiens GN=SHROOM2 PE=1 SV=1 | 1607 | L | 0.573087 | F | 0.488636 | 0.084451 | D to O | - |
| Q13796 | SHRM2_HUMAN Protein Shroom2 OS=Homo sapiens GN=SHROOM2 PE=1 SV=1 | 1245 | D | 0.74923 | H | 0.761253 | -0.012023 | No Change: Both D | A breast cancer sample |
| Q13796 | SHRM2_HUMAN Protein Shroom2 OS=Homo sapiens GN=SHROOM2 PE=1 SV=1 | 942 | D | 0.979922 | E | 0.984407 | -0.004485 | No Change: Both D | - |
| Q13796 | SHRM2_HUMAN Protein Shroom2 OS=Homo sapiens GN=SHROOM2 PE=1 SV=1 | 1475 | I | 0.201815 | V | 0.249779 | -0.047964 | No Change: Both O | - |
| Q8TF72 | SHRM3_HUMAN Protein Shroom3 OS=Homo sapiens GN=SHROOM3 PE=1 SV=2 | 147 | L | 0.802595 | H | 0.859671 | -0.057076 | No Change: Both D | - |
| Q8TF72 | SHRM3_HUMAN Protein Shroom3 OS=Homo sapiens GN=SHROOM3 PE=1 SV=2 | 279 | G | 0.821112 | A | 0.789781 | 0.031331 | No Change: Both D | - |
| Q8TF72 | SHRM3_HUMAN Protein Shroom3 OS=Homo sapiens GN=SHROOM3 PE=1 SV=2 | 469 | P | 0.813952 | A | 0.731666 | 0.082286 | No Change: Both D | - |
| Q8TF72 | SHRM3_HUMAN Protein Shroom3 OS=Homo sapiens GN=SHROOM3 PE=1 SV=2 | 1290 | P | 0.550614 | L | 0.394009 | 0.156605 | D to O | - |
| Q9ULL8 | SHRM4_HUMAN Protein Shroom4 OS=Homo sapiens GN=SHROOM4 PE=1 SV=3 | 970 | D | 0.603556 | G | 0.615947 | -0.012391 | No Change: Both D | - |
| Q9ULL8 | SHRM4_HUMAN Protein Shroom4 OS=Homo sapiens GN=SHROOM4 PE=1 SV=3 | 1089 | S | 0.843766 | L | 0.759887 | 0.083879 | No Change: Both D | Mental retardation syndromic X-linked Stocco dos Santos type (SDSX) [MIM:300434] |
| Q9ULL8 | SHRM4_HUMAN Protein Shroom4 OS=Homo sapiens GN=SHROOM4 PE=1 SV=3 | 722 | R | 0.663326 | H | 0.658754 | 0.004572 | No Change: Both D | - |
| Q9ULL8 | SHRM4_HUMAN Protein Shroom4 OS=Homo sapiens GN=SHROOM4 PE=1 SV=3 | 807 | I | 0.937125 | T | 0.968987 | -0.031862 | No Change: Both D | - |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1098 | Q | 0.125758 | P | 0.134642 | -0.008884 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 15 | V | 0.015482 | F | 0.013122 | 0.00236 | No Change: Both O | - |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 117 | Q | 0.448114 | R | 0.424502 | 0.023612 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 231 | T | 0.304822 | A | 0.276917 | 0.027905 | No Change: Both O | - |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 341 | L | 0.23094 | P | 0.406293 | -0.175353 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 577 | V | 0.326554 | G | 0.453776 | -0.127222 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 594 | S | 0.524386 | P | 0.479376 | 0.04501 | D to O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 620 | L | 0.113487 | P | 0.209017 | -0.09553 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 694 | T | 0.047838 | P | 0.06039 | -0.012552 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1073 | G | 0.31765 | D | 0.346903 | -0.029253 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1229 | C | 0.057146 | Y | 0.081098 | -0.023952 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1367 | R | 0.16285 | G | 0.166782 | -0.003932 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1523 | M | 0.186879 | I | 0.123892 | 0.062987 | No Change: Both O | - |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1745 | F | 0.200931 | C | 0.195335 | 0.005596 | No Change: Both O | Congenital sucrase-isomaltase deficiency (CSID) [MIM:222900] |
| P14410 | SUIS_HUMAN Sucrase-isomaltase intestinal OS=Homo sapiens GN=SI PE=1 SV=6 | 1802 | T | 0.349802 | S | 0.42029 | -0.070488 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 71 | K | 0.475989 | R | 0.408728 | 0.067261 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 467 | A | 0.261725 | V | 0.205068 | 0.056657 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 3 | A | 0.636736 | G | 0.728511 | -0.091775 | No Change: Both D | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 33 | N | 0.153757 | S | 0.179632 | -0.025875 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 62 | R | 0.328399 | H | 0.333745 | -0.005346 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 64 | G | 0.356284 | S | 0.401877 | -0.045593 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 89 | M | 0.367483 | V | 0.313195 | 0.054288 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 161 | Q | 0.44329 | K | 0.473921 | -0.030631 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 196 | C | 0.024866 | F | 0.029199 | -0.004333 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 212 | G | 0.114605 | R | 0.102909 | 0.011696 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 230 | R | 0.395109 | W | 0.216673 | 0.178436 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 266 | C | 0.085021 | G | 0.192355 | -0.107334 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 309 | Q | 0.580278 | P | 0.582212 | -0.001934 | No Change: Both D | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 312 | T | 0.535696 | M | 0.488269 | 0.047427 | D to O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 314 | R | 0.387742 | H | 0.373751 | 0.013991 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 349 | Y | 0.343846 | C | 0.393671 | -0.049825 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 393 | R | 0.22267 | H | 0.225605 | -0.002935 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 400 | K | 0.368445 | N | 0.343228 | 0.025217 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 404 | F | 0.402723 | S | 0.593056 | -0.190333 | O to D | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 447 | H | 0.15287 | R | 0.165859 | -0.012989 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 456 | M | 0.33356 | I | 0.243705 | 0.089855 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 462 | Q | 0.398007 | R | 0.379874 | 0.018133 | No Change: Both O | - |
| Q9HAT2 | SIAE_HUMAN Sialate O-acetylesterase OS=Homo sapiens GN=SIAE PE=1 SV=1 | 479 | R | 0.051637 | C | 0.028261 | 0.023376 | No Change: Both O | Autoimmune disease type 6 (AIS6) [MIM:613551] |
| Q9NXL6 | SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens GN=SIDT1 PE=2 SV=2 | 78 | V | 0.268142 | M | 0.303438 | -0.035296 | No Change: Both O | - |
| Q9NXL6 | SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens GN=SIDT1 PE=2 SV=2 | 363 | T | 0.850274 | I | 0.825901 | 0.024373 | No Change: Both D | - |
| Q9NXL6 | SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens GN=SIDT1 PE=2 SV=2 | 3 | G | 0.644936 | S | 0.728327 | -0.083391 | No Change: Both D | - |
| Q8NBJ9 | SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens GN=SIDT2 PE=1 SV=2 | 631 | T | 0.064753 | M | 0.052102 | 0.012651 | No Change: Both O | - |
| Q8NBJ9 | SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens GN=SIDT2 PE=1 SV=2 | 636 | V | 0.017039 | I | 0.016802 | 2.37E-04 | No Change: Both O | - |
| Q6IA17 | SIGIR_HUMAN Single Ig IL-1-related receptor OS=Homo sapiens GN=SIGIRR PE=1 SV=3 | 312 | Q | 0.507995 | R | 0.50289 | 0.005105 | No Change: Both D | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 239 | K | 0.280875 | R | 0.220742 | 0.060133 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 919 | H | 0.308871 | P | 0.403718 | -0.094847 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 1519 | A | 0.382859 | P | 0.45882 | -0.075961 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 974 | A | 0.432936 | V | 0.334892 | 0.098044 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 1335 | S | 0.710838 | Y | 0.526403 | 0.184435 | No Change: Both D | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 221 | V | 0.269387 | M | 0.330428 | -0.061041 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 141 | V | 0.475726 | L | 0.459282 | 0.016444 | No Change: Both O | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 464 | R | 0.864806 | H | 0.864435 | 3.71E-04 | No Change: Both D | - |
| Q9BZZ2 | SN_HUMAN Sialoadhesin OS=Homo sapiens GN=SIGLEC1 PE=1 SV=2 | 1487 | R | 0.157028 | W | 0.067167 | 0.089861 | No Change: Both O | - |
| Q96LC7 | SIG10_HUMAN Sialic acid-binding Ig-like lectin 10 OS=Homo sapiens GN=SIGLEC10 PE=1 SV=3 | 226 | A | 0.450958 | V | 0.406785 | 0.044173 | No Change: Both O | - |
| Q96LC7 | SIG10_HUMAN Sialic acid-binding Ig-like lectin 10 OS=Homo sapiens GN=SIGLEC10 PE=1 SV=3 | 520 | R | 0.318517 | S | 0.396446 | -0.077929 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 81 | P | 0.48863 | T | 0.441413 | 0.047217 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 478 | T | 0.244246 | M | 0.21322 | 0.031026 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 494 | Y | 0.005584 | S | 0.01631 | -0.010726 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 217 | H | 0.353715 | Q | 0.40003 | -0.046315 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 81 | P | 0.48863 | H | 0.440721 | 0.047909 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 82 | A | 0.509736 | V | 0.433802 | 0.075934 | D to O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 218 | G | 0.299702 | R | 0.294192 | 0.00551 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 398 | H | 0.305302 | Y | 0.210569 | 0.094733 | No Change: Both O | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 586 | Y | 0.668452 | C | 0.678129 | -0.009677 | No Change: Both D | - |
| Q96PQ1 | SIG12_HUMAN Sialic acid-binding Ig-like lectin 12 OS=Homo sapiens GN=SIGLEC12 PE=2 SV=1 | 546 | P | 0.947213 | Q | 0.932749 | 0.014464 | No Change: Both D | - |
| Q6ZMC9 | SIG15_HUMAN Sialic acid-binding Ig-like lectin 15 OS=Homo sapiens GN=SIGLEC15 PE=1 SV=1 | 273 | F | 0.206704 | L | 0.264113 | -0.057409 | No Change: Both O | - |
| O15389 | SIGL5_HUMAN Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens GN=SIGLEC5 PE=1 SV=1 | 72 | V | 0.224016 | A | 0.294539 | -0.070523 | No Change: Both O | - |
| O15389 | SIGL5_HUMAN Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens GN=SIGLEC5 PE=1 SV=1 | 215 | M | 0.616609 | V | 0.578712 | 0.037897 | No Change: Both D | - |
| O15389 | SIGL5_HUMAN Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens GN=SIGLEC5 PE=1 SV=1 | 322 | F | 0.096474 | S | 0.220489 | -0.124015 | No Change: Both O | - |
| O15389 | SIGL5_HUMAN Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens GN=SIGLEC5 PE=1 SV=1 | 499 | P | 0.974293 | A | 0.959375 | 0.014918 | No Change: Both D | - |
| O15389 | SIGL5_HUMAN Sialic acid-binding Ig-like lectin 5 OS=Homo sapiens GN=SIGLEC5 PE=1 SV=1 | 358 | R | 0.665711 | W | 0.484507 | 0.181204 | D to O | - |
| O43699 | SIGL6_HUMAN Sialic acid-binding Ig-like lectin 6 OS=Homo sapiens GN=SIGLEC6 PE=1 SV=2 | 57 | L | 0.217707 | V | 0.210649 | 0.007058 | No Change: Both O | - |
| O43699 | SIGL6_HUMAN Sialic acid-binding Ig-like lectin 6 OS=Homo sapiens GN=SIGLEC6 PE=1 SV=2 | 262 | L | 0.347282 | F | 0.300382 | 0.0469 | No Change: Both O | - |
| Q9Y286 | SIGL7_HUMAN Sialic acid-binding Ig-like lectin 7 OS=Homo sapiens GN=SIGLEC7 PE=1 SV=1 | 215 | L | 0.65378 | P | 0.77435 | -0.12057 | No Change: Both D | A colorectal cancer sample |
| Q9NYZ4 | SIGL8_HUMAN Sialic acid-binding Ig-like lectin 8 OS=Homo sapiens GN=SIGLEC8 PE=1 SV=2 | 170 | S | 0.477722 | P | 0.445175 | 0.032547 | No Change: Both O | - |
| Q9NYZ4 | SIGL8_HUMAN Sialic acid-binding Ig-like lectin 8 OS=Homo sapiens GN=SIGLEC8 PE=1 SV=2 | 388 | R | 0.364166 | G | 0.357198 | 0.006968 | No Change: Both O | - |
| Q9NYZ4 | SIGL8_HUMAN Sialic acid-binding Ig-like lectin 8 OS=Homo sapiens GN=SIGLEC8 PE=1 SV=2 | 282 | V | 0.536842 | L | 0.5723 | -0.035458 | No Change: Both D | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 100 | K | 0.409895 | E | 0.420107 | -0.010212 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 125 | S | 0.346978 | N | 0.323351 | 0.023627 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 147 | N | 0.235465 | K | 0.266829 | -0.031364 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 315 | A | 0.218967 | E | 0.300975 | -0.082008 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 316 | A | 0.24183 | D | 0.297616 | -0.055786 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 131 | K | 0.297286 | Q | 0.242672 | 0.054614 | No Change: Both O | - |
| Q9Y336 | SIGL9_HUMAN Sialic acid-binding Ig-like lectin 9 OS=Homo sapiens GN=SIGLEC9 PE=1 SV=2 | 349 | V | 0.4109 | A | 0.482529 | -0.071629 | No Change: Both O | - |
| Q99720 | SGMR1_HUMAN Sigma non-opioid intracellular receptor 1 OS=Homo sapiens GN=SIGMAR1 PE=1 SV=1 | 2 | Q | 0.604564 | P | 0.631306 | -0.026742 | No Change: Both D | - |
| Q99720 | SGMR1_HUMAN Sigma non-opioid intracellular receptor 1 OS=Homo sapiens GN=SIGMAR1 PE=1 SV=1 | 211 | R | 0.226277 | Q | 0.225647 | 6.30E-04 | No Change: Both O | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 615 | A | 0.728737 | V | 0.642667 | 0.08607 | No Change: Both D | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 430 | R | 0.698267 | W | 0.500564 | 0.197703 | No Change: Both D | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 15 | G | 0.723804 | S | 0.74445 | -0.020646 | No Change: Both D | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 142 | D | 0.223665 | N | 0.203186 | 0.020479 | No Change: Both O | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 211 | G | 0.031096 | S | 0.041156 | -0.01006 | No Change: Both O | A glioblastoma multiforme sample |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 469 | G | 0.939983 | D | 0.948013 | -0.00803 | No Change: Both D | A metastatic melanoma sample |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 696 | P | 0.933623 | L | 0.88586 | 0.047763 | No Change: Both D | - |
| P57059 | SIK1_HUMAN Serine/threonine-protein kinase SIK1 OS=Homo sapiens GN=SIK1 PE=1 SV=2 | 725 | A | 0.80728 | V | 0.746092 | 0.061188 | No Change: Both D | - |
| Q9H0K1 | SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | 458 | T | 0.848862 | I | 0.781505 | 0.067357 | No Change: Both D | - |
| Q9H0K1 | SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | 809 | R | 0.99647 | Q | 0.997658 | -0.001188 | No Change: Both D | - |
| Q9H0K1 | SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | 825 | P | 0.999716 | L | 0.999422 | 2.94E-04 | No Change: Both D | - |
| Q9H0K1 | SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | 828 | P | 0.999648 | L | 0.999273 | 3.75E-04 | No Change: Both D | - |
| Q9H0K1 | SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens GN=SIK2 PE=1 SV=1 | 829 | P | 0.999613 | S | 0.999493 | 1.20E-04 | No Change: Both D | - |
| Q9Y2K2 | SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | 331 | H | 0.47101 | L | 0.37619 | 0.09482 | No Change: Both O | A breast cancer sample |
| Q9Y2K2 | SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | 1103 | A | 0.545064 | V | 0.491887 | 0.053177 | D to O | A breast cancer sample |
| Q9Y2K2 | SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | 1040 | D | 0.948222 | E | 0.956862 | -0.00864 | No Change: Both D | - |
| Q9Y2K2 | SIK3_HUMAN Serine/threonine-protein kinase SIK3 OS=Homo sapiens GN=SIK3 PE=1 SV=3 | 1078 | P | 0.781126 | R | 0.7223 | 0.058826 | No Change: Both D | - |
| Q9H173 | SIL1_HUMAN Nucleotide exchange factor SIL1 OS=Homo sapiens GN=SIL1 PE=1 SV=1 | 80 | Q | 0.503221 | R | 0.476608 | 0.026613 | D to O | - |
| P81133 | SIM1_HUMAN Single-minded homolog 1 OS=Homo sapiens GN=SIM1 PE=2 SV=2 | 352 | P | 0.698578 | T | 0.683686 | 0.014892 | No Change: Both D | - |
| P81133 | SIM1_HUMAN Single-minded homolog 1 OS=Homo sapiens GN=SIM1 PE=2 SV=2 | 371 | A | 0.981249 | V | 0.972922 | 0.008327 | No Change: Both D | - |
| P81133 | SIM1_HUMAN Single-minded homolog 1 OS=Homo sapiens GN=SIM1 PE=2 SV=2 | 175 | L | 0.173674 | F | 0.148604 | 0.02507 | No Change: Both O | - |
| Q14190 | SIM2_HUMAN Single-minded homolog 2 OS=Homo sapiens GN=SIM2 PE=1 SV=2 | 483 | L | 0.626738 | M | 0.669525 | -0.042787 | No Change: Both D | - |
| Q96ST3 | SIN3A_HUMAN Paired amphipathic helix protein Sin3a OS=Homo sapiens GN=SIN3A PE=1 SV=2 | 1156 | M | 0.838327 | L | 0.806306 | 0.032021 | No Change: Both D | - |
| Q96FS4 | SIPA1_HUMAN Signal-induced proliferation-associated protein 1 OS=Homo sapiens GN=SIPA1 PE=1 SV=1 | 80 | R | 0.970314 | Q | 0.962397 | 0.007917 | No Change: Both D | - |
| Q96FS4 | SIPA1_HUMAN Signal-induced proliferation-associated protein 1 OS=Homo sapiens GN=SIPA1 PE=1 SV=1 | 106 | A | 0.602011 | S | 0.657576 | -0.055565 | No Change: Both D | - |
| Q96FS4 | SIPA1_HUMAN Signal-induced proliferation-associated protein 1 OS=Homo sapiens GN=SIPA1 PE=1 SV=1 | 174 | E | 0.827577 | D | 0.79216 | 0.035417 | No Change: Both D | - |
| Q96FS4 | SIPA1_HUMAN Signal-induced proliferation-associated protein 1 OS=Homo sapiens GN=SIPA1 PE=1 SV=1 | 182 | S | 0.826978 | F | 0.665089 | 0.161889 | No Change: Both D | - |
| O43166 | SI1L1_HUMAN Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens GN=SIPA1L1 PE=1 SV=4 | 996 | E | 0.118382 | D | 0.105755 | 0.012627 | No Change: Both O | A breast cancer sample |
| O43166 | SI1L1_HUMAN Signal-induced proliferation-associated 1-like protein 1 OS=Homo sapiens GN=SIPA1L1 PE=1 SV=4 | 56 | P | 0.838465 | T | 0.794719 | 0.043746 | No Change: Both D | - |
| Q9P2F8 | SI1L2_HUMAN Signal-induced proliferation-associated 1-like protein 2 OS=Homo sapiens GN=SIPA1L2 PE=1 SV=2 | 49 | T | 0.8112 | A | 0.800157 | 0.011043 | No Change: Both D | - |
| Q9P2F8 | SI1L2_HUMAN Signal-induced proliferation-associated 1-like protein 2 OS=Homo sapiens GN=SIPA1L2 PE=1 SV=2 | 1322 | T | 0.776441 | A | 0.812238 | -0.035797 | No Change: Both D | - |
| Q9P2F8 | SI1L2_HUMAN Signal-induced proliferation-associated 1-like protein 2 OS=Homo sapiens GN=SIPA1L2 PE=1 SV=2 | 1403 | S | 0.849719 | L | 0.714768 | 0.134951 | No Change: Both D | - |
| Q9P2F8 | SI1L2_HUMAN Signal-induced proliferation-associated 1-like protein 2 OS=Homo sapiens GN=SIPA1L2 PE=1 SV=2 | 1639 | G | 0.705669 | S | 0.748691 | -0.043022 | No Change: Both D | - |
| Q9P2F8 | SI1L2_HUMAN Signal-induced proliferation-associated 1-like protein 2 OS=Homo sapiens GN=SIPA1L2 PE=1 SV=2 | 1424 | M | 0.683182 | L | 0.573077 | 0.110105 | No Change: Both D | - |
| O60292 | SI1L3_HUMAN Signal-induced proliferation-associated 1-like protein 3 OS=Homo sapiens GN=SIPA1L3 PE=1 SV=3 | 1371 | G | 0.929852 | S | 0.943773 | -0.013921 | No Change: Both D | - |
| O60292 | SI1L3_HUMAN Signal-induced proliferation-associated 1-like protein 3 OS=Homo sapiens GN=SIPA1L3 PE=1 SV=3 | 1450 | P | 0.963473 | A | 0.938818 | 0.024655 | No Change: Both D | - |
| Q7Z4H9 | SIPAR_HUMAN STAT3-interacting protein as a repressor OS=Homo sapiens GN=SIPAR PE=2 SV=1 | 71 | G | 0.621334 | R | 0.642743 | -0.021409 | No Change: Both D | - |
| Q7Z4H9 | SIPAR_HUMAN STAT3-interacting protein as a repressor OS=Homo sapiens GN=SIPAR PE=2 SV=1 | 127 | R | 0.616335 | Q | 0.577333 | 0.039002 | No Change: Both D | - |
| Q7Z4H9 | SIPAR_HUMAN STAT3-interacting protein as a repressor OS=Homo sapiens GN=SIPAR PE=2 SV=1 | 161 | V | 0.912809 | L | 0.926265 | -0.013456 | No Change: Both D | - |
| Q7Z4H9 | SIPAR_HUMAN STAT3-interacting protein as a repressor OS=Homo sapiens GN=SIPAR PE=2 SV=1 | 198 | V | 0.249773 | M | 0.318935 | -0.069162 | No Change: Both O | - |
| Q7Z4H9 | SIPAR_HUMAN STAT3-interacting protein as a repressor OS=Homo sapiens GN=SIPAR PE=2 SV=1 | 237 | G | 0.442815 | S | 0.520711 | -0.077896 | O to D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 20 | A | 0.212112 | P | 0.297555 | -0.085443 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 40 | D | 0.344762 | E | 0.392348 | -0.047586 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 44 | L | 0.267547 | S | 0.472499 | -0.204952 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 50 | T | 0.275272 | S | 0.337743 | -0.062471 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 52 | T | 0.259777 | I | 0.141221 | 0.118556 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 54 | R | 0.229613 | H | 0.230962 | -0.001349 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 57 | A | 0.169631 | V | 0.122617 | 0.047014 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 61 | I | 0.114155 | N | 0.203359 | -0.089204 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 68 | W | 0.145722 | R | 0.320376 | -0.174654 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 75 | G | 0.282154 | A | 0.230878 | 0.051276 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 77 | E | 0.332066 | K | 0.334642 | -0.002576 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 81 | N | 0.415847 | H | 0.41574 | 1.07E-04 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 95 | D | 0.45398 | E | 0.473827 | -0.019847 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 96 | L | 0.505564 | S | 0.68962 | -0.184056 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 100 | N | 0.400008 | E | 0.413716 | -0.013708 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 107 | R | 0.212845 | S | 0.26894 | -0.056095 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 109 | G | 0.217461 | S | 0.269302 | -0.051841 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 125 | R | 0.370772 | Q | 0.36334 | 0.007432 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 132 | V | 0.613767 | T | 0.668341 | -0.054574 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 134 | F | 0.635238 | L | 0.65158 | -0.016342 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 163 | Q | 0.559448 | D | 0.582984 | -0.023536 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 181 | T | 0.257726 | S | 0.338821 | -0.081095 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 190 | E | 0.367022 | Q | 0.344583 | 0.022439 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 214 | K | 0.316177 | N | 0.278515 | 0.037662 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 220 | E | 0.300754 | G | 0.25409 | 0.046664 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 222 | V | 0.236008 | I | 0.203945 | 0.032063 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 236 | Q | 0.341584 | R | 0.33859 | 0.002994 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 251 | R | 0.430346 | Q | 0.460452 | -0.030106 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 261 | Q | 0.533854 | L | 0.372062 | 0.161792 | D to O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 263 | V | 0.540818 | M | 0.573916 | -0.033098 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 271 | V | 0.405658 | I | 0.333369 | 0.072289 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 276 | R | 0.374984 | T | 0.361037 | 0.013947 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 302 | V | 0.653011 | L | 0.647417 | 0.005594 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 339 | P | 0.67759 | S | 0.707699 | -0.030109 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 353 | P | 0.741484 | L | 0.644759 | 0.096725 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 357 | G | 0.789042 | S | 0.808529 | -0.019487 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 367 | S | 0.61003 | P | 0.581128 | 0.028902 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 370 | R | 0.340493 | Q | 0.361182 | -0.020689 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 389 | A | 0.044461 | E | 0.064807 | -0.020346 | No Change: Both O | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 443 | Q | 0.863188 | R | 0.841928 | 0.02126 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 460 | P | 0.844471 | L | 0.749666 | 0.094805 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 486 | A | 0.878063 | L | 0.859027 | 0.019036 | No Change: Both D | - |
| P78324 | SHPS1_HUMAN Tyrosine-protein phosphatase non-receptor type substrate 1 OS=Homo sapiens GN=SIRPA PE=1 SV=2 | 491 | P | 0.88594 | L | 0.789719 | 0.096221 | No Change: Both D | - |
| O00241 | SIRB1_HUMAN Signal-regulatory protein beta-1 OS=Homo sapiens GN=SIRPB1 PE=1 SV=5 | 23 | R | 0.215834 | G | 0.239402 | -0.023568 | No Change: Both O | - |
| O00241 | SIRB1_HUMAN Signal-regulatory protein beta-1 OS=Homo sapiens GN=SIRPB1 PE=1 SV=5 | 53 | R | 0.234536 | H | 0.231245 | 0.003291 | No Change: Both O | - |
| O00241 | SIRB1_HUMAN Signal-regulatory protein beta-1 OS=Homo sapiens GN=SIRPB1 PE=1 SV=5 | 229 | I | 0.121808 | M | 0.159561 | -0.037753 | No Change: Both O | - |
| O00241 | SIRB1_HUMAN Signal-regulatory protein beta-1 OS=Homo sapiens GN=SIRPB1 PE=1 SV=5 | 363 | A | 0.454784 | P | 0.533506 | -0.078722 | O to D | - |
| Q5TFQ8 | SIRBL_HUMAN Signal-regulatory protein beta-1 isoform 3 OS=Homo sapiens GN=SIRPB1 PE=1 SV=1 | 23 | R | 0.207543 | G | 0.238776 | -0.031233 | No Change: Both O | - |
| Q5TFQ8 | SIRBL_HUMAN Signal-regulatory protein beta-1 isoform 3 OS=Homo sapiens GN=SIRPB1 PE=1 SV=1 | 51 | T | 0.304336 | I | 0.179089 | 0.125247 | No Change: Both O | - |
| Q5JXA9 | SIRB2_HUMAN Signal-regulatory protein beta-2 OS=Homo sapiens GN=SIRPB2 PE=2 SV=1 | 153 | G | 0.466314 | E | 0.518909 | -0.052595 | O to D | - |
| Q5JXA9 | SIRB2_HUMAN Signal-regulatory protein beta-2 OS=Homo sapiens GN=SIRPB2 PE=2 SV=1 | 215 | E | 0.603324 | A | 0.522607 | 0.080717 | No Change: Both D | - |
| Q5JXA9 | SIRB2_HUMAN Signal-regulatory protein beta-2 OS=Homo sapiens GN=SIRPB2 PE=2 SV=1 | 304 | L | 0.15432 | F | 0.119391 | 0.034929 | No Change: Both O | - |
| Q9H106 | SIRPD_HUMAN Signal-regulatory protein delta OS=Homo sapiens GN=SIRPD PE=2 SV=2 | 55 | N | 0.323037 | D | 0.315253 | 0.007784 | No Change: Both O | - |
| Q9P1W8 | SIRPG_HUMAN Signal-regulatory protein gamma OS=Homo sapiens GN=SIRPG PE=1 SV=3 | 263 | V | 0.44703 | A | 0.485821 | -0.038791 | No Change: Both O | - |
| Q9P1W8 | SIRPG_HUMAN Signal-regulatory protein gamma OS=Homo sapiens GN=SIRPG PE=1 SV=3 | 286 | S | 0.346179 | L | 0.191909 | 0.15427 | No Change: Both O | - |
| Q96EB6 | SIRT1_HUMAN NAD-dependent deacetylase sirtuin-1 OS=Homo sapiens GN=SIRT1 PE=1 SV=2 | 3 | D | 0.97582 | E | 0.980041 | -0.004221 | No Change: Both D | - |
| Q96EB6 | SIRT1_HUMAN NAD-dependent deacetylase sirtuin-1 OS=Homo sapiens GN=SIRT1 PE=1 SV=2 | 484 | V | 0.092066 | D | 0.18412 | -0.092054 | No Change: Both O | - |
| Q9NTG7 | SIRT3_HUMAN NAD-dependent deacetylase sirtuin-3 mitochondrial OS=Homo sapiens GN=SIRT3 PE=1 SV=2 | 80 | R | 0.967925 | W | 0.910767 | 0.057158 | No Change: Both D | - |
| Q9NTG7 | SIRT3_HUMAN NAD-dependent deacetylase sirtuin-3 mitochondrial OS=Homo sapiens GN=SIRT3 PE=1 SV=2 | 208 | V | 0.219353 | I | 0.196225 | 0.023128 | No Change: Both O | - |
| Q9NTG7 | SIRT3_HUMAN NAD-dependent deacetylase sirtuin-3 mitochondrial OS=Homo sapiens GN=SIRT3 PE=1 SV=2 | 369 | G | 0.271158 | S | 0.316874 | -0.045716 | No Change: Both O | - |
| Q9NXA8 | SIRT5_HUMAN NAD-dependent deacetylase sirtuin-5 OS=Homo sapiens GN=SIRT5 PE=1 SV=2 | 285 | F | 0.492039 | L | 0.477385 | 0.014654 | No Change: Both O | - |
| Q9NXA8 | SIRT5_HUMAN NAD-dependent deacetylase sirtuin-5 OS=Homo sapiens GN=SIRT5 PE=1 SV=2 | 305 | E | 0.621043 | G | 0.564916 | 0.056127 | No Change: Both D | - |
| Q8N6T7 | SIRT6_HUMAN NAD-dependent deacetylase sirtuin-6 OS=Homo sapiens GN=SIRT6 PE=1 SV=2 | 46 | S | 0.206301 | N | 0.161836 | 0.044465 | No Change: Both O | - |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 110 | R | 0.304098 | W | 0.130823 | 0.173275 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 129 | Y | 0.387976 | C | 0.423166 | -0.03519 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 17 | V | 0.12443 | E | 0.26703 | -0.1426 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 73 | H | 0.480337 | P | 0.497234 | -0.016897 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 106 | V | 0.365103 | G | 0.493277 | -0.128174 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 110 | R | 0.304098 | Q | 0.286976 | 0.017122 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 112 | R | 0.309877 | C | 0.161876 | 0.148001 | No Change: Both O | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 122 | W | 0.292547 | R | 0.53179 | -0.239243 | O to D | Branchiootic syndrome type 3 (BOS3) [MIM:608389] |
| Q15475 | SIX1_HUMAN Homeobox protein SIX1 OS=Homo sapiens GN=SIX1 PE=1 SV=1 | 249 | P | 0.90256 | L | 0.850021 | 0.052539 | No Change: Both D | Branchiootorenal syndrome (BOR) |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 226 | L | 0.363321 | V | 0.318816 | 0.044505 | No Change: Both O | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 250 | V | 0.481895 | A | 0.628002 | -0.146107 | O to D | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 257 | R | 0.660484 | P | 0.670613 | -0.010129 | No Change: Both D | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 92 | V | 0.492341 | G | 0.597892 | -0.105551 | O to D | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 105 | I | 0.362505 | V | 0.397524 | -0.035019 | No Change: Both O | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 173 | H | 0.296806 | P | 0.343536 | -0.04673 | No Change: Both O | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 202 | T | 0.339189 | I | 0.220047 | 0.119142 | No Change: Both O | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 231 | P | 0.5791 | R | 0.552976 | 0.026124 | No Change: Both D | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 257 | R | 0.660484 | W | 0.44716 | 0.213324 | D to O | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| O95343 | SIX3_HUMAN Homeobox protein SIX3 OS=Homo sapiens GN=SIX3 PE=1 SV=1 | 69 | G | 0.942973 | D | 0.928106 | 0.014867 | No Change: Both D | Holoprosencephaly type 2 (HPE2) [MIM:157170] |
| Q9UIU6 | SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens GN=SIX4 PE=1 SV=2 | 23 | E | 0.92953 | Q | 0.924086 | 0.005444 | No Change: Both D | A breast cancer sample |
| Q9UIU6 | SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens GN=SIX4 PE=1 SV=2 | 446 | G | 0.645251 | D | 0.666749 | -0.021498 | No Change: Both D | A breast cancer sample |
| Q9UIU6 | SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens GN=SIX4 PE=1 SV=2 | 780 | D | 0.915439 | E | 0.917694 | -0.002255 | No Change: Both D | A breast cancer sample |
| Q9UIU6 | SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens GN=SIX4 PE=1 SV=2 | 605 | H | 0.788406 | P | 0.852562 | -0.064156 | No Change: Both D | - |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 158 | A | 0.293166 | T | 0.260816 | 0.03235 | No Change: Both O | Branchiootorenal syndrome type 2 (BOR2) [MIM:610896] |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 296 | A | 0.886228 | T | 0.879927 | 0.006301 | No Change: Both D | Branchiootorenal syndrome type 2 (BOR2) [MIM:610896] |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 365 | G | 0.886522 | R | 0.863839 | 0.022683 | No Change: Both D | Branchiootorenal syndrome type 2 (BOR2) [MIM:610896] |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 552 | T | 0.305983 | M | 0.269977 | 0.036006 | No Change: Both O | Branchiootorenal syndrome type 2 (BOR2) [MIM:610896] |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 556 | L | 0.272991 | V | 0.267229 | 0.005762 | No Change: Both O | - |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 635 | P | 0.977491 | S | 0.975848 | 0.001643 | No Change: Both D | - |
| Q8N196 | SIX5_HUMAN Homeobox protein SIX5 OS=Homo sapiens GN=SIX5 PE=1 SV=3 | 693 | V | 0.681384 | M | 0.73711 | -0.055726 | No Change: Both D | - |
| O95475 | SIX6_HUMAN Homeobox protein SIX6 OS=Homo sapiens GN=SIX6 PE=1 SV=2 | 165 | T | 0.58589 | A | 0.560432 | 0.025458 | No Change: Both D | Microphthalmia isolated with cataract type 2 (MCOPCT2) [MIM:212550] |
| O95475 | SIX6_HUMAN Homeobox protein SIX6 OS=Homo sapiens GN=SIX6 PE=1 SV=2 | 141 | H | 0.363234 | N | 0.382011 | -0.018777 | No Change: Both O | - |
| Q8N1H7 | S6OS1_HUMAN Protein SIX6OS1 OS=Homo sapiens GN=SIX6OS1 PE=2 SV=2 | 125 | Y | 0.440498 | C | 0.423989 | 0.016509 | No Change: Both O | - |
| Q8N1H7 | S6OS1_HUMAN Protein SIX6OS1 OS=Homo sapiens GN=SIX6OS1 PE=2 SV=2 | 309 | S | 0.830318 | L | 0.705256 | 0.125062 | No Change: Both D | - |
| Q8N1H7 | S6OS1_HUMAN Protein SIX6OS1 OS=Homo sapiens GN=SIX6OS1 PE=2 SV=2 | 404 | V | 0.724253 | I | 0.707469 | 0.016784 | No Change: Both D | - |
| Q96BD8 | SKA1_HUMAN Spindle and kinetochore-associated protein 1 OS=Homo sapiens GN=SKA1 PE=1 SV=1 | 91 | V | 0.78822 | I | 0.768169 | 0.020051 | No Change: Both D | - |
| Q8IX90 | SKA3_HUMAN Spindle and kinetochore-associated protein 3 OS=Homo sapiens GN=SKA3 PE=1 SV=2 | 254 | T | 0.642261 | A | 0.624618 | 0.017643 | No Change: Both D | - |
| Q8IX90 | SKA3_HUMAN Spindle and kinetochore-associated protein 3 OS=Homo sapiens GN=SKA3 PE=1 SV=2 | 58 | V | 0.256576 | I | 0.244218 | 0.012358 | No Change: Both O | - |
| Q8IX90 | SKA3_HUMAN Spindle and kinetochore-associated protein 3 OS=Homo sapiens GN=SKA3 PE=1 SV=2 | 335 | D | 0.873932 | E | 0.885617 | -0.011685 | No Change: Both D | - |
| Q86WV1 | SKAP1_HUMAN Src kinase-associated phosphoprotein 1 OS=Homo sapiens GN=SKAP1 PE=1 SV=3 | 161 | G | 0.215855 | S | 0.257807 | -0.041952 | No Change: Both O | - |
| Q86WV1 | SKAP1_HUMAN Src kinase-associated phosphoprotein 1 OS=Homo sapiens GN=SKAP1 PE=1 SV=3 | 242 | S | 0.912923 | G | 0.89465 | 0.018273 | No Change: Both D | - |
| O75563 | SKAP2_HUMAN Src kinase-associated phosphoprotein 2 OS=Homo sapiens GN=SKAP2 PE=1 SV=1 | 202 | A | 0.376394 | S | 0.465598 | -0.089204 | No Change: Both O | - |
| O75563 | SKAP2_HUMAN Src kinase-associated phosphoprotein 2 OS=Homo sapiens GN=SKAP2 PE=1 SV=1 | 253 | S | 0.913169 | T | 0.884156 | 0.029013 | No Change: Both D | - |
| P12757 | SKIL_HUMAN Ski-like protein OS=Homo sapiens GN=SKIL PE=1 SV=2 | 38 | A | 0.62706 | V | 0.571496 | 0.055564 | No Change: Both D | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 183 | L | 0.759063 | V | 0.698558 | 0.060505 | No Change: Both D | A breast cancer sample |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 765 | M | 0.556219 | I | 0.42045 | 0.135769 | D to O | A colorectal cancer sample |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 324 | R | 0.259816 | W | 0.11592 | 0.143896 | No Change: Both O | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 887 | D | 0.699912 | N | 0.666949 | 0.032963 | No Change: Both D | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 917 | V | 0.299154 | M | 0.353964 | -0.05481 | No Change: Both O | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 1071 | A | 0.290982 | V | 0.230279 | 0.060703 | No Change: Both O | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 151 | Q | 0.634934 | R | 0.643459 | -0.008525 | No Change: Both D | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 214 | M | 0.817643 | L | 0.792848 | 0.024795 | No Change: Both D | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 1153 | G | 0.147098 | R | 0.138466 | 0.008632 | No Change: Both O | - |
| Q15477 | SKIV2_HUMAN Helicase SKI2W OS=Homo sapiens GN=SKIV2L PE=1 SV=3 | 1238 | V | 0.099513 | G | 0.172392 | -0.072879 | No Change: Both O | - |
| P42285 | SK2L2_HUMAN Superkiller viralicidic activity 2-like 2 OS=Homo sapiens GN=SKIV2L2 PE=1 SV=3 | 346 | A | 0.356395 | P | 0.438962 | -0.082567 | No Change: Both O | - |
| Q2VWA4 | SKOR2_HUMAN SKI family transcriptional corepressor 2 OS=Homo sapiens GN=SKOR2 PE=1 SV=2 | 947 | F | 0.596518 | C | 0.596767 | -2.49E-04 | No Change: Both D | - |
| P63208 | SKP1_HUMAN S-phase kinase-associated protein 1 OS=Homo sapiens GN=SKP1 PE=1 SV=2 | 14 | F | 0.545605 | L | 0.623255 | -0.07765 | No Change: Both D | - |
| Q13309 | SKP2_HUMAN S-phase kinase-associated protein 2 OS=Homo sapiens GN=SKP2 PE=1 SV=2 | 85 | P | 0.595553 | L | 0.471091 | 0.124462 | D to O | - |
| Q13309 | SKP2_HUMAN S-phase kinase-associated protein 2 OS=Homo sapiens GN=SKP2 PE=1 SV=2 | 87 | L | 0.602058 | I | 0.56751 | 0.034548 | No Change: Both D | - |
| Q5T5P2 | SKT_HUMAN Sickle tail protein homolog OS=Homo sapiens GN=SKT PE=1 SV=2 | 145 | A | 0.971416 | G | 0.973681 | -0.002265 | No Change: Both D | - |
| Q5T5P2 | SKT_HUMAN Sickle tail protein homolog OS=Homo sapiens GN=SKT PE=1 SV=2 | 887 | A | 0.776221 | T | 0.771621 | 0.0046 | No Change: Both D | - |
| Q5T5P2 | SKT_HUMAN Sickle tail protein homolog OS=Homo sapiens GN=SKT PE=1 SV=2 | 1362 | P | 0.830125 | A | 0.792159 | 0.037966 | No Change: Both D | - |
| Q13239 | SLAP1_HUMAN Src-like-adapter OS=Homo sapiens GN=SLA PE=1 SV=3 | 15 | P | 0.917338 | T | 0.869431 | 0.047907 | No Change: Both D | - |
| Q9H6Q3 | SLAP2_HUMAN Src-like-adapter 2 OS=Homo sapiens GN=SLA2 PE=1 SV=3 | 210 | V | 0.348164 | M | 0.402421 | -0.054257 | No Change: Both O | - |
| Q13291 | SLAF1_HUMAN Signaling lymphocytic activation molecule OS=Homo sapiens GN=SLAMF1 PE=1 SV=1 | 11 | F | 0.065345 | L | 0.081813 | -0.016468 | No Change: Both O | - |
| Q13291 | SLAF1_HUMAN Signaling lymphocytic activation molecule OS=Homo sapiens GN=SLAMF1 PE=1 SV=1 | 333 | P | 0.80151 | T | 0.785368 | 0.016142 | No Change: Both D | - |
| Q13291 | SLAF1_HUMAN Signaling lymphocytic activation molecule OS=Homo sapiens GN=SLAMF1 PE=1 SV=1 | 81 | L | 0.516189 | F | 0.483828 | 0.032361 | D to O | A breast cancer sample |
| Q9NQ25 | SLAF7_HUMAN SLAM family member 7 OS=Homo sapiens GN=SLAMF7 PE=1 SV=1 | 175 | H | 0.593085 | Y | 0.466886 | 0.126199 | D to O | - |
| Q9NQ25 | SLAF7_HUMAN SLAM family member 7 OS=Homo sapiens GN=SLAMF7 PE=1 SV=1 | 302 | T | 0.545051 | M | 0.5054 | 0.039651 | No Change: Both D | - |
| Q9P0V8 | SLAF8_HUMAN SLAM family member 8 OS=Homo sapiens GN=SLAMF8 PE=1 SV=1 | 5 | P | 0.271691 | T | 0.226329 | 0.045362 | No Change: Both O | - |
| Q9P0V8 | SLAF8_HUMAN SLAM family member 8 OS=Homo sapiens GN=SLAMF8 PE=1 SV=1 | 99 | G | 0.527527 | S | 0.58488 | -0.057353 | No Change: Both D | - |
| Q9P0V8 | SLAF8_HUMAN SLAM family member 8 OS=Homo sapiens GN=SLAMF8 PE=1 SV=1 | 129 | V | 0.105304 | M | 0.123721 | -0.018417 | No Change: Both O | - |
| Q96A28 | SLAF9_HUMAN SLAM family member 9 OS=Homo sapiens GN=SLAMF9 PE=2 SV=2 | 127 | I | 0.077224 | L | 0.090218 | -0.012994 | No Change: Both O | - |
| Q96A28 | SLAF9_HUMAN SLAM family member 9 OS=Homo sapiens GN=SLAMF9 PE=2 SV=2 | 86 | V | 0.370366 | M | 0.428126 | -0.05776 | No Change: Both O | - |
| Q96A28 | SLAF9_HUMAN SLAM family member 9 OS=Homo sapiens GN=SLAMF9 PE=2 SV=2 | 164 | D | 0.344906 | H | 0.300798 | 0.044108 | No Change: Both O | - |
| Q96A28 | SLAF9_HUMAN SLAM family member 9 OS=Homo sapiens GN=SLAMF9 PE=2 SV=2 | 181 | E | 0.423571 | K | 0.422693 | 8.78E-04 | No Change: Both O | - |
| Q14973 | NTCP_HUMAN Sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A1 PE=2 SV=1 | 267 | S | 0.073708 | F | 0.028273 | 0.045435 | No Change: Both O | - |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 171 | S | 0.139181 | A | 0.078612 | 0.060569 | No Change: Both O | - |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 243 | L | 0.063075 | P | 0.124708 | -0.061633 | No Change: Both O | Primary bile acid malabsorption (PBAM) [MIM:613291] |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 262 | T | 0.285298 | M | 0.236619 | 0.048679 | No Change: Both O | Primary bile acid malabsorption (PBAM) [MIM:613291] |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 290 | P | 0.024675 | S | 0.030242 | -0.005567 | No Change: Both O | - |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 98 | V | 0.017794 | I | 0.015552 | 0.002242 | No Change: Both O | - |
| Q12908 | NTCP2_HUMAN Ileal sodium/bile acid cotransporter OS=Homo sapiens GN=SLC10A2 PE=1 SV=2 | 159 | V | 0.171874 | I | 0.160771 | 0.011103 | No Change: Both O | - |
| P09131 | P3_HUMAN P3 protein OS=Homo sapiens GN=SLC10A3 PE=2 SV=1 | 354 | V | 0.122115 | I | 0.098337 | 0.023778 | No Change: Both O | - |
| Q5PT55 | NTCP5_HUMAN Sodium/bile acid cotransporter 5 OS=Homo sapiens GN=SLC10A5 PE=1 SV=1 | 287 | I | 0.054637 | T | 0.091308 | -0.036671 | No Change: Both O | - |
| Q3KNW5 | SOAT_HUMAN Solute carrier family 10 member 6 OS=Homo sapiens GN=SLC10A6 PE=1 SV=2 | 6 | S | 0.885026 | F | 0.725238 | 0.159788 | No Change: Both D | - |
| Q3KNW5 | SOAT_HUMAN Solute carrier family 10 member 6 OS=Homo sapiens GN=SLC10A6 PE=1 SV=2 | 114 | I | 0.062916 | V | 0.072069 | -0.009153 | No Change: Both O | - |
| P49279 | NRAM1_HUMAN Natural resistance-associated macrophage protein 1 OS=Homo sapiens GN=SLC11A1 PE=1 SV=1 | 30 | Q | 0.968965 | R | 0.969803 | -8.38E-04 | No Change: Both D | - |
| P49279 | NRAM1_HUMAN Natural resistance-associated macrophage protein 1 OS=Homo sapiens GN=SLC11A1 PE=1 SV=1 | 318 | A | 0.210198 | V | 0.14039 | 0.069808 | No Change: Both O | - |
| P49279 | NRAM1_HUMAN Natural resistance-associated macrophage protein 1 OS=Homo sapiens GN=SLC11A1 PE=1 SV=1 | 543 | D | 0.737944 | N | 0.726072 | 0.011872 | No Change: Both D | - |
| P49281 | NRAM2_HUMAN Natural resistance-associated macrophage protein 2 OS=Homo sapiens GN=SLC11A2 PE=1 SV=2 | 435 | L | 0.227588 | I | 0.19719 | 0.030398 | No Change: Both O | - |
| P49281 | NRAM2_HUMAN Natural resistance-associated macrophage protein 2 OS=Homo sapiens GN=SLC11A2 PE=1 SV=2 | 212 | G | 0.028567 | V | 0.014341 | 0.014226 | No Change: Both O | Hypochromic microcytic anemia (HCMA) [MIM:206100] |
| P49281 | NRAM2_HUMAN Natural resistance-associated macrophage protein 2 OS=Homo sapiens GN=SLC11A2 PE=1 SV=2 | 399 | E | 0.129663 | D | 0.116218 | 0.013445 | No Change: Both O | Hypochromic microcytic anemia (HCMA) [MIM:206100] |
| P49281 | NRAM2_HUMAN Natural resistance-associated macrophage protein 2 OS=Homo sapiens GN=SLC11A2 PE=1 SV=2 | 416 | R | 0.079772 | C | 0.033303 | 0.046469 | No Change: Both O | Hypochromic microcytic anemia (HCMA) [MIM:206100] |
| P49281 | NRAM2_HUMAN Natural resistance-associated macrophage protein 2 OS=Homo sapiens GN=SLC11A2 PE=1 SV=2 | 48 | A | 0.438789 | T | 0.479269 | -0.04048 | No Change: Both O | A colorectal cancer sample |
| Q13621 | S12A1_HUMAN Solute carrier family 12 member 1 OS=Homo sapiens GN=SLC12A1 PE=1 SV=2 | 272 | V | 0.05342 | F | 0.045285 | 0.008135 | No Change: Both O | Bartter syndrome type 1 (BS1) [MIM:601678] |
| Q13621 | S12A1_HUMAN Solute carrier family 12 member 1 OS=Homo sapiens GN=SLC12A1 PE=1 SV=2 | 648 | D | 0.405765 | N | 0.404868 | 8.97E-04 | No Change: Both O | Bartter syndrome type 1 (BS1) [MIM:601678] |
| Q13621 | S12A1_HUMAN Solute carrier family 12 member 1 OS=Homo sapiens GN=SLC12A1 PE=1 SV=2 | 958 | V | 0.252911 | A | 0.347065 | -0.094154 | No Change: Both O | - |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 209 | R | 0.292587 | W | 0.136968 | 0.155619 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 349 | P | 0.123635 | L | 0.062928 | 0.060707 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 421 | C | 0.068192 | R | 0.132415 | -0.064223 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 486 | D | 0.061558 | N | 0.057223 | 0.004335 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 496 | G | 0.240412 | C | 0.107581 | 0.132831 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 588 | A | 0.007285 | V | 0.00474 | 0.002545 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 630 | G | 0.306522 | V | 0.203971 | 0.102551 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 655 | R | 0.224147 | H | 0.229037 | -0.00489 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 655 | R | 0.224147 | L | 0.149305 | 0.074842 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 728 | A | 0.226951 | T | 0.239033 | -0.012082 | No Change: Both O | - |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 741 | G | 0.131553 | R | 0.125459 | 0.006094 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 850 | L | 0.119585 | P | 0.218894 | -0.099309 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 955 | R | 0.323374 | Q | 0.326977 | -0.003603 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 60 | T | 0.290854 | M | 0.261372 | 0.029482 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 62 | D | 0.265241 | N | 0.268578 | -0.003337 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 68 | E | 0.325268 | K | 0.322149 | 0.003119 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 69 | H | 0.352949 | N | 0.377661 | -0.024712 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 90 | H | 0.395046 | Y | 0.262788 | 0.132258 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 145 | R | 0.019713 | H | 0.019839 | -1.26E-04 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 153 | V | 0.00978 | M | 0.014304 | -0.004524 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 154 | I | 0.009424 | F | 0.00867 | 7.54E-04 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 158 | R | 0.017566 | Q | 0.020493 | -0.002927 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 163 | T | 0.04215 | M | 0.032455 | 0.009695 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 172 | W | 0.010373 | R | 0.028318 | -0.017945 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 178 | S | 0.039517 | L | 0.016367 | 0.02315 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 180 | T | 0.08704 | K | 0.111823 | -0.024783 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 186 | G | 0.320339 | D | 0.349909 | -0.02957 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 209 | R | 0.292587 | Q | 0.3109 | -0.018313 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 215 | L | 0.468057 | P | 0.609895 | -0.141838 | O to D | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 226 | A | 0.066634 | T | 0.069506 | -0.002872 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 230 | G | 0.11968 | D | 0.128814 | -0.009134 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 261 | R | 0.073842 | H | 0.074829 | -9.87E-04 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 264 | A | 0.041833 | G | 0.053869 | -0.012036 | No Change: Both O | - |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 283 | S | 0.263491 | Y | 0.124384 | 0.139107 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 284 | K | 0.212642 | R | 0.165899 | 0.046743 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 304 | T | 0.157622 | P | 0.209411 | -0.051789 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 313 | A | 0.712308 | V | 0.635923 | 0.076385 | No Change: Both D | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 316 | G | 0.510049 | V | 0.376507 | 0.133542 | D to O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 321 | R | 0.111333 | W | 0.043787 | 0.067546 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 334 | R | 0.244997 | W | 0.120719 | 0.124278 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 342 | G | 0.107888 | A | 0.080085 | 0.027803 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 374 | G | 0.137746 | V | 0.077959 | 0.059787 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 399 | R | 0.222333 | C | 0.12099 | 0.101343 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 439 | G | 0.157716 | S | 0.207395 | -0.049679 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 463 | G | 0.168077 | E | 0.194906 | -0.026829 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 464 | A | 0.168473 | T | 0.187186 | -0.018713 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 478 | K | 0.065622 | E | 0.068745 | -0.003123 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 542 | L | 0.041254 | P | 0.081416 | -0.040162 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 555 | S | 0.484539 | L | 0.248227 | 0.236312 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 560 | P | 0.307087 | H | 0.256259 | 0.050828 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 569 | A | 0.059631 | E | 0.087015 | -0.027384 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 569 | A | 0.059631 | V | 0.036879 | 0.022752 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 578 | V | 0.013427 | M | 0.018311 | -0.004884 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 613 | G | 0.453021 | S | 0.52958 | -0.076559 | O to D | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 615 | S | 0.459071 | L | 0.236765 | 0.222306 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 615 | S | 0.459071 | W | 0.180896 | 0.278175 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 623 | L | 0.328307 | P | 0.488536 | -0.160229 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 642 | R | 0.185476 | C | 0.099664 | 0.085812 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 642 | R | 0.185476 | G | 0.199348 | -0.013872 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 642 | R | 0.185476 | H | 0.200531 | -0.015055 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 643 | P | 0.153109 | L | 0.079331 | 0.073778 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 649 | T | 0.194111 | R | 0.221749 | -0.027638 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 655 | R | 0.224147 | C | 0.115476 | 0.108671 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 672 | M | 0.074536 | I | 0.05233 | 0.022206 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 677 | V | 0.108249 | L | 0.118998 | -0.010749 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 677 | V | 0.108249 | M | 0.1539 | -0.045651 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 729 | G | 0.241186 | V | 0.133807 | 0.107379 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 731 | G | 0.263639 | R | 0.250956 | 0.012683 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 738 | L | 0.119791 | R | 0.204199 | -0.084408 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 849 | L | 0.107597 | H | 0.162968 | -0.055371 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 852 | R | 0.187128 | C | 0.09006 | 0.097068 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 852 | R | 0.187128 | H | 0.175418 | 0.01171 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 852 | R | 0.187128 | S | 0.23333 | -0.046202 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 867 | G | 0.18368 | S | 0.210914 | -0.027234 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 871 | R | 0.391421 | H | 0.377448 | 0.013973 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 904 | R | 0.518794 | Q | 0.530411 | -0.011617 | No Change: Both D | - |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 919 | R | 0.366973 | C | 0.246427 | 0.120546 | No Change: Both O | - |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 958 | R | 0.222378 | G | 0.197929 | 0.024449 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 985 | C | 0.408826 | Y | 0.475708 | -0.066882 | No Change: Both O | Gitelman syndrome (GS) [MIM:263800] |
| P55017 | S12A3_HUMAN Solute carrier family 12 member 3 OS=Homo sapiens GN=SLC12A3 PE=1 SV=3 | 854 | R | 0.225798 | K | 0.285181 | -0.059383 | No Change: Both O | - |
| Q9H2X9 | S12A5_HUMAN Solute carrier family 12 member 5 OS=Homo sapiens GN=SLC12A5 PE=2 SV=3 | 1100 | P | 0.617428 | L | 0.484332 | 0.133096 | D to O | - |
| Q9H2X9 | S12A5_HUMAN Solute carrier family 12 member 5 OS=Homo sapiens GN=SLC12A5 PE=2 SV=3 | 407 | P | 0.430772 | A | 0.341673 | 0.089099 | No Change: Both O | - |
| Q9H2X9 | S12A5_HUMAN Solute carrier family 12 member 5 OS=Homo sapiens GN=SLC12A5 PE=2 SV=3 | 847 | G | 0.272578 | D | 0.303398 | -0.03082 | No Change: Both O | A colorectal cancer sample |
| Q9UHW9 | S12A6_HUMAN Solute carrier family 12 member 6 OS=Homo sapiens GN=SLC12A6 PE=1 SV=2 | 415 | F | 0.151492 | S | 0.328122 | -0.17663 | No Change: Both O | - |
| Q9Y666 | S12A7_HUMAN Solute carrier family 12 member 7 OS=Homo sapiens GN=SLC12A7 PE=1 SV=3 | 408 | A | 0.326394 | T | 0.347248 | -0.020854 | No Change: Both O | - |
| A0AV02 | S12A8_HUMAN Solute carrier family 12 member 8 OS=Homo sapiens GN=SLC12A8 PE=2 SV=3 | 181 | R | 0.016512 | C | 0.007224 | 0.009288 | No Change: Both O | - |
| A0AV02 | S12A8_HUMAN Solute carrier family 12 member 8 OS=Homo sapiens GN=SLC12A8 PE=2 SV=3 | 266 | P | 0.529515 | L | 0.335624 | 0.193891 | D to O | - |
| A0AV02 | S12A8_HUMAN Solute carrier family 12 member 8 OS=Homo sapiens GN=SLC12A8 PE=2 SV=3 | 541 | K | 0.867646 | R | 0.855564 | 0.012082 | No Change: Both D | - |
| A0AV02 | S12A8_HUMAN Solute carrier family 12 member 8 OS=Homo sapiens GN=SLC12A8 PE=2 SV=3 | 664 | R | 0.572063 | Q | 0.589282 | -0.017219 | No Change: Both D | - |
| A0AV02 | S12A8_HUMAN Solute carrier family 12 member 8 OS=Homo sapiens GN=SLC12A8 PE=2 SV=3 | 281 | I | 0.003045 | V | 0.003452 | -4.07E-04 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 174 | N | 0.436974 | S | 0.471723 | -0.034749 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 42 | F | 0.020371 | L | 0.023672 | -0.003301 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 44 | V | 0.0171 | I | 0.013559 | 0.003541 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 157 | Q | 0.212896 | E | 0.254869 | -0.041973 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 205 | Y | 0.863093 | C | 0.882793 | -0.0197 | No Change: Both D | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 277 | R | 0.08476 | H | 0.079928 | 0.004832 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 332 | V | 0.290092 | A | 0.394659 | -0.104567 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 392 | I | 0.028037 | T | 0.058087 | -0.03005 | No Change: Both O | - |
| Q9BZW2 | S13A1_HUMAN Solute carrier family 13 member 1 OS=Homo sapiens GN=SLC13A1 PE=1 SV=1 | 240 | T | 0.189324 | M | 0.154072 | 0.035252 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 385 | P | 0.133812 | S | 0.140199 | -0.006387 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 550 | I | 0.014807 | V | 0.016131 | -0.001324 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 44 | L | 0.007793 | F | 0.006783 | 0.00101 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 254 | F | 0.322474 | L | 0.370288 | -0.047814 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 310 | A | 0.290679 | P | 0.359294 | -0.068615 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 477 | V | 0.207145 | M | 0.25666 | -0.049515 | No Change: Both O | - |
| Q13183 | S13A2_HUMAN Solute carrier family 13 member 2 OS=Homo sapiens GN=SLC13A2 PE=2 SV=1 | 45 | M | 0.007431 | L | 0.005996 | 0.001435 | No Change: Both O | - |
| Q9UKG4 | S13A4_HUMAN Solute carrier family 13 member 4 OS=Homo sapiens GN=SLC13A4 PE=2 SV=2 | 451 | P | 0.261033 | S | 0.297474 | -0.036441 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 280 | D | 0.105176 | N | 0.099302 | 0.005874 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 291 | S | 0.092622 | P | 0.076313 | 0.016309 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 44 | E | 0.440857 | K | 0.463419 | -0.022562 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 167 | M | 0.308448 | V | 0.254123 | 0.054325 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 171 | W | 0.192023 | R | 0.381666 | -0.189643 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 74 | N | 0.130101 | K | 0.145884 | -0.015783 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 299 | G | 0.075791 | E | 0.089179 | -0.013388 | No Change: Both O | - |
| Q13336 | UT1_HUMAN Urea transporter 1 OS=Homo sapiens GN=SLC14A1 PE=2 SV=2 | 319 | T | 0.041932 | M | 0.035796 | 0.006136 | No Change: Both O | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 880 | A | 0.233139 | T | 0.278561 | -0.045422 | No Change: Both O | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 37 | T | 0.940074 | I | 0.896487 | 0.043587 | No Change: Both D | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 443 | G | 0.679562 | S | 0.714335 | -0.034773 | No Change: Both D | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 750 | V | 0.075015 | I | 0.066504 | 0.008511 | No Change: Both O | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 132 | I | 0.129152 | V | 0.154827 | -0.025675 | No Change: Both O | - |
| Q15849 | UT2_HUMAN Urea transporter 2 OS=Homo sapiens GN=SLC14A2 PE=1 SV=3 | 510 | R | 0.615778 | Q | 0.606417 | 0.009361 | No Change: Both D | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 122 | V | 0.123935 | M | 0.146325 | -0.02239 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 419 | G | 0.43831 | A | 0.381717 | 0.056593 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 451 | T | 0.431364 | N | 0.448645 | -0.017281 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 117 | S | 0.586661 | N | 0.551254 | 0.035407 | No Change: Both D | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 450 | V | 0.432915 | I | 0.389534 | 0.043381 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 459 | R | 0.230061 | C | 0.134156 | 0.095905 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 21 | V | 0.03514 | I | 0.03123 | 0.00391 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 28 | F | 0.109782 | Y | 0.131317 | -0.021535 | No Change: Both O | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 117 | S | 0.586661 | R | 0.520029 | 0.066632 | No Change: Both D | - |
| P46059 | S15A1_HUMAN Solute carrier family 15 member 1 OS=Homo sapiens GN=SLC15A1 PE=2 SV=1 | 537 | P | 0.460914 | S | 0.483082 | -0.022168 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 57 | R | 0.106918 | H | 0.107465 | -5.47E-04 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 73 | Y | 0.011075 | C | 0.008014 | 0.003061 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 350 | L | 0.041272 | F | 0.034643 | 0.006629 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 409 | P | 0.526977 | S | 0.532739 | -0.005762 | No Change: Both D | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 509 | R | 0.690941 | K | 0.716759 | -0.025818 | No Change: Both D | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 609 | A | 0.141584 | G | 0.165873 | -0.024289 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 609 | A | 0.141584 | P | 0.197122 | -0.055538 | No Change: Both O | - |
| Q16348 | S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens GN=SLC15A2 PE=2 SV=2 | 704 | M | 0.626898 | L | 0.553893 | 0.073005 | No Change: Both D | - |
| Q8IY34 | S15A3_HUMAN Solute carrier family 15 member 3 OS=Homo sapiens GN=SLC15A3 PE=1 SV=2 | 349 | I | 0.268926 | F | 0.266843 | 0.002083 | No Change: Both O | - |
| Q8N697 | S15A4_HUMAN Solute carrier family 15 member 4 OS=Homo sapiens GN=SLC15A4 PE=2 SV=1 | 239 | V | 0.015729 | A | 0.022198 | -0.006469 | No Change: Both O | - |
| A6NIM6 | S15A5_HUMAN Solute carrier family 15 member 5 OS=Homo sapiens GN=SLC15A5 PE=3 SV=2 | 141 | H | 0.121934 | Q | 0.131689 | -0.009755 | No Change: Both O | - |
| A6NIM6 | S15A5_HUMAN Solute carrier family 15 member 5 OS=Homo sapiens GN=SLC15A5 PE=3 SV=2 | 271 | P | 0.183782 | L | 0.10453 | 0.079252 | No Change: Both O | - |
| A6NIM6 | S15A5_HUMAN Solute carrier family 15 member 5 OS=Homo sapiens GN=SLC15A5 PE=3 SV=2 | 494 | D | 0.091802 | E | 0.102614 | -0.010812 | No Change: Both O | - |
| A6NIM6 | S15A5_HUMAN Solute carrier family 15 member 5 OS=Homo sapiens GN=SLC15A5 PE=3 SV=2 | 508 | E | 0.212892 | K | 0.22447 | -0.011578 | No Change: Both O | - |
| P53985 | MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens GN=SLC16A1 PE=1 SV=3 | 204 | K | 0.788777 | E | 0.776593 | 0.012184 | No Change: Both D | Symptomatic deficiency in lactate transport (SDLT) [MIM:245340] |
| P53985 | MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens GN=SLC16A1 PE=1 SV=3 | 472 | G | 0.948739 | R | 0.952883 | -0.004144 | No Change: Both D | Symptomatic deficiency in lactate transport (SDLT) [MIM:245340] |
| P53985 | MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens GN=SLC16A1 PE=1 SV=3 | 490 | D | 0.990966 | E | 0.992498 | -0.001532 | No Change: Both D | - |
| P53985 | MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens GN=SLC16A1 PE=1 SV=3 | 85 | S | 0.139154 | G | 0.116187 | 0.022967 | No Change: Both O | - |
| Q8TF71 | MOT10_HUMAN Monocarboxylate transporter 10 OS=Homo sapiens GN=SLC16A10 PE=1 SV=1 | 508 | K | 0.981778 | Q | 0.97799 | 0.003788 | No Change: Both D | - |
| Q8NCK7 | MOT11_HUMAN Monocarboxylate transporter 11 OS=Homo sapiens GN=SLC16A11 PE=2 SV=1 | 127 | D | 0.12264 | G | 0.115814 | 0.006826 | No Change: Both O | - |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 150 | A | 0.037418 | V | 0.024702 | 0.012716 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 397 | L | 0.07144 | P | 0.132355 | -0.060915 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 438 | L | 0.183131 | P | 0.345554 | -0.162423 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 323 | I | 0.045746 | L | 0.04878 | -0.003034 | No Change: Both O | - |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 120 | S | 0.1483 | F | 0.05488 | 0.09342 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 161 | V | 0.053289 | M | 0.074158 | -0.020869 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 360 | L | 0.021793 | W | 0.014674 | 0.007119 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 490 | G | 0.037159 | R | 0.035115 | 0.002044 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| P36021 | MOT8_HUMAN Monocarboxylate transporter 8 OS=Homo sapiens GN=SLC16A2 PE=1 SV=2 | 494 | L | 0.036482 | P | 0.07893 | -0.042448 | No Change: Both O | Monocarboxylate transporter 8 deficiency (MCT8 deficiency) [MIM:300523] |
| O15374 | MOT5_HUMAN Monocarboxylate transporter 5 OS=Homo sapiens GN=SLC16A4 PE=2 SV=1 | 264 | N | 0.731805 | H | 0.659997 | 0.071808 | No Change: Both D | - |
| O15374 | MOT5_HUMAN Monocarboxylate transporter 5 OS=Homo sapiens GN=SLC16A4 PE=2 SV=1 | 185 | A | 0.06841 | T | 0.072195 | -0.003785 | No Change: Both O | - |
| O15403 | MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens GN=SLC16A6 PE=1 SV=2 | 121 | I | 0.087795 | T | 0.147296 | -0.059501 | No Change: Both O | - |
| O15403 | MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens GN=SLC16A6 PE=1 SV=2 | 204 | F | 0.132185 | I | 0.143241 | -0.011056 | No Change: Both O | - |
| O15403 | MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens GN=SLC16A6 PE=1 SV=2 | 217 | E | 0.462866 | D | 0.418005 | 0.044861 | No Change: Both O | - |
| O15403 | MOT7_HUMAN Monocarboxylate transporter 7 OS=Homo sapiens GN=SLC16A6 PE=1 SV=2 | 221 | E | 0.506357 | V | 0.302659 | 0.203698 | D to O | - |
| O60669 | MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens GN=SLC16A7 PE=2 SV=2 | 445 | T | 0.813621 | S | 0.853479 | -0.039858 | No Change: Both D | - |
| O95907 | MOT3_HUMAN Monocarboxylate transporter 3 OS=Homo sapiens GN=SLC16A8 PE=2 SV=1 | 405 | V | 0.129715 | A | 0.176695 | -0.04698 | No Change: Both O | - |
| O95907 | MOT3_HUMAN Monocarboxylate transporter 3 OS=Homo sapiens GN=SLC16A8 PE=2 SV=1 | 235 | R | 0.65367 | W | 0.462931 | 0.190739 | D to O | - |
| Q7RTY1 | MOT9_HUMAN Monocarboxylate transporter 9 OS=Homo sapiens GN=SLC16A9 PE=2 SV=1 | 258 | T | 0.607588 | K | 0.657159 | -0.049571 | No Change: Both D | - |
| Q7RTY1 | MOT9_HUMAN Monocarboxylate transporter 9 OS=Homo sapiens GN=SLC16A9 PE=2 SV=1 | 461 | D | 0.052574 | E | 0.055918 | -0.003344 | No Change: Both O | - |
| Q7RTY1 | MOT9_HUMAN Monocarboxylate transporter 9 OS=Homo sapiens GN=SLC16A9 PE=2 SV=1 | 203 | A | 0.6719 | V | 0.585445 | 0.086455 | No Change: Both D | - |
| Q14916 | NPT1_HUMAN Sodium-dependent phosphate transport protein 1 OS=Homo sapiens GN=SLC17A1 PE=2 SV=2 | 76 | S | 0.230889 | N | 0.210485 | 0.020404 | No Change: Both O | - |
| Q14916 | NPT1_HUMAN Sodium-dependent phosphate transport protein 1 OS=Homo sapiens GN=SLC17A1 PE=2 SV=2 | 269 | T | 0.114105 | I | 0.063664 | 0.050441 | No Change: Both O | - |
| O00476 | NPT4_HUMAN Sodium-dependent phosphate transport protein 4 OS=Homo sapiens GN=SLC17A3 PE=2 SV=2 | 100 | A | 0.709861 | T | 0.694188 | 0.015673 | No Change: Both D | - |
| O00476 | NPT4_HUMAN Sodium-dependent phosphate transport protein 4 OS=Homo sapiens GN=SLC17A3 PE=2 SV=2 | 201 | G | 0.724668 | R | 0.716036 | 0.008632 | No Change: Both D | - |
| O00476 | NPT4_HUMAN Sodium-dependent phosphate transport protein 4 OS=Homo sapiens GN=SLC17A3 PE=2 SV=2 | 300 | P | 0.309805 | L | 0.186569 | 0.123236 | No Change: Both O | - |
| Q9Y2C5 | S17A4_HUMAN Putative small intestine sodium-dependent phosphate transport protein OS=Homo sapiens GN=SLC17A4 PE=2 SV=1 | 372 | A | 0.043064 | T | 0.054546 | -0.011482 | No Change: Both O | - |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 39 | R | 0.073783 | C | 0.040937 | 0.032846 | No Change: Both O | Salla disease (SD) [MIM:604369] |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 136 | K | 0.225384 | E | 0.212618 | 0.012766 | No Change: Both O | Salla disease (SD) [MIM:604369] |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 183 | H | 0.185924 | R | 0.190588 | -0.004664 | No Change: Both O | Infantile sialic acid storage disorder (ISSD) [MIM:269920] |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 334 | P | 0.149834 | R | 0.128022 | 0.021812 | No Change: Both O | Infantile sialic acid storage disorder (ISSD) [MIM:269920] |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 371 | G | 0.052229 | V | 0.027204 | 0.025025 | No Change: Both O | Infantile sialic acid storage disorder (ISSD) [MIM:269920] |
| Q9NRA2 | S17A5_HUMAN Sialin OS=Homo sapiens GN=SLC17A5 PE=1 SV=2 | 296 | V | 0.025086 | I | 0.021622 | 0.003464 | No Change: Both O | - |
| Q9P2U8 | VGLU2_HUMAN Vesicular glutamate transporter 2 OS=Homo sapiens GN=SLC17A6 PE=1 SV=1 | 40 | T | 0.657753 | S | 0.675408 | -0.017655 | No Change: Both D | A breast cancer sample |
| Q9P2U8 | VGLU2_HUMAN Vesicular glutamate transporter 2 OS=Homo sapiens GN=SLC17A6 PE=1 SV=1 | 551 | N | 0.487548 | S | 0.549539 | -0.061991 | O to D | - |
| Q9P2U7 | VGLU1_HUMAN Vesicular glutamate transporter 1 OS=Homo sapiens GN=SLC17A7 PE=1 SV=1 | 431 | P | 0.16352 | R | 0.148875 | 0.014645 | No Change: Both O | - |
| Q8NDX2 | VGLU3_HUMAN Vesicular glutamate transporter 3 OS=Homo sapiens GN=SLC17A8 PE=1 SV=1 | 8 | T | 0.462516 | I | 0.35338 | 0.109136 | No Change: Both O | - |
| Q8NDX2 | VGLU3_HUMAN Vesicular glutamate transporter 3 OS=Homo sapiens GN=SLC17A8 PE=1 SV=1 | 211 | A | 0.342448 | V | 0.258351 | 0.084097 | No Change: Both O | Deafness autosomal dominant type 25 (DFNA25) [MIM:605583] |
| Q8NDX2 | VGLU3_HUMAN Vesicular glutamate transporter 3 OS=Homo sapiens GN=SLC17A8 PE=1 SV=1 | 220 | A | 0.359815 | T | 0.410356 | -0.050541 | No Change: Both O | - |
| Q8NDX2 | VGLU3_HUMAN Vesicular glutamate transporter 3 OS=Homo sapiens GN=SLC17A8 PE=1 SV=1 | 246 | G | 0.038303 | E | 0.046493 | -0.00819 | No Change: Both O | - |
| Q9BYT1 | S17A9_HUMAN Solute carrier family 17 member 9 OS=Homo sapiens GN=SLC17A9 PE=2 SV=2 | 228 | N | 0.483569 | S | 0.550042 | -0.066473 | O to D | - |
| Q9BYT1 | S17A9_HUMAN Solute carrier family 17 member 9 OS=Homo sapiens GN=SLC17A9 PE=2 SV=2 | 397 | T | 0.164765 | M | 0.132162 | 0.032603 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 136 | I | 0.23368 | T | 0.36452 | -0.13084 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 98 | S | 0.408112 | T | 0.33824 | 0.069872 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 4 | T | 0.585891 | P | 0.654202 | -0.068311 | No Change: Both D | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 74 | A | 0.580704 | V | 0.478088 | 0.102616 | D to O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 84 | F | 0.336158 | S | 0.534081 | -0.197923 | O to D | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 101 | A | 0.340523 | P | 0.442195 | -0.101672 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 164 | I | 0.15333 | M | 0.218851 | -0.065521 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 249 | V | 0.162188 | I | 0.131979 | 0.030209 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 392 | L | 0.155694 | V | 0.147204 | 0.00849 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 82 | F | 0.315316 | C | 0.29567 | 0.019646 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 140 | G | 0.111234 | R | 0.112973 | -0.001739 | No Change: Both O | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 202 | I | 0.401107 | T | 0.549077 | -0.14797 | O to D | - |
| P54219 | VMAT1_HUMAN Chromaffin granule amine transporter OS=Homo sapiens GN=SLC18A1 PE=2 SV=1 | 11 | R | 0.380403 | Q | 0.399421 | -0.019018 | No Change: Both O | - |
| Q16572 | VACHT_HUMAN Vesicular acetylcholine transporter OS=Homo sapiens GN=SLC18A3 PE=1 SV=2 | 13 | A | 0.707588 | P | 0.760452 | -0.052864 | No Change: Both D | - |
| Q16572 | VACHT_HUMAN Vesicular acetylcholine transporter OS=Homo sapiens GN=SLC18A3 PE=1 SV=2 | 29 | R | 0.468375 | W | 0.249217 | 0.219158 | No Change: Both O | - |
| Q16572 | VACHT_HUMAN Vesicular acetylcholine transporter OS=Homo sapiens GN=SLC18A3 PE=1 SV=2 | 520 | A | 0.788078 | E | 0.877655 | -0.089577 | No Change: Both D | - |
| Q16572 | VACHT_HUMAN Vesicular acetylcholine transporter OS=Homo sapiens GN=SLC18A3 PE=1 SV=2 | 11 | R | 0.762656 | Q | 0.775403 | -0.012747 | No Change: Both D | - |
| P41440 | S19A1_HUMAN Folate transporter 1 OS=Homo sapiens GN=SLC19A1 PE=1 SV=3 | 27 | H | 0.081836 | R | 0.116307 | -0.034471 | No Change: Both O | - |
| P41440 | S19A1_HUMAN Folate transporter 1 OS=Homo sapiens GN=SLC19A1 PE=1 SV=3 | 558 | A | 0.883074 | V | 0.847431 | 0.035643 | No Change: Both D | - |
| O60779 | S19A2_HUMAN Thiamine transporter 1 OS=Homo sapiens GN=SLC19A2 PE=1 SV=2 | 172 | G | 0.12414 | D | 0.126991 | -0.002851 | No Change: Both O | Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270] |
| O60779 | S19A2_HUMAN Thiamine transporter 1 OS=Homo sapiens GN=SLC19A2 PE=1 SV=2 | 93 | D | 0.070804 | H | 0.058954 | 0.01185 | No Change: Both O | Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270] |
| O60779 | S19A2_HUMAN Thiamine transporter 1 OS=Homo sapiens GN=SLC19A2 PE=1 SV=2 | 143 | S | 0.076954 | F | 0.02541 | 0.051544 | No Change: Both O | Thiamine-responsive megaloblastic anemia syndrome (TRMA) [MIM:249270] |
| Q9BZV2 | S19A3_HUMAN Thiamine transporter 2 OS=Homo sapiens GN=SLC19A3 PE=1 SV=1 | 23 | G | 0.050428 | V | 0.029385 | 0.021043 | No Change: Both O | Biotin-responsive basal ganglia disease (BBGD) [MIM:607483] |
| Q9BZV2 | S19A3_HUMAN Thiamine transporter 2 OS=Homo sapiens GN=SLC19A3 PE=1 SV=1 | 422 | T | 0.04127 | A | 0.034086 | 0.007184 | No Change: Both O | Biotin-responsive basal ganglia disease (BBGD) [MIM:607483] |
| Q9BZV2 | S19A3_HUMAN Thiamine transporter 2 OS=Homo sapiens GN=SLC19A3 PE=1 SV=1 | 350 | V | 0.051803 | A | 0.072941 | -0.021138 | No Change: Both O | - |
| Q9BZV2 | S19A3_HUMAN Thiamine transporter 2 OS=Homo sapiens GN=SLC19A3 PE=1 SV=1 | 174 | V | 0.097756 | I | 0.08488 | 0.012876 | No Change: Both O | - |
| P43005 | EAA3_HUMAN Excitatory amino acid transporter 3 OS=Homo sapiens GN=SLC1A1 PE=1 SV=2 | 50 | F | 0.163436 | Y | 0.184268 | -0.020832 | No Change: Both O | - |
| P43005 | EAA3_HUMAN Excitatory amino acid transporter 3 OS=Homo sapiens GN=SLC1A1 PE=1 SV=2 | 27 | A | 0.057152 | G | 0.075146 | -0.017994 | No Change: Both O | - |
| P43003 | EAA1_HUMAN Excitatory amino acid transporter 1 OS=Homo sapiens GN=SLC1A3 PE=1 SV=1 | 219 | E | 0.346837 | D | 0.302471 | 0.044366 | No Change: Both O | - |
| P43003 | EAA1_HUMAN Excitatory amino acid transporter 1 OS=Homo sapiens GN=SLC1A3 PE=1 SV=1 | 290 | P | 0.013661 | R | 0.011399 | 0.002262 | No Change: Both O | Episodic ataxia type 6 (EA6) [MIM:612656] |
| P43007 | SATT_HUMAN Neutral amino acid transporter A OS=Homo sapiens GN=SLC1A4 PE=1 SV=1 | 37 | G | 0.498808 | R | 0.527142 | -0.028334 | O to D | - |
| P43007 | SATT_HUMAN Neutral amino acid transporter A OS=Homo sapiens GN=SLC1A4 PE=1 SV=1 | 399 | V | 0.191145 | I | 0.177408 | 0.013737 | No Change: Both O | - |
| Q15758 | AAAT_HUMAN Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5 PE=1 SV=2 | 512 | V | 0.757118 | L | 0.784456 | -0.027338 | No Change: Both D | - |
| Q15758 | AAAT_HUMAN Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5 PE=1 SV=2 | 17 | P | 0.683561 | A | 0.632772 | 0.050789 | No Change: Both D | - |
| O00341 | EAA5_HUMAN Excitatory amino acid transporter 5 OS=Homo sapiens GN=SLC1A7 PE=2 SV=2 | 41 | R | 0.276952 | C | 0.136612 | 0.14034 | No Change: Both O | A colorectal cancer sample |
| O00341 | EAA5_HUMAN Excitatory amino acid transporter 5 OS=Homo sapiens GN=SLC1A7 PE=2 SV=2 | 537 | Q | 0.64989 | R | 0.601321 | 0.048569 | No Change: Both D | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 14 | S | 0.293675 | F | 0.133099 | 0.160576 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 41 | F | 0.039193 | L | 0.044558 | -0.005365 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 61 | R | 0.326953 | C | 0.203682 | 0.123271 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 85 | L | 0.222848 | F | 0.203549 | 0.019299 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 88 | C | 0.154327 | R | 0.265582 | -0.111255 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 160 | L | 0.093739 | F | 0.083176 | 0.010563 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 189 | S | 0.130943 | L | 0.058836 | 0.072107 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 220 | G | 0.080723 | V | 0.042705 | 0.038018 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 283 | P | 0.080628 | L | 0.040332 | 0.040296 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 287 | R | 0.215703 | G | 0.219354 | -0.003651 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 341 | P | 0.300618 | L | 0.181399 | 0.119219 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 342 | R | 0.279006 | H | 0.254624 | 0.024382 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 401 | G | 0.122146 | S | 0.157548 | -0.035402 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 408 | M | 0.18889 | V | 0.1395 | 0.04939 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 440 | M | 0.051656 | I | 0.034752 | 0.016904 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 461 | V | 0.082608 | I | 0.065321 | 0.017287 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 465 | G | 0.082171 | R | 0.082752 | -5.81E-04 | No Change: Both O | - |
| O15245 | S22A1_HUMAN Solute carrier family 22 member 1 OS=Homo sapiens GN=SLC22A1 PE=1 SV=2 | 488 | R | 0.038111 | M | 0.026274 | 0.011837 | No Change: Both O | - |
| Q9NSA0 | S22AB_HUMAN Solute carrier family 22 member 11 OS=Homo sapiens GN=SLC22A11 PE=1 SV=1 | 155 | V | 0.056469 | G | 0.115307 | -0.058838 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 65 | G | 0.592908 | W | 0.446133 | 0.146775 | D to O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 90 | R | 0.649539 | H | 0.597426 | 0.052113 | No Change: Both D | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 92 | R | 0.517254 | C | 0.376729 | 0.140525 | D to O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 138 | V | 0.099793 | M | 0.126783 | -0.02699 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 164 | G | 0.326826 | S | 0.37124 | -0.044414 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 217 | T | 0.180695 | M | 0.155726 | 0.024969 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 226 | A | 0.175708 | V | 0.119702 | 0.056006 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 284 | R | 0.103496 | G | 0.112632 | -0.009136 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 290 | G | 0.121484 | C | 0.049223 | 0.072261 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 297 | Q | 0.090997 | E | 0.119652 | -0.028655 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 298 | E | 0.075891 | D | 0.072496 | 0.003395 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 305 | I | 0.161147 | S | 0.334445 | -0.173298 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 312 | Q | 0.338214 | L | 0.236018 | 0.102196 | No Change: Both O | - |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 382 | Q | 0.027828 | L | 0.015358 | 0.01247 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 418 | L | 0.061669 | R | 0.093388 | -0.031719 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 430 | M | 0.342436 | T | 0.403429 | -0.060993 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q96S37 | S22AC_HUMAN Solute carrier family 22 member 12 OS=Homo sapiens GN=SLC22A12 PE=1 SV=1 | 477 | R | 0.293728 | H | 0.296601 | -0.002873 | No Change: Both O | Hypouricemia renal type 1 (RHUC1) [MIM:220150] |
| Q9Y226 | S22AD_HUMAN Solute carrier family 22 member 13 OS=Homo sapiens GN=SLC22A13 PE=2 SV=2 | 43 | V | 0.147818 | I | 0.121338 | 0.02648 | No Change: Both O | - |
| Q9Y226 | S22AD_HUMAN Solute carrier family 22 member 13 OS=Homo sapiens GN=SLC22A13 PE=2 SV=2 | 443 | L | 0.121589 | F | 0.10739 | 0.014199 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 108 | P | 0.210646 | H | 0.19664 | 0.014006 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 112 | K | 0.45631 | E | 0.474926 | -0.018616 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 144 | I | 0.08996 | T | 0.15543 | -0.06547 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 245 | S | 0.120016 | L | 0.048462 | 0.071554 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 284 | V | 0.037714 | M | 0.047262 | -0.009548 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 292 | S | 0.071117 | G | 0.059796 | 0.011321 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 466 | L | 0.269749 | P | 0.447051 | -0.177302 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 512 | A | 0.162676 | V | 0.123623 | 0.039053 | No Change: Both O | - |
| Q9Y267 | S22AE_HUMAN Solute carrier family 22 member 14 OS=Homo sapiens GN=SLC22A14 PE=2 SV=4 | 560 | P | 0.568197 | R | 0.539173 | 0.029024 | No Change: Both D | - |
| Q8IZD6 | S22AF_HUMAN Solute carrier family 22 member 15 OS=Homo sapiens GN=SLC22A15 PE=2 SV=1 | 349 | P | 0.112628 | Q | 0.096881 | 0.015747 | No Change: Both O | - |
| Q86VW1 | S22AG_HUMAN Solute carrier family 22 member 16 OS=Homo sapiens GN=SLC22A16 PE=1 SV=1 | 49 | H | 0.278313 | R | 0.275092 | 0.003221 | No Change: Both O | - |
| Q86VW1 | S22AG_HUMAN Solute carrier family 22 member 16 OS=Homo sapiens GN=SLC22A16 PE=1 SV=1 | 252 | V | 0.090317 | A | 0.129997 | -0.03968 | No Change: Both O | - |
| Q86VW1 | S22AG_HUMAN Solute carrier family 22 member 16 OS=Homo sapiens GN=SLC22A16 PE=1 SV=1 | 409 | M | 0.097995 | T | 0.130021 | -0.032026 | No Change: Both O | - |
| Q86VW1 | S22AG_HUMAN Solute carrier family 22 member 16 OS=Homo sapiens GN=SLC22A16 PE=1 SV=1 | 431 | V | 0.04188 | I | 0.035141 | 0.006739 | No Change: Both O | - |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 86 | R | 0.38081 | C | 0.210892 | 0.169918 | No Change: Both O | A rhabdomyosarcoma sample |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 233 | S | 0.204724 | F | 0.101765 | 0.102959 | No Change: Both O | Lung cancer (LNCR) [MIM:211980] |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 309 | R | 0.126902 | Q | 0.136699 | -0.009797 | No Change: Both O | - |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 6 | A | 0.833818 | T | 0.838832 | -0.005014 | No Change: Both D | - |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 12 | R | 0.780526 | Q | 0.783498 | -0.002972 | No Change: Both D | - |
| Q96BI1 | S22AI_HUMAN Solute carrier family 22 member 18 OS=Homo sapiens GN=SLC22A18 PE=1 SV=3 | 324 | W | 0.064288 | C | 0.07857 | -0.014282 | No Change: Both O | - |
| Q8N1D0 | BWR1B_HUMAN Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein OS=Homo sapiens GN=SLC22A18AS PE=2 SV=2 | 133 | R | 0.538424 | G | 0.538473 | -4.90E-05 | No Change: Both D | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 54 | P | 0.45194 | S | 0.494537 | -0.042597 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 165 | M | 0.113347 | I | 0.083179 | 0.030168 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 201 | T | 0.03401 | M | 0.027731 | 0.006279 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 270 | S | 0.046004 | A | 0.027186 | 0.018818 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 297 | A | 0.419028 | G | 0.462286 | -0.043258 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 400 | R | 0.081651 | C | 0.033536 | 0.048115 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 432 | K | 0.032564 | Q | 0.027866 | 0.004698 | No Change: Both O | - |
| O15244 | S22A2_HUMAN Solute carrier family 22 member 2 OS=Homo sapiens GN=SLC22A2 PE=1 SV=2 | 463 | R | 0.08221 | K | 0.109815 | -0.027605 | No Change: Both O | - |
| A6NK97 | S22AK_HUMAN Solute carrier family 22 member 20 OS=Homo sapiens GN=SLC22A20 PE=2 SV=1 | 58 | A | 0.600348 | D | 0.625482 | -0.025134 | No Change: Both D | - |
| A6NK97 | S22AK_HUMAN Solute carrier family 22 member 20 OS=Homo sapiens GN=SLC22A20 PE=2 SV=1 | 139 | A | 0.233661 | V | 0.170112 | 0.063549 | No Change: Both O | - |
| Q6T423 | S22AP_HUMAN Solute carrier family 22 member 25 OS=Homo sapiens GN=SLC22A25 PE=2 SV=2 | 250 | S | 0.096603 | G | 0.080891 | 0.015712 | No Change: Both O | - |
| Q6T423 | S22AP_HUMAN Solute carrier family 22 member 25 OS=Homo sapiens GN=SLC22A25 PE=2 SV=2 | 300 | R | 0.643496 | T | 0.614203 | 0.029293 | No Change: Both D | - |
| Q6T423 | S22AP_HUMAN Solute carrier family 22 member 25 OS=Homo sapiens GN=SLC22A25 PE=2 SV=2 | 89 | R | 0.336321 | C | 0.242118 | 0.094203 | No Change: Both O | - |
| Q6T423 | S22AP_HUMAN Solute carrier family 22 member 25 OS=Homo sapiens GN=SLC22A25 PE=2 SV=2 | 448 | G | 0.240444 | A | 0.199474 | 0.04097 | No Change: Both O | - |
| Q6T423 | S22AP_HUMAN Solute carrier family 22 member 25 OS=Homo sapiens GN=SLC22A25 PE=2 SV=2 | 486 | M | 0.109074 | V | 0.076393 | 0.032681 | No Change: Both O | - |
| O75751 | S22A3_HUMAN Solute carrier family 22 member 3 OS=Homo sapiens GN=SLC22A3 PE=1 SV=1 | 44 | T | 0.108995 | M | 0.086987 | 0.022008 | No Change: Both O | - |
| O75751 | S22A3_HUMAN Solute carrier family 22 member 3 OS=Homo sapiens GN=SLC22A3 PE=1 SV=1 | 116 | A | 0.436245 | S | 0.529236 | -0.092991 | O to D | - |
| Q9H015 | S22A4_HUMAN Solute carrier family 22 member 4 OS=Homo sapiens GN=SLC22A4 PE=1 SV=3 | 306 | I | 0.211023 | T | 0.291942 | -0.080919 | No Change: Both O | - |
| Q9H015 | S22A4_HUMAN Solute carrier family 22 member 4 OS=Homo sapiens GN=SLC22A4 PE=1 SV=3 | 462 | G | 0.337548 | E | 0.392601 | -0.055053 | No Change: Both O | - |
| Q9H015 | S22A4_HUMAN Solute carrier family 22 member 4 OS=Homo sapiens GN=SLC22A4 PE=1 SV=3 | 503 | L | 0.034665 | F | 0.029744 | 0.004921 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 169 | R | 0.287403 | Q | 0.301138 | -0.013735 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 211 | Y | 0.096165 | C | 0.0761 | 0.020065 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 283 | W | 0.18405 | R | 0.388087 | -0.204037 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 446 | V | 0.068755 | F | 0.059047 | 0.009708 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 452 | E | 0.118105 | K | 0.118006 | 9.90E-05 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 478 | P | 0.101806 | L | 0.054278 | 0.047528 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 17 | F | 0.058207 | L | 0.066418 | -0.008211 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 144 | L | 0.075141 | F | 0.067269 | 0.007872 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 481 | V | 0.049921 | F | 0.046994 | 0.002927 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 549 | P | 0.822396 | S | 0.830655 | -0.008259 | No Change: Both D | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 179 | M | 0.159088 | L | 0.121952 | 0.037136 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 283 | W | 0.18405 | C | 0.207021 | -0.022971 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 467 | S | 0.55689 | C | 0.27004 | 0.28685 | D to O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 449 | Y | 0.080814 | D | 0.144818 | -0.064004 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 508 | F | 0.107567 | L | 0.127973 | -0.020406 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 530 | M | 0.711921 | V | 0.632099 | 0.079822 | No Change: Both D | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 481 | V | 0.049921 | I | 0.045915 | 0.004006 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 12 | G | 0.107399 | S | 0.126097 | -0.018698 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 15 | G | 0.081655 | W | 0.029449 | 0.052206 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 19 | R | 0.038515 | P | 0.049847 | -0.011332 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 32 | N | 0.270773 | S | 0.334526 | -0.063753 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 46 | P | 0.208725 | S | 0.229636 | -0.020911 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 66 | T | 0.329475 | P | 0.414295 | -0.08482 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 75 | R | 0.497604 | P | 0.51001 | -0.012406 | O to D | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 83 | R | 0.287154 | L | 0.181792 | 0.105362 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 96 | G | 0.299938 | A | 0.25956 | 0.040378 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 122 | D | 0.133132 | Y | 0.067488 | 0.065644 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 123 | V | 0.119659 | G | 0.206119 | -0.08646 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 142 | A | 0.124309 | S | 0.203363 | -0.079054 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 143 | P | 0.10043 | L | 0.05323 | 0.0472 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 169 | R | 0.287403 | W | 0.121661 | 0.165742 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 177 | M | 0.138602 | V | 0.107167 | 0.031435 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 186 | L | 0.144323 | P | 0.268297 | -0.123974 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 214 | A | 0.058463 | V | 0.041393 | 0.01707 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 227 | R | 0.117201 | H | 0.118781 | -0.00158 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 230 | F | 0.047665 | L | 0.058174 | -0.010509 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 232 | T | 0.030483 | M | 0.024388 | 0.006095 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 234 | G | 0.017168 | R | 0.016697 | 4.71E-04 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 240 | A | 0.012262 | T | 0.01463 | -0.002368 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 242 | G | 0.013498 | V | 0.00736 | 0.006138 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 257 | R | 0.024912 | W | 0.009081 | 0.015831 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 264 | T | 0.051874 | R | 0.057708 | -0.005834 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 282 | R | 0.144302 | Q | 0.160172 | -0.01587 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 301 | A | 0.270698 | D | 0.326747 | -0.056049 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 312 | I | 0.271053 | V | 0.304915 | -0.033862 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 351 | W | 0.040357 | R | 0.103232 | -0.062875 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 355 | S | 0.049947 | L | 0.020613 | 0.029334 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 358 | Y | 0.095684 | N | 0.175636 | -0.079952 | No Change: Both O | - |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 362 | S | 0.271555 | L | 0.141276 | 0.130279 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 398 | P | 0.14194 | L | 0.07865 | 0.06329 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 399 | R | 0.162577 | Q | 0.176393 | -0.013816 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 399 | R | 0.162577 | W | 0.061992 | 0.100585 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 440 | T | 0.120574 | M | 0.107348 | 0.013226 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 442 | A | 0.094092 | I | 0.052709 | 0.041383 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 443 | F | 0.086717 | V | 0.105504 | -0.018787 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 447 | Y | 0.068823 | C | 0.050499 | 0.018324 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 455 | P | 0.143579 | R | 0.130407 | 0.013172 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 468 | T | 0.580661 | R | 0.613332 | -0.032671 | No Change: Both D | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 471 | R | 0.531699 | C | 0.336484 | 0.195215 | D to O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 488 | R | 0.053687 | C | 0.024743 | 0.028944 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 507 | L | 0.086105 | S | 0.172578 | -0.086473 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 26 | S | 0.056798 | N | 0.046397 | 0.010401 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 280 | S | 0.102898 | F | 0.037664 | 0.065234 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 471 | R | 0.531699 | P | 0.584973 | -0.053274 | No Change: Both D | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| O76082 | S22A5_HUMAN Solute carrier family 22 member 5 OS=Homo sapiens GN=SLC22A5 PE=1 SV=1 | 488 | R | 0.053687 | H | 0.053918 | -2.31E-04 | No Change: Both O | Systemic primary carnitine deficiency (CDSP) [MIM:212140] |
| Q4U2R8 | S22A6_HUMAN Solute carrier family 22 member 6 OS=Homo sapiens GN=SLC22A6 PE=1 SV=1 | 7 | L | 0.325062 | P | 0.479327 | -0.154265 | No Change: Both O | - |
| Q4U2R8 | S22A6_HUMAN Solute carrier family 22 member 6 OS=Homo sapiens GN=SLC22A6 PE=1 SV=1 | 50 | R | 0.459281 | H | 0.483964 | -0.024683 | No Change: Both O | - |
| Q4U2R8 | S22A6_HUMAN Solute carrier family 22 member 6 OS=Homo sapiens GN=SLC22A6 PE=1 SV=1 | 293 | R | 0.398273 | W | 0.185107 | 0.213166 | No Change: Both O | - |
| Q4U2R8 | S22A6_HUMAN Solute carrier family 22 member 6 OS=Homo sapiens GN=SLC22A6 PE=1 SV=1 | 104 | P | 0.323042 | L | 0.191019 | 0.132023 | No Change: Both O | - |
| Q9Y694 | S22A7_HUMAN Solute carrier family 22 member 7 OS=Homo sapiens GN=SLC22A7 PE=1 SV=1 | 303 | R | 0.16921 | K | 0.19344 | -0.02423 | No Change: Both O | - |
| Q9Y694 | S22A7_HUMAN Solute carrier family 22 member 7 OS=Homo sapiens GN=SLC22A7 PE=1 SV=1 | 327 | R | 0.419984 | W | 0.198527 | 0.221457 | No Change: Both O | - |
| Q9Y694 | S22A7_HUMAN Solute carrier family 22 member 7 OS=Homo sapiens GN=SLC22A7 PE=1 SV=1 | 507 | G | 0.213374 | V | 0.132923 | 0.080451 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 129 | F | 0.096938 | L | 0.119336 | -0.022398 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 149 | R | 0.264063 | S | 0.325152 | -0.061089 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 260 | I | 0.113718 | R | 0.227395 | -0.113677 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 277 | R | 0.225459 | W | 0.098717 | 0.126742 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 281 | V | 0.401467 | A | 0.478273 | -0.076806 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 305 | I | 0.424078 | F | 0.430879 | -0.006801 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 389 | A | 0.241248 | V | 0.160136 | 0.081112 | No Change: Both O | - |
| Q8TCC7 | S22A8_HUMAN Solute carrier family 22 member 8 OS=Homo sapiens GN=SLC22A8 PE=1 SV=1 | 448 | V | 0.229838 | I | 0.199283 | 0.030555 | No Change: Both O | - |
| Q8IVM8 | S22A9_HUMAN Solute carrier family 22 member 9 OS=Homo sapiens GN=SLC22A9 PE=2 SV=1 | 393 | A | 0.023178 | V | 0.015553 | 0.007625 | No Change: Both O | A breast cancer sample |
| Q8IVM8 | S22A9_HUMAN Solute carrier family 22 member 9 OS=Homo sapiens GN=SLC22A9 PE=2 SV=1 | 487 | M | 0.094718 | V | 0.071148 | 0.02357 | No Change: Both O | A breast cancer sample |
| Q8IVM8 | S22A9_HUMAN Solute carrier family 22 member 9 OS=Homo sapiens GN=SLC22A9 PE=2 SV=1 | 521 | N | 0.435121 | K | 0.481491 | -0.04637 | No Change: Both O | A colorectal cancer sample |
| Q9UHI7 | S23A1_HUMAN Solute carrier family 23 member 1 OS=Homo sapiens GN=SLC23A1 PE=1 SV=3 | 218 | I | 0.026968 | V | 0.02772 | -7.52E-04 | No Change: Both O | - |
| Q9UHI7 | S23A1_HUMAN Solute carrier family 23 member 1 OS=Homo sapiens GN=SLC23A1 PE=1 SV=3 | 258 | M | 0.026035 | V | 0.018224 | 0.007811 | No Change: Both O | - |
| Q9UHI7 | S23A1_HUMAN Solute carrier family 23 member 1 OS=Homo sapiens GN=SLC23A1 PE=1 SV=3 | 264 | V | 0.007038 | M | 0.010183 | -0.003145 | No Change: Both O | - |
| Q9UHI7 | S23A1_HUMAN Solute carrier family 23 member 1 OS=Homo sapiens GN=SLC23A1 PE=1 SV=3 | 421 | S | 0.211297 | A | 0.136401 | 0.074896 | No Change: Both O | - |
| O60721 | NCKX1_HUMAN Sodium/potassium/calcium exchanger 1 OS=Homo sapiens GN=SLC24A1 PE=1 SV=1 | 37 | T | 0.22282 | S | 0.311225 | -0.088405 | No Change: Both O | - |
| O60721 | NCKX1_HUMAN Sodium/potassium/calcium exchanger 1 OS=Homo sapiens GN=SLC24A1 PE=1 SV=1 | 311 | V | 0.724201 | L | 0.74192 | -0.017719 | No Change: Both D | - |
| O60721 | NCKX1_HUMAN Sodium/potassium/calcium exchanger 1 OS=Homo sapiens GN=SLC24A1 PE=1 SV=1 | 313 | L | 0.706857 | V | 0.709754 | -0.002897 | No Change: Both D | - |
| Q9HC58 | NCKX3_HUMAN Sodium/potassium/calcium exchanger 3 OS=Homo sapiens GN=SLC24A3 PE=2 SV=4 | 49 | L | 0.538865 | P | 0.620035 | -0.08117 | No Change: Both D | - |
| Q9HC58 | NCKX3_HUMAN Sodium/potassium/calcium exchanger 3 OS=Homo sapiens GN=SLC24A3 PE=2 SV=4 | 55 | V | 0.445426 | I | 0.388513 | 0.056913 | No Change: Both O | - |
| Q9HC58 | NCKX3_HUMAN Sodium/potassium/calcium exchanger 3 OS=Homo sapiens GN=SLC24A3 PE=2 SV=4 | 168 | V | 0.087094 | I | 0.077869 | 0.009225 | No Change: Both O | - |
| Q9HC58 | NCKX3_HUMAN Sodium/potassium/calcium exchanger 3 OS=Homo sapiens GN=SLC24A3 PE=2 SV=4 | 271 | G | 0.496268 | S | 0.534497 | -0.038229 | O to D | - |
| Q8NFF2 | NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens GN=SLC24A4 PE=2 SV=2 | 613 | V | 0.055864 | I | 0.045704 | 0.01016 | No Change: Both O | - |
| Q71RS6 | NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens GN=SLC24A5 PE=1 SV=1 | 111 | T | 0.336348 | A | 0.317497 | 0.018851 | No Change: Both O | - |
| Q6J4K2 | NCKX6_HUMAN Sodium/potassium/calcium exchanger 6 OS=Homo sapiens GN=SLC24A6 PE=2 SV=2 | 222 | R | 0.042741 | C | 0.017457 | 0.025284 | No Change: Both O | - |
| Q6J4K2 | NCKX6_HUMAN Sodium/potassium/calcium exchanger 6 OS=Homo sapiens GN=SLC24A6 PE=2 SV=2 | 358 | L | 0.15562 | F | 0.127777 | 0.027843 | No Change: Both O | - |
| O75746 | CMC1_HUMAN Calcium-binding mitochondrial carrier protein Aralar1 OS=Homo sapiens GN=SLC25A12 PE=1 SV=2 | 473 | R | 0.088236 | Q | 0.093428 | -0.005192 | No Change: Both O | - |
| O75746 | CMC1_HUMAN Calcium-binding mitochondrial carrier protein Aralar1 OS=Homo sapiens GN=SLC25A12 PE=1 SV=2 | 590 | Q | 0.277121 | R | 0.277916 | -7.95E-04 | No Change: Both O | Aspartate-glutamate carrier 1 deficiency (AGC1D) [MIM:612949] |
| Q9UJS0 | CMC2_HUMAN Calcium-binding mitochondrial carrier protein Aralar2 OS=Homo sapiens GN=SLC25A13 PE=1 SV=2 | 601 | E | 0.04914 | K | 0.050144 | -0.001004 | No Change: Both O | Neonatal intrahepatic cholestasis due to citrin deficiency (NICCD) [MIM:605814] |
| Q9UJS0 | CMC2_HUMAN Calcium-binding mitochondrial carrier protein Aralar2 OS=Homo sapiens GN=SLC25A13 PE=1 SV=2 | 141 | E | 0.513956 | K | 0.527202 | -0.013246 | No Change: Both D | - |
| Q9UJS0 | CMC2_HUMAN Calcium-binding mitochondrial carrier protein Aralar2 OS=Homo sapiens GN=SLC25A13 PE=1 SV=2 | 232 | L | 0.1843 | I | 0.164464 | 0.019836 | No Change: Both O | - |
| O95258 | UCP5_HUMAN Brain mitochondrial carrier protein 1 OS=Homo sapiens GN=SLC25A14 PE=2 SV=1 | 55 | E | 0.122359 | A | 0.084451 | 0.037908 | No Change: Both O | - |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 27 | G | 0.244549 | E | 0.263246 | -0.018697 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 27 | G | 0.244549 | R | 0.234531 | 0.010018 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 126 | P | 0.101662 | R | 0.098382 | 0.00328 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 180 | E | 0.193358 | K | 0.193075 | 2.83E-04 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 190 | G | 0.187413 | D | 0.188854 | -0.001441 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 254 | I | 0.074159 | L | 0.077868 | -0.003709 | No Change: Both O | - |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 275 | R | 0.19386 | Q | 0.208827 | -0.014967 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 37 | M | 0.348188 | R | 0.395391 | -0.047203 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 70 | A | 0.226635 | L | 0.162077 | 0.064558 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 71 | L | 0.220152 | Q | 0.356265 | -0.136113 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 113 | G | 0.399808 | C | 0.25225 | 0.147558 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 188 | F | 0.154686 | L | 0.163811 | -0.009125 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 216 | G | 0.170439 | S | 0.199488 | -0.029049 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 272 | T | 0.23203 | I | 0.141828 | 0.090202 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 273 | M | 0.222531 | K | 0.355987 | -0.133456 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| Q9Y619 | ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens GN=SLC25A15 PE=1 SV=1 | 283 | L | 0.111628 | F | 0.100507 | 0.011121 | No Change: Both O | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH syndrome) [MIM:238970] |
| O43808 | PM34_HUMAN Peroxisomal membrane protein PMP34 OS=Homo sapiens GN=SLC25A17 PE=1 SV=1 | 98 | H | 0.434193 | R | 0.429518 | 0.004675 | No Change: Both O | - |
| Q9HC21 | TPC_HUMAN Mitochondrial thiamine pyrophosphate carrier OS=Homo sapiens GN=SLC25A19 PE=1 SV=1 | 177 | G | 0.133755 | A | 0.107816 | 0.025939 | No Change: Both O | Microcephaly Amish type (MCPHA) [MIM:607196] |
| Q9HC21 | TPC_HUMAN Mitochondrial thiamine pyrophosphate carrier OS=Homo sapiens GN=SLC25A19 PE=1 SV=1 | 125 | G | 0.065378 | S | 0.082182 | -0.016804 | No Change: Both O | Striatal necrosis bilateral and progressive polyneuropathy (SNBPP) [MIM:613710] |
| Q9BXI2 | ORNT2_HUMAN Mitochondrial ornithine transporter 2 OS=Homo sapiens GN=SLC25A2 PE=1 SV=3 | 159 | G | 0.193193 | C | 0.086563 | 0.10663 | No Change: Both O | - |
| Q9BXI2 | ORNT2_HUMAN Mitochondrial ornithine transporter 2 OS=Homo sapiens GN=SLC25A2 PE=1 SV=3 | 181 | V | 0.15806 | G | 0.281138 | -0.123078 | No Change: Both O | - |
| Q9BXI2 | ORNT2_HUMAN Mitochondrial ornithine transporter 2 OS=Homo sapiens GN=SLC25A2 PE=1 SV=3 | 226 | V | 0.007191 | I | 0.00607 | 0.001121 | No Change: Both O | - |
| O43772 | MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens GN=SLC25A20 PE=1 SV=1 | 133 | R | 0.221184 | W | 0.097468 | 0.123716 | No Change: Both O | Carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138] |
| O43772 | MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens GN=SLC25A20 PE=1 SV=1 | 231 | D | 0.190545 | H | 0.167797 | 0.022748 | No Change: Both O | Carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138] |
| O43772 | MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens GN=SLC25A20 PE=1 SV=1 | 238 | Q | 0.443419 | R | 0.43133 | 0.012089 | No Change: Both O | Carnitine-acylcarnitine translocase deficiency (CACT deficiency) [MIM:212138] |
| Q9BQT8 | ODC_HUMAN Mitochondrial 2-oxodicarboxylate carrier OS=Homo sapiens GN=SLC25A21 PE=1 SV=1 | 299 | W | 0.809989 | C | 0.828618 | -0.018629 | No Change: Both D | - |
| Q9H936 | GHC1_HUMAN Mitochondrial glutamate carrier 1 OS=Homo sapiens GN=SLC25A22 PE=1 SV=1 | 206 | P | 0.052991 | L | 0.02606 | 0.026931 | No Change: Both O | Epileptic encephalopathy early infantile type 3 (EIEE3) [MIM:609304] |
| Q70HW3 | SAMC_HUMAN S-adenosylmethionine mitochondrial carrier protein OS=Homo sapiens GN=SLC25A26 PE=2 SV=1 | 208 | T | 0.338566 | M | 0.278054 | 0.060512 | No Change: Both O | - |
| O95847 | UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens GN=SLC25A27 PE=1 SV=1 | 197 | I | 0.098401 | T | 0.176747 | -0.078346 | No Change: Both O | - |
| Q00325 | MPCP_HUMAN Phosphate carrier protein mitochondrial OS=Homo sapiens GN=SLC25A3 PE=1 SV=2 | 72 | G | 0.084414 | E | 0.094168 | -0.009754 | No Change: Both O | Mitochondrial phosphate carrier deficiency (MPCD) [MIM:610773] |
| Q9H2D1 | MFTC_HUMAN Mitochondrial folate transporter/carrier OS=Homo sapiens GN=SLC25A32 PE=1 SV=2 | 117 | R | 0.583973 | H | 0.575655 | 0.008318 | No Change: Both D | - |
| Q9BSK2 | S2533_HUMAN Solute carrier family 25 member 33 OS=Homo sapiens GN=SLC25A33 PE=2 SV=1 | 242 | L | 0.306111 | I | 0.275201 | 0.03091 | No Change: Both O | - |
| Q9NYZ2 | MFRN1_HUMAN Mitoferrin-1 OS=Homo sapiens GN=SLC25A37 PE=1 SV=2 | 87 | I | 0.229534 | V | 0.249874 | -0.02034 | No Change: Both O | - |
| Q9NYZ2 | MFRN1_HUMAN Mitoferrin-1 OS=Homo sapiens GN=SLC25A37 PE=1 SV=2 | 96 | R | 0.174573 | Q | 0.177664 | -0.003091 | No Change: Both O | - |
| Q96DW6 | S2538_HUMAN Solute carrier family 25 member 38 OS=Homo sapiens GN=SLC25A38 PE=1 SV=1 | 66 | R | 0.495851 | G | 0.506639 | -0.010788 | O to D | - |
| Q96DW6 | S2538_HUMAN Solute carrier family 25 member 38 OS=Homo sapiens GN=SLC25A38 PE=1 SV=1 | 130 | G | 0.355086 | E | 0.407592 | -0.052506 | No Change: Both O | Anemia sideroblastic pyridoxine-refractory autosomal recessive (PRARSA) [MIM:205950] |
| Q96DW6 | S2538_HUMAN Solute carrier family 25 member 38 OS=Homo sapiens GN=SLC25A38 PE=1 SV=1 | 134 | R | 0.367565 | H | 0.372034 | -0.004469 | No Change: Both O | Anemia sideroblastic pyridoxine-refractory autosomal recessive (PRARSA) [MIM:205950] |
| Q96DW6 | S2538_HUMAN Solute carrier family 25 member 38 OS=Homo sapiens GN=SLC25A38 PE=1 SV=1 | 187 | R | 0.219455 | P | 0.266336 | -0.046881 | No Change: Both O | Anemia sideroblastic pyridoxine-refractory autosomal recessive (PRARSA) [MIM:205950] |
| Q96DW6 | S2538_HUMAN Solute carrier family 25 member 38 OS=Homo sapiens GN=SLC25A38 PE=1 SV=1 | 209 | D | 0.306296 | H | 0.27281 | 0.033486 | No Change: Both O | Anemia sideroblastic pyridoxine-refractory autosomal recessive (PRARSA) [MIM:205950] |
| Q9BZJ4 | S2539_HUMAN Solute carrier family 25 member 39 OS=Homo sapiens GN=SLC25A39 PE=2 SV=2 | 247 | F | 0.338191 | L | 0.385694 | -0.047503 | No Change: Both O | - |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 114 | A | 0.126738 | P | 0.162871 | -0.036133 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283] |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 289 | V | 0.042389 | M | 0.054788 | -0.012399 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283] |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 98 | L | 0.210477 | P | 0.349977 | -0.1395 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283] |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 104 | D | 0.184215 | G | 0.179498 | 0.004717 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283] |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 90 | A | 0.208308 | D | 0.281477 | -0.073169 | No Change: Both O | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant type 2 (PEOA2) [MIM:609283] |
| P12235 | ADT1_HUMAN ADP/ATP translocase 1 OS=Homo sapiens GN=SLC25A4 PE=1 SV=4 | 123 | A | 0.380921 | D | 0.431859 | -0.050938 | No Change: Both O | - |
| Q8TBP6 | S2540_HUMAN Solute carrier family 25 member 40 OS=Homo sapiens GN=SLC25A40 PE=2 SV=1 | 123 | T | 0.033168 | I | 0.016733 | 0.016435 | No Change: Both O | - |
| Q8TBP6 | S2540_HUMAN Solute carrier family 25 member 40 OS=Homo sapiens GN=SLC25A40 PE=2 SV=1 | 186 | K | 0.494405 | Q | 0.423643 | 0.070762 | No Change: Both O | - |
| Q8N5S1 | S2541_HUMAN Solute carrier family 25 member 41 OS=Homo sapiens GN=SLC25A41 PE=2 SV=2 | 144 | G | 0.339749 | S | 0.393953 | -0.054204 | No Change: Both O | - |
| Q8N5S1 | S2541_HUMAN Solute carrier family 25 member 41 OS=Homo sapiens GN=SLC25A41 PE=2 SV=2 | 258 | T | 0.047467 | S | 0.06827 | -0.020803 | No Change: Both O | - |
| Q86VD7 | S2542_HUMAN Solute carrier family 25 member 42 OS=Homo sapiens GN=SLC25A42 PE=1 SV=2 | 39 | S | 0.531187 | P | 0.47681 | 0.054377 | D to O | - |
| Q86VD7 | S2542_HUMAN Solute carrier family 25 member 42 OS=Homo sapiens GN=SLC25A42 PE=1 SV=2 | 312 | L | 0.229071 | M | 0.276255 | -0.047184 | No Change: Both O | - |
| Q8WUT9 | S2543_HUMAN Solute carrier family 25 member 43 OS=Homo sapiens GN=SLC25A43 PE=2 SV=2 | 334 | P | 0.976544 | L | 0.959322 | 0.017222 | No Change: Both D | - |
| Q96H78 | S2544_HUMAN Solute carrier family 25 member 44 OS=Homo sapiens GN=SLC25A44 PE=2 SV=1 | 52 | S | 0.447975 | I | 0.230663 | 0.217312 | No Change: Both O | - |
| Q8N413 | S2545_HUMAN Solute carrier family 25 member 45 OS=Homo sapiens GN=SLC25A45 PE=2 SV=2 | 224 | M | 0.310119 | V | 0.249101 | 0.061018 | No Change: Both O | - |
| Q8N413 | S2545_HUMAN Solute carrier family 25 member 45 OS=Homo sapiens GN=SLC25A45 PE=2 SV=2 | 251 | R | 0.259837 | Q | 0.285064 | -0.025227 | No Change: Both O | - |
| P05141 | ADT2_HUMAN ADP/ATP translocase 2 OS=Homo sapiens GN=SLC25A5 PE=1 SV=7 | 111 | L | 0.041051 | R | 0.0743 | -0.033249 | No Change: Both O | - |
| P12236 | ADT3_HUMAN ADP/ATP translocase 3 OS=Homo sapiens GN=SLC25A6 PE=1 SV=4 | 242 | S | 0.603406 | F | 0.383673 | 0.219733 | D to O | - |
| Q9H2B4 | S26A1_HUMAN Sulfate anion transporter 1 OS=Homo sapiens GN=SLC26A1 PE=2 SV=2 | 556 | Q | 0.147363 | R | 0.149994 | -0.002631 | No Change: Both O | - |
| Q8NG04 | S2610_HUMAN Solute carrier family 26 member 10 OS=Homo sapiens GN=SLC26A10 PE=2 SV=1 | 130 | M | 0.107418 | T | 0.11958 | -0.012162 | No Change: Both O | - |
| Q8NG04 | S2610_HUMAN Solute carrier family 26 member 10 OS=Homo sapiens GN=SLC26A10 PE=2 SV=1 | 193 | A | 0.489385 | T | 0.522373 | -0.032988 | O to D | - |
| Q8NG04 | S2610_HUMAN Solute carrier family 26 member 10 OS=Homo sapiens GN=SLC26A10 PE=2 SV=1 | 546 | L | 0.597679 | V | 0.572671 | 0.025008 | No Change: Both D | - |
| Q8NG04 | S2610_HUMAN Solute carrier family 26 member 10 OS=Homo sapiens GN=SLC26A10 PE=2 SV=1 | 270 | L | 0.315607 | S | 0.477289 | -0.161682 | No Change: Both O | A colorectal cancer sample |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 255 | G | 0.18857 | E | 0.219221 | -0.030651 | No Change: Both O | Atelosteogenesis type 2 (AO2) [MIM:256050] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 279 | R | 0.324474 | W | 0.151663 | 0.172811 | No Change: Both O | Atelosteogenesis type 2 (AO2) [MIM:256050] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 279 | R | 0.324474 | W | 0.151663 | 0.172811 | No Change: Both O | Multiple epiphyseal dysplasia type 4 (EDM4) [MIM:226900] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 425 | N | 0.037088 | D | 0.039065 | -0.001977 | No Change: Both O | Achondrogenesis type 1B (ACG1B) [MIM:600972] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 678 | G | 0.089872 | V | 0.053466 | 0.036406 | No Change: Both O | Achondrogenesis type 1B (ACG1B) [MIM:600972] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 715 | A | 0.201571 | V | 0.159971 | 0.0416 | No Change: Both O | Atelosteogenesis type 2 (AO2) [MIM:256050] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 715 | A | 0.201571 | V | 0.159971 | 0.0416 | No Change: Both O | Multiple epiphyseal dysplasia type 4 (EDM4) [MIM:226900] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 454 | Q | 0.329833 | P | 0.349207 | -0.019374 | No Change: Both O | - |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 653 | C | 0.059879 | S | 0.17394 | -0.114061 | No Change: Both O | Multiple epiphyseal dysplasia type 4 (EDM4) [MIM:226900] |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 689 | T | 0.290218 | S | 0.37401 | -0.083792 | No Change: Both O | - |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 574 | I | 0.231462 | T | 0.326318 | -0.094856 | No Change: Both O | - |
| P50443 | S26A2_HUMAN Sulfate transporter OS=Homo sapiens GN=SLC26A2 PE=1 SV=2 | 256 | F | 0.184688 | S | 0.406346 | -0.221658 | No Change: Both O | Multiple epiphyseal dysplasia type 4 (EDM4) [MIM:226900] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 120 | G | 0.09125 | S | 0.120176 | -0.028926 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 124 | H | 0.207391 | L | 0.128876 | 0.078515 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 131 | P | 0.201073 | R | 0.169509 | 0.031564 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 307 | C | 0.148645 | W | 0.12672 | 0.021925 | No Change: Both O | - |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 206 | S | 0.119615 | P | 0.096845 | 0.02277 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 468 | D | 0.048745 | V | 0.021075 | 0.02767 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 68 | R | 0.095156 | Q | 0.103967 | -0.008811 | No Change: Both O | - |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 554 | R | 0.11399 | Q | 0.106906 | 0.007084 | No Change: Both O | - |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 753 | N | 0.342864 | S | 0.356183 | -0.013319 | No Change: Both O | - |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 129 | P | 0.285645 | L | 0.154429 | 0.131216 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 131 | P | 0.201073 | L | 0.105686 | 0.095387 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 136 | M | 0.133567 | I | 0.088287 | 0.04528 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 204 | Y | 0.061169 | D | 0.122087 | -0.060918 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 220 | H | 0.112523 | P | 0.130471 | -0.017948 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 343 | C | 0.084972 | Y | 0.101868 | -0.016896 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 379 | G | 0.074531 | A | 0.056354 | 0.018177 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 398 | S | 0.594121 | F | 0.332839 | 0.261282 | D to O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 496 | L | 0.045689 | R | 0.080716 | -0.035027 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 520 | Y | 0.426283 | C | 0.352451 | 0.073832 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 521 | K | 0.483334 | N | 0.439871 | 0.043463 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 544 | I | 0.073008 | N | 0.146428 | -0.07342 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| P40879 | S26A3_HUMAN Chloride anion exchanger OS=Homo sapiens GN=SLC26A3 PE=1 SV=1 | 652 | D | 0.157063 | N | 0.142811 | 0.014252 | No Change: Both O | Diarrhea type 1 (DIAR1) [MIM:214700] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 209 | G | 0.035223 | V | 0.017889 | 0.017334 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 209 | G | 0.035223 | V | 0.017889 | 0.017334 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 236 | L | 0.118146 | P | 0.213047 | -0.094901 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 236 | L | 0.118146 | P | 0.213047 | -0.094901 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 369 | K | 0.189358 | E | 0.177907 | 0.011451 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 372 | A | 0.215951 | V | 0.168579 | 0.047372 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 384 | E | 0.17559 | G | 0.154445 | 0.021145 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 416 | T | 0.698151 | P | 0.718443 | -0.020292 | No Change: Both D | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 416 | T | 0.698151 | P | 0.718443 | -0.020292 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 497 | G | 0.061491 | S | 0.073012 | -0.011521 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 667 | F | 0.06404 | C | 0.065176 | -0.001136 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 721 | T | 0.058293 | M | 0.04375 | 0.014543 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 721 | T | 0.058293 | M | 0.04375 | 0.014543 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 723 | H | 0.057763 | R | 0.062516 | -0.004753 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 723 | H | 0.057763 | R | 0.062516 | -0.004753 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 193 | T | 0.039138 | I | 0.022443 | 0.016695 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 445 | L | 0.333027 | W | 0.230747 | 0.10228 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 445 | L | 0.333027 | W | 0.230747 | 0.10228 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 24 | R | 0.819283 | G | 0.772055 | 0.047228 | No Change: Both D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 28 | S | 0.843201 | R | 0.832156 | 0.011045 | No Change: Both D | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 28 | S | 0.843201 | R | 0.832156 | 0.011045 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 29 | E | 0.846119 | Q | 0.845423 | 6.96E-04 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 78 | Y | 0.110571 | C | 0.092997 | 0.017574 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 90 | S | 0.224008 | L | 0.103069 | 0.120939 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 102 | G | 0.133776 | R | 0.120763 | 0.013013 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 104 | A | 0.105522 | V | 0.070411 | 0.035111 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 105 | Y | 0.092925 | C | 0.073551 | 0.019374 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 106 | A | 0.087945 | D | 0.113952 | -0.026007 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 117 | L | 0.075568 | F | 0.0706 | 0.004968 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 117 | L | 0.075568 | F | 0.0706 | 0.004968 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 132 | T | 0.149666 | I | 0.085866 | 0.0638 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 133 | S | 0.177952 | T | 0.129463 | 0.048489 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 137 | S | 0.296948 | P | 0.273239 | 0.023709 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 138 | V | 0.312112 | F | 0.279206 | 0.032906 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 139 | G | 0.304613 | A | 0.245348 | 0.059265 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 239 | V | 0.173448 | D | 0.296332 | -0.122884 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 239 | V | 0.173448 | D | 0.296332 | -0.122884 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 252 | S | 0.066913 | P | 0.057444 | 0.009469 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 271 | D | 0.186971 | H | 0.15096 | 0.036011 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 335 | F | 0.342867 | L | 0.396057 | -0.05319 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 335 | F | 0.342867 | L | 0.396057 | -0.05319 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 391 | S | 0.103563 | N | 0.085747 | 0.017816 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 392 | N | 0.096477 | Y | 0.050492 | 0.045985 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 409 | R | 0.425442 | H | 0.429392 | -0.00395 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 409 | R | 0.425442 | P | 0.461962 | -0.03652 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 410 | T | 0.499638 | M | 0.422947 | 0.076691 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 410 | T | 0.499638 | M | 0.422947 | 0.076691 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 411 | A | 0.560884 | P | 0.626411 | -0.065527 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 421 | Q | 0.425768 | R | 0.399397 | 0.026371 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 446 | Q | 0.299978 | R | 0.280806 | 0.019172 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 446 | Q | 0.299978 | R | 0.280806 | 0.019172 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 455 | I | 0.076453 | F | 0.079966 | -0.003513 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 457 | N | 0.083443 | K | 0.108154 | -0.024711 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 480 | V | 0.020136 | D | 0.043706 | -0.02357 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 490 | I | 0.017386 | L | 0.020553 | -0.003167 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 530 | Y | 0.567574 | H | 0.679641 | -0.112067 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 552 | S | 0.144828 | I | 0.060482 | 0.084346 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 556 | Y | 0.16321 | C | 0.148345 | 0.014865 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 556 | Y | 0.16321 | H | 0.247189 | -0.083979 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 565 | C | 0.253886 | Y | 0.303827 | -0.049941 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 597 | L | 0.401864 | S | 0.573935 | -0.172071 | O to D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 653 | V | 0.262797 | A | 0.310888 | -0.048091 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 672 | G | 0.094066 | E | 0.116536 | -0.02247 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 676 | L | 0.102659 | Q | 0.188902 | -0.086243 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 683 | F | 0.13738 | S | 0.320601 | -0.183221 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 694 | S | 0.074485 | P | 0.065746 | 0.008739 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 724 | D | 0.057893 | N | 0.053387 | 0.004506 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 123 | P | 0.02631 | S | 0.032264 | -0.005954 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 147 | M | 0.163605 | V | 0.13786 | 0.025745 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 508 | T | 0.025553 | N | 0.030778 | -0.005225 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 514 | Q | 0.093796 | R | 0.092433 | 0.001363 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 530 | Y | 0.567574 | S | 0.742127 | -0.174553 | No Change: Both D | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 530 | Y | 0.567574 | S | 0.742127 | -0.174553 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 609 | V | 0.485732 | G | 0.620583 | -0.134851 | O to D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 666 | S | 0.062127 | F | 0.02304 | 0.039087 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 740 | G | 0.506417 | S | 0.552701 | -0.046284 | No Change: Both D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 776 | R | 0.813522 | C | 0.72399 | 0.089532 | No Change: Both D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 301 | P | 0.112093 | L | 0.048106 | 0.063987 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 324 | N | 0.309531 | Y | 0.190252 | 0.119279 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 687 | D | 0.082648 | Y | 0.043578 | 0.03907 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 402 | V | 0.087488 | M | 0.115902 | -0.028414 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 402 | V | 0.087488 | M | 0.115902 | -0.028414 | No Change: Both O | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 775 | M | 0.79043 | T | 0.846782 | -0.056352 | No Change: Both D | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 775 | M | 0.79043 | T | 0.846782 | -0.056352 | No Change: Both D | Pendred syndrome (PDS) [MIM:274600] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 6 | G | 0.911013 | V | 0.878451 | 0.032562 | No Change: Both D | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 99 | T | 0.196034 | M | 0.162711 | 0.033323 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 144 | V | 0.178946 | A | 0.218402 | -0.039456 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 185 | R | 0.226265 | T | 0.219418 | 0.006847 | No Change: Both O | - |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 281 | V | 0.025125 | I | 0.021038 | 0.004087 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| O43511 | S26A4_HUMAN Pendrin OS=Homo sapiens GN=SLC26A4 PE=1 SV=1 | 558 | N | 0.171406 | K | 0.21774 | -0.046334 | No Change: Both O | Deafness autosomal recessive type 4 (DFNB4) [MIM:600791] |
| Q9BXS9 | S26A6_HUMAN Solute carrier family 26 member 6 OS=Homo sapiens GN=SLC26A6 PE=1 SV=1 | 206 | V | 0.042215 | M | 0.052553 | -0.010338 | No Change: Both O | - |
| Q8TE54 | S26A7_HUMAN Anion exchange transporter OS=Homo sapiens GN=SLC26A7 PE=2 SV=2 | 215 | I | 0.016421 | V | 0.019855 | -0.003434 | No Change: Both O | - |
| Q8TE54 | S26A7_HUMAN Anion exchange transporter OS=Homo sapiens GN=SLC26A7 PE=2 SV=2 | 381 | V | 0.113332 | G | 0.204467 | -0.091135 | No Change: Both O | - |
| Q96RN1 | S26A8_HUMAN Testis anion transporter 1 OS=Homo sapiens GN=SLC26A8 PE=1 SV=1 | 73 | V | 0.017946 | M | 0.024709 | -0.006763 | No Change: Both O | - |
| Q96RN1 | S26A8_HUMAN Testis anion transporter 1 OS=Homo sapiens GN=SLC26A8 PE=1 SV=1 | 148 | I | 0.191407 | V | 0.223727 | -0.03232 | No Change: Both O | - |
| Q96RN1 | S26A8_HUMAN Testis anion transporter 1 OS=Homo sapiens GN=SLC26A8 PE=1 SV=1 | 230 | S | 0.30492 | N | 0.251618 | 0.053302 | No Change: Both O | - |
| Q96RN1 | S26A8_HUMAN Testis anion transporter 1 OS=Homo sapiens GN=SLC26A8 PE=1 SV=1 | 639 | I | 0.489874 | V | 0.491293 | -0.001419 | No Change: Both O | - |
| Q7LBE3 | S26A9_HUMAN Solute carrier family 26 member 9 OS=Homo sapiens GN=SLC26A9 PE=2 SV=1 | 744 | V | 0.451564 | M | 0.519021 | -0.067457 | O to D | - |
| Q7LBE3 | S26A9_HUMAN Solute carrier family 26 member 9 OS=Homo sapiens GN=SLC26A9 PE=2 SV=1 | 748 | H | 0.476061 | R | 0.486539 | -0.010478 | No Change: Both O | - |
| O14975 | S27A2_HUMAN Very long-chain acyl-CoA synthetase OS=Homo sapiens GN=SLC27A2 PE=1 SV=2 | 48 | K | 0.582688 | Q | 0.539635 | 0.043053 | No Change: Both D | - |
| Q5K4L6 | S27A3_HUMAN Long-chain fatty acid transport protein 3 OS=Homo sapiens GN=SLC27A3 PE=2 SV=3 | 110 | G | 0.570145 | A | 0.545089 | 0.025056 | No Change: Both D | - |
| Q5K4L6 | S27A3_HUMAN Long-chain fatty acid transport protein 3 OS=Homo sapiens GN=SLC27A3 PE=2 SV=3 | 439 | R | 0.616604 | H | 0.634963 | -0.018359 | No Change: Both D | - |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 209 | G | 0.742364 | S | 0.805599 | -0.063235 | No Change: Both D | - |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 92 | A | 0.330003 | T | 0.383332 | -0.053329 | No Change: Both O | Ichthyosis prematurity syndrome (IPS) [MIM:608649] |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 247 | S | 0.211918 | P | 0.204684 | 0.007234 | No Change: Both O | Ichthyosis prematurity syndrome (IPS) [MIM:608649] |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 300 | Q | 0.092855 | R | 0.084896 | 0.007959 | No Change: Both O | Ichthyosis prematurity syndrome (IPS) [MIM:608649] |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 583 | R | 0.156117 | H | 0.137782 | 0.018335 | No Change: Both O | Ichthyosis prematurity syndrome (IPS) [MIM:608649] |
| Q6P1M0 | S27A4_HUMAN Long-chain fatty acid transport protein 4 OS=Homo sapiens GN=SLC27A4 PE=1 SV=1 | 374 | R | 0.199662 | C | 0.115919 | 0.083743 | No Change: Both O | Ichthyosis prematurity syndrome (IPS) [MIM:608649] |
| Q9Y2P5 | S27A5_HUMAN Bile acyl-CoA synthetase OS=Homo sapiens GN=SLC27A5 PE=1 SV=1 | 50 | M | 0.057432 | T | 0.07226 | -0.014828 | No Change: Both O | - |
| Q9Y2P5 | S27A5_HUMAN Bile acyl-CoA synthetase OS=Homo sapiens GN=SLC27A5 PE=1 SV=1 | 53 | R | 0.105447 | W | 0.047331 | 0.058116 | No Change: Both O | - |
| Q9Y2P4 | S27A6_HUMAN Long-chain fatty acid transport protein 6 OS=Homo sapiens GN=SLC27A6 PE=1 SV=1 | 19 | L | 0.045446 | V | 0.045104 | 3.42E-04 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 34 | E | 0.835746 | G | 0.794587 | 0.041159 | No Change: Both D | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 189 | V | 0.011969 | I | 0.01018 | 0.001789 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 409 | N | 0.31275 | S | 0.371053 | -0.058303 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 521 | D | 0.241484 | N | 0.227145 | 0.014339 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 190 | A | 0.014855 | S | 0.024943 | -0.010088 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 237 | Q | 0.062857 | K | 0.07936 | -0.016503 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 510 | R | 0.455314 | C | 0.263741 | 0.191573 | No Change: Both O | - |
| O00337 | S28A1_HUMAN Sodium/nucleoside cotransporter 1 OS=Homo sapiens GN=SLC28A1 PE=2 SV=2 | 546 | S | 0.129321 | P | 0.107653 | 0.021668 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 163 | L | 0.038025 | W | 0.024294 | 0.013731 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 22 | P | 0.776418 | L | 0.672024 | 0.104394 | No Change: Both D | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 75 | S | 0.184771 | R | 0.143095 | 0.041676 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 245 | S | 0.182688 | T | 0.133051 | 0.049637 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 355 | F | 0.120415 | S | 0.274157 | -0.153742 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 462 | L | 0.035813 | F | 0.031433 | 0.00438 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 509 | G | 0.449649 | E | 0.527504 | -0.077855 | O to D | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 12 | L | 0.73991 | P | 0.857829 | -0.117919 | No Change: Both D | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 142 | R | 0.174414 | H | 0.16503 | 0.009384 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 172 | E | 0.325231 | D | 0.312037 | 0.013194 | No Change: Both O | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 385 | E | 0.796003 | K | 0.793644 | 0.002359 | No Change: Both D | - |
| O43868 | S28A2_HUMAN Sodium/nucleoside cotransporter 2 OS=Homo sapiens GN=SLC28A2 PE=2 SV=2 | 612 | M | 0.210834 | T | 0.270707 | -0.059873 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 4 | R | 0.764922 | K | 0.73338 | 0.031542 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 5 | S | 0.758968 | N | 0.748373 | 0.010595 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 62 | D | 0.974602 | H | 0.968416 | 0.006186 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 67 | R | 0.964455 | K | 0.963498 | 9.57E-04 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 113 | Y | 0.016436 | C | 0.01321 | 0.003226 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 131 | L | 0.039072 | F | 0.034577 | 0.004495 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 221 | P | 0.093603 | Q | 0.082022 | 0.011581 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 328 | I | 0.602601 | V | 0.655976 | -0.053375 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 349 | R | 0.167263 | Q | 0.185589 | -0.018326 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 367 | G | 0.219323 | R | 0.198922 | 0.020401 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 418 | L | 0.692662 | I | 0.657842 | 0.03482 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 513 | Y | 0.064277 | F | 0.060836 | 0.003441 | No Change: Both O | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 585 | R | 0.644794 | H | 0.645208 | -4.14E-04 | No Change: Both D | - |
| Q9HAS3 | S28A3_HUMAN Solute carrier family 28 member 3 OS=Homo sapiens GN=SLC28A3 PE=1 SV=1 | 602 | C | 0.042451 | R | 0.078047 | -0.035596 | No Change: Both O | - |
| Q99808 | S29A1_HUMAN Equilibrative nucleoside transporter 1 OS=Homo sapiens GN=SLC29A1 PE=1 SV=3 | 293 | A | 0.075983 | T | 0.091126 | -0.015143 | No Change: Both O | A colorectal cancer sample |
| Q99808 | S29A1_HUMAN Equilibrative nucleoside transporter 1 OS=Homo sapiens GN=SLC29A1 PE=1 SV=3 | 455 | I | 0.323573 | V | 0.403877 | -0.080304 | No Change: Both O | A colorectal cancer sample |
| Q99808 | S29A1_HUMAN Equilibrative nucleoside transporter 1 OS=Homo sapiens GN=SLC29A1 PE=1 SV=3 | 216 | I | 0.007155 | T | 0.013603 | -0.006448 | No Change: Both O | - |
| Q99808 | S29A1_HUMAN Equilibrative nucleoside transporter 1 OS=Homo sapiens GN=SLC29A1 PE=1 SV=3 | 391 | E | 0.039186 | K | 0.039065 | 1.21E-04 | No Change: Both O | - |
| Q14542 | S29A2_HUMAN Equilibrative nucleoside transporter 2 OS=Homo sapiens GN=SLC29A2 PE=1 SV=3 | 5 | D | 0.899243 | Y | 0.817534 | 0.081709 | No Change: Both D | - |
| Q14542 | S29A2_HUMAN Equilibrative nucleoside transporter 2 OS=Homo sapiens GN=SLC29A2 PE=1 SV=3 | 68 | N | 0.111564 | K | 0.120047 | -0.008483 | No Change: Both O | - |
| Q14542 | S29A2_HUMAN Equilibrative nucleoside transporter 2 OS=Homo sapiens GN=SLC29A2 PE=1 SV=3 | 94 | P | 0.084672 | L | 0.043635 | 0.041037 | No Change: Both O | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 18 | R | 0.874906 | G | 0.832498 | 0.042408 | No Change: Both D | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 158 | S | 0.238515 | F | 0.097298 | 0.141217 | No Change: Both O | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 239 | V | 0.016895 | I | 0.01295 | 0.003945 | No Change: Both O | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 326 | I | 0.071034 | V | 0.073723 | -0.002689 | No Change: Both O | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 452 | V | 0.078752 | E | 0.169439 | -0.090687 | No Change: Both O | - |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 427 | G | 0.311405 | S | 0.37345 | -0.062045 | No Change: Both O | H syndrome (HSYN) [MIM:612391] |
| Q9BZD2 | S29A3_HUMAN Equilibrative nucleoside transporter 3 OS=Homo sapiens GN=SLC29A3 PE=1 SV=3 | 437 | G | 0.144172 | R | 0.144348 | -1.76E-04 | No Change: Both O | H syndrome (HSYN) [MIM:612391] |
| Q7RTT9 | S29A4_HUMAN Equilibrative nucleoside transporter 4 OS=Homo sapiens GN=SLC29A4 PE=1 SV=1 | 79 | V | 0.051648 | E | 0.120672 | -0.069024 | No Change: Both O | - |
| Q7RTT9 | S29A4_HUMAN Equilibrative nucleoside transporter 4 OS=Homo sapiens GN=SLC29A4 PE=1 SV=1 | 124 | N | 0.095524 | K | 0.107253 | -0.011729 | No Change: Both O | - |
| Q7RTT9 | S29A4_HUMAN Equilibrative nucleoside transporter 4 OS=Homo sapiens GN=SLC29A4 PE=1 SV=1 | 429 | P | 0.008549 | T | 0.006267 | 0.002282 | No Change: Both O | - |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 91 | G | 0.299441 | D | 0.311156 | -0.011715 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 126 | R | 0.025086 | H | 0.025057 | 2.90E-05 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 126 | R | 0.025086 | L | 0.015467 | 0.009619 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 256 | K | 0.505184 | E | 0.518357 | -0.013173 | No Change: Both D | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 66 | S | 0.087864 | F | 0.030468 | 0.057396 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 146 | E | 0.298325 | K | 0.297977 | 3.48E-04 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 310 | T | 0.180746 | I | 0.106637 | 0.074109 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 333 | R | 0.228311 | W | 0.0891 | 0.139211 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 34 | N | 0.213102 | I | 0.105205 | 0.107897 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 34 | N | 0.213102 | S | 0.233664 | -0.020562 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 126 | R | 0.025086 | C | 0.012035 | 0.013051 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 126 | R | 0.025086 | C | 0.012035 | 0.013051 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 130 | G | 0.023035 | S | 0.026586 | -0.003551 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 153 | R | 0.362118 | C | 0.197453 | 0.164665 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 275 | A | 0.080691 | T | 0.089785 | -0.009094 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 295 | T | 0.128355 | M | 0.105514 | 0.022841 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 314 | G | 0.164297 | S | 0.202804 | -0.038507 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 34 | N | 0.213102 | Y | 0.117644 | 0.095458 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 93 | R | 0.35589 | W | 0.157603 | 0.198287 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 95 | S | 0.321125 | I | 0.144811 | 0.176314 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 96 | M | 0.279383 | V | 0.211962 | 0.067421 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 153 | R | 0.362118 | H | 0.376558 | -0.01444 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 155 | A | 0.329312 | V | 0.240842 | 0.08847 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 165 | V | 0.044031 | I | 0.039443 | 0.004588 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 212 | R | 0.200614 | C | 0.106565 | 0.094049 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 212 | R | 0.200614 | H | 0.186772 | 0.013842 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 223 | R | 0.601209 | P | 0.612472 | -0.011263 | No Change: Both D | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 223 | R | 0.601209 | P | 0.612472 | -0.011263 | No Change: Both D | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 223 | R | 0.601209 | W | 0.400174 | 0.201035 | D to O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 303 | V | 0.2733 | L | 0.259933 | 0.013367 | No Change: Both O | - |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 317 | N | 0.135822 | T | 0.127114 | 0.008708 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 324 | S | 0.060814 | L | 0.026374 | 0.03444 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 324 | S | 0.060814 | L | 0.026374 | 0.03444 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 329 | E | 0.209861 | Q | 0.175729 | 0.034132 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 333 | R | 0.228311 | Q | 0.226518 | 0.001793 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 382 | G | 0.117775 | D | 0.122676 | -0.004901 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 405 | A | 0.205662 | D | 0.253963 | -0.048301 | No Change: Both O | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 485 | P | 0.706092 | L | 0.514009 | 0.192083 | No Change: Both D | GLUT1 deficiency syndrome type 1 (GLUT1DS1) [MIM:606777] |
| P11166 | GTR1_HUMAN Solute carrier family 2 facilitated glucose transporter member 1 OS=Homo sapiens GN=SLC2A1 PE=1 SV=2 | 294 | S | 0.11201 | P | 0.092692 | 0.019318 | No Change: Both O | GLUT1 deficiency syndrome type 2 (GLUT1DS2) [MIM:612126] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 518 | T | 0.387698 | A | 0.355322 | 0.032376 | No Change: Both O | - |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 206 | A | 0.629123 | T | 0.657832 | -0.028709 | No Change: Both D | - |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 81 | S | 0.158301 | R | 0.1216 | 0.036701 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 106 | A | 0.045311 | S | 0.073561 | -0.02825 | No Change: Both O | - |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 537 | I | 0.664561 | V | 0.64514 | 0.019421 | No Change: Both D | - |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 132 | R | 0.306548 | W | 0.135097 | 0.171451 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 142 | G | 0.094789 | V | 0.051917 | 0.042872 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 225 | R | 0.378483 | H | 0.340172 | 0.038311 | No Change: Both O | - |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 231 | R | 0.385346 | Q | 0.380749 | 0.004597 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 246 | G | 0.172781 | E | 0.2087 | -0.035919 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 426 | G | 0.089668 | W | 0.032183 | 0.057485 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 437 | E | 0.073637 | K | 0.068496 | 0.005141 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| O95528 | GTR10_HUMAN Solute carrier family 2 facilitated glucose transporter member 10 OS=Homo sapiens GN=SLC2A10 PE=1 SV=2 | 445 | G | 0.113057 | E | 0.15259 | -0.039533 | No Change: Both O | Arterial tortuosity syndrome (ATS) [MIM:208050] |
| Q9BYW1 | GTR11_HUMAN Solute carrier family 2 facilitated glucose transporter member 11 OS=Homo sapiens GN=SLC2A11 PE=2 SV=1 | 60 | D | 0.25005 | N | 0.23607 | 0.01398 | No Change: Both O | - |
| Q9BYW1 | GTR11_HUMAN Solute carrier family 2 facilitated glucose transporter member 11 OS=Homo sapiens GN=SLC2A11 PE=2 SV=1 | 232 | R | 0.722822 | Q | 0.693968 | 0.028854 | No Change: Both D | - |
| Q9BYW1 | GTR11_HUMAN Solute carrier family 2 facilitated glucose transporter member 11 OS=Homo sapiens GN=SLC2A11 PE=2 SV=1 | 420 | I | 0.010851 | F | 0.010818 | 3.30E-05 | No Change: Both O | - |
| Q9BYW1 | GTR11_HUMAN Solute carrier family 2 facilitated glucose transporter member 11 OS=Homo sapiens GN=SLC2A11 PE=2 SV=1 | 301 | R | 0.342303 | Q | 0.363417 | -0.021114 | No Change: Both O | - |
| Q9BYW1 | GTR11_HUMAN Solute carrier family 2 facilitated glucose transporter member 11 OS=Homo sapiens GN=SLC2A11 PE=2 SV=1 | 469 | K | 0.451927 | E | 0.464988 | -0.013061 | No Change: Both O | - |
| Q8TDB8 | GTR14_HUMAN Solute carrier family 2 facilitated glucose transporter member 14 OS=Homo sapiens GN=SLC2A14 PE=2 SV=1 | 506 | G | 0.699819 | E | 0.743734 | -0.043915 | No Change: Both D | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 68 | P | 0.492964 | L | 0.319953 | 0.173011 | No Change: Both O | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 101 | V | 0.194296 | I | 0.165996 | 0.0283 | No Change: Both O | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 110 | T | 0.228849 | I | 0.134255 | 0.094594 | No Change: Both O | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 478 | L | 0.031621 | V | 0.031359 | 2.62E-04 | No Change: Both O | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 197 | V | 0.055938 | I | 0.054771 | 0.001167 | No Change: Both O | - |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 389 | L | 0.077472 | P | 0.140888 | -0.063416 | No Change: Both O | Fanconi-Bickel syndrome (FBS) [MIM:227810] |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 417 | P | 0.127542 | L | 0.055766 | 0.071776 | No Change: Both O | Fanconi-Bickel syndrome (FBS) [MIM:227810] |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 423 | V | 0.071286 | E | 0.174077 | -0.102791 | No Change: Both O | Fanconi-Bickel syndrome (FBS) [MIM:227810] |
| P11168 | GTR2_HUMAN Solute carrier family 2 facilitated glucose transporter member 2 OS=Homo sapiens GN=SLC2A2 PE=1 SV=1 | 404 | I | 0.021882 | T | 0.03896 | -0.017078 | No Change: Both O | - |
| P11169 | GTR3_HUMAN Solute carrier family 2 facilitated glucose transporter member 3 OS=Homo sapiens GN=SLC2A3 PE=1 SV=1 | 85 | V | 0.187547 | L | 0.186176 | 0.001371 | No Change: Both O | - |
| P14672 | GTR4_HUMAN Solute carrier family 2 facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1 | 383 | V | 0.079358 | I | 0.068889 | 0.010469 | No Change: Both O | Noninsulin-dependent diabetes mellitus (NIDDM) [MIM:125853] |
| P14672 | GTR4_HUMAN Solute carrier family 2 facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1 | 385 | I | 0.050332 | T | 0.089009 | -0.038677 | No Change: Both O | - |
| P14672 | GTR4_HUMAN Solute carrier family 2 facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1 | 78 | T | 0.19041 | S | 0.251487 | -0.061077 | No Change: Both O | - |
| P14672 | GTR4_HUMAN Solute carrier family 2 facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1 | 358 | A | 0.086619 | V | 0.057323 | 0.029296 | No Change: Both O | - |
| P14672 | GTR4_HUMAN Solute carrier family 2 facilitated glucose transporter member 4 OS=Homo sapiens GN=SLC2A4 PE=1 SV=1 | 55 | S | 0.316607 | R | 0.259217 | 0.05739 | No Change: Both O | - |
| Q9NR83 | S2A4R_HUMAN SLC2A4 regulator OS=Homo sapiens GN=SLC2A4RG PE=1 SV=4 | 233 | E | 0.750548 | D | 0.740398 | 0.01015 | No Change: Both D | - |
| Q9UGQ3 | GTR6_HUMAN Solute carrier family 2 facilitated glucose transporter member 6 OS=Homo sapiens GN=SLC2A6 PE=1 SV=2 | 500 | T | 0.482726 | M | 0.427059 | 0.055667 | No Change: Both O | - |
| Q6PXP3 | GTR7_HUMAN Solute carrier family 2 facilitated glucose transporter member 7 OS=Homo sapiens GN=SLC2A7 PE=2 SV=2 | 135 | V | 0.040677 | I | 0.033673 | 0.007004 | No Change: Both O | - |
| Q6PXP3 | GTR7_HUMAN Solute carrier family 2 facilitated glucose transporter member 7 OS=Homo sapiens GN=SLC2A7 PE=2 SV=2 | 261 | R | 0.732838 | Q | 0.721186 | 0.011652 | No Change: Both D | - |
| Q9NY64 | GTR8_HUMAN Solute carrier family 2 facilitated glucose transporter member 8 OS=Homo sapiens GN=SLC2A8 PE=2 SV=3 | 253 | I | 0.121224 | T | 0.197676 | -0.076452 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 25 | G | 0.822129 | R | 0.842056 | -0.019927 | No Change: Both D | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 282 | V | 0.424952 | I | 0.368011 | 0.056941 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 350 | P | 0.313292 | L | 0.158974 | 0.154318 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 294 | R | 0.435091 | H | 0.412001 | 0.02309 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 22 | S | 0.820901 | N | 0.791051 | 0.02985 | No Change: Both D | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 191 | E | 0.426173 | D | 0.382786 | 0.043387 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 216 | G | 0.05825 | R | 0.049727 | 0.008523 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 275 | T | 0.245353 | M | 0.231162 | 0.014191 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 281 | D | 0.397382 | H | 0.365556 | 0.031826 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 300 | R | 0.231295 | H | 0.213325 | 0.01797 | No Change: Both O | - |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 75 | L | 0.157979 | R | 0.234274 | -0.076295 | No Change: Both O | Hypouricemia renal type 2 (RHUC2) [MIM:612076] |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 125 | T | 0.062536 | M | 0.054326 | 0.00821 | No Change: Both O | Hypouricemia renal type 2 (RHUC2) [MIM:612076] |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 171 | R | 0.052747 | C | 0.025281 | 0.027466 | No Change: Both O | Hypouricemia renal type 2 (RHUC2) [MIM:612076] |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 198 | R | 0.517527 | C | 0.334264 | 0.183263 | D to O | Hypouricemia renal type 2 (RHUC2) [MIM:612076] |
| Q9NRM0 | GTR9_HUMAN Solute carrier family 2 facilitated glucose transporter member 9 OS=Homo sapiens GN=SLC2A9 PE=1 SV=2 | 380 | R | 0.191222 | W | 0.074119 | 0.117103 | No Change: Both O | Hypouricemia renal type 2 (RHUC2) [MIM:612076] |
| Q8IWU4 | ZNT8_HUMAN Zinc transporter 8 OS=Homo sapiens GN=SLC30A8 PE=2 SV=2 | 325 | R | 0.57524 | Q | 0.589082 | -0.013842 | No Change: Both D | - |
| Q8IWU4 | ZNT8_HUMAN Zinc transporter 8 OS=Homo sapiens GN=SLC30A8 PE=2 SV=2 | 325 | R | 0.57524 | W | 0.361245 | 0.213995 | D to O | - |
| Q6PML9 | ZNT9_HUMAN Zinc transporter 9 OS=Homo sapiens GN=SLC30A9 PE=1 SV=1 | 50 | M | 0.305911 | V | 0.269886 | 0.036025 | No Change: Both O | - |
| Q6PML9 | ZNT9_HUMAN Zinc transporter 9 OS=Homo sapiens GN=SLC30A9 PE=1 SV=1 | 97 | T | 0.648633 | A | 0.623554 | 0.025079 | No Change: Both D | - |
| Q6PML9 | ZNT9_HUMAN Zinc transporter 9 OS=Homo sapiens GN=SLC30A9 PE=1 SV=1 | 353 | L | 0.17256 | S | 0.34251 | -0.16995 | No Change: Both O | - |
| O15431 | COPT1_HUMAN High affinity copper uptake protein 1 OS=Homo sapiens GN=SLC31A1 PE=1 SV=1 | 25 | P | 0.971516 | A | 0.95899 | 0.012526 | No Change: Both D | - |
| Q9H598 | VIAAT_HUMAN Vesicular inhibitory amino acid transporter OS=Homo sapiens GN=SLC32A1 PE=1 SV=2 | 423 | S | 0.234774 | G | 0.19957 | 0.035204 | No Change: Both O | - |
| O00400 | ACATN_HUMAN Acetyl-coenzyme A transporter 1 OS=Homo sapiens GN=SLC33A1 PE=1 SV=1 | 400 | V | 0.19313 | A | 0.253529 | -0.060399 | No Change: Both O | A colorectal cancer sample |
| O00400 | ACATN_HUMAN Acetyl-coenzyme A transporter 1 OS=Homo sapiens GN=SLC33A1 PE=1 SV=1 | 171 | D | 0.492334 | G | 0.453903 | 0.038431 | No Change: Both O | - |
| O00400 | ACATN_HUMAN Acetyl-coenzyme A transporter 1 OS=Homo sapiens GN=SLC33A1 PE=1 SV=1 | 113 | S | 0.041041 | R | 0.027849 | 0.013192 | No Change: Both O | Spastic paraplegia autosomal dominant type 42 (SPG42) [MIM:612539] |
| Q06495 | NPT2A_HUMAN Sodium-dependent phosphate transport protein 2A OS=Homo sapiens GN=SLC34A1 PE=1 SV=1 | 48 | A | 0.335885 | F | 0.239308 | 0.096577 | No Change: Both O | Hypophosphatemic nephrolithiasis/osteoporosis type 1 (NPHLOP1) [MIM:612286] |
| Q06495 | NPT2A_HUMAN Sodium-dependent phosphate transport protein 2A OS=Homo sapiens GN=SLC34A1 PE=1 SV=1 | 147 | V | 0.14893 | M | 0.1735 | -0.02457 | No Change: Both O | Hypophosphatemic nephrolithiasis/osteoporosis type 1 (NPHLOP1) [MIM:612286] |
| O95436 | NPT2B_HUMAN Sodium-dependent phosphate transport protein 2B OS=Homo sapiens GN=SLC34A2 PE=1 SV=3 | 106 | G | 0.010213 | R | 0.009762 | 4.51E-04 | No Change: Both O | Pulmonary alveolar microlithiasis (PALM) [MIM:265100] |
| O95436 | NPT2B_HUMAN Sodium-dependent phosphate transport protein 2B OS=Homo sapiens GN=SLC34A2 PE=1 SV=3 | 634 | D | 0.844212 | G | 0.821864 | 0.022348 | No Change: Both D | - |
| O95436 | NPT2B_HUMAN Sodium-dependent phosphate transport protein 2B OS=Homo sapiens GN=SLC34A2 PE=1 SV=3 | 45 | V | 0.797153 | A | 0.854123 | -0.05697 | No Change: Both D | - |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 67 | R | 0.29177 | H | 0.267888 | 0.023882 | No Change: Both O | - |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 138 | S | 0.716012 | F | 0.494295 | 0.221717 | D to O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 180 | G | 0.651378 | A | 0.61352 | 0.037858 | No Change: Both D | - |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 192 | S | 0.243464 | L | 0.114069 | 0.129395 | No Change: Both O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 196 | G | 0.085298 | R | 0.081127 | 0.004171 | No Change: Both O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 237 | D | 0.372221 | N | 0.343572 | 0.028649 | No Change: Both O | - |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 337 | G | 0.012818 | S | 0.016837 | -0.004019 | No Change: Both O | - |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 353 | R | 0.189382 | L | 0.110859 | 0.078523 | No Change: Both O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 413 | A | 0.140257 | E | 0.201376 | -0.061119 | No Change: Both O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 468 | R | 0.090738 | W | 0.034184 | 0.056554 | No Change: Both O | Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) [MIM:241530] |
| Q8N130 | NPT2C_HUMAN Sodium-dependent phosphate transport protein 2C OS=Homo sapiens GN=SLC34A3 PE=1 SV=2 | 513 | E | 0.326667 | V | 0.171225 | 0.155442 | No Change: Both O | - |
| P78381 | S35A2_HUMAN UDP-galactose translocator OS=Homo sapiens GN=SLC35A2 PE=1 SV=1 | 252 | W | 0.064915 | C | 0.071541 | -0.006626 | No Change: Both O | A breast cancer sample |
| Q9BS91 | S35A5_HUMAN Probable UDP-sugar transporter protein SLC35A5 OS=Homo sapiens GN=SLC35A5 PE=1 SV=2 | 247 | N | 0.173708 | I | 0.085893 | 0.087815 | No Change: Both O | - |
| P78383 | S35B1_HUMAN Solute carrier family 35 member B1 OS=Homo sapiens GN=SLC35B1 PE=2 SV=1 | 81 | R | 0.225558 | H | 0.210147 | 0.015411 | No Change: Both O | - |
| Q8TB61 | S35B2_HUMAN Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Homo sapiens GN=SLC35B2 PE=1 SV=1 | 342 | L | 0.115795 | V | 0.106188 | 0.009607 | No Change: Both O | - |
| Q96A29 | FUCT1_HUMAN GDP-fucose transporter 1 OS=Homo sapiens GN=SLC35C1 PE=1 SV=1 | 147 | R | 0.139129 | C | 0.064859 | 0.07427 | No Change: Both O | Congenital disorder of glycosylation type 2C (CDG2C) [MIM:266265] |
| Q96A29 | FUCT1_HUMAN GDP-fucose transporter 1 OS=Homo sapiens GN=SLC35C1 PE=1 SV=1 | 308 | T | 0.093927 | R | 0.095054 | -0.001127 | No Change: Both O | Congenital disorder of glycosylation type 2C (CDG2C) [MIM:266265] |
| Q96A29 | FUCT1_HUMAN GDP-fucose transporter 1 OS=Homo sapiens GN=SLC35C1 PE=1 SV=1 | 49 | W | 0.036241 | S | 0.137665 | -0.101424 | No Change: Both O | - |
| Q96A29 | FUCT1_HUMAN GDP-fucose transporter 1 OS=Homo sapiens GN=SLC35C1 PE=1 SV=1 | 240 | I | 0.018914 | V | 0.023708 | -0.004794 | No Change: Both O | - |
| Q9NTN3 | S35D1_HUMAN UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter OS=Homo sapiens GN=SLC35D1 PE=1 SV=1 | 82 | A | 0.051848 | T | 0.059476 | -0.007628 | No Change: Both O | - |
| Q76EJ3 | S35D2_HUMAN UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter OS=Homo sapiens GN=SLC35D2 PE=1 SV=1 | 184 | A | 0.116678 | S | 0.171494 | -0.054816 | No Change: Both O | - |
| Q8IY50 | S35F3_HUMAN Solute carrier family 35 member F3 OS=Homo sapiens GN=SLC35F3 PE=2 SV=2 | 231 | S | 0.19443 | C | 0.066868 | 0.127562 | No Change: Both O | - |
| P0C7Q5 | S35G4_HUMAN Solute carrier family 35 member G4 OS=Homo sapiens GN=SLC35G4 PE=3 SV=1 | 104 | T | 0.075834 | A | 0.072167 | 0.003667 | No Change: Both O | - |
| Q96KT7 | S35G5_HUMAN Solute carrier family 35 member G5 OS=Homo sapiens GN=SLC35G5 PE=2 SV=1 | 46 | G | 0.38094 | D | 0.342028 | 0.038912 | No Change: Both O | - |
| Q96KT7 | S35G5_HUMAN Solute carrier family 35 member G5 OS=Homo sapiens GN=SLC35G5 PE=2 SV=1 | 307 | L | 0.217844 | P | 0.367484 | -0.14964 | No Change: Both O | - |
| P0C7Q6 | S35G6_HUMAN Solute carrier family 35 member G6 OS=Homo sapiens GN=SLC35G6 PE=1 SV=1 | 51 | A | 0.302564 | T | 0.322592 | -0.020028 | No Change: Both O | - |
| P0C7Q6 | S35G6_HUMAN Solute carrier family 35 member G6 OS=Homo sapiens GN=SLC35G6 PE=1 SV=1 | 251 | P | 0.314625 | L | 0.177802 | 0.136823 | No Change: Both O | - |
| P0C7Q6 | S35G6_HUMAN Solute carrier family 35 member G6 OS=Homo sapiens GN=SLC35G6 PE=1 SV=1 | 263 | A | 0.041703 | T | 0.047487 | -0.005784 | No Change: Both O | - |
| Q7Z2H8 | S36A1_HUMAN Proton-coupled amino acid transporter 1 OS=Homo sapiens GN=SLC36A1 PE=1 SV=1 | 362 | F | 0.092888 | L | 0.098415 | -0.005527 | No Change: Both O | - |
| Q495M3 | S36A2_HUMAN Proton-coupled amino acid transporter 2 OS=Homo sapiens GN=SLC36A2 PE=1 SV=1 | 445 | A | 0.086469 | V | 0.061867 | 0.024602 | No Change: Both O | - |
| Q495M3 | S36A2_HUMAN Proton-coupled amino acid transporter 2 OS=Homo sapiens GN=SLC36A2 PE=1 SV=1 | 87 | G | 0.130492 | V | 0.070697 | 0.059795 | No Change: Both O | Hyperglycinuria (HG) [MIM:138500] |
| Q495M3 | S36A2_HUMAN Proton-coupled amino acid transporter 2 OS=Homo sapiens GN=SLC36A2 PE=1 SV=1 | 87 | G | 0.130492 | V | 0.070697 | 0.059795 | No Change: Both O | Iminoglycinuria (IG) [MIM:242600] |
| Q495N2 | S36A3_HUMAN Proton-coupled amino acid transporter 3 OS=Homo sapiens GN=SLC36A3 PE=1 SV=2 | 167 | K | 0.406602 | E | 0.42375 | -0.017148 | No Change: Both O | - |
| Q495N2 | S36A3_HUMAN Proton-coupled amino acid transporter 3 OS=Homo sapiens GN=SLC36A3 PE=1 SV=2 | 185 | P | 0.075576 | S | 0.082369 | -0.006793 | No Change: Both O | - |
| Q495N2 | S36A3_HUMAN Proton-coupled amino acid transporter 3 OS=Homo sapiens GN=SLC36A3 PE=1 SV=2 | 190 | R | 0.024798 | H | 0.025156 | -3.58E-04 | No Change: Both O | - |
| Q495N2 | S36A3_HUMAN Proton-coupled amino acid transporter 3 OS=Homo sapiens GN=SLC36A3 PE=1 SV=2 | 415 | E | 0.027205 | D | 0.023778 | 0.003427 | No Change: Both O | - |
| Q495N2 | S36A3_HUMAN Proton-coupled amino acid transporter 3 OS=Homo sapiens GN=SLC36A3 PE=1 SV=2 | 421 | S | 0.094859 | F | 0.034001 | 0.060858 | No Change: Both O | - |
| Q6YBV0 | S36A4_HUMAN Proton-coupled amino acid transporter 4 OS=Homo sapiens GN=SLC36A4 PE=1 SV=1 | 209 | L | 0.101102 | I | 0.088924 | 0.012178 | No Change: Both O | - |
| Q6YBV0 | S36A4_HUMAN Proton-coupled amino acid transporter 4 OS=Homo sapiens GN=SLC36A4 PE=1 SV=1 | 376 | P | 0.16057 | H | 0.139887 | 0.020683 | No Change: Both O | - |
| Q6YBV0 | S36A4_HUMAN Proton-coupled amino acid transporter 4 OS=Homo sapiens GN=SLC36A4 PE=1 SV=1 | 429 | L | 0.157241 | I | 0.134726 | 0.022515 | No Change: Both O | - |
| P57057 | GLPT_HUMAN Glycerol-3-phosphate transporter OS=Homo sapiens GN=SLC37A1 PE=1 SV=2 | 247 | D | 0.298689 | N | 0.297666 | 0.001023 | No Change: Both O | - |
| P57057 | GLPT_HUMAN Glycerol-3-phosphate transporter OS=Homo sapiens GN=SLC37A1 PE=1 SV=2 | 414 | V | 0.191549 | I | 0.18282 | 0.008729 | No Change: Both O | - |
| Q8TED4 | SPX2_HUMAN Sugar phosphate exchanger 2 OS=Homo sapiens GN=SLC37A2 PE=2 SV=2 | 268 | G | 0.821808 | S | 0.857661 | -0.035853 | No Change: Both D | - |
| Q8TED4 | SPX2_HUMAN Sugar phosphate exchanger 2 OS=Homo sapiens GN=SLC37A2 PE=2 SV=2 | 96 | I | 0.035765 | V | 0.040549 | -0.004784 | No Change: Both O | - |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 149 | G | 0.291645 | E | 0.323933 | -0.032288 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 339 | G | 0.096261 | C | 0.038191 | 0.05807 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 118 | W | 0.181084 | R | 0.382739 | -0.201655 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 28 | R | 0.161452 | H | 0.168155 | -0.006703 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 20 | G | 0.103769 | D | 0.109268 | -0.005499 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 24 | Y | 0.120555 | H | 0.181643 | -0.061088 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 27 | N | 0.150674 | K | 0.190245 | -0.039571 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 28 | R | 0.161452 | C | 0.080763 | 0.080689 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 50 | G | 0.390286 | R | 0.376142 | 0.014144 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 54 | S | 0.388996 | R | 0.297734 | 0.091262 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 55 | S | 0.403893 | R | 0.31276 | 0.091133 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 68 | G | 0.308977 | R | 0.300282 | 0.008695 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 85 | L | 0.051185 | P | 0.09453 | -0.043345 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 88 | G | 0.031793 | D | 0.033811 | -0.002018 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 133 | Q | 0.089426 | P | 0.104144 | -0.014718 | No Change: Both O | Glycogen storage disease type 1C (GSD1C) [MIM:232240] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 150 | G | 0.267938 | R | 0.236714 | 0.031224 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 153 | P | 0.150426 | L | 0.083165 | 0.067261 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 176 | C | 0.042624 | R | 0.085109 | -0.042485 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 183 | C | 0.024142 | R | 0.045191 | -0.021049 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 198 | N | 0.491763 | I | 0.295292 | 0.196471 | No Change: Both O | - |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 229 | L | 0.067022 | P | 0.123636 | -0.056614 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 278 | I | 0.225593 | N | 0.398083 | -0.17249 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 300 | R | 0.326548 | H | 0.343682 | -0.017134 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 301 | H | 0.260027 | P | 0.305984 | -0.045957 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 339 | G | 0.096261 | D | 0.098877 | -0.002616 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 367 | A | 0.139481 | T | 0.159696 | -0.020215 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 373 | A | 0.119992 | D | 0.159482 | -0.03949 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 376 | G | 0.124842 | S | 0.142778 | -0.017936 | No Change: Both O | Glycogen storage disease type 1C (GSD1C) [MIM:232240] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 191 | P | 0.284515 | L | 0.180073 | 0.104442 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 50 | G | 0.390286 | E | 0.453411 | -0.063125 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 148 | A | 0.327522 | V | 0.240175 | 0.087347 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 246 | W | 0.039721 | R | 0.101769 | -0.062048 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| O43826 | G6PT1_HUMAN Glucose-6-phosphate translocase OS=Homo sapiens GN=SLC37A4 PE=1 SV=1 | 300 | R | 0.326548 | C | 0.185957 | 0.140591 | No Change: Both O | Glycogen storage disease type 1B (GSD1B) [MIM:232220] |
| Q9HBR0 | S38AA_HUMAN Putative sodium-coupled neutral amino acid transporter 10 OS=Homo sapiens GN=SLC38A10 PE=1 SV=2 | 831 | A | 0.981422 | G | 0.983036 | -0.001614 | No Change: Both D | - |
| Q9HBR0 | S38AA_HUMAN Putative sodium-coupled neutral amino acid transporter 10 OS=Homo sapiens GN=SLC38A10 PE=1 SV=2 | 559 | K | 0.993823 | R | 0.993651 | 1.72E-04 | No Change: Both D | - |
| Q08AI6 | S38AB_HUMAN Putative sodium-coupled neutral amino acid transporter 11 OS=Homo sapiens GN=SLC38A11 PE=2 SV=1 | 194 | A | 0.325897 | T | 0.375113 | -0.049216 | No Change: Both O | - |
| Q96QD8 | S38A2_HUMAN Sodium-coupled neutral amino acid transporter 2 OS=Homo sapiens GN=SLC38A2 PE=1 SV=2 | 48 | N | 0.556526 | K | 0.589039 | -0.032513 | No Change: Both D | - |
| Q969I6 | S38A4_HUMAN Sodium-coupled neutral amino acid transporter 4 OS=Homo sapiens GN=SLC38A4 PE=1 SV=1 | 29 | G | 0.833308 | R | 0.824698 | 0.00861 | No Change: Both D | - |
| Q969I6 | S38A4_HUMAN Sodium-coupled neutral amino acid transporter 4 OS=Homo sapiens GN=SLC38A4 PE=1 SV=1 | 366 | T | 0.563077 | M | 0.516463 | 0.046614 | No Change: Both D | - |
| Q8WUX1 | S38A5_HUMAN Sodium-coupled neutral amino acid transporter 5 OS=Homo sapiens GN=SLC38A5 PE=1 SV=1 | 451 | M | 0.039711 | T | 0.046984 | -0.007273 | No Change: Both O | - |
| Q8IZM9 | S38A6_HUMAN Probable sodium-coupled neutral amino acid transporter 6 OS=Homo sapiens GN=SLC38A6 PE=2 SV=2 | 70 | L | 0.065845 | M | 0.08093 | -0.015085 | No Change: Both O | - |
| Q9NVC3 | S38A7_HUMAN Putative sodium-coupled neutral amino acid transporter 7 OS=Homo sapiens GN=SLC38A7 PE=2 SV=1 | 46 | L | 0.590064 | P | 0.665892 | -0.075828 | No Change: Both D | - |
| Q9NVC3 | S38A7_HUMAN Putative sodium-coupled neutral amino acid transporter 7 OS=Homo sapiens GN=SLC38A7 PE=2 SV=1 | 78 | T | 0.286409 | I | 0.173896 | 0.112513 | No Change: Both O | - |
| A6NNN8 | S38A8_HUMAN Putative sodium-coupled neutral amino acid transporter 8 OS=Homo sapiens GN=SLC38A8 PE=2 SV=1 | 220 | S | 0.087833 | T | 0.061223 | 0.02661 | No Change: Both O | - |
| Q8NBW4 | S38A9_HUMAN Putative sodium-coupled neutral amino acid transporter 9 OS=Homo sapiens GN=SLC38A9 PE=1 SV=2 | 182 | S | 0.285425 | T | 0.22001 | 0.065415 | No Change: Both O | - |
| Q9ULF5 | S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens GN=SLC39A10 PE=1 SV=2 | 87 | T | 0.256662 | S | 0.344721 | -0.088059 | No Change: Both O | - |
| Q8N1S5 | S39AB_HUMAN Zinc transporter ZIP11 OS=Homo sapiens GN=SLC39A11 PE=2 SV=3 | 111 | T | 0.374789 | A | 0.350678 | 0.024111 | No Change: Both O | - |
| Q504Y0 | S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens GN=SLC39A12 PE=2 SV=3 | 36 | S | 0.894019 | G | 0.863372 | 0.030647 | No Change: Both D | - |
| Q504Y0 | S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens GN=SLC39A12 PE=2 SV=3 | 244 | T | 0.426593 | M | 0.362166 | 0.064427 | No Change: Both O | - |
| Q504Y0 | S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens GN=SLC39A12 PE=2 SV=3 | 304 | V | 0.546605 | I | 0.539596 | 0.007009 | No Change: Both D | - |
| Q504Y0 | S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens GN=SLC39A12 PE=2 SV=3 | 435 | F | 0.683841 | L | 0.699944 | -0.016103 | No Change: Both D | - |
| Q504Y0 | S39AC_HUMAN Zinc transporter ZIP12 OS=Homo sapiens GN=SLC39A12 PE=2 SV=3 | 471 | P | 0.272988 | T | 0.231394 | 0.041594 | No Change: Both O | A breast cancer sample |
| Q96H72 | S39AD_HUMAN Zinc transporter ZIP13 OS=Homo sapiens GN=SLC39A13 PE=2 SV=3 | 28 | E | 0.698849 | G | 0.662233 | 0.036616 | No Change: Both D | - |
| Q96H72 | S39AD_HUMAN Zinc transporter ZIP13 OS=Homo sapiens GN=SLC39A13 PE=2 SV=3 | 346 | P | 0.506311 | L | 0.347307 | 0.159004 | D to O | - |
| Q15043 | S39AE_HUMAN Zinc transporter ZIP14 OS=Homo sapiens GN=SLC39A14 PE=1 SV=3 | 33 | L | 0.596476 | P | 0.70391 | -0.107434 | No Change: Both D | - |
| Q9NP94 | S39A2_HUMAN Zinc transporter ZIP2 OS=Homo sapiens GN=SLC39A2 PE=1 SV=2 | 80 | M | 0.474986 | V | 0.396158 | 0.078828 | No Change: Both O | - |
| Q9NP94 | S39A2_HUMAN Zinc transporter ZIP2 OS=Homo sapiens GN=SLC39A2 PE=1 SV=2 | 129 | G | 0.283986 | E | 0.315454 | -0.031468 | No Change: Both O | - |
| Q9NP94 | S39A2_HUMAN Zinc transporter ZIP2 OS=Homo sapiens GN=SLC39A2 PE=1 SV=2 | 154 | H | 0.681827 | Y | 0.57266 | 0.109167 | No Change: Both D | - |
| Q9NP94 | S39A2_HUMAN Zinc transporter ZIP2 OS=Homo sapiens GN=SLC39A2 PE=1 SV=2 | 115 | F | 0.026668 | L | 0.030911 | -0.004243 | No Change: Both O | - |
| Q9NP94 | S39A2_HUMAN Zinc transporter ZIP2 OS=Homo sapiens GN=SLC39A2 PE=1 SV=2 | 48 | L | 0.066072 | P | 0.120851 | -0.054779 | No Change: Both O | - |
| Q9BRY0 | S39A3_HUMAN Zinc transporter ZIP3 OS=Homo sapiens GN=SLC39A3 PE=1 SV=2 | 100 | F | 0.033088 | L | 0.038327 | -0.005239 | No Change: Both O | - |
| Q9BRY0 | S39A3_HUMAN Zinc transporter ZIP3 OS=Homo sapiens GN=SLC39A3 PE=1 SV=2 | 257 | P | 0.49129 | L | 0.330209 | 0.161081 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 58 | A | 0.420867 | T | 0.433533 | -0.012666 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 84 | P | 0.653546 | L | 0.509181 | 0.144365 | No Change: Both D | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 95 | R | 0.308435 | C | 0.230746 | 0.077689 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 106 | N | 0.347205 | K | 0.384423 | -0.037218 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 114 | A | 0.349641 | T | 0.368479 | -0.018838 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 200 | P | 0.256735 | L | 0.144674 | 0.112061 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 251 | R | 0.848565 | W | 0.67581 | 0.172755 | No Change: Both D | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 303 | Q | 0.725164 | H | 0.620436 | 0.104728 | No Change: Both D | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 309 | C | 0.746889 | Y | 0.741392 | 0.005497 | No Change: Both D | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 330 | G | 0.202938 | D | 0.221728 | -0.01879 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 357 | T | 0.080919 | A | 0.064149 | 0.01677 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 372 | L | 0.192741 | P | 0.311437 | -0.118696 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 374 | G | 0.234192 | R | 0.210857 | 0.023335 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 410 | L | 0.061696 | P | 0.114054 | -0.052358 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 526 | G | 0.29459 | R | 0.281591 | 0.012999 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 630 | G | 0.067459 | R | 0.057311 | 0.010148 | No Change: Both O | Acrodermatitis enteropathica zinc-deficiency type (AEZ) [MIM:201100] |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 158 | T | 0.392181 | M | 0.364234 | 0.027947 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 284 | E | 0.451767 | K | 0.423526 | 0.028241 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 372 | L | 0.192741 | V | 0.191692 | 0.001049 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 22 | A | 0.407381 | E | 0.482163 | -0.074782 | No Change: Both O | - |
| Q6P5W5 | S39A4_HUMAN Zinc transporter ZIP4 OS=Homo sapiens GN=SLC39A4 PE=1 SV=3 | 378 | L | 0.177243 | V | 0.176267 | 9.76E-04 | No Change: Both O | - |
| Q13433 | S39A6_HUMAN Zinc transporter ZIP6 OS=Homo sapiens GN=SLC39A6 PE=1 SV=3 | 119 | E | 0.998574 | D | 0.998594 | -2.00E-05 | No Change: Both D | - |
| Q92504 | S39A7_HUMAN Zinc transporter SLC39A7 OS=Homo sapiens GN=SLC39A7 PE=1 SV=2 | 87 | D | 0.984488 | N | 0.978852 | 0.005636 | No Change: Both D | - |
| Q92504 | S39A7_HUMAN Zinc transporter SLC39A7 OS=Homo sapiens GN=SLC39A7 PE=1 SV=2 | 124 | G | 0.562986 | R | 0.523672 | 0.039314 | No Change: Both D | - |
| Q92504 | S39A7_HUMAN Zinc transporter SLC39A7 OS=Homo sapiens GN=SLC39A7 PE=1 SV=2 | 280 | E | 0.997088 | G | 0.996348 | 7.40E-04 | No Change: Both D | - |
| Q9C0K1 | S39A8_HUMAN Zinc transporter ZIP8 OS=Homo sapiens GN=SLC39A8 PE=1 SV=1 | 391 | A | 0.08849 | T | 0.094378 | -0.005888 | No Change: Both O | - |
| Q9NUM3 | S39A9_HUMAN Zinc transporter ZIP9 OS=Homo sapiens GN=SLC39A9 PE=2 SV=2 | 64 | E | 0.31767 | D | 0.290998 | 0.026672 | No Change: Both O | - |
| Q9NUM3 | S39A9_HUMAN Zinc transporter ZIP9 OS=Homo sapiens GN=SLC39A9 PE=2 SV=2 | 221 | M | 0.127597 | T | 0.147999 | -0.020402 | No Change: Both O | - |
| Q9NUM3 | S39A9_HUMAN Zinc transporter ZIP9 OS=Homo sapiens GN=SLC39A9 PE=2 SV=2 | 285 | R | 0.330978 | C | 0.174438 | 0.15654 | No Change: Both O | - |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 128 | P | 0.374529 | Q | 0.359478 | 0.015051 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 181 | R | 0.26344 | Q | 0.273862 | -0.010422 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 268 | E | 0.243578 | K | 0.242687 | 8.91E-04 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 341 | T | 0.328484 | A | 0.27755 | 0.050934 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 365 | R | 0.420075 | W | 0.198077 | 0.221998 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 452 | R | 0.600342 | W | 0.388339 | 0.212003 | D to O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 461 | Y | 0.228923 | H | 0.333599 | -0.104676 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 467 | M | 0.086389 | T | 0.1025 | -0.016111 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 467 | M | 0.086389 | K | 0.128113 | -0.041724 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 582 | Y | 0.19896 | H | 0.306758 | -0.107798 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 615 | P | 0.353053 | T | 0.311066 | 0.041987 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 618 | M | 0.378752 | I | 0.293513 | 0.085239 | No Change: Both O | - |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 648 | F | 0.298587 | S | 0.494345 | -0.195758 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 652 | T | 0.386332 | R | 0.407717 | -0.021385 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 678 | L | 0.14187 | P | 0.249092 | -0.107222 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 216 | T | 0.289096 | M | 0.245304 | 0.043792 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 362 | R | 0.36607 | C | 0.213085 | 0.152985 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 508 | P | 0.626177 | A | 0.557716 | 0.068461 | No Change: Both D | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 151 | Y | 0.138453 | C | 0.118124 | 0.020329 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 253 | N | 0.302634 | K | 0.334896 | -0.032262 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 362 | R | 0.36607 | H | 0.343039 | 0.023031 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 398 | G | 0.068563 | R | 0.070862 | -0.002299 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 481 | G | 0.300896 | V | 0.172957 | 0.127939 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 482 | E | 0.30228 | K | 0.286483 | 0.015797 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 510 | Q | 0.670719 | R | 0.668374 | 0.002345 | No Change: Both D | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 584 | R | 0.195128 | T | 0.189037 | 0.006091 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 599 | F | 0.095566 | S | 0.228639 | -0.133073 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 600 | G | 0.144694 | E | 0.185801 | -0.041107 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q07837 | SLC31_HUMAN Neutral and basic amino acid transport protein rBAT OS=Homo sapiens GN=SLC3A1 PE=1 SV=2 | 122 | P | 0.134975 | S | 0.14723 | -0.012255 | No Change: Both O | Cystinuria type 1 (CSNU1) [MIM:220100] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 561 | R | 0.709931 | G | 0.731883 | -0.021952 | No Change: Both D | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 248 | Q | 0.696926 | H | 0.690095 | 0.006831 | No Change: Both D | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 432 | M | 0.613231 | V | 0.558181 | 0.05505 | No Change: Both D | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 77 | A | 0.043815 | D | 0.070075 | -0.02626 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 144 | N | 0.205453 | H | 0.176482 | 0.028971 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 157 | D | 0.052391 | G | 0.047005 | 0.005386 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 182 | Q | 0.170077 | H | 0.158047 | 0.01203 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 323 | G | 0.037745 | V | 0.019893 | 0.017852 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 443 | P | 0.685809 | L | 0.517444 | 0.168365 | No Change: Both D | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 64 | Y | 0.063463 | N | 0.125086 | -0.061623 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 80 | G | 0.069652 | S | 0.083334 | -0.013682 | No Change: Both O | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 80 | G | 0.069652 | V | 0.037715 | 0.031937 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 144 | N | 0.205453 | D | 0.206216 | -7.63E-04 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 144 | N | 0.205453 | T | 0.182334 | 0.023119 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 174 | N | 0.316944 | I | 0.175012 | 0.141932 | No Change: Both O | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 181 | D | 0.184973 | V | 0.092318 | 0.092655 | No Change: Both O | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 267 | G | 0.754234 | D | 0.782369 | -0.028135 | No Change: Both D | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 270 | D | 0.710483 | V | 0.613585 | 0.096898 | No Change: Both D | Hemochromatosis type 4 (HFE4) [MIM:606069] |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 326 | C | 0.057797 | Y | 0.080601 | -0.022804 | No Change: Both O | - |
| Q9NP59 | S40A1_HUMAN Solute carrier family 40 member 1 OS=Homo sapiens GN=SLC40A1 PE=1 SV=1 | 490 | G | 0.382828 | D | 0.396217 | -0.013389 | No Change: Both O | - |
| Q96GZ6 | S41A3_HUMAN Solute carrier family 41 member 3 OS=Homo sapiens GN=SLC41A3 PE=2 SV=2 | 62 | T | 0.425833 | A | 0.378304 | 0.047529 | No Change: Both O | - |
| Q96GZ6 | S41A3_HUMAN Solute carrier family 41 member 3 OS=Homo sapiens GN=SLC41A3 PE=2 SV=2 | 71 | V | 0.080851 | M | 0.110586 | -0.029735 | No Change: Both O | - |
| O75387 | LAT3_HUMAN Large neutral amino acids transporter small subunit 3 OS=Homo sapiens GN=SLC43A1 PE=2 SV=1 | 238 | G | 0.324719 | V | 0.205104 | 0.119615 | No Change: Both O | - |
| O75387 | LAT3_HUMAN Large neutral amino acids transporter small subunit 3 OS=Homo sapiens GN=SLC43A1 PE=2 SV=1 | 443 | H | 0.045454 | Y | 0.025143 | 0.020311 | No Change: Both O | - |
| Q8NBI5 | S43A3_HUMAN Solute carrier family 43 member 3 OS=Homo sapiens GN=SLC43A3 PE=1 SV=2 | 53 | P | 0.488899 | L | 0.304776 | 0.184123 | No Change: Both O | - |
| Q8WWI5 | CTL1_HUMAN Choline transporter-like protein 1 OS=Homo sapiens GN=SLC44A1 PE=1 SV=1 | 644 | S | 0.903141 | A | 0.865578 | 0.037563 | No Change: Both D | - |
| Q8IWA5 | CTL2_HUMAN Choline transporter-like protein 2 OS=Homo sapiens GN=SLC44A2 PE=1 SV=3 | 154 | Q | 0.257925 | R | 0.243944 | 0.013981 | No Change: Both O | - |
| Q8N4M1 | CTL3_HUMAN Choline transporter-like protein 3 OS=Homo sapiens GN=SLC44A3 PE=2 SV=4 | 438 | V | 0.159424 | I | 0.138434 | 0.02099 | No Change: Both O | - |
| Q8N4M1 | CTL3_HUMAN Choline transporter-like protein 3 OS=Homo sapiens GN=SLC44A3 PE=2 SV=4 | 441 | G | 0.187409 | W | 0.070498 | 0.116911 | No Change: Both O | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 6 | R | 0.836873 | L | 0.774891 | 0.061982 | No Change: Both D | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 187 | V | 0.234404 | I | 0.243521 | -0.009117 | No Change: Both O | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 326 | M | 0.016731 | V | 0.012411 | 0.00432 | No Change: Both O | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 493 | R | 0.109217 | C | 0.046775 | 0.062442 | No Change: Both O | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 347 | A | 0.535239 | T | 0.560554 | -0.025315 | No Change: Both D | A colorectal cancer sample |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 411 | T | 0.404133 | M | 0.35911 | 0.045023 | No Change: Both O | A colorectal cancer sample |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 123 | D | 0.408758 | V | 0.308436 | 0.100322 | No Change: Both O | - |
| Q53GD3 | CTL4_HUMAN Choline transporter-like protein 4 OS=Homo sapiens GN=SLC44A4 PE=2 SV=2 | 128 | G | 0.421604 | E | 0.494779 | -0.073175 | No Change: Both O | - |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 374 | L | 0.033801 | F | 0.030815 | 0.002986 | No Change: Both O | - |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 58 | P | 0.107539 | A | 0.08027 | 0.027269 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 58 | P | 0.107539 | S | 0.126287 | -0.018748 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 157 | D | 0.091711 | N | 0.077513 | 0.014198 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 188 | G | 0.167273 | V | 0.082208 | 0.085065 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 202 | W | 0.074592 | C | 0.088169 | -0.013577 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 272 | E | 0.635073 | K | 0.641866 | -0.006793 | No Change: Both D | - |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 317 | Y | 0.117124 | C | 0.095246 | 0.021878 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 361 | L | 0.219424 | P | 0.382757 | -0.163333 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 477 | A | 0.198241 | T | 0.235528 | -0.037287 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 486 | A | 0.083867 | V | 0.06485 | 0.019017 | No Change: Both O | Albinism oculocutaneous type 4 (OCA4) [MIM:606574] |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 500 | T | 0.111614 | P | 0.131149 | -0.019535 | No Change: Both O | - |
| Q9UMX9 | S45A2_HUMAN Membrane-associated transporter protein OS=Homo sapiens GN=SLC45A2 PE=1 SV=2 | 507 | V | 0.069714 | L | 0.060894 | 0.00882 | No Change: Both O | - |
| Q5BKX6 | S45A4_HUMAN Solute carrier family 45 member 4 OS=Homo sapiens GN=SLC45A4 PE=1 SV=2 | 277 | P | 0.825393 | L | 0.709681 | 0.115712 | No Change: Both D | - |
| Q5BKX6 | S45A4_HUMAN Solute carrier family 45 member 4 OS=Homo sapiens GN=SLC45A4 PE=1 SV=2 | 718 | N | 0.300193 | D | 0.30596 | -0.005767 | No Change: Both O | - |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 113 | R | 0.28451 | S | 0.36196 | -0.07745 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 147 | G | 0.026568 | R | 0.025513 | 0.001055 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 318 | S | 0.137714 | R | 0.103304 | 0.03441 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 376 | R | 0.160106 | W | 0.063971 | 0.096135 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 425 | P | 0.099136 | R | 0.083159 | 0.015977 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 295 | T | 0.114601 | A | 0.097195 | 0.017406 | No Change: Both O | - |
| Q96NT5 | PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens GN=SLC46A1 PE=1 SV=1 | 113 | R | 0.28451 | C | 0.139139 | 0.145371 | No Change: Both O | Hereditary folate malabsorption (HFM) [MIM:229050] |
| Q9BY10 | TSCOT_HUMAN Thymic stromal cotransporter homolog OS=Homo sapiens GN=SLC46A2 PE=2 SV=1 | 366 | A | 0.07804 | V | 0.054056 | 0.023984 | No Change: Both O | - |
| Q96FL8 | S47A1_HUMAN Multidrug and toxin extrusion protein 1 OS=Homo sapiens GN=SLC47A1 PE=1 SV=1 | 338 | V | 0.293679 | I | 0.271219 | 0.02246 | No Change: Both O | - |
| Q86VL8 | S47A2_HUMAN Multidrug and toxin extrusion protein 2 OS=Homo sapiens GN=SLC47A2 PE=1 SV=1 | 429 | G | 0.077783 | R | 0.070243 | 0.00754 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 40 | E | 0.843765 | K | 0.825133 | 0.018632 | No Change: Both D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 56 | K | 0.4917 | E | 0.531708 | -0.040008 | O to D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 327 | P | 0.659211 | R | 0.629348 | 0.029863 | No Change: Both D | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 518 | R | 0.100361 | C | 0.042712 | 0.057649 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 548 | P | 0.268544 | L | 0.153571 | 0.114973 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 552 | T | 0.291873 | I | 0.17425 | 0.117623 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 557 | V | 0.188288 | M | 0.241286 | -0.052998 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 658 | E | 0.14855 | K | 0.148554 | -4.00E-06 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 854 | P | 0.227882 | L | 0.121962 | 0.10592 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 90 | E | 0.461864 | K | 0.439853 | 0.022011 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 130 | G | 0.257367 | R | 0.262402 | -0.005035 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 147 | P | 0.489695 | S | 0.525902 | -0.036207 | O to D | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 285 | A | 0.277329 | D | 0.345093 | -0.067764 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 432 | R | 0.552431 | W | 0.32348 | 0.228951 | D to O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 455 | G | 0.063758 | E | 0.075898 | -0.01214 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 480 | E | 0.124521 | K | 0.114799 | 0.009722 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 488 | V | 0.035918 | M | 0.045088 | -0.00917 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 490 | R | 0.016448 | C | 0.007277 | 0.009171 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 551 | K | 0.30961 | N | 0.286738 | 0.022872 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 555 | Y | 0.204906 | H | 0.306385 | -0.101479 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 561 | P | 0.401537 | S | 0.405804 | -0.004267 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 565 | G | 0.492974 | A | 0.453648 | 0.039326 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 566 | P | 0.501441 | A | 0.413599 | 0.087842 | D to O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 566 | P | 0.501441 | S | 0.510007 | -0.008566 | No Change: Both D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 569 | N | 0.367032 | K | 0.41383 | -0.046798 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 646 | R | 0.314736 | Q | 0.335017 | -0.020281 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 646 | R | 0.314736 | W | 0.155824 | 0.158912 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 656 | R | 0.147658 | C | 0.071198 | 0.07646 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 656 | R | 0.147658 | H | 0.159595 | -0.011937 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 707 | L | 0.091734 | P | 0.166083 | -0.074349 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 714 | G | 0.105027 | R | 0.090231 | 0.014796 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 760 | R | 0.312517 | Q | 0.354947 | -0.04243 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 760 | R | 0.312517 | W | 0.153338 | 0.159179 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 771 | G | 0.055787 | D | 0.059159 | -0.003372 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 783 | I | 0.074029 | N | 0.150567 | -0.076538 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 808 | R | 0.053732 | C | 0.024141 | 0.029591 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 808 | R | 0.053732 | H | 0.054281 | -5.49E-04 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 834 | H | 0.056641 | P | 0.066747 | -0.010106 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 837 | T | 0.02955 | A | 0.025232 | 0.004318 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 837 | T | 0.02955 | M | 0.024375 | 0.005175 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 868 | P | 0.051465 | L | 0.025262 | 0.026203 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 870 | R | 0.056314 | W | 0.019289 | 0.037025 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 38 | D | 0.87634 | A | 0.856495 | 0.019845 | No Change: Both D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 112 | R | 0.112775 | S | 0.145788 | -0.033013 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 442 | I | 0.164161 | F | 0.161109 | 0.003052 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 586 | M | 0.103483 | L | 0.07698 | 0.026503 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 688 | I | 0.266308 | V | 0.300001 | -0.033693 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 690 | S | 0.410127 | G | 0.35078 | 0.059347 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 832 | R | 0.098505 | H | 0.099213 | -7.08E-04 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 862 | V | 0.040563 | I | 0.034998 | 0.005565 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 589 | R | 0.227761 | C | 0.123601 | 0.10416 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 589 | R | 0.227761 | H | 0.229471 | -0.00171 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 589 | R | 0.227761 | S | 0.299806 | -0.072045 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 613 | S | 0.038521 | F | 0.014954 | 0.023567 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 858 | A | 0.13394 | D | 0.177501 | -0.043561 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 701 | G | 0.287914 | D | 0.313685 | -0.025771 | No Change: Both O | Autosomal recessive distal renal tubular acidosis (AR-dRTA) [MIM:611590] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 508 | E | 0.062484 | K | 0.062463 | 2.10E-05 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 45 | D | 0.749585 | E | 0.775842 | -0.026257 | No Change: Both D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 68 | E | 0.463723 | K | 0.45046 | 0.013263 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 73 | L | 0.340119 | M | 0.420999 | -0.08088 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 602 | R | 0.220433 | P | 0.253307 | -0.032874 | No Change: Both O | Autosomal recessive distal renal tubular acidosis (AR-dRTA) [MIM:611590] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 687 | L | 0.226271 | P | 0.389667 | -0.163396 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 705 | D | 0.110301 | Y | 0.053657 | 0.056644 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 731 | S | 0.358316 | P | 0.319977 | 0.038339 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 734 | H | 0.341272 | R | 0.358375 | -0.017103 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 773 | S | 0.073842 | P | 0.068084 | 0.005758 | No Change: Both O | Autosomal recessive distal renal tubular acidosis (AR-dRTA) [MIM:611590] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 27 | P | 0.969342 | H | 0.961449 | 0.007893 | No Change: Both D | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 72 | E | 0.40615 | D | 0.370892 | 0.035258 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 429 | E | 0.476394 | D | 0.44897 | 0.027424 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 455 | G | 0.063758 | R | 0.056173 | 0.007585 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 490 | R | 0.016448 | H | 0.016783 | -3.35E-04 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 561 | P | 0.401537 | A | 0.29719 | 0.104347 | No Change: Both O | - |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 609 | G | 0.084224 | R | 0.080776 | 0.003448 | No Change: Both O | Autosomal dominant distal renal tubular acidosis (AD-dRTA) [MIM:179800] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 663 | M | 0.06829 | K | 0.111383 | -0.043093 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| P02730 | B3AT_HUMAN Band 3 anion transport protein OS=Homo sapiens GN=SLC4A1 PE=1 SV=3 | 837 | T | 0.02955 | R | 0.032585 | -0.003035 | No Change: Both O | Spherocytosis type 4 (SPH4) [MIM:612653] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 408 | Q | 0.360903 | H | 0.331869 | 0.029034 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 409 | K | 0.351872 | N | 0.310721 | 0.041151 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 483 | M | 0.166389 | T | 0.207215 | -0.040826 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 708 | T | 0.065859 | A | 0.061637 | 0.004222 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 464 | G | 0.038127 | D | 0.044301 | -0.006174 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 489 | S | 0.308493 | L | 0.149071 | 0.159422 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 755 | R | 0.352067 | Q | 0.373819 | -0.021752 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 869 | R | 0.038012 | C | 0.016629 | 0.021383 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 150 | N | 0.369312 | S | 0.410837 | -0.041525 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 160 | A | 0.531515 | T | 0.570285 | -0.03877 | No Change: Both D | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 213 | S | 0.042442 | P | 0.038017 | 0.004425 | No Change: Both O | Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 488 | R | 0.30907 | K | 0.401271 | -0.092201 | No Change: Both O | Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 804 | R | 0.133527 | H | 0.134021 | -4.94E-04 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 824 | V | 0.338905 | M | 0.402253 | -0.063348 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 833 | T | 0.08259 | M | 0.067503 | 0.015087 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 843 | L | 0.037651 | P | 0.072291 | -0.03464 | No Change: Both O | Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 848 | M | 0.133115 | I | 0.083568 | 0.049547 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 856 | M | 0.110748 | V | 0.075731 | 0.035017 | No Change: Both O | Corneal dystrophy and perceptive deafness (CDPD) [MIM:217400] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 869 | R | 0.038012 | H | 0.034263 | 0.003749 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 72 | N | 0.491505 | T | 0.485289 | 0.006216 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 91 | M | 0.383989 | V | 0.34391 | 0.040079 | No Change: Both O | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 327 | A | 0.77312 | V | 0.728787 | 0.044333 | No Change: Both D | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 399 | E | 0.558676 | K | 0.552363 | 0.006313 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 561 | T | 0.629395 | M | 0.588766 | 0.040629 | No Change: Both D | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 565 | S | 0.722291 | L | 0.555456 | 0.166835 | No Change: Both D | - |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 709 | G | 0.06675 | E | 0.07962 | -0.01287 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 754 | T | 0.342236 | M | 0.275746 | 0.06649 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 125 | R | 0.349853 | H | 0.353979 | -0.004126 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 269 | A | 0.385068 | V | 0.304082 | 0.080986 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 386 | C | 0.017485 | R | 0.037969 | -0.020484 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 755 | R | 0.352067 | W | 0.169155 | 0.182912 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 773 | P | 0.066914 | L | 0.032698 | 0.034216 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 873 | L | 0.052598 | P | 0.118288 | -0.06569 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 167 | E | 0.622866 | D | 0.647253 | -0.024387 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 282 | R | 0.438214 | P | 0.450793 | -0.012579 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 526 | Y | 0.532112 | C | 0.447603 | 0.084509 | D to O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 575 | V | 0.181556 | M | 0.243719 | -0.062163 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 583 | G | 0.034278 | D | 0.036 | -0.001722 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 742 | G | 0.28373 | R | 0.285892 | -0.002162 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 834 | G | 0.07756 | S | 0.098292 | -0.020732 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 4 (FECD4) [MIM:613268] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 209 | R | 0.123836 | W | 0.054146 | 0.06969 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 213 | S | 0.042442 | L | 0.01886 | 0.023582 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 233 | R | 0.144467 | C | 0.069852 | 0.074615 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 394 | G | 0.250937 | R | 0.237105 | 0.013832 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 401 | T | 0.57132 | K | 0.660237 | -0.088917 | No Change: Both D | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 418 | G | 0.141527 | D | 0.144084 | -0.002557 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 473 | L | 0.024625 | R | 0.040344 | -0.015719 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q8NBS3 | S4A11_HUMAN Sodium bicarbonate transporter-like protein 11 OS=Homo sapiens GN=SLC4A11 PE=1 SV=2 | 584 | T | 0.034975 | K | 0.046642 | -0.011667 | No Change: Both O | Corneal endothelial dystrophy type 2 (CHED2) [MIM:217700] |
| Q9BWU0 | NADAP_HUMAN Kanadaptin OS=Homo sapiens GN=SLC4A1AP PE=1 SV=1 | 139 | P | 0.985741 | T | 0.978323 | 0.007418 | No Change: Both D | - |
| Q9BWU0 | NADAP_HUMAN Kanadaptin OS=Homo sapiens GN=SLC4A1AP PE=1 SV=1 | 181 | R | 0.43926 | C | 0.319521 | 0.119739 | No Change: Both O | - |
| P04920 | B3A2_HUMAN Anion exchange protein 2 OS=Homo sapiens GN=SLC4A2 PE=1 SV=4 | 26 | G | 0.957238 | E | 0.968179 | -0.010941 | No Change: Both D | - |
| P04920 | B3A2_HUMAN Anion exchange protein 2 OS=Homo sapiens GN=SLC4A2 PE=1 SV=4 | 202 | E | 0.926237 | V | 0.882135 | 0.044102 | No Change: Both D | - |
| P04920 | B3A2_HUMAN Anion exchange protein 2 OS=Homo sapiens GN=SLC4A2 PE=1 SV=4 | 311 | R | 0.942309 | W | 0.859849 | 0.08246 | No Change: Both D | - |
| P04920 | B3A2_HUMAN Anion exchange protein 2 OS=Homo sapiens GN=SLC4A2 PE=1 SV=4 | 1204 | L | 0.072263 | F | 0.063543 | 0.00872 | No Change: Both O | - |
| P04920 | B3A2_HUMAN Anion exchange protein 2 OS=Homo sapiens GN=SLC4A2 PE=1 SV=4 | 208 | S | 0.886585 | T | 0.863599 | 0.022986 | No Change: Both D | - |
| P48751 | B3A3_HUMAN Anion exchange protein 3 OS=Homo sapiens GN=SLC4A3 PE=1 SV=2 | 226 | S | 0.95471 | L | 0.92697 | 0.02774 | No Change: Both D | - |
| P48751 | B3A3_HUMAN Anion exchange protein 3 OS=Homo sapiens GN=SLC4A3 PE=1 SV=2 | 157 | H | 0.986463 | P | 0.992585 | -0.006122 | No Change: Both D | - |
| P48751 | B3A3_HUMAN Anion exchange protein 3 OS=Homo sapiens GN=SLC4A3 PE=1 SV=2 | 867 | D | 0.718961 | A | 0.710241 | 0.00872 | No Change: Both D | - |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 342 | R | 0.249689 | S | 0.32868 | -0.078991 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 471 | S | 0.04327 | L | 0.019721 | 0.023549 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 529 | T | 0.2432 | S | 0.32712 | -0.08392 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 554 | R | 0.024718 | H | 0.02521 | -4.92E-04 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 843 | A | 0.040589 | V | 0.027504 | 0.013085 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9Y6R1 | S4A4_HUMAN Electrogenic sodium bicarbonate cotransporter 1 OS=Homo sapiens GN=SLC4A4 PE=1 SV=1 | 925 | R | 0.137405 | C | 0.065052 | 0.072353 | No Change: Both O | Proximal renal tubular acidosis with ocular abnormalities (pRTA-OA) [MIM:604278] |
| Q9BY07 | S4A5_HUMAN Electrogenic sodium bicarbonate cotransporter 4 OS=Homo sapiens GN=SLC4A5 PE=2 SV=2 | 251 | S | 0.893321 | N | 0.862287 | 0.031034 | No Change: Both D | - |
| Q9BY07 | S4A5_HUMAN Electrogenic sodium bicarbonate cotransporter 4 OS=Homo sapiens GN=SLC4A5 PE=2 SV=2 | 253 | H | 0.874623 | Y | 0.800533 | 0.07409 | No Change: Both D | - |
| Q9Y6M7 | S4A7_HUMAN Sodium bicarbonate cotransporter 3 OS=Homo sapiens GN=SLC4A7 PE=1 SV=2 | 326 | E | 0.980891 | K | 0.975548 | 0.005343 | No Change: Both D | - |
| Q2Y0W8 | S4A8_HUMAN Electroneutral sodium bicarbonate exchanger 1 OS=Homo sapiens GN=SLC4A8 PE=1 SV=1 | 312 | D | 0.097787 | A | 0.067865 | 0.029922 | No Change: Both O | - |
| Q2Y0W8 | S4A8_HUMAN Electroneutral sodium bicarbonate exchanger 1 OS=Homo sapiens GN=SLC4A8 PE=1 SV=1 | 898 | I | 0.048607 | V | 0.056874 | -0.008267 | No Change: Both O | - |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 28 | D | 0.090366 | N | 0.090153 | 2.13E-04 | No Change: Both O | Congenital glucose/galactose malabsorption (GGM) [MIM:606824] |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 28 | D | 0.090366 | G | 0.080067 | 0.010299 | No Change: Both O | Congenital glucose/galactose malabsorption (GGM) [MIM:606824] |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 135 | R | 0.325256 | W | 0.135026 | 0.19023 | No Change: Both O | Congenital glucose/galactose malabsorption (GGM) [MIM:606824] |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 318 | G | 0.040665 | R | 0.034905 | 0.00576 | No Change: Both O | Congenital glucose/galactose malabsorption (GGM) [MIM:606824] |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 468 | A | 0.059281 | V | 0.039993 | 0.019288 | No Change: Both O | Congenital glucose/galactose malabsorption (GGM) [MIM:606824] |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 51 | N | 0.23508 | S | 0.288403 | -0.053323 | No Change: Both O | - |
| P13866 | SC5A1_HUMAN Sodium/glucose cotransporter 1 OS=Homo sapiens GN=SLC5A1 PE=1 SV=1 | 411 | A | 0.243493 | T | 0.2725 | -0.029007 | No Change: Both O | - |
| A0PJK1 | SC5AA_HUMAN Sodium/glucose cotransporter 5 OS=Homo sapiens GN=SLC5A10 PE=1 SV=2 | 522 | A | 0.076015 | V | 0.053175 | 0.02284 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 182 | V | 0.025511 | A | 0.041004 | -0.015493 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 258 | F | 0.225832 | L | 0.252318 | -0.026486 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 452 | Q | 0.140673 | R | 0.119235 | 0.021438 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 526 | M | 0.068388 | I | 0.048592 | 0.019796 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 47 | T | 0.231288 | P | 0.258008 | -0.02672 | No Change: Both O | - |
| Q8WWX8 | SC5AB_HUMAN Sodium/myo-inositol cotransporter 2 OS=Homo sapiens GN=SLC5A11 PE=2 SV=1 | 539 | V | 0.181692 | M | 0.221031 | -0.039339 | No Change: Both O | - |
| Q1EHB4 | SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens GN=SLC5A12 PE=2 SV=2 | 510 | V | 0.042984 | L | 0.045345 | -0.002361 | No Change: Both O | - |
| P31639 | SC5A2_HUMAN Sodium/glucose cotransporter 2 OS=Homo sapiens GN=SLC5A2 PE=1 SV=1 | 654 | N | 0.107198 | S | 0.128286 | -0.021088 | No Change: Both O | Renal glucosuria (GLYS1) [MIM:233100] |
| P53794 | SC5A3_HUMAN Sodium/myo-inositol cotransporter OS=Homo sapiens GN=SLC5A3 PE=2 SV=2 | 50 | T | 0.100305 | A | 0.089276 | 0.011029 | No Change: Both O | - |
| P53794 | SC5A3_HUMAN Sodium/myo-inositol cotransporter OS=Homo sapiens GN=SLC5A3 PE=2 SV=2 | 566 | Q | 0.835497 | K | 0.858211 | -0.022714 | No Change: Both D | - |
| Q9NY91 | SC5A4_HUMAN Low affinity sodium-glucose cotransporter OS=Homo sapiens GN=SLC5A4 PE=2 SV=1 | 46 | A | 0.081719 | T | 0.094639 | -0.01292 | No Change: Both O | - |
| Q9NY91 | SC5A4_HUMAN Low affinity sodium-glucose cotransporter OS=Homo sapiens GN=SLC5A4 PE=2 SV=1 | 4 | T | 0.833799 | M | 0.831994 | 0.001805 | No Change: Both D | - |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 93 | G | 0.037559 | R | 0.035089 | 0.00247 | No Change: Both O | Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400] |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 102 | A | 0.052614 | P | 0.081579 | -0.028965 | No Change: Both O | - |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 267 | Q | 0.191586 | E | 0.217073 | -0.025487 | No Change: Both O | Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400] |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 354 | T | 0.532344 | P | 0.554483 | -0.022139 | No Change: Both D | Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400] |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 395 | G | 0.110737 | R | 0.101539 | 0.009198 | No Change: Both O | Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400] |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 536 | T | 0.099857 | Q | 0.102598 | -0.002741 | No Change: Both O | - |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 543 | G | 0.05668 | E | 0.065476 | -0.008796 | No Change: Both O | Thyroid dyshormonogenesis 1 (TDH1) [MIM:274400] |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 556 | S | 0.467444 | Q | 0.41618 | 0.051264 | No Change: Both O | - |
| Q92911 | SC5A5_HUMAN Sodium/iodide cotransporter OS=Homo sapiens GN=SLC5A5 PE=1 SV=1 | 298 | C | 0.029121 | G | 0.068517 | -0.039396 | No Change: Both O | - |
| Q9Y289 | SC5A6_HUMAN Sodium-dependent multivitamin transporter OS=Homo sapiens GN=SLC5A6 PE=2 SV=2 | 481 | S | 0.740097 | F | 0.599102 | 0.140995 | No Change: Both D | - |
| Q9Y289 | SC5A6_HUMAN Sodium-dependent multivitamin transporter OS=Homo sapiens GN=SLC5A6 PE=2 SV=2 | 492 | S | 0.828655 | N | 0.789987 | 0.038668 | No Change: Both D | - |
| Q9GZV3 | SC5A7_HUMAN High affinity choline transporter 1 OS=Homo sapiens GN=SLC5A7 PE=2 SV=1 | 89 | I | 0.131514 | V | 0.144892 | -0.013378 | No Change: Both O | - |
| Q8N695 | SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens GN=SLC5A8 PE=1 SV=2 | 193 | V | 0.042326 | I | 0.035804 | 0.006522 | No Change: Both O | - |
| Q8N695 | SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens GN=SLC5A8 PE=1 SV=2 | 251 | F | 0.053728 | V | 0.063082 | -0.009354 | No Change: Both O | - |
| Q2M3M2 | SC5A9_HUMAN Sodium/glucose cotransporter 4 OS=Homo sapiens GN=SLC5A9 PE=2 SV=2 | 152 | V | 0.122764 | M | 0.160112 | -0.037348 | No Change: Both O | - |
| Q2M3M2 | SC5A9_HUMAN Sodium/glucose cotransporter 4 OS=Homo sapiens GN=SLC5A9 PE=2 SV=2 | 207 | M | 0.063566 | T | 0.086591 | -0.023025 | No Change: Both O | - |
| Q2M3M2 | SC5A9_HUMAN Sodium/glucose cotransporter 4 OS=Homo sapiens GN=SLC5A9 PE=2 SV=2 | 269 | I | 0.23584 | M | 0.319963 | -0.084123 | No Change: Both O | - |
| P30531 | SC6A1_HUMAN Sodium- and chloride-dependent GABA transporter 1 OS=Homo sapiens GN=SLC6A1 PE=1 SV=2 | 521 | P | 0.179273 | Q | 0.174659 | 0.004614 | No Change: Both O | - |
| P48065 | S6A12_HUMAN Sodium- and chloride-dependent betaine transporter OS=Homo sapiens GN=SLC6A12 PE=2 SV=2 | 10 | C | 0.746068 | R | 0.833504 | -0.087436 | No Change: Both D | - |
| Q9NSD5 | S6A13_HUMAN Sodium- and chloride-dependent GABA transporter 2 OS=Homo sapiens GN=SLC6A13 PE=1 SV=3 | 426 | V | 0.047681 | I | 0.039442 | 0.008239 | No Change: Both O | - |
| Q9H2J7 | S6A15_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT2 OS=Homo sapiens GN=SLC6A15 PE=1 SV=1 | 400 | A | 0.261269 | V | 0.216477 | 0.044792 | No Change: Both O | - |
| Q9H2J7 | S6A15_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT2 OS=Homo sapiens GN=SLC6A15 PE=1 SV=1 | 603 | I | 0.34519 | M | 0.453347 | -0.108157 | No Change: Both O | - |
| Q9GZN6 | S6A16_HUMAN Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 OS=Homo sapiens GN=SLC6A16 PE=1 SV=1 | 108 | S | 0.228518 | R | 0.181574 | 0.046944 | No Change: Both O | - |
| Q9GZN6 | S6A16_HUMAN Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 OS=Homo sapiens GN=SLC6A16 PE=1 SV=1 | 236 | E | 0.627049 | K | 0.612485 | 0.014564 | No Change: Both D | - |
| Q9H1V8 | S6A17_HUMAN Sodium-dependent neutral amino acid transporter SLC6A17 OS=Homo sapiens GN=SLC6A17 PE=2 SV=3 | 57 | A | 0.606207 | T | 0.617297 | -0.01109 | No Change: Both D | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 12 | C | 0.5333 | S | 0.751278 | -0.217978 | No Change: Both D | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 32 | T | 0.076091 | I | 0.040207 | 0.035884 | No Change: Both O | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 478 | P | 0.174568 | L | 0.095778 | 0.07879 | No Change: Both O | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 4 | A | 0.824087 | D | 0.829835 | -0.005748 | No Change: Both D | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 79 | G | 0.234262 | S | 0.274247 | -0.039985 | No Change: Both O | - |
| Q96N87 | S6A18_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Homo sapiens GN=SLC6A18 PE=2 SV=2 | 496 | G | 0.062469 | R | 0.059618 | 0.002851 | No Change: Both O | - |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 57 | R | 0.04238 | C | 0.020509 | 0.021871 | No Change: Both O | Hartnup disorder (HND) [MIM:234500] |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 173 | D | 0.161851 | N | 0.15111 | 0.010741 | No Change: Both O | Hartnup disorder (HND) [MIM:234500] |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 240 | R | 0.058137 | Q | 0.063409 | -0.005272 | No Change: Both O | - |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 242 | L | 0.108015 | P | 0.192771 | -0.084756 | No Change: Both O | Hartnup disorder (HND) [MIM:234500] |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 252 | V | 0.074824 | I | 0.067298 | 0.007526 | No Change: Both O | - |
| Q695T7 | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens GN=SLC6A19 PE=1 SV=1 | 501 | E | 0.017093 | K | 0.017072 | 2.10E-05 | No Change: Both O | Hartnup disorder (HND) [MIM:234500] |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 457 | A | 0.022655 | P | 0.033681 | -0.011026 | No Change: Both O | Orthostatic intolerance (OI) [MIM:604715] |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 69 | V | 0.049746 | I | 0.041022 | 0.008724 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 99 | T | 0.01964 | I | 0.011155 | 0.008485 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 245 | V | 0.005242 | I | 0.004284 | 9.58E-04 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 292 | N | 0.208438 | T | 0.171078 | 0.03736 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 356 | V | 0.076317 | L | 0.076337 | -2.00E-05 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 369 | A | 0.192962 | P | 0.257948 | -0.064986 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 375 | N | 0.507457 | S | 0.55266 | -0.045203 | No Change: Both D | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 463 | K | 0.038129 | R | 0.027522 | 0.010607 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 478 | G | 0.11 | S | 0.147548 | -0.037548 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 528 | F | 0.02257 | C | 0.019535 | 0.003035 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 548 | Y | 0.080537 | H | 0.128199 | -0.047662 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 449 | V | 0.085164 | I | 0.072984 | 0.01218 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 283 | T | 0.21008 | R | 0.221529 | -0.011449 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 549 | I | 0.070501 | T | 0.140262 | -0.069761 | No Change: Both O | - |
| P23975 | SC6A2_HUMAN Sodium-dependent noradrenaline transporter OS=Homo sapiens GN=SLC6A2 PE=1 SV=1 | 7 | N | 0.857191 | K | 0.86886 | -0.011669 | No Change: Both D | - |
| Q9NP91 | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3 OS=Homo sapiens GN=SLC6A20 PE=1 SV=1 | 9 | A | 0.13659 | G | 0.160195 | -0.023605 | No Change: Both O | - |
| Q9NP91 | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3 OS=Homo sapiens GN=SLC6A20 PE=1 SV=1 | 199 | T | 0.077219 | M | 0.059458 | 0.017761 | No Change: Both O | - |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 237 | R | 0.183028 | Q | 0.209146 | -0.026118 | No Change: Both O | - |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 121 | G | 0.220725 | S | 0.254305 | -0.03358 | No Change: Both O | A breast cancer sample |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 544 | R | 0.151891 | S | 0.211696 | -0.059805 | No Change: Both O | A breast cancer sample |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 368 | L | 0.096263 | Q | 0.188614 | -0.092351 | No Change: Both O | Dystonia-parkinsonism infantile (DYTPRI) [MIM:613135] |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 395 | P | 0.054099 | L | 0.025536 | 0.028563 | No Change: Both O | Dystonia-parkinsonism infantile (DYTPRI) [MIM:613135] |
| Q01959 | SC6A3_HUMAN Sodium-dependent dopamine transporter OS=Homo sapiens GN=SLC6A3 PE=1 SV=1 | 471 | V | 0.040696 | I | 0.036241 | 0.004455 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 56 | G | 0.691329 | A | 0.668354 | 0.022975 | No Change: Both D | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 605 | K | 0.29659 | N | 0.246287 | 0.050303 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 425 | I | 0.017888 | V | 0.01884 | -9.52E-04 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 201 | K | 0.327128 | N | 0.309684 | 0.017444 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 425 | I | 0.017888 | L | 0.02079 | -0.002902 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 465 | F | 0.080321 | L | 0.096271 | -0.01595 | No Change: Both O | - |
| P31645 | SC6A4_HUMAN Sodium-dependent serotonin transporter OS=Homo sapiens GN=SLC6A4 PE=1 SV=1 | 550 | L | 0.011351 | V | 0.010491 | 8.60E-04 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 184 | Q | 0.734303 | R | 0.729465 | 0.004838 | No Change: Both D | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 463 | D | 0.231441 | N | 0.207403 | 0.024038 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 751 | V | 0.160449 | A | 0.21617 | -0.055721 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 632 | V | 0.085678 | E | 0.194181 | -0.108503 | No Change: Both O | A breast cancer sample |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 89 | A | 0.954201 | E | 0.960129 | -0.005928 | No Change: Both D | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 102 | G | 0.933103 | S | 0.945898 | -0.012795 | No Change: Both D | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 124 | F | 0.481404 | S | 0.685898 | -0.204494 | O to D | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 132 | A | 0.536573 | G | 0.59974 | -0.063167 | No Change: Both D | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 162 | A | 0.309307 | G | 0.370041 | -0.060734 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 306 | L | 0.100749 | V | 0.109785 | -0.009036 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 425 | T | 0.071197 | M | 0.052762 | 0.018435 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 457 | K | 0.127527 | N | 0.100007 | 0.02752 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 482 | W | 0.123037 | C | 0.142955 | -0.019918 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 491 | Y | 0.300714 | C | 0.252615 | 0.048099 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 499 | Y | 0.12231 | F | 0.108044 | 0.014266 | No Change: Both O | - |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 509 | N | 0.169677 | S | 0.217355 | -0.047678 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 510 | S | 0.174101 | R | 0.123616 | 0.050485 | No Change: Both O | Startle disease (STHE) [MIM:149400] |
| Q9Y345 | SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens GN=SLC6A5 PE=1 SV=3 | 767 | G | 0.360277 | R | 0.368315 | -0.008038 | No Change: Both O | - |
| P31641 | SC6A6_HUMAN Sodium- and chloride-dependent taurine transporter OS=Homo sapiens GN=SLC6A6 PE=1 SV=2 | 17 | I | 0.935063 | M | 0.96876 | -0.033697 | No Change: Both D | - |
| P31641 | SC6A6_HUMAN Sodium- and chloride-dependent taurine transporter OS=Homo sapiens GN=SLC6A6 PE=1 SV=2 | 18 | L | 0.935829 | V | 0.912983 | 0.022846 | No Change: Both D | - |
| P31641 | SC6A6_HUMAN Sodium- and chloride-dependent taurine transporter OS=Homo sapiens GN=SLC6A6 PE=1 SV=2 | 236 | W | 0.02901 | C | 0.037869 | -0.008859 | No Change: Both O | - |
| Q99884 | SC6A7_HUMAN Sodium-dependent proline transporter OS=Homo sapiens GN=SLC6A7 PE=2 SV=2 | 345 | L | 0.089218 | V | 0.092043 | -0.002825 | No Change: Both O | - |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 87 | G | 0.093665 | R | 0.080046 | 0.013619 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 381 | G | 0.398338 | R | 0.36621 | 0.032128 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 390 | P | 0.081705 | L | 0.038764 | 0.042941 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 554 | P | 0.049972 | L | 0.022748 | 0.027224 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 164 | T | 0.101301 | S | 0.139031 | -0.03773 | No Change: Both O | - |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 132 | G | 0.072894 | V | 0.037512 | 0.035382 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 337 | C | 0.169317 | W | 0.14632 | 0.022997 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 491 | C | 0.007993 | W | 0.007501 | 4.92E-04 | No Change: Both O | X-linked creatine deficiency syndrome (XL-CDS) [MIM:300352] |
| P48029 | SC6A8_HUMAN Sodium- and chloride-dependent creatine transporter 1 OS=Homo sapiens GN=SLC6A8 PE=1 SV=1 | 560 | M | 0.068537 | V | 0.051434 | 0.017103 | No Change: Both O | - |
| Q9NS82 | AAA1_HUMAN Asc-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A10 PE=2 SV=1 | 112 | E | 0.101566 | D | 0.096132 | 0.005434 | No Change: Both O | - |
| Q9NS82 | AAA1_HUMAN Asc-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A10 PE=2 SV=1 | 413 | R | 0.174975 | Q | 0.172742 | 0.002233 | No Change: Both O | - |
| Q8TCU3 | S7A13_HUMAN Solute carrier family 7 member 13 OS=Homo sapiens GN=SLC7A13 PE=2 SV=1 | 249 | V | 0.022989 | M | 0.027788 | -0.004799 | No Change: Both O | - |
| Q8TCU3 | S7A13_HUMAN Solute carrier family 7 member 13 OS=Homo sapiens GN=SLC7A13 PE=2 SV=1 | 380 | R | 0.147073 | K | 0.175585 | -0.028512 | No Change: Both O | - |
| Q8TCU3 | S7A13_HUMAN Solute carrier family 7 member 13 OS=Homo sapiens GN=SLC7A13 PE=2 SV=1 | 452 | M | 0.042319 | T | 0.056733 | -0.014414 | No Change: Both O | - |
| Q8TCU3 | S7A13_HUMAN Solute carrier family 7 member 13 OS=Homo sapiens GN=SLC7A13 PE=2 SV=1 | 470 | E | 0.962353 | K | 0.953722 | 0.008631 | No Change: Both D | - |
| Q8TBB6 | S7A14_HUMAN Probable cationic amino acid transporter OS=Homo sapiens GN=SLC7A14 PE=2 SV=3 | 330 | G | 0.078661 | R | 0.074072 | 0.004589 | No Change: Both O | - |
| P52569 | CTR2_HUMAN Low affinity cationic amino acid transporter 2 OS=Homo sapiens GN=SLC7A2 PE=1 SV=2 | 20 | V | 0.17916 | M | 0.254634 | -0.075474 | No Change: Both O | - |
| P52569 | CTR2_HUMAN Low affinity cationic amino acid transporter 2 OS=Homo sapiens GN=SLC7A2 PE=1 SV=2 | 376 | C | 0.088441 | F | 0.100757 | -0.012316 | No Change: Both O | - |
| P52569 | CTR2_HUMAN Low affinity cationic amino acid transporter 2 OS=Homo sapiens GN=SLC7A2 PE=1 SV=2 | 531 | A | 0.015291 | T | 0.015905 | -6.14E-04 | No Change: Both O | - |
| P52569 | CTR2_HUMAN Low affinity cationic amino acid transporter 2 OS=Homo sapiens GN=SLC7A2 PE=1 SV=2 | 547 | Q | 0.212006 | L | 0.113713 | 0.098293 | No Change: Both O | - |
| Q8WY07 | CTR3_HUMAN Cationic amino acid transporter 3 OS=Homo sapiens GN=SLC7A3 PE=1 SV=1 | 508 | L | 0.057322 | V | 0.057705 | -3.83E-04 | No Change: Both O | - |
| Q8WY07 | CTR3_HUMAN Cationic amino acid transporter 3 OS=Homo sapiens GN=SLC7A3 PE=1 SV=1 | 356 | M | 0.168444 | K | 0.25427 | -0.085826 | No Change: Both O | - |
| O43246 | CTR4_HUMAN Cationic amino acid transporter 4 OS=Homo sapiens GN=SLC7A4 PE=2 SV=3 | 28 | T | 0.668195 | I | 0.50466 | 0.163535 | No Change: Both D | - |
| O43246 | CTR4_HUMAN Cationic amino acid transporter 4 OS=Homo sapiens GN=SLC7A4 PE=2 SV=3 | 349 | A | 0.066188 | T | 0.068495 | -0.002307 | No Change: Both O | - |
| O43246 | CTR4_HUMAN Cationic amino acid transporter 4 OS=Homo sapiens GN=SLC7A4 PE=2 SV=3 | 608 | F | 0.385824 | Y | 0.419135 | -0.033311 | No Change: Both O | - |
| Q01650 | LAT1_HUMAN Large neutral amino acids transporter small subunit 1 OS=Homo sapiens GN=SLC7A5 PE=1 SV=2 | 230 | N | 0.482552 | K | 0.528594 | -0.046042 | O to D | - |
| Q96CW6 | S7A6O_HUMAN Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Homo sapiens GN=SLC7A6OS PE=1 SV=2 | 24 | V | 0.789447 | M | 0.827895 | -0.038448 | No Change: Both D | - |
| Q96CW6 | S7A6O_HUMAN Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Homo sapiens GN=SLC7A6OS PE=1 SV=2 | 45 | G | 0.667346 | D | 0.711511 | -0.044165 | No Change: Both D | - |
| Q96CW6 | S7A6O_HUMAN Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Homo sapiens GN=SLC7A6OS PE=1 SV=2 | 116 | S | 0.922779 | A | 0.885057 | 0.037722 | No Change: Both D | - |
| Q96CW6 | S7A6O_HUMAN Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Homo sapiens GN=SLC7A6OS PE=1 SV=2 | 220 | Y | 0.357988 | C | 0.337075 | 0.020913 | No Change: Both O | - |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 54 | G | 0.19803 | V | 0.111625 | 0.086405 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 334 | L | 0.148058 | R | 0.261184 | -0.113126 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 338 | G | 0.320697 | D | 0.340376 | -0.019679 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 386 | S | 0.025068 | R | 0.016856 | 0.008212 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 50 | M | 0.097899 | K | 0.163265 | -0.065366 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 188 | T | 0.044416 | I | 0.023271 | 0.021145 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 238 | S | 0.129952 | F | 0.049032 | 0.08092 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 333 | R | 0.129189 | M | 0.094826 | 0.034363 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 489 | S | 0.211519 | P | 0.220371 | -0.008852 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 413 | P | 0.460751 | S | 0.484618 | -0.023867 | No Change: Both O | A breast cancer sample |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 5 | T | 0.889925 | I | 0.791935 | 0.09799 | No Change: Both D | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 53 | S | 0.181966 | L | 0.078151 | 0.103815 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 91 | A | 0.098205 | V | 0.066397 | 0.031808 | No Change: Both O | - |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 124 | L | 0.059474 | P | 0.118054 | -0.05858 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 140 | A | 0.047547 | P | 0.067573 | -0.020026 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 152 | F | 0.145148 | L | 0.165472 | -0.020324 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 159 | R | 0.124678 | C | 0.064799 | 0.059879 | No Change: Both O | - |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 191 | K | 0.033301 | E | 0.033303 | -2.00E-06 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 251 | E | 0.502652 | D | 0.456393 | 0.046259 | D to O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 261 | L | 0.328987 | P | 0.522636 | -0.193649 | O to D | Lysinuric protein intolerance (LPI) [MIM:222700] |
| Q9UM01 | YLAT1_HUMAN Y+L amino acid transporter 1 OS=Homo sapiens GN=SLC7A7 PE=1 SV=2 | 365 | N | 0.056 | Y | 0.02941 | 0.02659 | No Change: Both O | Lysinuric protein intolerance (LPI) [MIM:222700] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 105 | G | 0.15832 | R | 0.150117 | 0.008203 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 170 | V | 0.29365 | M | 0.339178 | -0.045528 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 182 | A | 0.054768 | T | 0.061945 | -0.007177 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 195 | G | 0.032531 | R | 0.028913 | 0.003618 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 259 | G | 0.027202 | R | 0.026084 | 0.001118 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 44 | I | 0.151451 | T | 0.231166 | -0.079715 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 261 | P | 0.019625 | L | 0.009422 | 0.010203 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 354 | A | 0.077902 | T | 0.088428 | -0.010526 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 330 | V | 0.162062 | M | 0.217466 | -0.055404 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 52 | P | 0.415543 | L | 0.265527 | 0.150016 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 63 | G | 0.080037 | R | 0.075591 | 0.004446 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 69 | W | 0.013152 | L | 0.022539 | -0.009387 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 70 | A | 0.012861 | V | 0.008477 | 0.004384 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 123 | T | 0.06625 | M | 0.053623 | 0.012627 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 126 | A | 0.051731 | T | 0.063679 | -0.011948 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 187 | I | 0.019572 | F | 0.017911 | 0.001661 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 223 | L | 0.073868 | M | 0.091121 | -0.017253 | No Change: Both O | - |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 230 | W | 0.046598 | R | 0.110322 | -0.063724 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 241 | I | 0.221802 | T | 0.371533 | -0.149731 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 333 | R | 0.234104 | W | 0.095765 | 0.138339 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 379 | S | 0.03176 | R | 0.021532 | 0.010228 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 382 | A | 0.018695 | T | 0.020766 | -0.002071 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 224 | A | 0.05816 | V | 0.039161 | 0.018999 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 331 | A | 0.198635 | V | 0.149892 | 0.048743 | No Change: Both O | Non-type I cystinuria (CSNU) [MIM:220100] |
| P82251 | BAT1_HUMAN B(0 +)-type amino acid transporter 1 OS=Homo sapiens GN=SLC7A9 PE=1 SV=1 | 142 | V | 0.074398 | A | 0.105004 | -0.030606 | No Change: Both O | - |
| P32418 | NAC1_HUMAN Sodium/calcium exchanger 1 OS=Homo sapiens GN=SLC8A1 PE=1 SV=3 | 692 | E | 0.76458 | V | 0.642453 | 0.122127 | No Change: Both D | - |
| Q9UPR5 | NAC2_HUMAN Sodium/calcium exchanger 2 OS=Homo sapiens GN=SLC8A2 PE=2 SV=2 | 429 | V | 0.346864 | L | 0.352165 | -0.005301 | No Change: Both O | - |
| P57103 | NAC3_HUMAN Sodium/calcium exchanger 3 OS=Homo sapiens GN=SLC8A3 PE=2 SV=2 | 612 | E | 0.336094 | Q | 0.282622 | 0.053472 | No Change: Both O | A breast cancer sample |
| P19634 | SL9A1_HUMAN Sodium/hydrogen exchanger 1 OS=Homo sapiens GN=SLC9A1 PE=1 SV=2 | 682 | N | 0.350186 | K | 0.401208 | -0.051022 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 158 | I | 0.246944 | V | 0.270505 | -0.023561 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 286 | I | 0.294261 | V | 0.32592 | -0.031659 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 348 | I | 0.087365 | M | 0.130992 | -0.043627 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 424 | T | 0.055004 | A | 0.050494 | 0.00451 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 705 | T | 0.076249 | I | 0.043031 | 0.033218 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 732 | Q | 0.177886 | K | 0.229403 | -0.051517 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 768 | S | 0.450514 | I | 0.239606 | 0.210908 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 364 | I | 0.015869 | V | 0.018567 | -0.002698 | No Change: Both O | - |
| Q4G0N8 | S9A10_HUMAN Sodium/hydrogen exchanger 10 OS=Homo sapiens GN=SLC9A10 PE=2 SV=2 | 826 | G | 0.19486 | S | 0.234706 | -0.039846 | No Change: Both O | - |
| Q5TAH2 | S9A11_HUMAN Sodium/hydrogen exchanger 11 OS=Homo sapiens GN=SLC9A11 PE=2 SV=1 | 481 | T | 0.228073 | M | 0.190718 | 0.037355 | No Change: Both O | - |
| Q5TAH2 | S9A11_HUMAN Sodium/hydrogen exchanger 11 OS=Homo sapiens GN=SLC9A11 PE=2 SV=1 | 505 | A | 0.616329 | G | 0.623698 | -0.007369 | No Change: Both D | - |
| Q5TAH2 | S9A11_HUMAN Sodium/hydrogen exchanger 11 OS=Homo sapiens GN=SLC9A11 PE=2 SV=1 | 934 | R | 0.450804 | S | 0.517198 | -0.066394 | O to D | - |
| Q9UBY0 | SL9A2_HUMAN Sodium/hydrogen exchanger 2 OS=Homo sapiens GN=SLC9A2 PE=2 SV=1 | 299 | T | 0.093736 | S | 0.121735 | -0.027999 | No Change: Both O | A breast cancer sample |
| Q9UBY0 | SL9A2_HUMAN Sodium/hydrogen exchanger 2 OS=Homo sapiens GN=SLC9A2 PE=2 SV=1 | 806 | R | 0.982324 | Q | 0.974229 | 0.008095 | No Change: Both D | A breast cancer sample |
| P48764 | SL9A3_HUMAN Sodium/hydrogen exchanger 3 OS=Homo sapiens GN=SLC9A3 PE=1 SV=2 | 799 | C | 0.628079 | R | 0.751079 | -0.123 | No Change: Both D | - |
| O14745 | NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF1 OS=Homo sapiens GN=SLC9A3R1 PE=1 SV=4 | 110 | L | 0.851586 | V | 0.847882 | 0.003704 | No Change: Both D | Hypophosphatemic nephrolithiasis/osteoporosis type 2 (NPHLOP2) [MIM:612287] |
| O14745 | NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF1 OS=Homo sapiens GN=SLC9A3R1 PE=1 SV=4 | 153 | R | 0.845953 | Q | 0.844172 | 0.001781 | No Change: Both D | Hypophosphatemic nephrolithiasis/osteoporosis type 2 (NPHLOP2) [MIM:612287] |
| O14745 | NHRF1_HUMAN Na(+)/H(+) exchange regulatory cofactor NHE-RF1 OS=Homo sapiens GN=SLC9A3R1 PE=1 SV=4 | 225 | E | 0.381931 | K | 0.391265 | -0.009334 | No Change: Both O | Hypophosphatemic nephrolithiasis/osteoporosis type 2 (NPHLOP2) [MIM:612287] |
| Q6AI14 | SL9A4_HUMAN Sodium/hydrogen exchanger 4 OS=Homo sapiens GN=SLC9A4 PE=1 SV=2 | 116 | G | 0.275228 | S | 0.318421 | -0.043193 | No Change: Both O | - |
| Q6AI14 | SL9A4_HUMAN Sodium/hydrogen exchanger 4 OS=Homo sapiens GN=SLC9A4 PE=1 SV=2 | 581 | I | 0.463882 | V | 0.473223 | -0.009341 | No Change: Both O | - |
| Q8IVB4 | SL9A9_HUMAN Sodium/hydrogen exchanger 9 OS=Homo sapiens GN=SLC9A9 PE=1 SV=1 | 589 | I | 0.638911 | V | 0.658012 | -0.019101 | No Change: Both D | - |
| Q8IVB4 | SL9A9_HUMAN Sodium/hydrogen exchanger 9 OS=Homo sapiens GN=SLC9A9 PE=1 SV=1 | 540 | I | 0.381505 | V | 0.410712 | -0.029207 | No Change: Both O | - |
| Q4ZJI4 | SL9B1_HUMAN Sodium/hydrogen exchanger 9B1 OS=Homo sapiens GN=SLC9B1 PE=2 SV=2 | 33 | Q | 0.891259 | H | 0.860378 | 0.030881 | No Change: Both D | - |
| Q86UD5 | SL9B2_HUMAN Mitochondrial sodium/hydrogen exchanger 9B2 OS=Homo sapiens GN=SLC9B2 PE=1 SV=2 | 159 | I | 0.077979 | T | 0.126859 | -0.04888 | No Change: Both O | - |
| Q86UD5 | SL9B2_HUMAN Mitochondrial sodium/hydrogen exchanger 9B2 OS=Homo sapiens GN=SLC9B2 PE=1 SV=2 | 161 | V | 0.121324 | A | 0.158053 | -0.036729 | No Change: Both O | - |
| Q86UD5 | SL9B2_HUMAN Mitochondrial sodium/hydrogen exchanger 9B2 OS=Homo sapiens GN=SLC9B2 PE=1 SV=2 | 357 | F | 0.26452 | C | 0.23712 | 0.0274 | No Change: Both O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 128 | N | 0.518146 | Y | 0.352228 | 0.165918 | D to O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 135 | N | 0.311007 | I | 0.167589 | 0.143418 | No Change: Both O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 172 | E | 0.273855 | D | 0.251977 | 0.021878 | No Change: Both O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 355 | I | 0.141302 | V | 0.147421 | -0.006119 | No Change: Both O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 668 | T | 0.885276 | S | 0.904348 | -0.019072 | No Change: Both D | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 13 | I | 0.276264 | T | 0.422458 | -0.146194 | No Change: Both O | - |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 220 | V | 0.062251 | I | 0.049168 | 0.013083 | No Change: Both O | A colorectal cancer sample |
| P46721 | SO1A2_HUMAN Solute carrier organic anion transporter family member 1A2 OS=Homo sapiens GN=SLCO1A2 PE=2 SV=1 | 187 | A | 0.27271 | T | 0.30224 | -0.02953 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 73 | F | 0.131612 | L | 0.152013 | -0.020401 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 82 | V | 0.022116 | A | 0.029187 | -0.007071 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 130 | N | 0.810792 | D | 0.814667 | -0.003875 | No Change: Both D | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 152 | R | 0.340618 | K | 0.405437 | -0.064819 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 155 | P | 0.35842 | T | 0.322915 | 0.035505 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 156 | E | 0.353822 | G | 0.323528 | 0.030294 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 174 | V | 0.0347 | A | 0.050383 | -0.015683 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 193 | L | 0.115085 | R | 0.181731 | -0.066646 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 241 | D | 0.110702 | N | 0.096367 | 0.014335 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 353 | I | 0.083742 | T | 0.165333 | -0.081591 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 432 | N | 0.118966 | D | 0.127082 | -0.008116 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 462 | D | 0.432592 | G | 0.390079 | 0.042513 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 488 | G | 0.426563 | A | 0.376724 | 0.049839 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 655 | D | 0.672447 | G | 0.659301 | 0.013146 | No Change: Both D | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 667 | E | 0.664262 | G | 0.604294 | 0.059968 | No Change: Both D | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 151 | N | 0.309131 | S | 0.362905 | -0.053774 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 643 | L | 0.04548 | F | 0.033676 | 0.011804 | No Change: Both O | - |
| Q9Y6L6 | SO1B1_HUMAN Solute carrier organic anion transporter family member 1B1 OS=Homo sapiens GN=SLCO1B1 PE=1 SV=2 | 245 | I | 0.216159 | V | 0.241397 | -0.025238 | No Change: Both O | - |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 112 | S | 0.222539 | A | 0.133462 | 0.089077 | No Change: Both O | - |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 292 | I | 0.633667 | M | 0.704315 | -0.070648 | No Change: Both D | A colorectal cancer sample |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 647 | M | 0.157603 | L | 0.12434 | 0.033263 | No Change: Both O | A colorectal cancer sample |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 233 | M | 0.07905 | I | 0.054855 | 0.024195 | No Change: Both O | - |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 560 | V | 0.067015 | A | 0.091519 | -0.024504 | No Change: Both O | - |
| Q9NPD5 | SO1B3_HUMAN Solute carrier organic anion transporter family member 1B3 OS=Homo sapiens GN=SLCO1B3 PE=1 SV=1 | 256 | G | 0.039453 | A | 0.030245 | 0.009208 | No Change: Both O | - |
| Q92959 | SO2A1_HUMAN Solute carrier organic anion transporter family member 2A1 OS=Homo sapiens GN=SLCO2A1 PE=1 SV=2 | 396 | A | 0.094927 | T | 0.108626 | -0.013699 | No Change: Both O | - |
| O94956 | SO2B1_HUMAN Solute carrier organic anion transporter family member 2B1 OS=Homo sapiens GN=SLCO2B1 PE=1 SV=2 | 486 | S | 0.596323 | F | 0.36584 | 0.230483 | D to O | - |
| O94956 | SO2B1_HUMAN Solute carrier organic anion transporter family member 2B1 OS=Homo sapiens GN=SLCO2B1 PE=1 SV=2 | 77 | E | 0.557018 | K | 0.576755 | -0.019737 | No Change: Both D | A breast cancer sample |
| O94956 | SO2B1_HUMAN Solute carrier organic anion transporter family member 2B1 OS=Homo sapiens GN=SLCO2B1 PE=1 SV=2 | 201 | V | 0.142877 | M | 0.17225 | -0.029373 | No Change: Both O | - |
| O94956 | SO2B1_HUMAN Solute carrier organic anion transporter family member 2B1 OS=Homo sapiens GN=SLCO2B1 PE=1 SV=2 | 312 | R | 0.660179 | Q | 0.656478 | 0.003701 | No Change: Both D | - |
| O94956 | SO2B1_HUMAN Solute carrier organic anion transporter family member 2B1 OS=Homo sapiens GN=SLCO2B1 PE=1 SV=2 | 392 | I | 0.103586 | T | 0.186516 | -0.08293 | No Change: Both O | - |
| Q9UIG8 | SO3A1_HUMAN Solute carrier organic anion transporter family member 3A1 OS=Homo sapiens GN=SLCO3A1 PE=1 SV=3 | 294 | E | 0.836576 | D | 0.813688 | 0.022888 | No Change: Both D | - |
| Q96BD0 | SO4A1_HUMAN Solute carrier organic anion transporter family member 4A1 OS=Homo sapiens GN=SLCO4A1 PE=1 SV=2 | 70 | R | 0.473864 | Q | 0.482171 | -0.008307 | No Change: Both O | - |
| Q96BD0 | SO4A1_HUMAN Solute carrier organic anion transporter family member 4A1 OS=Homo sapiens GN=SLCO4A1 PE=1 SV=2 | 78 | V | 0.379817 | I | 0.327828 | 0.051989 | No Change: Both O | - |
| Q9H2Y9 | SO5A1_HUMAN Solute carrier organic anion transporter family member 5A1 OS=Homo sapiens GN=SLCO5A1 PE=2 SV=2 | 33 | L | 0.945324 | F | 0.929735 | 0.015589 | No Change: Both D | - |
| Q86UG4 | SO6A1_HUMAN Solute carrier organic anion transporter family member 6A1 OS=Homo sapiens GN=SLCO6A1 PE=2 SV=2 | 27 | A | 0.90413 | V | 0.868971 | 0.035159 | No Change: Both D | - |
| Q86UG4 | SO6A1_HUMAN Solute carrier organic anion transporter family member 6A1 OS=Homo sapiens GN=SLCO6A1 PE=2 SV=2 | 381 | K | 0.029921 | R | 0.021551 | 0.00837 | No Change: Both O | - |
| Q86UG4 | SO6A1_HUMAN Solute carrier organic anion transporter family member 6A1 OS=Homo sapiens GN=SLCO6A1 PE=2 SV=2 | 654 | T | 0.112302 | R | 0.127451 | -0.015149 | No Change: Both O | - |
| Q86UG4 | SO6A1_HUMAN Solute carrier organic anion transporter family member 6A1 OS=Homo sapiens GN=SLCO6A1 PE=2 SV=2 | 527 | P | 0.252923 | A | 0.203455 | 0.049468 | No Change: Both O | - |
| Q7Z7L1 | SLN11_HUMAN Schlafen family member 11 OS=Homo sapiens GN=SLFN11 PE=1 SV=2 | 121 | V | 0.736115 | F | 0.750666 | -0.014551 | No Change: Both D | - |
| Q7Z7L1 | SLN11_HUMAN Schlafen family member 11 OS=Homo sapiens GN=SLFN11 PE=1 SV=2 | 301 | N | 0.098162 | D | 0.105697 | -0.007535 | No Change: Both O | - |
| Q7Z7L1 | SLN11_HUMAN Schlafen family member 11 OS=Homo sapiens GN=SLFN11 PE=1 SV=2 | 822 | Y | 0.384708 | C | 0.330215 | 0.054493 | No Change: Both O | - |
| Q7Z7L1 | SLN11_HUMAN Schlafen family member 11 OS=Homo sapiens GN=SLFN11 PE=1 SV=2 | 489 | R | 0.174412 | L | 0.110907 | 0.063505 | No Change: Both O | - |
| Q8IYM2 | SLN12_HUMAN Schlafen family member 12 OS=Homo sapiens GN=SLFN12 PE=1 SV=2 | 43 | S | 0.658047 | R | 0.627619 | 0.030428 | No Change: Both D | - |
| Q8IYM2 | SLN12_HUMAN Schlafen family member 12 OS=Homo sapiens GN=SLFN12 PE=1 SV=2 | 168 | C | 0.313557 | R | 0.479889 | -0.166332 | No Change: Both O | - |
| Q8IYM2 | SLN12_HUMAN Schlafen family member 12 OS=Homo sapiens GN=SLFN12 PE=1 SV=2 | 448 | S | 0.247479 | P | 0.230685 | 0.016794 | No Change: Both O | - |
| Q6IEE8 | SN12L_HUMAN Schlafen family member 12-like OS=Homo sapiens GN=SLFN12L PE=2 SV=3 | 307 | L | 0.43274 | S | 0.625053 | -0.192313 | O to D | - |
| Q6IEE8 | SN12L_HUMAN Schlafen family member 12-like OS=Homo sapiens GN=SLFN12L PE=2 SV=3 | 405 | A | 0.783091 | G | 0.802609 | -0.019518 | No Change: Both D | - |
| Q6IEE8 | SN12L_HUMAN Schlafen family member 12-like OS=Homo sapiens GN=SLFN12L PE=2 SV=3 | 462 | C | 0.307359 | Y | 0.327207 | -0.019848 | No Change: Both O | - |
| Q6IEE8 | SN12L_HUMAN Schlafen family member 12-like OS=Homo sapiens GN=SLFN12L PE=2 SV=3 | 550 | Y | 0.168082 | S | 0.313735 | -0.145653 | No Change: Both O | - |
| Q68D06 | SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens GN=SLFN13 PE=2 SV=1 | 4 | N | 0.707427 | S | 0.744899 | -0.037472 | No Change: Both D | - |
| Q68D06 | SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens GN=SLFN13 PE=2 SV=1 | 50 | A | 0.510306 | T | 0.524119 | -0.013813 | No Change: Both D | - |
| Q68D06 | SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens GN=SLFN13 PE=2 SV=1 | 652 | E | 0.382437 | K | 0.367681 | 0.014756 | No Change: Both O | - |
| Q68D06 | SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens GN=SLFN13 PE=2 SV=1 | 433 | P | 0.284984 | L | 0.171067 | 0.113917 | No Change: Both O | - |
| Q68D06 | SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens GN=SLFN13 PE=2 SV=1 | 642 | D | 0.254882 | V | 0.144851 | 0.110031 | No Change: Both O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 93 | Q | 0.508928 | R | 0.46525 | 0.043678 | D to O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 385 | K | 0.481674 | E | 0.471294 | 0.01038 | No Change: Both O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 870 | G | 0.239069 | S | 0.300547 | -0.061478 | No Change: Both O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 880 | S | 0.326621 | I | 0.139075 | 0.187546 | No Change: Both O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 905 | L | 0.220493 | F | 0.186413 | 0.03408 | No Change: Both O | - |
| P0C7P3 | SLN14_HUMAN Schlafen family member 14 OS=Homo sapiens GN=SLFN14 PE=2 SV=2 | 912 | Y | 0.748974 | F | 0.693376 | 0.055598 | No Change: Both D | - |
| Q08AF3 | SLFN5_HUMAN Schlafen family member 5 OS=Homo sapiens GN=SLFN5 PE=1 SV=1 | 787 | P | 0.242599 | L | 0.147159 | 0.09544 | No Change: Both O | - |
| Q08AF3 | SLFN5_HUMAN Schlafen family member 5 OS=Homo sapiens GN=SLFN5 PE=1 SV=1 | 797 | A | 0.343115 | V | 0.28077 | 0.062345 | No Change: Both O | - |
| Q08AF3 | SLFN5_HUMAN Schlafen family member 5 OS=Homo sapiens GN=SLFN5 PE=1 SV=1 | 754 | V | 0.254581 | L | 0.274006 | -0.019425 | No Change: Both O | - |
| Q499Z3 | SLNL1_HUMAN Schlafen-like protein 1 OS=Homo sapiens GN=SLFNL1 PE=2 SV=2 | 30 | A | 0.83111 | T | 0.854531 | -0.023421 | No Change: Both D | - |
| Q499Z3 | SLNL1_HUMAN Schlafen-like protein 1 OS=Homo sapiens GN=SLFNL1 PE=2 SV=2 | 128 | R | 0.584663 | S | 0.614261 | -0.029598 | No Change: Both D | - |
| Q499Z3 | SLNL1_HUMAN Schlafen-like protein 1 OS=Homo sapiens GN=SLFNL1 PE=2 SV=2 | 144 | R | 0.953234 | T | 0.945193 | 0.008041 | No Change: Both D | - |
| O75093 | SLIT1_HUMAN Slit homolog 1 protein OS=Homo sapiens GN=SLIT1 PE=2 SV=4 | 824 | P | 0.168245 | L | 0.101194 | 0.067051 | No Change: Both O | - |
| O94813 | SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens GN=SLIT2 PE=1 SV=1 | 636 | S | 0.182467 | P | 0.153176 | 0.029291 | No Change: Both O | - |
| O94813 | SLIT2_HUMAN Slit homolog 2 protein OS=Homo sapiens GN=SLIT2 PE=1 SV=1 | 1277 | S | 0.453925 | F | 0.255787 | 0.198138 | No Change: Both O | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 994 | E | 0.731527 | G | 0.687895 | 0.043632 | No Change: Both D | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 395 | R | 0.107952 | Q | 0.131798 | -0.023846 | No Change: Both O | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 618 | G | 0.149228 | S | 0.198042 | -0.048814 | No Change: Both O | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 371 | V | 0.148208 | A | 0.196666 | -0.048458 | No Change: Both O | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 810 | R | 0.11232 | Q | 0.103541 | 0.008779 | No Change: Both O | - |
| O75094 | SLIT3_HUMAN Slit homolog 3 protein OS=Homo sapiens GN=SLIT3 PE=2 SV=3 | 1064 | P | 0.291882 | A | 0.214273 | 0.077609 | No Change: Both O | - |
| Q96PX8 | SLIK1_HUMAN SLIT and NTRK-like protein 1 OS=Homo sapiens GN=SLITRK1 PE=1 SV=2 | 552 | L | 0.302626 | M | 0.363788 | -0.061162 | No Change: Both O | - |
| Q9H156 | SLIK2_HUMAN SLIT and NTRK-like protein 2 OS=Homo sapiens GN=SLITRK2 PE=1 SV=1 | 601 | S | 0.78381 | P | 0.767729 | 0.016081 | No Change: Both D | - |
| O94933 | SLIK3_HUMAN SLIT and NTRK-like protein 3 OS=Homo sapiens GN=SLITRK3 PE=2 SV=2 | 605 | I | 0.279547 | V | 0.335851 | -0.056304 | No Change: Both O | - |
| Q8IW52 | SLIK4_HUMAN SLIT and NTRK-like protein 4 OS=Homo sapiens GN=SLITRK4 PE=2 SV=1 | 206 | V | 0.203579 | I | 0.178787 | 0.024792 | No Change: Both O | A colorectal cancer sample |
| Q9H5Y7 | SLIK6_HUMAN SLIT and NTRK-like protein 6 OS=Homo sapiens GN=SLITRK6 PE=1 SV=3 | 25 | L | 0.627449 | F | 0.588897 | 0.038552 | No Change: Both D | - |
| Q9H5Y7 | SLIK6_HUMAN SLIT and NTRK-like protein 6 OS=Homo sapiens GN=SLITRK6 PE=1 SV=3 | 315 | P | 0.682331 | R | 0.589183 | 0.093148 | No Change: Both D | - |
| Q9H5Y7 | SLIK6_HUMAN SLIT and NTRK-like protein 6 OS=Homo sapiens GN=SLITRK6 PE=1 SV=3 | 414 | Q | 0.238223 | R | 0.241086 | -0.002863 | No Change: Both O | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 405 | Q | 0.821342 | K | 0.862006 | -0.040664 | No Change: Both D | A lung adenocarcinoma sample |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 552 | C | 0.836703 | Y | 0.789168 | 0.047535 | No Change: Both D | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 604 | E | 0.891113 | Q | 0.864859 | 0.026254 | No Change: Both D | An ovarian serous carcinoma sample |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 658 | A | 0.911989 | G | 0.920186 | -0.008197 | No Change: Both D | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 679 | I | 0.917742 | T | 0.948269 | -0.030527 | No Change: Both D | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 683 | K | 0.917955 | N | 0.878386 | 0.039569 | No Change: Both D | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 697 | T | 0.936647 | I | 0.911457 | 0.02519 | No Change: Both D | - |
| Q9H2G2 | SLK_HUMAN STE20-like serine/threonine-protein kinase OS=Homo sapiens GN=SLK PE=1 SV=1 | 666 | G | 0.914932 | E | 0.947372 | -0.03244 | No Change: Both D | - |
| Q9NWH9 | SLTM_HUMAN SAFB-like transcription modulator OS=Homo sapiens GN=SLTM PE=1 SV=2 | 235 | V | 0.771016 | L | 0.784004 | -0.012988 | No Change: Both D | - |
| O95391 | SLU7_HUMAN Pre-mRNA-splicing factor SLU7 OS=Homo sapiens GN=SLU7 PE=1 SV=2 | 111 | I | 0.6319 | V | 0.650854 | -0.018954 | No Change: Both D | - |
| O95391 | SLU7_HUMAN Pre-mRNA-splicing factor SLU7 OS=Homo sapiens GN=SLU7 PE=1 SV=2 | 229 | M | 0.97546 | T | 0.972774 | 0.002686 | No Change: Both D | - |
| P55000 | SLUR1_HUMAN Secreted Ly-6/uPAR-related protein 1 OS=Homo sapiens GN=SLURP1 PE=1 SV=2 | 15 | W | 0.107189 | R | 0.263045 | -0.155856 | No Change: Both O | Mal de Meleda (MDM) [MIM:248300] |
| P55000 | SLUR1_HUMAN Secreted Ly-6/uPAR-related protein 1 OS=Homo sapiens GN=SLURP1 PE=1 SV=2 | 71 | R | 0.514817 | H | 0.503927 | 0.01089 | No Change: Both D | Mal de Meleda (MDM) [MIM:248300] |
| P55000 | SLUR1_HUMAN Secreted Ly-6/uPAR-related protein 1 OS=Homo sapiens GN=SLURP1 PE=1 SV=2 | 77 | C | 0.495265 | R | 0.623779 | -0.128514 | O to D | Mal de Meleda (MDM) [MIM:248300] |
| P55000 | SLUR1_HUMAN Secreted Ly-6/uPAR-related protein 1 OS=Homo sapiens GN=SLURP1 PE=1 SV=2 | 86 | G | 0.228663 | R | 0.27342 | -0.044757 | No Change: Both O | Mal de Meleda (MDM) [MIM:248300] |
| P55000 | SLUR1_HUMAN Secreted Ly-6/uPAR-related protein 1 OS=Homo sapiens GN=SLURP1 PE=1 SV=2 | 99 | C | 0.339497 | Y | 0.357196 | -0.017699 | No Change: Both O | Mal de Meleda (MDM) [MIM:248300] |
| Q8IY92 | SLX4_HUMAN Structure-specific endonuclease subunit SLX4 OS=Homo sapiens GN=SLX4 PE=1 SV=3 | 1122 | P | 0.922443 | L | 0.883398 | 0.039045 | No Change: Both D | - |
| Q8IY92 | SLX4_HUMAN Structure-specific endonuclease subunit SLX4 OS=Homo sapiens GN=SLX4 PE=1 SV=3 | 1271 | S | 0.899556 | F | 0.779965 | 0.119591 | No Change: Both D | - |
| Q8IY92 | SLX4_HUMAN Structure-specific endonuclease subunit SLX4 OS=Homo sapiens GN=SLX4 PE=1 SV=3 | 1221 | A | 0.921289 | V | 0.893645 | 0.027644 | No Change: Both D | - |
| Q8IY92 | SLX4_HUMAN Structure-specific endonuclease subunit SLX4 OS=Homo sapiens GN=SLX4 PE=1 SV=3 | 1367 | A | 0.90173 | T | 0.907932 | -0.006202 | No Change: Both D | - |
| Q8IY92 | SLX4_HUMAN Structure-specific endonuclease subunit SLX4 OS=Homo sapiens GN=SLX4 PE=1 SV=3 | 1677 | P | 0.984059 | S | 0.983084 | 9.75E-04 | No Change: Both D | - |
| Q15797 | SMAD1_HUMAN Mothers against decapentaplegic homolog 1 OS=Homo sapiens GN=SMAD1 PE=1 SV=1 | 3 | V | 0.680872 | A | 0.663075 | 0.017797 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q15796 | SMAD2_HUMAN Mothers against decapentaplegic homolog 2 OS=Homo sapiens GN=SMAD2 PE=1 SV=1 | 133 | R | 0.098354 | C | 0.0506 | 0.047754 | No Change: Both O | A colorectal carcinoma sample |
| Q15796 | SMAD2_HUMAN Mothers against decapentaplegic homolog 2 OS=Homo sapiens GN=SMAD2 PE=1 SV=1 | 440 | L | 0.108582 | R | 0.168078 | -0.059496 | No Change: Both O | A colorectal carcinoma sample |
| Q15796 | SMAD2_HUMAN Mothers against decapentaplegic homolog 2 OS=Homo sapiens GN=SMAD2 PE=1 SV=1 | 445 | P | 0.147371 | H | 0.124774 | 0.022597 | No Change: Both O | A colorectal carcinoma sample |
| Q15796 | SMAD2_HUMAN Mothers against decapentaplegic homolog 2 OS=Homo sapiens GN=SMAD2 PE=1 SV=1 | 450 | D | 0.230153 | E | 0.267289 | -0.037136 | No Change: Both O | A colorectal carcinoma sample |
| Q15796 | SMAD2_HUMAN Mothers against decapentaplegic homolog 2 OS=Homo sapiens GN=SMAD2 PE=1 SV=1 | 300 | D | 0.525356 | V | 0.361322 | 0.164034 | D to O | A colorectal cancer sample |
| P84022 | SMAD3_HUMAN Mothers against decapentaplegic homolog 3 OS=Homo sapiens GN=SMAD3 PE=1 SV=1 | 393 | P | 0.134534 | L | 0.072102 | 0.062432 | No Change: Both O | A colorectal cancer sample |
| P84022 | SMAD3_HUMAN Mothers against decapentaplegic homolog 3 OS=Homo sapiens GN=SMAD3 PE=1 SV=1 | 170 | I | 0.892427 | V | 0.883086 | 0.009341 | No Change: Both D | - |
| P84022 | SMAD3_HUMAN Mothers against decapentaplegic homolog 3 OS=Homo sapiens GN=SMAD3 PE=1 SV=1 | 261 | T | 0.622886 | I | 0.459121 | 0.163765 | D to O | Loeys-Dietz syndrome type 1C (LDS1C) [MIM:613795] |
| P84022 | SMAD3_HUMAN Mothers against decapentaplegic homolog 3 OS=Homo sapiens GN=SMAD3 PE=1 SV=1 | 287 | R | 0.311592 | W | 0.13212 | 0.179472 | No Change: Both O | Loeys-Dietz syndrome type 1C (LDS1C) [MIM:613795] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 493 | D | 0.185302 | H | 0.14714 | 0.038162 | No Change: Both O | Pancreatic carcinoma |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 352 | G | 0.300219 | R | 0.275761 | 0.024458 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 352 | G | 0.300219 | R | 0.275761 | 0.024458 | No Change: Both O | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 361 | R | 0.292375 | C | 0.175581 | 0.116794 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 386 | G | 0.296816 | D | 0.303102 | -0.006286 | No Change: Both O | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 330 | E | 0.094074 | G | 0.07441 | 0.019664 | No Change: Both O | Juvenile polyposis syndrome (JPS) [MIM:174900] |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 130 | P | 0.175007 | S | 0.203539 | -0.028532 | No Change: Both O | A colorectal cancer sample |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 351 | D | 0.266237 | N | 0.236248 | 0.029989 | No Change: Both O | A colorectal cancer sample |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 361 | R | 0.292375 | H | 0.293754 | -0.001379 | No Change: Both O | A colorectal cancer sample |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 101 | W | 0.105596 | G | 0.230152 | -0.124556 | No Change: Both O | - |
| Q13485 | SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens GN=SMAD4 PE=1 SV=1 | 13 | N | 0.543955 | S | 0.609122 | -0.065167 | No Change: Both D | - |
| Q9Y6J3 | SMA5O_HUMAN SMAD5 antisense gene protein 1 OS=Homo sapiens GN=SMAD5-AS1 PE=2 SV=1 | 85 | K | 0.805882 | N | 0.801954 | 0.003928 | No Change: Both D | - |
| O15198 | SMAD9_HUMAN Mothers against decapentaplegic homolog 9 OS=Homo sapiens GN=SMAD9 PE=1 SV=1 | 43 | K | 0.820516 | E | 0.806884 | 0.013632 | No Change: Both D | Primary pulmonary hypertension (PPH1) [MIM:178600] |
| Q8IYB5 | SMAP1_HUMAN Stromal membrane-associated protein 1 OS=Homo sapiens GN=SMAP1 PE=1 SV=2 | 212 | A | 0.917045 | V | 0.902617 | 0.014428 | No Change: Both D | - |
| Q8WU79 | SMAP2_HUMAN Stromal membrane-associated protein 2 OS=Homo sapiens GN=SMAP2 PE=1 SV=1 | 289 | A | 0.874107 | T | 0.885887 | -0.01178 | No Change: Both D | - |
| P28370 | SMCA1_HUMAN Probable global transcription activator SNF2L1 OS=Homo sapiens GN=SMARCA1 PE=1 SV=2 | 656 | Q | 0.537834 | R | 0.519758 | 0.018076 | No Change: Both D | - |
| P51531 | SMCA2_HUMAN Probable global transcription activator SNF2L2 OS=Homo sapiens GN=SMARCA2 PE=1 SV=2 | 1416 | G | 0.732756 | A | 0.688542 | 0.044214 | No Change: Both D | - |
| P51531 | SMCA2_HUMAN Probable global transcription activator SNF2L2 OS=Homo sapiens GN=SMARCA2 PE=1 SV=2 | 1546 | D | 0.99456 | E | 0.994405 | 1.55E-04 | No Change: Both D | - |
| P51532 | SMCA4_HUMAN Transcription activator BRG1 OS=Homo sapiens GN=SMARCA4 PE=1 SV=2 | 561 | V | 0.661771 | E | 0.77308 | -0.111309 | No Change: Both D | - |
| P51532 | SMCA4_HUMAN Transcription activator BRG1 OS=Homo sapiens GN=SMARCA4 PE=1 SV=2 | 1036 | M | 0.391962 | I | 0.28724 | 0.104722 | No Change: Both O | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 66 | S | 0.928107 | F | 0.858443 | 0.069664 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 135 | L | 0.85478 | F | 0.841378 | 0.013402 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 140 | R | 0.849041 | C | 0.767206 | 0.081835 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 245 | S | 0.938705 | Y | 0.860726 | 0.077979 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 247 | S | 0.924149 | N | 0.908392 | 0.015757 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 301 | V | 0.675315 | A | 0.71798 | -0.042665 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 351 | P | 0.899195 | Q | 0.904086 | -0.004891 | No Change: Both D | - |
| Q9H4L7 | SMRCD_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Homo sapiens GN=SMARCAD1 PE=1 SV=2 | 972 | V | 0.239853 | A | 0.280428 | -0.040575 | No Change: Both O | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 43 | A | 0.868878 | T | 0.881262 | -0.012384 | No Change: Both D | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 114 | R | 0.902337 | H | 0.905465 | -0.003128 | No Change: Both D | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 206 | Y | 0.941274 | D | 0.96878 | -0.027506 | No Change: Both D | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 207 | I | 0.940405 | F | 0.933369 | 0.007036 | No Change: Both D | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 315 | S | 0.865737 | R | 0.830468 | 0.035269 | No Change: Both D | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 377 | E | 0.279846 | Q | 0.235092 | 0.044754 | No Change: Both O | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 424 | D | 0.627485 | V | 0.488631 | 0.138854 | D to O | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 468 | A | 0.056054 | P | 0.073245 | -0.017191 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 548 | I | 0.153312 | N | 0.283644 | -0.130332 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 579 | S | 0.271321 | L | 0.144609 | 0.126712 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 586 | R | 0.438678 | W | 0.256343 | 0.182335 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 644 | R | 0.300331 | W | 0.129127 | 0.171204 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 645 | R | 0.327052 | C | 0.178311 | 0.148741 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 647 | K | 0.399269 | Q | 0.368901 | 0.030368 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 647 | K | 0.399269 | T | 0.312293 | 0.086976 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 649 | D | 0.428758 | N | 0.414987 | 0.013771 | No Change: Both O | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 705 | T | 0.201232 | I | 0.131867 | 0.069365 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 742 | T | 0.301403 | M | 0.262609 | 0.038794 | No Change: Both O | - |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 764 | R | 0.636219 | Q | 0.666244 | -0.030025 | No Change: Both D | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 820 | R | 0.426045 | H | 0.429534 | -0.003489 | No Change: Both O | Schimke immuno-osseous dysplasia (SIOD) [MIM:242900] |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 432 | L | 0.427249 | V | 0.423171 | 0.004078 | No Change: Both O | A breast cancer sample |
| Q9NZC9 | SMAL1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Homo sapiens GN=SMARCAL1 PE=1 SV=1 | 22 | A | 0.922464 | G | 0.923239 | -7.75E-04 | No Change: Both D | - |
| Q92922 | SMRC1_HUMAN SWI/SNF complex subunit SMARCC1 OS=Homo sapiens GN=SMARCC1 PE=1 SV=3 | 1075 | P | 0.998852 | H | 0.997796 | 0.001056 | No Change: Both D | - |
| Q6STE5 | SMRD3_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 OS=Homo sapiens GN=SMARCD3 PE=1 SV=1 | 170 | P | 0.658444 | S | 0.668949 | -0.010505 | No Change: Both D | - |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 493 | E | 0.844473 | A | 0.792698 | 0.051775 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 28 | T | 0.152932 | P | 0.213537 | -0.060605 | No Change: Both O | - |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 133 | F | 0.102269 | V | 0.112146 | -0.009877 | No Change: Both O | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 141 | E | 0.249944 | K | 0.258232 | -0.008288 | No Change: Both O | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 196 | R | 0.921625 | H | 0.900955 | 0.02067 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 398 | R | 0.939947 | Q | 0.942844 | -0.002897 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 496 | R | 0.830754 | C | 0.737857 | 0.092897 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 496 | R | 0.830754 | H | 0.780534 | 0.05022 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 693 | R | 0.971744 | G | 0.962888 | 0.008856 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 711 | R | 0.887256 | W | 0.760971 | 0.126285 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 781 | C | 0.881055 | F | 0.88464 | -0.003585 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 790 | R | 0.884473 | Q | 0.880473 | 0.004 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 816 | R | 0.801402 | G | 0.771555 | 0.029847 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 1049 | R | 0.929036 | Q | 0.9292 | -1.64E-04 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 1085 | Y | 0.364867 | C | 0.388059 | -0.023192 | No Change: Both O | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 1122 | F | 0.381564 | L | 0.421778 | -0.040214 | No Change: Both O | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 1123 | R | 0.419629 | W | 0.22417 | 0.195459 | No Change: Both O | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 711 | R | 0.887256 | Q | 0.902038 | -0.014782 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q14683 | SMC1A_HUMAN Structural maintenance of chromosomes protein 1A OS=Homo sapiens GN=SMC1A PE=1 SV=2 | 784 | I | 0.890245 | T | 0.90612 | -0.015875 | No Change: Both D | Cornelia de Lange syndrome type 2 (CDLS2) [MIM:300590] |
| Q8NDV3 | SMC1B_HUMAN Structural maintenance of chromosomes protein 1B OS=Homo sapiens GN=SMC1B PE=1 SV=2 | 473 | F | 0.847394 | V | 0.866555 | -0.019161 | No Change: Both D | - |
| Q8NDV3 | SMC1B_HUMAN Structural maintenance of chromosomes protein 1B OS=Homo sapiens GN=SMC1B PE=1 SV=2 | 1050 | L | 0.596626 | M | 0.650059 | -0.053433 | No Change: Both D | - |
| Q8NDV3 | SMC1B_HUMAN Structural maintenance of chromosomes protein 1B OS=Homo sapiens GN=SMC1B PE=1 SV=2 | 758 | R | 0.730557 | Q | 0.752632 | -0.022075 | No Change: Both D | - |
| Q8NDV3 | SMC1B_HUMAN Structural maintenance of chromosomes protein 1B OS=Homo sapiens GN=SMC1B PE=1 SV=2 | 1008 | S | 0.481897 | A | 0.415753 | 0.066144 | No Change: Both O | - |
| O95347 | SMC2_HUMAN Structural maintenance of chromosomes protein 2 OS=Homo sapiens GN=SMC2 PE=1 SV=2 | 1009 | E | 0.664777 | K | 0.691751 | -0.026974 | No Change: Both D | - |
| Q9NTJ3 | SMC4_HUMAN Structural maintenance of chromosomes protein 4 OS=Homo sapiens GN=SMC4 PE=1 SV=2 | 181 | S | 0.267658 | R | 0.219873 | 0.047785 | No Change: Both O | - |
| Q9NTJ3 | SMC4_HUMAN Structural maintenance of chromosomes protein 4 OS=Homo sapiens GN=SMC4 PE=1 SV=2 | 356 | N | 0.923694 | S | 0.931309 | -0.007615 | No Change: Both D | - |
| Q9NTJ3 | SMC4_HUMAN Structural maintenance of chromosomes protein 4 OS=Homo sapiens GN=SMC4 PE=1 SV=2 | 415 | E | 0.950509 | D | 0.9419 | 0.008609 | No Change: Both D | - |
| Q8IY18 | SMC5_HUMAN Structural maintenance of chromosomes protein 5 OS=Homo sapiens GN=SMC5 PE=1 SV=2 | 306 | V | 0.779684 | I | 0.772656 | 0.007028 | No Change: Both D | - |
| Q8IY18 | SMC5_HUMAN Structural maintenance of chromosomes protein 5 OS=Homo sapiens GN=SMC5 PE=1 SV=2 | 308 | C | 0.786539 | R | 0.867727 | -0.081188 | No Change: Both D | - |
| Q8IY18 | SMC5_HUMAN Structural maintenance of chromosomes protein 5 OS=Homo sapiens GN=SMC5 PE=1 SV=2 | 682 | H | 0.893416 | R | 0.910562 | -0.017146 | No Change: Both D | - |
| Q96SB8 | SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens GN=SMC6 PE=1 SV=2 | 691 | A | 0.657695 | T | 0.688348 | -0.030653 | No Change: Both D | - |
| Q96SB8 | SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens GN=SMC6 PE=1 SV=2 | 1046 | I | 0.482141 | M | 0.609888 | -0.127747 | O to D | - |
| Q96SB8 | SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens GN=SMC6 PE=1 SV=2 | 292 | A | 0.41182 | V | 0.34019 | 0.07163 | No Change: Both O | A breast cancer sample |
| Q96SB8 | SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens GN=SMC6 PE=1 SV=2 | 464 | R | 0.681384 | G | 0.650953 | 0.030431 | No Change: Both D | - |
| Q96SB8 | SMC6_HUMAN Structural maintenance of chromosomes protein 6 OS=Homo sapiens GN=SMC6 PE=1 SV=2 | 928 | K | 0.270496 | Q | 0.250019 | 0.020477 | No Change: Both O | - |
| A6NHR9 | SMHD1_HUMAN Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens GN=SMCHD1 PE=1 SV=2 | 708 | V | 0.51417 | I | 0.507259 | 0.006911 | No Change: Both D | - |
| A6NHR9 | SMHD1_HUMAN Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens GN=SMCHD1 PE=1 SV=2 | 879 | K | 0.300488 | N | 0.279738 | 0.02075 | No Change: Both O | - |
| A6NHR9 | SMHD1_HUMAN Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Homo sapiens GN=SMCHD1 PE=1 SV=2 | 960 | I | 0.3573 | V | 0.390885 | -0.033585 | No Change: Both O | - |
| Q96C03 | MID49_HUMAN Mitochondrial dynamic protein MID49 OS=Homo sapiens GN=SMCR7 PE=1 SV=1 | 324 | G | 0.129333 | E | 0.162452 | -0.033119 | No Change: Both O | - |
| Q96C03 | MID49_HUMAN Mitochondrial dynamic protein MID49 OS=Homo sapiens GN=SMCR7 PE=1 SV=1 | 354 | R | 0.290553 | Q | 0.282636 | 0.007917 | No Change: Both O | - |
| Q9NQG6 | MID51_HUMAN Mitochondrial dynamic protein MID51 OS=Homo sapiens GN=SMCR7L PE=1 SV=1 | 78 | G | 0.845913 | R | 0.878408 | -0.032495 | No Change: Both D | - |
| Q9NQG6 | MID51_HUMAN Mitochondrial dynamic protein MID51 OS=Homo sapiens GN=SMCR7L PE=1 SV=1 | 89 | T | 0.911564 | M | 0.908272 | 0.003292 | No Change: Both D | - |
| Q9NQG6 | MID51_HUMAN Mitochondrial dynamic protein MID51 OS=Homo sapiens GN=SMCR7L PE=1 SV=1 | 169 | R | 0.160276 | W | 0.054691 | 0.105585 | No Change: Both O | - |
| Q9NQG6 | MID51_HUMAN Mitochondrial dynamic protein MID51 OS=Homo sapiens GN=SMCR7L PE=1 SV=1 | 264 | D | 0.278454 | N | 0.266497 | 0.011957 | No Change: Both O | - |
| Q8TEV9 | SMCR8_HUMAN Smith-Magenis syndrome chromosomal region candidate gene 8 protein OS=Homo sapiens GN=SMCR8 PE=1 SV=2 | 524 | P | 0.604539 | L | 0.431844 | 0.172695 | D to O | - |
| Q8TEV9 | SMCR8_HUMAN Smith-Magenis syndrome chromosomal region candidate gene 8 protein OS=Homo sapiens GN=SMCR8 PE=1 SV=2 | 556 | R | 0.846007 | H | 0.82533 | 0.020677 | No Change: Both D | - |
| Q8TEV9 | SMCR8_HUMAN Smith-Magenis syndrome chromosomal region candidate gene 8 protein OS=Homo sapiens GN=SMCR8 PE=1 SV=2 | 636 | N | 0.830076 | S | 0.862285 | -0.032209 | No Change: Both D | - |
| Q5MIZ7 | P4R3B_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3B OS=Homo sapiens GN=SMEK2 PE=1 SV=2 | 293 | S | 0.099101 | T | 0.072434 | 0.026667 | No Change: Both O | - |
| Q5MIZ7 | P4R3B_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 3B OS=Homo sapiens GN=SMEK2 PE=1 SV=2 | 503 | I | 0.473239 | V | 0.490806 | -0.017567 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 35 | A | 0.9545 | T | 0.960583 | -0.006083 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 126 | R | 0.782881 | C | 0.662088 | 0.120793 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 144 | S | 0.938867 | C | 0.885731 | 0.053136 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 151 | N | 0.88845 | Y | 0.827437 | 0.061013 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 160 | D | 0.839665 | N | 0.825642 | 0.014023 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 167 | A | 0.601577 | V | 0.558236 | 0.043341 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 320 | D | 0.086409 | G | 0.075762 | 0.010647 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 465 | G | 0.207881 | S | 0.254143 | -0.046262 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 546 | H | 0.121917 | R | 0.118864 | 0.003053 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 588 | A | 0.448369 | S | 0.584237 | -0.135868 | O to D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 612 | I | 0.051096 | K | 0.143388 | -0.092292 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 753 | S | 0.249728 | C | 0.094064 | 0.155664 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 809 | S | 0.251476 | C | 0.12333 | 0.128146 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 812 | R | 0.269909 | C | 0.149087 | 0.120822 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 829 | V | 0.282668 | I | 0.26303 | 0.019638 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 832 | N | 0.374157 | D | 0.381793 | -0.007636 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 952 | A | 0.251092 | G | 0.2916 | -0.040508 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 969 | N | 0.68232 | S | 0.71201 | -0.02969 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1016 | F | 0.105415 | L | 0.111532 | -0.006117 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1029 | R | 0.08029 | Q | 0.086286 | -0.005996 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1072 | T | 0.159585 | S | 0.219514 | -0.059929 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1103 | N | 0.145298 | H | 0.123391 | 0.021907 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1275 | P | 0.683324 | R | 0.629766 | 0.053558 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1292 | Q | 0.504228 | P | 0.52685 | -0.022622 | No Change: Both D | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1332 | I | 0.267943 | V | 0.28618 | -0.018237 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1358 | S | 0.430547 | P | 0.393297 | 0.03725 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 1418 | R | 0.27922 | T | 0.279032 | 1.88E-04 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2171 | S | 0.073068 | C | 0.025613 | 0.047455 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2258 | G | 0.327031 | S | 0.398166 | -0.071135 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2345 | M | 0.189789 | K | 0.297532 | -0.107743 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2730 | Q | 0.360125 | E | 0.411107 | -0.050982 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2889 | G | 0.379554 | S | 0.439118 | -0.059564 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 2899 | P | 0.323162 | A | 0.250004 | 0.073158 | No Change: Both O | - |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 3239 | I | 0.628598 | T | 0.737757 | -0.109159 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q96Q15 | SMG1_HUMAN Serine/threonine-protein kinase SMG1 OS=Homo sapiens GN=SMG1 PE=1 SV=3 | 3583 | K | 0.861482 | Q | 0.83507 | 0.026412 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q9UPR3 | SMG5_HUMAN Protein SMG5 OS=Homo sapiens GN=SMG5 PE=1 SV=3 | 1004 | N | 0.174898 | D | 0.201788 | -0.02689 | No Change: Both O | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 291 | R | 0.975315 | P | 0.973855 | 0.00146 | No Change: Both D | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 294 | K | 0.977445 | Q | 0.97689 | 5.55E-04 | No Change: Both D | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 341 | N | 0.864264 | T | 0.861455 | 0.002809 | No Change: Both D | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 972 | A | 0.262699 | T | 0.262672 | 2.70E-05 | No Change: Both O | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 1233 | H | 0.605377 | R | 0.655178 | -0.049801 | No Change: Both D | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 575 | N | 0.875442 | S | 0.904176 | -0.028734 | No Change: Both D | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 984 | R | 0.420971 | C | 0.38119 | 0.039781 | No Change: Both O | - |
| Q86US8 | EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens GN=SMG6 PE=1 SV=2 | 1189 | E | 0.953672 | K | 0.944813 | 0.008859 | No Change: Both D | - |
| Q92540 | SMG7_HUMAN Protein SMG7 OS=Homo sapiens GN=SMG7 PE=1 SV=2 | 627 | S | 0.912111 | F | 0.827706 | 0.084405 | No Change: Both D | - |
| Q92540 | SMG7_HUMAN Protein SMG7 OS=Homo sapiens GN=SMG7 PE=1 SV=2 | 900 | V | 0.884644 | I | 0.872418 | 0.012226 | No Change: Both D | - |
| Q8ND04 | SMG8_HUMAN Protein SMG8 OS=Homo sapiens GN=SMG8 PE=1 SV=1 | 280 | P | 0.848156 | L | 0.751392 | 0.096764 | No Change: Both D | - |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 2 | A | 0.937345 | G | 0.966865 | -0.02952 | No Change: Both D | Spinal muscular atrophy autosomal recessive type 2 (SMA2) [MIM:253550] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 2 | A | 0.937345 | G | 0.966865 | -0.02952 | No Change: Both D | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 262 | S | 0.364641 | I | 0.219175 | 0.145466 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 272 | Y | 0.215563 | C | 0.205871 | 0.009692 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 1 (SMA1) [MIM:253300] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 274 | T | 0.253856 | I | 0.173939 | 0.079917 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 2 (SMA2) [MIM:253550] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 274 | T | 0.253856 | I | 0.173939 | 0.079917 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 275 | G | 0.257578 | S | 0.309435 | -0.051857 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 279 | G | 0.34256 | V | 0.197597 | 0.144963 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 1 (SMA1) [MIM:253300] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 279 | G | 0.34256 | C | 0.179408 | 0.163152 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 2 (SMA2) [MIM:253550] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 279 | G | 0.34256 | C | 0.179408 | 0.163152 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 245 | P | 0.909579 | L | 0.856352 | 0.053227 | No Change: Both D | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 30 | D | 0.616903 | N | 0.575405 | 0.041498 | No Change: Both D | Spinal muscular atrophy autosomal recessive type 2 (SMA2) [MIM:253550] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 44 | D | 0.378151 | V | 0.244891 | 0.13326 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 95 | G | 0.453843 | R | 0.46697 | -0.013127 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 111 | A | 0.103049 | G | 0.129401 | -0.026352 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 2 (SMA2) [MIM:253550] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 116 | I | 0.165193 | F | 0.164234 | 9.59E-04 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 1 (SMA1) [MIM:253300] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 136 | Q | 0.554055 | E | 0.590444 | -0.036389 | No Change: Both D | Spinal muscular atrophy autosomal recessive type 1 (SMA1) [MIM:253300] |
| Q16637 | SMN_HUMAN Survival motor neuron protein OS=Homo sapiens GN=SMN1 PE=1 SV=1 | 262 | S | 0.364641 | G | 0.31672 | 0.047921 | No Change: Both O | Spinal muscular atrophy autosomal recessive type 3 (SMA3) [MIM:253400] |
| Q99835 | SMO_HUMAN Smoothened homolog OS=Homo sapiens GN=SMO PE=1 SV=1 | 535 | W | 0.065937 | L | 0.090721 | -0.024784 | No Change: Both O | Basal cell carcinoma samples |
| Q99835 | SMO_HUMAN Smoothened homolog OS=Homo sapiens GN=SMO PE=1 SV=1 | 562 | R | 0.725579 | Q | 0.732835 | -0.007256 | No Change: Both D | Basal cell carcinoma samples |
| Q99835 | SMO_HUMAN Smoothened homolog OS=Homo sapiens GN=SMO PE=1 SV=1 | 473 | D | 0.06481 | H | 0.059589 | 0.005221 | No Change: Both O | - |
| Q9H4F8 | SMOC1_HUMAN SPARC-related modular calcium-binding protein 1 OS=Homo sapiens GN=SMOC1 PE=1 SV=1 | 82 | V | 0.737867 | M | 0.800143 | -0.062276 | No Change: Both D | - |
| Q9NWM0 | SMOX_HUMAN Spermine oxidase OS=Homo sapiens GN=SMOX PE=1 SV=1 | 522 | H | 0.512752 | Y | 0.418709 | 0.094043 | D to O | - |
| Q9NWM0 | SMOX_HUMAN Spermine oxidase OS=Homo sapiens GN=SMOX PE=1 SV=1 | 340 | Q | 0.220409 | K | 0.276768 | -0.056359 | No Change: Both O | A breast cancer sample |
| Q9NWM0 | SMOX_HUMAN Spermine oxidase OS=Homo sapiens GN=SMOX PE=1 SV=1 | 301 | R | 0.826746 | P | 0.842394 | -0.015648 | No Change: Both D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 242 | G | 0.670319 | R | 0.683629 | -0.01331 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 246 | E | 0.526609 | Q | 0.476213 | 0.050396 | D to O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 302 | L | 0.122307 | P | 0.230542 | -0.108235 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 382 | M | 0.148664 | I | 0.105088 | 0.043576 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 383 | N | 0.135753 | S | 0.16163 | -0.025877 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 389 | N | 0.082694 | T | 0.064425 | 0.018269 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 391 | W | 0.080146 | G | 0.199119 | -0.118973 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 436 | S | 0.096021 | R | 0.072231 | 0.02379 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 496 | R | 0.146705 | L | 0.091167 | 0.055538 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 577 | G | 0.388149 | S | 0.442088 | -0.053939 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 157 | C | 0.305886 | R | 0.442586 | -0.1367 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 446 | Y | 0.138696 | C | 0.103582 | 0.035114 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 248 | S | 0.501986 | R | 0.477246 | 0.02474 | D to O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 248 | S | 0.501986 | R | 0.477246 | 0.02474 | D to O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 319 | H | 0.57355 | Y | 0.464983 | 0.108567 | D to O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 371 | P | 0.179844 | S | 0.203945 | -0.024101 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 421 | H | 0.34181 | Y | 0.210048 | 0.131762 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 463 | F | 0.34804 | S | 0.574238 | -0.226198 | O to D | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 475 | P | 0.220819 | L | 0.122694 | 0.098125 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 475 | P | 0.220819 | L | 0.122694 | 0.098125 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 537 | Y | 0.118528 | H | 0.195265 | -0.076737 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 36 | V | 0.244191 | A | 0.358982 | -0.114791 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 316 | V | 0.439938 | E | 0.593029 | -0.153091 | O to D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 322 | T | 0.652246 | I | 0.52418 | 0.128066 | No Change: Both D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 506 | G | 0.565816 | R | 0.53147 | 0.034346 | No Change: Both D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 49 | D | 0.277938 | V | 0.182586 | 0.095352 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 92 | C | 0.057249 | W | 0.043864 | 0.013385 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 103 | L | 0.325223 | P | 0.46625 | -0.141027 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 103 | L | 0.325223 | P | 0.46625 | -0.141027 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 130 | V | 0.107325 | A | 0.151106 | -0.043781 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 137 | L | 0.110179 | P | 0.211583 | -0.101404 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 166 | G | 0.312241 | R | 0.318759 | -0.006518 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 176 | I | 0.549184 | N | 0.6603 | -0.111116 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 184 | P | 0.864275 | L | 0.780224 | 0.084051 | No Change: Both D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 196 | A | 0.712213 | P | 0.816977 | -0.104764 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 200 | R | 0.574634 | C | 0.516451 | 0.058183 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 225 | L | 0.424874 | M | 0.464854 | -0.03998 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 225 | L | 0.424874 | P | 0.623064 | -0.19819 | O to D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 228 | R | 0.439116 | C | 0.325888 | 0.113228 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 228 | R | 0.439116 | H | 0.39163 | 0.047486 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 232 | G | 0.689697 | D | 0.715071 | -0.025374 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 241 | A | 0.688526 | V | 0.588288 | 0.100238 | No Change: Both D | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 244 | W | 0.597644 | C | 0.719303 | -0.121659 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 245 | G | 0.551747 | S | 0.596926 | -0.045179 | No Change: Both D | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 245 | G | 0.551747 | S | 0.596926 | -0.045179 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 246 | E | 0.526609 | K | 0.532099 | -0.00549 | No Change: Both D | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 251 | D | 0.401325 | E | 0.43383 | -0.032505 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 278 | D | 0.13805 | A | 0.096454 | 0.041596 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 281 | A | 0.192429 | T | 0.228479 | -0.03605 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 289 | R | 0.433106 | H | 0.439207 | -0.006101 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 292 | Q | 0.413433 | K | 0.438501 | -0.025068 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 294 | R | 0.338162 | Q | 0.365444 | -0.027282 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 313 | Y | 0.282945 | H | 0.42001 | -0.137065 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 323 | P | 0.654344 | A | 0.567193 | 0.087151 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 330 | P | 0.517096 | R | 0.460344 | 0.056752 | D to O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 341 | L | 0.256753 | P | 0.418104 | -0.161351 | No Change: Both O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 357 | A | 0.155096 | D | 0.196936 | -0.04184 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 367 | Y | 0.129823 | C | 0.101833 | 0.02799 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 376 | R | 0.175658 | H | 0.177594 | -0.001936 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 376 | R | 0.175658 | L | 0.116472 | 0.059186 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 379 | S | 0.138794 | P | 0.12426 | 0.014534 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 413 | A | 0.496923 | V | 0.410172 | 0.086751 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 421 | H | 0.34181 | R | 0.336707 | 0.005103 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 431 | C | 0.198764 | R | 0.360444 | -0.16168 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 432 | L | 0.191093 | P | 0.367248 | -0.176155 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 435 | W | 0.113715 | C | 0.132614 | -0.018899 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 450 | L | 0.191229 | P | 0.343368 | -0.152139 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 452 | A | 0.21475 | V | 0.149297 | 0.065453 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 456 | G | 0.193929 | D | 0.228537 | -0.034608 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 467 | Y | 0.338656 | S | 0.561727 | -0.223071 | O to D | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 474 | R | 0.23989 | W | 0.104882 | 0.135008 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 480 | F | 0.165224 | L | 0.202815 | -0.037591 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 482 | A | 0.163164 | E | 0.225693 | -0.062529 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 485 | A | 0.166667 | V | 0.113399 | 0.053268 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 486 | T | 0.171863 | A | 0.158596 | 0.013267 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 488 | Y | 0.209753 | N | 0.348342 | -0.138589 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 494 | G | 0.15407 | S | 0.177257 | -0.023187 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 496 | R | 0.146705 | C | 0.069619 | 0.077086 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 496 | R | 0.146705 | H | 0.148772 | -0.002067 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 505 | S | 0.549901 | G | 0.48877 | 0.061131 | D to O | - |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 514 | H | 0.256018 | Q | 0.258405 | -0.002387 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 515 | E | 0.213618 | V | 0.107284 | 0.106334 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 517 | Y | 0.149252 | C | 0.120858 | 0.028394 | No Change: Both O | Niemann-Pick disease type A (NPDA) [MIM:257200] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 533 | W | 0.090779 | R | 0.228098 | -0.137319 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 549 | L | 0.257492 | P | 0.426989 | -0.169497 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 563 | D | 0.176476 | Y | 0.10004 | 0.076436 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 576 | K | 0.288307 | N | 0.25665 | 0.031657 | No Change: Both O | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 600 | R | 0.646375 | H | 0.616679 | 0.029696 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| P17405 | ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens GN=SMPD1 PE=1 SV=4 | 600 | R | 0.646375 | P | 0.698458 | -0.052083 | No Change: Both D | Niemann-Pick disease type B (NPDB) [MIM:607616] |
| O60906 | NSMA_HUMAN Sphingomyelin phosphodiesterase 2 OS=Homo sapiens GN=SMPD2 PE=1 SV=2 | 265 | R | 0.642968 | S | 0.694535 | -0.051567 | No Change: Both D | - |
| O60906 | NSMA_HUMAN Sphingomyelin phosphodiesterase 2 OS=Homo sapiens GN=SMPD2 PE=1 SV=2 | 3 | P | 0.592754 | L | 0.598264 | -0.00551 | No Change: Both D | - |
| O60906 | NSMA_HUMAN Sphingomyelin phosphodiesterase 2 OS=Homo sapiens GN=SMPD2 PE=1 SV=2 | 223 | V | 0.276908 | I | 0.238095 | 0.038813 | No Change: Both O | - |
| Q92484 | ASM3A_HUMAN Acid sphingomyelinase-like phosphodiesterase 3a OS=Homo sapiens GN=SMPDL3A PE=1 SV=2 | 16 | H | 0.062004 | Y | 0.033964 | 0.02804 | No Change: Both O | - |
| Q92484 | ASM3A_HUMAN Acid sphingomyelinase-like phosphodiesterase 3a OS=Homo sapiens GN=SMPDL3A PE=1 SV=2 | 161 | P | 0.247128 | S | 0.272724 | -0.025596 | No Change: Both O | - |
| Q92485 | ASM3B_HUMAN Acid sphingomyelinase-like phosphodiesterase 3b OS=Homo sapiens GN=SMPDL3B PE=2 SV=2 | 381 | R | 0.359852 | H | 0.383901 | -0.024049 | No Change: Both O | - |
| Q99954 | SMR3A_HUMAN Submaxillary gland androgen-regulated protein 3A OS=Homo sapiens GN=SMR3A PE=2 SV=2 | 28 | G | 0.818207 | R | 0.826434 | -0.008227 | No Change: Both D | - |
| Q99954 | SMR3A_HUMAN Submaxillary gland androgen-regulated protein 3A OS=Homo sapiens GN=SMR3A PE=2 SV=2 | 42 | C | 0.986809 | R | 0.989568 | -0.002759 | No Change: Both D | - |
| Q99954 | SMR3A_HUMAN Submaxillary gland androgen-regulated protein 3A OS=Homo sapiens GN=SMR3A PE=2 SV=2 | 132 | P | 0.997834 | L | 0.99262 | 0.005214 | No Change: Both D | - |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 637 | R | 0.985081 | Q | 0.983554 | 0.001527 | No Change: Both D | A colorectal cancer sample |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 763 | A | 0.964003 | V | 0.943684 | 0.020319 | No Change: Both D | A colorectal cancer sample |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 455 | G | 0.722801 | D | 0.709881 | 0.01292 | No Change: Both D | - |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 547 | A | 0.84202 | P | 0.881447 | -0.039427 | No Change: Both D | - |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 559 | A | 0.87212 | V | 0.823108 | 0.049012 | No Change: Both D | - |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 580 | A | 0.787917 | T | 0.806326 | -0.018409 | No Change: Both D | - |
| P53814 | SMTN_HUMAN Smoothelin OS=Homo sapiens GN=SMTN PE=1 SV=7 | 642 | R | 0.975945 | C | 0.959344 | 0.016601 | No Change: Both D | - |
| Q2TAL5 | SMTL2_HUMAN Smoothelin-like protein 2 OS=Homo sapiens GN=SMTNL2 PE=2 SV=1 | 162 | A | 0.957363 | T | 0.958046 | -6.83E-04 | No Change: Both D | - |
| Q2TAL5 | SMTL2_HUMAN Smoothelin-like protein 2 OS=Homo sapiens GN=SMTNL2 PE=2 SV=1 | 251 | W | 0.926115 | R | 0.955978 | -0.029863 | No Change: Both D | - |
| Q53HV7 | SMUG1_HUMAN Single-strand selective monofunctional uracil DNA glycosylase OS=Homo sapiens GN=SMUG1 PE=1 SV=2 | 15 | G | 0.805327 | V | 0.653972 | 0.151355 | No Change: Both D | - |
| Q53HV7 | SMUG1_HUMAN Single-strand selective monofunctional uracil DNA glycosylase OS=Homo sapiens GN=SMUG1 PE=1 SV=2 | 105 | R | 0.259818 | W | 0.12855 | 0.131268 | No Change: Both O | - |
| Q9HCE7 | SMUF1_HUMAN E3 ubiquitin-protein ligase SMURF1 OS=Homo sapiens GN=SMURF1 PE=1 SV=2 | 466 | S | 0.150793 | Y | 0.075498 | 0.075295 | No Change: Both O | - |
| Q8NB12 | SMYD1_HUMAN SET and MYND domain-containing protein 1 OS=Homo sapiens GN=SMYD1 PE=2 SV=1 | 164 | Q | 0.475917 | P | 0.490555 | -0.014638 | No Change: Both O | - |
| Q9NRG4 | SMYD2_HUMAN N-lysine methyltransferase SMYD2 OS=Homo sapiens GN=SMYD2 PE=1 SV=2 | 165 | G | 0.392863 | E | 0.434876 | -0.042013 | No Change: Both O | - |
| Q9NRG4 | SMYD2_HUMAN N-lysine methyltransferase SMYD2 OS=Homo sapiens GN=SMYD2 PE=1 SV=2 | 430 | I | 0.746265 | M | 0.782976 | -0.036711 | No Change: Both D | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 131 | R | 0.313024 | I | 0.195049 | 0.117975 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 727 | Y | 0.240357 | C | 0.197889 | 0.042468 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 562 | R | 0.411256 | W | 0.20616 | 0.205096 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 101 | N | 0.641825 | D | 0.655552 | -0.013727 | No Change: Both D | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 236 | G | 0.359312 | S | 0.446703 | -0.087391 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 374 | I | 0.280442 | M | 0.351376 | -0.070934 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 382 | P | 0.424981 | R | 0.387677 | 0.037304 | No Change: Both O | - |
| Q8IYR2 | SMYD4_HUMAN SET and MYND domain-containing protein 4 OS=Homo sapiens GN=SMYD4 PE=2 SV=3 | 601 | A | 0.423451 | P | 0.506723 | -0.083272 | O to D | - |
| O95863 | SNAI1_HUMAN Zinc finger protein SNAI1 OS=Homo sapiens GN=SNAI1 PE=1 SV=2 | 118 | V | 0.949051 | A | 0.96443 | -0.015379 | No Change: Both D | - |
| O43623 | SNAI2_HUMAN Zinc finger protein SNAI2 OS=Homo sapiens GN=SNAI2 PE=1 SV=1 | 119 | D | 0.797674 | E | 0.827003 | -0.029329 | No Change: Both D | - |
| Q5SQN1 | SNP47_HUMAN Synaptosomal-associated protein 47 OS=Homo sapiens GN=SNAP47 PE=2 SV=3 | 48 | R | 0.506409 | G | 0.469879 | 0.03653 | D to O | - |
| Q5SQN1 | SNP47_HUMAN Synaptosomal-associated protein 47 OS=Homo sapiens GN=SNAP47 PE=2 SV=3 | 119 | G | 0.358677 | R | 0.351957 | 0.00672 | No Change: Both O | - |
| Q5SQN1 | SNP47_HUMAN Synaptosomal-associated protein 47 OS=Homo sapiens GN=SNAP47 PE=2 SV=3 | 154 | V | 0.437667 | M | 0.486257 | -0.04859 | No Change: Both O | - |
| Q5SQN1 | SNP47_HUMAN Synaptosomal-associated protein 47 OS=Homo sapiens GN=SNAP47 PE=2 SV=3 | 381 | R | 0.715326 | C | 0.624245 | 0.091081 | No Change: Both D | - |
| Q13487 | SNPC2_HUMAN snRNA-activating protein complex subunit 2 OS=Homo sapiens GN=SNAPC2 PE=1 SV=1 | 118 | L | 0.372111 | V | 0.361629 | 0.010482 | No Change: Both O | - |
| Q92966 | SNPC3_HUMAN snRNA-activating protein complex subunit 3 OS=Homo sapiens GN=SNAPC3 PE=1 SV=1 | 398 | E | 0.247885 | A | 0.173802 | 0.074083 | No Change: Both O | - |
| Q5SXM2 | SNPC4_HUMAN snRNA-activating protein complex subunit 4 OS=Homo sapiens GN=SNAPC4 PE=1 SV=1 | 799 | H | 0.195484 | Q | 0.290524 | -0.09504 | No Change: Both O | - |
| Q5SXM2 | SNPC4_HUMAN snRNA-activating protein complex subunit 4 OS=Homo sapiens GN=SNAPC4 PE=1 SV=1 | 1448 | P | 0.924282 | S | 0.932666 | -0.008384 | No Change: Both D | - |
| Q5SXM2 | SNPC4_HUMAN snRNA-activating protein complex subunit 4 OS=Homo sapiens GN=SNAPC4 PE=1 SV=1 | 44 | D | 0.993084 | N | 0.990287 | 0.002797 | No Change: Both D | - |
| O95295 | SNAPN_HUMAN SNARE-associated protein Snapin OS=Homo sapiens GN=SNAPIN PE=1 SV=1 | 112 | S | 0.595884 | C | 0.403507 | 0.192377 | D to O | - |
| P37840 | SYUA_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1 | 53 | A | 0.645235 | T | 0.686564 | -0.041329 | No Change: Both D | Parkinson disease type 1 (PARK1) [MIM:168601] |
| P37840 | SYUA_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1 | 30 | A | 0.78851 | P | 0.797382 | -0.008872 | No Change: Both D | Parkinson disease type 1 (PARK1) [MIM:168601] |
| P37840 | SYUA_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1 | 46 | E | 0.704675 | K | 0.718557 | -0.013882 | No Change: Both D | Dementia Lewy body (DLB) [MIM:127750] |
| P37840 | SYUA_HUMAN Alpha-synuclein OS=Homo sapiens GN=SNCA PE=1 SV=1 | 46 | E | 0.704675 | K | 0.718557 | -0.013882 | No Change: Both D | Parkinson disease type 1 (PARK1) [MIM:168601] |
| Q9Y6H5 | SNCAP_HUMAN Synphilin-1 OS=Homo sapiens GN=SNCAIP PE=1 SV=2 | 621 | R | 0.784018 | C | 0.707943 | 0.076075 | No Change: Both D | - |
| Q9Y6H5 | SNCAP_HUMAN Synphilin-1 OS=Homo sapiens GN=SNCAIP PE=1 SV=2 | 235 | E | 0.724142 | G | 0.662454 | 0.061688 | No Change: Both D | - |
| Q9Y6H5 | SNCAP_HUMAN Synphilin-1 OS=Homo sapiens GN=SNCAIP PE=1 SV=2 | 44 | V | 0.700436 | A | 0.734045 | -0.033609 | No Change: Both D | - |
| Q9Y6H5 | SNCAP_HUMAN Synphilin-1 OS=Homo sapiens GN=SNCAIP PE=1 SV=2 | 706 | E | 0.858979 | Q | 0.847507 | 0.011472 | No Change: Both D | - |
| O76070 | SYUG_HUMAN Gamma-synuclein OS=Homo sapiens GN=SNCG PE=1 SV=2 | 110 | E | 0.971206 | V | 0.948265 | 0.022941 | No Change: Both D | - |
| Q9HBX3 | SNIT1_HUMAN Uncharacterized protein encoded by SND1-IT1 OS=Homo sapiens GN=SND1-IT1 PE=2 SV=1 | 24 | T | 0.022382 | A | 0.016043 | 0.006339 | No Change: Both O | - |
| Q8TER0 | SNED1_HUMAN Sushi nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1 PE=1 SV=2 | 1228 | L | 0.903296 | P | 0.946133 | -0.042837 | No Change: Both D | - |
| Q8TER0 | SNED1_HUMAN Sushi nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1 PE=1 SV=2 | 1289 | R | 0.799506 | Q | 0.827827 | -0.028321 | No Change: Both D | - |
| Q8TER0 | SNED1_HUMAN Sushi nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1 PE=1 SV=2 | 1299 | H | 0.751638 | R | 0.794165 | -0.042527 | No Change: Both D | - |
| Q8TER0 | SNED1_HUMAN Sushi nidogen and EGF-like domain-containing protein 1 OS=Homo sapiens GN=SNED1 PE=1 SV=2 | 1362 | A | 0.196768 | S | 0.291506 | -0.094738 | No Change: Both O | - |
| O75324 | SNN_HUMAN Stannin OS=Homo sapiens GN=SNN PE=1 SV=1 | 17 | V | 0.015425 | I | 0.013493 | 0.001932 | No Change: Both O | - |
| O75324 | SNN_HUMAN Stannin OS=Homo sapiens GN=SNN PE=1 SV=1 | 88 | G | 0.805381 | S | 0.802486 | 0.002895 | No Change: Both D | - |
| Q9NRH2 | SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | 260 | L | 0.599828 | S | 0.720344 | -0.120516 | No Change: Both D | - |
| Q9NRH2 | SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | 391 | P | 0.768315 | S | 0.771305 | -0.00299 | No Change: Both D | - |
| Q9NRH2 | SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | 611 | G | 0.995524 | S | 0.996482 | -9.58E-04 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q9NRH2 | SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | 748 | P | 0.511172 | L | 0.356391 | 0.154781 | D to O | An ovarian serous carcinoma sample |
| Q9NRH2 | SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | 765 | I | 0.632869 | M | 0.716159 | -0.08329 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 1736 | F | 0.249559 | L | 0.282496 | -0.032937 | No Change: Both O | A colorectal cancer sample |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 1087 | S | 0.245162 | L | 0.120358 | 0.124804 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 1090 | R | 0.159237 | L | 0.093263 | 0.065974 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 681 | R | 0.212722 | C | 0.107868 | 0.104854 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 681 | R | 0.212722 | H | 0.216655 | -0.003933 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 683 | V | 0.25122 | L | 0.254598 | -0.003378 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| O75643 | U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens GN=SNRNP200 PE=1 SV=2 | 689 | Y | 0.208993 | C | 0.173164 | 0.035829 | No Change: Both O | Retinitis pigmentosa type 33 (RP33) [MIM:610359] |
| Q8WVK2 | SNR27_HUMAN U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Homo sapiens GN=SNRNP27 PE=1 SV=1 | 81 | T | 0.997399 | I | 0.99601 | 0.001389 | No Change: Both D | - |
| Q8WVK2 | SNR27_HUMAN U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein OS=Homo sapiens GN=SNRNP27 PE=1 SV=1 | 114 | S | 0.639591 | F | 0.498946 | 0.140645 | D to O | - |
| Q6IEG0 | SNR48_HUMAN U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Homo sapiens GN=SNRNP48 PE=1 SV=2 | 45 | P | 0.674055 | L | 0.577873 | 0.096182 | No Change: Both D | - |
| Q6IEG0 | SNR48_HUMAN U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Homo sapiens GN=SNRNP48 PE=1 SV=2 | 281 | R | 0.986539 | Q | 0.98605 | 4.89E-04 | No Change: Both D | - |
| P09661 | RU2A_HUMAN U2 small nuclear ribonucleoprotein A' OS=Homo sapiens GN=SNRPA1 PE=1 SV=2 | 234 | R | 0.884737 | H | 0.847147 | 0.03759 | No Change: Both D | - |
| P14678 | RSMB_HUMAN Small nuclear ribonucleoprotein-associated proteins B and B' OS=Homo sapiens GN=SNRPB PE=1 SV=2 | 79 | S | 0.605556 | P | 0.666379 | -0.060823 | No Change: Both D | - |
| P08579 | RU2B_HUMAN U2 small nuclear ribonucleoprotein B'' OS=Homo sapiens GN=SNRPB2 PE=1 SV=1 | 19 | K | 0.685218 | Q | 0.639265 | 0.045953 | No Change: Both D | A colorectal cancer sample |
| Q13424 | SNTA1_HUMAN Alpha-1-syntrophin OS=Homo sapiens GN=SNTA1 PE=1 SV=1 | 364 | L | 0.367693 | F | 0.336156 | 0.031537 | No Change: Both O | - |
| Q13424 | SNTA1_HUMAN Alpha-1-syntrophin OS=Homo sapiens GN=SNTA1 PE=1 SV=1 | 257 | A | 0.448307 | G | 0.447667 | 6.40E-04 | No Change: Both O | Long QT syndrome type 12 (LQT12) [MIM:612955] |
| Q13424 | SNTA1_HUMAN Alpha-1-syntrophin OS=Homo sapiens GN=SNTA1 PE=1 SV=1 | 390 | A | 0.287445 | V | 0.224124 | 0.063321 | No Change: Both O | Long QT syndrome type 12 (LQT12) [MIM:612955] |
| Q13425 | SNTB2_HUMAN Beta-2-syntrophin OS=Homo sapiens GN=SNTB2 PE=1 SV=1 | 424 | D | 0.332433 | E | 0.374555 | -0.042122 | No Change: Both O | - |
| Q9NY99 | SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens GN=SNTG2 PE=1 SV=2 | 168 | S | 0.746182 | Y | 0.6038 | 0.142382 | No Change: Both D | - |
| Q9NY99 | SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens GN=SNTG2 PE=1 SV=2 | 200 | S | 0.911531 | L | 0.858239 | 0.053292 | No Change: Both D | - |
| Q9NY99 | SNTG2_HUMAN Gamma-2-syntrophin OS=Homo sapiens GN=SNTG2 PE=1 SV=2 | 391 | I | 0.164678 | V | 0.198793 | -0.034115 | No Change: Both O | - |
| Q13596 | SNX1_HUMAN Sorting nexin-1 OS=Homo sapiens GN=SNX1 PE=1 SV=3 | 466 | D | 0.49193 | N | 0.465491 | 0.026439 | No Change: Both O | - |
| Q13596 | SNX1_HUMAN Sorting nexin-1 OS=Homo sapiens GN=SNX1 PE=1 SV=3 | 115 | S | 0.884448 | Y | 0.773339 | 0.111109 | No Change: Both D | - |
| Q9Y5X0 | SNX10_HUMAN Sorting nexin-10 OS=Homo sapiens GN=SNX10 PE=1 SV=2 | 187 | S | 0.987891 | I | 0.96135 | 0.026541 | No Change: Both D | - |
| Q9Y5W8 | SNX13_HUMAN Sorting nexin-13 OS=Homo sapiens GN=SNX13 PE=1 SV=4 | 472 | L | 0.450142 | S | 0.591534 | -0.141392 | O to D | - |
| Q9NRS6 | SNX15_HUMAN Sorting nexin-15 OS=Homo sapiens GN=SNX15 PE=1 SV=1 | 334 | R | 0.688035 | C | 0.522039 | 0.165996 | No Change: Both D | - |
| P57768 | SNX16_HUMAN Sorting nexin-16 OS=Homo sapiens GN=SNX16 PE=1 SV=2 | 98 | P | 0.764255 | L | 0.63117 | 0.133085 | No Change: Both D | - |
| Q96RF0 | SNX18_HUMAN Sorting nexin-18 OS=Homo sapiens GN=SNX18 PE=1 SV=2 | 571 | E | 0.402816 | D | 0.361004 | 0.041812 | No Change: Both O | - |
| Q96RF0 | SNX18_HUMAN Sorting nexin-18 OS=Homo sapiens GN=SNX18 PE=1 SV=2 | 593 | K | 0.173324 | T | 0.13855 | 0.034774 | No Change: Both O | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 407 | S | 0.842541 | G | 0.808072 | 0.034469 | No Change: Both D | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 361 | V | 0.629928 | L | 0.677177 | -0.047249 | No Change: Both D | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 396 | D | 0.748291 | E | 0.779973 | -0.031682 | No Change: Both D | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 618 | L | 0.621245 | F | 0.586667 | 0.034578 | No Change: Both D | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 753 | N | 0.633383 | S | 0.739435 | -0.106052 | No Change: Both D | - |
| Q92543 | SNX19_HUMAN Sorting nexin-19 OS=Homo sapiens GN=SNX19 PE=1 SV=2 | 878 | L | 0.062225 | R | 0.101925 | -0.0397 | No Change: Both O | - |
| Q7Z614 | SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens GN=SNX20 PE=1 SV=1 | 35 | P | 0.943057 | L | 0.896934 | 0.046123 | No Change: Both D | - |
| Q969T3 | SNX21_HUMAN Sorting nexin-21 OS=Homo sapiens GN=SNX21 PE=2 SV=1 | 154 | A | 0.147684 | T | 0.174081 | -0.026397 | No Change: Both O | - |
| Q9H3E2 | SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens GN=SNX25 PE=1 SV=2 | 318 | E | 0.180784 | K | 0.18098 | -1.96E-04 | No Change: Both O | - |
| Q9H3E2 | SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens GN=SNX25 PE=1 SV=2 | 586 | I | 0.864486 | V | 0.886418 | -0.021932 | No Change: Both D | - |
| Q9H3E2 | SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens GN=SNX25 PE=1 SV=2 | 725 | T | 0.149351 | I | 0.086212 | 0.063139 | No Change: Both O | - |
| Q96L92 | SNX27_HUMAN Sorting nexin-27 OS=Homo sapiens GN=SNX27 PE=1 SV=2 | 459 | E | 0.419532 | K | 0.408725 | 0.010807 | No Change: Both O | - |
| Q5VWJ9 | SNX30_HUMAN Sorting nexin-30 OS=Homo sapiens GN=SNX30 PE=1 SV=1 | 83 | D | 0.544731 | H | 0.466935 | 0.077796 | D to O | - |
| Q5VWJ9 | SNX30_HUMAN Sorting nexin-30 OS=Homo sapiens GN=SNX30 PE=1 SV=1 | 125 | P | 0.420599 | A | 0.318129 | 0.10247 | No Change: Both O | - |
| Q8N9S9 | SNX31_HUMAN Sorting nexin-31 OS=Homo sapiens GN=SNX31 PE=2 SV=3 | 73 | D | 0.544054 | H | 0.499668 | 0.044386 | D to O | - |
| Q8N9S9 | SNX31_HUMAN Sorting nexin-31 OS=Homo sapiens GN=SNX31 PE=2 SV=3 | 309 | Q | 0.348698 | R | 0.312831 | 0.035867 | No Change: Both O | - |
| Q8N9S9 | SNX31_HUMAN Sorting nexin-31 OS=Homo sapiens GN=SNX31 PE=2 SV=3 | 428 | D | 0.680855 | G | 0.619988 | 0.060867 | No Change: Both D | - |
| Q86XE0 | SNX32_HUMAN Sorting nexin-32 OS=Homo sapiens GN=SNX32 PE=2 SV=1 | 155 | H | 0.187394 | N | 0.206412 | -0.019018 | No Change: Both O | - |
| Q86XE0 | SNX32_HUMAN Sorting nexin-32 OS=Homo sapiens GN=SNX32 PE=2 SV=1 | 282 | A | 0.645339 | V | 0.576786 | 0.068553 | No Change: Both D | - |
| Q86XE0 | SNX32_HUMAN Sorting nexin-32 OS=Homo sapiens GN=SNX32 PE=2 SV=1 | 354 | S | 0.855651 | Y | 0.688592 | 0.167059 | No Change: Both D | - |
| Q9UNH6 | SNX7_HUMAN Sorting nexin-7 OS=Homo sapiens GN=SNX7 PE=1 SV=1 | 186 | F | 0.578097 | L | 0.590484 | -0.012387 | No Change: Both D | - |
| Q9UNH6 | SNX7_HUMAN Sorting nexin-7 OS=Homo sapiens GN=SNX7 PE=1 SV=1 | 278 | S | 0.221066 | N | 0.175694 | 0.045372 | No Change: Both O | - |
| Q9Y5X2 | SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens GN=SNX8 PE=1 SV=1 | 147 | A | 0.38164 | G | 0.413007 | -0.031367 | No Change: Both O | A colorectal cancer sample |
| P35610 | SOAT1_HUMAN Sterol O-acyltransferase 1 OS=Homo sapiens GN=SOAT1 PE=1 SV=3 | 526 | Q | 0.183596 | R | 0.171072 | 0.012524 | No Change: Both O | - |
| O75908 | SOAT2_HUMAN Sterol O-acyltransferase 2 OS=Homo sapiens GN=SOAT2 PE=2 SV=1 | 14 | E | 0.932185 | G | 0.919859 | 0.012326 | No Change: Both D | - |
| O75908 | SOAT2_HUMAN Sterol O-acyltransferase 2 OS=Homo sapiens GN=SOAT2 PE=2 SV=1 | 254 | T | 0.395648 | I | 0.265363 | 0.130285 | No Change: Both O | - |
| A7XYQ1 | SOBP_HUMAN Sine oculis-binding protein homolog OS=Homo sapiens GN=SOBP PE=2 SV=2 | 683 | S | 0.772442 | G | 0.769987 | 0.002455 | No Change: Both D | - |
| O15524 | SOCS1_HUMAN Suppressor of cytokine signaling 1 OS=Homo sapiens GN=SOCS1 PE=1 SV=1 | 210 | Q | 0.73716 | H | 0.751473 | -0.014313 | No Change: Both D | - |
| O14508 | SOCS2_HUMAN Suppressor of cytokine signaling 2 OS=Homo sapiens GN=SOCS2 PE=1 SV=1 | 52 | S | 0.262949 | N | 0.227405 | 0.035544 | No Change: Both O | - |
| O14543 | SOCS3_HUMAN Suppressor of cytokine signaling 3 OS=Homo sapiens GN=SOCS3 PE=1 SV=1 | 125 | H | 0.852811 | Y | 0.808953 | 0.043858 | No Change: Both D | - |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 5 | A | 0.421209 | T | 0.449833 | -0.028624 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 5 | A | 0.421209 | V | 0.347121 | 0.074088 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 8 | V | 0.227766 | E | 0.377679 | -0.149913 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 15 | V | 0.22512 | M | 0.274883 | -0.049763 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 17 | G | 0.243284 | S | 0.275857 | -0.032573 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 22 | E | 0.492845 | K | 0.493659 | -8.14E-04 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 38 | G | 0.29049 | R | 0.255561 | 0.034929 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 39 | L | 0.324647 | V | 0.327994 | -0.003347 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 42 | G | 0.36364 | S | 0.397746 | -0.034106 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 42 | G | 0.36364 | D | 0.362632 | 0.001008 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 44 | H | 0.337646 | R | 0.314968 | 0.022678 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 47 | H | 0.332615 | R | 0.313733 | 0.018882 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 49 | H | 0.380623 | Q | 0.369671 | 0.010952 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 85 | L | 0.581309 | V | 0.607562 | -0.026253 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 86 | G | 0.573763 | R | 0.572899 | 8.64E-04 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 91 | D | 0.545805 | A | 0.455297 | 0.090508 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 94 | G | 0.51651 | A | 0.473476 | 0.043034 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 94 | G | 0.51651 | C | 0.365526 | 0.150984 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 94 | G | 0.51651 | D | 0.564511 | -0.048001 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 94 | G | 0.51651 | R | 0.509363 | 0.007147 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 101 | E | 0.445889 | G | 0.421382 | 0.024507 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 102 | D | 0.448564 | G | 0.416371 | 0.032193 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 102 | D | 0.448564 | N | 0.402113 | 0.046451 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 107 | L | 0.364679 | V | 0.384456 | -0.019777 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 113 | I | 0.283172 | T | 0.391703 | -0.108531 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 114 | I | 0.284829 | T | 0.395779 | -0.11095 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 116 | R | 0.278953 | G | 0.310226 | -0.031273 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 126 | D | 0.6229 | H | 0.603431 | 0.019469 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 135 | S | 0.778353 | N | 0.776409 | 0.001944 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 140 | N | 0.654697 | K | 0.695416 | -0.040719 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 145 | L | 0.314928 | F | 0.265824 | 0.049104 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 149 | V | 0.325272 | G | 0.552888 | -0.227616 | O to D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 149 | V | 0.325272 | I | 0.330352 | -0.00508 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 150 | I | 0.395967 | T | 0.585711 | -0.189744 | O to D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 152 | I | 0.524766 | T | 0.67634 | -0.151574 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 7 | C | 0.251054 | F | 0.261769 | -0.010715 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 73 | G | 0.756598 | S | 0.778595 | -0.021997 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 94 | G | 0.51651 | V | 0.407839 | 0.108671 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 105 | I | 0.404454 | F | 0.36842 | 0.036034 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 125 | D | 0.59265 | V | 0.450927 | 0.141723 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 145 | L | 0.314928 | S | 0.550947 | -0.236019 | O to D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 146 | A | 0.280711 | T | 0.316256 | -0.035545 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 5 | A | 0.421209 | S | 0.499509 | -0.0783 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 9 | L | 0.221209 | Q | 0.376859 | -0.15565 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 9 | L | 0.221209 | V | 0.249158 | -0.027949 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 13 | G | 0.220711 | R | 0.193515 | 0.027196 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 15 | V | 0.22512 | G | 0.361979 | -0.136859 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 22 | E | 0.492845 | G | 0.446894 | 0.045951 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 39 | L | 0.324647 | R | 0.416137 | -0.09149 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 46 | F | 0.326945 | C | 0.323574 | 0.003371 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 50 | E | 0.398871 | K | 0.400345 | -0.001474 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 66 | N | 0.653803 | S | 0.703017 | -0.049214 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 68 | L | 0.715147 | R | 0.798705 | -0.083558 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 77 | D | 0.779626 | Y | 0.686537 | 0.093089 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 85 | L | 0.581309 | F | 0.550156 | 0.031153 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 87 | N | 0.561633 | S | 0.632969 | -0.071336 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 90 | A | 0.542483 | V | 0.492181 | 0.050302 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 91 | D | 0.545805 | V | 0.38682 | 0.158985 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 101 | E | 0.445889 | K | 0.450579 | -0.00469 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 106 | S | 0.385525 | L | 0.241015 | 0.14451 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 109 | G | 0.326535 | V | 0.233622 | 0.092913 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 113 | I | 0.283172 | M | 0.336189 | -0.053017 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 115 | G | 0.263289 | A | 0.217063 | 0.046226 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 127 | L | 0.658223 | S | 0.739131 | -0.080908 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 147 | C | 0.255682 | R | 0.444634 | -0.188952 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 81 | H | 0.684057 | A | 0.658822 | 0.025235 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 21 | F | 0.425664 | C | 0.416013 | 0.009651 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 23 | Q | 0.533194 | L | 0.378097 | 0.155097 | D to O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 49 | H | 0.380623 | R | 0.363604 | 0.017019 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 55 | T | 0.499368 | R | 0.503414 | -0.004046 | O to D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 88 | V | 0.553425 | A | 0.615173 | -0.061748 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 90 | A | 0.542483 | T | 0.577287 | -0.034804 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 98 | V | 0.454681 | M | 0.48744 | -0.032759 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 119 | V | 0.291598 | L | 0.298698 | -0.0071 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 125 | D | 0.59265 | G | 0.581962 | 0.010688 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 148 | G | 0.270787 | R | 0.26662 | 0.004167 | No Change: Both O | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 96 | A | 0.475667 | G | 0.536778 | -0.061111 | O to D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P00441 | SODC_HUMAN Superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD1 PE=1 SV=2 | 68 | L | 0.715147 | P | 0.821743 | -0.106596 | No Change: Both D | Amyotrophic lateral sclerosis type 1 (ALS1) [MIM:105400] |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 82 | I | 0.177073 | T | 0.304168 | -0.127095 | No Change: Both O | - |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 16 | A | 0.368934 | V | 0.263811 | 0.105123 | No Change: Both O | - |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 10 | S | 0.415021 | I | 0.165023 | 0.249998 | No Change: Both O | - |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 66 | E | 0.459613 | V | 0.283289 | 0.176324 | No Change: Both O | - |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 156 | R | 0.259205 | W | 0.123337 | 0.135868 | No Change: Both O | - |
| P04179 | SODM_HUMAN Superoxide dismutase [Mn] mitochondrial OS=Homo sapiens GN=SOD2 PE=1 SV=2 | 76 | G | 0.348627 | R | 0.336493 | 0.012134 | No Change: Both O | - |
| P08294 | SODE_HUMAN Extracellular superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD3 PE=1 SV=2 | 231 | R | 0.943453 | G | 0.928728 | 0.014725 | No Change: Both D | - |
| P08294 | SODE_HUMAN Extracellular superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD3 PE=1 SV=2 | 58 | A | 0.425838 | T | 0.433617 | -0.007779 | No Change: Both O | - |
| P08294 | SODE_HUMAN Extracellular superoxide dismutase [Cu-Zn] OS=Homo sapiens GN=SOD3 PE=1 SV=2 | 91 | A | 0.284265 | T | 0.288517 | -0.004252 | No Change: Both O | - |
| Q5JUK2 | SOLH1_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 OS=Homo sapiens GN=SOHLH1 PE=1 SV=4 | 37 | R | 0.9321 | Q | 0.9156 | 0.0165 | No Change: Both D | - |
| Q5JUK2 | SOLH1_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 OS=Homo sapiens GN=SOHLH1 PE=1 SV=4 | 269 | P | 0.786003 | S | 0.766426 | 0.019577 | No Change: Both D | - |
| Q5JUK2 | SOLH1_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 OS=Homo sapiens GN=SOHLH1 PE=1 SV=4 | 31 | C | 0.900764 | R | 0.925137 | -0.024373 | No Change: Both D | - |
| Q5JUK2 | SOLH1_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 OS=Homo sapiens GN=SOHLH1 PE=1 SV=4 | 177 | P | 0.815596 | T | 0.759261 | 0.056335 | No Change: Both D | - |
| Q9NX45 | SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 OS=Homo sapiens GN=SOHLH2 PE=2 SV=2 | 14 | S | 0.250645 | L | 0.119528 | 0.131117 | No Change: Both O | - |
| Q9NX45 | SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 OS=Homo sapiens GN=SOHLH2 PE=2 SV=2 | 339 | A | 0.742356 | T | 0.752566 | -0.01021 | No Change: Both D | - |
| P18583 | SON_HUMAN Protein SON OS=Homo sapiens GN=SON PE=1 SV=4 | 870 | T | 0.99466 | A | 0.994291 | 3.69E-04 | No Change: Both D | - |
| P18583 | SON_HUMAN Protein SON OS=Homo sapiens GN=SON PE=1 SV=4 | 1575 | R | 0.653512 | C | 0.583461 | 0.070051 | No Change: Both D | - |
| P18583 | SON_HUMAN Protein SON OS=Homo sapiens GN=SON PE=1 SV=4 | 473 | P | 0.977452 | S | 0.9686 | 0.008852 | No Change: Both D | - |
| P18583 | SON_HUMAN Protein SON OS=Homo sapiens GN=SON PE=1 SV=4 | 555 | T | 0.877086 | M | 0.860597 | 0.016489 | No Change: Both D | - |
| P18583 | SON_HUMAN Protein SON OS=Homo sapiens GN=SON PE=1 SV=4 | 1202 | S | 0.997487 | L | 0.994828 | 0.002659 | No Change: Both D | - |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 74 | R | 0.756605 | W | 0.60197 | 0.154635 | No Change: Both D | - |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 237 | T | 0.976627 | A | 0.977073 | -4.46E-04 | No Change: Both D | - |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 195 | T | 0.683594 | A | 0.657227 | 0.026367 | No Change: Both D | A breast cancer sample |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 61 | L | 0.444638 | P | 0.579541 | -0.134903 | O to D | - |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 175 | G | 0.684548 | V | 0.616913 | 0.067635 | No Change: Both D | - |
| Q9BX66 | SRBS1_HUMAN Sorbin and SH3 domain-containing protein 1 OS=Homo sapiens GN=SORBS1 PE=1 SV=3 | 485 | Y | 0.941146 | C | 0.950113 | -0.008967 | No Change: Both D | - |
| O94875 | SRBS2_HUMAN Sorbin and SH3 domain-containing protein 2 OS=Homo sapiens GN=SORBS2 PE=1 SV=3 | 1048 | A | 0.3487 | V | 0.311476 | 0.037224 | No Change: Both O | - |
| O60504 | VINEX_HUMAN Vinexin OS=Homo sapiens GN=SORBS3 PE=1 SV=2 | 556 | I | 0.982514 | T | 0.991452 | -0.008938 | No Change: Both D | - |
| O60504 | VINEX_HUMAN Vinexin OS=Homo sapiens GN=SORBS3 PE=1 SV=2 | 573 | T | 0.981093 | A | 0.976316 | 0.004777 | No Change: Both D | - |
| O60504 | VINEX_HUMAN Vinexin OS=Homo sapiens GN=SORBS3 PE=1 SV=2 | 255 | P | 0.83647 | L | 0.741664 | 0.094806 | No Change: Both D | - |
| Q8WY21 | SORC1_HUMAN VPS10 domain-containing receptor SorCS1 OS=Homo sapiens GN=SORCS1 PE=2 SV=3 | 223 | K | 0.359599 | N | 0.319974 | 0.039625 | No Change: Both O | A breast cancer sample |
| Q96PQ0 | SORC2_HUMAN VPS10 domain-containing receptor SorCS2 OS=Homo sapiens GN=SORCS2 PE=1 SV=3 | 345 | G | 0.351706 | R | 0.319572 | 0.032134 | No Change: Both O | - |
| Q96PQ0 | SORC2_HUMAN VPS10 domain-containing receptor SorCS2 OS=Homo sapiens GN=SORCS2 PE=1 SV=3 | 695 | T | 0.779644 | M | 0.757951 | 0.021693 | No Change: Both D | - |
| Q96PQ0 | SORC2_HUMAN VPS10 domain-containing receptor SorCS2 OS=Homo sapiens GN=SORCS2 PE=1 SV=3 | 745 | T | 0.447754 | I | 0.304232 | 0.143522 | No Change: Both O | - |
| Q00796 | DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens GN=SORD PE=1 SV=4 | 239 | Q | 0.505516 | L | 0.366867 | 0.138649 | D to O | - |
| Q00796 | DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens GN=SORD PE=1 SV=4 | 269 | N | 0.253654 | T | 0.235588 | 0.018066 | No Change: Both O | - |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 528 | A | 0.391112 | T | 0.398302 | -0.00719 | No Change: Both O | - |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 1074 | Q | 0.497823 | E | 0.519207 | -0.021384 | O to D | - |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 1967 | V | 0.137644 | I | 0.116407 | 0.021237 | No Change: Both O | - |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 120 | L | 0.167993 | S | 0.328797 | -0.160804 | No Change: Both O | A breast cancer sample |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 1581 | M | 0.498016 | L | 0.418254 | 0.079762 | No Change: Both O | A breast cancer sample |
| Q92673 | SORL_HUMAN Sortilin-related receptor OS=Homo sapiens GN=SORL1 PE=1 SV=2 | 1972 | L | 0.28673 | V | 0.29994 | -0.01321 | No Change: Both O | A colorectal cancer sample |
| Q99523 | SORT_HUMAN Sortilin OS=Homo sapiens GN=SORT1 PE=1 SV=3 | 358 | D | 0.20163 | Y | 0.101438 | 0.100192 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 108 | E | 0.397876 | K | 0.407499 | -0.009623 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 266 | T | 0.48223 | K | 0.544663 | -0.062433 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 269 | M | 0.656806 | R | 0.690203 | -0.033397 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 309 | D | 0.292587 | Y | 0.163099 | 0.129488 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 337 | Y | 0.104177 | C | 0.092254 | 0.011923 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 432 | W | 0.407968 | R | 0.624655 | -0.216687 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 433 | E | 0.388511 | K | 0.406867 | -0.018356 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 434 | G | 0.366823 | R | 0.340745 | 0.026078 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 441 | C | 0.166132 | Y | 0.1509 | 0.015232 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 548 | S | 0.394682 | R | 0.355228 | 0.039454 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 550 | L | 0.448662 | P | 0.558748 | -0.110086 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 552 | R | 0.470189 | G | 0.407173 | 0.063016 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 552 | R | 0.470189 | K | 0.500235 | -0.030046 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 552 | R | 0.470189 | S | 0.51912 | -0.048931 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 655 | P | 0.696736 | L | 0.55814 | 0.138596 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 702 | Y | 0.179427 | H | 0.290971 | -0.111544 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 729 | W | 0.300618 | L | 0.377195 | -0.076577 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 733 | I | 0.241022 | F | 0.224311 | 0.016711 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 846 | E | 0.394974 | K | 0.371442 | 0.023532 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 977 | Q | 0.298813 | R | 0.282165 | 0.016648 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 1320 | H | 0.964567 | R | 0.969375 | -0.004808 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 269 | M | 0.656806 | T | 0.699333 | -0.042527 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 477 | Q | 0.507594 | R | 0.508914 | -0.00132 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 497 | R | 0.267626 | Q | 0.290042 | -0.022416 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 37 | T | 0.499979 | A | 0.481613 | 0.018366 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 102 | P | 0.536219 | R | 0.509382 | 0.026837 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 112 | P | 0.250471 | R | 0.20776 | 0.042711 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 170 | K | 0.176253 | E | 0.173136 | 0.003117 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 252 | I | 0.165683 | T | 0.249605 | -0.083922 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 378 | T | 0.424661 | A | 0.45835 | -0.033689 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 422 | M | 0.589281 | V | 0.465398 | 0.123883 | D to O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 424 | E | 0.513817 | K | 0.540661 | -0.026844 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 434 | G | 0.366823 | K | 0.425096 | -0.058273 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 437 | I | 0.245309 | T | 0.35282 | -0.107511 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 478 | P | 0.561463 | L | 0.43446 | 0.127003 | D to O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 478 | P | 0.561463 | R | 0.534738 | 0.026725 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 482 | G | 0.552322 | R | 0.552873 | -5.51E-04 | No Change: Both D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 490 | L | 0.411918 | R | 0.564944 | -0.153026 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 549 | T | 0.433519 | K | 0.506403 | -0.072884 | O to D | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 552 | R | 0.470189 | M | 0.442948 | 0.027241 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 552 | R | 0.470189 | T | 0.444604 | 0.025585 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 569 | L | 0.657672 | V | 0.653382 | 0.00429 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 623 | F | 0.156341 | I | 0.145674 | 0.010667 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 708 | A | 0.220044 | T | 0.244513 | -0.024469 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 784 | I | 0.183822 | T | 0.296986 | -0.113164 | No Change: Both O | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 894 | P | 0.4981 | R | 0.480414 | 0.017686 | No Change: Both O | Noonan syndrome type 4 (NS4) [MIM:610733] |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 1011 | N | 0.763695 | S | 0.788111 | -0.024416 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 1131 | R | 0.848164 | K | 0.863062 | -0.014898 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 1140 | L | 0.903057 | I | 0.902236 | 8.21E-04 | No Change: Both D | - |
| Q07889 | SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens GN=SOS1 PE=1 SV=1 | 1257 | T | 0.993412 | A | 0.991815 | 0.001597 | No Change: Both D | - |
| Q07890 | SOS2_HUMAN Son of sevenless homolog 2 OS=Homo sapiens GN=SOS2 PE=1 SV=2 | 672 | L | 0.410168 | I | 0.395928 | 0.01424 | No Change: Both O | - |
| Q07890 | SOS2_HUMAN Son of sevenless homolog 2 OS=Homo sapiens GN=SOS2 PE=1 SV=2 | 483 | S | 0.440898 | N | 0.38887 | 0.052028 | No Change: Both O | - |
| Q07890 | SOS2_HUMAN Son of sevenless homolog 2 OS=Homo sapiens GN=SOS2 PE=1 SV=2 | 508 | H | 0.472162 | Y | 0.329521 | 0.142641 | No Change: Both O | - |
| Q9BQB4 | SOST_HUMAN Sclerostin OS=Homo sapiens GN=SOST PE=1 SV=1 | 167 | C | 0.64951 | R | 0.729171 | -0.079661 | No Change: Both D | Sclerosteosis type 1 (SOST1) [MIM:269500] |
| Q9BQB4 | SOST_HUMAN Sclerostin OS=Homo sapiens GN=SOST PE=1 SV=1 | 21 | V | 0.160315 | L | 0.150324 | 0.009991 | No Change: Both O | Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860] |
| Q9BQB4 | SOST_HUMAN Sclerostin OS=Homo sapiens GN=SOST PE=1 SV=1 | 21 | V | 0.160315 | M | 0.188015 | -0.0277 | No Change: Both O | Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860] |
| Q6X4U4 | SOSD1_HUMAN Sclerostin domain-containing protein 1 OS=Homo sapiens GN=SOSTDC1 PE=1 SV=2 | 189 | Q | 0.965402 | H | 0.965408 | -6.00E-06 | No Change: Both D | - |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 135 | S | 0.431458 | T | 0.384768 | 0.04669 | No Change: Both O | Yemenite deaf-blind hypopigmentation syndrome (YDBHS) [MIM:601706] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 106 | R | 0.485859 | W | 0.306121 | 0.179738 | No Change: Both O | Waardenburg syndrome type 4C (WS4C) [MIM:613266] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 112 | M | 0.156916 | I | 0.086255 | 0.070661 | No Change: Both O | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 112 | M | 0.156916 | I | 0.086255 | 0.070661 | No Change: Both O | Waardenburg syndrome type 2E (WS2E) [MIM:611584] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 131 | N | 0.42119 | H | 0.428057 | -0.006867 | No Change: Both O | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 145 | L | 0.459507 | P | 0.582927 | -0.12342 | O to D | Waardenburg syndrome type 4C (WS4C) [MIM:613266] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 150 | K | 0.622183 | N | 0.582298 | 0.039885 | No Change: Both D | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 157 | A | 0.721596 | V | 0.64757 | 0.074026 | No Change: Both D | Waardenburg syndrome type 4C (WS4C) [MIM:613266] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 161 | R | 0.789025 | H | 0.758769 | 0.030256 | No Change: Both D | Waardenburg syndrome type 2E (WS2E) [MIM:611584] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 174 | Q | 0.91555 | P | 0.926752 | -0.011202 | No Change: Both D | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 175 | P | 0.918064 | A | 0.889288 | 0.028776 | No Change: Both D | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 175 | P | 0.918064 | L | 0.846709 | 0.071355 | No Change: Both D | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 175 | P | 0.918064 | R | 0.915807 | 0.002257 | No Change: Both D | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| P56693 | SOX10_HUMAN Transcription factor SOX-10 OS=Homo sapiens GN=SOX10 PE=1 SV=1 | 321 | G | 0.456713 | R | 0.408639 | 0.048074 | No Change: Both O | Peripheral demyelinating neuropathy central dysmyelinating leukodystrophy Waardenburg syndrome and Hirschsprung disease (PCWH) [MIM:609136] |
| Q9UN79 | SOX13_HUMAN Transcription factor SOX-13 OS=Homo sapiens GN=SOX13 PE=1 SV=3 | 532 | P | 0.59544 | S | 0.60782 | -0.01238 | No Change: Both D | - |
| Q9H6I2 | SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens GN=SOX17 PE=1 SV=1 | 178 | G | 0.702235 | C | 0.592584 | 0.109651 | No Change: Both D | Vesicoureteral reflux type 3 (VUR3) [MIM:613674] |
| Q9H6I2 | SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens GN=SOX17 PE=1 SV=1 | 259 | Y | 0.921523 | N | 0.936878 | -0.015355 | No Change: Both D | Vesicoureteral reflux type 3 (VUR3) [MIM:613674] |
| P35713 | SOX18_HUMAN Transcription factor SOX-18 OS=Homo sapiens GN=SOX18 PE=1 SV=2 | 95 | W | 0.485775 | R | 0.727305 | -0.24153 | O to D | Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) [MIM:607823] |
| P35713 | SOX18_HUMAN Transcription factor SOX-18 OS=Homo sapiens GN=SOX18 PE=1 SV=2 | 104 | A | 0.585549 | P | 0.644914 | -0.059365 | No Change: Both D | Hypotrichosis-lymphedema-telangiectasia syndrome (HLTS) [MIM:607823] |
| Q9Y651 | SOX21_HUMAN Transcription factor SOX-21 OS=Homo sapiens GN=SOX21 PE=2 SV=1 | 230 | G | 0.855162 | R | 0.833742 | 0.02142 | No Change: Both D | - |
| P41225 | SOX3_HUMAN Transcription factor SOX-3 OS=Homo sapiens GN=SOX3 PE=1 SV=2 | 43 | A | 0.93899 | T | 0.940181 | -0.001191 | No Change: Both D | - |
| O94993 | SOX30_HUMAN Transcription factor SOX-30 OS=Homo sapiens GN=SOX30 PE=1 SV=1 | 749 | V | 0.875748 | M | 0.891609 | -0.015861 | No Change: Both D | - |
| O94993 | SOX30_HUMAN Transcription factor SOX-30 OS=Homo sapiens GN=SOX30 PE=1 SV=1 | 429 | Q | 0.553408 | K | 0.579096 | -0.025688 | No Change: Both D | - |
| P35711 | SOX5_HUMAN Transcription factor SOX-5 OS=Homo sapiens GN=SOX5 PE=1 SV=3 | 362 | Q | 0.755794 | P | 0.782923 | -0.027129 | No Change: Both D | - |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 108 | P | 0.411882 | L | 0.255975 | 0.155907 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 112 | F | 0.210861 | L | 0.261026 | -0.050165 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 112 | F | 0.210861 | S | 0.424701 | -0.21384 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 119 | A | 0.281982 | V | 0.214029 | 0.067953 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 143 | W | 0.345418 | R | 0.597246 | -0.251828 | O to D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 152 | R | 0.667887 | P | 0.684751 | -0.016864 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 170 | P | 0.857886 | R | 0.856543 | 0.001343 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 154 | F | 0.688442 | L | 0.753779 | -0.065337 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 158 | A | 0.724711 | T | 0.749734 | -0.025023 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 165 | H | 0.822088 | Y | 0.759595 | 0.062493 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 76 | A | 0.360929 | E | 0.501447 | -0.140518 | O to D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 113 | M | 0.161006 | T | 0.166956 | -0.00595 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 113 | M | 0.161006 | V | 0.118456 | 0.04255 | No Change: Both O | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 165 | H | 0.822088 | Q | 0.84872 | -0.026632 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 170 | P | 0.857886 | L | 0.771328 | 0.086558 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P48436 | SOX9_HUMAN Transcription factor SOX-9 OS=Homo sapiens GN=SOX9 PE=1 SV=1 | 173 | K | 0.864352 | E | 0.864535 | -1.83E-04 | No Change: Both D | Campomelic dysplasia (CMD1) [MIM:114290] |
| P08047 | SP1_HUMAN Transcription factor Sp1 OS=Homo sapiens GN=SP1 PE=1 SV=3 | 737 | T | 0.722587 | A | 0.70663 | 0.015957 | No Change: Both D | - |
| P23497 | SP100_HUMAN Nuclear autoantigen Sp-100 OS=Homo sapiens GN=SP100 PE=1 SV=3 | 433 | M | 0.975307 | V | 0.963879 | 0.011428 | No Change: Both D | - |
| P23497 | SP100_HUMAN Nuclear autoantigen Sp-100 OS=Homo sapiens GN=SP100 PE=1 SV=3 | 471 | S | 0.984288 | P | 0.98251 | 0.001778 | No Change: Both D | - |
| P23497 | SP100_HUMAN Nuclear autoantigen Sp-100 OS=Homo sapiens GN=SP100 PE=1 SV=3 | 699 | E | 0.852995 | G | 0.781204 | 0.071791 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 112 | W | 0.331517 | R | 0.526779 | -0.195262 | O to D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 128 | A | 0.703122 | V | 0.660297 | 0.042825 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 206 | A | 0.905797 | V | 0.892773 | 0.013024 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 207 | E | 0.906535 | K | 0.900649 | 0.005886 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 212 | E | 0.901203 | G | 0.855516 | 0.045687 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 249 | M | 0.978591 | V | 0.970327 | 0.008264 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 267 | E | 0.995514 | G | 0.994034 | 0.00148 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 299 | G | 0.96549 | R | 0.972413 | -0.006923 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 367 | T | 0.942447 | M | 0.937898 | 0.004549 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 425 | L | 0.973576 | S | 0.988282 | -0.014706 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 523 | M | 0.532568 | T | 0.592895 | -0.060327 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 579 | M | 0.598386 | I | 0.477582 | 0.120804 | D to O | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 8 | M | 0.421567 | T | 0.472743 | -0.051176 | No Change: Both O | A breast cancer sample |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 683 | G | 0.384171 | S | 0.415542 | -0.031371 | No Change: Both O | A breast cancer sample |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 173 | S | 0.976007 | L | 0.96079 | 0.015217 | No Change: Both D | - |
| Q9HB58 | SP110_HUMAN Sp110 nuclear body protein OS=Homo sapiens GN=SP110 PE=1 SV=5 | 210 | S | 0.904222 | A | 0.862338 | 0.041884 | No Change: Both D | - |
| Q13342 | LY10_HUMAN Nuclear body protein SP140 OS=Homo sapiens GN=SP140 PE=2 SV=2 | 356 | L | 0.900664 | F | 0.887785 | 0.012879 | No Change: Both D | - |
| Q13342 | LY10_HUMAN Nuclear body protein SP140 OS=Homo sapiens GN=SP140 PE=2 SV=2 | 512 | M | 0.96138 | T | 0.958081 | 0.003299 | No Change: Both D | - |
| Q13342 | LY10_HUMAN Nuclear body protein SP140 OS=Homo sapiens GN=SP140 PE=2 SV=2 | 516 | E | 0.971552 | K | 0.977045 | -0.005493 | No Change: Both D | - |
| Q13342 | LY10_HUMAN Nuclear body protein SP140 OS=Homo sapiens GN=SP140 PE=2 SV=2 | 558 | R | 0.925622 | C | 0.869127 | 0.056495 | No Change: Both D | - |
| Q9H930 | LY10L_HUMAN Nuclear body protein SP140-like protein OS=Homo sapiens GN=SP140L PE=2 SV=2 | 88 | M | 0.47942 | T | 0.531945 | -0.052525 | O to D | - |
| Q9H930 | LY10L_HUMAN Nuclear body protein SP140-like protein OS=Homo sapiens GN=SP140L PE=2 SV=2 | 225 | T | 0.955516 | M | 0.956361 | -8.45E-04 | No Change: Both D | - |
| Q9H930 | LY10L_HUMAN Nuclear body protein SP140-like protein OS=Homo sapiens GN=SP140L PE=2 SV=2 | 377 | P | 0.681822 | S | 0.681324 | 4.98E-04 | No Change: Both D | - |
| Q02447 | SP3_HUMAN Transcription factor Sp3 OS=Homo sapiens GN=SP3 PE=1 SV=3 | 164 | T | 0.825082 | A | 0.821599 | 0.003483 | No Change: Both D | - |
| Q02446 | SP4_HUMAN Transcription factor Sp4 OS=Homo sapiens GN=SP4 PE=1 SV=2 | 197 | Q | 0.711227 | K | 0.648734 | 0.062493 | No Change: Both D | - |
| Q6BEB4 | SP5_HUMAN Transcription factor Sp5 OS=Homo sapiens GN=SP5 PE=2 SV=1 | 75 | A | 0.86348 | T | 0.866441 | -0.002961 | No Change: Both D | - |
| Q3SY56 | SP6_HUMAN Transcription factor Sp6 OS=Homo sapiens GN=SP6 PE=1 SV=1 | 156 | V | 0.778059 | I | 0.767785 | 0.010274 | No Change: Both D | - |
| Q9HBV2 | SACA1_HUMAN Sperm acrosome membrane-associated protein 1 OS=Homo sapiens GN=SPACA1 PE=1 SV=1 | 237 | L | 0.001628 | S | 0.003898 | -0.00227 | No Change: Both O | - |
| Q8IXA5 | SACA3_HUMAN Sperm acrosome membrane-associated protein 3 OS=Homo sapiens GN=SPACA3 PE=1 SV=1 | 80 | C | 0.116907 | Y | 0.121007 | -0.0041 | No Change: Both O | - |
| Q8IXA5 | SACA3_HUMAN Sperm acrosome membrane-associated protein 3 OS=Homo sapiens GN=SPACA3 PE=1 SV=1 | 100 | H | 0.136734 | R | 0.14725 | -0.010516 | No Change: Both O | - |
| Q8IXA5 | SACA3_HUMAN Sperm acrosome membrane-associated protein 3 OS=Homo sapiens GN=SPACA3 PE=1 SV=1 | 128 | A | 0.276906 | T | 0.292136 | -0.01523 | No Change: Both O | - |
| Q96KW9 | SPAC7_HUMAN Protein SPACA7 OS=Homo sapiens GN=SPACA7 PE=2 SV=2 | 111 | V | 0.537371 | D | 0.695034 | -0.157663 | No Change: Both D | - |
| Q96KW9 | SPAC7_HUMAN Protein SPACA7 OS=Homo sapiens GN=SPACA7 PE=2 SV=2 | 25 | R | 0.33282 | W | 0.166972 | 0.165848 | No Change: Both O | A colorectal cancer sample |
| Q07617 | SPAG1_HUMAN Sperm-associated antigen 1 OS=Homo sapiens GN=SPAG1 PE=1 SV=3 | 331 | E | 0.926596 | K | 0.925635 | 9.61E-04 | No Change: Both D | - |
| Q07617 | SPAG1_HUMAN Sperm-associated antigen 1 OS=Homo sapiens GN=SPAG1 PE=1 SV=3 | 777 | M | 0.956108 | T | 0.95553 | 5.78E-04 | No Change: Both D | - |
| Q07617 | SPAG1_HUMAN Sperm-associated antigen 1 OS=Homo sapiens GN=SPAG1 PE=1 SV=3 | 827 | H | 0.16805 | Y | 0.106706 | 0.061344 | No Change: Both O | - |
| Q08648 | SG11B_HUMAN Sperm-associated antigen 11B OS=Homo sapiens GN=SPAG11B PE=2 SV=4 | 77 | R | 0.525724 | Q | 0.532481 | -0.006757 | No Change: Both D | - |
| Q08648 | SG11B_HUMAN Sperm-associated antigen 11B OS=Homo sapiens GN=SPAG11B PE=2 SV=4 | 89 | D | 0.196445 | G | 0.215312 | -0.018867 | No Change: Both O | - |
| Q8N0X2 | SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens GN=SPAG16 PE=2 SV=2 | 361 | Q | 0.320022 | H | 0.321904 | -0.001882 | No Change: Both O | - |
| Q8N0X2 | SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens GN=SPAG16 PE=2 SV=2 | 425 | K | 0.108656 | T | 0.08957 | 0.019086 | No Change: Both O | - |
| Q8N0X2 | SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens GN=SPAG16 PE=2 SV=2 | 324 | P | 0.794454 | T | 0.729052 | 0.065402 | No Change: Both D | - |
| Q6Q759 | SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens GN=SPAG17 PE=1 SV=1 | 143 | R | 0.852393 | Q | 0.867905 | -0.015512 | No Change: Both D | - |
| Q6Q759 | SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens GN=SPAG17 PE=1 SV=1 | 158 | E | 0.9883 | V | 0.979052 | 0.009248 | No Change: Both D | - |
| Q6Q759 | SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens GN=SPAG17 PE=1 SV=1 | 1253 | T | 0.217833 | P | 0.276928 | -0.059095 | No Change: Both O | - |
| Q6Q759 | SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens GN=SPAG17 PE=1 SV=1 | 1348 | P | 0.977132 | L | 0.956754 | 0.020378 | No Change: Both D | - |
| Q6Q759 | SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens GN=SPAG17 PE=1 SV=1 | 1707 | D | 0.590082 | E | 0.669719 | -0.079637 | No Change: Both D | A colorectal cancer sample |
| O75602 | SPAG6_HUMAN Sperm-associated antigen 6 OS=Homo sapiens GN=SPAG6 PE=1 SV=1 | 216 | Q | 0.233513 | R | 0.196195 | 0.037318 | No Change: Both O | - |
| O75602 | SPAG6_HUMAN Sperm-associated antigen 6 OS=Homo sapiens GN=SPAG6 PE=1 SV=1 | 106 | V | 0.145994 | L | 0.144797 | 0.001197 | No Change: Both O | A breast cancer sample |
| Q99932 | SPAG8_HUMAN Sperm-associated antigen 8 OS=Homo sapiens GN=SPAG8 PE=1 SV=2 | 69 | A | 0.969363 | T | 0.970481 | -0.001118 | No Change: Both D | - |
| O60271 | JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens GN=SPAG9 PE=1 SV=4 | 1320 | N | 0.652088 | S | 0.66109 | -0.009002 | No Change: Both D | - |
| P38567 | HYALP_HUMAN Hyaluronidase PH-20 OS=Homo sapiens GN=SPAM1 PE=1 SV=1 | 47 | V | 0.071268 | A | 0.104296 | -0.033028 | No Change: Both O | - |
| P38567 | HYALP_HUMAN Hyaluronidase PH-20 OS=Homo sapiens GN=SPAM1 PE=1 SV=1 | 5 | K | 0.386007 | Q | 0.321394 | 0.064613 | No Change: Both O | - |
| Q9NS25 | SPNXB_HUMAN Sperm protein associated with the nucleus on the X chromosome B/F OS=Homo sapiens GN=SPANXB1 PE=2 SV=1 | 74 | V | 0.835664 | L | 0.836413 | -7.49E-04 | No Change: Both D | - |
| Q9NY87 | SPNXC_HUMAN Sperm protein associated with the nucleus on the X chromosome C OS=Homo sapiens GN=SPANXC PE=2 SV=1 | 59 | V | 0.80982 | F | 0.783391 | 0.026429 | No Change: Both D | - |
| Q9NY87 | SPNXC_HUMAN Sperm protein associated with the nucleus on the X chromosome C OS=Homo sapiens GN=SPANXC PE=2 SV=1 | 59 | V | 0.80982 | L | 0.822637 | -0.012817 | No Change: Both D | - |
| Q9BXN6 | SPNXD_HUMAN Sperm protein associated with the nucleus on the X chromosome D OS=Homo sapiens GN=SPANXD PE=2 SV=1 | 68 | V | 0.733006 | L | 0.748911 | -0.015905 | No Change: Both D | - |
| Q8TAD1 | SPNXE_HUMAN Sperm protein associated with the nucleus on the X chromosome E OS=Homo sapiens GN=SPANXE PE=2 SV=1 | 68 | V | 0.781054 | L | 0.78863 | -0.007576 | No Change: Both D | - |
| Q5MJ10 | SPXN2_HUMAN Sperm protein associated with the nucleus on the X chromosome N2 OS=Homo sapiens GN=SPANXN2 PE=2 SV=1 | 8 | T | 0.99569 | I | 0.991598 | 0.004092 | No Change: Both D | - |
| Q5MJ09 | SPXN3_HUMAN Sperm protein associated with the nucleus on the X chromosome N3 OS=Homo sapiens GN=SPANXN3 PE=2 SV=1 | 43 | K | 0.616607 | N | 0.587381 | 0.029226 | No Change: Both D | - |
| Q5MJ09 | SPXN3_HUMAN Sperm protein associated with the nucleus on the X chromosome N3 OS=Homo sapiens GN=SPANXN3 PE=2 SV=1 | 89 | V | 0.988537 | I | 0.99034 | -0.001803 | No Change: Both D | - |
| Q5MJ08 | SPXN4_HUMAN Sperm protein associated with the nucleus on the X chromosome N4 OS=Homo sapiens GN=SPANXN4 PE=2 SV=1 | 48 | K | 0.896857 | N | 0.878354 | 0.018503 | No Change: Both D | - |
| P09486 | SPRC_HUMAN SPARC OS=Homo sapiens GN=SPARC PE=1 SV=1 | 19 | P | 0.490115 | S | 0.504225 | -0.01411 | O to D | - |
| P09486 | SPRC_HUMAN SPARC OS=Homo sapiens GN=SPARC PE=1 SV=1 | 70 | N | 0.853398 | S | 0.851577 | 0.001821 | No Change: Both D | - |
| Q14515 | SPRL1_HUMAN SPARC-like protein 1 OS=Homo sapiens GN=SPARCL1 PE=1 SV=2 | 49 | A | 0.954511 | D | 0.959974 | -0.005463 | No Change: Both D | - |
| Q14515 | SPRL1_HUMAN SPARC-like protein 1 OS=Homo sapiens GN=SPARCL1 PE=1 SV=2 | 419 | T | 0.942931 | A | 0.947889 | -0.004958 | No Change: Both D | - |
| Q14515 | SPRL1_HUMAN SPARC-like protein 1 OS=Homo sapiens GN=SPARCL1 PE=1 SV=2 | 106 | H | 0.913694 | D | 0.942448 | -0.028754 | No Change: Both D | - |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 44 | S | 0.700792 | L | 0.668182 | 0.03261 | No Change: Both D | - |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 362 | S | 0.176422 | C | 0.083624 | 0.092798 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 424 | R | 0.153602 | G | 0.163282 | -0.00968 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 448 | C | 0.410283 | Y | 0.41602 | -0.005737 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 499 | R | 0.134449 | C | 0.066725 | 0.067724 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 584 | D | 0.547667 | H | 0.476679 | 0.070988 | D to O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 378 | L | 0.289552 | Q | 0.399485 | -0.109933 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 386 | N | 0.489435 | S | 0.538186 | -0.048751 | O to D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 390 | M | 0.438395 | V | 0.392736 | 0.045659 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 503 | R | 0.181558 | L | 0.114463 | 0.067095 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 534 | L | 0.534629 | P | 0.669779 | -0.13515 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 614 | T | 0.705263 | I | 0.627634 | 0.077629 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 344 | I | 0.290355 | K | 0.510853 | -0.220498 | O to D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 407 | S | 0.293028 | R | 0.220548 | 0.07248 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 551 | A | 0.577957 | Y | 0.458309 | 0.119648 | D to O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 615 | T | 0.767663 | I | 0.697411 | 0.070252 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 195 | L | 0.526911 | V | 0.503916 | 0.022995 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 406 | I | 0.296544 | V | 0.338354 | -0.04181 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 493 | D | 0.421519 | G | 0.403348 | 0.018171 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 499 | R | 0.134449 | H | 0.103474 | 0.030975 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 503 | R | 0.181558 | W | 0.060161 | 0.121397 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 607 | W | 0.163485 | C | 0.228254 | -0.064769 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 45 | P | 0.671802 | Q | 0.637821 | 0.033981 | No Change: Both D | - |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 347 | Q | 0.341729 | K | 0.384525 | -0.042796 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 361 | P | 0.174802 | L | 0.094419 | 0.080383 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 370 | G | 0.32923 | R | 0.343939 | -0.014709 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 381 | F | 0.349561 | C | 0.343094 | 0.006467 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 386 | N | 0.489435 | K | 0.550496 | -0.061061 | O to D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 388 | K | 0.492221 | R | 0.429142 | 0.063079 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 399 | S | 0.355971 | L | 0.200928 | 0.155043 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 426 | L | 0.128198 | V | 0.12907 | -8.72E-04 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 435 | P | 0.163348 | L | 0.103173 | 0.060175 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 436 | S | 0.172779 | F | 0.079915 | 0.092864 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 441 | D | 0.174819 | G | 0.146932 | 0.027887 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 459 | R | 0.555549 | G | 0.546898 | 0.008651 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 460 | R | 0.498464 | C | 0.343775 | 0.154689 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 460 | R | 0.498464 | L | 0.378891 | 0.119573 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 470 | D | 0.342478 | V | 0.214195 | 0.128283 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 485 | A | 0.314299 | V | 0.26678 | 0.047519 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 489 | P | 0.452507 | L | 0.32852 | 0.123987 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 512 | E | 0.365918 | D | 0.324484 | 0.041434 | No Change: Both O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 555 | D | 0.563749 | N | 0.526422 | 0.037327 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 556 | A | 0.551337 | V | 0.428713 | 0.122624 | D to O | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 559 | G | 0.553454 | D | 0.615178 | -0.061724 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 562 | R | 0.594052 | G | 0.577955 | 0.016097 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 562 | R | 0.594052 | Q | 0.605843 | -0.011791 | No Change: Both D | Spastic paraplegia autosomal dominant type 4 (SPG4) [MIM:182601] |
| Q9UBP0 | SPAST_HUMAN Spastin OS=Homo sapiens GN=SPAST PE=1 SV=1 | 423 | V | 0.196007 | L | 0.198222 | -0.002215 | No Change: Both O | A breast cancer sample |
| Q5VX52 | SPAT1_HUMAN Spermatogenesis-associated protein 1 OS=Homo sapiens GN=SPATA1 PE=2 SV=3 | 153 | V | 0.377071 | L | 0.41705 | -0.039979 | No Change: Both O | - |
| Q96N96 | SPT13_HUMAN Spermatogenesis-associated protein 13 OS=Homo sapiens GN=SPATA13 PE=1 SV=1 | 20 | R | 0.619354 | W | 0.348121 | 0.271233 | D to O | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 50 | N | 0.77501 | S | 0.806087 | -0.031077 | No Change: Both D | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 78 | E | 0.933742 | K | 0.938412 | -0.00467 | No Change: Both D | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 90 | E | 0.9171 | G | 0.891564 | 0.025536 | No Change: Both D | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 133 | M | 0.150512 | V | 0.121788 | 0.028724 | No Change: Both O | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 147 | G | 0.568988 | E | 0.62989 | -0.060902 | No Change: Both D | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 283 | R | 0.41341 | Q | 0.421771 | -0.008361 | No Change: Both O | Spermatogenic failure type 6 (SPGF6) [MIM:102530] |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 286 | M | 0.20672 | V | 0.155049 | 0.051671 | No Change: Both O | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 423 | V | 0.554897 | M | 0.682886 | -0.127989 | No Change: Both D | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 509 | A | 0.442823 | V | 0.342033 | 0.10079 | No Change: Both O | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 526 | M | 0.260614 | T | 0.275665 | -0.015051 | No Change: Both O | - |
| Q9BXB7 | SPT16_HUMAN Spermatogenesis-associated protein 16 OS=Homo sapiens GN=SPATA16 PE=1 SV=3 | 564 | Q | 0.937876 | R | 0.938014 | -1.38E-04 | No Change: Both D | - |
| Q96L03 | SPT17_HUMAN Spermatogenesis-associated protein 17 OS=Homo sapiens GN=SPATA17 PE=1 SV=1 | 16 | N | 0.379346 | S | 0.438917 | -0.059571 | No Change: Both O | - |
| Q8TC71 | MIEAP_HUMAN Mitochondria-eating protein OS=Homo sapiens GN=SPATA18 PE=1 SV=1 | 227 | S | 0.894232 | P | 0.874363 | 0.019869 | No Change: Both D | - |
| Q8TC71 | MIEAP_HUMAN Mitochondria-eating protein OS=Homo sapiens GN=SPATA18 PE=1 SV=1 | 483 | K | 0.238911 | R | 0.213667 | 0.025244 | No Change: Both O | - |
| Q7Z5L4 | SPT19_HUMAN Spermatogenesis-associated protein 19 mitochondrial OS=Homo sapiens GN=SPATA19 PE=1 SV=2 | 50 | A | 0.683533 | V | 0.660884 | 0.022649 | No Change: Both D | - |
| Q9UM82 | SPAT2_HUMAN Spermatogenesis-associated protein 2 OS=Homo sapiens GN=SPATA2 PE=1 SV=2 | 443 | L | 0.907272 | F | 0.890572 | 0.0167 | No Change: Both D | - |
| Q8TB22 | SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens GN=SPATA20 PE=2 SV=3 | 88 | Q | 0.19653 | E | 0.244389 | -0.047859 | No Change: Both O | - |
| Q8TB22 | SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens GN=SPATA20 PE=2 SV=3 | 483 | S | 0.273591 | T | 0.219615 | 0.053976 | No Change: Both O | - |
| Q8TB22 | SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens GN=SPATA20 PE=2 SV=3 | 609 | K | 0.363175 | R | 0.317298 | 0.045877 | No Change: Both O | - |
| Q7Z572 | SPT21_HUMAN Spermatogenesis-associated protein 21 OS=Homo sapiens GN=SPATA21 PE=2 SV=3 | 24 | P | 0.931288 | S | 0.917004 | 0.014284 | No Change: Both D | A breast cancer sample |
| Q7Z572 | SPT21_HUMAN Spermatogenesis-associated protein 21 OS=Homo sapiens GN=SPATA21 PE=2 SV=3 | 53 | I | 0.974469 | L | 0.98074 | -0.006271 | No Change: Both D | - |
| Q7Z572 | SPT21_HUMAN Spermatogenesis-associated protein 21 OS=Homo sapiens GN=SPATA21 PE=2 SV=3 | 184 | Q | 0.723012 | R | 0.74143 | -0.018418 | No Change: Both D | - |
| Q7Z572 | SPT21_HUMAN Spermatogenesis-associated protein 21 OS=Homo sapiens GN=SPATA21 PE=2 SV=3 | 255 | V | 0.092912 | L | 0.097498 | -0.004586 | No Change: Both O | - |
| Q7Z572 | SPT21_HUMAN Spermatogenesis-associated protein 21 OS=Homo sapiens GN=SPATA21 PE=2 SV=3 | 390 | N | 0.740096 | K | 0.773817 | -0.033721 | No Change: Both D | - |
| Q8NHS9 | SPT22_HUMAN Spermatogenesis-associated protein 22 OS=Homo sapiens GN=SPATA22 PE=1 SV=2 | 112 | R | 0.780136 | T | 0.766312 | 0.013824 | No Change: Both D | - |
| Q8NHS9 | SPT22_HUMAN Spermatogenesis-associated protein 22 OS=Homo sapiens GN=SPATA22 PE=1 SV=2 | 148 | V | 0.885411 | M | 0.909115 | -0.023704 | No Change: Both D | - |
| Q8NHS9 | SPT22_HUMAN Spermatogenesis-associated protein 22 OS=Homo sapiens GN=SPATA22 PE=1 SV=2 | 155 | Q | 0.908227 | R | 0.901697 | 0.00653 | No Change: Both D | - |
| Q8NHS9 | SPT22_HUMAN Spermatogenesis-associated protein 22 OS=Homo sapiens GN=SPATA22 PE=1 SV=2 | 160 | I | 0.919253 | T | 0.954113 | -0.03486 | No Change: Both D | - |
| Q9BR10 | SPT25_HUMAN Spermatogenesis-associated protein 25 OS=Homo sapiens GN=SPATA25 PE=1 SV=1 | 94 | P | 0.464707 | L | 0.333471 | 0.131236 | No Change: Both O | - |
| Q8NEY3 | SPAT4_HUMAN Spermatogenesis-associated protein 4 OS=Homo sapiens GN=SPATA4 PE=2 SV=1 | 149 | Y | 0.124784 | C | 0.10353 | 0.021254 | No Change: Both O | - |
| Q8NB90 | SPAT5_HUMAN Spermatogenesis-associated protein 5 OS=Homo sapiens GN=SPATA5 PE=1 SV=3 | 27 | C | 0.915138 | S | 0.95408 | -0.038942 | No Change: Both D | - |
| Q8NB90 | SPAT5_HUMAN Spermatogenesis-associated protein 5 OS=Homo sapiens GN=SPATA5 PE=1 SV=3 | 673 | S | 0.326566 | Y | 0.178719 | 0.147847 | No Change: Both O | - |
| Q9BVQ7 | SPA5L_HUMAN Spermatogenesis-associated protein 5-like protein 1 OS=Homo sapiens GN=SPATA5L1 PE=1 SV=2 | 119 | R | 0.562373 | P | 0.589364 | -0.026991 | No Change: Both D | - |
| Q9BVQ7 | SPA5L_HUMAN Spermatogenesis-associated protein 5-like protein 1 OS=Homo sapiens GN=SPATA5L1 PE=1 SV=2 | 592 | N | 0.363235 | D | 0.416615 | -0.05338 | No Change: Both O | - |
| Q9BVQ7 | SPA5L_HUMAN Spermatogenesis-associated protein 5-like protein 1 OS=Homo sapiens GN=SPATA5L1 PE=1 SV=2 | 252 | R | 0.53778 | Q | 0.534361 | 0.003419 | No Change: Both D | - |
| Q9NWH7 | SPAT6_HUMAN Spermatogenesis-associated protein 6 OS=Homo sapiens GN=SPATA6 PE=1 SV=1 | 333 | R | 0.909185 | W | 0.792797 | 0.116388 | No Change: Both D | - |
| Q9NWH7 | SPAT6_HUMAN Spermatogenesis-associated protein 6 OS=Homo sapiens GN=SPATA6 PE=1 SV=1 | 478 | C | 0.715099 | Y | 0.712706 | 0.002393 | No Change: Both D | - |
| Q9NWH7 | SPAT6_HUMAN Spermatogenesis-associated protein 6 OS=Homo sapiens GN=SPATA6 PE=1 SV=1 | 478 | C | 0.715099 | F | 0.708924 | 0.006175 | No Change: Both D | - |
| Q9NWH7 | SPAT6_HUMAN Spermatogenesis-associated protein 6 OS=Homo sapiens GN=SPATA6 PE=1 SV=1 | 478 | C | 0.715099 | S | 0.849994 | -0.134895 | No Change: Both D | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 74 | V | 0.427577 | M | 0.476104 | -0.048527 | No Change: Both O | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 2 | D | 0.72077 | N | 0.714259 | 0.006511 | No Change: Both D | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 119 | F | 0.827638 | L | 0.850054 | -0.022416 | No Change: Both D | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 165 | S | 0.915543 | N | 0.891058 | 0.024485 | No Change: Both D | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 324 | G | 0.522887 | E | 0.636994 | -0.114107 | No Change: Both D | - |
| Q9P0W8 | SPAT7_HUMAN Spermatogenesis-associated protein 7 OS=Homo sapiens GN=SPATA7 PE=2 SV=3 | 534 | R | 0.860407 | Q | 0.878192 | -0.017785 | No Change: Both D | - |
| Q9BWV2 | SPAT9_HUMAN Spermatogenesis-associated protein 9 OS=Homo sapiens GN=SPATA9 PE=2 SV=2 | 209 | K | 0.797643 | E | 0.803318 | -0.005675 | No Change: Both D | - |
| Q96M53 | SPATL_HUMAN Protein SPATIAL OS=Homo sapiens GN=SPATIAL PE=2 SV=3 | 237 | R | 0.095728 | Q | 0.11317 | -0.017442 | No Change: Both O | - |
| Q496A3 | SPAS1_HUMAN Spermatogenesis-associated serine-rich protein 1 OS=Homo sapiens GN=SPATS1 PE=2 SV=2 | 8 | G | 0.972598 | R | 0.978833 | -0.006235 | No Change: Both D | - |
| O95238 | SPDEF_HUMAN SAM pointed domain-containing Ets transcription factor OS=Homo sapiens GN=SPDEF PE=1 SV=1 | 57 | A | 0.560079 | T | 0.556581 | 0.003498 | No Change: Both D | - |
| Q5M775 | CYTSB_HUMAN Cytospin-B OS=Homo sapiens GN=SPECC1 PE=1 SV=1 | 293 | M | 0.908774 | L | 0.888394 | 0.02038 | No Change: Both D | - |
| Q5M775 | CYTSB_HUMAN Cytospin-B OS=Homo sapiens GN=SPECC1 PE=1 SV=1 | 274 | S | 0.88307 | R | 0.838227 | 0.044843 | No Change: Both D | - |
| Q5M775 | CYTSB_HUMAN Cytospin-B OS=Homo sapiens GN=SPECC1 PE=1 SV=1 | 769 | D | 0.865083 | N | 0.85846 | 0.006623 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 301 | D | 0.844694 | G | 0.837856 | 0.006838 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 712 | S | 0.641484 | F | 0.505291 | 0.136193 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 717 | T | 0.65362 | A | 0.625467 | 0.028153 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 943 | V | 0.966543 | A | 0.976114 | -0.009571 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 951 | V | 0.972122 | M | 0.981904 | -0.009782 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 190 | T | 0.519484 | M | 0.513141 | 0.006343 | No Change: Both D | - |
| Q69YQ0 | CYTSA_HUMAN Cytospin-A OS=Homo sapiens GN=SPECC1L PE=1 SV=2 | 415 | Q | 0.880063 | P | 0.85582 | 0.024243 | No Change: Both D | Facial clefting oblique type 1 (OBLFC1) [MIM:600251] |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 71 | N | 0.185834 | H | 0.164053 | 0.021781 | No Change: Both O | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 74 | G | 0.158354 | S | 0.198002 | -0.039648 | No Change: Both O | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 366 | R | 0.685938 | K | 0.689524 | -0.003586 | No Change: Both D | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 447 | R | 0.185663 | Q | 0.199929 | -0.014266 | No Change: Both O | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 500 | D | 0.600982 | N | 0.592832 | 0.00815 | No Change: Both D | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 616 | N | 0.702985 | K | 0.745259 | -0.042274 | No Change: Both D | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 655 | E | 0.861593 | G | 0.817205 | 0.044388 | No Change: Both D | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 1482 | K | 0.265315 | N | 0.237036 | 0.028279 | No Change: Both O | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 904 | A | 0.993246 | V | 0.990095 | 0.003151 | No Change: Both D | - |
| Q9C093 | SPEF2_HUMAN Sperm flagellar protein 2 OS=Homo sapiens GN=SPEF2 PE=1 SV=2 | 934 | A | 0.995389 | P | 0.996995 | -0.001606 | No Change: Both D | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 206 | R | 0.926614 | H | 0.902351 | 0.024263 | No Change: Both D | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 934 | R | 0.381997 | C | 0.296529 | 0.085468 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 966 | R | 0.521123 | Q | 0.526538 | -0.005415 | No Change: Both D | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1103 | P | 0.347653 | L | 0.226282 | 0.121371 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1135 | A | 0.345024 | V | 0.285161 | 0.059863 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1178 | E | 0.91964 | D | 0.901436 | 0.018204 | No Change: Both D | A gastric adenocarcinoma sample |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1234 | R | 0.697519 | W | 0.48471 | 0.212809 | D to O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1340 | R | 0.232054 | Q | 0.249116 | -0.017062 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1621 | R | 0.498074 | C | 0.3411 | 0.156974 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 1903 | R | 0.794725 | W | 0.677582 | 0.117143 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 2687 | P | 0.466958 | T | 0.415696 | 0.051262 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 2742 | V | 0.128608 | M | 0.145827 | -0.017219 | No Change: Both O | A gastric adenocarcinoma sample |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 3079 | H | 0.226682 | R | 0.201043 | 0.025639 | No Change: Both O | - |
| Q15772 | SPEG_HUMAN Striated muscle preferentially expressed protein kinase OS=Homo sapiens GN=SPEG PE=1 SV=4 | 2189 | P | 0.999721 | L | 0.999437 | 2.84E-04 | No Change: Both D | - |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 970 | A | 0.902682 | V | 0.882205 | 0.020477 | No Change: Both D | - |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 1091 | L | 0.924128 | P | 0.954193 | -0.030065 | No Change: Both D | - |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 2360 | N | 0.978074 | D | 0.973847 | 0.004227 | No Change: Both D | - |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 990 | D | 0.950959 | H | 0.936579 | 0.01438 | No Change: Both D | A breast cancer sample |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 1488 | R | 0.856858 | I | 0.7739 | 0.082958 | No Change: Both D | A breast cancer sample |
| Q96T58 | MINT_HUMAN Msx2-interacting protein OS=Homo sapiens GN=SPEN PE=1 SV=1 | 1363 | D | 0.86747 | E | 0.866564 | 9.06E-04 | No Change: Both D | - |
| Q8NA61 | SPERT_HUMAN Spermatid-associated protein OS=Homo sapiens GN=SPERT PE=2 SV=1 | 329 | K | 0.960513 | E | 0.96424 | -0.003727 | No Change: Both D | - |
| Q6UW49 | SPESP_HUMAN Sperm equatorial segment protein 1 OS=Homo sapiens GN=SPESP1 PE=1 SV=2 | 191 | G | 0.848507 | E | 0.886541 | -0.038034 | No Change: Both D | - |
| Q6UW49 | SPESP_HUMAN Sperm equatorial segment protein 1 OS=Homo sapiens GN=SPESP1 PE=1 SV=2 | 133 | L | 0.766341 | F | 0.786342 | -0.020001 | No Change: Both D | - |
| Q6UW49 | SPESP_HUMAN Sperm equatorial segment protein 1 OS=Homo sapiens GN=SPESP1 PE=1 SV=2 | 134 | H | 0.766239 | Q | 0.782893 | -0.016654 | No Change: Both D | - |
| Q96JI7 | SPTCS_HUMAN Spatacsin OS=Homo sapiens GN=SPG11 PE=1 SV=3 | 396 | Y | 0.319224 | C | 0.341522 | -0.022298 | No Change: Both O | - |
| Q96JI7 | SPTCS_HUMAN Spatacsin OS=Homo sapiens GN=SPG11 PE=1 SV=3 | 463 | F | 0.157027 | S | 0.36315 | -0.206123 | No Change: Both O | - |
| Q96JI7 | SPTCS_HUMAN Spatacsin OS=Homo sapiens GN=SPG11 PE=1 SV=3 | 1349 | F | 0.079596 | I | 0.086522 | -0.006926 | No Change: Both O | Spastic paraplegia autosomal recessive type 11 (SPG11) [MIM:604360] |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 503 | T | 0.470869 | A | 0.431487 | 0.039382 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 688 | R | 0.471367 | Q | 0.500143 | -0.028776 | O to D | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 692 | S | 0.530122 | T | 0.449782 | 0.08034 | D to O | Spastic paraplegia autosomal recessive type 7 (SPG7) [MIM:607259] |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 623 | F | 0.312253 | C | 0.337882 | -0.025629 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 730 | N | 0.270469 | D | 0.29413 | -0.023661 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 645 | S | 0.448575 | T | 0.373606 | 0.074969 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 2 | A | 0.867319 | T | 0.853448 | 0.013871 | No Change: Both D | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 284 | F | 0.416452 | P | 0.603183 | -0.186731 | O to D | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 294 | R | 0.131113 | H | 0.130294 | 8.19E-04 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 349 | G | 0.370031 | S | 0.390351 | -0.02032 | No Change: Both O | Spastic paraplegia autosomal recessive type 7 (SPG7) [MIM:607259] |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 486 | R | 0.479816 | Q | 0.499738 | -0.019922 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 510 | A | 0.363636 | V | 0.277256 | 0.08638 | No Change: Both O | Spastic paraplegia autosomal recessive type 7 (SPG7) [MIM:607259] |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 545 | F | 0.231045 | L | 0.273126 | -0.042081 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 583 | W | 0.209258 | C | 0.25827 | -0.049012 | No Change: Both O | Spastic paraplegia autosomal recessive type 7 (SPG7) [MIM:607259] |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 603 | A | 0.246564 | T | 0.271508 | -0.024944 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 635 | S | 0.431834 | L | 0.266217 | 0.165617 | No Change: Both O | - |
| Q9UQ90 | SPG7_HUMAN Paraplegin OS=Homo sapiens GN=SPG7 PE=1 SV=2 | 650 | D | 0.416628 | H | 0.375342 | 0.041286 | No Change: Both O | - |
| Q9NRA0 | SPHK2_HUMAN Sphingosine kinase 2 OS=Homo sapiens GN=SPHK2 PE=1 SV=2 | 652 | R | 0.886716 | Q | 0.913334 | -0.026618 | No Change: Both D | - |
| Q2M3C7 | SPKAP_HUMAN A-kinase anchor protein SPHKAP OS=Homo sapiens GN=SPHKAP PE=1 SV=1 | 425 | G | 0.669246 | R | 0.713401 | -0.044155 | No Change: Both D | - |
| Q2M3C7 | SPKAP_HUMAN A-kinase anchor protein SPHKAP OS=Homo sapiens GN=SPHKAP PE=1 SV=1 | 617 | K | 0.467119 | E | 0.478133 | -0.011014 | No Change: Both O | - |
| Q2M3C7 | SPKAP_HUMAN A-kinase anchor protein SPHKAP OS=Homo sapiens GN=SPHKAP PE=1 SV=1 | 847 | H | 0.945797 | Q | 0.950464 | -0.004667 | No Change: Both D | - |
| Q2M3C7 | SPKAP_HUMAN A-kinase anchor protein SPHKAP OS=Homo sapiens GN=SPHKAP PE=1 SV=1 | 867 | Q | 0.976694 | R | 0.976408 | 2.86E-04 | No Change: Both D | - |
| Q2M3C7 | SPKAP_HUMAN A-kinase anchor protein SPHKAP OS=Homo sapiens GN=SPHKAP PE=1 SV=1 | 1603 | S | 0.73884 | R | 0.702085 | 0.036755 | No Change: Both D | - |
| Q01892 | SPIB_HUMAN Transcription factor Spi-B OS=Homo sapiens GN=SPIB PE=1 SV=1 | 104 | A | 0.867199 | P | 0.913972 | -0.046773 | No Change: Both D | - |
| Q8N0Z3 | SPICE_HUMAN Spindle and centriole-associated protein 1 OS=Homo sapiens GN=SPICE1 PE=1 SV=1 | 275 | L | 0.714332 | V | 0.708714 | 0.005618 | No Change: Both D | - |
| Q8N0Z3 | SPICE_HUMAN Spindle and centriole-associated protein 1 OS=Homo sapiens GN=SPICE1 PE=1 SV=1 | 472 | R | 0.715095 | G | 0.701694 | 0.013401 | No Change: Both D | - |
| Q9Y657 | SPIN1_HUMAN Spindlin-1 OS=Homo sapiens GN=SPIN1 PE=1 SV=3 | 221 | A | 0.600012 | P | 0.655627 | -0.055615 | No Change: Both D | - |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 14 | L | 0.202447 | P | 0.312598 | -0.110151 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 34 | N | 0.270847 | S | 0.297703 | -0.026856 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 34 | N | 0.270847 | S | 0.297703 | -0.026856 | No Change: Both O | Tropical calcific pancreatitis (TCP) [MIM:608189] |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 55 | P | 0.274726 | S | 0.281758 | -0.007032 | No Change: Both O | - |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 12 | L | 0.11901 | F | 0.095911 | 0.023099 | No Change: Both O | Pancreatitis (PCTT) [MIM:167800] |
| P00995 | ISK1_HUMAN Pancreatic secretory trypsin inhibitor OS=Homo sapiens GN=SPINK1 PE=1 SV=2 | 67 | R | 0.361745 | H | 0.304684 | 0.057061 | No Change: Both O | - |
| O60575 | ISK4_HUMAN Serine protease inhibitor Kazal-type 4 OS=Homo sapiens GN=SPINK4 PE=2 SV=1 | 7 | V | 0.069503 | I | 0.059154 | 0.010349 | No Change: Both O | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 420 | K | 0.97794 | E | 0.978067 | -1.27E-04 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 267 | Q | 0.633407 | R | 0.657286 | -0.023879 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 368 | S | 0.695093 | N | 0.678117 | 0.016976 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 386 | D | 0.535923 | N | 0.541131 | -0.005208 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 395 | V | 0.62754 | M | 0.691277 | -0.063737 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 441 | R | 0.89186 | H | 0.862691 | 0.029169 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 588 | I | 0.517522 | M | 0.602024 | -0.084502 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 711 | R | 0.91221 | Q | 0.91308 | -8.70E-04 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 825 | E | 0.993923 | D | 0.993096 | 8.27E-04 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 887 | S | 0.770173 | R | 0.786421 | -0.016248 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 969 | K | 0.71868 | E | 0.727518 | -0.008838 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 972 | H | 0.756502 | R | 0.794092 | -0.03759 | No Change: Both D | - |
| Q9NQ38 | ISK5_HUMAN Serine protease inhibitor Kazal-type 5 OS=Homo sapiens GN=SPINK5 PE=1 SV=2 | 335 | A | 0.636178 | V | 0.513186 | 0.122992 | No Change: Both D | - |
| Q6UWN8 | ISK6_HUMAN Serine protease inhibitor Kazal-type 6 OS=Homo sapiens GN=SPINK6 PE=1 SV=1 | 36 | P | 0.316339 | T | 0.277846 | 0.038493 | No Change: Both O | - |
| P0C7L1 | ISK8_HUMAN Serine protease inhibitor Kazal-type 8 OS=Homo sapiens GN=SPINK8 PE=2 SV=1 | 78 | K | 0.137828 | N | 0.117895 | 0.019933 | No Change: Both O | - |
| O95925 | EPPI_HUMAN Eppin OS=Homo sapiens GN=SPINLW1 PE=2 SV=1 | 92 | H | 0.041673 | R | 0.047787 | -0.006114 | No Change: Both O | - |
| O95925 | EPPI_HUMAN Eppin OS=Homo sapiens GN=SPINLW1 PE=2 SV=1 | 128 | K | 0.777219 | T | 0.719035 | 0.058184 | No Change: Both D | - |
| O43278 | SPIT1_HUMAN Kunitz-type protease inhibitor 1 OS=Homo sapiens GN=SPINT1 PE=1 SV=2 | 123 | Y | 0.033096 | C | 0.036693 | -0.003597 | No Change: Both O | - |
| O43278 | SPIT1_HUMAN Kunitz-type protease inhibitor 1 OS=Homo sapiens GN=SPINT1 PE=1 SV=2 | 142 | T | 0.152677 | R | 0.178993 | -0.026316 | No Change: Both O | - |
| O43278 | SPIT1_HUMAN Kunitz-type protease inhibitor 1 OS=Homo sapiens GN=SPINT1 PE=1 SV=2 | 337 | P | 0.865637 | L | 0.761329 | 0.104308 | No Change: Both D | - |
| O43291 | SPIT2_HUMAN Kunitz-type protease inhibitor 2 OS=Homo sapiens GN=SPINT2 PE=1 SV=2 | 200 | V | 0.080699 | L | 0.082505 | -0.001806 | No Change: Both O | - |
| O43291 | SPIT2_HUMAN Kunitz-type protease inhibitor 2 OS=Homo sapiens GN=SPINT2 PE=1 SV=2 | 163 | Y | 0.326831 | C | 0.398004 | -0.071173 | No Change: Both O | Diarrhea type 3 (DIAR3) [MIM:270420] |
| P49223 | SPIT3_HUMAN Kunitz-type protease inhibitor 3 OS=Homo sapiens GN=SPINT3 PE=2 SV=3 | 77 | L | 0.54866 | S | 0.726704 | -0.178044 | No Change: Both D | - |
| Q6UDR6 | SPIT4_HUMAN Kunitz-type protease inhibitor 4 OS=Homo sapiens GN=SPINT4 PE=2 SV=1 | 73 | G | 0.185356 | S | 0.231157 | -0.045801 | No Change: Both O | - |
| Q6UDR6 | SPIT4_HUMAN Kunitz-type protease inhibitor 4 OS=Homo sapiens GN=SPINT4 PE=2 SV=1 | 30 | A | 0.23308 | E | 0.354904 | -0.121824 | No Change: Both O | - |
| Q08AE8 | SPIR1_HUMAN Protein spire homolog 1 OS=Homo sapiens GN=SPIRE1 PE=1 SV=2 | 249 | Q | 0.782308 | P | 0.786875 | -0.004567 | No Change: Both D | - |
| P16150 | LEUK_HUMAN Leukosialin OS=Homo sapiens GN=SPN PE=1 SV=1 | 22 | T | 0.688431 | I | 0.511643 | 0.176788 | No Change: Both D | - |
| P16150 | LEUK_HUMAN Leukosialin OS=Homo sapiens GN=SPN PE=1 SV=1 | 93 | T | 0.898685 | A | 0.87593 | 0.022755 | No Change: Both D | - |
| Q9H2V7 | SPNS1_HUMAN Protein spinster homolog 1 OS=Homo sapiens GN=SPNS1 PE=1 SV=1 | 230 | A | 0.035102 | P | 0.057188 | -0.022086 | No Change: Both O | - |
| Q6ZMD2 | SPNS3_HUMAN Protein spinster homolog 3 OS=Homo sapiens GN=SPNS3 PE=2 SV=2 | 293 | G | 0.175284 | R | 0.177143 | -0.001859 | No Change: Both O | - |
| Q6ZMD2 | SPNS3_HUMAN Protein spinster homolog 3 OS=Homo sapiens GN=SPNS3 PE=2 SV=2 | 330 | A | 0.245614 | S | 0.327332 | -0.081718 | No Change: Both O | - |
| Q6ZMD2 | SPNS3_HUMAN Protein spinster homolog 3 OS=Homo sapiens GN=SPNS3 PE=2 SV=2 | 507 | A | 0.897252 | T | 0.916836 | -0.019584 | No Change: Both D | A colorectal cancer sample |
| Q9Y5K1 | SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens GN=SPO11 PE=2 SV=1 | 36 | T | 0.81808 | A | 0.827459 | -0.009379 | No Change: Both D | - |
| Q9Y5K1 | SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens GN=SPO11 PE=2 SV=1 | 211 | R | 0.176448 | W | 0.074334 | 0.102114 | No Change: Both O | - |
| Q9Y5K1 | SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens GN=SPO11 PE=2 SV=1 | 91 | M | 0.331246 | V | 0.278139 | 0.053107 | No Change: Both O | - |
| Q9Y5K1 | SPO11_HUMAN Meiotic recombination protein SPO11 OS=Homo sapiens GN=SPO11 PE=2 SV=1 | 202 | A | 0.181045 | V | 0.132481 | 0.048564 | No Change: Both O | - |
| Q6ZMY3 | SPOC1_HUMAN SPOC domain-containing protein 1 OS=Homo sapiens GN=SPOCD1 PE=2 SV=1 | 671 | R | 0.2786 | W | 0.114641 | 0.163959 | No Change: Both O | A breast cancer sample |
| Q6ZMY3 | SPOC1_HUMAN SPOC domain-containing protein 1 OS=Homo sapiens GN=SPOCD1 PE=2 SV=1 | 109 | T | 0.680349 | A | 0.670986 | 0.009363 | No Change: Both D | - |
| Q6ZMY3 | SPOC1_HUMAN SPOC domain-containing protein 1 OS=Homo sapiens GN=SPOCD1 PE=2 SV=1 | 436 | R | 0.97257 | W | 0.927661 | 0.044909 | No Change: Both D | - |
| Q92563 | TICN2_HUMAN Testican-2 OS=Homo sapiens GN=SPOCK2 PE=1 SV=1 | 353 | G | 0.400121 | S | 0.468728 | -0.068607 | No Change: Both O | - |
| Q9BQ16 | TICN3_HUMAN Testican-3 OS=Homo sapiens GN=SPOCK3 PE=1 SV=2 | 112 | I | 0.441609 | V | 0.479728 | -0.038119 | No Change: Both O | - |
| Q9BUD6 | SPON2_HUMAN Spondin-2 OS=Homo sapiens GN=SPON2 PE=1 SV=3 | 40 | L | 0.233037 | P | 0.382583 | -0.149546 | No Change: Both O | - |
| Q9BUD6 | SPON2_HUMAN Spondin-2 OS=Homo sapiens GN=SPON2 PE=1 SV=3 | 122 | E | 0.430591 | A | 0.335421 | 0.09517 | No Change: Both O | - |
| Q9BUD6 | SPON2_HUMAN Spondin-2 OS=Homo sapiens GN=SPON2 PE=1 SV=3 | 242 | V | 0.610547 | L | 0.632835 | -0.022288 | No Change: Both D | - |
| Q9BUD6 | SPON2_HUMAN Spondin-2 OS=Homo sapiens GN=SPON2 PE=1 SV=3 | 38 | R | 0.26827 | G | 0.291117 | -0.022847 | No Change: Both O | - |
| Q6IQ16 | SPOPL_HUMAN Speckle-type POZ protein-like OS=Homo sapiens GN=SPOPL PE=2 SV=1 | 45 | R | 0.278509 | Q | 0.292844 | -0.014335 | No Change: Both O | - |
| P10451 | OSTP_HUMAN Osteopontin OS=Homo sapiens GN=SPP1 PE=1 SV=1 | 301 | R | 0.895793 | H | 0.903056 | -0.007263 | No Change: Both D | - |
| P10451 | OSTP_HUMAN Osteopontin OS=Homo sapiens GN=SPP1 PE=1 SV=1 | 224 | S | 0.821597 | N | 0.784417 | 0.03718 | No Change: Both D | - |
| Q13103 | SPP24_HUMAN Secreted phosphoprotein 24 OS=Homo sapiens GN=SPP2 PE=1 SV=1 | 38 | S | 0.519616 | F | 0.292408 | 0.227208 | D to O | - |
| Q8TCT8 | PSL2_HUMAN Signal peptide peptidase-like 2A OS=Homo sapiens GN=SPPL2A PE=1 SV=2 | 90 | V | 0.11702 | I | 0.098275 | 0.018745 | No Change: Both O | - |
| Q8TCT7 | PSL1_HUMAN Signal peptide peptidase-like 2B OS=Homo sapiens GN=SPPL2B PE=1 SV=2 | 574 | S | 0.997367 | P | 0.997664 | -2.97E-04 | No Change: Both D | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 123 | R | 0.347338 | Q | 0.388407 | -0.041069 | No Change: Both O | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 303 | R | 0.153359 | H | 0.143614 | 0.009745 | No Change: Both O | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 461 | R | 0.029218 | P | 0.03358 | -0.004362 | No Change: Both O | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 471 | I | 0.036687 | V | 0.048047 | -0.01136 | No Change: Both O | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 601 | S | 0.932759 | P | 0.935094 | -0.002335 | No Change: Both D | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 620 | G | 0.937579 | R | 0.941427 | -0.003848 | No Change: Both D | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 643 | P | 0.831326 | R | 0.782444 | 0.048882 | No Change: Both D | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 659 | T | 0.684708 | I | 0.568412 | 0.116296 | No Change: Both D | - |
| Q8IUH8 | IMP5_HUMAN Signal peptide peptidase-like 2C OS=Homo sapiens GN=SPPL2C PE=1 SV=3 | 626 | M | 0.926482 | V | 0.866537 | 0.059945 | No Change: Both D | - |
| P35270 | SPRE_HUMAN Sepiapterin reductase OS=Homo sapiens GN=SPR PE=1 SV=1 | 150 | R | 0.320819 | G | 0.351161 | -0.030342 | No Change: Both O | Dystonia DOPA-responsive due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716] |
| P35270 | SPRE_HUMAN Sepiapterin reductase OS=Homo sapiens GN=SPR PE=1 SV=1 | 163 | P | 0.087632 | L | 0.046276 | 0.041356 | No Change: Both O | Dystonia DOPA-responsive due to sepiapterin reductase deficiency (DRDSPRD) [MIM:612716] |
| Q7Z699 | SPRE1_HUMAN Sprouty-related EVH1 domain-containing protein 1 OS=Homo sapiens GN=SPRED1 PE=1 SV=2 | 31 | W | 0.514636 | C | 0.574208 | -0.059572 | No Change: Both D | Neurofibromatosis type 1-like syndrome (NFLS) [MIM:611431] |
| Q7Z699 | SPRE1_HUMAN Sprouty-related EVH1 domain-containing protein 1 OS=Homo sapiens GN=SPRED1 PE=1 SV=2 | 44 | V | 0.352647 | D | 0.501349 | -0.148702 | O to D | Neurofibromatosis type 1-like syndrome (NFLS) [MIM:611431] |
| Q5BIV9 | SPRN_HUMAN Shadow of prion protein OS=Homo sapiens GN=SPRN PE=2 SV=1 | 7 | T | 0.153219 | M | 0.186744 | -0.033525 | No Change: Both O | - |
| P35321 | SPR1A_HUMAN Cornifin-A OS=Homo sapiens GN=SPRR1A PE=1 SV=2 | 42 | H | 0.999813 | Q | 0.999862 | -4.90E-05 | No Change: Both D | - |
| P35321 | SPR1A_HUMAN Cornifin-A OS=Homo sapiens GN=SPRR1A PE=1 SV=2 | 61 | V | 0.99954 | I | 0.999365 | 1.75E-04 | No Change: Both D | - |
| P22528 | SPR1B_HUMAN Cornifin-B OS=Homo sapiens GN=SPRR1B PE=1 SV=2 | 23 | Q | 0.999819 | H | 0.999718 | 1.01E-04 | No Change: Both D | - |
| P22528 | SPR1B_HUMAN Cornifin-B OS=Homo sapiens GN=SPRR1B PE=1 SV=2 | 61 | V | 0.998919 | L | 0.998586 | 3.33E-04 | No Change: Both D | - |
| P22528 | SPR1B_HUMAN Cornifin-B OS=Homo sapiens GN=SPRR1B PE=1 SV=2 | 80 | A | 0.997278 | P | 0.998798 | -0.00152 | No Change: Both D | - |
| P22528 | SPR1B_HUMAN Cornifin-B OS=Homo sapiens GN=SPRR1B PE=1 SV=2 | 11 | T | 0.999902 | I | 0.999845 | 5.70E-05 | No Change: Both D | - |
| P35325 | SPR2B_HUMAN Small proline-rich protein 2B OS=Homo sapiens GN=SPRR2B PE=2 SV=1 | 39 | P | 0.999984 | S | 0.999977 | 7.00E-06 | No Change: Both D | - |
| P22532 | SPR2D_HUMAN Small proline-rich protein 2D OS=Homo sapiens GN=SPRR2D PE=2 SV=2 | 20 | T | 0.999921 | A | 0.999906 | 1.50E-05 | No Change: Both D | - |
| Q9UBC9 | SPRR3_HUMAN Small proline-rich protein 3 OS=Homo sapiens GN=SPRR3 PE=1 SV=2 | 149 | L | 0.906218 | V | 0.927399 | -0.021181 | No Change: Both D | - |
| Q9UBC9 | SPRR3_HUMAN Small proline-rich protein 3 OS=Homo sapiens GN=SPRR3 PE=1 SV=2 | 156 | T | 0.960449 | M | 0.949708 | 0.010741 | No Change: Both D | - |
| Q96PI1 | SPRR4_HUMAN Small proline-rich protein 4 OS=Homo sapiens GN=SPRR4 PE=2 SV=1 | 45 | P | 0.997076 | S | 0.996032 | 0.001044 | No Change: Both D | - |
| O43597 | SPY2_HUMAN Protein sprouty homolog 2 OS=Homo sapiens GN=SPRY2 PE=1 SV=1 | 106 | P | 0.991263 | S | 0.992044 | -7.81E-04 | No Change: Both D | - |
| O43610 | SPY3_HUMAN Protein sprouty homolog 3 OS=Homo sapiens GN=SPRY3 PE=1 SV=2 | 161 | A | 0.382326 | T | 0.404554 | -0.022228 | No Change: Both O | - |
| Q8WW59 | SPRY4_HUMAN SPRY domain-containing protein 4 OS=Homo sapiens GN=SPRYD4 PE=1 SV=2 | 50 | M | 0.22443 | T | 0.262918 | -0.038488 | No Change: Both O | - |
| Q6PJ21 | SPSB3_HUMAN SPRY domain-containing SOCS box protein 3 OS=Homo sapiens GN=SPSB3 PE=1 SV=2 | 171 | S | 0.361702 | L | 0.205652 | 0.15605 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 24 | I | 0.832425 | S | 0.92621 | -0.093785 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 28 | R | 0.789627 | H | 0.729044 | 0.060583 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 28 | R | 0.789627 | L | 0.678823 | 0.110804 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 28 | R | 0.789627 | S | 0.802751 | -0.013124 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 28 | R | 0.789627 | C | 0.653715 | 0.135912 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 31 | V | 0.755391 | A | 0.795659 | -0.040268 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 34 | R | 0.695791 | W | 0.430268 | 0.265523 | D to O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 41 | R | 0.615684 | W | 0.383212 | 0.232472 | D to O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 45 | R | 0.611724 | S | 0.649488 | -0.037764 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 45 | R | 0.611724 | T | 0.578339 | 0.033385 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 46 | G | 0.614426 | V | 0.524407 | 0.090019 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 48 | K | 0.589672 | R | 0.565154 | 0.024518 | No Change: Both D | Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 49 | L | 0.548589 | F | 0.524378 | 0.024211 | No Change: Both D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 151 | G | 0.380043 | D | 0.424535 | -0.044492 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 207 | L | 0.286353 | P | 0.43906 | -0.152707 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 207 | L | 0.286353 | P | 0.43906 | -0.152707 | No Change: Both O | Hereditary pyropoikilocytosis (HPP) [MIM:266140] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 260 | L | 0.494999 | P | 0.589651 | -0.094652 | O to D | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 261 | S | 0.480147 | P | 0.471753 | 0.008394 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 469 | H | 0.290713 | P | 0.317439 | -0.026726 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 471 | Q | 0.297387 | P | 0.291543 | 0.005844 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 701 | R | 0.389758 | H | 0.367273 | 0.022485 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 791 | D | 0.422031 | E | 0.465024 | -0.042993 | No Change: Both O | Elliptocytosis type 2 (EL2) [MIM:130600] |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 809 | I | 0.533524 | V | 0.543294 | -0.00977 | No Change: Both D | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 853 | T | 0.538689 | R | 0.614009 | -0.07532 | No Change: Both D | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 970 | A | 0.579 | D | 0.620179 | -0.041179 | No Change: Both D | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1858 | L | 0.359954 | V | 0.339733 | 0.020221 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 2025 | A | 0.460722 | G | 0.444326 | 0.016396 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 109 | S | 0.871398 | F | 0.757865 | 0.113533 | No Change: Both D | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 152 | D | 0.347297 | N | 0.331633 | 0.015664 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 766 | A | 0.481824 | T | 0.504183 | -0.022359 | O to D | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 957 | A | 0.532449 | V | 0.418465 | 0.113984 | D to O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1163 | S | 0.457684 | A | 0.352575 | 0.105109 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1330 | R | 0.535088 | I | 0.383988 | 0.1511 | D to O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1568 | C | 0.330017 | R | 0.459015 | -0.128998 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1693 | K | 0.374616 | Q | 0.325056 | 0.04956 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 1836 | N | 0.411183 | S | 0.433096 | -0.021913 | No Change: Both O | - |
| P02549 | SPTA1_HUMAN Spectrin alpha chain erythrocyte OS=Homo sapiens GN=SPTA1 PE=1 SV=5 | 2265 | I | 0.494467 | T | 0.603954 | -0.109487 | O to D | - |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 1300 | I | 0.691841 | T | 0.810161 | -0.11832 | No Change: Both D | - |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 904 | S | 0.658265 | C | 0.501969 | 0.156296 | No Change: Both D | A breast cancer sample |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 1017 | P | 0.20848 | S | 0.224793 | -0.016313 | No Change: Both O | A breast cancer sample |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 1794 | R | 0.458601 | W | 0.23909 | 0.219511 | No Change: Both O | A breast cancer sample |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 1918 | D | 0.408285 | N | 0.385504 | 0.022781 | No Change: Both O | A breast cancer sample |
| Q13813 | SPTA2_HUMAN Spectrin alpha chain brain OS=Homo sapiens GN=SPTAN1 PE=1 SV=3 | 385 | N | 0.288671 | S | 0.348661 | -0.05999 | No Change: Both O | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 202 | W | 0.285495 | R | 0.462321 | -0.176826 | No Change: Both O | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 439 | S | 0.411792 | N | 0.418491 | -0.006699 | No Change: Both O | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 1151 | N | 0.214569 | D | 0.260714 | -0.046145 | No Change: Both O | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 1374 | H | 0.748963 | R | 0.778594 | -0.029631 | No Change: Both D | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 1403 | R | 0.697376 | Q | 0.705316 | -0.00794 | No Change: Both D | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2018 | A | 0.229438 | G | 0.250188 | -0.02075 | No Change: Both O | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2019 | S | 0.202731 | P | 0.175145 | 0.027586 | No Change: Both O | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2023 | A | 0.152663 | V | 0.106005 | 0.046658 | No Change: Both O | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2024 | W | 0.1378 | R | 0.299196 | -0.161396 | No Change: Both O | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2025 | L | 0.115861 | R | 0.184199 | -0.068338 | No Change: Both O | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 2053 | A | 0.508756 | P | 0.566648 | -0.057892 | No Change: Both D | Elliptocytosis type 3 (EL3) [MIM:182870] |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 613 | S | 0.26368 | I | 0.129313 | 0.134367 | No Change: Both O | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 1408 | G | 0.705853 | R | 0.772165 | -0.066312 | No Change: Both D | - |
| P11277 | SPTB1_HUMAN Spectrin beta chain erythrocyte OS=Homo sapiens GN=SPTB PE=1 SV=5 | 525 | E | 0.42839 | K | 0.436742 | -0.008352 | No Change: Both O | - |
| Q01082 | SPTB2_HUMAN Spectrin beta chain brain 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 | 1411 | D | 0.496715 | H | 0.428164 | 0.068551 | No Change: Both O | - |
| O15020 | SPTN2_HUMAN Spectrin beta chain brain 2 OS=Homo sapiens GN=SPTBN2 PE=1 SV=3 | 253 | L | 0.37047 | P | 0.534975 | -0.164505 | O to D | Spinocerebellar ataxia type 5 (SCA5) [MIM:600224] |
| O15020 | SPTN2_HUMAN Spectrin beta chain brain 2 OS=Homo sapiens GN=SPTBN2 PE=1 SV=3 | 825 | S | 0.878722 | G | 0.840912 | 0.03781 | No Change: Both D | - |
| O15020 | SPTN2_HUMAN Spectrin beta chain brain 2 OS=Homo sapiens GN=SPTBN2 PE=1 SV=3 | 1034 | V | 0.48591 | A | 0.600673 | -0.114763 | O to D | - |
| O15020 | SPTN2_HUMAN Spectrin beta chain brain 2 OS=Homo sapiens GN=SPTBN2 PE=1 SV=3 | 774 | E | 0.545097 | K | 0.512612 | 0.032485 | No Change: Both D | A colorectal cancer sample |
| O15020 | SPTN2_HUMAN Spectrin beta chain brain 2 OS=Homo sapiens GN=SPTBN2 PE=1 SV=3 | 835 | E | 0.768509 | K | 0.711341 | 0.057168 | No Change: Both D | - |
| Q9H254 | SPTN4_HUMAN Spectrin beta chain brain 3 OS=Homo sapiens GN=SPTBN4 PE=1 SV=2 | 1331 | G | 0.594443 | S | 0.626891 | -0.032448 | No Change: Both D | - |
| Q9NRC6 | SPTN5_HUMAN Spectrin beta chain brain 4 OS=Homo sapiens GN=SPTBN5 PE=1 SV=1 | 1345 | R | 0.626978 | H | 0.596412 | 0.030566 | No Change: Both D | - |
| Q9NRC6 | SPTN5_HUMAN Spectrin beta chain brain 4 OS=Homo sapiens GN=SPTBN5 PE=1 SV=1 | 1367 | R | 0.707236 | T | 0.657477 | 0.049759 | No Change: Both D | - |
| Q9NRC6 | SPTN5_HUMAN Spectrin beta chain brain 4 OS=Homo sapiens GN=SPTBN5 PE=1 SV=1 | 2862 | Q | 0.773162 | R | 0.772086 | 0.001076 | No Change: Both D | - |
| Q9NRC6 | SPTN5_HUMAN Spectrin beta chain brain 4 OS=Homo sapiens GN=SPTBN5 PE=1 SV=1 | 3275 | A | 0.736019 | G | 0.742898 | -0.006879 | No Change: Both D | - |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 133 | C | 0.249068 | W | 0.218732 | 0.030336 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400] |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 133 | C | 0.249068 | Y | 0.317876 | -0.068808 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400] |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 144 | V | 0.153081 | D | 0.304325 | -0.151244 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400] |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 239 | R | 0.198823 | W | 0.071339 | 0.127484 | No Change: Both O | A breast cancer sample |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 151 | R | 0.336103 | L | 0.239071 | 0.097032 | No Change: Both O | - |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 387 | G | 0.447408 | A | 0.389833 | 0.057575 | No Change: Both O | - |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 331 | S | 0.278967 | F | 0.134472 | 0.144495 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400] |
| O15269 | SPTC1_HUMAN Serine palmitoyltransferase 1 OS=Homo sapiens GN=SPTLC1 PE=1 SV=1 | 352 | A | 0.23337 | V | 0.155569 | 0.077801 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400] |
| O15270 | SPTC2_HUMAN Serine palmitoyltransferase 2 OS=Homo sapiens GN=SPTLC2 PE=1 SV=1 | 359 | V | 0.238535 | M | 0.28222 | -0.043685 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1C (HSAN1C) [MIM:613640] |
| O15270 | SPTC2_HUMAN Serine palmitoyltransferase 2 OS=Homo sapiens GN=SPTLC2 PE=1 SV=1 | 382 | G | 0.44018 | V | 0.280855 | 0.159325 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1C (HSAN1C) [MIM:613640] |
| O15270 | SPTC2_HUMAN Serine palmitoyltransferase 2 OS=Homo sapiens GN=SPTLC2 PE=1 SV=1 | 504 | I | 0.219724 | F | 0.222875 | -0.003151 | No Change: Both O | Hereditary sensory and autonomic neuropathy type 1C (HSAN1C) [MIM:613640] |
| Q9NUV7 | SPTC3_HUMAN Serine palmitoyltransferase 3 OS=Homo sapiens GN=SPTLC3 PE=1 SV=3 | 140 | L | 0.283655 | V | 0.285321 | -0.001666 | No Change: Both O | - |
| Q68D10 | SPT2_HUMAN Protein SPT2 homolog OS=Homo sapiens GN=SPTY2D1 PE=1 SV=3 | 317 | S | 0.983221 | F | 0.964148 | 0.019073 | No Change: Both D | - |
| Q68D10 | SPT2_HUMAN Protein SPT2 homolog OS=Homo sapiens GN=SPTY2D1 PE=1 SV=3 | 447 | R | 0.997481 | Q | 0.997183 | 2.98E-04 | No Change: Both D | - |
| Q68D10 | SPT2_HUMAN Protein SPT2 homolog OS=Homo sapiens GN=SPTY2D1 PE=1 SV=3 | 617 | K | 0.871745 | R | 0.864852 | 0.006893 | No Change: Both D | - |
| Q9BXG8 | SPZ1_HUMAN Spermatogenic leucine zipper protein 1 OS=Homo sapiens GN=SPZ1 PE=2 SV=2 | 17 | V | 0.745308 | L | 0.779985 | -0.034677 | No Change: Both D | - |
| Q9BXG8 | SPZ1_HUMAN Spermatogenic leucine zipper protein 1 OS=Homo sapiens GN=SPZ1 PE=2 SV=2 | 302 | E | 0.677508 | K | 0.671553 | 0.005955 | No Change: Both D | - |
| Q9Y6N5 | SQRD_HUMAN Sulfide:quinone oxidoreductase mitochondrial OS=Homo sapiens GN=SQRDL PE=1 SV=1 | 264 | I | 0.287217 | T | 0.441236 | -0.154019 | No Change: Both O | - |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 117 | A | 0.656841 | V | 0.61129 | 0.045551 | No Change: Both D | - |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 274 | E | 0.966937 | Q | 0.95768 | 0.009257 | No Change: Both D | - |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 387 | P | 0.755571 | L | 0.673456 | 0.082115 | No Change: Both D | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 392 | P | 0.662141 | L | 0.553178 | 0.108963 | No Change: Both D | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 399 | S | 0.472938 | P | 0.459785 | 0.013153 | No Change: Both O | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 404 | M | 0.468364 | T | 0.49152 | -0.023156 | No Change: Both O | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 404 | M | 0.468364 | V | 0.380568 | 0.087796 | No Change: Both O | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 411 | G | 0.279939 | S | 0.33029 | -0.050351 | No Change: Both O | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 425 | G | 0.208942 | R | 0.208592 | 3.50E-04 | No Change: Both O | Paget disease of bone (PDB) [MIM:602080] |
| Q13501 | SQSTM_HUMAN Sequestosome-1 OS=Homo sapiens GN=SQSTM1 PE=1 SV=1 | 274 | E | 0.966937 | D | 0.962453 | 0.004484 | No Change: Both D | - |
| Q9HD15 | SRA1_HUMAN Steroid receptor RNA activator 1 OS=Homo sapiens GN=SRA1 PE=1 SV=1 | 32 | Q | 0.571089 | E | 0.579601 | -0.008512 | No Change: Both D | - |
| Q8N5C6 | SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 OS=Homo sapiens GN=SRBD1 PE=1 SV=2 | 361 | T | 0.258806 | M | 0.22363 | 0.035176 | No Change: Both O | - |
| Q8N5C6 | SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 OS=Homo sapiens GN=SRBD1 PE=1 SV=2 | 798 | V | 0.696787 | F | 0.644861 | 0.051926 | No Change: Both D | - |
| Q8N5C6 | SRBD1_HUMAN S1 RNA-binding domain-containing protein 1 OS=Homo sapiens GN=SRBD1 PE=1 SV=2 | 811 | K | 0.664743 | R | 0.590283 | 0.07446 | No Change: Both D | - |
| P12931 | SRC_HUMAN Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens GN=SRC PE=1 SV=3 | 237 | A | 0.31356 | T | 0.340649 | -0.027089 | No Change: Both O | - |
| P12931 | SRC_HUMAN Proto-oncogene tyrosine-protein kinase Src OS=Homo sapiens GN=SRC PE=1 SV=3 | 176 | L | 0.411885 | F | 0.39645 | 0.015435 | No Change: Both O | - |
| Q8WTU2 | SRB4D_HUMAN Scavenger receptor cysteine-rich domain-containing group B protein OS=Homo sapiens GN=SRCRB4D PE=2 SV=1 | 128 | R | 0.316772 | H | 0.308567 | 0.008205 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 246 | R | 0.371608 | W | 0.190953 | 0.180655 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 49 | A | 0.253398 | T | 0.257594 | -0.004196 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 55 | L | 0.191222 | Q | 0.29428 | -0.103058 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 115 | G | 0.061116 | D | 0.06481 | -0.003694 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 183 | G | 0.194678 | S | 0.237326 | -0.042648 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 196 | G | 0.07532 | S | 0.093028 | -0.017708 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 197 | E | 0.066733 | D | 0.055039 | 0.011694 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 212 | P | 0.079653 | R | 0.066794 | 0.012859 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 228 | A | 0.113638 | T | 0.129073 | -0.015435 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 231 | H | 0.118532 | R | 0.117576 | 9.56E-04 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 85 | G | 0.04836 | D | 0.049726 | -0.001366 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 89 | V | 0.024757 | L | 0.026182 | -0.001425 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 200 | E | 0.038858 | K | 0.036041 | 0.002817 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 245 | S | 0.401368 | Y | 0.239756 | 0.161612 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 246 | R | 0.371608 | Q | 0.393002 | -0.021394 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 113 | L | 0.057108 | V | 0.053701 | 0.003407 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 145 | R | 0.0555 | W | 0.02202 | 0.03348 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 181 | P | 0.225741 | L | 0.118761 | 0.10698 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 235 | Y | 0.211299 | F | 0.19416 | 0.017139 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 123 | G | 0.123471 | R | 0.107388 | 0.016083 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 126 | Q | 0.057008 | R | 0.051988 | 0.00502 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 158 | G | 0.069338 | R | 0.06041 | 0.008928 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 207 | A | 0.041423 | D | 0.055752 | -0.014329 | No Change: Both O | Pseudovaginal perineoscrotal hypospadias (PPSH) [MIM:264600] |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 224 | L | 0.066604 | M | 0.081087 | -0.014483 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 227 | R | 0.108701 | Q | 0.112357 | -0.003656 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 203 | G | 0.028905 | S | 0.037279 | -0.008374 | No Change: Both O | - |
| P31213 | S5A2_HUMAN 3-oxo-5-alpha-steroid 4-dehydrogenase 2 OS=Homo sapiens GN=SRD5A2 PE=1 SV=1 | 224 | L | 0.066604 | H | 0.116828 | -0.050224 | No Change: Both O | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 306 | N | 0.434495 | S | 0.516651 | -0.082156 | O to D | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 309 | A | 0.531737 | T | 0.537202 | -0.005465 | No Change: Both D | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 417 | V | 0.791838 | M | 0.835458 | -0.04362 | No Change: Both D | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 580 | V | 0.249041 | M | 0.306308 | -0.057267 | No Change: Both O | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 746 | R | 0.29932 | H | 0.290419 | 0.008901 | No Change: Both O | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 834 | S | 0.577555 | L | 0.415911 | 0.161644 | D to O | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 1000 | T | 0.896524 | A | 0.902729 | -0.006205 | No Change: Both D | - |
| P36956 | SRBP1_HUMAN Sterol regulatory element-binding protein 1 OS=Homo sapiens GN=SREBF1 PE=1 SV=2 | 1008 | A | 0.912851 | P | 0.938513 | -0.025662 | No Change: Both D | - |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 595 | G | 0.214738 | A | 0.200648 | 0.01409 | No Change: Both O | - |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 623 | V | 0.085727 | M | 0.11181 | -0.026083 | No Change: Both O | - |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 273 | A | 0.483135 | S | 0.562822 | -0.079687 | O to D | A breast cancer sample |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 347 | N | 0.478635 | K | 0.556376 | -0.077741 | O to D | A breast cancer sample |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 536 | M | 0.043546 | L | 0.033661 | 0.009885 | No Change: Both O | - |
| Q12772 | SRBP2_HUMAN Sterol regulatory element-binding protein 2 OS=Homo sapiens GN=SREBF2 PE=1 SV=2 | 860 | R | 0.682215 | S | 0.752061 | -0.069846 | No Change: Both D | - |
| O75044 | FNBP2_HUMAN SLIT-ROBO Rho GTPase-activating protein 2 OS=Homo sapiens GN=SRGAP2 PE=1 SV=2 | 874 | R | 0.983324 | G | 0.984082 | -7.58E-04 | No Change: Both D | - |
| O43295 | SRGP2_HUMAN SLIT-ROBO Rho GTPase-activating protein 3 OS=Homo sapiens GN=SRGAP3 PE=1 SV=3 | 623 | L | 0.054902 | I | 0.049953 | 0.004949 | No Change: Both O | A breast cancer sample |
| O43295 | SRGP2_HUMAN SLIT-ROBO Rho GTPase-activating protein 3 OS=Homo sapiens GN=SRGAP3 PE=1 SV=3 | 628 | I | 0.023173 | V | 0.030311 | -0.007138 | No Change: Both O | - |
| P10124 | SRGN_HUMAN Serglycin OS=Homo sapiens GN=SRGN PE=1 SV=3 | 31 | R | 0.332717 | Q | 0.346146 | -0.013429 | No Change: Both O | - |
| P19623 | SPEE_HUMAN Spermidine synthase OS=Homo sapiens GN=SRM PE=1 SV=1 | 149 | L | 0.387111 | V | 0.388893 | -0.001782 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 73 | R | 0.375224 | C | 0.260163 | 0.115061 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 75 | G | 0.345549 | R | 0.362446 | -0.016897 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 88 | I | 0.233721 | V | 0.265641 | -0.03192 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 301 | V | 0.148515 | L | 0.152119 | -0.003604 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 377 | D | 0.412535 | E | 0.417113 | -0.004578 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 397 | A | 0.244972 | V | 0.179357 | 0.065615 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 452 | P | 0.290485 | L | 0.162341 | 0.128144 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 453 | A | 0.273928 | T | 0.289474 | -0.015546 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 457 | V | 0.200223 | L | 0.235043 | -0.03482 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 465 | S | 0.531048 | T | 0.445946 | 0.085102 | D to O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 218 | P | 0.476442 | L | 0.295343 | 0.181099 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 255 | V | 0.094761 | M | 0.11696 | -0.022199 | No Change: Both O | - |
| Q9H3Y6 | SRMS_HUMAN Tyrosine-protein kinase Srms OS=Homo sapiens GN=SRMS PE=2 SV=1 | 325 | P | 0.208077 | L | 0.114824 | 0.093253 | No Change: Both O | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 51 | P | 0.548311 | S | 0.55649 | -0.008179 | No Change: Both D | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 68 | S | 0.594701 | I | 0.418216 | 0.176485 | D to O | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 124 | P | 0.997716 | A | 0.99759 | 1.26E-04 | No Change: Both D | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 125 | T | 0.997996 | A | 0.998 | -4.00E-06 | No Change: Both D | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 127 | A | 0.99837 | T | 0.998418 | -4.80E-05 | No Change: Both D | - |
| P37108 | SRP14_HUMAN Signal recognition particle 14 kDa protein OS=Homo sapiens GN=SRP14 PE=1 SV=2 | 130 | T | 0.99881 | A | 0.998817 | -7.00E-06 | No Change: Both D | - |
| P09132 | SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens GN=SRP19 PE=1 SV=3 | 4 | A | 0.659479 | T | 0.655147 | 0.004332 | No Change: Both D | - |
| Q96SB4 | SRPK1_HUMAN SRSF protein kinase 1 OS=Homo sapiens GN=SRPK1 PE=1 SV=2 | 72 | I | 0.176783 | T | 0.287935 | -0.111152 | No Change: Both O | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 43 | P | 0.9927 | L | 0.986973 | 0.005727 | No Change: Both D | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 243 | G | 0.695497 | D | 0.717834 | -0.022337 | No Change: Both D | A glioblastoma multiforme sample |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 426 | T | 0.906168 | P | 0.939205 | -0.033037 | No Change: Both D | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 486 | S | 0.973444 | F | 0.934659 | 0.038785 | No Change: Both D | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 515 | P | 0.476928 | T | 0.414431 | 0.062497 | No Change: Both O | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 615 | L | 0.355783 | I | 0.337943 | 0.01784 | No Change: Both O | - |
| P78362 | SRPK2_HUMAN SRSF protein kinase 2 OS=Homo sapiens GN=SRPK2 PE=1 SV=3 | 608 | S | 0.24379 | N | 0.192673 | 0.051117 | No Change: Both O | - |
| Q9UPE1 | SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens GN=SRPK3 PE=2 SV=2 | 101 | R | 0.049377 | C | 0.021978 | 0.027399 | No Change: Both O | - |
| Q9UPE1 | SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens GN=SRPK3 PE=2 SV=2 | 114 | G | 0.387572 | E | 0.465077 | -0.077505 | No Change: Both O | - |
| Q9UPE1 | SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens GN=SRPK3 PE=2 SV=2 | 233 | E | 0.314236 | K | 0.298119 | 0.016117 | No Change: Both O | - |
| Q9Y5M8 | SRPRB_HUMAN Signal recognition particle receptor subunit beta OS=Homo sapiens GN=SRPRB PE=1 SV=3 | 9 | V | 0.696568 | L | 0.741654 | -0.045086 | No Change: Both D | - |
| P78539 | SRPX_HUMAN Sushi repeat-containing protein SRPX OS=Homo sapiens GN=SRPX PE=2 SV=1 | 225 | P | 0.38866 | S | 0.407233 | -0.018573 | No Change: Both O | - |
| P78539 | SRPX_HUMAN Sushi repeat-containing protein SRPX OS=Homo sapiens GN=SRPX PE=2 SV=1 | 413 | S | 0.080044 | F | 0.029194 | 0.05085 | No Change: Both O | - |
| O60687 | SRPX2_HUMAN Sushi repeat-containing protein SRPX2 OS=Homo sapiens GN=SRPX2 PE=1 SV=1 | 72 | Y | 0.414354 | S | 0.549851 | -0.135497 | O to D | Bilateral perisylvian polymicrogyria (BPP) [MIM:300388] |
| O60687 | SRPX2_HUMAN Sushi repeat-containing protein SRPX2 OS=Homo sapiens GN=SRPX2 PE=1 SV=1 | 287 | T | 0.50123 | S | 0.553079 | -0.051849 | No Change: Both D | - |
| O60687 | SRPX2_HUMAN Sushi repeat-containing protein SRPX2 OS=Homo sapiens GN=SRPX2 PE=1 SV=1 | 327 | N | 0.298198 | S | 0.341311 | -0.043113 | No Change: Both O | Rolandic epilepsy with speech dyspraxia and mental retardation X-linked (RESDX) [MIM:300643] |
| Q9UH36 | SRR1L_HUMAN SRR1-like protein OS=Homo sapiens GN=SRRD PE=2 SV=1 | 99 | A | 0.337377 | T | 0.379901 | -0.042524 | No Change: Both O | - |
| Q8IYB3 | SRRM1_HUMAN Serine/arginine repetitive matrix protein 1 OS=Homo sapiens GN=SRRM1 PE=1 SV=2 | 170 | R | 0.999971 | H | 0.999951 | 2.00E-05 | No Change: Both D | - |
| Q9UQ35 | SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens GN=SRRM2 PE=1 SV=2 | 804 | P | 0.999938 | T | 0.999913 | 2.50E-05 | No Change: Both D | - |
| Q9UQ35 | SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens GN=SRRM2 PE=1 SV=2 | 883 | S | 0.997197 | C | 0.995774 | 0.001423 | No Change: Both D | - |
| Q9UQ35 | SRRM2_HUMAN Serine/arginine repetitive matrix protein 2 OS=Homo sapiens GN=SRRM2 PE=1 SV=2 | 856 | T | 0.994806 | R | 0.99565 | -8.44E-04 | No Change: Both D | - |
| A7MD48 | SRRM4_HUMAN Serine/arginine repetitive matrix protein 4 OS=Homo sapiens GN=SRRM4 PE=1 SV=2 | 243 | S | 0.881286 | N | 0.825171 | 0.056115 | No Change: Both D | - |
| A7MD48 | SRRM4_HUMAN Serine/arginine repetitive matrix protein 4 OS=Homo sapiens GN=SRRM4 PE=1 SV=2 | 406 | R | 0.99962 | Q | 0.999517 | 1.03E-04 | No Change: Both D | - |
| A7MD48 | SRRM4_HUMAN Serine/arginine repetitive matrix protein 4 OS=Homo sapiens GN=SRRM4 PE=1 SV=2 | 547 | R | 0.999939 | S | 0.99995 | -1.10E-05 | No Change: Both D | - |
| Q07955 | SRSF1_HUMAN Serine/arginine-rich splicing factor 1 OS=Homo sapiens GN=SRSF1 PE=1 SV=2 | 89 | P | 0.896786 | S | 0.893527 | 0.003259 | No Change: Both D | A breast cancer sample |
| Q08170 | SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens GN=SRSF4 PE=1 SV=2 | 253 | E | 0.99972 | D | 0.999695 | 2.50E-05 | No Change: Both D | - |
| Q08170 | SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens GN=SRSF4 PE=1 SV=2 | 338 | G | 0.999965 | A | 0.999949 | 1.60E-05 | No Change: Both D | - |
| Q08170 | SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens GN=SRSF4 PE=1 SV=2 | 356 | G | 0.999992 | S | 0.999995 | -3.00E-06 | No Change: Both D | - |
| Q08170 | SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens GN=SRSF4 PE=1 SV=2 | 438 | Q | 0.999444 | E | 0.999561 | -1.17E-04 | No Change: Both D | - |
| Q13243 | SRSF5_HUMAN Serine/arginine-rich splicing factor 5 OS=Homo sapiens GN=SRSF5 PE=1 SV=1 | 160 | A | 0.512814 | S | 0.59213 | -0.079316 | No Change: Both D | - |
| Q13247 | SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens GN=SRSF6 PE=1 SV=2 | 145 | R | 0.463556 | Q | 0.463473 | 8.30E-05 | No Change: Both O | A colorectal cancer sample |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 18 | S | 0.614807 | N | 0.54896 | 0.065847 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 60 | V | 0.654748 | A | 0.699532 | -0.044784 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 60 | V | 0.654748 | L | 0.645635 | 0.009113 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 62 | R | 0.620066 | G | 0.564682 | 0.055384 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 64 | M | 0.549521 | I | 0.435436 | 0.114085 | D to O | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 68 | I | 0.484501 | T | 0.607644 | -0.123143 | O to D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 78 | M | 0.622368 | T | 0.601885 | 0.020483 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 90 | I | 0.590713 | M | 0.71962 | -0.128907 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 91 | S | 0.55949 | G | 0.497431 | 0.062059 | D to O | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 95 | G | 0.40648 | R | 0.496567 | -0.090087 | No Change: Both O | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 101 | L | 0.490184 | H | 0.537199 | -0.047015 | O to D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 106 | K | 0.560957 | I | 0.359068 | 0.201889 | D to O | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 108 | P | 0.540454 | R | 0.523763 | 0.016691 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 109 | F | 0.548029 | S | 0.686358 | -0.138329 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 113 | A | 0.600658 | T | 0.606317 | -0.005659 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 125 | P | 0.729375 | L | 0.569268 | 0.160107 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 127 | Y | 0.755303 | C | 0.764169 | -0.008866 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 133 | R | 0.767315 | W | 0.538571 | 0.228744 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 64 | M | 0.549521 | R | 0.620118 | -0.070597 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 67 | F | 0.532979 | V | 0.595083 | -0.062104 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 76 | R | 0.584583 | S | 0.600548 | -0.015965 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 87 | N | 0.622151 | Y | 0.492 | 0.130151 | D to O | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 95 | G | 0.40648 | E | 0.539933 | -0.133453 | O to D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 127 | Y | 0.755303 | F | 0.735744 | 0.019559 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 131 | P | 0.754367 | R | 0.729078 | 0.025289 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| Q05066 | SRY_HUMAN Sex-determining region Y protein OS=Homo sapiens GN=SRY PE=1 SV=1 | 3 | S | 0.68706 | L | 0.562511 | 0.124549 | No Change: Both D | 46 XY sex reversal type 1 (SRXY1) [MIM:400044] |
| O75177 | CREST_HUMAN Calcium-responsive transactivator OS=Homo sapiens GN=SS18L1 PE=1 SV=2 | 321 | A | 0.991049 | T | 0.99212 | -0.001071 | No Change: Both D | - |
| O75177 | CREST_HUMAN Calcium-responsive transactivator OS=Homo sapiens GN=SS18L1 PE=1 SV=2 | 189 | M | 0.931617 | I | 0.89131 | 0.040307 | No Change: Both D | - |
| P05455 | LA_HUMAN Lupus La protein OS=Homo sapiens GN=SSB PE=1 SV=2 | 48 | P | 0.076485 | S | 0.085506 | -0.009021 | No Change: Both O | - |
| P28290 | SSFA2_HUMAN Sperm-specific antigen 2 OS=Homo sapiens GN=SSFA2 PE=1 SV=3 | 833 | R | 0.965687 | W | 0.92416 | 0.041527 | No Change: Both D | - |
| P28290 | SSFA2_HUMAN Sperm-specific antigen 2 OS=Homo sapiens GN=SSFA2 PE=1 SV=3 | 836 | P | 0.964736 | L | 0.933602 | 0.031134 | No Change: Both D | - |
| P28290 | SSFA2_HUMAN Sperm-specific antigen 2 OS=Homo sapiens GN=SSFA2 PE=1 SV=3 | 817 | A | 0.933351 | V | 0.923371 | 0.00998 | No Change: Both D | - |
| P28290 | SSFA2_HUMAN Sperm-specific antigen 2 OS=Homo sapiens GN=SSFA2 PE=1 SV=3 | 1258 | Y | 0.809918 | N | 0.852067 | -0.042149 | No Change: Both D | - |
| Q76I76 | SSH2_HUMAN Protein phosphatase Slingshot homolog 2 OS=Homo sapiens GN=SSH2 PE=1 SV=1 | 743 | S | 0.688545 | L | 0.535413 | 0.153132 | No Change: Both D | - |
| Q76I76 | SSH2_HUMAN Protein phosphatase Slingshot homolog 2 OS=Homo sapiens GN=SSH2 PE=1 SV=1 | 763 | V | 0.446137 | A | 0.517212 | -0.071075 | O to D | - |
| Q76I76 | SSH2_HUMAN Protein phosphatase Slingshot homolog 2 OS=Homo sapiens GN=SSH2 PE=1 SV=1 | 1300 | H | 0.883166 | Q | 0.90448 | -0.021314 | No Change: Both D | - |
| Q8TE77 | SSH3_HUMAN Protein phosphatase Slingshot homolog 3 OS=Homo sapiens GN=SSH3 PE=1 SV=2 | 239 | E | 0.585604 | V | 0.439365 | 0.146239 | D to O | - |
| Q8TE77 | SSH3_HUMAN Protein phosphatase Slingshot homolog 3 OS=Homo sapiens GN=SSH3 PE=1 SV=2 | 600 | R | 0.887214 | H | 0.845916 | 0.041298 | No Change: Both D | - |
| O43805 | SSNA1_HUMAN Sjoegren syndrome nuclear autoantigen 1 OS=Homo sapiens GN=SSNA1 PE=1 SV=2 | 17 | K | 0.730778 | N | 0.727269 | 0.003509 | No Change: Both D | A breast cancer sample |
| Q14714 | SSPN_HUMAN Sarcospan OS=Homo sapiens GN=SSPN PE=2 SV=3 | 186 | S | 0.212615 | N | 0.17997 | 0.032645 | No Change: Both O | - |
| Q14714 | SSPN_HUMAN Sarcospan OS=Homo sapiens GN=SSPN PE=2 SV=3 | 228 | V | 0.041942 | I | 0.035186 | 0.006756 | No Change: Both O | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 146 | Q | 0.815142 | R | 0.804893 | 0.010249 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 298 | V | 0.185505 | M | 0.216433 | -0.030928 | No Change: Both O | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1273 | L | 0.520219 | P | 0.656809 | -0.13659 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 539 | V | 0.254075 | M | 0.292439 | -0.038364 | No Change: Both O | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1272 | S | 0.509082 | P | 0.512281 | -0.003199 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1424 | S | 0.889352 | G | 0.879693 | 0.009659 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1448 | P | 0.897515 | Q | 0.880999 | 0.016516 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1453 | P | 0.881154 | R | 0.852668 | 0.028486 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1778 | S | 0.893731 | P | 0.899222 | -0.005491 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1793 | L | 0.9339 | P | 0.965001 | -0.031101 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 1882 | R | 0.346276 | C | 0.271992 | 0.074284 | No Change: Both O | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 2017 | T | 0.565978 | M | 0.547614 | 0.018364 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 2891 | L | 0.906716 | V | 0.885095 | 0.021621 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 3273 | R | 0.892459 | W | 0.776794 | 0.115665 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 3512 | N | 0.993798 | S | 0.995651 | -0.001853 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 3892 | C | 0.878955 | W | 0.827446 | 0.051509 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 3909 | R | 0.849666 | C | 0.82129 | 0.028376 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4028 | S | 0.97259 | I | 0.923118 | 0.049472 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4164 | H | 0.952849 | R | 0.956589 | -0.00374 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4330 | R | 0.850356 | C | 0.827716 | 0.02264 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4787 | H | 0.882619 | R | 0.909756 | -0.027137 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4941 | E | 0.545378 | K | 0.512862 | 0.032516 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 2452 | M | 0.666659 | T | 0.6566 | 0.010059 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 2541 | R | 0.678674 | Q | 0.68407 | -0.005396 | No Change: Both D | - |
| A2VEC9 | SSPO_HUMAN SCO-spondin OS=Homo sapiens GN=SSPO PE=2 SV=1 | 4107 | Q | 0.823829 | H | 0.784113 | 0.039716 | No Change: Both D | - |
| P43307 | SSRA_HUMAN Translocon-associated protein subunit alpha OS=Homo sapiens GN=SSR1 PE=1 SV=3 | 28 | L | 0.338308 | S | 0.451444 | -0.113136 | No Change: Both O | - |
| P51571 | SSRD_HUMAN Translocon-associated protein subunit delta OS=Homo sapiens GN=SSR4 PE=1 SV=1 | 144 | G | 0.267493 | R | 0.254432 | 0.013061 | No Change: Both O | - |
| Q08945 | SSRP1_HUMAN FACT complex subunit SSRP1 OS=Homo sapiens GN=SSRP1 PE=1 SV=1 | 225 | L | 0.149173 | V | 0.141297 | 0.007876 | No Change: Both O | - |
| Q08945 | SSRP1_HUMAN FACT complex subunit SSRP1 OS=Homo sapiens GN=SSRP1 PE=1 SV=1 | 458 | E | 0.95568 | Q | 0.944986 | 0.010694 | No Change: Both D | - |
| O60232 | SSA27_HUMAN Sjoegren syndrome/scleroderma autoantigen 1 OS=Homo sapiens GN=SSSCA1 PE=1 SV=1 | 21 | T | 0.592115 | M | 0.567871 | 0.024244 | No Change: Both D | - |
| P61278 | SMS_HUMAN Somatostatin OS=Homo sapiens GN=SST PE=1 SV=1 | 11 | A | 0.126435 | V | 0.076416 | 0.050019 | No Change: Both O | - |
| P61278 | SMS_HUMAN Somatostatin OS=Homo sapiens GN=SST PE=1 SV=1 | 61 | N | 0.857791 | T | 0.849545 | 0.008246 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 411 | S | 0.934141 | T | 0.906558 | 0.027583 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 251 | S | 0.758173 | F | 0.520857 | 0.237316 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 33 | A | 0.58847 | V | 0.530644 | 0.057826 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 336 | R | 0.809798 | C | 0.755797 | 0.054001 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 414 | R | 0.927242 | H | 0.895932 | 0.03131 | No Change: Both D | - |
| P32745 | SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens GN=SSTR3 PE=1 SV=1 | 37 | P | 0.574204 | L | 0.43687 | 0.137334 | D to O | - |
| P31391 | SSR4_HUMAN Somatostatin receptor type 4 OS=Homo sapiens GN=SSTR4 PE=2 SV=2 | 83 | N | 0.143422 | T | 0.125009 | 0.018413 | No Change: Both O | - |
| P31391 | SSR4_HUMAN Somatostatin receptor type 4 OS=Homo sapiens GN=SSTR4 PE=2 SV=2 | 284 | F | 0.067729 | V | 0.085929 | -0.0182 | No Change: Both O | - |
| P31391 | SSR4_HUMAN Somatostatin receptor type 4 OS=Homo sapiens GN=SSTR4 PE=2 SV=2 | 321 | F | 0.086034 | S | 0.204239 | -0.118205 | No Change: Both O | - |
| P31391 | SSR4_HUMAN Somatostatin receptor type 4 OS=Homo sapiens GN=SSTR4 PE=2 SV=2 | 236 | G | 0.05831 | D | 0.064977 | -0.006667 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 335 | P | 0.829926 | L | 0.739483 | 0.090443 | No Change: Both D | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 37 | G | 0.411134 | R | 0.403825 | 0.007309 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 48 | L | 0.024698 | M | 0.029683 | -0.004985 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 52 | A | 0.056029 | V | 0.03949 | 0.016539 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 109 | P | 0.043552 | S | 0.049182 | -0.00563 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 333 | T | 0.803435 | M | 0.796527 | 0.006908 | No Change: Both D | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 105 | W | 0.092897 | R | 0.221946 | -0.129049 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 251 | L | 0.040634 | S | 0.091081 | -0.050447 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 339 | R | 0.890837 | K | 0.893121 | -0.002284 | No Change: Both D | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 234 | R | 0.219645 | C | 0.104199 | 0.115446 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 267 | V | 0.021063 | I | 0.017749 | 0.003314 | No Change: Both O | - |
| P35346 | SSR5_HUMAN Somatostatin receptor type 5 OS=Homo sapiens GN=SSTR5 PE=1 SV=3 | 357 | G | 0.926373 | R | 0.958768 | -0.032395 | No Change: Both D | - |
| Q9Y2D8 | ADIP_HUMAN Afadin- and alpha-actinin-binding protein OS=Homo sapiens GN=SSX2IP PE=1 SV=3 | 578 | C | 0.541573 | R | 0.626565 | -0.084992 | No Change: Both D | - |
| O60225 | SSX5_HUMAN Protein SSX5 OS=Homo sapiens GN=SSX5 PE=2 SV=3 | 19 | E | 0.631229 | Q | 0.625772 | 0.005457 | No Change: Both D | - |
| Q7RTT6 | SSX6_HUMAN Putative protein SSX6 OS=Homo sapiens GN=SSX6 PE=5 SV=1 | 90 | R | 0.906524 | C | 0.837104 | 0.06942 | No Change: Both D | - |
| Q7RTT6 | SSX6_HUMAN Putative protein SSX6 OS=Homo sapiens GN=SSX6 PE=5 SV=1 | 138 | K | 0.976382 | Q | 0.971526 | 0.004856 | No Change: Both D | - |
| Q7RTT5 | SSX7_HUMAN Protein SSX7 OS=Homo sapiens GN=SSX7 PE=2 SV=1 | 43 | L | 0.553665 | S | 0.728379 | -0.174714 | No Change: Both D | - |
| Q7RTT3 | SSX9_HUMAN Protein SSX9 OS=Homo sapiens GN=SSX9 PE=2 SV=1 | 72 | C | 0.284785 | R | 0.443226 | -0.158441 | No Change: Both O | - |
| Q7RTT3 | SSX9_HUMAN Protein SSX9 OS=Homo sapiens GN=SSX9 PE=2 SV=1 | 97 | S | 0.663922 | P | 0.704826 | -0.040904 | No Change: Both D | - |
| P50502 | F10A1_HUMAN Hsc70-interacting protein OS=Homo sapiens GN=ST13 PE=1 SV=2 | 297 | M | 0.977847 | I | 0.95537 | 0.022477 | No Change: Both D | - |
| Q8IZP2 | ST134_HUMAN Putative protein FAM10A4 OS=Homo sapiens GN=ST13P4 PE=5 SV=1 | 71 | S | 0.991666 | L | 0.986221 | 0.005445 | No Change: Both D | - |
| Q9Y5Y6 | ST14_HUMAN Suppressor of tumorigenicity 14 protein OS=Homo sapiens GN=ST14 PE=1 SV=2 | 285 | M | 0.382071 | I | 0.288449 | 0.093622 | No Change: Both O | - |
| Q9Y5Y6 | ST14_HUMAN Suppressor of tumorigenicity 14 protein OS=Homo sapiens GN=ST14 PE=1 SV=2 | 381 | R | 0.120773 | S | 0.1552 | -0.034427 | No Change: Both O | - |
| Q9Y5Y6 | ST14_HUMAN Suppressor of tumorigenicity 14 protein OS=Homo sapiens GN=ST14 PE=1 SV=2 | 827 | G | 0.224777 | R | 0.214562 | 0.010215 | No Change: Both O | Ichthyosis autosomal recessive with hypotrichosis (ARIH) [MIM:610765] |
| O60284 | ST18_HUMAN Suppression of tumorigenicity 18 protein OS=Homo sapiens GN=ST18 PE=1 SV=1 | 515 | R | 0.55398 | C | 0.439501 | 0.114479 | D to O | - |
| Q9HBF5 | ST20_HUMAN Suppressor of tumorigenicity 20 protein OS=Homo sapiens GN=ST20 PE=2 SV=2 | 57 | P | 0.222995 | L | 0.126728 | 0.096267 | No Change: Both O | - |
| Q11201 | SIA4A_HUMAN CMP-N-acetylneuraminate-beta-galactosamide-alpha-2 3-sialyltransferase 1 OS=Homo sapiens GN=ST3GAL1 PE=2 SV=1 | 111 | N | 0.571333 | S | 0.573764 | -0.002431 | No Change: Both D | - |
| Q11203 | SIAT6_HUMAN CMP-N-acetylneuraminate-beta-1 4-galactoside alpha-2 3-sialyltransferase OS=Homo sapiens GN=ST3GAL3 PE=1 SV=1 | 13 | A | 0.011463 | D | 0.017353 | -0.00589 | No Change: Both O | Mental retardation autosomal recessive type 12 (MRT12) [MIM:611090] |
| Q11203 | SIAT6_HUMAN CMP-N-acetylneuraminate-beta-1 4-galactoside alpha-2 3-sialyltransferase OS=Homo sapiens GN=ST3GAL3 PE=1 SV=1 | 370 | D | 0.439856 | Y | 0.308355 | 0.131501 | No Change: Both O | Mental retardation autosomal recessive type 12 (MRT12) [MIM:611090] |
| Q9UNP4 | SIAT9_HUMAN Lactosylceramide alpha-2 3-sialyltransferase OS=Homo sapiens GN=ST3GAL5 PE=1 SV=4 | 104 | H | 0.56634 | R | 0.566525 | -1.85E-04 | No Change: Both D | - |
| Q9Y274 | SIA10_HUMAN Type 2 lactosamine alpha-2 3-sialyltransferase OS=Homo sapiens GN=ST3GAL6 PE=1 SV=1 | 311 | A | 0.192396 | T | 0.216796 | -0.0244 | No Change: Both O | - |
| P78524 | ST5_HUMAN Suppression of tumorigenicity 5 protein OS=Homo sapiens GN=ST5 PE=1 SV=3 | 316 | K | 0.849174 | N | 0.799575 | 0.049599 | No Change: Both D | - |
| P78524 | ST5_HUMAN Suppression of tumorigenicity 5 protein OS=Homo sapiens GN=ST5 PE=1 SV=3 | 399 | D | 0.993073 | E | 0.994072 | -9.99E-04 | No Change: Both D | - |
| P78524 | ST5_HUMAN Suppression of tumorigenicity 5 protein OS=Homo sapiens GN=ST5 PE=1 SV=3 | 620 | I | 0.83947 | T | 0.882236 | -0.042766 | No Change: Both D | - |
| P78524 | ST5_HUMAN Suppression of tumorigenicity 5 protein OS=Homo sapiens GN=ST5 PE=1 SV=3 | 774 | S | 0.504457 | G | 0.464386 | 0.040071 | D to O | - |
| P78524 | ST5_HUMAN Suppression of tumorigenicity 5 protein OS=Homo sapiens GN=ST5 PE=1 SV=3 | 657 | S | 0.884969 | F | 0.810842 | 0.074127 | No Change: Both D | - |
| Q96JF0 | SIAT2_HUMAN Beta-galactoside alpha-2 6-sialyltransferase 2 OS=Homo sapiens GN=ST6GAL2 PE=1 SV=2 | 154 | G | 0.867911 | R | 0.871029 | -0.003118 | No Change: Both D | - |
| Q96JF0 | SIAT2_HUMAN Beta-galactoside alpha-2 6-sialyltransferase 2 OS=Homo sapiens GN=ST6GAL2 PE=1 SV=2 | 341 | I | 0.230868 | V | 0.246802 | -0.015934 | No Change: Both O | - |
| Q8NDV1 | SIA7C_HUMAN Alpha-N-acetylgalactosaminide alpha-2 6-sialyltransferase 3 OS=Homo sapiens GN=ST6GALNAC3 PE=2 SV=1 | 223 | L | 0.027564 | I | 0.022219 | 0.005345 | No Change: Both O | - |
| Q9NSC7 | SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2 6-sialyltransferase 1 OS=Homo sapiens GN=ST6GALNAC1 PE=1 SV=1 | 80 | V | 0.908172 | A | 0.946339 | -0.038167 | No Change: Both D | - |
| Q9NSC7 | SIA7A_HUMAN Alpha-N-acetylgalactosaminide alpha-2 6-sialyltransferase 1 OS=Homo sapiens GN=ST6GALNAC1 PE=1 SV=1 | 424 | I | 0.140451 | V | 0.162276 | -0.021825 | No Change: Both O | - |
| Q9NRC1 | ST7_HUMAN Suppressor of tumorigenicity 7 protein OS=Homo sapiens GN=ST7 PE=1 SV=1 | 186 | A | 0.421339 | T | 0.432399 | -0.01106 | No Change: Both O | - |
| Q9NRC1 | ST7_HUMAN Suppressor of tumorigenicity 7 protein OS=Homo sapiens GN=ST7 PE=1 SV=1 | 361 | I | 0.352916 | V | 0.388317 | -0.035401 | No Change: Both O | - |
| Q8TDW4 | ST7L_HUMAN Suppressor of tumorigenicity 7 protein-like OS=Homo sapiens GN=ST7L PE=2 SV=1 | 451 | R | 0.179562 | Q | 0.207235 | -0.027673 | No Change: Both O | - |
| Q8TDW4 | ST7L_HUMAN Suppressor of tumorigenicity 7 protein-like OS=Homo sapiens GN=ST7L PE=2 SV=1 | 455 | A | 0.122917 | T | 0.142505 | -0.019588 | No Change: Both O | - |
| Q8TDW4 | ST7L_HUMAN Suppressor of tumorigenicity 7 protein-like OS=Homo sapiens GN=ST7L PE=2 SV=1 | 571 | G | 0.807692 | D | 0.813533 | -0.005841 | No Change: Both D | - |
| O43173 | SIA8C_HUMAN Sia-alpha-2 3-Gal-beta-1 4-GlcNAc-R:alpha 2 8-sialyltransferase OS=Homo sapiens GN=ST8SIA3 PE=2 SV=3 | 91 | K | 0.392836 | T | 0.322189 | 0.070647 | No Change: Both O | - |
| Q92187 | SIA8D_HUMAN CMP-N-acetylneuraminate-poly-alpha-2 8-sialyltransferase OS=Homo sapiens GN=ST8SIA4 PE=1 SV=1 | 92 | E | 0.303636 | G | 0.258496 | 0.04514 | No Change: Both O | A colorectal cancer sample |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 2506 | M | 0.381016 | T | 0.423014 | -0.041998 | No Change: Both O | - |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 1127 | G | 0.546718 | R | 0.527694 | 0.019024 | No Change: Both D | - |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 2282 | I | 0.205946 | V | 0.247521 | -0.041575 | No Change: Both O | - |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 672 | L | 0.309712 | M | 0.36432 | -0.054608 | No Change: Both O | - |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 912 | M | 0.337242 | V | 0.288635 | 0.048607 | No Change: Both O | - |
| Q9NY15 | STAB1_HUMAN Stabilin-1 OS=Homo sapiens GN=STAB1 PE=1 SV=3 | 1833 | A | 0.412256 | P | 0.507235 | -0.094979 | O to D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 510 | P | 0.549877 | H | 0.525867 | 0.02401 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 110 | I | 0.809155 | V | 0.802132 | 0.007023 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 306 | E | 0.602461 | K | 0.621134 | -0.018673 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 787 | R | 0.643272 | Q | 0.66538 | -0.022108 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 881 | R | 0.644512 | H | 0.621717 | 0.022795 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 1736 | N | 0.447266 | T | 0.413901 | 0.033365 | No Change: Both O | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 2039 | P | 0.714 | T | 0.677344 | 0.036656 | No Change: Both D | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 2401 | L | 0.338044 | V | 0.317198 | 0.020846 | No Change: Both O | - |
| Q8WWQ8 | STAB2_HUMAN Stabilin-2 OS=Homo sapiens GN=STAB2 PE=1 SV=3 | 2519 | Y | 0.826315 | S | 0.912526 | -0.086211 | No Change: Both D | - |
| Q99469 | STAC_HUMAN SH3 and cysteine-rich domain-containing protein OS=Homo sapiens GN=STAC PE=1 SV=1 | 262 | N | 0.592022 | S | 0.629808 | -0.037786 | No Change: Both D | - |
| Q8WVM7 | STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens GN=STAG1 PE=1 SV=3 | 1132 | Q | 0.925355 | H | 0.90458 | 0.020775 | No Change: Both D | - |
| Q8N3U4 | STAG2_HUMAN Cohesin subunit SA-2 OS=Homo sapiens GN=STAG2 PE=1 SV=3 | 699 | N | 0.222017 | K | 0.269965 | -0.047948 | No Change: Both O | - |
| Q8TBR4 | STG34_HUMAN STAG3-like protein 4 OS=Homo sapiens GN=STAG3L4 PE=2 SV=1 | 116 | E | 0.455861 | Q | 0.440624 | 0.015237 | No Change: Both O | - |
| Q92783 | STAM1_HUMAN Signal transducing adapter molecule 1 OS=Homo sapiens GN=STAM PE=1 SV=3 | 212 | G | 0.486748 | D | 0.526864 | -0.040116 | O to D | A colorectal cancer sample |
| Q96FJ0 | STALP_HUMAN AMSH-like protease OS=Homo sapiens GN=STAMBPL1 PE=1 SV=2 | 196 | S | 0.876782 | N | 0.838749 | 0.038033 | No Change: Both D | - |
| Q96FJ0 | STALP_HUMAN AMSH-like protease OS=Homo sapiens GN=STAMBPL1 PE=1 SV=2 | 204 | E | 0.813936 | K | 0.818206 | -0.00427 | No Change: Both D | - |
| Q96FJ0 | STALP_HUMAN AMSH-like protease OS=Homo sapiens GN=STAMBPL1 PE=1 SV=2 | 210 | A | 0.695234 | T | 0.728606 | -0.033372 | No Change: Both D | - |
| Q9UGK3 | STAP2_HUMAN Signal-transducing adaptor protein 2 OS=Homo sapiens GN=STAP2 PE=1 SV=2 | 93 | D | 0.225573 | N | 0.209967 | 0.015606 | No Change: Both O | - |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 182 | R | 0.232755 | L | 0.148221 | 0.084534 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 203 | A | 0.276971 | D | 0.339286 | -0.062315 | No Change: Both O | - |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 169 | E | 0.254054 | G | 0.21354 | 0.040514 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 169 | E | 0.254054 | K | 0.249423 | 0.004631 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 217 | R | 0.400941 | T | 0.400363 | 5.78E-04 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 218 | A | 0.350148 | V | 0.294521 | 0.055627 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 225 | M | 0.230654 | T | 0.277569 | -0.046915 | No Change: Both O | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 275 | L | 0.693265 | P | 0.77027 | -0.077005 | No Change: Both D | Adrenal hyperplasia type 1 (AH1) [MIM:201710] |
| P49675 | STAR_HUMAN Steroidogenic acute regulatory protein mitochondrial OS=Homo sapiens GN=STAR PE=1 SV=2 | 121 | R | 0.464266 | W | 0.27312 | 0.191146 | No Change: Both O | - |
| Q9Y3M8 | STA13_HUMAN StAR-related lipid transfer protein 13 OS=Homo sapiens GN=STARD13 PE=1 SV=2 | 250 | K | 0.91394 | R | 0.91361 | 3.30E-04 | No Change: Both D | - |
| Q9Y3M8 | STA13_HUMAN StAR-related lipid transfer protein 13 OS=Homo sapiens GN=STARD13 PE=1 SV=2 | 175 | T | 0.898736 | M | 0.889915 | 0.008821 | No Change: Both D | - |
| Q9Y3M8 | STA13_HUMAN StAR-related lipid transfer protein 13 OS=Homo sapiens GN=STARD13 PE=1 SV=2 | 383 | R | 0.618409 | P | 0.65146 | -0.033051 | No Change: Both D | - |
| Q9Y3M8 | STA13_HUMAN StAR-related lipid transfer protein 13 OS=Homo sapiens GN=STARD13 PE=1 SV=2 | 798 | N | 0.185286 | S | 0.195382 | -0.010096 | No Change: Both O | - |
| Q14849 | STAR3_HUMAN StAR-related lipid transfer protein 3 OS=Homo sapiens GN=STARD3 PE=1 SV=2 | 117 | R | 0.022793 | Q | 0.023213 | -4.20E-04 | No Change: Both O | - |
| Q14849 | STAR3_HUMAN StAR-related lipid transfer protein 3 OS=Homo sapiens GN=STARD3 PE=1 SV=2 | 216 | G | 0.834667 | A | 0.827791 | 0.006876 | No Change: Both D | - |
| Q9NSY2 | STAR5_HUMAN StAR-related lipid transfer protein 5 OS=Homo sapiens GN=STARD5 PE=1 SV=2 | 74 | G | 0.143803 | S | 0.166987 | -0.023184 | No Change: Both O | - |
| P59095 | STAR6_HUMAN StAR-related lipid transfer protein 6 OS=Homo sapiens GN=STARD6 PE=2 SV=1 | 159 | E | 0.454688 | K | 0.446718 | 0.00797 | No Change: Both O | - |
| Q9NQZ5 | STAR7_HUMAN StAR-related lipid transfer protein 7 mitochondrial OS=Homo sapiens GN=STARD7 PE=1 SV=2 | 140 | R | 0.635626 | P | 0.658327 | -0.022701 | No Change: Both D | - |
| Q92502 | STAR8_HUMAN StAR-related lipid transfer protein 8 OS=Homo sapiens GN=STARD8 PE=1 SV=2 | 188 | G | 0.581051 | S | 0.614062 | -0.033011 | No Change: Both D | A breast cancer sample |
| Q92502 | STAR8_HUMAN StAR-related lipid transfer protein 8 OS=Homo sapiens GN=STARD8 PE=1 SV=2 | 242 | E | 0.669043 | K | 0.650635 | 0.018408 | No Change: Both D | A breast cancer sample |
| Q92502 | STAR8_HUMAN StAR-related lipid transfer protein 8 OS=Homo sapiens GN=STARD8 PE=1 SV=2 | 327 | R | 0.261805 | Q | 0.288693 | -0.026888 | No Change: Both O | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 1124 | R | 0.944421 | C | 0.901397 | 0.043024 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 1634 | P | 0.466389 | L | 0.315501 | 0.150888 | No Change: Both O | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 2119 | A | 0.726789 | V | 0.62411 | 0.102679 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 2591 | R | 0.801133 | H | 0.762285 | 0.038848 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 2769 | T | 0.707887 | I | 0.587176 | 0.120711 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 2783 | P | 0.618642 | S | 0.619703 | -0.001061 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 2929 | R | 0.644189 | G | 0.630079 | 0.01411 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 3297 | N | 0.894678 | D | 0.912036 | -0.017358 | No Change: Both D | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 3383 | Y | 0.397381 | C | 0.436496 | -0.039115 | No Change: Both O | - |
| Q9P2P6 | STAR9_HUMAN StAR-related lipid transfer protein 9 OS=Homo sapiens GN=STARD9 PE=2 SV=2 | 787 | R | 0.955786 | C | 0.945975 | 0.009811 | No Change: Both D | - |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 600 | L | 0.344573 | P | 0.518532 | -0.173959 | O to D | STAT1 deficiency complete (STAT1D) [MIM:613796] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 706 | L | 0.566056 | S | 0.718908 | -0.152852 | No Change: Both D | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 30 | I | 0.174425 | T | 0.285822 | -0.111397 | No Change: Both O | - |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 491 | P | 0.098974 | A | 0.070024 | 0.02895 | No Change: Both O | A breast cancer sample |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 201 | K | 0.405113 | N | 0.348171 | 0.056942 | No Change: Both O | STAT1 deficiency complete (STAT1D) [MIM:613796] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 320 | E | 0.369671 | Q | 0.381774 | -0.012103 | No Change: Both O | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 463 | Q | 0.282044 | H | 0.269853 | 0.012191 | No Change: Both O | Mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 165 | D | 0.672458 | G | 0.591857 | 0.080601 | No Change: Both D | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 165 | D | 0.672458 | H | 0.621551 | 0.050907 | No Change: Both D | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 170 | Y | 0.648911 | N | 0.793408 | -0.144497 | No Change: Both D | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 174 | C | 0.590987 | R | 0.70042 | -0.109433 | No Change: Both D | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 202 | M | 0.350329 | I | 0.242373 | 0.107956 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 202 | M | 0.350329 | V | 0.27032 | 0.080009 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 267 | A | 0.188797 | V | 0.153743 | 0.035054 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 271 | Q | 0.333243 | P | 0.322536 | 0.010707 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 274 | R | 0.463004 | Q | 0.522471 | -0.059467 | O to D | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 274 | R | 0.463004 | W | 0.265143 | 0.197861 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 286 | K | 0.532595 | I | 0.325616 | 0.206979 | D to O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P42224 | STAT1_HUMAN Signal transducer and activator of transcription 1-alpha/beta OS=Homo sapiens GN=STAT1 PE=1 SV=2 | 288 | T | 0.483582 | A | 0.436976 | 0.046606 | No Change: Both O | Familial candidiasis type 7 (CANDF7) [MIM:614162] |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 66 | Q | 0.129221 | H | 0.116505 | 0.012716 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 220 | L | 0.505524 | P | 0.60373 | -0.098206 | No Change: Both D | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 448 | T | 0.352238 | M | 0.291729 | 0.060509 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 464 | I | 0.104868 | V | 0.121409 | -0.016541 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 501 | S | 0.350943 | I | 0.138331 | 0.212612 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 594 | M | 0.431684 | I | 0.328812 | 0.102872 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 826 | Q | 0.314915 | H | 0.304159 | 0.010756 | No Change: Both O | - |
| P52630 | STAT2_HUMAN Signal transducer and activator of transcription 2 OS=Homo sapiens GN=STAT2 PE=1 SV=1 | 246 | C | 0.259059 | S | 0.475076 | -0.216017 | No Change: Both O | - |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 143 | M | 0.776028 | I | 0.654823 | 0.121205 | No Change: Both D | - |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 32 | Q | 0.138102 | K | 0.157288 | -0.019186 | No Change: Both O | - |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 382 | R | 0.331066 | L | 0.227316 | 0.10375 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 382 | R | 0.331066 | Q | 0.32958 | 0.001486 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 382 | R | 0.331066 | W | 0.146014 | 0.185052 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 384 | F | 0.354369 | L | 0.408192 | -0.053823 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 384 | F | 0.354369 | S | 0.582092 | -0.227723 | O to D | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 389 | T | 0.386236 | I | 0.258328 | 0.127908 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 423 | R | 0.419898 | Q | 0.430884 | -0.010986 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 437 | H | 0.148017 | Y | 0.089197 | 0.05882 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 561 | F | 0.039372 | Y | 0.043453 | -0.004081 | No Change: Both O | - |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 611 | S | 0.550744 | N | 0.470151 | 0.080593 | D to O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 621 | F | 0.395597 | V | 0.41751 | -0.021913 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 622 | T | 0.375649 | I | 0.250963 | 0.124686 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 637 | V | 0.526159 | L | 0.530338 | -0.004179 | No Change: Both D | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 637 | V | 0.526159 | M | 0.591044 | -0.064885 | No Change: Both D | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| P40763 | STAT3_HUMAN Signal transducer and activator of transcription 3 OS=Homo sapiens GN=STAT3 PE=1 SV=2 | 657 | Y | 0.115607 | C | 0.097241 | 0.018366 | No Change: Both O | Hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060] |
| Q14765 | STAT4_HUMAN Signal transducer and activator of transcription 4 OS=Homo sapiens GN=STAT4 PE=1 SV=1 | 115 | I | 0.413322 | V | 0.455508 | -0.042186 | No Change: Both O | - |
| Q14765 | STAT4_HUMAN Signal transducer and activator of transcription 4 OS=Homo sapiens GN=STAT4 PE=1 SV=1 | 112 | E | 0.383598 | Q | 0.362548 | 0.02105 | No Change: Both O | A breast cancer sample |
| Q14765 | STAT4_HUMAN Signal transducer and activator of transcription 4 OS=Homo sapiens GN=STAT4 PE=1 SV=1 | 584 | R | 0.550005 | W | 0.31914 | 0.230865 | D to O | - |
| P42229 | STA5A_HUMAN Signal transducer and activator of transcription 5A OS=Homo sapiens GN=STAT5A PE=1 SV=1 | 389 | R | 0.601803 | H | 0.60556 | -0.003757 | No Change: Both D | - |
| P51692 | STA5B_HUMAN Signal transducer and activator of transcription 5B OS=Homo sapiens GN=STAT5B PE=1 SV=2 | 630 | A | 0.128181 | P | 0.182299 | -0.054118 | No Change: Both O | Laron type dwarfism II (LTD2) [MIM:245590] |
| P51692 | STA5B_HUMAN Signal transducer and activator of transcription 5B OS=Homo sapiens GN=STAT5B PE=1 SV=2 | 130 | A | 0.661533 | V | 0.601899 | 0.059634 | No Change: Both D | - |
| P42226 | STAT6_HUMAN Signal transducer and activator of transcription 6 OS=Homo sapiens GN=STAT6 PE=1 SV=1 | 181 | M | 0.450389 | R | 0.521724 | -0.071335 | O to D | - |
| P42226 | STAT6_HUMAN Signal transducer and activator of transcription 6 OS=Homo sapiens GN=STAT6 PE=1 SV=1 | 419 | D | 0.448211 | N | 0.458674 | -0.010463 | No Change: Both O | - |
| Q9NUL3 | STAU2_HUMAN Double-stranded RNA-binding protein Staufen homolog 2 OS=Homo sapiens GN=STAU2 PE=1 SV=1 | 198 | M | 0.891784 | V | 0.860818 | 0.030966 | No Change: Both D | - |
| Q9UHE8 | STEA1_HUMAN Metalloreductase STEAP1 OS=Homo sapiens GN=STEAP1 PE=1 SV=1 | 47 | H | 0.392348 | Q | 0.424061 | -0.031713 | No Change: Both O | - |
| Q9UHE8 | STEA1_HUMAN Metalloreductase STEAP1 OS=Homo sapiens GN=STEAP1 PE=1 SV=1 | 169 | F | 0.036965 | L | 0.042331 | -0.005366 | No Change: Both O | - |
| Q6NZ63 | STEAL_HUMAN STEAP family member 1B OS=Homo sapiens GN=STEAP1B PE=2 SV=1 | 7 | I | 0.774189 | V | 0.758427 | 0.015762 | No Change: Both D | - |
| Q6NZ63 | STEAL_HUMAN STEAP family member 1B OS=Homo sapiens GN=STEAP1B PE=2 SV=1 | 29 | Q | 0.462969 | R | 0.448106 | 0.014863 | No Change: Both O | - |
| Q6NZ63 | STEAL_HUMAN STEAP family member 1B OS=Homo sapiens GN=STEAP1B PE=2 SV=1 | 166 | R | 0.269247 | M | 0.209811 | 0.059436 | No Change: Both O | - |
| Q6NZ63 | STEAL_HUMAN STEAP family member 1B OS=Homo sapiens GN=STEAP1B PE=2 SV=1 | 210 | I | 0.033632 | T | 0.063124 | -0.029492 | No Change: Both O | - |
| Q8NFT2 | STEA2_HUMAN Metalloreductase STEAP2 OS=Homo sapiens GN=STEAP2 PE=1 SV=3 | 214 | G | 0.043542 | E | 0.056207 | -0.012665 | No Change: Both O | - |
| Q8NFT2 | STEA2_HUMAN Metalloreductase STEAP2 OS=Homo sapiens GN=STEAP2 PE=1 SV=3 | 456 | R | 0.193949 | Q | 0.196755 | -0.002806 | No Change: Both O | - |
| Q8NFT2 | STEA2_HUMAN Metalloreductase STEAP2 OS=Homo sapiens GN=STEAP2 PE=1 SV=3 | 17 | F | 0.514251 | C | 0.527589 | -0.013338 | No Change: Both D | - |
| Q8NFT2 | STEA2_HUMAN Metalloreductase STEAP2 OS=Homo sapiens GN=STEAP2 PE=1 SV=3 | 40 | D | 0.281699 | Y | 0.160422 | 0.121277 | No Change: Both O | - |
| Q8NFT2 | STEA2_HUMAN Metalloreductase STEAP2 OS=Homo sapiens GN=STEAP2 PE=1 SV=3 | 475 | M | 0.512287 | I | 0.418049 | 0.094238 | D to O | - |
| Q658P3 | STEA3_HUMAN Metalloreductase STEAP3 OS=Homo sapiens GN=STEAP3 PE=1 SV=2 | 184 | A | 0.379829 | T | 0.349117 | 0.030712 | No Change: Both O | - |
| Q687X5 | STEA4_HUMAN Metalloreductase STEAP4 OS=Homo sapiens GN=STEAP4 PE=1 SV=1 | 75 | G | 0.286497 | D | 0.310178 | -0.023681 | No Change: Both O | - |
| Q687X5 | STEA4_HUMAN Metalloreductase STEAP4 OS=Homo sapiens GN=STEAP4 PE=1 SV=1 | 122 | A | 0.247536 | T | 0.256166 | -0.00863 | No Change: Both O | - |
| Q8IWL8 | STH_HUMAN Saitohin OS=Homo sapiens GN=STH PE=1 SV=1 | 7 | Q | 0.435228 | R | 0.421984 | 0.013244 | No Change: Both O | - |
| Q15468 | STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens GN=STIL PE=1 SV=2 | 86 | A | 0.51098 | V | 0.458132 | 0.052848 | D to O | - |
| Q15468 | STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens GN=STIL PE=1 SV=2 | 984 | H | 0.612305 | R | 0.626825 | -0.01452 | No Change: Both D | - |
| Q15468 | STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens GN=STIL PE=1 SV=2 | 1012 | P | 0.564261 | R | 0.546656 | 0.017605 | No Change: Both D | - |
| Q15468 | STIL_HUMAN SCL-interrupting locus protein OS=Homo sapiens GN=STIL PE=1 SV=2 | 1145 | A | 0.955054 | V | 0.939974 | 0.01508 | No Change: Both D | - |
| Q13586 | STIM1_HUMAN Stromal interaction molecule 1 OS=Homo sapiens GN=STIM1 PE=1 SV=3 | 538 | P | 0.896683 | S | 0.899115 | -0.002432 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 277 | K | 0.539833 | E | 0.543529 | -0.003696 | No Change: Both D | Testicular tumors (TEST) [MIM:273300] |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 268 | R | 0.33956 | C | 0.224559 | 0.115001 | No Change: Both O | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 322 | R | 0.903929 | W | 0.813665 | 0.090264 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 336 | T | 0.95421 | I | 0.926405 | 0.027805 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 467 | N | 0.974165 | S | 0.982502 | -0.008337 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 710 | M | 0.918017 | T | 0.921629 | -0.003612 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 853 | S | 0.993376 | L | 0.988477 | 0.004899 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 905 | S | 0.910623 | T | 0.899921 | 0.010702 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 947 | C | 0.96232 | Y | 0.954391 | 0.007929 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 480 | P | 0.960789 | L | 0.935331 | 0.025458 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 520 | P | 0.695031 | L | 0.608884 | 0.086147 | No Change: Both D | - |
| O94804 | STK10_HUMAN Serine/threonine-protein kinase 10 OS=Homo sapiens GN=STK10 PE=1 SV=1 | 942 | S | 0.956125 | N | 0.946219 | 0.009906 | No Change: Both D | - |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 67 | L | 0.470038 | P | 0.563226 | -0.093188 | O to D | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 194 | D | 0.314333 | N | 0.295452 | 0.018881 | No Change: Both O | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 297 | R | 0.521745 | K | 0.549099 | -0.027354 | No Change: Both D | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 49 | Y | 0.198977 | D | 0.35649 | -0.157513 | No Change: Both O | Melanoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 135 | G | 0.146424 | R | 0.151225 | -0.004801 | No Change: Both O | Melanoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 163 | G | 0.134179 | D | 0.152014 | -0.017835 | No Change: Both O | Testicular tumors (TEST) [MIM:273300] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 194 | D | 0.314333 | Y | 0.180075 | 0.134258 | No Change: Both O | Melanoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 239 | W | 0.084356 | C | 0.102743 | -0.018387 | No Change: Both O | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 315 | P | 0.738982 | S | 0.725063 | 0.013919 | No Change: Both D | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 87 | R | 0.569956 | K | 0.632644 | -0.062688 | No Change: Both D | A metastatic melanoma sample |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 14 | E | 0.428276 | K | 0.396985 | 0.031291 | No Change: Both O | Cervical cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 16 | E | 0.430003 | G | 0.382944 | 0.047059 | No Change: Both O | Peutz-Jeghers syndrome (PJS) [MIM:175200] |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 66 | V | 0.478864 | M | 0.539683 | -0.060819 | O to D | Cervical carcinoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 86 | R | 0.577675 | G | 0.552453 | 0.025222 | No Change: Both D | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 123 | Q | 0.447569 | R | 0.431052 | 0.016517 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 157 | F | 0.0528 | S | 0.134041 | -0.081241 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 160 | L | 0.082955 | P | 0.152497 | -0.069542 | No Change: Both O | Cervical cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 170 | Q | 0.279405 | P | 0.299779 | -0.020374 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 171 | G | 0.297424 | S | 0.356798 | -0.059374 | No Change: Both O | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 174 | H | 0.401784 | R | 0.379547 | 0.022237 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 176 | D | 0.421857 | Y | 0.258069 | 0.163788 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 177 | I | 0.406126 | N | 0.601381 | -0.195255 | O to D | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 181 | N | 0.331199 | E | 0.373312 | -0.042113 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 194 | D | 0.314333 | V | 0.191381 | 0.122952 | No Change: Both O | Lung cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 199 | E | 0.281378 | K | 0.295764 | -0.014386 | No Change: Both O | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 199 | E | 0.281378 | Q | 0.267423 | 0.013955 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 205 | A | 0.351215 | T | 0.380962 | -0.029747 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 208 | D | 0.454429 | N | 0.418415 | 0.036014 | No Change: Both O | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 215 | G | 0.585298 | D | 0.615111 | -0.029813 | No Change: Both D | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 216 | S | 0.622866 | F | 0.402667 | 0.220199 | D to O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 223 | E | 0.445024 | V | 0.25521 | 0.189814 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 230 | T | 0.201981 | P | 0.25179 | -0.049809 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 231 | F | 0.180422 | L | 0.199867 | -0.019445 | No Change: Both O | Cervical cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 232 | S | 0.162964 | P | 0.145007 | 0.017957 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 245 | L | 0.08253 | R | 0.133982 | -0.051452 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 250 | T | 0.114521 | P | 0.139246 | -0.024725 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 272 | Y | 0.315465 | H | 0.440819 | -0.125354 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 277 | D | 0.399159 | Y | 0.254405 | 0.144754 | No Change: Both O | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 281 | P | 0.407217 | L | 0.249877 | 0.15734 | No Change: Both O | Ovarian carcinoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 285 | L | 0.399208 | Q | 0.508629 | -0.109421 | O to D | Sporadic cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 314 | P | 0.734144 | H | 0.668092 | 0.066052 | No Change: Both D | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 324 | P | 0.778274 | L | 0.610277 | 0.167997 | No Change: Both D | Gastric carcinoma |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 354 | F | 0.441794 | L | 0.482754 | -0.04096 | No Change: Both O | Colorectal cancer |
| Q15831 | STK11_HUMAN Serine/threonine-protein kinase STK11 OS=Homo sapiens GN=STK11 PE=1 SV=1 | 367 | T | 0.315324 | M | 0.278757 | 0.036567 | No Change: Both O | Colorectal cancer |
| Q8N1F8 | S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens GN=STK11IP PE=1 SV=3 | 393 | R | 0.838624 | H | 0.797989 | 0.040635 | No Change: Both D | - |
| Q8N1F8 | S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens GN=STK11IP PE=1 SV=3 | 410 | R | 0.825197 | G | 0.794184 | 0.031013 | No Change: Both D | - |
| Q8N1F8 | S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens GN=STK11IP PE=1 SV=3 | 563 | V | 0.66469 | I | 0.597398 | 0.067292 | No Change: Both D | - |
| Q8N1F8 | S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens GN=STK11IP PE=1 SV=3 | 752 | S | 0.950349 | F | 0.889356 | 0.060993 | No Change: Both D | - |
| Q8N1F8 | S11IP_HUMAN Serine/threonine-protein kinase 11-interacting protein OS=Homo sapiens GN=STK11IP PE=1 SV=3 | 1085 | I | 0.100148 | V | 0.116455 | -0.016307 | No Change: Both O | - |
| O75716 | STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4 | 41 | H | 0.236308 | R | 0.224764 | 0.011544 | No Change: Both O | - |
| O75716 | STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4 | 55 | E | 0.432354 | K | 0.422306 | 0.010048 | No Change: Both O | - |
| O75716 | STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4 | 77 | I | 0.133023 | V | 0.156786 | -0.023763 | No Change: Both O | - |
| O75716 | STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4 | 266 | R | 0.774217 | W | 0.561956 | 0.212261 | No Change: Both D | - |
| O75716 | STK16_HUMAN Serine/threonine-protein kinase 16 OS=Homo sapiens GN=STK16 PE=1 SV=4 | 277 | P | 0.848604 | L | 0.754063 | 0.094541 | No Change: Both D | - |
| Q9UEE5 | ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | 362 | K | 0.783519 | E | 0.808144 | -0.024625 | No Change: Both D | - |
| Q9UEE5 | ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | 286 | E | 0.559444 | Q | 0.511334 | 0.04811 | No Change: Both D | - |
| Q9UEE5 | ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | 126 | E | 0.152958 | D | 0.128349 | 0.024609 | No Change: Both O | - |
| Q9UEE5 | ST17A_HUMAN Serine/threonine-protein kinase 17A OS=Homo sapiens GN=STK17A PE=1 SV=2 | 167 | M | 0.218052 | T | 0.256537 | -0.038485 | No Change: Both O | - |
| O94768 | ST17B_HUMAN Serine/threonine-protein kinase 17B OS=Homo sapiens GN=STK17B PE=1 SV=1 | 320 | S | 0.978277 | F | 0.953055 | 0.025222 | No Change: Both D | - |
| P49842 | STK19_HUMAN Serine/threonine-protein kinase 19 OS=Homo sapiens GN=STK19 PE=1 SV=2 | 89 | D | 0.675602 | N | 0.627184 | 0.048418 | No Change: Both D | A metastatic melanoma sample |
| P49842 | STK19_HUMAN Serine/threonine-protein kinase 19 OS=Homo sapiens GN=STK19 PE=1 SV=2 | 311 | S | 0.257902 | G | 0.222323 | 0.035579 | No Change: Both O | - |
| P49842 | STK19_HUMAN Serine/threonine-protein kinase 19 OS=Homo sapiens GN=STK19 PE=1 SV=2 | 331 | A | 0.198279 | V | 0.159499 | 0.03878 | No Change: Both O | - |
| P49842 | STK19_HUMAN Serine/threonine-protein kinase 19 OS=Homo sapiens GN=STK19 PE=1 SV=2 | 39 | A | 0.774173 | D | 0.803258 | -0.029085 | No Change: Both D | - |
| Q9Y6E0 | STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1 | 414 | A | 0.265271 | V | 0.190241 | 0.07503 | No Change: Both O | - |
| Q9Y6E0 | STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1 | 426 | L | 0.246525 | I | 0.210213 | 0.036312 | No Change: Both O | - |
| O00506 | STK25_HUMAN Serine/threonine-protein kinase 25 OS=Homo sapiens GN=STK25 PE=1 SV=1 | 64 | Q | 0.404445 | H | 0.365759 | 0.038686 | No Change: Both O | - |
| Q13188 | STK3_HUMAN Serine/threonine-protein kinase 3 OS=Homo sapiens GN=STK3 PE=1 SV=2 | 60 | V | 0.335199 | L | 0.324724 | 0.010475 | No Change: Both O | An ovarian clear cell carcinoma sample |
| Q13188 | STK3_HUMAN Serine/threonine-protein kinase 3 OS=Homo sapiens GN=STK3 PE=1 SV=2 | 418 | F | 0.817976 | C | 0.827482 | -0.009506 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 71 | Q | 0.385517 | H | 0.36901 | 0.016507 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 261 | E | 0.658302 | K | 0.681217 | -0.022915 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 268 | K | 0.620784 | N | 0.595042 | 0.025742 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 362 | T | 0.285597 | P | 0.306112 | -0.020515 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 410 | G | 0.133878 | E | 0.18042 | -0.046542 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 1009 | K | 0.887681 | T | 0.848393 | 0.039288 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 125 | S | 0.240232 | F | 0.09576 | 0.144472 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 277 | I | 0.457628 | K | 0.682705 | -0.225077 | O to D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 393 | A | 0.227651 | T | 0.253083 | -0.025432 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 489 | A | 0.460152 | P | 0.488159 | -0.028007 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 600 | A | 0.273468 | T | 0.304519 | -0.031051 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 621 | N | 0.436791 | K | 0.535318 | -0.098527 | O to D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 623 | S | 0.493429 | I | 0.288048 | 0.205381 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 684 | H | 0.400136 | R | 0.442177 | -0.042041 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 684 | H | 0.400136 | Y | 0.3263 | 0.073836 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 709 | E | 0.271186 | K | 0.267369 | 0.003817 | No Change: Both O | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 860 | V | 0.286676 | L | 0.305009 | -0.018333 | No Change: Both O | A lung small cell carcinoma sample |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 1000 | T | 0.898468 | M | 0.896805 | 0.001663 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 1010 | T | 0.886323 | S | 0.887449 | -0.001126 | No Change: Both D | - |
| Q9BXU1 | STK31_HUMAN Serine/threonine-protein kinase 31 OS=Homo sapiens GN=STK31 PE=2 SV=2 | 385 | R | 0.28986 | C | 0.148548 | 0.141312 | No Change: Both O | - |
| Q8WU08 | ST32A_HUMAN Serine/threonine-protein kinase 32A OS=Homo sapiens GN=STK32A PE=2 SV=2 | 58 | K | 0.486918 | M | 0.347698 | 0.13922 | No Change: Both O | - |
| Q8WU08 | ST32A_HUMAN Serine/threonine-protein kinase 32A OS=Homo sapiens GN=STK32A PE=2 SV=2 | 89 | S | 0.120444 | F | 0.053293 | 0.067151 | No Change: Both O | A metastatic melanoma sample |
| Q8WU08 | ST32A_HUMAN Serine/threonine-protein kinase 32A OS=Homo sapiens GN=STK32A PE=2 SV=2 | 316 | M | 0.663894 | I | 0.602409 | 0.061485 | No Change: Both D | A lung neuroendocrine carcinoma sample |
| Q9NY57 | ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | 198 | R | 0.340103 | G | 0.377604 | -0.037501 | No Change: Both O | - |
| Q9NY57 | ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | 35 | G | 0.222243 | E | 0.256267 | -0.034024 | No Change: Both O | A metastatic melanoma sample |
| Q9NY57 | ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | 244 | R | 0.198011 | H | 0.214187 | -0.016176 | No Change: Both O | - |
| Q9NY57 | ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | 310 | D | 0.434604 | V | 0.304494 | 0.13011 | No Change: Both O | - |
| Q9NY57 | ST32B_HUMAN Serine/threonine-protein kinase 32B OS=Homo sapiens GN=STK32B PE=2 SV=1 | 342 | K | 0.743619 | T | 0.703273 | 0.040346 | No Change: Both D | - |
| Q86UX6 | ST32C_HUMAN Serine/threonine-protein kinase 32C OS=Homo sapiens GN=STK32C PE=1 SV=1 | 334 | T | 0.281299 | A | 0.266629 | 0.01467 | No Change: Both O | - |
| Q86UX6 | ST32C_HUMAN Serine/threonine-protein kinase 32C OS=Homo sapiens GN=STK32C PE=1 SV=1 | 376 | R | 0.444532 | H | 0.433128 | 0.011404 | No Change: Both O | A colorectal cancer sample |
| Q86UX6 | ST32C_HUMAN Serine/threonine-protein kinase 32C OS=Homo sapiens GN=STK32C PE=1 SV=1 | 454 | A | 0.931888 | T | 0.923126 | 0.008762 | No Change: Both D | - |
| Q86UX6 | ST32C_HUMAN Serine/threonine-protein kinase 32C OS=Homo sapiens GN=STK32C PE=1 SV=1 | 467 | E | 0.97441 | K | 0.966292 | 0.008118 | No Change: Both D | - |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 98 | E | 0.436072 | D | 0.399171 | 0.036901 | No Change: Both O | - |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 160 | L | 0.421864 | V | 0.427591 | -0.005727 | No Change: Both O | A lung large cell carcinoma sample |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 436 | D | 0.923502 | E | 0.936187 | -0.012685 | No Change: Both D | - |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 437 | A | 0.919082 | T | 0.934054 | -0.014972 | No Change: Both D | - |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 458 | A | 0.870056 | E | 0.914791 | -0.044735 | No Change: Both D | - |
| Q9BYT3 | STK33_HUMAN Serine/threonine-protein kinase 33 OS=Homo sapiens GN=STK33 PE=1 SV=1 | 60 | K | 0.87917 | E | 0.882469 | -0.003299 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 463 | K | 0.330485 | N | 0.292942 | 0.037543 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 767 | S | 0.033762 | T | 0.024648 | 0.009114 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1003 | G | 0.106359 | D | 0.136607 | -0.030248 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 90 | I | 0.275306 | M | 0.368299 | -0.092993 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 240 | R | 0.421648 | W | 0.233039 | 0.188609 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 295 | K | 0.742878 | R | 0.738243 | 0.004635 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 329 | D | 0.881468 | N | 0.89011 | -0.008642 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 462 | L | 0.33612 | V | 0.316616 | 0.019504 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 476 | F | 0.233252 | S | 0.478374 | -0.245122 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 477 | R | 0.230408 | W | 0.094399 | 0.136009 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 583 | R | 0.483313 | Q | 0.504284 | -0.020971 | O to D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 660 | S | 0.386048 | C | 0.266817 | 0.119231 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 672 | L | 0.199705 | P | 0.333559 | -0.133854 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 767 | S | 0.033762 | Y | 0.014606 | 0.019156 | No Change: Both O | An ovarian papillary serous adenocarcinoma sample |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 816 | T | 0.265709 | A | 0.245598 | 0.020111 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 839 | R | 0.439263 | Q | 0.454249 | -0.014986 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 840 | L | 0.403355 | V | 0.417025 | -0.01367 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1111 | Y | 0.600528 | C | 0.598211 | 0.002317 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1112 | R | 0.583118 | Q | 0.5777 | 0.005418 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1138 | Q | 0.417106 | K | 0.427673 | -0.010567 | No Change: Both O | An ovarian serous carcinoma sample |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1185 | P | 0.410957 | S | 0.413784 | -0.002827 | No Change: Both O | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1313 | H | 0.958872 | P | 0.971244 | -0.012372 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 638 | Q | 0.703388 | P | 0.726852 | -0.023464 | No Change: Both D | - |
| Q9NRP7 | STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | 1004 | V | 0.116977 | I | 0.107438 | 0.009539 | No Change: Both O | - |
| Q15208 | STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | 18 | E | 0.793961 | K | 0.799192 | -0.005231 | No Change: Both D | A metastatic melanoma sample |
| Q15208 | STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | 145 | D | 0.100742 | N | 0.087995 | 0.012747 | No Change: Both O | - |
| Q15208 | STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | 267 | K | 0.622166 | R | 0.598861 | 0.023305 | No Change: Both D | - |
| Q9Y2H1 | ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | 99 | G | 0.25526 | A | 0.213638 | 0.041622 | No Change: Both O | - |
| Q13043 | STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | 312 | V | 0.950155 | M | 0.962858 | -0.012703 | No Change: Both D | - |
| Q13043 | STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | 162 | H | 0.319624 | N | 0.36131 | -0.041686 | No Change: Both O | - |
| Q13043 | STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | 310 | R | 0.924615 | Q | 0.929366 | -0.004751 | No Change: Both D | - |
| Q13043 | STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | 355 | I | 0.733197 | T | 0.837212 | -0.104015 | No Change: Both D | - |
| Q13043 | STK4_HUMAN Serine/threonine-protein kinase 4 OS=Homo sapiens GN=STK4 PE=1 SV=2 | 416 | P | 0.712947 | L | 0.586701 | 0.126246 | No Change: Both D | - |
| Q8N2I9 | STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens GN=STK40 PE=2 SV=2 | 10 | A | 0.934211 | V | 0.881544 | 0.052667 | No Change: Both D | - |
| Q8N2I9 | STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens GN=STK40 PE=2 SV=2 | 133 | M | 0.493714 | T | 0.522281 | -0.028567 | O to D | A colorectal adenocarcinoma sample |
| Q8N2I9 | STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens GN=STK40 PE=2 SV=2 | 211 | R | 0.187192 | Q | 0.188964 | -0.001772 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8N2I9 | STK40_HUMAN Serine/threonine-protein kinase 40 OS=Homo sapiens GN=STK40 PE=2 SV=2 | 395 | A | 0.515608 | T | 0.526849 | -0.011241 | No Change: Both D | - |
| Q9UJZ1 | STML2_HUMAN Stomatin-like protein 2 OS=Homo sapiens GN=STOML2 PE=1 SV=1 | 129 | L | 0.333181 | P | 0.507578 | -0.174397 | O to D | - |
| Q9Y6Q2 | STON1_HUMAN Stonin-1 OS=Homo sapiens GN=STON1 PE=1 SV=2 | 127 | R | 0.871315 | T | 0.889083 | -0.017768 | No Change: Both D | - |
| Q9Y6Q2 | STON1_HUMAN Stonin-1 OS=Homo sapiens GN=STON1 PE=1 SV=2 | 544 | Q | 0.123569 | H | 0.108372 | 0.015197 | No Change: Both O | - |
| Q9Y6Q2 | STON1_HUMAN Stonin-1 OS=Homo sapiens GN=STON1 PE=1 SV=2 | 607 | Q | 0.462644 | H | 0.434366 | 0.028278 | No Change: Both O | - |
| Q9Y6Q2 | STON1_HUMAN Stonin-1 OS=Homo sapiens GN=STON1 PE=1 SV=2 | 8 | K | 0.700973 | N | 0.672498 | 0.028475 | No Change: Both D | - |
| Q8WXE9 | STON2_HUMAN Stonin-2 OS=Homo sapiens GN=STON2 PE=1 SV=1 | 307 | S | 0.704871 | P | 0.711134 | -0.006263 | No Change: Both D | - |
| Q8WXE9 | STON2_HUMAN Stonin-2 OS=Homo sapiens GN=STON2 PE=1 SV=1 | 851 | S | 0.610169 | A | 0.485023 | 0.125146 | D to O | - |
| Q8WXE9 | STON2_HUMAN Stonin-2 OS=Homo sapiens GN=STON2 PE=1 SV=1 | 646 | R | 0.094706 | H | 0.105268 | -0.010562 | No Change: Both O | - |
| Q8WXE9 | STON2_HUMAN Stonin-2 OS=Homo sapiens GN=STON2 PE=1 SV=1 | 694 | T | 0.324068 | A | 0.294112 | 0.029956 | No Change: Both O | - |
| Q6ZVD7 | STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens GN=STOX1 PE=1 SV=2 | 18 | R | 0.501767 | P | 0.531134 | -0.029367 | No Change: Both D | Pre-eclampsia/eclampsia 4 (PEE4) [MIM:609404] |
| Q6ZVD7 | STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens GN=STOX1 PE=1 SV=2 | 153 | Y | 0.237118 | H | 0.365625 | -0.128507 | No Change: Both O | Pre-eclampsia/eclampsia 4 (PEE4) [MIM:609404] |
| Q6ZVD7 | STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens GN=STOX1 PE=1 SV=2 | 608 | E | 0.380938 | D | 0.331457 | 0.049481 | No Change: Both O | - |
| Q6ZVD7 | STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens GN=STOX1 PE=1 SV=2 | 825 | N | 0.685928 | I | 0.509774 | 0.176154 | No Change: Both D | Pre-eclampsia/eclampsia 4 (PEE4) [MIM:609404] |
| Q6ZVD7 | STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens GN=STOX1 PE=1 SV=2 | 863 | A | 0.484579 | T | 0.482724 | 0.001855 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 90 | P | 0.494997 | L | 0.319675 | 0.175322 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 293 | P | 0.199235 | L | 0.103473 | 0.095762 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 321 | T | 0.136204 | P | 0.175058 | -0.038854 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 339 | G | 0.07308 | S | 0.094921 | -0.021841 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 517 | L | 0.029527 | F | 0.025243 | 0.004284 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 527 | M | 0.044334 | I | 0.028372 | 0.015962 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 644 | T | 0.205483 | M | 0.187297 | 0.018186 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 655 | R | 0.240161 | C | 0.133037 | 0.107124 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 217 | G | 0.065674 | E | 0.075382 | -0.009708 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 438 | Q | 0.018079 | R | 0.015296 | 0.002783 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 638 | R | 0.381045 | P | 0.40047 | -0.019425 | No Change: Both O | - |
| Q9BX79 | STRA6_HUMAN Stimulated by retinoic acid gene 6 protein homolog OS=Homo sapiens GN=STRA6 PE=1 SV=1 | 304 | G | 0.138665 | K | 0.174917 | -0.036252 | No Change: Both O | Microphthalmia syndromic type 9 (MCOPS9) [MIM:601186] |
| Q7RTN6 | STRAA_HUMAN STE20-related kinase adapter protein alpha OS=Homo sapiens GN=STRADA PE=1 SV=1 | 13 | R | 0.375667 | W | 0.15377 | 0.221897 | No Change: Both O | - |
| Q7RTN6 | STRAA_HUMAN STE20-related kinase adapter protein alpha OS=Homo sapiens GN=STRADA PE=1 SV=1 | 60 | S | 0.478867 | I | 0.261911 | 0.216956 | No Change: Both O | - |
| Q7RTN6 | STRAA_HUMAN STE20-related kinase adapter protein alpha OS=Homo sapiens GN=STRADA PE=1 SV=1 | 64 | P | 0.350622 | S | 0.398317 | -0.047695 | No Change: Both O | - |
| Q9C0K7 | STRAB_HUMAN STE20-related kinase adapter protein beta OS=Homo sapiens GN=STRADB PE=1 SV=1 | 155 | G | 0.363486 | E | 0.449726 | -0.08624 | No Change: Both O | A metastatic melanoma sample |
| Q9C0K7 | STRAB_HUMAN STE20-related kinase adapter protein beta OS=Homo sapiens GN=STRADB PE=1 SV=1 | 386 | P | 0.70059 | L | 0.548223 | 0.152367 | No Change: Both D | - |
| Q96SI9 | STRBP_HUMAN Spermatid perinuclear RNA-binding protein OS=Homo sapiens GN=STRBP PE=1 SV=1 | 280 | G | 0.52097 | R | 0.518647 | 0.002323 | No Change: Both D | A breast cancer sample |
| Q7RTU9 | STRC_HUMAN Stereocilin OS=Homo sapiens GN=STRC PE=2 SV=1 | 1640 | L | 0.086426 | F | 0.071452 | 0.014974 | No Change: Both O | - |
| Q13033 | STRN3_HUMAN Striatin-3 OS=Homo sapiens GN=STRN3 PE=1 SV=3 | 471 | N | 0.312983 | S | 0.358636 | -0.045653 | No Change: Both O | - |
| Q9NRL3 | STRN4_HUMAN Striatin-4 OS=Homo sapiens GN=STRN4 PE=1 SV=2 | 568 | V | 0.474884 | I | 0.449135 | 0.025749 | No Change: Both O | - |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 341 | S | 0.258718 | L | 0.133748 | 0.12497 | No Change: Both O | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 372 | W | 0.366453 | R | 0.550341 | -0.183888 | O to D | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 446 | C | 0.054617 | Y | 0.073579 | -0.018962 | No Change: Both O | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 372 | W | 0.366453 | S | 0.569919 | -0.203466 | O to D | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 380 | G | 0.12737 | R | 0.126915 | 4.55E-04 | No Change: Both O | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 444 | H | 0.075551 | R | 0.074736 | 8.15E-04 | No Change: Both O | Ichthyosis X-linked (IXL) [MIM:308100] |
| P08842 | STS_HUMAN Steryl-sulfatase OS=Homo sapiens GN=STS PE=1 SV=2 | 560 | Q | 0.314913 | P | 0.341601 | -0.026688 | No Change: Both O | Ichthyosis X-linked (IXL) [MIM:308100] |
| O75558 | STX11_HUMAN Syntaxin-11 OS=Homo sapiens GN=STX11 PE=2 SV=1 | 31 | E | 0.587788 | Q | 0.548187 | 0.039601 | No Change: Both D | - |
| O75558 | STX11_HUMAN Syntaxin-11 OS=Homo sapiens GN=STX11 PE=2 SV=1 | 204 | L | 0.478227 | H | 0.59222 | -0.113993 | O to D | - |
| O75558 | STX11_HUMAN Syntaxin-11 OS=Homo sapiens GN=STX11 PE=2 SV=1 | 49 | R | 0.354203 | Q | 0.373245 | -0.019042 | No Change: Both O | - |
| O75558 | STX11_HUMAN Syntaxin-11 OS=Homo sapiens GN=STX11 PE=2 SV=1 | 277 | T | 0.319973 | A | 0.302739 | 0.017234 | No Change: Both O | - |
| Q86Y82 | STX12_HUMAN Syntaxin-12 OS=Homo sapiens GN=STX12 PE=1 SV=1 | 88 | P | 0.918616 | R | 0.914266 | 0.00435 | No Change: Both D | A breast cancer sample |
| Q9P2W9 | STX18_HUMAN Syntaxin-18 OS=Homo sapiens GN=STX18 PE=1 SV=1 | 32 | D | 0.61775 | Y | 0.424352 | 0.193398 | D to O | - |
| Q9P2W9 | STX18_HUMAN Syntaxin-18 OS=Homo sapiens GN=STX18 PE=1 SV=1 | 51 | S | 0.6605 | G | 0.604459 | 0.056041 | No Change: Both D | - |
| Q9P2W9 | STX18_HUMAN Syntaxin-18 OS=Homo sapiens GN=STX18 PE=1 SV=1 | 228 | S | 0.860778 | T | 0.839609 | 0.021169 | No Change: Both D | - |
| P32856 | STX2_HUMAN Syntaxin-2 OS=Homo sapiens GN=STX2 PE=1 SV=3 | 42 | S | 0.378607 | T | 0.329513 | 0.049094 | No Change: Both O | - |
| P32856 | STX2_HUMAN Syntaxin-2 OS=Homo sapiens GN=STX2 PE=1 SV=3 | 54 | K | 0.520726 | R | 0.458177 | 0.062549 | D to O | - |
| Q13277 | STX3_HUMAN Syntaxin-3 OS=Homo sapiens GN=STX3 PE=1 SV=3 | 83 | E | 0.803974 | D | 0.781151 | 0.022823 | No Change: Both D | - |
| Q13277 | STX3_HUMAN Syntaxin-3 OS=Homo sapiens GN=STX3 PE=1 SV=3 | 276 | G | 0.01231 | S | 0.015559 | -0.003249 | No Change: Both O | - |
| Q13277 | STX3_HUMAN Syntaxin-3 OS=Homo sapiens GN=STX3 PE=1 SV=3 | 285 | S | 0.33255 | P | 0.30096 | 0.03159 | No Change: Both O | - |
| Q13190 | STX5_HUMAN Syntaxin-5 OS=Homo sapiens GN=STX5 PE=1 SV=2 | 79 | Q | 0.700217 | H | 0.604442 | 0.095775 | No Change: Both D | A breast cancer sample |
| Q13190 | STX5_HUMAN Syntaxin-5 OS=Homo sapiens GN=STX5 PE=1 SV=2 | 51 | P | 0.918167 | L | 0.854261 | 0.063906 | No Change: Both D | - |
| Q13190 | STX5_HUMAN Syntaxin-5 OS=Homo sapiens GN=STX5 PE=1 SV=2 | 72 | Q | 0.748686 | H | 0.655555 | 0.093131 | No Change: Both D | - |
| P61764 | STXB1_HUMAN Syntaxin-binding protein 1 OS=Homo sapiens GN=STXBP1 PE=1 SV=1 | 84 | V | 0.544818 | D | 0.677613 | -0.132795 | No Change: Both D | Epileptic encephalopathy early infantile type 4 (EIEE4) [MIM:612164] |
| P61764 | STXB1_HUMAN Syntaxin-binding protein 1 OS=Homo sapiens GN=STXBP1 PE=1 SV=1 | 180 | C | 0.130412 | Y | 0.15495 | -0.024538 | No Change: Both O | Epileptic encephalopathy early infantile type 4 (EIEE4) [MIM:612164] |
| P61764 | STXB1_HUMAN Syntaxin-binding protein 1 OS=Homo sapiens GN=STXBP1 PE=1 SV=1 | 443 | M | 0.333461 | R | 0.415151 | -0.08169 | No Change: Both O | Epileptic encephalopathy early infantile type 4 (EIEE4) [MIM:612164] |
| P61764 | STXB1_HUMAN Syntaxin-binding protein 1 OS=Homo sapiens GN=STXBP1 PE=1 SV=1 | 544 | G | 0.069518 | D | 0.07315 | -0.003632 | No Change: Both O | Epileptic encephalopathy early infantile type 4 (EIEE4) [MIM:612164] |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 526 | I | 0.466049 | V | 0.485624 | -0.019575 | No Change: Both O | - |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 209 | L | 0.348504 | P | 0.500322 | -0.151818 | O to D | Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) [MIM:613101] |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 292 | R | 0.216619 | H | 0.205283 | 0.011336 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) [MIM:613101] |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 405 | R | 0.054002 | Q | 0.057817 | -0.003815 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) [MIM:613101] |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 405 | R | 0.054002 | W | 0.020539 | 0.033463 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) [MIM:613101] |
| Q15833 | STXB2_HUMAN Syntaxin-binding protein 2 OS=Homo sapiens GN=STXBP2 PE=1 SV=2 | 477 | P | 0.499638 | L | 0.345597 | 0.154041 | No Change: Both O | Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) [MIM:613101] |
| O00186 | STXB3_HUMAN Syntaxin-binding protein 3 OS=Homo sapiens GN=STXBP3 PE=1 SV=2 | 433 | E | 0.44016 | G | 0.374254 | 0.065906 | No Change: Both O | - |
| O00186 | STXB3_HUMAN Syntaxin-binding protein 3 OS=Homo sapiens GN=STXBP3 PE=1 SV=2 | 546 | C | 0.217324 | G | 0.398884 | -0.18156 | No Change: Both O | - |
| O00186 | STXB3_HUMAN Syntaxin-binding protein 3 OS=Homo sapiens GN=STXBP3 PE=1 SV=2 | 295 | R | 0.269431 | Q | 0.230115 | 0.039316 | No Change: Both O | - |
| Q6ZWJ1 | STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens GN=STXBP4 PE=1 SV=2 | 120 | C | 0.459772 | R | 0.602385 | -0.142613 | O to D | - |
| Q6ZWJ1 | STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens GN=STXBP4 PE=1 SV=2 | 92 | G | 0.293591 | R | 0.31699 | -0.023399 | No Change: Both O | - |
| Q5T5C0 | STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens GN=STXBP5 PE=1 SV=1 | 436 | N | 0.296857 | S | 0.331619 | -0.034762 | No Change: Both O | - |
| Q9Y2K9 | STB5L_HUMAN Syntaxin-binding protein 5-like OS=Homo sapiens GN=STXBP5L PE=2 SV=2 | 568 | T | 0.636028 | S | 0.694349 | -0.058321 | No Change: Both D | - |
| Q9Y2K9 | STB5L_HUMAN Syntaxin-binding protein 5-like OS=Homo sapiens GN=STXBP5L PE=2 SV=2 | 855 | V | 0.109297 | I | 0.101678 | 0.007619 | No Change: Both O | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 204 | S | 0.060182 | G | 0.051617 | 0.008565 | No Change: Both O | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 71 | R | 0.518612 | G | 0.540392 | -0.02178 | No Change: Both D | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 210 | R | 0.085154 | W | 0.03286 | 0.052294 | No Change: Both O | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 237 | L | 0.090444 | S | 0.18032 | -0.089876 | No Change: Both O | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 379 | R | 0.418807 | H | 0.363887 | 0.05492 | No Change: Both O | - |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 395 | V | 0.237245 | I | 0.194669 | 0.042576 | No Change: Both O | A glioblastoma multiforme sample |
| Q6J9G0 | STYK1_HUMAN Tyrosine-protein kinase STYK1 OS=Homo sapiens GN=STYK1 PE=2 SV=4 | 400 | V | 0.160082 | L | 0.15993 | 1.52E-04 | No Change: Both O | - |
| P53999 | TCP4_HUMAN Activated RNA polymerase II transcriptional coactivator p15 OS=Homo sapiens GN=SUB1 PE=1 SV=3 | 11 | S | 0.998504 | G | 0.997509 | 9.95E-04 | No Change: Both D | - |
| Q9P2R7 | SUCB1_HUMAN Succinyl-CoA ligase [ADP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLA2 PE=1 SV=3 | 199 | S | 0.534509 | T | 0.447803 | 0.086706 | D to O | - |
| Q9P2R7 | SUCB1_HUMAN Succinyl-CoA ligase [ADP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLA2 PE=1 SV=3 | 13 | V | 0.233998 | M | 0.336051 | -0.102053 | No Change: Both O | - |
| Q9P2R7 | SUCB1_HUMAN Succinyl-CoA ligase [ADP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLA2 PE=1 SV=3 | 118 | G | 0.537736 | R | 0.518688 | 0.019048 | No Change: Both D | Mitochondrial DNA depletion syndrome type 5 (MTDPS5) [MIM:612073] |
| Q9P2R7 | SUCB1_HUMAN Succinyl-CoA ligase [ADP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLA2 PE=1 SV=3 | 284 | R | 0.428965 | C | 0.283937 | 0.145028 | No Change: Both O | Mitochondrial DNA depletion syndrome type 5 (MTDPS5) [MIM:612073] |
| P53597 | SUCA_HUMAN Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha mitochondrial OS=Homo sapiens GN=SUCLG1 PE=1 SV=4 | 14 | M | 0.461653 | L | 0.395232 | 0.066421 | No Change: Both O | Mitochondrial DNA depletion syndrome type 9 (MTDPS9) [MIM:245400] |
| P53597 | SUCA_HUMAN Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha mitochondrial OS=Homo sapiens GN=SUCLG1 PE=1 SV=4 | 170 | P | 0.377024 | R | 0.337003 | 0.040021 | No Change: Both O | Mitochondrial DNA depletion syndrome type 9 (MTDPS9) [MIM:245400] |
| P53597 | SUCA_HUMAN Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha mitochondrial OS=Homo sapiens GN=SUCLG1 PE=1 SV=4 | 85 | G | 0.601738 | A | 0.527123 | 0.074615 | No Change: Both D | Mitochondrial DNA depletion syndrome type 9 (MTDPS9) [MIM:245400] |
| Q96I99 | SUCB2_HUMAN Succinyl-CoA ligase [GDP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLG2 PE=1 SV=2 | 347 | K | 0.14958 | R | 0.104719 | 0.044861 | No Change: Both O | - |
| Q96I99 | SUCB2_HUMAN Succinyl-CoA ligase [GDP-forming] subunit beta mitochondrial OS=Homo sapiens GN=SUCLG2 PE=1 SV=2 | 381 | R | 0.190571 | W | 0.080469 | 0.110102 | No Change: Both O | - |
| Q9UMX1 | SUFU_HUMAN Suppressor of fused homolog OS=Homo sapiens GN=SUFU PE=1 SV=2 | 15 | P | 0.966176 | L | 0.926357 | 0.039819 | No Change: Both D | - |
| Q9UMX1 | SUFU_HUMAN Suppressor of fused homolog OS=Homo sapiens GN=SUFU PE=1 SV=2 | 340 | A | 0.855858 | S | 0.902486 | -0.046628 | No Change: Both D | - |
| Q8IWZ8 | SUGP1_HUMAN SURP and G-patch domain-containing protein 1 OS=Homo sapiens GN=SUGP1 PE=1 SV=2 | 290 | R | 0.436457 | H | 0.412212 | 0.024245 | No Change: Both O | - |
| Q8IWZ8 | SUGP1_HUMAN SURP and G-patch domain-containing protein 1 OS=Homo sapiens GN=SUGP1 PE=1 SV=2 | 568 | Q | 0.41016 | H | 0.336527 | 0.073633 | No Change: Both O | - |
| Q8IX01 | SUGP2_HUMAN SURP and G-patch domain-containing protein 2 OS=Homo sapiens GN=SUGP2 PE=1 SV=2 | 206 | G | 0.641493 | S | 0.687659 | -0.046166 | No Change: Both D | - |
| Q8IX01 | SUGP2_HUMAN SURP and G-patch domain-containing protein 2 OS=Homo sapiens GN=SUGP2 PE=1 SV=2 | 552 | M | 0.829223 | T | 0.826145 | 0.003078 | No Change: Both D | - |
| Q8IX01 | SUGP2_HUMAN SURP and G-patch domain-containing protein 2 OS=Homo sapiens GN=SUGP2 PE=1 SV=2 | 649 | Q | 0.608558 | R | 0.625361 | -0.016803 | No Change: Both D | - |
| Q8IX01 | SUGP2_HUMAN SURP and G-patch domain-containing protein 2 OS=Homo sapiens GN=SUGP2 PE=1 SV=2 | 722 | Q | 0.957551 | R | 0.959573 | -0.002022 | No Change: Both D | - |
| Q8IX01 | SUGP2_HUMAN SURP and G-patch domain-containing protein 2 OS=Homo sapiens GN=SUGP2 PE=1 SV=2 | 881 | R | 0.993815 | Q | 0.994848 | -0.001033 | No Change: Both D | - |
| Q8IWU5 | SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens GN=SULF2 PE=1 SV=1 | 531 | Y | 0.523135 | H | 0.607517 | -0.084382 | No Change: Both D | A breast cancer sample |
| Q8IWU5 | SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens GN=SULF2 PE=1 SV=1 | 573 | D | 0.718567 | N | 0.69272 | 0.025847 | No Change: Both D | A breast cancer sample |
| Q8IWU5 | SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens GN=SULF2 PE=1 SV=1 | 674 | R | 0.821703 | H | 0.811719 | 0.009984 | No Change: Both D | - |
| Q8IWU5 | SULF2_HUMAN Extracellular sulfatase Sulf-2 OS=Homo sapiens GN=SULF2 PE=1 SV=1 | 76 | A | 0.218664 | T | 0.243004 | -0.02434 | No Change: Both O | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 213 | R | 0.330875 | H | 0.316561 | 0.014314 | No Change: Both O | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 37 | R | 0.367156 | Q | 0.410822 | -0.043666 | No Change: Both O | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 223 | V | 0.452962 | M | 0.538126 | -0.085164 | O to D | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 235 | N | 0.666963 | T | 0.668044 | -0.001081 | No Change: Both D | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 151 | E | 0.485412 | D | 0.471545 | 0.013867 | No Change: Both O | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 151 | E | 0.485412 | Q | 0.428492 | 0.05692 | No Change: Both O | - |
| P50225 | ST1A1_HUMAN Sulfotransferase 1A1 OS=Homo sapiens GN=SULT1A1 PE=1 SV=3 | 282 | E | 0.388575 | K | 0.398239 | -0.009664 | No Change: Both O | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 7 | I | 0.445316 | T | 0.553112 | -0.107796 | O to D | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 235 | N | 0.700904 | T | 0.706091 | -0.005187 | No Change: Both D | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 19 | P | 0.120946 | L | 0.060029 | 0.060917 | No Change: Both O | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 62 | Y | 0.149918 | F | 0.133333 | 0.016585 | No Change: Both O | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 239 | N | 0.616329 | S | 0.664157 | -0.047828 | No Change: Both D | - |
| P50226 | ST1A2_HUMAN Sulfotransferase 1A2 OS=Homo sapiens GN=SULT1A2 PE=1 SV=2 | 282 | K | 0.398239 | E | 0.388575 | 0.009664 | No Change: Both O | - |
| O00338 | ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens GN=SULT1C2 PE=1 SV=1 | 128 | Y | 0.078035 | H | 0.130744 | -0.052709 | No Change: Both O | - |
| O00338 | ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens GN=SULT1C2 PE=1 SV=1 | 255 | S | 0.502088 | A | 0.371077 | 0.131011 | D to O | - |
| O00338 | ST1C2_HUMAN Sulfotransferase 1C2 OS=Homo sapiens GN=SULT1C2 PE=1 SV=1 | 282 | R | 0.387385 | T | 0.363774 | 0.023611 | No Change: Both O | - |
| Q6IMI6 | ST1C3_HUMAN Sulfotransferase 1C3 OS=Homo sapiens GN=SULT1C3 PE=1 SV=1 | 148 | Y | 0.120956 | C | 0.104424 | 0.016532 | No Change: Both O | - |
| Q6IMI6 | ST1C3_HUMAN Sulfotransferase 1C3 OS=Homo sapiens GN=SULT1C3 PE=1 SV=1 | 179 | G | 0.271664 | R | 0.238831 | 0.032833 | No Change: Both O | - |
| Q6IMI6 | ST1C3_HUMAN Sulfotransferase 1C3 OS=Homo sapiens GN=SULT1C3 PE=1 SV=1 | 194 | M | 0.079303 | T | 0.094493 | -0.01519 | No Change: Both O | - |
| Q6IMI6 | ST1C3_HUMAN Sulfotransferase 1C3 OS=Homo sapiens GN=SULT1C3 PE=1 SV=1 | 88 | A | 0.294883 | T | 0.340486 | -0.045603 | No Change: Both O | - |
| O75897 | ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens GN=SULT1C4 PE=1 SV=2 | 5 | D | 0.72509 | E | 0.745809 | -0.020719 | No Change: Both D | - |
| O75897 | ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens GN=SULT1C4 PE=1 SV=2 | 68 | I | 0.304326 | M | 0.379522 | -0.075196 | No Change: Both O | - |
| P49888 | ST1E1_HUMAN Estrogen sulfotransferase OS=Homo sapiens GN=SULT1E1 PE=1 SV=1 | 22 | D | 0.074549 | Y | 0.036492 | 0.038057 | No Change: Both O | - |
| Q06520 | ST2A1_HUMAN Bile salt sulfotransferase OS=Homo sapiens GN=SULT2A1 PE=1 SV=3 | 63 | A | 0.334086 | P | 0.41269 | -0.078604 | No Change: Both O | - |
| Q06520 | ST2A1_HUMAN Bile salt sulfotransferase OS=Homo sapiens GN=SULT2A1 PE=1 SV=3 | 261 | A | 0.23708 | T | 0.262355 | -0.025275 | No Change: Both O | - |
| O00204 | ST2B1_HUMAN Sulfotransferase family cytosolic 2B member 1 OS=Homo sapiens GN=SULT2B1 PE=1 SV=2 | 51 | L | 0.438809 | S | 0.633469 | -0.19466 | O to D | - |
| O00204 | ST2B1_HUMAN Sulfotransferase family cytosolic 2B member 1 OS=Homo sapiens GN=SULT2B1 PE=1 SV=2 | 345 | P | 0.999892 | L | 0.999748 | 1.44E-04 | No Change: Both D | - |
| O00204 | ST2B1_HUMAN Sulfotransferase family cytosolic 2B member 1 OS=Homo sapiens GN=SULT2B1 PE=1 SV=2 | 240 | V | 0.339257 | I | 0.295743 | 0.043514 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 61 | A | 0.192179 | T | 0.210281 | -0.018102 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 75 | V | 0.048593 | D | 0.097234 | -0.048641 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 88 | K | 0.478999 | E | 0.472107 | 0.006892 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 167 | E | 0.189819 | V | 0.084833 | 0.104986 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 181 | R | 0.064714 | S | 0.092649 | -0.027935 | No Change: Both O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 296 | K | 0.526357 | R | 0.42151 | 0.104847 | D to O | - |
| Q6IMI4 | ST6B1_HUMAN Sulfotransferase 6B1 OS=Homo sapiens GN=SULT6B1 PE=2 SV=2 | 150 | L | 0.182482 | F | 0.178174 | 0.004308 | No Change: Both O | - |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 63 | S | 0.940435 | N | 0.920909 | 0.019526 | No Change: Both D | - |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 155 | S | 0.302935 | P | 0.27017 | 0.032765 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 218 | C | 0.059334 | Y | 0.075413 | -0.016079 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 279 | A | 0.414676 | V | 0.326591 | 0.088085 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 336 | C | 0.526429 | R | 0.650988 | -0.124559 | No Change: Both D | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 345 | R | 0.695747 | C | 0.626527 | 0.06922 | No Change: Both D | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 348 | A | 0.744424 | P | 0.805867 | -0.061443 | No Change: Both D | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 349 | R | 0.752081 | Q | 0.728562 | 0.023519 | No Change: Both D | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 349 | R | 0.752081 | W | 0.507255 | 0.244826 | No Change: Both D | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 20 | L | 0.274374 | F | 0.173689 | 0.100685 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 177 | A | 0.08928 | P | 0.128237 | -0.038957 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 224 | R | 0.233861 | W | 0.11638 | 0.117481 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 259 | N | 0.184863 | I | 0.093678 | 0.091185 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 266 | P | 0.253819 | L | 0.134934 | 0.118885 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBK3 | SUMF1_HUMAN Sulfatase-modifying factor 1 OS=Homo sapiens GN=SUMF1 PE=1 SV=3 | 179 | W | 0.081191 | S | 0.224536 | -0.143345 | No Change: Both O | Multiple sulfatase deficiency (MSD) [MIM:272200] |
| Q8NBJ7 | SUMF2_HUMAN Sulfatase-modifying factor 2 OS=Homo sapiens GN=SUMF2 PE=1 SV=2 | 51 | D | 0.673262 | E | 0.670059 | 0.003203 | No Change: Both D | - |
| P61956 | SUMO2_HUMAN Small ubiquitin-related modifier 2 OS=Homo sapiens GN=SUMO2 PE=1 SV=2 | 16 | D | 0.564471 | N | 0.572823 | -0.008352 | No Change: Both D | - |
| P55854 | SUMO3_HUMAN Small ubiquitin-related modifier 3 OS=Homo sapiens GN=SUMO3 PE=1 SV=2 | 38 | P | 0.374376 | S | 0.417586 | -0.04321 | No Change: Both O | - |
| Q6EEV6 | SUMO4_HUMAN Small ubiquitin-related modifier 4 OS=Homo sapiens GN=SUMO4 PE=1 SV=2 | 55 | M | 0.545868 | V | 0.428547 | 0.117321 | D to O | - |
| O94901 | SUN1_HUMAN SUN domain-containing protein 1 OS=Homo sapiens GN=SUN1 PE=1 SV=3 | 118 | H | 0.690218 | Y | 0.58238 | 0.107838 | No Change: Both D | - |
| Q9UH99 | SUN2_HUMAN SUN domain-containing protein 2 OS=Homo sapiens GN=SUN2 PE=1 SV=3 | 671 | G | 0.497353 | S | 0.541673 | -0.04432 | O to D | - |
| Q9UH99 | SUN2_HUMAN SUN domain-containing protein 2 OS=Homo sapiens GN=SUN2 PE=1 SV=3 | 33 | T | 0.983695 | A | 0.981769 | 0.001926 | No Change: Both D | - |
| Q9UH99 | SUN2_HUMAN SUN domain-containing protein 2 OS=Homo sapiens GN=SUN2 PE=1 SV=3 | 89 | L | 0.755994 | R | 0.829225 | -0.073231 | No Change: Both D | - |
| Q9UH99 | SUN2_HUMAN SUN domain-containing protein 2 OS=Homo sapiens GN=SUN2 PE=1 SV=3 | 348 | R | 0.758855 | C | 0.605055 | 0.1538 | No Change: Both D | - |
| Q8TAQ9 | SUN3_HUMAN SUN domain-containing protein 3 OS=Homo sapiens GN=SUN3 PE=2 SV=4 | 127 | I | 0.187529 | V | 0.193271 | -0.005742 | No Change: Both O | - |
| Q8TAQ9 | SUN3_HUMAN SUN domain-containing protein 3 OS=Homo sapiens GN=SUN3 PE=2 SV=4 | 177 | L | 0.374168 | V | 0.381027 | -0.006859 | No Change: Both O | - |
| Q8TC36 | SUN5_HUMAN SUN domain-containing protein 5 OS=Homo sapiens GN=SUN5 PE=2 SV=1 | 16 | E | 0.957234 | K | 0.953296 | 0.003938 | No Change: Both D | - |
| Q8TC36 | SUN5_HUMAN SUN domain-containing protein 5 OS=Homo sapiens GN=SUN5 PE=2 SV=1 | 39 | E | 0.820002 | D | 0.837807 | -0.017805 | No Change: Both D | - |
| Q8TC36 | SUN5_HUMAN SUN domain-containing protein 5 OS=Homo sapiens GN=SUN5 PE=2 SV=1 | 174 | A | 0.791669 | T | 0.778775 | 0.012894 | No Change: Both D | - |
| Q8TC36 | SUN5_HUMAN SUN domain-containing protein 5 OS=Homo sapiens GN=SUN5 PE=2 SV=1 | 120 | I | 0.087472 | V | 0.103193 | -0.015721 | No Change: Both O | - |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 217 | R | 0.359183 | Q | 0.363865 | -0.004682 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 265 | A | 0.287087 | D | 0.363018 | -0.075931 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 427 | S | 0.508894 | Y | 0.296021 | 0.212873 | D to O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 530 | G | 0.090433 | D | 0.103304 | -0.012871 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 258 | I | 0.119101 | L | 0.153287 | -0.034186 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 268 | R | 0.448258 | Q | 0.471803 | -0.023545 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 362 | G | 0.338483 | S | 0.373898 | -0.035415 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 366 | R | 0.223645 | H | 0.218504 | 0.005141 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 379 | K | 0.207191 | R | 0.199835 | 0.007356 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 396 | Q | 0.473717 | R | 0.477023 | -0.003306 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| P51687 | SUOX_HUMAN Sulfite oxidase mitochondrial OS=Homo sapiens GN=SUOX PE=1 SV=2 | 450 | W | 0.245255 | R | 0.459863 | -0.214608 | No Change: Both O | Isolated sulfite oxidase deficiency (ISOD) [MIM:272300] |
| O75486 | SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens GN=SUPT3H PE=1 SV=2 | 324 | D | 0.205649 | A | 0.151548 | 0.054101 | No Change: Both O | - |
| Q8IYB8 | SUV3_HUMAN ATP-dependent RNA helicase SUPV3L1 mitochondrial OS=Homo sapiens GN=SUPV3L1 PE=1 SV=1 | 30 | P | 0.369266 | T | 0.272136 | 0.09713 | No Change: Both O | - |
| Q8IYB8 | SUV3_HUMAN ATP-dependent RNA helicase SUPV3L1 mitochondrial OS=Homo sapiens GN=SUPV3L1 PE=1 SV=1 | 2 | S | 0.677166 | F | 0.459852 | 0.217314 | D to O | - |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 124 | G | 0.473688 | E | 0.584091 | -0.110403 | O to D | Leigh syndrome (LS) [MIM:256000] |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 202 | D | 0.383482 | H | 0.34594 | 0.037542 | No Change: Both O | - |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 246 | I | 0.157652 | T | 0.263134 | -0.105482 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 124 | G | 0.473688 | R | 0.555537 | -0.081849 | O to D | Leigh syndrome (LS) [MIM:256000] |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 274 | Y | 0.059233 | D | 0.112165 | -0.052932 | No Change: Both O | Leigh syndrome (LS) [MIM:256000] |
| Q15526 | SURF1_HUMAN Surfeit locus protein 1 OS=Homo sapiens GN=SURF1 PE=1 SV=1 | 89 | N | 0.175499 | K | 0.224387 | -0.048888 | No Change: Both O | A breast cancer sample |
| Q15527 | SURF2_HUMAN Surfeit locus protein 2 OS=Homo sapiens GN=SURF2 PE=1 SV=3 | 213 | S | 0.959035 | G | 0.954955 | 0.00408 | No Change: Both D | - |
| Q15527 | SURF2_HUMAN Surfeit locus protein 2 OS=Homo sapiens GN=SURF2 PE=1 SV=3 | 221 | R | 0.945625 | Q | 0.942799 | 0.002826 | No Change: Both D | - |
| O75683 | SURF6_HUMAN Surfeit locus protein 6 OS=Homo sapiens GN=SURF6 PE=1 SV=3 | 163 | R | 0.99791 | W | 0.994099 | 0.003811 | No Change: Both D | - |
| O75683 | SURF6_HUMAN Surfeit locus protein 6 OS=Homo sapiens GN=SURF6 PE=1 SV=3 | 175 | T | 0.973303 | M | 0.96883 | 0.004473 | No Change: Both D | - |
| O75683 | SURF6_HUMAN Surfeit locus protein 6 OS=Homo sapiens GN=SURF6 PE=1 SV=3 | 311 | T | 0.985448 | M | 0.988186 | -0.002738 | No Change: Both D | - |
| O75683 | SURF6_HUMAN Surfeit locus protein 6 OS=Homo sapiens GN=SURF6 PE=1 SV=3 | 193 | R | 0.934196 | Q | 0.935832 | -0.001636 | No Change: Both D | - |
| O75683 | SURF6_HUMAN Surfeit locus protein 6 OS=Homo sapiens GN=SURF6 PE=1 SV=3 | 201 | N | 0.903361 | H | 0.886764 | 0.016597 | No Change: Both D | - |
| Q6UWL2 | SUSD1_HUMAN Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1 PE=1 SV=1 | 524 | H | 0.045798 | Q | 0.062031 | -0.016233 | No Change: Both O | - |
| Q6UWL2 | SUSD1_HUMAN Sushi domain-containing protein 1 OS=Homo sapiens GN=SUSD1 PE=1 SV=1 | 201 | Q | 0.349635 | E | 0.407576 | -0.057941 | No Change: Both O | - |
| Q9UGT4 | SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens GN=SUSD2 PE=1 SV=1 | 59 | R | 0.350243 | Q | 0.323957 | 0.026286 | No Change: Both O | - |
| Q9UGT4 | SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens GN=SUSD2 PE=1 SV=1 | 110 | S | 0.468327 | T | 0.395816 | 0.072511 | No Change: Both O | - |
| Q9UGT4 | SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens GN=SUSD2 PE=1 SV=1 | 466 | N | 0.260691 | S | 0.281285 | -0.020594 | No Change: Both O | - |
| Q96L08 | SUSD3_HUMAN Sushi domain-containing protein 3 OS=Homo sapiens GN=SUSD3 PE=2 SV=1 | 136 | K | 0.750068 | E | 0.732845 | 0.017223 | No Change: Both D | - |
| Q96L08 | SUSD3_HUMAN Sushi domain-containing protein 3 OS=Homo sapiens GN=SUSD3 PE=2 SV=1 | 140 | S | 0.773125 | T | 0.698152 | 0.074973 | No Change: Both D | A breast cancer sample |
| O60279 | SUSD5_HUMAN Sushi domain-containing protein 5 OS=Homo sapiens GN=SUSD5 PE=1 SV=3 | 52 | L | 0.592772 | F | 0.549204 | 0.043568 | No Change: Both D | - |
| O60279 | SUSD5_HUMAN Sushi domain-containing protein 5 OS=Homo sapiens GN=SUSD5 PE=1 SV=3 | 228 | R | 0.935904 | K | 0.929237 | 0.006667 | No Change: Both D | - |
| O60279 | SUSD5_HUMAN Sushi domain-containing protein 5 OS=Homo sapiens GN=SUSD5 PE=1 SV=3 | 40 | F | 0.306763 | L | 0.363356 | -0.056593 | No Change: Both O | - |
| O60279 | SUSD5_HUMAN Sushi domain-containing protein 5 OS=Homo sapiens GN=SUSD5 PE=1 SV=3 | 216 | R | 0.671407 | K | 0.67333 | -0.001923 | No Change: Both D | - |
| O60279 | SUSD5_HUMAN Sushi domain-containing protein 5 OS=Homo sapiens GN=SUSD5 PE=1 SV=3 | 378 | E | 0.720931 | D | 0.705964 | 0.014967 | No Change: Both D | - |
| Q9H5I1 | SUV92_HUMAN Histone-lysine N-methyltransferase SUV39H2 OS=Homo sapiens GN=SUV39H2 PE=1 SV=2 | 383 | D | 0.769736 | H | 0.760565 | 0.009171 | No Change: Both D | A breast cancer sample |
| Q4FZB7 | SV421_HUMAN Histone-lysine N-methyltransferase SUV420H1 OS=Homo sapiens GN=SUV420H1 PE=1 SV=4 | 9 | I | 0.652316 | N | 0.850915 | -0.198599 | No Change: Both D | - |
| Q15022 | SUZ12_HUMAN Polycomb protein SUZ12 OS=Homo sapiens GN=SUZ12 PE=1 SV=3 | 216 | N | 0.79809 | I | 0.654218 | 0.143872 | No Change: Both D | - |
| Q496J9 | SV2C_HUMAN Synaptic vesicle glycoprotein 2C OS=Homo sapiens GN=SV2C PE=2 SV=1 | 482 | T | 0.153465 | S | 0.198752 | -0.045287 | No Change: Both O | - |
| Q496J9 | SV2C_HUMAN Synaptic vesicle glycoprotein 2C OS=Homo sapiens GN=SV2C PE=2 SV=1 | 543 | D | 0.314321 | N | 0.29577 | 0.018551 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 332 | G | 0.877015 | A | 0.845832 | 0.031183 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 428 | G | 0.352033 | S | 0.418549 | -0.066516 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 507 | V | 0.368676 | I | 0.366219 | 0.002457 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 581 | Q | 0.543641 | H | 0.48258 | 0.061061 | D to O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 637 | I | 0.083579 | V | 0.093856 | -0.010277 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 899 | K | 0.686942 | R | 0.652862 | 0.03408 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1157 | I | 0.66449 | V | 0.692659 | -0.028169 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1330 | L | 0.466626 | M | 0.501051 | -0.034425 | O to D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1416 | K | 0.578455 | Q | 0.571028 | 0.007427 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1444 | M | 0.199096 | L | 0.16239 | 0.036706 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1648 | L | 0.637124 | V | 0.634439 | 0.002685 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1810 | E | 0.229005 | A | 0.153021 | 0.075984 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 1953 | R | 0.209819 | K | 0.264295 | -0.054476 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 2607 | T | 0.331239 | A | 0.296502 | 0.034737 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 2750 | A | 0.320118 | V | 0.251192 | 0.068926 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 2922 | I | 0.172421 | V | 0.195755 | -0.023334 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 3161 | F | 0.43459 | I | 0.429145 | 0.005445 | No Change: Both O | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 3230 | P | 0.632761 | T | 0.567826 | 0.064935 | No Change: Both D | - |
| Q4LDE5 | SVEP1_HUMAN Sushi von Willebrand factor type A EGF and pentraxin domain-containing protein 1 OS=Homo sapiens GN=SVEP1 PE=1 SV=3 | 3559 | T | 0.811394 | M | 0.779328 | 0.032066 | No Change: Both D | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 189 | V | 0.576134 | A | 0.650443 | -0.074309 | No Change: Both D | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 1235 | P | 0.627512 | A | 0.527986 | 0.099526 | No Change: Both D | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 1688 | S | 0.664491 | P | 0.677504 | -0.013013 | No Change: Both D | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 1041 | V | 0.715799 | L | 0.731932 | -0.016133 | No Change: Both D | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 2005 | I | 0.292011 | V | 0.335687 | -0.043676 | No Change: Both O | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 2041 | A | 0.303079 | V | 0.220584 | 0.082495 | No Change: Both O | - |
| O95425 | SVIL_HUMAN Supervillin OS=Homo sapiens GN=SVIL PE=1 SV=2 | 422 | V | 0.868213 | I | 0.825484 | 0.042729 | No Change: Both D | - |
| Q8N434 | SVOPL_HUMAN Putative transporter SVOPL OS=Homo sapiens GN=SVOPL PE=2 SV=2 | 385 | F | 0.01729 | C | 0.017626 | -3.36E-04 | No Change: Both O | - |
| Q9UH65 | SWP70_HUMAN Switch-associated protein 70 OS=Homo sapiens GN=SWAP70 PE=1 SV=1 | 505 | Q | 0.973465 | E | 0.976571 | -0.003106 | No Change: Both D | - |
| Q9UH65 | SWP70_HUMAN Switch-associated protein 70 OS=Homo sapiens GN=SWAP70 PE=1 SV=1 | 230 | R | 0.123678 | G | 0.122666 | 0.001012 | No Change: Both O | - |
| Q6NVH7 | SWAP1_HUMAN ATPase SWSAP1 OS=Homo sapiens GN=SWSAP1 PE=1 SV=1 | 171 | D | 0.467494 | G | 0.47471 | -0.007216 | No Change: Both O | - |
| Q5T5J6 | SWT1_HUMAN Transcriptional protein SWT1 OS=Homo sapiens GN=SWT1 PE=2 SV=1 | 148 | I | 0.81864 | V | 0.826604 | -0.007964 | No Change: Both D | - |
| Q5T5J6 | SWT1_HUMAN Transcriptional protein SWT1 OS=Homo sapiens GN=SWT1 PE=2 SV=1 | 536 | H | 0.516811 | R | 0.550007 | -0.033196 | No Change: Both D | - |
| Q5T5J6 | SWT1_HUMAN Transcriptional protein SWT1 OS=Homo sapiens GN=SWT1 PE=2 SV=1 | 638 | L | 0.060991 | F | 0.051545 | 0.009446 | No Change: Both O | - |
| Q5T5J6 | SWT1_HUMAN Transcriptional protein SWT1 OS=Homo sapiens GN=SWT1 PE=2 SV=1 | 821 | N | 0.366958 | D | 0.383277 | -0.016319 | No Change: Both O | - |
| Q8N0S2 | SYCE1_HUMAN Synaptonemal complex central element protein 1 OS=Homo sapiens GN=SYCE1 PE=2 SV=2 | 132 | E | 0.906605 | D | 0.863887 | 0.042718 | No Change: Both D | - |
| Q8N0S2 | SYCE1_HUMAN Synaptonemal complex central element protein 1 OS=Homo sapiens GN=SYCE1 PE=2 SV=2 | 183 | K | 0.524175 | R | 0.472144 | 0.052031 | D to O | - |
| Q8N0S2 | SYCE1_HUMAN Synaptonemal complex central element protein 1 OS=Homo sapiens GN=SYCE1 PE=2 SV=2 | 317 | P | 0.874994 | A | 0.831085 | 0.043909 | No Change: Both D | - |
| A1L190 | SYCE3_HUMAN Synaptonemal complex central element protein 3 OS=Homo sapiens GN=SYCE3 PE=3 SV=1 | 88 | L | 0.804371 | P | 0.833792 | -0.029421 | No Change: Both D | - |
| Q0VAF6 | SYCN_HUMAN Syncollin OS=Homo sapiens GN=SYCN PE=2 SV=1 | 111 | L | 0.420893 | M | 0.483577 | -0.062684 | No Change: Both O | - |
| Q15431 | SYCP1_HUMAN Synaptonemal complex protein 1 OS=Homo sapiens GN=SYCP1 PE=1 SV=2 | 78 | E | 0.376907 | D | 0.366463 | 0.010444 | No Change: Both O | - |
| Q15431 | SYCP1_HUMAN Synaptonemal complex protein 1 OS=Homo sapiens GN=SYCP1 PE=1 SV=2 | 805 | E | 0.529615 | D | 0.516298 | 0.013317 | No Change: Both D | - |
| Q9BX26 | SYCP2_HUMAN Synaptonemal complex protein 2 OS=Homo sapiens GN=SYCP2 PE=2 SV=2 | 523 | P | 0.974259 | L | 0.955915 | 0.018344 | No Change: Both D | - |
| Q9BX26 | SYCP2_HUMAN Synaptonemal complex protein 2 OS=Homo sapiens GN=SYCP2 PE=2 SV=2 | 353 | T | 0.187045 | K | 0.264746 | -0.077701 | No Change: Both O | - |
| Q9BX26 | SYCP2_HUMAN Synaptonemal complex protein 2 OS=Homo sapiens GN=SYCP2 PE=2 SV=2 | 751 | T | 0.559509 | I | 0.427603 | 0.131906 | D to O | - |
| Q9BX26 | SYCP2_HUMAN Synaptonemal complex protein 2 OS=Homo sapiens GN=SYCP2 PE=2 SV=2 | 1155 | V | 0.872186 | A | 0.907227 | -0.035041 | No Change: Both D | - |
| Q5T4T6 | SYC2L_HUMAN Synaptonemal complex protein 2-like OS=Homo sapiens GN=SYCP2L PE=1 SV=2 | 94 | V | 0.153 | I | 0.147916 | 0.005084 | No Change: Both O | - |
| Q5T4T6 | SYC2L_HUMAN Synaptonemal complex protein 2-like OS=Homo sapiens GN=SYCP2L PE=1 SV=2 | 647 | N | 0.917851 | D | 0.932684 | -0.014833 | No Change: Both D | - |
| Q5T4T6 | SYC2L_HUMAN Synaptonemal complex protein 2-like OS=Homo sapiens GN=SYCP2L PE=1 SV=2 | 672 | P | 0.916288 | S | 0.921384 | -0.005096 | No Change: Both D | - |
| Q6ZW31 | SYDE1_HUMAN Rho GTPase-activating protein SYDE1 OS=Homo sapiens GN=SYDE1 PE=1 SV=1 | 408 | R | 0.627277 | Q | 0.637067 | -0.00979 | No Change: Both D | A pancreatic ductal adenocarcinoma sample |
| Q5VT97 | SYDE2_HUMAN Rho GTPase-activating protein SYDE2 OS=Homo sapiens GN=SYDE2 PE=1 SV=2 | 484 | I | 0.662085 | M | 0.75927 | -0.097185 | No Change: Both D | - |
| Q5VT97 | SYDE2_HUMAN Rho GTPase-activating protein SYDE2 OS=Homo sapiens GN=SYDE2 PE=1 SV=2 | 569 | V | 0.395145 | I | 0.388419 | 0.006726 | No Change: Both O | - |
| Q5VT97 | SYDE2_HUMAN Rho GTPase-activating protein SYDE2 OS=Homo sapiens GN=SYDE2 PE=1 SV=2 | 1157 | V | 0.567543 | I | 0.556449 | 0.011094 | No Change: Both D | - |
| O95926 | SYF2_HUMAN Pre-mRNA-splicing factor SYF2 OS=Homo sapiens GN=SYF2 PE=1 SV=1 | 89 | A | 0.947903 | V | 0.926485 | 0.021418 | No Change: Both D | - |
| P43405 | KSYK_HUMAN Tyrosine-protein kinase SYK OS=Homo sapiens GN=SYK PE=1 SV=1 | 45 | R | 0.249241 | H | 0.241215 | 0.008026 | No Change: Both O | - |
| Q92777 | SYN2_HUMAN Synapsin-2 OS=Homo sapiens GN=SYN2 PE=1 SV=3 | 506 | T | 0.999193 | A | 0.999231 | -3.80E-05 | No Change: Both D | - |
| Q9H7V2 | SYNG1_HUMAN Synapse differentiation-inducing gene protein 1 OS=Homo sapiens GN=SYNDIG1 PE=2 SV=1 | 54 | G | 0.714266 | R | 0.750205 | -0.035939 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8323 | G | 0.656863 | A | 0.629824 | 0.027039 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 3671 | V | 0.447503 | M | 0.535585 | -0.088082 | O to D | A colorectal cancer sample |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4210 | E | 0.787732 | D | 0.764628 | 0.023104 | No Change: Both D | A colorectal cancer sample |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4223 | R | 0.462573 | H | 0.423997 | 0.038576 | No Change: Both O | A colorectal cancer sample |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 5507 | L | 0.595124 | R | 0.690215 | -0.095091 | No Change: Both D | A colorectal cancer sample |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8468 | R | 0.535708 | H | 0.519955 | 0.015753 | No Change: Both D | A colorectal cancer sample |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 655 | Q | 0.22585 | R | 0.205412 | 0.020438 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 885 | L | 0.294255 | V | 0.296506 | -0.002251 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 1035 | V | 0.364187 | A | 0.454016 | -0.089829 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 2030 | S | 0.595962 | G | 0.545719 | 0.050243 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 2795 | A | 0.560738 | V | 0.453702 | 0.107036 | D to O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 3874 | K | 0.778887 | T | 0.729102 | 0.049785 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 3954 | S | 0.463563 | T | 0.401241 | 0.062322 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4060 | E | 0.830386 | D | 0.822027 | 0.008359 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4121 | K | 0.535459 | N | 0.494463 | 0.040996 | D to O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4121 | K | 0.535459 | R | 0.452857 | 0.082602 | D to O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4203 | E | 0.815646 | K | 0.819965 | -0.004319 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4546 | V | 0.689353 | I | 0.615923 | 0.07343 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4596 | S | 0.598234 | T | 0.525698 | 0.072536 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 4944 | L | 0.729838 | M | 0.779137 | -0.049299 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 5015 | L | 0.313054 | M | 0.352367 | -0.039313 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 5377 | M | 0.671011 | L | 0.641901 | 0.02911 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 5426 | T | 0.877136 | M | 0.856171 | 0.020965 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 6566 | M | 0.629644 | I | 0.498516 | 0.131128 | D to O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 6664 | T | 0.398185 | I | 0.245447 | 0.152738 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 6951 | Q | 0.230526 | H | 0.229318 | 0.001208 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 7302 | F | 0.222233 | V | 0.239984 | -0.017751 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 7506 | S | 0.383464 | G | 0.32357 | 0.059894 | No Change: Both O | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8161 | N | 0.573268 | H | 0.547357 | 0.025911 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8168 | A | 0.569603 | S | 0.659357 | -0.089754 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8687 | T | 0.988589 | I | 0.978896 | 0.009693 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8741 | L | 0.510864 | M | 0.528797 | -0.017933 | No Change: Both D | - |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8095 | R | 0.30268 | H | 0.270401 | 0.032279 | No Change: Both O | Emery-Dreifuss muscular dystrophy type 4 (EDMD4) [MIM:612998] |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8387 | V | 0.748778 | L | 0.786901 | -0.038123 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 4 (EDMD4) [MIM:612998] |
| Q8NF91 | SYNE1_HUMAN Nesprin-1 OS=Homo sapiens GN=SYNE1 PE=1 SV=3 | 8461 | E | 0.55984 | K | 0.534716 | 0.025124 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 4 (EDMD4) [MIM:612998] |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 8 | P | 0.788661 | S | 0.806538 | -0.017877 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 574 | I | 0.216642 | T | 0.356498 | -0.139856 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2358 | N | 0.879512 | S | 0.910852 | -0.03134 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2394 | A | 0.905912 | T | 0.915039 | -0.009127 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2801 | G | 0.629046 | S | 0.724771 | -0.095725 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 5940 | V | 0.303682 | I | 0.294241 | 0.009441 | No Change: Both O | A breast cancer sample |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 6200 | Y | 0.602666 | C | 0.657952 | -0.055286 | No Change: Both D | A breast cancer sample |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 432 | S | 0.48677 | R | 0.438294 | 0.048476 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 1393 | R | 0.693096 | W | 0.530906 | 0.16219 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 1969 | M | 0.799037 | T | 0.823517 | -0.02448 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2284 | A | 0.462749 | V | 0.413434 | 0.049315 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2347 | A | 0.874344 | E | 0.917085 | -0.042741 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2359 | S | 0.901481 | G | 0.865229 | 0.036252 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2359 | S | 0.901481 | N | 0.87896 | 0.022521 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2395 | A | 0.903378 | T | 0.912523 | -0.009145 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2490 | V | 0.192188 | G | 0.32271 | -0.130522 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2564 | I | 0.452059 | V | 0.458328 | -0.006269 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2802 | S | 0.641372 | G | 0.575422 | 0.06595 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 2942 | I | 0.509578 | V | 0.514696 | -0.005118 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3026 | E | 0.618749 | D | 0.582362 | 0.036387 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3130 | N | 0.711226 | S | 0.723794 | -0.012568 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3253 | D | 0.30418 | H | 0.254474 | 0.049706 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3309 | H | 0.508143 | R | 0.57645 | -0.068307 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3523 | K | 0.439366 | Q | 0.468022 | -0.028656 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 3982 | N | 0.539697 | H | 0.450653 | 0.089044 | D to O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 4041 | R | 0.634725 | H | 0.620198 | 0.014527 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 4912 | P | 0.34164 | A | 0.292946 | 0.048694 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 4913 | E | 0.359015 | K | 0.353028 | 0.005987 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 5086 | H | 0.822335 | Y | 0.747487 | 0.074848 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 5186 | L | 0.481402 | M | 0.517698 | -0.036296 | O to D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 5547 | D | 0.48781 | N | 0.490184 | -0.002374 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 6155 | A | 0.418711 | V | 0.324701 | 0.09401 | No Change: Both O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 6681 | K | 0.546511 | E | 0.524079 | 0.022432 | No Change: Both D | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 6697 | R | 0.704879 | W | 0.470807 | 0.234072 | D to O | - |
| Q8WXH0 | SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3 | 6211 | T | 0.671923 | M | 0.652784 | 0.019139 | No Change: Both D | Emery-Dreifuss muscular dystrophy type 5 (EDMD5) [MIM:612999] |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 201 | D | 0.595094 | E | 0.642951 | -0.047857 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 749 | R | 0.910517 | Q | 0.913115 | -0.002598 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 790 | T | 0.969631 | N | 0.975404 | -0.005773 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 991 | G | 0.885797 | R | 0.886237 | -4.40E-04 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 1115 | I | 0.992643 | T | 0.995232 | -0.002589 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 1283 | P | 0.922929 | L | 0.868753 | 0.054176 | No Change: Both D | - |
| Q96PV0 | SYGP1_HUMAN Ras GTPase-activating protein SynGAP OS=Homo sapiens GN=SYNGAP1 PE=1 SV=4 | 1310 | T | 0.961411 | M | 0.95746 | 0.003951 | No Change: Both D | - |
| O43759 | SNG1_HUMAN Synaptogyrin-1 OS=Homo sapiens GN=SYNGR1 PE=1 SV=2 | 222 | D | 0.916874 | G | 0.926317 | -0.009443 | No Change: Both D | - |
| O95473 | SNG4_HUMAN Synaptogyrin-4 OS=Homo sapiens GN=SYNGR4 PE=2 SV=2 | 27 | R | 0.157336 | W | 0.058979 | 0.098357 | No Change: Both O | - |
| O43426 | SYNJ1_HUMAN Synaptojanin-1 OS=Homo sapiens GN=SYNJ1 PE=1 SV=2 | 295 | K | 0.157521 | R | 0.130124 | 0.027397 | No Change: Both O | - |
| O43426 | SYNJ1_HUMAN Synaptojanin-1 OS=Homo sapiens GN=SYNJ1 PE=1 SV=2 | 1366 | V | 0.961806 | A | 0.968746 | -0.00694 | No Change: Both D | - |
| O43426 | SYNJ1_HUMAN Synaptojanin-1 OS=Homo sapiens GN=SYNJ1 PE=1 SV=2 | 1545 | L | 0.958275 | P | 0.980676 | -0.022401 | No Change: Both D | - |
| O43426 | SYNJ1_HUMAN Synaptojanin-1 OS=Homo sapiens GN=SYNJ1 PE=1 SV=2 | 1547 | P | 0.965584 | L | 0.924502 | 0.041082 | No Change: Both D | - |
| O43426 | SYNJ1_HUMAN Synaptojanin-1 OS=Homo sapiens GN=SYNJ1 PE=1 SV=2 | 1508 | P | 0.7966 | L | 0.709449 | 0.087151 | No Change: Both D | - |
| O15056 | SYNJ2_HUMAN Synaptojanin-2 OS=Homo sapiens GN=SYNJ2 PE=1 SV=3 | 1468 | E | 0.625097 | G | 0.586177 | 0.03892 | No Change: Both D | - |
| P57105 | SYJ2B_HUMAN Synaptojanin-2-binding protein OS=Homo sapiens GN=SYNJ2BP PE=1 SV=2 | 9 | V | 0.253044 | I | 0.227524 | 0.02552 | No Change: Both O | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 272 | A | 0.536139 | V | 0.413634 | 0.122505 | D to O | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 330 | V | 0.284134 | I | 0.267292 | 0.016842 | No Change: Both O | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 338 | R | 0.612426 | W | 0.439017 | 0.173409 | D to O | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 567 | P | 0.992183 | L | 0.987144 | 0.005039 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 612 | E | 0.838555 | A | 0.790628 | 0.047927 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 761 | P | 0.817641 | L | 0.704481 | 0.11316 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 946 | R | 0.808159 | W | 0.635877 | 0.172282 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 976 | Q | 0.826055 | R | 0.827322 | -0.001267 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1059 | P | 0.858279 | L | 0.757808 | 0.100471 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1067 | R | 0.813028 | P | 0.827028 | -0.014 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1077 | S | 0.792215 | L | 0.660015 | 0.1322 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1386 | G | 0.945759 | E | 0.957179 | -0.01142 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1462 | F | 0.508561 | C | 0.51809 | -0.009529 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 355 | R | 0.673777 | W | 0.440498 | 0.233279 | D to O | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 462 | G | 0.65408 | S | 0.713736 | -0.059656 | No Change: Both D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1130 | G | 0.45026 | S | 0.535958 | -0.085698 | O to D | - |
| O15061 | SYNEM_HUMAN Synemin OS=Homo sapiens GN=SYNM PE=1 SV=2 | 1345 | G | 0.858675 | A | 0.83261 | 0.026065 | No Change: Both D | - |
| Q9UMS6 | SYNP2_HUMAN Synaptopodin-2 OS=Homo sapiens GN=SYNPO2 PE=1 SV=2 | 573 | T | 0.710711 | A | 0.680827 | 0.029884 | No Change: Both D | - |
| Q9UMS6 | SYNP2_HUMAN Synaptopodin-2 OS=Homo sapiens GN=SYNPO2 PE=1 SV=2 | 154 | G | 0.819192 | A | 0.803748 | 0.015444 | No Change: Both D | - |
| Q9UMS6 | SYNP2_HUMAN Synaptopodin-2 OS=Homo sapiens GN=SYNPO2 PE=1 SV=2 | 174 | Q | 0.86723 | H | 0.808414 | 0.058816 | No Change: Both D | - |
| Q9UMS6 | SYNP2_HUMAN Synaptopodin-2 OS=Homo sapiens GN=SYNPO2 PE=1 SV=2 | 179 | A | 0.823717 | T | 0.824084 | -3.67E-04 | No Change: Both D | - |
| Q9H987 | SYP2L_HUMAN Synaptopodin 2-like protein OS=Homo sapiens GN=SYNPO2L PE=2 SV=3 | 707 | P | 0.958408 | L | 0.929483 | 0.028925 | No Change: Both D | - |
| Q9H987 | SYP2L_HUMAN Synaptopodin 2-like protein OS=Homo sapiens GN=SYNPO2L PE=2 SV=3 | 833 | S | 0.815102 | Y | 0.714789 | 0.100313 | No Change: Both D | - |
| Q9H987 | SYP2L_HUMAN Synaptopodin 2-like protein OS=Homo sapiens GN=SYNPO2L PE=2 SV=3 | 508 | P | 0.965026 | H | 0.937792 | 0.027234 | No Change: Both D | - |
| Q9UMZ2 | SYNRG_HUMAN Synergin gamma OS=Homo sapiens GN=SYNRG PE=1 SV=2 | 40 | A | 0.934924 | G | 0.950173 | -0.015249 | No Change: Both D | - |
| Q9UMZ2 | SYNRG_HUMAN Synergin gamma OS=Homo sapiens GN=SYNRG PE=1 SV=2 | 222 | T | 0.688923 | A | 0.674607 | 0.014316 | No Change: Both D | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 2 | L | 0.631744 | Q | 0.753028 | -0.121284 | No Change: Both D | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 158 | S | 0.19847 | L | 0.092751 | 0.105719 | No Change: Both O | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 166 | D | 0.403126 | N | 0.381605 | 0.021521 | No Change: Both O | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 217 | G | 0.018799 | R | 0.017602 | 0.001197 | No Change: Both O | Mental retardation X-linked SYP-related (MRXSYP) [MIM:300802] |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 248 | D | 0.788968 | N | 0.768755 | 0.020213 | No Change: Both D | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 277 | D | 0.994171 | E | 0.993065 | 0.001106 | No Change: Both D | - |
| P08247 | SYPH_HUMAN Synaptophysin OS=Homo sapiens GN=SYP PE=1 SV=3 | 293 | G | 0.988128 | S | 0.989603 | -0.001475 | No Change: Both D | - |
| Q6XYQ8 | SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens GN=SYT10 PE=2 SV=1 | 420 | T | 0.686423 | S | 0.699037 | -0.012614 | No Change: Both D | - |
| Q6XYQ8 | SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens GN=SYT10 PE=2 SV=1 | 488 | H | 0.265256 | P | 0.296855 | -0.031599 | No Change: Both O | - |
| Q6XYQ8 | SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens GN=SYT10 PE=2 SV=1 | 505 | A | 0.649241 | V | 0.57282 | 0.076421 | No Change: Both D | - |
| Q6XYQ8 | SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens GN=SYT10 PE=2 SV=1 | 172 | S | 0.895721 | I | 0.785424 | 0.110297 | No Change: Both D | - |
| Q9BT88 | SYT11_HUMAN Synaptotagmin-11 OS=Homo sapiens GN=SYT11 PE=1 SV=2 | 48 | Q | 0.782239 | H | 0.779278 | 0.002961 | No Change: Both D | - |
| Q9BT88 | SYT11_HUMAN Synaptotagmin-11 OS=Homo sapiens GN=SYT11 PE=1 SV=2 | 231 | G | 0.112947 | V | 0.067244 | 0.045703 | No Change: Both O | - |
| Q8IV01 | SYT12_HUMAN Synaptotagmin-12 OS=Homo sapiens GN=SYT12 PE=2 SV=1 | 170 | N | 0.292655 | H | 0.290261 | 0.002394 | No Change: Both O | - |
| Q8NB59 | SYT14_HUMAN Synaptotagmin-14 OS=Homo sapiens GN=SYT14 PE=1 SV=2 | 138 | G | 0.731541 | E | 0.794167 | -0.062626 | No Change: Both D | - |
| Q8NB59 | SYT14_HUMAN Synaptotagmin-14 OS=Homo sapiens GN=SYT14 PE=1 SV=2 | 439 | G | 0.352145 | D | 0.37197 | -0.019825 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 11 (SCAR11) [MIM:614229] |
| Q58G82 | SY14L_HUMAN Putative synaptotagmin-14-like protein OS=Homo sapiens GN=SYT14L PE=5 SV=2 | 97 | T | 0.616531 | M | 0.588934 | 0.027597 | No Change: Both D | - |
| Q17RD7 | SYT16_HUMAN Synaptotagmin-16 OS=Homo sapiens GN=SYT16 PE=2 SV=2 | 10 | V | 0.324621 | A | 0.4154 | -0.090779 | No Change: Both O | - |
| Q17RD7 | SYT16_HUMAN Synaptotagmin-16 OS=Homo sapiens GN=SYT16 PE=2 SV=2 | 131 | R | 0.761134 | L | 0.712872 | 0.048262 | No Change: Both D | - |
| Q9BQG1 | SYT3_HUMAN Synaptotagmin-3 OS=Homo sapiens GN=SYT3 PE=2 SV=1 | 474 | S | 0.4017 | F | 0.199725 | 0.201975 | No Change: Both O | A breast cancer sample |
| Q9H2B2 | SYT4_HUMAN Synaptotagmin-4 OS=Homo sapiens GN=SYT4 PE=1 SV=1 | 142 | S | 0.933199 | N | 0.915207 | 0.017992 | No Change: Both D | - |
| O00445 | SYT5_HUMAN Synaptotagmin-5 OS=Homo sapiens GN=SYT5 PE=2 SV=2 | 111 | R | 0.409879 | Q | 0.479452 | -0.069573 | No Change: Both O | - |
| O00445 | SYT5_HUMAN Synaptotagmin-5 OS=Homo sapiens GN=SYT5 PE=2 SV=2 | 4 | E | 0.992038 | D | 0.993573 | -0.001535 | No Change: Both D | - |
| O43581 | SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens GN=SYT7 PE=1 SV=3 | 332 | I | 0.328874 | N | 0.50835 | -0.179476 | O to D | - |
| Q8NBV8 | SYT8_HUMAN Synaptotagmin-8 OS=Homo sapiens GN=SYT8 PE=2 SV=4 | 120 | C | 0.358472 | R | 0.503983 | -0.145511 | O to D | - |
| Q8NBV8 | SYT8_HUMAN Synaptotagmin-8 OS=Homo sapiens GN=SYT8 PE=2 SV=4 | 129 | F | 0.363072 | I | 0.354183 | 0.008889 | No Change: Both O | - |
| Q8NBV8 | SYT8_HUMAN Synaptotagmin-8 OS=Homo sapiens GN=SYT8 PE=2 SV=4 | 17 | H | 0.803603 | Q | 0.834811 | -0.031208 | No Change: Both D | - |
| Q86SS6 | SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens GN=SYT9 PE=2 SV=1 | 445 | D | 0.230273 | N | 0.21713 | 0.013143 | No Change: Both O | A colorectal cancer sample |
| Q86SS6 | SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens GN=SYT9 PE=2 SV=1 | 154 | V | 0.71117 | M | 0.760738 | -0.049568 | No Change: Both D | - |
| Q86SS6 | SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens GN=SYT9 PE=2 SV=1 | 238 | I | 0.124027 | V | 0.139942 | -0.015915 | No Change: Both O | - |
| Q86SS6 | SYT9_HUMAN Synaptotagmin-9 OS=Homo sapiens GN=SYT9 PE=2 SV=1 | 353 | L | 0.227212 | V | 0.23254 | -0.005328 | No Change: Both O | - |
| Q4VX76 | SYTL3_HUMAN Synaptotagmin-like protein 3 OS=Homo sapiens GN=SYTL3 PE=2 SV=3 | 414 | P | 0.043616 | S | 0.050462 | -0.006846 | No Change: Both O | - |
| Q4VX76 | SYTL3_HUMAN Synaptotagmin-like protein 3 OS=Homo sapiens GN=SYTL3 PE=2 SV=3 | 540 | V | 0.326802 | I | 0.275882 | 0.05092 | No Change: Both O | - |
| Q4VX76 | SYTL3_HUMAN Synaptotagmin-like protein 3 OS=Homo sapiens GN=SYTL3 PE=2 SV=3 | 587 | L | 0.274621 | Q | 0.419151 | -0.14453 | No Change: Both O | - |
| Q96C24 | SYTL4_HUMAN Synaptotagmin-like protein 4 OS=Homo sapiens GN=SYTL4 PE=1 SV=2 | 420 | I | 0.463433 | V | 0.469536 | -0.006103 | No Change: Both O | - |
| Q8TDW5 | SYTL5_HUMAN Synaptotagmin-like protein 5 OS=Homo sapiens GN=SYTL5 PE=1 SV=1 | 275 | I | 0.784619 | V | 0.807436 | -0.022817 | No Change: Both D | - |
| Q8TDW5 | SYTL5_HUMAN Synaptotagmin-like protein 5 OS=Homo sapiens GN=SYTL5 PE=1 SV=1 | 302 | R | 0.817854 | C | 0.75242 | 0.065434 | No Change: Both D | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 369 | N | 0.705384 | S | 0.770459 | -0.065075 | No Change: Both D | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 177 | G | 0.325103 | D | 0.336999 | -0.011896 | No Change: Both O | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 356 | G | 0.760621 | S | 0.806294 | -0.045673 | No Change: Both D | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 367 | V | 0.716377 | M | 0.745604 | -0.029227 | No Change: Both D | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 402 | E | 0.633348 | K | 0.63312 | 2.28E-04 | No Change: Both D | - |
| O15178 | BRAC_HUMAN Brachyury protein OS=Homo sapiens GN=T PE=2 SV=1 | 358 | V | 0.741185 | I | 0.688788 | 0.052397 | No Change: Both D | - |
| Q96RJ0 | TAAR1_HUMAN Trace amine-associated receptor 1 OS=Homo sapiens GN=TAAR1 PE=1 SV=1 | 23 | R | 0.295456 | C | 0.158623 | 0.136833 | No Change: Both O | - |
| Q96RJ0 | TAAR1_HUMAN Trace amine-associated receptor 1 OS=Homo sapiens GN=TAAR1 PE=1 SV=1 | 252 | T | 0.234134 | A | 0.223385 | 0.010749 | No Change: Both O | - |
| O14804 | TAAR5_HUMAN Trace amine-associated receptor 5 OS=Homo sapiens GN=TAAR5 PE=2 SV=2 | 272 | T | 0.098314 | M | 0.079697 | 0.018617 | No Change: Both O | - |
| O14804 | TAAR5_HUMAN Trace amine-associated receptor 5 OS=Homo sapiens GN=TAAR5 PE=2 SV=2 | 330 | R | 0.417567 | C | 0.240027 | 0.17754 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 37 | I | 0.023383 | T | 0.042332 | -0.018949 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 165 | G | 0.067708 | S | 0.087407 | -0.019699 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 173 | Y | 0.229073 | C | 0.179798 | 0.049275 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 228 | A | 0.437734 | V | 0.364886 | 0.072848 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 265 | V | 0.051026 | I | 0.045272 | 0.005754 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 291 | C | 0.015127 | Y | 0.018953 | -0.003826 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 326 | V | 0.106691 | I | 0.09314 | 0.013551 | No Change: Both O | - |
| Q96RI8 | TAAR6_HUMAN Trace amine-associated receptor 6 OS=Homo sapiens GN=TAAR6 PE=2 SV=1 | 99 | Y | 0.053673 | C | 0.048006 | 0.005667 | No Change: Both O | - |
| Q969N4 | TAAR8_HUMAN Trace amine-associated receptor 8 OS=Homo sapiens GN=TAAR8 PE=2 SV=1 | 153 | S | 0.05102 | N | 0.037417 | 0.013603 | No Change: Both O | - |
| Q969N4 | TAAR8_HUMAN Trace amine-associated receptor 8 OS=Homo sapiens GN=TAAR8 PE=2 SV=1 | 328 | D | 0.346852 | A | 0.278213 | 0.068639 | No Change: Both O | - |
| Q969N4 | TAAR8_HUMAN Trace amine-associated receptor 8 OS=Homo sapiens GN=TAAR8 PE=2 SV=1 | 211 | V | 0.013886 | D | 0.030841 | -0.016955 | No Change: Both O | - |
| Q96RI9 | TAAR9_HUMAN Trace amine-associated receptor 9 OS=Homo sapiens GN=TAAR9 PE=2 SV=1 | 278 | A | 0.04648 | T | 0.049691 | -0.003211 | No Change: Both O | - |
| Q15750 | TAB1_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens GN=TAB1 PE=1 SV=1 | 224 | D | 0.318342 | E | 0.34354 | -0.025198 | No Change: Both O | - |
| Q9NYJ8 | TAB2_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 OS=Homo sapiens GN=TAB2 PE=1 SV=1 | 208 | P | 0.671841 | S | 0.659477 | 0.012364 | No Change: Both D | Congenital heart disease non-syndromic type 2 (CHTD2) [MIM:612863] |
| Q9NYJ8 | TAB2_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 OS=Homo sapiens GN=TAB2 PE=1 SV=1 | 230 | Q | 0.809767 | K | 0.761822 | 0.047945 | No Change: Both D | Congenital heart disease non-syndromic type 2 (CHTD2) [MIM:612863] |
| Q8N5C8 | TAB3_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 OS=Homo sapiens GN=TAB3 PE=1 SV=2 | 394 | W | 0.960664 | R | 0.982948 | -0.022284 | No Change: Both D | - |
| O75410 | TACC1_HUMAN Transforming acidic coiled-coil-containing protein 1 OS=Homo sapiens GN=TACC1 PE=1 SV=2 | 187 | P | 0.790736 | L | 0.6945 | 0.096236 | No Change: Both D | - |
| O75410 | TACC1_HUMAN Transforming acidic coiled-coil-containing protein 1 OS=Homo sapiens GN=TACC1 PE=1 SV=2 | 243 | I | 0.787919 | T | 0.875659 | -0.08774 | No Change: Both D | - |
| O75410 | TACC1_HUMAN Transforming acidic coiled-coil-containing protein 1 OS=Homo sapiens GN=TACC1 PE=1 SV=2 | 255 | E | 0.716388 | G | 0.673254 | 0.043134 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2102 | N | 0.940715 | S | 0.96556 | -0.024845 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2197 | V | 0.96103 | A | 0.972301 | -0.011271 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2261 | L | 0.895208 | H | 0.904831 | -0.009623 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2718 | V | 0.541617 | I | 0.550092 | -0.008475 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2732 | A | 0.406026 | T | 0.426649 | -0.020623 | No Change: Both O | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2078 | I | 0.924947 | T | 0.961244 | -0.036297 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2210 | A | 0.934633 | V | 0.920297 | 0.014336 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2900 | Q | 0.898189 | K | 0.894489 | 0.0037 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 798 | L | 0.392861 | V | 0.338796 | 0.054065 | No Change: Both O | A breast cancer sample |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 1347 | A | 0.951372 | S | 0.957427 | -0.006055 | No Change: Both D | A breast cancer sample |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 170 | V | 0.950885 | I | 0.958524 | -0.007639 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 830 | L | 0.808631 | F | 0.784388 | 0.024243 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 1103 | W | 0.934005 | R | 0.969228 | -0.035223 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 1425 | A | 0.499664 | T | 0.517863 | -0.018199 | O to D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 1492 | P | 0.578119 | L | 0.45992 | 0.118199 | D to O | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 1916 | E | 0.864591 | K | 0.858456 | 0.006135 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2216 | P | 0.924275 | L | 0.857131 | 0.067144 | No Change: Both D | - |
| O95359 | TACC2_HUMAN Transforming acidic coiled-coil-containing protein 2 OS=Homo sapiens GN=TACC2 PE=1 SV=3 | 2271 | E | 0.901889 | D | 0.899349 | 0.00254 | No Change: Both D | - |
| Q9Y6A5 | TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 OS=Homo sapiens GN=TACC3 PE=1 SV=1 | 143 | E | 0.942094 | K | 0.942488 | -3.94E-04 | No Change: Both D | - |
| Q9Y6A5 | TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 OS=Homo sapiens GN=TACC3 PE=1 SV=1 | 275 | C | 0.862762 | Y | 0.790259 | 0.072503 | No Change: Both D | - |
| Q9Y6A5 | TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 OS=Homo sapiens GN=TACC3 PE=1 SV=1 | 287 | G | 0.803758 | S | 0.816621 | -0.012863 | No Change: Both D | - |
| Q9Y6A5 | TACC3_HUMAN Transforming acidic coiled-coil-containing protein 3 OS=Homo sapiens GN=TACC3 PE=1 SV=1 | 514 | G | 0.873648 | E | 0.90383 | -0.030182 | No Change: Both D | - |
| Q9BSH4 | TACO1_HUMAN Translational activator of cytochrome c oxidase 1 OS=Homo sapiens GN=TACO1 PE=1 SV=1 | 145 | G | 0.560509 | S | 0.616475 | -0.055966 | No Change: Both D | - |
| P25103 | NK1R_HUMAN Substance-P receptor OS=Homo sapiens GN=TACR1 PE=1 SV=1 | 192 | Y | 0.35278 | H | 0.494188 | -0.141408 | No Change: Both O | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 375 | R | 0.662418 | H | 0.678311 | -0.015893 | No Change: Both D | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 23 | I | 0.455937 | T | 0.627663 | -0.171726 | O to D | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 47 | A | 0.037813 | T | 0.042287 | -0.004474 | No Change: Both O | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 245 | M | 0.326484 | K | 0.495545 | -0.169061 | No Change: Both O | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 363 | T | 0.656194 | A | 0.629018 | 0.027176 | No Change: Both D | - |
| P21452 | NK2R_HUMAN Substance-K receptor OS=Homo sapiens GN=TACR2 PE=2 SV=3 | 395 | H | 0.608405 | R | 0.540385 | 0.06802 | No Change: Both D | - |
| P29371 | NK3R_HUMAN Neuromedin-K receptor OS=Homo sapiens GN=TACR3 PE=2 SV=1 | 286 | K | 0.445278 | R | 0.354755 | 0.090523 | No Change: Both O | - |
| P29371 | NK3R_HUMAN Neuromedin-K receptor OS=Homo sapiens GN=TACR3 PE=2 SV=1 | 449 | A | 0.975366 | T | 0.980655 | -0.005289 | No Change: Both D | - |
| P09758 | TACD2_HUMAN Tumor-associated calcium signal transducer 2 OS=Homo sapiens GN=TACSTD2 PE=1 SV=3 | 173 | D | 0.457313 | A | 0.376075 | 0.081238 | No Change: Both O | - |
| P09758 | TACD2_HUMAN Tumor-associated calcium signal transducer 2 OS=Homo sapiens GN=TACSTD2 PE=1 SV=3 | 216 | D | 0.480435 | E | 0.48382 | -0.003385 | No Change: Both O | - |
| P09758 | TACD2_HUMAN Tumor-associated calcium signal transducer 2 OS=Homo sapiens GN=TACSTD2 PE=1 SV=3 | 147 | E | 0.293472 | D | 0.306664 | -0.013192 | No Change: Both O | - |
| Q96BN2 | TADA1_HUMAN Transcriptional adapter 1 OS=Homo sapiens GN=TADA1 PE=1 SV=1 | 198 | R | 0.398188 | Q | 0.392363 | 0.005825 | No Change: Both O | - |
| O75478 | TAD2A_HUMAN Transcriptional adapter 2-alpha OS=Homo sapiens GN=TADA2A PE=1 SV=3 | 6 | P | 0.93413 | S | 0.930196 | 0.003934 | No Change: Both D | - |
| O75478 | TAD2A_HUMAN Transcriptional adapter 2-alpha OS=Homo sapiens GN=TADA2A PE=1 SV=3 | 115 | M | 0.327083 | V | 0.257741 | 0.069342 | No Change: Both O | - |
| O75478 | TAD2A_HUMAN Transcriptional adapter 2-alpha OS=Homo sapiens GN=TADA2A PE=1 SV=3 | 351 | I | 0.845531 | M | 0.896716 | -0.051185 | No Change: Both D | - |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 269 | L | 0.768869 | V | 0.775428 | -0.006559 | No Change: Both D | - |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 297 | A | 0.785027 | G | 0.798321 | -0.013294 | No Change: Both D | - |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 453 | G | 0.222283 | D | 0.260916 | -0.038633 | No Change: Both O | A colorectal adenocarcinoma sample |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 651 | E | 0.852048 | K | 0.862311 | -0.010263 | No Change: Both D | A metastatic melanoma sample |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 691 | M | 0.469881 | I | 0.340637 | 0.129244 | No Change: Both O | A lung bronchoalveolar carcinoma sample |
| P21675 | TAF1_HUMAN Transcription initiation factor TFIID subunit 1 OS=Homo sapiens GN=TAF1 PE=1 SV=2 | 1383 | V | 0.481205 | I | 0.481735 | -5.30E-04 | No Change: Both O | - |
| Q12962 | TAF10_HUMAN Transcription initiation factor TFIID subunit 10 OS=Homo sapiens GN=TAF10 PE=1 SV=1 | 92 | I | 0.633944 | T | 0.744815 | -0.110871 | No Change: Both D | - |
| Q15544 | TAF11_HUMAN Transcription initiation factor TFIID subunit 11 OS=Homo sapiens GN=TAF11 PE=1 SV=1 | 68 | T | 0.931174 | R | 0.936245 | -0.005071 | No Change: Both D | - |
| Q15544 | TAF11_HUMAN Transcription initiation factor TFIID subunit 11 OS=Homo sapiens GN=TAF11 PE=1 SV=1 | 155 | S | 0.179534 | F | 0.074377 | 0.105157 | No Change: Both O | - |
| Q15573 | TAF1A_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit A OS=Homo sapiens GN=TAF1A PE=1 SV=1 | 98 | I | 0.165379 | M | 0.226384 | -0.061005 | No Change: Both O | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 6 | A | 0.710691 | S | 0.730782 | -0.020091 | No Change: Both D | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 282 | V | 0.213282 | I | 0.190505 | 0.022777 | No Change: Both O | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 351 | T | 0.318551 | A | 0.313477 | 0.005074 | No Change: Both O | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 462 | E | 0.503405 | D | 0.473495 | 0.02991 | D to O | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 487 | T | 0.496173 | M | 0.424046 | 0.072127 | No Change: Both O | - |
| Q53T94 | TAF1B_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Homo sapiens GN=TAF1B PE=1 SV=1 | 292 | R | 0.181457 | H | 0.1829 | -0.001443 | No Change: Both O | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 304 | S | 0.462325 | F | 0.230544 | 0.231781 | No Change: Both O | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 357 | R | 0.20609 | H | 0.184045 | 0.022045 | No Change: Both O | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 387 | S | 0.251398 | L | 0.12724 | 0.124158 | No Change: Both O | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 518 | H | 0.832988 | Y | 0.766036 | 0.066952 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 573 | P | 0.381963 | L | 0.2319 | 0.150063 | No Change: Both O | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 575 | L | 0.468528 | M | 0.503397 | -0.034869 | O to D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 591 | A | 0.486963 | G | 0.525447 | -0.038484 | O to D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 635 | G | 0.527742 | S | 0.613021 | -0.085279 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 791 | T | 0.977769 | M | 0.977221 | 5.48E-04 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 793 | P | 0.977335 | L | 0.957426 | 0.019909 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 816 | R | 0.944252 | H | 0.926083 | 0.018169 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 523 | G | 0.831304 | R | 0.842976 | -0.011672 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 808 | P | 0.951865 | S | 0.943371 | 0.008494 | No Change: Both D | - |
| Q15572 | TAF1C_HUMAN TATA box-binding protein-associated factor RNA polymerase I subunit C OS=Homo sapiens GN=TAF1C PE=1 SV=2 | 91 | C | 0.281734 | Y | 0.309255 | -0.027521 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 47 | G | 0.455272 | A | 0.397999 | 0.057273 | No Change: Both O | A lung small cell carcinoma sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 171 | Q | 0.896019 | E | 0.917552 | -0.021533 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 256 | G | 0.32383 | A | 0.281859 | 0.041971 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 371 | M | 0.179254 | V | 0.149336 | 0.029918 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 532 | I | 0.8596 | N | 0.909606 | -0.050006 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 637 | P | 0.550746 | S | 0.537179 | 0.013567 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 750 | L | 0.342778 | F | 0.31581 | 0.026968 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 762 | L | 0.271573 | I | 0.222309 | 0.049264 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 794 | E | 0.06213 | D | 0.059359 | 0.002771 | No Change: Both O | A lung adenocarcinoma sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 845 | R | 0.594735 | Q | 0.565293 | 0.029442 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1016 | R | 0.632528 | C | 0.512186 | 0.120342 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1038 | K | 0.439244 | N | 0.371034 | 0.06821 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1169 | T | 0.647274 | I | 0.507151 | 0.140123 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1312 | V | 0.656317 | L | 0.653977 | 0.00234 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1356 | R | 0.411972 | C | 0.25174 | 0.160232 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1389 | P | 0.501927 | S | 0.513697 | -0.01177 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1411 | I | 0.344192 | V | 0.355438 | -0.011246 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1540 | A | 0.25218 | T | 0.292319 | -0.040139 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1549 | H | 0.31337 | Y | 0.201023 | 0.112347 | No Change: Both O | A glioblastoma multiforme sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1731 | K | 0.988537 | N | 0.984561 | 0.003976 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1810 | P | 0.740946 | L | 0.570716 | 0.17023 | No Change: Both D | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1824 | H | 0.84624 | Q | 0.867111 | -0.020871 | No Change: Both D | A lung adenocarcinoma sample |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 820 | M | 0.32492 | T | 0.371469 | -0.046549 | No Change: Both O | - |
| Q8IZX4 | TAF1L_HUMAN Transcription initiation factor TFIID subunit 1-like OS=Homo sapiens GN=TAF1L PE=1 SV=1 | 1805 | I | 0.760183 | V | 0.785242 | -0.025059 | No Change: Both D | - |
| Q6P1X5 | TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens GN=TAF2 PE=1 SV=3 | 8 | P | 0.665331 | L | 0.471466 | 0.193865 | D to O | - |
| Q6P1X5 | TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens GN=TAF2 PE=1 SV=3 | 447 | S | 0.111419 | T | 0.076335 | 0.035084 | No Change: Both O | - |
| Q6P1X5 | TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens GN=TAF2 PE=1 SV=3 | 1122 | S | 0.904231 | N | 0.855239 | 0.048992 | No Change: Both D | - |
| Q6P1X5 | TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens GN=TAF2 PE=1 SV=3 | 1139 | T | 0.974561 | A | 0.974506 | 5.50E-05 | No Change: Both D | - |
| Q6P1X5 | TAF2_HUMAN Transcription initiation factor TFIID subunit 2 OS=Homo sapiens GN=TAF2 PE=1 SV=3 | 686 | E | 0.173741 | K | 0.1627 | 0.011041 | No Change: Both O | - |
| Q5VWG9 | TAF3_HUMAN Transcription initiation factor TFIID subunit 3 OS=Homo sapiens GN=TAF3 PE=1 SV=1 | 349 | S | 0.960546 | T | 0.955904 | 0.004642 | No Change: Both D | - |
| Q5VWG9 | TAF3_HUMAN Transcription initiation factor TFIID subunit 3 OS=Homo sapiens GN=TAF3 PE=1 SV=1 | 442 | N | 0.960449 | S | 0.971556 | -0.011107 | No Change: Both D | - |
| Q5VWG9 | TAF3_HUMAN Transcription initiation factor TFIID subunit 3 OS=Homo sapiens GN=TAF3 PE=1 SV=1 | 696 | V | 0.98999 | A | 0.992059 | -0.002069 | No Change: Both D | - |
| Q5VWG9 | TAF3_HUMAN Transcription initiation factor TFIID subunit 3 OS=Homo sapiens GN=TAF3 PE=1 SV=1 | 696 | V | 0.98999 | L | 0.991489 | -0.001499 | No Change: Both D | - |
| O00268 | TAF4_HUMAN Transcription initiation factor TFIID subunit 4 OS=Homo sapiens GN=TAF4 PE=1 SV=2 | 651 | P | 0.525039 | L | 0.384699 | 0.14034 | D to O | - |
| Q92750 | TAF4B_HUMAN Transcription initiation factor TFIID subunit 4B OS=Homo sapiens GN=TAF4B PE=1 SV=2 | 249 | I | 0.693846 | V | 0.727817 | -0.033971 | No Change: Both D | - |
| Q92750 | TAF4B_HUMAN Transcription initiation factor TFIID subunit 4B OS=Homo sapiens GN=TAF4B PE=1 SV=2 | 539 | N | 0.826116 | S | 0.874974 | -0.048858 | No Change: Both D | - |
| Q15542 | TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens GN=TAF5 PE=1 SV=3 | 130 | S | 0.864493 | A | 0.833157 | 0.031336 | No Change: Both D | - |
| P49848 | TAF6_HUMAN Transcription initiation factor TFIID subunit 6 OS=Homo sapiens GN=TAF6 PE=1 SV=1 | 36 | C | 0.326964 | S | 0.534187 | -0.207223 | O to D | - |
| Q15545 | TAF7_HUMAN Transcription initiation factor TFIID subunit 7 OS=Homo sapiens GN=TAF7 PE=1 SV=1 | 178 | S | 0.592129 | R | 0.56091 | 0.031219 | No Change: Both D | - |
| Q5H9L4 | TAF7L_HUMAN Transcription initiation factor TFIID subunit 7-like OS=Homo sapiens GN=TAF7L PE=2 SV=1 | 34 | L | 0.934085 | P | 0.969606 | -0.035521 | No Change: Both D | - |
| Q5H9L4 | TAF7L_HUMAN Transcription initiation factor TFIID subunit 7-like OS=Homo sapiens GN=TAF7L PE=2 SV=1 | 61 | E | 0.962666 | K | 0.952143 | 0.010523 | No Change: Both D | - |
| Q5H9L4 | TAF7L_HUMAN Transcription initiation factor TFIID subunit 7-like OS=Homo sapiens GN=TAF7L PE=2 SV=1 | 308 | S | 0.860401 | G | 0.829632 | 0.030769 | No Change: Both D | - |
| Q5H9L4 | TAF7L_HUMAN Transcription initiation factor TFIID subunit 7-like OS=Homo sapiens GN=TAF7L PE=2 SV=1 | 458 | R | 0.966967 | H | 0.964412 | 0.002555 | No Change: Both D | - |
| Q16594 | TAF9_HUMAN Transcription initiation factor TFIID subunit 9 OS=Homo sapiens GN=TAF9 PE=1 SV=1 | 6 | T | 0.93217 | M | 0.947072 | -0.014902 | No Change: Both D | - |
| Q16594 | TAF9_HUMAN Transcription initiation factor TFIID subunit 9 OS=Homo sapiens GN=TAF9 PE=1 SV=1 | 210 | Q | 0.610436 | H | 0.505904 | 0.104532 | No Change: Both D | - |
| Q8N103 | TAGAP_HUMAN T-cell activation Rho GTPase-activating protein OS=Homo sapiens GN=TAGAP PE=2 SV=1 | 346 | G | 0.92195 | D | 0.936191 | -0.014241 | No Change: Both D | - |
| Q01995 | TAGL_HUMAN Transgelin OS=Homo sapiens GN=TAGLN PE=1 SV=4 | 182 | N | 0.710112 | S | 0.791867 | -0.081755 | No Change: Both D | - |
| P37802 | TAGL2_HUMAN Transgelin-2 OS=Homo sapiens GN=TAGLN2 PE=1 SV=3 | 69 | L | 0.183479 | Q | 0.294121 | -0.110642 | No Change: Both O | - |
| P57077 | TAK1L_HUMAN TAK1-like protein OS=Homo sapiens GN=TAK1L PE=1 SV=1 | 112 | I | 0.704969 | V | 0.733315 | -0.028346 | No Change: Both D | - |
| Q96BW9 | TAM41_HUMAN Mitochondrial translocator assembly and maintenance protein 41 homolog OS=Homo sapiens GN=TAMM41 PE=2 SV=1 | 116 | N | 0.081036 | S | 0.101771 | -0.020735 | No Change: Both O | - |
| Q96BW9 | TAM41_HUMAN Mitochondrial translocator assembly and maintenance protein 41 homolog OS=Homo sapiens GN=TAMM41 PE=2 SV=1 | 179 | I | 0.202571 | V | 0.215517 | -0.012946 | No Change: Both O | - |
| Q9C0D5 | TANC1_HUMAN Protein TANC1 OS=Homo sapiens GN=TANC1 PE=1 SV=3 | 251 | N | 0.661605 | S | 0.711843 | -0.050238 | No Change: Both D | - |
| Q9C0D5 | TANC1_HUMAN Protein TANC1 OS=Homo sapiens GN=TANC1 PE=1 SV=3 | 1511 | G | 0.91143 | S | 0.933203 | -0.021773 | No Change: Both D | - |
| Q9C0D5 | TANC1_HUMAN Protein TANC1 OS=Homo sapiens GN=TANC1 PE=1 SV=3 | 1573 | T | 0.883035 | A | 0.868497 | 0.014538 | No Change: Both D | - |
| Q9C0D5 | TANC1_HUMAN Protein TANC1 OS=Homo sapiens GN=TANC1 PE=1 SV=3 | 30 | P | 0.840895 | S | 0.851395 | -0.0105 | No Change: Both D | - |
| Q92844 | TANK_HUMAN TRAF family member-associated NF-kappa-B activator OS=Homo sapiens GN=TANK PE=1 SV=2 | 292 | G | 0.314689 | R | 0.347285 | -0.032596 | No Change: Both O | - |
| Q92844 | TANK_HUMAN TRAF family member-associated NF-kappa-B activator OS=Homo sapiens GN=TANK PE=1 SV=2 | 358 | P | 0.802255 | L | 0.675136 | 0.127119 | No Change: Both D | - |
| Q92844 | TANK_HUMAN TRAF family member-associated NF-kappa-B activator OS=Homo sapiens GN=TANK PE=1 SV=2 | 394 | R | 0.239117 | Q | 0.263469 | -0.024352 | No Change: Both O | - |
| Q7L7X3 | TAOK1_HUMAN Serine/threonine-protein kinase TAO1 OS=Homo sapiens GN=TAOK1 PE=1 SV=1 | 855 | A | 0.931633 | T | 0.935361 | -0.003728 | No Change: Both D | - |
| Q9H2K8 | TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2 | 47 | S | 0.320089 | N | 0.295323 | 0.024766 | No Change: Both O | - |
| Q9H2K8 | TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2 | 20 | P | 0.359793 | T | 0.303923 | 0.05587 | No Change: Both O | A lung adenocarcinoma sample |
| Q9H2K8 | TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2 | 392 | S | 0.910875 | Y | 0.796785 | 0.11409 | No Change: Both D | A lung small cell carcinoma sample |
| Q9H2K8 | TAOK3_HUMAN Serine/threonine-protein kinase TAO3 OS=Homo sapiens GN=TAOK3 PE=1 SV=2 | 727 | C | 0.810541 | Y | 0.795268 | 0.015273 | No Change: Both D | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 393 | I | 0.051571 | V | 0.064979 | -0.013408 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 697 | D | 0.613266 | G | 0.603117 | 0.010149 | No Change: Both D | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 430 | A | 0.452635 | V | 0.372838 | 0.079797 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 518 | V | 0.111495 | L | 0.113732 | -0.002237 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 578 | V | 0.182593 | I | 0.145035 | 0.037558 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 708 | R | 0.481496 | Q | 0.511805 | -0.030309 | O to D | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 719 | R | 0.207588 | Q | 0.228399 | -0.020811 | No Change: Both O | A lung cancer cell line deficient in MHC class I presentation |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 67 | P | 0.696087 | S | 0.693539 | 0.002548 | No Change: Both D | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 77 | G | 0.33013 | R | 0.365253 | -0.035123 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 479 | G | 0.176914 | C | 0.07852 | 0.098394 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 768 | Q | 0.247621 | R | 0.223475 | 0.024146 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 170 | L | 0.139941 | V | 0.111661 | 0.02828 | No Change: Both O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 346 | S | 0.514181 | F | 0.267021 | 0.24716 | D to O | - |
| Q03518 | TAP1_HUMAN Antigen peptide transporter 1 OS=Homo sapiens GN=TAP1 PE=1 SV=2 | 304 | V | 0.124609 | L | 0.12349 | 0.001119 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 379 | V | 0.129401 | I | 0.094963 | 0.034438 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 565 | A | 0.2302 | T | 0.249151 | -0.018951 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 651 | R | 0.328866 | C | 0.18691 | 0.141956 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 665 | T | 0.28125 | A | 0.273563 | 0.007687 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 374 | A | 0.155352 | T | 0.166452 | -0.0111 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 467 | V | 0.337905 | I | 0.263151 | 0.074754 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 513 | A | 0.311078 | S | 0.426537 | -0.115459 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 577 | M | 0.440547 | V | 0.39066 | 0.049887 | No Change: Both O | - |
| Q03519 | TAP2_HUMAN Antigen peptide transporter 2 OS=Homo sapiens GN=TAP2 PE=1 SV=1 | 56 | R | 0.144275 | K | 0.176199 | -0.031924 | No Change: Both O | - |
| O15533 | TPSN_HUMAN Tapasin OS=Homo sapiens GN=TAPBP PE=1 SV=1 | 260 | R | 0.155122 | T | 0.15906 | -0.003938 | No Change: Both O | - |
| Q9BX59 | TPSNR_HUMAN Tapasin-related protein OS=Homo sapiens GN=TAPBPL PE=1 SV=2 | 151 | G | 0.525209 | R | 0.493135 | 0.032074 | D to O | - |
| Q9BX59 | TPSNR_HUMAN Tapasin-related protein OS=Homo sapiens GN=TAPBPL PE=1 SV=2 | 334 | T | 0.113218 | M | 0.088001 | 0.025217 | No Change: Both O | - |
| Q6NXT6 | TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog OS=Homo sapiens GN=TAPT1 PE=1 SV=1 | 465 | E | 0.723589 | K | 0.730145 | -0.006556 | No Change: Both D | - |
| Q6NXT6 | TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog OS=Homo sapiens GN=TAPT1 PE=1 SV=1 | 522 | N | 0.73227 | S | 0.77697 | -0.0447 | No Change: Both D | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 221 | L | 0.57717 | P | 0.669047 | -0.091877 | No Change: Both D | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 425 | A | 0.47251 | T | 0.522553 | -0.050043 | O to D | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 678 | S | 0.19062 | G | 0.154807 | 0.035813 | No Change: Both O | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 743 | N | 0.485211 | S | 0.537275 | -0.052064 | O to D | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 864 | H | 0.706541 | P | 0.764322 | -0.057781 | No Change: Both D | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 997 | F | 0.053469 | L | 0.059981 | -0.006512 | No Change: Both O | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 1038 | T | 0.063948 | I | 0.037056 | 0.026892 | No Change: Both O | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 1359 | I | 0.030578 | V | 0.032824 | -0.002246 | No Change: Both O | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 1461 | I | 0.268014 | V | 0.299815 | -0.031801 | No Change: Both O | - |
| Q13395 | TARB1_HUMAN Probable methyltransferase TARBP1 OS=Homo sapiens GN=TARBP1 PE=1 SV=1 | 513 | D | 0.064765 | G | 0.058201 | 0.006564 | No Change: Both O | - |
| Q15633 | TRBP2_HUMAN RISC-loading complex subunit TARBP2 OS=Homo sapiens GN=TARBP2 PE=1 SV=3 | 251 | S | 0.522354 | F | 0.301974 | 0.22038 | D to O | - |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 90 | A | 0.682065 | V | 0.620869 | 0.061196 | No Change: Both D | - |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 169 | D | 0.327214 | G | 0.300202 | 0.027012 | No Change: Both O | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 287 | G | 0.970656 | S | 0.973186 | -0.00253 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 290 | G | 0.975412 | A | 0.965224 | 0.010188 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 294 | G | 0.973116 | A | 0.96374 | 0.009376 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 298 | G | 0.96607 | S | 0.968504 | -0.002434 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 315 | A | 0.903926 | T | 0.882287 | 0.021639 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 331 | Q | 0.937779 | K | 0.919433 | 0.018346 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 337 | M | 0.950988 | V | 0.902361 | 0.048627 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 348 | G | 0.987176 | C | 0.981473 | 0.005703 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 361 | R | 0.987634 | S | 0.992171 | -0.004537 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 382 | A | 0.976131 | T | 0.971898 | 0.004233 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 390 | N | 0.977311 | D | 0.973919 | 0.003392 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 390 | N | 0.977311 | S | 0.983395 | -0.006084 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 267 | N | 0.753749 | S | 0.779246 | -0.025497 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 294 | G | 0.973116 | V | 0.939991 | 0.033125 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 295 | G | 0.972288 | R | 0.969757 | 0.002531 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 295 | G | 0.972288 | S | 0.973869 | -0.001581 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 332 | S | 0.940373 | N | 0.932455 | 0.007918 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 335 | G | 0.949319 | D | 0.938774 | 0.010545 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 379 | S | 0.979002 | C | 0.957796 | 0.021206 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 379 | S | 0.979002 | P | 0.973944 | 0.005058 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 393 | S | 0.980779 | L | 0.947004 | 0.033775 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| Q13148 | TADBP_HUMAN TAR DNA-binding protein 43 OS=Homo sapiens GN=TARDBP PE=1 SV=1 | 343 | Q | 0.97448 | R | 0.965193 | 0.009287 | No Change: Both D | Amyotrophic lateral sclerosis type 10 (ALS10) [MIM:612069] |
| B6A8C7 | TARM1_HUMAN T-cell-interacting activating receptor on myeloid cells protein 1 OS=Homo sapiens GN=TARM1 PE=2 SV=1 | 37 | S | 0.541597 | P | 0.515447 | 0.02615 | No Change: Both D | - |
| B6A8C7 | TARM1_HUMAN T-cell-interacting activating receptor on myeloid cells protein 1 OS=Homo sapiens GN=TARM1 PE=2 SV=1 | 111 | R | 0.329316 | H | 0.350293 | -0.020977 | No Change: Both O | - |
| B6A8C7 | TARM1_HUMAN T-cell-interacting activating receptor on myeloid cells protein 1 OS=Homo sapiens GN=TARM1 PE=2 SV=1 | 258 | R | 0.359119 | W | 0.200825 | 0.158294 | No Change: Both O | - |
| P26639 | SYTC_HUMAN Threonine--tRNA ligase cytoplasmic OS=Homo sapiens GN=TARS PE=1 SV=3 | 21 | G | 0.994796 | D | 0.994023 | 7.73E-04 | No Change: Both D | - |
| Q7RTX1 | TS1R1_HUMAN Taste receptor type 1 member 1 OS=Homo sapiens GN=TAS1R1 PE=2 SV=1 | 347 | K | 0.651346 | E | 0.645303 | 0.006043 | No Change: Both D | - |
| Q7RTX1 | TS1R1_HUMAN Taste receptor type 1 member 1 OS=Homo sapiens GN=TAS1R1 PE=2 SV=1 | 372 | A | 0.317357 | T | 0.318191 | -8.34E-04 | No Change: Both O | - |
| Q7RTX1 | TS1R1_HUMAN Taste receptor type 1 member 1 OS=Homo sapiens GN=TAS1R1 PE=2 SV=1 | 507 | R | 0.287692 | Q | 0.328411 | -0.040719 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 574 | A | 0.059777 | T | 0.065639 | -0.005862 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 9 | S | 0.1623 | C | 0.059711 | 0.102589 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 838 | R | 0.820094 | K | 0.820418 | -3.24E-04 | No Change: Both D | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 191 | I | 0.383064 | V | 0.438085 | -0.055021 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 317 | R | 0.218562 | G | 0.24585 | -0.027288 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 486 | I | 0.331787 | V | 0.329401 | 0.002386 | No Change: Both O | - |
| Q8TE23 | TS1R2_HUMAN Taste receptor type 1 member 2 OS=Homo sapiens GN=TAS1R2 PE=2 SV=2 | 595 | I | 0.239742 | T | 0.391285 | -0.151543 | No Change: Both O | - |
| Q7RTX0 | TS1R3_HUMAN Taste receptor type 1 member 3 OS=Homo sapiens GN=TAS1R3 PE=1 SV=2 | 757 | C | 0.284258 | R | 0.507937 | -0.223679 | O to D | - |
| Q9NYW7 | TA2R1_HUMAN Taste receptor type 2 member 1 OS=Homo sapiens GN=TAS2R1 PE=1 SV=1 | 111 | R | 0.068185 | H | 0.074482 | -0.006297 | No Change: Both O | - |
| Q9NYW7 | TA2R1_HUMAN Taste receptor type 2 member 1 OS=Homo sapiens GN=TAS2R1 PE=1 SV=1 | 206 | R | 0.439284 | W | 0.216895 | 0.222389 | No Change: Both O | - |
| Q9NYW7 | TA2R1_HUMAN Taste receptor type 2 member 1 OS=Homo sapiens GN=TAS2R1 PE=1 SV=1 | 141 | C | 0.04557 | Y | 0.063442 | -0.017872 | No Change: Both O | - |
| Q9NYW0 | T2R10_HUMAN Taste receptor type 2 member 10 OS=Homo sapiens GN=TAS2R10 PE=1 SV=3 | 156 | T | 0.391153 | M | 0.320892 | 0.070261 | No Change: Both O | - |
| Q9NYV9 | T2R13_HUMAN Taste receptor type 2 member 13 OS=Homo sapiens GN=TAS2R13 PE=1 SV=1 | 259 | N | 0.071855 | S | 0.094223 | -0.022368 | No Change: Both O | - |
| Q9NYV9 | T2R13_HUMAN Taste receptor type 2 member 13 OS=Homo sapiens GN=TAS2R13 PE=1 SV=1 | 149 | N | 0.066863 | S | 0.075281 | -0.008418 | No Change: Both O | A breast cancer sample |
| Q9NYV8 | T2R14_HUMAN Taste receptor type 2 member 14 OS=Homo sapiens GN=TAS2R14 PE=1 SV=1 | 86 | T | 0.057084 | A | 0.046522 | 0.010562 | No Change: Both O | - |
| Q9NYV8 | T2R14_HUMAN Taste receptor type 2 member 14 OS=Homo sapiens GN=TAS2R14 PE=1 SV=1 | 201 | L | 0.032396 | F | 0.028808 | 0.003588 | No Change: Both O | - |
| Q9NYV7 | T2R16_HUMAN Taste receptor type 2 member 16 OS=Homo sapiens GN=TAS2R16 PE=1 SV=1 | 222 | R | 0.356852 | H | 0.351482 | 0.00537 | No Change: Both O | - |
| Q9NYV7 | T2R16_HUMAN Taste receptor type 2 member 16 OS=Homo sapiens GN=TAS2R16 PE=1 SV=1 | 172 | N | 0.371659 | K | 0.430884 | -0.059225 | No Change: Both O | - |
| P59542 | T2R19_HUMAN Taste receptor type 2 member 19 OS=Homo sapiens GN=TAS2R19 PE=1 SV=1 | 126 | K | 0.210807 | Q | 0.163034 | 0.047773 | No Change: Both O | - |
| P59542 | T2R19_HUMAN Taste receptor type 2 member 19 OS=Homo sapiens GN=TAS2R19 PE=1 SV=1 | 299 | R | 0.683449 | C | 0.462666 | 0.220783 | D to O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 79 | K | 0.171452 | E | 0.171567 | -1.15E-04 | No Change: Both O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 143 | H | 0.029708 | Q | 0.030007 | -2.99E-04 | No Change: Both O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 148 | H | 0.072701 | N | 0.078964 | -0.006263 | No Change: Both O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 236 | I | 0.016367 | V | 0.018696 | -0.002329 | No Change: Both O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 252 | F | 0.078835 | S | 0.199814 | -0.120979 | No Change: Both O | - |
| P59543 | T2R20_HUMAN Taste receptor type 2 member 20 OS=Homo sapiens GN=TAS2R20 PE=2 SV=2 | 255 | R | 0.151026 | L | 0.092588 | 0.058438 | No Change: Both O | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 35 | R | 0.330965 | W | 0.145026 | 0.185939 | No Change: Both O | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 162 | L | 0.243194 | M | 0.293677 | -0.050483 | No Change: Both O | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 217 | Q | 0.834804 | E | 0.855036 | -0.020232 | No Change: Both D | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 227 | A | 0.135142 | V | 0.106391 | 0.028751 | No Change: Both O | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 240 | V | 0.007808 | I | 0.007227 | 5.81E-04 | No Change: Both O | - |
| P59538 | T2R31_HUMAN Taste receptor type 2 member 31 OS=Homo sapiens GN=TAS2R31 PE=2 SV=2 | 276 | P | 0.059009 | R | 0.047414 | 0.011595 | No Change: Both O | - |
| P59533 | T2R38_HUMAN Taste receptor type 2 member 38 OS=Homo sapiens GN=TAS2R38 PE=2 SV=3 | 49 | A | 0.268843 | P | 0.354305 | -0.085462 | No Change: Both O | - |
| P59533 | T2R38_HUMAN Taste receptor type 2 member 38 OS=Homo sapiens GN=TAS2R38 PE=2 SV=3 | 262 | A | 0.045804 | V | 0.032308 | 0.013496 | No Change: Both O | - |
| P59533 | T2R38_HUMAN Taste receptor type 2 member 38 OS=Homo sapiens GN=TAS2R38 PE=2 SV=3 | 296 | I | 0.231176 | V | 0.244478 | -0.013302 | No Change: Both O | - |
| P59534 | T2R39_HUMAN Taste receptor type 2 member 39 OS=Homo sapiens GN=TAS2R39 PE=2 SV=3 | 193 | S | 0.752843 | F | 0.52061 | 0.232233 | No Change: Both D | - |
| P59534 | T2R39_HUMAN Taste receptor type 2 member 39 OS=Homo sapiens GN=TAS2R39 PE=2 SV=3 | 197 | K | 0.764535 | E | 0.762961 | 0.001574 | No Change: Both D | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 74 | T | 0.451733 | M | 0.389962 | 0.061771 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 96 | V | 0.068665 | L | 0.070797 | -0.002132 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 171 | S | 0.3571 | N | 0.313564 | 0.043536 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 3 | R | 0.346649 | Q | 0.376855 | -0.030206 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 7 | F | 0.060567 | S | 0.171738 | -0.111171 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 62 | F | 0.02041 | L | 0.02453 | -0.00412 | No Change: Both O | - |
| Q9NYW5 | TA2R4_HUMAN Taste receptor type 2 member 4 OS=Homo sapiens GN=TAS2R4 PE=1 SV=1 | 191 | I | 0.178216 | V | 0.197758 | -0.019542 | No Change: Both O | - |
| P59535 | T2R40_HUMAN Taste receptor type 2 member 40 OS=Homo sapiens GN=TAS2R40 PE=2 SV=1 | 23 | V | 0.064369 | L | 0.062025 | 0.002344 | No Change: Both O | - |
| P59535 | T2R40_HUMAN Taste receptor type 2 member 40 OS=Homo sapiens GN=TAS2R40 PE=2 SV=1 | 187 | S | 0.499883 | Y | 0.317665 | 0.182218 | No Change: Both O | - |
| P59536 | T2R41_HUMAN Taste receptor type 2 member 41 OS=Homo sapiens GN=TAS2R41 PE=2 SV=2 | 127 | P | 0.019668 | L | 0.009285 | 0.010383 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 196 | F | 0.23234 | S | 0.405456 | -0.173116 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 265 | Y | 0.050647 | C | 0.039707 | 0.01094 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 175 | Y | 0.381495 | F | 0.350214 | 0.031281 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 255 | G | 0.041824 | W | 0.01552 | 0.026304 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 292 | R | 0.247906 | Q | 0.266102 | -0.018196 | No Change: Both O | - |
| Q7RTR8 | T2R42_HUMAN Taste receptor type 2 member 42 OS=Homo sapiens GN=TAS2R42 PE=2 SV=1 | 311 | A | 0.822373 | P | 0.848093 | -0.02572 | No Change: Both D | - |
| P59540 | T2R46_HUMAN Taste receptor type 2 member 46 OS=Homo sapiens GN=TAS2R46 PE=2 SV=2 | 228 | L | 0.217379 | M | 0.271277 | -0.053898 | No Change: Both O | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 26 | S | 0.083531 | I | 0.029879 | 0.053652 | No Change: Both O | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 213 | R | 0.502828 | Q | 0.502585 | 2.43E-04 | No Change: Both D | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 113 | P | 0.09782 | L | 0.050324 | 0.047496 | No Change: Both O | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 167 | Y | 0.063366 | C | 0.046022 | 0.017344 | No Change: Both O | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 20 | G | 0.054795 | S | 0.067611 | -0.012816 | No Change: Both O | - |
| Q9NYW4 | TA2R5_HUMAN Taste receptor type 2 member 5 OS=Homo sapiens GN=TAS2R5 PE=1 SV=1 | 294 | R | 0.158214 | L | 0.0859 | 0.072314 | No Change: Both O | - |
| P59544 | T2R50_HUMAN Taste receptor type 2 member 50 OS=Homo sapiens GN=TAS2R50 PE=2 SV=2 | 203 | C | 0.141368 | Y | 0.153379 | -0.012011 | No Change: Both O | - |
| Q9NYW3 | TA2R7_HUMAN Taste receptor type 2 member 7 OS=Homo sapiens GN=TAS2R7 PE=1 SV=1 | 263 | T | 0.245509 | S | 0.336778 | -0.091269 | No Change: Both O | - |
| Q9NYW3 | TA2R7_HUMAN Taste receptor type 2 member 7 OS=Homo sapiens GN=TAS2R7 PE=1 SV=1 | 304 | M | 0.103494 | I | 0.075752 | 0.027742 | No Change: Both O | - |
| Q9NYW3 | TA2R7_HUMAN Taste receptor type 2 member 7 OS=Homo sapiens GN=TAS2R7 PE=1 SV=1 | 263 | T | 0.245509 | M | 0.21255 | 0.032959 | No Change: Both O | - |
| Q9NYW2 | TA2R8_HUMAN Taste receptor type 2 member 8 OS=Homo sapiens GN=TAS2R8 PE=1 SV=1 | 308 | M | 0.33489 | V | 0.235305 | 0.099585 | No Change: Both O | - |
| Q9NYW1 | TA2R9_HUMAN Taste receptor type 2 member 9 OS=Homo sapiens GN=TAS2R9 PE=1 SV=1 | 187 | V | 0.035278 | A | 0.047604 | -0.012326 | No Change: Both O | - |
| Q9NYW1 | TA2R9_HUMAN Taste receptor type 2 member 9 OS=Homo sapiens GN=TAS2R9 PE=1 SV=1 | 170 | K | 0.235799 | Q | 0.180705 | 0.055094 | No Change: Both O | - |
| Q9NYW1 | TA2R9_HUMAN Taste receptor type 2 member 9 OS=Homo sapiens GN=TAS2R9 PE=1 SV=1 | 238 | L | 0.005362 | V | 0.005318 | 4.40E-05 | No Change: Both O | - |
| P17735 | ATTY_HUMAN Tyrosine aminotransferase OS=Homo sapiens GN=TAT PE=1 SV=1 | 362 | G | 0.269172 | V | 0.166489 | 0.102683 | No Change: Both O | Tyrosinemia type 2 (TYRO2) [MIM:276600] |
| P17735 | ATTY_HUMAN Tyrosine aminotransferase OS=Homo sapiens GN=TAT PE=1 SV=1 | 70 | N | 0.67109 | D | 0.678981 | -0.007891 | No Change: Both D | - |
| Q93075 | TATD2_HUMAN Putative deoxyribonuclease TATDN2 OS=Homo sapiens GN=TATDN2 PE=1 SV=2 | 217 | H | 0.962082 | R | 0.968792 | -0.00671 | No Change: Both D | - |
| Q93075 | TATD2_HUMAN Putative deoxyribonuclease TATDN2 OS=Homo sapiens GN=TATDN2 PE=1 SV=2 | 256 | V | 0.940292 | I | 0.924259 | 0.016033 | No Change: Both D | - |
| Q93075 | TATD2_HUMAN Putative deoxyribonuclease TATDN2 OS=Homo sapiens GN=TATDN2 PE=1 SV=2 | 358 | P | 0.775952 | L | 0.631096 | 0.144856 | No Change: Both D | - |
| Q86VP1 | TAXB1_HUMAN Tax1-binding protein 1 OS=Homo sapiens GN=TAX1BP1 PE=1 SV=2 | 307 | L | 0.582404 | I | 0.544803 | 0.037601 | No Change: Both D | - |
| Q86VP1 | TAXB1_HUMAN Tax1-binding protein 1 OS=Homo sapiens GN=TAX1BP1 PE=1 SV=2 | 457 | Q | 0.725318 | R | 0.704643 | 0.020675 | No Change: Both D | A breast cancer sample |
| Q86VP1 | TAXB1_HUMAN Tax1-binding protein 1 OS=Homo sapiens GN=TAX1BP1 PE=1 SV=2 | 58 | S | 0.097431 | N | 0.080971 | 0.01646 | No Change: Both O | - |
| Q16635 | TAZ_HUMAN Tafazzin OS=Homo sapiens GN=TAZ PE=1 SV=1 | 94 | R | 0.078847 | S | 0.105703 | -0.026856 | No Change: Both O | 3-methylglutaconic aciduria type 2 (MGA2) [MIM:302060] |
| Q16635 | TAZ_HUMAN Tafazzin OS=Homo sapiens GN=TAZ PE=1 SV=1 | 118 | C | 0.145381 | R | 0.259474 | -0.114093 | No Change: Both O | Left ventricular non-compaction X-linked (LVNCX) [MIM:300183] |
| Q16635 | TAZ_HUMAN Tafazzin OS=Homo sapiens GN=TAZ PE=1 SV=1 | 197 | G | 0.054758 | R | 0.053015 | 0.001743 | No Change: Both O | Left ventricular non-compaction X-linked (LVNCX) [MIM:300183] |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 14 | S | 0.358153 | P | 0.312326 | 0.045827 | No Change: Both O | - |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 55 | T | 0.793989 | I | 0.688772 | 0.105217 | No Change: Both D | - |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 228 | V | 0.971293 | G | 0.983679 | -0.012386 | No Change: Both D | - |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 685 | Y | 0.817609 | S | 0.895185 | -0.077576 | No Change: Both D | - |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 1136 | R | 0.92166 | Q | 0.925709 | -0.004049 | No Change: Both D | - |
| Q86TI0 | TBCD1_HUMAN TBC1 domain family member 1 OS=Homo sapiens GN=TBC1D1 PE=1 SV=2 | 125 | R | 0.146922 | W | 0.057839 | 0.089083 | No Change: Both O | - |
| Q9BXI6 | TB10A_HUMAN TBC1 domain family member 10A OS=Homo sapiens GN=TBC1D10A PE=1 SV=1 | 411 | R | 0.985379 | H | 0.981263 | 0.004116 | No Change: Both D | - |
| Q9P2M4 | TBC14_HUMAN TBC1 domain family member 14 OS=Homo sapiens GN=TBC1D14 PE=1 SV=3 | 446 | E | 0.661986 | Q | 0.6232 | 0.038786 | No Change: Both D | - |
| Q8TBP0 | TBC16_HUMAN TBC1 domain family member 16 OS=Homo sapiens GN=TBC1D16 PE=1 SV=1 | 476 | E | 0.587325 | K | 0.580145 | 0.00718 | No Change: Both D | - |
| Q9HA65 | TBC17_HUMAN TBC1 domain family member 17 OS=Homo sapiens GN=TBC1D17 PE=2 SV=2 | 99 | L | 0.641299 | P | 0.805665 | -0.164366 | No Change: Both D | - |
| Q9HA65 | TBC17_HUMAN TBC1 domain family member 17 OS=Homo sapiens GN=TBC1D17 PE=2 SV=2 | 84 | D | 0.780546 | G | 0.745223 | 0.035323 | No Change: Both D | - |
| Q8N5T2 | TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens GN=TBC1D19 PE=1 SV=2 | 241 | S | 0.480883 | G | 0.435683 | 0.0452 | No Change: Both O | - |
| Q8N5T2 | TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens GN=TBC1D19 PE=1 SV=2 | 509 | S | 0.198721 | F | 0.078228 | 0.120493 | No Change: Both O | - |
| Q9BYX2 | TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens GN=TBC1D2 PE=1 SV=3 | 241 | P | 0.987396 | T | 0.983777 | 0.003619 | No Change: Both D | - |
| Q9BYX2 | TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens GN=TBC1D2 PE=1 SV=3 | 253 | L | 0.996313 | S | 0.998249 | -0.001936 | No Change: Both D | - |
| Q9BYX2 | TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens GN=TBC1D2 PE=1 SV=3 | 261 | G | 0.992331 | V | 0.98934 | 0.002991 | No Change: Both D | - |
| Q96BZ9 | TBC20_HUMAN TBC1 domain family member 20 OS=Homo sapiens GN=TBC1D20 PE=1 SV=1 | 79 | N | 0.533374 | S | 0.56237 | -0.028996 | No Change: Both D | - |
| Q8IYX1 | TBC21_HUMAN TBC1 domain family member 21 OS=Homo sapiens GN=TBC1D21 PE=2 SV=1 | 113 | R | 0.378555 | Q | 0.388387 | -0.009832 | No Change: Both O | - |
| Q9ULP9 | TBC24_HUMAN TBC1 domain family member 24 OS=Homo sapiens GN=TBC1D24 PE=1 SV=2 | 147 | D | 0.205823 | H | 0.187949 | 0.017874 | No Change: Both O | Familial infantile myoclonic epilepsy (FIME) [MIM:605021] |
| Q9ULP9 | TBC24_HUMAN TBC1 domain family member 24 OS=Homo sapiens GN=TBC1D24 PE=1 SV=2 | 251 | F | 0.100599 | L | 0.116644 | -0.016045 | No Change: Both O | Familial infantile myoclonic epilepsy (FIME) [MIM:605021] |
| Q9ULP9 | TBC24_HUMAN TBC1 domain family member 24 OS=Homo sapiens GN=TBC1D24 PE=1 SV=2 | 515 | A | 0.273692 | V | 0.216275 | 0.057417 | No Change: Both O | Familial infantile myoclonic epilepsy (FIME) [MIM:605021] |
| Q3MII6 | TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens GN=TBC1D25 PE=1 SV=2 | 277 | N | 0.494451 | S | 0.575176 | -0.080725 | O to D | - |
| Q86UD7 | TBC26_HUMAN TBC1 domain family member 26 OS=Homo sapiens GN=TBC1D26 PE=2 SV=3 | 206 | A | 0.104623 | V | 0.068091 | 0.036532 | No Change: Both O | - |
| Q86UD7 | TBC26_HUMAN TBC1 domain family member 26 OS=Homo sapiens GN=TBC1D26 PE=2 SV=3 | 234 | G | 0.703483 | S | 0.755808 | -0.052325 | No Change: Both D | - |
| Q8IZP1 | TBC3A_HUMAN TBC1 domain family member 3 OS=Homo sapiens GN=TBC1D3 PE=2 SV=5 | 526 | P | 0.918173 | Q | 0.903098 | 0.015075 | No Change: Both D | - |
| Q9Y2I9 | TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens GN=TBC1D30 PE=2 SV=2 | 296 | Q | 0.325778 | H | 0.317929 | 0.007849 | No Change: Both O | - |
| Q9Y2I9 | TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens GN=TBC1D30 PE=2 SV=2 | 752 | V | 0.513284 | I | 0.516883 | -0.003599 | No Change: Both D | - |
| Q9Y2I9 | TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens GN=TBC1D30 PE=2 SV=2 | 596 | N | 0.799692 | D | 0.793336 | 0.006356 | No Change: Both D | - |
| Q9Y2I9 | TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens GN=TBC1D30 PE=2 SV=2 | 759 | N | 0.675234 | D | 0.691623 | -0.016389 | No Change: Both D | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 1147 | T | 0.414609 | M | 0.394638 | 0.019971 | No Change: Both O | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 1275 | V | 0.361524 | A | 0.47281 | -0.111286 | No Change: Both O | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 1284 | L | 0.527248 | I | 0.438096 | 0.089152 | D to O | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 819 | V | 0.832891 | I | 0.82593 | 0.006961 | No Change: Both D | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 619 | P | 0.992521 | L | 0.983156 | 0.009365 | No Change: Both D | - |
| O60343 | TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens GN=TBC1D4 PE=1 SV=2 | 1119 | V | 0.12321 | A | 0.170925 | -0.047715 | No Change: Both O | - |
| Q92609 | TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens GN=TBC1D5 PE=1 SV=1 | 696 | I | 0.887966 | V | 0.890798 | -0.002832 | No Change: Both D | - |
| Q9P0N9 | TBCD7_HUMAN TBC1 domain family member 7 OS=Homo sapiens GN=TBC1D7 PE=1 SV=1 | 67 | L | 0.273929 | W | 0.200066 | 0.073863 | No Change: Both O | - |
| Q9P0N9 | TBCD7_HUMAN TBC1 domain family member 7 OS=Homo sapiens GN=TBC1D7 PE=1 SV=1 | 136 | A | 0.177813 | T | 0.184551 | -0.006738 | No Change: Both O | - |
| O95759 | TBCD8_HUMAN TBC1 domain family member 8 OS=Homo sapiens GN=TBC1D8 PE=1 SV=3 | 1079 | R | 0.468589 | G | 0.461332 | 0.007257 | No Change: Both O | - |
| O95759 | TBCD8_HUMAN TBC1 domain family member 8 OS=Homo sapiens GN=TBC1D8 PE=1 SV=3 | 1108 | M | 0.559188 | V | 0.497314 | 0.061874 | D to O | - |
| O95759 | TBCD8_HUMAN TBC1 domain family member 8 OS=Homo sapiens GN=TBC1D8 PE=1 SV=3 | 954 | G | 0.704201 | R | 0.747687 | -0.043486 | No Change: Both D | - |
| O95759 | TBCD8_HUMAN TBC1 domain family member 8 OS=Homo sapiens GN=TBC1D8 PE=1 SV=3 | 317 | T | 0.350275 | A | 0.319577 | 0.030698 | No Change: Both O | - |
| O95759 | TBCD8_HUMAN TBC1 domain family member 8 OS=Homo sapiens GN=TBC1D8 PE=1 SV=3 | 1073 | F | 0.636835 | L | 0.661072 | -0.024237 | No Change: Both D | - |
| Q6ZT07 | TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens GN=TBC1D9 PE=1 SV=2 | 7 | E | 0.306723 | K | 0.288882 | 0.017841 | No Change: Both O | - |
| Q6ZT07 | TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens GN=TBC1D9 PE=1 SV=2 | 779 | E | 0.253124 | K | 0.261317 | -0.008193 | No Change: Both O | - |
| Q66K14 | TBC9B_HUMAN TBC1 domain family member 9B OS=Homo sapiens GN=TBC1D9B PE=1 SV=3 | 240 | L | 0.265973 | P | 0.377722 | -0.111749 | No Change: Both O | - |
| Q66K14 | TBC9B_HUMAN TBC1 domain family member 9B OS=Homo sapiens GN=TBC1D9B PE=1 SV=3 | 706 | V | 0.099869 | I | 0.083251 | 0.016618 | No Change: Both O | - |
| Q66K14 | TBC9B_HUMAN TBC1 domain family member 9B OS=Homo sapiens GN=TBC1D9B PE=1 SV=3 | 1119 | K | 0.948908 | T | 0.940269 | 0.008639 | No Change: Both D | - |
| Q66K14 | TBC9B_HUMAN TBC1 domain family member 9B OS=Homo sapiens GN=TBC1D9B PE=1 SV=3 | 1086 | P | 0.925535 | Q | 0.91082 | 0.014715 | No Change: Both D | A breast cancer sample |
| Q15814 | TBCC_HUMAN Tubulin-specific chaperone C OS=Homo sapiens GN=TBCC PE=1 SV=2 | 169 | P | 0.756426 | S | 0.758412 | -0.001986 | No Change: Both D | - |
| Q15814 | TBCC_HUMAN Tubulin-specific chaperone C OS=Homo sapiens GN=TBCC PE=1 SV=2 | 180 | P | 0.479352 | S | 0.495559 | -0.016207 | No Change: Both O | - |
| Q15814 | TBCC_HUMAN Tubulin-specific chaperone C OS=Homo sapiens GN=TBCC PE=1 SV=2 | 65 | V | 0.832427 | A | 0.863654 | -0.031227 | No Change: Both D | - |
| Q15814 | TBCC_HUMAN Tubulin-specific chaperone C OS=Homo sapiens GN=TBCC PE=1 SV=2 | 157 | G | 0.805778 | D | 0.832407 | -0.026629 | No Change: Both D | - |
| Q15814 | TBCC_HUMAN Tubulin-specific chaperone C OS=Homo sapiens GN=TBCC PE=1 SV=2 | 279 | A | 0.151876 | T | 0.181738 | -0.029862 | No Change: Both O | - |
| Q9NVR7 | TBCC1_HUMAN TBCC domain-containing protein 1 OS=Homo sapiens GN=TBCCD1 PE=1 SV=1 | 149 | K | 0.823386 | R | 0.804985 | 0.018401 | No Change: Both D | - |
| Q9BTW9 | TBCD_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=2 | 617 | M | 0.368032 | T | 0.407009 | -0.038977 | No Change: Both O | - |
| Q9BTW9 | TBCD_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=2 | 923 | S | 0.194638 | N | 0.146766 | 0.047872 | No Change: Both O | - |
| Q9BTW9 | TBCD_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=2 | 943 | G | 0.529626 | V | 0.437765 | 0.091861 | D to O | - |
| Q9BTW9 | TBCD_HUMAN Tubulin-specific chaperone D OS=Homo sapiens GN=TBCD PE=1 SV=2 | 1185 | L | 0.588256 | P | 0.751762 | -0.163506 | No Change: Both D | - |
| Q15813 | TBCE_HUMAN Tubulin-specific chaperone E OS=Homo sapiens GN=TBCE PE=1 SV=1 | 205 | V | 0.141278 | A | 0.175763 | -0.034485 | No Change: Both O | - |
| Q15813 | TBCE_HUMAN Tubulin-specific chaperone E OS=Homo sapiens GN=TBCE PE=1 SV=1 | 333 | S | 0.354767 | T | 0.262992 | 0.091775 | No Change: Both O | - |
| Q15813 | TBCE_HUMAN Tubulin-specific chaperone E OS=Homo sapiens GN=TBCE PE=1 SV=1 | 409 | E | 0.509291 | G | 0.448924 | 0.060367 | D to O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 266 | Q | 0.671852 | E | 0.718474 | -0.046622 | No Change: Both D | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 489 | K | 0.319505 | N | 0.269515 | 0.04999 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 66 | R | 0.33637 | L | 0.220888 | 0.115482 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 151 | I | 0.232698 | M | 0.313426 | -0.080728 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 265 | D | 0.67904 | N | 0.6499 | 0.02914 | No Change: Both D | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 425 | T | 0.22171 | M | 0.188889 | 0.032821 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 471 | M | 0.117515 | I | 0.08373 | 0.033785 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 503 | R | 0.42518 | I | 0.287531 | 0.137649 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 692 | R | 0.222182 | C | 0.134824 | 0.087358 | No Change: Both O | - |
| Q8TEA7 | TBCK_HUMAN TBC domain-containing protein kinase-like protein OS=Homo sapiens GN=TBCK PE=1 SV=4 | 806 | I | 0.419319 | V | 0.425468 | -0.006149 | No Change: Both O | A head & Neck squamous cell carcinoma sample |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 388 | N | 0.168094 | D | 0.178979 | -0.010885 | No Change: Both O | - |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 570 | K | 0.475735 | Q | 0.443025 | 0.03271 | No Change: Both O | - |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 271 | R | 0.253736 | Q | 0.289118 | -0.035382 | No Change: Both O | - |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 291 | K | 0.183676 | E | 0.198499 | -0.014823 | No Change: Both O | - |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 296 | D | 0.114761 | H | 0.091632 | 0.023129 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 410 | G | 0.541166 | R | 0.541009 | 1.57E-04 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q9UHD2 | TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens GN=TBK1 PE=1 SV=1 | 464 | V | 0.200122 | A | 0.241824 | -0.041702 | No Change: Both O | - |
| Q9Y4P3 | TBL2_HUMAN Transducin beta-like protein 2 OS=Homo sapiens GN=TBL2 PE=1 SV=1 | 345 | V | 0.356852 | I | 0.344625 | 0.012227 | No Change: Both O | - |
| Q12788 | TBL3_HUMAN Transducin beta-like protein 3 OS=Homo sapiens GN=TBL3 PE=1 SV=2 | 457 | S | 0.504446 | P | 0.514589 | -0.010143 | No Change: Both D | - |
| Q12788 | TBL3_HUMAN Transducin beta-like protein 3 OS=Homo sapiens GN=TBL3 PE=1 SV=2 | 293 | Q | 0.575598 | R | 0.544227 | 0.031371 | No Change: Both D | - |
| Q12788 | TBL3_HUMAN Transducin beta-like protein 3 OS=Homo sapiens GN=TBL3 PE=1 SV=2 | 294 | E | 0.532083 | Q | 0.522753 | 0.00933 | No Change: Both D | - |
| Q6SJ96 | TBPL2_HUMAN TATA box-binding protein-like protein 2 OS=Homo sapiens GN=TBPL2 PE=2 SV=1 | 31 | R | 0.849788 | P | 0.883704 | -0.033916 | No Change: Both D | - |
| Q16650 | TBR1_HUMAN T-box brain protein 1 OS=Homo sapiens GN=TBR1 PE=1 SV=1 | 289 | H | 0.465424 | Q | 0.482176 | -0.016752 | No Change: Both O | - |
| Q969Z0 | TBRG4_HUMAN Protein TBRG4 OS=Homo sapiens GN=TBRG4 PE=1 SV=1 | 22 | A | 0.487492 | S | 0.542204 | -0.054712 | O to D | - |
| Q969Z0 | TBRG4_HUMAN Protein TBRG4 OS=Homo sapiens GN=TBRG4 PE=1 SV=1 | 57 | P | 0.713709 | L | 0.584287 | 0.129422 | No Change: Both D | - |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 350 | T | 0.842383 | M | 0.820515 | 0.021868 | No Change: Both D | - |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 310 | G | 0.669888 | S | 0.732526 | -0.062638 | No Change: Both D | DiGeorge syndrome (DGS) [MIM:188400] |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 148 | F | 0.186068 | Y | 0.199679 | -0.013611 | No Change: Both O | Conotruncal heart malformations (CTHM) [MIM:217095] |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 148 | F | 0.186068 | Y | 0.199679 | -0.013611 | No Change: Both O | Velocardiofacial syndrome (VCFS) [MIM:192430] |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 194 | H | 0.550906 | Q | 0.549448 | 0.001458 | No Change: Both D | Velocardiofacial syndrome (VCFS) [MIM:192430] |
| O43435 | TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens GN=TBX1 PE=1 SV=1 | 337 | G | 0.871717 | E | 0.892994 | -0.021277 | No Change: Both D | A colorectal cancer sample |
| O75333 | TBX10_HUMAN T-box transcription factor TBX10 OS=Homo sapiens GN=TBX10 PE=2 SV=2 | 101 | K | 0.171835 | T | 0.125043 | 0.046792 | No Change: Both O | - |
| O75333 | TBX10_HUMAN T-box transcription factor TBX10 OS=Homo sapiens GN=TBX10 PE=2 SV=2 | 160 | Q | 0.302474 | H | 0.278697 | 0.023777 | No Change: Both O | - |
| Q96SF7 | TBX15_HUMAN T-box transcription factor TBX15 OS=Homo sapiens GN=TBX15 PE=2 SV=2 | 156 | H | 0.234176 | N | 0.25372 | -0.019544 | No Change: Both O | - |
| O95935 | TBX18_HUMAN T-box transcription factor TBX18 OS=Homo sapiens GN=TBX18 PE=2 SV=3 | 48 | G | 0.908812 | R | 0.911802 | -0.00299 | No Change: Both D | - |
| O60806 | TBX19_HUMAN T-box transcription factor TBX19 OS=Homo sapiens GN=TBX19 PE=1 SV=3 | 128 | S | 0.381758 | F | 0.195769 | 0.185989 | No Change: Both O | ACTH deficiency isolated (IAD) [MIM:201400] |
| Q9UMR3 | TBX20_HUMAN T-box transcription factor TBX20 OS=Homo sapiens GN=TBX20 PE=1 SV=4 | 152 | I | 0.09331 | M | 0.141094 | -0.047784 | No Change: Both O | Atrial septal defect type 4 (ASD4) [MIM:611363] |
| Q9UL17 | TBX21_HUMAN T-box transcription factor TBX21 OS=Homo sapiens GN=TBX21 PE=1 SV=1 | 33 | H | 0.913632 | Q | 0.940718 | -0.027086 | No Change: Both D | - |
| Q9UL17 | TBX21_HUMAN T-box transcription factor TBX21 OS=Homo sapiens GN=TBX21 PE=1 SV=1 | 339 | I | 0.66173 | V | 0.695793 | -0.034063 | No Change: Both D | - |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 118 | G | 0.295648 | C | 0.160383 | 0.135265 | No Change: Both O | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 260 | T | 0.41227 | M | 0.328312 | 0.083958 | No Change: Both O | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 214 | L | 0.384457 | P | 0.558728 | -0.174271 | O to D | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 264 | N | 0.390767 | Y | 0.259696 | 0.131071 | No Change: Both O | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 121 | M | 0.280779 | V | 0.240324 | 0.040455 | No Change: Both O | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 183 | P | 0.471417 | L | 0.286148 | 0.185269 | No Change: Both O | X-linked cleft palate with ankyloglossia (CPX) [MIM:303400] |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 187 | E | 0.347364 | K | 0.347416 | -5.20E-05 | No Change: Both O | - |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 16 | V | 0.885722 | A | 0.925447 | -0.039725 | No Change: Both D | A colorectal cancer sample |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 51 | A | 0.998155 | T | 0.99823 | -7.50E-05 | No Change: Both D | A colorectal cancer sample |
| Q9Y458 | TBX22_HUMAN T-box transcription factor TBX22 OS=Homo sapiens GN=TBX22 PE=1 SV=3 | 307 | D | 0.578143 | N | 0.545186 | 0.032957 | No Change: Both D | A colorectal cancer sample |
| O15119 | TBX3_HUMAN T-box transcription factor TBX3 OS=Homo sapiens GN=TBX3 PE=1 SV=4 | 143 | L | 0.333114 | P | 0.500439 | -0.167325 | O to D | Ulnar-mammary syndrome (UMS) [MIM:181450] |
| O15119 | TBX3_HUMAN T-box transcription factor TBX3 OS=Homo sapiens GN=TBX3 PE=1 SV=4 | 149 | Y | 0.173324 | S | 0.32082 | -0.147496 | No Change: Both O | Ulnar-mammary syndrome (UMS) [MIM:181450] |
| P57082 | TBX4_HUMAN T-box transcription factor TBX4 OS=Homo sapiens GN=TBX4 PE=1 SV=2 | 6 | G | 0.931378 | A | 0.932605 | -0.001227 | No Change: Both D | - |
| P57082 | TBX4_HUMAN T-box transcription factor TBX4 OS=Homo sapiens GN=TBX4 PE=1 SV=2 | 314 | A | 0.736975 | V | 0.649481 | 0.087494 | No Change: Both D | - |
| P57082 | TBX4_HUMAN T-box transcription factor TBX4 OS=Homo sapiens GN=TBX4 PE=1 SV=2 | 248 | G | 0.488982 | V | 0.367575 | 0.121407 | No Change: Both O | Small patella syndrome (SPS) [MIM:147891] |
| P57082 | TBX4_HUMAN T-box transcription factor TBX4 OS=Homo sapiens GN=TBX4 PE=1 SV=2 | 531 | Q | 0.612926 | R | 0.615712 | -0.002786 | No Change: Both D | Small patella syndrome (SPS) [MIM:147891] |
| P57082 | TBX4_HUMAN T-box transcription factor TBX4 OS=Homo sapiens GN=TBX4 PE=1 SV=2 | 35 | A | 0.945325 | V | 0.913381 | 0.031944 | No Change: Both D | - |
| Q99593 | TBX5_HUMAN T-box transcription factor TBX5 OS=Homo sapiens GN=TBX5 PE=1 SV=2 | 237 | R | 0.526872 | Q | 0.539068 | -0.012196 | No Change: Both D | Holt-Oram syndrome (HOS) [MIM:142900] |
| Q99593 | TBX5_HUMAN T-box transcription factor TBX5 OS=Homo sapiens GN=TBX5 PE=1 SV=2 | 80 | G | 0.293428 | R | 0.298777 | -0.005349 | No Change: Both O | Holt-Oram syndrome (HOS) [MIM:142900] |
| Q99593 | TBX5_HUMAN T-box transcription factor TBX5 OS=Homo sapiens GN=TBX5 PE=1 SV=2 | 237 | R | 0.526872 | W | 0.315761 | 0.211111 | D to O | Holt-Oram syndrome (HOS) [MIM:142900] |
| Q99593 | TBX5_HUMAN T-box transcription factor TBX5 OS=Homo sapiens GN=TBX5 PE=1 SV=2 | 49 | Q | 0.516011 | K | 0.54275 | -0.026739 | No Change: Both D | Holt-Oram syndrome (HOS) [MIM:142900] |
| Q99593 | TBX5_HUMAN T-box transcription factor TBX5 OS=Homo sapiens GN=TBX5 PE=1 SV=2 | 54 | I | 0.382373 | T | 0.511806 | -0.129433 | O to D | Holt-Oram syndrome (HOS) [MIM:142900] |
| O95947 | TBX6_HUMAN T-box transcription factor TBX6 OS=Homo sapiens GN=TBX6 PE=2 SV=2 | 178 | S | 0.491132 | F | 0.296928 | 0.194204 | No Change: Both O | - |
| O95947 | TBX6_HUMAN T-box transcription factor TBX6 OS=Homo sapiens GN=TBX6 PE=2 SV=2 | 179 | P | 0.496703 | S | 0.510172 | -0.013469 | O to D | - |
| O95947 | TBX6_HUMAN T-box transcription factor TBX6 OS=Homo sapiens GN=TBX6 PE=2 SV=2 | 162 | G | 0.637283 | S | 0.668526 | -0.031243 | No Change: Both D | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 60 | R | 0.525664 | L | 0.40873 | 0.116934 | D to O | Bleeding disorder platelet-type 13 (BDPLT13) [MIM:614009] |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 68 | C | 0.039537 | S | 0.120938 | -0.081401 | No Change: Both O | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 80 | V | 0.064473 | E | 0.133978 | -0.069505 | No Change: Both O | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 94 | E | 0.14113 | V | 0.064856 | 0.076274 | No Change: Both O | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 160 | A | 0.046135 | T | 0.048247 | -0.002112 | No Change: Both O | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 176 | V | 0.127881 | E | 0.251493 | -0.123612 | No Change: Both O | - |
| P21731 | TA2R_HUMAN Thromboxane A2 receptor OS=Homo sapiens GN=TBXA2R PE=1 SV=3 | 217 | V | 0.107095 | I | 0.083807 | 0.023288 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 160 | D | 0.097859 | E | 0.11081 | -0.012951 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 245 | N | 0.408757 | S | 0.425957 | -0.0172 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 356 | L | 0.130329 | V | 0.120883 | 0.009446 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 416 | Q | 0.27636 | E | 0.328698 | -0.052338 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 449 | E | 0.635895 | K | 0.596812 | 0.039083 | No Change: Both D | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 450 | T | 0.629816 | N | 0.653055 | -0.023239 | No Change: Both D | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 465 | R | 0.421945 | Q | 0.436819 | -0.014874 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 60 | R | 0.107062 | H | 0.104617 | 0.002445 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 162 | L | 0.102254 | I | 0.082744 | 0.01951 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 331 | I | 0.114299 | T | 0.194972 | -0.080673 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 424 | R | 0.227957 | C | 0.145369 | 0.082588 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 429 | A | 0.263363 | T | 0.266502 | -0.003139 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 257 | K | 0.17807 | E | 0.194494 | -0.016424 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 260 | R | 0.217673 | G | 0.172104 | 0.045569 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 316 | Q | 0.774875 | K | 0.7852 | -0.010325 | No Change: Both D | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 389 | G | 0.267041 | V | 0.2148 | 0.052241 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 124 | V | 0.231779 | I | 0.188274 | 0.043505 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 388 | E | 0.277931 | K | 0.254644 | 0.023287 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 501 | R | 0.155922 | Q | 0.181551 | -0.025629 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 85 | R | 0.052345 | W | 0.018056 | 0.034289 | No Change: Both O | A breast cancer sample |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 82 | L | 0.049925 | P | 0.103757 | -0.053832 | No Change: Both O | Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095] |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 357 | L | 0.134096 | V | 0.125154 | 0.008942 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 412 | R | 0.28227 | Q | 0.297066 | -0.014796 | No Change: Both O | Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095] |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 481 | G | 0.1898 | W | 0.072202 | 0.117598 | No Change: Both O | Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095] |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 487 | L | 0.161222 | P | 0.253509 | -0.092287 | No Change: Both O | Ghosal hematodiaphyseal dysplasia (GHDD) [MIM:231095] |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 512 | L | 0.466674 | P | 0.635938 | -0.169264 | O to D | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 387 | E | 0.304581 | K | 0.280883 | 0.023698 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 511 | P | 0.42703 | L | 0.26536 | 0.16167 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 70 | L | 0.265498 | P | 0.407176 | -0.141678 | No Change: Both O | - |
| P24557 | THAS_HUMAN Thromboxane-A synthase OS=Homo sapiens GN=TBXAS1 PE=1 SV=3 | 70 | L | 0.265498 | V | 0.249578 | 0.01592 | No Change: Both O | - |
| Q8N9U0 | TAC2N_HUMAN Tandem C2 domains nuclear protein OS=Homo sapiens GN=TC2N PE=1 SV=2 | 151 | K | 0.581081 | T | 0.521894 | 0.059187 | No Change: Both D | - |
| Q8N9U0 | TAC2N_HUMAN Tandem C2 domains nuclear protein OS=Homo sapiens GN=TC2N PE=1 SV=2 | 172 | S | 0.83725 | N | 0.800016 | 0.037234 | No Change: Both D | - |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 87 | R | 0.273734 | Q | 0.305149 | -0.031415 | No Change: Both O | Cardiomyopathy dilated type 1N (CMD1N) [MIM:607487] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 70 | R | 0.260509 | W | 0.108976 | 0.151533 | No Change: Both O | Cardiomyopathy dilated type 1N (CMD1N) [MIM:607487] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 90 | P | 0.277768 | L | 0.159885 | 0.117883 | No Change: Both O | Cardiomyopathy dilated type 1N (CMD1N) [MIM:607487] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 74 | L | 0.298753 | H | 0.368384 | -0.069631 | No Change: Both O | - |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 132 | E | 0.636916 | Q | 0.633328 | 0.003588 | No Change: Both D | Cardiomyopathy dilated type 1N (CMD1N) [MIM:607487] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 137 | T | 0.668996 | I | 0.576396 | 0.0926 | No Change: Both D | Familial hypertrophic cardiomyopathy (CMH) [MIM:192600] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 153 | R | 0.884667 | H | 0.832073 | 0.052594 | No Change: Both D | Familial hypertrophic cardiomyopathy (CMH) [MIM:192600] |
| O15273 | TELT_HUMAN Telethonin OS=Homo sapiens GN=TCAP PE=1 SV=1 | 106 | R | 0.68559 | C | 0.59469 | 0.0909 | No Change: Both D | - |
| Q15170 | TCAL1_HUMAN Transcription elongation factor A protein-like 1 OS=Homo sapiens GN=TCEAL1 PE=1 SV=2 | 5 | R | 0.998772 | C | 0.997436 | 0.001336 | No Change: Both D | - |
| Q9H3H9 | TCAL2_HUMAN Transcription elongation factor A protein-like 2 OS=Homo sapiens GN=TCEAL2 PE=2 SV=1 | 19 | D | 0.959647 | G | 0.961542 | -0.001895 | No Change: Both D | - |
| Q9H3H9 | TCAL2_HUMAN Transcription elongation factor A protein-like 2 OS=Homo sapiens GN=TCEAL2 PE=2 SV=1 | 68 | G | 0.99641 | A | 0.995762 | 6.48E-04 | No Change: Both D | - |
| Q969E4 | TCAL3_HUMAN Transcription elongation factor A protein-like 3 OS=Homo sapiens GN=TCEAL3 PE=1 SV=1 | 87 | Q | 0.997725 | E | 0.997959 | -2.34E-04 | No Change: Both D | - |
| Q8N8B7 | TEANC_HUMAN Transcription elongation factor A N-terminal and central domain-containing protein OS=Homo sapiens GN=TCEANC PE=2 SV=2 | 163 | S | 0.866076 | L | 0.792097 | 0.073979 | No Change: Both D | - |
| Q14241 | ELOA1_HUMAN Transcription elongation factor B polypeptide 3 OS=Homo sapiens GN=TCEB3 PE=1 SV=2 | 145 | T | 0.941555 | M | 0.941792 | -2.37E-04 | No Change: Both D | - |
| Q14241 | ELOA1_HUMAN Transcription elongation factor B polypeptide 3 OS=Homo sapiens GN=TCEB3 PE=1 SV=2 | 324 | V | 0.996974 | I | 0.996725 | 2.49E-04 | No Change: Both D | - |
| Q14241 | ELOA1_HUMAN Transcription elongation factor B polypeptide 3 OS=Homo sapiens GN=TCEB3 PE=1 SV=2 | 516 | A | 0.679279 | V | 0.620402 | 0.058877 | No Change: Both D | - |
| Q8IYF1 | ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2 OS=Homo sapiens GN=TCEB3B PE=1 SV=2 | 498 | R | 0.857006 | Q | 0.859543 | -0.002537 | No Change: Both D | A colorectal cancer sample |
| Q8IYF1 | ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2 OS=Homo sapiens GN=TCEB3B PE=1 SV=2 | 179 | R | 0.984414 | P | 0.987283 | -0.002869 | No Change: Both D | - |
| Q8IYF1 | ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2 OS=Homo sapiens GN=TCEB3B PE=1 SV=2 | 254 | C | 0.838474 | F | 0.775073 | 0.063401 | No Change: Both D | - |
| Q8IYF1 | ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2 OS=Homo sapiens GN=TCEB3B PE=1 SV=2 | 403 | A | 0.920565 | S | 0.94294 | -0.022375 | No Change: Both D | - |
| Q8IYF1 | ELOA2_HUMAN RNA polymerase II transcription factor SIII subunit A2 OS=Homo sapiens GN=TCEB3B PE=1 SV=2 | 446 | A | 0.714269 | T | 0.713925 | 3.44E-04 | No Change: Both D | - |
| Q8NG57 | ELOA3_HUMAN RNA polymerase II transcription factor SIII subunit A3 OS=Homo sapiens GN=TCEB3C PE=1 SV=2 | 375 | L | 0.327217 | P | 0.481559 | -0.154342 | No Change: Both O | - |
| A6NLF2 | EA3L2_HUMAN RNA polymerase II transcription factor SIII subunit A3-like-2 OS=Homo sapiens GN=TCEB3CL2 PE=3 SV=1 | 375 | P | 0.494423 | L | 0.338703 | 0.15572 | No Change: Both O | - |
| Q5VWI1 | TCRGL_HUMAN Transcription elongation regulator 1-like protein OS=Homo sapiens GN=TCERG1L PE=2 SV=2 | 339 | P | 0.556565 | Q | 0.492152 | 0.064413 | D to O | - |
| Q5VWI1 | TCRGL_HUMAN Transcription elongation regulator 1-like protein OS=Homo sapiens GN=TCERG1L PE=2 SV=2 | 437 | K | 0.92115 | T | 0.916566 | 0.004584 | No Change: Both D | A colorectal cancer sample |
| Q5VWI1 | TCRGL_HUMAN Transcription elongation regulator 1-like protein OS=Homo sapiens GN=TCERG1L PE=2 SV=2 | 529 | E | 0.902463 | K | 0.906016 | -0.003553 | No Change: Both D | - |
| Q5VWI1 | TCRGL_HUMAN Transcription elongation regulator 1-like protein OS=Homo sapiens GN=TCERG1L PE=2 SV=2 | 566 | Q | 0.614343 | K | 0.654287 | -0.039944 | No Change: Both D | - |
| Q99081 | HTF4_HUMAN Transcription factor 12 OS=Homo sapiens GN=TCF12 PE=1 SV=1 | 300 | G | 0.944843 | S | 0.96406 | -0.019217 | No Change: Both D | - |
| Q9Y242 | TCF19_HUMAN Transcription factor 19 OS=Homo sapiens GN=TCF19 PE=1 SV=2 | 211 | M | 0.96945 | V | 0.964436 | 0.005014 | No Change: Both D | - |
| Q9Y242 | TCF19_HUMAN Transcription factor 19 OS=Homo sapiens GN=TCF19 PE=1 SV=2 | 241 | P | 0.980545 | L | 0.965145 | 0.0154 | No Change: Both D | - |
| Q9Y242 | TCF19_HUMAN Transcription factor 19 OS=Homo sapiens GN=TCF19 PE=1 SV=2 | 109 | P | 0.730047 | S | 0.733131 | -0.003084 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 485 | T | 0.96886 | N | 0.968926 | -6.60E-05 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 722 | S | 0.790806 | G | 0.761441 | 0.029365 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 1165 | M | 0.764483 | I | 0.613336 | 0.151147 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 1325 | S | 0.914063 | N | 0.889266 | 0.024797 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 405 | M | 0.957613 | V | 0.934408 | 0.023205 | No Change: Both D | - |
| Q9UGU0 | TCF20_HUMAN Transcription factor 20 OS=Homo sapiens GN=TCF20 PE=1 SV=3 | 1910 | Y | 0.168314 | C | 0.227684 | -0.05937 | No Change: Both O | - |
| Q7RTU1 | TCF23_HUMAN Transcription factor 23 OS=Homo sapiens GN=TCF23 PE=2 SV=1 | 25 | R | 0.942625 | Q | 0.941094 | 0.001531 | No Change: Both D | - |
| Q7RTU1 | TCF23_HUMAN Transcription factor 23 OS=Homo sapiens GN=TCF23 PE=2 SV=1 | 40 | T | 0.944775 | S | 0.960658 | -0.015883 | No Change: Both D | - |
| P15923 | TFE2_HUMAN Transcription factor E2-alpha OS=Homo sapiens GN=TCF3 PE=1 SV=1 | 8 | A | 0.742424 | V | 0.716273 | 0.026151 | No Change: Both D | A colorectal cancer sample |
| P15923 | TFE2_HUMAN Transcription factor E2-alpha OS=Homo sapiens GN=TCF3 PE=1 SV=1 | 120 | L | 0.613351 | P | 0.736148 | -0.122797 | No Change: Both D | - |
| P15923 | TFE2_HUMAN Transcription factor E2-alpha OS=Homo sapiens GN=TCF3 PE=1 SV=1 | 198 | T | 0.863394 | A | 0.858996 | 0.004398 | No Change: Both D | - |
| P15923 | TFE2_HUMAN Transcription factor E2-alpha OS=Homo sapiens GN=TCF3 PE=1 SV=1 | 431 | G | 0.653892 | S | 0.6894 | -0.035508 | No Change: Both D | - |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 576 | R | 0.765585 | Q | 0.752959 | 0.012626 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 576 | R | 0.765585 | W | 0.575571 | 0.190014 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 450 | M | 0.54141 | I | 0.41582 | 0.12559 | D to O | - |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 535 | D | 0.996633 | G | 0.994757 | 0.001876 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 572 | R | 0.868139 | G | 0.828312 | 0.039827 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 610 | A | 0.232153 | V | 0.189511 | 0.042642 | No Change: Both O | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 358 | G | 0.895574 | V | 0.844609 | 0.050965 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 574 | R | 0.819815 | P | 0.810796 | 0.009019 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| P15884 | ITF2_HUMAN Transcription factor 4 OS=Homo sapiens GN=TCF4 PE=1 SV=3 | 578 | R | 0.706303 | H | 0.652428 | 0.053875 | No Change: Both D | Pitt-Hopkins syndrome (PTHS) [MIM:610954] |
| Q9HCS4 | TF7L1_HUMAN Transcription factor 7-like 1 OS=Homo sapiens GN=TCF7L1 PE=2 SV=1 | 147 | T | 0.577359 | N | 0.603409 | -0.02605 | No Change: Both D | A breast cancer sample |
| Q9HCS4 | TF7L1_HUMAN Transcription factor 7-like 1 OS=Homo sapiens GN=TCF7L1 PE=2 SV=1 | 533 | G | 0.961794 | R | 0.966967 | -0.005173 | No Change: Both D | - |
| Q9NQB0 | TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens GN=TCF7L2 PE=1 SV=2 | 465 | R | 0.572805 | C | 0.49592 | 0.076885 | D to O | A colorectal cancer sample |
| Q9NQB0 | TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens GN=TCF7L2 PE=1 SV=2 | 346 | K | 0.930263 | N | 0.907438 | 0.022825 | No Change: Both D | - |
| Q9UL49 | TCFL5_HUMAN Transcription factor-like 5 protein OS=Homo sapiens GN=TCFL5 PE=2 SV=2 | 380 | E | 0.932462 | D | 0.916026 | 0.016436 | No Change: Both D | - |
| Q9UL49 | TCFL5_HUMAN Transcription factor-like 5 protein OS=Homo sapiens GN=TCFL5 PE=2 SV=2 | 272 | N | 0.861724 | D | 0.849606 | 0.012118 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 63 | L | 0.265921 | R | 0.381053 | -0.115132 | No Change: Both O | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 237 | V | 0.998876 | L | 0.999062 | -1.86E-04 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 552 | R | 0.999935 | S | 0.999915 | 2.00E-05 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 790 | L | 0.996928 | M | 0.997291 | -3.63E-04 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 1258 | L | 0.955595 | V | 0.9522 | 0.003395 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 1902 | K | 0.904369 | Q | 0.913197 | -0.008828 | No Change: Both D | - |
| Q07283 | TRHY_HUMAN Trichohyalin OS=Homo sapiens GN=TCHH PE=1 SV=2 | 1400 | R | 0.999385 | P | 0.999166 | 2.19E-04 | No Change: Both D | - |
| Q5QJ38 | TCHL1_HUMAN Trichohyalin-like protein 1 OS=Homo sapiens GN=TCHHL1 PE=2 SV=1 | 193 | A | 0.951726 | G | 0.958871 | -0.007145 | No Change: Both D | - |
| Q9BT92 | TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens GN=TCHP PE=1 SV=1 | 127 | K | 0.885027 | R | 0.874886 | 0.010141 | No Change: Both D | - |
| Q9BT92 | TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens GN=TCHP PE=1 SV=1 | 417 | E | 0.989945 | K | 0.988747 | 0.001198 | No Change: Both D | - |
| Q9BT92 | TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens GN=TCHP PE=1 SV=1 | 44 | S | 0.914919 | P | 0.886593 | 0.028326 | No Change: Both D | A gastric carcinoma sample |
| Q9BT92 | TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens GN=TCHP PE=1 SV=1 | 93 | E | 0.985508 | K | 0.98369 | 0.001818 | No Change: Both D | A pancreatic carcinoma sample |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 405 | G | 0.098802 | R | 0.084612 | 0.01419 | No Change: Both O | Osteopetrosis autosomal recessive type 1 (OPTB1) [MIM:259700] |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 444 | R | 0.039465 | L | 0.022889 | 0.016576 | No Change: Both O | Osteopetrosis autosomal recessive type 1 (OPTB1) [MIM:259700] |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 141 | A | 0.758333 | P | 0.810999 | -0.052666 | No Change: Both D | Osteopetrosis autosomal recessive type 1 (OPTB1) [MIM:259700] |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 517 | D | 0.106944 | N | 0.102459 | 0.004485 | No Change: Both O | Osteopetrosis autosomal recessive type 1 (OPTB1) [MIM:259700] |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 775 | P | 0.029616 | R | 0.024658 | 0.004958 | No Change: Both O | Osteopetrosis autosomal recessive type 1 (OPTB1) [MIM:259700] |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 56 | R | 0.343699 | W | 0.133563 | 0.210136 | No Change: Both O | - |
| Q13488 | VPP3_HUMAN V-type proton ATPase 116 kDa subunit a isoform 3 OS=Homo sapiens GN=TCIRG1 PE=1 SV=3 | 161 | P | 0.559078 | L | 0.411827 | 0.147251 | D to O | - |
| P56279 | TCL1A_HUMAN T-cell leukemia/lymphoma protein 1A OS=Homo sapiens GN=TCL1A PE=1 SV=1 | 56 | V | 0.302022 | I | 0.264006 | 0.038016 | No Change: Both O | - |
| O95988 | TCL1B_HUMAN T-cell leukemia/lymphoma protein 1B OS=Homo sapiens GN=TCL1B PE=1 SV=1 | 93 | G | 0.248979 | R | 0.257964 | -0.008985 | No Change: Both O | - |
| P20061 | TCO1_HUMAN Transcobalamin-1 OS=Homo sapiens GN=TCN1 PE=1 SV=2 | 35 | R | 0.226669 | H | 0.227141 | -4.72E-04 | No Change: Both O | - |
| P20061 | TCO1_HUMAN Transcobalamin-1 OS=Homo sapiens GN=TCN1 PE=1 SV=2 | 301 | D | 0.372054 | Y | 0.211322 | 0.160732 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 198 | M | 0.234684 | T | 0.283936 | -0.049252 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 219 | I | 0.31308 | L | 0.330854 | -0.017774 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 259 | R | 0.392682 | P | 0.448922 | -0.05624 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 376 | L | 0.445986 | S | 0.618949 | -0.172963 | O to D | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 23 | I | 0.374561 | V | 0.410143 | -0.035582 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 89 | F | 0.463851 | L | 0.536054 | -0.072203 | O to D | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 215 | R | 0.470979 | W | 0.254873 | 0.216106 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 227 | R | 0.286828 | Q | 0.292277 | -0.005449 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 348 | S | 0.300916 | F | 0.127869 | 0.173047 | No Change: Both O | - |
| P20062 | TCO2_HUMAN Transcobalamin-2 OS=Homo sapiens GN=TCN2 PE=1 SV=3 | 399 | R | 0.22472 | Q | 0.247094 | -0.022374 | No Change: Both O | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 53 | W | 0.279423 | R | 0.51045 | -0.231027 | O to D | Treacher Collins syndrome type 1 (TCS1) [MIM:154500] |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 516 | P | 0.957453 | L | 0.913703 | 0.04375 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 887 | V | 0.978453 | A | 0.987965 | -0.009512 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1390 | A | 0.995711 | V | 0.994455 | 0.001256 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1432 | D | 0.997661 | G | 0.997726 | -6.50E-05 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 665 | A | 0.965236 | P | 0.974888 | -0.009652 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1030 | R | 0.804649 | K | 0.816571 | -0.011922 | No Change: Both D | A colorectal cancer sample |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 221 | A | 0.991926 | P | 0.994404 | -0.002478 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1176 | P | 0.961183 | R | 0.953474 | 0.007709 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1280 | G | 0.929372 | R | 0.93331 | -0.003938 | No Change: Both D | - |
| Q13428 | TCOF_HUMAN Treacle protein OS=Homo sapiens GN=TCOF1 PE=1 SV=3 | 1431 | G | 0.997409 | A | 0.996541 | 8.68E-04 | No Change: Both D | - |
| P17987 | TCPA_HUMAN T-complex protein 1 subunit alpha OS=Homo sapiens GN=TCP1 PE=1 SV=1 | 7 | V | 0.578799 | L | 0.590272 | -0.011473 | No Change: Both D | A breast cancer sample |
| Q12799 | TCP10_HUMAN T-complex protein 10A homolog OS=Homo sapiens GN=TCP10 PE=1 SV=3 | 45 | G | 0.85261 | E | 0.888444 | -0.035834 | No Change: Both D | - |
| Q8TDR4 | TCP1L_HUMAN T-complex protein 10A homolog 2 OS=Homo sapiens GN=TCP10L PE=1 SV=1 | 145 | H | 0.776487 | R | 0.803527 | -0.02704 | No Change: Both D | - |
| Q8TDR4 | TCP1L_HUMAN T-complex protein 10A homolog 2 OS=Homo sapiens GN=TCP10L PE=1 SV=1 | 194 | R | 0.984385 | H | 0.97193 | 0.012455 | No Change: Both D | - |
| Q8WWU5 | TCP11_HUMAN T-complex protein 11 homolog OS=Homo sapiens GN=TCP11 PE=2 SV=1 | 253 | G | 0.704 | A | 0.717922 | -0.013922 | No Change: Both D | - |
| Q8WWU5 | TCP11_HUMAN T-complex protein 11 homolog OS=Homo sapiens GN=TCP11 PE=2 SV=1 | 429 | R | 0.055876 | Q | 0.067304 | -0.011428 | No Change: Both O | - |
| Q9NUJ3 | T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens GN=TCP11L1 PE=1 SV=1 | 109 | H | 0.119099 | Q | 0.137218 | -0.018119 | No Change: Both O | - |
| Q9NUJ3 | T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens GN=TCP11L1 PE=1 SV=1 | 178 | K | 0.189166 | R | 0.15337 | 0.035796 | No Change: Both O | - |
| Q8N4U5 | T11L2_HUMAN T-complex protein 11-like protein 2 OS=Homo sapiens GN=TCP11L2 PE=2 SV=1 | 41 | A | 0.990147 | T | 0.991208 | -0.001061 | No Change: Both D | - |
| Q8N4U5 | T11L2_HUMAN T-complex protein 11-like protein 2 OS=Homo sapiens GN=TCP11L2 PE=2 SV=1 | 82 | A | 0.249736 | S | 0.337725 | -0.087989 | No Change: Both O | - |
| Q8N4U5 | T11L2_HUMAN T-complex protein 11-like protein 2 OS=Homo sapiens GN=TCP11L2 PE=2 SV=1 | 261 | D | 0.630891 | N | 0.647975 | -0.017084 | No Change: Both D | - |
| Q5JU00 | TCTE1_HUMAN T-complex-associated testis-expressed protein 1 OS=Homo sapiens GN=TCTE1 PE=2 SV=1 | 35 | P | 0.985401 | L | 0.970615 | 0.014786 | No Change: Both D | - |
| Q5JU00 | TCTE1_HUMAN T-complex-associated testis-expressed protein 1 OS=Homo sapiens GN=TCTE1 PE=2 SV=1 | 53 | H | 0.798778 | R | 0.845067 | -0.046289 | No Change: Both D | - |
| Q5JU00 | TCTE1_HUMAN T-complex-associated testis-expressed protein 1 OS=Homo sapiens GN=TCTE1 PE=2 SV=1 | 261 | F | 0.025894 | S | 0.065908 | -0.040014 | No Change: Both O | - |
| Q8IZS6 | TC1D3_HUMAN Tctex1 domain-containing protein 3 OS=Homo sapiens GN=TCTE3 PE=1 SV=1 | 67 | I | 0.324227 | V | 0.343072 | -0.018845 | No Change: Both O | - |
| Q8IZS6 | TC1D3_HUMAN Tctex1 domain-containing protein 3 OS=Homo sapiens GN=TCTE3 PE=1 SV=1 | 88 | R | 0.358016 | I | 0.229516 | 0.1285 | No Change: Both O | - |
| Q8IZS6 | TC1D3_HUMAN Tctex1 domain-containing protein 3 OS=Homo sapiens GN=TCTE3 PE=1 SV=1 | 121 | V | 0.374174 | A | 0.445072 | -0.070898 | No Change: Both O | - |
| Q8N7M0 | TC1D1_HUMAN Tctex1 domain-containing protein 1 OS=Homo sapiens GN=TCTEX1D1 PE=2 SV=2 | 49 | E | 0.726729 | D | 0.714359 | 0.01237 | No Change: Both D | - |
| Q8N7M0 | TC1D1_HUMAN Tctex1 domain-containing protein 1 OS=Homo sapiens GN=TCTEX1D1 PE=2 SV=2 | 143 | L | 0.141999 | I | 0.128007 | 0.013992 | No Change: Both O | - |
| Q13569 | TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens GN=TDG PE=1 SV=2 | 199 | G | 0.702317 | S | 0.739475 | -0.037158 | No Change: Both D | - |
| Q13569 | TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens GN=TDG PE=1 SV=2 | 367 | V | 0.625383 | M | 0.73376 | -0.108377 | No Change: Both D | - |
| Q13569 | TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens GN=TDG PE=1 SV=2 | 381 | G | 0.656122 | E | 0.703659 | -0.047537 | No Change: Both D | - |
| Q13569 | TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens GN=TDG PE=1 SV=2 | 367 | V | 0.625383 | L | 0.678321 | -0.052938 | No Change: Both D | - |
| P13385 | TDGF1_HUMAN Teratocarcinoma-derived growth factor 1 OS=Homo sapiens GN=TDGF1 PE=1 SV=1 | 43 | Y | 0.320182 | D | 0.504226 | -0.184044 | O to D | - |
| P13385 | TDGF1_HUMAN Teratocarcinoma-derived growth factor 1 OS=Homo sapiens GN=TDGF1 PE=1 SV=1 | 22 | V | 0.068732 | A | 0.0996 | -0.030868 | No Change: Both O | - |
| P13385 | TDGF1_HUMAN Teratocarcinoma-derived growth factor 1 OS=Homo sapiens GN=TDGF1 PE=1 SV=1 | 111 | R | 0.535836 | G | 0.541461 | -0.005625 | No Change: Both D | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 493 | H | 0.498698 | R | 0.516753 | -0.018055 | O to D | Spinocerebellar ataxia autosomal recessive with axonal neuropathy (SCAN1) [MIM:607250] |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 566 | P | 0.439686 | L | 0.254511 | 0.185175 | No Change: Both O | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 95 | E | 0.92398 | D | 0.921356 | 0.002624 | No Change: Both D | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 101 | P | 0.913189 | L | 0.851468 | 0.061721 | No Change: Both D | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 134 | A | 0.686781 | T | 0.714303 | -0.027522 | No Change: Both D | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 187 | D | 0.202372 | G | 0.195595 | 0.006777 | No Change: Both O | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 304 | R | 0.277352 | Q | 0.296468 | -0.019116 | No Change: Both O | - |
| Q9NUW8 | TYDP1_HUMAN Tyrosyl-DNA phosphodiesterase 1 OS=Homo sapiens GN=TDP1 PE=1 SV=2 | 569 | T | 0.335953 | A | 0.3297 | 0.006253 | No Change: Both O | - |
| O95551 | TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens GN=TDP2 PE=1 SV=1 | 249 | Q | 0.551141 | E | 0.590451 | -0.03931 | No Change: Both D | - |
| O95551 | TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens GN=TDP2 PE=1 SV=1 | 268 | R | 0.411851 | Q | 0.407542 | 0.004309 | No Change: Both O | - |
| O95551 | TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens GN=TDP2 PE=1 SV=1 | 166 | S | 0.508892 | G | 0.442278 | 0.066614 | D to O | - |
| Q9BXT4 | TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens GN=TDRD1 PE=2 SV=2 | 864 | V | 0.249667 | L | 0.237131 | 0.012536 | No Change: Both O | - |
| Q9BXT4 | TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens GN=TDRD1 PE=2 SV=2 | 1138 | Y | 0.261274 | C | 0.323336 | -0.062062 | No Change: Both O | - |
| Q5VZ19 | TDR10_HUMAN Tudor domain-containing protein 10 OS=Homo sapiens GN=TDRD10 PE=2 SV=3 | 181 | R | 0.052074 | Q | 0.052465 | -3.91E-04 | No Change: Both O | - |
| Q5VZ19 | TDR10_HUMAN Tudor domain-containing protein 10 OS=Homo sapiens GN=TDRD10 PE=2 SV=3 | 215 | V | 0.140472 | I | 0.12327 | 0.017202 | No Change: Both O | - |
| Q8NAT2 | TDRD5_HUMAN Tudor domain-containing protein 5 OS=Homo sapiens GN=TDRD5 PE=1 SV=3 | 104 | M | 0.82412 | T | 0.837686 | -0.013566 | No Change: Both D | - |
| Q8NAT2 | TDRD5_HUMAN Tudor domain-containing protein 5 OS=Homo sapiens GN=TDRD5 PE=1 SV=3 | 358 | K | 0.315765 | E | 0.320082 | -0.004317 | No Change: Both O | - |
| Q8NAT2 | TDRD5_HUMAN Tudor domain-containing protein 5 OS=Homo sapiens GN=TDRD5 PE=1 SV=3 | 722 | E | 0.377789 | K | 0.358688 | 0.019101 | No Change: Both O | - |
| Q8NAT2 | TDRD5_HUMAN Tudor domain-containing protein 5 OS=Homo sapiens GN=TDRD5 PE=1 SV=3 | 239 | F | 0.864387 | V | 0.86496 | -5.73E-04 | No Change: Both D | - |
| O60522 | TDRD6_HUMAN Tudor domain-containing protein 6 OS=Homo sapiens GN=TDRD6 PE=2 SV=2 | 192 | R | 0.274113 | Q | 0.293219 | -0.019106 | No Change: Both O | - |
| O60522 | TDRD6_HUMAN Tudor domain-containing protein 6 OS=Homo sapiens GN=TDRD6 PE=2 SV=2 | 398 | T | 0.216681 | A | 0.203214 | 0.013467 | No Change: Both O | - |
| O60522 | TDRD6_HUMAN Tudor domain-containing protein 6 OS=Homo sapiens GN=TDRD6 PE=2 SV=2 | 1014 | Q | 0.226389 | E | 0.273112 | -0.046723 | No Change: Both O | - |
| O60522 | TDRD6_HUMAN Tudor domain-containing protein 6 OS=Homo sapiens GN=TDRD6 PE=2 SV=2 | 795 | I | 0.182025 | M | 0.259123 | -0.077098 | No Change: Both O | - |
| Q8NHU6 | TDRD7_HUMAN Tudor domain-containing protein 7 OS=Homo sapiens GN=TDRD7 PE=1 SV=2 | 150 | V | 0.665178 | A | 0.716746 | -0.051568 | No Change: Both D | - |
| Q8NHU6 | TDRD7_HUMAN Tudor domain-containing protein 7 OS=Homo sapiens GN=TDRD7 PE=1 SV=2 | 456 | P | 0.315379 | L | 0.170715 | 0.144664 | No Change: Both O | - |
| Q9Y2W6 | TDRKH_HUMAN Tudor and KH domain-containing protein OS=Homo sapiens GN=TDRKH PE=1 SV=2 | 257 | G | 0.913696 | A | 0.902997 | 0.010699 | No Change: Both D | - |
| P28347 | TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens GN=TEAD1 PE=1 SV=2 | 421 | Y | 0.462152 | H | 0.599878 | -0.137726 | O to D | Sveinsson chorioretinal atrophy (SCRA) [MIM:108985] |
| Q99594 | TEAD3_HUMAN Transcriptional enhancer factor TEF-5 OS=Homo sapiens GN=TEAD3 PE=1 SV=2 | 254 | T | 0.322846 | M | 0.289328 | 0.033518 | No Change: Both O | - |
| Q15561 | TEAD4_HUMAN Transcriptional enhancer factor TEF-3 OS=Homo sapiens GN=TEAD4 PE=1 SV=3 | 323 | P | 0.585767 | S | 0.638404 | -0.052637 | No Change: Both D | - |
| P42680 | TEC_HUMAN Tyrosine-protein kinase Tec OS=Homo sapiens GN=TEC PE=1 SV=2 | 44 | R | 0.467284 | Q | 0.465988 | 0.001296 | No Change: Both O | - |
| P42680 | TEC_HUMAN Tyrosine-protein kinase Tec OS=Homo sapiens GN=TEC PE=1 SV=2 | 563 | R | 0.268861 | K | 0.341359 | -0.072498 | No Change: Both O | A lung adenocarcinoma sample |
| Q7Z6L1 | TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens GN=TECPR1 PE=1 SV=1 | 733 | S | 0.254171 | Y | 0.09735 | 0.156821 | No Change: Both O | - |
| Q7Z6L1 | TCPR1_HUMAN Tectonin beta-propeller repeat-containing protein 1 OS=Homo sapiens GN=TECPR1 PE=1 SV=1 | 944 | P | 0.701578 | L | 0.588563 | 0.113015 | No Change: Both D | - |
| O15040 | TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens GN=TECPR2 PE=1 SV=4 | 320 | V | 0.32434 | I | 0.280215 | 0.044125 | No Change: Both O | - |
| O15040 | TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens GN=TECPR2 PE=1 SV=4 | 386 | A | 0.904883 | T | 0.920268 | -0.015385 | No Change: Both D | - |
| O15040 | TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens GN=TECPR2 PE=1 SV=4 | 439 | P | 0.84513 | S | 0.848514 | -0.003384 | No Change: Both D | - |
| O15040 | TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens GN=TECPR2 PE=1 SV=4 | 683 | I | 0.70981 | V | 0.744477 | -0.034667 | No Change: Both D | - |
| Q9NZ01 | TECR_HUMAN Trans-2 3-enoyl-CoA reductase OS=Homo sapiens GN=TECR PE=1 SV=1 | 182 | P | 0.190963 | L | 0.093118 | 0.097845 | No Change: Both O | Mental retardation autosomal recessive type 14 (MRT14) [MIM:614020] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 371 | R | 0.557855 | G | 0.570078 | -0.012223 | No Change: Both D | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 932 | V | 0.092268 | A | 0.1245 | -0.032232 | No Change: Both O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1057 | C | 0.054029 | S | 0.084247 | -0.030218 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1619 | C | 0.137386 | S | 0.315389 | -0.178003 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1724 | S | 0.225454 | N | 0.184442 | 0.041012 | No Change: Both O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1820 | L | 0.177282 | F | 0.171753 | 0.005529 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1824 | G | 0.21948 | D | 0.238264 | -0.018784 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1837 | C | 0.34176 | G | 0.494868 | -0.153108 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1870 | Y | 0.163669 | C | 0.150214 | 0.013455 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 2021 | R | 0.066559 | H | 0.072444 | -0.005885 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 2100 | S | 0.54468 | T | 0.484592 | 0.060088 | D to O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 284 | R | 0.089425 | H | 0.07628 | 0.013145 | No Change: Both O | A breast cancer sample |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 771 | I | 0.098682 | N | 0.182936 | -0.084254 | No Change: Both O | A breast cancer sample |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 813 | N | 0.583285 | T | 0.550947 | 0.032338 | No Change: Both D | A breast cancer sample |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 19 | Q | 0.150365 | R | 0.13499 | 0.015375 | No Change: Both O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1584 | S | 0.226253 | T | 0.167799 | 0.058454 | No Change: Both O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1878 | S | 0.274371 | R | 0.218024 | 0.056347 | No Change: Both O | - |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 197 | D | 0.595365 | N | 0.582506 | 0.012859 | No Change: Both D | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 211 | F | 0.347652 | S | 0.560873 | -0.213221 | O to D | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 317 | V | 0.140527 | E | 0.285691 | -0.145164 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 362 | S | 0.430099 | C | 0.190172 | 0.239927 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 465 | N | 0.341107 | K | 0.378414 | -0.037307 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 562 | T | 0.134557 | M | 0.111011 | 0.023546 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 815 | T | 0.611642 | M | 0.554775 | 0.056867 | No Change: Both D | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 886 | N | 0.223983 | S | 0.258465 | -0.034482 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1036 | C | 0.29952 | Y | 0.303548 | -0.004028 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1098 | A | 0.196631 | V | 0.144213 | 0.052418 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1136 | D | 0.688755 | H | 0.664417 | 0.024338 | No Change: Both D | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1248 | P | 0.61453 | L | 0.476693 | 0.137837 | D to O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1509 | C | 0.052757 | G | 0.114946 | -0.062189 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1517 | C | 0.097362 | R | 0.190754 | -0.093392 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1791 | P | 0.499157 | R | 0.444489 | 0.054668 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1837 | C | 0.34176 | R | 0.494907 | -0.153147 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1866 | T | 0.264711 | M | 0.233639 | 0.031072 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1867 | H | 0.238587 | R | 0.246558 | -0.007971 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1890 | R | 0.215417 | C | 0.104563 | 0.110854 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1898 | C | 0.083922 | R | 0.173351 | -0.089429 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 1947 | R | 0.423197 | C | 0.241501 | 0.181696 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| O75443 | TECTA_HUMAN Alpha-tectorin OS=Homo sapiens GN=TECTA PE=1 SV=3 | 2009 | I | 0.333836 | T | 0.484703 | -0.150867 | No Change: Both O | Deafness autosomal dominant type 12 (DFNA12) [MIM:601543] |
| Q5T9Z0 | TEDM1_HUMAN Transmembrane epididymal protein 1 OS=Homo sapiens GN=TEDDM1 PE=2 SV=1 | 130 | Y | 0.064271 | H | 0.116164 | -0.051893 | No Change: Both O | - |
| Q96QE5 | TEFM_HUMAN Transcription elongation factor mitochondrial OS=Homo sapiens GN=TEFM PE=1 SV=1 | 348 | I | 0.061183 | V | 0.075688 | -0.014505 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 849 | R | 0.420593 | W | 0.201099 | 0.219494 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 897 | Y | 0.082002 | S | 0.164451 | -0.082449 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 486 | V | 0.247021 | I | 0.223042 | 0.023979 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 117 | K | 0.375779 | N | 0.334181 | 0.041598 | No Change: Both O | Breast cancer samples |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 148 | I | 0.241621 | T | 0.355116 | -0.113495 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 226 | A | 0.244845 | V | 0.193916 | 0.050929 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 600 | V | 0.31625 | L | 0.327963 | -0.011713 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 634 | L | 0.19442 | F | 0.158028 | 0.036392 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 676 | V | 0.397309 | I | 0.384966 | 0.012343 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 724 | A | 0.504659 | T | 0.547419 | -0.04276 | No Change: Both D | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 883 | P | 0.160049 | A | 0.117879 | 0.04217 | No Change: Both O | An ovarian serous carcinoma sample |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 1124 | A | 0.81041 | V | 0.850448 | -0.040038 | No Change: Both D | A renal clear cell carcinoma sample |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 346 | Q | 0.381696 | P | 0.413396 | -0.0317 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 391 | T | 0.392457 | I | 0.254274 | 0.138183 | No Change: Both O | - |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 897 | Y | 0.082002 | C | 0.065895 | 0.016107 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 915 | R | 0.266262 | H | 0.260198 | 0.006064 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 918 | R | 0.30276 | C | 0.152319 | 0.150441 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 919 | V | 0.300322 | L | 0.3241 | -0.023778 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 925 | A | 0.283965 | S | 0.394091 | -0.110126 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q02763 | TIE2_HUMAN Angiopoietin-1 receptor OS=Homo sapiens GN=TEK PE=1 SV=2 | 1100 | K | 0.415656 | N | 0.399049 | 0.016607 | No Change: Both O | Dominantly inherited venous malformations (VMCM) [MIM:600195] |
| Q969V4 | TEKT1_HUMAN Tektin-1 OS=Homo sapiens GN=TEKT1 PE=2 SV=1 | 254 | R | 0.543417 | C | 0.450645 | 0.092772 | D to O | - |
| Q969V4 | TEKT1_HUMAN Tektin-1 OS=Homo sapiens GN=TEKT1 PE=2 SV=1 | 332 | V | 0.28618 | I | 0.248219 | 0.037961 | No Change: Both O | - |
| Q969V4 | TEKT1_HUMAN Tektin-1 OS=Homo sapiens GN=TEKT1 PE=2 SV=1 | 146 | I | 0.161759 | V | 0.155418 | 0.006341 | No Change: Both O | - |
| Q9UIF3 | TEKT2_HUMAN Tektin-2 OS=Homo sapiens GN=TEKT2 PE=1 SV=1 | 46 | R | 0.601203 | C | 0.410218 | 0.190985 | D to O | - |
| Q9UIF3 | TEKT2_HUMAN Tektin-2 OS=Homo sapiens GN=TEKT2 PE=1 SV=1 | 114 | I | 0.378158 | T | 0.506431 | -0.128273 | O to D | - |
| Q9BXF9 | TEKT3_HUMAN Tektin-3 OS=Homo sapiens GN=TEKT3 PE=1 SV=1 | 282 | G | 0.291851 | A | 0.233088 | 0.058763 | No Change: Both O | - |
| Q9BXF9 | TEKT3_HUMAN Tektin-3 OS=Homo sapiens GN=TEKT3 PE=1 SV=1 | 296 | V | 0.329676 | A | 0.393898 | -0.064222 | No Change: Both O | - |
| Q9BXF9 | TEKT3_HUMAN Tektin-3 OS=Homo sapiens GN=TEKT3 PE=1 SV=1 | 410 | E | 0.521949 | D | 0.51135 | 0.010599 | No Change: Both D | - |
| Q9BXF9 | TEKT3_HUMAN Tektin-3 OS=Homo sapiens GN=TEKT3 PE=1 SV=1 | 3 | R | 0.700596 | H | 0.689636 | 0.01096 | No Change: Both D | - |
| Q8WW24 | TEKT4_HUMAN Tektin-4 OS=Homo sapiens GN=TEKT4 PE=2 SV=1 | 83 | T | 0.956848 | M | 0.949456 | 0.007392 | No Change: Both D | - |
| Q8WW24 | TEKT4_HUMAN Tektin-4 OS=Homo sapiens GN=TEKT4 PE=2 SV=1 | 102 | K | 0.836618 | N | 0.823694 | 0.012924 | No Change: Both D | - |
| Q8WW24 | TEKT4_HUMAN Tektin-4 OS=Homo sapiens GN=TEKT4 PE=2 SV=1 | 409 | N | 0.221727 | K | 0.276103 | -0.054376 | No Change: Both O | - |
| Q8WW24 | TEKT4_HUMAN Tektin-4 OS=Homo sapiens GN=TEKT4 PE=2 SV=1 | 272 | C | 0.388831 | S | 0.494402 | -0.105571 | No Change: Both O | A breast cancer sample |
| Q8WW24 | TEKT4_HUMAN Tektin-4 OS=Homo sapiens GN=TEKT4 PE=2 SV=1 | 100 | S | 0.852764 | G | 0.811669 | 0.041095 | No Change: Both D | - |
| Q96M29 | TEKT5_HUMAN Tektin-5 OS=Homo sapiens GN=TEKT5 PE=2 SV=1 | 59 | A | 0.146423 | T | 0.18521 | -0.038787 | No Change: Both O | - |
| Q96M29 | TEKT5_HUMAN Tektin-5 OS=Homo sapiens GN=TEKT5 PE=2 SV=1 | 196 | H | 0.183359 | R | 0.224079 | -0.04072 | No Change: Both O | - |
| Q96M29 | TEKT5_HUMAN Tektin-5 OS=Homo sapiens GN=TEKT5 PE=2 SV=1 | 239 | M | 0.745695 | T | 0.724994 | 0.020701 | No Change: Both D | - |
| Q96M29 | TEKT5_HUMAN Tektin-5 OS=Homo sapiens GN=TEKT5 PE=2 SV=1 | 315 | Q | 0.541974 | R | 0.539696 | 0.002278 | No Change: Both D | - |
| Q9Y4R8 | TELO2_HUMAN Telomere length regulation protein TEL2 homolog OS=Homo sapiens GN=TELO2 PE=1 SV=2 | 7 | E | 0.639511 | G | 0.576966 | 0.062545 | No Change: Both D | - |
| Q9Y4R8 | TELO2_HUMAN Telomere length regulation protein TEL2 homolog OS=Homo sapiens GN=TELO2 PE=1 SV=2 | 146 | Q | 0.321103 | R | 0.309883 | 0.01122 | No Change: Both O | - |
| Q9Y4R8 | TELO2_HUMAN Telomere length regulation protein TEL2 homolog OS=Homo sapiens GN=TELO2 PE=1 SV=2 | 674 | Q | 0.780387 | R | 0.795783 | -0.015396 | No Change: Both D | - |
| Q9Y4R8 | TELO2_HUMAN Telomere length regulation protein TEL2 homolog OS=Homo sapiens GN=TELO2 PE=1 SV=2 | 7 | E | 0.639511 | Q | 0.577895 | 0.061616 | No Change: Both D | - |
| Q9Y4R8 | TELO2_HUMAN Telomere length regulation protein TEL2 homolog OS=Homo sapiens GN=TELO2 PE=1 SV=2 | 511 | A | 0.606099 | V | 0.541776 | 0.064323 | No Change: Both D | - |
| Q63HR2 | TENC1_HUMAN Tensin-like C1 domain-containing phosphatase OS=Homo sapiens GN=TENC1 PE=1 SV=2 | 353 | S | 0.168732 | T | 0.121972 | 0.04676 | No Change: Both O | - |
| Q63HR2 | TENC1_HUMAN Tensin-like C1 domain-containing phosphatase OS=Homo sapiens GN=TENC1 PE=1 SV=2 | 670 | A | 0.451659 | T | 0.470299 | -0.01864 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 116 | S | 0.513489 | P | 0.471678 | 0.041811 | D to O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 307 | N | 0.115913 | K | 0.124168 | -0.008255 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1055 | R | 0.657718 | C | 0.485117 | 0.172601 | D to O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1195 | S | 0.204013 | P | 0.192826 | 0.011187 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1447 | S | 0.484157 | T | 0.426854 | 0.057303 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1468 | C | 0.374361 | Y | 0.329616 | 0.044745 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 2214 | V | 0.186743 | I | 0.151218 | 0.035525 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 2486 | I | 0.456447 | M | 0.568764 | -0.112317 | O to D | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 2562 | H | 0.410631 | R | 0.467208 | -0.056577 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 137 | T | 0.376034 | M | 0.369753 | 0.006281 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 368 | K | 0.470842 | R | 0.451863 | 0.018979 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 434 | K | 0.703506 | N | 0.671723 | 0.031783 | No Change: Both D | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 510 | S | 0.459371 | L | 0.322826 | 0.136545 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 553 | A | 0.399486 | G | 0.45011 | -0.050624 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 933 | R | 0.365345 | H | 0.359933 | 0.005412 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1155 | R | 0.698947 | Q | 0.722825 | -0.023878 | No Change: Both D | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1351 | R | 0.313388 | Q | 0.312769 | 6.19E-04 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1408 | G | 0.551863 | R | 0.553985 | -0.002122 | No Change: Both D | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1661 | R | 0.797979 | Q | 0.811161 | -0.013182 | No Change: Both D | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 1772 | R | 0.079911 | Q | 0.088174 | -0.008263 | No Change: Both O | - |
| Q99973 | TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens GN=TEP1 PE=1 SV=2 | 2310 | A | 0.193615 | S | 0.259001 | -0.065386 | No Change: Both O | - |
| Q6URK8 | TEPP_HUMAN Testis prostate and placenta-expressed protein OS=Homo sapiens GN=TEPP PE=2 SV=3 | 260 | S | 0.470027 | N | 0.414046 | 0.055981 | No Change: Both O | - |
| Q15554 | TERF2_HUMAN Telomeric repeat-binding factor 2 OS=Homo sapiens GN=TERF2 PE=1 SV=2 | 413 | S | 0.896327 | G | 0.878668 | 0.017659 | No Change: Both D | - |
| Q9NYB0 | TE2IP_HUMAN Telomeric repeat-binding factor 2-interacting protein 1 OS=Homo sapiens GN=TERF2IP PE=1 SV=1 | 324 | K | 0.401171 | E | 0.423014 | -0.021843 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 412 | H | 0.209998 | Y | 0.144622 | 0.065376 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 1062 | A | 0.641654 | T | 0.646223 | -0.004569 | No Change: Both D | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 202 | A | 0.85975 | T | 0.850783 | 0.008967 | No Change: Both D | Susceptibilty to aplastic anemia (AA) [MIM:609135] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 279 | A | 0.893496 | T | 0.901504 | -0.008008 | No Change: Both D | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 694 | V | 0.089344 | M | 0.109076 | -0.019732 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 772 | Y | 0.249684 | C | 0.25823 | -0.008546 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 865 | R | 0.086488 | H | 0.080691 | 0.005797 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 902 | K | 0.117139 | N | 0.108053 | 0.009086 | No Change: Both O | Dyskeratosis congenita autosomal dominant type 2 (DKCA2) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 1090 | V | 0.22717 | M | 0.270452 | -0.043282 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 948 | S | 0.550457 | R | 0.470829 | 0.079628 | D to O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 55 | L | 0.201508 | Q | 0.308337 | -0.106829 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 570 | K | 0.2406 | N | 0.212103 | 0.028497 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 682 | G | 0.202875 | D | 0.226697 | -0.023822 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 721 | P | 0.289215 | R | 0.269299 | 0.019916 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 4 (DKCB4) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 726 | T | 0.194728 | M | 0.158344 | 0.036384 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 811 | R | 0.0682 | C | 0.038478 | 0.029722 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 4 (DKCB4) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 901 | R | 0.112536 | W | 0.044237 | 0.068299 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 4 (DKCB4) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 979 | R | 0.1132 | W | 0.040431 | 0.072769 | No Change: Both O | Dyskeratosis congenita autosomal dominant type 2 (DKCA2) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 1110 | T | 0.506749 | M | 0.411417 | 0.095332 | D to O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 1127 | F | 0.626137 | L | 0.730486 | -0.104349 | No Change: Both D | Dyskeratosis congenita autosomal dominant type 2 (DKCA2) [MIM:613989] |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 65 | P | 0.54646 | A | 0.458255 | 0.088205 | D to O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 299 | V | 0.953331 | M | 0.961864 | -0.008533 | No Change: Both D | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 522 | R | 0.176517 | K | 0.209586 | -0.033069 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 631 | R | 0.342488 | Q | 0.303808 | 0.03868 | No Change: Both O | - |
| O14746 | TERT_HUMAN Telomerase reverse transcriptase OS=Homo sapiens GN=TERT PE=1 SV=1 | 785 | P | 0.380533 | L | 0.249477 | 0.131056 | No Change: Both O | - |
| Q9UGI8 | TES_HUMAN Testin OS=Homo sapiens GN=TES PE=1 SV=1 | 221 | A | 0.734559 | V | 0.659574 | 0.074985 | No Change: Both D | - |
| Q15569 | TESK1_HUMAN Dual specificity testis-specific protein kinase 1 OS=Homo sapiens GN=TESK1 PE=1 SV=2 | 539 | H | 0.905265 | Y | 0.869765 | 0.0355 | No Change: Both D | Breast cancer samples |
| Q15569 | TESK1_HUMAN Dual specificity testis-specific protein kinase 1 OS=Homo sapiens GN=TESK1 PE=1 SV=2 | 574 | G | 0.82739 | S | 0.850898 | -0.023508 | No Change: Both D | - |
| Q96S53 | TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens GN=TESK2 PE=2 SV=1 | 11 | G | 0.798329 | A | 0.738661 | 0.059668 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q8NFU7 | TET1_HUMAN Methylcytosine dioxygenase TET1 OS=Homo sapiens GN=TET1 PE=1 SV=2 | 162 | D | 0.51329 | G | 0.465372 | 0.047918 | D to O | - |
| Q8NFU7 | TET1_HUMAN Methylcytosine dioxygenase TET1 OS=Homo sapiens GN=TET1 PE=1 SV=2 | 193 | S | 0.491034 | T | 0.422545 | 0.068489 | No Change: Both O | - |
| Q8NFU7 | TET1_HUMAN Methylcytosine dioxygenase TET1 OS=Homo sapiens GN=TET1 PE=1 SV=2 | 256 | A | 0.706646 | V | 0.656602 | 0.050044 | No Change: Both D | - |
| Q8NFU7 | TET1_HUMAN Methylcytosine dioxygenase TET1 OS=Homo sapiens GN=TET1 PE=1 SV=2 | 1018 | N | 0.681211 | S | 0.723936 | -0.042725 | No Change: Both D | - |
| Q8NFU7 | TET1_HUMAN Methylcytosine dioxygenase TET1 OS=Homo sapiens GN=TET1 PE=1 SV=2 | 1123 | I | 0.944516 | M | 0.959709 | -0.015193 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 29 | P | 0.633489 | R | 0.570785 | 0.062704 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 218 | V | 0.608002 | M | 0.631508 | -0.023506 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 363 | P | 0.870821 | L | 0.823291 | 0.04753 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 912 | A | 0.699482 | G | 0.720117 | -0.020635 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 123 | R | 0.918541 | H | 0.88603 | 0.032511 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 308 | A | 0.818164 | T | 0.813604 | 0.00456 | No Change: Both D | Chronic myelomonocytic leukemia |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 355 | G | 0.876633 | D | 0.859742 | 0.016891 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 399 | P | 0.939501 | L | 0.898434 | 0.041067 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 429 | G | 0.884358 | R | 0.888723 | -0.004365 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 817 | S | 0.807676 | T | 0.756289 | 0.051387 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 924 | H | 0.45095 | R | 0.485935 | -0.034985 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 949 | H | 0.796905 | R | 0.80351 | -0.006605 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1167 | R | 0.425705 | T | 0.391105 | 0.0346 | No Change: Both O | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1175 | I | 0.326908 | V | 0.34306 | -0.016152 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1261 | R | 0.338177 | L | 0.224831 | 0.113346 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1287 | F | 0.27719 | L | 0.287081 | -0.009891 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1291 | W | 0.305667 | R | 0.547734 | -0.242067 | O to D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1299 | K | 0.319935 | E | 0.309957 | 0.009978 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1299 | K | 0.319935 | N | 0.26976 | 0.050175 | No Change: Both O | Chronic myelomonocytic leukemia samples |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1302 | R | 0.387336 | G | 0.38786 | -5.24E-04 | No Change: Both O | Chronic myelomonocytic leukemia samples |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1318 | E | 0.751618 | G | 0.72093 | 0.030688 | No Change: Both D | Chronic myelomonocytic leukemia samples |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1367 | P | 0.34524 | S | 0.383341 | -0.038101 | No Change: Both O | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1396 | C | 0.261638 | W | 0.198286 | 0.063352 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1398 | L | 0.307127 | R | 0.445707 | -0.13858 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1757 | H | 0.771986 | D | 0.770439 | 0.001547 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1811 | C | 0.468922 | R | 0.605642 | -0.13672 | O to D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1828 | Q | 0.604452 | L | 0.483699 | 0.120753 | D to O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1869 | G | 0.233921 | W | 0.105502 | 0.128419 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1872 | L | 0.213292 | P | 0.375949 | -0.162657 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1873 | I | 0.2296 | T | 0.35756 | -0.12796 | No Change: Both O | Chronic myelomonocytic leukemia |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1881 | H | 0.391672 | R | 0.415028 | -0.023356 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1896 | R | 0.394055 | M | 0.340962 | 0.053093 | No Change: Both O | A primary acute myeloid leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1898 | S | 0.366305 | F | 0.205715 | 0.16059 | No Change: Both O | A secondary acute myeloid leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1900 | V | 0.385786 | A | 0.5207 | -0.134914 | O to D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1913 | G | 0.564986 | D | 0.595376 | -0.03039 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1919 | A | 0.647478 | V | 0.562006 | 0.085472 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1926 | R | 0.821502 | H | 0.824757 | -0.003255 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1941 | P | 0.900152 | S | 0.895032 | 0.00512 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1962 | P | 0.792392 | L | 0.650592 | 0.1418 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1966 | R | 0.691522 | H | 0.645009 | 0.046513 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1974 | R | 0.603876 | M | 0.561706 | 0.04217 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 2000 | R | 0.608683 | K | 0.626708 | -0.018025 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 34 | L | 0.634798 | F | 0.595858 | 0.03894 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 145 | S | 0.962166 | N | 0.952954 | 0.009212 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 174 | P | 0.689586 | H | 0.651445 | 0.038141 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 312 | N | 0.767189 | S | 0.807208 | -0.040019 | No Change: Both D | An acute myeloid leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 460 | S | 0.957231 | F | 0.908645 | 0.048586 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 666 | D | 0.774341 | G | 0.754255 | 0.020086 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 867 | Y | 0.446304 | H | 0.626448 | -0.180144 | O to D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 941 | P | 0.787809 | S | 0.771939 | 0.01587 | No Change: Both D | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1073 | E | 0.852869 | V | 0.780275 | 0.072594 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1084 | Q | 0.915788 | P | 0.926195 | -0.010407 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1135 | C | 0.140377 | Y | 0.141976 | -0.001599 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1204 | S | 0.521655 | C | 0.273972 | 0.247683 | D to O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1214 | R | 0.206964 | W | 0.085483 | 0.121481 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1242 | D | 0.310398 | V | 0.176306 | 0.134092 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1245 | Y | 0.397246 | S | 0.588674 | -0.191428 | O to D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1261 | R | 0.338177 | C | 0.211879 | 0.126298 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1261 | R | 0.338177 | H | 0.295367 | 0.04281 | No Change: Both O | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1417 | V | 0.389451 | F | 0.359286 | 0.030165 | No Change: Both O | A chronic myelomonocytic leukemia sample |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1701 | M | 0.518585 | I | 0.439563 | 0.079022 | D to O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1718 | V | 0.476704 | L | 0.494081 | -0.017377 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1721 | L | 0.571795 | W | 0.493259 | 0.078536 | D to O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1723 | P | 0.589096 | S | 0.58104 | 0.008056 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1762 | I | 0.722464 | V | 0.704513 | 0.017951 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1778 | H | 0.569422 | R | 0.541405 | 0.028017 | No Change: Both D | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1875 | C | 0.275364 | R | 0.454698 | -0.179334 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1881 | H | 0.391672 | Q | 0.404377 | -0.012705 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1896 | R | 0.394055 | S | 0.438411 | -0.044356 | No Change: Both O | - |
| Q6N021 | TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens GN=TET2 PE=1 SV=3 | 1242 | D | 0.310398 | R | 0.273055 | 0.037343 | No Change: Both O | - |
| O43151 | TET3_HUMAN Methylcytosine dioxygenase TET3 OS=Homo sapiens GN=TET3 PE=2 SV=3 | 577 | R | 0.867831 | Q | 0.895105 | -0.027274 | No Change: Both D | - |
| Q9BY14 | TX101_HUMAN Testis-expressed protein 101 OS=Homo sapiens GN=TEX101 PE=2 SV=2 | 99 | G | 0.4602 | V | 0.356768 | 0.103432 | No Change: Both O | - |
| Q8IYF3 | TEX11_HUMAN Testis-expressed sequence 11 protein OS=Homo sapiens GN=TEX11 PE=1 SV=3 | 130 | K | 0.212168 | R | 0.176968 | 0.0352 | No Change: Both O | - |
| Q8IYF3 | TEX11_HUMAN Testis-expressed sequence 11 protein OS=Homo sapiens GN=TEX11 PE=1 SV=3 | 451 | E | 0.372465 | K | 0.381588 | -0.009123 | No Change: Both O | - |
| Q8IWB6 | TEX14_HUMAN Testis-expressed protein 14 OS=Homo sapiens GN=TEX14 PE=2 SV=2 | 88 | D | 0.490396 | G | 0.468684 | 0.021712 | No Change: Both O | - |
| Q8IWB6 | TEX14_HUMAN Testis-expressed protein 14 OS=Homo sapiens GN=TEX14 PE=2 SV=2 | 321 | K | 0.284469 | E | 0.303287 | -0.018818 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8IWB6 | TEX14_HUMAN Testis-expressed protein 14 OS=Homo sapiens GN=TEX14 PE=2 SV=2 | 443 | S | 0.161189 | C | 0.053371 | 0.107818 | No Change: Both O | - |
| Q8IWB6 | TEX14_HUMAN Testis-expressed protein 14 OS=Homo sapiens GN=TEX14 PE=2 SV=2 | 559 | I | 0.667339 | M | 0.774838 | -0.107499 | No Change: Both D | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 104 | C | 0.678536 | R | 0.698097 | -0.019561 | No Change: Both D | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 383 | P | 0.438374 | L | 0.272279 | 0.166095 | No Change: Both O | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 1035 | I | 0.099426 | V | 0.107543 | -0.008117 | No Change: Both O | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 1311 | N | 0.315156 | S | 0.337007 | -0.021851 | No Change: Both O | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 1337 | L | 0.420775 | V | 0.425093 | -0.004318 | No Change: Both O | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 1439 | K | 0.864784 | R | 0.827569 | 0.037215 | No Change: Both D | - |
| Q9BXT5 | TEX15_HUMAN Testis-expressed sequence 15 protein OS=Homo sapiens GN=TEX15 PE=1 SV=2 | 2138 | D | 0.274062 | N | 0.252097 | 0.021965 | No Change: Both O | - |
| Q8IWB9 | TEX2_HUMAN Testis-expressed sequence 2 protein OS=Homo sapiens GN=TEX2 PE=1 SV=2 | 158 | T | 0.999531 | I | 0.999242 | 2.89E-04 | No Change: Both D | - |
| Q9Y6I9 | TX264_HUMAN Testis-expressed sequence 264 protein OS=Homo sapiens GN=TEX264 PE=1 SV=1 | 292 | G | 0.950079 | E | 0.961457 | -0.011378 | No Change: Both D | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 296 | D | 0.66528 | G | 0.658447 | 0.006833 | No Change: Both D | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 319 | H | 0.333761 | R | 0.354882 | -0.021121 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 142 | G | 0.34065 | S | 0.394199 | -0.053549 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 277 | G | 0.314187 | S | 0.359495 | -0.045308 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 377 | W | 0.401129 | C | 0.549363 | -0.148234 | O to D | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 589 | P | 0.43174 | S | 0.414415 | 0.017325 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 645 | T | 0.307566 | P | 0.351797 | -0.044231 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 477 | A | 0.185016 | P | 0.247963 | -0.062947 | No Change: Both O | Atransferrinemia (ATRAF) [MIM:209300] |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 646 | K | 0.325607 | E | 0.341035 | -0.015428 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 671 | G | 0.343918 | E | 0.412508 | -0.06859 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 55 | S | 0.444379 | R | 0.357096 | 0.087283 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 42 | R | 0.445001 | L | 0.315852 | 0.129149 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 76 | A | 0.290422 | V | 0.213539 | 0.076883 | No Change: Both O | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 562 | G | 0.652897 | V | 0.564736 | 0.088161 | No Change: Both D | - |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 77 | D | 0.300978 | N | 0.286359 | 0.014619 | No Change: Both O | Atransferrinemia (ATRAF) [MIM:209300] |
| P02787 | TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 | 448 | I | 0.155046 | V | 0.199408 | -0.044362 | No Change: Both O | - |
| Q00059 | TFAM_HUMAN Transcription factor A mitochondrial OS=Homo sapiens GN=TFAM PE=1 SV=1 | 12 | S | 0.280913 | T | 0.189356 | 0.091557 | No Change: Both O | - |
| P05549 | AP2A_HUMAN Transcription factor AP-2-alpha OS=Homo sapiens GN=TFAP2A PE=1 SV=1 | 249 | L | 0.621385 | P | 0.740825 | -0.11944 | No Change: Both D | Branchiooculofacial syndrome (BOFS) [MIM:113620] |
| P05549 | AP2A_HUMAN Transcription factor AP-2-alpha OS=Homo sapiens GN=TFAP2A PE=1 SV=1 | 254 | R | 0.721133 | G | 0.698494 | 0.022639 | No Change: Both D | Branchiooculofacial syndrome (BOFS) [MIM:113620] |
| P05549 | AP2A_HUMAN Transcription factor AP-2-alpha OS=Homo sapiens GN=TFAP2A PE=1 SV=1 | 255 | R | 0.749674 | G | 0.728318 | 0.021356 | No Change: Both D | Branchiooculofacial syndrome (BOFS) [MIM:113620] |
| P05549 | AP2A_HUMAN Transcription factor AP-2-alpha OS=Homo sapiens GN=TFAP2A PE=1 SV=1 | 262 | G | 0.80155 | E | 0.819737 | -0.018187 | No Change: Both D | Branchiooculofacial syndrome (BOFS) [MIM:113620] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 275 | A | 0.802348 | D | 0.81626 | -0.013912 | No Change: Both D | Char syndrome (CHAR) [MIM:169100] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 300 | R | 0.452785 | C | 0.294441 | 0.158344 | No Change: Both O | Char syndrome (CHAR) [MIM:169100] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 73 | P | 0.986075 | R | 0.975879 | 0.010196 | No Change: Both D | Char syndrome (CHAR) [MIM:169100] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 236 | R | 0.517873 | C | 0.43647 | 0.081403 | D to O | Char syndrome (CHAR) [MIM:169100] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 236 | R | 0.517873 | S | 0.606267 | -0.088394 | No Change: Both D | Char syndrome (CHAR) [MIM:169100] |
| Q92481 | AP2B_HUMAN Transcription factor AP-2-beta OS=Homo sapiens GN=TFAP2B PE=1 SV=2 | 285 | R | 0.798381 | Q | 0.75218 | 0.046201 | No Change: Both D | Char syndrome (CHAR) [MIM:169100] |
| Q7Z6R9 | AP2D_HUMAN Transcription factor AP-2-delta OS=Homo sapiens GN=TFAP2D PE=2 SV=1 | 214 | V | 0.26664 | F | 0.244512 | 0.022128 | No Change: Both O | A breast cancer sample |
| Q01664 | TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens GN=TFAP4 PE=1 SV=2 | 218 | Q | 0.975373 | H | 0.966752 | 0.008621 | No Change: Both D | - |
| Q9H5Q4 | TFB2M_HUMAN Dimethyladenosine transferase 2 mitochondrial OS=Homo sapiens GN=TFB2M PE=1 SV=1 | 156 | P | 0.335054 | L | 0.201407 | 0.133647 | No Change: Both O | - |
| Q9H5Q4 | TFB2M_HUMAN Dimethyladenosine transferase 2 mitochondrial OS=Homo sapiens GN=TFB2M PE=1 SV=1 | 264 | H | 0.138469 | Y | 0.084543 | 0.053926 | No Change: Both O | - |
| Q14186 | TFDP1_HUMAN Transcription factor Dp-1 OS=Homo sapiens GN=TFDP1 PE=1 SV=1 | 401 | D | 0.961078 | N | 0.954499 | 0.006579 | No Change: Both D | - |
| Q14188 | TFDP2_HUMAN Transcription factor Dp-2 OS=Homo sapiens GN=TFDP2 PE=1 SV=2 | 64 | I | 0.562425 | T | 0.687974 | -0.125549 | No Change: Both D | - |
| Q14188 | TFDP2_HUMAN Transcription factor Dp-2 OS=Homo sapiens GN=TFDP2 PE=1 SV=2 | 81 | P | 0.449714 | S | 0.46812 | -0.018406 | No Change: Both O | - |
| P19532 | TFE3_HUMAN Transcription factor E3 OS=Homo sapiens GN=TFE3 PE=1 SV=4 | 96 | S | 0.987474 | C | 0.97532 | 0.012154 | No Change: Both D | - |
| P19532 | TFE3_HUMAN Transcription factor E3 OS=Homo sapiens GN=TFE3 PE=1 SV=4 | 313 | T | 0.475951 | A | 0.446906 | 0.029045 | No Change: Both O | - |
| O14948 | TFEC_HUMAN Transcription factor EC OS=Homo sapiens GN=TFEC PE=1 SV=1 | 6 | Q | 0.424386 | H | 0.416886 | 0.0075 | No Change: Both O | - |
| O14948 | TFEC_HUMAN Transcription factor EC OS=Homo sapiens GN=TFEC PE=1 SV=1 | 100 | G | 0.622047 | S | 0.693449 | -0.071402 | No Change: Both D | - |
| O14948 | TFEC_HUMAN Transcription factor EC OS=Homo sapiens GN=TFEC PE=1 SV=1 | 146 | L | 0.742872 | V | 0.694347 | 0.048525 | No Change: Both D | A colorectal cancer sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 32 | T | 0.443814 | I | 0.270872 | 0.172942 | No Change: Both O | A gastric carcinoma sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 32 | T | 0.443814 | K | 0.487584 | -0.04377 | No Change: Both O | A gastric carcinoma sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 34 | A | 0.458843 | D | 0.518557 | -0.059714 | O to D | A gastric carcinoma sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 37 | E | 0.451048 | K | 0.440952 | 0.010096 | No Change: Both O | A gastric carcinoma sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 46 | V | 0.412275 | I | 0.363943 | 0.048332 | No Change: Both O | - |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 55 | G | 0.437495 | V | 0.359994 | 0.077501 | No Change: Both O | A gastric carcinoma sample |
| P04155 | TFF1_HUMAN Trefoil factor 1 OS=Homo sapiens GN=TFF1 PE=1 SV=1 | 22 | T | 0.289928 | I | 0.164621 | 0.125307 | No Change: Both O | - |
| Q03403 | TFF2_HUMAN Trefoil factor 2 OS=Homo sapiens GN=TFF2 PE=1 SV=2 | 3 | R | 0.637921 | W | 0.530059 | 0.107862 | No Change: Both D | - |
| Q92734 | TFG_HUMAN Protein TFG OS=Homo sapiens GN=TFG PE=1 SV=2 | 149 | A | 0.958792 | S | 0.973028 | -0.014236 | No Change: Both D | A colorectal cancer sample |
| Q92734 | TFG_HUMAN Protein TFG OS=Homo sapiens GN=TFG PE=1 SV=2 | 211 | A | 0.979565 | V | 0.971552 | 0.008013 | No Change: Both D | - |
| Q92734 | TFG_HUMAN Protein TFG OS=Homo sapiens GN=TFG PE=1 SV=2 | 364 | T | 0.989542 | P | 0.992808 | -0.003266 | No Change: Both D | - |
| Q92734 | TFG_HUMAN Protein TFG OS=Homo sapiens GN=TFG PE=1 SV=2 | 43 | V | 0.149142 | F | 0.136781 | 0.012361 | No Change: Both O | - |
| Q9UBB9 | TFP11_HUMAN Tuftelin-interacting protein 11 OS=Homo sapiens GN=TFIP11 PE=1 SV=1 | 177 | N | 0.495073 | S | 0.532341 | -0.037268 | O to D | - |
| P10646 | TFPI1_HUMAN Tissue factor pathway inhibitor OS=Homo sapiens GN=TFPI PE=1 SV=1 | 292 | V | 0.649198 | M | 0.749078 | -0.09988 | No Change: Both D | - |
| P48307 | TFPI2_HUMAN Tissue factor pathway inhibitor 2 OS=Homo sapiens GN=TFPI2 PE=1 SV=1 | 102 | V | 0.339048 | A | 0.390957 | -0.051909 | No Change: Both O | - |
| P48307 | TFPI2_HUMAN Tissue factor pathway inhibitor 2 OS=Homo sapiens GN=TFPI2 PE=1 SV=1 | 231 | R | 0.984605 | Q | 0.981624 | 0.002981 | No Change: Both D | - |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 172 | M | 0.367315 | K | 0.494402 | -0.127087 | No Change: Both O | Hemochromatosis type 3 (HFE3) [MIM:604250] |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 230 | D | 0.280833 | E | 0.304604 | -0.023771 | No Change: Both O | - |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 238 | I | 0.149482 | M | 0.218265 | -0.068783 | No Change: Both O | - |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 752 | R | 0.667092 | H | 0.639323 | 0.027769 | No Change: Both D | - |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 22 | V | 0.783266 | I | 0.732598 | 0.050668 | No Change: Both D | Hemochromatosis type 3 (HFE3) [MIM:604250] |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 455 | R | 0.156774 | Q | 0.167399 | -0.010625 | No Change: Both O | - |
| Q9UP52 | TFR2_HUMAN Transferrin receptor protein 2 OS=Homo sapiens GN=TFR2 PE=1 SV=1 | 690 | Q | 0.532831 | P | 0.551986 | -0.019155 | No Change: Both D | Hemochromatosis type 3 (HFE3) [MIM:604250] |
| P02786 | TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens GN=TFRC PE=1 SV=2 | 142 | G | 0.379819 | S | 0.471125 | -0.091306 | No Change: Both O | - |
| P02786 | TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens GN=TFRC PE=1 SV=2 | 212 | L | 0.166795 | V | 0.173801 | -0.007006 | No Change: Both O | - |
| P02786 | TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens GN=TFRC PE=1 SV=2 | 420 | G | 0.414543 | S | 0.463053 | -0.04851 | No Change: Both O | - |
| P02786 | TFR1_HUMAN Transferrin receptor protein 1 OS=Homo sapiens GN=TFRC PE=1 SV=2 | 677 | R | 0.310875 | H | 0.287628 | 0.023247 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 870 | Q | 0.077451 | H | 0.055935 | 0.021516 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 135 | Q | 0.30794 | H | 0.19612 | 0.11182 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 734 | S | 0.608731 | A | 0.507889 | 0.100842 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 830 | Q | 0.305512 | E | 0.327754 | -0.022242 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1028 | M | 0.389136 | V | 0.324435 | 0.064701 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1264 | C | 0.751073 | R | 0.803998 | -0.052925 | No Change: Both D | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1312 | D | 0.144039 | G | 0.122746 | 0.021293 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1838 | D | 0.684129 | N | 0.661044 | 0.023085 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1996 | C | 0.341673 | S | 0.514537 | -0.172864 | O to D | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1999 | R | 0.334501 | W | 0.143699 | 0.190802 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2501 | W | 0.115423 | R | 0.276673 | -0.16125 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2530 | R | 0.708923 | Q | 0.717886 | -0.008963 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 515 | Q | 0.634906 | E | 0.644966 | -0.01006 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 604 | S | 0.511198 | D | 0.480633 | 0.030565 | D to O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 653 | G | 0.78551 | D | 0.789326 | -0.003816 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1043 | H | 0.216534 | Y | 0.133152 | 0.083382 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1059 | I | 0.351076 | T | 0.492673 | -0.141597 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1437 | W | 0.254365 | R | 0.474757 | -0.220392 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1463 | P | 0.564629 | H | 0.466059 | 0.09857 | D to O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1936 | A | 0.241378 | T | 0.266507 | -0.025129 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2091 | D | 0.426093 | E | 0.467973 | -0.04188 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2149 | P | 0.289426 | L | 0.21104 | 0.078386 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2170 | Q | 0.340615 | R | 0.326492 | 0.014123 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2242 | R | 0.468243 | H | 0.431963 | 0.03628 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1979 | R | 0.407707 | W | 0.21218 | 0.195527 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 777 | P | 0.404875 | L | 0.248676 | 0.156199 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 815 | G | 0.311124 | R | 0.313971 | -0.002847 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 988 | R | 0.413074 | P | 0.440287 | -0.027213 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1063 | L | 0.398755 | M | 0.445335 | -0.04658 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1222 | S | 0.607018 | L | 0.471083 | 0.135935 | D to O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1740 | T | 0.078175 | K | 0.109485 | -0.03131 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2455 | R | 0.366316 | H | 0.35834 | 0.007976 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2469 | L | 0.242555 | P | 0.352082 | -0.109527 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2526 | F | 0.634104 | L | 0.664757 | -0.030653 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2616 | N | 0.533219 | S | 0.594857 | -0.061638 | No Change: Both D | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1974 | M | 0.299265 | T | 0.304382 | -0.005117 | No Change: Both O | - |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 183 | C | 0.595236 | Y | 0.585993 | 0.009243 | No Change: Both D | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 1897 | C | 0.119463 | Y | 0.114452 | 0.005011 | No Change: Both O | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2234 | A | 0.255826 | D | 0.303803 | -0.047977 | No Change: Both O | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2336 | R | 0.086121 | Q | 0.093537 | -0.007416 | No Change: Both O | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| P01266 | THYG_HUMAN Thyroglobulin OS=Homo sapiens GN=TG PE=1 SV=5 | 2375 | G | 0.420146 | R | 0.415139 | 0.005007 | No Change: Both O | Thyroid dyshormonogenesis 3 (TDH3) [MIM:274700] |
| O95455 | TGDS_HUMAN dTDP-D-glucose 4 6-dehydratase OS=Homo sapiens GN=TGDS PE=2 SV=1 | 15 | G | 0.188486 | S | 0.21233 | -0.023844 | No Change: Both O | - |
| P01135 | TGFA_HUMAN Protransforming growth factor alpha OS=Homo sapiens GN=TGFA PE=1 SV=1 | 109 | V | 0.022927 | M | 0.026941 | -0.004014 | No Change: Both O | - |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 10 | L | 0.176799 | P | 0.319914 | -0.143115 | No Change: Both O | - |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 25 | R | 0.312843 | P | 0.368838 | -0.055995 | No Change: Both O | - |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 263 | T | 0.31502 | I | 0.190143 | 0.124877 | No Change: Both O | - |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 81 | Y | 0.752423 | H | 0.801294 | -0.048871 | No Change: Both D | Camurati-Engelmann disease (CE) [MIM:131300] |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 218 | R | 0.322923 | C | 0.210873 | 0.11205 | No Change: Both O | Camurati-Engelmann disease (CE) [MIM:131300] |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 218 | R | 0.322923 | H | 0.317524 | 0.005399 | No Change: Both O | Camurati-Engelmann disease (CE) [MIM:131300] |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 222 | H | 0.316276 | D | 0.387542 | -0.071266 | No Change: Both O | Camurati-Engelmann disease (CE) [MIM:131300] |
| P01137 | TGFB1_HUMAN Transforming growth factor beta-1 OS=Homo sapiens GN=TGFB1 PE=1 SV=2 | 225 | C | 0.441691 | R | 0.601247 | -0.159556 | O to D | Camurati-Engelmann disease (CE) [MIM:131300] |
| O43294 | TGFI1_HUMAN Transforming growth factor beta-1-induced transcript 1 protein OS=Homo sapiens GN=TGFB1I1 PE=1 SV=2 | 129 | Q | 0.973012 | H | 0.959825 | 0.013187 | No Change: Both D | - |
| P61812 | TGFB2_HUMAN Transforming growth factor beta-2 OS=Homo sapiens GN=TGFB2 PE=1 SV=1 | 91 | R | 0.766063 | H | 0.695747 | 0.070316 | No Change: Both D | - |
| P61812 | TGFB2_HUMAN Transforming growth factor beta-2 OS=Homo sapiens GN=TGFB2 PE=1 SV=1 | 207 | V | 0.2391 | L | 0.237703 | 0.001397 | No Change: Both O | - |
| P10600 | TGFB3_HUMAN Transforming growth factor beta-3 OS=Homo sapiens GN=TGFB3 PE=1 SV=1 | 60 | T | 0.536712 | M | 0.502867 | 0.033845 | No Change: Both D | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 124 | R | 0.538416 | C | 0.400833 | 0.137583 | D to O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 124 | R | 0.538416 | H | 0.505005 | 0.033411 | No Change: Both D | Avellino corneal dystrophy (ACD) [MIM:607541] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 124 | R | 0.538416 | L | 0.443681 | 0.094735 | D to O | Reis-Buecklers corneal dystrophy (CDRB) [MIM:608470] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 501 | P | 0.32906 | T | 0.28669 | 0.04237 | No Change: Both O | Lattice corneal dystrophy type 3A (CDL3A) [MIM:608471] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 527 | L | 0.301748 | R | 0.391496 | -0.089748 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 555 | R | 0.557731 | Q | 0.555488 | 0.002243 | No Change: Both D | Corneal dystrophy Thiel-Behnke type (CDTB) [MIM:602082] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 555 | R | 0.557731 | W | 0.324915 | 0.232816 | D to O | Corneal dystrophy Groenouw type 1 (CDGG1) [MIM:121900] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 124 | R | 0.538416 | S | 0.579995 | -0.041579 | No Change: Both D | Corneal dystrophy Groenouw type 1 (CDGG1) [MIM:121900] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 518 | L | 0.146307 | P | 0.265102 | -0.118795 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 544 | N | 0.298734 | S | 0.340363 | -0.041629 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 546 | A | 0.375023 | T | 0.402671 | -0.027648 | No Change: Both O | Lattice corneal dystrophy type 3A (CDL3A) [MIM:608471] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 622 | N | 0.318136 | H | 0.275852 | 0.042284 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 626 | H | 0.23198 | R | 0.300843 | -0.068863 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 200 | I | 0.437966 | F | 0.422468 | 0.015498 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 518 | L | 0.146307 | R | 0.245554 | -0.099247 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 538 | T | 0.195606 | R | 0.216494 | -0.020888 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 622 | N | 0.318136 | K | 0.336624 | -0.018488 | No Change: Both O | Lattice corneal dystrophy type 3A (CDL3A) [MIM:608471] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 623 | G | 0.292301 | D | 0.352045 | -0.059744 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 626 | H | 0.23198 | P | 0.364678 | -0.132698 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 631 | V | 0.331225 | D | 0.459334 | -0.128109 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 113 | V | 0.40102 | I | 0.351134 | 0.049886 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 123 | D | 0.524869 | H | 0.491579 | 0.03329 | D to O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 269 | L | 0.40899 | F | 0.363274 | 0.045716 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 496 | R | 0.226937 | G | 0.248769 | -0.021832 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 505 | V | 0.289099 | D | 0.436591 | -0.147492 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 509 | L | 0.352249 | R | 0.486341 | -0.134092 | No Change: Both O | Epithelial basement membrane corneal dystrophy (EBMD) [MIM:121820] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 539 | V | 0.197231 | D | 0.31744 | -0.120209 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 540 | F | 0.218313 | S | 0.394261 | -0.175948 | No Change: Both O | Lattice corneal dystrophy type 3A (CDL3A) [MIM:608471] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 546 | A | 0.375023 | D | 0.434362 | -0.059339 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 551 | P | 0.540382 | Q | 0.501351 | 0.039031 | No Change: Both D | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 569 | L | 0.172999 | R | 0.257625 | -0.084626 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 572 | H | 0.146461 | R | 0.181433 | -0.034972 | No Change: Both O | Corneal dystrophy lattice type 1 (CDL1) [MIM:122200] |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 594 | G | 0.490949 | V | 0.372559 | 0.11839 | No Change: Both O | - |
| Q15582 | BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens GN=TGFBI PE=1 SV=1 | 666 | R | 0.684401 | S | 0.715546 | -0.031145 | No Change: Both D | Epithelial basement membrane corneal dystrophy (EBMD) [MIM:121820] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 200 | T | 0.12173 | I | 0.068579 | 0.053151 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 318 | M | 0.252484 | R | 0.310923 | -0.058439 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 400 | D | 0.171086 | G | 0.164224 | 0.006862 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 487 | R | 0.328655 | P | 0.336287 | -0.007632 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 487 | R | 0.328655 | P | 0.336287 | -0.007632 | No Change: Both O | Loeys-Dietz syndrome type 2A (LDS2A) [MIM:608967] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 232 | K | 0.365252 | E | 0.393538 | -0.028286 | No Change: Both O | Loeys-Dietz syndrome type 2A (LDS2A) [MIM:608967] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 241 | S | 0.48407 | L | 0.272771 | 0.211299 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 267 | N | 0.372485 | H | 0.333085 | 0.0394 | No Change: Both O | - |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 487 | R | 0.328655 | Q | 0.342369 | -0.013714 | No Change: Both O | Familial aortic aneurysm thoracic type 5 (AAT5) [MIM:608967] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 487 | R | 0.328655 | Q | 0.342369 | -0.013714 | No Change: Both O | Loeys-Dietz syndrome type 2A (LDS2A) [MIM:608967] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 487 | R | 0.328655 | W | 0.146348 | 0.182307 | No Change: Both O | Loeys-Dietz syndrome type 2A (LDS2A) [MIM:608967] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 153 | V | 0.201556 | I | 0.180818 | 0.020738 | No Change: Both O | - |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 291 | Y | 0.188964 | C | 0.142995 | 0.045969 | No Change: Both O | - |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 139 | I | 0.017431 | V | 0.021657 | -0.004226 | No Change: Both O | - |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 41 | C | 0.075909 | Y | 0.074538 | 0.001371 | No Change: Both O | Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 45 | N | 0.149872 | S | 0.178432 | -0.02856 | No Change: Both O | Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 52 | G | 0.082278 | R | 0.082748 | -4.70E-04 | No Change: Both O | Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 83 | P | 0.259331 | L | 0.133289 | 0.126042 | No Change: Both O | Multiple self-healing squamous epithelioma (MSSE) [MIM:132800] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 266 | D | 0.330188 | Y | 0.186558 | 0.14363 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 351 | D | 0.133038 | G | 0.118327 | 0.014711 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P36897 | TGFR1_HUMAN TGF-beta receptor type-1 OS=Homo sapiens GN=TGFBR1 PE=1 SV=1 | 375 | T | 0.40347 | I | 0.27443 | 0.12904 | No Change: Both O | Loeys-Dietz syndrome type 1A (LDS1A) [MIM:609192] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 315 | T | 0.512943 | M | 0.454248 | 0.058695 | D to O | Hereditary non-polyposis colorectal cancer type 6 (HNPCC6) [MIM:614331] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 526 | E | 0.381906 | Q | 0.346796 | 0.03511 | No Change: Both O | Esophageal cancer (ESCR) [MIM:133239] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 191 | V | 0.131579 | I | 0.121435 | 0.010144 | No Change: Both O | - |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 36 | M | 0.390099 | V | 0.348059 | 0.04204 | No Change: Both O | - |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 308 | L | 0.246284 | P | 0.387792 | -0.141508 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 308 | L | 0.246284 | P | 0.387792 | -0.141508 | No Change: Both O | Loeys-Dietz syndrome type 2B (LDS2B) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 336 | Y | 0.219241 | N | 0.350225 | -0.130984 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 355 | A | 0.445979 | P | 0.515898 | -0.069919 | O to D | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 357 | G | 0.49663 | W | 0.257106 | 0.239524 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 387 | V | 0.329347 | M | 0.415324 | -0.085977 | No Change: Both O | A breast tumor |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 435 | N | 0.469072 | S | 0.515859 | -0.046787 | O to D | A breast tumor |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 447 | V | 0.205434 | A | 0.25742 | -0.051986 | No Change: Both O | A breast tumor |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 449 | S | 0.135574 | F | 0.057041 | 0.078533 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 449 | S | 0.135574 | F | 0.057041 | 0.078533 | No Change: Both O | Loeys-Dietz syndrome type 2B (LDS2B) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 452 | L | 0.124862 | M | 0.186719 | -0.061857 | No Change: Both O | A breast tumor |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 528 | R | 0.379948 | C | 0.28447 | 0.095478 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 528 | R | 0.379948 | H | 0.37192 | 0.008028 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 537 | R | 0.523623 | C | 0.437222 | 0.086401 | D to O | Loeys-Dietz syndrome type 2B (LDS2B) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 439 | V | 0.458956 | A | 0.512627 | -0.053671 | O to D | - |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 460 | R | 0.211734 | C | 0.155969 | 0.055765 | No Change: Both O | Familial aortic aneurysm thoracic type 3 (AAT3) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 460 | R | 0.211734 | H | 0.189407 | 0.022327 | No Change: Both O | Familial aortic aneurysm thoracic type 3 (AAT3) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 73 | I | 0.40211 | V | 0.435565 | -0.033455 | No Change: Both O | A colorectal cancer sample |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 61 | C | 0.485279 | R | 0.573656 | -0.088377 | O to D | A gastric adenocarcinoma sample |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 328 | H | 0.108659 | Y | 0.06931 | 0.039349 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 373 | M | 0.477243 | I | 0.404657 | 0.072586 | No Change: Both O | - |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 490 | N | 0.537978 | S | 0.597578 | -0.0596 | No Change: Both D | A gastric adenocarcinoma sample |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 377 | H | 0.462513 | R | 0.508108 | -0.045595 | O to D | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 446 | D | 0.26709 | N | 0.271085 | -0.003995 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 457 | M | 0.182864 | K | 0.22994 | -0.047076 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 509 | G | 0.15458 | V | 0.111173 | 0.043407 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 510 | I | 0.165027 | F | 0.178611 | -0.013584 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 510 | I | 0.165027 | S | 0.323765 | -0.158738 | No Change: Both O | Loeys-Dietz syndrome type 2B (LDS2B) [MIM:610380] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 514 | C | 0.147337 | R | 0.238494 | -0.091157 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| P37173 | TGFR2_HUMAN TGF-beta receptor type-2 OS=Homo sapiens GN=TGFBR2 PE=1 SV=2 | 521 | W | 0.28671 | R | 0.488708 | -0.201998 | No Change: Both O | Loeys-Dietz syndrome type 1B (LDS1B) [MIM:610168] |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 15 | S | 0.20083 | F | 0.082366 | 0.118464 | No Change: Both O | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 14 | S | 0.157204 | N | 0.101584 | 0.05562 | No Change: Both O | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 163 | W | 0.257277 | L | 0.359304 | -0.102027 | No Change: Both O | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 635 | A | 0.103977 | T | 0.125117 | -0.02114 | No Change: Both O | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 765 | G | 0.827742 | R | 0.81998 | 0.007762 | No Change: Both D | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 351 | F | 0.241138 | I | 0.251576 | -0.010438 | No Change: Both O | - |
| Q03167 | TGBR3_HUMAN Transforming growth factor beta receptor type 3 OS=Homo sapiens GN=TGFBR3 PE=1 SV=3 | 777 | P | 0.384659 | S | 0.401023 | -0.016364 | No Change: Both O | - |
| Q8WUH2 | TGFA1_HUMAN Transforming growth factor-beta receptor-associated protein 1 OS=Homo sapiens GN=TGFBRAP1 PE=1 SV=1 | 725 | H | 0.180512 | R | 0.168954 | 0.011558 | No Change: Both O | - |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 157 | S | 0.831896 | C | 0.680943 | 0.150953 | No Change: Both D | Holoprosencephaly type 4 (HPE4) [MIM:142946] |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 192 | P | 0.534127 | R | 0.519089 | 0.015038 | No Change: Both D | Holoprosencephaly type 4 (HPE4) [MIM:142946] |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 280 | T | 0.855132 | A | 0.834792 | 0.02034 | No Change: Both D | Holoprosencephaly type 4 (HPE4) [MIM:142946] |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 291 | S | 0.847752 | F | 0.735768 | 0.111984 | No Change: Both D | Holoprosencephaly type 4 (HPE4) [MIM:142946] |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 292 | P | 0.83351 | L | 0.744718 | 0.088792 | No Change: Both D | - |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 236 | Q | 0.571782 | L | 0.443129 | 0.128653 | D to O | Holoprosencephaly type 4 (HPE4) [MIM:142946] |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 289 | P | 0.866321 | S | 0.863356 | 0.002965 | No Change: Both D | - |
| Q15583 | TGIF1_HUMAN Homeobox protein TGIF1 OS=Homo sapiens GN=TGIF1 PE=1 SV=3 | 292 | P | 0.83351 | S | 0.831775 | 0.001735 | No Change: Both D | - |
| Q8IUE1 | TF2LX_HUMAN Homeobox protein TGIF2LX OS=Homo sapiens GN=TGIF2LX PE=1 SV=1 | 197 | V | 0.899014 | I | 0.874988 | 0.024026 | No Change: Both D | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 142 | R | 0.295469 | H | 0.266581 | 0.028888 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 143 | R | 0.317965 | C | 0.184037 | 0.133928 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 143 | R | 0.317965 | C | 0.184037 | 0.133928 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 143 | R | 0.317965 | H | 0.285895 | 0.03207 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 218 | G | 0.186645 | S | 0.239122 | -0.052477 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 379 | V | 0.036842 | L | 0.03358 | 0.003262 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 379 | V | 0.036842 | L | 0.03358 | 0.003262 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 396 | R | 0.179562 | L | 0.115185 | 0.064377 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 42 | S | 0.981172 | Y | 0.95448 | 0.026692 | No Change: Both D | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 323 | R | 0.29932 | Q | 0.300667 | -0.001347 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 389 | R | 0.09179 | H | 0.088363 | 0.003427 | No Change: Both O | Non-bullous congenital ichthyosiform erythroderma (NCIE) [MIM:242100] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 102 | D | 0.817701 | V | 0.767444 | 0.050257 | No Change: Both D | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 289 | N | 0.200919 | T | 0.18402 | 0.016899 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 307 | R | 0.188528 | W | 0.075621 | 0.112907 | No Change: Both O | Ichthyosis lamellar type 1 (LI1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 802 | D | 0.678909 | V | 0.508652 | 0.170257 | No Change: Both D | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 132 | D | 0.6151 | N | 0.592215 | 0.022885 | No Change: Both D | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 518 | V | 0.157533 | M | 0.190214 | -0.032681 | No Change: Both O | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 607 | R | 0.528029 | C | 0.352967 | 0.175062 | D to O | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 755 | S | 0.3698 | L | 0.21905 | 0.15075 | No Change: Both O | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 372 | V | 0.12253 | I | 0.105302 | 0.017228 | No Change: Both O | - |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 53 | C | 0.984771 | S | 0.988332 | -0.003561 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 94 | G | 0.933366 | D | 0.93666 | -0.003294 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 126 | R | 0.786475 | C | 0.710226 | 0.076249 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 126 | R | 0.786475 | H | 0.793442 | -0.006967 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 134 | Y | 0.582553 | C | 0.561425 | 0.021128 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 142 | R | 0.295469 | C | 0.162287 | 0.133182 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 142 | R | 0.295469 | P | 0.311749 | -0.01628 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 144 | G | 0.318229 | E | 0.415894 | -0.097665 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 144 | G | 0.318229 | R | 0.388352 | -0.070123 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 160 | S | 0.494818 | C | 0.25082 | 0.243998 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 205 | L | 0.429833 | Q | 0.566908 | -0.137075 | O to D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 209 | V | 0.323828 | F | 0.296592 | 0.027236 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 225 | R | 0.2964 | H | 0.299134 | -0.002734 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 225 | R | 0.2964 | P | 0.33139 | -0.03499 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 243 | I | 0.101685 | S | 0.219297 | -0.117612 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 249 | P | 0.03444 | L | 0.01547 | 0.01897 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 264 | R | 0.290438 | Q | 0.325167 | -0.034729 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 264 | R | 0.290438 | W | 0.143225 | 0.147213 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 272 | S | 0.301042 | P | 0.272931 | 0.028111 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 276 | Y | 0.247041 | N | 0.387507 | -0.140466 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 278 | G | 0.312736 | R | 0.296005 | 0.016731 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 285 | E | 0.298831 | K | 0.284535 | 0.014296 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 286 | R | 0.283497 | Q | 0.323324 | -0.039827 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 293 | F | 0.151944 | V | 0.180427 | -0.028483 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 304 | I | 0.073747 | F | 0.073837 | -9.00E-05 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 307 | R | 0.188528 | G | 0.201114 | -0.012586 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 315 | R | 0.620344 | C | 0.417756 | 0.202588 | D to O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 315 | R | 0.620344 | H | 0.610612 | 0.009732 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 315 | R | 0.620344 | L | 0.46776 | 0.152584 | D to O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 323 | R | 0.29932 | W | 0.134072 | 0.165248 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 330 | N | 0.320657 | H | 0.275774 | 0.044883 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 331 | S | 0.347151 | P | 0.30776 | 0.039391 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 342 | W | 0.291865 | R | 0.512181 | -0.220316 | O to D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 358 | S | 0.143993 | R | 0.100565 | 0.043428 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 359 | V | 0.129142 | M | 0.157605 | -0.028463 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 365 | Y | 0.128953 | D | 0.228189 | -0.099236 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 366 | L | 0.1403 | P | 0.253847 | -0.113547 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 382 | G | 0.038508 | R | 0.036724 | 0.001784 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 383 | V | 0.040571 | M | 0.049509 | -0.008938 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 389 | R | 0.09179 | P | 0.104153 | -0.012363 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 392 | G | 0.110383 | D | 0.125289 | -0.014906 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 396 | R | 0.179562 | H | 0.179175 | 3.87E-04 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 396 | R | 0.179562 | S | 0.231506 | -0.051944 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 401 | F | 0.515902 | V | 0.562883 | -0.046981 | No Change: Both D | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 430 | D | 0.272958 | V | 0.160418 | 0.11254 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 473 | G | 0.144674 | S | 0.187748 | -0.043074 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 490 | D | 0.09259 | G | 0.086789 | 0.005801 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 520 | E | 0.16444 | G | 0.133869 | 0.030571 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 544 | Y | 0.362944 | C | 0.320235 | 0.042709 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 687 | R | 0.29694 | C | 0.156818 | 0.140122 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 687 | R | 0.29694 | H | 0.299091 | -0.002151 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P22735 | TGM1_HUMAN Protein-glutamine gamma-glutamyltransferase K OS=Homo sapiens GN=TGM1 PE=1 SV=4 | 764 | R | 0.49337 | C | 0.334219 | 0.159151 | No Change: Both O | Ichthyosis congenital autosomal recessive TGM1-related (ARCI-TGM1) [MIM:242300] |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 660 | G | 0.197844 | V | 0.136003 | 0.061841 | No Change: Both O | A colorectal cancer sample |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 330 | M | 0.190249 | R | 0.227887 | -0.037638 | No Change: Both O | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 331 | I | 0.113719 | N | 0.219347 | -0.105628 | No Change: Both O | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 76 | R | 0.478792 | H | 0.428197 | 0.050595 | No Change: Both O | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 536 | P | 0.421531 | S | 0.463407 | -0.041876 | No Change: Both O | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 214 | R | 0.574942 | H | 0.560531 | 0.014411 | No Change: Both D | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 324 | Q | 0.502742 | R | 0.490836 | 0.011906 | D to O | - |
| P21980 | TGM2_HUMAN Protein-glutamine gamma-glutamyltransferase 2 OS=Homo sapiens GN=TGM2 PE=1 SV=2 | 436 | R | 0.678059 | W | 0.48374 | 0.194319 | D to O | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 13 | T | 0.254316 | K | 0.322951 | -0.068635 | No Change: Both O | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 163 | I | 0.116481 | L | 0.122012 | -0.005531 | No Change: Both O | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 249 | S | 0.504928 | N | 0.461065 | 0.043863 | D to O | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 562 | K | 0.386817 | R | 0.316324 | 0.070493 | No Change: Both O | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 654 | G | 0.50953 | R | 0.518759 | -0.009229 | No Change: Both D | - |
| Q08188 | TGM3_HUMAN Protein-glutamine gamma-glutamyltransferase E OS=Homo sapiens GN=TGM3 PE=1 SV=4 | 687 | L | 0.27476 | M | 0.355738 | -0.080978 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 100 | E | 0.557773 | D | 0.52021 | 0.037563 | No Change: Both D | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 244 | Y | 0.402213 | H | 0.530024 | -0.127811 | O to D | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 249 | S | 0.239844 | T | 0.189342 | 0.050502 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 313 | E | 0.596239 | K | 0.590821 | 0.005418 | No Change: Both D | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 372 | R | 0.170784 | C | 0.08428 | 0.086504 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 372 | R | 0.170784 | H | 0.172881 | -0.002097 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 376 | I | 0.077379 | V | 0.086828 | -0.009449 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 409 | V | 0.359656 | I | 0.340104 | 0.019552 | No Change: Both O | - |
| P49221 | TGM4_HUMAN Protein-glutamine gamma-glutamyltransferase 4 OS=Homo sapiens GN=TGM4 PE=1 SV=2 | 437 | E | 0.553318 | Q | 0.504926 | 0.048392 | No Change: Both D | - |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 67 | P | 0.291015 | S | 0.303384 | -0.012369 | No Change: Both O | - |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 352 | A | 0.226772 | G | 0.285225 | -0.058453 | No Change: Both O | - |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 109 | T | 0.220491 | M | 0.1822 | 0.038291 | No Change: Both O | - |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 113 | G | 0.124059 | C | 0.056696 | 0.067363 | No Change: Both O | Peeling skin syndrome type A (APSS) [MIM:609796] |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 504 | V | 0.692866 | M | 0.745862 | -0.052996 | No Change: Both D | - |
| O43548 | TGM5_HUMAN Protein-glutamine gamma-glutamyltransferase 5 OS=Homo sapiens GN=TGM5 PE=1 SV=4 | 521 | Q | 0.314098 | R | 0.27411 | 0.039988 | No Change: Both O | - |
| O95932 | TGM3L_HUMAN Protein-glutamine gamma-glutamyltransferase 6 OS=Homo sapiens GN=TGM6 PE=1 SV=3 | 58 | M | 0.301753 | V | 0.250482 | 0.051271 | No Change: Both O | - |
| O95932 | TGM3L_HUMAN Protein-glutamine gamma-glutamyltransferase 6 OS=Homo sapiens GN=TGM6 PE=1 SV=3 | 327 | D | 0.316428 | G | 0.282375 | 0.034053 | No Change: Both O | Spinocerebellar ataxia type 35 (SCA35) [MIM:613908] |
| O95932 | TGM3L_HUMAN Protein-glutamine gamma-glutamyltransferase 6 OS=Homo sapiens GN=TGM6 PE=1 SV=3 | 517 | L | 0.138686 | W | 0.083635 | 0.055051 | No Change: Both O | Spinocerebellar ataxia type 35 (SCA35) [MIM:613908] |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 10 | L | 0.077411 | V | 0.08133 | -0.003919 | No Change: Both O | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 86 | A | 0.998818 | G | 0.998869 | -5.10E-05 | No Change: Both D | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 91 | Q | 0.998828 | L | 0.997653 | 0.001175 | No Change: Both D | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 103 | K | 0.998653 | Q | 0.998536 | 1.17E-04 | No Change: Both D | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 105 | Q | 0.998659 | P | 0.998705 | -4.60E-05 | No Change: Both D | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 259 | R | 0.990703 | W | 0.981868 | 0.008835 | No Change: Both D | - |
| O43493 | TGON2_HUMAN Trans-Golgi network integral membrane protein 2 OS=Homo sapiens GN=TGOLN2 PE=1 SV=2 | 322 | E | 0.997358 | G | 0.996111 | 0.001247 | No Change: Both D | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 16 | I | 0.172668 | T | 0.275036 | -0.102368 | No Change: Both O | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 160 | I | 0.869251 | V | 0.869242 | 9.00E-06 | No Change: Both D | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 511 | I | 0.744301 | T | 0.834634 | -0.090333 | No Change: Both D | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 576 | V | 0.922141 | I | 0.901229 | 0.020912 | No Change: Both D | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 754 | F | 0.075202 | C | 0.066005 | 0.009197 | No Change: Both O | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 299 | P | 0.88401 | S | 0.901741 | -0.017731 | No Change: Both D | - |
| Q96RS0 | TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens GN=TGS1 PE=1 SV=3 | 595 | T | 0.901917 | A | 0.890545 | 0.011372 | No Change: Both D | - |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 112 | V | 0.561907 | M | 0.60605 | -0.044143 | No Change: Both D | - |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 233 | R | 0.25775 | H | 0.238257 | 0.019493 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 236 | L | 0.193128 | P | 0.341502 | -0.148374 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 276 | T | 0.222844 | P | 0.25604 | -0.033196 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 314 | T | 0.321915 | M | 0.286429 | 0.035486 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 337 | R | 0.105606 | H | 0.088882 | 0.016724 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 412 | Q | 0.283733 | K | 0.34137 | -0.057637 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 494 | T | 0.248473 | M | 0.23077 | 0.017703 | No Change: Both O | Segawa syndrome autosomal recessive (ARSEGS) [MIM:605407] |
| P07101 | TY3H_HUMAN Tyrosine 3-monooxygenase OS=Homo sapiens GN=TH PE=1 SV=5 | 499 | V | 0.281265 | M | 0.327146 | -0.045881 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 63 | E | 0.299108 | G | 0.263983 | 0.035125 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 699 | V | 0.796878 | I | 0.797186 | -3.08E-04 | No Change: Both D | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 1187 | T | 0.250677 | A | 0.234206 | 0.016471 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 1385 | T | 0.239714 | S | 0.308893 | -0.069179 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 1451 | P | 0.132874 | S | 0.148274 | -0.0154 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 1605 | C | 0.199056 | Y | 0.146688 | 0.052368 | No Change: Both O | - |
| Q6YHU6 | THADA_HUMAN Thyroid adenoma-associated protein OS=Homo sapiens GN=THADA PE=1 SV=1 | 1668 | C | 0.28314 | R | 0.435014 | -0.151874 | No Change: Both O | - |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 81 | F | 0.779168 | L | 0.801366 | -0.022198 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 12 | N | 0.504022 | K | 0.615424 | -0.111402 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 21 | S | 0.507934 | T | 0.428437 | 0.079497 | D to O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 29 | R | 0.428545 | P | 0.487653 | -0.059108 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 39 | A | 0.541337 | T | 0.589502 | -0.048165 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 59 | T | 0.528914 | I | 0.40097 | 0.127944 | D to O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 89 | K | 0.876067 | R | 0.850792 | 0.025275 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 136 | N | 0.297192 | K | 0.33935 | -0.042158 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 170 | C | 0.905147 | R | 0.943773 | -0.038626 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 6 | S | 0.503543 | F | 0.257054 | 0.246489 | D to O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 6 | S | 0.503543 | P | 0.481184 | 0.022359 | D to O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 8 | Y | 0.420679 | C | 0.500303 | -0.079624 | O to D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 9 | G | 0.416026 | C | 0.383016 | 0.03301 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 13 | R | 0.523213 | H | 0.507114 | 0.016099 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 16 | K | 0.587155 | E | 0.54261 | 0.044545 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 17 | D | 0.580212 | G | 0.547929 | 0.032283 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 23 | H | 0.476881 | P | 0.606371 | -0.12949 | O to D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 24 | K | 0.470232 | E | 0.436929 | 0.033303 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 26 | P | 0.476027 | L | 0.300576 | 0.175451 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 26 | P | 0.476027 | R | 0.440809 | 0.035218 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 29 | R | 0.428545 | Q | 0.411088 | 0.017457 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 30 | P | 0.438907 | R | 0.404138 | 0.034769 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 32 | L | 0.452675 | H | 0.553153 | -0.100478 | O to D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 54 | C | 0.52825 | F | 0.500609 | 0.027641 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 57 | H | 0.508231 | N | 0.579519 | -0.071288 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 72 | L | 0.675075 | R | 0.751351 | -0.076276 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 75 | N | 0.696096 | I | 0.588057 | 0.108039 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 80 | I | 0.740162 | V | 0.763946 | -0.023784 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 83 | C | 0.788497 | R | 0.813552 | -0.025055 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 132 | F | 0.283176 | S | 0.474464 | -0.191288 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 136 | N | 0.297192 | S | 0.341644 | -0.044452 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 137 | Y | 0.325888 | C | 0.38239 | -0.056502 | No Change: Both O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 143 | M | 0.528642 | V | 0.490711 | 0.037931 | D to O | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 149 | I | 0.660779 | T | 0.759295 | -0.098516 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 150 | H | 0.679845 | P | 0.7084 | -0.028555 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 166 | A | 0.938575 | T | 0.956301 | -0.017726 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 169 | R | 0.919771 | Q | 0.923829 | -0.004058 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 174 | E | 0.861574 | G | 0.818951 | 0.042623 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 180 | L | 0.734582 | S | 0.809273 | -0.074691 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 187 | Q | 0.586067 | K | 0.620036 | -0.033969 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9NVV9 | THAP1_HUMAN THAP domain-containing protein 1 OS=Homo sapiens GN=THAP1 PE=1 SV=1 | 192 | D | 0.546574 | N | 0.526347 | 0.020227 | No Change: Both D | Dystonia type 6 (DYT6) [MIM:602629] |
| Q9H0W7 | THAP2_HUMAN THAP domain-containing protein 2 OS=Homo sapiens GN=THAP2 PE=1 SV=1 | 170 | T | 0.442013 | M | 0.431503 | 0.01051 | No Change: Both O | - |
| Q8WY91 | THAP4_HUMAN THAP domain-containing protein 4 OS=Homo sapiens GN=THAP4 PE=1 SV=2 | 121 | S | 0.97409 | G | 0.967513 | 0.006577 | No Change: Both D | - |
| Q9BT49 | THAP7_HUMAN THAP domain-containing protein 7 OS=Homo sapiens GN=THAP7 PE=1 SV=2 | 115 | A | 0.92221 | P | 0.9517 | -0.02949 | No Change: Both D | - |
| Q8NA92 | THAP8_HUMAN THAP domain-containing protein 8 OS=Homo sapiens GN=THAP8 PE=2 SV=1 | 112 | K | 0.986942 | R | 0.987 | -5.80E-05 | No Change: Both D | - |
| Q8NA92 | THAP8_HUMAN THAP domain-containing protein 8 OS=Homo sapiens GN=THAP8 PE=2 SV=1 | 70 | R | 0.170238 | H | 0.139639 | 0.030599 | No Change: Both O | - |
| Q8NA92 | THAP8_HUMAN THAP domain-containing protein 8 OS=Homo sapiens GN=THAP8 PE=2 SV=1 | 157 | P | 0.943349 | S | 0.933756 | 0.009593 | No Change: Both D | - |
| Q8NA92 | THAP8_HUMAN THAP domain-containing protein 8 OS=Homo sapiens GN=THAP8 PE=2 SV=1 | 185 | R | 0.942221 | Q | 0.946138 | -0.003917 | No Change: Both D | - |
| Q8NA92 | THAP8_HUMAN THAP domain-containing protein 8 OS=Homo sapiens GN=THAP8 PE=2 SV=1 | 189 | R | 0.948671 | W | 0.859531 | 0.08914 | No Change: Both D | - |
| Q9H5L6 | THAP9_HUMAN THAP domain-containing protein 9 OS=Homo sapiens GN=THAP9 PE=2 SV=2 | 284 | M | 0.361953 | I | 0.27096 | 0.090993 | No Change: Both O | - |
| Q9H5L6 | THAP9_HUMAN THAP domain-containing protein 9 OS=Homo sapiens GN=THAP9 PE=2 SV=2 | 299 | L | 0.495396 | F | 0.471793 | 0.023603 | No Change: Both O | - |
| Q9H5L6 | THAP9_HUMAN THAP domain-containing protein 9 OS=Homo sapiens GN=THAP9 PE=2 SV=2 | 812 | N | 0.101122 | D | 0.109498 | -0.008376 | No Change: Both O | - |
| Q9H5L6 | THAP9_HUMAN THAP domain-containing protein 9 OS=Homo sapiens GN=THAP9 PE=2 SV=2 | 833 | V | 0.046713 | I | 0.043298 | 0.003415 | No Change: Both O | - |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 43 | A | 0.196719 | T | 0.210265 | -0.013546 | No Change: Both O | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 79 | G | 0.357644 | A | 0.282669 | 0.074975 | No Change: Both O | - |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 473 | A | 0.654213 | V | 0.6183 | 0.035913 | No Change: Both D | - |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 486 | D | 0.897239 | Y | 0.820126 | 0.077113 | No Change: Both D | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 486 | D | 0.897239 | Y | 0.820126 | 0.077113 | No Change: Both D | Thrombophilia due to thrombomodulin defect (THR-THBD) [MIM:188040] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 495 | P | 0.951299 | S | 0.949907 | 0.001392 | No Change: Both D | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 501 | P | 0.886611 | L | 0.82088 | 0.065731 | No Change: Both D | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 162 | A | 0.261605 | P | 0.343617 | -0.082012 | No Change: Both O | - |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 53 | D | 0.197671 | G | 0.193871 | 0.0038 | No Change: Both O | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 81 | V | 0.329954 | L | 0.356902 | -0.026948 | No Change: Both O | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 34 | D | 0.175564 | E | 0.209393 | -0.033829 | No Change: Both O | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07204 | TRBM_HUMAN Thrombomodulin OS=Homo sapiens GN=THBD PE=1 SV=2 | 236 | A | 0.419625 | G | 0.455227 | -0.035602 | No Change: Both O | Hemolytic uremic syndrome atypical type 6 (AHUS6) [MIM:612926] |
| P07996 | TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens GN=THBS1 PE=1 SV=2 | 523 | T | 0.592163 | A | 0.524081 | 0.068082 | No Change: Both D | - |
| P07996 | TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens GN=THBS1 PE=1 SV=2 | 700 | N | 0.258339 | S | 0.259671 | -0.001332 | No Change: Both O | - |
| P07996 | TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens GN=THBS1 PE=1 SV=2 | 24 | S | 0.60512 | A | 0.497303 | 0.107817 | D to O | - |
| P35442 | TSP2_HUMAN Thrombospondin-2 OS=Homo sapiens GN=THBS2 PE=1 SV=2 | 133 | T | 0.126444 | S | 0.176331 | -0.049887 | No Change: Both O | - |
| P35442 | TSP2_HUMAN Thrombospondin-2 OS=Homo sapiens GN=THBS2 PE=1 SV=2 | 375 | L | 0.598331 | F | 0.629655 | -0.031324 | No Change: Both D | - |
| P49746 | TSP3_HUMAN Thrombospondin-3 OS=Homo sapiens GN=THBS3 PE=1 SV=1 | 955 | R | 0.808266 | G | 0.830133 | -0.021867 | No Change: Both D | A breast cancer sample |
| P49746 | TSP3_HUMAN Thrombospondin-3 OS=Homo sapiens GN=THBS3 PE=1 SV=1 | 279 | S | 0.575448 | G | 0.528179 | 0.047269 | No Change: Both D | - |
| P35443 | TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | 55 | L | 0.243767 | Q | 0.331761 | -0.087994 | No Change: Both O | - |
| P35443 | TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | 387 | A | 0.251655 | P | 0.370021 | -0.118366 | No Change: Both O | - |
| P35443 | TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | 420 | A | 0.664946 | V | 0.625265 | 0.039681 | No Change: Both D | - |
| P35443 | TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | 646 | V | 0.940897 | I | 0.942575 | -0.001678 | No Change: Both D | - |
| P35443 | TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | 737 | V | 0.211638 | I | 0.183082 | 0.028556 | No Change: Both O | - |
| Q9P2T0 | THEG_HUMAN Testicular haploid expressed gene protein OS=Homo sapiens GN=THEG PE=1 SV=1 | 202 | R | 0.402872 | I | 0.23312 | 0.169752 | No Change: Both O | - |
| Q9P2T0 | THEG_HUMAN Testicular haploid expressed gene protein OS=Homo sapiens GN=THEG PE=1 SV=1 | 267 | R | 0.777096 | Q | 0.796087 | -0.018991 | No Change: Both D | - |
| Q9P2T0 | THEG_HUMAN Testicular haploid expressed gene protein OS=Homo sapiens GN=THEG PE=1 SV=1 | 297 | H | 0.820867 | Y | 0.695113 | 0.125754 | No Change: Both D | - |
| Q9P2T0 | THEG_HUMAN Testicular haploid expressed gene protein OS=Homo sapiens GN=THEG PE=1 SV=1 | 353 | D | 0.802877 | N | 0.798597 | 0.00428 | No Change: Both D | - |
| Q5T1C6 | THEM4_HUMAN Thioesterase superfamily member 4 OS=Homo sapiens GN=THEM4 PE=1 SV=1 | 17 | L | 0.831777 | R | 0.902019 | -0.070242 | No Change: Both D | - |
| Q5T1C6 | THEM4_HUMAN Thioesterase superfamily member 4 OS=Homo sapiens GN=THEM4 PE=1 SV=1 | 38 | S | 0.779125 | C | 0.652575 | 0.12655 | No Change: Both D | - |
| Q8N1Q8 | THEM5_HUMAN Thioesterase superfamily member 5 OS=Homo sapiens GN=THEM5 PE=2 SV=2 | 55 | Y | 0.437243 | S | 0.651307 | -0.214064 | O to D | - |
| Q8N1Q8 | THEM5_HUMAN Thioesterase superfamily member 5 OS=Homo sapiens GN=THEM5 PE=2 SV=2 | 197 | D | 0.117859 | G | 0.097986 | 0.019873 | No Change: Both O | - |
| Q8N1Q8 | THEM5_HUMAN Thioesterase superfamily member 5 OS=Homo sapiens GN=THEM5 PE=2 SV=2 | 206 | L | 0.336691 | V | 0.348828 | -0.012137 | No Change: Both O | - |
| Q8N1K5 | THMS1_HUMAN Protein THEMIS OS=Homo sapiens GN=THEMIS PE=1 SV=3 | 284 | V | 0.258872 | G | 0.379932 | -0.12106 | No Change: Both O | - |
| Q8N1K5 | THMS1_HUMAN Protein THEMIS OS=Homo sapiens GN=THEMIS PE=1 SV=3 | 630 | I | 0.681868 | V | 0.716856 | -0.034988 | No Change: Both D | - |
| Q5TEJ8 | THMS2_HUMAN Protein THEMIS2 OS=Homo sapiens GN=THEMIS2 PE=2 SV=1 | 431 | V | 0.657406 | L | 0.674038 | -0.016632 | No Change: Both D | - |
| Q5TEJ8 | THMS2_HUMAN Protein THEMIS2 OS=Homo sapiens GN=THEMIS2 PE=2 SV=1 | 511 | K | 0.318189 | E | 0.31512 | 0.003069 | No Change: Both O | - |
| Q9NWX6 | THG1_HUMAN Probable tRNA(His) guanylyltransferase OS=Homo sapiens GN=THG1L PE=1 SV=2 | 232 | L | 0.303294 | P | 0.460007 | -0.156713 | No Change: Both O | - |
| Q8IYQ7 | THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens GN=THNSL1 PE=1 SV=2 | 154 | L | 0.045524 | P | 0.087944 | -0.04242 | No Change: Both O | - |
| Q8IYQ7 | THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens GN=THNSL1 PE=1 SV=2 | 248 | A | 0.364067 | E | 0.475919 | -0.111852 | No Change: Both O | - |
| Q8IYQ7 | THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens GN=THNSL1 PE=1 SV=2 | 399 | Q | 0.344786 | R | 0.346253 | -0.001467 | No Change: Both O | - |
| Q8IYQ7 | THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens GN=THNSL1 PE=1 SV=2 | 239 | P | 0.302618 | R | 0.287406 | 0.015212 | No Change: Both O | - |
| Q86YJ6 | THNS2_HUMAN Threonine synthase-like 2 OS=Homo sapiens GN=THNSL2 PE=2 SV=3 | 41 | G | 0.229367 | E | 0.284719 | -0.055352 | No Change: Both O | - |
| Q86YJ6 | THNS2_HUMAN Threonine synthase-like 2 OS=Homo sapiens GN=THNSL2 PE=2 SV=3 | 108 | V | 0.059578 | I | 0.049081 | 0.010497 | No Change: Both O | - |
| Q86YJ6 | THNS2_HUMAN Threonine synthase-like 2 OS=Homo sapiens GN=THNSL2 PE=2 SV=3 | 204 | T | 0.187509 | N | 0.215818 | -0.028309 | No Change: Both O | - |
| Q86YJ6 | THNS2_HUMAN Threonine synthase-like 2 OS=Homo sapiens GN=THNSL2 PE=2 SV=3 | 324 | R | 0.128877 | G | 0.121409 | 0.007468 | No Change: Both O | - |
| Q13769 | THOC5_HUMAN THO complex subunit 5 homolog OS=Homo sapiens GN=THOC5 PE=1 SV=2 | 579 | V | 0.112723 | I | 0.105601 | 0.007122 | No Change: Both O | - |
| Q13769 | THOC5_HUMAN THO complex subunit 5 homolog OS=Homo sapiens GN=THOC5 PE=1 SV=2 | 380 | T | 0.245754 | K | 0.314906 | -0.069152 | No Change: Both O | A breast cancer sample |
| Q13769 | THOC5_HUMAN THO complex subunit 5 homolog OS=Homo sapiens GN=THOC5 PE=1 SV=2 | 499 | G | 0.237177 | S | 0.301528 | -0.064351 | No Change: Both O | A breast cancer sample |
| Q13769 | THOC5_HUMAN THO complex subunit 5 homolog OS=Homo sapiens GN=THOC5 PE=1 SV=2 | 475 | T | 0.557208 | S | 0.617736 | -0.060528 | No Change: Both D | - |
| Q13769 | THOC5_HUMAN THO complex subunit 5 homolog OS=Homo sapiens GN=THOC5 PE=1 SV=2 | 525 | V | 0.117283 | I | 0.093788 | 0.023495 | No Change: Both O | - |
| P40225 | TPO_HUMAN Thrombopoietin OS=Homo sapiens GN=THPO PE=1 SV=1 | 14 | L | 0.26484 | P | 0.413622 | -0.148782 | No Change: Both O | - |
| P40225 | TPO_HUMAN Thrombopoietin OS=Homo sapiens GN=THPO PE=1 SV=1 | 116 | G | 0.551532 | E | 0.557551 | -0.006019 | No Change: Both D | - |
| Q9Y2W1 | TR150_HUMAN Thyroid hormone receptor-associated protein 3 OS=Homo sapiens GN=THRAP3 PE=1 SV=2 | 201 | A | 0.988359 | V | 0.980992 | 0.007367 | No Change: Both D | - |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 234 | A | 0.468499 | T | 0.496147 | -0.027648 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 243 | R | 0.437272 | W | 0.284803 | 0.152469 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 316 | R | 0.195285 | H | 0.169653 | 0.025632 | No Change: Both O | Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 317 | A | 0.224697 | T | 0.245674 | -0.020977 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 320 | R | 0.376561 | C | 0.226563 | 0.149998 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 320 | R | 0.376561 | H | 0.360699 | 0.015862 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 332 | G | 0.419479 | R | 0.412276 | 0.007203 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 338 | R | 0.385268 | W | 0.20285 | 0.182418 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 340 | Q | 0.403777 | H | 0.388914 | 0.014863 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 342 | K | 0.435193 | I | 0.241012 | 0.194181 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 345 | G | 0.358906 | V | 0.24287 | 0.116036 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 345 | G | 0.358906 | S | 0.399099 | -0.040193 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 345 | G | 0.358906 | R | 0.336462 | 0.022444 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 347 | G | 0.244386 | E | 0.26917 | -0.024784 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 348 | V | 0.200262 | E | 0.352129 | -0.151867 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 426 | T | 0.12179 | I | 0.069558 | 0.052232 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 438 | R | 0.165189 | H | 0.178942 | -0.013753 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 442 | M | 0.212968 | V | 0.177422 | 0.035546 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 443 | K | 0.23064 | E | 0.253251 | -0.022611 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 446 | C | 0.253935 | R | 0.428206 | -0.174271 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 453 | P | 0.156179 | H | 0.116295 | 0.039884 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 453 | P | 0.156179 | S | 0.150335 | 0.005844 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 453 | P | 0.156179 | T | 0.116012 | 0.040167 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 337 | T | 0.354957 | I | 0.22692 | 0.128037 | No Change: Both O | - |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 216 | D | 0.742314 | G | 0.748199 | -0.005885 | No Change: Both D | - |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 429 | R | 0.137182 | Q | 0.145086 | -0.007904 | No Change: Both O | Selective pituitary thyroid hormone resistance (PRTH) [MIM:145650] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 268 | A | 0.255383 | G | 0.314384 | -0.059001 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 331 | N | 0.449175 | D | 0.469888 | -0.020713 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 335 | A | 0.334131 | P | 0.416357 | -0.082226 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 341 | L | 0.41281 | P | 0.521531 | -0.108721 | O to D | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 346 | L | 0.303956 | F | 0.269801 | 0.034155 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 431 | I | 0.134648 | M | 0.213341 | -0.078693 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 447 | P | 0.251127 | T | 0.200533 | 0.050594 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 453 | P | 0.156179 | L | 0.074842 | 0.081337 | No Change: Both O | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| P10828 | THB_HUMAN Thyroid hormone receptor beta OS=Homo sapiens GN=THRB PE=1 SV=2 | 459 | F | 0.654206 | C | 0.617164 | 0.037042 | No Change: Both D | Generalized thyroid hormone resistance (GTHR) [MIM:188570] |
| Q9NS62 | THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 OS=Homo sapiens GN=THSD1 PE=1 SV=1 | 125 | V | 0.111923 | G | 0.176142 | -0.064219 | No Change: Both O | - |
| Q9NS62 | THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 OS=Homo sapiens GN=THSD1 PE=1 SV=1 | 224 | R | 0.247937 | G | 0.274097 | -0.02616 | No Change: Both O | - |
| Q9NS62 | THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 OS=Homo sapiens GN=THSD1 PE=1 SV=1 | 768 | K | 0.974409 | R | 0.976398 | -0.001989 | No Change: Both D | - |
| Q9NS62 | THSD1_HUMAN Thrombospondin type-1 domain-containing protein 1 OS=Homo sapiens GN=THSD1 PE=1 SV=1 | 491 | D | 0.949795 | H | 0.926751 | 0.023044 | No Change: Both D | - |
| Q9UPZ6 | THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens GN=THSD7A PE=1 SV=4 | 238 | F | 0.602546 | L | 0.643551 | -0.041005 | No Change: Both D | - |
| Q9UPZ6 | THS7A_HUMAN Thrombospondin type-1 domain-containing protein 7A OS=Homo sapiens GN=THSD7A PE=1 SV=4 | 771 | D | 0.767603 | E | 0.785532 | -0.017929 | No Change: Both D | - |
| Q9BU02 | THTPA_HUMAN Thiamine-triphosphatase OS=Homo sapiens GN=THTPA PE=1 SV=3 | 176 | H | 0.346178 | R | 0.365907 | -0.019729 | No Change: Both O | - |
| Q9NXG2 | THUM1_HUMAN THUMP domain-containing protein 1 OS=Homo sapiens GN=THUMPD1 PE=1 SV=2 | 311 | E | 0.982841 | D | 0.977521 | 0.00532 | No Change: Both D | - |
| Q9BV44 | THUM3_HUMAN THUMP domain-containing protein 3 OS=Homo sapiens GN=THUMPD3 PE=1 SV=1 | 459 | R | 0.174559 | Q | 0.177287 | -0.002728 | No Change: Both O | - |
| Q13009 | TIAM1_HUMAN T-lymphoma invasion and metastasis-inducing protein 1 OS=Homo sapiens GN=TIAM1 PE=1 SV=2 | 678 | R | 0.819333 | C | 0.698762 | 0.120571 | No Change: Both D | A colorectal cancer sample |
| Q13009 | TIAM1_HUMAN T-lymphoma invasion and metastasis-inducing protein 1 OS=Homo sapiens GN=TIAM1 PE=1 SV=2 | 1339 | A | 0.255246 | V | 0.193812 | 0.061434 | No Change: Both O | A colorectal cancer sample |
| Q13009 | TIAM1_HUMAN T-lymphoma invasion and metastasis-inducing protein 1 OS=Homo sapiens GN=TIAM1 PE=1 SV=2 | 247 | G | 0.55236 | R | 0.54612 | 0.00624 | No Change: Both D | - |
| Q13009 | TIAM1_HUMAN T-lymphoma invasion and metastasis-inducing protein 1 OS=Homo sapiens GN=TIAM1 PE=1 SV=2 | 247 | G | 0.55236 | V | 0.459281 | 0.093079 | D to O | - |
| Q13009 | TIAM1_HUMAN T-lymphoma invasion and metastasis-inducing protein 1 OS=Homo sapiens GN=TIAM1 PE=1 SV=2 | 844 | Q | 0.300642 | H | 0.297891 | 0.002751 | No Change: Both O | - |
| Q8IVF5 | TIAM2_HUMAN T-lymphoma invasion and metastasis-inducing protein 2 OS=Homo sapiens GN=TIAM2 PE=2 SV=4 | 1101 | R | 0.525899 | C | 0.404005 | 0.121894 | D to O | - |
| Q8IVF5 | TIAM2_HUMAN T-lymphoma invasion and metastasis-inducing protein 2 OS=Homo sapiens GN=TIAM2 PE=2 SV=4 | 1572 | D | 0.801911 | E | 0.796096 | 0.005815 | No Change: Both D | - |
| Q8IVF5 | TIAM2_HUMAN T-lymphoma invasion and metastasis-inducing protein 2 OS=Homo sapiens GN=TIAM2 PE=2 SV=4 | 332 | R | 0.512969 | H | 0.513595 | -6.26E-04 | No Change: Both D | - |
| Q8IVF5 | TIAM2_HUMAN T-lymphoma invasion and metastasis-inducing protein 2 OS=Homo sapiens GN=TIAM2 PE=2 SV=4 | 913 | R | 0.394584 | H | 0.400718 | -0.006134 | No Change: Both O | - |
| Q8IVF5 | TIAM2_HUMAN T-lymphoma invasion and metastasis-inducing protein 2 OS=Homo sapiens GN=TIAM2 PE=2 SV=4 | 1089 | S | 0.820248 | P | 0.826678 | -0.00643 | No Change: Both D | - |
| Q8IUC6 | TCAM1_HUMAN TIR domain-containing adapter molecule 1 OS=Homo sapiens GN=TICAM1 PE=1 SV=1 | 46 | M | 0.212947 | I | 0.150706 | 0.062241 | No Change: Both O | A breast cancer sample |
| Q8IUC6 | TCAM1_HUMAN TIR domain-containing adapter molecule 1 OS=Homo sapiens GN=TICAM1 PE=1 SV=1 | 75 | R | 0.21253 | C | 0.110046 | 0.102484 | No Change: Both O | - |
| Q8IUC6 | TCAM1_HUMAN TIR domain-containing adapter molecule 1 OS=Homo sapiens GN=TICAM1 PE=1 SV=1 | 275 | L | 0.993333 | V | 0.99311 | 2.23E-04 | No Change: Both D | - |
| Q8IUC6 | TCAM1_HUMAN TIR domain-containing adapter molecule 1 OS=Homo sapiens GN=TICAM1 PE=1 SV=1 | 666 | A | 0.938223 | T | 0.939025 | -8.02E-04 | No Change: Both D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 628 | R | 0.805285 | C | 0.699595 | 0.10569 | No Change: Both D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 287 | R | 0.339817 | C | 0.210648 | 0.129169 | No Change: Both O | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 402 | R | 0.545225 | W | 0.354553 | 0.190672 | D to O | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 747 | V | 0.495939 | A | 0.540233 | -0.044294 | O to D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 923 | S | 0.863701 | C | 0.758741 | 0.10496 | No Change: Both D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 1523 | R | 0.941314 | C | 0.931846 | 0.009468 | No Change: Both D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 1718 | S | 0.804033 | T | 0.740327 | 0.063706 | No Change: Both D | - |
| Q7Z2Z1 | TICRR_HUMAN Treslin OS=Homo sapiens GN=TICRR PE=1 SV=2 | 1885 | R | 0.812782 | C | 0.711406 | 0.101376 | No Change: Both D | - |
| P35590 | TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens GN=TIE1 PE=1 SV=1 | 448 | V | 0.50037 | M | 0.526771 | -0.026401 | No Change: Both D | - |
| P35590 | TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens GN=TIE1 PE=1 SV=1 | 1104 | A | 0.188863 | V | 0.129494 | 0.059369 | No Change: Both O | - |
| P35590 | TIE1_HUMAN Tyrosine-protein kinase receptor Tie-1 OS=Homo sapiens GN=TIE1 PE=1 SV=1 | 1109 | R | 0.204252 | H | 0.185682 | 0.01857 | No Change: Both O | - |
| Q96CG3 | TIFA_HUMAN TRAF-interacting protein with FHA domain-containing protein A OS=Homo sapiens GN=TIFA PE=1 SV=1 | 19 | T | 0.184104 | M | 0.159445 | 0.024659 | No Change: Both O | - |
| Q4W5G0 | TIGD2_HUMAN Tigger transposable element-derived protein 2 OS=Homo sapiens GN=TIGD2 PE=2 SV=1 | 475 | H | 0.778034 | R | 0.796307 | -0.018273 | No Change: Both D | - |
| Q8IY51 | TIGD4_HUMAN Tigger transposable element-derived protein 4 OS=Homo sapiens GN=TIGD4 PE=1 SV=2 | 439 | I | 0.854439 | V | 0.854265 | 1.74E-04 | No Change: Both D | - |
| Q8IY51 | TIGD4_HUMAN Tigger transposable element-derived protein 4 OS=Homo sapiens GN=TIGD4 PE=1 SV=2 | 432 | A | 0.734466 | T | 0.748324 | -0.013858 | No Change: Both D | - |
| Q8IY51 | TIGD4_HUMAN Tigger transposable element-derived protein 4 OS=Homo sapiens GN=TIGD4 PE=1 SV=2 | 489 | Q | 0.699391 | R | 0.695047 | 0.004344 | No Change: Both D | - |
| Q53EQ6 | TIGD5_HUMAN Tigger transposable element-derived protein 5 OS=Homo sapiens GN=TIGD5 PE=2 SV=2 | 519 | M | 0.95316 | I | 0.931271 | 0.021889 | No Change: Both D | - |
| Q17RP2 | TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens GN=TIGD6 PE=2 SV=2 | 59 | R | 0.638406 | W | 0.410761 | 0.227645 | D to O | - |
| Q17RP2 | TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens GN=TIGD6 PE=2 SV=2 | 327 | Q | 0.179444 | R | 0.155917 | 0.023527 | No Change: Both O | - |
| Q495A1 | TIGIT_HUMAN T cell immunoreceptor with Ig and ITIM domains OS=Homo sapiens GN=TIGIT PE=1 SV=1 | 33 | I | 0.606263 | V | 0.614294 | -0.008031 | No Change: Both D | - |
| Q96H15 | TIMD4_HUMAN T-cell immunoglobulin and mucin domain-containing protein 4 OS=Homo sapiens GN=TIMD4 PE=1 SV=2 | 240 | V | 0.924463 | A | 0.937146 | -0.012683 | No Change: Both D | - |
| Q96H15 | TIMD4_HUMAN T-cell immunoglobulin and mucin domain-containing protein 4 OS=Homo sapiens GN=TIMD4 PE=1 SV=2 | 365 | V | 0.516262 | M | 0.552325 | -0.036063 | No Change: Both D | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 455 | I | 0.481456 | L | 0.516989 | -0.035533 | O to D | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 831 | R | 0.455804 | Q | 0.447769 | 0.008035 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 1018 | P | 0.201477 | L | 0.134071 | 0.067406 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 429 | A | 0.480199 | D | 0.541224 | -0.061025 | O to D | A breast cancer sample |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 1008 | Q | 0.60199 | E | 0.613224 | -0.011234 | No Change: Both D | A breast cancer sample |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 129 | A | 0.354824 | S | 0.457597 | -0.102773 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 471 | N | 0.159951 | S | 0.191159 | -0.031208 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 870 | M | 0.210941 | V | 0.180315 | 0.030626 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 922 | R | 0.38109 | H | 0.352744 | 0.028346 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 924 | R | 0.361235 | W | 0.173373 | 0.187862 | No Change: Both O | - |
| Q9UNS1 | TIM_HUMAN Protein timeless homolog OS=Homo sapiens GN=TIMELESS PE=1 SV=2 | 1017 | I | 0.258427 | T | 0.341849 | -0.083422 | No Change: Both O | - |
| Q99595 | TI17A_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-A OS=Homo sapiens GN=TIMM17A PE=1 SV=1 | 113 | V | 0.348385 | I | 0.309716 | 0.038669 | No Change: Both O | - |
| Q9BVV7 | TIM21_HUMAN Mitochondrial import inner membrane translocase subunit Tim21 OS=Homo sapiens GN=TIMM21 PE=1 SV=1 | 79 | G | 0.837157 | S | 0.865758 | -0.028601 | No Change: Both D | - |
| O60220 | TIM8A_HUMAN Mitochondrial import inner membrane translocase subunit Tim8 A OS=Homo sapiens GN=TIMM8A PE=1 SV=1 | 66 | C | 0.180327 | W | 0.100899 | 0.079428 | No Change: Both O | Mohr-Tranebjaerg syndrome (MTS) [MIM:304700] |
| Q9NPL8 | TIDC1_HUMAN Translocase of inner mitochondrial membrane domain-containing protein 1 OS=Homo sapiens GN=TIMMDC1 PE=1 SV=2 | 76 | N | 0.232328 | D | 0.259686 | -0.027358 | No Change: Both O | - |
| Q9NPL8 | TIDC1_HUMAN Translocase of inner mitochondrial membrane domain-containing protein 1 OS=Homo sapiens GN=TIMMDC1 PE=1 SV=2 | 217 | V | 0.654759 | I | 0.629323 | 0.025436 | No Change: Both D | - |
| P35625 | TIMP3_HUMAN Metalloproteinase inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 SV=2 | 179 | S | 0.328162 | C | 0.14558 | 0.182582 | No Change: Both O | Sorsby fundus dystrophy (SFD) [MIM:136900] |
| P35625 | TIMP3_HUMAN Metalloproteinase inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 SV=2 | 191 | Y | 0.122845 | C | 0.10814 | 0.014705 | No Change: Both O | Sorsby fundus dystrophy (SFD) [MIM:136900] |
| P35625 | TIMP3_HUMAN Metalloproteinase inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 SV=2 | 204 | S | 0.460397 | C | 0.259455 | 0.200942 | No Change: Both O | Sorsby fundus dystrophy (SFD) [MIM:136900] |
| P35625 | TIMP3_HUMAN Metalloproteinase inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 SV=2 | 189 | G | 0.159432 | C | 0.081503 | 0.077929 | No Change: Both O | Sorsby fundus dystrophy (SFD) [MIM:136900] |
| P35625 | TIMP3_HUMAN Metalloproteinase inhibitor 3 OS=Homo sapiens GN=TIMP3 PE=1 SV=2 | 190 | G | 0.135925 | C | 0.067318 | 0.068607 | No Change: Both O | Sorsby fundus dystrophy (SFD) [MIM:136900] |
| Q9UJW2 | TINAG_HUMAN Tubulointerstitial nephritis antigen OS=Homo sapiens GN=TINAG PE=2 SV=3 | 3 | T | 0.336762 | A | 0.294554 | 0.042208 | No Change: Both O | - |
| Q9UJW2 | TINAG_HUMAN Tubulointerstitial nephritis antigen OS=Homo sapiens GN=TINAG PE=2 SV=3 | 22 | Q | 0.285146 | R | 0.2656 | 0.019546 | No Change: Both O | - |
| Q9UJW2 | TINAG_HUMAN Tubulointerstitial nephritis antigen OS=Homo sapiens GN=TINAG PE=2 SV=3 | 158 | S | 0.207197 | P | 0.177374 | 0.029823 | No Change: Both O | - |
| Q9UJW2 | TINAG_HUMAN Tubulointerstitial nephritis antigen OS=Homo sapiens GN=TINAG PE=2 SV=3 | 413 | V | 0.222243 | I | 0.200743 | 0.0215 | No Change: Both O | - |
| Q9UJW2 | TINAG_HUMAN Tubulointerstitial nephritis antigen OS=Homo sapiens GN=TINAG PE=2 SV=3 | 433 | I | 0.141701 | L | 0.16106 | -0.019359 | No Change: Both O | - |
| Q9GZM7 | TINAL_HUMAN Tubulointerstitial nephritis antigen-like OS=Homo sapiens GN=TINAGL1 PE=1 SV=1 | 69 | A | 0.099089 | S | 0.131207 | -0.032118 | No Change: Both O | - |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 280 | K | 0.622798 | E | 0.652897 | -0.030099 | No Change: Both D | Dyskeratosis congenita autosomal dominant type 3 (DKCA3) [MIM:613990] |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 282 | R | 0.58186 | H | 0.552927 | 0.028933 | No Change: Both D | Dyskeratosis congenita autosomal dominant type 3 (DKCA3) [MIM:613990] |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 282 | R | 0.58186 | H | 0.552927 | 0.028933 | No Change: Both D | Retinopathy exudative with bone marrow failure (ERBMF) [MIM:268130] |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 282 | R | 0.58186 | S | 0.610075 | -0.028215 | No Change: Both D | Dyskeratosis congenita autosomal dominant type 3 (DKCA3) [MIM:613990] |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 43 | A | 0.169964 | T | 0.176016 | -0.006052 | No Change: Both O | - |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 237 | G | 0.955669 | D | 0.954018 | 0.001651 | No Change: Both D | - |
| Q9BSI4 | TINF2_HUMAN TERF1-interacting nuclear factor 2 OS=Homo sapiens GN=TINF2 PE=1 SV=1 | 241 | P | 0.951771 | S | 0.944927 | 0.006844 | No Change: Both D | - |
| Q7Z3E1 | PARPT_HUMAN TCDD-inducible poly [ADP-ribose] polymerase OS=Homo sapiens GN=TIPARP PE=2 SV=1 | 406 | R | 0.102795 | S | 0.122539 | -0.019744 | No Change: Both O | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 53 | R | 0.885481 | P | 0.896926 | -0.011445 | No Change: Both D | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 111 | A | 0.19922 | G | 0.241318 | -0.042098 | No Change: Both O | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 267 | A | 0.730742 | S | 0.798004 | -0.067262 | No Change: Both D | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 260 | L | 0.774698 | P | 0.858239 | -0.083541 | No Change: Both D | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 270 | N | 0.760219 | S | 0.764571 | -0.004352 | No Change: Both D | - |
| Q9BVW5 | TIPIN_HUMAN TIMELESS-interacting protein OS=Homo sapiens GN=TIPIN PE=1 SV=2 | 270 | N | 0.760219 | D | 0.767055 | -0.006836 | No Change: Both D | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 9 | A | 0.968762 | P | 0.982743 | -0.013981 | No Change: Both D | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 13 | R | 0.970279 | W | 0.93244 | 0.037839 | No Change: Both D | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 96 | D | 0.427003 | N | 0.362576 | 0.064427 | No Change: Both O | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 180 | S | 0.243865 | L | 0.13084 | 0.113025 | No Change: Both O | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 55 | S | 0.997651 | N | 0.996141 | 0.00151 | No Change: Both D | - |
| P58753 | TIRAP_HUMAN Toll/interleukin-1 receptor domain-containing adapter protein OS=Homo sapiens GN=TIRAP PE=1 SV=2 | 197 | V | 0.248048 | I | 0.221809 | 0.026239 | No Change: Both O | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 471 | N | 0.157505 | S | 0.168441 | -0.010936 | No Change: Both O | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 790 | I | 0.355959 | V | 0.393788 | -0.037829 | No Change: Both O | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 930 | P | 0.936459 | L | 0.870264 | 0.066195 | No Change: Both D | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 1110 | H | 0.967842 | R | 0.975956 | -0.008114 | No Change: Both D | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 1347 | D | 0.861821 | A | 0.812522 | 0.049299 | No Change: Both D | - |
| Q07157 | ZO1_HUMAN Tight junction protein ZO-1 OS=Homo sapiens GN=TJP1 PE=1 SV=3 | 1605 | N | 0.55645 | S | 0.627987 | -0.071537 | No Change: Both D | - |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 48 | V | 0.405314 | A | 0.50345 | -0.098136 | O to D | Familial hypercholanemia (FHCA) [MIM:607748] |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 482 | D | 0.93827 | E | 0.948282 | -0.010012 | No Change: Both D | - |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 668 | M | 0.64947 | I | 0.574402 | 0.075068 | No Change: Both D | - |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 711 | S | 0.310076 | P | 0.294041 | 0.016035 | No Change: Both O | - |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 822 | K | 0.559348 | N | 0.540987 | 0.018361 | No Change: Both D | - |
| Q9UDY2 | ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens GN=TJP2 PE=1 SV=2 | 829 | N | 0.720633 | D | 0.720034 | 5.99E-04 | No Change: Both D | - |
| O95049 | ZO3_HUMAN Tight junction protein ZO-3 OS=Homo sapiens GN=TJP3 PE=1 SV=2 | 912 | M | 0.620975 | T | 0.640062 | -0.019087 | No Change: Both D | - |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 53 | I | 0.579638 | M | 0.646957 | -0.067319 | No Change: Both D | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 108 | T | 0.158607 | M | 0.136107 | 0.0225 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 121 | H | 0.4694 | N | 0.487226 | -0.017826 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 212 | I | 0.217943 | N | 0.356208 | -0.138265 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 64 | T | 0.324548 | M | 0.273863 | 0.050685 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 183 | R | 0.120633 | W | 0.046995 | 0.073638 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| O00142 | KITM_HUMAN Thymidine kinase 2 mitochondrial OS=Homo sapiens GN=TK2 PE=1 SV=4 | 192 | R | 0.386201 | K | 0.459099 | -0.072898 | No Change: Both O | Mitochondrial DNA depletion syndrome type 2 (MTDPS2) [MIM:609560] |
| P29401 | TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 | 181 | I | 0.076236 | V | 0.086711 | -0.010475 | No Change: Both O | - |
| P51854 | TKTL1_HUMAN Transketolase-like protein 1 OS=Homo sapiens GN=TKTL1 PE=1 SV=2 | 24 | L | 0.812003 | F | 0.791976 | 0.020027 | No Change: Both D | - |
| P51854 | TKTL1_HUMAN Transketolase-like protein 1 OS=Homo sapiens GN=TKTL1 PE=1 SV=2 | 152 | I | 0.084449 | T | 0.151757 | -0.067308 | No Change: Both O | - |
| Q9H0I9 | TKTL2_HUMAN Transketolase-like protein 2 OS=Homo sapiens GN=TKTL2 PE=1 SV=1 | 442 | R | 0.104112 | Q | 0.115529 | -0.011417 | No Change: Both O | - |
| Q9H0I9 | TKTL2_HUMAN Transketolase-like protein 2 OS=Homo sapiens GN=TKTL2 PE=1 SV=1 | 590 | Q | 0.16938 | H | 0.163727 | 0.005653 | No Change: Both O | - |
| Q04726 | TLE3_HUMAN Transducin-like enhancer protein 3 OS=Homo sapiens GN=TLE3 PE=1 SV=2 | 229 | A | 0.982943 | V | 0.978579 | 0.004364 | No Change: Both D | - |
| Q9UKI8 | TLK1_HUMAN Serine/threonine-protein kinase tousled-like 1 OS=Homo sapiens GN=TLK1 PE=1 SV=2 | 121 | R | 0.995009 | C | 0.991863 | 0.003146 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 6 | H | 0.76512 | R | 0.849814 | -0.084694 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 54 | E | 0.975571 | D | 0.972365 | 0.003206 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 95 | A | 0.910584 | G | 0.927107 | -0.016523 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 108 | A | 0.931527 | G | 0.943257 | -0.01173 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 109 | R | 0.93153 | L | 0.890687 | 0.040843 | No Change: Both D | - |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 173 | F | 0.60403 | L | 0.64497 | -0.04094 | No Change: Both D | A gastric adenocarcinoma sample |
| Q86UE8 | TLK2_HUMAN Serine/threonine-protein kinase tousled-like 2 OS=Homo sapiens GN=TLK2 PE=1 SV=2 | 262 | R | 0.855269 | Q | 0.855124 | 1.45E-04 | No Change: Both D | - |
| O43897 | TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens GN=TLL1 PE=1 SV=1 | 688 | L | 0.567957 | V | 0.559926 | 0.008031 | No Change: Both D | A breast cancer sample |
| O43897 | TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens GN=TLL1 PE=1 SV=1 | 958 | T | 0.260219 | A | 0.248371 | 0.011848 | No Change: Both O | - |
| O43897 | TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens GN=TLL1 PE=1 SV=1 | 182 | M | 0.338562 | L | 0.264183 | 0.074379 | No Change: Both O | Atrial septal defect type 6 (ASD6) [MIM:613087] |
| O43897 | TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens GN=TLL1 PE=1 SV=1 | 238 | V | 0.112214 | A | 0.141779 | -0.029565 | No Change: Both O | Atrial septal defect type 6 (ASD6) [MIM:613087] |
| O43897 | TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens GN=TLL1 PE=1 SV=1 | 629 | I | 0.321572 | V | 0.357501 | -0.035929 | No Change: Both O | Atrial septal defect type 6 (ASD6) [MIM:613087] |
| Q9Y490 | TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 PE=1 SV=3 | 1227 | S | 0.775782 | L | 0.649682 | 0.1261 | No Change: Both D | - |
| Q9Y490 | TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 PE=1 SV=3 | 1919 | R | 0.444668 | W | 0.2623 | 0.182368 | No Change: Both O | - |
| Q9Y490 | TLN1_HUMAN Talin-1 OS=Homo sapiens GN=TLN1 PE=1 SV=3 | 1984 | A | 0.196798 | T | 0.212711 | -0.015913 | No Change: Both O | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 1148 | A | 0.676107 | S | 0.726964 | -0.050857 | No Change: Both D | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 2266 | F | 0.498676 | L | 0.536506 | -0.03783 | O to D | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 340 | V | 0.428552 | A | 0.476312 | -0.04776 | No Change: Both O | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 1877 | V | 0.596403 | I | 0.570893 | 0.02551 | No Change: Both D | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 2144 | T | 0.517355 | I | 0.381347 | 0.136008 | D to O | - |
| Q9Y4G6 | TLN2_HUMAN Talin-2 OS=Homo sapiens GN=TLN2 PE=1 SV=4 | 1148 | A | 0.676107 | T | 0.681028 | -0.004921 | No Change: Both D | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 118 | H | 0.264619 | Y | 0.16317 | 0.101449 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 80 | R | 0.109364 | T | 0.099553 | 0.009811 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 248 | N | 0.465001 | S | 0.502037 | -0.037036 | O to D | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 305 | H | 0.196566 | L | 0.128214 | 0.068352 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 315 | P | 0.129045 | L | 0.063272 | 0.065773 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 587 | V | 0.024282 | G | 0.042051 | -0.017769 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 602 | S | 0.068446 | I | 0.02293 | 0.045516 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 631 | L | 0.380084 | R | 0.512467 | -0.132383 | O to D | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 733 | P | 0.204211 | L | 0.113215 | 0.090996 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 44 | S | 0.418778 | P | 0.402554 | 0.016224 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 75 | I | 0.123359 | T | 0.192782 | -0.069423 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 352 | H | 0.214829 | N | 0.253154 | -0.038325 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 460 | I | 0.480607 | V | 0.515179 | -0.034572 | O to D | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 542 | V | 0.334505 | A | 0.379542 | -0.045037 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 554 | Y | 0.355701 | C | 0.310953 | 0.044748 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 651 | V | 0.228521 | A | 0.29501 | -0.066489 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 674 | V | 0.257992 | A | 0.313751 | -0.055759 | No Change: Both O | - |
| Q15399 | TLR1_HUMAN Toll-like receptor 1 OS=Homo sapiens GN=TLR1 PE=1 SV=3 | 720 | H | 0.431069 | P | 0.435163 | -0.004094 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 163 | A | 0.208845 | S | 0.30677 | -0.097925 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 241 | N | 0.503375 | H | 0.460364 | 0.043011 | D to O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 326 | M | 0.170295 | T | 0.218399 | -0.048104 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 369 | I | 0.209341 | L | 0.254904 | -0.045563 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 381 | G | 0.326602 | D | 0.360198 | -0.033596 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 525 | R | 0.154093 | W | 0.058402 | 0.095691 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 167 | L | 0.080121 | P | 0.147612 | -0.067491 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 298 | V | 0.252467 | I | 0.236316 | 0.016151 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 469 | R | 0.11671 | G | 0.121276 | -0.004566 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 473 | I | 0.086732 | T | 0.160833 | -0.074101 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 736 | Y | 0.057662 | C | 0.049403 | 0.008259 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 775 | I | 0.104427 | L | 0.132878 | -0.028451 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 799 | R | 0.6725 | Q | 0.680178 | -0.007678 | No Change: Both D | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 775 | I | 0.104427 | F | 0.109716 | -0.005289 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 775 | I | 0.104427 | V | 0.13005 | -0.025623 | No Change: Both O | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 799 | R | 0.6725 | L | 0.58868 | 0.08382 | No Change: Both D | - |
| Q9BXR5 | TLR10_HUMAN Toll-like receptor 10 OS=Homo sapiens GN=TLR10 PE=1 SV=2 | 799 | R | 0.6725 | P | 0.686527 | -0.014027 | No Change: Both D | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 631 | P | 0.737452 | H | 0.691908 | 0.045544 | No Change: Both D | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 411 | T | 0.353296 | I | 0.213186 | 0.14011 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 579 | R | 0.409046 | H | 0.409355 | -3.09E-04 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 677 | R | 0.131812 | W | 0.055007 | 0.076805 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 753 | R | 0.197654 | Q | 0.208897 | -0.011243 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 715 | Y | 0.18455 | N | 0.308919 | -0.124369 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 89 | N | 0.436053 | D | 0.447723 | -0.01167 | No Change: Both O | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 571 | R | 0.544207 | H | 0.561654 | -0.017447 | No Change: Both D | - |
| O60603 | TLR2_HUMAN Toll-like receptor 2 OS=Homo sapiens GN=TLR2 PE=1 SV=1 | 636 | S | 0.476623 | R | 0.432601 | 0.044022 | No Change: Both O | - |
| O15455 | TLR3_HUMAN Toll-like receptor 3 OS=Homo sapiens GN=TLR3 PE=1 SV=1 | 412 | L | 0.314833 | F | 0.267862 | 0.046971 | No Change: Both O | - |
| O15455 | TLR3_HUMAN Toll-like receptor 3 OS=Homo sapiens GN=TLR3 PE=1 SV=1 | 737 | S | 0.06245 | T | 0.040295 | 0.022155 | No Change: Both O | - |
| O15455 | TLR3_HUMAN Toll-like receptor 3 OS=Homo sapiens GN=TLR3 PE=1 SV=1 | 284 | N | 0.256774 | I | 0.116002 | 0.140772 | No Change: Both O | - |
| O15455 | TLR3_HUMAN Toll-like receptor 3 OS=Homo sapiens GN=TLR3 PE=1 SV=1 | 307 | Y | 0.131532 | D | 0.226991 | -0.095459 | No Change: Both O | - |
| O15455 | TLR3_HUMAN Toll-like receptor 3 OS=Homo sapiens GN=TLR3 PE=1 SV=1 | 554 | P | 0.232149 | S | 0.247681 | -0.015532 | No Change: Both O | Herpes simplex encephalitis type 2 (HSE2) [MIM:613002] |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 299 | D | 0.055879 | G | 0.043532 | 0.012347 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 399 | T | 0.409768 | I | 0.25787 | 0.151898 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 188 | Q | 0.291251 | R | 0.27796 | 0.013291 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 246 | C | 0.113144 | S | 0.26861 | -0.155466 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 329 | N | 0.122824 | S | 0.155467 | -0.032643 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 443 | F | 0.152499 | L | 0.176491 | -0.023992 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 474 | E | 0.308079 | K | 0.32328 | -0.015201 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 510 | Q | 0.508653 | H | 0.432777 | 0.075876 | D to O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 694 | K | 0.388311 | R | 0.334104 | 0.054207 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 763 | R | 0.083658 | H | 0.085076 | -0.001418 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 834 | Q | 0.481196 | H | 0.469994 | 0.011202 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 342 | F | 0.141401 | Y | 0.14753 | -0.006129 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 400 | S | 0.40202 | N | 0.336734 | 0.065286 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 175 | T | 0.332718 | A | 0.302375 | 0.030343 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 385 | L | 0.439202 | F | 0.413848 | 0.025354 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 306 | C | 0.076404 | W | 0.064558 | 0.011846 | No Change: Both O | - |
| O00206 | TLR4_HUMAN Toll-like receptor 4 OS=Homo sapiens GN=TLR4 PE=1 SV=2 | 310 | V | 0.206252 | G | 0.317448 | -0.111196 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 592 | N | 0.081932 | S | 0.096383 | -0.014451 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 616 | F | 0.25863 | L | 0.289753 | -0.031123 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 82 | T | 0.263141 | I | 0.155059 | 0.108082 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 112 | P | 0.144492 | A | 0.109317 | 0.035175 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 822 | F | 0.238411 | L | 0.267631 | -0.02922 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 143 | N | 0.184582 | T | 0.168754 | 0.015828 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 181 | Q | 0.209459 | K | 0.24617 | -0.036711 | No Change: Both O | - |
| O60602 | TLR5_HUMAN Toll-like receptor 5 OS=Homo sapiens GN=TLR5 PE=1 SV=4 | 769 | L | 0.077249 | F | 0.069912 | 0.007337 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 120 | I | 0.168265 | T | 0.256684 | -0.088419 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 194 | L | 0.283815 | P | 0.434226 | -0.150411 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 247 | R | 0.296971 | K | 0.37433 | -0.077359 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 327 | V | 0.12161 | M | 0.17712 | -0.05551 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 345 | H | 0.162391 | Y | 0.091635 | 0.070756 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 427 | V | 0.144403 | A | 0.160642 | -0.016239 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 465 | V | 0.500388 | I | 0.468283 | 0.032105 | D to O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 474 | A | 0.260578 | T | 0.282334 | -0.021756 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 783 | M | 0.145753 | V | 0.117832 | 0.027921 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 249 | S | 0.321917 | P | 0.279469 | 0.042448 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 128 | L | 0.210825 | V | 0.200772 | 0.010053 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 210 | A | 0.103866 | G | 0.132363 | -0.028497 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 210 | A | 0.103866 | T | 0.127604 | -0.023738 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 283 | I | 0.062983 | V | 0.070778 | -0.007795 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 442 | D | 0.269066 | A | 0.197345 | 0.071721 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 474 | A | 0.260578 | V | 0.21421 | 0.046368 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 592 | G | 0.042068 | V | 0.024276 | 0.017792 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 690 | N | 0.145533 | T | 0.119863 | 0.02567 | No Change: Both O | - |
| Q9Y2C9 | TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens GN=TLR6 PE=1 SV=2 | 708 | Q | 0.149353 | H | 0.147978 | 0.001375 | No Change: Both O | - |
| Q9NYK1 | TLR7_HUMAN Toll-like receptor 7 OS=Homo sapiens GN=TLR7 PE=1 SV=1 | 448 | A | 0.461847 | V | 0.421573 | 0.040274 | No Change: Both O | - |
| Q9NYK1 | TLR7_HUMAN Toll-like receptor 7 OS=Homo sapiens GN=TLR7 PE=1 SV=1 | 11 | Q | 0.032781 | L | 0.018176 | 0.014605 | No Change: Both O | - |
| Q9NR97 | TLR8_HUMAN Toll-like receptor 8 OS=Homo sapiens GN=TLR8 PE=1 SV=1 | 10 | M | 0.305637 | V | 0.142895 | 0.162742 | No Change: Both O | - |
| Q9NR97 | TLR8_HUMAN Toll-like receptor 8 OS=Homo sapiens GN=TLR8 PE=1 SV=1 | 715 | R | 0.662752 | Q | 0.636012 | 0.02674 | No Change: Both D | - |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 5 | R | 0.498308 | C | 0.336031 | 0.162277 | No Change: Both O | - |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 863 | R | 0.7162 | Q | 0.730059 | -0.013859 | No Change: Both D | - |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 901 | R | 0.132075 | H | 0.120898 | 0.011177 | No Change: Both O | A colorectal cancer sample |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 933 | T | 0.192901 | M | 0.157284 | 0.035617 | No Change: Both O | A colorectal cancer sample |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 79 | H | 0.563437 | Q | 0.536482 | 0.026955 | No Change: Both D | - |
| Q9NR96 | TLR9_HUMAN Toll-like receptor 9 OS=Homo sapiens GN=TLR9 PE=1 SV=2 | 882 | A | 0.160008 | T | 0.178136 | -0.018128 | No Change: Both O | - |
| Q96DZ7 | T4S19_HUMAN Transmembrane 4 L6 family member 19 OS=Homo sapiens GN=TM4SF19 PE=1 SV=2 | 162 | V | 0.167539 | I | 0.142573 | 0.024966 | No Change: Both O | - |
| Q96DZ7 | T4S19_HUMAN Transmembrane 4 L6 family member 19 OS=Homo sapiens GN=TM4SF19 PE=1 SV=2 | 8 | Q | 0.703523 | P | 0.73634 | -0.032817 | No Change: Both D | - |
| Q53R12 | T4S20_HUMAN Transmembrane 4 L6 family member 20 OS=Homo sapiens GN=TM4SF20 PE=2 SV=1 | 27 | A | 0.043279 | V | 0.033671 | 0.009608 | No Change: Both O | - |
| Q9BZW5 | TM6S1_HUMAN Transmembrane 6 superfamily member 1 OS=Homo sapiens GN=TM6SF1 PE=2 SV=2 | 17 | I | 0.081295 | T | 0.160832 | -0.079537 | No Change: Both O | - |
| Q9BZW5 | TM6S1_HUMAN Transmembrane 6 superfamily member 1 OS=Homo sapiens GN=TM6SF1 PE=2 SV=2 | 59 | P | 0.476676 | S | 0.484319 | -0.007643 | No Change: Both O | - |
| Q9BZW4 | TM6S2_HUMAN Transmembrane 6 superfamily member 2 OS=Homo sapiens GN=TM6SF2 PE=2 SV=3 | 167 | E | 0.278976 | K | 0.295987 | -0.017011 | No Change: Both O | - |
| O76062 | ERG24_HUMAN Delta(14)-sterol reductase OS=Homo sapiens GN=TM7SF2 PE=2 SV=3 | 299 | T | 0.041159 | I | 0.023279 | 0.01788 | No Change: Both O | - |
| O76062 | ERG24_HUMAN Delta(14)-sterol reductase OS=Homo sapiens GN=TM7SF2 PE=2 SV=3 | 119 | A | 0.30304 | V | 0.225947 | 0.077093 | No Change: Both O | - |
| Q9NS93 | TM7S3_HUMAN Transmembrane 7 superfamily member 3 OS=Homo sapiens GN=TM7SF3 PE=2 SV=1 | 179 | P | 0.561927 | R | 0.52041 | 0.041517 | No Change: Both D | - |
| Q9NS93 | TM7S3_HUMAN Transmembrane 7 superfamily member 3 OS=Homo sapiens GN=TM7SF3 PE=2 SV=1 | 248 | P | 0.375874 | L | 0.236106 | 0.139768 | No Change: Both O | - |
| Q9H295 | TM7S4_HUMAN Transmembrane 7 superfamily member 4 OS=Homo sapiens GN=TM7SF4 PE=2 SV=1 | 349 | D | 0.501287 | G | 0.482069 | 0.019218 | D to O | - |
| O15321 | TM9S1_HUMAN Transmembrane 9 superfamily member 1 OS=Homo sapiens GN=TM9SF1 PE=2 SV=2 | 215 | R | 0.744384 | H | 0.726699 | 0.017685 | No Change: Both D | - |
| O15321 | TM9S1_HUMAN Transmembrane 9 superfamily member 1 OS=Homo sapiens GN=TM9SF1 PE=2 SV=2 | 18 | L | 0.023127 | M | 0.027884 | -0.004757 | No Change: Both O | - |
| Q969X1 | TMBI1_HUMAN Transmembrane BAX inhibitor motif-containing protein 1 OS=Homo sapiens GN=TMBIM1 PE=1 SV=2 | 21 | P | 0.991218 | L | 0.979717 | 0.011501 | No Change: Both D | - |
| Q9HC24 | TMBI4_HUMAN Transmembrane BAX inhibitor motif-containing protein 4 OS=Homo sapiens GN=TMBIM4 PE=2 SV=3 | 88 | I | 0.056767 | T | 0.099977 | -0.04321 | No Change: Both O | - |
| Q9HC24 | TMBI4_HUMAN Transmembrane BAX inhibitor motif-containing protein 4 OS=Homo sapiens GN=TMBIM4 PE=2 SV=3 | 2 | A | 0.816287 | V | 0.80252 | 0.013767 | No Change: Both D | - |
| Q8TDI8 | TMC1_HUMAN Transmembrane channel-like protein 1 OS=Homo sapiens GN=TMC1 PE=1 SV=2 | 572 | D | 0.250229 | N | 0.249535 | 6.94E-04 | No Change: Both O | Deafness autosomal dominant type 36 (DFNA36) [MIM:606705] |
| Q8TDI8 | TMC1_HUMAN Transmembrane channel-like protein 1 OS=Homo sapiens GN=TMC1 PE=1 SV=2 | 654 | M | 0.102484 | V | 0.078083 | 0.024401 | No Change: Both O | Deafness autosomal recessive type 7 (DFNB7) [MIM:600974] |
| Q8TDI8 | TMC1_HUMAN Transmembrane channel-like protein 1 OS=Homo sapiens GN=TMC1 PE=1 SV=2 | 81 | E | 0.984859 | K | 0.983797 | 0.001062 | No Change: Both D | - |
| Q8TDI8 | TMC1_HUMAN Transmembrane channel-like protein 1 OS=Homo sapiens GN=TMC1 PE=1 SV=2 | 141 | R | 0.525195 | W | 0.355411 | 0.169784 | D to O | - |
| Q8TDI8 | TMC1_HUMAN Transmembrane channel-like protein 1 OS=Homo sapiens GN=TMC1 PE=1 SV=2 | 486 | M | 0.15424 | T | 0.191933 | -0.037693 | No Change: Both O | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 123 | R | 0.998587 | K | 0.998623 | -3.60E-05 | No Change: Both D | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 573 | S | 0.242 | C | 0.099152 | 0.142848 | No Change: Both O | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 800 | E | 0.797793 | Q | 0.796771 | 0.001022 | No Change: Both D | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 205 | Q | 0.472763 | R | 0.457766 | 0.014997 | No Change: Both O | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 217 | W | 0.239182 | R | 0.452065 | -0.212883 | No Change: Both O | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 589 | S | 0.10929 | C | 0.037269 | 0.072021 | No Change: Both O | - |
| Q8TDI7 | TMC2_HUMAN Transmembrane channel-like protein 2 OS=Homo sapiens GN=TMC2 PE=2 SV=3 | 816 | E | 0.970896 | Q | 0.970863 | 3.30E-05 | No Change: Both D | - |
| Q7Z5M5 | TMC3_HUMAN Transmembrane channel-like protein 3 OS=Homo sapiens GN=TMC3 PE=1 SV=3 | 196 | V | 0.195685 | I | 0.172001 | 0.023684 | No Change: Both O | - |
| Q7Z5M5 | TMC3_HUMAN Transmembrane channel-like protein 3 OS=Homo sapiens GN=TMC3 PE=1 SV=3 | 893 | C | 0.297116 | Y | 0.354257 | -0.057141 | No Change: Both O | - |
| Q7Z5M5 | TMC3_HUMAN Transmembrane channel-like protein 3 OS=Homo sapiens GN=TMC3 PE=1 SV=3 | 1012 | R | 0.860507 | K | 0.858142 | 0.002365 | No Change: Both D | - |
| Q7Z5M5 | TMC3_HUMAN Transmembrane channel-like protein 3 OS=Homo sapiens GN=TMC3 PE=1 SV=3 | 1099 | D | 0.726686 | N | 0.647159 | 0.079527 | No Change: Both D | - |
| Q7Z404 | TMC4_HUMAN Transmembrane channel-like protein 4 OS=Homo sapiens GN=TMC4 PE=2 SV=3 | 17 | G | 0.935699 | E | 0.952875 | -0.017176 | No Change: Both D | - |
| Q7Z404 | TMC4_HUMAN Transmembrane channel-like protein 4 OS=Homo sapiens GN=TMC4 PE=2 SV=3 | 689 | Q | 0.591572 | E | 0.62597 | -0.034398 | No Change: Both D | - |
| Q6UXY8 | TMC5_HUMAN Transmembrane channel-like protein 5 OS=Homo sapiens GN=TMC5 PE=2 SV=3 | 328 | S | 0.600325 | N | 0.561556 | 0.038769 | No Change: Both D | - |
| Q6UXY8 | TMC5_HUMAN Transmembrane channel-like protein 5 OS=Homo sapiens GN=TMC5 PE=2 SV=3 | 355 | A | 0.49732 | T | 0.535664 | -0.038344 | O to D | - |
| Q7Z403 | TMC6_HUMAN Transmembrane channel-like protein 6 OS=Homo sapiens GN=TMC6 PE=1 SV=2 | 125 | W | 0.232175 | R | 0.499561 | -0.267386 | No Change: Both O | - |
| Q7Z403 | TMC6_HUMAN Transmembrane channel-like protein 6 OS=Homo sapiens GN=TMC6 PE=1 SV=2 | 153 | L | 0.734785 | F | 0.652161 | 0.082624 | No Change: Both D | - |
| Q7Z403 | TMC6_HUMAN Transmembrane channel-like protein 6 OS=Homo sapiens GN=TMC6 PE=1 SV=2 | 191 | G | 0.753187 | D | 0.730851 | 0.022336 | No Change: Both D | - |
| Q7Z402 | TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens GN=TMC7 PE=2 SV=1 | 59 | R | 0.812819 | W | 0.624058 | 0.188761 | No Change: Both D | - |
| Q7Z402 | TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens GN=TMC7 PE=2 SV=1 | 254 | G | 0.188124 | E | 0.221353 | -0.033229 | No Change: Both O | - |
| Q7Z402 | TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens GN=TMC7 PE=2 SV=1 | 635 | T | 0.239623 | I | 0.134738 | 0.104885 | No Change: Both O | - |
| Q7Z402 | TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens GN=TMC7 PE=2 SV=1 | 355 | T | 0.449479 | S | 0.540305 | -0.090826 | O to D | - |
| Q8IU68 | TMC8_HUMAN Transmembrane channel-like protein 8 OS=Homo sapiens GN=TMC8 PE=1 SV=1 | 306 | N | 0.079536 | I | 0.033491 | 0.046045 | No Change: Both O | - |
| Q8IU68 | TMC8_HUMAN Transmembrane channel-like protein 8 OS=Homo sapiens GN=TMC8 PE=1 SV=1 | 501 | V | 0.040353 | I | 0.036086 | 0.004267 | No Change: Both O | - |
| O94876 | TMCC1_HUMAN Transmembrane and coiled-coil domains protein 1 OS=Homo sapiens GN=TMCC1 PE=1 SV=3 | 165 | S | 0.945762 | G | 0.927769 | 0.017993 | No Change: Both D | - |
| Q9ULS5 | TMCC3_HUMAN Transmembrane and coiled-coil domains protein 3 OS=Homo sapiens GN=TMCC3 PE=2 SV=3 | 16 | Y | 0.674772 | D | 0.813279 | -0.138507 | No Change: Both D | - |
| Q9ULS5 | TMCC3_HUMAN Transmembrane and coiled-coil domains protein 3 OS=Homo sapiens GN=TMCC3 PE=2 SV=3 | 232 | P | 0.579671 | Q | 0.547889 | 0.031782 | No Change: Both D | - |
| Q6UWJ1 | TMCO3_HUMAN Transmembrane and coiled-coil domain-containing protein 3 OS=Homo sapiens GN=TMCO3 PE=2 SV=1 | 443 | A | 0.510852 | T | 0.535032 | -0.02418 | No Change: Both D | - |
| Q6UWJ1 | TMCO3_HUMAN Transmembrane and coiled-coil domain-containing protein 3 OS=Homo sapiens GN=TMCO3 PE=2 SV=1 | 445 | A | 0.501936 | T | 0.518607 | -0.016671 | No Change: Both D | - |
| Q5TGY1 | TMCO4_HUMAN Transmembrane and coiled-coil domain-containing protein 4 OS=Homo sapiens GN=TMCO4 PE=2 SV=1 | 72 | Q | 0.097533 | K | 0.111364 | -0.013831 | No Change: Both O | - |
| Q5TGY1 | TMCO4_HUMAN Transmembrane and coiled-coil domain-containing protein 4 OS=Homo sapiens GN=TMCO4 PE=2 SV=1 | 478 | R | 0.250558 | H | 0.243978 | 0.00658 | No Change: Both O | - |
| Q96DC7 | TMCO6_HUMAN Transmembrane and coiled-coil domain-containing protein 6 OS=Homo sapiens GN=TMCO6 PE=2 SV=2 | 299 | T | 0.455816 | S | 0.522308 | -0.066492 | O to D | - |
| Q13445 | TMED1_HUMAN Transmembrane emp24 domain-containing protein 1 OS=Homo sapiens GN=TMED1 PE=1 SV=1 | 102 | D | 0.297411 | N | 0.276538 | 0.020873 | No Change: Both O | A breast cancer sample |
| P49755 | TMEDA_HUMAN Transmembrane emp24 domain-containing protein 10 OS=Homo sapiens GN=TMED10 PE=1 SV=2 | 64 | S | 0.595092 | Y | 0.461286 | 0.133806 | D to O | - |
| P49755 | TMEDA_HUMAN Transmembrane emp24 domain-containing protein 10 OS=Homo sapiens GN=TMED10 PE=1 SV=2 | 152 | R | 0.604903 | G | 0.550888 | 0.054015 | No Change: Both D | - |
| Q9Y3Q3 | TMED3_HUMAN Transmembrane emp24 domain-containing protein 3 OS=Homo sapiens GN=TMED3 PE=1 SV=1 | 86 | D | 0.442329 | N | 0.427148 | 0.015181 | No Change: Both O | - |
| Q9Y3A6 | TMED5_HUMAN Transmembrane emp24 domain-containing protein 5 OS=Homo sapiens GN=TMED5 PE=1 SV=1 | 175 | T | 0.26803 | I | 0.179675 | 0.088355 | No Change: Both O | - |
| Q6PL24 | TMED8_HUMAN Protein TMED8 OS=Homo sapiens GN=TMED8 PE=1 SV=1 | 5 | Q | 0.920456 | K | 0.910865 | 0.009591 | No Change: Both D | - |
| Q9BVK6 | TMED9_HUMAN Transmembrane emp24 domain-containing protein 9 OS=Homo sapiens GN=TMED9 PE=1 SV=2 | 16 | T | 0.48863 | S | 0.570565 | -0.081935 | O to D | - |
| Q8IYR6 | TEFF1_HUMAN Tomoregulin-1 OS=Homo sapiens GN=TMEFF1 PE=1 SV=1 | 189 | V | 0.545535 | I | 0.507067 | 0.038468 | No Change: Both D | - |
| Q8N9M5 | TM102_HUMAN Transmembrane protein 102 OS=Homo sapiens GN=TMEM102 PE=1 SV=1 | 110 | A | 0.475554 | V | 0.380371 | 0.095183 | No Change: Both O | - |
| Q8NE00 | TM104_HUMAN Transmembrane protein 104 OS=Homo sapiens GN=TMEM104 PE=1 SV=2 | 58 | V | 0.058273 | M | 0.078461 | -0.020188 | No Change: Both O | - |
| Q8NE00 | TM104_HUMAN Transmembrane protein 104 OS=Homo sapiens GN=TMEM104 PE=1 SV=2 | 439 | A | 0.031672 | T | 0.037759 | -0.006087 | No Change: Both O | - |
| Q8N8V8 | TM105_HUMAN Transmembrane protein 105 OS=Homo sapiens GN=TMEM105 PE=2 SV=1 | 122 | R | 0.382351 | W | 0.18351 | 0.198841 | No Change: Both O | - |
| Q9NUM4 | T106B_HUMAN Transmembrane protein 106B OS=Homo sapiens GN=TMEM106B PE=1 SV=2 | 185 | T | 0.120608 | S | 0.168104 | -0.047496 | No Change: Both O | - |
| Q9BVX2 | T106C_HUMAN Transmembrane protein 106C OS=Homo sapiens GN=TMEM106C PE=2 SV=1 | 175 | S | 0.320355 | F | 0.13342 | 0.186935 | No Change: Both O | - |
| Q9BVX2 | T106C_HUMAN Transmembrane protein 106C OS=Homo sapiens GN=TMEM106C PE=2 SV=1 | 103 | V | 0.033304 | F | 0.029886 | 0.003418 | No Change: Both O | - |
| Q6UXF1 | TM108_HUMAN Transmembrane protein 108 OS=Homo sapiens GN=TMEM108 PE=2 SV=2 | 84 | P | 0.972129 | L | 0.93889 | 0.033239 | No Change: Both D | - |
| B3SHH9 | TM114_HUMAN Transmembrane protein 114 OS=Homo sapiens GN=TMEM114 PE=2 SV=2 | 35 | I | 0.097754 | T | 0.169966 | -0.072212 | No Change: Both O | - |
| B3SHH9 | TM114_HUMAN Transmembrane protein 114 OS=Homo sapiens GN=TMEM114 PE=2 SV=2 | 147 | A | 0.036822 | V | 0.025232 | 0.01159 | No Change: Both O | - |
| B3SHH9 | TM114_HUMAN Transmembrane protein 114 OS=Homo sapiens GN=TMEM114 PE=2 SV=2 | 206 | F | 0.150721 | L | 0.189301 | -0.03858 | No Change: Both O | - |
| Q8NCL8 | TM116_HUMAN Transmembrane protein 116 OS=Homo sapiens GN=TMEM116 PE=2 SV=1 | 22 | C | 0.051417 | G | 0.085774 | -0.034357 | No Change: Both O | - |
| Q9H0C3 | TM117_HUMAN Transmembrane protein 117 OS=Homo sapiens GN=TMEM117 PE=2 SV=1 | 90 | R | 0.100391 | H | 0.103592 | -0.003201 | No Change: Both O | - |
| Q4V9L6 | TM119_HUMAN Transmembrane protein 119 OS=Homo sapiens GN=TMEM119 PE=2 SV=1 | 72 | I | 0.698074 | T | 0.760663 | -0.062589 | No Change: Both D | - |
| Q9BXJ8 | T120A_HUMAN Transmembrane protein 120A OS=Homo sapiens GN=TMEM120A PE=2 SV=1 | 86 | Q | 0.68953 | R | 0.672642 | 0.016888 | No Change: Both D | - |
| Q9BXJ8 | T120A_HUMAN Transmembrane protein 120A OS=Homo sapiens GN=TMEM120A PE=2 SV=1 | 201 | T | 0.122407 | A | 0.104121 | 0.018286 | No Change: Both O | - |
| Q8N131 | PORIM_HUMAN Porimin OS=Homo sapiens GN=TMEM123 PE=1 SV=1 | 71 | V | 0.987609 | M | 0.990132 | -0.002523 | No Change: Both D | - |
| Q8N131 | PORIM_HUMAN Porimin OS=Homo sapiens GN=TMEM123 PE=1 SV=1 | 86 | V | 0.992496 | F | 0.990255 | 0.002241 | No Change: Both D | - |
| Q8N131 | PORIM_HUMAN Porimin OS=Homo sapiens GN=TMEM123 PE=1 SV=1 | 158 | A | 0.7191 | T | 0.73981 | -0.02071 | No Change: Both D | - |
| Q96AQ2 | TM125_HUMAN Transmembrane protein 125 OS=Homo sapiens GN=TMEM125 PE=2 SV=1 | 107 | R | 0.434081 | L | 0.322249 | 0.111832 | No Change: Both O | A breast cancer sample |
| Q96AQ2 | TM125_HUMAN Transmembrane protein 125 OS=Homo sapiens GN=TMEM125 PE=2 SV=1 | 112 | A | 0.302245 | D | 0.376807 | -0.074562 | No Change: Both O | - |
| Q9H061 | T126A_HUMAN Transmembrane protein 126A OS=Homo sapiens GN=TMEM126A PE=1 SV=1 | 64 | R | 0.189525 | H | 0.187892 | 0.001633 | No Change: Both O | - |
| Q8IUX1 | T126B_HUMAN Transmembrane protein 126B OS=Homo sapiens GN=TMEM126B PE=2 SV=2 | 198 | A | 0.069308 | V | 0.051275 | 0.018033 | No Change: Both O | - |
| O75204 | TM127_HUMAN Transmembrane protein 127 OS=Homo sapiens GN=TMEM127 PE=1 SV=1 | 90 | V | 0.056509 | M | 0.075116 | -0.018607 | No Change: Both O | - |
| A0AVI4 | TM129_HUMAN Transmembrane protein 129 OS=Homo sapiens GN=TMEM129 PE=2 SV=1 | 83 | L | 0.53358 | I | 0.477577 | 0.056003 | D to O | - |
| Q8N3G9 | TM130_HUMAN Transmembrane protein 130 OS=Homo sapiens GN=TMEM130 PE=2 SV=1 | 407 | E | 0.380911 | V | 0.224892 | 0.156019 | No Change: Both O | - |
| Q24JP5 | T132A_HUMAN Transmembrane protein 132A OS=Homo sapiens GN=TMEM132A PE=2 SV=1 | 699 | R | 0.388026 | H | 0.361609 | 0.026417 | No Change: Both O | - |
| Q24JP5 | T132A_HUMAN Transmembrane protein 132A OS=Homo sapiens GN=TMEM132A PE=2 SV=1 | 969 | A | 0.798081 | V | 0.754729 | 0.043352 | No Change: Both D | - |
| Q14DG7 | T132B_HUMAN Transmembrane protein 132B OS=Homo sapiens GN=TMEM132B PE=2 SV=2 | 658 | A | 0.1364 | V | 0.10662 | 0.02978 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 161 | H | 0.454449 | R | 0.45634 | -0.001891 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 232 | V | 0.41199 | M | 0.497837 | -0.085847 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 272 | V | 0.240462 | I | 0.234881 | 0.005581 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 444 | V | 0.183982 | I | 0.164852 | 0.01913 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 730 | T | 0.360129 | S | 0.438847 | -0.078718 | No Change: Both O | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 799 | F | 0.525404 | I | 0.55617 | -0.030766 | No Change: Both D | - |
| Q8N3T6 | T132C_HUMAN Transmembrane protein 132C OS=Homo sapiens GN=TMEM132C PE=2 SV=3 | 810 | G | 0.784045 | R | 0.795625 | -0.01158 | No Change: Both D | - |
| Q14C87 | T132D_HUMAN Transmembrane protein 132D OS=Homo sapiens GN=TMEM132D PE=2 SV=1 | 878 | L | 0.796046 | F | 0.758259 | 0.037787 | No Change: Both D | - |
| Q14C87 | T132D_HUMAN Transmembrane protein 132D OS=Homo sapiens GN=TMEM132D PE=2 SV=1 | 436 | E | 0.175368 | Q | 0.13836 | 0.037008 | No Change: Both O | - |
| Q14C87 | T132D_HUMAN Transmembrane protein 132D OS=Homo sapiens GN=TMEM132D PE=2 SV=1 | 460 | D | 0.522213 | H | 0.456459 | 0.065754 | D to O | - |
| Q86UB9 | TM135_HUMAN Transmembrane protein 135 OS=Homo sapiens GN=TMEM135 PE=2 SV=2 | 193 | P | 0.514332 | H | 0.48662 | 0.027712 | D to O | - |
| Q86UB9 | TM135_HUMAN Transmembrane protein 135 OS=Homo sapiens GN=TMEM135 PE=2 SV=2 | 218 | G | 0.652026 | R | 0.693909 | -0.041883 | No Change: Both D | - |
| Q86UB9 | TM135_HUMAN Transmembrane protein 135 OS=Homo sapiens GN=TMEM135 PE=2 SV=2 | 430 | G | 0.298999 | A | 0.249993 | 0.049006 | No Change: Both O | - |
| Q9NV12 | TM140_HUMAN Transmembrane protein 140 OS=Homo sapiens GN=TMEM140 PE=2 SV=2 | 6 | P | 0.619214 | S | 0.631212 | -0.011998 | No Change: Both D | - |
| Q9NV12 | TM140_HUMAN Transmembrane protein 140 OS=Homo sapiens GN=TMEM140 PE=2 SV=2 | 7 | R | 0.491621 | Q | 0.506453 | -0.014832 | O to D | - |
| Q9NV12 | TM140_HUMAN Transmembrane protein 140 OS=Homo sapiens GN=TMEM140 PE=2 SV=2 | 11 | Q | 0.144498 | E | 0.173095 | -0.028597 | No Change: Both O | - |
| Q9NV12 | TM140_HUMAN Transmembrane protein 140 OS=Homo sapiens GN=TMEM140 PE=2 SV=2 | 29 | F | 0.00517 | L | 0.006731 | -0.001561 | No Change: Both O | - |
| Q9NV12 | TM140_HUMAN Transmembrane protein 140 OS=Homo sapiens GN=TMEM140 PE=2 SV=2 | 112 | A | 0.187981 | E | 0.274456 | -0.086475 | No Change: Both O | A colorectal cancer sample |
| Q96AN5 | TM143_HUMAN Transmembrane protein 143 OS=Homo sapiens GN=TMEM143 PE=2 SV=1 | 143 | D | 0.795149 | N | 0.781282 | 0.013867 | No Change: Both D | - |
| Q7Z5S9 | TM144_HUMAN Transmembrane protein 144 OS=Homo sapiens GN=TMEM144 PE=2 SV=1 | 157 | D | 0.386803 | G | 0.358015 | 0.028788 | No Change: Both O | - |
| Q8NBT3 | TM145_HUMAN Transmembrane protein 145 OS=Homo sapiens GN=TMEM145 PE=2 SV=2 | 256 | L | 0.018431 | M | 0.023708 | -0.005277 | No Change: Both O | - |
| Q86XM0 | TM146_HUMAN Transmembrane protein 146 OS=Homo sapiens GN=TMEM146 PE=2 SV=3 | 504 | T | 0.23899 | A | 0.211811 | 0.027179 | No Change: Both O | - |
| Q86XM0 | TM146_HUMAN Transmembrane protein 146 OS=Homo sapiens GN=TMEM146 PE=2 SV=3 | 743 | T | 0.219598 | S | 0.283388 | -0.06379 | No Change: Both O | - |
| Q86XM0 | TM146_HUMAN Transmembrane protein 146 OS=Homo sapiens GN=TMEM146 PE=2 SV=3 | 212 | M | 0.140425 | T | 0.167159 | -0.026734 | No Change: Both O | - |
| Q9BVK8 | TM147_HUMAN Transmembrane protein 147 OS=Homo sapiens GN=TMEM147 PE=1 SV=1 | 132 | Y | 0.109497 | H | 0.182876 | -0.073379 | No Change: Both O | - |
| Q9Y6G1 | TM14A_HUMAN Transmembrane protein 14A OS=Homo sapiens GN=TMEM14A PE=2 SV=1 | 37 | C | 0.047232 | R | 0.105108 | -0.057876 | No Change: Both O | - |
| Q9P0S9 | TM14C_HUMAN Transmembrane protein 14C OS=Homo sapiens GN=TMEM14C PE=1 SV=1 | 106 | S | 0.366472 | R | 0.325522 | 0.04095 | No Change: Both O | - |
| Q9P0S9 | TM14C_HUMAN Transmembrane protein 14C OS=Homo sapiens GN=TMEM14C PE=1 SV=1 | 108 | F | 0.607739 | L | 0.632324 | -0.024585 | No Change: Both D | - |
| Q9P0S9 | TM14C_HUMAN Transmembrane protein 14C OS=Homo sapiens GN=TMEM14C PE=1 SV=1 | 109 | N | 0.715249 | I | 0.594723 | 0.120526 | No Change: Both D | - |
| Q9P0S9 | TM14C_HUMAN Transmembrane protein 14C OS=Homo sapiens GN=TMEM14C PE=1 SV=1 | 112 | H | 0.70631 | D | 0.704694 | 0.001616 | No Change: Both D | - |
| A8MWL7 | TM14D_HUMAN Transmembrane protein 14D OS=Homo sapiens GN=TMEM14D PE=3 SV=2 | 108 | R | 0.338801 | C | 0.199803 | 0.138998 | No Change: Both O | - |
| Q6UXP3 | TM14E_HUMAN Transmembrane protein 14E OS=Homo sapiens GN=TMEM14E PE=2 SV=1 | 82 | L | 0.040171 | P | 0.079077 | -0.038906 | No Change: Both O | - |
| A6NC51 | T150B_HUMAN Transmembrane protein 150B OS=Homo sapiens GN=TMEM150B PE=2 SV=1 | 199 | L | 0.073201 | F | 0.063389 | 0.009812 | No Change: Both O | - |
| Q6P9G4 | TM154_HUMAN Transmembrane protein 154 OS=Homo sapiens GN=TMEM154 PE=2 SV=2 | 93 | S | 0.030216 | F | 0.011831 | 0.018385 | No Change: Both O | - |
| Q4W5P6 | TM155_HUMAN Protein TMEM155 OS=Homo sapiens GN=TMEM155 PE=2 SV=3 | 11 | A | 0.066271 | V | 0.042931 | 0.02334 | No Change: Both O | - |
| Q8N614 | TM156_HUMAN Transmembrane protein 156 OS=Homo sapiens GN=TMEM156 PE=2 SV=2 | 48 | Y | 0.322135 | C | 0.318954 | 0.003181 | No Change: Both O | - |
| Q8N614 | TM156_HUMAN Transmembrane protein 156 OS=Homo sapiens GN=TMEM156 PE=2 SV=2 | 212 | M | 0.056867 | T | 0.075887 | -0.01902 | No Change: Both O | - |
| Q8N614 | TM156_HUMAN Transmembrane protein 156 OS=Homo sapiens GN=TMEM156 PE=2 SV=2 | 105 | S | 0.507568 | P | 0.452962 | 0.054606 | D to O | - |
| Q96B96 | TM159_HUMAN Promethin OS=Homo sapiens GN=TMEM159 PE=2 SV=2 | 107 | G | 0.04501 | S | 0.058361 | -0.013351 | No Change: Both O | - |
| Q96B96 | TM159_HUMAN Promethin OS=Homo sapiens GN=TMEM159 PE=2 SV=2 | 154 | E | 0.492339 | D | 0.450935 | 0.041404 | No Change: Both O | - |
| Q96B96 | TM159_HUMAN Promethin OS=Homo sapiens GN=TMEM159 PE=2 SV=2 | 97 | F | 0.048728 | L | 0.062837 | -0.014109 | No Change: Both O | - |
| Q9NX00 | TM160_HUMAN Transmembrane protein 160 OS=Homo sapiens GN=TMEM160 PE=2 SV=1 | 120 | G | 0.20071 | S | 0.244718 | -0.044008 | No Change: Both O | - |
| Q9NX61 | T161A_HUMAN Transmembrane protein 161A OS=Homo sapiens GN=TMEM161A PE=2 SV=1 | 85 | E | 0.253994 | V | 0.134246 | 0.119748 | No Change: Both O | A breast cancer sample |
| Q5U3C3 | TM164_HUMAN Transmembrane protein 164 OS=Homo sapiens GN=TMEM164 PE=1 SV=1 | 276 | Y | 0.04559 | H | 0.079081 | -0.033491 | No Change: Both O | A colorectal cancer sample |
| Q5U3C3 | TM164_HUMAN Transmembrane protein 164 OS=Homo sapiens GN=TMEM164 PE=1 SV=1 | 204 | S | 0.314924 | N | 0.258922 | 0.056002 | No Change: Both O | - |
| Q86X19 | TMM17_HUMAN Transmembrane protein 17 OS=Homo sapiens GN=TMEM17 PE=2 SV=2 | 26 | G | 0.800993 | S | 0.83701 | -0.036017 | No Change: Both D | - |
| Q8WVE6 | TM171_HUMAN Transmembrane protein 171 OS=Homo sapiens GN=TMEM171 PE=2 SV=3 | 23 | F | 0.0244 | L | 0.026254 | -0.001854 | No Change: Both O | - |
| Q8WVE6 | TM171_HUMAN Transmembrane protein 171 OS=Homo sapiens GN=TMEM171 PE=2 SV=3 | 86 | R | 0.511816 | G | 0.507823 | 0.003993 | No Change: Both D | - |
| Q8WVE6 | TM171_HUMAN Transmembrane protein 171 OS=Homo sapiens GN=TMEM171 PE=2 SV=3 | 139 | N | 0.250359 | K | 0.274478 | -0.024119 | No Change: Both O | - |
| Q86WV6 | TM173_HUMAN Transmembrane protein 173 OS=Homo sapiens GN=TMEM173 PE=1 SV=1 | 71 | R | 0.396415 | H | 0.405607 | -0.009192 | No Change: Both O | - |
| Q86WV6 | TM173_HUMAN Transmembrane protein 173 OS=Homo sapiens GN=TMEM173 PE=1 SV=1 | 232 | H | 0.49384 | R | 0.497577 | -0.003737 | No Change: Both O | - |
| Q86WV6 | TM173_HUMAN Transmembrane protein 173 OS=Homo sapiens GN=TMEM173 PE=1 SV=1 | 293 | R | 0.37423 | Q | 0.399127 | -0.024897 | No Change: Both O | - |
| Q9BSA9 | TM175_HUMAN Transmembrane protein 175 OS=Homo sapiens GN=TMEM175 PE=1 SV=1 | 65 | Q | 0.618435 | P | 0.629923 | -0.011488 | No Change: Both D | - |
| Q9BSA9 | TM175_HUMAN Transmembrane protein 175 OS=Homo sapiens GN=TMEM175 PE=1 SV=1 | 393 | M | 0.054707 | T | 0.074699 | -0.019992 | No Change: Both O | - |
| Q96HP8 | T176A_HUMAN Transmembrane protein 176A OS=Homo sapiens GN=TMEM176A PE=2 SV=1 | 122 | T | 0.080512 | A | 0.072273 | 0.008239 | No Change: Both O | - |
| Q96HP8 | T176A_HUMAN Transmembrane protein 176A OS=Homo sapiens GN=TMEM176A PE=2 SV=1 | 187 | L | 0.139424 | F | 0.12178 | 0.017644 | No Change: Both O | - |
| Q96HP8 | T176A_HUMAN Transmembrane protein 176A OS=Homo sapiens GN=TMEM176A PE=2 SV=1 | 208 | T | 0.025774 | A | 0.02398 | 0.001794 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 55 | P | 0.4299 | S | 0.461282 | -0.031382 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 70 | T | 0.07562 | A | 0.070908 | 0.004712 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 94 | S | 0.11504 | R | 0.079596 | 0.035444 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 134 | A | 0.151544 | T | 0.168443 | -0.016899 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 180 | R | 0.37971 | W | 0.189137 | 0.190573 | No Change: Both O | - |
| Q3YBM2 | T176B_HUMAN Transmembrane protein 176B OS=Homo sapiens GN=TMEM176B PE=2 SV=2 | 40 | G | 0.380368 | E | 0.414431 | -0.034063 | No Change: Both O | - |
| Q53S58 | TM177_HUMAN Transmembrane protein 177 OS=Homo sapiens GN=TMEM177 PE=2 SV=1 | 29 | G | 0.094219 | A | 0.07212 | 0.022099 | No Change: Both O | - |
| Q53S58 | TM177_HUMAN Transmembrane protein 177 OS=Homo sapiens GN=TMEM177 PE=2 SV=1 | 32 | I | 0.098986 | V | 0.12379 | -0.024804 | No Change: Both O | - |
| Q53S58 | TM177_HUMAN Transmembrane protein 177 OS=Homo sapiens GN=TMEM177 PE=2 SV=1 | 267 | D | 0.536562 | E | 0.570092 | -0.03353 | No Change: Both D | - |
| Q8NBL3 | TM178_HUMAN Transmembrane protein 178 OS=Homo sapiens GN=TMEM178 PE=2 SV=1 | 107 | L | 0.158881 | V | 0.143002 | 0.015879 | No Change: Both O | - |
| Q6ZP80 | TM182_HUMAN Transmembrane protein 182 OS=Homo sapiens GN=TMEM182 PE=2 SV=2 | 223 | W | 0.091706 | R | 0.215503 | -0.123797 | No Change: Both O | - |
| Q8IXX5 | T183A_HUMAN Transmembrane protein 183A OS=Homo sapiens GN=TMEM183A PE=2 SV=2 | 10 | R | 0.935487 | M | 0.919072 | 0.016415 | No Change: Both D | - |
| Q8IXX5 | T183A_HUMAN Transmembrane protein 183A OS=Homo sapiens GN=TMEM183A PE=2 SV=2 | 80 | A | 0.798665 | T | 0.770113 | 0.028552 | No Change: Both D | - |
| Q1AE95 | T183B_HUMAN Transmembrane protein 183B OS=Homo sapiens GN=TMEM183B PE=2 SV=1 | 193 | M | 0.509068 | V | 0.446896 | 0.062172 | D to O | - |
| Q6ZMB5 | T184A_HUMAN Transmembrane protein 184A OS=Homo sapiens GN=TMEM184A PE=2 SV=1 | 390 | S | 0.93012 | G | 0.917329 | 0.012791 | No Change: Both D | - |
| Q6ZMB5 | T184A_HUMAN Transmembrane protein 184A OS=Homo sapiens GN=TMEM184A PE=2 SV=1 | 18 | A | 0.769321 | V | 0.7236 | 0.045721 | No Change: Both D | - |
| Q8NFB2 | T185A_HUMAN Transmembrane protein 185A OS=Homo sapiens GN=TMEM185A PE=2 SV=1 | 179 | M | 0.007332 | V | 0.006043 | 0.001289 | No Change: Both O | - |
| Q8NFB2 | T185A_HUMAN Transmembrane protein 185A OS=Homo sapiens GN=TMEM185A PE=2 SV=1 | 243 | C | 0.051976 | S | 0.158576 | -0.1066 | No Change: Both O | - |
| Q14656 | TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens GN=TMEM187 PE=2 SV=1 | 70 | S | 0.12681 | L | 0.062157 | 0.064653 | No Change: Both O | - |
| Q14656 | TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens GN=TMEM187 PE=2 SV=1 | 78 | M | 0.375389 | V | 0.308191 | 0.067198 | No Change: Both O | - |
| Q14656 | TM187_HUMAN Transmembrane protein 187 OS=Homo sapiens GN=TMEM187 PE=2 SV=1 | 138 | R | 0.040379 | Q | 0.041731 | -0.001352 | No Change: Both O | - |
| A5PLL7 | TM189_HUMAN Transmembrane protein 189 OS=Homo sapiens GN=TMEM189 PE=2 SV=3 | 7 | W | 0.636229 | G | 0.810033 | -0.173804 | No Change: Both D | - |
| O14524 | T194A_HUMAN Transmembrane protein 194A OS=Homo sapiens GN=TMEM194A PE=1 SV=2 | 217 | I | 0.160437 | V | 0.184146 | -0.023709 | No Change: Both O | - |
| Q8N511 | TM199_HUMAN Transmembrane protein 199 OS=Homo sapiens GN=TMEM199 PE=1 SV=1 | 158 | V | 0.013807 | I | 0.011436 | 0.002371 | No Change: Both O | - |
| Q8N511 | TM199_HUMAN Transmembrane protein 199 OS=Homo sapiens GN=TMEM199 PE=1 SV=1 | 166 | L | 0.046377 | V | 0.050836 | -0.004459 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 245 | R | 0.256603 | K | 0.317757 | -0.061154 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 291 | R | 0.59229 | H | 0.583709 | 0.008581 | No Change: Both D | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 423 | D | 0.32771 | E | 0.333749 | -0.006039 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 765 | P | 0.660309 | S | 0.661106 | -7.97E-04 | No Change: Both D | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 1010 | I | 0.405852 | V | 0.437645 | -0.031793 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 1254 | S | 0.134763 | N | 0.108552 | 0.026211 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 1280 | G | 0.323425 | D | 0.350726 | -0.027301 | No Change: Both O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 291 | R | 0.59229 | L | 0.488353 | 0.103937 | D to O | - |
| Q9UHN6 | TMEM2_HUMAN Transmembrane protein 2 OS=Homo sapiens GN=TMEM2 PE=1 SV=1 | 291 | R | 0.59229 | P | 0.586495 | 0.005795 | No Change: Both D | - |
| A6NGA9 | TM202_HUMAN Transmembrane protein 202 OS=Homo sapiens GN=TMEM202 PE=2 SV=1 | 204 | M | 0.021344 | L | 0.016796 | 0.004548 | No Change: Both O | - |
| Q9BSN7 | TM204_HUMAN Transmembrane protein 204 OS=Homo sapiens GN=TMEM204 PE=2 SV=1 | 57 | G | 0.566943 | A | 0.519799 | 0.047144 | No Change: Both D | - |
| Q9H813 | TM206_HUMAN Transmembrane protein 206 OS=Homo sapiens GN=TMEM206 PE=1 SV=1 | 336 | K | 0.257932 | N | 0.196787 | 0.061145 | No Change: Both O | A breast cancer sample |
| Q6UWW9 | TM207_HUMAN Transmembrane protein 207 OS=Homo sapiens GN=TMEM207 PE=2 SV=1 | 57 | L | 0.003763 | V | 0.003613 | 1.50E-04 | No Change: Both O | - |
| Q9BTX3 | TM208_HUMAN Transmembrane protein 208 OS=Homo sapiens GN=TMEM208 PE=2 SV=1 | 82 | D | 0.577501 | Y | 0.371119 | 0.206382 | D to O | - |
| Q9BTX3 | TM208_HUMAN Transmembrane protein 208 OS=Homo sapiens GN=TMEM208 PE=2 SV=1 | 102 | L | 0.251528 | P | 0.392701 | -0.141173 | No Change: Both O | - |
| Q96SK2 | TM209_HUMAN Transmembrane protein 209 OS=Homo sapiens GN=TMEM209 PE=1 SV=2 | 469 | P | 0.687471 | R | 0.654165 | 0.033306 | No Change: Both D | - |
| Q96SK2 | TM209_HUMAN Transmembrane protein 209 OS=Homo sapiens GN=TMEM209 PE=1 SV=2 | 505 | H | 0.276775 | R | 0.277324 | -5.49E-04 | No Change: Both O | - |
| Q6NUQ4 | TM214_HUMAN Transmembrane protein 214 OS=Homo sapiens GN=TMEM214 PE=1 SV=2 | 351 | V | 0.265726 | M | 0.390902 | -0.125176 | No Change: Both O | - |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 66 | R | 0.039081 | L | 0.02387 | 0.015211 | No Change: Both O | Joubert syndrome type 2 (JBTS2) [MIM:608091] |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 66 | R | 0.039081 | C | 0.017458 | 0.021623 | No Change: Both O | Joubert syndrome type 2 (JBTS2) [MIM:608091] |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 66 | R | 0.039081 | H | 0.039557 | -4.76E-04 | No Change: Both O | Joubert syndrome type 2 (JBTS2) [MIM:608091] |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 66 | R | 0.039081 | H | 0.039557 | -4.76E-04 | No Change: Both O | Meckel syndrome type 2 (MKS2) [MIM:603194] |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 70 | G | 0.100143 | A | 0.072976 | 0.027167 | No Change: Both O | Meckel syndrome type 2 (MKS2) [MIM:603194] |
| Q9P0N5 | TM216_HUMAN Transmembrane protein 216 OS=Homo sapiens GN=TMEM216 PE=1 SV=2 | 107 | L | 0.050179 | R | 0.084866 | -0.034687 | No Change: Both O | Meckel syndrome type 2 (MKS2) [MIM:603194] |
| Q8TBE7 | TMM22_HUMAN Transmembrane protein 22 OS=Homo sapiens GN=TMEM22 PE=1 SV=3 | 400 | K | 0.283933 | R | 0.237539 | 0.046394 | No Change: Both O | - |
| A0PJW6 | TM223_HUMAN Transmembrane protein 223 OS=Homo sapiens GN=TMEM223 PE=1 SV=1 | 28 | T | 0.279156 | A | 0.234573 | 0.044583 | No Change: Both O | - |
| A0PJW6 | TM223_HUMAN Transmembrane protein 223 OS=Homo sapiens GN=TMEM223 PE=1 SV=1 | 196 | V | 0.329004 | G | 0.480226 | -0.151222 | No Change: Both O | - |
| Q6GV28 | TM225_HUMAN Transmembrane protein 225 OS=Homo sapiens GN=TMEM225 PE=2 SV=1 | 196 | C | 0.52684 | R | 0.642213 | -0.115373 | No Change: Both D | - |
| Q6GV28 | TM225_HUMAN Transmembrane protein 225 OS=Homo sapiens GN=TMEM225 PE=2 SV=1 | 134 | N | 0.169815 | S | 0.217345 | -0.04753 | No Change: Both O | - |
| Q9H6L2 | TM231_HUMAN Transmembrane protein 231 OS=Homo sapiens GN=TMEM231 PE=2 SV=1 | 6 | L | 0.436487 | V | 0.44429 | -0.007803 | No Change: Both O | - |
| Q86YD3 | TMM25_HUMAN Transmembrane protein 25 OS=Homo sapiens GN=TMEM25 PE=1 SV=1 | 342 | Q | 0.256659 | R | 0.261995 | -0.005336 | No Change: Both O | - |
| Q86YD3 | TMM25_HUMAN Transmembrane protein 25 OS=Homo sapiens GN=TMEM25 PE=1 SV=1 | 25 | W | 0.407309 | C | 0.481891 | -0.074582 | No Change: Both O | - |
| Q9NVV0 | TM38B_HUMAN Trimeric intracellular cation channel type B OS=Homo sapiens GN=TMEM38B PE=1 SV=1 | 254 | C | 0.787186 | S | 0.878228 | -0.091042 | No Change: Both D | - |
| Q9NV64 | TM39A_HUMAN Transmembrane protein 39A OS=Homo sapiens GN=TMEM39A PE=2 SV=1 | 487 | A | 0.933104 | T | 0.941526 | -0.008422 | No Change: Both D | - |
| Q9NV64 | TM39A_HUMAN Transmembrane protein 39A OS=Homo sapiens GN=TMEM39A PE=2 SV=1 | 247 | S | 0.439629 | L | 0.273881 | 0.165748 | No Change: Both O | A breast cancer sample |
| Q9BTV4 | TMM43_HUMAN Transmembrane protein 43 OS=Homo sapiens GN=TMEM43 PE=1 SV=1 | 168 | K | 0.567849 | N | 0.548354 | 0.019495 | No Change: Both D | - |
| Q9BTV4 | TMM43_HUMAN Transmembrane protein 43 OS=Homo sapiens GN=TMEM43 PE=1 SV=1 | 179 | M | 0.229065 | T | 0.258641 | -0.029576 | No Change: Both O | - |
| Q9BTV4 | TMM43_HUMAN Transmembrane protein 43 OS=Homo sapiens GN=TMEM43 PE=1 SV=1 | 233 | Y | 0.543634 | C | 0.502095 | 0.041539 | No Change: Both D | - |
| Q9BTV4 | TMM43_HUMAN Transmembrane protein 43 OS=Homo sapiens GN=TMEM43 PE=1 SV=1 | 318 | A | 0.074754 | V | 0.04669 | 0.028064 | No Change: Both O | - |
| Q9BTV4 | TMM43_HUMAN Transmembrane protein 43 OS=Homo sapiens GN=TMEM43 PE=1 SV=1 | 358 | S | 0.070501 | L | 0.03205 | 0.038451 | No Change: Both O | Familial arrhythmogenic right ventricular dysplasia type 5 (ARVD5) [MIM:604400] |
| Q2T9K0 | TMM44_HUMAN Transmembrane protein 44 OS=Homo sapiens GN=TMEM44 PE=2 SV=2 | 24 | H | 0.056045 | N | 0.062159 | -0.006114 | No Change: Both O | - |
| Q96B21 | TM45B_HUMAN Transmembrane protein 45B OS=Homo sapiens GN=TMEM45B PE=1 SV=1 | 59 | T | 0.086402 | I | 0.045982 | 0.04042 | No Change: Both O | - |
| Q9BTX1 | NDC1_HUMAN Nucleoporin NDC1 OS=Homo sapiens GN=TMEM48 PE=1 SV=2 | 154 | G | 0.536878 | D | 0.55241 | -0.015532 | No Change: Both D | - |
| O95807 | TM50A_HUMAN Transmembrane protein 50A OS=Homo sapiens GN=TMEM50A PE=1 SV=1 | 141 | F | 0.023304 | L | 0.024989 | -0.001685 | No Change: Both O | - |
| O95807 | TM50A_HUMAN Transmembrane protein 50A OS=Homo sapiens GN=TMEM50A PE=1 SV=1 | 58 | A | 0.111566 | V | 0.077414 | 0.034152 | No Change: Both O | - |
| Q9NW97 | TMM51_HUMAN Transmembrane protein 51 OS=Homo sapiens GN=TMEM51 PE=1 SV=1 | 34 | V | 0.123686 | A | 0.178709 | -0.055023 | No Change: Both O | - |
| Q9NW97 | TMM51_HUMAN Transmembrane protein 51 OS=Homo sapiens GN=TMEM51 PE=1 SV=1 | 92 | R | 0.64446 | Q | 0.650776 | -0.006316 | No Change: Both D | - |
| Q8NDY8 | TMM52_HUMAN Transmembrane protein 52 OS=Homo sapiens GN=TMEM52 PE=2 SV=1 | 141 | M | 0.771143 | T | 0.774199 | -0.003056 | No Change: Both D | - |
| Q8NDY8 | TMM52_HUMAN Transmembrane protein 52 OS=Homo sapiens GN=TMEM52 PE=2 SV=1 | 141 | M | 0.771143 | V | 0.702409 | 0.068734 | No Change: Both D | - |
| Q969K7 | TMM54_HUMAN Transmembrane protein 54 OS=Homo sapiens GN=TMEM54 PE=2 SV=1 | 110 | L | 0.10399 | F | 0.081768 | 0.022222 | No Change: Both O | - |
| Q9BXS4 | TMM59_HUMAN Transmembrane protein 59 OS=Homo sapiens GN=TMEM59 PE=1 SV=1 | 46 | A | 0.311244 | V | 0.231979 | 0.079265 | No Change: Both O | - |
| Q9H2L4 | TMM60_HUMAN Transmembrane protein 60 OS=Homo sapiens GN=TMEM60 PE=2 SV=1 | 42 | V | 0.004531 | G | 0.008748 | -0.004217 | No Change: Both O | - |
| Q8N0U2 | TMM61_HUMAN Transmembrane protein 61 OS=Homo sapiens GN=TMEM61 PE=2 SV=1 | 40 | E | 0.241704 | K | 0.226829 | 0.014875 | No Change: Both O | - |
| O94886 | TM63A_HUMAN Transmembrane protein 63A OS=Homo sapiens GN=TMEM63A PE=1 SV=3 | 622 | V | 0.0147 | M | 0.018467 | -0.003767 | No Change: Both O | - |
| O94886 | TM63A_HUMAN Transmembrane protein 63A OS=Homo sapiens GN=TMEM63A PE=1 SV=3 | 121 | F | 0.05679 | I | 0.059973 | -0.003183 | No Change: Both O | - |
| Q5T3F8 | TM63B_HUMAN Transmembrane protein 63B OS=Homo sapiens GN=TMEM63B PE=1 SV=1 | 307 | V | 0.501915 | M | 0.579525 | -0.07761 | No Change: Both D | - |
| Q9P1W3 | TM63C_HUMAN Transmembrane protein 63C OS=Homo sapiens GN=TMEM63C PE=2 SV=1 | 654 | M | 0.226856 | V | 0.18968 | 0.037176 | No Change: Both O | - |
| Q6PI78 | TMM65_HUMAN Transmembrane protein 65 OS=Homo sapiens GN=TMEM65 PE=1 SV=2 | 97 | I | 0.288143 | V | 0.296434 | -0.008291 | No Change: Both O | - |
| Q96BY9 | TMM66_HUMAN Transmembrane protein 66 OS=Homo sapiens GN=TMEM66 PE=1 SV=1 | 78 | P | 0.245567 | T | 0.216406 | 0.029161 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 376 | Q | 0.238668 | P | 0.254894 | -0.016226 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 604 | I | 0.238823 | V | 0.289783 | -0.05096 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 513 | Y | 0.421933 | C | 0.365323 | 0.05661 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 513 | Y | 0.421933 | C | 0.365323 | 0.05661 | No Change: Both O | Joubert syndrome type 6 (JBTS6) [MIM:610688] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 513 | Y | 0.421933 | C | 0.365323 | 0.05661 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 545 | G | 0.276809 | E | 0.317316 | -0.040507 | No Change: Both O | Joubert syndrome type 6 (JBTS6) [MIM:610688] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 54 | Y | 0.312122 | C | 0.403434 | -0.091312 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 218 | G | 0.336933 | A | 0.284694 | 0.052239 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 245 | S | 0.0957 | F | 0.034875 | 0.060825 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 252 | M | 0.160972 | T | 0.18208 | -0.021108 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 252 | M | 0.160972 | T | 0.18208 | -0.021108 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 261 | D | 0.177618 | N | 0.170588 | 0.00703 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 296 | W | 0.052083 | C | 0.063675 | -0.011592 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 320 | S | 0.57456 | C | 0.306653 | 0.267907 | D to O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 437 | L | 0.167922 | V | 0.160546 | 0.007376 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 440 | R | 0.056004 | Q | 0.057034 | -0.00103 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 440 | R | 0.056004 | Q | 0.057034 | -0.00103 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 615 | C | 0.034643 | R | 0.079777 | -0.045134 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 615 | C | 0.034643 | R | 0.079777 | -0.045134 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 615 | C | 0.034643 | R | 0.079777 | -0.045134 | No Change: Both O | Nephronophthisis type 11 (NPHP11) [MIM:613550] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 966 | L | 0.075831 | P | 0.14385 | -0.068019 | No Change: Both O | Meckel syndrome type 3 (MKS3) [MIM:607361] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 82 | P | 0.21165 | R | 0.180427 | 0.031223 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 82 | P | 0.21165 | S | 0.223865 | -0.012215 | No Change: Both O | - |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 99 | K | 0.439843 | N | 0.408032 | 0.031811 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 130 | P | 0.178979 | R | 0.155229 | 0.02375 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 172 | R | 0.334449 | Q | 0.310544 | 0.023905 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 242 | N | 0.062664 | T | 0.055659 | 0.007005 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 257 | M | 0.188191 | V | 0.142268 | 0.045923 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 349 | L | 0.137769 | S | 0.24733 | -0.109561 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 358 | P | 0.253531 | L | 0.148052 | 0.105479 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 358 | P | 0.253531 | L | 0.148052 | 0.105479 | No Change: Both O | Joubert syndrome type 6 (JBTS6) [MIM:610688] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 372 | T | 0.228236 | K | 0.288216 | -0.05998 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 376 | Q | 0.238668 | E | 0.280729 | -0.042061 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 441 | R | 0.049164 | C | 0.021149 | 0.028015 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 485 | P | 0.13583 | S | 0.144934 | -0.009104 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 590 | F | 0.054604 | S | 0.146699 | -0.092095 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 637 | F | 0.032404 | L | 0.034864 | -0.00246 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 728 | S | 0.095012 | G | 0.069426 | 0.025586 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 782 | H | 0.078345 | R | 0.076181 | 0.002164 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 820 | R | 0.432945 | S | 0.478608 | -0.045663 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 833 | I | 0.368142 | T | 0.486571 | -0.118429 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 833 | I | 0.368142 | T | 0.486571 | -0.118429 | No Change: Both O | Joubert syndrome type 6 (JBTS6) [MIM:610688] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 841 | Q | 0.398047 | P | 0.400436 | -0.002389 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 942 | F | 0.015861 | C | 0.014087 | 0.001774 | No Change: Both O | COACH syndrome (COACHS) [MIM:216360] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 290 | W | 0.104863 | L | 0.151371 | -0.046508 | No Change: Both O | Nephronophthisis type 11 (NPHP11) [MIM:613550] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 821 | G | 0.42116 | R | 0.453776 | -0.032616 | No Change: Both O | Nephronophthisis type 11 (NPHP11) [MIM:613550] |
| Q5HYA8 | MKS3_HUMAN Meckelin OS=Homo sapiens GN=TMEM67 PE=1 SV=2 | 821 | G | 0.42116 | S | 0.488816 | -0.067656 | No Change: Both O | Nephronophthisis type 11 (NPHP11) [MIM:613550] |
| Q9BUB7 | TMM70_HUMAN Transmembrane protein 70 mitochondrial OS=Homo sapiens GN=TMEM70 PE=1 SV=2 | 34 | A | 0.893703 | P | 0.9138 | -0.020097 | No Change: Both D | - |
| Q9BUB7 | TMM70_HUMAN Transmembrane protein 70 mitochondrial OS=Homo sapiens GN=TMEM70 PE=1 SV=2 | 250 | T | 0.712418 | A | 0.687617 | 0.024801 | No Change: Both D | - |
| Q9BUB7 | TMM70_HUMAN Transmembrane protein 70 mitochondrial OS=Homo sapiens GN=TMEM70 PE=1 SV=2 | 259 | D | 0.848323 | E | 0.865148 | -0.016825 | No Change: Both D | - |
| Q9BUB7 | TMM70_HUMAN Transmembrane protein 70 mitochondrial OS=Homo sapiens GN=TMEM70 PE=1 SV=2 | 228 | N | 0.214073 | K | 0.238704 | -0.024631 | No Change: Both O | - |
| Q9NUR3 | TM74B_HUMAN Transmembrane protein 74B OS=Homo sapiens GN=TMEM74B PE=2 SV=1 | 33 | L | 0.927369 | M | 0.943435 | -0.016066 | No Change: Both D | - |
| Q9BSE2 | TMM79_HUMAN Transmembrane protein 79 OS=Homo sapiens GN=TMEM79 PE=1 SV=1 | 147 | V | 0.553319 | M | 0.639694 | -0.086375 | No Change: Both D | - |
| Q6P7N7 | TMM81_HUMAN Transmembrane protein 81 OS=Homo sapiens GN=TMEM81 PE=2 SV=1 | 77 | R | 0.230812 | Q | 0.235325 | -0.004513 | No Change: Both O | - |
| Q6P7N7 | TMM81_HUMAN Transmembrane protein 81 OS=Homo sapiens GN=TMEM81 PE=2 SV=1 | 100 | F | 0.215849 | S | 0.439064 | -0.223215 | No Change: Both O | - |
| A0PJX8 | TMM82_HUMAN Transmembrane protein 82 OS=Homo sapiens GN=TMEM82 PE=2 SV=2 | 284 | R | 0.032442 | H | 0.031783 | 6.59E-04 | No Change: Both O | - |
| Q5J8M3 | TMM85_HUMAN Transmembrane protein 85 OS=Homo sapiens GN=TMEM85 PE=1 SV=2 | 98 | P | 0.098218 | T | 0.083587 | 0.014631 | No Change: Both O | - |
| Q8N2M4 | TM86A_HUMAN Lysoplasmalogenase-like protein TMEM86A OS=Homo sapiens GN=TMEM86A PE=2 SV=1 | 215 | V | 0.076703 | A | 0.112607 | -0.035904 | No Change: Both O | - |
| Q8N661 | TM86B_HUMAN Lysoplasmalogenase OS=Homo sapiens GN=TMEM86B PE=1 SV=2 | 176 | A | 0.141915 | T | 0.159581 | -0.017666 | No Change: Both O | - |
| Q8N661 | TM86B_HUMAN Lysoplasmalogenase OS=Homo sapiens GN=TMEM86B PE=1 SV=2 | 199 | H | 0.136929 | R | 0.126709 | 0.01022 | No Change: Both O | - |
| Q6PEY1 | TMM88_HUMAN Transmembrane protein 88 OS=Homo sapiens GN=TMEM88 PE=2 SV=1 | 44 | L | 0.020201 | F | 0.016214 | 0.003987 | No Change: Both O | - |
| A2RUT3 | TMM89_HUMAN Transmembrane protein 89 OS=Homo sapiens GN=TMEM89 PE=2 SV=1 | 61 | P | 0.197498 | T | 0.148743 | 0.048755 | No Change: Both O | - |
| Q9HCN3 | TMM8A_HUMAN Transmembrane protein 8A OS=Homo sapiens GN=TMEM8A PE=1 SV=3 | 136 | T | 0.706852 | A | 0.692434 | 0.014418 | No Change: Both D | - |
| Q9HCN3 | TMM8A_HUMAN Transmembrane protein 8A OS=Homo sapiens GN=TMEM8A PE=1 SV=3 | 310 | I | 0.597052 | V | 0.668354 | -0.071302 | No Change: Both D | - |
| Q9HCN3 | TMM8A_HUMAN Transmembrane protein 8A OS=Homo sapiens GN=TMEM8A PE=1 SV=3 | 567 | R | 0.068895 | W | 0.024027 | 0.044868 | No Change: Both O | - |
| Q6UXU6 | TMM92_HUMAN Transmembrane protein 92 OS=Homo sapiens GN=TMEM92 PE=2 SV=1 | 90 | S | 0.710492 | T | 0.657003 | 0.053489 | No Change: Both D | - |
| Q6UXU6 | TMM92_HUMAN Transmembrane protein 92 OS=Homo sapiens GN=TMEM92 PE=2 SV=1 | 90 | S | 0.710492 | N | 0.687908 | 0.022584 | No Change: Both D | - |
| Q6UXU6 | TMM92_HUMAN Transmembrane protein 92 OS=Homo sapiens GN=TMEM92 PE=2 SV=1 | 4 | A | 0.621022 | T | 0.646929 | -0.025907 | No Change: Both D | - |
| Q9Y2Y6 | TMM98_HUMAN Transmembrane protein 98 OS=Homo sapiens GN=TMEM98 PE=2 SV=1 | 83 | W | 0.317639 | R | 0.478168 | -0.160529 | No Change: Both O | - |
| Q8N816 | TMM99_HUMAN Transmembrane protein 99 OS=Homo sapiens GN=TMEM99 PE=2 SV=2 | 4 | I | 0.48713 | M | 0.722106 | -0.234976 | O to D | - |
| Q8N816 | TMM99_HUMAN Transmembrane protein 99 OS=Homo sapiens GN=TMEM99 PE=2 SV=2 | 79 | Y | 0.04179 | H | 0.073972 | -0.032182 | No Change: Both O | - |
| Q8N816 | TMM99_HUMAN Transmembrane protein 99 OS=Homo sapiens GN=TMEM99 PE=2 SV=2 | 95 | L | 0.151172 | R | 0.238482 | -0.08731 | No Change: Both O | - |
| P82094 | TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens GN=TMF1 PE=1 SV=2 | 798 | D | 0.783279 | H | 0.754795 | 0.028484 | No Change: Both D | - |
| P82094 | TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens GN=TMF1 PE=1 SV=2 | 430 | Q | 0.850051 | E | 0.872315 | -0.022264 | No Change: Both D | - |
| P82094 | TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens GN=TMF1 PE=1 SV=2 | 448 | C | 0.898007 | Y | 0.852385 | 0.045622 | No Change: Both D | - |
| P82094 | TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens GN=TMF1 PE=1 SV=2 | 682 | Q | 0.951732 | R | 0.953273 | -0.001541 | No Change: Both D | - |
| Q8NEW7 | TMIE_HUMAN Transmembrane inner ear expressed protein OS=Homo sapiens GN=TMIE PE=1 SV=2 | 81 | R | 0.092648 | C | 0.044208 | 0.04844 | No Change: Both O | Deafness autosomal recessive type 6 (DFNB6) [MIM:600971] |
| Q8NEW7 | TMIE_HUMAN Transmembrane inner ear expressed protein OS=Homo sapiens GN=TMIE PE=1 SV=2 | 84 | R | 0.28684 | W | 0.12429 | 0.16255 | No Change: Both O | Deafness autosomal recessive type 6 (DFNB6) [MIM:600971] |
| Q8NEW7 | TMIE_HUMAN Transmembrane inner ear expressed protein OS=Homo sapiens GN=TMIE PE=1 SV=2 | 92 | R | 0.417121 | W | 0.198476 | 0.218645 | No Change: Both O | Deafness autosomal recessive type 6 (DFNB6) [MIM:600971] |
| Q96BF3 | TMIG2_HUMAN Transmembrane and immunoglobulin domain-containing protein 2 OS=Homo sapiens GN=TMIGD2 PE=1 SV=2 | 202 | A | 0.821854 | P | 0.875606 | -0.053752 | No Change: Both D | - |
| Q96BF3 | TMIG2_HUMAN Transmembrane and immunoglobulin domain-containing protein 2 OS=Homo sapiens GN=TMIGD2 PE=1 SV=2 | 168 | W | 0.024443 | L | 0.032087 | -0.007644 | No Change: Both O | - |
| Q9NZR1 | TMOD2_HUMAN Tropomodulin-2 OS=Homo sapiens GN=TMOD2 PE=1 SV=1 | 63 | P | 0.67373 | A | 0.606639 | 0.067091 | No Change: Both D | - |
| Q9NZQ9 | TMOD4_HUMAN Tropomodulin-4 OS=Homo sapiens GN=TMOD4 PE=2 SV=1 | 336 | N | 0.820938 | S | 0.836898 | -0.01596 | No Change: Both D | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 599 | Q | 0.482681 | E | 0.488302 | -0.005621 | No Change: Both O | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 238 | L | 0.743472 | R | 0.815144 | -0.071672 | No Change: Both D | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 293 | S | 0.942301 | A | 0.913144 | 0.029157 | No Change: Both D | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 317 | T | 0.542994 | S | 0.604812 | -0.061818 | No Change: Both D | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 416 | K | 0.859184 | E | 0.86895 | -0.009766 | No Change: Both D | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 478 | K | 0.525999 | N | 0.462802 | 0.063197 | D to O | - |
| P42166 | LAP2A_HUMAN Lamina-associated polypeptide 2 isoform alpha OS=Homo sapiens GN=TMPO PE=1 SV=2 | 690 | R | 0.707467 | C | 0.667918 | 0.039549 | No Change: Both D | Cardiomyopathy dilated type 1T (CMD1T) [MIM:613740] |
| P42167 | LAP2B_HUMAN Lamina-associated polypeptide 2 isoforms beta/gamma OS=Homo sapiens GN=TMPO PE=1 SV=2 | 427 | L | 0.011599 | F | 0.01047 | 0.001129 | No Change: Both O | - |
| P42167 | LAP2B_HUMAN Lamina-associated polypeptide 2 isoforms beta/gamma OS=Homo sapiens GN=TMPO PE=1 SV=2 | 287 | A | 0.519105 | P | 0.612152 | -0.093047 | No Change: Both D | - |
| Q6ZMR5 | TM11A_HUMAN Transmembrane protease serine 11A OS=Homo sapiens GN=TMPRSS11A PE=1 SV=1 | 293 | R | 0.178654 | Q | 0.178504 | 1.50E-04 | No Change: Both O | - |
| Q86T26 | TM11B_HUMAN Transmembrane protease serine 11B OS=Homo sapiens GN=TMPRSS11B PE=2 SV=3 | 242 | I | 0.081266 | V | 0.103735 | -0.022469 | No Change: Both O | - |
| Q86T26 | TM11B_HUMAN Transmembrane protease serine 11B OS=Homo sapiens GN=TMPRSS11B PE=2 SV=3 | 348 | T | 0.12068 | S | 0.169517 | -0.048837 | No Change: Both O | - |
| Q86T26 | TM11B_HUMAN Transmembrane protease serine 11B OS=Homo sapiens GN=TMPRSS11B PE=2 SV=3 | 325 | D | 0.100943 | A | 0.065108 | 0.035835 | No Change: Both O | - |
| Q9UL52 | TM11E_HUMAN Transmembrane protease serine 11E OS=Homo sapiens GN=TMPRSS11E PE=1 SV=2 | 303 | Y | 0.273582 | C | 0.244045 | 0.029537 | No Change: Both O | - |
| Q6ZWK6 | TM11F_HUMAN Transmembrane protease serine 11F OS=Homo sapiens GN=TMPRSS11F PE=2 SV=2 | 4 | A | 0.704722 | T | 0.711619 | -0.006897 | No Change: Both D | - |
| Q6ZWK6 | TM11F_HUMAN Transmembrane protease serine 11F OS=Homo sapiens GN=TMPRSS11F PE=2 SV=2 | 124 | D | 0.128855 | N | 0.107205 | 0.02165 | No Change: Both O | - |
| Q86WS5 | TMPSC_HUMAN Transmembrane protease serine 12 OS=Homo sapiens GN=TMPRSS12 PE=2 SV=2 | 19 | Y | 0.665673 | H | 0.768921 | -0.103248 | No Change: Both D | - |
| Q86WS5 | TMPSC_HUMAN Transmembrane protease serine 12 OS=Homo sapiens GN=TMPRSS12 PE=2 SV=2 | 62 | E | 0.685823 | K | 0.67916 | 0.006663 | No Change: Both D | - |
| Q86WS5 | TMPSC_HUMAN Transmembrane protease serine 12 OS=Homo sapiens GN=TMPRSS12 PE=2 SV=2 | 127 | A | 0.472553 | T | 0.506042 | -0.033489 | O to D | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 641 | E | 0.363774 | K | 0.379559 | -0.015785 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 77 | K | 0.341778 | R | 0.272172 | 0.069606 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 660 | N | 0.214449 | H | 0.196829 | 0.01762 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 65 | T | 0.273096 | I | 0.160739 | 0.112357 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 134 | E | 0.340202 | Q | 0.294515 | 0.045687 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 545 | S | 0.3471 | C | 0.20626 | 0.14084 | No Change: Both O | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 732 | P | 0.507979 | S | 0.523525 | -0.015546 | No Change: Both D | - |
| P98073 | ENTK_HUMAN Enteropeptidase OS=Homo sapiens GN=TMPRSS15 PE=2 SV=3 | 828 | Y | 0.172261 | C | 0.150504 | 0.021757 | No Change: Both O | - |
| O15393 | TMPS2_HUMAN Transmembrane protease serine 2 OS=Homo sapiens GN=TMPRSS2 PE=1 SV=3 | 449 | K | 0.175386 | N | 0.163024 | 0.012362 | No Change: Both O | - |
| O15393 | TMPS2_HUMAN Transmembrane protease serine 2 OS=Homo sapiens GN=TMPRSS2 PE=1 SV=3 | 160 | V | 0.200585 | M | 0.247504 | -0.046919 | No Change: Both O | - |
| O15393 | TMPS2_HUMAN Transmembrane protease serine 2 OS=Homo sapiens GN=TMPRSS2 PE=1 SV=3 | 254 | S | 0.562931 | C | 0.323218 | 0.239713 | D to O | - |
| O15393 | TMPS2_HUMAN Transmembrane protease serine 2 OS=Homo sapiens GN=TMPRSS2 PE=1 SV=3 | 329 | E | 0.31029 | Q | 0.281673 | 0.028617 | No Change: Both O | - |
| O15393 | TMPS2_HUMAN Transmembrane protease serine 2 OS=Homo sapiens GN=TMPRSS2 PE=1 SV=3 | 491 | D | 0.856245 | N | 0.839491 | 0.016754 | No Change: Both D | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 53 | V | 0.01151 | I | 0.011918 | -4.08E-04 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 251 | W | 0.034701 | C | 0.043433 | -0.008732 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 404 | P | 0.397053 | L | 0.259526 | 0.137527 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 253 | I | 0.024496 | V | 0.028074 | -0.003578 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 103 | D | 0.465953 | G | 0.442983 | 0.02297 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 109 | R | 0.202485 | W | 0.080979 | 0.121506 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 111 | G | 0.182517 | S | 0.212013 | -0.029496 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 173 | D | 0.222459 | N | 0.192452 | 0.030007 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 194 | C | 0.327115 | F | 0.338399 | -0.011284 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 407 | C | 0.205953 | R | 0.367793 | -0.16184 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 426 | A | 0.198394 | T | 0.221291 | -0.022897 | No Change: Both O | - |
| P57727 | TMPS3_HUMAN Transmembrane protease serine 3 OS=Homo sapiens GN=TMPRSS3 PE=1 SV=2 | 216 | R | 0.476406 | L | 0.336473 | 0.139933 | No Change: Both O | - |
| Q9NRS4 | TMPS4_HUMAN Transmembrane protease serine 4 OS=Homo sapiens GN=TMPRSS4 PE=2 SV=2 | 177 | R | 0.673822 | Q | 0.684586 | -0.010764 | No Change: Both D | - |
| Q9NRS4 | TMPS4_HUMAN Transmembrane protease serine 4 OS=Homo sapiens GN=TMPRSS4 PE=2 SV=2 | 198 | K | 0.387104 | E | 0.388639 | -0.001535 | No Change: Both O | - |
| Q9NRS4 | TMPS4_HUMAN Transmembrane protease serine 4 OS=Homo sapiens GN=TMPRSS4 PE=2 SV=2 | 208 | V | 0.378577 | G | 0.473312 | -0.094735 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 31 | D | 0.644297 | V | 0.548324 | 0.095973 | No Change: Both D | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 46 | R | 0.150946 | Q | 0.153239 | -0.002293 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 125 | V | 0.233507 | M | 0.284051 | -0.050544 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 249 | A | 0.141068 | V | 0.108442 | 0.032626 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 317 | A | 0.169848 | S | 0.25962 | -0.089772 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 337 | P | 0.418549 | S | 0.458367 | -0.039818 | No Change: Both O | - |
| Q9H3S3 | TMPS5_HUMAN Transmembrane protease serine 5 OS=Homo sapiens GN=TMPRSS5 PE=1 SV=2 | 369 | F | 0.21201 | L | 0.272735 | -0.060725 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 223 | R | 0.140849 | H | 0.141737 | -8.88E-04 | No Change: Both O | A breast cancer sample |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 234 | R | 0.383228 | S | 0.463196 | -0.079968 | No Change: Both O | A breast cancer sample |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 262 | E | 0.121508 | K | 0.124098 | -0.00259 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 442 | G | 0.350578 | R | 0.333217 | 0.017361 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 521 | D | 0.882324 | N | 0.866716 | 0.015608 | No Change: Both D | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 774 | R | 0.072467 | C | 0.039191 | 0.033276 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 253 | K | 0.307258 | E | 0.297097 | 0.010161 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 288 | S | 0.175784 | L | 0.080053 | 0.095731 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 736 | V | 0.182164 | A | 0.228522 | -0.046358 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 763 | G | 0.418292 | D | 0.443359 | -0.025067 | No Change: Both O | - |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 141 | Y | 0.462948 | C | 0.39446 | 0.068488 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 212 | I | 0.260747 | T | 0.402628 | -0.141881 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 271 | R | 0.160021 | Q | 0.161782 | -0.001761 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 304 | S | 0.129089 | L | 0.059371 | 0.069718 | No Change: Both O | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q8IU80 | TMPS6_HUMAN Transmembrane protease serine 6 OS=Homo sapiens GN=TMPRSS6 PE=1 SV=3 | 510 | C | 0.778328 | S | 0.8231 | -0.044772 | No Change: Both D | Iron-refractory iron deficiency anemia (IRIDA) [MIM:206200] |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 30 | S | 0.124153 | T | 0.091468 | 0.032685 | No Change: Both O | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 793 | S | 0.922136 | N | 0.902536 | 0.0196 | No Change: Both D | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 938 | E | 0.594128 | K | 0.574591 | 0.019537 | No Change: Both D | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 73 | R | 0.574009 | W | 0.36815 | 0.205859 | D to O | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 4 | T | 0.724441 | A | 0.714175 | 0.010266 | No Change: Both D | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 456 | A | 0.937616 | T | 0.945791 | -0.008175 | No Change: Both D | - |
| Q7Z410 | TMPS9_HUMAN Transmembrane protease serine 9 OS=Homo sapiens GN=TMPRSS9 PE=1 SV=2 | 659 | S | 0.104708 | T | 0.07813 | 0.026578 | No Change: Both O | - |
| P63313 | TYB10_HUMAN Thymosin beta-10 OS=Homo sapiens GN=TMSB10 PE=1 SV=2 | 7 | M | 0.950148 | R | 0.945676 | 0.004472 | No Change: Both D | - |
| Q8IUR5 | TMTC1_HUMAN Transmembrane and TPR repeat-containing protein 1 OS=Homo sapiens GN=TMTC1 PE=2 SV=3 | 814 | V | 0.172566 | L | 0.174916 | -0.00235 | No Change: Both O | - |
| Q8N394 | TMTC2_HUMAN Transmembrane and TPR repeat-containing protein 2 OS=Homo sapiens GN=TMTC2 PE=2 SV=1 | 315 | A | 0.048141 | T | 0.059962 | -0.011821 | No Change: Both O | - |
| Q8N394 | TMTC2_HUMAN Transmembrane and TPR repeat-containing protein 2 OS=Homo sapiens GN=TMTC2 PE=2 SV=1 | 443 | Y | 0.117106 | S | 0.247178 | -0.130072 | No Change: Both O | - |
| Q8N394 | TMTC2_HUMAN Transmembrane and TPR repeat-containing protein 2 OS=Homo sapiens GN=TMTC2 PE=2 SV=1 | 741 | D | 0.463659 | Y | 0.293102 | 0.170557 | No Change: Both O | - |
| Q5T4D3 | TMTC4_HUMAN Transmembrane and TPR repeat-containing protein 4 OS=Homo sapiens GN=TMTC4 PE=1 SV=2 | 286 | V | 0.092097 | M | 0.148103 | -0.056006 | No Change: Both O | - |
| Q5T4D3 | TMTC4_HUMAN Transmembrane and TPR repeat-containing protein 4 OS=Homo sapiens GN=TMTC4 PE=1 SV=2 | 419 | V | 0.053127 | I | 0.041658 | 0.011469 | No Change: Both O | - |
| Q5T4D3 | TMTC4_HUMAN Transmembrane and TPR repeat-containing protein 4 OS=Homo sapiens GN=TMTC4 PE=1 SV=2 | 655 | M | 0.230937 | V | 0.189715 | 0.041222 | No Change: Both O | A breast cancer sample |
| Q71RG4 | TMUB2_HUMAN Transmembrane and ubiquitin-like domain-containing protein 2 OS=Homo sapiens GN=TMUB2 PE=2 SV=2 | 228 | R | 0.367716 | H | 0.33358 | 0.034136 | No Change: Both O | - |
| Q96JJ7 | TMX3_HUMAN Protein disulfide-isomerase TMX3 OS=Homo sapiens GN=TMX3 PE=1 SV=2 | 61 | P | 0.179586 | S | 0.198574 | -0.018988 | No Change: Both O | - |
| Q9H1E5 | TMX4_HUMAN Thioredoxin-related transmembrane protein 4 OS=Homo sapiens GN=TMX4 PE=1 SV=1 | 215 | Y | 0.087775 | C | 0.084693 | 0.003082 | No Change: Both O | - |
| Q9H1E5 | TMX4_HUMAN Thioredoxin-related transmembrane protein 4 OS=Homo sapiens GN=TMX4 PE=1 SV=1 | 303 | G | 0.992752 | R | 0.993328 | -5.76E-04 | No Change: Both D | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 2008 | E | 0.234729 | Q | 0.186979 | 0.04775 | No Change: Both O | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 1781 | A | 0.188118 | T | 0.227055 | -0.038937 | No Change: Both O | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 539 | Q | 0.77015 | R | 0.760882 | 0.009268 | No Change: Both D | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 605 | V | 0.603541 | I | 0.58594 | 0.017601 | No Change: Both D | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 680 | Q | 0.362627 | R | 0.329302 | 0.033325 | No Change: Both O | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 213 | G | 0.655315 | S | 0.690506 | -0.035191 | No Change: Both D | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 850 | D | 0.502579 | H | 0.433323 | 0.069256 | D to O | - |
| P24821 | TENA_HUMAN Tenascin OS=Homo sapiens GN=TNC PE=1 SV=3 | 1677 | I | 0.518876 | L | 0.566498 | -0.047622 | No Change: Both D | - |
| P01375 | TNFA_HUMAN Tumor necrosis factor OS=Homo sapiens GN=TNF PE=1 SV=1 | 94 | A | 0.567911 | T | 0.556641 | 0.01127 | No Change: Both D | - |
| P01375 | TNFA_HUMAN Tumor necrosis factor OS=Homo sapiens GN=TNF PE=1 SV=1 | 84 | P | 0.764487 | L | 0.675348 | 0.089139 | No Change: Both D | - |
| Q03169 | TNAP2_HUMAN Tumor necrosis factor alpha-induced protein 2 OS=Homo sapiens GN=TNFAIP2 PE=1 SV=2 | 282 | Q | 0.04312 | E | 0.05312 | -0.01 | No Change: Both O | - |
| Q03169 | TNAP2_HUMAN Tumor necrosis factor alpha-induced protein 2 OS=Homo sapiens GN=TNFAIP2 PE=1 SV=2 | 565 | T | 0.263433 | I | 0.156743 | 0.10669 | No Change: Both O | - |
| Q03169 | TNAP2_HUMAN Tumor necrosis factor alpha-induced protein 2 OS=Homo sapiens GN=TNFAIP2 PE=1 SV=2 | 580 | T | 0.137172 | M | 0.109765 | 0.027407 | No Change: Both O | - |
| P21580 | TNAP3_HUMAN Tumor necrosis factor alpha-induced protein 3 OS=Homo sapiens GN=TNFAIP3 PE=1 SV=1 | 125 | A | 0.194033 | V | 0.157775 | 0.036258 | No Change: Both O | - |
| P21580 | TNAP3_HUMAN Tumor necrosis factor alpha-induced protein 3 OS=Homo sapiens GN=TNFAIP3 PE=1 SV=1 | 127 | F | 0.243706 | C | 0.238994 | 0.004712 | No Change: Both O | - |
| P21580 | TNAP3_HUMAN Tumor necrosis factor alpha-induced protein 3 OS=Homo sapiens GN=TNFAIP3 PE=1 SV=1 | 766 | A | 0.854573 | P | 0.897585 | -0.043012 | No Change: Both D | - |
| P98066 | TSG6_HUMAN Tumor necrosis factor-inducible gene 6 protein OS=Homo sapiens GN=TNFAIP6 PE=1 SV=2 | 144 | Q | 0.401907 | R | 0.380871 | 0.021036 | No Change: Both O | - |
| O95379 | TFIP8_HUMAN Tumor necrosis factor alpha-induced protein 8 OS=Homo sapiens GN=TNFAIP8 PE=2 SV=1 | 151 | S | 0.497421 | C | 0.255623 | 0.241798 | No Change: Both O | - |
| Q8WVP5 | TP8L1_HUMAN Tumor necrosis factor alpha-induced protein 8-like protein 1 OS=Homo sapiens GN=TNFAIP8L1 PE=2 SV=2 | 118 | A | 0.116508 | V | 0.083452 | 0.033056 | No Change: Both O | - |
| Q5GJ75 | TP8L3_HUMAN Tumor necrosis factor alpha-induced protein 8-like protein 3 OS=Homo sapiens GN=TNFAIP8L3 PE=2 SV=1 | 38 | A | 0.410145 | T | 0.452922 | -0.042777 | No Change: Both O | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 33 | T | 0.809927 | I | 0.713336 | 0.096591 | No Change: Both D | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 141 | H | 0.771524 | R | 0.787138 | -0.015614 | No Change: Both D | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 209 | R | 0.771277 | T | 0.743215 | 0.028062 | No Change: Both D | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 228 | E | 0.290533 | A | 0.18596 | 0.104573 | No Change: Both O | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 11 | G | 0.693272 | V | 0.5892 | 0.104072 | No Change: Both D | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 105 | P | 0.245155 | R | 0.21423 | 0.030925 | No Change: Both O | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 297 | N | 0.558038 | H | 0.538183 | 0.019855 | No Change: Both D | - |
| O00220 | TR10A_HUMAN Tumor necrosis factor receptor superfamily member 10A OS=Homo sapiens GN=TNFRSF10A PE=1 SV=3 | 441 | R | 0.542688 | K | 0.589446 | -0.046758 | No Change: Both D | - |
| O14763 | TR10B_HUMAN Tumor necrosis factor receptor superfamily member 10B OS=Homo sapiens GN=TNFRSF10B PE=1 SV=2 | 32 | P | 0.701366 | L | 0.586627 | 0.114739 | No Change: Both D | - |
| O14763 | TR10B_HUMAN Tumor necrosis factor receptor superfamily member 10B OS=Homo sapiens GN=TNFRSF10B PE=1 SV=2 | 67 | A | 0.847552 | V | 0.789591 | 0.057961 | No Change: Both D | - |
| O14763 | TR10B_HUMAN Tumor necrosis factor receptor superfamily member 10B OS=Homo sapiens GN=TNFRSF10B PE=1 SV=2 | 191 | V | 0.820268 | A | 0.844411 | -0.024143 | No Change: Both D | - |
| O14798 | TR10C_HUMAN Tumor necrosis factor receptor superfamily member 10C OS=Homo sapiens GN=TNFRSF10C PE=1 SV=3 | 199 | T | 0.999115 | N | 0.998866 | 2.49E-04 | No Change: Both D | - |
| O14798 | TR10C_HUMAN Tumor necrosis factor receptor superfamily member 10C OS=Homo sapiens GN=TNFRSF10C PE=1 SV=3 | 229 | I | 0.669021 | T | 0.72545 | -0.056429 | No Change: Both D | - |
| Q9UBN6 | TR10D_HUMAN Tumor necrosis factor receptor superfamily member 10D OS=Homo sapiens GN=TNFRSF10D PE=1 SV=1 | 35 | P | 0.114512 | S | 0.116465 | -0.001953 | No Change: Both O | - |
| Q9UBN6 | TR10D_HUMAN Tumor necrosis factor receptor superfamily member 10D OS=Homo sapiens GN=TNFRSF10D PE=1 SV=1 | 310 | S | 0.903009 | L | 0.856952 | 0.046057 | No Change: Both D | - |
| Q9UBN6 | TR10D_HUMAN Tumor necrosis factor receptor superfamily member 10D OS=Homo sapiens GN=TNFRSF10D PE=1 SV=1 | 345 | T | 0.535027 | P | 0.58459 | -0.049563 | No Change: Both D | - |
| Q9UBN6 | TR10D_HUMAN Tumor necrosis factor receptor superfamily member 10D OS=Homo sapiens GN=TNFRSF10D PE=1 SV=1 | 276 | R | 0.817901 | H | 0.763575 | 0.054326 | No Change: Both D | - |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 192 | A | 0.648698 | V | 0.59786 | 0.050838 | No Change: Both D | - |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 53 | G | 0.701282 | R | 0.720421 | -0.019139 | No Change: Both D | Osteopetrosis autosomal recessive type 7 (OPTB7) [MIM:612301] |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 129 | R | 0.332859 | C | 0.2466 | 0.086259 | No Change: Both O | Osteopetrosis autosomal recessive type 7 (OPTB7) [MIM:612301] |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 141 | H | 0.439064 | Y | 0.341722 | 0.097342 | No Change: Both O | - |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 170 | R | 0.342584 | G | 0.341925 | 6.59E-04 | No Change: Both O | Osteopetrosis autosomal recessive type 7 (OPTB7) [MIM:612301] |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 175 | C | 0.373215 | R | 0.440883 | -0.067668 | No Change: Both O | Osteopetrosis autosomal recessive type 7 (OPTB7) [MIM:612301] |
| Q9Y6Q6 | TNR11_HUMAN Tumor necrosis factor receptor superfamily member 11A OS=Homo sapiens GN=TNFRSF11A PE=1 SV=1 | 244 | A | 0.120244 | S | 0.17646 | -0.056216 | No Change: Both O | Osteopetrosis autosomal recessive type 7 (OPTB7) [MIM:612301] |
| O00300 | TR11B_HUMAN Tumor necrosis factor receptor superfamily member 11B OS=Homo sapiens GN=TNFRSF11B PE=1 SV=3 | 3 | N | 0.439511 | K | 0.455772 | -0.016261 | No Change: Both O | - |
| O00300 | TR11B_HUMAN Tumor necrosis factor receptor superfamily member 11B OS=Homo sapiens GN=TNFRSF11B PE=1 SV=3 | 104 | V | 0.383532 | M | 0.449525 | -0.065993 | No Change: Both O | - |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 104 | C | 0.469897 | R | 0.552744 | -0.082847 | O to D | Immunodeficiency common variable type 2 (CVID2) [MIM:240500] |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 104 | C | 0.469897 | R | 0.552744 | -0.082847 | O to D | Immunoglobulin A deficiency 2 (IGAD2) [MIM:609529] |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 181 | A | 0.272645 | G | 0.281166 | -0.008521 | No Change: Both O | Immunodeficiency common variable type 2 (CVID2) [MIM:240500] |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 202 | R | 0.94108 | H | 0.92356 | 0.01752 | No Change: Both D | Immunodeficiency common variable type 2 (CVID2) [MIM:240500] |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 251 | P | 0.827895 | L | 0.703086 | 0.124809 | No Change: Both D | - |
| O14836 | TR13B_HUMAN Tumor necrosis factor receptor superfamily member 13B OS=Homo sapiens GN=TNFRSF13B PE=1 SV=1 | 56 | H | 0.366965 | N | 0.412519 | -0.045554 | No Change: Both O | - |
| Q96RJ3 | TR13C_HUMAN Tumor necrosis factor receptor superfamily member 13C OS=Homo sapiens GN=TNFRSF13C PE=1 SV=1 | 64 | G | 0.803912 | V | 0.727138 | 0.076774 | No Change: Both D | - |
| Q96RJ3 | TR13C_HUMAN Tumor necrosis factor receptor superfamily member 13C OS=Homo sapiens GN=TNFRSF13C PE=1 SV=1 | 159 | H | 0.946217 | Y | 0.915611 | 0.030606 | No Change: Both D | - |
| Q92956 | TNR14_HUMAN Tumor necrosis factor receptor superfamily member 14 OS=Homo sapiens GN=TNFRSF14 PE=1 SV=3 | 17 | K | 0.454243 | R | 0.451135 | 0.003108 | No Change: Both O | - |
| Q92956 | TNR14_HUMAN Tumor necrosis factor receptor superfamily member 14 OS=Homo sapiens GN=TNFRSF14 PE=1 SV=3 | 241 | V | 0.400386 | I | 0.358032 | 0.042354 | No Change: Both O | - |
| Q92956 | TNR14_HUMAN Tumor necrosis factor receptor superfamily member 14 OS=Homo sapiens GN=TNFRSF14 PE=1 SV=3 | 117 | A | 0.507825 | T | 0.53054 | -0.022715 | No Change: Both D | - |
| Q92956 | TNR14_HUMAN Tumor necrosis factor receptor superfamily member 14 OS=Homo sapiens GN=TNFRSF14 PE=1 SV=3 | 174 | G | 0.686866 | E | 0.721371 | -0.034505 | No Change: Both D | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 153 | A | 0.447963 | T | 0.500213 | -0.05225 | O to D | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 54 | A | 0.099767 | V | 0.076826 | 0.022941 | No Change: Both O | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 65 | I | 0.026756 | V | 0.031483 | -0.004727 | No Change: Both O | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 75 | F | 0.031285 | V | 0.03654 | -0.005255 | No Change: Both O | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 81 | N | 0.362598 | S | 0.419201 | -0.056603 | No Change: Both O | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 165 | C | 0.44962 | S | 0.63608 | -0.18646 | O to D | - |
| Q02223 | TNR17_HUMAN Tumor necrosis factor receptor superfamily member 17 OS=Homo sapiens GN=TNFRSF17 PE=1 SV=2 | 176 | E | 0.592738 | D | 0.556839 | 0.035899 | No Change: Both D | - |
| Q9Y5U5 | TNR18_HUMAN Tumor necrosis factor receptor superfamily member 18 OS=Homo sapiens GN=TNFRSF18 PE=1 SV=1 | 43 | T | 0.713873 | R | 0.749141 | -0.035268 | No Change: Both D | - |
| Q9Y5U5 | TNR18_HUMAN Tumor necrosis factor receptor superfamily member 18 OS=Homo sapiens GN=TNFRSF18 PE=1 SV=1 | 64 | E | 0.79063 | K | 0.745248 | 0.045382 | No Change: Both D | - |
| Q9Y5U5 | TNR18_HUMAN Tumor necrosis factor receptor superfamily member 18 OS=Homo sapiens GN=TNFRSF18 PE=1 SV=1 | 83 | D | 0.846864 | N | 0.811078 | 0.035786 | No Change: Both D | - |
| Q9Y5U5 | TNR18_HUMAN Tumor necrosis factor receptor superfamily member 18 OS=Homo sapiens GN=TNFRSF18 PE=1 SV=1 | 173 | V | 0.02479 | M | 0.030454 | -0.005664 | No Change: Both O | - |
| Q9NS68 | TNR19_HUMAN Tumor necrosis factor receptor superfamily member 19 OS=Homo sapiens GN=TNFRSF19 PE=1 SV=1 | 31 | S | 0.440772 | T | 0.379121 | 0.061651 | No Change: Both O | - |
| Q9NS68 | TNR19_HUMAN Tumor necrosis factor receptor superfamily member 19 OS=Homo sapiens GN=TNFRSF19 PE=1 SV=1 | 405 | V | 0.651502 | I | 0.629149 | 0.022353 | No Change: Both D | - |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 305 | P | 0.817242 | T | 0.769621 | 0.047621 | No Change: Both D | - |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 59 | C | 0.497013 | R | 0.555838 | -0.058825 | O to D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 62 | C | 0.546246 | Y | 0.460712 | 0.085534 | D to O | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 79 | T | 0.751872 | M | 0.717215 | 0.034657 | No Change: Both D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 81 | C | 0.765341 | F | 0.689456 | 0.075885 | No Change: Both D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 117 | C | 0.418268 | R | 0.537835 | -0.119567 | O to D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 117 | C | 0.418268 | Y | 0.38023 | 0.038038 | No Change: Both O | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 59 | C | 0.497013 | S | 0.599744 | -0.102731 | O to D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 62 | C | 0.546246 | G | 0.578022 | -0.031776 | No Change: Both D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 99 | C | 0.756975 | S | 0.828331 | -0.071356 | No Change: Both D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 121 | R | 0.35391 | P | 0.349553 | 0.004357 | No Change: Both O | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 51 | H | 0.444623 | Q | 0.500529 | -0.055906 | O to D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 75 | P | 0.718562 | L | 0.573734 | 0.144828 | No Change: Both D | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 115 | S | 0.475713 | G | 0.404772 | 0.070941 | No Change: Both O | Familial hibernian fever (FHF) [MIM:142680] |
| P19438 | TNR1A_HUMAN Tumor necrosis factor receptor superfamily member 1A OS=Homo sapiens GN=TNFRSF1A PE=1 SV=1 | 121 | R | 0.35391 | Q | 0.35826 | -0.00435 | No Change: Both O | Familial hibernian fever (FHF) [MIM:142680] |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 196 | M | 0.70754 | R | 0.741702 | -0.034162 | No Change: Both D | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 232 | E | 0.984189 | K | 0.981928 | 0.002261 | No Change: Both D | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 187 | V | 0.540898 | M | 0.620046 | -0.079148 | No Change: Both D | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 236 | A | 0.970126 | T | 0.976316 | -0.00619 | No Change: Both D | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 264 | L | 0.104176 | P | 0.187163 | -0.082987 | No Change: Both O | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 269 | T | 0.055637 | P | 0.076797 | -0.02116 | No Change: Both O | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 295 | Q | 0.372169 | R | 0.363334 | 0.008835 | No Change: Both O | - |
| P20333 | TNR1B_HUMAN Tumor necrosis factor receptor superfamily member 1B OS=Homo sapiens GN=TNFRSF1B PE=1 SV=3 | 301 | P | 0.537018 | R | 0.495686 | 0.041332 | D to O | - |
| Q93038 | TNR25_HUMAN Tumor necrosis factor receptor superfamily member 25 OS=Homo sapiens GN=TNFRSF25 PE=1 SV=2 | 370 | R | 0.306554 | L | 0.186407 | 0.120147 | No Change: Both O | - |
| Q93038 | TNR25_HUMAN Tumor necrosis factor receptor superfamily member 25 OS=Homo sapiens GN=TNFRSF25 PE=1 SV=2 | 381 | R | 0.395172 | H | 0.355524 | 0.039648 | No Change: Both O | - |
| Q93038 | TNR25_HUMAN Tumor necrosis factor receptor superfamily member 25 OS=Homo sapiens GN=TNFRSF25 PE=1 SV=2 | 23 | R | 0.403092 | Q | 0.401985 | 0.001107 | No Change: Both O | - |
| Q93038 | TNR25_HUMAN Tumor necrosis factor receptor superfamily member 25 OS=Homo sapiens GN=TNFRSF25 PE=1 SV=2 | 159 | D | 0.659973 | G | 0.639591 | 0.020382 | No Change: Both D | - |
| Q93038 | TNR25_HUMAN Tumor necrosis factor receptor superfamily member 25 OS=Homo sapiens GN=TNFRSF25 PE=1 SV=2 | 254 | P | 0.726485 | R | 0.654575 | 0.07191 | No Change: Both D | - |
| P43489 | TNR4_HUMAN Tumor necrosis factor receptor superfamily member 4 OS=Homo sapiens GN=TNFRSF4 PE=1 SV=1 | 10 | R | 0.306292 | C | 0.181635 | 0.124657 | No Change: Both O | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 273 | C | 0.603462 | Y | 0.501685 | 0.101777 | No Change: Both D | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 402 | S | 0.100288 | G | 0.079325 | 0.020963 | No Change: Both O | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 273 | C | 0.603462 | F | 0.472226 | 0.131236 | D to O | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 297 | C | 0.599708 | R | 0.655602 | -0.055894 | No Change: Both D | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 314 | P | 0.784481 | S | 0.758414 | 0.026067 | No Change: Both D | - |
| P28908 | TNR8_HUMAN Tumor necrosis factor receptor superfamily member 8 OS=Homo sapiens GN=TNFRSF8 PE=1 SV=1 | 466 | Q | 0.819622 | R | 0.823832 | -0.00421 | No Change: Both D | - |
| Q07011 | TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 OS=Homo sapiens GN=TNFRSF9 PE=1 SV=1 | 56 | A | 0.923904 | T | 0.941712 | -0.017808 | No Change: Both D | - |
| Q07011 | TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 OS=Homo sapiens GN=TNFRSF9 PE=1 SV=1 | 115 | K | 0.786534 | N | 0.744232 | 0.042302 | No Change: Both D | - |
| Q07011 | TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 OS=Homo sapiens GN=TNFRSF9 PE=1 SV=1 | 176 | A | 0.816588 | D | 0.834616 | -0.018028 | No Change: Both D | - |
| Q07011 | TNR9_HUMAN Tumor necrosis factor receptor superfamily member 9 OS=Homo sapiens GN=TNFRSF9 PE=1 SV=1 | 250 | E | 0.89244 | G | 0.861831 | 0.030609 | No Change: Both D | A colorectal cancer sample |
| P50591 | TNF10_HUMAN Tumor necrosis factor ligand superfamily member 10 OS=Homo sapiens GN=TNFSF10 PE=1 SV=1 | 33 | V | 0.028305 | I | 0.022052 | 0.006253 | No Change: Both O | - |
| P50591 | TNF10_HUMAN Tumor necrosis factor ligand superfamily member 10 OS=Homo sapiens GN=TNFSF10 PE=1 SV=1 | 47 | D | 0.653211 | E | 0.686465 | -0.033254 | No Change: Both D | - |
| O14788 | TNF11_HUMAN Tumor necrosis factor ligand superfamily member 11 OS=Homo sapiens GN=TNFSF11 PE=1 SV=1 | 199 | M | 0.27259 | K | 0.42123 | -0.14864 | No Change: Both O | Osteopetrosis autosomal recessive type 2 (OPTB2) [MIM:259710] |
| O75888 | TNF13_HUMAN Tumor necrosis factor ligand superfamily member 13 OS=Homo sapiens GN=TNFSF13 PE=1 SV=1 | 67 | G | 0.800116 | R | 0.809885 | -0.009769 | No Change: Both D | - |
| O75888 | TNF13_HUMAN Tumor necrosis factor ligand superfamily member 13 OS=Homo sapiens GN=TNFSF13 PE=1 SV=1 | 96 | N | 0.79457 | S | 0.842322 | -0.047752 | No Change: Both D | - |
| Q9Y275 | TN13B_HUMAN Tumor necrosis factor ligand superfamily member 13B OS=Homo sapiens GN=TNFSF13B PE=1 SV=1 | 105 | A | 0.83707 | T | 0.827152 | 0.009918 | No Change: Both D | - |
| O43557 | TNF14_HUMAN Tumor necrosis factor ligand superfamily member 14 OS=Homo sapiens GN=TNFSF14 PE=1 SV=2 | 32 | S | 0.562417 | L | 0.347965 | 0.214452 | D to O | - |
| O43557 | TNF14_HUMAN Tumor necrosis factor ligand superfamily member 14 OS=Homo sapiens GN=TNFSF14 PE=1 SV=2 | 120 | L | 0.091464 | V | 0.081359 | 0.010105 | No Change: Both O | - |
| O43557 | TNF14_HUMAN Tumor necrosis factor ligand superfamily member 14 OS=Homo sapiens GN=TNFSF14 PE=1 SV=2 | 214 | K | 0.289377 | E | 0.316334 | -0.026957 | No Change: Both O | - |
| O95150 | TNF15_HUMAN Tumor necrosis factor ligand superfamily member 15 OS=Homo sapiens GN=TNFSF15 PE=1 SV=2 | 110 | F | 0.455822 | L | 0.47864 | -0.022818 | No Change: Both O | - |
| P41273 | TNFL9_HUMAN Tumor necrosis factor ligand superfamily member 9 OS=Homo sapiens GN=TNFSF9 PE=1 SV=1 | 17 | P | 0.617035 | A | 0.526077 | 0.090958 | No Change: Both D | - |
| Q9UKE5 | TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1 | 778 | K | 0.965346 | E | 0.967021 | -0.001675 | No Change: Both D | - |
| Q9UKE5 | TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1 | 910 | G | 0.844025 | E | 0.861471 | -0.017446 | No Change: Both D | - |
| Q9UKE5 | TNIK_HUMAN TRAF2 and NCK-interacting protein kinase OS=Homo sapiens GN=TNIK PE=1 SV=1 | 999 | A | 0.830384 | T | 0.845666 | -0.015282 | No Change: Both D | - |
| Q15025 | TNIP1_HUMAN TNFAIP3-interacting protein 1 OS=Homo sapiens GN=TNIP1 PE=1 SV=2 | 103 | P | 0.981203 | S | 0.980099 | 0.001104 | No Change: Both D | - |
| Q15025 | TNIP1_HUMAN TNFAIP3-interacting protein 1 OS=Homo sapiens GN=TNIP1 PE=1 SV=2 | 146 | A | 0.847088 | V | 0.80935 | 0.037738 | No Change: Both D | - |
| Q15025 | TNIP1_HUMAN TNFAIP3-interacting protein 1 OS=Homo sapiens GN=TNIP1 PE=1 SV=2 | 151 | P | 0.7546 | A | 0.689558 | 0.065042 | No Change: Both D | - |
| Q15025 | TNIP1_HUMAN TNFAIP3-interacting protein 1 OS=Homo sapiens GN=TNIP1 PE=1 SV=2 | 233 | R | 0.950249 | Q | 0.9525 | -0.002251 | No Change: Both D | - |
| Q15025 | TNIP1_HUMAN TNFAIP3-interacting protein 1 OS=Homo sapiens GN=TNIP1 PE=1 SV=2 | 260 | A | 0.962869 | V | 0.948702 | 0.014167 | No Change: Both D | - |
| Q8NFZ5 | TNIP2_HUMAN TNFAIP3-interacting protein 2 OS=Homo sapiens GN=TNIP2 PE=1 SV=1 | 396 | A | 0.928918 | V | 0.898878 | 0.03004 | No Change: Both D | - |
| Q96KP6 | TNIP3_HUMAN TNFAIP3-interacting protein 3 OS=Homo sapiens GN=TNIP3 PE=1 SV=2 | 99 | K | 0.990865 | E | 0.991194 | -3.29E-04 | No Change: Both D | - |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 278 | V | 0.384742 | I | 0.362732 | 0.02201 | No Change: Both O | - |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 339 | R | 0.488865 | K | 0.492338 | -0.003473 | No Change: Both O | A lung adenocarcinoma sample |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 514 | T | 0.978633 | K | 0.984355 | -0.005722 | No Change: Both D | - |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 539 | R | 0.999096 | C | 0.998518 | 5.78E-04 | No Change: Both D | - |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 546 | S | 0.99927 | C | 0.998671 | 5.99E-04 | No Change: Both D | - |
| Q13470 | TNK1_HUMAN Non-receptor tyrosine-protein kinase TNK1 OS=Homo sapiens GN=TNK1 PE=1 SV=3 | 598 | V | 0.383943 | M | 0.461104 | -0.077161 | No Change: Both O | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 34 | R | 0.237873 | L | 0.155395 | 0.082478 | No Change: Both O | A lung adenocarcinoma sample |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 71 | K | 0.660394 | R | 0.636912 | 0.023482 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 99 | R | 0.891754 | Q | 0.898931 | -0.007177 | No Change: Both D | An ovarian mucinous carcinoma sample |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 99 | R | 0.891754 | W | 0.771313 | 0.120441 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 152 | T | 0.397735 | M | 0.388346 | 0.009389 | No Change: Both O | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 346 | E | 0.659165 | K | 0.662833 | -0.003668 | No Change: Both D | An ovarian endometrioid cancer sample |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 409 | M | 0.187256 | I | 0.140891 | 0.046365 | No Change: Both O | A gastric adenocarcinoma sample |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 507 | P | 0.81078 | S | 0.802957 | 0.007823 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 725 | P | 0.98518 | L | 0.970381 | 0.014799 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 748 | R | 0.996169 | Q | 0.99635 | -1.81E-04 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 1038 | R | 0.89933 | H | 0.903299 | -0.003969 | No Change: Both D | - |
| Q07912 | ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens GN=TNK2 PE=1 SV=3 | 802 | P | 0.995454 | L | 0.991389 | 0.004065 | No Change: Both D | - |
| Q9C0C2 | TB182_HUMAN 182 kDa tankyrase-1-binding protein OS=Homo sapiens GN=TNKS1BP1 PE=1 SV=4 | 322 | T | 0.99126 | S | 0.994169 | -0.002909 | No Change: Both D | - |
| Q9C0C2 | TB182_HUMAN 182 kDa tankyrase-1-binding protein OS=Homo sapiens GN=TNKS1BP1 PE=1 SV=4 | 714 | S | 0.890991 | N | 0.834923 | 0.056068 | No Change: Both D | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 930 | P | 0.667007 | L | 0.54539 | 0.121617 | No Change: Both D | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 289 | D | 0.397329 | N | 0.378574 | 0.018755 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 499 | T | 0.463884 | M | 0.4075 | 0.056384 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 807 | W | 0.29918 | R | 0.496346 | -0.197166 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 941 | T | 0.462363 | M | 0.440363 | 0.022 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 79 | R | 0.43959 | G | 0.435051 | 0.004539 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 440 | R | 0.417125 | S | 0.492099 | -0.074974 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 1135 | D | 0.260849 | E | 0.305328 | -0.044479 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 1156 | A | 0.358082 | V | 0.297871 | 0.060211 | No Change: Both O | - |
| Q9UQP3 | TENN_HUMAN Tenascin-N OS=Homo sapiens GN=TNN PE=1 SV=2 | 859 | M | 0.395546 | V | 0.368453 | 0.027093 | No Change: Both O | - |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 29 | L | 0.160652 | Q | 0.266538 | -0.105886 | No Change: Both O | Familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:613243] |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 159 | G | 0.751986 | R | 0.77584 | -0.023854 | No Change: Both D | Cardiomyopathy dilated type 1Z (CMD1Z) [MIM:611879] |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 8 | A | 0.36634 | V | 0.281707 | 0.084633 | No Change: Both O | Familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:613243] |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 84 | C | 0.707191 | Y | 0.67342 | 0.033771 | No Change: Both D | Familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:613243] |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 134 | E | 0.70152 | D | 0.692339 | 0.009181 | No Change: Both D | Familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:613243] |
| P63316 | TNNC1_HUMAN Troponin C slow skeletal and cardiac muscles OS=Homo sapiens GN=TNNC1 PE=1 SV=1 | 145 | D | 0.725182 | E | 0.736721 | -0.011539 | No Change: Both D | Familial hypertrophic cardiomyopathy type 13 (CMH13) [MIM:613243] |
| P19237 | TNNI1_HUMAN Troponin I slow skeletal muscle OS=Homo sapiens GN=TNNI1 PE=1 SV=3 | 67 | R | 0.29207 | W | 0.119945 | 0.172125 | No Change: Both O | - |
| P48788 | TNNI2_HUMAN Troponin I fast skeletal muscle OS=Homo sapiens GN=TNNI2 PE=1 SV=2 | 174 | R | 0.973047 | Q | 0.965186 | 0.007861 | No Change: Both D | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 145 | R | 0.384939 | G | 0.344934 | 0.040005 | No Change: Both O | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 206 | K | 0.879363 | Q | 0.824865 | 0.054498 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 82 | P | 0.638455 | S | 0.66679 | -0.028335 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 144 | L | 0.380787 | Q | 0.514197 | -0.13341 | O to D | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 145 | R | 0.384939 | W | 0.164119 | 0.22082 | No Change: Both O | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 171 | A | 0.653391 | T | 0.661947 | -0.008556 | No Change: Both D | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 178 | K | 0.799974 | E | 0.801478 | -0.001504 | No Change: Both D | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 190 | D | 0.805057 | H | 0.752283 | 0.052774 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 190 | D | 0.805057 | H | 0.752283 | 0.052774 | No Change: Both D | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 192 | R | 0.811943 | H | 0.747682 | 0.064261 | No Change: Both D | Familial restrictive cardiomyopathy type 1 (RCM1) [MIM:115210] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 196 | D | 0.79251 | N | 0.781534 | 0.010976 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 141 | R | 0.432632 | Q | 0.417134 | 0.015498 | No Change: Both O | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 157 | A | 0.547189 | V | 0.449201 | 0.097988 | D to O | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 162 | R | 0.595138 | P | 0.589787 | 0.005351 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 186 | R | 0.810674 | Q | 0.798732 | 0.011942 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 79 | R | 0.700731 | C | 0.605661 | 0.09507 | No Change: Both D | - |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 166 | S | 0.683748 | F | 0.508468 | 0.17528 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 162 | R | 0.595138 | Q | 0.591676 | 0.003462 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 204 | R | 0.870937 | H | 0.805004 | 0.065933 | No Change: Both D | Familial hypertrophic cardiomyopathy type 7 (CMH7) [MIM:613690] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 2 | A | 0.990596 | V | 0.981063 | 0.009533 | No Change: Both D | Cardiomyopathy dilated type 2A (CMD2A) [MIM:611880] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 36 | K | 0.925697 | Q | 0.916739 | 0.008958 | No Change: Both D | Cardiomyopathy dilated type 1FF (CMD1FF) [MIM:613286] |
| P19429 | TNNI3_HUMAN Troponin I cardiac muscle OS=Homo sapiens GN=TNNI3 PE=1 SV=3 | 185 | N | 0.819026 | K | 0.863085 | -0.044059 | No Change: Both D | Cardiomyopathy dilated type 1FF (CMD1FF) [MIM:613286] |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 629 | R | 0.222653 | G | 0.245472 | -0.022819 | No Change: Both O | A colorectal cancer sample |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 785 | A | 0.757814 | G | 0.780828 | -0.023014 | No Change: Both D | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 833 | D | 0.925355 | Y | 0.897316 | 0.028039 | No Change: Both D | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 151 | D | 0.286703 | H | 0.267901 | 0.018802 | No Change: Both O | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 263 | P | 0.216134 | L | 0.119864 | 0.09627 | No Change: Both O | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 309 | F | 0.249909 | L | 0.260835 | -0.010926 | No Change: Both O | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 430 | S | 0.566447 | L | 0.381999 | 0.184448 | D to O | A colorectal adenocarcinoma sample |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 510 | V | 0.078656 | L | 0.081264 | -0.002608 | No Change: Both O | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 637 | T | 0.098856 | M | 0.07744 | 0.021416 | No Change: Both O | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 686 | I | 0.400941 | T | 0.517435 | -0.116494 | O to D | - |
| Q59H18 | TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | 798 | M | 0.701212 | I | 0.603687 | 0.097525 | No Change: Both D | A head & Neck squamous cell carcinoma sample |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 89 | I | 0.855555 | N | 0.895381 | -0.039826 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 102 | R | 0.788194 | Q | 0.775857 | 0.012337 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 120 | F | 0.880707 | I | 0.888718 | -0.008011 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 173 | E | 0.987404 | K | 0.986778 | 6.26E-04 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 254 | E | 0.46025 | D | 0.421269 | 0.038981 | No Change: Both O | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 263 | K | 0.595048 | R | 0.539246 | 0.055802 | No Change: Both D | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 288 | R | 0.730094 | C | 0.581707 | 0.148387 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 288 | R | 0.730094 | P | 0.710607 | 0.019487 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 104 | R | 0.783466 | L | 0.709575 | 0.073891 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 139 | R | 0.983064 | K | 0.982087 | 9.77E-04 | No Change: Both D | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 249 | S | 0.384553 | T | 0.320062 | 0.064491 | No Change: Both O | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 102 | R | 0.788194 | L | 0.714863 | 0.073331 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 102 | R | 0.788194 | W | 0.605393 | 0.182801 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 114 | A | 0.784483 | V | 0.748871 | 0.035612 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 151 | R | 0.997904 | W | 0.993912 | 0.003992 | No Change: Both D | Cardiomyopathy dilated type 1D (CMD1D) [MIM:601494] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 189 | S | 0.9562 | F | 0.932026 | 0.024174 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 80 | F | 0.971245 | L | 0.973568 | -0.002323 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 120 | F | 0.880707 | V | 0.887618 | -0.006911 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 281 | N | 0.681179 | I | 0.514183 | 0.166996 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 296 | R | 0.792607 | C | 0.67863 | 0.113977 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 140 | R | 0.98465 | K | 0.983602 | 0.001048 | No Change: Both D | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 279 | N | 0.587214 | Y | 0.394625 | 0.192589 | D to O | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 140 | R | 0.98465 | C | 0.973402 | 0.011248 | No Change: Both D | Familial hypertrophic cardiomyopathy type 2 (CMH2) [MIM:115195] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 221 | I | 0.814573 | T | 0.873485 | -0.058912 | No Change: Both D | - |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 141 | R | 0.986141 | W | 0.962994 | 0.023147 | No Change: Both D | Cardiomyopathy dilated type 1D (CMD1D) [MIM:601494] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 215 | R | 0.917465 | L | 0.873862 | 0.043603 | No Change: Both D | Cardiomyopathy dilated type 1D (CMD1D) [MIM:601494] |
| P45379 | TNNT2_HUMAN Troponin T cardiac muscle OS=Homo sapiens GN=TNNT2 PE=1 SV=3 | 231 | I | 0.680914 | T | 0.741692 | -0.060778 | No Change: Both D | - |
| P45378 | TNNT3_HUMAN Troponin T fast skeletal muscle OS=Homo sapiens GN=TNNT3 PE=1 SV=3 | 74 | R | 0.84673 | H | 0.824716 | 0.022014 | No Change: Both D | Distal arthrogryposis type 2B (DA2B) [MIM:601680] |
| Q05952 | STP2_HUMAN Nuclear transition protein 2 OS=Homo sapiens GN=TNP2 PE=2 SV=1 | 131 | R | 0.934576 | W | 0.848517 | 0.086059 | No Change: Both D | - |
| Q92973 | TNPO1_HUMAN Transportin-1 OS=Homo sapiens GN=TNPO1 PE=1 SV=2 | 34 | D | 0.730927 | E | 0.758876 | -0.027949 | No Change: Both D | - |
| Q92752 | TENR_HUMAN Tenascin-R OS=Homo sapiens GN=TNR PE=1 SV=3 | 17 | I | 0.09362 | V | 0.102006 | -0.008386 | No Change: Both O | - |
| Q92752 | TENR_HUMAN Tenascin-R OS=Homo sapiens GN=TNR PE=1 SV=3 | 128 | A | 0.380131 | S | 0.498264 | -0.118133 | No Change: Both O | - |
| Q92752 | TENR_HUMAN Tenascin-R OS=Homo sapiens GN=TNR PE=1 SV=3 | 293 | G | 0.856898 | S | 0.863446 | -0.006548 | No Change: Both D | - |
| Q92752 | TENR_HUMAN Tenascin-R OS=Homo sapiens GN=TNR PE=1 SV=3 | 643 | R | 0.303747 | K | 0.356072 | -0.052325 | No Change: Both O | - |
| Q92752 | TENR_HUMAN Tenascin-R OS=Homo sapiens GN=TNR PE=1 SV=3 | 302 | S | 0.831378 | N | 0.822303 | 0.009075 | No Change: Both D | - |
| O15417 | TNC18_HUMAN Trinucleotide repeat-containing gene 18 protein OS=Homo sapiens GN=TNRC18 PE=1 SV=3 | 1193 | A | 0.959088 | G | 0.962975 | -0.003887 | No Change: Both D | - |
| Q8NDV7 | TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens GN=TNRC6A PE=1 SV=2 | 185 | N | 0.939564 | K | 0.938945 | 6.19E-04 | No Change: Both D | - |
| Q8NDV7 | TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens GN=TNRC6A PE=1 SV=2 | 592 | A | 0.927049 | T | 0.939275 | -0.012226 | No Change: Both D | - |
| Q8NDV7 | TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens GN=TNRC6A PE=1 SV=2 | 788 | P | 0.778532 | S | 0.797599 | -0.019067 | No Change: Both D | - |
| Q8NDV7 | TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens GN=TNRC6A PE=1 SV=2 | 1268 | E | 0.852158 | K | 0.859261 | -0.007103 | No Change: Both D | - |
| Q9UPQ9 | TNR6B_HUMAN Trinucleotide repeat-containing gene 6B protein OS=Homo sapiens GN=TNRC6B PE=1 SV=4 | 517 | S | 0.894788 | C | 0.820192 | 0.074596 | No Change: Both D | - |
| Q9HCJ0 | TNR6C_HUMAN Trinucleotide repeat-containing gene 6C protein OS=Homo sapiens GN=TNRC6C PE=1 SV=3 | 820 | P | 0.911776 | R | 0.882083 | 0.029693 | No Change: Both D | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 311 | I | 0.466972 | M | 0.5694 | -0.102428 | O to D | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 466 | R | 0.744897 | C | 0.614672 | 0.130225 | No Change: Both D | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 528 | T | 0.818207 | I | 0.696974 | 0.121233 | No Change: Both D | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 1004 | R | 0.65584 | W | 0.396456 | 0.259384 | D to O | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 1197 | W | 0.882743 | R | 0.951504 | -0.068761 | No Change: Both D | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 1604 | V | 0.46313 | I | 0.428413 | 0.034717 | No Change: Both O | - |
| Q9HBL0 | TENS1_HUMAN Tensin-1 OS=Homo sapiens GN=TNS1 PE=1 SV=2 | 1093 | F | 0.988004 | L | 0.989782 | -0.001778 | No Change: Both D | A breast cancer sample |
| Q68CZ2 | TENS3_HUMAN Tensin-3 OS=Homo sapiens GN=TNS3 PE=1 SV=2 | 600 | Q | 0.462664 | H | 0.382859 | 0.079805 | No Change: Both O | - |
| Q68CZ2 | TENS3_HUMAN Tensin-3 OS=Homo sapiens GN=TNS3 PE=1 SV=2 | 679 | G | 0.87404 | S | 0.896796 | -0.022756 | No Change: Both D | - |
| Q68CZ2 | TENS3_HUMAN Tensin-3 OS=Homo sapiens GN=TNS3 PE=1 SV=2 | 1034 | E | 0.850017 | K | 0.823658 | 0.026359 | No Change: Both D | - |
| Q8IZW8 | TENS4_HUMAN Tensin-4 OS=Homo sapiens GN=TNS4 PE=1 SV=3 | 179 | L | 0.866045 | P | 0.920054 | -0.054009 | No Change: Both D | - |
| Q8IZW8 | TENS4_HUMAN Tensin-4 OS=Homo sapiens GN=TNS4 PE=1 SV=3 | 498 | S | 0.672631 | N | 0.628819 | 0.043812 | No Change: Both D | - |
| Q8IZW8 | TENS4_HUMAN Tensin-4 OS=Homo sapiens GN=TNS4 PE=1 SV=3 | 642 | R | 0.149209 | C | 0.069168 | 0.080041 | No Change: Both O | A colorectal cancer sample |
| Q8IZW8 | TENS4_HUMAN Tensin-4 OS=Homo sapiens GN=TNS4 PE=1 SV=3 | 327 | T | 0.966373 | K | 0.966232 | 1.41E-04 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 2363 | P | 0.834746 | H | 0.776639 | 0.058107 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 2555 | G | 0.75017 | S | 0.76783 | -0.01766 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 2578 | G | 0.983037 | E | 0.986412 | -0.003375 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 511 | R | 0.935046 | H | 0.904213 | 0.030833 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 1248 | H | 0.533955 | R | 0.540798 | -0.006843 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 302 | T | 0.967842 | A | 0.960563 | 0.007279 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 29 | R | 0.812167 | W | 0.64561 | 0.166557 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 1195 | V | 0.564608 | M | 0.60145 | -0.036842 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 4033 | L | 0.305293 | I | 0.264902 | 0.040391 | No Change: Both O | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 641 | G | 0.805311 | C | 0.788358 | 0.016953 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 650 | R | 0.810214 | H | 0.762399 | 0.047815 | No Change: Both D | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 825 | S | 0.19028 | A | 0.132282 | 0.057998 | No Change: Both O | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 2425 | P | 0.464549 | H | 0.438159 | 0.02639 | No Change: Both O | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 1987 | E | 0.350268 | K | 0.305258 | 0.04501 | No Change: Both O | - |
| P22105 | TENX_HUMAN Tenascin-X OS=Homo sapiens GN=TNXB PE=1 SV=3 | 2472 | P | 0.958955 | L | 0.929717 | 0.029238 | No Change: Both D | - |
| P50616 | TOB1_HUMAN Protein Tob1 OS=Homo sapiens GN=TOB1 PE=1 SV=1 | 319 | K | 0.368399 | R | 0.331958 | 0.036441 | No Change: Both O | - |
| Q96GM8 | TOE1_HUMAN Target of EGR1 protein 1 OS=Homo sapiens GN=TOE1 PE=1 SV=1 | 341 | R | 0.950778 | H | 0.927555 | 0.023223 | No Change: Both D | - |
| Q96GM8 | TOE1_HUMAN Target of EGR1 protein 1 OS=Homo sapiens GN=TOE1 PE=1 SV=1 | 381 | E | 0.902029 | K | 0.89972 | 0.002309 | No Change: Both D | - |
| Q9H0E2 | TOLIP_HUMAN Toll-interacting protein OS=Homo sapiens GN=TOLLIP PE=1 SV=1 | 222 | A | 0.495881 | S | 0.58691 | -0.091029 | O to D | - |
| O60784 | TOM1_HUMAN Target of Myb protein 1 OS=Homo sapiens GN=TOM1 PE=1 SV=2 | 264 | M | 0.538804 | V | 0.469045 | 0.069759 | D to O | - |
| O60784 | TOM1_HUMAN Target of Myb protein 1 OS=Homo sapiens GN=TOM1 PE=1 SV=2 | 84 | R | 0.111981 | H | 0.12446 | -0.012479 | No Change: Both O | - |
| O75674 | TM1L1_HUMAN TOM1-like protein 1 OS=Homo sapiens GN=TOM1L1 PE=1 SV=2 | 108 | R | 0.206567 | S | 0.254165 | -0.047598 | No Change: Both O | - |
| Q15388 | TOM20_HUMAN Mitochondrial import receptor subunit TOM20 homolog OS=Homo sapiens GN=TOMM20 PE=1 SV=1 | 117 | P | 0.38243 | L | 0.231631 | 0.150799 | No Change: Both O | - |
| Q15388 | TOM20_HUMAN Mitochondrial import receptor subunit TOM20 homolog OS=Homo sapiens GN=TOMM20 PE=1 SV=1 | 134 | V | 0.505906 | L | 0.548588 | -0.042682 | No Change: Both D | - |
| Q15785 | TOM34_HUMAN Mitochondrial import receptor subunit TOM34 OS=Homo sapiens GN=TOMM34 PE=1 SV=2 | 293 | R | 0.596701 | K | 0.650151 | -0.05345 | No Change: Both D | - |
| Q969M1 | TM40L_HUMAN Mitochondrial import receptor subunit TOM40B OS=Homo sapiens GN=TOMM40L PE=2 SV=1 | 100 | D | 0.506737 | N | 0.48187 | 0.024867 | D to O | A colorectal cancer sample |
| Q96HA7 | TONSL_HUMAN Tonsoku-like protein OS=Homo sapiens GN=TONSL PE=1 SV=2 | 488 | V | 0.982604 | M | 0.988095 | -0.005491 | No Change: Both D | - |
| Q96HA7 | TONSL_HUMAN Tonsoku-like protein OS=Homo sapiens GN=TONSL PE=1 SV=2 | 493 | G | 0.974627 | S | 0.977896 | -0.003269 | No Change: Both D | - |
| Q96HA7 | TONSL_HUMAN Tonsoku-like protein OS=Homo sapiens GN=TONSL PE=1 SV=2 | 714 | A | 0.991203 | V | 0.988298 | 0.002905 | No Change: Both D | - |
| Q96HA7 | TONSL_HUMAN Tonsoku-like protein OS=Homo sapiens GN=TONSL PE=1 SV=2 | 1276 | P | 0.428236 | L | 0.328344 | 0.099892 | No Change: Both O | - |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 533 | D | 0.21642 | G | 0.194615 | 0.021805 | No Change: Both O | CPT-resistant leukemia |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 729 | T | 0.047827 | A | 0.044545 | 0.003282 | No Change: Both O | CPT-resistant lung cancer |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 370 | M | 0.737142 | T | 0.684224 | 0.052918 | No Change: Both D | CPT-resistant leukemia |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 722 | N | 0.235579 | S | 0.277527 | -0.041948 | No Change: Both O | CPT-resistant leukemia |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 326 | K | 0.865908 | R | 0.832349 | 0.033559 | No Change: Both D | Breast cancer |
| P11387 | TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens GN=TOP1 PE=1 SV=2 | 214 | G | 0.709181 | S | 0.714458 | -0.005277 | No Change: Both D | - |
| Q969P6 | TOP1M_HUMAN DNA topoisomerase I mitochondrial OS=Homo sapiens GN=TOP1MT PE=2 SV=1 | 525 | R | 0.928778 | W | 0.830265 | 0.098513 | No Change: Both D | - |
| Q969P6 | TOP1M_HUMAN DNA topoisomerase I mitochondrial OS=Homo sapiens GN=TOP1MT PE=2 SV=1 | 256 | V | 0.192982 | I | 0.184214 | 0.008768 | No Change: Both O | - |
| P11388 | TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sapiens GN=TOP2A PE=1 SV=3 | 450 | R | 0.536829 | Q | 0.534445 | 0.002384 | No Change: Both D | - |
| P11388 | TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sapiens GN=TOP2A PE=1 SV=3 | 487 | R | 0.151158 | K | 0.197827 | -0.046669 | No Change: Both O | - |
| P11388 | TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sapiens GN=TOP2A PE=1 SV=3 | 1324 | T | 0.984708 | K | 0.986779 | -0.002071 | No Change: Both D | - |
| P11388 | TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sapiens GN=TOP2A PE=1 SV=3 | 1386 | G | 0.93468 | D | 0.957336 | -0.022656 | No Change: Both D | - |
| P11388 | TOP2A_HUMAN DNA topoisomerase 2-alpha OS=Homo sapiens GN=TOP2A PE=1 SV=3 | 1515 | A | 0.814708 | S | 0.873443 | -0.058735 | No Change: Both D | - |
| Q13472 | TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens GN=TOP3A PE=1 SV=1 | 596 | C | 0.331222 | Y | 0.346058 | -0.014836 | No Change: Both O | - |
| Q13472 | TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens GN=TOP3A PE=1 SV=1 | 459 | D | 0.281624 | N | 0.267042 | 0.014582 | No Change: Both O | - |
| Q13472 | TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens GN=TOP3A PE=1 SV=1 | 742 | D | 0.401655 | N | 0.353007 | 0.048648 | No Change: Both O | - |
| Q13472 | TOP3A_HUMAN DNA topoisomerase 3-alpha OS=Homo sapiens GN=TOP3A PE=1 SV=1 | 773 | N | 0.972875 | D | 0.975205 | -0.00233 | No Change: Both D | - |
| O95985 | TOP3B_HUMAN DNA topoisomerase 3-beta-1 OS=Homo sapiens GN=TOP3B PE=1 SV=1 | 365 | D | 0.271393 | N | 0.265387 | 0.006006 | No Change: Both O | - |
| Q92547 | TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens GN=TOPBP1 PE=1 SV=3 | 955 | N | 0.702255 | S | 0.728833 | -0.026578 | No Change: Both D | - |
| Q92547 | TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens GN=TOPBP1 PE=1 SV=3 | 817 | S | 0.81835 | L | 0.718045 | 0.100305 | No Change: Both D | - |
| Q92547 | TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens GN=TOPBP1 PE=1 SV=3 | 1042 | N | 0.924867 | S | 0.934156 | -0.009289 | No Change: Both D | - |
| Q9NS56 | TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens GN=TOPORS PE=1 SV=1 | 154 | A | 0.398365 | T | 0.43212 | -0.033755 | No Change: Both O | - |
| Q9NS56 | TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens GN=TOPORS PE=1 SV=1 | 517 | E | 0.960482 | K | 0.957925 | 0.002557 | No Change: Both D | - |
| Q9NS56 | TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens GN=TOPORS PE=1 SV=1 | 749 | N | 0.969044 | D | 0.962681 | 0.006363 | No Change: Both D | - |
| Q9NS56 | TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens GN=TOPORS PE=1 SV=1 | 812 | P | 0.888087 | R | 0.895321 | -0.007234 | No Change: Both D | - |
| O14656 | TOR1A_HUMAN Torsin-1A OS=Homo sapiens GN=TOR1A PE=1 SV=1 | 264 | D | 0.055516 | H | 0.044197 | 0.011319 | No Change: Both O | - |
| O14656 | TOR1A_HUMAN Torsin-1A OS=Homo sapiens GN=TOR1A PE=1 SV=1 | 216 | D | 0.14699 | H | 0.118775 | 0.028215 | No Change: Both O | - |
| Q5JTV8 | TOIP1_HUMAN Torsin-1A-interacting protein 1 OS=Homo sapiens GN=TOR1AIP1 PE=1 SV=2 | 146 | M | 0.991626 | T | 0.993221 | -0.001595 | No Change: Both D | - |
| Q5JTV8 | TOIP1_HUMAN Torsin-1A-interacting protein 1 OS=Homo sapiens GN=TOR1AIP1 PE=1 SV=2 | 276 | P | 0.815295 | R | 0.797448 | 0.017847 | No Change: Both D | - |
| Q5JTV8 | TOIP1_HUMAN Torsin-1A-interacting protein 1 OS=Homo sapiens GN=TOR1AIP1 PE=1 SV=2 | 293 | Q | 0.794269 | H | 0.723037 | 0.071232 | No Change: Both D | - |
| Q5JTV8 | TOIP1_HUMAN Torsin-1A-interacting protein 1 OS=Homo sapiens GN=TOR1AIP1 PE=1 SV=2 | 190 | V | 0.687533 | I | 0.66795 | 0.019583 | No Change: Both D | A breast cancer sample |
| O14657 | TOR1B_HUMAN Torsin-1B OS=Homo sapiens GN=TOR1B PE=1 SV=2 | 54 | A | 0.091012 | T | 0.102107 | -0.011095 | No Change: Both O | - |
| Q5JU69 | TOR2A_HUMAN Torsin-2A OS=Homo sapiens GN=TOR2A PE=2 SV=1 | 203 | K | 0.379702 | E | 0.386503 | -0.006801 | No Change: Both O | - |
| Q9H497 | TOR3A_HUMAN Torsin-3A OS=Homo sapiens GN=TOR3A PE=1 SV=1 | 13 | F | 0.201366 | L | 0.259448 | -0.058082 | No Change: Both O | - |
| O94900 | TOX_HUMAN Thymocyte selection-associated high mobility group box protein TOX OS=Homo sapiens GN=TOX PE=2 SV=3 | 267 | A | 0.719458 | T | 0.725681 | -0.006223 | No Change: Both D | - |
| Q96NM4 | TOX2_HUMAN TOX high mobility group box family member 2 OS=Homo sapiens GN=TOX2 PE=2 SV=2 | 223 | V | 0.997303 | A | 0.998328 | -0.001025 | No Change: Both D | - |
| O15405 | TOX3_HUMAN TOX high mobility group box family member 3 OS=Homo sapiens GN=TOX3 PE=1 SV=2 | 128 | V | 0.710097 | M | 0.781235 | -0.071138 | No Change: Both D | - |
| O15405 | TOX3_HUMAN TOX high mobility group box family member 3 OS=Homo sapiens GN=TOX3 PE=1 SV=2 | 572 | Q | 0.986996 | P | 0.985262 | 0.001734 | No Change: Both D | - |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 7 | D | 0.968944 | H | 0.95638 | 0.012564 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 35 | L | 0.823908 | F | 0.796964 | 0.026944 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 43 | L | 0.819352 | S | 0.881321 | -0.061969 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 53 | W | 0.893106 | C | 0.919982 | -0.026876 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 60 | P | 0.968394 | S | 0.962354 | 0.00604 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 72 | P | 0.990172 | R | 0.985554 | 0.004618 | No Change: Both D | - |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 79 | A | 0.98268 | T | 0.982471 | 2.09E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 87 | P | 0.949276 | Q | 0.937098 | 0.012178 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 94 | S | 0.868913 | T | 0.837327 | 0.031586 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | C | 0.425128 | 0.035414 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | L | 0.410475 | 0.050067 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | P | 0.54853 | -0.087988 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | C | 0.402067 | -0.032574 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 125 | T | 0.29174 | M | 0.254967 | 0.036773 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | D | 0.401608 | -0.130095 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | N | 0.406937 | -0.135424 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 127 | S | 0.253105 | F | 0.117393 | 0.135712 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 128 | P | 0.240791 | S | 0.266616 | -0.025825 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 129 | A | 0.218729 | D | 0.268106 | -0.049377 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | R | 0.297901 | -0.090993 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | S | 0.263108 | -0.067527 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | K | 0.260836 | -0.065255 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | M | 0.114508 | 0.05835 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | Q | 0.151431 | 0.021427 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | T | 0.203536 | -0.04388 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | S | 0.285541 | -0.150807 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | F | 0.132055 | 0.002679 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 136 | Q | 0.134018 | E | 0.141417 | -0.007399 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 136 | Q | 0.134018 | K | 0.165665 | -0.031647 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 137 | L | 0.12616 | Q | 0.225628 | -0.099468 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 138 | A | 0.126585 | P | 0.196855 | -0.07027 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 139 | K | 0.127031 | N | 0.100841 | 0.02619 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | G | 0.191968 | -0.060083 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | F | 0.11277 | 0.019115 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | Y | 0.116116 | 0.015769 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 143 | V | 0.142476 | A | 0.192774 | -0.050298 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 144 | Q | 0.181082 | P | 0.214819 | -0.033737 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 145 | L | 0.217907 | P | 0.394126 | -0.176219 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 145 | L | 0.217907 | Q | 0.358775 | -0.140868 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | D | 0.43027 | -0.124768 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | G | 0.398001 | -0.092499 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 149 | S | 0.390405 | P | 0.408621 | -0.018216 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | A | 0.366533 | 0.090099 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | S | 0.46297 | -0.006338 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | T | 0.408521 | 0.048111 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | L | 0.331944 | 0.153534 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | S | 0.49517 | -0.009692 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | T | 0.447208 | 0.043953 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | V | 0.425504 | 0.062807 | No Change: Both O | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | A | 0.446169 | 0.02456 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | P | 0.496663 | -0.045033 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | D | 0.53938 | -0.114749 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | F | 0.385338 | 0.039293 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | C | 0.276276 | 0.113678 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | G | 0.36816 | 0.021794 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | H | 0.356164 | 0.03379 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 160 | M | 0.385351 | I | 0.279304 | 0.106047 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | S | 0.53505 | -0.105029 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | S | 0.676347 | -0.210646 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | V | 0.545203 | -0.079502 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | H | 0.637684 | -0.153021 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | N | 0.444033 | 0.047338 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | Q | 0.513236 | -0.021865 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 165 | Q | 0.50664 | L | 0.357445 | 0.149195 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 165 | Q | 0.50664 | R | 0.507477 | -8.37E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 166 | S | 0.515188 | L | 0.353326 | 0.161862 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | R | 0.560874 | -0.055229 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 169 | M | 0.52285 | I | 0.415556 | 0.107294 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 169 | M | 0.52285 | T | 0.551265 | -0.028415 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 170 | T | 0.530525 | M | 0.536638 | -0.006113 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 170 | T | 0.530525 | S | 0.618659 | -0.088134 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 172 | V | 0.566093 | A | 0.621796 | -0.055703 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | E | 0.717605 | -0.155497 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | L | 0.547892 | 0.014216 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | M | 0.644103 | -0.081995 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | K | 0.564956 | -0.006068 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | C | 0.380051 | 0.15542 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | G | 0.500766 | 0.034705 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | L | 0.367643 | 0.167828 | D to O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | P | 0.572084 | -0.036613 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | H | 0.519018 | 0.016453 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | F | 0.489188 | 0.046145 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | W | 0.434585 | 0.100748 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | L | 0.382149 | 0.181079 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | L | 0.507193 | 0.126998 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 182 | C | 0.663371 | S | 0.764219 | -0.100848 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 184 | D | 0.678797 | Y | 0.546818 | 0.131979 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | Y | 0.514639 | 0.134239 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | C | 0.515985 | 0.104979 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | S | 0.685242 | -0.064278 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | P | 0.656304 | -0.124591 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | L | 0.315461 | 0.172247 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 191 | P | 0.451998 | T | 0.371126 | 0.080872 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 192 | Q | 0.420192 | R | 0.44626 | -0.026068 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | D | 0.461368 | -0.052921 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | R | 0.460216 | -0.051769 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | P | 0.577794 | -0.164807 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | R | 0.552394 | -0.139407 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | T | 0.558009 | -0.155803 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 198 | E | 0.396287 | K | 0.342944 | 0.053343 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | C | 0.372409 | -0.030216 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | D | 0.513544 | -0.171351 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 213 | R | 0.284169 | Q | 0.276368 | 0.007801 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | M | 0.339242 | -0.04654 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | C | 0.43016 | -0.005638 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | H | 0.516792 | -0.09227 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | S | 0.558013 | -0.133491 | O to D | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | E | 0.429216 | -0.045441 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 230 | T | 0.273194 | I | 0.171026 | 0.102168 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | T | 0.392165 | -0.152128 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | C | 0.266791 | -0.036501 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | H | 0.335613 | -0.105323 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | I | 0.198316 | 0.088633 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | F | 0.281112 | 0.042101 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | Y | 0.32562 | -0.002407 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | I | 0.187034 | 0.192255 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | F | 0.198351 | 0.209842 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | F | 0.404897 | 0.025603 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | A | 0.339346 | 0.08144 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | C | 0.28832 | 0.132466 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | D | 0.435142 | -0.014356 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | S | 0.490029 | -0.069243 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | V | 0.279866 | 0.14092 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | R | 0.448875 | -0.061985 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | T | 0.418606 | -0.031716 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | V | 0.295553 | 0.091337 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | I | 0.213282 | 0.143864 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | G | 0.351591 | -2.29E-04 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | L | 0.233906 | 0.117456 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | Q | 0.327947 | 0.023415 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | W | 0.155859 | 0.195503 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | G | 0.324757 | 0.004175 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | S | 0.37823 | -0.049298 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | N | 0.470176 | -0.15906 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 252 | L | 0.315855 | P | 0.482866 | -0.167011 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 257 | L | 0.434018 | P | 0.578067 | -0.144049 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | D | 0.452407 | 0.009889 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | K | 0.430277 | 0.032019 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 272 | V | 0.635728 | L | 0.674284 | -0.038556 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | C | 0.574569 | 0.079594 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | G | 0.618205 | 0.035958 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | H | 0.563337 | 0.090826 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | F | 0.664877 | -0.001223 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | Y | 0.576462 | 0.103348 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | W | 0.53851 | 0.1413 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | G | 0.773994 | -0.045161 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | A | 0.667182 | 0.077047 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | H | 0.674991 | 0.069238 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | L | 0.641441 | 0.102788 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | S | 0.752005 | -0.007776 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | T | 0.708188 | 0.036041 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 279 | G | 0.771086 | E | 0.817175 | -0.046089 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | K | 0.777224 | 0.012303 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | I | 0.646978 | 0.142549 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | T | 0.756072 | 0.033455 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | A | 0.769873 | 0.036986 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | E | 0.845181 | -0.038322 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | G | 0.807379 | -5.20E-04 | No Change: Both D | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | H | 0.778248 | 0.028611 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | V | 0.725037 | 0.081822 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | L | 0.760312 | 0.076104 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | W | 0.656334 | 0.180082 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | C | 0.808008 | 0.046941 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | G | 0.833976 | 0.020973 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | H | 0.812738 | 0.042211 | No Change: Both D | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | P | 0.857506 | -0.002557 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 284 | T | 0.868557 | A | 0.856758 | 0.011799 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 284 | T | 0.868557 | P | 0.895434 | -0.026877 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | K | 0.873696 | 0.010604 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | Q | 0.851042 | 0.033258 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | V | 0.818458 | 0.065842 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | A | 0.858633 | 0.03891 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | D | 0.883045 | 0.014498 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | G | 0.879103 | 0.01844 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | K | 0.889552 | 0.007991 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | Q | 0.867722 | 0.029821 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | P | 0.978501 | -0.010129 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 300 | P | 0.968383 | R | 0.963141 | 0.005242 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 301 | P | 0.968959 | L | 0.943206 | 0.025753 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 302 | G | 0.965308 | E | 0.97412 | -0.008812 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 302 | G | 0.965308 | V | 0.942149 | 0.023159 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 306 | R | 0.967417 | Q | 0.966338 | 0.001079 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 307 | A | 0.965908 | T | 0.976736 | -0.010828 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 309 | P | 0.960517 | S | 0.95821 | 0.002307 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 325 | G | 0.814708 | V | 0.717152 | 0.097556 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 334 | G | 0.74023 | V | 0.616542 | 0.123688 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 337 | R | 0.73474 | C | 0.615405 | 0.119335 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | I | 0.397101 | 0.02753 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 47 | P | 0.827208 | S | 0.817706 | 0.009502 | No Change: Both D | - |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | I | 0.916482 | 0.041448 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | N | 0.488439 | -0.167993 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | T | 0.459986 | -0.13954 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 339 | E | 0.734583 | K | 0.721559 | 0.013024 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 366 | S | 0.963044 | A | 0.947069 | 0.015975 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | V | 0.376277 | -0.006784 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 138 | A | 0.126585 | V | 0.095602 | 0.030983 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | C | 0.584078 | -0.099415 | O to D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | A | 0.273326 | 0.134867 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | M | 0.298335 | 0.030597 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | S | 0.510199 | -0.199083 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | Y | 0.326877 | 0.154294 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 337 | R | 0.73474 | H | 0.654659 | 0.080081 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 134 | F | 0.153304 | L | 0.187686 | -0.034382 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | R | 0.54992 | 0.013308 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 213 | R | 0.284169 | P | 0.320846 | -0.036677 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 267 | R | 0.600216 | W | 0.362083 | 0.238133 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | K | 0.600229 | 0.034713 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | L | 0.539623 | 0.11454 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | L | 0.308861 | 0.078029 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 5 | Q | 0.970419 | H | 0.954947 | 0.015472 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 6 | S | 0.969522 | L | 0.945413 | 0.024109 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 8 | P | 0.967692 | S | 0.966136 | 0.001556 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 10 | V | 0.962855 | I | 0.954389 | 0.008466 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 11 | E | 0.961104 | K | 0.95618 | 0.004924 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 11 | E | 0.961104 | Q | 0.958929 | 0.002175 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 15 | S | 0.946464 | R | 0.917967 | 0.028497 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 16 | Q | 0.944144 | L | 0.920107 | 0.024037 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 17 | E | 0.941424 | D | 0.937532 | 0.003892 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 24 | K | 0.838192 | N | 0.851771 | -0.013579 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 28 | E | 0.833878 | A | 0.775004 | 0.058874 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 31 | V | 0.830788 | I | 0.835733 | -0.004945 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 33 | S | 0.829252 | T | 0.784955 | 0.044297 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 34 | P | 0.828997 | L | 0.749004 | 0.079993 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 36 | P | 0.822923 | L | 0.735581 | 0.087342 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 37 | S | 0.825182 | P | 0.839114 | -0.013932 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 37 | S | 0.825182 | T | 0.779842 | 0.04534 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 39 | A | 0.822493 | P | 0.898397 | -0.075904 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 39 | A | 0.822493 | V | 0.803858 | 0.018635 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 42 | D | 0.830735 | Y | 0.690242 | 0.140493 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 44 | M | 0.806048 | I | 0.719079 | 0.086969 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 44 | M | 0.806048 | T | 0.801692 | 0.004356 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 44 | M | 0.806048 | V | 0.733076 | 0.072972 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 45 | L | 0.81889 | M | 0.856093 | -0.037203 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 46 | S | 0.817448 | F | 0.710451 | 0.106997 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 46 | S | 0.817448 | P | 0.835394 | -0.017946 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 47 | P | 0.827208 | L | 0.739023 | 0.088185 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 48 | D | 0.82519 | G | 0.772289 | 0.052901 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 49 | D | 0.833973 | H | 0.764817 | 0.069156 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 49 | D | 0.833973 | N | 0.808268 | 0.025705 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 49 | D | 0.833973 | Y | 0.69294 | 0.141033 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 52 | Q | 0.878888 | H | 0.843528 | 0.03536 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 53 | W | 0.893106 | G | 0.934686 | -0.04158 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 54 | F | 0.91008 | L | 0.932337 | -0.022257 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 54 | F | 0.91008 | Y | 0.903557 | 0.006523 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 56 | E | 0.935989 | K | 0.922522 | 0.013467 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 56 | E | 0.935989 | V | 0.893482 | 0.042507 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 58 | P | 0.954006 | Q | 0.943321 | 0.010685 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 58 | P | 0.954006 | T | 0.932952 | 0.021054 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 59 | G | 0.963664 | C | 0.962623 | 0.001041 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 59 | G | 0.963664 | D | 0.977368 | -0.013704 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 60 | P | 0.968394 | L | 0.942544 | 0.02585 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 60 | P | 0.968394 | Q | 0.960067 | 0.008327 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 61 | D | 0.972355 | G | 0.963465 | 0.00889 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 61 | D | 0.972355 | N | 0.963328 | 0.009027 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 62 | E | 0.975916 | D | 0.976152 | -2.36E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 63 | A | 0.977678 | T | 0.977733 | -5.50E-05 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 63 | A | 0.977678 | V | 0.968771 | 0.008907 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 65 | R | 0.981813 | T | 0.982978 | -0.001165 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 66 | M | 0.984794 | I | 0.975606 | 0.009188 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 66 | M | 0.984794 | R | 0.985202 | -4.08E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 67 | P | 0.985987 | L | 0.970362 | 0.015625 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 67 | P | 0.985987 | R | 0.980146 | 0.005841 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 67 | P | 0.985987 | S | 0.982177 | 0.00381 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 68 | E | 0.986736 | G | 0.982002 | 0.004734 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 68 | E | 0.986736 | Q | 0.985375 | 0.001361 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 69 | A | 0.987836 | D | 0.989905 | -0.002069 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 69 | A | 0.987836 | G | 0.986452 | 0.001384 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 69 | A | 0.987836 | T | 0.987352 | 4.84E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 69 | A | 0.987836 | V | 0.981834 | 0.006002 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 70 | A | 0.988869 | T | 0.988398 | 4.71E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 71 | P | 0.989739 | T | 0.983731 | 0.006008 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 73 | V | 0.989363 | E | 0.995443 | -0.00608 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 73 | V | 0.989363 | L | 0.990929 | -0.001566 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 73 | V | 0.989363 | M | 0.994123 | -0.00476 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 74 | A | 0.990324 | T | 0.990021 | 3.03E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 75 | P | 0.990339 | L | 0.976006 | 0.014333 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 75 | P | 0.990339 | R | 0.985114 | 0.005225 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 75 | P | 0.990339 | S | 0.987807 | 0.002532 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 76 | A | 0.990721 | G | 0.989629 | 0.001092 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 76 | A | 0.990721 | T | 0.990486 | 2.35E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 77 | P | 0.989045 | A | 0.983381 | 0.005664 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 78 | A | 0.985633 | V | 0.978012 | 0.007621 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 79 | A | 0.98268 | G | 0.981973 | 7.07E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 79 | A | 0.98268 | V | 0.973178 | 0.009502 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 80 | P | 0.980062 | L | 0.954367 | 0.025695 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 80 | P | 0.980062 | S | 0.977381 | 0.002681 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 81 | T | 0.97756 | I | 0.960481 | 0.017079 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 82 | P | 0.973767 | L | 0.945591 | 0.028176 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 82 | P | 0.973767 | S | 0.971138 | 0.002629 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 83 | A | 0.968213 | E | 0.967439 | 7.74E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 83 | A | 0.968213 | V | 0.952738 | 0.015475 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 84 | A | 0.963928 | G | 0.964166 | -2.38E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 84 | A | 0.963928 | V | 0.947387 | 0.016541 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 85 | P | 0.959385 | L | 0.921835 | 0.03755 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 85 | P | 0.959385 | S | 0.956735 | 0.00265 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 86 | A | 0.955543 | V | 0.936736 | 0.018807 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 88 | A | 0.940639 | T | 0.942641 | -0.002002 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 88 | A | 0.940639 | V | 0.918547 | 0.022092 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 89 | P | 0.929589 | L | 0.877345 | 0.052244 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 89 | P | 0.929589 | S | 0.928057 | 0.001532 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 90 | S | 0.920568 | F | 0.862087 | 0.058481 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 90 | S | 0.920568 | Y | 0.856849 | 0.063719 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 91 | W | 0.905229 | C | 0.937822 | -0.032593 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 92 | P | 0.892889 | A | 0.857612 | 0.035277 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 92 | P | 0.892889 | L | 0.82655 | 0.066339 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 92 | P | 0.892889 | S | 0.893122 | -2.33E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 93 | L | 0.881641 | M | 0.894434 | -0.012793 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 93 | L | 0.881641 | P | 0.929964 | -0.048323 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 94 | S | 0.868913 | L | 0.794858 | 0.074055 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 95 | S | 0.851312 | F | 0.756672 | 0.09464 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 95 | S | 0.851312 | T | 0.816828 | 0.034484 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 96 | S | 0.829107 | C | 0.739106 | 0.090001 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 96 | S | 0.829107 | F | 0.723791 | 0.105316 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 96 | S | 0.829107 | P | 0.829421 | -3.14E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 97 | V | 0.817891 | A | 0.857322 | -0.039431 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 97 | V | 0.817891 | F | 0.82968 | -0.011789 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 97 | V | 0.817891 | I | 0.795835 | 0.022056 | No Change: Both D | Familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 98 | P | 0.801721 | L | 0.71818 | 0.083541 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 98 | P | 0.801721 | S | 0.808322 | -0.006601 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 99 | S | 0.785843 | F | 0.684438 | 0.101405 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 99 | S | 0.785843 | P | 0.78436 | 0.001483 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 100 | Q | 0.76674 | R | 0.762347 | 0.004393 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 101 | K | 0.7467 | N | 0.715423 | 0.031277 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 101 | K | 0.7467 | R | 0.742322 | 0.004378 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 102 | T | 0.718966 | I | 0.611264 | 0.107702 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 104 | Q | 0.660928 | H | 0.624682 | 0.036246 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 104 | Q | 0.660928 | L | 0.578507 | 0.082421 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 105 | G | 0.624665 | C | 0.564939 | 0.059726 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 105 | G | 0.624665 | D | 0.602494 | 0.022171 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 105 | G | 0.624665 | R | 0.631282 | -0.006617 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 105 | G | 0.624665 | S | 0.686371 | -0.061706 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 105 | G | 0.624665 | V | 0.533313 | 0.091352 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 106 | S | 0.583884 | G | 0.526193 | 0.057691 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 106 | S | 0.583884 | R | 0.525148 | 0.058736 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 107 | Y | 0.544541 | C | 0.587662 | -0.043121 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 107 | Y | 0.544541 | D | 0.625875 | -0.081334 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 107 | Y | 0.544541 | H | 0.624934 | -0.080393 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 108 | G | 0.495222 | D | 0.47242 | 0.022802 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 108 | G | 0.495222 | S | 0.567369 | -0.072147 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 109 | F | 0.475251 | C | 0.514845 | -0.039594 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 109 | F | 0.475251 | L | 0.505029 | -0.029778 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 109 | F | 0.475251 | S | 0.649252 | -0.174001 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | G | 0.49881 | -0.038268 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | H | 0.466544 | -0.006002 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 110 | R | 0.460542 | S | 0.562007 | -0.101465 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 111 | L | 0.419931 | M | 0.471872 | -0.051941 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 111 | L | 0.419931 | P | 0.564695 | -0.144764 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 111 | L | 0.419931 | Q | 0.54079 | -0.120859 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 111 | L | 0.419931 | R | 0.518818 | -0.098887 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 112 | G | 0.414567 | D | 0.392278 | 0.022289 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 112 | G | 0.414567 | S | 0.483279 | -0.068712 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | I | 0.324133 | 0.04536 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | L | 0.399965 | -0.030472 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | S | 0.55716 | -0.187667 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 115 | H | 0.360264 | Y | 0.304348 | 0.055916 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 116 | S | 0.353686 | C | 0.195066 | 0.15862 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 116 | S | 0.353686 | F | 0.186158 | 0.167528 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 116 | S | 0.353686 | P | 0.327795 | 0.025891 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 117 | G | 0.367689 | E | 0.386636 | -0.018947 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 117 | G | 0.367689 | R | 0.357117 | 0.010572 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 118 | T | 0.393617 | A | 0.359405 | 0.034212 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 118 | T | 0.393617 | I | 0.241352 | 0.152265 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 118 | T | 0.393617 | R | 0.392414 | 0.001203 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 119 | A | 0.410135 | D | 0.464983 | -0.054848 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 119 | A | 0.410135 | T | 0.462384 | -0.052249 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 120 | K | 0.434303 | E | 0.429466 | 0.004837 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 120 | K | 0.434303 | M | 0.32812 | 0.106183 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 120 | K | 0.434303 | Q | 0.400765 | 0.033538 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 120 | K | 0.434303 | R | 0.379765 | 0.054538 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 121 | S | 0.425811 | F | 0.22377 | 0.202041 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 122 | V | 0.382519 | L | 0.404424 | -0.021905 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 123 | T | 0.359006 | I | 0.225117 | 0.133889 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 123 | T | 0.359006 | N | 0.363391 | -0.004385 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 124 | C | 0.323819 | G | 0.428325 | -0.104506 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 124 | C | 0.323819 | R | 0.421373 | -0.097554 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 124 | C | 0.323819 | S | 0.479413 | -0.155594 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 124 | C | 0.323819 | W | 0.265798 | 0.058021 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 124 | C | 0.323819 | Y | 0.341877 | -0.018058 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 125 | T | 0.29174 | A | 0.262031 | 0.029709 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 125 | T | 0.29174 | K | 0.345013 | -0.053273 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 125 | T | 0.29174 | P | 0.337903 | -0.046163 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 125 | T | 0.29174 | R | 0.286459 | 0.005281 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | C | 0.313157 | -0.041644 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | F | 0.277938 | -0.006425 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | H | 0.376223 | -0.10471 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | S | 0.468515 | -0.197002 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 127 | S | 0.253105 | C | 0.134828 | 0.118277 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 127 | S | 0.253105 | P | 0.244509 | 0.008596 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 127 | S | 0.253105 | T | 0.204293 | 0.048812 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 127 | S | 0.253105 | Y | 0.127397 | 0.125708 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 128 | P | 0.240791 | A | 0.183961 | 0.05683 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 128 | P | 0.240791 | L | 0.142497 | 0.098294 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 128 | P | 0.240791 | R | 0.207966 | 0.032825 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 129 | A | 0.218729 | G | 0.255278 | -0.036549 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 129 | A | 0.218729 | T | 0.262811 | -0.044082 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 129 | A | 0.218729 | V | 0.172406 | 0.046323 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | F | 0.193024 | 0.013884 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | H | 0.283016 | -0.076108 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | I | 0.166069 | 0.040839 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | P | 0.352249 | -0.145341 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 130 | L | 0.206908 | V | 0.204171 | 0.002737 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | D | 0.217785 | -0.022204 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | H | 0.187584 | 0.007997 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | I | 0.102044 | 0.093537 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | T | 0.210535 | -0.014954 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 131 | N | 0.195581 | Y | 0.128788 | 0.066793 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | E | 0.159882 | 0.012976 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | N | 0.147329 | 0.025529 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | R | 0.135161 | 0.037697 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | T | 0.136623 | 0.036235 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | I | 0.103977 | 0.055679 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | K | 0.270924 | -0.111268 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | L | 0.13258 | 0.027076 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | R | 0.202424 | -0.042768 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 133 | M | 0.159656 | V | 0.122239 | 0.037417 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 134 | F | 0.153304 | C | 0.177794 | -0.02449 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 134 | F | 0.153304 | I | 0.148513 | 0.004791 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 134 | F | 0.153304 | S | 0.340616 | -0.187312 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 134 | F | 0.153304 | V | 0.175686 | -0.022382 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | G | 0.227966 | -0.093232 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | R | 0.225683 | -0.090949 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | W | 0.097892 | 0.036842 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | Y | 0.141287 | -0.006553 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 136 | Q | 0.134018 | H | 0.112027 | 0.021991 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 136 | Q | 0.134018 | P | 0.158585 | -0.024567 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 136 | Q | 0.134018 | R | 0.123768 | 0.01025 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 137 | L | 0.12616 | M | 0.172707 | -0.046547 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 137 | L | 0.12616 | P | 0.246551 | -0.120391 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 137 | L | 0.12616 | V | 0.125081 | 0.001079 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 138 | A | 0.126585 | D | 0.1643 | -0.037715 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 138 | A | 0.126585 | S | 0.190304 | -0.063719 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 138 | A | 0.126585 | T | 0.154512 | -0.027927 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 139 | K | 0.127031 | E | 0.108105 | 0.018926 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 139 | K | 0.127031 | Q | 0.117736 | 0.009295 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 139 | K | 0.127031 | R | 0.102628 | 0.024403 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 139 | K | 0.127031 | T | 0.101577 | 0.025454 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 140 | T | 0.141876 | A | 0.125751 | 0.016125 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 140 | T | 0.141876 | I | 0.070899 | 0.070977 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 140 | T | 0.141876 | N | 0.142504 | -6.28E-04 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 140 | T | 0.141876 | P | 0.188187 | -0.046311 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 140 | T | 0.141876 | S | 0.18166 | -0.039784 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | R | 0.199941 | -0.068056 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | S | 0.24693 | -0.115045 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | W | 0.089159 | 0.042726 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | A | 0.091411 | 0.044436 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | H | 0.093996 | 0.041851 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | L | 0.066602 | 0.069245 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | R | 0.108462 | 0.027385 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | S | 0.139083 | -0.003236 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | T | 0.109238 | 0.026609 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 143 | V | 0.142476 | E | 0.246933 | -0.104457 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 143 | V | 0.142476 | G | 0.211262 | -0.068786 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 143 | V | 0.142476 | L | 0.145299 | -0.002823 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 143 | V | 0.142476 | M | 0.193049 | -0.050573 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 144 | Q | 0.181082 | H | 0.149836 | 0.031246 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 144 | Q | 0.181082 | K | 0.210567 | -0.029485 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 144 | Q | 0.181082 | L | 0.106574 | 0.074508 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 144 | Q | 0.181082 | R | 0.169694 | 0.011388 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 145 | L | 0.217907 | M | 0.296316 | -0.078409 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 145 | L | 0.217907 | R | 0.331751 | -0.113844 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 145 | L | 0.217907 | V | 0.234351 | -0.016444 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 146 | W | 0.252465 | C | 0.390177 | -0.137712 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 146 | W | 0.252465 | G | 0.457254 | -0.204789 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 146 | W | 0.252465 | L | 0.364108 | -0.111643 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 146 | W | 0.252465 | R | 0.48132 | -0.228855 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 146 | W | 0.252465 | S | 0.533693 | -0.281228 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | A | 0.365287 | -0.059785 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | E | 0.429564 | -0.124062 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | F | 0.268282 | 0.03722 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 147 | V | 0.305502 | I | 0.260284 | 0.045218 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | A | 0.309952 | 0.034631 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | E | 0.376152 | -0.031569 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | G | 0.342404 | 0.002179 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | N | 0.342686 | 0.001897 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | V | 0.260595 | 0.083988 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 148 | D | 0.344583 | Y | 0.230364 | 0.114219 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 149 | S | 0.390405 | F | 0.21408 | 0.176325 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 149 | S | 0.390405 | T | 0.348925 | 0.04148 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | A | 0.390794 | 0.03632 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | I | 0.289934 | 0.13718 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | K | 0.46969 | -0.042576 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | N | 0.42575 | 0.001364 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | P | 0.488819 | -0.061705 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 150 | T | 0.427114 | R | 0.444739 | -0.017625 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | H | 0.39463 | 0.062002 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | L | 0.304157 | 0.152475 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 151 | P | 0.456632 | R | 0.421851 | 0.034781 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | A | 0.401222 | 0.084256 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | Q | 0.458747 | 0.026731 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | R | 0.453542 | 0.031936 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 152 | P | 0.485478 | T | 0.439624 | 0.045854 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | A | 0.414545 | 0.076616 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | H | 0.435899 | 0.055262 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | L | 0.34242 | 0.148741 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | R | 0.462612 | 0.028549 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | S | 0.496626 | -0.005465 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | A | 0.486596 | 0.001715 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | C | 0.420734 | 0.067577 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | D | 0.536422 | -0.048111 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | S | 0.567635 | -0.079324 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | I | 0.345027 | 0.125702 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | M | 0.453402 | 0.017327 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | N | 0.463855 | 0.006874 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | P | 0.530189 | -0.05946 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 155 | T | 0.470729 | S | 0.523104 | -0.052375 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | C | 0.336795 | 0.114835 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | G | 0.436647 | 0.014983 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | H | 0.424617 | 0.027013 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | L | 0.326959 | 0.124671 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 156 | R | 0.45163 | S | 0.488646 | -0.037016 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | A | 0.495686 | -0.071055 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | G | 0.515356 | -0.090725 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 157 | V | 0.424631 | L | 0.419139 | 0.005492 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | L | 0.257608 | 0.132346 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | P | 0.439853 | -0.049899 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | Q | 0.403217 | -0.013263 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | S | 0.430725 | -0.040771 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | D | 0.434095 | -0.070063 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | G | 0.4059 | -0.041868 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | P | 0.477003 | -0.112971 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | S | 0.472334 | -0.108302 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | T | 0.405353 | -0.041321 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | V | 0.298741 | 0.065291 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 160 | M | 0.385351 | K | 0.482674 | -0.097323 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 160 | M | 0.385351 | T | 0.422448 | -0.037097 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 160 | M | 0.385351 | V | 0.318049 | 0.067302 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | D | 0.49622 | -0.066199 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | G | 0.461015 | -0.030994 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | P | 0.542932 | -0.112911 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | T | 0.474113 | -0.044092 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | V | 0.373949 | 0.056072 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | F | 0.486797 | -0.021096 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | M | 0.627642 | -0.161941 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | N | 0.599727 | -0.134026 | O to D | A breast cancer with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 162 | I | 0.465701 | T | 0.631278 | -0.165577 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | D | 0.656615 | -0.171952 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | F | 0.49827 | -0.013607 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | N | 0.611862 | -0.127199 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 163 | Y | 0.484663 | S | 0.688624 | -0.203961 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | E | 0.518162 | -0.026791 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | M | 0.454492 | 0.036879 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | R | 0.502544 | -0.011173 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 164 | K | 0.491371 | T | 0.467681 | 0.02369 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 165 | Q | 0.50664 | E | 0.523245 | -0.016605 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 165 | Q | 0.50664 | H | 0.476215 | 0.030425 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 165 | Q | 0.50664 | P | 0.536783 | -0.030143 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 166 | S | 0.515188 | A | 0.43392 | 0.081268 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 166 | S | 0.515188 | G | 0.453498 | 0.06169 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 166 | S | 0.515188 | P | 0.533365 | -0.018177 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 166 | S | 0.515188 | T | 0.46568 | 0.049508 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 167 | Q | 0.497725 | H | 0.468131 | 0.029594 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 167 | Q | 0.497725 | K | 0.514565 | -0.01684 | O to D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 167 | Q | 0.497725 | L | 0.346418 | 0.151307 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 167 | Q | 0.497725 | R | 0.500889 | -0.003164 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | D | 0.544153 | -0.038508 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | L | 0.405296 | 0.100349 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | N | 0.491592 | 0.014053 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | P | 0.587991 | -0.082346 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | Q | 0.563951 | -0.058306 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | Y | 0.38846 | 0.117185 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 169 | M | 0.52285 | K | 0.59341 | -0.07056 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 169 | M | 0.52285 | V | 0.461703 | 0.061147 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 170 | T | 0.530525 | A | 0.510007 | 0.020518 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 170 | T | 0.530525 | K | 0.597643 | -0.067118 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 170 | T | 0.530525 | P | 0.621288 | -0.090763 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | A | 0.437495 | 0.098927 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | D | 0.519029 | 0.017393 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | G | 0.479433 | 0.056989 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | K | 0.536776 | -3.54E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | Q | 0.532231 | 0.004191 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 171 | E | 0.536422 | V | 0.380527 | 0.155895 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 172 | V | 0.566093 | D | 0.682592 | -0.116499 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 172 | V | 0.566093 | F | 0.502736 | 0.063357 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 172 | V | 0.566093 | G | 0.651751 | -0.085658 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 172 | V | 0.566093 | I | 0.522928 | 0.043165 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | A | 0.622313 | -0.060205 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | G | 0.659317 | -0.097209 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | G | 0.518886 | 0.040002 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | M | 0.498643 | 0.060245 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | S | 0.591843 | -0.032955 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | T | 0.518197 | 0.040691 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 174 | R | 0.558888 | W | 0.301787 | 0.257101 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | Q | 0.53528 | 1.91E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 175 | R | 0.535471 | S | 0.576314 | -0.040843 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | G | 0.654593 | -0.11926 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | R | 0.69108 | -0.155747 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | S | 0.714911 | -0.179578 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 176 | C | 0.535333 | Y | 0.527069 | 0.008264 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | A | 0.454945 | 0.108283 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | H | 0.517925 | 0.045303 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | S | 0.577094 | -0.013866 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | T | 0.494011 | 0.069217 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | D | 0.625179 | -0.035017 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | L | 0.479452 | 0.11071 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | N | 0.576106 | 0.014056 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | P | 0.654057 | -0.063895 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | Q | 0.619202 | -0.02904 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | R | 0.633688 | -0.043526 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 178 | H | 0.590162 | Y | 0.453265 | 0.136897 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | D | 0.646069 | -0.032509 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | L | 0.508875 | 0.104685 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | N | 0.598705 | 0.014855 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | P | 0.672048 | -0.058488 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | Q | 0.639416 | -0.025856 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | R | 0.654492 | -0.040932 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 179 | H | 0.61356 | Y | 0.481557 | 0.132003 | D to O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | A | 0.533025 | 0.091999 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | D | 0.618862 | 0.006162 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | G | 0.576634 | 0.04839 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | K | 0.603937 | 0.021087 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | Q | 0.605953 | 0.019071 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 180 | E | 0.625024 | V | 0.475176 | 0.149848 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | C | 0.526238 | 0.107953 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | G | 0.601579 | 0.032612 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | H | 0.616907 | 0.017284 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | P | 0.656596 | -0.022405 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 181 | R | 0.634191 | S | 0.658568 | -0.024377 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 182 | C | 0.663371 | R | 0.752417 | -0.089046 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 182 | C | 0.663371 | Y | 0.651695 | 0.011676 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 183 | S | 0.666717 | L | 0.52251 | 0.144207 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 183 | S | 0.666717 | P | 0.666852 | -1.35E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 184 | D | 0.678797 | G | 0.659645 | 0.019152 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 184 | D | 0.678797 | H | 0.669828 | 0.008969 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 184 | D | 0.678797 | V | 0.55534 | 0.123457 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | C | 0.52689 | 0.139348 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | G | 0.629672 | 0.036566 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | I | 0.492117 | 0.174121 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | N | 0.621718 | 0.04452 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | R | 0.646577 | 0.019661 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 185 | S | 0.666238 | T | 0.605401 | 0.060837 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | E | 0.666545 | -0.017667 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | G | 0.629906 | 0.018972 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | H | 0.636296 | 0.012582 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | N | 0.623332 | 0.025546 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 186 | D | 0.648878 | V | 0.522702 | 0.126176 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | D | 0.666112 | -0.045148 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | R | 0.650947 | -0.029983 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | V | 0.518963 | 0.102001 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 188 | L | 0.583337 | P | 0.716588 | -0.133251 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 188 | L | 0.583337 | V | 0.579402 | 0.003935 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | D | 0.644183 | -0.11247 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | G | 0.606907 | -0.075194 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | S | 0.664756 | -0.133043 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | T | 0.575935 | -0.044222 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 189 | A | 0.531713 | V | 0.479387 | 0.052326 | D to O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | A | 0.387288 | 0.10042 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | H | 0.441483 | 0.046225 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | R | 0.454581 | 0.033127 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | S | 0.51151 | -0.023802 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 190 | P | 0.487708 | T | 0.406626 | 0.081082 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 191 | P | 0.451998 | H | 0.403826 | 0.048172 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 191 | P | 0.451998 | L | 0.285682 | 0.166316 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 191 | P | 0.451998 | R | 0.420363 | 0.031635 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 191 | P | 0.451998 | S | 0.470014 | -0.018016 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 192 | Q | 0.420192 | H | 0.418044 | 0.002148 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 192 | Q | 0.420192 | K | 0.446706 | -0.026514 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 192 | Q | 0.420192 | L | 0.309376 | 0.110816 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 192 | Q | 0.420192 | P | 0.483561 | -0.063369 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | L | 0.324685 | 0.083762 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | N | 0.42841 | -0.019963 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | P | 0.491801 | -0.083354 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | Q | 0.448437 | -0.03999 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 193 | H | 0.408447 | Y | 0.28857 | 0.119877 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | F | 0.365296 | 0.047691 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | H | 0.511269 | -0.098282 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | I | 0.371046 | 0.041941 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 194 | L | 0.412987 | V | 0.417672 | -0.004685 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | F | 0.437513 | -0.035307 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | N | 0.590267 | -0.188061 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | S | 0.631474 | -0.229268 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | V | 0.492664 | -0.090458 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 196 | R | 0.395042 | G | 0.358364 | 0.036678 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 196 | R | 0.395042 | L | 0.275034 | 0.120008 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 196 | R | 0.395042 | P | 0.431212 | -0.03617 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 196 | R | 0.395042 | Q | 0.385325 | 0.009717 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 196 | R | 0.395042 | S | 0.415201 | -0.020159 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 197 | V | 0.393701 | E | 0.555447 | -0.161746 | O to D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 197 | V | 0.393701 | G | 0.489027 | -0.095326 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 197 | V | 0.393701 | L | 0.402436 | -0.008735 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 197 | V | 0.393701 | M | 0.441898 | -0.048197 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 198 | E | 0.396287 | D | 0.378216 | 0.018071 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 198 | E | 0.396287 | G | 0.337226 | 0.059061 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 198 | E | 0.396287 | Q | 0.359233 | 0.037054 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 198 | E | 0.396287 | V | 0.260943 | 0.135344 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 199 | G | 0.381833 | A | 0.341001 | 0.040832 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 199 | G | 0.381833 | E | 0.467456 | -0.085623 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 199 | G | 0.381833 | R | 0.446264 | -0.064431 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 199 | G | 0.381833 | V | 0.319116 | 0.062717 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | D | 0.417301 | -0.04811 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | I | 0.254875 | 0.114316 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | K | 0.373585 | -0.004394 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | S | 0.428118 | -0.058927 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | T | 0.359793 | 0.009398 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 201 | L | 0.357653 | F | 0.318304 | 0.039349 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 201 | L | 0.357653 | P | 0.508097 | -0.150444 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 201 | L | 0.357653 | S | 0.494819 | -0.137166 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | C | 0.222429 | 0.111703 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | G | 0.30722 | 0.026912 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | H | 0.301363 | 0.032769 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | L | 0.225464 | 0.108668 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | P | 0.359471 | -0.025339 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 202 | R | 0.334132 | S | 0.354246 | -0.020114 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 203 | V | 0.333 | A | 0.365791 | -0.032791 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 203 | V | 0.333 | E | 0.487163 | -0.154163 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 203 | V | 0.333 | L | 0.340137 | -0.007137 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 203 | V | 0.333 | M | 0.370038 | -0.037038 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | A | 0.228526 | 0.1047 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | D | 0.322412 | 0.010814 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | G | 0.282105 | 0.051121 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | K | 0.29301 | 0.040216 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | Q | 0.289241 | 0.043985 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 204 | E | 0.333226 | V | 0.203696 | 0.12953 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | H | 0.468207 | -0.126014 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | N | 0.492536 | -0.150343 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | S | 0.520666 | -0.178473 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 206 | L | 0.353774 | F | 0.324737 | 0.029037 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 206 | L | 0.353774 | M | 0.397491 | -0.043717 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | E | 0.393441 | -0.025688 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | G | 0.330967 | 0.036786 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | H | 0.330378 | 0.037375 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | N | 0.354678 | 0.013075 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | V | 0.236847 | 0.130906 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 207 | D | 0.367753 | Y | 0.230192 | 0.137561 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | E | 0.407095 | -0.025865 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | G | 0.341379 | 0.039851 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | H | 0.343618 | 0.037612 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | N | 0.36742 | 0.01381 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | V | 0.242388 | 0.138842 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | Y | 0.237067 | 0.144163 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 209 | R | 0.379964 | I | 0.222922 | 0.157042 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 209 | R | 0.379964 | K | 0.403458 | -0.023494 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 209 | R | 0.379964 | S | 0.427398 | -0.047434 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 209 | R | 0.379964 | T | 0.355531 | 0.024433 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | D | 0.390244 | -0.037617 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | H | 0.349622 | 0.003005 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | I | 0.208901 | 0.143726 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | K | 0.376261 | -0.023634 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | S | 0.40812 | -0.055493 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | T | 0.33576 | 0.016867 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 210 | N | 0.352627 | Y | 0.244253 | 0.108374 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 211 | T | 0.319202 | A | 0.289107 | 0.030095 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 211 | T | 0.319202 | I | 0.212352 | 0.10685 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 211 | T | 0.319202 | N | 0.370554 | -0.051352 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 211 | T | 0.319202 | P | 0.39602 | -0.076818 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 211 | T | 0.319202 | S | 0.410973 | -0.091771 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 212 | F | 0.294919 | I | 0.305423 | -0.010504 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 212 | F | 0.294919 | L | 0.347074 | -0.052155 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 212 | F | 0.294919 | S | 0.523431 | -0.228512 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 212 | F | 0.294919 | V | 0.361723 | -0.066804 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 212 | F | 0.294919 | Y | 0.34585 | -0.050931 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 213 | R | 0.284169 | G | 0.269898 | 0.014271 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 213 | R | 0.284169 | L | 0.178297 | 0.105872 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 213 | R | 0.284169 | W | 0.11854 | 0.165629 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 214 | H | 0.275813 | D | 0.332311 | -0.056498 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 214 | H | 0.275813 | P | 0.346743 | -0.07093 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 214 | H | 0.275813 | R | 0.310536 | -0.034723 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 214 | H | 0.275813 | Y | 0.192709 | 0.083104 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | C | 0.136917 | 0.145454 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | G | 0.234438 | 0.047933 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | I | 0.12527 | 0.157101 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | N | 0.258352 | 0.024019 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | R | 0.251011 | 0.03136 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | T | 0.227809 | 0.054562 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | A | 0.336953 | -0.044251 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | E | 0.476015 | -0.183313 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | G | 0.400949 | -0.108247 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | L | 0.270947 | 0.021755 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | A | 0.355149 | -0.044157 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | E | 0.49402 | -0.183028 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | G | 0.422025 | -0.111033 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | I | 0.260636 | 0.050356 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | L | 0.287625 | 0.023367 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 218 | V | 0.365939 | A | 0.405822 | -0.039883 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 218 | V | 0.365939 | E | 0.534158 | -0.168219 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 218 | V | 0.365939 | G | 0.471256 | -0.105317 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 218 | V | 0.365939 | L | 0.341184 | 0.024755 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 218 | V | 0.365939 | M | 0.409187 | -0.043248 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | H | 0.378507 | 0.038317 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | L | 0.26283 | 0.153994 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | R | 0.380048 | 0.036776 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | S | 0.43311 | -0.016286 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | T | 0.358306 | 0.058518 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | D | 0.532697 | -0.108175 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | F | 0.40832 | 0.016202 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 220 | Y | 0.424522 | N | 0.521309 | -0.096787 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 221 | E | 0.47635 | A | 0.371786 | 0.104564 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 221 | E | 0.47635 | D | 0.454795 | 0.021555 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 221 | E | 0.47635 | G | 0.435119 | 0.041231 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 221 | E | 0.47635 | K | 0.458987 | 0.017363 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 221 | E | 0.47635 | Q | 0.424092 | 0.052258 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | A | 0.44028 | 0.091369 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | L | 0.359197 | 0.172452 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | Q | 0.491665 | 0.039984 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | R | 0.483204 | 0.048445 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | S | 0.553362 | -0.021713 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 222 | P | 0.531649 | T | 0.475566 | 0.056083 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | H | 0.462546 | 0.043778 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | L | 0.337836 | 0.168488 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | R | 0.456303 | 0.050021 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | S | 0.52641 | -0.020086 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | T | 0.453531 | 0.052793 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 224 | E | 0.503419 | D | 0.482111 | 0.021308 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 224 | E | 0.503419 | G | 0.455608 | 0.047811 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 224 | E | 0.503419 | K | 0.487231 | 0.016188 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 224 | E | 0.503419 | V | 0.333401 | 0.170018 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | A | 0.543779 | -0.056438 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | D | 0.617132 | -0.129791 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | F | 0.44564 | 0.041701 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | G | 0.598778 | -0.111437 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | I | 0.453103 | 0.034238 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 225 | V | 0.487341 | L | 0.471664 | 0.015677 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 226 | G | 0.462494 | A | 0.408398 | 0.054096 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 226 | G | 0.462494 | S | 0.531258 | -0.068764 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 226 | G | 0.462494 | V | 0.359287 | 0.103207 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 227 | S | 0.429016 | C | 0.238268 | 0.190748 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 227 | S | 0.429016 | F | 0.223365 | 0.205651 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 227 | S | 0.429016 | P | 0.427443 | 0.001573 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 227 | S | 0.429016 | T | 0.370734 | 0.058282 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | A | 0.300913 | 0.082862 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | G | 0.37403 | 0.009745 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | H | 0.36445 | 0.019325 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | N | 0.383616 | 1.59E-04 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | V | 0.257512 | 0.126263 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | Y | 0.260629 | 0.123146 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 229 | C | 0.319356 | G | 0.473891 | -0.154535 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 229 | C | 0.319356 | R | 0.459577 | -0.140221 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 229 | C | 0.319356 | S | 0.525925 | -0.206569 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 229 | C | 0.319356 | Y | 0.360245 | -0.040889 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 230 | T | 0.273194 | A | 0.219431 | 0.053763 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 230 | T | 0.273194 | N | 0.305116 | -0.031922 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 230 | T | 0.273194 | P | 0.32971 | -0.056516 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 230 | T | 0.273194 | S | 0.343814 | -0.07062 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 231 | T | 0.239421 | A | 0.18384 | 0.055581 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 231 | T | 0.239421 | I | 0.145245 | 0.094176 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 231 | T | 0.239421 | N | 0.26931 | -0.029889 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 231 | T | 0.239421 | S | 0.30899 | -0.069569 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | F | 0.238998 | 0.001039 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | L | 0.265898 | -0.025861 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | N | 0.420686 | -0.180649 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | S | 0.467409 | -0.227372 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 232 | I | 0.240037 | V | 0.275749 | -0.035712 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | D | 0.291842 | -0.064486 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | L | 0.162447 | 0.064909 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | P | 0.308849 | -0.081493 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | Q | 0.245011 | -0.017655 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | Y | 0.167706 | 0.05965 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | D | 0.385854 | -0.155564 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | F | 0.204824 | 0.025466 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | N | 0.381059 | -0.150769 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | S | 0.427099 | -0.196809 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | H | 0.206681 | 0.025174 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | I | 0.121909 | 0.109946 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | S | 0.277951 | -0.046096 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | T | 0.21211 | 0.019745 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | Y | 0.135196 | 0.096659 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | C | 0.295108 | -0.036406 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | D | 0.417375 | -0.158673 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | F | 0.231889 | 0.026813 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | H | 0.373152 | -0.11445 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | N | 0.417762 | -0.15906 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 236 | Y | 0.258702 | S | 0.466214 | -0.207512 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | K | 0.3338 | -0.046851 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | L | 0.208066 | 0.078883 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | R | 0.328213 | -0.041264 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | T | 0.314181 | -0.027232 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 237 | M | 0.286949 | V | 0.206548 | 0.080401 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | G | 0.443229 | -0.120016 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | R | 0.440766 | -0.117553 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | S | 0.505234 | -0.182021 | O to D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | W | 0.229178 | 0.094035 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | D | 0.357612 | 0.002081 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | H | 0.325332 | 0.034361 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | I | 0.212402 | 0.147291 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | K | 0.354183 | 0.00551 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | S | 0.409233 | -0.04954 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | T | 0.328323 | 0.03137 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 239 | N | 0.359693 | Y | 0.233443 | 0.12625 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | C | 0.214752 | 0.164537 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | G | 0.328337 | 0.050952 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | N | 0.346368 | 0.032921 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | P | 0.352738 | 0.026551 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | R | 0.322399 | 0.05689 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 240 | S | 0.379289 | T | 0.298257 | 0.081032 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | C | 0.235015 | 0.173178 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | P | 0.38175 | 0.026443 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | Y | 0.235184 | 0.173009 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | G | 0.582059 | -0.151559 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | R | 0.575749 | -0.145249 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | S | 0.62734 | -0.19684 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | W | 0.351896 | 0.078604 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 242 | C | 0.4305 | Y | 0.457937 | -0.027437 | No Change: Both O | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | I | 0.30844 | 0.111284 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | K | 0.47736 | -0.057636 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | L | 0.328394 | 0.09133 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | R | 0.468475 | -0.048751 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | T | 0.435084 | -0.01536 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 243 | M | 0.419724 | V | 0.322222 | 0.097502 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | C | 0.296134 | 0.132261 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | D | 0.442782 | -0.014387 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | E | 0.470254 | -0.041859 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | R | 0.437379 | -0.008984 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | S | 0.497413 | -0.069018 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | V | 0.284675 | 0.14372 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | E | 0.46269 | -0.041904 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | R | 0.431313 | -0.010527 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | I | 0.288035 | 0.098855 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 246 | M | 0.38689 | K | 0.47202 | -0.08513 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | D | 0.362425 | -0.005279 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | K | 0.369316 | -0.01217 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | S | 0.408636 | -0.05149 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | Y | 0.212724 | 0.144422 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | C | 0.249503 | 0.101859 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 248 | R | 0.351362 | P | 0.388748 | -0.037386 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | I | 0.206004 | 0.122928 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | K | 0.324175 | 0.004757 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | T | 0.310452 | 0.01848 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | W | 0.138035 | 0.190897 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | A | 0.200844 | 0.093548 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | H | 0.231236 | 0.063156 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | Q | 0.247875 | 0.046517 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | S | 0.323972 | -0.02958 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | T | 0.261132 | 0.03326 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | F | 0.290003 | 0.021113 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | L | 0.340895 | -0.029779 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | M | 0.43203 | -0.120914 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | T | 0.44134 | -0.130224 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 251 | I | 0.311116 | V | 0.311957 | -8.41E-04 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 252 | L | 0.315855 | F | 0.275843 | 0.040012 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 252 | L | 0.315855 | H | 0.380538 | -0.064683 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 252 | L | 0.315855 | I | 0.303384 | 0.012471 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 252 | L | 0.315855 | V | 0.295744 | 0.020111 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 253 | T | 0.317948 | A | 0.258185 | 0.059763 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 253 | T | 0.317948 | I | 0.222399 | 0.095549 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 253 | T | 0.317948 | N | 0.35556 | -0.037612 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 253 | T | 0.317948 | S | 0.397559 | -0.079611 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | F | 0.302442 | 0.018004 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | L | 0.354044 | -0.033598 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | M | 0.437509 | -0.117063 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | S | 0.536241 | -0.215795 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | V | 0.323869 | -0.003423 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | F | 0.323985 | 0.018778 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | M | 0.458033 | -0.11527 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | N | 0.512733 | -0.16997 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | S | 0.561691 | -0.218928 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | T | 0.484098 | -0.141335 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 255 | I | 0.342763 | V | 0.346021 | -0.003258 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 256 | T | 0.397376 | I | 0.289168 | 0.108208 | No Change: Both O | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 256 | T | 0.397376 | K | 0.409567 | -0.012191 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 256 | T | 0.397376 | P | 0.458957 | -0.061581 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 256 | T | 0.397376 | S | 0.482273 | -0.084897 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 257 | L | 0.434018 | Q | 0.511535 | -0.077517 | O to D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 257 | L | 0.434018 | R | 0.56705 | -0.133032 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 257 | L | 0.434018 | V | 0.404779 | 0.029239 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | A | 0.352288 | 0.110008 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | G | 0.433408 | 0.028888 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | Q | 0.404746 | 0.05755 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | V | 0.298659 | 0.163637 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | E | 0.534459 | -0.053288 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | G | 0.487881 | -0.00671 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | H | 0.434432 | 0.046739 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | N | 0.506146 | -0.024975 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | V | 0.345275 | 0.135896 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | A | 0.392027 | 0.128162 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | C | 0.374693 | 0.145496 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | F | 0.317027 | 0.203162 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | P | 0.498738 | 0.021451 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | T | 0.456995 | 0.063194 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 260 | S | 0.520189 | Y | 0.316065 | 0.204124 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 261 | S | 0.551743 | C | 0.390697 | 0.161046 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 261 | S | 0.551743 | G | 0.502556 | 0.049187 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 261 | S | 0.551743 | I | 0.356833 | 0.19491 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 261 | S | 0.551743 | N | 0.516976 | 0.034767 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 261 | S | 0.551743 | R | 0.519051 | 0.032692 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 262 | G | 0.565974 | C | 0.465263 | 0.100711 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 262 | G | 0.565974 | S | 0.626436 | -0.060462 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 262 | G | 0.565974 | V | 0.434346 | 0.131628 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 263 | N | 0.572281 | D | 0.578663 | -0.006382 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 263 | N | 0.572281 | H | 0.515798 | 0.056483 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 263 | N | 0.572281 | I | 0.419835 | 0.152446 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 263 | N | 0.572281 | K | 0.564158 | 0.008123 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 263 | N | 0.572281 | S | 0.617779 | -0.045498 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 264 | L | 0.582005 | I | 0.549889 | 0.032116 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 264 | L | 0.582005 | P | 0.68605 | -0.104045 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 264 | L | 0.582005 | Q | 0.637744 | -0.055739 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 264 | L | 0.582005 | R | 0.687309 | -0.105304 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 264 | L | 0.582005 | V | 0.560606 | 0.021399 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 265 | L | 0.587413 | M | 0.639124 | -0.051711 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 265 | L | 0.587413 | P | 0.688041 | -0.100628 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 265 | L | 0.587413 | Q | 0.635387 | -0.047974 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 266 | G | 0.58656 | A | 0.524692 | 0.061868 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 266 | G | 0.58656 | E | 0.636037 | -0.049477 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 266 | G | 0.58656 | R | 0.62533 | -0.03877 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 266 | G | 0.58656 | V | 0.479517 | 0.107043 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 267 | R | 0.600216 | G | 0.570914 | 0.029302 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 267 | R | 0.600216 | H | 0.516449 | 0.083767 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 267 | R | 0.600216 | P | 0.60531 | -0.005094 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 267 | R | 0.600216 | Q | 0.5421 | 0.058116 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | H | 0.549814 | 0.062697 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | I | 0.487127 | 0.125384 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | K | 0.60425 | 0.008261 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | S | 0.653113 | -0.040602 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | Y | 0.44185 | 0.170661 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | C | 0.52419 | 0.085691 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | G | 0.569399 | 0.040482 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | N | 0.58488 | 0.025001 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | R | 0.609564 | 3.17E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | T | 0.555301 | 0.05458 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | C | 0.726039 | -0.103534 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | I | 0.660047 | -0.037542 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | L | 0.696307 | -0.073802 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | S | 0.793936 | -0.171431 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | V | 0.673372 | -0.050867 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 270 | F | 0.622505 | Y | 0.612118 | 0.010387 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | A | 0.532077 | 0.102865 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | D | 0.605324 | 0.029618 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | G | 0.594242 | 0.0407 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | Q | 0.561283 | 0.073659 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 272 | V | 0.635728 | A | 0.689081 | -0.053353 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 272 | V | 0.635728 | E | 0.779833 | -0.144105 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 272 | V | 0.635728 | G | 0.741978 | -0.10625 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 272 | V | 0.635728 | M | 0.715526 | -0.079798 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | P | 0.665357 | -0.011194 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | Q | 0.585422 | 0.068741 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | S | 0.661668 | -0.007505 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | A | 0.71478 | -0.051126 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | D | 0.773366 | -0.109712 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | I | 0.661966 | 0.001688 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | L | 0.699672 | -0.036018 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | F | 0.627667 | 0.052143 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | G | 0.732493 | -0.052683 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | R | 0.766596 | -0.086786 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 275 | C | 0.67981 | S | 0.768602 | -0.088792 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | D | 0.793276 | -0.085279 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | G | 0.7819 | -0.073903 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | P | 0.815476 | -0.107479 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | S | 0.812712 | -0.104715 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | T | 0.777123 | -0.069126 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 276 | A | 0.707997 | V | 0.705498 | 0.002499 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | F | 0.682162 | 0.046671 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | R | 0.805791 | -0.076958 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | S | 0.804761 | -0.075928 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | Y | 0.638088 | 0.090745 | No Change: Both D | An osteosarcoma with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | R | 0.752312 | -0.008083 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 279 | G | 0.771086 | R | 0.808856 | -0.03777 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 279 | G | 0.771086 | V | 0.697361 | 0.073725 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 279 | G | 0.771086 | W | 0.60049 | 0.170596 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | G | 0.761998 | 0.027529 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | P | 0.797532 | -0.008005 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 280 | R | 0.789527 | S | 0.794116 | -0.004589 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | Y | 0.675193 | 0.131666 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | G | 0.813669 | 0.022747 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | H | 0.788626 | 0.04779 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | P | 0.840901 | -0.004485 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 282 | R | 0.836416 | Q | 0.797714 | 0.038702 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | L | 0.791703 | 0.063246 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 283 | R | 0.854949 | S | 0.855925 | -9.76E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 284 | T | 0.868557 | I | 0.816971 | 0.051586 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 284 | T | 0.868557 | K | 0.88587 | -0.017313 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | A | 0.840024 | 0.044276 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | D | 0.868481 | 0.015819 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 285 | E | 0.8843 | G | 0.8634 | 0.0209 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | V | 0.841138 | 0.056405 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 287 | E | 0.912482 | D | 0.898971 | 0.013511 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 287 | E | 0.912482 | G | 0.895764 | 0.016718 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 287 | E | 0.912482 | K | 0.905743 | 0.006739 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 287 | E | 0.912482 | V | 0.860195 | 0.052287 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 288 | N | 0.924973 | D | 0.927403 | -0.00243 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 288 | N | 0.924973 | K | 0.932602 | -0.007629 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 288 | N | 0.924973 | S | 0.935391 | -0.010418 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 288 | N | 0.924973 | T | 0.922482 | 0.002491 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 288 | N | 0.924973 | Y | 0.873352 | 0.051621 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 289 | L | 0.936482 | F | 0.928816 | 0.007666 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 289 | L | 0.936482 | H | 0.945976 | -0.009494 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 289 | L | 0.936482 | P | 0.959851 | -0.023369 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 289 | L | 0.936482 | R | 0.959666 | -0.023184 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 289 | L | 0.936482 | V | 0.932284 | 0.004198 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 290 | R | 0.946731 | C | 0.930482 | 0.016249 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 290 | R | 0.946731 | H | 0.932247 | 0.014484 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 290 | R | 0.946731 | L | 0.919884 | 0.026847 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | E | 0.960069 | -0.006744 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | M | 0.938861 | 0.014464 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | N | 0.951595 | 0.00173 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | R | 0.958617 | -0.005292 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | T | 0.946832 | 0.006493 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | E | 0.963873 | -0.005943 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | N | 0.956123 | 0.001807 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | Q | 0.949178 | 0.008752 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | R | 0.96252 | -0.00459 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | T | 0.951707 | 0.006223 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 293 | G | 0.961414 | A | 0.954873 | 0.006541 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 293 | G | 0.961414 | R | 0.969564 | -0.00815 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 293 | G | 0.961414 | V | 0.945827 | 0.015587 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 293 | G | 0.961414 | W | 0.921859 | 0.039555 | No Change: Both D | A brain tumor with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | A | 0.944501 | 0.018449 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | D | 0.954726 | 0.008224 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | G | 0.95418 | 0.00877 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | Q | 0.949701 | 0.013249 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | V | 0.932261 | 0.030689 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 295 | P | 0.96591 | H | 0.954518 | 0.011392 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 295 | P | 0.96591 | L | 0.942644 | 0.023266 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 295 | P | 0.96591 | R | 0.96371 | 0.0022 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 295 | P | 0.96591 | S | 0.962495 | 0.003415 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | D | 0.971314 | -0.002942 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | N | 0.972233 | -0.003861 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | Q | 0.968709 | -3.37E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | R | 0.976316 | -0.007944 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | Y | 0.947258 | 0.021114 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 297 | H | 0.968493 | D | 0.971521 | -0.003028 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 297 | H | 0.968493 | N | 0.972297 | -0.003804 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 297 | H | 0.968493 | P | 0.978766 | -0.010273 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 297 | H | 0.968493 | R | 0.976097 | -0.007604 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 297 | H | 0.968493 | Y | 0.947597 | 0.020896 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 298 | E | 0.968283 | A | 0.951814 | 0.016469 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 298 | E | 0.968283 | D | 0.961357 | 0.006926 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 298 | E | 0.968283 | K | 0.967646 | 6.37E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 298 | E | 0.968283 | Q | 0.958749 | 0.009534 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 298 | E | 0.968283 | V | 0.936321 | 0.031962 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 299 | L | 0.968719 | P | 0.983368 | -0.014649 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 299 | L | 0.968719 | Q | 0.976452 | -0.007733 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 299 | L | 0.968719 | R | 0.980749 | -0.01203 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 299 | L | 0.968719 | V | 0.963685 | 0.005034 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 300 | P | 0.968383 | A | 0.947602 | 0.020781 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 300 | P | 0.968383 | L | 0.940181 | 0.028202 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 300 | P | 0.968383 | S | 0.965372 | 0.003011 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 301 | P | 0.968959 | A | 0.949182 | 0.019777 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 301 | P | 0.968959 | Q | 0.958303 | 0.010656 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 301 | P | 0.968959 | S | 0.965913 | 0.003046 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 302 | G | 0.965308 | A | 0.959644 | 0.005664 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 302 | G | 0.965308 | R | 0.971696 | -0.006388 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 303 | S | 0.966469 | C | 0.944938 | 0.021531 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 303 | S | 0.966469 | I | 0.927026 | 0.039443 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 303 | S | 0.966469 | N | 0.961995 | 0.004474 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 303 | S | 0.966469 | T | 0.960522 | 0.005947 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 304 | T | 0.965416 | A | 0.959329 | 0.006087 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 304 | T | 0.965416 | I | 0.938404 | 0.027012 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 304 | T | 0.965416 | N | 0.968398 | -0.002982 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 305 | K | 0.967893 | E | 0.968684 | -7.91E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 305 | K | 0.967893 | M | 0.952257 | 0.015636 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 305 | K | 0.967893 | N | 0.963184 | 0.004709 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 305 | K | 0.967893 | R | 0.966622 | 0.001271 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 305 | K | 0.967893 | T | 0.961779 | 0.006114 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 306 | R | 0.967417 | P | 0.974151 | -0.006734 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 307 | A | 0.965908 | P | 0.982818 | -0.01691 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 307 | A | 0.965908 | S | 0.981063 | -0.015155 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 308 | L | 0.964287 | M | 0.96918 | -0.004893 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 308 | L | 0.964287 | V | 0.952922 | 0.011365 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 309 | P | 0.960517 | R | 0.954815 | 0.005702 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 310 | N | 0.95637 | I | 0.931022 | 0.025348 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 310 | N | 0.95637 | T | 0.957928 | -0.001558 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 311 | N | 0.951253 | H | 0.943187 | 0.008066 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 311 | N | 0.951253 | K | 0.960628 | -0.009375 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 311 | N | 0.951253 | S | 0.96151 | -0.010257 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 311 | N | 0.951253 | T | 0.952465 | -0.001212 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 312 | T | 0.944289 | I | 0.916719 | 0.02757 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 312 | T | 0.944289 | S | 0.9565 | -0.012211 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 313 | S | 0.936689 | C | 0.900099 | 0.03659 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 313 | S | 0.936689 | I | 0.886532 | 0.050157 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 313 | S | 0.936689 | N | 0.92815 | 0.008539 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 313 | S | 0.936689 | R | 0.935399 | 0.00129 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 314 | S | 0.931002 | F | 0.890347 | 0.040655 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 315 | S | 0.922892 | C | 0.881407 | 0.041485 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 315 | S | 0.922892 | F | 0.880628 | 0.042264 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 315 | S | 0.922892 | P | 0.93023 | -0.007338 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 316 | P | 0.915638 | L | 0.872735 | 0.042903 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 316 | P | 0.915638 | T | 0.894963 | 0.020675 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 317 | Q | 0.909356 | H | 0.886508 | 0.022848 | No Change: Both D | A kidney cancer with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 317 | Q | 0.909356 | K | 0.919235 | -0.009879 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 317 | Q | 0.909356 | P | 0.925957 | -0.016601 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 317 | Q | 0.909356 | R | 0.918188 | -0.008832 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 318 | P | 0.902946 | L | 0.85632 | 0.046626 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 319 | K | 0.895387 | E | 0.900677 | -0.00529 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 319 | K | 0.895387 | N | 0.883528 | 0.011859 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 319 | K | 0.895387 | R | 0.896389 | -0.001002 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 320 | K | 0.886784 | N | 0.873174 | 0.01361 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 321 | K | 0.877377 | E | 0.883712 | -0.006335 | No Change: Both D | Kidney cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 321 | K | 0.877377 | R | 0.877183 | 1.94E-04 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 322 | P | 0.866215 | L | 0.799603 | 0.066612 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 322 | P | 0.866215 | R | 0.856411 | 0.009804 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 323 | L | 0.850958 | M | 0.876273 | -0.025315 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 323 | L | 0.850958 | P | 0.907835 | -0.056877 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 323 | L | 0.850958 | R | 0.898365 | -0.047407 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 324 | D | 0.838212 | E | 0.876743 | -0.038531 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 324 | D | 0.838212 | Y | 0.768828 | 0.069384 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 325 | G | 0.814708 | A | 0.799382 | 0.015326 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 325 | G | 0.814708 | E | 0.86173 | -0.047022 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 326 | E | 0.782896 | G | 0.735055 | 0.047841 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 327 | Y | 0.774498 | H | 0.843085 | -0.068587 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 327 | Y | 0.774498 | S | 0.887802 | -0.113304 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 328 | F | 0.778819 | L | 0.801157 | -0.022338 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 328 | F | 0.778819 | S | 0.85576 | -0.076941 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 328 | F | 0.778819 | V | 0.738643 | 0.040176 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 329 | T | 0.771632 | I | 0.704316 | 0.067316 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 329 | T | 0.771632 | S | 0.818277 | -0.046645 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 330 | L | 0.768416 | H | 0.770763 | -0.002347 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 330 | L | 0.768416 | R | 0.840121 | -0.071705 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 331 | Q | 0.753843 | H | 0.684345 | 0.069498 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 331 | Q | 0.753843 | P | 0.784486 | -0.030643 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 331 | Q | 0.753843 | R | 0.772848 | -0.019005 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 332 | I | 0.744642 | V | 0.754147 | -0.009505 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 334 | G | 0.74023 | W | 0.567648 | 0.172582 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 335 | R | 0.733458 | G | 0.700724 | 0.032734 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 335 | R | 0.733458 | H | 0.651177 | 0.082281 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 335 | R | 0.733458 | L | 0.640481 | 0.092977 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 337 | R | 0.73474 | L | 0.641492 | 0.093248 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 337 | R | 0.73474 | P | 0.747443 | -0.012703 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 338 | F | 0.73532 | I | 0.711768 | 0.023552 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 338 | F | 0.73532 | L | 0.758648 | -0.023328 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 339 | E | 0.734583 | Q | 0.706046 | 0.028537 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 341 | F | 0.744341 | C | 0.746008 | -0.001667 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 342 | R | 0.753438 | L | 0.669159 | 0.084279 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 342 | R | 0.753438 | P | 0.763933 | -0.010495 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 343 | E | 0.764767 | G | 0.715204 | 0.049563 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 344 | L | 0.769058 | P | 0.8434 | -0.074342 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 344 | L | 0.769058 | R | 0.840763 | -0.071705 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 346 | E | 0.780462 | A | 0.71046 | 0.070002 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 347 | A | 0.783469 | G | 0.809992 | -0.026523 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 347 | A | 0.783469 | T | 0.790838 | -0.007369 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 348 | L | 0.793284 | F | 0.782017 | 0.011267 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 348 | L | 0.793284 | S | 0.850898 | -0.057614 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 349 | E | 0.801076 | D | 0.769259 | 0.031817 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 352 | D | 0.825364 | H | 0.811979 | 0.013385 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 353 | A | 0.831731 | T | 0.834098 | -0.002367 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 354 | Q | 0.845011 | E | 0.870202 | -0.025191 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 354 | Q | 0.845011 | K | 0.861497 | -0.016486 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 356 | G | 0.866687 | A | 0.855786 | 0.010901 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 356 | G | 0.866687 | W | 0.750875 | 0.115812 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 358 | E | 0.892666 | D | 0.87554 | 0.017126 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 358 | E | 0.892666 | K | 0.888147 | 0.004519 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 360 | G | 0.913071 | A | 0.908147 | 0.004924 | No Change: Both D | - |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 360 | G | 0.913071 | V | 0.863718 | 0.049353 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 363 | R | 0.944689 | K | 0.94825 | -0.003561 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 364 | A | 0.95173 | P | 0.962649 | -0.010919 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 364 | A | 0.95173 | T | 0.950578 | 0.001152 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 364 | A | 0.95173 | V | 0.925473 | 0.026257 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 365 | H | 0.958304 | Y | 0.926606 | 0.031698 | No Change: Both D | A familial cancer not matching LFS |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 370 | K | 0.973132 | Q | 0.969351 | 0.003781 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 376 | S | 0.98189 | A | 0.970656 | 0.011234 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 376 | S | 0.98189 | T | 0.974508 | 0.007382 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 379 | R | 0.982927 | H | 0.982602 | 3.25E-04 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 385 | F | 0.988301 | L | 0.991624 | -0.003323 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 389 | G | 0.990572 | W | 0.974928 | 0.015644 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 392 | S | 0.990953 | L | 0.979703 | 0.01125 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 59 | G | 0.963664 | N | 0.970304 | -0.00664 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 72 | P | 0.990172 | C | 0.977697 | 0.012475 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 72 | P | 0.990172 | G | 0.983141 | 0.007031 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 72 | P | 0.990172 | H | 0.98041 | 0.009762 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 72 | P | 0.990172 | L | 0.977341 | 0.012831 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 113 | F | 0.369493 | G | 0.500053 | -0.13056 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 126 | Y | 0.271513 | G | 0.396917 | -0.125404 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | L | 0.085707 | 0.087151 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 132 | K | 0.172858 | W | 0.052873 | 0.119985 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 135 | C | 0.134734 | T | 0.227178 | -0.092444 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 141 | C | 0.131885 | A | 0.174248 | -0.042363 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 142 | P | 0.135847 | F | 0.055666 | 0.080181 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 153 | P | 0.491161 | F | 0.310063 | 0.181098 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 154 | G | 0.488311 | I | 0.377808 | 0.110503 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | F | 0.228227 | 0.161727 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 158 | R | 0.389954 | Y | 0.253249 | 0.136705 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 159 | A | 0.364032 | F | 0.252099 | 0.111933 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 161 | A | 0.430021 | F | 0.320413 | 0.109608 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 168 | H | 0.505645 | V | 0.426722 | 0.078923 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 173 | V | 0.562108 | W | 0.446669 | 0.115439 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | F | 0.329787 | 0.233441 | D to O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 177 | P | 0.563228 | I | 0.348161 | 0.215067 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 187 | G | 0.620964 | N | 0.631603 | -0.010639 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | Y | 0.448 | -0.045794 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 200 | N | 0.369191 | P | 0.443425 | -0.074234 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 203 | V | 0.333 | W | 0.230667 | 0.102333 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 208 | D | 0.38123 | I | 0.201624 | 0.179606 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 215 | S | 0.282371 | K | 0.268556 | 0.013815 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 216 | V | 0.292702 | W | 0.196216 | 0.096486 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 219 | P | 0.416824 | C | 0.248527 | 0.168297 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 226 | G | 0.462494 | N | 0.48185 | -0.019356 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 228 | D | 0.383775 | P | 0.416449 | -0.032674 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 229 | C | 0.319356 | N | 0.484501 | -0.165145 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | K | 0.366514 | -0.136224 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 234 | Y | 0.23029 | Q | 0.334943 | -0.104653 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | M | 0.192528 | 0.039327 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 238 | C | 0.323213 | H | 0.428846 | -0.105633 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | F | 0.249234 | 0.171552 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | H | 0.391932 | 0.028854 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | L | 0.290843 | 0.129943 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 245 | G | 0.420786 | N | 0.443737 | -0.022951 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | F | 0.193853 | 0.163293 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 249 | R | 0.328932 | N | 0.338926 | -0.009994 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | F | 0.14743 | 0.146962 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | N | 0.288138 | 0.006254 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 254 | I | 0.320446 | D | 0.491793 | -0.171347 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 258 | E | 0.462296 | L | 0.33179 | 0.130506 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | P | 0.520581 | -0.03941 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | S | 0.549301 | -0.06813 | O to D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 262 | G | 0.565974 | H | 0.52481 | 0.041164 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 268 | N | 0.612511 | F | 0.488635 | 0.123876 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | P | 0.641138 | -0.006196 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | R | 0.636268 | -0.001326 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | N | 0.630144 | 0.024019 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 273 | R | 0.654163 | Y | 0.441339 | 0.212824 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 278 | P | 0.744229 | F | 0.601116 | 0.143113 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | R | 0.833274 | -0.026415 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 286 | E | 0.897543 | L | 0.853482 | 0.044061 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 292 | K | 0.95793 | G | 0.954222 | 0.003708 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | C | 0.966962 | 0.00141 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 323 | L | 0.850958 | G | 0.879509 | -0.028551 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 324 | D | 0.838212 | S | 0.865045 | -0.026833 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 184 | D | 0.678797 | N | 0.653163 | 0.025634 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 195 | I | 0.402206 | L | 0.494622 | -0.092416 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 205 | Y | 0.342193 | F | 0.342292 | -9.90E-05 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 214 | H | 0.275813 | Q | 0.293927 | -0.018114 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 217 | V | 0.310992 | M | 0.357353 | -0.046361 | No Change: Both O | - |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 223 | P | 0.506324 | A | 0.414623 | 0.091701 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 226 | G | 0.462494 | D | 0.504131 | -0.041637 | O to D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 233 | H | 0.227356 | R | 0.271264 | -0.043908 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 235 | N | 0.231855 | D | 0.240651 | -0.008796 | No Change: Both O | An adrenocortical carcinoma with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 241 | S | 0.408193 | T | 0.323052 | 0.085141 | No Change: Both O | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 244 | G | 0.428395 | A | 0.34672 | 0.081675 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 247 | N | 0.357146 | T | 0.323195 | 0.033951 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 250 | P | 0.294392 | L | 0.180465 | 0.113927 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 253 | T | 0.317948 | P | 0.384742 | -0.066794 | No Change: Both O | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 259 | D | 0.481171 | A | 0.404518 | 0.076653 | No Change: Both O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 262 | G | 0.565974 | D | 0.587115 | -0.021141 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 265 | L | 0.587413 | R | 0.691036 | -0.103623 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 269 | S | 0.609881 | I | 0.445847 | 0.164034 | D to O | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 271 | E | 0.634942 | V | 0.488318 | 0.146624 | D to O | An osteosarcoma with no family history |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 274 | V | 0.663654 | G | 0.763887 | -0.100233 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 277 | C | 0.728833 | W | 0.601576 | 0.127257 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 281 | D | 0.806859 | N | 0.816874 | -0.010015 | No Change: Both D | Li-Fraumeni syndrome (LFS) [MIM:151623] |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 287 | E | 0.912482 | A | 0.876862 | 0.03562 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 291 | K | 0.953325 | Q | 0.94381 | 0.009515 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 294 | E | 0.96295 | K | 0.960511 | 0.002439 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 296 | H | 0.968372 | L | 0.962763 | 0.005609 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 301 | P | 0.968959 | T | 0.958103 | 0.010856 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 304 | T | 0.965416 | S | 0.973762 | -0.008346 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 317 | Q | 0.909356 | L | 0.88592 | 0.023436 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 323 | L | 0.850958 | V | 0.807873 | 0.043085 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 330 | L | 0.768416 | P | 0.848848 | -0.080432 | No Change: Both D | A sporadic cancer |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 342 | R | 0.753438 | Q | 0.749031 | 0.004407 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 354 | Q | 0.845011 | R | 0.857755 | -0.012744 | No Change: Both D | Sporadic cancers |
| P04637 | P53_HUMAN Cellular tumor antigen p53 OS=Homo sapiens GN=TP53 PE=1 SV=4 | 365 | H | 0.958304 | R | 0.966359 | -0.008055 | No Change: Both D | A sporadic cancer |
| Q9HCN2 | TPIP1_HUMAN p53-regulated apoptosis-inducing protein 1 OS=Homo sapiens GN=TP53AIP1 PE=2 SV=1 | 7 | A | 0.983067 | V | 0.97343 | 0.009637 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 353 | D | 0.885946 | E | 0.882244 | 0.003702 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 412 | G | 0.97988 | S | 0.985825 | -0.005945 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 648 | M | 0.948272 | V | 0.941548 | 0.006724 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 699 | Q | 0.936446 | R | 0.916858 | 0.019588 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1014 | E | 0.849472 | G | 0.813348 | 0.036124 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1026 | V | 0.855124 | A | 0.888603 | -0.033479 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1136 | K | 0.884254 | Q | 0.886601 | -0.002347 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1170 | A | 0.567685 | G | 0.603933 | -0.036248 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1174 | I | 0.606441 | V | 0.655596 | -0.049155 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 841 | D | 0.966659 | G | 0.955396 | 0.011263 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1137 | E | 0.879933 | K | 0.876467 | 0.003466 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1442 | R | 0.882016 | Q | 0.857305 | 0.024711 | No Change: Both D | - |
| Q12888 | TP53B_HUMAN Tumor suppressor p53-binding protein 1 OS=Homo sapiens GN=TP53BP1 PE=1 SV=2 | 1488 | G | 0.272316 | W | 0.127656 | 0.14466 | No Change: Both O | - |
| Q53FA7 | QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens GN=TP53I3 PE=1 SV=2 | 180 | M | 0.554749 | K | 0.64826 | -0.093511 | No Change: Both D | A breast cancer sample |
| Q53FA7 | QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens GN=TP53I3 PE=1 SV=2 | 223 | E | 0.137024 | K | 0.1456 | -0.008576 | No Change: Both O | - |
| Q96A56 | T53I1_HUMAN Tumor protein p53-inducible nuclear protein 1 OS=Homo sapiens GN=TP53INP1 PE=1 SV=1 | 75 | C | 0.860125 | R | 0.84905 | 0.011075 | No Change: Both D | - |
| Q96S44 | PRPK_HUMAN TP53-regulating kinase OS=Homo sapiens GN=TP53RK PE=1 SV=2 | 25 | A | 0.905154 | T | 0.890617 | 0.014537 | No Change: Both D | - |
| Q96S44 | PRPK_HUMAN TP53-regulating kinase OS=Homo sapiens GN=TP53RK PE=1 SV=2 | 129 | T | 0.537848 | A | 0.483275 | 0.054573 | D to O | - |
| Q96S44 | PRPK_HUMAN TP53-regulating kinase OS=Homo sapiens GN=TP53RK PE=1 SV=2 | 123 | R | 0.303137 | Q | 0.340344 | -0.037207 | No Change: Both O | - |
| Q96S44 | PRPK_HUMAN TP53-regulating kinase OS=Homo sapiens GN=TP53RK PE=1 SV=2 | 145 | T | 0.330623 | A | 0.299159 | 0.031464 | No Change: Both O | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 57 | R | 0.638218 | H | 0.597969 | 0.040249 | No Change: Both D | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 172 | V | 0.775769 | A | 0.792535 | -0.016766 | No Change: Both D | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 191 | R | 0.344516 | H | 0.328379 | 0.016137 | No Change: Both O | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 219 | H | 0.21219 | Q | 0.231581 | -0.019391 | No Change: Both O | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 221 | P | 0.26575 | L | 0.158216 | 0.107534 | No Change: Both O | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 257 | V | 0.281691 | A | 0.348109 | -0.066418 | No Change: Both O | - |
| Q9Y2B4 | T53G5_HUMAN TP53-target gene 5 protein OS=Homo sapiens GN=TP53TG5 PE=1 SV=1 | 275 | H | 0.596054 | N | 0.634742 | -0.038688 | No Change: Both D | - |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 184 | S | 0.648877 | L | 0.492998 | 0.155879 | D to O | Neck cancer |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 187 | A | 0.635538 | P | 0.69858 | -0.063042 | No Change: Both D | Lung carcinoma |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 204 | Q | 0.231117 | L | 0.132966 | 0.098151 | No Change: Both O | Cervical cancer |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 233 | K | 0.462202 | E | 0.470136 | -0.007934 | No Change: Both O | Split-hand/foot malformation type 4 (SHFM4) [MIM:605289] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 243 | R | 0.46501 | Q | 0.470934 | -0.005924 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 243 | R | 0.46501 | W | 0.24439 | 0.22062 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 279 | P | 0.42897 | H | 0.398494 | 0.030476 | No Change: Both O | Colon cancer |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 318 | R | 0.175782 | H | 0.16087 | 0.014912 | No Change: Both O | Ectodermal dysplasia Rapp-Hodgkin type (EDRH) [MIM:129400] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 318 | R | 0.175782 | H | 0.16087 | 0.014912 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 319 | R | 0.146242 | C | 0.082525 | 0.063717 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 337 | R | 0.36943 | Q | 0.351463 | 0.017967 | No Change: Both O | Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) [MIM:103285] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 343 | R | 0.42726 | Q | 0.404829 | 0.022431 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 345 | C | 0.498805 | R | 0.604771 | -0.105966 | O to D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 351 | D | 0.717088 | G | 0.687146 | 0.029942 | No Change: Both D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 553 | L | 0.391475 | F | 0.373004 | 0.018471 | No Change: Both O | Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) [MIM:106260] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 560 | S | 0.222038 | A | 0.157466 | 0.064572 | No Change: Both O | Ovarian cancer |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 561 | C | 0.208576 | G | 0.280164 | -0.071588 | No Change: Both O | Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) [MIM:106260] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 232 | K | 0.440789 | E | 0.447587 | -0.006798 | No Change: Both O | Split-hand/foot malformation type 4 (SHFM4) [MIM:605289] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 266 | R | 0.480705 | Q | 0.505325 | -0.02462 | O to D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 308 | C | 0.129925 | Y | 0.140676 | -0.010751 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 311 | S | 0.22563 | N | 0.203061 | 0.022569 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 318 | R | 0.175782 | C | 0.097719 | 0.078063 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 318 | R | 0.175782 | Q | 0.175456 | 3.26E-04 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 319 | R | 0.146242 | H | 0.12803 | 0.018212 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 319 | R | 0.146242 | H | 0.12803 | 0.018212 | No Change: Both O | Split-hand/foot malformation type 4 (SHFM4) [MIM:605289] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 319 | R | 0.146242 | S | 0.173075 | -0.026833 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 343 | R | 0.42726 | W | 0.194197 | 0.233063 | No Change: Both O | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 347 | C | 0.60261 | S | 0.671986 | -0.069376 | No Change: Both D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 348 | P | 0.619064 | S | 0.626523 | -0.007459 | No Change: Both D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 351 | D | 0.717088 | H | 0.635485 | 0.081603 | No Change: Both D | Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome type 3 (EEC3) [MIM:604292] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 129 | S | 0.909986 | L | 0.842808 | 0.067178 | No Change: Both D | - |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 352 | R | 0.75428 | G | 0.726696 | 0.027584 | No Change: Both D | Ectodermal dysplasia Rapp-Hodgkin type (EDRH) [MIM:129400] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 352 | R | 0.75428 | G | 0.726696 | 0.027584 | No Change: Both D | Non-syndromic orofacial cleft type 8 (OFC8) [MIM:129400] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 549 | I | 0.473154 | T | 0.614281 | -0.141127 | O to D | Ectodermal dysplasia Rapp-Hodgkin type (EDRH) [MIM:129400] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 580 | S | 0.307428 | P | 0.267745 | 0.039683 | No Change: Both O | Ectodermal dysplasia Rapp-Hodgkin type (EDRH) [MIM:129400] |
| Q9H3D4 | P63_HUMAN Tumor protein 63 OS=Homo sapiens GN=TP63 PE=1 SV=1 | 603 | D | 0.29817 | H | 0.290947 | 0.007223 | No Change: Both O | - |
| Q9UF72 | T73AS_HUMAN Putative TP73 antisense gene protein 1 OS=Homo sapiens GN=TP73-AS1 PE=5 SV=1 | 120 | P | 0.597131 | L | 0.430164 | 0.166967 | D to O | - |
| Q8NHX9 | TPC2_HUMAN Two pore calcium channel protein 2 OS=Homo sapiens GN=TPCN2 PE=1 SV=2 | 376 | K | 0.658368 | R | 0.611576 | 0.046792 | No Change: Both D | - |
| Q8NHX9 | TPC2_HUMAN Two pore calcium channel protein 2 OS=Homo sapiens GN=TPCN2 PE=1 SV=2 | 564 | L | 0.147548 | P | 0.286992 | -0.139444 | No Change: Both O | - |
| Q8NHX9 | TPC2_HUMAN Two pore calcium channel protein 2 OS=Homo sapiens GN=TPCN2 PE=1 SV=2 | 734 | G | 0.623378 | E | 0.71205 | -0.088672 | No Change: Both D | - |
| Q8NHX9 | TPC2_HUMAN Two pore calcium channel protein 2 OS=Homo sapiens GN=TPCN2 PE=1 SV=2 | 484 | M | 0.02844 | L | 0.023963 | 0.004477 | No Change: Both O | - |
| P55327 | TPD52_HUMAN Tumor protein D52 OS=Homo sapiens GN=TPD52 PE=1 SV=2 | 52 | D | 0.827569 | Y | 0.722031 | 0.105538 | No Change: Both D | - |
| Q16890 | TPD53_HUMAN Tumor protein D53 OS=Homo sapiens GN=TPD52L1 PE=1 SV=1 | 62 | R | 0.545623 | K | 0.604363 | -0.05874 | No Change: Both D | - |
| Q96J77 | TPD55_HUMAN Tumor protein D55 OS=Homo sapiens GN=TPD52L3 PE=1 SV=2 | 118 | F | 0.495159 | L | 0.531382 | -0.036223 | O to D | - |
| Q68CL5 | TPGS2_HUMAN Tubulin polyglutamylase complex subunit 2 OS=Homo sapiens GN=TPGS2 PE=2 SV=2 | 47 | R | 0.512994 | C | 0.350843 | 0.162151 | D to O | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 441 | R | 0.260868 | H | 0.228791 | 0.032077 | No Change: Both O | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 206 | P | 0.332509 | S | 0.344913 | -0.012404 | No Change: Both O | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 36 | L | 0.836104 | P | 0.888245 | -0.052141 | No Change: Both D | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 36 | L | 0.836104 | V | 0.819992 | 0.016112 | No Change: Both D | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 41 | S | 0.899335 | Y | 0.814983 | 0.084352 | No Change: Both D | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 55 | R | 0.885894 | C | 0.851116 | 0.034778 | No Change: Both D | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 303 | R | 0.245674 | W | 0.111802 | 0.133872 | No Change: Both O | Attention deficit-hyperactivity disorder type 7 (ADHD7) [MIM:613003] |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 328 | A | 0.280795 | V | 0.215308 | 0.065487 | No Change: Both O | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 479 | D | 0.198791 | E | 0.207293 | -0.008502 | No Change: Both O | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 433 | R | 0.544997 | G | 0.535454 | 0.009543 | No Change: Both D | - |
| Q8IWU9 | TPH2_HUMAN Tryptophan 5-hydroxylase 2 OS=Homo sapiens GN=TPH2 PE=1 SV=1 | 468 | Q | 0.348702 | R | 0.34861 | 9.20E-05 | No Change: Both O | - |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 79 | C | 0.190461 | Y | 0.231678 | -0.041217 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 110 | G | 0.228738 | A | 0.184983 | 0.043755 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 142 | E | 0.497984 | D | 0.470824 | 0.02716 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 160 | G | 0.128258 | R | 0.121003 | 0.007255 | No Change: Both O | - |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 192 | V | 0.252051 | M | 0.286341 | -0.03429 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 208 | I | 0.17721 | V | 0.212974 | -0.035764 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 269 | V | 0.23016 | M | 0.272109 | -0.041949 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P60174 | TPIS_HUMAN Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 | 278 | F | 0.223304 | L | 0.259241 | -0.035937 | No Change: Both O | Triosephosphate isomerase deficiency (TPI deficiency) [MIM:190450] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 175 | D | 0.825945 | N | 0.805486 | 0.020459 | No Change: Both D | Familial hypertrophic cardiomyopathy type 3 (CMH3) [MIM:115196] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 180 | E | 0.881157 | G | 0.822628 | 0.058529 | No Change: Both D | Familial hypertrophic cardiomyopathy type 3 (CMH3) [MIM:115196] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 63 | A | 0.939472 | V | 0.913828 | 0.025644 | No Change: Both D | Familial hypertrophic cardiomyopathy type 3 (CMH3) [MIM:115196] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 180 | E | 0.881157 | V | 0.772626 | 0.108531 | No Change: Both D | Familial hypertrophic cardiomyopathy type 3 (CMH3) [MIM:115196] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 40 | E | 0.975736 | K | 0.97612 | -3.84E-04 | No Change: Both D | Cardiomyopathy dilated type 1Y (CMD1Y) [MIM:611878] |
| P09493 | TPM1_HUMAN Tropomyosin alpha-1 chain OS=Homo sapiens GN=TPM1 PE=1 SV=2 | 54 | E | 0.971796 | K | 0.972261 | -4.65E-04 | No Change: Both D | Cardiomyopathy dilated type 1Y (CMD1Y) [MIM:611878] |
| P07951 | TPM2_HUMAN Tropomyosin beta chain OS=Homo sapiens GN=TPM2 PE=1 SV=1 | 117 | E | 0.946828 | A | 0.92745 | 0.019378 | No Change: Both D | Nemaline myopathy type 4 (NEM4) [MIM:609285] |
| P07951 | TPM2_HUMAN Tropomyosin beta chain OS=Homo sapiens GN=TPM2 PE=1 SV=1 | 147 | Q | 0.933702 | P | 0.928441 | 0.005261 | No Change: Both D | Nemaline myopathy type 4 (NEM4) [MIM:609285] |
| P07951 | TPM2_HUMAN Tropomyosin beta chain OS=Homo sapiens GN=TPM2 PE=1 SV=1 | 91 | R | 0.903157 | G | 0.859622 | 0.043535 | No Change: Both D | Distal arthrogryposis type 1A (DA1A) [MIM:108120] |
| P07951 | TPM2_HUMAN Tropomyosin beta chain OS=Homo sapiens GN=TPM2 PE=1 SV=1 | 273 | E | 0.487223 | K | 0.502983 | -0.01576 | O to D | - |
| P06753 | TPM3_HUMAN Tropomyosin alpha-3 chain OS=Homo sapiens GN=TPM3 PE=1 SV=1 | 8 | M | 0.984192 | R | 0.985159 | -9.67E-04 | No Change: Both D | Nemaline myopathy type 1 (NEM1) [MIM:609284] |
| P67936 | TPM4_HUMAN Tropomyosin alpha-4 chain OS=Homo sapiens GN=TPM4 PE=1 SV=3 | 204 | E | 0.901752 | Q | 0.868686 | 0.033066 | No Change: Both D | A breast cancer sample |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 49 | L | 0.510951 | S | 0.649159 | -0.138208 | No Change: Both D | - |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 80 | A | 0.226586 | P | 0.286462 | -0.059876 | No Change: Both O | Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460] |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 154 | A | 0.080474 | T | 0.085915 | -0.005441 | No Change: Both O | Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460] |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 180 | Y | 0.061798 | F | 0.056396 | 0.005402 | No Change: Both O | - |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 227 | H | 0.332541 | Q | 0.3501 | -0.017559 | No Change: Both O | Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460] |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 240 | Y | 0.260266 | C | 0.236291 | 0.023975 | No Change: Both O | Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460] |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 215 | R | 0.065756 | H | 0.062638 | 0.003118 | No Change: Both O | Thiopurine S-methyltransferase deficiency (TPMT deficiency) [MIM:610460] |
| P51580 | TPMT_HUMAN Thiopurine S-methyltransferase OS=Homo sapiens GN=TPMT PE=1 SV=1 | 179 | Q | 0.075763 | H | 0.070147 | 0.005616 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 257 | A | 0.410357 | S | 0.497088 | -0.086731 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 373 | A | 0.708882 | S | 0.758183 | -0.049301 | No Change: Both D | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 398 | S | 0.509644 | T | 0.466688 | 0.042956 | D to O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 453 | Y | 0.103237 | D | 0.209272 | -0.106035 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 725 | T | 0.336073 | P | 0.406173 | -0.0701 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 799 | E | 0.52113 | K | 0.526728 | -0.005598 | No Change: Both D | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 648 | R | 0.208766 | Q | 0.210363 | -0.001597 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 447 | I | 0.076293 | F | 0.070296 | 0.005997 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 53 | A | 0.452423 | P | 0.553964 | -0.101541 | O to D | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 240 | D | 0.204742 | N | 0.181325 | 0.023417 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 307 | N | 0.537066 | T | 0.527047 | 0.010019 | No Change: Both D | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 326 | A | 0.43706 | T | 0.486784 | -0.049724 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 433 | V | 0.272179 | M | 0.324239 | -0.05206 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 458 | L | 0.159204 | P | 0.307164 | -0.14796 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 491 | R | 0.206934 | H | 0.223734 | -0.0168 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 493 | G | 0.190962 | S | 0.243419 | -0.052457 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 499 | P | 0.19474 | L | 0.108564 | 0.086176 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 527 | W | 0.124077 | C | 0.153406 | -0.029329 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 660 | Q | 0.203054 | E | 0.239542 | -0.036488 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 665 | R | 0.142298 | W | 0.0641 | 0.078198 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 693 | R | 0.256771 | W | 0.114999 | 0.141772 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 771 | G | 0.35216 | R | 0.371793 | -0.019633 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 796 | D | 0.456733 | Y | 0.278221 | 0.178512 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 808 | C | 0.607313 | R | 0.672941 | -0.065628 | No Change: Both D | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 378 | E | 0.759207 | K | 0.722063 | 0.037144 | No Change: Both D | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 533 | G | 0.235289 | C | 0.12305 | 0.112239 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 590 | G | 0.354402 | S | 0.391255 | -0.036853 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 618 | V | 0.299508 | M | 0.358031 | -0.058523 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 706 | M | 0.234701 | V | 0.198331 | 0.03637 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 793 | L | 0.352401 | P | 0.549334 | -0.196933 | O to D | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 839 | V | 0.406003 | I | 0.367928 | 0.038075 | No Change: Both O | Thyroid dyshormonogenesis 2A (TDH2A) [MIM:274500] |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 846 | R | 0.182271 | W | 0.076566 | 0.105705 | No Change: Both O | - |
| P07202 | PERT_HUMAN Thyroid peroxidase OS=Homo sapiens GN=TPO PE=1 SV=4 | 847 | V | 0.164814 | A | 0.225902 | -0.061088 | No Change: Both O | - |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 175 | R | 0.614517 | H | 0.593829 | 0.020688 | No Change: Both D | - |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 365 | C | 0.423323 | R | 0.596534 | -0.173211 | O to D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 365 | C | 0.423323 | Y | 0.465837 | -0.042514 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 447 | R | 0.416013 | H | 0.402832 | 0.013181 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 77 | G | 0.487553 | R | 0.496856 | -0.009303 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 100 | Q | 0.141614 | R | 0.129092 | 0.012522 | No Change: Both O | - |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 206 | R | 0.419819 | C | 0.287419 | 0.1324 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 287 | I | 0.240114 | N | 0.417421 | -0.177307 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 343 | E | 0.285162 | K | 0.298155 | -0.012993 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 385 | V | 0.43195 | D | 0.573976 | -0.142026 | O to D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 389 | G | 0.37662 | E | 0.418756 | -0.042136 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 422 | Q | 0.511764 | H | 0.497154 | 0.01461 | D to O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 454 | A | 0.235456 | E | 0.293229 | -0.057773 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 475 | S | 0.386046 | L | 0.201457 | 0.184589 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 127 | R | 0.073517 | Q | 0.086304 | -0.012787 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 153 | S | 0.530587 | P | 0.546531 | -0.015944 | No Change: Both D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 206 | R | 0.419819 | H | 0.38292 | 0.036899 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 277 | V | 0.225181 | M | 0.29712 | -0.071939 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 278 | Q | 0.207259 | P | 0.218376 | -0.011117 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 284 | G | 0.186069 | V | 0.117082 | 0.068987 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 286 | N | 0.213936 | S | 0.277151 | -0.063215 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 353 | T | 0.214329 | P | 0.254818 | -0.040489 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 428 | K | 0.549595 | N | 0.526291 | 0.023304 | No Change: Both D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 473 | G | 0.372407 | R | 0.362248 | 0.010159 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 481 | F | 0.263588 | C | 0.253813 | 0.009775 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 62 | S | 0.552423 | L | 0.394025 | 0.158398 | D to O | - |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 185 | R | 0.731946 | C | 0.601977 | 0.129969 | No Change: Both D | - |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 482 | G | 0.196515 | R | 0.178096 | 0.018419 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 202 | P | 0.435306 | L | 0.298192 | 0.137114 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 544 | P | 0.33346 | S | 0.336712 | -0.003252 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 62 | S | 0.552423 | T | 0.461484 | 0.090939 | D to O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 209 | Y | 0.424864 | H | 0.553473 | -0.128609 | O to D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 266 | R | 0.497637 | Q | 0.518109 | -0.020472 | O to D | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 339 | R | 0.26148 | Q | 0.291431 | -0.029951 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 382 | S | 0.477572 | R | 0.400069 | 0.077503 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 448 | A | 0.403417 | V | 0.332279 | 0.071138 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 501 | G | 0.306158 | C | 0.163816 | 0.142342 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 504 | N | 0.305745 | Y | 0.201696 | 0.104049 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| O14773 | TPP1_HUMAN Tripeptidyl-peptidase 1 OS=Homo sapiens GN=TPP1 PE=1 SV=2 | 548 | W | 0.285363 | R | 0.495862 | -0.210499 | No Change: Both O | Neuronal ceroid lipofuscinosis type 2 (CLN2) [MIM:204500] |
| P59282 | TPPP2_HUMAN Tubulin polymerization-promoting protein family member 2 OS=Homo sapiens GN=TPPP2 PE=2 SV=2 | 133 | R | 0.827473 | L | 0.741269 | 0.086204 | No Change: Both D | - |
| P12270 | TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens GN=TPR PE=1 SV=3 | 960 | S | 0.896474 | N | 0.880624 | 0.01585 | No Change: Both D | - |
| P12270 | TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens GN=TPR PE=1 SV=3 | 1428 | V | 0.724442 | G | 0.779461 | -0.055019 | No Change: Both D | - |
| P12270 | TPR_HUMAN Nucleoprotein TPR OS=Homo sapiens GN=TPR PE=1 SV=3 | 1707 | T | 0.97202 | A | 0.965368 | 0.006652 | No Change: Both D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 18 | A | 0.416527 | V | 0.310585 | 0.105942 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 23 | G | 0.439839 | V | 0.31616 | 0.123679 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 85 | A | 0.205554 | T | 0.216932 | -0.011378 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 141 | T | 0.508595 | A | 0.474611 | 0.033984 | D to O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 162 | D | 0.342266 | N | 0.320523 | 0.021743 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 170 | P | 0.499795 | S | 0.496027 | 0.003768 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 215 | T | 0.437871 | S | 0.54351 | -0.105639 | O to D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 216 | R | 0.494665 | Q | 0.514689 | -0.020024 | O to D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 132 | N | 0.56145 | K | 0.597432 | -0.035982 | No Change: Both D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 136 | H | 0.453001 | R | 0.433171 | 0.01983 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 3 | N | 0.453225 | S | 0.521921 | -0.068696 | O to D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 15 | R | 0.322072 | P | 0.395079 | -0.073007 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 28 | R | 0.293197 | Q | 0.336736 | -0.043539 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 29 | V | 0.280127 | A | 0.370957 | -0.09083 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 51 | H | 0.10549 | R | 0.108252 | -0.002762 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 52 | G | 0.109855 | D | 0.118135 | -0.00828 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 53 | P | 0.097095 | R | 0.088442 | 0.008653 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 76 | V | 0.173448 | L | 0.172129 | 0.001319 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 115 | T | 0.122453 | I | 0.074872 | 0.047581 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 116 | A | 0.125826 | I | 0.080027 | 0.045799 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 118 | I | 0.127671 | T | 0.214862 | -0.087191 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 133 | V | 0.553621 | I | 0.493547 | 0.060074 | D to O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 141 | T | 0.508595 | M | 0.449759 | 0.058836 | D to O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 168 | R | 0.530259 | P | 0.595833 | -0.065574 | No Change: Both D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 205 | V | 0.209975 | I | 0.188312 | 0.021663 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 221 | Q | 0.658801 | K | 0.689802 | -0.031001 | No Change: Both D | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 245 | G | 0.24136 | D | 0.245763 | -0.004403 | No Change: Both O | - |
| Q15661 | TRYB1_HUMAN Tryptase alpha/beta-1 OS=Homo sapiens GN=TPSAB1 PE=1 SV=1 | 263 | Y | 0.052217 | N | 0.090248 | -0.038031 | No Change: Both O | - |
| Q9BZJ3 | TRYD_HUMAN Tryptase delta OS=Homo sapiens GN=TPSD1 PE=1 SV=2 | 22 | P | 0.406288 | R | 0.314286 | 0.092002 | No Change: Both O | - |
| Q9BZJ3 | TRYD_HUMAN Tryptase delta OS=Homo sapiens GN=TPSD1 PE=1 SV=2 | 25 | V | 0.43748 | A | 0.555479 | -0.117999 | O to D | - |
| Q9BZJ3 | TRYD_HUMAN Tryptase delta OS=Homo sapiens GN=TPSD1 PE=1 SV=2 | 83 | V | 0.178209 | M | 0.214196 | -0.035987 | No Change: Both O | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 60 | M | 0.224654 | V | 0.189379 | 0.035275 | No Change: Both O | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 126 | I | 0.475802 | M | 0.547604 | -0.071802 | O to D | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 132 | S | 0.318942 | T | 0.244339 | 0.074603 | No Change: Both O | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 204 | L | 0.617709 | I | 0.57691 | 0.040799 | No Change: Both D | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 288 | L | 0.076179 | F | 0.062874 | 0.013305 | No Change: Both O | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 160 | W | 0.124399 | S | 0.301569 | -0.17717 | No Change: Both O | - |
| Q9NRR2 | TRYG1_HUMAN Tryptase gamma OS=Homo sapiens GN=TPSG1 PE=2 SV=3 | 239 | T | 0.210447 | I | 0.122745 | 0.087702 | No Change: Both O | - |
| P13693 | TCTP_HUMAN Translationally-controlled tumor protein OS=Homo sapiens GN=TPT1 PE=1 SV=1 | 146 | V | 0.228025 | F | 0.2044 | 0.023625 | No Change: Both O | - |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 470 | L | 0.116277 | P | 0.222629 | -0.106352 | No Change: Both O | - |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 144 | R | 0.058605 | Q | 0.062595 | -0.00399 | No Change: Both O | A breast cancer sample |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 195 | R | 0.037519 | Q | 0.036983 | 5.36E-04 | No Change: Both O | - |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 549 | G | 0.787742 | E | 0.760148 | 0.027594 | No Change: Both D | - |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 482 | Y | 0.110556 | S | 0.228821 | -0.118265 | No Change: Both O | - |
| P56180 | TPTE_HUMAN Putative tyrosine-protein phosphatase TPTE OS=Homo sapiens GN=TPTE PE=2 SV=3 | 386 | K | 0.641053 | E | 0.633189 | 0.007864 | No Change: Both D | - |
| Q6XPS3 | TPTE2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens GN=TPTE2 PE=1 SV=2 | 367 | V | 0.636202 | I | 0.603061 | 0.033141 | No Change: Both D | - |
| Q6XPS3 | TPTE2_HUMAN Phosphatidylinositol-3 4 5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens GN=TPTE2 PE=1 SV=2 | 444 | I | 0.153123 | V | 0.168093 | -0.01497 | No Change: Both O | - |
| Q9ULW0 | TPX2_HUMAN Targeting protein for Xklp2 OS=Homo sapiens GN=TPX2 PE=1 SV=2 | 464 | T | 0.688383 | N | 0.680209 | 0.008174 | No Change: Both D | A colorectal cancer sample |
| Q13077 | TRAF1_HUMAN TNF receptor-associated factor 1 OS=Homo sapiens GN=TRAF1 PE=1 SV=1 | 139 | M | 0.468156 | T | 0.516271 | -0.048115 | O to D | - |
| Q13114 | TRAF3_HUMAN TNF receptor-associated factor 3 OS=Homo sapiens GN=TRAF3 PE=1 SV=2 | 129 | M | 0.212161 | T | 0.230141 | -0.01798 | No Change: Both O | - |
| Q8TDR0 | MIPT3_HUMAN TRAF3-interacting protein 1 OS=Homo sapiens GN=TRAF3IP1 PE=1 SV=1 | 228 | N | 0.9993 | S | 0.999303 | -3.00E-06 | No Change: Both D | - |
| Q8TDR0 | MIPT3_HUMAN TRAF3-interacting protein 1 OS=Homo sapiens GN=TRAF3IP1 PE=1 SV=1 | 239 | R | 0.999562 | W | 0.998692 | 8.70E-04 | No Change: Both D | - |
| Q8TDR0 | MIPT3_HUMAN TRAF3-interacting protein 1 OS=Homo sapiens GN=TRAF3IP1 PE=1 SV=1 | 620 | M | 0.509736 | L | 0.436015 | 0.073721 | D to O | - |
| Q8TDR0 | MIPT3_HUMAN TRAF3-interacting protein 1 OS=Homo sapiens GN=TRAF3IP1 PE=1 SV=1 | 295 | K | 0.992532 | N | 0.990413 | 0.002119 | No Change: Both D | - |
| Q8TDR0 | MIPT3_HUMAN TRAF3-interacting protein 1 OS=Homo sapiens GN=TRAF3IP1 PE=1 SV=1 | 416 | T | 0.969431 | S | 0.977188 | -0.007757 | No Change: Both D | - |
| O43734 | CIKS_HUMAN Adapter protein CIKS OS=Homo sapiens GN=TRAF3IP2 PE=1 SV=3 | 332 | H | 0.716743 | Q | 0.757796 | -0.041053 | No Change: Both D | - |
| O43734 | CIKS_HUMAN Adapter protein CIKS OS=Homo sapiens GN=TRAF3IP2 PE=1 SV=3 | 83 | R | 0.67325 | W | 0.425594 | 0.247656 | D to O | - |
| O43734 | CIKS_HUMAN Adapter protein CIKS OS=Homo sapiens GN=TRAF3IP2 PE=1 SV=3 | 19 | D | 0.973123 | N | 0.977666 | -0.004543 | No Change: Both D | Psoriasis type 13 (PSORS13) [MIM:614070] |
| Q9Y228 | T3JAM_HUMAN TRAF3-interacting JNK-activating modulator OS=Homo sapiens GN=TRAF3IP3 PE=1 SV=2 | 373 | Q | 0.76178 | E | 0.757899 | 0.003881 | No Change: Both D | - |
| Q9Y228 | T3JAM_HUMAN TRAF3-interacting JNK-activating modulator OS=Homo sapiens GN=TRAF3IP3 PE=1 SV=2 | 529 | P | 0.06204 | S | 0.06158 | 4.60E-04 | No Change: Both O | A colorectal cancer sample |
| Q9BUZ4 | TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens GN=TRAF4 PE=1 SV=1 | 173 | A | 0.573246 | T | 0.601147 | -0.027901 | No Change: Both D | - |
| Q9BUZ4 | TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens GN=TRAF4 PE=1 SV=1 | 178 | R | 0.529805 | G | 0.493951 | 0.035854 | D to O | - |
| Q9Y448 | T4AF1_HUMAN Putative TRAF4-associated factor 1 OS=Homo sapiens GN=TRAF4AF1 PE=1 SV=2 | 40 | A | 0.328012 | E | 0.410635 | -0.082623 | No Change: Both O | - |
| Q9Y448 | T4AF1_HUMAN Putative TRAF4-associated factor 1 OS=Homo sapiens GN=TRAF4AF1 PE=1 SV=2 | 75 | R | 0.529494 | L | 0.421326 | 0.108168 | D to O | - |
| Q9Y448 | T4AF1_HUMAN Putative TRAF4-associated factor 1 OS=Homo sapiens GN=TRAF4AF1 PE=1 SV=2 | 92 | P | 0.803428 | S | 0.80633 | -0.002902 | No Change: Both D | - |
| O00463 | TRAF5_HUMAN TNF receptor-associated factor 5 OS=Homo sapiens GN=TRAF5 PE=1 SV=2 | 186 | N | 0.386418 | H | 0.359619 | 0.026799 | No Change: Both O | - |
| O00463 | TRAF5_HUMAN TNF receptor-associated factor 5 OS=Homo sapiens GN=TRAF5 PE=1 SV=2 | 120 | V | 0.168437 | G | 0.262509 | -0.094072 | No Change: Both O | - |
| O00463 | TRAF5_HUMAN TNF receptor-associated factor 5 OS=Homo sapiens GN=TRAF5 PE=1 SV=2 | 358 | L | 0.508838 | V | 0.4909 | 0.017938 | D to O | - |
| O60296 | TRAK2_HUMAN Trafficking kinesin-binding protein 2 OS=Homo sapiens GN=TRAK2 PE=1 SV=2 | 142 | V | 0.58063 | I | 0.559629 | 0.021001 | No Change: Both D | - |
| O60296 | TRAK2_HUMAN Trafficking kinesin-binding protein 2 OS=Homo sapiens GN=TRAK2 PE=1 SV=2 | 528 | T | 0.538252 | I | 0.390218 | 0.148034 | D to O | - |
| O60296 | TRAK2_HUMAN Trafficking kinesin-binding protein 2 OS=Homo sapiens GN=TRAK2 PE=1 SV=2 | 863 | I | 0.657675 | N | 0.781079 | -0.123404 | No Change: Both D | - |
| O15050 | TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 OS=Homo sapiens GN=TRANK1 PE=2 SV=4 | 703 | P | 0.6891 | L | 0.564249 | 0.124851 | No Change: Both D | - |
| O15050 | TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 OS=Homo sapiens GN=TRANK1 PE=2 SV=4 | 1090 | E | 0.995025 | G | 0.992897 | 0.002128 | No Change: Both D | - |
| O15050 | TRNK1_HUMAN TPR and ankyrin repeat-containing protein 1 OS=Homo sapiens GN=TRANK1 PE=2 SV=4 | 153 | P | 0.449959 | L | 0.289398 | 0.160561 | No Change: Both O | - |
| Q12931 | TRAP1_HUMAN Heat shock protein 75 kDa mitochondrial OS=Homo sapiens GN=TRAP1 PE=1 SV=3 | 307 | R | 0.422998 | G | 0.437518 | -0.01452 | No Change: Both O | - |
| Q12931 | TRAP1_HUMAN Heat shock protein 75 kDa mitochondrial OS=Homo sapiens GN=TRAP1 PE=1 SV=3 | 395 | D | 0.379118 | E | 0.406731 | -0.027613 | No Change: Both O | - |
| Q12931 | TRAP1_HUMAN Heat shock protein 75 kDa mitochondrial OS=Homo sapiens GN=TRAP1 PE=1 SV=3 | 692 | R | 0.218516 | H | 0.203508 | 0.015008 | No Change: Both O | - |
| Q12931 | TRAP1_HUMAN Heat shock protein 75 kDa mitochondrial OS=Homo sapiens GN=TRAP1 PE=1 SV=3 | 572 | E | 0.618196 | K | 0.604429 | 0.013767 | No Change: Both D | - |
| Q9Y5R8 | TPPC1_HUMAN Trafficking protein particle complex subunit 1 OS=Homo sapiens GN=TRAPPC1 PE=1 SV=1 | 129 | R | 0.423407 | G | 0.412653 | 0.010754 | No Change: Both O | A melanoma |
| P48553 | TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens GN=TRAPPC10 PE=1 SV=2 | 257 | V | 0.10148 | E | 0.207433 | -0.105953 | No Change: Both O | - |
| P48553 | TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens GN=TRAPPC10 PE=1 SV=2 | 633 | I | 0.358075 | M | 0.432407 | -0.074332 | No Change: Both O | - |
| P48553 | TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens GN=TRAPPC10 PE=1 SV=2 | 726 | V | 0.405417 | M | 0.484844 | -0.079427 | No Change: Both O | - |
| P0DI81 | TPC2A_HUMAN Trafficking protein particle complex subunit 2 OS=Homo sapiens GN=TRAPPC2 PE=1 SV=1 | 47 | D | 0.148496 | Y | 0.071372 | 0.077124 | No Change: Both O | Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400] |
| P0DI81 | TPC2A_HUMAN Trafficking protein particle complex subunit 2 OS=Homo sapiens GN=TRAPPC2 PE=1 SV=1 | 73 | S | 0.074362 | L | 0.030228 | 0.044134 | No Change: Both O | Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400] |
| P0DI81 | TPC2A_HUMAN Trafficking protein particle complex subunit 2 OS=Homo sapiens GN=TRAPPC2 PE=1 SV=1 | 130 | V | 0.35718 | D | 0.559751 | -0.202571 | O to D | Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400] |
| P0DI81 | TPC2A_HUMAN Trafficking protein particle complex subunit 2 OS=Homo sapiens GN=TRAPPC2 PE=1 SV=1 | 83 | F | 0.106252 | S | 0.252633 | -0.146381 | No Change: Both O | Spondyloepiphyseal dysplasia tarda (SEDT) [MIM:313400] |
| Q9Y296 | TPPC4_HUMAN Trafficking protein particle complex subunit 4 OS=Homo sapiens GN=TRAPPC4 PE=1 SV=1 | 78 | D | 0.394088 | A | 0.321068 | 0.07302 | No Change: Both O | - |
| Q8IUR0 | TPPC5_HUMAN Trafficking protein particle complex subunit 5 OS=Homo sapiens GN=TRAPPC5 PE=1 SV=1 | 52 | S | 0.411404 | A | 0.327155 | 0.084249 | No Change: Both O | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 537 | R | 0.504751 | Q | 0.526204 | -0.021453 | No Change: Both D | A breast cancer sample |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 74 | N | 0.286977 | S | 0.328824 | -0.041847 | No Change: Both O | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 708 | Q | 0.712548 | E | 0.737389 | -0.024841 | No Change: Both D | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 1189 | I | 0.389729 | V | 0.368153 | 0.021576 | No Change: Both O | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 137 | L | 0.314219 | S | 0.495427 | -0.181208 | No Change: Both O | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 517 | S | 0.637859 | G | 0.579695 | 0.058164 | No Change: Both D | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 954 | R | 0.346216 | H | 0.342879 | 0.003337 | No Change: Both O | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 1146 | T | 0.795685 | A | 0.80111 | -0.005425 | No Change: Both D | - |
| Q9Y2L5 | TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens GN=TRAPPC8 PE=1 SV=2 | 1298 | S | 0.76379 | P | 0.764914 | -0.001124 | No Change: Both D | - |
| Q6PIZ9 | TRAT1_HUMAN T-cell receptor-associated transmembrane adapter 1 OS=Homo sapiens GN=TRAT1 PE=1 SV=1 | 137 | D | 0.783189 | G | 0.742222 | 0.040967 | No Change: Both D | - |
| Q6PIZ9 | TRAT1_HUMAN T-cell receptor-associated transmembrane adapter 1 OS=Homo sapiens GN=TRAT1 PE=1 SV=1 | 148 | S | 0.620736 | P | 0.600094 | 0.020642 | No Change: Both D | - |
| O14717 | TRDMT_HUMAN tRNA (cytosine(38)-C(5))-methyltransferase OS=Homo sapiens GN=TRDMT1 PE=1 SV=1 | 101 | H | 0.2122 | Y | 0.153548 | 0.058652 | No Change: Both O | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 128 | T | 0.965159 | S | 0.974157 | -0.008998 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 339 | S | 0.99665 | N | 0.995338 | 0.001312 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 404 | V | 0.997961 | G | 0.998303 | -3.42E-04 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 419 | D | 0.988555 | E | 0.992447 | -0.003892 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 470 | L | 0.993021 | M | 0.994796 | -0.001775 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 540 | I | 0.952665 | M | 0.959721 | -0.007056 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 201 | L | 0.999558 | V | 0.99962 | -6.20E-05 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 396 | K | 0.999254 | N | 0.998695 | 5.59E-04 | No Change: Both D | - |
| Q13061 | TRDN_HUMAN Triadin OS=Homo sapiens GN=TRDN PE=1 SV=4 | 438 | I | 0.978082 | S | 0.98836 | -0.010278 | No Change: Both D | - |
| O43280 | TREA_HUMAN Trehalase OS=Homo sapiens GN=TREH PE=1 SV=2 | 389 | T | 0.126293 | A | 0.118126 | 0.008167 | No Change: Both O | - |
| O43280 | TREA_HUMAN Trehalase OS=Homo sapiens GN=TREH PE=1 SV=2 | 449 | Y | 0.167295 | H | 0.248724 | -0.081429 | No Change: Both O | - |
| O43280 | TREA_HUMAN Trehalase OS=Homo sapiens GN=TREH PE=1 SV=2 | 486 | R | 0.321445 | W | 0.14649 | 0.174955 | No Change: Both O | - |
| O43280 | TREA_HUMAN Trehalase OS=Homo sapiens GN=TREH PE=1 SV=2 | 558 | A | 0.325829 | P | 0.407813 | -0.081984 | No Change: Both O | - |
| O43280 | TREA_HUMAN Trehalase OS=Homo sapiens GN=TREH PE=1 SV=2 | 561 | A | 0.239996 | P | 0.314044 | -0.074048 | No Change: Both O | - |
| Q9NP99 | TREM1_HUMAN Triggering receptor expressed on myeloid cells 1 OS=Homo sapiens GN=TREM1 PE=1 SV=1 | 25 | T | 0.575069 | S | 0.620429 | -0.04536 | No Change: Both D | - |
| Q9NP99 | TREM1_HUMAN Triggering receptor expressed on myeloid cells 1 OS=Homo sapiens GN=TREM1 PE=1 SV=1 | 214 | F | 0.132394 | L | 0.158548 | -0.026154 | No Change: Both O | - |
| Q9NP99 | TREM1_HUMAN Triggering receptor expressed on myeloid cells 1 OS=Homo sapiens GN=TREM1 PE=1 SV=1 | 97 | R | 0.190168 | S | 0.225757 | -0.035589 | No Change: Both O | A breast cancer sample |
| Q9NP99 | TREM1_HUMAN Triggering receptor expressed on myeloid cells 1 OS=Homo sapiens GN=TREM1 PE=1 SV=1 | 135 | K | 0.323817 | T | 0.28008 | 0.043737 | No Change: Both O | - |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 134 | D | 0.41017 | G | 0.366628 | 0.043542 | No Change: Both O | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) [MIM:221770] |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 186 | K | 0.036716 | N | 0.027613 | 0.009103 | No Change: Both O | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) [MIM:221770] |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 157 | H | 0.588351 | Y | 0.43943 | 0.148921 | D to O | - |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 211 | L | 0.72938 | P | 0.825075 | -0.095695 | No Change: Both D | - |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 96 | T | 0.239102 | K | 0.287031 | -0.047929 | No Change: Both O | - |
| Q9NZC2 | TREM2_HUMAN Triggering receptor expressed on myeloid cells 2 OS=Homo sapiens GN=TREM2 PE=1 SV=1 | 96 | T | 0.239102 | R | 0.245543 | -0.006441 | No Change: Both O | - |
| Q86YW5 | TRML1_HUMAN Trem-like transcript 1 protein OS=Homo sapiens GN=TREML1 PE=1 SV=2 | 6 | L | 0.170664 | V | 0.142365 | 0.028299 | No Change: Both O | A breast cancer sample |
| Q86YW5 | TRML1_HUMAN Trem-like transcript 1 protein OS=Homo sapiens GN=TREML1 PE=1 SV=2 | 231 | H | 0.837429 | P | 0.888388 | -0.050959 | No Change: Both D | - |
| Q5T2D2 | TRML2_HUMAN Trem-like transcript 2 protein OS=Homo sapiens GN=TREML2 PE=1 SV=2 | 50 | V | 0.300871 | M | 0.343521 | -0.04265 | No Change: Both O | - |
| Q5T2D2 | TRML2_HUMAN Trem-like transcript 2 protein OS=Homo sapiens GN=TREML2 PE=1 SV=2 | 144 | S | 0.458229 | G | 0.427279 | 0.03095 | No Change: Both O | - |
| Q5T2D2 | TRML2_HUMAN Trem-like transcript 2 protein OS=Homo sapiens GN=TREML2 PE=1 SV=2 | 285 | V | 0.039031 | I | 0.03352 | 0.005511 | No Change: Both O | - |
| Q5T2D2 | TRML2_HUMAN Trem-like transcript 2 protein OS=Homo sapiens GN=TREML2 PE=1 SV=2 | 19 | G | 0.4508 | C | 0.271696 | 0.179104 | No Change: Both O | - |
| Q8IWX9 | TRML3_HUMAN Trem-like transcript 3 protein OS=Homo sapiens GN=TREML3 PE=2 SV=2 | 100 | S | 0.304262 | L | 0.150608 | 0.153654 | No Change: Both O | - |
| Q8IWX9 | TRML3_HUMAN Trem-like transcript 3 protein OS=Homo sapiens GN=TREML3 PE=2 SV=2 | 115 | I | 0.15246 | V | 0.174363 | -0.021903 | No Change: Both O | - |
| Q8IWX9 | TRML3_HUMAN Trem-like transcript 3 protein OS=Homo sapiens GN=TREML3 PE=2 SV=2 | 160 | D | 0.575796 | E | 0.586046 | -0.01025 | No Change: Both D | - |
| Q6UXN2 | TRML4_HUMAN Trem-like transcript 4 protein OS=Homo sapiens GN=TREML4 PE=2 SV=1 | 73 | W | 0.445919 | R | 0.568815 | -0.122896 | O to D | - |
| Q6UXN2 | TRML4_HUMAN Trem-like transcript 4 protein OS=Homo sapiens GN=TREML4 PE=2 SV=1 | 146 | T | 0.579377 | K | 0.571756 | 0.007621 | No Change: Both D | - |
| Q6UXN2 | TRML4_HUMAN Trem-like transcript 4 protein OS=Homo sapiens GN=TREML4 PE=2 SV=1 | 168 | T | 0.761352 | I | 0.68313 | 0.078222 | No Change: Both D | - |
| Q96PN7 | TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens GN=TRERF1 PE=1 SV=1 | 431 | T | 0.960537 | A | 0.955609 | 0.004928 | No Change: Both D | - |
| Q96PN7 | TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens GN=TRERF1 PE=1 SV=1 | 834 | C | 0.1876 | S | 0.383818 | -0.196218 | No Change: Both O | - |
| Q96PN7 | TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens GN=TRERF1 PE=1 SV=1 | 1019 | N | 0.477014 | T | 0.461225 | 0.015789 | No Change: Both O | - |
| Q96PN7 | TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens GN=TRERF1 PE=1 SV=1 | 1187 | D | 0.593043 | N | 0.474234 | 0.118809 | D to O | - |
| Q96PN7 | TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens GN=TRERF1 PE=1 SV=1 | 766 | V | 0.634104 | I | 0.610834 | 0.02327 | No Change: Both D | - |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 169 | R | 0.117288 | H | 0.108191 | 0.009097 | No Change: Both O | Aicardi-Goutieres syndrome type 1 (AGS1) [MIM:225750] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 169 | R | 0.117288 | H | 0.108191 | 0.009097 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 256 | V | 0.254923 | D | 0.395197 | -0.140274 | No Change: Both O | Aicardi-Goutieres syndrome type 1 (AGS1) [MIM:225750] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 255 | D | 0.340203 | N | 0.314738 | 0.025465 | No Change: Both O | Aicardi-Goutieres syndrome type 1 (AGS1) [MIM:225750] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 73 | D | 0.439854 | N | 0.425097 | 0.014757 | No Change: Both O | Aicardi-Goutieres syndrome type 1 (AGS1) [MIM:225750] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 73 | D | 0.439854 | N | 0.425097 | 0.014757 | No Change: Both O | Chilblain lupus (CHBL) [MIM:610448] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 213 | A | 0.245631 | V | 0.180551 | 0.06508 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 282 | G | 0.273614 | S | 0.318538 | -0.044924 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 295 | R | 0.66378 | S | 0.679635 | -0.015855 | No Change: Both D | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 302 | A | 0.776081 | P | 0.822576 | -0.046495 | No Change: Both D | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 321 | E | 0.907495 | G | 0.906377 | 0.001118 | No Change: Both D | - |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 345 | P | 0.363452 | L | 0.259067 | 0.104385 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 360 | Y | 0.158344 | C | 0.181506 | -0.023162 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9NSU2 | TREX1_HUMAN Three prime repair exonuclease 1 OS=Homo sapiens GN=TREX1 PE=1 SV=1 | 361 | G | 0.195599 | A | 0.169735 | 0.025864 | No Change: Both O | Systemic lupus erythematosus (SLE) [MIM:152700] |
| Q9BQ50 | TREX2_HUMAN Three prime repair exonuclease 2 OS=Homo sapiens GN=TREX2 PE=1 SV=1 | 180 | R | 0.369832 | C | 0.251994 | 0.117838 | No Change: Both O | - |
| P20396 | TRH_HUMAN Prothyroliberin OS=Homo sapiens GN=TRH PE=1 SV=1 | 8 | L | 0.297358 | V | 0.242034 | 0.055324 | No Change: Both O | - |
| P34981 | TRFR_HUMAN Thyrotropin-releasing hormone receptor OS=Homo sapiens GN=TRHR PE=1 SV=1 | 10 | N | 0.605477 | K | 0.640825 | -0.035348 | No Change: Both D | - |
| P34981 | TRFR_HUMAN Thyrotropin-releasing hormone receptor OS=Homo sapiens GN=TRHR PE=1 SV=1 | 168 | I | 0.082128 | M | 0.118102 | -0.035974 | No Change: Both O | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 173 | S | 0.626065 | R | 0.572856 | 0.053209 | No Change: Both D | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 215 | T | 0.404269 | M | 0.353784 | 0.050485 | No Change: Both O | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 267 | V | 0.172052 | I | 0.143874 | 0.028178 | No Change: Both O | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 298 | R | 0.238813 | C | 0.144277 | 0.094536 | No Change: Both O | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 360 | E | 0.597452 | A | 0.46172 | 0.135732 | D to O | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 360 | E | 0.597452 | D | 0.583427 | 0.014025 | No Change: Both D | - |
| Q96RU8 | TRIB1_HUMAN Tribbles homolog 1 OS=Homo sapiens GN=TRIB1 PE=1 SV=2 | 371 | F | 0.785821 | L | 0.784801 | 0.00102 | No Change: Both D | A lung large cell carcinoma sample |
| Q92519 | TRIB2_HUMAN Tribbles homolog 2 OS=Homo sapiens GN=TRIB2 PE=2 SV=1 | 4 | H | 0.728962 | R | 0.818969 | -0.090007 | No Change: Both D | - |
| Q96RU7 | TRIB3_HUMAN Tribbles homolog 3 OS=Homo sapiens GN=TRIB3 PE=1 SV=2 | 84 | Q | 0.380229 | R | 0.392568 | -0.012339 | No Change: Both O | - |
| Q96RU7 | TRIB3_HUMAN Tribbles homolog 3 OS=Homo sapiens GN=TRIB3 PE=1 SV=2 | 60 | T | 0.81707 | I | 0.709374 | 0.107696 | No Change: Both D | A glioblastoma multiforme sample |
| Q96RU7 | TRIB3_HUMAN Tribbles homolog 3 OS=Homo sapiens GN=TRIB3 PE=1 SV=2 | 153 | R | 0.539683 | H | 0.542964 | -0.003281 | No Change: Both D | - |
| Q96RU7 | TRIB3_HUMAN Tribbles homolog 3 OS=Homo sapiens GN=TRIB3 PE=1 SV=2 | 274 | R | 0.165346 | H | 0.151158 | 0.014188 | No Change: Both O | - |
| Q96RU7 | TRIB3_HUMAN Tribbles homolog 3 OS=Homo sapiens GN=TRIB3 PE=1 SV=2 | 347 | E | 0.688688 | K | 0.646195 | 0.042493 | No Change: Both D | - |
| Q7L0X0 | TRIL_HUMAN TLR4 interactor with leucine rich repeats OS=Homo sapiens GN=TRIL PE=1 SV=2 | 240 | N | 0.528001 | S | 0.590206 | -0.062205 | No Change: Both D | - |
| Q7L0X0 | TRIL_HUMAN TLR4 interactor with leucine rich repeats OS=Homo sapiens GN=TRIL PE=1 SV=2 | 347 | A | 0.225125 | T | 0.22896 | -0.003835 | No Change: Both O | - |
| Q7L0X0 | TRIL_HUMAN TLR4 interactor with leucine rich repeats OS=Homo sapiens GN=TRIL PE=1 SV=2 | 369 | G | 0.133117 | D | 0.151924 | -0.018807 | No Change: Both O | - |
| Q9UDY6 | TRI10_HUMAN Tripartite motif-containing protein 10 OS=Homo sapiens GN=TRIM10 PE=2 SV=3 | 65 | R | 0.49013 | H | 0.432353 | 0.057777 | No Change: Both O | - |
| Q9UDY6 | TRI10_HUMAN Tripartite motif-containing protein 10 OS=Homo sapiens GN=TRIM10 PE=2 SV=3 | 119 | V | 0.167133 | M | 0.240423 | -0.07329 | No Change: Both O | - |
| O60858 | TRI13_HUMAN E3 ubiquitin-protein ligase TRIM13 OS=Homo sapiens GN=TRIM13 PE=1 SV=2 | 355 | S | 0.262282 | T | 0.193229 | 0.069053 | No Change: Both O | - |
| Q14142 | TRI14_HUMAN Tripartite motif-containing protein 14 OS=Homo sapiens GN=TRIM14 PE=2 SV=2 | 219 | V | 0.475117 | M | 0.529276 | -0.054159 | O to D | - |
| Q9C019 | TRI15_HUMAN Tripartite motif-containing protein 15 OS=Homo sapiens GN=TRIM15 PE=2 SV=1 | 29 | I | 0.219058 | V | 0.264167 | -0.045109 | No Change: Both O | - |
| Q9C019 | TRI15_HUMAN Tripartite motif-containing protein 15 OS=Homo sapiens GN=TRIM15 PE=2 SV=1 | 42 | A | 0.409012 | T | 0.431561 | -0.022549 | No Change: Both O | - |
| Q9C019 | TRI15_HUMAN Tripartite motif-containing protein 15 OS=Homo sapiens GN=TRIM15 PE=2 SV=1 | 84 | E | 0.442309 | Q | 0.377628 | 0.064681 | No Change: Both O | - |
| Q9C019 | TRI15_HUMAN Tripartite motif-containing protein 15 OS=Homo sapiens GN=TRIM15 PE=2 SV=1 | 235 | L | 0.641713 | V | 0.649828 | -0.008115 | No Change: Both D | - |
| Q9C019 | TRI15_HUMAN Tripartite motif-containing protein 15 OS=Homo sapiens GN=TRIM15 PE=2 SV=1 | 324 | S | 0.769213 | N | 0.696579 | 0.072634 | No Change: Both D | - |
| O95361 | TRI16_HUMAN Tripartite motif-containing protein 16 OS=Homo sapiens GN=TRIM16 PE=1 SV=3 | 121 | E | 0.4073 | D | 0.404772 | 0.002528 | No Change: Both O | - |
| O95361 | TRI16_HUMAN Tripartite motif-containing protein 16 OS=Homo sapiens GN=TRIM16 PE=1 SV=3 | 561 | G | 0.819244 | V | 0.766526 | 0.052718 | No Change: Both D | - |
| O95361 | TRI16_HUMAN Tripartite motif-containing protein 16 OS=Homo sapiens GN=TRIM16 PE=1 SV=3 | 493 | R | 0.15684 | W | 0.060872 | 0.095968 | No Change: Both O | - |
| P19474 | RO52_HUMAN E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens GN=TRIM21 PE=1 SV=1 | 52 | P | 0.370678 | A | 0.255917 | 0.114761 | No Change: Both O | - |
| P19474 | RO52_HUMAN E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens GN=TRIM21 PE=1 SV=1 | 96 | G | 0.367834 | R | 0.404467 | -0.036633 | No Change: Both O | - |
| P19474 | RO52_HUMAN E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens GN=TRIM21 PE=1 SV=1 | 231 | E | 0.722273 | K | 0.694654 | 0.027619 | No Change: Both D | - |
| P19474 | RO52_HUMAN E3 ubiquitin-protein ligase TRIM21 OS=Homo sapiens GN=TRIM21 PE=1 SV=1 | 88 | Q | 0.639071 | K | 0.657424 | -0.018353 | No Change: Both D | - |
| Q8IYM9 | TRI22_HUMAN E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens GN=TRIM22 PE=1 SV=1 | 155 | D | 0.742974 | N | 0.723936 | 0.019038 | No Change: Both D | - |
| Q8IYM9 | TRI22_HUMAN E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens GN=TRIM22 PE=1 SV=1 | 232 | T | 0.653737 | A | 0.645199 | 0.008538 | No Change: Both D | - |
| Q8IYM9 | TRI22_HUMAN E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens GN=TRIM22 PE=1 SV=1 | 242 | R | 0.723511 | T | 0.681134 | 0.042377 | No Change: Both D | - |
| Q8IYM9 | TRI22_HUMAN E3 ubiquitin-protein ligase TRIM22 OS=Homo sapiens GN=TRIM22 PE=1 SV=1 | 321 | R | 0.371475 | K | 0.444018 | -0.072543 | No Change: Both O | - |
| P36406 | TRI23_HUMAN E3 ubiquitin-protein ligase TRIM23 OS=Homo sapiens GN=TRIM23 PE=1 SV=1 | 480 | D | 0.3502 | N | 0.320813 | 0.029387 | No Change: Both O | - |
| O15164 | TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens GN=TRIM24 PE=1 SV=3 | 320 | I | 0.346486 | T | 0.444486 | -0.098 | No Change: Both O | An ovarian serous carcinoma sample |
| O15164 | TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens GN=TRIM24 PE=1 SV=3 | 403 | T | 0.281482 | N | 0.324705 | -0.043223 | No Change: Both O | A lung squamous cell carcinoma sample |
| O15164 | TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens GN=TRIM24 PE=1 SV=3 | 762 | S | 0.840346 | N | 0.804039 | 0.036307 | No Change: Both D | - |
| O15164 | TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens GN=TRIM24 PE=1 SV=3 | 1009 | R | 0.868096 | S | 0.882825 | -0.014729 | No Change: Both D | - |
| O15164 | TIF1A_HUMAN Transcription intermediary factor 1-alpha OS=Homo sapiens GN=TRIM24 PE=1 SV=3 | 796 | N | 0.962788 | S | 0.972281 | -0.009493 | No Change: Both D | - |
| Q14258 | TRI25_HUMAN E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens GN=TRIM25 PE=1 SV=2 | 89 | V | 0.586228 | G | 0.634463 | -0.048235 | No Change: Both D | - |
| Q14258 | TRI25_HUMAN E3 ubiquitin/ISG15 ligase TRIM25 OS=Homo sapiens GN=TRIM25 PE=1 SV=2 | 358 | P | 0.866972 | L | 0.80029 | 0.066682 | No Change: Both D | - |
| Q12899 | TRI26_HUMAN Tripartite motif-containing protein 26 OS=Homo sapiens GN=TRIM26 PE=2 SV=1 | 197 | Q | 0.706914 | H | 0.651757 | 0.055157 | No Change: Both D | - |
| Q13263 | TIF1B_HUMAN Transcription intermediary factor 1-beta OS=Homo sapiens GN=TRIM28 PE=1 SV=5 | 794 | T | 0.312697 | M | 0.310788 | 0.001909 | No Change: Both O | - |
| Q14134 | TRI29_HUMAN Tripartite motif-containing protein 29 OS=Homo sapiens GN=TRIM29 PE=1 SV=2 | 514 | S | 0.540506 | F | 0.338758 | 0.201748 | D to O | A breast cancer sample |
| O75382 | TRIM3_HUMAN Tripartite motif-containing protein 3 OS=Homo sapiens GN=TRIM3 PE=1 SV=2 | 298 | L | 0.367211 | R | 0.487065 | -0.119854 | No Change: Both O | - |
| Q9BZY9 | TRI31_HUMAN E3 ubiquitin-protein ligase TRIM31 OS=Homo sapiens GN=TRIM31 PE=1 SV=2 | 421 | E | 0.402016 | K | 0.396873 | 0.005143 | No Change: Both O | - |
| Q9BZY9 | TRI31_HUMAN E3 ubiquitin-protein ligase TRIM31 OS=Homo sapiens GN=TRIM31 PE=1 SV=2 | 118 | R | 0.373289 | C | 0.308616 | 0.064673 | No Change: Both O | - |
| Q9BZY9 | TRI31_HUMAN E3 ubiquitin-protein ligase TRIM31 OS=Homo sapiens GN=TRIM31 PE=1 SV=2 | 232 | V | 0.520015 | I | 0.483581 | 0.036434 | D to O | - |
| Q9BZY9 | TRI31_HUMAN E3 ubiquitin-protein ligase TRIM31 OS=Homo sapiens GN=TRIM31 PE=1 SV=2 | 17 | P | 0.043038 | R | 0.033149 | 0.009889 | No Change: Both O | - |
| Q9BZY9 | TRI31_HUMAN E3 ubiquitin-protein ligase TRIM31 OS=Homo sapiens GN=TRIM31 PE=1 SV=2 | 235 | L | 0.608703 | P | 0.732351 | -0.123648 | No Change: Both D | - |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 487 | D | 0.179688 | N | 0.169671 | 0.010017 | No Change: Both O | Limb-girdle muscular dystrophy type 2H (LGMD2H) [MIM:254110] |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 130 | P | 0.860233 | S | 0.836014 | 0.024219 | No Change: Both D | Bardet-Biedl syndrome type 11 (BBS11) [MIM:209900] |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 257 | T | 0.674596 | R | 0.687588 | -0.012992 | No Change: Both D | - |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 408 | R | 0.510316 | C | 0.312206 | 0.19811 | D to O | - |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 394 | R | 0.149883 | H | 0.135767 | 0.014116 | No Change: Both O | Limb-girdle muscular dystrophy type 2H (LGMD2H) [MIM:254110] |
| Q13049 | TRI32_HUMAN E3 ubiquitin-protein ligase TRIM32 OS=Homo sapiens GN=TRIM32 PE=1 SV=2 | 299 | R | 0.42385 | Q | 0.458652 | -0.034802 | No Change: Both O | - |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 840 | I | 0.793242 | T | 0.854773 | -0.061531 | No Change: Both D | - |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 67 | V | 0.979828 | A | 0.987077 | -0.007249 | No Change: Both D | - |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 580 | M | 0.840708 | I | 0.770553 | 0.070155 | No Change: Both D | A glioblastoma multiforme sample |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 696 | L | 0.901689 | S | 0.938811 | -0.037122 | No Change: Both D | - |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 811 | E | 0.914614 | K | 0.906499 | 0.008115 | No Change: Both D | A lung adenocarcinoma sample |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 885 | P | 0.638465 | S | 0.645271 | -0.006806 | No Change: Both D | A glioblastoma multiforme sample |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 961 | V | 0.441425 | M | 0.504542 | -0.063117 | O to D | - |
| Q9UPN9 | TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens GN=TRIM33 PE=1 SV=3 | 1090 | P | 0.701922 | T | 0.665886 | 0.036036 | No Change: Both D | - |
| Q9BYJ4 | TRI34_HUMAN Tripartite motif-containing protein 34 OS=Homo sapiens GN=TRIM34 PE=1 SV=2 | 276 | T | 0.395306 | S | 0.500366 | -0.10506 | O to D | - |
| Q9BYJ4 | TRI34_HUMAN Tripartite motif-containing protein 34 OS=Homo sapiens GN=TRIM34 PE=1 SV=2 | 282 | D | 0.281035 | H | 0.26178 | 0.019255 | No Change: Both O | - |
| Q9BYJ4 | TRI34_HUMAN Tripartite motif-containing protein 34 OS=Homo sapiens GN=TRIM34 PE=1 SV=2 | 404 | N | 0.099498 | K | 0.129246 | -0.029748 | No Change: Both O | - |
| Q9NQ86 | TRI36_HUMAN E3 ubiquitin-protein ligase TRIM36 OS=Homo sapiens GN=TRIM36 PE=2 SV=2 | 678 | D | 0.319797 | N | 0.276682 | 0.043115 | No Change: Both O | - |
| Q9NQ86 | TRI36_HUMAN E3 ubiquitin-protein ligase TRIM36 OS=Homo sapiens GN=TRIM36 PE=2 SV=2 | 428 | K | 0.429577 | R | 0.3717 | 0.057877 | No Change: Both O | - |
| Q9NQ86 | TRI36_HUMAN E3 ubiquitin-protein ligase TRIM36 OS=Homo sapiens GN=TRIM36 PE=2 SV=2 | 456 | N | 0.436169 | S | 0.488931 | -0.052762 | No Change: Both O | - |
| Q9NQ86 | TRI36_HUMAN E3 ubiquitin-protein ligase TRIM36 OS=Homo sapiens GN=TRIM36 PE=2 SV=2 | 725 | Q | 0.764366 | E | 0.793013 | -0.028647 | No Change: Both D | - |
| O94972 | TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens GN=TRIM37 PE=1 SV=2 | 838 | V | 0.188448 | I | 0.15259 | 0.035858 | No Change: Both O | - |
| O94972 | TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens GN=TRIM37 PE=1 SV=2 | 76 | L | 0.647689 | P | 0.738706 | -0.091017 | No Change: Both D | Mulibrey nanism (MUL) [MIM:253250] |
| O94972 | TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens GN=TRIM37 PE=1 SV=2 | 108 | T | 0.14714 | A | 0.126395 | 0.020745 | No Change: Both O | - |
| O94972 | TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens GN=TRIM37 PE=1 SV=2 | 109 | C | 0.146548 | S | 0.202213 | -0.055665 | No Change: Both O | Mulibrey nanism (MUL) [MIM:253250] |
| O94972 | TRI37_HUMAN E3 ubiquitin-protein ligase TRIM37 OS=Homo sapiens GN=TRIM37 PE=1 SV=2 | 322 | G | 0.111955 | V | 0.064328 | 0.047627 | No Change: Both O | Mulibrey nanism (MUL) [MIM:253250] |
| O00635 | TRI38_HUMAN Tripartite motif-containing protein 38 OS=Homo sapiens GN=TRIM38 PE=2 SV=1 | 421 | G | 0.105956 | R | 0.093858 | 0.012098 | No Change: Both O | - |
| Q9C037 | TRIM4_HUMAN Tripartite motif-containing protein 4 OS=Homo sapiens GN=TRIM4 PE=2 SV=2 | 367 | P | 0.080261 | S | 0.092649 | -0.012388 | No Change: Both O | - |
| Q9C037 | TRIM4_HUMAN Tripartite motif-containing protein 4 OS=Homo sapiens GN=TRIM4 PE=2 SV=2 | 474 | S | 0.410134 | C | 0.185979 | 0.224155 | No Change: Both O | - |
| Q6P9F5 | TRI40_HUMAN Tripartite motif-containing protein 40 OS=Homo sapiens GN=TRIM40 PE=2 SV=3 | 142 | K | 0.864758 | Q | 0.870073 | -0.005315 | No Change: Both D | - |
| Q6P9F5 | TRI40_HUMAN Tripartite motif-containing protein 40 OS=Homo sapiens GN=TRIM40 PE=2 SV=3 | 215 | E | 0.519673 | K | 0.522995 | -0.003322 | No Change: Both D | - |
| Q6P9F5 | TRI40_HUMAN Tripartite motif-containing protein 40 OS=Homo sapiens GN=TRIM40 PE=2 SV=3 | 244 | E | 0.604021 | K | 0.623596 | -0.019575 | No Change: Both D | - |
| Q8WV44 | TRI41_HUMAN E3 ubiquitin-protein ligase TRIM41 OS=Homo sapiens GN=TRIM41 PE=1 SV=3 | 78 | A | 0.982892 | T | 0.984489 | -0.001597 | No Change: Both D | - |
| Q8WV44 | TRI41_HUMAN E3 ubiquitin-protein ligase TRIM41 OS=Homo sapiens GN=TRIM41 PE=1 SV=3 | 438 | D | 0.638809 | G | 0.563188 | 0.075621 | No Change: Both D | - |
| Q8IWZ5 | TRI42_HUMAN Tripartite motif-containing protein 42 OS=Homo sapiens GN=TRIM42 PE=2 SV=2 | 475 | V | 0.165076 | M | 0.196773 | -0.031697 | No Change: Both O | - |
| Q8IWZ5 | TRI42_HUMAN Tripartite motif-containing protein 42 OS=Homo sapiens GN=TRIM42 PE=2 SV=2 | 579 | A | 0.511506 | E | 0.578726 | -0.06722 | No Change: Both D | - |
| Q8IWZ5 | TRI42_HUMAN Tripartite motif-containing protein 42 OS=Homo sapiens GN=TRIM42 PE=2 SV=2 | 244 | K | 0.13117 | R | 0.10848 | 0.02269 | No Change: Both O | - |
| Q9H8W5 | TRI45_HUMAN Tripartite motif-containing protein 45 OS=Homo sapiens GN=TRIM45 PE=1 SV=2 | 375 | C | 0.281709 | Y | 0.294319 | -0.01261 | No Change: Both O | - |
| Q9H8W5 | TRI45_HUMAN Tripartite motif-containing protein 45 OS=Homo sapiens GN=TRIM45 PE=1 SV=2 | 413 | R | 0.607367 | Q | 0.625944 | -0.018577 | No Change: Both D | - |
| Q9H8W5 | TRI45_HUMAN Tripartite motif-containing protein 45 OS=Homo sapiens GN=TRIM45 PE=1 SV=2 | 496 | M | 0.424758 | T | 0.486283 | -0.061525 | No Change: Both O | - |
| Q9H8W5 | TRI45_HUMAN Tripartite motif-containing protein 45 OS=Homo sapiens GN=TRIM45 PE=1 SV=2 | 353 | R | 0.267489 | Q | 0.266713 | 7.76E-04 | No Change: Both O | - |
| Q96LD4 | TRI47_HUMAN Tripartite motif-containing protein 47 OS=Homo sapiens GN=TRIM47 PE=1 SV=2 | 500 | E | 0.437399 | A | 0.333323 | 0.104076 | No Change: Both O | - |
| P0CI25 | TRI49_HUMAN Tripartite motif-containing protein 49 OS=Homo sapiens GN=TRIM49 PE=2 SV=1 | 373 | G | 0.413232 | R | 0.380854 | 0.032378 | No Change: Both O | - |
| A6NDI0 | TR49B_HUMAN Putative tripartite motif-containing protein 49B OS=Homo sapiens GN=TRIM49B PE=3 SV=1 | 398 | L | 0.188583 | M | 0.216593 | -0.02801 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 43 | H | 0.495593 | Y | 0.370234 | 0.125359 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 136 | R | 0.501672 | Q | 0.526527 | -0.024855 | No Change: Both D | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 112 | V | 0.145201 | F | 0.141524 | 0.003677 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 249 | G | 0.434583 | D | 0.472412 | -0.037829 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 419 | H | 0.47565 | Y | 0.342475 | 0.133175 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 479 | P | 0.333748 | L | 0.173516 | 0.160232 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 31 | G | 0.261728 | S | 0.346708 | -0.08498 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 58 | C | 0.415726 | Y | 0.370775 | 0.044951 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 110 | G | 0.16588 | E | 0.230417 | -0.064537 | No Change: Both O | - |
| Q9C035 | TRIM5_HUMAN Tripartite motif-containing protein 5 OS=Homo sapiens GN=TRIM5 PE=1 SV=1 | 467 | C | 0.181363 | S | 0.409235 | -0.227872 | No Change: Both O | - |
| Q86XT4 | TRI50_HUMAN E3 ubiquitin-protein ligase TRIM50 OS=Homo sapiens GN=TRIM50 PE=1 SV=1 | 8 | L | 0.125471 | P | 0.221478 | -0.096007 | No Change: Both O | - |
| Q9BYV6 | TRI55_HUMAN Tripartite motif-containing protein 55 OS=Homo sapiens GN=TRIM55 PE=1 SV=2 | 343 | K | 0.994294 | R | 0.994639 | -3.45E-04 | No Change: Both D | - |
| Q8NG06 | TRI58_HUMAN Tripartite motif-containing protein 58 OS=Homo sapiens GN=TRIM58 PE=2 SV=2 | 3 | W | 0.729587 | S | 0.834266 | -0.104679 | No Change: Both D | - |
| Q8NG06 | TRI58_HUMAN Tripartite motif-containing protein 58 OS=Homo sapiens GN=TRIM58 PE=2 SV=2 | 322 | V | 0.544683 | I | 0.51064 | 0.034043 | No Change: Both D | - |
| Q8NG06 | TRI58_HUMAN Tripartite motif-containing protein 58 OS=Homo sapiens GN=TRIM58 PE=2 SV=2 | 374 | T | 0.740497 | M | 0.698308 | 0.042189 | No Change: Both D | - |
| Q9C030 | TRIM6_HUMAN Tripartite motif-containing protein 6 OS=Homo sapiens GN=TRIM6 PE=1 SV=1 | 154 | E | 0.915627 | K | 0.912631 | 0.002996 | No Change: Both D | - |
| Q969Q1 | TRI63_HUMAN E3 ubiquitin-protein ligase TRIM63 OS=Homo sapiens GN=TRIM63 PE=1 SV=1 | 237 | K | 0.772294 | E | 0.782331 | -0.010037 | No Change: Both D | - |
| Q6PJ69 | TRI65_HUMAN Tripartite motif-containing protein 65 OS=Homo sapiens GN=TRIM65 PE=1 SV=3 | 364 | G | 0.630736 | R | 0.640005 | -0.009269 | No Change: Both D | - |
| Q6PJ69 | TRI65_HUMAN Tripartite motif-containing protein 65 OS=Homo sapiens GN=TRIM65 PE=1 SV=3 | 366 | G | 0.540943 | S | 0.592235 | -0.051292 | No Change: Both D | - |
| Q6PJ69 | TRI65_HUMAN Tripartite motif-containing protein 65 OS=Homo sapiens GN=TRIM65 PE=1 SV=3 | 222 | V | 0.606593 | G | 0.687342 | -0.080749 | No Change: Both D | - |
| Q6PJ69 | TRI65_HUMAN Tripartite motif-containing protein 65 OS=Homo sapiens GN=TRIM65 PE=1 SV=3 | 509 | L | 0.403818 | P | 0.575956 | -0.172138 | O to D | - |
| Q6AZZ1 | TRI68_HUMAN E3 ubiquitin-protein ligase TRIM68 OS=Homo sapiens GN=TRIM68 PE=1 SV=1 | 442 | C | 0.139498 | Y | 0.177227 | -0.037729 | No Change: Both O | - |
| Q6AZZ1 | TRI68_HUMAN E3 ubiquitin-protein ligase TRIM68 OS=Homo sapiens GN=TRIM68 PE=1 SV=1 | 457 | R | 0.21325 | H | 0.202497 | 0.010753 | No Change: Both O | - |
| Q6AZZ1 | TRI68_HUMAN E3 ubiquitin-protein ligase TRIM68 OS=Homo sapiens GN=TRIM68 PE=1 SV=1 | 466 | Y | 0.194736 | S | 0.371756 | -0.17702 | No Change: Both O | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 31 | V | 0.240552 | A | 0.277904 | -0.037352 | No Change: Both O | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 12 | D | 0.690067 | N | 0.683278 | 0.006789 | No Change: Both D | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 15 | D | 0.60078 | N | 0.590259 | 0.010521 | No Change: Both D | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 104 | K | 0.581047 | R | 0.474077 | 0.10697 | D to O | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 161 | T | 0.257086 | M | 0.23048 | 0.026606 | No Change: Both O | - |
| Q86WT6 | TRI69_HUMAN Tripartite motif-containing protein 69 OS=Homo sapiens GN=TRIM69 PE=2 SV=2 | 190 | A | 0.688498 | V | 0.597982 | 0.090516 | No Change: Both D | - |
| Q9C029 | TRIM7_HUMAN Tripartite motif-containing protein 7 OS=Homo sapiens GN=TRIM7 PE=1 SV=2 | 18 | A | 0.477807 | S | 0.55418 | -0.076373 | O to D | - |
| Q9C029 | TRIM7_HUMAN Tripartite motif-containing protein 7 OS=Homo sapiens GN=TRIM7 PE=1 SV=2 | 73 | P | 0.862372 | S | 0.843213 | 0.019159 | No Change: Both D | - |
| Q9C029 | TRIM7_HUMAN Tripartite motif-containing protein 7 OS=Homo sapiens GN=TRIM7 PE=1 SV=2 | 95 | Q | 0.918634 | E | 0.91752 | 0.001114 | No Change: Both D | - |
| Q9C029 | TRIM7_HUMAN Tripartite motif-containing protein 7 OS=Homo sapiens GN=TRIM7 PE=1 SV=2 | 258 | V | 0.70942 | A | 0.779579 | -0.070159 | No Change: Both D | - |
| Q9C029 | TRIM7_HUMAN Tripartite motif-containing protein 7 OS=Homo sapiens GN=TRIM7 PE=1 SV=2 | 363 | G | 0.472326 | S | 0.534171 | -0.061845 | O to D | - |
| Q86UV6 | TRI74_HUMAN Tripartite motif-containing protein 74 OS=Homo sapiens GN=TRIM74 PE=2 SV=1 | 13 | W | 0.07333 | R | 0.174448 | -0.101118 | No Change: Both O | - |
| Q9C026 | TRIM9_HUMAN E3 ubiquitin-protein ligase TRIM9 OS=Homo sapiens GN=TRIM9 PE=1 SV=1 | 653 | L | 0.144181 | F | 0.123396 | 0.020785 | No Change: Both O | - |
| Q8N9V2 | TRIML_HUMAN Probable E3 ubiquitin-protein ligase TRIML1 OS=Homo sapiens GN=TRIML1 PE=1 SV=1 | 21 | D | 0.087043 | H | 0.073604 | 0.013439 | No Change: Both O | A breast cancer sample |
| Q8N9V2 | TRIML_HUMAN Probable E3 ubiquitin-protein ligase TRIML1 OS=Homo sapiens GN=TRIML1 PE=1 SV=1 | 132 | E | 0.808976 | K | 0.791203 | 0.017773 | No Change: Both D | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 291 | S | 0.852984 | T | 0.789076 | 0.063908 | No Change: Both D | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 1644 | T | 0.769474 | M | 0.731558 | 0.037916 | No Change: Both D | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 1690 | H | 0.417887 | R | 0.453949 | -0.036062 | No Change: Both O | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 1978 | V | 0.538129 | M | 0.607638 | -0.069509 | No Change: Both D | A metastatic melanoma sample |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 2242 | T | 0.258458 | M | 0.204275 | 0.054183 | No Change: Both O | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 348 | D | 0.270769 | E | 0.300329 | -0.02956 | No Change: Both O | - |
| O75962 | TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | 1613 | A | 0.8262 | T | 0.848367 | -0.022167 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 1019 | G | 0.927899 | R | 0.945396 | -0.017497 | No Change: Both D | Deafness autosomal recessive type 28 (DFNB28) [MIM:609823] |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 863 | N | 0.991518 | K | 0.992054 | -5.36E-04 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 1372 | E | 0.988782 | D | 0.986191 | 0.002591 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 1377 | W | 0.990707 | R | 0.996571 | -0.005864 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 217 | S | 0.912967 | N | 0.870085 | 0.042882 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 493 | S | 0.999281 | N | 0.999142 | 1.39E-04 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 1187 | F | 0.925753 | L | 0.932441 | -0.006688 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 1300 | H | 0.959772 | R | 0.975279 | -0.015507 | No Change: Both D | - |
| Q9H2D6 | TARA_HUMAN TRIO and F-actin-binding protein OS=Homo sapiens GN=TRIOBP PE=1 SV=3 | 817 | T | 0.990165 | S | 0.992225 | -0.00206 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1846 | T | 0.698426 | I | 0.573804 | 0.124622 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 39 | M | 0.633563 | L | 0.570468 | 0.063095 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 506 | E | 0.856398 | A | 0.795913 | 0.060485 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 795 | V | 0.930377 | L | 0.951232 | -0.020855 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 884 | D | 0.871881 | G | 0.837421 | 0.03446 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1040 | I | 0.731773 | V | 0.721709 | 0.010064 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1503 | M | 0.870759 | V | 0.791452 | 0.079307 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1576 | R | 0.918172 | H | 0.889312 | 0.02886 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1749 | E | 0.9146 | A | 0.868982 | 0.045618 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1752 | R | 0.92059 | K | 0.931613 | -0.011023 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1107 | E | 0.487257 | D | 0.442641 | 0.044616 | No Change: Both O | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1413 | D | 0.891603 | A | 0.86174 | 0.029863 | No Change: Both D | - |
| Q15643 | TRIPB_HUMAN Thyroid receptor-interacting protein 11 OS=Homo sapiens GN=TRIP11 PE=1 SV=3 | 1827 | G | 0.395327 | S | 0.432099 | -0.036772 | No Change: Both O | - |
| Q15654 | TRIP6_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=1 SV=3 | 296 | L | 0.149553 | F | 0.152416 | -0.002863 | No Change: Both O | - |
| Q15654 | TRIP6_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=1 SV=3 | 230 | V | 0.969018 | I | 0.96043 | 0.008588 | No Change: Both D | - |
| Q15654 | TRIP6_HUMAN Thyroid receptor-interacting protein 6 OS=Homo sapiens GN=TRIP6 PE=1 SV=3 | 111 | R | 0.901739 | Q | 0.890357 | 0.011382 | No Change: Both D | - |
| Q9H3H1 | MOD5_HUMAN tRNA dimethylallyltransferase mitochondrial OS=Homo sapiens GN=TRIT1 PE=1 SV=1 | 202 | F | 0.606669 | L | 0.645982 | -0.039313 | No Change: Both D | - |
| Q7Z4G4 | TRM11_HUMAN tRNA (guanine(10)-N2)-methyltransferase homolog OS=Homo sapiens GN=TRMT11 PE=1 SV=1 | 230 | L | 0.072886 | Q | 0.1281 | -0.055214 | No Change: Both O | - |
| Q53H54 | TYW2_HUMAN tRNA wybutosine-synthesizing protein 2 homolog OS=Homo sapiens GN=TRMT12 PE=1 SV=1 | 28 | W | 0.183104 | R | 0.421292 | -0.238188 | No Change: Both O | - |
| Q8IZ69 | TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens GN=TRMT2A PE=1 SV=2 | 602 | S | 0.861651 | R | 0.864738 | -0.003087 | No Change: Both D | - |
| Q8IZ69 | TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens GN=TRMT2A PE=1 SV=2 | 604 | P | 0.902738 | S | 0.882482 | 0.020256 | No Change: Both D | A breast cancer sample |
| Q96GJ1 | TRM2_HUMAN tRNA (uracil(54)-C(5))-methyltransferase homolog OS=Homo sapiens GN=TRMT2B PE=2 SV=1 | 12 | S | 0.160545 | R | 0.133673 | 0.026872 | No Change: Both O | - |
| Q32P41 | TRM5_HUMAN tRNA (guanine(37)-N1)-methyltransferase OS=Homo sapiens GN=TRMT5 PE=1 SV=2 | 217 | S | 0.287326 | P | 0.261916 | 0.02541 | No Change: Both O | - |
| Q32P41 | TRM5_HUMAN tRNA (guanine(37)-N1)-methyltransferase OS=Homo sapiens GN=TRMT5 PE=1 SV=2 | 255 | L | 0.441871 | P | 0.609279 | -0.167408 | O to D | - |
| Q32P41 | TRM5_HUMAN tRNA (guanine(37)-N1)-methyltransferase OS=Homo sapiens GN=TRMT5 PE=1 SV=2 | 294 | E | 0.413746 | A | 0.287084 | 0.126662 | No Change: Both O | - |
| Q9UJA5 | TRM6_HUMAN tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Homo sapiens GN=TRMT6 PE=1 SV=1 | 293 | E | 0.974366 | K | 0.971988 | 0.002378 | No Change: Both D | - |
| Q9UJA5 | TRM6_HUMAN tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Homo sapiens GN=TRMT6 PE=1 SV=1 | 299 | E | 0.989264 | G | 0.984339 | 0.004925 | No Change: Both D | - |
| Q9UJA5 | TRM6_HUMAN tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Homo sapiens GN=TRMT6 PE=1 SV=1 | 333 | P | 0.989883 | L | 0.980969 | 0.008914 | No Change: Both D | - |
| Q96FX7 | TRM61_HUMAN tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A OS=Homo sapiens GN=TRMT61A PE=1 SV=1 | 66 | V | 0.084098 | A | 0.109796 | -0.025698 | No Change: Both O | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 10 | A | 0.161578 | S | 0.247658 | -0.08608 | No Change: Both O | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 25 | R | 0.157588 | S | 0.190894 | -0.033306 | No Change: Both O | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 148 | E | 0.534515 | K | 0.542995 | -0.00848 | No Change: Both D | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 398 | R | 0.722662 | C | 0.610712 | 0.11195 | No Change: Both D | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 14 | G | 0.293072 | S | 0.354234 | -0.061162 | No Change: Both O | - |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 77 | Y | 0.164932 | H | 0.248218 | -0.083286 | No Change: Both O | Transient infantile liver failure (LFIT) [MIM:613070] |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 272 | G | 0.196011 | D | 0.202097 | -0.006086 | No Change: Both O | Transient infantile liver failure (LFIT) [MIM:613070] |
| O75648 | MTU1_HUMAN Mitochondrial tRNA-specific 2-thiouridylase 1 OS=Homo sapiens GN=TRMU PE=1 SV=2 | 279 | V | 0.208876 | M | 0.241823 | -0.032947 | No Change: Both O | - |
| Q6NT89 | TRNP1_HUMAN TMF-regulated nuclear protein 1 OS=Homo sapiens GN=TRNP1 PE=2 SV=2 | 27 | W | 0.998166 | R | 0.999319 | -0.001153 | No Change: Both D | - |
| Q96Q11 | TRNT1_HUMAN CCA tRNA nucleotidyltransferase 1 mitochondrial OS=Homo sapiens GN=TRNT1 PE=1 SV=2 | 23 | P | 0.138261 | L | 0.076261 | 0.062 | No Change: Both O | - |
| Q12816 | TROP_HUMAN Trophinin OS=Homo sapiens GN=TRO PE=1 SV=3 | 738 | S | 0.925516 | G | 0.906089 | 0.019427 | No Change: Both D | - |
| Q12816 | TROP_HUMAN Trophinin OS=Homo sapiens GN=TRO PE=1 SV=3 | 65 | R | 0.898726 | W | 0.818271 | 0.080455 | No Change: Both D | - |
| O75762 | TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens GN=TRPA1 PE=2 SV=3 | 3 | R | 0.920683 | C | 0.855407 | 0.065276 | No Change: Both D | - |
| O75762 | TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens GN=TRPA1 PE=2 SV=3 | 179 | E | 0.300973 | K | 0.315952 | -0.014979 | No Change: Both O | - |
| O75762 | TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens GN=TRPA1 PE=2 SV=3 | 186 | K | 0.360903 | N | 0.310976 | 0.049927 | No Change: Both O | - |
| O75762 | TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens GN=TRPA1 PE=2 SV=3 | 1018 | H | 0.03618 | R | 0.048019 | -0.011839 | No Change: Both O | - |
| O75762 | TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens GN=TRPA1 PE=2 SV=3 | 58 | R | 0.417248 | T | 0.419752 | -0.002504 | No Change: Both O | - |
| Q9UBN4 | TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens GN=TRPC4 PE=1 SV=1 | 138 | E | 0.301972 | K | 0.315353 | -0.013381 | No Change: Both O | A breast cancer sample |
| Q9UL62 | TRPC5_HUMAN Short transient receptor potential channel 5 OS=Homo sapiens GN=TRPC5 PE=1 SV=1 | 702 | R | 0.554381 | H | 0.515233 | 0.039148 | No Change: Both D | - |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 112 | P | 0.174451 | Q | 0.165459 | 0.008992 | No Change: Both O | Focal segmental glomerulosclerosis type 2 (FSGS2) [MIM:603965] |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 143 | N | 0.24285 | S | 0.274048 | -0.031198 | No Change: Both O | Focal segmental glomerulosclerosis type 2 (FSGS2) [MIM:603965] |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 270 | S | 0.707588 | T | 0.608329 | 0.099259 | No Change: Both D | Focal segmental glomerulosclerosis type 2 (FSGS2) [MIM:603965] |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 895 | R | 0.801423 | C | 0.705538 | 0.095885 | No Change: Both D | Focal segmental glomerulosclerosis type 2 (FSGS2) [MIM:603965] |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 897 | E | 0.859395 | K | 0.84691 | 0.012485 | No Change: Both D | Focal segmental glomerulosclerosis type 2 (FSGS2) [MIM:603965] |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 157 | N | 0.449991 | T | 0.414874 | 0.035117 | No Change: Both O | - |
| Q9Y210 | TRPC6_HUMAN Short transient receptor potential channel 6 OS=Homo sapiens GN=TRPC6 PE=1 SV=1 | 404 | A | 0.123993 | V | 0.095917 | 0.028076 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 32 | S | 0.920627 | N | 0.902941 | 0.017686 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 605 | V | 0.453703 | M | 0.513398 | -0.059695 | O to D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1229 | N | 0.471214 | T | 0.428665 | 0.042549 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1305 | R | 0.616736 | H | 0.593653 | 0.023083 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1395 | V | 0.70843 | I | 0.708321 | 1.09E-04 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1422 | R | 0.326634 | G | 0.325566 | 0.001068 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1498 | H | 0.587402 | Q | 0.622854 | -0.035452 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 6 | R | 0.8882 | W | 0.732043 | 0.156157 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 56 | Y | 0.390602 | C | 0.364703 | 0.025899 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 72 | Y | 0.232693 | C | 0.178896 | 0.053797 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 74 | R | 0.229956 | C | 0.119828 | 0.110128 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 99 | L | 0.17447 | P | 0.300373 | -0.125903 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 364 | L | 0.195836 | R | 0.28015 | -0.084314 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 399 | P | 0.393906 | T | 0.324521 | 0.069385 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 473 | R | 0.081855 | P | 0.096525 | -0.01467 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 534 | G | 0.060878 | R | 0.056674 | 0.004204 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 541 | M | 0.082351 | K | 0.139682 | -0.057331 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 611 | P | 0.277504 | H | 0.230549 | 0.046955 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 721 | R | 0.249865 | Q | 0.269643 | -0.019778 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 883 | E | 0.56487 | G | 0.502351 | 0.062519 | No Change: Both D | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 962 | M | 0.10878 | T | 0.117915 | -0.009135 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1002 | I | 0.047885 | F | 0.050964 | -0.003079 | No Change: Both O | Congenital stationary night blindness type 1C (CSNB1C) [MIM:613216] |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1161 | Q | 0.973503 | H | 0.967206 | 0.006297 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1379 | P | 0.918745 | T | 0.920031 | -0.001286 | No Change: Both D | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1422 | R | 0.326634 | W | 0.149345 | 0.177289 | No Change: Both O | - |
| Q7Z4N2 | TRPM1_HUMAN Transient receptor potential cation channel subfamily M member 1 OS=Homo sapiens GN=TRPM1 PE=1 SV=2 | 1438 | R | 0.415062 | G | 0.414037 | 0.001025 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 543 | D | 0.496492 | E | 0.549727 | -0.053235 | O to D | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 52 | N | 0.612802 | K | 0.649095 | -0.036293 | No Change: Both D | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 166 | V | 0.123835 | I | 0.111985 | 0.01185 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 385 | V | 0.142377 | M | 0.196808 | -0.054431 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 780 | D | 0.459422 | E | 0.509183 | -0.049761 | O to D | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1189 | Q | 0.334631 | R | 0.321737 | 0.012894 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1199 | R | 0.497448 | W | 0.311322 | 0.186126 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1201 | S | 0.543353 | G | 0.473117 | 0.070236 | D to O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1249 | N | 0.336791 | S | 0.353855 | -0.017064 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1347 | T | 0.210746 | M | 0.190075 | 0.020671 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1359 | E | 0.329065 | K | 0.340396 | -0.011331 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1368 | I | 0.271109 | M | 0.365419 | -0.09431 | No Change: Both O | - |
| O94759 | TRPM2_HUMAN Transient receptor potential cation channel subfamily M member 2 OS=Homo sapiens GN=TRPM2 PE=1 SV=2 | 1438 | A | 0.252321 | S | 0.342193 | -0.089872 | No Change: Both O | - |
| Q9HCF6 | TRPM3_HUMAN Transient receptor potential cation channel subfamily M member 3 OS=Homo sapiens GN=TRPM3 PE=2 SV=4 | 1695 | R | 0.963279 | Q | 0.961034 | 0.002245 | No Change: Both D | - |
| Q9HCF6 | TRPM3_HUMAN Transient receptor potential cation channel subfamily M member 3 OS=Homo sapiens GN=TRPM3 PE=2 SV=4 | 1653 | T | 0.826674 | I | 0.765395 | 0.061279 | No Change: Both D | - |
| Q9HCF6 | TRPM3_HUMAN Transient receptor potential cation channel subfamily M member 3 OS=Homo sapiens GN=TRPM3 PE=2 SV=4 | 1732 | N | 0.978912 | T | 0.982798 | -0.003886 | No Change: Both D | - |
| Q9HCF6 | TRPM3_HUMAN Transient receptor potential cation channel subfamily M member 3 OS=Homo sapiens GN=TRPM3 PE=2 SV=4 | 1717 | R | 0.98117 | K | 0.979947 | 0.001223 | No Change: Both D | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 7 | E | 0.589584 | K | 0.632265 | -0.042681 | No Change: Both D | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 101 | A | 0.292012 | T | 0.325009 | -0.032997 | No Change: Both O | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 103 | Y | 0.197236 | C | 0.172592 | 0.024644 | No Change: Both O | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 131 | Q | 0.183827 | H | 0.159611 | 0.024216 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 164 | R | 0.314537 | W | 0.144392 | 0.170145 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 252 | R | 0.291723 | H | 0.273956 | 0.017767 | No Change: Both O | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 293 | Q | 0.243738 | R | 0.229318 | 0.01442 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 432 | A | 0.278985 | T | 0.291663 | -0.012678 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 561 | D | 0.110692 | A | 0.089385 | 0.021307 | No Change: Both O | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 582 | G | 0.278732 | S | 0.345407 | -0.066675 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 790 | Y | 0.026637 | H | 0.047313 | -0.020676 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 844 | G | 0.842518 | D | 0.835047 | 0.007471 | No Change: Both D | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 854 | Q | 0.45322 | R | 0.457939 | -0.004719 | No Change: Both O | - |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 914 | K | 0.184395 | R | 0.132207 | 0.052188 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 970 | P | 0.065696 | S | 0.071642 | -0.005946 | No Change: Both O | Progressive familial heart block type 1B (PFHB1B) [MIM:604559] |
| Q8TD43 | TRPM4_HUMAN Transient receptor potential cation channel subfamily M member 4 OS=Homo sapiens GN=TRPM4 PE=1 SV=1 | 1204 | P | 0.911213 | L | 0.839685 | 0.071528 | No Change: Both D | - |
| Q9NZQ8 | TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens GN=TRPM5 PE=1 SV=1 | 254 | V | 0.077251 | A | 0.116188 | -0.038937 | No Change: Both O | - |
| Q9NZQ8 | TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens GN=TRPM5 PE=1 SV=1 | 235 | N | 0.353633 | S | 0.390956 | -0.037323 | No Change: Both O | - |
| Q9NZQ8 | TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens GN=TRPM5 PE=1 SV=1 | 335 | V | 0.238438 | L | 0.250106 | -0.011668 | No Change: Both O | - |
| Q9NZQ8 | TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens GN=TRPM5 PE=1 SV=1 | 456 | A | 0.711701 | T | 0.716698 | -0.004997 | No Change: Both D | - |
| Q9NZQ8 | TRPM5_HUMAN Transient receptor potential cation channel subfamily M member 5 OS=Homo sapiens GN=TRPM5 PE=1 SV=1 | 578 | R | 0.522192 | Q | 0.468076 | 0.054116 | D to O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 141 | S | 0.147935 | L | 0.071114 | 0.076821 | No Change: Both O | Hypomagnesemia type 1 (HOMG1) [MIM:602014] |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1071 | N | 0.054255 | D | 0.058058 | -0.003803 | No Change: Both O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1393 | V | 0.452663 | I | 0.398561 | 0.054102 | No Change: Both O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1584 | K | 0.705319 | E | 0.668162 | 0.037157 | No Change: Both D | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 75 | G | 0.661341 | V | 0.548598 | 0.112743 | No Change: Both D | A lung adenocarcinoma sample |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 338 | M | 0.434057 | I | 0.345375 | 0.088682 | No Change: Both O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1007 | W | 0.419158 | C | 0.455092 | -0.035934 | No Change: Both O | A lung large cell carcinoma sample |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1243 | H | 0.551228 | R | 0.557394 | -0.006166 | No Change: Both D | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1274 | Q | 0.484163 | R | 0.478788 | 0.005375 | No Change: Both O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1663 | Q | 0.67199 | R | 0.635922 | 0.036068 | No Change: Both D | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1673 | L | 0.795771 | S | 0.87957 | -0.083799 | No Change: Both D | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 1724 | T | 0.295111 | I | 0.202859 | 0.092252 | No Change: Both O | - |
| Q9BX84 | TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens GN=TRPM6 PE=1 SV=2 | 948 | F | 0.006518 | L | 0.007604 | -0.001086 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1482 | T | 0.66781 | I | 0.551025 | 0.116785 | No Change: Both D | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 68 | G | 0.341804 | V | 0.228857 | 0.112947 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 406 | S | 0.254442 | C | 0.099669 | 0.154773 | No Change: Both O | An ovarian serous carcinoma sample |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 459 | I | 0.145239 | T | 0.245195 | -0.099956 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 574 | K | 0.873654 | N | 0.849047 | 0.024607 | No Change: Both D | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 720 | T | 0.261143 | S | 0.353752 | -0.092609 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 830 | M | 0.699917 | V | 0.653889 | 0.046028 | No Change: Both D | A gastric adenocarcinoma sample |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 949 | F | 0.164378 | Y | 0.191302 | -0.026924 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1064 | Q | 0.133847 | R | 0.123001 | 0.010846 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1211 | I | 0.261495 | T | 0.368213 | -0.106718 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1254 | A | 0.661886 | V | 0.602343 | 0.059543 | No Change: Both D | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1306 | D | 0.656838 | E | 0.666953 | -0.010115 | No Change: Both D | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1444 | R | 0.582643 | K | 0.628833 | -0.04619 | No Change: Both D | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1033 | A | 0.167983 | G | 0.200519 | -0.032536 | No Change: Both O | - |
| Q96QT4 | TRPM7_HUMAN Transient receptor potential cation channel subfamily M member 7 OS=Homo sapiens GN=TRPM7 PE=1 SV=1 | 1145 | I | 0.183081 | V | 0.190022 | -0.006941 | No Change: Both O | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 247 | R | 0.19015 | T | 0.191366 | -0.001216 | No Change: Both O | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 251 | Y | 0.22601 | C | 0.188821 | 0.037189 | No Change: Both O | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 462 | M | 0.117846 | T | 0.152467 | -0.034621 | No Change: Both O | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 732 | T | 0.033774 | I | 0.01703 | 0.016744 | No Change: Both O | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 821 | N | 0.731144 | S | 0.787541 | -0.056397 | No Change: Both D | - |
| Q7Z2W7 | TRPM8_HUMAN Transient receptor potential cation channel subfamily M member 8 OS=Homo sapiens GN=TRPM8 PE=2 SV=2 | 419 | S | 0.583192 | N | 0.541027 | 0.042165 | No Change: Both D | - |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 894 | V | 0.373571 | D | 0.522008 | -0.148437 | O to D | Tricho-rhino-phalangeal syndrome type 3 (TRPS3) [MIM:190351] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 901 | T | 0.323151 | P | 0.34971 | -0.026559 | No Change: Both O | Tricho-rhino-phalangeal syndrome type 3 (TRPS3) [MIM:190351] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 908 | R | 0.339971 | P | 0.360603 | -0.020632 | No Change: Both O | Tricho-rhino-phalangeal syndrome type 3 (TRPS3) [MIM:190351] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 908 | R | 0.339971 | Q | 0.350449 | -0.010478 | No Change: Both O | Tricho-rhino-phalangeal syndrome type 3 (TRPS3) [MIM:190351] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 919 | A | 0.132252 | T | 0.157486 | -0.025234 | No Change: Both O | Tricho-rhino-phalangeal syndrome type 3 (TRPS3) [MIM:190351] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 654 | S | 0.850552 | L | 0.737006 | 0.113546 | No Change: Both D | - |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 952 | R | 0.896471 | C | 0.834482 | 0.061989 | No Change: Both D | Tricho-rhino-phalangeal syndrome type 1 (TRPS1) [MIM:190350] |
| Q9UHF7 | TRPS1_HUMAN Zinc finger transcription factor Trps1 OS=Homo sapiens GN=TRPS1 PE=1 SV=2 | 952 | R | 0.896471 | H | 0.860496 | 0.035975 | No Change: Both D | Tricho-rhino-phalangeal syndrome type 1 (TRPS1) [MIM:190350] |
| Q86TN4 | TRPT1_HUMAN tRNA 2'-phosphotransferase 1 OS=Homo sapiens GN=TRPT1 PE=1 SV=2 | 3 | F | 0.98152 | L | 0.985322 | -0.003802 | No Change: Both D | - |
| Q86TN4 | TRPT1_HUMAN tRNA 2'-phosphotransferase 1 OS=Homo sapiens GN=TRPT1 PE=1 SV=2 | 172 | H | 0.178022 | R | 0.194046 | -0.016024 | No Change: Both O | - |
| Q86TN4 | TRPT1_HUMAN tRNA 2'-phosphotransferase 1 OS=Homo sapiens GN=TRPT1 PE=1 SV=2 | 221 | R | 0.58832 | C | 0.478426 | 0.109894 | D to O | - |
| Q8NER1 | TRPV1_HUMAN Transient receptor potential cation channel subfamily V member 1 OS=Homo sapiens GN=TRPV1 PE=1 SV=2 | 585 | I | 0.007672 | V | 0.009879 | -0.002207 | No Change: Both O | - |
| Q8NER1 | TRPV1_HUMAN Transient receptor potential cation channel subfamily V member 1 OS=Homo sapiens GN=TRPV1 PE=1 SV=2 | 91 | P | 0.633973 | S | 0.64269 | -0.008717 | No Change: Both D | - |
| Q8NER1 | TRPV1_HUMAN Transient receptor potential cation channel subfamily V member 1 OS=Homo sapiens GN=TRPV1 PE=1 SV=2 | 469 | T | 0.462119 | I | 0.29341 | 0.168709 | No Change: Both O | - |
| Q8NER1 | TRPV1_HUMAN Transient receptor potential cation channel subfamily V member 1 OS=Homo sapiens GN=TRPV1 PE=1 SV=2 | 505 | T | 0.369951 | A | 0.337508 | 0.032443 | No Change: Both O | - |
| Q9Y5S1 | TRPV2_HUMAN Transient receptor potential cation channel subfamily V member 2 OS=Homo sapiens GN=TRPV2 PE=1 SV=1 | 17 | G | 0.936169 | A | 0.914324 | 0.021845 | No Change: Both D | - |
| Q9Y5S1 | TRPV2_HUMAN Transient receptor potential cation channel subfamily V member 2 OS=Homo sapiens GN=TRPV2 PE=1 SV=1 | 764 | N | 0.872996 | S | 0.90291 | -0.029914 | No Change: Both D | - |
| Q8NET8 | TRPV3_HUMAN Transient receptor potential cation channel subfamily V member 3 OS=Homo sapiens GN=TRPV3 PE=1 SV=2 | 25 | I | 0.814484 | V | 0.824343 | -0.009859 | No Change: Both D | - |
| Q8NET8 | TRPV3_HUMAN Transient receptor potential cation channel subfamily V member 3 OS=Homo sapiens GN=TRPV3 PE=1 SV=2 | 117 | R | 0.89183 | G | 0.858645 | 0.033185 | No Change: Both D | - |
| Q8NET8 | TRPV3_HUMAN Transient receptor potential cation channel subfamily V member 3 OS=Homo sapiens GN=TRPV3 PE=1 SV=2 | 774 | T | 0.805588 | I | 0.685518 | 0.12007 | No Change: Both D | - |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 19 | P | 0.969337 | S | 0.968634 | 7.03E-04 | No Change: Both D | - |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 616 | R | 0.019119 | Q | 0.02156 | -0.002441 | No Change: Both O | Brachyolmia type 3 (BRAC3) [MIM:113500] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 620 | V | 0.008416 | I | 0.007664 | 7.52E-04 | No Change: Both O | Brachyolmia type 3 (BRAC3) [MIM:113500] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 331 | I | 0.224636 | F | 0.234096 | -0.00946 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 333 | D | 0.277988 | G | 0.25115 | 0.026838 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 594 | R | 0.148839 | H | 0.148553 | 2.86E-04 | No Change: Both O | Parastremmatic dwarfism (PSTD) [MIM:168400] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 594 | R | 0.148839 | H | 0.148553 | 2.86E-04 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 716 | A | 0.068303 | S | 0.111361 | -0.043058 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 799 | P | 0.534949 | L | 0.407134 | 0.127815 | D to O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 269 | R | 0.366675 | C | 0.19806 | 0.168615 | No Change: Both O | Charcot-Marie-Tooth disease type 2C (CMT2C) [MIM:606071] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 269 | R | 0.366675 | H | 0.372047 | -0.005372 | No Change: Both O | Charcot-Marie-Tooth disease type 2C (CMT2C) [MIM:606071] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 269 | R | 0.366675 | H | 0.372047 | -0.005372 | No Change: Both O | Distal spinal muscular atrophy congenital non-progressive (DSMAC) [MIM:600175] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 316 | R | 0.640506 | C | 0.506638 | 0.133868 | No Change: Both D | Charcot-Marie-Tooth disease type 2C (CMT2C) [MIM:606071] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 316 | R | 0.640506 | C | 0.506638 | 0.133868 | No Change: Both D | Scapuloperoneal spinal muscular atrophy (SPSMA) [MIM:181405] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 315 | R | 0.631492 | W | 0.507695 | 0.123797 | No Change: Both D | Charcot-Marie-Tooth disease type 2C (CMT2C) [MIM:606071] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 89 | T | 0.455317 | I | 0.35301 | 0.102307 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 183 | E | 0.710536 | K | 0.712643 | -0.002107 | No Change: Both D | - |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 197 | K | 0.443987 | R | 0.404525 | 0.039462 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 199 | L | 0.423475 | F | 0.370207 | 0.053268 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 278 | E | 0.404053 | K | 0.414311 | -0.010258 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 295 | T | 0.190495 | A | 0.185394 | 0.005101 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 331 | I | 0.224636 | T | 0.365167 | -0.140531 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 342 | V | 0.254613 | F | 0.245092 | 0.009521 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 592 | F | 0.079308 | L | 0.100141 | -0.020833 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 596 | L | 0.205954 | P | 0.347934 | -0.14198 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 600 | G | 0.194829 | W | 0.069797 | 0.125032 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 602 | Y | 0.151382 | C | 0.12229 | 0.029092 | No Change: Both O | - |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 604 | I | 0.097004 | M | 0.142572 | -0.045568 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 617 | F | 0.013876 | L | 0.01658 | -0.002704 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 618 | L | 0.010968 | P | 0.021306 | -0.010338 | No Change: Both O | - |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 625 | M | 0.023339 | I | 0.015959 | 0.00738 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 709 | L | 0.011008 | M | 0.014323 | -0.003315 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 775 | R | 0.25111 | K | 0.281941 | -0.030831 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 777 | C | 0.131329 | Y | 0.149329 | -0.018 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 797 | E | 0.442668 | K | 0.446953 | -0.004285 | No Change: Both O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 797 | E | 0.442668 | K | 0.446953 | -0.004285 | No Change: Both O | Spondylometaphyseal dysplasia Kozlowski type (SMDK) [MIM:184252] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 799 | P | 0.534949 | A | 0.484287 | 0.050662 | D to O | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 799 | P | 0.534949 | R | 0.503081 | 0.031868 | No Change: Both D | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9HBA0 | TRPV4_HUMAN Transient receptor potential cation channel subfamily V member 4 OS=Homo sapiens GN=TRPV4 PE=1 SV=2 | 799 | P | 0.534949 | S | 0.563511 | -0.028562 | No Change: Both D | Metatropic dysplasia (MTD) [MIM:156530] |
| Q9NQA5 | TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens GN=TRPV5 PE=1 SV=2 | 8 | A | 0.72981 | V | 0.693682 | 0.036128 | No Change: Both D | - |
| Q9NQA5 | TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens GN=TRPV5 PE=1 SV=2 | 154 | R | 0.361699 | H | 0.336459 | 0.02524 | No Change: Both O | - |
| Q9NQA5 | TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens GN=TRPV5 PE=1 SV=2 | 563 | A | 0.020336 | T | 0.022814 | -0.002478 | No Change: Both O | - |
| Q9NQA5 | TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens GN=TRPV5 PE=1 SV=2 | 712 | L | 0.3833 | F | 0.319027 | 0.064273 | No Change: Both O | - |
| Q9H1D0 | TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens GN=TRPV6 PE=1 SV=2 | 157 | C | 0.150191 | R | 0.284512 | -0.134321 | No Change: Both O | - |
| Q9H1D0 | TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens GN=TRPV6 PE=1 SV=2 | 378 | M | 0.322372 | V | 0.265022 | 0.05735 | No Change: Both O | - |
| Q9H1D0 | TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens GN=TRPV6 PE=1 SV=2 | 681 | M | 0.866543 | T | 0.88775 | -0.021207 | No Change: Both D | - |
| Q9H1D0 | TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens GN=TRPV6 PE=1 SV=2 | 359 | R | 0.783892 | Q | 0.78204 | 0.001852 | No Change: Both D | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 878 | R | 0.149342 | L | 0.09027 | 0.059072 | No Change: Both O | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 893 | R | 0.172303 | C | 0.088461 | 0.083842 | No Change: Both O | An ovarian serous carcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1070 | S | 0.413867 | G | 0.35934 | 0.054527 | No Change: Both O | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1669 | R | 0.210638 | H | 0.203208 | 0.00743 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1724 | R | 0.06549 | H | 0.060725 | 0.004765 | No Change: Both O | A gastric adenocarcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1925 | A | 0.142159 | V | 0.098152 | 0.044007 | No Change: Both O | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1932 | P | 0.347093 | L | 0.206247 | 0.140846 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 1947 | R | 0.17557 | L | 0.109266 | 0.066304 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2139 | W | 0.365646 | G | 0.536621 | -0.170975 | O to D | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2302 | R | 0.480399 | W | 0.255564 | 0.224835 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2433 | S | 0.561842 | G | 0.516418 | 0.045424 | No Change: Both D | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2690 | P | 0.095933 | L | 0.045373 | 0.05056 | No Change: Both O | A lung large cell carcinoma sample |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2750 | E | 0.352203 | D | 0.313711 | 0.038492 | No Change: Both O | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2801 | K | 0.804312 | E | 0.810062 | -0.00575 | No Change: Both D | - |
| Q9Y4A5 | TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens GN=TRRAP PE=1 SV=3 | 2931 | T | 0.330589 | M | 0.297417 | 0.033172 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WWH5 | TRUB1_HUMAN Probable tRNA pseudouridine synthase 1 OS=Homo sapiens GN=TRUB1 PE=1 SV=1 | 167 | R | 0.638339 | K | 0.702951 | -0.064612 | No Change: Both D | - |
| Q8WWH5 | TRUB1_HUMAN Probable tRNA pseudouridine synthase 1 OS=Homo sapiens GN=TRUB1 PE=1 SV=1 | 103 | E | 0.67155 | A | 0.597149 | 0.074401 | No Change: Both D | - |
| O95900 | TRUB2_HUMAN Probable tRNA pseudouridine synthase 2 OS=Homo sapiens GN=TRUB2 PE=2 SV=1 | 93 | V | 0.2936 | L | 0.296894 | -0.003294 | No Change: Both O | - |
| O95900 | TRUB2_HUMAN Probable tRNA pseudouridine synthase 2 OS=Homo sapiens GN=TRUB2 PE=2 SV=1 | 79 | P | 0.159719 | L | 0.079957 | 0.079762 | No Change: Both O | - |
| O95900 | TRUB2_HUMAN Probable tRNA pseudouridine synthase 2 OS=Homo sapiens GN=TRUB2 PE=2 SV=1 | 209 | T | 0.092446 | S | 0.133436 | -0.04099 | No Change: Both O | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 51 | E | 0.335126 | D | 0.326228 | 0.008898 | No Change: Both O | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 190 | R | 0.061026 | S | 0.086171 | -0.025145 | No Change: Both O | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 191 | L | 0.055301 | H | 0.098635 | -0.043334 | No Change: Both O | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 224 | M | 0.50083 | R | 0.548539 | -0.047709 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 322 | M | 0.846857 | T | 0.864422 | -0.017565 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 417 | T | 0.846948 | I | 0.777593 | 0.069355 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 577 | E | 0.885767 | D | 0.880884 | 0.004883 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 587 | K | 0.791476 | R | 0.795146 | -0.00367 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 654 | Q | 0.616721 | E | 0.653538 | -0.036817 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 726 | A | 0.523056 | E | 0.622744 | -0.099688 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 732 | H | 0.662323 | Y | 0.54722 | 0.115103 | No Change: Both D | Focal cortical dysplasia of Taylor balloon cell type (FCDBC) [MIM:607341] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 809 | E | 0.528167 | Q | 0.506369 | 0.021798 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 829 | S | 0.607331 | R | 0.546369 | 0.060962 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 899 | T | 0.833705 | S | 0.870404 | -0.036699 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 1035 | G | 0.998722 | S | 0.999046 | -3.24E-04 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 1108 | G | 0.909059 | S | 0.934604 | -0.025545 | No Change: Both D | - |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 68 | H | 0.56703 | R | 0.551041 | 0.015989 | No Change: Both D | A bladder tumor |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 72 | L | 0.397482 | P | 0.556634 | -0.159152 | O to D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 158 | F | 0.073645 | C | 0.064892 | 0.008753 | No Change: Both O | A bladder tumor |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 206 | H | 0.367485 | D | 0.406981 | -0.039496 | No Change: Both O | A bladder tumor |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 216 | F | 0.481081 | L | 0.52467 | -0.043589 | O to D | A bladder tumor |
| Q92574 | TSC1_HUMAN Hamartin OS=Homo sapiens GN=TSC1 PE=1 SV=2 | 500 | R | 0.809886 | Q | 0.796654 | 0.013232 | No Change: Both D | Tuberous sclerosis type 1 (TSC1) [MIM:191100] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 292 | L | 0.125931 | P | 0.231133 | -0.105202 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 407 | Y | 0.408795 | D | 0.597992 | -0.189197 | O to D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 449 | M | 0.205681 | I | 0.149332 | 0.056349 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 607 | A | 0.263047 | T | 0.296458 | -0.033411 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 611 | R | 0.129875 | Q | 0.149613 | -0.019738 | No Change: Both O | Lymphangioleiomyomatosis (LAM) [MIM:606690] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 611 | R | 0.129875 | Q | 0.149613 | -0.019738 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 611 | R | 0.129875 | W | 0.051843 | 0.078032 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 826 | L | 0.067776 | M | 0.083674 | -0.015898 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 905 | R | 0.110974 | Q | 0.109873 | 0.001101 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 905 | R | 0.110974 | W | 0.040119 | 0.070855 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1084 | D | 0.817777 | E | 0.852784 | -0.035007 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1200 | R | 0.214216 | W | 0.099699 | 0.114517 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1227 | P | 0.592074 | L | 0.433522 | 0.158552 | D to O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1240 | R | 0.696841 | W | 0.501036 | 0.195805 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1295 | D | 0.614514 | V | 0.523959 | 0.090555 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1549 | Y | 0.201759 | C | 0.174836 | 0.026923 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1643 | N | 0.239405 | I | 0.123349 | 0.116056 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1650 | Y | 0.244321 | C | 0.212229 | 0.032092 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1690 | D | 0.362122 | Y | 0.202537 | 0.159585 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1712 | A | 0.227737 | E | 0.299416 | -0.071679 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1750 | L | 0.474969 | F | 0.411513 | 0.063456 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 94 | P | 0.521109 | T | 0.451521 | 0.069588 | D to O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 227 | C | 0.036656 | Y | 0.044884 | -0.008228 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 331 | N | 0.186713 | K | 0.219709 | -0.032996 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 486 | N | 0.225858 | I | 0.125225 | 0.100633 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 490 | I | 0.235081 | V | 0.264088 | -0.029007 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 536 | A | 0.353261 | V | 0.29009 | 0.063171 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 615 | F | 0.073055 | S | 0.190225 | -0.11717 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 816 | P | 0.12092 | L | 0.060846 | 0.060074 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1144 | V | 0.845722 | M | 0.880295 | -0.034573 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1315 | P | 0.804164 | S | 0.805755 | -0.001591 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1329 | R | 0.849263 | H | 0.808284 | 0.040979 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1709 | P | 0.242912 | L | 0.147562 | 0.09535 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1743 | R | 0.3407 | Q | 0.324291 | 0.016409 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1773 | H | 0.849854 | P | 0.892481 | -0.042627 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1783 | E | 0.794055 | Q | 0.780593 | 0.013462 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 137 | H | 0.486799 | R | 0.497509 | -0.01071 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 160 | L | 0.172094 | V | 0.169829 | 0.002265 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 258 | K | 0.082383 | N | 0.072158 | 0.010225 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 261 | R | 0.115245 | P | 0.141794 | -0.026549 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 261 | R | 0.115245 | W | 0.048987 | 0.066258 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 286 | M | 0.401478 | T | 0.442465 | -0.040987 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 286 | M | 0.401478 | V | 0.321968 | 0.07951 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 294 | G | 0.081146 | E | 0.102423 | -0.021277 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 309 | L | 0.221094 | Q | 0.332941 | -0.111847 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 320 | L | 0.38127 | F | 0.360253 | 0.021017 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 361 | L | 0.025015 | P | 0.04795 | -0.022935 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 367 | R | 0.105839 | Q | 0.127243 | -0.021404 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 378 | P | 0.451336 | L | 0.298328 | 0.153008 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 440 | G | 0.271689 | S | 0.33655 | -0.064861 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 463 | I | 0.184406 | V | 0.227394 | -0.042988 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 525 | N | 0.21843 | S | 0.285447 | -0.067017 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 583 | A | 0.271041 | T | 0.303505 | -0.032464 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 593 | H | 0.208953 | R | 0.195132 | 0.013821 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 599 | K | 0.313284 | M | 0.199319 | 0.113965 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 614 | A | 0.087675 | D | 0.128641 | -0.040966 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 647 | D | 0.602409 | N | 0.581339 | 0.02107 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 696 | C | 0.163057 | Y | 0.174012 | -0.010955 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 717 | L | 0.20572 | R | 0.299241 | -0.093521 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 769 | V | 0.075624 | E | 0.152492 | -0.076868 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 895 | M | 0.018049 | V | 0.014335 | 0.003714 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 963 | V | 0.901704 | M | 0.916478 | -0.014774 | No Change: Both D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1282 | S | 0.721235 | G | 0.640262 | 0.080973 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1497 | P | 0.362827 | R | 0.320489 | 0.042338 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1498 | S | 0.359803 | N | 0.318309 | 0.041494 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1594 | L | 0.172951 | M | 0.20991 | -0.036959 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1620 | H | 0.083657 | Y | 0.047239 | 0.036418 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1643 | N | 0.239405 | K | 0.292385 | -0.05298 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1651 | N | 0.295147 | S | 0.352138 | -0.056991 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1675 | P | 0.078978 | L | 0.041514 | 0.037464 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1681 | N | 0.105216 | K | 0.128811 | -0.023595 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1704 | S | 0.275449 | T | 0.211204 | 0.064245 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1743 | R | 0.3407 | P | 0.365456 | -0.024756 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1744 | L | 0.356749 | P | 0.528666 | -0.171917 | O to D | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1787 | G | 0.730521 | S | 0.79126 | -0.060739 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1791 | G | 0.648827 | S | 0.725178 | -0.076351 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 862 | A | 0.224946 | V | 0.158141 | 0.066805 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1429 | A | 0.962953 | S | 0.973955 | -0.011002 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1450 | P | 0.994707 | R | 0.994099 | 6.08E-04 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1653 | S | 0.369838 | F | 0.184697 | 0.185141 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1027 | L | 0.191587 | P | 0.28962 | -0.098033 | No Change: Both O | Tuberous sclerosis type 2 (TSC2) [MIM:613254] |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1341 | S | 0.892415 | R | 0.879923 | 0.012492 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1636 | D | 0.671091 | N | 0.647528 | 0.023563 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1673 | V | 0.048658 | L | 0.047263 | 0.001395 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1141 | A | 0.837548 | V | 0.795739 | 0.041809 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 1774 | S | 0.855675 | T | 0.81925 | 0.036425 | No Change: Both D | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 619 | L | 0.075917 | F | 0.064591 | 0.011326 | No Change: Both O | - |
| P49815 | TSC2_HUMAN Tuberin OS=Homo sapiens GN=TSC2 PE=1 SV=2 | 802 | S | 0.086738 | R | 0.066395 | 0.020343 | No Change: Both O | - |
| Q96LM6 | TSC21_HUMAN Protein TSC21 OS=Homo sapiens GN=TSC21 PE=2 SV=1 | 24 | D | 0.54153 | N | 0.48801 | 0.05352 | D to O | - |
| Q15714 | T22D1_HUMAN TSC22 domain family protein 1 OS=Homo sapiens GN=TSC22D1 PE=1 SV=3 | 652 | P | 0.906699 | S | 0.907822 | -0.001123 | No Change: Both D | - |
| O75157 | T22D2_HUMAN TSC22 domain family protein 2 OS=Homo sapiens GN=TSC22D2 PE=1 SV=3 | 419 | A | 0.970865 | T | 0.971831 | -9.66E-04 | No Change: Both D | - |
| Q9Y3Q8 | T22D4_HUMAN TSC22 domain family protein 4 OS=Homo sapiens GN=TSC22D4 PE=1 SV=2 | 329 | V | 0.380342 | M | 0.47808 | -0.097738 | No Change: Both O | A breast cancer sample |
| Q8WW01 | SEN15_HUMAN tRNA-splicing endonuclease subunit Sen15 OS=Homo sapiens GN=TSEN15 PE=1 SV=1 | 19 | G | 0.836768 | D | 0.834902 | 0.001866 | No Change: Both D | - |
| Q8WW01 | SEN15_HUMAN tRNA-splicing endonuclease subunit Sen15 OS=Homo sapiens GN=TSEN15 PE=1 SV=1 | 59 | Q | 0.075312 | H | 0.070409 | 0.004903 | No Change: Both O | - |
| Q8NCE0 | SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens GN=TSEN2 PE=1 SV=2 | 41 | R | 0.162396 | H | 0.159786 | 0.00261 | No Change: Both O | - |
| Q8NCE0 | SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens GN=TSEN2 PE=1 SV=2 | 126 | R | 0.495582 | H | 0.449086 | 0.046496 | No Change: Both O | - |
| Q8NCE0 | SEN2_HUMAN tRNA-splicing endonuclease subunit Sen2 OS=Homo sapiens GN=TSEN2 PE=1 SV=2 | 309 | Y | 0.019561 | C | 0.016288 | 0.003273 | No Change: Both O | Pontocerebellar hypoplasia type 2B (PCH2B) [MIM:612389] |
| Q9BSV6 | SEN34_HUMAN tRNA-splicing endonuclease subunit Sen34 OS=Homo sapiens GN=TSEN34 PE=1 SV=1 | 58 | R | 0.541566 | W | 0.276422 | 0.265144 | D to O | Pontocerebellar hypoplasia type 2C (PCH2C) [MIM:612390] |
| Q9BSV6 | SEN34_HUMAN tRNA-splicing endonuclease subunit Sen34 OS=Homo sapiens GN=TSEN34 PE=1 SV=1 | 112 | L | 0.979614 | V | 0.971958 | 0.007656 | No Change: Both D | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 4 | E | 0.957166 | D | 0.930333 | 0.026833 | No Change: Both D | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 38 | H | 0.890571 | Q | 0.927251 | -0.03668 | No Change: Both D | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 347 | K | 0.887075 | N | 0.87591 | 0.011165 | No Change: Both D | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 437 | A | 0.484688 | V | 0.409738 | 0.07495 | No Change: Both O | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 93 | S | 0.428966 | P | 0.436748 | -0.007782 | No Change: Both O | Pontocerebellar hypoplasia type 4 (PCH4) [MIM:225753] |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 307 | A | 0.520763 | S | 0.606793 | -0.08603 | No Change: Both D | Pontocerebellar hypoplasia type 2A (PCH2A) [MIM:277470] |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 307 | A | 0.520763 | S | 0.606793 | -0.08603 | No Change: Both D | Pontocerebellar hypoplasia type 4 (PCH4) [MIM:225753] |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 137 | I | 0.25262 | L | 0.306354 | -0.053734 | No Change: Both O | - |
| Q7Z6J9 | SEN54_HUMAN tRNA-splicing endonuclease subunit Sen54 OS=Homo sapiens GN=TSEN54 PE=1 SV=3 | 525 | G | 0.893895 | R | 0.880839 | 0.013056 | No Change: Both D | - |
| Q99816 | TS101_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens GN=TSG101 PE=1 SV=2 | 167 | M | 0.972303 | I | 0.961309 | 0.010994 | No Change: Both D | - |
| Q3SY00 | T10IP_HUMAN Testis-specific protein 10-interacting protein OS=Homo sapiens GN=TSGA10IP PE=2 SV=1 | 210 | A | 0.975215 | V | 0.971201 | 0.004014 | No Change: Both D | - |
| Q3SY00 | T10IP_HUMAN Testis-specific protein 10-interacting protein OS=Homo sapiens GN=TSGA10IP PE=2 SV=1 | 237 | R | 0.9803 | S | 0.982881 | -0.002581 | No Change: Both D | - |
| Q3SY00 | T10IP_HUMAN Testis-specific protein 10-interacting protein OS=Homo sapiens GN=TSGA10IP PE=2 SV=1 | 292 | S | 0.944419 | N | 0.931834 | 0.012585 | No Change: Both D | - |
| Q3SY00 | T10IP_HUMAN Testis-specific protein 10-interacting protein OS=Homo sapiens GN=TSGA10IP PE=2 SV=1 | 305 | R | 0.860579 | P | 0.863825 | -0.003246 | No Change: Both D | - |
| Q3SY00 | T10IP_HUMAN Testis-specific protein 10-interacting protein OS=Homo sapiens GN=TSGA10IP PE=2 SV=1 | 521 | V | 0.971324 | M | 0.979315 | -0.007991 | No Change: Both D | - |
| P01222 | TSHB_HUMAN Thyrotropin subunit beta OS=Homo sapiens GN=TSHB PE=1 SV=2 | 14 | T | 0.126477 | A | 0.115 | 0.011477 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 36 | D | 0.653534 | H | 0.603768 | 0.049766 | No Change: Both D | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 52 | P | 0.656401 | T | 0.600271 | 0.05613 | No Change: Both D | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 183 | K | 0.207001 | R | 0.160901 | 0.0461 | No Change: Both O | Familial gestational hyperthyroidism (HTFG) [MIM:603373] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 197 | F | 0.21379 | I | 0.210818 | 0.002972 | No Change: Both O | Papillary cancer |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 219 | D | 0.221859 | E | 0.228091 | -0.006232 | No Change: Both O | Papillary cancer |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 281 | S | 0.259659 | I | 0.113513 | 0.146146 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 281 | S | 0.259659 | N | 0.214151 | 0.045508 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 505 | S | 0.13769 | N | 0.107658 | 0.030032 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 528 | R | 0.13284 | H | 0.123888 | 0.008952 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 619 | D | 0.712982 | G | 0.68719 | 0.025792 | No Change: Both D | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 623 | A | 0.348401 | I | 0.251438 | 0.096963 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 629 | L | 0.032005 | F | 0.031385 | 6.20E-04 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 715 | N | 0.623731 | D | 0.654526 | -0.030795 | No Change: Both D | Papillary cancer |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 723 | K | 0.49109 | M | 0.403421 | 0.087669 | No Change: Both O | Papillary cancer |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 727 | D | 0.512407 | E | 0.536918 | -0.024511 | No Change: Both D | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 41 | C | 0.63747 | S | 0.750759 | -0.113289 | No Change: Both D | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 109 | R | 0.303571 | Q | 0.307412 | -0.003841 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 162 | P | 0.225052 | A | 0.15915 | 0.065902 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 167 | I | 0.196254 | N | 0.377969 | -0.181715 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 281 | S | 0.259659 | T | 0.190011 | 0.069648 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 310 | R | 0.763834 | C | 0.678163 | 0.085671 | No Change: Both D | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 390 | C | 0.329923 | W | 0.260153 | 0.06977 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 410 | D | 0.20241 | N | 0.193396 | 0.009014 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 431 | G | 0.026471 | S | 0.036476 | -0.010005 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 450 | R | 0.096669 | H | 0.103625 | -0.006956 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 453 | M | 0.036215 | T | 0.045367 | -0.009152 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 463 | M | 0.025235 | V | 0.017197 | 0.008038 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 486 | I | 0.215467 | F | 0.215618 | -1.51E-04 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 486 | I | 0.215467 | M | 0.303005 | -0.087538 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 498 | G | 0.134371 | S | 0.159444 | -0.025073 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 505 | S | 0.13769 | R | 0.096225 | 0.041465 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 509 | V | 0.114879 | A | 0.158123 | -0.043244 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 512 | L | 0.078964 | R | 0.130745 | -0.051781 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 525 | F | 0.049249 | L | 0.061139 | -0.01189 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 553 | A | 0.013121 | T | 0.015077 | -0.001956 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 568 | I | 0.156382 | T | 0.280313 | -0.123931 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 597 | V | 0.003251 | L | 0.002948 | 3.03E-04 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 606 | I | 0.055023 | M | 0.07807 | -0.023047 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 623 | A | 0.348401 | V | 0.275371 | 0.07303 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 630 | I | 0.025832 | L | 0.028992 | -0.00316 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 631 | F | 0.023498 | C | 0.023108 | 3.90E-04 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 631 | F | 0.023498 | L | 0.026861 | -0.003363 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 632 | T | 0.024763 | A | 0.023723 | 0.00104 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 632 | T | 0.024763 | I | 0.014139 | 0.010624 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 633 | D | 0.023836 | A | 0.017701 | 0.006135 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 633 | D | 0.023836 | E | 0.026149 | -0.002313 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 633 | D | 0.023836 | H | 0.019162 | 0.004674 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 633 | D | 0.023836 | Y | 0.010999 | 0.012837 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 639 | P | 0.04651 | S | 0.057483 | -0.010973 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 647 | A | 0.098268 | V | 0.06471 | 0.033558 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 650 | N | 0.185127 | Y | 0.103293 | 0.081834 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 670 | N | 0.081455 | S | 0.09797 | -0.016515 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 672 | C | 0.093058 | Y | 0.127766 | -0.034708 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 677 | L | 0.053304 | V | 0.051864 | 0.00144 | No Change: Both O | Thyroid carcinoma |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 703 | A | 0.320311 | G | 0.38217 | -0.061859 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 720 | Q | 0.530852 | E | 0.550688 | -0.019836 | No Change: Both D | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 467 | L | 0.022672 | P | 0.045004 | -0.022332 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 477 | T | 0.273204 | I | 0.168718 | 0.104486 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 600 | C | 0.004561 | R | 0.009533 | -0.004972 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 252 | L | 0.278156 | P | 0.403496 | -0.12534 | No Change: Both O | Congenital hypothyroidism non-goitrous type 1 (CHNG1) [MIM:275200] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 425 | S | 0.013191 | I | 0.004656 | 0.008535 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 512 | L | 0.078964 | Q | 0.13768 | -0.058716 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 593 | A | 0.006068 | N | 0.009154 | -0.003086 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 597 | V | 0.003251 | F | 0.002665 | 5.86E-04 | No Change: Both O | Hyperthyroidism non-autoimmune (HTNA) [MIM:609152] |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 639 | P | 0.04651 | A | 0.034836 | 0.011674 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 656 | V | 0.210712 | F | 0.181568 | 0.029144 | No Change: Both O | - |
| P16473 | TSHR_HUMAN Thyrotropin receptor OS=Homo sapiens GN=TSHR PE=1 SV=2 | 34 | E | 0.667765 | K | 0.650188 | 0.017577 | No Change: Both D | - |
| Q6ZSZ6 | TSH1_HUMAN Teashirt homolog 1 OS=Homo sapiens GN=TSHZ1 PE=2 SV=2 | 666 | L | 0.981278 | P | 0.991091 | -0.009813 | No Change: Both D | - |
| Q9NRE2 | TSH2_HUMAN Teashirt homolog 2 OS=Homo sapiens GN=TSHZ2 PE=1 SV=3 | 113 | R | 0.502581 | S | 0.564856 | -0.062275 | No Change: Both D | - |
| Q9NRE2 | TSH2_HUMAN Teashirt homolog 2 OS=Homo sapiens GN=TSHZ2 PE=1 SV=3 | 681 | A | 0.802523 | T | 0.799067 | 0.003456 | No Change: Both D | - |
| Q63HK5 | TSH3_HUMAN Teashirt homolog 3 OS=Homo sapiens GN=TSHZ3 PE=1 SV=2 | 687 | P | 0.908849 | L | 0.853894 | 0.054955 | No Change: Both D | - |
| Q63HK5 | TSH3_HUMAN Teashirt homolog 3 OS=Homo sapiens GN=TSHZ3 PE=1 SV=2 | 469 | E | 0.93449 | G | 0.903261 | 0.031229 | No Change: Both D | - |
| Q9UJT2 | TSKS_HUMAN Testis-specific serine kinase substrate OS=Homo sapiens GN=TSKS PE=1 SV=3 | 19 | G | 0.560415 | R | 0.56749 | -0.007075 | No Change: Both D | A colorectal cancer sample |
| Q9UJT2 | TSKS_HUMAN Testis-specific serine kinase substrate OS=Homo sapiens GN=TSKS PE=1 SV=3 | 167 | E | 0.798266 | K | 0.783574 | 0.014692 | No Change: Both D | - |
| Q9UJT2 | TSKS_HUMAN Testis-specific serine kinase substrate OS=Homo sapiens GN=TSKS PE=1 SV=3 | 382 | D | 0.791319 | G | 0.781665 | 0.009654 | No Change: Both D | - |
| Q8WUA8 | TSK_HUMAN Tsukushin OS=Homo sapiens GN=TSKU PE=2 SV=3 | 344 | D | 0.682849 | E | 0.676483 | 0.006366 | No Change: Both D | - |
| Q8WUA8 | TSK_HUMAN Tsukushin OS=Homo sapiens GN=TSKU PE=2 SV=3 | 208 | R | 0.239291 | C | 0.121948 | 0.117343 | No Change: Both O | - |
| Q8WUA8 | TSK_HUMAN Tsukushin OS=Homo sapiens GN=TSKU PE=2 SV=3 | 248 | S | 0.500848 | N | 0.445886 | 0.054962 | D to O | - |
| Q8WUA8 | TSK_HUMAN Tsukushin OS=Homo sapiens GN=TSKU PE=2 SV=3 | 308 | V | 0.499658 | I | 0.411721 | 0.087937 | No Change: Both O | - |
| Q96NA8 | TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens GN=TSNARE1 PE=2 SV=2 | 55 | R | 0.653617 | P | 0.696752 | -0.043135 | No Change: Both D | - |
| Q96NA8 | TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens GN=TSNARE1 PE=2 SV=2 | 118 | T | 0.879256 | A | 0.868218 | 0.011038 | No Change: Both D | - |
| Q96NA8 | TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens GN=TSNARE1 PE=2 SV=2 | 268 | V | 0.682399 | I | 0.661081 | 0.021318 | No Change: Both D | - |
| Q96NA8 | TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens GN=TSNARE1 PE=2 SV=2 | 18 | F | 0.842417 | L | 0.865289 | -0.022872 | No Change: Both D | - |
| O60635 | TSN1_HUMAN Tetraspanin-1 OS=Homo sapiens GN=TSPAN1 PE=1 SV=2 | 87 | V | 0.030137 | M | 0.040476 | -0.010339 | No Change: Both O | - |
| O60635 | TSN1_HUMAN Tetraspanin-1 OS=Homo sapiens GN=TSPAN1 PE=1 SV=2 | 38 | S | 0.115207 | F | 0.043286 | 0.071921 | No Change: Both O | - |
| Q9H1Z9 | TSN10_HUMAN Tetraspanin-10 OS=Homo sapiens GN=TSPAN10 PE=2 SV=1 | 187 | R | 0.198255 | H | 0.217777 | -0.019522 | No Change: Both O | - |
| Q9H1Z9 | TSN10_HUMAN Tetraspanin-10 OS=Homo sapiens GN=TSPAN10 PE=2 SV=1 | 218 | Y | 0.218946 | H | 0.306621 | -0.087675 | No Change: Both O | - |
| A1L157 | TSN11_HUMAN Tetraspanin-11 OS=Homo sapiens GN=TSPAN11 PE=2 SV=2 | 190 | V | 0.140924 | A | 0.186307 | -0.045383 | No Change: Both O | - |
| O95859 | TSN12_HUMAN Tetraspanin-12 OS=Homo sapiens GN=TSPAN12 PE=1 SV=1 | 57 | L | 0.06467 | S | 0.150947 | -0.086277 | No Change: Both O | - |
| O95859 | TSN12_HUMAN Tetraspanin-12 OS=Homo sapiens GN=TSPAN12 PE=1 SV=1 | 101 | L | 0.008618 | H | 0.014598 | -0.00598 | No Change: Both O | Vitreoretinopathy exudative type 5 (EVR5) [MIM:613310] |
| O95859 | TSN12_HUMAN Tetraspanin-12 OS=Homo sapiens GN=TSPAN12 PE=1 SV=1 | 188 | G | 0.429204 | R | 0.447426 | -0.018222 | No Change: Both O | Vitreoretinopathy exudative type 5 (EVR5) [MIM:613310] |
| O95859 | TSN12_HUMAN Tetraspanin-12 OS=Homo sapiens GN=TSPAN12 PE=1 SV=1 | 210 | M | 0.334589 | R | 0.416438 | -0.081849 | No Change: Both O | Vitreoretinopathy exudative type 5 (EVR5) [MIM:613310] |
| O95859 | TSN12_HUMAN Tetraspanin-12 OS=Homo sapiens GN=TSPAN12 PE=1 SV=1 | 237 | A | 0.033471 | P | 0.04952 | -0.016049 | No Change: Both O | Vitreoretinopathy exudative type 5 (EVR5) [MIM:613310] |
| Q9UKR8 | TSN16_HUMAN Tetraspanin-16 OS=Homo sapiens GN=TSPAN16 PE=2 SV=1 | 53 | Y | 0.146089 | D | 0.264065 | -0.117976 | No Change: Both O | - |
| Q9UKR8 | TSN16_HUMAN Tetraspanin-16 OS=Homo sapiens GN=TSPAN16 PE=2 SV=1 | 55 | L | 0.089691 | P | 0.159606 | -0.069915 | No Change: Both O | - |
| Q9UKR8 | TSN16_HUMAN Tetraspanin-16 OS=Homo sapiens GN=TSPAN16 PE=2 SV=1 | 233 | S | 0.1598 | C | 0.057438 | 0.102362 | No Change: Both O | - |
| Q96FV3 | TSN17_HUMAN Tetraspanin-17 OS=Homo sapiens GN=TSPAN17 PE=2 SV=2 | 140 | I | 0.228717 | T | 0.355547 | -0.12683 | No Change: Both O | - |
| Q96SJ8 | TSN18_HUMAN Tetraspanin-18 OS=Homo sapiens GN=TSPAN18 PE=2 SV=1 | 133 | V | 0.327506 | I | 0.291034 | 0.036472 | No Change: Both O | - |
| O60636 | TSN2_HUMAN Tetraspanin-2 OS=Homo sapiens GN=TSPAN2 PE=2 SV=2 | 118 | R | 0.14883 | L | 0.08513 | 0.0637 | No Change: Both O | - |
| O14817 | TSN4_HUMAN Tetraspanin-4 OS=Homo sapiens GN=TSPAN4 PE=1 SV=1 | 67 | I | 0.030892 | M | 0.050286 | -0.019394 | No Change: Both O | A breast cancer sample |
| O43657 | TSN6_HUMAN Tetraspanin-6 OS=Homo sapiens GN=TSPAN6 PE=1 SV=1 | 108 | A | 0.027555 | T | 0.029456 | -0.001901 | No Change: Both O | - |
| P41732 | TSN7_HUMAN Tetraspanin-7 OS=Homo sapiens GN=TSPAN7 PE=1 SV=2 | 172 | P | 0.282459 | H | 0.237923 | 0.044536 | No Change: Both O | Mental retardation X-linked type 58 (MRX58) [MIM:300210] |
| P41732 | TSN7_HUMAN Tetraspanin-7 OS=Homo sapiens GN=TSPAN7 PE=1 SV=2 | 53 | E | 0.34712 | K | 0.346616 | 5.04E-04 | No Change: Both O | - |
| P41732 | TSN7_HUMAN Tetraspanin-7 OS=Homo sapiens GN=TSPAN7 PE=1 SV=2 | 127 | A | 0.339644 | T | 0.399608 | -0.059964 | No Change: Both O | - |
| P19075 | TSN8_HUMAN Tetraspanin-8 OS=Homo sapiens GN=TSPAN8 PE=1 SV=1 | 213 | S | 0.026955 | A | 0.017051 | 0.009904 | No Change: Both O | - |
| P19075 | TSN8_HUMAN Tetraspanin-8 OS=Homo sapiens GN=TSPAN8 PE=1 SV=1 | 73 | G | 0.029424 | A | 0.021877 | 0.007547 | No Change: Both O | - |
| P19075 | TSN8_HUMAN Tetraspanin-8 OS=Homo sapiens GN=TSPAN8 PE=1 SV=1 | 35 | V | 0.128062 | I | 0.114633 | 0.013429 | No Change: Both O | - |
| Q8WU66 | TSEAR_HUMAN Protein TSPEAR OS=Homo sapiens GN=TSPEAR PE=2 SV=2 | 166 | A | 0.127921 | T | 0.147973 | -0.020052 | No Change: Both O | A colorectal cancer sample |
| B1AH88 | TSPOB_HUMAN Peripheral benzodiazepine receptor-related protein OS=Homo sapiens GN=TSPO PE=1 SV=1 | 53 | H | 0.540445 | R | 0.589497 | -0.049052 | No Change: Both D | - |
| P30536 | TSPOA_HUMAN Translocator protein OS=Homo sapiens GN=TSPO PE=1 SV=3 | 147 | T | 0.029068 | A | 0.025238 | 0.00383 | No Change: Both O | - |
| P30536 | TSPOA_HUMAN Translocator protein OS=Homo sapiens GN=TSPO PE=1 SV=3 | 162 | R | 0.491019 | H | 0.488385 | 0.002634 | No Change: Both O | - |
| P30536 | TSPOA_HUMAN Translocator protein OS=Homo sapiens GN=TSPO PE=1 SV=3 | 169 | E | 0.946611 | Q | 0.939016 | 0.007595 | No Change: Both D | - |
| Q01534 | TSPY1_HUMAN Testis-specific Y-encoded protein 1 OS=Homo sapiens GN=TSPY1 PE=1 SV=4 | 195 | P | 0.337815 | R | 0.306681 | 0.031134 | No Change: Both O | - |
| Q01534 | TSPY1_HUMAN Testis-specific Y-encoded protein 1 OS=Homo sapiens GN=TSPY1 PE=1 SV=4 | 216 | I | 0.176686 | F | 0.184301 | -0.007615 | No Change: Both O | - |
| Q9H489 | TSY26_HUMAN Putative testis-specific Y-encoded-like protein 3 OS=Homo sapiens GN=TSPY26P PE=5 SV=1 | 246 | P | 0.120725 | H | 0.103949 | 0.016776 | No Change: Both O | - |
| Q9H0U9 | TSYL1_HUMAN Testis-specific Y-encoded-like protein 1 OS=Homo sapiens GN=TSPYL1 PE=1 SV=3 | 62 | P | 0.954705 | S | 0.947674 | 0.007031 | No Change: Both D | - |
| Q9H0U9 | TSYL1_HUMAN Testis-specific Y-encoded-like protein 1 OS=Homo sapiens GN=TSPYL1 PE=1 SV=3 | 74 | A | 0.93588 | P | 0.957259 | -0.021379 | No Change: Both D | - |
| Q9H0U9 | TSYL1_HUMAN Testis-specific Y-encoded-like protein 1 OS=Homo sapiens GN=TSPYL1 PE=1 SV=3 | 181 | A | 0.976441 | T | 0.975973 | 4.68E-04 | No Change: Both D | - |
| Q9UJ04 | TSYL4_HUMAN Testis-specific Y-encoded-like protein 4 OS=Homo sapiens GN=TSPYL4 PE=2 SV=2 | 30 | R | 0.866786 | L | 0.819169 | 0.047617 | No Change: Both D | - |
| Q86VY4 | TSYL5_HUMAN Testis-specific Y-encoded-like protein 5 OS=Homo sapiens GN=TSPYL5 PE=1 SV=2 | 120 | T | 0.746957 | S | 0.781406 | -0.034449 | No Change: Both D | - |
| Q86VY4 | TSYL5_HUMAN Testis-specific Y-encoded-like protein 5 OS=Homo sapiens GN=TSPYL5 PE=1 SV=2 | 365 | I | 0.405963 | V | 0.411381 | -0.005418 | No Change: Both O | - |
| Q8N831 | TSYL6_HUMAN Testis-specific Y-encoded-like protein 6 OS=Homo sapiens GN=TSPYL6 PE=2 SV=1 | 60 | A | 0.704063 | V | 0.649001 | 0.055062 | No Change: Both D | - |
| Q8N831 | TSYL6_HUMAN Testis-specific Y-encoded-like protein 6 OS=Homo sapiens GN=TSPYL6 PE=2 SV=1 | 109 | G | 0.841772 | S | 0.863407 | -0.021635 | No Change: Both D | - |
| Q8N831 | TSYL6_HUMAN Testis-specific Y-encoded-like protein 6 OS=Homo sapiens GN=TSPYL6 PE=2 SV=1 | 116 | P | 0.855887 | L | 0.800157 | 0.05573 | No Change: Both D | - |
| Q8N831 | TSYL6_HUMAN Testis-specific Y-encoded-like protein 6 OS=Homo sapiens GN=TSPYL6 PE=2 SV=1 | 246 | R | 0.104183 | C | 0.046326 | 0.057857 | No Change: Both O | - |
| Q2NL82 | TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens GN=TSR1 PE=1 SV=1 | 386 | S | 0.826211 | G | 0.783053 | 0.043158 | No Change: Both D | - |
| Q2NL82 | TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens GN=TSR1 PE=1 SV=1 | 719 | N | 0.070746 | S | 0.085692 | -0.014946 | No Change: Both O | - |
| Q2NL82 | TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens GN=TSR1 PE=1 SV=1 | 727 | K | 0.110851 | Q | 0.085277 | 0.025574 | No Change: Both O | - |
| Q2NL82 | TSR1_HUMAN Pre-rRNA-processing protein TSR1 homolog OS=Homo sapiens GN=TSR1 PE=1 SV=1 | 750 | H | 0.405646 | Q | 0.407019 | -0.001373 | No Change: Both O | - |
| Q9Y5U2 | TSSC4_HUMAN Protein TSSC4 OS=Homo sapiens GN=TSSC4 PE=1 SV=3 | 17 | H | 0.957871 | P | 0.97836 | -0.020489 | No Change: Both D | - |
| Q9Y5U2 | TSSC4_HUMAN Protein TSSC4 OS=Homo sapiens GN=TSSC4 PE=1 SV=3 | 230 | R | 0.772851 | S | 0.766259 | 0.006592 | No Change: Both D | - |
| Q9Y5U2 | TSSC4_HUMAN Protein TSSC4 OS=Homo sapiens GN=TSSC4 PE=1 SV=3 | 262 | G | 0.891083 | R | 0.882575 | 0.008508 | No Change: Both D | - |
| Q9Y5U2 | TSSC4_HUMAN Protein TSSC4 OS=Homo sapiens GN=TSSC4 PE=1 SV=3 | 124 | R | 0.900183 | Q | 0.875807 | 0.024376 | No Change: Both D | - |
| Q9Y5U2 | TSSC4_HUMAN Protein TSSC4 OS=Homo sapiens GN=TSSC4 PE=1 SV=3 | 274 | H | 0.869612 | P | 0.901673 | -0.032061 | No Change: Both D | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 50 | A | 0.357871 | T | 0.368556 | -0.010685 | No Change: Both O | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 83 | H | 0.233165 | Y | 0.159339 | 0.073826 | No Change: Both O | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 233 | V | 0.469291 | L | 0.484826 | -0.015535 | No Change: Both O | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 237 | R | 0.510084 | C | 0.341235 | 0.168849 | D to O | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 288 | G | 0.807019 | W | 0.727015 | 0.080004 | No Change: Both D | - |
| Q9BXA7 | TSSK1_HUMAN Testis-specific serine/threonine-protein kinase 1 OS=Homo sapiens GN=TSSK1B PE=1 SV=1 | 293 | G | 0.86481 | E | 0.88753 | -0.02272 | No Change: Both D | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 27 | K | 0.567987 | R | 0.499005 | 0.068982 | D to O | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 61 | M | 0.184502 | V | 0.152942 | 0.03156 | No Change: Both O | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 197 | Y | 0.11402 | C | 0.086516 | 0.027504 | No Change: Both O | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 280 | T | 0.766639 | M | 0.767735 | -0.001096 | No Change: Both D | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 244 | E | 0.334 | K | 0.359084 | -0.025084 | No Change: Both O | - |
| Q96PF2 | TSSK2_HUMAN Testis-specific serine/threonine-protein kinase 2 OS=Homo sapiens GN=TSSK2 PE=1 SV=2 | 245 | C | 0.336179 | S | 0.482177 | -0.145998 | No Change: Both O | - |
| Q96PN8 | TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | 140 | A | 0.187401 | T | 0.205494 | -0.018093 | No Change: Both O | - |
| Q96PN8 | TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | 235 | S | 0.324317 | L | 0.179061 | 0.145256 | No Change: Both O | - |
| Q96PN8 | TSSK3_HUMAN Testis-specific serine/threonine-protein kinase 3 OS=Homo sapiens GN=TSSK3 PE=2 SV=1 | 71 | I | 0.154129 | V | 0.174848 | -0.020719 | No Change: Both O | - |
| Q6SA08 | TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | 33 | H | 0.407946 | Y | 0.317308 | 0.090638 | No Change: Both O | - |
| Q6SA08 | TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | 89 | Y | 0.119028 | C | 0.08867 | 0.030358 | No Change: Both O | - |
| Q6SA08 | TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | 145 | V | 0.353913 | M | 0.421302 | -0.067389 | No Change: Both O | - |
| Q6SA08 | TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | 196 | Q | 0.214183 | R | 0.198379 | 0.015804 | No Change: Both O | - |
| Q6SA08 | TSSK4_HUMAN Testis-specific serine/threonine-protein kinase 4 OS=Homo sapiens GN=TSSK4 PE=1 SV=1 | 327 | T | 0.784123 | M | 0.772659 | 0.011464 | No Change: Both D | - |
| Q16762 | THTR_HUMAN Thiosulfate sulfurtransferase OS=Homo sapiens GN=TST PE=1 SV=4 | 102 | E | 0.302572 | D | 0.293797 | 0.008775 | No Change: Both O | - |
| Q16762 | THTR_HUMAN Thiosulfate sulfurtransferase OS=Homo sapiens GN=TST PE=1 SV=4 | 228 | E | 0.490146 | G | 0.434164 | 0.055982 | No Change: Both O | - |
| Q5T7W7 | TSTD2_HUMAN Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 OS=Homo sapiens GN=TSTD2 PE=1 SV=1 | 83 | R | 0.207005 | Q | 0.230121 | -0.023116 | No Change: Both O | - |
| Q5T7W7 | TSTD2_HUMAN Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 OS=Homo sapiens GN=TSTD2 PE=1 SV=1 | 109 | A | 0.360639 | D | 0.432028 | -0.071389 | No Change: Both O | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 613 | P | 0.990397 | L | 0.983152 | 0.007245 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 623 | G | 0.995842 | A | 0.995374 | 4.68E-04 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 649 | P | 0.988272 | R | 0.986659 | 0.001613 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 741 | D | 0.997631 | E | 0.998483 | -8.52E-04 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 744 | E | 0.999521 | D | 0.999361 | 1.60E-04 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 806 | S | 0.978628 | F | 0.948927 | 0.029701 | No Change: Both D | A lung large cell carcinoma sample |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 855 | P | 0.895962 | S | 0.885724 | 0.010238 | No Change: Both D | A metastatic melanoma sample |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 1145 | K | 0.980334 | R | 0.985748 | -0.005414 | No Change: Both D | - |
| Q5TCY1 | TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens GN=TTBK1 PE=1 SV=2 | 1184 | L | 0.928614 | S | 0.95753 | -0.028916 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 8 | L | 0.446873 | P | 0.567597 | -0.120724 | O to D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 120 | R | 0.279933 | Q | 0.28948 | -0.009547 | No Change: Both O | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 313 | T | 0.734187 | A | 0.676783 | 0.057404 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 440 | V | 0.638411 | M | 0.706822 | -0.068411 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 500 | R | 0.309623 | P | 0.406112 | -0.096489 | No Change: Both O | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 635 | D | 0.672369 | G | 0.679595 | -0.007226 | No Change: Both D | A lung small cell carcinoma sample |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 1062 | T | 0.930479 | I | 0.900053 | 0.030426 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 1084 | T | 0.908895 | M | 0.903233 | 0.005662 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 1097 | V | 0.851638 | A | 0.883911 | -0.032273 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 1122 | P | 0.936941 | R | 0.940098 | -0.003157 | No Change: Both D | - |
| Q6IQ55 | TTBK2_HUMAN Tau-tubulin kinase 2 OS=Homo sapiens GN=TTBK2 PE=1 SV=2 | 1241 | K | 0.996275 | T | 0.994788 | 0.001487 | No Change: Both D | - |
| Q9H892 | TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens GN=TTC12 PE=2 SV=2 | 73 | M | 0.905368 | L | 0.876462 | 0.028906 | No Change: Both D | - |
| Q9H892 | TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens GN=TTC12 PE=2 SV=2 | 468 | M | 0.415868 | L | 0.350687 | 0.065181 | No Change: Both O | - |
| Q9H892 | TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens GN=TTC12 PE=2 SV=2 | 563 | V | 0.282043 | A | 0.367566 | -0.085523 | No Change: Both O | - |
| Q8WVT3 | TPC12_HUMAN Trafficking protein particle complex subunit 12 OS=Homo sapiens GN=TTC15 PE=1 SV=3 | 301 | S | 0.568765 | G | 0.515406 | 0.053359 | No Change: Both D | - |
| Q8WVT3 | TPC12_HUMAN Trafficking protein particle complex subunit 12 OS=Homo sapiens GN=TTC15 PE=1 SV=3 | 717 | E | 0.461149 | Q | 0.425671 | 0.035478 | No Change: Both O | A breast cancer sample |
| Q8NEE8 | TTC16_HUMAN Tetratricopeptide repeat protein 16 OS=Homo sapiens GN=TTC16 PE=2 SV=2 | 405 | M | 0.55115 | T | 0.578282 | -0.027132 | No Change: Both D | - |
| Q8NEE8 | TTC16_HUMAN Tetratricopeptide repeat protein 16 OS=Homo sapiens GN=TTC16 PE=2 SV=2 | 588 | E | 0.996159 | G | 0.993979 | 0.00218 | No Change: Both D | - |
| Q8NEE8 | TTC16_HUMAN Tetratricopeptide repeat protein 16 OS=Homo sapiens GN=TTC16 PE=2 SV=2 | 872 | A | 0.696425 | S | 0.822325 | -0.1259 | No Change: Both D | - |
| Q8NEE8 | TTC16_HUMAN Tetratricopeptide repeat protein 16 OS=Homo sapiens GN=TTC16 PE=2 SV=2 | 809 | Y | 0.808931 | C | 0.834527 | -0.025596 | No Change: Both D | - |
| Q96AE7 | TTC17_HUMAN Tetratricopeptide repeat protein 17 OS=Homo sapiens GN=TTC17 PE=1 SV=1 | 145 | I | 0.752543 | L | 0.77011 | -0.017567 | No Change: Both D | - |
| Q96AE7 | TTC17_HUMAN Tetratricopeptide repeat protein 17 OS=Homo sapiens GN=TTC17 PE=1 SV=1 | 270 | N | 0.152218 | H | 0.142575 | 0.009643 | No Change: Both O | - |
| Q5T0N1 | TTC18_HUMAN Tetratricopeptide repeat protein 18 OS=Homo sapiens GN=TTC18 PE=2 SV=2 | 849 | W | 0.901825 | L | 0.941093 | -0.039268 | No Change: Both D | - |
| Q5T0N1 | TTC18_HUMAN Tetratricopeptide repeat protein 18 OS=Homo sapiens GN=TTC18 PE=2 SV=2 | 944 | N | 0.414432 | D | 0.433361 | -0.018929 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 91 | R | 0.2679 | Q | 0.289715 | -0.021815 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 108 | V | 0.312927 | L | 0.326956 | -0.014029 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 290 | R | 0.616763 | K | 0.658967 | -0.042204 | No Change: Both D | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 293 | E | 0.702651 | K | 0.696659 | 0.005992 | No Change: Both D | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 622 | R | 0.512675 | W | 0.281547 | 0.231128 | D to O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 719 | R | 0.176253 | Q | 0.162872 | 0.013381 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 1055 | R | 0.482694 | L | 0.365382 | 0.117312 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 1160 | S | 0.360046 | R | 0.315329 | 0.044717 | No Change: Both O | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 1316 | R | 0.829735 | K | 0.837951 | -0.008216 | No Change: Both D | - |
| Q8NDW8 | TT21A_HUMAN Tetratricopeptide repeat protein 21A OS=Homo sapiens GN=TTC21A PE=2 SV=3 | 719 | R | 0.176253 | H | 0.15143 | 0.024823 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 201 | V | 0.154676 | M | 0.182871 | -0.028195 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 276 | T | 0.450611 | A | 0.430145 | 0.020466 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 463 | P | 0.47838 | S | 0.499696 | -0.021316 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 473 | L | 0.130623 | F | 0.105434 | 0.025189 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 846 | K | 0.410157 | R | 0.360658 | 0.049499 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 60 | F | 0.380154 | Y | 0.419965 | -0.039811 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 66 | K | 0.374076 | R | 0.308204 | 0.065872 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 150 | W | 0.158321 | R | 0.355163 | -0.196842 | No Change: Both O | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 157 | K | 0.441363 | E | 0.435595 | 0.005768 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 209 | P | 0.078325 | L | 0.037399 | 0.040926 | No Change: Both O | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 222 | Q | 0.213568 | L | 0.129486 | 0.084082 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 231 | T | 0.315529 | S | 0.385131 | -0.069602 | No Change: Both O | Asphyxiating thoracic dystrophy type 4 (ATD4) [MIM:613819] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 231 | T | 0.315529 | S | 0.385131 | -0.069602 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 231 | T | 0.315529 | S | 0.385131 | -0.069602 | No Change: Both O | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 242 | D | 0.40436 | N | 0.400084 | 0.004276 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 255 | Y | 0.139325 | C | 0.177508 | -0.038183 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 280 | M | 0.448837 | V | 0.387481 | 0.061356 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 327 | A | 0.380182 | S | 0.489599 | -0.109417 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 347 | Y | 0.203858 | C | 0.173467 | 0.030391 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 411 | R | 0.570571 | G | 0.579442 | -0.008871 | No Change: Both D | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 412 | Q | 0.543211 | R | 0.544603 | -0.001392 | No Change: Both D | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 424 | D | 0.200021 | E | 0.216555 | -0.016534 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 566 | H | 0.188805 | R | 0.210624 | -0.021819 | No Change: Both O | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 591 | S | 0.528461 | N | 0.439949 | 0.088512 | D to O | Joubert syndrome (JBTS) [MIM:213300] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 616 | R | 0.366908 | C | 0.22559 | 0.141318 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 624 | I | 0.259041 | V | 0.28064 | -0.021599 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 645 | H | 0.34229 | R | 0.346084 | -0.003794 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 724 | S | 0.224237 | T | 0.170322 | 0.053915 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 753 | P | 0.642072 | L | 0.508512 | 0.13356 | No Change: Both D | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 755 | D | 0.666494 | Y | 0.524364 | 0.14213 | No Change: Both D | Asphyxiating thoracic dystrophy type 4 (ATD4) [MIM:613819] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 795 | L | 0.070863 | P | 0.127031 | -0.056168 | No Change: Both O | Asphyxiating thoracic dystrophy type 4 (ATD4) [MIM:613819] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 844 | M | 0.405301 | V | 0.355017 | 0.050284 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 867 | R | 0.535966 | C | 0.390782 | 0.145184 | D to O | Joubert syndrome (JBTS) [MIM:213300] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 867 | R | 0.535966 | H | 0.485628 | 0.050338 | D to O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 869 | Q | 0.582092 | R | 0.562536 | 0.019556 | No Change: Both D | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 939 | R | 0.432365 | Q | 0.472124 | -0.039759 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 939 | R | 0.432365 | W | 0.216825 | 0.21554 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1002 | L | 0.323485 | V | 0.310952 | 0.012533 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1011 | M | 0.447903 | V | 0.39831 | 0.049593 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1035 | Y | 0.114864 | C | 0.101699 | 0.013165 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1041 | D | 0.336345 | N | 0.341755 | -0.00541 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1103 | T | 0.422979 | R | 0.453297 | -0.030318 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1167 | Y | 0.174199 | C | 0.195359 | -0.02116 | No Change: Both O | Nephronophthisis type 12 (NPHP12) [MIM:613820] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1186 | M | 0.203931 | V | 0.155719 | 0.048212 | No Change: Both O | Joubert syndrome (JBTS) [MIM:213300] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1208 | I | 0.129719 | S | 0.275431 | -0.145712 | No Change: Both O | Bardet-Biedl syndrome (BBS) [MIM:209900] |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1284 | D | 0.156502 | H | 0.131521 | 0.024981 | No Change: Both O | - |
| Q7Z4L5 | TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens GN=TTC21B PE=1 SV=2 | 1311 | R | 0.652779 | G | 0.645532 | 0.007247 | No Change: Both D | - |
| Q5TAA0 | TTC22_HUMAN Tetratricopeptide repeat protein 22 OS=Homo sapiens GN=TTC22 PE=2 SV=1 | 14 | L | 0.319533 | V | 0.279044 | 0.040489 | No Change: Both O | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 22 | H | 0.297912 | R | 0.338216 | -0.040304 | No Change: Both O | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 67 | K | 0.898497 | E | 0.894891 | 0.003606 | No Change: Both D | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 150 | T | 0.588515 | M | 0.518463 | 0.070052 | No Change: Both D | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 153 | N | 0.653191 | D | 0.658087 | -0.004896 | No Change: Both D | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 247 | K | 0.411904 | N | 0.367304 | 0.0446 | No Change: Both O | - |
| Q6PF05 | TT23L_HUMAN Tetratricopeptide repeat protein 23-like OS=Homo sapiens GN=TTC23L PE=2 SV=2 | 325 | R | 0.080401 | K | 0.097198 | -0.016797 | No Change: Both O | - |
| A2A3L6 | TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens GN=TTC24 PE=2 SV=1 | 231 | E | 0.580462 | G | 0.534007 | 0.046455 | No Change: Both D | - |
| A2A3L6 | TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens GN=TTC24 PE=2 SV=1 | 532 | P | 0.713195 | A | 0.60233 | 0.110865 | No Change: Both D | - |
| A2A3L6 | TTC24_HUMAN Tetratricopeptide repeat protein 24 OS=Homo sapiens GN=TTC24 PE=2 SV=1 | 550 | N | 0.900915 | S | 0.924433 | -0.023518 | No Change: Both D | - |
| Q96NG3 | TTC25_HUMAN Tetratricopeptide repeat protein 25 OS=Homo sapiens GN=TTC25 PE=1 SV=2 | 4 | P | 0.83367 | S | 0.847764 | -0.014094 | No Change: Both D | - |
| Q96NG3 | TTC25_HUMAN Tetratricopeptide repeat protein 25 OS=Homo sapiens GN=TTC25 PE=1 SV=2 | 18 | A | 0.502937 | G | 0.56441 | -0.061473 | No Change: Both D | - |
| A0AVF1 | TTC26_HUMAN Tetratricopeptide repeat protein 26 OS=Homo sapiens GN=TTC26 PE=2 SV=1 | 310 | D | 0.38242 | N | 0.382626 | -2.06E-04 | No Change: Both O | - |
| Q6P3X3 | TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens GN=TTC27 PE=1 SV=1 | 476 | Y | 0.140782 | C | 0.147974 | -0.007192 | No Change: Both O | - |
| Q6P3X3 | TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens GN=TTC27 PE=1 SV=1 | 525 | R | 0.491336 | H | 0.460029 | 0.031307 | No Change: Both O | - |
| Q6P3X3 | TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens GN=TTC27 PE=1 SV=1 | 586 | R | 0.166043 | H | 0.167688 | -0.001645 | No Change: Both O | - |
| Q6P3X3 | TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens GN=TTC27 PE=1 SV=1 | 498 | T | 0.491925 | M | 0.454753 | 0.037172 | No Change: Both O | - |
| Q8NA56 | TTC29_HUMAN Tetratricopeptide repeat protein 29 OS=Homo sapiens GN=TTC29 PE=2 SV=2 | 94 | L | 0.300492 | P | 0.460798 | -0.160306 | No Change: Both O | - |
| Q8NA56 | TTC29_HUMAN Tetratricopeptide repeat protein 29 OS=Homo sapiens GN=TTC29 PE=2 SV=2 | 140 | H | 0.291031 | Y | 0.209471 | 0.08156 | No Change: Both O | - |
| Q8NA56 | TTC29_HUMAN Tetratricopeptide repeat protein 29 OS=Homo sapiens GN=TTC29 PE=2 SV=2 | 276 | A | 0.496463 | T | 0.497522 | -0.001059 | No Change: Both O | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1117 | F | 0.335377 | L | 0.364467 | -0.02909 | No Change: Both O | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 840 | M | 0.170201 | T | 0.213715 | -0.043514 | No Change: Both O | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1751 | D | 0.738132 | H | 0.711514 | 0.026618 | No Change: Both D | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1289 | K | 0.751594 | M | 0.686635 | 0.064959 | No Change: Both D | A breast cancer sample |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1063 | S | 0.7806 | T | 0.710419 | 0.070181 | No Change: Both D | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1128 | N | 0.550736 | H | 0.548499 | 0.002237 | No Change: Both D | - |
| P53804 | TTC3_HUMAN E3 ubiquitin-protein ligase TTC3 OS=Homo sapiens GN=TTC3 PE=1 SV=2 | 1154 | P | 0.212821 | S | 0.213694 | -8.73E-04 | No Change: Both O | - |
| Q86WT1 | TT30A_HUMAN Tetratricopeptide repeat protein 30A OS=Homo sapiens GN=TTC30A PE=2 SV=3 | 577 | K | 0.450874 | R | 0.358405 | 0.092469 | No Change: Both O | - |
| Q86WT1 | TT30A_HUMAN Tetratricopeptide repeat protein 30A OS=Homo sapiens GN=TTC30A PE=2 SV=3 | 446 | V | 0.282874 | I | 0.234699 | 0.048175 | No Change: Both O | - |
| Q8N4P2 | TT30B_HUMAN Tetratricopeptide repeat protein 30B OS=Homo sapiens GN=TTC30B PE=2 SV=2 | 117 | R | 0.226551 | H | 0.214214 | 0.012337 | No Change: Both O | - |
| Q8N4P2 | TT30B_HUMAN Tetratricopeptide repeat protein 30B OS=Homo sapiens GN=TTC30B PE=2 SV=2 | 446 | I | 0.234699 | V | 0.282874 | -0.048175 | No Change: Both O | - |
| Q49AM3 | TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens GN=TTC31 PE=2 SV=3 | 28 | A | 0.469482 | V | 0.394938 | 0.074544 | No Change: Both O | - |
| Q49AM3 | TTC31_HUMAN Tetratricopeptide repeat protein 31 OS=Homo sapiens GN=TTC31 PE=2 SV=3 | 205 | T | 0.991832 | P | 0.994399 | -0.002567 | No Change: Both D | - |
| Q6PID6 | TTC33_HUMAN Tetratricopeptide repeat protein 33 OS=Homo sapiens GN=TTC33 PE=1 SV=2 | 69 | L | 0.673088 | M | 0.710448 | -0.03736 | No Change: Both D | - |
| A6NLP5 | TTC36_HUMAN Tetratricopeptide repeat protein 36 OS=Homo sapiens GN=TTC36 PE=2 SV=1 | 78 | I | 0.26798 | M | 0.414491 | -0.146511 | No Change: Both O | - |
| Q6PGP7 | TTC37_HUMAN Tetratricopeptide repeat protein 37 OS=Homo sapiens GN=TTC37 PE=1 SV=1 | 437 | L | 0.279087 | V | 0.27773 | 0.001357 | No Change: Both O | - |
| Q6PGP7 | TTC37_HUMAN Tetratricopeptide repeat protein 37 OS=Homo sapiens GN=TTC37 PE=1 SV=1 | 1296 | R | 0.22915 | S | 0.287425 | -0.058275 | No Change: Both O | - |
| Q6PGP7 | TTC37_HUMAN Tetratricopeptide repeat protein 37 OS=Homo sapiens GN=TTC37 PE=1 SV=1 | 1077 | A | 0.461125 | D | 0.533988 | -0.072863 | O to D | - |
| Q6PGP7 | TTC37_HUMAN Tetratricopeptide repeat protein 37 OS=Homo sapiens GN=TTC37 PE=1 SV=1 | 1270 | P | 0.286706 | A | 0.235039 | 0.051667 | No Change: Both O | - |
| Q6PGP7 | TTC37_HUMAN Tetratricopeptide repeat protein 37 OS=Homo sapiens GN=TTC37 PE=1 SV=1 | 1485 | L | 0.051186 | R | 0.08357 | -0.032384 | No Change: Both O | - |
| Q5R3I4 | TTC38_HUMAN Tetratricopeptide repeat protein 38 OS=Homo sapiens GN=TTC38 PE=1 SV=1 | 243 | F | 0.413059 | L | 0.448093 | -0.035034 | No Change: Both O | - |
| Q5VTQ0 | TT39B_HUMAN Tetratricopeptide repeat protein 39B OS=Homo sapiens GN=TTC39B PE=2 SV=3 | 354 | I | 0.181104 | V | 0.221299 | -0.040195 | No Change: Both O | - |
| Q5VTQ0 | TT39B_HUMAN Tetratricopeptide repeat protein 39B OS=Homo sapiens GN=TTC39B PE=2 SV=3 | 62 | T | 0.803889 | P | 0.8194 | -0.015511 | No Change: Both D | - |
| O95801 | TTC4_HUMAN Tetratricopeptide repeat protein 4 OS=Homo sapiens GN=TTC4 PE=1 SV=3 | 47 | S | 0.652271 | T | 0.541641 | 0.11063 | No Change: Both D | - |
| Q8N0Z6 | TTC5_HUMAN Tetratricopeptide repeat protein 5 OS=Homo sapiens GN=TTC5 PE=1 SV=2 | 14 | Q | 0.412556 | H | 0.339291 | 0.073265 | No Change: Both O | - |
| Q8N0Z6 | TTC5_HUMAN Tetratricopeptide repeat protein 5 OS=Homo sapiens GN=TTC5 PE=1 SV=2 | 47 | Q | 0.796024 | R | 0.771236 | 0.024788 | No Change: Both D | - |
| Q86TZ1 | TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens GN=TTC6 PE=2 SV=1 | 140 | T | 0.249411 | I | 0.154609 | 0.094802 | No Change: Both O | - |
| Q86TZ1 | TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens GN=TTC6 PE=2 SV=1 | 87 | I | 0.533203 | S | 0.703358 | -0.170155 | No Change: Both D | - |
| Q86TZ1 | TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens GN=TTC6 PE=2 SV=1 | 98 | A | 0.33177 | T | 0.349755 | -0.017985 | No Change: Both O | - |
| Q86TZ1 | TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens GN=TTC6 PE=2 SV=1 | 376 | T | 0.252691 | S | 0.342794 | -0.090103 | No Change: Both O | - |
| Q9ULT0 | TTC7A_HUMAN Tetratricopeptide repeat protein 7A OS=Homo sapiens GN=TTC7A PE=1 SV=3 | 538 | V | 0.409011 | L | 0.451973 | -0.042962 | No Change: Both O | - |
| Q9ULT0 | TTC7A_HUMAN Tetratricopeptide repeat protein 7A OS=Homo sapiens GN=TTC7A PE=1 SV=3 | 545 | V | 0.335434 | I | 0.313486 | 0.021948 | No Change: Both O | - |
| Q92623 | TTC9A_HUMAN Tetratricopeptide repeat protein 9A OS=Homo sapiens GN=TTC9 PE=2 SV=3 | 103 | P | 0.919222 | A | 0.886712 | 0.03251 | No Change: Both D | - |
| Q8N6N2 | TTC9B_HUMAN Tetratricopeptide repeat protein 9B OS=Homo sapiens GN=TTC9B PE=2 SV=1 | 223 | L | 0.603735 | P | 0.718867 | -0.115132 | No Change: Both D | - |
| Q8TAP9 | TTDN1_HUMAN TTD non-photosensitive 1 protein OS=Homo sapiens GN=TTDN1 PE=1 SV=1 | 144 | M | 0.483791 | V | 0.42003 | 0.063761 | No Change: Both O | Trichothiodystrophy non-photosensitive type 1 (TTDN1) [MIM:234050] |
| Q8TAP9 | TTDN1_HUMAN TTD non-photosensitive 1 protein OS=Homo sapiens GN=TTDN1 PE=1 SV=1 | 29 | G | 0.99809 | E | 0.997492 | 5.98E-04 | No Change: Both D | A breast cancer sample |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 35 | E | 0.953439 | K | 0.958747 | -0.005308 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 290 | A | 0.925909 | S | 0.946319 | -0.02041 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 303 | V | 0.846156 | A | 0.881641 | -0.035485 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 360 | G | 0.912599 | V | 0.886145 | 0.026454 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 401 | R | 0.953642 | Q | 0.943947 | 0.009695 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 473 | E | 0.769021 | K | 0.739978 | 0.029043 | No Change: Both D | - |
| Q15361 | TTF1_HUMAN Transcription termination factor 1 OS=Homo sapiens GN=TTF1 PE=1 SV=3 | 885 | A | 0.571074 | V | 0.456095 | 0.114979 | D to O | - |
| Q9UNY4 | TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens GN=TTF2 PE=1 SV=2 | 167 | K | 0.993397 | E | 0.993138 | 2.59E-04 | No Change: Both D | - |
| Q9UNY4 | TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens GN=TTF2 PE=1 SV=2 | 213 | K | 0.94829 | R | 0.941534 | 0.006756 | No Change: Both D | - |
| Q9UNY4 | TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens GN=TTF2 PE=1 SV=2 | 256 | E | 0.938616 | G | 0.923396 | 0.01522 | No Change: Both D | - |
| Q9UNY4 | TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens GN=TTF2 PE=1 SV=2 | 1134 | K | 0.646809 | R | 0.574228 | 0.072581 | No Change: Both D | - |
| Q9UNY4 | TTF2_HUMAN Transcription termination factor 2 OS=Homo sapiens GN=TTF2 PE=1 SV=2 | 1155 | D | 0.199378 | H | 0.151745 | 0.047633 | No Change: Both O | - |
| O43156 | TTI1_HUMAN TEL2-interacting protein 1 homolog OS=Homo sapiens GN=TTI1 PE=1 SV=3 | 671 | A | 0.24855 | V | 0.198424 | 0.050126 | No Change: Both O | - |
| O43156 | TTI1_HUMAN TEL2-interacting protein 1 homolog OS=Homo sapiens GN=TTI1 PE=1 SV=3 | 979 | A | 0.136267 | T | 0.151268 | -0.015001 | No Change: Both O | - |
| O43156 | TTI1_HUMAN TEL2-interacting protein 1 homolog OS=Homo sapiens GN=TTI1 PE=1 SV=3 | 450 | R | 0.369703 | H | 0.347718 | 0.021985 | No Change: Both O | - |
| O43156 | TTI1_HUMAN TEL2-interacting protein 1 homolog OS=Homo sapiens GN=TTI1 PE=1 SV=3 | 1028 | R | 0.231738 | K | 0.301715 | -0.069977 | No Change: Both O | - |
| O43156 | TTI1_HUMAN TEL2-interacting protein 1 homolog OS=Homo sapiens GN=TTI1 PE=1 SV=3 | 751 | K | 0.278124 | E | 0.274664 | 0.00346 | No Change: Both O | - |
| Q6NXR4 | TTI2_HUMAN TELO2-interacting protein 2 OS=Homo sapiens GN=TTI2 PE=1 SV=1 | 63 | E | 0.298804 | G | 0.247606 | 0.051198 | No Change: Both O | - |
| Q6NXR4 | TTI2_HUMAN TELO2-interacting protein 2 OS=Homo sapiens GN=TTI2 PE=1 SV=1 | 425 | L | 0.061532 | R | 0.099605 | -0.038073 | No Change: Both O | - |
| P33981 | TTK_HUMAN Dual specificity protein kinase TTK OS=Homo sapiens GN=TTK PE=1 SV=2 | 97 | A | 0.385679 | V | 0.300617 | 0.085062 | No Change: Both O | - |
| P33981 | TTK_HUMAN Dual specificity protein kinase TTK OS=Homo sapiens GN=TTK PE=1 SV=2 | 758 | D | 0.54226 | N | 0.510352 | 0.031908 | No Change: Both D | - |
| O95922 | TTLL1_HUMAN Probable tubulin polyglutamylase TTLL1 OS=Homo sapiens GN=TTLL1 PE=2 SV=1 | 168 | S | 0.672117 | L | 0.520374 | 0.151743 | No Change: Both D | - |
| Q6ZVT0 | TTL10_HUMAN Inactive polyglycylase TTLL10 OS=Homo sapiens GN=TTLL10 PE=1 SV=2 | 130 | A | 0.894355 | T | 0.898095 | -0.00374 | No Change: Both D | A colorectal cancer sample |
| Q6ZVT0 | TTL10_HUMAN Inactive polyglycylase TTLL10 OS=Homo sapiens GN=TTLL10 PE=1 SV=2 | 249 | V | 0.609176 | A | 0.708562 | -0.099386 | No Change: Both D | - |
| Q6ZVT0 | TTL10_HUMAN Inactive polyglycylase TTLL10 OS=Homo sapiens GN=TTLL10 PE=1 SV=2 | 448 | S | 0.149892 | N | 0.132993 | 0.016899 | No Change: Both O | - |
| Q6ZVT0 | TTL10_HUMAN Inactive polyglycylase TTLL10 OS=Homo sapiens GN=TTLL10 PE=1 SV=2 | 578 | G | 0.832418 | D | 0.838648 | -0.00623 | No Change: Both D | - |
| Q14166 | TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2 | 84 | R | 0.769863 | W | 0.573407 | 0.196456 | No Change: Both D | - |
| Q14166 | TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2 | 95 | N | 0.434944 | S | 0.459734 | -0.02479 | No Change: Both O | - |
| Q14166 | TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2 | 297 | V | 0.310041 | M | 0.351741 | -0.0417 | No Change: Both O | - |
| Q14166 | TTL12_HUMAN Tubulin--tyrosine ligase-like protein 12 OS=Homo sapiens GN=TTLL12 PE=1 SV=2 | 464 | V | 0.225912 | M | 0.263659 | -0.037747 | No Change: Both O | - |
| A6NNM8 | TTL13_HUMAN Tubulin polyglutamylase TTLL13 OS=Homo sapiens GN=TTLL13 PE=1 SV=2 | 126 | A | 0.083008 | T | 0.103791 | -0.020783 | No Change: Both O | - |
| A6NNM8 | TTL13_HUMAN Tubulin polyglutamylase TTLL13 OS=Homo sapiens GN=TTLL13 PE=1 SV=2 | 262 | T | 0.132529 | I | 0.076332 | 0.056197 | No Change: Both O | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 3 | G | 0.880539 | R | 0.91054 | -0.030001 | No Change: Both D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 127 | T | 0.230704 | A | 0.195739 | 0.034965 | No Change: Both O | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 202 | L | 0.328754 | P | 0.501815 | -0.173061 | O to D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 425 | R | 0.669151 | G | 0.680547 | -0.011396 | No Change: Both D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 445 | G | 0.645725 | S | 0.707872 | -0.062147 | No Change: Both D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 529 | Q | 0.76356 | H | 0.748418 | 0.015142 | No Change: Both D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 63 | P | 0.92707 | S | 0.914102 | 0.012968 | No Change: Both D | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 356 | I | 0.074466 | V | 0.08505 | -0.010584 | No Change: Both O | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 559 | V | 0.195179 | I | 0.16544 | 0.029739 | No Change: Both O | - |
| Q9BWV7 | TTLL2_HUMAN Probable tubulin polyglutamylase TTLL2 OS=Homo sapiens GN=TTLL2 PE=5 SV=3 | 441 | K | 0.687303 | T | 0.651268 | 0.036035 | No Change: Both D | - |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 502 | M | 0.171401 | R | 0.233985 | -0.062584 | No Change: Both O | - |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 454 | G | 0.126138 | S | 0.158161 | -0.032023 | No Change: Both O | A colorectal cancer sample |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 476 | M | 0.525894 | I | 0.445101 | 0.080793 | D to O | A colorectal cancer sample |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 174 | E | 0.713465 | K | 0.71338 | 8.50E-05 | No Change: Both D | - |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 418 | N | 0.243839 | H | 0.242279 | 0.00156 | No Change: Both O | - |
| Q9Y4R7 | TTLL3_HUMAN Tubulin monoglycylase TTLL3 OS=Homo sapiens GN=TTLL3 PE=1 SV=2 | 689 | A | 0.940355 | T | 0.941244 | -8.89E-04 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 418 | R | 0.149049 | H | 0.153368 | -0.004319 | No Change: Both O | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 17 | N | 0.842072 | S | 0.906697 | -0.064625 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 34 | E | 0.884681 | Q | 0.889218 | -0.004537 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 364 | L | 0.572169 | P | 0.72816 | -0.155991 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 518 | G | 0.989011 | S | 0.993158 | -0.004147 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 524 | S | 0.988241 | G | 0.983337 | 0.004904 | No Change: Both D | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 852 | A | 0.254101 | S | 0.382598 | -0.128497 | No Change: Both O | - |
| Q14679 | TTLL4_HUMAN Tubulin polyglutamylase TTLL4 OS=Homo sapiens GN=TTLL4 PE=1 SV=2 | 1138 | T | 0.988593 | I | 0.978537 | 0.010056 | No Change: Both D | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 149 | A | 0.243438 | V | 0.180124 | 0.063314 | No Change: Both O | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 203 | E | 0.349636 | D | 0.308353 | 0.041283 | No Change: Both O | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 592 | A | 0.973408 | T | 0.976759 | -0.003351 | No Change: Both D | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 1223 | A | 0.965675 | S | 0.977742 | -0.012067 | No Change: Both D | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 1231 | P | 0.970184 | T | 0.957234 | 0.01295 | No Change: Both D | - |
| Q6EMB2 | TTLL5_HUMAN Tubulin polyglutamylase TTLL5 OS=Homo sapiens GN=TTLL5 PE=1 SV=3 | 1267 | F | 0.675671 | S | 0.872909 | -0.197238 | No Change: Both D | - |
| Q8N841 | TTLL6_HUMAN Tubulin polyglutamylase TTLL6 OS=Homo sapiens GN=TTLL6 PE=2 SV=2 | 664 | E | 0.902522 | D | 0.893771 | 0.008751 | No Change: Both D | - |
| A6PVC2 | TTLL8_HUMAN Protein monoglycylase TTLL8 OS=Homo sapiens GN=TTLL8 PE=1 SV=4 | 191 | R | 0.171041 | H | 0.161788 | 0.009253 | No Change: Both O | - |
| A6PVC2 | TTLL8_HUMAN Protein monoglycylase TTLL8 OS=Homo sapiens GN=TTLL8 PE=1 SV=4 | 294 | E | 0.504966 | K | 0.478105 | 0.026861 | D to O | - |
| A6PVC2 | TTLL8_HUMAN Protein monoglycylase TTLL8 OS=Homo sapiens GN=TTLL8 PE=1 SV=4 | 127 | L | 0.316943 | W | 0.23953 | 0.077413 | No Change: Both O | - |
| Q3SXZ7 | TTLL9_HUMAN Probable tubulin polyglutamylase TTLL9 OS=Homo sapiens GN=TTLL9 PE=2 SV=3 | 76 | Y | 0.039305 | C | 0.036076 | 0.003229 | No Change: Both O | - |
| Q5BVD1 | TTMP_HUMAN TPA-induced transmembrane protein OS=Homo sapiens GN=TTMP PE=2 SV=2 | 111 | I | 0.122347 | V | 0.131278 | -0.008931 | No Change: Both O | - |
| Q5BVD1 | TTMP_HUMAN TPA-induced transmembrane protein OS=Homo sapiens GN=TTMP PE=2 SV=2 | 144 | G | 0.382031 | S | 0.464911 | -0.08288 | No Change: Both O | - |
| Q5BVD1 | TTMP_HUMAN TPA-induced transmembrane protein OS=Homo sapiens GN=TTMP PE=2 SV=2 | 66 | L | 0.033552 | P | 0.072039 | -0.038487 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 279 | R | 0.996248 | W | 0.990121 | 0.006127 | No Change: Both D | Hereditary myopathy with early respiratory failure (HMERF) [MIM:603689] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4215 | T | 0.467258 | P | 0.526383 | -0.059125 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4283 | L | 0.68511 | F | 0.648022 | 0.037088 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 54 | V | 0.384363 | M | 0.447506 | -0.063143 | No Change: Both O | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 328 | R | 0.892574 | C | 0.837477 | 0.055097 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 740 | R | 0.782462 | L | 0.688484 | 0.093978 | No Change: Both D | Familial hypertrophic cardiomyopathy type 9 (CMH9) [MIM:613765] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 743 | A | 0.828195 | V | 0.787235 | 0.04096 | No Change: Both D | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 976 | W | 0.222717 | R | 0.443628 | -0.220911 | No Change: Both O | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3799 | S | 0.672996 | Y | 0.451557 | 0.221439 | D to O | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4084 | R | 0.217385 | Q | 0.242585 | -0.0252 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4465 | S | 0.343571 | N | 0.289716 | 0.053855 | No Change: Both O | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32996 | R | 0.80553 | Q | 0.776384 | 0.029146 | No Change: Both D | Cardiomyopathy dilated type 1G (CMD1G) [MIM:604145] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 34306 | I | 0.438976 | N | 0.617853 | -0.178877 | O to D | Tardive tibial muscular dystrophy (TMD) [MIM:600334] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 34315 | L | 0.144004 | P | 0.248993 | -0.104989 | No Change: Both O | Tardive tibial muscular dystrophy (TMD) [MIM:600334] |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 60 | D | 0.371244 | Y | 0.23676 | 0.134484 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 115 | V | 0.529776 | M | 0.593608 | -0.063832 | No Change: Both D | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 360 | R | 0.874872 | T | 0.876505 | -0.001633 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 498 | V | 0.898616 | I | 0.886331 | 0.012285 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 799 | T | 0.728654 | M | 0.685258 | 0.043396 | No Change: Both D | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 811 | T | 0.657655 | I | 0.529456 | 0.128199 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 922 | R | 0.657075 | H | 0.612063 | 0.045012 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 937 | E | 0.554199 | D | 0.471607 | 0.082592 | D to O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1081 | A | 0.447567 | T | 0.48849 | -0.040923 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1137 | G | 0.319054 | R | 0.306969 | 0.012085 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1201 | K | 0.542883 | E | 0.57188 | -0.028997 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1202 | V | 0.540514 | A | 0.596125 | -0.055611 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1295 | S | 0.405655 | L | 0.223089 | 0.182566 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1345 | G | 0.306113 | D | 0.355392 | -0.049279 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1347 | A | 0.240949 | T | 0.266268 | -0.025319 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1350 | R | 0.189537 | H | 0.179773 | 0.009764 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1353 | V | 0.188291 | L | 0.191581 | -0.00329 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1393 | I | 0.563187 | V | 0.57538 | -0.012193 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1416 | R | 0.99232 | C | 0.986718 | 0.005602 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1441 | R | 0.906468 | P | 0.914003 | -0.007535 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1544 | I | 0.218436 | V | 0.254081 | -0.035645 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1572 | R | 0.495078 | Q | 0.497384 | -0.002306 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1658 | R | 0.594902 | G | 0.568603 | 0.026299 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1664 | R | 0.505611 | Q | 0.47694 | 0.028671 | D to O | An ovarian mucinous carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1692 | G | 0.687677 | D | 0.723657 | -0.03598 | No Change: Both D | A lung squamous cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1744 | P | 0.433056 | L | 0.291486 | 0.14157 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1772 | S | 0.25633 | G | 0.215939 | 0.040391 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1907 | T | 0.355044 | I | 0.234931 | 0.120113 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1998 | R | 0.929122 | H | 0.905593 | 0.023529 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2107 | P | 0.38774 | L | 0.216651 | 0.171089 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2118 | I | 0.285944 | T | 0.403187 | -0.117243 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2164 | A | 0.228858 | T | 0.251641 | -0.022783 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2240 | D | 0.402091 | Y | 0.250923 | 0.151168 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2392 | G | 0.525513 | S | 0.589062 | -0.063549 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2432 | L | 0.285951 | F | 0.260023 | 0.025928 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2610 | M | 0.426391 | I | 0.330504 | 0.095887 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2771 | I | 0.098611 | M | 0.138282 | -0.039671 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2823 | V | 0.382444 | F | 0.345657 | 0.036787 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2831 | S | 0.458829 | N | 0.389778 | 0.069051 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 2930 | V | 0.226808 | I | 0.205084 | 0.021724 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3154 | K | 0.428346 | R | 0.365429 | 0.062917 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3191 | Q | 0.264487 | E | 0.30987 | -0.045383 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3238 | P | 0.529779 | L | 0.375664 | 0.154115 | D to O | A bladder carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3250 | V | 0.482205 | G | 0.591514 | -0.109309 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3261 | V | 0.253201 | M | 0.305825 | -0.052624 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3367 | R | 0.381275 | Q | 0.406032 | -0.024757 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3482 | E | 0.73491 | K | 0.720155 | 0.014755 | No Change: Both D | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3491 | S | 0.669503 | P | 0.646771 | 0.022732 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3570 | E | 0.403512 | K | 0.39549 | 0.008022 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3590 | L | 0.380997 | V | 0.359848 | 0.021149 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3762 | I | 0.329919 | V | 0.336544 | -0.006625 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3877 | I | 0.675649 | F | 0.665191 | 0.010458 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3965 | I | 0.536802 | L | 0.591152 | -0.05435 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4238 | G | 0.635363 | W | 0.539395 | 0.095968 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4291 | I | 0.39068 | T | 0.528194 | -0.137514 | O to D | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4303 | G | 0.44828 | D | 0.492435 | -0.044155 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 4427 | D | 0.570084 | E | 0.611329 | -0.041245 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12310 | G | 0.398112 | E | 0.487802 | -0.08969 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12383 | R | 0.264624 | H | 0.244349 | 0.020275 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12469 | V | 0.208861 | A | 0.280321 | -0.07146 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12642 | R | 0.406897 | C | 0.310269 | 0.096628 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12657 | E | 0.42971 | K | 0.471222 | -0.041512 | No Change: Both O | A Wilms tumor |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12679 | K | 0.231963 | E | 0.237701 | -0.005738 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12720 | S | 0.352128 | F | 0.169663 | 0.182465 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 12798 | R | 0.374073 | C | 0.246629 | 0.127444 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13049 | E | 0.528505 | G | 0.441394 | 0.087111 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13083 | E | 0.510689 | K | 0.510182 | 5.07E-04 | No Change: Both D | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13096 | R | 0.219373 | L | 0.149912 | 0.069461 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13099 | Q | 0.273367 | R | 0.263834 | 0.009533 | No Change: Both O | A lung small cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13297 | V | 0.28638 | A | 0.330567 | -0.044187 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13399 | I | 0.331629 | M | 0.422763 | -0.091134 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13418 | A | 0.20706 | T | 0.236643 | -0.029583 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13428 | E | 0.320818 | V | 0.156621 | 0.164197 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13430 | I | 0.328582 | T | 0.464078 | -0.135496 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13434 | R | 0.301832 | K | 0.364618 | -0.062786 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13469 | D | 0.55595 | N | 0.549857 | 0.006093 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13495 | K | 0.430007 | N | 0.368778 | 0.061229 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13785 | N | 0.374784 | S | 0.415832 | -0.041048 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 13870 | Q | 0.201949 | H | 0.184863 | 0.017086 | No Change: Both O | A lung small cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 14109 | V | 0.62958 | I | 0.576122 | 0.053458 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 14131 | R | 0.207305 | Q | 0.196097 | 0.011208 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 14208 | P | 0.568381 | T | 0.496653 | 0.071728 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 14728 | L | 0.203317 | V | 0.208771 | -0.005454 | No Change: Both O | A lung adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 14999 | S | 0.794603 | T | 0.72861 | 0.065993 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15021 | N | 0.415843 | T | 0.41765 | -0.001807 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15520 | A | 0.464065 | V | 0.402967 | 0.061098 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15555 | R | 0.301008 | I | 0.171279 | 0.129729 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15620 | R | 0.485885 | Q | 0.464132 | 0.021753 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15629 | S | 0.421454 | I | 0.249503 | 0.171951 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15635 | Y | 0.31997 | C | 0.338557 | -0.018587 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15700 | R | 0.471057 | Q | 0.470691 | 3.66E-04 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15705 | L | 0.27599 | P | 0.433399 | -0.157409 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 15837 | I | 0.732374 | M | 0.812721 | -0.080347 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16058 | R | 0.331857 | H | 0.29418 | 0.037677 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16067 | K | 0.508771 | I | 0.309207 | 0.199564 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16090 | I | 0.322334 | T | 0.451725 | -0.129391 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16195 | R | 0.200076 | H | 0.181351 | 0.018725 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16409 | R | 0.383605 | C | 0.251932 | 0.131673 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16424 | R | 0.510184 | P | 0.542594 | -0.03241 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16629 | I | 0.918088 | M | 0.944066 | -0.025978 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16877 | K | 0.308984 | R | 0.264562 | 0.044422 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 17060 | N | 0.452793 | D | 0.475976 | -0.023183 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 17637 | I | 0.286666 | V | 0.322465 | -0.035799 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 17838 | R | 0.518224 | H | 0.471851 | 0.046373 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 17866 | D | 0.454867 | N | 0.431754 | 0.023113 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 17906 | G | 0.220599 | E | 0.272197 | -0.051598 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18094 | E | 0.61844 | A | 0.522086 | 0.096354 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18109 | G | 0.326482 | S | 0.36597 | -0.039488 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18164 | R | 0.194088 | T | 0.184378 | 0.00971 | No Change: Both O | An ovarian serous carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18221 | P | 0.474061 | L | 0.362798 | 0.111263 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18222 | A | 0.485039 | T | 0.530297 | -0.045258 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18726 | R | 0.860216 | Q | 0.846217 | 0.013999 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18835 | V | 0.312881 | A | 0.358365 | -0.045484 | No Change: Both O | A breast infiltrating ductal carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18881 | R | 0.330287 | K | 0.383773 | -0.053486 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 18939 | N | 0.345439 | S | 0.368123 | -0.022684 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19000 | R | 0.092777 | Q | 0.098323 | -0.005546 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19060 | L | 0.511205 | Q | 0.614526 | -0.103321 | No Change: Both D | A lung large cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19091 | R | 0.200071 | K | 0.243858 | -0.043787 | No Change: Both O | A lung large cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19224 | P | 0.34679 | S | 0.356396 | -0.009606 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19367 | T | 0.457675 | I | 0.323345 | 0.13433 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19392 | E | 0.423934 | K | 0.423578 | 3.56E-04 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19480 | A | 0.177136 | S | 0.241517 | -0.064381 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19495 | D | 0.408643 | G | 0.39782 | 0.010823 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19665 | R | 0.472193 | H | 0.466476 | 0.005717 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19762 | T | 0.327904 | I | 0.222332 | 0.105572 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19947 | G | 0.35574 | R | 0.333569 | 0.022171 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19956 | V | 0.176737 | M | 0.21183 | -0.035093 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 19992 | R | 0.170556 | Q | 0.174132 | -0.003576 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20057 | R | 0.303771 | C | 0.155631 | 0.14814 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20075 | S | 0.249423 | L | 0.132169 | 0.117254 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20179 | T | 0.499358 | K | 0.552441 | -0.053083 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20198 | A | 0.471935 | T | 0.498824 | -0.026889 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20198 | A | 0.471935 | V | 0.385145 | 0.08679 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20331 | R | 0.532978 | H | 0.475633 | 0.057345 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20408 | A | 0.472438 | T | 0.504879 | -0.032441 | O to D | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20564 | R | 0.180688 | K | 0.231317 | -0.050629 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20718 | V | 0.410588 | I | 0.363898 | 0.04669 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20726 | S | 0.422101 | P | 0.400086 | 0.022015 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20892 | T | 0.634806 | N | 0.655287 | -0.020481 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20894 | S | 0.533242 | R | 0.496871 | 0.036371 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21125 | D | 0.568027 | E | 0.574583 | -0.006556 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21403 | P | 0.542173 | S | 0.527947 | 0.014226 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21730 | R | 0.299815 | C | 0.169614 | 0.130201 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21747 | R | 0.476074 | Q | 0.498912 | -0.022838 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21851 | C | 0.365083 | R | 0.482784 | -0.117701 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21925 | G | 0.29458 | R | 0.275879 | 0.018701 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 21995 | R | 0.197535 | H | 0.165023 | 0.032512 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22045 | A | 0.308604 | V | 0.266099 | 0.042505 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22149 | R | 0.299005 | H | 0.295462 | 0.003543 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22160 | V | 0.246427 | I | 0.216353 | 0.030074 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22261 | I | 0.339321 | T | 0.441749 | -0.102428 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22306 | K | 0.305279 | N | 0.255871 | 0.049408 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22357 | R | 0.234009 | H | 0.204957 | 0.029052 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22408 | L | 0.50457 | P | 0.665462 | -0.160892 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22537 | Q | 0.307599 | H | 0.291866 | 0.015733 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22584 | P | 0.769882 | L | 0.648107 | 0.121775 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22646 | L | 0.430208 | P | 0.547052 | -0.116844 | O to D | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22670 | T | 0.558684 | A | 0.554827 | 0.003857 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22770 | A | 0.541844 | D | 0.605801 | -0.063957 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22801 | A | 0.196954 | T | 0.220636 | -0.023682 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22823 | R | 0.463325 | W | 0.267675 | 0.19565 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 22968 | E | 0.620479 | Q | 0.563851 | 0.056628 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23074 | P | 0.106677 | L | 0.05341 | 0.053267 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23079 | L | 0.072486 | F | 0.06611 | 0.006376 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23282 | D | 0.5582 | N | 0.556704 | 0.001496 | No Change: Both D | A breast infiltrating ductal carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23303 | H | 0.372703 | Y | 0.286815 | 0.085888 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23306 | R | 0.398808 | C | 0.246838 | 0.15197 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23515 | A | 0.436594 | S | 0.560635 | -0.124041 | O to D | A lung squamous cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23551 | E | 0.422972 | Q | 0.379601 | 0.043371 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23807 | S | 0.157376 | N | 0.135365 | 0.022011 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23872 | D | 0.278518 | N | 0.249125 | 0.029393 | No Change: Both O | An ovarian serous carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23891 | V | 0.230422 | A | 0.297192 | -0.06677 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23933 | Y | 0.384447 | H | 0.483419 | -0.098972 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23939 | T | 0.474523 | M | 0.411009 | 0.063514 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 23952 | F | 0.381747 | L | 0.441767 | -0.06002 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24098 | A | 0.408321 | G | 0.463768 | -0.055447 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24119 | N | 0.205156 | S | 0.249126 | -0.04397 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24133 | V | 0.28759 | I | 0.247034 | 0.040556 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24159 | V | 0.414027 | A | 0.465491 | -0.051464 | No Change: Both O | Neck squamous cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24239 | T | 0.344381 | A | 0.311231 | 0.03315 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24265 | E | 0.350658 | K | 0.373136 | -0.022478 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24584 | I | 0.253617 | T | 0.390436 | -0.136819 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24781 | I | 0.294358 | T | 0.408245 | -0.113887 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24799 | R | 0.236948 | H | 0.198263 | 0.038685 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24954 | D | 0.593218 | H | 0.528969 | 0.064249 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24980 | T | 0.467697 | M | 0.405645 | 0.062052 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25659 | R | 0.260254 | H | 0.256736 | 0.003518 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25679 | A | 0.525702 | T | 0.562263 | -0.036561 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25720 | P | 0.313101 | A | 0.222558 | 0.090543 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25821 | T | 0.495336 | K | 0.585296 | -0.08996 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25859 | E | 0.439855 | K | 0.436715 | 0.00314 | No Change: Both O | A metastatic melanoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25879 | N | 0.382328 | K | 0.468448 | -0.08612 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 25923 | A | 0.560059 | V | 0.493213 | 0.066846 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 26045 | V | 0.260491 | I | 0.229395 | 0.031096 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 26059 | K | 0.293577 | E | 0.309276 | -0.015699 | No Change: Both O | A lung small cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 26134 | I | 0.349634 | V | 0.410774 | -0.06114 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 26477 | R | 0.23875 | C | 0.135627 | 0.103123 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 26843 | D | 0.210644 | Y | 0.116331 | 0.094313 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27346 | K | 0.295805 | R | 0.218608 | 0.077197 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27652 | R | 0.152494 | C | 0.072767 | 0.079727 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27728 | G | 0.234873 | V | 0.142619 | 0.092254 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27754 | F | 0.184494 | L | 0.205839 | -0.021345 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27755 | I | 0.201834 | T | 0.333564 | -0.13173 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 27929 | I | 0.286224 | V | 0.315557 | -0.029333 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28132 | I | 0.369743 | L | 0.401629 | -0.031886 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28168 | R | 0.111898 | Q | 0.124476 | -0.012578 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28538 | R | 0.493188 | H | 0.493791 | -6.03E-04 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28572 | I | 0.066839 | T | 0.112785 | -0.045946 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28948 | A | 0.401581 | T | 0.451666 | -0.050085 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28986 | I | 0.190861 | V | 0.219851 | -0.02899 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28993 | G | 0.180972 | E | 0.223666 | -0.042694 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 28998 | L | 0.104397 | V | 0.100867 | 0.00353 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29070 | V | 0.292237 | M | 0.334105 | -0.041868 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29090 | I | 0.5588 | V | 0.556067 | 0.002733 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29419 | R | 0.513326 | C | 0.303069 | 0.210257 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29479 | L | 0.553162 | P | 0.729512 | -0.17635 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29880 | S | 0.355504 | L | 0.197301 | 0.158203 | No Change: Both O | A colorectal adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 29976 | D | 0.448519 | E | 0.46713 | -0.018611 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30042 | S | 0.443039 | G | 0.390048 | 0.052991 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30107 | R | 0.34221 | C | 0.182007 | 0.160203 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30125 | S | 0.107741 | F | 0.040422 | 0.067319 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30211 | L | 0.449772 | P | 0.600773 | -0.151001 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30412 | I | 0.233076 | T | 0.357193 | -0.124117 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30617 | T | 0.302591 | S | 0.359609 | -0.057018 | No Change: Both O | A renal chromophobe cancer sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30674 | T | 0.433599 | I | 0.304411 | 0.129188 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30809 | V | 0.419861 | I | 0.373722 | 0.046139 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30818 | F | 0.394326 | I | 0.375506 | 0.01882 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30825 | E | 0.275514 | K | 0.270603 | 0.004911 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30856 | I | 0.398634 | T | 0.528458 | -0.129824 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30887 | G | 0.493202 | D | 0.512573 | -0.019371 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30887 | G | 0.493202 | S | 0.526398 | -0.033196 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30897 | R | 0.321863 | H | 0.297393 | 0.02447 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30907 | R | 0.198247 | H | 0.17338 | 0.024867 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 30946 | R | 0.818718 | H | 0.786758 | 0.03196 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31081 | I | 0.115366 | F | 0.109164 | 0.006202 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31107 | R | 0.478875 | C | 0.320048 | 0.158827 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31124 | A | 0.527438 | G | 0.591396 | -0.063958 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31156 | N | 0.543265 | S | 0.595967 | -0.052702 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31246 | P | 0.894952 | T | 0.870953 | 0.023999 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31330 | R | 0.152595 | H | 0.141994 | 0.010601 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31690 | C | 0.340088 | R | 0.488661 | -0.148573 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31724 | R | 0.154193 | Q | 0.177354 | -0.023161 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31725 | V | 0.171641 | I | 0.156114 | 0.015527 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31732 | G | 0.300593 | S | 0.366499 | -0.065906 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 31886 | V | 0.272991 | I | 0.253185 | 0.019806 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32097 | R | 0.230471 | C | 0.108133 | 0.122338 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32171 | T | 0.69243 | N | 0.671619 | 0.020811 | No Change: Both D | A lung large cell carcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32248 | V | 0.180717 | I | 0.182493 | -0.001776 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32281 | Q | 0.086296 | H | 0.082374 | 0.003922 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32323 | R | 0.328962 | H | 0.327179 | 0.001783 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32411 | R | 0.267404 | W | 0.109179 | 0.158225 | No Change: Both O | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32558 | I | 0.217866 | V | 0.248336 | -0.03047 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32610 | M | 0.475543 | V | 0.400568 | 0.074975 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32637 | G | 0.162568 | V | 0.105499 | 0.057069 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32922 | V | 0.758536 | A | 0.765949 | -0.007413 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32943 | L | 0.606012 | R | 0.747067 | -0.141055 | No Change: Both D | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 32953 | R | 0.546537 | H | 0.442358 | 0.104179 | D to O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33213 | V | 0.978158 | L | 0.984741 | -0.006583 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33242 | R | 0.997583 | C | 0.995661 | 0.001922 | No Change: Both D | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33387 | T | 0.401602 | M | 0.331165 | 0.070437 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33419 | E | 0.822936 | D | 0.800364 | 0.022572 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33536 | V | 0.553845 | M | 0.595208 | -0.041363 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33568 | K | 0.709842 | Q | 0.710921 | -0.001079 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33616 | E | 0.997639 | K | 0.997857 | -2.18E-04 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33620 | P | 0.996075 | L | 0.991817 | 0.004258 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33886 | E | 0.953912 | V | 0.922788 | 0.031124 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33899 | I | 0.968469 | T | 0.978508 | -0.010039 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33904 | L | 0.977441 | P | 0.986708 | -0.009267 | No Change: Both D | A gastric adenocarcinoma sample |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 33955 | T | 0.840436 | I | 0.777849 | 0.062587 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 34115 | V | 0.604475 | A | 0.670032 | -0.065557 | No Change: Both D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 1249 | S | 0.41887 | L | 0.291718 | 0.127152 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3026 | N | 0.304089 | I | 0.159491 | 0.144598 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3419 | S | 0.319062 | N | 0.27707 | 0.041992 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 3637 | P | 0.106617 | S | 0.104359 | 0.002258 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 8288 | A | 0.297265 | V | 0.258178 | 0.039087 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 8474 | I | 0.190022 | T | 0.307176 | -0.117154 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 16575 | V | 0.335529 | M | 0.393185 | -0.057656 | No Change: Both O | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 20359 | R | 0.461966 | K | 0.515908 | -0.053942 | O to D | - |
| Q8WZ42 | TITIN_HUMAN Titin OS=Homo sapiens GN=TTN PE=1 SV=3 | 24098 | A | 0.408321 | T | 0.437771 | -0.02945 | No Change: Both O | - |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 101 | H | 0.229976 | Q | 0.244908 | -0.014932 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 192 | R | 0.14905 | H | 0.159155 | -0.010105 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 59 | R | 0.192757 | W | 0.077312 | 0.115445 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 120 | A | 0.051849 | T | 0.060241 | -0.008392 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 141 | E | 0.194789 | K | 0.180047 | 0.014742 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 221 | R | 0.470047 | W | 0.258613 | 0.211434 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 246 | G | 0.375409 | R | 0.357917 | 0.017492 | No Change: Both O | Ataxia with isolated vitamin E deficiency (AVED) [MIM:277460] |
| P49638 | TTPA_HUMAN Alpha-tocopherol transfer protein OS=Homo sapiens GN=TTPA PE=1 SV=1 | 172 | T | 0.297287 | S | 0.402249 | -0.104962 | No Change: Both O | - |
| Q9BTX7 | TTPAL_HUMAN Alpha-tocopherol transfer protein-like OS=Homo sapiens GN=TTPAL PE=2 SV=2 | 278 | A | 0.458149 | G | 0.528031 | -0.069882 | O to D | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 26 | G | 0.652811 | S | 0.68296 | -0.030149 | No Change: Both D | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 30 | C | 0.372487 | R | 0.518197 | -0.14571 | O to D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 38 | D | 0.188439 | E | 0.210209 | -0.02177 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 38 | D | 0.188439 | G | 0.182027 | 0.006412 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 40 | V | 0.221404 | I | 0.189689 | 0.031715 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 44 | P | 0.240593 | S | 0.268053 | -0.02746 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 50 | V | 0.162265 | A | 0.216924 | -0.054659 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 50 | V | 0.162265 | L | 0.15198 | 0.010285 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 50 | V | 0.162265 | M | 0.194829 | -0.032564 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 53 | F | 0.196979 | I | 0.194438 | 0.002541 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 53 | F | 0.196979 | L | 0.218145 | -0.021166 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 56 | A | 0.272867 | P | 0.334253 | -0.061386 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 62 | E | 0.447224 | G | 0.404057 | 0.043167 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 65 | A | 0.573317 | D | 0.641787 | -0.06847 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 65 | A | 0.573317 | T | 0.610324 | -0.037007 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 67 | G | 0.631225 | A | 0.598117 | 0.033108 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 67 | G | 0.631225 | R | 0.613621 | 0.017604 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 67 | G | 0.631225 | V | 0.526805 | 0.10442 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 69 | T | 0.737233 | A | 0.727861 | 0.009372 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 70 | S | 0.73758 | I | 0.588746 | 0.148834 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 70 | S | 0.73758 | R | 0.691608 | 0.045972 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 72 | S | 0.770477 | P | 0.74642 | 0.024057 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 74 | E | 0.774128 | G | 0.745749 | 0.028379 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 75 | L | 0.738655 | P | 0.811893 | -0.073238 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 78 | L | 0.603028 | H | 0.707596 | -0.104568 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 78 | L | 0.603028 | R | 0.689738 | -0.08671 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 79 | T | 0.548279 | K | 0.598896 | -0.050617 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 80 | T | 0.51178 | A | 0.465749 | 0.046031 | D to O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 81 | E | 0.499392 | K | 0.474374 | 0.025018 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 84 | F | 0.36435 | L | 0.402207 | -0.037857 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 88 | I | 0.253683 | L | 0.270118 | -0.016435 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 89 | Y | 0.236564 | H | 0.346606 | -0.110042 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 90 | K | 0.229567 | N | 0.181618 | 0.047949 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 91 | V | 0.234728 | A | 0.291931 | -0.057203 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 93 | I | 0.221889 | V | 0.244588 | -0.022699 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 94 | D | 0.225983 | H | 0.20857 | 0.017413 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 97 | S | 0.195709 | Y | 0.099902 | 0.095807 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 104 | I | 0.242743 | N | 0.419955 | -0.177212 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 104 | I | 0.242743 | S | 0.483459 | -0.240716 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 109 | E | 0.26513 | Q | 0.216043 | 0.049087 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 110 | H | 0.284943 | N | 0.293963 | -0.00902 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 111 | A | 0.306016 | S | 0.42137 | -0.115354 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 117 | A | 0.417688 | G | 0.482372 | -0.064684 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 121 | G | 0.433219 | S | 0.499098 | -0.065879 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 122 | P | 0.386765 | R | 0.373169 | 0.013596 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 124 | R | 0.333118 | C | 0.183132 | 0.149986 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 127 | I | 0.228427 | V | 0.259572 | -0.031145 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 129 | A | 0.214742 | T | 0.242996 | -0.028254 | No Change: Both O | Hyperthyroxinemia dystransthyretinemic euthyroidal (HTDE) [MIM:145680] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 131 | L | 0.268339 | M | 0.315742 | -0.047403 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 134 | Y | 0.327858 | C | 0.280538 | 0.04732 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 136 | Y | 0.345391 | S | 0.549052 | -0.203661 | O to D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 136 | Y | 0.345391 | V | 0.349776 | -0.004385 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 134 | Y | 0.327858 | H | 0.426522 | -0.098664 | No Change: Both O | Carpal tunnel syndrome type 1 (CTS1) [MIM:115430] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 139 | T | 0.413608 | M | 0.341738 | 0.07187 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 142 | V | 0.613692 | I | 0.585921 | 0.027771 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 48 | V | 0.181499 | M | 0.213828 | -0.032329 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 109 | E | 0.26513 | K | 0.254425 | 0.010705 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 32 | L | 0.213262 | P | 0.363301 | -0.150039 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 33 | M | 0.182986 | I | 0.124852 | 0.058134 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 43 | S | 0.246675 | N | 0.225689 | 0.020986 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 50 | V | 0.162265 | G | 0.23698 | -0.074715 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 53 | F | 0.196979 | C | 0.212963 | -0.015984 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 53 | F | 0.196979 | V | 0.234546 | -0.037567 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 54 | R | 0.221427 | T | 0.224183 | -0.002756 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 55 | K | 0.24322 | N | 0.212846 | 0.030374 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 58 | D | 0.327813 | A | 0.268198 | 0.059615 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 58 | D | 0.327813 | V | 0.196847 | 0.130966 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 61 | W | 0.417501 | L | 0.505278 | -0.087777 | O to D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 62 | E | 0.447224 | D | 0.439444 | 0.00778 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 64 | F | 0.537048 | S | 0.716512 | -0.179464 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 65 | A | 0.573317 | S | 0.667336 | -0.094019 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 67 | G | 0.631225 | E | 0.663874 | -0.032649 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 69 | T | 0.737233 | I | 0.649682 | 0.087551 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 73 | G | 0.756951 | E | 0.775309 | -0.018358 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 74 | E | 0.774128 | K | 0.76547 | 0.008658 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 75 | L | 0.738655 | Q | 0.806605 | -0.06795 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 81 | E | 0.499392 | G | 0.444002 | 0.05539 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 98 | Y | 0.188451 | F | 0.169723 | 0.018728 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 104 | I | 0.242743 | T | 0.38156 | -0.138817 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 114 | V | 0.355891 | A | 0.452403 | -0.096512 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 117 | A | 0.417688 | S | 0.533324 | -0.115636 | O to D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 124 | R | 0.333118 | H | 0.320336 | 0.012782 | No Change: Both O | - |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 126 | T | 0.244319 | N | 0.282662 | -0.038343 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 127 | I | 0.228427 | M | 0.319062 | -0.090635 | No Change: Both O | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 140 | A | 0.481334 | S | 0.610788 | -0.129454 | O to D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 142 | V | 0.613692 | A | 0.663608 | -0.049916 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| P02766 | TTHY_HUMAN Transthyretin OS=Homo sapiens GN=TTR PE=1 SV=1 | 144 | N | 0.739002 | S | 0.758069 | -0.019067 | No Change: Both D | Amyloidosis transthyretin-related (AMYL-TTR) [MIM:105210] |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 11 | P | 0.016102 | H | 0.013979 | 0.002123 | No Change: Both O | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 85 | H | 0.222056 | D | 0.24761 | -0.025554 | No Change: Both O | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 262 | A | 0.386326 | T | 0.389785 | -0.003459 | No Change: Both O | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 265 | S | 0.450793 | A | 0.357832 | 0.092961 | No Change: Both O | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 419 | T | 0.347691 | I | 0.216448 | 0.131243 | No Change: Both O | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 423 | D | 0.555801 | E | 0.542564 | 0.013237 | No Change: Both D | - |
| Q9BSA4 | TTYH2_HUMAN Protein tweety homolog 2 OS=Homo sapiens GN=TTYH2 PE=1 SV=3 | 409 | A | 0.120131 | E | 0.171553 | -0.051422 | No Change: Both O | - |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 447 | E | 0.976635 | K | 0.969056 | 0.007579 | No Change: Both D | - |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 188 | I | 0.3079 | L | 0.35569 | -0.04779 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 263 | P | 0.138967 | T | 0.10922 | 0.029747 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 264 | R | 0.121966 | C | 0.058019 | 0.063947 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 286 | L | 0.329052 | F | 0.304705 | 0.024347 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 402 | R | 0.094422 | C | 0.048209 | 0.046213 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 402 | R | 0.094422 | H | 0.097253 | -0.002831 | No Change: Both O | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q71U36 | TBA1A_HUMAN Tubulin alpha-1A chain OS=Homo sapiens GN=TUBA1A PE=1 SV=1 | 419 | S | 0.64158 | L | 0.570765 | 0.070815 | No Change: Both D | Lissencephaly type 3 (LIS3) [MIM:611603] |
| Q13748 | TBA3C_HUMAN Tubulin alpha-3C/D chain OS=Homo sapiens GN=TUBA3C PE=1 SV=3 | 440 | V | 0.920663 | M | 0.938057 | -0.017394 | No Change: Both D | - |
| Q13748 | TBA3C_HUMAN Tubulin alpha-3C/D chain OS=Homo sapiens GN=TUBA3C PE=1 SV=3 | 75 | V | 0.303797 | L | 0.293617 | 0.01018 | No Change: Both O | - |
| Q13748 | TBA3C_HUMAN Tubulin alpha-3C/D chain OS=Homo sapiens GN=TUBA3C PE=1 SV=3 | 392 | D | 0.16249 | V | 0.075827 | 0.086663 | No Change: Both O | - |
| Q6PEY2 | TBA3E_HUMAN Tubulin alpha-3E chain OS=Homo sapiens GN=TUBA3E PE=1 SV=2 | 101 | S | 0.511775 | N | 0.483369 | 0.028406 | D to O | - |
| Q6PEY2 | TBA3E_HUMAN Tubulin alpha-3E chain OS=Homo sapiens GN=TUBA3E PE=1 SV=2 | 126 | A | 0.133532 | V | 0.097766 | 0.035766 | No Change: Both O | - |
| Q6PEY2 | TBA3E_HUMAN Tubulin alpha-3E chain OS=Homo sapiens GN=TUBA3E PE=1 SV=2 | 402 | W | 0.035971 | R | 0.085357 | -0.049386 | No Change: Both O | - |
| Q6PEY2 | TBA3E_HUMAN Tubulin alpha-3E chain OS=Homo sapiens GN=TUBA3E PE=1 SV=2 | 162 | S | 0.602477 | G | 0.527243 | 0.075234 | No Change: Both D | - |
| Q6PEY2 | TBA3E_HUMAN Tubulin alpha-3E chain OS=Homo sapiens GN=TUBA3E PE=1 SV=2 | 449 | A | 0.922203 | E | 0.950602 | -0.028399 | No Change: Both D | - |
| Q9NY65 | TBA8_HUMAN Tubulin alpha-8 chain OS=Homo sapiens GN=TUBA8 PE=1 SV=1 | 301 | Q | 0.448671 | R | 0.441092 | 0.007579 | No Change: Both O | - |
| Q9NY65 | TBA8_HUMAN Tubulin alpha-8 chain OS=Homo sapiens GN=TUBA8 PE=1 SV=1 | 128 | A | 0.21088 | V | 0.157589 | 0.053291 | No Change: Both O | - |
| A6NHL2 | TBAL3_HUMAN Tubulin alpha chain-like 3 OS=Homo sapiens GN=TUBAL3 PE=1 SV=2 | 135 | Q | 0.33147 | H | 0.296206 | 0.035264 | No Change: Both O | - |
| A6NHL2 | TBAL3_HUMAN Tubulin alpha chain-like 3 OS=Homo sapiens GN=TUBAL3 PE=1 SV=2 | 250 | R | 0.255028 | W | 0.113499 | 0.141529 | No Change: Both O | - |
| Q9H4B7 | TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1 | 43 | Q | 0.333586 | H | 0.319182 | 0.014404 | No Change: Both O | - |
| Q9H4B7 | TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1 | 43 | Q | 0.333586 | P | 0.351576 | -0.01799 | No Change: Both O | - |
| Q9H4B7 | TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1 | 274 | T | 0.394708 | M | 0.384658 | 0.01005 | No Change: Both O | - |
| Q9H4B7 | TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1 | 307 | R | 0.215195 | H | 0.166365 | 0.04883 | No Change: Both O | - |
| Q9H4B7 | TBB1_HUMAN Tubulin beta-1 chain OS=Homo sapiens GN=TUBB1 PE=1 SV=1 | 318 | R | 0.168908 | W | 0.067876 | 0.101032 | No Change: Both O | Macrothrombocytopenia autosomal dominant TUBB1-related (MAD-TUBB1) [MIM:613112] |
| Q13885 | TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens GN=TUBB2A PE=1 SV=1 | 62 | R | 0.130245 | W | 0.052786 | 0.077459 | No Change: Both O | A colorectal cancer sample |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 172 | S | 0.565704 | P | 0.545156 | 0.020548 | No Change: Both D | Polymicrogyria asymmetric (PMGA) [MIM:610031] |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 201 | C | 0.195515 | S | 0.395898 | -0.200383 | No Change: Both O | - |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 210 | I | 0.045711 | T | 0.094518 | -0.048807 | No Change: Both O | Polymicrogyria asymmetric (PMGA) [MIM:610031] |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 228 | L | 0.30712 | P | 0.477408 | -0.170288 | No Change: Both O | Polymicrogyria asymmetric (PMGA) [MIM:610031] |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 265 | F | 0.176648 | L | 0.190017 | -0.013369 | No Change: Both O | Polymicrogyria asymmetric (PMGA) [MIM:610031] |
| Q9BVA1 | TBB2B_HUMAN Tubulin beta-2B chain OS=Homo sapiens GN=TUBB2B PE=1 SV=1 | 312 | T | 0.164676 | M | 0.176881 | -0.012205 | No Change: Both O | Polymicrogyria asymmetric (PMGA) [MIM:610031] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 62 | R | 0.20092 | Q | 0.21433 | -0.01341 | No Change: Both O | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 262 | R | 0.200899 | C | 0.109842 | 0.091057 | No Change: Both O | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 262 | R | 0.200899 | H | 0.176727 | 0.024172 | No Change: Both O | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 302 | A | 0.369071 | T | 0.387194 | -0.018123 | No Change: Both O | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 380 | R | 0.261502 | C | 0.143772 | 0.11773 | No Change: Both O | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 410 | E | 0.621818 | K | 0.591343 | 0.030475 | No Change: Both D | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 417 | D | 0.710432 | H | 0.676167 | 0.034265 | No Change: Both D | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 417 | D | 0.710432 | N | 0.704878 | 0.005554 | No Change: Both D | Congenital fibrosis of extraocular muscles type 3A (CFEOM3A) [MIM:600638] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 178 | T | 0.466375 | M | 0.413829 | 0.052546 | No Change: Both O | Cortical dysplasia complex with other brain malformations (CDCBM) [MIM:614039] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 205 | E | 0.104913 | K | 0.099662 | 0.005251 | No Change: Both O | Cortical dysplasia complex with other brain malformations (CDCBM) [MIM:614039] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 302 | A | 0.369071 | V | 0.28811 | 0.080961 | No Change: Both O | Cortical dysplasia complex with other brain malformations (CDCBM) [MIM:614039] |
| Q13509 | TBB3_HUMAN Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 | 323 | M | 0.513589 | V | 0.454255 | 0.059334 | D to O | Cortical dysplasia complex with other brain malformations (CDCBM) [MIM:614039] |
| P04350 | TBB4A_HUMAN Tubulin beta-4A chain OS=Homo sapiens GN=TUBB4A PE=1 SV=2 | 365 | A | 0.20334 | V | 0.139979 | 0.063361 | No Change: Both O | - |
| P04350 | TBB4A_HUMAN Tubulin beta-4A chain OS=Homo sapiens GN=TUBB4A PE=1 SV=2 | 155 | I | 0.355224 | M | 0.46888 | -0.113656 | No Change: Both O | - |
| Q3ZCM7 | TBB8_HUMAN Tubulin beta-8 chain OS=Homo sapiens GN=TUBB8 PE=1 SV=2 | 345 | L | 0.171167 | F | 0.169275 | 0.001892 | No Change: Both O | - |
| Q9UJT1 | TBD_HUMAN Tubulin delta chain OS=Homo sapiens GN=TUBD1 PE=1 SV=2 | 76 | M | 0.3889 | T | 0.421278 | -0.032378 | No Change: Both O | - |
| P23258 | TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens GN=TUBG1 PE=1 SV=2 | 413 | M | 0.638012 | V | 0.54117 | 0.096842 | No Change: Both D | - |
| Q9NRH3 | TBG2_HUMAN Tubulin gamma-2 chain OS=Homo sapiens GN=TUBG2 PE=1 SV=1 | 413 | M | 0.723724 | V | 0.64759 | 0.076134 | No Change: Both D | - |
| Q9BSJ2 | GCP2_HUMAN Gamma-tubulin complex component 2 OS=Homo sapiens GN=TUBGCP2 PE=1 SV=2 | 111 | A | 0.583104 | T | 0.597109 | -0.014005 | No Change: Both D | - |
| Q9BSJ2 | GCP2_HUMAN Gamma-tubulin complex component 2 OS=Homo sapiens GN=TUBGCP2 PE=1 SV=2 | 193 | I | 0.113395 | T | 0.193842 | -0.080447 | No Change: Both O | - |
| Q9BSJ2 | GCP2_HUMAN Gamma-tubulin complex component 2 OS=Homo sapiens GN=TUBGCP2 PE=1 SV=2 | 809 | A | 0.409203 | T | 0.431522 | -0.022319 | No Change: Both O | - |
| Q96CW5 | GCP3_HUMAN Gamma-tubulin complex component 3 OS=Homo sapiens GN=TUBGCP3 PE=1 SV=2 | 208 | T | 0.834016 | S | 0.870456 | -0.03644 | No Change: Both D | - |
| Q96RT8 | GCP5_HUMAN Gamma-tubulin complex component 5 OS=Homo sapiens GN=TUBGCP5 PE=1 SV=1 | 662 | E | 0.398414 | D | 0.382213 | 0.016201 | No Change: Both O | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 567 | L | 0.136296 | S | 0.274616 | -0.13832 | No Change: Both O | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 104 | L | 0.34393 | P | 0.497656 | -0.153726 | No Change: Both O | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 624 | I | 0.135395 | M | 0.186894 | -0.051499 | No Change: Both O | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 884 | A | 0.703608 | V | 0.624423 | 0.079185 | No Change: Both D | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 1232 | V | 0.619124 | M | 0.657513 | -0.038389 | No Change: Both D | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 1364 | S | 0.901093 | C | 0.824909 | 0.076184 | No Change: Both D | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 1377 | T | 0.952356 | A | 0.944908 | 0.007448 | No Change: Both D | - |
| Q96RT7 | GCP6_HUMAN Gamma-tubulin complex component 6 OS=Homo sapiens GN=TUBGCP6 PE=1 SV=3 | 1621 | V | 0.195054 | L | 0.181131 | 0.013923 | No Change: Both O | - |
| P49411 | EFTU_HUMAN Elongation factor Tu mitochondrial OS=Homo sapiens GN=TUFM PE=1 SV=2 | 336 | R | 0.413355 | Q | 0.396062 | 0.017293 | No Change: Both O | Combined oxidative phosphorylation deficiency type 4 (COXPD4) [MIM:610678] |
| Q9NNX1 | TUFT1_HUMAN Tuftelin OS=Homo sapiens GN=TUFT1 PE=2 SV=1 | 296 | K | 0.776257 | R | 0.75526 | 0.020997 | No Change: Both D | - |
| Q9NNX1 | TUFT1_HUMAN Tuftelin OS=Homo sapiens GN=TUFT1 PE=2 SV=1 | 18 | Q | 0.494541 | R | 0.478927 | 0.015614 | No Change: Both O | - |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 420 | R | 0.244042 | P | 0.273366 | -0.029324 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 459 | I | 0.337209 | K | 0.525961 | -0.188752 | O to D | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 491 | F | 0.272437 | L | 0.302238 | -0.029801 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 67 | T | 0.993858 | R | 0.995448 | -0.00159 | No Change: Both D | - |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 245 | A | 0.987762 | V | 0.983289 | 0.004473 | No Change: Both D | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 259 | I | 0.994677 | T | 0.9971 | -0.002423 | No Change: Both D | - |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 261 | K | 0.994887 | T | 0.99263 | 0.002257 | No Change: Both D | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 378 | R | 0.231516 | H | 0.209203 | 0.022313 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 454 | T | 0.271993 | M | 0.245325 | 0.026668 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 489 | K | 0.301443 | R | 0.250741 | 0.050702 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 496 | A | 0.193861 | T | 0.216979 | -0.023118 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 261 | K | 0.994887 | N | 0.992748 | 0.002139 | No Change: Both D | - |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 382 | F | 0.33896 | S | 0.526381 | -0.187421 | O to D | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 368 | G | 0.434091 | W | 0.218461 | 0.21563 | No Change: Both O | Leber congenital amaurosis type 15 (LCA15) [MIM:613843] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 400 | R | 0.268607 | W | 0.124977 | 0.14363 | No Change: Both O | Leber congenital amaurosis type 15 (LCA15) [MIM:613843] |
| O00294 | TULP1_HUMAN Tubby-related protein 1 OS=Homo sapiens GN=TULP1 PE=1 SV=3 | 482 | R | 0.283051 | W | 0.132238 | 0.150813 | No Change: Both O | Retinitis pigmentosa type 14 (RP14) [MIM:600132] |
| O00295 | TULP2_HUMAN Tubby-related protein 2 OS=Homo sapiens GN=TULP2 PE=2 SV=2 | 245 | E | 0.901515 | K | 0.894226 | 0.007289 | No Change: Both D | - |
| O00295 | TULP2_HUMAN Tubby-related protein 2 OS=Homo sapiens GN=TULP2 PE=2 SV=2 | 251 | D | 0.852072 | N | 0.82766 | 0.024412 | No Change: Both D | - |
| O00295 | TULP2_HUMAN Tubby-related protein 2 OS=Homo sapiens GN=TULP2 PE=2 SV=2 | 18 | A | 0.779783 | T | 0.798531 | -0.018748 | No Change: Both D | - |
| O00295 | TULP2_HUMAN Tubby-related protein 2 OS=Homo sapiens GN=TULP2 PE=2 SV=2 | 122 | G | 0.57149 | S | 0.636959 | -0.065469 | No Change: Both D | - |
| O00295 | TULP2_HUMAN Tubby-related protein 2 OS=Homo sapiens GN=TULP2 PE=2 SV=2 | 149 | V | 0.861154 | I | 0.838839 | 0.022315 | No Change: Both D | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 214 | G | 0.211179 | S | 0.260809 | -0.04963 | No Change: Both O | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 522 | S | 0.88809 | N | 0.854112 | 0.033978 | No Change: Both D | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 979 | D | 0.777425 | N | 0.786849 | -0.009424 | No Change: Both D | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 1084 | V | 0.818533 | I | 0.799071 | 0.019462 | No Change: Both D | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 1281 | P | 0.886985 | T | 0.835771 | 0.051214 | No Change: Both D | - |
| Q9NRJ4 | TULP4_HUMAN Tubby-related protein 4 OS=Homo sapiens GN=TULP4 PE=2 SV=2 | 199 | R | 0.136788 | S | 0.178469 | -0.041681 | No Change: Both O | - |
| Q2TAM9 | TUSC1_HUMAN Tumor suppressor candidate gene 1 protein OS=Homo sapiens GN=TUSC1 PE=1 SV=3 | 123 | N | 0.969216 | D | 0.96513 | 0.004086 | No Change: Both D | - |
| Q13454 | TUSC3_HUMAN Tumor suppressor candidate 3 OS=Homo sapiens GN=TUSC3 PE=1 SV=1 | 65 | I | 0.432481 | V | 0.457671 | -0.02519 | No Change: Both O | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 3 | H | 0.853415 | Y | 0.796224 | 0.057191 | No Change: Both D | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 15 | P | 0.767058 | S | 0.766923 | 1.35E-04 | No Change: Both D | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 18 | A | 0.716838 | T | 0.723006 | -0.006168 | No Change: Both D | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 20 | F | 0.695488 | S | 0.849387 | -0.153899 | No Change: Both D | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 34 | E | 0.779595 | D | 0.768859 | 0.010736 | No Change: Both D | - |
| Q8IXB3 | TUSC5_HUMAN Tumor suppressor candidate 5 OS=Homo sapiens GN=TUSC5 PE=2 SV=2 | 57 | S | 0.852655 | G | 0.816558 | 0.036097 | No Change: Both D | - |
| Q9H6E5 | STPAP_HUMAN Speckle targeted PIP5K1A-regulated poly(A) polymerase OS=Homo sapiens GN=TUT1 PE=1 SV=2 | 442 | L | 0.077433 | F | 0.064243 | 0.01319 | No Change: Both O | - |
| Q6IBS0 | TWF2_HUMAN Twinfilin-2 OS=Homo sapiens GN=TWF2 PE=1 SV=2 | 72 | R | 0.159301 | C | 0.088422 | 0.070879 | No Change: Both O | - |
| Q6IBS0 | TWF2_HUMAN Twinfilin-2 OS=Homo sapiens GN=TWF2 PE=1 SV=2 | 76 | Q | 0.249346 | R | 0.232294 | 0.017052 | No Change: Both O | - |
| Q6IBS0 | TWF2_HUMAN Twinfilin-2 OS=Homo sapiens GN=TWF2 PE=1 SV=2 | 103 | A | 0.188327 | T | 0.210708 | -0.022381 | No Change: Both O | A lung neuroendocrine carcinoma sample |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 119 | Q | 0.708152 | P | 0.713007 | -0.004855 | No Change: Both D | Saethre-Chotzen syndrome (SCS) [MIM:101400] |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 131 | L | 0.280946 | P | 0.432382 | -0.151436 | No Change: Both O | Saethre-Chotzen syndrome (SCS) [MIM:101400] |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 31 | S | 0.9985 | G | 0.998118 | 3.82E-04 | No Change: Both D | - |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 84 | G | 0.991582 | S | 0.992474 | -8.92E-04 | No Change: Both D | - |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 156 | I | 0.078446 | V | 0.089639 | -0.011193 | No Change: Both O | Saethre-Chotzen syndrome (SCS) [MIM:101400] |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 186 | A | 0.173597 | T | 0.175451 | -0.001854 | No Change: Both O | Craniosynostosis type 1 (CRS1) [MIM:123100] |
| Q15672 | TWST1_HUMAN Twist-related protein 1 OS=Homo sapiens GN=TWIST1 PE=1 SV=1 | 188 | S | 0.166252 | L | 0.066903 | 0.099349 | No Change: Both O | Craniosynostosis type 1 (CRS1) [MIM:123100] |
| P42681 | TXK_HUMAN Tyrosine-protein kinase TXK OS=Homo sapiens GN=TXK PE=1 SV=3 | 45 | R | 0.924844 | H | 0.886845 | 0.037999 | No Change: Both D | - |
| P42681 | TXK_HUMAN Tyrosine-protein kinase TXK OS=Homo sapiens GN=TXK PE=1 SV=3 | 336 | R | 0.085458 | Q | 0.099863 | -0.014405 | No Change: Both O | - |
| P42681 | TXK_HUMAN Tyrosine-protein kinase TXK OS=Homo sapiens GN=TXK PE=1 SV=3 | 63 | R | 0.951158 | C | 0.917169 | 0.033989 | No Change: Both D | - |
| Q8N3L3 | TXLNB_HUMAN Beta-taxilin OS=Homo sapiens GN=TXLNB PE=1 SV=3 | 11 | A | 0.990987 | T | 0.992625 | -0.001638 | No Change: Both D | - |
| Q8N3L3 | TXLNB_HUMAN Beta-taxilin OS=Homo sapiens GN=TXLNB PE=1 SV=3 | 348 | V | 0.61342 | M | 0.669616 | -0.056196 | No Change: Both D | - |
| Q8N3L3 | TXLNB_HUMAN Beta-taxilin OS=Homo sapiens GN=TXLNB PE=1 SV=3 | 527 | I | 0.932311 | T | 0.953337 | -0.021026 | No Change: Both D | - |
| Q8N3L3 | TXLNB_HUMAN Beta-taxilin OS=Homo sapiens GN=TXLNB PE=1 SV=3 | 602 | A | 0.951894 | P | 0.964206 | -0.012312 | No Change: Both D | - |
| Q9NUQ3 | TXLNG_HUMAN Gamma-taxilin OS=Homo sapiens GN=TXLNG PE=1 SV=2 | 246 | I | 0.835922 | V | 0.807482 | 0.02844 | No Change: Both D | - |
| Q6PKC3 | TXD11_HUMAN Thioredoxin domain-containing protein 11 OS=Homo sapiens GN=TXNDC11 PE=1 SV=2 | 783 | V | 0.316792 | L | 0.334053 | -0.017261 | No Change: Both O | - |
| Q96J42 | TXD15_HUMAN Thioredoxin domain-containing protein 15 OS=Homo sapiens GN=TXNDC15 PE=1 SV=1 | 248 | S | 0.531603 | P | 0.491042 | 0.040561 | D to O | A breast cancer sample |
| Q9P2K2 | TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens GN=TXNDC16 PE=2 SV=4 | 486 | E | 0.18398 | K | 0.194674 | -0.010694 | No Change: Both O | - |
| Q9P2K2 | TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens GN=TXNDC16 PE=2 SV=4 | 136 | S | 0.068174 | N | 0.059331 | 0.008843 | No Change: Both O | - |
| Q9P2K2 | TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens GN=TXNDC16 PE=2 SV=4 | 152 | N | 0.405967 | Y | 0.236632 | 0.169335 | No Change: Both O | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 341 | E | 0.995222 | K | 0.995148 | 7.40E-05 | No Change: Both D | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 357 | G | 0.996765 | D | 0.997323 | -5.58E-04 | No Change: Both D | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 461 | A | 0.562131 | T | 0.571716 | -0.009585 | No Change: Both D | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 487 | R | 0.098594 | T | 0.091267 | 0.007327 | No Change: Both O | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 225 | A | 0.988469 | P | 0.993329 | -0.00486 | No Change: Both D | - |
| Q86VQ3 | TXND2_HUMAN Thioredoxin domain-containing protein 2 OS=Homo sapiens GN=TXNDC2 PE=1 SV=4 | 314 | I | 0.993695 | L | 0.993748 | -5.30E-05 | No Change: Both D | - |
| Q8N427 | TXND3_HUMAN Thioredoxin domain-containing protein 3 OS=Homo sapiens GN=TXNDC3 PE=1 SV=2 | 208 | C | 0.185196 | R | 0.332908 | -0.147712 | No Change: Both O | - |
| Q8N427 | TXND3_HUMAN Thioredoxin domain-containing protein 3 OS=Homo sapiens GN=TXNDC3 PE=1 SV=2 | 43 | R | 0.091453 | K | 0.12043 | -0.028977 | No Change: Both O | - |
| Q8N427 | TXND3_HUMAN Thioredoxin domain-containing protein 3 OS=Homo sapiens GN=TXNDC3 PE=1 SV=2 | 289 | I | 0.42297 | T | 0.558853 | -0.135883 | O to D | A breast cancer sample |
| Q8N427 | TXND3_HUMAN Thioredoxin domain-containing protein 3 OS=Homo sapiens GN=TXNDC3 PE=1 SV=2 | 493 | I | 0.352987 | T | 0.488058 | -0.135071 | No Change: Both O | - |
| Q6A555 | TXND8_HUMAN Thioredoxin domain-containing protein 8 OS=Homo sapiens GN=TXNDC8 PE=1 SV=2 | 60 | N | 0.341628 | H | 0.310328 | 0.0313 | No Change: Both O | - |
| O14530 | TXND9_HUMAN Thioredoxin domain-containing protein 9 OS=Homo sapiens GN=TXNDC9 PE=1 SV=2 | 2 | E | 0.712886 | G | 0.708716 | 0.00417 | No Change: Both D | - |
| O14530 | TXND9_HUMAN Thioredoxin domain-containing protein 9 OS=Homo sapiens GN=TXNDC9 PE=1 SV=2 | 14 | L | 0.601813 | Q | 0.734623 | -0.13281 | No Change: Both D | - |
| O14530 | TXND9_HUMAN Thioredoxin domain-containing protein 9 OS=Homo sapiens GN=TXNDC9 PE=1 SV=2 | 38 | Q | 0.92524 | R | 0.913605 | 0.011635 | No Change: Both D | - |
| Q9H3M7 | TXNIP_HUMAN Thioredoxin-interacting protein OS=Homo sapiens GN=TXNIP PE=1 SV=1 | 177 | R | 0.435013 | Q | 0.398196 | 0.036817 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 684 | I | 0.240339 | S | 0.459402 | -0.219063 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 4 | R | 0.760836 | H | 0.757313 | 0.003523 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 197 | R | 0.180681 | H | 0.191821 | -0.01114 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 362 | V | 0.610822 | F | 0.606673 | 0.004149 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 363 | G | 0.618261 | S | 0.648287 | -0.030026 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 4 | R | 0.760836 | C | 0.574017 | 0.186819 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 81 | A | 0.108496 | V | 0.07399 | 0.034506 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 442 | R | 0.220909 | Q | 0.225695 | -0.004786 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 820 | P | 0.726353 | H | 0.708056 | 0.018297 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 386 | V | 0.11455 | M | 0.136409 | -0.021859 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 703 | R | 0.243752 | W | 0.106422 | 0.13733 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 732 | H | 0.227258 | R | 0.235673 | -0.008415 | No Change: Both O | A colorectal adenocarcinoma sample |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 928 | A | 0.266724 | V | 0.203072 | 0.063652 | No Change: Both O | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 1104 | P | 0.655094 | A | 0.56299 | 0.092104 | No Change: Both D | - |
| P29597 | TYK2_HUMAN Non-receptor tyrosine-protein kinase TYK2 OS=Homo sapiens GN=TYK2 PE=1 SV=3 | 1163 | E | 0.185495 | G | 0.143586 | 0.041909 | No Change: Both O | - |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 145 | G | 0.383917 | R | 0.364477 | 0.01944 | No Change: Both O | Mitochondrial DNA depletion syndrome type 1 (MTDPS1) [MIM:603041] |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 153 | G | 0.500112 | S | 0.532652 | -0.03254 | No Change: Both D | Mitochondrial DNA depletion syndrome type 1 (MTDPS1) [MIM:603041] |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 222 | K | 0.359246 | R | 0.280523 | 0.078723 | No Change: Both O | Mitochondrial DNA depletion syndrome type 1 (MTDPS1) [MIM:603041] |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 289 | E | 0.299636 | A | 0.220563 | 0.079073 | No Change: Both O | Mitochondrial DNA depletion syndrome type 1 (MTDPS1) [MIM:603041] |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 471 | S | 0.848505 | L | 0.764936 | 0.083569 | No Change: Both D | - |
| P19971 | TYPH_HUMAN Thymidine phosphorylase OS=Homo sapiens GN=TYMP PE=1 SV=2 | 44 | R | 0.687582 | Q | 0.68683 | 7.52E-04 | No Change: Both D | Mitochondrial DNA depletion syndrome type 1 (MTDPS1) [MIM:603041] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 19 | H | 0.306554 | Q | 0.339438 | -0.032884 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 21 | P | 0.360643 | S | 0.409686 | -0.049043 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 42 | D | 0.776071 | G | 0.799545 | -0.023474 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 47 | G | 0.795308 | D | 0.804357 | -0.009049 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 52 | R | 0.73545 | I | 0.606118 | 0.129332 | No Change: Both D | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 55 | C | 0.617748 | Y | 0.553792 | 0.063956 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 77 | R | 0.413899 | Q | 0.434827 | -0.020928 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 77 | R | 0.413899 | W | 0.247734 | 0.166165 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 80 | W | 0.338851 | R | 0.563622 | -0.224771 | O to D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 81 | P | 0.313541 | L | 0.176644 | 0.136897 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 89 | C | 0.189129 | R | 0.299843 | -0.110714 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 97 | G | 0.208553 | R | 0.207085 | 0.001468 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 176 | F | 0.019185 | I | 0.020703 | -0.001518 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 192 | S | 0.205625 | Y | 0.091582 | 0.114043 | No Change: Both O | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 206 | A | 0.178602 | T | 0.184613 | -0.006011 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 216 | L | 0.064373 | M | 0.077392 | -0.013019 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 217 | R | 0.088459 | G | 0.087312 | 0.001147 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 217 | R | 0.088459 | W | 0.034972 | 0.053487 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 217 | R | 0.088459 | Q | 0.098465 | -0.010006 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 253 | G | 0.457379 | R | 0.42803 | 0.029349 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 275 | V | 0.337026 | F | 0.38655 | -0.049524 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 289 | C | 0.734399 | R | 0.796157 | -0.061758 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 299 | R | 0.836467 | H | 0.817821 | 0.018646 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 299 | R | 0.836467 | S | 0.855654 | -0.019187 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 312 | L | 0.79646 | V | 0.78011 | 0.01635 | No Change: Both D | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 313 | P | 0.779298 | R | 0.767783 | 0.011515 | No Change: Both D | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 325 | T | 0.515727 | A | 0.496675 | 0.019052 | D to O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 339 | S | 0.384455 | G | 0.317665 | 0.06679 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 340 | F | 0.374464 | L | 0.399611 | -0.025147 | No Change: Both O | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 355 | A | 0.514157 | P | 0.568211 | -0.054054 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 371 | N | 0.310917 | T | 0.281345 | 0.029572 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 373 | T | 0.393771 | K | 0.476848 | -0.083077 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 380 | S | 0.444369 | P | 0.414349 | 0.03002 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 382 | N | 0.370379 | K | 0.415012 | -0.044633 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 383 | D | 0.322291 | N | 0.322647 | -3.56E-04 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 390 | H | 0.071161 | D | 0.084701 | -0.01354 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 395 | S | 0.116661 | N | 0.098343 | 0.018318 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 402 | R | 0.177189 | Q | 0.189668 | -0.012479 | No Change: Both O | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 403 | R | 0.219446 | S | 0.259745 | -0.040299 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 403 | R | 0.219446 | S | 0.259745 | -0.040299 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 404 | H | 0.248838 | P | 0.293046 | -0.044208 | No Change: Both O | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 406 | P | 0.320634 | L | 0.19081 | 0.129824 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 406 | P | 0.320634 | L | 0.19081 | 0.129824 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 419 | G | 0.513194 | R | 0.514727 | -0.001533 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 422 | R | 0.416445 | Q | 0.438494 | -0.022049 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 422 | R | 0.416445 | Q | 0.438494 | -0.022049 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 446 | G | 0.387614 | S | 0.479645 | -0.092031 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 448 | D | 0.424295 | N | 0.379303 | 0.044992 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 152 | P | 0.191751 | S | 0.230787 | -0.039036 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 288 | L | 0.716095 | S | 0.823968 | -0.107873 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 294 | E | 0.785422 | K | 0.768091 | 0.017331 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 294 | E | 0.785422 | K | 0.768091 | 0.017331 | No Change: Both D | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 328 | E | 0.575912 | Q | 0.560778 | 0.015134 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 346 | G | 0.369414 | E | 0.430674 | -0.06126 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 355 | A | 0.514157 | E | 0.559487 | -0.04533 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 361 | S | 0.547109 | R | 0.472079 | 0.07503 | D to O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 367 | H | 0.33227 | Y | 0.220154 | 0.112116 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 370 | M | 0.290299 | T | 0.330139 | -0.03984 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 371 | N | 0.310917 | Y | 0.191517 | 0.1194 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 393 | V | 0.083197 | F | 0.082386 | 8.11E-04 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 402 | R | 0.177189 | G | 0.169765 | 0.007424 | No Change: Both O | Albinism oculocutaneous type 1B (OCA1B) [MIM:606952] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 431 | P | 0.126362 | L | 0.061542 | 0.06482 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 289 | C | 0.734399 | G | 0.776417 | -0.042018 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 400 | W | 0.169561 | L | 0.245499 | -0.075938 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 308 | R | 0.850078 | T | 0.83415 | 0.015928 | No Change: Both D | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 36 | C | 0.540345 | Y | 0.49081 | 0.049535 | D to O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 44 | S | 0.782329 | G | 0.737168 | 0.045161 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 44 | S | 0.782329 | R | 0.745466 | 0.036863 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 47 | G | 0.795308 | V | 0.673464 | 0.121844 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 68 | Q | 0.441888 | H | 0.373287 | 0.068601 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 79 | S | 0.375671 | L | 0.20009 | 0.175581 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 109 | G | 0.134411 | R | 0.134983 | -5.72E-04 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 155 | T | 0.243179 | S | 0.32977 | -0.086591 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 177 | V | 0.017801 | F | 0.015741 | 0.00206 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 179 | M | 0.022641 | L | 0.016736 | 0.005905 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 180 | H | 0.025695 | N | 0.029117 | -0.003422 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 199 | D | 0.188521 | N | 0.165942 | 0.022579 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 201 | A | 0.174865 | S | 0.24824 | -0.073375 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 205 | P | 0.195353 | T | 0.147449 | 0.047904 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 217 | R | 0.088459 | S | 0.108997 | -0.020538 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 236 | W | 0.077912 | L | 0.104899 | -0.026987 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 236 | W | 0.077912 | S | 0.219204 | -0.141292 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 239 | R | 0.105685 | W | 0.04694 | 0.058745 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 240 | D | 0.127826 | V | 0.055464 | 0.072362 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 243 | K | 0.18164 | T | 0.143023 | 0.038617 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 256 | H | 0.557747 | Y | 0.460739 | 0.097008 | D to O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 272 | W | 0.317233 | C | 0.479888 | -0.162655 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 294 | E | 0.785422 | G | 0.759207 | 0.026215 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 318 | V | 0.651478 | E | 0.817336 | -0.165858 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 329 | S | 0.576393 | P | 0.550064 | 0.026329 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 332 | M | 0.572567 | T | 0.611092 | -0.038525 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 345 | E | 0.385293 | G | 0.355084 | 0.030209 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 378 | Q | 0.505112 | K | 0.535978 | -0.030866 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 395 | S | 0.116661 | R | 0.095482 | 0.021179 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 398 | E | 0.146496 | A | 0.096968 | 0.049528 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 398 | E | 0.146496 | V | 0.068488 | 0.078008 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 402 | R | 0.177189 | L | 0.105721 | 0.071468 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 404 | H | 0.248838 | N | 0.264472 | -0.015634 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 405 | R | 0.258864 | L | 0.165834 | 0.09303 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 408 | Q | 0.4273 | H | 0.426976 | 3.24E-04 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 409 | E | 0.443489 | D | 0.399478 | 0.044011 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 416 | A | 0.502587 | S | 0.604476 | -0.101889 | No Change: Both D | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 417 | P | 0.533342 | H | 0.496401 | 0.036941 | D to O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 424 | S | 0.28273 | F | 0.136119 | 0.146611 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 426 | M | 0.19949 | K | 0.300505 | -0.101015 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 427 | V | 0.158873 | G | 0.268949 | -0.110076 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 434 | R | 0.142265 | I | 0.082386 | 0.059879 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 435 | N | 0.169681 | D | 0.201413 | -0.031732 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 439 | F | 0.248429 | V | 0.253734 | -0.005305 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 444 | D | 0.36855 | G | 0.336292 | 0.032258 | No Change: Both O | Albinism oculocutaneous type 1A (OCA1A) [MIM:203100] |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 134 | F | 0.261882 | C | 0.237386 | 0.024496 | No Change: Both O | - |
| P14679 | TYRO_HUMAN Tyrosinase OS=Homo sapiens GN=TYR PE=1 SV=3 | 142 | K | 0.206047 | N | 0.173838 | 0.032209 | No Change: Both O | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 831 | A | 0.820767 | T | 0.833891 | -0.013124 | No Change: Both D | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 21 | P | 0.955336 | L | 0.924714 | 0.030622 | No Change: Both D | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 346 | I | 0.294124 | N | 0.42497 | -0.130846 | No Change: Both O | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 542 | G | 0.472686 | S | 0.546039 | -0.073353 | O to D | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 815 | A | 0.725619 | V | 0.656506 | 0.069113 | No Change: Both D | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 819 | L | 0.742423 | M | 0.778824 | -0.036401 | No Change: Both D | - |
| Q06418 | TYRO3_HUMAN Tyrosine-protein kinase receptor TYRO3 OS=Homo sapiens GN=TYRO3 PE=1 SV=1 | 824 | R | 0.784245 | G | 0.799538 | -0.015293 | No Change: Both D | - |
| O43914 | TYOBP_HUMAN TYRO protein tyrosine kinase-binding protein OS=Homo sapiens GN=TYROBP PE=1 SV=1 | 111 | Y | 0.805572 | H | 0.82671 | -0.021138 | No Change: Both D | - |
| P17643 | TYRP1_HUMAN 5 6-dihydroxyindole-2-carboxylic acid oxidase OS=Homo sapiens GN=TYRP1 PE=1 SV=2 | 326 | R | 0.573824 | H | 0.501363 | 0.072461 | No Change: Both D | - |
| P17643 | TYRP1_HUMAN 5 6-dihydroxyindole-2-carboxylic acid oxidase OS=Homo sapiens GN=TYRP1 PE=1 SV=2 | 356 | R | 0.563538 | Q | 0.577331 | -0.013793 | No Change: Both D | Albinism oculocutaneous type 3 (OCA3) [MIM:203290] |
| Q2T9J0 | TYSD1_HUMAN Peroxisomal leader peptide-processing protease OS=Homo sapiens GN=TYSND1 PE=2 SV=3 | 65 | T | 0.203033 | A | 0.205165 | -0.002132 | No Change: Both O | - |
| Q9NV66 | TYW1_HUMAN tRNA wybutosine-synthesizing protein 1 homolog OS=Homo sapiens GN=TYW1 PE=1 SV=2 | 462 | G | 0.376747 | V | 0.259953 | 0.116794 | No Change: Both O | - |
| Q9NV66 | TYW1_HUMAN tRNA wybutosine-synthesizing protein 1 homolog OS=Homo sapiens GN=TYW1 PE=1 SV=2 | 632 | H | 0.10105 | R | 0.097084 | 0.003966 | No Change: Both O | - |
| Q9NV66 | TYW1_HUMAN tRNA wybutosine-synthesizing protein 1 homolog OS=Homo sapiens GN=TYW1 PE=1 SV=2 | 671 | D | 0.034637 | N | 0.034302 | 3.35E-04 | No Change: Both O | - |
| Q6IPR3 | TYW3_HUMAN tRNA wybutosine-synthesizing protein 3 homolog OS=Homo sapiens GN=TYW3 PE=2 SV=2 | 110 | R | 0.162922 | Q | 0.195249 | -0.032327 | No Change: Both O | - |
| Q6IPR3 | TYW3_HUMAN tRNA wybutosine-synthesizing protein 3 homolog OS=Homo sapiens GN=TYW3 PE=2 SV=2 | 121 | M | 0.26009 | V | 0.208821 | 0.051269 | No Change: Both O | - |
| A2RUC4 | TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens GN=TYW5 PE=1 SV=1 | 50 | S | 0.276704 | G | 0.243656 | 0.033048 | No Change: Both O | - |
| Q9BZF9 | UACA_HUMAN Uveal autoantigen with coiled-coil domains and ankyrin repeats OS=Homo sapiens GN=UACA PE=1 SV=2 | 814 | I | 0.680955 | T | 0.758126 | -0.077171 | No Change: Both D | - |
| Q16222 | UAP1_HUMAN UDP-N-acetylhexosamine pyrophosphorylase OS=Homo sapiens GN=UAP1 PE=1 SV=3 | 418 | P | 0.694288 | H | 0.690667 | 0.003621 | No Change: Both D | - |
| Q3KQV9 | UAP1L_HUMAN UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 OS=Homo sapiens GN=UAP1L1 PE=2 SV=2 | 319 | A | 0.477943 | V | 0.37801 | 0.099933 | No Change: Both O | - |
| Q3KQV9 | UAP1L_HUMAN UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 OS=Homo sapiens GN=UAP1L1 PE=2 SV=2 | 373 | P | 0.480461 | S | 0.476975 | 0.003486 | No Change: Both O | - |
| P22314 | UBA1_HUMAN Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1 PE=1 SV=3 | 447 | R | 0.385182 | H | 0.367743 | 0.017439 | No Change: Both O | - |
| P22314 | UBA1_HUMAN Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1 PE=1 SV=3 | 539 | M | 0.375229 | I | 0.302669 | 0.07256 | No Change: Both O | Spinal muscular atrophy X-linked type 2 (SMAX2) [MIM:301830] |
| P22314 | UBA1_HUMAN Ubiquitin-like modifier-activating enzyme 1 OS=Homo sapiens GN=UBA1 PE=1 SV=3 | 547 | S | 0.506445 | G | 0.466613 | 0.039832 | D to O | Spinal muscular atrophy X-linked type 2 (SMAX2) [MIM:301830] |
| Q9UBT2 | SAE2_HUMAN SUMO-activating enzyme subunit 2 OS=Homo sapiens GN=UBA2 PE=1 SV=2 | 307 | L | 0.627667 | R | 0.706058 | -0.078391 | No Change: Both D | - |
| Q8TBC4 | UBA3_HUMAN NEDD8-activating enzyme E1 catalytic subunit OS=Homo sapiens GN=UBA3 PE=1 SV=2 | 9 | K | 0.886863 | R | 0.88694 | -7.70E-05 | No Change: Both D | - |
| A0AVT1 | UBA6_HUMAN Ubiquitin-like modifier-activating enzyme 6 OS=Homo sapiens GN=UBA6 PE=1 SV=1 | 224 | A | 0.226748 | T | 0.300304 | -0.073556 | No Change: Both O | - |
| P41226 | UBA7_HUMAN Ubiquitin-like modifier-activating enzyme 7 OS=Homo sapiens GN=UBA7 PE=1 SV=2 | 817 | H | 0.267778 | R | 0.276305 | -0.008527 | No Change: Both O | - |
| P41226 | UBA7_HUMAN Ubiquitin-like modifier-activating enzyme 7 OS=Homo sapiens GN=UBA7 PE=1 SV=2 | 712 | P | 0.435805 | S | 0.452636 | -0.016831 | No Change: Both O | - |
| Q9BSL1 | UBAC1_HUMAN Ubiquitin-associated domain-containing protein 1 OS=Homo sapiens GN=UBAC1 PE=1 SV=1 | 374 | E | 0.420509 | D | 0.400248 | 0.020261 | No Change: Both O | - |
| Q9NZ09 | UBAP1_HUMAN Ubiquitin-associated protein 1 OS=Homo sapiens GN=UBAP1 PE=1 SV=1 | 357 | N | 0.978302 | K | 0.975765 | 0.002537 | No Change: Both D | - |
| Q5T6F2 | UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens GN=UBAP2 PE=1 SV=1 | 606 | N | 0.963281 | S | 0.97549 | -0.012209 | No Change: Both D | - |
| Q5T6F2 | UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens GN=UBAP2 PE=1 SV=1 | 756 | A | 0.996023 | V | 0.99409 | 0.001933 | No Change: Both D | - |
| Q5T6F2 | UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens GN=UBAP2 PE=1 SV=1 | 14 | R | 0.915075 | Q | 0.926065 | -0.01099 | No Change: Both D | - |
| Q5T6F2 | UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens GN=UBAP2 PE=1 SV=1 | 429 | P | 0.984892 | L | 0.972759 | 0.012133 | No Change: Both D | - |
| Q5T6F2 | UBAP2_HUMAN Ubiquitin-associated protein 2 OS=Homo sapiens GN=UBAP2 PE=1 SV=1 | 762 | M | 0.994 | I | 0.990478 | 0.003522 | No Change: Both D | - |
| Q14157 | UBP2L_HUMAN Ubiquitin-associated protein 2-like OS=Homo sapiens GN=UBAP2L PE=1 SV=2 | 482 | Q | 0.990881 | H | 0.985357 | 0.005524 | No Change: Both D | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 18 | S | 0.735388 | G | 0.67979 | 0.055598 | No Change: Both D | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 28 | L | 0.41399 | F | 0.35929 | 0.0547 | No Change: Both O | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 286 | Q | 0.19733 | R | 0.181339 | 0.015991 | No Change: Both O | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 466 | D | 0.397588 | E | 0.400603 | -0.003015 | No Change: Both O | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 324 | R | 0.191656 | L | 0.112966 | 0.07869 | No Change: Both O | - |
| P57075 | UBS3A_HUMAN Ubiquitin-associated and SH3 domain-containing protein A OS=Homo sapiens GN=UBASH3A PE=1 SV=1 | 324 | R | 0.191656 | Q | 0.205384 | -0.013728 | No Change: Both O | - |
| Q8TF42 | UBS3B_HUMAN Ubiquitin-associated and SH3 domain-containing protein B OS=Homo sapiens GN=UBASH3B PE=1 SV=2 | 68 | A | 0.185485 | T | 0.200091 | -0.014606 | No Change: Both O | - |
| Q8TF42 | UBS3B_HUMAN Ubiquitin-associated and SH3 domain-containing protein B OS=Homo sapiens GN=UBASH3B PE=1 SV=2 | 569 | N | 0.332647 | S | 0.389626 | -0.056979 | No Change: Both O | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 51 | L | 0.31221 | S | 0.487608 | -0.175398 | No Change: Both O | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 68 | I | 0.598128 | T | 0.69491 | -0.096782 | No Change: Both D | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 95 | S | 0.49444 | P | 0.481998 | 0.012442 | No Change: Both O | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 162 | C | 0.140403 | F | 0.149694 | -0.009291 | No Change: Both O | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 99 | A | 0.539622 | G | 0.587003 | -0.047381 | No Change: Both D | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 160 | C | 0.047515 | S | 0.133489 | -0.085974 | No Change: Both O | - |
| O15205 | UBD_HUMAN Ubiquitin D OS=Homo sapiens GN=UBD PE=1 SV=2 | 120 | E | 0.326497 | K | 0.34083 | -0.014333 | No Change: Both O | - |
| P49459 | UBE2A_HUMAN Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens GN=UBE2A PE=1 SV=2 | 11 | R | 0.60213 | Q | 0.580772 | 0.021358 | No Change: Both D | Mental retardation syndromic X-linked Nascimento-type (MRXSN) [MIM:300860] |
| P49459 | UBE2A_HUMAN Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens GN=UBE2A PE=1 SV=2 | 23 | G | 0.636757 | R | 0.646952 | -0.010195 | No Change: Both D | Mental retardation syndromic X-linked Nascimento-type (MRXSN) [MIM:300860] |
| O00762 | UBE2C_HUMAN Ubiquitin-conjugating enzyme E2 C OS=Homo sapiens GN=UBE2C PE=1 SV=1 | 25 | G | 0.874566 | D | 0.872739 | 0.001827 | No Change: Both D | - |
| Q7Z6J8 | UB2CB_HUMAN Ubiquitin-conjugating enzyme E2C-binding protein OS=Homo sapiens GN=UBE2CBP PE=1 SV=2 | 174 | T | 0.24387 | P | 0.355867 | -0.111997 | No Change: Both O | - |
| Q7Z6J8 | UB2CB_HUMAN Ubiquitin-conjugating enzyme E2C-binding protein OS=Homo sapiens GN=UBE2CBP PE=1 SV=2 | 379 | V | 0.413264 | M | 0.514114 | -0.10085 | O to D | - |
| P51965 | UB2E1_HUMAN Ubiquitin-conjugating enzyme E2 E1 OS=Homo sapiens GN=UBE2E1 PE=1 SV=1 | 25 | E | 0.997999 | D | 0.997561 | 4.38E-04 | No Change: Both D | - |
| Q969T4 | UB2E3_HUMAN Ubiquitin-conjugating enzyme E2 E3 OS=Homo sapiens GN=UBE2E3 PE=1 SV=1 | 201 | W | 0.409849 | R | 0.612994 | -0.203145 | O to D | - |
| Q9Y385 | UB2J1_HUMAN Ubiquitin-conjugating enzyme E2 J1 OS=Homo sapiens GN=UBE2J1 PE=1 SV=2 | 55 | G | 0.438886 | V | 0.323703 | 0.115183 | No Change: Both O | - |
| Q9Y385 | UB2J1_HUMAN Ubiquitin-conjugating enzyme E2 J1 OS=Homo sapiens GN=UBE2J1 PE=1 SV=2 | 229 | L | 0.854735 | V | 0.837617 | 0.017118 | No Change: Both D | - |
| Q9C0C9 | UBE2O_HUMAN Ubiquitin-conjugating enzyme E2 O OS=Homo sapiens GN=UBE2O PE=1 SV=3 | 1207 | G | 0.989634 | S | 0.992332 | -0.002698 | No Change: Both D | - |
| Q5VVX9 | UBE2U_HUMAN Ubiquitin-conjugating enzyme E2 U OS=Homo sapiens GN=UBE2U PE=1 SV=1 | 90 | I | 0.221076 | T | 0.363798 | -0.142722 | No Change: Both O | - |
| Q15819 | UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens GN=UBE2V2 PE=1 SV=4 | 36 | E | 0.514236 | G | 0.469243 | 0.044993 | D to O | - |
| Q15819 | UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens GN=UBE2V2 PE=1 SV=4 | 40 | D | 0.453577 | H | 0.388425 | 0.065152 | No Change: Both O | - |
| Q15819 | UB2V2_HUMAN Ubiquitin-conjugating enzyme E2 variant 2 OS=Homo sapiens GN=UBE2V2 PE=1 SV=4 | 78 | P | 0.433198 | Q | 0.374613 | 0.058585 | No Change: Both O | - |
| Q05086 | UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens GN=UBE3A PE=1 SV=4 | 44 | C | 0.346051 | Y | 0.359905 | -0.013854 | No Change: Both O | - |
| Q05086 | UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens GN=UBE3A PE=1 SV=4 | 201 | A | 0.984697 | T | 0.981583 | 0.003114 | No Change: Both D | - |
| Q05086 | UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens GN=UBE3A PE=1 SV=4 | 62 | R | 0.221174 | H | 0.21927 | 0.001904 | No Change: Both O | - |
| Q05086 | UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens GN=UBE3A PE=1 SV=4 | 372 | S | 0.166234 | P | 0.151244 | 0.01499 | No Change: Both O | - |
| Q05086 | UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens GN=UBE3A PE=1 SV=4 | 290 | V | 0.104039 | G | 0.171414 | -0.067375 | No Change: Both O | - |
| Q7Z3V4 | UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens GN=UBE3B PE=1 SV=3 | 346 | R | 0.155744 | Q | 0.181359 | -0.025615 | No Change: Both O | - |
| O95155 | UBE4B_HUMAN Ubiquitin conjugation factor E4 B OS=Homo sapiens GN=UBE4B PE=1 SV=1 | 605 | V | 0.313097 | I | 0.263885 | 0.049212 | No Change: Both O | - |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 75 | S | 0.308587 | F | 0.125009 | 0.183578 | No Change: Both O | - |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 102 | N | 0.180006 | S | 0.20943 | -0.029424 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 112 | D | 0.730573 | G | 0.69987 | 0.030703 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 118 | D | 0.652723 | G | 0.606307 | 0.046416 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 119 | R | 0.567311 | G | 0.567981 | -6.70E-04 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 121 | L | 0.415593 | F | 0.366689 | 0.048904 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 171 | S | 0.218951 | P | 0.184527 | 0.034424 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 175 | T | 0.172512 | I | 0.10096 | 0.071552 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 177 | G | 0.126223 | R | 0.106993 | 0.01923 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 186 | G | 0.029767 | R | 0.026024 | 0.003743 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 232 | N | 0.613642 | S | 0.661469 | -0.047827 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 236 | D | 0.793066 | E | 0.810082 | -0.017016 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 97 | A | 0.193924 | T | 0.21165 | -0.017726 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 98 | G | 0.195365 | S | 0.2241 | -0.028735 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 112 | D | 0.730573 | N | 0.695874 | 0.034699 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 122 | V | 0.351859 | E | 0.587709 | -0.23585 | O to D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 122 | V | 0.351859 | G | 0.50757 | -0.155711 | O to D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 188 | L | 0.025365 | H | 0.042458 | -0.017093 | No Change: Both O | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9Y5Z9 | UBIA1_HUMAN UbiA prenyltransferase domain-containing protein 1 OS=Homo sapiens GN=UBIAD1 PE=1 SV=1 | 240 | D | 0.676453 | N | 0.654548 | 0.021905 | No Change: Both D | Crystalline corneal dystrophy of Schnyder (SCCD) [MIM:121800] |
| Q9NPG3 | UBN1_HUMAN Ubinuclein-1 OS=Homo sapiens GN=UBN1 PE=1 SV=2 | 435 | Y | 0.530901 | C | 0.547821 | -0.01692 | No Change: Both D | - |
| Q6ZU65 | UBN2_HUMAN Ubinuclein-2 OS=Homo sapiens GN=UBN2 PE=1 SV=2 | 1308 | P | 0.814236 | A | 0.784353 | 0.029883 | No Change: Both D | - |
| O94941 | RNF37_HUMAN RING finger protein 37 OS=Homo sapiens GN=UBOX5 PE=2 SV=1 | 96 | T | 0.456607 | M | 0.398021 | 0.058586 | No Change: Both O | - |
| O94941 | RNF37_HUMAN RING finger protein 37 OS=Homo sapiens GN=UBOX5 PE=2 SV=1 | 479 | L | 0.624848 | P | 0.786588 | -0.16174 | No Change: Both D | - |
| Q9NZI7 | UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens GN=UBP1 PE=2 SV=1 | 212 | T | 0.343754 | A | 0.307338 | 0.036416 | No Change: Both O | - |
| Q9NZI7 | UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens GN=UBP1 PE=2 SV=1 | 109 | N | 0.41608 | S | 0.470772 | -0.054692 | No Change: Both O | - |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 235 | L | 0.783061 | H | 0.813362 | -0.030301 | No Change: Both D | - |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 497 | P | 0.824049 | H | 0.720401 | 0.103648 | No Change: Both D | Amyotrophic lateral sclerosis type 15 with or without frontotemporal dementia (ALS15) [MIM:300857] |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 497 | P | 0.824049 | S | 0.779695 | 0.044354 | No Change: Both D | Amyotrophic lateral sclerosis type 15 with or without frontotemporal dementia (ALS15) [MIM:300857] |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 506 | P | 0.925148 | T | 0.900507 | 0.024641 | No Change: Both D | Amyotrophic lateral sclerosis type 15 with or without frontotemporal dementia (ALS15) [MIM:300857] |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 509 | P | 0.945931 | S | 0.924392 | 0.021539 | No Change: Both D | Amyotrophic lateral sclerosis type 15 with or without frontotemporal dementia (ALS15) [MIM:300857] |
| Q9UHD9 | UBQL2_HUMAN Ubiquilin-2 OS=Homo sapiens GN=UBQLN2 PE=1 SV=2 | 525 | P | 0.995234 | S | 0.994224 | 0.00101 | No Change: Both D | Amyotrophic lateral sclerosis type 15 with or without frontotemporal dementia (ALS15) [MIM:300857] |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 624 | R | 0.381929 | Q | 0.431848 | -0.049919 | No Change: Both O | - |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 546 | M | 0.230777 | T | 0.240734 | -0.009957 | No Change: Both O | - |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 255 | C | 0.145707 | R | 0.235531 | -0.089824 | No Change: Both O | - |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 285 | N | 0.816803 | D | 0.825057 | -0.008254 | No Change: Both D | - |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 287 | T | 0.854859 | A | 0.829105 | 0.025754 | No Change: Both D | - |
| Q9H347 | UBQL3_HUMAN Ubiquilin-3 OS=Homo sapiens GN=UBQLN3 PE=1 SV=2 | 290 | T | 0.892453 | S | 0.900508 | -0.008055 | No Change: Both D | - |
| Q9NRR5 | UBQL4_HUMAN Ubiquilin-4 OS=Homo sapiens GN=UBQLN4 PE=1 SV=2 | 495 | I | 0.901826 | M | 0.930274 | -0.028448 | No Change: Both D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 92 | D | 0.234298 | V | 0.12699 | 0.107308 | No Change: Both O | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 143 | Q | 0.66277 | K | 0.670628 | -0.007858 | No Change: Both D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 171 | C | 0.52889 | R | 0.659073 | -0.130183 | No Change: Both D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 259 | G | 0.730406 | D | 0.742584 | -0.012178 | No Change: Both D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 274 | Y | 0.6026 | H | 0.683219 | -0.080619 | No Change: Both D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 275 | A | 0.589443 | V | 0.484479 | 0.104964 | D to O | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 379 | W | 0.368343 | G | 0.574317 | -0.205974 | O to D | - |
| Q8IYU4 | UBQLN_HUMAN Ubiquilin-like protein OS=Homo sapiens GN=UBQLNL PE=2 SV=3 | 455 | Q | 0.611451 | E | 0.603883 | 0.007568 | No Change: Both D | - |
| Q8IWV7 | UBR1_HUMAN E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens GN=UBR1 PE=1 SV=1 | 136 | H | 0.570813 | R | 0.561678 | 0.009135 | No Change: Both D | Johanson-Blizzard syndrome (JBS) [MIM:243800] |
| Q8IWV7 | UBR1_HUMAN E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens GN=UBR1 PE=1 SV=1 | 1279 | G | 0.358877 | S | 0.443741 | -0.084864 | No Change: Both O | Johanson-Blizzard syndrome (JBS) [MIM:243800] |
| Q8IWV7 | UBR1_HUMAN E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens GN=UBR1 PE=1 SV=1 | 596 | K | 0.620304 | M | 0.532769 | 0.087535 | No Change: Both D | - |
| Q8IWV7 | UBR1_HUMAN E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens GN=UBR1 PE=1 SV=1 | 899 | I | 0.23368 | V | 0.274046 | -0.040366 | No Change: Both O | - |
| Q8IWV7 | UBR1_HUMAN E3 ubiquitin-protein ligase UBR1 OS=Homo sapiens GN=UBR1 PE=1 SV=1 | 1548 | T | 0.102415 | A | 0.091183 | 0.011232 | No Change: Both O | - |
| Q8IWV8 | UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens GN=UBR2 PE=1 SV=1 | 1095 | A | 0.57401 | T | 0.615233 | -0.041223 | No Change: Both D | - |
| Q8IWV8 | UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens GN=UBR2 PE=1 SV=1 | 172 | E | 0.738417 | D | 0.711896 | 0.026521 | No Change: Both D | - |
| Q8IWV8 | UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens GN=UBR2 PE=1 SV=1 | 1095 | A | 0.57401 | P | 0.660093 | -0.086083 | No Change: Both D | - |
| Q8IWV8 | UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens GN=UBR2 PE=1 SV=1 | 1095 | A | 0.57401 | S | 0.651601 | -0.077591 | No Change: Both D | - |
| Q5T4S7 | UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1 | 1107 | T | 0.104331 | A | 0.085897 | 0.018434 | No Change: Both O | - |
| Q5T4S7 | UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1 | 4867 | M | 0.679925 | L | 0.637444 | 0.042481 | No Change: Both D | - |
| Q5T4S7 | UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1 | 4924 | G | 0.206069 | R | 0.20768 | -0.001611 | No Change: Both O | A melanoma patient |
| Q5T4S7 | UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1 | 5084 | V | 0.523175 | M | 0.583226 | -0.060051 | No Change: Both D | - |
| Q5T4S7 | UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens GN=UBR4 PE=1 SV=1 | 1394 | R | 0.718946 | H | 0.702259 | 0.016687 | No Change: Both D | A breast cancer sample |
| O95071 | UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens GN=UBR5 PE=1 SV=2 | 2150 | S | 0.812549 | R | 0.773066 | 0.039483 | No Change: Both D | - |
| Q8WUN7 | UBTD2_HUMAN Ubiquitin domain-containing protein 2 OS=Homo sapiens GN=UBTD2 PE=1 SV=2 | 129 | M | 0.402941 | I | 0.352781 | 0.05016 | No Change: Both O | - |
| Q04323 | UBXN1_HUMAN UBX domain-containing protein 1 OS=Homo sapiens GN=UBXN1 PE=1 SV=2 | 56 | L | 0.790197 | F | 0.730822 | 0.059375 | No Change: Both D | - |
| Q5T124 | UBX11_HUMAN UBX domain-containing protein 11 OS=Homo sapiens GN=UBXN11 PE=2 SV=2 | 165 | E | 0.782408 | G | 0.74876 | 0.033648 | No Change: Both D | - |
| Q5T124 | UBX11_HUMAN UBX domain-containing protein 11 OS=Homo sapiens GN=UBXN11 PE=2 SV=2 | 312 | L | 0.376083 | R | 0.528234 | -0.152151 | O to D | - |
| Q5T124 | UBX11_HUMAN UBX domain-containing protein 11 OS=Homo sapiens GN=UBXN11 PE=2 SV=2 | 474 | A | 0.844247 | V | 0.803785 | 0.040462 | No Change: Both D | - |
| Q5T124 | UBX11_HUMAN UBX domain-containing protein 11 OS=Homo sapiens GN=UBXN11 PE=2 SV=2 | 501 | P | 0.999933 | S | 0.999921 | 1.20E-05 | No Change: Both D | - |
| Q5T124 | UBX11_HUMAN UBX domain-containing protein 11 OS=Homo sapiens GN=UBXN11 PE=2 SV=2 | 509 | P | 0.999996 | S | 0.999995 | 1.00E-06 | No Change: Both D | - |
| Q92575 | UBXN4_HUMAN UBX domain-containing protein 4 OS=Homo sapiens GN=UBXN4 PE=1 SV=2 | 458 | S | 0.980898 | R | 0.979098 | 0.0018 | No Change: Both D | - |
| Q9BZV1 | UBXN6_HUMAN UBX domain-containing protein 6 OS=Homo sapiens GN=UBXN6 PE=1 SV=1 | 425 | P | 0.555488 | L | 0.388439 | 0.167049 | D to O | - |
| Q9BZV1 | UBXN6_HUMAN UBX domain-containing protein 6 OS=Homo sapiens GN=UBXN6 PE=1 SV=1 | 31 | A | 0.974135 | T | 0.971391 | 0.002744 | No Change: Both D | - |
| O00124 | UBXN8_HUMAN UBX domain-containing protein 8 OS=Homo sapiens GN=UBXN8 PE=1 SV=2 | 18 | V | 0.053955 | M | 0.067577 | -0.013622 | No Change: Both O | - |
| O00124 | UBXN8_HUMAN UBX domain-containing protein 8 OS=Homo sapiens GN=UBXN8 PE=1 SV=2 | 51 | I | 0.052431 | T | 0.100875 | -0.048444 | No Change: Both O | - |
| P09936 | UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L1 OS=Homo sapiens GN=UCHL1 PE=1 SV=2 | 18 | S | 0.231547 | Y | 0.106347 | 0.1252 | No Change: Both O | - |
| P09936 | UCHL1_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L1 OS=Homo sapiens GN=UCHL1 PE=1 SV=2 | 93 | I | 0.154086 | M | 0.20901 | -0.054924 | No Change: Both O | Parkinson disease type 5 (PARK5) [MIM:613643] |
| Q9Y5K5 | UCHL5_HUMAN Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Homo sapiens GN=UCHL5 PE=1 SV=3 | 197 | I | 0.137689 | F | 0.131392 | 0.006297 | No Change: Both O | - |
| Q969E3 | UCN3_HUMAN Urocortin-3 OS=Homo sapiens GN=UCN3 PE=1 SV=2 | 77 | E | 0.920193 | K | 0.918286 | 0.001907 | No Change: Both D | - |
| Q969E3 | UCN3_HUMAN Urocortin-3 OS=Homo sapiens GN=UCN3 PE=1 SV=2 | 91 | R | 0.909151 | G | 0.896211 | 0.01294 | No Change: Both D | - |
| P25874 | UCP1_HUMAN Mitochondrial brown fat uncoupling protein 1 OS=Homo sapiens GN=UCP1 PE=1 SV=3 | 64 | A | 0.195391 | T | 0.240181 | -0.04479 | No Change: Both O | - |
| P25874 | UCP1_HUMAN Mitochondrial brown fat uncoupling protein 1 OS=Homo sapiens GN=UCP1 PE=1 SV=3 | 229 | M | 0.229138 | L | 0.182176 | 0.046962 | No Change: Both O | - |
| P55851 | UCP2_HUMAN Mitochondrial uncoupling protein 2 OS=Homo sapiens GN=UCP2 PE=1 SV=1 | 55 | A | 0.476413 | V | 0.388688 | 0.087725 | No Change: Both O | - |
| P55851 | UCP2_HUMAN Mitochondrial uncoupling protein 2 OS=Homo sapiens GN=UCP2 PE=1 SV=1 | 76 | R | 0.39515 | Q | 0.39751 | -0.00236 | No Change: Both O | - |
| P55851 | UCP2_HUMAN Mitochondrial uncoupling protein 2 OS=Homo sapiens GN=UCP2 PE=1 SV=1 | 154 | R | 0.534055 | Q | 0.545944 | -0.011889 | No Change: Both D | - |
| P55851 | UCP2_HUMAN Mitochondrial uncoupling protein 2 OS=Homo sapiens GN=UCP2 PE=1 SV=1 | 268 | A | 0.324448 | G | 0.405456 | -0.081008 | No Change: Both O | - |
| P55851 | UCP2_HUMAN Mitochondrial uncoupling protein 2 OS=Homo sapiens GN=UCP2 PE=1 SV=1 | 282 | S | 0.07877 | C | 0.027974 | 0.050796 | No Change: Both O | - |
| P55916 | UCP3_HUMAN Mitochondrial uncoupling protein 3 OS=Homo sapiens GN=UCP3 PE=1 SV=1 | 70 | R | 0.235417 | W | 0.105273 | 0.130144 | No Change: Both O | - |
| P55916 | UCP3_HUMAN Mitochondrial uncoupling protein 3 OS=Homo sapiens GN=UCP3 PE=1 SV=1 | 102 | V | 0.246008 | I | 0.221306 | 0.024702 | No Change: Both O | Obesity (OBESITY) [MIM:601665] |
| P55916 | UCP3_HUMAN Mitochondrial uncoupling protein 3 OS=Homo sapiens GN=UCP3 PE=1 SV=1 | 9 | V | 0.483258 | M | 0.559933 | -0.076675 | O to D | - |
| Q9Y3C8 | UFC1_HUMAN Ubiquitin-fold modifier-conjugating enzyme 1 OS=Homo sapiens GN=UFC1 PE=1 SV=3 | 90 | Y | 0.208187 | C | 0.174451 | 0.033736 | No Change: Both O | - |
| Q92890 | UFD1_HUMAN Ubiquitin fusion degradation protein 1 homolog OS=Homo sapiens GN=UFD1L PE=1 SV=3 | 130 | P | 0.452408 | A | 0.347693 | 0.104715 | No Change: Both O | - |
| O94874 | UFL1_HUMAN E3 UFM1-protein ligase 1 OS=Homo sapiens GN=UFL1 PE=1 SV=2 | 137 | V | 0.359245 | F | 0.329871 | 0.029374 | No Change: Both O | - |
| Q6NVU6 | UFSP1_HUMAN Inactive Ufm1-specific protease 1 OS=Homo sapiens GN=UFSP1 PE=2 SV=2 | 47 | L | 0.439382 | V | 0.431303 | 0.008079 | No Change: Both O | - |
| Q9NUQ7 | UFSP2_HUMAN Ufm1-specific protease 2 OS=Homo sapiens GN=UFSP2 PE=2 SV=3 | 83 | N | 0.210404 | T | 0.201938 | 0.008466 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 323 | A | 0.346224 | T | 0.352083 | -0.005859 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 328 | S | 0.354967 | A | 0.256479 | 0.098488 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 994 | M | 0.100454 | L | 0.076937 | 0.023517 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 821 | A | 0.236732 | T | 0.260615 | -0.023883 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 924 | F | 0.265854 | I | 0.283472 | -0.017618 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 1274 | F | 0.293506 | L | 0.337613 | -0.044107 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 865 | K | 0.172443 | R | 0.141727 | 0.030716 | No Change: Both O | - |
| Q9NYU1 | UGGG2_HUMAN UDP-glucose:glycoprotein glucosyltransferase 2 OS=Homo sapiens GN=UGGT2 PE=1 SV=4 | 1285 | Y | 0.246072 | F | 0.210816 | 0.035256 | No Change: Both O | - |
| Q16851 | UGPA_HUMAN UTP--glucose-1-phosphate uridylyltransferase OS=Homo sapiens GN=UGP2 PE=1 SV=5 | 268 | M | 0.293057 | I | 0.226679 | 0.066378 | No Change: Both O | - |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 177 | C | 0.21983 | R | 0.308432 | -0.088602 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 209 | R | 0.195624 | W | 0.083401 | 0.112223 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 276 | G | 0.089144 | R | 0.079381 | 0.009763 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 292 | A | 0.365002 | V | 0.2786 | 0.086402 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 308 | G | 0.234371 | E | 0.292877 | -0.058506 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 331 | Q | 0.110235 | R | 0.109361 | 8.74E-04 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 357 | Q | 0.191309 | R | 0.178017 | 0.013292 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 368 | A | 0.30353 | T | 0.328239 | -0.024709 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 375 | S | 0.31664 | F | 0.14104 | 0.1756 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 381 | S | 0.273129 | R | 0.209605 | 0.063524 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 401 | A | 0.594808 | P | 0.652658 | -0.05785 | No Change: Both D | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 428 | K | 0.44727 | E | 0.456841 | -0.009571 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 486 | Y | 0.090001 | D | 0.183107 | -0.093106 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 486 | Y | 0.090001 | D | 0.183107 | -0.093106 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 486 | Y | 0.090001 | D | 0.183107 | -0.093106 | No Change: Both O | Transient familial neonatal hyperbilirubinemia (TNHBB) [MIM:237900] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 71 | G | 0.125349 | R | 0.127042 | -0.001693 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 71 | G | 0.125349 | R | 0.127042 | -0.001693 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 71 | G | 0.125349 | R | 0.127042 | -0.001693 | No Change: Both O | Transient familial neonatal hyperbilirubinemia (TNHBB) [MIM:237900] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 229 | P | 0.114749 | Q | 0.107618 | 0.007131 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 229 | P | 0.114749 | Q | 0.107618 | 0.007131 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 367 | R | 0.280172 | G | 0.311497 | -0.031325 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 15 | L | 0.049405 | R | 0.082264 | -0.032859 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 175 | L | 0.183196 | Q | 0.267199 | -0.084003 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 400 | N | 0.561241 | D | 0.592614 | -0.031373 | No Change: Both D | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 511 | A | 0.041816 | P | 0.058604 | -0.016788 | No Change: Both O | - |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 34 | P | 0.156591 | Q | 0.146094 | 0.010497 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 39 | H | 0.146619 | D | 0.182306 | -0.035687 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 83 | F | 0.341874 | L | 0.376726 | -0.034852 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 225 | V | 0.067164 | G | 0.111003 | -0.043839 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 291 | E | 0.364551 | V | 0.188792 | 0.175759 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 294 | I | 0.350182 | T | 0.483015 | -0.132833 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 294 | I | 0.350182 | T | 0.483015 | -0.132833 | No Change: Both O | Gilbert syndrome (GILBS) [MIM:143500] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 336 | R | 0.147179 | L | 0.089726 | 0.057453 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 336 | R | 0.147179 | L | 0.089726 | 0.057453 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 336 | R | 0.147179 | Q | 0.158124 | -0.010945 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 336 | R | 0.147179 | W | 0.062299 | 0.08488 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 354 | W | 0.102282 | R | 0.234009 | -0.131727 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 376 | H | 0.330648 | R | 0.312394 | 0.018254 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 376 | H | 0.330648 | R | 0.312394 | 0.018254 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 377 | G | 0.312886 | V | 0.198759 | 0.114127 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 377 | G | 0.312886 | V | 0.198759 | 0.114127 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 387 | P | 0.142843 | S | 0.152361 | -0.009518 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 395 | G | 0.355546 | V | 0.251499 | 0.104047 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 403 | R | 0.617878 | C | 0.489976 | 0.127902 | D to O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 461 | W | 0.036954 | R | 0.106885 | -0.069931 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 461 | W | 0.036954 | R | 0.106885 | -0.069931 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 478 | A | 0.309726 | D | 0.398909 | -0.089183 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 191 | S | 0.391487 | F | 0.200402 | 0.191085 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 279 | N | 0.113136 | Y | 0.05592 | 0.057216 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 370 | I | 0.314327 | V | 0.349241 | -0.034914 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 387 | P | 0.142843 | H | 0.111177 | 0.031666 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 402 | K | 0.607255 | T | 0.549424 | 0.057831 | No Change: Both D | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22309 | UD11_HUMAN UDP-glucuronosyltransferase 1-1 OS=Homo sapiens GN=UGT1A1 PE=1 SV=1 | 443 | L | 0.447417 | P | 0.587446 | -0.140029 | O to D | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| Q9HAW8 | UD110_HUMAN UDP-glucuronosyltransferase 1-10 OS=Homo sapiens GN=UGT1A10 PE=2 SV=1 | 59 | M | 0.169074 | I | 0.114308 | 0.054766 | No Change: Both O | - |
| Q9HAW8 | UD110_HUMAN UDP-glucuronosyltransferase 1-10 OS=Homo sapiens GN=UGT1A10 PE=2 SV=1 | 202 | T | 0.195415 | I | 0.111064 | 0.084351 | No Change: Both O | - |
| Q9HAW8 | UD110_HUMAN UDP-glucuronosyltransferase 1-10 OS=Homo sapiens GN=UGT1A10 PE=2 SV=1 | 139 | E | 0.348831 | K | 0.351441 | -0.00261 | No Change: Both O | - |
| Q9HAW8 | UD110_HUMAN UDP-glucuronosyltransferase 1-10 OS=Homo sapiens GN=UGT1A10 PE=2 SV=1 | 244 | L | 0.198937 | I | 0.179532 | 0.019405 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 6 | Q | 0.331033 | R | 0.310955 | 0.020078 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 11 | W | 0.078055 | R | 0.188639 | -0.110584 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 45 | R | 0.322304 | W | 0.1508 | 0.171504 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 47 | V | 0.365923 | A | 0.4664 | -0.100477 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 49 | R | 0.398474 | W | 0.194307 | 0.204167 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 78 | T | 0.078353 | I | 0.039813 | 0.03854 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 114 | M | 0.22362 | I | 0.141694 | 0.081926 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 144 | T | 0.175707 | I | 0.098182 | 0.077525 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 270 | M | 0.175034 | V | 0.133717 | 0.041317 | No Change: Both O | - |
| P35503 | UD13_HUMAN UDP-glucuronosyltransferase 1-3 OS=Homo sapiens GN=UGT1A3 PE=1 SV=1 | 158 | A | 0.059171 | V | 0.041024 | 0.018147 | No Change: Both O | - |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 332 | Q | 0.110235 | R | 0.109361 | 8.74E-04 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 376 | S | 0.31664 | F | 0.14104 | 0.1756 | No Change: Both O | Crigler-Najjar syndrome type 1 (CN1) [MIM:218800] |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 132 | L | 0.125808 | P | 0.215769 | -0.089961 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 487 | Y | 0.090001 | D | 0.183107 | -0.093106 | No Change: Both O | Crigler-Najjar syndrome type 2 (CN2) [MIM:606785] |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 24 | P | 0.235972 | T | 0.183015 | 0.052957 | No Change: Both O | - |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 176 | I | 0.023246 | F | 0.026367 | -0.003121 | No Change: Both O | - |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 48 | L | 0.466541 | V | 0.448384 | 0.018157 | No Change: Both O | - |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 11 | R | 0.226401 | W | 0.087281 | 0.13912 | No Change: Both O | - |
| P22310 | UD14_HUMAN UDP-glucuronosyltransferase 1-4 OS=Homo sapiens GN=UGT1A4 PE=1 SV=1 | 68 | H | 0.337064 | Y | 0.227552 | 0.109512 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 48 | L | 0.46698 | S | 0.665779 | -0.198799 | O to D | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 63 | L | 0.087511 | P | 0.16532 | -0.077809 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 144 | T | 0.185064 | S | 0.253752 | -0.068688 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 158 | A | 0.051147 | G | 0.060123 | -0.008976 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 225 | H | 0.135313 | Y | 0.089219 | 0.046094 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 249 | V | 0.188287 | L | 0.180189 | 0.008098 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 259 | G | 0.084769 | R | 0.088417 | -0.003648 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 50 | D | 0.438946 | E | 0.483594 | -0.044648 | No Change: Both O | - |
| P35504 | UD15_HUMAN UDP-glucuronosyltransferase 1-5 OS=Homo sapiens GN=UGT1A5 PE=2 SV=1 | 142 | H | 0.163241 | N | 0.17022 | -0.006979 | No Change: Both O | - |
| P19224 | UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens GN=UGT1A6 PE=1 SV=2 | 181 | T | 0.503269 | A | 0.470113 | 0.033156 | D to O | - |
| P19224 | UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens GN=UGT1A6 PE=1 SV=2 | 184 | R | 0.617491 | S | 0.697076 | -0.079585 | No Change: Both D | - |
| P19224 | UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens GN=UGT1A6 PE=1 SV=2 | 7 | S | 0.22244 | A | 0.143745 | 0.078695 | No Change: Both O | - |
| P19224 | UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens GN=UGT1A6 PE=1 SV=2 | 70 | S | 0.363326 | Y | 0.216387 | 0.146939 | No Change: Both O | - |
| P19224 | UD16_HUMAN UDP-glucuronosyltransferase 1-6 OS=Homo sapiens GN=UGT1A6 PE=1 SV=2 | 510 | A | 0.041816 | P | 0.058604 | -0.016788 | No Change: Both O | - |
| Q9HAW7 | UD17_HUMAN UDP-glucuronosyltransferase 1-7 OS=Homo sapiens GN=UGT1A7 PE=1 SV=2 | 129 | N | 0.229333 | K | 0.266931 | -0.037598 | No Change: Both O | - |
| Q9HAW7 | UD17_HUMAN UDP-glucuronosyltransferase 1-7 OS=Homo sapiens GN=UGT1A7 PE=1 SV=2 | 131 | R | 0.279119 | K | 0.345142 | -0.066023 | No Change: Both O | - |
| Q9HAW7 | UD17_HUMAN UDP-glucuronosyltransferase 1-7 OS=Homo sapiens GN=UGT1A7 PE=1 SV=2 | 208 | W | 0.160228 | R | 0.33814 | -0.177912 | No Change: Both O | - |
| Q9HAW7 | UD17_HUMAN UDP-glucuronosyltransferase 1-7 OS=Homo sapiens GN=UGT1A7 PE=1 SV=2 | 131 | R | 0.279119 | Q | 0.284053 | -0.004934 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 132 | K | 0.29017 | R | 0.242335 | 0.047835 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 154 | G | 0.043642 | A | 0.038079 | 0.005563 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 173 | A | 0.073757 | G | 0.095136 | -0.021379 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 202 | T | 0.285088 | A | 0.268332 | 0.016756 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 212 | M | 0.2667 | L | 0.22742 | 0.03928 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 277 | C | 0.199074 | Y | 0.239081 | -0.040007 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 53 | H | 0.127965 | N | 0.141138 | -0.013173 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 144 | A | 0.201711 | V | 0.154119 | 0.047592 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 231 | A | 0.280114 | T | 0.307403 | -0.027289 | No Change: Both O | - |
| Q9HAW9 | UD18_HUMAN UDP-glucuronosyltransferase 1-8 OS=Homo sapiens GN=UGT1A8 PE=1 SV=1 | 173 | A | 0.073757 | V | 0.050428 | 0.023329 | No Change: Both O | - |
| O60656 | UD19_HUMAN UDP-glucuronosyltransferase 1-9 OS=Homo sapiens GN=UGT1A9 PE=1 SV=1 | 442 | S | 0.448773 | I | 0.241933 | 0.20684 | No Change: Both O | A breast cancer sample |
| O60656 | UD19_HUMAN UDP-glucuronosyltransferase 1-9 OS=Homo sapiens GN=UGT1A9 PE=1 SV=1 | 33 | M | 0.169961 | T | 0.205624 | -0.035663 | No Change: Both O | - |
| Q9Y4X1 | UD2A1_HUMAN UDP-glucuronosyltransferase 2A1 OS=Homo sapiens GN=UGT2A1 PE=1 SV=2 | 308 | G | 0.268315 | R | 0.254751 | 0.013564 | No Change: Both O | - |
| Q9Y4X1 | UD2A1_HUMAN UDP-glucuronosyltransferase 2A1 OS=Homo sapiens GN=UGT2A1 PE=1 SV=2 | 391 | V | 0.221686 | I | 0.184451 | 0.037235 | No Change: Both O | - |
| Q9Y4X1 | UD2A1_HUMAN UDP-glucuronosyltransferase 2A1 OS=Homo sapiens GN=UGT2A1 PE=1 SV=2 | 75 | R | 0.129558 | K | 0.170731 | -0.041173 | No Change: Both O | - |
| P54855 | UDB15_HUMAN UDP-glucuronosyltransferase 2B15 OS=Homo sapiens GN=UGT2B15 PE=1 SV=3 | 85 | Y | 0.390159 | D | 0.549532 | -0.159373 | O to D | - |
| P54855 | UDB15_HUMAN UDP-glucuronosyltransferase 2B15 OS=Homo sapiens GN=UGT2B15 PE=1 SV=3 | 523 | K | 0.708374 | T | 0.654309 | 0.054065 | No Change: Both D | - |
| Q9BY64 | UDB28_HUMAN UDP-glucuronosyltransferase 2B28 OS=Homo sapiens GN=UGT2B28 PE=1 SV=1 | 365 | L | 0.231647 | H | 0.339859 | -0.108212 | No Change: Both O | - |
| Q9BY64 | UDB28_HUMAN UDP-glucuronosyltransferase 2B28 OS=Homo sapiens GN=UGT2B28 PE=1 SV=1 | 447 | I | 0.25823 | R | 0.396136 | -0.137906 | No Change: Both O | - |
| Q9BY64 | UDB28_HUMAN UDP-glucuronosyltransferase 2B28 OS=Homo sapiens GN=UGT2B28 PE=1 SV=1 | 458 | H | 0.139814 | D | 0.162211 | -0.022397 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 458 | D | 0.172541 | E | 0.18441 | -0.011869 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 109 | F | 0.099576 | L | 0.106448 | -0.006872 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 396 | F | 0.199006 | L | 0.232891 | -0.033885 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 40 | K | 0.125652 | N | 0.113701 | 0.011951 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 78 | P | 0.256922 | T | 0.225988 | 0.030934 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 80 | S | 0.264686 | P | 0.256799 | 0.007887 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 277 | V | 0.190137 | I | 0.157361 | 0.032776 | No Change: Both O | - |
| P06133 | UD2B4_HUMAN UDP-glucuronosyltransferase 2B4 OS=Homo sapiens GN=UGT2B4 PE=1 SV=2 | 511 | C | 0.006436 | R | 0.013668 | -0.007232 | No Change: Both O | - |
| P16662 | UD2B7_HUMAN UDP-glucuronosyltransferase 2B7 OS=Homo sapiens GN=UGT2B7 PE=1 SV=1 | 268 | H | 0.185899 | Y | 0.115454 | 0.070445 | No Change: Both O | - |
| P16662 | UD2B7_HUMAN UDP-glucuronosyltransferase 2B7 OS=Homo sapiens GN=UGT2B7 PE=1 SV=1 | 71 | A | 0.385598 | S | 0.523005 | -0.137407 | O to D | - |
| P16662 | UD2B7_HUMAN UDP-glucuronosyltransferase 2B7 OS=Homo sapiens GN=UGT2B7 PE=1 SV=1 | 378 | N | 0.279091 | S | 0.321603 | -0.042512 | No Change: Both O | - |
| Q6NUS8 | UD3A1_HUMAN UDP-glucuronosyltransferase 3A1 OS=Homo sapiens GN=UGT3A1 PE=2 SV=1 | 121 | C | 0.122217 | G | 0.250363 | -0.128146 | No Change: Both O | - |
| Q3SY77 | UD3A2_HUMAN UDP-glucuronosyltransferase 3A2 OS=Homo sapiens GN=UGT3A2 PE=2 SV=1 | 515 | R | 0.109091 | H | 0.104236 | 0.004855 | No Change: Both O | A colorectal cancer sample |
| Q3SY77 | UD3A2_HUMAN UDP-glucuronosyltransferase 3A2 OS=Homo sapiens GN=UGT3A2 PE=2 SV=1 | 74 | Y | 0.388711 | N | 0.546945 | -0.158234 | O to D | - |
| Q16880 | CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens GN=UGT8 PE=2 SV=2 | 226 | P | 0.389459 | L | 0.249641 | 0.139818 | No Change: Both O | - |
| Q16880 | CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens GN=UGT8 PE=2 SV=2 | 368 | I | 0.109718 | M | 0.151829 | -0.042111 | No Change: Both O | - |
| Q8TAS1 | UHMK1_HUMAN Serine/threonine-protein kinase Kist OS=Homo sapiens GN=UHMK1 PE=1 SV=2 | 159 | L | 0.279165 | V | 0.28553 | -0.006365 | No Change: Both O | - |
| Q8TAS1 | UHMK1_HUMAN Serine/threonine-protein kinase Kist OS=Homo sapiens GN=UHMK1 PE=1 SV=2 | 197 | Y | 0.335232 | D | 0.479676 | -0.144444 | No Change: Both O | - |
| Q96T88 | UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Homo sapiens GN=UHRF1 PE=1 SV=1 | 240 | D | 0.248083 | H | 0.214879 | 0.033204 | No Change: Both O | - |
| Q96T88 | UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Homo sapiens GN=UHRF1 PE=1 SV=1 | 379 | E | 0.863127 | K | 0.866487 | -0.00336 | No Change: Both D | - |
| Q96T88 | UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Homo sapiens GN=UHRF1 PE=1 SV=1 | 638 | A | 0.989366 | T | 0.990287 | -9.21E-04 | No Change: Both D | - |
| Q96T88 | UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Homo sapiens GN=UHRF1 PE=1 SV=1 | 642 | T | 0.990275 | M | 0.98984 | 4.35E-04 | No Change: Both D | - |
| Q96T88 | UHRF1_HUMAN E3 ubiquitin-protein ligase UHRF1 OS=Homo sapiens GN=UHRF1 PE=1 SV=1 | 713 | L | 0.295759 | F | 0.27649 | 0.019269 | No Change: Both O | - |
| Q6BDS2 | URFB1_HUMAN UHRF1-binding protein 1 OS=Homo sapiens GN=UHRF1BP1 PE=1 SV=1 | 404 | K | 0.541687 | N | 0.472115 | 0.069572 | D to O | - |
| Q6BDS2 | URFB1_HUMAN UHRF1-binding protein 1 OS=Homo sapiens GN=UHRF1BP1 PE=1 SV=1 | 454 | Q | 0.799368 | R | 0.802497 | -0.003129 | No Change: Both D | - |
| Q6BDS2 | URFB1_HUMAN UHRF1-binding protein 1 OS=Homo sapiens GN=UHRF1BP1 PE=1 SV=1 | 854 | K | 0.72198 | E | 0.740082 | -0.018102 | No Change: Both D | - |
| Q6BDS2 | URFB1_HUMAN UHRF1-binding protein 1 OS=Homo sapiens GN=UHRF1BP1 PE=1 SV=1 | 984 | Q | 0.913811 | H | 0.886274 | 0.027537 | No Change: Both D | - |
| Q6BDS2 | URFB1_HUMAN UHRF1-binding protein 1 OS=Homo sapiens GN=UHRF1BP1 PE=1 SV=1 | 1098 | M | 0.759839 | T | 0.77217 | -0.012331 | No Change: Both D | - |
| A0JNW5 | UH1BL_HUMAN UHRF1-binding protein 1-like OS=Homo sapiens GN=UHRF1BP1L PE=1 SV=2 | 1147 | S | 0.755972 | L | 0.639109 | 0.116863 | No Change: Both D | - |
| A0JNW5 | UH1BL_HUMAN UHRF1-binding protein 1-like OS=Homo sapiens GN=UHRF1BP1L PE=1 SV=2 | 1175 | I | 0.668659 | V | 0.695335 | -0.026676 | No Change: Both D | - |
| A0JNW5 | UH1BL_HUMAN UHRF1-binding protein 1-like OS=Homo sapiens GN=UHRF1BP1L PE=1 SV=2 | 1111 | M | 0.88462 | L | 0.854918 | 0.029702 | No Change: Both D | - |
| Q96PU4 | UHRF2_HUMAN E3 ubiquitin-protein ligase UHRF2 OS=Homo sapiens GN=UHRF2 PE=1 SV=1 | 87 | I | 0.704974 | N | 0.773826 | -0.068852 | No Change: Both D | A colorectal cancer sample |
| Q96RL1 | UIMC1_HUMAN BRCA1-A complex subunit RAP80 OS=Homo sapiens GN=UIMC1 PE=1 SV=2 | 15 | R | 0.975298 | W | 0.925127 | 0.050171 | No Change: Both D | - |
| Q96RL1 | UIMC1_HUMAN BRCA1-A complex subunit RAP80 OS=Homo sapiens GN=UIMC1 PE=1 SV=2 | 435 | P | 0.896731 | L | 0.837815 | 0.058916 | No Change: Both D | - |
| Q96RL1 | UIMC1_HUMAN BRCA1-A complex subunit RAP80 OS=Homo sapiens GN=UIMC1 PE=1 SV=2 | 511 | C | 0.381049 | R | 0.454233 | -0.073184 | No Change: Both O | - |
| Q96RL1 | UIMC1_HUMAN BRCA1-A complex subunit RAP80 OS=Homo sapiens GN=UIMC1 PE=1 SV=2 | 596 | G | 0.72764 | E | 0.751939 | -0.024299 | No Change: Both D | - |
| Q96RL1 | UIMC1_HUMAN BRCA1-A complex subunit RAP80 OS=Homo sapiens GN=UIMC1 PE=1 SV=2 | 353 | M | 0.977934 | T | 0.978518 | -5.84E-04 | No Change: Both D | - |
| Q9BZM6 | N2DL1_HUMAN NKG2D ligand 1 OS=Homo sapiens GN=ULBP1 PE=1 SV=1 | 101 | L | 0.157426 | I | 0.130764 | 0.026662 | No Change: Both O | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 290 | V | 0.95518 | M | 0.96551 | -0.01033 | No Change: Both D | An ovarian mucinous carcinoma sample |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 298 | S | 0.99554 | L | 0.990402 | 0.005138 | No Change: Both D | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 478 | P | 0.92737 | L | 0.875381 | 0.051989 | No Change: Both D | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 503 | T | 0.893166 | M | 0.896396 | -0.00323 | No Change: Both D | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 665 | S | 0.80741 | L | 0.747722 | 0.059688 | No Change: Both D | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 714 | P | 0.869443 | L | 0.795147 | 0.074296 | No Change: Both D | - |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 784 | S | 0.977582 | C | 0.965862 | 0.01172 | No Change: Both D | A lung adenocarcinoma sample |
| O75385 | ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2 | 816 | T | 0.644998 | A | 0.641617 | 0.003381 | No Change: Both D | - |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 242 | P | 0.506236 | S | 0.504977 | 0.001259 | No Change: Both D | - |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 627 | G | 0.739745 | E | 0.79781 | -0.058065 | No Change: Both D | A metastatic melanoma sample |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 662 | A | 0.85704 | V | 0.832664 | 0.024376 | No Change: Both D | A metastatic melanoma sample |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 752 | G | 0.879699 | R | 0.889389 | -0.00969 | No Change: Both D | - |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 842 | D | 0.16932 | E | 0.204013 | -0.034693 | No Change: Both O | - |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 370 | V | 0.629673 | M | 0.692614 | -0.062941 | No Change: Both D | - |
| Q8IYT8 | ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | 533 | T | 0.841368 | I | 0.774909 | 0.066459 | No Change: Both D | - |
| Q6PHR2 | ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2 | 101 | R | 0.195691 | H | 0.193789 | 0.001902 | No Change: Both O | - |
| Q6PHR2 | ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2 | 445 | K | 0.712026 | R | 0.716275 | -0.004249 | No Change: Both D | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 542 | A | 0.424014 | T | 0.464627 | -0.040613 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 569 | K | 0.330746 | R | 0.288245 | 0.042501 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 603 | L | 0.070073 | S | 0.130429 | -0.060356 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 640 | S | 0.352741 | A | 0.246078 | 0.106663 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 715 | A | 0.052353 | T | 0.060037 | -0.007684 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 18 | V | 0.475455 | A | 0.543081 | -0.067626 | O to D | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 39 | K | 0.226702 | R | 0.182641 | 0.044061 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 139 | N | 0.17611 | K | 0.221502 | -0.045392 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 223 | S | 0.698422 | N | 0.618091 | 0.080331 | No Change: Both D | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 348 | S | 0.928912 | G | 0.907244 | 0.021668 | No Change: Both D | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 415 | T | 0.409534 | M | 0.401356 | 0.008178 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 417 | S | 0.367163 | P | 0.386647 | -0.019484 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 224 | I | 0.705923 | V | 0.684214 | 0.021709 | No Change: Both D | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 1261 | A | 0.394054 | V | 0.300485 | 0.093569 | No Change: Both O | - |
| Q96C45 | ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=2 SV=2 | 1260 | S | 0.441096 | N | 0.366137 | 0.074959 | No Change: Both O | - |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 103 | G | 0.488972 | C | 0.436636 | 0.052336 | No Change: Both O | Medullary cystic kidney disease type 2 (MCKD2) [MIM:603860] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 148 | C | 0.408214 | Y | 0.376647 | 0.031567 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 217 | C | 0.151386 | R | 0.274164 | -0.122778 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 77 | C | 0.577642 | Y | 0.481375 | 0.096267 | D to O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 126 | C | 0.157249 | R | 0.206153 | -0.048904 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 128 | N | 0.139655 | S | 0.208124 | -0.068469 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 148 | C | 0.408214 | W | 0.308342 | 0.099872 | No Change: Both O | - |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 150 | C | 0.445439 | S | 0.611383 | -0.165944 | O to D | - |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 223 | C | 0.105755 | Y | 0.114132 | -0.008377 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 225 | T | 0.112204 | K | 0.144412 | -0.032208 | No Change: Both O | Medullary cystic kidney disease type 2 (MCKD2) [MIM:603860] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 248 | C | 0.214428 | W | 0.191792 | 0.022636 | No Change: Both O | Medullary cystic kidney disease type 2 (MCKD2) [MIM:603860] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 255 | C | 0.064808 | Y | 0.07197 | -0.007162 | No Change: Both O | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 300 | C | 0.522902 | G | 0.664867 | -0.141965 | No Change: Both D | Familial juvenile hyperuricemic nephropathy type 1 (HNFJ1) [MIM:162000] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 315 | C | 0.333323 | R | 0.429205 | -0.095882 | No Change: Both O | Glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI) [MIM:609886] |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 317 | C | 0.398163 | Y | 0.288485 | 0.109678 | No Change: Both O | - |
| P07911 | UROM_HUMAN Uromodulin OS=Homo sapiens GN=UMOD PE=1 SV=1 | 458 | V | 0.162338 | L | 0.169977 | -0.007639 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 173 | V | 0.069052 | L | 0.069591 | -5.39E-04 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 274 | N | 0.219576 | D | 0.225709 | -0.006133 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 274 | N | 0.219576 | H | 0.196317 | 0.023259 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 447 | R | 0.383227 | Q | 0.397813 | -0.014586 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 559 | M | 0.685322 | T | 0.744268 | -0.058946 | No Change: Both D | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 639 | I | 0.743043 | T | 0.853097 | -0.110054 | No Change: Both D | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 698 | T | 0.295971 | P | 0.349691 | -0.05372 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 850 | V | 0.264411 | I | 0.22641 | 0.038001 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 1027 | S | 0.654351 | N | 0.616111 | 0.03824 | No Change: Both D | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 1068 | G | 0.331441 | S | 0.400638 | -0.069197 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 1115 | E | 0.150214 | K | 0.150723 | -5.09E-04 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 1208 | D | 0.073637 | N | 0.077248 | -0.003611 | No Change: Both O | - |
| Q5DID0 | UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens GN=UMODL1 PE=2 SV=2 | 1309 | N | 0.327357 | H | 0.284772 | 0.042585 | No Change: Both O | - |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 96 | R | 0.344404 | G | 0.347933 | -0.003529 | No Change: Both O | Orotic aciduria type 1 (ORAC1) [MIM:258900] |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 109 | V | 0.377106 | G | 0.535398 | -0.158292 | O to D | Orotic aciduria type 1 (ORAC1) [MIM:258900] |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 213 | G | 0.461155 | A | 0.448806 | 0.012349 | No Change: Both O | - |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 429 | G | 0.563248 | R | 0.534827 | 0.028421 | No Change: Both D | Orotic aciduria type 1 (ORAC1) [MIM:258900] |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 30 | S | 0.30511 | G | 0.25412 | 0.05099 | No Change: Both O | - |
| P11172 | UMPS_HUMAN Uridine 5'-monophosphate synthase OS=Homo sapiens GN=UMPS PE=1 SV=1 | 446 | I | 0.212827 | V | 0.226402 | -0.013575 | No Change: Both O | - |
| Q9UPW8 | UN13A_HUMAN Protein unc-13 homolog A OS=Homo sapiens GN=UNC13A PE=2 SV=4 | 359 | A | 0.942122 | T | 0.932665 | 0.009457 | No Change: Both D | - |
| O14795 | UN13B_HUMAN Protein unc-13 homolog B OS=Homo sapiens GN=UNC13B PE=1 SV=2 | 209 | P | 0.939894 | S | 0.939624 | 2.70E-04 | No Change: Both D | A colorectal cancer sample |
| O14795 | UN13B_HUMAN Protein unc-13 homolog B OS=Homo sapiens GN=UNC13B PE=1 SV=2 | 238 | D | 0.925284 | E | 0.919474 | 0.00581 | No Change: Both D | - |
| O14795 | UN13B_HUMAN Protein unc-13 homolog B OS=Homo sapiens GN=UNC13B PE=1 SV=2 | 1232 | E | 0.221159 | D | 0.22852 | -0.007361 | No Change: Both O | - |
| Q8NB66 | UN13C_HUMAN Protein unc-13 homolog C OS=Homo sapiens GN=UNC13C PE=1 SV=3 | 942 | S | 0.940978 | L | 0.902586 | 0.038392 | No Change: Both D | - |
| Q8NB66 | UN13C_HUMAN Protein unc-13 homolog C OS=Homo sapiens GN=UNC13C PE=1 SV=3 | 609 | G | 0.720666 | S | 0.756571 | -0.035905 | No Change: Both D | - |
| Q70J99 | UN13D_HUMAN Protein unc-13 homolog D OS=Homo sapiens GN=UNC13D PE=1 SV=1 | 858 | H | 0.2141 | Q | 0.276293 | -0.062193 | No Change: Both O | - |
| Q70J99 | UN13D_HUMAN Protein unc-13 homolog D OS=Homo sapiens GN=UNC13D PE=1 SV=1 | 867 | K | 0.388817 | E | 0.406825 | -0.018008 | No Change: Both O | - |
| Q70J99 | UN13D_HUMAN Protein unc-13 homolog D OS=Homo sapiens GN=UNC13D PE=1 SV=1 | 59 | A | 0.427947 | T | 0.452066 | -0.024119 | No Change: Both O | - |
| Q9H3U1 | UN45A_HUMAN Protein unc-45 homolog A OS=Homo sapiens GN=UNC45A PE=1 SV=1 | 796 | T | 0.259906 | M | 0.290255 | -0.030349 | No Change: Both O | - |
| Q8IWX7 | UN45B_HUMAN Protein unc-45 homolog B OS=Homo sapiens GN=UNC45B PE=2 SV=1 | 60 | V | 0.444433 | I | 0.443242 | 0.001191 | No Change: Both O | - |
| Q8IWX7 | UN45B_HUMAN Protein unc-45 homolog B OS=Homo sapiens GN=UNC45B PE=2 SV=1 | 852 | I | 0.077761 | N | 0.165061 | -0.0873 | No Change: Both O | - |
| Q8IWX7 | UN45B_HUMAN Protein unc-45 homolog B OS=Homo sapiens GN=UNC45B PE=2 SV=1 | 496 | D | 0.386693 | H | 0.353087 | 0.033606 | No Change: Both O | A breast cancer sample |
| Q8IWX7 | UN45B_HUMAN Protein unc-45 homolog B OS=Homo sapiens GN=UNC45B PE=2 SV=1 | 199 | A | 0.150137 | V | 0.110024 | 0.040113 | No Change: Both O | - |
| Q8IWX7 | UN45B_HUMAN Protein unc-45 homolog B OS=Homo sapiens GN=UNC45B PE=2 SV=1 | 377 | K | 0.274819 | R | 0.240869 | 0.03395 | No Change: Both O | - |
| Q8IZJ1 | UNC5B_HUMAN Netrin receptor UNC5B OS=Homo sapiens GN=UNC5B PE=1 SV=2 | 516 | A | 0.641533 | T | 0.677132 | -0.035599 | No Change: Both D | - |
| Q8IZJ1 | UNC5B_HUMAN Netrin receptor UNC5B OS=Homo sapiens GN=UNC5B PE=1 SV=2 | 242 | I | 0.128155 | V | 0.161251 | -0.033096 | No Change: Both O | - |
| O95185 | UNC5C_HUMAN Netrin receptor UNC5C OS=Homo sapiens GN=UNC5C PE=1 SV=2 | 37 | G | 0.648568 | V | 0.532271 | 0.116297 | No Change: Both D | - |
| O95185 | UNC5C_HUMAN Netrin receptor UNC5C OS=Homo sapiens GN=UNC5C PE=1 SV=2 | 721 | M | 0.442937 | T | 0.4871 | -0.044163 | No Change: Both O | - |
| O95185 | UNC5C_HUMAN Netrin receptor UNC5C OS=Homo sapiens GN=UNC5C PE=1 SV=2 | 841 | A | 0.381751 | T | 0.448624 | -0.066873 | No Change: Both O | - |
| Q8IV45 | UN5CL_HUMAN UNC5C-like protein OS=Homo sapiens GN=UNC5CL PE=1 SV=2 | 432 | R | 0.296853 | G | 0.28445 | 0.012403 | No Change: Both O | - |
| Q6UXZ4 | UNC5D_HUMAN Netrin receptor UNC5D OS=Homo sapiens GN=UNC5D PE=1 SV=1 | 728 | R | 0.590813 | K | 0.641308 | -0.050495 | No Change: Both D | - |
| Q9P2D8 | UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens GN=UNC79 PE=2 SV=3 | 1597 | V | 0.811548 | A | 0.833521 | -0.021973 | No Change: Both D | - |
| Q9P2D8 | UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens GN=UNC79 PE=2 SV=3 | 1670 | V | 0.958143 | I | 0.943694 | 0.014449 | No Change: Both D | - |
| Q9P2D8 | UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens GN=UNC79 PE=2 SV=3 | 2183 | K | 0.153441 | R | 0.126357 | 0.027084 | No Change: Both O | - |
| Q9P2D8 | UNC79_HUMAN Protein unc-79 homolog OS=Homo sapiens GN=UNC79 PE=2 SV=3 | 2444 | G | 0.336219 | S | 0.408278 | -0.072059 | No Change: Both O | - |
| Q8N2C7 | UNC80_HUMAN Protein unc-80 homolog OS=Homo sapiens GN=UNC80 PE=2 SV=2 | 131 | R | 0.533961 | W | 0.35342 | 0.180541 | D to O | - |
| Q8N2C7 | UNC80_HUMAN Protein unc-80 homolog OS=Homo sapiens GN=UNC80 PE=2 SV=2 | 1505 | D | 0.464596 | G | 0.429343 | 0.035253 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 292 | V | 0.021759 | I | 0.019106 | 0.002653 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 387 | Y | 0.10728 | H | 0.176979 | -0.069699 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 403 | M | 0.025995 | T | 0.03254 | -0.006545 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 409 | V | 0.020358 | I | 0.017314 | 0.003044 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 445 | V | 0.648865 | A | 0.723918 | -0.075053 | No Change: Both D | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 6 | R | 0.441873 | K | 0.485869 | -0.043996 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 128 | K | 0.787238 | Q | 0.738722 | 0.048516 | No Change: Both D | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 295 | V | 0.021522 | M | 0.029281 | -0.007759 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 403 | M | 0.025995 | I | 0.017499 | 0.008496 | No Change: Both O | - |
| Q86WB7 | UN93A_HUMAN Protein unc-93 homolog A OS=Homo sapiens GN=UNC93A PE=2 SV=1 | 308 | V | 0.114818 | M | 0.141011 | -0.026193 | No Change: Both O | - |
| Q9H1C4 | UN93B_HUMAN Protein unc-93 homolog B1 OS=Homo sapiens GN=UNC93B1 PE=1 SV=2 | 436 | Y | 0.024638 | C | 0.019246 | 0.005392 | No Change: Both O | - |
| P13051 | UNG_HUMAN Uracil-DNA glycosylase OS=Homo sapiens GN=UNG PE=1 SV=2 | 251 | F | 0.074972 | S | 0.195561 | -0.120589 | No Change: Both O | Immunodeficiency with hyper-IgM type 5 (HIGM5) [MIM:608106] |
| P13051 | UNG_HUMAN Uracil-DNA glycosylase OS=Homo sapiens GN=UNG PE=1 SV=2 | 4 | Q | 0.775946 | R | 0.797336 | -0.02139 | No Change: Both D | - |
| Q9UBR1 | BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens GN=UPB1 PE=1 SV=1 | 85 | A | 0.35912 | E | 0.46027 | -0.10115 | No Change: Both O | Beta-ureidopropionase deficiency (BUPD) [MIM:613161] |
| Q9UBR1 | BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens GN=UPB1 PE=1 SV=1 | 340 | A | 0.188167 | D | 0.274988 | -0.086821 | No Change: Both O | - |
| Q92900 | RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens GN=UPF1 PE=1 SV=2 | 69 | A | 0.904986 | S | 0.915274 | -0.010288 | No Change: Both D | - |
| Q9HAU5 | RENT2_HUMAN Regulator of nonsense transcripts 2 OS=Homo sapiens GN=UPF2 PE=1 SV=1 | 496 | N | 0.912729 | S | 0.918511 | -0.005782 | No Change: Both D | - |
| Q9H1J1 | REN3A_HUMAN Regulator of nonsense transcripts 3A OS=Homo sapiens GN=UPF3A PE=1 SV=1 | 64 | R | 0.91167 | K | 0.914198 | -0.002528 | No Change: Both D | - |
| Q9BZI7 | REN3B_HUMAN Regulator of nonsense transcripts 3B OS=Homo sapiens GN=UPF3B PE=1 SV=1 | 160 | Y | 0.76375 | D | 0.86899 | -0.10524 | No Change: Both D | Mental retardation syndromic X-linked type 14 (MRXS14) [MIM:300676] |
| O00322 | UPK1A_HUMAN Uroplakin-1a OS=Homo sapiens GN=UPK1A PE=2 SV=1 | 257 | M | 0.383812 | T | 0.451767 | -0.067955 | No Change: Both O | - |
| O00322 | UPK1A_HUMAN Uroplakin-1a OS=Homo sapiens GN=UPK1A PE=2 SV=1 | 33 | S | 0.061421 | A | 0.036961 | 0.02446 | No Change: Both O | - |
| O75841 | UPK1B_HUMAN Uroplakin-1b OS=Homo sapiens GN=UPK1B PE=2 SV=5 | 113 | Q | 0.234566 | R | 0.206156 | 0.02841 | No Change: Both O | - |
| O00526 | UPK2_HUMAN Uroplakin-2 OS=Homo sapiens GN=UPK2 PE=2 SV=2 | 47 | A | 0.233082 | S | 0.342695 | -0.109613 | No Change: Both O | - |
| O00526 | UPK2_HUMAN Uroplakin-2 OS=Homo sapiens GN=UPK2 PE=2 SV=2 | 160 | T | 0.065647 | M | 0.062937 | 0.00271 | No Change: Both O | - |
| O75631 | UPK3A_HUMAN Uroplakin-3a OS=Homo sapiens GN=UPK3A PE=1 SV=3 | 154 | A | 0.235253 | P | 0.310176 | -0.074923 | No Change: Both O | - |
| O75631 | UPK3A_HUMAN Uroplakin-3a OS=Homo sapiens GN=UPK3A PE=1 SV=3 | 91 | Q | 0.504121 | L | 0.370479 | 0.133642 | D to O | - |
| O75631 | UPK3A_HUMAN Uroplakin-3a OS=Homo sapiens GN=UPK3A PE=1 SV=3 | 202 | G | 0.405704 | D | 0.429358 | -0.023654 | No Change: Both O | Renal adysplasia (RADYS) [MIM:191830] |
| O75631 | UPK3A_HUMAN Uroplakin-3a OS=Homo sapiens GN=UPK3A PE=1 SV=3 | 273 | P | 0.784741 | L | 0.636058 | 0.148683 | No Change: Both D | Renal adysplasia (RADYS) [MIM:191830] |
| Q9BT76 | UPK3B_HUMAN Uroplakin-3b OS=Homo sapiens GN=UPK3B PE=1 SV=2 | 293 | Q | 0.917698 | R | 0.913998 | 0.0037 | No Change: Both D | - |
| Q9BT76 | UPK3B_HUMAN Uroplakin-3b OS=Homo sapiens GN=UPK3B PE=1 SV=2 | 319 | W | 0.90934 | R | 0.958359 | -0.049019 | No Change: Both D | - |
| O95045 | UPP2_HUMAN Uridine phosphorylase 2 OS=Homo sapiens GN=UPP2 PE=1 SV=1 | 10 | R | 0.680864 | S | 0.724683 | -0.043819 | No Change: Both D | - |
| O95045 | UPP2_HUMAN Uridine phosphorylase 2 OS=Homo sapiens GN=UPP2 PE=1 SV=1 | 78 | M | 0.200342 | L | 0.157579 | 0.042763 | No Change: Both O | - |
| Q9NVA1 | UQCC_HUMAN Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog OS=Homo sapiens GN=UQCC PE=1 SV=3 | 51 | R | 0.797246 | Q | 0.816738 | -0.019492 | No Change: Both D | - |
| Q9NVA1 | UQCC_HUMAN Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog OS=Homo sapiens GN=UQCC PE=1 SV=3 | 85 | P | 0.63221 | L | 0.516502 | 0.115708 | No Change: Both D | - |
| Q9NVA1 | UQCC_HUMAN Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog OS=Homo sapiens GN=UQCC PE=1 SV=3 | 44 | W | 0.805198 | S | 0.933672 | -0.128474 | No Change: Both D | A breast cancer sample |
| Q9UDW1 | QCR9_HUMAN Cytochrome b-c1 complex subunit 9 OS=Homo sapiens GN=UQCR10 PE=1 SV=3 | 47 | I | 0.239518 | V | 0.251554 | -0.012036 | No Change: Both O | - |
| P14927 | QCR7_HUMAN Cytochrome b-c1 complex subunit 7 OS=Homo sapiens GN=UQCRB PE=1 SV=2 | 30 | L | 0.236037 | P | 0.365277 | -0.12924 | No Change: Both O | - |
| P31930 | QCR1_HUMAN Cytochrome b-c1 complex subunit 1 mitochondrial OS=Homo sapiens GN=UQCRC1 PE=1 SV=3 | 301 | N | 0.285178 | S | 0.326147 | -0.040969 | No Change: Both O | - |
| P31930 | QCR1_HUMAN Cytochrome b-c1 complex subunit 1 mitochondrial OS=Homo sapiens GN=UQCRC1 PE=1 SV=3 | 215 | D | 0.39943 | H | 0.376074 | 0.023356 | No Change: Both O | - |
| P22695 | QCR2_HUMAN Cytochrome b-c1 complex subunit 2 mitochondrial OS=Homo sapiens GN=UQCRC2 PE=1 SV=3 | 148 | R | 0.218998 | S | 0.26233 | -0.043332 | No Change: Both O | - |
| P22695 | QCR2_HUMAN Cytochrome b-c1 complex subunit 2 mitochondrial OS=Homo sapiens GN=UQCRC2 PE=1 SV=3 | 183 | R | 0.26993 | Q | 0.288004 | -0.018074 | No Change: Both O | - |
| P22695 | QCR2_HUMAN Cytochrome b-c1 complex subunit 2 mitochondrial OS=Homo sapiens GN=UQCRC2 PE=1 SV=3 | 254 | R | 0.4821 | H | 0.467134 | 0.014966 | No Change: Both O | - |
| P22695 | QCR2_HUMAN Cytochrome b-c1 complex subunit 2 mitochondrial OS=Homo sapiens GN=UQCRC2 PE=1 SV=3 | 208 | F | 0.222473 | Y | 0.254601 | -0.032128 | No Change: Both O | A colorectal cancer sample |
| P47985 | UCRI_HUMAN Cytochrome b-c1 complex subunit Rieske mitochondrial OS=Homo sapiens GN=UQCRFS1 PE=1 SV=2 | 6 | S | 0.795093 | A | 0.715835 | 0.079258 | No Change: Both D | - |
| P07919 | QCR6_HUMAN Cytochrome b-c1 complex subunit 6 mitochondrial OS=Homo sapiens GN=UQCRH PE=1 SV=2 | 51 | E | 0.9215 | Q | 0.898058 | 0.023442 | No Change: Both D | - |
| O14949 | QCR8_HUMAN Cytochrome b-c1 complex subunit 8 OS=Homo sapiens GN=UQCRQ PE=1 SV=4 | 45 | S | 0.15954 | F | 0.070812 | 0.088728 | No Change: Both O | Mitochondrial complex III deficiency (MT-C3D) [MIM:124000] |
| O60287 | NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens GN=URB1 PE=1 SV=4 | 2071 | P | 0.557128 | R | 0.491523 | 0.065605 | D to O | - |
| O60287 | NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens GN=URB1 PE=1 SV=4 | 1791 | V | 0.083927 | L | 0.083408 | 5.19E-04 | No Change: Both O | - |
| Q14146 | URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog OS=Homo sapiens GN=URB2 PE=1 SV=2 | 778 | V | 0.467796 | G | 0.617983 | -0.150187 | O to D | - |
| Q14146 | URB2_HUMAN Unhealthy ribosome biogenesis protein 2 homolog OS=Homo sapiens GN=URB2 PE=1 SV=2 | 1400 | V | 0.182725 | M | 0.236509 | -0.053784 | No Change: Both O | - |
| Q8TCY9 | URGCP_HUMAN Up-regulator of cell proliferation OS=Homo sapiens GN=URGCP PE=1 SV=2 | 779 | M | 0.153606 | L | 0.133914 | 0.019692 | No Change: Both O | - |
| Q8TCY9 | URGCP_HUMAN Up-regulator of cell proliferation OS=Homo sapiens GN=URGCP PE=1 SV=2 | 697 | T | 0.353901 | A | 0.288165 | 0.065736 | No Change: Both O | - |
| Q8TCY9 | URGCP_HUMAN Up-regulator of cell proliferation OS=Homo sapiens GN=URGCP PE=1 SV=2 | 756 | L | 0.24258 | F | 0.20447 | 0.03811 | No Change: Both O | - |
| Q96N76 | HUTU_HUMAN Urocanate hydratase OS=Homo sapiens GN=UROC1 PE=1 SV=1 | 188 | R | 0.413444 | W | 0.231997 | 0.181447 | No Change: Both O | - |
| Q96N76 | HUTU_HUMAN Urocanate hydratase OS=Homo sapiens GN=UROC1 PE=1 SV=1 | 311 | S | 0.347045 | T | 0.277128 | 0.069917 | No Change: Both O | - |
| Q96N76 | HUTU_HUMAN Urocanate hydratase OS=Homo sapiens GN=UROC1 PE=1 SV=1 | 429 | R | 0.333725 | C | 0.173721 | 0.160004 | No Change: Both O | - |
| Q96N76 | HUTU_HUMAN Urocanate hydratase OS=Homo sapiens GN=UROC1 PE=1 SV=1 | 450 | R | 0.106093 | C | 0.056088 | 0.050005 | No Change: Both O | Urocanase deficiency (UROD) [MIM:276880] |
| Q96N76 | HUTU_HUMAN Urocanate hydratase OS=Homo sapiens GN=UROC1 PE=1 SV=1 | 70 | L | 0.134648 | P | 0.240106 | -0.105458 | No Change: Both O | Urocanase deficiency (UROD) [MIM:276880] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 167 | E | 0.449926 | K | 0.444775 | 0.005151 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 167 | E | 0.449926 | K | 0.444775 | 0.005151 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 281 | G | 0.100027 | E | 0.126442 | -0.026415 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 281 | G | 0.100027 | V | 0.056514 | 0.043513 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 292 | R | 0.371096 | G | 0.396916 | -0.02582 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 80 | A | 0.175596 | G | 0.185377 | -0.009781 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 165 | M | 0.280736 | R | 0.311787 | -0.031051 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 195 | L | 0.109381 | F | 0.08493 | 0.024451 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 253 | L | 0.208319 | Q | 0.315863 | -0.107544 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 304 | N | 0.2168 | K | 0.263372 | -0.046572 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 318 | G | 0.341206 | R | 0.330834 | 0.010372 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 332 | R | 0.206801 | H | 0.225392 | -0.018591 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 334 | I | 0.228603 | T | 0.357446 | -0.128843 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 62 | P | 0.38324 | L | 0.233244 | 0.149996 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 134 | V | 0.141496 | Q | 0.239436 | -0.09794 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 134 | V | 0.141496 | Q | 0.239436 | -0.09794 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 220 | H | 0.41539 | P | 0.444046 | -0.028656 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 229 | F | 0.206222 | L | 0.235721 | -0.029499 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 311 | Y | 0.242248 | C | 0.220364 | 0.021884 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 324 | M | 0.293397 | T | 0.338281 | -0.044884 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 142 | R | 0.197276 | Q | 0.209166 | -0.01189 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 161 | L | 0.095899 | Q | 0.174819 | -0.07892 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 219 | S | 0.417891 | F | 0.213573 | 0.204318 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 235 | P | 0.086429 | S | 0.09165 | -0.005221 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 25 | G | 0.251996 | E | 0.314179 | -0.062183 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 46 | F | 0.471081 | L | 0.496515 | -0.025434 | No Change: Both O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 80 | A | 0.175596 | S | 0.243647 | -0.068051 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 144 | R | 0.211739 | P | 0.232699 | -0.02096 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 156 | G | 0.085591 | D | 0.087538 | -0.001947 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 193 | R | 0.15919 | P | 0.190428 | -0.031238 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 216 | L | 0.351634 | Q | 0.50438 | -0.152746 | O to D | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 218 | E | 0.427978 | K | 0.423613 | 0.004365 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 232 | F | 0.106575 | L | 0.124626 | -0.018051 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 260 | I | 0.103971 | T | 0.171921 | -0.06795 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 282 | L | 0.10207 | R | 0.173052 | -0.070982 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 303 | G | 0.208516 | S | 0.243586 | -0.03507 | No Change: Both O | Familial porphyria cutanea tarda (FPCT) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 15 | K | 0.38189 | E | 0.413284 | -0.031394 | No Change: Both O | - |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 106 | P | 0.672937 | L | 0.514544 | 0.158393 | No Change: Both D | - |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 113 | R | 0.719494 | T | 0.694762 | 0.024732 | No Change: Both D | - |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 303 | G | 0.208516 | V | 0.125527 | 0.082989 | No Change: Both O | - |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 168 | G | 0.524038 | R | 0.48656 | 0.037478 | D to O | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P06132 | DCUP_HUMAN Uroporphyrinogen decarboxylase OS=Homo sapiens GN=UROD PE=1 SV=2 | 170 | G | 0.614709 | D | 0.61566 | -9.51E-04 | No Change: Both D | Hepatoerythropoietic porphyria (HEP) [MIM:176100] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 4 | L | 0.64649 | F | 0.594053 | 0.052437 | No Change: Both D | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 19 | Y | 0.255766 | C | 0.244438 | 0.011328 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 53 | P | 0.585607 | L | 0.441263 | 0.144344 | D to O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 62 | T | 0.236958 | A | 0.23396 | 0.002998 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 66 | A | 0.276923 | V | 0.214353 | 0.06257 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 73 | C | 0.314435 | R | 0.479092 | -0.164657 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 82 | V | 0.444084 | F | 0.409351 | 0.034733 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 99 | V | 0.232112 | A | 0.300386 | -0.068274 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 104 | A | 0.266495 | V | 0.216746 | 0.049749 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 212 | S | 0.430095 | P | 0.397795 | 0.0323 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 225 | G | 0.267191 | S | 0.323087 | -0.055896 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 228 | T | 0.343268 | M | 0.280903 | 0.062365 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 188 | G | 0.37156 | R | 0.358249 | 0.013311 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 3 | V | 0.715053 | F | 0.678743 | 0.03631 | No Change: Both D | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 47 | S | 0.647812 | P | 0.617282 | 0.03053 | No Change: Both D | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 69 | A | 0.299549 | T | 0.318193 | -0.018644 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 129 | I | 0.401025 | T | 0.538591 | -0.137566 | O to D | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 188 | G | 0.37156 | W | 0.181217 | 0.190343 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 219 | I | 0.252377 | S | 0.423279 | -0.170902 | No Change: Both O | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 124 | K | 0.366359 | R | 0.317643 | 0.048716 | No Change: Both O | - |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 171 | V | 0.199082 | G | 0.3202 | -0.121118 | No Change: Both O | - |
| P10746 | HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens GN=UROS PE=1 SV=1 | 248 | P | 0.670991 | Q | 0.64485 | 0.026141 | No Change: Both D | Congenital erythropoietic porphyria (CEP) [MIM:263700] |
| Q9NZ43 | USE1_HUMAN Vesicle transport protein USE1 OS=Homo sapiens GN=USE1 PE=1 SV=2 | 154 | L | 0.704479 | S | 0.794997 | -0.090518 | No Change: Both D | - |
| Q9Y6N9 | USH1C_HUMAN Harmonin OS=Homo sapiens GN=USH1C PE=1 SV=3 | 519 | E | 0.339871 | D | 0.308929 | 0.030942 | No Change: Both O | - |
| Q495M9 | USH1G_HUMAN Usher syndrome type-1G protein OS=Homo sapiens GN=USH1G PE=1 SV=1 | 48 | L | 0.26921 | P | 0.383122 | -0.113912 | No Change: Both O | Usher syndrome type 1G (USH1G) [MIM:606943] |
| Q495M9 | USH1G_HUMAN Usher syndrome type-1G protein OS=Homo sapiens GN=USH1G PE=1 SV=1 | 458 | D | 0.900658 | V | 0.868501 | 0.032157 | No Change: Both D | Usher syndrome type 1G (USH1G) [MIM:606943] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 125 | A | 0.712767 | T | 0.728405 | -0.015638 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 163 | C | 0.146323 | Y | 0.169788 | -0.023465 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 218 | V | 0.194719 | E | 0.35076 | -0.156041 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 230 | V | 0.329954 | M | 0.393418 | -0.063464 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 319 | C | 0.4638 | Y | 0.408309 | 0.055491 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 334 | R | 0.562462 | W | 0.344759 | 0.217703 | D to O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 346 | N | 0.383992 | H | 0.359226 | 0.024766 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 419 | C | 0.182839 | F | 0.18881 | -0.005971 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 478 | E | 0.271383 | D | 0.250104 | 0.021279 | No Change: Both O | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 478 | E | 0.271383 | D | 0.250104 | 0.021279 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 536 | C | 0.401008 | R | 0.527306 | -0.126298 | O to D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 555 | L | 0.46849 | V | 0.431534 | 0.036956 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 610 | H | 0.440584 | P | 0.496009 | -0.055425 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 644 | D | 0.396521 | V | 0.257875 | 0.138646 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 703 | D | 0.628737 | E | 0.614335 | 0.014402 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 713 | G | 0.482774 | R | 0.478007 | 0.004767 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 759 | C | 0.621117 | F | 0.579559 | 0.041558 | No Change: Both D | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 759 | C | 0.621117 | F | 0.579559 | 0.041558 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 761 | P | 0.592073 | R | 0.56124 | 0.030833 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 841 | S | 0.490586 | Y | 0.333981 | 0.156605 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1486 | R | 0.340216 | K | 0.354423 | -0.014207 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1515 | T | 0.29841 | M | 0.289708 | 0.008702 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4115 | R | 0.179975 | C | 0.081824 | 0.098151 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4425 | T | 0.214858 | M | 0.182027 | 0.032831 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3199 | N | 0.339464 | D | 0.324217 | 0.015247 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1665 | I | 0.20245 | T | 0.312941 | -0.110491 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2106 | I | 0.194893 | T | 0.331604 | -0.136711 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2169 | I | 0.291089 | T | 0.414013 | -0.122924 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2875 | R | 0.3313 | Q | 0.351828 | -0.020528 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3099 | N | 0.296355 | S | 0.361763 | -0.065408 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3144 | D | 0.049632 | N | 0.045063 | 0.004569 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3335 | I | 0.395643 | M | 0.530215 | -0.134572 | O to D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4674 | R | 0.169413 | G | 0.163212 | 0.006201 | No Change: Both O | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3411 | E | 0.483527 | A | 0.3781 | 0.105427 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3835 | T | 0.250615 | I | 0.143488 | 0.107127 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4739 | R | 0.44993 | K | 0.50359 | -0.05366 | O to D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 268 | G | 0.195114 | R | 0.194675 | 4.39E-04 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 280 | L | 0.114612 | F | 0.098078 | 0.016534 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 284 | E | 0.167883 | K | 0.153475 | 0.014408 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 303 | R | 0.535884 | C | 0.37682 | 0.159064 | D to O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 303 | R | 0.535884 | S | 0.5987 | -0.062816 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 307 | S | 0.56914 | I | 0.373547 | 0.195593 | D to O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 334 | R | 0.562462 | Q | 0.558097 | 0.004365 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 352 | T | 0.301704 | I | 0.188699 | 0.113005 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 357 | N | 0.153179 | T | 0.133818 | 0.019361 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 365 | L | 0.232208 | F | 0.219512 | 0.012696 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 391 | S | 0.162471 | I | 0.074264 | 0.088207 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 464 | R | 0.477295 | C | 0.30678 | 0.170515 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 479 | F | 0.273155 | S | 0.501256 | -0.228101 | O to D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 516 | G | 0.250982 | V | 0.154952 | 0.09603 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 517 | R | 0.265389 | T | 0.264341 | 0.001048 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 575 | C | 0.416534 | S | 0.582768 | -0.166234 | O to D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 595 | F | 0.393557 | S | 0.586637 | -0.19308 | O to D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 739 | F | 0.385061 | L | 0.384036 | 0.001025 | No Change: Both O | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 911 | T | 0.492366 | N | 0.523289 | -0.030923 | O to D | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1047 | L | 0.629416 | V | 0.62871 | 7.06E-04 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1059 | P | 0.821423 | L | 0.705797 | 0.115626 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1212 | P | 0.056422 | L | 0.02796 | 0.028462 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1349 | S | 0.401122 | P | 0.363308 | 0.037814 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1470 | L | 0.351485 | R | 0.477942 | -0.126457 | No Change: Both O | Retinitis pigmentosa type 39 (RP39) [MIM:613809] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1572 | L | 0.225125 | F | 0.203766 | 0.021359 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1757 | Y | 0.126199 | C | 0.103468 | 0.022731 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 1833 | V | 0.314793 | E | 0.489855 | -0.175062 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2080 | K | 0.381816 | N | 0.354639 | 0.027177 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2086 | T | 0.08586 | N | 0.109673 | -0.023813 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2238 | E | 0.625216 | A | 0.53721 | 0.088006 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2249 | A | 0.659499 | D | 0.704897 | -0.045398 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2292 | R | 0.298503 | H | 0.311238 | -0.012735 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2354 | R | 0.27527 | H | 0.281628 | -0.006358 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2562 | V | 0.292708 | A | 0.363029 | -0.070321 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2795 | A | 0.155874 | S | 0.254652 | -0.098778 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2886 | L | 0.229203 | F | 0.200858 | 0.028345 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3088 | E | 0.048469 | K | 0.050298 | -0.001829 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3115 | T | 0.568855 | A | 0.505458 | 0.063397 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3124 | R | 0.308531 | G | 0.313578 | -0.005047 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3251 | C | 0.427294 | R | 0.512743 | -0.085449 | O to D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3267 | C | 0.444316 | R | 0.545213 | -0.100897 | O to D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3282 | C | 0.511019 | R | 0.575871 | -0.064852 | No Change: Both D | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3504 | P | 0.415951 | T | 0.361192 | 0.054759 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3521 | W | 0.16293 | R | 0.334147 | -0.171217 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3571 | T | 0.242315 | M | 0.190411 | 0.051904 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3590 | P | 0.486727 | L | 0.309908 | 0.176819 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3868 | M | 0.467512 | V | 0.414775 | 0.052737 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3893 | P | 0.327664 | T | 0.270191 | 0.057473 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3895 | G | 0.211411 | E | 0.263647 | -0.052236 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 3976 | T | 0.365405 | M | 0.317634 | 0.047771 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4054 | S | 0.152091 | I | 0.06451 | 0.087581 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4232 | P | 0.15787 | R | 0.135938 | 0.021932 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4337 | T | 0.499432 | M | 0.423471 | 0.075961 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4433 | V | 0.442688 | L | 0.447682 | -0.004994 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4439 | T | 0.455848 | I | 0.304245 | 0.151603 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4487 | Y | 0.256967 | C | 0.238214 | 0.018753 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4592 | Q | 0.30761 | H | 0.292941 | 0.014669 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4624 | F | 0.187186 | V | 0.205085 | -0.017899 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4795 | L | 0.265515 | R | 0.361733 | -0.096218 | No Change: Both O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4818 | P | 0.550279 | L | 0.40808 | 0.142199 | D to O | Usher syndrome type 2A (USH2A) [MIM:276901] |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 5031 | R | 0.849363 | W | 0.775446 | 0.073917 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 2820 | V | 0.506102 | I | 0.459455 | 0.046647 | D to O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4692 | G | 0.34036 | R | 0.332095 | 0.008265 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4838 | G | 0.661071 | E | 0.69889 | -0.037819 | No Change: Both D | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 453 | T | 0.332832 | I | 0.205592 | 0.12724 | No Change: Both O | - |
| O75445 | USH2A_HUMAN Usherin OS=Homo sapiens GN=USH2A PE=1 SV=3 | 4203 | Q | 0.277293 | R | 0.246133 | 0.03116 | No Change: Both O | - |
| Q8N6Y0 | USBP1_HUMAN Usher syndrome type-1C protein-binding protein 1 OS=Homo sapiens GN=USHBP1 PE=1 SV=1 | 439 | M | 0.743307 | V | 0.673889 | 0.069418 | No Change: Both D | - |
| Q8N6Y0 | USBP1_HUMAN Usher syndrome type-1C protein-binding protein 1 OS=Homo sapiens GN=USHBP1 PE=1 SV=1 | 525 | V | 0.612068 | M | 0.703919 | -0.091851 | No Change: Both D | - |
| Q8N6Y0 | USBP1_HUMAN Usher syndrome type-1C protein-binding protein 1 OS=Homo sapiens GN=USHBP1 PE=1 SV=1 | 677 | A | 0.90527 | V | 0.867932 | 0.037338 | No Change: Both D | - |
| Q14694 | UBP10_HUMAN Ubiquitin carboxyl-terminal hydrolase 10 OS=Homo sapiens GN=USP10 PE=1 SV=2 | 200 | M | 0.896109 | V | 0.867519 | 0.02859 | No Change: Both D | - |
| Q14694 | UBP10_HUMAN Ubiquitin carboxyl-terminal hydrolase 10 OS=Homo sapiens GN=USP10 PE=1 SV=2 | 203 | S | 0.901634 | P | 0.905221 | -0.003587 | No Change: Both D | - |
| Q14694 | UBP10_HUMAN Ubiquitin carboxyl-terminal hydrolase 10 OS=Homo sapiens GN=USP10 PE=1 SV=2 | 204 | V | 0.909452 | L | 0.900161 | 0.009291 | No Change: Both D | - |
| Q9Y5T5 | UBP16_HUMAN Ubiquitin carboxyl-terminal hydrolase 16 OS=Homo sapiens GN=USP16 PE=1 SV=1 | 141 | Q | 0.452193 | H | 0.396067 | 0.056126 | No Change: Both O | - |
| Q6R6M4 | U17L2_HUMAN Ubiquitin carboxyl-terminal hydrolase 17-like protein 2 OS=Homo sapiens GN=USP17L2 PE=1 SV=2 | 438 | K | 0.648444 | R | 0.606936 | 0.041508 | No Change: Both D | - |
| P0C7H9 | U17L7_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7 OS=Homo sapiens GN=USP17L7 PE=3 SV=1 | 161 | A | 0.454806 | G | 0.506346 | -0.05154 | O to D | - |
| P0C7H9 | U17L7_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7 OS=Homo sapiens GN=USP17L7 PE=3 SV=1 | 494 | P | 0.940501 | L | 0.914001 | 0.0265 | No Change: Both D | - |
| Q9UMW8 | UBP18_HUMAN Ubl carboxyl-terminal hydrolase 18 OS=Homo sapiens GN=USP18 PE=1 SV=1 | 169 | T | 0.090868 | M | 0.075092 | 0.015776 | No Change: Both O | - |
| O94966 | UBP19_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens GN=USP19 PE=1 SV=2 | 36 | D | 0.9671 | H | 0.955464 | 0.011636 | No Change: Both D | - |
| O75604 | UBP2_HUMAN Ubiquitin carboxyl-terminal hydrolase 2 OS=Homo sapiens GN=USP2 PE=1 SV=2 | 174 | R | 0.495144 | Q | 0.485682 | 0.009462 | No Change: Both O | - |
| O75604 | UBP2_HUMAN Ubiquitin carboxyl-terminal hydrolase 2 OS=Homo sapiens GN=USP2 PE=1 SV=2 | 383 | N | 0.713553 | S | 0.728318 | -0.014765 | No Change: Both D | - |
| Q9Y2K6 | UBP20_HUMAN Ubiquitin carboxyl-terminal hydrolase 20 OS=Homo sapiens GN=USP20 PE=1 SV=2 | 103 | S | 0.676683 | Y | 0.484206 | 0.192477 | D to O | - |
| Q9Y2K6 | UBP20_HUMAN Ubiquitin carboxyl-terminal hydrolase 20 OS=Homo sapiens GN=USP20 PE=1 SV=2 | 444 | V | 0.365234 | I | 0.350959 | 0.014275 | No Change: Both O | - |
| Q9UK80 | UBP21_HUMAN Ubiquitin carboxyl-terminal hydrolase 21 OS=Homo sapiens GN=USP21 PE=1 SV=1 | 91 | P | 0.97309 | S | 0.969972 | 0.003118 | No Change: Both D | - |
| Q9UK80 | UBP21_HUMAN Ubiquitin carboxyl-terminal hydrolase 21 OS=Homo sapiens GN=USP21 PE=1 SV=1 | 321 | G | 0.678962 | D | 0.691075 | -0.012113 | No Change: Both D | - |
| Q9UK80 | UBP21_HUMAN Ubiquitin carboxyl-terminal hydrolase 21 OS=Homo sapiens GN=USP21 PE=1 SV=1 | 336 | P | 0.882395 | T | 0.808979 | 0.073416 | No Change: Both D | - |
| Q9UPU5 | UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens GN=USP24 PE=1 SV=3 | 226 | T | 0.221123 | I | 0.133168 | 0.087955 | No Change: Both O | - |
| Q9UPU5 | UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens GN=USP24 PE=1 SV=3 | 1940 | G | 0.74162 | S | 0.761807 | -0.020187 | No Change: Both D | - |
| Q9UPU5 | UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens GN=USP24 PE=1 SV=3 | 2134 | Y | 0.339154 | S | 0.526166 | -0.187012 | O to D | - |
| Q9UPU5 | UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens GN=USP24 PE=1 SV=3 | 2468 | V | 0.159543 | A | 0.194214 | -0.034671 | No Change: Both O | - |
| Q9BXU7 | UBP26_HUMAN Ubiquitin carboxyl-terminal hydrolase 26 OS=Homo sapiens GN=USP26 PE=1 SV=1 | 165 | L | 0.796958 | S | 0.871389 | -0.074431 | No Change: Both D | - |
| Q9BXU7 | UBP26_HUMAN Ubiquitin carboxyl-terminal hydrolase 26 OS=Homo sapiens GN=USP26 PE=1 SV=1 | 364 | L | 0.253523 | F | 0.210163 | 0.04336 | No Change: Both O | - |
| Q9BXU7 | UBP26_HUMAN Ubiquitin carboxyl-terminal hydrolase 26 OS=Homo sapiens GN=USP26 PE=1 SV=1 | 475 | H | 0.537325 | Y | 0.427673 | 0.109652 | D to O | - |
| Q9BXU7 | UBP26_HUMAN Ubiquitin carboxyl-terminal hydrolase 26 OS=Homo sapiens GN=USP26 PE=1 SV=1 | 517 | L | 0.112618 | F | 0.095512 | 0.017106 | No Change: Both O | - |
| Q9BXU7 | UBP26_HUMAN Ubiquitin carboxyl-terminal hydrolase 26 OS=Homo sapiens GN=USP26 PE=1 SV=1 | 579 | M | 0.388809 | I | 0.34437 | 0.044439 | No Change: Both O | - |
| Q9HBJ7 | UBP29_HUMAN Ubiquitin carboxyl-terminal hydrolase 29 OS=Homo sapiens GN=USP29 PE=2 SV=1 | 586 | E | 0.904771 | K | 0.902274 | 0.002497 | No Change: Both D | - |
| Q9HBJ7 | UBP29_HUMAN Ubiquitin carboxyl-terminal hydrolase 29 OS=Homo sapiens GN=USP29 PE=2 SV=1 | 368 | N | 0.387496 | S | 0.426223 | -0.038727 | No Change: Both O | - |
| Q9Y6I4 | UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens GN=USP3 PE=1 SV=2 | 360 | P | 0.786994 | T | 0.750255 | 0.036739 | No Change: Both D | - |
| Q70CQ3 | UBP30_HUMAN Ubiquitin carboxyl-terminal hydrolase 30 OS=Homo sapiens GN=USP30 PE=1 SV=1 | 357 | H | 0.375292 | R | 0.369534 | 0.005758 | No Change: Both O | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 445 | D | 0.729101 | Y | 0.645756 | 0.083345 | No Change: Both D | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 532 | Q | 0.399413 | H | 0.384799 | 0.014614 | No Change: Both O | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 538 | I | 0.19425 | T | 0.32147 | -0.12722 | No Change: Both O | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 552 | A | 0.261059 | T | 0.300419 | -0.03936 | No Change: Both O | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 931 | R | 0.817811 | L | 0.744265 | 0.073546 | No Change: Both D | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 1269 | D | 0.927959 | N | 0.925398 | 0.002561 | No Change: Both D | - |
| Q70CQ4 | UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens GN=USP31 PE=1 SV=2 | 1309 | R | 0.981691 | C | 0.976735 | 0.004956 | No Change: Both D | - |
| Q8NFA0 | UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens GN=USP32 PE=1 SV=1 | 76 | H | 0.235509 | Y | 0.152471 | 0.083038 | No Change: Both O | - |
| Q8NFA0 | UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens GN=USP32 PE=1 SV=1 | 1469 | A | 0.329149 | G | 0.380162 | -0.051013 | No Change: Both O | - |
| Q8NFA0 | UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens GN=USP32 PE=1 SV=1 | 1568 | G | 0.263802 | R | 0.259658 | 0.004144 | No Change: Both O | - |
| Q8NFA0 | UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens GN=USP32 PE=1 SV=1 | 1578 | T | 0.572185 | I | 0.443201 | 0.128984 | D to O | - |
| Q70CQ2 | UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens GN=USP34 PE=1 SV=2 | 661 | M | 0.848496 | T | 0.866254 | -0.017758 | No Change: Both D | - |
| Q70CQ2 | UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens GN=USP34 PE=1 SV=2 | 1663 | L | 0.178402 | R | 0.253604 | -0.075202 | No Change: Both O | - |
| Q70CQ2 | UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens GN=USP34 PE=1 SV=2 | 2348 | D | 0.105923 | N | 0.090133 | 0.01579 | No Change: Both O | - |
| Q9P2H5 | UBP35_HUMAN Ubiquitin carboxyl-terminal hydrolase 35 OS=Homo sapiens GN=USP35 PE=1 SV=3 | 236 | V | 0.447453 | M | 0.517088 | -0.069635 | O to D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 271 | V | 0.148299 | I | 0.139001 | 0.009298 | No Change: Both O | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 489 | I | 0.893456 | M | 0.922616 | -0.02916 | No Change: Both D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 775 | R | 0.981143 | Q | 0.985207 | -0.004064 | No Change: Both D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 806 | Q | 0.971644 | R | 0.970379 | 0.001265 | No Change: Both D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 814 | K | 0.968417 | N | 0.957036 | 0.011381 | No Change: Both D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 828 | R | 0.970396 | C | 0.950721 | 0.019675 | No Change: Both D | - |
| Q9P275 | UBP36_HUMAN Ubiquitin carboxyl-terminal hydrolase 36 OS=Homo sapiens GN=USP36 PE=1 SV=3 | 887 | R | 0.932179 | P | 0.936636 | -0.004457 | No Change: Both D | - |
| Q86T82 | UBP37_HUMAN Ubiquitin carboxyl-terminal hydrolase 37 OS=Homo sapiens GN=USP37 PE=1 SV=2 | 979 | L | 0.785071 | S | 0.826837 | -0.041766 | No Change: Both D | - |
| Q13107 | UBP4_HUMAN Ubiquitin carboxyl-terminal hydrolase 4 OS=Homo sapiens GN=USP4 PE=1 SV=3 | 620 | Y | 0.354022 | C | 0.421823 | -0.067801 | No Change: Both O | - |
| Q9NVE5 | UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens GN=USP40 PE=2 SV=3 | 666 | V | 0.24944 | A | 0.322077 | -0.072637 | No Change: Both O | - |
| Q9NVE5 | UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens GN=USP40 PE=2 SV=3 | 1111 | R | 0.111422 | C | 0.04891 | 0.062512 | No Change: Both O | - |
| Q9NVE5 | UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens GN=USP40 PE=2 SV=3 | 1025 | T | 0.471477 | M | 0.435932 | 0.035545 | No Change: Both O | - |
| Q3LFD5 | UBP41_HUMAN Putative ubiquitin carboxyl-terminal hydrolase 41 OS=Homo sapiens GN=USP41 PE=2 SV=2 | 130 | Y | 0.086033 | C | 0.070746 | 0.015287 | No Change: Both O | - |
| Q3LFD5 | UBP41_HUMAN Putative ubiquitin carboxyl-terminal hydrolase 41 OS=Homo sapiens GN=USP41 PE=2 SV=2 | 325 | N | 0.059646 | S | 0.073769 | -0.014123 | No Change: Both O | - |
| Q9H9J4 | UBP42_HUMAN Ubiquitin carboxyl-terminal hydrolase 42 OS=Homo sapiens GN=USP42 PE=1 SV=3 | 1030 | L | 0.772234 | P | 0.864165 | -0.091931 | No Change: Both D | - |
| Q9H0E7 | UBP44_HUMAN Ubiquitin carboxyl-terminal hydrolase 44 OS=Homo sapiens GN=USP44 PE=1 SV=2 | 91 | T | 0.375107 | A | 0.329671 | 0.045436 | No Change: Both O | - |
| Q9H0E7 | UBP44_HUMAN Ubiquitin carboxyl-terminal hydrolase 44 OS=Homo sapiens GN=USP44 PE=1 SV=2 | 316 | E | 0.577765 | Q | 0.544455 | 0.03331 | No Change: Both D | - |
| Q9H0E7 | UBP44_HUMAN Ubiquitin carboxyl-terminal hydrolase 44 OS=Homo sapiens GN=USP44 PE=1 SV=2 | 348 | R | 0.780276 | G | 0.785042 | -0.004766 | No Change: Both D | - |
| Q70EL2 | UBP45_HUMAN Ubiquitin carboxyl-terminal hydrolase 45 OS=Homo sapiens GN=USP45 PE=1 SV=3 | 67 | K | 0.22447 | E | 0.242648 | -0.018178 | No Change: Both O | - |
| Q70EL2 | UBP45_HUMAN Ubiquitin carboxyl-terminal hydrolase 45 OS=Homo sapiens GN=USP45 PE=1 SV=3 | 778 | N | 0.501174 | S | 0.548899 | -0.047725 | No Change: Both D | - |
| Q70EL2 | UBP45_HUMAN Ubiquitin carboxyl-terminal hydrolase 45 OS=Homo sapiens GN=USP45 PE=1 SV=3 | 521 | R | 0.941591 | T | 0.948109 | -0.006518 | No Change: Both D | - |
| P62068 | UBP46_HUMAN Ubiquitin carboxyl-terminal hydrolase 46 OS=Homo sapiens GN=USP46 PE=1 SV=1 | 81 | A | 0.132322 | V | 0.094481 | 0.037841 | No Change: Both O | - |
| Q96K76 | UBP47_HUMAN Ubiquitin carboxyl-terminal hydrolase 47 OS=Homo sapiens GN=USP47 PE=1 SV=3 | 163 | G | 0.771915 | V | 0.697636 | 0.074279 | No Change: Both D | - |
| Q86UV5 | UBP48_HUMAN Ubiquitin carboxyl-terminal hydrolase 48 OS=Homo sapiens GN=USP48 PE=1 SV=1 | 125 | S | 0.199811 | C | 0.075453 | 0.124358 | No Change: Both O | - |
| Q86UV5 | UBP48_HUMAN Ubiquitin carboxyl-terminal hydrolase 48 OS=Homo sapiens GN=USP48 PE=1 SV=1 | 135 | E | 0.646049 | K | 0.642978 | 0.003071 | No Change: Both D | - |
| Q70EK8 | UBP53_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 53 OS=Homo sapiens GN=USP53 PE=2 SV=2 | 962 | S | 0.907289 | R | 0.882709 | 0.02458 | No Change: Both D | - |
| Q70EL1 | UBP54_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 54 OS=Homo sapiens GN=USP54 PE=1 SV=4 | 505 | L | 0.892983 | V | 0.89274 | 2.43E-04 | No Change: Both D | A breast cancer sample |
| Q70EL1 | UBP54_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 54 OS=Homo sapiens GN=USP54 PE=1 SV=4 | 976 | K | 0.630266 | E | 0.646059 | -0.015793 | No Change: Both D | - |
| Q70EL1 | UBP54_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 54 OS=Homo sapiens GN=USP54 PE=1 SV=4 | 1231 | D | 0.815825 | N | 0.796289 | 0.019536 | No Change: Both D | - |
| Q70EL1 | UBP54_HUMAN Inactive ubiquitin carboxyl-terminal hydrolase 54 OS=Homo sapiens GN=USP54 PE=1 SV=4 | 1367 | G | 0.879632 | D | 0.888902 | -0.00927 | No Change: Both D | - |
| P35125 | UBP6_HUMAN Ubiquitin carboxyl-terminal hydrolase 6 OS=Homo sapiens GN=USP6 PE=1 SV=2 | 475 | W | 0.047783 | R | 0.117234 | -0.069451 | No Change: Both O | - |
| P35125 | UBP6_HUMAN Ubiquitin carboxyl-terminal hydrolase 6 OS=Homo sapiens GN=USP6 PE=1 SV=2 | 912 | R | 0.276832 | Q | 0.292701 | -0.015869 | No Change: Both O | - |
| P35125 | UBP6_HUMAN Ubiquitin carboxyl-terminal hydrolase 6 OS=Homo sapiens GN=USP6 PE=1 SV=2 | 1330 | I | 0.203518 | V | 0.215157 | -0.011639 | No Change: Both O | - |
| P35125 | UBP6_HUMAN Ubiquitin carboxyl-terminal hydrolase 6 OS=Homo sapiens GN=USP6 PE=1 SV=2 | 525 | V | 0.662449 | I | 0.665865 | -0.003416 | No Change: Both D | - |
| P40818 | UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens GN=USP8 PE=1 SV=1 | 443 | D | 0.787728 | G | 0.770343 | 0.017385 | No Change: Both D | - |
| P40818 | UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens GN=USP8 PE=1 SV=1 | 827 | A | 0.395494 | G | 0.484074 | -0.08858 | No Change: Both O | - |
| P40818 | UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens GN=USP8 PE=1 SV=1 | 739 | T | 0.87554 | A | 0.853267 | 0.022273 | No Change: Both D | - |
| O00507 | USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens GN=USP9Y PE=1 SV=2 | 1060 | A | 0.455663 | T | 0.465125 | -0.009462 | No Change: Both O | - |
| O00507 | USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens GN=USP9Y PE=1 SV=2 | 1035 | P | 0.480351 | S | 0.507893 | -0.027542 | O to D | - |
| O00507 | USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens GN=USP9Y PE=1 SV=2 | 65 | E | 0.850845 | D | 0.84254 | 0.008305 | No Change: Both D | - |
| O00507 | USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens GN=USP9Y PE=1 SV=2 | 211 | R | 0.638703 | C | 0.480258 | 0.158445 | D to O | - |
| O00507 | USP9Y_HUMAN Probable ubiquitin carboxyl-terminal hydrolase FAF-Y OS=Homo sapiens GN=USP9Y PE=1 SV=2 | 1705 | A | 0.3473 | S | 0.453654 | -0.106354 | No Change: Both O | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 173 | E | 0.792933 | G | 0.746718 | 0.046215 | No Change: Both D | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 384 | P | 0.150389 | S | 0.157642 | -0.007253 | No Change: Both O | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 522 | A | 0.66851 | P | 0.738101 | -0.069591 | No Change: Both D | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 531 | L | 0.736423 | S | 0.852992 | -0.116569 | No Change: Both D | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 739 | S | 0.925682 | C | 0.872826 | 0.052856 | No Change: Both D | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 950 | S | 0.547911 | N | 0.474766 | 0.073145 | D to O | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 1043 | T | 0.614656 | S | 0.683994 | -0.069338 | No Change: Both D | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 583 | I | 0.267034 | V | 0.307692 | -0.040658 | No Change: Both O | - |
| Q5W0Q7 | USPL1_HUMAN Ubiquitin-specific peptidase-like protein 1 OS=Homo sapiens GN=USPL1 PE=2 SV=1 | 786 | L | 0.417412 | I | 0.409199 | 0.008213 | No Change: Both O | - |
| Q9Y2C2 | UST_HUMAN Uronyl 2-sulfotransferase OS=Homo sapiens GN=UST PE=2 SV=1 | 21 | M | 0.786673 | L | 0.75536 | 0.031313 | No Change: Both D | - |
| Q5T230 | UTF1_HUMAN Undifferentiated embryonic cell transcription factor 1 OS=Homo sapiens GN=UTF1 PE=1 SV=1 | 73 | G | 0.435896 | R | 0.509827 | -0.073931 | O to D | - |
| Q9BVJ6 | UT14A_HUMAN U3 small nucleolar RNA-associated protein 14 homolog A OS=Homo sapiens GN=UTP14A PE=1 SV=1 | 487 | V | 0.985172 | A | 0.988883 | -0.003711 | No Change: Both D | - |
| Q5TAP6 | UT14C_HUMAN U3 small nucleolar RNA-associated protein 14 homolog C OS=Homo sapiens GN=UTP14C PE=1 SV=1 | 85 | G | 0.889676 | V | 0.859444 | 0.030232 | No Change: Both D | - |
| Q5TAP6 | UT14C_HUMAN U3 small nucleolar RNA-associated protein 14 homolog C OS=Homo sapiens GN=UTP14C PE=1 SV=1 | 101 | T | 0.805054 | A | 0.791009 | 0.014045 | No Change: Both D | - |
| Q5TAP6 | UT14C_HUMAN U3 small nucleolar RNA-associated protein 14 homolog C OS=Homo sapiens GN=UTP14C PE=1 SV=1 | 319 | R | 0.848551 | H | 0.830567 | 0.017984 | No Change: Both D | - |
| Q8TED0 | UTP15_HUMAN U3 small nucleolar RNA-associated protein 15 homolog OS=Homo sapiens GN=UTP15 PE=1 SV=3 | 228 | Y | 0.142456 | H | 0.233064 | -0.090608 | No Change: Both O | - |
| Q8TED0 | UTP15_HUMAN U3 small nucleolar RNA-associated protein 15 homolog OS=Homo sapiens GN=UTP15 PE=1 SV=3 | 332 | R | 0.634987 | S | 0.64827 | -0.013283 | No Change: Both D | - |
| Q8TED0 | UTP15_HUMAN U3 small nucleolar RNA-associated protein 15 homolog OS=Homo sapiens GN=UTP15 PE=1 SV=3 | 483 | T | 0.311419 | P | 0.362883 | -0.051464 | No Change: Both O | - |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 502 | S | 0.167598 | C | 0.067595 | 0.100003 | No Change: Both O | - |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 2612 | E | 0.738679 | Q | 0.69456 | 0.044119 | No Change: Both D | - |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 1645 | K | 0.078861 | I | 0.031551 | 0.04731 | No Change: Both O | A breast cancer sample |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 2452 | I | 0.121043 | F | 0.120394 | 6.49E-04 | No Change: Both O | A breast cancer sample |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 120 | M | 0.20235 | T | 0.239014 | -0.036664 | No Change: Both O | - |
| O75691 | UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens GN=UTP20 PE=1 SV=3 | 1882 | L | 0.0433 | Q | 0.078288 | -0.034988 | No Change: Both O | - |
| Q9BRU9 | UTP23_HUMAN rRNA-processing protein UTP23 homolog OS=Homo sapiens GN=UTP23 PE=2 SV=2 | 170 | H | 0.676419 | R | 0.681298 | -0.004879 | No Change: Both D | - |
| Q9BRU9 | UTP23_HUMAN rRNA-processing protein UTP23 homolog OS=Homo sapiens GN=UTP23 PE=2 SV=2 | 195 | K | 0.978333 | Q | 0.975089 | 0.003244 | No Change: Both D | - |
| Q9BRU9 | UTP23_HUMAN rRNA-processing protein UTP23 homolog OS=Homo sapiens GN=UTP23 PE=2 SV=2 | 215 | P | 0.99468 | L | 0.99125 | 0.00343 | No Change: Both D | - |
| Q9NQZ2 | SAS10_HUMAN Something about silencing protein 10 OS=Homo sapiens GN=UTP3 PE=1 SV=1 | 23 | T | 0.669827 | M | 0.634141 | 0.035686 | No Change: Both D | - |
| Q9NYH9 | UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens GN=UTP6 PE=1 SV=2 | 69 | Q | 0.202187 | R | 0.210134 | -0.007947 | No Change: Both O | - |
| Q9NYH9 | UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens GN=UTP6 PE=1 SV=2 | 35 | K | 0.377799 | R | 0.296135 | 0.081664 | No Change: Both O | - |
| Q9NYH9 | UTP6_HUMAN U3 small nucleolar RNA-associated protein 6 homolog OS=Homo sapiens GN=UTP6 PE=1 SV=2 | 134 | L | 0.210796 | V | 0.215493 | -0.004697 | No Change: Both O | - |
| P46939 | UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN PE=1 SV=2 | 1880 | L | 0.073164 | I | 0.06298 | 0.010184 | No Change: Both O | - |
| P46939 | UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN PE=1 SV=2 | 1974 | A | 0.264915 | T | 0.293799 | -0.028884 | No Change: Both O | - |
| P46939 | UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN PE=1 SV=2 | 2060 | G | 0.296838 | D | 0.337207 | -0.040369 | No Change: Both O | - |
| P46939 | UTRO_HUMAN Utrophin OS=Homo sapiens GN=UTRN PE=1 SV=2 | 2202 | N | 0.565091 | S | 0.664646 | -0.099555 | No Change: Both D | - |
| O95399 | UTS2_HUMAN Urotensin-2 OS=Homo sapiens GN=UTS2 PE=1 SV=1 | 74 | S | 0.547706 | N | 0.515707 | 0.031999 | No Change: Both D | - |
| O95399 | UTS2_HUMAN Urotensin-2 OS=Homo sapiens GN=UTS2 PE=1 SV=1 | 12 | I | 0.040537 | T | 0.072245 | -0.031708 | No Change: Both O | - |
| Q765I0 | UTS2B_HUMAN Urotensin-2B OS=Homo sapiens GN=UTS2D PE=2 SV=2 | 21 | S | 0.168503 | I | 0.059488 | 0.109015 | No Change: Both O | - |
| Q9UKP6 | UR2R_HUMAN Urotensin-2 receptor OS=Homo sapiens GN=UTS2R PE=1 SV=1 | 146 | S | 0.312788 | R | 0.247899 | 0.064889 | No Change: Both O | A breast cancer sample |
| Q9UKP6 | UR2R_HUMAN Urotensin-2 receptor OS=Homo sapiens GN=UTS2R PE=1 SV=1 | 70 | A | 0.097005 | P | 0.137131 | -0.040126 | No Change: Both O | - |
| Q9P2Y5 | UVRAG_HUMAN UV radiation resistance-associated gene protein OS=Homo sapiens GN=UVRAG PE=1 SV=1 | 10 | P | 0.989605 | H | 0.981194 | 0.008411 | No Change: Both D | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 116 | A | 0.058209 | T | 0.071553 | -0.013344 | No Change: Both O | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 239 | V | 0.036577 | I | 0.034534 | 0.002043 | No Change: Both O | Sacral defect with anterior meningocele (SDAM) [MIM:600145] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 274 | R | 0.147003 | Q | 0.169189 | -0.022186 | No Change: Both O | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 328 | M | 0.605056 | T | 0.622902 | -0.017846 | No Change: Both D | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 347 | E | 0.766667 | A | 0.68852 | 0.078147 | No Change: Both D | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 25 | E | 0.989948 | K | 0.990609 | -6.61E-04 | No Change: Both D | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 83 | S | 0.725362 | L | 0.557869 | 0.167493 | No Change: Both D | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 153 | F | 0.043357 | S | 0.118306 | -0.074949 | No Change: Both O | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 175 | R | 0.244688 | Q | 0.240479 | 0.004209 | No Change: Both O | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 181 | R | 0.181475 | Q | 0.176981 | 0.004494 | No Change: Both O | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 202 | L | 0.010922 | F | 0.009712 | 0.00121 | No Change: Both O | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 251 | T | 0.172435 | M | 0.144416 | 0.028019 | No Change: Both O | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 290 | Y | 0.151924 | H | 0.22678 | -0.074856 | No Change: Both O | - |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 404 | A | 0.333797 | S | 0.418333 | -0.084536 | No Change: Both O | Neural tube defects (NTD) [MIM:182940] |
| Q8TAA9 | VANG1_HUMAN Vang-like protein 1 OS=Homo sapiens GN=VANGL1 PE=1 SV=1 | 468 | D | 0.289909 | E | 0.329056 | -0.039147 | No Change: Both O | - |
| Q9P0L0 | VAPA_HUMAN Vesicle-associated membrane protein-associated protein A OS=Homo sapiens GN=VAPA PE=1 SV=3 | 8 | M | 0.56405 | T | 0.580486 | -0.016436 | No Change: Both D | - |
| Q9P0L0 | VAPA_HUMAN Vesicle-associated membrane protein-associated protein A OS=Homo sapiens GN=VAPA PE=1 SV=3 | 104 | P | 0.534403 | L | 0.345662 | 0.188741 | D to O | - |
| O95292 | VAPB_HUMAN Vesicle-associated membrane protein-associated protein B/C OS=Homo sapiens GN=VAPB PE=1 SV=3 | 56 | P | 0.250991 | S | 0.270336 | -0.019345 | No Change: Both O | Amyotrophic lateral sclerosis type 8 (ALS8) [MIM:608627] |
| O95292 | VAPB_HUMAN Vesicle-associated membrane protein-associated protein B/C OS=Homo sapiens GN=VAPB PE=1 SV=3 | 56 | P | 0.250991 | S | 0.270336 | -0.019345 | No Change: Both O | Spinal muscular atrophy proximal adult autosomal dominant (SMAPAD) [MIM:182980] |
| P26640 | SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=1 SV=4 | 51 | P | 0.81969 | R | 0.783303 | 0.036387 | No Change: Both D | - |
| P26640 | SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=1 SV=4 | 181 | R | 0.162224 | C | 0.07071 | 0.091514 | No Change: Both O | - |
| P26640 | SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=1 SV=4 | 626 | P | 0.212186 | S | 0.209225 | 0.002961 | No Change: Both O | - |
| P26640 | SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=1 SV=4 | 1008 | P | 0.208839 | L | 0.105452 | 0.103387 | No Change: Both O | - |
| P26640 | SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens GN=VARS PE=1 SV=4 | 51 | P | 0.81969 | T | 0.763315 | 0.056375 | No Change: Both D | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 64 | G | 0.897869 | R | 0.920749 | -0.02288 | No Change: Both D | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 449 | W | 0.141312 | R | 0.314753 | -0.173441 | No Change: Both O | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 680 | V | 0.439791 | L | 0.457474 | -0.017683 | No Change: Both O | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 917 | R | 0.379959 | Q | 0.3879 | -0.007941 | No Change: Both O | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 965 | A | 0.445776 | T | 0.444624 | 0.001152 | No Change: Both O | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 1049 | R | 0.95738 | Q | 0.966139 | -0.008759 | No Change: Both D | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 26 | H | 0.8989 | Y | 0.812333 | 0.086567 | No Change: Both D | - |
| Q5ST30 | SYVM_HUMAN Valine--tRNA ligase mitochondrial OS=Homo sapiens GN=VARS2 PE=1 SV=2 | 765 | V | 0.383405 | M | 0.456096 | -0.072691 | No Change: Both O | - |
| Q6EMK4 | VASN_HUMAN Vasorin OS=Homo sapiens GN=VASN PE=1 SV=1 | 384 | E | 0.993227 | A | 0.99177 | 0.001457 | No Change: Both D | - |
| P50552 | VASP_HUMAN Vasodilator-stimulated phosphoprotein OS=Homo sapiens GN=VASP PE=1 SV=3 | 104 | A | 0.530267 | T | 0.509705 | 0.020562 | No Change: Both D | - |
| P50552 | VASP_HUMAN Vasodilator-stimulated phosphoprotein OS=Homo sapiens GN=VASP PE=1 SV=3 | 140 | Q | 0.990334 | H | 0.986475 | 0.003859 | No Change: Both D | - |
| P15498 | VAV_HUMAN Proto-oncogene vav OS=Homo sapiens GN=VAV1 PE=1 SV=4 | 739 | T | 0.187308 | M | 0.155324 | 0.031984 | No Change: Both O | - |
| P52735 | VAV2_HUMAN Guanine nucleotide exchange factor VAV2 OS=Homo sapiens GN=VAV2 PE=1 SV=2 | 594 | M | 0.608482 | V | 0.52724 | 0.081242 | No Change: Both D | - |
| Q9UKW4 | VAV3_HUMAN Guanine nucleotide exchange factor VAV3 OS=Homo sapiens GN=VAV3 PE=1 SV=1 | 298 | T | 0.591544 | S | 0.684954 | -0.09341 | No Change: Both D | - |
| Q9UKW4 | VAV3_HUMAN Guanine nucleotide exchange factor VAV3 OS=Homo sapiens GN=VAV3 PE=1 SV=1 | 618 | Q | 0.511808 | H | 0.481455 | 0.030353 | D to O | - |
| Q9UKW4 | VAV3_HUMAN Guanine nucleotide exchange factor VAV3 OS=Homo sapiens GN=VAV3 PE=1 SV=1 | 616 | P | 0.563166 | S | 0.548879 | 0.014287 | No Change: Both D | - |
| Q9UKW4 | VAV3_HUMAN Guanine nucleotide exchange factor VAV3 OS=Homo sapiens GN=VAV3 PE=1 SV=1 | 139 | D | 0.520914 | N | 0.481655 | 0.039259 | D to O | - |
| Q9UIW0 | VAX2_HUMAN Ventral anterior homeobox 2 OS=Homo sapiens GN=VAX2 PE=1 SV=1 | 254 | P | 0.813463 | R | 0.771659 | 0.041804 | No Change: Both D | - |
| P61758 | PFD3_HUMAN Prefoldin subunit 3 OS=Homo sapiens GN=VBP1 PE=1 SV=3 | 123 | M | 0.159238 | V | 0.124353 | 0.034885 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 318 | S | 0.374471 | F | 0.189428 | 0.185043 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 384 | T | 0.310896 | A | 0.233459 | 0.077437 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 413 | G | 0.503695 | A | 0.425046 | 0.078649 | D to O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 716 | I | 0.037642 | L | 0.038928 | -0.001286 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 18 | M | 0.040809 | I | 0.028645 | 0.012164 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 421 | V | 0.409321 | I | 0.359305 | 0.050016 | No Change: Both O | - |
| P19320 | VCAM1_HUMAN Vascular cell adhesion protein 1 OS=Homo sapiens GN=VCAM1 PE=1 SV=1 | 488 | H | 0.261576 | R | 0.308509 | -0.046933 | No Change: Both O | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 428 | G | 0.820104 | D | 0.85302 | -0.032916 | No Change: Both D | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 2301 | F | 0.593866 | Y | 0.593433 | 4.33E-04 | No Change: Both D | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 2315 | V | 0.479581 | L | 0.47795 | 0.001631 | No Change: Both O | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 300 | S | 0.227727 | L | 0.109084 | 0.118643 | No Change: Both O | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 1516 | K | 0.916733 | R | 0.91091 | 0.005823 | No Change: Both D | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 2937 | D | 0.555397 | Y | 0.390214 | 0.165183 | D to O | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 1826 | R | 0.76192 | H | 0.76575 | -0.00383 | No Change: Both D | - |
| P13611 | CSPG2_HUMAN Versican core protein OS=Homo sapiens GN=VCAN PE=1 SV=3 | 3011 | N | 0.836254 | K | 0.848544 | -0.01229 | No Change: Both D | - |
| P18206 | VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4 | 277 | L | 0.611687 | M | 0.66741 | -0.055723 | No Change: Both D | Familial hypertrophic cardiomyopathy type 15 (CMH15) [MIM:613255] |
| P18206 | VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4 | 934 | A | 0.616424 | V | 0.530286 | 0.086138 | No Change: Both D | - |
| P18206 | VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4 | 943 | P | 0.733001 | A | 0.654325 | 0.078676 | No Change: Both D | - |
| P18206 | VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4 | 975 | R | 0.514935 | W | 0.341535 | 0.1734 | D to O | Cardiomyopathy dilated type 1W (CMD1W) [MIM:611407] |
| P18206 | VINC_HUMAN Vinculin OS=Homo sapiens GN=VCL PE=1 SV=4 | 234 | V | 0.424138 | L | 0.436714 | -0.012576 | No Change: Both O | - |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 95 | R | 0.213175 | G | 0.20068 | 0.012495 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 155 | R | 0.122411 | C | 0.053078 | 0.069333 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 155 | R | 0.122411 | H | 0.114128 | 0.008283 | No Change: Both O | Amyotrophic lateral sclerosis type 14 with or without frontotemporal dementia (ALS14) [MIM:613954] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 155 | R | 0.122411 | H | 0.114128 | 0.008283 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 155 | R | 0.122411 | P | 0.134153 | -0.011742 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 159 | R | 0.161997 | H | 0.153762 | 0.008235 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 191 | R | 0.712427 | Q | 0.713288 | -8.61E-04 | No Change: Both D | Amyotrophic lateral sclerosis type 14 with or without frontotemporal dementia (ALS14) [MIM:613954] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 191 | R | 0.712427 | Q | 0.713288 | -8.61E-04 | No Change: Both D | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 232 | A | 0.273318 | E | 0.36214 | -0.088822 | No Change: Both O | Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) [MIM:167320] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 159 | R | 0.161997 | G | 0.173888 | -0.011891 | No Change: Both O | Amyotrophic lateral sclerosis type 14 with or without frontotemporal dementia (ALS14) [MIM:613954] |
| P55072 | TERA_HUMAN Transitional endoplasmic reticulum ATPase OS=Homo sapiens GN=VCP PE=1 SV=4 | 592 | D | 0.610348 | N | 0.602002 | 0.008346 | No Change: Both D | Amyotrophic lateral sclerosis type 14 with or without frontotemporal dementia (ALS14) [MIM:613954] |
| Q9H322 | VCX2_HUMAN Variable charge X-linked protein 2 OS=Homo sapiens GN=VCX2 PE=2 SV=3 | 70 | A | 0.987658 | G | 0.987675 | -1.70E-05 | No Change: Both D | - |
| Q9H322 | VCX2_HUMAN Variable charge X-linked protein 2 OS=Homo sapiens GN=VCX2 PE=2 SV=3 | 104 | L | 0.993188 | P | 0.99629 | -0.003102 | No Change: Both D | - |
| Q9H322 | VCX2_HUMAN Variable charge X-linked protein 2 OS=Homo sapiens GN=VCX2 PE=2 SV=3 | 110 | V | 0.99076 | L | 0.991076 | -3.16E-04 | No Change: Both D | - |
| Q9H322 | VCX2_HUMAN Variable charge X-linked protein 2 OS=Homo sapiens GN=VCX2 PE=2 SV=3 | 138 | T | 0.950381 | S | 0.971462 | -0.021081 | No Change: Both D | - |
| Q9H321 | VCX3B_HUMAN Variable charge X-linked protein 3B OS=Homo sapiens GN=VCX3B PE=2 SV=3 | 15 | K | 0.999556 | T | 0.999316 | 2.40E-04 | No Change: Both D | - |
| P45880 | VDAC2_HUMAN Voltage-dependent anion-selective channel protein 2 OS=Homo sapiens GN=VDAC2 PE=1 SV=2 | 24 | A | 0.315304 | V | 0.228383 | 0.086921 | No Change: Both O | - |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 33 | G | 0.35115 | D | 0.378535 | -0.027385 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 35 | H | 0.348482 | Q | 0.393222 | -0.04474 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 45 | K | 0.444541 | E | 0.43445 | 0.010091 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 46 | G | 0.450188 | D | 0.472033 | -0.021845 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 47 | F | 0.460572 | I | 0.411474 | 0.049098 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 50 | R | 0.493108 | Q | 0.44626 | 0.046848 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 73 | R | 0.525966 | Q | 0.504744 | 0.021222 | No Change: Both D | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 80 | R | 0.476553 | Q | 0.450032 | 0.026521 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 274 | R | 0.297939 | L | 0.208762 | 0.089177 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 305 | H | 0.337982 | Q | 0.352721 | -0.014739 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 314 | I | 0.128477 | S | 0.283586 | -0.155109 | No Change: Both O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 391 | R | 0.501087 | C | 0.369064 | 0.132023 | D to O | Rickets vitamin D-dependent type 2A (VDDR2A) [MIM:277440] |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 230 | L | 0.334557 | V | 0.318608 | 0.015949 | No Change: Both O | - |
| P11473 | VDR_HUMAN Vitamin D3 receptor OS=Homo sapiens GN=VDR PE=1 SV=1 | 362 | T | 0.261189 | I | 0.165297 | 0.095892 | No Change: Both O | - |
| O95231 | VENTX_HUMAN Homeobox protein VENTX OS=Homo sapiens GN=VENTX PE=2 SV=1 | 42 | L | 0.938082 | P | 0.971336 | -0.033254 | No Change: Both D | - |
| O95231 | VENTX_HUMAN Homeobox protein VENTX OS=Homo sapiens GN=VENTX PE=2 SV=1 | 79 | M | 0.862757 | V | 0.824806 | 0.037951 | No Change: Both D | - |
| O95231 | VENTX_HUMAN Homeobox protein VENTX OS=Homo sapiens GN=VENTX PE=2 SV=1 | 101 | E | 0.553305 | K | 0.528195 | 0.02511 | No Change: Both D | - |
| O95231 | VENTX_HUMAN Homeobox protein VENTX OS=Homo sapiens GN=VENTX PE=2 SV=1 | 191 | G | 0.518744 | R | 0.480609 | 0.038135 | D to O | - |
| O95231 | VENTX_HUMAN Homeobox protein VENTX OS=Homo sapiens GN=VENTX PE=2 SV=1 | 247 | G | 0.934772 | D | 0.93108 | 0.003692 | No Change: Both D | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 208 | S | 0.427371 | C | 0.263613 | 0.163758 | No Change: Both O | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 263 | V | 0.061864 | G | 0.107342 | -0.045478 | No Change: Both O | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 271 | S | 0.142108 | C | 0.048997 | 0.093111 | No Change: Both O | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 319 | M | 0.413881 | V | 0.35985 | 0.054031 | No Change: Both O | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 329 | L | 0.179872 | V | 0.1625 | 0.017372 | No Change: Both O | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 365 | R | 0.565795 | Q | 0.565435 | 3.60E-04 | No Change: Both D | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 522 | S | 0.831475 | P | 0.820623 | 0.010852 | No Change: Both D | - |
| Q14D04 | MELT_HUMAN Ventricular zone-expressed PH domain-containing protein homolog 1 OS=Homo sapiens GN=VEPH1 PE=1 SV=1 | 501 | S | 0.764912 | L | 0.643663 | 0.121249 | No Change: Both D | - |
| Q9HBM0 | VEZA_HUMAN Vezatin OS=Homo sapiens GN=VEZT PE=1 SV=3 | 762 | G | 0.841455 | D | 0.842805 | -0.00135 | No Change: Both D | - |
| Q9HBM0 | VEZA_HUMAN Vezatin OS=Homo sapiens GN=VEZT PE=1 SV=3 | 162 | T | 0.021789 | A | 0.018836 | 0.002953 | No Change: Both O | - |
| Q9HBM0 | VEZA_HUMAN Vezatin OS=Homo sapiens GN=VEZT PE=1 SV=3 | 496 | V | 0.37057 | I | 0.364461 | 0.006109 | No Change: Both O | - |
| Q9HBM0 | VEZA_HUMAN Vezatin OS=Homo sapiens GN=VEZT PE=1 SV=3 | 612 | V | 0.653752 | M | 0.706912 | -0.05316 | No Change: Both D | - |
| Q9HBM0 | VEZA_HUMAN Vezatin OS=Homo sapiens GN=VEZT PE=1 SV=3 | 668 | S | 0.911343 | A | 0.868586 | 0.042757 | No Change: Both D | - |
| Q99990 | VGLL1_HUMAN Transcription cofactor vestigial-like protein 1 OS=Homo sapiens GN=VGLL1 PE=1 SV=1 | 59 | T | 0.808517 | I | 0.762304 | 0.046213 | No Change: Both D | - |
| Q14135 | VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens GN=VGLL4 PE=1 SV=4 | 32 | M | 0.880173 | I | 0.821343 | 0.05883 | No Change: Both D | - |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 38 | S | 0.998776 | P | 0.998862 | -8.60E-05 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 52 | E | 0.982095 | K | 0.97418 | 0.007915 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 65 | S | 0.848789 | L | 0.780812 | 0.067977 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 65 | S | 0.848789 | W | 0.72108 | 0.127709 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 68 | S | 0.802738 | W | 0.648018 | 0.15472 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 68 | S | 0.802738 | W | 0.648018 | 0.15472 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 70 | E | 0.773522 | K | 0.734806 | 0.038716 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 74 | V | 0.686167 | G | 0.738515 | -0.052348 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 76 | F | 0.61782 | I | 0.612666 | 0.005154 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 76 | F | 0.61782 | L | 0.654445 | -0.036625 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 76 | F | 0.61782 | S | 0.771533 | -0.153713 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 78 | N | 0.580283 | H | 0.511111 | 0.069172 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 78 | N | 0.580283 | S | 0.632568 | -0.052285 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 78 | N | 0.580283 | T | 0.545524 | 0.034759 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 79 | R | 0.553788 | P | 0.598076 | -0.044288 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 80 | S | 0.522105 | I | 0.350872 | 0.171233 | D to O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 80 | S | 0.522105 | R | 0.52343 | -0.001325 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 80 | S | 0.522105 | N | 0.489916 | 0.032189 | D to O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 80 | S | 0.522105 | N | 0.489916 | 0.032189 | D to O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 81 | P | 0.526551 | S | 0.500773 | 0.025778 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 82 | R | 0.462299 | P | 0.510419 | -0.04812 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 84 | V | 0.412519 | L | 0.416106 | -0.003587 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 86 | P | 0.357501 | A | 0.208019 | 0.149482 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 86 | P | 0.357501 | L | 0.206588 | 0.150913 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 86 | P | 0.357501 | R | 0.320964 | 0.036537 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 86 | P | 0.357501 | S | 0.32917 | 0.028331 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 88 | W | 0.301065 | R | 0.550655 | -0.24959 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 88 | W | 0.301065 | S | 0.561724 | -0.260659 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 89 | L | 0.262858 | H | 0.318545 | -0.055687 | No Change: Both O | Lung cancer |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 89 | L | 0.262858 | P | 0.444202 | -0.181344 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 91 | F | 0.307602 | L | 0.349914 | -0.042312 | No Change: Both O | - |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 93 | G | 0.365993 | C | 0.248048 | 0.117945 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 93 | G | 0.365993 | C | 0.248048 | 0.117945 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 93 | G | 0.365993 | D | 0.405123 | -0.03913 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 93 | G | 0.365993 | S | 0.425829 | -0.059836 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 93 | G | 0.365993 | S | 0.425829 | -0.059836 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 96 | Q | 0.493304 | P | 0.548026 | -0.054722 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 98 | Y | 0.576558 | H | 0.652945 | -0.076387 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 98 | Y | 0.576558 | H | 0.652945 | -0.076387 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 101 | L | 0.628219 | G | 0.731033 | -0.102814 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 101 | L | 0.628219 | R | 0.720374 | -0.092155 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 104 | G | 0.606237 | A | 0.535637 | 0.0706 | No Change: Both D | - |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 105 | T | 0.596371 | P | 0.646376 | -0.050005 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 106 | G | 0.575071 | D | 0.580263 | -0.005192 | No Change: Both D | Lung cancer |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 107 | R | 0.548383 | P | 0.583984 | -0.035601 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 111 | S | 0.300632 | C | 0.141725 | 0.158907 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 111 | S | 0.300632 | N | 0.267774 | 0.032858 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 111 | S | 0.300632 | R | 0.274576 | 0.026056 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 112 | Y | 0.237599 | H | 0.372304 | -0.134705 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 114 | G | 0.152844 | C | 0.069779 | 0.083065 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 114 | G | 0.152844 | R | 0.158187 | -0.005343 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 114 | G | 0.152844 | S | 0.189962 | -0.037118 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 115 | H | 0.143612 | Y | 0.086876 | 0.056736 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 115 | H | 0.143612 | Q | 0.14894 | -0.005328 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 116 | L | 0.134439 | V | 0.124186 | 0.010253 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 117 | W | 0.124679 | C | 0.152617 | -0.027938 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 118 | L | 0.153489 | P | 0.262165 | -0.108676 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 118 | L | 0.153489 | R | 0.247036 | -0.093547 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 119 | F | 0.183303 | L | 0.221334 | -0.038031 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 119 | F | 0.183303 | L | 0.221334 | -0.038031 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 119 | F | 0.183303 | S | 0.365145 | -0.181842 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 121 | D | 0.205564 | G | 0.192246 | 0.013318 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 128 | L | 0.275474 | F | 0.241195 | 0.034279 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 130 | V | 0.234726 | L | 0.246476 | -0.01175 | No Change: Both O | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 130 | V | 0.234726 | L | 0.246476 | -0.01175 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 131 | N | 0.212055 | K | 0.24605 | -0.033995 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 131 | N | 0.212055 | T | 0.196999 | 0.015056 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 136 | F | 0.18404 | S | 0.410372 | -0.226332 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 136 | F | 0.18404 | C | 0.173704 | 0.010336 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 136 | F | 0.18404 | C | 0.173704 | 0.010336 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 143 | D | 0.21784 | E | 0.241915 | -0.024075 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 149 | A | 0.089809 | T | 0.111793 | -0.021984 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 154 | P | 0.068151 | L | 0.034469 | 0.033682 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 155 | V | 0.076176 | G | 0.133919 | -0.057743 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 156 | Y | 0.08324 | C | 0.075884 | 0.007356 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 156 | Y | 0.08324 | C | 0.075884 | 0.007356 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 156 | Y | 0.08324 | D | 0.163728 | -0.080488 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 157 | T | 0.100232 | I | 0.052993 | 0.047239 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 158 | L | 0.121605 | P | 0.224725 | -0.10312 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 158 | L | 0.121605 | V | 0.122427 | -8.22E-04 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 159 | K | 0.14456 | E | 0.154953 | -0.010393 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 161 | R | 0.146512 | Q | 0.15893 | -0.012418 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 161 | R | 0.146512 | Q | 0.15893 | -0.012418 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 161 | R | 0.146512 | P | 0.1694 | -0.022888 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 161 | R | 0.146512 | P | 0.1694 | -0.022888 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 161 | R | 0.146512 | G | 0.14315 | 0.003362 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 162 | C | 0.145449 | F | 0.15027 | -0.004821 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 162 | C | 0.145449 | R | 0.282771 | -0.137322 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 162 | C | 0.145449 | W | 0.120968 | 0.024481 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 162 | C | 0.145449 | Y | 0.178543 | -0.033094 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 164 | Q | 0.134053 | R | 0.139038 | -0.004985 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 166 | V | 0.165404 | F | 0.133264 | 0.03214 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 167 | R | 0.181954 | G | 0.168908 | 0.013046 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 167 | R | 0.181954 | Q | 0.191629 | -0.009675 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 167 | R | 0.181954 | Q | 0.191629 | -0.009675 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 167 | R | 0.181954 | W | 0.068401 | 0.113553 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 167 | R | 0.181954 | W | 0.068401 | 0.113553 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 170 | V | 0.323438 | D | 0.450743 | -0.127305 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 170 | V | 0.323438 | F | 0.274878 | 0.04856 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 170 | V | 0.323438 | G | 0.415987 | -0.092549 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 175 | Y | 0.34119 | D | 0.502499 | -0.161309 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 178 | L | 0.268089 | P | 0.429056 | -0.160967 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 178 | L | 0.268089 | Q | 0.394847 | -0.126758 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 180 | I | 0.294263 | V | 0.349928 | -0.055665 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 184 | L | 0.404646 | R | 0.544293 | -0.139647 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 184 | L | 0.404646 | P | 0.556082 | -0.151436 | O to D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 186 | E | 0.473704 | K | 0.454216 | 0.019488 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 188 | L | 0.557424 | P | 0.679363 | -0.121939 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 188 | L | 0.557424 | Q | 0.666009 | -0.108585 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 188 | L | 0.557424 | V | 0.548462 | 0.008962 | No Change: Both D | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 188 | L | 0.557424 | V | 0.548462 | 0.008962 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 188 | L | 0.557424 | V | 0.548462 | 0.008962 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 198 | L | 0.622237 | R | 0.750549 | -0.128312 | No Change: Both D | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 200 | R | 0.58922 | W | 0.288314 | 0.300906 | D to O | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 200 | R | 0.58922 | W | 0.288314 | 0.300906 | D to O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 86 | P | 0.357501 | H | 0.235042 | 0.122459 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 115 | H | 0.143612 | R | 0.1548 | -0.011188 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 136 | F | 0.18404 | Y | 0.21255 | -0.02851 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 145 | Q | 0.203467 | H | 0.19023 | 0.013237 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 155 | V | 0.076176 | M | 0.100105 | -0.023929 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 164 | Q | 0.134053 | H | 0.122799 | 0.011254 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 166 | V | 0.165404 | D | 0.27567 | -0.110266 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 176 | R | 0.310265 | W | 0.127978 | 0.182287 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 25 | P | 0.992705 | L | 0.983697 | 0.009008 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 63 | L | 0.861948 | P | 0.919005 | -0.057057 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 64 | R | 0.856513 | P | 0.86998 | -0.013467 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 65 | S | 0.848789 | A | 0.792268 | 0.056521 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 107 | R | 0.548383 | G | 0.566731 | -0.018348 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 112 | Y | 0.237599 | N | 0.370096 | -0.132497 | No Change: Both O | Von Hippel-Lindau disease (VHLD) [MIM:193300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 122 | A | 0.208383 | I | 0.143071 | 0.065312 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 126 | D | 0.281667 | Y | 0.148744 | 0.132923 | No Change: Both O | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 135 | L | 0.170425 | F | 0.147615 | 0.02281 | No Change: Both O | - |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 147 | I | 0.140919 | T | 0.237533 | -0.096614 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 156 | Y | 0.08324 | N | 0.161081 | -0.077841 | No Change: Both O | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 163 | L | 0.13947 | P | 0.243299 | -0.103829 | No Change: Both O | Renal cell carcinoma (RCC) [MIM:144700] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 191 | H | 0.611158 | D | 0.681636 | -0.070478 | No Change: Both D | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 192 | P | 0.611686 | S | 0.635401 | -0.023715 | No Change: Both D | Familial erythrocytosis type 2 (ECYT2) [MIM:263400] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 198 | L | 0.622237 | Q | 0.749844 | -0.127607 | No Change: Both D | Pheochromocytoma (PCC) [MIM:171300] |
| P40337 | VHL_HUMAN Von Hippel-Lindau disease tumor suppressor OS=Homo sapiens GN=VHL PE=1 SV=2 | 110 | H | 0.366832 | Y | 0.263261 | 0.103571 | No Change: Both O | - |
| P09327 | VILI_HUMAN Villin-1 OS=Homo sapiens GN=VIL1 PE=1 SV=4 | 254 | K | 0.288994 | R | 0.243053 | 0.045941 | No Change: Both O | - |
| O15195 | VILL_HUMAN Villin-like protein OS=Homo sapiens GN=VILL PE=2 SV=3 | 610 | F | 0.527868 | L | 0.555595 | -0.027727 | No Change: Both D | - |
| O15195 | VILL_HUMAN Villin-like protein OS=Homo sapiens GN=VILL PE=2 SV=3 | 740 | L | 0.382383 | F | 0.317817 | 0.064566 | No Change: Both O | - |
| P32241 | VIPR1_HUMAN Vasoactive intestinal polypeptide receptor 1 OS=Homo sapiens GN=VIPR1 PE=1 SV=1 | 445 | R | 0.845822 | L | 0.743879 | 0.101943 | No Change: Both D | - |
| P32241 | VIPR1_HUMAN Vasoactive intestinal polypeptide receptor 1 OS=Homo sapiens GN=VIPR1 PE=1 SV=1 | 341 | R | 0.300173 | M | 0.233992 | 0.066181 | No Change: Both O | - |
| P41587 | VIPR2_HUMAN Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens GN=VIPR2 PE=1 SV=2 | 39 | A | 0.489563 | T | 0.544261 | -0.054698 | O to D | - |
| P41587 | VIPR2_HUMAN Vasoactive intestinal polypeptide receptor 2 OS=Homo sapiens GN=VIPR2 PE=1 SV=2 | 412 | R | 0.792238 | H | 0.746647 | 0.045591 | No Change: Both D | - |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 29 | V | 0.235551 | L | 0.249899 | -0.014348 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 45 | V | 0.134004 | A | 0.199083 | -0.065079 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 58 | R | 0.281462 | G | 0.298782 | -0.01732 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 98 | R | 0.054683 | W | 0.02043 | 0.034253 | No Change: Both O | Combined deficiency of vitamin K-dependent clotting factors type 2 (VKCFD2) [MIM:607473] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 128 | L | 0.002588 | R | 0.004422 | -0.001834 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 26 | A | 0.10371 | T | 0.109172 | -0.005462 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 36 | D | 0.453454 | G | 0.404291 | 0.049163 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 36 | D | 0.453454 | Y | 0.291272 | 0.162182 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 52 | S | 0.229024 | W | 0.069715 | 0.159309 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 56 | S | 0.276135 | F | 0.115914 | 0.160221 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 59 | W | 0.278761 | C | 0.325819 | -0.047058 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 59 | W | 0.278761 | L | 0.37129 | -0.092529 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 66 | V | 0.18761 | G | 0.316614 | -0.129004 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 66 | V | 0.18761 | M | 0.224563 | -0.036953 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 71 | G | 0.282235 | A | 0.226369 | 0.055866 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 77 | N | 0.396532 | S | 0.446574 | -0.050042 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 77 | N | 0.396532 | Y | 0.23747 | 0.159062 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 123 | I | 0.005463 | N | 0.013396 | -0.007933 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| Q9BQB6 | VKOR1_HUMAN Vitamin K epoxide reductase complex subunit 1 OS=Homo sapiens GN=VKORC1 PE=1 SV=1 | 139 | Y | 0.021218 | H | 0.038004 | -0.016786 | No Change: Both O | Coumarin resistance (CMRES) [MIM:122700] |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 59 | V | 0.659058 | I | 0.631147 | 0.027911 | No Change: Both D | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 379 | E | 0.105917 | K | 0.104098 | 0.001819 | No Change: Both O | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 262 | P | 0.895281 | H | 0.865146 | 0.030135 | No Change: Both D | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 464 | L | 0.202707 | I | 0.179916 | 0.022791 | No Change: Both O | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 561 | I | 0.322594 | V | 0.364241 | -0.041647 | No Change: Both O | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 613 | R | 0.116087 | H | 0.118228 | -0.002141 | No Change: Both O | - |
| P98155 | VLDLR_HUMAN Very low-density lipoprotein receptor OS=Homo sapiens GN=VLDLR PE=1 SV=1 | 791 | V | 0.627551 | I | 0.579891 | 0.04766 | No Change: Both D | - |
| Q7Z5L0 | VMO1_HUMAN Vitelline membrane outer layer protein 1 homolog OS=Homo sapiens GN=VMO1 PE=1 SV=1 | 77 | T | 0.380562 | S | 0.457755 | -0.077193 | No Change: Both O | - |
| Q7Z5L0 | VMO1_HUMAN Vitelline membrane outer layer protein 1 homolog OS=Homo sapiens GN=VMO1 PE=1 SV=1 | 26 | T | 0.373901 | A | 0.342935 | 0.030966 | No Change: Both O | - |
| Q9GZP7 | VN1R1_HUMAN Vomeronasal type-1 receptor 1 OS=Homo sapiens GN=VN1R1 PE=2 SV=1 | 139 | I | 0.078568 | T | 0.155683 | -0.077115 | No Change: Both O | - |
| Q9GZP7 | VN1R1_HUMAN Vomeronasal type-1 receptor 1 OS=Homo sapiens GN=VN1R1 PE=2 SV=1 | 241 | S | 0.122684 | F | 0.05591 | 0.066774 | No Change: Both O | - |
| Q9GZP7 | VN1R1_HUMAN Vomeronasal type-1 receptor 1 OS=Homo sapiens GN=VN1R1 PE=2 SV=1 | 269 | A | 0.554734 | D | 0.623801 | -0.069067 | No Change: Both D | - |
| Q9GZP7 | VN1R1_HUMAN Vomeronasal type-1 receptor 1 OS=Homo sapiens GN=VN1R1 PE=2 SV=1 | 103 | I | 0.144289 | M | 0.22657 | -0.082281 | No Change: Both O | - |
| Q8NFZ6 | VN1R2_HUMAN Vomeronasal type-1 receptor 2 OS=Homo sapiens GN=VN1R2 PE=2 SV=2 | 38 | C | 0.166152 | R | 0.301916 | -0.135764 | No Change: Both O | - |
| Q7Z5H5 | VN1R4_HUMAN Vomeronasal type-1 receptor 4 OS=Homo sapiens GN=VN1R4 PE=2 SV=2 | 52 | A | 0.036836 | V | 0.025722 | 0.011114 | No Change: Both O | - |
| Q7Z5H5 | VN1R4_HUMAN Vomeronasal type-1 receptor 4 OS=Homo sapiens GN=VN1R4 PE=2 SV=2 | 58 | R | 0.094072 | L | 0.059034 | 0.035038 | No Change: Both O | - |
| Q7Z5H5 | VN1R4_HUMAN Vomeronasal type-1 receptor 4 OS=Homo sapiens GN=VN1R4 PE=2 SV=2 | 220 | D | 0.694928 | N | 0.671864 | 0.023064 | No Change: Both D | - |
| Q7Z5H4 | VN1R5_HUMAN Vomeronasal type-1 receptor 5 OS=Homo sapiens GN=VN1R5 PE=2 SV=2 | 350 | R | 0.431019 | C | 0.291962 | 0.139057 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 26 | T | 0.208258 | I | 0.113766 | 0.094492 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 63 | A | 0.279386 | T | 0.298917 | -0.019531 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 131 | N | 0.324798 | S | 0.352472 | -0.027674 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 136 | V | 0.248066 | L | 0.238561 | 0.009505 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 146 | D | 0.631883 | N | 0.608976 | 0.022907 | No Change: Both D | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 296 | E | 0.538414 | D | 0.52266 | 0.015754 | No Change: Both D | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 325 | A | 0.572261 | E | 0.646602 | -0.074341 | No Change: Both D | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 336 | T | 0.27051 | A | 0.241108 | 0.029402 | No Change: Both O | - |
| O95497 | VNN1_HUMAN Pantetheinase OS=Homo sapiens GN=VNN1 PE=1 SV=2 | 373 | I | 0.469662 | T | 0.622383 | -0.152721 | O to D | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 404 | L | 0.126934 | M | 0.156756 | -0.029822 | No Change: Both O | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 17 | T | 0.068658 | N | 0.075404 | -0.006746 | No Change: Both O | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 112 | D | 0.261244 | E | 0.28524 | -0.023996 | No Change: Both O | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 241 | V | 0.048978 | I | 0.044761 | 0.004217 | No Change: Both O | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 349 | T | 0.234269 | S | 0.313356 | -0.079087 | No Change: Both O | - |
| O95498 | VNN2_HUMAN Vascular non-inflammatory molecule 2 OS=Homo sapiens GN=VNN2 PE=1 SV=3 | 30 | V | 0.097677 | A | 0.141765 | -0.044088 | No Change: Both O | - |
| Q9NY84 | VNN3_HUMAN Vascular non-inflammatory molecule 3 OS=Homo sapiens GN=VNN3 PE=2 SV=2 | 33 | H | 0.089629 | R | 0.093373 | -0.003744 | No Change: Both O | - |
| Q9NY84 | VNN3_HUMAN Vascular non-inflammatory molecule 3 OS=Homo sapiens GN=VNN3 PE=2 SV=2 | 89 | T | 0.069034 | A | 0.059607 | 0.009427 | No Change: Both O | - |
| Q9NY84 | VNN3_HUMAN Vascular non-inflammatory molecule 3 OS=Homo sapiens GN=VNN3 PE=2 SV=2 | 91 | E | 0.086181 | K | 0.081741 | 0.00444 | No Change: Both O | - |
| Q9NY84 | VNN3_HUMAN Vascular non-inflammatory molecule 3 OS=Homo sapiens GN=VNN3 PE=2 SV=2 | 222 | V | 0.192329 | A | 0.247332 | -0.055003 | No Change: Both O | - |
| Q9Y4B6 | VPRBP_HUMAN Protein VPRBP OS=Homo sapiens GN=VPRBP PE=1 SV=3 | 267 | N | 0.952915 | D | 0.958863 | -0.005948 | No Change: Both D | - |
| Q9Y4B6 | VPRBP_HUMAN Protein VPRBP OS=Homo sapiens GN=VPRBP PE=1 SV=3 | 378 | L | 0.209722 | F | 0.178821 | 0.030901 | No Change: Both O | - |
| Q9Y4B6 | VPRBP_HUMAN Protein VPRBP OS=Homo sapiens GN=VPRBP PE=1 SV=3 | 1031 | L | 0.750986 | P | 0.86676 | -0.115774 | No Change: Both D | - |
| P12018 | VPREB_HUMAN Immunoglobulin iota chain OS=Homo sapiens GN=VPREB1 PE=1 SV=2 | 76 | D | 0.759978 | N | 0.743831 | 0.016147 | No Change: Both D | - |
| P12018 | VPREB_HUMAN Immunoglobulin iota chain OS=Homo sapiens GN=VPREB1 PE=1 SV=2 | 122 | S | 0.930304 | L | 0.879707 | 0.050597 | No Change: Both D | - |
| P12018 | VPREB_HUMAN Immunoglobulin iota chain OS=Homo sapiens GN=VPREB1 PE=1 SV=2 | 132 | E | 0.981022 | K | 0.975325 | 0.005697 | No Change: Both D | - |
| Q9UKI3 | VPRE3_HUMAN Pre-B lymphocyte protein 3 OS=Homo sapiens GN=VPREB3 PE=2 SV=1 | 4 | R | 0.257776 | W | 0.090924 | 0.166852 | No Change: Both O | - |
| Q9H270 | VPS11_HUMAN Vacuolar protein sorting-associated protein 11 homolog OS=Homo sapiens GN=VPS11 PE=1 SV=1 | 770 | V | 0.235699 | I | 0.215009 | 0.02069 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 1452 | S | 0.359362 | P | 0.327234 | 0.032128 | No Change: Both O | Chorea-acanthocytosis (CHAC) [MIM:200150] |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 161 | R | 0.306203 | H | 0.313002 | -0.006799 | No Change: Both O | A colorectal cancer sample |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 90 | I | 0.143829 | K | 0.285097 | -0.141268 | No Change: Both O | Chorea-acanthocytosis (CHAC) [MIM:200150] |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 2721 | Y | 0.060847 | C | 0.056051 | 0.004796 | No Change: Both O | Chorea-acanthocytosis (CHAC) [MIM:200150] |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 565 | F | 0.199811 | L | 0.229872 | -0.030061 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 898 | V | 0.076861 | A | 0.099477 | -0.022616 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 1095 | A | 0.325798 | P | 0.417636 | -0.091838 | No Change: Both O | Chorea-acanthocytosis (CHAC) [MIM:200150] |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 1490 | R | 0.336271 | K | 0.404104 | -0.067833 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 1587 | Y | 0.182059 | C | 0.184809 | -0.00275 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 1973 | V | 0.474565 | I | 0.447099 | 0.027466 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 2460 | W | 0.383143 | R | 0.592245 | -0.209102 | O to D | Chorea-acanthocytosis (CHAC) [MIM:200150] |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 2486 | I | 0.114143 | T | 0.193467 | -0.079324 | No Change: Both O | - |
| Q96RL7 | VP13A_HUMAN Vacuolar protein sorting-associated protein 13A OS=Homo sapiens GN=VPS13A PE=1 SV=2 | 3172 | P | 0.727689 | L | 0.763645 | -0.035956 | No Change: Both D | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2193 | L | 0.267865 | R | 0.366436 | -0.098571 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 3001 | L | 0.071748 | V | 0.069596 | 0.002152 | No Change: Both O | A breast cancer sample |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2341 | Y | 0.180816 | C | 0.179884 | 9.32E-04 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2645 | G | 0.327123 | D | 0.377027 | -0.049904 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2993 | N | 0.074611 | S | 0.096409 | -0.021798 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 1138 | P | 0.160191 | L | 0.077093 | 0.083098 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2584 | V | 0.286288 | A | 0.355389 | -0.069101 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 3432 | G | 0.623273 | R | 0.589542 | 0.033731 | No Change: Both D | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 829 | A | 0.153233 | T | 0.163431 | -0.010198 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 866 | V | 0.386753 | I | 0.37629 | 0.010463 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 1994 | I | 0.339821 | V | 0.377839 | -0.038018 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2773 | S | 0.291021 | L | 0.161387 | 0.129634 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2820 | I | 0.142073 | T | 0.227039 | -0.084966 | No Change: Both O | Cohen syndrome (COH1) [MIM:216550] |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 2822 | Y | 0.068516 | C | 0.079361 | -0.010845 | No Change: Both O | - |
| Q7Z7G8 | VP13B_HUMAN Vacuolar protein sorting-associated protein 13B OS=Homo sapiens GN=VPS13B PE=1 SV=2 | 3142 | S | 0.36151 | R | 0.297349 | 0.064161 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 153 | R | 0.83654 | H | 0.830874 | 0.005666 | No Change: Both D | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 974 | R | 0.633125 | K | 0.688374 | -0.055249 | No Change: Both D | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 1132 | I | 0.124675 | V | 0.143348 | -0.018673 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 1302 | Y | 0.098974 | C | 0.079799 | 0.019175 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 1485 | T | 0.365441 | A | 0.336355 | 0.029086 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 1495 | I | 0.435013 | V | 0.455283 | -0.02027 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 1592 | S | 0.465232 | Y | 0.288006 | 0.177226 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 2322 | V | 0.15588 | M | 0.193369 | -0.037489 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 2913 | S | 0.252436 | N | 0.203782 | 0.048654 | No Change: Both O | - |
| Q709C8 | VP13C_HUMAN Vacuolar protein sorting-associated protein 13C OS=Homo sapiens GN=VPS13C PE=1 SV=1 | 2808 | K | 0.348334 | R | 0.26293 | 0.085404 | No Change: Both O | - |
| Q5THJ4 | VP13D_HUMAN Vacuolar protein sorting-associated protein 13D OS=Homo sapiens GN=VPS13D PE=1 SV=1 | 225 | A | 0.605701 | T | 0.616106 | -0.010405 | No Change: Both D | - |
| Q5THJ4 | VP13D_HUMAN Vacuolar protein sorting-associated protein 13D OS=Homo sapiens GN=VPS13D PE=1 SV=1 | 1341 | S | 0.433326 | L | 0.26489 | 0.168436 | No Change: Both O | - |
| Q5THJ4 | VP13D_HUMAN Vacuolar protein sorting-associated protein 13D OS=Homo sapiens GN=VPS13D PE=1 SV=1 | 1505 | E | 0.55194 | V | 0.326295 | 0.225645 | D to O | - |
| Q5THJ4 | VP13D_HUMAN Vacuolar protein sorting-associated protein 13D OS=Homo sapiens GN=VPS13D PE=1 SV=1 | 1707 | S | 0.906402 | F | 0.79705 | 0.109352 | No Change: Both D | - |
| Q5THJ4 | VP13D_HUMAN Vacuolar protein sorting-associated protein 13D OS=Homo sapiens GN=VPS13D PE=1 SV=1 | 1624 | I | 0.32807 | T | 0.471718 | -0.143648 | No Change: Both O | - |
| Q9H269 | VPS16_HUMAN Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens GN=VPS16 PE=1 SV=2 | 637 | S | 0.348735 | I | 0.176961 | 0.171774 | No Change: Both O | - |
| Q9P253 | VPS18_HUMAN Vacuolar protein sorting-associated protein 18 homolog OS=Homo sapiens GN=VPS18 PE=1 SV=2 | 913 | A | 0.950135 | S | 0.955728 | -0.005593 | No Change: Both D | A colorectal cancer sample |
| Q9BRG1 | VPS25_HUMAN Vacuolar protein-sorting-associated protein 25 OS=Homo sapiens GN=VPS25 PE=1 SV=1 | 76 | I | 0.422036 | V | 0.458219 | -0.036183 | No Change: Both O | - |
| Q96AX1 | VP33A_HUMAN Vacuolar protein sorting-associated protein 33A OS=Homo sapiens GN=VPS33A PE=1 SV=1 | 256 | I | 0.21738 | L | 0.24825 | -0.03087 | No Change: Both O | - |
| Q9H267 | VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens GN=VPS33B PE=1 SV=2 | 514 | G | 0.096181 | S | 0.11797 | -0.021789 | No Change: Both O | - |
| Q9H267 | VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens GN=VPS33B PE=1 SV=2 | 30 | L | 0.285603 | P | 0.428481 | -0.142878 | No Change: Both O | Arthrogryposis-renal dysfunction-cholestasis syndrome type 1 (ARCS1) [MIM:208085] |
| Q9H267 | VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens GN=VPS33B PE=1 SV=2 | 513 | F | 0.099087 | S | 0.246178 | -0.147091 | No Change: Both O | - |
| Q9H267 | VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens GN=VPS33B PE=1 SV=2 | 243 | S | 0.085368 | F | 0.040584 | 0.044784 | No Change: Both O | Arthrogryposis-renal dysfunction-cholestasis syndrome type 1 (ARCS1) [MIM:208085] |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 602 | V | 0.283964 | D | 0.450317 | -0.166353 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 51 | G | 0.53643 | S | 0.630674 | -0.094244 | No Change: Both D | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 57 | M | 0.509269 | I | 0.399817 | 0.109452 | D to O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 82 | T | 0.188427 | R | 0.206739 | -0.018312 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 241 | I | 0.107606 | M | 0.149759 | -0.042153 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 316 | P | 0.48121 | S | 0.495225 | -0.014015 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 524 | R | 0.282812 | W | 0.123729 | 0.159083 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 620 | D | 0.51386 | N | 0.48432 | 0.02954 | D to O | Parkinson disease type 17 (PARK17) [MIM:614203] |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 737 | A | 0.211249 | V | 0.178303 | 0.032946 | No Change: Both O | - |
| Q96QK1 | VPS35_HUMAN Vacuolar protein sorting-associated protein 35 OS=Homo sapiens GN=VPS35 PE=1 SV=2 | 774 | L | 0.753845 | M | 0.770248 | -0.016403 | No Change: Both D | - |
| Q8NEZ2 | VP37A_HUMAN Vacuolar protein sorting-associated protein 37A OS=Homo sapiens GN=VPS37A PE=1 SV=1 | 206 | I | 0.612014 | F | 0.639807 | -0.027793 | No Change: Both D | - |
| Q8NEZ2 | VP37A_HUMAN Vacuolar protein sorting-associated protein 37A OS=Homo sapiens GN=VPS37A PE=1 SV=1 | 213 | I | 0.581045 | V | 0.621196 | -0.040151 | No Change: Both D | - |
| A5D8V6 | VP37C_HUMAN Vacuolar protein sorting-associated protein 37C OS=Homo sapiens GN=VPS37C PE=1 SV=2 | 182 | V | 0.997374 | D | 0.997996 | -6.22E-04 | No Change: Both D | - |
| A5D8V6 | VP37C_HUMAN Vacuolar protein sorting-associated protein 37C OS=Homo sapiens GN=VPS37C PE=1 SV=2 | 198 | L | 0.994083 | S | 0.99639 | -0.002307 | No Change: Both D | - |
| A5D8V6 | VP37C_HUMAN Vacuolar protein sorting-associated protein 37C OS=Homo sapiens GN=VPS37C PE=1 SV=2 | 261 | S | 0.962082 | A | 0.948008 | 0.014074 | No Change: Both D | - |
| P49754 | VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog OS=Homo sapiens GN=VPS41 PE=1 SV=3 | 146 | T | 0.253568 | P | 0.29925 | -0.045682 | No Change: Both O | - |
| P49754 | VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog OS=Homo sapiens GN=VPS41 PE=1 SV=3 | 647 | C | 0.184915 | R | 0.321915 | -0.137 | No Change: Both O | - |
| P49754 | VPS41_HUMAN Vacuolar protein sorting-associated protein 41 homolog OS=Homo sapiens GN=VPS41 PE=1 SV=3 | 843 | R | 0.718116 | H | 0.692387 | 0.025729 | No Change: Both D | - |
| O75351 | VPS4B_HUMAN Vacuolar protein sorting-associated protein 4B OS=Homo sapiens GN=VPS4B PE=1 SV=2 | 58 | I | 0.4753 | M | 0.555269 | -0.079969 | O to D | - |
| Q5VIR6 | VPS53_HUMAN Vacuolar protein sorting-associated protein 53 homolog OS=Homo sapiens GN=VPS53 PE=1 SV=1 | 328 | L | 0.282281 | I | 0.27197 | 0.010311 | No Change: Both O | - |
| Q5VIR6 | VPS53_HUMAN Vacuolar protein sorting-associated protein 53 homolog OS=Homo sapiens GN=VPS53 PE=1 SV=1 | 375 | L | 0.832978 | R | 0.862043 | -0.029065 | No Change: Both D | - |
| Q9P1Q0 | VPS54_HUMAN Vacuolar protein sorting-associated protein 54 OS=Homo sapiens GN=VPS54 PE=1 SV=2 | 561 | S | 0.987217 | C | 0.979646 | 0.007571 | No Change: Both D | - |
| Q9P1Q0 | VPS54_HUMAN Vacuolar protein sorting-associated protein 54 OS=Homo sapiens GN=VPS54 PE=1 SV=2 | 912 | M | 0.179734 | I | 0.131648 | 0.048086 | No Change: Both O | - |
| Q15906 | VPS72_HUMAN Vacuolar protein sorting-associated protein 72 homolog OS=Homo sapiens GN=VPS72 PE=1 SV=1 | 318 | I | 0.31835 | V | 0.317196 | 0.001154 | No Change: Both O | A breast cancer sample |
| Q8N3P4 | VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens GN=VPS8 PE=1 SV=3 | 83 | I | 0.852002 | V | 0.846966 | 0.005036 | No Change: Both D | - |
| Q8N3P4 | VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens GN=VPS8 PE=1 SV=3 | 1165 | H | 0.604465 | Y | 0.459552 | 0.144913 | D to O | - |
| Q8N3P4 | VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens GN=VPS8 PE=1 SV=3 | 1364 | I | 0.652429 | T | 0.782603 | -0.130174 | No Change: Both D | - |
| Q8N3P4 | VPS8_HUMAN Vacuolar protein sorting-associated protein 8 homolog OS=Homo sapiens GN=VPS8 PE=1 SV=3 | 1372 | R | 0.63559 | H | 0.546411 | 0.089179 | No Change: Both D | - |
| Q86Y07 | VRK2_HUMAN Serine/threonine-protein kinase VRK2 OS=Homo sapiens GN=VRK2 PE=1 SV=3 | 167 | I | 0.262714 | V | 0.307836 | -0.045122 | No Change: Both O | - |
| Q86Y07 | VRK2_HUMAN Serine/threonine-protein kinase VRK2 OS=Homo sapiens GN=VRK2 PE=1 SV=3 | 50 | N | 0.480124 | D | 0.506488 | -0.026364 | O to D | - |
| Q86Y07 | VRK2_HUMAN Serine/threonine-protein kinase VRK2 OS=Homo sapiens GN=VRK2 PE=1 SV=3 | 157 | I | 0.231531 | M | 0.319831 | -0.0883 | No Change: Both O | - |
| Q86Y07 | VRK2_HUMAN Serine/threonine-protein kinase VRK2 OS=Homo sapiens GN=VRK2 PE=1 SV=3 | 211 | N | 0.558967 | S | 0.597542 | -0.038575 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 59 | S | 0.92979 | F | 0.866945 | 0.062845 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 105 | P | 0.999707 | T | 0.999622 | 8.50E-05 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 171 | F | 0.513809 | L | 0.58449 | -0.070681 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 268 | S | 0.550126 | L | 0.340212 | 0.209914 | D to O | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 288 | C | 0.104848 | Y | 0.116028 | -0.01118 | No Change: Both O | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 370 | R | 0.651982 | C | 0.488779 | 0.163203 | D to O | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 371 | S | 0.599085 | G | 0.553825 | 0.04526 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 170 | S | 0.528318 | P | 0.517455 | 0.010863 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 188 | T | 0.560489 | A | 0.521877 | 0.038612 | No Change: Both D | - |
| Q8IV63 | VRK3_HUMAN Inactive serine/threonine-protein kinase VRK3 OS=Homo sapiens GN=VRK3 PE=1 SV=2 | 304 | H | 0.352813 | L | 0.225094 | 0.127719 | No Change: Both O | - |
| Q9H8Y1 | VRTN_HUMAN Vertnin OS=Homo sapiens GN=VRTN PE=2 SV=1 | 133 | V | 0.201425 | M | 0.275365 | -0.07394 | No Change: Both O | A colorectal cancer sample |
| Q9H8Y1 | VRTN_HUMAN Vertnin OS=Homo sapiens GN=VRTN PE=2 SV=1 | 53 | L | 0.385237 | F | 0.331719 | 0.053518 | No Change: Both O | - |
| Q86XK7 | VSIG1_HUMAN V-set and immunoglobulin domain-containing protein 1 OS=Homo sapiens GN=VSIG1 PE=1 SV=1 | 147 | V | 0.528758 | I | 0.492813 | 0.035945 | D to O | - |
| Q8N0Z9 | VSI10_HUMAN V-set and immunoglobulin domain-containing protein 10 OS=Homo sapiens GN=VSIG10 PE=2 SV=1 | 333 | V | 0.207481 | M | 0.252488 | -0.045007 | No Change: Both O | - |
| Q8N0Z9 | VSI10_HUMAN V-set and immunoglobulin domain-containing protein 10 OS=Homo sapiens GN=VSIG10 PE=2 SV=1 | 435 | H | 0.04555 | Y | 0.027872 | 0.017678 | No Change: Both O | - |
| Q86VR7 | VS10L_HUMAN V-set and immunoglobulin domain-containing protein 10-like OS=Homo sapiens GN=VSIG10L PE=2 SV=2 | 3 | N | 0.749332 | T | 0.741163 | 0.008169 | No Change: Both D | - |
| Q86VR7 | VS10L_HUMAN V-set and immunoglobulin domain-containing protein 10-like OS=Homo sapiens GN=VSIG10L PE=2 SV=2 | 356 | M | 0.80548 | I | 0.749408 | 0.056072 | No Change: Both D | - |
| Q86VR7 | VS10L_HUMAN V-set and immunoglobulin domain-containing protein 10-like OS=Homo sapiens GN=VSIG10L PE=2 SV=2 | 592 | R | 0.789617 | Q | 0.748188 | 0.041429 | No Change: Both D | - |
| Q86VR7 | VS10L_HUMAN V-set and immunoglobulin domain-containing protein 10-like OS=Homo sapiens GN=VSIG10L PE=2 SV=2 | 627 | R | 0.679714 | H | 0.646877 | 0.032837 | No Change: Both D | - |
| Q9Y279 | VSIG4_HUMAN V-set and immunoglobulin domain-containing protein 4 OS=Homo sapiens GN=VSIG4 PE=1 SV=1 | 108 | R | 0.448428 | W | 0.264815 | 0.183613 | No Change: Both O | - |
| Q9Y279 | VSIG4_HUMAN V-set and immunoglobulin domain-containing protein 4 OS=Homo sapiens GN=VSIG4 PE=1 SV=1 | 272 | G | 0.551822 | E | 0.589286 | -0.037464 | No Change: Both D | - |
| Q9Y279 | VSIG4_HUMAN V-set and immunoglobulin domain-containing protein 4 OS=Homo sapiens GN=VSIG4 PE=1 SV=1 | 279 | G | 0.576315 | E | 0.621393 | -0.045078 | No Change: Both D | - |
| Q9Y279 | VSIG4_HUMAN V-set and immunoglobulin domain-containing protein 4 OS=Homo sapiens GN=VSIG4 PE=1 SV=1 | 397 | S | 0.852176 | I | 0.596896 | 0.25528 | No Change: Both D | - |
| P62760 | VISL1_HUMAN Visinin-like protein 1 OS=Homo sapiens GN=VSNL1 PE=1 SV=2 | 65 | A | 0.345154 | G | 0.390466 | -0.045312 | No Change: Both O | - |
| P62760 | VISL1_HUMAN Visinin-like protein 1 OS=Homo sapiens GN=VSNL1 PE=1 SV=2 | 172 | K | 0.675412 | R | 0.599725 | 0.075687 | No Change: Both D | - |
| Q6UX27 | VSTM1_HUMAN V-set and transmembrane domain-containing protein 1 OS=Homo sapiens GN=VSTM1 PE=1 SV=2 | 163 | S | 0.72907 | G | 0.686156 | 0.042914 | No Change: Both D | - |
| Q8TAG5 | VTM2A_HUMAN V-set and transmembrane domain-containing protein 2A OS=Homo sapiens GN=VSTM2A PE=2 SV=3 | 84 | E | 0.487309 | K | 0.475673 | 0.011636 | No Change: Both O | - |
| Q8IW00 | VSTM4_HUMAN V-set and transmembrane domain-containing protein 4 OS=Homo sapiens GN=VSTM4 PE=2 SV=3 | 68 | F | 0.224748 | S | 0.383966 | -0.159218 | No Change: Both O | - |
| Q8IW00 | VSTM4_HUMAN V-set and transmembrane domain-containing protein 4 OS=Homo sapiens GN=VSTM4 PE=2 SV=3 | 100 | R | 0.513092 | H | 0.461893 | 0.051199 | D to O | A colorectal cancer sample |
| Q8IW00 | VSTM4_HUMAN V-set and transmembrane domain-containing protein 4 OS=Homo sapiens GN=VSTM4 PE=2 SV=3 | 243 | K | 0.935265 | R | 0.924504 | 0.010761 | No Change: Both D | - |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 144 | D | 0.985512 | E | 0.985758 | -2.46E-04 | No Change: Both D | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 144 | D | 0.985512 | E | 0.985758 | -2.46E-04 | No Change: Both D | Posterior polymorphous corneal dystrophy type 1 (PPCD1) [MIM:122000] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 159 | L | 0.868698 | M | 0.877457 | -0.008759 | No Change: Both D | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 160 | G | 0.859381 | D | 0.891227 | -0.031846 | No Change: Both D | Posterior polymorphous corneal dystrophy type 1 (PPCD1) [MIM:122000] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 166 | R | 0.76652 | W | 0.584814 | 0.181706 | No Change: Both D | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 244 | H | 0.113336 | R | 0.142504 | -0.029168 | No Change: Both O | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 247 | P | 0.19049 | R | 0.168552 | 0.021938 | No Change: Both O | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 175 | Q | 0.578029 | H | 0.586964 | -0.008935 | No Change: Both D | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 17 | L | 0.944825 | P | 0.971796 | -0.026971 | No Change: Both D | Keratoconus type 1 (KTCN1) [MIM:148300] |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 131 | R | 0.989879 | S | 0.991119 | -0.00124 | No Change: Both D | - |
| Q9NZR4 | VSX1_HUMAN Visual system homeobox 1 OS=Homo sapiens GN=VSX1 PE=1 SV=2 | 256 | A | 0.450545 | S | 0.545329 | -0.094784 | O to D | Craniofacial anomalies and anterior segment dysgenesis syndrome (CAASDS) [MIM:614195] |
| P58304 | VSX2_HUMAN Visual system homeobox 2 OS=Homo sapiens GN=VSX2 PE=1 SV=1 | 200 | R | 0.258888 | P | 0.268641 | -0.009753 | No Change: Both O | Microphthalmia with cataracts and iris abnormalities (MCOPCTI) [MIM:610092] |
| P58304 | VSX2_HUMAN Visual system homeobox 2 OS=Homo sapiens GN=VSX2 PE=1 SV=1 | 200 | R | 0.258888 | Q | 0.267861 | -0.008973 | No Change: Both O | Microphthalmia with cataracts and iris abnormalities (MCOPCTI) [MIM:610092] |
| P58304 | VSX2_HUMAN Visual system homeobox 2 OS=Homo sapiens GN=VSX2 PE=1 SV=1 | 227 | R | 0.230111 | W | 0.104682 | 0.125429 | No Change: Both O | Microphthalmia isolated type 2 (MCOP2) [MIM:610093] |
| P58304 | VSX2_HUMAN Visual system homeobox 2 OS=Homo sapiens GN=VSX2 PE=1 SV=1 | 100 | P | 0.723729 | Q | 0.701564 | 0.022165 | No Change: Both D | - |
| Q9NP79 | VTA1_HUMAN Vacuolar protein sorting-associated protein VTA1 homolog OS=Homo sapiens GN=VTA1 PE=1 SV=1 | 239 | I | 0.710763 | M | 0.756216 | -0.045453 | No Change: Both D | - |
| P04004 | VTNC_HUMAN Vitronectin OS=Homo sapiens GN=VTN PE=1 SV=1 | 122 | A | 0.98115 | S | 0.986478 | -0.005328 | No Change: Both D | - |
| P04004 | VTNC_HUMAN Vitronectin OS=Homo sapiens GN=VTN PE=1 SV=1 | 268 | R | 0.387648 | Q | 0.391549 | -0.003901 | No Change: Both O | - |
| P04004 | VTNC_HUMAN Vitronectin OS=Homo sapiens GN=VTN PE=1 SV=1 | 400 | T | 0.712426 | M | 0.714671 | -0.002245 | No Change: Both D | - |
| Q5GFL6 | VWA2_HUMAN von Willebrand factor A domain-containing protein 2 OS=Homo sapiens GN=VWA2 PE=1 SV=1 | 9 | A | 0.087418 | T | 0.108138 | -0.02072 | No Change: Both O | - |
| Q5GFL6 | VWA2_HUMAN von Willebrand factor A domain-containing protein 2 OS=Homo sapiens GN=VWA2 PE=1 SV=1 | 131 | E | 0.359024 | G | 0.313692 | 0.045332 | No Change: Both O | - |
| Q5GFL6 | VWA2_HUMAN von Willebrand factor A domain-containing protein 2 OS=Homo sapiens GN=VWA2 PE=1 SV=1 | 137 | L | 0.190098 | R | 0.284837 | -0.094739 | No Change: Both O | A colorectal cancer sample |
| A6NCI4 | VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens GN=VWA3A PE=2 SV=3 | 657 | T | 0.649497 | I | 0.50116 | 0.148337 | No Change: Both D | - |
| A6NCI4 | VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens GN=VWA3A PE=2 SV=3 | 1165 | Q | 0.539857 | P | 0.544066 | -0.004209 | No Change: Both D | - |
| A6NCI4 | VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens GN=VWA3A PE=2 SV=3 | 464 | T | 0.257015 | I | 0.169228 | 0.087787 | No Change: Both O | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 181 | R | 0.167798 | W | 0.073837 | 0.093961 | No Change: Both O | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 677 | L | 0.343011 | V | 0.339212 | 0.003799 | No Change: Both O | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 885 | V | 0.229983 | M | 0.258387 | -0.028404 | No Change: Both O | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 1223 | D | 0.983591 | E | 0.984459 | -8.68E-04 | No Change: Both D | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 1245 | R | 0.883417 | K | 0.868207 | 0.01521 | No Change: Both D | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 1277 | T | 0.674399 | I | 0.505791 | 0.168608 | No Change: Both D | - |
| Q502W6 | VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens GN=VWA3B PE=2 SV=3 | 1103 | I | 0.06662 | M | 0.095186 | -0.028566 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 499 | S | 0.197217 | I | 0.086462 | 0.110755 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 506 | R | 0.36936 | K | 0.409845 | -0.040485 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 757 | R | 0.275414 | C | 0.140805 | 0.134609 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 759 | H | 0.348352 | R | 0.3631 | -0.014748 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 202 | S | 0.44121 | G | 0.379532 | 0.061678 | No Change: Both O | - |
| O00534 | VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens GN=VWA5A PE=2 SV=2 | 205 | E | 0.523118 | K | 0.51896 | 0.004158 | No Change: Both D | - |
| Q5TIE3 | VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens GN=VWA5B1 PE=1 SV=2 | 319 | A | 0.755112 | S | 0.831766 | -0.076654 | No Change: Both D | - |
| Q5TIE3 | VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens GN=VWA5B1 PE=1 SV=2 | 469 | N | 0.268026 | S | 0.291904 | -0.023878 | No Change: Both O | - |
| Q5TIE3 | VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens GN=VWA5B1 PE=1 SV=2 | 506 | S | 0.495718 | N | 0.432704 | 0.063014 | No Change: Both O | - |
| Q5TIE3 | VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens GN=VWA5B1 PE=1 SV=2 | 634 | K | 0.534576 | R | 0.506298 | 0.028278 | No Change: Both D | - |
| Q8N398 | VW5B2_HUMAN von Willebrand factor A domain-containing protein 5B2 OS=Homo sapiens GN=VWA5B2 PE=2 SV=2 | 211 | P | 0.385869 | S | 0.394365 | -0.008496 | No Change: Both O | - |
| Q2TAL6 | VWC2_HUMAN Brorin OS=Homo sapiens GN=VWC2 PE=2 SV=1 | 120 | A | 0.804279 | G | 0.818092 | -0.013813 | No Change: Both D | - |
| Q96DN2 | VWCE_HUMAN von Willebrand factor C and EGF domain-containing protein OS=Homo sapiens GN=VWCE PE=2 SV=2 | 842 | P | 0.988504 | R | 0.984188 | 0.004316 | No Change: Both D | - |
| Q8N2E2 | VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens GN=VWDE PE=2 SV=4 | 964 | K | 0.30552 | N | 0.266839 | 0.038681 | No Change: Both O | - |
| Q8N2E2 | VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens GN=VWDE PE=2 SV=4 | 1032 | T | 0.142249 | M | 0.119541 | 0.022708 | No Change: Both O | - |
| Q8N2E2 | VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens GN=VWDE PE=2 SV=4 | 1256 | Q | 0.43261 | K | 0.455831 | -0.023221 | No Change: Both O | - |
| Q8N2E2 | VWDE_HUMAN von Willebrand factor D and EGF domain-containing protein OS=Homo sapiens GN=VWDE PE=2 SV=4 | 1485 | F | 0.678751 | C | 0.780792 | -0.102041 | No Change: Both D | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 377 | W | 0.423967 | C | 0.616833 | -0.192866 | O to D | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 528 | N | 0.374473 | S | 0.395564 | -0.021091 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 550 | G | 0.356259 | R | 0.367743 | -0.011484 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 789 | T | 0.562054 | A | 0.540527 | 0.021527 | No Change: Both D | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 791 | T | 0.546751 | M | 0.580425 | -0.033674 | No Change: Both D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 816 | R | 0.428288 | W | 0.197172 | 0.231116 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 852 | Q | 0.134867 | R | 0.135249 | -3.82E-04 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 854 | R | 0.170135 | Q | 0.19631 | -0.026175 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 857 | N | 0.166598 | D | 0.195222 | -0.028624 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1266 | P | 0.360239 | L | 0.22156 | 0.138679 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1268 | H | 0.303584 | D | 0.389545 | -0.085961 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1272 | C | 0.150111 | R | 0.273546 | -0.123435 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1306 | R | 0.17762 | W | 0.07198 | 0.10564 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1308 | R | 0.180678 | C | 0.083331 | 0.097347 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1313 | W | 0.130833 | C | 0.171021 | -0.040188 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1314 | V | 0.115068 | L | 0.109096 | 0.005972 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1316 | V | 0.111506 | M | 0.136879 | -0.025373 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1318 | V | 0.149264 | L | 0.135845 | 0.013419 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1324 | G | 0.312279 | S | 0.369244 | -0.056965 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1341 | R | 0.510618 | Q | 0.520902 | -0.010284 | No Change: Both D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1374 | R | 0.404101 | C | 0.242272 | 0.161829 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1374 | R | 0.404101 | H | 0.383318 | 0.020783 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1381 | T | 0.251694 | A | 0.244847 | 0.006847 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1399 | R | 0.21781 | H | 0.192061 | 0.025749 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1460 | L | 0.550867 | V | 0.538386 | 0.012481 | No Change: Both D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1461 | A | 0.586253 | V | 0.522606 | 0.063647 | No Change: Both D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1514 | F | 0.532818 | C | 0.507574 | 0.025244 | No Change: Both D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1540 | L | 0.135021 | P | 0.254025 | -0.119004 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1584 | Y | 0.252232 | C | 0.23525 | 0.016982 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1597 | R | 0.489408 | G | 0.513074 | -0.023666 | O to D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1597 | R | 0.489408 | Q | 0.524268 | -0.03486 | O to D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1597 | R | 0.489408 | W | 0.310704 | 0.178704 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1607 | V | 0.234381 | D | 0.381326 | -0.146945 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1609 | G | 0.307751 | R | 0.305638 | 0.002113 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1613 | S | 0.485454 | P | 0.488268 | -0.002814 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1628 | I | 0.225353 | T | 0.32749 | -0.102137 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1638 | E | 0.311869 | K | 0.287081 | 0.024788 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1648 | P | 0.173202 | S | 0.14707 | 0.026132 | No Change: Both O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1665 | V | 0.331049 | E | 0.566539 | -0.23549 | O to D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2739 | C | 0.384464 | Y | 0.410177 | -0.025713 | No Change: Both O | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2773 | C | 0.360052 | R | 0.507809 | -0.147757 | O to D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 788 | C | 0.581121 | Y | 0.472539 | 0.108582 | D to O | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2063 | P | 0.303907 | S | 0.331786 | -0.027879 | No Change: Both O | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2362 | C | 0.942824 | F | 0.915597 | 0.027227 | No Change: Both D | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2546 | N | 0.612011 | Y | 0.441538 | 0.170473 | D to O | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 273 | R | 0.205102 | W | 0.095188 | 0.109914 | No Change: Both O | Von Willebrand disease type 1 (VWD1) [MIM:193400] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 273 | R | 0.205102 | W | 0.095188 | 0.109914 | No Change: Both O | Von Willebrand disease type 3 (VWD3) [MIM:277480] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1565 | V | 0.25549 | L | 0.269117 | -0.013627 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 484 | H | 0.228707 | R | 0.260743 | -0.032036 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1060 | C | 0.399248 | R | 0.505516 | -0.106268 | O to D | Von Willebrand disease type 2 (VWD2) [MIM:613554] |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1472 | D | 0.622962 | H | 0.553225 | 0.069737 | No Change: Both D | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1570 | Y | 0.396965 | C | 0.355607 | 0.041358 | No Change: Both O | A breast cancer sample |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 318 | N | 0.687123 | K | 0.714824 | -0.027701 | No Change: Both D | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 740 | M | 0.483141 | I | 0.350386 | 0.132755 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 885 | F | 0.095445 | S | 0.226153 | -0.130708 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2178 | A | 0.10395 | S | 0.160002 | -0.056052 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2185 | R | 0.089427 | Q | 0.096983 | -0.007556 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 2705 | G | 0.461908 | R | 0.454964 | 0.006944 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 471 | V | 0.315724 | I | 0.27608 | 0.039644 | No Change: Both O | - |
| P04275 | VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 | 1149 | C | 0.597262 | R | 0.63292 | -0.035658 | No Change: Both D | Von Willebrand disease type 1 (VWD1) [MIM:193400] |
| Q9BTA9 | WAC_HUMAN WW domain-containing adapter protein with coiled-coil OS=Homo sapiens GN=WAC PE=1 SV=3 | 242 | S | 0.925045 | R | 0.916271 | 0.008774 | No Change: Both D | - |
| Q9BTA9 | WAC_HUMAN WW domain-containing adapter protein with coiled-coil OS=Homo sapiens GN=WAC PE=1 SV=3 | 531 | T | 0.993898 | S | 0.995671 | -0.001773 | No Change: Both D | - |
| Q9BTA9 | WAC_HUMAN WW domain-containing adapter protein with coiled-coil OS=Homo sapiens GN=WAC PE=1 SV=3 | 475 | S | 0.983836 | L | 0.967637 | 0.016199 | No Change: Both D | A colorectal cancer sample |
| Q9BTA9 | WAC_HUMAN WW domain-containing adapter protein with coiled-coil OS=Homo sapiens GN=WAC PE=1 SV=3 | 309 | T | 0.989538 | A | 0.987348 | 0.00219 | No Change: Both D | - |
| Q7Z5K2 | WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens GN=WAPAL PE=1 SV=1 | 124 | V | 0.483435 | I | 0.430812 | 0.052623 | No Change: Both O | - |
| P23381 | SYWC_HUMAN Tryptophan--tRNA ligase cytoplasmic OS=Homo sapiens GN=WARS PE=1 SV=2 | 455 | E | 0.456633 | D | 0.417056 | 0.039577 | No Change: Both O | A breast cancer sample |
| P23381 | SYWC_HUMAN Tryptophan--tRNA ligase cytoplasmic OS=Homo sapiens GN=WARS PE=1 SV=2 | 54 | A | 0.74603 | S | 0.798805 | -0.052775 | No Change: Both D | - |
| Q9UGM6 | SYWM_HUMAN Tryptophan--tRNA ligase mitochondrial OS=Homo sapiens GN=WARS2 PE=1 SV=1 | 267 | A | 0.380238 | P | 0.442217 | -0.061979 | No Change: Both O | - |
| Q9UGM6 | SYWM_HUMAN Tryptophan--tRNA ligase mitochondrial OS=Homo sapiens GN=WARS2 PE=1 SV=1 | 50 | G | 0.124885 | S | 0.14638 | -0.021495 | No Change: Both O | - |
| Q9UGM6 | SYWM_HUMAN Tryptophan--tRNA ligase mitochondrial OS=Homo sapiens GN=WARS2 PE=1 SV=1 | 360 | L | 0.61775 | P | 0.768583 | -0.150833 | No Change: Both D | - |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 27 | L | 0.482208 | F | 0.435264 | 0.046944 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 31 | E | 0.443323 | K | 0.432632 | 0.010691 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 48 | T | 0.059781 | I | 0.028362 | 0.031419 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 56 | A | 0.131519 | V | 0.093629 | 0.03789 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 75 | V | 0.197025 | M | 0.234961 | -0.037936 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 82 | S | 0.21127 | P | 0.200892 | 0.010378 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 86 | R | 0.093804 | H | 0.093547 | 2.57E-04 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 86 | R | 0.093804 | L | 0.057802 | 0.036002 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 86 | R | 0.093804 | C | 0.043011 | 0.050793 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 97 | W | 0.172709 | C | 0.197598 | -0.024889 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 131 | E | 0.542933 | K | 0.527955 | 0.014978 | No Change: Both D | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 133 | E | 0.576923 | K | 0.565547 | 0.011376 | No Change: Both D | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 187 | G | 0.899572 | C | 0.856849 | 0.042723 | No Change: Both D | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 236 | A | 0.809454 | E | 0.824395 | -0.014941 | No Change: Both D | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 476 | K | 0.919621 | E | 0.937216 | -0.017595 | No Change: Both D | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 477 | R | 0.925032 | K | 0.92878 | -0.003748 | No Change: Both D | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 43 | C | 0.119126 | W | 0.09731 | 0.021816 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 45 | T | 0.086292 | M | 0.069934 | 0.016358 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 45 | T | 0.086292 | M | 0.069934 | 0.016358 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 73 | C | 0.118966 | R | 0.218763 | -0.099797 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 83 | Y | 0.176825 | C | 0.134835 | 0.04199 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 84 | F | 0.1432 | L | 0.173296 | -0.030096 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 89 | G | 0.073897 | D | 0.078995 | -0.005098 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 52 | Q | 0.069369 | H | 0.063092 | 0.006277 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 70 | G | 0.109872 | W | 0.04303 | 0.066842 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 58 | P | 0.218864 | L | 0.120448 | 0.098416 | No Change: Both O | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 134 | A | 0.583255 | T | 0.584582 | -0.001327 | No Change: Both D | Wiskott-Aldrich syndrome (WAS) [MIM:301000] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 58 | P | 0.218864 | R | 0.179425 | 0.039439 | No Change: Both O | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 270 | L | 0.35269 | P | 0.517283 | -0.164593 | O to D | Neutropenia severe congenital X-linked (XLN) [MIM:300299] |
| P42768 | WASP_HUMAN Wiskott-Aldrich syndrome protein OS=Homo sapiens GN=WAS PE=1 SV=4 | 481 | I | 0.937074 | N | 0.960196 | -0.023122 | No Change: Both D | Thrombocytopenia type 1 (THC1) [MIM:313900] |
| Q9UPY6 | WASF3_HUMAN Wiskott-Aldrich syndrome protein family member 3 OS=Homo sapiens GN=WASF3 PE=1 SV=2 | 415 | S | 0.996518 | L | 0.994066 | 0.002452 | No Change: Both D | - |
| Q6ICG8 | WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein OS=Homo sapiens GN=WBP2NL PE=2 SV=1 | 5 | Q | 0.762394 | E | 0.805067 | -0.042673 | No Change: Both D | - |
| Q6ICG8 | WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein OS=Homo sapiens GN=WBP2NL PE=2 SV=1 | 121 | D | 0.138195 | G | 0.132375 | 0.00582 | No Change: Both O | - |
| Q6ICG8 | WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein OS=Homo sapiens GN=WBP2NL PE=2 SV=1 | 170 | C | 0.281288 | F | 0.249933 | 0.031355 | No Change: Both O | - |
| Q6ICG8 | WBP2L_HUMAN Postacrosomal sheath WW domain-binding protein OS=Homo sapiens GN=WBP2NL PE=2 SV=1 | 285 | Q | 0.991724 | H | 0.988871 | 0.002853 | No Change: Both D | - |
| O75554 | WBP4_HUMAN WW domain-binding protein 4 OS=Homo sapiens GN=WBP4 PE=1 SV=1 | 113 | K | 0.953992 | R | 0.947254 | 0.006738 | No Change: Both D | A breast cancer sample |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 587 | P | 0.997572 | R | 0.996965 | 6.07E-04 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 754 | P | 0.996693 | L | 0.993625 | 0.003068 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 1097 | P | 0.986508 | L | 0.974406 | 0.012102 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 1829 | P | 0.974628 | L | 0.952223 | 0.022405 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 2364 | D | 0.988207 | G | 0.987201 | 0.001006 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 2408 | K | 0.889362 | N | 0.879037 | 0.010325 | No Change: Both D | - |
| Q9UMN6 | MLL4_HUMAN Histone-lysine N-methyltransferase MLL4 OS=Homo sapiens GN=WBP7 PE=1 SV=1 | 172 | T | 0.985454 | I | 0.970616 | 0.014838 | No Change: Both D | - |
| Q96I51 | WBS16_HUMAN Williams-Beuren syndrome chromosomal region 16 protein OS=Homo sapiens GN=WBSCR16 PE=1 SV=2 | 30 | R | 0.838267 | G | 0.810745 | 0.027522 | No Change: Both D | - |
| Q8N6F8 | WBS27_HUMAN Williams-Beuren syndrome chromosomal region 27 protein OS=Homo sapiens GN=WBSCR27 PE=2 SV=2 | 107 | Q | 0.519995 | R | 0.488028 | 0.031967 | D to O | - |
| Q8N6F8 | WBS27_HUMAN Williams-Beuren syndrome chromosomal region 27 protein OS=Homo sapiens GN=WBSCR27 PE=2 SV=2 | 171 | S | 0.500575 | W | 0.227331 | 0.273244 | D to O | - |
| Q6UE05 | WBS28_HUMAN Williams-Beuren syndrome chromosomal region 28 protein OS=Homo sapiens GN=WBSCR28 PE=2 SV=2 | 14 | I | 0.133675 | N | 0.271656 | -0.137981 | No Change: Both O | - |
| Q6UE05 | WBS28_HUMAN Williams-Beuren syndrome chromosomal region 28 protein OS=Homo sapiens GN=WBSCR28 PE=2 SV=2 | 70 | A | 0.203489 | D | 0.251307 | -0.047818 | No Change: Both O | - |
| Q6UE05 | WBS28_HUMAN Williams-Beuren syndrome chromosomal region 28 protein OS=Homo sapiens GN=WBSCR28 PE=2 SV=2 | 78 | W | 0.0652 | R | 0.153318 | -0.088118 | No Change: Both O | - |
| Q6UE05 | WBS28_HUMAN Williams-Beuren syndrome chromosomal region 28 protein OS=Homo sapiens GN=WBSCR28 PE=2 SV=2 | 67 | G | 0.201664 | V | 0.111006 | 0.090658 | No Change: Both O | - |
| Q8IZQ1 | WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens GN=WDFY3 PE=1 SV=2 | 3032 | I | 0.139063 | V | 0.166231 | -0.027168 | No Change: Both O | - |
| Q6ZS81 | WDFY4_HUMAN WD repeat- and FYVE domain-containing protein 4 OS=Homo sapiens GN=WDFY4 PE=1 SV=3 | 214 | S | 0.582485 | P | 0.528045 | 0.05444 | No Change: Both D | - |
| Q6ZS81 | WDFY4_HUMAN WD repeat- and FYVE domain-containing protein 4 OS=Homo sapiens GN=WDFY4 PE=1 SV=3 | 944 | S | 0.69457 | F | 0.489071 | 0.205499 | D to O | - |
| Q6ZS81 | WDFY4_HUMAN WD repeat- and FYVE domain-containing protein 4 OS=Homo sapiens GN=WDFY4 PE=1 SV=3 | 2527 | S | 0.580689 | N | 0.509872 | 0.070817 | No Change: Both D | - |
| O75717 | WDHD1_HUMAN WD repeat and HMG-box DNA-binding protein 1 OS=Homo sapiens GN=WDHD1 PE=1 SV=1 | 338 | F | 0.724598 | L | 0.738035 | -0.013437 | No Change: Both D | - |
| O75717 | WDHD1_HUMAN WD repeat and HMG-box DNA-binding protein 1 OS=Homo sapiens GN=WDHD1 PE=1 SV=1 | 411 | L | 0.794026 | P | 0.879459 | -0.085433 | No Change: Both D | - |
| O75717 | WDHD1_HUMAN WD repeat and HMG-box DNA-binding protein 1 OS=Homo sapiens GN=WDHD1 PE=1 SV=1 | 1102 | E | 0.977772 | K | 0.97868 | -9.08E-04 | No Change: Both D | - |
| O95876 | FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens GN=WDPCP PE=1 SV=2 | 268 | G | 0.12205 | S | 0.144535 | -0.022485 | No Change: Both O | - |
| O95876 | FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens GN=WDPCP PE=1 SV=2 | 55 | R | 0.180675 | K | 0.232039 | -0.051364 | No Change: Both O | - |
| O95876 | FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens GN=WDPCP PE=1 SV=2 | 205 | L | 0.341064 | F | 0.29916 | 0.041904 | No Change: Both O | - |
| O95876 | FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens GN=WDPCP PE=1 SV=2 | 708 | S | 0.607349 | F | 0.447072 | 0.160277 | D to O | - |
| O75083 | WDR1_HUMAN WD repeat-containing protein 1 OS=Homo sapiens GN=WDR1 PE=1 SV=4 | 185 | I | 0.264754 | V | 0.304759 | -0.040005 | No Change: Both O | - |
| Q9GZL7 | WDR12_HUMAN Ribosome biogenesis protein WDR12 OS=Homo sapiens GN=WDR12 PE=1 SV=2 | 72 | M | 0.581562 | V | 0.520076 | 0.061486 | No Change: Both D | - |
| Q9GZL7 | WDR12_HUMAN Ribosome biogenesis protein WDR12 OS=Homo sapiens GN=WDR12 PE=1 SV=2 | 89 | Y | 0.412818 | C | 0.376714 | 0.036104 | No Change: Both O | - |
| Q9GZL7 | WDR12_HUMAN Ribosome biogenesis protein WDR12 OS=Homo sapiens GN=WDR12 PE=1 SV=2 | 286 | E | 0.363355 | G | 0.332193 | 0.031162 | No Change: Both O | - |
| Q9GZL7 | WDR12_HUMAN Ribosome biogenesis protein WDR12 OS=Homo sapiens GN=WDR12 PE=1 SV=2 | 75 | I | 0.652657 | V | 0.683459 | -0.030802 | No Change: Both D | - |
| Q9H1Z4 | WDR13_HUMAN WD repeat-containing protein 13 OS=Homo sapiens GN=WDR13 PE=1 SV=2 | 325 | H | 0.257294 | R | 0.280614 | -0.02332 | No Change: Both O | - |
| Q8N1V2 | WDR16_HUMAN WD repeat-containing protein 16 OS=Homo sapiens GN=WDR16 PE=1 SV=3 | 336 | E | 0.111178 | K | 0.111036 | 1.42E-04 | No Change: Both O | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 814 | A | 0.505871 | T | 0.523187 | -0.017316 | No Change: Both D | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 913 | C | 0.268567 | S | 0.507381 | -0.238814 | O to D | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 952 | E | 0.19176 | K | 0.194653 | -0.002893 | No Change: Both O | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 1215 | A | 0.465445 | T | 0.522413 | -0.056968 | O to D | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 1295 | A | 0.342193 | T | 0.355362 | -0.013169 | No Change: Both O | - |
| Q8IZU2 | WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens GN=WDR17 PE=2 SV=2 | 418 | I | 0.126714 | V | 0.14408 | -0.017366 | No Change: Both O | - |
| Q9BV38 | WDR18_HUMAN WD repeat-containing protein 18 OS=Homo sapiens GN=WDR18 PE=1 SV=2 | 172 | A | 0.226646 | T | 0.262369 | -0.035723 | No Change: Both O | - |
| Q9BV38 | WDR18_HUMAN WD repeat-containing protein 18 OS=Homo sapiens GN=WDR18 PE=1 SV=2 | 213 | L | 0.088211 | F | 0.074664 | 0.013547 | No Change: Both O | - |
| Q9BV38 | WDR18_HUMAN WD repeat-containing protein 18 OS=Homo sapiens GN=WDR18 PE=1 SV=2 | 264 | V | 0.495121 | I | 0.45079 | 0.044331 | No Change: Both O | - |
| Q8NEZ3 | WDR19_HUMAN WD repeat-containing protein 19 OS=Homo sapiens GN=WDR19 PE=2 SV=2 | 1084 | G | 0.56666 | S | 0.600883 | -0.034223 | No Change: Both D | - |
| Q8TBZ3 | WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens GN=WDR20 PE=1 SV=2 | 159 | P | 0.16837 | H | 0.145592 | 0.022778 | No Change: Both O | - |
| Q8TBZ3 | WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens GN=WDR20 PE=1 SV=2 | 444 | G | 0.889439 | C | 0.854578 | 0.034861 | No Change: Both D | - |
| Q64LD2 | WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens GN=WDR25 PE=1 SV=3 | 88 | W | 0.731985 | R | 0.863798 | -0.131813 | No Change: Both D | - |
| Q64LD2 | WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens GN=WDR25 PE=1 SV=3 | 149 | H | 0.845497 | R | 0.872555 | -0.027058 | No Change: Both D | - |
| Q64LD2 | WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens GN=WDR25 PE=1 SV=3 | 59 | K | 0.789031 | R | 0.774608 | 0.014423 | No Change: Both D | - |
| Q64LD2 | WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens GN=WDR25 PE=1 SV=3 | 119 | T | 0.641433 | M | 0.650154 | -0.008721 | No Change: Both D | - |
| A2RRH5 | WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens GN=WDR27 PE=2 SV=3 | 133 | L | 0.132621 | P | 0.22402 | -0.091399 | No Change: Both O | - |
| A2RRH5 | WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens GN=WDR27 PE=2 SV=3 | 393 | V | 0.233013 | L | 0.25037 | -0.017357 | No Change: Both O | - |
| A2RRH5 | WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens GN=WDR27 PE=2 SV=3 | 437 | R | 0.664756 | H | 0.617229 | 0.047527 | No Change: Both D | - |
| A2RRH5 | WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens GN=WDR27 PE=2 SV=3 | 470 | P | 0.789424 | L | 0.651584 | 0.13784 | No Change: Both D | - |
| A2RRH5 | WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens GN=WDR27 PE=2 SV=3 | 697 | A | 0.384212 | V | 0.297965 | 0.086247 | No Change: Both O | - |
| Q9UNX4 | WDR3_HUMAN WD repeat-containing protein 3 OS=Homo sapiens GN=WDR3 PE=1 SV=1 | 234 | P | 0.834262 | A | 0.784527 | 0.049735 | No Change: Both D | - |
| Q8NA23 | WDR31_HUMAN WD repeat-containing protein 31 OS=Homo sapiens GN=WDR31 PE=2 SV=1 | 113 | P | 0.322882 | S | 0.375094 | -0.052212 | No Change: Both O | - |
| Q9C0J8 | WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens GN=WDR33 PE=1 SV=2 | 33 | A | 0.704653 | S | 0.75628 | -0.051627 | No Change: Both D | - |
| Q9C0J8 | WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens GN=WDR33 PE=1 SV=2 | 711 | P | 0.999888 | R | 0.999811 | 7.70E-05 | No Change: Both D | - |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 18 | Q | 0.164368 | R | 0.14725 | 0.017118 | No Change: Both O | - |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 983 | E | 0.535058 | G | 0.472545 | 0.062513 | D to O | - |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 878 | A | 0.136711 | P | 0.183902 | -0.047191 | No Change: Both O | - |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 878 | A | 0.136711 | T | 0.151523 | -0.014812 | No Change: Both O | - |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 626 | E | 0.474455 | G | 0.425495 | 0.04896 | No Change: Both O | Cranioectodermal dysplasia type 2 (CED2) [MIM:613610] |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 875 | A | 0.11042 | T | 0.123582 | -0.013162 | No Change: Both O | Cranioectodermal dysplasia type 2 (CED2) [MIM:613610] |
| Q9P2L0 | WDR35_HUMAN WD repeat-containing protein 35 OS=Homo sapiens GN=WDR35 PE=1 SV=3 | 261 | W | 0.109813 | R | 0.242643 | -0.13283 | No Change: Both O | Short rib-polydactyly syndrome type 5 (SRPS5) [MIM:614091] |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 264 | I | 0.100636 | V | 0.12615 | -0.025514 | No Change: Both O | - |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 25 | L | 0.239016 | P | 0.379146 | -0.14013 | No Change: Both O | - |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 163 | A | 0.363446 | V | 0.287596 | 0.07585 | No Change: Both O | - |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 216 | Y | 0.206609 | P | 0.373843 | -0.167234 | No Change: Both O | - |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 355 | N | 0.110239 | S | 0.122225 | -0.011986 | No Change: Both O | Primary open angle glaucoma type 1G (GLC1G) [MIM:609887] |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 449 | A | 0.433572 | T | 0.452172 | -0.0186 | No Change: Both O | Primary open angle glaucoma type 1G (GLC1G) [MIM:609887] |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 529 | R | 0.497008 | Q | 0.533009 | -0.036001 | O to D | Primary open angle glaucoma type 1G (GLC1G) [MIM:609887] |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 658 | D | 0.084627 | G | 0.068765 | 0.015862 | No Change: Both O | Primary open angle glaucoma type 1G (GLC1G) [MIM:609887] |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 671 | M | 0.480234 | V | 0.428891 | 0.051343 | No Change: Both O | - |
| Q8NI36 | WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens GN=WDR36 PE=1 SV=1 | 454 | E | 0.445749 | Q | 0.384466 | 0.061283 | No Change: Both O | - |
| Q9Y2I8 | WDR37_HUMAN WD repeat-containing protein 37 OS=Homo sapiens GN=WDR37 PE=2 SV=2 | 225 | I | 0.169324 | V | 0.199614 | -0.03029 | No Change: Both O | - |
| Q5JTN6 | WDR38_HUMAN WD repeat-containing protein 38 OS=Homo sapiens GN=WDR38 PE=2 SV=1 | 172 | H | 0.112463 | R | 0.120821 | -0.008358 | No Change: Both O | - |
| Q5JTN6 | WDR38_HUMAN WD repeat-containing protein 38 OS=Homo sapiens GN=WDR38 PE=2 SV=1 | 193 | A | 0.304003 | G | 0.355237 | -0.051234 | No Change: Both O | - |
| P57081 | WDR4_HUMAN tRNA (guanine-N(7)-)-methyltransferase subunit WDR4 OS=Homo sapiens GN=WDR4 PE=1 SV=2 | 71 | K | 0.521435 | N | 0.468368 | 0.053067 | D to O | - |
| P57081 | WDR4_HUMAN tRNA (guanine-N(7)-)-methyltransferase subunit WDR4 OS=Homo sapiens GN=WDR4 PE=1 SV=2 | 266 | P | 0.040125 | S | 0.044906 | -0.004781 | No Change: Both O | - |
| P57081 | WDR4_HUMAN tRNA (guanine-N(7)-)-methyltransferase subunit WDR4 OS=Homo sapiens GN=WDR4 PE=1 SV=2 | 390 | R | 0.96722 | Q | 0.968544 | -0.001324 | No Change: Both D | - |
| Q9HAD4 | WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens GN=WDR41 PE=2 SV=3 | 329 | V | 0.268052 | I | 0.230477 | 0.037575 | No Change: Both O | - |
| Q9HAD4 | WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens GN=WDR41 PE=2 SV=3 | 61 | G | 0.271254 | D | 0.308358 | -0.037104 | No Change: Both O | - |
| Q9HAD4 | WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens GN=WDR41 PE=2 SV=3 | 260 | R | 0.22867 | C | 0.119392 | 0.109278 | No Change: Both O | - |
| Q5JSH3 | WDR44_HUMAN WD repeat-containing protein 44 OS=Homo sapiens GN=WDR44 PE=1 SV=1 | 289 | A | 0.895228 | T | 0.91484 | -0.019612 | No Change: Both D | - |
| Q5JSH3 | WDR44_HUMAN WD repeat-containing protein 44 OS=Homo sapiens GN=WDR44 PE=1 SV=1 | 296 | T | 0.907395 | A | 0.897361 | 0.010034 | No Change: Both D | - |
| O15213 | WDR46_HUMAN WD repeat-containing protein 46 OS=Homo sapiens GN=WDR46 PE=1 SV=3 | 341 | V | 0.391543 | A | 0.475664 | -0.084121 | No Change: Both O | - |
| O15213 | WDR46_HUMAN WD repeat-containing protein 46 OS=Homo sapiens GN=WDR46 PE=1 SV=3 | 94 | T | 0.887453 | A | 0.891001 | -0.003548 | No Change: Both D | - |
| O15213 | WDR46_HUMAN WD repeat-containing protein 46 OS=Homo sapiens GN=WDR46 PE=1 SV=3 | 124 | S | 0.879301 | Y | 0.755777 | 0.123524 | No Change: Both D | - |
| Q8IV35 | WDR49_HUMAN WD repeat-containing protein 49 OS=Homo sapiens GN=WDR49 PE=1 SV=1 | 651 | L | 0.768563 | P | 0.856434 | -0.087871 | No Change: Both D | - |
| Q8IV35 | WDR49_HUMAN WD repeat-containing protein 49 OS=Homo sapiens GN=WDR49 PE=1 SV=1 | 10 | R | 0.590386 | H | 0.588178 | 0.002208 | No Change: Both D | A colorectal cancer sample |
| Q96MT7 | WDR52_HUMAN WD repeat-containing protein 52 OS=Homo sapiens GN=WDR52 PE=1 SV=1 | 284 | K | 0.620888 | N | 0.601254 | 0.019634 | No Change: Both D | - |
| Q96MT7 | WDR52_HUMAN WD repeat-containing protein 52 OS=Homo sapiens GN=WDR52 PE=1 SV=1 | 53 | K | 0.966776 | E | 0.97593 | -0.009154 | No Change: Both D | - |
| Q7Z5U6 | WDR53_HUMAN WD repeat-containing protein 53 OS=Homo sapiens GN=WDR53 PE=2 SV=1 | 338 | H | 0.252944 | P | 0.281598 | -0.028654 | No Change: Both O | - |
| Q7Z5U6 | WDR53_HUMAN WD repeat-containing protein 53 OS=Homo sapiens GN=WDR53 PE=2 SV=1 | 60 | S | 0.318674 | C | 0.153929 | 0.164745 | No Change: Both O | A breast cancer sample |
| Q9H6Y2 | WDR55_HUMAN WD repeat-containing protein 55 OS=Homo sapiens GN=WDR55 PE=1 SV=2 | 50 | R | 0.315387 | C | 0.203388 | 0.111999 | No Change: Both O | - |
| Q9H6Y2 | WDR55_HUMAN WD repeat-containing protein 55 OS=Homo sapiens GN=WDR55 PE=1 SV=2 | 151 | C | 0.173313 | R | 0.312357 | -0.139044 | No Change: Both O | - |
| Q9H6Y2 | WDR55_HUMAN WD repeat-containing protein 55 OS=Homo sapiens GN=WDR55 PE=1 SV=2 | 210 | S | 0.624795 | F | 0.39199 | 0.232805 | D to O | - |
| Q9H6Y2 | WDR55_HUMAN WD repeat-containing protein 55 OS=Homo sapiens GN=WDR55 PE=1 SV=2 | 235 | Y | 0.095699 | C | 0.095405 | 2.94E-04 | No Change: Both O | - |
| Q6PJI9 | WDR59_HUMAN WD repeat-containing protein 59 OS=Homo sapiens GN=WDR59 PE=1 SV=2 | 201 | P | 0.45286 | T | 0.406272 | 0.046588 | No Change: Both O | - |
| Q8WVS4 | WDR60_HUMAN WD repeat-containing protein 60 OS=Homo sapiens GN=WDR60 PE=1 SV=3 | 91 | E | 0.998786 | G | 0.998221 | 5.65E-04 | No Change: Both D | - |
| Q8WVS4 | WDR60_HUMAN WD repeat-containing protein 60 OS=Homo sapiens GN=WDR60 PE=1 SV=3 | 273 | Q | 0.994187 | R | 0.995403 | -0.001216 | No Change: Both D | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 850 | L | 0.333193 | S | 0.493305 | -0.160112 | No Change: Both O | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 1370 | G | 0.911618 | S | 0.926378 | -0.01476 | No Change: Both D | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 1385 | L | 0.79234 | F | 0.727291 | 0.065049 | No Change: Both D | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 289 | K | 0.170458 | R | 0.12856 | 0.041898 | No Change: Both O | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 1305 | Q | 0.591465 | L | 0.49087 | 0.100595 | D to O | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 1311 | Q | 0.661157 | E | 0.679172 | -0.018015 | No Change: Both D | - |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 224 | W | 0.082292 | S | 0.264325 | -0.182033 | No Change: Both O | Microcephaly primary type 2 (MCPH2) [MIM:604317] |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 526 | E | 0.309986 | K | 0.303197 | 0.006789 | No Change: Both O | Microcephaly primary type 2 (MCPH2) [MIM:604317] |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 65 | V | 0.350256 | M | 0.391564 | -0.041308 | No Change: Both O | Microcephaly primary type 2 (MCPH2) [MIM:604317] |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 438 | R | 0.239283 | H | 0.237892 | 0.001391 | No Change: Both O | Microcephaly primary type 2 (MCPH2) [MIM:604317] |
| O43379 | WDR62_HUMAN WD repeat-containing protein 62 OS=Homo sapiens GN=WDR62 PE=1 SV=4 | 511 | D | 0.589796 | N | 0.5816 | 0.008196 | No Change: Both D | Microcephaly primary type 2 (MCPH2) [MIM:604317] |
| Q8IWG1 | WDR63_HUMAN WD repeat-containing protein 63 OS=Homo sapiens GN=WDR63 PE=2 SV=1 | 674 | T | 0.51675 | A | 0.460745 | 0.056005 | D to O | - |
| Q8IWG1 | WDR63_HUMAN WD repeat-containing protein 63 OS=Homo sapiens GN=WDR63 PE=2 SV=1 | 798 | R | 0.453848 | H | 0.459801 | -0.005953 | No Change: Both O | - |
| B1ANS9 | WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens GN=WDR64 PE=2 SV=1 | 647 | R | 0.094319 | Q | 0.104329 | -0.01001 | No Change: Both O | - |
| B1ANS9 | WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens GN=WDR64 PE=2 SV=1 | 952 | R | 0.501246 | W | 0.295537 | 0.205709 | D to O | - |
| Q96MR6 | WDR65_HUMAN WD repeat-containing protein 65 OS=Homo sapiens GN=WDR65 PE=1 SV=3 | 183 | A | 0.23363 | S | 0.346634 | -0.113004 | No Change: Both O | - |
| Q96MR6 | WDR65_HUMAN WD repeat-containing protein 65 OS=Homo sapiens GN=WDR65 PE=1 SV=3 | 241 | N | 0.667568 | D | 0.714614 | -0.047046 | No Change: Both D | - |
| Q96MR6 | WDR65_HUMAN WD repeat-containing protein 65 OS=Homo sapiens GN=WDR65 PE=1 SV=3 | 345 | C | 0.607695 | S | 0.748603 | -0.140908 | No Change: Both D | - |
| Q96MR6 | WDR65_HUMAN WD repeat-containing protein 65 OS=Homo sapiens GN=WDR65 PE=1 SV=3 | 523 | D | 0.31239 | Y | 0.172766 | 0.139624 | No Change: Both O | Van der Woude syndrome type 2 (VWS2) [MIM:606713] |
| Q8TBY9 | WDR66_HUMAN WD repeat-containing protein 66 OS=Homo sapiens GN=WDR66 PE=1 SV=2 | 61 | E | 0.996805 | G | 0.995428 | 0.001377 | No Change: Both D | - |
| Q8TBY9 | WDR66_HUMAN WD repeat-containing protein 66 OS=Homo sapiens GN=WDR66 PE=1 SV=2 | 383 | T | 0.146074 | M | 0.110408 | 0.035666 | No Change: Both O | - |
| Q8TBY9 | WDR66_HUMAN WD repeat-containing protein 66 OS=Homo sapiens GN=WDR66 PE=1 SV=2 | 445 | L | 0.334539 | F | 0.322455 | 0.012084 | No Change: Both O | - |
| Q8TBY9 | WDR66_HUMAN WD repeat-containing protein 66 OS=Homo sapiens GN=WDR66 PE=1 SV=2 | 66 | G | 0.997628 | E | 0.998413 | -7.85E-04 | No Change: Both D | - |
| Q96DN5 | WDR67_HUMAN WD repeat-containing protein 67 OS=Homo sapiens GN=WDR67 PE=2 SV=2 | 414 | R | 0.403092 | H | 0.370796 | 0.032296 | No Change: Both O | - |
| Q96DN5 | WDR67_HUMAN WD repeat-containing protein 67 OS=Homo sapiens GN=WDR67 PE=2 SV=2 | 709 | V | 0.786568 | F | 0.761587 | 0.024981 | No Change: Both D | - |
| Q96DN5 | WDR67_HUMAN WD repeat-containing protein 67 OS=Homo sapiens GN=WDR67 PE=2 SV=2 | 1065 | A | 0.787127 | T | 0.807369 | -0.020242 | No Change: Both D | - |
| Q8N136 | WDR69_HUMAN Outer row dynein assembly protein 16 homolog OS=Homo sapiens GN=WDR69 PE=1 SV=1 | 27 | T | 0.554887 | I | 0.444466 | 0.110421 | D to O | - |
| Q8N136 | WDR69_HUMAN Outer row dynein assembly protein 16 homolog OS=Homo sapiens GN=WDR69 PE=1 SV=1 | 121 | T | 0.291709 | S | 0.372875 | -0.081166 | No Change: Both O | - |
| Q8N136 | WDR69_HUMAN Outer row dynein assembly protein 16 homolog OS=Homo sapiens GN=WDR69 PE=1 SV=1 | 259 | G | 0.100277 | S | 0.133225 | -0.032948 | No Change: Both O | - |
| Q8N136 | WDR69_HUMAN Outer row dynein assembly protein 16 homolog OS=Homo sapiens GN=WDR69 PE=1 SV=1 | 317 | L | 0.24755 | F | 0.235253 | 0.012297 | No Change: Both O | - |
| Q8N136 | WDR69_HUMAN Outer row dynein assembly protein 16 homolog OS=Homo sapiens GN=WDR69 PE=1 SV=1 | 129 | T | 0.55133 | M | 0.512448 | 0.038882 | No Change: Both D | A breast cancer sample |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 819 | L | 0.074827 | F | 0.058007 | 0.01682 | No Change: Both O | - |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 833 | S | 0.339448 | A | 0.218566 | 0.120882 | No Change: Both O | - |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 399 | K | 0.351763 | Q | 0.307481 | 0.044282 | No Change: Both O | - |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 479 | Q | 0.529589 | H | 0.521394 | 0.008195 | No Change: Both D | - |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 100 | M | 0.291305 | V | 0.24591 | 0.045395 | No Change: Both O | - |
| Q3MJ13 | WDR72_HUMAN WD repeat-containing protein 72 OS=Homo sapiens GN=WDR72 PE=1 SV=2 | 781 | K | 0.805073 | E | 0.772176 | 0.032897 | No Change: Both D | - |
| Q6P4I2 | WDR73_HUMAN WD repeat-containing protein 73 OS=Homo sapiens GN=WDR73 PE=1 SV=1 | 249 | R | 0.763203 | H | 0.722278 | 0.040925 | No Change: Both D | - |
| Q9H967 | WDR76_HUMAN WD repeat-containing protein 76 OS=Homo sapiens GN=WDR76 PE=1 SV=2 | 153 | S | 0.865568 | A | 0.789987 | 0.075581 | No Change: Both D | - |
| Q9H967 | WDR76_HUMAN WD repeat-containing protein 76 OS=Homo sapiens GN=WDR76 PE=1 SV=2 | 614 | S | 0.479239 | G | 0.432807 | 0.046432 | No Change: Both O | - |
| Q9BQA1 | MEP50_HUMAN Methylosome protein 50 OS=Homo sapiens GN=WDR77 PE=1 SV=1 | 48 | S | 0.387351 | I | 0.174096 | 0.213255 | No Change: Both O | - |
| Q5VTH9 | WDR78_HUMAN WD repeat-containing protein 78 OS=Homo sapiens GN=WDR78 PE=2 SV=1 | 16 | G | 0.537187 | A | 0.493793 | 0.043394 | D to O | - |
| Q5VTH9 | WDR78_HUMAN WD repeat-containing protein 78 OS=Homo sapiens GN=WDR78 PE=2 SV=1 | 33 | C | 0.388885 | W | 0.339314 | 0.049571 | No Change: Both O | - |
| Q5VTH9 | WDR78_HUMAN WD repeat-containing protein 78 OS=Homo sapiens GN=WDR78 PE=2 SV=1 | 832 | R | 0.432745 | Q | 0.455472 | -0.022727 | No Change: Both O | - |
| Q562E7 | WDR81_HUMAN WD repeat-containing protein 81 OS=Homo sapiens GN=WDR81 PE=2 SV=1 | 484 | M | 0.793205 | V | 0.761084 | 0.032121 | No Change: Both D | - |
| Q9BRX9 | WDR83_HUMAN WD repeat domain-containing protein 83 OS=Homo sapiens GN=WDR83 PE=1 SV=1 | 278 | G | 0.276984 | S | 0.334749 | -0.057765 | No Change: Both O | - |
| Q9BRX9 | WDR83_HUMAN WD repeat domain-containing protein 83 OS=Homo sapiens GN=WDR83 PE=1 SV=1 | 304 | R | 0.317043 | Q | 0.362687 | -0.045644 | No Change: Both O | - |
| Q9BTV6 | WDR85_HUMAN WD repeat-containing protein 85 OS=Homo sapiens GN=WDR85 PE=2 SV=2 | 158 | G | 0.559246 | R | 0.559318 | -7.20E-05 | No Change: Both D | - |
| Q86TI4 | WDR86_HUMAN WD repeat-containing protein 86 OS=Homo sapiens GN=WDR86 PE=2 SV=3 | 355 | M | 0.7734 | T | 0.78615 | -0.01275 | No Change: Both D | - |
| Q6ZQQ6 | WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens GN=WDR87 PE=2 SV=3 | 496 | H | 0.230616 | Y | 0.156653 | 0.073963 | No Change: Both O | - |
| Q6ZQQ6 | WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens GN=WDR87 PE=2 SV=3 | 1583 | R | 0.994339 | Q | 0.99432 | 1.90E-05 | No Change: Both D | - |
| Q6ZQQ6 | WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens GN=WDR87 PE=2 SV=3 | 1885 | N | 0.717393 | K | 0.769532 | -0.052139 | No Change: Both D | - |
| Q6ZQQ6 | WDR87_HUMAN WD repeat-containing protein 87 OS=Homo sapiens GN=WDR87 PE=2 SV=3 | 2570 | H | 0.251974 | L | 0.184241 | 0.067733 | No Change: Both O | - |
| Q6ZMY6 | WDR88_HUMAN WD repeat-containing protein 88 OS=Homo sapiens GN=WDR88 PE=2 SV=2 | 310 | C | 0.148787 | R | 0.261335 | -0.112548 | No Change: Both O | - |
| Q6ZMY6 | WDR88_HUMAN WD repeat-containing protein 88 OS=Homo sapiens GN=WDR88 PE=2 SV=2 | 166 | D | 0.25949 | H | 0.223941 | 0.035549 | No Change: Both O | A breast cancer sample |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 165 | S | 0.149293 | T | 0.100454 | 0.048839 | No Change: Both O | - |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 250 | P | 0.948545 | L | 0.904057 | 0.044488 | No Change: Both D | - |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 537 | V | 0.181953 | A | 0.231872 | -0.049919 | No Change: Both O | - |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 1001 | P | 0.616296 | T | 0.53458 | 0.081716 | No Change: Both D | - |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 1492 | R | 0.433723 | H | 0.415888 | 0.017835 | No Change: Both O | - |
| Q96KV7 | WDR90_HUMAN WD repeat-containing protein 90 OS=Homo sapiens GN=WDR90 PE=1 SV=2 | 1555 | C | 0.283792 | R | 0.424445 | -0.140653 | No Change: Both O | - |
| A4D1P6 | WDR91_HUMAN WD repeat-containing protein 91 OS=Homo sapiens GN=WDR91 PE=1 SV=2 | 257 | P | 0.89184 | L | 0.854375 | 0.037465 | No Change: Both D | - |
| Q96MX6 | WDR92_HUMAN WD repeat-containing protein 92 OS=Homo sapiens GN=WDR92 PE=1 SV=1 | 241 | M | 0.370136 | V | 0.320092 | 0.050044 | No Change: Both O | - |
| Q6P2C0 | WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens GN=WDR93 PE=2 SV=1 | 66 | L | 0.241317 | H | 0.264934 | -0.023617 | No Change: Both O | - |
| Q6P2C0 | WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens GN=WDR93 PE=2 SV=1 | 254 | S | 0.642111 | T | 0.548748 | 0.093363 | No Change: Both D | - |
| Q6P2C0 | WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens GN=WDR93 PE=2 SV=1 | 352 | T | 0.231307 | M | 0.194245 | 0.037062 | No Change: Both O | - |
| Q8NDM7 | WDR96_HUMAN WD repeat-containing protein 96 OS=Homo sapiens GN=WDR96 PE=2 SV=3 | 393 | I | 0.145688 | T | 0.25875 | -0.113062 | No Change: Both O | - |
| Q8NDM7 | WDR96_HUMAN WD repeat-containing protein 96 OS=Homo sapiens GN=WDR96 PE=2 SV=3 | 616 | L | 0.205406 | F | 0.174178 | 0.031228 | No Change: Both O | - |
| Q8NDM7 | WDR96_HUMAN WD repeat-containing protein 96 OS=Homo sapiens GN=WDR96 PE=2 SV=3 | 634 | V | 0.515406 | I | 0.490843 | 0.024563 | D to O | - |
| Q8NDM7 | WDR96_HUMAN WD repeat-containing protein 96 OS=Homo sapiens GN=WDR96 PE=2 SV=3 | 835 | A | 0.809488 | S | 0.877267 | -0.067779 | No Change: Both D | - |
| Q8N9V3 | WSDU1_HUMAN WD repeat SAM and U-box domain-containing protein 1 OS=Homo sapiens GN=WDSUB1 PE=1 SV=3 | 215 | K | 0.060689 | T | 0.04515 | 0.015539 | No Change: Both O | - |
| Q8N9V3 | WSDU1_HUMAN WD repeat SAM and U-box domain-containing protein 1 OS=Homo sapiens GN=WDSUB1 PE=1 SV=3 | 223 | H | 0.033138 | D | 0.039699 | -0.006561 | No Change: Both O | - |
| Q8N9V3 | WSDU1_HUMAN WD repeat SAM and U-box domain-containing protein 1 OS=Homo sapiens GN=WDSUB1 PE=1 SV=3 | 320 | R | 0.398064 | S | 0.446519 | -0.048455 | No Change: Both O | - |
| Q96HA8 | NTAQ1_HUMAN Protein N-terminal glutamine amidohydrolase OS=Homo sapiens GN=WDYHV1 PE=1 SV=2 | 32 | I | 0.1094 | V | 0.121013 | -0.011613 | No Change: Both O | - |
| Q96HA8 | NTAQ1_HUMAN Protein N-terminal glutamine amidohydrolase OS=Homo sapiens GN=WDYHV1 PE=1 SV=2 | 93 | N | 0.264752 | S | 0.323347 | -0.058595 | No Change: Both O | - |
| Q96HA8 | NTAQ1_HUMAN Protein N-terminal glutamine amidohydrolase OS=Homo sapiens GN=WDYHV1 PE=1 SV=2 | 116 | F | 0.463404 | I | 0.470583 | -0.007179 | No Change: Both O | - |
| Q96HA8 | NTAQ1_HUMAN Protein N-terminal glutamine amidohydrolase OS=Homo sapiens GN=WDYHV1 PE=1 SV=2 | 134 | R | 0.418961 | C | 0.293514 | 0.125447 | No Change: Both O | - |
| P30291 | WEE1_HUMAN Wee1-like protein kinase OS=Homo sapiens GN=WEE1 PE=1 SV=2 | 210 | G | 0.809194 | C | 0.737807 | 0.071387 | No Change: Both D | - |
| P30291 | WEE1_HUMAN Wee1-like protein kinase OS=Homo sapiens GN=WEE1 PE=1 SV=2 | 472 | S | 0.544604 | I | 0.359735 | 0.184869 | D to O | - |
| P0C1S8 | WEE2_HUMAN Wee1-like protein kinase 2 OS=Homo sapiens GN=WEE2 PE=2 SV=2 | 8 | K | 0.850496 | T | 0.783692 | 0.066804 | No Change: Both D | - |
| P0C1S8 | WEE2_HUMAN Wee1-like protein kinase 2 OS=Homo sapiens GN=WEE2 PE=2 SV=2 | 332 | N | 0.299648 | K | 0.325958 | -0.02631 | No Change: Both O | A gastric adenocarcinoma sample |
| P0C1S8 | WEE2_HUMAN Wee1-like protein kinase 2 OS=Homo sapiens GN=WEE2 PE=2 SV=2 | 398 | R | 0.377651 | H | 0.381386 | -0.003735 | No Change: Both O | An ovarian mucinous carcinoma sample |
| P0C1S8 | WEE2_HUMAN Wee1-like protein kinase 2 OS=Homo sapiens GN=WEE2 PE=2 SV=2 | 470 | D | 0.717724 | E | 0.763817 | -0.046093 | No Change: Both D | - |
| P0C1S8 | WEE2_HUMAN Wee1-like protein kinase 2 OS=Homo sapiens GN=WEE2 PE=2 SV=2 | 526 | Y | 0.863828 | D | 0.92725 | -0.063422 | No Change: Both D | - |
| Q9HC57 | WFDC1_HUMAN WAP four-disulfide core domain protein 1 OS=Homo sapiens GN=WFDC1 PE=2 SV=2 | 138 | V | 0.44017 | M | 0.509839 | -0.069669 | O to D | A breast cancer sample |
| Q9HC57 | WFDC1_HUMAN WAP four-disulfide core domain protein 1 OS=Homo sapiens GN=WFDC1 PE=2 SV=2 | 196 | L | 0.626998 | V | 0.627634 | -6.36E-04 | No Change: Both D | - |
| Q9HC57 | WFDC1_HUMAN WAP four-disulfide core domain protein 1 OS=Homo sapiens GN=WFDC1 PE=2 SV=2 | 217 | K | 0.840976 | R | 0.835869 | 0.005107 | No Change: Both D | - |
| Q8IUB3 | WF10B_HUMAN Protein WFDC10B OS=Homo sapiens GN=WFDC10B PE=2 SV=2 | 8 | L | 0.07417 | P | 0.143468 | -0.069298 | No Change: Both O | - |
| Q8IUB2 | WFDC3_HUMAN WAP four-disulfide core domain protein 3 OS=Homo sapiens GN=WFDC3 PE=2 SV=1 | 36 | H | 0.77634 | D | 0.793492 | -0.017152 | No Change: Both D | - |
| Q8IUB2 | WFDC3_HUMAN WAP four-disulfide core domain protein 3 OS=Homo sapiens GN=WFDC3 PE=2 SV=1 | 198 | G | 0.39401 | S | 0.443448 | -0.049438 | No Change: Both O | - |
| Q8TCV5 | WFDC5_HUMAN WAP four-disulfide core domain protein 5 OS=Homo sapiens GN=WFDC5 PE=2 SV=1 | 97 | H | 0.903922 | Y | 0.838552 | 0.06537 | No Change: Both D | - |
| Q8IUA0 | WFDC8_HUMAN WAP four-disulfide core domain protein 8 OS=Homo sapiens GN=WFDC8 PE=2 SV=2 | 96 | M | 0.448224 | T | 0.443684 | 0.00454 | No Change: Both O | - |
| Q8IUA0 | WFDC8_HUMAN WAP four-disulfide core domain protein 8 OS=Homo sapiens GN=WFDC8 PE=2 SV=2 | 137 | N | 0.323047 | S | 0.324101 | -0.001054 | No Change: Both O | - |
| Q8NEX5 | WFDC9_HUMAN Protein WFDC9 OS=Homo sapiens GN=WFDC9 PE=2 SV=1 | 27 | N | 0.158488 | T | 0.134731 | 0.023757 | No Change: Both O | - |
| Q8TEU8 | WFKN2_HUMAN WAP kazal immunoglobulin kunitz and NTR domain-containing protein 2 OS=Homo sapiens GN=WFIKKN2 PE=1 SV=1 | 96 | V | 0.603543 | M | 0.689254 | -0.085711 | No Change: Both D | - |
| Q8TEU8 | WFKN2_HUMAN WAP kazal immunoglobulin kunitz and NTR domain-containing protein 2 OS=Homo sapiens GN=WFIKKN2 PE=1 SV=1 | 31 | R | 0.288609 | Q | 0.300494 | -0.011885 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 333 | V | 0.018962 | I | 0.01846 | 5.02E-04 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 456 | R | 0.455629 | H | 0.456891 | -0.001262 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 504 | P | 0.035883 | L | 0.018778 | 0.017105 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 611 | R | 0.041236 | H | 0.041406 | -1.70E-04 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 695 | G | 0.215109 | V | 0.126733 | 0.088376 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 724 | P | 0.063389 | L | 0.032369 | 0.03102 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 169 | E | 0.669536 | K | 0.661252 | 0.008284 | No Change: Both D | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 292 | P | 0.159661 | S | 0.168535 | -0.008874 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 296 | I | 0.148044 | S | 0.292165 | -0.144121 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 437 | G | 0.066029 | R | 0.064453 | 0.001576 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 690 | C | 0.207071 | R | 0.389507 | -0.182436 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 700 | W | 0.195528 | C | 0.223736 | -0.028208 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 736 | G | 0.127202 | S | 0.160673 | -0.033471 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 885 | P | 0.157837 | L | 0.085448 | 0.072389 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 559 | A | 0.100015 | T | 0.119649 | -0.019634 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 576 | G | 0.040467 | S | 0.048327 | -0.00786 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 720 | I | 0.233097 | V | 0.242145 | -0.009048 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 58 | A | 0.978817 | V | 0.969362 | 0.009455 | No Change: Both D | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 126 | A | 0.152732 | T | 0.169639 | -0.016907 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 443 | S | 0.210529 | I | 0.079092 | 0.131437 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 674 | G | 0.14653 | R | 0.138641 | 0.007889 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 684 | A | 0.225444 | V | 0.160314 | 0.06513 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 708 | R | 0.15376 | C | 0.068914 | 0.084846 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 737 | E | 0.165821 | K | 0.163779 | 0.002042 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 780 | G | 0.38912 | R | 0.422884 | -0.033764 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 818 | R | 0.351805 | C | 0.221225 | 0.13058 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 133 | A | 0.216214 | T | 0.228831 | -0.012617 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 653 | R | 0.101109 | C | 0.051787 | 0.049322 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 669 | Y | 0.129639 | C | 0.108508 | 0.021131 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 193 | K | 0.534273 | Q | 0.500334 | 0.033939 | No Change: Both D | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 871 | V | 0.224928 | M | 0.264374 | -0.039446 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 602 | A | 0.047316 | V | 0.034528 | 0.012788 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 110 | Y | 0.350256 | N | 0.506522 | -0.156266 | O to D | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 326 | A | 0.039928 | V | 0.028384 | 0.011544 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 457 | R | 0.421535 | S | 0.478825 | -0.05729 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 629 | R | 0.409977 | W | 0.204055 | 0.205922 | No Change: Both O | Wolfram syndrome type 1 (WFS1) [MIM:222300] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 802 | I | 0.557424 | V | 0.603306 | -0.045882 | No Change: Both D | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 16 | P | 0.997032 | L | 0.993224 | 0.003808 | No Change: Both D | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 107 | G | 0.448257 | R | 0.439205 | 0.009052 | No Change: Both O | - |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 634 | K | 0.09795 | T | 0.072708 | 0.025242 | No Change: Both O | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 699 | T | 0.204439 | M | 0.160469 | 0.04397 | No Change: Both O | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 716 | A | 0.517734 | T | 0.546058 | -0.028324 | No Change: Both D | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 779 | V | 0.374615 | M | 0.485251 | -0.110636 | No Change: Both O | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 829 | L | 0.249845 | P | 0.37382 | -0.123975 | No Change: Both O | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 831 | G | 0.238335 | D | 0.247111 | -0.008776 | No Change: Both O | Deafness autosomal dominant type 6 (DFNA6) [MIM:600965] |
| O76024 | WFS1_HUMAN Wolframin OS=Homo sapiens GN=WFS1 PE=1 SV=2 | 864 | E | 0.503005 | K | 0.517945 | -0.01494 | No Change: Both D | Wolfram-like syndrome autosomal dominant (WFSL) [MIM:614296] |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 340 | Q | 0.526081 | K | 0.548291 | -0.02221 | No Change: Both D | - |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 345 | R | 0.577224 | Q | 0.593242 | -0.016018 | No Change: Both D | - |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 686 | R | 0.925237 | H | 0.902745 | 0.022492 | No Change: Both D | - |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 736 | H | 0.563951 | P | 0.642335 | -0.078384 | No Change: Both D | - |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 736 | H | 0.563951 | Q | 0.575065 | -0.011114 | No Change: Both D | - |
| Q8TF30 | WHAMM_HUMAN WASP homolog-associated protein with actin membranes and microtubules OS=Homo sapiens GN=WHAMM PE=1 SV=2 | 212 | N | 0.325064 | S | 0.356604 | -0.03154 | No Change: Both O | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 440 | A | 0.347543 | T | 0.375095 | -0.027552 | No Change: Both O | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 783 | V | 0.986721 | A | 0.990871 | -0.00415 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 796 | N | 0.966421 | K | 0.973252 | -0.006831 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 813 | T | 0.755673 | M | 0.714108 | 0.041565 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 364 | R | 0.409787 | H | 0.384333 | 0.025454 | No Change: Both O | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 423 | R | 0.397612 | P | 0.43034 | -0.032728 | No Change: Both O | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 562 | P | 0.688933 | A | 0.615703 | 0.07323 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 613 | M | 0.979972 | T | 0.982725 | -0.002753 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 752 | H | 0.896887 | Q | 0.920091 | -0.023204 | No Change: Both D | - |
| Q9P202 | WHRN_HUMAN Whirlin OS=Homo sapiens GN=WHRN PE=1 SV=3 | 443 | A | 0.248611 | S | 0.339094 | -0.090483 | No Change: Both O | - |
| Q9BZ95 | NSD3_HUMAN Histone-lysine N-methyltransferase NSD3 OS=Homo sapiens GN=WHSC1L1 PE=1 SV=1 | 383 | R | 0.579138 | P | 0.592635 | -0.013497 | No Change: Both D | - |
| Q9BZ95 | NSD3_HUMAN Histone-lysine N-methyltransferase NSD3 OS=Homo sapiens GN=WHSC1L1 PE=1 SV=1 | 186 | T | 0.921866 | M | 0.914106 | 0.00776 | No Change: Both D | - |
| Q9H3P2 | NELFA_HUMAN Negative elongation factor A OS=Homo sapiens GN=WHSC2 PE=1 SV=3 | 335 | S | 0.979091 | A | 0.969122 | 0.009969 | No Change: Both D | - |
| Q9BRP8 | WIBG_HUMAN Partner of Y14 and mago OS=Homo sapiens GN=WIBG PE=1 SV=1 | 66 | E | 0.937883 | Q | 0.922561 | 0.015322 | No Change: Both D | - |
| O43516 | WIPF1_HUMAN WAS/WASL-interacting protein family member 1 OS=Homo sapiens GN=WIPF1 PE=1 SV=3 | 495 | A | 0.990934 | G | 0.992561 | -0.001627 | No Change: Both D | - |
| O43516 | WIPF1_HUMAN WAS/WASL-interacting protein family member 1 OS=Homo sapiens GN=WIPF1 PE=1 SV=3 | 198 | P | 0.999447 | L | 0.998579 | 8.68E-04 | No Change: Both D | - |
| A6NGB9 | WIPF3_HUMAN WAS/WASL-interacting protein family member 3 OS=Homo sapiens GN=WIPF3 PE=2 SV=3 | 321 | E | 0.998638 | G | 0.998657 | -1.90E-05 | No Change: Both D | - |
| Q5MNZ9 | WIPI1_HUMAN WD repeat domain phosphoinositide-interacting protein 1 OS=Homo sapiens GN=WIPI1 PE=1 SV=3 | 31 | T | 0.383683 | I | 0.232032 | 0.151651 | No Change: Both O | - |
| Q5MNZ9 | WIPI1_HUMAN WD repeat domain phosphoinositide-interacting protein 1 OS=Homo sapiens GN=WIPI1 PE=1 SV=3 | 308 | R | 0.292113 | H | 0.273697 | 0.018416 | No Change: Both O | - |
| O95388 | WISP1_HUMAN WNT1-inducible-signaling pathway protein 1 OS=Homo sapiens GN=WISP1 PE=1 SV=1 | 205 | A | 0.342185 | S | 0.418835 | -0.07665 | No Change: Both O | - |
| O76076 | WISP2_HUMAN WNT1-inducible-signaling pathway protein 2 OS=Homo sapiens GN=WISP2 PE=1 SV=1 | 59 | R | 0.760589 | Q | 0.760969 | -3.80E-04 | No Change: Both D | - |
| O95389 | WISP3_HUMAN WNT1-inducible-signaling pathway protein 3 OS=Homo sapiens GN=WISP3 PE=1 SV=1 | 56 | Q | 0.912843 | H | 0.886498 | 0.026345 | No Change: Both D | - |
| O95389 | WISP3_HUMAN WNT1-inducible-signaling pathway protein 3 OS=Homo sapiens GN=WISP3 PE=1 SV=1 | 78 | C | 0.618571 | R | 0.645217 | -0.026646 | No Change: Both D | Progressive pseudorheumatoid arthropathy of childhood (PPAC) [MIM:208230] |
| O95389 | WISP3_HUMAN WNT1-inducible-signaling pathway protein 3 OS=Homo sapiens GN=WISP3 PE=1 SV=1 | 60 | R | 0.902679 | C | 0.89413 | 0.008549 | No Change: Both D | - |
| Q5T9L3 | WLS_HUMAN Protein wntless homolog OS=Homo sapiens GN=WLS PE=1 SV=2 | 465 | V | 0.156063 | I | 0.125296 | 0.030767 | No Change: Both O | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 665 | T | 0.942664 | I | 0.901403 | 0.041261 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1199 | E | 0.83082 | G | 0.788978 | 0.041842 | No Change: Both D | A colorectal cancer sample |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1799 | Q | 0.848361 | E | 0.854083 | -0.005722 | No Change: Both D | Breast cancer samples |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 141 | A | 0.990163 | T | 0.990503 | -3.40E-04 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 149 | A | 0.990331 | V | 0.98695 | 0.003381 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 419 | E | 0.441824 | Q | 0.39003 | 0.051794 | No Change: Both O | A breast pleomorphic lobular carcinoma sample |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 509 | I | 0.392974 | T | 0.464797 | -0.071823 | No Change: Both O | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 527 | D | 0.338523 | G | 0.286701 | 0.051822 | No Change: Both O | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 674 | T | 0.950585 | A | 0.937137 | 0.013448 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 823 | H | 0.806813 | R | 0.79783 | 0.008983 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1546 | A | 0.942902 | V | 0.924131 | 0.018771 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1808 | M | 0.775298 | I | 0.698991 | 0.076307 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1823 | P | 0.706915 | L | 0.550067 | 0.156848 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1957 | R | 0.80562 | H | 0.764719 | 0.040901 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 2190 | S | 0.917454 | C | 0.844599 | 0.072855 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 2362 | F | 0.817487 | L | 0.840522 | -0.023035 | No Change: Both D | A lung adenocarcinoma sample |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 2380 | R | 0.909332 | W | 0.821682 | 0.08765 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1056 | T | 0.933656 | P | 0.947433 | -0.013777 | No Change: Both D | - |
| Q9H4A3 | WNK1_HUMAN Serine/threonine-protein kinase WNK1 OS=Homo sapiens GN=WNK1 PE=1 SV=2 | 1506 | C | 0.930338 | S | 0.966845 | -0.036507 | No Change: Both D | - |
| Q9Y3S1 | WNK2_HUMAN Serine/threonine-protein kinase WNK2 OS=Homo sapiens GN=WNK2 PE=1 SV=4 | 828 | V | 0.927638 | M | 0.937257 | -0.009619 | No Change: Both D | - |
| Q9Y3S1 | WNK2_HUMAN Serine/threonine-protein kinase WNK2 OS=Homo sapiens GN=WNK2 PE=1 SV=4 | 974 | R | 0.999923 | L | 0.99991 | 1.30E-05 | No Change: Both D | - |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 704 | Q | 0.8241 | H | 0.748536 | 0.075564 | No Change: Both D | - |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 854 | S | 0.969947 | C | 0.941538 | 0.028409 | No Change: Both D | A lung squamous cell carcinoma sample |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 998 | A | 0.359002 | T | 0.395834 | -0.036832 | No Change: Both O | - |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 1169 | K | 0.61638 | E | 0.622854 | -0.006474 | No Change: Both D | - |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 1375 | T | 0.736802 | I | 0.639544 | 0.097258 | No Change: Both D | - |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 1533 | L | 0.899966 | F | 0.873281 | 0.026685 | No Change: Both D | A lung large cell carcinoma sample |
| Q9BYP7 | WNK3_HUMAN Serine/threonine-protein kinase WNK3 OS=Homo sapiens GN=WNK3 PE=1 SV=3 | 1634 | S | 0.597022 | P | 0.570828 | 0.026194 | No Change: Both D | A renal clear cell carcinoma sample |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 562 | E | 0.958538 | K | 0.944125 | 0.014413 | No Change: Both D | Pseudohypoaldosteronism type II (PHAII) [MIM:145260] |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 564 | D | 0.95059 | A | 0.940923 | 0.009667 | No Change: Both D | Pseudohypoaldosteronism type II (PHAII) [MIM:145260] |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 565 | Q | 0.945106 | E | 0.953361 | -0.008255 | No Change: Both D | Pseudohypoaldosteronism type II (PHAII) [MIM:145260] |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 1185 | R | 0.910405 | C | 0.858327 | 0.052078 | No Change: Both D | Pseudohypoaldosteronism type II (PHAII) [MIM:145260] |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 434 | E | 0.405277 | D | 0.36691 | 0.038367 | No Change: Both O | An ovarian mucinous carcinoma sample |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 813 | P | 0.99348 | L | 0.986571 | 0.006909 | No Change: Both D | - |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 992 | P | 0.982698 | S | 0.980869 | 0.001829 | No Change: Both D | A metastatic melanoma sample |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 1013 | L | 0.961938 | P | 0.979851 | -0.017913 | No Change: Both D | - |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 677 | R | 0.895892 | W | 0.724472 | 0.17142 | No Change: Both D | - |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 961 | P | 0.998196 | S | 0.998032 | 1.64E-04 | No Change: Both D | - |
| Q96J92 | WNK4_HUMAN Serine/threonine-protein kinase WNK4 OS=Homo sapiens GN=WNK4 PE=1 SV=1 | 601 | A | 0.863922 | S | 0.912286 | -0.048364 | No Change: Both D | - |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 302 | P | 0.670072 | T | 0.631608 | 0.038464 | No Change: Both D | - |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 128 | R | 0.318548 | Q | 0.320035 | -0.001487 | No Change: Both O | Odonto-onycho-dermal dysplasia (OODD) [MIM:257980] |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 228 | F | 0.705149 | I | 0.676566 | 0.028583 | No Change: Both D | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 228 | F | 0.705149 | I | 0.676566 | 0.028583 | No Change: Both D | Odonto-onycho-dermal dysplasia (OODD) [MIM:257980] |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 143 | H | 0.200301 | Y | 0.143257 | 0.057044 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 145 | V | 0.212742 | M | 0.247503 | -0.034761 | No Change: Both O | Ectodermal dysplasia anhidrotic (EDA) [MIM:224900] |
| Q9GZT5 | WN10A_HUMAN Protein Wnt-10a OS=Homo sapiens GN=WNT10A PE=1 SV=1 | 360 | R | 0.749159 | C | 0.677379 | 0.07178 | No Change: Both D | - |
| O00744 | WN10B_HUMAN Protein Wnt-10b OS=Homo sapiens GN=WNT10B PE=1 SV=2 | 77 | H | 0.235143 | Y | 0.129221 | 0.105922 | No Change: Both O | - |
| O00744 | WN10B_HUMAN Protein Wnt-10b OS=Homo sapiens GN=WNT10B PE=1 SV=2 | 256 | C | 0.339776 | Y | 0.322541 | 0.017235 | No Change: Both O | - |
| O00744 | WN10B_HUMAN Protein Wnt-10b OS=Homo sapiens GN=WNT10B PE=1 SV=2 | 285 | I | 0.289765 | T | 0.419902 | -0.130137 | No Change: Both O | - |
| O00744 | WN10B_HUMAN Protein Wnt-10b OS=Homo sapiens GN=WNT10B PE=1 SV=2 | 301 | P | 0.57184 | S | 0.579626 | -0.007786 | No Change: Both D | - |
| O00744 | WN10B_HUMAN Protein Wnt-10b OS=Homo sapiens GN=WNT10B PE=1 SV=2 | 332 | R | 0.804375 | W | 0.565903 | 0.238472 | No Change: Both D | Split-hand/foot malformation type 6 (SHFM6) [MIM:225300] |
| Q9UBV4 | WNT16_HUMAN Protein Wnt-16 OS=Homo sapiens GN=WNT16 PE=2 SV=1 | 126 | V | 0.128849 | M | 0.195896 | -0.067047 | No Change: Both O | A colorectal cancer sample |
| Q9UBV4 | WNT16_HUMAN Protein Wnt-16 OS=Homo sapiens GN=WNT16 PE=2 SV=1 | 82 | G | 0.383298 | R | 0.401526 | -0.018228 | No Change: Both O | - |
| Q9UBV4 | WNT16_HUMAN Protein Wnt-16 OS=Homo sapiens GN=WNT16 PE=2 SV=1 | 263 | T | 0.834807 | I | 0.791898 | 0.042909 | No Change: Both D | - |
| P09544 | WNT2_HUMAN Protein Wnt-2 OS=Homo sapiens GN=WNT2 PE=1 SV=1 | 5 | L | 0.319453 | R | 0.424235 | -0.104782 | No Change: Both O | - |
| P09544 | WNT2_HUMAN Protein Wnt-2 OS=Homo sapiens GN=WNT2 PE=1 SV=1 | 299 | R | 0.466827 | W | 0.219424 | 0.247403 | No Change: Both O | - |
| P09544 | WNT2_HUMAN Protein Wnt-2 OS=Homo sapiens GN=WNT2 PE=1 SV=1 | 294 | C | 0.436401 | F | 0.377393 | 0.059008 | No Change: Both O | - |
| P56705 | WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens GN=WNT4 PE=1 SV=4 | 216 | E | 0.282094 | G | 0.247862 | 0.034232 | No Change: Both O | Rokitansky-Kuster-Hauser syndrome (RKH syndrome) [MIM:277000] |
| P56705 | WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens GN=WNT4 PE=1 SV=4 | 12 | L | 0.124371 | P | 0.220342 | -0.095971 | No Change: Both O | Rokitansky-Kuster-Hauser syndrome (RKH syndrome) [MIM:277000] |
| P56705 | WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens GN=WNT4 PE=1 SV=4 | 83 | R | 0.182915 | C | 0.097843 | 0.085072 | No Change: Both O | Rokitansky-Kuster-Hauser syndrome (RKH syndrome) [MIM:277000] |
| P56705 | WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens GN=WNT4 PE=1 SV=4 | 114 | A | 0.149614 | V | 0.105627 | 0.043987 | No Change: Both O | Female sex reversal with dysgenesis of kidneys adrenals and lungs (SERKAL) [MIM:611812] |
| P56705 | WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens GN=WNT4 PE=1 SV=4 | 277 | P | 0.517208 | L | 0.365376 | 0.151832 | D to O | - |
| P41221 | WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens GN=WNT5A PE=1 SV=2 | 83 | C | 0.3552 | S | 0.59699 | -0.24179 | O to D | Robinow syndrome autosomal dominant (DRS) [MIM:180700] |
| P41221 | WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens GN=WNT5A PE=1 SV=2 | 182 | C | 0.188727 | R | 0.293812 | -0.105085 | No Change: Both O | Robinow syndrome autosomal dominant (DRS) [MIM:180700] |
| O00755 | WNT7A_HUMAN Protein Wnt-7a OS=Homo sapiens GN=WNT7A PE=1 SV=2 | 109 | A | 0.095206 | T | 0.100965 | -0.005759 | No Change: Both O | Fuhrmann syndrome (FUHRS) [MIM:228930] |
| O00755 | WNT7A_HUMAN Protein Wnt-7a OS=Homo sapiens GN=WNT7A PE=1 SV=2 | 292 | R | 0.518442 | C | 0.395919 | 0.122523 | D to O | Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820] |
| O00755 | WNT7A_HUMAN Protein Wnt-7a OS=Homo sapiens GN=WNT7A PE=1 SV=2 | 222 | R | 0.15966 | W | 0.06996 | 0.0897 | No Change: Both O | Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820] |
| O00755 | WNT7A_HUMAN Protein Wnt-7a OS=Homo sapiens GN=WNT7A PE=1 SV=2 | 72 | E | 0.345727 | K | 0.329668 | 0.016059 | No Change: Both O | Limb pelvis hypoplasia aplasia syndrome (LPHAS) [MIM:276820] |
| Q93098 | WNT8B_HUMAN Protein Wnt-8b OS=Homo sapiens GN=WNT8B PE=2 SV=3 | 11 | C | 0.018979 | S | 0.059113 | -0.040134 | No Change: Both O | - |
| Q93098 | WNT8B_HUMAN Protein Wnt-8b OS=Homo sapiens GN=WNT8B PE=2 SV=3 | 53 | E | 0.287261 | Q | 0.253281 | 0.03398 | No Change: Both O | A colorectal cancer sample |
| O14904 | WNT9A_HUMAN Protein Wnt-9a OS=Homo sapiens GN=WNT9A PE=2 SV=2 | 260 | A | 0.701165 | T | 0.71517 | -0.014005 | No Change: Both D | - |
| O14905 | WNT9B_HUMAN Protein Wnt-9b OS=Homo sapiens GN=WNT9B PE=1 SV=3 | 106 | M | 0.284241 | T | 0.324171 | -0.03993 | No Change: Both O | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 11 | P | 0.988298 | S | 0.985666 | 0.002632 | No Change: Both D | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 68 | R | 0.979168 | G | 0.977642 | 0.001526 | No Change: Both D | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 522 | A | 0.414153 | G | 0.542413 | -0.12826 | O to D | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 136 | P | 0.866228 | R | 0.847739 | 0.018489 | No Change: Both D | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 187 | N | 0.221165 | T | 0.191965 | 0.0292 | No Change: Both O | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 494 | E | 0.767387 | Q | 0.741334 | 0.026053 | No Change: Both D | - |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 164 | F | 0.507676 | L | 0.528219 | -0.020543 | No Change: Both D | Dyskeratosis congenita autosomal recessive type 3 (DKCB3) [MIM:613988] |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 376 | H | 0.208267 | Y | 0.12392 | 0.084347 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 3 (DKCB3) [MIM:613988] |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 398 | R | 0.110774 | W | 0.047891 | 0.062883 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 3 (DKCB3) [MIM:613988] |
| Q9BUR4 | WAP53_HUMAN Telomerase Cajal body protein 1 OS=Homo sapiens GN=WRAP53 PE=1 SV=1 | 435 | G | 0.471382 | R | 0.444498 | 0.026884 | No Change: Both O | Dyskeratosis congenita autosomal recessive type 3 (DKCB3) [MIM:613988] |
| Q9P2S5 | WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens GN=WRAP73 PE=2 SV=1 | 331 | I | 0.27127 | M | 0.359312 | -0.088042 | No Change: Both O | - |
| Q9P2S5 | WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens GN=WRAP73 PE=2 SV=1 | 358 | V | 0.032478 | I | 0.028872 | 0.003606 | No Change: Both O | - |
| O00258 | WRB_HUMAN Tail-anchored protein insertion receptor WRB OS=Homo sapiens GN=WRB PE=1 SV=2 | 110 | V | 0.031171 | I | 0.026965 | 0.004206 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 324 | T | 0.546951 | A | 0.486353 | 0.060598 | D to O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 387 | M | 0.710325 | I | 0.605389 | 0.104936 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1367 | C | 0.53639 | R | 0.637035 | -0.100645 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1074 | L | 0.746281 | F | 0.667803 | 0.078478 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 834 | R | 0.187447 | C | 0.096401 | 0.091046 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1079 | S | 0.814716 | L | 0.713641 | 0.101075 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 32 | K | 0.452504 | R | 0.416236 | 0.036268 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 114 | V | 0.192102 | I | 0.159918 | 0.032184 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 172 | T | 0.30879 | P | 0.336844 | -0.028054 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 240 | N | 0.328779 | K | 0.38518 | -0.056401 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 383 | L | 0.779281 | W | 0.680824 | 0.098457 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 724 | Q | 0.198192 | L | 0.125156 | 0.073036 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1269 | K | 0.52228 | E | 0.51489 | 0.00739 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 343 | E | 0.408201 | K | 0.383444 | 0.024757 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 533 | N | 0.480685 | S | 0.514397 | -0.033712 | O to D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 612 | S | 0.166904 | C | 0.064892 | 0.102012 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 708 | S | 0.430818 | F | 0.210956 | 0.219862 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 912 | I | 0.439723 | S | 0.645115 | -0.205392 | O to D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1133 | S | 0.871512 | A | 0.802135 | 0.069377 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1339 | V | 0.146913 | I | 0.150254 | -0.003341 | No Change: Both O | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 329 | Q | 0.596481 | R | 0.577045 | 0.019436 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 383 | L | 0.779281 | F | 0.747486 | 0.031795 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 125 | K | 0.253522 | N | 0.22007 | 0.033452 | No Change: Both O | Werner syndrome (WRN) [MIM:277700] |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 135 | K | 0.436899 | E | 0.435009 | 0.00189 | No Change: Both O | Werner syndrome (WRN) [MIM:277700] |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 92 | G | 0.253696 | V | 0.156825 | 0.096871 | No Change: Both O | A colorectal cancer sample |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 1141 | S | 0.806879 | L | 0.677237 | 0.129642 | No Change: Both D | - |
| Q14191 | WRN_HUMAN Werner syndrome ATP-dependent helicase OS=Homo sapiens GN=WRN PE=1 SV=2 | 711 | R | 0.359037 | W | 0.183563 | 0.175474 | No Change: Both O | - |
| Q9Y6I7 | WSB1_HUMAN WD repeat and SOCS box-containing protein 1 OS=Homo sapiens GN=WSB1 PE=1 SV=1 | 16 | L | 0.22583 | S | 0.385071 | -0.159241 | No Change: Both O | - |
| Q658N2 | WSCD1_HUMAN WSC domain-containing protein 1 OS=Homo sapiens GN=WSCD1 PE=1 SV=1 | 212 | H | 0.568741 | Y | 0.47781 | 0.090931 | D to O | - |
| Q2TBF2 | WSCD2_HUMAN WSC domain-containing protein 2 OS=Homo sapiens GN=WSCD2 PE=2 SV=2 | 266 | T | 0.214116 | I | 0.11765 | 0.096466 | No Change: Both O | - |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 181 | P | 0.850066 | S | 0.847866 | 0.0022 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 223 | S | 0.537377 | N | 0.485746 | 0.051631 | D to O | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 253 | G | 0.608323 | A | 0.571652 | 0.036671 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 273 | S | 0.707507 | G | 0.677979 | 0.029528 | No Change: Both D | - |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 330 | C | 0.446833 | Y | 0.396476 | 0.050357 | No Change: Both O | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 360 | C | 0.886867 | G | 0.895614 | -0.008747 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | C | 0.918102 | 0.021523 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | C | 0.918102 | 0.021523 | No Change: Both D | Meacham syndrome (MEACHS) [MIM:608978] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | C | 0.918102 | 0.021523 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | H | 0.926387 | 0.013238 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | H | 0.926387 | 0.013238 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 373 | H | 0.954341 | Q | 0.963608 | -0.009267 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 373 | H | 0.954341 | Q | 0.963608 | -0.009267 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 377 | H | 0.95154 | Y | 0.916085 | 0.035455 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 383 | F | 0.9545 | L | 0.953902 | 5.98E-04 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | W | 0.906846 | 0.054325 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | W | 0.906846 | 0.054325 | No Change: Both D | Meacham syndrome (MEACHS) [MIM:608978] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | W | 0.906846 | 0.054325 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 396 | D | 0.960111 | N | 0.955029 | 0.005082 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 396 | D | 0.960111 | N | 0.955029 | 0.005082 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 396 | D | 0.960111 | G | 0.959754 | 3.57E-04 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 312 | R | 0.530267 | Q | 0.540554 | -0.010287 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 342 | M | 0.73217 | R | 0.775128 | -0.042958 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 355 | C | 0.781914 | Y | 0.738967 | 0.042947 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 373 | H | 0.954341 | Y | 0.924198 | 0.030143 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 377 | H | 0.95154 | R | 0.962679 | -0.011139 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 385 | C | 0.956189 | R | 0.968925 | -0.012736 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 388 | C | 0.956016 | F | 0.947091 | 0.008925 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 392 | F | 0.960331 | L | 0.960193 | 1.38E-04 | No Change: Both D | Frasier syndrome (FS) [MIM:136680] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | Q | 0.960462 | 7.09E-04 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 398 | L | 0.956726 | P | 0.978492 | -0.021766 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 131 | A | 0.770544 | T | 0.788604 | -0.01806 | No Change: Both D | - |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 355 | C | 0.781914 | G | 0.8111 | -0.029186 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 360 | C | 0.886867 | Y | 0.852821 | 0.034046 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 364 | F | 0.920952 | L | 0.922735 | -0.001783 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 366 | R | 0.939625 | L | 0.896074 | 0.043551 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 369 | Q | 0.94943 | P | 0.949408 | 2.20E-05 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 379 | G | 0.95391 | C | 0.955529 | -0.001619 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 388 | C | 0.956016 | R | 0.969233 | -0.013217 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 388 | C | 0.956016 | Y | 0.927044 | 0.028972 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | L | 0.932982 | 0.028189 | No Change: Both D | Wilms tumor 1 (WT1) [MIM:194070] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 394 | R | 0.961171 | P | 0.961761 | -5.90E-04 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 396 | D | 0.960111 | Y | 0.927327 | 0.032784 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 397 | H | 0.95794 | P | 0.96607 | -0.00813 | No Change: Both D | Nephrotic syndrome type 4 (NPHS4) [MIM:256370] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 401 | H | 0.945007 | Y | 0.898542 | 0.046465 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 405 | H | 0.923123 | R | 0.933872 | -0.010749 | No Change: Both D | Denys-Drash syndrome (DDS) [MIM:194080] |
| P19544 | WT1_HUMAN Wilms tumor protein OS=Homo sapiens GN=WT1 PE=1 SV=2 | 281 | L | 0.196938 | P | 0.362937 | -0.165999 | No Change: Both O | - |
| Q06250 | WIT1_HUMAN Putative Wilms tumor upstream neighbor 1 gene protein OS=Homo sapiens GN=WT1-AS PE=5 SV=2 | 13 | A | 0.206314 | T | 0.196545 | 0.009769 | No Change: Both O | - |
| Q06250 | WIT1_HUMAN Putative Wilms tumor upstream neighbor 1 gene protein OS=Homo sapiens GN=WT1-AS PE=5 SV=2 | 66 | G | 0.950177 | A | 0.943245 | 0.006932 | No Change: Both D | - |
| Q15007 | FL2D_HUMAN Pre-mRNA-splicing regulator WTAP OS=Homo sapiens GN=WTAP PE=1 SV=2 | 84 | E | 0.842833 | D | 0.803921 | 0.038912 | No Change: Both D | - |
| Q8IX03 | KIBRA_HUMAN Protein KIBRA OS=Homo sapiens GN=WWC1 PE=1 SV=1 | 250 | R | 0.777256 | C | 0.689238 | 0.088018 | No Change: Both D | - |
| Q8IX03 | KIBRA_HUMAN Protein KIBRA OS=Homo sapiens GN=WWC1 PE=1 SV=1 | 734 | M | 0.122788 | I | 0.081725 | 0.041063 | No Change: Both O | - |
| Q8IX03 | KIBRA_HUMAN Protein KIBRA OS=Homo sapiens GN=WWC1 PE=1 SV=1 | 735 | S | 0.14258 | A | 0.090489 | 0.052091 | No Change: Both O | - |
| Q6AWC2 | WWC2_HUMAN Protein WWC2 OS=Homo sapiens GN=WWC2 PE=1 SV=2 | 773 | A | 0.172855 | S | 0.262101 | -0.089246 | No Change: Both O | - |
| Q6AWC2 | WWC2_HUMAN Protein WWC2 OS=Homo sapiens GN=WWC2 PE=1 SV=2 | 816 | V | 0.199101 | F | 0.209841 | -0.01074 | No Change: Both O | - |
| Q6AWC2 | WWC2_HUMAN Protein WWC2 OS=Homo sapiens GN=WWC2 PE=1 SV=2 | 904 | D | 0.913623 | H | 0.874891 | 0.038732 | No Change: Both D | - |
| Q6AWC2 | WWC2_HUMAN Protein WWC2 OS=Homo sapiens GN=WWC2 PE=1 SV=2 | 1189 | A | 0.566079 | T | 0.576854 | -0.010775 | No Change: Both D | - |
| Q6AWC2 | WWC2_HUMAN Protein WWC2 OS=Homo sapiens GN=WWC2 PE=1 SV=2 | 979 | R | 0.883039 | C | 0.810687 | 0.072352 | No Change: Both D | - |
| Q9ULE0 | WWC3_HUMAN Protein WWC3 OS=Homo sapiens GN=WWC3 PE=2 SV=3 | 495 | A | 0.876217 | T | 0.858088 | 0.018129 | No Change: Both D | - |
| Q9ULE0 | WWC3_HUMAN Protein WWC3 OS=Homo sapiens GN=WWC3 PE=2 SV=3 | 593 | Y | 0.646708 | C | 0.656486 | -0.009778 | No Change: Both D | - |
| Q9ULE0 | WWC3_HUMAN Protein WWC3 OS=Homo sapiens GN=WWC3 PE=2 SV=3 | 831 | P | 0.760642 | L | 0.586115 | 0.174527 | No Change: Both D | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 98 | P | 0.635276 | L | 0.489459 | 0.145817 | D to O | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 111 | T | 0.46154 | S | 0.511869 | -0.050329 | O to D | A Burkitt lymphoma cell line |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 120 | R | 0.250548 | W | 0.108624 | 0.141924 | No Change: Both O | A primary colorectal tumor |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 179 | A | 0.262901 | T | 0.284213 | -0.021312 | No Change: Both O | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 272 | L | 0.425721 | F | 0.397374 | 0.028347 | No Change: Both O | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 282 | P | 0.381877 | A | 0.317764 | 0.064113 | No Change: Both O | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 291 | L | 0.137993 | P | 0.241175 | -0.103182 | No Change: Both O | - |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 314 | R | 0.627556 | H | 0.627728 | -1.72E-04 | No Change: Both D | A cervical carcinoma cell line |
| Q9NZC7 | WWOX_HUMAN WW domain-containing oxidoreductase OS=Homo sapiens GN=WWOX PE=1 SV=1 | 216 | L | 0.097266 | V | 0.092515 | 0.004751 | No Change: Both O | - |
| Q9H0M0 | WWP1_HUMAN NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Homo sapiens GN=WWP1 PE=1 SV=1 | 852 | G | 0.102196 | V | 0.057394 | 0.044802 | No Change: Both O | - |
| Q9HCS7 | SYF1_HUMAN Pre-mRNA-splicing factor SYF1 OS=Homo sapiens GN=XAB2 PE=1 SV=2 | 126 | V | 0.394189 | I | 0.361136 | 0.033053 | No Change: Both O | - |
| Q9HCS7 | SYF1_HUMAN Pre-mRNA-splicing factor SYF1 OS=Homo sapiens GN=XAB2 PE=1 SV=2 | 454 | R | 0.287106 | Q | 0.28548 | 0.001626 | No Change: Both O | - |
| Q9HCS7 | SYF1_HUMAN Pre-mRNA-splicing factor SYF1 OS=Homo sapiens GN=XAB2 PE=1 SV=2 | 702 | A | 0.112277 | T | 0.142458 | -0.030181 | No Change: Both O | - |
| Q6GPH4 | XAF1_HUMAN XIAP-associated factor 1 OS=Homo sapiens GN=XAF1 PE=1 SV=1 | 85 | E | 0.768808 | G | 0.701288 | 0.06752 | No Change: Both D | - |
| Q6GPH4 | XAF1_HUMAN XIAP-associated factor 1 OS=Homo sapiens GN=XAF1 PE=1 SV=1 | 132 | R | 0.535544 | H | 0.506836 | 0.028708 | No Change: Both D | - |
| Q6GPH4 | XAF1_HUMAN XIAP-associated factor 1 OS=Homo sapiens GN=XAF1 PE=1 SV=1 | 188 | E | 0.772522 | K | 0.779624 | -0.007102 | No Change: Both D | - |
| Q6GPH4 | XAF1_HUMAN XIAP-associated factor 1 OS=Homo sapiens GN=XAF1 PE=1 SV=1 | 219 | R | 0.968651 | I | 0.944773 | 0.023878 | No Change: Both D | - |
| P17861 | XBP1_HUMAN X-box-binding protein 1 OS=Homo sapiens GN=XBP1 PE=1 SV=2 | 232 | R | 0.815666 | K | 0.830683 | -0.015017 | No Change: Both D | A breast cancer sample |
| P17861 | XBP1_HUMAN X-box-binding protein 1 OS=Homo sapiens GN=XBP1 PE=1 SV=2 | 12 | D | 0.718979 | V | 0.680367 | 0.038612 | No Change: Both D | A breast cancer sample |
| Q9UBD3 | XCL2_HUMAN Cytokine SCM-1 beta OS=Homo sapiens GN=XCL2 PE=1 SV=1 | 28 | H | 0.483671 | D | 0.517391 | -0.03372 | O to D | - |
| Q9UBD3 | XCL2_HUMAN Cytokine SCM-1 beta OS=Homo sapiens GN=XCL2 PE=1 SV=1 | 29 | R | 0.474966 | K | 0.526356 | -0.05139 | O to D | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 133 | E | 0.566275 | K | 0.531679 | 0.034596 | No Change: Both D | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 172 | G | 0.644429 | R | 0.643719 | 7.10E-04 | No Change: Both D | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 235 | T | 0.317975 | M | 0.266543 | 0.051432 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 395 | K | 0.314093 | M | 0.226721 | 0.087372 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 555 | P | 0.677598 | S | 0.65299 | 0.024608 | No Change: Both D | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 584 | D | 0.513684 | A | 0.460504 | 0.05318 | D to O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 607 | R | 0.349586 | Q | 0.34736 | 0.002226 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 617 | K | 0.525279 | N | 0.477504 | 0.047775 | D to O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 623 | T | 0.569836 | I | 0.472774 | 0.097062 | D to O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 646 | I | 0.305772 | V | 0.333111 | -0.027339 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 703 | I | 0.290609 | V | 0.288668 | 0.001941 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 910 | T | 0.355106 | M | 0.306755 | 0.048351 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 1091 | V | 0.215268 | L | 0.224177 | -0.008909 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 1109 | N | 0.675497 | T | 0.65255 | 0.022947 | No Change: Both D | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 1176 | R | 0.33652 | C | 0.187168 | 0.149352 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 1296 | R | 0.33735 | W | 0.160004 | 0.177346 | No Change: Both O | - |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 763 | L | 0.364683 | F | 0.350821 | 0.013862 | No Change: Both O | A breast cancer sample |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 791 | R | 0.271904 | G | 0.272877 | -9.73E-04 | No Change: Both O | A breast cancer sample |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 149 | R | 0.301859 | C | 0.235435 | 0.066424 | No Change: Both O | Xanthinuria type 1 (XU1) [MIM:278300] |
| P47989 | XDH_HUMAN Xanthine dehydrogenase/oxidase OS=Homo sapiens GN=XDH PE=1 SV=4 | 1150 | P | 0.420558 | R | 0.382344 | 0.038214 | No Change: Both O | - |
| P55808 | XG_HUMAN Glycoprotein Xg OS=Homo sapiens GN=XG PE=2 SV=1 | 60 | D | 0.992333 | N | 0.99221 | 1.23E-04 | No Change: Both D | - |
| P98170 | XIAP_HUMAN Baculoviral IAP repeat-containing protein 4 OS=Homo sapiens GN=XIAP PE=1 SV=2 | 107 | N | 0.585657 | S | 0.606353 | -0.020696 | No Change: Both D | - |
| P98170 | XIAP_HUMAN Baculoviral IAP repeat-containing protein 4 OS=Homo sapiens GN=XIAP PE=1 SV=2 | 133 | S | 0.49639 | F | 0.334438 | 0.161952 | No Change: Both O | - |
| P98170 | XIAP_HUMAN Baculoviral IAP repeat-containing protein 4 OS=Homo sapiens GN=XIAP PE=1 SV=2 | 242 | D | 0.709596 | E | 0.724183 | -0.014587 | No Change: Both D | - |
| P98170 | XIAP_HUMAN Baculoviral IAP repeat-containing protein 4 OS=Homo sapiens GN=XIAP PE=1 SV=2 | 423 | Q | 0.887161 | P | 0.865444 | 0.021717 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 3 | D | 0.9857 | N | 0.980344 | 0.005356 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 346 | Q | 0.79567 | R | 0.77244 | 0.02323 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 551 | R | 0.418316 | Q | 0.437506 | -0.01919 | No Change: Both O | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 929 | L | 0.61075 | H | 0.641718 | -0.030968 | No Change: Both D | A breast cancer sample |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 965 | H | 0.881694 | P | 0.918051 | -0.036357 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1046 | P | 0.874295 | A | 0.837804 | 0.036491 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1604 | G | 0.884223 | R | 0.889311 | -0.005088 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1608 | A | 0.864995 | V | 0.836045 | 0.02895 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1634 | R | 0.899091 | K | 0.899867 | -7.76E-04 | No Change: Both D | A breast cancer sample |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1724 | I | 0.844784 | V | 0.872981 | -0.028197 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 695 | R | 0.825652 | C | 0.764466 | 0.061186 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 776 | R | 0.628833 | W | 0.406587 | 0.222246 | D to O | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1061 | A | 0.813771 | V | 0.73965 | 0.074121 | No Change: Both D | - |
| Q702N8 | XIRP1_HUMAN Xin actin-binding repeat-containing protein 1 OS=Homo sapiens GN=XIRP1 PE=1 SV=1 | 1707 | Q | 0.750681 | H | 0.683939 | 0.066742 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 450 | P | 0.217433 | A | 0.172855 | 0.044578 | No Change: Both O | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 457 | Y | 0.392 | H | 0.510931 | -0.118931 | O to D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 1397 | I | 0.241585 | T | 0.308251 | -0.066666 | No Change: Both O | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 1488 | I | 0.383706 | T | 0.520866 | -0.13716 | O to D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 1626 | R | 0.510046 | H | 0.482182 | 0.027864 | D to O | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 1833 | N | 0.518409 | S | 0.568582 | -0.050173 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2423 | L | 0.771744 | R | 0.839306 | -0.067562 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2553 | S | 0.833672 | N | 0.805061 | 0.028611 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2595 | H | 0.891974 | Y | 0.846937 | 0.045037 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2607 | V | 0.90565 | I | 0.895629 | 0.010021 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2728 | G | 0.883577 | D | 0.908794 | -0.025217 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2910 | A | 0.843304 | T | 0.861293 | -0.017989 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 2975 | Y | 0.991188 | C | 0.993675 | -0.002487 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 3022 | I | 0.748788 | V | 0.756422 | -0.007634 | No Change: Both D | - |
| A4UGR9 | XIRP2_HUMAN Xin actin-binding repeat-containing protein 2 OS=Homo sapiens GN=XIRP2 PE=1 SV=2 | 3202 | G | 0.607778 | E | 0.683936 | -0.076158 | No Change: Both D | - |
| P51811 | XK_HUMAN Membrane transport protein XK OS=Homo sapiens GN=XK PE=1 SV=5 | 222 | R | 0.039939 | G | 0.040518 | -5.79E-04 | No Change: Both O | McLeod syndrome (MLS) [MIM:300842] |
| P51811 | XK_HUMAN Membrane transport protein XK OS=Homo sapiens GN=XK PE=1 SV=5 | 294 | C | 0.02278 | R | 0.05119 | -0.02841 | No Change: Both O | McLeod syndrome (MLS) [MIM:300842] |
| P51811 | XK_HUMAN Membrane transport protein XK OS=Homo sapiens GN=XK PE=1 SV=5 | 327 | E | 0.025389 | K | 0.025379 | 1.00E-05 | No Change: Both O | McLeod syndrome (MLS) [MIM:300842] |
| Q5GH77 | XKR3_HUMAN XK-related protein 3 OS=Homo sapiens GN=XKR3 PE=2 SV=1 | 143 | T | 0.398645 | M | 0.360157 | 0.038488 | No Change: Both O | - |
| Q5GH77 | XKR3_HUMAN XK-related protein 3 OS=Homo sapiens GN=XKR3 PE=2 SV=1 | 232 | P | 0.100235 | L | 0.047787 | 0.052448 | No Change: Both O | - |
| Q5GH77 | XKR3_HUMAN XK-related protein 3 OS=Homo sapiens GN=XKR3 PE=2 SV=1 | 255 | F | 0.037899 | L | 0.045128 | -0.007229 | No Change: Both O | - |
| Q5GH77 | XKR3_HUMAN XK-related protein 3 OS=Homo sapiens GN=XKR3 PE=2 SV=1 | 442 | H | 0.381231 | N | 0.508038 | -0.126807 | O to D | - |
| Q5T750 | XP32_HUMAN Skin-specific protein 32 OS=Homo sapiens GN=XP32 PE=1 SV=1 | 26 | S | 0.922356 | T | 0.905807 | 0.016549 | No Change: Both D | - |
| Q5T750 | XP32_HUMAN Skin-specific protein 32 OS=Homo sapiens GN=XP32 PE=1 SV=1 | 159 | T | 0.721237 | P | 0.781529 | -0.060292 | No Change: Both D | - |
| Q5T750 | XP32_HUMAN Skin-specific protein 32 OS=Homo sapiens GN=XP32 PE=1 SV=1 | 173 | L | 0.583389 | V | 0.597631 | -0.014242 | No Change: Both D | - |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 94 | P | 0.432841 | L | 0.252896 | 0.179945 | No Change: Both O | Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 108 | C | 0.338218 | F | 0.304758 | 0.03346 | No Change: Both O | Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 130 | R | 0.531484 | K | 0.614668 | -0.083184 | No Change: Both D | Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 185 | Q | 0.328783 | H | 0.281431 | 0.047352 | No Change: Both O | Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 244 | H | 0.521373 | R | 0.560554 | -0.039181 | No Change: Both D | Xeroderma pigmentosum complementation group A (XP-A) [MIM:278700] |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 228 | R | 0.722377 | Q | 0.712618 | 0.009759 | No Change: Both D | - |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 252 | L | 0.626 | V | 0.625141 | 8.59E-04 | No Change: Both D | - |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 234 | V | 0.608258 | L | 0.602009 | 0.006249 | No Change: Both D | - |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 97 | V | 0.364262 | I | 0.33733 | 0.026932 | No Change: Both O | - |
| P23025 | XPA_HUMAN DNA repair protein complementing XP-A cells OS=Homo sapiens GN=XPA PE=1 SV=1 | 256 | M | 0.505917 | V | 0.398752 | 0.107165 | D to O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 334 | P | 0.872728 | H | 0.834045 | 0.038683 | No Change: Both D | Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720] |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 939 | Q | 0.963133 | K | 0.977111 | -0.013978 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 16 | L | 0.998113 | V | 0.997965 | 1.48E-04 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 48 | L | 0.989373 | F | 0.988359 | 0.001014 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 86 | K | 0.788607 | R | 0.74748 | 0.041127 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 314 | R | 0.176074 | Q | 0.183829 | -0.007755 | No Change: Both O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 492 | R | 0.998504 | H | 0.998167 | 3.37E-04 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 499 | A | 0.99564 | V | 0.993234 | 0.002406 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 513 | M | 0.920851 | I | 0.905573 | 0.015278 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 632 | Q | 0.441988 | E | 0.482574 | -0.040586 | No Change: Both O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 671 | R | 0.126939 | H | 0.122674 | 0.004265 | No Change: Both O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 689 | T | 0.334918 | M | 0.278872 | 0.056046 | No Change: Both O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 928 | K | 0.94112 | Q | 0.926125 | 0.014995 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 287 | F | 0.202917 | C | 0.192254 | 0.010663 | No Change: Both O | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 514 | C | 0.901069 | S | 0.922753 | -0.021684 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 511 | K | 0.95227 | Q | 0.947454 | 0.004816 | No Change: Both D | - |
| Q01831 | XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens GN=XPC PE=1 SV=4 | 690 | W | 0.345282 | S | 0.597696 | -0.252414 | O to D | Xeroderma pigmentosum complementation group C (XP-C) [MIM:278720] |
| Q9NQH7 | XPP3_HUMAN Probable Xaa-Pro aminopeptidase 3 OS=Homo sapiens GN=XPNPEP3 PE=1 SV=1 | 450 | I | 0.305305 | L | 0.319505 | -0.0142 | No Change: Both O | - |
| Q9NQH7 | XPP3_HUMAN Probable Xaa-Pro aminopeptidase 3 OS=Homo sapiens GN=XPNPEP3 PE=1 SV=1 | 453 | G | 0.370923 | C | 0.248679 | 0.122244 | No Change: Both O | Nephronophthisis-like nephropathy type 1 (NPHPL1) [MIM:613159] |
| Q9C0E2 | XPO4_HUMAN Exportin-4 OS=Homo sapiens GN=XPO4 PE=1 SV=2 | 149 | N | 0.469238 | S | 0.555283 | -0.086045 | O to D | - |
| Q9C0E2 | XPO4_HUMAN Exportin-4 OS=Homo sapiens GN=XPO4 PE=1 SV=2 | 451 | T | 0.500985 | A | 0.485015 | 0.01597 | D to O | - |
| Q9HAV4 | XPO5_HUMAN Exportin-5 OS=Homo sapiens GN=XPO5 PE=1 SV=1 | 610 | K | 0.19616 | N | 0.170966 | 0.025194 | No Change: Both O | - |
| Q9HAV4 | XPO5_HUMAN Exportin-5 OS=Homo sapiens GN=XPO5 PE=1 SV=1 | 241 | S | 0.138324 | N | 0.115385 | 0.022939 | No Change: Both O | - |
| Q96QU8 | XPO6_HUMAN Exportin-6 OS=Homo sapiens GN=XPO6 PE=1 SV=1 | 1029 | V | 0.041342 | L | 0.041562 | -2.20E-04 | No Change: Both O | - |
| Q9UIA9 | XPO7_HUMAN Exportin-7 OS=Homo sapiens GN=XPO7 PE=1 SV=3 | 398 | E | 0.470369 | D | 0.423409 | 0.04696 | No Change: Both O | - |
| Q9UIA9 | XPO7_HUMAN Exportin-7 OS=Homo sapiens GN=XPO7 PE=1 SV=3 | 835 | C | 0.084231 | Y | 0.105426 | -0.021195 | No Change: Both O | - |
| O43592 | XPOT_HUMAN Exportin-T OS=Homo sapiens GN=XPOT PE=1 SV=2 | 526 | A | 0.081265 | V | 0.062665 | 0.0186 | No Change: Both O | - |
| O43592 | XPOT_HUMAN Exportin-T OS=Homo sapiens GN=XPOT PE=1 SV=2 | 716 | E | 0.138418 | D | 0.11468 | 0.023738 | No Change: Both O | - |
| Q9UBH6 | XPR1_HUMAN Xenotropic and polytropic retrovirus receptor 1 OS=Homo sapiens GN=XPR1 PE=1 SV=1 | 491 | T | 0.075837 | A | 0.065612 | 0.010225 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 399 | R | 0.716628 | Q | 0.682738 | 0.03389 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 194 | R | 0.632253 | W | 0.391734 | 0.240519 | D to O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 280 | R | 0.993986 | H | 0.990742 | 0.003244 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 7 | R | 0.410445 | L | 0.269543 | 0.140902 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 10 | V | 0.396352 | M | 0.48282 | -0.086468 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 157 | E | 0.806662 | K | 0.816847 | -0.010185 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 161 | P | 0.789479 | L | 0.671426 | 0.118053 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 298 | K | 0.945534 | N | 0.932492 | 0.013042 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 309 | P | 0.85548 | S | 0.83787 | 0.01761 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 485 | S | 0.949976 | Y | 0.897203 | 0.052773 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 559 | R | 0.360518 | Q | 0.355452 | 0.005066 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 560 | R | 0.335431 | W | 0.161364 | 0.174067 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 576 | N | 0.483367 | S | 0.52447 | -0.041103 | O to D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 72 | V | 0.401508 | A | 0.467903 | -0.066395 | No Change: Both O | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 514 | P | 0.977815 | L | 0.95924 | 0.018575 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 304 | T | 0.915146 | A | 0.912955 | 0.002191 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 107 | R | 0.725751 | H | 0.660219 | 0.065532 | No Change: Both D | - |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 350 | R | 0.37251 | W | 0.186272 | 0.186238 | No Change: Both O | A colorectal cancer sample |
| P18887 | XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens GN=XRCC1 PE=1 SV=2 | 576 | N | 0.483367 | Y | 0.333829 | 0.149538 | No Change: Both O | - |
| O43543 | XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens GN=XRCC2 PE=1 SV=1 | 16 | A | 0.626866 | S | 0.751767 | -0.124901 | No Change: Both D | - |
| O43543 | XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens GN=XRCC2 PE=1 SV=1 | 188 | R | 0.280948 | H | 0.225714 | 0.055234 | No Change: Both O | - |
| O43543 | XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens GN=XRCC2 PE=1 SV=1 | 221 | I | 0.341919 | T | 0.470813 | -0.128894 | No Change: Both O | - |
| O43542 | XRCC3_HUMAN DNA repair protein XRCC3 OS=Homo sapiens GN=XRCC3 PE=1 SV=1 | 241 | T | 0.545303 | M | 0.529905 | 0.015398 | No Change: Both D | - |
| O43542 | XRCC3_HUMAN DNA repair protein XRCC3 OS=Homo sapiens GN=XRCC3 PE=1 SV=1 | 94 | R | 0.317608 | H | 0.277347 | 0.040261 | No Change: Both O | - |
| O43542 | XRCC3_HUMAN DNA repair protein XRCC3 OS=Homo sapiens GN=XRCC3 PE=1 SV=1 | 271 | G | 0.299409 | R | 0.273196 | 0.026213 | No Change: Both O | - |
| O43542 | XRCC3_HUMAN DNA repair protein XRCC3 OS=Homo sapiens GN=XRCC3 PE=1 SV=1 | 302 | R | 0.461673 | H | 0.439126 | 0.022547 | No Change: Both O | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 240 | Q | 0.893289 | P | 0.910912 | -0.017623 | No Change: Both D | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 247 | A | 0.86287 | S | 0.910459 | -0.047589 | No Change: Both D | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 12 | S | 0.395191 | C | 0.167099 | 0.228092 | No Change: Both O | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 56 | A | 0.696309 | T | 0.704707 | -0.008398 | No Change: Both D | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 134 | I | 0.207136 | T | 0.310809 | -0.103673 | No Change: Both O | - |
| Q13426 | XRCC4_HUMAN DNA repair protein XRCC4 OS=Homo sapiens GN=XRCC4 PE=1 SV=2 | 142 | E | 0.620276 | Q | 0.604084 | 0.016192 | No Change: Both D | - |
| P13010 | XRCC5_HUMAN X-ray repair cross-complementing protein 5 OS=Homo sapiens GN=XRCC5 PE=1 SV=3 | 463 | L | 0.64881 | F | 0.612983 | 0.035827 | No Change: Both D | - |
| P13010 | XRCC5_HUMAN X-ray repair cross-complementing protein 5 OS=Homo sapiens GN=XRCC5 PE=1 SV=3 | 508 | I | 0.547608 | V | 0.533472 | 0.014136 | No Change: Both D | - |
| Q9Y6H3 | ATP23_HUMAN Mitochondrial inner membrane protease ATP23 homolog OS=Homo sapiens GN=XRCC6BP1 PE=1 SV=3 | 48 | S | 0.43796 | C | 0.27958 | 0.15838 | No Change: Both O | - |
| Q8IZH2 | XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens GN=XRN1 PE=1 SV=1 | 674 | S | 0.366096 | G | 0.318617 | 0.047479 | No Change: Both O | - |
| Q8IZH2 | XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens GN=XRN1 PE=1 SV=1 | 1259 | V | 0.498848 | A | 0.56804 | -0.069192 | O to D | - |
| Q9H0D6 | XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapiens GN=XRN2 PE=1 SV=1 | 743 | R | 0.252036 | M | 0.221919 | 0.030117 | No Change: Both O | - |
| Q9H0D6 | XRN2_HUMAN 5'-3' exoribonuclease 2 OS=Homo sapiens GN=XRN2 PE=1 SV=1 | 925 | R | 0.956507 | C | 0.922419 | 0.034088 | No Change: Both D | - |
| Q6P2D8 | XRRA1_HUMAN X-ray radiation resistance-associated protein 1 OS=Homo sapiens GN=XRRA1 PE=2 SV=2 | 473 | T | 0.951908 | R | 0.954512 | -0.002604 | No Change: Both D | - |
| Q6P2D8 | XRRA1_HUMAN X-ray radiation resistance-associated protein 1 OS=Homo sapiens GN=XRRA1 PE=2 SV=2 | 480 | K | 0.963667 | E | 0.964594 | -9.27E-04 | No Change: Both D | - |
| O75191 | XYLB_HUMAN Xylulose kinase OS=Homo sapiens GN=XYLB PE=1 SV=3 | 85 | D | 0.294093 | E | 0.325811 | -0.031718 | No Change: Both O | - |
| O75191 | XYLB_HUMAN Xylulose kinase OS=Homo sapiens GN=XYLB PE=1 SV=3 | 133 | D | 0.285619 | N | 0.225648 | 0.059971 | No Change: Both O | - |
| O75191 | XYLB_HUMAN Xylulose kinase OS=Homo sapiens GN=XYLB PE=1 SV=3 | 139 | D | 0.447989 | E | 0.451043 | -0.003054 | No Change: Both O | - |
| O75191 | XYLB_HUMAN Xylulose kinase OS=Homo sapiens GN=XYLB PE=1 SV=3 | 262 | Y | 0.200454 | N | 0.289176 | -0.088722 | No Change: Both O | - |
| O75191 | XYLB_HUMAN Xylulose kinase OS=Homo sapiens GN=XYLB PE=1 SV=3 | 348 | N | 0.661476 | D | 0.674853 | -0.013377 | No Change: Both D | - |
| Q86Y38 | XYLT1_HUMAN Xylosyltransferase 1 OS=Homo sapiens GN=XYLT1 PE=1 SV=1 | 325 | P | 0.145443 | R | 0.125659 | 0.019784 | No Change: Both O | - |
| Q86Y38 | XYLT1_HUMAN Xylosyltransferase 1 OS=Homo sapiens GN=XYLT1 PE=1 SV=1 | 766 | P | 0.487718 | A | 0.381445 | 0.106273 | No Change: Both O | - |
| Q86Y38 | XYLT1_HUMAN Xylosyltransferase 1 OS=Homo sapiens GN=XYLT1 PE=1 SV=1 | 839 | V | 0.148582 | I | 0.128381 | 0.020201 | No Change: Both O | - |
| Q86Y38 | XYLT1_HUMAN Xylosyltransferase 1 OS=Homo sapiens GN=XYLT1 PE=1 SV=1 | 892 | R | 0.592748 | Q | 0.614479 | -0.021731 | No Change: Both D | - |
| Q9H1B5 | XYLT2_HUMAN Xylosyltransferase 2 OS=Homo sapiens GN=XYLT2 PE=2 SV=2 | 305 | R | 0.169705 | T | 0.147571 | 0.022134 | No Change: Both O | - |
| Q9H1B5 | XYLT2_HUMAN Xylosyltransferase 2 OS=Homo sapiens GN=XYLT2 PE=2 SV=2 | 801 | T | 0.551656 | R | 0.573982 | -0.022326 | No Change: Both D | - |
| Q9H1B5 | XYLT2_HUMAN Xylosyltransferase 2 OS=Homo sapiens GN=XYLT2 PE=2 SV=2 | 60 | G | 0.975343 | R | 0.978108 | -0.002765 | No Change: Both D | - |
| P54577 | SYYC_HUMAN Tyrosine--tRNA ligase cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4 | 41 | G | 0.184695 | R | 0.17189 | 0.012805 | No Change: Both O | Charcot-Marie-Tooth disease dominant intermediate type C (CMTDIC) [MIM:608323] |
| P54577 | SYYC_HUMAN Tyrosine--tRNA ligase cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4 | 170 | Q | 0.243398 | H | 0.226121 | 0.017277 | No Change: Both O | - |
| P54577 | SYYC_HUMAN Tyrosine--tRNA ligase cytoplasmic OS=Homo sapiens GN=YARS PE=1 SV=4 | 196 | E | 0.148006 | K | 0.161964 | -0.013958 | No Change: Both O | Charcot-Marie-Tooth disease dominant intermediate type C (CMTDIC) [MIM:608323] |
| Q9Y2Z4 | SYYM_HUMAN Tyrosine--tRNA ligase mitochondrial OS=Homo sapiens GN=YARS2 PE=1 SV=2 | 191 | G | 0.152866 | V | 0.084943 | 0.067923 | No Change: Both O | - |
| Q9Y2Z4 | SYYM_HUMAN Tyrosine--tRNA ligase mitochondrial OS=Homo sapiens GN=YARS2 PE=1 SV=2 | 52 | F | 0.326386 | L | 0.349904 | -0.023518 | No Change: Both O | Myopathy with lactic acidosis and sideroblastic anemia type 2 (MLASA2) [MIM:613561] |
| Q9Y2T7 | YBOX2_HUMAN Y-box-binding protein 2 OS=Homo sapiens GN=YBX2 PE=1 SV=2 | 9 | G | 0.854164 | V | 0.820173 | 0.033991 | No Change: Both D | - |
| Q9Y2T7 | YBOX2_HUMAN Y-box-binding protein 2 OS=Homo sapiens GN=YBX2 PE=1 SV=2 | 63 | S | 0.986321 | P | 0.9883 | -0.001979 | No Change: Both D | - |
| A8MPS7 | YDJC_HUMAN UPF0249 protein ydjC homolog OS=Homo sapiens GN=YDJC PE=2 SV=1 | 263 | A | 0.427819 | T | 0.46557 | -0.037751 | No Change: Both O | - |
| Q9ULM3 | YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens GN=YEATS2 PE=1 SV=2 | 184 | I | 0.877004 | V | 0.888324 | -0.01132 | No Change: Both D | - |
| Q9ULM3 | YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens GN=YEATS2 PE=1 SV=2 | 530 | V | 0.911033 | I | 0.904559 | 0.006474 | No Change: Both D | - |
| Q9ULM3 | YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens GN=YEATS2 PE=1 SV=2 | 993 | Q | 0.941373 | H | 0.908698 | 0.032675 | No Change: Both D | - |
| P07947 | YES_HUMAN Tyrosine-protein kinase Yes OS=Homo sapiens GN=YES1 PE=1 SV=3 | 198 | I | 0.2324 | V | 0.247383 | -0.014983 | No Change: Both O | - |
| P07947 | YES_HUMAN Tyrosine-protein kinase Yes OS=Homo sapiens GN=YES1 PE=1 SV=3 | 282 | K | 0.244907 | R | 0.218377 | 0.02653 | No Change: Both O | - |
| Q5BJH7 | YIF1B_HUMAN Protein YIF1B OS=Homo sapiens GN=YIF1B PE=1 SV=1 | 56 | P | 0.824131 | S | 0.824027 | 1.04E-04 | No Change: Both D | - |
| Q9GZM5 | YIPF3_HUMAN Protein YIPF3 OS=Homo sapiens GN=YIPF3 PE=1 SV=1 | 5 | A | 0.830098 | V | 0.746756 | 0.083342 | No Change: Both D | - |
| Q96EC8 | YIPF6_HUMAN Protein YIPF6 OS=Homo sapiens GN=YIPF6 PE=2 SV=2 | 202 | F | 0.261984 | L | 0.303508 | -0.041524 | No Change: Both O | - |
| Q8N8F6 | YIPF7_HUMAN Protein YIPF7 OS=Homo sapiens GN=YIPF7 PE=1 SV=2 | 54 | A | 0.823962 | T | 0.833397 | -0.009435 | No Change: Both D | - |
| A6XGL0 | YJEN3_HUMAN YjeF N-terminal domain-containing protein 3 OS=Homo sapiens GN=YJEFN3 PE=1 SV=1 | 213 | A | 0.207135 | T | 0.236158 | -0.029023 | No Change: Both O | - |
| Q56UN5 | YSK4_HUMAN SPS1/STE20-related protein kinase YSK4 OS=Homo sapiens GN=YSK4 PE=1 SV=1 | 500 | I | 0.617526 | M | 0.691252 | -0.073726 | No Change: Both D | A breast pleomorphic lobular carcinoma sample |
| Q56UN5 | YSK4_HUMAN SPS1/STE20-related protein kinase YSK4 OS=Homo sapiens GN=YSK4 PE=1 SV=1 | 438 | T | 0.578389 | I | 0.50753 | 0.070859 | No Change: Both D | - |
| Q56UN5 | YSK4_HUMAN SPS1/STE20-related protein kinase YSK4 OS=Homo sapiens GN=YSK4 PE=1 SV=1 | 676 | E | 0.465766 | Q | 0.401022 | 0.064744 | No Change: Both O | - |
| Q56UN5 | YSK4_HUMAN SPS1/STE20-related protein kinase YSK4 OS=Homo sapiens GN=YSK4 PE=1 SV=1 | 812 | E | 0.861181 | G | 0.803901 | 0.05728 | No Change: Both D | - |
| Q96MU7 | YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens GN=YTHDC1 PE=1 SV=3 | 183 | H | 0.996696 | R | 0.997749 | -0.001053 | No Change: Both D | - |
| Q9H6S0 | YTDC2_HUMAN Probable ATP-dependent RNA helicase YTHDC2 OS=Homo sapiens GN=YTHDC2 PE=1 SV=2 | 652 | S | 0.369645 | N | 0.327196 | 0.042449 | No Change: Both O | - |
| Q9H6S0 | YTDC2_HUMAN Probable ATP-dependent RNA helicase YTHDC2 OS=Homo sapiens GN=YTHDC2 PE=1 SV=2 | 1409 | L | 0.475148 | Q | 0.621214 | -0.146066 | O to D | - |
| Q9Y5A9 | YTHD2_HUMAN YTH domain family protein 2 OS=Homo sapiens GN=YTHDF2 PE=1 SV=2 | 217 | T | 0.735908 | S | 0.80653 | -0.070622 | No Change: Both D | - |
| Q9Y5A9 | YTHD2_HUMAN YTH domain family protein 2 OS=Homo sapiens GN=YTHDF2 PE=1 SV=2 | 454 | P | 0.253943 | S | 0.294922 | -0.040979 | No Change: Both O | - |
| P31946 | 1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapiens GN=YWHAB PE=1 SV=3 | 99 | V | 0.269974 | I | 0.284382 | -0.014408 | No Change: Both O | - |
| P25490 | TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens GN=YY1 PE=1 SV=2 | 380 | D | 0.289841 | Y | 0.177081 | 0.11276 | No Change: Both O | - |
| Q9H869 | YYAP1_HUMAN YY1-associated protein 1 OS=Homo sapiens GN=YY1AP1 PE=1 SV=2 | 412 | G | 0.728093 | S | 0.768835 | -0.040742 | No Change: Both D | - |
| Q9H869 | YYAP1_HUMAN YY1-associated protein 1 OS=Homo sapiens GN=YY1AP1 PE=1 SV=2 | 786 | E | 0.812839 | Q | 0.758721 | 0.054118 | No Change: Both D | - |
| O15391 | TYY2_HUMAN Transcription factor YY2 OS=Homo sapiens GN=YY2 PE=2 SV=1 | 103 | D | 0.673791 | N | 0.639891 | 0.0339 | No Change: Both D | A breast cancer sample |
| Q401N2 | ZACN_HUMAN Zinc-activated ligand-gated ion channel OS=Homo sapiens GN=ZACN PE=1 SV=2 | 152 | A | 0.208604 | T | 0.237806 | -0.029202 | No Change: Both O | - |
| Q8N4Q0 | ZADH2_HUMAN Zinc-binding alcohol dehydrogenase domain-containing protein 2 OS=Homo sapiens GN=ZADH2 PE=1 SV=1 | 323 | C | 0.167223 | F | 0.169027 | -0.001804 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 412 | G | 0.605174 | S | 0.622816 | -0.017642 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 690 | S | 0.999074 | T | 0.99898 | 9.40E-05 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1012 | L | 0.946804 | R | 0.961904 | -0.0151 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1096 | F | 0.238034 | C | 0.299344 | -0.06131 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1375 | A | 0.259905 | T | 0.306976 | -0.047071 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1674 | G | 0.289867 | C | 0.168369 | 0.121498 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1698 | L | 0.662849 | P | 0.762515 | -0.099666 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1742 | C | 0.508539 | R | 0.506082 | 0.002457 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1878 | P | 0.360583 | S | 0.380081 | -0.019498 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1903 | C | 0.191175 | Y | 0.210221 | -0.019046 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1995 | I | 0.09389 | M | 0.130732 | -0.036842 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2073 | N | 0.555986 | S | 0.578973 | -0.022987 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2527 | T | 0.645486 | M | 0.603697 | 0.041789 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2643 | W | 0.571665 | R | 0.773018 | -0.201353 | No Change: Both D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 113 | G | 0.182421 | A | 0.153251 | 0.02917 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2334 | Y | 0.385651 | S | 0.574077 | -0.188426 | O to D | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2349 | L | 0.194952 | F | 0.182965 | 0.011987 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 16 | L | 0.202935 | F | 0.177727 | 0.025208 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 430 | Q | 0.448641 | H | 0.41813 | 0.030511 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1922 | R | 0.107525 | C | 0.062838 | 0.044687 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 1969 | F | 0.209193 | L | 0.232185 | -0.022992 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2035 | S | 0.24561 | T | 0.164453 | 0.081157 | No Change: Both O | - |
| Q9Y493 | ZAN_HUMAN Zonadhesin OS=Homo sapiens GN=ZAN PE=2 SV=4 | 2111 | L | 0.840978 | P | 0.91388 | -0.072902 | No Change: Both D | - |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 518 | S | 0.338991 | R | 0.279044 | 0.059947 | No Change: Both O | Selective T-cell defect (STD) [MIM:176947] |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 465 | R | 0.192099 | H | 0.191606 | 4.93E-04 | No Change: Both O | Selective T-cell defect (STD) [MIM:176947] |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 175 | R | 0.616447 | L | 0.51838 | 0.098067 | No Change: Both D | - |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 191 | P | 0.442551 | L | 0.302711 | 0.13984 | No Change: Both O | - |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 448 | G | 0.351575 | E | 0.431412 | -0.079837 | No Change: Both O | Neck squamous cell carcinoma sample |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 523 | W | 0.264043 | L | 0.326751 | -0.062708 | No Change: Both O | - |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 337 | L | 0.200977 | R | 0.290428 | -0.089451 | No Change: Both O | Selective T-cell defect (STD) [MIM:176947] |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 465 | R | 0.192099 | C | 0.086726 | 0.105373 | No Change: Both O | Selective T-cell defect (STD) [MIM:176947] |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 507 | A | 0.06436 | V | 0.043171 | 0.021189 | No Change: Both O | Selective T-cell defect (STD) [MIM:176947] |
| P43403 | ZAP70_HUMAN Tyrosine-protein kinase ZAP-70 OS=Homo sapiens GN=ZAP70 PE=1 SV=1 | 564 | C | 0.527688 | R | 0.604001 | -0.076313 | No Change: Both D | Selective T-cell defect (STD) [MIM:176947] |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 636 | A | 0.949372 | G | 0.95298 | -0.003608 | No Change: Both D | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 14 | P | 0.470607 | T | 0.359545 | 0.111062 | No Change: Both O | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 160 | K | 0.220581 | N | 0.176355 | 0.044226 | No Change: Both O | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 178 | K | 0.233293 | R | 0.194144 | 0.039149 | No Change: Both O | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 473 | A | 0.703188 | G | 0.728956 | -0.025768 | No Change: Both D | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 511 | I | 0.884912 | T | 0.922205 | -0.037293 | No Change: Both D | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 555 | E | 0.899201 | K | 0.898729 | 4.72E-04 | No Change: Both D | - |
| A8MT70 | ZBBX_HUMAN Zinc finger B-box domain-containing protein 1 OS=Homo sapiens GN=ZBBX PE=2 SV=3 | 346 | H | 0.821795 | R | 0.828298 | -0.006503 | No Change: Both D | - |
| O75132 | ZBED4_HUMAN Zinc finger BED domain-containing protein 4 OS=Homo sapiens GN=ZBED4 PE=1 SV=2 | 420 | I | 0.90945 | V | 0.921804 | -0.012354 | No Change: Both D | - |
| Q49AG3 | ZBED5_HUMAN Zinc finger BED domain-containing protein 5 OS=Homo sapiens GN=ZBED5 PE=1 SV=2 | 17 | A | 0.064022 | V | 0.047518 | 0.016504 | No Change: Both O | - |
| Q49AG3 | ZBED5_HUMAN Zinc finger BED domain-containing protein 5 OS=Homo sapiens GN=ZBED5 PE=1 SV=2 | 47 | Q | 0.495878 | R | 0.444409 | 0.051469 | No Change: Both O | - |
| Q49AG3 | ZBED5_HUMAN Zinc finger BED domain-containing protein 5 OS=Homo sapiens GN=ZBED5 PE=1 SV=2 | 77 | P | 0.92498 | S | 0.944298 | -0.019318 | No Change: Both D | - |
| Q49AG3 | ZBED5_HUMAN Zinc finger BED domain-containing protein 5 OS=Homo sapiens GN=ZBED5 PE=1 SV=2 | 480 | I | 0.076379 | V | 0.093231 | -0.016852 | No Change: Both O | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 88 | E | 0.907421 | K | 0.889614 | 0.017807 | No Change: Both D | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 17 | R | 0.556864 | I | 0.365173 | 0.191691 | D to O | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 70 | G | 0.665053 | R | 0.675355 | -0.010302 | No Change: Both D | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 154 | D | 0.553244 | H | 0.513281 | 0.039963 | No Change: Both D | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 166 | R | 0.458624 | H | 0.418229 | 0.040395 | No Change: Both O | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 53 | K | 0.495161 | R | 0.450688 | 0.044473 | No Change: Both O | - |
| Q9H171 | ZBP1_HUMAN Z-DNA-binding protein 1 OS=Homo sapiens GN=ZBP1 PE=1 SV=2 | 332 | A | 0.630078 | V | 0.544531 | 0.085547 | No Change: Both D | - |
| Q96DT7 | ZBT10_HUMAN Zinc finger and BTB domain-containing protein 10 OS=Homo sapiens GN=ZBTB10 PE=1 SV=2 | 50 | P | 0.996509 | T | 0.993856 | 0.002653 | No Change: Both D | - |
| Q96DT7 | ZBT10_HUMAN Zinc finger and BTB domain-containing protein 10 OS=Homo sapiens GN=ZBTB10 PE=1 SV=2 | 174 | M | 0.789035 | I | 0.720604 | 0.068431 | No Change: Both D | - |
| O95625 | ZBT11_HUMAN Zinc finger and BTB domain-containing protein 11 OS=Homo sapiens GN=ZBTB11 PE=1 SV=2 | 44 | G | 0.242492 | S | 0.245734 | -0.003242 | No Change: Both O | - |
| O95625 | ZBT11_HUMAN Zinc finger and BTB domain-containing protein 11 OS=Homo sapiens GN=ZBTB11 PE=1 SV=2 | 350 | T | 0.75131 | N | 0.742044 | 0.009266 | No Change: Both D | - |
| Q05516 | ZBT16_HUMAN Zinc finger and BTB domain-containing protein 16 OS=Homo sapiens GN=ZBTB16 PE=1 SV=2 | 617 | M | 0.464598 | V | 0.384809 | 0.079789 | No Change: Both O | Skeletal defects genital hypoplasia and mental retardation (SGYMR) [MIM:612447] |
| O15209 | ZBT22_HUMAN Zinc finger and BTB domain-containing protein 22 OS=Homo sapiens GN=ZBTB22 PE=2 SV=1 | 310 | T | 0.748448 | A | 0.724108 | 0.02434 | No Change: Both D | - |
| O15209 | ZBT22_HUMAN Zinc finger and BTB domain-containing protein 22 OS=Homo sapiens GN=ZBTB22 PE=2 SV=1 | 250 | G | 0.758013 | A | 0.71677 | 0.041243 | No Change: Both D | - |
| O43167 | ZBT24_HUMAN Zinc finger and BTB domain-containing protein 24 OS=Homo sapiens GN=ZBTB24 PE=1 SV=2 | 518 | A | 0.821373 | T | 0.824383 | -0.00301 | No Change: Both D | - |
| O43167 | ZBT24_HUMAN Zinc finger and BTB domain-containing protein 24 OS=Homo sapiens GN=ZBTB24 PE=1 SV=2 | 408 | C | 0.644059 | G | 0.706774 | -0.062715 | No Change: Both D | Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 (ICF2) [MIM:614069] |
| Q9HCK0 | ZBT26_HUMAN Zinc finger and BTB domain-containing protein 26 OS=Homo sapiens GN=ZBTB26 PE=2 SV=2 | 236 | H | 0.409814 | R | 0.40806 | 0.001754 | No Change: Both O | - |
| Q9H5J0 | ZBTB3_HUMAN Zinc finger and BTB domain-containing protein 3 OS=Homo sapiens GN=ZBTB3 PE=1 SV=1 | 574 | I | 0.905451 | M | 0.949542 | -0.044091 | No Change: Both D | - |
| Q9H5J0 | ZBTB3_HUMAN Zinc finger and BTB domain-containing protein 3 OS=Homo sapiens GN=ZBTB3 PE=1 SV=1 | 424 | H | 0.609706 | L | 0.542439 | 0.067267 | No Change: Both D | A breast cancer sample |
| Q9H5J0 | ZBTB3_HUMAN Zinc finger and BTB domain-containing protein 3 OS=Homo sapiens GN=ZBTB3 PE=1 SV=1 | 455 | S | 0.5949 | F | 0.366967 | 0.227933 | D to O | A breast cancer sample |
| Q9Y2Y4 | ZBT32_HUMAN Zinc finger and BTB domain-containing protein 32 OS=Homo sapiens GN=ZBTB32 PE=1 SV=1 | 174 | R | 0.990121 | S | 0.990115 | 6.00E-06 | No Change: Both D | - |
| Q8NAP3 | ZBT38_HUMAN Zinc finger and BTB domain-containing protein 38 OS=Homo sapiens GN=ZBTB38 PE=1 SV=2 | 319 | S | 0.920852 | A | 0.885017 | 0.035835 | No Change: Both D | - |
| Q8NAP3 | ZBT38_HUMAN Zinc finger and BTB domain-containing protein 38 OS=Homo sapiens GN=ZBTB38 PE=1 SV=2 | 615 | T | 0.717693 | M | 0.6769 | 0.040793 | No Change: Both D | - |
| Q8NAP3 | ZBT38_HUMAN Zinc finger and BTB domain-containing protein 38 OS=Homo sapiens GN=ZBTB38 PE=1 SV=2 | 809 | A | 0.748284 | T | 0.788426 | -0.040142 | No Change: Both D | - |
| O15060 | ZBT39_HUMAN Zinc finger and BTB domain-containing protein 39 OS=Homo sapiens GN=ZBTB39 PE=2 SV=1 | 689 | P | 0.402346 | A | 0.307545 | 0.094801 | No Change: Both O | - |
| Q9P1Z0 | ZBTB4_HUMAN Zinc finger and BTB domain-containing protein 4 OS=Homo sapiens GN=ZBTB4 PE=1 SV=3 | 550 | M | 0.959552 | I | 0.944279 | 0.015273 | No Change: Both D | - |
| Q9P1Z0 | ZBTB4_HUMAN Zinc finger and BTB domain-containing protein 4 OS=Homo sapiens GN=ZBTB4 PE=1 SV=3 | 539 | A | 0.991295 | V | 0.98664 | 0.004655 | No Change: Both D | - |
| Q9P1Z0 | ZBTB4_HUMAN Zinc finger and BTB domain-containing protein 4 OS=Homo sapiens GN=ZBTB4 PE=1 SV=3 | 561 | N | 0.940706 | S | 0.953268 | -0.012562 | No Change: Both D | - |
| Q9NUA8 | ZBT40_HUMAN Zinc finger and BTB domain-containing protein 40 OS=Homo sapiens GN=ZBTB40 PE=1 SV=4 | 225 | A | 0.786705 | T | 0.808402 | -0.021697 | No Change: Both D | - |
| Q9NUA8 | ZBT40_HUMAN Zinc finger and BTB domain-containing protein 40 OS=Homo sapiens GN=ZBTB40 PE=1 SV=4 | 267 | M | 0.357497 | I | 0.271085 | 0.086412 | No Change: Both O | - |
| Q9NUA8 | ZBT40_HUMAN Zinc finger and BTB domain-containing protein 40 OS=Homo sapiens GN=ZBTB40 PE=1 SV=4 | 595 | Y | 0.455377 | C | 0.506855 | -0.051478 | O to D | - |
| Q9NUA8 | ZBT40_HUMAN Zinc finger and BTB domain-containing protein 40 OS=Homo sapiens GN=ZBTB40 PE=1 SV=4 | 997 | V | 0.318435 | M | 0.378227 | -0.059792 | No Change: Both O | - |
| Q5SVQ8 | ZBT41_HUMAN Zinc finger and BTB domain-containing protein 41 OS=Homo sapiens GN=ZBTB41 PE=2 SV=1 | 327 | D | 0.954949 | Y | 0.919542 | 0.035407 | No Change: Both D | - |
| Q8NCP5 | ZBT44_HUMAN Zinc finger and BTB domain-containing protein 44 OS=Homo sapiens GN=ZBTB44 PE=1 SV=1 | 185 | K | 0.940958 | E | 0.944677 | -0.003719 | No Change: Both D | - |
| Q96K62 | ZBT45_HUMAN Zinc finger and BTB domain-containing protein 45 OS=Homo sapiens GN=ZBTB45 PE=2 SV=1 | 293 | D | 0.593178 | E | 0.60894 | -0.015762 | No Change: Both D | - |
| Q86UZ6 | ZBT46_HUMAN Zinc finger and BTB domain-containing protein 46 OS=Homo sapiens GN=ZBTB46 PE=2 SV=2 | 11 | T | 0.529607 | A | 0.496542 | 0.033065 | D to O | - |
| Q9UFB7 | ZBT47_HUMAN Zinc finger and BTB domain-containing protein 47 OS=Homo sapiens GN=ZBTB47 PE=2 SV=2 | 9 | A | 0.998767 | T | 0.998901 | -1.34E-04 | No Change: Both D | - |
| P10074 | ZBT48_HUMAN Zinc finger and BTB domain-containing protein 48 OS=Homo sapiens GN=ZBTB48 PE=1 SV=2 | 675 | S | 0.354662 | A | 0.272954 | 0.081708 | No Change: Both O | - |
| Q6ZSB9 | ZBT49_HUMAN Zinc finger and BTB domain-containing protein 49 OS=Homo sapiens GN=ZBTB49 PE=1 SV=3 | 320 | Y | 0.797068 | S | 0.906895 | -0.109827 | No Change: Both D | - |
| Q6ZSB9 | ZBT49_HUMAN Zinc finger and BTB domain-containing protein 49 OS=Homo sapiens GN=ZBTB49 PE=1 SV=3 | 348 | A | 0.980756 | T | 0.982809 | -0.002053 | No Change: Both D | - |
| Q6ZSB9 | ZBT49_HUMAN Zinc finger and BTB domain-containing protein 49 OS=Homo sapiens GN=ZBTB49 PE=1 SV=3 | 642 | A | 0.635555 | V | 0.650522 | -0.014967 | No Change: Both D | - |
| O15062 | ZBTB5_HUMAN Zinc finger and BTB domain-containing protein 5 OS=Homo sapiens GN=ZBTB5 PE=1 SV=1 | 300 | D | 0.885162 | G | 0.886495 | -0.001333 | No Change: Both D | - |
| Q96BR9 | ZBT8A_HUMAN Zinc finger and BTB domain-containing protein 8A OS=Homo sapiens GN=ZBTB8A PE=1 SV=2 | 418 | G | 0.834905 | A | 0.783473 | 0.051432 | No Change: Both D | - |
| Q8NAP8 | ZBT8B_HUMAN Zinc finger and BTB domain-containing protein 8B OS=Homo sapiens GN=ZBTB8B PE=2 SV=2 | 181 | E | 0.951919 | K | 0.947223 | 0.004696 | No Change: Both D | A colorectal cancer sample |
| Q96C00 | ZBTB9_HUMAN Zinc finger and BTB domain-containing protein 9 OS=Homo sapiens GN=ZBTB9 PE=1 SV=1 | 274 | A | 0.964723 | G | 0.967454 | -0.002731 | No Change: Both D | - |
| O75152 | ZC11A_HUMAN Zinc finger CCCH domain-containing protein 11A OS=Homo sapiens GN=ZC3H11A PE=1 SV=3 | 640 | T | 0.744616 | N | 0.76399 | -0.019374 | No Change: Both D | - |
| Q5D1E8 | ZC12A_HUMAN Ribonuclease ZC3H12A OS=Homo sapiens GN=ZC3H12A PE=1 SV=1 | 547 | G | 0.599069 | D | 0.578739 | 0.02033 | No Change: Both D | - |
| Q5D1E8 | ZC12A_HUMAN Ribonuclease ZC3H12A OS=Homo sapiens GN=ZC3H12A PE=1 SV=1 | 240 | V | 0.292762 | M | 0.338478 | -0.045716 | No Change: Both O | - |
| A2A288 | ZC12D_HUMAN Probable ribonuclease ZC3H12D OS=Homo sapiens GN=ZC3H12D PE=2 SV=3 | 53 | P | 0.672041 | L | 0.521098 | 0.150943 | No Change: Both D | - |
| A2A288 | ZC12D_HUMAN Probable ribonuclease ZC3H12D OS=Homo sapiens GN=ZC3H12D PE=2 SV=3 | 106 | K | 0.593692 | R | 0.534216 | 0.059476 | No Change: Both D | Some sporadic lung cancer sample |
| Q5T200 | ZC3HD_HUMAN Zinc finger CCCH domain-containing protein 13 OS=Homo sapiens GN=ZC3H13 PE=1 SV=1 | 1429 | E | 0.963972 | D | 0.960994 | 0.002978 | No Change: Both D | - |
| Q8WU90 | ZC3HF_HUMAN Zinc finger CCCH domain-containing protein 15 OS=Homo sapiens GN=ZC3H15 PE=1 SV=1 | 342 | V | 0.412637 | E | 0.574435 | -0.161798 | O to D | - |
| Q8WU90 | ZC3HF_HUMAN Zinc finger CCCH domain-containing protein 15 OS=Homo sapiens GN=ZC3H15 PE=1 SV=1 | 408 | T | 0.885585 | P | 0.908902 | -0.023317 | No Change: Both D | - |
| Q86VM9 | ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens GN=ZC3H18 PE=1 SV=2 | 368 | A | 0.288571 | T | 0.343623 | -0.055052 | No Change: Both O | - |
| Q86VM9 | ZCH18_HUMAN Zinc finger CCCH domain-containing protein 18 OS=Homo sapiens GN=ZC3H18 PE=1 SV=2 | 440 | R | 0.99999 | H | 0.999983 | 7.00E-06 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 6 | I | 0.553793 | M | 0.622535 | -0.068742 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 149 | F | 0.963218 | Y | 0.960616 | 0.002602 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 151 | E | 0.970286 | D | 0.964185 | 0.006101 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 399 | S | 0.987073 | G | 0.980573 | 0.0065 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 452 | S | 0.943017 | G | 0.922419 | 0.020598 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 168 | R | 0.988241 | W | 0.970242 | 0.017999 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 228 | A | 0.827716 | S | 0.8769 | -0.049184 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 351 | P | 0.929653 | L | 0.870368 | 0.059285 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 415 | P | 0.953078 | L | 0.92428 | 0.028798 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 503 | T | 0.81011 | K | 0.838324 | -0.028214 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 102 | Q | 0.915989 | R | 0.910446 | 0.005543 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 165 | E | 0.990626 | K | 0.987805 | 0.002821 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 231 | P | 0.790641 | A | 0.727052 | 0.063589 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 578 | R | 0.715618 | H | 0.622602 | 0.093016 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 636 | R | 0.892116 | W | 0.736318 | 0.155798 | No Change: Both D | - |
| Q8IXZ2 | ZC3H3_HUMAN Zinc finger CCCH domain-containing protein 3 OS=Homo sapiens GN=ZC3H3 PE=1 SV=3 | 727 | P | 0.433173 | R | 0.394746 | 0.038427 | No Change: Both O | - |
| Q9UPT8 | ZC3H4_HUMAN Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens GN=ZC3H4 PE=1 SV=3 | 287 | E | 0.993415 | K | 0.991409 | 0.002006 | No Change: Both D | - |
| Q9UPT8 | ZC3H4_HUMAN Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens GN=ZC3H4 PE=1 SV=3 | 464 | M | 0.460398 | V | 0.335807 | 0.124591 | No Change: Both O | - |
| Q9UPT8 | ZC3H4_HUMAN Zinc finger CCCH domain-containing protein 4 OS=Homo sapiens GN=ZC3H4 PE=1 SV=3 | 1228 | A | 0.968496 | G | 0.968745 | -2.49E-04 | No Change: Both D | - |
| Q8IWR0 | Z3H7A_HUMAN Zinc finger CCCH domain-containing protein 7A OS=Homo sapiens GN=ZC3H7A PE=1 SV=1 | 3 | N | 0.904806 | S | 0.928562 | -0.023756 | No Change: Both D | - |
| Q8IWR0 | Z3H7A_HUMAN Zinc finger CCCH domain-containing protein 7A OS=Homo sapiens GN=ZC3H7A PE=1 SV=1 | 57 | H | 0.427726 | R | 0.434471 | -0.006745 | No Change: Both O | - |
| Q9UGR2 | Z3H7B_HUMAN Zinc finger CCCH domain-containing protein 7B OS=Homo sapiens GN=ZC3H7B PE=1 SV=1 | 379 | D | 0.889089 | N | 0.853548 | 0.035541 | No Change: Both D | - |
| Q8N5P1 | ZC3H8_HUMAN Zinc finger CCCH domain-containing protein 8 OS=Homo sapiens GN=ZC3H8 PE=1 SV=2 | 240 | C | 0.203412 | W | 0.144417 | 0.058995 | No Change: Both O | - |
| Q7Z2W4 | ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1 SV=3 | 485 | R | 0.828228 | K | 0.800065 | 0.028163 | No Change: Both D | - |
| Q7Z2W4 | ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1 SV=3 | 565 | H | 0.134589 | Q | 0.145172 | -0.010583 | No Change: Both O | - |
| Q7Z2W4 | ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1 SV=3 | 851 | T | 0.245077 | I | 0.144645 | 0.100432 | No Change: Both O | - |
| Q7Z2W4 | ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens GN=ZC3HAV1 PE=1 SV=3 | 701 | Q | 0.699465 | E | 0.680627 | 0.018838 | No Change: Both D | - |
| Q86WB0 | NIPA_HUMAN Nuclear-interacting partner of ALK OS=Homo sapiens GN=ZC3HC1 PE=1 SV=1 | 271 | T | 0.202553 | A | 0.179954 | 0.022599 | No Change: Both O | - |
| Q86WB0 | NIPA_HUMAN Nuclear-interacting partner of ALK OS=Homo sapiens GN=ZC3HC1 PE=1 SV=1 | 363 | R | 0.991573 | H | 0.986944 | 0.004629 | No Change: Both D | - |
| Q5TAX3 | TUT4_HUMAN Terminal uridylyltransferase 4 OS=Homo sapiens GN=ZCCHC11 PE=1 SV=3 | 796 | D | 0.854336 | Y | 0.738277 | 0.116059 | No Change: Both D | - |
| Q6PEW1 | ZCH12_HUMAN Zinc finger CCHC domain-containing protein 12 OS=Homo sapiens GN=ZCCHC12 PE=2 SV=2 | 7 | R | 0.648632 | C | 0.439027 | 0.209605 | D to O | - |
| Q6PEW1 | ZCH12_HUMAN Zinc finger CCHC domain-containing protein 12 OS=Homo sapiens GN=ZCCHC12 PE=2 SV=2 | 179 | L | 0.368091 | I | 0.303494 | 0.064597 | No Change: Both O | - |
| Q6PEW1 | ZCH12_HUMAN Zinc finger CCHC domain-containing protein 12 OS=Homo sapiens GN=ZCCHC12 PE=2 SV=2 | 214 | R | 0.565549 | G | 0.44695 | 0.118599 | D to O | - |
| Q8WYQ9 | ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 OS=Homo sapiens GN=ZCCHC14 PE=1 SV=1 | 693 | V | 0.639827 | M | 0.718261 | -0.078434 | No Change: Both D | - |
| Q8WYQ9 | ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 OS=Homo sapiens GN=ZCCHC14 PE=1 SV=1 | 290 | L | 0.625985 | V | 0.599939 | 0.026046 | No Change: Both D | A breast cancer sample |
| Q8WYQ9 | ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 OS=Homo sapiens GN=ZCCHC14 PE=1 SV=1 | 54 | I | 0.867656 | V | 0.893213 | -0.025557 | No Change: Both D | - |
| Q8WYQ9 | ZCH14_HUMAN Zinc finger CCHC domain-containing protein 14 OS=Homo sapiens GN=ZCCHC14 PE=1 SV=1 | 244 | G | 0.926338 | A | 0.914729 | 0.011609 | No Change: Both D | - |
| Q6ZR62 | ZCH16_HUMAN Zinc finger CCHC domain-containing protein 16 OS=Homo sapiens GN=ZCCHC16 PE=2 SV=2 | 27 | L | 0.585395 | P | 0.726162 | -0.140767 | No Change: Both D | - |
| Q6ZR62 | ZCH16_HUMAN Zinc finger CCHC domain-containing protein 16 OS=Homo sapiens GN=ZCCHC16 PE=2 SV=2 | 162 | D | 0.715844 | Y | 0.548218 | 0.167626 | No Change: Both D | - |
| Q9C0B9 | ZCHC2_HUMAN Zinc finger CCHC domain-containing protein 2 OS=Homo sapiens GN=ZCCHC2 PE=1 SV=6 | 941 | T | 0.977599 | A | 0.978164 | -5.65E-04 | No Change: Both D | - |
| Q8N2G6 | ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens GN=ZCCHC24 PE=1 SV=1 | 43 | E | 0.606245 | V | 0.431582 | 0.174663 | D to O | - |
| Q9H5U6 | ZCHC4_HUMAN Zinc finger CCHC domain-containing protein 4 OS=Homo sapiens GN=ZCCHC4 PE=1 SV=3 | 396 | L | 0.410564 | H | 0.531135 | -0.120571 | O to D | - |
| Q9H5U6 | ZCHC4_HUMAN Zinc finger CCHC domain-containing protein 4 OS=Homo sapiens GN=ZCCHC4 PE=1 SV=3 | 382 | P | 0.311925 | L | 0.17728 | 0.134645 | No Change: Both O | - |
| Q8N8U3 | ZCHC5_HUMAN Zinc finger CCHC domain-containing protein 5 OS=Homo sapiens GN=ZCCHC5 PE=2 SV=1 | 117 | P | 0.967708 | S | 0.961289 | 0.006419 | No Change: Both D | - |
| Q5VYS8 | TUT7_HUMAN Terminal uridylyltransferase 7 OS=Homo sapiens GN=ZCCHC6 PE=1 SV=1 | 40 | A | 0.748474 | V | 0.709133 | 0.039341 | No Change: Both D | - |
| Q8N3Z6 | ZCHC7_HUMAN Zinc finger CCHC domain-containing protein 7 OS=Homo sapiens GN=ZCCHC7 PE=1 SV=2 | 118 | G | 0.76392 | D | 0.795311 | -0.031391 | No Change: Both D | - |
| Q8N3Z6 | ZCHC7_HUMAN Zinc finger CCHC domain-containing protein 7 OS=Homo sapiens GN=ZCCHC7 PE=1 SV=2 | 539 | R | 0.975312 | K | 0.981946 | -0.006634 | No Change: Both D | - |
| Q6NZY4 | ZCHC8_HUMAN Zinc finger CCHC domain-containing protein 8 OS=Homo sapiens GN=ZCCHC8 PE=1 SV=2 | 672 | P | 0.584202 | A | 0.491953 | 0.092249 | D to O | - |
| Q8N567 | ZCHC9_HUMAN Zinc finger CCHC domain-containing protein 9 OS=Homo sapiens GN=ZCCHC9 PE=2 SV=2 | 15 | P | 0.654531 | A | 0.553908 | 0.100623 | No Change: Both D | - |
| Q8TBF4 | ZCRB1_HUMAN Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Homo sapiens GN=ZCRB1 PE=1 SV=2 | 131 | P | 0.985681 | Q | 0.98043 | 0.005251 | No Change: Both D | - |
| Q9H0M4 | ZCPW1_HUMAN Zinc finger CW-type PWWP domain protein 1 OS=Homo sapiens GN=ZCWPW1 PE=1 SV=2 | 153 | T | 0.804481 | A | 0.78482 | 0.019661 | No Change: Both D | - |
| Q9H0M4 | ZCPW1_HUMAN Zinc finger CW-type PWWP domain protein 1 OS=Homo sapiens GN=ZCWPW1 PE=1 SV=2 | 365 | E | 0.151867 | K | 0.155929 | -0.004062 | No Change: Both O | - |
| Q504Y3 | ZCPW2_HUMAN Zinc finger CW-type PWWP domain protein 2 OS=Homo sapiens GN=ZCWPW2 PE=2 SV=1 | 202 | L | 0.660734 | Q | 0.748246 | -0.087512 | No Change: Both D | - |
| Q9HCK1 | ZDBF2_HUMAN DBF4-type zinc finger-containing protein 2 OS=Homo sapiens GN=ZDBF2 PE=1 SV=3 | 160 | R | 0.264107 | K | 0.313037 | -0.04893 | No Change: Both O | - |
| Q8WTX9 | ZDHC1_HUMAN Probable palmitoyltransferase ZDHHC1 OS=Homo sapiens GN=ZDHHC1 PE=2 SV=1 | 124 | R | 0.31171 | Q | 0.343353 | -0.031643 | No Change: Both O | - |
| Q9H8X9 | ZDH11_HUMAN Probable palmitoyltransferase ZDHHC11 OS=Homo sapiens GN=ZDHHC11 PE=2 SV=1 | 372 | R | 0.653993 | H | 0.595522 | 0.058471 | No Change: Both D | - |
| Q9H8X9 | ZDH11_HUMAN Probable palmitoyltransferase ZDHHC11 OS=Homo sapiens GN=ZDHHC11 PE=2 SV=1 | 341 | R | 0.723368 | Q | 0.737495 | -0.014127 | No Change: Both D | - |
| Q9H8X9 | ZDH11_HUMAN Probable palmitoyltransferase ZDHHC11 OS=Homo sapiens GN=ZDHHC11 PE=2 SV=1 | 325 | L | 0.396975 | S | 0.566717 | -0.169742 | O to D | - |
| P0C7U3 | ZH11B_HUMAN Probable palmitoyltransferase ZDHHC11B OS=Homo sapiens GN=ZDHHC11B PE=2 SV=1 | 42 | R | 0.024083 | Q | 0.026364 | -0.002281 | No Change: Both O | - |
| P0C7U3 | ZH11B_HUMAN Probable palmitoyltransferase ZDHHC11B OS=Homo sapiens GN=ZDHHC11B PE=2 SV=1 | 200 | R | 0.203334 | G | 0.198821 | 0.004513 | No Change: Both O | - |
| P0C7U3 | ZH11B_HUMAN Probable palmitoyltransferase ZDHHC11B OS=Homo sapiens GN=ZDHHC11B PE=2 SV=1 | 228 | V | 0.044824 | L | 0.044481 | 3.43E-04 | No Change: Both O | - |
| Q96GR4 | ZDH12_HUMAN Probable palmitoyltransferase ZDHHC12 OS=Homo sapiens GN=ZDHHC12 PE=2 SV=2 | 69 | P | 0.287538 | S | 0.292867 | -0.005329 | No Change: Both O | - |
| Q96GR4 | ZDH12_HUMAN Probable palmitoyltransferase ZDHHC12 OS=Homo sapiens GN=ZDHHC12 PE=2 SV=2 | 172 | Q | 0.131868 | L | 0.070775 | 0.061093 | No Change: Both O | - |
| Q8IUH4 | ZDH13_HUMAN Palmitoyltransferase ZDHHC13 OS=Homo sapiens GN=ZDHHC13 PE=2 SV=3 | 99 | K | 0.092519 | R | 0.067641 | 0.024878 | No Change: Both O | - |
| Q8IUH4 | ZDH13_HUMAN Palmitoyltransferase ZDHHC13 OS=Homo sapiens GN=ZDHHC13 PE=2 SV=3 | 392 | Y | 0.032619 | C | 0.024101 | 0.008518 | No Change: Both O | - |
| Q8IZN3 | ZDH14_HUMAN Probable palmitoyltransferase ZDHHC14 OS=Homo sapiens GN=ZDHHC14 PE=1 SV=1 | 334 | T | 0.692064 | M | 0.676277 | 0.015787 | No Change: Both D | - |
| Q8IUH5 | ZDH17_HUMAN Palmitoyltransferase ZDHHC17 OS=Homo sapiens GN=ZDHHC17 PE=1 SV=2 | 383 | N | 0.017412 | S | 0.019758 | -0.002346 | No Change: Both O | - |
| Q8WVZ1 | ZDH19_HUMAN Probable palmitoyltransferase ZDHHC19 OS=Homo sapiens GN=ZDHHC19 PE=2 SV=2 | 66 | G | 0.046518 | A | 0.037171 | 0.009347 | No Change: Both O | - |
| Q9UIJ5 | ZDHC2_HUMAN Palmitoyltransferase ZDHHC2 OS=Homo sapiens GN=ZDHHC2 PE=2 SV=1 | 306 | S | 0.690645 | F | 0.514283 | 0.176362 | No Change: Both D | A hepatocellular carcinoma sample |
| Q9UIJ5 | ZDHC2_HUMAN Palmitoyltransferase ZDHHC2 OS=Homo sapiens GN=ZDHHC2 PE=2 SV=1 | 356 | M | 0.862238 | I | 0.775562 | 0.086676 | No Change: Both D | A colorectal cancer sample |
| Q8IYP9 | ZDH23_HUMAN Probable palmitoyltransferase ZDHHC23 OS=Homo sapiens GN=ZDHHC23 PE=2 SV=3 | 132 | H | 0.177116 | N | 0.192814 | -0.015698 | No Change: Both O | - |
| Q8IYP9 | ZDH23_HUMAN Probable palmitoyltransferase ZDHHC23 OS=Homo sapiens GN=ZDHHC23 PE=2 SV=3 | 221 | T | 0.959404 | A | 0.958493 | 9.11E-04 | No Change: Both D | - |
| Q8IYP9 | ZDH23_HUMAN Probable palmitoyltransferase ZDHHC23 OS=Homo sapiens GN=ZDHHC23 PE=2 SV=3 | 247 | K | 0.904672 | R | 0.895402 | 0.00927 | No Change: Both D | - |
| Q8IYP9 | ZDH23_HUMAN Probable palmitoyltransferase ZDHHC23 OS=Homo sapiens GN=ZDHHC23 PE=2 SV=3 | 274 | H | 0.101081 | R | 0.131101 | -0.03002 | No Change: Both O | - |
| Q9NYG2 | ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens GN=ZDHHC3 PE=1 SV=1 | 220 | H | 0.488146 | Q | 0.52996 | -0.041814 | O to D | - |
| Q9NPG8 | ZDHC4_HUMAN Probable palmitoyltransferase ZDHHC4 OS=Homo sapiens GN=ZDHHC4 PE=1 SV=1 | 53 | V | 0.104944 | M | 0.138056 | -0.033112 | No Change: Both O | - |
| Q9NPG8 | ZDHC4_HUMAN Probable palmitoyltransferase ZDHHC4 OS=Homo sapiens GN=ZDHHC4 PE=1 SV=1 | 104 | P | 0.048884 | S | 0.058511 | -0.009627 | No Change: Both O | A breast cancer sample |
| Q9H6R6 | ZDHC6_HUMAN Probable palmitoyltransferase ZDHHC6 OS=Homo sapiens GN=ZDHHC6 PE=2 SV=1 | 41 | D | 0.049374 | N | 0.045696 | 0.003678 | No Change: Both O | - |
| Q9NXF8 | ZDHC7_HUMAN Palmitoyltransferase ZDHHC7 OS=Homo sapiens GN=ZDHHC7 PE=2 SV=2 | 201 | V | 0.06725 | I | 0.062672 | 0.004578 | No Change: Both O | - |
| Q9NXF8 | ZDHC7_HUMAN Palmitoyltransferase ZDHHC7 OS=Homo sapiens GN=ZDHHC7 PE=2 SV=2 | 44 | D | 0.042712 | N | 0.037095 | 0.005617 | No Change: Both O | A colorectal cancer sample |
| Q9Y397 | ZDHC9_HUMAN Palmitoyltransferase ZDHHC9 OS=Homo sapiens GN=ZDHHC9 PE=1 SV=2 | 148 | R | 0.263934 | W | 0.115598 | 0.148336 | No Change: Both O | Mental retardation syndromic X-linked ZDHHC9-related (MRXSZ) [MIM:300799] |
| Q9Y397 | ZDHC9_HUMAN Palmitoyltransferase ZDHHC9 OS=Homo sapiens GN=ZDHHC9 PE=1 SV=2 | 150 | P | 0.287486 | S | 0.303785 | -0.016299 | No Change: Both O | Mental retardation syndromic X-linked ZDHHC9-related (MRXSZ) [MIM:300799] |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 553 | K | 0.857295 | R | 0.822022 | 0.035273 | No Change: Both D | - |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 90 | G | 0.895116 | R | 0.906007 | -0.010891 | No Change: Both D | - |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 78 | N | 0.875463 | T | 0.874248 | 0.001215 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 6 (FECD6) [MIM:613270] |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 649 | P | 0.925108 | A | 0.895937 | 0.029171 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 6 (FECD6) [MIM:613270] |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 810 | Q | 0.302457 | P | 0.359458 | -0.057001 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 6 (FECD6) [MIM:613270] |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 840 | Q | 0.215154 | P | 0.238584 | -0.02343 | No Change: Both O | Corneal dystrophy Fuchs endothelial type 6 (FECD6) [MIM:613270] |
| P37275 | ZEB1_HUMAN Zinc finger E-box-binding homeobox 1 OS=Homo sapiens GN=ZEB1 PE=1 SV=2 | 905 | A | 0.69311 | T | 0.762521 | -0.069411 | No Change: Both D | Corneal dystrophy Fuchs endothelial type 6 (FECD6) [MIM:613270] |
| O60315 | ZEB2_HUMAN Zinc finger E-box-binding homeobox 2 OS=Homo sapiens GN=ZEB2 PE=1 SV=1 | 953 | R | 0.687972 | G | 0.67305 | 0.014922 | No Change: Both D | Mowat-Wilson syndrome (MWIS) [MIM:235730] |
| O60315 | ZEB2_HUMAN Zinc finger E-box-binding homeobox 2 OS=Homo sapiens GN=ZEB2 PE=1 SV=1 | 1119 | Q | 0.923734 | R | 0.930821 | -0.007087 | No Change: Both D | Mowat-Wilson syndrome (MWIS) [MIM:235730] |
| O60315 | ZEB2_HUMAN Zinc finger E-box-binding homeobox 2 OS=Homo sapiens GN=ZEB2 PE=1 SV=1 | 983 | D | 0.87866 | N | 0.828232 | 0.050428 | No Change: Both D | A colorectal cancer sample |
| Q7Z7L7 | ZER1_HUMAN Protein zer-1 homolog OS=Homo sapiens GN=ZER1 PE=1 SV=1 | 539 | T | 0.249225 | I | 0.152449 | 0.096776 | No Change: Both O | - |
| Q8N6M9 | ZFN2A_HUMAN AN1-type zinc finger protein 2A OS=Homo sapiens GN=ZFAND2A PE=2 SV=2 | 53 | H | 0.348122 | L | 0.255792 | 0.09233 | No Change: Both O | - |
| Q9P243 | ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens GN=ZFAT PE=1 SV=2 | 64 | G | 0.910575 | R | 0.924715 | -0.01414 | No Change: Both D | - |
| Q9P243 | ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens GN=ZFAT PE=1 SV=2 | 102 | P | 0.974536 | S | 0.975009 | -4.73E-04 | No Change: Both D | - |
| Q9P243 | ZFAT_HUMAN Zinc finger protein ZFAT OS=Homo sapiens GN=ZFAT PE=1 SV=2 | 672 | R | 0.894204 | K | 0.885418 | 0.008786 | No Change: Both D | - |
| O60293 | ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens GN=ZFC3H1 PE=1 SV=3 | 1006 | E | 0.872799 | K | 0.862143 | 0.010656 | No Change: Both D | - |
| O60293 | ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens GN=ZFC3H1 PE=1 SV=3 | 1807 | K | 0.191317 | R | 0.148121 | 0.043196 | No Change: Both O | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 3374 | A | 0.992803 | V | 0.989172 | 0.003631 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 460 | E | 0.999267 | Q | 0.999021 | 2.46E-04 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 72 | S | 0.946525 | A | 0.927243 | 0.019282 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 428 | T | 0.957487 | P | 0.968179 | -0.010692 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 777 | V | 0.709887 | A | 0.813161 | -0.103274 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 3421 | P | 0.998593 | A | 0.997703 | 8.90E-04 | No Change: Both D | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 997 | A | 0.250956 | S | 0.350288 | -0.099332 | No Change: Both O | - |
| Q15911 | ZFHX3_HUMAN Zinc finger homeobox protein 3 OS=Homo sapiens GN=ZFHX3 PE=1 SV=2 | 146 | S | 0.636528 | G | 0.588965 | 0.047563 | No Change: Both D | - |
| Q86UP3 | ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens GN=ZFHX4 PE=1 SV=1 | 2036 | I | 0.964056 | V | 0.972383 | -0.008327 | No Change: Both D | - |
| Q86UP3 | ZFHX4_HUMAN Zinc finger homeobox protein 4 OS=Homo sapiens GN=ZFHX4 PE=1 SV=1 | 3033 | V | 0.524427 | G | 0.65826 | -0.133833 | No Change: Both D | - |
| Q9H2Y7 | ZF106_HUMAN Zinc finger protein 106 homolog OS=Homo sapiens GN=ZFP106 PE=1 SV=1 | 103 | W | 0.979381 | R | 0.991384 | -0.012003 | No Change: Both D | - |
| Q9H2Y7 | ZF106_HUMAN Zinc finger protein 106 homolog OS=Homo sapiens GN=ZFP106 PE=1 SV=1 | 646 | I | 0.869948 | T | 0.925003 | -0.055055 | No Change: Both D | - |
| Q9H2Y7 | ZF106_HUMAN Zinc finger protein 106 homolog OS=Homo sapiens GN=ZFP106 PE=1 SV=1 | 656 | M | 0.818101 | V | 0.786926 | 0.031175 | No Change: Both D | - |
| Q9H2Y7 | ZF106_HUMAN Zinc finger protein 106 homolog OS=Homo sapiens GN=ZFP106 PE=1 SV=1 | 1162 | P | 0.909041 | T | 0.880994 | 0.028047 | No Change: Both D | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 159 | F | 0.200261 | L | 0.222973 | -0.022712 | No Change: Both O | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 163 | G | 0.262567 | E | 0.294177 | -0.03161 | No Change: Both O | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 287 | T | 0.500062 | K | 0.603759 | -0.103697 | No Change: Both D | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 780 | E | 0.72078 | A | 0.629405 | 0.091375 | No Change: Both D | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 54 | P | 0.430579 | S | 0.440838 | -0.010259 | No Change: Both O | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 446 | E | 0.66747 | Q | 0.622112 | 0.045358 | No Change: Both D | - |
| Q9UJU3 | ZF112_HUMAN Zinc finger protein 112 homolog OS=Homo sapiens GN=ZFP112 PE=2 SV=2 | 485 | Y | 0.381132 | H | 0.52811 | -0.146978 | O to D | - |
| O43829 | ZF161_HUMAN Zinc finger protein 161 homolog OS=Homo sapiens GN=ZFP161 PE=2 SV=2 | 77 | E | 0.286802 | G | 0.231276 | 0.055526 | No Change: Both O | - |
| O43829 | ZF161_HUMAN Zinc finger protein 161 homolog OS=Homo sapiens GN=ZFP161 PE=2 SV=2 | 139 | Q | 0.8217 | R | 0.820052 | 0.001648 | No Change: Both D | - |
| Q6ZN57 | ZFP2_HUMAN Zinc finger protein 2 homolog OS=Homo sapiens GN=ZFP2 PE=2 SV=1 | 113 | Q | 0.679977 | H | 0.651686 | 0.028291 | No Change: Both D | - |
| Q6ZN57 | ZFP2_HUMAN Zinc finger protein 2 homolog OS=Homo sapiens GN=ZFP2 PE=2 SV=1 | 142 | R | 0.45321 | G | 0.442331 | 0.010879 | No Change: Both O | - |
| Q8NHY6 | ZFP28_HUMAN Zinc finger protein 28 homolog OS=Homo sapiens GN=ZFP28 PE=1 SV=1 | 620 | A | 0.541806 | V | 0.433084 | 0.108722 | D to O | - |
| Q8NHY6 | ZFP28_HUMAN Zinc finger protein 28 homolog OS=Homo sapiens GN=ZFP28 PE=1 SV=1 | 141 | S | 0.168511 | W | 0.051198 | 0.117313 | No Change: Both O | - |
| P26651 | TTP_HUMAN Tristetraprolin OS=Homo sapiens GN=ZFP36 PE=1 SV=1 | 37 | P | 0.986714 | S | 0.987528 | -8.14E-04 | No Change: Both D | - |
| P26651 | TTP_HUMAN Tristetraprolin OS=Homo sapiens GN=ZFP36 PE=1 SV=1 | 259 | I | 0.781197 | F | 0.801303 | -0.020106 | No Change: Both D | - |
| P26651 | TTP_HUMAN Tristetraprolin OS=Homo sapiens GN=ZFP36 PE=1 SV=1 | 324 | V | 0.753648 | F | 0.757411 | -0.003763 | No Change: Both D | - |
| P26651 | TTP_HUMAN Tristetraprolin OS=Homo sapiens GN=ZFP36 PE=1 SV=1 | 55 | P | 0.978093 | S | 0.977515 | 5.78E-04 | No Change: Both D | - |
| Q9Y6Q3 | ZFP37_HUMAN Zinc finger protein 37 homolog OS=Homo sapiens GN=ZFP37 PE=2 SV=3 | 7 | V | 0.863055 | D | 0.915443 | -0.052388 | No Change: Both D | - |
| Q9NU63 | ZFP57_HUMAN Zinc finger protein 57 homolog OS=Homo sapiens GN=ZFP57 PE=1 SV=2 | 114 | N | 0.558103 | S | 0.628635 | -0.070532 | No Change: Both D | - |
| Q9NU63 | ZFP57_HUMAN Zinc finger protein 57 homolog OS=Homo sapiens GN=ZFP57 PE=1 SV=2 | 284 | D | 0.652925 | V | 0.572492 | 0.080433 | No Change: Both D | - |
| Q9NU63 | ZFP57_HUMAN Zinc finger protein 57 homolog OS=Homo sapiens GN=ZFP57 PE=1 SV=2 | 166 | R | 0.611817 | H | 0.582397 | 0.02942 | No Change: Both D | Transient neonatal diabetes mellitus type 1 (TNDM1) [MIM:601410] |
| Q9NU63 | ZFP57_HUMAN Zinc finger protein 57 homolog OS=Homo sapiens GN=ZFP57 PE=1 SV=2 | 193 | H | 0.806036 | N | 0.81366 | -0.007624 | No Change: Both D | Transient neonatal diabetes mellitus type 1 (TNDM1) [MIM:601410] |
| Q9NU63 | ZFP57_HUMAN Zinc finger protein 57 homolog OS=Homo sapiens GN=ZFP57 PE=1 SV=2 | 374 | H | 0.322696 | D | 0.377027 | -0.054331 | No Change: Both O | Transient neonatal diabetes mellitus type 1 (TNDM1) [MIM:601410] |
| Q8NB50 | ZFP62_HUMAN Zinc finger protein 62 homolog OS=Homo sapiens GN=ZFP62 PE=1 SV=3 | 34 | M | 0.902089 | I | 0.847786 | 0.054303 | No Change: Both D | - |
| Q8NB50 | ZFP62_HUMAN Zinc finger protein 62 homolog OS=Homo sapiens GN=ZFP62 PE=1 SV=3 | 698 | R | 0.673208 | K | 0.703549 | -0.030341 | No Change: Both D | - |
| Q9NPA5 | ZF64A_HUMAN Zinc finger protein 64 homolog isoforms 1 and 2 OS=Homo sapiens GN=ZFP64 PE=1 SV=3 | 68 | Q | 0.738747 | P | 0.746313 | -0.007566 | No Change: Both D | - |
| Q9NPA5 | ZF64A_HUMAN Zinc finger protein 64 homolog isoforms 1 and 2 OS=Homo sapiens GN=ZFP64 PE=1 SV=3 | 139 | P | 0.78458 | L | 0.64267 | 0.14191 | No Change: Both D | - |
| Q9NPA5 | ZF64A_HUMAN Zinc finger protein 64 homolog isoforms 1 and 2 OS=Homo sapiens GN=ZFP64 PE=1 SV=3 | 425 | F | 0.805305 | Y | 0.777929 | 0.027376 | No Change: Both D | - |
| Q9NPA5 | ZF64A_HUMAN Zinc finger protein 64 homolog isoforms 1 and 2 OS=Homo sapiens GN=ZFP64 PE=1 SV=3 | 451 | S | 0.83741 | N | 0.800567 | 0.036843 | No Change: Both D | - |
| Q9NTW7 | ZF64B_HUMAN Zinc finger protein 64 homolog isoforms 3 and 4 OS=Homo sapiens GN=ZFP64 PE=2 SV=3 | 593 | D | 0.698616 | E | 0.714253 | -0.015637 | No Change: Both D | A breast cancer sample |
| Q9NTW7 | ZF64B_HUMAN Zinc finger protein 64 homolog isoforms 3 and 4 OS=Homo sapiens GN=ZFP64 PE=2 SV=3 | 609 | K | 0.860938 | N | 0.850521 | 0.010417 | No Change: Both D | A breast cancer sample |
| Q96JP5 | ZFP91_HUMAN E3 ubiquitin-protein ligase ZFP91 OS=Homo sapiens GN=ZFP91 PE=1 SV=1 | 207 | S | 0.982385 | G | 0.977766 | 0.004619 | No Change: Both D | - |
| Q96JP5 | ZFP91_HUMAN E3 ubiquitin-protein ligase ZFP91 OS=Homo sapiens GN=ZFP91 PE=1 SV=1 | 37 | V | 0.984625 | I | 0.98053 | 0.004095 | No Change: Both D | - |
| O95159 | ZFPL1_HUMAN Zinc finger protein-like 1 OS=Homo sapiens GN=ZFPL1 PE=1 SV=2 | 218 | R | 0.838207 | Q | 0.812231 | 0.025976 | No Change: Both D | - |
| Q8IX07 | FOG1_HUMAN Zinc finger protein ZFPM1 OS=Homo sapiens GN=ZFPM1 PE=1 SV=2 | 70 | G | 0.998788 | A | 0.998322 | 4.66E-04 | No Change: Both D | - |
| Q8WW38 | FOG2_HUMAN Zinc finger protein ZFPM2 OS=Homo sapiens GN=ZFPM2 PE=1 SV=3 | 30 | E | 0.975236 | G | 0.962023 | 0.013213 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| Q8WW38 | FOG2_HUMAN Zinc finger protein ZFPM2 OS=Homo sapiens GN=ZFPM2 PE=1 SV=3 | 657 | S | 0.94547 | G | 0.930294 | 0.015176 | No Change: Both D | Tetralogy of Fallot (TOF) [MIM:187500] |
| Q8WW38 | FOG2_HUMAN Zinc finger protein ZFPM2 OS=Homo sapiens GN=ZFPM2 PE=1 SV=3 | 782 | E | 0.391471 | D | 0.357074 | 0.034397 | No Change: Both O | - |
| Q8WW38 | FOG2_HUMAN Zinc finger protein ZFPM2 OS=Homo sapiens GN=ZFPM2 PE=1 SV=3 | 403 | A | 0.970031 | G | 0.973126 | -0.003095 | No Change: Both D | - |
| Q8WW38 | FOG2_HUMAN Zinc finger protein ZFPM2 OS=Homo sapiens GN=ZFPM2 PE=1 SV=3 | 1055 | A | 0.856266 | V | 0.823134 | 0.033132 | No Change: Both D | - |
| Q96KR1 | ZFR_HUMAN Zinc finger RNA-binding protein OS=Homo sapiens GN=ZFR PE=1 SV=2 | 461 | V | 0.976834 | I | 0.972543 | 0.004291 | No Change: Both D | - |
| Q96KR1 | ZFR_HUMAN Zinc finger RNA-binding protein OS=Homo sapiens GN=ZFR PE=1 SV=2 | 520 | I | 0.740291 | T | 0.832517 | -0.092226 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 164 | S | 0.955114 | L | 0.91216 | 0.042954 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 183 | V | 0.907286 | M | 0.924854 | -0.017568 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 210 | V | 0.969286 | L | 0.966634 | 0.002652 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 235 | P | 0.999566 | L | 0.998998 | 5.68E-04 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 577 | A | 0.926188 | T | 0.927001 | -8.13E-04 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 589 | D | 0.766173 | N | 0.729771 | 0.036402 | No Change: Both D | - |
| Q9UPR6 | ZFR2_HUMAN Zinc finger RNA-binding protein 2 OS=Homo sapiens GN=ZFR2 PE=2 SV=3 | 718 | I | 0.786183 | M | 0.853463 | -0.06728 | No Change: Both D | - |
| Q7Z3T8 | ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 OS=Homo sapiens GN=ZFYVE16 PE=1 SV=3 | 192 | I | 0.799845 | T | 0.863366 | -0.063521 | No Change: Both D | - |
| Q7Z3T8 | ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 OS=Homo sapiens GN=ZFYVE16 PE=1 SV=3 | 598 | I | 0.194175 | T | 0.278443 | -0.084268 | No Change: Both O | - |
| Q7Z3T8 | ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 OS=Homo sapiens GN=ZFYVE16 PE=1 SV=3 | 1055 | S | 0.210153 | G | 0.181236 | 0.028917 | No Change: Both O | - |
| Q7Z3T8 | ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 OS=Homo sapiens GN=ZFYVE16 PE=1 SV=3 | 35 | A | 0.791787 | E | 0.852186 | -0.060399 | No Change: Both D | - |
| Q7Z3T8 | ZFY16_HUMAN Zinc finger FYVE domain-containing protein 16 OS=Homo sapiens GN=ZFYVE16 PE=1 SV=3 | 1519 | T | 0.522548 | N | 0.568384 | -0.045836 | No Change: Both D | - |
| Q96K21 | ZFY19_HUMAN Zinc finger FYVE domain-containing protein 19 OS=Homo sapiens GN=ZFYVE19 PE=1 SV=3 | 210 | R | 0.870378 | H | 0.820135 | 0.050243 | No Change: Both D | - |
| Q96K21 | ZFY19_HUMAN Zinc finger FYVE domain-containing protein 19 OS=Homo sapiens GN=ZFYVE19 PE=1 SV=3 | 376 | S | 0.840655 | A | 0.805024 | 0.035631 | No Change: Both D | - |
| Q96K21 | ZFY19_HUMAN Zinc finger FYVE domain-containing protein 19 OS=Homo sapiens GN=ZFYVE19 PE=1 SV=3 | 398 | R | 0.922725 | C | 0.889507 | 0.033218 | No Change: Both D | - |
| Q9H1K0 | RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens GN=ZFYVE20 PE=1 SV=2 | 591 | L | 0.968611 | P | 0.983519 | -0.014908 | No Change: Both D | - |
| Q9H1K0 | RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens GN=ZFYVE20 PE=1 SV=2 | 641 | T | 0.931914 | A | 0.932766 | -8.52E-04 | No Change: Both D | - |
| Q9H1K0 | RBNS5_HUMAN Rabenosyn-5 OS=Homo sapiens GN=ZFYVE20 PE=1 SV=2 | 722 | M | 0.86281 | I | 0.840399 | 0.022411 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 429 | K | 0.515414 | E | 0.50972 | 0.005694 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 898 | T | 0.753835 | S | 0.805676 | -0.051841 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 951 | T | 0.158657 | M | 0.141997 | 0.01666 | No Change: Both O | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1071 | S | 0.66707 | N | 0.550832 | 0.116238 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1103 | P | 0.941822 | L | 0.902784 | 0.039038 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1122 | A | 0.877973 | V | 0.843357 | 0.034616 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1164 | A | 0.237649 | E | 0.319733 | -0.082084 | No Change: Both O | A breast cancer sample |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1457 | C | 0.115552 | Y | 0.13068 | -0.015128 | No Change: Both O | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1891 | S | 0.929023 | N | 0.904389 | 0.024634 | No Change: Both D | - |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 1945 | R | 0.167365 | Q | 0.186245 | -0.01888 | No Change: Both O | A breast cancer sample |
| Q68DK2 | ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens GN=ZFYVE26 PE=1 SV=3 | 2411 | R | 0.254974 | H | 0.228183 | 0.026791 | No Change: Both O | - |
| Q5T4F4 | ZFY27_HUMAN Protrudin OS=Homo sapiens GN=ZFYVE27 PE=1 SV=1 | 82 | V | 0.040417 | I | 0.034851 | 0.005566 | No Change: Both O | - |
| Q5T4F4 | ZFY27_HUMAN Protrudin OS=Homo sapiens GN=ZFYVE27 PE=1 SV=1 | 138 | G | 0.638149 | V | 0.571897 | 0.066252 | No Change: Both D | - |
| Q5T4F4 | ZFY27_HUMAN Protrudin OS=Homo sapiens GN=ZFYVE27 PE=1 SV=1 | 191 | G | 0.044879 | V | 0.023695 | 0.021184 | No Change: Both O | Spastic paraplegia autosomal dominant type 33 (SPG33) [MIM:610244] |
| Q9HCC9 | LST2_HUMAN Lateral signaling target protein 2 homolog OS=Homo sapiens GN=ZFYVE28 PE=1 SV=3 | 603 | S | 0.926294 | N | 0.89702 | 0.029274 | No Change: Both D | - |
| Q9HCC9 | LST2_HUMAN Lateral signaling target protein 2 homolog OS=Homo sapiens GN=ZFYVE28 PE=1 SV=3 | 672 | S | 0.983241 | P | 0.982923 | 3.18E-04 | No Change: Both D | - |
| O95405 | ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens GN=ZFYVE9 PE=1 SV=2 | 287 | Y | 0.676547 | C | 0.757174 | -0.080627 | No Change: Both D | - |
| O95405 | ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens GN=ZFYVE9 PE=1 SV=2 | 414 | Q | 0.854395 | P | 0.850882 | 0.003513 | No Change: Both D | - |
| O95405 | ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens GN=ZFYVE9 PE=1 SV=2 | 639 | I | 0.668878 | V | 0.697171 | -0.028293 | No Change: Both D | - |
| O60844 | ZG16_HUMAN Zymogen granule membrane protein 16 OS=Homo sapiens GN=ZG16 PE=1 SV=1 | 32 | S | 0.826482 | G | 0.804571 | 0.021911 | No Change: Both D | - |
| O60844 | ZG16_HUMAN Zymogen granule membrane protein 16 OS=Homo sapiens GN=ZG16 PE=1 SV=1 | 162 | T | 0.372905 | S | 0.469623 | -0.096718 | No Change: Both O | - |
| Q96DA0 | ZG16B_HUMAN Zymogen granule protein 16 homolog B OS=Homo sapiens GN=ZG16B PE=1 SV=3 | 133 | M | 0.115901 | V | 0.088646 | 0.027255 | No Change: Both O | - |
| Q8N5A5 | ZGPAT_HUMAN Zinc finger CCCH-type with G patch domain-containing protein OS=Homo sapiens GN=ZGPAT PE=1 SV=3 | 61 | S | 0.719565 | R | 0.696758 | 0.022807 | No Change: Both D | - |
| Q9Y6X8 | ZHX2_HUMAN Zinc fingers and homeoboxes protein 2 OS=Homo sapiens GN=ZHX2 PE=1 SV=1 | 357 | V | 0.582645 | M | 0.646899 | -0.064254 | No Change: Both D | - |
| Q9Y6X8 | ZHX2_HUMAN Zinc fingers and homeoboxes protein 2 OS=Homo sapiens GN=ZHX2 PE=1 SV=1 | 649 | R | 0.406347 | K | 0.440806 | -0.034459 | No Change: Both O | - |
| Q9Y6X8 | ZHX2_HUMAN Zinc fingers and homeoboxes protein 2 OS=Homo sapiens GN=ZHX2 PE=1 SV=1 | 779 | G | 0.979552 | S | 0.985542 | -0.00599 | No Change: Both D | - |
| Q9H4I2 | ZHX3_HUMAN Zinc fingers and homeoboxes protein 3 OS=Homo sapiens GN=ZHX3 PE=1 SV=3 | 310 | N | 0.469912 | S | 0.535848 | -0.065936 | O to D | - |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 36 | Q | 0.700963 | P | 0.712229 | -0.011266 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 152 | D | 0.858295 | F | 0.80908 | 0.049215 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 37 | D | 0.697129 | N | 0.688976 | 0.008153 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 128 | D | 0.813422 | N | 0.796358 | 0.017064 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 272 | S | 0.693182 | N | 0.664518 | 0.028664 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 286 | H | 0.492359 | L | 0.366192 | 0.126167 | No Change: Both O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 286 | H | 0.492359 | Q | 0.508256 | -0.015897 | O to D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 286 | H | 0.492359 | Y | 0.32292 | 0.169439 | No Change: Both O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 291 | H | 0.569442 | Y | 0.435417 | 0.134025 | D to O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 304 | W | 0.304563 | R | 0.55838 | -0.253817 | O to D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 314 | F | 0.498315 | C | 0.53406 | -0.035745 | O to D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 325 | R | 0.391079 | L | 0.271855 | 0.119224 | No Change: Both O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 325 | R | 0.391079 | S | 0.412063 | -0.020984 | No Change: Both O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 327 | H | 0.420875 | Y | 0.289463 | 0.131412 | No Change: Both O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 335 | C | 0.528237 | F | 0.497989 | 0.030248 | D to O | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 373 | R | 0.695179 | P | 0.710115 | -0.014936 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 402 | Y | 0.941424 | N | 0.960379 | -0.018955 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 403 | T | 0.94713 | K | 0.96408 | -0.01695 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 404 | H | 0.954263 | R | 0.957444 | -0.003181 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 409 | R | 0.96906 | W | 0.936826 | 0.032234 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O95409 | ZIC2_HUMAN Zinc finger protein ZIC 2 OS=Homo sapiens GN=ZIC2 PE=1 SV=2 | 415 | H | 0.978064 | Q | 0.979414 | -0.00135 | No Change: Both D | Holoprosencephaly type 5 (HPE5) [MIM:609637] |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 323 | T | 0.406941 | M | 0.37945 | 0.027491 | No Change: Both O | Visceral heterotaxy X-linked type 1 (HTX1) [MIM:306955] |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 217 | P | 0.558951 | A | 0.465941 | 0.09301 | D to O | - |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 253 | C | 0.244342 | S | 0.465273 | -0.220931 | No Change: Both O | Visceral heterotaxy X-linked type 1 (HTX1) [MIM:306955] |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 286 | H | 0.507418 | R | 0.495032 | 0.012386 | D to O | Visceral heterotaxy X-linked type 1 (HTX1) [MIM:306955] |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 405 | K | 0.927704 | E | 0.919066 | 0.008638 | No Change: Both D | Visceral heterotaxy X-linked type 1 (HTX1) [MIM:306955] |
| O60481 | ZIC3_HUMAN Zinc finger protein ZIC 3 OS=Homo sapiens GN=ZIC3 PE=1 SV=1 | 255 | W | 0.257053 | G | 0.47914 | -0.222087 | No Change: Both O | Visceral heterotaxy X-linked type 1 (HTX1) [MIM:306955] |
| Q9NZV7 | ZIM2_HUMAN Zinc finger imprinted 2 OS=Homo sapiens GN=ZIM2 PE=2 SV=1 | 110 | A | 0.622596 | T | 0.641221 | -0.018625 | No Change: Both D | - |
| Q9NZV7 | ZIM2_HUMAN Zinc finger imprinted 2 OS=Homo sapiens GN=ZIM2 PE=2 SV=1 | 408 | Q | 0.316136 | R | 0.312735 | 0.003401 | No Change: Both O | - |
| Q9NZV7 | ZIM2_HUMAN Zinc finger imprinted 2 OS=Homo sapiens GN=ZIM2 PE=2 SV=1 | 473 | R | 0.162199 | K | 0.175003 | -0.012804 | No Change: Both O | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 7 | R | 0.571725 | K | 0.584161 | -0.012436 | No Change: Both D | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 28 | E | 0.453828 | K | 0.426698 | 0.02713 | No Change: Both O | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 157 | N | 0.58157 | D | 0.579912 | 0.001658 | No Change: Both D | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 379 | I | 0.456876 | V | 0.447183 | 0.009693 | No Change: Both O | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 69 | L | 0.656958 | M | 0.685056 | -0.028098 | No Change: Both D | - |
| Q96PE6 | ZIM3_HUMAN Zinc finger imprinted 3 OS=Homo sapiens GN=ZIM3 PE=2 SV=1 | 205 | G | 0.736628 | R | 0.776832 | -0.040204 | No Change: Both D | - |
| P17029 | ZKSC1_HUMAN Zinc finger protein with KRAB and SCAN domains 1 OS=Homo sapiens GN=ZKSCAN1 PE=1 SV=3 | 26 | V | 0.743148 | A | 0.792514 | -0.049366 | No Change: Both D | - |
| Q63HK3 | ZKSC2_HUMAN Zinc finger protein with KRAB and SCAN domains 2 OS=Homo sapiens GN=ZKSCAN2 PE=1 SV=2 | 253 | L | 0.323257 | F | 0.319668 | 0.003589 | No Change: Both O | - |
| Q63HK3 | ZKSC2_HUMAN Zinc finger protein with KRAB and SCAN domains 2 OS=Homo sapiens GN=ZKSCAN2 PE=1 SV=2 | 615 | E | 0.991939 | D | 0.988624 | 0.003315 | No Change: Both D | - |
| Q63HK3 | ZKSC2_HUMAN Zinc finger protein with KRAB and SCAN domains 2 OS=Homo sapiens GN=ZKSCAN2 PE=1 SV=2 | 947 | P | 0.879586 | S | 0.866284 | 0.013302 | No Change: Both D | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 3 | R | 0.887426 | T | 0.89812 | -0.010694 | No Change: Both D | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 33 | G | 0.894264 | V | 0.85597 | 0.038294 | No Change: Both D | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 34 | F | 0.895264 | L | 0.910466 | -0.015202 | No Change: Both D | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 189 | V | 0.392494 | M | 0.439241 | -0.046747 | No Change: Both O | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 200 | K | 0.444581 | E | 0.472912 | -0.028331 | No Change: Both O | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 200 | K | 0.444581 | T | 0.392727 | 0.051854 | No Change: Both O | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 246 | H | 0.868424 | Q | 0.908199 | -0.039775 | No Change: Both D | - |
| Q9BRR0 | ZKSC3_HUMAN Zinc finger protein with KRAB and SCAN domains 3 OS=Homo sapiens GN=ZKSCAN3 PE=1 SV=2 | 200 | K | 0.444581 | A | 0.366793 | 0.077788 | No Change: Both O | - |
| Q969J2 | ZKSC4_HUMAN Zinc finger protein with KRAB and SCAN domains 4 OS=Homo sapiens GN=ZKSCAN4 PE=1 SV=1 | 33 | S | 0.864261 | F | 0.760114 | 0.104147 | No Change: Both D | - |
| Q5H9K5 | ZMAT1_HUMAN Zinc finger matrin-type protein 1 OS=Homo sapiens GN=ZMAT1 PE=2 SV=1 | 214 | R | 0.555297 | K | 0.607296 | -0.051999 | No Change: Both D | - |
| Q5H9K5 | ZMAT1_HUMAN Zinc finger matrin-type protein 1 OS=Homo sapiens GN=ZMAT1 PE=2 SV=1 | 536 | Q | 0.970164 | R | 0.969227 | 9.37E-04 | No Change: Both D | - |
| Q9H898 | ZMAT4_HUMAN Zinc finger matrin-type protein 4 OS=Homo sapiens GN=ZMAT4 PE=2 SV=1 | 201 | T | 0.171348 | A | 0.150405 | 0.020943 | No Change: Both O | - |
| Q9ULJ6 | ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens GN=ZMIZ1 PE=1 SV=3 | 551 | L | 0.874772 | V | 0.869625 | 0.005147 | No Change: Both D | A breast cancer sample |
| Q8NF64 | ZMIZ2_HUMAN Zinc finger MIZ domain-containing protein 2 OS=Homo sapiens GN=ZMIZ2 PE=1 SV=2 | 408 | L | 0.888035 | F | 0.873959 | 0.014076 | No Change: Both D | - |
| O75844 | FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens GN=ZMPSTE24 PE=1 SV=2 | 340 | W | 0.320096 | R | 0.522841 | -0.202745 | O to D | Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612] |
| O75844 | FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens GN=ZMPSTE24 PE=1 SV=2 | 137 | T | 0.117466 | A | 0.104748 | 0.012718 | No Change: Both O | - |
| O75844 | FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens GN=ZMPSTE24 PE=1 SV=2 | 248 | P | 0.163059 | L | 0.086563 | 0.076496 | No Change: Both O | Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612] |
| O75844 | FACE1_HUMAN CAAX prenyl protease 1 homolog OS=Homo sapiens GN=ZMPSTE24 PE=1 SV=2 | 265 | N | 0.474739 | S | 0.533356 | -0.058617 | O to D | Mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612] |
| Q5SVZ6 | ZMYM1_HUMAN Zinc finger MYM-type protein 1 OS=Homo sapiens GN=ZMYM1 PE=1 SV=1 | 73 | V | 0.595108 | M | 0.670228 | -0.07512 | No Change: Both D | - |
| Q5SVZ6 | ZMYM1_HUMAN Zinc finger MYM-type protein 1 OS=Homo sapiens GN=ZMYM1 PE=1 SV=1 | 454 | R | 0.854783 | Q | 0.881468 | -0.026685 | No Change: Both D | - |
| Q5SVZ6 | ZMYM1_HUMAN Zinc finger MYM-type protein 1 OS=Homo sapiens GN=ZMYM1 PE=1 SV=1 | 493 | E | 0.470619 | G | 0.428951 | 0.041668 | No Change: Both O | - |
| Q5VZL5 | ZMYM4_HUMAN Zinc finger MYM-type protein 4 OS=Homo sapiens GN=ZMYM4 PE=1 SV=1 | 452 | V | 0.261094 | I | 0.238827 | 0.022267 | No Change: Both O | - |
| Q5VZL5 | ZMYM4_HUMAN Zinc finger MYM-type protein 4 OS=Homo sapiens GN=ZMYM4 PE=1 SV=1 | 1410 | R | 0.370734 | W | 0.17358 | 0.197154 | No Change: Both O | A colorectal cancer sample |
| Q9UJ78 | ZMYM5_HUMAN Zinc finger MYM-type protein 5 OS=Homo sapiens GN=ZMYM5 PE=1 SV=4 | 125 | I | 0.691981 | V | 0.69035 | 0.001631 | No Change: Both D | - |
| Q9UJ78 | ZMYM5_HUMAN Zinc finger MYM-type protein 5 OS=Homo sapiens GN=ZMYM5 PE=1 SV=4 | 137 | C | 0.660921 | F | 0.655351 | 0.00557 | No Change: Both D | - |
| Q9UJ78 | ZMYM5_HUMAN Zinc finger MYM-type protein 5 OS=Homo sapiens GN=ZMYM5 PE=1 SV=4 | 231 | T | 0.879099 | A | 0.872952 | 0.006147 | No Change: Both D | - |
| O95789 | ZMYM6_HUMAN Zinc finger MYM-type protein 6 OS=Homo sapiens GN=ZMYM6 PE=1 SV=2 | 660 | K | 0.72993 | R | 0.669668 | 0.060262 | No Change: Both D | - |
| O95789 | ZMYM6_HUMAN Zinc finger MYM-type protein 6 OS=Homo sapiens GN=ZMYM6 PE=1 SV=2 | 1233 | E | 0.616128 | K | 0.60514 | 0.010988 | No Change: Both D | - |
| O75800 | ZMY10_HUMAN Zinc finger MYND domain-containing protein 10 OS=Homo sapiens GN=ZMYND10 PE=1 SV=2 | 407 | R | 0.522151 | Q | 0.522326 | -1.75E-04 | No Change: Both D | Non-small cell lung cancer cell lines |
| Q9H0C1 | ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 OS=Homo sapiens GN=ZMYND12 PE=2 SV=3 | 316 | F | 0.037217 | L | 0.048416 | -0.011199 | No Change: Both O | - |
| Q9H091 | ZMY15_HUMAN Zinc finger MYND domain-containing protein 15 OS=Homo sapiens GN=ZMYND15 PE=2 SV=2 | 401 | R | 0.262172 | H | 0.227825 | 0.034347 | No Change: Both O | - |
| Q4VC12 | ZMY17_HUMAN Zinc finger MYND domain-containing protein 17 OS=Homo sapiens GN=ZMYND17 PE=2 SV=2 | 417 | L | 0.500181 | P | 0.642955 | -0.142774 | No Change: Both D | - |
| Q9ULU4 | PKCB1_HUMAN Protein kinase C-binding protein 1 OS=Homo sapiens GN=ZMYND8 PE=1 SV=2 | 752 | V | 0.990765 | A | 0.992318 | -0.001553 | No Change: Both D | - |
| P21506 | ZNF10_HUMAN Zinc finger protein 10 OS=Homo sapiens GN=ZNF10 PE=2 SV=3 | 227 | Q | 0.32236 | R | 0.299186 | 0.023174 | No Change: Both O | - |
| Q8IYN0 | ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens GN=ZNF100 PE=2 SV=2 | 8 | M | 0.548074 | V | 0.421698 | 0.126376 | D to O | - |
| Q8IYN0 | ZN100_HUMAN Zinc finger protein 100 OS=Homo sapiens GN=ZNF100 PE=2 SV=2 | 389 | T | 0.599141 | I | 0.433411 | 0.16573 | D to O | - |
| Q8IZC7 | ZN101_HUMAN Zinc finger protein 101 OS=Homo sapiens GN=ZNF101 PE=1 SV=1 | 121 | M | 0.656712 | L | 0.622715 | 0.033997 | No Change: Both D | - |
| Q8NC26 | ZN114_HUMAN Zinc finger protein 114 OS=Homo sapiens GN=ZNF114 PE=2 SV=1 | 99 | H | 0.82589 | N | 0.846323 | -0.020433 | No Change: Both D | - |
| Q8NC26 | ZN114_HUMAN Zinc finger protein 114 OS=Homo sapiens GN=ZNF114 PE=2 SV=1 | 207 | V | 0.410075 | A | 0.494314 | -0.084239 | No Change: Both O | - |
| Q03924 | ZN117_HUMAN Zinc finger protein 117 OS=Homo sapiens GN=ZNF117 PE=2 SV=5 | 83 | C | 0.350762 | Y | 0.296096 | 0.054666 | No Change: Both O | - |
| Q03924 | ZN117_HUMAN Zinc finger protein 117 OS=Homo sapiens GN=ZNF117 PE=2 SV=5 | 112 | K | 0.631391 | N | 0.578216 | 0.053175 | No Change: Both D | - |
| P52740 | ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens GN=ZNF132 PE=2 SV=2 | 252 | P | 0.66157 | L | 0.538622 | 0.122948 | No Change: Both D | - |
| P52740 | ZN132_HUMAN Zinc finger protein 132 OS=Homo sapiens GN=ZNF132 PE=2 SV=2 | 203 | G | 0.221319 | D | 0.246459 | -0.02514 | No Change: Both O | - |
| P52736 | ZN133_HUMAN Zinc finger protein 133 OS=Homo sapiens GN=ZNF133 PE=1 SV=2 | 193 | S | 0.762377 | T | 0.727804 | 0.034573 | No Change: Both D | - |
| P52736 | ZN133_HUMAN Zinc finger protein 133 OS=Homo sapiens GN=ZNF133 PE=1 SV=2 | 194 | G | 0.742438 | E | 0.774665 | -0.032227 | No Change: Both D | - |
| P52741 | ZN134_HUMAN Zinc finger protein 134 OS=Homo sapiens GN=ZNF134 PE=2 SV=2 | 30 | I | 0.672582 | T | 0.74721 | -0.074628 | No Change: Both D | - |
| P52741 | ZN134_HUMAN Zinc finger protein 134 OS=Homo sapiens GN=ZNF134 PE=2 SV=2 | 46 | A | 0.401728 | T | 0.431461 | -0.029733 | No Change: Both O | - |
| P52741 | ZN134_HUMAN Zinc finger protein 134 OS=Homo sapiens GN=ZNF134 PE=2 SV=2 | 207 | S | 0.649369 | R | 0.62759 | 0.021779 | No Change: Both D | - |
| P52742 | ZN135_HUMAN Zinc finger protein 135 OS=Homo sapiens GN=ZNF135 PE=2 SV=3 | 22 | G | 0.257899 | D | 0.298181 | -0.040282 | No Change: Both O | - |
| P52742 | ZN135_HUMAN Zinc finger protein 135 OS=Homo sapiens GN=ZNF135 PE=2 SV=3 | 507 | S | 0.720185 | L | 0.574964 | 0.145221 | No Change: Both D | - |
| P52742 | ZN135_HUMAN Zinc finger protein 135 OS=Homo sapiens GN=ZNF135 PE=2 SV=3 | 517 | T | 0.634419 | A | 0.60284 | 0.031579 | No Change: Both D | - |
| P52742 | ZN135_HUMAN Zinc finger protein 135 OS=Homo sapiens GN=ZNF135 PE=2 SV=3 | 579 | G | 0.820428 | R | 0.837625 | -0.017197 | No Change: Both D | - |
| P52742 | ZN135_HUMAN Zinc finger protein 135 OS=Homo sapiens GN=ZNF135 PE=2 SV=3 | 592 | S | 0.936388 | L | 0.881938 | 0.05445 | No Change: Both D | - |
| P52737 | ZN136_HUMAN Zinc finger protein 136 OS=Homo sapiens GN=ZNF136 PE=1 SV=1 | 107 | Y | 0.400912 | C | 0.46923 | -0.068318 | No Change: Both O | - |
| P52743 | ZN137_HUMAN Putative zinc finger protein 137 OS=Homo sapiens GN=ZNF137P PE=5 SV=1 | 181 | Q | 0.454842 | H | 0.448692 | 0.00615 | No Change: Both O | - |
| P52743 | ZN137_HUMAN Putative zinc finger protein 137 OS=Homo sapiens GN=ZNF137P PE=5 SV=1 | 112 | R | 0.142807 | Q | 0.144682 | -0.001875 | No Change: Both O | - |
| P52744 | ZN138_HUMAN Zinc finger protein 138 OS=Homo sapiens GN=ZNF138 PE=2 SV=2 | 62 | G | 0.517406 | E | 0.550914 | -0.033508 | No Change: Both D | - |
| P17017 | ZNF14_HUMAN Zinc finger protein 14 OS=Homo sapiens GN=ZNF14 PE=2 SV=3 | 274 | T | 0.881195 | S | 0.897553 | -0.016358 | No Change: Both D | - |
| P17017 | ZNF14_HUMAN Zinc finger protein 14 OS=Homo sapiens GN=ZNF14 PE=2 SV=3 | 379 | R | 0.752017 | Q | 0.726231 | 0.025786 | No Change: Both D | - |
| P52738 | ZN140_HUMAN Zinc finger protein 140 OS=Homo sapiens GN=ZNF140 PE=2 SV=2 | 386 | A | 0.367219 | V | 0.276273 | 0.090946 | No Change: Both O | - |
| Q15928 | ZN141_HUMAN Zinc finger protein 141 OS=Homo sapiens GN=ZNF141 PE=2 SV=1 | 349 | R | 0.781757 | K | 0.817461 | -0.035704 | No Change: Both D | - |
| Q15928 | ZN141_HUMAN Zinc finger protein 141 OS=Homo sapiens GN=ZNF141 PE=2 SV=1 | 358 | K | 0.797815 | N | 0.755175 | 0.04264 | No Change: Both D | - |
| Q15928 | ZN141_HUMAN Zinc finger protein 141 OS=Homo sapiens GN=ZNF141 PE=2 SV=1 | 124 | K | 0.601049 | E | 0.591371 | 0.009678 | No Change: Both D | - |
| P52746 | ZN142_HUMAN Zinc finger protein 142 OS=Homo sapiens GN=ZNF142 PE=1 SV=4 | 751 | S | 0.948034 | G | 0.93512 | 0.012914 | No Change: Both D | - |
| P52746 | ZN142_HUMAN Zinc finger protein 142 OS=Homo sapiens GN=ZNF142 PE=1 SV=4 | 956 | L | 0.982877 | H | 0.984796 | -0.001919 | No Change: Both D | - |
| P52746 | ZN142_HUMAN Zinc finger protein 142 OS=Homo sapiens GN=ZNF142 PE=1 SV=4 | 1313 | A | 0.97117 | T | 0.972661 | -0.001491 | No Change: Both D | - |
| P52747 | ZN143_HUMAN Zinc finger protein 143 OS=Homo sapiens GN=ZNF143 PE=1 SV=2 | 561 | E | 0.545113 | Q | 0.523515 | 0.021598 | No Change: Both D | - |
| P52747 | ZN143_HUMAN Zinc finger protein 143 OS=Homo sapiens GN=ZNF143 PE=1 SV=2 | 461 | G | 0.706116 | D | 0.726836 | -0.02072 | No Change: Both D | - |
| Q15072 | OZF_HUMAN Zinc finger protein OZF OS=Homo sapiens GN=ZNF146 PE=1 SV=2 | 8 | R | 0.532188 | K | 0.581849 | -0.049661 | No Change: Both D | - |
| Q13106 | ZN154_HUMAN Zinc finger protein 154 OS=Homo sapiens GN=ZNF154 PE=2 SV=3 | 122 | G | 0.746455 | V | 0.653062 | 0.093393 | No Change: Both D | - |
| Q13106 | ZN154_HUMAN Zinc finger protein 154 OS=Homo sapiens GN=ZNF154 PE=2 SV=3 | 182 | L | 0.545512 | V | 0.506691 | 0.038821 | No Change: Both D | - |
| Q13106 | ZN154_HUMAN Zinc finger protein 154 OS=Homo sapiens GN=ZNF154 PE=2 SV=3 | 384 | P | 0.806792 | L | 0.698467 | 0.108325 | No Change: Both D | - |
| Q13106 | ZN154_HUMAN Zinc finger protein 154 OS=Homo sapiens GN=ZNF154 PE=2 SV=3 | 57 | H | 0.556882 | R | 0.527967 | 0.028915 | No Change: Both D | - |
| Q12901 | ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens GN=ZNF155 PE=2 SV=4 | 474 | H | 0.657122 | R | 0.701043 | -0.043921 | No Change: Both D | A colorectal cancer sample |
| Q12901 | ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens GN=ZNF155 PE=2 SV=4 | 379 | K | 0.39139 | R | 0.343299 | 0.048091 | No Change: Both O | - |
| Q12901 | ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens GN=ZNF155 PE=2 SV=4 | 157 | I | 0.657255 | F | 0.65505 | 0.002205 | No Change: Both D | - |
| Q12901 | ZN155_HUMAN Zinc finger protein 155 OS=Homo sapiens GN=ZNF155 PE=2 SV=4 | 251 | R | 0.485893 | H | 0.481533 | 0.00436 | No Change: Both O | - |
| P17020 | ZNF16_HUMAN Zinc finger protein 16 OS=Homo sapiens GN=ZNF16 PE=1 SV=3 | 105 | E | 0.634943 | K | 0.579362 | 0.055581 | No Change: Both D | - |
| P17020 | ZNF16_HUMAN Zinc finger protein 16 OS=Homo sapiens GN=ZNF16 PE=1 SV=3 | 227 | R | 0.303322 | H | 0.310735 | -0.007413 | No Change: Both O | - |
| Q9HCG1 | ZN160_HUMAN Zinc finger protein 160 OS=Homo sapiens GN=ZNF160 PE=1 SV=3 | 7 | R | 0.225342 | Q | 0.241417 | -0.016075 | No Change: Both O | - |
| Q9HCG1 | ZN160_HUMAN Zinc finger protein 160 OS=Homo sapiens GN=ZNF160 PE=1 SV=3 | 82 | P | 0.604717 | R | 0.562652 | 0.042065 | No Change: Both D | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 24 | R | 0.595913 | C | 0.443361 | 0.152552 | D to O | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 153 | F | 0.91252 | S | 0.954835 | -0.042315 | No Change: Both D | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 342 | T | 0.934875 | I | 0.896412 | 0.038463 | No Change: Both D | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 359 | E | 0.905805 | K | 0.907927 | -0.002122 | No Change: Both D | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 432 | T | 0.490495 | A | 0.416945 | 0.07355 | No Change: Both O | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 483 | T | 0.737485 | I | 0.61082 | 0.126665 | No Change: Both D | - |
| Q9P0L1 | ZN167_HUMAN Zinc finger protein 167 OS=Homo sapiens GN=ZNF167 PE=2 SV=2 | 746 | S | 0.777742 | F | 0.593693 | 0.184049 | No Change: Both D | - |
| Q14929 | ZN169_HUMAN Zinc finger protein 169 OS=Homo sapiens GN=ZNF169 PE=1 SV=3 | 72 | P | 0.68831 | L | 0.566562 | 0.121748 | No Change: Both D | - |
| Q14929 | ZN169_HUMAN Zinc finger protein 169 OS=Homo sapiens GN=ZNF169 PE=1 SV=3 | 381 | R | 0.631368 | C | 0.573713 | 0.057655 | No Change: Both D | - |
| Q14929 | ZN169_HUMAN Zinc finger protein 169 OS=Homo sapiens GN=ZNF169 PE=1 SV=3 | 78 | E | 0.632089 | K | 0.588035 | 0.044054 | No Change: Both D | - |
| Q14929 | ZN169_HUMAN Zinc finger protein 169 OS=Homo sapiens GN=ZNF169 PE=1 SV=3 | 152 | S | 0.958891 | L | 0.924915 | 0.033976 | No Change: Both D | - |
| Q14929 | ZN169_HUMAN Zinc finger protein 169 OS=Homo sapiens GN=ZNF169 PE=1 SV=3 | 596 | Q | 0.839834 | H | 0.822217 | 0.017617 | No Change: Both D | - |
| P17021 | ZNF17_HUMAN Zinc finger protein 17 OS=Homo sapiens GN=ZNF17 PE=2 SV=3 | 148 | T | 0.500343 | K | 0.575036 | -0.074693 | No Change: Both D | - |
| Q9Y473 | ZN175_HUMAN Zinc finger protein 175 OS=Homo sapiens GN=ZNF175 PE=1 SV=1 | 505 | C | 0.597903 | R | 0.672411 | -0.074508 | No Change: Both D | - |
| Q9Y473 | ZN175_HUMAN Zinc finger protein 175 OS=Homo sapiens GN=ZNF175 PE=1 SV=1 | 363 | Y | 0.593363 | N | 0.692844 | -0.099481 | No Change: Both D | - |
| Q13360 | ZN177_HUMAN Zinc finger protein 177 OS=Homo sapiens GN=ZNF177 PE=2 SV=3 | 94 | D | 0.525353 | G | 0.50071 | 0.024643 | No Change: Both D | - |
| Q13360 | ZN177_HUMAN Zinc finger protein 177 OS=Homo sapiens GN=ZNF177 PE=2 SV=3 | 112 | T | 0.49408 | M | 0.45384 | 0.04024 | No Change: Both O | - |
| Q13360 | ZN177_HUMAN Zinc finger protein 177 OS=Homo sapiens GN=ZNF177 PE=2 SV=3 | 295 | I | 0.35202 | F | 0.37328 | -0.02126 | No Change: Both O | - |
| P17022 | ZNF18_HUMAN Zinc finger protein 18 OS=Homo sapiens GN=ZNF18 PE=2 SV=2 | 210 | Q | 0.719139 | R | 0.713595 | 0.005544 | No Change: Both D | - |
| P17022 | ZNF18_HUMAN Zinc finger protein 18 OS=Homo sapiens GN=ZNF18 PE=2 SV=2 | 240 | M | 0.227965 | I | 0.146845 | 0.08112 | No Change: Both O | - |
| Q9UJW8 | ZN180_HUMAN Zinc finger protein 180 OS=Homo sapiens GN=ZNF180 PE=1 SV=2 | 41 | A | 0.90394 | V | 0.878402 | 0.025538 | No Change: Both D | - |
| Q9UJW8 | ZN180_HUMAN Zinc finger protein 180 OS=Homo sapiens GN=ZNF180 PE=1 SV=2 | 89 | W | 0.458346 | C | 0.500066 | -0.04172 | O to D | - |
| Q9UJW8 | ZN180_HUMAN Zinc finger protein 180 OS=Homo sapiens GN=ZNF180 PE=1 SV=2 | 272 | C | 0.452755 | S | 0.611684 | -0.158929 | O to D | - |
| Q99676 | ZN184_HUMAN Zinc finger protein 184 OS=Homo sapiens GN=ZNF184 PE=1 SV=4 | 27 | A | 0.303237 | S | 0.422505 | -0.119268 | No Change: Both O | - |
| Q16670 | ZN187_HUMAN Zinc finger protein 187 OS=Homo sapiens GN=ZNF187 PE=2 SV=2 | 220 | R | 0.844689 | S | 0.87243 | -0.027741 | No Change: Both D | - |
| Q16670 | ZN187_HUMAN Zinc finger protein 187 OS=Homo sapiens GN=ZNF187 PE=2 SV=2 | 59 | Y | 0.778492 | C | 0.838956 | -0.060464 | No Change: Both D | - |
| Q16670 | ZN187_HUMAN Zinc finger protein 187 OS=Homo sapiens GN=ZNF187 PE=2 SV=2 | 73 | R | 0.536366 | Q | 0.564885 | -0.028519 | No Change: Both D | - |
| Q16670 | ZN187_HUMAN Zinc finger protein 187 OS=Homo sapiens GN=ZNF187 PE=2 SV=2 | 83 | E | 0.578317 | K | 0.551259 | 0.027058 | No Change: Both D | - |
| O75820 | ZN189_HUMAN Zinc finger protein 189 OS=Homo sapiens GN=ZNF189 PE=2 SV=2 | 221 | R | 0.538725 | K | 0.549347 | -0.010622 | No Change: Both D | - |
| P17023 | ZNF19_HUMAN Zinc finger protein 19 OS=Homo sapiens GN=ZNF19 PE=2 SV=4 | 218 | Q | 0.516015 | H | 0.494914 | 0.021101 | D to O | - |
| P17023 | ZNF19_HUMAN Zinc finger protein 19 OS=Homo sapiens GN=ZNF19 PE=2 SV=4 | 224 | R | 0.402613 | Q | 0.408438 | -0.005825 | No Change: Both O | - |
| Q15776 | ZN192_HUMAN Zinc finger protein 192 OS=Homo sapiens GN=ZNF192 PE=1 SV=2 | 163 | P | 0.821716 | L | 0.756362 | 0.065354 | No Change: Both D | - |
| P98182 | ZN200_HUMAN Zinc finger protein 200 OS=Homo sapiens GN=ZNF200 PE=2 SV=2 | 140 | T | 0.799607 | M | 0.802608 | -0.003001 | No Change: Both D | - |
| O95125 | ZN202_HUMAN Zinc finger protein 202 OS=Homo sapiens GN=ZNF202 PE=1 SV=4 | 154 | V | 0.917852 | A | 0.907253 | 0.010599 | No Change: Both D | - |
| O95125 | ZN202_HUMAN Zinc finger protein 202 OS=Homo sapiens GN=ZNF202 PE=1 SV=4 | 533 | G | 0.36385 | A | 0.290695 | 0.073155 | No Change: Both O | - |
| O95201 | ZN205_HUMAN Zinc finger protein 205 OS=Homo sapiens GN=ZNF205 PE=1 SV=2 | 43 | T | 0.957507 | A | 0.960912 | -0.003405 | No Change: Both D | - |
| O95201 | ZN205_HUMAN Zinc finger protein 205 OS=Homo sapiens GN=ZNF205 PE=1 SV=2 | 255 | A | 0.987333 | D | 0.988939 | -0.001606 | No Change: Both D | - |
| O43670 | ZN207_HUMAN Zinc finger protein 207 OS=Homo sapiens GN=ZNF207 PE=1 SV=1 | 224 | A | 0.989232 | S | 0.990947 | -0.001715 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 282 | E | 0.713674 | K | 0.731381 | -0.017707 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 298 | S | 0.692433 | L | 0.533855 | 0.158578 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 456 | E | 0.662092 | Q | 0.576707 | 0.085385 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 540 | K | 0.689738 | E | 0.669431 | 0.020307 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 907 | D | 0.7025 | G | 0.718019 | -0.015519 | No Change: Both D | - |
| O43345 | ZN208_HUMAN Zinc finger protein 208 OS=Homo sapiens GN=ZNF208 PE=2 SV=1 | 1165 | L | 0.797474 | H | 0.849308 | -0.051834 | No Change: Both D | - |
| Q13398 | ZN211_HUMAN Zinc finger protein 211 OS=Homo sapiens GN=ZNF211 PE=2 SV=2 | 110 | D | 0.599563 | N | 0.598684 | 8.79E-04 | No Change: Both D | - |
| Q13398 | ZN211_HUMAN Zinc finger protein 211 OS=Homo sapiens GN=ZNF211 PE=2 SV=2 | 314 | A | 0.381827 | V | 0.332913 | 0.048914 | No Change: Both O | - |
| Q9UDV6 | ZN212_HUMAN Zinc finger protein 212 OS=Homo sapiens GN=ZNF212 PE=1 SV=3 | 293 | H | 0.933302 | Y | 0.912465 | 0.020837 | No Change: Both D | - |
| Q9UL59 | ZN214_HUMAN Zinc finger protein 214 OS=Homo sapiens GN=ZNF214 PE=2 SV=2 | 128 | L | 0.438861 | H | 0.526452 | -0.087591 | O to D | - |
| Q9UL59 | ZN214_HUMAN Zinc finger protein 214 OS=Homo sapiens GN=ZNF214 PE=2 SV=2 | 185 | I | 0.334596 | R | 0.472213 | -0.137617 | No Change: Both O | - |
| Q9UL59 | ZN214_HUMAN Zinc finger protein 214 OS=Homo sapiens GN=ZNF214 PE=2 SV=2 | 66 | Y | 0.105425 | C | 0.092657 | 0.012768 | No Change: Both O | - |
| Q9UL59 | ZN214_HUMAN Zinc finger protein 214 OS=Homo sapiens GN=ZNF214 PE=2 SV=2 | 160 | H | 0.519876 | R | 0.566059 | -0.046183 | No Change: Both D | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 376 | M | 0.533398 | V | 0.453788 | 0.07961 | D to O | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 119 | M | 0.408261 | V | 0.357695 | 0.050566 | No Change: Both O | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 36 | N | 0.638871 | S | 0.716964 | -0.078093 | No Change: Both D | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 38 | V | 0.638451 | I | 0.583872 | 0.054579 | No Change: Both D | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 263 | S | 0.609312 | F | 0.437208 | 0.172104 | D to O | - |
| Q9UL58 | ZN215_HUMAN Zinc finger protein 215 OS=Homo sapiens GN=ZNF215 PE=2 SV=2 | 323 | V | 0.46264 | L | 0.447604 | 0.015036 | No Change: Both O | - |
| O75362 | ZN217_HUMAN Zinc finger protein 217 OS=Homo sapiens GN=ZNF217 PE=1 SV=1 | 323 | D | 0.912958 | N | 0.904853 | 0.008105 | No Change: Both D | A colorectal cancer sample |
| O75362 | ZN217_HUMAN Zinc finger protein 217 OS=Homo sapiens GN=ZNF217 PE=1 SV=1 | 739 | V | 0.582593 | I | 0.546388 | 0.036205 | No Change: Both D | - |
| O75362 | ZN217_HUMAN Zinc finger protein 217 OS=Homo sapiens GN=ZNF217 PE=1 SV=1 | 889 | D | 0.751286 | G | 0.732784 | 0.018502 | No Change: Both D | - |
| P17026 | ZNF22_HUMAN Zinc finger protein 22 OS=Homo sapiens GN=ZNF22 PE=1 SV=3 | 129 | H | 0.767055 | L | 0.68436 | 0.082695 | No Change: Both D | A breast cancer sample |
| P17026 | ZNF22_HUMAN Zinc finger protein 22 OS=Homo sapiens GN=ZNF22 PE=1 SV=3 | 65 | S | 0.8999 | G | 0.852737 | 0.047163 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 337 | A | 0.549983 | P | 0.644099 | -0.094116 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 519 | S | 0.88147 | T | 0.847617 | 0.033853 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 557 | G | 0.547464 | R | 0.560922 | -0.013458 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 165 | V | 0.626243 | M | 0.669628 | -0.043385 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 179 | F | 0.651581 | I | 0.629708 | 0.021873 | No Change: Both D | - |
| Q9UK13 | ZN221_HUMAN Zinc finger protein 221 OS=Homo sapiens GN=ZNF221 PE=2 SV=3 | 256 | C | 0.661895 | R | 0.727031 | -0.065136 | No Change: Both D | - |
| Q9UK12 | ZN222_HUMAN Zinc finger protein 222 OS=Homo sapiens GN=ZNF222 PE=2 SV=2 | 50 | K | 0.374598 | E | 0.398114 | -0.023516 | No Change: Both O | - |
| Q9UK12 | ZN222_HUMAN Zinc finger protein 222 OS=Homo sapiens GN=ZNF222 PE=2 SV=2 | 58 | V | 0.600393 | F | 0.582883 | 0.01751 | No Change: Both D | - |
| Q9UK12 | ZN222_HUMAN Zinc finger protein 222 OS=Homo sapiens GN=ZNF222 PE=2 SV=2 | 263 | G | 0.340321 | D | 0.332524 | 0.007797 | No Change: Both O | - |
| Q9UK12 | ZN222_HUMAN Zinc finger protein 222 OS=Homo sapiens GN=ZNF222 PE=2 SV=2 | 82 | R | 0.706274 | G | 0.6894 | 0.016874 | No Change: Both D | - |
| Q9UK11 | ZN223_HUMAN Zinc finger protein 223 OS=Homo sapiens GN=ZNF223 PE=2 SV=2 | 60 | L | 0.240869 | I | 0.221297 | 0.019572 | No Change: Both O | - |
| Q9UK11 | ZN223_HUMAN Zinc finger protein 223 OS=Homo sapiens GN=ZNF223 PE=2 SV=2 | 138 | L | 0.783811 | I | 0.791303 | -0.007492 | No Change: Both D | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 640 | K | 0.727543 | E | 0.724281 | 0.003262 | No Change: Both D | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 162 | H | 0.594267 | L | 0.463178 | 0.131089 | D to O | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 118 | M | 0.560712 | V | 0.485857 | 0.074855 | D to O | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 438 | K | 0.504823 | N | 0.427903 | 0.07692 | D to O | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 506 | H | 0.788406 | D | 0.777725 | 0.010681 | No Change: Both D | - |
| Q9NZL3 | ZN224_HUMAN Zinc finger protein 224 OS=Homo sapiens GN=ZNF224 PE=1 SV=3 | 447 | Q | 0.499076 | H | 0.510084 | -0.011008 | O to D | - |
| Q9UK10 | ZN225_HUMAN Zinc finger protein 225 OS=Homo sapiens GN=ZNF225 PE=1 SV=2 | 50 | Q | 0.406264 | R | 0.411541 | -0.005277 | No Change: Both O | - |
| Q9UK10 | ZN225_HUMAN Zinc finger protein 225 OS=Homo sapiens GN=ZNF225 PE=1 SV=2 | 679 | T | 0.914842 | S | 0.939258 | -0.024416 | No Change: Both D | - |
| Q9UJW7 | ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens GN=ZNF229 PE=2 SV=3 | 156 | S | 0.435673 | F | 0.254526 | 0.181147 | No Change: Both O | - |
| Q9UJW7 | ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens GN=ZNF229 PE=2 SV=3 | 337 | R | 0.569178 | C | 0.404143 | 0.165035 | D to O | - |
| Q9UJW7 | ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens GN=ZNF229 PE=2 SV=3 | 662 | G | 0.640812 | R | 0.665532 | -0.02472 | No Change: Both D | - |
| Q9UJW7 | ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens GN=ZNF229 PE=2 SV=3 | 804 | G | 0.35501 | R | 0.356574 | -0.001564 | No Change: Both O | - |
| Q9UJW7 | ZN229_HUMAN Zinc finger protein 229 OS=Homo sapiens GN=ZNF229 PE=2 SV=3 | 417 | S | 0.537043 | N | 0.43642 | 0.100623 | D to O | - |
| P17027 | ZNF23_HUMAN Zinc finger protein 23 OS=Homo sapiens GN=ZNF23 PE=2 SV=3 | 28 | S | 0.713579 | G | 0.684174 | 0.029405 | No Change: Both D | - |
| Q9UIE0 | ZN230_HUMAN Zinc finger protein 230 OS=Homo sapiens GN=ZNF230 PE=2 SV=3 | 441 | D | 0.847658 | E | 0.851505 | -0.003847 | No Change: Both D | - |
| Q9UIE0 | ZN230_HUMAN Zinc finger protein 230 OS=Homo sapiens GN=ZNF230 PE=2 SV=3 | 310 | S | 0.556836 | C | 0.406445 | 0.150391 | D to O | - |
| Q9UIE0 | ZN230_HUMAN Zinc finger protein 230 OS=Homo sapiens GN=ZNF230 PE=2 SV=3 | 434 | F | 0.849702 | Y | 0.837858 | 0.011844 | No Change: Both D | - |
| Q9UNY5 | ZN232_HUMAN Zinc finger protein 232 OS=Homo sapiens GN=ZNF232 PE=2 SV=1 | 123 | A | 0.671902 | V | 0.660553 | 0.011349 | No Change: Both D | A colorectal cancer sample |
| A6NK53 | ZN233_HUMAN Zinc finger protein 233 OS=Homo sapiens GN=ZNF233 PE=2 SV=3 | 247 | S | 0.871091 | P | 0.831766 | 0.039325 | No Change: Both D | - |
| A6NK53 | ZN233_HUMAN Zinc finger protein 233 OS=Homo sapiens GN=ZNF233 PE=2 SV=3 | 531 | K | 0.756467 | T | 0.702088 | 0.054379 | No Change: Both D | - |
| Q14588 | ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens GN=ZNF234 PE=2 SV=3 | 16 | V | 0.139098 | I | 0.106624 | 0.032474 | No Change: Both O | - |
| Q14588 | ZN234_HUMAN Zinc finger protein 234 OS=Homo sapiens GN=ZNF234 PE=2 SV=3 | 208 | V | 0.36363 | M | 0.447618 | -0.083988 | No Change: Both O | - |
| Q14590 | ZN235_HUMAN Zinc finger protein 235 OS=Homo sapiens GN=ZNF235 PE=2 SV=3 | 296 | H | 0.804508 | P | 0.83753 | -0.033022 | No Change: Both D | - |
| Q9UL36 | ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens GN=ZNF236 PE=2 SV=2 | 166 | S | 0.833628 | L | 0.720421 | 0.113207 | No Change: Both D | - |
| Q9UL36 | ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens GN=ZNF236 PE=2 SV=2 | 614 | P | 0.400139 | S | 0.372007 | 0.028132 | No Change: Both O | - |
| Q9UL36 | ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens GN=ZNF236 PE=2 SV=2 | 643 | S | 0.230214 | G | 0.189229 | 0.040985 | No Change: Both O | - |
| Q9UL36 | ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens GN=ZNF236 PE=2 SV=2 | 818 | A | 0.798566 | T | 0.803698 | -0.005132 | No Change: Both D | - |
| Q9UL36 | ZN236_HUMAN Zinc finger protein 236 OS=Homo sapiens GN=ZNF236 PE=2 SV=2 | 613 | I | 0.428675 | V | 0.450118 | -0.021443 | No Change: Both O | - |
| Q99592 | ZN238_HUMAN Zinc finger protein 238 OS=Homo sapiens GN=ZNF238 PE=1 SV=1 | 132 | E | 0.967352 | G | 0.951257 | 0.016095 | No Change: Both D | - |
| Q16600 | ZN239_HUMAN Zinc finger protein 239 OS=Homo sapiens GN=ZNF239 PE=1 SV=3 | 172 | A | 0.683482 | G | 0.745946 | -0.062464 | No Change: Both D | - |
| Q16600 | ZN239_HUMAN Zinc finger protein 239 OS=Homo sapiens GN=ZNF239 PE=1 SV=3 | 209 | C | 0.745611 | G | 0.779662 | -0.034051 | No Change: Both D | - |
| Q16600 | ZN239_HUMAN Zinc finger protein 239 OS=Homo sapiens GN=ZNF239 PE=1 SV=3 | 266 | D | 0.52678 | E | 0.552417 | -0.025637 | No Change: Both D | - |
| P17028 | ZNF24_HUMAN Zinc finger protein 24 OS=Homo sapiens GN=ZNF24 PE=1 SV=4 | 220 | N | 0.496871 | S | 0.555816 | -0.058945 | O to D | - |
| P17028 | ZNF24_HUMAN Zinc finger protein 24 OS=Homo sapiens GN=ZNF24 PE=1 SV=4 | 331 | G | 0.54067 | W | 0.332613 | 0.208057 | D to O | - |
| Q8NDW4 | ZN248_HUMAN Zinc finger protein 248 OS=Homo sapiens GN=ZNF248 PE=1 SV=1 | 218 | K | 0.618745 | E | 0.634682 | -0.015937 | No Change: Both D | - |
| P17030 | ZNF25_HUMAN Zinc finger protein 25 OS=Homo sapiens GN=ZNF25 PE=2 SV=2 | 21 | E | 0.290949 | K | 0.290649 | 3.00E-04 | No Change: Both O | A breast cancer sample |
| P17030 | ZNF25_HUMAN Zinc finger protein 25 OS=Homo sapiens GN=ZNF25 PE=2 SV=2 | 81 | D | 0.317748 | G | 0.300494 | 0.017254 | No Change: Both O | A breast cancer sample |
| P17030 | ZNF25_HUMAN Zinc finger protein 25 OS=Homo sapiens GN=ZNF25 PE=2 SV=2 | 453 | N | 0.93768 | K | 0.964903 | -0.027223 | No Change: Both D | - |
| Q8WUN3 | ZN252_HUMAN Zinc finger protein 252 OS=Homo sapiens GN=ZNF252 PE=5 SV=2 | 167 | C | 0.599619 | R | 0.73066 | -0.131041 | No Change: Both D | - |
| Q8WUN3 | ZN252_HUMAN Zinc finger protein 252 OS=Homo sapiens GN=ZNF252 PE=5 SV=2 | 189 | T | 0.651511 | P | 0.685914 | -0.034403 | No Change: Both D | - |
| O75437 | ZN254_HUMAN Zinc finger protein 254 OS=Homo sapiens GN=ZNF254 PE=1 SV=3 | 93 | D | 0.42846 | G | 0.409513 | 0.018947 | No Change: Both O | - |
| O75437 | ZN254_HUMAN Zinc finger protein 254 OS=Homo sapiens GN=ZNF254 PE=1 SV=3 | 386 | A | 0.382146 | T | 0.475618 | -0.093472 | No Change: Both O | - |
| O75437 | ZN254_HUMAN Zinc finger protein 254 OS=Homo sapiens GN=ZNF254 PE=1 SV=3 | 457 | T | 0.638993 | A | 0.591669 | 0.047324 | No Change: Both D | - |
| O75437 | ZN254_HUMAN Zinc finger protein 254 OS=Homo sapiens GN=ZNF254 PE=1 SV=3 | 594 | V | 0.567088 | I | 0.55882 | 0.008268 | No Change: Both D | - |
| O75437 | ZN254_HUMAN Zinc finger protein 254 OS=Homo sapiens GN=ZNF254 PE=1 SV=3 | 537 | K | 0.658785 | N | 0.583035 | 0.07575 | No Change: Both D | - |
| Q9Y2P7 | ZN256_HUMAN Zinc finger protein 256 OS=Homo sapiens GN=ZNF256 PE=1 SV=2 | 304 | F | 0.3217 | I | 0.34462 | -0.02292 | No Change: Both O | - |
| O75312 | ZPR1_HUMAN Zinc finger protein ZPR1 OS=Homo sapiens GN=ZNF259 PE=1 SV=1 | 264 | A | 0.56654 | V | 0.507536 | 0.059004 | No Change: Both D | - |
| O14978 | ZN263_HUMAN Zinc finger protein 263 OS=Homo sapiens GN=ZNF263 PE=2 SV=2 | 310 | C | 0.75827 | S | 0.847206 | -0.088936 | No Change: Both D | - |
| O14978 | ZN263_HUMAN Zinc finger protein 263 OS=Homo sapiens GN=ZNF263 PE=2 SV=2 | 534 | V | 0.720818 | I | 0.721647 | -8.29E-04 | No Change: Both D | - |
| O14978 | ZN263_HUMAN Zinc finger protein 263 OS=Homo sapiens GN=ZNF263 PE=2 SV=2 | 646 | R | 0.871945 | Q | 0.851001 | 0.020944 | No Change: Both D | - |
| O43296 | ZN264_HUMAN Zinc finger protein 264 OS=Homo sapiens GN=ZNF264 PE=1 SV=1 | 181 | R | 0.899592 | T | 0.876004 | 0.023588 | No Change: Both D | - |
| O43296 | ZN264_HUMAN Zinc finger protein 264 OS=Homo sapiens GN=ZNF264 PE=1 SV=1 | 183 | R | 0.892829 | H | 0.873951 | 0.018878 | No Change: Both D | - |
| Q14584 | ZN266_HUMAN Zinc finger protein 266 OS=Homo sapiens GN=ZNF266 PE=2 SV=2 | 519 | P | 0.914921 | L | 0.869629 | 0.045292 | No Change: Both D | - |
| Q14586 | ZN267_HUMAN Zinc finger protein 267 OS=Homo sapiens GN=ZNF267 PE=1 SV=3 | 257 | M | 0.844165 | V | 0.822768 | 0.021397 | No Change: Both D | - |
| Q14586 | ZN267_HUMAN Zinc finger protein 267 OS=Homo sapiens GN=ZNF267 PE=1 SV=3 | 350 | C | 0.457414 | Y | 0.431757 | 0.025657 | No Change: Both O | - |
| Q14587 | ZN268_HUMAN Zinc finger protein 268 OS=Homo sapiens GN=ZNF268 PE=1 SV=2 | 175 | T | 0.527972 | M | 0.487769 | 0.040203 | D to O | - |
| Q14593 | ZN273_HUMAN Zinc finger protein 273 OS=Homo sapiens GN=ZNF273 PE=2 SV=3 | 454 | G | 0.481236 | E | 0.556487 | -0.075251 | O to D | - |
| Q14593 | ZN273_HUMAN Zinc finger protein 273 OS=Homo sapiens GN=ZNF273 PE=2 SV=3 | 461 | E | 0.501978 | D | 0.42515 | 0.076828 | D to O | - |
| Q96GC6 | ZN274_HUMAN Neurotrophin receptor-interacting factor homolog OS=Homo sapiens GN=ZNF274 PE=1 SV=2 | 147 | V | 0.88578 | I | 0.882751 | 0.003029 | No Change: Both D | - |
| Q8N554 | ZN276_HUMAN Zinc finger protein 276 OS=Homo sapiens GN=ZNF276 PE=1 SV=4 | 275 | R | 0.659952 | W | 0.499439 | 0.160513 | D to O | - |
| Q8N554 | ZN276_HUMAN Zinc finger protein 276 OS=Homo sapiens GN=ZNF276 PE=1 SV=4 | 605 | E | 0.990872 | D | 0.988776 | 0.002096 | No Change: Both D | - |
| Q8N554 | ZN276_HUMAN Zinc finger protein 276 OS=Homo sapiens GN=ZNF276 PE=1 SV=4 | 263 | W | 0.381664 | R | 0.547152 | -0.165488 | O to D | - |
| Q8N554 | ZN276_HUMAN Zinc finger protein 276 OS=Homo sapiens GN=ZNF276 PE=1 SV=4 | 351 | R | 0.971398 | W | 0.936652 | 0.034746 | No Change: Both D | - |
| Q9NRM2 | ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens GN=ZNF277 PE=2 SV=2 | 332 | I | 0.299116 | L | 0.355865 | -0.056749 | No Change: Both O | A breast cancer sample |
| Q9NRM2 | ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens GN=ZNF277 PE=2 SV=2 | 445 | L | 0.520106 | F | 0.424164 | 0.095942 | D to O | A breast cancer sample |
| Q9NRM2 | ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens GN=ZNF277 PE=2 SV=2 | 364 | V | 0.200353 | M | 0.258931 | -0.058578 | No Change: Both O | - |
| Q9NRM2 | ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens GN=ZNF277 PE=2 SV=2 | 174 | V | 0.273309 | I | 0.277338 | -0.004029 | No Change: Both O | - |
| P17035 | ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens GN=ZNF28 PE=2 SV=5 | 179 | R | 0.66532 | G | 0.641106 | 0.024214 | No Change: Both D | - |
| P17035 | ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens GN=ZNF28 PE=2 SV=5 | 465 | K | 0.678222 | Q | 0.639291 | 0.038931 | No Change: Both D | - |
| P17035 | ZNF28_HUMAN Zinc finger protein 28 OS=Homo sapiens GN=ZNF28 PE=2 SV=5 | 524 | M | 0.470816 | T | 0.535097 | -0.064281 | O to D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 71 | K | 0.71821 | N | 0.699445 | 0.018765 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 136 | N | 0.941242 | S | 0.961172 | -0.01993 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 137 | Y | 0.937766 | S | 0.973158 | -0.035392 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 246 | N | 0.586995 | S | 0.622876 | -0.035881 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 249 | G | 0.559132 | A | 0.546286 | 0.012846 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 276 | L | 0.256541 | F | 0.244199 | 0.012342 | No Change: Both O | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 278 | N | 0.242338 | D | 0.258795 | -0.016457 | No Change: Both O | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 486 | F | 0.708539 | L | 0.732009 | -0.02347 | No Change: Both D | - |
| P59817 | Z280A_HUMAN Zinc finger protein 280A OS=Homo sapiens GN=ZNF280A PE=2 SV=3 | 488 | R | 0.731075 | S | 0.797001 | -0.065926 | No Change: Both D | - |
| Q86YH2 | Z280B_HUMAN Zinc finger protein 280B OS=Homo sapiens GN=ZNF280B PE=1 SV=2 | 256 | E | 0.59197 | A | 0.510897 | 0.081073 | No Change: Both D | - |
| Q86YH2 | Z280B_HUMAN Zinc finger protein 280B OS=Homo sapiens GN=ZNF280B PE=1 SV=2 | 522 | V | 0.944901 | G | 0.957759 | -0.012858 | No Change: Both D | - |
| Q6N043 | Z280D_HUMAN Zinc finger protein 280D OS=Homo sapiens GN=ZNF280D PE=1 SV=3 | 568 | V | 0.997459 | I | 0.997824 | -3.65E-04 | No Change: Both D | - |
| Q6N043 | Z280D_HUMAN Zinc finger protein 280D OS=Homo sapiens GN=ZNF280D PE=1 SV=3 | 778 | A | 0.993785 | V | 0.990825 | 0.00296 | No Change: Both D | - |
| Q6N043 | Z280D_HUMAN Zinc finger protein 280D OS=Homo sapiens GN=ZNF280D PE=1 SV=3 | 781 | K | 0.992204 | I | 0.984341 | 0.007863 | No Change: Both D | - |
| Q6N043 | Z280D_HUMAN Zinc finger protein 280D OS=Homo sapiens GN=ZNF280D PE=1 SV=3 | 785 | G | 0.989781 | A | 0.990106 | -3.25E-04 | No Change: Both D | - |
| Q9Y2X9 | ZN281_HUMAN Zinc finger protein 281 OS=Homo sapiens GN=ZNF281 PE=1 SV=1 | 527 | I | 0.734846 | T | 0.810507 | -0.075661 | No Change: Both D | A breast cancer sample |
| Q9UDV7 | ZN282_HUMAN Zinc finger protein 282 OS=Homo sapiens GN=ZNF282 PE=1 SV=3 | 273 | M | 0.947294 | V | 0.94104 | 0.006254 | No Change: Both D | - |
| Q8N7M2 | ZN283_HUMAN Zinc finger protein 283 OS=Homo sapiens GN=ZNF283 PE=2 SV=4 | 629 | R | 0.528011 | H | 0.524075 | 0.003936 | No Change: Both D | - |
| Q8N7M2 | ZN283_HUMAN Zinc finger protein 283 OS=Homo sapiens GN=ZNF283 PE=2 SV=4 | 646 | R | 0.584449 | I | 0.442835 | 0.141614 | D to O | - |
| Q8N7M2 | ZN283_HUMAN Zinc finger protein 283 OS=Homo sapiens GN=ZNF283 PE=2 SV=4 | 314 | T | 0.466214 | I | 0.344469 | 0.121745 | No Change: Both O | - |
| Q8N7M2 | ZN283_HUMAN Zinc finger protein 283 OS=Homo sapiens GN=ZNF283 PE=2 SV=4 | 638 | C | 0.340502 | R | 0.518961 | -0.178459 | O to D | - |
| Q8N7M2 | ZN283_HUMAN Zinc finger protein 283 OS=Homo sapiens GN=ZNF283 PE=2 SV=4 | 638 | C | 0.340502 | Y | 0.371281 | -0.030779 | No Change: Both O | - |
| Q2VY69 | ZN284_HUMAN Zinc finger protein 284 OS=Homo sapiens GN=ZNF284 PE=2 SV=1 | 546 | K | 0.943405 | E | 0.947354 | -0.003949 | No Change: Both D | - |
| Q2VY69 | ZN284_HUMAN Zinc finger protein 284 OS=Homo sapiens GN=ZNF284 PE=2 SV=1 | 577 | E | 0.592246 | K | 0.614247 | -0.022001 | No Change: Both D | - |
| Q96NJ3 | ZN285_HUMAN Zinc finger protein 285 OS=Homo sapiens GN=ZNF285 PE=2 SV=2 | 208 | N | 0.825726 | S | 0.844349 | -0.018623 | No Change: Both D | - |
| Q96NJ3 | ZN285_HUMAN Zinc finger protein 285 OS=Homo sapiens GN=ZNF285 PE=2 SV=2 | 536 | R | 0.437099 | G | 0.411422 | 0.025677 | No Change: Both O | - |
| Q9HBT8 | Z286A_HUMAN Zinc finger protein 286A OS=Homo sapiens GN=ZNF286A PE=2 SV=1 | 90 | Y | 0.746245 | H | 0.77763 | -0.031385 | No Change: Both D | - |
| Q9HBT7 | ZN287_HUMAN Zinc finger protein 287 OS=Homo sapiens GN=ZNF287 PE=2 SV=1 | 274 | K | 0.537504 | T | 0.475531 | 0.061973 | D to O | - |
| O60281 | ZN292_HUMAN Zinc finger protein 292 OS=Homo sapiens GN=ZNF292 PE=1 SV=3 | 1740 | I | 0.568223 | V | 0.572233 | -0.00401 | No Change: Both D | - |
| O60281 | ZN292_HUMAN Zinc finger protein 292 OS=Homo sapiens GN=ZNF292 PE=1 SV=3 | 2045 | V | 0.863212 | I | 0.848851 | 0.014361 | No Change: Both D | - |
| Q9ULJ3 | ZN295_HUMAN Zinc finger protein 295 OS=Homo sapiens GN=ZNF295 PE=1 SV=2 | 185 | N | 0.896071 | S | 0.915806 | -0.019735 | No Change: Both D | - |
| Q9ULJ3 | ZN295_HUMAN Zinc finger protein 295 OS=Homo sapiens GN=ZNF295 PE=1 SV=2 | 218 | K | 0.737946 | Q | 0.685279 | 0.052667 | No Change: Both D | - |
| P17036 | ZNF3_HUMAN Zinc finger protein 3 OS=Homo sapiens GN=ZNF3 PE=1 SV=3 | 102 | I | 0.733896 | T | 0.805447 | -0.071551 | No Change: Both D | - |
| P17039 | ZNF30_HUMAN Zinc finger protein 30 OS=Homo sapiens GN=ZNF30 PE=2 SV=5 | 123 | Q | 0.871121 | R | 0.865046 | 0.006075 | No Change: Both D | - |
| P17039 | ZNF30_HUMAN Zinc finger protein 30 OS=Homo sapiens GN=ZNF30 PE=2 SV=5 | 190 | A | 0.358345 | T | 0.396546 | -0.038201 | No Change: Both O | - |
| P17039 | ZNF30_HUMAN Zinc finger protein 30 OS=Homo sapiens GN=ZNF30 PE=2 SV=5 | 379 | R | 0.34314 | K | 0.387713 | -0.044573 | No Change: Both O | - |
| P17039 | ZNF30_HUMAN Zinc finger protein 30 OS=Homo sapiens GN=ZNF30 PE=2 SV=5 | 400 | Y | 0.533334 | C | 0.585672 | -0.052338 | No Change: Both D | - |
| Q96RE9 | ZN300_HUMAN Zinc finger protein 300 OS=Homo sapiens GN=ZNF300 PE=2 SV=1 | 336 | Q | 0.574783 | H | 0.553075 | 0.021708 | No Change: Both D | - |
| Q9HCX3 | ZN304_HUMAN Zinc finger protein 304 OS=Homo sapiens GN=ZNF304 PE=2 SV=2 | 121 | L | 0.333617 | P | 0.460198 | -0.126581 | No Change: Both O | - |
| Q9HCX3 | ZN304_HUMAN Zinc finger protein 304 OS=Homo sapiens GN=ZNF304 PE=2 SV=2 | 367 | K | 0.564398 | E | 0.552945 | 0.011453 | No Change: Both D | - |
| Q5JNZ3 | ZN311_HUMAN Zinc finger protein 311 OS=Homo sapiens GN=ZNF311 PE=2 SV=2 | 486 | R | 0.913268 | C | 0.881877 | 0.031391 | No Change: Both D | - |
| Q5JNZ3 | ZN311_HUMAN Zinc finger protein 311 OS=Homo sapiens GN=ZNF311 PE=2 SV=2 | 511 | K | 0.65128 | Q | 0.629942 | 0.021338 | No Change: Both D | - |
| Q96PQ6 | ZN317_HUMAN Zinc finger protein 317 OS=Homo sapiens GN=ZNF317 PE=2 SV=2 | 19 | Q | 0.857842 | H | 0.818756 | 0.039086 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 812 | N | 0.836996 | S | 0.879467 | -0.042471 | No Change: Both D | A breast cancer sample |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 1274 | G | 0.987714 | R | 0.989246 | -0.001532 | No Change: Both D | A breast cancer sample |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 407 | S | 0.91381 | I | 0.83575 | 0.07806 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 870 | L | 0.797265 | V | 0.815107 | -0.017842 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 1292 | T | 0.993828 | I | 0.99131 | 0.002518 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 1580 | A | 0.76036 | T | 0.773983 | -0.013623 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 1583 | T | 0.800385 | I | 0.733212 | 0.067173 | No Change: Both D | - |
| Q5VUA4 | ZN318_HUMAN Zinc finger protein 318 OS=Homo sapiens GN=ZNF318 PE=1 SV=2 | 1797 | V | 0.649472 | A | 0.654433 | -0.004961 | No Change: Both D | - |
| Q96LW9 | ZN323_HUMAN Zinc finger protein 323 OS=Homo sapiens GN=ZNF323 PE=2 SV=2 | 50 | T | 0.578613 | S | 0.660828 | -0.082215 | No Change: Both D | - |
| Q96LW9 | ZN323_HUMAN Zinc finger protein 323 OS=Homo sapiens GN=ZNF323 PE=2 SV=2 | 205 | K | 0.904392 | R | 0.895341 | 0.009051 | No Change: Both D | - |
| Q96LW9 | ZN323_HUMAN Zinc finger protein 323 OS=Homo sapiens GN=ZNF323 PE=2 SV=2 | 128 | A | 0.91097 | P | 0.943935 | -0.032965 | No Change: Both D | - |
| Q96LW9 | ZN323_HUMAN Zinc finger protein 323 OS=Homo sapiens GN=ZNF323 PE=2 SV=2 | 222 | R | 0.94139 | Q | 0.941699 | -3.09E-04 | No Change: Both D | - |
| Q96LW9 | ZN323_HUMAN Zinc finger protein 323 OS=Homo sapiens GN=ZNF323 PE=2 SV=2 | 365 | G | 0.248148 | E | 0.295934 | -0.047786 | No Change: Both O | - |
| Q6AW86 | Z324B_HUMAN Zinc finger protein 324B OS=Homo sapiens GN=ZNF324B PE=2 SV=1 | 63 | S | 0.499167 | G | 0.457184 | 0.041983 | No Change: Both O | - |
| Q86UD4 | ZN329_HUMAN Zinc finger protein 329 OS=Homo sapiens GN=ZNF329 PE=2 SV=2 | 182 | N | 0.691731 | D | 0.643105 | 0.048626 | No Change: Both D | - |
| Q86UD4 | ZN329_HUMAN Zinc finger protein 329 OS=Homo sapiens GN=ZNF329 PE=2 SV=2 | 99 | S | 0.652229 | N | 0.597627 | 0.054602 | No Change: Both D | - |
| Q9Y3S2 | ZN330_HUMAN Zinc finger protein 330 OS=Homo sapiens GN=ZNF330 PE=1 SV=1 | 28 | T | 0.900756 | A | 0.911624 | -0.010868 | No Change: Both D | - |
| Q9Y3S2 | ZN330_HUMAN Zinc finger protein 330 OS=Homo sapiens GN=ZNF330 PE=1 SV=1 | 298 | L | 0.825398 | M | 0.842045 | -0.016647 | No Change: Both D | - |
| Q96JL9 | ZN333_HUMAN Zinc finger protein 333 OS=Homo sapiens GN=ZNF333 PE=2 SV=3 | 251 | A | 0.352903 | E | 0.452169 | -0.099266 | No Change: Both O | - |
| Q96JL9 | ZN333_HUMAN Zinc finger protein 333 OS=Homo sapiens GN=ZNF333 PE=2 SV=3 | 537 | A | 0.31939 | V | 0.310191 | 0.009199 | No Change: Both O | - |
| Q9HCZ1 | ZN334_HUMAN Zinc finger protein 334 OS=Homo sapiens GN=ZNF334 PE=2 SV=2 | 547 | N | 0.396317 | S | 0.449806 | -0.053489 | No Change: Both O | - |
| Q9H4Z2 | ZN335_HUMAN Zinc finger protein 335 OS=Homo sapiens GN=ZNF335 PE=1 SV=1 | 294 | S | 0.932276 | T | 0.917709 | 0.014567 | No Change: Both D | - |
| Q9H4Z2 | ZN335_HUMAN Zinc finger protein 335 OS=Homo sapiens GN=ZNF335 PE=1 SV=1 | 65 | R | 0.996504 | C | 0.994851 | 0.001653 | No Change: Both D | - |
| Q9H4Z2 | ZN335_HUMAN Zinc finger protein 335 OS=Homo sapiens GN=ZNF335 PE=1 SV=1 | 101 | G | 0.910736 | S | 0.93329 | -0.022554 | No Change: Both D | - |
| Q9H4Z2 | ZN335_HUMAN Zinc finger protein 335 OS=Homo sapiens GN=ZNF335 PE=1 SV=1 | 603 | Y | 0.477821 | H | 0.615035 | -0.137214 | O to D | - |
| Q9Y3M9 | ZN337_HUMAN Zinc finger protein 337 OS=Homo sapiens GN=ZNF337 PE=2 SV=2 | 17 | V | 0.136823 | I | 0.107988 | 0.028835 | No Change: Both O | - |
| Q9Y3M9 | ZN337_HUMAN Zinc finger protein 337 OS=Homo sapiens GN=ZNF337 PE=2 SV=2 | 467 | R | 0.542055 | G | 0.52986 | 0.012195 | No Change: Both D | - |
| Q06730 | ZN33A_HUMAN Zinc finger protein 33A OS=Homo sapiens GN=ZNF33A PE=1 SV=3 | 549 | Q | 0.593132 | E | 0.611278 | -0.018146 | No Change: Both D | - |
| Q06730 | ZN33A_HUMAN Zinc finger protein 33A OS=Homo sapiens GN=ZNF33A PE=1 SV=3 | 614 | G | 0.51427 | R | 0.536102 | -0.021832 | No Change: Both D | - |
| Q06730 | ZN33A_HUMAN Zinc finger protein 33A OS=Homo sapiens GN=ZNF33A PE=1 SV=3 | 804 | D | 0.585337 | H | 0.564729 | 0.020608 | No Change: Both D | - |
| Q06732 | ZN33B_HUMAN Zinc finger protein 33B OS=Homo sapiens GN=ZNF33B PE=2 SV=2 | 145 | R | 0.370353 | C | 0.263442 | 0.106911 | No Change: Both O | - |
| Q06732 | ZN33B_HUMAN Zinc finger protein 33B OS=Homo sapiens GN=ZNF33B PE=2 SV=2 | 356 | H | 0.704824 | R | 0.720427 | -0.015603 | No Change: Both D | - |
| Q6P1L6 | ZN343_HUMAN Zinc finger protein 343 OS=Homo sapiens GN=ZNF343 PE=2 SV=1 | 520 | P | 0.616574 | L | 0.481962 | 0.134612 | D to O | - |
| Q96SE7 | ZN347_HUMAN Zinc finger protein 347 OS=Homo sapiens GN=ZNF347 PE=1 SV=2 | 117 | M | 0.388979 | V | 0.334867 | 0.054112 | No Change: Both O | - |
| Q96SE7 | ZN347_HUMAN Zinc finger protein 347 OS=Homo sapiens GN=ZNF347 PE=1 SV=2 | 264 | N | 0.462947 | D | 0.450543 | 0.012404 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 66 | L | 0.234881 | P | 0.379359 | -0.144478 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 472 | S | 0.50041 | P | 0.490698 | 0.009712 | D to O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 501 | R | 0.525928 | S | 0.593649 | -0.067721 | No Change: Both D | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 524 | V | 0.043501 | I | 0.035493 | 0.008008 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 37 | M | 0.214849 | I | 0.147448 | 0.067401 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 69 | I | 0.265413 | T | 0.403712 | -0.138299 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 132 | R | 0.437666 | C | 0.301831 | 0.135835 | No Change: Both O | - |
| Q9GZX5 | ZN350_HUMAN Zinc finger protein 350 OS=Homo sapiens GN=ZNF350 PE=1 SV=3 | 406 | E | 0.324711 | K | 0.336942 | -0.012231 | No Change: Both O | - |
| Q86Y25 | Z354C_HUMAN Zinc finger protein 354C OS=Homo sapiens GN=ZNF354C PE=2 SV=1 | 250 | E | 0.774429 | K | 0.777942 | -0.003513 | No Change: Both D | - |
| Q86Y25 | Z354C_HUMAN Zinc finger protein 354C OS=Homo sapiens GN=ZNF354C PE=2 SV=1 | 546 | F | 0.307099 | L | 0.324786 | -0.017687 | No Change: Both O | - |
| Q86Y25 | Z354C_HUMAN Zinc finger protein 354C OS=Homo sapiens GN=ZNF354C PE=2 SV=1 | 553 | E | 0.83891 | K | 0.824509 | 0.014401 | No Change: Both D | - |
| Q9NW07 | ZN358_HUMAN Zinc finger protein 358 OS=Homo sapiens GN=ZNF358 PE=1 SV=2 | 32 | N | 0.98338 | S | 0.987281 | -0.003901 | No Change: Both D | - |
| Q70YC4 | TALAN_HUMAN Talanin OS=Homo sapiens GN=ZNF365 PE=2 SV=2 | 62 | T | 0.585578 | A | 0.549815 | 0.035763 | No Change: Both D | - |
| Q70YC5 | ZN365_HUMAN Protein ZNF365 OS=Homo sapiens GN=ZNF365 PE=1 SV=3 | 337 | A | 0.854254 | S | 0.90455 | -0.050296 | No Change: Both D | - |
| Q8N895 | ZN366_HUMAN Zinc finger protein 366 OS=Homo sapiens GN=ZNF366 PE=2 SV=1 | 739 | A | 0.467737 | G | 0.562587 | -0.09485 | O to D | - |
| P17032 | ZN37A_HUMAN Zinc finger protein 37A OS=Homo sapiens GN=ZNF37A PE=2 SV=3 | 105 | D | 0.538882 | N | 0.566873 | -0.027991 | No Change: Both D | - |
| Q96SR6 | ZN382_HUMAN Zinc finger protein 382 OS=Homo sapiens GN=ZNF382 PE=2 SV=3 | 168 | E | 0.494576 | G | 0.451685 | 0.042891 | No Change: Both O | - |
| Q569K4 | Z385B_HUMAN Zinc finger protein 385B OS=Homo sapiens GN=ZNF385B PE=2 SV=1 | 242 | S | 0.995183 | G | 0.993226 | 0.001957 | No Change: Both D | - |
| Q9H6B1 | Z385D_HUMAN Zinc finger protein 385D OS=Homo sapiens GN=ZNF385D PE=2 SV=1 | 386 | A | 0.67734 | T | 0.707214 | -0.029874 | No Change: Both D | A colorectal cancer sample |
| Q9H6B1 | Z385D_HUMAN Zinc finger protein 385D OS=Homo sapiens GN=ZNF385D PE=2 SV=1 | 387 | H | 0.657781 | Q | 0.74243 | -0.084649 | No Change: Both D | A colorectal cancer sample |
| Q9UJN7 | ZN391_HUMAN Zinc finger protein 391 OS=Homo sapiens GN=ZNF391 PE=1 SV=2 | 51 | K | 0.752814 | R | 0.717632 | 0.035182 | No Change: Both D | - |
| Q9UJN7 | ZN391_HUMAN Zinc finger protein 391 OS=Homo sapiens GN=ZNF391 PE=1 SV=2 | 59 | G | 0.840072 | C | 0.802083 | 0.037989 | No Change: Both D | - |
| Q53GI3 | ZN394_HUMAN Zinc finger protein 394 OS=Homo sapiens GN=ZNF394 PE=2 SV=2 | 325 | T | 0.519795 | M | 0.519474 | 3.21E-04 | No Change: Both D | - |
| Q96N95 | ZN396_HUMAN Zinc finger protein 396 OS=Homo sapiens GN=ZNF396 PE=1 SV=2 | 211 | H | 0.39497 | L | 0.329665 | 0.065305 | No Change: Both O | - |
| Q8TD17 | ZN398_HUMAN Zinc finger protein 398 OS=Homo sapiens GN=ZNF398 PE=2 SV=1 | 87 | E | 0.465345 | D | 0.386373 | 0.078972 | No Change: Both O | - |
| Q8TD17 | ZN398_HUMAN Zinc finger protein 398 OS=Homo sapiens GN=ZNF398 PE=2 SV=1 | 294 | S | 0.867727 | L | 0.76335 | 0.104377 | No Change: Both D | - |
| Q494X3 | ZN404_HUMAN Zinc finger protein 404 OS=Homo sapiens GN=ZNF404 PE=2 SV=1 | 233 | H | 0.567228 | Y | 0.434589 | 0.132639 | D to O | - |
| Q9C0G0 | ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens GN=ZNF407 PE=2 SV=2 | 972 | N | 0.739644 | T | 0.700896 | 0.038748 | No Change: Both D | - |
| Q9C0G0 | ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens GN=ZNF407 PE=2 SV=2 | 69 | N | 0.913682 | S | 0.938931 | -0.025249 | No Change: Both D | - |
| Q9C0G0 | ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens GN=ZNF407 PE=2 SV=2 | 512 | G | 0.867415 | R | 0.878015 | -0.0106 | No Change: Both D | - |
| Q9C0G0 | ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens GN=ZNF407 PE=2 SV=2 | 1913 | A | 0.461728 | T | 0.493458 | -0.03173 | No Change: Both O | - |
| Q9C0G0 | ZN407_HUMAN Zinc finger protein 407 OS=Homo sapiens GN=ZNF407 PE=2 SV=2 | 1259 | S | 0.598794 | L | 0.476101 | 0.122693 | D to O | - |
| Q9H9D4 | ZN408_HUMAN Zinc finger protein 408 OS=Homo sapiens GN=ZNF408 PE=1 SV=1 | 337 | R | 0.976015 | P | 0.980061 | -0.004046 | No Change: Both D | - |
| P51814 | ZNF41_HUMAN Zinc finger protein 41 OS=Homo sapiens GN=ZNF41 PE=1 SV=2 | 153 | P | 0.525902 | L | 0.360407 | 0.165495 | D to O | Mental retardation X-linked type 89 (MRX89) [MIM:300848] |
| P51814 | ZNF41_HUMAN Zinc finger protein 41 OS=Homo sapiens GN=ZNF41 PE=1 SV=2 | 167 | I | 0.566693 | R | 0.684875 | -0.118182 | No Change: Both D | - |
| P51814 | ZNF41_HUMAN Zinc finger protein 41 OS=Homo sapiens GN=ZNF41 PE=1 SV=2 | 357 | D | 0.535825 | E | 0.576197 | -0.040372 | No Change: Both D | - |
| Q96IQ9 | ZN414_HUMAN Zinc finger protein 414 OS=Homo sapiens GN=ZNF414 PE=2 SV=2 | 65 | Q | 0.988875 | R | 0.987745 | 0.00113 | No Change: Both D | - |
| Q96IQ9 | ZN414_HUMAN Zinc finger protein 414 OS=Homo sapiens GN=ZNF414 PE=2 SV=2 | 77 | P | 0.98937 | S | 0.988702 | 6.68E-04 | No Change: Both D | - |
| Q09FC8 | ZN415_HUMAN Zinc finger protein 415 OS=Homo sapiens GN=ZNF415 PE=2 SV=2 | 196 | H | 0.545126 | P | 0.602379 | -0.057253 | No Change: Both D | - |
| Q09FC8 | ZN415_HUMAN Zinc finger protein 415 OS=Homo sapiens GN=ZNF415 PE=2 SV=2 | 229 | I | 0.624516 | L | 0.61794 | 0.006576 | No Change: Both D | - |
| Q09FC8 | ZN415_HUMAN Zinc finger protein 415 OS=Homo sapiens GN=ZNF415 PE=2 SV=2 | 233 | I | 0.572612 | V | 0.586216 | -0.013604 | No Change: Both D | - |
| Q09FC8 | ZN415_HUMAN Zinc finger protein 415 OS=Homo sapiens GN=ZNF415 PE=2 SV=2 | 241 | Y | 0.460246 | C | 0.531127 | -0.070881 | O to D | - |
| Q09FC8 | ZN415_HUMAN Zinc finger protein 415 OS=Homo sapiens GN=ZNF415 PE=2 SV=2 | 463 | N | 0.38203 | D | 0.368042 | 0.013988 | No Change: Both O | - |
| Q8TAU3 | ZN417_HUMAN Zinc finger protein 417 OS=Homo sapiens GN=ZNF417 PE=2 SV=2 | 495 | N | 0.469291 | S | 0.537962 | -0.068671 | O to D | - |
| Q96HQ0 | ZN419_HUMAN Zinc finger protein 419 OS=Homo sapiens GN=ZNF419 PE=2 SV=2 | 141 | E | 0.85117 | Q | 0.851344 | -1.74E-04 | No Change: Both D | - |
| Q96HQ0 | ZN419_HUMAN Zinc finger protein 419 OS=Homo sapiens GN=ZNF419 PE=2 SV=2 | 336 | I | 0.545319 | V | 0.569849 | -0.02453 | No Change: Both D | - |
| Q2M1K9 | ZN423_HUMAN Zinc finger protein 423 OS=Homo sapiens GN=ZNF423 PE=1 SV=1 | 629 | N | 0.714531 | S | 0.754477 | -0.039946 | No Change: Both D | - |
| Q6IV72 | ZN425_HUMAN Zinc finger protein 425 OS=Homo sapiens GN=ZNF425 PE=2 SV=1 | 166 | D | 0.720819 | V | 0.588602 | 0.132217 | No Change: Both D | - |
| Q9BUY5 | ZN426_HUMAN Zinc finger protein 426 OS=Homo sapiens GN=ZNF426 PE=2 SV=1 | 4 | A | 0.807502 | V | 0.777437 | 0.030065 | No Change: Both D | - |
| Q9BUY5 | ZN426_HUMAN Zinc finger protein 426 OS=Homo sapiens GN=ZNF426 PE=2 SV=1 | 219 | T | 0.615676 | A | 0.553718 | 0.061958 | No Change: Both D | - |
| Q86V71 | ZN429_HUMAN Zinc finger protein 429 OS=Homo sapiens GN=ZNF429 PE=1 SV=2 | 650 | H | 0.542806 | Y | 0.391354 | 0.151452 | D to O | - |
| P17038 | ZNF43_HUMAN Zinc finger protein 43 OS=Homo sapiens GN=ZNF43 PE=2 SV=4 | 244 | R | 0.419025 | C | 0.32828 | 0.090745 | No Change: Both O | A colorectal cancer sample |
| P17038 | ZNF43_HUMAN Zinc finger protein 43 OS=Homo sapiens GN=ZNF43 PE=2 SV=4 | 718 | S | 0.687169 | P | 0.676753 | 0.010416 | No Change: Both D | - |
| Q8TF32 | ZN431_HUMAN Zinc finger protein 431 OS=Homo sapiens GN=ZNF431 PE=2 SV=2 | 3 | D | 0.749053 | G | 0.732811 | 0.016242 | No Change: Both D | - |
| O94892 | ZN432_HUMAN Zinc finger protein 432 OS=Homo sapiens GN=ZNF432 PE=1 SV=1 | 416 | L | 0.427385 | V | 0.44774 | -0.020355 | No Change: Both O | A breast cancer sample |
| O94892 | ZN432_HUMAN Zinc finger protein 432 OS=Homo sapiens GN=ZNF432 PE=1 SV=1 | 490 | C | 0.345434 | Y | 0.312558 | 0.032876 | No Change: Both O | A breast cancer sample |
| Q9NX65 | ZN434_HUMAN Zinc finger protein 434 OS=Homo sapiens GN=ZNF434 PE=2 SV=2 | 120 | Y | 0.413124 | H | 0.494959 | -0.081835 | No Change: Both O | - |
| Q9NX65 | ZN434_HUMAN Zinc finger protein 434 OS=Homo sapiens GN=ZNF434 PE=2 SV=2 | 54 | A | 0.237042 | V | 0.175535 | 0.061507 | No Change: Both O | - |
| Q9C0F3 | ZN436_HUMAN Zinc finger protein 436 OS=Homo sapiens GN=ZNF436 PE=2 SV=2 | 196 | C | 0.73215 | G | 0.783044 | -0.050894 | No Change: Both D | A breast cancer sample |
| Q7Z4V0 | ZN438_HUMAN Zinc finger protein 438 OS=Homo sapiens GN=ZNF438 PE=2 SV=1 | 173 | P | 0.920105 | S | 0.916292 | 0.003813 | No Change: Both D | - |
| Q7Z4V0 | ZN438_HUMAN Zinc finger protein 438 OS=Homo sapiens GN=ZNF438 PE=2 SV=1 | 381 | K | 0.782912 | N | 0.743121 | 0.039791 | No Change: Both D | A breast cancer sample |
| Q7Z4V0 | ZN438_HUMAN Zinc finger protein 438 OS=Homo sapiens GN=ZNF438 PE=2 SV=1 | 693 | L | 0.810036 | V | 0.807794 | 0.002242 | No Change: Both D | - |
| Q8NDP4 | ZN439_HUMAN Zinc finger protein 439 OS=Homo sapiens GN=ZNF439 PE=2 SV=1 | 427 | L | 0.722016 | S | 0.829628 | -0.107612 | No Change: Both D | - |
| Q8NDP4 | ZN439_HUMAN Zinc finger protein 439 OS=Homo sapiens GN=ZNF439 PE=2 SV=1 | 6 | P | 0.306484 | S | 0.357827 | -0.051343 | No Change: Both O | - |
| P15621 | ZNF44_HUMAN Zinc finger protein 44 OS=Homo sapiens GN=ZNF44 PE=1 SV=3 | 92 | G | 0.226164 | A | 0.186462 | 0.039702 | No Change: Both O | - |
| P15621 | ZNF44_HUMAN Zinc finger protein 44 OS=Homo sapiens GN=ZNF44 PE=1 SV=3 | 212 | T | 0.811736 | A | 0.759178 | 0.052558 | No Change: Both D | - |
| Q8IYI8 | ZN440_HUMAN Zinc finger protein 440 OS=Homo sapiens GN=ZNF440 PE=2 SV=1 | 88 | P | 0.694054 | R | 0.661667 | 0.032387 | No Change: Both D | - |
| Q8IYI8 | ZN440_HUMAN Zinc finger protein 440 OS=Homo sapiens GN=ZNF440 PE=2 SV=1 | 569 | S | 0.715182 | N | 0.690931 | 0.024251 | No Change: Both D | - |
| Q8IYI8 | ZN440_HUMAN Zinc finger protein 440 OS=Homo sapiens GN=ZNF440 PE=2 SV=1 | 43 | L | 0.343609 | I | 0.305346 | 0.038263 | No Change: Both O | - |
| Q8IYI8 | ZN440_HUMAN Zinc finger protein 440 OS=Homo sapiens GN=ZNF440 PE=2 SV=1 | 124 | N | 0.417782 | S | 0.46266 | -0.044878 | No Change: Both O | - |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 110 | P | 0.762681 | T | 0.71564 | 0.047041 | No Change: Both D | - |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 443 | R | 0.57232 | C | 0.458171 | 0.114149 | D to O | - |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 152 | P | 0.677592 | S | 0.68464 | -0.007048 | No Change: Both D | A colorectal cancer sample |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 243 | C | 0.402974 | S | 0.512383 | -0.109409 | O to D | A colorectal cancer sample |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 93 | I | 0.767209 | V | 0.759699 | 0.00751 | No Change: Both D | - |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 422 | G | 0.533878 | R | 0.549936 | -0.016058 | No Change: Both D | - |
| Q9H7R0 | ZN442_HUMAN Zinc finger protein 442 OS=Homo sapiens GN=ZNF442 PE=2 SV=1 | 590 | H | 0.874435 | L | 0.834254 | 0.040181 | No Change: Both D | - |
| Q9Y2A4 | ZN443_HUMAN Zinc finger protein 443 OS=Homo sapiens GN=ZNF443 PE=2 SV=2 | 591 | P | 0.531416 | Q | 0.538527 | -0.007111 | No Change: Both D | - |
| Q9Y2A4 | ZN443_HUMAN Zinc finger protein 443 OS=Homo sapiens GN=ZNF443 PE=2 SV=2 | 111 | K | 0.678991 | N | 0.660553 | 0.018438 | No Change: Both D | - |
| Q9Y2A4 | ZN443_HUMAN Zinc finger protein 443 OS=Homo sapiens GN=ZNF443 PE=2 SV=2 | 485 | C | 0.539538 | F | 0.468798 | 0.07074 | D to O | - |
| Q9Y2A4 | ZN443_HUMAN Zinc finger protein 443 OS=Homo sapiens GN=ZNF443 PE=2 SV=2 | 111 | K | 0.678991 | I | 0.546592 | 0.132399 | No Change: Both D | - |
| Q9Y2A4 | ZN443_HUMAN Zinc finger protein 443 OS=Homo sapiens GN=ZNF443 PE=2 SV=2 | 397 | Q | 0.804395 | H | 0.809574 | -0.005179 | No Change: Both D | - |
| P59923 | ZN445_HUMAN Zinc finger protein 445 OS=Homo sapiens GN=ZNF445 PE=2 SV=1 | 428 | Y | 0.65215 | C | 0.65327 | -0.00112 | No Change: Both D | - |
| Q9NWS9 | ZN446_HUMAN Zinc finger protein 446 OS=Homo sapiens GN=ZNF446 PE=1 SV=1 | 192 | N | 0.910743 | H | 0.923309 | -0.012566 | No Change: Both D | - |
| Q9NWS9 | ZN446_HUMAN Zinc finger protein 446 OS=Homo sapiens GN=ZNF446 PE=1 SV=1 | 300 | P | 0.990898 | S | 0.987986 | 0.002912 | No Change: Both D | - |
| Q9NWS9 | ZN446_HUMAN Zinc finger protein 446 OS=Homo sapiens GN=ZNF446 PE=1 SV=1 | 387 | R | 0.843549 | H | 0.829094 | 0.014455 | No Change: Both D | - |
| Q02386 | ZNF45_HUMAN Zinc finger protein 45 OS=Homo sapiens GN=ZNF45 PE=2 SV=2 | 187 | A | 0.540643 | T | 0.536677 | 0.003966 | No Change: Both D | - |
| Q02386 | ZNF45_HUMAN Zinc finger protein 45 OS=Homo sapiens GN=ZNF45 PE=2 SV=2 | 255 | R | 0.641318 | K | 0.688969 | -0.047651 | No Change: Both D | - |
| Q02386 | ZNF45_HUMAN Zinc finger protein 45 OS=Homo sapiens GN=ZNF45 PE=2 SV=2 | 299 | T | 0.527359 | A | 0.495396 | 0.031963 | D to O | - |
| Q02386 | ZNF45_HUMAN Zinc finger protein 45 OS=Homo sapiens GN=ZNF45 PE=2 SV=2 | 303 | P | 0.589207 | R | 0.593251 | -0.004044 | No Change: Both D | - |
| Q02386 | ZNF45_HUMAN Zinc finger protein 45 OS=Homo sapiens GN=ZNF45 PE=2 SV=2 | 504 | R | 0.504321 | K | 0.558045 | -0.053724 | No Change: Both D | - |
| Q8N9F8 | ZN454_HUMAN Zinc finger protein 454 OS=Homo sapiens GN=ZNF454 PE=2 SV=2 | 166 | D | 0.966792 | A | 0.958365 | 0.008427 | No Change: Both D | - |
| Q8N9F8 | ZN454_HUMAN Zinc finger protein 454 OS=Homo sapiens GN=ZNF454 PE=2 SV=2 | 152 | C | 0.873187 | Y | 0.831618 | 0.041569 | No Change: Both D | - |
| Q8TAF7 | ZN461_HUMAN Zinc finger protein 461 OS=Homo sapiens GN=ZNF461 PE=2 SV=2 | 87 | N | 0.199245 | S | 0.208873 | -0.009628 | No Change: Both O | - |
| Q96JM2 | ZN462_HUMAN Zinc finger protein 462 OS=Homo sapiens GN=ZNF462 PE=1 SV=3 | 404 | M | 0.878296 | V | 0.812176 | 0.06612 | No Change: Both D | - |
| Q96JM2 | ZN462_HUMAN Zinc finger protein 462 OS=Homo sapiens GN=ZNF462 PE=1 SV=3 | 1187 | P | 0.658048 | S | 0.660959 | -0.002911 | No Change: Both D | - |
| Q96JM2 | ZN462_HUMAN Zinc finger protein 462 OS=Homo sapiens GN=ZNF462 PE=1 SV=3 | 1828 | N | 0.736482 | S | 0.770671 | -0.034189 | No Change: Both D | - |
| Q96JM2 | ZN462_HUMAN Zinc finger protein 462 OS=Homo sapiens GN=ZNF462 PE=1 SV=3 | 2052 | K | 0.581535 | R | 0.537752 | 0.043783 | No Change: Both D | - |
| Q96JM2 | ZN462_HUMAN Zinc finger protein 462 OS=Homo sapiens GN=ZNF462 PE=1 SV=3 | 2452 | H | 0.738463 | L | 0.663553 | 0.07491 | No Change: Both D | - |
| Q7Z7K2 | ZN467_HUMAN Zinc finger protein 467 OS=Homo sapiens GN=ZNF467 PE=2 SV=1 | 324 | T | 0.935981 | A | 0.934434 | 0.001547 | No Change: Both D | - |
| Q5VIY5 | ZN468_HUMAN Zinc finger protein 468 OS=Homo sapiens GN=ZNF468 PE=2 SV=1 | 374 | H | 0.571 | R | 0.597969 | -0.026969 | No Change: Both D | - |
| Q5VIY5 | ZN468_HUMAN Zinc finger protein 468 OS=Homo sapiens GN=ZNF468 PE=2 SV=1 | 477 | G | 0.4817 | R | 0.503411 | -0.021711 | O to D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 366 | R | 0.94505 | S | 0.95821 | -0.01316 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 1162 | K | 0.972249 | E | 0.975866 | -0.003617 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 1420 | P | 0.969635 | L | 0.947746 | 0.021889 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2129 | R | 0.958976 | K | 0.958003 | 9.73E-04 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2358 | G | 0.985762 | R | 0.986755 | -9.93E-04 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2670 | L | 0.896057 | Q | 0.934621 | -0.038564 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2710 | A | 0.86293 | T | 0.86999 | -0.00706 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2749 | D | 0.94963 | V | 0.938271 | 0.011359 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 2848 | H | 0.788998 | R | 0.855416 | -0.066418 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 3630 | E | 0.912969 | Q | 0.908912 | 0.004057 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 3636 | T | 0.928406 | A | 0.925998 | 0.002408 | No Change: Both D | - |
| Q96JG9 | ZN469_HUMAN Zinc finger protein 469 OS=Homo sapiens GN=ZNF469 PE=1 SV=3 | 357 | S | 0.950353 | P | 0.951326 | -9.73E-04 | No Change: Both D | - |
| Q6ECI4 | ZN470_HUMAN Zinc finger protein 470 OS=Homo sapiens GN=ZNF470 PE=1 SV=3 | 23 | V | 0.176177 | L | 0.175669 | 5.08E-04 | No Change: Both O | - |
| Q6ECI4 | ZN470_HUMAN Zinc finger protein 470 OS=Homo sapiens GN=ZNF470 PE=1 SV=3 | 254 | K | 0.490585 | R | 0.449675 | 0.04091 | No Change: Both O | - |
| Q6ECI4 | ZN470_HUMAN Zinc finger protein 470 OS=Homo sapiens GN=ZNF470 PE=1 SV=3 | 418 | T | 0.517722 | I | 0.387921 | 0.129801 | D to O | - |
| Q6ECI4 | ZN470_HUMAN Zinc finger protein 470 OS=Homo sapiens GN=ZNF470 PE=1 SV=3 | 642 | I | 0.517699 | T | 0.681005 | -0.163306 | No Change: Both D | - |
| Q9BX82 | ZN471_HUMAN Zinc finger protein 471 OS=Homo sapiens GN=ZNF471 PE=2 SV=1 | 361 | F | 0.195415 | C | 0.19077 | 0.004645 | No Change: Both O | A colorectal cancer sample |
| Q9BX82 | ZN471_HUMAN Zinc finger protein 471 OS=Homo sapiens GN=ZNF471 PE=2 SV=1 | 192 | M | 0.652868 | I | 0.599155 | 0.053713 | No Change: Both D | - |
| Q9BX82 | ZN471_HUMAN Zinc finger protein 471 OS=Homo sapiens GN=ZNF471 PE=2 SV=1 | 406 | G | 0.343648 | D | 0.344145 | -4.97E-04 | No Change: Both O | - |
| Q9BX82 | ZN471_HUMAN Zinc finger protein 471 OS=Homo sapiens GN=ZNF471 PE=2 SV=1 | 556 | S | 0.804789 | C | 0.749468 | 0.055321 | No Change: Both D | - |
| Q9BX82 | ZN471_HUMAN Zinc finger protein 471 OS=Homo sapiens GN=ZNF471 PE=2 SV=1 | 309 | Q | 0.788598 | R | 0.788184 | 4.14E-04 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 59 | S | 0.903789 | G | 0.887439 | 0.01635 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 74 | S | 0.91581 | G | 0.895728 | 0.020082 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 164 | T | 0.842382 | M | 0.832898 | 0.009484 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 309 | E | 0.918864 | G | 0.910929 | 0.007935 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 654 | T | 0.646663 | I | 0.531587 | 0.115076 | No Change: Both D | - |
| Q8WTR7 | ZN473_HUMAN Zinc finger protein 473 OS=Homo sapiens GN=ZNF473 PE=1 SV=1 | 662 | S | 0.638204 | A | 0.541867 | 0.096337 | No Change: Both D | - |
| Q6S9Z5 | ZN474_HUMAN Zinc finger protein 474 OS=Homo sapiens GN=ZNF474 PE=2 SV=1 | 173 | R | 0.639699 | H | 0.629802 | 0.009897 | No Change: Both D | - |
| Q96MX3 | ZNF48_HUMAN Zinc finger protein 48 OS=Homo sapiens GN=ZNF48 PE=2 SV=2 | 65 | A | 0.65328 | V | 0.620494 | 0.032786 | No Change: Both D | - |
| Q96MX3 | ZNF48_HUMAN Zinc finger protein 48 OS=Homo sapiens GN=ZNF48 PE=2 SV=2 | 224 | I | 0.759466 | V | 0.774446 | -0.01498 | No Change: Both D | - |
| Q96MX3 | ZNF48_HUMAN Zinc finger protein 48 OS=Homo sapiens GN=ZNF48 PE=2 SV=2 | 21 | Q | 0.925316 | R | 0.935995 | -0.010679 | No Change: Both D | - |
| Q8WV37 | ZN480_HUMAN Zinc finger protein 480 OS=Homo sapiens GN=ZNF480 PE=1 SV=2 | 177 | P | 0.695829 | S | 0.738039 | -0.04221 | No Change: Both D | - |
| Q8WV37 | ZN480_HUMAN Zinc finger protein 480 OS=Homo sapiens GN=ZNF480 PE=1 SV=2 | 361 | H | 0.220929 | Q | 0.234495 | -0.013566 | No Change: Both O | A colorectal cancer sample |
| Q5JVG2 | ZN484_HUMAN Zinc finger protein 484 OS=Homo sapiens GN=ZNF484 PE=1 SV=1 | 502 | G | 0.152419 | D | 0.174206 | -0.021787 | No Change: Both O | - |
| Q8NCK3 | ZN485_HUMAN Zinc finger protein 485 OS=Homo sapiens GN=ZNF485 PE=2 SV=1 | 252 | A | 0.421542 | T | 0.442359 | -0.020817 | No Change: Both O | - |
| B1APH4 | ZN487_HUMAN Putative zinc finger protein 487 OS=Homo sapiens GN=ZNF487P PE=5 SV=3 | 61 | P | 0.470282 | R | 0.456058 | 0.014224 | No Change: Both O | - |
| B1APH4 | ZN487_HUMAN Putative zinc finger protein 487 OS=Homo sapiens GN=ZNF487P PE=5 SV=3 | 120 | R | 0.775672 | S | 0.807022 | -0.03135 | No Change: Both D | - |
| Q96MN9 | ZN488_HUMAN Zinc finger protein 488 OS=Homo sapiens GN=ZNF488 PE=1 SV=1 | 72 | A | 0.817124 | V | 0.776387 | 0.040737 | No Change: Both D | - |
| Q96MN9 | ZN488_HUMAN Zinc finger protein 488 OS=Homo sapiens GN=ZNF488 PE=1 SV=1 | 106 | P | 0.966985 | L | 0.940093 | 0.026892 | No Change: Both D | - |
| Q96MN9 | ZN488_HUMAN Zinc finger protein 488 OS=Homo sapiens GN=ZNF488 PE=1 SV=1 | 249 | P | 0.824416 | S | 0.824377 | 3.90E-05 | No Change: Both D | - |
| Q9P255 | ZN492_HUMAN Zinc finger protein 492 OS=Homo sapiens GN=ZNF492 PE=2 SV=2 | 106 | T | 0.296166 | K | 0.372233 | -0.076067 | No Change: Both O | - |
| Q6ZR52 | ZN493_HUMAN Zinc finger protein 493 OS=Homo sapiens GN=ZNF493 PE=2 SV=3 | 195 | C | 0.692481 | F | 0.653545 | 0.038936 | No Change: Both D | - |
| Q6ZR52 | ZN493_HUMAN Zinc finger protein 493 OS=Homo sapiens GN=ZNF493 PE=2 SV=3 | 292 | L | 0.840178 | V | 0.834861 | 0.005317 | No Change: Both D | - |
| Q6ZNH5 | ZN497_HUMAN Zinc finger protein 497 OS=Homo sapiens GN=ZNF497 PE=2 SV=2 | 174 | H | 0.586571 | Q | 0.621733 | -0.035162 | No Change: Both D | - |
| Q6NSZ9 | ZN498_HUMAN Zinc finger protein 498 OS=Homo sapiens GN=ZNF498 PE=2 SV=3 | 325 | P | 0.908412 | A | 0.859635 | 0.048777 | No Change: Both D | - |
| Q96CX3 | ZN501_HUMAN Zinc finger protein 501 OS=Homo sapiens GN=ZNF501 PE=2 SV=2 | 17 | M | 0.929846 | V | 0.893516 | 0.03633 | No Change: Both D | - |
| Q96CX3 | ZN501_HUMAN Zinc finger protein 501 OS=Homo sapiens GN=ZNF501 PE=2 SV=2 | 147 | I | 0.679604 | V | 0.663421 | 0.016183 | No Change: Both D | - |
| Q8TBZ5 | ZN502_HUMAN Zinc finger protein 502 OS=Homo sapiens GN=ZNF502 PE=2 SV=1 | 243 | E | 0.734143 | A | 0.605627 | 0.128516 | No Change: Both D | - |
| Q8TBZ5 | ZN502_HUMAN Zinc finger protein 502 OS=Homo sapiens GN=ZNF502 PE=2 SV=1 | 28 | L | 0.417244 | P | 0.607987 | -0.190743 | O to D | - |
| Q8TBZ5 | ZN502_HUMAN Zinc finger protein 502 OS=Homo sapiens GN=ZNF502 PE=2 SV=1 | 174 | Q | 0.881318 | R | 0.87769 | 0.003628 | No Change: Both D | - |
| Q96F45 | ZN503_HUMAN Zinc finger protein 503 OS=Homo sapiens GN=ZNF503 PE=1 SV=1 | 509 | N | 0.289225 | K | 0.308636 | -0.019411 | No Change: Both O | - |
| Q5JVG8 | ZN506_HUMAN Zinc finger protein 506 OS=Homo sapiens GN=ZNF506 PE=2 SV=2 | 189 | T | 0.802252 | P | 0.793437 | 0.008815 | No Change: Both D | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 43 | Q | 0.48537 | R | 0.444177 | 0.041193 | No Change: Both O | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 89 | C | 0.113362 | R | 0.158496 | -0.045134 | No Change: Both O | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 273 | N | 0.847545 | K | 0.869197 | -0.021652 | No Change: Both D | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 398 | H | 0.842965 | D | 0.833253 | 0.009712 | No Change: Both D | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 401 | M | 0.839568 | I | 0.749077 | 0.090491 | No Change: Both D | - |
| Q9Y2H8 | ZN510_HUMAN Zinc finger protein 510 OS=Homo sapiens GN=ZNF510 PE=2 SV=1 | 634 | G | 0.638755 | E | 0.683924 | -0.045169 | No Change: Both D | - |
| Q96KM6 | Z512B_HUMAN Zinc finger protein 512B OS=Homo sapiens GN=ZNF512B PE=1 SV=1 | 372 | M | 0.964238 | V | 0.945708 | 0.01853 | No Change: Both D | - |
| Q96KM6 | Z512B_HUMAN Zinc finger protein 512B OS=Homo sapiens GN=ZNF512B PE=1 SV=1 | 453 | A | 0.894588 | T | 0.904285 | -0.009697 | No Change: Both D | - |
| Q96KM6 | Z512B_HUMAN Zinc finger protein 512B OS=Homo sapiens GN=ZNF512B PE=1 SV=1 | 288 | V | 0.938811 | M | 0.938683 | 1.28E-04 | No Change: Both D | - |
| Q8N8E2 | ZN513_HUMAN Zinc finger protein 513 OS=Homo sapiens GN=ZNF513 PE=1 SV=2 | 339 | C | 0.876153 | R | 0.909893 | -0.03374 | No Change: Both D | Retinitis pigmentosa type 58 (RP58) [MIM:613617] |
| Q92618 | ZN516_HUMAN Zinc finger protein 516 OS=Homo sapiens GN=ZNF516 PE=1 SV=1 | 4 | N | 0.966925 | S | 0.976936 | -0.010011 | No Change: Both D | - |
| Q92618 | ZN516_HUMAN Zinc finger protein 516 OS=Homo sapiens GN=ZNF516 PE=1 SV=1 | 239 | G | 0.689165 | S | 0.729665 | -0.0405 | No Change: Both D | - |
| Q6ZMY9 | ZN517_HUMAN Zinc finger protein 517 OS=Homo sapiens GN=ZNF517 PE=2 SV=2 | 6 | P | 0.65931 | L | 0.521238 | 0.138072 | No Change: Both D | - |
| Q6AHZ1 | Z518A_HUMAN Zinc finger protein 518A OS=Homo sapiens GN=ZNF518A PE=1 SV=2 | 946 | N | 0.391606 | H | 0.317953 | 0.073653 | No Change: Both O | - |
| Q6AHZ1 | Z518A_HUMAN Zinc finger protein 518A OS=Homo sapiens GN=ZNF518A PE=1 SV=2 | 1328 | R | 0.694874 | Q | 0.677297 | 0.017577 | No Change: Both D | - |
| Q9C0D4 | Z518B_HUMAN Zinc finger protein 518B OS=Homo sapiens GN=ZNF518B PE=2 SV=2 | 105 | S | 0.65168 | P | 0.630265 | 0.021415 | No Change: Both D | - |
| Q9C0D4 | Z518B_HUMAN Zinc finger protein 518B OS=Homo sapiens GN=ZNF518B PE=2 SV=2 | 523 | S | 0.684952 | N | 0.629158 | 0.055794 | No Change: Both D | - |
| Q9C0D4 | Z518B_HUMAN Zinc finger protein 518B OS=Homo sapiens GN=ZNF518B PE=2 SV=2 | 92 | G | 0.29367 | S | 0.363951 | -0.070281 | No Change: Both O | - |
| Q8TB69 | ZN519_HUMAN Zinc finger protein 519 OS=Homo sapiens GN=ZNF519 PE=2 SV=2 | 18 | W | 0.302799 | R | 0.522315 | -0.219516 | O to D | - |
| Q8TB69 | ZN519_HUMAN Zinc finger protein 519 OS=Homo sapiens GN=ZNF519 PE=2 SV=2 | 89 | G | 0.472674 | S | 0.51477 | -0.042096 | O to D | - |
| Q8TB69 | ZN519_HUMAN Zinc finger protein 519 OS=Homo sapiens GN=ZNF519 PE=2 SV=2 | 206 | K | 0.596123 | E | 0.603521 | -0.007398 | No Change: Both D | - |
| Q8TB69 | ZN519_HUMAN Zinc finger protein 519 OS=Homo sapiens GN=ZNF519 PE=2 SV=2 | 229 | R | 0.513458 | I | 0.397249 | 0.116209 | D to O | - |
| Q8TF50 | ZN526_HUMAN Zinc finger protein 526 OS=Homo sapiens GN=ZNF526 PE=2 SV=2 | 94 | V | 0.657048 | A | 0.726665 | -0.069617 | No Change: Both D | - |
| Q8TF50 | ZN526_HUMAN Zinc finger protein 526 OS=Homo sapiens GN=ZNF526 PE=2 SV=2 | 511 | S | 0.459592 | F | 0.26956 | 0.190032 | No Change: Both O | - |
| Q3MIS6 | ZN528_HUMAN Zinc finger protein 528 OS=Homo sapiens GN=ZNF528 PE=2 SV=1 | 419 | S | 0.610103 | N | 0.530359 | 0.079744 | No Change: Both D | - |
| Q6P280 | ZN529_HUMAN Zinc finger protein 529 OS=Homo sapiens GN=ZNF529 PE=2 SV=1 | 98 | V | 0.466623 | L | 0.454612 | 0.012011 | No Change: Both O | - |
| Q6P9A1 | ZN530_HUMAN Zinc finger protein 530 OS=Homo sapiens GN=ZNF530 PE=2 SV=2 | 64 | T | 0.586207 | A | 0.588372 | -0.002165 | No Change: Both D | - |
| Q6P9A1 | ZN530_HUMAN Zinc finger protein 530 OS=Homo sapiens GN=ZNF530 PE=2 SV=2 | 110 | H | 0.235128 | Q | 0.277108 | -0.04198 | No Change: Both O | - |
| Q6P9A1 | ZN530_HUMAN Zinc finger protein 530 OS=Homo sapiens GN=ZNF530 PE=2 SV=2 | 124 | S | 0.264776 | P | 0.228643 | 0.036133 | No Change: Both O | - |
| Q6P9A1 | ZN530_HUMAN Zinc finger protein 530 OS=Homo sapiens GN=ZNF530 PE=2 SV=2 | 169 | T | 0.38192 | M | 0.349375 | 0.032545 | No Change: Both O | - |
| Q6P9A1 | ZN530_HUMAN Zinc finger protein 530 OS=Homo sapiens GN=ZNF530 PE=2 SV=2 | 262 | G | 0.950247 | S | 0.96321 | -0.012963 | No Change: Both D | - |
| Q9HCE3 | ZN532_HUMAN Zinc finger protein 532 OS=Homo sapiens GN=ZNF532 PE=1 SV=2 | 761 | E | 0.596612 | D | 0.580842 | 0.01577 | No Change: Both D | - |
| Q9HCE3 | ZN532_HUMAN Zinc finger protein 532 OS=Homo sapiens GN=ZNF532 PE=1 SV=2 | 822 | S | 0.175103 | L | 0.081528 | 0.093575 | No Change: Both O | A breast cancer sample |
| Q8NDQ6 | ZN540_HUMAN Zinc finger protein 540 OS=Homo sapiens GN=ZNF540 PE=1 SV=1 | 53 | D | 0.379938 | V | 0.255755 | 0.124183 | No Change: Both O | - |
| Q8NDQ6 | ZN540_HUMAN Zinc finger protein 540 OS=Homo sapiens GN=ZNF540 PE=1 SV=1 | 275 | K | 0.598782 | I | 0.382713 | 0.216069 | D to O | A colorectal cancer sample |
| Q9H0D2 | ZN541_HUMAN Zinc finger protein 541 OS=Homo sapiens GN=ZNF541 PE=1 SV=2 | 712 | S | 0.949433 | L | 0.918833 | 0.0306 | No Change: Both D | A breast cancer sample |
| Q9H0D2 | ZN541_HUMAN Zinc finger protein 541 OS=Homo sapiens GN=ZNF541 PE=1 SV=2 | 486 | P | 0.963112 | S | 0.959479 | 0.003633 | No Change: Both D | - |
| Q9H0D2 | ZN541_HUMAN Zinc finger protein 541 OS=Homo sapiens GN=ZNF541 PE=1 SV=2 | 791 | K | 0.723481 | E | 0.710423 | 0.013058 | No Change: Both D | - |
| Q9H0D2 | ZN541_HUMAN Zinc finger protein 541 OS=Homo sapiens GN=ZNF541 PE=1 SV=2 | 795 | T | 0.602175 | S | 0.723807 | -0.121632 | No Change: Both D | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 55 | P | 0.168769 | A | 0.112029 | 0.05674 | No Change: Both O | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 107 | Q | 0.873923 | R | 0.828219 | 0.045704 | No Change: Both D | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 246 | L | 0.345227 | H | 0.465558 | -0.120331 | No Change: Both O | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 287 | E | 0.67266 | V | 0.498062 | 0.174598 | D to O | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 439 | V | 0.528692 | D | 0.695509 | -0.166817 | No Change: Both D | - |
| Q08ER8 | ZN543_HUMAN Zinc finger protein 543 OS=Homo sapiens GN=ZNF543 PE=2 SV=3 | 573 | M | 0.267605 | V | 0.232168 | 0.035437 | No Change: Both O | - |
| Q6NX49 | ZN544_HUMAN Zinc finger protein 544 OS=Homo sapiens GN=ZNF544 PE=2 SV=1 | 203 | H | 0.656731 | D | 0.684271 | -0.02754 | No Change: Both D | - |
| Q6NX49 | ZN544_HUMAN Zinc finger protein 544 OS=Homo sapiens GN=ZNF544 PE=2 SV=1 | 700 | Q | 0.801452 | R | 0.808032 | -0.00658 | No Change: Both D | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 15 | L | 0.139293 | V | 0.122481 | 0.016812 | No Change: Both O | A breast cancer sample |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 201 | Q | 0.704246 | R | 0.685211 | 0.019035 | No Change: Both D | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 243 | R | 0.385181 | T | 0.362051 | 0.02313 | No Change: Both O | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 253 | A | 0.177601 | V | 0.139419 | 0.038182 | No Change: Both O | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 298 | V | 0.429381 | E | 0.596075 | -0.166694 | O to D | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 427 | E | 0.605071 | G | 0.539442 | 0.065629 | No Change: Both D | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 452 | L | 0.669488 | F | 0.666604 | 0.002884 | No Change: Both D | - |
| Q86UE3 | ZN546_HUMAN Zinc finger protein 546 OS=Homo sapiens GN=ZNF546 PE=2 SV=2 | 652 | L | 0.645575 | F | 0.659868 | -0.014293 | No Change: Both D | - |
| Q8NEK5 | ZN548_HUMAN Zinc finger protein 548 OS=Homo sapiens GN=ZNF548 PE=2 SV=2 | 58 | A | 0.727003 | S | 0.778398 | -0.051395 | No Change: Both D | - |
| Q8NEK5 | ZN548_HUMAN Zinc finger protein 548 OS=Homo sapiens GN=ZNF548 PE=2 SV=2 | 73 | A | 0.749757 | T | 0.789 | -0.039243 | No Change: Both D | - |
| Q6P9A3 | ZN549_HUMAN Zinc finger protein 549 OS=Homo sapiens GN=ZNF549 PE=2 SV=2 | 8 | I | 0.198235 | N | 0.341731 | -0.143496 | No Change: Both O | - |
| Q7Z398 | ZN550_HUMAN Zinc finger protein 550 OS=Homo sapiens GN=ZNF550 PE=1 SV=2 | 359 | I | 0.38326 | T | 0.520305 | -0.137045 | O to D | - |
| Q7Z340 | ZN551_HUMAN Zinc finger protein 551 OS=Homo sapiens GN=ZNF551 PE=1 SV=3 | 218 | N | 0.500919 | S | 0.621636 | -0.120717 | No Change: Both D | - |
| Q7Z340 | ZN551_HUMAN Zinc finger protein 551 OS=Homo sapiens GN=ZNF551 PE=1 SV=3 | 550 | R | 0.836954 | W | 0.623935 | 0.213019 | No Change: Both D | - |
| Q9H707 | ZN552_HUMAN Zinc finger protein 552 OS=Homo sapiens GN=ZNF552 PE=2 SV=2 | 242 | W | 0.546119 | C | 0.711465 | -0.165346 | No Change: Both D | - |
| Q86TJ5 | ZN554_HUMAN Zinc finger protein 554 OS=Homo sapiens GN=ZNF554 PE=2 SV=1 | 190 | E | 0.66466 | G | 0.632727 | 0.031933 | No Change: Both D | - |
| Q86TJ5 | ZN554_HUMAN Zinc finger protein 554 OS=Homo sapiens GN=ZNF554 PE=2 SV=1 | 211 | V | 0.407616 | I | 0.340136 | 0.06748 | No Change: Both O | - |
| Q8NEP9 | ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens GN=ZNF555 PE=2 SV=4 | 515 | K | 0.26259 | T | 0.187745 | 0.074845 | No Change: Both O | - |
| Q8NEP9 | ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens GN=ZNF555 PE=2 SV=4 | 107 | N | 0.61011 | D | 0.609009 | 0.001101 | No Change: Both D | - |
| Q8NEP9 | ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens GN=ZNF555 PE=2 SV=4 | 137 | P | 0.374637 | L | 0.233778 | 0.140859 | No Change: Both O | - |
| Q8NEP9 | ZN555_HUMAN Zinc finger protein 555 OS=Homo sapiens GN=ZNF555 PE=2 SV=4 | 194 | H | 0.543705 | N | 0.549023 | -0.005318 | No Change: Both D | - |
| Q9HAH1 | ZN556_HUMAN Zinc finger protein 556 OS=Homo sapiens GN=ZNF556 PE=2 SV=1 | 137 | R | 0.899695 | C | 0.875302 | 0.024393 | No Change: Both D | - |
| Q9HAH1 | ZN556_HUMAN Zinc finger protein 556 OS=Homo sapiens GN=ZNF556 PE=2 SV=1 | 146 | R | 0.805792 | L | 0.712637 | 0.093155 | No Change: Both D | - |
| Q9HAH1 | ZN556_HUMAN Zinc finger protein 556 OS=Homo sapiens GN=ZNF556 PE=2 SV=1 | 353 | A | 0.95191 | T | 0.963971 | -0.012061 | No Change: Both D | - |
| Q9HAH1 | ZN556_HUMAN Zinc finger protein 556 OS=Homo sapiens GN=ZNF556 PE=2 SV=1 | 428 | E | 0.915212 | K | 0.939909 | -0.024697 | No Change: Both D | - |
| Q9BR84 | ZN559_HUMAN Zinc finger protein 559 OS=Homo sapiens GN=ZNF559 PE=2 SV=1 | 251 | T | 0.423023 | N | 0.424702 | -0.001679 | No Change: Both O | - |
| Q96MR9 | ZN560_HUMAN Zinc finger protein 560 OS=Homo sapiens GN=ZNF560 PE=2 SV=2 | 186 | G | 0.228321 | E | 0.291623 | -0.063302 | No Change: Both O | A colorectal cancer sample |
| Q96MR9 | ZN560_HUMAN Zinc finger protein 560 OS=Homo sapiens GN=ZNF560 PE=2 SV=2 | 630 | Y | 0.504456 | C | 0.532407 | -0.027951 | No Change: Both D | - |
| Q6V9R5 | ZN562_HUMAN Zinc finger protein 562 OS=Homo sapiens GN=ZNF562 PE=2 SV=2 | 178 | F | 0.310488 | L | 0.340074 | -0.029586 | No Change: Both O | - |
| Q6V9R5 | ZN562_HUMAN Zinc finger protein 562 OS=Homo sapiens GN=ZNF562 PE=2 SV=2 | 205 | K | 0.380741 | E | 0.377569 | 0.003172 | No Change: Both O | - |
| Q6V9R5 | ZN562_HUMAN Zinc finger protein 562 OS=Homo sapiens GN=ZNF562 PE=2 SV=2 | 260 | E | 0.849862 | K | 0.866166 | -0.016304 | No Change: Both D | - |
| Q8N9K5 | ZN565_HUMAN Zinc finger protein 565 OS=Homo sapiens GN=ZNF565 PE=2 SV=1 | 188 | I | 0.707872 | T | 0.791857 | -0.083985 | No Change: Both D | - |
| Q3ZCX4 | ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens GN=ZNF568 PE=2 SV=2 | 437 | M | 0.640238 | T | 0.687261 | -0.047023 | No Change: Both D | - |
| Q3ZCX4 | ZN568_HUMAN Zinc finger protein 568 OS=Homo sapiens GN=ZNF568 PE=2 SV=2 | 642 | Q | 0.742881 | R | 0.75094 | -0.008059 | No Change: Both D | - |
| Q5MCW4 | ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens GN=ZNF569 PE=2 SV=1 | 29 | Q | 0.357805 | E | 0.411601 | -0.053796 | No Change: Both O | A breast cancer sample |
| Q5MCW4 | ZN569_HUMAN Zinc finger protein 569 OS=Homo sapiens GN=ZNF569 PE=2 SV=1 | 87 | E | 0.551601 | G | 0.475854 | 0.075747 | D to O | A breast cancer sample |
| Q68EA5 | ZNF57_HUMAN Zinc finger protein 57 OS=Homo sapiens GN=ZNF57 PE=2 SV=3 | 223 | T | 0.536326 | N | 0.520828 | 0.015498 | No Change: Both D | - |
| Q68EA5 | ZNF57_HUMAN Zinc finger protein 57 OS=Homo sapiens GN=ZNF57 PE=2 SV=3 | 230 | R | 0.342642 | W | 0.142386 | 0.200256 | No Change: Both O | - |
| Q68EA5 | ZNF57_HUMAN Zinc finger protein 57 OS=Homo sapiens GN=ZNF57 PE=2 SV=3 | 357 | T | 0.607984 | M | 0.546869 | 0.061115 | No Change: Both D | - |
| Q7Z3V5 | ZN571_HUMAN Zinc finger protein 571 OS=Homo sapiens GN=ZNF571 PE=2 SV=3 | 189 | Q | 0.661945 | H | 0.621429 | 0.040516 | No Change: Both D | - |
| Q7Z3V5 | ZN571_HUMAN Zinc finger protein 571 OS=Homo sapiens GN=ZNF571 PE=2 SV=3 | 252 | E | 0.579815 | D | 0.517187 | 0.062628 | No Change: Both D | - |
| Q7Z3V5 | ZN571_HUMAN Zinc finger protein 571 OS=Homo sapiens GN=ZNF571 PE=2 SV=3 | 573 | L | 0.643647 | H | 0.72654 | -0.082893 | No Change: Both D | - |
| Q7Z3V5 | ZN571_HUMAN Zinc finger protein 571 OS=Homo sapiens GN=ZNF571 PE=2 SV=3 | 593 | K | 0.448902 | E | 0.447897 | 0.001005 | No Change: Both O | - |
| Q7Z3V5 | ZN571_HUMAN Zinc finger protein 571 OS=Homo sapiens GN=ZNF571 PE=2 SV=3 | 170 | K | 0.764111 | M | 0.675259 | 0.088852 | No Change: Both D | - |
| Q7Z3I7 | ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens GN=ZNF572 PE=2 SV=1 | 317 | K | 0.674626 | T | 0.620037 | 0.054589 | No Change: Both D | - |
| Q7Z3I7 | ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens GN=ZNF572 PE=2 SV=1 | 380 | G | 0.657891 | E | 0.722667 | -0.064776 | No Change: Both D | - |
| Q7Z3I7 | ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens GN=ZNF572 PE=2 SV=1 | 448 | S | 0.60428 | C | 0.477051 | 0.127229 | D to O | - |
| Q7Z3I7 | ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens GN=ZNF572 PE=2 SV=1 | 500 | V | 0.54694 | I | 0.53292 | 0.01402 | No Change: Both D | - |
| Q7Z3I7 | ZN572_HUMAN Zinc finger protein 572 OS=Homo sapiens GN=ZNF572 PE=2 SV=1 | 512 | C | 0.523596 | F | 0.542874 | -0.019278 | No Change: Both D | A colorectal cancer sample |
| Q86YE8 | ZN573_HUMAN Zinc finger protein 573 OS=Homo sapiens GN=ZNF573 PE=2 SV=3 | 166 | G | 0.563361 | A | 0.482492 | 0.080869 | D to O | - |
| Q86YE8 | ZN573_HUMAN Zinc finger protein 573 OS=Homo sapiens GN=ZNF573 PE=2 SV=3 | 204 | G | 0.19959 | A | 0.172154 | 0.027436 | No Change: Both O | - |
| Q6ZN55 | ZN574_HUMAN Zinc finger protein 574 OS=Homo sapiens GN=ZNF574 PE=1 SV=2 | 332 | R | 0.733103 | Q | 0.756778 | -0.023675 | No Change: Both D | - |
| Q6ZN55 | ZN574_HUMAN Zinc finger protein 574 OS=Homo sapiens GN=ZNF574 PE=1 SV=2 | 785 | R | 0.635138 | Q | 0.621098 | 0.01404 | No Change: Both D | - |
| Q6ZN55 | ZN574_HUMAN Zinc finger protein 574 OS=Homo sapiens GN=ZNF574 PE=1 SV=2 | 711 | T | 0.98171 | S | 0.986645 | -0.004935 | No Change: Both D | - |
| Q9H609 | ZN576_HUMAN Zinc finger protein 576 OS=Homo sapiens GN=ZNF576 PE=1 SV=1 | 81 | P | 0.414339 | L | 0.295591 | 0.118748 | No Change: Both O | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 357 | R | 0.505275 | S | 0.544308 | -0.039033 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 84 | A | 0.609101 | V | 0.520891 | 0.08821 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 123 | R | 0.420972 | C | 0.305771 | 0.115201 | No Change: Both O | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 234 | R | 0.882368 | K | 0.891558 | -0.00919 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 246 | K | 0.808382 | E | 0.793241 | 0.015141 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 346 | R | 0.729613 | C | 0.657928 | 0.071685 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 373 | E | 0.531391 | K | 0.535742 | -0.004351 | No Change: Both D | - |
| Q9BSK1 | ZN577_HUMAN Zinc finger protein 577 OS=Homo sapiens GN=ZNF577 PE=2 SV=3 | 375 | T | 0.533712 | I | 0.418473 | 0.115239 | D to O | - |
| Q8NAF0 | ZN579_HUMAN Zinc finger protein 579 OS=Homo sapiens GN=ZNF579 PE=1 SV=2 | 353 | E | 0.986927 | D | 0.985362 | 0.001565 | No Change: Both D | - |
| Q96NG8 | ZN582_HUMAN Zinc finger protein 582 OS=Homo sapiens GN=ZNF582 PE=2 SV=1 | 69 | R | 0.207837 | T | 0.194167 | 0.01367 | No Change: Both O | - |
| Q96ND8 | ZN583_HUMAN Zinc finger protein 583 OS=Homo sapiens GN=ZNF583 PE=2 SV=2 | 324 | F | 0.373767 | I | 0.37044 | 0.003327 | No Change: Both O | - |
| Q8IVC4 | ZN584_HUMAN Zinc finger protein 584 OS=Homo sapiens GN=ZNF584 PE=2 SV=1 | 142 | P | 0.7433 | S | 0.757577 | -0.014277 | No Change: Both D | - |
| Q8IVC4 | ZN584_HUMAN Zinc finger protein 584 OS=Homo sapiens GN=ZNF584 PE=2 SV=1 | 301 | T | 0.266402 | A | 0.221313 | 0.045089 | No Change: Both O | - |
| Q52M93 | Z585B_HUMAN Zinc finger protein 585B OS=Homo sapiens GN=ZNF585B PE=2 SV=1 | 467 | V | 0.376371 | I | 0.376229 | 1.42E-04 | No Change: Both O | - |
| Q86UQ0 | ZN589_HUMAN Zinc finger protein 589 OS=Homo sapiens GN=ZNF589 PE=1 SV=1 | 216 | T | 0.419672 | R | 0.466209 | -0.046537 | No Change: Both O | - |
| Q86UQ0 | ZN589_HUMAN Zinc finger protein 589 OS=Homo sapiens GN=ZNF589 PE=1 SV=1 | 12 | T | 0.240065 | A | 0.245632 | -0.005567 | No Change: Both O | - |
| Q92610 | ZN592_HUMAN Zinc finger protein 592 OS=Homo sapiens GN=ZNF592 PE=1 SV=2 | 926 | S | 0.904748 | N | 0.87641 | 0.028338 | No Change: Both D | - |
| Q92610 | ZN592_HUMAN Zinc finger protein 592 OS=Homo sapiens GN=ZNF592 PE=1 SV=2 | 1046 | G | 0.393058 | R | 0.470929 | -0.077871 | No Change: Both O | Spinocerebellar ataxia autosomal recessive type 5 (SCAR5) [MIM:606937] |
| O00488 | ZN593_HUMAN Zinc finger protein 593 OS=Homo sapiens GN=ZNF593 PE=1 SV=2 | 6 | R | 0.978943 | Q | 0.972957 | 0.005986 | No Change: Both D | - |
| Q96JF6 | ZN594_HUMAN Zinc finger protein 594 OS=Homo sapiens GN=ZNF594 PE=2 SV=3 | 171 | I | 0.45427 | T | 0.573016 | -0.118746 | O to D | - |
| Q96JF6 | ZN594_HUMAN Zinc finger protein 594 OS=Homo sapiens GN=ZNF594 PE=2 SV=3 | 199 | V | 0.567109 | G | 0.70817 | -0.141061 | No Change: Both D | - |
| Q96JF6 | ZN594_HUMAN Zinc finger protein 594 OS=Homo sapiens GN=ZNF594 PE=2 SV=3 | 166 | Q | 0.581941 | H | 0.571529 | 0.010412 | No Change: Both D | - |
| Q8IYB9 | ZN595_HUMAN Zinc finger protein 595 OS=Homo sapiens GN=ZNF595 PE=2 SV=1 | 628 | A | 0.583213 | G | 0.669568 | -0.086355 | No Change: Both D | - |
| Q8TC21 | ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens GN=ZNF596 PE=2 SV=2 | 136 | T | 0.21172 | K | 0.278351 | -0.066631 | No Change: Both O | - |
| Q8TC21 | ZN596_HUMAN Zinc finger protein 596 OS=Homo sapiens GN=ZNF596 PE=2 SV=2 | 476 | V | 0.232523 | G | 0.357539 | -0.125016 | No Change: Both O | - |
| Q96LX8 | ZN597_HUMAN Zinc finger protein 597 OS=Homo sapiens GN=ZNF597 PE=2 SV=1 | 30 | T | 0.490323 | S | 0.571708 | -0.081385 | O to D | - |
| Q86UK7 | ZN598_HUMAN Zinc finger protein 598 OS=Homo sapiens GN=ZNF598 PE=1 SV=1 | 453 | S | 0.91983 | Y | 0.837449 | 0.082381 | No Change: Both D | - |
| Q86UK7 | ZN598_HUMAN Zinc finger protein 598 OS=Homo sapiens GN=ZNF598 PE=1 SV=1 | 725 | C | 0.948965 | S | 0.968429 | -0.019464 | No Change: Both D | - |
| Q86UK7 | ZN598_HUMAN Zinc finger protein 598 OS=Homo sapiens GN=ZNF598 PE=1 SV=1 | 637 | T | 0.961356 | M | 0.959741 | 0.001615 | No Change: Both D | - |
| Q86UK7 | ZN598_HUMAN Zinc finger protein 598 OS=Homo sapiens GN=ZNF598 PE=1 SV=1 | 608 | A | 0.971663 | T | 0.974416 | -0.002753 | No Change: Both D | - |
| Q96NL3 | ZN599_HUMAN Zinc finger protein 599 OS=Homo sapiens GN=ZNF599 PE=2 SV=1 | 178 | L | 0.759539 | F | 0.716072 | 0.043467 | No Change: Both D | - |
| Q6ZNG1 | ZN600_HUMAN Zinc finger protein 600 OS=Homo sapiens GN=ZNF600 PE=1 SV=2 | 2 | M | 0.883655 | V | 0.883439 | 2.16E-04 | No Change: Both D | - |
| Q6ZNG1 | ZN600_HUMAN Zinc finger protein 600 OS=Homo sapiens GN=ZNF600 PE=1 SV=2 | 13 | T | 0.523353 | R | 0.51238 | 0.010973 | No Change: Both D | - |
| Q6ZNG1 | ZN600_HUMAN Zinc finger protein 600 OS=Homo sapiens GN=ZNF600 PE=1 SV=2 | 209 | C | 0.399356 | R | 0.468546 | -0.06919 | No Change: Both O | - |
| Q8WXB4 | ZN606_HUMAN Zinc finger protein 606 OS=Homo sapiens GN=ZNF606 PE=2 SV=1 | 141 | S | 0.368347 | G | 0.299261 | 0.069086 | No Change: Both O | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 2 | S | 0.886632 | A | 0.787143 | 0.099489 | No Change: Both D | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 70 | R | 0.383604 | H | 0.346746 | 0.036858 | No Change: Both O | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 123 | F | 0.59583 | L | 0.648944 | -0.053114 | No Change: Both D | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 375 | S | 0.522649 | T | 0.450511 | 0.072138 | D to O | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 653 | A | 0.523908 | P | 0.615343 | -0.091435 | No Change: Both D | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 433 | R | 0.515555 | H | 0.524746 | -0.009191 | No Change: Both D | - |
| Q96SK3 | ZN607_HUMAN Zinc finger protein 607 OS=Homo sapiens GN=ZNF607 PE=2 SV=3 | 531 | K | 0.604825 | R | 0.540413 | 0.064412 | No Change: Both D | - |
| Q9ULD9 | ZN608_HUMAN Zinc finger protein 608 OS=Homo sapiens GN=ZNF608 PE=1 SV=4 | 721 | T | 0.952618 | N | 0.958355 | -0.005737 | No Change: Both D | - |
| Q8N9Z0 | ZN610_HUMAN Zinc finger protein 610 OS=Homo sapiens GN=ZNF610 PE=2 SV=2 | 216 | R | 0.260165 | P | 0.278067 | -0.017902 | No Change: Both O | - |
| Q8N9Z0 | ZN610_HUMAN Zinc finger protein 610 OS=Homo sapiens GN=ZNF610 PE=2 SV=2 | 104 | V | 0.488216 | M | 0.537037 | -0.048821 | O to D | - |
| Q8N9Z0 | ZN610_HUMAN Zinc finger protein 610 OS=Homo sapiens GN=ZNF610 PE=2 SV=2 | 131 | A | 0.341536 | S | 0.467065 | -0.125529 | No Change: Both O | - |
| Q8N9Z0 | ZN610_HUMAN Zinc finger protein 610 OS=Homo sapiens GN=ZNF610 PE=2 SV=2 | 298 | R | 0.505658 | I | 0.346158 | 0.1595 | D to O | - |
| Q8N823 | ZN611_HUMAN Zinc finger protein 611 OS=Homo sapiens GN=ZNF611 PE=2 SV=2 | 252 | P | 0.462928 | L | 0.35039 | 0.112538 | No Change: Both O | - |
| Q8N823 | ZN611_HUMAN Zinc finger protein 611 OS=Homo sapiens GN=ZNF611 PE=2 SV=2 | 340 | E | 0.433751 | G | 0.387419 | 0.046332 | No Change: Both O | - |
| Q8N823 | ZN611_HUMAN Zinc finger protein 611 OS=Homo sapiens GN=ZNF611 PE=2 SV=2 | 252 | P | 0.462928 | T | 0.406606 | 0.056322 | No Change: Both O | - |
| Q8N823 | ZN611_HUMAN Zinc finger protein 611 OS=Homo sapiens GN=ZNF611 PE=2 SV=2 | 234 | N | 0.722996 | I | 0.561227 | 0.161769 | No Change: Both D | - |
| Q8N823 | ZN611_HUMAN Zinc finger protein 611 OS=Homo sapiens GN=ZNF611 PE=2 SV=2 | 252 | P | 0.462928 | I | 0.305418 | 0.15751 | No Change: Both O | - |
| Q6PF04 | ZN613_HUMAN Zinc finger protein 613 OS=Homo sapiens GN=ZNF613 PE=2 SV=2 | 84 | D | 0.548331 | N | 0.565393 | -0.017062 | No Change: Both D | - |
| Q6PF04 | ZN613_HUMAN Zinc finger protein 613 OS=Homo sapiens GN=ZNF613 PE=2 SV=2 | 93 | K | 0.665704 | E | 0.65595 | 0.009754 | No Change: Both D | - |
| Q6PF04 | ZN613_HUMAN Zinc finger protein 613 OS=Homo sapiens GN=ZNF613 PE=2 SV=2 | 135 | I | 0.395154 | R | 0.553985 | -0.158831 | O to D | - |
| Q6PF04 | ZN613_HUMAN Zinc finger protein 613 OS=Homo sapiens GN=ZNF613 PE=2 SV=2 | 163 | S | 0.558046 | F | 0.380548 | 0.177498 | D to O | - |
| Q6PF04 | ZN613_HUMAN Zinc finger protein 613 OS=Homo sapiens GN=ZNF613 PE=2 SV=2 | 611 | D | 0.798389 | V | 0.754707 | 0.043682 | No Change: Both D | - |
| Q8N883 | ZN614_HUMAN Zinc finger protein 614 OS=Homo sapiens GN=ZNF614 PE=2 SV=2 | 68 | T | 0.44059 | I | 0.309302 | 0.131288 | No Change: Both O | - |
| Q8N883 | ZN614_HUMAN Zinc finger protein 614 OS=Homo sapiens GN=ZNF614 PE=2 SV=2 | 223 | H | 0.353777 | R | 0.402423 | -0.048646 | No Change: Both O | - |
| Q8N883 | ZN614_HUMAN Zinc finger protein 614 OS=Homo sapiens GN=ZNF614 PE=2 SV=2 | 415 | V | 0.307525 | I | 0.296258 | 0.011267 | No Change: Both O | - |
| Q8N883 | ZN614_HUMAN Zinc finger protein 614 OS=Homo sapiens GN=ZNF614 PE=2 SV=2 | 160 | G | 0.444965 | E | 0.510885 | -0.06592 | O to D | - |
| Q8N8J6 | ZN615_HUMAN Zinc finger protein 615 OS=Homo sapiens GN=ZNF615 PE=1 SV=2 | 129 | T | 0.609567 | M | 0.639906 | -0.030339 | No Change: Both D | - |
| Q8N8J6 | ZN615_HUMAN Zinc finger protein 615 OS=Homo sapiens GN=ZNF615 PE=1 SV=2 | 360 | T | 0.634399 | I | 0.499 | 0.135399 | D to O | - |
| Q8N8J6 | ZN615_HUMAN Zinc finger protein 615 OS=Homo sapiens GN=ZNF615 PE=1 SV=2 | 727 | R | 0.567694 | K | 0.593655 | -0.025961 | No Change: Both D | - |
| Q08AN1 | ZN616_HUMAN Zinc finger protein 616 OS=Homo sapiens GN=ZNF616 PE=2 SV=2 | 451 | H | 0.301137 | R | 0.29306 | 0.008077 | No Change: Both O | - |
| Q08AN1 | ZN616_HUMAN Zinc finger protein 616 OS=Homo sapiens GN=ZNF616 PE=2 SV=2 | 50 | P | 0.125792 | S | 0.138838 | -0.013046 | No Change: Both O | - |
| O75123 | ZN623_HUMAN Zinc finger protein 623 OS=Homo sapiens GN=ZNF623 PE=2 SV=2 | 126 | N | 0.180352 | D | 0.180508 | -1.56E-04 | No Change: Both O | - |
| Q9P2J8 | ZN624_HUMAN Zinc finger protein 624 OS=Homo sapiens GN=ZNF624 PE=2 SV=3 | 558 | C | 0.432843 | S | 0.592148 | -0.159305 | O to D | A colorectal cancer sample |
| Q9P2J8 | ZN624_HUMAN Zinc finger protein 624 OS=Homo sapiens GN=ZNF624 PE=2 SV=3 | 135 | K | 0.778226 | N | 0.727125 | 0.051101 | No Change: Both D | - |
| Q96I27 | ZN625_HUMAN Zinc finger protein 625 OS=Homo sapiens GN=ZNF625 PE=2 SV=1 | 41 | V | 0.569044 | M | 0.631879 | -0.062835 | No Change: Both D | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 31 | N | 0.229521 | D | 0.225991 | 0.00353 | No Change: Both O | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 68 | N | 0.493566 | H | 0.48698 | 0.006586 | No Change: Both O | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 65 | M | 0.508176 | T | 0.540588 | -0.032412 | No Change: Both D | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 89 | Q | 0.518549 | E | 0.539153 | -0.020604 | No Change: Both D | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 90 | S | 0.512083 | N | 0.452761 | 0.059322 | D to O | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 464 | C | 0.679496 | Y | 0.60789 | 0.071606 | No Change: Both D | - |
| Q68DY1 | ZN626_HUMAN Zinc finger protein 626 OS=Homo sapiens GN=ZNF626 PE=2 SV=2 | 500 | E | 0.449931 | K | 0.450742 | -8.11E-04 | No Change: Both O | - |
| Q9UEG4 | ZN629_HUMAN Zinc finger protein 629 OS=Homo sapiens GN=ZNF629 PE=2 SV=2 | 707 | P | 0.67384 | A | 0.568207 | 0.105633 | No Change: Both D | - |
| Q14966 | ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens GN=ZNF638 PE=1 SV=2 | 110 | I | 0.840082 | V | 0.881531 | -0.041449 | No Change: Both D | - |
| Q14966 | ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens GN=ZNF638 PE=1 SV=2 | 980 | N | 0.53087 | S | 0.568173 | -0.037303 | No Change: Both D | - |
| Q14966 | ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens GN=ZNF638 PE=1 SV=2 | 1726 | V | 0.661273 | M | 0.695812 | -0.034539 | No Change: Both D | - |
| Q14966 | ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens GN=ZNF638 PE=1 SV=2 | 1912 | A | 0.802903 | V | 0.789863 | 0.01304 | No Change: Both D | - |
| Q14966 | ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens GN=ZNF638 PE=1 SV=2 | 1462 | S | 0.940494 | N | 0.902846 | 0.037648 | No Change: Both D | - |
| Q96N77 | ZN641_HUMAN Zinc finger protein 641 OS=Homo sapiens GN=ZNF641 PE=2 SV=2 | 231 | S | 0.903745 | C | 0.83224 | 0.071505 | No Change: Both D | - |
| Q96N77 | ZN641_HUMAN Zinc finger protein 641 OS=Homo sapiens GN=ZNF641 PE=2 SV=2 | 363 | Q | 0.893921 | P | 0.91802 | -0.024099 | No Change: Both D | - |
| Q49AA0 | ZN642_HUMAN Zinc finger protein 642 OS=Homo sapiens GN=ZNF642 PE=1 SV=2 | 113 | V | 0.298017 | L | 0.306372 | -0.008355 | No Change: Both O | - |
| Q9UJL9 | ZN643_HUMAN Zinc finger protein 643 OS=Homo sapiens GN=ZNF643 PE=2 SV=2 | 115 | C | 0.270967 | Y | 0.293496 | -0.022529 | No Change: Both O | - |
| Q9UJL9 | ZN643_HUMAN Zinc finger protein 643 OS=Homo sapiens GN=ZNF643 PE=2 SV=2 | 359 | G | 0.532275 | R | 0.580835 | -0.04856 | No Change: Both D | - |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 53 | E | 0.777264 | Q | 0.759943 | 0.017321 | No Change: Both D | A breast cancer sample |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 556 | M | 0.310435 | V | 0.258345 | 0.05209 | No Change: Both O | - |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 794 | A | 0.956655 | V | 0.950532 | 0.006123 | No Change: Both D | - |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 587 | I | 0.658523 | V | 0.713455 | -0.054932 | No Change: Both D | Myopia type 21 (MYP21) [MIM:614167] |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 672 | S | 0.949335 | G | 0.925749 | 0.023586 | No Change: Both D | Myopia type 21 (MYP21) [MIM:614167] |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 680 | R | 0.933066 | G | 0.918641 | 0.014425 | No Change: Both D | Myopia type 21 (MYP21) [MIM:614167] |
| Q9H582 | ZN644_HUMAN Zinc finger protein 644 OS=Homo sapiens GN=ZNF644 PE=1 SV=2 | 699 | C | 0.890405 | Y | 0.86974 | 0.020665 | No Change: Both D | Myopia type 21 (MYP21) [MIM:614167] |
| Q8N7E2 | ZN645_HUMAN E3 ubiquitin-protein ligase ZNF645 OS=Homo sapiens GN=ZNF645 PE=2 SV=1 | 166 | D | 0.836745 | E | 0.850418 | -0.013673 | No Change: Both D | - |
| Q8N7E2 | ZN645_HUMAN E3 ubiquitin-protein ligase ZNF645 OS=Homo sapiens GN=ZNF645 PE=2 SV=1 | 287 | S | 0.985115 | F | 0.964097 | 0.021018 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 1337 | N | 0.83097 | I | 0.713899 | 0.117071 | No Change: Both D | A breast cancer sample |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 98 | A | 0.940826 | V | 0.918233 | 0.022593 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 327 | E | 0.962063 | G | 0.949537 | 0.012526 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 774 | I | 0.785791 | M | 0.853077 | -0.067286 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 921 | G | 0.974292 | A | 0.973127 | 0.001165 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 1249 | R | 0.690248 | W | 0.415766 | 0.274482 | D to O | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 1318 | R | 0.797693 | Q | 0.786675 | 0.011018 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 1477 | G | 0.547657 | D | 0.526432 | 0.021225 | No Change: Both D | - |
| O15015 | ZN646_HUMAN Zinc finger protein 646 OS=Homo sapiens GN=ZNF646 PE=1 SV=1 | 1788 | T | 0.88303 | M | 0.867705 | 0.015325 | No Change: Both D | - |
| Q5T619 | ZN648_HUMAN Zinc finger protein 648 OS=Homo sapiens GN=ZNF648 PE=1 SV=1 | 111 | N | 0.791569 | K | 0.846368 | -0.054799 | No Change: Both D | - |
| Q5T619 | ZN648_HUMAN Zinc finger protein 648 OS=Homo sapiens GN=ZNF648 PE=1 SV=1 | 42 | E | 0.945025 | K | 0.934796 | 0.010229 | No Change: Both D | - |
| Q9BS31 | ZN649_HUMAN Zinc finger protein 649 OS=Homo sapiens GN=ZNF649 PE=2 SV=1 | 352 | G | 0.305851 | D | 0.315701 | -0.00985 | No Change: Both O | - |
| Q9BS31 | ZN649_HUMAN Zinc finger protein 649 OS=Homo sapiens GN=ZNF649 PE=2 SV=1 | 469 | A | 0.843456 | T | 0.864487 | -0.021031 | No Change: Both D | - |
| Q96CK0 | ZN653_HUMAN Zinc finger protein 653 OS=Homo sapiens GN=ZNF653 PE=1 SV=1 | 54 | K | 0.772989 | R | 0.791266 | -0.018277 | No Change: Both D | - |
| Q96CK0 | ZN653_HUMAN Zinc finger protein 653 OS=Homo sapiens GN=ZNF653 PE=1 SV=1 | 329 | A | 0.291911 | T | 0.298409 | -0.006498 | No Change: Both O | - |
| Q8N720 | ZN655_HUMAN Zinc finger protein 655 OS=Homo sapiens GN=ZNF655 PE=1 SV=3 | 52 | E | 0.740998 | D | 0.712529 | 0.028469 | No Change: Both D | - |
| Q5TYW1 | ZN658_HUMAN Zinc finger protein 658 OS=Homo sapiens GN=ZNF658 PE=2 SV=2 | 68 | S | 0.452015 | Y | 0.287205 | 0.16481 | No Change: Both O | - |
| Q6ZS27 | ZN662_HUMAN Zinc finger protein 662 OS=Homo sapiens GN=ZNF662 PE=2 SV=1 | 176 | N | 0.426036 | S | 0.457337 | -0.031301 | No Change: Both O | - |
| Q9H7R5 | ZN665_HUMAN Zinc finger protein 665 OS=Homo sapiens GN=ZNF665 PE=1 SV=2 | 19 | V | 0.255165 | A | 0.318549 | -0.063384 | No Change: Both O | - |
| Q9H7R5 | ZN665_HUMAN Zinc finger protein 665 OS=Homo sapiens GN=ZNF665 PE=1 SV=2 | 92 | H | 0.549925 | R | 0.576945 | -0.02702 | No Change: Both D | - |
| Q9H7R5 | ZN665_HUMAN Zinc finger protein 665 OS=Homo sapiens GN=ZNF665 PE=1 SV=2 | 582 | V | 0.408056 | I | 0.371642 | 0.036414 | No Change: Both O | - |
| Q5HYK9 | ZN667_HUMAN Zinc finger protein 667 OS=Homo sapiens GN=ZNF667 PE=2 SV=2 | 260 | K | 0.427411 | R | 0.363598 | 0.063813 | No Change: Both O | - |
| Q5HYK9 | ZN667_HUMAN Zinc finger protein 667 OS=Homo sapiens GN=ZNF667 PE=2 SV=2 | 540 | T | 0.615386 | A | 0.577132 | 0.038254 | No Change: Both D | - |
| Q5HYK9 | ZN667_HUMAN Zinc finger protein 667 OS=Homo sapiens GN=ZNF667 PE=2 SV=2 | 134 | P | 0.935664 | L | 0.89924 | 0.036424 | No Change: Both D | - |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 25 | V | 0.822627 | L | 0.800986 | 0.021641 | No Change: Both D | - |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 304 | G | 0.820465 | E | 0.852368 | -0.031903 | No Change: Both D | - |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 447 | A | 0.840333 | V | 0.786596 | 0.053737 | No Change: Both D | - |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 66 | A | 0.983549 | T | 0.98298 | 5.69E-04 | No Change: Both D | A breast cancer sample |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 286 | G | 0.835885 | S | 0.874834 | -0.038949 | No Change: Both D | A breast cancer sample |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 331 | T | 0.46239 | R | 0.526681 | -0.064291 | O to D | A breast cancer sample |
| Q96K58 | ZN668_HUMAN Zinc finger protein 668 OS=Homo sapiens GN=ZNF668 PE=2 SV=3 | 556 | R | 0.895896 | Q | 0.881655 | 0.014241 | No Change: Both D | A breast cancer sample |
| Q96BR6 | ZN669_HUMAN Zinc finger protein 669 OS=Homo sapiens GN=ZNF669 PE=2 SV=2 | 76 | E | 0.696148 | D | 0.661015 | 0.035133 | No Change: Both D | - |
| Q96BR6 | ZN669_HUMAN Zinc finger protein 669 OS=Homo sapiens GN=ZNF669 PE=2 SV=2 | 460 | G | 0.403492 | S | 0.447414 | -0.043922 | No Change: Both O | - |
| Q8TAW3 | ZN671_HUMAN Zinc finger protein 671 OS=Homo sapiens GN=ZNF671 PE=2 SV=2 | 149 | A | 0.317698 | V | 0.276007 | 0.041691 | No Change: Both O | - |
| Q8TAW3 | ZN671_HUMAN Zinc finger protein 671 OS=Homo sapiens GN=ZNF671 PE=2 SV=2 | 237 | P | 0.750669 | S | 0.771961 | -0.021292 | No Change: Both D | - |
| Q2M3X9 | ZN674_HUMAN Zinc finger protein 674 OS=Homo sapiens GN=ZNF674 PE=1 SV=1 | 343 | T | 0.495785 | M | 0.442676 | 0.053109 | No Change: Both O | - |
| Q2M3X9 | ZN674_HUMAN Zinc finger protein 674 OS=Homo sapiens GN=ZNF674 PE=1 SV=1 | 412 | P | 0.714883 | L | 0.599524 | 0.115359 | No Change: Both D | Mental retardation X-linked type 92 (MRX92) [MIM:300851] |
| Q2M3X9 | ZN674_HUMAN Zinc finger protein 674 OS=Homo sapiens GN=ZNF674 PE=1 SV=1 | 182 | L | 0.131744 | F | 0.119447 | 0.012297 | No Change: Both O | - |
| Q8TD23 | ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens GN=ZNF675 PE=1 SV=3 | 197 | V | 0.651787 | A | 0.708022 | -0.056235 | No Change: Both D | - |
| Q8TD23 | ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens GN=ZNF675 PE=1 SV=3 | 124 | L | 0.502662 | V | 0.498024 | 0.004638 | D to O | - |
| Q8TD23 | ZN675_HUMAN Zinc finger protein 675 OS=Homo sapiens GN=ZNF675 PE=1 SV=3 | 410 | A | 0.866851 | T | 0.892021 | -0.02517 | No Change: Both D | - |
| Q8N7Q3 | ZN676_HUMAN Zinc finger protein 676 OS=Homo sapiens GN=ZNF676 PE=2 SV=2 | 27 | G | 0.296215 | E | 0.365334 | -0.069119 | No Change: Both O | - |
| Q8N7Q3 | ZN676_HUMAN Zinc finger protein 676 OS=Homo sapiens GN=ZNF676 PE=2 SV=2 | 96 | E | 0.48923 | K | 0.503783 | -0.014553 | O to D | - |
| Q8N7Q3 | ZN676_HUMAN Zinc finger protein 676 OS=Homo sapiens GN=ZNF676 PE=2 SV=2 | 292 | S | 0.913736 | W | 0.778914 | 0.134822 | No Change: Both D | - |
| Q86XU0 | ZN677_HUMAN Zinc finger protein 677 OS=Homo sapiens GN=ZNF677 PE=2 SV=1 | 56 | D | 0.59125 | N | 0.573507 | 0.017743 | No Change: Both D | - |
| Q86XU0 | ZN677_HUMAN Zinc finger protein 677 OS=Homo sapiens GN=ZNF677 PE=2 SV=1 | 254 | G | 0.394134 | E | 0.460747 | -0.066613 | No Change: Both O | - |
| Q5SXM1 | ZN678_HUMAN Zinc finger protein 678 OS=Homo sapiens GN=ZNF678 PE=2 SV=1 | 144 | K | 0.578258 | E | 0.569523 | 0.008735 | No Change: Both D | - |
| Q5SXM1 | ZN678_HUMAN Zinc finger protein 678 OS=Homo sapiens GN=ZNF678 PE=2 SV=1 | 197 | T | 0.412114 | I | 0.303275 | 0.108839 | No Change: Both O | - |
| Q5SXM1 | ZN678_HUMAN Zinc finger protein 678 OS=Homo sapiens GN=ZNF678 PE=2 SV=1 | 152 | P | 0.492482 | T | 0.480177 | 0.012305 | No Change: Both O | - |
| Q8IYX0 | ZN679_HUMAN Zinc finger protein 679 OS=Homo sapiens GN=ZNF679 PE=2 SV=2 | 69 | E | 0.255389 | G | 0.198214 | 0.057175 | No Change: Both O | - |
| Q8IYX0 | ZN679_HUMAN Zinc finger protein 679 OS=Homo sapiens GN=ZNF679 PE=2 SV=2 | 120 | H | 0.611738 | R | 0.668605 | -0.056867 | No Change: Both D | - |
| Q8IYX0 | ZN679_HUMAN Zinc finger protein 679 OS=Homo sapiens GN=ZNF679 PE=2 SV=2 | 212 | Y | 0.659591 | H | 0.778531 | -0.11894 | No Change: Both D | - |
| Q8IYX0 | ZN679_HUMAN Zinc finger protein 679 OS=Homo sapiens GN=ZNF679 PE=2 SV=2 | 223 | C | 0.680116 | S | 0.805956 | -0.12584 | No Change: Both D | - |
| Q8NEM1 | ZN680_HUMAN Zinc finger protein 680 OS=Homo sapiens GN=ZNF680 PE=2 SV=2 | 132 | S | 0.555376 | F | 0.349948 | 0.205428 | D to O | - |
| Q8NEM1 | ZN680_HUMAN Zinc finger protein 680 OS=Homo sapiens GN=ZNF680 PE=2 SV=2 | 330 | D | 0.630691 | G | 0.647611 | -0.01692 | No Change: Both D | - |
| Q8NEM1 | ZN680_HUMAN Zinc finger protein 680 OS=Homo sapiens GN=ZNF680 PE=2 SV=2 | 525 | N | 0.797282 | D | 0.800089 | -0.002807 | No Change: Both D | - |
| Q96N22 | ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens GN=ZNF681 PE=2 SV=2 | 84 | D | 0.532127 | H | 0.511725 | 0.020402 | No Change: Both D | - |
| Q96N22 | ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens GN=ZNF681 PE=2 SV=2 | 295 | L | 0.419609 | S | 0.593266 | -0.173657 | O to D | - |
| Q96N22 | ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens GN=ZNF681 PE=2 SV=2 | 367 | R | 0.658157 | K | 0.705007 | -0.04685 | No Change: Both D | - |
| Q96N22 | ZN681_HUMAN Zinc finger protein 681 OS=Homo sapiens GN=ZNF681 PE=2 SV=2 | 548 | H | 0.628148 | Q | 0.626249 | 0.001899 | No Change: Both D | - |
| O95780 | ZN682_HUMAN Zinc finger protein 682 OS=Homo sapiens GN=ZNF682 PE=2 SV=1 | 65 | V | 0.543735 | M | 0.638404 | -0.094669 | No Change: Both D | - |
| O95780 | ZN682_HUMAN Zinc finger protein 682 OS=Homo sapiens GN=ZNF682 PE=2 SV=1 | 209 | T | 0.286876 | I | 0.193521 | 0.093355 | No Change: Both O | - |
| O95780 | ZN682_HUMAN Zinc finger protein 682 OS=Homo sapiens GN=ZNF682 PE=2 SV=1 | 450 | V | 0.69623 | I | 0.707655 | -0.011425 | No Change: Both D | - |
| Q8IZ20 | ZN683_HUMAN Zinc finger protein 683 OS=Homo sapiens GN=ZNF683 PE=2 SV=3 | 204 | H | 0.480615 | N | 0.479177 | 0.001438 | No Change: Both O | - |
| Q8IZ20 | ZN683_HUMAN Zinc finger protein 683 OS=Homo sapiens GN=ZNF683 PE=2 SV=3 | 22 | G | 0.698486 | V | 0.555149 | 0.143337 | No Change: Both D | - |
| Q8IZ20 | ZN683_HUMAN Zinc finger protein 683 OS=Homo sapiens GN=ZNF683 PE=2 SV=3 | 48 | D | 0.569912 | G | 0.537093 | 0.032819 | No Change: Both D | - |
| Q8IZ20 | ZN683_HUMAN Zinc finger protein 683 OS=Homo sapiens GN=ZNF683 PE=2 SV=3 | 53 | H | 0.569441 | R | 0.653584 | -0.084143 | No Change: Both D | - |
| Q8IZ20 | ZN683_HUMAN Zinc finger protein 683 OS=Homo sapiens GN=ZNF683 PE=2 SV=3 | 288 | R | 0.924157 | L | 0.89704 | 0.027117 | No Change: Both D | - |
| Q8N1G0 | ZN687_HUMAN Zinc finger protein 687 OS=Homo sapiens GN=ZNF687 PE=1 SV=1 | 259 | G | 0.960954 | E | 0.964473 | -0.003519 | No Change: Both D | - |
| Q8N1G0 | ZN687_HUMAN Zinc finger protein 687 OS=Homo sapiens GN=ZNF687 PE=1 SV=1 | 344 | R | 0.713564 | T | 0.723809 | -0.010245 | No Change: Both D | - |
| P0C7X2 | ZN688_HUMAN Zinc finger protein 688 OS=Homo sapiens GN=ZNF688 PE=2 SV=1 | 131 | S | 0.971354 | I | 0.951922 | 0.019432 | No Change: Both D | - |
| Q9BU19 | ZN692_HUMAN Zinc finger protein 692 OS=Homo sapiens GN=ZNF692 PE=1 SV=1 | 230 | P | 0.979897 | R | 0.971856 | 0.008041 | No Change: Both D | - |
| Q8IW36 | ZN695_HUMAN Zinc finger protein 695 OS=Homo sapiens GN=ZNF695 PE=2 SV=4 | 84 | R | 0.50745 | K | 0.580752 | -0.073302 | No Change: Both D | - |
| Q8IW36 | ZN695_HUMAN Zinc finger protein 695 OS=Homo sapiens GN=ZNF695 PE=2 SV=4 | 87 | V | 0.407389 | A | 0.495396 | -0.088007 | No Change: Both O | - |
| Q8IW36 | ZN695_HUMAN Zinc finger protein 695 OS=Homo sapiens GN=ZNF695 PE=2 SV=4 | 110 | M | 0.178973 | I | 0.124787 | 0.054186 | No Change: Both O | - |
| P17097 | ZNF7_HUMAN Zinc finger protein 7 OS=Homo sapiens GN=ZNF7 PE=1 SV=1 | 188 | G | 0.877913 | R | 0.87799 | -7.70E-05 | No Change: Both D | - |
| P17097 | ZNF7_HUMAN Zinc finger protein 7 OS=Homo sapiens GN=ZNF7 PE=1 SV=1 | 347 | S | 0.813792 | L | 0.696727 | 0.117065 | No Change: Both D | - |
| P17097 | ZNF7_HUMAN Zinc finger protein 7 OS=Homo sapiens GN=ZNF7 PE=1 SV=1 | 596 | L | 0.391148 | F | 0.375496 | 0.015652 | No Change: Both O | - |
| Q9H0M5 | ZN700_HUMAN Zinc finger protein 700 OS=Homo sapiens GN=ZNF700 PE=2 SV=1 | 321 | L | 0.743322 | V | 0.716341 | 0.026981 | No Change: Both D | - |
| Q9H0M5 | ZN700_HUMAN Zinc finger protein 700 OS=Homo sapiens GN=ZNF700 PE=2 SV=1 | 269 | E | 0.758587 | G | 0.710443 | 0.048144 | No Change: Both D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 4 | L | 0.456296 | P | 0.602026 | -0.14573 | O to D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 116 | T | 0.71472 | I | 0.599732 | 0.114988 | No Change: Both D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 455 | R | 0.869036 | C | 0.804503 | 0.064533 | No Change: Both D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 271 | T | 0.405214 | K | 0.472034 | -0.06682 | No Change: Both O | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 119 | L | 0.754215 | V | 0.739824 | 0.014391 | No Change: Both D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 429 | R | 0.593844 | H | 0.575074 | 0.01877 | No Change: Both D | - |
| Q9NV72 | ZN701_HUMAN Zinc finger protein 701 OS=Homo sapiens GN=ZNF701 PE=2 SV=2 | 240 | D | 0.3704 | E | 0.378985 | -0.008585 | No Change: Both O | - |
| Q6ZNC4 | ZN704_HUMAN Zinc finger protein 704 OS=Homo sapiens GN=ZNF704 PE=2 SV=1 | 35 | A | 0.736613 | S | 0.804577 | -0.067964 | No Change: Both D | - |
| Q6ZN79 | Z705A_HUMAN Zinc finger protein 705A OS=Homo sapiens GN=ZNF705A PE=2 SV=1 | 142 | K | 0.776762 | Q | 0.760457 | 0.016305 | No Change: Both D | - |
| Q6ZN79 | Z705A_HUMAN Zinc finger protein 705A OS=Homo sapiens GN=ZNF705A PE=2 SV=1 | 126 | T | 0.748681 | A | 0.675312 | 0.073369 | No Change: Both D | - |
| Q6ZN79 | Z705A_HUMAN Zinc finger protein 705A OS=Homo sapiens GN=ZNF705A PE=2 SV=1 | 134 | R | 0.730953 | C | 0.688086 | 0.042867 | No Change: Both D | - |
| Q6ZN79 | Z705A_HUMAN Zinc finger protein 705A OS=Homo sapiens GN=ZNF705A PE=2 SV=1 | 186 | R | 0.401618 | H | 0.37302 | 0.028598 | No Change: Both O | - |
| Q96C28 | ZN707_HUMAN Zinc finger protein 707 OS=Homo sapiens GN=ZNF707 PE=2 SV=2 | 96 | P | 0.95038 | H | 0.933586 | 0.016794 | No Change: Both D | - |
| P17019 | ZN708_HUMAN Zinc finger protein 708 OS=Homo sapiens GN=ZNF708 PE=2 SV=4 | 71 | A | 0.636946 | V | 0.533607 | 0.103339 | No Change: Both D | - |
| P17019 | ZN708_HUMAN Zinc finger protein 708 OS=Homo sapiens GN=ZNF708 PE=2 SV=4 | 113 | K | 0.549492 | E | 0.528653 | 0.020839 | No Change: Both D | - |
| P17019 | ZN708_HUMAN Zinc finger protein 708 OS=Homo sapiens GN=ZNF708 PE=2 SV=4 | 122 | K | 0.67727 | T | 0.615383 | 0.061887 | No Change: Both D | - |
| P17019 | ZN708_HUMAN Zinc finger protein 708 OS=Homo sapiens GN=ZNF708 PE=2 SV=4 | 130 | R | 0.452651 | Q | 0.490282 | -0.037631 | No Change: Both O | - |
| Q9NQZ8 | ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens GN=ZNF71 PE=2 SV=1 | 105 | V | 0.842904 | I | 0.807923 | 0.034981 | No Change: Both D | - |
| Q9NQZ8 | ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens GN=ZNF71 PE=2 SV=1 | 27 | R | 0.885672 | G | 0.888233 | -0.002561 | No Change: Both D | - |
| Q9NQZ8 | ZNF71_HUMAN Endothelial zinc finger protein induced by tumor necrosis factor alpha OS=Homo sapiens GN=ZNF71 PE=2 SV=1 | 121 | P | 0.954654 | L | 0.915187 | 0.039467 | No Change: Both D | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 139 | G | 0.394187 | E | 0.449236 | -0.055049 | No Change: Both O | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 221 | T | 0.658454 | A | 0.641583 | 0.016871 | No Change: Both D | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 274 | H | 0.555107 | R | 0.59815 | -0.043043 | No Change: Both D | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 524 | M | 0.682525 | T | 0.719618 | -0.037093 | No Change: Both D | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 601 | N | 0.815448 | S | 0.871619 | -0.056171 | No Change: Both D | - |
| Q9Y462 | ZN711_HUMAN Zinc finger protein 711 OS=Homo sapiens GN=ZNF711 PE=1 SV=2 | 622 | E | 0.810654 | D | 0.825266 | -0.014612 | No Change: Both D | - |
| Q96N38 | ZN714_HUMAN Zinc finger protein 714 OS=Homo sapiens GN=ZNF714 PE=2 SV=1 | 332 | R | 0.600053 | K | 0.656774 | -0.056721 | No Change: Both D | - |
| Q96N38 | ZN714_HUMAN Zinc finger protein 714 OS=Homo sapiens GN=ZNF714 PE=2 SV=1 | 474 | I | 0.709529 | V | 0.682251 | 0.027278 | No Change: Both D | - |
| Q96N38 | ZN714_HUMAN Zinc finger protein 714 OS=Homo sapiens GN=ZNF714 PE=2 SV=1 | 473 | I | 0.713076 | V | 0.685151 | 0.027925 | No Change: Both D | - |
| Q9BY31 | ZN717_HUMAN Zinc finger protein 717 OS=Homo sapiens GN=ZNF717 PE=1 SV=2 | 432 | T | 0.661944 | I | 0.498343 | 0.163601 | D to O | - |
| Q3SXZ3 | ZN718_HUMAN Zinc finger protein 718 OS=Homo sapiens GN=ZNF718 PE=2 SV=1 | 140 | K | 0.481866 | N | 0.441934 | 0.039932 | No Change: Both O | - |
| Q3SXZ3 | ZN718_HUMAN Zinc finger protein 718 OS=Homo sapiens GN=ZNF718 PE=2 SV=1 | 140 | K | 0.481866 | R | 0.419999 | 0.061867 | No Change: Both O | - |
| Q3SXZ3 | ZN718_HUMAN Zinc finger protein 718 OS=Homo sapiens GN=ZNF718 PE=2 SV=1 | 297 | S | 0.608875 | Y | 0.387199 | 0.221676 | D to O | - |
| Q3SXZ3 | ZN718_HUMAN Zinc finger protein 718 OS=Homo sapiens GN=ZNF718 PE=2 SV=1 | 413 | R | 0.475927 | H | 0.501994 | -0.026067 | O to D | - |
| Q6ZMV8 | ZN730_HUMAN Putative zinc finger protein 730 OS=Homo sapiens GN=ZNF730 PE=2 SV=1 | 365 | G | 0.615959 | E | 0.651768 | -0.035809 | No Change: Both D | - |
| Q16587 | ZNF74_HUMAN Zinc finger protein 74 OS=Homo sapiens GN=ZNF74 PE=2 SV=3 | 117 | E | 0.899856 | K | 0.888961 | 0.010895 | No Change: Both D | - |
| O43361 | ZN749_HUMAN Zinc finger protein 749 OS=Homo sapiens GN=ZNF749 PE=1 SV=2 | 243 | Q | 0.447706 | R | 0.439451 | 0.008255 | No Change: Both O | - |
| O43361 | ZN749_HUMAN Zinc finger protein 749 OS=Homo sapiens GN=ZNF749 PE=1 SV=2 | 405 | A | 0.388178 | T | 0.429022 | -0.040844 | No Change: Both O | - |
| O43361 | ZN749_HUMAN Zinc finger protein 749 OS=Homo sapiens GN=ZNF749 PE=1 SV=2 | 771 | I | 0.566864 | R | 0.736592 | -0.169728 | No Change: Both D | - |
| Q32MQ0 | ZN750_HUMAN Protein ZNF750 OS=Homo sapiens GN=ZNF750 PE=2 SV=1 | 235 | M | 0.496938 | V | 0.397951 | 0.098987 | No Change: Both O | - |
| Q32MQ0 | ZN750_HUMAN Protein ZNF750 OS=Homo sapiens GN=ZNF750 PE=2 SV=1 | 288 | P | 0.628475 | L | 0.461693 | 0.166782 | D to O | - |
| Q32MQ0 | ZN750_HUMAN Protein ZNF750 OS=Homo sapiens GN=ZNF750 PE=2 SV=1 | 392 | Q | 0.985737 | R | 0.988796 | -0.003059 | No Change: Both D | - |
| Q96N20 | ZN75A_HUMAN Zinc finger protein 75A OS=Homo sapiens GN=ZNF75A PE=2 SV=1 | 84 | V | 0.724335 | A | 0.776299 | -0.051964 | No Change: Both D | - |
| Q96N20 | ZN75A_HUMAN Zinc finger protein 75A OS=Homo sapiens GN=ZNF75A PE=2 SV=1 | 228 | Q | 0.688571 | E | 0.683295 | 0.005276 | No Change: Both D | A breast cancer sample |
| P36508 | ZNF76_HUMAN Zinc finger protein 76 OS=Homo sapiens GN=ZNF76 PE=2 SV=2 | 48 | T | 0.25876 | M | 0.216365 | 0.042395 | No Change: Both O | - |
| P36508 | ZNF76_HUMAN Zinc finger protein 76 OS=Homo sapiens GN=ZNF76 PE=2 SV=2 | 272 | R | 0.717801 | C | 0.625847 | 0.091954 | No Change: Both D | - |
| P36508 | ZNF76_HUMAN Zinc finger protein 76 OS=Homo sapiens GN=ZNF76 PE=2 SV=2 | 403 | R | 0.912022 | Q | 0.91603 | -0.004008 | No Change: Both D | - |
| Q86XN6 | ZN761_HUMAN Zinc finger protein 761 OS=Homo sapiens GN=ZNF761 PE=2 SV=2 | 122 | S | 0.696716 | I | 0.530614 | 0.166102 | No Change: Both D | - |
| Q86XN6 | ZN761_HUMAN Zinc finger protein 761 OS=Homo sapiens GN=ZNF761 PE=2 SV=2 | 168 | I | 0.40994 | V | 0.449998 | -0.040058 | No Change: Both O | - |
| Q86XN6 | ZN761_HUMAN Zinc finger protein 761 OS=Homo sapiens GN=ZNF761 PE=2 SV=2 | 528 | S | 0.766167 | G | 0.703726 | 0.062441 | No Change: Both D | - |
| Q86XN6 | ZN761_HUMAN Zinc finger protein 761 OS=Homo sapiens GN=ZNF761 PE=2 SV=2 | 603 | Q | 0.721583 | E | 0.755351 | -0.033768 | No Change: Both D | - |
| Q0D2J5 | ZN763_HUMAN Zinc finger protein 763 OS=Homo sapiens GN=ZNF763 PE=2 SV=2 | 327 | Y | 0.854293 | H | 0.904079 | -0.049786 | No Change: Both D | - |
| Q0D2J5 | ZN763_HUMAN Zinc finger protein 763 OS=Homo sapiens GN=ZNF763 PE=2 SV=2 | 324 | Y | 0.81099 | H | 0.875954 | -0.064964 | No Change: Both D | - |
| Q96H86 | ZN764_HUMAN Zinc finger protein 764 OS=Homo sapiens GN=ZNF764 PE=1 SV=2 | 332 | A | 0.908523 | V | 0.880474 | 0.028049 | No Change: Both D | - |
| Q7L2R6 | ZN765_HUMAN Zinc finger protein 765 OS=Homo sapiens GN=ZNF765 PE=2 SV=2 | 389 | S | 0.894066 | G | 0.856786 | 0.03728 | No Change: Both D | - |
| Q5HY98 | ZN766_HUMAN Zinc finger protein 766 OS=Homo sapiens GN=ZNF766 PE=2 SV=1 | 95 | C | 0.409312 | Y | 0.42359 | -0.014278 | No Change: Both O | - |
| Q75MW2 | ZN767_HUMAN Protein ZNF767 OS=Homo sapiens GN=ZNF767 PE=2 SV=1 | 31 | H | 0.569333 | R | 0.636076 | -0.066743 | No Change: Both D | - |
| Q75MW2 | ZN767_HUMAN Protein ZNF767 OS=Homo sapiens GN=ZNF767 PE=2 SV=1 | 38 | Q | 0.577993 | R | 0.550946 | 0.027047 | No Change: Both D | - |
| Q75MW2 | ZN767_HUMAN Protein ZNF767 OS=Homo sapiens GN=ZNF767 PE=2 SV=1 | 131 | A | 0.87533 | T | 0.893637 | -0.018307 | No Change: Both D | - |
| Q75MW2 | ZN767_HUMAN Protein ZNF767 OS=Homo sapiens GN=ZNF767 PE=2 SV=1 | 134 | T | 0.83965 | A | 0.825454 | 0.014196 | No Change: Both D | - |
| Q9H5H4 | ZN768_HUMAN Zinc finger protein 768 OS=Homo sapiens GN=ZNF768 PE=1 SV=2 | 181 | E | 0.784881 | D | 0.750375 | 0.034506 | No Change: Both D | - |
| Q9H5H4 | ZN768_HUMAN Zinc finger protein 768 OS=Homo sapiens GN=ZNF768 PE=1 SV=2 | 488 | A | 0.534528 | S | 0.693524 | -0.158996 | No Change: Both D | - |
| Q15935 | ZNF77_HUMAN Zinc finger protein 77 OS=Homo sapiens GN=ZNF77 PE=2 SV=2 | 20 | L | 0.21567 | W | 0.15588 | 0.05979 | No Change: Both O | - |
| Q15935 | ZNF77_HUMAN Zinc finger protein 77 OS=Homo sapiens GN=ZNF77 PE=2 SV=2 | 179 | P | 0.952521 | S | 0.955405 | -0.002884 | No Change: Both D | - |
| Q15935 | ZNF77_HUMAN Zinc finger protein 77 OS=Homo sapiens GN=ZNF77 PE=2 SV=2 | 460 | G | 0.748555 | R | 0.779167 | -0.030612 | No Change: Both D | - |
| Q15935 | ZNF77_HUMAN Zinc finger protein 77 OS=Homo sapiens GN=ZNF77 PE=2 SV=2 | 3 | C | 0.459387 | S | 0.743986 | -0.284599 | O to D | - |
| Q15935 | ZNF77_HUMAN Zinc finger protein 77 OS=Homo sapiens GN=ZNF77 PE=2 SV=2 | 5 | I | 0.239065 | V | 0.300113 | -0.061048 | No Change: Both O | - |
| Q7L3S4 | ZN771_HUMAN Zinc finger protein 771 OS=Homo sapiens GN=ZNF771 PE=1 SV=1 | 207 | D | 0.686247 | N | 0.657135 | 0.029112 | No Change: Both D | - |
| Q68DY9 | ZN772_HUMAN Zinc finger protein 772 OS=Homo sapiens GN=ZNF772 PE=2 SV=2 | 182 | C | 0.354228 | W | 0.2197 | 0.134528 | No Change: Both O | - |
| Q68DY9 | ZN772_HUMAN Zinc finger protein 772 OS=Homo sapiens GN=ZNF772 PE=2 SV=2 | 218 | M | 0.467873 | L | 0.391299 | 0.076574 | No Change: Both O | - |
| Q6NX45 | ZN774_HUMAN Zinc finger protein 774 OS=Homo sapiens GN=ZNF774 PE=2 SV=2 | 65 | P | 0.736537 | L | 0.618892 | 0.117645 | No Change: Both D | - |
| Q6NX45 | ZN774_HUMAN Zinc finger protein 774 OS=Homo sapiens GN=ZNF774 PE=2 SV=2 | 83 | N | 0.801606 | S | 0.829788 | -0.028182 | No Change: Both D | - |
| Q6NX45 | ZN774_HUMAN Zinc finger protein 774 OS=Homo sapiens GN=ZNF774 PE=2 SV=2 | 147 | V | 0.414783 | I | 0.416394 | -0.001611 | No Change: Both O | - |
| Q96BV0 | ZN775_HUMAN Zinc finger protein 775 OS=Homo sapiens GN=ZNF775 PE=1 SV=2 | 428 | T | 0.791476 | A | 0.812755 | -0.021279 | No Change: Both D | - |
| Q9ULD5 | ZN777_HUMAN Zinc finger protein 777 OS=Homo sapiens GN=ZNF777 PE=1 SV=2 | 70 | R | 0.967515 | W | 0.931319 | 0.036196 | No Change: Both D | - |
| Q9ULD5 | ZN777_HUMAN Zinc finger protein 777 OS=Homo sapiens GN=ZNF777 PE=1 SV=2 | 115 | V | 0.979589 | A | 0.986782 | -0.007193 | No Change: Both D | - |
| Q9ULD5 | ZN777_HUMAN Zinc finger protein 777 OS=Homo sapiens GN=ZNF777 PE=1 SV=2 | 512 | A | 0.959151 | T | 0.95934 | -1.89E-04 | No Change: Both D | - |
| Q96MU6 | ZN778_HUMAN Zinc finger protein 778 OS=Homo sapiens GN=ZNF778 PE=2 SV=3 | 683 | N | 0.228309 | D | 0.244921 | -0.016612 | No Change: Both O | - |
| Q6ZMW2 | ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens GN=ZNF782 PE=2 SV=1 | 130 | R | 0.213757 | P | 0.245766 | -0.032009 | No Change: Both O | - |
| Q6ZMW2 | ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens GN=ZNF782 PE=2 SV=1 | 165 | R | 0.365485 | H | 0.376797 | -0.011312 | No Change: Both O | - |
| Q6ZMW2 | ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens GN=ZNF782 PE=2 SV=1 | 246 | N | 0.65306 | S | 0.683155 | -0.030095 | No Change: Both D | - |
| Q6ZMW2 | ZN782_HUMAN Zinc finger protein 782 OS=Homo sapiens GN=ZNF782 PE=2 SV=1 | 289 | T | 0.547317 | A | 0.480582 | 0.066735 | D to O | - |
| Q6DD87 | ZN787_HUMAN Zinc finger protein 787 OS=Homo sapiens GN=ZNF787 PE=1 SV=2 | 379 | G | 0.991967 | A | 0.98978 | 0.002187 | No Change: Both D | - |
| Q5FWF6 | ZN789_HUMAN Zinc finger protein 789 OS=Homo sapiens GN=ZNF789 PE=2 SV=3 | 77 | T | 0.487475 | A | 0.491015 | -0.00354 | No Change: Both O | - |
| Q15937 | ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens GN=ZNF79 PE=1 SV=2 | 31 | T | 0.586602 | I | 0.423093 | 0.163509 | D to O | - |
| Q15937 | ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens GN=ZNF79 PE=1 SV=2 | 51 | R | 0.21527 | G | 0.195624 | 0.019646 | No Change: Both O | - |
| Q15937 | ZNF79_HUMAN Zinc finger protein 79 OS=Homo sapiens GN=ZNF79 PE=1 SV=2 | 401 | S | 0.688142 | N | 0.647615 | 0.040527 | No Change: Both D | - |
| Q6PG37 | ZN790_HUMAN Zinc finger protein 790 OS=Homo sapiens GN=ZNF790 PE=2 SV=2 | 486 | T | 0.643621 | S | 0.699269 | -0.055648 | No Change: Both D | - |
| Q6PG37 | ZN790_HUMAN Zinc finger protein 790 OS=Homo sapiens GN=ZNF790 PE=2 SV=2 | 301 | Q | 0.668228 | R | 0.694142 | -0.025914 | No Change: Both D | - |
| Q3KQV3 | ZN792_HUMAN Zinc finger protein 792 OS=Homo sapiens GN=ZNF792 PE=2 SV=2 | 177 | R | 0.617905 | Q | 0.652319 | -0.034414 | No Change: Both D | - |
| Q3KQV3 | ZN792_HUMAN Zinc finger protein 792 OS=Homo sapiens GN=ZNF792 PE=2 SV=2 | 525 | R | 0.882118 | W | 0.716166 | 0.165952 | No Change: Both D | - |
| Q6ZN11 | ZN793_HUMAN Zinc finger protein 793 OS=Homo sapiens GN=ZNF793 PE=2 SV=1 | 68 | I | 0.263933 | M | 0.353819 | -0.089886 | No Change: Both O | - |
| Q6ZN11 | ZN793_HUMAN Zinc finger protein 793 OS=Homo sapiens GN=ZNF793 PE=2 SV=1 | 133 | I | 0.583218 | V | 0.564683 | 0.018535 | No Change: Both D | - |
| Q96GE5 | ZN799_HUMAN Zinc finger protein 799 OS=Homo sapiens GN=ZNF799 PE=2 SV=4 | 44 | G | 0.20115 | V | 0.143437 | 0.057713 | No Change: Both O | - |
| Q96GE5 | ZN799_HUMAN Zinc finger protein 799 OS=Homo sapiens GN=ZNF799 PE=2 SV=4 | 593 | C | 0.719339 | R | 0.773161 | -0.053822 | No Change: Both D | - |
| P51504 | ZNF80_HUMAN Zinc finger protein 80 OS=Homo sapiens GN=ZNF80 PE=2 SV=2 | 253 | D | 0.467146 | A | 0.426203 | 0.040943 | No Change: Both O | - |
| P51504 | ZNF80_HUMAN Zinc finger protein 80 OS=Homo sapiens GN=ZNF80 PE=2 SV=2 | 201 | R | 0.445182 | H | 0.421684 | 0.023498 | No Change: Both O | - |
| Q2TB10 | ZN800_HUMAN Zinc finger protein 800 OS=Homo sapiens GN=ZNF800 PE=1 SV=1 | 102 | L | 0.625437 | V | 0.624847 | 5.90E-04 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 261 | Q | 0.817553 | L | 0.737473 | 0.08008 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 542 | E | 0.785511 | K | 0.804248 | -0.018737 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 707 | T | 0.544876 | K | 0.604792 | -0.059916 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 747 | H | 0.792551 | R | 0.82524 | -0.032689 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 1081 | L | 0.83968 | V | 0.82138 | 0.0183 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 324 | N | 0.650962 | S | 0.707761 | -0.056799 | No Change: Both D | A colorectal cancer sample |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 479 | D | 0.855919 | G | 0.810474 | 0.045445 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 600 | K | 0.941369 | R | 0.934379 | 0.00699 | No Change: Both D | - |
| Q7Z570 | Z804A_HUMAN Zinc finger protein 804A OS=Homo sapiens GN=ZNF804A PE=1 SV=3 | 1152 | G | 0.70646 | R | 0.728054 | -0.021594 | No Change: Both D | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 248 | C | 0.790239 | Y | 0.752384 | 0.037855 | No Change: Both D | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 909 | E | 0.90488 | K | 0.903384 | 0.001496 | No Change: Both D | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 1105 | M | 0.354815 | V | 0.296857 | 0.057958 | No Change: Both O | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 1195 | V | 0.641542 | I | 0.601492 | 0.04005 | No Change: Both D | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 634 | F | 0.456968 | I | 0.459048 | -0.00208 | No Change: Both O | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 914 | N | 0.908795 | H | 0.883087 | 0.025708 | No Change: Both D | - |
| A4D1E1 | Z804B_HUMAN Zinc finger protein 804B OS=Homo sapiens GN=ZNF804B PE=1 SV=2 | 915 | T | 0.910942 | I | 0.861552 | 0.04939 | No Change: Both D | - |
| Q5CZA5 | ZN805_HUMAN Zinc finger protein 805 OS=Homo sapiens GN=ZNF805 PE=2 SV=3 | 68 | G | 0.559978 | E | 0.617522 | -0.057544 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 8 | V | 0.198664 | A | 0.266039 | -0.067375 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 28 | A | 0.18786 | S | 0.266494 | -0.078634 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 44 | F | 0.140119 | L | 0.154849 | -0.01473 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 60 | K | 0.222445 | T | 0.160383 | 0.062062 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 163 | G | 0.524513 | E | 0.573346 | -0.048833 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 189 | R | 0.749298 | C | 0.666192 | 0.083106 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 276 | V | 0.379809 | I | 0.381572 | -0.001763 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 375 | D | 0.520571 | E | 0.591412 | -0.070841 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 498 | F | 0.094476 | C | 0.090064 | 0.004412 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 561 | R | 0.525742 | H | 0.494075 | 0.031667 | D to O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 564 | K | 0.573096 | E | 0.568639 | 0.004457 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 539 | C | 0.397202 | Y | 0.405399 | -0.008197 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 113 | M | 0.271379 | V | 0.219747 | 0.051632 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 223 | A | 0.476492 | V | 0.450126 | 0.026366 | No Change: Both O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 248 | V | 0.61571 | A | 0.68217 | -0.06646 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 283 | G | 0.533517 | R | 0.531474 | 0.002043 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 367 | G | 0.506005 | V | 0.390223 | 0.115782 | D to O | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 396 | E | 0.687933 | G | 0.659037 | 0.028896 | No Change: Both D | - |
| P0C7X5 | ZN806_HUMAN Zinc finger protein 806 OS=Homo sapiens GN=ZNF806 PE=2 SV=1 | 556 | A | 0.457442 | V | 0.405072 | 0.05237 | No Change: Both O | - |
| Q8N4W9 | ZN808_HUMAN Zinc finger protein 808 OS=Homo sapiens GN=ZNF808 PE=2 SV=2 | 134 | K | 0.801634 | N | 0.764709 | 0.036925 | No Change: Both D | - |
| Q8N4W9 | ZN808_HUMAN Zinc finger protein 808 OS=Homo sapiens GN=ZNF808 PE=2 SV=2 | 262 | D | 0.367574 | N | 0.363822 | 0.003752 | No Change: Both O | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 3 | A | 0.861483 | V | 0.844201 | 0.017282 | No Change: Both D | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 157 | N | 0.279563 | S | 0.31494 | -0.035377 | No Change: Both O | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 179 | S | 0.378774 | N | 0.338243 | 0.040531 | No Change: Both O | Mental retardation X-linked type 45 (MRX45) [MIM:300498] |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 185 | S | 0.624183 | L | 0.463293 | 0.16089 | D to O | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 499 | I | 0.568383 | V | 0.537981 | 0.030402 | No Change: Both D | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 117 | G | 0.79922 | V | 0.722752 | 0.076468 | No Change: Both D | - |
| P51508 | ZNF81_HUMAN Zinc finger protein 81 OS=Homo sapiens GN=ZNF81 PE=1 SV=3 | 213 | A | 0.667135 | E | 0.711069 | -0.043934 | No Change: Both D | - |
| P0C7V5 | ZN812_HUMAN Putative zinc finger protein 812 OS=Homo sapiens GN=ZNF812 PE=5 SV=1 | 63 | K | 0.164405 | Q | 0.142411 | 0.021994 | No Change: Both O | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 231 | R | 0.320204 | K | 0.392404 | -0.0722 | No Change: Both O | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 439 | Y | 0.496449 | F | 0.507869 | -0.01142 | O to D | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 62 | A | 0.564454 | T | 0.625932 | -0.061478 | No Change: Both D | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 93 | D | 0.517557 | V | 0.325313 | 0.192244 | D to O | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 168 | I | 0.739043 | F | 0.730339 | 0.008704 | No Change: Both D | - |
| Q6ZN06 | ZN813_HUMAN Zinc finger protein 813 OS=Homo sapiens GN=ZNF813 PE=2 SV=2 | 192 | Y | 0.775214 | C | 0.845146 | -0.069932 | No Change: Both D | - |
| B7Z6K7 | ZN814_HUMAN Putative uncharacterized zinc finger protein 814 OS=Homo sapiens GN=ZNF814 PE=2 SV=2 | 83 | M | 0.532336 | V | 0.480785 | 0.051551 | D to O | - |
| Q0VGE8 | ZN816_HUMAN Zinc finger protein 816 OS=Homo sapiens GN=ZNF816 PE=2 SV=2 | 80 | I | 0.56691 | N | 0.684773 | -0.117863 | No Change: Both D | - |
| Q0VGE8 | ZN816_HUMAN Zinc finger protein 816 OS=Homo sapiens GN=ZNF816 PE=2 SV=2 | 162 | S | 0.67348 | L | 0.533162 | 0.140318 | No Change: Both D | - |
| Q6ZRF7 | ZN818_HUMAN Putative zinc finger protein 818 OS=Homo sapiens GN=ZNF818P PE=5 SV=1 | 14 | E | 0.813645 | K | 0.787766 | 0.025879 | No Change: Both D | - |
| P16415 | ZN823_HUMAN Zinc finger protein 823 OS=Homo sapiens GN=ZNF823 PE=2 SV=2 | 566 | R | 0.51467 | H | 0.475442 | 0.039228 | D to O | - |
| Q6ZT77 | ZN826_HUMAN Putative zinc finger protein 826 OS=Homo sapiens GN=ZNF826P PE=5 SV=2 | 148 | C | 0.701841 | Y | 0.630567 | 0.071274 | No Change: Both D | - |
| P51522 | ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens GN=ZNF83 PE=2 SV=3 | 70 | T | 0.388918 | I | 0.268832 | 0.120086 | No Change: Both O | - |
| P51522 | ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens GN=ZNF83 PE=2 SV=3 | 96 | S | 0.519453 | N | 0.490013 | 0.02944 | D to O | - |
| P51522 | ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens GN=ZNF83 PE=2 SV=3 | 119 | T | 0.347277 | M | 0.291746 | 0.055531 | No Change: Both O | - |
| P51522 | ZNF83_HUMAN Zinc finger protein 83 OS=Homo sapiens GN=ZNF83 PE=2 SV=3 | 392 | H | 0.488677 | R | 0.474263 | 0.014414 | No Change: Both O | - |
| Q96NB3 | ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens GN=ZNF830 PE=1 SV=2 | 99 | H | 0.966186 | Q | 0.975025 | -0.008839 | No Change: Both D | - |
| Q96NB3 | ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens GN=ZNF830 PE=1 SV=2 | 154 | S | 0.853855 | T | 0.831724 | 0.022131 | No Change: Both D | - |
| Q96NB3 | ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens GN=ZNF830 PE=1 SV=2 | 16 | I | 0.889767 | V | 0.90632 | -0.016553 | No Change: Both D | - |
| Q96NB3 | ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens GN=ZNF830 PE=1 SV=2 | 93 | S | 0.951254 | P | 0.946893 | 0.004361 | No Change: Both D | - |
| Q96NB3 | ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens GN=ZNF830 PE=1 SV=2 | 135 | F | 0.568072 | L | 0.592866 | -0.024794 | No Change: Both D | - |
| Q5JPB2 | ZN831_HUMAN Zinc finger protein 831 OS=Homo sapiens GN=ZNF831 PE=2 SV=4 | 845 | G | 0.978162 | R | 0.978666 | -5.04E-04 | No Change: Both D | - |
| Q5JPB2 | ZN831_HUMAN Zinc finger protein 831 OS=Homo sapiens GN=ZNF831 PE=2 SV=4 | 1513 | S | 0.803843 | P | 0.789475 | 0.014368 | No Change: Both D | - |
| Q9Y2P0 | ZN835_HUMAN Zinc finger protein 835 OS=Homo sapiens GN=ZNF835 PE=2 SV=1 | 51 | E | 0.876807 | K | 0.855783 | 0.021024 | No Change: Both D | - |
| Q9Y2P0 | ZN835_HUMAN Zinc finger protein 835 OS=Homo sapiens GN=ZNF835 PE=2 SV=1 | 110 | E | 0.994995 | A | 0.993566 | 0.001429 | No Change: Both D | - |
| Q6ZNA1 | ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens GN=ZNF836 PE=2 SV=2 | 219 | M | 0.36338 | I | 0.281337 | 0.082043 | No Change: Both O | - |
| Q6ZNA1 | ZN836_HUMAN Zinc finger protein 836 OS=Homo sapiens GN=ZNF836 PE=2 SV=2 | 809 | N | 0.248282 | S | 0.288942 | -0.04066 | No Change: Both O | - |
| Q96EG3 | ZN837_HUMAN Zinc finger protein 837 OS=Homo sapiens GN=ZNF837 PE=2 SV=2 | 153 | Q | 0.851936 | R | 0.860213 | -0.008277 | No Change: Both D | - |
| Q96EG3 | ZN837_HUMAN Zinc finger protein 837 OS=Homo sapiens GN=ZNF837 PE=2 SV=2 | 242 | A | 0.979967 | T | 0.981254 | -0.001287 | No Change: Both D | - |
| A8K0R7 | ZN839_HUMAN Zinc finger protein 839 OS=Homo sapiens GN=ZNF839 PE=2 SV=1 | 531 | P | 0.834358 | S | 0.836545 | -0.002187 | No Change: Both D | - |
| A8K0R7 | ZN839_HUMAN Zinc finger protein 839 OS=Homo sapiens GN=ZNF839 PE=2 SV=1 | 693 | V | 0.489998 | M | 0.517021 | -0.027023 | O to D | - |
| A8K0R7 | ZN839_HUMAN Zinc finger protein 839 OS=Homo sapiens GN=ZNF839 PE=2 SV=1 | 731 | F | 0.537425 | L | 0.601747 | -0.064322 | No Change: Both D | - |
| A8K0R7 | ZN839_HUMAN Zinc finger protein 839 OS=Homo sapiens GN=ZNF839 PE=2 SV=1 | 314 | A | 0.931154 | T | 0.936098 | -0.004944 | No Change: Both D | - |
| A6NDX5 | ZN840_HUMAN Putative zinc finger protein 840 OS=Homo sapiens GN=ZNF840 PE=5 SV=5 | 181 | Y | 0.624272 | C | 0.608423 | 0.015849 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 113 | V | 0.512272 | M | 0.552705 | -0.040433 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 146 | R | 0.800254 | H | 0.784534 | 0.01572 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 226 | K | 0.483136 | E | 0.475566 | 0.00757 | No Change: Both O | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 276 | T | 0.696934 | A | 0.670878 | 0.026056 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 308 | A | 0.663646 | P | 0.72701 | -0.063364 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 329 | V | 0.714916 | A | 0.798982 | -0.084066 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 584 | M | 0.688683 | L | 0.587886 | 0.100797 | No Change: Both D | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 642 | I | 0.193898 | M | 0.257585 | -0.063687 | No Change: Both O | - |
| Q08AG5 | ZN844_HUMAN Zinc finger protein 844 OS=Homo sapiens GN=ZNF844 PE=2 SV=1 | 658 | V | 0.073528 | I | 0.062546 | 0.010982 | No Change: Both O | - |
| Q147U1 | ZN846_HUMAN Zinc finger protein 846 OS=Homo sapiens GN=ZNF846 PE=1 SV=2 | 450 | C | 0.82908 | Y | 0.755205 | 0.073875 | No Change: Both D | - |
| Q147U1 | ZN846_HUMAN Zinc finger protein 846 OS=Homo sapiens GN=ZNF846 PE=1 SV=2 | 492 | Y | 0.393677 | C | 0.457222 | -0.063545 | No Change: Both O | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 60 | K | 0.392029 | T | 0.312813 | 0.079216 | No Change: Both O | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 184 | G | 0.455139 | R | 0.491705 | -0.036566 | No Change: Both O | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 270 | F | 0.685356 | S | 0.804999 | -0.119643 | No Change: Both D | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 266 | T | 0.665324 | A | 0.58583 | 0.079494 | No Change: Both D | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 84 | Q | 0.170009 | R | 0.153172 | 0.016837 | No Change: Both O | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 115 | R | 0.623418 | I | 0.443285 | 0.180133 | D to O | - |
| Q03923 | ZNF85_HUMAN Zinc finger protein 85 OS=Homo sapiens GN=ZNF85 PE=2 SV=3 | 177 | T | 0.623145 | R | 0.652699 | -0.029554 | No Change: Both D | - |
| P0CG23 | ZN853_HUMAN Zinc finger protein 853 OS=Homo sapiens GN=ZNF853 PE=2 SV=1 | 8 | G | 0.722425 | R | 0.748105 | -0.02568 | No Change: Both D | - |
| P0CG23 | ZN853_HUMAN Zinc finger protein 853 OS=Homo sapiens GN=ZNF853 PE=2 SV=1 | 30 | Q | 0.818275 | R | 0.827658 | -0.009383 | No Change: Both D | - |
| P0CG23 | ZN853_HUMAN Zinc finger protein 853 OS=Homo sapiens GN=ZNF853 PE=2 SV=1 | 212 | Q | 0.999987 | E | 0.999984 | 3.00E-06 | No Change: Both D | - |
| O60290 | ZN862_HUMAN Zinc finger protein 862 OS=Homo sapiens GN=ZNF862 PE=2 SV=2 | 178 | I | 0.355242 | T | 0.511356 | -0.156114 | O to D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 112 | Y | 0.521807 | H | 0.672963 | -0.151156 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 896 | T | 0.760319 | A | 0.713658 | 0.046661 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 455 | F | 0.732007 | I | 0.708157 | 0.02385 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 1164 | L | 0.105175 | P | 0.208255 | -0.10308 | No Change: Both O | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 1164 | L | 0.105175 | V | 0.103642 | 0.001533 | No Change: Both O | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 336 | T | 0.877931 | A | 0.86849 | 0.009441 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 386 | A | 0.671746 | T | 0.717507 | -0.045761 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 521 | E | 0.645534 | K | 0.666079 | -0.020545 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 1011 | R | 0.850227 | I | 0.747626 | 0.102601 | No Change: Both D | - |
| Q05481 | ZNF91_HUMAN Zinc finger protein 91 OS=Homo sapiens GN=ZNF91 PE=2 SV=2 | 1033 | R | 0.78405 | Q | 0.777407 | 0.006643 | No Change: Both D | - |
| Q03936 | ZNF92_HUMAN Zinc finger protein 92 OS=Homo sapiens GN=ZNF92 PE=2 SV=2 | 492 | Q | 0.58886 | R | 0.590358 | -0.001498 | No Change: Both D | - |
| Q03936 | ZNF92_HUMAN Zinc finger protein 92 OS=Homo sapiens GN=ZNF92 PE=2 SV=2 | 122 | A | 0.370375 | V | 0.32358 | 0.046795 | No Change: Both O | - |
| Q03936 | ZNF92_HUMAN Zinc finger protein 92 OS=Homo sapiens GN=ZNF92 PE=2 SV=2 | 527 | R | 0.347761 | H | 0.348439 | -6.78E-04 | No Change: Both O | - |
| P35789 | ZNF93_HUMAN Zinc finger protein 93 OS=Homo sapiens GN=ZNF93 PE=2 SV=4 | 93 | D | 0.302297 | Y | 0.17716 | 0.125137 | No Change: Both O | - |
| A8MXY4 | ZNF99_HUMAN Zinc finger protein 99 OS=Homo sapiens GN=ZNF99 PE=2 SV=2 | 150 | A | 0.491335 | G | 0.558231 | -0.066896 | O to D | - |
| A8MXY4 | ZNF99_HUMAN Zinc finger protein 99 OS=Homo sapiens GN=ZNF99 PE=2 SV=2 | 28 | W | 0.057914 | R | 0.143837 | -0.085923 | No Change: Both O | - |
| A8MXY4 | ZNF99_HUMAN Zinc finger protein 99 OS=Homo sapiens GN=ZNF99 PE=2 SV=2 | 416 | K | 0.710492 | I | 0.514983 | 0.195509 | No Change: Both D | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 864 | L | 0.749374 | V | 0.71968 | 0.029694 | No Change: Both D | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 910 | T | 0.552039 | A | 0.534986 | 0.017053 | No Change: Both D | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 924 | Q | 0.227014 | H | 0.187239 | 0.039775 | No Change: Both O | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 1351 | T | 0.88019 | I | 0.856739 | 0.023451 | No Change: Both D | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 1259 | M | 0.180209 | I | 0.128677 | 0.051532 | No Change: Both O | - |
| Q9P2E3 | ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens GN=ZNFX1 PE=1 SV=2 | 1297 | G | 0.409662 | S | 0.478338 | -0.068676 | No Change: Both O | - |
| O43257 | ZNHI1_HUMAN Zinc finger HIT domain-containing protein 1 OS=Homo sapiens GN=ZNHIT1 PE=1 SV=1 | 134 | R | 0.293618 | W | 0.115362 | 0.178256 | No Change: Both O | A colorectal cancer sample |
| Q9UHR6 | ZNHI2_HUMAN Zinc finger HIT domain-containing protein 2 OS=Homo sapiens GN=ZNHIT2 PE=1 SV=1 | 59 | A | 0.721533 | P | 0.780292 | -0.058759 | No Change: Both D | A breast cancer sample |
| Q9UHR6 | ZNHI2_HUMAN Zinc finger HIT domain-containing protein 2 OS=Homo sapiens GN=ZNHIT2 PE=1 SV=1 | 155 | E | 0.853231 | K | 0.830169 | 0.023062 | No Change: Both D | - |
| Q9UHR6 | ZNHI2_HUMAN Zinc finger HIT domain-containing protein 2 OS=Homo sapiens GN=ZNHIT2 PE=1 SV=1 | 176 | A | 0.834262 | V | 0.794951 | 0.039311 | No Change: Both D | - |
| Q9NWK9 | BCD1_HUMAN Box C/D snoRNA protein 1 OS=Homo sapiens GN=ZNHIT6 PE=1 SV=1 | 9 | G | 0.85152 | R | 0.85618 | -0.00466 | No Change: Both D | - |
| Q9NWK9 | BCD1_HUMAN Box C/D snoRNA protein 1 OS=Homo sapiens GN=ZNHIT6 PE=1 SV=1 | 455 | L | 0.568862 | H | 0.68423 | -0.115368 | No Change: Both D | A colorectal cancer sample |
| Q9P1U0 | RPA12_HUMAN DNA-directed RNA polymerase I subunit RPA12 OS=Homo sapiens GN=ZNRD1 PE=1 SV=1 | 14 | Q | 0.544256 | H | 0.47593 | 0.068326 | D to O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 37 | P | 0.979201 | S | 0.976313 | 0.002888 | No Change: Both D | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 78 | R | 0.405195 | Q | 0.408508 | -0.003313 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 100 | V | 0.196678 | I | 0.154851 | 0.041827 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 157 | A | 0.122332 | S | 0.19829 | -0.075958 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 159 | V | 0.064218 | A | 0.098697 | -0.034479 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 163 | R | 0.040179 | C | 0.018803 | 0.021376 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 163 | R | 0.040179 | H | 0.036802 | 0.003377 | No Change: Both O | - |
| Q8WWF5 | ZNRF4_HUMAN Zinc/RING finger protein 4 OS=Homo sapiens GN=ZNRF4 PE=2 SV=3 | 192 | D | 0.495891 | N | 0.481271 | 0.01462 | No Change: Both O | - |
| P60852 | ZP1_HUMAN Zona pellucida sperm-binding protein 1 OS=Homo sapiens GN=ZP1 PE=2 SV=1 | 158 | T | 0.918292 | I | 0.858988 | 0.059304 | No Change: Both D | - |
| Q05996 | ZP2_HUMAN Zona pellucida sperm-binding protein 2 OS=Homo sapiens GN=ZP2 PE=2 SV=1 | 36 | G | 0.265033 | V | 0.182548 | 0.082485 | No Change: Both O | - |
| P21754 | ZP3_HUMAN Zona pellucida sperm-binding protein 3 OS=Homo sapiens GN=ZP3 PE=1 SV=2 | 31 | G | 0.427869 | R | 0.395101 | 0.032768 | No Change: Both O | - |
| P21754 | ZP3_HUMAN Zona pellucida sperm-binding protein 3 OS=Homo sapiens GN=ZP3 PE=1 SV=2 | 315 | S | 0.65563 | P | 0.655727 | -9.70E-05 | No Change: Both D | - |
| P21754 | ZP3_HUMAN Zona pellucida sperm-binding protein 3 OS=Homo sapiens GN=ZP3 PE=1 SV=2 | 340 | M | 0.784584 | V | 0.752859 | 0.031725 | No Change: Both D | - |
| Q12836 | ZP4_HUMAN Zona pellucida sperm-binding protein 4 OS=Homo sapiens GN=ZP4 PE=2 SV=1 | 114 | A | 0.51195 | V | 0.43749 | 0.07446 | D to O | - |
| Q12836 | ZP4_HUMAN Zona pellucida sperm-binding protein 4 OS=Homo sapiens GN=ZP4 PE=2 SV=1 | 295 | P | 0.500216 | S | 0.529463 | -0.029247 | No Change: Both D | - |
| Q6X784 | ZPBP2_HUMAN Zona pellucida-binding protein 2 OS=Homo sapiens GN=ZPBP2 PE=2 SV=1 | 68 | P | 0.128387 | A | 0.084258 | 0.044129 | No Change: Both O | - |
| Q6X784 | ZPBP2_HUMAN Zona pellucida-binding protein 2 OS=Homo sapiens GN=ZPBP2 PE=2 SV=1 | 118 | A | 0.605187 | T | 0.652814 | -0.047627 | No Change: Both D | - |
| Q6X784 | ZPBP2_HUMAN Zona pellucida-binding protein 2 OS=Homo sapiens GN=ZPBP2 PE=2 SV=1 | 173 | S | 0.232916 | I | 0.095682 | 0.137234 | No Change: Both O | - |
| Q6X784 | ZPBP2_HUMAN Zona pellucida-binding protein 2 OS=Homo sapiens GN=ZPBP2 PE=2 SV=1 | 335 | Q | 0.767574 | E | 0.74598 | 0.021594 | No Change: Both D | - |
| Q8TCW7 | ZPLD1_HUMAN Zona pellucida-like domain-containing protein 1 OS=Homo sapiens GN=ZPLD1 PE=2 SV=2 | 12 | I | 0.042771 | F | 0.043425 | -6.54E-04 | No Change: Both O | - |
| Q8TCW7 | ZPLD1_HUMAN Zona pellucida-like domain-containing protein 1 OS=Homo sapiens GN=ZPLD1 PE=2 SV=2 | 29 | N | 0.287894 | S | 0.327427 | -0.039533 | No Change: Both O | - |
| Q8TCW7 | ZPLD1_HUMAN Zona pellucida-like domain-containing protein 1 OS=Homo sapiens GN=ZPLD1 PE=2 SV=2 | 197 | T | 0.248703 | A | 0.224298 | 0.024405 | No Change: Both O | - |
| O95218 | ZRAB2_HUMAN Zinc finger Ran-binding domain-containing protein 2 OS=Homo sapiens GN=ZRANB2 PE=1 SV=2 | 207 | R | 0.999896 | G | 0.999827 | 6.90E-05 | No Change: Both D | - |
| Q5FWF4 | ZRAB3_HUMAN Zinc finger Ran-binding domain-containing protein 3 OS=Homo sapiens GN=ZRANB3 PE=2 SV=2 | 541 | E | 0.839443 | K | 0.842141 | -0.002698 | No Change: Both D | - |
| Q5FWF4 | ZRAB3_HUMAN Zinc finger Ran-binding domain-containing protein 3 OS=Homo sapiens GN=ZRANB3 PE=2 SV=2 | 546 | R | 0.863087 | Q | 0.855211 | 0.007876 | No Change: Both D | - |
| Q5FWF4 | ZRAB3_HUMAN Zinc finger Ran-binding domain-containing protein 3 OS=Homo sapiens GN=ZRANB3 PE=2 SV=2 | 637 | E | 0.299939 | V | 0.15259 | 0.147349 | No Change: Both O | - |
| Q9H4T2 | ZSC16_HUMAN Zinc finger and SCAN domain-containing protein 16 OS=Homo sapiens GN=ZSCAN16 PE=1 SV=2 | 137 | R | 0.737907 | Q | 0.739678 | -0.001771 | No Change: Both D | A colorectal cancer sample |
| Q8TBC5 | ZSC18_HUMAN Zinc finger and SCAN domain-containing protein 18 OS=Homo sapiens GN=ZSCAN18 PE=2 SV=2 | 379 | G | 0.969001 | E | 0.971702 | -0.002701 | No Change: Both D | - |
| Q7Z7L9 | ZSCA2_HUMAN Zinc finger and SCAN domain-containing protein 2 OS=Homo sapiens GN=ZSCAN2 PE=2 SV=2 | 191 | S | 0.830733 | T | 0.790751 | 0.039982 | No Change: Both D | - |
| P17040 | ZSC20_HUMAN Zinc finger and SCAN domain-containing protein 20 OS=Homo sapiens GN=ZSCAN20 PE=2 SV=3 | 248 | D | 0.838884 | N | 0.824136 | 0.014748 | No Change: Both D | - |
| P17040 | ZSC20_HUMAN Zinc finger and SCAN domain-containing protein 20 OS=Homo sapiens GN=ZSCAN20 PE=2 SV=3 | 432 | Y | 0.63611 | D | 0.802985 | -0.166875 | No Change: Both D | - |
| Q8IWY8 | ZSC29_HUMAN Zinc finger and SCAN domain-containing protein 29 OS=Homo sapiens GN=ZSCAN29 PE=1 SV=2 | 199 | G | 0.810759 | S | 0.849342 | -0.038583 | No Change: Both D | - |
| Q8IWY8 | ZSC29_HUMAN Zinc finger and SCAN domain-containing protein 29 OS=Homo sapiens GN=ZSCAN29 PE=1 SV=2 | 104 | R | 0.903105 | G | 0.891702 | 0.011403 | No Change: Both D | - |
| Q86W11 | ZSC30_HUMAN Zinc finger and SCAN domain-containing protein 30 OS=Homo sapiens GN=ZSCAN30 PE=1 SV=1 | 238 | Q | 0.809749 | P | 0.817895 | -0.008146 | No Change: Both D | - |
| Q8NAM6 | ZSCA4_HUMAN Zinc finger and SCAN domain-containing protein 4 OS=Homo sapiens GN=ZSCAN4 PE=2 SV=1 | 387 | E | 0.814692 | K | 0.835672 | -0.02098 | No Change: Both D | - |
| Q9BUG6 | ZSA5A_HUMAN Zinc finger and SCAN domain-containing protein 5A OS=Homo sapiens GN=ZSCAN5A PE=2 SV=1 | 146 | E | 0.571373 | Q | 0.552541 | 0.018832 | No Change: Both D | A colorectal cancer sample |
| Q9BUG6 | ZSA5A_HUMAN Zinc finger and SCAN domain-containing protein 5A OS=Homo sapiens GN=ZSCAN5A PE=2 SV=1 | 337 | G | 0.909833 | V | 0.879231 | 0.030602 | No Change: Both D | - |
| A6NJL1 | ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B OS=Homo sapiens GN=ZSCAN5B PE=2 SV=1 | 187 | P | 0.634005 | S | 0.643378 | -0.009373 | No Change: Both D | - |
| A6NJL1 | ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B OS=Homo sapiens GN=ZSCAN5B PE=2 SV=1 | 208 | V | 0.795018 | I | 0.798495 | -0.003477 | No Change: Both D | - |
| A6NJL1 | ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B OS=Homo sapiens GN=ZSCAN5B PE=2 SV=1 | 236 | S | 0.990555 | T | 0.986706 | 0.003849 | No Change: Both D | - |
| A6NJL1 | ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B OS=Homo sapiens GN=ZSCAN5B PE=2 SV=1 | 304 | S | 0.961914 | T | 0.945359 | 0.016555 | No Change: Both D | - |
| A6NJL1 | ZSA5B_HUMAN Zinc finger and SCAN domain-containing protein 5B OS=Homo sapiens GN=ZSCAN5B PE=2 SV=1 | 412 | M | 0.451566 | L | 0.412378 | 0.039188 | No Change: Both O | - |
| A6NGD5 | ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C OS=Homo sapiens GN=ZSCAN5C PE=3 SV=1 | 181 | Q | 0.890574 | R | 0.886103 | 0.004471 | No Change: Both D | - |
| A6NGD5 | ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C OS=Homo sapiens GN=ZSCAN5C PE=3 SV=1 | 197 | E | 0.864043 | D | 0.843549 | 0.020494 | No Change: Both D | - |
| A6NGD5 | ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C OS=Homo sapiens GN=ZSCAN5C PE=3 SV=1 | 24 | Q | 0.978688 | R | 0.976741 | 0.001947 | No Change: Both D | - |
| A6NGD5 | ZSA5C_HUMAN Zinc finger and SCAN domain-containing protein 5C OS=Homo sapiens GN=ZSCAN5C PE=3 SV=1 | 259 | Q | 0.929681 | K | 0.942484 | -0.012803 | No Change: Both D | - |
| Q9BR11 | ZSWM1_HUMAN Zinc finger SWIM domain-containing protein 1 OS=Homo sapiens GN=ZSWIM1 PE=2 SV=2 | 101 | R | 0.269244 | Q | 0.299936 | -0.030692 | No Change: Both O | - |
| Q96MP5 | ZSWM3_HUMAN Zinc finger SWIM domain-containing protein 3 OS=Homo sapiens GN=ZSWIM3 PE=1 SV=2 | 259 | V | 0.308422 | A | 0.396464 | -0.088042 | No Change: Both O | - |
| Q96MP5 | ZSWM3_HUMAN Zinc finger SWIM domain-containing protein 3 OS=Homo sapiens GN=ZSWIM3 PE=1 SV=2 | 291 | R | 0.094325 | W | 0.037099 | 0.057226 | No Change: Both O | - |
| Q9P217 | ZSWM5_HUMAN Zinc finger SWIM domain-containing protein 5 OS=Homo sapiens GN=ZSWIM5 PE=2 SV=2 | 368 | V | 0.406904 | G | 0.546192 | -0.139288 | O to D | - |
| Q96AP4 | ZUFSP_HUMAN Zinc finger with UFM1-specific peptidase domain protein OS=Homo sapiens GN=ZUFSP PE=1 SV=1 | 379 | N | 0.228329 | D | 0.247391 | -0.019062 | No Change: Both O | - |
| O43264 | ZW10_HUMAN Centromere/kinetochore protein zw10 homolog OS=Homo sapiens GN=ZW10 PE=1 SV=3 | 77 | I | 0.653757 | M | 0.728424 | -0.074667 | No Change: Both D | - |
| Q9H900 | ZWILC_HUMAN Protein zwilch homolog OS=Homo sapiens GN=ZWILCH PE=1 SV=2 | 344 | S | 0.297898 | G | 0.22827 | 0.069628 | No Change: Both O | - |
| O95229 | ZWINT_HUMAN ZW10 interactor OS=Homo sapiens GN=ZWINT PE=1 SV=2 | 4 | A | 0.85979 | S | 0.848599 | 0.011191 | No Change: Both D | - |
| O95229 | ZWINT_HUMAN ZW10 interactor OS=Homo sapiens GN=ZWINT PE=1 SV=2 | 187 | R | 0.793502 | G | 0.767458 | 0.026044 | No Change: Both D | - |
| P98168 | ZXDA_HUMAN Zinc finger X-linked protein ZXDA OS=Homo sapiens GN=ZXDA PE=1 SV=2 | 376 | G | 0.673896 | S | 0.742463 | -0.068567 | No Change: Both D | - |
| P98169 | ZXDB_HUMAN Zinc finger X-linked protein ZXDB OS=Homo sapiens GN=ZXDB PE=2 SV=2 | 736 | A | 0.873232 | T | 0.899883 | -0.026651 | No Change: Both D | - |
| P98169 | ZXDB_HUMAN Zinc finger X-linked protein ZXDB OS=Homo sapiens GN=ZXDB PE=2 SV=2 | 760 | N | 0.551377 | S | 0.612591 | -0.061214 | No Change: Both D | - |
| P98169 | ZXDB_HUMAN Zinc finger X-linked protein ZXDB OS=Homo sapiens GN=ZXDB PE=2 SV=2 | 764 | D | 0.508481 | N | 0.502379 | 0.006102 | No Change: Both D | - |
| P98169 | ZXDB_HUMAN Zinc finger X-linked protein ZXDB OS=Homo sapiens GN=ZXDB PE=2 SV=2 | 791 | T | 0.530584 | R | 0.520735 | 0.009849 | No Change: Both D | - |
| Q2QGD7 | ZXDC_HUMAN Zinc finger protein ZXDC OS=Homo sapiens GN=ZXDC PE=1 SV=2 | 562 | P | 0.660948 | L | 0.503364 | 0.157584 | No Change: Both D | - |
| Q15942 | ZYX_HUMAN Zyxin OS=Homo sapiens GN=ZYX PE=1 SV=1 | 223 | H | 0.995996 | L | 0.995001 | 9.95E-04 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 30 | V | 0.821196 | A | 0.885359 | -0.064163 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 1021 | I | 0.220999 | V | 0.263373 | -0.042374 | No Change: Both O | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 1437 | S | 0.843952 | A | 0.76711 | 0.076842 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 1972 | L | 0.707632 | P | 0.786483 | -0.078851 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2014 | I | 0.763188 | V | 0.812817 | -0.049629 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2051 | P | 0.981927 | S | 0.981963 | -3.60E-05 | No Change: Both D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2301 | Y | 0.467196 | H | 0.603677 | -0.136481 | O to D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2303 | L | 0.430367 | P | 0.608875 | -0.178508 | O to D | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2369 | E | 0.285449 | Q | 0.238385 | 0.047064 | No Change: Both O | - |
| O43149 | ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens GN=ZZEF1 PE=1 SV=6 | 2421 | A | 0.59064 | T | 0.608189 | -0.017549 | No Change: Both D | - |
| Q8IYH5 | ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens GN=ZZZ3 PE=1 SV=1 | 456 | P | 0.912026 | S | 0.916379 | -0.004353 | No Change: Both D | A colorectal cancer sample |
| A6NG73 | S72L3_HUMAN Putative RNA polymerase II subunit A C-terminal domain phosphatase SSU72-like protein 3 OS=Homo sapiens PE=3 SV=2 | 16 | I | 0.458119 | V | 0.533849 | -0.07573 | O to D | - |
| A6NGZ7 | U93BL_HUMAN Putative protein unc-93 homolog B1-like protein OS=Homo sapiens PE=5 SV=3 | 192 | G | 0.919956 | R | 0.935385 | -0.015429 | No Change: Both D | - |
| A6NLB4 | YJ008_HUMAN Putative ZP domain-containing protein LOC729800 OS=Homo sapiens PE=5 SV=3 | 263 | W | 0.194864 | R | 0.404585 | -0.209721 | No Change: Both O | - |
| A8MXQ7 | YH010_HUMAN Putative IQ motif and ankyrin repeat domain-containing protein LOC642574 OS=Homo sapiens PE=5 SV=2 | 509 | T | 0.207428 | R | 0.232644 | -0.025216 | No Change: Both O | - |
| O42043 | ENK7_HUMAN HERV-K_1q23.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=1 SV=2 | 97 | C | 0.429129 | Y | 0.409082 | 0.020047 | No Change: Both O | - |
| O42043 | ENK7_HUMAN HERV-K_1q23.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=1 SV=2 | 272 | V | 0.188431 | I | 0.15721 | 0.031221 | No Change: Both O | - |
| O42043 | ENK7_HUMAN HERV-K_1q23.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=1 SV=2 | 348 | V | 0.208881 | I | 0.200522 | 0.008359 | No Change: Both O | - |
| O42043 | ENK7_HUMAN HERV-K_1q23.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=1 SV=2 | 534 | V | 0.003486 | I | 0.00325 | 2.36E-04 | No Change: Both O | - |
| P0C867 | YB052_HUMAN Putative uncharacterized protein LOC100130201 OS=Homo sapiens PE=5 SV=1 | 98 | S | 0.110399 | L | 0.054508 | 0.055891 | No Change: Both O | - |
| Q0VG73 | YC023_HUMAN Putative uncharacterized protein LOC152225 OS=Homo sapiens PE=5 SV=1 | 19 | S | 0.592635 | R | 0.526843 | 0.065792 | No Change: Both D | - |
| Q0VG73 | YC023_HUMAN Putative uncharacterized protein LOC152225 OS=Homo sapiens PE=5 SV=1 | 63 | I | 0.317123 | M | 0.422973 | -0.10585 | No Change: Both O | - |
| Q6ZQR6 | YJ015_HUMAN Putative uncharacterized protein FLJ45983 OS=Homo sapiens PE=5 SV=1 | 7 | H | 0.897443 | R | 0.915213 | -0.01777 | No Change: Both D | - |
| Q6ZQR6 | YJ015_HUMAN Putative uncharacterized protein FLJ45983 OS=Homo sapiens PE=5 SV=1 | 57 | S | 0.769586 | R | 0.754536 | 0.01505 | No Change: Both D | - |
| Q6ZQY2 | YV012_HUMAN Leucine-rich repeat-containing protein LOC400891 OS=Homo sapiens PE=2 SV=2 | 3 | G | 0.984298 | R | 0.988116 | -0.003818 | No Change: Both D | - |
| Q6ZQY2 | YV012_HUMAN Leucine-rich repeat-containing protein LOC400891 OS=Homo sapiens PE=2 SV=2 | 77 | R | 0.338729 | C | 0.245279 | 0.09345 | No Change: Both O | - |
| Q6ZRM9 | YG024_HUMAN Putative uncharacterized protein FLJ46235 OS=Homo sapiens PE=1 SV=1 | 149 | A | 0.690945 | V | 0.653628 | 0.037317 | No Change: Both D | - |
| Q6ZRM9 | YG024_HUMAN Putative uncharacterized protein FLJ46235 OS=Homo sapiens PE=1 SV=1 | 158 | V | 0.522458 | M | 0.601753 | -0.079295 | No Change: Both D | - |
| Q6ZRM9 | YG024_HUMAN Putative uncharacterized protein FLJ46235 OS=Homo sapiens PE=1 SV=1 | 205 | F | 0.226154 | L | 0.335121 | -0.108967 | No Change: Both O | - |
| Q6ZRN7 | YP029_HUMAN Putative uncharacterized protein FLJ46214 OS=Homo sapiens PE=2 SV=1 | 108 | A | 0.960794 | G | 0.964836 | -0.004042 | No Change: Both D | - |
| Q6ZRP5 | YD019_HUMAN Putative uncharacterized protein FLJ46204 OS=Homo sapiens PE=5 SV=2 | 2 | R | 0.62537 | H | 0.609162 | 0.016208 | No Change: Both D | - |
| Q6ZT83 | YR005_HUMAN Uncharacterized protein FLJ44881 OS=Homo sapiens PE=1 SV=1 | 88 | R | 0.510835 | W | 0.293048 | 0.217787 | D to O | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 100 | Q | 0.304768 | R | 0.275725 | 0.029043 | No Change: Both O | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 183 | Q | 0.570446 | H | 0.549743 | 0.020703 | No Change: Both D | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 275 | V | 0.097522 | A | 0.142075 | -0.044553 | No Change: Both O | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 330 | E | 0.590636 | Q | 0.564502 | 0.026134 | No Change: Both D | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 345 | V | 0.179076 | I | 0.144912 | 0.034164 | No Change: Both O | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 368 | T | 0.274565 | A | 0.269635 | 0.00493 | No Change: Both O | - |
| Q6ZTK2 | YP015_HUMAN Putative uncharacterized protein LOC400499 OS=Homo sapiens PE=2 SV=1 | 419 | W | 0.225738 | R | 0.43081 | -0.205072 | No Change: Both O | - |
| Q6ZU11 | YD002_HUMAN Uncharacterized protein FLJ44066 OS=Homo sapiens PE=1 SV=1 | 232 | I | 0.249561 | T | 0.361815 | -0.112254 | No Change: Both O | - |
| Q6ZU11 | YD002_HUMAN Uncharacterized protein FLJ44066 OS=Homo sapiens PE=1 SV=1 | 390 | S | 0.475839 | L | 0.312076 | 0.163763 | No Change: Both O | - |
| Q6ZU11 | YD002_HUMAN Uncharacterized protein FLJ44066 OS=Homo sapiens PE=1 SV=1 | 518 | S | 0.275837 | C | 0.098686 | 0.177151 | No Change: Both O | - |
| Q6ZVL8 | YP033_HUMAN Putative uncharacterized protein FLJ42384 OS=Homo sapiens PE=2 SV=1 | 30 | T | 0.553332 | A | 0.516207 | 0.037125 | No Change: Both D | - |
| Q6ZVL8 | YP033_HUMAN Putative uncharacterized protein FLJ42384 OS=Homo sapiens PE=2 SV=1 | 75 | G | 0.503447 | R | 0.534605 | -0.031158 | No Change: Both D | - |
| Q6ZVL8 | YP033_HUMAN Putative uncharacterized protein FLJ42384 OS=Homo sapiens PE=2 SV=1 | 82 | K | 0.682392 | R | 0.697695 | -0.015303 | No Change: Both D | - |
| Q6ZVL8 | YP033_HUMAN Putative uncharacterized protein FLJ42384 OS=Homo sapiens PE=2 SV=1 | 105 | P | 0.712691 | S | 0.688994 | 0.023697 | No Change: Both D | - |
| Q6ZVL8 | YP033_HUMAN Putative uncharacterized protein FLJ42384 OS=Homo sapiens PE=2 SV=1 | 136 | C | 0.510799 | S | 0.637235 | -0.126436 | No Change: Both D | - |
| Q8IYB0 | YK038_HUMAN Putative uncharacterized protein MGC39545 OS=Homo sapiens PE=5 SV=2 | 129 | D | 0.239623 | Y | 0.131917 | 0.107706 | No Change: Both O | A colorectal cancer sample |
| Q8N1W0 | YF005_HUMAN Transmembrane protein FLJ37396 OS=Homo sapiens PE=2 SV=2 | 363 | D | 0.674965 | G | 0.657487 | 0.017478 | No Change: Both D | - |
| Q8N1W0 | YF005_HUMAN Transmembrane protein FLJ37396 OS=Homo sapiens PE=2 SV=2 | 419 | P | 0.173907 | S | 0.195109 | -0.021202 | No Change: Both O | - |
| Q8N1W0 | YF005_HUMAN Transmembrane protein FLJ37396 OS=Homo sapiens PE=2 SV=2 | 458 | V | 0.153792 | A | 0.210676 | -0.056884 | No Change: Both O | - |
| Q8N2B8 | YB035_HUMAN Putative uncharacterized protein FLJ33534 OS=Homo sapiens PE=2 SV=1 | 127 | R | 0.473783 | Q | 0.493122 | -0.019339 | No Change: Both O | A colorectal cancer sample |
| Q8N402 | YV020_HUMAN Putative uncharacterized protein LOC388882 OS=Homo sapiens PE=2 SV=1 | 97 | P | 0.217273 | L | 0.119108 | 0.098165 | No Change: Both O | - |
| Q8N402 | YV020_HUMAN Putative uncharacterized protein LOC388882 OS=Homo sapiens PE=2 SV=1 | 114 | T | 0.302222 | S | 0.392218 | -0.089996 | No Change: Both O | - |
| Q8N402 | YV020_HUMAN Putative uncharacterized protein LOC388882 OS=Homo sapiens PE=2 SV=1 | 131 | T | 0.668806 | P | 0.704458 | -0.035652 | No Change: Both D | - |
| Q8N7K9 | YS059_HUMAN Uncharacterized protein FLJ40925 OS=Homo sapiens PE=1 SV=1 | 20 | I | 0.985336 | T | 0.993295 | -0.007959 | No Change: Both D | - |
| Q8N7K9 | YS059_HUMAN Uncharacterized protein FLJ40925 OS=Homo sapiens PE=1 SV=1 | 201 | E | 0.981904 | G | 0.981227 | 6.77E-04 | No Change: Both D | - |
| Q8N7K9 | YS059_HUMAN Uncharacterized protein FLJ40925 OS=Homo sapiens PE=1 SV=1 | 214 | S | 0.985917 | P | 0.983943 | 0.001974 | No Change: Both D | - |
| Q8N7K9 | YS059_HUMAN Uncharacterized protein FLJ40925 OS=Homo sapiens PE=1 SV=1 | 442 | I | 0.932761 | L | 0.940604 | -0.007843 | No Change: Both D | - |
| Q96FF7 | YS003_HUMAN Uncharacterized protein LOC113230 OS=Homo sapiens PE=2 SV=3 | 340 | V | 0.630615 | A | 0.677559 | -0.046944 | No Change: Both D | - |
| Q96M66 | YP010_HUMAN Putative uncharacterized protein FLJ32790 OS=Homo sapiens PE=2 SV=2 | 37 | R | 0.962891 | H | 0.940527 | 0.022364 | No Change: Both D | - |
| Q96M66 | YP010_HUMAN Putative uncharacterized protein FLJ32790 OS=Homo sapiens PE=2 SV=2 | 171 | R | 0.918795 | S | 0.928047 | -0.009252 | No Change: Both D | - |
| Q9N2K0 | ENH1_HUMAN HERV-H_2q24.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=2 SV=1 | 81 | V | 0.269076 | L | 0.266609 | 0.002467 | No Change: Both O | - |
| Q9N2K0 | ENH1_HUMAN HERV-H_2q24.3 provirus ancestral Env polyprotein OS=Homo sapiens PE=2 SV=1 | 150 | F | 0.385601 | L | 0.454451 | -0.06885 | No Change: Both O | - |
| | | | | | | | | |
|